id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
148779521|NCT01472939|536667932|FG000|Overall Study|Adverse Event|3|||
148779522|NCT01472939|536667933|FG001|Overall Study|Adverse Event|7|||
148779523|NCT01472939|536667934|FG002|Overall Study|Adverse Event|7|||
148779524|NCT01472939|536667935|FG003|Overall Study|Adverse Event|14|||
148779525|NCT01472939|536667932|FG000|Overall Study|Lack of Efficacy|1|||
148779526|NCT01472939|536667933|FG001|Overall Study|Lack of Efficacy|0|||
148779527|NCT01472939|536667934|FG002|Overall Study|Lack of Efficacy|0|||
148779528|NCT01472939|536667935|FG003|Overall Study|Lack of Efficacy|1|||
148779529|NCT01472939|536667932|FG000|Overall Study|Lost to Follow-up|3|||
148779530|NCT01472939|536667933|FG001|Overall Study|Lost to Follow-up|0|||
148779531|NCT01472939|536667934|FG002|Overall Study|Lost to Follow-up|2|||
148779532|NCT01472939|536667935|FG003|Overall Study|Lost to Follow-up|0|||
148779533|NCT01472939|536667932|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
148779534|NCT01472939|536667933|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
148779535|NCT01472939|536667934|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
148779536|NCT01472939|536667935|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
148779537|NCT01472939|536667932|FG000|Overall Study|Prohibited Medication|0|||
148779538|NCT01472939|536667933|FG001|Overall Study|Prohibited Medication|1|||
148779539|NCT01472939|536667934|FG002|Overall Study|Prohibited Medication|0|||
148779540|NCT01472939|536667935|FG003|Overall Study|Prohibited Medication|0|||
148779541|NCT01472939|536667932|FG000|Overall Study|Withdrawal By PI|1|||
148779542|NCT01472939|536667933|FG001|Overall Study|Withdrawal By PI|0|||
148779543|NCT01472939|536667934|FG002|Overall Study|Withdrawal By PI|0|||
148779544|NCT01472939|536667935|FG003|Overall Study|Withdrawal By PI|0|||
148779545|NCT01472939|536667932|FG000|Overall Study|Protocol Violation|3|||
148779546|NCT01472939|536667933|FG001|Overall Study|Protocol Violation|3|||
148779547|NCT01472939|536667934|FG002|Overall Study|Protocol Violation|0|||
148779548|NCT01472939|536667935|FG003|Overall Study|Protocol Violation|1|||
148779549|NCT01472939|536667932|FG000|Overall Study|Withdrawal by Subject|9|||
148779550|NCT01472939|536667933|FG001|Overall Study|Withdrawal by Subject|3|||
148779551|NCT01472939|536667934|FG002|Overall Study|Withdrawal by Subject|1|||
148779552|NCT01472939|536667935|FG003|Overall Study|Withdrawal by Subject|4|||
148779553|NCT02539134|536667936|FG000|Overall Study|Lost to Follow-up|1|||
148779554|NCT02539134|536667937|FG001|Overall Study|Lost to Follow-up|0|||
148779555|NCT02539134|536667938|FG002|Overall Study|Lost to Follow-up|0|||
149120421|NCT00432666|537919917|FG000|Main Period|Adverse Event|1|||
149120422|NCT00432666|537919918|FG001|Main Period|Adverse Event|1|||
149120423|NCT00432666|537919917|FG000|Main Period|Consent Withdrawn|1|||
149120424|NCT00432666|537919918|FG001|Main Period|Consent Withdrawn|0|||
149120425|NCT00432666|537919917|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
148779556|NCT02539134|536667939|FG003|Overall Study|Lost to Follow-up|0|||
148779557|NCT02539134|536667940|FG004|Overall Study|Lost to Follow-up|0|||
148779558|NCT02539134|536667941|FG005|Overall Study|Lost to Follow-up|0|||
148779559|NCT00616603|536667944|FG000|Overall Study|Physician Decision|2|||
148779560|NCT00616603|536667945|FG001|Overall Study|Physician Decision|0|||
148779561|NCT00616603|536667946|FG002|Overall Study|Physician Decision|2|||
148779562|NCT00908076|536667955|FG000|Overall Study|Lack of Efficacy|1|||
148779563|NCT00908076|536667956|FG001|Overall Study|Lack of Efficacy|1|||
148779564|NCT02609724|536667957|FG000|Overall Study|Death|2|||
148779565|NCT02609724|536667958|FG001|Overall Study|Death|0|||
148779566|NCT02609724|536667959|FG002|Overall Study|Death|1|||
148779567|NCT02609724|536667957|FG000|Overall Study|Withdrawal by Subject|1|||
148779568|NCT02609724|536667958|FG001|Overall Study|Withdrawal by Subject|2|||
148779569|NCT02609724|536667959|FG002|Overall Study|Withdrawal by Subject|3|||
148779570|NCT02609724|536667957|FG000|Overall Study|Illness|2|||
148779571|NCT02609724|536667958|FG001|Overall Study|Illness|1|||
148779572|NCT02609724|536667959|FG002|Overall Study|Illness|0|||
148779573|NCT03077659|536667960|FG000|Overall Study|Withdrawal by Subject|0|||
148779574|NCT03077659|536667961|FG001|Overall Study|Withdrawal by Subject|0|||
148779575|NCT03077659|536667962|FG002|Overall Study|Withdrawal by Subject|1|||
148779576|NCT04068688|536667969|FG000|Overall Study|Lost to Follow-up|1|||
148779577|NCT04068688|536667970|FG001|Overall Study|Lost to Follow-up|1|||
148779578|NCT04068688|536667971|FG002|Overall Study|Lost to Follow-up|0|||
148779579|NCT04068688|536667972|FG003|Overall Study|Lost to Follow-up|0|||
148779580|NCT04068688|536667973|FG004|Overall Study|Lost to Follow-up|5|||
148779581|NCT04068688|536667974|FG005|Overall Study|Lost to Follow-up|5|||
148779582|NCT04068688|536667975|FG006|Overall Study|Lost to Follow-up|0|||
148779583|NCT04068688|536667976|FG007|Overall Study|Lost to Follow-up|0|||
148779584|NCT04068688|536667977|FG008|Overall Study|Lost to Follow-up|1|||
148779585|NCT04068688|536667978|FG009|Overall Study|Lost to Follow-up|0|||
149120426|NCT00432666|537919918|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
148779586|NCT04068688|536667969|FG000|Overall Study|Withdrawal by Subject|1|||
148779587|NCT04068688|536667970|FG001|Overall Study|Withdrawal by Subject|1|||
148779588|NCT04068688|536667971|FG002|Overall Study|Withdrawal by Subject|0|||
148779589|NCT04068688|536667972|FG003|Overall Study|Withdrawal by Subject|0|||
148779590|NCT04068688|536667973|FG004|Overall Study|Withdrawal by Subject|0|||
148779591|NCT04068688|536667974|FG005|Overall Study|Withdrawal by Subject|0|||
149006745|NCT03145766|537503595|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
148779592|NCT04068688|536667975|FG006|Overall Study|Withdrawal by Subject|0|||
148779593|NCT04068688|536667976|FG007|Overall Study|Withdrawal by Subject|0|||
148779594|NCT04068688|536667977|FG008|Overall Study|Withdrawal by Subject|0|||
148779595|NCT04068688|536667978|FG009|Overall Study|Withdrawal by Subject|0|||
148779596|NCT04068688|536667969|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
148779597|NCT04068688|536667970|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
148779598|NCT04068688|536667971|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779599|NCT04068688|536667972|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779600|NCT04068688|536667973|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779601|NCT04068688|536667974|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779602|NCT04068688|536667975|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779603|NCT04068688|536667976|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779604|NCT04068688|536667977|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779605|NCT04068688|536667978|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
148779606|NCT04679051|536667979|FG000|Overall Study|felt tired after restricted time in bed|3|||
148779607|NCT04679051|536667980|FG001|Overall Study|felt tired after restricted time in bed|0|||
148779608|NCT04679051|536667979|FG000|Overall Study|discomfort with blood pressure cuff|2|||
148779609|NCT04679051|536667980|FG001|Overall Study|discomfort with blood pressure cuff|0|||
148779610|NCT04679051|536667979|FG000|Overall Study|scheduling conflict|1|||
148779611|NCT04679051|536667980|FG001|Overall Study|scheduling conflict|1|||
148779612|NCT04679051|536667979|FG000|Overall Study|Protocol Violation|0|||
148779613|NCT04679051|536667980|FG001|Overall Study|Protocol Violation|4|||
148779614|NCT02554318|536667981|FG000|Overall Study|Withdrawal by Subject|10|||
148779615|NCT02554318|536667982|FG001|Overall Study|Withdrawal by Subject|8|||
148779616|NCT00006305|536667983|FG000|Overall Study|Withdrawal by Subject|17|||
148779617|NCT00006305|536667984|FG001|Overall Study|Withdrawal by Subject|10|||
148779618|NCT00006305|536667985|FG002|Overall Study|Withdrawal by Subject|15|||
148779619|NCT00006305|536667986|FG003|Overall Study|Withdrawal by Subject|14|||
148779620|NCT00662558|536667987|FG000|Overall Study|Adverse Event|21|||
148779621|NCT00662558|536667988|FG001|Overall Study|Adverse Event|59|||
148779622|NCT00662558|536667987|FG000|Overall Study|Lack of Efficacy|4|||
148779623|NCT00662558|536667988|FG001|Overall Study|Lack of Efficacy|7|||
149006746|NCT03145766|537503596|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
149006747|NCT03145766|537503597|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
149006748|NCT03145766|537503598|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
149006749|NCT03145766|537503599|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
149006750|NCT03145766|537503595|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
149006751|NCT03145766|537503596|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
149006752|NCT03145766|537503597|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
149006753|NCT03145766|537503598|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
148779624|NCT00662558|536667987|FG000|Overall Study|Lost to Follow-up|13|||
149006754|NCT03145766|537503599|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
149006755|NCT03145766|537503595|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
149006756|NCT03145766|537503596|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
149006757|NCT03145766|537503597|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
149006758|NCT03145766|537503598|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
149006759|NCT03145766|537503599|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
149006760|NCT03145766|537503595|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
149006761|NCT03145766|537503596|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
149006762|NCT03145766|537503597|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
149006763|NCT03145766|537503598|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
149006764|NCT03145766|537503599|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
149234353|NCT00437294|538328484|FG000|Overall Study|Adverse Event|5|||
148779625|NCT00662558|536667988|FG001|Overall Study|Lost to Follow-up|10|||
148779626|NCT00662558|536667987|FG000|Overall Study|Other|9|||
148779627|NCT00662558|536667988|FG001|Overall Study|Other|14|||
148779628|NCT00662558|536667987|FG000|Overall Study|Withdrawal by Subject|7|||
148779629|NCT00662558|536667988|FG001|Overall Study|Withdrawal by Subject|12|||
148779630|NCT00662558|536667987|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
148779631|NCT00662558|536667988|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
148779632|NCT00396877|536667991|FG000|Overall Study|Lost to Follow-up|2|||
148779633|NCT00396877|536667992|FG001|Overall Study|Lost to Follow-up|1|||
148779634|NCT00396877|536667991|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
148779635|NCT00396877|536667992|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
148779636|NCT02470403|536667993|FG000|Overall Study|Adverse Event|1|||
148779637|NCT02470403|536667994|FG001|Overall Study|Adverse Event|0|||
148779638|NCT02470403|536667995|FG002|Overall Study|Adverse Event|0|||
148779639|NCT02470403|536667996|FG003|Overall Study|Adverse Event|0|||
148779640|NCT02470403|536667997|FG004|Overall Study|Adverse Event|0|||
148779641|NCT02470403|536667993|FG000|Overall Study|Lost to Follow-up|0|||
148779642|NCT02470403|536667994|FG001|Overall Study|Lost to Follow-up|1|||
148779643|NCT02470403|536667995|FG002|Overall Study|Lost to Follow-up|0|||
148779644|NCT02470403|536667996|FG003|Overall Study|Lost to Follow-up|0|||
148779645|NCT02470403|536667997|FG004|Overall Study|Lost to Follow-up|0|||
148779646|NCT02470403|536667993|FG000|Overall Study|Subject/guardian decision|1|||
148779647|NCT02470403|536667994|FG001|Overall Study|Subject/guardian decision|0|||
148779648|NCT02470403|536667995|FG002|Overall Study|Subject/guardian decision|0|||
149120427|NCT00432666|537919917|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
149120428|NCT00432666|537919918|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
149120429|NCT00432666|537919917|FG000|Open-Label Extension Period|Adverse Event|5|||
149120430|NCT00432666|537919918|FG001|Open-Label Extension Period|Adverse Event|0|||
149120431|NCT00432666|537919917|FG000|Open-Label Extension Period|Consent withdrawn|10|||
149120432|NCT00432666|537919918|FG001|Open-Label Extension Period|Consent withdrawn|0|||
149120433|NCT00432666|537919917|FG000|Open-Label Extension Period|Physician Decision|3|||
149120434|NCT00432666|537919918|FG001|Open-Label Extension Period|Physician Decision|0|||
149120435|NCT00978627|537919919|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
149120436|NCT00978627|537919920|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
149120437|NCT00978627|537919919|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
149120438|NCT00978627|537919920|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
149120439|NCT00978627|537919919|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
149120440|NCT00978627|537919920|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
149120441|NCT00978627|537919919|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
149120442|NCT00978627|537919920|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
149120443|NCT00978627|537919919|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
149120444|NCT00978627|537919920|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
149120445|NCT00978627|537919919|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
149120446|NCT00978627|537919920|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
149120447|NCT00978627|537919919|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
149120448|NCT00978627|537919920|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
149120449|NCT00978627|537919919|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
149120450|NCT00978627|537919920|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
149120451|NCT00978627|537919919|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
149120452|NCT00978627|537919920|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
149120453|NCT00565851|537919921|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
149120454|NCT00565851|537919922|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
149120455|NCT00565851|537919923|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
149120456|NCT00565851|537919924|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
149120457|NCT00565851|537919925|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
149120458|NCT00565851|537919926|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
149120459|NCT00565851|537919927|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
149120460|NCT00565851|537919928|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
149120461|NCT00565851|537919921|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
149120462|NCT00565851|537919922|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
149120463|NCT00565851|537919923|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
149120464|NCT00565851|537919924|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
149120465|NCT00565851|537919925|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
149120466|NCT00565851|537919926|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
149120467|NCT00565851|537919927|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
149120468|NCT00565851|537919928|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
149120469|NCT04058366|537919929|FG000|Overall Study|Adverse Event|14|||
149120470|NCT04058366|537919929|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
149120471|NCT04058366|537919929|FG000|Overall Study|Commercial drug is available for participants|6|||
149120472|NCT04058366|537919929|FG000|Overall Study|Death|1|||
149120473|NCT04058366|537919929|FG000|Overall Study|Other non-compliance|2|||
149120474|NCT04058366|537919929|FG000|Overall Study|Other|6|||
149120475|NCT02594163|537919930|FG000|Treatment Period|Progressive disease|2|||
149120476|NCT02594163|537919931|FG001|Treatment Period|Progressive disease|3|||
149120477|NCT02594163|537919930|FG000|Treatment Period|Adverse Event|1|||
149120478|NCT02594163|537919931|FG001|Treatment Period|Adverse Event|5|||
149120479|NCT02594163|537919930|FG000|Treatment Period|Physician Decision|1|||
149120480|NCT02594163|537919931|FG001|Treatment Period|Physician Decision|3|||
149120481|NCT02594163|537919930|FG000|Treatment Period|Study termination by sponsor|2|||
149120482|NCT02594163|537919931|FG001|Treatment Period|Study termination by sponsor|1|||
149120483|NCT02594163|537919930|FG000|Treatment Period|Other, Non-AE|1|||
149120484|NCT02594163|537919931|FG001|Treatment Period|Other, Non-AE|0|||
149120485|NCT02594163|537919930|FG000|Follow-up Period|Withdrawal by Subject|0|||
149120486|NCT02594163|537919931|FG001|Follow-up Period|Withdrawal by Subject|1|||
148779649|NCT02470403|536667996|FG003|Overall Study|Subject/guardian decision|4|||
148779650|NCT02470403|536667997|FG004|Overall Study|Subject/guardian decision|0|||
148779651|NCT02631070|536668005|FG000|Overall Study|Withdrawal by Subject|35|||
149120487|NCT02594163|537919930|FG000|Follow-up Period|Study Termination by Sponsor|6|||
149120488|NCT02594163|537919931|FG001|Follow-up Period|Study Termination by Sponsor|4|||
149120489|NCT02594163|537919930|FG000|Follow-up Period|Lost to Follow-up|1|||
149006765|NCT03145766|537503595|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
149006766|NCT03145766|537503596|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
149006767|NCT03145766|537503597|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
149006768|NCT03145766|537503598|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
149006769|NCT03145766|537503599|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
149006770|NCT03145766|537503595|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
149006771|NCT03145766|537503596|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
149006772|NCT03145766|537503597|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
149006773|NCT03145766|537503598|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
149006774|NCT03145766|537503599|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
149006775|NCT03145766|537503595|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
149006776|NCT03145766|537503596|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
149006777|NCT03145766|537503597|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
149006778|NCT03145766|537503598|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
149120490|NCT02594163|537919931|FG001|Follow-up Period|Lost to Follow-up|0|||
149120491|NCT02594163|537919930|FG000|Follow-up Period|Death|2|||
149120492|NCT02594163|537919931|FG001|Follow-up Period|Death|5|||
149120493|NCT02594163|537919930|FG000|Follow-up Period|Adverse Event|0|||
149120494|NCT02594163|537919931|FG001|Follow-up Period|Adverse Event|1|||
149120495|NCT02594163|537919930|FG000|Follow-up Period|Progressive Disease|2|||
149120496|NCT02594163|537919931|FG001|Follow-up Period|Progressive Disease|0|||
149120497|NCT02594163|537919930|FG000|Follow-up Period|Physician Decision|0|||
149120498|NCT02594163|537919931|FG001|Follow-up Period|Physician Decision|1|||
149120499|NCT00603304|537919934|FG000|Overall Study|Lost to Follow-up|5|||
149120500|NCT00603304|537919935|FG001|Overall Study|Lost to Follow-up|7|||
149120501|NCT00603304|537919934|FG000|Overall Study|Withdrawal by Subject|8|||
149120502|NCT00603304|537919935|FG001|Overall Study|Withdrawal by Subject|5|||
149120503|NCT00603304|537919934|FG000|Overall Study|Protocol Violation|1|||
149120504|NCT00603304|537919935|FG001|Overall Study|Protocol Violation|0|||
149120505|NCT00603304|537919934|FG000|Overall Study|Adverse Event|4|||
149120506|NCT00603304|537919935|FG001|Overall Study|Adverse Event|2|||
149120507|NCT00603304|537919934|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
149120508|NCT00603304|537919935|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
149120509|NCT00603304|537919934|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
149120510|NCT00603304|537919935|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
149120511|NCT00603304|537919934|FG000|Overall Study|Exclusionary Medication|2|||
149120512|NCT00603304|537919935|FG001|Overall Study|Exclusionary Medication|3|||
149120513|NCT00603304|537919934|FG000|Overall Study|Non-Compliant|0|||
149120514|NCT00603304|537919935|FG001|Overall Study|Non-Compliant|1|||
149120515|NCT00603304|537919934|FG000|Overall Study|Moved Away|0|||
148779652|NCT02631070|536668006|FG001|Overall Study|Withdrawal by Subject|13|||
148779653|NCT02631070|536668005|FG000|Overall Study|Death|45|||
148779654|NCT02631070|536668006|FG001|Overall Study|Death|24|||
148779655|NCT02631070|536668005|FG000|Overall Study|Lost to Follow-up|5|||
148779656|NCT02631070|536668006|FG001|Overall Study|Lost to Follow-up|1|||
148779657|NCT02631070|536668005|FG000|Overall Study|Transition to rollover protocol|52|||
148779658|NCT02631070|536668006|FG001|Overall Study|Transition to rollover protocol|21|||
148779659|NCT02631070|536668005|FG000|Overall Study|Other reasons|12|||
148779660|NCT02631070|536668006|FG001|Overall Study|Other reasons|5|||
148779661|NCT00085098|536668010|FG000|Overall Study|Withdrawal by Subject|0|||
148779662|NCT00085098|536668011|FG001|Overall Study|Withdrawal by Subject|1|||
148779663|NCT00085098|536668010|FG000|Overall Study|Ineligible|1|||
148779664|NCT00085098|536668011|FG001|Overall Study|Ineligible|1|||
148779665|NCT01886781|536668016|FG000|Overall Study|Protocol Violation|5|||
148779666|NCT01886781|536668017|FG001|Overall Study|Protocol Violation|0|||
148779667|NCT01886781|536668016|FG000|Overall Study|Adverse Event|1|||
148779668|NCT01886781|536668017|FG001|Overall Study|Adverse Event|0|||
148893180|NCT00948064|537088625|FG000|Phase I|No treatment received|1|||
148893181|NCT00948064|537088626|FG001|Phase I|No treatment received|0|||
148779669|NCT01886781|536668016|FG000|Overall Study|Lost to Follow-up|5|||
148779670|NCT01886781|536668017|FG001|Overall Study|Lost to Follow-up|0|||
148779671|NCT01886781|536668016|FG000|Overall Study|Withdrawal by Subject|2|||
148893182|NCT00948064|537088627|FG002|Phase I|No treatment received|0|||
148893183|NCT00948064|537088625|FG000|Phase II|Physician Decision|0|||
148893184|NCT00948064|537088626|FG001|Phase II|Physician Decision|0|||
149120516|NCT00603304|537919935|FG001|Overall Study|Moved Away|2|||
148893185|NCT00948064|537088627|FG002|Phase II|Physician Decision|1|||
149120517|NCT00603304|537919934|FG000|Overall Study|Other|2|||
148893186|NCT00948064|537088625|FG000|Phase II|Withdrawal by Subject|0|||
148893187|NCT00948064|537088626|FG001|Phase II|Withdrawal by Subject|1|||
148893188|NCT00948064|537088627|FG002|Phase II|Withdrawal by Subject|0|||
149120518|NCT00603304|537919935|FG001|Overall Study|Other|0|||
149120519|NCT00603304|537919934|FG000|Overall Study|Patient Decision|2|||
149120520|NCT00603304|537919935|FG001|Overall Study|Patient Decision|0|||
149120521|NCT01076192|537919936|FG000|Overall Study|Other|197|||
149120522|NCT01034176|537919937|FG000|Overall Study|Physician Decision|2|||
149120523|NCT01034176|537919938|FG001|Overall Study|Physician Decision|0|||
149120524|NCT01034176|537919937|FG000|Overall Study|Withdrawal by Subject|0|||
149120525|NCT01034176|537919938|FG001|Overall Study|Withdrawal by Subject|1|||
149120526|NCT01034176|537919937|FG000|Overall Study|Lost to Follow-up|0|||
149120527|NCT01034176|537919938|FG001|Overall Study|Lost to Follow-up|1|||
149120528|NCT05087979|537919941|FG000|Overall Study|Converted to general anesthesia|1|||
149120529|NCT05087979|537919942|FG001|Overall Study|Converted to general anesthesia|0|||
149120530|NCT00705679|537919943|FG000|Overall Study|Adverse Event|1|||
149120531|NCT00705679|537919944|FG001|Overall Study|Adverse Event|1|||
149120532|NCT00705679|537919945|FG002|Overall Study|Adverse Event|0|||
149120533|NCT00705679|537919946|FG003|Overall Study|Adverse Event|0|||
149120534|NCT00705679|537919947|FG004|Overall Study|Adverse Event|0|||
149120535|NCT00705679|537919943|FG000|Overall Study|Death|0|||
149120536|NCT00705679|537919944|FG001|Overall Study|Death|0|||
149120537|NCT00705679|537919945|FG002|Overall Study|Death|3|||
149120538|NCT00705679|537919946|FG003|Overall Study|Death|2|||
149120539|NCT00705679|537919947|FG004|Overall Study|Death|1|||
149120540|NCT00705679|537919943|FG000|Overall Study|Lost to Follow-up|32|||
149120541|NCT00705679|537919944|FG001|Overall Study|Lost to Follow-up|60|||
149120542|NCT00705679|537919945|FG002|Overall Study|Lost to Follow-up|44|||
149120543|NCT00705679|537919946|FG003|Overall Study|Lost to Follow-up|30|||
149120544|NCT00705679|537919947|FG004|Overall Study|Lost to Follow-up|35|||
149120545|NCT00705679|537919943|FG000|Overall Study|Physician Decision|0|||
149120546|NCT00705679|537919944|FG001|Overall Study|Physician Decision|1|||
149120547|NCT00705679|537919945|FG002|Overall Study|Physician Decision|0|||
149120548|NCT00705679|537919946|FG003|Overall Study|Physician Decision|1|||
149120549|NCT00705679|537919947|FG004|Overall Study|Physician Decision|0|||
149120550|NCT00705679|537919943|FG000|Overall Study|Withdrawal by Subject|32|||
149120551|NCT00705679|537919944|FG001|Overall Study|Withdrawal by Subject|77|||
149120552|NCT00705679|537919945|FG002|Overall Study|Withdrawal by Subject|68|||
149120553|NCT00705679|537919946|FG003|Overall Study|Withdrawal by Subject|47|||
149120554|NCT00705679|537919947|FG004|Overall Study|Withdrawal by Subject|33|||
149120555|NCT03730480|537919948|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
149120556|NCT00621777|537919956|FG000|Open Phase|Adverse Event|20|||
149120557|NCT00621777|537919957|FG001|Open Phase|Adverse Event|0|||
149120558|NCT00621777|537919956|FG000|Open Phase|Did not abstain during open phase|56|||
149120559|NCT00621777|537919957|FG001|Open Phase|Did not abstain during open phase|0|||
149120560|NCT00621777|537919956|FG000|Open Phase|Withdrawal by Subject|17|||
149120561|NCT00621777|537919957|FG001|Open Phase|Withdrawal by Subject|0|||
149120562|NCT00621777|537919956|FG000|Open Phase|administrative|13|||
149120563|NCT00621777|537919957|FG001|Open Phase|administrative|0|||
149120564|NCT00621777|537919956|FG000|Open Phase|Lost to Follow-up|10|||
149120565|NCT00621777|537919957|FG001|Open Phase|Lost to Follow-up|0|||
149120566|NCT00621777|537919956|FG000|Randomized Phase|Adverse Event|3|||
149120567|NCT00621777|537919957|FG001|Randomized Phase|Adverse Event|3|||
148893189|NCT02426580|537088631|FG000|Overall Study|Death|2|||
148779672|NCT01886781|536668017|FG001|Overall Study|Withdrawal by Subject|1|||
148779673|NCT01886781|536668016|FG000|Overall Study|Worsening of symptoms|1|||
148779674|NCT01886781|536668017|FG001|Overall Study|Worsening of symptoms|1|||
148779675|NCT00980018|536668018|FG000|Overall Study|Adverse Event|8|||
148779676|NCT00980018|536668018|FG000|Overall Study|Patient withdrew consent|3|||
148779677|NCT00980018|536668018|FG000|Overall Study|Lost to Follow-up|1|||
148779678|NCT00934856|536668020|FG000|Feasibility Part|Progressive disease|4|||
148779679|NCT00934856|536668021|FG001|Feasibility Part|Progressive disease|4|||
148779680|NCT00934856|536668022|FG002|Feasibility Part|Progressive disease|2|||
148779681|NCT00934856|536668023|FG003|Feasibility Part|Progressive disease|3|||
148779682|NCT00934856|536668024|FG004|Feasibility Part|Progressive disease|0|||
148779683|NCT00934856|536668025|FG005|Feasibility Part|Progressive disease|0|||
148779684|NCT00934856|536668020|FG000|Feasibility Part|Physician Decision|0|||
148779685|NCT00934856|536668021|FG001|Feasibility Part|Physician Decision|0|||
148779686|NCT00934856|536668022|FG002|Feasibility Part|Physician Decision|1|||
149120568|NCT00621777|537919956|FG000|Randomized Phase|Lost to Follow-up|3|||
149120569|NCT00621777|537919957|FG001|Randomized Phase|Lost to Follow-up|3|||
149120570|NCT00621777|537919956|FG000|Randomized Phase|Withdrawal by Subject|1|||
149120571|NCT00621777|537919957|FG001|Randomized Phase|Withdrawal by Subject|9|||
149120572|NCT00621777|537919956|FG000|Randomized Phase|administrative|0|||
149120573|NCT00621777|537919957|FG001|Randomized Phase|administrative|3|||
149120574|NCT00621777|537919956|FG000|Randomized Phase|Death|0|||
149120575|NCT00621777|537919957|FG001|Randomized Phase|Death|1|||
149120576|NCT02663518|537919962|FG000|Part 1: Phase 1a Escalation|Death|0|||
148779687|NCT00934856|536668023|FG003|Feasibility Part|Physician Decision|0|||
148779688|NCT00934856|536668024|FG004|Feasibility Part|Physician Decision|0|||
148893190|NCT02426580|537088632|FG001|Overall Study|Death|2|||
149120577|NCT02663518|537919963|FG001|Part 1: Phase 1a Escalation|Death|0|||
149120578|NCT02663518|537919964|FG002|Part 1: Phase 1a Escalation|Death|1|||
148779689|NCT00934856|536668025|FG005|Feasibility Part|Physician Decision|0|||
149120579|NCT02663518|537919965|FG003|Part 1: Phase 1a Escalation|Death|0|||
149120580|NCT02663518|537919966|FG004|Part 1: Phase 1a Escalation|Death|0|||
149120581|NCT02663518|537919967|FG005|Part 1: Phase 1a Escalation|Death|0|||
149120582|NCT02663518|537919968|FG006|Part 1: Phase 1a Escalation|Death|0|||
149120583|NCT02663518|537919969|FG007|Part 1: Phase 1a Escalation|Death|0|||
149120584|NCT02663518|537919970|FG008|Part 1: Phase 1a Escalation|Death|0|||
149120585|NCT02663518|537919971|FG009|Part 1: Phase 1a Escalation|Death|0|||
149120586|NCT02663518|537919972|FG010|Part 1: Phase 1a Escalation|Death|0|||
149120587|NCT02663518|537919973|FG011|Part 1: Phase 1a Escalation|Death|0|||
149120588|NCT02663518|537919974|FG012|Part 1: Phase 1a Escalation|Death|0|||
148779690|NCT00934856|536668020|FG000|Feasibility Part|Adverse Event|1|||
148779691|NCT00934856|536668021|FG001|Feasibility Part|Adverse Event|1|||
148779692|NCT00934856|536668022|FG002|Feasibility Part|Adverse Event|0|||
148779693|NCT00934856|536668023|FG003|Feasibility Part|Adverse Event|1|||
148779694|NCT00934856|536668024|FG004|Feasibility Part|Adverse Event|0|||
148779695|NCT00934856|536668025|FG005|Feasibility Part|Adverse Event|2|||
148779696|NCT00934856|536668020|FG000|Feasibility Part|Withdrawal by Subject|0|||
148779697|NCT00934856|536668021|FG001|Feasibility Part|Withdrawal by Subject|0|||
148779698|NCT00934856|536668022|FG002|Feasibility Part|Withdrawal by Subject|0|||
148779699|NCT00934856|536668023|FG003|Feasibility Part|Withdrawal by Subject|1|||
148779700|NCT00934856|536668024|FG004|Feasibility Part|Withdrawal by Subject|0|||
148779701|NCT00934856|536668025|FG005|Feasibility Part|Withdrawal by Subject|1|||
148779702|NCT00934856|536668020|FG000|Extension Part|Adverse Event|0|||
148779703|NCT00934856|536668021|FG001|Extension Part|Adverse Event|0|||
148779704|NCT00934856|536668022|FG002|Extension Part|Adverse Event|0|||
148779705|NCT00934856|536668023|FG003|Extension Part|Adverse Event|1|||
148779706|NCT00934856|536668024|FG004|Extension Part|Adverse Event|4|||
149120589|NCT02663518|537919975|FG013|Part 1: Phase 1a Escalation|Death|0|||
149120590|NCT02663518|537919962|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120591|NCT02663518|537919963|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120592|NCT02663518|537919964|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
149120593|NCT02663518|537919965|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120594|NCT02663518|537919966|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120595|NCT02663518|537919967|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120596|NCT02663518|537919968|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120597|NCT02663518|537919969|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120598|NCT02663518|537919970|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120599|NCT02663518|537919971|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120600|NCT02663518|537919972|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120601|NCT02663518|537919973|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120602|NCT02663518|537919974|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
148779707|NCT00934856|536668025|FG005|Extension Part|Adverse Event|4|||
149120603|NCT02663518|537919975|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
149120604|NCT02663518|537919962|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
149120605|NCT02663518|537919963|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
149120606|NCT02663518|537919964|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
149120607|NCT02663518|537919965|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
149120608|NCT02663518|537919966|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120609|NCT02663518|537919967|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120610|NCT02663518|537919968|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120611|NCT02663518|537919969|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120612|NCT02663518|537919970|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120613|NCT02663518|537919971|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120614|NCT02663518|537919972|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120615|NCT02663518|537919973|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120616|NCT02663518|537919974|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120617|NCT02663518|537919975|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
149120618|NCT02663518|537919962|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
149120619|NCT02663518|537919963|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120620|NCT02663518|537919964|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
149120621|NCT02663518|537919965|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
149120622|NCT02663518|537919966|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120623|NCT02663518|537919967|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120624|NCT02663518|537919968|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120625|NCT02663518|537919969|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
148779708|NCT00934856|536668020|FG000|Extension Part|Progressive disease|0|||
149120626|NCT02663518|537919970|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120627|NCT02663518|537919971|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120628|NCT02663518|537919972|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149234354|NCT00437294|538328485|FG001|Overall Study|Adverse Event|4|||
149006779|NCT03145766|537503599|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
148779709|NCT00934856|536668021|FG001|Extension Part|Progressive disease|0|||
149120629|NCT02663518|537919973|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120630|NCT02663518|537919974|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120631|NCT02663518|537919975|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
149120632|NCT02663518|537919962|FG000|Part 1: Phase 1a Escalation|Other|0|||
149120633|NCT02663518|537919963|FG001|Part 1: Phase 1a Escalation|Other|0|||
149120634|NCT02663518|537919964|FG002|Part 1: Phase 1a Escalation|Other|2|||
149120635|NCT02663518|537919965|FG003|Part 1: Phase 1a Escalation|Other|0|||
149120636|NCT02663518|537919966|FG004|Part 1: Phase 1a Escalation|Other|0|||
149120637|NCT02663518|537919967|FG005|Part 1: Phase 1a Escalation|Other|0|||
149120638|NCT02663518|537919968|FG006|Part 1: Phase 1a Escalation|Other|0|||
149120639|NCT02663518|537919969|FG007|Part 1: Phase 1a Escalation|Other|0|||
149120640|NCT02663518|537919970|FG008|Part 1: Phase 1a Escalation|Other|0|||
149120641|NCT02663518|537919971|FG009|Part 1: Phase 1a Escalation|Other|0|||
149120642|NCT02663518|537919972|FG010|Part 1: Phase 1a Escalation|Other|0|||
149120643|NCT02663518|537919973|FG011|Part 1: Phase 1a Escalation|Other|0|||
149120644|NCT02663518|537919974|FG012|Part 1: Phase 1a Escalation|Other|0|||
149120645|NCT02663518|537919975|FG013|Part 1: Phase 1a Escalation|Other|0|||
149120646|NCT02663518|537919962|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120647|NCT02663518|537919963|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120648|NCT02663518|537919964|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120649|NCT02663518|537919965|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120650|NCT02663518|537919966|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
149120651|NCT02663518|537919967|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120652|NCT02663518|537919968|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
149120653|NCT02663518|537919969|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
149120654|NCT02663518|537919970|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120655|NCT02663518|537919971|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120656|NCT02663518|537919972|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120657|NCT02663518|537919973|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120658|NCT02663518|537919974|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120659|NCT02663518|537919975|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
149120660|NCT02663518|537919962|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120661|NCT02663518|537919963|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120662|NCT02663518|537919964|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120663|NCT02663518|537919965|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120664|NCT02663518|537919966|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
149120665|NCT02663518|537919967|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120666|NCT02663518|537919968|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
149120667|NCT02663518|537919969|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
149120668|NCT02663518|537919970|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120669|NCT02663518|537919971|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120670|NCT02663518|537919972|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120671|NCT02663518|537919973|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120672|NCT02663518|537919974|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120673|NCT02663518|537919975|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
149120674|NCT02663518|537919962|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120675|NCT02663518|537919963|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120676|NCT02663518|537919964|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120677|NCT02663518|537919965|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120678|NCT02663518|537919966|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
149120679|NCT02663518|537919967|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120680|NCT02663518|537919968|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120681|NCT02663518|537919969|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120682|NCT02663518|537919970|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120683|NCT02663518|537919971|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120684|NCT02663518|537919972|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120685|NCT02663518|537919973|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120686|NCT02663518|537919974|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120687|NCT02663518|537919975|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
149120688|NCT02663518|537919962|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120689|NCT02663518|537919963|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120690|NCT02663518|537919964|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120691|NCT02663518|537919965|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120692|NCT02663518|537919966|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
149120693|NCT02663518|537919967|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
149120694|NCT02663518|537919968|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
149120695|NCT02663518|537919969|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
149120696|NCT02663518|537919970|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120697|NCT02663518|537919971|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120698|NCT02663518|537919972|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120699|NCT02663518|537919973|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120700|NCT02663518|537919974|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120701|NCT02663518|537919975|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
149120702|NCT02663518|537919962|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120703|NCT02663518|537919963|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120704|NCT02663518|537919964|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120705|NCT02663518|537919965|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120706|NCT02663518|537919966|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
149120707|NCT02663518|537919967|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120708|NCT02663518|537919968|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
149120709|NCT02663518|537919969|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120710|NCT02663518|537919970|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
149006780|NCT02801669|537503600|FG000|Overall Study|Death|66|||
149006781|NCT02801669|537503601|FG001|Overall Study|Death|69|||
149006782|NCT02801669|537503600|FG000|Overall Study|Withdrawal by Subject|81|||
149006783|NCT02801669|537503601|FG001|Overall Study|Withdrawal by Subject|77|||
149006784|NCT02801669|537503600|FG000|Overall Study|Other|4|||
149006785|NCT02801669|537503601|FG001|Overall Study|Other|6|||
149006786|NCT04461795|537503603|FG000|Overall Study|Lost to Follow-up|2|||
149006787|NCT04461795|537503603|FG000|Overall Study|Withdrawal by Subject|2|||
149006788|NCT04461795|537503603|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
149006789|NCT00615264|537503604|FG000|Overall Study|Withdrawal by Subject|17|||
149006790|NCT00615264|537503605|FG001|Overall Study|Withdrawal by Subject|19|||
149006791|NCT00615264|537503604|FG000|Overall Study|Lost to Follow-up|6|||
149006792|NCT00615264|537503605|FG001|Overall Study|Lost to Follow-up|13|||
149006793|NCT00615264|537503604|FG000|Overall Study|Adverse Event|8|||
149006794|NCT00615264|537503605|FG001|Overall Study|Adverse Event|5|||
149006795|NCT00615264|537503604|FG000|Overall Study|Death|1|||
149006796|NCT00615264|537503605|FG001|Overall Study|Death|1|||
149006797|NCT00615264|537503604|FG000|Overall Study|Protocol Violation|11|||
149006798|NCT00615264|537503605|FG001|Overall Study|Protocol Violation|7|||
149006799|NCT00615264|537503604|FG000|Overall Study|Not defined|7|||
149006800|NCT00615264|537503605|FG001|Overall Study|Not defined|4|||
149006801|NCT00615264|537503604|FG000|Overall Study|Dermal Hypersensitivity|0|||
149006802|NCT00615264|537503605|FG001|Overall Study|Dermal Hypersensitivity|3|||
149006803|NCT00058422|537503606|FG000|Overall Study|Not treated|2|||
149006804|NCT00185640|537503607|FG000|Overall Study|Not Eligible|4|||
149120711|NCT02663518|537919971|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120712|NCT02663518|537919972|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
149006805|NCT00185640|537503607|FG000|Overall Study|Withdrawal by Subject|3|||
149006806|NCT00185640|537503607|FG000|Overall Study|Death|138|||
149006807|NCT02396537|537503616|FG000|Overall Study|Protocol Violation|0|||
149006808|NCT02396537|537503617|FG001|Overall Study|Protocol Violation|1|||
149006809|NCT01982435|537503618|FG000|Overall Study|Adverse Event|1|||
149006810|NCT01982435|537503619|FG001|Overall Study|Adverse Event|0|||
149006811|NCT00871403|537503620|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
149006812|NCT00871403|537503621|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
149006813|NCT00871403|537503622|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
149006814|NCT00871403|537503620|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
149006815|NCT00871403|537503621|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
149006816|NCT00871403|537503622|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
149006817|NCT00871403|537503620|FG000|Combination Treatment Phase|Adverse Event|0|||
149006818|NCT00871403|537503621|FG001|Combination Treatment Phase|Adverse Event|17|||
149120713|NCT02663518|537919973|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120714|NCT02663518|537919974|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120715|NCT02663518|537919975|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
149120716|NCT02663518|537919962|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120717|NCT02663518|537919963|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120718|NCT02663518|537919964|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120719|NCT02663518|537919965|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120720|NCT02663518|537919966|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120721|NCT02663518|537919967|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120722|NCT02663518|537919968|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
149120723|NCT02663518|537919969|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120724|NCT02663518|537919970|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120725|NCT02663518|537919971|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120726|NCT02663518|537919972|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120727|NCT02663518|537919973|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120728|NCT02663518|537919974|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149120729|NCT02663518|537919975|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
149006819|NCT00871403|537503622|FG002|Combination Treatment Phase|Adverse Event|2|||
149120730|NCT02663518|537919962|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
149120731|NCT02663518|537919963|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
149120732|NCT02663518|537919964|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
149120733|NCT02663518|537919965|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
149120734|NCT02663518|537919966|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
149120735|NCT02663518|537919967|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
149120736|NCT02663518|537919968|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
149120737|NCT02663518|537919969|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
149120738|NCT02663518|537919970|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
149120739|NCT02663518|537919971|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
149120740|NCT02663518|537919972|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
149120741|NCT02663518|537919973|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
149120742|NCT02663518|537919974|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
149120743|NCT02663518|537919975|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
149120744|NCT02663518|537919962|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120745|NCT02663518|537919963|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120746|NCT02663518|537919964|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120747|NCT02663518|537919965|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120748|NCT02663518|537919966|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120749|NCT02663518|537919967|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120750|NCT02663518|537919968|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120751|NCT02663518|537919969|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120752|NCT02663518|537919970|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120753|NCT02663518|537919971|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120754|NCT02663518|537919972|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120755|NCT02663518|537919973|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120756|NCT02663518|537919974|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
149120757|NCT02663518|537919975|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
149120758|NCT02663518|537919962|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120759|NCT02663518|537919963|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120760|NCT02663518|537919964|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120761|NCT02663518|537919965|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120762|NCT02663518|537919966|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120763|NCT02663518|537919967|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120764|NCT02663518|537919968|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120765|NCT02663518|537919969|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120766|NCT02663518|537919970|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120767|NCT02663518|537919971|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120768|NCT02663518|537919972|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120769|NCT02663518|537919973|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
149120770|NCT02663518|537919974|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120771|NCT02663518|537919975|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
149120772|NCT02663518|537919962|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120773|NCT02663518|537919963|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120774|NCT02663518|537919964|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120775|NCT02663518|537919965|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120776|NCT02663518|537919966|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120777|NCT02663518|537919967|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120778|NCT02663518|537919968|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120779|NCT02663518|537919969|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120780|NCT02663518|537919970|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120781|NCT02663518|537919971|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
149120782|NCT02663518|537919972|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
149120783|NCT02663518|537919973|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
149120784|NCT02663518|537919974|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
149120785|NCT02663518|537919975|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
149120786|NCT02663518|537919962|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
149120787|NCT02663518|537919963|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
149120788|NCT02663518|537919964|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
149120789|NCT02663518|537919965|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
149120790|NCT02663518|537919966|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
149120791|NCT02663518|537919967|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
149120792|NCT02663518|537919968|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
149120793|NCT02663518|537919969|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
149120794|NCT02663518|537919970|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
149120795|NCT02663518|537919971|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
149120796|NCT02663518|537919972|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
149120797|NCT02663518|537919973|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
149120798|NCT02663518|537919974|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
149120799|NCT02663518|537919975|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
149120800|NCT02663518|537919962|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120801|NCT02663518|537919963|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120802|NCT02663518|537919964|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120803|NCT02663518|537919965|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120804|NCT02663518|537919966|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120805|NCT02663518|537919967|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120806|NCT02663518|537919968|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120807|NCT02663518|537919969|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120808|NCT02663518|537919970|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120809|NCT02663518|537919971|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120810|NCT02663518|537919972|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120811|NCT02663518|537919973|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120812|NCT02663518|537919974|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
149120813|NCT02663518|537919975|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
149120814|NCT01983254|537919976|FG000|Overall Study|Death|6|||
149120815|NCT01983254|537919977|FG001|Overall Study|Death|6|||
149120816|NCT01983254|537919976|FG000|Overall Study|Lost to Follow-up|17|||
149120817|NCT01983254|537919977|FG001|Overall Study|Lost to Follow-up|16|||
149120818|NCT01983254|537919976|FG000|Overall Study|too ill|11|||
149120819|NCT01983254|537919977|FG001|Overall Study|too ill|8|||
149120820|NCT00434213|537919980|FG000|Overall Study|Adverse Event|12|||
149120821|NCT00434213|537919980|FG000|Overall Study|Lack of Efficacy|9|||
149120822|NCT00434213|537919980|FG000|Overall Study|Lost to Follow-up|14|||
149120823|NCT00434213|537919980|FG000|Overall Study|Withdrawal by Subject|7|||
149120824|NCT00434213|537919980|FG000|Overall Study|Protocol Violation|3|||
149120825|NCT00434213|537919980|FG000|Overall Study|Unable to comply with study visit window|2|||
149120826|NCT00434213|537919980|FG000|Overall Study|Application site reaction|1|||
149120827|NCT00434213|537919980|FG000|Overall Study|Non-compliant to study schedule|1|||
149120828|NCT01253304|537919981|FG000|Overall Study|Adverse Event|0|||
149120829|NCT01253304|537919982|FG001|Overall Study|Adverse Event|0|||
149120830|NCT01253304|537919983|FG002|Overall Study|Adverse Event|0|||
149120831|NCT01253304|537919984|FG003|Overall Study|Adverse Event|1|||
149120832|NCT01699503|537919985|FG000|Overall Study|Death|31|||
149120833|NCT01699503|537919986|FG001|Overall Study|Death|40|||
149120834|NCT01699503|537919985|FG000|Overall Study|Withdrawal by Subject|65|||
149120835|NCT01699503|537919986|FG001|Overall Study|Withdrawal by Subject|57|||
149120836|NCT01699503|537919985|FG000|Overall Study|Lost to Follow-up|121|||
149120837|NCT01699503|537919986|FG001|Overall Study|Lost to Follow-up|117|||
149120838|NCT01699503|537919985|FG000|Overall Study|Excluded due to quality|783|||
149120839|NCT01699503|537919986|FG001|Overall Study|Excluded due to quality|791|||
149120840|NCT00911937|537919988|FG000|Overall Study|Death|1|||
149120841|NCT00911937|537919989|FG001|Overall Study|Death|0|||
149006820|NCT00871403|537503620|FG000|Combination Treatment Phase|Disease Progression|0|||
149006821|NCT00871403|537503621|FG001|Combination Treatment Phase|Disease Progression|8|||
149006822|NCT00871403|537503622|FG002|Combination Treatment Phase|Disease Progression|5|||
149006823|NCT00871403|537503620|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
149006824|NCT00871403|537503621|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
149006825|NCT00871403|537503622|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
149006826|NCT00871403|537503620|FG000|Combination Treatment Phase|Physician Decision|0|||
149006827|NCT00871403|537503621|FG001|Combination Treatment Phase|Physician Decision|1|||
149006828|NCT00871403|537503622|FG002|Combination Treatment Phase|Physician Decision|3|||
149006829|NCT00871403|537503620|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
149120842|NCT00911937|537919988|FG000|Overall Study|Lost to Follow-up|8|||
149120843|NCT00911937|537919989|FG001|Overall Study|Lost to Follow-up|5|||
149120844|NCT00911937|537919988|FG000|Overall Study|Withdrawal by Subject|10|||
149120845|NCT00911937|537919989|FG001|Overall Study|Withdrawal by Subject|7|||
149120846|NCT00911937|537919988|FG000|Overall Study|Withdrawn due to pregnancy|1|||
149120847|NCT00911937|537919989|FG001|Overall Study|Withdrawn due to pregnancy|0|||
149120848|NCT00911937|537919988|FG000|Overall Study|Adverse Event|11|||
149120849|NCT00911937|537919989|FG001|Overall Study|Adverse Event|25|||
149120850|NCT00911937|537919988|FG000|Overall Study|Lack of Efficacy|11|||
149120851|NCT00911937|537919989|FG001|Overall Study|Lack of Efficacy|6|||
149234355|NCT00437294|538328484|FG000|Overall Study|Death|5|||
149120852|NCT00911937|537919988|FG000|Overall Study|Did not meet inclusion criteria|9|||
149120853|NCT00911937|537919989|FG001|Overall Study|Did not meet inclusion criteria|11|||
149120854|NCT00911937|537919988|FG000|Overall Study|Protocol Violation|14|||
149120855|NCT00911937|537919989|FG001|Overall Study|Protocol Violation|23|||
149120856|NCT00911937|537919988|FG000|Overall Study|Randomized but not treated|13|||
149120857|NCT00911937|537919989|FG001|Overall Study|Randomized but not treated|13|||
149120858|NCT00911937|537919988|FG000|Overall Study|Other|9|||
149120859|NCT00911937|537919989|FG001|Overall Study|Other|5|||
149120860|NCT01871805|537919992|FG000|Phase I|Death|7|||
149120861|NCT01871805|537919993|FG001|Phase I|Death|4|||
149120862|NCT01871805|537919994|FG002|Phase I|Death|6|||
149120863|NCT01871805|537919995|FG003|Phase I|Death|2|||
149120864|NCT01871805|537919996|FG004|Phase I|Death|9|||
149120865|NCT01871805|537919997|FG005|Phase I|Death|0|||
149120866|NCT01871805|537919992|FG000|Phase I|Alive in Survival Follow-up|0|||
149120867|NCT01871805|537919993|FG001|Phase I|Alive in Survival Follow-up|2|||
149120868|NCT01871805|537919994|FG002|Phase I|Alive in Survival Follow-up|4|||
149120869|NCT01871805|537919995|FG003|Phase I|Alive in Survival Follow-up|5|||
149120870|NCT01871805|537919996|FG004|Phase I|Alive in Survival Follow-up|4|||
149120871|NCT01871805|537919997|FG005|Phase I|Alive in Survival Follow-up|0|||
149120872|NCT01871805|537919992|FG000|Phase I|Lost to Follow-up|0|||
149120873|NCT01871805|537919993|FG001|Phase I|Lost to Follow-up|1|||
149120874|NCT01871805|537919994|FG002|Phase I|Lost to Follow-up|3|||
149120875|NCT01871805|537919995|FG003|Phase I|Lost to Follow-up|0|||
149120876|NCT01871805|537919996|FG004|Phase I|Lost to Follow-up|0|||
149120877|NCT01871805|537919997|FG005|Phase I|Lost to Follow-up|0|||
149120878|NCT01871805|537919992|FG000|Phase II|Death|0|||
149120879|NCT01871805|537919993|FG001|Phase II|Death|0|||
149120880|NCT01871805|537919994|FG002|Phase II|Death|0|||
149120881|NCT01871805|537919995|FG003|Phase II|Death|0|||
149120882|NCT01871805|537919996|FG004|Phase II|Death|0|||
149120883|NCT01871805|537919997|FG005|Phase II|Death|45|||
149120884|NCT01871805|537919992|FG000|Phase II|Alive in Survival Follow-up|0|||
149120885|NCT01871805|537919993|FG001|Phase II|Alive in Survival Follow-up|0|||
149120886|NCT01871805|537919994|FG002|Phase II|Alive in Survival Follow-up|0|||
149120887|NCT01871805|537919995|FG003|Phase II|Alive in Survival Follow-up|0|||
149120888|NCT01871805|537919996|FG004|Phase II|Alive in Survival Follow-up|0|||
149120889|NCT01871805|537919997|FG005|Phase II|Alive in Survival Follow-up|29|||
149120890|NCT01871805|537919992|FG000|Phase II|Lost to Follow-up|0|||
149120891|NCT01871805|537919993|FG001|Phase II|Lost to Follow-up|0|||
149120892|NCT01871805|537919994|FG002|Phase II|Lost to Follow-up|0|||
149120893|NCT01871805|537919995|FG003|Phase II|Lost to Follow-up|0|||
149120894|NCT01871805|537919996|FG004|Phase II|Lost to Follow-up|0|||
149120895|NCT01871805|537919997|FG005|Phase II|Lost to Follow-up|13|||
149120896|NCT01435616|537920003|FG000|Overall Study|Adverse Event|39|||
149120897|NCT01435616|537920004|FG001|Overall Study|Adverse Event|21|||
149120898|NCT01435616|537920003|FG000|Overall Study|Death|7|||
149120899|NCT01435616|537920004|FG001|Overall Study|Death|2|||
149120900|NCT01435616|537920003|FG000|Overall Study|Lost to Follow-up|22|||
149120901|NCT01435616|537920004|FG001|Overall Study|Lost to Follow-up|13|||
149120902|NCT01435616|537920003|FG000|Overall Study|Protocol Violation|16|||
149120903|NCT01435616|537920004|FG001|Overall Study|Protocol Violation|13|||
149120904|NCT01435616|537920003|FG000|Overall Study|Withdrawal by Subject|66|||
149120905|NCT01435616|537920004|FG001|Overall Study|Withdrawal by Subject|24|||
149120906|NCT01435616|537920003|FG000|Overall Study|Physician Decision|20|||
149120907|NCT01435616|537920004|FG001|Overall Study|Physician Decision|7|||
149120908|NCT01435616|537920003|FG000|Overall Study|Sponsor Decision|1|||
149120909|NCT01435616|537920004|FG001|Overall Study|Sponsor Decision|0|||
149120910|NCT04860297|537920005|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
149120911|NCT04860297|537920006|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
149120912|NCT04860297|537920007|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
149120913|NCT04860297|537920008|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
149120914|NCT04860297|537920009|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
149120915|NCT04860297|537920010|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
149120916|NCT04860297|537920011|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
149120917|NCT04860297|537920012|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
149120918|NCT04860297|537920005|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
149120919|NCT04860297|537920006|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
149120920|NCT04860297|537920007|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
149120921|NCT04860297|537920008|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
149120922|NCT04860297|537920009|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
149120923|NCT04860297|537920010|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
149120924|NCT04860297|537920011|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
149120925|NCT04860297|537920012|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
149120926|NCT04860297|537920005|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
149120927|NCT04860297|537920006|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
149120928|NCT04860297|537920007|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
149120929|NCT04860297|537920008|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
149120930|NCT04860297|537920009|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
149120931|NCT04860297|537920010|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
149120932|NCT04860297|537920011|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
149120933|NCT04860297|537920012|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
149120934|NCT04860297|537920005|FG000|Part B (Booster Dose)|Other Than Specified|0|||
149120935|NCT04860297|537920006|FG001|Part B (Booster Dose)|Other Than Specified|0|||
149120936|NCT04860297|537920007|FG002|Part B (Booster Dose)|Other Than Specified|0|||
149120937|NCT04860297|537920008|FG003|Part B (Booster Dose)|Other Than Specified|0|||
149120938|NCT04860297|537920009|FG004|Part B (Booster Dose)|Other Than Specified|0|||
149120939|NCT04860297|537920010|FG005|Part B (Booster Dose)|Other Than Specified|1|||
149120940|NCT04860297|537920011|FG006|Part B (Booster Dose)|Other Than Specified|1|||
149120941|NCT04860297|537920012|FG007|Part B (Booster Dose)|Other Than Specified|0|||
149120942|NCT04860297|537920005|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
149120943|NCT04860297|537920006|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
149120944|NCT04860297|537920007|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
149120945|NCT04860297|537920008|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
149120946|NCT04860297|537920009|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
149120947|NCT04860297|537920010|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
149120948|NCT04860297|537920011|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
149120949|NCT04860297|537920012|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
149120950|NCT04860297|537920005|FG000|Part B (Booster Dose)|Death|0|||
149120951|NCT04860297|537920006|FG001|Part B (Booster Dose)|Death|0|||
149120952|NCT04860297|537920007|FG002|Part B (Booster Dose)|Death|0|||
149120953|NCT04860297|537920008|FG003|Part B (Booster Dose)|Death|0|||
149120954|NCT04860297|537920009|FG004|Part B (Booster Dose)|Death|1|||
149120955|NCT04860297|537920010|FG005|Part B (Booster Dose)|Death|2|||
149120956|NCT04860297|537920011|FG006|Part B (Booster Dose)|Death|1|||
149120957|NCT04860297|537920012|FG007|Part B (Booster Dose)|Death|0|||
149120958|NCT04860297|537920005|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
149120959|NCT04860297|537920006|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
149120960|NCT04860297|537920007|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
149120961|NCT04860297|537920008|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
149120962|NCT04860297|537920009|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
149120963|NCT04860297|537920010|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
149120964|NCT04860297|537920011|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
149120965|NCT04860297|537920012|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
149120966|NCT04811131|537920024|FG000|Overall Study|Adverse Event|0|||
149120967|NCT04811131|537920025|FG001|Overall Study|Adverse Event|0|||
149120968|NCT04811131|537920026|FG002|Overall Study|Adverse Event|1|||
149120969|NCT04811131|537920027|FG003|Overall Study|Adverse Event|0|||
149120970|NCT04811131|537920024|FG000|Overall Study|Lack of Efficacy|0|||
149120971|NCT04811131|537920025|FG001|Overall Study|Lack of Efficacy|0|||
149120972|NCT04811131|537920026|FG002|Overall Study|Lack of Efficacy|0|||
149120973|NCT04811131|537920027|FG003|Overall Study|Lack of Efficacy|1|||
149120974|NCT04811131|537920024|FG000|Overall Study|Lost to Follow-up|0|||
149120975|NCT04811131|537920025|FG001|Overall Study|Lost to Follow-up|1|||
149120976|NCT04811131|537920026|FG002|Overall Study|Lost to Follow-up|0|||
149120977|NCT04811131|537920027|FG003|Overall Study|Lost to Follow-up|0|||
149120978|NCT04811131|537920024|FG000|Overall Study|Sponsor request|31|||
149120979|NCT04811131|537920025|FG001|Overall Study|Sponsor request|35|||
149120980|NCT04811131|537920026|FG002|Overall Study|Sponsor request|27|||
149120981|NCT04811131|537920027|FG003|Overall Study|Sponsor request|10|||
149120982|NCT04811131|537920024|FG000|Overall Study|Withdrawal by Subject|3|||
149120983|NCT04811131|537920025|FG001|Overall Study|Withdrawal by Subject|1|||
149120984|NCT04811131|537920026|FG002|Overall Study|Withdrawal by Subject|3|||
149120985|NCT04811131|537920027|FG003|Overall Study|Withdrawal by Subject|1|||
149120986|NCT00620282|537920035|FG000|Overall Study|Adverse Event|0|||
149120987|NCT00620282|537920036|FG001|Overall Study|Adverse Event|1|||
149120988|NCT00620282|537920037|FG002|Overall Study|Adverse Event|0|||
149120989|NCT00620282|537920035|FG000|Overall Study|Arterial line unable to be placed|0|||
149120990|NCT00620282|537920036|FG001|Overall Study|Arterial line unable to be placed|0|||
149120991|NCT00620282|537920037|FG002|Overall Study|Arterial line unable to be placed|1|||
149120992|NCT00620282|537920035|FG000|Overall Study|Withdrawal by Subject|0|||
149120993|NCT00620282|537920036|FG001|Overall Study|Withdrawal by Subject|1|||
149120994|NCT00620282|537920037|FG002|Overall Study|Withdrawal by Subject|0|||
149120995|NCT02217475|537920038|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
149120996|NCT02217475|537920039|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
149120997|NCT02217475|537920040|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
149120998|NCT02217475|537920038|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
149120999|NCT02217475|537920039|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
149121000|NCT02217475|537920040|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
149121001|NCT02217475|537920038|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
149121002|NCT02217475|537920039|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
149121003|NCT02217475|537920040|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
149121004|NCT02217475|537920038|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
149121005|NCT02217475|537920039|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
149006830|NCT00871403|537503621|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
149121006|NCT02217475|537920040|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
149121007|NCT02217475|537920038|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
149121008|NCT02217475|537920039|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
149121009|NCT02217475|537920040|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
149121010|NCT02217475|537920038|FG000|Discontinued After Period 1|Adverse Event|1|||
149121011|NCT02217475|537920039|FG001|Discontinued After Period 1|Adverse Event|2|||
149121012|NCT02217475|537920040|FG002|Discontinued After Period 1|Adverse Event|0|||
149121013|NCT02217475|537920038|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
149121014|NCT02217475|537920039|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
149121015|NCT02217475|537920040|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
149121016|NCT02217475|537920038|FG000|Discontinued After Period 1|Physician Decision|0|||
149121017|NCT02217475|537920039|FG001|Discontinued After Period 1|Physician Decision|0|||
149121018|NCT02217475|537920040|FG002|Discontinued After Period 1|Physician Decision|1|||
149121019|NCT02217475|537920038|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
149121020|NCT02217475|537920039|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
149121021|NCT02217475|537920040|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
149121022|NCT02217475|537920038|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
149121023|NCT02217475|537920039|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
149121024|NCT02217475|537920040|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
149121025|NCT02217475|537920038|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
149121026|NCT02217475|537920039|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
149121027|NCT02217475|537920040|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
149121028|NCT02217475|537920038|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
149121029|NCT02217475|537920039|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
149121030|NCT02217475|537920040|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
149121031|NCT02217475|537920038|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
149121032|NCT02217475|537920039|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
149121033|NCT02217475|537920040|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
149121034|NCT04738292|537920045|FG000|Overall Study|Death|1|||
149121035|NCT02971761|537920046|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
149121036|NCT02442336|537920047|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
149121037|NCT02442336|537920047|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
149121038|NCT02442336|537920047|FG000|Overall Study|Lost to Follow-up|11|||
149121039|NCT01237587|537920048|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
149121040|NCT01237587|537920049|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
149121041|NCT01237587|537920048|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
149121042|NCT01237587|537920049|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
149121043|NCT01237587|537920048|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
149121044|NCT01237587|537920049|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
149121045|NCT01237587|537920048|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
149121046|NCT01237587|537920049|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
149121047|NCT01237587|537920048|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
149121048|NCT01237587|537920049|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
149121049|NCT01237587|537920048|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
149121050|NCT01237587|537920049|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
149121051|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
149121052|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
149121053|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
149121054|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
149121055|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
149121056|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
149121057|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
149121058|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
149121059|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
149121060|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
149121061|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
149121062|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
149121063|NCT01237587|537920048|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
149121064|NCT01237587|537920049|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
149121065|NCT01237587|537920048|FG000|Taper Phase|Adverse Event|0|||
149121066|NCT01237587|537920049|FG001|Taper Phase|Adverse Event|2|||
149121067|NCT01237587|537920048|FG000|Taper Phase|Protocol Violation|2|||
149121068|NCT01237587|537920049|FG001|Taper Phase|Protocol Violation|0|||
149121069|NCT01237587|537920048|FG000|Taper Phase|Lack of Efficacy|2|||
149121070|NCT01237587|537920049|FG001|Taper Phase|Lack of Efficacy|5|||
149121071|NCT01237587|537920048|FG000|Taper Phase|Parent/Guardian Decision|0|||
149121072|NCT01237587|537920049|FG001|Taper Phase|Parent/Guardian Decision|2|||
149121073|NCT01237587|537920048|FG000|Taper Phase|Sponsor Decision|1|||
149121074|NCT01237587|537920049|FG001|Taper Phase|Sponsor Decision|0|||
149121075|NCT01237587|537920048|FG000|Taper Phase|Withdrawal by Subject|0|||
149121076|NCT01237587|537920049|FG001|Taper Phase|Withdrawal by Subject|1|||
149121077|NCT01142115|537920050|FG000|First Intervention|Lack of Efficacy|1|||
149121078|NCT01142115|537920051|FG001|First Intervention|Lack of Efficacy|1|||
149121079|NCT01142115|537920050|FG000|First Intervention|Adverse Event|1|||
149121080|NCT01142115|537920051|FG001|First Intervention|Adverse Event|0|||
149121081|NCT03208036|537920052|FG000|Baseline Assessment|Withdrawal by Subject|1|||
149121082|NCT03208036|537920053|FG001|Baseline Assessment|Withdrawal by Subject|1|||
149121083|NCT03208036|537920052|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
149121084|NCT03208036|537920053|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
149121085|NCT03208036|537920052|FG000|Intervention|Withdrawal by Subject|3|||
149121086|NCT03208036|537920053|FG001|Intervention|Withdrawal by Subject|2|||
149121087|NCT03208036|537920052|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
149121088|NCT03208036|537920053|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
149121089|NCT01879553|537920055|FG000|Overall Study|Withdrawal by Subject|1|||
149121090|NCT01879553|537920056|FG001|Overall Study|Withdrawal by Subject|0|||
149121091|NCT00320528|537920057|FG000|Study Period II|Adverse Event|3|||
149121092|NCT00320528|537920058|FG001|Study Period II|Adverse Event|4|||
149121093|NCT00320528|537920059|FG002|Study Period II|Adverse Event|8|||
149121094|NCT00320528|537920057|FG000|Study Period II|Parent/Caregiver Decision|8|||
149121095|NCT00320528|537920058|FG001|Study Period II|Parent/Caregiver Decision|3|||
149121096|NCT00320528|537920059|FG002|Study Period II|Parent/Caregiver Decision|11|||
149121097|NCT00320528|537920057|FG000|Study Period II|Withdrawal by Subject|0|||
149121098|NCT00320528|537920058|FG001|Study Period II|Withdrawal by Subject|1|||
149121099|NCT00320528|537920059|FG002|Study Period II|Withdrawal by Subject|1|||
149121100|NCT00320528|537920057|FG000|Study Period II|Entry Criteria Exclusion|0|||
149121101|NCT00320528|537920058|FG001|Study Period II|Entry Criteria Exclusion|2|||
149121102|NCT00320528|537920059|FG002|Study Period II|Entry Criteria Exclusion|2|||
149121103|NCT00320528|537920057|FG000|Study Period III|Adverse Event|1|||
149121104|NCT00320528|537920058|FG001|Study Period III|Adverse Event|0|||
149121105|NCT00320528|537920059|FG002|Study Period III|Adverse Event|0|||
149121106|NCT00320528|537920057|FG000|Study Period III|Lost to Follow-up|1|||
149121107|NCT00320528|537920058|FG001|Study Period III|Lost to Follow-up|0|||
149121108|NCT00320528|537920059|FG002|Study Period III|Lost to Follow-up|0|||
149121109|NCT00320528|537920057|FG000|Study Period III|Withdrawal by Subject|1|||
149121110|NCT00320528|537920058|FG001|Study Period III|Withdrawal by Subject|1|||
149121111|NCT00320528|537920059|FG002|Study Period III|Withdrawal by Subject|2|||
149121112|NCT00320528|537920057|FG000|Study Period III|Lack of Efficacy|2|||
149121113|NCT00320528|537920058|FG001|Study Period III|Lack of Efficacy|0|||
149121114|NCT00320528|537920059|FG002|Study Period III|Lack of Efficacy|0|||
149121115|NCT00320528|537920057|FG000|Study Period III|Parent/Caregiver Decision|14|||
149121116|NCT00320528|537920058|FG001|Study Period III|Parent/Caregiver Decision|3|||
149121117|NCT00320528|537920059|FG002|Study Period III|Parent/Caregiver Decision|11|||
149121118|NCT00320528|537920057|FG000|Study Period III|Protocol Violation|0|||
149234356|NCT00437294|538328485|FG001|Overall Study|Death|2|||
149234357|NCT00437294|538328484|FG000|Overall Study|Physician Decision|0|||
149234358|NCT00437294|538328485|FG001|Overall Study|Physician Decision|3|||
149234359|NCT00437294|538328484|FG000|Overall Study|Withdrawal by Subject|5|||
149234360|NCT00437294|538328485|FG001|Overall Study|Withdrawal by Subject|0|||
149234361|NCT00437294|538328484|FG000|Overall Study|Progressive Disease|19|||
149234362|NCT00437294|538328485|FG001|Overall Study|Progressive Disease|23|||
149234363|NCT00437294|538328484|FG000|Overall Study|Sponsor Decision|8|||
149234364|NCT00437294|538328485|FG001|Overall Study|Sponsor Decision|9|||
149234365|NCT00437294|538328484|FG000|Overall Study|Protocol Violation|0|||
149234366|NCT00437294|538328485|FG001|Overall Study|Protocol Violation|1|||
149234367|NCT00437294|538328484|FG000|Overall Study|Entry criteria not met|1|||
149234368|NCT00437294|538328485|FG001|Overall Study|Entry criteria not met|1|||
149234369|NCT01473602|538328493|FG000|Overall Study|Adverse Event|1|||
149234370|NCT01473602|538328494|FG001|Overall Study|Adverse Event|2|||
149234371|NCT01473602|538328493|FG000|Overall Study|Death|0|||
149234372|NCT01473602|538328494|FG001|Overall Study|Death|1|||
149234373|NCT01473602|538328493|FG000|Overall Study|Lost to Follow-up|1|||
149234374|NCT01473602|538328494|FG001|Overall Study|Lost to Follow-up|1|||
149234375|NCT01473602|538328493|FG000|Overall Study|Withdrawal by Subject|5|||
149234376|NCT01473602|538328494|FG001|Overall Study|Withdrawal by Subject|4|||
149234377|NCT01473602|538328493|FG000|Overall Study|Physician Decision|1|||
149234378|NCT01473602|538328494|FG001|Overall Study|Physician Decision|0|||
149234379|NCT00449761|538328495|FG000|Overall Study|Disease progression|12|||
149234380|NCT00449761|538328495|FG000|Overall Study|Death|5|||
149234381|NCT00449761|538328495|FG000|Overall Study|New cancer therapy|1|||
149234382|NCT00560573|538328496|FG000|Overall Study|Death|4|||
149234383|NCT00560573|538328497|FG001|Overall Study|Death|1|||
149234384|NCT00560573|538328498|FG002|Overall Study|Death|4|||
149234385|NCT00560573|538328499|FG003|Overall Study|Death|5|||
149234386|NCT00560573|538328500|FG004|Overall Study|Death|1|||
149234387|NCT00560573|538328501|FG005|Overall Study|Death|10|||
149234388|NCT00560573|538328496|FG000|Overall Study|Lost to Follow-up|0|||
149234389|NCT00560573|538328497|FG001|Overall Study|Lost to Follow-up|0|||
149234390|NCT00560573|538328498|FG002|Overall Study|Lost to Follow-up|0|||
149234391|NCT00560573|538328499|FG003|Overall Study|Lost to Follow-up|1|||
149121119|NCT00320528|537920058|FG001|Study Period III|Protocol Violation|1|||
149121120|NCT00320528|537920059|FG002|Study Period III|Protocol Violation|0|||
149234392|NCT00560573|538328500|FG004|Overall Study|Lost to Follow-up|1|||
149234393|NCT00560573|538328501|FG005|Overall Study|Lost to Follow-up|0|||
149234394|NCT00560573|538328496|FG000|Overall Study|Withdrawal by Subject|0|||
149234395|NCT00560573|538328497|FG001|Overall Study|Withdrawal by Subject|0|||
149234396|NCT00560573|538328498|FG002|Overall Study|Withdrawal by Subject|0|||
149234397|NCT00560573|538328499|FG003|Overall Study|Withdrawal by Subject|1|||
149234398|NCT00560573|538328500|FG004|Overall Study|Withdrawal by Subject|1|||
149234399|NCT00560573|538328501|FG005|Overall Study|Withdrawal by Subject|0|||
149234400|NCT00560573|538328496|FG000|Overall Study|Other|2|||
149234401|NCT00560573|538328497|FG001|Overall Study|Other|2|||
149234402|NCT00560573|538328498|FG002|Overall Study|Other|2|||
149234403|NCT00560573|538328499|FG003|Overall Study|Other|3|||
149234404|NCT00560573|538328500|FG004|Overall Study|Other|3|||
149234405|NCT00560573|538328501|FG005|Overall Study|Other|3|||
149234406|NCT00560573|538328496|FG000|Overall Study|Enrolled, not treated|0|||
149234407|NCT00560573|538328497|FG001|Overall Study|Enrolled, not treated|0|||
149234408|NCT00560573|538328498|FG002|Overall Study|Enrolled, not treated|0|||
149234409|NCT00560573|538328499|FG003|Overall Study|Enrolled, not treated|0|||
149234410|NCT00560573|538328500|FG004|Overall Study|Enrolled, not treated|1|||
149234411|NCT00560573|538328501|FG005|Overall Study|Enrolled, not treated|0|||
149234412|NCT02506101|538328503|FG000|Overall Study|Transportation issues|1|||
149234413|NCT02506101|538328504|FG001|Overall Study|Transportation issues|0|||
149234414|NCT02506101|538328503|FG000|Overall Study|No enrollment and staff unavailability|1|||
149234415|NCT02506101|538328504|FG001|Overall Study|No enrollment and staff unavailability|0|||
149234416|NCT01308476|538328505|FG000|Overall Study|Lost to Follow-up|2|||
149234417|NCT01308476|538328506|FG001|Overall Study|Lost to Follow-up|2|||
149234418|NCT01308476|538328505|FG000|Overall Study|Other|1|||
149234419|NCT01308476|538328506|FG001|Overall Study|Other|0|||
149234420|NCT02696382|538328507|FG000|Overall Study|Death|7|||
149234421|NCT02696382|538328508|FG001|Overall Study|Death|2|||
149234422|NCT02696382|538328507|FG000|Overall Study|Withdrawal by Subject|5|||
149234423|NCT02696382|538328508|FG001|Overall Study|Withdrawal by Subject|12|||
149234424|NCT02696382|538328507|FG000|Overall Study|Lost to Follow-up|4|||
149234425|NCT02696382|538328508|FG001|Overall Study|Lost to Follow-up|7|||
149234426|NCT03246152|538328510|FG000|Overall Study|Lost to Follow-up|2|||
149234427|NCT03246152|538328510|FG000|Overall Study|Protocol Violation|1|||
149234428|NCT04359758|538328517|FG000|Overall Study|Protocol Violation|3|||
149234429|NCT04359758|538328518|FG001|Overall Study|Protocol Violation|2|||
149234430|NCT03358407|538328522|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234431|NCT03358407|538328523|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234432|NCT03358407|538328524|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
149234433|NCT03358407|538328525|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234434|NCT03358407|538328526|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234435|NCT03358407|538328527|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234436|NCT03358407|538328528|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234437|NCT03358407|538328529|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234438|NCT03358407|538328530|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234439|NCT03358407|538328531|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
149234440|NCT03358407|538328522|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234441|NCT03358407|538328523|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234442|NCT03358407|538328524|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234443|NCT03358407|538328525|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234444|NCT03358407|538328526|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
149234445|NCT03358407|538328527|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234446|NCT03358407|538328528|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234447|NCT03358407|538328529|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234448|NCT03358407|538328530|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234449|NCT03358407|538328531|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234450|NCT03358407|538328522|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234451|NCT03358407|538328523|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234452|NCT03358407|538328524|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234453|NCT03358407|538328525|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234454|NCT03358407|538328526|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234455|NCT03358407|538328527|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
149234456|NCT03358407|538328528|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234457|NCT03358407|538328529|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
149234458|NCT03358407|538328530|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234459|NCT03358407|538328531|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
149234460|NCT03358407|538328522|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234461|NCT03358407|538328523|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234462|NCT03358407|538328524|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234463|NCT03358407|538328525|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234464|NCT03358407|538328526|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234465|NCT03358407|538328527|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
149234466|NCT03358407|538328528|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234467|NCT03358407|538328529|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
149234468|NCT03358407|538328530|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234469|NCT03358407|538328531|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
149234470|NCT03358407|538328522|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234471|NCT03358407|538328523|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234472|NCT03358407|538328524|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234473|NCT03358407|538328525|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234474|NCT03358407|538328526|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234475|NCT03358407|538328527|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
149234476|NCT03358407|538328528|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
149234477|NCT03358407|538328529|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234478|NCT03358407|538328530|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234479|NCT03358407|538328531|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
149234480|NCT03358407|538328522|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234481|NCT03358407|538328523|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234482|NCT03358407|538328524|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234483|NCT03358407|538328525|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234484|NCT03358407|538328526|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234485|NCT03358407|538328527|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
149234486|NCT03358407|538328528|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
149234487|NCT03358407|538328529|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
149234488|NCT03358407|538328530|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234489|NCT03358407|538328531|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
149234490|NCT00483574|538328532|FG000|Overall Study|Adverse Event|6|||
149234491|NCT00483574|538328533|FG001|Overall Study|Adverse Event|0|||
149234492|NCT00483574|538328532|FG000|Overall Study|Protocol Violation|28|||
149234493|NCT00483574|538328533|FG001|Overall Study|Protocol Violation|9|||
149234494|NCT00483574|538328532|FG000|Overall Study|Lost to Follow-up|16|||
149234495|NCT00483574|538328533|FG001|Overall Study|Lost to Follow-up|4|||
149234496|NCT00483574|538328532|FG000|Overall Study|Withdrawal by Subject|52|||
149234497|NCT00483574|538328533|FG001|Overall Study|Withdrawal by Subject|0|||
149234498|NCT04753606|538328534|FG000|Overall Study|Adverse Event|1|||
149234499|NCT04753606|538328535|FG001|Overall Study|Adverse Event|0|||
149234500|NCT04753606|538328536|FG002|Overall Study|Adverse Event|0|||
149234501|NCT01012609|538328539|FG000|Overall Study|Withdrawal by Subject|1|||
149234502|NCT01012609|538328540|FG001|Overall Study|Withdrawal by Subject|1|||
149234503|NCT00924820|538328542|FG000|Overall Study|Death|2|||
149234504|NCT00924820|538328542|FG000|Overall Study|Ineligible, Screen Failure|5|||
149234505|NCT04983589|538328543|FG000|Overall Study|Withdrawal by Subject|0|||
149234506|NCT04983589|538328544|FG001|Overall Study|Withdrawal by Subject|3|||
149234507|NCT04983589|538328543|FG000|Overall Study|COVID-19 Infection|1|||
149234508|NCT04983589|538328544|FG001|Overall Study|COVID-19 Infection|0|||
149234509|NCT04983589|538328543|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
149234510|NCT04983589|538328544|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
149234511|NCT01725217|538328545|FG000|Overall Study|Withdrawal by Subject|1|||
149234512|NCT01725217|538328546|FG001|Overall Study|Withdrawal by Subject|0|||
149234513|NCT01725217|538328547|FG002|Overall Study|Withdrawal by Subject|0|||
149234514|NCT00585468|538328548|FG000|First Intervention|Withdrawal by Subject|1|||
149234515|NCT00585468|538328549|FG001|First Intervention|Withdrawal by Subject|1|||
149234516|NCT00978120|538328554|FG000|Overall Study|Death|0|||
149234517|NCT00978120|538328555|FG001|Overall Study|Death|0|||
149234518|NCT00978120|538328556|FG002|Overall Study|Death|0|||
149234519|NCT00978120|538328557|FG003|Overall Study|Death|1|||
149234520|NCT00978120|538328554|FG000|Overall Study|Lost to Follow-up|0|||
149234521|NCT00978120|538328555|FG001|Overall Study|Lost to Follow-up|0|||
149234522|NCT00978120|538328556|FG002|Overall Study|Lost to Follow-up|3|||
149234523|NCT00978120|538328557|FG003|Overall Study|Lost to Follow-up|0|||
149234524|NCT00978120|538328554|FG000|Overall Study|Withdrawal by Subject|2|||
149234525|NCT00978120|538328555|FG001|Overall Study|Withdrawal by Subject|0|||
149234526|NCT00978120|538328556|FG002|Overall Study|Withdrawal by Subject|0|||
149234527|NCT00978120|538328557|FG003|Overall Study|Withdrawal by Subject|0|||
149234528|NCT00978120|538328554|FG000|Overall Study|Moved out of state|0|||
149234529|NCT00978120|538328555|FG001|Overall Study|Moved out of state|0|||
149234530|NCT00978120|538328556|FG002|Overall Study|Moved out of state|0|||
149234531|NCT00978120|538328557|FG003|Overall Study|Moved out of state|1|||
149234532|NCT03253809|538328558|FG000|Overall Study|Unable to obtain study related data|14|||
149234533|NCT03992456|538328561|FG000|Overall Study|Withdrawal by Subject|1|||
149234534|NCT03992456|538328562|FG001|Overall Study|Withdrawal by Subject|0|||
149234535|NCT03992456|538328561|FG000|Overall Study|Disease progression|4|||
149234536|NCT03992456|538328562|FG001|Overall Study|Disease progression|5|||
149234537|NCT03992456|538328561|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
149234538|NCT03992456|538328562|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
149234539|NCT00762073|538328563|FG000|Overall Study|Lack of Efficacy|1|||
149234540|NCT00762073|538328564|FG001|Overall Study|Lack of Efficacy|1|||
149234541|NCT00762073|538328565|FG002|Overall Study|Lack of Efficacy|0|||
149234542|NCT00762073|538328566|FG003|Overall Study|Lack of Efficacy|0|||
149234543|NCT00762073|538328563|FG000|Overall Study|Adverse Event|1|||
149234544|NCT00762073|538328564|FG001|Overall Study|Adverse Event|0|||
149234545|NCT00762073|538328565|FG002|Overall Study|Adverse Event|1|||
149234546|NCT00762073|538328566|FG003|Overall Study|Adverse Event|1|||
149234547|NCT00762073|538328563|FG000|Overall Study|Significant Subject Noncompliance|0|||
149234548|NCT00762073|538328564|FG001|Overall Study|Significant Subject Noncompliance|1|||
149234549|NCT00762073|538328565|FG002|Overall Study|Significant Subject Noncompliance|0|||
149234550|NCT00762073|538328566|FG003|Overall Study|Significant Subject Noncompliance|1|||
149234551|NCT00762073|538328563|FG000|Overall Study|Withdrawal by Subject|1|||
149234552|NCT00762073|538328564|FG001|Overall Study|Withdrawal by Subject|2|||
149234553|NCT00762073|538328565|FG002|Overall Study|Withdrawal by Subject|1|||
149234554|NCT00762073|538328566|FG003|Overall Study|Withdrawal by Subject|1|||
149234555|NCT00762073|538328563|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
149234556|NCT00762073|538328564|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
149234557|NCT00762073|538328565|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
149234558|NCT00762073|538328566|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
149234559|NCT01068418|538328567|FG000|Overall Study|Physician Decision|12|||
149234560|NCT03155269|538328568|FG000|Overall Study|Withdrawal by Subject|4|||
149234561|NCT03155269|538328569|FG001|Overall Study|Withdrawal by Subject|5|||
149234562|NCT03155269|538328568|FG000|Overall Study|Lost to Follow-up|1|||
149234563|NCT03155269|538328569|FG001|Overall Study|Lost to Follow-up|2|||
149234564|NCT00910000|538328570|FG000|Overall Study|Adverse Event|0|||
149234565|NCT00910000|538328571|FG001|Overall Study|Adverse Event|3|||
149234566|NCT00910000|538328572|FG002|Overall Study|Adverse Event|2|||
149234567|NCT00910000|538328573|FG003|Overall Study|Adverse Event|2|||
149234568|NCT00910000|538328574|FG004|Overall Study|Adverse Event|0|||
149234569|NCT00910000|538328575|FG005|Overall Study|Adverse Event|1|||
149234570|NCT00910000|538328570|FG000|Overall Study|Withdrawal by Subject|0|||
149234571|NCT00910000|538328571|FG001|Overall Study|Withdrawal by Subject|0|||
149234572|NCT00910000|538328572|FG002|Overall Study|Withdrawal by Subject|1|||
149234573|NCT00910000|538328573|FG003|Overall Study|Withdrawal by Subject|0|||
149234574|NCT00910000|538328574|FG004|Overall Study|Withdrawal by Subject|1|||
149234575|NCT00910000|538328575|FG005|Overall Study|Withdrawal by Subject|0|||
149234576|NCT04637815|538328576|FG000|Overall Study|Death|1|||
149234577|NCT04637815|538328577|FG001|Overall Study|Death|0|||
149234578|NCT04637815|538328576|FG000|Overall Study|Lost to Follow-up|5|||
149234579|NCT04637815|538328577|FG001|Overall Study|Lost to Follow-up|2|||
149234580|NCT01977625|538328578|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
149234581|NCT01977625|538328579|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
149234582|NCT01977625|538328578|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
149234583|NCT01977625|538328579|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
149234584|NCT02594384|538328580|FG000|Overall Study|Disease Progression|3|||
149234585|NCT02594384|538328581|FG001|Overall Study|Disease Progression|7|||
149234586|NCT02594384|538328582|FG002|Overall Study|Disease Progression|0|||
149234587|NCT02594384|538328583|FG003|Overall Study|Disease Progression|2|||
149234588|NCT02594384|538328584|FG004|Overall Study|Disease Progression|2|||
149234589|NCT02594384|538328585|FG005|Overall Study|Disease Progression|12|||
149234590|NCT02594384|538328586|FG006|Overall Study|Disease Progression|5|||
149234591|NCT02594384|538328587|FG007|Overall Study|Disease Progression|5|||
149234592|NCT02594384|538328580|FG000|Overall Study|Adverse Event|0|||
149234593|NCT02594384|538328581|FG001|Overall Study|Adverse Event|1|||
149234594|NCT02594384|538328582|FG002|Overall Study|Adverse Event|4|||
149234595|NCT02594384|538328583|FG003|Overall Study|Adverse Event|1|||
149234596|NCT02594384|538328584|FG004|Overall Study|Adverse Event|0|||
149234597|NCT02594384|538328585|FG005|Overall Study|Adverse Event|6|||
149234598|NCT02594384|538328586|FG006|Overall Study|Adverse Event|1|||
149234599|NCT02594384|538328587|FG007|Overall Study|Adverse Event|1|||
149234600|NCT02594384|538328580|FG000|Overall Study|Withdrawal by Subject|0|||
149234601|NCT02594384|538328581|FG001|Overall Study|Withdrawal by Subject|0|||
149234602|NCT02594384|538328582|FG002|Overall Study|Withdrawal by Subject|0|||
149234603|NCT02594384|538328583|FG003|Overall Study|Withdrawal by Subject|1|||
149234604|NCT02594384|538328584|FG004|Overall Study|Withdrawal by Subject|0|||
149234605|NCT02594384|538328585|FG005|Overall Study|Withdrawal by Subject|0|||
149234606|NCT02594384|538328586|FG006|Overall Study|Withdrawal by Subject|0|||
149234607|NCT02594384|538328587|FG007|Overall Study|Withdrawal by Subject|1|||
149234608|NCT02594384|538328580|FG000|Overall Study|Physician Decision|0|||
149234609|NCT02594384|538328581|FG001|Overall Study|Physician Decision|0|||
149234610|NCT02594384|538328582|FG002|Overall Study|Physician Decision|0|||
149234611|NCT02594384|538328583|FG003|Overall Study|Physician Decision|0|||
149234612|NCT02594384|538328584|FG004|Overall Study|Physician Decision|0|||
149234613|NCT02594384|538328585|FG005|Overall Study|Physician Decision|1|||
149234614|NCT02594384|538328586|FG006|Overall Study|Physician Decision|2|||
149234615|NCT02594384|538328587|FG007|Overall Study|Physician Decision|0|||
149234616|NCT02594384|538328580|FG000|Overall Study|Progressive Leukocytosis|0|||
149234617|NCT02594384|538328581|FG001|Overall Study|Progressive Leukocytosis|0|||
149234618|NCT02594384|538328582|FG002|Overall Study|Progressive Leukocytosis|1|||
149234619|NCT02594384|538328583|FG003|Overall Study|Progressive Leukocytosis|0|||
149234620|NCT02594384|538328584|FG004|Overall Study|Progressive Leukocytosis|0|||
149234621|NCT02594384|538328585|FG005|Overall Study|Progressive Leukocytosis|0|||
149234622|NCT02594384|538328586|FG006|Overall Study|Progressive Leukocytosis|0|||
149234623|NCT02594384|538328587|FG007|Overall Study|Progressive Leukocytosis|0|||
149234624|NCT02594384|538328580|FG000|Overall Study|Lack of Efficacy|0|||
149234625|NCT02594384|538328581|FG001|Overall Study|Lack of Efficacy|0|||
149234626|NCT02594384|538328582|FG002|Overall Study|Lack of Efficacy|0|||
149234627|NCT02594384|538328583|FG003|Overall Study|Lack of Efficacy|0|||
149234628|NCT02594384|538328584|FG004|Overall Study|Lack of Efficacy|1|||
149234629|NCT02594384|538328585|FG005|Overall Study|Lack of Efficacy|0|||
149234630|NCT02594384|538328586|FG006|Overall Study|Lack of Efficacy|0|||
149234631|NCT02594384|538328587|FG007|Overall Study|Lack of Efficacy|0|||
149234632|NCT02594384|538328580|FG000|Overall Study|Substantial noncompliance|0|||
149234633|NCT02594384|538328581|FG001|Overall Study|Substantial noncompliance|0|||
149234634|NCT02594384|538328582|FG002|Overall Study|Substantial noncompliance|0|||
149234635|NCT02594384|538328583|FG003|Overall Study|Substantial noncompliance|0|||
149234636|NCT02594384|538328584|FG004|Overall Study|Substantial noncompliance|0|||
149234637|NCT02594384|538328585|FG005|Overall Study|Substantial noncompliance|0|||
149234638|NCT02594384|538328586|FG006|Overall Study|Substantial noncompliance|1|||
149234639|NCT02594384|538328587|FG007|Overall Study|Substantial noncompliance|0|||
149234640|NCT03919669|538328591|FG000|Overall Study|Withdrawal by Subject|1|||
149234641|NCT03919669|538328592|FG001|Overall Study|Withdrawal by Subject|0|||
149234642|NCT03919669|538328593|FG002|Overall Study|Withdrawal by Subject|0|||
149234643|NCT02319642|538328594|FG000|Overall Study|Adverse Event|2|||
149234644|NCT02319642|538328595|FG001|Overall Study|Adverse Event|4|||
149234645|NCT02319642|538328594|FG000|Overall Study|Lack of Efficacy|1|||
149234646|NCT02319642|538328595|FG001|Overall Study|Lack of Efficacy|1|||
149234647|NCT02319642|538328594|FG000|Overall Study|Withdrawal by Subject|1|||
149234648|NCT02319642|538328595|FG001|Overall Study|Withdrawal by Subject|1|||
149234649|NCT01265875|538328596|FG000|Overall Study|Uncooperative/unreliable|1|||
149234650|NCT04409509|538328597|FG000|Overall Study|Failure to meet randomization requirement|1|||
149234651|NCT04409509|538328598|FG001|Overall Study|Failure to meet randomization requirement|0|||
149234652|NCT04409509|538328597|FG000|Overall Study|Adverse Event|0|||
149234653|NCT04409509|538328598|FG001|Overall Study|Adverse Event|1|||
149234654|NCT04409509|538328597|FG000|Overall Study|Death|11|||
149234655|NCT04409509|538328598|FG001|Overall Study|Death|10|||
149234656|NCT04409509|538328597|FG000|Overall Study|Non-compliance with study drug|0|||
149234657|NCT04409509|538328598|FG001|Overall Study|Non-compliance with study drug|1|||
149234658|NCT04409509|538328597|FG000|Overall Study|Lost to Follow-up|0|||
149234659|NCT04409509|538328598|FG001|Overall Study|Lost to Follow-up|3|||
149234660|NCT04409509|538328597|FG000|Overall Study|Withdrawal by Subject|0|||
149234661|NCT04409509|538328598|FG001|Overall Study|Withdrawal by Subject|3|||
149234662|NCT04409509|538328597|FG000|Overall Study|Randomized by mistake|0|||
149234663|NCT04409509|538328598|FG001|Overall Study|Randomized by mistake|1|||
149234664|NCT04409509|538328597|FG000|Overall Study|Other|1|||
149234665|NCT04409509|538328598|FG001|Overall Study|Other|1|||
149234666|NCT02331680|538328601|FG000|Overall Study|Adverse Event|3|||
149234667|NCT02331680|538328602|FG001|Overall Study|Adverse Event|0|||
149234668|NCT02331680|538328603|FG002|Overall Study|Adverse Event|2|||
149234669|NCT02331680|538328601|FG000|Overall Study|Physician Decision|1|||
149234670|NCT02331680|538328602|FG001|Overall Study|Physician Decision|1|||
149234671|NCT02331680|538328603|FG002|Overall Study|Physician Decision|2|||
149234672|NCT02331680|538328601|FG000|Overall Study|Withdrawal by Subject|0|||
149234673|NCT02331680|538328602|FG001|Overall Study|Withdrawal by Subject|1|||
149234674|NCT02331680|538328603|FG002|Overall Study|Withdrawal by Subject|2|||
149234675|NCT02331680|538328601|FG000|Overall Study|Met withdrawal criteria|2|||
149234676|NCT02331680|538328602|FG001|Overall Study|Met withdrawal criteria|2|||
149234677|NCT02331680|538328603|FG002|Overall Study|Met withdrawal criteria|5|||
149234678|NCT02331680|538328601|FG000|Overall Study|Non-compliance with study drug|0|||
149234679|NCT02331680|538328602|FG001|Overall Study|Non-compliance with study drug|0|||
149234680|NCT02331680|538328603|FG002|Overall Study|Non-compliance with study drug|1|||
149234681|NCT02331680|538328601|FG000|Overall Study|Protocol Violation|0|||
149234682|NCT02331680|538328602|FG001|Overall Study|Protocol Violation|0|||
149234683|NCT02331680|538328603|FG002|Overall Study|Protocol Violation|3|||
149234684|NCT05147311|538328604|FG000|Overall Study|Did not complete survey|2|||
149234685|NCT05147311|538328605|FG001|Overall Study|Did not complete survey|1|||
149234686|NCT05147311|538328604|FG000|Overall Study|Patient too sick|1|||
149234687|NCT05147311|538328605|FG001|Overall Study|Patient too sick|2|||
149234688|NCT05147311|538328604|FG000|Overall Study|Death|0|||
149234689|NCT05147311|538328605|FG001|Overall Study|Death|1|||
149234690|NCT05147311|538328604|FG000|Overall Study|Declined survey|1|||
149234691|NCT05147311|538328605|FG001|Overall Study|Declined survey|0|||
149234692|NCT00145795|538328607|FG000|Overall Study|Adverse Event|1|||
149234693|NCT00145795|538328608|FG001|Overall Study|Adverse Event|0|||
149234694|NCT04505592|538328609|FG000|Overall Study|Death|2|||
149234695|NCT04505592|538328610|FG001|Overall Study|Death|1|||
149234696|NCT03480243|538328612|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
149234697|NCT03480243|538328612|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
149234698|NCT02388906|538328621|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
149234699|NCT02388906|538328622|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
149234700|NCT02388906|538328621|FG000|Treatment Period|Disease progression|121|||
149234701|NCT02388906|538328622|FG001|Treatment Period|Disease progression|100|||
149234702|NCT02388906|538328621|FG000|Treatment Period|Study drug toxicity|41|||
149234703|NCT02388906|538328622|FG001|Treatment Period|Study drug toxicity|208|||
149234704|NCT02388906|538328621|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
149234705|NCT02388906|538328622|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
149234706|NCT02388906|538328621|FG000|Treatment Period|Participant request to stop treatment|5|||
149234707|NCT02388906|538328622|FG001|Treatment Period|Participant request to stop treatment|9|||
149234708|NCT02388906|538328621|FG000|Treatment Period|Participant withdrew consent|2|||
149234709|NCT02388906|538328622|FG001|Treatment Period|Participant withdrew consent|3|||
149234710|NCT02388906|538328621|FG000|Treatment Period|Poor/non-compliance|0|||
149234711|NCT02388906|538328622|FG001|Treatment Period|Poor/non-compliance|1|||
149234712|NCT02388906|538328621|FG000|Treatment Period|Participant no longer meets study criteria|0|||
149234713|NCT02388906|538328622|FG001|Treatment Period|Participant no longer meets study criteria|1|||
149234714|NCT02388906|538328621|FG000|Treatment Period|Other reasons|3|||
149234715|NCT02388906|538328622|FG001|Treatment Period|Other reasons|3|||
149234716|NCT05770401|538328631|FG000|Overall Study|Lost to Follow-up|5|||
149234717|NCT05770401|538328632|FG001|Overall Study|Lost to Follow-up|4|||
149234718|NCT00402298|538328633|FG000|Overall Study|Withdrawal by Subject|1|||
149234719|NCT00402298|538328634|FG001|Overall Study|Withdrawal by Subject|0|||
149234720|NCT04784455|538328635|FG000|Overall Study|Death|4|||
149234721|NCT04298229|538328638|FG000|Overall Study|Physician Decision|1|||
149234722|NCT04298229|538328639|FG001|Overall Study|Physician Decision|1|||
149234723|NCT04298229|538328638|FG000|Overall Study|Withdrawal by Subject|1|||
149234724|NCT04298229|538328639|FG001|Overall Study|Withdrawal by Subject|1|||
149234725|NCT04298229|538328638|FG000|Overall Study|Did not receive IV loop diuretics|2|||
149234726|NCT04298229|538328639|FG001|Overall Study|Did not receive IV loop diuretics|0|||
149234727|NCT05261126|538328644|FG000|Overall Study|Death|0|||
149234728|NCT05261126|538328645|FG001|Overall Study|Death|0|||
149234729|NCT05261126|538328646|FG002|Overall Study|Death|1|||
149234730|NCT05261126|538328647|FG003|Overall Study|Death|0|||
149234731|NCT05261126|538328648|FG004|Overall Study|Death|0|||
149234732|NCT05261126|538328644|FG000|Overall Study|Lost to Follow-up|0|||
149234733|NCT05261126|538328645|FG001|Overall Study|Lost to Follow-up|0|||
149234734|NCT05261126|538328646|FG002|Overall Study|Lost to Follow-up|0|||
149234735|NCT05261126|538328647|FG003|Overall Study|Lost to Follow-up|0|||
149234736|NCT05261126|538328648|FG004|Overall Study|Lost to Follow-up|1|||
149234737|NCT05261126|538328644|FG000|Overall Study|Physician Decision|1|||
149234738|NCT05261126|538328645|FG001|Overall Study|Physician Decision|0|||
149234739|NCT05261126|538328646|FG002|Overall Study|Physician Decision|0|||
149234740|NCT05261126|538328647|FG003|Overall Study|Physician Decision|0|||
149234741|NCT05261126|538328648|FG004|Overall Study|Physician Decision|0|||
149234742|NCT05261126|538328644|FG000|Overall Study|Screen Failure|0|||
149234743|NCT05261126|538328645|FG001|Overall Study|Screen Failure|0|||
149234744|NCT05261126|538328646|FG002|Overall Study|Screen Failure|0|||
149234745|NCT05261126|538328647|FG003|Overall Study|Screen Failure|0|||
149234746|NCT05261126|538328648|FG004|Overall Study|Screen Failure|1|||
149234747|NCT05261126|538328644|FG000|Overall Study|Withdrawal by Subject|1|||
149234748|NCT05261126|538328645|FG001|Overall Study|Withdrawal by Subject|0|||
149234749|NCT05261126|538328646|FG002|Overall Study|Withdrawal by Subject|1|||
149234750|NCT05261126|538328647|FG003|Overall Study|Withdrawal by Subject|1|||
149234751|NCT05261126|538328648|FG004|Overall Study|Withdrawal by Subject|0|||
149234752|NCT05261126|538328644|FG000|Overall Study|Not Recorded|0|||
149234753|NCT05261126|538328645|FG001|Overall Study|Not Recorded|0|||
149234754|NCT05261126|538328646|FG002|Overall Study|Not Recorded|0|||
149234755|NCT05261126|538328647|FG003|Overall Study|Not Recorded|1|||
149234756|NCT05261126|538328648|FG004|Overall Study|Not Recorded|0|||
149234757|NCT05939388|538328649|FG000|Overall Study|Lost to Follow-up|1|||
149234758|NCT03901274|538328650|FG000|Overall Study|Lost to Follow-up|120|||
149234759|NCT03901274|538328651|FG001|Overall Study|Lost to Follow-up|124|||
149234760|NCT03901274|538328650|FG000|Overall Study|Withdrawal by Subject|0|||
149234761|NCT03901274|538328651|FG001|Overall Study|Withdrawal by Subject|6|||
149234762|NCT05570604|538328652|FG000|Overall Study|Lost to Follow-up|1|||
149234763|NCT05570604|538328653|FG001|Overall Study|Lost to Follow-up|5|||
149234764|NCT05570604|538328652|FG000|Overall Study|Illness|2|||
149234765|NCT05570604|538328653|FG001|Overall Study|Illness|2|||
149234766|NCT04527380|538328656|FG000|Overall Study|Lack of Efficacy|0|||
149234767|NCT04527380|538328657|FG001|Overall Study|Lack of Efficacy|1|||
149234768|NCT04527380|538328656|FG000|Overall Study|Withdrawal by Subject|1|||
149234769|NCT04527380|538328657|FG001|Overall Study|Withdrawal by Subject|0|||
149234770|NCT01869959|538328671|FG000|Randomization Period|Physician Decision|0|||
149234771|NCT01869959|538328672|FG001|Randomization Period|Physician Decision|0|||
149234772|NCT01869959|538328673|FG002|Randomization Period|Physician Decision|0|||
149234773|NCT01869959|538328674|FG003|Randomization Period|Physician Decision|0|||
149234774|NCT01869959|538328675|FG004|Randomization Period|Physician Decision|1|||
149234775|NCT01869959|538328671|FG000|Treatment Period|Adverse Event|1|||
149234776|NCT01869959|538328672|FG001|Treatment Period|Adverse Event|0|||
149234777|NCT01869959|538328673|FG002|Treatment Period|Adverse Event|3|||
149234778|NCT01869959|538328674|FG003|Treatment Period|Adverse Event|1|||
149234779|NCT01869959|538328675|FG004|Treatment Period|Adverse Event|0|||
149234780|NCT01869959|538328671|FG000|Treatment Period|Sponsor decision|0|||
149234781|NCT01869959|538328672|FG001|Treatment Period|Sponsor decision|1|||
149234782|NCT01869959|538328673|FG002|Treatment Period|Sponsor decision|0|||
149234783|NCT01869959|538328674|FG003|Treatment Period|Sponsor decision|1|||
149234784|NCT01869959|538328675|FG004|Treatment Period|Sponsor decision|0|||
149234785|NCT01869959|538328671|FG000|Treatment Period|Withdrawal by Subject|0|||
149234786|NCT01869959|538328672|FG001|Treatment Period|Withdrawal by Subject|1|||
149234787|NCT01869959|538328673|FG002|Treatment Period|Withdrawal by Subject|0|||
149234788|NCT01869959|538328674|FG003|Treatment Period|Withdrawal by Subject|0|||
149234789|NCT01869959|538328675|FG004|Treatment Period|Withdrawal by Subject|0|||
149234790|NCT01965600|538328676|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
149234791|NCT01965600|538328677|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
149234792|NCT01965600|538328678|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
149234793|NCT01965600|538328679|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
149234794|NCT01965600|538328676|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
149234795|NCT01965600|538328677|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
149234796|NCT01965600|538328678|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
149234797|NCT01965600|538328679|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
149234798|NCT01965600|538328676|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
149234799|NCT01965600|538328677|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
149234800|NCT01965600|538328678|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
149234801|NCT01965600|538328679|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
149234802|NCT01965600|538328676|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
149234803|NCT01965600|538328677|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
149234804|NCT01965600|538328678|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
149234805|NCT01965600|538328679|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
149234806|NCT01965600|538328676|FG000|Second Intervention|Study terminated by Sponsor|0|||
149234807|NCT01965600|538328677|FG001|Second Intervention|Study terminated by Sponsor|0|||
149234808|NCT01965600|538328678|FG002|Second Intervention|Study terminated by Sponsor|2|||
149234809|NCT01965600|538328679|FG003|Second Intervention|Study terminated by Sponsor|2|||
149234810|NCT02983305|538330293|FG000|Overall Study|incomplete data|2|||
149234811|NCT02983305|538330294|FG001|Overall Study|incomplete data|0|||
149234812|NCT00822237|538330295|FG000|Dose 1 Vaccination|Not vaccinated|3|||
149234813|NCT00822237|538330296|FG001|Dose 1 Vaccination|Not vaccinated|0|||
149234814|NCT00822237|538330295|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
149234815|NCT00822237|538330296|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
149234816|NCT00822237|538330295|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
149234817|NCT00822237|538330296|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
149234818|NCT00822237|538330295|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
149234819|NCT00822237|538330296|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
149234820|NCT00822237|538330295|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
149234821|NCT00822237|538330296|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
149234822|NCT00347776|538330297|FG000|1.5 Month Follow-up|Death|2|||
149234823|NCT00347776|538330298|FG001|1.5 Month Follow-up|Death|0|||
149234824|NCT00347776|538330299|FG002|1.5 Month Follow-up|Death|0|||
149234825|NCT00347776|538330297|FG000|1.5 Month Follow-up|reached the endpoint|12|||
149234826|NCT00347776|538330298|FG001|1.5 Month Follow-up|reached the endpoint|8|||
149234827|NCT00347776|538330299|FG002|1.5 Month Follow-up|reached the endpoint|12|||
149234828|NCT00347776|538330297|FG000|6 Month Follow-up|Death|2|||
149234829|NCT00347776|538330298|FG001|6 Month Follow-up|Death|1|||
149234830|NCT00347776|538330299|FG002|6 Month Follow-up|Death|3|||
149234831|NCT00347776|538330297|FG000|6 Month Follow-up|reached endpont|20|||
149234832|NCT00347776|538330298|FG001|6 Month Follow-up|reached endpont|12|||
149234833|NCT00347776|538330299|FG002|6 Month Follow-up|reached endpont|15|||
149234834|NCT00347776|538330297|FG000|12 Month Follow-up|Lost to Follow-up|7|||
149234835|NCT00347776|538330298|FG001|12 Month Follow-up|Lost to Follow-up|6|||
149234836|NCT00347776|538330299|FG002|12 Month Follow-up|Lost to Follow-up|6|||
149234837|NCT00347776|538330297|FG000|12 Month Follow-up|Death|3|||
149234838|NCT00347776|538330298|FG001|12 Month Follow-up|Death|4|||
149234839|NCT00347776|538330299|FG002|12 Month Follow-up|Death|4|||
149234840|NCT00347776|538330297|FG000|12 Month Follow-up|Reached endpoint|13|||
149234841|NCT00347776|538330298|FG001|12 Month Follow-up|Reached endpoint|6|||
149234842|NCT00347776|538330299|FG002|12 Month Follow-up|Reached endpoint|9|||
149234843|NCT04621227|538330304|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
149234844|NCT04621227|538330304|FG000|Period 3 (29 Days)|Adverse Event|1|||
149234845|NCT04621227|538330304|FG000|Period 8 (2 Days)|Adverse Event|1|||
149234846|NCT00938392|538330305|FG000|Overall Study|Adverse Event|0|||
149234847|NCT00938392|538330306|FG001|Overall Study|Adverse Event|1|||
149234848|NCT00938392|538330305|FG000|Overall Study|Withdrawal by Subject|0|||
149234849|NCT00938392|538330306|FG001|Overall Study|Withdrawal by Subject|1|||
149234850|NCT00938392|538330305|FG000|Overall Study|Lost to Follow-up|2|||
149234851|NCT00938392|538330306|FG001|Overall Study|Lost to Follow-up|2|||
149234852|NCT02916056|538330307|FG000|Overall Study|Adverse Event|6|||
149234853|NCT02916056|538330307|FG000|Overall Study|Lost to Follow-up|1|||
149234854|NCT02916056|538330307|FG000|Overall Study|Other|12|||
149234855|NCT02916056|538330307|FG000|Overall Study|Protocol Violation|1|||
149234856|NCT02916056|538330307|FG000|Overall Study|Withdrawal by Subject|8|||
149234857|NCT02916056|538330307|FG000|Overall Study|Study Terminated by Sponsor|269|||
149234858|NCT00124709|538330308|FG000|Overall Study|Randomized but did not take medication|3|||
149234859|NCT00124709|538330309|FG001|Overall Study|Randomized but did not take medication|1|||
149234860|NCT00124709|538330308|FG000|Overall Study|Adverse Event|3|||
149234861|NCT00124709|538330309|FG001|Overall Study|Adverse Event|0|||
149234862|NCT00124709|538330308|FG000|Overall Study|Lack of Efficacy|5|||
149234863|NCT00124709|538330309|FG001|Overall Study|Lack of Efficacy|10|||
149234864|NCT00124709|538330308|FG000|Overall Study|Protocol Violation|3|||
149234865|NCT00124709|538330309|FG001|Overall Study|Protocol Violation|5|||
149234866|NCT00124709|538330308|FG000|Overall Study|Withdrawal by Subject|127|||
149234867|NCT00124709|538330309|FG001|Overall Study|Withdrawal by Subject|136|||
149234868|NCT00124709|538330308|FG000|Overall Study|Lost to Follow-up|114|||
149234869|NCT00124709|538330309|FG001|Overall Study|Lost to Follow-up|120|||
149234870|NCT00122954|538330310|FG000|Overall Study|Withdrawal by Subject|2|||
149234871|NCT00122954|538330311|FG001|Overall Study|Withdrawal by Subject|2|||
149234872|NCT00122954|538330310|FG000|Overall Study|Protocol Violation|0|||
149234873|NCT00122954|538330311|FG001|Overall Study|Protocol Violation|1|||
149234874|NCT01728376|538330312|FG000|Overall Study|Adverse Event|1|||
149234875|NCT01728376|538330313|FG001|Overall Study|Adverse Event|1|||
149234876|NCT01728376|538330314|FG002|Overall Study|Adverse Event|1|||
149234877|NCT01728376|538330315|FG003|Overall Study|Adverse Event|1|||
149234878|NCT01728376|538330316|FG004|Overall Study|Adverse Event|1|||
149234879|NCT01728376|538330317|FG005|Overall Study|Adverse Event|0|||
149234880|NCT01728376|538330312|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
149234881|NCT01728376|538330313|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
149234882|NCT01728376|538330314|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
149234883|NCT01728376|538330315|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
149234884|NCT01728376|538330316|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
149234885|NCT01728376|538330317|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
149234886|NCT01728376|538330312|FG000|Overall Study|No relevant bacteria|2|||
149234887|NCT01728376|538330313|FG001|Overall Study|No relevant bacteria|0|||
149121121|NCT00320528|537920057|FG000|Study Period III|Physician Decision|0|||
149121122|NCT00320528|537920058|FG001|Study Period III|Physician Decision|1|||
149121123|NCT00320528|537920059|FG002|Study Period III|Physician Decision|2|||
149121124|NCT00320528|537920057|FG000|Study Period III|Sponsor Decision|0|||
149121125|NCT00320528|537920058|FG001|Study Period III|Sponsor Decision|0|||
149121126|NCT00320528|537920059|FG002|Study Period III|Sponsor Decision|1|||
149121127|NCT00320528|537920057|FG000|Study Period III|Atomoxetine Commercially Available|68|||
149121128|NCT00320528|537920058|FG001|Study Period III|Atomoxetine Commercially Available|25|||
149121129|NCT00320528|537920059|FG002|Study Period III|Atomoxetine Commercially Available|90|||
149121130|NCT00513305|537920065|FG000|Overall Study|Adverse Event|6|||
149121131|NCT00513305|537920066|FG001|Overall Study|Adverse Event|2|||
149121132|NCT00513305|537920065|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
149234888|NCT01728376|538330314|FG002|Overall Study|No relevant bacteria|0|||
149234889|NCT01728376|538330315|FG003|Overall Study|No relevant bacteria|0|||
149234890|NCT01728376|538330316|FG004|Overall Study|No relevant bacteria|1|||
149234891|NCT01728376|538330317|FG005|Overall Study|No relevant bacteria|1|||
149234892|NCT01728376|538330312|FG000|Overall Study|Did not receive treatment|0|||
149234893|NCT01728376|538330313|FG001|Overall Study|Did not receive treatment|1|||
149234894|NCT01728376|538330314|FG002|Overall Study|Did not receive treatment|0|||
149234895|NCT01728376|538330315|FG003|Overall Study|Did not receive treatment|0|||
149234896|NCT01728376|538330316|FG004|Overall Study|Did not receive treatment|0|||
149234897|NCT01728376|538330317|FG005|Overall Study|Did not receive treatment|0|||
149234898|NCT01728376|538330312|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149234899|NCT01728376|538330313|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149234900|NCT01728376|538330314|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149234901|NCT01728376|538330315|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
149234902|NCT01728376|538330316|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
149234903|NCT01728376|538330317|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
149234904|NCT04341727|538330328|FG000|Overall Study|Withdrawal by Subject|0|||
149234905|NCT04341727|538330329|FG001|Overall Study|Withdrawal by Subject|0|||
149234906|NCT04341727|538330330|FG002|Overall Study|Withdrawal by Subject|1|||
149234907|NCT04341727|538330331|FG003|Overall Study|Withdrawal by Subject|0|||
149234908|NCT04341727|538330328|FG000|Overall Study|Lost to Follow-up|0|||
149234909|NCT04341727|538330329|FG001|Overall Study|Lost to Follow-up|0|||
149234910|NCT04341727|538330330|FG002|Overall Study|Lost to Follow-up|0|||
149234911|NCT04341727|538330331|FG003|Overall Study|Lost to Follow-up|1|||
149234912|NCT05604521|538330332|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
149234913|NCT05604521|538330333|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
149234914|NCT05604521|538330332|FG000|Overall Study|Adverse Event|1|||
149234915|NCT05604521|538330333|FG001|Overall Study|Adverse Event|0|||
149234916|NCT00057330|538330334|FG000|Overall Study|Adverse Event|9|||
149234917|NCT00057330|538330335|FG001|Overall Study|Adverse Event|12|||
149234918|NCT00057330|538330334|FG000|Overall Study|Death|1|||
149234919|NCT00057330|538330335|FG001|Overall Study|Death|0|||
149234920|NCT00057330|538330334|FG000|Overall Study|Protocol Violation|1|||
149234921|NCT00057330|538330335|FG001|Overall Study|Protocol Violation|1|||
149234922|NCT00057330|538330334|FG000|Overall Study|Withdrawal by Subject|115|||
149234923|NCT00057330|538330335|FG001|Overall Study|Withdrawal by Subject|84|||
149234924|NCT00057330|538330334|FG000|Overall Study|Lost to Follow-up|745|||
149234925|NCT00057330|538330335|FG001|Overall Study|Lost to Follow-up|617|||
149234926|NCT00057330|538330334|FG000|Overall Study|Physician Decision|1|||
149234927|NCT00057330|538330335|FG001|Overall Study|Physician Decision|0|||
149234928|NCT00057330|538330334|FG000|Overall Study|Other|260|||
149234929|NCT00057330|538330335|FG001|Overall Study|Other|206|||
149234930|NCT01491737|538330336|FG000|Overall Study|Withdrawal by Subject|20|||
149234931|NCT01491737|538330337|FG001|Overall Study|Withdrawal by Subject|17|||
149234932|NCT01491737|538330336|FG000|Overall Study|Lost to Follow-up|2|||
149234933|NCT01491737|538330337|FG001|Overall Study|Lost to Follow-up|10|||
149234934|NCT01491737|538330336|FG000|Overall Study|Death|63|||
149234935|NCT01491737|538330337|FG001|Overall Study|Death|57|||
149234936|NCT01491737|538330336|FG000|Overall Study|Study Termination by Sponsor|36|||
149234937|NCT01491737|538330337|FG001|Overall Study|Study Termination by Sponsor|36|||
149234938|NCT01491737|538330336|FG000|Overall Study|Reason Not Specified|8|||
149234939|NCT01491737|538330337|FG001|Overall Study|Reason Not Specified|9|||
149234940|NCT00812968|538330340|FG000|Overall Study|Relapse after erythroid response|6|||
149234941|NCT00812968|538330340|FG000|Overall Study|Disease progression|1|||
149234942|NCT00812968|538330340|FG000|Overall Study|No further treatment required|1|||
149234943|NCT00812968|538330340|FG000|Overall Study|Study closed due to marketing approval|3|||
149234944|NCT00494234|538330341|FG000|Overall Study|Withdrawal by Subject|1|||
149234945|NCT00494234|538330342|FG001|Overall Study|Withdrawal by Subject|0|||
149234946|NCT00494234|538330341|FG000|Overall Study|Disease progression|11|||
149234947|NCT00494234|538330342|FG001|Overall Study|Disease progression|8|||
149234948|NCT00494234|538330341|FG000|Overall Study|Death|2|||
149234949|NCT00494234|538330342|FG001|Overall Study|Death|1|||
149234950|NCT00505765|538330343|FG000|Overall Study|Withdrawal by Subject|1|||
149121133|NCT00513305|537920066|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
149121134|NCT00513305|537920065|FG000|Overall Study|Lack of Efficacy|8|||
149121135|NCT00513305|537920066|FG001|Overall Study|Lack of Efficacy|13|||
149234951|NCT00505765|538330344|FG001|Overall Study|Withdrawal by Subject|0|||
149234952|NCT00505765|538330345|FG002|Overall Study|Withdrawal by Subject|0|||
149234953|NCT00505765|538330343|FG000|Overall Study|Adverse Event|1|||
149234954|NCT00505765|538330344|FG001|Overall Study|Adverse Event|2|||
149234955|NCT00505765|538330345|FG002|Overall Study|Adverse Event|0|||
149234956|NCT00505765|538330343|FG000|Overall Study|Noncompliance|0|||
149234957|NCT00505765|538330344|FG001|Overall Study|Noncompliance|1|||
149234958|NCT00505765|538330345|FG002|Overall Study|Noncompliance|3|||
149234959|NCT02743117|538330346|FG000|Overall Study|Lost to Follow-up|0|||
149234960|NCT02743117|538330347|FG001|Overall Study|Lost to Follow-up|1|||
149234961|NCT02743117|538330346|FG000|Overall Study|Other|1|||
149234962|NCT02743117|538330347|FG001|Overall Study|Other|0|||
149234963|NCT01207219|538330349|FG000|Overall Study|changed diagnosis during study period|5|||
149234964|NCT01207219|538330350|FG001|Overall Study|changed diagnosis during study period|3|||
149234965|NCT01207219|538330351|FG002|Overall Study|changed diagnosis during study period|1|||
149234966|NCT01207219|538330349|FG000|Overall Study|Lost to Follow-up|6|||
149234967|NCT01207219|538330350|FG001|Overall Study|Lost to Follow-up|8|||
149234968|NCT01207219|538330351|FG002|Overall Study|Lost to Follow-up|6|||
149234969|NCT01453296|538330352|FG000|Treatment Period 1|Adverse Event|0|||
149234970|NCT01453296|538330353|FG001|Treatment Period 1|Adverse Event|1|||
149234971|NCT01453296|538330352|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
149234972|NCT01453296|538330353|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
149234973|NCT01453296|538330352|FG000|Treatment Period 2|Adverse Event|1|||
149234974|NCT01453296|538330353|FG001|Treatment Period 2|Adverse Event|0|||
149234975|NCT01453296|538330352|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149234976|NCT01453296|538330353|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149234977|NCT00620776|538330354|FG000|Overall Study|Did not receive treatment|3|||
149234978|NCT00620776|538330355|FG001|Overall Study|Did not receive treatment|5|||
149234979|NCT00620776|538330354|FG000|Overall Study|Adverse Event|2|||
149234980|NCT00620776|538330355|FG001|Overall Study|Adverse Event|3|||
149234981|NCT00620776|538330354|FG000|Overall Study|Lack of Efficacy|2|||
149234982|NCT00620776|538330355|FG001|Overall Study|Lack of Efficacy|1|||
149234983|NCT00620776|538330354|FG000|Overall Study|Lost to Follow-up|2|||
149234984|NCT00620776|538330355|FG001|Overall Study|Lost to Follow-up|5|||
149234985|NCT00620776|538330354|FG000|Overall Study|Withdrawal by Subject|3|||
149234986|NCT00620776|538330355|FG001|Overall Study|Withdrawal by Subject|2|||
149234987|NCT00183170|538330359|FG000|First Intervention|Did not complete study|1|||
149234988|NCT00183170|538330360|FG001|First Intervention|Did not complete study|0|||
149234989|NCT00183170|538330359|FG000|First Intervention|Did not meet targeted BrAC|1|||
149234990|NCT00183170|538330360|FG001|First Intervention|Did not meet targeted BrAC|0|||
149234991|NCT00183170|538330359|FG000|Washout 1 Week|Did not complete study|6|||
149234992|NCT00183170|538330360|FG001|Washout 1 Week|Did not complete study|8|||
149234993|NCT00183170|538330359|FG000|Second Intervention|Did not complete study|1|||
149234994|NCT00183170|538330360|FG001|Second Intervention|Did not complete study|0|||
149234995|NCT00183170|538330359|FG000|Second Intervention|Did not meet targeted BrAC|0|||
149234996|NCT00183170|538330360|FG001|Second Intervention|Did not meet targeted BrAC|2|||
149234997|NCT00761969|538330361|FG000|Overall Study|Death|112|||
149234998|NCT00761969|538330362|FG001|Overall Study|Death|47|||
149234999|NCT00761969|538330361|FG000|Overall Study|Lost to Follow-up|88|||
149235000|NCT00761969|538330362|FG001|Overall Study|Lost to Follow-up|93|||
149235001|NCT00483119|538330367|FG000|Overall Study|Adverse Event|0|||
149235002|NCT00483119|538330368|FG001|Overall Study|Adverse Event|1|||
149235003|NCT00483119|538330367|FG000|Overall Study|Physician Decision|1|||
149235004|NCT00483119|538330368|FG001|Overall Study|Physician Decision|0|||
149235005|NCT04668066|538330369|FG000|Part 1: Treatment Phase|Adverse Event|0|||
149235006|NCT04668066|538330370|FG001|Part 1: Treatment Phase|Adverse Event|0|||
149235007|NCT04668066|538330371|FG002|Part 1: Treatment Phase|Adverse Event|0|||
149235008|NCT04668066|538330372|FG003|Part 1: Treatment Phase|Adverse Event|0|||
149235009|NCT04668066|538330373|FG004|Part 1: Treatment Phase|Adverse Event|0|||
149235010|NCT04668066|538330374|FG005|Part 1: Treatment Phase|Adverse Event|0|||
149235011|NCT04668066|538330375|FG006|Part 1: Treatment Phase|Adverse Event|0|||
149235012|NCT04668066|538330376|FG007|Part 1: Treatment Phase|Adverse Event|0|||
149235013|NCT04668066|538330377|FG008|Part 1: Treatment Phase|Adverse Event|0|||
149235014|NCT04668066|538330378|FG009|Part 1: Treatment Phase|Adverse Event|0|||
149235015|NCT04668066|538330379|FG010|Part 1: Treatment Phase|Adverse Event|0|||
149235016|NCT04668066|538330380|FG011|Part 1: Treatment Phase|Adverse Event|1|||
149235017|NCT04668066|538330381|FG012|Part 1: Treatment Phase|Adverse Event|1|||
149235018|NCT04668066|538330382|FG013|Part 1: Treatment Phase|Adverse Event|0|||
149235019|NCT04668066|538330383|FG014|Part 1: Treatment Phase|Adverse Event|0|||
149235020|NCT04668066|538330384|FG015|Part 1: Treatment Phase|Adverse Event|0|||
149235021|NCT04668066|538330385|FG016|Part 1: Treatment Phase|Adverse Event|0|||
149235022|NCT04668066|538330386|FG017|Part 1: Treatment Phase|Adverse Event|0|||
149235023|NCT04668066|538330387|FG018|Part 1: Treatment Phase|Adverse Event|0|||
149235024|NCT04668066|538330369|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235025|NCT04668066|538330370|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235026|NCT04668066|538330371|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
149235027|NCT04668066|538330372|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235028|NCT04668066|538330373|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235029|NCT04668066|538330374|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235030|NCT04668066|538330375|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235031|NCT04668066|538330376|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235032|NCT04668066|538330377|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235033|NCT04668066|538330378|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235034|NCT04668066|538330379|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235035|NCT04668066|538330380|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235036|NCT04668066|538330381|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235037|NCT04668066|538330382|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235038|NCT04668066|538330383|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235039|NCT04668066|538330384|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235040|NCT04668066|538330385|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235041|NCT04668066|538330386|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235042|NCT04668066|538330387|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
149235043|NCT04668066|538330369|FG000|Part 1: Treatment Phase|Other|0|||
149235044|NCT04668066|538330370|FG001|Part 1: Treatment Phase|Other|0|||
149235045|NCT04668066|538330371|FG002|Part 1: Treatment Phase|Other|0|||
149235046|NCT04668066|538330372|FG003|Part 1: Treatment Phase|Other|0|||
149235047|NCT04668066|538330373|FG004|Part 1: Treatment Phase|Other|0|||
149235048|NCT04668066|538330374|FG005|Part 1: Treatment Phase|Other|0|||
149235049|NCT04668066|538330375|FG006|Part 1: Treatment Phase|Other|0|||
149235050|NCT04668066|538330376|FG007|Part 1: Treatment Phase|Other|0|||
149235051|NCT04668066|538330377|FG008|Part 1: Treatment Phase|Other|0|||
149235052|NCT04668066|538330378|FG009|Part 1: Treatment Phase|Other|0|||
149235053|NCT04668066|538330379|FG010|Part 1: Treatment Phase|Other|0|||
149235054|NCT04668066|538330380|FG011|Part 1: Treatment Phase|Other|1|||
149235055|NCT04668066|538330381|FG012|Part 1: Treatment Phase|Other|0|||
149235056|NCT04668066|538330382|FG013|Part 1: Treatment Phase|Other|0|||
149235057|NCT04668066|538330383|FG014|Part 1: Treatment Phase|Other|0|||
149235058|NCT04668066|538330384|FG015|Part 1: Treatment Phase|Other|0|||
149235059|NCT04668066|538330385|FG016|Part 1: Treatment Phase|Other|0|||
149235060|NCT04668066|538330386|FG017|Part 1: Treatment Phase|Other|0|||
149235061|NCT04668066|538330387|FG018|Part 1: Treatment Phase|Other|0|||
149235062|NCT04668066|538330369|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235063|NCT04668066|538330370|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235064|NCT04668066|538330371|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235065|NCT04668066|538330372|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235066|NCT04668066|538330373|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235067|NCT04668066|538330374|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235068|NCT04668066|538330375|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235069|NCT04668066|538330376|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235070|NCT04668066|538330377|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235071|NCT04668066|538330378|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235072|NCT04668066|538330379|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235073|NCT04668066|538330380|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235074|NCT04668066|538330381|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
149235075|NCT04668066|538330382|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235076|NCT04668066|538330383|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235077|NCT04668066|538330384|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
149235078|NCT04668066|538330385|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235079|NCT04668066|538330386|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235080|NCT04668066|538330387|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
149235081|NCT04668066|538330369|FG000|Part 1: Follow-Up|Adverse Event|0|||
149235082|NCT04668066|538330370|FG001|Part 1: Follow-Up|Adverse Event|0|||
149235083|NCT04668066|538330371|FG002|Part 1: Follow-Up|Adverse Event|0|||
149235084|NCT04668066|538330372|FG003|Part 1: Follow-Up|Adverse Event|0|||
149235085|NCT04668066|538330373|FG004|Part 1: Follow-Up|Adverse Event|0|||
149235086|NCT04668066|538330374|FG005|Part 1: Follow-Up|Adverse Event|0|||
149235087|NCT04668066|538330375|FG006|Part 1: Follow-Up|Adverse Event|0|||
149235088|NCT04668066|538330376|FG007|Part 1: Follow-Up|Adverse Event|0|||
148893191|NCT02426580|537088631|FG000|Overall Study|Lost to Follow-up|0|||
149235089|NCT04668066|538330377|FG008|Part 1: Follow-Up|Adverse Event|0|||
149235090|NCT04668066|538330378|FG009|Part 1: Follow-Up|Adverse Event|0|||
149235091|NCT04668066|538330379|FG010|Part 1: Follow-Up|Adverse Event|0|||
149235092|NCT04668066|538330380|FG011|Part 1: Follow-Up|Adverse Event|1|||
149006831|NCT00871403|537503622|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
149235093|NCT04668066|538330381|FG012|Part 1: Follow-Up|Adverse Event|0|||
149235094|NCT04668066|538330382|FG013|Part 1: Follow-Up|Adverse Event|0|||
149235095|NCT04668066|538330383|FG014|Part 1: Follow-Up|Adverse Event|0|||
149235096|NCT04668066|538330384|FG015|Part 1: Follow-Up|Adverse Event|0|||
149235097|NCT04668066|538330385|FG016|Part 1: Follow-Up|Adverse Event|0|||
149235098|NCT04668066|538330386|FG017|Part 1: Follow-Up|Adverse Event|0|||
149235099|NCT04668066|538330387|FG018|Part 1: Follow-Up|Adverse Event|0|||
149235100|NCT04668066|538330369|FG000|Part 1: Follow-Up|Other|0|||
149235101|NCT04668066|538330370|FG001|Part 1: Follow-Up|Other|0|||
149235102|NCT04668066|538330371|FG002|Part 1: Follow-Up|Other|0|||
149121136|NCT00513305|537920065|FG000|Overall Study|Withdrawal by Subject|1|||
149121137|NCT00513305|537920066|FG001|Overall Study|Withdrawal by Subject|2|||
149121138|NCT00513305|537920065|FG000|Overall Study|Disease progression|8|||
149235103|NCT04668066|538330372|FG003|Part 1: Follow-Up|Other|0|||
149235104|NCT04668066|538330373|FG004|Part 1: Follow-Up|Other|0|||
149235105|NCT04668066|538330374|FG005|Part 1: Follow-Up|Other|0|||
149235106|NCT04668066|538330375|FG006|Part 1: Follow-Up|Other|0|||
149235107|NCT04668066|538330376|FG007|Part 1: Follow-Up|Other|0|||
149235108|NCT04668066|538330377|FG008|Part 1: Follow-Up|Other|0|||
149235109|NCT04668066|538330378|FG009|Part 1: Follow-Up|Other|0|||
149235110|NCT04668066|538330379|FG010|Part 1: Follow-Up|Other|0|||
149235111|NCT04668066|538330380|FG011|Part 1: Follow-Up|Other|1|||
149235112|NCT04668066|538330381|FG012|Part 1: Follow-Up|Other|1|||
149235113|NCT04668066|538330382|FG013|Part 1: Follow-Up|Other|0|||
149235114|NCT04668066|538330383|FG014|Part 1: Follow-Up|Other|0|||
149121139|NCT00513305|537920066|FG001|Overall Study|Disease progression|5|||
149235115|NCT04668066|538330384|FG015|Part 1: Follow-Up|Other|0|||
149235116|NCT04668066|538330385|FG016|Part 1: Follow-Up|Other|0|||
149235117|NCT04668066|538330386|FG017|Part 1: Follow-Up|Other|0|||
149235118|NCT04668066|538330387|FG018|Part 1: Follow-Up|Other|0|||
149235119|NCT04668066|538330369|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235120|NCT04668066|538330370|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235121|NCT04668066|538330371|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235122|NCT04668066|538330372|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235123|NCT04668066|538330373|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235124|NCT04668066|538330374|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235125|NCT04668066|538330375|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235126|NCT04668066|538330376|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235127|NCT04668066|538330377|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235128|NCT04668066|538330378|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235129|NCT04668066|538330379|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235130|NCT04668066|538330380|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235131|NCT04668066|538330381|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
149235132|NCT04668066|538330382|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235133|NCT04668066|538330383|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235134|NCT04668066|538330384|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
149235135|NCT04668066|538330385|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235136|NCT04668066|538330386|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235137|NCT04668066|538330387|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
149235138|NCT04668066|538330369|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235139|NCT04668066|538330370|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235140|NCT04668066|538330371|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235141|NCT04668066|538330372|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235142|NCT04668066|538330373|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235143|NCT04668066|538330374|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235144|NCT04668066|538330375|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235145|NCT04668066|538330376|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235146|NCT04668066|538330377|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235147|NCT04668066|538330378|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235148|NCT04668066|538330379|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235149|NCT04668066|538330380|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235150|NCT04668066|538330381|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235151|NCT04668066|538330382|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235152|NCT04668066|538330383|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235153|NCT04668066|538330384|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235154|NCT04668066|538330385|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235155|NCT04668066|538330386|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
149235156|NCT04668066|538330387|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
149235157|NCT04668066|538330369|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235158|NCT04668066|538330370|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235159|NCT04668066|538330371|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235160|NCT04668066|538330372|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235161|NCT04668066|538330373|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235162|NCT04668066|538330374|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235163|NCT04668066|538330375|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
148893192|NCT02426580|537088632|FG001|Overall Study|Lost to Follow-up|9|||
149235164|NCT04668066|538330376|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235165|NCT04668066|538330377|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235166|NCT04668066|538330378|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235167|NCT04668066|538330379|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235168|NCT04668066|538330380|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235169|NCT04668066|538330381|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235170|NCT04668066|538330382|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235171|NCT04668066|538330383|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235172|NCT04668066|538330384|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235173|NCT04668066|538330385|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235174|NCT04668066|538330386|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
149235175|NCT04668066|538330387|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
149235176|NCT04668066|538330369|FG000|Part 2: Treatment Phase|Other|0|||
149235177|NCT04668066|538330370|FG001|Part 2: Treatment Phase|Other|0|||
149235178|NCT04668066|538330371|FG002|Part 2: Treatment Phase|Other|0|||
149235179|NCT04668066|538330372|FG003|Part 2: Treatment Phase|Other|0|||
149235180|NCT04668066|538330373|FG004|Part 2: Treatment Phase|Other|0|||
149235181|NCT04668066|538330374|FG005|Part 2: Treatment Phase|Other|0|||
149235182|NCT04668066|538330375|FG006|Part 2: Treatment Phase|Other|0|||
149235183|NCT04668066|538330376|FG007|Part 2: Treatment Phase|Other|0|||
149235184|NCT04668066|538330377|FG008|Part 2: Treatment Phase|Other|0|||
149235185|NCT04668066|538330378|FG009|Part 2: Treatment Phase|Other|0|||
149235186|NCT04668066|538330379|FG010|Part 2: Treatment Phase|Other|0|||
149235187|NCT04668066|538330380|FG011|Part 2: Treatment Phase|Other|0|||
149235188|NCT04668066|538330381|FG012|Part 2: Treatment Phase|Other|0|||
149235189|NCT04668066|538330382|FG013|Part 2: Treatment Phase|Other|0|||
149235190|NCT04668066|538330383|FG014|Part 2: Treatment Phase|Other|0|||
149235191|NCT04668066|538330384|FG015|Part 2: Treatment Phase|Other|0|||
149235192|NCT04668066|538330385|FG016|Part 2: Treatment Phase|Other|0|||
149235193|NCT04668066|538330386|FG017|Part 2: Treatment Phase|Other|0|||
149235194|NCT04668066|538330387|FG018|Part 2: Treatment Phase|Other|1|||
149235195|NCT04668066|538330369|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235196|NCT04668066|538330370|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235197|NCT04668066|538330371|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235198|NCT04668066|538330372|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235199|NCT04668066|538330373|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235200|NCT04668066|538330374|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235201|NCT04668066|538330375|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235202|NCT04668066|538330376|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235203|NCT04668066|538330377|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235204|NCT04668066|538330378|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235205|NCT04668066|538330379|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235206|NCT04668066|538330380|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235207|NCT04668066|538330381|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235208|NCT04668066|538330382|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235209|NCT04668066|538330383|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235210|NCT04668066|538330384|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235211|NCT04668066|538330385|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235212|NCT04668066|538330386|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
149235213|NCT04668066|538330387|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
149235214|NCT02369874|538330388|FG000|Overall Study|Lost to Follow-up|2|||
149235215|NCT02369874|538330389|FG001|Overall Study|Lost to Follow-up|2|||
149235216|NCT02369874|538330390|FG002|Overall Study|Lost to Follow-up|2|||
149235217|NCT02369874|538330388|FG000|Overall Study|Withdrawal by Subject|7|||
149235218|NCT02369874|538330389|FG001|Overall Study|Withdrawal by Subject|9|||
149235219|NCT02369874|538330390|FG002|Overall Study|Withdrawal by Subject|27|||
149235220|NCT02369874|538330388|FG000|Overall Study|Miscellaneous|1|||
149235221|NCT02369874|538330389|FG001|Overall Study|Miscellaneous|1|||
149235222|NCT02369874|538330390|FG002|Overall Study|Miscellaneous|0|||
149235223|NCT02369874|538330388|FG000|Overall Study|On Treatment/Off Study|34|||
149235224|NCT02369874|538330389|FG001|Overall Study|On Treatment/Off Study|45|||
149235225|NCT02369874|538330390|FG002|Overall Study|On Treatment/Off Study|32|||
149235226|NCT00596466|538330391|FG000|Overall Study|Lack of Efficacy|5|||
149235227|NCT00596466|538330391|FG000|Overall Study|Adverse Event|4|||
149235228|NCT00596466|538330391|FG000|Overall Study|Withdrawal by Subject|2|||
149235229|NCT00596466|538330391|FG000|Overall Study|Protocol Violation|2|||
149235230|NCT00596466|538330391|FG000|Overall Study|Unpecified|2|||
149235231|NCT00596466|538330391|FG000|Overall Study|Enrolled, not treated|2|||
149235232|NCT01891669|538330392|FG000|Overall Study|Death|0|||
149235233|NCT01891669|538330393|FG001|Overall Study|Death|0|||
149235234|NCT01891669|538330394|FG002|Overall Study|Death|0|||
149235235|NCT01891669|538330395|FG003|Overall Study|Death|0|||
148779710|NCT00934856|536668022|FG002|Extension Part|Progressive disease|0|||
149235236|NCT01891669|538330396|FG004|Overall Study|Death|0|||
149235237|NCT01891669|538330397|FG005|Overall Study|Death|0|||
149235238|NCT01891669|538330398|FG006|Overall Study|Death|0|||
149235239|NCT01891669|538330399|FG007|Overall Study|Death|1|||
149235240|NCT01891669|538330400|FG008|Overall Study|Death|0|||
149006832|NCT00871403|537503620|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
149235241|NCT01891669|538330401|FG009|Overall Study|Death|1|||
149235242|NCT01891669|538330392|FG000|Overall Study|Withdrawal by Subject|1|||
149235243|NCT01891669|538330393|FG001|Overall Study|Withdrawal by Subject|1|||
149235244|NCT01891669|538330394|FG002|Overall Study|Withdrawal by Subject|0|||
149235245|NCT01891669|538330395|FG003|Overall Study|Withdrawal by Subject|0|||
149235246|NCT01891669|538330396|FG004|Overall Study|Withdrawal by Subject|0|||
149235247|NCT01891669|538330397|FG005|Overall Study|Withdrawal by Subject|0|||
149235248|NCT01891669|538330398|FG006|Overall Study|Withdrawal by Subject|1|||
149235249|NCT01891669|538330399|FG007|Overall Study|Withdrawal by Subject|2|||
149235250|NCT01891669|538330400|FG008|Overall Study|Withdrawal by Subject|1|||
149235251|NCT01891669|538330401|FG009|Overall Study|Withdrawal by Subject|1|||
149235252|NCT01891669|538330392|FG000|Overall Study|Other|1|||
149235253|NCT01891669|538330393|FG001|Overall Study|Other|0|||
149235254|NCT01891669|538330394|FG002|Overall Study|Other|0|||
149235255|NCT01891669|538330395|FG003|Overall Study|Other|0|||
149235256|NCT01891669|538330396|FG004|Overall Study|Other|0|||
149235257|NCT01891669|538330397|FG005|Overall Study|Other|0|||
149235258|NCT01891669|538330398|FG006|Overall Study|Other|0|||
149235259|NCT01891669|538330399|FG007|Overall Study|Other|1|||
149235260|NCT01891669|538330400|FG008|Overall Study|Other|0|||
149235261|NCT01891669|538330401|FG009|Overall Study|Other|0|||
149235262|NCT01015118|538330402|FG000|Overall Study|Protocol Violation|5|||
149235263|NCT01015118|538330403|FG001|Overall Study|Protocol Violation|6|||
149235264|NCT01015118|538330402|FG000|Overall Study|Withdrawal by Subject|103|||
149235265|NCT01015118|538330403|FG001|Overall Study|Withdrawal by Subject|27|||
149235266|NCT01015118|538330402|FG000|Overall Study|Other Adverse Event (AE)|141|||
149235267|NCT01015118|538330403|FG001|Overall Study|Other Adverse Event (AE)|33|||
149235268|NCT01015118|538330402|FG000|Overall Study|Worsening or AE of underlying disease|5|||
149235269|NCT01015118|538330403|FG001|Overall Study|Worsening or AE of underlying disease|4|||
149235270|NCT01015118|538330402|FG000|Overall Study|Progressive disease|364|||
149235271|NCT01015118|538330403|FG001|Overall Study|Progressive disease|229|||
149235272|NCT01015118|538330402|FG000|Overall Study|Not treated|9|||
149235273|NCT01015118|538330403|FG001|Overall Study|Not treated|5|||
149235274|NCT01015118|538330402|FG000|Overall Study|Other than stated above|42|||
149235275|NCT01015118|538330403|FG001|Overall Study|Other than stated above|23|||
149235276|NCT04365387|538330404|FG000|Overall Study|Adverse Event|4|||
149235277|NCT04365387|538330405|FG001|Overall Study|Adverse Event|2|||
149235278|NCT04365387|538330404|FG000|Overall Study|Participants request|14|||
149235279|NCT04365387|538330405|FG001|Overall Study|Participants request|14|||
149235280|NCT04365387|538330404|FG000|Overall Study|Lost to Follow-up|8|||
149235281|NCT04365387|538330405|FG001|Overall Study|Lost to Follow-up|5|||
149235282|NCT04365387|538330404|FG000|Overall Study|Protocol deviation|3|||
149235283|NCT04365387|538330405|FG001|Overall Study|Protocol deviation|4|||
149235284|NCT04365387|538330404|FG000|Overall Study|Participant compliance with visit schedule|1|||
149235285|NCT04365387|538330405|FG001|Overall Study|Participant compliance with visit schedule|0|||
149235286|NCT04365387|538330404|FG000|Overall Study|Participant incarcerated|1|||
149235287|NCT04365387|538330405|FG001|Overall Study|Participant incarcerated|0|||
149235288|NCT04365387|538330404|FG000|Overall Study|Participant moved out of town (relocated)|0|||
149235289|NCT04365387|538330405|FG001|Overall Study|Participant moved out of town (relocated)|1|||
149006833|NCT00871403|537503621|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
149235290|NCT04365387|538330404|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
149235291|NCT04365387|538330405|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
149235292|NCT04365387|538330404|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
149235293|NCT04365387|538330405|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
149235294|NCT00480077|538330406|FG000|Overall Study|Death|19|||
149235295|NCT00480077|538330407|FG001|Overall Study|Death|15|||
149235296|NCT00480077|538330406|FG000|Overall Study|early exit|12|||
149235297|NCT00480077|538330407|FG001|Overall Study|early exit|11|||
149235298|NCT00262119|538330408|FG000|Overall Study|Lost to Follow-up|38|||
149235299|NCT00262119|538330409|FG001|Overall Study|Lost to Follow-up|51|||
149235300|NCT00262119|538330410|FG002|Overall Study|Lost to Follow-up|42|||
149235301|NCT00262119|538330408|FG000|Overall Study|Death|20|||
149235302|NCT00262119|538330409|FG001|Overall Study|Death|19|||
149235303|NCT00262119|538330410|FG002|Overall Study|Death|16|||
149235304|NCT00071006|538330411|FG000|Overall Study|Lack of Efficacy|7|||
149235305|NCT00071006|538330411|FG000|Overall Study|Adverse Event|1|||
149235306|NCT00071006|538330411|FG000|Overall Study|Withdrawal by Subject|1|||
149235307|NCT00071006|538330411|FG000|Overall Study|Other|3|||
149235308|NCT00859313|538330412|FG000|Overall Study|Lack of Efficacy|2|||
149235309|NCT00859313|538330412|FG000|Overall Study|Adverse Event|1|||
149235310|NCT00859313|538330412|FG000|Overall Study|staff error|1|||
149235311|NCT00938366|538330413|FG000|Overall Study|Withdrawal by Subject|1|||
149235312|NCT00938366|538330414|FG001|Overall Study|Withdrawal by Subject|0|||
149235313|NCT01215968|538330417|FG000|Overall Study|Adverse Event|0|||
149235314|NCT01215968|538330418|FG001|Overall Study|Adverse Event|2|||
149235315|NCT01215968|538330417|FG000|Overall Study|Protocol Violation|2|||
149235316|NCT01215968|538330418|FG001|Overall Study|Protocol Violation|4|||
149235317|NCT01215968|538330417|FG000|Overall Study|Not received study drug|0|||
149235318|NCT01215968|538330418|FG001|Overall Study|Not received study drug|1|||
149235319|NCT02500732|538330421|FG000|Overall Study|Physician Decision|0|||
149235320|NCT02500732|538330422|FG001|Overall Study|Physician Decision|1|||
149235321|NCT01958619|538330423|FG000|Overall Study|Protocol Violation|2|||
149235322|NCT01958619|538330424|FG001|Overall Study|Protocol Violation|0|||
149235323|NCT01958619|538330425|FG002|Overall Study|Protocol Violation|1|||
149235324|NCT01958619|538330426|FG003|Overall Study|Protocol Violation|0|||
149235325|NCT03759340|538330429|FG000|Overall Study|Adverse Event|2|||
149235326|NCT03759340|538330429|FG000|Overall Study|Lost to Follow-up|1|||
149235327|NCT03759340|538330429|FG000|Overall Study|Withdrawal by Subject|15|||
149235328|NCT03759340|538330429|FG000|Overall Study|Study Terminated by Sponsor|38|||
149235329|NCT01054443|538330430|FG000|Overall Study|Withdrawal by Subject|0|||
149235330|NCT01054443|538330431|FG001|Overall Study|Withdrawal by Subject|0|||
149235331|NCT01054443|538330432|FG002|Overall Study|Withdrawal by Subject|0|||
149235332|NCT01054443|538330433|FG003|Overall Study|Withdrawal by Subject|1|||
149235333|NCT00985114|538330435|FG000|Overall Study|Adverse Event|1|||
149235334|NCT00985114|538330436|FG001|Overall Study|Adverse Event|0|||
149235335|NCT00985114|538330435|FG000|Overall Study|Withdrawal by Subject|0|||
149235336|NCT00985114|538330436|FG001|Overall Study|Withdrawal by Subject|2|||
149235337|NCT02950831|538330437|FG000|Overall Study|Lost to Follow-up|1|||
149235338|NCT02950831|538330437|FG000|Overall Study|Withdrawal by Subject|3|||
149235339|NCT02950831|538330437|FG000|Overall Study|stimulation trail failure|5|||
149235340|NCT01119118|538330438|FG000|Overall Study|Adverse Event|1|||
149235341|NCT04075656|538330444|FG000|Overall Study|Withdrawal by Subject|5|||
149235342|NCT04075656|538330445|FG001|Overall Study|Withdrawal by Subject|5|||
149235343|NCT00563706|538332458|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
149235344|NCT00563706|538332459|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149235345|NCT00563706|538332460|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149235346|NCT00563706|538332461|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149235347|NCT00563706|538332462|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
149235348|NCT00563706|538332463|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
149235349|NCT00563706|538332464|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
149235350|NCT00563706|538332465|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
149235351|NCT00563706|538332466|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
149235352|NCT00563706|538332458|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149235353|NCT00563706|538332459|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
149235354|NCT00563706|538332460|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149235355|NCT00563706|538332461|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
149235356|NCT00563706|538332462|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
149235357|NCT00563706|538332463|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149235358|NCT00563706|538332464|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
149235359|NCT00563706|538332465|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
149235360|NCT00563706|538332466|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
149235361|NCT00563706|538332458|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
149235362|NCT00563706|538332459|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
149235363|NCT00563706|538332460|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
149235364|NCT00563706|538332461|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
149235365|NCT00563706|538332462|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
149235366|NCT00563706|538332463|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
149235367|NCT00563706|538332464|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
149235368|NCT00563706|538332465|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
149235369|NCT00563706|538332466|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
149235370|NCT00563706|538332458|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
149235371|NCT00563706|538332459|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235372|NCT00563706|538332460|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235373|NCT00563706|538332461|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235374|NCT00563706|538332462|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235375|NCT00563706|538332463|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235376|NCT00563706|538332464|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235377|NCT00563706|538332465|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
149235378|NCT00563706|538332466|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
149235379|NCT00563706|538332458|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235380|NCT00563706|538332459|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235381|NCT00563706|538332460|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235382|NCT00563706|538332461|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235383|NCT00563706|538332462|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235384|NCT00563706|538332463|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235385|NCT00563706|538332464|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
149235386|NCT00563706|538332465|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
149235387|NCT00563706|538332466|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
149235388|NCT03280628|538332469|FG000|Overall Study|Lost to Follow-up|8|||
149235389|NCT03280628|538332470|FG001|Overall Study|Lost to Follow-up|6|||
149235390|NCT03280628|538332471|FG002|Overall Study|Lost to Follow-up|11|||
149235391|NCT01361308|538332474|FG000|Overall Study|Withdrawal by Subject|9|||
149235392|NCT01361308|538332475|FG001|Overall Study|Withdrawal by Subject|13|||
149235393|NCT01361308|538332474|FG000|Overall Study|Physician Decision|3|||
149235394|NCT01361308|538332475|FG001|Overall Study|Physician Decision|3|||
149235395|NCT01361308|538332474|FG000|Overall Study|Lack of Efficacy|2|||
149235396|NCT01361308|538332475|FG001|Overall Study|Lack of Efficacy|0|||
149235397|NCT01361308|538332474|FG000|Overall Study|Protocol Violation|1|||
149235398|NCT01361308|538332475|FG001|Overall Study|Protocol Violation|0|||
149235399|NCT01361308|538332474|FG000|Overall Study|Lost to Follow-up|5|||
149235400|NCT01361308|538332475|FG001|Overall Study|Lost to Follow-up|4|||
149235401|NCT01361308|538332474|FG000|Overall Study|Adverse Event|8|||
149235402|NCT01361308|538332475|FG001|Overall Study|Adverse Event|4|||
149235403|NCT01361308|538332474|FG000|Overall Study|Eligibility Criteria Not Met|2|||
149235404|NCT01361308|538332475|FG001|Overall Study|Eligibility Criteria Not Met|3|||
149235405|NCT01361308|538332474|FG000|Overall Study|Failed C-SSRS|5|||
149235406|NCT01361308|538332475|FG001|Overall Study|Failed C-SSRS|2|||
149235407|NCT01361308|538332474|FG000|Overall Study|Other|0|||
149235408|NCT01361308|538332475|FG001|Overall Study|Other|1|||
149235409|NCT03839693|538332480|FG000|Overall Study|Lost to Follow-up|0|||
149235410|NCT03839693|538332481|FG001|Overall Study|Lost to Follow-up|2|||
149235411|NCT03839693|538332482|FG002|Overall Study|Lost to Follow-up|2|||
149235412|NCT03839693|538332480|FG000|Overall Study|Withdrawal by Subject|1|||
149235413|NCT03839693|538332481|FG001|Overall Study|Withdrawal by Subject|0|||
149235414|NCT03839693|538332482|FG002|Overall Study|Withdrawal by Subject|2|||
149235415|NCT03839693|538332480|FG000|Overall Study|subject moved out of the area|1|||
149235416|NCT03839693|538332481|FG001|Overall Study|subject moved out of the area|0|||
149235417|NCT03839693|538332482|FG002|Overall Study|subject moved out of the area|0|||
149235418|NCT00700115|538332491|FG000|Overall Study|Withdrawal by Subject|1|||
149235419|NCT00700115|538332492|FG001|Overall Study|Withdrawal by Subject|0|||
149235420|NCT00700115|538332491|FG000|Overall Study|Lost to Follow-up|0|||
149235421|NCT00700115|538332492|FG001|Overall Study|Lost to Follow-up|1|||
149235422|NCT00706901|538332493|FG000|Overall Study|Lost to Follow-up|2|||
149235423|NCT00706901|538332494|FG001|Overall Study|Lost to Follow-up|3|||
149235424|NCT00706901|538332495|FG002|Overall Study|Lost to Follow-up|2|||
149235425|NCT00706901|538332493|FG000|Overall Study|Withdrawal by Subject|4|||
149235426|NCT00706901|538332494|FG001|Overall Study|Withdrawal by Subject|2|||
149235427|NCT00706901|538332495|FG002|Overall Study|Withdrawal by Subject|5|||
149235428|NCT00706901|538332493|FG000|Overall Study|In Jail|1|||
149235429|NCT00706901|538332494|FG001|Overall Study|In Jail|0|||
149235430|NCT00706901|538332495|FG002|Overall Study|In Jail|1|||
149235431|NCT00706901|538332493|FG000|Overall Study|Death|1|||
149235432|NCT00706901|538332494|FG001|Overall Study|Death|0|||
149235433|NCT00706901|538332495|FG002|Overall Study|Death|0|||
149235434|NCT01519635|538332498|FG000|Overall Study|Withdrawal by Subject|0|||
149235435|NCT01519635|538332499|FG001|Overall Study|Withdrawal by Subject|1|||
149235436|NCT01519635|538332498|FG000|Overall Study|No possibility to put a catheter|1|||
149235437|NCT01519635|538332499|FG001|Overall Study|No possibility to put a catheter|2|||
149235438|NCT00518531|538332500|FG000|Treatment Period 1|Adverse Event|5|||
149235439|NCT00518531|538332501|FG001|Treatment Period 1|Adverse Event|0|||
149235440|NCT00518531|538332500|FG000|Treatment Period 1|Lost to Follow-up|5|||
149235441|NCT00518531|538332501|FG001|Treatment Period 1|Lost to Follow-up|3|||
149235442|NCT00518531|538332500|FG000|Treatment Period 1|Physician Decision|1|||
149235443|NCT00518531|538332501|FG001|Treatment Period 1|Physician Decision|0|||
149235444|NCT00518531|538332500|FG000|Treatment Period 1|Protocol Violation|2|||
149235445|NCT00518531|538332501|FG001|Treatment Period 1|Protocol Violation|0|||
149235446|NCT00518531|538332500|FG000|Treatment Period 1|Withdrawal by Subject|4|||
149235447|NCT00518531|538332501|FG001|Treatment Period 1|Withdrawal by Subject|6|||
149235448|NCT00518531|538332500|FG000|Treatment Period 1|Early crossover|1|||
148779711|NCT00934856|536668023|FG003|Extension Part|Progressive disease|1|||
148779712|NCT00934856|536668024|FG004|Extension Part|Progressive disease|0|||
149235449|NCT00518531|538332501|FG001|Treatment Period 1|Early crossover|3|||
149235450|NCT00518531|538332500|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149235451|NCT00518531|538332501|FG001|Treatment Period 2|Withdrawal by Subject|8|||
149235452|NCT00518531|538332500|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
149235453|NCT00518531|538332501|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
149235454|NCT00518531|538332500|FG000|Treatment Period 2|Adverse Event|1|||
148779713|NCT00934856|536668025|FG005|Extension Part|Progressive disease|0|||
149235455|NCT00518531|538332501|FG001|Treatment Period 2|Adverse Event|7|||
149235456|NCT00518531|538332500|FG000|Treatment Period 2|Protocol-specified criteria|0|||
149235457|NCT00518531|538332501|FG001|Treatment Period 2|Protocol-specified criteria|1|||
149235458|NCT00518531|538332500|FG000|Treatment Period 2|Non-compliance|1|||
149235459|NCT00518531|538332501|FG001|Treatment Period 2|Non-compliance|2|||
149235460|NCT00457249|538332502|FG000|Overall Study|Lost to Follow-up|3|||
149235461|NCT00457249|538332503|FG001|Overall Study|Lost to Follow-up|0|||
149235462|NCT00457249|538332502|FG000|Overall Study|Protocol Violation|4|||
149235463|NCT00457249|538332503|FG001|Overall Study|Protocol Violation|1|||
149235464|NCT00457249|538332502|FG000|Overall Study|Withdrawal by Subject|3|||
149235465|NCT00457249|538332503|FG001|Overall Study|Withdrawal by Subject|1|||
149235466|NCT00457249|538332502|FG000|Overall Study|Serious Adverse Events|2|||
149235467|NCT00457249|538332503|FG001|Overall Study|Serious Adverse Events|0|||
149235468|NCT04888377|538332506|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
149235469|NCT04888377|538332507|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
149235470|NCT04888377|538332506|FG000|Overall Study|Physician Decision|6|||
149235471|NCT04888377|538332507|FG001|Overall Study|Physician Decision|6|||
149235472|NCT04888377|538332506|FG000|Overall Study|Withdrawal by Subject|7|||
149235473|NCT04888377|538332507|FG001|Overall Study|Withdrawal by Subject|3|||
149235474|NCT00526162|538332508|FG000|Overall Study|Device not implanted|3|||
149235475|NCT05279807|538332509|FG000|Overall Study|Withdrawal by Subject|1|||
149235476|NCT05279807|538332510|FG001|Overall Study|Withdrawal by Subject|0|||
149235477|NCT05279807|538332509|FG000|Overall Study|Adverse Event|0|||
149235478|NCT05279807|538332510|FG001|Overall Study|Adverse Event|1|||
149235479|NCT05279807|538332509|FG000|Overall Study|Laboratory Abnormal Results|1|||
149235480|NCT05279807|538332510|FG001|Overall Study|Laboratory Abnormal Results|0|||
149235481|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
149235482|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
149235483|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
149235484|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149235485|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149235486|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149235487|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149235488|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149235489|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
149235490|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
149235491|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149235492|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149235493|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149235494|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149235495|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
149235496|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
149235497|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
149235498|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149235499|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149235500|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149235501|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149235502|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
149235503|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
149235504|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
149235505|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149235506|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149235507|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149235508|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149235509|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
149235510|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149235511|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149235512|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149235513|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149235514|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149235515|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
149235516|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149235517|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149235518|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
149235519|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149235520|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149235521|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149235522|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
149235523|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149235524|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149235525|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
149235526|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149235527|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149235528|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149235529|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
149235530|NCT04242446|538332515|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149235531|NCT04242446|538332516|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
149235532|NCT04242446|538332517|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
149235533|NCT04242446|538332518|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149235534|NCT04242446|538332519|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149235535|NCT04242446|538332520|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149235536|NCT04242446|538332521|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149235537|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149235538|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149235539|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149235540|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
149235541|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
149235542|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
149235543|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
149235544|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149235545|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149235546|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149235547|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
149235548|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
149235549|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
149235550|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
149235551|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149235552|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149235553|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149235554|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
149235555|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
149235556|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
149235557|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
149235558|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149235559|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149235560|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149235561|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
149235562|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
149235563|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
149235564|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
149235565|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149235566|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149235567|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149235568|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
149235569|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
149235570|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
149235571|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
149235572|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149235573|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149235574|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149235575|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
149235576|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149235577|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149235578|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
149235579|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149235580|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149235581|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149235582|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149235583|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
149235584|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
148779714|NCT00934856|536668020|FG000|Extension Part|Non-compliance with drug|0|||
148779715|NCT00934856|536668021|FG001|Extension Part|Non-compliance with drug|0|||
148779716|NCT00934856|536668022|FG002|Extension Part|Non-compliance with drug|0|||
148779717|NCT00934856|536668023|FG003|Extension Part|Non-compliance with drug|0|||
148779718|NCT00934856|536668024|FG004|Extension Part|Non-compliance with drug|0|||
149235585|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
149235586|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149235587|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149235588|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149235589|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149235590|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
149235591|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149235592|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
149235593|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149235594|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149235595|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149235596|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149235597|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
149235598|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149235599|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
149235600|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149235601|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149235602|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149235603|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149235604|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
149235605|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149235606|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
149235607|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149235608|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149235609|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149235610|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149235611|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
149235612|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149235613|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
149235614|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149235615|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149235616|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149235617|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149235618|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149235619|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
149235620|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
149235621|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149235622|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149235623|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149235624|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149235625|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149235626|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
149235627|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
149235628|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149235629|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149235630|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149235631|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149235632|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149235633|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
149235634|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
149235635|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149235636|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149235637|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149235638|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149235639|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149235640|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
149235641|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
149235642|NCT04242446|538332515|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149235643|NCT04242446|538332516|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149235644|NCT04242446|538332517|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149235645|NCT04242446|538332518|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149235646|NCT04242446|538332519|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149235647|NCT04242446|538332520|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
149235648|NCT04242446|538332521|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
149235649|NCT03587116|538332522|FG000|Overall Study|Lost to Follow-up|0|||
149235650|NCT03587116|538332523|FG001|Overall Study|Lost to Follow-up|1|||
149235651|NCT03587116|538332522|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
149235652|NCT03587116|538332523|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
149235653|NCT03587116|538332522|FG000|Overall Study|Withdrawal by Subject|4|||
149235654|NCT03587116|538332523|FG001|Overall Study|Withdrawal by Subject|0|||
149235655|NCT05993299|538332525|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
149235656|NCT05993299|538332525|FG000|Overall Study|Ongoing|4|||
149235657|NCT05644756|538332526|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
149235658|NCT05644756|538332526|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
149235659|NCT03110107|538332527|FG000|Treatment Period|Disease Progression|3|||
149235660|NCT03110107|538332528|FG001|Treatment Period|Disease Progression|9|||
149235661|NCT03110107|538332529|FG002|Treatment Period|Disease Progression|8|||
148779719|NCT00934856|536668025|FG005|Extension Part|Non-compliance with drug|1|||
148779720|NCT03887117|536668026|FG000|Overall Study|Discontinued prematurely|0|||
148779721|NCT03887117|536668027|FG001|Overall Study|Discontinued prematurely|1|||
148779722|NCT03887117|536668028|FG002|Overall Study|Discontinued prematurely|1|||
148779723|NCT03887117|536668029|FG003|Overall Study|Discontinued prematurely|2|||
148779724|NCT00195494|536668030|FG000|Year 1|Adverse Event|0|||
148779725|NCT00195494|536668031|FG001|Year 1|Adverse Event|0|||
148779726|NCT00195494|536668032|FG002|Year 1|Adverse Event|0|||
148779727|NCT00195494|536668033|FG003|Year 1|Adverse Event|0|||
148779728|NCT00195494|536668034|FG004|Year 1|Adverse Event|34|||
148779729|NCT00195494|536668035|FG005|Year 1|Adverse Event|27|||
148779730|NCT00195494|536668030|FG000|Year 1|System Toxicity|0|||
149006834|NCT00871403|537503622|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
149235662|NCT03110107|538332530|FG003|Treatment Period|Disease Progression|11|||
149235663|NCT03110107|538332531|FG004|Treatment Period|Disease Progression|8|||
149235664|NCT03110107|538332532|FG005|Treatment Period|Disease Progression|4|||
149235665|NCT03110107|538332533|FG006|Treatment Period|Disease Progression|6|||
149235666|NCT03110107|538332534|FG007|Treatment Period|Disease Progression|7|||
149235667|NCT03110107|538332535|FG008|Treatment Period|Disease Progression|2|||
149235668|NCT03110107|538332536|FG009|Treatment Period|Disease Progression|10|||
149235669|NCT03110107|538332537|FG010|Treatment Period|Disease Progression|5|||
149235670|NCT03110107|538332538|FG011|Treatment Period|Disease Progression|2|||
149235671|NCT03110107|538332539|FG012|Treatment Period|Disease Progression|0|||
149235672|NCT03110107|538332540|FG013|Treatment Period|Disease Progression|5|||
149235673|NCT03110107|538332541|FG014|Treatment Period|Disease Progression|14|||
149235674|NCT03110107|538332542|FG015|Treatment Period|Disease Progression|14|||
149235675|NCT03110107|538332543|FG016|Treatment Period|Disease Progression|4|||
149235676|NCT03110107|538332544|FG017|Treatment Period|Disease Progression|3|||
149235677|NCT03110107|538332545|FG018|Treatment Period|Disease Progression|16|||
149235678|NCT03110107|538332546|FG019|Treatment Period|Disease Progression|14|||
149235679|NCT03110107|538332547|FG020|Treatment Period|Disease Progression|12|||
149235680|NCT03110107|538332548|FG021|Treatment Period|Disease Progression|16|||
149235681|NCT03110107|538332549|FG022|Treatment Period|Disease Progression|18|||
149235682|NCT03110107|538332550|FG023|Treatment Period|Disease Progression|13|||
149235683|NCT03110107|538332551|FG024|Treatment Period|Disease Progression|16|||
149235684|NCT03110107|538332552|FG025|Treatment Period|Disease Progression|31|||
149235685|NCT03110107|538332527|FG000|Treatment Period|Study drug toxicity|1|||
149235686|NCT03110107|538332528|FG001|Treatment Period|Study drug toxicity|0|||
149235687|NCT03110107|538332529|FG002|Treatment Period|Study drug toxicity|1|||
149235688|NCT03110107|538332530|FG003|Treatment Period|Study drug toxicity|2|||
149235689|NCT03110107|538332531|FG004|Treatment Period|Study drug toxicity|0|||
149235690|NCT03110107|538332532|FG005|Treatment Period|Study drug toxicity|3|||
149235691|NCT03110107|538332533|FG006|Treatment Period|Study drug toxicity|1|||
149235692|NCT03110107|538332534|FG007|Treatment Period|Study drug toxicity|1|||
149235693|NCT03110107|538332535|FG008|Treatment Period|Study drug toxicity|3|||
149235694|NCT03110107|538332536|FG009|Treatment Period|Study drug toxicity|2|||
149235695|NCT03110107|538332537|FG010|Treatment Period|Study drug toxicity|0|||
149235696|NCT03110107|538332538|FG011|Treatment Period|Study drug toxicity|2|||
148779731|NCT00195494|536668031|FG001|Year 1|System Toxicity|0|||
148779732|NCT00195494|536668032|FG002|Year 1|System Toxicity|0|||
149235697|NCT03110107|538332539|FG012|Treatment Period|Study drug toxicity|0|||
149235698|NCT03110107|538332540|FG013|Treatment Period|Study drug toxicity|0|||
149235699|NCT03110107|538332541|FG014|Treatment Period|Study drug toxicity|2|||
149235700|NCT03110107|538332542|FG015|Treatment Period|Study drug toxicity|3|||
149235701|NCT03110107|538332543|FG016|Treatment Period|Study drug toxicity|3|||
149235702|NCT03110107|538332544|FG017|Treatment Period|Study drug toxicity|3|||
149235703|NCT03110107|538332545|FG018|Treatment Period|Study drug toxicity|1|||
149235704|NCT03110107|538332546|FG019|Treatment Period|Study drug toxicity|2|||
149235705|NCT03110107|538332547|FG020|Treatment Period|Study drug toxicity|2|||
149235706|NCT03110107|538332548|FG021|Treatment Period|Study drug toxicity|0|||
149235707|NCT03110107|538332549|FG022|Treatment Period|Study drug toxicity|2|||
149235708|NCT03110107|538332550|FG023|Treatment Period|Study drug toxicity|6|||
149235709|NCT03110107|538332551|FG024|Treatment Period|Study drug toxicity|7|||
149235710|NCT03110107|538332552|FG025|Treatment Period|Study drug toxicity|6|||
149235711|NCT03110107|538332527|FG000|Treatment Period|Death|0|||
149235712|NCT03110107|538332528|FG001|Treatment Period|Death|0|||
149235713|NCT03110107|538332529|FG002|Treatment Period|Death|0|||
149235714|NCT03110107|538332530|FG003|Treatment Period|Death|0|||
149235715|NCT03110107|538332531|FG004|Treatment Period|Death|0|||
149235716|NCT03110107|538332532|FG005|Treatment Period|Death|0|||
148779733|NCT00195494|536668033|FG003|Year 1|System Toxicity|0|||
148779734|NCT00195494|536668034|FG004|Year 1|System Toxicity|0|||
148779735|NCT00195494|536668035|FG005|Year 1|System Toxicity|1|||
148779736|NCT00195494|536668030|FG000|Year 1|Lack of Efficacy|0|||
148779737|NCT00195494|536668031|FG001|Year 1|Lack of Efficacy|0|||
148779738|NCT00195494|536668032|FG002|Year 1|Lack of Efficacy|0|||
148779739|NCT00195494|536668033|FG003|Year 1|Lack of Efficacy|0|||
148779740|NCT00195494|536668034|FG004|Year 1|Lack of Efficacy|24|||
148779741|NCT00195494|536668035|FG005|Year 1|Lack of Efficacy|9|||
148779742|NCT00195494|536668030|FG000|Year 1|Compliance|0|||
148779743|NCT00195494|536668031|FG001|Year 1|Compliance|0|||
148779744|NCT00195494|536668032|FG002|Year 1|Compliance|0|||
148779745|NCT00195494|536668033|FG003|Year 1|Compliance|0|||
148779746|NCT00195494|536668034|FG004|Year 1|Compliance|5|||
148779747|NCT00195494|536668035|FG005|Year 1|Compliance|1|||
148779748|NCT00195494|536668030|FG000|Year 1|Lost to Follow-up|0|||
148779749|NCT00195494|536668031|FG001|Year 1|Lost to Follow-up|0|||
148779750|NCT00195494|536668032|FG002|Year 1|Lost to Follow-up|0|||
148779751|NCT00195494|536668033|FG003|Year 1|Lost to Follow-up|0|||
148779752|NCT00195494|536668034|FG004|Year 1|Lost to Follow-up|1|||
148779753|NCT00195494|536668035|FG005|Year 1|Lost to Follow-up|0|||
148779754|NCT00195494|536668030|FG000|Year 1|Missed >4 consecutive doses|0|||
148779755|NCT00195494|536668031|FG001|Year 1|Missed >4 consecutive doses|0|||
148779756|NCT00195494|536668032|FG002|Year 1|Missed >4 consecutive doses|0|||
148779757|NCT00195494|536668033|FG003|Year 1|Missed >4 consecutive doses|0|||
148779758|NCT00195494|536668034|FG004|Year 1|Missed >4 consecutive doses|3|||
148779759|NCT00195494|536668035|FG005|Year 1|Missed >4 consecutive doses|2|||
148779760|NCT00195494|536668030|FG000|Year 1|Protocol deviation|0|||
148779761|NCT00195494|536668031|FG001|Year 1|Protocol deviation|0|||
148779762|NCT00195494|536668032|FG002|Year 1|Protocol deviation|0|||
148779763|NCT00195494|536668033|FG003|Year 1|Protocol deviation|0|||
148779764|NCT00195494|536668034|FG004|Year 1|Protocol deviation|2|||
148779765|NCT00195494|536668035|FG005|Year 1|Protocol deviation|3|||
148779766|NCT00195494|536668030|FG000|Year 1|Physician Decision|0|||
148779767|NCT00195494|536668031|FG001|Year 1|Physician Decision|0|||
148779768|NCT00195494|536668032|FG002|Year 1|Physician Decision|0|||
148779769|NCT00195494|536668033|FG003|Year 1|Physician Decision|0|||
148779770|NCT00195494|536668034|FG004|Year 1|Physician Decision|1|||
148779771|NCT00195494|536668035|FG005|Year 1|Physician Decision|0|||
148779772|NCT00195494|536668030|FG000|Year 1|Withdrawal by Subject|0|||
148779773|NCT00195494|536668031|FG001|Year 1|Withdrawal by Subject|0|||
148779774|NCT00195494|536668032|FG002|Year 1|Withdrawal by Subject|0|||
148779775|NCT00195494|536668033|FG003|Year 1|Withdrawal by Subject|0|||
148779776|NCT00195494|536668034|FG004|Year 1|Withdrawal by Subject|8|||
148779777|NCT00195494|536668035|FG005|Year 1|Withdrawal by Subject|9|||
148779778|NCT00195494|536668030|FG000|Year 1|Protocol Violation|0|||
148779779|NCT00195494|536668031|FG001|Year 1|Protocol Violation|0|||
148779780|NCT00195494|536668032|FG002|Year 1|Protocol Violation|0|||
148779781|NCT00195494|536668033|FG003|Year 1|Protocol Violation|0|||
148779782|NCT00195494|536668034|FG004|Year 1|Protocol Violation|1|||
148779783|NCT00195494|536668035|FG005|Year 1|Protocol Violation|1|||
148779784|NCT00195494|536668030|FG000|Year 2|Adverse Event|3|||
148779785|NCT00195494|536668031|FG001|Year 2|Adverse Event|7|||
148779786|NCT00195494|536668032|FG002|Year 2|Adverse Event|5|||
148779787|NCT00195494|536668033|FG003|Year 2|Adverse Event|9|||
148779788|NCT00195494|536668034|FG004|Year 2|Adverse Event|0|||
148779789|NCT00195494|536668035|FG005|Year 2|Adverse Event|0|||
148779790|NCT00195494|536668030|FG000|Year 2|Lack of Efficacy|0|||
148779791|NCT00195494|536668031|FG001|Year 2|Lack of Efficacy|1|||
148779792|NCT00195494|536668032|FG002|Year 2|Lack of Efficacy|7|||
148779793|NCT00195494|536668033|FG003|Year 2|Lack of Efficacy|7|||
148779794|NCT00195494|536668034|FG004|Year 2|Lack of Efficacy|0|||
148779795|NCT00195494|536668035|FG005|Year 2|Lack of Efficacy|0|||
148779796|NCT00195494|536668030|FG000|Year 2|Compliance|1|||
149235717|NCT03110107|538332533|FG006|Treatment Period|Death|0|||
148779797|NCT00195494|536668031|FG001|Year 2|Compliance|0|||
148779798|NCT00195494|536668032|FG002|Year 2|Compliance|0|||
148779799|NCT00195494|536668033|FG003|Year 2|Compliance|2|||
148779800|NCT00195494|536668034|FG004|Year 2|Compliance|0|||
148779801|NCT00195494|536668035|FG005|Year 2|Compliance|0|||
148779802|NCT00195494|536668030|FG000|Year 2|Lost to Follow-up|0|||
148779803|NCT00195494|536668031|FG001|Year 2|Lost to Follow-up|0|||
148779804|NCT00195494|536668032|FG002|Year 2|Lost to Follow-up|1|||
148779805|NCT00195494|536668033|FG003|Year 2|Lost to Follow-up|1|||
148779806|NCT00195494|536668034|FG004|Year 2|Lost to Follow-up|0|||
148779807|NCT00195494|536668035|FG005|Year 2|Lost to Follow-up|0|||
148779808|NCT00195494|536668030|FG000|Year 2|Missed >4 consecutive doses|1|||
148779809|NCT00195494|536668031|FG001|Year 2|Missed >4 consecutive doses|1|||
148779810|NCT00195494|536668032|FG002|Year 2|Missed >4 consecutive doses|1|||
148779811|NCT00195494|536668033|FG003|Year 2|Missed >4 consecutive doses|0|||
148779812|NCT00195494|536668034|FG004|Year 2|Missed >4 consecutive doses|0|||
148779813|NCT00195494|536668035|FG005|Year 2|Missed >4 consecutive doses|0|||
148779814|NCT00195494|536668030|FG000|Year 2|Protocol deviation|0|||
148779815|NCT00195494|536668031|FG001|Year 2|Protocol deviation|1|||
148779816|NCT00195494|536668032|FG002|Year 2|Protocol deviation|0|||
148779817|NCT00195494|536668033|FG003|Year 2|Protocol deviation|0|||
148779818|NCT00195494|536668034|FG004|Year 2|Protocol deviation|0|||
148779819|NCT00195494|536668035|FG005|Year 2|Protocol deviation|0|||
148779820|NCT00195494|536668030|FG000|Year 2|Physician Decision|1|||
148779821|NCT00195494|536668031|FG001|Year 2|Physician Decision|1|||
148779822|NCT00195494|536668032|FG002|Year 2|Physician Decision|0|||
148779823|NCT00195494|536668033|FG003|Year 2|Physician Decision|0|||
148779824|NCT00195494|536668034|FG004|Year 2|Physician Decision|0|||
148779825|NCT00195494|536668035|FG005|Year 2|Physician Decision|0|||
148779826|NCT00195494|536668030|FG000|Year 2|Withdrawal by Subject|1|||
148779827|NCT00195494|536668031|FG001|Year 2|Withdrawal by Subject|5|||
148779828|NCT00195494|536668032|FG002|Year 2|Withdrawal by Subject|4|||
148779829|NCT00195494|536668033|FG003|Year 2|Withdrawal by Subject|3|||
148779830|NCT00195494|536668034|FG004|Year 2|Withdrawal by Subject|0|||
148779831|NCT00195494|536668035|FG005|Year 2|Withdrawal by Subject|0|||
148779832|NCT00195494|536668030|FG000|Year 2|System toxicity|0|||
148779833|NCT00195494|536668031|FG001|Year 2|System toxicity|0|||
148779834|NCT00195494|536668032|FG002|Year 2|System toxicity|0|||
148779835|NCT00195494|536668033|FG003|Year 2|System toxicity|1|||
149235718|NCT03110107|538332534|FG007|Treatment Period|Death|0|||
149235719|NCT03110107|538332535|FG008|Treatment Period|Death|0|||
149235720|NCT03110107|538332536|FG009|Treatment Period|Death|0|||
149235721|NCT03110107|538332537|FG010|Treatment Period|Death|0|||
149235722|NCT03110107|538332538|FG011|Treatment Period|Death|0|||
149235723|NCT03110107|538332539|FG012|Treatment Period|Death|1|||
149235724|NCT03110107|538332540|FG013|Treatment Period|Death|0|||
149235725|NCT03110107|538332541|FG014|Treatment Period|Death|0|||
149235726|NCT03110107|538332542|FG015|Treatment Period|Death|0|||
149235727|NCT03110107|538332543|FG016|Treatment Period|Death|0|||
149235728|NCT03110107|538332544|FG017|Treatment Period|Death|0|||
149235729|NCT03110107|538332545|FG018|Treatment Period|Death|0|||
149235730|NCT03110107|538332546|FG019|Treatment Period|Death|0|||
149235731|NCT03110107|538332547|FG020|Treatment Period|Death|0|||
149235732|NCT03110107|538332548|FG021|Treatment Period|Death|0|||
149235733|NCT03110107|538332549|FG022|Treatment Period|Death|0|||
149235734|NCT03110107|538332550|FG023|Treatment Period|Death|0|||
149235735|NCT03110107|538332551|FG024|Treatment Period|Death|0|||
149235736|NCT03110107|538332552|FG025|Treatment Period|Death|0|||
149235737|NCT03110107|538332527|FG000|Treatment Period|Adverse Event|0|||
149235738|NCT03110107|538332528|FG001|Treatment Period|Adverse Event|0|||
149235739|NCT03110107|538332529|FG002|Treatment Period|Adverse Event|1|||
149235740|NCT03110107|538332530|FG003|Treatment Period|Adverse Event|0|||
149235741|NCT03110107|538332531|FG004|Treatment Period|Adverse Event|0|||
149235742|NCT03110107|538332532|FG005|Treatment Period|Adverse Event|2|||
149235743|NCT03110107|538332533|FG006|Treatment Period|Adverse Event|0|||
149235744|NCT03110107|538332534|FG007|Treatment Period|Adverse Event|2|||
149235745|NCT03110107|538332535|FG008|Treatment Period|Adverse Event|0|||
149235746|NCT03110107|538332536|FG009|Treatment Period|Adverse Event|1|||
149235747|NCT03110107|538332537|FG010|Treatment Period|Adverse Event|0|||
149235748|NCT03110107|538332538|FG011|Treatment Period|Adverse Event|0|||
148779836|NCT00195494|536668034|FG004|Year 2|System toxicity|0|||
148779837|NCT00195494|536668035|FG005|Year 2|System toxicity|0|||
148779838|NCT00513357|536668036|FG000|Overall Study|did not receive allocated placebo|2|||
148779839|NCT00513357|536668037|FG001|Overall Study|did not receive allocated placebo|3|||
148779840|NCT00513357|536668036|FG000|Overall Study|Adverse Event|4|||
148779841|NCT00513357|536668037|FG001|Overall Study|Adverse Event|2|||
148779842|NCT00513357|536668036|FG000|Overall Study|Death|2|||
148779843|NCT00513357|536668037|FG001|Overall Study|Death|0|||
149006835|NCT02569437|537503626|FG000|Overall Study|Lost to Follow-up|12|||
149235749|NCT03110107|538332539|FG012|Treatment Period|Adverse Event|0|||
149235750|NCT03110107|538332540|FG013|Treatment Period|Adverse Event|0|||
149235751|NCT03110107|538332541|FG014|Treatment Period|Adverse Event|0|||
149235752|NCT03110107|538332542|FG015|Treatment Period|Adverse Event|2|||
149235753|NCT03110107|538332543|FG016|Treatment Period|Adverse Event|0|||
149235754|NCT03110107|538332544|FG017|Treatment Period|Adverse Event|1|||
148779844|NCT00513357|536668036|FG000|Overall Study|Withdrawal by Subject|5|||
148779845|NCT00513357|536668037|FG001|Overall Study|Withdrawal by Subject|4|||
148779846|NCT00513357|536668036|FG000|Overall Study|Disease Progression|2|||
148779847|NCT00513357|536668037|FG001|Overall Study|Disease Progression|1|||
148779848|NCT00926536|536668041|FG000|Overall Study|Physician Decision|1|||
148779849|NCT00926536|536668042|FG001|Overall Study|Physician Decision|2|||
148779850|NCT03301844|536668043|FG000|Overall Study|suspected colon cancer|1|||
149006836|NCT02569437|537503627|FG001|Overall Study|Lost to Follow-up|14|||
149006837|NCT00985985|537503628|FG000|Overall Study|Adverse Event|4|||
149235755|NCT03110107|538332545|FG018|Treatment Period|Adverse Event|2|||
149235756|NCT03110107|538332546|FG019|Treatment Period|Adverse Event|1|||
149235757|NCT03110107|538332547|FG020|Treatment Period|Adverse Event|4|||
149235758|NCT03110107|538332548|FG021|Treatment Period|Adverse Event|2|||
149235759|NCT03110107|538332549|FG022|Treatment Period|Adverse Event|2|||
149235760|NCT03110107|538332550|FG023|Treatment Period|Adverse Event|2|||
149235761|NCT03110107|538332551|FG024|Treatment Period|Adverse Event|2|||
149235762|NCT03110107|538332552|FG025|Treatment Period|Adverse Event|4|||
149235763|NCT03110107|538332527|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
149235764|NCT03110107|538332528|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
149235765|NCT03110107|538332529|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
149235766|NCT03110107|538332530|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
149235767|NCT03110107|538332531|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
149235768|NCT03110107|538332532|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
149235769|NCT03110107|538332533|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
149235770|NCT03110107|538332534|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
149235771|NCT03110107|538332535|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
149235772|NCT03110107|538332536|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
149235773|NCT03110107|538332537|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
149235774|NCT03110107|538332538|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
149235775|NCT03110107|538332539|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
149235776|NCT03110107|538332540|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
149235777|NCT03110107|538332541|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
149235778|NCT03110107|538332542|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
149235779|NCT03110107|538332543|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
149235780|NCT03110107|538332544|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
149235781|NCT03110107|538332545|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
149235782|NCT03110107|538332546|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
149235783|NCT03110107|538332547|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
149235784|NCT03110107|538332548|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
149235785|NCT03110107|538332549|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
149235786|NCT03110107|538332550|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
149235787|NCT03110107|538332551|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
149235788|NCT03110107|538332552|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
149235789|NCT03110107|538332527|FG000|Treatment Period|Participant withdrew consent|0|||
149235790|NCT03110107|538332528|FG001|Treatment Period|Participant withdrew consent|0|||
149235791|NCT03110107|538332529|FG002|Treatment Period|Participant withdrew consent|1|||
149235792|NCT03110107|538332530|FG003|Treatment Period|Participant withdrew consent|0|||
149235793|NCT03110107|538332531|FG004|Treatment Period|Participant withdrew consent|4|||
149235794|NCT03110107|538332532|FG005|Treatment Period|Participant withdrew consent|3|||
149235795|NCT03110107|538332533|FG006|Treatment Period|Participant withdrew consent|0|||
149235796|NCT03110107|538332534|FG007|Treatment Period|Participant withdrew consent|0|||
149235797|NCT03110107|538332535|FG008|Treatment Period|Participant withdrew consent|0|||
149235798|NCT03110107|538332536|FG009|Treatment Period|Participant withdrew consent|1|||
149235799|NCT03110107|538332537|FG010|Treatment Period|Participant withdrew consent|0|||
149235800|NCT03110107|538332538|FG011|Treatment Period|Participant withdrew consent|0|||
149235801|NCT03110107|538332539|FG012|Treatment Period|Participant withdrew consent|0|||
149235802|NCT03110107|538332540|FG013|Treatment Period|Participant withdrew consent|0|||
149235803|NCT03110107|538332541|FG014|Treatment Period|Participant withdrew consent|0|||
149235804|NCT03110107|538332542|FG015|Treatment Period|Participant withdrew consent|0|||
149235805|NCT03110107|538332543|FG016|Treatment Period|Participant withdrew consent|0|||
149235806|NCT03110107|538332544|FG017|Treatment Period|Participant withdrew consent|0|||
149235807|NCT03110107|538332545|FG018|Treatment Period|Participant withdrew consent|0|||
149235808|NCT03110107|538332546|FG019|Treatment Period|Participant withdrew consent|1|||
149235809|NCT03110107|538332547|FG020|Treatment Period|Participant withdrew consent|0|||
149235810|NCT03110107|538332548|FG021|Treatment Period|Participant withdrew consent|2|||
148779851|NCT03301844|536668044|FG001|Overall Study|suspected colon cancer|1|||
149235811|NCT03110107|538332549|FG022|Treatment Period|Participant withdrew consent|0|||
149235812|NCT03110107|538332550|FG023|Treatment Period|Participant withdrew consent|0|||
149235813|NCT03110107|538332551|FG024|Treatment Period|Participant withdrew consent|0|||
149235814|NCT03110107|538332552|FG025|Treatment Period|Participant withdrew consent|2|||
149235815|NCT03110107|538332527|FG000|Treatment Period|Participants no longer meets study criteria|0|||
149235816|NCT03110107|538332528|FG001|Treatment Period|Participants no longer meets study criteria|0|||
149235817|NCT03110107|538332529|FG002|Treatment Period|Participants no longer meets study criteria|0|||
149235818|NCT03110107|538332530|FG003|Treatment Period|Participants no longer meets study criteria|0|||
149235819|NCT03110107|538332531|FG004|Treatment Period|Participants no longer meets study criteria|0|||
149235820|NCT03110107|538332532|FG005|Treatment Period|Participants no longer meets study criteria|0|||
149235821|NCT03110107|538332533|FG006|Treatment Period|Participants no longer meets study criteria|0|||
149235822|NCT03110107|538332534|FG007|Treatment Period|Participants no longer meets study criteria|0|||
149235823|NCT03110107|538332535|FG008|Treatment Period|Participants no longer meets study criteria|0|||
149235824|NCT03110107|538332536|FG009|Treatment Period|Participants no longer meets study criteria|0|||
149235825|NCT03110107|538332537|FG010|Treatment Period|Participants no longer meets study criteria|0|||
149235826|NCT03110107|538332538|FG011|Treatment Period|Participants no longer meets study criteria|0|||
149235827|NCT03110107|538332539|FG012|Treatment Period|Participants no longer meets study criteria|0|||
149235828|NCT03110107|538332540|FG013|Treatment Period|Participants no longer meets study criteria|0|||
149235829|NCT03110107|538332541|FG014|Treatment Period|Participants no longer meets study criteria|0|||
149235830|NCT03110107|538332542|FG015|Treatment Period|Participants no longer meets study criteria|0|||
149235831|NCT03110107|538332543|FG016|Treatment Period|Participants no longer meets study criteria|0|||
149235832|NCT03110107|538332544|FG017|Treatment Period|Participants no longer meets study criteria|0|||
149235833|NCT03110107|538332545|FG018|Treatment Period|Participants no longer meets study criteria|0|||
149235834|NCT03110107|538332546|FG019|Treatment Period|Participants no longer meets study criteria|0|||
149235835|NCT03110107|538332547|FG020|Treatment Period|Participants no longer meets study criteria|0|||
149235836|NCT03110107|538332548|FG021|Treatment Period|Participants no longer meets study criteria|0|||
149235837|NCT03110107|538332549|FG022|Treatment Period|Participants no longer meets study criteria|0|||
149235838|NCT03110107|538332550|FG023|Treatment Period|Participants no longer meets study criteria|1|||
149235839|NCT03110107|538332551|FG024|Treatment Period|Participants no longer meets study criteria|0|||
149235840|NCT03110107|538332552|FG025|Treatment Period|Participants no longer meets study criteria|0|||
149235841|NCT03110107|538332527|FG000|Treatment Period|Other Reasons|0|||
149235842|NCT03110107|538332528|FG001|Treatment Period|Other Reasons|0|||
149235843|NCT03110107|538332529|FG002|Treatment Period|Other Reasons|1|||
149235844|NCT03110107|538332530|FG003|Treatment Period|Other Reasons|1|||
149235845|NCT03110107|538332531|FG004|Treatment Period|Other Reasons|0|||
149235846|NCT03110107|538332532|FG005|Treatment Period|Other Reasons|1|||
149235847|NCT03110107|538332533|FG006|Treatment Period|Other Reasons|0|||
149235848|NCT03110107|538332534|FG007|Treatment Period|Other Reasons|0|||
149235849|NCT03110107|538332535|FG008|Treatment Period|Other Reasons|0|||
149235850|NCT03110107|538332536|FG009|Treatment Period|Other Reasons|0|||
149235851|NCT03110107|538332537|FG010|Treatment Period|Other Reasons|0|||
149235852|NCT03110107|538332538|FG011|Treatment Period|Other Reasons|0|||
149235853|NCT03110107|538332539|FG012|Treatment Period|Other Reasons|0|||
149235854|NCT03110107|538332540|FG013|Treatment Period|Other Reasons|0|||
149235855|NCT03110107|538332541|FG014|Treatment Period|Other Reasons|0|||
149235856|NCT03110107|538332542|FG015|Treatment Period|Other Reasons|0|||
149235857|NCT03110107|538332543|FG016|Treatment Period|Other Reasons|0|||
149235858|NCT03110107|538332544|FG017|Treatment Period|Other Reasons|0|||
149235859|NCT03110107|538332545|FG018|Treatment Period|Other Reasons|0|||
149235860|NCT03110107|538332546|FG019|Treatment Period|Other Reasons|0|||
149235861|NCT03110107|538332547|FG020|Treatment Period|Other Reasons|0|||
149235862|NCT03110107|538332548|FG021|Treatment Period|Other Reasons|0|||
149235863|NCT03110107|538332549|FG022|Treatment Period|Other Reasons|0|||
149235864|NCT03110107|538332550|FG023|Treatment Period|Other Reasons|0|||
149235865|NCT03110107|538332551|FG024|Treatment Period|Other Reasons|1|||
149235866|NCT03110107|538332552|FG025|Treatment Period|Other Reasons|0|||
149235867|NCT03985982|538332553|FG000|Double-Blind Phase|Lost to Follow-up|4|||
149235868|NCT03985982|538332554|FG001|Double-Blind Phase|Lost to Follow-up|3|||
149235869|NCT03985982|538332555|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149235870|NCT03985982|538332553|FG000|Double-Blind Phase|Physician Decision|1|||
149235871|NCT03985982|538332554|FG001|Double-Blind Phase|Physician Decision|0|||
149235872|NCT03985982|538332555|FG002|Double-Blind Phase|Physician Decision|0|||
149235873|NCT03985982|538332553|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
149235874|NCT03985982|538332554|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
149235875|NCT03985982|538332555|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
149235876|NCT03985982|538332553|FG000|Double-Blind Phase|COVID-19|1|||
149235877|NCT03985982|538332554|FG001|Double-Blind Phase|COVID-19|0|||
149235878|NCT03985982|538332555|FG002|Double-Blind Phase|COVID-19|0|||
149235879|NCT03985982|538332553|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
149235880|NCT03985982|538332554|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
149235881|NCT03985982|538332555|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
149235882|NCT03985982|538332553|FG000|Open-Label Phase|Lost to Follow-up|0|||
149235883|NCT03985982|538332554|FG001|Open-Label Phase|Lost to Follow-up|0|||
149235884|NCT03985982|538332555|FG002|Open-Label Phase|Lost to Follow-up|13|||
149235885|NCT03985982|538332553|FG000|Open-Label Phase|Physician Decision|0|||
149235886|NCT03985982|538332554|FG001|Open-Label Phase|Physician Decision|0|||
149235887|NCT03985982|538332555|FG002|Open-Label Phase|Physician Decision|2|||
149235888|NCT03985982|538332553|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149235889|NCT03985982|538332554|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149235890|NCT03985982|538332555|FG002|Open-Label Phase|Withdrawal by Subject|11|||
149235891|NCT03526549|538332557|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
149235892|NCT03526549|538332558|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
149235893|NCT03526549|538332557|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
149235894|NCT03526549|538332558|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
149235895|NCT03526549|538332557|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
149235896|NCT03526549|538332558|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
149235897|NCT03526549|538332557|FG000|Open-label Phase|Adverse Event|4|||
149235898|NCT03526549|538332558|FG001|Open-label Phase|Adverse Event|0|||
149235899|NCT03526549|538332557|FG000|Open-label Phase|Withdrawal by Subject|54|||
149235900|NCT03526549|538332558|FG001|Open-label Phase|Withdrawal by Subject|0|||
149235901|NCT03526549|538332557|FG000|Open-label Phase|Lost to Follow-up|35|||
149235902|NCT03526549|538332558|FG001|Open-label Phase|Lost to Follow-up|0|||
149235903|NCT03526549|538332557|FG000|Open-label Phase|Other than Specified|5|||
149235904|NCT03526549|538332558|FG001|Open-label Phase|Other than Specified|0|||
149235905|NCT03927989|538332562|FG000|Overall Study|Withdrawal by Subject|0|||
149235906|NCT03927989|538332563|FG001|Overall Study|Withdrawal by Subject|1|||
149235907|NCT02593175|538332564|FG000|Overall Study|Adverse Event|5|||
149235908|NCT02593175|538332564|FG000|Overall Study|Disease progression|4|||
149235909|NCT00478933|538332568|FG000|Overall Study|Protocol Violation|22|||
149235910|NCT00478933|538332568|FG000|Overall Study|Informed consent not verified|3|||
149235911|NCT00478933|538332568|FG000|Overall Study|Inadequate data available|53|||
149235912|NCT01298362|538332570|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
149235913|NCT01298362|538332571|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
149235914|NCT00455923|538332585|FG000|Overall Study|Pregnancy|0|||
149235915|NCT00455923|538332586|FG001|Overall Study|Pregnancy|2|||
149235916|NCT00455923|538332585|FG000|Overall Study|Other|3|||
149235917|NCT00455923|538332586|FG001|Overall Study|Other|1|||
149235918|NCT02686749|538332587|FG000|Overall Study|terminated for poor enrollment|2|||
149235919|NCT02686749|538332588|FG001|Overall Study|terminated for poor enrollment|2|||
149235920|NCT00145119|538332593|FG000|Overall Study|Death|45|||
149235921|NCT02951130|538332594|FG000|Overall Study|Protocol Violation|1|||
149235922|NCT02951130|538332595|FG001|Overall Study|Protocol Violation|1|||
149235923|NCT03795233|538332596|FG000|Overall Study|Withdrawal by Subject|2|||
149235924|NCT03795233|538332597|FG001|Overall Study|Withdrawal by Subject|1|||
149235925|NCT03795233|538332596|FG000|Overall Study|Lost to Follow-up|1|||
149235926|NCT03795233|538332597|FG001|Overall Study|Lost to Follow-up|0|||
149235927|NCT03795233|538332596|FG000|Overall Study|Death|1|||
149235928|NCT03795233|538332597|FG001|Overall Study|Death|0|||
149235929|NCT02756182|538332598|FG000|Overall Study|StudyTechnical Difficulties|4|||
149235930|NCT02711306|538332601|FG000|Overall Study|Withdrawal by Subject|2|||
149235931|NCT02711306|538332602|FG001|Overall Study|Withdrawal by Subject|2|||
149235932|NCT01676818|538332606|FG000|Overall Study|Physician Decision|1|||
149235933|NCT01676818|538332606|FG000|Overall Study|Withdrawal by Subject|1|||
149235934|NCT02207413|538332611|FG000|Overall Study|Withdrawal by Subject|1|||
149235935|NCT02207413|538332612|FG001|Overall Study|Withdrawal by Subject|0|||
149235936|NCT02207413|538332613|FG002|Overall Study|Withdrawal by Subject|0|||
149235937|NCT02207413|538332614|FG003|Overall Study|Withdrawal by Subject|0|||
149235938|NCT02207413|538332615|FG004|Overall Study|Withdrawal by Subject|3|||
149235939|NCT02207413|538332616|FG005|Overall Study|Withdrawal by Subject|7|||
149235940|NCT02207413|538332611|FG000|Overall Study|Lost to Follow-up|0|||
149235941|NCT02207413|538332612|FG001|Overall Study|Lost to Follow-up|0|||
149235942|NCT02207413|538332613|FG002|Overall Study|Lost to Follow-up|0|||
149235943|NCT02207413|538332614|FG003|Overall Study|Lost to Follow-up|1|||
149235944|NCT02207413|538332615|FG004|Overall Study|Lost to Follow-up|1|||
149235945|NCT02207413|538332616|FG005|Overall Study|Lost to Follow-up|5|||
149235946|NCT02207413|538332611|FG000|Overall Study|Adverse Event|0|||
149235947|NCT02207413|538332612|FG001|Overall Study|Adverse Event|0|||
149235948|NCT02207413|538332613|FG002|Overall Study|Adverse Event|0|||
149235949|NCT02207413|538332614|FG003|Overall Study|Adverse Event|0|||
149235950|NCT02207413|538332615|FG004|Overall Study|Adverse Event|2|||
149235951|NCT02207413|538332616|FG005|Overall Study|Adverse Event|1|||
148779852|NCT05087966|536668045|FG000|Overall Study|Lost to Follow-up|1|||
149235952|NCT02207413|538332611|FG000|Overall Study|Migrated/moved from study area|0|||
149235953|NCT02207413|538332612|FG001|Overall Study|Migrated/moved from study area|0|||
149235954|NCT02207413|538332613|FG002|Overall Study|Migrated/moved from study area|0|||
149235955|NCT02207413|538332614|FG003|Overall Study|Migrated/moved from study area|0|||
149235956|NCT02207413|538332615|FG004|Overall Study|Migrated/moved from study area|1|||
149235957|NCT02207413|538332616|FG005|Overall Study|Migrated/moved from study area|0|||
149235958|NCT02503215|538334184|FG000|Overall Study|Unable to wear compression stockings|1|||
149235959|NCT02503215|538334184|FG000|Overall Study|Unable to use positive airway pressure|2|||
149235960|NCT03433482|538334185|FG000|Overall Study|Lost to Follow-up|1|||
149235961|NCT03433482|538334186|FG001|Overall Study|Lost to Follow-up|0|||
149235962|NCT03433482|538334187|FG002|Overall Study|Lost to Follow-up|1|||
149235963|NCT03433482|538334188|FG003|Overall Study|Lost to Follow-up|1|||
149235964|NCT03433482|538334185|FG000|Overall Study|Withdrawal by Subject|0|||
149235965|NCT03433482|538334186|FG001|Overall Study|Withdrawal by Subject|0|||
149235966|NCT03433482|538334187|FG002|Overall Study|Withdrawal by Subject|1|||
149235967|NCT03433482|538334188|FG003|Overall Study|Withdrawal by Subject|0|||
149235968|NCT03433482|538334185|FG000|Overall Study|Unknown reason|0|||
149235969|NCT03433482|538334186|FG001|Overall Study|Unknown reason|0|||
149235970|NCT03433482|538334187|FG002|Overall Study|Unknown reason|2|||
149235971|NCT03433482|538334188|FG003|Overall Study|Unknown reason|0|||
149235972|NCT01646268|538334189|FG000|Overall Study|Adverse Event|6|||
149235973|NCT01646268|538334190|FG001|Overall Study|Adverse Event|7|||
149235974|NCT01646268|538334189|FG000|Overall Study|Lack of Efficacy|1|||
149235975|NCT01646268|538334190|FG001|Overall Study|Lack of Efficacy|3|||
149235976|NCT01646268|538334189|FG000|Overall Study|Protocol Violation|0|||
149235977|NCT01646268|538334190|FG001|Overall Study|Protocol Violation|1|||
149235978|NCT01646268|538334189|FG000|Overall Study|Withdrawal by Subject|2|||
149235979|NCT01646268|538334190|FG001|Overall Study|Withdrawal by Subject|5|||
149235980|NCT01646268|538334189|FG000|Overall Study|Other|2|||
149235981|NCT01646268|538334190|FG001|Overall Study|Other|0|||
149235982|NCT04478994|538334193|FG000|Overall Study|Withdrawal by Subject|1|||
149235983|NCT04478994|538334194|FG001|Overall Study|Withdrawal by Subject|1|||
149235984|NCT01100073|538334195|FG000|Overall Study|Lack of Efficacy|4|||
149235985|NCT01100073|538334195|FG000|Overall Study|Insufficient Tolerability|21|||
149235986|NCT01100073|538334195|FG000|Overall Study|Withdrawal by Subject|13|||
149235987|NCT01100073|538334195|FG000|Overall Study|Lost to Follow-up|39|||
149235988|NCT01100073|538334195|FG000|Overall Study|Lack of effect + patient's wish|2|||
149235989|NCT01100073|538334195|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
149235990|NCT01100073|538334195|FG000|Overall Study|Other|8|||
149235991|NCT01100073|538334195|FG000|Overall Study|Missing|5|||
149235992|NCT00299546|538334196|FG000|Overall Study|Death|3|||
149235993|NCT00299546|538334197|FG001|Overall Study|Death|2|||
149235994|NCT00299546|538334198|FG002|Overall Study|Death|0|||
149235995|NCT00299546|538334196|FG000|Overall Study|Lost to Follow-up|2|||
149235996|NCT00299546|538334197|FG001|Overall Study|Lost to Follow-up|2|||
149235997|NCT00299546|538334198|FG002|Overall Study|Lost to Follow-up|5|||
149235998|NCT00299546|538334196|FG000|Overall Study|Adverse Event|37|||
149235999|NCT00299546|538334197|FG001|Overall Study|Adverse Event|22|||
149236000|NCT00299546|538334198|FG002|Overall Study|Adverse Event|27|||
149236001|NCT00299546|538334196|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
149236002|NCT00299546|538334197|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
149236003|NCT00299546|538334198|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
149236004|NCT00299546|538334196|FG000|Overall Study|Other|24|||
149236005|NCT00299546|538334197|FG001|Overall Study|Other|26|||
149236006|NCT00299546|538334198|FG002|Overall Study|Other|19|||
149236007|NCT00299546|538334196|FG000|Overall Study|Not treated|0|||
149236008|NCT00299546|538334197|FG001|Overall Study|Not treated|1|||
149236009|NCT00299546|538334198|FG002|Overall Study|Not treated|1|||
149236010|NCT03099265|538334199|FG000|Overall Study|Adverse Event|1|||
149236011|NCT00968539|538334203|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
149236012|NCT00968539|538334204|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
149236013|NCT00326118|538334205|FG000|Active Phase|Withdrawal by Subject|4|||
149236014|NCT00326118|538334206|FG001|Active Phase|Withdrawal by Subject|1|||
149236015|NCT01741259|538334207|FG000|Overall Study|Protocol Violation|6|||
149236016|NCT01741259|538334208|FG001|Overall Study|Protocol Violation|4|||
149236017|NCT01741259|538334207|FG000|Overall Study|Withdrawal by Subject|0|||
149236018|NCT01741259|538334208|FG001|Overall Study|Withdrawal by Subject|2|||
149236019|NCT02094573|538334215|FG000|Overall Study|Adverse Event|4|||
149236020|NCT02094573|538334216|FG001|Overall Study|Adverse Event|14|||
149236021|NCT02094573|538334215|FG000|Overall Study|Clinical Progressive Disease|9|||
149236022|NCT02094573|538334216|FG001|Overall Study|Clinical Progressive Disease|13|||
149236023|NCT02094573|538334215|FG000|Overall Study|Death|11|||
149236024|NCT02094573|538334216|FG001|Overall Study|Death|3|||
149236025|NCT02094573|538334215|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
149236026|NCT02094573|538334216|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
149236027|NCT02094573|538334215|FG000|Overall Study|Non-compliance with Study Drug|1|||
149236028|NCT02094573|538334216|FG001|Overall Study|Non-compliance with Study Drug|1|||
149236029|NCT02094573|538334215|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
149236030|NCT02094573|538334216|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
149236031|NCT02094573|538334215|FG000|Overall Study|Physician Decision|4|||
149236032|NCT02094573|538334216|FG001|Overall Study|Physician Decision|4|||
149236033|NCT02094573|538334215|FG000|Overall Study|Site Terminated by Sponsor|10|||
149236034|NCT02094573|538334216|FG001|Overall Study|Site Terminated by Sponsor|17|||
149236035|NCT02094573|538334215|FG000|Overall Study|Withdrawal by Subject|6|||
149236036|NCT02094573|538334216|FG001|Overall Study|Withdrawal by Subject|8|||
149236037|NCT02094573|538334215|FG000|Overall Study|Randomized but not Treated|3|||
149236038|NCT02094573|538334216|FG001|Overall Study|Randomized but not Treated|0|||
149236039|NCT05981365|538334222|FG000|Period 1|Adverse Event|1|||
149236040|NCT05981365|538334223|FG001|Period 1|Adverse Event|0|||
149236041|NCT01471197|538334231|FG000|Overall Study|Disease Progression|4|||
149236042|NCT01471197|538334232|FG001|Overall Study|Disease Progression|2|||
149236043|NCT01471197|538334231|FG000|Overall Study|Death|1|||
148779853|NCT05087966|536668045|FG000|Overall Study|Withdrawal by Subject|5|||
148779854|NCT01267201|536668046|FG000|First Intervention Period|Withdrawal by Subject|1|||
148779855|NCT01267201|536668047|FG001|First Intervention Period|Withdrawal by Subject|0|||
148779856|NCT01267201|536668048|FG002|First Intervention Period|Withdrawal by Subject|0|||
148779857|NCT01267201|536668049|FG003|First Intervention Period|Withdrawal by Subject|0|||
149006838|NCT00985985|537503629|FG001|Overall Study|Adverse Event|2|||
148779858|NCT01267201|536668050|FG004|First Intervention Period|Withdrawal by Subject|0|||
148779859|NCT01267201|536668051|FG005|First Intervention Period|Withdrawal by Subject|0|||
148779860|NCT01267201|536668046|FG000|Second Intervention Period|Withdrawal by Subject|0|||
148779861|NCT01267201|536668047|FG001|Second Intervention Period|Withdrawal by Subject|1|||
148779862|NCT01267201|536668048|FG002|Second Intervention Period|Withdrawal by Subject|0|||
148779863|NCT01267201|536668049|FG003|Second Intervention Period|Withdrawal by Subject|0|||
148779864|NCT01267201|536668050|FG004|Second Intervention Period|Withdrawal by Subject|0|||
148779865|NCT01267201|536668051|FG005|Second Intervention Period|Withdrawal by Subject|0|||
148779866|NCT00501059|536668052|FG000|Overall Study|Protocol Violation|80|||
148779867|NCT00501059|536668053|FG001|Overall Study|Protocol Violation|69|||
148779868|NCT00501059|536668052|FG000|Overall Study|Death|140|||
148779869|NCT00501059|536668053|FG001|Overall Study|Death|137|||
148779870|NCT00501059|536668052|FG000|Overall Study|Other|236|||
148779871|NCT00501059|536668053|FG001|Overall Study|Other|239|||
148779872|NCT00501059|536668052|FG000|Overall Study|Missing end-of-study page|91|||
148779873|NCT00501059|536668053|FG001|Overall Study|Missing end-of-study page|92|||
148779874|NCT00501059|536668052|FG000|Overall Study|Clinical endpoint reached|110|||
148779875|NCT00501059|536668053|FG001|Overall Study|Clinical endpoint reached|123|||
148779876|NCT00501059|536668052|FG000|Overall Study|Insufficient therapeutic effect|4|||
148779877|NCT00501059|536668053|FG001|Overall Study|Insufficient therapeutic effect|5|||
148779878|NCT00501059|536668052|FG000|Overall Study|Consent withdrawn by subject|817|||
148779879|NCT00501059|536668053|FG001|Overall Study|Consent withdrawn by subject|873|||
148779880|NCT00501059|536668052|FG000|Overall Study|Non-compliant with study treatment|23|||
148779881|NCT00501059|536668053|FG001|Overall Study|Non-compliant with study treatment|16|||
148779882|NCT00501059|536668052|FG000|Overall Study|Reason not given|3|||
148779883|NCT00501059|536668053|FG001|Overall Study|Reason not given|1|||
148779884|NCT00501059|536668052|FG000|Overall Study|Adverse Event|129|||
148779885|NCT00501059|536668053|FG001|Overall Study|Adverse Event|122|||
148779886|NCT00501059|536668052|FG000|Overall Study|Lost to Follow-up|210|||
148779887|NCT00501059|536668053|FG001|Overall Study|Lost to Follow-up|198|||
148779888|NCT00501059|536668052|FG000|Overall Study|Not treated|25|||
148779889|NCT00501059|536668053|FG001|Overall Study|Not treated|17|||
148779890|NCT02124759|536668054|FG000|Overall Study|Withdrawal by Subject|3|||
148779891|NCT02124759|536668055|FG001|Overall Study|Withdrawal by Subject|1|||
148779892|NCT02124759|536668056|FG002|Overall Study|Withdrawal by Subject|1|||
148779893|NCT02124759|536668054|FG000|Overall Study|Screen Fail|2|||
148779894|NCT02124759|536668055|FG001|Overall Study|Screen Fail|2|||
148779895|NCT02124759|536668056|FG002|Overall Study|Screen Fail|3|||
148779896|NCT04249622|536668059|FG000|Overall Study|Withdrawal by Subject|1|||
148779897|NCT04249622|536668060|FG001|Overall Study|Withdrawal by Subject|1|||
148779898|NCT04249622|536668059|FG000|Overall Study|Alternative therapy|1|||
148779899|NCT04249622|536668060|FG001|Overall Study|Alternative therapy|0|||
148779900|NCT04249622|536668059|FG000|Overall Study|Discontinuation of pertuzumab|1|||
148779901|NCT04249622|536668060|FG001|Overall Study|Discontinuation of pertuzumab|0|||
148779902|NCT03689543|536668062|FG000|Overall Study|Adverse Event|0|||
148779903|NCT03689543|536668063|FG001|Overall Study|Adverse Event|0|||
148779904|NCT03689543|536668064|FG002|Overall Study|Adverse Event|1|||
148779905|NCT03627416|536668065|FG000|Overall Study|Adverse Event|0|||
148779906|NCT03627416|536668066|FG001|Overall Study|Adverse Event|1|||
148779907|NCT02520427|536668070|FG000|Overall Study|Decision by sponsor|0|||
148779908|NCT02520427|536668071|FG001|Overall Study|Decision by sponsor|0|||
148779909|NCT02520427|536668072|FG002|Overall Study|Decision by sponsor|0|||
148779910|NCT02520427|536668073|FG003|Overall Study|Decision by sponsor|0|||
148779911|NCT02520427|536668074|FG004|Overall Study|Decision by sponsor|0|||
148779912|NCT02520427|536668075|FG005|Overall Study|Decision by sponsor|0|||
148779913|NCT02520427|536668076|FG006|Overall Study|Decision by sponsor|0|||
148779914|NCT02520427|536668077|FG007|Overall Study|Decision by sponsor|0|||
148779915|NCT02520427|536668078|FG008|Overall Study|Decision by sponsor|1|||
148779916|NCT02520427|536668079|FG009|Overall Study|Decision by sponsor|1|||
148779917|NCT02520427|536668080|FG010|Overall Study|Decision by sponsor|0|||
148779918|NCT02520427|536668081|FG011|Overall Study|Decision by sponsor|0|||
148779919|NCT02520427|536668082|FG012|Overall Study|Decision by sponsor|0|||
148779920|NCT02520427|536668083|FG013|Overall Study|Decision by sponsor|0|||
148779921|NCT02520427|536668084|FG014|Overall Study|Decision by sponsor|0|||
148779922|NCT02520427|536668085|FG015|Overall Study|Decision by sponsor|0|||
148779923|NCT02520427|536668086|FG016|Overall Study|Decision by sponsor|0|||
148779924|NCT02520427|536668087|FG017|Overall Study|Decision by sponsor|0|||
148779925|NCT02520427|536668088|FG018|Overall Study|Decision by sponsor|0|||
148779926|NCT02520427|536668089|FG019|Overall Study|Decision by sponsor|0|||
148779927|NCT02520427|536668090|FG020|Overall Study|Decision by sponsor|0|||
148779928|NCT02520427|536668091|FG021|Overall Study|Decision by sponsor|0|||
148779929|NCT02520427|536668092|FG022|Overall Study|Decision by sponsor|0|||
148779930|NCT02520427|536668093|FG023|Overall Study|Decision by sponsor|0|||
148779931|NCT02520427|536668094|FG024|Overall Study|Decision by sponsor|0|||
148779932|NCT02520427|536668095|FG025|Overall Study|Decision by sponsor|0|||
148779933|NCT02520427|536668070|FG000|Overall Study|Withdrawal by Subject|0|||
148779934|NCT02520427|536668071|FG001|Overall Study|Withdrawal by Subject|0|||
148779935|NCT02520427|536668072|FG002|Overall Study|Withdrawal by Subject|1|||
148779936|NCT02520427|536668073|FG003|Overall Study|Withdrawal by Subject|0|||
148779937|NCT02520427|536668074|FG004|Overall Study|Withdrawal by Subject|0|||
148779938|NCT02520427|536668075|FG005|Overall Study|Withdrawal by Subject|0|||
148779939|NCT02520427|536668076|FG006|Overall Study|Withdrawal by Subject|0|||
148779940|NCT02520427|536668077|FG007|Overall Study|Withdrawal by Subject|0|||
148779941|NCT02520427|536668078|FG008|Overall Study|Withdrawal by Subject|0|||
148779942|NCT02520427|536668079|FG009|Overall Study|Withdrawal by Subject|0|||
148779943|NCT02520427|536668080|FG010|Overall Study|Withdrawal by Subject|0|||
148779944|NCT02520427|536668081|FG011|Overall Study|Withdrawal by Subject|0|||
148779945|NCT02520427|536668082|FG012|Overall Study|Withdrawal by Subject|1|||
148779946|NCT02520427|536668083|FG013|Overall Study|Withdrawal by Subject|1|||
148779947|NCT02520427|536668084|FG014|Overall Study|Withdrawal by Subject|1|||
148779948|NCT02520427|536668085|FG015|Overall Study|Withdrawal by Subject|0|||
148779949|NCT02520427|536668086|FG016|Overall Study|Withdrawal by Subject|1|||
148779950|NCT02520427|536668087|FG017|Overall Study|Withdrawal by Subject|0|||
148779951|NCT02520427|536668088|FG018|Overall Study|Withdrawal by Subject|0|||
148779952|NCT02520427|536668089|FG019|Overall Study|Withdrawal by Subject|3|||
148779953|NCT02520427|536668090|FG020|Overall Study|Withdrawal by Subject|2|||
148779954|NCT02520427|536668091|FG021|Overall Study|Withdrawal by Subject|0|||
148779955|NCT02520427|536668092|FG022|Overall Study|Withdrawal by Subject|0|||
148779956|NCT02520427|536668093|FG023|Overall Study|Withdrawal by Subject|0|||
148779957|NCT02520427|536668094|FG024|Overall Study|Withdrawal by Subject|0|||
148779958|NCT02520427|536668095|FG025|Overall Study|Withdrawal by Subject|0|||
148779959|NCT02520427|536668070|FG000|Overall Study|Death|1|||
148779960|NCT02520427|536668071|FG001|Overall Study|Death|0|||
148779961|NCT02520427|536668072|FG002|Overall Study|Death|0|||
148779962|NCT02520427|536668073|FG003|Overall Study|Death|0|||
148779963|NCT02520427|536668074|FG004|Overall Study|Death|0|||
148779964|NCT02520427|536668075|FG005|Overall Study|Death|0|||
148779965|NCT02520427|536668076|FG006|Overall Study|Death|0|||
148779966|NCT02520427|536668077|FG007|Overall Study|Death|0|||
148779967|NCT02520427|536668078|FG008|Overall Study|Death|0|||
148779968|NCT02520427|536668079|FG009|Overall Study|Death|0|||
148779969|NCT02520427|536668080|FG010|Overall Study|Death|0|||
148779970|NCT02520427|536668081|FG011|Overall Study|Death|0|||
148779971|NCT02520427|536668082|FG012|Overall Study|Death|0|||
148779972|NCT02520427|536668083|FG013|Overall Study|Death|0|||
148779973|NCT02520427|536668084|FG014|Overall Study|Death|0|||
148779974|NCT02520427|536668085|FG015|Overall Study|Death|0|||
148779975|NCT02520427|536668086|FG016|Overall Study|Death|2|||
148779976|NCT02520427|536668087|FG017|Overall Study|Death|1|||
148779977|NCT02520427|536668088|FG018|Overall Study|Death|3|||
148779978|NCT02520427|536668089|FG019|Overall Study|Death|2|||
148779979|NCT02520427|536668090|FG020|Overall Study|Death|0|||
148779980|NCT02520427|536668091|FG021|Overall Study|Death|0|||
148779981|NCT02520427|536668092|FG022|Overall Study|Death|1|||
148779982|NCT02520427|536668093|FG023|Overall Study|Death|0|||
148779983|NCT02520427|536668094|FG024|Overall Study|Death|1|||
148779984|NCT02520427|536668095|FG025|Overall Study|Death|0|||
148779985|NCT00157248|536668096|FG000|Overall Study|Adverse Event|36|||
148779986|NCT00157248|536668097|FG001|Overall Study|Adverse Event|25|||
148779987|NCT00157248|536668098|FG002|Overall Study|Adverse Event|13|||
148779988|NCT00157248|536668099|FG003|Overall Study|Adverse Event|33|||
148779989|NCT00157248|536668096|FG000|Overall Study|Protocol Violation|4|||
148779990|NCT00157248|536668097|FG001|Overall Study|Protocol Violation|0|||
148779991|NCT00157248|536668098|FG002|Overall Study|Protocol Violation|2|||
148779992|NCT00157248|536668099|FG003|Overall Study|Protocol Violation|2|||
148779993|NCT00157248|536668096|FG000|Overall Study|Lost to Follow-up|0|||
148779994|NCT00157248|536668097|FG001|Overall Study|Lost to Follow-up|1|||
148779995|NCT00157248|536668098|FG002|Overall Study|Lost to Follow-up|0|||
148779996|NCT00157248|536668099|FG003|Overall Study|Lost to Follow-up|0|||
148779997|NCT00157248|536668096|FG000|Overall Study|Withdrawal by Subject|1|||
148779998|NCT00157248|536668097|FG001|Overall Study|Withdrawal by Subject|4|||
148779999|NCT00157248|536668098|FG002|Overall Study|Withdrawal by Subject|3|||
148780000|NCT00157248|536668099|FG003|Overall Study|Withdrawal by Subject|3|||
149236044|NCT01471197|538334232|FG001|Overall Study|Death|0|||
149236045|NCT01471197|538334231|FG000|Overall Study|Study Drug Toxicity|1|||
149236046|NCT01471197|538334232|FG001|Overall Study|Study Drug Toxicity|0|||
149236047|NCT00924313|538334233|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
149236048|NCT01283009|538334234|FG000|Overall Study|Death|83|||
149236049|NCT01283009|538334235|FG001|Overall Study|Death|78|||
149236050|NCT01283009|538334234|FG000|Overall Study|Study ended early|23|||
149236051|NCT01283009|538334235|FG001|Overall Study|Study ended early|26|||
149236052|NCT01283009|538334234|FG000|Overall Study|Withdrawal by Subject|10|||
149236053|NCT01283009|538334235|FG001|Overall Study|Withdrawal by Subject|8|||
149236054|NCT01283009|538334234|FG000|Overall Study|Physician Decision|1|||
149236055|NCT01283009|538334235|FG001|Overall Study|Physician Decision|1|||
149236056|NCT01283009|538334234|FG000|Overall Study|Lost to Follow-up|1|||
149236057|NCT01283009|538334235|FG001|Overall Study|Lost to Follow-up|0|||
149236058|NCT01283009|538334234|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
149236059|NCT01283009|538334235|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
149236060|NCT05102162|538334236|FG000|Overall Study|Withdrawal by Subject|3|||
149236061|NCT05102162|538334237|FG001|Overall Study|Withdrawal by Subject|0|||
149236062|NCT05102162|538334236|FG000|Overall Study|Baseline cultures negative|4|||
149236063|NCT05102162|538334237|FG001|Overall Study|Baseline cultures negative|2|||
149236064|NCT05102162|538334236|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
149236065|NCT05102162|538334237|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
149236066|NCT05102162|538334236|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
149236067|NCT05102162|538334237|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
149236068|NCT01353586|538334238|FG000|Overall Study|Procedure terminated prior to ablation|3|||
149236069|NCT01353586|538334239|FG001|Overall Study|Procedure terminated prior to ablation|0|||
149236070|NCT01353586|538334238|FG000|Overall Study|Never had insertion of study catheter|4|||
149236071|NCT01353586|538334239|FG001|Overall Study|Never had insertion of study catheter|1|||
149236072|NCT01353586|538334238|FG000|Overall Study|Neurological exam not done|0|||
149236073|NCT01353586|538334239|FG001|Overall Study|Neurological exam not done|1|||
149236074|NCT05027958|538334240|FG000|Overall Study|Lost to Follow-up|1|||
149236075|NCT05027958|538334241|FG001|Overall Study|Lost to Follow-up|1|||
149236076|NCT05027958|538334240|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
149236077|NCT05027958|538334241|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
149236078|NCT05027958|538334240|FG000|Overall Study|Physician Decision|1|||
149236079|NCT05027958|538334241|FG001|Overall Study|Physician Decision|4|||
149236080|NCT05027958|538334240|FG000|Overall Study|Adverse Event|0|||
149236081|NCT05027958|538334241|FG001|Overall Study|Adverse Event|1|||
149236082|NCT02242942|538334252|FG000|Overall Study|Death|17|||
149236083|NCT02242942|538334253|FG001|Overall Study|Death|20|||
149236084|NCT02242942|538334254|FG002|Overall Study|Death|2|||
149236085|NCT02242942|538334252|FG000|Overall Study|Physician Decision|1|||
149236086|NCT02242942|538334253|FG001|Overall Study|Physician Decision|0|||
149236087|NCT02242942|538334254|FG002|Overall Study|Physician Decision|0|||
149236088|NCT02242942|538334252|FG000|Overall Study|Withdrawal by Subject|8|||
149236089|NCT02242942|538334253|FG001|Overall Study|Withdrawal by Subject|10|||
149236090|NCT02242942|538334254|FG002|Overall Study|Withdrawal by Subject|0|||
149236091|NCT02242942|538334252|FG000|Overall Study|On-going in Study|190|||
149236092|NCT02242942|538334253|FG001|Overall Study|On-going in Study|186|||
149236093|NCT02242942|538334254|FG002|Overall Study|On-going in Study|11|||
149236094|NCT04882085|538334255|FG000|Overall Study|Death|6|||
149236095|NCT04882085|538334256|FG001|Overall Study|Death|9|||
149236096|NCT04882085|538334255|FG000|Overall Study|Withdrawal by Subject|0|||
149236097|NCT04882085|538334256|FG001|Overall Study|Withdrawal by Subject|3|||
149236098|NCT04882085|538334255|FG000|Overall Study|Randomized not treated|1|||
149236099|NCT04882085|538334256|FG001|Overall Study|Randomized not treated|0|||
149236100|NCT04455620|538334263|FG000|Overall Study|Withdrawal by Subject|0|||
149236101|NCT04455620|538334264|FG001|Overall Study|Withdrawal by Subject|0|||
149236102|NCT04455620|538334265|FG002|Overall Study|Withdrawal by Subject|2|||
149236103|NCT04455620|538334266|FG003|Overall Study|Withdrawal by Subject|0|||
149236104|NCT04455620|538334267|FG004|Overall Study|Withdrawal by Subject|1|||
149006839|NCT00985985|537503630|FG002|Overall Study|Adverse Event|2|||
149236105|NCT04455620|538334263|FG000|Overall Study|Lost to Follow-up|0|||
149236106|NCT04455620|538334264|FG001|Overall Study|Lost to Follow-up|0|||
149236107|NCT04455620|538334265|FG002|Overall Study|Lost to Follow-up|1|||
149236108|NCT04455620|538334266|FG003|Overall Study|Lost to Follow-up|1|||
149236109|NCT04455620|538334267|FG004|Overall Study|Lost to Follow-up|0|||
149236110|NCT04455620|538334263|FG000|Overall Study|Death|1|||
149236111|NCT04455620|538334264|FG001|Overall Study|Death|6|||
149236112|NCT04455620|538334265|FG002|Overall Study|Death|20|||
149236113|NCT04455620|538334266|FG003|Overall Study|Death|1|||
149236114|NCT04455620|538334267|FG004|Overall Study|Death|7|||
149236115|NCT04455620|538334263|FG000|Overall Study|Study Termination|0|||
149236116|NCT04455620|538334264|FG001|Overall Study|Study Termination|2|||
149236117|NCT04455620|538334265|FG002|Overall Study|Study Termination|1|||
149236118|NCT04455620|538334266|FG003|Overall Study|Study Termination|0|||
149236119|NCT04455620|538334267|FG004|Overall Study|Study Termination|6|||
149236120|NCT05681715|538334269|FG000|Training Period (6-weeks)|Adverse Event|3|||
149236121|NCT05681715|538334270|FG001|Training Period (6-weeks)|Adverse Event|0|||
149236122|NCT05681715|538334271|FG002|Training Period (6-weeks)|Adverse Event|0|||
149236123|NCT05681715|538334269|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
149236124|NCT05681715|538334270|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
149236125|NCT05681715|538334271|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
149236126|NCT05681715|538334269|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
149236127|NCT05681715|538334270|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
149236128|NCT05681715|538334271|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
149236129|NCT05681715|538334269|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
149236130|NCT05681715|538334270|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
149236131|NCT05681715|538334271|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
149236132|NCT05681715|538334269|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
149236133|NCT05681715|538334270|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
149236134|NCT05681715|538334271|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
149236135|NCT05681715|538334269|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
149236136|NCT05681715|538334270|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
149236137|NCT05681715|538334271|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
149236138|NCT05681715|538334269|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
149236139|NCT05681715|538334270|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
148780001|NCT00157248|536668096|FG000|Overall Study|site closures, subject moving|7|||
148780002|NCT00157248|536668097|FG001|Overall Study|site closures, subject moving|7|||
148780003|NCT00157248|536668098|FG002|Overall Study|site closures, subject moving|3|||
148780004|NCT00157248|536668099|FG003|Overall Study|site closures, subject moving|9|||
148780005|NCT03191864|536668100|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
148780006|NCT03191864|536668101|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
148780007|NCT03191864|536668102|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
148780008|NCT03191864|536668103|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
148780009|NCT03191864|536668104|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
148780010|NCT03191864|536668105|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
149006840|NCT00985985|537503631|FG003|Overall Study|Adverse Event|2|||
148780011|NCT03191864|536668100|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
148780012|NCT03191864|536668101|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
148780013|NCT03191864|536668102|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
148780014|NCT03191864|536668103|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
148780015|NCT03191864|536668104|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
148780016|NCT03191864|536668105|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
148780017|NCT03191864|536668100|FG000|Baseline Symptom Assessment|Adverse Event|0|||
148780018|NCT03191864|536668101|FG001|Baseline Symptom Assessment|Adverse Event|0|||
148780019|NCT03191864|536668102|FG002|Baseline Symptom Assessment|Adverse Event|0|||
148780020|NCT03191864|536668103|FG003|Baseline Symptom Assessment|Adverse Event|0|||
148780021|NCT03191864|536668104|FG004|Baseline Symptom Assessment|Adverse Event|0|||
148780022|NCT03191864|536668105|FG005|Baseline Symptom Assessment|Adverse Event|2|||
148780023|NCT03191864|536668100|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
148780024|NCT03191864|536668101|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
148780025|NCT03191864|536668102|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
148780026|NCT03191864|536668103|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
148780027|NCT03191864|536668104|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
148780028|NCT03191864|536668105|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
148780029|NCT03191864|536668100|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
148780030|NCT03191864|536668101|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
148780031|NCT03191864|536668102|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
148780032|NCT03191864|536668103|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
148780033|NCT03191864|536668104|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
148780034|NCT03191864|536668105|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
148780035|NCT03191864|536668100|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
148780036|NCT03191864|536668101|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
148780037|NCT03191864|536668102|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
148780038|NCT03191864|536668103|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
148780039|NCT03191864|536668104|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
148780040|NCT03191864|536668105|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
148780041|NCT03191864|536668100|FG000|Part 1 - Induction|Adverse Event|0|||
148780042|NCT03191864|536668101|FG001|Part 1 - Induction|Adverse Event|2|||
148780043|NCT03191864|536668102|FG002|Part 1 - Induction|Adverse Event|0|||
148780044|NCT03191864|536668103|FG003|Part 1 - Induction|Adverse Event|1|||
148780045|NCT03191864|536668104|FG004|Part 1 - Induction|Adverse Event|0|||
148780046|NCT03191864|536668105|FG005|Part 1 - Induction|Adverse Event|2|||
148780047|NCT03191864|536668100|FG000|Part 1 - Induction|Randomized but never dosed|0|||
148780048|NCT03191864|536668101|FG001|Part 1 - Induction|Randomized but never dosed|0|||
148780049|NCT03191864|536668102|FG002|Part 1 - Induction|Randomized but never dosed|1|||
148780050|NCT03191864|536668103|FG003|Part 1 - Induction|Randomized but never dosed|0|||
148780051|NCT03191864|536668104|FG004|Part 1 - Induction|Randomized but never dosed|0|||
148780052|NCT03191864|536668105|FG005|Part 1 - Induction|Randomized but never dosed|0|||
148780053|NCT03191864|536668100|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
148780054|NCT03191864|536668101|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
148780055|NCT03191864|536668102|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
148780056|NCT03191864|536668103|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
148780057|NCT03191864|536668104|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
148780058|NCT03191864|536668105|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
148780059|NCT03191864|536668100|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
148780060|NCT03191864|536668101|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
148780061|NCT03191864|536668102|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
148780062|NCT03191864|536668103|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
148780063|NCT03191864|536668104|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
148780064|NCT03191864|536668105|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
148780065|NCT03191864|536668100|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
148780066|NCT03191864|536668101|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
148780067|NCT03191864|536668102|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
148780068|NCT03191864|536668103|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
148780069|NCT03191864|536668104|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
148780070|NCT03191864|536668105|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
148780071|NCT03191864|536668100|FG000|Part 2 - Maintenance|Physician Decision|1|||
148780072|NCT03191864|536668101|FG001|Part 2 - Maintenance|Physician Decision|0|||
148780073|NCT03191864|536668102|FG002|Part 2 - Maintenance|Physician Decision|0|||
148780074|NCT03191864|536668103|FG003|Part 2 - Maintenance|Physician Decision|0|||
148780075|NCT03191864|536668104|FG004|Part 2 - Maintenance|Physician Decision|0|||
148780076|NCT03191864|536668105|FG005|Part 2 - Maintenance|Physician Decision|0|||
148780077|NCT03191864|536668100|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
148780078|NCT03191864|536668101|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
148780079|NCT03191864|536668102|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
148780080|NCT03191864|536668103|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
148780081|NCT03191864|536668104|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
148780082|NCT03191864|536668105|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
148780083|NCT03191864|536668100|FG000|Part 2 - Maintenance|Adverse Event|0|||
148780084|NCT03191864|536668101|FG001|Part 2 - Maintenance|Adverse Event|0|||
148780085|NCT03191864|536668102|FG002|Part 2 - Maintenance|Adverse Event|0|||
148780086|NCT03191864|536668103|FG003|Part 2 - Maintenance|Adverse Event|0|||
148780087|NCT03191864|536668104|FG004|Part 2 - Maintenance|Adverse Event|1|||
148780088|NCT03191864|536668105|FG005|Part 2 - Maintenance|Adverse Event|0|||
148780089|NCT03191864|536668100|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
148780090|NCT03191864|536668101|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
148780091|NCT03191864|536668102|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
148780092|NCT03191864|536668103|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
148780093|NCT03191864|536668104|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
148780094|NCT03191864|536668105|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
148780095|NCT03191864|536668100|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
148780096|NCT03191864|536668101|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
148780097|NCT03191864|536668102|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
148780098|NCT03191864|536668103|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
148780099|NCT03191864|536668104|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
148780100|NCT03191864|536668105|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
148780101|NCT01447927|536668106|FG000|Overall Study|Adverse Event|4|||
148780102|NCT01447927|536668107|FG001|Overall Study|Adverse Event|3|||
148780103|NCT01447927|536668106|FG000|Overall Study|Withdrawal by Subject|1|||
148780104|NCT01447927|536668107|FG001|Overall Study|Withdrawal by Subject|0|||
148780105|NCT02342548|536668108|FG000|Overall Study|Adverse Event|12|||
148780106|NCT02342548|536668109|FG001|Overall Study|Adverse Event|17|||
148780107|NCT02342548|536668110|FG002|Overall Study|Adverse Event|13|||
148780108|NCT02342548|536668108|FG000|Overall Study|Lost to Follow-up|0|||
148780109|NCT02342548|536668109|FG001|Overall Study|Lost to Follow-up|1|||
148780110|NCT02342548|536668110|FG002|Overall Study|Lost to Follow-up|0|||
148780111|NCT02342548|536668108|FG000|Overall Study|Study terminated by sponsor|20|||
148780112|NCT02342548|536668109|FG001|Overall Study|Study terminated by sponsor|39|||
148780113|NCT02342548|536668110|FG002|Overall Study|Study terminated by sponsor|25|||
148780114|NCT02342548|536668108|FG000|Overall Study|Protocol Violation|0|||
148780115|NCT02342548|536668109|FG001|Overall Study|Protocol Violation|1|||
148780116|NCT02342548|536668110|FG002|Overall Study|Protocol Violation|0|||
148780117|NCT02342548|536668108|FG000|Overall Study|Withdrawal by Subject|1|||
148780118|NCT02342548|536668109|FG001|Overall Study|Withdrawal by Subject|3|||
148780119|NCT02342548|536668110|FG002|Overall Study|Withdrawal by Subject|4|||
148780120|NCT02342548|536668108|FG000|Overall Study|Other|1|||
148780121|NCT02342548|536668109|FG001|Overall Study|Other|1|||
148780122|NCT02342548|536668110|FG002|Overall Study|Other|1|||
148811165|NCT04809974|536787020|FG001|Lead-in Phase|Withdrawal by Subject|0|||
148811166|NCT04809974|536787021|FG002|Lead-in Phase|Withdrawal by Subject|0|||
148811167|NCT04809974|536787019|FG000|Lead-in Phase|No longer eligible|11|||
148811168|NCT04809974|536787020|FG001|Lead-in Phase|No longer eligible|0|||
148811169|NCT04809974|536787021|FG002|Lead-in Phase|No longer eligible|0|||
148811170|NCT04809974|536787019|FG000|Randomized Phase|Lost to Follow-up|0|||
148811171|NCT04809974|536787020|FG001|Randomized Phase|Lost to Follow-up|1|||
148811172|NCT04809974|536787021|FG002|Randomized Phase|Lost to Follow-up|5|||
148811173|NCT04809974|536787019|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
148811174|NCT04809974|536787020|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
148811175|NCT04809974|536787021|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
148811176|NCT04809974|536787019|FG000|Randomized Phase|Adverse Event|0|||
148811177|NCT04809974|536787020|FG001|Randomized Phase|Adverse Event|1|||
148811178|NCT04809974|536787021|FG002|Randomized Phase|Adverse Event|4|||
148811179|NCT04809974|536787019|FG000|Randomized Phase|Withdrawal by Subject|0|||
148811180|NCT04809974|536787020|FG001|Randomized Phase|Withdrawal by Subject|0|||
148811181|NCT04809974|536787021|FG002|Randomized Phase|Withdrawal by Subject|5|||
148811182|NCT00549055|536787030|FG000|Overall Study|Adverse Event|4|||
148811183|NCT00549055|536787030|FG000|Overall Study|Lack of Efficacy|18|||
148811184|NCT00549055|536787030|FG000|Overall Study|Stabilization|5|||
148811185|NCT00549055|536787030|FG000|Overall Study|Progression to fibrosis|2|||
148811186|NCT00549055|536787030|FG000|Overall Study|Decrease of size|1|||
148811187|NCT00549055|536787030|FG000|Overall Study|Active choroidal neovascula increased|1|||
148811188|NCT00549055|536787030|FG000|Overall Study|Vitreous hemorrhage|1|||
148811189|NCT00549055|536787030|FG000|Overall Study|Growth choroidal neovascularisation|1|||
148811190|NCT00549055|536787030|FG000|Overall Study|Choroidal neovascularization|1|||
148811191|NCT00549055|536787030|FG000|Overall Study|Very low visual acuity (VA)|1|||
148811192|NCT02472405|536787031|FG000|Overall Study|Lost to Follow-up|9|||
148811193|NCT02472405|536787031|FG000|Overall Study|Adverse Event|1|||
148811194|NCT01431976|536787032|FG000|Overall Study|Adverse Event|6|||
148811195|NCT01431976|536787032|FG000|Overall Study|Lack of Efficacy|2|||
148780123|NCT03435224|536669555|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
148780124|NCT00367484|536669556|FG000|Overall Study|Adverse Event|7|||
148780125|NCT00367484|536669556|FG000|Overall Study|Withdrew informed consent|5|||
148780126|NCT00367484|536669556|FG000|Overall Study|Travel to USA|1|||
148780127|NCT00367484|536669556|FG000|Overall Study|Lost to Follow-up|1|||
148780128|NCT00367484|536669556|FG000|Overall Study|Protocol Violation|1|||
148780129|NCT00367484|536669556|FG000|Overall Study|The choice of the patient|1|||
148780130|NCT00367484|536669556|FG000|Overall Study|Lack of Efficacy|1|||
148780131|NCT04472026|536669557|FG000|Overall Study|Lost to Follow-up|5|||
148780132|NCT02382796|536669558|FG000|Overall Study|Global deterioration of health status|1|||
148780133|NCT02382796|536669558|FG000|Overall Study|Objective progression or relapse|3|||
148780134|NCT02382796|536669558|FG000|Overall Study|Commercial dacomitinib became available|3|||
148780135|NCT04007107|536669563|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
148780136|NCT04007107|536669564|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
148780137|NCT04007107|536669565|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
148780138|NCT04007107|536669566|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
148780139|NCT04526574|536669567|FG000|Overall Study|Protocol Violation|3|||
148780140|NCT04526574|536669568|FG001|Overall Study|Protocol Violation|1|||
148780141|NCT04526574|536669567|FG000|Overall Study|Withdrawal by Subject|12|||
148780142|NCT04526574|536669568|FG001|Overall Study|Withdrawal by Subject|9|||
148780143|NCT04526574|536669567|FG000|Overall Study|Other|1|||
148780144|NCT04526574|536669568|FG001|Overall Study|Other|2|||
148780145|NCT04526574|536669567|FG000|Overall Study|Adverse Event|1|||
148780146|NCT04526574|536669568|FG001|Overall Study|Adverse Event|1|||
148780147|NCT04526574|536669567|FG000|Overall Study|Death|2|||
148780148|NCT04526574|536669568|FG001|Overall Study|Death|3|||
148780149|NCT04526574|536669567|FG000|Overall Study|Lost to Follow-up|9|||
148780150|NCT04526574|536669568|FG001|Overall Study|Lost to Follow-up|9|||
148780151|NCT04526574|536669567|FG000|Overall Study|No longer meets eligibility criteria|8|||
148780152|NCT04526574|536669568|FG001|Overall Study|No longer meets eligibility criteria|8|||
148780153|NCT00329641|536669574|FG000|Overall Study|Did not start treatment|1|||
148780154|NCT00329641|536669574|FG000|Overall Study|Not eligible|1|||
148780155|NCT00329641|536669574|FG000|Overall Study|Adverse Event|3|||
148780156|NCT00329641|536669574|FG000|Overall Study|Other reason, not protocol specified|1|||
148780157|NCT03329248|536669578|FG000|Overall Study|Progressive Disease|6|||
148780158|NCT01522235|536669579|FG000|Overall Study|Physician Decision|1|||
148780159|NCT01522235|536669580|FG001|Overall Study|Physician Decision|1|||
148780160|NCT00987402|536669581|FG000|Overall Study|Insufficient data entry|86|||
148780161|NCT00987402|536669582|FG001|Overall Study|Insufficient data entry|98|||
148780162|NCT03000530|536669583|FG000|Overall Study|Adverse Event|0|||
148780163|NCT03000530|536669584|FG001|Overall Study|Adverse Event|0|||
148780164|NCT03000530|536669585|FG002|Overall Study|Adverse Event|2|||
148780165|NCT03000530|536669583|FG000|Overall Study|Lost to Follow-up|0|||
148780166|NCT03000530|536669584|FG001|Overall Study|Lost to Follow-up|3|||
148780167|NCT03000530|536669585|FG002|Overall Study|Lost to Follow-up|1|||
148780168|NCT03000530|536669583|FG000|Overall Study|Withdrawal by Subject|0|||
148780169|NCT03000530|536669584|FG001|Overall Study|Withdrawal by Subject|2|||
148780170|NCT03000530|536669585|FG002|Overall Study|Withdrawal by Subject|1|||
148780171|NCT01430624|536669588|FG000|Overall Study|Lost to Follow-up|23|||
148780172|NCT01430624|536669589|FG001|Overall Study|Lost to Follow-up|29|||
148780173|NCT01430624|536669590|FG002|Overall Study|Lost to Follow-up|27|||
148780174|NCT01430624|536669588|FG000|Overall Study|technical or eligibility|5|||
148780175|NCT01430624|536669589|FG001|Overall Study|technical or eligibility|5|||
148780176|NCT01430624|536669590|FG002|Overall Study|technical or eligibility|2|||
148780177|NCT01362517|536669591|FG000|Overall Study|Protocol Violation|1|||
148780178|NCT01362517|536669591|FG000|Overall Study|Lost to Follow-up|1|||
148780179|NCT02565706|536669596|FG000|Overall Study|Withdrawal by Subject|5|||
148780180|NCT02565706|536669597|FG001|Overall Study|Withdrawal by Subject|7|||
148780181|NCT02565706|536669598|FG002|Overall Study|Withdrawal by Subject|7|||
148780182|NCT02565706|536669599|FG003|Overall Study|Withdrawal by Subject|11|||
148780183|NCT02565706|536669596|FG000|Overall Study|Lost to Follow-up|72|||
148780184|NCT02565706|536669597|FG001|Overall Study|Lost to Follow-up|75|||
148780185|NCT02565706|536669598|FG002|Overall Study|Lost to Follow-up|82|||
148780186|NCT02565706|536669599|FG003|Overall Study|Lost to Follow-up|74|||
148780187|NCT01285492|536669600|FG000|Overall Study|Adverse Event|11|||
148780188|NCT01285492|536669601|FG001|Overall Study|Adverse Event|0|||
148780189|NCT01285492|536669600|FG000|Overall Study|Protocol Violation|3|||
148780190|NCT01285492|536669601|FG001|Overall Study|Protocol Violation|0|||
148780191|NCT01285492|536669600|FG000|Overall Study|Withdrawal by Subject|2|||
148780192|NCT01285492|536669601|FG001|Overall Study|Withdrawal by Subject|1|||
148780193|NCT01285492|536669600|FG000|Overall Study|Death|1|||
148780194|NCT01285492|536669601|FG001|Overall Study|Death|0|||
148780195|NCT03379792|536669602|FG000|Overall Study|Physician Decision|0|||
148780196|NCT03379792|536669603|FG001|Overall Study|Physician Decision|0|||
148780197|NCT03379792|536669604|FG002|Overall Study|Physician Decision|0|||
148780198|NCT03379792|536669605|FG003|Overall Study|Physician Decision|1|||
148780199|NCT03379792|536669606|FG004|Overall Study|Physician Decision|0|||
148780200|NCT03379792|536669607|FG005|Overall Study|Physician Decision|0|||
148780201|NCT03379792|536669602|FG000|Overall Study|Withdrawal by Subject|0|||
148780202|NCT03379792|536669603|FG001|Overall Study|Withdrawal by Subject|0|||
148780203|NCT03379792|536669604|FG002|Overall Study|Withdrawal by Subject|0|||
148780204|NCT03379792|536669605|FG003|Overall Study|Withdrawal by Subject|0|||
148780205|NCT03379792|536669606|FG004|Overall Study|Withdrawal by Subject|1|||
148780206|NCT03379792|536669607|FG005|Overall Study|Withdrawal by Subject|1|||
148780207|NCT01121536|536669608|FG000|Overall Study|Adverse Event|63|||
148780208|NCT01121536|536669608|FG000|Overall Study|Lack of Efficacy|35|||
148780209|NCT01121536|536669608|FG000|Overall Study|Withdrawal by Subject|65|||
148780210|NCT01121536|536669608|FG000|Overall Study|Protocol Violation|20|||
148780211|NCT01121536|536669608|FG000|Overall Study|Noncompliance with study medication|12|||
148780212|NCT01121536|536669608|FG000|Overall Study|Noncompliance with study procedures|9|||
148780213|NCT01121536|536669608|FG000|Overall Study|Lost to Follow-up|39|||
148780214|NCT01121536|536669608|FG000|Overall Study|Other|118|||
148780215|NCT01273155|536669610|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
148780216|NCT01273155|536669611|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
148780217|NCT01273155|536669612|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
148780218|NCT01273155|536669613|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
148780219|NCT01273155|536669614|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
148780220|NCT01273155|536669615|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
148780221|NCT01273155|536669616|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
148780222|NCT01273155|536669610|FG000|Overall Study|Change in liver function/no longer eval.|0|||
148780223|NCT01273155|536669611|FG001|Overall Study|Change in liver function/no longer eval.|1|||
148780224|NCT01273155|536669612|FG002|Overall Study|Change in liver function/no longer eval.|0|||
148780225|NCT01273155|536669613|FG003|Overall Study|Change in liver function/no longer eval.|0|||
148780226|NCT01273155|536669614|FG004|Overall Study|Change in liver function/no longer eval.|1|||
148780227|NCT01273155|536669615|FG005|Overall Study|Change in liver function/no longer eval.|0|||
148780228|NCT01273155|536669616|FG006|Overall Study|Change in liver function/no longer eval.|0|||
148780229|NCT01273155|536669610|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
148780230|NCT01273155|536669611|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
148780231|NCT01273155|536669612|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
148780232|NCT01273155|536669613|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
148780233|NCT01273155|536669614|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
148780234|NCT01273155|536669615|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
148780235|NCT01273155|536669616|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
148780236|NCT01273155|536669610|FG000|Overall Study|Died during Cycle 1|0|||
148780237|NCT01273155|536669611|FG001|Overall Study|Died during Cycle 1|0|||
148780238|NCT01273155|536669612|FG002|Overall Study|Died during Cycle 1|1|||
148780239|NCT01273155|536669613|FG003|Overall Study|Died during Cycle 1|1|||
148780240|NCT01273155|536669614|FG004|Overall Study|Died during Cycle 1|0|||
148780241|NCT01273155|536669615|FG005|Overall Study|Died during Cycle 1|2|||
148780242|NCT01273155|536669616|FG006|Overall Study|Died during Cycle 1|2|||
148780243|NCT01273155|536669610|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
148780244|NCT01273155|536669611|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
148780245|NCT01273155|536669612|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
148780246|NCT01273155|536669613|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
148780247|NCT01273155|536669614|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
148780248|NCT01273155|536669615|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
148780249|NCT01273155|536669616|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
148780250|NCT01256385|536669617|FG000|Overall Study|Physician Decision|1|||
148780251|NCT01256385|536669618|FG001|Overall Study|Physician Decision|1|||
148780252|NCT01256385|536669617|FG000|Overall Study|Withdrawal by Subject|2|||
148780253|NCT01256385|536669618|FG001|Overall Study|Withdrawal by Subject|2|||
148780254|NCT00401960|536669619|FG000|Overall Study|Lost to Follow-up|3|||
148780255|NCT00401960|536669620|FG001|Overall Study|Lost to Follow-up|0|||
148780256|NCT00401960|536669619|FG000|Overall Study|Death|2|||
148780257|NCT00401960|536669620|FG001|Overall Study|Death|0|||
148780258|NCT02649426|536669621|FG000|Overall Study|Follow-up on going|1|||
148780259|NCT02649426|536669622|FG001|Overall Study|Follow-up on going|26|||
148780260|NCT02649426|536669623|FG002|Overall Study|Follow-up on going|28|||
148780261|NCT02649426|536669624|FG003|Overall Study|Follow-up on going|31|||
148780262|NCT01606202|536669625|FG000|Overall Study|Adverse Event|5|||
148780263|NCT01606202|536669626|FG001|Overall Study|Adverse Event|0|||
148780264|NCT01606202|536669625|FG000|Overall Study|Withdrawal by Subject|2|||
148780265|NCT01606202|536669626|FG001|Overall Study|Withdrawal by Subject|1|||
148780266|NCT01606202|536669625|FG000|Overall Study|Personal problems|0|||
148780267|NCT01606202|536669626|FG001|Overall Study|Personal problems|1|||
148780268|NCT01606202|536669625|FG000|Overall Study|Problems with administration|0|||
148780269|NCT01606202|536669626|FG001|Overall Study|Problems with administration|1|||
148780270|NCT00306787|536669627|FG000|Overall Study|Discontinued without taking study drug|208|||
148780271|NCT00306787|536669628|FG001|Overall Study|Discontinued without taking study drug|215|||
148780272|NCT00306787|536669627|FG000|Overall Study|Adverse Event|1|||
148780273|NCT00306787|536669628|FG001|Overall Study|Adverse Event|1|||
148780274|NCT00306787|536669627|FG000|Overall Study|Lack of Efficacy|1|||
148780275|NCT00306787|536669628|FG001|Overall Study|Lack of Efficacy|0|||
148780276|NCT00306787|536669627|FG000|Overall Study|Protocol Violation|8|||
148780277|NCT00306787|536669628|FG001|Overall Study|Protocol Violation|10|||
148780278|NCT00306787|536669627|FG000|Overall Study|Withdrawal by Subject|2|||
148780279|NCT00306787|536669628|FG001|Overall Study|Withdrawal by Subject|9|||
148780280|NCT00306787|536669627|FG000|Overall Study|Lost to Follow-up|9|||
148780281|NCT00306787|536669628|FG001|Overall Study|Lost to Follow-up|6|||
148780282|NCT00306787|536669627|FG000|Overall Study|Administrative problems|4|||
148780283|NCT00306787|536669628|FG001|Overall Study|Administrative problems|0|||
148780284|NCT00306787|536669627|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148780285|NCT00306787|536669628|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148780286|NCT01438814|536669629|FG000|Overall Study|Adverse Event|3|||
148780287|NCT01438814|536669630|FG001|Overall Study|Adverse Event|3|||
148780288|NCT01438814|536669629|FG000|Overall Study|Protocol Violation|1|||
148780289|NCT01438814|536669630|FG001|Overall Study|Protocol Violation|2|||
148780290|NCT01438814|536669629|FG000|Overall Study|Lost to Follow-up|4|||
148780291|NCT01438814|536669630|FG001|Overall Study|Lost to Follow-up|3|||
148780292|NCT01438814|536669629|FG000|Overall Study|Withdrawal by Subject|4|||
148780293|NCT01438814|536669630|FG001|Overall Study|Withdrawal by Subject|2|||
148780294|NCT01438814|536669629|FG000|Overall Study|Other|2|||
148780295|NCT01438814|536669630|FG001|Overall Study|Other|4|||
148780296|NCT02273908|536669633|FG000|Overall Study|Adverse Event|16|||
148780297|NCT02273908|536669634|FG001|Overall Study|Adverse Event|0|||
148780298|NCT02273908|536669633|FG000|Overall Study|Lost to Follow-up|10|||
148780299|NCT02273908|536669634|FG001|Overall Study|Lost to Follow-up|1|||
148780300|NCT02273908|536669633|FG000|Overall Study|Did not meet entrance criteria|3|||
148780301|NCT02273908|536669634|FG001|Overall Study|Did not meet entrance criteria|2|||
148780302|NCT02273908|536669633|FG000|Overall Study|Withdrawal by Subject|4|||
148780303|NCT02273908|536669634|FG001|Overall Study|Withdrawal by Subject|2|||
148780304|NCT00369161|536669635|FG000|Overall Study|Adverse Event|15|||
148780305|NCT00369161|536669636|FG001|Overall Study|Adverse Event|13|||
148780306|NCT00369161|536669635|FG000|Overall Study|Abnormal laboratory value|0|||
148780307|NCT00369161|536669636|FG001|Overall Study|Abnormal laboratory value|1|||
148780308|NCT00369161|536669635|FG000|Overall Study|Lack of Efficacy|3|||
148780309|NCT00369161|536669636|FG001|Overall Study|Lack of Efficacy|1|||
148780310|NCT00369161|536669635|FG000|Overall Study|Protocol Violation|0|||
148780311|NCT00369161|536669636|FG001|Overall Study|Protocol Violation|2|||
148780312|NCT00369161|536669635|FG000|Overall Study|Withdrawal by Subject|2|||
148780313|NCT00369161|536669636|FG001|Overall Study|Withdrawal by Subject|3|||
148780314|NCT00369161|536669635|FG000|Overall Study|Death|1|||
148780315|NCT00369161|536669636|FG001|Overall Study|Death|2|||
148780316|NCT00369161|536669635|FG000|Overall Study|Graft loss|4|||
148780317|NCT00369161|536669636|FG001|Overall Study|Graft loss|0|||
148780318|NCT00369161|536669635|FG000|Overall Study|Administrative Problem|2|||
148780319|NCT00369161|536669636|FG001|Overall Study|Administrative Problem|2|||
148780320|NCT00932451|536669638|FG000|Overall Study|Withdrawal by Subject|69|||
148780321|NCT00932451|536669638|FG000|Overall Study|Lost to Follow-up|22|||
148780322|NCT00932451|536669638|FG000|Overall Study|Death|726|||
148780323|NCT00932451|536669638|FG000|Overall Study|Other reasons|5|||
148780324|NCT01634659|536669656|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
148780325|NCT01634659|536669657|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
148780326|NCT01634659|536669656|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
148780327|NCT01634659|536669657|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
148780328|NCT02968433|536669658|FG000|Overall Study|Withdrawal by Subject|1|||
148780329|NCT01294371|536669659|FG000|Overall Study|Adverse Event|1|||
148780330|NCT01294371|536669659|FG000|Overall Study|Withdrawal by Subject|12|||
148780331|NCT01294371|536669659|FG000|Overall Study|Lost to Follow-up|6|||
148780332|NCT01294371|536669659|FG000|Overall Study|Administrative Reason|1|||
148780333|NCT01294371|536669659|FG000|Overall Study|Other|14|||
148780334|NCT05619536|536669660|FG000|Overall Study|Withdrawal by Subject|0|||
148780335|NCT05619536|536669661|FG001|Overall Study|Withdrawal by Subject|1|||
148780336|NCT05619536|536669662|FG002|Overall Study|Withdrawal by Subject|0|||
148780337|NCT05619536|536669663|FG003|Overall Study|Withdrawal by Subject|1|||
148780338|NCT05619536|536669660|FG000|Overall Study|Lost to Follow-up|0|||
148780339|NCT05619536|536669661|FG001|Overall Study|Lost to Follow-up|1|||
148780340|NCT05619536|536669662|FG002|Overall Study|Lost to Follow-up|1|||
148780341|NCT05619536|536669663|FG003|Overall Study|Lost to Follow-up|0|||
148780342|NCT00875433|536669664|FG000|Overall Study|Progressive disease|41|||
148780343|NCT00875433|536669664|FG000|Overall Study|Other Adverse Event|14|||
148780344|NCT00875433|536669664|FG000|Overall Study|Withdrawal by Subject|2|||
148780345|NCT00875433|536669664|FG000|Overall Study|Other|3|||
148780346|NCT00637806|536669665|FG000|Double-blind Phase|Study Discontinued|2|||
148780347|NCT00637806|536669666|FG001|Double-blind Phase|Study Discontinued|0|||
148780348|NCT00637806|536669667|FG002|Double-blind Phase|Study Discontinued|1|||
148780349|NCT00637806|536669668|FG003|Double-blind Phase|Study Discontinued|0|||
148780350|NCT00637806|536669665|FG000|Extension Phase|Study Discontinued|0|||
148780351|NCT00637806|536669666|FG001|Extension Phase|Study Discontinued|0|||
148780352|NCT00637806|536669667|FG002|Extension Phase|Study Discontinued|0|||
148780353|NCT00637806|536669668|FG003|Extension Phase|Study Discontinued|1|||
148780354|NCT04272606|536669669|FG000|Overall Study|Protocol Violation|1|||
148780355|NCT04272606|536669670|FG001|Overall Study|Protocol Violation|1|||
148780356|NCT04272606|536669669|FG000|Overall Study|Physician Decision|0|||
148780357|NCT04272606|536669670|FG001|Overall Study|Physician Decision|1|||
148780358|NCT00725101|536669671|FG000|Overall Study|Death|3|||
148780359|NCT00725101|536669671|FG000|Overall Study|Lost to Follow-up|353|||
148780360|NCT00725101|536669671|FG000|Overall Study|Protocol Violation|1|||
148780361|NCT00725101|536669671|FG000|Overall Study|Withdrawal by Subject|127|||
148780362|NCT00725101|536669671|FG000|Overall Study|not specified/no reason given|11|||
148780363|NCT00622336|536669674|FG000|Treatment Phase|Progression of Disease|181|||
148780364|NCT00622336|536669674|FG000|Treatment Phase|Adverse Event|46|||
148780365|NCT00622336|536669674|FG000|Treatment Phase|Other|40|||
148780366|NCT00622336|536669674|FG000|Treatment Phase|Death|14|||
148780367|NCT00622336|536669674|FG000|Treatment Phase|Lack of therapeutic effect|13|||
148780368|NCT00622336|536669674|FG000|Treatment Phase|Withdrawal by Subject|13|||
148780369|NCT00622336|536669674|FG000|Treatment Phase|Lost to Follow-up|2|||
148780370|NCT00622336|536669674|FG000|Extension Phase|Adverse Event|2|||
148780371|NCT00622336|536669674|FG000|Extension Phase|Progressive Disease|6|||
148780372|NCT00622336|536669674|FG000|Extension Phase|Lack of therapeutic effect|2|||
148780373|NCT00622336|536669674|FG000|Extension Phase|Withdrawal by Subject|1|||
148780374|NCT00622336|536669674|FG000|Extension Phase|Lost to Follow-up|1|||
148780375|NCT00622336|536669674|FG000|Extension Phase|Other|9|||
148780376|NCT00819780|536669675|FG000|Overall Study|Did not receive study drug|3|||
148780377|NCT00819780|536669676|FG001|Overall Study|Did not receive study drug|4|||
148780378|NCT00819780|536669675|FG000|Overall Study|Still in treatment|25|||
148780379|NCT00819780|536669676|FG001|Overall Study|Still in treatment|17|||
148780380|NCT02923245|536669677|FG000|Overall Study|ultrasound order was cancelled|2|||
148780381|NCT02923245|536669678|FG001|Overall Study|ultrasound order was cancelled|1|||
148780382|NCT01764997|536669679|FG000|Run-in Period|Adverse Event|15|||
148780383|NCT01764997|536669680|FG001|Run-in Period|Adverse Event|0|||
148780384|NCT01764997|536669681|FG002|Run-in Period|Adverse Event|0|||
148780385|NCT01764997|536669682|FG003|Run-in Period|Adverse Event|0|||
148780386|NCT01764997|536669683|FG004|Run-in Period|Adverse Event|0|||
148780387|NCT01764997|536669679|FG000|Run-in Period|Lack of Efficacy|5|||
148780388|NCT01764997|536669680|FG001|Run-in Period|Lack of Efficacy|0|||
148780389|NCT01764997|536669681|FG002|Run-in Period|Lack of Efficacy|0|||
148780390|NCT01764997|536669682|FG003|Run-in Period|Lack of Efficacy|0|||
148780391|NCT01764997|536669683|FG004|Run-in Period|Lack of Efficacy|0|||
148780392|NCT01764997|536669679|FG000|Run-in Period|Poor compliance to protocol|1|||
148780393|NCT01764997|536669680|FG001|Run-in Period|Poor compliance to protocol|0|||
148780394|NCT01764997|536669681|FG002|Run-in Period|Poor compliance to protocol|0|||
148780395|NCT01764997|536669682|FG003|Run-in Period|Poor compliance to protocol|0|||
148780396|NCT01764997|536669683|FG004|Run-in Period|Poor compliance to protocol|0|||
148780397|NCT01764997|536669679|FG000|Run-in Period|Other than specified above|17|||
148780398|NCT01764997|536669680|FG001|Run-in Period|Other than specified above|0|||
148780399|NCT01764997|536669681|FG002|Run-in Period|Other than specified above|0|||
148780400|NCT01764997|536669682|FG003|Run-in Period|Other than specified above|0|||
148780401|NCT01764997|536669683|FG004|Run-in Period|Other than specified above|0|||
148780402|NCT01764997|536669679|FG000|Study Drug Treatment Period|Adverse Event|0|||
148780403|NCT01764997|536669680|FG001|Study Drug Treatment Period|Adverse Event|1|||
148780404|NCT01764997|536669681|FG002|Study Drug Treatment Period|Adverse Event|0|||
148780405|NCT01764997|536669682|FG003|Study Drug Treatment Period|Adverse Event|0|||
148780406|NCT01764997|536669683|FG004|Study Drug Treatment Period|Adverse Event|24|||
148780407|NCT01764997|536669679|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
148780408|NCT01764997|536669680|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
148780409|NCT01764997|536669681|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
148780410|NCT01764997|536669682|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
148780411|NCT01764997|536669683|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
148780412|NCT01764997|536669679|FG000|Study Drug Treatment Period|Other than specified above|0|||
148780413|NCT01764997|536669680|FG001|Study Drug Treatment Period|Other than specified above|0|||
148780414|NCT01764997|536669681|FG002|Study Drug Treatment Period|Other than specified above|0|||
148780415|NCT01764997|536669682|FG003|Study Drug Treatment Period|Other than specified above|0|||
148780416|NCT01764997|536669683|FG004|Study Drug Treatment Period|Other than specified above|10|||
148780417|NCT00787917|536669684|FG000|Blinded Treatment|Adverse Event|1|||
148780418|NCT00787917|536669685|FG001|Blinded Treatment|Adverse Event|0|||
148780419|NCT00787917|536669684|FG000|Blinded Treatment|Lack of Efficacy|1|||
148780420|NCT00787917|536669685|FG001|Blinded Treatment|Lack of Efficacy|0|||
148780421|NCT00787917|536669684|FG000|Blinded Treatment|Administrative problems|3|||
148780422|NCT00787917|536669685|FG001|Blinded Treatment|Administrative problems|2|||
148780423|NCT00787917|536669684|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
148780424|NCT00787917|536669685|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
148780425|NCT00787917|536669684|FG000|Open Label|Administrative problems|3|||
148780426|NCT00787917|536669685|FG001|Open Label|Administrative problems|0|||
148780427|NCT02172040|536669691|FG000|Overall Study|Adverse Event|0|||
148780428|NCT02172040|536669692|FG001|Overall Study|Adverse Event|2|||
148780429|NCT02172040|536669693|FG002|Overall Study|Adverse Event|0|||
148780430|NCT02172040|536669694|FG003|Overall Study|Adverse Event|0|||
148780431|NCT02172040|536669691|FG000|Overall Study|Protocol Violation|0|||
148780432|NCT02172040|536669692|FG001|Overall Study|Protocol Violation|1|||
148780433|NCT02172040|536669693|FG002|Overall Study|Protocol Violation|0|||
148780434|NCT02172040|536669694|FG003|Overall Study|Protocol Violation|0|||
148780435|NCT02172040|536669691|FG000|Overall Study|Withdrawal by Subject|0|||
148893193|NCT02426580|537088631|FG000|Overall Study|transfer to hemodialysis|5|||
148893194|NCT02426580|537088632|FG001|Overall Study|transfer to hemodialysis|5|||
148893195|NCT02426580|537088631|FG000|Overall Study|Kidney transplant|3|||
148893196|NCT02426580|537088632|FG001|Overall Study|Kidney transplant|0|||
148893197|NCT02426580|537088631|FG000|Overall Study|Allergic to egg white|1|||
148893198|NCT02426580|537088632|FG001|Overall Study|Allergic to egg white|0|||
148893199|NCT00383552|537088635|FG000|Overall Study|Adverse Event|7|||
148893200|NCT00383552|537088636|FG001|Overall Study|Adverse Event|6|||
148893201|NCT00383552|537088637|FG002|Overall Study|Adverse Event|9|||
148893202|NCT00383552|537088638|FG003|Overall Study|Adverse Event|6|||
148893203|NCT00383552|537088635|FG000|Overall Study|Lack of Efficacy|4|||
148893204|NCT00383552|537088636|FG001|Overall Study|Lack of Efficacy|13|||
148893205|NCT00383552|537088637|FG002|Overall Study|Lack of Efficacy|29|||
148893206|NCT00383552|537088638|FG003|Overall Study|Lack of Efficacy|42|||
148893207|NCT00383552|537088635|FG000|Overall Study|Lost to Follow-up|0|||
148893208|NCT00383552|537088636|FG001|Overall Study|Lost to Follow-up|1|||
148893209|NCT00383552|537088637|FG002|Overall Study|Lost to Follow-up|5|||
148893210|NCT00383552|537088638|FG003|Overall Study|Lost to Follow-up|1|||
148893211|NCT00383552|537088635|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
148893212|NCT00383552|537088636|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
148893213|NCT00383552|537088637|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
148893214|NCT00383552|537088638|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
148893215|NCT00383552|537088635|FG000|Overall Study|Did not wish to continue (related)|1|||
148893216|NCT00383552|537088636|FG001|Overall Study|Did not wish to continue (related)|0|||
148893217|NCT00383552|537088637|FG002|Overall Study|Did not wish to continue (related)|2|||
148893218|NCT00383552|537088638|FG003|Overall Study|Did not wish to continue (related)|3|||
148893219|NCT00383552|537088635|FG000|Overall Study|Noncompliance with the protocol|11|||
148893220|NCT00383552|537088636|FG001|Overall Study|Noncompliance with the protocol|6|||
148893221|NCT00383552|537088637|FG002|Overall Study|Noncompliance with the protocol|8|||
148893222|NCT00383552|537088638|FG003|Overall Study|Noncompliance with the protocol|10|||
148893223|NCT00383552|537088635|FG000|Overall Study|Did not meet protocol eligibility|8|||
148893224|NCT00383552|537088636|FG001|Overall Study|Did not meet protocol eligibility|6|||
149006841|NCT00985985|537503628|FG000|Overall Study|Lost to Follow-up|4|||
149006842|NCT00985985|537503629|FG001|Overall Study|Lost to Follow-up|11|||
149006843|NCT00985985|537503630|FG002|Overall Study|Lost to Follow-up|2|||
149006844|NCT00985985|537503631|FG003|Overall Study|Lost to Follow-up|3|||
149006845|NCT00985985|537503628|FG000|Overall Study|Protocol Violation|1|||
149006846|NCT00985985|537503629|FG001|Overall Study|Protocol Violation|2|||
149006847|NCT00985985|537503630|FG002|Overall Study|Protocol Violation|0|||
149006848|NCT00985985|537503631|FG003|Overall Study|Protocol Violation|1|||
149006849|NCT00985985|537503628|FG000|Overall Study|Lack of Efficacy|5|||
149006850|NCT00985985|537503629|FG001|Overall Study|Lack of Efficacy|6|||
149006851|NCT00985985|537503630|FG002|Overall Study|Lack of Efficacy|1|||
149006852|NCT00985985|537503631|FG003|Overall Study|Lack of Efficacy|3|||
149006853|NCT00985985|537503628|FG000|Overall Study|Withdrawal by Subject|4|||
149006854|NCT00985985|537503629|FG001|Overall Study|Withdrawal by Subject|2|||
149006855|NCT00985985|537503630|FG002|Overall Study|Withdrawal by Subject|2|||
149006856|NCT00985985|537503631|FG003|Overall Study|Withdrawal by Subject|2|||
149006857|NCT00985985|537503628|FG000|Overall Study|Other Reason|6|||
149006858|NCT00985985|537503629|FG001|Overall Study|Other Reason|1|||
149006859|NCT00985985|537503630|FG002|Overall Study|Other Reason|4|||
149006860|NCT00985985|537503631|FG003|Overall Study|Other Reason|2|||
149006861|NCT02255357|537503634|FG000|Overall Study|Physician Decision|10|||
149006862|NCT02255357|537503635|FG001|Overall Study|Physician Decision|24|||
149006863|NCT00509236|537503636|FG000|Overall Study|Adverse Event|7|||
149006864|NCT00509236|537503637|FG001|Overall Study|Adverse Event|9|||
149006865|NCT00509236|537503636|FG000|Overall Study|Withdrawal by Subject|5|||
149006866|NCT00509236|537503637|FG001|Overall Study|Withdrawal by Subject|10|||
149006867|NCT00509236|537503636|FG000|Overall Study|Protocol Violation|3|||
149006868|NCT00509236|537503637|FG001|Overall Study|Protocol Violation|0|||
149006869|NCT00509236|537503636|FG000|Overall Study|Excluded Medication|1|||
149006870|NCT00509236|537503637|FG001|Overall Study|Excluded Medication|1|||
149006871|NCT00509236|537503636|FG000|Overall Study|Scheduled Kidney Transplant|1|||
149006872|NCT00509236|537503637|FG001|Overall Study|Scheduled Kidney Transplant|0|||
149006873|NCT04146896|537503642|FG000|Overall Study|Adverse Event|5|||
148893225|NCT00383552|537088637|FG002|Overall Study|Did not meet protocol eligibility|2|||
148893226|NCT00383552|537088638|FG003|Overall Study|Did not meet protocol eligibility|3|||
148893227|NCT00383552|537088635|FG000|Overall Study|Administrative|1|||
149006874|NCT04146896|537503643|FG001|Overall Study|Adverse Event|8|||
149006875|NCT04146896|537503642|FG000|Overall Study|Lack of Efficacy|3|||
149006876|NCT04146896|537503643|FG001|Overall Study|Lack of Efficacy|2|||
149006877|NCT04146896|537503642|FG000|Overall Study|Lost to Follow-up|0|||
149006878|NCT04146896|537503643|FG001|Overall Study|Lost to Follow-up|1|||
149006879|NCT04146896|537503642|FG000|Overall Study|Non-compliance|5|||
149006880|NCT04146896|537503643|FG001|Overall Study|Non-compliance|4|||
149006881|NCT04146896|537503642|FG000|Overall Study|Withdrawal by Subject|3|||
149006882|NCT04146896|537503643|FG001|Overall Study|Withdrawal by Subject|5|||
149006883|NCT04146896|537503642|FG000|Overall Study|Randomized in error|1|||
149006884|NCT04146896|537503643|FG001|Overall Study|Randomized in error|2|||
149006885|NCT01597505|537503644|FG000|Overall Study|Physician Decision|5|||
149006886|NCT01597505|537503645|FG001|Overall Study|Physician Decision|0|||
149006887|NCT01597505|537503644|FG000|Overall Study|Adverse Event|19|||
149006888|NCT01597505|537503645|FG001|Overall Study|Adverse Event|7|||
149006889|NCT01597505|537503644|FG000|Overall Study|Lost to Follow-up|4|||
149006890|NCT01597505|537503645|FG001|Overall Study|Lost to Follow-up|2|||
149006891|NCT01597505|537503644|FG000|Overall Study|Withdrawal by Subject|10|||
149006892|NCT01597505|537503645|FG001|Overall Study|Withdrawal by Subject|18|||
149006893|NCT01597505|537503644|FG000|Overall Study|Other|5|||
149006894|NCT01597505|537503645|FG001|Overall Study|Other|6|||
149006895|NCT01597505|537503644|FG000|Overall Study|Missing|1|||
149006896|NCT01597505|537503645|FG001|Overall Study|Missing|0|||
149006897|NCT04543188|537503653|FG000|Phase 1a|Adverse Event|0|||
149006898|NCT04543188|537503654|FG001|Phase 1a|Adverse Event|0|||
149006899|NCT04543188|537503655|FG002|Phase 1a|Adverse Event|0|||
149006900|NCT04543188|537503656|FG003|Phase 1a|Adverse Event|1|||
149006901|NCT04543188|537503657|FG004|Phase 1a|Adverse Event|0|||
149006902|NCT04543188|537503658|FG005|Phase 1a|Adverse Event|0|||
149006903|NCT04543188|537503659|FG006|Phase 1a|Adverse Event|1|||
149006904|NCT04543188|537503660|FG007|Phase 1a|Adverse Event|0|||
149006905|NCT04543188|537503661|FG008|Phase 1a|Adverse Event|0|||
149006906|NCT04543188|537503662|FG009|Phase 1a|Adverse Event|0|||
149006907|NCT04543188|537503663|FG010|Phase 1a|Adverse Event|0|||
149006908|NCT04543188|537503664|FG011|Phase 1a|Adverse Event|0|||
149006909|NCT04543188|537503665|FG012|Phase 1a|Adverse Event|0|||
149006910|NCT04543188|537503666|FG013|Phase 1a|Adverse Event|0|||
149006911|NCT04543188|537503667|FG014|Phase 1a|Adverse Event|0|||
149006912|NCT04543188|537503653|FG000|Phase 1a|Other (Death)|0|||
149006913|NCT04543188|537503654|FG001|Phase 1a|Other (Death)|1|||
149006914|NCT04543188|537503655|FG002|Phase 1a|Other (Death)|0|||
149006915|NCT04543188|537503656|FG003|Phase 1a|Other (Death)|0|||
149006916|NCT04543188|537503657|FG004|Phase 1a|Other (Death)|1|||
149006917|NCT04543188|537503658|FG005|Phase 1a|Other (Death)|0|||
149006918|NCT04543188|537503659|FG006|Phase 1a|Other (Death)|0|||
149006919|NCT04543188|537503660|FG007|Phase 1a|Other (Death)|0|||
149006920|NCT04543188|537503661|FG008|Phase 1a|Other (Death)|0|||
149006921|NCT04543188|537503662|FG009|Phase 1a|Other (Death)|1|||
149006922|NCT04543188|537503663|FG010|Phase 1a|Other (Death)|0|||
149006923|NCT04543188|537503664|FG011|Phase 1a|Other (Death)|0|||
149006924|NCT04543188|537503665|FG012|Phase 1a|Other (Death)|0|||
149006925|NCT04543188|537503666|FG013|Phase 1a|Other (Death)|0|||
149006926|NCT04543188|537503667|FG014|Phase 1a|Other (Death)|0|||
149006927|NCT04543188|537503653|FG000|Phase 1a|Lost to Follow-up|0|||
149006928|NCT04543188|537503654|FG001|Phase 1a|Lost to Follow-up|0|||
149006929|NCT04543188|537503655|FG002|Phase 1a|Lost to Follow-up|0|||
149006930|NCT04543188|537503656|FG003|Phase 1a|Lost to Follow-up|0|||
149006931|NCT04543188|537503657|FG004|Phase 1a|Lost to Follow-up|0|||
149006932|NCT04543188|537503658|FG005|Phase 1a|Lost to Follow-up|0|||
149006933|NCT04543188|537503659|FG006|Phase 1a|Lost to Follow-up|0|||
149006934|NCT04543188|537503660|FG007|Phase 1a|Lost to Follow-up|0|||
149006935|NCT04543188|537503661|FG008|Phase 1a|Lost to Follow-up|0|||
149006936|NCT04543188|537503662|FG009|Phase 1a|Lost to Follow-up|0|||
149006937|NCT04543188|537503663|FG010|Phase 1a|Lost to Follow-up|1|||
149006938|NCT04543188|537503664|FG011|Phase 1a|Lost to Follow-up|0|||
149006939|NCT04543188|537503665|FG012|Phase 1a|Lost to Follow-up|0|||
149006940|NCT04543188|537503666|FG013|Phase 1a|Lost to Follow-up|0|||
149006941|NCT04543188|537503667|FG014|Phase 1a|Lost to Follow-up|0|||
149006942|NCT04543188|537503653|FG000|Phase 1a|Progressive Disease|2|||
149006943|NCT04543188|537503654|FG001|Phase 1a|Progressive Disease|2|||
149006944|NCT04543188|537503655|FG002|Phase 1a|Progressive Disease|3|||
149006945|NCT04543188|537503656|FG003|Phase 1a|Progressive Disease|1|||
149006946|NCT04543188|537503657|FG004|Phase 1a|Progressive Disease|4|||
149006947|NCT04543188|537503658|FG005|Phase 1a|Progressive Disease|2|||
149006948|NCT04543188|537503659|FG006|Phase 1a|Progressive Disease|3|||
149006949|NCT04543188|537503660|FG007|Phase 1a|Progressive Disease|4|||
149006950|NCT04543188|537503661|FG008|Phase 1a|Progressive Disease|1|||
149006951|NCT04543188|537503662|FG009|Phase 1a|Progressive Disease|0|||
149006952|NCT04543188|537503663|FG010|Phase 1a|Progressive Disease|4|||
149006953|NCT04543188|537503664|FG011|Phase 1a|Progressive Disease|0|||
149006954|NCT04543188|537503665|FG012|Phase 1a|Progressive Disease|0|||
149006955|NCT04543188|537503666|FG013|Phase 1a|Progressive Disease|0|||
149006956|NCT04543188|537503667|FG014|Phase 1a|Progressive Disease|0|||
149006957|NCT04543188|537503653|FG000|Phase 1a|Study terminated by sponsor|0|||
149006958|NCT04543188|537503654|FG001|Phase 1a|Study terminated by sponsor|0|||
149006959|NCT04543188|537503655|FG002|Phase 1a|Study terminated by sponsor|0|||
149006960|NCT04543188|537503656|FG003|Phase 1a|Study terminated by sponsor|0|||
149006961|NCT04543188|537503657|FG004|Phase 1a|Study terminated by sponsor|1|||
149006962|NCT04543188|537503658|FG005|Phase 1a|Study terminated by sponsor|0|||
149006963|NCT04543188|537503659|FG006|Phase 1a|Study terminated by sponsor|0|||
149006964|NCT04543188|537503660|FG007|Phase 1a|Study terminated by sponsor|0|||
149006965|NCT04543188|537503661|FG008|Phase 1a|Study terminated by sponsor|0|||
149006966|NCT04543188|537503662|FG009|Phase 1a|Study terminated by sponsor|0|||
149006967|NCT04543188|537503663|FG010|Phase 1a|Study terminated by sponsor|1|||
149006968|NCT04543188|537503664|FG011|Phase 1a|Study terminated by sponsor|0|||
149006969|NCT04543188|537503665|FG012|Phase 1a|Study terminated by sponsor|0|||
149006970|NCT04543188|537503666|FG013|Phase 1a|Study terminated by sponsor|0|||
149006971|NCT04543188|537503667|FG014|Phase 1a|Study terminated by sponsor|0|||
149006972|NCT04543188|537503653|FG000|Phase 1a|Withdrawal by Subject|0|||
149006973|NCT04543188|537503654|FG001|Phase 1a|Withdrawal by Subject|0|||
149006974|NCT04543188|537503655|FG002|Phase 1a|Withdrawal by Subject|0|||
149006975|NCT04543188|537503656|FG003|Phase 1a|Withdrawal by Subject|0|||
149006976|NCT04543188|537503657|FG004|Phase 1a|Withdrawal by Subject|3|||
149006977|NCT04543188|537503658|FG005|Phase 1a|Withdrawal by Subject|0|||
149006978|NCT04543188|537503659|FG006|Phase 1a|Withdrawal by Subject|0|||
149006979|NCT04543188|537503660|FG007|Phase 1a|Withdrawal by Subject|0|||
149006980|NCT04543188|537503661|FG008|Phase 1a|Withdrawal by Subject|1|||
149006981|NCT04543188|537503662|FG009|Phase 1a|Withdrawal by Subject|1|||
149006982|NCT04543188|537503663|FG010|Phase 1a|Withdrawal by Subject|2|||
149006983|NCT04543188|537503664|FG011|Phase 1a|Withdrawal by Subject|0|||
149006984|NCT04543188|537503665|FG012|Phase 1a|Withdrawal by Subject|0|||
149006985|NCT04543188|537503666|FG013|Phase 1a|Withdrawal by Subject|0|||
149006986|NCT04543188|537503667|FG014|Phase 1a|Withdrawal by Subject|0|||
149006987|NCT04543188|537503653|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
149006988|NCT04543188|537503654|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
149006989|NCT04543188|537503655|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
149006990|NCT04543188|537503656|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
149006991|NCT04543188|537503657|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
149006992|NCT04543188|537503658|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
149006993|NCT04543188|537503659|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
149006994|NCT04543188|537503660|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
149006995|NCT04543188|537503661|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
149006996|NCT04543188|537503662|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
149006997|NCT04543188|537503663|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
149006998|NCT04543188|537503664|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
149006999|NCT04543188|537503665|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
149007000|NCT04543188|537503666|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
149007001|NCT04543188|537503667|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
149007002|NCT04543188|537503653|FG000|Phase 1a|Other|0|||
149007003|NCT04543188|537503654|FG001|Phase 1a|Other|0|||
149007004|NCT04543188|537503655|FG002|Phase 1a|Other|0|||
149007005|NCT04543188|537503656|FG003|Phase 1a|Other|0|||
149007006|NCT04543188|537503657|FG004|Phase 1a|Other|0|||
149007007|NCT04543188|537503658|FG005|Phase 1a|Other|0|||
149007008|NCT04543188|537503659|FG006|Phase 1a|Other|0|||
149007009|NCT04543188|537503660|FG007|Phase 1a|Other|0|||
149007010|NCT04543188|537503661|FG008|Phase 1a|Other|0|||
148893228|NCT00383552|537088636|FG001|Overall Study|Administrative|0|||
148893229|NCT00383552|537088637|FG002|Overall Study|Administrative|1|||
148893230|NCT00383552|537088638|FG003|Overall Study|Administrative|1|||
148893231|NCT03096834|537088639|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
148893232|NCT03096834|537088640|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
148893233|NCT03096834|537088641|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
148893234|NCT03096834|537088642|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
148893235|NCT03096834|537088639|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
148893236|NCT03096834|537088640|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
148893237|NCT03096834|537088641|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
148893238|NCT03096834|537088642|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
148893239|NCT03096834|537088639|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
148893240|NCT03096834|537088640|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
148893241|NCT03096834|537088641|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
148893242|NCT03096834|537088642|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
148893243|NCT03096834|537088639|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
148893244|NCT03096834|537088640|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
148893245|NCT03096834|537088641|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
148893246|NCT03096834|537088642|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
148893247|NCT03096834|537088639|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
148893248|NCT03096834|537088640|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
148893249|NCT03096834|537088641|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
148893250|NCT03096834|537088642|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
148893251|NCT03096834|537088639|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
148893252|NCT03096834|537088640|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
148893253|NCT03096834|537088641|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
148893254|NCT03096834|537088642|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
148893255|NCT03096834|537088639|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
148893256|NCT03096834|537088640|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
148893257|NCT03096834|537088641|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
148893258|NCT03096834|537088642|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
148893259|NCT03096834|537088639|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
148893260|NCT03096834|537088640|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
148893261|NCT03096834|537088641|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
148893262|NCT03096834|537088642|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
148893263|NCT03096834|537088639|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
148893264|NCT03096834|537088640|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
148893265|NCT03096834|537088641|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
148893266|NCT03096834|537088642|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
148893267|NCT03096834|537088639|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
148893268|NCT03096834|537088640|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
148893269|NCT03096834|537088641|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
148893270|NCT03096834|537088642|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
148893271|NCT03096834|537088639|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
148893272|NCT03096834|537088640|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
148893273|NCT03096834|537088641|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
148893274|NCT03096834|537088642|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
148893275|NCT03096834|537088639|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
148893276|NCT03096834|537088640|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
148893277|NCT03096834|537088641|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
148893278|NCT03096834|537088642|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
148893279|NCT00966654|537088643|FG000|Overall Study|Study was terminated,PI left institution|12|||
148893280|NCT01600326|537088650|FG000|Overall Study|Lost to Follow-up|1|||
148893281|NCT01600326|537088651|FG001|Overall Study|Lost to Follow-up|1|||
148893282|NCT04456504|537088652|FG000|Overall Study|Lost to Follow-up|2|||
148893283|NCT01393158|537088653|FG000|Overall Study|Adverse Event|1|||
148893284|NCT01393158|537088654|FG001|Overall Study|Adverse Event|0|||
148893285|NCT02173769|537088656|FG000|Overall Study|Protocol Violation|4|||
148893286|NCT04233801|537088657|FG000|Overall Study|Other than listed|0|||
148893287|NCT04233801|537088658|FG001|Overall Study|Other than listed|0|||
148893288|NCT04233801|537088659|FG002|Overall Study|Other than listed|1|||
148893289|NCT04233801|537088657|FG000|Overall Study|Withdrawal by Subject|0|||
148893290|NCT04233801|537088658|FG001|Overall Study|Withdrawal by Subject|2|||
148893291|NCT04233801|537088659|FG002|Overall Study|Withdrawal by Subject|3|||
148893292|NCT00762359|537088660|FG000|Overall Study|Adverse Event|20|||
148893293|NCT00762359|537088661|FG001|Overall Study|Adverse Event|23|||
148893294|NCT00762359|537088660|FG000|Overall Study|Protocol Violation|21|||
148893295|NCT00762359|537088661|FG001|Overall Study|Protocol Violation|13|||
148893296|NCT00762359|537088660|FG000|Overall Study|Withdrawal by Subject|13|||
148893297|NCT00762359|537088661|FG001|Overall Study|Withdrawal by Subject|10|||
148893298|NCT00762359|537088660|FG000|Overall Study|Lack of Efficacy|0|||
148893299|NCT00762359|537088661|FG001|Overall Study|Lack of Efficacy|4|||
148893300|NCT00762359|537088660|FG000|Overall Study|Institution closed|2|||
148893301|NCT00762359|537088661|FG001|Overall Study|Institution closed|3|||
148893302|NCT00762359|537088660|FG000|Overall Study|Physician Decision|2|||
148893303|NCT00762359|537088661|FG001|Overall Study|Physician Decision|3|||
148893304|NCT00762359|537088660|FG000|Overall Study|Removal|0|||
148893305|NCT00762359|537088661|FG001|Overall Study|Removal|1|||
148893306|NCT00762359|537088660|FG000|Overall Study|Withdrew consent|1|||
148893307|NCT00762359|537088661|FG001|Overall Study|Withdrew consent|0|||
148893308|NCT01690052|537088666|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
148893309|NCT01690052|537088667|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
148893310|NCT02421172|537088668|FG000|Period 1|Adverse Event|1|||
148893311|NCT02421172|537088669|FG001|Period 1|Adverse Event|0|||
148893312|NCT02421172|537088670|FG002|Period 1|Adverse Event|0|||
148893313|NCT02421172|537088671|FG003|Period 1|Adverse Event|0|||
148893314|NCT02421172|537088672|FG004|Period 1|Adverse Event|0|||
148893315|NCT02421172|537088668|FG000|Period 1|Lost to Follow-up|3|||
148893316|NCT02421172|537088669|FG001|Period 1|Lost to Follow-up|1|||
148893317|NCT02421172|537088670|FG002|Period 1|Lost to Follow-up|0|||
148893318|NCT02421172|537088671|FG003|Period 1|Lost to Follow-up|0|||
148893319|NCT02421172|537088672|FG004|Period 1|Lost to Follow-up|0|||
148893320|NCT02421172|537088668|FG000|Period 1|Patient/guardian decision|0|||
148893321|NCT02421172|537088669|FG001|Period 1|Patient/guardian decision|1|||
148893322|NCT02421172|537088670|FG002|Period 1|Patient/guardian decision|0|||
148893323|NCT02421172|537088671|FG003|Period 1|Patient/guardian decision|0|||
148893324|NCT02421172|537088672|FG004|Period 1|Patient/guardian decision|0|||
148893325|NCT02421172|537088668|FG000|Period 2|Adverse Event|0|||
148893326|NCT02421172|537088669|FG001|Period 2|Adverse Event|0|||
148893327|NCT02421172|537088670|FG002|Period 2|Adverse Event|4|||
148893328|NCT02421172|537088671|FG003|Period 2|Adverse Event|0|||
148893329|NCT02421172|537088672|FG004|Period 2|Adverse Event|0|||
148893330|NCT02421172|537088668|FG000|Period 2|Lost to Follow-up|0|||
148893331|NCT02421172|537088669|FG001|Period 2|Lost to Follow-up|0|||
148893332|NCT02421172|537088670|FG002|Period 2|Lost to Follow-up|0|||
148893333|NCT02421172|537088671|FG003|Period 2|Lost to Follow-up|1|||
148893334|NCT02421172|537088672|FG004|Period 2|Lost to Follow-up|0|||
148893335|NCT02421172|537088668|FG000|Period 2|Patient/guardian decision|0|||
148893336|NCT02421172|537088669|FG001|Period 2|Patient/guardian decision|0|||
148893337|NCT02421172|537088670|FG002|Period 2|Patient/guardian decision|3|||
148893338|NCT02421172|537088671|FG003|Period 2|Patient/guardian decision|2|||
148893339|NCT02421172|537088672|FG004|Period 2|Patient/guardian decision|1|||
149007011|NCT04543188|537503662|FG009|Phase 1a|Other|1|||
149007012|NCT04543188|537503663|FG010|Phase 1a|Other|0|||
149007013|NCT04543188|537503664|FG011|Phase 1a|Other|0|||
149007014|NCT04543188|537503665|FG012|Phase 1a|Other|0|||
149007015|NCT04543188|537503666|FG013|Phase 1a|Other|0|||
149007016|NCT04543188|537503667|FG014|Phase 1a|Other|0|||
149007017|NCT04543188|537503653|FG000|Phase 1b|Adverse Event|0|||
149007018|NCT04543188|537503654|FG001|Phase 1b|Adverse Event|0|||
149007019|NCT04543188|537503655|FG002|Phase 1b|Adverse Event|0|||
149007020|NCT04543188|537503656|FG003|Phase 1b|Adverse Event|0|||
149007021|NCT04543188|537503657|FG004|Phase 1b|Adverse Event|0|||
149007022|NCT04543188|537503658|FG005|Phase 1b|Adverse Event|0|||
149007023|NCT04543188|537503659|FG006|Phase 1b|Adverse Event|0|||
149007024|NCT04543188|537503660|FG007|Phase 1b|Adverse Event|0|||
149007025|NCT04543188|537503661|FG008|Phase 1b|Adverse Event|0|||
149007026|NCT04543188|537503662|FG009|Phase 1b|Adverse Event|0|||
149007027|NCT04543188|537503663|FG010|Phase 1b|Adverse Event|0|||
149007028|NCT04543188|537503664|FG011|Phase 1b|Adverse Event|0|||
149007029|NCT04543188|537503665|FG012|Phase 1b|Adverse Event|0|||
149007030|NCT04543188|537503666|FG013|Phase 1b|Adverse Event|0|||
149007031|NCT04543188|537503667|FG014|Phase 1b|Adverse Event|2|||
149007032|NCT04543188|537503653|FG000|Phase 1b|Other (Death)|0|||
149007033|NCT04543188|537503654|FG001|Phase 1b|Other (Death)|0|||
149007034|NCT04543188|537503655|FG002|Phase 1b|Other (Death)|0|||
149007035|NCT04543188|537503656|FG003|Phase 1b|Other (Death)|0|||
149007036|NCT04543188|537503657|FG004|Phase 1b|Other (Death)|0|||
149007037|NCT04543188|537503658|FG005|Phase 1b|Other (Death)|0|||
149007038|NCT04543188|537503659|FG006|Phase 1b|Other (Death)|0|||
149007039|NCT04543188|537503660|FG007|Phase 1b|Other (Death)|0|||
149007040|NCT04543188|537503661|FG008|Phase 1b|Other (Death)|0|||
149007041|NCT04543188|537503662|FG009|Phase 1b|Other (Death)|0|||
149007042|NCT04543188|537503663|FG010|Phase 1b|Other (Death)|0|||
149007043|NCT04543188|537503664|FG011|Phase 1b|Other (Death)|0|||
149007044|NCT04543188|537503665|FG012|Phase 1b|Other (Death)|1|||
149007045|NCT04543188|537503666|FG013|Phase 1b|Other (Death)|0|||
149007046|NCT04543188|537503667|FG014|Phase 1b|Other (Death)|1|||
149007047|NCT04543188|537503653|FG000|Phase 1b|Progressive Disease|0|||
149007048|NCT04543188|537503654|FG001|Phase 1b|Progressive Disease|0|||
149007049|NCT04543188|537503655|FG002|Phase 1b|Progressive Disease|0|||
149007050|NCT04543188|537503656|FG003|Phase 1b|Progressive Disease|0|||
149007051|NCT04543188|537503657|FG004|Phase 1b|Progressive Disease|0|||
149007052|NCT04543188|537503658|FG005|Phase 1b|Progressive Disease|0|||
149007053|NCT04543188|537503659|FG006|Phase 1b|Progressive Disease|0|||
149007054|NCT04543188|537503660|FG007|Phase 1b|Progressive Disease|0|||
149007055|NCT04543188|537503661|FG008|Phase 1b|Progressive Disease|0|||
149007056|NCT04543188|537503662|FG009|Phase 1b|Progressive Disease|0|||
149007057|NCT04543188|537503663|FG010|Phase 1b|Progressive Disease|0|||
149007058|NCT04543188|537503664|FG011|Phase 1b|Progressive Disease|0|||
149007059|NCT04543188|537503665|FG012|Phase 1b|Progressive Disease|2|||
149007060|NCT04543188|537503666|FG013|Phase 1b|Progressive Disease|1|||
149007061|NCT04543188|537503667|FG014|Phase 1b|Progressive Disease|5|||
149007062|NCT04543188|537503653|FG000|Phase 1b|Study Terminated By Sponsor|0|||
149007063|NCT04543188|537503654|FG001|Phase 1b|Study Terminated By Sponsor|0|||
149007064|NCT04543188|537503655|FG002|Phase 1b|Study Terminated By Sponsor|0|||
149007065|NCT04543188|537503656|FG003|Phase 1b|Study Terminated By Sponsor|0|||
149007066|NCT04543188|537503657|FG004|Phase 1b|Study Terminated By Sponsor|0|||
149007067|NCT04543188|537503658|FG005|Phase 1b|Study Terminated By Sponsor|0|||
149007068|NCT04543188|537503659|FG006|Phase 1b|Study Terminated By Sponsor|0|||
149007069|NCT04543188|537503660|FG007|Phase 1b|Study Terminated By Sponsor|0|||
149007070|NCT04543188|537503661|FG008|Phase 1b|Study Terminated By Sponsor|0|||
149007071|NCT04543188|537503662|FG009|Phase 1b|Study Terminated By Sponsor|0|||
149007072|NCT04543188|537503663|FG010|Phase 1b|Study Terminated By Sponsor|0|||
149007073|NCT04543188|537503664|FG011|Phase 1b|Study Terminated By Sponsor|1|||
149007074|NCT04543188|537503665|FG012|Phase 1b|Study Terminated By Sponsor|1|||
149007075|NCT04543188|537503666|FG013|Phase 1b|Study Terminated By Sponsor|0|||
149007076|NCT04543188|537503667|FG014|Phase 1b|Study Terminated By Sponsor|1|||
149007077|NCT04543188|537503653|FG000|Phase 1b|Withdrawal by Subject|0|||
149007078|NCT04543188|537503654|FG001|Phase 1b|Withdrawal by Subject|0|||
149007079|NCT04543188|537503655|FG002|Phase 1b|Withdrawal by Subject|0|||
149007080|NCT04543188|537503656|FG003|Phase 1b|Withdrawal by Subject|0|||
149007081|NCT04543188|537503657|FG004|Phase 1b|Withdrawal by Subject|0|||
149007082|NCT04543188|537503658|FG005|Phase 1b|Withdrawal by Subject|0|||
149007083|NCT04543188|537503659|FG006|Phase 1b|Withdrawal by Subject|0|||
149007084|NCT04543188|537503660|FG007|Phase 1b|Withdrawal by Subject|0|||
149007085|NCT04543188|537503661|FG008|Phase 1b|Withdrawal by Subject|0|||
149007086|NCT04543188|537503662|FG009|Phase 1b|Withdrawal by Subject|0|||
149007087|NCT04543188|537503663|FG010|Phase 1b|Withdrawal by Subject|0|||
149007088|NCT04543188|537503664|FG011|Phase 1b|Withdrawal by Subject|0|||
149007089|NCT04543188|537503665|FG012|Phase 1b|Withdrawal by Subject|0|||
149007090|NCT04543188|537503666|FG013|Phase 1b|Withdrawal by Subject|0|||
149007091|NCT04543188|537503667|FG014|Phase 1b|Withdrawal by Subject|2|||
149007092|NCT05004688|537503670|FG000|Overall Study|Protocol Violation|7|||
149007093|NCT05004688|537503670|FG000|Overall Study|Physician Decision|2|||
149007094|NCT05004688|537503670|FG000|Overall Study|Withdrawal by Subject|2|||
149007095|NCT01313286|537503671|FG000|Period 1|Withdrawal by Subject|2|||
149007096|NCT01313286|537503672|FG001|Period 1|Withdrawal by Subject|0|||
149007097|NCT02552238|537503673|FG000|Overall Study|Withdrawal by Subject|2|||
149007098|NCT02552238|537503673|FG000|Overall Study|Adverse Event|2|||
149007099|NCT05158296|537503674|FG000|Overall Study|Sponsor Decision|2|||
149007100|NCT05158296|537503675|FG001|Overall Study|Sponsor Decision|3|||
149007101|NCT05158296|537503676|FG002|Overall Study|Sponsor Decision|2|||
149007102|NCT02036645|537503677|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007103|NCT02036645|537503678|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007104|NCT02036645|537503679|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007105|NCT02036645|537503680|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007106|NCT02036645|537503681|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007107|NCT02036645|537503682|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007108|NCT02036645|537503683|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
149007109|NCT02036645|537503684|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007110|NCT02036645|537503685|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007111|NCT02036645|537503686|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007112|NCT02036645|537503687|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007113|NCT02036645|537503688|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
149007114|NCT02036645|537503677|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007115|NCT02036645|537503678|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007116|NCT02036645|537503679|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007117|NCT02036645|537503680|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
149007118|NCT02036645|537503681|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007119|NCT02036645|537503682|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007120|NCT02036645|537503683|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007121|NCT02036645|537503684|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007122|NCT02036645|537503685|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007123|NCT02036645|537503686|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007124|NCT02036645|537503687|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007125|NCT02036645|537503688|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
149007126|NCT01547299|537503695|FG000|Overall Study|Withdrawal by Subject|2|||
149007127|NCT01547299|537503696|FG001|Overall Study|Withdrawal by Subject|2|||
149007128|NCT02272725|537503710|FG000|Overall Study|equipment malfunction|2|||
149007129|NCT02272725|537503711|FG001|Overall Study|equipment malfunction|0|||
149007130|NCT03881696|537503718|FG000|Overall Study|Adverse Event|2|||
149007131|NCT03881696|537503719|FG001|Overall Study|Adverse Event|0|||
149007132|NCT03881696|537503718|FG000|Overall Study|Withdrawal by Subject|2|||
149007133|NCT03881696|537503719|FG001|Overall Study|Withdrawal by Subject|0|||
149007134|NCT03881696|537503718|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
149007135|NCT03881696|537503719|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
149007136|NCT03881696|537503718|FG000|Overall Study|Failure to meet continuation criteria|1|||
149007137|NCT03881696|537503719|FG001|Overall Study|Failure to meet continuation criteria|0|||
149007138|NCT01061333|537503720|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
149007139|NCT01061333|537503721|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
149007140|NCT02202434|537505359|FG000|Overall Study|Death|70|||
149007141|NCT02202434|537505360|FG001|Overall Study|Death|39|||
149007142|NCT02202434|537505361|FG002|Overall Study|Death|13|||
148780436|NCT02172040|536669692|FG001|Overall Study|Withdrawal by Subject|0|||
149007143|NCT02202434|537505362|FG003|Overall Study|Death|27|||
149007144|NCT02202434|537505359|FG000|Overall Study|Lost to Follow-up|1|||
149007145|NCT02202434|537505360|FG001|Overall Study|Lost to Follow-up|1|||
149007146|NCT02202434|537505361|FG002|Overall Study|Lost to Follow-up|1|||
149007147|NCT02202434|537505362|FG003|Overall Study|Lost to Follow-up|0|||
149007148|NCT02202434|537505359|FG000|Overall Study|Physician Decision|2|||
149007149|NCT02202434|537505360|FG001|Overall Study|Physician Decision|3|||
149007150|NCT02202434|537505361|FG002|Overall Study|Physician Decision|0|||
149007151|NCT02202434|537505362|FG003|Overall Study|Physician Decision|0|||
149007152|NCT02202434|537505359|FG000|Overall Study|Withdrawal by Subject|13|||
149007153|NCT02202434|537505360|FG001|Overall Study|Withdrawal by Subject|14|||
149007154|NCT02202434|537505361|FG002|Overall Study|Withdrawal by Subject|1|||
149007155|NCT02202434|537505362|FG003|Overall Study|Withdrawal by Subject|4|||
149007156|NCT02202434|537505359|FG000|Overall Study|Completed Study|1|||
149007157|NCT02202434|537505360|FG001|Overall Study|Completed Study|0|||
149007158|NCT02202434|537505361|FG002|Overall Study|Completed Study|0|||
149007159|NCT02202434|537505362|FG003|Overall Study|Completed Study|0|||
149007160|NCT02202434|537505359|FG000|Overall Study|Visit Missed|21|||
149007161|NCT02202434|537505360|FG001|Overall Study|Visit Missed|12|||
149007162|NCT02202434|537505361|FG002|Overall Study|Visit Missed|0|||
149007163|NCT02202434|537505362|FG003|Overall Study|Visit Missed|5|||
149007164|NCT02202434|537505359|FG000|Overall Study|Other|1|||
149007165|NCT02202434|537505360|FG001|Overall Study|Other|0|||
149007166|NCT02202434|537505361|FG002|Overall Study|Other|0|||
149007167|NCT02202434|537505362|FG003|Overall Study|Other|1|||
149007168|NCT03237858|537505363|FG000|Overall Study|Death|19|||
149007169|NCT03237858|537505363|FG000|Overall Study|Withdrawal by Subject|37|||
149007170|NCT04858802|537505366|FG000|Overall Study|Lost to Follow-up|1|||
149007171|NCT04858802|537505367|FG001|Overall Study|Lost to Follow-up|1|||
149007172|NCT04858802|537505366|FG000|Overall Study|Withdrawal by Subject|1|||
149007173|NCT04858802|537505367|FG001|Overall Study|Withdrawal by Subject|1|||
149007174|NCT02026232|537505368|FG000|Overall Study|incomplete visit/missing data|3|||
149007175|NCT02026232|537505369|FG001|Overall Study|incomplete visit/missing data|2|||
149007176|NCT03075501|537505370|FG000|Overall Study|Scheduling difficulties|15|||
149007177|NCT03075501|537505371|FG001|Overall Study|Scheduling difficulties|9|||
149007178|NCT03610737|537505374|FG000|Overall Study|Withdrawal by Subject|1|||
149007179|NCT03610737|537505375|FG001|Overall Study|Withdrawal by Subject|5|||
149007180|NCT03610737|537505374|FG000|Overall Study|Death|1|||
149007181|NCT03610737|537505375|FG001|Overall Study|Death|0|||
149007182|NCT03610737|537505374|FG000|Overall Study|Not treated|5|||
149007183|NCT03610737|537505375|FG001|Overall Study|Not treated|2|||
149007184|NCT03610737|537505374|FG000|Overall Study|Missed Visit|1|||
149007185|NCT03610737|537505375|FG001|Overall Study|Missed Visit|2|||
149007186|NCT02013388|537505378|FG000|Overall Study|work emergency|1|||
149007187|NCT02013388|537505379|FG001|Overall Study|work emergency|0|||
149007188|NCT02013388|537505380|FG002|Overall Study|work emergency|0|||
149007189|NCT02013388|537505381|FG003|Overall Study|work emergency|0|||
149007190|NCT02013388|537505382|FG004|Overall Study|work emergency|1|||
149007191|NCT02013388|537505383|FG005|Overall Study|work emergency|0|||
149007192|NCT02013388|537505384|FG006|Overall Study|work emergency|0|||
149007193|NCT02013388|537505385|FG007|Overall Study|work emergency|0|||
149007194|NCT00927355|537505387|FG000|Overall Study|Adverse Event|1|||
149007195|NCT00927355|537505388|FG001|Overall Study|Adverse Event|1|||
149007196|NCT01572389|537505389|FG000|Overall Study|Death|1|||
149007197|NCT01572389|537505390|FG001|Overall Study|Death|3|||
149007198|NCT01572389|537505389|FG000|Overall Study|Withdrawal by Subject|14|||
149007199|NCT01572389|537505390|FG001|Overall Study|Withdrawal by Subject|2|||
149007200|NCT01572389|537505389|FG000|Overall Study|Lost to Follow-up|25|||
149007201|NCT01572389|537505390|FG001|Overall Study|Lost to Follow-up|14|||
149007202|NCT01572389|537505389|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
149007203|NCT01572389|537505390|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
149007204|NCT01153269|537505391|FG000|Overall Study|Withdrawal by Subject|1|||
149007205|NCT01153269|537505391|FG000|Overall Study|Antiretroviral therapy break|1|||
149007206|NCT02635724|537505402|FG000|Overall Study|Withdrawal by Subject|0|||
149007207|NCT02635724|537505403|FG001|Overall Study|Withdrawal by Subject|1|||
149007208|NCT02635724|537505404|FG002|Overall Study|Withdrawal by Subject|0|||
149007209|NCT00100932|537505411|FG000|Overall Study|Adverse Event|11|||
149007210|NCT00100932|537505412|FG001|Overall Study|Adverse Event|2|||
149007211|NCT00100932|537505411|FG000|Overall Study|Withdrawal by Subject|6|||
149007212|NCT00100932|537505412|FG001|Overall Study|Withdrawal by Subject|0|||
149007213|NCT00100932|537505411|FG000|Overall Study|Progressive Disease|44|||
149007214|NCT00100932|537505412|FG001|Overall Study|Progressive Disease|18|||
149007215|NCT00100932|537505411|FG000|Overall Study|Physician Decision|7|||
149007216|NCT00100932|537505412|FG001|Overall Study|Physician Decision|5|||
149007217|NCT00100932|537505411|FG000|Overall Study|Other|5|||
149007218|NCT00100932|537505412|FG001|Overall Study|Other|2|||
149007219|NCT02387996|537505415|FG000|Overall Study|Disease Progression|167|||
149007220|NCT02387996|537505415|FG000|Overall Study|Study Drug Toxicity|31|||
149007221|NCT02387996|537505415|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
148893340|NCT00928486|537088673|FG000|Overall Study|Adverse Event|2|||
149007222|NCT02387996|537505415|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
149007223|NCT02387996|537505415|FG000|Overall Study|Subject Withdrew Consent|5|||
149007224|NCT02387996|537505415|FG000|Overall Study|Lost to Follow-up|1|||
149007225|NCT02387996|537505415|FG000|Overall Study|Poor/Non-Compliance|1|||
149007226|NCT02387996|537505415|FG000|Overall Study|Other Reasons|5|||
149007227|NCT02387996|537505415|FG000|Overall Study|Death|1|||
149007228|NCT01446796|537505416|FG000|Overall Study|Withdrawal by Subject|1|||
149007229|NCT01446796|537505417|FG001|Overall Study|Withdrawal by Subject|0|||
149007230|NCT02424591|537505418|FG000|Overall Study|Protocol Violation|2|||
149007231|NCT02424591|537505419|FG001|Overall Study|Protocol Violation|3|||
149007232|NCT00770432|537505422|FG000|Overall Study|Other|4|||
149007233|NCT00770432|537505423|FG001|Overall Study|Other|6|||
149007234|NCT00770432|537505422|FG000|Overall Study|Non-compliance|0|||
149007235|NCT00770432|537505423|FG001|Overall Study|Non-compliance|1|||
149007236|NCT00312702|537505424|FG000|Immunization Phase|Lost to Follow-up|0|||
149007237|NCT00312702|537505425|FG001|Immunization Phase|Lost to Follow-up|1|||
149007238|NCT00312702|537505426|FG002|Immunization Phase|Lost to Follow-up|0|||
149007239|NCT01453348|537505427|FG000|Overall Study|Death|0|||
149007240|NCT01453348|537505428|FG001|Overall Study|Death|0|||
149007241|NCT01453348|537505429|FG002|Overall Study|Death|1|||
149007242|NCT01453348|537505427|FG000|Overall Study|Withdrawal by Subject|0|||
149007243|NCT01453348|537505428|FG001|Overall Study|Withdrawal by Subject|1|||
149007244|NCT01453348|537505429|FG002|Overall Study|Withdrawal by Subject|0|||
149007245|NCT01453348|537505427|FG000|Overall Study|Protocol Violation|1|||
149007246|NCT01453348|537505428|FG001|Overall Study|Protocol Violation|0|||
149007247|NCT01453348|537505429|FG002|Overall Study|Protocol Violation|0|||
149007248|NCT02756832|537505433|FG000|Overall Study|Lost for Observation after Baseline|6|||
149007249|NCT02756832|537505433|FG000|Overall Study|Lost for Observation|13|||
149007250|NCT02756832|537505433|FG000|Overall Study|Patient's Unwillingness|12|||
149007251|NCT02756832|537505433|FG000|Overall Study|Insufficient Efficacy|2|||
149007252|NCT02756832|537505433|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
149007253|NCT02756832|537505433|FG000|Overall Study|Reason not Specified|9|||
149007254|NCT02756832|537505433|FG000|Overall Study|Protocol Deviation|10|||
149007255|NCT00954733|537505437|FG000|Overall Study|blood gas machine did not work|1|||
149007256|NCT03592277|537505438|FG000|Overall Study|Withdrawal by Subject|6|||
149007257|NCT03592277|537505439|FG001|Overall Study|Withdrawal by Subject|8|||
149007258|NCT03579290|537505440|FG000|Overall Study|Lost to Follow-up|9|||
149007259|NCT01781390|537505443|FG000|Overall Study|Withdrawal of Consent|0|||
149007260|NCT01781390|537505444|FG001|Overall Study|Withdrawal of Consent|3|||
149007261|NCT01781390|537505445|FG002|Overall Study|Withdrawal of Consent|1|||
149007262|NCT01781390|537505443|FG000|Overall Study|Lost to Follow-up|1|||
149007263|NCT01781390|537505444|FG001|Overall Study|Lost to Follow-up|1|||
149007264|NCT01781390|537505445|FG002|Overall Study|Lost to Follow-up|1|||
149007265|NCT01781390|537505443|FG000|Overall Study|Adverse Event|1|||
149007266|NCT01781390|537505444|FG001|Overall Study|Adverse Event|2|||
149007267|NCT01781390|537505445|FG002|Overall Study|Adverse Event|1|||
149007268|NCT01781390|537505443|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
149007269|NCT01781390|537505444|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
149007270|NCT01781390|537505445|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
149007271|NCT00622713|537505448|FG000|Overall Study|Adverse Event|35|||
149007272|NCT00622713|537505448|FG000|Overall Study|Administrative problems|4|||
149007273|NCT00622713|537505448|FG000|Overall Study|Withdrawal by Subject|11|||
149007274|NCT00622713|537505448|FG000|Overall Study|Lost to Follow-up|5|||
149007275|NCT00622713|537505448|FG000|Overall Study|Death|2|||
149007276|NCT00622713|537505448|FG000|Overall Study|Subject no longer required study drug|1|||
149007277|NCT00622713|537505448|FG000|Overall Study|Did not meet eligibility criteria|1|||
149007278|NCT01719237|537505456|FG000|Overall Study|Physician Decision|0|||
149007279|NCT01719237|537505457|FG001|Overall Study|Physician Decision|1|||
149007280|NCT02914314|537505461|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
149007281|NCT02914314|537505462|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
149007282|NCT02914314|537505463|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
149007283|NCT02914314|537505464|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
149007284|NCT02914314|537505461|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
149007285|NCT02914314|537505462|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
149007286|NCT02914314|537505463|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
149007287|NCT02914314|537505464|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
149007288|NCT02914314|537505461|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
149007289|NCT02914314|537505462|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
149007290|NCT02914314|537505463|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
149007291|NCT02914314|537505464|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
149007292|NCT02914314|537505461|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
149007293|NCT02914314|537505462|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
149007294|NCT02914314|537505463|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
149007295|NCT02914314|537505464|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
149007296|NCT02914314|537505461|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
149007297|NCT02914314|537505462|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
149007298|NCT02914314|537505463|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
149007299|NCT02914314|537505464|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
149007300|NCT03728972|537505467|FG000|Overall Study|Death|1|||
149007301|NCT03728972|537505468|FG001|Overall Study|Death|0|||
149007302|NCT03728972|537505467|FG000|Overall Study|Lack of Efficacy|1|||
149007303|NCT03728972|537505468|FG001|Overall Study|Lack of Efficacy|0|||
149007304|NCT03728972|537505467|FG000|Overall Study|Physician Decision|3|||
149007305|NCT03728972|537505468|FG001|Overall Study|Physician Decision|0|||
149007306|NCT03728972|537505467|FG000|Overall Study|Disease progression|4|||
149007307|NCT03728972|537505468|FG001|Overall Study|Disease progression|3|||
149007308|NCT00895622|537505469|FG000|Overall Study|Protocol Violation|5|||
149007309|NCT00895622|537505470|FG001|Overall Study|Protocol Violation|4|||
149007310|NCT00895622|537505471|FG002|Overall Study|Protocol Violation|4|||
149007311|NCT00652938|537505472|FG000|Overall Study|Adverse Event|1|||
149007312|NCT00652938|537505473|FG001|Overall Study|Adverse Event|0|||
149007313|NCT00652938|537505474|FG002|Overall Study|Adverse Event|2|||
149007314|NCT00652938|537505472|FG000|Overall Study|Withdrawal by Subject|0|||
149007315|NCT00652938|537505473|FG001|Overall Study|Withdrawal by Subject|6|||
149007316|NCT00652938|537505474|FG002|Overall Study|Withdrawal by Subject|1|||
149007317|NCT00652938|537505472|FG000|Overall Study|Lost to Follow-up|0|||
149007318|NCT00652938|537505473|FG001|Overall Study|Lost to Follow-up|0|||
149007319|NCT00652938|537505474|FG002|Overall Study|Lost to Follow-up|2|||
149007320|NCT00652938|537505472|FG000|Overall Study|fear of blood sampling|0|||
149007321|NCT00652938|537505473|FG001|Overall Study|fear of blood sampling|1|||
149007322|NCT00652938|537505474|FG002|Overall Study|fear of blood sampling|0|||
149007323|NCT01412801|537505475|FG000|Overall Study|Death|0|||
149007324|NCT01412801|537505476|FG001|Overall Study|Death|1|||
149007325|NCT01412801|537505477|FG002|Overall Study|Death|0|||
149007326|NCT01412801|537505478|FG003|Overall Study|Death|4|||
149007327|NCT01412801|537505479|FG004|Overall Study|Death|2|||
149007328|NCT01412801|537505480|FG005|Overall Study|Death|2|||
149007329|NCT01412801|537505475|FG000|Overall Study|Lost to Follow-up|1|||
149007330|NCT01412801|537505476|FG001|Overall Study|Lost to Follow-up|2|||
149007331|NCT01412801|537505477|FG002|Overall Study|Lost to Follow-up|4|||
149007332|NCT01412801|537505478|FG003|Overall Study|Lost to Follow-up|0|||
149007333|NCT01412801|537505479|FG004|Overall Study|Lost to Follow-up|1|||
149007334|NCT01412801|537505480|FG005|Overall Study|Lost to Follow-up|1|||
149007335|NCT01412801|537505475|FG000|Overall Study|Withdrawal by Subject|3|||
149007336|NCT01412801|537505476|FG001|Overall Study|Withdrawal by Subject|2|||
149007337|NCT01412801|537505477|FG002|Overall Study|Withdrawal by Subject|1|||
149007338|NCT01412801|537505478|FG003|Overall Study|Withdrawal by Subject|0|||
149007339|NCT01412801|537505479|FG004|Overall Study|Withdrawal by Subject|0|||
149007340|NCT01412801|537505480|FG005|Overall Study|Withdrawal by Subject|0|||
149007341|NCT01412801|537505475|FG000|Overall Study|Relocated to another area|0|||
149007342|NCT01412801|537505476|FG001|Overall Study|Relocated to another area|0|||
149007343|NCT01412801|537505477|FG002|Overall Study|Relocated to another area|2|||
149007344|NCT01412801|537505478|FG003|Overall Study|Relocated to another area|0|||
149007345|NCT01412801|537505479|FG004|Overall Study|Relocated to another area|0|||
149007346|NCT01412801|537505480|FG005|Overall Study|Relocated to another area|0|||
149007347|NCT00117156|537505484|FG000|Overall Study|Adverse Event|9|||
149007348|NCT00117156|537505484|FG000|Overall Study|Physician Decision|1|||
149007349|NCT00117156|537505484|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
149007350|NCT01919970|537505485|FG000|Overall Study|Withdrawal by Subject|3|||
149007351|NCT01919970|537505486|FG001|Overall Study|Withdrawal by Subject|0|||
149007352|NCT04043962|537505487|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
149007353|NCT04043962|537505487|FG000|Post-Treatment|Withdrawal by Subject|5|||
149007354|NCT04043962|537505487|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
149007355|NCT01987817|537505489|FG000|Overall Study|Adverse Event|4|||
149007356|NCT01987817|537505490|FG001|Overall Study|Adverse Event|0|||
149007357|NCT01987817|537505489|FG000|Overall Study|Withdrawal by Subject|1|||
149007358|NCT01987817|537505490|FG001|Overall Study|Withdrawal by Subject|1|||
149007359|NCT01987817|537505489|FG000|Overall Study|Physician Decision|1|||
149007360|NCT01987817|537505490|FG001|Overall Study|Physician Decision|0|||
149007361|NCT01576718|537505493|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
149007362|NCT01576718|537505494|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
149007363|NCT01576718|537505495|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
149007364|NCT01576718|537505496|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
149007365|NCT01576718|537505497|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
149007366|NCT01576718|537505498|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
149007367|NCT01576718|537505499|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
149007368|NCT01576718|537505493|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
149007369|NCT01576718|537505494|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
149007370|NCT01576718|537505495|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
149007371|NCT01576718|537505496|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
149007372|NCT01576718|537505497|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
149007373|NCT01576718|537505498|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
149007374|NCT01576718|537505499|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
149007375|NCT01576718|537505493|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
149007376|NCT01576718|537505494|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
149007377|NCT01576718|537505495|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
149007378|NCT01576718|537505496|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
149007379|NCT01576718|537505497|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
149007380|NCT01576718|537505498|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
149007381|NCT01576718|537505499|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
149007382|NCT01576718|537505493|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
149007383|NCT01576718|537505494|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
149007384|NCT01576718|537505495|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
149007385|NCT01576718|537505496|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
149007386|NCT01576718|537505497|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
149007387|NCT01576718|537505498|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
149007388|NCT01576718|537505499|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
149007389|NCT01576718|537505493|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
149007390|NCT01576718|537505494|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
149007391|NCT01576718|537505495|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
149007392|NCT01576718|537505496|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
149007393|NCT01576718|537505497|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
149007394|NCT01576718|537505498|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
149007395|NCT01576718|537505499|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
149007396|NCT01576718|537505493|FG000|Treatment Period|Adverse Event|0|||
149007397|NCT01576718|537505494|FG001|Treatment Period|Adverse Event|1|||
149007398|NCT01576718|537505495|FG002|Treatment Period|Adverse Event|1|||
149007399|NCT01576718|537505496|FG003|Treatment Period|Adverse Event|1|||
149007400|NCT01576718|537505497|FG004|Treatment Period|Adverse Event|1|||
149007401|NCT01576718|537505498|FG005|Treatment Period|Adverse Event|1|||
149007402|NCT01576718|537505499|FG006|Treatment Period|Adverse Event|0|||
149007403|NCT01576718|537505493|FG000|Treatment Period|Withdrawal by Subject|0|||
149007404|NCT01576718|537505494|FG001|Treatment Period|Withdrawal by Subject|1|||
149007405|NCT01576718|537505495|FG002|Treatment Period|Withdrawal by Subject|1|||
149007406|NCT01576718|537505496|FG003|Treatment Period|Withdrawal by Subject|0|||
149007407|NCT01576718|537505497|FG004|Treatment Period|Withdrawal by Subject|2|||
149007408|NCT01576718|537505498|FG005|Treatment Period|Withdrawal by Subject|4|||
149007409|NCT01576718|537505499|FG006|Treatment Period|Withdrawal by Subject|2|||
149007410|NCT01576718|537505493|FG000|Treatment Period|Physician Decision|0|||
149007411|NCT01576718|537505494|FG001|Treatment Period|Physician Decision|1|||
149007412|NCT01576718|537505495|FG002|Treatment Period|Physician Decision|1|||
149007413|NCT01576718|537505496|FG003|Treatment Period|Physician Decision|1|||
149007414|NCT01576718|537505497|FG004|Treatment Period|Physician Decision|1|||
149007415|NCT01576718|537505498|FG005|Treatment Period|Physician Decision|0|||
149007416|NCT01576718|537505499|FG006|Treatment Period|Physician Decision|0|||
149007417|NCT01576718|537505493|FG000|Treatment Period|Protocol Violation|0|||
149007418|NCT01576718|537505494|FG001|Treatment Period|Protocol Violation|5|||
149007419|NCT01576718|537505495|FG002|Treatment Period|Protocol Violation|4|||
149007420|NCT01576718|537505496|FG003|Treatment Period|Protocol Violation|10|||
149007421|NCT01576718|537505497|FG004|Treatment Period|Protocol Violation|6|||
149007422|NCT01576718|537505498|FG005|Treatment Period|Protocol Violation|8|||
149007423|NCT01576718|537505499|FG006|Treatment Period|Protocol Violation|12|||
149007424|NCT01576718|537505493|FG000|Treatment Period|Sponsor request|0|||
149007425|NCT01576718|537505494|FG001|Treatment Period|Sponsor request|1|||
149007426|NCT01576718|537505495|FG002|Treatment Period|Sponsor request|0|||
149007427|NCT01576718|537505496|FG003|Treatment Period|Sponsor request|0|||
149007428|NCT01576718|537505497|FG004|Treatment Period|Sponsor request|0|||
149007429|NCT01576718|537505498|FG005|Treatment Period|Sponsor request|1|||
149007430|NCT01576718|537505499|FG006|Treatment Period|Sponsor request|0|||
149007431|NCT01576718|537505493|FG000|Treatment Period|Met stopping criteria|0|||
149007432|NCT01576718|537505494|FG001|Treatment Period|Met stopping criteria|16|||
149007433|NCT01576718|537505495|FG002|Treatment Period|Met stopping criteria|13|||
149007434|NCT01576718|537505496|FG003|Treatment Period|Met stopping criteria|19|||
149007435|NCT01576718|537505497|FG004|Treatment Period|Met stopping criteria|16|||
149007436|NCT01576718|537505498|FG005|Treatment Period|Met stopping criteria|33|||
149007437|NCT01576718|537505499|FG006|Treatment Period|Met stopping criteria|15|||
149007438|NCT01576718|537505493|FG000|Treatment Period|Lost to Follow-up|0|||
149007439|NCT01576718|537505494|FG001|Treatment Period|Lost to Follow-up|0|||
149007440|NCT01576718|537505495|FG002|Treatment Period|Lost to Follow-up|0|||
149007441|NCT01576718|537505496|FG003|Treatment Period|Lost to Follow-up|0|||
149007442|NCT01576718|537505497|FG004|Treatment Period|Lost to Follow-up|1|||
149007443|NCT01576718|537505498|FG005|Treatment Period|Lost to Follow-up|0|||
149007444|NCT01576718|537505499|FG006|Treatment Period|Lost to Follow-up|0|||
149007445|NCT01576718|537505493|FG000|Treatment Period|Noncompliance to study medication|0|||
149007446|NCT01576718|537505494|FG001|Treatment Period|Noncompliance to study medication|0|||
149007447|NCT01576718|537505495|FG002|Treatment Period|Noncompliance to study medication|0|||
149007448|NCT01576718|537505496|FG003|Treatment Period|Noncompliance to study medication|0|||
149007449|NCT01576718|537505497|FG004|Treatment Period|Noncompliance to study medication|0|||
149007450|NCT01576718|537505498|FG005|Treatment Period|Noncompliance to study medication|1|||
149007451|NCT01576718|537505499|FG006|Treatment Period|Noncompliance to study medication|1|||
149007452|NCT01874145|537505500|FG000|Core Period|Non-compliance|1|||
149007453|NCT01874145|537505501|FG001|Core Period|Non-compliance|0|||
149007454|NCT01874145|537505500|FG000|Core Period|Protocol Violation|1|||
149007455|NCT01874145|537505501|FG001|Core Period|Protocol Violation|1|||
149007456|NCT01874145|537505500|FG000|Core Period|Physician Decision|1|||
149007457|NCT01874145|537505501|FG001|Core Period|Physician Decision|1|||
149007458|NCT01874145|537505500|FG000|Core Period|Adverse Event|0|||
149007459|NCT01874145|537505501|FG001|Core Period|Adverse Event|1|||
149007460|NCT01874145|537505500|FG000|Core Period|Withdrawal by Subject|0|||
149007461|NCT01874145|537505501|FG001|Core Period|Withdrawal by Subject|4|||
149007462|NCT01874145|537505500|FG000|Extension Period|Adverse Event|3|||
149007463|NCT01874145|537505501|FG001|Extension Period|Adverse Event|2|||
149007464|NCT01874145|537505500|FG000|Extension Period|Withdrawal by Subject|2|||
149007465|NCT01874145|537505501|FG001|Extension Period|Withdrawal by Subject|1|||
149007466|NCT01874145|537505500|FG000|Extension Period|Lost to Follow-up|1|||
149007467|NCT01874145|537505501|FG001|Extension Period|Lost to Follow-up|1|||
149007468|NCT04631705|537505502|FG000|Overall Study|Withdrawal by Subject|0|||
149007469|NCT04631705|537505503|FG001|Overall Study|Withdrawal by Subject|0|||
149007470|NCT04631705|537505504|FG002|Overall Study|Withdrawal by Subject|0|||
149007471|NCT04631705|537505505|FG003|Overall Study|Withdrawal by Subject|0|||
149007472|NCT04631705|537505506|FG004|Overall Study|Withdrawal by Subject|0|||
149007473|NCT04631705|537505507|FG005|Overall Study|Withdrawal by Subject|0|||
149007474|NCT04631705|537505508|FG006|Overall Study|Withdrawal by Subject|1|||
149007475|NCT04631705|537505509|FG007|Overall Study|Withdrawal by Subject|0|||
149007476|NCT04631705|537505510|FG008|Overall Study|Withdrawal by Subject|0|||
149007477|NCT04739761|537505516|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
149007478|NCT04739761|537505517|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
149007479|NCT04739761|537505516|FG000|Overall Study|By complete response from the participant|1|||
149007480|NCT04739761|537505517|FG001|Overall Study|By complete response from the participant|0|||
149007481|NCT04739761|537505516|FG000|Overall Study|Lost to Follow-up|3|||
149007482|NCT04739761|537505517|FG001|Overall Study|Lost to Follow-up|3|||
149007483|NCT04739761|537505516|FG000|Overall Study|Death|13|||
149007484|NCT04739761|537505517|FG001|Overall Study|Death|13|||
149007485|NCT04739761|537505516|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
149007486|NCT04739761|537505517|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
149007487|NCT04739761|537505516|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
149007488|NCT04739761|537505517|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
149007489|NCT04739761|537505516|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
149007490|NCT04739761|537505517|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
149007491|NCT04739761|537505516|FG000|Overall Study|Adverse Event|0|||
149007492|NCT04739761|537505517|FG001|Overall Study|Adverse Event|3|||
149007493|NCT04739761|537505516|FG000|Overall Study|Participant decision|1|||
149007494|NCT04739761|537505517|FG001|Overall Study|Participant decision|0|||
149007495|NCT04739761|537505516|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
149007496|NCT04739761|537505517|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
149007497|NCT04739761|537505516|FG000|Overall Study|Participant immediately started next line of treatment|1|||
149007498|NCT04739761|537505517|FG001|Overall Study|Participant immediately started next line of treatment|0|||
149007499|NCT04739761|537505516|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
149007500|NCT04739761|537505517|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
149007501|NCT04739761|537505516|FG000|Overall Study|Lack of clinical benefit|1|||
149007502|NCT04739761|537505517|FG001|Overall Study|Lack of clinical benefit|0|||
149007503|NCT04739761|537505516|FG000|Overall Study|Disease progression|5|||
149007504|NCT04739761|537505517|FG001|Overall Study|Disease progression|5|||
149007505|NCT04739761|537505516|FG000|Overall Study|Withdrawal by Subject|14|||
149007506|NCT04739761|537505517|FG001|Overall Study|Withdrawal by Subject|13|||
149007507|NCT04739761|537505516|FG000|Overall Study|Protocol Violation|1|||
149007508|NCT04739761|537505517|FG001|Overall Study|Protocol Violation|0|||
149007509|NCT04739761|537505516|FG000|Overall Study|Physician Decision|2|||
149007510|NCT04739761|537505517|FG001|Overall Study|Physician Decision|0|||
149007511|NCT01816763|537507836|FG000|Overall Study|The main reason for an incomplete survey|4|||
149007512|NCT01816763|537507837|FG001|Overall Study|The main reason for an incomplete survey|15|||
149007513|NCT01816763|537507838|FG002|Overall Study|The main reason for an incomplete survey|11|||
149007514|NCT00975221|537507839|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
149007515|NCT00975221|537507840|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
149007516|NCT00975221|537507839|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
149007517|NCT00975221|537507840|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
149007518|NCT00975221|537507839|FG000|Titration Phase (Weeks 1-12)|Other|0|||
149007519|NCT00975221|537507840|FG001|Titration Phase (Weeks 1-12)|Other|1|||
149007520|NCT00975221|537507839|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
149007521|NCT00975221|537507840|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
149007522|NCT00975221|537507839|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
149007523|NCT00975221|537507840|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
149007524|NCT00975221|537507839|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
149007525|NCT00975221|537507840|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
149007526|NCT01186328|537507848|FG000|Overall Study|Death|1|||
149007527|NCT01186328|537507849|FG001|Overall Study|Death|0|||
149007528|NCT01186328|537507850|FG002|Overall Study|Death|0|||
149007529|NCT01862991|537507851|FG000|Overall Study|Lost to Follow-up|2|||
149007530|NCT01862991|537507852|FG001|Overall Study|Lost to Follow-up|1|||
149007531|NCT01862991|537507853|FG002|Overall Study|Lost to Follow-up|1|||
149007532|NCT01862991|537507851|FG000|Overall Study|Protocol Violation|1|||
149007533|NCT01862991|537507852|FG001|Overall Study|Protocol Violation|0|||
149007534|NCT01862991|537507853|FG002|Overall Study|Protocol Violation|0|||
149007535|NCT02762981|537507854|FG000|Overall Study|Adverse Event|2|||
149007536|NCT02762981|537507855|FG001|Overall Study|Adverse Event|3|||
149007537|NCT02762981|537507856|FG002|Overall Study|Adverse Event|1|||
149007538|NCT02762981|537507857|FG003|Overall Study|Adverse Event|1|||
149007539|NCT02762981|537507858|FG004|Overall Study|Adverse Event|3|||
149007540|NCT02762981|537507854|FG000|Overall Study|Physician Decision|0|||
149007541|NCT02762981|537507855|FG001|Overall Study|Physician Decision|1|||
149007542|NCT02762981|537507856|FG002|Overall Study|Physician Decision|0|||
149007543|NCT02762981|537507857|FG003|Overall Study|Physician Decision|0|||
149007544|NCT02762981|537507858|FG004|Overall Study|Physician Decision|1|||
149007545|NCT02762981|537507854|FG000|Overall Study|Disease progression|11|||
149007546|NCT02762981|537507855|FG001|Overall Study|Disease progression|23|||
149007547|NCT02762981|537507856|FG002|Overall Study|Disease progression|4|||
149007548|NCT02762981|537507857|FG003|Overall Study|Disease progression|10|||
149007549|NCT02762981|537507858|FG004|Overall Study|Disease progression|1|||
149007550|NCT02762981|537507854|FG000|Overall Study|Enrolled not treated|1|||
149007551|NCT02762981|537507855|FG001|Overall Study|Enrolled not treated|5|||
149007552|NCT02762981|537507856|FG002|Overall Study|Enrolled not treated|0|||
149007553|NCT02762981|537507857|FG003|Overall Study|Enrolled not treated|2|||
149007554|NCT02762981|537507858|FG004|Overall Study|Enrolled not treated|0|||
149007555|NCT02762981|537507854|FG000|Overall Study|Other|2|||
149007556|NCT02762981|537507855|FG001|Overall Study|Other|3|||
149007557|NCT02762981|537507856|FG002|Overall Study|Other|1|||
149007558|NCT02762981|537507857|FG003|Overall Study|Other|0|||
149007559|NCT02762981|537507858|FG004|Overall Study|Other|0|||
149007560|NCT02762981|537507854|FG000|Overall Study|Missing|1|||
149007561|NCT02762981|537507855|FG001|Overall Study|Missing|0|||
149007562|NCT02762981|537507856|FG002|Overall Study|Missing|0|||
149007563|NCT02762981|537507857|FG003|Overall Study|Missing|0|||
149007564|NCT02762981|537507858|FG004|Overall Study|Missing|0|||
149007565|NCT02762981|537507854|FG000|Overall Study|Withdrawal by Subject|0|||
149007566|NCT02762981|537507855|FG001|Overall Study|Withdrawal by Subject|5|||
149007567|NCT02762981|537507856|FG002|Overall Study|Withdrawal by Subject|1|||
149007568|NCT02762981|537507857|FG003|Overall Study|Withdrawal by Subject|3|||
149007569|NCT02762981|537507858|FG004|Overall Study|Withdrawal by Subject|0|||
149007570|NCT02392611|537507861|FG000|Overall Study|Adverse Event|0|||
149007571|NCT02392611|537507862|FG001|Overall Study|Adverse Event|0|||
149007572|NCT02392611|537507863|FG002|Overall Study|Adverse Event|0|||
149007573|NCT02392611|537507864|FG003|Overall Study|Adverse Event|1|||
149007574|NCT02392611|537507865|FG004|Overall Study|Adverse Event|0|||
149007575|NCT02392611|537507866|FG005|Overall Study|Adverse Event|0|||
149007576|NCT02392611|537507867|FG006|Overall Study|Adverse Event|0|||
149007577|NCT02392611|537507868|FG007|Overall Study|Adverse Event|0|||
149007578|NCT02392611|537507869|FG008|Overall Study|Adverse Event|0|||
149007579|NCT02392611|537507861|FG000|Overall Study|Progressive disease|0|||
149007580|NCT02392611|537507862|FG001|Overall Study|Progressive disease|0|||
149007581|NCT02392611|537507863|FG002|Overall Study|Progressive disease|0|||
148780437|NCT02172040|536669693|FG002|Overall Study|Withdrawal by Subject|1|||
148780438|NCT02172040|536669694|FG003|Overall Study|Withdrawal by Subject|0|||
148780439|NCT02172040|536669691|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
148780440|NCT02172040|536669692|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
148780441|NCT02172040|536669693|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
148780442|NCT02172040|536669694|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
148780443|NCT02172040|536669691|FG000|Overall Study|Family emergency abroad|0|||
148780444|NCT02172040|536669692|FG001|Overall Study|Family emergency abroad|0|||
148780445|NCT02172040|536669693|FG002|Overall Study|Family emergency abroad|0|||
148780446|NCT02172040|536669694|FG003|Overall Study|Family emergency abroad|1|||
148780447|NCT02093390|536669698|FG000|Overall Study|Withdrawal by Subject|0|||
148780448|NCT02093390|536669699|FG001|Overall Study|Withdrawal by Subject|1|||
148780449|NCT03334422|536671496|FG000|Overall Study|Adverse Event|1|||
148780450|NCT03334422|536671497|FG001|Overall Study|Adverse Event|3|||
148780451|NCT03334422|536671498|FG002|Overall Study|Adverse Event|2|||
148780452|NCT03334422|536671499|FG003|Overall Study|Adverse Event|2|||
148780453|NCT03334422|536671496|FG000|Overall Study|Lack of Efficacy|10|||
148780454|NCT03334422|536671497|FG001|Overall Study|Lack of Efficacy|2|||
148780455|NCT03334422|536671498|FG002|Overall Study|Lack of Efficacy|7|||
148780456|NCT03334422|536671499|FG003|Overall Study|Lack of Efficacy|3|||
148780457|NCT03334422|536671496|FG000|Overall Study|Withdrawal by Subject|8|||
148780458|NCT03334422|536671497|FG001|Overall Study|Withdrawal by Subject|3|||
148780459|NCT03334422|536671498|FG002|Overall Study|Withdrawal by Subject|1|||
148780460|NCT03334422|536671499|FG003|Overall Study|Withdrawal by Subject|0|||
148780461|NCT03334422|536671496|FG000|Overall Study|Lost to Follow-up|0|||
148780462|NCT03334422|536671497|FG001|Overall Study|Lost to Follow-up|0|||
148780463|NCT03334422|536671498|FG002|Overall Study|Lost to Follow-up|0|||
148780464|NCT03334422|536671499|FG003|Overall Study|Lost to Follow-up|1|||
148780465|NCT03334422|536671496|FG000|Overall Study|Inability to obtain laboratory samples|0|||
148780466|NCT03334422|536671497|FG001|Overall Study|Inability to obtain laboratory samples|1|||
148780467|NCT03334422|536671498|FG002|Overall Study|Inability to obtain laboratory samples|0|||
148780468|NCT03334422|536671499|FG003|Overall Study|Inability to obtain laboratory samples|0|||
148780469|NCT03334422|536671496|FG000|Overall Study|Pregnancy|0|||
148780470|NCT03334422|536671497|FG001|Overall Study|Pregnancy|1|||
148780471|NCT03334422|536671498|FG002|Overall Study|Pregnancy|0|||
148780472|NCT03334422|536671499|FG003|Overall Study|Pregnancy|0|||
148780473|NCT03246061|536671500|FG000|Overall Study|Still in follow-up|15|||
148780474|NCT03246061|536671501|FG001|Overall Study|Still in follow-up|21|||
148780475|NCT02864316|536671506|FG000|Overall Study|Progressive Disease|2|||
148780476|NCT02864316|536671507|FG001|Overall Study|Progressive Disease|1|||
148780477|NCT02864316|536671506|FG000|Overall Study|Adverse Event|0|||
148780478|NCT02864316|536671507|FG001|Overall Study|Adverse Event|1|||
148780479|NCT04710368|536671508|FG000|Overall Study|Withdrawal by Subject|9|||
148780480|NCT04710368|536671508|FG000|Overall Study|Lost to Follow-up|4|||
148780481|NCT04710368|536671508|FG000|Overall Study|Death|2|||
148780482|NCT04710368|536671508|FG000|Overall Study|Patient preference|11|||
148780483|NCT04710368|536671508|FG000|Overall Study|Treatment discontinuation|1|||
148780484|NCT05459558|536671509|FG000|Overall Study|Adverse Event|1|||
148780485|NCT05459558|536671510|FG001|Overall Study|Adverse Event|0|||
148780486|NCT05459558|536671511|FG002|Overall Study|Adverse Event|0|||
148780487|NCT05459558|536671509|FG000|Overall Study|Scheduling issue|0|||
148780488|NCT05459558|536671510|FG001|Overall Study|Scheduling issue|1|||
148780489|NCT05459558|536671511|FG002|Overall Study|Scheduling issue|3|||
148780490|NCT05459558|536671509|FG000|Overall Study|Withdrawal by Subject|0|||
148780491|NCT05459558|536671510|FG001|Overall Study|Withdrawal by Subject|0|||
148780492|NCT05459558|536671511|FG002|Overall Study|Withdrawal by Subject|2|||
148780493|NCT01777139|536671516|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
148780494|NCT01777139|536671517|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
148780495|NCT01777139|536671516|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
148780496|NCT01777139|536671517|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
148780497|NCT01777139|536671516|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
148780498|NCT01777139|536671517|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
148780499|NCT01777139|536671516|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
148780500|NCT01777139|536671517|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
148780501|NCT01777139|536671516|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
148780502|NCT01777139|536671517|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
148780503|NCT01777139|536671516|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
149007582|NCT02392611|537507864|FG003|Overall Study|Progressive disease|2|||
148780504|NCT01777139|536671517|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
148780505|NCT01777139|536671516|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
148780506|NCT01777139|536671517|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
148780507|NCT01777139|536671516|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
148780508|NCT01777139|536671517|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
148780509|NCT01887288|536671518|FG000|Overall Study|The study was terminated and the PI has|16|||
148780510|NCT01092637|536671519|FG000|Overall Study|Death|47|||
148780511|NCT01092637|536671520|FG001|Overall Study|Death|49|||
148780512|NCT02921750|536671521|FG000|Overall Study|Adverse Event|1|||
148780513|NCT02921750|536671522|FG001|Overall Study|Adverse Event|2|||
148780514|NCT02921750|536671521|FG000|Overall Study|Withdrawal by Subject|1|||
148780515|NCT02921750|536671522|FG001|Overall Study|Withdrawal by Subject|1|||
148780516|NCT02921750|536671521|FG000|Overall Study|Lost to Follow-up|3|||
148780517|NCT02921750|536671522|FG001|Overall Study|Lost to Follow-up|3|||
148780518|NCT02921750|536671521|FG000|Overall Study|Wound healed|3|||
148780519|NCT02921750|536671522|FG001|Overall Study|Wound healed|3|||
148780520|NCT02921750|536671521|FG000|Overall Study|Serious Adverse Event|1|||
148780521|NCT02921750|536671522|FG001|Overall Study|Serious Adverse Event|2|||
148780522|NCT03292458|536671527|FG000|Period 1|Adverse Event|2|||
148780523|NCT03292458|536671528|FG001|Period 1|Adverse Event|0|||
148780524|NCT02542293|536671529|FG000|Overall Study|Death|367|||
148780525|NCT02542293|536671530|FG001|Overall Study|Death|377|||
148780526|NCT02542293|536671529|FG000|Overall Study|Withdrawal by Subject|8|||
148780527|NCT02542293|536671530|FG001|Overall Study|Withdrawal by Subject|19|||
148780528|NCT03030118|536671531|FG000|Overall Study|Achieved SLE Diagnosis|11|||
148780529|NCT03030118|536671532|FG001|Overall Study|Achieved SLE Diagnosis|10|||
148780530|NCT03030118|536671531|FG000|Overall Study|Adverse Event|1|||
148780531|NCT03030118|536671532|FG001|Overall Study|Adverse Event|1|||
148780532|NCT03030118|536671531|FG000|Overall Study|Pregnancy|2|||
148780533|NCT03030118|536671532|FG001|Overall Study|Pregnancy|2|||
148780534|NCT03030118|536671531|FG000|Overall Study|Lost to Follow-up|5|||
148780535|NCT03030118|536671532|FG001|Overall Study|Lost to Follow-up|6|||
148780536|NCT03030118|536671531|FG000|Overall Study|Concomitant Medications|1|||
148780537|NCT03030118|536671532|FG001|Overall Study|Concomitant Medications|1|||
148780538|NCT03030118|536671531|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
148780539|NCT03030118|536671532|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
148780540|NCT03030118|536671531|FG000|Overall Study|Other|2|||
148780541|NCT03030118|536671532|FG001|Overall Study|Other|0|||
148780542|NCT03030118|536671531|FG000|Overall Study|Withdrawal by Subject|26|||
148780543|NCT03030118|536671532|FG001|Overall Study|Withdrawal by Subject|21|||
148780544|NCT03030118|536671531|FG000|Overall Study|Protocol Violation|1|||
148780545|NCT03030118|536671532|FG001|Overall Study|Protocol Violation|6|||
148780546|NCT04529850|536671533|FG000|Overall Study|Death|2|||
148780547|NCT04529850|536671533|FG000|Overall Study|Physician Decision|1|||
148780548|NCT04529850|536671533|FG000|Overall Study|Withdrawal by Subject|2|||
148780549|NCT00593606|536671536|FG000|Overall Study|Adverse Event|13|||
148780550|NCT00593606|536671536|FG000|Overall Study|Withdrawal by Subject|1|||
148780551|NCT00593606|536671536|FG000|Overall Study|Protocol Violation|3|||
148780552|NCT00593606|536671536|FG000|Overall Study|Lost to Follow-up|2|||
148780553|NCT00593606|536671536|FG000|Overall Study|Run-In Failure|5|||
148780554|NCT00593606|536671536|FG000|Overall Study|Screen Failure|3|||
148780555|NCT02278367|536671537|FG000|Overall Study|Physician Decision|5|||
148780556|NCT02278367|536671538|FG001|Overall Study|Physician Decision|0|||
148780557|NCT02278367|536671537|FG000|Overall Study|Withdrawal by Subject|5|||
148780558|NCT02278367|536671538|FG001|Overall Study|Withdrawal by Subject|0|||
148780559|NCT04643964|536671540|FG000|Overall Study|Lost to Follow-up|55|||
148780560|NCT04643964|536671541|FG001|Overall Study|Lost to Follow-up|59|||
148780561|NCT04643964|536671542|FG002|Overall Study|Lost to Follow-up|54|||
148780562|NCT04643964|536671543|FG003|Overall Study|Lost to Follow-up|129|||
148780563|NCT04643964|536671544|FG004|Overall Study|Lost to Follow-up|48|||
148780564|NCT04643964|536671540|FG000|Overall Study|Failed attention check|1|||
148780565|NCT04643964|536671541|FG001|Overall Study|Failed attention check|8|||
148780566|NCT04643964|536671542|FG002|Overall Study|Failed attention check|2|||
148780567|NCT04643964|536671543|FG003|Overall Study|Failed attention check|14|||
148780568|NCT04643964|536671544|FG004|Overall Study|Failed attention check|11|||
148780569|NCT02638129|536671545|FG000|Overall Study|Study terminated|28|||
148780570|NCT02638129|536671546|FG001|Overall Study|Study terminated|30|||
148780571|NCT00869557|536671549|FG000|Randomized Phase|Lost to Follow-up|2|||
148780572|NCT00869557|536671550|FG001|Randomized Phase|Lost to Follow-up|1|||
148780573|NCT00869557|536671549|FG000|Randomized Phase|Investigator's Discretion|1|||
148780574|NCT00869557|536671550|FG001|Randomized Phase|Investigator's Discretion|0|||
148780575|NCT00869557|536671549|FG000|Randomized Phase|Withdrew Consent|0|||
148780576|NCT00869557|536671550|FG001|Randomized Phase|Withdrew Consent|1|||
148780577|NCT00869557|536671549|FG000|Extension Phase|Adverse Event|2|||
148780578|NCT00869557|536671550|FG001|Extension Phase|Adverse Event|2|||
148780579|NCT00869557|536671549|FG000|Extension Phase|Lack of Efficacy|1|||
148780580|NCT00869557|536671550|FG001|Extension Phase|Lack of Efficacy|0|||
148780581|NCT00869557|536671549|FG000|Extension Phase|Lost to Follow-up|3|||
148780582|NCT00869557|536671550|FG001|Extension Phase|Lost to Follow-up|1|||
148780583|NCT00869557|536671549|FG000|Extension Phase|Investigator's Discretion|2|||
148780584|NCT00869557|536671550|FG001|Extension Phase|Investigator's Discretion|0|||
148780585|NCT00869557|536671549|FG000|Extension Phase|Withdrew Consent|2|||
148780586|NCT00869557|536671550|FG001|Extension Phase|Withdrew Consent|0|||
148780587|NCT00114738|536671551|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
148780588|NCT00114738|536671552|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
148780589|NCT00114738|536671553|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
148780590|NCT00114738|536671551|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
148780591|NCT00114738|536671552|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
148780592|NCT00114738|536671553|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
148780593|NCT00114738|536671551|FG000|Screening for Randomization|Neuropathy|17|||
148780594|NCT00114738|536671552|FG001|Screening for Randomization|Neuropathy|0|||
148780595|NCT00114738|536671553|FG002|Screening for Randomization|Neuropathy|0|||
148780596|NCT00114738|536671551|FG000|Screening for Randomization|Progressive disease|2|||
148780597|NCT00114738|536671552|FG001|Screening for Randomization|Progressive disease|0|||
148780598|NCT00114738|536671553|FG002|Screening for Randomization|Progressive disease|0|||
148780599|NCT00114738|536671551|FG000|Screening for Randomization|CNS Hemorrhage|1|||
148780600|NCT00114738|536671552|FG001|Screening for Randomization|CNS Hemorrhage|0|||
148780601|NCT00114738|536671553|FG002|Screening for Randomization|CNS Hemorrhage|0|||
148780602|NCT00114738|536671551|FG000|Screening for Randomization|Other|1|||
148780603|NCT00114738|536671552|FG001|Screening for Randomization|Other|0|||
148780604|NCT00114738|536671553|FG002|Screening for Randomization|Other|0|||
148780605|NCT02368210|536671554|FG000|Overall Study|Withdrawal by Subject|1|||
148780606|NCT02368210|536671555|FG001|Overall Study|Withdrawal by Subject|0|||
148780607|NCT02368210|536671554|FG000|Overall Study|Adverse Event|0|||
148780608|NCT02368210|536671555|FG001|Overall Study|Adverse Event|1|||
148780609|NCT01492101|536671556|FG000|Overall Study|Death|323|||
148780610|NCT01492101|536671557|FG001|Overall Study|Death|322|||
148780611|NCT01492101|536671556|FG000|Overall Study|Withdrawal by Subject|14|||
149007583|NCT02392611|537507865|FG004|Overall Study|Progressive disease|1|||
149007584|NCT02392611|537507866|FG005|Overall Study|Progressive disease|0|||
149007585|NCT02392611|537507867|FG006|Overall Study|Progressive disease|0|||
149007586|NCT02392611|537507868|FG007|Overall Study|Progressive disease|0|||
149007587|NCT02392611|537507869|FG008|Overall Study|Progressive disease|0|||
149007588|NCT02392611|537507861|FG000|Overall Study|Death|1|||
149007589|NCT02392611|537507862|FG001|Overall Study|Death|0|||
149007590|NCT02392611|537507863|FG002|Overall Study|Death|0|||
149007591|NCT02392611|537507864|FG003|Overall Study|Death|0|||
149007592|NCT02392611|537507865|FG004|Overall Study|Death|0|||
149007593|NCT02392611|537507866|FG005|Overall Study|Death|1|||
149007594|NCT02392611|537507867|FG006|Overall Study|Death|0|||
149007595|NCT02392611|537507868|FG007|Overall Study|Death|0|||
149007596|NCT02392611|537507869|FG008|Overall Study|Death|0|||
149007597|NCT02392611|537507861|FG000|Overall Study|Withdrawal by Subject|0|||
149007598|NCT02392611|537507862|FG001|Overall Study|Withdrawal by Subject|0|||
149007599|NCT02392611|537507863|FG002|Overall Study|Withdrawal by Subject|0|||
149007600|NCT02392611|537507864|FG003|Overall Study|Withdrawal by Subject|1|||
149007601|NCT02392611|537507865|FG004|Overall Study|Withdrawal by Subject|0|||
149007602|NCT02392611|537507866|FG005|Overall Study|Withdrawal by Subject|0|||
149007603|NCT02392611|537507867|FG006|Overall Study|Withdrawal by Subject|0|||
149007604|NCT02392611|537507868|FG007|Overall Study|Withdrawal by Subject|0|||
149007605|NCT02392611|537507869|FG008|Overall Study|Withdrawal by Subject|0|||
149007606|NCT02392611|537507861|FG000|Overall Study|Lost to Follow-up|0|||
149007607|NCT02392611|537507862|FG001|Overall Study|Lost to Follow-up|0|||
149007608|NCT02392611|537507863|FG002|Overall Study|Lost to Follow-up|0|||
149007609|NCT02392611|537507864|FG003|Overall Study|Lost to Follow-up|0|||
149007610|NCT02392611|537507865|FG004|Overall Study|Lost to Follow-up|0|||
149007611|NCT02392611|537507866|FG005|Overall Study|Lost to Follow-up|0|||
149007612|NCT02392611|537507867|FG006|Overall Study|Lost to Follow-up|1|||
149007613|NCT02392611|537507868|FG007|Overall Study|Lost to Follow-up|0|||
149007614|NCT02392611|537507869|FG008|Overall Study|Lost to Follow-up|0|||
149007615|NCT02392611|537507861|FG000|Overall Study|Enrolled, not treated|0|||
149007616|NCT02392611|537507862|FG001|Overall Study|Enrolled, not treated|0|||
149007617|NCT02392611|537507863|FG002|Overall Study|Enrolled, not treated|0|||
149007618|NCT02392611|537507864|FG003|Overall Study|Enrolled, not treated|2|||
148780612|NCT01492101|536671557|FG001|Overall Study|Withdrawal by Subject|18|||
148780613|NCT01492101|536671556|FG000|Overall Study|Lost to Follow-up|0|||
148780614|NCT01492101|536671557|FG001|Overall Study|Lost to Follow-up|2|||
148780615|NCT00316914|536671558|FG000|Overall Study|Withdrawal by Subject|5|||
149007619|NCT02392611|537507865|FG004|Overall Study|Enrolled, not treated|0|||
149007620|NCT02392611|537507866|FG005|Overall Study|Enrolled, not treated|0|||
149007621|NCT02392611|537507867|FG006|Overall Study|Enrolled, not treated|0|||
148780616|NCT00316914|536671559|FG001|Overall Study|Withdrawal by Subject|3|||
149007622|NCT02392611|537507868|FG007|Overall Study|Enrolled, not treated|0|||
149007623|NCT02392611|537507869|FG008|Overall Study|Enrolled, not treated|0|||
149007624|NCT02714868|537507871|FG000|Overall Study|Withdrawal by Subject|3|||
149007625|NCT02714868|537507872|FG001|Overall Study|Withdrawal by Subject|0|||
148780617|NCT00316914|536671558|FG000|Overall Study|Adverse Event|8|||
149007626|NCT02714868|537507871|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
149007627|NCT02714868|537507872|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
148780618|NCT00316914|536671559|FG001|Overall Study|Adverse Event|7|||
148780619|NCT00316914|536671558|FG000|Overall Study|Other Problems|6|||
149007628|NCT02714868|537507871|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
149007629|NCT02714868|537507872|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
149007630|NCT02207725|537507873|FG000|Overall Study|Did Not Receive Treatment|0|||
149007631|NCT02207725|537507874|FG001|Overall Study|Did Not Receive Treatment|1|||
149007632|NCT02207725|537507875|FG002|Overall Study|Did Not Receive Treatment|1|||
149007633|NCT02207725|537507876|FG003|Overall Study|Did Not Receive Treatment|1|||
149007634|NCT00674570|537507878|FG000|Overall Study|Withdrawal by Subject|0|||
149007635|NCT00674570|537507879|FG001|Overall Study|Withdrawal by Subject|2|||
149007636|NCT00674570|537507880|FG002|Overall Study|Withdrawal by Subject|0|||
149007637|NCT01966003|537507881|FG000|Overall Study|Death|43|||
149007638|NCT01966003|537507882|FG001|Overall Study|Death|36|||
149007639|NCT01966003|537507881|FG000|Overall Study|Protocol Violation|6|||
149007640|NCT01966003|537507882|FG001|Overall Study|Protocol Violation|4|||
149007641|NCT01966003|537507881|FG000|Overall Study|Lost to Follow-up|4|||
149007642|NCT01966003|537507882|FG001|Overall Study|Lost to Follow-up|3|||
149007643|NCT01966003|537507881|FG000|Overall Study|Physician Decision|12|||
149007644|NCT01966003|537507882|FG001|Overall Study|Physician Decision|13|||
149007645|NCT01966003|537507881|FG000|Overall Study|Withdrawal by Subject|29|||
149007646|NCT01966003|537507882|FG001|Overall Study|Withdrawal by Subject|19|||
149007647|NCT01966003|537507881|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
149007648|NCT01966003|537507882|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
149007649|NCT01966003|537507881|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
149007650|NCT01966003|537507882|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
149007651|NCT01966003|537507881|FG000|Overall Study|Other|1|||
149007652|NCT01966003|537507882|FG001|Overall Study|Other|1|||
149007653|NCT02110732|537507887|FG000|Overall Study|Physician Decision|5|||
149007654|NCT02110732|537507888|FG001|Overall Study|Physician Decision|2|||
149007655|NCT02110732|537507887|FG000|Overall Study|Lost to Follow-up|1|||
149007656|NCT02110732|537507888|FG001|Overall Study|Lost to Follow-up|1|||
149007657|NCT00633932|537507889|FG000|Overall Study|Adverse Event|1|||
149007658|NCT00633932|537507890|FG001|Overall Study|Adverse Event|3|||
149007659|NCT00633932|537507891|FG002|Overall Study|Adverse Event|4|||
149007660|NCT00633932|537507889|FG000|Overall Study|Withdrawal by Subject|3|||
149007661|NCT00633932|537507890|FG001|Overall Study|Withdrawal by Subject|9|||
149007662|NCT00633932|537507891|FG002|Overall Study|Withdrawal by Subject|1|||
149007663|NCT00633932|537507889|FG000|Overall Study|Lost to Follow-up|1|||
149007664|NCT00633932|537507890|FG001|Overall Study|Lost to Follow-up|0|||
149007665|NCT00633932|537507891|FG002|Overall Study|Lost to Follow-up|2|||
149007666|NCT00633932|537507889|FG000|Overall Study|Protocol Violation|5|||
149007667|NCT00633932|537507890|FG001|Overall Study|Protocol Violation|2|||
149007668|NCT00633932|537507891|FG002|Overall Study|Protocol Violation|3|||
149007669|NCT00633932|537507889|FG000|Overall Study|Physician Decision|0|||
149007670|NCT00633932|537507890|FG001|Overall Study|Physician Decision|0|||
149007671|NCT00633932|537507891|FG002|Overall Study|Physician Decision|1|||
149007672|NCT00633932|537507889|FG000|Overall Study|Doctor's judgement|1|||
149007673|NCT00633932|537507890|FG001|Overall Study|Doctor's judgement|0|||
149007674|NCT00633932|537507891|FG002|Overall Study|Doctor's judgement|0|||
149007675|NCT00633932|537507889|FG000|Overall Study|Moved Away|1|||
149007676|NCT00633932|537507890|FG001|Overall Study|Moved Away|0|||
149007677|NCT00633932|537507891|FG002|Overall Study|Moved Away|0|||
149007678|NCT00482274|537507892|FG000|Overall Study|Adverse Event|1|||
149007679|NCT04836858|537507893|FG000|Overall Study|Adverse Event|0|||
149007680|NCT04836858|537507894|FG001|Overall Study|Adverse Event|0|||
149007681|NCT04836858|537507895|FG002|Overall Study|Adverse Event|0|||
149007682|NCT04836858|537507896|FG003|Overall Study|Adverse Event|1|||
149007683|NCT04836858|537507893|FG000|Overall Study|Lost to Follow-up|1|||
149007684|NCT04836858|537507894|FG001|Overall Study|Lost to Follow-up|0|||
149007685|NCT04836858|537507895|FG002|Overall Study|Lost to Follow-up|0|||
149007686|NCT04836858|537507896|FG003|Overall Study|Lost to Follow-up|0|||
149007687|NCT04836858|537507893|FG000|Overall Study|Subject/Guardian decision|3|||
149007688|NCT04836858|537507894|FG001|Overall Study|Subject/Guardian decision|0|||
149007689|NCT04836858|537507895|FG002|Overall Study|Subject/Guardian decision|0|||
149007690|NCT04836858|537507896|FG003|Overall Study|Subject/Guardian decision|1|||
149007691|NCT04836858|537507893|FG000|Overall Study|Randomized but not treated|4|||
149007692|NCT04836858|537507894|FG001|Overall Study|Randomized but not treated|0|||
149007693|NCT04836858|537507895|FG002|Overall Study|Randomized but not treated|0|||
149007694|NCT04836858|537507896|FG003|Overall Study|Randomized but not treated|0|||
149007695|NCT04887948|537507900|FG000|Overall Study|Death|1|||
149007696|NCT04887948|537507901|FG001|Overall Study|Death|0|||
149007697|NCT04887948|537507902|FG002|Overall Study|Death|0|||
149007698|NCT04887948|537507900|FG000|Overall Study|Lost to Follow-up|1|||
149007699|NCT04887948|537507901|FG001|Overall Study|Lost to Follow-up|0|||
149007700|NCT04887948|537507902|FG002|Overall Study|Lost to Follow-up|3|||
149007701|NCT04887948|537507900|FG000|Overall Study|Physician Decision|0|||
149007702|NCT04887948|537507901|FG001|Overall Study|Physician Decision|4|||
148780620|NCT00316914|536671559|FG001|Overall Study|Other Problems|11|||
149007703|NCT04887948|537507902|FG002|Overall Study|Physician Decision|1|||
149007704|NCT04887948|537507900|FG000|Overall Study|Protocol Violation|1|||
149007705|NCT04887948|537507901|FG001|Overall Study|Protocol Violation|1|||
149007706|NCT04887948|537507902|FG002|Overall Study|Protocol Violation|0|||
149007707|NCT04887948|537507900|FG000|Overall Study|Withdrawal by Subject|0|||
149007708|NCT04887948|537507901|FG001|Overall Study|Withdrawal by Subject|6|||
149007709|NCT04887948|537507902|FG002|Overall Study|Withdrawal by Subject|1|||
149007710|NCT04887948|537507900|FG000|Overall Study|No longer met eligibility criteria|1|||
149007711|NCT04887948|537507901|FG001|Overall Study|No longer met eligibility criteria|2|||
149007712|NCT04887948|537507902|FG002|Overall Study|No longer met eligibility criteria|1|||
149007713|NCT04887948|537507900|FG000|Overall Study|Other|2|||
149007714|NCT04887948|537507901|FG001|Overall Study|Other|1|||
149007715|NCT04887948|537507902|FG002|Overall Study|Other|1|||
149007716|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
149007717|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
149007718|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Adverse Event|2|||
149007719|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Adverse Event|5|||
149007720|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
149007721|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
149007722|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
149007723|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
149007724|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Randomized by error|0|||
149007725|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Randomized by error|5|||
149007726|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
149007727|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
149007728|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
149007729|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
149007730|NCT02948959|537507903|FG000|52 Weeks Treatment Period|Change of residence location|0|||
149007731|NCT02948959|537507904|FG001|52 Weeks Treatment Period|Change of residence location|1|||
149007732|NCT02948959|537507903|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
149007733|NCT02948959|537507904|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
149007734|NCT02948959|537507903|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
149007735|NCT02948959|537507904|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
149007736|NCT02948959|537507903|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
149007737|NCT02948959|537507904|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
149007738|NCT02948959|537507903|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
149007739|NCT02948959|537507904|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
149007740|NCT02948959|537507903|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
149007741|NCT02948959|537507904|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
149007742|NCT02948959|537507903|FG000|12 Weeks Follow-up Period|Study site closure|1|||
149007743|NCT02948959|537507904|FG001|12 Weeks Follow-up Period|Study site closure|0|||
149007744|NCT00787319|537507905|FG000|Overall Study|Lost to Follow-up|2|||
149007745|NCT00787319|537507905|FG000|Overall Study|Withdrawal by Subject|15|||
149007746|NCT00787319|537507905|FG000|Overall Study|Adverse Event|3|||
149007747|NCT00787319|537507905|FG000|Overall Study|Objective progression or relapse|30|||
149007748|NCT00787319|537507905|FG000|Overall Study|Lack of Efficacy|1|||
149007749|NCT00787319|537507905|FG000|Overall Study|Budget exhausted/exceeded|1|||
149007750|NCT00787319|537507905|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
149007751|NCT00787319|537507905|FG000|Overall Study|No health insurance reimbursement|2|||
149007752|NCT00787319|537507905|FG000|Overall Study|Stabilized disease findings|3|||
149007753|NCT00787319|537507905|FG000|Overall Study|Inactive disease|5|||
149007754|NCT02312856|537507906|FG000|Overall Study|Death|1|||
149007755|NCT02312856|537507906|FG000|Overall Study|Lost to Follow-up|3|||
149007756|NCT01932294|537507907|FG000|Overall Study|Death|43|||
149007757|NCT01932294|537507907|FG000|Overall Study|Lost to Follow-up|8|||
149007758|NCT01932294|537507907|FG000|Overall Study|VAD Implantation|20|||
149007759|NCT01932294|537507907|FG000|Overall Study|Heart Transplantation|16|||
149007760|NCT01932294|537507907|FG000|Overall Study|Transferred to other hospitals|12|||
149007761|NCT04415151|537507908|FG000|Overall Study|Death|1|||
149007762|NCT04415151|537507909|FG001|Overall Study|Death|1|||
149007763|NCT04415151|537507908|FG000|Overall Study|Withdrawal by Subject|1|||
149007764|NCT04415151|537507909|FG001|Overall Study|Withdrawal by Subject|0|||
149007765|NCT00409786|537507913|FG000|Overall Study|Withdrawal by Subject|3|||
149007766|NCT00638235|537507914|FG000|Overall Study|Lost to Follow-up|31|||
149007767|NCT00638235|537507915|FG001|Overall Study|Lost to Follow-up|3|||
149007768|NCT00638235|537507916|FG002|Overall Study|Lost to Follow-up|18|||
149007769|NCT00638235|537507917|FG003|Overall Study|Lost to Follow-up|10|||
149007770|NCT00638235|537507918|FG004|Overall Study|Lost to Follow-up|13|||
149007771|NCT00638235|537507919|FG005|Overall Study|Lost to Follow-up|26|||
149007772|NCT00638235|537507920|FG006|Overall Study|Lost to Follow-up|0|||
149007773|NCT00638235|537507921|FG007|Overall Study|Lost to Follow-up|1|||
149007774|NCT00638235|537507922|FG008|Overall Study|Lost to Follow-up|18|||
149007775|NCT03075904|537507927|FG000|Overall Study|Physician Decision|3|||
149007776|NCT03075904|537507927|FG000|Overall Study|Need for Medication not Permitted|1|||
149007777|NCT00597714|537507928|FG000|Overall Study|Death|56|||
149007778|NCT00597714|537507929|FG001|Overall Study|Death|46|||
149007779|NCT00597714|537507930|FG002|Overall Study|Death|0|||
149007780|NCT00597714|537507928|FG000|Overall Study|Recipient death|0|||
149007781|NCT00597714|537507929|FG001|Overall Study|Recipient death|0|||
149007782|NCT00597714|537507930|FG002|Overall Study|Recipient death|10|||
149007783|NCT01350141|537507931|FG000|Overall Study|Lost to Follow-up|1|||
149007784|NCT01350141|537507932|FG001|Overall Study|Lost to Follow-up|0|||
149007785|NCT01350141|537507933|FG002|Overall Study|Lost to Follow-up|1|||
149007786|NCT01350141|537507931|FG000|Overall Study|Withdrawal by Subject|1|||
149007787|NCT01350141|537507932|FG001|Overall Study|Withdrawal by Subject|0|||
149007788|NCT01350141|537507933|FG002|Overall Study|Withdrawal by Subject|0|||
149007789|NCT01350141|537507931|FG000|Overall Study|Randomized but not treated|1|||
149007790|NCT01350141|537507932|FG001|Overall Study|Randomized but not treated|0|||
149007791|NCT01350141|537507933|FG002|Overall Study|Randomized but not treated|0|||
149007792|NCT00810082|537507934|FG000|Overall Study|Lost to Follow-up|0|||
149007793|NCT00810082|537507935|FG001|Overall Study|Lost to Follow-up|4|||
149007794|NCT01588990|537507936|FG000|Phase A|Withdrawal by Subject|5|||
149007795|NCT01588990|537507936|FG000|Phase A|Physician Decision|11|||
149007796|NCT01588990|537507936|FG000|Phase A|Other|14|||
149007797|NCT01588990|537507936|FG000|Phase A|Lost to Follow-up|1|||
149007798|NCT01588990|537507936|FG000|Phase A|Death|5|||
149007799|NCT01588990|537507936|FG000|Phase A|Adverse Event|28|||
149007800|NCT01588990|537507936|FG000|Phase A|Still on therapy at end of study|6|||
149007801|NCT01588990|537507936|FG000|Phase B|Adverse Event|2|||
149007802|NCT01588990|537507936|FG000|Phase B|Still on therapy at end of study|5|||
148780621|NCT00316914|536671558|FG000|Overall Study|Missing end of treatment documentation|14|||
148780622|NCT00316914|536671559|FG001|Overall Study|Missing end of treatment documentation|15|||
148780623|NCT01675154|536671560|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
148780624|NCT01675154|536671561|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
148780625|NCT01675154|536671562|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
148780626|NCT01675154|536671563|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
148780627|NCT02971800|536671564|FG000|Overall Study|Protocol Violation|1|||
148780628|NCT02971800|536671564|FG000|Overall Study|Withdrawal by Subject|1|||
148780629|NCT02971800|536671564|FG000|Overall Study|Exclusion criteria prior intervention|1|||
148780630|NCT02971800|536671564|FG000|Overall Study|Number evaluable participant already reached|4|||
148780631|NCT05323994|536671565|FG000|Overall Study|Protocol Violation|1|||
148780632|NCT01149421|536671567|FG000|Overall Study|Adverse Event|22|||
148780633|NCT01149421|536671568|FG001|Overall Study|Adverse Event|6|||
148780634|NCT01149421|536671569|FG002|Overall Study|Adverse Event|11|||
148780635|NCT01149421|536671567|FG000|Overall Study|Withdrawal by Subject|20|||
148780636|NCT01149421|536671568|FG001|Overall Study|Withdrawal by Subject|12|||
148780637|NCT01149421|536671569|FG002|Overall Study|Withdrawal by Subject|13|||
148780638|NCT01149421|536671567|FG000|Overall Study|Sponsor Decision|0|||
148780639|NCT01149421|536671568|FG001|Overall Study|Sponsor Decision|1|||
148780640|NCT01149421|536671569|FG002|Overall Study|Sponsor Decision|1|||
148780641|NCT01149421|536671567|FG000|Overall Study|Lost to Follow-up|2|||
148780642|NCT01149421|536671568|FG001|Overall Study|Lost to Follow-up|4|||
148780643|NCT01149421|536671569|FG002|Overall Study|Lost to Follow-up|5|||
148780644|NCT01149421|536671567|FG000|Overall Study|Physician Decision|5|||
148780645|NCT01149421|536671568|FG001|Overall Study|Physician Decision|3|||
148780646|NCT01149421|536671569|FG002|Overall Study|Physician Decision|6|||
148780647|NCT01149421|536671567|FG000|Overall Study|Entry Criteria Not Met|1|||
148780648|NCT01149421|536671568|FG001|Overall Study|Entry Criteria Not Met|1|||
148780649|NCT01149421|536671569|FG002|Overall Study|Entry Criteria Not Met|2|||
148780650|NCT01149421|536671567|FG000|Overall Study|Protocol Violation|2|||
148780651|NCT01149421|536671568|FG001|Overall Study|Protocol Violation|2|||
148780652|NCT01149421|536671569|FG002|Overall Study|Protocol Violation|6|||
148780653|NCT03738800|536671575|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
148780654|NCT03738800|536671576|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
148780655|NCT03738800|536671577|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
148780656|NCT03738800|536671575|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
149007803|NCT01588990|537507936|FG000|Phase B|Withdrawal by Subject|3|||
149007804|NCT01588990|537507936|FG000|Phase B|Physician Decision|4|||
149007805|NCT01588990|537507936|FG000|Phase B|Other|2|||
149007806|NCT02367716|537507939|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
148780657|NCT03738800|536671576|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
148780658|NCT03738800|536671577|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
148780659|NCT03738800|536671575|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
148780660|NCT03738800|536671576|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
148780661|NCT03738800|536671577|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
148780662|NCT00766467|536671579|FG000|Overall Study|Withdrawal by Subject|7|||
148780663|NCT00766467|536671580|FG001|Overall Study|Withdrawal by Subject|2|||
149007807|NCT01473381|537507940|FG000|Overall Study|Adverse Event|8|||
149007808|NCT01473381|537507941|FG001|Overall Study|Adverse Event|20|||
149007809|NCT01473381|537507942|FG002|Overall Study|Adverse Event|25|||
149007810|NCT01473381|537507943|FG003|Overall Study|Adverse Event|17|||
148780664|NCT00766467|536671579|FG000|Overall Study|Adverse Event|1|||
148780665|NCT00766467|536671580|FG001|Overall Study|Adverse Event|1|||
148780666|NCT00766467|536671579|FG000|Overall Study|Protocol Violation|2|||
148780667|NCT00766467|536671580|FG001|Overall Study|Protocol Violation|4|||
148780668|NCT00766467|536671579|FG000|Overall Study|Tumor Progression on Study|0|||
148780669|NCT00766467|536671580|FG001|Overall Study|Tumor Progression on Study|1|||
148780670|NCT00766467|536671579|FG000|Overall Study|Physician Decision|1|||
148780671|NCT00766467|536671580|FG001|Overall Study|Physician Decision|0|||
148780672|NCT02223819|536671583|FG000|Overall Study|Lost to Follow-up|2|||
148780673|NCT01917344|536671585|FG000|Overall Study|Withdrawal by Subject|1|||
148780674|NCT02956057|536671586|FG000|Overall Study|Discontinued intervention|14|||
148780675|NCT02956057|536671587|FG001|Overall Study|Discontinued intervention|10|||
148780676|NCT02956057|536671588|FG002|Overall Study|Discontinued intervention|7|||
148780677|NCT02956057|536671589|FG003|Overall Study|Discontinued intervention|14|||
148780678|NCT02956057|536671590|FG004|Overall Study|Discontinued intervention|4|||
148780679|NCT02956057|536671591|FG005|Overall Study|Discontinued intervention|17|||
148780680|NCT02956057|536671586|FG000|Overall Study|Lost to Follow-up|0|||
148780681|NCT02956057|536671587|FG001|Overall Study|Lost to Follow-up|2|||
148780682|NCT02956057|536671588|FG002|Overall Study|Lost to Follow-up|1|||
148780683|NCT02956057|536671589|FG003|Overall Study|Lost to Follow-up|1|||
148780684|NCT02956057|536671590|FG004|Overall Study|Lost to Follow-up|1|||
148780685|NCT02956057|536671591|FG005|Overall Study|Lost to Follow-up|0|||
148780686|NCT00426660|536671594|FG000|Overall Study|Death|14|||
148780687|NCT00426660|536671594|FG000|Overall Study|Adverse Event|23|||
148780688|NCT00426660|536671594|FG000|Overall Study|Insufficient Clinical Response|22|||
148780689|NCT00426660|536671594|FG000|Overall Study|Lost to Follow-up|15|||
148780690|NCT00426660|536671594|FG000|Overall Study|Other|23|||
148780691|NCT00426660|536671594|FG000|Overall Study|Withdrawal by Subject|18|||
148780692|NCT00426660|536671594|FG000|Overall Study|Protocol Violation|1|||
148780693|NCT00426660|536671594|FG000|Overall Study|Enrolled Not Treated|15|||
148780694|NCT00980174|536671595|FG000|Overall Study|Withdrawal by Subject|1|||
148780695|NCT00980174|536671596|FG001|Overall Study|Withdrawal by Subject|4|||
148780696|NCT00980174|536671595|FG000|Overall Study|Adverse Event|0|||
148780697|NCT00980174|536671596|FG001|Overall Study|Adverse Event|3|||
148780698|NCT00980174|536671595|FG000|Overall Study|Ineligibility determined|2|||
148780699|NCT00980174|536671596|FG001|Overall Study|Ineligibility determined|1|||
148780700|NCT00980174|536671595|FG000|Overall Study|Death|1|||
148780701|NCT00980174|536671596|FG001|Overall Study|Death|1|||
148780702|NCT00980174|536671595|FG000|Overall Study|Other|0|||
148780703|NCT00980174|536671596|FG001|Overall Study|Other|1|||
148780704|NCT03769194|536671598|FG000|Overall Study|Withdrawal by Subject|0|||
148780705|NCT03769194|536671599|FG001|Overall Study|Withdrawal by Subject|7|||
148780706|NCT03769194|536671600|FG002|Overall Study|Withdrawal by Subject|4|||
148780707|NCT03769194|536671601|FG003|Overall Study|Withdrawal by Subject|1|||
148780708|NCT03769194|536671598|FG000|Overall Study|moved from study area|0|||
148780709|NCT03769194|536671599|FG001|Overall Study|moved from study area|2|||
148780710|NCT03769194|536671600|FG002|Overall Study|moved from study area|1|||
148780711|NCT03769194|536671601|FG003|Overall Study|moved from study area|1|||
148780712|NCT03769194|536671598|FG000|Overall Study|Lost to Follow-up|3|||
148780713|NCT03769194|536671599|FG001|Overall Study|Lost to Follow-up|6|||
148780714|NCT03769194|536671600|FG002|Overall Study|Lost to Follow-up|3|||
148780715|NCT03769194|536671601|FG003|Overall Study|Lost to Follow-up|6|||
148780716|NCT03769194|536671598|FG000|Overall Study|other|1|||
148780717|NCT03769194|536671599|FG001|Overall Study|other|3|||
148780718|NCT03769194|536671600|FG002|Overall Study|other|0|||
148780719|NCT03769194|536671601|FG003|Overall Study|other|1|||
148780720|NCT01133288|536671607|FG000|Eligibility Assessment|met exclusion criteria|5|||
149007811|NCT01473381|537507940|FG000|Overall Study|Insufficient Therapeutic Response|10|||
149007812|NCT01473381|537507941|FG001|Overall Study|Insufficient Therapeutic Response|1|||
149007813|NCT01473381|537507942|FG002|Overall Study|Insufficient Therapeutic Response|2|||
148780721|NCT01133288|536671607|FG000|Intervention Allocation|study terminated|2|||
148780722|NCT00551161|536671608|FG000|Overall Study|Withdrawal by Subject|1|||
148780723|NCT01672294|536671610|FG000|Overall Study|Withdrawal by Subject|4|||
148780724|NCT01672294|536671611|FG001|Overall Study|Withdrawal by Subject|4|||
148780725|NCT01672294|536671612|FG002|Overall Study|Withdrawal by Subject|4|||
148780726|NCT01672294|536671613|FG003|Overall Study|Withdrawal by Subject|4|||
148780727|NCT01672294|536671610|FG000|Overall Study|Excluded by study|1|||
148780728|NCT01672294|536671611|FG001|Overall Study|Excluded by study|1|||
148780729|NCT01672294|536671612|FG002|Overall Study|Excluded by study|0|||
148780730|NCT01672294|536671613|FG003|Overall Study|Excluded by study|0|||
148780731|NCT01672294|536671610|FG000|Overall Study|Lost to Follow-up|1|||
148780732|NCT01672294|536671611|FG001|Overall Study|Lost to Follow-up|16|||
148780733|NCT01672294|536671612|FG002|Overall Study|Lost to Follow-up|7|||
148780734|NCT01672294|536671613|FG003|Overall Study|Lost to Follow-up|9|||
149007814|NCT01473381|537507943|FG003|Overall Study|Insufficient Therapeutic Response|3|||
148780735|NCT04908475|536671614|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
148780736|NCT04908475|536671615|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148780737|NCT04908475|536671616|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148780738|NCT04908475|536671617|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148780739|NCT04908475|536671618|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148780740|NCT04908475|536671619|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148780741|NCT04908475|536671614|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
148780742|NCT04908475|536671615|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
148780743|NCT04908475|536671616|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
148780744|NCT04908475|536671617|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
148780745|NCT04908475|536671618|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
149007815|NCT01473381|537507940|FG000|Overall Study|Protocol Violation|17|||
149007816|NCT01473381|537507941|FG001|Overall Study|Protocol Violation|23|||
149007817|NCT01473381|537507942|FG002|Overall Study|Protocol Violation|19|||
149007818|NCT01473381|537507943|FG003|Overall Study|Protocol Violation|17|||
149007819|NCT01473381|537507940|FG000|Overall Study|Withdrawal of Consent|20|||
149007820|NCT01473381|537507941|FG001|Overall Study|Withdrawal of Consent|21|||
148780746|NCT04908475|536671619|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
148780747|NCT04908475|536671614|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
148780748|NCT04908475|536671615|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
148780749|NCT04908475|536671616|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
148780750|NCT04908475|536671617|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
148780751|NCT04908475|536671618|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
148780752|NCT04908475|536671619|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
148780753|NCT04908475|536671614|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
148780754|NCT04908475|536671615|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
148780755|NCT04908475|536671616|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
148780756|NCT04908475|536671617|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
148780757|NCT04908475|536671618|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
148780758|NCT04908475|536671619|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
148780759|NCT04908475|536671614|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
148780760|NCT04908475|536671615|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
148780761|NCT04908475|536671616|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
148780762|NCT04908475|536671617|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
148780763|NCT04908475|536671618|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
148780764|NCT04908475|536671619|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
148780765|NCT04908475|536671614|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
148780766|NCT04908475|536671615|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
148780767|NCT04908475|536671616|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
148780768|NCT04908475|536671617|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
148780769|NCT04908475|536671618|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
148780770|NCT04908475|536671619|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
148780771|NCT01870297|536671622|FG000|Overall Study|Adverse Event|0|||
148780772|NCT01870297|536671623|FG001|Overall Study|Adverse Event|0|||
148780773|NCT01870297|536671624|FG002|Overall Study|Adverse Event|0|||
148780774|NCT01870297|536671625|FG003|Overall Study|Adverse Event|0|||
148780775|NCT01870297|536671626|FG004|Overall Study|Adverse Event|2|||
148780776|NCT01870297|536671627|FG005|Overall Study|Adverse Event|0|||
148780777|NCT01870297|536671628|FG006|Overall Study|Adverse Event|0|||
148780778|NCT01870297|536671622|FG000|Overall Study|Lost to Follow-up|0|||
148780779|NCT01870297|536671623|FG001|Overall Study|Lost to Follow-up|1|||
148780780|NCT01870297|536671624|FG002|Overall Study|Lost to Follow-up|1|||
148780781|NCT01870297|536671625|FG003|Overall Study|Lost to Follow-up|0|||
148780782|NCT01870297|536671626|FG004|Overall Study|Lost to Follow-up|0|||
148780783|NCT01870297|536671627|FG005|Overall Study|Lost to Follow-up|0|||
148780784|NCT01870297|536671628|FG006|Overall Study|Lost to Follow-up|0|||
148780785|NCT01870297|536671622|FG000|Overall Study|Withdrawal by Subject|0|||
148780786|NCT01870297|536671623|FG001|Overall Study|Withdrawal by Subject|0|||
148780787|NCT01870297|536671624|FG002|Overall Study|Withdrawal by Subject|0|||
148780788|NCT01870297|536671625|FG003|Overall Study|Withdrawal by Subject|0|||
148780789|NCT01870297|536671626|FG004|Overall Study|Withdrawal by Subject|1|||
148780790|NCT01870297|536671627|FG005|Overall Study|Withdrawal by Subject|1|||
148893341|NCT00928486|537088673|FG000|Overall Study|Disease Progression|7|||
149007821|NCT01473381|537507942|FG002|Overall Study|Withdrawal of Consent|20|||
149007822|NCT01473381|537507943|FG003|Overall Study|Withdrawal of Consent|26|||
149007823|NCT01473381|537507940|FG000|Overall Study|Lost to Follow-up|25|||
149007824|NCT01473381|537507941|FG001|Overall Study|Lost to Follow-up|28|||
149007825|NCT01473381|537507942|FG002|Overall Study|Lost to Follow-up|35|||
149007826|NCT01473381|537507943|FG003|Overall Study|Lost to Follow-up|23|||
149007827|NCT01473381|537507940|FG000|Overall Study|Other Reasons|0|||
149007828|NCT01473381|537507941|FG001|Overall Study|Other Reasons|0|||
149007829|NCT01473381|537507942|FG002|Overall Study|Other Reasons|1|||
149007830|NCT01473381|537507943|FG003|Overall Study|Other Reasons|3|||
149007831|NCT02228395|537507944|FG000|First Intervention Period|No longer willing to participate|1|||
149007832|NCT02228395|537507945|FG001|First Intervention Period|No longer willing to participate|0|||
149007833|NCT02228395|537507946|FG002|First Intervention Period|No longer willing to participate|0|||
149007834|NCT02228395|537507944|FG000|First Intervention Period|Unable to comply with study dates|0|||
148780791|NCT01870297|536671628|FG006|Overall Study|Withdrawal by Subject|1|||
148780792|NCT01870297|536671622|FG000|Overall Study|Sponsor Decision|0|||
148780793|NCT01870297|536671623|FG001|Overall Study|Sponsor Decision|6|||
148780794|NCT01870297|536671624|FG002|Overall Study|Sponsor Decision|0|||
148780795|NCT01870297|536671625|FG003|Overall Study|Sponsor Decision|0|||
148780796|NCT01870297|536671626|FG004|Overall Study|Sponsor Decision|0|||
148780797|NCT01870297|536671627|FG005|Overall Study|Sponsor Decision|0|||
148780798|NCT01870297|536671628|FG006|Overall Study|Sponsor Decision|1|||
148780799|NCT01739764|536671629|FG000|Overall Study|Adverse Event|0|||
148780800|NCT01739764|536671630|FG001|Overall Study|Adverse Event|3|||
148780801|NCT01739764|536671631|FG002|Overall Study|Adverse Event|4|||
148780802|NCT01739764|536671629|FG000|Overall Study|Death|4|||
148780803|NCT01739764|536671630|FG001|Overall Study|Death|6|||
148780804|NCT01739764|536671631|FG002|Overall Study|Death|38|||
149007835|NCT02228395|537507945|FG001|First Intervention Period|Unable to comply with study dates|1|||
149007836|NCT02228395|537507946|FG002|First Intervention Period|Unable to comply with study dates|1|||
149007837|NCT01641926|537507952|FG000|Overall Study|Adverse Event|5|||
149007838|NCT01641926|537507953|FG001|Overall Study|Adverse Event|2|||
149007839|NCT01641926|537507954|FG002|Overall Study|Adverse Event|3|||
149007840|NCT01641926|537507955|FG003|Overall Study|Adverse Event|1|||
149007841|NCT01641926|537507952|FG000|Overall Study|Lost to Follow-up|2|||
149007842|NCT01641926|537507953|FG001|Overall Study|Lost to Follow-up|2|||
149007843|NCT01641926|537507954|FG002|Overall Study|Lost to Follow-up|1|||
149007844|NCT01641926|537507955|FG003|Overall Study|Lost to Follow-up|0|||
149007845|NCT01641926|537507952|FG000|Overall Study|Physician Decision|6|||
149007846|NCT01641926|537507953|FG001|Overall Study|Physician Decision|5|||
149007847|NCT01641926|537507954|FG002|Overall Study|Physician Decision|0|||
149007848|NCT01641926|537507955|FG003|Overall Study|Physician Decision|1|||
149007849|NCT01641926|537507952|FG000|Overall Study|Protocol Violation|1|||
149007850|NCT01641926|537507953|FG001|Overall Study|Protocol Violation|0|||
149007851|NCT01641926|537507954|FG002|Overall Study|Protocol Violation|0|||
149007852|NCT01641926|537507955|FG003|Overall Study|Protocol Violation|1|||
149007853|NCT01641926|537507952|FG000|Overall Study|Withdrawal by Subject|13|||
149007854|NCT01641926|537507953|FG001|Overall Study|Withdrawal by Subject|5|||
149007855|NCT01641926|537507954|FG002|Overall Study|Withdrawal by Subject|6|||
149007856|NCT01641926|537507955|FG003|Overall Study|Withdrawal by Subject|1|||
149007857|NCT01641926|537507952|FG000|Overall Study|Not Treated|1|||
149007858|NCT01641926|537507953|FG001|Overall Study|Not Treated|1|||
149007859|NCT01641926|537507954|FG002|Overall Study|Not Treated|1|||
149007860|NCT01641926|537507955|FG003|Overall Study|Not Treated|0|||
148780805|NCT01739764|536671629|FG000|Overall Study|Lost to Follow-up|0|||
148780806|NCT01739764|536671630|FG001|Overall Study|Lost to Follow-up|0|||
148780807|NCT01739764|536671631|FG002|Overall Study|Lost to Follow-up|5|||
148780808|NCT01739764|536671629|FG000|Overall Study|Non-Compliance|0|||
148780809|NCT01739764|536671630|FG001|Overall Study|Non-Compliance|0|||
148780810|NCT01739764|536671631|FG002|Overall Study|Non-Compliance|1|||
148780811|NCT01739764|536671629|FG000|Overall Study|Multiple Reasons|3|||
148780812|NCT01739764|536671630|FG001|Overall Study|Multiple Reasons|2|||
148780813|NCT01739764|536671631|FG002|Overall Study|Multiple Reasons|3|||
148780814|NCT01739764|536671629|FG000|Overall Study|Physician Decision|2|||
148780815|NCT01739764|536671630|FG001|Overall Study|Physician Decision|2|||
148780816|NCT01739764|536671631|FG002|Overall Study|Physician Decision|4|||
148780817|NCT01739764|536671629|FG000|Overall Study|Progressive Disease|3|||
148780818|NCT01739764|536671630|FG001|Overall Study|Progressive Disease|5|||
148780819|NCT01739764|536671631|FG002|Overall Study|Progressive Disease|16|||
148780820|NCT01739764|536671629|FG000|Overall Study|Protocol Violation|0|||
148780821|NCT01739764|536671630|FG001|Overall Study|Protocol Violation|0|||
148780822|NCT01739764|536671631|FG002|Overall Study|Protocol Violation|2|||
148780823|NCT01739764|536671629|FG000|Overall Study|Study Terminated by Sponsor|8|||
148780824|NCT01739764|536671630|FG001|Overall Study|Study Terminated by Sponsor|13|||
148780825|NCT01739764|536671631|FG002|Overall Study|Study Terminated by Sponsor|26|||
148780826|NCT01739764|536671629|FG000|Overall Study|Withdrawal by Subject|6|||
148780827|NCT01739764|536671630|FG001|Overall Study|Withdrawal by Subject|5|||
148780828|NCT01739764|536671631|FG002|Overall Study|Withdrawal by Subject|27|||
148780829|NCT00337779|536671632|FG000|Overall Study|Withdrawal by Subject|10|||
148780830|NCT00337779|536671633|FG001|Overall Study|Withdrawal by Subject|12|||
148780831|NCT00337779|536671632|FG000|Overall Study|Sponsor decision|1|||
149007861|NCT01691521|537507956|FG000|Overall Study|Adverse Event|4|||
149007862|NCT01691521|537507957|FG001|Overall Study|Adverse Event|0|||
149007863|NCT01691521|537507958|FG002|Overall Study|Adverse Event|1|||
149007864|NCT01691521|537507956|FG000|Overall Study|Lack of Efficacy|1|||
148780832|NCT00337779|536671633|FG001|Overall Study|Sponsor decision|1|||
148780833|NCT00337779|536671632|FG000|Overall Study|Physician Decision|3|||
148780834|NCT00337779|536671633|FG001|Overall Study|Physician Decision|6|||
148780835|NCT00337779|536671632|FG000|Overall Study|Protocol Violation|1|||
148780836|NCT00337779|536671633|FG001|Overall Study|Protocol Violation|1|||
148780837|NCT00337779|536671632|FG000|Overall Study|Lost to Follow-up|6|||
148780838|NCT00337779|536671633|FG001|Overall Study|Lost to Follow-up|5|||
148780839|NCT00337779|536671632|FG000|Overall Study|Adverse Event|28|||
149007865|NCT01691521|537507957|FG001|Overall Study|Lack of Efficacy|1|||
149007866|NCT01691521|537507958|FG002|Overall Study|Lack of Efficacy|2|||
149007867|NCT01691521|537507956|FG000|Overall Study|Protocol Violation|0|||
149007868|NCT01691521|537507957|FG001|Overall Study|Protocol Violation|3|||
149007869|NCT01691521|537507958|FG002|Overall Study|Protocol Violation|0|||
149007870|NCT01691521|537507956|FG000|Overall Study|Lost to Follow-up|0|||
149007871|NCT01691521|537507957|FG001|Overall Study|Lost to Follow-up|2|||
149007872|NCT01691521|537507958|FG002|Overall Study|Lost to Follow-up|2|||
149007873|NCT01691521|537507956|FG000|Overall Study|Physician Decision|2|||
149007874|NCT01691521|537507957|FG001|Overall Study|Physician Decision|1|||
149007875|NCT01691521|537507958|FG002|Overall Study|Physician Decision|0|||
149007876|NCT01691521|537507956|FG000|Overall Study|Withdrawal by Subject|5|||
149007877|NCT01691521|537507957|FG001|Overall Study|Withdrawal by Subject|9|||
149007878|NCT01691521|537507958|FG002|Overall Study|Withdrawal by Subject|4|||
149007879|NCT02343003|537507959|FG000|Overall Study|Withdrawal by Subject|9|||
149007880|NCT02343003|537507960|FG001|Overall Study|Withdrawal by Subject|4|||
149007881|NCT02343003|537507959|FG000|Overall Study|Lost to Follow-up|5|||
149007882|NCT02343003|537507960|FG001|Overall Study|Lost to Follow-up|1|||
149007883|NCT02343003|537507959|FG000|Overall Study|Protocol Violation|1|||
149007884|NCT02343003|537507960|FG001|Overall Study|Protocol Violation|0|||
149007885|NCT02343003|537507959|FG000|Overall Study|Death|0|||
149007886|NCT02343003|537507960|FG001|Overall Study|Death|1|||
149007887|NCT02343003|537507959|FG000|Overall Study|exclusion criteria met|1|||
149007888|NCT02343003|537507960|FG001|Overall Study|exclusion criteria met|1|||
149007889|NCT02343003|537507959|FG000|Overall Study|terminated by sponsor|2|||
148780840|NCT00337779|536671633|FG001|Overall Study|Adverse Event|51|||
148780841|NCT00337779|536671632|FG000|Overall Study|Pregnancy|3|||
148780842|NCT00337779|536671633|FG001|Overall Study|Pregnancy|2|||
148780843|NCT00337779|536671632|FG000|Overall Study|Death|0|||
148780844|NCT00337779|536671633|FG001|Overall Study|Death|1|||
148780845|NCT00404924|536671634|FG000|Overall Study|Adverse Event|75|||
148780846|NCT00404924|536671635|FG001|Overall Study|Adverse Event|16|||
148780847|NCT00404924|536671634|FG000|Overall Study|Condition under investigation worsened|475|||
148780848|NCT00404924|536671635|FG001|Overall Study|Condition under investigation worsened|264|||
148780849|NCT00404924|536671634|FG000|Overall Study|Lost to Follow-up|1|||
148780850|NCT00404924|536671635|FG001|Overall Study|Lost to Follow-up|1|||
148780851|NCT00404924|536671634|FG000|Overall Study|Withdrawal by Subject|26|||
148780852|NCT00404924|536671635|FG001|Overall Study|Withdrawal by Subject|13|||
148780853|NCT00404924|536671634|FG000|Overall Study|Other|25|||
148780854|NCT00404924|536671635|FG001|Overall Study|Other|11|||
148780855|NCT00404924|536671634|FG000|Overall Study|Randomised but not received treatment|1|||
148780856|NCT00404924|536671635|FG001|Overall Study|Randomised but not received treatment|1|||
148780857|NCT03008278|536671642|FG000|Overall Study|Progressive Disease|0|||
148780858|NCT03008278|536671643|FG001|Overall Study|Progressive Disease|0|||
148780859|NCT03008278|536671644|FG002|Overall Study|Progressive Disease|32|||
148780860|NCT03008278|536671642|FG000|Overall Study|Adverse Event|0|||
148780861|NCT03008278|536671643|FG001|Overall Study|Adverse Event|0|||
148780862|NCT03008278|536671644|FG002|Overall Study|Adverse Event|4|||
148780863|NCT03008278|536671642|FG000|Overall Study|Withdrawal by Subject|0|||
148780864|NCT03008278|536671643|FG001|Overall Study|Withdrawal by Subject|0|||
148780865|NCT03008278|536671644|FG002|Overall Study|Withdrawal by Subject|3|||
148780866|NCT03008278|536671642|FG000|Overall Study|Physician Decision|0|||
148780867|NCT03008278|536671643|FG001|Overall Study|Physician Decision|2|||
148780868|NCT03008278|536671644|FG002|Overall Study|Physician Decision|0|||
148780869|NCT01074255|536671645|FG000|Overall Study|Did not receive EMEND|2|||
148780870|NCT00422422|536671646|FG000|Overall Study|Lack of Efficacy|1|||
148780871|NCT00422422|536671646|FG000|Overall Study|Protocol Violation|1|||
148780872|NCT00422422|536671646|FG000|Overall Study|Withdrawal by Subject|2|||
148780873|NCT00422422|536671646|FG000|Overall Study|SAE, non-fatal|1|||
148780874|NCT00422422|536671646|FG000|Overall Study|AE, non-serious non-fatal|5|||
148780875|NCT01389258|536671647|FG000|Overall Study|Lost to Follow-up|5|||
148780876|NCT02943785|536671649|FG000|Overall Study|Adverse Event|112|||
148780877|NCT02943785|536671650|FG001|Overall Study|Adverse Event|97|||
148780878|NCT02943785|536671649|FG000|Overall Study|Withdrawal by Subject|63|||
148780879|NCT02943785|536671650|FG001|Overall Study|Withdrawal by Subject|126|||
148780880|NCT02943785|536671649|FG000|Overall Study|Physician Decision|23|||
148780881|NCT02943785|536671650|FG001|Overall Study|Physician Decision|47|||
148780882|NCT02943785|536671649|FG000|Overall Study|Death|46|||
148780883|NCT02943785|536671650|FG001|Overall Study|Death|46|||
148780884|NCT02943785|536671649|FG000|Overall Study|Lost to Follow-up|1|||
149007890|NCT02343003|537507960|FG001|Overall Study|terminated by sponsor|0|||
148780885|NCT02943785|536671650|FG001|Overall Study|Lost to Follow-up|0|||
148780886|NCT02943785|536671649|FG000|Overall Study|Other|16|||
148780887|NCT02943785|536671650|FG001|Overall Study|Other|19|||
148780888|NCT02943785|536671649|FG000|Overall Study|Did not receive any study medication|21|||
148780889|NCT02943785|536671650|FG001|Overall Study|Did not receive any study medication|28|||
149007891|NCT03954743|537507961|FG000|Overall Study|Adverse Event|1|||
149007892|NCT03954743|537507962|FG001|Overall Study|Adverse Event|0|||
149007893|NCT03954743|537507961|FG000|Overall Study|Lost to Follow-up|6|||
149007894|NCT03954743|537507962|FG001|Overall Study|Lost to Follow-up|4|||
148780890|NCT03313310|536671651|FG000|Phase 2|Lost to Follow-up|4|||
148780891|NCT03313310|536671652|FG001|Phase 2|Lost to Follow-up|0|||
148780892|NCT03313310|536671651|FG000|Phase 3|Lost to Follow-up|0|||
148780893|NCT03313310|536671652|FG001|Phase 3|Lost to Follow-up|1|||
148780894|NCT01281956|536671653|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
148780895|NCT01281956|536671654|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
148780896|NCT03170609|536671655|FG000|Overall Study|Death|0|||
148780897|NCT03170609|536671656|FG001|Overall Study|Death|0|||
148780898|NCT03170609|536671657|FG002|Overall Study|Death|1|||
148780899|NCT03170609|536671658|FG003|Overall Study|Death|0|||
149007895|NCT03954743|537507961|FG000|Overall Study|Protocol Violation|1|||
149007896|NCT03954743|537507962|FG001|Overall Study|Protocol Violation|0|||
149007897|NCT03954743|537507961|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
149007898|NCT03954743|537507962|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
149007899|NCT03954743|537507961|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
149007900|NCT03954743|537507962|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149007901|NCT02281760|537507963|FG000|Overall Study|Withdrawal by Subject|1|||
149007902|NCT01725386|537507964|FG000|Overall Study|Death|84|||
149007903|NCT01725386|537507965|FG001|Overall Study|Death|40|||
149007904|NCT01725386|537507964|FG000|Overall Study|Lost to Follow-up|81|||
149007905|NCT01725386|537507965|FG001|Overall Study|Lost to Follow-up|6|||
149007906|NCT01725386|537507964|FG000|Overall Study|Withdrawal by Subject|10|||
149007907|NCT01725386|537507965|FG001|Overall Study|Withdrawal by Subject|0|||
149007908|NCT00879996|537507966|FG000|Overall Study|Lost to Follow-up|7|||
149007909|NCT00879996|537507967|FG001|Overall Study|Lost to Follow-up|6|||
149007910|NCT00879996|537507966|FG000|Overall Study|non-compliance|6|||
149007911|NCT00879996|537507967|FG001|Overall Study|non-compliance|4|||
149007912|NCT00879996|537507966|FG000|Overall Study|Physician Decision|1|||
148780900|NCT03170609|536671659|FG004|Overall Study|Death|0|||
148780901|NCT03170609|536671660|FG005|Overall Study|Death|0|||
148780902|NCT03170609|536671661|FG006|Overall Study|Death|0|||
148780903|NCT03170609|536671655|FG000|Overall Study|Withdrawal by Subject|1|||
148780904|NCT03170609|536671656|FG001|Overall Study|Withdrawal by Subject|2|||
148780905|NCT03170609|536671657|FG002|Overall Study|Withdrawal by Subject|0|||
148780906|NCT03170609|536671658|FG003|Overall Study|Withdrawal by Subject|0|||
148780907|NCT03170609|536671659|FG004|Overall Study|Withdrawal by Subject|0|||
148780908|NCT03170609|536671660|FG005|Overall Study|Withdrawal by Subject|0|||
148780909|NCT03170609|536671661|FG006|Overall Study|Withdrawal by Subject|1|||
148780910|NCT03170609|536671655|FG000|Overall Study|Lost to Follow-up|1|||
148780911|NCT03170609|536671656|FG001|Overall Study|Lost to Follow-up|0|||
149007913|NCT00879996|537507967|FG001|Overall Study|Physician Decision|2|||
149007914|NCT00879996|537507966|FG000|Overall Study|psychiatric problem|0|||
149007915|NCT00879996|537507967|FG001|Overall Study|psychiatric problem|1|||
149007916|NCT00879996|537507966|FG000|Overall Study|put on parole|1|||
149007917|NCT00879996|537507967|FG001|Overall Study|put on parole|0|||
149007918|NCT05375955|537507977|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
149007919|NCT05375955|537507978|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
148780912|NCT03170609|536671657|FG002|Overall Study|Lost to Follow-up|5|||
148780913|NCT03170609|536671658|FG003|Overall Study|Lost to Follow-up|2|||
148780914|NCT03170609|536671659|FG004|Overall Study|Lost to Follow-up|1|||
148780915|NCT03170609|536671660|FG005|Overall Study|Lost to Follow-up|1|||
148780916|NCT03170609|536671661|FG006|Overall Study|Lost to Follow-up|0|||
148780917|NCT03170609|536671655|FG000|Overall Study|Other|1|||
148780918|NCT03170609|536671656|FG001|Overall Study|Other|0|||
148780919|NCT03170609|536671657|FG002|Overall Study|Other|0|||
148780920|NCT03170609|536671658|FG003|Overall Study|Other|0|||
148780921|NCT03170609|536671659|FG004|Overall Study|Other|0|||
148780922|NCT03170609|536671660|FG005|Overall Study|Other|1|||
148780923|NCT03170609|536671661|FG006|Overall Study|Other|0|||
148780924|NCT01593254|536671663|FG000|Overall Study|Disease progression|2|||
148780925|NCT01593254|536671664|FG001|Overall Study|Disease progression|7|||
148780926|NCT01593254|536671663|FG000|Overall Study|Study drug toxicity|6|||
148780927|NCT01593254|536671664|FG001|Overall Study|Study drug toxicity|20|||
148780928|NCT01593254|536671663|FG000|Overall Study|Death|3|||
148780929|NCT01593254|536671664|FG001|Overall Study|Death|3|||
148780930|NCT01593254|536671663|FG000|Overall Study|AE unrelated to study drug|0|||
148780931|NCT01593254|536671664|FG001|Overall Study|AE unrelated to study drug|1|||
148780932|NCT01593254|536671663|FG000|Overall Study|participant request to discontinue study treatment|1|||
148780933|NCT01593254|536671664|FG001|Overall Study|participant request to discontinue study treatment|3|||
148780934|NCT01593254|536671663|FG000|Overall Study|participant withdrew consent|0|||
148780935|NCT01593254|536671664|FG001|Overall Study|participant withdrew consent|9|||
149007920|NCT05375955|537507979|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
149007921|NCT05375955|537507980|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
148780936|NCT01593254|536671663|FG000|Overall Study|lost to follow up|1|||
148780937|NCT01593254|536671664|FG001|Overall Study|lost to follow up|6|||
148780938|NCT01593254|536671663|FG000|Overall Study|maximum clinical benefit|1|||
148780939|NCT01593254|536671664|FG001|Overall Study|maximum clinical benefit|2|||
149007922|NCT05375955|537507981|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
149007923|NCT05375955|537507982|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
148780940|NCT01593254|536671663|FG000|Overall Study|Poor/non compliance|1|||
148780941|NCT01593254|536671664|FG001|Overall Study|Poor/non compliance|1|||
148780942|NCT01593254|536671663|FG000|Overall Study|Pregnancy|0|||
148780943|NCT01593254|536671664|FG001|Overall Study|Pregnancy|3|||
148780944|NCT01593254|536671663|FG000|Overall Study|participant no longer meets study criteria|1|||
148780945|NCT01593254|536671664|FG001|Overall Study|participant no longer meets study criteria|1|||
148780946|NCT01593254|536671663|FG000|Overall Study|Admin reason by sponsor|7|||
148780947|NCT01593254|536671664|FG001|Overall Study|Admin reason by sponsor|3|||
148780948|NCT01593254|536671663|FG000|Overall Study|Imatinib treatment failure|2|||
148780949|NCT01593254|536671664|FG001|Overall Study|Imatinib treatment failure|0|||
148780950|NCT01593254|536671663|FG000|Overall Study|Other Reasons|61|||
148780951|NCT01593254|536671664|FG001|Overall Study|Other Reasons|115|||
148780952|NCT02918552|536671667|FG000|Overall Study|Failed Pharmacokinetics|1|||
148780953|NCT02918552|536671668|FG001|Overall Study|Failed Pharmacokinetics|0|||
148780954|NCT02918552|536671667|FG000|Overall Study|Withdrawal by Subject|0|||
148780955|NCT02918552|536671668|FG001|Overall Study|Withdrawal by Subject|1|||
148780956|NCT02918552|536671667|FG000|Overall Study|Lost to Follow-up|0|||
148780957|NCT02918552|536671668|FG001|Overall Study|Lost to Follow-up|1|||
148780958|NCT04395274|536671669|FG000|Overall Study|Lost to Follow-up|20|||
148780959|NCT04395274|536671670|FG001|Overall Study|Lost to Follow-up|11|||
148780960|NCT04395274|536671669|FG000|Overall Study|Withdrawal by Subject|13|||
148780961|NCT04395274|536671670|FG001|Overall Study|Withdrawal by Subject|10|||
148780962|NCT04395274|536671669|FG000|Overall Study|Moved Abroad|0|||
148780963|NCT04395274|536671670|FG001|Overall Study|Moved Abroad|1|||
148780964|NCT01592292|536671671|FG000|Overall Study|Follow-up loss|3|||
148780965|NCT01592292|536671672|FG001|Overall Study|Follow-up loss|3|||
148780966|NCT01592292|536671673|FG002|Overall Study|Follow-up loss|1|||
148780967|NCT01592292|536671674|FG003|Overall Study|Follow-up loss|0|||
148780968|NCT01592292|536671671|FG000|Overall Study|Withdrew consent|2|||
148780969|NCT01592292|536671672|FG001|Overall Study|Withdrew consent|1|||
148780970|NCT01592292|536671673|FG002|Overall Study|Withdrew consent|0|||
148780971|NCT01592292|536671674|FG003|Overall Study|Withdrew consent|0|||
148780972|NCT01592292|536671671|FG000|Overall Study|Other|1|||
148780973|NCT01592292|536671672|FG001|Overall Study|Other|1|||
148780974|NCT01592292|536671673|FG002|Overall Study|Other|2|||
148780975|NCT01592292|536671674|FG003|Overall Study|Other|1|||
148780976|NCT02680834|536671675|FG000|Overall Study|Physician Decision|5|||
148780977|NCT02680834|536671676|FG001|Overall Study|Physician Decision|2|||
148780978|NCT02680834|536671675|FG000|Overall Study|Withdrawal by Subject|6|||
148780979|NCT02680834|536671676|FG001|Overall Study|Withdrawal by Subject|0|||
148780980|NCT02680834|536671675|FG000|Overall Study|Lost to Follow-up|0|||
148780981|NCT02680834|536671676|FG001|Overall Study|Lost to Follow-up|1|||
149007924|NCT05375955|537507983|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
149007925|NCT05375955|537507977|FG000|Treatment (12 Weeks)|Physician Decision|4|||
149007926|NCT05375955|537507978|FG001|Treatment (12 Weeks)|Physician Decision|1|||
149007927|NCT05375955|537507979|FG002|Treatment (12 Weeks)|Physician Decision|3|||
149007928|NCT05375955|537507980|FG003|Treatment (12 Weeks)|Physician Decision|0|||
149007929|NCT05375955|537507981|FG004|Treatment (12 Weeks)|Physician Decision|0|||
149007930|NCT05375955|537507982|FG005|Treatment (12 Weeks)|Physician Decision|1|||
149007931|NCT05375955|537507983|FG006|Treatment (12 Weeks)|Physician Decision|0|||
149007932|NCT05375955|537507977|FG000|Treatment (12 Weeks)|Other|0|||
149007933|NCT05375955|537507978|FG001|Treatment (12 Weeks)|Other|1|||
149007934|NCT05375955|537507979|FG002|Treatment (12 Weeks)|Other|0|||
149007935|NCT05375955|537507980|FG003|Treatment (12 Weeks)|Other|0|||
149007936|NCT05375955|537507981|FG004|Treatment (12 Weeks)|Other|0|||
149007937|NCT05375955|537507982|FG005|Treatment (12 Weeks)|Other|0|||
149007938|NCT05375955|537507983|FG006|Treatment (12 Weeks)|Other|0|||
149007939|NCT05375955|537507977|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
149007940|NCT05375955|537507978|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
149007941|NCT05375955|537507979|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
149007942|NCT05375955|537507980|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
149007943|NCT05375955|537507981|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
149007944|NCT05375955|537507982|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
149007945|NCT05375955|537507983|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
149007946|NCT05375955|537507977|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
149007947|NCT05375955|537507978|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
149007948|NCT05375955|537507979|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
149007949|NCT05375955|537507980|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
149007950|NCT05375955|537507981|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
149007951|NCT05375955|537507982|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
148780982|NCT01362244|536671677|FG000|Overall Study|Adverse Event|3|||
148780983|NCT01362244|536671678|FG001|Overall Study|Adverse Event|5|||
148780984|NCT01362244|536671677|FG000|Overall Study|Lack of Efficacy|5|||
148780985|NCT01362244|536671678|FG001|Overall Study|Lack of Efficacy|11|||
148780986|NCT01362244|536671677|FG000|Overall Study|Lost to Follow-up|0|||
148780987|NCT01362244|536671678|FG001|Overall Study|Lost to Follow-up|2|||
148780988|NCT01362244|536671677|FG000|Overall Study|Protocol Violation|5|||
148780989|NCT01362244|536671678|FG001|Overall Study|Protocol Violation|1|||
148780990|NCT01362244|536671677|FG000|Overall Study|Withdrawal by Subject|2|||
148780991|NCT01362244|536671678|FG001|Overall Study|Withdrawal by Subject|1|||
148780992|NCT01362244|536671677|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
148780993|NCT01362244|536671678|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
148780994|NCT01362244|536671677|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
148780995|NCT01362244|536671678|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
148780996|NCT04438499|536671684|FG000|Overall Study|Lack of Efficacy|3|||
148780997|NCT02824562|536673477|FG000|Overall Study|Lost to Follow-up|3|||
148780998|NCT02824562|536673478|FG001|Overall Study|Lost to Follow-up|4|||
148780999|NCT02824562|536673477|FG000|Overall Study|Death|0|||
148781000|NCT02824562|536673478|FG001|Overall Study|Death|1|||
148781001|NCT02168777|536673479|FG000|Overall Study|Withdrawal by Subject|1|||
148781002|NCT02168777|536673480|FG001|Overall Study|Withdrawal by Subject|0|||
148781003|NCT02168777|536673481|FG002|Overall Study|Withdrawal by Subject|2|||
148781004|NCT02168777|536673479|FG000|Overall Study|Adverse Event|1|||
148781005|NCT02168777|536673480|FG001|Overall Study|Adverse Event|0|||
148781006|NCT02168777|536673481|FG002|Overall Study|Adverse Event|1|||
148781007|NCT02168777|536673479|FG000|Overall Study|Disease recurrence|0|||
148781008|NCT02168777|536673480|FG001|Overall Study|Disease recurrence|0|||
148781009|NCT02168777|536673481|FG002|Overall Study|Disease recurrence|1|||
148781010|NCT02168777|536673479|FG000|Overall Study|Radiological disease progression|0|||
148781011|NCT02168777|536673480|FG001|Overall Study|Radiological disease progression|5|||
148781012|NCT02168777|536673481|FG002|Overall Study|Radiological disease progression|5|||
148781013|NCT02168777|536673479|FG000|Overall Study|Clinical disease progression|0|||
148781014|NCT02168777|536673480|FG001|Overall Study|Clinical disease progression|1|||
148781015|NCT02168777|536673481|FG002|Overall Study|Clinical disease progression|2|||
148781016|NCT02168777|536673479|FG000|Overall Study|Other reason|0|||
148781017|NCT02168777|536673480|FG001|Overall Study|Other reason|1|||
148781018|NCT02168777|536673481|FG002|Overall Study|Other reason|0|||
148781019|NCT01663857|536673482|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
148781020|NCT01663857|536673483|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
148781021|NCT01663857|536673484|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
148781022|NCT01663857|536673485|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
148781023|NCT01663857|536673482|FG000|Overall Study|Lost to Follow-up|0|||
148781024|NCT01663857|536673483|FG001|Overall Study|Lost to Follow-up|0|||
148781025|NCT01663857|536673484|FG002|Overall Study|Lost to Follow-up|3|||
148781026|NCT01663857|536673485|FG003|Overall Study|Lost to Follow-up|1|||
148781027|NCT01709864|536673486|FG000|Overall Study|Physician Decision|0|||
148781028|NCT01709864|536673487|FG001|Overall Study|Physician Decision|1|||
148781029|NCT01709864|536673486|FG000|Overall Study|subject/guardian decision|5|||
148781030|NCT01709864|536673487|FG001|Overall Study|subject/guardian decision|6|||
148781031|NCT01709864|536673486|FG000|Overall Study|Lost to Follow-up|1|||
148781032|NCT01709864|536673487|FG001|Overall Study|Lost to Follow-up|0|||
148781033|NCT01709864|536673486|FG000|Overall Study|non-compliance with study treatment|1|||
148781034|NCT01709864|536673487|FG001|Overall Study|non-compliance with study treatment|1|||
148781035|NCT01709864|536673486|FG000|Overall Study|Adverse Event|0|||
148781036|NCT01709864|536673487|FG001|Overall Study|Adverse Event|2|||
148781037|NCT01709864|536673486|FG000|Overall Study|Death|0|||
148781038|NCT01709864|536673487|FG001|Overall Study|Death|1|||
148781039|NCT01172808|536673490|FG000|Overall Study|Adverse Event|8|||
148781040|NCT01172808|536673491|FG001|Overall Study|Adverse Event|4|||
148781041|NCT01172808|536673492|FG002|Overall Study|Adverse Event|8|||
148781042|NCT01172808|536673493|FG003|Overall Study|Adverse Event|3|||
148781043|NCT01172808|536673490|FG000|Overall Study|Lack of Efficacy|1|||
148781044|NCT01172808|536673491|FG001|Overall Study|Lack of Efficacy|0|||
148781045|NCT01172808|536673492|FG002|Overall Study|Lack of Efficacy|0|||
148781046|NCT01172808|536673493|FG003|Overall Study|Lack of Efficacy|0|||
148781047|NCT01172808|536673490|FG000|Overall Study|Protocol Violation|2|||
148781048|NCT01172808|536673491|FG001|Overall Study|Protocol Violation|2|||
148781049|NCT01172808|536673492|FG002|Overall Study|Protocol Violation|2|||
148781050|NCT01172808|536673493|FG003|Overall Study|Protocol Violation|0|||
148781051|NCT01172808|536673490|FG000|Overall Study|Lost to Follow-up|0|||
148781052|NCT01172808|536673491|FG001|Overall Study|Lost to Follow-up|1|||
148781053|NCT01172808|536673492|FG002|Overall Study|Lost to Follow-up|1|||
148781054|NCT01172808|536673493|FG003|Overall Study|Lost to Follow-up|3|||
148781055|NCT01172808|536673490|FG000|Overall Study|Withdrawal by Subject|4|||
148781056|NCT01172808|536673491|FG001|Overall Study|Withdrawal by Subject|1|||
148781057|NCT01172808|536673492|FG002|Overall Study|Withdrawal by Subject|3|||
148781058|NCT01172808|536673493|FG003|Overall Study|Withdrawal by Subject|2|||
148781059|NCT01172808|536673490|FG000|Overall Study|Other|6|||
148781060|NCT01172808|536673491|FG001|Overall Study|Other|5|||
148781061|NCT01172808|536673492|FG002|Overall Study|Other|9|||
148781062|NCT01172808|536673493|FG003|Overall Study|Other|7|||
148781063|NCT01066793|536673498|FG000|Overall Study|Death|4|||
148781064|NCT01066793|536673499|FG001|Overall Study|Death|1|||
148781065|NCT01066793|536673500|FG002|Overall Study|Death|1|||
148781066|NCT01066793|536673501|FG003|Overall Study|Death|0|||
149007952|NCT05375955|537507983|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
149007953|NCT05375955|537507977|FG000|Treatment (12 Weeks)|Pregnancy|0|||
149007954|NCT05375955|537507978|FG001|Treatment (12 Weeks)|Pregnancy|0|||
149007955|NCT05375955|537507979|FG002|Treatment (12 Weeks)|Pregnancy|1|||
149007956|NCT05375955|537507980|FG003|Treatment (12 Weeks)|Pregnancy|0|||
149007957|NCT05375955|537507981|FG004|Treatment (12 Weeks)|Pregnancy|0|||
149007958|NCT05375955|537507982|FG005|Treatment (12 Weeks)|Pregnancy|0|||
149007959|NCT05375955|537507983|FG006|Treatment (12 Weeks)|Pregnancy|0|||
149007960|NCT05375955|537507977|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
149007961|NCT05375955|537507978|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
149007962|NCT05375955|537507979|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
149007963|NCT05375955|537507980|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
149007964|NCT05375955|537507981|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
149007965|NCT05375955|537507982|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
149007966|NCT05375955|537507983|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
149007967|NCT05375955|537507977|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
149007968|NCT05375955|537507978|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
149007969|NCT05375955|537507979|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
149007970|NCT05375955|537507980|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
149007971|NCT05375955|537507981|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
149007972|NCT05375955|537507982|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
149007973|NCT05375955|537507983|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
149007974|NCT05375955|537507977|FG000|Follow-up (up to 5 Weeks)|Other|0|||
149007975|NCT05375955|537507978|FG001|Follow-up (up to 5 Weeks)|Other|1|||
149007976|NCT05375955|537507979|FG002|Follow-up (up to 5 Weeks)|Other|0|||
149007977|NCT05375955|537507980|FG003|Follow-up (up to 5 Weeks)|Other|0|||
149007978|NCT05375955|537507981|FG004|Follow-up (up to 5 Weeks)|Other|0|||
149007979|NCT05375955|537507982|FG005|Follow-up (up to 5 Weeks)|Other|0|||
149007980|NCT05375955|537507983|FG006|Follow-up (up to 5 Weeks)|Other|0|||
149007981|NCT05375955|537507977|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
149007982|NCT05375955|537507978|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
149007983|NCT05375955|537507979|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
149007984|NCT05375955|537507980|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
149007985|NCT05375955|537507981|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
149007986|NCT05375955|537507982|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
149007987|NCT05375955|537507983|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
149007988|NCT05375955|537507977|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
149007989|NCT05375955|537507978|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
149007990|NCT05375955|537507979|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
149007991|NCT05375955|537507980|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
149007992|NCT05375955|537507981|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
149007993|NCT05375955|537507982|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
149007994|NCT05375955|537507983|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
149007995|NCT05454410|537507984|FG000|Overall Study|Withdrawal by Subject|0|||
149007996|NCT05454410|537507985|FG001|Overall Study|Withdrawal by Subject|0|||
149007997|NCT05454410|537507986|FG002|Overall Study|Withdrawal by Subject|1|||
149007998|NCT05454410|537507987|FG003|Overall Study|Withdrawal by Subject|1|||
149007999|NCT03879408|537507997|FG000|Overall Study|Lost to Follow-up|0|||
149008000|NCT03879408|537507998|FG001|Overall Study|Lost to Follow-up|3|||
149008001|NCT03879408|537507999|FG002|Overall Study|Lost to Follow-up|2|||
149008002|NCT03879408|537508000|FG003|Overall Study|Lost to Follow-up|1|||
149008003|NCT03879408|537508001|FG004|Overall Study|Lost to Follow-up|0|||
149008004|NCT03879408|537507997|FG000|Overall Study|Withdrawal by Subject|2|||
149008005|NCT03879408|537507998|FG001|Overall Study|Withdrawal by Subject|1|||
149008006|NCT03879408|537507999|FG002|Overall Study|Withdrawal by Subject|1|||
149008007|NCT03879408|537508000|FG003|Overall Study|Withdrawal by Subject|0|||
149008008|NCT03879408|537508001|FG004|Overall Study|Withdrawal by Subject|1|||
149008009|NCT01320943|537508002|FG000|Overall Study|Lost to Follow-up|1|||
149008010|NCT01320943|537508003|FG001|Overall Study|Lost to Follow-up|0|||
149008011|NCT01320943|537508002|FG000|Overall Study|Physician Decision|0|||
149008012|NCT01320943|537508003|FG001|Overall Study|Physician Decision|1|||
149008013|NCT01320943|537508002|FG000|Overall Study|Randomized but not Treated|0|||
149008014|NCT01320943|537508003|FG001|Overall Study|Randomized but not Treated|1|||
149008015|NCT03489057|537508012|FG000|Overall Study|Lost to Follow-up|16|||
149008016|NCT03489057|537508013|FG001|Overall Study|Lost to Follow-up|16|||
149008017|NCT03489057|537508014|FG002|Overall Study|Lost to Follow-up|14|||
149008018|NCT03489057|537508015|FG003|Overall Study|Lost to Follow-up|14|||
149008019|NCT03489057|537508012|FG000|Overall Study|Withdrawal by Subject|12|||
149008020|NCT03489057|537508013|FG001|Overall Study|Withdrawal by Subject|12|||
149008021|NCT03489057|537508014|FG002|Overall Study|Withdrawal by Subject|8|||
149008022|NCT03489057|537508015|FG003|Overall Study|Withdrawal by Subject|8|||
149008023|NCT03489057|537508012|FG000|Overall Study|Protocol Violation|7|||
149008024|NCT03489057|537508013|FG001|Overall Study|Protocol Violation|7|||
149008025|NCT03489057|537508014|FG002|Overall Study|Protocol Violation|2|||
149008026|NCT03489057|537508015|FG003|Overall Study|Protocol Violation|2|||
149008027|NCT02034708|537508016|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
149008028|NCT02034708|537508017|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
149008029|NCT02034708|537508016|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
149008030|NCT02034708|537508017|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
149008031|NCT02034708|537508016|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
149008032|NCT02034708|537508017|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
149008033|NCT02034708|537508016|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
149008034|NCT02034708|537508017|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
149008035|NCT00654901|537508018|FG000|Overall Study|Lost to Follow-up|1|||
149008036|NCT00654901|537508019|FG001|Overall Study|Lost to Follow-up|0|||
149008037|NCT00654901|537508020|FG002|Overall Study|Lost to Follow-up|1|||
149008038|NCT00654901|537508021|FG003|Overall Study|Lost to Follow-up|0|||
149008039|NCT00654901|537508018|FG000|Overall Study|Withdrawal by Subject|3|||
149008040|NCT00654901|537508019|FG001|Overall Study|Withdrawal by Subject|0|||
149008041|NCT00654901|537508020|FG002|Overall Study|Withdrawal by Subject|1|||
149008042|NCT00654901|537508021|FG003|Overall Study|Withdrawal by Subject|0|||
149008043|NCT03324880|537508022|FG000|Overall Study|Adverse Event|0|||
149008044|NCT03324880|537508023|FG001|Overall Study|Adverse Event|2|||
149008045|NCT03324880|537508022|FG000|Overall Study|Withdrawal by Subject|2|||
149008046|NCT03324880|537508023|FG001|Overall Study|Withdrawal by Subject|2|||
149008047|NCT03324880|537508022|FG000|Overall Study|Lost to Follow-up|0|||
149008048|NCT03324880|537508023|FG001|Overall Study|Lost to Follow-up|1|||
149008049|NCT03324880|537508022|FG000|Overall Study|Product Recall|0|||
149008050|NCT03324880|537508023|FG001|Overall Study|Product Recall|1|||
149008051|NCT05076149|537508024|FG000|Overall Study|Adverse Event|3|||
149008052|NCT05076149|537508025|FG001|Overall Study|Adverse Event|9|||
149008053|NCT05076149|537508024|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
149008054|NCT05076149|537508025|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
149008055|NCT05076149|537508024|FG000|Overall Study|Lost to Follow-up|0|||
149008056|NCT05076149|537508025|FG001|Overall Study|Lost to Follow-up|1|||
149008057|NCT05076149|537508024|FG000|Overall Study|Commercial drug is available for participant|0|||
149008058|NCT05076149|537508025|FG001|Overall Study|Commercial drug is available for participant|1|||
149008059|NCT05076149|537508024|FG000|Overall Study|Other non compliance|1|||
149008060|NCT05076149|537508025|FG001|Overall Study|Other non compliance|1|||
149008061|NCT05076149|537508024|FG000|Overall Study|Physician Decision|0|||
149008062|NCT05076149|537508025|FG001|Overall Study|Physician Decision|1|||
149008063|NCT05076149|537508024|FG000|Overall Study|Other|5|||
149008064|NCT05076149|537508025|FG001|Overall Study|Other|4|||
149008065|NCT05096208|537508026|FG000|Overall Study|Lost to Follow-up|3|||
149008066|NCT05096208|537508027|FG001|Overall Study|Lost to Follow-up|5|||
149008067|NCT05096208|537508028|FG002|Overall Study|Lost to Follow-up|5|||
149008068|NCT05096208|537508029|FG003|Overall Study|Lost to Follow-up|2|||
149008069|NCT05096208|537508026|FG000|Overall Study|Withdrawal by Subject|0|||
149008070|NCT05096208|537508027|FG001|Overall Study|Withdrawal by Subject|1|||
149008071|NCT05096208|537508028|FG002|Overall Study|Withdrawal by Subject|2|||
149008072|NCT05096208|537508029|FG003|Overall Study|Withdrawal by Subject|3|||
149008073|NCT05096208|537508026|FG000|Overall Study|No longer met eligibility criteria|1|||
149008074|NCT05096208|537508027|FG001|Overall Study|No longer met eligibility criteria|0|||
149008075|NCT05096208|537508028|FG002|Overall Study|No longer met eligibility criteria|0|||
149008076|NCT05096208|537508029|FG003|Overall Study|No longer met eligibility criteria|0|||
149008077|NCT05096208|537508026|FG000|Overall Study|Other|0|||
149008078|NCT05096208|537508027|FG001|Overall Study|Other|0|||
149008079|NCT05096208|537508028|FG002|Overall Study|Other|1|||
149008080|NCT05096208|537508029|FG003|Overall Study|Other|0|||
149008081|NCT00782496|537508030|FG000|Overall Study|Lost to Follow-up|14|||
149008082|NCT00782496|537508031|FG001|Overall Study|Lost to Follow-up|15|||
149021100|NCT04423393|537557183|FG002|Overall Study|Withdrawal by Subject|0|||
149021101|NCT04423393|537557184|FG003|Overall Study|Withdrawal by Subject|0|||
149021102|NCT04423393|537557185|FG004|Overall Study|Withdrawal by Subject|0|||
149021103|NCT04423393|537557186|FG005|Overall Study|Withdrawal by Subject|1|||
149021104|NCT04423393|537557187|FG006|Overall Study|Withdrawal by Subject|0|||
149021105|NCT04423393|537557188|FG007|Overall Study|Withdrawal by Subject|0|||
149021106|NCT04423393|537557189|FG008|Overall Study|Withdrawal by Subject|0|||
149021107|NCT04423393|537557190|FG009|Overall Study|Withdrawal by Subject|0|||
149021108|NCT04423393|537557191|FG010|Overall Study|Withdrawal by Subject|0|||
149021109|NCT04423393|537557192|FG011|Overall Study|Withdrawal by Subject|0|||
149021110|NCT04423393|537557193|FG012|Overall Study|Withdrawal by Subject|0|||
149021111|NCT04423393|537557194|FG013|Overall Study|Withdrawal by Subject|1|||
149021112|NCT04423393|537557195|FG014|Overall Study|Withdrawal by Subject|0|||
149021113|NCT04423393|537557196|FG015|Overall Study|Withdrawal by Subject|0|||
149021114|NCT04423393|537557197|FG016|Overall Study|Withdrawal by Subject|0|||
149021115|NCT04423393|537557198|FG017|Overall Study|Withdrawal by Subject|0|||
149021116|NCT04423393|537557181|FG000|Overall Study|Sponsor Decision|0|||
149021117|NCT04423393|537557182|FG001|Overall Study|Sponsor Decision|0|||
149021118|NCT04423393|537557183|FG002|Overall Study|Sponsor Decision|0|||
149021119|NCT04423393|537557184|FG003|Overall Study|Sponsor Decision|0|||
148781067|NCT01066793|536673502|FG004|Overall Study|Death|0|||
148781068|NCT01066793|536673503|FG005|Overall Study|Death|0|||
148781069|NCT01066793|536673498|FG000|Overall Study|Lack of Efficacy|2|||
148781070|NCT01066793|536673499|FG001|Overall Study|Lack of Efficacy|1|||
148781071|NCT01066793|536673500|FG002|Overall Study|Lack of Efficacy|0|||
148781072|NCT01066793|536673501|FG003|Overall Study|Lack of Efficacy|0|||
148781073|NCT01066793|536673502|FG004|Overall Study|Lack of Efficacy|0|||
148781074|NCT01066793|536673503|FG005|Overall Study|Lack of Efficacy|0|||
148781075|NCT01066793|536673498|FG000|Overall Study|Lost to Follow-up|180|||
148781076|NCT01066793|536673499|FG001|Overall Study|Lost to Follow-up|39|||
148781077|NCT01066793|536673500|FG002|Overall Study|Lost to Follow-up|82|||
148781078|NCT01066793|536673501|FG003|Overall Study|Lost to Follow-up|16|||
148781079|NCT01066793|536673502|FG004|Overall Study|Lost to Follow-up|0|||
148781080|NCT01066793|536673503|FG005|Overall Study|Lost to Follow-up|1|||
148781081|NCT01066793|536673498|FG000|Overall Study|Physician Decision|3|||
148781082|NCT01066793|536673499|FG001|Overall Study|Physician Decision|0|||
148781083|NCT01066793|536673500|FG002|Overall Study|Physician Decision|0|||
148781084|NCT01066793|536673501|FG003|Overall Study|Physician Decision|0|||
148781085|NCT01066793|536673502|FG004|Overall Study|Physician Decision|0|||
148781086|NCT01066793|536673503|FG005|Overall Study|Physician Decision|0|||
148781087|NCT01066793|536673498|FG000|Overall Study|Protocol Violation|3|||
148781088|NCT01066793|536673499|FG001|Overall Study|Protocol Violation|2|||
148781089|NCT01066793|536673500|FG002|Overall Study|Protocol Violation|2|||
148781090|NCT01066793|536673501|FG003|Overall Study|Protocol Violation|0|||
148781091|NCT01066793|536673502|FG004|Overall Study|Protocol Violation|0|||
148781092|NCT01066793|536673503|FG005|Overall Study|Protocol Violation|0|||
148781093|NCT01066793|536673498|FG000|Overall Study|Withdrawal by Subject|7|||
148781094|NCT01066793|536673499|FG001|Overall Study|Withdrawal by Subject|4|||
148781095|NCT01066793|536673500|FG002|Overall Study|Withdrawal by Subject|1|||
148781096|NCT01066793|536673501|FG003|Overall Study|Withdrawal by Subject|0|||
148781097|NCT01066793|536673502|FG004|Overall Study|Withdrawal by Subject|0|||
148781098|NCT01066793|536673503|FG005|Overall Study|Withdrawal by Subject|0|||
148781099|NCT01066793|536673498|FG000|Overall Study|Early Termination|3|||
148781100|NCT01066793|536673499|FG001|Overall Study|Early Termination|0|||
148781101|NCT01066793|536673500|FG002|Overall Study|Early Termination|0|||
148781102|NCT01066793|536673501|FG003|Overall Study|Early Termination|0|||
148781103|NCT01066793|536673502|FG004|Overall Study|Early Termination|0|||
148781104|NCT01066793|536673503|FG005|Overall Study|Early Termination|0|||
148781105|NCT01066793|536673498|FG000|Overall Study|Lab test not done|7|||
148781106|NCT01066793|536673499|FG001|Overall Study|Lab test not done|0|||
148781107|NCT01066793|536673500|FG002|Overall Study|Lab test not done|0|||
148781108|NCT01066793|536673501|FG003|Overall Study|Lab test not done|1|||
148781109|NCT01066793|536673502|FG004|Overall Study|Lab test not done|0|||
148781110|NCT01066793|536673503|FG005|Overall Study|Lab test not done|0|||
148781111|NCT01066793|536673498|FG000|Overall Study|Miscellaneous|4|||
148781112|NCT01066793|536673499|FG001|Overall Study|Miscellaneous|5|||
148781113|NCT01066793|536673500|FG002|Overall Study|Miscellaneous|6|||
149008083|NCT00605319|537509994|FG000|Overall Study|Adverse Event|6|||
149008084|NCT02991482|537509995|FG000|Overall Study|Disease progression|56|||
149008085|NCT02991482|537509996|FG001|Overall Study|Disease progression|47|||
149008086|NCT02991482|537509995|FG000|Overall Study|Death|4|||
149008087|NCT02991482|537509996|FG001|Overall Study|Death|4|||
149008088|NCT02991482|537509995|FG000|Overall Study|Adverse Event|1|||
149008089|NCT02991482|537509996|FG001|Overall Study|Adverse Event|6|||
149008090|NCT02991482|537509995|FG000|Overall Study|Patient decision|1|||
149008091|NCT02991482|537509996|FG001|Overall Study|Patient decision|1|||
149008092|NCT02991482|537509995|FG000|Overall Study|Physician Decision|0|||
149008093|NCT02991482|537509996|FG001|Overall Study|Physician Decision|6|||
149008094|NCT02991482|537509995|FG000|Overall Study|Clinical deterioration|1|||
149008095|NCT02991482|537509996|FG001|Overall Study|Clinical deterioration|0|||
149008096|NCT02991482|537509995|FG000|Overall Study|Patient feeling too unwell|1|||
149008097|NCT02991482|537509996|FG001|Overall Study|Patient feeling too unwell|0|||
148781114|NCT01066793|536673501|FG003|Overall Study|Miscellaneous|0|||
148781115|NCT01066793|536673502|FG004|Overall Study|Miscellaneous|0|||
148781116|NCT01066793|536673503|FG005|Overall Study|Miscellaneous|0|||
148781117|NCT01066793|536673498|FG000|Overall Study|Non-responders|104|||
148781118|NCT01066793|536673499|FG001|Overall Study|Non-responders|5|||
148781119|NCT01066793|536673500|FG002|Overall Study|Non-responders|11|||
148781120|NCT01066793|536673501|FG003|Overall Study|Non-responders|25|||
148781121|NCT01066793|536673502|FG004|Overall Study|Non-responders|0|||
148781122|NCT01066793|536673503|FG005|Overall Study|Non-responders|0|||
148781123|NCT01066793|536673498|FG000|Overall Study|Other|15|||
148781124|NCT01066793|536673499|FG001|Overall Study|Other|5|||
148781125|NCT01066793|536673500|FG002|Overall Study|Other|6|||
149008098|NCT02991482|537509995|FG000|Overall Study|Worsening of performance status|0|||
149008099|NCT02991482|537509996|FG001|Overall Study|Worsening of performance status|1|||
149008100|NCT02991482|537509995|FG000|Overall Study|Death prior to study drug initiation|1|||
149021120|NCT04423393|537557185|FG004|Overall Study|Sponsor Decision|0|||
148781126|NCT01066793|536673501|FG003|Overall Study|Other|2|||
148781127|NCT01066793|536673502|FG004|Overall Study|Other|0|||
148781128|NCT01066793|536673503|FG005|Overall Study|Other|0|||
148781129|NCT01066793|536673498|FG000|Overall Study|Relapse|20|||
148781130|NCT01066793|536673499|FG001|Overall Study|Relapse|8|||
148781131|NCT01066793|536673500|FG002|Overall Study|Relapse|2|||
148781132|NCT01066793|536673501|FG003|Overall Study|Relapse|3|||
148781133|NCT01066793|536673502|FG004|Overall Study|Relapse|0|||
148781134|NCT01066793|536673503|FG005|Overall Study|Relapse|0|||
148781135|NCT01066793|536673498|FG000|Overall Study|Result Not Available|1|||
148781136|NCT01066793|536673499|FG001|Overall Study|Result Not Available|0|||
148781137|NCT01066793|536673500|FG002|Overall Study|Result Not Available|0|||
148781138|NCT01066793|536673501|FG003|Overall Study|Result Not Available|0|||
148781139|NCT01066793|536673502|FG004|Overall Study|Result Not Available|0|||
148781140|NCT01066793|536673503|FG005|Overall Study|Result Not Available|0|||
148781141|NCT01066793|536673498|FG000|Overall Study|Treatment Interrupted|1|||
148781142|NCT01066793|536673499|FG001|Overall Study|Treatment Interrupted|1|||
148781143|NCT01066793|536673500|FG002|Overall Study|Treatment Interrupted|0|||
148781144|NCT01066793|536673501|FG003|Overall Study|Treatment Interrupted|0|||
148781145|NCT01066793|536673502|FG004|Overall Study|Treatment Interrupted|0|||
148781146|NCT01066793|536673503|FG005|Overall Study|Treatment Interrupted|0|||
148781147|NCT01066793|536673498|FG000|Overall Study|Treatment Never Started|18|||
148781148|NCT01066793|536673499|FG001|Overall Study|Treatment Never Started|5|||
148781149|NCT01066793|536673500|FG002|Overall Study|Treatment Never Started|4|||
148781150|NCT01066793|536673501|FG003|Overall Study|Treatment Never Started|1|||
148781151|NCT01066793|536673502|FG004|Overall Study|Treatment Never Started|0|||
148781152|NCT01066793|536673503|FG005|Overall Study|Treatment Never Started|0|||
148781153|NCT01066793|536673498|FG000|Overall Study|Treatment Stopped|2|||
148781154|NCT01066793|536673499|FG001|Overall Study|Treatment Stopped|1|||
148781155|NCT01066793|536673500|FG002|Overall Study|Treatment Stopped|0|||
148781156|NCT01066793|536673501|FG003|Overall Study|Treatment Stopped|1|||
148781157|NCT01066793|536673502|FG004|Overall Study|Treatment Stopped|0|||
148781158|NCT01066793|536673503|FG005|Overall Study|Treatment Stopped|0|||
148781159|NCT01911793|536673505|FG000|Overall Study|Physician Decision|1|||
148781160|NCT01911793|536673506|FG001|Overall Study|Physician Decision|5|||
148781161|NCT03774394|536673507|FG000|Overall Study|Withdrawal by Subject|2|||
148781162|NCT03774394|536673508|FG001|Overall Study|Withdrawal by Subject|0|||
148781163|NCT02697916|536673509|FG000|Overall Study|Death|357|||
148781164|NCT02697916|536673510|FG001|Overall Study|Death|315|||
148781165|NCT02697916|536673509|FG000|Overall Study|Withdrawal by Subject|221|||
148781166|NCT02697916|536673510|FG001|Overall Study|Withdrawal by Subject|393|||
148781167|NCT01313221|536673511|FG000|Overall Study|Protocol Violation|0|||
148781168|NCT01313221|536673512|FG001|Overall Study|Protocol Violation|1|||
148781169|NCT01313221|536673513|FG002|Overall Study|Protocol Violation|1|||
148781170|NCT01313221|536673511|FG000|Overall Study|Non-compliance|3|||
148781171|NCT01313221|536673512|FG001|Overall Study|Non-compliance|0|||
148781172|NCT01313221|536673513|FG002|Overall Study|Non-compliance|2|||
148781173|NCT01313221|536673511|FG000|Overall Study|Withdrawal by Subject|2|||
148781174|NCT01313221|536673512|FG001|Overall Study|Withdrawal by Subject|3|||
148781175|NCT01313221|536673513|FG002|Overall Study|Withdrawal by Subject|5|||
148781176|NCT01313221|536673511|FG000|Overall Study|Requirement for alternative therapy|0|||
148781177|NCT01313221|536673512|FG001|Overall Study|Requirement for alternative therapy|1|||
148781178|NCT01313221|536673513|FG002|Overall Study|Requirement for alternative therapy|1|||
148781179|NCT01313221|536673511|FG000|Overall Study|Lost to Follow-up|6|||
148781180|NCT01313221|536673512|FG001|Overall Study|Lost to Follow-up|3|||
148781181|NCT01313221|536673513|FG002|Overall Study|Lost to Follow-up|1|||
148781182|NCT01313221|536673511|FG000|Overall Study|Other|1|||
148781183|NCT01313221|536673512|FG001|Overall Study|Other|0|||
148781184|NCT01313221|536673513|FG002|Overall Study|Other|0|||
148781185|NCT01313221|536673511|FG000|Overall Study|Adverse Event|0|||
148781186|NCT01313221|536673512|FG001|Overall Study|Adverse Event|0|||
148781187|NCT01313221|536673513|FG002|Overall Study|Adverse Event|7|||
148781188|NCT01313221|536673511|FG000|Overall Study|Disease progression|0|||
148781189|NCT01313221|536673512|FG001|Overall Study|Disease progression|0|||
148781190|NCT01313221|536673513|FG002|Overall Study|Disease progression|2|||
148781191|NCT01313221|536673511|FG000|Overall Study|Physician Decision|0|||
148781192|NCT01313221|536673512|FG001|Overall Study|Physician Decision|0|||
148781193|NCT01313221|536673513|FG002|Overall Study|Physician Decision|2|||
148781194|NCT01313221|536673511|FG000|Overall Study|Pregnancy|0|||
148781195|NCT01313221|536673512|FG001|Overall Study|Pregnancy|0|||
149008101|NCT02991482|537509996|FG001|Overall Study|Death prior to study drug initiation|0|||
148781196|NCT01313221|536673513|FG002|Overall Study|Pregnancy|2|||
148781197|NCT00994214|536673514|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
148781198|NCT00994214|536673515|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
149008102|NCT02991482|537509995|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
148781199|NCT00994214|536673516|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
148781200|NCT00994214|536673517|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
148781201|NCT00994214|536673514|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
148781202|NCT00994214|536673515|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
148781203|NCT00994214|536673516|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
148781204|NCT00994214|536673517|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
148781205|NCT00994214|536673514|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
148781206|NCT00994214|536673515|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
148781207|NCT00994214|536673516|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
148781208|NCT00994214|536673517|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
148781209|NCT00994214|536673514|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
148781210|NCT00994214|536673515|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
148781211|NCT00994214|536673516|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
148781212|NCT00994214|536673517|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
148781213|NCT00994214|536673514|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
148781214|NCT00994214|536673515|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
148781215|NCT00994214|536673516|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
148781216|NCT00994214|536673517|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
148781217|NCT00994214|536673514|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
148781218|NCT00994214|536673515|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
148781219|NCT00994214|536673516|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
148781220|NCT00994214|536673517|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
148781221|NCT00290693|536673520|FG000|Overall Study|Withdrawal by Subject|2|||
148781222|NCT05625477|536673521|FG000|Overall Study|Lost to Follow-up|2|||
148781223|NCT05625477|536673522|FG001|Overall Study|Lost to Follow-up|2|||
148781224|NCT05625477|536673523|FG002|Overall Study|Lost to Follow-up|1|||
148781225|NCT05625477|536673524|FG003|Overall Study|Lost to Follow-up|1|||
148781226|NCT05625477|536673525|FG004|Overall Study|Lost to Follow-up|0|||
148781227|NCT05625477|536673521|FG000|Overall Study|Covid quarantine|1|||
148781228|NCT05625477|536673522|FG001|Overall Study|Covid quarantine|0|||
148781229|NCT05625477|536673523|FG002|Overall Study|Covid quarantine|0|||
148781230|NCT05625477|536673524|FG003|Overall Study|Covid quarantine|0|||
148781231|NCT05625477|536673525|FG004|Overall Study|Covid quarantine|0|||
148781232|NCT04849416|536673528|FG000|Overall Study|Ongoing Treatment|12|||
148781233|NCT04849416|536673529|FG001|Overall Study|Ongoing Treatment|5|||
148781234|NCT04849416|536673530|FG002|Overall Study|Ongoing Treatment|3|||
148781235|NCT04849416|536673528|FG000|Overall Study|On Post-Treatment Follow-up|8|||
148781236|NCT04849416|536673529|FG001|Overall Study|On Post-Treatment Follow-up|9|||
148781237|NCT04849416|536673530|FG002|Overall Study|On Post-Treatment Follow-up|10|||
148781238|NCT04849416|536673528|FG000|Overall Study|Withdrawal by Subject|0|||
148781239|NCT04849416|536673529|FG001|Overall Study|Withdrawal by Subject|0|||
148781240|NCT04849416|536673530|FG002|Overall Study|Withdrawal by Subject|1|||
148781241|NCT04849416|536673528|FG000|Overall Study|Lost to Follow-up|1|||
148781242|NCT04849416|536673529|FG001|Overall Study|Lost to Follow-up|0|||
148781243|NCT04849416|536673530|FG002|Overall Study|Lost to Follow-up|0|||
148781244|NCT02667587|536673537|FG000|Pre-Treatment|Not reported|1|||
148781245|NCT02667587|536673538|FG001|Pre-Treatment|Not reported|0|||
148781246|NCT02667587|536673537|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
148781247|NCT02667587|536673538|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
148781248|NCT02667587|536673537|FG000|Pre-Treatment|Participant withdrew consent|0|||
148781249|NCT02667587|536673538|FG001|Pre-Treatment|Participant withdrew consent|1|||
148781250|NCT02667587|536673537|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
148781251|NCT02667587|536673538|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
148781252|NCT02667587|536673537|FG000|End of Treatment|Disease Progression|193|||
148781253|NCT02667587|536673538|FG001|End of Treatment|Disease Progression|226|||
148781254|NCT02667587|536673537|FG000|End of Treatment|Study Drug Toxicity|75|||
148781255|NCT02667587|536673538|FG001|End of Treatment|Study Drug Toxicity|19|||
148781256|NCT02667587|536673537|FG000|End of Treatment|Death|2|||
148781257|NCT02667587|536673538|FG001|End of Treatment|Death|1|||
148781258|NCT02667587|536673537|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
148781259|NCT02667587|536673538|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
148781260|NCT02667587|536673537|FG000|End of Treatment|participant request to discontinue treatment|33|||
148781261|NCT02667587|536673538|FG001|End of Treatment|participant request to discontinue treatment|35|||
148781262|NCT02667587|536673537|FG000|End of Treatment|participant withdrew consent|5|||
148781263|NCT02667587|536673538|FG001|End of Treatment|participant withdrew consent|6|||
148781264|NCT02667587|536673537|FG000|End of Treatment|Lost to Follow-up|1|||
148781265|NCT02667587|536673538|FG001|End of Treatment|Lost to Follow-up|2|||
148781266|NCT02667587|536673537|FG000|End of Treatment|maximum clinical benefit|4|||
148781267|NCT02667587|536673538|FG001|End of Treatment|maximum clinical benefit|4|||
148781268|NCT02667587|536673537|FG000|End of Treatment|poor or non compliant|0|||
148781269|NCT02667587|536673538|FG001|End of Treatment|poor or non compliant|1|||
148781270|NCT02667587|536673537|FG000|End of Treatment|participant no longer meets study criteria|1|||
148781271|NCT02667587|536673538|FG001|End of Treatment|participant no longer meets study criteria|1|||
148781272|NCT02667587|536673537|FG000|End of Treatment|administrative reason by sponsor|1|||
148781273|NCT02667587|536673538|FG001|End of Treatment|administrative reason by sponsor|29|||
148781274|NCT02667587|536673537|FG000|End of Treatment|other reasonse|21|||
148781275|NCT02667587|536673538|FG001|End of Treatment|other reasonse|10|||
148781276|NCT05940077|536673539|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
148781277|NCT00388297|536673540|FG000|Overall Study|Lost to Follow-up|16|||
148781278|NCT00388297|536673541|FG001|Overall Study|Lost to Follow-up|12|||
148781279|NCT00388297|536673542|FG002|Overall Study|Lost to Follow-up|11|||
148781280|NCT00388297|536673543|FG003|Overall Study|Lost to Follow-up|8|||
148781281|NCT01420679|536673550|FG000|Overall Study|Disease Progression|3|||
148781282|NCT01420679|536673551|FG001|Overall Study|Disease Progression|2|||
148781283|NCT01420679|536673550|FG000|Overall Study|Adverse Event|4|||
148781284|NCT01420679|536673551|FG001|Overall Study|Adverse Event|0|||
148781285|NCT01420679|536673550|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
148781286|NCT01420679|536673551|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
148781287|NCT01420679|536673550|FG000|Overall Study|Patient Decision|1|||
148781288|NCT01420679|536673551|FG001|Overall Study|Patient Decision|0|||
148781289|NCT01420679|536673550|FG000|Overall Study|Investigator Decision|1|||
148781290|NCT01420679|536673551|FG001|Overall Study|Investigator Decision|2|||
148781291|NCT01420679|536673550|FG000|Overall Study|Sponsor Decision|3|||
148781292|NCT01420679|536673551|FG001|Overall Study|Sponsor Decision|3|||
148781293|NCT01420679|536673550|FG000|Overall Study|Other|1|||
148781294|NCT01420679|536673551|FG001|Overall Study|Other|0|||
148781295|NCT00943670|536673552|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
148781296|NCT00943670|536673552|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
148781297|NCT00943670|536673552|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
148781298|NCT00943670|536673552|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
148781299|NCT00943670|536673552|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
148781300|NCT00943670|536673552|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
148781301|NCT00943670|536673552|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
148781302|NCT00943670|536673552|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
148781303|NCT00943670|536673552|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
148781304|NCT00943670|536673552|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
148781305|NCT01777295|536673553|FG000|Overall Study|Withdrawal by Subject|2|||
148781306|NCT01777295|536673554|FG001|Overall Study|Withdrawal by Subject|2|||
148781307|NCT01777295|536673553|FG000|Overall Study|Pregnancy|0|||
148781308|NCT01777295|536673554|FG001|Overall Study|Pregnancy|1|||
148781309|NCT01777295|536673553|FG000|Overall Study|Personal problem|1|||
148781310|NCT01777295|536673554|FG001|Overall Study|Personal problem|0|||
148781311|NCT01777295|536673553|FG000|Overall Study|Investigator call for AEs check|1|||
148781312|NCT01777295|536673554|FG001|Overall Study|Investigator call for AEs check|0|||
148781313|NCT00717275|536673555|FG000|Overall Study|Premature study termination.|3|||
148781314|NCT00312572|536673556|FG000|Overall Study|Adverse Event|10|||
148781315|NCT00312572|536673557|FG001|Overall Study|Adverse Event|16|||
148781316|NCT00312572|536673556|FG000|Overall Study|Lost to Follow-up|1|||
148781317|NCT00312572|536673557|FG001|Overall Study|Lost to Follow-up|1|||
148781318|NCT00312572|536673556|FG000|Overall Study|Administrative|4|||
148781319|NCT00312572|536673557|FG001|Overall Study|Administrative|2|||
148781320|NCT00312572|536673556|FG000|Overall Study|Lack of Efficacy|1|||
148781321|NCT00312572|536673557|FG001|Overall Study|Lack of Efficacy|2|||
148781322|NCT01904903|536673560|FG000|Overall Study|Withdrawal by Subject|1|||
148781323|NCT00634049|536673563|FG000|Overall Study|Never received study drug|1|||
148781324|NCT00634049|536673563|FG000|Overall Study|Died prior to receiving study drug|1|||
148781325|NCT00634049|536673563|FG000|Overall Study|Screening failure|1|||
148781326|NCT00314132|536673564|FG000|Overall Study|Lost to Follow-up|3|||
148781327|NCT00314132|536673565|FG001|Overall Study|Lost to Follow-up|13|||
148781328|NCT00314132|536673564|FG000|Overall Study|Withdrawal by Subject|3|||
148781329|NCT00314132|536673565|FG001|Overall Study|Withdrawal by Subject|5|||
148781330|NCT00314132|536673564|FG000|Overall Study|Adverse Event|1|||
148781331|NCT00314132|536673565|FG001|Overall Study|Adverse Event|0|||
148781332|NCT00314132|536673564|FG000|Overall Study|Physician Decision|1|||
148781333|NCT00314132|536673565|FG001|Overall Study|Physician Decision|0|||
148781334|NCT01260584|536673566|FG000|Period 1|Protocol Violation|0|||
148781335|NCT01260584|536673567|FG001|Period 1|Protocol Violation|0|||
148781336|NCT01260584|536673568|FG002|Period 1|Protocol Violation|1|||
148781337|NCT01260584|536673569|FG003|Period 1|Protocol Violation|1|||
148781338|NCT01260584|536673566|FG000|Period 1|Adverse Event|0|||
148781339|NCT01260584|536673567|FG001|Period 1|Adverse Event|0|||
148781340|NCT01260584|536673568|FG002|Period 1|Adverse Event|1|||
148781341|NCT01260584|536673569|FG003|Period 1|Adverse Event|0|||
148781342|NCT01260584|536673566|FG000|Period 2|Protocol Violation|0|||
148781343|NCT01260584|536673567|FG001|Period 2|Protocol Violation|2|||
148781344|NCT01260584|536673568|FG002|Period 2|Protocol Violation|3|||
148781345|NCT01260584|536673569|FG003|Period 2|Protocol Violation|1|||
148781346|NCT01260584|536673566|FG000|Period 2|Adverse Event|1|||
148781347|NCT01260584|536673567|FG001|Period 2|Adverse Event|0|||
148781348|NCT01260584|536673568|FG002|Period 2|Adverse Event|2|||
148781349|NCT01260584|536673569|FG003|Period 2|Adverse Event|0|||
148893342|NCT00928486|537088673|FG000|Overall Study|Withdrawal by Subject|1|||
148781350|NCT01260584|536673566|FG000|Period 2|Withdrawal by Subject|0|||
148781351|NCT01260584|536673567|FG001|Period 2|Withdrawal by Subject|1|||
148781352|NCT01260584|536673568|FG002|Period 2|Withdrawal by Subject|0|||
148781353|NCT01260584|536673569|FG003|Period 2|Withdrawal by Subject|0|||
148781354|NCT00586508|536673571|FG000|Overall Study|Progressive disease|52|||
148781355|NCT00586508|536673572|FG001|Overall Study|Progressive disease|8|||
148781356|NCT00586508|536673571|FG000|Overall Study|Death|0|||
148781357|NCT00586508|536673572|FG001|Overall Study|Death|1|||
148781358|NCT00586508|536673571|FG000|Overall Study|Adverse Event|12|||
148781359|NCT00586508|536673572|FG001|Overall Study|Adverse Event|4|||
148781360|NCT00586508|536673571|FG000|Overall Study|Withdrawal by Subject|4|||
148781361|NCT00586508|536673572|FG001|Overall Study|Withdrawal by Subject|0|||
148781362|NCT02079636|536673573|FG000|Overall Study|Death|2|||
148781363|NCT02079636|536673574|FG001|Overall Study|Death|1|||
148781364|NCT02079636|536673575|FG002|Overall Study|Death|0|||
148781365|NCT02079636|536673576|FG003|Overall Study|Death|5|||
148781366|NCT02079636|536673577|FG004|Overall Study|Death|1|||
148781367|NCT02079636|536673578|FG005|Overall Study|Death|2|||
148781368|NCT02079636|536673579|FG006|Overall Study|Death|1|||
148781369|NCT02079636|536673580|FG007|Overall Study|Death|0|||
148781370|NCT02079636|536673581|FG008|Overall Study|Death|0|||
148781371|NCT02079636|536673582|FG009|Overall Study|Death|0|||
148781372|NCT02079636|536673583|FG010|Overall Study|Death|0|||
148781373|NCT02079636|536673584|FG011|Overall Study|Death|1|||
148781374|NCT02079636|536673585|FG012|Overall Study|Death|1|||
148781375|NCT02079636|536673586|FG013|Overall Study|Death|0|||
148781376|NCT02079636|536673587|FG014|Overall Study|Death|2|||
148781377|NCT02079636|536673573|FG000|Overall Study|Adverse Event|1|||
148781378|NCT02079636|536673574|FG001|Overall Study|Adverse Event|1|||
148781379|NCT02079636|536673575|FG002|Overall Study|Adverse Event|0|||
148781380|NCT02079636|536673576|FG003|Overall Study|Adverse Event|1|||
148781381|NCT02079636|536673577|FG004|Overall Study|Adverse Event|1|||
148781382|NCT02079636|536673578|FG005|Overall Study|Adverse Event|2|||
148781383|NCT02079636|536673579|FG006|Overall Study|Adverse Event|0|||
148781384|NCT02079636|536673580|FG007|Overall Study|Adverse Event|0|||
148781385|NCT02079636|536673581|FG008|Overall Study|Adverse Event|0|||
148781386|NCT02079636|536673582|FG009|Overall Study|Adverse Event|0|||
148781387|NCT02079636|536673583|FG010|Overall Study|Adverse Event|0|||
148781388|NCT02079636|536673584|FG011|Overall Study|Adverse Event|0|||
148781389|NCT02079636|536673585|FG012|Overall Study|Adverse Event|0|||
148781390|NCT02079636|536673586|FG013|Overall Study|Adverse Event|0|||
148781391|NCT02079636|536673587|FG014|Overall Study|Adverse Event|0|||
148781392|NCT02079636|536673573|FG000|Overall Study|Progressive disease|0|||
148781393|NCT02079636|536673574|FG001|Overall Study|Progressive disease|0|||
148781394|NCT02079636|536673575|FG002|Overall Study|Progressive disease|0|||
148781395|NCT02079636|536673576|FG003|Overall Study|Progressive disease|2|||
148781396|NCT02079636|536673577|FG004|Overall Study|Progressive disease|0|||
148781397|NCT02079636|536673578|FG005|Overall Study|Progressive disease|0|||
148781398|NCT02079636|536673579|FG006|Overall Study|Progressive disease|0|||
148781399|NCT02079636|536673580|FG007|Overall Study|Progressive disease|0|||
148781400|NCT02079636|536673581|FG008|Overall Study|Progressive disease|0|||
148781401|NCT02079636|536673582|FG009|Overall Study|Progressive disease|0|||
148781402|NCT02079636|536673583|FG010|Overall Study|Progressive disease|0|||
148781403|NCT02079636|536673584|FG011|Overall Study|Progressive disease|0|||
148781404|NCT02079636|536673585|FG012|Overall Study|Progressive disease|1|||
148781405|NCT02079636|536673586|FG013|Overall Study|Progressive disease|0|||
148781406|NCT02079636|536673587|FG014|Overall Study|Progressive disease|0|||
148781407|NCT02079636|536673573|FG000|Overall Study|Withdrawal by Subject|0|||
148781408|NCT02079636|536673574|FG001|Overall Study|Withdrawal by Subject|0|||
148781409|NCT02079636|536673575|FG002|Overall Study|Withdrawal by Subject|0|||
148781410|NCT02079636|536673576|FG003|Overall Study|Withdrawal by Subject|4|||
148781411|NCT02079636|536673577|FG004|Overall Study|Withdrawal by Subject|0|||
148781412|NCT02079636|536673578|FG005|Overall Study|Withdrawal by Subject|1|||
148781413|NCT02079636|536673579|FG006|Overall Study|Withdrawal by Subject|0|||
148781414|NCT02079636|536673580|FG007|Overall Study|Withdrawal by Subject|0|||
148781415|NCT02079636|536673581|FG008|Overall Study|Withdrawal by Subject|0|||
148781416|NCT02079636|536673582|FG009|Overall Study|Withdrawal by Subject|2|||
148781417|NCT02079636|536673583|FG010|Overall Study|Withdrawal by Subject|1|||
148781418|NCT02079636|536673584|FG011|Overall Study|Withdrawal by Subject|1|||
148781419|NCT02079636|536673585|FG012|Overall Study|Withdrawal by Subject|1|||
148781420|NCT02079636|536673586|FG013|Overall Study|Withdrawal by Subject|0|||
148781421|NCT02079636|536673587|FG014|Overall Study|Withdrawal by Subject|2|||
148781422|NCT02079636|536673573|FG000|Overall Study|Physician Decision|0|||
148781423|NCT02079636|536673574|FG001|Overall Study|Physician Decision|0|||
148781424|NCT02079636|536673575|FG002|Overall Study|Physician Decision|0|||
148781425|NCT02079636|536673576|FG003|Overall Study|Physician Decision|0|||
148781426|NCT02079636|536673577|FG004|Overall Study|Physician Decision|0|||
148781427|NCT02079636|536673578|FG005|Overall Study|Physician Decision|1|||
148781428|NCT02079636|536673579|FG006|Overall Study|Physician Decision|0|||
148781429|NCT02079636|536673580|FG007|Overall Study|Physician Decision|0|||
148781430|NCT02079636|536673581|FG008|Overall Study|Physician Decision|0|||
148781431|NCT02079636|536673582|FG009|Overall Study|Physician Decision|1|||
148781432|NCT02079636|536673583|FG010|Overall Study|Physician Decision|1|||
148781433|NCT02079636|536673584|FG011|Overall Study|Physician Decision|0|||
148781434|NCT02079636|536673585|FG012|Overall Study|Physician Decision|0|||
148781435|NCT02079636|536673586|FG013|Overall Study|Physician Decision|0|||
148781436|NCT02079636|536673587|FG014|Overall Study|Physician Decision|1|||
148781437|NCT02079636|536673573|FG000|Overall Study|Lost to Follow-up|0|||
148781438|NCT02079636|536673574|FG001|Overall Study|Lost to Follow-up|0|||
148781439|NCT02079636|536673575|FG002|Overall Study|Lost to Follow-up|0|||
148781440|NCT02079636|536673576|FG003|Overall Study|Lost to Follow-up|0|||
148781441|NCT02079636|536673577|FG004|Overall Study|Lost to Follow-up|0|||
148781442|NCT02079636|536673578|FG005|Overall Study|Lost to Follow-up|0|||
148781443|NCT02079636|536673579|FG006|Overall Study|Lost to Follow-up|0|||
148781444|NCT02079636|536673580|FG007|Overall Study|Lost to Follow-up|1|||
148781445|NCT02079636|536673581|FG008|Overall Study|Lost to Follow-up|0|||
148781446|NCT02079636|536673582|FG009|Overall Study|Lost to Follow-up|0|||
148781447|NCT02079636|536673583|FG010|Overall Study|Lost to Follow-up|0|||
148781448|NCT02079636|536673584|FG011|Overall Study|Lost to Follow-up|0|||
148781449|NCT02079636|536673585|FG012|Overall Study|Lost to Follow-up|0|||
148781450|NCT02079636|536673586|FG013|Overall Study|Lost to Follow-up|0|||
148781451|NCT02079636|536673587|FG014|Overall Study|Lost to Follow-up|0|||
148781452|NCT03434249|536673588|FG000|Overall Study|Adverse Event|1|||
148781453|NCT03434249|536673589|FG001|Overall Study|Adverse Event|0|||
148781454|NCT03434249|536673588|FG000|Overall Study|Lost to Follow-up|0|||
148781455|NCT03434249|536673589|FG001|Overall Study|Lost to Follow-up|1|||
148781456|NCT03434249|536673588|FG000|Overall Study|Non-compliance of family|2|||
148781457|NCT03434249|536673589|FG001|Overall Study|Non-compliance of family|1|||
148781458|NCT03434249|536673588|FG000|Overall Study|Difficulties in completing daily diary|2|||
148781459|NCT03434249|536673589|FG001|Overall Study|Difficulties in completing daily diary|1|||
148781460|NCT03325894|536673590|FG000|Overall Study|Adverse Event|2|||
148781461|NCT03325894|536673591|FG001|Overall Study|Adverse Event|3|||
148781462|NCT03325894|536673590|FG000|Overall Study|Protocol Violation|1|||
148781463|NCT03325894|536673591|FG001|Overall Study|Protocol Violation|2|||
148781464|NCT03325894|536673590|FG000|Overall Study|Withdrawal by Subject|10|||
148781465|NCT03325894|536673591|FG001|Overall Study|Withdrawal by Subject|6|||
148781466|NCT03325894|536673590|FG000|Overall Study|Lost to Follow-up|4|||
148781467|NCT03325894|536673591|FG001|Overall Study|Lost to Follow-up|9|||
148781468|NCT03325894|536673590|FG000|Overall Study|Lack of Efficacy|8|||
148781469|NCT03325894|536673591|FG001|Overall Study|Lack of Efficacy|14|||
148781470|NCT03325894|536673590|FG000|Overall Study|Study Terminated by Sponsor|38|||
148781471|NCT03325894|536673591|FG001|Overall Study|Study Terminated by Sponsor|43|||
148781472|NCT03325894|536673590|FG000|Overall Study|Other (Not received Treatment)|1|||
148781473|NCT03325894|536673591|FG001|Overall Study|Other (Not received Treatment)|0|||
148781474|NCT03482167|536673592|FG000|Allocated to Intervention|Physician Decision|1|||
148781475|NCT03482167|536673593|FG001|Allocated to Intervention|Physician Decision|2|||
148781476|NCT03482167|536673592|FG000|Received Intervention|Adverse Event|3|||
148781477|NCT03482167|536673593|FG001|Received Intervention|Adverse Event|1|||
148781478|NCT03482167|536673592|FG000|Received Intervention|Physician Decision|1|||
148781479|NCT03482167|536673593|FG001|Received Intervention|Physician Decision|1|||
148781480|NCT03482167|536673592|FG000|Received Intervention|Withdrawal by Subject|1|||
148781481|NCT03482167|536673593|FG001|Received Intervention|Withdrawal by Subject|0|||
148781482|NCT04148287|536673599|FG000|Overall Study|Death|2|||
148781483|NCT00824382|536673601|FG000|Overall Study|Adverse Event|4|||
148781484|NCT00824382|536673602|FG001|Overall Study|Adverse Event|1|||
148781485|NCT00824382|536673603|FG002|Overall Study|Adverse Event|1|||
148781486|NCT00824382|536673604|FG003|Overall Study|Adverse Event|4|||
148781487|NCT00824382|536673601|FG000|Overall Study|Protocol Violation|1|||
148781488|NCT00824382|536673602|FG001|Overall Study|Protocol Violation|0|||
148781489|NCT00824382|536673603|FG002|Overall Study|Protocol Violation|0|||
148781490|NCT00824382|536673604|FG003|Overall Study|Protocol Violation|1|||
148781491|NCT00824382|536673601|FG000|Overall Study|Investigator's decision|0|||
148781492|NCT00824382|536673602|FG001|Overall Study|Investigator's decision|1|||
148781493|NCT00824382|536673603|FG002|Overall Study|Investigator's decision|2|||
148781494|NCT00824382|536673604|FG003|Overall Study|Investigator's decision|0|||
148781495|NCT02407054|536673605|FG000|Overall Study|Adverse Event|1|||
148781496|NCT02407054|536673606|FG001|Overall Study|Adverse Event|4|||
148781497|NCT02407054|536673607|FG002|Overall Study|Adverse Event|1|||
148781498|NCT02407054|536673605|FG000|Overall Study|Non-compliance with Study|0|||
148781499|NCT02407054|536673606|FG001|Overall Study|Non-compliance with Study|2|||
148781500|NCT02407054|536673607|FG002|Overall Study|Non-compliance with Study|1|||
148781501|NCT02407054|536673605|FG000|Overall Study|Physician Decision|1|||
148781502|NCT02407054|536673606|FG001|Overall Study|Physician Decision|3|||
148781503|NCT02407054|536673607|FG002|Overall Study|Physician Decision|3|||
148781504|NCT02407054|536673605|FG000|Overall Study|Withdrawal by Subject|5|||
148781505|NCT02407054|536673606|FG001|Overall Study|Withdrawal by Subject|9|||
148781506|NCT02407054|536673607|FG002|Overall Study|Withdrawal by Subject|2|||
148781507|NCT00415597|536673608|FG000|Enrollment|Withdrawal by Subject|1|||
148781508|NCT00415597|536673608|FG000|Enrollment|Protocol Violation|1|||
148781509|NCT00415597|536673608|FG000|Treatment|Adverse Event|110|||
148781510|NCT00415597|536673608|FG000|Treatment|Lack of Efficacy|39|||
148781511|NCT00415597|536673608|FG000|Treatment|Protocol Violation|67|||
148781512|NCT00415597|536673608|FG000|Treatment|Physician Decision|3|||
148781513|NCT00415597|536673608|FG000|Treatment|Withdrawal by Subject|51|||
148781514|NCT00415597|536673608|FG000|Treatment|Lost to Follow-up|28|||
148781515|NCT00415597|536673608|FG000|Treatment|Drug Screen|2|||
148781516|NCT00415597|536673608|FG000|Treatment|Administrative|3|||
148781517|NCT00415597|536673608|FG000|Treatment|Sponsor Decision|1|||
148781518|NCT00415597|536673608|FG000|Treatment|Multiple Reasons|1|||
148781519|NCT04102865|536673610|FG000|Overall Study|Adverse Event|4|||
148781520|NCT04102865|536673611|FG001|Overall Study|Adverse Event|0|||
148781521|NCT04102865|536673610|FG000|Overall Study|Lost to Follow-up|1|||
148781522|NCT04102865|536673611|FG001|Overall Study|Lost to Follow-up|0|||
148781523|NCT04102865|536673610|FG000|Overall Study|Withdrawal by Subject|2|||
148781524|NCT04102865|536673611|FG001|Overall Study|Withdrawal by Subject|0|||
148781525|NCT03959488|536675442|FG000|Season 1|Other|6|||
148781526|NCT03959488|536675443|FG001|Season 1|Other|7|||
148781527|NCT03959488|536675444|FG002|Season 1|Other|0|||
148781528|NCT03959488|536675445|FG003|Season 1|Other|0|||
148781529|NCT03959488|536675446|FG004|Season 1|Other|0|||
148781530|NCT03959488|536675442|FG000|Season 1|Withdrawal by parent/guardian|43|||
148781531|NCT03959488|536675443|FG001|Season 1|Withdrawal by parent/guardian|28|||
148781532|NCT03959488|536675444|FG002|Season 1|Withdrawal by parent/guardian|0|||
148781533|NCT03959488|536675445|FG003|Season 1|Withdrawal by parent/guardian|0|||
148781534|NCT03959488|536675446|FG004|Season 1|Withdrawal by parent/guardian|0|||
148781535|NCT03959488|536675442|FG000|Season 1|Due to COVID-19 pandemic|2|||
148781536|NCT03959488|536675443|FG001|Season 1|Due to COVID-19 pandemic|3|||
148781537|NCT03959488|536675444|FG002|Season 1|Due to COVID-19 pandemic|0|||
148781538|NCT03959488|536675445|FG003|Season 1|Due to COVID-19 pandemic|0|||
148781539|NCT03959488|536675446|FG004|Season 1|Due to COVID-19 pandemic|0|||
148781540|NCT03959488|536675442|FG000|Season 1|Lost to Follow-up|17|||
148781541|NCT03959488|536675443|FG001|Season 1|Lost to Follow-up|7|||
148781542|NCT03959488|536675444|FG002|Season 1|Lost to Follow-up|0|||
148781543|NCT03959488|536675445|FG003|Season 1|Lost to Follow-up|0|||
148781544|NCT03959488|536675446|FG004|Season 1|Lost to Follow-up|0|||
148781545|NCT03959488|536675442|FG000|Season 1|Death|5|||
148781546|NCT03959488|536675443|FG001|Season 1|Death|1|||
148781547|NCT03959488|536675444|FG002|Season 1|Death|0|||
148781548|NCT03959488|536675445|FG003|Season 1|Death|0|||
148781549|NCT03959488|536675446|FG004|Season 1|Death|0|||
148781550|NCT03959488|536675442|FG000|Season 2|Other|0|||
148781551|NCT03959488|536675443|FG001|Season 2|Other|0|||
148781552|NCT03959488|536675444|FG002|Season 2|Other|2|||
148781553|NCT03959488|536675445|FG003|Season 2|Other|0|||
148781554|NCT03959488|536675446|FG004|Season 2|Other|0|||
148781555|NCT03959488|536675442|FG000|Season 2|Withdrawal by parent/guardian|0|||
148781556|NCT03959488|536675443|FG001|Season 2|Withdrawal by parent/guardian|0|||
148781557|NCT03959488|536675444|FG002|Season 2|Withdrawal by parent/guardian|3|||
148781558|NCT03959488|536675445|FG003|Season 2|Withdrawal by parent/guardian|1|||
148781559|NCT03959488|536675446|FG004|Season 2|Withdrawal by parent/guardian|1|||
148781560|NCT03959488|536675442|FG000|Season 2|Lost to Follow-up|0|||
148781561|NCT03959488|536675443|FG001|Season 2|Lost to Follow-up|0|||
148781562|NCT03959488|536675444|FG002|Season 2|Lost to Follow-up|1|||
148781563|NCT03959488|536675445|FG003|Season 2|Lost to Follow-up|0|||
148781564|NCT03959488|536675446|FG004|Season 2|Lost to Follow-up|1|||
148781565|NCT02696434|536675450|FG000|Overall Study|Adverse Event|3|||
148781566|NCT02696434|536675451|FG001|Overall Study|Adverse Event|1|||
148781567|NCT02696434|536675450|FG000|Overall Study|Lost to Follow-up|5|||
148781568|NCT02696434|536675451|FG001|Overall Study|Lost to Follow-up|4|||
148781569|NCT02696434|536675450|FG000|Overall Study|Withdrawal by Subject|14|||
148781570|NCT02696434|536675451|FG001|Overall Study|Withdrawal by Subject|12|||
148781571|NCT02696434|536675450|FG000|Overall Study|Physician Decision|0|||
148781572|NCT02696434|536675451|FG001|Overall Study|Physician Decision|1|||
148781573|NCT04105010|536675474|FG000|Overall Study|Death|3|||
148781574|NCT04105010|536675475|FG001|Overall Study|Death|1|||
148781575|NCT04105010|536675476|FG002|Overall Study|Death|1|||
148781576|NCT04105010|536675477|FG003|Overall Study|Death|54|||
148781577|NCT04105010|536675474|FG000|Overall Study|Lost to Follow-up|0|||
148781578|NCT04105010|536675475|FG001|Overall Study|Lost to Follow-up|0|||
148781579|NCT04105010|536675476|FG002|Overall Study|Lost to Follow-up|0|||
148781580|NCT04105010|536675477|FG003|Overall Study|Lost to Follow-up|4|||
148781581|NCT04105010|536675474|FG000|Overall Study|Withdrawal by Subject|8|||
148781582|NCT04105010|536675475|FG001|Overall Study|Withdrawal by Subject|1|||
148781583|NCT04105010|536675476|FG002|Overall Study|Withdrawal by Subject|1|||
148781584|NCT04105010|536675477|FG003|Overall Study|Withdrawal by Subject|4|||
148781585|NCT04105010|536675474|FG000|Overall Study|Other reason|4|||
148781586|NCT04105010|536675475|FG001|Overall Study|Other reason|7|||
148781587|NCT04105010|536675476|FG002|Overall Study|Other reason|0|||
148781588|NCT04105010|536675477|FG003|Overall Study|Other reason|19|||
148781589|NCT01211483|536675478|FG000|Phase 1b|Death|6|||
148781590|NCT01211483|536675479|FG001|Phase 1b|Death|0|||
148781591|NCT01211483|536675480|FG002|Phase 1b|Death|0|||
148781592|NCT01211483|536675481|FG003|Phase 1b|Death|0|||
148781593|NCT01211483|536675478|FG000|Phase 1b|Withdrawal by Subject|1|||
148781594|NCT01211483|536675479|FG001|Phase 1b|Withdrawal by Subject|0|||
148781595|NCT01211483|536675480|FG002|Phase 1b|Withdrawal by Subject|0|||
148781596|NCT01211483|536675481|FG003|Phase 1b|Withdrawal by Subject|0|||
148781597|NCT01211483|536675478|FG000|Phase 2|Lost to Follow-up|0|||
148781598|NCT01211483|536675479|FG001|Phase 2|Lost to Follow-up|1|||
148781599|NCT01211483|536675480|FG002|Phase 2|Lost to Follow-up|1|||
148781600|NCT01211483|536675481|FG003|Phase 2|Lost to Follow-up|2|||
148781601|NCT01211483|536675478|FG000|Phase 2|Death|0|||
148781602|NCT01211483|536675479|FG001|Phase 2|Death|64|||
148781603|NCT01211483|536675480|FG002|Phase 2|Death|53|||
148781604|NCT01211483|536675481|FG003|Phase 2|Death|53|||
148781605|NCT01211483|536675478|FG000|Phase 2|Withdrawal by Subject|0|||
148781606|NCT01211483|536675479|FG001|Phase 2|Withdrawal by Subject|1|||
148781607|NCT01211483|536675480|FG002|Phase 2|Withdrawal by Subject|10|||
148781608|NCT01211483|536675481|FG003|Phase 2|Withdrawal by Subject|5|||
148781609|NCT01211483|536675478|FG000|Phase 2|Study terminated by Sponsor|0|||
148781610|NCT01211483|536675479|FG001|Phase 2|Study terminated by Sponsor|6|||
148781611|NCT01211483|536675480|FG002|Phase 2|Study terminated by Sponsor|8|||
148781612|NCT01211483|536675481|FG003|Phase 2|Study terminated by Sponsor|11|||
148781613|NCT00427999|536675482|FG000|Overall Study|Adverse Event|6|||
148781614|NCT00427999|536675482|FG000|Overall Study|Abnormal laboratory values|1|||
148781615|NCT00427999|536675482|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
148781616|NCT00427999|536675482|FG000|Overall Study|Protocol Violation|2|||
148781617|NCT00427999|536675482|FG000|Overall Study|Withdrawal by Subject|9|||
148781618|NCT00427999|536675482|FG000|Overall Study|Death|1|||
148781619|NCT02284568|536675483|FG000|Overall Study|Adverse Event|2|||
148781620|NCT02284568|536675484|FG001|Overall Study|Adverse Event|9|||
148781621|NCT02284568|536675485|FG002|Overall Study|Adverse Event|4|||
148781622|NCT02284568|536675483|FG000|Overall Study|Withdrawal by Subject|22|||
148781623|NCT02284568|536675484|FG001|Overall Study|Withdrawal by Subject|21|||
148781624|NCT02284568|536675485|FG002|Overall Study|Withdrawal by Subject|1|||
148781625|NCT02284568|536675483|FG000|Overall Study|Noncompliance with study drug admin|1|||
148781626|NCT02284568|536675484|FG001|Overall Study|Noncompliance with study drug admin|2|||
148781627|NCT02284568|536675485|FG002|Overall Study|Noncompliance with study drug admin|0|||
148781628|NCT02284568|536675483|FG000|Overall Study|Noncompliance|1|||
148781629|NCT02284568|536675484|FG001|Overall Study|Noncompliance|0|||
148781630|NCT02284568|536675485|FG002|Overall Study|Noncompliance|0|||
148781631|NCT02284568|536675483|FG000|Overall Study|Protocol Violation|0|||
148781632|NCT02284568|536675484|FG001|Overall Study|Protocol Violation|1|||
148781633|NCT02284568|536675485|FG002|Overall Study|Protocol Violation|0|||
148781634|NCT02284568|536675483|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
148781635|NCT02284568|536675484|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
148781636|NCT02284568|536675485|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
148781637|NCT02284568|536675483|FG000|Overall Study|Lost to Follow-up|0|||
148781638|NCT02284568|536675484|FG001|Overall Study|Lost to Follow-up|3|||
148781639|NCT02284568|536675485|FG002|Overall Study|Lost to Follow-up|0|||
148781640|NCT02284568|536675483|FG000|Overall Study|Lack of Efficacy|4|||
148781641|NCT02284568|536675484|FG001|Overall Study|Lack of Efficacy|7|||
148781642|NCT02284568|536675485|FG002|Overall Study|Lack of Efficacy|0|||
148781643|NCT02284568|536675483|FG000|Overall Study|Other|1|||
148781644|NCT02284568|536675484|FG001|Overall Study|Other|2|||
148781645|NCT02284568|536675485|FG002|Overall Study|Other|0|||
148781646|NCT02284568|536675483|FG000|Overall Study|Withdrew before taking study drug|0|||
148781647|NCT02284568|536675484|FG001|Overall Study|Withdrew before taking study drug|1|||
148781648|NCT02284568|536675485|FG002|Overall Study|Withdrew before taking study drug|0|||
148781649|NCT00460265|536675486|FG000|Overall Study|Lost to Follow-up|14|||
148781650|NCT00460265|536675487|FG001|Overall Study|Lost to Follow-up|15|||
148781651|NCT00460265|536675486|FG000|Overall Study|Physician Decision|1|||
148781652|NCT00460265|536675487|FG001|Overall Study|Physician Decision|2|||
148781653|NCT00460265|536675486|FG000|Overall Study|Withdrawal by Subject|10|||
148781654|NCT00460265|536675487|FG001|Overall Study|Withdrawal by Subject|25|||
148781655|NCT00460265|536675486|FG000|Overall Study|Ongoing|60|||
148781656|NCT00460265|536675487|FG001|Overall Study|Ongoing|47|||
148781657|NCT03570554|536675488|FG000|Overall Study|Non-compliance with study drug|0|||
148781658|NCT03570554|536675489|FG001|Overall Study|Non-compliance with study drug|0|||
148781659|NCT03570554|536675490|FG002|Overall Study|Non-compliance with study drug|1|||
148781660|NCT03570554|536675491|FG003|Overall Study|Non-compliance with study drug|0|||
148781661|NCT03570554|536675488|FG000|Overall Study|Adverse Event|0|||
148781662|NCT03570554|536675489|FG001|Overall Study|Adverse Event|0|||
148781663|NCT03570554|536675490|FG002|Overall Study|Adverse Event|0|||
148781664|NCT03570554|536675491|FG003|Overall Study|Adverse Event|1|||
148781665|NCT03114657|536675506|FG000|Overall Study|Adverse Event|9|||
148781666|NCT03114657|536675507|FG001|Overall Study|Adverse Event|6|||
148781667|NCT03114657|536675506|FG000|Overall Study|Death|4|||
148781668|NCT03114657|536675507|FG001|Overall Study|Death|0|||
148781669|NCT03114657|536675506|FG000|Overall Study|Multiple Reasons|1|||
148781670|NCT03114657|536675507|FG001|Overall Study|Multiple Reasons|2|||
148781671|NCT03114657|536675506|FG000|Overall Study|Physician Decision|2|||
148781672|NCT03114657|536675507|FG001|Overall Study|Physician Decision|2|||
148781673|NCT03114657|536675506|FG000|Overall Study|Study Terminated By Sponsor|355|||
148781674|NCT03114657|536675507|FG001|Overall Study|Study Terminated By Sponsor|374|||
148781675|NCT03114657|536675506|FG000|Overall Study|Symptomatic Deterioration|0|||
148781676|NCT03114657|536675507|FG001|Overall Study|Symptomatic Deterioration|1|||
148781677|NCT03114657|536675506|FG000|Overall Study|Withdrawal by Subject|28|||
148781678|NCT03114657|536675507|FG001|Overall Study|Withdrawal by Subject|22|||
148781679|NCT00115037|536675508|FG000|Phase1|Lost to Follow-up|16|||
148781680|NCT00115037|536675509|FG001|Phase1|Lost to Follow-up|23|||
148781681|NCT00115037|536675510|FG002|Phase1|Lost to Follow-up|0|||
148781682|NCT00115037|536675511|FG003|Phase1|Lost to Follow-up|0|||
148781683|NCT00115037|536675512|FG004|Phase1|Lost to Follow-up|0|||
148781684|NCT00115037|536675513|FG005|Phase1|Lost to Follow-up|0|||
148781685|NCT00115037|536675508|FG000|Phase1|Withdrawal by Subject|9|||
148781686|NCT00115037|536675509|FG001|Phase1|Withdrawal by Subject|4|||
148781687|NCT00115037|536675510|FG002|Phase1|Withdrawal by Subject|0|||
148781688|NCT00115037|536675511|FG003|Phase1|Withdrawal by Subject|0|||
148781689|NCT00115037|536675512|FG004|Phase1|Withdrawal by Subject|0|||
148781690|NCT00115037|536675513|FG005|Phase1|Withdrawal by Subject|0|||
148781691|NCT00115037|536675508|FG000|Phase2|Death|0|||
148781692|NCT00115037|536675509|FG001|Phase2|Death|0|||
148781693|NCT00115037|536675510|FG002|Phase2|Death|1|||
148781694|NCT00115037|536675511|FG003|Phase2|Death|0|||
148781695|NCT00115037|536675512|FG004|Phase2|Death|0|||
148781696|NCT00115037|536675513|FG005|Phase2|Death|1|||
148781697|NCT00115037|536675508|FG000|Phase2|Withdrawal by Subject|0|||
148781698|NCT00115037|536675509|FG001|Phase2|Withdrawal by Subject|0|||
148781699|NCT00115037|536675510|FG002|Phase2|Withdrawal by Subject|2|||
148781700|NCT00115037|536675511|FG003|Phase2|Withdrawal by Subject|1|||
148781701|NCT00115037|536675512|FG004|Phase2|Withdrawal by Subject|2|||
148781702|NCT00115037|536675513|FG005|Phase2|Withdrawal by Subject|1|||
148781703|NCT00115037|536675508|FG000|Phase2|Lost to Follow-up|0|||
148781704|NCT00115037|536675509|FG001|Phase2|Lost to Follow-up|0|||
148781705|NCT00115037|536675510|FG002|Phase2|Lost to Follow-up|12|||
148781706|NCT00115037|536675511|FG003|Phase2|Lost to Follow-up|14|||
148781707|NCT00115037|536675512|FG004|Phase2|Lost to Follow-up|4|||
148781708|NCT00115037|536675513|FG005|Phase2|Lost to Follow-up|10|||
148781709|NCT01179737|536675514|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
148781710|NCT01179737|536675515|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
148781711|NCT01179737|536675516|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
148781712|NCT01179737|536675517|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
148781713|NCT01179737|536675514|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
148781714|NCT01179737|536675515|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
148781715|NCT01179737|536675516|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
148781716|NCT01179737|536675517|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
148781717|NCT01179737|536675514|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
148781718|NCT01179737|536675515|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
148781719|NCT01179737|536675516|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
148781720|NCT01179737|536675517|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
148781721|NCT01179737|536675514|FG000|Cohort 1 & Cohort 2|Death|0|||
148781722|NCT01179737|536675515|FG001|Cohort 1 & Cohort 2|Death|0|||
148781723|NCT01179737|536675516|FG002|Cohort 1 & Cohort 2|Death|1|||
148781724|NCT01179737|536675517|FG003|Cohort 1 & Cohort 2|Death|0|||
148781725|NCT01179737|536675514|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
148781726|NCT01179737|536675515|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
148781727|NCT01179737|536675516|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
148781728|NCT01179737|536675517|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
148781729|NCT01179737|536675514|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
148781730|NCT01179737|536675515|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
148781731|NCT01179737|536675516|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
148781732|NCT01179737|536675517|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
148781733|NCT01179737|536675514|FG000|Extension|The study was terminated|3|||
148781734|NCT01179737|536675515|FG001|Extension|The study was terminated|0|||
148781735|NCT01179737|536675516|FG002|Extension|The study was terminated|0|||
148781736|NCT01179737|536675517|FG003|Extension|The study was terminated|0|||
148781737|NCT01546038|536675518|FG000|Overall Study|Death|15|||
148781738|NCT01546038|536675519|FG001|Overall Study|Death|6|||
148781739|NCT01546038|536675520|FG002|Overall Study|Death|4|||
148781740|NCT01546038|536675521|FG003|Overall Study|Death|2|||
148781741|NCT01546038|536675522|FG004|Overall Study|Death|9|||
148781742|NCT01546038|536675523|FG005|Overall Study|Death|3|||
148781743|NCT01546038|536675524|FG006|Overall Study|Death|46|||
148781744|NCT01546038|536675525|FG007|Overall Study|Death|76|||
148781745|NCT01546038|536675526|FG008|Overall Study|Death|39|||
148781746|NCT01546038|536675518|FG000|Overall Study|Lost to Follow-up|0|||
148781747|NCT01546038|536675519|FG001|Overall Study|Lost to Follow-up|0|||
148781748|NCT01546038|536675520|FG002|Overall Study|Lost to Follow-up|0|||
148781749|NCT01546038|536675521|FG003|Overall Study|Lost to Follow-up|0|||
148781750|NCT01546038|536675522|FG004|Overall Study|Lost to Follow-up|1|||
148781751|NCT01546038|536675523|FG005|Overall Study|Lost to Follow-up|0|||
148781752|NCT01546038|536675524|FG006|Overall Study|Lost to Follow-up|2|||
148781753|NCT01546038|536675525|FG007|Overall Study|Lost to Follow-up|1|||
148781754|NCT01546038|536675526|FG008|Overall Study|Lost to Follow-up|0|||
148781755|NCT01546038|536675518|FG000|Overall Study|Withdrawal by Subject|1|||
148781756|NCT01546038|536675519|FG001|Overall Study|Withdrawal by Subject|0|||
148781757|NCT01546038|536675520|FG002|Overall Study|Withdrawal by Subject|0|||
148781758|NCT01546038|536675521|FG003|Overall Study|Withdrawal by Subject|1|||
148781759|NCT01546038|536675522|FG004|Overall Study|Withdrawal by Subject|0|||
148781760|NCT01546038|536675523|FG005|Overall Study|Withdrawal by Subject|1|||
148781761|NCT01546038|536675524|FG006|Overall Study|Withdrawal by Subject|3|||
148781762|NCT01546038|536675525|FG007|Overall Study|Withdrawal by Subject|3|||
148781763|NCT01546038|536675526|FG008|Overall Study|Withdrawal by Subject|1|||
148781764|NCT01546038|536675518|FG000|Overall Study|: Randomized, not treated|0|||
148781765|NCT01546038|536675519|FG001|Overall Study|: Randomized, not treated|0|||
148781766|NCT01546038|536675520|FG002|Overall Study|: Randomized, not treated|0|||
148781767|NCT01546038|536675521|FG003|Overall Study|: Randomized, not treated|0|||
148781768|NCT01546038|536675522|FG004|Overall Study|: Randomized, not treated|0|||
148781769|NCT01546038|536675523|FG005|Overall Study|: Randomized, not treated|0|||
148781770|NCT01546038|536675524|FG006|Overall Study|: Randomized, not treated|2|||
148781771|NCT01546038|536675525|FG007|Overall Study|: Randomized, not treated|4|||
148781772|NCT01546038|536675526|FG008|Overall Study|: Randomized, not treated|3|||
148781773|NCT01398410|536675527|FG000|Overall Study|Adverse Event|12|||
148781774|NCT01398410|536675528|FG001|Overall Study|Adverse Event|16|||
148781775|NCT01398410|536675527|FG000|Overall Study|Participants Choice|8|||
148781776|NCT01398410|536675528|FG001|Overall Study|Participants Choice|11|||
148781777|NCT01398410|536675527|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
148781778|NCT01398410|536675528|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
148781779|NCT01398410|536675527|FG000|Overall Study|Other|36|||
148781780|NCT01398410|536675528|FG001|Overall Study|Other|29|||
148781781|NCT04245202|536675529|FG000|Overall Study|Lack of Efficacy|10|||
148781782|NCT04245202|536675530|FG001|Overall Study|Lack of Efficacy|1|||
148781783|NCT03515629|536675532|FG000|Overall Study|Death|0|||
148781784|NCT03515629|536675533|FG001|Overall Study|Death|1|||
148781785|NCT03515629|536675534|FG002|Overall Study|Death|1|||
148781786|NCT03515629|536675532|FG000|Overall Study|Progressive disease|0|||
148781787|NCT03515629|536675533|FG001|Overall Study|Progressive disease|1|||
148781788|NCT03515629|536675534|FG002|Overall Study|Progressive disease|0|||
148781789|NCT01254721|536675535|FG000|Overall Study|Lost to Follow-up|0|||
148781790|NCT01254721|536675536|FG001|Overall Study|Lost to Follow-up|4|||
148781791|NCT01254721|536675535|FG000|Overall Study|Lack of Efficacy|4|||
148781792|NCT01254721|536675536|FG001|Overall Study|Lack of Efficacy|2|||
148781793|NCT01254721|536675535|FG000|Overall Study|Death|0|||
148781794|NCT01254721|536675536|FG001|Overall Study|Death|1|||
148781795|NCT01254721|536675535|FG000|Overall Study|technical problum|1|||
148781796|NCT01254721|536675536|FG001|Overall Study|technical problum|0|||
148781797|NCT01254721|536675535|FG000|Overall Study|Adverse Event|2|||
148781798|NCT01254721|536675536|FG001|Overall Study|Adverse Event|3|||
148781799|NCT01254721|536675535|FG000|Overall Study|Withdrawal by Subject|8|||
148781800|NCT01254721|536675536|FG001|Overall Study|Withdrawal by Subject|11|||
148781801|NCT01254721|536675535|FG000|Overall Study|Wrongly randomization|0|||
148781802|NCT01254721|536675536|FG001|Overall Study|Wrongly randomization|1|||
148781803|NCT00424021|536675537|FG000|NCT00046319 Study Period|Adverse Event|1|||
148781804|NCT00424021|536675538|FG001|NCT00046319 Study Period|Adverse Event|0|||
148781805|NCT00424021|536675539|FG002|NCT00046319 Study Period|Adverse Event|1|||
148781806|NCT00424021|536675540|FG003|NCT00046319 Study Period|Adverse Event|1|||
148781807|NCT00424021|536675537|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
148781808|NCT00424021|536675538|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
148781809|NCT00424021|536675539|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
148781810|NCT00424021|536675540|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
148781811|NCT00424021|536675537|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
148781812|NCT00424021|536675538|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
148781813|NCT00424021|536675539|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
148781814|NCT00424021|536675540|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
148781815|NCT00424021|536675537|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
148781816|NCT00424021|536675538|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
148781817|NCT00424021|536675539|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
148781818|NCT00424021|536675540|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
148781819|NCT00424021|536675537|FG000|AMB-220-E Study Period|Adverse Event|1|||
148781820|NCT00424021|536675538|FG001|AMB-220-E Study Period|Adverse Event|1|||
148781821|NCT00424021|536675539|FG002|AMB-220-E Study Period|Adverse Event|3|||
148893343|NCT00683878|537088678|FG000|Overall Study|Lack of Efficacy|3|||
148781822|NCT00424021|536675540|FG003|AMB-220-E Study Period|Adverse Event|7|||
148781823|NCT00424021|536675537|FG000|AMB-220-E Study Period|Death|0|||
148781824|NCT00424021|536675538|FG001|AMB-220-E Study Period|Death|0|||
148781825|NCT00424021|536675539|FG002|AMB-220-E Study Period|Death|1|||
148781826|NCT00424021|536675540|FG003|AMB-220-E Study Period|Death|1|||
148781827|NCT00424021|536675537|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
148781828|NCT00424021|536675538|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
148781829|NCT00424021|536675539|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
148781830|NCT00424021|536675540|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
148781831|NCT00424021|536675537|FG000|AMB-220-E Study Period|Physician Decision|0|||
148781832|NCT00424021|536675538|FG001|AMB-220-E Study Period|Physician Decision|0|||
148781833|NCT00424021|536675539|FG002|AMB-220-E Study Period|Physician Decision|0|||
148781834|NCT00424021|536675540|FG003|AMB-220-E Study Period|Physician Decision|1|||
148781835|NCT03597022|536675542|FG000|Overall Study|Premature termination of the study|7|||
148781836|NCT03597022|536675543|FG001|Overall Study|Premature termination of the study|7|||
148781837|NCT03597022|536675544|FG002|Overall Study|Premature termination of the study|8|||
148781838|NCT03597022|536675542|FG000|Overall Study|Serious adverse event|1|||
148781839|NCT03597022|536675543|FG001|Overall Study|Serious adverse event|1|||
148781840|NCT03597022|536675544|FG002|Overall Study|Serious adverse event|0|||
148781841|NCT00904839|536675545|FG000|Overall Study|Adverse Event|0|||
148781842|NCT00904839|536675546|FG001|Overall Study|Adverse Event|5|||
148781843|NCT00904839|536675547|FG002|Overall Study|Adverse Event|4|||
148781844|NCT00904839|536675545|FG000|Overall Study|Protocol Violation|0|||
148781845|NCT00904839|536675546|FG001|Overall Study|Protocol Violation|1|||
148781846|NCT00904839|536675547|FG002|Overall Study|Protocol Violation|1|||
148781847|NCT00904839|536675545|FG000|Overall Study|Lost to Follow-up|0|||
148781848|NCT00904839|536675546|FG001|Overall Study|Lost to Follow-up|1|||
148781849|NCT00904839|536675547|FG002|Overall Study|Lost to Follow-up|2|||
148781850|NCT00904839|536675545|FG000|Overall Study|Withdrawal by Subject|0|||
148781851|NCT00904839|536675546|FG001|Overall Study|Withdrawal by Subject|2|||
148781852|NCT00904839|536675547|FG002|Overall Study|Withdrawal by Subject|0|||
148781853|NCT00904839|536675545|FG000|Overall Study|Not treated|1|||
148781854|NCT00904839|536675546|FG001|Overall Study|Not treated|0|||
148781855|NCT00904839|536675547|FG002|Overall Study|Not treated|1|||
148781856|NCT00904839|536675545|FG000|Overall Study|Other than above|0|||
148781857|NCT00904839|536675546|FG001|Overall Study|Other than above|9|||
148781858|NCT00904839|536675547|FG002|Overall Study|Other than above|7|||
148781859|NCT05385224|536675548|FG000|Overall Study|Unable to swallow capsule|2|||
148781860|NCT05385224|536675548|FG000|Overall Study|Withdrawal by Subject|2|||
148781861|NCT05385224|536675548|FG000|Overall Study|Did not meet study criteria|1|||
148781862|NCT04521114|536675555|FG000|Overall Study|Lost to Follow-up|1|||
148781863|NCT04521114|536675556|FG001|Overall Study|Lost to Follow-up|2|||
148781864|NCT04521114|536675557|FG002|Overall Study|Lost to Follow-up|0|||
148781865|NCT04521114|536675555|FG000|Overall Study|Withdrawal by Subject|1|||
148781866|NCT04521114|536675556|FG001|Overall Study|Withdrawal by Subject|2|||
148781867|NCT04521114|536675557|FG002|Overall Study|Withdrawal by Subject|2|||
148781868|NCT04521114|536675555|FG000|Overall Study|Adverse Event|1|||
149008103|NCT02991482|537509996|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
149008104|NCT01250119|537509999|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
148781869|NCT04521114|536675556|FG001|Overall Study|Adverse Event|0|||
148781870|NCT04521114|536675557|FG002|Overall Study|Adverse Event|0|||
148781871|NCT04521114|536675555|FG000|Overall Study|Sponsor Wish|1|||
148781872|NCT04521114|536675556|FG001|Overall Study|Sponsor Wish|0|||
148781873|NCT04521114|536675557|FG002|Overall Study|Sponsor Wish|0|||
148781874|NCT04521114|536675555|FG000|Overall Study|Withdrawal of Consent|2|||
148781875|NCT04521114|536675556|FG001|Overall Study|Withdrawal of Consent|2|||
148781876|NCT04521114|536675557|FG002|Overall Study|Withdrawal of Consent|0|||
148781877|NCT00553358|536675558|FG000|Overall Study|Randomized but did not receive treatment|3|||
148781878|NCT00553358|536675559|FG001|Overall Study|Randomized but did not receive treatment|3|||
148781879|NCT00553358|536675560|FG002|Overall Study|Randomized but did not receive treatment|1|||
148781880|NCT00553358|536675558|FG000|Overall Study|Lost to Follow-up|22|||
148781881|NCT00553358|536675559|FG001|Overall Study|Lost to Follow-up|26|||
148781882|NCT00553358|536675560|FG002|Overall Study|Lost to Follow-up|18|||
148781883|NCT00553358|536675558|FG000|Overall Study|Withdrew completely|23|||
148781884|NCT00553358|536675559|FG001|Overall Study|Withdrew completely|33|||
148781885|NCT00553358|536675560|FG002|Overall Study|Withdrew completely|34|||
148781886|NCT00553358|536675558|FG000|Overall Study|Died during clinical follow-up|25|||
148781887|NCT00553358|536675559|FG001|Overall Study|Died during clinical follow-up|29|||
149008105|NCT01250119|537510000|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
149008106|NCT01250119|537509999|FG000|Diagnostic Phase|Participants Not Tested|44|||
149008107|NCT01250119|537510000|FG001|Diagnostic Phase|Participants Not Tested|0|||
149008108|NCT01250119|537509999|FG000|Treatment Phase|Progressive Disease|0|||
149008109|NCT01250119|537510000|FG001|Treatment Phase|Progressive Disease|32|||
149008110|NCT01250119|537509999|FG000|Treatment Phase|Death|0|||
148781888|NCT00553358|536675560|FG002|Overall Study|Died during clinical follow-up|32|||
148781889|NCT00553358|536675558|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
148781890|NCT00553358|536675559|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
148781891|NCT00553358|536675560|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
148781892|NCT00553358|536675558|FG000|Overall Study|Died after clinical follow-up ended|1|||
149008111|NCT01250119|537510000|FG001|Treatment Phase|Death|2|||
148781893|NCT00553358|536675559|FG001|Overall Study|Died after clinical follow-up ended|2|||
148781894|NCT00553358|536675560|FG002|Overall Study|Died after clinical follow-up ended|0|||
149008112|NCT01250119|537509999|FG000|Treatment Phase|Withdrawal by Subject|0|||
148781895|NCT00553358|536675558|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
148781896|NCT00553358|536675559|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
148781897|NCT00553358|536675560|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
148781898|NCT01832818|536675561|FG000|Overall Study|Lost to Follow-up|6|||
148781899|NCT03209518|536675562|FG000|Overall Study|Case Report Forms Uncollected|1|||
148781900|NCT03209518|536675562|FG000|Overall Study|Protocol Deviation|1|||
148781901|NCT00236899|536675563|FG000|Overall Study|Adverse Event (Study Related)|1|||
148781902|NCT00236899|536675564|FG001|Overall Study|Adverse Event (Study Related)|1|||
148781903|NCT00236899|536675565|FG002|Overall Study|Adverse Event (Study Related)|2|||
148781904|NCT00236899|536675566|FG003|Overall Study|Adverse Event (Study Related)|1|||
148781905|NCT00236899|536675563|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
148781906|NCT00236899|536675564|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
148781907|NCT00236899|536675565|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
148781908|NCT00236899|536675566|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
148781909|NCT00236899|536675563|FG000|Overall Study|Death (Study Disease)|1|||
148781910|NCT00236899|536675564|FG001|Overall Study|Death (Study Disease)|4|||
148781911|NCT00236899|536675565|FG002|Overall Study|Death (Study Disease)|0|||
148781912|NCT00236899|536675566|FG003|Overall Study|Death (Study Disease)|0|||
148781913|NCT00236899|536675563|FG000|Overall Study|Death (Not Study Related)|2|||
148781914|NCT00236899|536675564|FG001|Overall Study|Death (Not Study Related)|0|||
148781915|NCT00236899|536675565|FG002|Overall Study|Death (Not Study Related)|0|||
148781916|NCT00236899|536675566|FG003|Overall Study|Death (Not Study Related)|0|||
148781917|NCT00236899|536675563|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
148781918|NCT00236899|536675564|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
148781919|NCT00236899|536675565|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
148781920|NCT00236899|536675566|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
148781921|NCT00236899|536675563|FG000|Overall Study|Lost to Follow-up|0|||
148781922|NCT00236899|536675564|FG001|Overall Study|Lost to Follow-up|1|||
148781923|NCT00236899|536675565|FG002|Overall Study|Lost to Follow-up|0|||
148781924|NCT00236899|536675566|FG003|Overall Study|Lost to Follow-up|0|||
148781925|NCT00236899|536675563|FG000|Overall Study|Entry Criteria Exclusion|0|||
148781926|NCT00236899|536675564|FG001|Overall Study|Entry Criteria Exclusion|1|||
148781927|NCT00236899|536675565|FG002|Overall Study|Entry Criteria Exclusion|1|||
148781928|NCT00236899|536675566|FG003|Overall Study|Entry Criteria Exclusion|0|||
148781929|NCT00236899|536675563|FG000|Overall Study|Protocol Violation|1|||
148781930|NCT00236899|536675564|FG001|Overall Study|Protocol Violation|0|||
148781931|NCT00236899|536675565|FG002|Overall Study|Protocol Violation|0|||
148781932|NCT00236899|536675566|FG003|Overall Study|Protocol Violation|0|||
148781933|NCT00236899|536675563|FG000|Overall Study|Withdrawal by Subject|6|||
148781934|NCT00236899|536675564|FG001|Overall Study|Withdrawal by Subject|4|||
148781935|NCT00236899|536675565|FG002|Overall Study|Withdrawal by Subject|5|||
148781936|NCT00236899|536675566|FG003|Overall Study|Withdrawal by Subject|2|||
148781937|NCT00236899|536675563|FG000|Overall Study|Physician Decision|7|||
148781938|NCT00236899|536675564|FG001|Overall Study|Physician Decision|8|||
148781939|NCT00236899|536675565|FG002|Overall Study|Physician Decision|7|||
148781940|NCT00236899|536675566|FG003|Overall Study|Physician Decision|6|||
148781941|NCT00236899|536675563|FG000|Overall Study|Satisfactory Response|2|||
149008113|NCT01250119|537510000|FG001|Treatment Phase|Withdrawal by Subject|1|||
149008114|NCT01250119|537509999|FG000|Treatment Phase|Adverse Event|0|||
149008115|NCT01250119|537510000|FG001|Treatment Phase|Adverse Event|2|||
149008116|NCT01250119|537509999|FG000|Treatment Phase|Unknown reason|0|||
149008117|NCT01250119|537510000|FG001|Treatment Phase|Unknown reason|4|||
149008118|NCT05648357|537510001|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
149008119|NCT00255346|537510002|FG000|Overall Study|Adverse Event|1|||
149008120|NCT00255346|537510003|FG001|Overall Study|Adverse Event|0|||
149008121|NCT00255346|537510004|FG002|Overall Study|Adverse Event|0|||
149008122|NCT00255346|537510005|FG003|Overall Study|Adverse Event|0|||
149008123|NCT00255346|537510006|FG004|Overall Study|Adverse Event|0|||
149008124|NCT02045433|537510014|FG000|Overall Study|Withdrawal by Subject|1|||
149008125|NCT01559454|537510015|FG000|Overall Study|Lost to Follow-up|3|||
149008126|NCT01559454|537510016|FG001|Overall Study|Lost to Follow-up|2|||
149008127|NCT01559454|537510015|FG000|Overall Study|Withdrawal by Subject|0|||
149008128|NCT01559454|537510016|FG001|Overall Study|Withdrawal by Subject|1|||
149008129|NCT01559454|537510015|FG000|Overall Study|Physician Decision|0|||
149008130|NCT01559454|537510016|FG001|Overall Study|Physician Decision|1|||
149008131|NCT01559454|537510015|FG000|Overall Study|Protocol Violation|0|||
149008132|NCT01559454|537510016|FG001|Overall Study|Protocol Violation|1|||
148781942|NCT00236899|536675564|FG001|Overall Study|Satisfactory Response|0|||
148781943|NCT00236899|536675565|FG002|Overall Study|Satisfactory Response|0|||
148781944|NCT00236899|536675566|FG003|Overall Study|Satisfactory Response|1|||
148781945|NCT00236899|536675563|FG000|Overall Study|Lack of Efficacy|18|||
148781946|NCT00236899|536675564|FG001|Overall Study|Lack of Efficacy|18|||
148781947|NCT00236899|536675565|FG002|Overall Study|Lack of Efficacy|25|||
148781948|NCT00236899|536675566|FG003|Overall Study|Lack of Efficacy|23|||
149008133|NCT01559454|537510015|FG000|Overall Study|Lack of Efficacy|0|||
149008134|NCT01559454|537510016|FG001|Overall Study|Lack of Efficacy|1|||
149008135|NCT00539643|537510017|FG000|Overall Study|Adverse Event|1|||
149008136|NCT00539643|537510018|FG001|Overall Study|Adverse Event|0|||
149008137|NCT00539643|537510017|FG000|Overall Study|Death|2|||
149008138|NCT00539643|537510018|FG001|Overall Study|Death|1|||
149008139|NCT00539643|537510017|FG000|Overall Study|Physician Decision|3|||
149008140|NCT00539643|537510018|FG001|Overall Study|Physician Decision|1|||
149008141|NCT00539643|537510017|FG000|Overall Study|Withdrawal by Subject|0|||
149008142|NCT00539643|537510018|FG001|Overall Study|Withdrawal by Subject|1|||
149008143|NCT01287520|537510019|FG000|Overall Study|Adverse Event|2|||
149008144|NCT01287520|537510020|FG001|Overall Study|Adverse Event|2|||
149008145|NCT01287520|537510021|FG002|Overall Study|Adverse Event|2|||
149008146|NCT01287520|537510022|FG003|Overall Study|Adverse Event|1|||
149008147|NCT01287520|537510023|FG004|Overall Study|Adverse Event|1|||
149008148|NCT01287520|537510024|FG005|Overall Study|Adverse Event|2|||
149008149|NCT01287520|537510025|FG006|Overall Study|Adverse Event|0|||
149008150|NCT01287520|537510026|FG007|Overall Study|Adverse Event|2|||
149008151|NCT01287520|537510027|FG008|Overall Study|Adverse Event|0|||
149008152|NCT01287520|537510019|FG000|Overall Study|Physician Decision|1|||
149008153|NCT01287520|537510020|FG001|Overall Study|Physician Decision|1|||
149008154|NCT01287520|537510021|FG002|Overall Study|Physician Decision|2|||
149008155|NCT01287520|537510022|FG003|Overall Study|Physician Decision|0|||
149008156|NCT01287520|537510023|FG004|Overall Study|Physician Decision|1|||
149008157|NCT01287520|537510024|FG005|Overall Study|Physician Decision|1|||
149008158|NCT01287520|537510025|FG006|Overall Study|Physician Decision|0|||
149008159|NCT01287520|537510026|FG007|Overall Study|Physician Decision|1|||
149008160|NCT01287520|537510027|FG008|Overall Study|Physician Decision|0|||
149008161|NCT01287520|537510019|FG000|Overall Study|Progressive disease|0|||
149008162|NCT01287520|537510020|FG001|Overall Study|Progressive disease|4|||
149008163|NCT01287520|537510021|FG002|Overall Study|Progressive disease|1|||
149008164|NCT01287520|537510022|FG003|Overall Study|Progressive disease|6|||
149008165|NCT01287520|537510023|FG004|Overall Study|Progressive disease|1|||
149008166|NCT01287520|537510024|FG005|Overall Study|Progressive disease|0|||
149008167|NCT01287520|537510025|FG006|Overall Study|Progressive disease|2|||
149008168|NCT01287520|537510026|FG007|Overall Study|Progressive disease|2|||
149008169|NCT01287520|537510027|FG008|Overall Study|Progressive disease|4|||
149008170|NCT01287520|537510019|FG000|Overall Study|Withdrawal by Subject|0|||
149008171|NCT01287520|537510020|FG001|Overall Study|Withdrawal by Subject|0|||
149008172|NCT01287520|537510021|FG002|Overall Study|Withdrawal by Subject|0|||
149008173|NCT01287520|537510022|FG003|Overall Study|Withdrawal by Subject|0|||
149008174|NCT01287520|537510023|FG004|Overall Study|Withdrawal by Subject|0|||
149008175|NCT01287520|537510024|FG005|Overall Study|Withdrawal by Subject|1|||
149008176|NCT01287520|537510025|FG006|Overall Study|Withdrawal by Subject|0|||
149008177|NCT01287520|537510026|FG007|Overall Study|Withdrawal by Subject|0|||
149008178|NCT01287520|537510027|FG008|Overall Study|Withdrawal by Subject|1|||
149008179|NCT03587142|537510028|FG000|Overall Study|Lost to Follow-up|5|||
149008180|NCT03587142|537510029|FG001|Overall Study|Lost to Follow-up|3|||
149008181|NCT03587142|537510028|FG000|Overall Study|Did not complete the f4 visit|3|||
149008182|NCT03587142|537510029|FG001|Overall Study|Did not complete the f4 visit|7|||
149008183|NCT02768662|537510030|FG000|Overall Study|Adverse Event|1|||
149008184|NCT02768662|537510030|FG000|Overall Study|Lost to Follow-up|4|||
149008185|NCT02768662|537510030|FG000|Overall Study|Withdrawal by Subject|3|||
149008186|NCT02768662|537510030|FG000|Overall Study|Study terminated by Sponsor|78|||
149008187|NCT01800201|537510031|FG000|Overall Study|Withdrawal by Subject|2|||
149008188|NCT01800201|537510032|FG001|Overall Study|Withdrawal by Subject|0|||
149008189|NCT01800201|537510031|FG000|Overall Study|patient privacy concerns|1|||
149008190|NCT01800201|537510032|FG001|Overall Study|patient privacy concerns|1|||
149008191|NCT01800201|537510031|FG000|Overall Study|did not want to use device|0|||
149008192|NCT01800201|537510032|FG001|Overall Study|did not want to use device|1|||
149008193|NCT01800201|537510031|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
149008194|NCT01800201|537510032|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
149008195|NCT00708435|537510033|FG000|Overall Study|Death / Serious Adverse Event|10|||
149008196|NCT00708435|537510034|FG001|Overall Study|Death / Serious Adverse Event|5|||
149008197|NCT00708435|537510033|FG000|Overall Study|Lost to Follow-up|9|||
149008198|NCT00708435|537510034|FG001|Overall Study|Lost to Follow-up|4|||
149008199|NCT00708435|537510033|FG000|Overall Study|Withdrawal by Subject|3|||
149008200|NCT00708435|537510034|FG001|Overall Study|Withdrawal by Subject|7|||
149008201|NCT00708435|537510033|FG000|Overall Study|Adverse Event|1|||
149008202|NCT00708435|537510034|FG001|Overall Study|Adverse Event|0|||
149008203|NCT00708435|537510033|FG000|Overall Study|Protocol Violation|0|||
149008204|NCT00708435|537510034|FG001|Overall Study|Protocol Violation|1|||
149008205|NCT00708435|537510033|FG000|Overall Study|Intervention by primary care physician|1|||
149008206|NCT00708435|537510034|FG001|Overall Study|Intervention by primary care physician|0|||
149008207|NCT00708435|537510033|FG000|Overall Study|Refused hospitalization|1|||
149008208|NCT00708435|537510034|FG001|Overall Study|Refused hospitalization|0|||
149008209|NCT05061537|537510038|FG000|Treatment Phase|Progressive disease|0|||
149008210|NCT05061537|537510039|FG001|Treatment Phase|Progressive disease|1|||
149008211|NCT05061537|537510040|FG002|Treatment Phase|Progressive disease|2|||
149008212|NCT05061537|537510041|FG003|Treatment Phase|Progressive disease|0|||
149008213|NCT05061537|537510042|FG004|Treatment Phase|Progressive disease|0|||
149008214|NCT05061537|537510038|FG000|Treatment Phase|Adverse Event|0|||
149008215|NCT05061537|537510039|FG001|Treatment Phase|Adverse Event|0|||
149008216|NCT05061537|537510040|FG002|Treatment Phase|Adverse Event|2|||
149008217|NCT05061537|537510041|FG003|Treatment Phase|Adverse Event|0|||
149008218|NCT05061537|537510042|FG004|Treatment Phase|Adverse Event|0|||
149008219|NCT05061537|537510038|FG000|Treatment Phase|Global deterioration of health status|0|||
149008220|NCT05061537|537510039|FG001|Treatment Phase|Global deterioration of health status|1|||
149008221|NCT05061537|537510040|FG002|Treatment Phase|Global deterioration of health status|0|||
149008222|NCT05061537|537510041|FG003|Treatment Phase|Global deterioration of health status|0|||
149008223|NCT05061537|537510042|FG004|Treatment Phase|Global deterioration of health status|0|||
149008224|NCT05061537|537510038|FG000|Follow up|Other|2|||
149008225|NCT05061537|537510039|FG001|Follow up|Other|0|||
149008226|NCT05061537|537510040|FG002|Follow up|Other|2|||
149008227|NCT05061537|537510041|FG003|Follow up|Other|0|||
149008228|NCT05061537|537510042|FG004|Follow up|Other|0|||
149008229|NCT05061537|537510038|FG000|Follow up|Study terminated by sponsor|0|||
149008230|NCT05061537|537510039|FG001|Follow up|Study terminated by sponsor|0|||
149008231|NCT05061537|537510040|FG002|Follow up|Study terminated by sponsor|2|||
149008232|NCT05061537|537510041|FG003|Follow up|Study terminated by sponsor|0|||
149008233|NCT05061537|537510042|FG004|Follow up|Study terminated by sponsor|0|||
149008234|NCT05061537|537510038|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
149008235|NCT05061537|537510039|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
149008236|NCT05061537|537510040|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
149008237|NCT05061537|537510041|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
149008238|NCT05061537|537510042|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
149008239|NCT05061537|537510038|FG000|Long-term Follow-up|Death|0|||
149008240|NCT05061537|537510039|FG001|Long-term Follow-up|Death|1|||
149008241|NCT05061537|537510040|FG002|Long-term Follow-up|Death|0|||
149008242|NCT05061537|537510041|FG003|Long-term Follow-up|Death|0|||
149008243|NCT05061537|537510042|FG004|Long-term Follow-up|Death|0|||
149008244|NCT04503096|537510047|FG000|Overall Study|Withdrawal by Subject|3|||
149008245|NCT01480596|537510048|FG000|Overall Study|Adverse Event|3|||
149008246|NCT01480596|537510049|FG001|Overall Study|Adverse Event|0|||
149008247|NCT01480596|537510048|FG000|Overall Study|MG exacerbation or change in medication|2|||
149008248|NCT01480596|537510049|FG001|Overall Study|MG exacerbation or change in medication|2|||
149008249|NCT01576367|537510050|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149008250|NCT01576367|537510050|FG000|Overall Study|Moved to commercial use after 6 months|1|||
149008251|NCT00988221|537510051|FG000|Part I|Adverse Event|0|||
149008252|NCT00988221|537510052|FG001|Part I|Adverse Event|1|||
149008253|NCT00988221|537510053|FG002|Part I|Adverse Event|2|||
149008254|NCT00988221|537510054|FG003|Part I|Adverse Event|0|||
149008255|NCT00988221|537510051|FG000|Part I|Insufficient Therapeutic Response|4|||
149008256|NCT00988221|537510052|FG001|Part I|Insufficient Therapeutic Response|6|||
149008257|NCT00988221|537510053|FG002|Part I|Insufficient Therapeutic Response|5|||
149008258|NCT00988221|537510054|FG003|Part I|Insufficient Therapeutic Response|0|||
149008259|NCT00988221|537510051|FG000|Part I|Refused Treatment|0|||
149008260|NCT00988221|537510052|FG001|Part I|Refused Treatment|2|||
149008261|NCT00988221|537510053|FG002|Part I|Refused Treatment|1|||
149008262|NCT00988221|537510054|FG003|Part I|Refused Treatment|0|||
148781949|NCT02854605|536675567|FG000|Overall Study|Adverse Event|1|||
148781950|NCT02854605|536675568|FG001|Overall Study|Adverse Event|5|||
148781951|NCT02854605|536675569|FG002|Overall Study|Adverse Event|2|||
148781952|NCT02854605|536675567|FG000|Overall Study|Lost to Follow-up|0|||
148781953|NCT02854605|536675568|FG001|Overall Study|Lost to Follow-up|2|||
148781954|NCT02854605|536675569|FG002|Overall Study|Lost to Follow-up|0|||
148781955|NCT02854605|536675567|FG000|Overall Study|Withdrew Consent|1|||
148781956|NCT02854605|536675568|FG001|Overall Study|Withdrew Consent|0|||
149008263|NCT00988221|537510051|FG000|Part I|Lost to Follow-up|0|||
149008264|NCT00988221|537510052|FG001|Part I|Lost to Follow-up|1|||
149008265|NCT00988221|537510053|FG002|Part I|Lost to Follow-up|0|||
148781957|NCT02854605|536675569|FG002|Overall Study|Withdrew Consent|1|||
149008266|NCT00988221|537510054|FG003|Part I|Lost to Follow-up|0|||
149008267|NCT00988221|537510051|FG000|Part II|Adverse Event|1|||
149008268|NCT00988221|537510052|FG001|Part II|Adverse Event|0|||
149008269|NCT00988221|537510053|FG002|Part II|Adverse Event|0|||
149008270|NCT00988221|537510054|FG003|Part II|Adverse Event|1|||
148781958|NCT02854605|536675567|FG000|Overall Study|Investigator's Discretion|1|||
148781959|NCT02854605|536675568|FG001|Overall Study|Investigator's Discretion|0|||
149008271|NCT00988221|537510051|FG000|Part II|Withdrawal by Subject|0|||
149008272|NCT00988221|537510052|FG001|Part II|Withdrawal by Subject|0|||
149008273|NCT00988221|537510053|FG002|Part II|Withdrawal by Subject|2|||
149008274|NCT00988221|537510054|FG003|Part II|Withdrawal by Subject|2|||
149008275|NCT00988221|537510051|FG000|Part II|Reason not Specified|0|||
149008276|NCT00988221|537510052|FG001|Part II|Reason not Specified|0|||
149008277|NCT00988221|537510053|FG002|Part II|Reason not Specified|1|||
149008278|NCT00988221|537510054|FG003|Part II|Reason not Specified|0|||
149008279|NCT00988221|537510051|FG000|Part III|Adverse Event|1|||
149008280|NCT00988221|537510052|FG001|Part III|Adverse Event|0|||
149008281|NCT00988221|537510053|FG002|Part III|Adverse Event|1|||
148781960|NCT02854605|536675569|FG002|Overall Study|Investigator's Discretion|0|||
148781961|NCT02854605|536675567|FG000|Overall Study|Protocol Violation|0|||
148781962|NCT02854605|536675568|FG001|Overall Study|Protocol Violation|0|||
148781963|NCT02854605|536675569|FG002|Overall Study|Protocol Violation|1|||
149008282|NCT00988221|537510054|FG003|Part III|Adverse Event|0|||
149008283|NCT00988221|537510051|FG000|Part III|Insufficient Therapeutic Response|0|||
149008284|NCT00988221|537510052|FG001|Part III|Insufficient Therapeutic Response|1|||
148781964|NCT00568334|536675570|FG000|Overall Study|Withdrawal by Subject|0|||
148781965|NCT00568334|536675571|FG001|Overall Study|Withdrawal by Subject|1|||
148781966|NCT00568334|536675570|FG000|Overall Study|Lost to Follow-up|1|||
148781967|NCT00568334|536675571|FG001|Overall Study|Lost to Follow-up|0|||
148781968|NCT01897571|536675572|FG000|Overall Study|Lost to Follow-up|3|||
148781969|NCT01897571|536675573|FG001|Overall Study|Lost to Follow-up|0|||
148781970|NCT01897571|536675574|FG002|Overall Study|Lost to Follow-up|0|||
148781971|NCT01897571|536675575|FG003|Overall Study|Lost to Follow-up|0|||
148781972|NCT01897571|536675576|FG004|Overall Study|Lost to Follow-up|2|||
148781973|NCT01897571|536675577|FG005|Overall Study|Lost to Follow-up|0|||
148781974|NCT01897571|536675578|FG006|Overall Study|Lost to Follow-up|0|||
148781975|NCT01897571|536675579|FG007|Overall Study|Lost to Follow-up|0|||
148781976|NCT01897571|536675580|FG008|Overall Study|Lost to Follow-up|1|||
148781977|NCT01897571|536675581|FG009|Overall Study|Lost to Follow-up|2|||
148781978|NCT01897571|536675582|FG010|Overall Study|Lost to Follow-up|4|||
148781979|NCT01897571|536675572|FG000|Overall Study|Withdrawal by Subject|0|||
148781980|NCT01897571|536675573|FG001|Overall Study|Withdrawal by Subject|0|||
148781981|NCT01897571|536675574|FG002|Overall Study|Withdrawal by Subject|0|||
148781982|NCT01897571|536675575|FG003|Overall Study|Withdrawal by Subject|0|||
148781983|NCT01897571|536675576|FG004|Overall Study|Withdrawal by Subject|0|||
148781984|NCT01897571|536675577|FG005|Overall Study|Withdrawal by Subject|0|||
148781985|NCT01897571|536675578|FG006|Overall Study|Withdrawal by Subject|0|||
148781986|NCT01897571|536675579|FG007|Overall Study|Withdrawal by Subject|1|||
148781987|NCT01897571|536675580|FG008|Overall Study|Withdrawal by Subject|4|||
148781988|NCT01897571|536675581|FG009|Overall Study|Withdrawal by Subject|3|||
148781989|NCT01897571|536675582|FG010|Overall Study|Withdrawal by Subject|1|||
148781990|NCT01897571|536675572|FG000|Overall Study|Other|1|||
148781991|NCT01897571|536675573|FG001|Overall Study|Other|0|||
148781992|NCT01897571|536675574|FG002|Overall Study|Other|0|||
148781993|NCT01897571|536675575|FG003|Overall Study|Other|3|||
148781994|NCT01897571|536675576|FG004|Overall Study|Other|3|||
148781995|NCT01897571|536675577|FG005|Overall Study|Other|4|||
148781996|NCT01897571|536675578|FG006|Overall Study|Other|7|||
148781997|NCT01897571|536675579|FG007|Overall Study|Other|0|||
148781998|NCT01897571|536675580|FG008|Overall Study|Other|0|||
148781999|NCT01897571|536675581|FG009|Overall Study|Other|0|||
148782000|NCT01897571|536675582|FG010|Overall Study|Other|0|||
148782001|NCT01897571|536675572|FG000|Overall Study|Enrolled in rollover study|0|||
148782002|NCT01897571|536675573|FG001|Overall Study|Enrolled in rollover study|0|||
148782003|NCT01897571|536675574|FG002|Overall Study|Enrolled in rollover study|0|||
148782004|NCT01897571|536675575|FG003|Overall Study|Enrolled in rollover study|0|||
148782005|NCT01897571|536675576|FG004|Overall Study|Enrolled in rollover study|0|||
148782006|NCT01897571|536675577|FG005|Overall Study|Enrolled in rollover study|0|||
148782007|NCT01897571|536675578|FG006|Overall Study|Enrolled in rollover study|0|||
149008285|NCT00988221|537510053|FG002|Part III|Insufficient Therapeutic Response|1|||
149008286|NCT00988221|537510054|FG003|Part III|Insufficient Therapeutic Response|0|||
149008287|NCT00988221|537510051|FG000|Part III|Refused Treatment|0|||
149008288|NCT00988221|537510052|FG001|Part III|Refused Treatment|0|||
149008289|NCT00988221|537510053|FG002|Part III|Refused Treatment|1|||
149008290|NCT00988221|537510054|FG003|Part III|Refused Treatment|0|||
149008291|NCT01346514|537510058|FG000|Overall Study|Lost to Follow-up|19|||
149008292|NCT01346514|537510059|FG001|Overall Study|Lost to Follow-up|30|||
149008293|NCT01346514|537510058|FG000|Overall Study|Withdrawal by Subject|7|||
149008294|NCT01346514|537510059|FG001|Overall Study|Withdrawal by Subject|3|||
149008295|NCT01346514|537510058|FG000|Overall Study|Death|3|||
149008296|NCT01346514|537510059|FG001|Overall Study|Death|4|||
149008297|NCT00909480|537510060|FG000|Overall Study|Adverse Event|5|||
149008298|NCT00909480|537510061|FG001|Overall Study|Adverse Event|3|||
148782008|NCT01897571|536675579|FG007|Overall Study|Enrolled in rollover study|9|||
148782009|NCT01897571|536675580|FG008|Overall Study|Enrolled in rollover study|7|||
148782010|NCT01897571|536675581|FG009|Overall Study|Enrolled in rollover study|9|||
148782011|NCT01897571|536675582|FG010|Overall Study|Enrolled in rollover study|1|||
149008299|NCT00909480|537510060|FG000|Overall Study|Protocol Violation|6|||
149008300|NCT00909480|537510061|FG001|Overall Study|Protocol Violation|8|||
149008301|NCT00909480|537510060|FG000|Overall Study|Withdrawal criteria|9|||
149008302|NCT00909480|537510061|FG001|Overall Study|Withdrawal criteria|11|||
149008303|NCT00909480|537510060|FG000|Overall Study|Unclassified|18|||
149008304|NCT00909480|537510061|FG001|Overall Study|Unclassified|19|||
148782012|NCT01897571|536675572|FG000|Overall Study|Death|2|||
148782013|NCT01897571|536675573|FG001|Overall Study|Death|2|||
148782014|NCT01897571|536675574|FG002|Overall Study|Death|3|||
148782015|NCT01897571|536675575|FG003|Overall Study|Death|6|||
148782016|NCT01897571|536675576|FG004|Overall Study|Death|7|||
149008305|NCT03528174|537510068|FG000|Overall Study|Adverse Event|1|||
149008306|NCT03528174|537510068|FG000|Overall Study|sensors dislodged|1|||
149008307|NCT00979602|537510075|FG000|Overall Study|Serious Adverse Event|5|||
149008308|NCT00979602|537510076|FG001|Overall Study|Serious Adverse Event|3|||
149008309|NCT00979602|537510075|FG000|Overall Study|Protocol Violation|3|||
149008310|NCT00979602|537510076|FG001|Overall Study|Protocol Violation|0|||
149008311|NCT00979602|537510075|FG000|Overall Study|Withdrawal by Subject|31|||
149008312|NCT00979602|537510076|FG001|Overall Study|Withdrawal by Subject|25|||
149008313|NCT00979602|537510075|FG000|Overall Study|Lost to Follow-up|100|||
149008314|NCT00979602|537510076|FG001|Overall Study|Lost to Follow-up|96|||
149008315|NCT00979602|537510075|FG000|Overall Study|Migrated/moved from study area|3|||
149008316|NCT00979602|537510076|FG001|Overall Study|Migrated/moved from study area|6|||
149008317|NCT00979602|537510075|FG000|Overall Study|Others|3|||
149008318|NCT00979602|537510076|FG001|Overall Study|Others|3|||
149008319|NCT02904902|537510077|FG000|Overall Study|Withdrawal by Subject|1|||
149008320|NCT02712398|537510078|FG000|Overall Study|Withdrawal by Subject|6|||
149008321|NCT02712398|537510078|FG000|Overall Study|Lost to Follow-up|6|||
149008322|NCT02712398|537510078|FG000|Overall Study|Sponsor Decision|1|||
149008323|NCT02712398|537510078|FG000|Overall Study|Physician Decision|1|||
149008324|NCT02712398|537510078|FG000|Overall Study|Death|2|||
149008325|NCT02712398|537510078|FG000|Overall Study|Re-operation|21|||
149008326|NCT02002182|537510088|FG000|Overall Study|Withdraw from study|3|||
149008327|NCT02002182|537510089|FG001|Overall Study|Withdraw from study|1|||
149008328|NCT02002182|537510088|FG000|Overall Study|Health Reasons|1|||
149008329|NCT02002182|537510089|FG001|Overall Study|Health Reasons|0|||
149008330|NCT02002182|537510088|FG000|Overall Study|Death|1|||
149008331|NCT02002182|537510089|FG001|Overall Study|Death|0|||
149008332|NCT04772053|537510092|FG000|Overall Study|Physician Decision|2|||
149008333|NCT04772053|537510092|FG000|Overall Study|Withdrawal by Subject|3|||
149008334|NCT04772053|537510092|FG000|Overall Study|Study Terminated by Sponsor|1|||
149008335|NCT02118337|537510093|FG000|Overall Study|Other|1|||
149008336|NCT02118337|537510094|FG001|Overall Study|Other|0|||
149008337|NCT02118337|537510095|FG002|Overall Study|Other|0|||
149008338|NCT02118337|537510096|FG003|Overall Study|Other|0|||
149008339|NCT02118337|537510097|FG004|Overall Study|Other|2|||
148782017|NCT01897571|536675577|FG005|Overall Study|Death|9|||
148782018|NCT01897571|536675578|FG006|Overall Study|Death|5|||
148782019|NCT01897571|536675579|FG007|Overall Study|Death|22|||
148782020|NCT01897571|536675580|FG008|Overall Study|Death|23|||
148782021|NCT01897571|536675581|FG009|Overall Study|Death|129|||
148782022|NCT01897571|536675582|FG010|Overall Study|Death|59|||
148782023|NCT01797094|536675583|FG000|Overall Study|Adverse Event|1|||
148782024|NCT01797094|536675584|FG001|Overall Study|Adverse Event|1|||
148782025|NCT01797094|536675583|FG000|Overall Study|Personal Reasons|4|||
148782026|NCT01797094|536675584|FG001|Overall Study|Personal Reasons|0|||
148782027|NCT01797094|536675583|FG000|Overall Study|Protocol Violation|0|||
148782028|NCT01797094|536675584|FG001|Overall Study|Protocol Violation|1|||
148782029|NCT01797094|536675583|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148782030|NCT01797094|536675584|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148782031|NCT03217968|536675585|FG000|Overall Study|Withdrawal by Subject|4|||
148782032|NCT03217968|536675585|FG000|Overall Study|Lost to Follow-up|1|||
148782033|NCT03217968|536675585|FG000|Overall Study|Protocol Violation|6|||
148782034|NCT05268016|536675588|FG000|Overall Study|Unacceptable toxicity or AE|2|||
148782035|NCT05268016|536675589|FG001|Overall Study|Unacceptable toxicity or AE|2|||
148782036|NCT05268016|536675590|FG002|Overall Study|Unacceptable toxicity or AE|4|||
148782037|NCT05268016|536675591|FG003|Overall Study|Unacceptable toxicity or AE|3|||
148782038|NCT05268016|536675592|FG004|Overall Study|Unacceptable toxicity or AE|1|||
148782039|NCT05268016|536675588|FG000|Overall Study|Withdrawal by Subject|1|||
148782040|NCT05268016|536675589|FG001|Overall Study|Withdrawal by Subject|3|||
148782041|NCT05268016|536675590|FG002|Overall Study|Withdrawal by Subject|2|||
148782042|NCT05268016|536675591|FG003|Overall Study|Withdrawal by Subject|2|||
148782043|NCT05268016|536675592|FG004|Overall Study|Withdrawal by Subject|1|||
148782044|NCT05268016|536675588|FG000|Overall Study|Lost to Follow-up|4|||
148782045|NCT05268016|536675589|FG001|Overall Study|Lost to Follow-up|7|||
148782046|NCT05268016|536675590|FG002|Overall Study|Lost to Follow-up|1|||
149008340|NCT02118337|537510098|FG005|Overall Study|Other|3|||
149008341|NCT02118337|537510099|FG006|Overall Study|Other|1|||
149008342|NCT02118337|537510100|FG007|Overall Study|Other|28|||
149008343|NCT02118337|537510101|FG008|Overall Study|Other|15|||
149008344|NCT02118337|537510093|FG000|Overall Study|Lost to Follow-up|0|||
149008345|NCT02118337|537510094|FG001|Overall Study|Lost to Follow-up|0|||
149008346|NCT02118337|537510095|FG002|Overall Study|Lost to Follow-up|0|||
149008347|NCT02118337|537510096|FG003|Overall Study|Lost to Follow-up|0|||
149008348|NCT02118337|537510097|FG004|Overall Study|Lost to Follow-up|0|||
149008349|NCT02118337|537510098|FG005|Overall Study|Lost to Follow-up|0|||
149008350|NCT02118337|537510099|FG006|Overall Study|Lost to Follow-up|0|||
149008351|NCT02118337|537510100|FG007|Overall Study|Lost to Follow-up|1|||
149008352|NCT02118337|537510101|FG008|Overall Study|Lost to Follow-up|0|||
148782047|NCT05268016|536675591|FG003|Overall Study|Lost to Follow-up|3|||
148782048|NCT05268016|536675592|FG004|Overall Study|Lost to Follow-up|5|||
149008353|NCT02118337|537510093|FG000|Overall Study|Withdrawal by Subject|1|||
148782049|NCT05268016|536675588|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
148782050|NCT05268016|536675589|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
148782051|NCT05268016|536675590|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
148782052|NCT05268016|536675591|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
148782053|NCT05268016|536675592|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
148782054|NCT05268016|536675588|FG000|Overall Study|Lack of Efficacy|0|||
148782055|NCT05268016|536675589|FG001|Overall Study|Lack of Efficacy|0|||
148782056|NCT05268016|536675590|FG002|Overall Study|Lack of Efficacy|0|||
148782057|NCT05268016|536675591|FG003|Overall Study|Lack of Efficacy|0|||
148782058|NCT05268016|536675592|FG004|Overall Study|Lack of Efficacy|4|||
148782059|NCT05268016|536675588|FG000|Overall Study|Physician Decision|0|||
148782060|NCT05268016|536675589|FG001|Overall Study|Physician Decision|0|||
148782061|NCT05268016|536675590|FG002|Overall Study|Physician Decision|0|||
148782062|NCT05268016|536675591|FG003|Overall Study|Physician Decision|1|||
148782063|NCT05268016|536675592|FG004|Overall Study|Physician Decision|0|||
148782064|NCT05268016|536675588|FG000|Overall Study|Other|1|||
148782065|NCT05268016|536675589|FG001|Overall Study|Other|0|||
148782066|NCT05268016|536675590|FG002|Overall Study|Other|1|||
148782067|NCT05268016|536675591|FG003|Overall Study|Other|2|||
148782068|NCT05268016|536675592|FG004|Overall Study|Other|0|||
148782069|NCT03013985|536675599|FG000|Overall Study|Protocol Violation|2|||
148782070|NCT03013985|536675600|FG001|Overall Study|Protocol Violation|2|||
148782071|NCT03013985|536675599|FG000|Overall Study|Withdrawal by Subject|14|||
148782072|NCT03013985|536675600|FG001|Overall Study|Withdrawal by Subject|17|||
148782073|NCT03411902|536675601|FG000|Overall Study|Lost to Follow-up|3|||
148782074|NCT03411902|536675602|FG001|Overall Study|Lost to Follow-up|0|||
148782075|NCT00791492|536675603|FG000|Overall Study|Withdrawal by Subject|1|||
148782076|NCT00791492|536675604|FG001|Overall Study|Withdrawal by Subject|2|||
148782077|NCT00791492|536675603|FG000|Overall Study|Liver transplantation|5|||
148782078|NCT00791492|536675604|FG001|Overall Study|Liver transplantation|1|||
148782079|NCT00076999|536675607|FG000|Overall Study|Adverse Event|2|||
148782080|NCT00076999|536675608|FG001|Overall Study|Adverse Event|8|||
148782081|NCT00076999|536675609|FG002|Overall Study|Adverse Event|6|||
148782082|NCT00076999|536675610|FG003|Overall Study|Adverse Event|0|||
148782083|NCT00076999|536675611|FG004|Overall Study|Adverse Event|2|||
148782084|NCT00076999|536675607|FG000|Overall Study|Protocol Violation|0|||
148782085|NCT00076999|536675608|FG001|Overall Study|Protocol Violation|3|||
148782086|NCT00076999|536675609|FG002|Overall Study|Protocol Violation|4|||
148782087|NCT00076999|536675610|FG003|Overall Study|Protocol Violation|0|||
148782088|NCT00076999|536675611|FG004|Overall Study|Protocol Violation|9|||
148782089|NCT00076999|536675607|FG000|Overall Study|Lost to Follow-up|2|||
148782090|NCT00076999|536675608|FG001|Overall Study|Lost to Follow-up|1|||
148782091|NCT00076999|536675609|FG002|Overall Study|Lost to Follow-up|0|||
148782092|NCT00076999|536675610|FG003|Overall Study|Lost to Follow-up|0|||
148782093|NCT00076999|536675611|FG004|Overall Study|Lost to Follow-up|0|||
148782094|NCT00076999|536675607|FG000|Overall Study|Withdrawal by Subject|0|||
148782095|NCT00076999|536675608|FG001|Overall Study|Withdrawal by Subject|4|||
148782096|NCT00076999|536675609|FG002|Overall Study|Withdrawal by Subject|3|||
148782097|NCT00076999|536675610|FG003|Overall Study|Withdrawal by Subject|0|||
148782098|NCT00076999|536675611|FG004|Overall Study|Withdrawal by Subject|1|||
148782099|NCT00076999|536675607|FG000|Overall Study|Other reason (not specified)|8|||
148782100|NCT00076999|536675608|FG001|Overall Study|Other reason (not specified)|8|||
148782101|NCT00076999|536675609|FG002|Overall Study|Other reason (not specified)|4|||
148782102|NCT00076999|536675610|FG003|Overall Study|Other reason (not specified)|1|||
148782103|NCT00076999|536675611|FG004|Overall Study|Other reason (not specified)|13|||
148782104|NCT00090987|536675614|FG000|Overall Study|Adverse Event|5|||
148782105|NCT00090987|536675614|FG000|Overall Study|Lack of Efficacy|7|||
148782106|NCT00090987|536675614|FG000|Overall Study|Withdrawal by Subject|3|||
148782107|NCT00090987|536675614|FG000|Overall Study|alternative therapy|1|||
148782108|NCT00090987|536675614|FG000|Overall Study|Non-compliance|4|||
148782109|NCT00090987|536675614|FG000|Overall Study|Incarcerated|1|||
148782110|NCT00990665|536675615|FG000|Overall Study|Unsuccessful Implant|8|||
148782111|NCT00990665|536675615|FG000|Overall Study|Death|29|||
148782112|NCT00990665|536675615|FG000|Overall Study|Heart Transplant|1|||
148782113|NCT00990665|536675615|FG000|Overall Study|Withdrawal by Subject|6|||
148782114|NCT00990665|536675615|FG000|Overall Study|Lost to Follow-up|1|||
148782115|NCT00990665|536675615|FG000|Overall Study|System Explant|3|||
148782116|NCT02603562|536675616|FG000|Overall Study|Lost to Follow-up|1|||
148782117|NCT01534208|536675620|FG000|Overall Study|Lost to Follow-up|19|||
148782118|NCT01534208|536675621|FG001|Overall Study|Lost to Follow-up|14|||
148782119|NCT01534208|536675620|FG000|Overall Study|Withdrawal by Subject|6|||
148782120|NCT01534208|536675621|FG001|Overall Study|Withdrawal by Subject|20|||
148782121|NCT01534208|536675620|FG000|Overall Study|Adverse Event|15|||
148782122|NCT01534208|536675621|FG001|Overall Study|Adverse Event|8|||
148782123|NCT01534208|536675620|FG000|Overall Study|Physician Decision|2|||
148782124|NCT01534208|536675621|FG001|Overall Study|Physician Decision|0|||
148782125|NCT01534208|536675620|FG000|Overall Study|Lack of Efficacy|0|||
148782126|NCT01534208|536675621|FG001|Overall Study|Lack of Efficacy|3|||
148782127|NCT01534208|536675620|FG000|Overall Study|Protocol Violation|2|||
148782128|NCT01534208|536675621|FG001|Overall Study|Protocol Violation|2|||
148782129|NCT01534208|536675620|FG000|Overall Study|Sponsor decision|4|||
148782130|NCT01534208|536675621|FG001|Overall Study|Sponsor decision|1|||
148782131|NCT01534208|536675620|FG000|Overall Study|Subject relocation|2|||
148782132|NCT01534208|536675621|FG001|Overall Study|Subject relocation|0|||
148782133|NCT01534208|536675620|FG000|Overall Study|Lab assessment|2|||
148782134|NCT01534208|536675621|FG001|Overall Study|Lab assessment|1|||
148782135|NCT01534208|536675620|FG000|Overall Study|Eligibility error|3|||
148782136|NCT01534208|536675621|FG001|Overall Study|Eligibility error|0|||
148782137|NCT01534208|536675620|FG000|Overall Study|PCP decision|1|||
148782138|NCT01534208|536675621|FG001|Overall Study|PCP decision|0|||
148782139|NCT01534208|536675620|FG000|Overall Study|Needed prohibited meds|1|||
148782140|NCT01534208|536675621|FG001|Overall Study|Needed prohibited meds|0|||
148782141|NCT03578146|536675624|FG000|Overall Study|Did Not Receive Treatment|1|||
148782142|NCT03578146|536675625|FG001|Overall Study|Did Not Receive Treatment|0|||
148782143|NCT03578146|536675626|FG002|Overall Study|Did Not Receive Treatment|0|||
148782144|NCT03578146|536675627|FG003|Overall Study|Did Not Receive Treatment|0|||
148782145|NCT03578146|536675628|FG004|Overall Study|Did Not Receive Treatment|0|||
148782146|NCT03578146|536675629|FG005|Overall Study|Did Not Receive Treatment|2|||
148782147|NCT03578146|536675624|FG000|Overall Study|Lost to Follow-up|0|||
148782148|NCT03578146|536675625|FG001|Overall Study|Lost to Follow-up|1|||
148782149|NCT03578146|536675626|FG002|Overall Study|Lost to Follow-up|1|||
148782150|NCT03578146|536675627|FG003|Overall Study|Lost to Follow-up|0|||
148782151|NCT03578146|536675628|FG004|Overall Study|Lost to Follow-up|0|||
148782152|NCT03578146|536675629|FG005|Overall Study|Lost to Follow-up|1|||
148782153|NCT02240069|536675630|FG000|Overall Study|Withdrawal by Subject|5|||
148782154|NCT02240069|536675631|FG001|Overall Study|Withdrawal by Subject|5|||
148782155|NCT02240069|536675632|FG002|Overall Study|Withdrawal by Subject|2|||
148782156|NCT00441363|536677364|FG000|Overall Study|Adverse Event|4|||
148782157|NCT00441363|536677365|FG001|Overall Study|Adverse Event|2|||
148782158|NCT00441363|536677364|FG000|Overall Study|Withdrawal by Subject|3|||
148782159|NCT00441363|536677365|FG001|Overall Study|Withdrawal by Subject|4|||
148782160|NCT00441363|536677364|FG000|Overall Study|Physician Decision|6|||
148782161|NCT00441363|536677365|FG001|Overall Study|Physician Decision|7|||
148782162|NCT00441363|536677364|FG000|Overall Study|Lost to Follow-up|2|||
148782163|NCT00441363|536677365|FG001|Overall Study|Lost to Follow-up|2|||
148782164|NCT00441363|536677364|FG000|Overall Study|Other|2|||
148782165|NCT00441363|536677365|FG001|Overall Study|Other|0|||
148782166|NCT02437188|536677368|FG000|Overall Study|Randomized but did not receive surgery|4|||
148782167|NCT02437188|536677369|FG001|Overall Study|Randomized but did not receive surgery|8|||
148782168|NCT02437188|536677368|FG000|Overall Study|Adverse Event|0|||
148782169|NCT02437188|536677369|FG001|Overall Study|Adverse Event|1|||
148782170|NCT02290925|536677376|FG000|First Period of Three Months|Lost to Follow-up|2|||
148782171|NCT02290925|536677377|FG001|First Period of Three Months|Lost to Follow-up|1|||
148782172|NCT02290925|536677376|FG000|First Period of Three Months|Death|1|||
148782173|NCT02290925|536677377|FG001|First Period of Three Months|Death|0|||
148782174|NCT02290925|536677376|FG000|First Period of Three Months|Insulin Started|1|||
148782175|NCT02290925|536677377|FG001|First Period of Three Months|Insulin Started|1|||
148782176|NCT02290925|536677376|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
148782177|NCT02290925|536677377|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
148782178|NCT02290925|536677376|FG000|Second Period of 3 Months|insulin started|0|||
148782179|NCT02290925|536677377|FG001|Second Period of 3 Months|insulin started|1|||
148782180|NCT02305446|536677379|FG000|Overall Study|Adverse Event|1|||
148782181|NCT02719353|536677386|FG000|First Intervention|Physician Decision|0|||
148782182|NCT02719353|536677387|FG001|First Intervention|Physician Decision|1|||
148782183|NCT03956615|536677388|FG000|Overall Study|No multiple myeloma confirmed|2|||
148782184|NCT03956615|536677388|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
148782185|NCT03956615|536677388|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
148782186|NCT03956615|536677388|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
148782187|NCT00412217|536677389|FG000|Overall Study|Insufficient Data Available|8|||
148782188|NCT00412217|536677390|FG001|Overall Study|Insufficient Data Available|3|||
148782189|NCT00412217|536677389|FG000|Overall Study|Death|5|||
148893344|NCT00683878|537088679|FG001|Overall Study|Lack of Efficacy|0|||
148782190|NCT00412217|536677390|FG001|Overall Study|Death|4|||
148782191|NCT00412217|536677389|FG000|Overall Study|Disease Progression|2|||
148782192|NCT00412217|536677390|FG001|Overall Study|Disease Progression|3|||
148782193|NCT00412217|536677389|FG000|Overall Study|Investigator Decision|1|||
148782194|NCT00412217|536677390|FG001|Overall Study|Investigator Decision|0|||
148782195|NCT00412217|536677389|FG000|Overall Study|Withdrawal by Subject|2|||
148782196|NCT00412217|536677390|FG001|Overall Study|Withdrawal by Subject|0|||
148782197|NCT00412217|536677389|FG000|Overall Study|Lost to Follow-up|1|||
148782198|NCT00412217|536677390|FG001|Overall Study|Lost to Follow-up|4|||
148782199|NCT00412217|536677389|FG000|Overall Study|Study Terminated by Sponsor|26|||
148782200|NCT00412217|536677390|FG001|Overall Study|Study Terminated by Sponsor|33|||
148782201|NCT00412217|536677389|FG000|Overall Study|Other|1|||
148782202|NCT00412217|536677390|FG001|Overall Study|Other|1|||
148782203|NCT01069419|536677391|FG000|Overall Study|Adverse Event|233|||
148782204|NCT01069419|536677391|FG000|Overall Study|Lack of Efficacy|332|||
148782205|NCT01069419|536677391|FG000|Overall Study|Lost to Follow-up|49|||
148782206|NCT01069419|536677391|FG000|Overall Study|Remission of disease|11|||
148782207|NCT01069419|536677391|FG000|Overall Study|Withdrawal by Subject|34|||
148782208|NCT01069419|536677391|FG000|Overall Study|Other Reason|43|||
148782209|NCT01069419|536677391|FG000|Overall Study|Missing termination information|13|||
148782210|NCT01217385|536677396|FG000|Overall Study|Withdrawal by Subject|3|||
148782211|NCT01217385|536677396|FG000|Overall Study|DOSI not performed/not eval|12|||
148782212|NCT01217385|536677396|FG000|Overall Study|Central Path not Available|1|||
149008354|NCT02118337|537510094|FG001|Overall Study|Withdrawal by Subject|3|||
149008355|NCT02118337|537510095|FG002|Overall Study|Withdrawal by Subject|2|||
149008356|NCT02118337|537510096|FG003|Overall Study|Withdrawal by Subject|1|||
149008357|NCT02118337|537510097|FG004|Overall Study|Withdrawal by Subject|2|||
149008358|NCT02118337|537510098|FG005|Overall Study|Withdrawal by Subject|2|||
149008359|NCT02118337|537510099|FG006|Overall Study|Withdrawal by Subject|1|||
149008360|NCT02118337|537510100|FG007|Overall Study|Withdrawal by Subject|4|||
149008361|NCT02118337|537510101|FG008|Overall Study|Withdrawal by Subject|2|||
149008362|NCT02118337|537510093|FG000|Overall Study|Death|2|||
149008363|NCT02118337|537510094|FG001|Overall Study|Death|2|||
149008364|NCT02118337|537510095|FG002|Overall Study|Death|1|||
149008365|NCT02118337|537510096|FG003|Overall Study|Death|2|||
149008366|NCT02118337|537510097|FG004|Overall Study|Death|5|||
149008367|NCT02118337|537510098|FG005|Overall Study|Death|1|||
149008368|NCT02118337|537510099|FG006|Overall Study|Death|2|||
149008369|NCT02118337|537510100|FG007|Overall Study|Death|9|||
149008370|NCT02118337|537510101|FG008|Overall Study|Death|4|||
149008371|NCT04296890|537510103|FG000|Overall Study|Withdrawal by Subject|1|||
149008372|NCT04296890|537510103|FG000|Overall Study|Death|62|||
149008373|NCT04296890|537510103|FG000|Overall Study|Lost to Follow-up|3|||
149008374|NCT04296890|537510103|FG000|Overall Study|Other than specified|2|||
149008375|NCT03787680|537510104|FG000|Overall Study|Physician Decision|2|||
149008376|NCT03787680|537510105|FG001|Overall Study|Physician Decision|3|||
149008377|NCT03787680|537510104|FG000|Overall Study|Adverse Event|7|||
149008378|NCT03787680|537510105|FG001|Overall Study|Adverse Event|3|||
149008379|NCT03787680|537510104|FG000|Overall Study|Withdrawal by Subject|2|||
149008380|NCT03787680|537510105|FG001|Overall Study|Withdrawal by Subject|1|||
149008381|NCT05400746|537510106|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
149008382|NCT05400746|537510107|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
149008383|NCT05400746|537510108|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
149008384|NCT03724396|537510109|FG000|Overall Study|Lost to Follow-up|1|||
149008385|NCT03724396|537510110|FG001|Overall Study|Lost to Follow-up|1|||
149008386|NCT03724396|537510109|FG000|Overall Study|Withdrawal by Subject|1|||
149008387|NCT03724396|537510110|FG001|Overall Study|Withdrawal by Subject|0|||
149008388|NCT01490125|537510111|FG000|Period I|Adverse Event|4|||
149008389|NCT01490125|537510112|FG001|Period I|Adverse Event|1|||
149008390|NCT01490125|537510113|FG002|Period I|Adverse Event|1|||
149008391|NCT01490125|537510114|FG003|Period I|Adverse Event|3|||
149008392|NCT01490125|537510115|FG004|Period I|Adverse Event|2|||
149008393|NCT01490125|537510116|FG005|Period I|Adverse Event|4|||
149008394|NCT01490125|537510111|FG000|Period I|Protocol Violation|1|||
149008395|NCT01490125|537510112|FG001|Period I|Protocol Violation|1|||
149008396|NCT01490125|537510113|FG002|Period I|Protocol Violation|1|||
149008397|NCT01490125|537510114|FG003|Period I|Protocol Violation|1|||
149008398|NCT01490125|537510115|FG004|Period I|Protocol Violation|0|||
149008399|NCT01490125|537510116|FG005|Period I|Protocol Violation|0|||
149008400|NCT01490125|537510111|FG000|Period I|Withdrawal by Subject|1|||
149008401|NCT01490125|537510112|FG001|Period I|Withdrawal by Subject|3|||
149008402|NCT01490125|537510113|FG002|Period I|Withdrawal by Subject|2|||
149008403|NCT01490125|537510114|FG003|Period I|Withdrawal by Subject|1|||
148782213|NCT01217385|536677396|FG000|Overall Study|Normal Breast TOI not available|10|||
148782214|NCT00270231|536677401|FG000|First Intervention|Lost to Follow-up|1|||
148782215|NCT00270231|536677402|FG001|First Intervention|Lost to Follow-up|1|||
149008404|NCT01490125|537510115|FG004|Period I|Withdrawal by Subject|2|||
149008405|NCT01490125|537510116|FG005|Period I|Withdrawal by Subject|1|||
148782216|NCT00270231|536677401|FG000|Washout Period|Lost to Follow-up|1|||
148782217|NCT00270231|536677402|FG001|Washout Period|Lost to Follow-up|0|||
149008406|NCT01490125|537510111|FG000|Period II|Adverse Event|2|||
149008407|NCT01490125|537510112|FG001|Period II|Adverse Event|3|||
149008408|NCT01490125|537510113|FG002|Period II|Adverse Event|2|||
149008409|NCT01490125|537510114|FG003|Period II|Adverse Event|2|||
149008410|NCT01490125|537510115|FG004|Period II|Adverse Event|4|||
149008411|NCT01490125|537510116|FG005|Period II|Adverse Event|2|||
149008412|NCT01490125|537510111|FG000|Period II|Protocol Violation|0|||
149008413|NCT01490125|537510112|FG001|Period II|Protocol Violation|0|||
149008414|NCT01490125|537510113|FG002|Period II|Protocol Violation|1|||
149008415|NCT01490125|537510114|FG003|Period II|Protocol Violation|1|||
149008416|NCT01490125|537510115|FG004|Period II|Protocol Violation|0|||
149008417|NCT01490125|537510116|FG005|Period II|Protocol Violation|0|||
149008418|NCT01490125|537510111|FG000|Period II|Lost to Follow-up|0|||
149008419|NCT01490125|537510112|FG001|Period II|Lost to Follow-up|1|||
149008420|NCT01490125|537510113|FG002|Period II|Lost to Follow-up|0|||
149008421|NCT01490125|537510114|FG003|Period II|Lost to Follow-up|0|||
149008422|NCT01490125|537510115|FG004|Period II|Lost to Follow-up|0|||
149008423|NCT01490125|537510116|FG005|Period II|Lost to Follow-up|0|||
149008424|NCT01490125|537510111|FG000|Period II|Withdrawal by Subject|1|||
149008425|NCT01490125|537510112|FG001|Period II|Withdrawal by Subject|0|||
149008426|NCT01490125|537510113|FG002|Period II|Withdrawal by Subject|0|||
149008427|NCT01490125|537510114|FG003|Period II|Withdrawal by Subject|0|||
149008428|NCT01490125|537510115|FG004|Period II|Withdrawal by Subject|0|||
149008429|NCT01490125|537510116|FG005|Period II|Withdrawal by Subject|0|||
149008430|NCT01490125|537510111|FG000|Period III|Adverse Event|3|||
149008431|NCT01490125|537510112|FG001|Period III|Adverse Event|1|||
149008432|NCT01490125|537510113|FG002|Period III|Adverse Event|0|||
149008433|NCT01490125|537510114|FG003|Period III|Adverse Event|1|||
149008434|NCT01490125|537510115|FG004|Period III|Adverse Event|0|||
149008435|NCT01490125|537510116|FG005|Period III|Adverse Event|0|||
149008436|NCT01490125|537510111|FG000|Period III|Death|0|||
149008437|NCT01490125|537510112|FG001|Period III|Death|0|||
149008438|NCT01490125|537510113|FG002|Period III|Death|0|||
149008439|NCT01490125|537510114|FG003|Period III|Death|1|||
149008440|NCT01490125|537510115|FG004|Period III|Death|0|||
149008441|NCT01490125|537510116|FG005|Period III|Death|0|||
149008442|NCT01490125|537510111|FG000|Period III|Lack of Efficacy|0|||
149008443|NCT01490125|537510112|FG001|Period III|Lack of Efficacy|0|||
149008444|NCT01490125|537510113|FG002|Period III|Lack of Efficacy|0|||
149008445|NCT01490125|537510114|FG003|Period III|Lack of Efficacy|0|||
149008446|NCT01490125|537510115|FG004|Period III|Lack of Efficacy|1|||
149008447|NCT01490125|537510116|FG005|Period III|Lack of Efficacy|0|||
149008448|NCT04522180|537510117|FG000|Overall Study|Investigator judgement|3|||
149008449|NCT04522180|537510118|FG001|Overall Study|Investigator judgement|4|||
149008450|NCT04522180|537510117|FG000|Overall Study|Voluntary withdrawal|1|||
149008451|NCT04522180|537510118|FG001|Overall Study|Voluntary withdrawal|0|||
149008452|NCT04522180|537510117|FG000|Overall Study|Pregnancy|0|||
149008453|NCT04522180|537510118|FG001|Overall Study|Pregnancy|1|||
149008454|NCT04522180|537510117|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
149008455|NCT04522180|537510118|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
149008456|NCT04522180|537510117|FG000|Overall Study|Reason not specified|8|||
149008457|NCT04522180|537510118|FG001|Overall Study|Reason not specified|5|||
149008458|NCT05807919|537510119|FG000|Overall Study|Received antibiotics - excluded|0|||
149008459|NCT05807919|537510120|FG001|Overall Study|Received antibiotics - excluded|1|||
149008460|NCT05807919|537510119|FG000|Overall Study|Withdrawal by Subject|0|||
149008461|NCT05807919|537510120|FG001|Overall Study|Withdrawal by Subject|3|||
149008462|NCT05807919|537510119|FG000|Overall Study|Adverse Event|1|||
149008463|NCT05807919|537510120|FG001|Overall Study|Adverse Event|1|||
149008464|NCT03635489|537510125|FG000|Overall Study|Death|19|||
149008465|NCT03635489|537510126|FG001|Overall Study|Death|13|||
149008466|NCT03635489|537510125|FG000|Overall Study|Lost to Follow-up|1|||
149008467|NCT03635489|537510126|FG001|Overall Study|Lost to Follow-up|2|||
149008468|NCT03635489|537510125|FG000|Overall Study|Withdrawal by Subject|1|||
149008469|NCT03635489|537510126|FG001|Overall Study|Withdrawal by Subject|2|||
149008470|NCT03635489|537510125|FG000|Overall Study|Study Ended by Sponsor|28|||
149008471|NCT03635489|537510126|FG001|Overall Study|Study Ended by Sponsor|34|||
149008472|NCT01368900|537510127|FG000|Overall Study|Lost to Follow-up|7|||
149008473|NCT02277743|537510137|FG000|Overall Study|Protocol Violation|1|||
149008474|NCT02277743|537510138|FG001|Overall Study|Protocol Violation|1|||
149008475|NCT02277743|537510139|FG002|Overall Study|Protocol Violation|1|||
149008476|NCT02277743|537510137|FG000|Overall Study|Adverse Event|10|||
149008477|NCT02277743|537510138|FG001|Overall Study|Adverse Event|6|||
149008478|NCT02277743|537510139|FG002|Overall Study|Adverse Event|6|||
148782218|NCT00270231|536677401|FG000|Second Intervention|Lost to Follow-up|0|||
149008479|NCT02277743|537510137|FG000|Overall Study|Lack of Efficacy|11|||
149008480|NCT02277743|537510138|FG001|Overall Study|Lack of Efficacy|4|||
149008481|NCT02277743|537510139|FG002|Overall Study|Lack of Efficacy|3|||
149008482|NCT02277743|537510137|FG000|Overall Study|Other than specified above|18|||
149008483|NCT02277743|537510138|FG001|Overall Study|Other than specified above|5|||
149008484|NCT02277743|537510139|FG002|Overall Study|Other than specified above|16|||
149008485|NCT01224158|537510140|FG000|Overall Study|Withdrawal by Subject|1|||
149008486|NCT01224158|537510141|FG001|Overall Study|Withdrawal by Subject|0|||
149008487|NCT01931735|537510143|FG000|Randomized Phase|Lost to Follow-up|2|||
149008488|NCT01931735|537510144|FG001|Randomized Phase|Lost to Follow-up|2|||
149008489|NCT01931735|537510145|FG002|Randomized Phase|Lost to Follow-up|5|||
149008490|NCT01931735|537510146|FG003|Randomized Phase|Lost to Follow-up|0|||
149008491|NCT01931735|537510143|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
149008492|NCT01931735|537510144|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
149008493|NCT01931735|537510145|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
149008494|NCT01931735|537510146|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
149021121|NCT04423393|537557186|FG005|Overall Study|Sponsor Decision|0|||
149008495|NCT01931735|537510143|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
149008496|NCT01931735|537510144|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
149008497|NCT01931735|537510145|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
149008498|NCT01931735|537510146|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
149008499|NCT02719990|537510147|FG000|Overall Study|Physician Decision|2|||
149008500|NCT02719990|537510147|FG000|Overall Study|Withdrawal by Subject|2|||
149008501|NCT02719990|537510147|FG000|Overall Study|Study Terminated By Sponsor|32|||
149008502|NCT02404389|537510148|FG000|Overall Study|Adverse Event|1|||
149008503|NCT02404389|537510149|FG001|Overall Study|Adverse Event|0|||
149008504|NCT02404389|537510150|FG002|Overall Study|Adverse Event|1|||
149008505|NCT02404389|537510151|FG003|Overall Study|Adverse Event|0|||
149008506|NCT02404389|537510152|FG004|Overall Study|Adverse Event|2|||
149008507|NCT02404389|537510148|FG000|Overall Study|Subject/guardian decision|1|||
149008508|NCT02404389|537510149|FG001|Overall Study|Subject/guardian decision|0|||
149008509|NCT02404389|537510150|FG002|Overall Study|Subject/guardian decision|0|||
149008510|NCT02404389|537510151|FG003|Overall Study|Subject/guardian decision|1|||
149008511|NCT02404389|537510152|FG004|Overall Study|Subject/guardian decision|1|||
149008512|NCT00717314|537510156|FG000|Overall Study|Adverse Event|3|||
149008513|NCT00717314|537510157|FG001|Overall Study|Adverse Event|2|||
149008514|NCT00717314|537510156|FG000|Overall Study|Protocol Violation|1|||
149008515|NCT00717314|537510157|FG001|Overall Study|Protocol Violation|0|||
149008516|NCT00717314|537510156|FG000|Overall Study|Lost to Follow-up|1|||
149008517|NCT00717314|537510157|FG001|Overall Study|Lost to Follow-up|5|||
149008518|NCT00717314|537510156|FG000|Overall Study|Withdrawal by Subject|1|||
149008519|NCT00717314|537510157|FG001|Overall Study|Withdrawal by Subject|3|||
149008520|NCT01126060|537510158|FG000|Overall Study|Protocol Violation|0|||
149008521|NCT01126060|537510159|FG001|Overall Study|Protocol Violation|2|||
149008522|NCT02070484|537510160|FG000|Overall Study|Withdrawal by Subject|1|||
149008523|NCT02070484|537510161|FG001|Overall Study|Withdrawal by Subject|0|||
149008524|NCT02658630|537510162|FG000|Overall Study|Withdrawal by Subject|4|||
149008525|NCT01521884|537510163|FG000|Overall Study|Non Responders|10|||
149008526|NCT01521884|537510163|FG000|Overall Study|Adverse Event|5|||
149008527|NCT01521884|537510163|FG000|Overall Study|Pregnancy|1|||
149008528|NCT01521884|537510163|FG000|Overall Study|Withdrawal by Subject|1|||
149008529|NCT01521884|537510163|FG000|Overall Study|Physician Decision|2|||
149008530|NCT01521884|537510163|FG000|Overall Study|Protocol Violation|3|||
149008531|NCT01521884|537510163|FG000|Overall Study|Participant non-eligible|1|||
149008532|NCT01521884|537510163|FG000|Overall Study|Lost to Follow-up|4|||
149008533|NCT02821819|537510164|FG000|Overall Study|Protocol Violation|1|||
149008534|NCT04182880|537510166|FG000|Overall Study|Pregnancy|1|||
149008535|NCT04182880|537510167|FG001|Overall Study|Pregnancy|0|||
149008536|NCT03389477|537510168|FG000|Step 1|Withdrawal by Subject|1|||
149008537|NCT03389477|537510169|FG001|Step 1|Withdrawal by Subject|0|||
149008538|NCT03389477|537510168|FG000|Step 2|Withdrawal by Subject|1|||
149008539|NCT03389477|537510169|FG001|Step 2|Withdrawal by Subject|2|||
149008540|NCT03389477|537510168|FG000|Step 2|Disease progression|1|||
149008541|NCT03389477|537510169|FG001|Step 2|Disease progression|0|||
149008542|NCT03389477|537510168|FG000|Step 2|Death|0|||
149008543|NCT03389477|537510169|FG001|Step 2|Death|1|||
149008544|NCT03389477|537510168|FG000|Step 2|Poor performance status and nutrition|0|||
149008545|NCT03389477|537510169|FG001|Step 2|Poor performance status and nutrition|1|||
149008546|NCT03389477|537510168|FG000|Step 3|Withdrawal after 3 cycles|0|||
149008547|NCT03389477|537510169|FG001|Step 3|Withdrawal after 3 cycles|1|||
149008548|NCT03389477|537510168|FG000|Step 3|Still receiving active treatment|4|||
149008549|NCT03389477|537510169|FG001|Step 3|Still receiving active treatment|0|||
149008550|NCT03389477|537510168|FG000|Step 3|Progressive disease after 2 cycles|1|||
149008551|NCT03389477|537510169|FG001|Step 3|Progressive disease after 2 cycles|0|||
149008552|NCT01806584|537510177|FG000|Overall Study|Adverse Event|2|||
149008553|NCT01806584|537510178|FG001|Overall Study|Adverse Event|1|||
149008554|NCT01806584|537510177|FG000|Overall Study|Death|1|||
149008555|NCT01806584|537510178|FG001|Overall Study|Death|0|||
149008556|NCT01806584|537510177|FG000|Overall Study|Lost to Follow-up|0|||
149008557|NCT01806584|537510178|FG001|Overall Study|Lost to Follow-up|2|||
149008558|NCT01806584|537510177|FG000|Overall Study|Study terminated by sponsor|9|||
149008559|NCT01806584|537510178|FG001|Overall Study|Study terminated by sponsor|14|||
149008560|NCT01806584|537510177|FG000|Overall Study|Withdrawal by Subject|1|||
149008561|NCT01806584|537510178|FG001|Overall Study|Withdrawal by Subject|1|||
149008562|NCT01806584|537510177|FG000|Overall Study|Other unspecified|1|||
149008563|NCT01806584|537510178|FG001|Overall Study|Other unspecified|0|||
149008564|NCT03995784|537510179|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
149008565|NCT02764775|537511866|FG000|Overall Study|Death|1|||
149008566|NCT02764775|537511866|FG000|Overall Study|Lost to Follow-up|2|||
149008567|NCT02764775|537511866|FG000|Overall Study|Withdrawal by Subject|3|||
149008568|NCT00429494|537511867|FG000|Overall Study|Withdrawal by Subject|9|||
149008569|NCT00429494|537511867|FG000|Overall Study|Death|6|||
149008570|NCT00976703|537511868|FG000|Overall Study|Physician Decision|1|||
149008571|NCT00976703|537511869|FG001|Overall Study|Physician Decision|1|||
149008572|NCT00976703|537511868|FG000|Overall Study|ineligible for study|2|||
149008573|NCT00976703|537511869|FG001|Overall Study|ineligible for study|2|||
149008574|NCT01992549|537511873|FG000|Overall Study|Lost to Follow-up|2|||
149008575|NCT01992549|537511873|FG000|Overall Study|Serious Adverse Event|1|||
149008576|NCT01992549|537511873|FG000|Overall Study|Product Switch to Extend Half Life|1|||
149008577|NCT01900054|537511877|FG000|Overall Study|Physician Decision|1|||
149008578|NCT01900054|537511877|FG000|Overall Study|Withdrawal by Subject|1|||
149008579|NCT03285295|537511880|FG000|Alinity s HBsAg|Protocol Violation|11|||
149008580|NCT03285295|537511881|FG001|Alinity s HBsAg|Protocol Violation|0|||
149008581|NCT03285295|537511882|FG002|Alinity s HBsAg|Protocol Violation|0|||
149008582|NCT03285295|537511883|FG003|Alinity s HBsAg|Protocol Violation|0|||
149008583|NCT03285295|537511884|FG004|Alinity s HBsAg|Protocol Violation|0|||
149008584|NCT03285295|537511880|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
149008585|NCT03285295|537511881|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
149008586|NCT03285295|537511882|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
149008587|NCT03285295|537511883|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
149008588|NCT03285295|537511884|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
149008589|NCT03285295|537511880|FG000|Alinity s HBsAg|No Results Generated|74|||
149008590|NCT03285295|537511881|FG001|Alinity s HBsAg|No Results Generated|6|||
149008591|NCT03285295|537511882|FG002|Alinity s HBsAg|No Results Generated|0|||
149008592|NCT03285295|537511883|FG003|Alinity s HBsAg|No Results Generated|0|||
149008593|NCT03285295|537511884|FG004|Alinity s HBsAg|No Results Generated|0|||
149008594|NCT03285295|537511880|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
149008595|NCT03285295|537511881|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
149008596|NCT03285295|537511882|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
149008597|NCT03285295|537511883|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
149008598|NCT03285295|537511884|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
149008599|NCT03285295|537511880|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
149008600|NCT03285295|537511881|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
149008601|NCT03285295|537511882|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
149008602|NCT03285295|537511883|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
149008603|NCT03285295|537511884|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
149008604|NCT03285295|537511880|FG000|Alinity s HTLV I/II|No Results Generated|70|||
149008605|NCT03285295|537511881|FG001|Alinity s HTLV I/II|No Results Generated|0|||
149008606|NCT03285295|537511882|FG002|Alinity s HTLV I/II|No Results Generated|0|||
149008607|NCT03285295|537511883|FG003|Alinity s HTLV I/II|No Results Generated|0|||
149008608|NCT03285295|537511884|FG004|Alinity s HTLV I/II|No Results Generated|0|||
149008609|NCT03285295|537511880|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
149008610|NCT03285295|537511881|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
149008611|NCT03285295|537511882|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
149008612|NCT03285295|537511883|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
149008613|NCT03285295|537511884|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
149008614|NCT03285295|537511880|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
149008615|NCT03285295|537511881|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
149008616|NCT03285295|537511882|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
149008617|NCT03285295|537511883|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
149008618|NCT03285295|537511884|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
149008619|NCT03285295|537511880|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
149008620|NCT03285295|537511881|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
149008621|NCT03285295|537511882|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
149008622|NCT03285295|537511883|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
149008623|NCT03285295|537511884|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
149008624|NCT03285295|537511880|FG000|Alinity s Anti-HCV|No Results Generated|71|||
149008625|NCT03285295|537511881|FG001|Alinity s Anti-HCV|No Results Generated|0|||
149008626|NCT03285295|537511882|FG002|Alinity s Anti-HCV|No Results Generated|0|||
149008627|NCT03285295|537511883|FG003|Alinity s Anti-HCV|No Results Generated|0|||
149008628|NCT03285295|537511884|FG004|Alinity s Anti-HCV|No Results Generated|0|||
149008629|NCT03285295|537511880|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
149008630|NCT03285295|537511881|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
149008631|NCT03285295|537511882|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
149008632|NCT03285295|537511883|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
149008633|NCT03285295|537511884|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
149008634|NCT03285295|537511880|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
149008635|NCT03285295|537511881|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
149121140|NCT00513305|537920065|FG000|Overall Study|Eligible for stem cell transplant|1|||
149121141|NCT00513305|537920066|FG001|Overall Study|Eligible for stem cell transplant|0|||
149121142|NCT00513305|537920065|FG000|Overall Study|Hematologic counts did not recover|1|||
149121143|NCT00513305|537920066|FG001|Overall Study|Hematologic counts did not recover|0|||
149121144|NCT00513305|537920065|FG000|Overall Study|Physician Decision|1|||
149121145|NCT00513305|537920066|FG001|Overall Study|Physician Decision|0|||
149121146|NCT00513305|537920065|FG000|Overall Study|Persistent hypocellularity|0|||
149121147|NCT00513305|537920066|FG001|Overall Study|Persistent hypocellularity|1|||
149121148|NCT00513305|537920065|FG000|Overall Study|Sponsor Decision|0|||
149121149|NCT00513305|537920066|FG001|Overall Study|Sponsor Decision|2|||
149008636|NCT03285295|537511882|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
149008637|NCT03285295|537511883|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
149008638|NCT03285295|537511884|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
149008639|NCT03285295|537511880|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
149008640|NCT03285295|537511881|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
149008641|NCT03285295|537511882|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
149008642|NCT03285295|537511883|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
149008643|NCT03285295|537511884|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
149008644|NCT03285295|537511880|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
149008645|NCT03285295|537511881|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
149008646|NCT03285295|537511882|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
149008647|NCT03285295|537511883|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
149008648|NCT03285295|537511884|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
149008649|NCT03285295|537511880|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
149008650|NCT03285295|537511881|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
149008651|NCT03285295|537511882|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
149008652|NCT03285295|537511883|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
149008653|NCT03285295|537511884|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
149008654|NCT03285295|537511880|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
149008655|NCT03285295|537511881|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
149008656|NCT03285295|537511882|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
149008657|NCT03285295|537511883|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
149008658|NCT03285295|537511884|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
149008659|NCT03285295|537511880|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
149008660|NCT03285295|537511881|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
149008661|NCT03285295|537511882|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
149008662|NCT03285295|537511883|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
149008663|NCT03285295|537511884|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
149008664|NCT03285295|537511880|FG000|Alinity s Anti-HBc|No Results Generated|70|||
149008665|NCT03285295|537511881|FG001|Alinity s Anti-HBc|No Results Generated|0|||
149008666|NCT03285295|537511882|FG002|Alinity s Anti-HBc|No Results Generated|0|||
149008667|NCT03285295|537511883|FG003|Alinity s Anti-HBc|No Results Generated|0|||
149008668|NCT03285295|537511884|FG004|Alinity s Anti-HBc|No Results Generated|0|||
149008669|NCT03285295|537511880|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
149008670|NCT03285295|537511881|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
149008671|NCT03285295|537511882|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
149008672|NCT03285295|537511883|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
149008673|NCT03285295|537511884|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
149008674|NCT03285295|537511880|FG000|Alinity s Chagas|Protocol Violation|76|||
149008675|NCT03285295|537511881|FG001|Alinity s Chagas|Protocol Violation|0|||
149008676|NCT03285295|537511882|FG002|Alinity s Chagas|Protocol Violation|0|||
149008677|NCT03285295|537511883|FG003|Alinity s Chagas|Protocol Violation|0|||
149008678|NCT03285295|537511884|FG004|Alinity s Chagas|Protocol Violation|0|||
149008679|NCT03285295|537511880|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
149008680|NCT03285295|537511881|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
149008681|NCT03285295|537511882|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
149008682|NCT03285295|537511883|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
149008683|NCT03285295|537511884|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
149008684|NCT03285295|537511880|FG000|Alinity s Chagas|No Results Generated|105|||
149008685|NCT03285295|537511881|FG001|Alinity s Chagas|No Results Generated|0|||
149008686|NCT03285295|537511882|FG002|Alinity s Chagas|No Results Generated|0|||
149008687|NCT03285295|537511883|FG003|Alinity s Chagas|No Results Generated|0|||
149008688|NCT03285295|537511884|FG004|Alinity s Chagas|No Results Generated|0|||
149008689|NCT03285295|537511880|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
149008690|NCT03285295|537511881|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
149008691|NCT03285295|537511882|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
149008692|NCT03285295|537511883|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
149008693|NCT03285295|537511884|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
149008694|NCT00957931|537511886|FG000|Overall Study|Death|4|||
149008695|NCT00857805|537511887|FG000|Overall Study|Withdrawal by Subject|1|||
149008696|NCT00857805|537511888|FG001|Overall Study|Withdrawal by Subject|1|||
149008697|NCT01289041|537511889|FG000|Overall Study|Adverse Event|24|||
149008698|NCT01289041|537511889|FG000|Overall Study|Physician Decision|1|||
149008699|NCT01289041|537511889|FG000|Overall Study|Progressive Disease|41|||
149008700|NCT01289041|537511889|FG000|Overall Study|Withdrawal by Subject|3|||
149008701|NCT01289041|537511889|FG000|Overall Study|Death|1|||
149008702|NCT01062763|537511890|FG000|Overall Study|Adverse Event|3|||
149008703|NCT01062763|537511891|FG001|Overall Study|Adverse Event|4|||
149008704|NCT00369681|537511903|FG000|Overall Study|Death|1|||
149008705|NCT02670538|537511907|FG000|Overall Study|Withdrawal of Consent|8|||
149008706|NCT02670538|537511908|FG001|Overall Study|Withdrawal of Consent|6|||
149008707|NCT02670538|537511909|FG002|Overall Study|Withdrawal of Consent|5|||
149008708|NCT02670538|537511907|FG000|Overall Study|Lost to Follow-up|8|||
149008709|NCT02670538|537511908|FG001|Overall Study|Lost to Follow-up|12|||
149008710|NCT02670538|537511909|FG002|Overall Study|Lost to Follow-up|7|||
149008711|NCT02670538|537511907|FG000|Overall Study|Adverse Event|5|||
149008712|NCT02670538|537511908|FG001|Overall Study|Adverse Event|5|||
149008713|NCT02670538|537511909|FG002|Overall Study|Adverse Event|11|||
149008714|NCT02670538|537511907|FG000|Overall Study|Lack of Efficacy|7|||
149008715|NCT02670538|537511908|FG001|Overall Study|Lack of Efficacy|1|||
149008716|NCT02670538|537511909|FG002|Overall Study|Lack of Efficacy|2|||
149008717|NCT02670538|537511907|FG000|Overall Study|Protocol Violation|3|||
149008718|NCT02670538|537511908|FG001|Overall Study|Protocol Violation|4|||
149008719|NCT02670538|537511909|FG002|Overall Study|Protocol Violation|1|||
149008720|NCT02670538|537511907|FG000|Overall Study|Noncompliance with Study Drug|1|||
149008721|NCT02670538|537511908|FG001|Overall Study|Noncompliance with Study Drug|3|||
149008722|NCT02670538|537511909|FG002|Overall Study|Noncompliance with Study Drug|2|||
149008723|NCT02670538|537511907|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149008724|NCT02670538|537511908|FG001|Overall Study|Other Miscellaneous Reasons|1|||
149008725|NCT02670538|537511909|FG002|Overall Study|Other Miscellaneous Reasons|2|||
149008726|NCT02887989|537511910|FG000|Overall Study|Withdrawal by Subject|8|||
149008727|NCT02887989|537511911|FG001|Overall Study|Withdrawal by Subject|11|||
149008728|NCT02887989|537511910|FG000|Overall Study|Death|1|||
149008729|NCT02887989|537511911|FG001|Overall Study|Death|0|||
149008730|NCT00674323|537511915|FG000|Overall Study|Adverse Event|0|||
149008731|NCT00674323|537511916|FG001|Overall Study|Adverse Event|1|||
149008732|NCT00674323|537511917|FG002|Overall Study|Adverse Event|0|||
149008733|NCT00674323|537511915|FG000|Overall Study|Protocol Violation|1|||
149008734|NCT00674323|537511916|FG001|Overall Study|Protocol Violation|0|||
149008735|NCT00674323|537511917|FG002|Overall Study|Protocol Violation|0|||
149008736|NCT00519896|537511924|FG000|Overall Study|Protocol Violation|1|||
149008737|NCT00519896|537511924|FG000|Overall Study|Adverse Event|1|||
149008738|NCT02341456|537511925|FG000|Overall Study|Disease progression|2|||
149008739|NCT02341456|537511926|FG001|Overall Study|Disease progression|3|||
149008740|NCT02341456|537511927|FG002|Overall Study|Disease progression|1|||
149008741|NCT02341456|537511925|FG000|Overall Study|Death|1|||
149008742|NCT02341456|537511926|FG001|Overall Study|Death|1|||
149008743|NCT02341456|537511927|FG002|Overall Study|Death|1|||
149008744|NCT02341456|537511925|FG000|Overall Study|Withdrawal by Subject|0|||
149008745|NCT02341456|537511926|FG001|Overall Study|Withdrawal by Subject|1|||
149008746|NCT02341456|537511927|FG002|Overall Study|Withdrawal by Subject|1|||
149008747|NCT02341456|537511925|FG000|Overall Study|Moved to local access programme.|0|||
149008748|NCT02341456|537511926|FG001|Overall Study|Moved to local access programme.|1|||
149008749|NCT02341456|537511927|FG002|Overall Study|Moved to local access programme.|1|||
149008750|NCT02341456|537511925|FG000|Overall Study|Physician Decision|1|||
149008751|NCT02341456|537511926|FG001|Overall Study|Physician Decision|0|||
149008752|NCT02341456|537511927|FG002|Overall Study|Physician Decision|0|||
149008753|NCT02508532|537511928|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008754|NCT02508532|537511929|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008755|NCT02508532|537511930|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008756|NCT02508532|537511931|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008757|NCT02508532|537511932|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008758|NCT02508532|537511933|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008759|NCT02508532|537511934|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
149008760|NCT02508532|537511935|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008761|NCT02508532|537511936|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
149008762|NCT02508532|537511928|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008763|NCT02508532|537511929|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008764|NCT02508532|537511930|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008765|NCT02508532|537511931|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008766|NCT02508532|537511932|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008767|NCT02508532|537511933|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008768|NCT02508532|537511934|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008769|NCT02508532|537511935|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
149008770|NCT02508532|537511936|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
149008771|NCT02508532|537511928|FG000|Part 2 - Treatment|Disease Progression|0|||
149008772|NCT02508532|537511929|FG001|Part 2 - Treatment|Disease Progression|0|||
149008773|NCT02508532|537511930|FG002|Part 2 - Treatment|Disease Progression|0|||
149008774|NCT02508532|537511931|FG003|Part 2 - Treatment|Disease Progression|0|||
149008775|NCT02508532|537511932|FG004|Part 2 - Treatment|Disease Progression|0|||
149008776|NCT02508532|537511933|FG005|Part 2 - Treatment|Disease Progression|0|||
149008777|NCT02508532|537511934|FG006|Part 2 - Treatment|Disease Progression|0|||
149008778|NCT02508532|537511935|FG007|Part 2 - Treatment|Disease Progression|0|||
149008779|NCT02508532|537511936|FG008|Part 2 - Treatment|Disease Progression|118|||
149008780|NCT02508532|537511928|FG000|Part 2 - Treatment|Adverse Event|0|||
149008781|NCT02508532|537511929|FG001|Part 2 - Treatment|Adverse Event|0|||
149008782|NCT02508532|537511930|FG002|Part 2 - Treatment|Adverse Event|0|||
149008783|NCT02508532|537511931|FG003|Part 2 - Treatment|Adverse Event|0|||
149008784|NCT02508532|537511932|FG004|Part 2 - Treatment|Adverse Event|0|||
149008785|NCT02508532|537511933|FG005|Part 2 - Treatment|Adverse Event|0|||
149008786|NCT02508532|537511934|FG006|Part 2 - Treatment|Adverse Event|0|||
149008787|NCT02508532|537511935|FG007|Part 2 - Treatment|Adverse Event|0|||
149008788|NCT02508532|537511936|FG008|Part 2 - Treatment|Adverse Event|49|||
149008789|NCT02508532|537511928|FG000|Part 2 - Treatment|Physician Decision|0|||
149008790|NCT02508532|537511929|FG001|Part 2 - Treatment|Physician Decision|0|||
149008791|NCT02508532|537511930|FG002|Part 2 - Treatment|Physician Decision|0|||
149008792|NCT02508532|537511931|FG003|Part 2 - Treatment|Physician Decision|0|||
149008793|NCT02508532|537511932|FG004|Part 2 - Treatment|Physician Decision|0|||
149008794|NCT02508532|537511933|FG005|Part 2 - Treatment|Physician Decision|0|||
149008795|NCT02508532|537511934|FG006|Part 2 - Treatment|Physician Decision|0|||
149008796|NCT02508532|537511935|FG007|Part 2 - Treatment|Physician Decision|0|||
149008797|NCT02508532|537511936|FG008|Part 2 - Treatment|Physician Decision|12|||
149008798|NCT02508532|537511928|FG000|Part 2 - Treatment|Administrative|0|||
149008799|NCT02508532|537511929|FG001|Part 2 - Treatment|Administrative|0|||
149008800|NCT02508532|537511930|FG002|Part 2 - Treatment|Administrative|0|||
149008801|NCT02508532|537511931|FG003|Part 2 - Treatment|Administrative|0|||
149008802|NCT02508532|537511932|FG004|Part 2 - Treatment|Administrative|0|||
149008803|NCT02508532|537511933|FG005|Part 2 - Treatment|Administrative|0|||
149008804|NCT02508532|537511934|FG006|Part 2 - Treatment|Administrative|0|||
149008805|NCT02508532|537511935|FG007|Part 2 - Treatment|Administrative|0|||
149008806|NCT02508532|537511936|FG008|Part 2 - Treatment|Administrative|3|||
149008807|NCT02508532|537511928|FG000|Part 2 - Treatment|Sponsor Decision|0|||
149008808|NCT02508532|537511929|FG001|Part 2 - Treatment|Sponsor Decision|0|||
149008809|NCT02508532|537511930|FG002|Part 2 - Treatment|Sponsor Decision|0|||
149008810|NCT02508532|537511931|FG003|Part 2 - Treatment|Sponsor Decision|0|||
149008811|NCT02508532|537511932|FG004|Part 2 - Treatment|Sponsor Decision|0|||
149008812|NCT02508532|537511933|FG005|Part 2 - Treatment|Sponsor Decision|0|||
149008813|NCT02508532|537511934|FG006|Part 2 - Treatment|Sponsor Decision|0|||
149008814|NCT02508532|537511935|FG007|Part 2 - Treatment|Sponsor Decision|0|||
149008815|NCT02508532|537511936|FG008|Part 2 - Treatment|Sponsor Decision|28|||
149008816|NCT02508532|537511928|FG000|Part 2 - Treatment|Death|0|||
149008817|NCT02508532|537511929|FG001|Part 2 - Treatment|Death|0|||
149008818|NCT02508532|537511930|FG002|Part 2 - Treatment|Death|0|||
149008819|NCT02508532|537511931|FG003|Part 2 - Treatment|Death|0|||
149008820|NCT02508532|537511932|FG004|Part 2 - Treatment|Death|0|||
149008821|NCT02508532|537511933|FG005|Part 2 - Treatment|Death|0|||
149008822|NCT02508532|537511934|FG006|Part 2 - Treatment|Death|0|||
149008823|NCT02508532|537511935|FG007|Part 2 - Treatment|Death|0|||
149008824|NCT02508532|537511936|FG008|Part 2 - Treatment|Death|1|||
149008825|NCT02508532|537511928|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
149008826|NCT02508532|537511929|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
149008827|NCT02508532|537511930|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
149008828|NCT02508532|537511931|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
149008829|NCT02508532|537511932|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
149008830|NCT02508532|537511933|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
149008831|NCT02508532|537511934|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
149008832|NCT02508532|537511935|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
149008833|NCT02508532|537511936|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
149008834|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
149008835|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
149008836|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
149008837|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
149008838|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
149008839|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
149008840|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
149008841|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
149008842|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
149008843|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
149008844|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
149008845|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
149008846|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
149008847|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
149008848|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
149008849|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
149008850|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
149008851|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
149008852|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Death|0|||
149008853|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Death|4|||
149008854|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Death|2|||
149008855|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Death|4|||
149008856|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Death|3|||
149008857|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Death|0|||
149008858|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Death|0|||
149008859|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Death|1|||
149008860|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Death|111|||
149008861|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
149008862|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
149008863|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
149008864|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
149008865|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
149008866|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
149008867|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
149008868|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
149008869|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
149008870|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008871|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008872|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008873|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008874|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008875|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008876|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008877|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
149008878|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
149008879|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
149008880|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
149008881|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
149008882|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
149008883|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
149008884|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
149008885|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
149008886|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
149008887|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
149008888|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008889|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008890|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008891|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008892|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008893|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008894|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008895|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
149008896|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
149008897|NCT02508532|537511928|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
149008898|NCT02508532|537511929|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
149008899|NCT02508532|537511930|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
149008900|NCT02508532|537511931|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
149008901|NCT02508532|537511932|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
149008902|NCT02508532|537511933|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
149008903|NCT02508532|537511934|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
149008904|NCT02508532|537511935|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
149008905|NCT02508532|537511936|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
149008906|NCT00301080|537511939|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
149008907|NCT00301080|537511940|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
149008908|NCT00301080|537511941|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
149008909|NCT00301080|537511942|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
149008910|NCT00301080|537511943|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
149008911|NCT03673462|537511944|FG000|Overall Study|Adverse Event|11|||
149008912|NCT03673462|537511945|FG001|Overall Study|Adverse Event|1|||
149008913|NCT03673462|537511944|FG000|Overall Study|Protocol Violation|25|||
149008914|NCT03673462|537511945|FG001|Overall Study|Protocol Violation|11|||
149008915|NCT03673462|537511944|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
149008916|NCT03673462|537511945|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
149008917|NCT03673462|537511944|FG000|Overall Study|Lost to Follow-up|102|||
149008918|NCT03673462|537511945|FG001|Overall Study|Lost to Follow-up|19|||
149008919|NCT03502616|537511948|FG000|Up to Week 16|Withdrawal by Subject|1|||
149008920|NCT03502616|537511949|FG001|Up to Week 16|Withdrawal by Subject|2|||
148782219|NCT00270231|536677402|FG001|Second Intervention|Lost to Follow-up|1|||
149008921|NCT03502616|537511948|FG000|Up to Week 16|Lost to Follow-up|0|||
149008922|NCT03502616|537511949|FG001|Up to Week 16|Lost to Follow-up|1|||
149008923|NCT03502616|537511948|FG000|Up to Week 16|Randomized, but not treated|1|||
149008924|NCT03502616|537511949|FG001|Up to Week 16|Randomized, but not treated|0|||
149008925|NCT03502616|537511948|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
149008926|NCT03502616|537511949|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
149008927|NCT03502616|537511948|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
149008928|NCT03502616|537511949|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
149008929|NCT02387216|537511951|FG000|Overall Study|Progressive disease|2|||
149008930|NCT02387216|537511952|FG001|Overall Study|Progressive disease|0|||
149008931|NCT02387216|537511951|FG000|Overall Study|Withdrawal by Subject|3|||
149008932|NCT02387216|537511952|FG001|Overall Study|Withdrawal by Subject|5|||
149008933|NCT02387216|537511951|FG000|Overall Study|Physician Decision|2|||
149008934|NCT02387216|537511952|FG001|Overall Study|Physician Decision|0|||
149008935|NCT02387216|537511951|FG000|Overall Study|Sponsor Decision|28|||
149008936|NCT02387216|537511952|FG001|Overall Study|Sponsor Decision|12|||
149008937|NCT02387216|537511951|FG000|Overall Study|Death|60|||
149008938|NCT02387216|537511952|FG001|Overall Study|Death|23|||
149008939|NCT02387216|537511951|FG000|Overall Study|Other|5|||
149008940|NCT02387216|537511952|FG001|Overall Study|Other|4|||
149008941|NCT02387216|537511951|FG000|Overall Study|Lost to Follow-up|0|||
149008942|NCT02387216|537511952|FG001|Overall Study|Lost to Follow-up|3|||
149008943|NCT04359771|537511953|FG000|Overall Study|Lack of Efficacy|2|||
149008944|NCT04359771|537511954|FG001|Overall Study|Lack of Efficacy|2|||
149008945|NCT02306265|537511955|FG000|Overall Study|Withdrawal by Subject|1|||
149008946|NCT02917265|537511956|FG000|Overall Study|Physician Decision|1|||
149008947|NCT02917265|537511957|FG001|Overall Study|Physician Decision|0|||
149008948|NCT02917265|537511956|FG000|Overall Study|Withdrawal by Subject|1|||
149008949|NCT02917265|537511957|FG001|Overall Study|Withdrawal by Subject|0|||
149008950|NCT03002038|537511960|FG000|Overall Study|Adverse Event|3|||
149008951|NCT03002038|537511961|FG001|Overall Study|Adverse Event|1|||
149008952|NCT03002038|537511960|FG000|Overall Study|Withdrawal by Subject|8|||
149008953|NCT03002038|537511961|FG001|Overall Study|Withdrawal by Subject|4|||
149008954|NCT03002038|537511960|FG000|Overall Study|Immigration to another region|0|||
149008955|NCT03002038|537511961|FG001|Overall Study|Immigration to another region|2|||
149008956|NCT01216163|537511965|FG000|Overall Study|Withdrawal by Subject|1|||
149008957|NCT01216163|537511966|FG001|Overall Study|Withdrawal by Subject|1|||
149008958|NCT01216163|537511967|FG002|Overall Study|Withdrawal by Subject|0|||
149008959|NCT00453102|537511970|FG000|Overall Study|Withdrawal by Subject|2|||
149008960|NCT02237508|537511977|FG000|Overall Study|Withdrawal by Subject|0|||
149008961|NCT02237508|537511978|FG001|Overall Study|Withdrawal by Subject|2|||
149008962|NCT02237508|537511979|FG002|Overall Study|Withdrawal by Subject|0|||
149008963|NCT02237508|537511980|FG003|Overall Study|Withdrawal by Subject|1|||
149008964|NCT02237508|537511981|FG004|Overall Study|Withdrawal by Subject|0|||
149008965|NCT02237508|537511982|FG005|Overall Study|Withdrawal by Subject|1|||
149008966|NCT02237508|537511983|FG006|Overall Study|Withdrawal by Subject|1|||
149008967|NCT02237508|537511984|FG007|Overall Study|Withdrawal by Subject|0|||
149008968|NCT02237508|537511985|FG008|Overall Study|Withdrawal by Subject|1|||
149008969|NCT02237508|537511986|FG009|Overall Study|Withdrawal by Subject|0|||
149008970|NCT02237508|537511977|FG000|Overall Study|Physician Decision|0|||
149008971|NCT02237508|537511978|FG001|Overall Study|Physician Decision|1|||
149008972|NCT02237508|537511979|FG002|Overall Study|Physician Decision|0|||
149008973|NCT02237508|537511980|FG003|Overall Study|Physician Decision|0|||
149008974|NCT02237508|537511981|FG004|Overall Study|Physician Decision|0|||
149008975|NCT02237508|537511982|FG005|Overall Study|Physician Decision|0|||
149008976|NCT02237508|537511983|FG006|Overall Study|Physician Decision|0|||
149008977|NCT02237508|537511984|FG007|Overall Study|Physician Decision|0|||
149008978|NCT02237508|537511985|FG008|Overall Study|Physician Decision|0|||
149008979|NCT02237508|537511986|FG009|Overall Study|Physician Decision|0|||
149008980|NCT02237508|537511977|FG000|Overall Study|Protocol Violation|0|||
149008981|NCT02237508|537511978|FG001|Overall Study|Protocol Violation|0|||
149008982|NCT02237508|537511979|FG002|Overall Study|Protocol Violation|1|||
149008983|NCT02237508|537511980|FG003|Overall Study|Protocol Violation|0|||
149008984|NCT02237508|537511981|FG004|Overall Study|Protocol Violation|0|||
149008985|NCT02237508|537511982|FG005|Overall Study|Protocol Violation|0|||
149008986|NCT02237508|537511983|FG006|Overall Study|Protocol Violation|0|||
149008987|NCT02237508|537511984|FG007|Overall Study|Protocol Violation|0|||
149008988|NCT02237508|537511985|FG008|Overall Study|Protocol Violation|0|||
149008989|NCT02237508|537511986|FG009|Overall Study|Protocol Violation|0|||
149008990|NCT05458024|537511987|FG000|Overall Study|Withdrawal by Subject|1|||
149008991|NCT05458024|537511988|FG001|Overall Study|Withdrawal by Subject|1|||
149008992|NCT04000594|537511990|FG000|Overall Study|Withdrawal by Subject|1|||
149008993|NCT04000594|537511991|FG001|Overall Study|Withdrawal by Subject|0|||
149008994|NCT04000594|537511992|FG002|Overall Study|Withdrawal by Subject|0|||
149008995|NCT00747123|537511993|FG000|Overall Study|Investigator's request|0|||
149008996|NCT00747123|537511994|FG001|Overall Study|Investigator's request|0|||
149008997|NCT00747123|537511995|FG002|Overall Study|Investigator's request|1|||
149008998|NCT00747123|537511996|FG003|Overall Study|Investigator's request|0|||
149008999|NCT00747123|537511993|FG000|Overall Study|Withdrew consent|0|||
149009000|NCT00747123|537511994|FG001|Overall Study|Withdrew consent|1|||
149009001|NCT00747123|537511995|FG002|Overall Study|Withdrew consent|0|||
149009002|NCT00747123|537511996|FG003|Overall Study|Withdrew consent|0|||
149009003|NCT00747123|537511993|FG000|Overall Study|Adverse Event|0|||
149009004|NCT00747123|537511994|FG001|Overall Study|Adverse Event|1|||
149009005|NCT00747123|537511995|FG002|Overall Study|Adverse Event|0|||
149009006|NCT00747123|537511996|FG003|Overall Study|Adverse Event|1|||
149009007|NCT03976466|537512001|FG000|Overall Study|Lost to Follow-up|1|||
149009008|NCT03976466|537512002|FG001|Overall Study|Lost to Follow-up|3|||
149009009|NCT02055157|537512003|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
149009010|NCT02055157|537512004|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
149009011|NCT02055157|537512005|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
149009012|NCT02055157|537512006|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
149009013|NCT02055157|537512003|FG000|Initial 6 Months|Adverse Event|0|||
149009014|NCT02055157|537512004|FG001|Initial 6 Months|Adverse Event|0|||
149009015|NCT02055157|537512005|FG002|Initial 6 Months|Adverse Event|0|||
149009016|NCT02055157|537512006|FG003|Initial 6 Months|Adverse Event|1|||
149009017|NCT02055157|537512003|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
149009018|NCT02055157|537512004|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
149009019|NCT02055157|537512005|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
149009020|NCT02055157|537512006|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
149009021|NCT02055157|537512003|FG000|18-month Extension|Investigator decision|0|||
149009022|NCT02055157|537512004|FG001|18-month Extension|Investigator decision|1|||
149009023|NCT02055157|537512005|FG002|18-month Extension|Investigator decision|0|||
149009024|NCT02055157|537512006|FG003|18-month Extension|Investigator decision|0|||
149009025|NCT02055157|537512003|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
149009026|NCT02055157|537512004|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
149009027|NCT02055157|537512005|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
149009028|NCT02055157|537512006|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
149009029|NCT00943306|537512011|FG000|Overall Study|Physician Decision|1|||
149009030|NCT00943306|537512011|FG000|Overall Study|Death|1|||
149009031|NCT00943306|537512011|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
149009032|NCT00733499|537512012|FG000|Pre-operative|Protocol Violation|0|||
149009033|NCT00733499|537512013|FG001|Pre-operative|Protocol Violation|1|||
149009034|NCT00733499|537512012|FG000|3 Months Follow-up|Death|1|||
149009035|NCT00733499|537512013|FG001|3 Months Follow-up|Death|2|||
149009036|NCT00733499|537512012|FG000|6 Months Follow-up|Death|0|||
149009037|NCT00733499|537512013|FG001|6 Months Follow-up|Death|2|||
149009038|NCT00733499|537512012|FG000|6 Months Follow-up|Adverse Event|0|||
149009039|NCT00733499|537512013|FG001|6 Months Follow-up|Adverse Event|1|||
149009040|NCT00733499|537512012|FG000|12 Months Follow-up|Death|2|||
149009041|NCT00733499|537512013|FG001|12 Months Follow-up|Death|1|||
149009042|NCT00733499|537512012|FG000|24 Months Follow-up|Death|0|||
149009043|NCT00733499|537512013|FG001|24 Months Follow-up|Death|1|||
149009044|NCT00733499|537512012|FG000|5 Year Followup|Adverse Event|2|||
149009045|NCT00733499|537512013|FG001|5 Year Followup|Adverse Event|2|||
149009046|NCT00733499|537512012|FG000|5 Year Followup|Non device related AE|0|||
149009047|NCT00733499|537512013|FG001|5 Year Followup|Non device related AE|1|||
149009048|NCT00733499|537512012|FG000|5 Year Followup|Revision of Study Implant|0|||
149009049|NCT00733499|537512013|FG001|5 Year Followup|Revision of Study Implant|1|||
149009050|NCT00733499|537512012|FG000|5 Year Followup|Lost to Follow-up|2|||
149009051|NCT00733499|537512013|FG001|5 Year Followup|Lost to Follow-up|0|||
149009052|NCT00733499|537512012|FG000|5 Year Followup|Death|13|||
149009053|NCT00733499|537512013|FG001|5 Year Followup|Death|19|||
149009054|NCT00733499|537512012|FG000|5 Year Followup|missing, unable to locate|0|||
149009055|NCT00733499|537512013|FG001|5 Year Followup|missing, unable to locate|1|||
149009056|NCT00733499|537512012|FG000|5 Year Followup|Withdrawal by Subject|4|||
149009057|NCT00733499|537512013|FG001|5 Year Followup|Withdrawal by Subject|1|||
149009058|NCT00733499|537512012|FG000|10 Year Followup|Death|9|||
149009059|NCT00733499|537512013|FG001|10 Year Followup|Death|7|||
149009060|NCT00733499|537512012|FG000|10 Year Followup|Adverse Event|3|||
149009061|NCT00733499|537512013|FG001|10 Year Followup|Adverse Event|3|||
149009062|NCT00733499|537512012|FG000|10 Year Followup|Lost to Follow-up|3|||
149009063|NCT00733499|537512013|FG001|10 Year Followup|Lost to Follow-up|2|||
149009064|NCT00733499|537512012|FG000|10 Year Followup|Withdrawal by Subject|5|||
149009065|NCT00733499|537512013|FG001|10 Year Followup|Withdrawal by Subject|5|||
149009066|NCT00733499|537512012|FG000|10 Year Followup|missing, unable to locate|0|||
149009067|NCT00733499|537512013|FG001|10 Year Followup|missing, unable to locate|2|||
149009068|NCT00733980|537512014|FG000|Overall Study|Adverse Event|5|||
149009069|NCT00733980|537512015|FG001|Overall Study|Adverse Event|2|||
149009070|NCT00733980|537512014|FG000|Overall Study|Lack of Efficacy|0|||
149009071|NCT00733980|537512015|FG001|Overall Study|Lack of Efficacy|1|||
149009072|NCT00733980|537512014|FG000|Overall Study|Protocol Violation|2|||
149009073|NCT00733980|537512015|FG001|Overall Study|Protocol Violation|1|||
149009074|NCT00733980|537512014|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
149009075|NCT00733980|537512015|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
149009076|NCT00733980|537512014|FG000|Overall Study|Lost to Follow-up|6|||
149009077|NCT00733980|537512015|FG001|Overall Study|Lost to Follow-up|11|||
149009078|NCT00733980|537512014|FG000|Overall Study|Physician Decision|2|||
149009079|NCT00733980|537512015|FG001|Overall Study|Physician Decision|3|||
149009080|NCT00733980|537512014|FG000|Overall Study|Withdrawal by Subject|6|||
149009081|NCT00733980|537512015|FG001|Overall Study|Withdrawal by Subject|2|||
149009082|NCT00263328|537512016|FG000|Overall Study|Death|0|||
149009083|NCT00263328|537512017|FG001|Overall Study|Death|0|||
149009084|NCT00263328|537512018|FG002|Overall Study|Death|1|||
149009085|NCT00263328|537512016|FG000|Overall Study|Lost to Follow-up|1|||
149009086|NCT00263328|537512017|FG001|Overall Study|Lost to Follow-up|1|||
149009087|NCT00263328|537512018|FG002|Overall Study|Lost to Follow-up|0|||
149009088|NCT00263328|537512016|FG000|Overall Study|Withdrawal by Subject|3|||
149009089|NCT00263328|537512017|FG001|Overall Study|Withdrawal by Subject|0|||
149009090|NCT00263328|537512018|FG002|Overall Study|Withdrawal by Subject|1|||
149009091|NCT00263328|537512016|FG000|Overall Study|Other|3|||
148893345|NCT00683878|537088680|FG002|Overall Study|Lack of Efficacy|1|||
148893346|NCT00683878|537088678|FG000|Overall Study|Adverse Event|4|||
149009092|NCT00263328|537512017|FG001|Overall Study|Other|0|||
149009093|NCT00263328|537512018|FG002|Overall Study|Other|1|||
149009094|NCT00263328|537512016|FG000|Overall Study|Adverse Event|1|||
149121150|NCT01262027|537920067|FG000|Overall Study|Adverse Event|1|||
149121151|NCT01262027|537920067|FG000|Overall Study|Withdrawal by Subject|3|||
149121152|NCT01262027|537920067|FG000|Overall Study|Protocol Violation|1|||
149009095|NCT00263328|537512017|FG001|Overall Study|Adverse Event|1|||
149009096|NCT00263328|537512018|FG002|Overall Study|Adverse Event|4|||
149009097|NCT00311155|537514168|FG000|Overall Study|Adverse Event|21|||
149009098|NCT00311155|537514168|FG000|Overall Study|Withdrawal by Subject|17|||
149009099|NCT00311155|537514168|FG000|Overall Study|Did not meet entry criteria|55|||
149009100|NCT00767104|537514169|FG000|Overall Study|Lost to Follow-up|1|||
149009101|NCT00767104|537514170|FG001|Overall Study|Lost to Follow-up|2|||
149009102|NCT00840996|537514171|FG000|Overall Study|Withdrawal by Subject|1|||
149009103|NCT00840996|537514172|FG001|Overall Study|Withdrawal by Subject|0|||
149009104|NCT04022889|537514173|FG000|Stage 1: Period 1|Adverse Event|1|||
149009105|NCT04022889|537514174|FG001|Stage 1: Period 1|Adverse Event|0|||
149009106|NCT04022889|537514175|FG002|Stage 1: Period 1|Adverse Event|0|||
149009107|NCT04022889|537514173|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
149009108|NCT04022889|537514174|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
149009109|NCT04022889|537514175|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
149009110|NCT04022889|537514173|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
149009111|NCT04022889|537514174|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
149009112|NCT04022889|537514175|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
149009113|NCT04022889|537514173|FG000|Stage 2|Screen Failure|0|||
149009114|NCT04022889|537514174|FG001|Stage 2|Screen Failure|0|||
149009115|NCT04022889|537514175|FG002|Stage 2|Screen Failure|3|||
149009116|NCT04022889|537514173|FG000|Stage 2|Ineligible for apheresis donation|0|||
149009117|NCT04022889|537514174|FG001|Stage 2|Ineligible for apheresis donation|0|||
149009118|NCT04022889|537514175|FG002|Stage 2|Ineligible for apheresis donation|2|||
149009119|NCT04022889|537514173|FG000|Stage 2|Adverse Event|0|||
149009120|NCT04022889|537514174|FG001|Stage 2|Adverse Event|0|||
149009121|NCT04022889|537514175|FG002|Stage 2|Adverse Event|2|||
149009122|NCT04022889|537514173|FG000|Stage 2|Protocol Violation|0|||
149009123|NCT04022889|537514174|FG001|Stage 2|Protocol Violation|0|||
149009124|NCT04022889|537514175|FG002|Stage 2|Protocol Violation|1|||
149009125|NCT04022889|537514173|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
149009126|NCT04022889|537514174|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
149009127|NCT04022889|537514175|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
149009128|NCT03107377|537514183|FG000|Overall Study|Adverse Event|3|||
149009129|NCT03107377|537514184|FG001|Overall Study|Adverse Event|3|||
149009130|NCT03107377|537514183|FG000|Overall Study|Protocol Violation|9|||
149009131|NCT03107377|537514184|FG001|Overall Study|Protocol Violation|12|||
149009132|NCT03107377|537514183|FG000|Overall Study|Physician Decision|3|||
149009133|NCT03107377|537514184|FG001|Overall Study|Physician Decision|6|||
149009134|NCT03107377|537514183|FG000|Overall Study|Pregnancy|7|||
149009135|NCT03107377|537514184|FG001|Overall Study|Pregnancy|7|||
149009136|NCT03107377|537514183|FG000|Overall Study|Withdrawal by Subject|16|||
149009137|NCT03107377|537514184|FG001|Overall Study|Withdrawal by Subject|22|||
149009138|NCT03107377|537514183|FG000|Overall Study|Lost to Follow-up|37|||
149009139|NCT03107377|537514184|FG001|Overall Study|Lost to Follow-up|34|||
149009140|NCT03107377|537514183|FG000|Overall Study|Other reason not specified|16|||
149009141|NCT03107377|537514184|FG001|Overall Study|Other reason not specified|15|||
149009142|NCT01650519|537514186|FG000|Overall Study|Withdrawal by Subject|1|||
149009143|NCT01650519|537514187|FG001|Overall Study|Withdrawal by Subject|0|||
149009144|NCT02954458|537514188|FG000|Overall Study|Adverse Event|0|||
149009145|NCT02954458|537514189|FG001|Overall Study|Adverse Event|0|||
149009146|NCT02954458|537514190|FG002|Overall Study|Adverse Event|0|||
149009147|NCT02954458|537514191|FG003|Overall Study|Adverse Event|1|||
149009148|NCT02954458|537514188|FG000|Overall Study|Withdrawal by Subject|0|||
149009149|NCT02954458|537514189|FG001|Overall Study|Withdrawal by Subject|0|||
149009150|NCT02954458|537514190|FG002|Overall Study|Withdrawal by Subject|0|||
149009151|NCT02954458|537514191|FG003|Overall Study|Withdrawal by Subject|1|||
149009152|NCT02954458|537514188|FG000|Overall Study|Physician Decision|0|||
149009153|NCT02954458|537514189|FG001|Overall Study|Physician Decision|0|||
149009154|NCT02954458|537514190|FG002|Overall Study|Physician Decision|1|||
149009155|NCT02954458|537514191|FG003|Overall Study|Physician Decision|1|||
149009156|NCT02954458|537514188|FG000|Overall Study|Lost to Follow-up|1|||
149009157|NCT02954458|537514189|FG001|Overall Study|Lost to Follow-up|0|||
149009158|NCT02954458|537514190|FG002|Overall Study|Lost to Follow-up|0|||
149009159|NCT02954458|537514191|FG003|Overall Study|Lost to Follow-up|1|||
149009160|NCT02954458|537514188|FG000|Overall Study|Death|0|||
149009161|NCT02954458|537514189|FG001|Overall Study|Death|0|||
149009162|NCT02954458|537514190|FG002|Overall Study|Death|0|||
149009163|NCT02954458|537514191|FG003|Overall Study|Death|1|||
149009164|NCT02954458|537514188|FG000|Overall Study|Other|0|||
149009165|NCT02954458|537514189|FG001|Overall Study|Other|0|||
149009166|NCT02954458|537514190|FG002|Overall Study|Other|0|||
149009167|NCT02954458|537514191|FG003|Overall Study|Other|7|||
149009168|NCT02739347|537514192|FG000|Overall Study|Adverse Event|3|||
149009169|NCT02739347|537514193|FG001|Overall Study|Adverse Event|0|||
149009170|NCT02739347|537514192|FG000|Overall Study|Protocol Violation|0|||
149009171|NCT02739347|537514193|FG001|Overall Study|Protocol Violation|1|||
149009172|NCT02739347|537514192|FG000|Overall Study|Lost to Follow-up|0|||
149009173|NCT02739347|537514193|FG001|Overall Study|Lost to Follow-up|2|||
149009174|NCT01552954|537514194|FG000|Overall Study|Adverse Event|1|||
149009175|NCT01552954|537514195|FG001|Overall Study|Adverse Event|2|||
149009176|NCT01552954|537514194|FG000|Overall Study|Lost to Follow-up|1|||
149009177|NCT01552954|537514195|FG001|Overall Study|Lost to Follow-up|1|||
149009178|NCT01552954|537514194|FG000|Overall Study|Withdrawal by Subject|1|||
149009179|NCT01552954|537514195|FG001|Overall Study|Withdrawal by Subject|1|||
149009180|NCT01552954|537514194|FG000|Overall Study|Protocol Violation|1|||
149009181|NCT01552954|537514195|FG001|Overall Study|Protocol Violation|2|||
149009182|NCT01552954|537514194|FG000|Overall Study|diagnosed DM|1|||
149009183|NCT01552954|537514195|FG001|Overall Study|diagnosed DM|0|||
149009184|NCT00779779|537514196|FG000|Overall Study|Adverse Event|1|||
149009185|NCT00779779|537514196|FG000|Overall Study|Protocol Violation|14|||
149009186|NCT00779779|537514196|FG000|Overall Study|Withdrawal by Subject|4|||
149009187|NCT00779779|537514196|FG000|Overall Study|Lost to Follow-up|5|||
149009188|NCT01395823|537514197|FG000|Overall Study|Death|4|||
149009189|NCT01395823|537514198|FG001|Overall Study|Death|4|||
149009190|NCT01395823|537514197|FG000|Overall Study|Physician Decision|3|||
149009191|NCT01395823|537514198|FG001|Overall Study|Physician Decision|1|||
149009192|NCT01395823|537514197|FG000|Overall Study|Lost to Follow-up|1|||
149009193|NCT01395823|537514198|FG001|Overall Study|Lost to Follow-up|0|||
149009194|NCT01395823|537514197|FG000|Overall Study|Transplant|1|||
149009195|NCT01395823|537514198|FG001|Overall Study|Transplant|0|||
149009196|NCT01395823|537514197|FG000|Overall Study|GI symptoms|1|||
149009197|NCT01395823|537514198|FG001|Overall Study|GI symptoms|0|||
149009198|NCT01395823|537514197|FG000|Overall Study|Withdrawal by Subject|5|||
149009199|NCT01395823|537514198|FG001|Overall Study|Withdrawal by Subject|4|||
149009200|NCT01778556|537514199|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
149009201|NCT01778556|537514200|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
149009202|NCT01778556|537514199|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
149009203|NCT01778556|537514200|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
149009204|NCT01778556|537514199|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
149009205|NCT01778556|537514200|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
149009206|NCT01778556|537514199|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
149009207|NCT01778556|537514200|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
149009208|NCT03300570|537514202|FG000|Overall Study|Adverse Event|0|||
149009209|NCT03300570|537514203|FG001|Overall Study|Adverse Event|1|||
149009210|NCT03300570|537514202|FG000|Overall Study|Withdrawal by Subject|1|||
149009211|NCT03300570|537514203|FG001|Overall Study|Withdrawal by Subject|0|||
149009212|NCT03300570|537514202|FG000|Overall Study|Inadequate bowel prep|1|||
149009213|NCT03300570|537514203|FG001|Overall Study|Inadequate bowel prep|0|||
149009214|NCT00116272|537514204|FG000|Overall Study|Lost to Follow-up|11|||
148782220|NCT00574795|536677411|FG000|Infant Series|Withdrawal by Subject|2|||
149009215|NCT00116272|537514205|FG001|Overall Study|Lost to Follow-up|6|||
149009216|NCT00576732|537514206|FG000|DOUBLE BLIND|Adverse Event|0|||
149009217|NCT00576732|537514207|FG001|DOUBLE BLIND|Adverse Event|0|||
149009218|NCT00576732|537514208|FG002|DOUBLE BLIND|Adverse Event|1|||
149009219|NCT00576732|537514209|FG003|DOUBLE BLIND|Adverse Event|0|||
149009220|NCT00576732|537514210|FG004|DOUBLE BLIND|Adverse Event|0|||
149009221|NCT00576732|537514211|FG005|DOUBLE BLIND|Adverse Event|0|||
149009222|NCT00576732|537514206|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
149009223|NCT00576732|537514207|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
149009224|NCT00576732|537514208|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
149009225|NCT00576732|537514209|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
149009226|NCT00576732|537514210|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
149009227|NCT00576732|537514211|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
149009228|NCT00576732|537514206|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
149009229|NCT00576732|537514207|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
149009230|NCT00576732|537514208|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
149009231|NCT00576732|537514209|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
149009232|NCT00576732|537514210|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
149009233|NCT00576732|537514211|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
149009234|NCT00576732|537514206|FG000|DOUBLE BLIND|OTHER|0|||
149009235|NCT00576732|537514207|FG001|DOUBLE BLIND|OTHER|2|||
149009236|NCT00576732|537514208|FG002|DOUBLE BLIND|OTHER|1|||
149009237|NCT00576732|537514209|FG003|DOUBLE BLIND|OTHER|0|||
149009238|NCT00576732|537514210|FG004|DOUBLE BLIND|OTHER|0|||
149009239|NCT00576732|537514211|FG005|DOUBLE BLIND|OTHER|0|||
149009240|NCT00576732|537514206|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
149009241|NCT00576732|537514207|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
149009242|NCT00576732|537514208|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
149009243|NCT00576732|537514209|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
149009244|NCT00576732|537514210|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
149009245|NCT00576732|537514211|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
149009246|NCT00576732|537514206|FG000|DOUBLE BLIND|Protocol Violation|1|||
149009247|NCT00576732|537514207|FG001|DOUBLE BLIND|Protocol Violation|0|||
149009248|NCT00576732|537514208|FG002|DOUBLE BLIND|Protocol Violation|0|||
149009249|NCT00576732|537514209|FG003|DOUBLE BLIND|Protocol Violation|0|||
149009250|NCT00576732|537514210|FG004|DOUBLE BLIND|Protocol Violation|0|||
149009251|NCT00576732|537514211|FG005|DOUBLE BLIND|Protocol Violation|0|||
149009252|NCT00576732|537514206|FG000|OPEN LABEL|Adverse Event|0|||
149009253|NCT00576732|537514207|FG001|OPEN LABEL|Adverse Event|0|||
149009254|NCT00576732|537514208|FG002|OPEN LABEL|Adverse Event|0|||
149009255|NCT00576732|537514209|FG003|OPEN LABEL|Adverse Event|4|||
149009256|NCT00576732|537514210|FG004|OPEN LABEL|Adverse Event|0|||
149009257|NCT00576732|537514211|FG005|OPEN LABEL|Adverse Event|1|||
149009258|NCT00576732|537514206|FG000|OPEN LABEL|Lost to Follow-up|0|||
149009259|NCT00576732|537514207|FG001|OPEN LABEL|Lost to Follow-up|0|||
149009260|NCT00576732|537514208|FG002|OPEN LABEL|Lost to Follow-up|0|||
149009261|NCT00576732|537514209|FG003|OPEN LABEL|Lost to Follow-up|2|||
149009262|NCT00576732|537514210|FG004|OPEN LABEL|Lost to Follow-up|1|||
149009263|NCT00576732|537514211|FG005|OPEN LABEL|Lost to Follow-up|1|||
149009264|NCT00576732|537514206|FG000|OPEN LABEL|Withdrawal by Subject|0|||
149009265|NCT00576732|537514207|FG001|OPEN LABEL|Withdrawal by Subject|0|||
149009266|NCT00576732|537514208|FG002|OPEN LABEL|Withdrawal by Subject|0|||
149009267|NCT00576732|537514209|FG003|OPEN LABEL|Withdrawal by Subject|1|||
149009268|NCT00576732|537514210|FG004|OPEN LABEL|Withdrawal by Subject|0|||
149009269|NCT00576732|537514211|FG005|OPEN LABEL|Withdrawal by Subject|1|||
149009270|NCT00576732|537514206|FG000|OPEN LABEL|OTHER|0|||
149009271|NCT00576732|537514207|FG001|OPEN LABEL|OTHER|0|||
149009272|NCT00576732|537514208|FG002|OPEN LABEL|OTHER|0|||
149009273|NCT00576732|537514209|FG003|OPEN LABEL|OTHER|0|||
149009274|NCT00576732|537514210|FG004|OPEN LABEL|OTHER|0|||
149009275|NCT00576732|537514211|FG005|OPEN LABEL|OTHER|2|||
149009276|NCT00576732|537514206|FG000|OPEN LABEL|Lack of Efficacy|0|||
149009277|NCT00576732|537514207|FG001|OPEN LABEL|Lack of Efficacy|0|||
149009278|NCT00576732|537514208|FG002|OPEN LABEL|Lack of Efficacy|0|||
149009279|NCT00576732|537514209|FG003|OPEN LABEL|Lack of Efficacy|2|||
149009280|NCT00576732|537514210|FG004|OPEN LABEL|Lack of Efficacy|2|||
149009281|NCT00576732|537514211|FG005|OPEN LABEL|Lack of Efficacy|3|||
149009282|NCT00576732|537514206|FG000|OPEN LABEL|Protocol Violation|0|||
149009283|NCT00576732|537514207|FG001|OPEN LABEL|Protocol Violation|0|||
149009284|NCT00576732|537514208|FG002|OPEN LABEL|Protocol Violation|0|||
149009285|NCT00576732|537514209|FG003|OPEN LABEL|Protocol Violation|2|||
149009286|NCT00576732|537514210|FG004|OPEN LABEL|Protocol Violation|1|||
149009287|NCT00576732|537514211|FG005|OPEN LABEL|Protocol Violation|0|||
149009288|NCT03188120|537514212|FG000|Overall Study|Adverse Event|4|||
149009289|NCT03188120|537514212|FG000|Overall Study|Insufficient Effectiveness|8|||
149009290|NCT03188120|537514212|FG000|Overall Study|Improved|12|||
149009291|NCT03188120|537514212|FG000|Overall Study|Lost to Follow-up|7|||
149009292|NCT03188120|537514212|FG000|Overall Study|Other than specified|3|||
149009293|NCT03188120|537514212|FG000|Overall Study|No visit after the first visit|13|||
149009294|NCT01235403|537514214|FG000|Overall Study|Adverse Event|14|||
149009295|NCT01235403|537514214|FG000|Overall Study|Lost to Follow-up|2|||
149009296|NCT01235403|537514214|FG000|Overall Study|Withdrawal by Subject|4|||
149009297|NCT01235403|537514214|FG000|Overall Study|Lack of Efficacy|2|||
149009298|NCT01235403|537514214|FG000|Overall Study|Other reasons for premature termination|4|||
149009299|NCT02296190|537514217|FG000|Overall Study|Lost to Follow-up|0|||
149009300|NCT02296190|537514218|FG001|Overall Study|Lost to Follow-up|0|||
149009301|NCT02296190|537514219|FG002|Overall Study|Lost to Follow-up|0|||
149009302|NCT02296190|537514220|FG003|Overall Study|Lost to Follow-up|0|||
149009303|NCT02296190|537514221|FG004|Overall Study|Lost to Follow-up|1|||
149009304|NCT02296190|537514222|FG005|Overall Study|Lost to Follow-up|0|||
149009305|NCT02296190|537514217|FG000|Overall Study|Failure to induce PSVT|6|||
149009306|NCT02296190|537514218|FG001|Overall Study|Failure to induce PSVT|10|||
149009307|NCT02296190|537514219|FG002|Overall Study|Failure to induce PSVT|5|||
149009308|NCT02296190|537514220|FG003|Overall Study|Failure to induce PSVT|13|||
149009309|NCT02296190|537514221|FG004|Overall Study|Failure to induce PSVT|8|||
149009310|NCT02296190|537514222|FG005|Overall Study|Failure to induce PSVT|0|||
149009311|NCT02296190|537514217|FG000|Overall Study|Physician Decision|1|||
149009312|NCT02296190|537514218|FG001|Overall Study|Physician Decision|1|||
149009313|NCT02296190|537514219|FG002|Overall Study|Physician Decision|0|||
149009314|NCT02296190|537514220|FG003|Overall Study|Physician Decision|1|||
149009315|NCT02296190|537514221|FG004|Overall Study|Physician Decision|2|||
149009316|NCT02296190|537514222|FG005|Overall Study|Physician Decision|0|||
149009317|NCT02296190|537514217|FG000|Overall Study|Withdrawal by Subject|0|||
149009318|NCT02296190|537514218|FG001|Overall Study|Withdrawal by Subject|1|||
149009319|NCT02296190|537514219|FG002|Overall Study|Withdrawal by Subject|0|||
149009320|NCT02296190|537514220|FG003|Overall Study|Withdrawal by Subject|0|||
149009321|NCT02296190|537514221|FG004|Overall Study|Withdrawal by Subject|0|||
149009322|NCT02296190|537514222|FG005|Overall Study|Withdrawal by Subject|0|||
149009323|NCT02296190|537514217|FG000|Overall Study|PSVT < 5 minutes|5|||
149009324|NCT02296190|537514218|FG001|Overall Study|PSVT < 5 minutes|6|||
149009325|NCT02296190|537514219|FG002|Overall Study|PSVT < 5 minutes|6|||
149009326|NCT02296190|537514220|FG003|Overall Study|PSVT < 5 minutes|6|||
149009327|NCT02296190|537514221|FG004|Overall Study|PSVT < 5 minutes|5|||
149009328|NCT02296190|537514222|FG005|Overall Study|PSVT < 5 minutes|0|||
149009329|NCT02296190|537514217|FG000|Overall Study|Patient was given Propofol|0|||
149009330|NCT02296190|537514218|FG001|Overall Study|Patient was given Propofol|1|||
149009331|NCT02296190|537514219|FG002|Overall Study|Patient was given Propofol|0|||
149009332|NCT02296190|537514220|FG003|Overall Study|Patient was given Propofol|1|||
149009333|NCT02296190|537514221|FG004|Overall Study|Patient was given Propofol|0|||
149009334|NCT02296190|537514222|FG005|Overall Study|Patient was given Propofol|0|||
149009335|NCT02296190|537514217|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
149009336|NCT02296190|537514218|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
149009337|NCT02296190|537514219|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
149009338|NCT02296190|537514220|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
149009339|NCT02296190|537514221|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
149009340|NCT02296190|537514222|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
149009341|NCT02296190|537514217|FG000|Overall Study|Blood pressure <100 after sedation|0|||
149009342|NCT02296190|537514218|FG001|Overall Study|Blood pressure <100 after sedation|0|||
149009343|NCT02296190|537514219|FG002|Overall Study|Blood pressure <100 after sedation|0|||
149009344|NCT02296190|537514220|FG003|Overall Study|Blood pressure <100 after sedation|1|||
149009345|NCT02296190|537514221|FG004|Overall Study|Blood pressure <100 after sedation|0|||
149009346|NCT02296190|537514222|FG005|Overall Study|Blood pressure <100 after sedation|0|||
149009347|NCT02296190|537514217|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
149009348|NCT02296190|537514218|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
149009349|NCT02296190|537514219|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
149009350|NCT02296190|537514220|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
149009351|NCT02296190|537514221|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
149009352|NCT02296190|537514222|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
149009353|NCT02296190|537514217|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
149009354|NCT02296190|537514218|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
149009355|NCT02296190|537514219|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
149009356|NCT02296190|537514220|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
149009357|NCT02296190|537514221|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
149009358|NCT02296190|537514222|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
149009359|NCT02296190|537514217|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
149009360|NCT02296190|537514218|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
149009361|NCT02296190|537514219|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
149009362|NCT02296190|537514220|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
149009363|NCT02296190|537514221|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
149009364|NCT02296190|537514222|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
149009365|NCT02296190|537514217|FG000|Overall Study|Lab result not available in time|1|||
149009366|NCT02296190|537514218|FG001|Overall Study|Lab result not available in time|0|||
149009367|NCT02296190|537514219|FG002|Overall Study|Lab result not available in time|0|||
149009368|NCT02296190|537514220|FG003|Overall Study|Lab result not available in time|0|||
149009369|NCT02296190|537514221|FG004|Overall Study|Lab result not available in time|0|||
149009370|NCT02296190|537514222|FG005|Overall Study|Lab result not available in time|0|||
149009371|NCT02978443|537514223|FG000|Overall Study|Withdrawal by Subject|1|||
149009372|NCT02978443|537514223|FG000|Overall Study|Adverse Event|3|||
149009373|NCT02978443|537514223|FG000|Overall Study|Disease Progression on study|6|||
149009374|NCT02978443|537514223|FG000|Overall Study|Death|1|||
149009375|NCT02978443|537514223|FG000|Overall Study|Physician Decision|1|||
149009376|NCT02978443|537514223|FG000|Overall Study|Switch to alternative therapy|1|||
149009377|NCT02978443|537514223|FG000|Overall Study|Refused further treatment|1|||
149009378|NCT02087501|537514225|FG000|Overall Study|Death|7|||
149009379|NCT02087501|537514225|FG000|Overall Study|Open repair of aneurysm|1|||
149009380|NCT02087501|537514225|FG000|Overall Study|Lost to Follow-up|2|||
149009381|NCT03682705|537514226|FG000|Overall Study|Adverse Event|1|||
149009382|NCT03682705|537514227|FG001|Overall Study|Adverse Event|1|||
149009383|NCT03682705|537514228|FG002|Overall Study|Adverse Event|1|||
149009384|NCT03682705|537514229|FG003|Overall Study|Adverse Event|0|||
149009385|NCT03682705|537514230|FG004|Overall Study|Adverse Event|1|||
149009386|NCT03682705|537514231|FG005|Overall Study|Adverse Event|1|||
149009387|NCT03682705|537514226|FG000|Overall Study|Withdrawal by Subject|1|||
149009388|NCT03682705|537514227|FG001|Overall Study|Withdrawal by Subject|3|||
149009389|NCT03682705|537514228|FG002|Overall Study|Withdrawal by Subject|2|||
149009390|NCT03682705|537514229|FG003|Overall Study|Withdrawal by Subject|4|||
149009391|NCT03682705|537514230|FG004|Overall Study|Withdrawal by Subject|0|||
149009392|NCT03682705|537514231|FG005|Overall Study|Withdrawal by Subject|1|||
149009393|NCT03682705|537514226|FG000|Overall Study|Other, not specified|0|||
149009394|NCT03682705|537514227|FG001|Overall Study|Other, not specified|0|||
149009395|NCT03682705|537514228|FG002|Overall Study|Other, not specified|0|||
149009396|NCT03682705|537514229|FG003|Overall Study|Other, not specified|1|||
149009397|NCT03682705|537514230|FG004|Overall Study|Other, not specified|2|||
149009398|NCT03682705|537514231|FG005|Overall Study|Other, not specified|0|||
149009399|NCT03682705|537514226|FG000|Overall Study|Lost to Follow-up|0|||
149009400|NCT03682705|537514227|FG001|Overall Study|Lost to Follow-up|0|||
149009401|NCT03682705|537514228|FG002|Overall Study|Lost to Follow-up|0|||
149009402|NCT03682705|537514229|FG003|Overall Study|Lost to Follow-up|0|||
149009403|NCT03682705|537514230|FG004|Overall Study|Lost to Follow-up|3|||
149009404|NCT03682705|537514231|FG005|Overall Study|Lost to Follow-up|0|||
149009405|NCT00094328|537514232|FG000|Overall Study|Lost to Follow-up|1|||
149009406|NCT01483937|537514233|FG000|Overall Study|Withdrawal by Subject|4|||
149009407|NCT01483937|537514234|FG001|Overall Study|Withdrawal by Subject|3|||
149009408|NCT00265330|537514235|FG000|Overall Study|Adverse Event|41|||
149009409|NCT00265330|537514235|FG000|Overall Study|Lost to Follow-up|8|||
149009410|NCT00265330|537514235|FG000|Overall Study|Withdrawal by Subject|34|||
149009411|NCT00265330|537514235|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
149009412|NCT00265330|537514235|FG000|Overall Study|Lack of Efficacy|4|||
149009413|NCT00265330|537514235|FG000|Overall Study|Family Scheduling Conflicts|1|||
149009414|NCT00265330|537514235|FG000|Overall Study|Began Taking Formulary Geodon|1|||
149009415|NCT00265330|537514235|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
149009416|NCT00265330|537514235|FG000|Overall Study|Site Closed by Sponsor|1|||
149009417|NCT00265330|537514235|FG000|Overall Study|Principal Investigators Request|1|||
149009418|NCT00265330|537514235|FG000|Overall Study|Withdrew Consent|1|||
149009419|NCT00265330|537514235|FG000|Overall Study|Protocol Violation|1|||
149009420|NCT02213328|537514236|FG000|Overall Study|Withdrawal by Subject|10|||
149009421|NCT02213328|537514236|FG000|Overall Study|Physician Decision|2|||
149009422|NCT02213328|537514236|FG000|Overall Study|Lost to Follow-up|16|||
149009423|NCT00990340|537514237|FG000|First 14-day Treatment|Not Compliant|2|||
149009424|NCT00990340|537514238|FG001|First 14-day Treatment|Not Compliant|1|||
149009425|NCT00990340|537514237|FG000|First 14-day Treatment|Lost to Follow-up|2|||
149009426|NCT00990340|537514238|FG001|First 14-day Treatment|Lost to Follow-up|1|||
149009427|NCT00990340|537514237|FG000|First 14-day Treatment|Protocol Violation|2|||
149009428|NCT00990340|537514238|FG001|First 14-day Treatment|Protocol Violation|2|||
149009429|NCT04615182|537514239|FG000|Overall Study|Re-transplanted|2|||
149009430|NCT04615182|537514239|FG000|Overall Study|Protocol Violation|6|||
149009431|NCT04615182|537514239|FG000|Overall Study|Death|6|||
149009432|NCT04615182|537514239|FG000|Overall Study|Death and protocol violation|1|||
149009433|NCT00402337|537514240|FG000|Overall Study|Adverse Event|0|||
149009434|NCT00402337|537514241|FG001|Overall Study|Adverse Event|2|||
149009435|NCT00402337|537514242|FG002|Overall Study|Adverse Event|2|||
149009436|NCT00402337|537514243|FG003|Overall Study|Adverse Event|3|||
149009437|NCT00402337|537514244|FG004|Overall Study|Adverse Event|2|||
149009438|NCT00402337|537514240|FG000|Overall Study|Noncompliance|0|||
149009439|NCT00402337|537514241|FG001|Overall Study|Noncompliance|0|||
149009440|NCT00402337|537514242|FG002|Overall Study|Noncompliance|0|||
149009441|NCT00402337|537514243|FG003|Overall Study|Noncompliance|0|||
149009442|NCT00402337|537514244|FG004|Overall Study|Noncompliance|2|||
149009443|NCT00402337|537514240|FG000|Overall Study|Withdrawal by Subject|5|||
149009444|NCT00402337|537514241|FG001|Overall Study|Withdrawal by Subject|3|||
149009445|NCT00402337|537514242|FG002|Overall Study|Withdrawal by Subject|1|||
149009446|NCT00402337|537514243|FG003|Overall Study|Withdrawal by Subject|6|||
149009447|NCT00402337|537514244|FG004|Overall Study|Withdrawal by Subject|4|||
149009448|NCT00402337|537514240|FG000|Overall Study|Lost to Follow-up|0|||
149009449|NCT00402337|537514241|FG001|Overall Study|Lost to Follow-up|0|||
149009450|NCT00402337|537514242|FG002|Overall Study|Lost to Follow-up|1|||
149009451|NCT00402337|537514243|FG003|Overall Study|Lost to Follow-up|2|||
149009452|NCT00402337|537514244|FG004|Overall Study|Lost to Follow-up|0|||
149009453|NCT00402337|537514240|FG000|Overall Study|Physician Decision|0|||
149009454|NCT00402337|537514241|FG001|Overall Study|Physician Decision|0|||
149009455|NCT00402337|537514242|FG002|Overall Study|Physician Decision|0|||
149009456|NCT00402337|537514243|FG003|Overall Study|Physician Decision|1|||
149009457|NCT00402337|537514244|FG004|Overall Study|Physician Decision|0|||
149009458|NCT00402337|537514240|FG000|Overall Study|Other Reason|0|||
149009459|NCT00402337|537514241|FG001|Overall Study|Other Reason|1|||
149009460|NCT00402337|537514242|FG002|Overall Study|Other Reason|0|||
149009461|NCT00402337|537514243|FG003|Overall Study|Other Reason|0|||
149009462|NCT00402337|537514244|FG004|Overall Study|Other Reason|0|||
149009463|NCT02178566|537514245|FG000|Overall Study|patient did not complete due to noncompliance|0|||
149009464|NCT02178566|537514246|FG001|Overall Study|patient did not complete due to noncompliance|1|||
149009465|NCT03565068|537514247|FG000|Overall Study|Protocol Violation|0|||
149009466|NCT03565068|537514248|FG001|Overall Study|Protocol Violation|0|||
149009467|NCT03565068|537514249|FG002|Overall Study|Protocol Violation|0|||
149009468|NCT03565068|537514250|FG003|Overall Study|Protocol Violation|0|||
149009469|NCT03565068|537514251|FG004|Overall Study|Protocol Violation|1|||
149009470|NCT03565068|537514252|FG005|Overall Study|Protocol Violation|0|||
149009471|NCT03565068|537514253|FG006|Overall Study|Protocol Violation|0|||
149009472|NCT03565068|537514254|FG007|Overall Study|Protocol Violation|1|||
149009473|NCT03565068|537514255|FG008|Overall Study|Protocol Violation|0|||
149009474|NCT03565068|537514247|FG000|Overall Study|Sponsor decision|0|||
149009475|NCT03565068|537514248|FG001|Overall Study|Sponsor decision|0|||
149009476|NCT03565068|537514249|FG002|Overall Study|Sponsor decision|0|||
149009477|NCT03565068|537514250|FG003|Overall Study|Sponsor decision|0|||
149009478|NCT03565068|537514251|FG004|Overall Study|Sponsor decision|1|||
149009479|NCT03565068|537514252|FG005|Overall Study|Sponsor decision|1|||
149009480|NCT03565068|537514253|FG006|Overall Study|Sponsor decision|0|||
149009481|NCT03565068|537514254|FG007|Overall Study|Sponsor decision|0|||
149009482|NCT03565068|537514255|FG008|Overall Study|Sponsor decision|0|||
149009483|NCT03565068|537514247|FG000|Overall Study|Withdrawal by Subject|0|||
149009484|NCT03565068|537514248|FG001|Overall Study|Withdrawal by Subject|0|||
149009485|NCT03565068|537514249|FG002|Overall Study|Withdrawal by Subject|1|||
149009486|NCT03565068|537514250|FG003|Overall Study|Withdrawal by Subject|0|||
149009487|NCT03565068|537514251|FG004|Overall Study|Withdrawal by Subject|2|||
149009488|NCT03565068|537514252|FG005|Overall Study|Withdrawal by Subject|0|||
149009489|NCT03565068|537514253|FG006|Overall Study|Withdrawal by Subject|1|||
149009490|NCT03565068|537514254|FG007|Overall Study|Withdrawal by Subject|5|||
149009491|NCT03565068|537514255|FG008|Overall Study|Withdrawal by Subject|1|||
149009492|NCT03565068|537514247|FG000|Overall Study|Physician Decision|0|||
149009493|NCT03565068|537514248|FG001|Overall Study|Physician Decision|0|||
149009494|NCT03565068|537514249|FG002|Overall Study|Physician Decision|0|||
149009495|NCT03565068|537514250|FG003|Overall Study|Physician Decision|0|||
149009496|NCT03565068|537514251|FG004|Overall Study|Physician Decision|0|||
149009497|NCT03565068|537514252|FG005|Overall Study|Physician Decision|0|||
149009498|NCT03565068|537514253|FG006|Overall Study|Physician Decision|0|||
149009499|NCT03565068|537514254|FG007|Overall Study|Physician Decision|1|||
149009500|NCT03565068|537514255|FG008|Overall Study|Physician Decision|0|||
149009501|NCT03565068|537514247|FG000|Overall Study|Lost to Follow-up|0|||
149009502|NCT03565068|537514248|FG001|Overall Study|Lost to Follow-up|0|||
149009503|NCT03565068|537514249|FG002|Overall Study|Lost to Follow-up|0|||
149009504|NCT03565068|537514250|FG003|Overall Study|Lost to Follow-up|0|||
149009505|NCT03565068|537514251|FG004|Overall Study|Lost to Follow-up|0|||
149009506|NCT03565068|537514252|FG005|Overall Study|Lost to Follow-up|0|||
149009507|NCT03565068|537514253|FG006|Overall Study|Lost to Follow-up|0|||
149009508|NCT03565068|537514254|FG007|Overall Study|Lost to Follow-up|1|||
149009509|NCT03565068|537514255|FG008|Overall Study|Lost to Follow-up|0|||
149009510|NCT05778526|537514256|FG000|Overall Study|Lost to Follow-up|0|||
149009511|NCT05778526|537514257|FG001|Overall Study|Lost to Follow-up|1|||
149009512|NCT05778526|537514258|FG002|Overall Study|Lost to Follow-up|3|||
149009513|NCT05778526|537514256|FG000|Overall Study|Protocol Violation|0|||
149009514|NCT05778526|537514257|FG001|Overall Study|Protocol Violation|0|||
149009515|NCT05778526|537514258|FG002|Overall Study|Protocol Violation|8|||
149009516|NCT00085202|537514259|FG000|Overall Study|Still on therapy|2|||
149009517|NCT00085202|537514260|FG001|Overall Study|Still on therapy|0|||
149009518|NCT00085202|537514259|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
149009519|NCT00085202|537514260|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
149009520|NCT00085202|537514259|FG000|Overall Study|Excessive toxicity|6|||
149009521|NCT00085202|537514260|FG001|Overall Study|Excessive toxicity|5|||
149009522|NCT00085202|537514259|FG000|Overall Study|Non-specified|3|||
149009523|NCT00085202|537514260|FG001|Overall Study|Non-specified|5|||
149009524|NCT00085202|537514259|FG000|Overall Study|Withdrawal by Subject|2|||
149009525|NCT00085202|537514260|FG001|Overall Study|Withdrawal by Subject|1|||
149009526|NCT00085202|537514259|FG000|Overall Study|Physician Decision|4|||
149009527|NCT00085202|537514260|FG001|Overall Study|Physician Decision|1|||
149009528|NCT00085202|537514259|FG000|Overall Study|Progressive disease|1|||
149009529|NCT00085202|537514260|FG001|Overall Study|Progressive disease|11|||
149009530|NCT03238300|537514261|FG000|Baseline (Before Intervention)|Physician Decision|0|||
149009531|NCT03238300|537514262|FG001|Baseline (Before Intervention)|Physician Decision|1|||
149009532|NCT03238300|537514261|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
149009533|NCT03238300|537514262|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
149009534|NCT03238300|537514261|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
149009535|NCT03238300|537514262|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
149009536|NCT03238300|537514261|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
149009537|NCT03238300|537514262|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
149009538|NCT02613221|537514271|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
149009539|NCT02613221|537514271|FG000|Overall Study|Adverse Event|2|||
149009540|NCT02613221|537514271|FG000|Overall Study|Voluntary Discontinuation|1|||
149009541|NCT02613221|537514271|FG000|Overall Study|Delayed Treatment|1|||
149009542|NCT02613221|537514271|FG000|Overall Study|Enrolled but Not Treated|1|||
149009543|NCT01301274|537514272|FG000|Overall Study|Physician Decision|2|||
149009544|NCT01301274|537514273|FG001|Overall Study|Physician Decision|1|||
149009545|NCT02917941|537514274|FG000|Treatment Period|Adverse Event|11|||
149009546|NCT02917941|537514274|FG000|Treatment Period|Progressive Disease|11|||
149009547|NCT02917941|537514274|FG000|Treatment Period|Reason not Specified|2|||
149009548|NCT02917941|537514274|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
149009549|NCT02917941|537514274|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
149009550|NCT01893827|537514275|FG000|Overall Study|Lost to Follow-up|19|||
149009551|NCT01893827|537514276|FG001|Overall Study|Lost to Follow-up|26|||
149009552|NCT00399763|537514277|FG000|Overall Study|Lost to Follow-up|2|||
149009553|NCT00399763|537514278|FG001|Overall Study|Lost to Follow-up|3|||
149009554|NCT00445679|537514285|FG000|Overall Study|Adverse Event|22|||
149009555|NCT00445679|537514286|FG001|Overall Study|Adverse Event|12|||
149009556|NCT00445679|537514287|FG002|Overall Study|Adverse Event|30|||
149009557|NCT00445679|537514288|FG003|Overall Study|Adverse Event|19|||
149009558|NCT00445679|537514285|FG000|Overall Study|Failed to return|1|||
149009559|NCT00445679|537514286|FG001|Overall Study|Failed to return|3|||
149009560|NCT00445679|537514287|FG002|Overall Study|Failed to return|2|||
149009561|NCT00445679|537514288|FG003|Overall Study|Failed to return|2|||
149009562|NCT00445679|537514285|FG000|Overall Study|Physician Decision|0|||
149009563|NCT00445679|537514286|FG001|Overall Study|Physician Decision|0|||
149009564|NCT00445679|537514287|FG002|Overall Study|Physician Decision|1|||
149009565|NCT00445679|537514288|FG003|Overall Study|Physician Decision|0|||
149009566|NCT00445679|537514285|FG000|Overall Study|Lost to Follow-up|10|||
149009567|NCT00445679|537514286|FG001|Overall Study|Lost to Follow-up|6|||
149009568|NCT00445679|537514287|FG002|Overall Study|Lost to Follow-up|6|||
149009569|NCT00445679|537514288|FG003|Overall Study|Lost to Follow-up|5|||
149009570|NCT00445679|537514285|FG000|Overall Study|Compliance|3|||
149009571|NCT00445679|537514286|FG001|Overall Study|Compliance|2|||
149009572|NCT00445679|537514287|FG002|Overall Study|Compliance|1|||
149009573|NCT00445679|537514288|FG003|Overall Study|Compliance|2|||
149009574|NCT00445679|537514285|FG000|Overall Study|Withdrawal of Informed Consent|0|||
149009575|NCT00445679|537514286|FG001|Overall Study|Withdrawal of Informed Consent|0|||
149009576|NCT00445679|537514287|FG002|Overall Study|Withdrawal of Informed Consent|1|||
149009577|NCT00445679|537514288|FG003|Overall Study|Withdrawal of Informed Consent|0|||
149009578|NCT00445679|537514285|FG000|Overall Study|Protocol Violation|2|||
149009579|NCT00445679|537514286|FG001|Overall Study|Protocol Violation|3|||
149009580|NCT00445679|537514287|FG002|Overall Study|Protocol Violation|3|||
149009581|NCT00445679|537514288|FG003|Overall Study|Protocol Violation|1|||
149009582|NCT00445679|537514285|FG000|Overall Study|Withdrawal by Subject|8|||
149009583|NCT00445679|537514286|FG001|Overall Study|Withdrawal by Subject|14|||
149009584|NCT00445679|537514287|FG002|Overall Study|Withdrawal by Subject|20|||
149009585|NCT00445679|537514288|FG003|Overall Study|Withdrawal by Subject|18|||
149009586|NCT00445679|537514285|FG000|Overall Study|Lack of Efficacy|2|||
149009587|NCT00445679|537514286|FG001|Overall Study|Lack of Efficacy|6|||
149009588|NCT00445679|537514287|FG002|Overall Study|Lack of Efficacy|2|||
149009589|NCT00445679|537514288|FG003|Overall Study|Lack of Efficacy|0|||
149009590|NCT01353222|537514292|FG000|Overall Study|Death|30|||
149009591|NCT01353222|537514293|FG001|Overall Study|Death|30|||
149009592|NCT01353222|537514292|FG000|Overall Study|Withdrawal by Subject|8|||
149009593|NCT01353222|537514293|FG001|Overall Study|Withdrawal by Subject|5|||
149009594|NCT01353222|537514292|FG000|Overall Study|Study Terminated|31|||
149009595|NCT01353222|537514293|FG001|Overall Study|Study Terminated|37|||
149009596|NCT01353222|537514292|FG000|Overall Study|Site closed research department|1|||
149009597|NCT01353222|537514293|FG001|Overall Study|Site closed research department|0|||
149009598|NCT01654601|537514294|FG000|1st Administration|Withdrawal by Subject|2|||
149009599|NCT01654601|537514295|FG001|1st Administration|Withdrawal by Subject|0|||
149009600|NCT01654601|537514294|FG000|1st Administration|Protocol Violation|0|||
149009601|NCT01654601|537514295|FG001|1st Administration|Protocol Violation|2|||
149009602|NCT01654601|537514294|FG000|2nd Administration|Adverse Event|1|||
149009603|NCT01654601|537514295|FG001|2nd Administration|Adverse Event|0|||
149009604|NCT01654601|537514294|FG000|2nd Administration|Protocol Violation|0|||
149009605|NCT01654601|537514295|FG001|2nd Administration|Protocol Violation|1|||
149009606|NCT02636270|537514296|FG000|Overall Study|Adverse Event|1|||
149009607|NCT02636270|537514297|FG001|Overall Study|Adverse Event|0|||
149009608|NCT02636270|537514298|FG002|Overall Study|Adverse Event|0|||
149009609|NCT02636270|537514296|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
149009610|NCT02636270|537514297|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
149009611|NCT02636270|537514298|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
149009612|NCT01119898|537514299|FG000|Overall Study|Adverse Event|4|||
149009613|NCT01119898|537514300|FG001|Overall Study|Adverse Event|5|||
149009614|NCT01119898|537514299|FG000|Overall Study|Withdrawal by Subject|1|||
149009615|NCT01119898|537514300|FG001|Overall Study|Withdrawal by Subject|4|||
149009616|NCT01119898|537514299|FG000|Overall Study|Lack of Efficacy|0|||
149009617|NCT01119898|537514300|FG001|Overall Study|Lack of Efficacy|2|||
149009618|NCT01119898|537514299|FG000|Overall Study|Protocol Violation|1|||
149009619|NCT01119898|537514300|FG001|Overall Study|Protocol Violation|1|||
149009620|NCT01119898|537514299|FG000|Overall Study|Medical procedure|1|||
149009621|NCT01119898|537514300|FG001|Overall Study|Medical procedure|0|||
149009622|NCT01119898|537514299|FG000|Overall Study|Randomized in error did not participate|1|||
149009623|NCT01119898|537514300|FG001|Overall Study|Randomized in error did not participate|0|||
149009624|NCT01833143|537514301|FG000|Overall Study|Not Treated|1|||
149009625|NCT03021668|537514302|FG000|Overall Study|Physician Decision|0|||
149009626|NCT03021668|537514303|FG001|Overall Study|Physician Decision|1|||
149009627|NCT00909428|537514304|FG000|Overall Study|Lost to Follow-up|13|||
149009628|NCT00909428|537514305|FG001|Overall Study|Lost to Follow-up|10|||
149009629|NCT00909428|537514306|FG002|Overall Study|Lost to Follow-up|9|||
149009630|NCT02217280|537514309|FG000|Overall Study|Withdrawal by Subject|2|||
149009631|NCT02217280|537514309|FG000|Overall Study|Post-consent sceen fail|2|||
149009632|NCT00116844|537514310|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
149009633|NCT00116844|537514311|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
149009634|NCT00116844|537514310|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
149009635|NCT00116844|537514311|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
149009636|NCT00116844|537514310|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
149009637|NCT00116844|537514311|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
149009638|NCT00116844|537514310|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
149009639|NCT00116844|537514311|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
149009640|NCT00116844|537514310|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
149009641|NCT00116844|537514311|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
149009642|NCT00116844|537514310|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
149009643|NCT00116844|537514311|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
149009644|NCT00116844|537514310|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
149009645|NCT00116844|537514311|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
149009646|NCT00116844|537514310|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
149009647|NCT00116844|537514311|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
149009648|NCT00116844|537514310|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
149009649|NCT00116844|537514311|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
149009650|NCT01933880|537514312|FG000|Overall Study|Withdrawal by Subject|5|||
149009651|NCT01933880|537514313|FG001|Overall Study|Withdrawal by Subject|0|||
149009652|NCT01933880|537514312|FG000|Overall Study|Lack of Efficacy|1|||
149009653|NCT01933880|537514313|FG001|Overall Study|Lack of Efficacy|0|||
149009654|NCT01933880|537514312|FG000|Overall Study|Concomitant medication Interference|0|||
149009655|NCT01933880|537514313|FG001|Overall Study|Concomitant medication Interference|1|||
149009656|NCT01933880|537514312|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
149009657|NCT01933880|537514313|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
149009658|NCT01933880|537514312|FG000|Overall Study|Other|4|||
149009659|NCT01933880|537514313|FG001|Overall Study|Other|0|||
149009660|NCT01933880|537514312|FG000|Overall Study|Protocol Violation|1|||
149009661|NCT01933880|537514313|FG001|Overall Study|Protocol Violation|0|||
149009662|NCT00510458|537514314|FG000|Overall Study|5 year not evaluable/missed|21|||
149009663|NCT00510458|537514314|FG000|Overall Study|Death|1|||
149009664|NCT00510458|537514314|FG000|Overall Study|Terminated|14|||
149009665|NCT00510458|537514314|FG000|Overall Study|Lost to Follow-up|6|||
149009666|NCT00510458|537514314|FG000|Overall Study|Withdrawal by Subject|3|||
149009667|NCT00510458|537514314|FG000|Overall Study|Revision|2|||
149009668|NCT02569710|537514315|FG000|Overall Study|Adverse Event|1|||
149009669|NCT02569710|537514316|FG001|Overall Study|Adverse Event|0|||
149009670|NCT02569710|537514317|FG002|Overall Study|Adverse Event|0|||
149009671|NCT02569710|537514318|FG003|Overall Study|Adverse Event|0|||
149009672|NCT02569710|537514319|FG004|Overall Study|Adverse Event|0|||
149009673|NCT02569710|537514320|FG005|Overall Study|Adverse Event|0|||
149009674|NCT02569710|537514321|FG006|Overall Study|Adverse Event|0|||
149009675|NCT02569710|537514322|FG007|Overall Study|Adverse Event|0|||
149009676|NCT02569710|537514323|FG008|Overall Study|Adverse Event|0|||
149009677|NCT02569710|537514324|FG009|Overall Study|Adverse Event|0|||
149009678|NCT02569710|537514315|FG000|Overall Study|Lost to Follow-up|0|||
149009679|NCT02569710|537514316|FG001|Overall Study|Lost to Follow-up|0|||
149009680|NCT02569710|537514317|FG002|Overall Study|Lost to Follow-up|0|||
149009681|NCT02569710|537514318|FG003|Overall Study|Lost to Follow-up|0|||
149009682|NCT02569710|537514319|FG004|Overall Study|Lost to Follow-up|0|||
149009683|NCT02569710|537514320|FG005|Overall Study|Lost to Follow-up|0|||
149009684|NCT02569710|537514321|FG006|Overall Study|Lost to Follow-up|1|||
149009685|NCT02569710|537514322|FG007|Overall Study|Lost to Follow-up|0|||
149009686|NCT02569710|537514323|FG008|Overall Study|Lost to Follow-up|1|||
149009687|NCT02569710|537514324|FG009|Overall Study|Lost to Follow-up|0|||
149009688|NCT02569710|537514315|FG000|Overall Study|Virologic failure|0|||
149009689|NCT02569710|537514316|FG001|Overall Study|Virologic failure|0|||
149009690|NCT02569710|537514317|FG002|Overall Study|Virologic failure|0|||
149009691|NCT02569710|537514318|FG003|Overall Study|Virologic failure|0|||
149009692|NCT02569710|537514319|FG004|Overall Study|Virologic failure|1|||
149009693|NCT02569710|537514320|FG005|Overall Study|Virologic failure|0|||
149009694|NCT02569710|537514321|FG006|Overall Study|Virologic failure|1|||
149009695|NCT02569710|537514322|FG007|Overall Study|Virologic failure|0|||
149009696|NCT02569710|537514323|FG008|Overall Study|Virologic failure|0|||
149009697|NCT02569710|537514324|FG009|Overall Study|Virologic failure|0|||
149009698|NCT02569710|537514315|FG000|Overall Study|Withdrawal by Subject|0|||
149009699|NCT02569710|537514316|FG001|Overall Study|Withdrawal by Subject|0|||
149009700|NCT02569710|537514317|FG002|Overall Study|Withdrawal by Subject|0|||
149009701|NCT02569710|537514318|FG003|Overall Study|Withdrawal by Subject|0|||
149009702|NCT02569710|537514319|FG004|Overall Study|Withdrawal by Subject|0|||
149009703|NCT02569710|537514320|FG005|Overall Study|Withdrawal by Subject|1|||
149009704|NCT02569710|537514321|FG006|Overall Study|Withdrawal by Subject|0|||
149009705|NCT02569710|537514322|FG007|Overall Study|Withdrawal by Subject|0|||
149009706|NCT02569710|537514323|FG008|Overall Study|Withdrawal by Subject|0|||
149009707|NCT02569710|537514324|FG009|Overall Study|Withdrawal by Subject|0|||
149009708|NCT01125722|537514325|FG000|Overall Study|Withdrawal by Subject|2|||
149009709|NCT01125722|537514326|FG001|Overall Study|Withdrawal by Subject|1|||
149009710|NCT01125722|537514325|FG000|Overall Study|Lost to Follow-up|1|||
149009711|NCT01125722|537514326|FG001|Overall Study|Lost to Follow-up|0|||
149009712|NCT00709059|537514334|FG000|Overall Study|Lost to Follow-up|34|||
149009713|NCT00709059|537514334|FG000|Overall Study|Withdrawal by Subject|19|||
149009714|NCT00709059|537514334|FG000|Overall Study|Physician Decision|7|||
149009715|NCT00709059|537514334|FG000|Overall Study|Disease complication|3|||
149009716|NCT00709059|537514334|FG000|Overall Study|Side effects|20|||
149009717|NCT00709059|537514334|FG000|Overall Study|Serious side effects|11|||
149009718|NCT01396317|537514335|FG000|Overall Study|Adverse Event|1|||
149009719|NCT01396317|537514336|FG001|Overall Study|Adverse Event|0|||
149009720|NCT01786330|537514337|FG000|Overall Study|Withdrawal by Subject|0|||
149009721|NCT01786330|537514338|FG001|Overall Study|Withdrawal by Subject|1|||
149009722|NCT01786330|537514337|FG000|Overall Study|Lost to Follow-up|0|||
149009723|NCT01786330|537514338|FG001|Overall Study|Lost to Follow-up|1|||
149009724|NCT01786330|537514337|FG000|Overall Study|Excluded intraoperatively|0|||
149009725|NCT01786330|537514338|FG001|Overall Study|Excluded intraoperatively|1|||
149009726|NCT01786330|537514337|FG000|Overall Study|Protocol Violation|1|||
149009727|NCT01786330|537514338|FG001|Overall Study|Protocol Violation|0|||
149009728|NCT02172625|537514339|FG000|Overall Study|Adverse Event|0|||
149009729|NCT02172625|537514340|FG001|Overall Study|Adverse Event|1|||
149009730|NCT02172625|537514339|FG000|Overall Study|Pregnancy|0|||
149009731|NCT02172625|537514340|FG001|Overall Study|Pregnancy|1|||
149009732|NCT02172625|537514339|FG000|Overall Study|car accident|0|||
149009733|NCT02172625|537514340|FG001|Overall Study|car accident|1|||
149009734|NCT03315130|537514341|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
149009735|NCT03315130|537514342|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
149009736|NCT03315130|537514343|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
149009737|NCT03315130|537514344|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
149009738|NCT03315130|537514341|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
149009739|NCT03315130|537514342|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
149009740|NCT03315130|537514343|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
149009741|NCT03315130|537514344|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
149009742|NCT03315130|537514341|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
149009743|NCT03315130|537514342|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
149009744|NCT03315130|537514343|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
149009745|NCT03315130|537514344|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
149009746|NCT03315130|537514341|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
149009747|NCT03315130|537514342|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
149009748|NCT03315130|537514343|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
149009749|NCT03315130|537514344|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
149009750|NCT03315130|537514341|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
149009751|NCT03315130|537514342|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
149009752|NCT03315130|537514343|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
149009753|NCT03315130|537514344|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
149009754|NCT03315130|537514341|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
149009755|NCT03315130|537514342|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
149009756|NCT03315130|537514343|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
149009757|NCT03315130|537514344|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
149009758|NCT02944656|537514352|FG000|Overall Study|No longer eligible|3|||
149009759|NCT02944656|537514353|FG001|Overall Study|No longer eligible|0|||
149009760|NCT02944656|537514352|FG000|Overall Study|Lost to Follow-up|7|||
149009761|NCT02944656|537514353|FG001|Overall Study|Lost to Follow-up|10|||
149009762|NCT02243631|537516153|FG000|Overall Study|no synovial fluid on second aspirate|0|||
149009763|NCT02243631|537516154|FG001|Overall Study|no synovial fluid on second aspirate|1|||
149009764|NCT01590771|537516161|FG000|Overall Study|Other Protocol Specified Criteria|5|||
149009765|NCT01590771|537516162|FG001|Overall Study|Other Protocol Specified Criteria|14|||
149009766|NCT01590771|537516161|FG000|Overall Study|Withdrawal by Subject|8|||
149009767|NCT01590771|537516162|FG001|Overall Study|Withdrawal by Subject|15|||
149009768|NCT01590771|537516161|FG000|Overall Study|Protocol Violation|1|||
149009769|NCT01590771|537516162|FG001|Overall Study|Protocol Violation|2|||
149009770|NCT01590771|537516161|FG000|Overall Study|Lost to Follow-up|1|||
149009771|NCT01590771|537516162|FG001|Overall Study|Lost to Follow-up|1|||
149009772|NCT01590771|537516161|FG000|Overall Study|Lack of Efficacy|1|||
149009773|NCT01590771|537516162|FG001|Overall Study|Lack of Efficacy|0|||
149009774|NCT01590771|537516161|FG000|Overall Study|Adverse Event|3|||
149009775|NCT01590771|537516162|FG001|Overall Study|Adverse Event|7|||
149009776|NCT01785628|537516165|FG000|Overall Study|Lost to Follow-up|2|||
149009777|NCT01785628|537516166|FG001|Overall Study|Lost to Follow-up|3|||
149009778|NCT03015116|537516167|FG000|Overall Study|Lost to Follow-up|3|||
149009779|NCT03015116|537516168|FG001|Overall Study|Lost to Follow-up|0|||
149009780|NCT03015116|537516169|FG002|Overall Study|Lost to Follow-up|2|||
149009781|NCT03015116|537516167|FG000|Overall Study|Withdrawal by Subject|3|||
149009782|NCT03015116|537516168|FG001|Overall Study|Withdrawal by Subject|1|||
149009783|NCT03015116|537516169|FG002|Overall Study|Withdrawal by Subject|0|||
149009784|NCT03015116|537516167|FG000|Overall Study|Subject has New Medical Status|1|||
149009785|NCT03015116|537516168|FG001|Overall Study|Subject has New Medical Status|0|||
149009786|NCT03015116|537516169|FG002|Overall Study|Subject has New Medical Status|0|||
149009787|NCT03015116|537516167|FG000|Overall Study|Physician Decision|0|||
149009788|NCT03015116|537516168|FG001|Overall Study|Physician Decision|1|||
149009789|NCT03015116|537516169|FG002|Overall Study|Physician Decision|0|||
149009790|NCT02200939|537516173|FG000|Overall Study|Participant withdrew consent|0|||
149009791|NCT02200939|537516174|FG001|Overall Study|Participant withdrew consent|1|||
149009792|NCT02200939|537516173|FG000|Overall Study|Lost to Follow-up|2|||
149009793|NCT02200939|537516174|FG001|Overall Study|Lost to Follow-up|9|||
149009794|NCT02200939|537516173|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
149009795|NCT02200939|537516174|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
149009796|NCT03239873|537516175|FG000|Overall Study|Lost to Follow-up|15|||
149009797|NCT03239873|537516176|FG001|Overall Study|Lost to Follow-up|16|||
149009798|NCT03239873|537516175|FG000|Overall Study|Physician Decision|1|||
149009799|NCT03239873|537516176|FG001|Overall Study|Physician Decision|0|||
149009800|NCT03239873|537516175|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
149009801|NCT03239873|537516176|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
149009802|NCT03239873|537516175|FG000|Overall Study|Withdrawal by Subject|2|||
149009803|NCT03239873|537516176|FG001|Overall Study|Withdrawal by Subject|0|||
149009804|NCT03239873|537516175|FG000|Overall Study|Contraindication to study medication|1|||
149009805|NCT03239873|537516176|FG001|Overall Study|Contraindication to study medication|0|||
149009806|NCT03239873|537516175|FG000|Overall Study|Protocol Violation|1|||
149009807|NCT03239873|537516176|FG001|Overall Study|Protocol Violation|0|||
149009808|NCT01478113|537516187|FG000|Overall Study|Withdrawal by Subject|0|||
149009809|NCT01478113|537516188|FG001|Overall Study|Withdrawal by Subject|1|||
149009810|NCT01478113|537516187|FG000|Overall Study|Physician Decision|1|||
149009811|NCT01478113|537516188|FG001|Overall Study|Physician Decision|0|||
149009812|NCT03585296|537516191|FG000|Overall Study|Adverse Event|1|||
149009813|NCT03585296|537516191|FG000|Overall Study|Lost to Follow-up|2|||
149009814|NCT03585296|537516191|FG000|Overall Study|Withdrawal by Subject|2|||
149009815|NCT03980184|537516194|FG000|Overall Study|Dropped out before treatment|2|||
149009816|NCT03980184|537516195|FG001|Overall Study|Dropped out before treatment|2|||
149009817|NCT03980184|537516194|FG000|Overall Study|Lost to Follow-up|11|||
149009818|NCT03980184|537516195|FG001|Overall Study|Lost to Follow-up|13|||
149009819|NCT00462670|537516196|FG000|Overall Study|Adverse Event|3|||
149009820|NCT00462670|537516197|FG001|Overall Study|Adverse Event|5|||
149009821|NCT00462670|537516196|FG000|Overall Study|Lack of Efficacy|1|||
149009822|NCT00462670|537516197|FG001|Overall Study|Lack of Efficacy|0|||
149009823|NCT00462670|537516196|FG000|Overall Study|Protocol Violation|1|||
149009824|NCT00462670|537516197|FG001|Overall Study|Protocol Violation|0|||
149009825|NCT00462670|537516196|FG000|Overall Study|Resolution of signs and symptoms|0|||
149009826|NCT00462670|537516197|FG001|Overall Study|Resolution of signs and symptoms|2|||
149009827|NCT02002884|537516198|FG000|Main Period (MP)|Other|0|||
149009828|NCT02002884|537516199|FG001|Main Period (MP)|Other|3|||
149009829|NCT02002884|537516200|FG002|Main Period (MP)|Other|3|||
148782221|NCT00574795|536677411|FG000|Infant Series|Protocol Violation|2|||
149009830|NCT02002884|537516201|FG003|Main Period (MP)|Other|0|||
149009831|NCT02002884|537516198|FG000|Main Period (MP)|Adverse Event|0|||
149009832|NCT02002884|537516199|FG001|Main Period (MP)|Adverse Event|1|||
149009833|NCT02002884|537516200|FG002|Main Period (MP)|Adverse Event|1|||
149009834|NCT02002884|537516201|FG003|Main Period (MP)|Adverse Event|0|||
149009835|NCT02002884|537516198|FG000|Main Period (MP)|Withdrawal by Subject|6|||
149009836|NCT02002884|537516199|FG001|Main Period (MP)|Withdrawal by Subject|2|||
149009837|NCT02002884|537516200|FG002|Main Period (MP)|Withdrawal by Subject|2|||
149009838|NCT02002884|537516201|FG003|Main Period (MP)|Withdrawal by Subject|0|||
149009839|NCT02002884|537516198|FG000|Main Period (MP)|Lost to Follow-up|0|||
149009840|NCT02002884|537516199|FG001|Main Period (MP)|Lost to Follow-up|0|||
149009841|NCT02002884|537516200|FG002|Main Period (MP)|Lost to Follow-up|2|||
149009842|NCT02002884|537516201|FG003|Main Period (MP)|Lost to Follow-up|0|||
149009843|NCT02002884|537516198|FG000|Open-Label Extension Period (OLEX)|Other|0|||
149009844|NCT02002884|537516199|FG001|Open-Label Extension Period (OLEX)|Other|0|||
149009845|NCT02002884|537516200|FG002|Open-Label Extension Period (OLEX)|Other|0|||
149009846|NCT02002884|537516201|FG003|Open-Label Extension Period (OLEX)|Other|24|||
149009847|NCT02002884|537516198|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
149009848|NCT02002884|537516199|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
149009849|NCT02002884|537516200|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
149009850|NCT02002884|537516201|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
149009851|NCT02002884|537516198|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
149009852|NCT02002884|537516199|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
149009853|NCT02002884|537516200|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
149009854|NCT02002884|537516201|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
149009855|NCT02002884|537516198|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
149009856|NCT02002884|537516199|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
149009857|NCT02002884|537516200|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
149009858|NCT02002884|537516201|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
149009859|NCT02002884|537516198|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
149009860|NCT02002884|537516199|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
149009861|NCT02002884|537516200|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
149009862|NCT02002884|537516201|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
149009863|NCT02966002|537516202|FG000|Overall Study|Withdrawal by Subject|2|||
149009864|NCT02966002|537516202|FG000|Overall Study|Adverse Event|1|||
149009865|NCT02966002|537516202|FG000|Overall Study|Lost to Follow-up|1|||
149009866|NCT02291432|537516204|FG000|Overall Study|Withdrawal by Subject|2|||
149009867|NCT02145078|537516207|FG000|Overall Study|Death|1|||
149009868|NCT02145078|537516207|FG000|Overall Study|Reason not given|3|||
149009869|NCT03327402|537516208|FG000|Overall Study|Withdrawal by Subject|1|||
149009870|NCT03327402|537516208|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
149009871|NCT01454830|537516211|FG000|Overall Study|Withdrawal by Subject|4|||
149009872|NCT01454830|537516212|FG001|Overall Study|Withdrawal by Subject|4|||
149009873|NCT01454830|537516211|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
149009874|NCT01454830|537516212|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
149009875|NCT01454830|537516211|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
149009876|NCT01454830|537516212|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
149009877|NCT01454830|537516211|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
149009878|NCT01454830|537516212|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
149009879|NCT01454830|537516211|FG000|Overall Study|Withdrawal - no polysomnography|3|||
149009880|NCT01454830|537516212|FG001|Overall Study|Withdrawal - no polysomnography|2|||
149009881|NCT01077362|537516213|FG000|Overall Study|Lack of Efficacy|13|||
149009882|NCT01077362|537516214|FG001|Overall Study|Lack of Efficacy|8|||
149009883|NCT01077362|537516215|FG002|Overall Study|Lack of Efficacy|10|||
149009884|NCT01077362|537516213|FG000|Overall Study|Lost to Follow-up|1|||
149009885|NCT01077362|537516214|FG001|Overall Study|Lost to Follow-up|0|||
149009886|NCT01077362|537516215|FG002|Overall Study|Lost to Follow-up|3|||
149009887|NCT01077362|537516213|FG000|Overall Study|Adverse Event|12|||
149009888|NCT01077362|537516214|FG001|Overall Study|Adverse Event|7|||
149009889|NCT01077362|537516215|FG002|Overall Study|Adverse Event|4|||
149009890|NCT01077362|537516213|FG000|Overall Study|Withdrawal by Subject|5|||
149009891|NCT01077362|537516214|FG001|Overall Study|Withdrawal by Subject|3|||
149009892|NCT01077362|537516215|FG002|Overall Study|Withdrawal by Subject|5|||
149009893|NCT01077362|537516213|FG000|Overall Study|Other|0|||
149009894|NCT01077362|537516214|FG001|Overall Study|Other|1|||
149009895|NCT01077362|537516215|FG002|Overall Study|Other|2|||
149009896|NCT03097861|537516220|FG000|Overall Study|Adverse Event|3|||
149009897|NCT03097861|537516221|FG001|Overall Study|Adverse Event|8|||
149009898|NCT03097861|537516222|FG002|Overall Study|Adverse Event|4|||
149009899|NCT03097861|537516220|FG000|Overall Study|Investigator Decision|0|||
149009900|NCT03097861|537516221|FG001|Overall Study|Investigator Decision|1|||
149009901|NCT03097861|537516222|FG002|Overall Study|Investigator Decision|0|||
149009902|NCT03097861|537516220|FG000|Overall Study|Lost to Follow-up|0|||
149009903|NCT03097861|537516221|FG001|Overall Study|Lost to Follow-up|7|||
149009904|NCT03097861|537516222|FG002|Overall Study|Lost to Follow-up|1|||
149009905|NCT03097861|537516220|FG000|Overall Study|Withdrawal by Subject|1|||
149009906|NCT03097861|537516221|FG001|Overall Study|Withdrawal by Subject|5|||
149009907|NCT03097861|537516222|FG002|Overall Study|Withdrawal by Subject|3|||
149009908|NCT03097861|537516220|FG000|Overall Study|Reason not provided|3|||
149009909|NCT03097861|537516221|FG001|Overall Study|Reason not provided|1|||
149009910|NCT03097861|537516222|FG002|Overall Study|Reason not provided|1|||
149009911|NCT01785563|537516223|FG000|Overall Study|Physician Decision|10|||
149009912|NCT01785563|537516223|FG000|Overall Study|Withdrawal by Subject|1|||
149009913|NCT01785563|537516223|FG000|Overall Study|Protocol Violation|2|||
149009914|NCT01616771|537516226|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
149009915|NCT00744328|537516227|FG000|Overall Study|Lost to Follow-up|2|||
149009916|NCT00744328|537516228|FG001|Overall Study|Lost to Follow-up|5|||
149009917|NCT00744328|537516229|FG002|Overall Study|Lost to Follow-up|3|||
149009918|NCT00744328|537516227|FG000|Overall Study|Withdrawal by Subject|5|||
149009919|NCT00744328|537516228|FG001|Overall Study|Withdrawal by Subject|3|||
149009920|NCT00744328|537516229|FG002|Overall Study|Withdrawal by Subject|4|||
149009921|NCT00744328|537516227|FG000|Overall Study|Found ineligible after randomization|0|||
149009922|NCT00744328|537516228|FG001|Overall Study|Found ineligible after randomization|0|||
149009923|NCT00744328|537516229|FG002|Overall Study|Found ineligible after randomization|1|||
149009924|NCT04399356|537516234|FG000|Overall Study|Lost to Follow-up|1|||
149009925|NCT04399356|537516235|FG001|Overall Study|Lost to Follow-up|1|||
149009926|NCT04399356|537516234|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
149009927|NCT04399356|537516235|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
149009928|NCT04399356|537516234|FG000|Overall Study|Withdrawal by Subject|1|||
149009929|NCT04399356|537516235|FG001|Overall Study|Withdrawal by Subject|0|||
149009930|NCT02091739|537516236|FG000|MP: 16 Weeks|Adverse Event|1|||
149009931|NCT02091739|537516237|FG001|MP: 16 Weeks|Adverse Event|1|||
149009932|NCT02091739|537516238|FG002|MP: 16 Weeks|Adverse Event|1|||
149009933|NCT02091739|537516239|FG003|MP: 16 Weeks|Adverse Event|0|||
149009934|NCT02091739|537516240|FG004|MP: 16 Weeks|Adverse Event|0|||
149009935|NCT02091739|537516236|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
149009936|NCT02091739|537516237|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
149009937|NCT02091739|537516238|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
149009938|NCT02091739|537516239|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
149009939|NCT02091739|537516240|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
149009940|NCT02091739|537516236|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
149009941|NCT02091739|537516237|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
149009942|NCT02091739|537516238|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
149009943|NCT02091739|537516239|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
149009944|NCT02091739|537516240|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
149009945|NCT02091739|537516236|FG000|EP: 48 Weeks|Other|0|||
149009946|NCT02091739|537516237|FG001|EP: 48 Weeks|Other|0|||
149009947|NCT02091739|537516238|FG002|EP: 48 Weeks|Other|0|||
149009948|NCT02091739|537516239|FG003|EP: 48 Weeks|Other|1|||
149009949|NCT02091739|537516240|FG004|EP: 48 Weeks|Other|0|||
149009950|NCT02091739|537516236|FG000|EP: 48 Weeks|Death|0|||
149009951|NCT02091739|537516237|FG001|EP: 48 Weeks|Death|0|||
149009952|NCT02091739|537516238|FG002|EP: 48 Weeks|Death|0|||
149009953|NCT02091739|537516239|FG003|EP: 48 Weeks|Death|3|||
149009954|NCT02091739|537516240|FG004|EP: 48 Weeks|Death|2|||
149009955|NCT02091739|537516236|FG000|EP: 48 Weeks|Adverse Event|0|||
149009956|NCT02091739|537516237|FG001|EP: 48 Weeks|Adverse Event|0|||
149009957|NCT02091739|537516238|FG002|EP: 48 Weeks|Adverse Event|0|||
149009958|NCT02091739|537516239|FG003|EP: 48 Weeks|Adverse Event|2|||
149009959|NCT02091739|537516240|FG004|EP: 48 Weeks|Adverse Event|6|||
149009960|NCT02091739|537516236|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
149009961|NCT02091739|537516237|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
149009962|NCT02091739|537516238|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
149009963|NCT02091739|537516239|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
149009964|NCT02091739|537516240|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
149009965|NCT04041440|537516242|FG000|Overall Study|Withdrawal by Subject|0|||
149009966|NCT04041440|537516243|FG001|Overall Study|Withdrawal by Subject|1|||
149009967|NCT04041440|537516242|FG000|Overall Study|Lost to Follow-up|0|||
149009968|NCT04041440|537516243|FG001|Overall Study|Lost to Follow-up|1|||
149009969|NCT02247804|537516248|FG000|Treatment Period 1|Adverse Event|9|||
149009970|NCT02247804|537516249|FG001|Treatment Period 1|Adverse Event|2|||
149009971|NCT02247804|537516250|FG002|Treatment Period 1|Adverse Event|0|||
149009972|NCT02247804|537516248|FG000|Treatment Period 1|Lack of Efficacy|0|||
149009973|NCT02247804|537516249|FG001|Treatment Period 1|Lack of Efficacy|0|||
149009974|NCT02247804|537516250|FG002|Treatment Period 1|Lack of Efficacy|2|||
149009975|NCT02247804|537516248|FG000|Treatment Period 1|Lost to Follow-up|1|||
149009976|NCT02247804|537516249|FG001|Treatment Period 1|Lost to Follow-up|0|||
149009977|NCT02247804|537516250|FG002|Treatment Period 1|Lost to Follow-up|2|||
149009978|NCT02247804|537516248|FG000|Treatment Period 1|Personal Reasons|7|||
149009979|NCT02247804|537516249|FG001|Treatment Period 1|Personal Reasons|1|||
149009980|NCT02247804|537516250|FG002|Treatment Period 1|Personal Reasons|2|||
149009981|NCT02247804|537516248|FG000|Treatment Period 1|Protocol Deviation|0|||
149009982|NCT02247804|537516249|FG001|Treatment Period 1|Protocol Deviation|0|||
149009983|NCT02247804|537516250|FG002|Treatment Period 1|Protocol Deviation|1|||
149009984|NCT02247804|537516248|FG000|Treatment Period 1|Randomized but not Treated|5|||
149009985|NCT02247804|537516249|FG001|Treatment Period 1|Randomized but not Treated|1|||
149009986|NCT02247804|537516250|FG002|Treatment Period 1|Randomized but not Treated|1|||
149009987|NCT02247804|537516248|FG000|Treatment Period 2|Adverse Event|6|||
149009988|NCT02247804|537516249|FG001|Treatment Period 2|Adverse Event|3|||
149009989|NCT02247804|537516250|FG002|Treatment Period 2|Adverse Event|3|||
149009990|NCT02247804|537516248|FG000|Treatment Period 2|Lack of Efficacy|0|||
149009991|NCT02247804|537516249|FG001|Treatment Period 2|Lack of Efficacy|0|||
149009992|NCT02247804|537516250|FG002|Treatment Period 2|Lack of Efficacy|1|||
149009993|NCT02247804|537516248|FG000|Treatment Period 2|Lost to Follow-up|0|||
149009994|NCT02247804|537516249|FG001|Treatment Period 2|Lost to Follow-up|1|||
149009995|NCT02247804|537516250|FG002|Treatment Period 2|Lost to Follow-up|1|||
149009996|NCT02247804|537516248|FG000|Treatment Period 2|Personal Reasons|2|||
149009997|NCT02247804|537516249|FG001|Treatment Period 2|Personal Reasons|1|||
149009998|NCT02247804|537516250|FG002|Treatment Period 2|Personal Reasons|1|||
149009999|NCT02247804|537516248|FG000|Treatment Period 2|Reason not Specified|0|||
149010000|NCT02247804|537516249|FG001|Treatment Period 2|Reason not Specified|0|||
149010001|NCT02247804|537516250|FG002|Treatment Period 2|Reason not Specified|2|||
149010002|NCT02247804|537516248|FG000|Treatment Period 3|Adverse Event|4|||
149010003|NCT02247804|537516249|FG001|Treatment Period 3|Adverse Event|3|||
149010004|NCT02247804|537516250|FG002|Treatment Period 3|Adverse Event|3|||
149010005|NCT02247804|537516248|FG000|Treatment Period 3|Lack of Efficacy|0|||
149010006|NCT02247804|537516249|FG001|Treatment Period 3|Lack of Efficacy|1|||
149010007|NCT02247804|537516250|FG002|Treatment Period 3|Lack of Efficacy|0|||
149010008|NCT02247804|537516248|FG000|Treatment Period 3|Lost to Follow-up|1|||
149010009|NCT02247804|537516249|FG001|Treatment Period 3|Lost to Follow-up|2|||
149010010|NCT02247804|537516250|FG002|Treatment Period 3|Lost to Follow-up|2|||
149010011|NCT02247804|537516248|FG000|Treatment Period 3|Personal Reasons|4|||
149010012|NCT02247804|537516249|FG001|Treatment Period 3|Personal Reasons|3|||
149010013|NCT02247804|537516250|FG002|Treatment Period 3|Personal Reasons|2|||
149010014|NCT02247804|537516248|FG000|Treatment Period 3|Reason not Specified|2|||
149010015|NCT02247804|537516249|FG001|Treatment Period 3|Reason not Specified|1|||
149010016|NCT02247804|537516250|FG002|Treatment Period 3|Reason not Specified|3|||
149010017|NCT01350505|537516254|FG000|Overall Study|Lost to Follow-up|4|||
149010018|NCT04251065|537516258|FG000|Overall Study|Death|2|||
149010019|NCT04251065|537516258|FG000|Overall Study|Lack of Efficacy|3|||
149010020|NCT04251065|537516258|FG000|Overall Study|Death|1|||
149010021|NCT01054573|537516259|FG000|Overall Study|Adverse Event|1|||
149010022|NCT01054573|537516260|FG001|Overall Study|Adverse Event|0|||
149010023|NCT01054573|537516261|FG002|Overall Study|Adverse Event|1|||
149010024|NCT01054573|537516262|FG003|Overall Study|Adverse Event|1|||
149010025|NCT01054573|537516259|FG000|Overall Study|Lost to Follow-up|0|||
149010026|NCT01054573|537516260|FG001|Overall Study|Lost to Follow-up|2|||
149010027|NCT01054573|537516261|FG002|Overall Study|Lost to Follow-up|0|||
149010028|NCT01054573|537516262|FG003|Overall Study|Lost to Follow-up|0|||
149010029|NCT01054573|537516259|FG000|Overall Study|Withdrawal by Subject|0|||
149010030|NCT01054573|537516260|FG001|Overall Study|Withdrawal by Subject|2|||
149010031|NCT01054573|537516261|FG002|Overall Study|Withdrawal by Subject|2|||
149010032|NCT01054573|537516262|FG003|Overall Study|Withdrawal by Subject|1|||
149010033|NCT00423852|537516263|FG000|Overall Study|Removed pior to the high-dose portion|3|||
149010034|NCT01905046|537516266|FG000|Months 13-24|Withdrawal by Subject|10|||
149010035|NCT01905046|537516267|FG001|Months 13-24|Withdrawal by Subject|10|||
149010036|NCT01905046|537516266|FG000|Months 13-24|Adverse Event|3|||
149010037|NCT01905046|537516267|FG001|Months 13-24|Adverse Event|2|||
149010038|NCT01905046|537516266|FG000|Months 13-24|Protocol Violation|3|||
149010039|NCT01905046|537516267|FG001|Months 13-24|Protocol Violation|3|||
149010040|NCT01905046|537516266|FG000|Months 13-24|Physician Decision|1|||
149010041|NCT01905046|537516267|FG001|Months 13-24|Physician Decision|0|||
149010042|NCT05672680|537516268|FG000|Overall Study|Patient Did Not Complete the Form|5|||
149010043|NCT05672680|537516269|FG001|Overall Study|Patient Did Not Complete the Form|4|||
149010044|NCT05672680|537516268|FG000|Overall Study|Procedure Aborted|1|||
149010045|NCT05672680|537516269|FG001|Overall Study|Procedure Aborted|0|||
149010046|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
149010047|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
149010048|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
149010049|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
149010050|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
149010051|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
149010052|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
149010053|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
149010054|NCT01336621|537516277|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
149010055|NCT01336621|537516277|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
149010056|NCT01336621|537516277|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
149010057|NCT01336621|537516277|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
149010058|NCT01336621|537516277|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
149010059|NCT01336621|537516277|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
149010060|NCT02130284|537516293|FG000|Overall Study|Withdrawal by Subject|3|||
149010061|NCT02130284|537516293|FG000|Overall Study|Subject Withdrew Consent|1|||
149010062|NCT02130284|537516293|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
149010063|NCT02130284|537516293|FG000|Overall Study|Subject was screened as backup for study|3|||
149010064|NCT02130284|537516293|FG000|Overall Study|Screen Failure|1|||
149010065|NCT00682643|537516294|FG000|Overall Study|Adverse Event|12|||
148893347|NCT00683878|537088679|FG001|Overall Study|Adverse Event|3|||
149010066|NCT00682643|537516295|FG001|Overall Study|Adverse Event|23|||
149010067|NCT00682643|537516294|FG000|Overall Study|Lack of Efficacy|2|||
149010068|NCT00682643|537516295|FG001|Overall Study|Lack of Efficacy|0|||
149010069|NCT00682643|537516294|FG000|Overall Study|Protocol Violation|38|||
149010070|NCT00682643|537516295|FG001|Overall Study|Protocol Violation|76|||
149021122|NCT04423393|537557187|FG006|Overall Study|Sponsor Decision|0|||
149010071|NCT00682643|537516294|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
149010072|NCT00682643|537516295|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
149010073|NCT00682643|537516294|FG000|Overall Study|Lost to Follow-up|1|||
149010074|NCT00682643|537516295|FG001|Overall Study|Lost to Follow-up|6|||
149010075|NCT00682643|537516294|FG000|Overall Study|Physician Decision|2|||
149010076|NCT00682643|537516295|FG001|Overall Study|Physician Decision|6|||
149010077|NCT00682643|537516294|FG000|Overall Study|Withdrawal by Subject|19|||
149010078|NCT00682643|537516295|FG001|Overall Study|Withdrawal by Subject|53|||
149010079|NCT00682643|537516294|FG000|Overall Study|Did Not Receive Study Drug|1|||
149010080|NCT00682643|537516295|FG001|Overall Study|Did Not Receive Study Drug|1|||
149010081|NCT01875185|537516296|FG000|Overall Study|study was terminated|52|||
149010082|NCT01875185|537516297|FG001|Overall Study|study was terminated|48|||
149010083|NCT01436201|537516302|FG000|Overall Study|Adverse Event|2|||
149010084|NCT01436201|537516302|FG000|Overall Study|Withdrawal by Subject|1|||
149010085|NCT01436201|537516302|FG000|Overall Study|Protocol Violation|1|||
149010086|NCT01435655|537516304|FG000|Overall Study|Death|2|||
149010087|NCT01435655|537516304|FG000|Overall Study|Other|1|||
149010088|NCT00110890|537516305|FG000|Overall Study|Adverse Event|30|||
149010089|NCT00110890|537516306|FG001|Overall Study|Adverse Event|7|||
149010090|NCT00110890|537516305|FG000|Overall Study|Death|16|||
149010091|NCT00110890|537516306|FG001|Overall Study|Death|9|||
149010092|NCT00110890|537516305|FG000|Overall Study|Lost to Follow-up|3|||
149010093|NCT00110890|537516306|FG001|Overall Study|Lost to Follow-up|1|||
149010094|NCT00110890|537516305|FG000|Overall Study|Physician Decision|4|||
149010095|NCT00110890|537516306|FG001|Overall Study|Physician Decision|5|||
149010096|NCT00110890|537516305|FG000|Overall Study|Withdrawal by Subject|17|||
149010097|NCT00110890|537516306|FG001|Overall Study|Withdrawal by Subject|5|||
149010098|NCT00110890|537516305|FG000|Overall Study|Protocol Deviation|1|||
149010099|NCT00110890|537516306|FG001|Overall Study|Protocol Deviation|0|||
149010100|NCT00110890|537516305|FG000|Overall Study|Noncompliance|10|||
149010101|NCT00110890|537516306|FG001|Overall Study|Noncompliance|0|||
149010102|NCT00110890|537516305|FG000|Overall Study|Kidney Transplant|16|||
149010103|NCT00110890|537516306|FG001|Overall Study|Kidney Transplant|12|||
149010104|NCT00110890|537516305|FG000|Overall Study|Invest. Product Commercially Available|217|||
149010105|NCT00110890|537516306|FG001|Overall Study|Invest. Product Commercially Available|110|||
149010106|NCT00110890|537516305|FG000|Overall Study|Other|34|||
149010107|NCT00110890|537516306|FG001|Overall Study|Other|23|||
149010108|NCT00110890|537516305|FG000|Overall Study|Ineligibility determined|3|||
149010109|NCT00110890|537516306|FG001|Overall Study|Ineligibility determined|0|||
149010110|NCT00110890|537516305|FG000|Overall Study|Requirement for alternative therapy|0|||
149010111|NCT00110890|537516306|FG001|Overall Study|Requirement for alternative therapy|1|||
149010112|NCT00110890|537516305|FG000|Overall Study|Disease progression|0|||
149010113|NCT00110890|537516306|FG001|Overall Study|Disease progression|1|||
149010114|NCT00110890|537516305|FG000|Overall Study|Parathyroidectomy|0|||
149010115|NCT00110890|537516306|FG001|Overall Study|Parathyroidectomy|1|||
149010116|NCT00110890|537516305|FG000|Overall Study|Did not enter follow-up phase|10|||
149010117|NCT00110890|537516306|FG001|Overall Study|Did not enter follow-up phase|4|||
149010118|NCT00661661|537516307|FG000|Overall Study|Adverse Event|99|||
149010119|NCT00661661|537516308|FG001|Overall Study|Adverse Event|24|||
149010120|NCT00661661|537516307|FG000|Overall Study|Lack of Efficacy|3|||
149010121|NCT00661661|537516308|FG001|Overall Study|Lack of Efficacy|2|||
149010122|NCT00661661|537516307|FG000|Overall Study|Lost to Follow-up|0|||
149010123|NCT00661661|537516308|FG001|Overall Study|Lost to Follow-up|1|||
149010124|NCT00661661|537516307|FG000|Overall Study|Withdrawal by Subject|15|||
149010125|NCT00661661|537516308|FG001|Overall Study|Withdrawal by Subject|5|||
149010126|NCT00661661|537516307|FG000|Overall Study|Other|22|||
149010127|NCT00661661|537516308|FG001|Overall Study|Other|7|||
149010128|NCT00661661|537516307|FG000|Overall Study|Not assigned treatment|1|||
149010129|NCT00661661|537516308|FG001|Overall Study|Not assigned treatment|0|||
149010130|NCT04512066|537516315|FG000|Double-blind Treatment Period|Adverse Event|6|||
149010131|NCT04512066|537516316|FG001|Double-blind Treatment Period|Adverse Event|4|||
149010132|NCT04512066|537516317|FG002|Double-blind Treatment Period|Adverse Event|5|||
149010133|NCT04512066|537516318|FG003|Double-blind Treatment Period|Adverse Event|1|||
149010134|NCT04512066|537516319|FG004|Double-blind Treatment Period|Adverse Event|0|||
149010135|NCT04512066|537516320|FG005|Double-blind Treatment Period|Adverse Event|0|||
149010136|NCT04512066|537516315|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
149010137|NCT04512066|537516316|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
149010138|NCT04512066|537516317|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
149010139|NCT04512066|537516318|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
149010140|NCT04512066|537516319|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
149010141|NCT04512066|537516320|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
149010142|NCT04512066|537516315|FG000|Double-blind Treatment Period|Physician Decision|1|||
149121153|NCT03014479|537920069|FG000|Overall Study|Adverse Event|0|||
149010143|NCT04512066|537516316|FG001|Double-blind Treatment Period|Physician Decision|0|||
149010144|NCT04512066|537516317|FG002|Double-blind Treatment Period|Physician Decision|1|||
149010145|NCT04512066|537516318|FG003|Double-blind Treatment Period|Physician Decision|0|||
149010146|NCT04512066|537516319|FG004|Double-blind Treatment Period|Physician Decision|0|||
149010147|NCT04512066|537516320|FG005|Double-blind Treatment Period|Physician Decision|0|||
149010148|NCT04512066|537516315|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
149010149|NCT04512066|537516316|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
149010150|NCT04512066|537516317|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
149010151|NCT04512066|537516318|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
149010152|NCT04512066|537516319|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
149010153|NCT04512066|537516320|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
149010154|NCT04512066|537516315|FG000|Extension Period|Adverse Event|0|||
149010155|NCT04512066|537516316|FG001|Extension Period|Adverse Event|1|||
149010156|NCT04512066|537516317|FG002|Extension Period|Adverse Event|4|||
149010157|NCT04512066|537516318|FG003|Extension Period|Adverse Event|3|||
149010158|NCT04512066|537516319|FG004|Extension Period|Adverse Event|1|||
149010159|NCT04512066|537516320|FG005|Extension Period|Adverse Event|3|||
149010160|NCT04512066|537516315|FG000|Extension Period|Death|0|||
149010161|NCT04512066|537516316|FG001|Extension Period|Death|0|||
149010162|NCT04512066|537516317|FG002|Extension Period|Death|0|||
149010163|NCT04512066|537516318|FG003|Extension Period|Death|0|||
149010164|NCT04512066|537516319|FG004|Extension Period|Death|0|||
149010165|NCT04512066|537516320|FG005|Extension Period|Death|1|||
149010166|NCT04512066|537516315|FG000|Extension Period|Lack of Efficacy|0|||
149010167|NCT04512066|537516316|FG001|Extension Period|Lack of Efficacy|4|||
149010168|NCT04512066|537516317|FG002|Extension Period|Lack of Efficacy|4|||
149010169|NCT04512066|537516318|FG003|Extension Period|Lack of Efficacy|1|||
149010170|NCT04512066|537516319|FG004|Extension Period|Lack of Efficacy|3|||
149010171|NCT04512066|537516320|FG005|Extension Period|Lack of Efficacy|3|||
149010172|NCT04512066|537516315|FG000|Extension Period|Lost to Follow-up|0|||
149010173|NCT04512066|537516316|FG001|Extension Period|Lost to Follow-up|1|||
149010174|NCT04512066|537516317|FG002|Extension Period|Lost to Follow-up|5|||
149010175|NCT04512066|537516318|FG003|Extension Period|Lost to Follow-up|2|||
149010176|NCT04512066|537516319|FG004|Extension Period|Lost to Follow-up|3|||
149010177|NCT04512066|537516320|FG005|Extension Period|Lost to Follow-up|2|||
149010178|NCT04512066|537516315|FG000|Extension Period|Non-compliance with study drug|0|||
149010179|NCT04512066|537516316|FG001|Extension Period|Non-compliance with study drug|1|||
149010180|NCT04512066|537516317|FG002|Extension Period|Non-compliance with study drug|0|||
149010181|NCT04512066|537516318|FG003|Extension Period|Non-compliance with study drug|0|||
149010182|NCT04512066|537516319|FG004|Extension Period|Non-compliance with study drug|0|||
149010183|NCT04512066|537516320|FG005|Extension Period|Non-compliance with study drug|1|||
149010184|NCT04512066|537516315|FG000|Extension Period|Other|0|||
149010185|NCT04512066|537516316|FG001|Extension Period|Other|2|||
149010186|NCT04512066|537516317|FG002|Extension Period|Other|0|||
149010187|NCT04512066|537516318|FG003|Extension Period|Other|0|||
149010188|NCT04512066|537516319|FG004|Extension Period|Other|0|||
149010189|NCT04512066|537516320|FG005|Extension Period|Other|0|||
149010190|NCT04512066|537516315|FG000|Extension Period|Physician Decision|0|||
149010191|NCT04512066|537516316|FG001|Extension Period|Physician Decision|2|||
149010192|NCT04512066|537516317|FG002|Extension Period|Physician Decision|0|||
149010193|NCT04512066|537516318|FG003|Extension Period|Physician Decision|1|||
149010194|NCT04512066|537516319|FG004|Extension Period|Physician Decision|1|||
149010195|NCT04512066|537516320|FG005|Extension Period|Physician Decision|0|||
149010196|NCT04512066|537516315|FG000|Extension Period|Withdrawal by Subject|0|||
149010197|NCT04512066|537516316|FG001|Extension Period|Withdrawal by Subject|3|||
149010198|NCT04512066|537516317|FG002|Extension Period|Withdrawal by Subject|7|||
149010199|NCT04512066|537516318|FG003|Extension Period|Withdrawal by Subject|11|||
149010200|NCT04512066|537516319|FG004|Extension Period|Withdrawal by Subject|8|||
149010201|NCT04512066|537516320|FG005|Extension Period|Withdrawal by Subject|4|||
149010202|NCT03403426|537516321|FG000|Overall Study|Death|1|||
149010203|NCT03403426|537516321|FG000|Overall Study|Lost to Follow-up|2|||
149010204|NCT03520400|537516322|FG000|Overall Study|Physician Decision|15|||
149010205|NCT03520400|537516323|FG001|Overall Study|Physician Decision|7|||
149010206|NCT00524030|537516324|FG000|Overall Study|Lack of Efficacy|10|||
149010207|NCT00524030|537516325|FG001|Overall Study|Lack of Efficacy|24|||
149010208|NCT00524030|537516324|FG000|Overall Study|Lost to Follow-up|0|||
149010209|NCT00524030|537516325|FG001|Overall Study|Lost to Follow-up|2|||
149010210|NCT00524030|537516324|FG000|Overall Study|Withdrawal by Subject|3|||
149010211|NCT00524030|537516325|FG001|Overall Study|Withdrawal by Subject|8|||
149010212|NCT00524030|537516324|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
149010213|NCT00524030|537516325|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
149010214|NCT00524030|537516324|FG000|Overall Study|Protocol Violation|0|||
149010215|NCT00524030|537516325|FG001|Overall Study|Protocol Violation|1|||
149010216|NCT00524030|537516324|FG000|Overall Study|Pregnancy|1|||
149010217|NCT00524030|537516325|FG001|Overall Study|Pregnancy|0|||
149010218|NCT00524030|537516324|FG000|Overall Study|Adverse Event|3|||
149010219|NCT00524030|537516325|FG001|Overall Study|Adverse Event|21|||
149010220|NCT00524030|537516324|FG000|Overall Study|Death|0|||
149010221|NCT00524030|537516325|FG001|Overall Study|Death|1|||
149010222|NCT04398537|537516326|FG000|Overall Study|Physician Decision|10|||
149010223|NCT04398537|537516327|FG001|Overall Study|Physician Decision|15|||
149010224|NCT02746575|537517664|FG000|Overall Study|Surgery cancelled or time chaned|13|||
149010225|NCT02746575|537517664|FG000|Overall Study|Received epidural|10|||
149010226|NCT02746575|537517664|FG000|Overall Study|Withdrawal by Subject|3|||
149010227|NCT02746575|537517664|FG000|Overall Study|Bradycardia/hypotension|9|||
149010228|NCT02746575|537517664|FG000|Overall Study|Study paused|8|||
149010229|NCT02746575|537517664|FG000|Overall Study|put on beta-blocker|3|||
149010230|NCT02746575|537517664|FG000|Overall Study|type of surgery|1|||
149010231|NCT02746575|537517664|FG000|Overall Study|typ of surgery|1|||
149010232|NCT02746575|537517664|FG000|Overall Study|PI unavailable|1|||
149010233|NCT02746575|537517664|FG000|Overall Study|Unknown history of CVA|1|||
149010234|NCT04567693|537517665|FG000|Overall Study|Death|0|||
149010235|NCT04567693|537517666|FG001|Overall Study|Death|0|||
149010236|NCT04567693|537517667|FG002|Overall Study|Death|2|||
149010237|NCT04567693|537517665|FG000|Overall Study|Lost to Follow-up|1|||
149010238|NCT04567693|537517666|FG001|Overall Study|Lost to Follow-up|0|||
149010239|NCT04567693|537517667|FG002|Overall Study|Lost to Follow-up|2|||
149010240|NCT04567693|537517665|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
149010241|NCT04567693|537517666|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
149010242|NCT04567693|537517667|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
149010243|NCT03722264|537517672|FG000|Overall Study|Physician Decision|3|||
149010244|NCT04867785|537517673|FG000|Overall Study|Adverse Event|1|||
149010245|NCT04867785|537517674|FG001|Overall Study|Adverse Event|0|||
149010246|NCT04867785|537517675|FG002|Overall Study|Adverse Event|1|||
149010247|NCT04867785|537517676|FG003|Overall Study|Adverse Event|0|||
149010248|NCT04867785|537517677|FG004|Overall Study|Adverse Event|0|||
149010249|NCT04867785|537517678|FG005|Overall Study|Adverse Event|0|||
149010250|NCT04867785|537517679|FG006|Overall Study|Adverse Event|0|||
149010251|NCT04867785|537517680|FG007|Overall Study|Adverse Event|2|||
149010252|NCT04867785|537517673|FG000|Overall Study|Lost to Follow-up|4|||
149010253|NCT04867785|537517674|FG001|Overall Study|Lost to Follow-up|4|||
149010254|NCT04867785|537517675|FG002|Overall Study|Lost to Follow-up|3|||
149010255|NCT04867785|537517676|FG003|Overall Study|Lost to Follow-up|2|||
149010256|NCT04867785|537517677|FG004|Overall Study|Lost to Follow-up|0|||
149010257|NCT04867785|537517678|FG005|Overall Study|Lost to Follow-up|1|||
149010258|NCT04867785|537517679|FG006|Overall Study|Lost to Follow-up|0|||
149010259|NCT04867785|537517680|FG007|Overall Study|Lost to Follow-up|1|||
149010260|NCT04867785|537517673|FG000|Overall Study|Withdrawal by Subject|6|||
149010261|NCT04867785|537517674|FG001|Overall Study|Withdrawal by Subject|2|||
149010262|NCT04867785|537517675|FG002|Overall Study|Withdrawal by Subject|2|||
149010263|NCT04867785|537517676|FG003|Overall Study|Withdrawal by Subject|1|||
149010264|NCT04867785|537517677|FG004|Overall Study|Withdrawal by Subject|2|||
149010265|NCT04867785|537517678|FG005|Overall Study|Withdrawal by Subject|0|||
149010266|NCT04867785|537517679|FG006|Overall Study|Withdrawal by Subject|2|||
149010267|NCT04867785|537517680|FG007|Overall Study|Withdrawal by Subject|5|||
149010268|NCT04867785|537517673|FG000|Overall Study|Physician Decision|0|||
149010269|NCT04867785|537517674|FG001|Overall Study|Physician Decision|0|||
149010270|NCT04867785|537517675|FG002|Overall Study|Physician Decision|0|||
149010271|NCT04867785|537517676|FG003|Overall Study|Physician Decision|0|||
149010272|NCT04867785|537517677|FG004|Overall Study|Physician Decision|0|||
149010273|NCT04867785|537517678|FG005|Overall Study|Physician Decision|0|||
149010274|NCT04867785|537517679|FG006|Overall Study|Physician Decision|0|||
149010275|NCT04867785|537517680|FG007|Overall Study|Physician Decision|1|||
149010276|NCT04867785|537517673|FG000|Overall Study|Inadvertent Enrollment|0|||
149010277|NCT04867785|537517674|FG001|Overall Study|Inadvertent Enrollment|0|||
149010278|NCT04867785|537517675|FG002|Overall Study|Inadvertent Enrollment|0|||
149010279|NCT04867785|537517676|FG003|Overall Study|Inadvertent Enrollment|1|||
149010280|NCT04867785|537517677|FG004|Overall Study|Inadvertent Enrollment|1|||
149010281|NCT04867785|537517678|FG005|Overall Study|Inadvertent Enrollment|0|||
149010282|NCT04867785|537517679|FG006|Overall Study|Inadvertent Enrollment|0|||
149010283|NCT04867785|537517680|FG007|Overall Study|Inadvertent Enrollment|1|||
149010284|NCT04867785|537517673|FG000|Overall Study|Eligibility Criteria Not Met|0|||
149010285|NCT04867785|537517674|FG001|Overall Study|Eligibility Criteria Not Met|0|||
149010286|NCT04867785|537517675|FG002|Overall Study|Eligibility Criteria Not Met|0|||
149010287|NCT04867785|537517676|FG003|Overall Study|Eligibility Criteria Not Met|0|||
149010288|NCT04867785|537517677|FG004|Overall Study|Eligibility Criteria Not Met|0|||
149010289|NCT04867785|537517678|FG005|Overall Study|Eligibility Criteria Not Met|0|||
149010290|NCT04867785|537517679|FG006|Overall Study|Eligibility Criteria Not Met|0|||
149010291|NCT04867785|537517680|FG007|Overall Study|Eligibility Criteria Not Met|1|||
149010292|NCT01486758|537517681|FG000|Overall Study|Lost to Follow-up|0|||
149010293|NCT01486758|537517682|FG001|Overall Study|Lost to Follow-up|1|||
149010294|NCT02494921|537517693|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
149010295|NCT02494921|537517694|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
149010296|NCT02494921|537517695|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
149010297|NCT02494921|537517696|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
149010298|NCT02494921|537517697|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
149010299|NCT02494921|537517693|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
149010300|NCT02494921|537517694|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
149010301|NCT02494921|537517695|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
149010302|NCT02494921|537517696|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
149010303|NCT02494921|537517697|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
149010304|NCT02494921|537517693|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
149010305|NCT02494921|537517694|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
149010306|NCT02494921|537517695|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
149010307|NCT02494921|537517696|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
149010308|NCT02494921|537517697|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
149010309|NCT04105972|537517702|FG000|Overall Study|Adverse Event|2|||
149010310|NCT04105972|537517703|FG001|Overall Study|Adverse Event|1|||
149010311|NCT02254408|537517704|FG000|Overall Study|Randomized But Not Treated|1|||
149010312|NCT02254408|537517705|FG001|Overall Study|Randomized But Not Treated|3|||
149010313|NCT02254408|537517704|FG000|Overall Study|Adverse Event|1|||
149010314|NCT02254408|537517705|FG001|Overall Study|Adverse Event|0|||
149010315|NCT02254408|537517704|FG000|Overall Study|Death|2|||
149010316|NCT02254408|537517705|FG001|Overall Study|Death|3|||
149010317|NCT02254408|537517704|FG000|Overall Study|Investigator's Discretion|0|||
149010318|NCT02254408|537517705|FG001|Overall Study|Investigator's Discretion|1|||
149010319|NCT02254408|537517704|FG000|Overall Study|Withdrawal by Subject|3|||
149010320|NCT02254408|537517705|FG001|Overall Study|Withdrawal by Subject|3|||
149010321|NCT02254408|537517704|FG000|Overall Study|Lost to Follow-up|1|||
149010322|NCT02254408|537517705|FG001|Overall Study|Lost to Follow-up|0|||
149010323|NCT00553202|537517708|FG000|Overall Study|Death|16|||
149010324|NCT00553202|537517708|FG000|Overall Study|Lost to Follow-up|1|||
149010325|NCT00553202|537517708|FG000|Overall Study|Physician Decision|28|||
149010326|NCT00553202|537517708|FG000|Overall Study|Withdrawal by Subject|1|||
149010327|NCT00553202|537517708|FG000|Overall Study|No donor identified|16|||
149010328|NCT00553202|537517708|FG000|Overall Study|Fails to meet organ function|6|||
149010329|NCT00768430|537517710|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
149010330|NCT00768430|537517711|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
149010331|NCT00041756|537517713|FG000|Overall Study|Adverse Event|4|||
149010332|NCT00041756|537517714|FG001|Overall Study|Adverse Event|10|||
149010333|NCT00041756|537517715|FG002|Overall Study|Adverse Event|6|||
149010334|NCT00041756|537517716|FG003|Overall Study|Adverse Event|11|||
149010335|NCT00041756|537517717|FG004|Overall Study|Adverse Event|34|||
149010336|NCT00041756|537517713|FG000|Overall Study|Protocol Violation|1|||
149010337|NCT00041756|537517714|FG001|Overall Study|Protocol Violation|1|||
149010338|NCT00041756|537517715|FG002|Overall Study|Protocol Violation|2|||
149010339|NCT00041756|537517716|FG003|Overall Study|Protocol Violation|2|||
149010340|NCT00041756|537517717|FG004|Overall Study|Protocol Violation|1|||
149010341|NCT00041756|537517713|FG000|Overall Study|Withdrawal by Subject|3|||
149010342|NCT00041756|537517714|FG001|Overall Study|Withdrawal by Subject|3|||
149010343|NCT00041756|537517715|FG002|Overall Study|Withdrawal by Subject|4|||
149010344|NCT00041756|537517716|FG003|Overall Study|Withdrawal by Subject|2|||
149010345|NCT00041756|537517717|FG004|Overall Study|Withdrawal by Subject|3|||
149010346|NCT00041756|537517713|FG000|Overall Study|Lost to Follow-up|0|||
149010347|NCT00041756|537517714|FG001|Overall Study|Lost to Follow-up|1|||
149010348|NCT00041756|537517715|FG002|Overall Study|Lost to Follow-up|0|||
149010349|NCT00041756|537517716|FG003|Overall Study|Lost to Follow-up|1|||
149010350|NCT00041756|537517717|FG004|Overall Study|Lost to Follow-up|0|||
149010351|NCT00041756|537517713|FG000|Overall Study|Unable to meet protocol criteria|0|||
149010352|NCT00041756|537517714|FG001|Overall Study|Unable to meet protocol criteria|0|||
149010353|NCT00041756|537517715|FG002|Overall Study|Unable to meet protocol criteria|1|||
149010354|NCT00041756|537517716|FG003|Overall Study|Unable to meet protocol criteria|0|||
149010355|NCT00041756|537517717|FG004|Overall Study|Unable to meet protocol criteria|1|||
149010356|NCT00041756|537517713|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
149010357|NCT00041756|537517714|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
149010358|NCT00041756|537517715|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
149010359|NCT00041756|537517716|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
149010360|NCT00041756|537517717|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
149010361|NCT00584805|537517720|FG000|Overall Study|No longer at risk of exposure|39|||
149010362|NCT00584805|537517720|FG000|Overall Study|Relocation|36|||
149010363|NCT00584805|537517720|FG000|Overall Study|Withdrawal by Subject|18|||
149010364|NCT00584805|537517720|FG000|Overall Study|Non-compliance|1|||
149010365|NCT00584805|537517720|FG000|Overall Study|Lost to follow up|3|||
149010366|NCT00584805|537517720|FG000|Overall Study|Screen failures|2|||
149010367|NCT00154310|537517722|FG000|Overall Study|Adverse Event|19|||
149010368|NCT00154310|537517723|FG001|Overall Study|Adverse Event|9|||
149010369|NCT00154310|537517722|FG000|Overall Study|Lack of Efficacy|5|||
149010370|NCT00154310|537517723|FG001|Overall Study|Lack of Efficacy|4|||
149010371|NCT00154310|537517722|FG000|Overall Study|Protocol Violation|4|||
149010372|NCT00154310|537517723|FG001|Overall Study|Protocol Violation|2|||
149010373|NCT00154310|537517722|FG000|Overall Study|Withdrawal by Subject|9|||
149010374|NCT00154310|537517723|FG001|Overall Study|Withdrawal by Subject|3|||
149010375|NCT00154310|537517722|FG000|Overall Study|Lost to Follow-up|0|||
149010376|NCT00154310|537517723|FG001|Overall Study|Lost to Follow-up|8|||
149010377|NCT00154310|537517722|FG000|Overall Study|Administrative problems|0|||
149010378|NCT00154310|537517723|FG001|Overall Study|Administrative problems|1|||
149010379|NCT00154310|537517722|FG000|Overall Study|Death|0|||
149010380|NCT00154310|537517723|FG001|Overall Study|Death|1|||
149010381|NCT03447730|537517725|FG000|Overall Study|Adverse Event|0|||
149010382|NCT03447730|537517726|FG001|Overall Study|Adverse Event|2|||
149010383|NCT03447730|537517727|FG002|Overall Study|Adverse Event|0|||
149010384|NCT02086162|537517728|FG000|Overall Study|Withdrawal by Subject|4|||
149010385|NCT02086162|537517729|FG001|Overall Study|Withdrawal by Subject|4|||
149010386|NCT02086162|537517728|FG000|Overall Study|moved|1|||
149010387|NCT02086162|537517729|FG001|Overall Study|moved|1|||
149010388|NCT02086162|537517728|FG000|Overall Study|Lost to Follow-up|4|||
149010389|NCT02086162|537517729|FG001|Overall Study|Lost to Follow-up|2|||
149010390|NCT02086162|537517728|FG000|Overall Study|Death|1|||
149010391|NCT02086162|537517729|FG001|Overall Study|Death|0|||
149010392|NCT01827254|537517730|FG000|Overall Study|Death|10|||
149010393|NCT01827254|537517730|FG000|Overall Study|Case report form not completed|4|||
149010394|NCT01827254|537517730|FG000|Overall Study|Invalidated centre|3|||
149010395|NCT01827254|537517730|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
149010396|NCT01827254|537517730|FG000|Overall Study|Did not complete re-challenge|1|||
149010397|NCT01827254|537517730|FG000|Overall Study|Disease progression|36|||
149010398|NCT01827254|537517730|FG000|Overall Study|Intolerance to treatment|4|||
149010399|NCT01834222|537517731|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
149010400|NCT05266963|537517732|FG000|Drug Period A|Withdrawal by Subject|0|||
149010401|NCT05266963|537517733|FG001|Drug Period A|Withdrawal by Subject|1|||
149010402|NCT03812536|537517734|FG000|Overall Study|Protocol Violation|2|||
149010403|NCT03812536|537517735|FG001|Overall Study|Protocol Violation|0|||
149010404|NCT03812536|537517734|FG000|Overall Study|Withdrawal by Subject|1|||
149010405|NCT03812536|537517735|FG001|Overall Study|Withdrawal by Subject|1|||
149010406|NCT00152009|537517736|FG000|Overall Study|Adverse Event|9|||
149010407|NCT00152009|537517737|FG001|Overall Study|Adverse Event|13|||
149010408|NCT00152009|537517738|FG002|Overall Study|Adverse Event|20|||
149010409|NCT00152009|537517739|FG003|Overall Study|Adverse Event|1|||
149010410|NCT00152009|537517736|FG000|Overall Study|Protocol Violation|3|||
149010411|NCT00152009|537517737|FG001|Overall Study|Protocol Violation|0|||
149010412|NCT00152009|537517738|FG002|Overall Study|Protocol Violation|0|||
149010413|NCT00152009|537517739|FG003|Overall Study|Protocol Violation|1|||
149010414|NCT00152009|537517736|FG000|Overall Study|Withdrawal by Subject|2|||
149010415|NCT00152009|537517737|FG001|Overall Study|Withdrawal by Subject|3|||
149010416|NCT00152009|537517738|FG002|Overall Study|Withdrawal by Subject|4|||
149010417|NCT00152009|537517739|FG003|Overall Study|Withdrawal by Subject|9|||
149010418|NCT00152009|537517736|FG000|Overall Study|Lost to Follow-up|2|||
149010419|NCT00152009|537517737|FG001|Overall Study|Lost to Follow-up|4|||
149010420|NCT00152009|537517738|FG002|Overall Study|Lost to Follow-up|3|||
149010421|NCT00152009|537517739|FG003|Overall Study|Lost to Follow-up|3|||
149010422|NCT00152009|537517736|FG000|Overall Study|Lack of Efficacy|8|||
149010423|NCT00152009|537517737|FG001|Overall Study|Lack of Efficacy|6|||
149010424|NCT00152009|537517738|FG002|Overall Study|Lack of Efficacy|7|||
149010425|NCT00152009|537517739|FG003|Overall Study|Lack of Efficacy|15|||
149010426|NCT00152009|537517736|FG000|Overall Study|ECG abnormalities|2|||
149010427|NCT00152009|537517737|FG001|Overall Study|ECG abnormalities|2|||
149010428|NCT00152009|537517738|FG002|Overall Study|ECG abnormalities|2|||
149010429|NCT00152009|537517739|FG003|Overall Study|ECG abnormalities|1|||
149010430|NCT00152009|537517736|FG000|Overall Study|Sponsor's decision|3|||
149010431|NCT00152009|537517737|FG001|Overall Study|Sponsor's decision|3|||
149010432|NCT00152009|537517738|FG002|Overall Study|Sponsor's decision|1|||
149010433|NCT00152009|537517739|FG003|Overall Study|Sponsor's decision|3|||
149010434|NCT01306201|537517740|FG000|Overall Study|Arrhythmia|4|||
149010435|NCT01306201|537517740|FG000|Overall Study|Files could not be processed|3|||
149010436|NCT01306201|537517740|FG000|Overall Study|Files unreadable|3|||
149010437|NCT04702568|537517741|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
149010438|NCT04702568|537517742|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
149010439|NCT04702568|537517741|FG000|Overall Study|Pregnancy|1|||
149010440|NCT04702568|537517742|FG001|Overall Study|Pregnancy|0|||
149010441|NCT04702568|537517741|FG000|Overall Study|Bone marrow transplant|1|||
149010442|NCT04702568|537517742|FG001|Overall Study|Bone marrow transplant|0|||
149010443|NCT04702568|537517741|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
149010444|NCT04702568|537517742|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
149010445|NCT04702568|537517741|FG000|Overall Study|Withdrawal by Subject|0|||
149010446|NCT04702568|537517742|FG001|Overall Study|Withdrawal by Subject|2|||
149010447|NCT00393523|537517743|FG000|Overall Study|Lost to Follow-up|0|||
149010448|NCT00393523|537517744|FG001|Overall Study|Lost to Follow-up|0|||
149010449|NCT00393523|537517745|FG002|Overall Study|Lost to Follow-up|0|||
149010450|NCT00393523|537517746|FG003|Overall Study|Lost to Follow-up|2|||
149010451|NCT00393523|537517747|FG004|Overall Study|Lost to Follow-up|1|||
149010452|NCT00393523|537517743|FG000|Overall Study|Protocol Violation|6|||
149010453|NCT00393523|537517744|FG001|Overall Study|Protocol Violation|2|||
149010454|NCT00393523|537517745|FG002|Overall Study|Protocol Violation|0|||
149010455|NCT00393523|537517746|FG003|Overall Study|Protocol Violation|1|||
149010456|NCT00393523|537517747|FG004|Overall Study|Protocol Violation|0|||
149010457|NCT00393523|537517743|FG000|Overall Study|Withdrawal by Subject|6|||
149010458|NCT00393523|537517744|FG001|Overall Study|Withdrawal by Subject|7|||
149010459|NCT00393523|537517745|FG002|Overall Study|Withdrawal by Subject|2|||
149010460|NCT00393523|537517746|FG003|Overall Study|Withdrawal by Subject|3|||
149010461|NCT00393523|537517747|FG004|Overall Study|Withdrawal by Subject|0|||
149010462|NCT00393523|537517743|FG000|Overall Study|Difficulties in specimen collection|0|||
149010463|NCT00393523|537517744|FG001|Overall Study|Difficulties in specimen collection|0|||
149010464|NCT00393523|537517745|FG002|Overall Study|Difficulties in specimen collection|1|||
149010465|NCT00393523|537517746|FG003|Overall Study|Difficulties in specimen collection|0|||
149010466|NCT00393523|537517747|FG004|Overall Study|Difficulties in specimen collection|0|||
149010467|NCT00393523|537517743|FG000|Overall Study|Vaccine supply issue|0|||
149010468|NCT00393523|537517744|FG001|Overall Study|Vaccine supply issue|0|||
149010469|NCT00393523|537517745|FG002|Overall Study|Vaccine supply issue|1|||
149010470|NCT00393523|537517746|FG003|Overall Study|Vaccine supply issue|0|||
149010471|NCT00393523|537517747|FG004|Overall Study|Vaccine supply issue|0|||
149010472|NCT01735396|537517751|FG000|Overall Study|not evaluable|1|||
149010473|NCT00980005|537517756|FG000|Overall Study|Withdrawal by Subject|6|||
149010474|NCT00980005|537517757|FG001|Overall Study|Withdrawal by Subject|17|||
149010475|NCT00980005|537517756|FG000|Overall Study|Lost to Follow-up|37|||
149010476|NCT00980005|537517757|FG001|Overall Study|Lost to Follow-up|43|||
149010477|NCT00980005|537517756|FG000|Overall Study|Other|4|||
149010478|NCT00980005|537517757|FG001|Overall Study|Other|3|||
149010479|NCT00572624|537517758|FG000|Overall Study|Lost to Follow-up|10|||
149010480|NCT00572624|537517759|FG001|Overall Study|Lost to Follow-up|4|||
149010481|NCT00572624|537517758|FG000|Overall Study|Wanted to do a different diet program|1|||
149010482|NCT00572624|537517759|FG001|Overall Study|Wanted to do a different diet program|0|||
149010483|NCT00572624|537517758|FG000|Overall Study|Medication change|1|||
149010484|NCT00572624|537517759|FG001|Overall Study|Medication change|0|||
149010485|NCT00572624|537517758|FG000|Overall Study|Started a new job-- no time for study|1|||
149010486|NCT00572624|537517759|FG001|Overall Study|Started a new job-- no time for study|0|||
149010487|NCT00572624|537517758|FG000|Overall Study|Admitted to being a smoker|1|||
149010488|NCT00572624|537517759|FG001|Overall Study|Admitted to being a smoker|0|||
149010489|NCT00572624|537517758|FG000|Overall Study|Refused to do the stress test|1|||
149010490|NCT00572624|537517759|FG001|Overall Study|Refused to do the stress test|0|||
149010491|NCT00572624|537517758|FG000|Overall Study|Problem with vascular access|1|||
149010492|NCT00572624|537517759|FG001|Overall Study|Problem with vascular access|0|||
149010493|NCT00572624|537517758|FG000|Overall Study|Health issues unrelated to the study|1|||
149010494|NCT00572624|537517759|FG001|Overall Study|Health issues unrelated to the study|0|||
149010495|NCT04145037|537517760|FG000|Overall Study|Study terminated|2|||
149010496|NCT04145037|537517761|FG001|Overall Study|Study terminated|0|||
149010497|NCT04145037|537517760|FG000|Overall Study|Withdrawal by Subject|1|||
149010498|NCT04145037|537517761|FG001|Overall Study|Withdrawal by Subject|0|||
149010499|NCT04145037|537517760|FG000|Overall Study|Lost to Follow-up|1|||
149010500|NCT04145037|537517761|FG001|Overall Study|Lost to Follow-up|0|||
149010501|NCT00098254|537517766|FG000|Overall Study|Adverse Event|2|||
149010502|NCT00098254|537517766|FG000|Overall Study|Death|1|||
149010503|NCT00744263|537517769|FG000|Overall Study|Death|3006|||
149010504|NCT00744263|537517770|FG001|Overall Study|Death|3005|||
149010505|NCT00744263|537517769|FG000|Overall Study|Lost to Follow-up|2038|||
149010506|NCT00744263|537517770|FG001|Overall Study|Lost to Follow-up|2135|||
149010507|NCT00744263|537517769|FG000|Overall Study|Withdrawal by Subject|166|||
149010508|NCT00744263|537517770|FG001|Overall Study|Withdrawal by Subject|150|||
149010509|NCT00744263|537517769|FG000|Overall Study|Physician Decision|20|||
149010510|NCT00744263|537517770|FG001|Overall Study|Physician Decision|23|||
149010511|NCT00744263|537517769|FG000|Overall Study|Protocol Violation|3|||
149010512|NCT00744263|537517770|FG001|Overall Study|Protocol Violation|5|||
149010513|NCT00744263|537517769|FG000|Overall Study|Adverse Event|1|||
149010514|NCT00744263|537517770|FG001|Overall Study|Adverse Event|0|||
149010515|NCT00744263|537517769|FG000|Overall Study|Other|2|||
149010516|NCT00744263|537517770|FG001|Overall Study|Other|2|||
149010517|NCT01686581|537517775|FG000|Overall Study|Side-effects or Health Problems|15|||
149010518|NCT01686581|537517775|FG000|Overall Study|Lack of Efficacy|90|||
149010519|NCT01686581|537517775|FG000|Overall Study|Participant Concerned about Risks|6|||
149010520|NCT01686581|537517775|FG000|Overall Study|Thinks Injections Too Painful|8|||
149010521|NCT01686581|537517775|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
149010522|NCT01686581|537517775|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
149010523|NCT01686581|537517775|FG000|Overall Study|Thinks it is Inconvenient|17|||
149010524|NCT01686581|537517775|FG000|Overall Study|Other Miscellaneous Reasons|36|||
149010525|NCT01686581|537517775|FG000|Overall Study|Reason Missing|1|||
149010526|NCT01975220|537517776|FG000|Test Period 1|Not treated|0|||
149010527|NCT01975220|537517777|FG001|Test Period 1|Not treated|1|||
149010528|NCT01975220|537517778|FG002|Test Period 1|Not treated|0|||
149010529|NCT01975220|537517779|FG003|Test Period 1|Not treated|0|||
149010530|NCT01975220|537517780|FG004|Test Period 1|Not treated|0|||
149010531|NCT01975220|537517781|FG005|Test Period 1|Not treated|0|||
149010532|NCT02839343|537517782|FG000|Overall Study|Withdrawal by Subject|3|||
149010533|NCT02839343|537517783|FG001|Overall Study|Withdrawal by Subject|1|||
149010534|NCT02839343|537517782|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
149010535|NCT02839343|537517783|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
149010536|NCT02839343|537517782|FG000|Overall Study|Adverse Event|1|||
149010537|NCT02839343|537517783|FG001|Overall Study|Adverse Event|0|||
149010538|NCT01852058|537517786|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
149010539|NCT01852058|537517787|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010540|NCT01852058|537517788|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010541|NCT01852058|537517789|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010542|NCT01852058|537517790|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010543|NCT01852058|537517791|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010544|NCT01852058|537517792|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010545|NCT01852058|537517793|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010546|NCT01852058|537517794|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010547|NCT01852058|537517795|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010548|NCT01852058|537517796|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010549|NCT01852058|537517797|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
149010550|NCT01852058|537517786|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010551|NCT01852058|537517787|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010552|NCT01852058|537517788|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010553|NCT01852058|537517789|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010554|NCT01852058|537517790|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
149010555|NCT01852058|537517791|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010556|NCT01852058|537517792|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010557|NCT01852058|537517793|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010558|NCT01852058|537517794|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010559|NCT01852058|537517795|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010560|NCT01852058|537517796|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010561|NCT01852058|537517797|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
149010562|NCT01852058|537517786|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010563|NCT01852058|537517787|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010564|NCT01852058|537517788|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010565|NCT01852058|537517789|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010566|NCT01852058|537517790|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
149010567|NCT01852058|537517791|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
149010568|NCT01852058|537517792|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010569|NCT01852058|537517793|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010570|NCT01852058|537517794|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010571|NCT01852058|537517795|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010572|NCT01852058|537517796|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010573|NCT01852058|537517797|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
149010574|NCT01852058|537517786|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010575|NCT01852058|537517787|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010576|NCT01852058|537517788|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010577|NCT01852058|537517789|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010578|NCT01852058|537517790|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
149010579|NCT01852058|537517791|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010580|NCT01852058|537517792|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010581|NCT01852058|537517793|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010582|NCT01852058|537517794|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010583|NCT01852058|537517795|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010584|NCT01852058|537517796|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010585|NCT01852058|537517797|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
149010586|NCT01852058|537517786|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010587|NCT01852058|537517787|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010588|NCT01852058|537517788|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010589|NCT01852058|537517789|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010590|NCT01852058|537517790|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
149010591|NCT01852058|537517791|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
149010592|NCT01852058|537517792|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010593|NCT01852058|537517793|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010594|NCT01852058|537517794|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010595|NCT01852058|537517795|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010596|NCT01852058|537517796|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010597|NCT01852058|537517797|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
149010598|NCT01852058|537517786|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010599|NCT01852058|537517787|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010600|NCT01852058|537517788|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010601|NCT01852058|537517789|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
149010602|NCT01852058|537517790|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010603|NCT01852058|537517791|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010604|NCT01852058|537517792|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010605|NCT01852058|537517793|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010606|NCT01852058|537517794|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010607|NCT01852058|537517795|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010608|NCT01852058|537517796|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010609|NCT01852058|537517797|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
149010610|NCT01852058|537517786|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010611|NCT01852058|537517787|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010612|NCT01852058|537517788|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010613|NCT01852058|537517789|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010614|NCT01852058|537517790|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
149010615|NCT01852058|537517791|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
149010616|NCT01852058|537517792|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010617|NCT01852058|537517793|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010618|NCT01852058|537517794|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010619|NCT01852058|537517795|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010620|NCT01852058|537517796|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010621|NCT01852058|537517797|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
149010622|NCT01852058|537517786|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010623|NCT01852058|537517787|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010624|NCT01852058|537517788|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010625|NCT01852058|537517789|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010626|NCT01852058|537517790|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010627|NCT01852058|537517791|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010628|NCT01852058|537517792|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010629|NCT01852058|537517793|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
149010630|NCT01852058|537517794|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010631|NCT01852058|537517795|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010632|NCT01852058|537517796|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010633|NCT01852058|537517797|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
149010634|NCT01852058|537517786|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010635|NCT01852058|537517787|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010636|NCT01852058|537517788|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010637|NCT01852058|537517789|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010638|NCT01852058|537517790|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010639|NCT01852058|537517791|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010640|NCT01852058|537517792|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010641|NCT01852058|537517793|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010642|NCT01852058|537517794|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
149010643|NCT01852058|537517795|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010644|NCT01852058|537517796|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010645|NCT01852058|537517797|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
149010646|NCT03474549|537517799|FG000|Overall Study|Death|31|||
149010647|NCT03474549|537517799|FG000|Overall Study|Lost to Follow-up|4|||
149010648|NCT03474549|537517799|FG000|Overall Study|Withdrawal by Subject|2|||
149010649|NCT03573908|537517803|FG000|Treatment Period|Adverse Event|4|||
149010650|NCT03573908|537517804|FG001|Treatment Period|Adverse Event|9|||
148782222|NCT00574795|536677411|FG000|Infant Series|Adverse Event|1|||
148782223|NCT00574795|536677411|FG000|After Infant Series|Withdrawal by Subject|1|||
148782224|NCT00574795|536677411|FG000|After Infant Series|Adverse Event|2|||
148782225|NCT00574795|536677411|FG000|Toddler Dose|Withdrawal by Subject|1|||
148782226|NCT00672841|536677412|FG000|Overall Study|Comfort care|1|||
148782227|NCT00672841|536677413|FG001|Overall Study|Comfort care|4|||
148782228|NCT00672841|536677412|FG000|Overall Study|icteric specimens|0|||
148782229|NCT00672841|536677413|FG001|Overall Study|icteric specimens|3|||
148782230|NCT00672841|536677412|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
148782231|NCT00672841|536677413|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
148782232|NCT00672841|536677412|FG000|Overall Study|Adverse Event|0|||
148782233|NCT00672841|536677413|FG001|Overall Study|Adverse Event|3|||
148782234|NCT00672841|536677412|FG000|Overall Study|Pregnancy|0|||
148782235|NCT00672841|536677413|FG001|Overall Study|Pregnancy|1|||
148782236|NCT02638259|536677414|FG000|Treatment Period 1|Adverse Event|1|||
149010651|NCT03573908|537517805|FG002|Treatment Period|Adverse Event|0|||
149010652|NCT03573908|537517806|FG003|Treatment Period|Adverse Event|0|||
149010653|NCT03573908|537517807|FG004|Treatment Period|Adverse Event|0|||
149010654|NCT03573908|537517803|FG000|Treatment Period|Protocol Violation|1|||
149010655|NCT03573908|537517804|FG001|Treatment Period|Protocol Violation|0|||
149010656|NCT03573908|537517805|FG002|Treatment Period|Protocol Violation|0|||
149010657|NCT03573908|537517806|FG003|Treatment Period|Protocol Violation|0|||
149010658|NCT03573908|537517807|FG004|Treatment Period|Protocol Violation|0|||
149010659|NCT03573908|537517803|FG000|Treatment Period|Withdrawal by Subject|7|||
149010660|NCT03573908|537517804|FG001|Treatment Period|Withdrawal by Subject|5|||
149010661|NCT03573908|537517805|FG002|Treatment Period|Withdrawal by Subject|0|||
149010662|NCT03573908|537517806|FG003|Treatment Period|Withdrawal by Subject|0|||
149010663|NCT03573908|537517807|FG004|Treatment Period|Withdrawal by Subject|0|||
149010664|NCT03573908|537517803|FG000|Treatment Period|Lost to Follow-up|7|||
149010665|NCT03573908|537517804|FG001|Treatment Period|Lost to Follow-up|6|||
149010666|NCT03573908|537517805|FG002|Treatment Period|Lost to Follow-up|0|||
149010667|NCT03573908|537517806|FG003|Treatment Period|Lost to Follow-up|0|||
149010668|NCT03573908|537517807|FG004|Treatment Period|Lost to Follow-up|0|||
149010669|NCT03573908|537517803|FG000|Treatment Period|Pregnancy|1|||
149010670|NCT03573908|537517804|FG001|Treatment Period|Pregnancy|0|||
149010671|NCT03573908|537517805|FG002|Treatment Period|Pregnancy|0|||
149010672|NCT03573908|537517806|FG003|Treatment Period|Pregnancy|0|||
149010673|NCT03573908|537517807|FG004|Treatment Period|Pregnancy|0|||
149010674|NCT03573908|537517803|FG000|Treatment Period|Other, Not Specified|4|||
149010675|NCT03573908|537517804|FG001|Treatment Period|Other, Not Specified|6|||
149010676|NCT03573908|537517805|FG002|Treatment Period|Other, Not Specified|0|||
149010677|NCT03573908|537517806|FG003|Treatment Period|Other, Not Specified|0|||
149010678|NCT03573908|537517807|FG004|Treatment Period|Other, Not Specified|0|||
149010679|NCT03573908|537517803|FG000|Randomized Withdrawal Period|Adverse Event|0|||
149010680|NCT03573908|537517804|FG001|Randomized Withdrawal Period|Adverse Event|0|||
149010681|NCT03573908|537517805|FG002|Randomized Withdrawal Period|Adverse Event|3|||
149010682|NCT03573908|537517806|FG003|Randomized Withdrawal Period|Adverse Event|0|||
149010683|NCT03573908|537517807|FG004|Randomized Withdrawal Period|Adverse Event|0|||
149010684|NCT03573908|537517803|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149010685|NCT03573908|537517804|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149010686|NCT03573908|537517805|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149010687|NCT03573908|537517806|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149010688|NCT03573908|537517807|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
149010689|NCT03573908|537517803|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
149010690|NCT03573908|537517804|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
149010691|NCT03573908|537517805|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
149010692|NCT03573908|537517806|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
149010693|NCT03573908|537517807|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
149010694|NCT03573908|537517803|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
149010695|NCT03573908|537517804|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
149010696|NCT03573908|537517805|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
149010697|NCT03573908|537517806|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
149010698|NCT03573908|537517807|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
149010699|NCT04006925|537517808|FG000|Overall Study|Side effects|2|||
149010700|NCT04006925|537517809|FG001|Overall Study|Side effects|0|||
149010701|NCT00738101|537517815|FG000|Overall Study|Physician Decision|5|||
149010702|NCT00738101|537517815|FG000|Overall Study|Death|1|||
149010703|NCT00738101|537517815|FG000|Overall Study|Repeat enrollment|1|||
149010704|NCT03535337|537517817|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
149010705|NCT03535337|537517818|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
149010706|NCT03535337|537517819|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
148782237|NCT02638259|536677415|FG001|Treatment Period 1|Adverse Event|5|||
148782238|NCT02638259|536677414|FG000|Treatment Period 1|Death|0|||
148782239|NCT02638259|536677415|FG001|Treatment Period 1|Death|1|||
149010707|NCT03535337|537517820|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
149010708|NCT03535337|537517821|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
149010709|NCT03535337|537517822|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
149010710|NCT03535337|537517823|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
149010711|NCT03535337|537517824|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
149010712|NCT03535337|537517825|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
149010713|NCT03535337|537517826|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
148782240|NCT02638259|536677414|FG000|Treatment Period 1|Lack of Efficacy|0|||
148782241|NCT02638259|536677415|FG001|Treatment Period 1|Lack of Efficacy|1|||
148782242|NCT02638259|536677414|FG000|Treatment Period 1|Protocol Violation|0|||
148782243|NCT02638259|536677415|FG001|Treatment Period 1|Protocol Violation|3|||
148782244|NCT02638259|536677414|FG000|Treatment Period 1|Withdrawal by Subject|4|||
148782245|NCT02638259|536677415|FG001|Treatment Period 1|Withdrawal by Subject|6|||
148782246|NCT02638259|536677414|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
148782247|NCT02638259|536677415|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
148782248|NCT02638259|536677414|FG000|Treatment Period 2|Adverse Event|5|||
148782249|NCT02638259|536677415|FG001|Treatment Period 2|Adverse Event|4|||
148782250|NCT02638259|536677414|FG000|Treatment Period 2|Withdrawal by Subject|1|||
148782251|NCT02638259|536677415|FG001|Treatment Period 2|Withdrawal by Subject|7|||
148782252|NCT04299048|536677417|FG000|Overall Study|Death|1|||
148782253|NCT04299048|536677417|FG000|Overall Study|Global deterioration of health status|2|||
148782254|NCT04299048|536677417|FG000|Overall Study|Enrolled and not treated|1|||
148782255|NCT01717391|536677418|FG000|Overall Study|Withdrawal by Subject|5|||
148782256|NCT01717391|536677418|FG000|Overall Study|Physician Decision|1|||
148782257|NCT01717391|536677418|FG000|Overall Study|FLT technical failure|3|||
148782258|NCT03677934|536677419|FG000|Overall Study|Adverse Event|1|||
148782259|NCT03677934|536677420|FG001|Overall Study|Adverse Event|1|||
148782260|NCT03677934|536677419|FG000|Overall Study|Death|8|||
148782261|NCT03677934|536677420|FG001|Overall Study|Death|4|||
148782262|NCT03677934|536677419|FG000|Overall Study|Lost to Follow-up|3|||
148782263|NCT03677934|536677420|FG001|Overall Study|Lost to Follow-up|0|||
148782264|NCT03677934|536677419|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148782265|NCT03677934|536677420|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148782266|NCT03677934|536677419|FG000|Overall Study|Physician Decision|0|||
148782267|NCT03677934|536677420|FG001|Overall Study|Physician Decision|1|||
148782268|NCT03677934|536677419|FG000|Overall Study|Withdrawal by Subject|1|||
148782269|NCT03677934|536677420|FG001|Overall Study|Withdrawal by Subject|7|||
148782270|NCT04769739|536677437|FG000|Overall Study|Colorectal cancer obstruction|2|||
148782271|NCT04769739|536677438|FG001|Overall Study|Colorectal cancer obstruction|0|||
148782272|NCT04769739|536677439|FG002|Overall Study|Colorectal cancer obstruction|0|||
148782273|NCT04769739|536677440|FG003|Overall Study|Colorectal cancer obstruction|0|||
148782274|NCT04769739|536677437|FG000|Overall Study|Failed cecal intubation|1|||
148782275|NCT04769739|536677438|FG001|Overall Study|Failed cecal intubation|0|||
148782276|NCT04769739|536677439|FG002|Overall Study|Failed cecal intubation|0|||
148782277|NCT04769739|536677440|FG003|Overall Study|Failed cecal intubation|1|||
148782278|NCT04769739|536677437|FG000|Overall Study|Poor bowel preparation|0|||
148782279|NCT04769739|536677438|FG001|Overall Study|Poor bowel preparation|0|||
148782280|NCT04769739|536677439|FG002|Overall Study|Poor bowel preparation|0|||
148782281|NCT04769739|536677440|FG003|Overall Study|Poor bowel preparation|1|||
148782282|NCT00045734|536677441|FG000|Overall Study|Protocol Violation|1|||
148782283|NCT02069093|536677442|FG000|Overall Study|Disease progression|14|||
148782284|NCT02069093|536677442|FG000|Overall Study|New cancer therapy|1|||
148782285|NCT02069093|536677442|FG000|Overall Study|Death|1|||
148782286|NCT02069093|536677442|FG000|Overall Study|Administrative problems|1|||
148782287|NCT02069093|536677442|FG000|Overall Study|Withdrawal by Subject|2|||
148782288|NCT02069093|536677442|FG000|Overall Study|Abnormal laboratory values|1|||
148782289|NCT02069093|536677442|FG000|Overall Study|Adverse Event|10|||
148782290|NCT00561470|536677448|FG000|Overall Study|Adverse Event|74|||
148782291|NCT00561470|536677449|FG001|Overall Study|Adverse Event|163|||
148782292|NCT00561470|536677448|FG000|Overall Study|Disease progression|437|||
148782293|NCT00561470|536677449|FG001|Overall Study|Disease progression|305|||
148782294|NCT00561470|536677448|FG000|Overall Study|poor compliance to protocol|4|||
149010714|NCT00386308|537519792|FG000|Overall Study|Adverse Event|3|||
148782295|NCT00561470|536677449|FG001|Overall Study|poor compliance to protocol|4|||
148782296|NCT00561470|536677448|FG000|Overall Study|Lost to Follow-up|2|||
148782297|NCT00561470|536677449|FG001|Overall Study|Lost to Follow-up|0|||
148782298|NCT00561470|536677448|FG000|Overall Study|Physician Decision|21|||
148782299|NCT00561470|536677449|FG001|Overall Study|Physician Decision|20|||
148782300|NCT00561470|536677448|FG000|Overall Study|Consent Withdrawn|2|||
148782301|NCT00561470|536677449|FG001|Overall Study|Consent Withdrawn|6|||
148782302|NCT00561470|536677448|FG000|Overall Study|Subject request|43|||
148782303|NCT00561470|536677449|FG001|Overall Study|Subject request|77|||
149010715|NCT00386308|537519793|FG001|Overall Study|Adverse Event|3|||
148782304|NCT00561470|536677448|FG000|Overall Study|Metastatic surgery|10|||
148782305|NCT00561470|536677449|FG001|Overall Study|Metastatic surgery|12|||
148782306|NCT00561470|536677448|FG000|Overall Study|Unauthorized procedure|3|||
148782307|NCT00561470|536677449|FG001|Overall Study|Unauthorized procedure|1|||
148782308|NCT00561470|536677448|FG000|Overall Study|Randomized but not treated|5|||
149010716|NCT00386308|537519792|FG000|Overall Study|Protocol Violation|2|||
149010717|NCT00386308|537519793|FG001|Overall Study|Protocol Violation|5|||
149010718|NCT00386308|537519792|FG000|Overall Study|Lack of Efficacy|0|||
149010719|NCT00386308|537519793|FG001|Overall Study|Lack of Efficacy|2|||
149010720|NCT00386308|537519792|FG000|Overall Study|Lost to Follow-up|10|||
149010721|NCT00386308|537519793|FG001|Overall Study|Lost to Follow-up|6|||
149010722|NCT00386308|537519792|FG000|Overall Study|Withdrawal by Subject|6|||
149010723|NCT00386308|537519793|FG001|Overall Study|Withdrawal by Subject|2|||
149010724|NCT00386308|537519792|FG000|Overall Study|Other Event|8|||
149010725|NCT00386308|537519793|FG001|Overall Study|Other Event|1|||
149010726|NCT00720902|537519794|FG000|Overall Study|Withdrawal by Subject|1|||
149010727|NCT00720902|537519795|FG001|Overall Study|Withdrawal by Subject|0|||
149010728|NCT00720902|537519794|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
149010729|NCT00720902|537519795|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
149010730|NCT02959671|537519796|FG000|Overall Study|Adverse Event|2|||
149010731|NCT02959671|537519796|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
149010732|NCT00067990|537519798|FG000|Overall Study|Death|5|||
149010733|NCT00067990|537519799|FG001|Overall Study|Death|7|||
149010734|NCT00067990|537519798|FG000|Overall Study|ESRD, Non IF/TA|1|||
149010735|NCT00067990|537519799|FG001|Overall Study|ESRD, Non IF/TA|3|||
149010736|NCT00067990|537519798|FG000|Overall Study|Withdrawal by Subject|4|||
149010737|NCT00067990|537519799|FG001|Overall Study|Withdrawal by Subject|12|||
149010738|NCT03810313|537519806|FG000|Overall Study|Study terminated by sponsor|164|||
149010739|NCT03810313|537519807|FG001|Overall Study|Study terminated by sponsor|159|||
149010740|NCT03810313|537519806|FG000|Overall Study|Subject decision|10|||
149010741|NCT03810313|537519807|FG001|Overall Study|Subject decision|11|||
149010742|NCT03810313|537519806|FG000|Overall Study|Lost to Follow-up|3|||
149010743|NCT03810313|537519807|FG001|Overall Study|Lost to Follow-up|3|||
149010744|NCT03810313|537519806|FG000|Overall Study|Adverse Event|2|||
149010745|NCT03810313|537519807|FG001|Overall Study|Adverse Event|1|||
149010746|NCT03810313|537519806|FG000|Overall Study|Death|2|||
149010747|NCT03810313|537519807|FG001|Overall Study|Death|1|||
149010748|NCT03810313|537519806|FG000|Overall Study|Physician Decision|0|||
149010749|NCT03810313|537519807|FG001|Overall Study|Physician Decision|1|||
149010750|NCT01111838|537519814|FG000|Overall Study|Patient Ineligible|2|||
149010751|NCT01111838|537519814|FG000|Overall Study|Not Treated|3|||
149010752|NCT01111838|537519814|FG000|Overall Study|Clinical deterioration|1|||
149010753|NCT01111838|537519814|FG000|Overall Study|Other Complicating Disease|1|||
149010754|NCT02567825|537519815|FG000|Overall Study|No follow-up post-randomization|5|||
149010755|NCT02567825|537519816|FG001|Overall Study|No follow-up post-randomization|1|||
149010756|NCT02567825|537519815|FG000|Overall Study|Follow-up less than 23 months|16|||
149010757|NCT02567825|537519816|FG001|Overall Study|Follow-up less than 23 months|20|||
149010758|NCT01872910|537519820|FG000|Overall Study|Lost to Follow-up|2|||
149010759|NCT01872910|537519821|FG001|Overall Study|Lost to Follow-up|0|||
149010760|NCT01872910|537519822|FG002|Overall Study|Lost to Follow-up|2|||
149010761|NCT01872910|537519823|FG003|Overall Study|Lost to Follow-up|0|||
149010762|NCT01872910|537519824|FG004|Overall Study|Lost to Follow-up|0|||
149010763|NCT01872910|537519825|FG005|Overall Study|Lost to Follow-up|0|||
149010764|NCT01540565|537519826|FG000|Overall Study|Ineligible|2|||
149010765|NCT03469349|537519827|FG000|Overall Study|Withdrawal by Subject|1|||
149010766|NCT03469349|537519828|FG001|Overall Study|Withdrawal by Subject|3|||
149010767|NCT03469349|537519827|FG000|Overall Study|Progressive Disease|0|||
149010768|NCT03469349|537519828|FG001|Overall Study|Progressive Disease|1|||
149010769|NCT03469349|537519827|FG000|Overall Study|Lost to Follow-up|2|||
149010770|NCT03469349|537519828|FG001|Overall Study|Lost to Follow-up|2|||
149010771|NCT03469349|537519827|FG000|Overall Study|Adverse Event|2|||
149010772|NCT03469349|537519828|FG001|Overall Study|Adverse Event|4|||
149010773|NCT03820323|537519832|FG000|Overall Study|Lost to Follow-up|2|||
149010774|NCT03820323|537519833|FG001|Overall Study|Lost to Follow-up|1|||
149010775|NCT03820323|537519832|FG000|Overall Study|Missed 12-month visit|22|||
149010776|NCT03820323|537519833|FG001|Overall Study|Missed 12-month visit|14|||
149010777|NCT03820323|537519832|FG000|Overall Study|Death|2|||
149010778|NCT03820323|537519833|FG001|Overall Study|Death|1|||
149010779|NCT03820323|537519832|FG000|Overall Study|Transferred out|13|||
149010780|NCT03820323|537519833|FG001|Overall Study|Transferred out|11|||
149010781|NCT03820323|537519832|FG000|Overall Study|Terminated|0|||
149010782|NCT03820323|537519833|FG001|Overall Study|Terminated|3|||
149010783|NCT03820323|537519832|FG000|Overall Study|Withdrawal by Subject|1|||
149010784|NCT03820323|537519833|FG001|Overall Study|Withdrawal by Subject|6|||
149010785|NCT02912468|537519837|FG000|Overall Study|Adverse Event|3|||
149010786|NCT02912468|537519838|FG001|Overall Study|Adverse Event|2|||
149010787|NCT02912468|537519837|FG000|Overall Study|Withdrawal by Subject|6|||
149010788|NCT02912468|537519838|FG001|Overall Study|Withdrawal by Subject|2|||
149010789|NCT02912468|537519837|FG000|Overall Study|Randomized and not treated|0|||
149010790|NCT02912468|537519838|FG001|Overall Study|Randomized and not treated|1|||
149010791|NCT04091360|537519839|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010792|NCT04091360|537519840|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010793|NCT04091360|537519841|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010794|NCT04091360|537519842|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010795|NCT04091360|537519843|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010796|NCT04091360|537519844|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010797|NCT04091360|537519845|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010798|NCT04091360|537519846|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
149010799|NCT04091360|537519847|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
149010800|NCT04091360|537519848|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
149010801|NCT04091360|537519839|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010802|NCT04091360|537519840|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010803|NCT04091360|537519841|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010804|NCT04091360|537519842|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010805|NCT04091360|537519843|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010806|NCT04091360|537519844|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010807|NCT04091360|537519845|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
149010808|NCT04091360|537519846|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
149010809|NCT04091360|537519847|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010810|NCT04091360|537519848|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
149010811|NCT04091360|537519839|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010812|NCT04091360|537519840|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010813|NCT04091360|537519841|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010814|NCT04091360|537519842|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010815|NCT04091360|537519843|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010816|NCT04091360|537519844|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149021123|NCT04423393|537557188|FG007|Overall Study|Sponsor Decision|0|||
149010817|NCT04091360|537519845|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
149010818|NCT04091360|537519846|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010819|NCT04091360|537519847|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
149010820|NCT04091360|537519848|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
149010821|NCT00692406|537519850|FG000|Overall Study|PI dropped, bad data|57|||
149010822|NCT02597933|537519851|FG000|Overall Study|Withdrawal by Subject|7|||
149010823|NCT02597933|537519852|FG001|Overall Study|Withdrawal by Subject|5|||
149010824|NCT02597933|537519851|FG000|Overall Study|Protocol Violation|2|||
149010825|NCT02597933|537519852|FG001|Overall Study|Protocol Violation|2|||
149010826|NCT02597933|537519851|FG000|Overall Study|Adverse Event|20|||
149010827|NCT02597933|537519852|FG001|Overall Study|Adverse Event|28|||
149010828|NCT02597933|537519851|FG000|Overall Study|Not treated|2|||
149010829|NCT02597933|537519852|FG001|Overall Study|Not treated|2|||
149010830|NCT02597933|537519851|FG000|Overall Study|Other than stated above|7|||
149010831|NCT02597933|537519852|FG001|Overall Study|Other than stated above|14|||
149010832|NCT01617005|537519857|FG000|Overall Study|Pregnancy|1|||
149010833|NCT01617005|537519857|FG000|Overall Study|Lack of motivation for treatment|1|||
149010834|NCT01320735|537519861|FG000|Overall Study|Adverse Event|3|||
149010835|NCT01320735|537519861|FG000|Overall Study|Withdrawal by Subject|3|||
149010836|NCT01320735|537519861|FG000|Overall Study|Lost to Follow-up|13|||
149010837|NCT01320735|537519861|FG000|Overall Study|Administrative Reason|6|||
149010838|NCT01320735|537519861|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
149010839|NCT01320735|537519861|FG000|Overall Study|Protocol Violation|1|||
149010840|NCT01320735|537519861|FG000|Overall Study|Other|1|||
149010841|NCT01320735|537519861|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
149010842|NCT01320735|537519861|FG000|Overall Study|Investigator Unable to be Contacted|17|||
149010843|NCT04599101|537519862|FG000|Overall Study|Lost to Follow-up|5|||
149010844|NCT04599101|537519863|FG001|Overall Study|Lost to Follow-up|5|||
149010845|NCT02307513|537519864|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
149010846|NCT02307513|537519865|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
149010847|NCT02307513|537519864|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
149010848|NCT02307513|537519865|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
149010849|NCT02307513|537519864|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
149010850|NCT02307513|537519865|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
149010851|NCT02307513|537519864|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
149010852|NCT02307513|537519865|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
149010853|NCT02307513|537519864|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
149010854|NCT02307513|537519865|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
149010855|NCT02307513|537519864|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
149010856|NCT02307513|537519865|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
149010857|NCT02307513|537519864|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
149010858|NCT02307513|537519865|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
149010859|NCT02307513|537519864|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
149010860|NCT02307513|537519865|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
149010861|NCT02307513|537519864|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
149010862|NCT02307513|537519865|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
149010863|NCT02307513|537519864|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
149010864|NCT02307513|537519865|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
149010865|NCT02307513|537519864|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
149010866|NCT02307513|537519865|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
149010867|NCT02307513|537519864|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
149010868|NCT02307513|537519865|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
149010869|NCT02307513|537519864|FG000|Long-term Extension|Physician Decision|1|||
149010870|NCT02307513|537519865|FG001|Long-term Extension|Physician Decision|0|||
149010871|NCT05952297|537519867|FG000|Overall Study|Withdrawal by Subject|1|||
149010872|NCT05952297|537519868|FG001|Overall Study|Withdrawal by Subject|0|||
149010873|NCT00525265|537519875|FG000|Overall Study|Protocol Violation|1|||
149010874|NCT00525265|537519876|FG001|Overall Study|Protocol Violation|0|||
149010875|NCT01107743|537519877|FG000|Overall Study|Protocol Violation|46|||
149010876|NCT00308737|537519878|FG000|Overall Study|Adverse Event|104|||
149010877|NCT00308737|537519879|FG001|Overall Study|Adverse Event|9|||
149010878|NCT00308737|537519880|FG002|Overall Study|Adverse Event|0|||
149010879|NCT00308737|537519878|FG000|Overall Study|Death|4|||
149010880|NCT00308737|537519879|FG001|Overall Study|Death|3|||
149010881|NCT00308737|537519880|FG002|Overall Study|Death|0|||
149010882|NCT00308737|537519878|FG000|Overall Study|Lost to Follow-up|56|||
149010883|NCT00308737|537519879|FG001|Overall Study|Lost to Follow-up|80|||
149010884|NCT00308737|537519880|FG002|Overall Study|Lost to Follow-up|5|||
149010885|NCT00308737|537519878|FG000|Overall Study|Physician Decision|15|||
149010886|NCT00308737|537519879|FG001|Overall Study|Physician Decision|2|||
149010887|NCT00308737|537519880|FG002|Overall Study|Physician Decision|1|||
149010888|NCT00308737|537519878|FG000|Overall Study|Protocol Violation|34|||
149010889|NCT00308737|537519879|FG001|Overall Study|Protocol Violation|9|||
149010890|NCT00308737|537519880|FG002|Overall Study|Protocol Violation|5|||
149010891|NCT00308737|537519878|FG000|Overall Study|Withdrawal by Subject|218|||
149010892|NCT00308737|537519879|FG001|Overall Study|Withdrawal by Subject|166|||
149010893|NCT00308737|537519880|FG002|Overall Study|Withdrawal by Subject|18|||
149010894|NCT00308737|537519878|FG000|Overall Study|Various|32|||
149010895|NCT00308737|537519879|FG001|Overall Study|Various|20|||
149010896|NCT00308737|537519880|FG002|Overall Study|Various|8|||
149010897|NCT01913639|537519881|FG000|Overall Study|Not Eligible|3|||
149010898|NCT01225822|537519891|FG000|Overall Study|Adverse Event|13|||
149010899|NCT01225822|537519892|FG001|Overall Study|Adverse Event|31|||
149010900|NCT01225822|537519893|FG002|Overall Study|Adverse Event|18|||
149010901|NCT01225822|537519894|FG003|Overall Study|Adverse Event|23|||
149010902|NCT01225822|537519895|FG004|Overall Study|Adverse Event|14|||
149010903|NCT01225822|537519891|FG000|Overall Study|Protocol Violation|6|||
149010904|NCT01225822|537519892|FG001|Overall Study|Protocol Violation|8|||
148782309|NCT00561470|536677449|FG001|Overall Study|Randomized but not treated|5|||
148782310|NCT00561470|536677448|FG000|Overall Study|Missed visit window|1|||
148782311|NCT00561470|536677449|FG001|Overall Study|Missed visit window|4|||
148782312|NCT00561470|536677448|FG000|Overall Study|Planning surgery|1|||
148782313|NCT00561470|536677449|FG001|Overall Study|Planning surgery|1|||
148782314|NCT00561470|536677448|FG000|Overall Study|Ongoing Treatment|11|||
148782315|NCT00561470|536677449|FG001|Overall Study|Ongoing Treatment|14|||
148782316|NCT00335959|536677452|FG000|Overall Study|Adverse Event|2|||
148782317|NCT00335959|536677452|FG000|Overall Study|Ineligible|1|||
148782318|NCT01001598|536677456|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
148782319|NCT01001598|536677456|FG000|Overall Study|Adverse Event|1|||
148782320|NCT02450552|536677457|FG000|Overall Study|Withdrawal by Subject|4|||
148782321|NCT02450552|536677458|FG001|Overall Study|Withdrawal by Subject|0|||
148782322|NCT02450552|536677459|FG002|Overall Study|Withdrawal by Subject|4|||
148782323|NCT02450552|536677457|FG000|Overall Study|Physician Decision|1|||
148782324|NCT02450552|536677458|FG001|Overall Study|Physician Decision|0|||
148782325|NCT02450552|536677459|FG002|Overall Study|Physician Decision|1|||
148782326|NCT05079230|536677471|FG000|Overall Study|Study Terminated by Sponsor|101|||
148782327|NCT05079230|536677472|FG001|Overall Study|Study Terminated by Sponsor|102|||
148782328|NCT05079230|536677471|FG000|Overall Study|Death|72|||
148782329|NCT05079230|536677472|FG001|Overall Study|Death|66|||
148782330|NCT05079230|536677471|FG000|Overall Study|Withdrew Consent|16|||
148782331|NCT05079230|536677472|FG001|Overall Study|Withdrew Consent|18|||
148782332|NCT05079230|536677471|FG000|Overall Study|Lost to Follow-up|0|||
148782333|NCT05079230|536677472|FG001|Overall Study|Lost to Follow-up|3|||
148782334|NCT01524783|536677473|FG000|Blinded Period|Adverse Event|64|||
148782335|NCT01524783|536677474|FG001|Blinded Period|Adverse Event|7|||
148782336|NCT01524783|536677475|FG002|Blinded Period|Adverse Event|0|||
148782337|NCT01524783|536677473|FG000|Blinded Period|Disease Progression|89|||
148782338|NCT01524783|536677474|FG001|Blinded Period|Disease Progression|75|||
148782339|NCT01524783|536677475|FG002|Blinded Period|Disease Progression|0|||
148782340|NCT01524783|536677473|FG000|Blinded Period|Withdrawal by Subject|19|||
148782341|NCT01524783|536677474|FG001|Blinded Period|Withdrawal by Subject|6|||
148782342|NCT01524783|536677475|FG002|Blinded Period|Withdrawal by Subject|0|||
149010905|NCT01225822|537519893|FG002|Overall Study|Protocol Violation|6|||
149010906|NCT01225822|537519894|FG003|Overall Study|Protocol Violation|7|||
149010907|NCT01225822|537519895|FG004|Overall Study|Protocol Violation|4|||
149010908|NCT01225822|537519891|FG000|Overall Study|Lost to Follow-up|0|||
149010909|NCT01225822|537519892|FG001|Overall Study|Lost to Follow-up|0|||
149010910|NCT01225822|537519893|FG002|Overall Study|Lost to Follow-up|0|||
148782343|NCT01524783|536677473|FG000|Blinded Period|Protocol deviation|2|||
148782344|NCT01524783|536677474|FG001|Blinded Period|Protocol deviation|1|||
148782345|NCT01524783|536677475|FG002|Blinded Period|Protocol deviation|0|||
149010911|NCT01225822|537519894|FG003|Overall Study|Lost to Follow-up|1|||
149010912|NCT01225822|537519895|FG004|Overall Study|Lost to Follow-up|0|||
148782346|NCT01524783|536677473|FG000|Blinded Period|Death|5|||
148782347|NCT01524783|536677474|FG001|Blinded Period|Death|2|||
148782348|NCT01524783|536677475|FG002|Blinded Period|Death|0|||
148782349|NCT01524783|536677473|FG000|Open-label Period|Disease progression|13|||
148782350|NCT01524783|536677474|FG001|Open-label Period|Disease progression|0|||
148782351|NCT01524783|536677475|FG002|Open-label Period|Disease progression|2|||
148782352|NCT01524783|536677473|FG000|Open-label Period|Administrative problems|5|||
148782353|NCT01524783|536677474|FG001|Open-label Period|Administrative problems|0|||
148782354|NCT01524783|536677475|FG002|Open-label Period|Administrative problems|2|||
148782355|NCT01524783|536677473|FG000|Open-label Period|Adverse Event|5|||
148782356|NCT01524783|536677474|FG001|Open-label Period|Adverse Event|0|||
148893348|NCT00683878|537088680|FG002|Overall Study|Adverse Event|3|||
149010913|NCT01225822|537519891|FG000|Overall Study|Withdrawal by Subject|6|||
149010914|NCT01225822|537519892|FG001|Overall Study|Withdrawal by Subject|7|||
149010915|NCT01225822|537519893|FG002|Overall Study|Withdrawal by Subject|7|||
149010916|NCT01225822|537519894|FG003|Overall Study|Withdrawal by Subject|11|||
149010917|NCT01225822|537519895|FG004|Overall Study|Withdrawal by Subject|6|||
149010918|NCT01225822|537519891|FG000|Overall Study|Other|13|||
149010919|NCT01225822|537519892|FG001|Overall Study|Other|10|||
149010920|NCT01225822|537519893|FG002|Overall Study|Other|7|||
149010921|NCT01225822|537519894|FG003|Overall Study|Other|10|||
149010922|NCT01225822|537519895|FG004|Overall Study|Other|7|||
149010923|NCT00130793|537519896|FG000|Overall Study|Lost to Follow-up|1|||
149010924|NCT00130793|537519897|FG001|Overall Study|Lost to Follow-up|4|||
149010925|NCT00130793|537519896|FG000|Overall Study|Withdrew consent|2|||
149010926|NCT00130793|537519897|FG001|Overall Study|Withdrew consent|0|||
149010927|NCT00211237|537519898|FG000|Baseline|Withdrew|1|||
149010928|NCT00211237|537519899|FG001|Baseline|Withdrew|3|||
149010929|NCT00211237|537519900|FG002|Baseline|Withdrew|0|||
149010930|NCT00211237|537519898|FG000|Baseline|Refused random assignment|1|||
149010931|NCT00211237|537519899|FG001|Baseline|Refused random assignment|0|||
149010932|NCT00211237|537519900|FG002|Baseline|Refused random assignment|0|||
149010933|NCT00211237|537519898|FG000|1 Month|Death|2|||
149010934|NCT00211237|537519899|FG001|1 Month|Death|1|||
149010935|NCT00211237|537519900|FG002|1 Month|Death|0|||
149010936|NCT00211237|537519898|FG000|1 Month|Lost to Follow-up|0|||
149010937|NCT00211237|537519899|FG001|1 Month|Lost to Follow-up|2|||
149010938|NCT00211237|537519900|FG002|1 Month|Lost to Follow-up|0|||
149010939|NCT00211237|537519898|FG000|1 Month|Withdrew|0|||
149010940|NCT00211237|537519899|FG001|1 Month|Withdrew|4|||
149010941|NCT00211237|537519900|FG002|1 Month|Withdrew|0|||
149010942|NCT00211237|537519898|FG000|1 Month|Additional surgery needed|1|||
149010943|NCT00211237|537519899|FG001|1 Month|Additional surgery needed|0|||
149010944|NCT00211237|537519900|FG002|1 Month|Additional surgery needed|0|||
149010945|NCT00211237|537519898|FG000|1 Month|Non-medical problem|0|||
149010946|NCT00211237|537519899|FG001|1 Month|Non-medical problem|2|||
149010947|NCT00211237|537519900|FG002|1 Month|Non-medical problem|0|||
149010948|NCT00211237|537519898|FG000|3 Months|Death|7|||
149010949|NCT00211237|537519899|FG001|3 Months|Death|3|||
149010950|NCT00211237|537519900|FG002|3 Months|Death|0|||
149010951|NCT00211237|537519898|FG000|3 Months|Could not comply with protocol|1|||
149010952|NCT00211237|537519899|FG001|3 Months|Could not comply with protocol|0|||
149010953|NCT00211237|537519900|FG002|3 Months|Could not comply with protocol|0|||
149010954|NCT00211237|537519898|FG000|3 Months|Withdrew|0|||
149010955|NCT00211237|537519899|FG001|3 Months|Withdrew|1|||
149010956|NCT00211237|537519900|FG002|3 Months|Withdrew|0|||
149010957|NCT00211237|537519898|FG000|3 Months|Non-medical problem|0|||
149010958|NCT00211237|537519899|FG001|3 Months|Non-medical problem|0|||
149010959|NCT00211237|537519900|FG002|3 Months|Non-medical problem|1|||
149010960|NCT00211237|537519898|FG000|6 Months|Death|6|||
149010961|NCT00211237|537519899|FG001|6 Months|Death|0|||
149010962|NCT00211237|537519900|FG002|6 Months|Death|3|||
149010963|NCT00211237|537519898|FG000|6 Months|Lost to Follow-up|2|||
149010964|NCT00211237|537519899|FG001|6 Months|Lost to Follow-up|0|||
149010965|NCT00211237|537519900|FG002|6 Months|Lost to Follow-up|0|||
149010966|NCT00211237|537519898|FG000|6 Months|Could not comply with protocol|0|||
149010967|NCT00211237|537519899|FG001|6 Months|Could not comply with protocol|2|||
149010968|NCT00211237|537519900|FG002|6 Months|Could not comply with protocol|0|||
149010969|NCT00211237|537519898|FG000|12 Months|Death|8|||
149010970|NCT00211237|537519899|FG001|12 Months|Death|2|||
149010971|NCT00211237|537519900|FG002|12 Months|Death|3|||
149010972|NCT00211237|537519898|FG000|12 Months|Lost to Follow-up|1|||
149010973|NCT00211237|537519899|FG001|12 Months|Lost to Follow-up|0|||
149010974|NCT00211237|537519900|FG002|12 Months|Lost to Follow-up|1|||
149010975|NCT00211237|537519898|FG000|12 Months|Withdrew|0|||
149010976|NCT00211237|537519899|FG001|12 Months|Withdrew|0|||
149010977|NCT00211237|537519900|FG002|12 Months|Withdrew|1|||
149010978|NCT00211237|537519898|FG000|12 Months|unrelated medical problem|0|||
149010979|NCT00211237|537519899|FG001|12 Months|unrelated medical problem|0|||
149010980|NCT00211237|537519900|FG002|12 Months|unrelated medical problem|1|||
149010981|NCT01290822|537519901|FG000|Overall Study|Withdrawal by Subject|1|||
149010982|NCT01290822|537519901|FG000|Overall Study|Physician Decision|10|||
149010983|NCT01003639|537519902|FG000|Overall Study|Lost to Follow-up|6|||
149010984|NCT01003639|537519903|FG001|Overall Study|Lost to Follow-up|9|||
149010985|NCT01003639|537519902|FG000|Overall Study|Withdrawal by Subject|9|||
149010986|NCT01003639|537519903|FG001|Overall Study|Withdrawal by Subject|5|||
149010987|NCT01003639|537519902|FG000|Overall Study|Lack of Efficacy|1|||
149010988|NCT01003639|537519903|FG001|Overall Study|Lack of Efficacy|6|||
149010989|NCT01003639|537519902|FG000|Overall Study|Adverse Event|0|||
149010990|NCT01003639|537519903|FG001|Overall Study|Adverse Event|1|||
149010991|NCT01003639|537519902|FG000|Overall Study|Protocol Violation|0|||
149010992|NCT01003639|537519903|FG001|Overall Study|Protocol Violation|1|||
149010993|NCT01003639|537519902|FG000|Overall Study|Physician Decision|1|||
149010994|NCT01003639|537519903|FG001|Overall Study|Physician Decision|0|||
149010995|NCT01515189|537519904|FG000|Induction|Disease Progression|109|||
149010996|NCT01515189|537519905|FG001|Induction|Disease Progression|155|||
149010997|NCT01515189|537519904|FG000|Induction|Study drug toxicity|86|||
149010998|NCT01515189|537519905|FG001|Induction|Study drug toxicity|36|||
149010999|NCT01515189|537519904|FG000|Induction|Death|24|||
149011000|NCT01515189|537519905|FG001|Induction|Death|17|||
149011001|NCT01515189|537519904|FG000|Induction|Adverse Event|14|||
149011002|NCT01515189|537519905|FG001|Induction|Adverse Event|9|||
149011003|NCT01515189|537519904|FG000|Induction|Withdrawal by Subject|3|||
149011004|NCT01515189|537519905|FG001|Induction|Withdrawal by Subject|9|||
149011005|NCT01515189|537519904|FG000|Induction|No longer meets study criteria|0|||
149011006|NCT01515189|537519905|FG001|Induction|No longer meets study criteria|2|||
149011007|NCT01515189|537519904|FG000|Induction|Lost to Follow-up|1|||
149011008|NCT01515189|537519905|FG001|Induction|Lost to Follow-up|0|||
149011009|NCT01515189|537519904|FG000|Induction|Other|0|||
149011010|NCT01515189|537519905|FG001|Induction|Other|4|||
149011011|NCT01515189|537519904|FG000|First Re-Induction Phase|Disease progression|6|||
149011012|NCT01515189|537519905|FG001|First Re-Induction Phase|Disease progression|14|||
149011013|NCT01515189|537519904|FG000|First Re-Induction Phase|Study drug toxicity|5|||
149011014|NCT01515189|537519905|FG001|First Re-Induction Phase|Study drug toxicity|0|||
149011015|NCT01515189|537519904|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
149011016|NCT01515189|537519905|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
149011017|NCT01515189|537519904|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
149011018|NCT01515189|537519905|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
149011019|NCT01515189|537519904|FG000|First Re-Induction Phase|Other|1|||
149011020|NCT01515189|537519905|FG001|First Re-Induction Phase|Other|0|||
149011021|NCT04078035|537519906|FG000|Session 2|Lost to Follow-up|3|||
149011022|NCT04078035|537519907|FG001|Session 2|Lost to Follow-up|1|||
149011023|NCT04078035|537519906|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
149011024|NCT04078035|537519907|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
149011025|NCT05644353|537519910|FG000|Overall Study|Physician Decision|1|||
149011026|NCT05644353|537519911|FG001|Overall Study|Physician Decision|0|||
149011027|NCT05644353|537519912|FG002|Overall Study|Physician Decision|0|||
149011028|NCT05644353|537519913|FG003|Overall Study|Physician Decision|0|||
149011029|NCT05644353|537519914|FG004|Overall Study|Physician Decision|0|||
149011030|NCT05644353|537519915|FG005|Overall Study|Physician Decision|0|||
149011031|NCT05644353|537519910|FG000|Overall Study|Protocol Violation|1|||
149011032|NCT05644353|537519911|FG001|Overall Study|Protocol Violation|0|||
149011033|NCT05644353|537519912|FG002|Overall Study|Protocol Violation|0|||
149011034|NCT05644353|537519913|FG003|Overall Study|Protocol Violation|0|||
149011035|NCT05644353|537519914|FG004|Overall Study|Protocol Violation|0|||
149011036|NCT05644353|537519915|FG005|Overall Study|Protocol Violation|0|||
149011037|NCT05644353|537519910|FG000|Overall Study|Withdrawal by Subject|0|||
149011038|NCT05644353|537519911|FG001|Overall Study|Withdrawal by Subject|2|||
149011039|NCT05644353|537519912|FG002|Overall Study|Withdrawal by Subject|0|||
149121154|NCT03014479|537920070|FG001|Overall Study|Adverse Event|1|||
149121155|NCT03014479|537920069|FG000|Overall Study|Voluntary Withdrawal|0|||
149121156|NCT03014479|537920070|FG001|Overall Study|Voluntary Withdrawal|2|||
149121157|NCT03014479|537920069|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
148782357|NCT01524783|536677475|FG002|Open-label Period|Adverse Event|1|||
148782358|NCT01524783|536677473|FG000|Open-label Period|Withdrawal by Subject|2|||
148782359|NCT01524783|536677474|FG001|Open-label Period|Withdrawal by Subject|0|||
148782360|NCT01524783|536677475|FG002|Open-label Period|Withdrawal by Subject|1|||
148782361|NCT01524783|536677473|FG000|Open-label Period|Protocol deviation|1|||
148782362|NCT01524783|536677474|FG001|Open-label Period|Protocol deviation|0|||
148782363|NCT01524783|536677475|FG002|Open-label Period|Protocol deviation|0|||
149121158|NCT03014479|537920070|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
149121159|NCT01394978|537920075|FG000|Overall Study|Withdrawal by Subject|2|||
149121160|NCT01394978|537920076|FG001|Overall Study|Withdrawal by Subject|4|||
149121161|NCT01394978|537920075|FG000|Overall Study|Lost to Follow-up|13|||
149121162|NCT01394978|537920076|FG001|Overall Study|Lost to Follow-up|20|||
149121163|NCT01394978|537920075|FG000|Overall Study|Death|6|||
149121164|NCT01394978|537920076|FG001|Overall Study|Death|7|||
149121165|NCT02217501|537920077|FG000|Overall Study|Death|3|||
149121166|NCT02217501|537920078|FG001|Overall Study|Death|4|||
149121167|NCT02019667|537920079|FG000|First Intervention (6 Months)|Adverse Event|0|||
149121168|NCT02019667|537920080|FG001|First Intervention (6 Months)|Adverse Event|1|||
149121169|NCT02019667|537920079|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
149121170|NCT02019667|537920080|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
149121171|NCT02019667|537920079|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
149121172|NCT02019667|537920080|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
149121173|NCT02592876|537920082|FG000|Overall Study|Withdrawal by Subject|3|||
149121174|NCT02592876|537920083|FG001|Overall Study|Withdrawal by Subject|3|||
149121175|NCT02592876|537920082|FG000|Overall Study|Study Termination by Sponsor|32|||
149121176|NCT02592876|537920083|FG001|Overall Study|Study Termination by Sponsor|27|||
149121177|NCT02592876|537920082|FG000|Overall Study|Lost to Follow-up|0|||
149121178|NCT02592876|537920083|FG001|Overall Study|Lost to Follow-up|1|||
149121179|NCT02592876|537920082|FG000|Overall Study|Death|6|||
149121180|NCT02592876|537920083|FG001|Overall Study|Death|9|||
149121181|NCT02233543|537921572|FG000|Period 1|Withdrawal by Subject|1|||
149121182|NCT02233543|537921573|FG001|Period 1|Withdrawal by Subject|0|||
149121183|NCT02233543|537921572|FG000|Period 1|Participants required other treatment.|2|||
149121184|NCT02233543|537921573|FG001|Period 1|Participants required other treatment.|3|||
149121185|NCT02233543|537921572|FG000|Period 2|Adverse Event|1|||
149121186|NCT02233543|537921573|FG001|Period 2|Adverse Event|0|||
149121187|NCT02233543|537921572|FG000|Period 2|Participant required other treatment.|0|||
149121188|NCT02233543|537921573|FG001|Period 2|Participant required other treatment.|1|||
149121189|NCT02233543|537921572|FG000|Period 2|COPD exacerbation|1|||
149121190|NCT02233543|537921573|FG001|Period 2|COPD exacerbation|0|||
149121191|NCT00616902|537921574|FG000|Overall Study|Termination of study|6|||
149121192|NCT00616902|537921575|FG001|Overall Study|Termination of study|6|||
149121193|NCT02680002|537921577|FG000|Overall Study|Lost to Follow-up|5|||
149121194|NCT02680002|537921578|FG001|Overall Study|Lost to Follow-up|1|||
149121195|NCT02680002|537921579|FG002|Overall Study|Lost to Follow-up|4|||
149121196|NCT02680002|537921580|FG003|Overall Study|Lost to Follow-up|2|||
149121197|NCT02680002|537921581|FG004|Overall Study|Lost to Follow-up|0|||
149121198|NCT02680002|537921582|FG005|Overall Study|Lost to Follow-up|2|||
149121199|NCT02680002|537921577|FG000|Overall Study|Physician Decision|5|||
149121200|NCT02680002|537921578|FG001|Overall Study|Physician Decision|1|||
149121201|NCT02680002|537921579|FG002|Overall Study|Physician Decision|1|||
148782364|NCT03164265|536677477|FG000|Overall Study|Physician Decision|3|||
149121202|NCT02680002|537921580|FG003|Overall Study|Physician Decision|1|||
149121203|NCT02680002|537921581|FG004|Overall Study|Physician Decision|1|||
149121204|NCT02680002|537921582|FG005|Overall Study|Physician Decision|1|||
149121205|NCT02680002|537921577|FG000|Overall Study|Protocol Violation|1|||
149121206|NCT02680002|537921578|FG001|Overall Study|Protocol Violation|0|||
149121207|NCT02680002|537921579|FG002|Overall Study|Protocol Violation|1|||
149011040|NCT05644353|537519913|FG003|Overall Study|Withdrawal by Subject|0|||
149121208|NCT02680002|537921580|FG003|Overall Study|Protocol Violation|0|||
149121209|NCT02680002|537921581|FG004|Overall Study|Protocol Violation|1|||
149121210|NCT02680002|537921582|FG005|Overall Study|Protocol Violation|2|||
149011041|NCT05644353|537519914|FG004|Overall Study|Withdrawal by Subject|1|||
149121211|NCT02680002|537921577|FG000|Overall Study|Withdrawal by Subject|0|||
149121212|NCT02680002|537921578|FG001|Overall Study|Withdrawal by Subject|0|||
149011042|NCT05644353|537519915|FG005|Overall Study|Withdrawal by Subject|0|||
149011043|NCT05644353|537519910|FG000|Overall Study|Lost to Follow-up|0|||
149011044|NCT05644353|537519911|FG001|Overall Study|Lost to Follow-up|0|||
149011045|NCT05644353|537519912|FG002|Overall Study|Lost to Follow-up|1|||
149011046|NCT05644353|537519913|FG003|Overall Study|Lost to Follow-up|0|||
149011047|NCT05644353|537519914|FG004|Overall Study|Lost to Follow-up|0|||
149011048|NCT05644353|537519915|FG005|Overall Study|Lost to Follow-up|0|||
149011049|NCT03500640|537519916|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
149011050|NCT03500640|537519917|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
149011051|NCT03500640|537519918|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
149011052|NCT03500640|537519916|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
149011053|NCT03500640|537519917|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
149011054|NCT03500640|537519918|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
149011055|NCT03500640|537519916|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
149011056|NCT03500640|537519917|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
149011057|NCT03500640|537519918|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
149011058|NCT03500640|537519916|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
149011059|NCT03500640|537519917|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
149011060|NCT03500640|537519918|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
149011061|NCT03500640|537519916|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
149011062|NCT03500640|537519917|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
149011063|NCT03500640|537519918|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
149011064|NCT03500640|537519916|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
149011065|NCT03500640|537519917|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
149011066|NCT03500640|537519918|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
149011067|NCT03500640|537519916|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
149011068|NCT03500640|537519917|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
149011069|NCT03500640|537519918|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
149011070|NCT03500640|537519916|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
149011071|NCT03500640|537519917|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
149011072|NCT03500640|537519918|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
149011073|NCT03500640|537519916|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
149011074|NCT03500640|537519917|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
149011075|NCT03500640|537519918|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
149011076|NCT03500640|537519916|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
149011077|NCT03500640|537519917|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
149011078|NCT03500640|537519918|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
149011079|NCT03929562|537519925|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
149011080|NCT03929562|537519926|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
149011081|NCT03929562|537519925|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
149011082|NCT03929562|537519926|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
148782365|NCT01876979|536677478|FG000|Overall Study|Physician Decision|2|||
148782366|NCT01876979|536677479|FG001|Overall Study|Physician Decision|3|||
148782367|NCT00106639|536677480|FG000|Overall Study|Adverse Event|3|||
148782368|NCT00106639|536677481|FG001|Overall Study|Adverse Event|4|||
148782369|NCT00106639|536677482|FG002|Overall Study|Adverse Event|1|||
148782370|NCT00106639|536677480|FG000|Overall Study|Protocol Violation|0|||
148782371|NCT00106639|536677481|FG001|Overall Study|Protocol Violation|1|||
148782372|NCT00106639|536677482|FG002|Overall Study|Protocol Violation|0|||
148782373|NCT00106639|536677480|FG000|Overall Study|Withdrawal by Subject|0|||
148782374|NCT00106639|536677481|FG001|Overall Study|Withdrawal by Subject|1|||
148782375|NCT00106639|536677482|FG002|Overall Study|Withdrawal by Subject|0|||
148782376|NCT00106639|536677480|FG000|Overall Study|Participant defaulted|0|||
148782377|NCT00106639|536677481|FG001|Overall Study|Participant defaulted|1|||
148782378|NCT00106639|536677482|FG002|Overall Study|Participant defaulted|1|||
148782379|NCT01096589|536677483|FG000|Overall Study|Adverse Event|2|||
148782380|NCT01096589|536677484|FG001|Overall Study|Adverse Event|1|||
148782381|NCT01096589|536677485|FG002|Overall Study|Adverse Event|2|||
148782382|NCT01096589|536677486|FG003|Overall Study|Adverse Event|1|||
148782383|NCT01096589|536677483|FG000|Overall Study|Withdrawal by Subject|2|||
148782384|NCT01096589|536677484|FG001|Overall Study|Withdrawal by Subject|1|||
148782385|NCT01096589|536677485|FG002|Overall Study|Withdrawal by Subject|1|||
149011083|NCT03929562|537519925|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
149011084|NCT03929562|537519926|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
148782386|NCT01096589|536677486|FG003|Overall Study|Withdrawal by Subject|1|||
148782387|NCT01096589|536677483|FG000|Overall Study|Compliance with protocol|0|||
148782388|NCT01096589|536677484|FG001|Overall Study|Compliance with protocol|0|||
148782389|NCT01096589|536677485|FG002|Overall Study|Compliance with protocol|1|||
149011085|NCT01036022|537519928|FG000|Overall Study|Adverse Event|1|||
148782390|NCT01096589|536677486|FG003|Overall Study|Compliance with protocol|0|||
148782391|NCT01096589|536677483|FG000|Overall Study|found treatment exhausting|0|||
148782392|NCT01096589|536677484|FG001|Overall Study|found treatment exhausting|0|||
148782393|NCT01096589|536677485|FG002|Overall Study|found treatment exhausting|0|||
148782394|NCT01096589|536677486|FG003|Overall Study|found treatment exhausting|1|||
148782395|NCT00721279|536677488|FG000|Overall Study|Lack of Efficacy|6|||
148782396|NCT00721279|536677489|FG001|Overall Study|Lack of Efficacy|3|||
148782397|NCT00721279|536677488|FG000|Overall Study|Tolerability insufficient|5|||
148782398|NCT00721279|536677489|FG001|Overall Study|Tolerability insufficient|2|||
148782399|NCT00721279|536677488|FG000|Overall Study|Withdrawal by Subject|13|||
148782400|NCT00721279|536677489|FG001|Overall Study|Withdrawal by Subject|3|||
148782401|NCT00721279|536677488|FG000|Overall Study|Other|12|||
148782402|NCT00721279|536677489|FG001|Overall Study|Other|16|||
148782403|NCT03673345|536677490|FG000|Overall Study|Lost to Follow-up|1|||
148782404|NCT03673345|536677491|FG001|Overall Study|Lost to Follow-up|0|||
148782405|NCT03673345|536677492|FG002|Overall Study|Lost to Follow-up|3|||
148782406|NCT03673345|536677493|FG003|Overall Study|Lost to Follow-up|3|||
148782407|NCT03673345|536677494|FG004|Overall Study|Lost to Follow-up|2|||
148782408|NCT03673345|536677495|FG005|Overall Study|Lost to Follow-up|1|||
148782409|NCT03673345|536677496|FG006|Overall Study|Lost to Follow-up|0|||
148782410|NCT03673345|536677497|FG007|Overall Study|Lost to Follow-up|0|||
148782411|NCT03673345|536677490|FG000|Overall Study|Withdrawal by Subject|1|||
148782412|NCT03673345|536677491|FG001|Overall Study|Withdrawal by Subject|0|||
148782413|NCT03673345|536677492|FG002|Overall Study|Withdrawal by Subject|4|||
148782414|NCT03673345|536677493|FG003|Overall Study|Withdrawal by Subject|2|||
148782415|NCT03673345|536677494|FG004|Overall Study|Withdrawal by Subject|0|||
148782416|NCT03673345|536677495|FG005|Overall Study|Withdrawal by Subject|0|||
148782417|NCT03673345|536677496|FG006|Overall Study|Withdrawal by Subject|0|||
148782418|NCT03673345|536677497|FG007|Overall Study|Withdrawal by Subject|0|||
148782419|NCT03673345|536677490|FG000|Overall Study|Physician Decision|0|||
148782420|NCT03673345|536677491|FG001|Overall Study|Physician Decision|0|||
148782421|NCT03673345|536677492|FG002|Overall Study|Physician Decision|2|||
148782422|NCT03673345|536677493|FG003|Overall Study|Physician Decision|0|||
148782423|NCT03673345|536677494|FG004|Overall Study|Physician Decision|0|||
148782424|NCT03673345|536677495|FG005|Overall Study|Physician Decision|0|||
148782425|NCT03673345|536677496|FG006|Overall Study|Physician Decision|0|||
148782426|NCT03673345|536677497|FG007|Overall Study|Physician Decision|0|||
148782427|NCT05153148|536677498|FG000|Overall Study|Adverse Event|1|||
148782428|NCT05153148|536677499|FG001|Overall Study|Adverse Event|0|||
148782429|NCT05153148|536677500|FG002|Overall Study|Adverse Event|3|||
148782430|NCT05153148|536677501|FG003|Overall Study|Adverse Event|5|||
148782431|NCT05153148|536677498|FG000|Overall Study|Lost to Follow-up|1|||
148782432|NCT05153148|536677499|FG001|Overall Study|Lost to Follow-up|1|||
148782433|NCT05153148|536677500|FG002|Overall Study|Lost to Follow-up|2|||
148782434|NCT05153148|536677501|FG003|Overall Study|Lost to Follow-up|0|||
148782435|NCT05153148|536677498|FG000|Overall Study|Withdrawal by Subject|6|||
148782436|NCT05153148|536677499|FG001|Overall Study|Withdrawal by Subject|8|||
148782437|NCT05153148|536677500|FG002|Overall Study|Withdrawal by Subject|6|||
148782438|NCT05153148|536677501|FG003|Overall Study|Withdrawal by Subject|8|||
148782439|NCT05153148|536677498|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
148782440|NCT05153148|536677499|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
148782441|NCT05153148|536677500|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
148782442|NCT05153148|536677501|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
148782443|NCT05153148|536677498|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
148782444|NCT05153148|536677499|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
148782445|NCT05153148|536677500|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
148782446|NCT05153148|536677501|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
148782447|NCT05153148|536677498|FG000|Overall Study|Reason not Specified|1|||
148782448|NCT05153148|536677499|FG001|Overall Study|Reason not Specified|1|||
148782449|NCT05153148|536677500|FG002|Overall Study|Reason not Specified|1|||
148782450|NCT05153148|536677501|FG003|Overall Study|Reason not Specified|1|||
148782451|NCT01712334|536677502|FG000|Treatment Period 1|Randomized in Error|0|||
148782452|NCT01712334|536677503|FG001|Treatment Period 1|Randomized in Error|2|||
148782453|NCT00232596|536677504|FG000|6-Week Titration Phase|Adverse Event|6|||
148782454|NCT00232596|536677505|FG001|6-Week Titration Phase|Adverse Event|19|||
148782455|NCT00232596|536677504|FG000|6-Week Titration Phase|Failed to Return|2|||
148782456|NCT00232596|536677505|FG001|6-Week Titration Phase|Failed to Return|1|||
148782457|NCT00232596|536677504|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
148782458|NCT00232596|536677505|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
148782459|NCT00232596|536677504|FG000|6-Week Titration Phase|Protocol Violation|1|||
148782460|NCT00232596|536677505|FG001|6-Week Titration Phase|Protocol Violation|3|||
148782461|NCT00232596|536677504|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
148782462|NCT00232596|536677505|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
148782463|NCT00232596|536677504|FG000|6-Week Titration Phase|Other|3|||
148782464|NCT00232596|536677505|FG001|6-Week Titration Phase|Other|3|||
148782465|NCT00232596|536677504|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
148782466|NCT00232596|536677505|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
149011086|NCT01036022|537519929|FG001|Overall Study|Adverse Event|3|||
148782467|NCT00232596|536677504|FG000|12-Week Maintenance Phase|Adverse Event|7|||
148782468|NCT00232596|536677505|FG001|12-Week Maintenance Phase|Adverse Event|22|||
148782469|NCT00232596|536677504|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
148782470|NCT00232596|536677505|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
149011087|NCT01036022|537519930|FG002|Overall Study|Adverse Event|2|||
149011088|NCT01036022|537519931|FG003|Overall Study|Adverse Event|1|||
149011089|NCT01036022|537519932|FG004|Overall Study|Adverse Event|0|||
148782471|NCT00232596|536677504|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
148782472|NCT00232596|536677505|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
148782473|NCT00232596|536677504|FG000|12-Week Maintenance Phase|Other|1|||
148782474|NCT00232596|536677505|FG001|12-Week Maintenance Phase|Other|3|||
148782475|NCT01253174|536677506|FG000|Period 1|Randomized but not treated|0|||
148782476|NCT01253174|536677507|FG001|Period 1|Randomized but not treated|1|||
148782477|NCT01253174|536677508|FG002|Period 1|Randomized but not treated|1|||
148782478|NCT01253174|536677509|FG003|Period 1|Randomized but not treated|0|||
148782479|NCT01253174|536677510|FG004|Period 1|Randomized but not treated|1|||
148782480|NCT01253174|536677511|FG005|Period 1|Randomized but not treated|0|||
148782481|NCT01253174|536677506|FG000|Period 2|Adverse Event|0|||
148782482|NCT01253174|536677507|FG001|Period 2|Adverse Event|0|||
148782483|NCT01253174|536677508|FG002|Period 2|Adverse Event|1|||
148782484|NCT01253174|536677509|FG003|Period 2|Adverse Event|0|||
148782485|NCT01253174|536677510|FG004|Period 2|Adverse Event|0|||
148782486|NCT01253174|536677511|FG005|Period 2|Adverse Event|0|||
148782487|NCT01253174|536677506|FG000|Period 3|Withdrawal by Subject|0|||
148782488|NCT01253174|536677507|FG001|Period 3|Withdrawal by Subject|1|||
148782489|NCT01253174|536677508|FG002|Period 3|Withdrawal by Subject|0|||
148782490|NCT01253174|536677509|FG003|Period 3|Withdrawal by Subject|0|||
148782491|NCT01253174|536677510|FG004|Period 3|Withdrawal by Subject|1|||
148782492|NCT01253174|536677511|FG005|Period 3|Withdrawal by Subject|0|||
148782493|NCT01253174|536677506|FG000|Period 3|Pregnancy|0|||
148782494|NCT01253174|536677507|FG001|Period 3|Pregnancy|0|||
148782495|NCT01253174|536677508|FG002|Period 3|Pregnancy|1|||
148782496|NCT01253174|536677509|FG003|Period 3|Pregnancy|0|||
148782497|NCT01253174|536677510|FG004|Period 3|Pregnancy|0|||
148782498|NCT01253174|536677511|FG005|Period 3|Pregnancy|0|||
148782499|NCT02267135|536677512|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
148782500|NCT02267135|536677513|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
148782501|NCT02267135|536677512|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
148782502|NCT02267135|536677513|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
148782503|NCT02267135|536677512|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
148782504|NCT02267135|536677513|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
148782505|NCT02267135|536677512|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
148782506|NCT02267135|536677513|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
149011090|NCT01036022|537519933|FG005|Overall Study|Adverse Event|2|||
149011091|NCT01036022|537519928|FG000|Overall Study|Lack of Efficacy|1|||
149011092|NCT01036022|537519929|FG001|Overall Study|Lack of Efficacy|1|||
149011093|NCT01036022|537519930|FG002|Overall Study|Lack of Efficacy|1|||
149011094|NCT01036022|537519931|FG003|Overall Study|Lack of Efficacy|0|||
149011095|NCT01036022|537519932|FG004|Overall Study|Lack of Efficacy|1|||
149011096|NCT01036022|537519933|FG005|Overall Study|Lack of Efficacy|1|||
149011097|NCT01036022|537519928|FG000|Overall Study|Physician Decision|0|||
149011098|NCT01036022|537519929|FG001|Overall Study|Physician Decision|0|||
149011099|NCT01036022|537519930|FG002|Overall Study|Physician Decision|1|||
149011100|NCT01036022|537519931|FG003|Overall Study|Physician Decision|0|||
149011101|NCT01036022|537519932|FG004|Overall Study|Physician Decision|0|||
149011102|NCT01036022|537519933|FG005|Overall Study|Physician Decision|0|||
149011103|NCT01036022|537519928|FG000|Overall Study|Withdrawal by Subject|0|||
149011104|NCT01036022|537519929|FG001|Overall Study|Withdrawal by Subject|0|||
149011105|NCT01036022|537519930|FG002|Overall Study|Withdrawal by Subject|0|||
149011106|NCT01036022|537519931|FG003|Overall Study|Withdrawal by Subject|1|||
149011107|NCT01036022|537519932|FG004|Overall Study|Withdrawal by Subject|2|||
149011108|NCT01036022|537519933|FG005|Overall Study|Withdrawal by Subject|0|||
149011109|NCT04395183|537519938|FG000|Overall Study|Withdrawal by Subject|1|||
149011110|NCT04395183|537519939|FG001|Overall Study|Withdrawal by Subject|0|||
149011111|NCT04395183|537519940|FG002|Overall Study|Withdrawal by Subject|2|||
149011112|NCT04395183|537519941|FG003|Overall Study|Withdrawal by Subject|2|||
149011113|NCT01008475|537519942|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
148782507|NCT02267135|536677512|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
148782508|NCT02267135|536677513|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
148782509|NCT00900731|536677514|FG000|Overall Study|Adverse Event|31|||
148782510|NCT00900731|536677515|FG001|Overall Study|Adverse Event|27|||
148782511|NCT00900731|536677514|FG000|Overall Study|Withdrawal by Subject|8|||
148782512|NCT00900731|536677515|FG001|Overall Study|Withdrawal by Subject|7|||
148782513|NCT00900731|536677514|FG000|Overall Study|Protocol Deviation|8|||
148782514|NCT00900731|536677515|FG001|Overall Study|Protocol Deviation|11|||
148782515|NCT00900731|536677514|FG000|Overall Study|Administrative Problems|5|||
149011114|NCT01008475|537519943|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
149011115|NCT01008475|537519944|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
149011116|NCT01008475|537519945|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
149011117|NCT01008475|537519946|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
149011118|NCT01008475|537519947|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
149011119|NCT01008475|537519948|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
149011120|NCT02668016|537519949|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
149011121|NCT02668016|537519949|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
149011122|NCT02668016|537519949|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
149011123|NCT02668016|537519949|FG000|Month 4|Withdrawal due to severe symptoms|1|||
149011124|NCT02668016|537519949|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
149011125|NCT02668016|537519949|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
149011126|NCT02668016|537519949|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
149011127|NCT02668016|537519949|FG000|Month 6|Withdrawal due to severe symptoms|2|||
149011128|NCT02668016|537519949|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
149011129|NCT02668016|537519949|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
149011130|NCT02668016|537519949|FG000|Month 8|Withdrawal due to severe symptoms|1|||
149011131|NCT02668016|537519949|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
149011132|NCT02668016|537519949|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
149011133|NCT02668016|537519949|FG000|Month 10|Withdrawal due to severe symptoms|1|||
149011134|NCT02668016|537519949|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
149011135|NCT01657266|537519952|FG000|Overall Study|Lost to Follow-up|2|||
149011136|NCT01657266|537519953|FG001|Overall Study|Lost to Follow-up|2|||
149011137|NCT01657266|537519952|FG000|Overall Study|Adverse Event|2|||
149121213|NCT02680002|537921579|FG002|Overall Study|Withdrawal by Subject|1|||
149121214|NCT02680002|537921580|FG003|Overall Study|Withdrawal by Subject|0|||
149121215|NCT02680002|537921581|FG004|Overall Study|Withdrawal by Subject|2|||
149121216|NCT02680002|537921582|FG005|Overall Study|Withdrawal by Subject|2|||
148782516|NCT00900731|536677515|FG001|Overall Study|Administrative Problems|4|||
148782517|NCT00900731|536677514|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
148782518|NCT00900731|536677515|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
148782519|NCT00900731|536677514|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
148782520|NCT00900731|536677515|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
148782521|NCT00900731|536677514|FG000|Overall Study|Lost to Follow-up|2|||
148782522|NCT00900731|536677515|FG001|Overall Study|Lost to Follow-up|3|||
148782523|NCT00900731|536677514|FG000|Overall Study|Lack of Efficacy|1|||
148782524|NCT00900731|536677515|FG001|Overall Study|Lack of Efficacy|3|||
148782525|NCT00900731|536677514|FG000|Overall Study|Death|0|||
148782526|NCT00900731|536677515|FG001|Overall Study|Death|2|||
148782527|NCT03806231|536677516|FG000|Overall Study|Physician Decision|1|||
148782528|NCT03806231|536677517|FG001|Overall Study|Physician Decision|0|||
148782529|NCT03806231|536677516|FG000|Overall Study|Withdrawal by Subject|1|||
148782530|NCT03806231|536677517|FG001|Overall Study|Withdrawal by Subject|0|||
148782531|NCT02919267|536677518|FG000|Overall Study|Protocol Violation|0|||
148782532|NCT02919267|536677519|FG001|Overall Study|Protocol Violation|3|||
148782533|NCT02919267|536677520|FG002|Overall Study|Protocol Violation|3|||
148782534|NCT02919267|536677521|FG003|Overall Study|Protocol Violation|4|||
148782535|NCT03467763|536677522|FG000|Overall Study|Lost to Follow-up|1|||
148782536|NCT03467763|536677522|FG000|Overall Study|Protocol Violation|2|||
148782537|NCT04608344|536677525|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
148782538|NCT04608344|536677526|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
148782539|NCT04608344|536677525|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
148782540|NCT04608344|536677526|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
148782541|NCT00131365|536677527|FG000|Overall Study|Withdrawal by Subject|1|||
148782542|NCT00131365|536677527|FG000|Overall Study|Alternative treatment|3|||
148782543|NCT02908074|536677528|FG000|Overall Study|sponsor/ICON decision|0|||
148782544|NCT02908074|536677529|FG001|Overall Study|sponsor/ICON decision|0|||
148782545|NCT02908074|536677530|FG002|Overall Study|sponsor/ICON decision|1|||
148782546|NCT02908074|536677531|FG003|Overall Study|sponsor/ICON decision|0|||
148782547|NCT02908074|536677532|FG004|Overall Study|sponsor/ICON decision|0|||
148782548|NCT02908074|536677533|FG005|Overall Study|sponsor/ICON decision|0|||
148782549|NCT02908074|536677528|FG000|Overall Study|Protocol Violation|0|||
148782550|NCT02908074|536677529|FG001|Overall Study|Protocol Violation|1|||
148782551|NCT02908074|536677530|FG002|Overall Study|Protocol Violation|0|||
149011138|NCT01657266|537519953|FG001|Overall Study|Adverse Event|3|||
149011139|NCT02969525|537519962|FG000|Double-Blind Period|Adverse Event|0|||
149011140|NCT02969525|537519963|FG001|Double-Blind Period|Adverse Event|0|||
149121217|NCT02680002|537921577|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
148782552|NCT02908074|536677531|FG003|Overall Study|Protocol Violation|0|||
148782553|NCT02908074|536677532|FG004|Overall Study|Protocol Violation|0|||
148782554|NCT02908074|536677533|FG005|Overall Study|Protocol Violation|0|||
148782555|NCT02908074|536677528|FG000|Overall Study|Adverse Event|5|||
149011141|NCT02969525|537519964|FG002|Double-Blind Period|Adverse Event|1|||
149011142|NCT02969525|537519965|FG003|Double-Blind Period|Adverse Event|1|||
149011143|NCT02969525|537519966|FG004|Double-Blind Period|Adverse Event|0|||
149011144|NCT02969525|537519967|FG005|Double-Blind Period|Adverse Event|0|||
149011145|NCT02969525|537519968|FG006|Double-Blind Period|Adverse Event|0|||
149011146|NCT02969525|537519969|FG007|Double-Blind Period|Adverse Event|0|||
149011147|NCT02969525|537519970|FG008|Double-Blind Period|Adverse Event|0|||
149011148|NCT02969525|537519971|FG009|Double-Blind Period|Adverse Event|0|||
149011149|NCT02969525|537519972|FG010|Double-Blind Period|Adverse Event|0|||
149011150|NCT02969525|537519973|FG011|Double-Blind Period|Adverse Event|0|||
149011151|NCT02969525|537519962|FG000|Double-Blind Period|LOW EGFR|0|||
149011152|NCT02969525|537519963|FG001|Double-Blind Period|LOW EGFR|0|||
149011153|NCT02969525|537519964|FG002|Double-Blind Period|LOW EGFR|0|||
149011154|NCT02969525|537519965|FG003|Double-Blind Period|LOW EGFR|1|||
149011155|NCT02969525|537519966|FG004|Double-Blind Period|LOW EGFR|0|||
149011156|NCT02969525|537519967|FG005|Double-Blind Period|LOW EGFR|0|||
149121218|NCT02680002|537921578|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
149121219|NCT02680002|537921579|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
149121220|NCT02680002|537921580|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
149121221|NCT02680002|537921581|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
149121222|NCT02680002|537921582|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
149121223|NCT02680002|537921577|FG000|Overall Study|Other|0|||
149121224|NCT02680002|537921578|FG001|Overall Study|Other|1|||
149011157|NCT02969525|537519968|FG006|Double-Blind Period|LOW EGFR|0|||
149011158|NCT02969525|537519969|FG007|Double-Blind Period|LOW EGFR|0|||
149011159|NCT02969525|537519970|FG008|Double-Blind Period|LOW EGFR|0|||
149011160|NCT02969525|537519971|FG009|Double-Blind Period|LOW EGFR|0|||
149011161|NCT02969525|537519972|FG010|Double-Blind Period|LOW EGFR|0|||
149011162|NCT02969525|537519973|FG011|Double-Blind Period|LOW EGFR|0|||
149011163|NCT02969525|537519962|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
149011164|NCT02969525|537519963|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011165|NCT02969525|537519964|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011166|NCT02969525|537519965|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
149011167|NCT02969525|537519966|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011168|NCT02969525|537519967|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011169|NCT02969525|537519968|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011170|NCT02969525|537519969|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011171|NCT02969525|537519970|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011172|NCT02969525|537519971|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011173|NCT02969525|537519972|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011174|NCT02969525|537519973|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
149011175|NCT02969525|537519962|FG000|Dose-Blind Period|Adverse Event|0|||
149011176|NCT02969525|537519963|FG001|Dose-Blind Period|Adverse Event|0|||
149011177|NCT02969525|537519964|FG002|Dose-Blind Period|Adverse Event|0|||
149011178|NCT02969525|537519965|FG003|Dose-Blind Period|Adverse Event|0|||
149011179|NCT02969525|537519966|FG004|Dose-Blind Period|Adverse Event|0|||
149011180|NCT02969525|537519967|FG005|Dose-Blind Period|Adverse Event|0|||
149011181|NCT02969525|537519968|FG006|Dose-Blind Period|Adverse Event|0|||
149011182|NCT02969525|537519969|FG007|Dose-Blind Period|Adverse Event|0|||
149011183|NCT02969525|537519970|FG008|Dose-Blind Period|Adverse Event|0|||
149011184|NCT02969525|537519971|FG009|Dose-Blind Period|Adverse Event|1|||
149011185|NCT02969525|537519972|FG010|Dose-Blind Period|Adverse Event|1|||
149011186|NCT02969525|537519973|FG011|Dose-Blind Period|Adverse Event|1|||
149011187|NCT02969525|537519962|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
149011188|NCT02969525|537519963|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
149011189|NCT02969525|537519964|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
149011190|NCT02969525|537519965|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
149011191|NCT02969525|537519966|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
149011192|NCT02969525|537519967|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
149011193|NCT02969525|537519968|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
149011194|NCT02969525|537519969|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
149011195|NCT02969525|537519970|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
149011196|NCT02969525|537519971|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
149011197|NCT02969525|537519972|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
149011198|NCT02969525|537519973|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
149011199|NCT02969525|537519962|FG000|Dose-Blind Period|Non-cooperating patient|0|||
149011200|NCT02969525|537519963|FG001|Dose-Blind Period|Non-cooperating patient|0|||
149011201|NCT02969525|537519964|FG002|Dose-Blind Period|Non-cooperating patient|0|||
149011202|NCT02969525|537519965|FG003|Dose-Blind Period|Non-cooperating patient|0|||
149011203|NCT02969525|537519966|FG004|Dose-Blind Period|Non-cooperating patient|0|||
149011204|NCT02969525|537519967|FG005|Dose-Blind Period|Non-cooperating patient|0|||
149011205|NCT02969525|537519968|FG006|Dose-Blind Period|Non-cooperating patient|0|||
149011206|NCT02969525|537519969|FG007|Dose-Blind Period|Non-cooperating patient|0|||
149011207|NCT02969525|537519970|FG008|Dose-Blind Period|Non-cooperating patient|0|||
149011208|NCT02969525|537519971|FG009|Dose-Blind Period|Non-cooperating patient|0|||
149011209|NCT02969525|537519972|FG010|Dose-Blind Period|Non-cooperating patient|0|||
149011210|NCT02969525|537519973|FG011|Dose-Blind Period|Non-cooperating patient|1|||
149011211|NCT02969525|537519962|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011212|NCT02969525|537519963|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011213|NCT02969525|537519964|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011214|NCT02969525|537519965|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011215|NCT02969525|537519966|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011216|NCT02969525|537519967|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011217|NCT02969525|537519968|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011218|NCT02969525|537519969|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011219|NCT02969525|537519970|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011220|NCT02969525|537519971|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011221|NCT02969525|537519972|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
149011222|NCT02969525|537519973|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
149011223|NCT03445065|537519974|FG000|Overall Study|Withdrawal by Subject|3|||
149011224|NCT03445065|537519975|FG001|Overall Study|Withdrawal by Subject|6|||
149011225|NCT03445065|537519976|FG002|Overall Study|Withdrawal by Subject|2|||
149011226|NCT03445065|537519977|FG003|Overall Study|Withdrawal by Subject|2|||
149011227|NCT03445065|537519974|FG000|Overall Study|Other|4|||
149011228|NCT03445065|537519975|FG001|Overall Study|Other|3|||
149011229|NCT03445065|537519976|FG002|Overall Study|Other|3|||
149011230|NCT03445065|537519977|FG003|Overall Study|Other|1|||
149011231|NCT02089230|537519978|FG000|Overall Study|Death|0|||
149011232|NCT02089230|537519979|FG001|Overall Study|Death|0|||
149011233|NCT02089230|537519980|FG002|Overall Study|Death|2|||
149011234|NCT02089230|537519978|FG000|Overall Study|Seeking Alternative Therapy|0|||
149011235|NCT02089230|537519979|FG001|Overall Study|Seeking Alternative Therapy|0|||
149011236|NCT02089230|537519980|FG002|Overall Study|Seeking Alternative Therapy|4|||
149011237|NCT01598298|537519981|FG000|Overall Study|Not eligible|5|||
149011238|NCT01598298|537519982|FG001|Overall Study|Not eligible|5|||
149011239|NCT01598298|537519981|FG000|Overall Study|Adverse Event|21|||
149011240|NCT01598298|537519982|FG001|Overall Study|Adverse Event|19|||
149011241|NCT01598298|537519981|FG000|Overall Study|Progression/relapse|0|||
149011242|NCT01598298|537519982|FG001|Overall Study|Progression/relapse|2|||
149011243|NCT01598298|537519981|FG000|Overall Study|Withdrawal by Subject|10|||
149011244|NCT01598298|537519982|FG001|Overall Study|Withdrawal by Subject|15|||
149011245|NCT01598298|537519981|FG000|Overall Study|Other reason (not protocol specified)|4|||
149011246|NCT01598298|537519982|FG001|Overall Study|Other reason (not protocol specified)|0|||
149011247|NCT00976482|537521410|FG000|Overall Study|Death|208|||
149011248|NCT00976482|537521410|FG000|Overall Study|Withdrawal by Subject|45|||
149011249|NCT00976482|537521410|FG000|Overall Study|Center terminated|1|||
149011250|NCT00976482|537521410|FG000|Overall Study|Protocol Violation|5|||
149011251|NCT03462706|537521413|FG000|Overall Study|Polyp was pedunculated|1|||
149011252|NCT03462706|537521414|FG001|Overall Study|Polyp was pedunculated|0|||
149011253|NCT03462706|537521415|FG002|Overall Study|Polyp was pedunculated|1|||
149011254|NCT03462706|537521416|FG003|Overall Study|Polyp was pedunculated|0|||
149011255|NCT03462706|537521413|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
149011256|NCT03462706|537521414|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
149011257|NCT03462706|537521415|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
149011258|NCT03462706|537521416|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
149011259|NCT01161472|537521422|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
149011260|NCT01161472|537521423|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
149011261|NCT01161472|537521424|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
149011262|NCT01161472|537521425|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
149011263|NCT02914184|537521426|FG000|Overall Study|Lost to Follow-up|7|||
149011264|NCT02914184|537521427|FG001|Overall Study|Lost to Follow-up|10|||
149011265|NCT02914184|537521428|FG002|Overall Study|Lost to Follow-up|8|||
149011266|NCT02914184|537521429|FG003|Overall Study|Lost to Follow-up|7|||
149011267|NCT02914184|537521426|FG000|Overall Study|Withdrawal by Subject|4|||
149011268|NCT02914184|537521427|FG001|Overall Study|Withdrawal by Subject|2|||
149011269|NCT02914184|537521428|FG002|Overall Study|Withdrawal by Subject|7|||
149011270|NCT02914184|537521429|FG003|Overall Study|Withdrawal by Subject|3|||
149011271|NCT02914184|537521426|FG000|Overall Study|Other|1|||
149011272|NCT02914184|537521427|FG001|Overall Study|Other|0|||
149011273|NCT02914184|537521428|FG002|Overall Study|Other|0|||
149011274|NCT02914184|537521429|FG003|Overall Study|Other|0|||
149011275|NCT02914184|537521426|FG000|Overall Study|Migrated/moved from the study area|2|||
149011276|NCT02914184|537521427|FG001|Overall Study|Migrated/moved from the study area|1|||
149011277|NCT02914184|537521428|FG002|Overall Study|Migrated/moved from the study area|2|||
149011278|NCT02914184|537521429|FG003|Overall Study|Migrated/moved from the study area|1|||
149011279|NCT00798174|537521430|FG000|Overall Study|inability to implant azygos coil|3|||
149011280|NCT00798174|537521431|FG001|Overall Study|inability to implant azygos coil|3|||
149011281|NCT00798174|537521430|FG000|Overall Study|Inability to sedate for DFT testing|1|||
149011282|NCT00798174|537521431|FG001|Overall Study|Inability to sedate for DFT testing|0|||
149011283|NCT00802659|537521432|FG000|Overall Study|Physician Decision|0|||
149011284|NCT00802659|537521433|FG001|Overall Study|Physician Decision|1|||
149011285|NCT00802659|537521434|FG002|Overall Study|Physician Decision|0|||
149011286|NCT00802659|537521435|FG003|Overall Study|Physician Decision|0|||
149011287|NCT03093428|537521436|FG000|Overall Study|Not eligible for treatment|2|||
149011288|NCT03093428|537521437|FG001|Overall Study|Not eligible for treatment|1|||
149011289|NCT03093428|537521436|FG000|Overall Study|Progression|14|||
149011290|NCT03093428|537521437|FG001|Overall Study|Progression|4|||
149011291|NCT03093428|537521436|FG000|Overall Study|Death|1|||
149011292|NCT03093428|537521437|FG001|Overall Study|Death|0|||
149011293|NCT03093428|537521436|FG000|Overall Study|Adverse Event|1|||
149011294|NCT03093428|537521437|FG001|Overall Study|Adverse Event|0|||
149011295|NCT03093428|537521436|FG000|Overall Study|Withdrawal by Subject|1|||
149011296|NCT03093428|537521437|FG001|Overall Study|Withdrawal by Subject|1|||
149011297|NCT00284089|537521441|FG000|Multiple Dose Phase|Adverse Event|1|||
149011298|NCT00284089|537521442|FG001|Multiple Dose Phase|Adverse Event|0|||
149011299|NCT00284089|537521443|FG002|Multiple Dose Phase|Adverse Event|1|||
149011300|NCT00284089|537521444|FG003|Multiple Dose Phase|Adverse Event|1|||
149011301|NCT00284089|537521441|FG000|Multiple Dose Phase|Protocol Violation|0|||
149011302|NCT00284089|537521442|FG001|Multiple Dose Phase|Protocol Violation|0|||
149011303|NCT00284089|537521443|FG002|Multiple Dose Phase|Protocol Violation|1|||
149011304|NCT00284089|537521444|FG003|Multiple Dose Phase|Protocol Violation|0|||
149011305|NCT00284089|537521441|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
149011306|NCT00284089|537521442|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
149011307|NCT00284089|537521443|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
149011308|NCT00284089|537521444|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
149011309|NCT00284089|537521441|FG000|Multiple Dose Phase|Death|0|||
149011310|NCT00284089|537521442|FG001|Multiple Dose Phase|Death|0|||
149011311|NCT00284089|537521443|FG002|Multiple Dose Phase|Death|1|||
149011312|NCT00284089|537521444|FG003|Multiple Dose Phase|Death|1|||
149011313|NCT00284089|537521441|FG000|Extension Phase|Adverse Event|0|||
149011314|NCT00284089|537521442|FG001|Extension Phase|Adverse Event|0|||
149011315|NCT00284089|537521443|FG002|Extension Phase|Adverse Event|2|||
149011316|NCT00284089|537521444|FG003|Extension Phase|Adverse Event|2|||
149011317|NCT00284089|537521441|FG000|Extension Phase|condition no longer requires study drug|2|||
149011318|NCT00284089|537521442|FG001|Extension Phase|condition no longer requires study drug|0|||
149011319|NCT00284089|537521443|FG002|Extension Phase|condition no longer requires study drug|2|||
149011320|NCT00284089|537521444|FG003|Extension Phase|condition no longer requires study drug|7|||
149011321|NCT00284089|537521441|FG000|Extension Phase|Protocol Violation|0|||
149011322|NCT00284089|537521442|FG001|Extension Phase|Protocol Violation|0|||
149011323|NCT00284089|537521443|FG002|Extension Phase|Protocol Violation|1|||
149011324|NCT00284089|537521444|FG003|Extension Phase|Protocol Violation|0|||
149011325|NCT00284089|537521441|FG000|Extension Phase|Withdrawal by Subject|0|||
149011326|NCT00284089|537521442|FG001|Extension Phase|Withdrawal by Subject|0|||
149011327|NCT00284089|537521443|FG002|Extension Phase|Withdrawal by Subject|1|||
149011328|NCT00284089|537521444|FG003|Extension Phase|Withdrawal by Subject|3|||
149011329|NCT00089895|537521445|FG000|Overall Study|Consent Withdrawn|11|||
149011330|NCT00089895|537521446|FG001|Overall Study|Consent Withdrawn|14|||
149011331|NCT00089895|537521445|FG000|Overall Study|Technical reason|7|||
149011332|NCT00089895|537521446|FG001|Overall Study|Technical reason|2|||
149011333|NCT00089895|537521445|FG000|Overall Study|Surgery|0|||
149011334|NCT00089895|537521446|FG001|Overall Study|Surgery|1|||
149011335|NCT00089895|537521445|FG000|Overall Study|Bleeding|0|||
149011336|NCT00089895|537521446|FG001|Overall Study|Bleeding|2|||
149011337|NCT00089895|537521445|FG000|Overall Study|Physician Decision|3|||
149011338|NCT00089895|537521446|FG001|Overall Study|Physician Decision|7|||
149121225|NCT02680002|537921579|FG002|Overall Study|Other|0|||
149121226|NCT02680002|537921580|FG003|Overall Study|Other|0|||
149011339|NCT00089895|537521445|FG000|Overall Study|Exclusion criteria met|6|||
149121227|NCT02680002|537921581|FG004|Overall Study|Other|1|||
149011340|NCT00089895|537521446|FG001|Overall Study|Exclusion criteria met|6|||
149011341|NCT00089895|537521445|FG000|Overall Study|Not otherwise specified|4|||
149011342|NCT00089895|537521446|FG001|Overall Study|Not otherwise specified|8|||
149011343|NCT00089895|537521445|FG000|Overall Study|Missing|4|||
149011344|NCT00089895|537521446|FG001|Overall Study|Missing|2|||
149011345|NCT01013792|537521447|FG000|Overall Study|Study suspended|2|||
149011346|NCT01013792|537521448|FG001|Overall Study|Study suspended|1|||
149011347|NCT01013792|537521447|FG000|Overall Study|Adverse Event|0|||
149011348|NCT01013792|537521448|FG001|Overall Study|Adverse Event|3|||
149011349|NCT01013792|537521447|FG000|Overall Study|Lost to Follow-up|0|||
149011350|NCT01013792|537521448|FG001|Overall Study|Lost to Follow-up|1|||
149011351|NCT02100722|537521449|FG000|Overall Study|Withdrawal pre-procedure|4|||
149011352|NCT02100722|537521450|FG001|Overall Study|Withdrawal pre-procedure|9|||
149011353|NCT02100722|537521449|FG000|Overall Study|Withdrawal post-procedure|0|||
149121228|NCT02680002|537921582|FG005|Overall Study|Other|0|||
149011354|NCT02100722|537521450|FG001|Overall Study|Withdrawal post-procedure|3|||
149011355|NCT02100722|537521449|FG000|Overall Study|Lost to Follow-up|2|||
149011356|NCT02100722|537521450|FG001|Overall Study|Lost to Follow-up|2|||
149011357|NCT02100722|537521449|FG000|Overall Study|Continuing on study|751|||
149011358|NCT02100722|537521450|FG001|Overall Study|Continuing on study|729|||
149011359|NCT02541383|537521453|FG000|Overall Study|Death|50|||
149011360|NCT02541383|537521454|FG001|Overall Study|Death|37|||
149011361|NCT02541383|537521455|FG002|Overall Study|Death|48|||
149011362|NCT02541383|537521456|FG003|Overall Study|Death|41|||
149011363|NCT02541383|537521457|FG004|Overall Study|Death|21|||
149011364|NCT02541383|537521458|FG005|Overall Study|Death|25|||
149011365|NCT02541383|537521453|FG000|Overall Study|Lost to Follow-up|5|||
149011366|NCT02541383|537521454|FG001|Overall Study|Lost to Follow-up|3|||
149011367|NCT02541383|537521455|FG002|Overall Study|Lost to Follow-up|1|||
149011368|NCT02541383|537521456|FG003|Overall Study|Lost to Follow-up|1|||
149011369|NCT02541383|537521457|FG004|Overall Study|Lost to Follow-up|3|||
149121229|NCT02680002|537921577|FG000|Overall Study|Adverse Event|0|||
149121230|NCT02680002|537921578|FG001|Overall Study|Adverse Event|0|||
149121231|NCT02680002|537921579|FG002|Overall Study|Adverse Event|0|||
149121232|NCT02680002|537921580|FG003|Overall Study|Adverse Event|0|||
149121233|NCT02680002|537921581|FG004|Overall Study|Adverse Event|1|||
149121234|NCT02680002|537921582|FG005|Overall Study|Adverse Event|2|||
149121235|NCT00759915|537921583|FG000|Overall Study|Withdrawal by Subject|1|||
149121236|NCT00759915|537921584|FG001|Overall Study|Withdrawal by Subject|0|||
149121237|NCT00759915|537921583|FG000|Overall Study|Adverse Event|0|||
149121238|NCT00759915|537921584|FG001|Overall Study|Adverse Event|1|||
149121239|NCT01227577|537921587|FG000|Overall Study|Protocol deviation|3|||
149121240|NCT01227577|537921587|FG000|Overall Study|Death|3|||
149121241|NCT01227577|537921587|FG000|Overall Study|Administrative problems|2|||
149011370|NCT02541383|537521458|FG005|Overall Study|Lost to Follow-up|0|||
149011371|NCT02541383|537521453|FG000|Overall Study|Consent withdrawn|5|||
149011372|NCT02541383|537521454|FG001|Overall Study|Consent withdrawn|6|||
149121242|NCT01227577|537921587|FG000|Overall Study|Lost to Follow-up|1|||
149121243|NCT01227577|537921587|FG000|Overall Study|Withdrawal by Subject|4|||
149121244|NCT01227577|537921587|FG000|Overall Study|Lack of Efficacy|5|||
149121245|NCT01227577|537921587|FG000|Overall Study|Adverse Event|17|||
149121246|NCT00107120|537921588|FG000|Overall Study|Adverse Event|4|||
149121247|NCT00107120|537921589|FG001|Overall Study|Adverse Event|1|||
149121248|NCT00107120|537921588|FG000|Overall Study|Lack of Efficacy|5|||
149121249|NCT00107120|537921589|FG001|Overall Study|Lack of Efficacy|5|||
149121250|NCT00107120|537921588|FG000|Overall Study|Protocol Violation|3|||
149121251|NCT00107120|537921589|FG001|Overall Study|Protocol Violation|0|||
149121252|NCT00107120|537921588|FG000|Overall Study|Withdrawal by Subject|8|||
149121253|NCT00107120|537921589|FG001|Overall Study|Withdrawal by Subject|9|||
149121254|NCT00107120|537921588|FG000|Overall Study|Lost to Follow-up|8|||
149121255|NCT00107120|537921589|FG001|Overall Study|Lost to Follow-up|6|||
149121256|NCT00107120|537921588|FG000|Overall Study|Pregnancy|0|||
149121257|NCT00107120|537921589|FG001|Overall Study|Pregnancy|1|||
149121258|NCT00107120|537921588|FG000|Overall Study|moving away from site|1|||
149121259|NCT00107120|537921589|FG001|Overall Study|moving away from site|1|||
149121260|NCT00107120|537921588|FG000|Overall Study|death of parent|0|||
149121261|NCT00107120|537921589|FG001|Overall Study|death of parent|1|||
149121262|NCT03241225|537921590|FG000|Overall Study|Lost to Follow-up|2|||
149121263|NCT03241225|537921591|FG001|Overall Study|Lost to Follow-up|1|||
149121264|NCT03241225|537921590|FG000|Overall Study|Protocol Violation|4|||
149011373|NCT02541383|537521455|FG002|Overall Study|Consent withdrawn|1|||
149011374|NCT02541383|537521456|FG003|Overall Study|Consent withdrawn|1|||
149011375|NCT02541383|537521457|FG004|Overall Study|Consent withdrawn|0|||
149011376|NCT02541383|537521458|FG005|Overall Study|Consent withdrawn|0|||
149011377|NCT02541383|537521453|FG000|Overall Study|Sponsor's decision|1|||
149011378|NCT02541383|537521454|FG001|Overall Study|Sponsor's decision|1|||
149011379|NCT02541383|537521455|FG002|Overall Study|Sponsor's decision|0|||
149011380|NCT02541383|537521456|FG003|Overall Study|Sponsor's decision|0|||
149011381|NCT02541383|537521457|FG004|Overall Study|Sponsor's decision|0|||
149011382|NCT02541383|537521458|FG005|Overall Study|Sponsor's decision|0|||
149011383|NCT05796518|537521459|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
149011384|NCT01535274|537521460|FG000|Overall Study|Determined to be ineligible|0|||
149121265|NCT03241225|537921591|FG001|Overall Study|Protocol Violation|1|||
149121266|NCT03241225|537921590|FG000|Overall Study|Withdrawal by Subject|1|||
149121267|NCT03241225|537921591|FG001|Overall Study|Withdrawal by Subject|0|||
149121268|NCT00852540|537921592|FG000|Overall Study|Adverse Event|10|||
149121269|NCT00852540|537921593|FG001|Overall Study|Adverse Event|3|||
149121270|NCT00852540|537921592|FG000|Overall Study|Lack of Efficacy|15|||
149121271|NCT00852540|537921593|FG001|Overall Study|Lack of Efficacy|3|||
149121272|NCT00852540|537921592|FG000|Overall Study|Protocol Violation|1|||
149121273|NCT00852540|537921593|FG001|Overall Study|Protocol Violation|2|||
149121274|NCT00852540|537921592|FG000|Overall Study|Lost to Follow-up|2|||
149121275|NCT00852540|537921593|FG001|Overall Study|Lost to Follow-up|3|||
149121276|NCT00852540|537921592|FG000|Overall Study|Investigator Discretion|2|||
149121277|NCT00852540|537921593|FG001|Overall Study|Investigator Discretion|3|||
149121278|NCT00852540|537921592|FG000|Overall Study|Withdrawal by Subject|3|||
149121279|NCT00852540|537921593|FG001|Overall Study|Withdrawal by Subject|1|||
149121280|NCT00852540|537921592|FG000|Overall Study|Did Not Receive Study Drug|3|||
149121281|NCT00852540|537921593|FG001|Overall Study|Did Not Receive Study Drug|3|||
149121282|NCT01639495|537921594|FG000|Overall Study|Lost to Follow-up|6|||
149121283|NCT01639495|537921594|FG000|Overall Study|Consented but didn't have study catheter|4|||
149121284|NCT01639495|537921594|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
149121285|NCT01639495|537921594|FG000|Overall Study|No radiofrequency energy applied|2|||
149121286|NCT01119105|537921595|FG000|Overall Study|Withdrawal by Subject|1|||
149121287|NCT01119105|537921596|FG001|Overall Study|Withdrawal by Subject|1|||
149121288|NCT01119105|537921597|FG002|Overall Study|Withdrawal by Subject|1|||
149121289|NCT01119105|537921595|FG000|Overall Study|Lost to Follow-up|0|||
149121290|NCT01119105|537921596|FG001|Overall Study|Lost to Follow-up|2|||
149121291|NCT01119105|537921597|FG002|Overall Study|Lost to Follow-up|5|||
149121292|NCT01119105|537921595|FG000|Overall Study|Adverse Event|1|||
149121293|NCT01119105|537921596|FG001|Overall Study|Adverse Event|0|||
149121294|NCT01119105|537921597|FG002|Overall Study|Adverse Event|1|||
149121295|NCT01119105|537921595|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
149121296|NCT01119105|537921596|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
149121297|NCT01119105|537921597|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
149121298|NCT01119105|537921595|FG000|Overall Study|Other|1|||
149121299|NCT01119105|537921596|FG001|Overall Study|Other|1|||
149121300|NCT01119105|537921597|FG002|Overall Study|Other|0|||
149121301|NCT04214600|537921600|FG000|Overall Study|Lost to Follow-up|9|||
149121302|NCT04214600|537921601|FG001|Overall Study|Lost to Follow-up|14|||
149121303|NCT02935452|537921602|FG000|Overall Study|work and life commintment|3|||
149121304|NCT02935452|537921603|FG001|Overall Study|work and life commintment|1|||
149121305|NCT01635920|537921604|FG000|Overall Study|Adverse Event|1|||
149011385|NCT01535274|537521461|FG001|Overall Study|Determined to be ineligible|1|||
149121306|NCT01635920|537921605|FG001|Overall Study|Adverse Event|0|||
148782556|NCT02908074|536677529|FG001|Overall Study|Adverse Event|2|||
148782557|NCT02908074|536677530|FG002|Overall Study|Adverse Event|0|||
148782558|NCT02908074|536677531|FG003|Overall Study|Adverse Event|0|||
148782559|NCT02908074|536677532|FG004|Overall Study|Adverse Event|1|||
149121307|NCT01635920|537921604|FG000|Overall Study|Lost to Follow-up|0|||
149121308|NCT01635920|537921605|FG001|Overall Study|Lost to Follow-up|1|||
149121309|NCT01635920|537921604|FG000|Overall Study|Subject decision|2|||
148782560|NCT02908074|536677533|FG005|Overall Study|Adverse Event|0|||
148782561|NCT02908074|536677528|FG000|Overall Study|AESI|1|||
148782562|NCT02908074|536677529|FG001|Overall Study|AESI|0|||
148782563|NCT02908074|536677530|FG002|Overall Study|AESI|1|||
148782564|NCT02908074|536677531|FG003|Overall Study|AESI|0|||
148782565|NCT02908074|536677532|FG004|Overall Study|AESI|1|||
148782566|NCT02908074|536677533|FG005|Overall Study|AESI|0|||
148782567|NCT02908074|536677528|FG000|Overall Study|Discontinuation criteria per protocol|0|||
148782568|NCT02908074|536677529|FG001|Overall Study|Discontinuation criteria per protocol|0|||
148782569|NCT02908074|536677530|FG002|Overall Study|Discontinuation criteria per protocol|1|||
148782570|NCT02908074|536677531|FG003|Overall Study|Discontinuation criteria per protocol|0|||
148782571|NCT02908074|536677532|FG004|Overall Study|Discontinuation criteria per protocol|0|||
148782572|NCT02908074|536677533|FG005|Overall Study|Discontinuation criteria per protocol|1|||
148782573|NCT02908074|536677528|FG000|Overall Study|Withdrawal by Subject|3|||
148782574|NCT02908074|536677529|FG001|Overall Study|Withdrawal by Subject|2|||
148782575|NCT02908074|536677530|FG002|Overall Study|Withdrawal by Subject|2|||
148782576|NCT02908074|536677531|FG003|Overall Study|Withdrawal by Subject|2|||
148782577|NCT02908074|536677532|FG004|Overall Study|Withdrawal by Subject|2|||
148782578|NCT02908074|536677533|FG005|Overall Study|Withdrawal by Subject|2|||
148782579|NCT02908074|536677528|FG000|Overall Study|Lost to Follow-up|0|||
148782580|NCT02908074|536677529|FG001|Overall Study|Lost to Follow-up|1|||
148782581|NCT02908074|536677530|FG002|Overall Study|Lost to Follow-up|1|||
148782582|NCT02908074|536677531|FG003|Overall Study|Lost to Follow-up|1|||
148782583|NCT02908074|536677532|FG004|Overall Study|Lost to Follow-up|0|||
148782584|NCT02908074|536677533|FG005|Overall Study|Lost to Follow-up|1|||
148782585|NCT02073565|536677534|FG000|Cohort A|Withdrawal by Subject|1|||
148782586|NCT02073565|536677535|FG001|Cohort A|Withdrawal by Subject|0|||
148782587|NCT02073565|536677534|FG000|Cohort B|Withdrawal by Subject|1|||
148782588|NCT02073565|536677535|FG001|Cohort B|Withdrawal by Subject|2|||
148782589|NCT02073565|536677534|FG000|Cohort C|Withdrawal by Subject|0|||
148782590|NCT02073565|536677535|FG001|Cohort C|Withdrawal by Subject|2|||
148782591|NCT02073565|536677534|FG000|Cohort C|Lost to Follow-up|0|||
148782592|NCT02073565|536677535|FG001|Cohort C|Lost to Follow-up|2|||
148782593|NCT02227368|536679004|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
148782594|NCT02227368|536679005|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
148782595|NCT02227368|536679004|FG000|Overall Study|Lost to Follow-up|1|||
148782596|NCT02227368|536679005|FG001|Overall Study|Lost to Follow-up|0|||
148782597|NCT02227368|536679004|FG000|Overall Study|Adverse Event|1|||
148893349|NCT00683878|537088678|FG000|Overall Study|Withdrawal by Subject|9|||
149121310|NCT01635920|537921605|FG001|Overall Study|Subject decision|0|||
149121311|NCT00686725|537921607|FG000|Overall Study|Adverse Event|1|||
149121312|NCT00686725|537921608|FG001|Overall Study|Adverse Event|1|||
149121313|NCT00686725|537921607|FG000|Overall Study|Progressive Disease|17|||
149121314|NCT00686725|537921608|FG001|Overall Study|Progressive Disease|23|||
149121315|NCT00686725|537921607|FG000|Overall Study|Lost to Follow-up|7|||
149121316|NCT00686725|537921608|FG001|Overall Study|Lost to Follow-up|5|||
149121317|NCT00686725|537921607|FG000|Overall Study|Death|6|||
149121318|NCT00686725|537921608|FG001|Overall Study|Death|3|||
149121319|NCT00686725|537921607|FG000|Overall Study|Withdrawal by Subject|13|||
149121320|NCT00686725|537921608|FG001|Overall Study|Withdrawal by Subject|4|||
149121321|NCT00686725|537921607|FG000|Overall Study|Protocol Violation|1|||
149121322|NCT00686725|537921608|FG001|Overall Study|Protocol Violation|3|||
149121323|NCT00686725|537921607|FG000|Overall Study|Other|1|||
149121324|NCT00686725|537921608|FG001|Overall Study|Other|3|||
149121325|NCT00092495|537921609|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
149121326|NCT00092495|537921610|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
149121327|NCT00092495|537921611|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149121328|NCT00092495|537921612|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
148782598|NCT02227368|536679005|FG001|Overall Study|Adverse Event|0|||
148782599|NCT02510820|536679009|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
148782600|NCT02510820|536679010|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148782601|NCT02510820|536679009|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148782602|NCT02510820|536679010|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
148782603|NCT03046056|536679011|FG000|Overall Study|Non-responder at Week 10|6|||
148782604|NCT03046056|536679012|FG001|Overall Study|Non-responder at Week 10|6|||
148782605|NCT03046056|536679013|FG002|Overall Study|Non-responder at Week 10|4|||
148782606|NCT03046056|536679011|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
148782607|NCT03046056|536679012|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
148782608|NCT03046056|536679013|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
149121329|NCT00092495|537921613|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149121330|NCT00092495|537921609|FG000|Base Study Vaccination Period|Extended|0|||
149121331|NCT00092495|537921610|FG001|Base Study Vaccination Period|Extended|0|||
149121332|NCT00092495|537921611|FG002|Base Study Vaccination Period|Extended|0|||
149121333|NCT00092495|537921612|FG003|Base Study Vaccination Period|Extended|1|||
149121334|NCT00092495|537921613|FG004|Base Study Vaccination Period|Extended|0|||
149121335|NCT00092495|537921609|FG000|Base Study Vaccination Period|*Clinical AE|1|||
149121336|NCT00092495|537921610|FG001|Base Study Vaccination Period|*Clinical AE|0|||
149121337|NCT00092495|537921611|FG002|Base Study Vaccination Period|*Clinical AE|1|||
149121338|NCT00092495|537921612|FG003|Base Study Vaccination Period|*Clinical AE|2|||
149121339|NCT00092495|537921613|FG004|Base Study Vaccination Period|*Clinical AE|0|||
149121340|NCT00092495|537921609|FG000|Base Study Vaccination Period|*Other reasons|1|||
149121341|NCT00092495|537921610|FG001|Base Study Vaccination Period|*Other reasons|0|||
149121342|NCT00092495|537921611|FG002|Base Study Vaccination Period|*Other reasons|0|||
149121343|NCT00092495|537921612|FG003|Base Study Vaccination Period|*Other reasons|1|||
149121344|NCT00092495|537921613|FG004|Base Study Vaccination Period|*Other reasons|0|||
149121345|NCT00092495|537921609|FG000|Base Study Vaccination Period|*Pregnancy|0|||
149121346|NCT00092495|537921610|FG001|Base Study Vaccination Period|*Pregnancy|2|||
149121347|NCT00092495|537921611|FG002|Base Study Vaccination Period|*Pregnancy|5|||
149121348|NCT00092495|537921612|FG003|Base Study Vaccination Period|*Pregnancy|7|||
149121349|NCT00092495|537921613|FG004|Base Study Vaccination Period|*Pregnancy|0|||
149121350|NCT00092495|537921609|FG000|Base Study Vaccination Period|Adverse Event|1|||
149121351|NCT00092495|537921610|FG001|Base Study Vaccination Period|Adverse Event|0|||
149121352|NCT00092495|537921611|FG002|Base Study Vaccination Period|Adverse Event|0|||
149121353|NCT00092495|537921612|FG003|Base Study Vaccination Period|Adverse Event|3|||
149121354|NCT00092495|537921613|FG004|Base Study Vaccination Period|Adverse Event|0|||
149121355|NCT00092495|537921609|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
149121356|NCT00092495|537921610|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
149121357|NCT00092495|537921611|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
149121358|NCT00092495|537921612|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
149121359|NCT00092495|537921613|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
149121360|NCT00092495|537921609|FG000|Base Study Vaccination Period|Moved|3|||
149121361|NCT00092495|537921610|FG001|Base Study Vaccination Period|Moved|1|||
149121362|NCT00092495|537921611|FG002|Base Study Vaccination Period|Moved|2|||
149121363|NCT00092495|537921612|FG003|Base Study Vaccination Period|Moved|2|||
149121364|NCT00092495|537921613|FG004|Base Study Vaccination Period|Moved|0|||
149121365|NCT00092495|537921609|FG000|Base Study Vaccination Period|Other|1|||
149121366|NCT00092495|537921610|FG001|Base Study Vaccination Period|Other|1|||
149121367|NCT00092495|537921611|FG002|Base Study Vaccination Period|Other|0|||
149121368|NCT00092495|537921612|FG003|Base Study Vaccination Period|Other|2|||
149121369|NCT00092495|537921613|FG004|Base Study Vaccination Period|Other|0|||
149121370|NCT00092495|537921609|FG000|Base Study Vaccination Period|Pregnancy|2|||
149121371|NCT00092495|537921610|FG001|Base Study Vaccination Period|Pregnancy|0|||
149121372|NCT00092495|537921611|FG002|Base Study Vaccination Period|Pregnancy|0|||
149121373|NCT00092495|537921612|FG003|Base Study Vaccination Period|Pregnancy|0|||
149121374|NCT00092495|537921613|FG004|Base Study Vaccination Period|Pregnancy|0|||
149121375|NCT00092495|537921609|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
149121376|NCT00092495|537921610|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
149121377|NCT00092495|537921611|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
149121378|NCT00092495|537921612|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
149121379|NCT00092495|537921613|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
149121380|NCT00092495|537921609|FG000|Base Study Vaccination Period|Protocol Violation|1|||
149121381|NCT00092495|537921610|FG001|Base Study Vaccination Period|Protocol Violation|0|||
149121382|NCT00092495|537921611|FG002|Base Study Vaccination Period|Protocol Violation|0|||
149121383|NCT00092495|537921612|FG003|Base Study Vaccination Period|Protocol Violation|0|||
149121384|NCT00092495|537921613|FG004|Base Study Vaccination Period|Protocol Violation|0|||
149121385|NCT00092495|537921609|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
149121386|NCT00092495|537921610|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
149121387|NCT00092495|537921611|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
149121388|NCT00092495|537921612|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
149121389|NCT00092495|537921613|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
149121390|NCT00092495|537921609|FG000|Base Study Follow-up Period|Extended|0|||
149121391|NCT00092495|537921610|FG001|Base Study Follow-up Period|Extended|0|||
149121392|NCT00092495|537921611|FG002|Base Study Follow-up Period|Extended|1|||
149121393|NCT00092495|537921612|FG003|Base Study Follow-up Period|Extended|2|||
149121394|NCT00092495|537921613|FG004|Base Study Follow-up Period|Extended|0|||
149121395|NCT00092495|537921609|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
149121396|NCT00092495|537921610|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
149121397|NCT00092495|537921611|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
149121398|NCT00092495|537921612|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
149121399|NCT00092495|537921613|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
149121400|NCT00092495|537921609|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
149121401|NCT00092495|537921610|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
149121402|NCT00092495|537921611|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
149121403|NCT00092495|537921612|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
149121404|NCT00092495|537921613|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
149121405|NCT04772898|537921616|FG000|Overall Study|Withdrawal by Subject|0|||
149121406|NCT04772898|537921617|FG001|Overall Study|Withdrawal by Subject|1|||
149121407|NCT01004848|537921620|FG000|Overall Study|Lost to Follow-up|55|||
149121408|NCT01004848|537921621|FG001|Overall Study|Lost to Follow-up|45|||
149121409|NCT00768079|537921622|FG000|Overall Study|Lost to Follow-up|2|||
149121410|NCT00768079|537921623|FG001|Overall Study|Lost to Follow-up|0|||
149121411|NCT00768079|537921624|FG002|Overall Study|Lost to Follow-up|4|||
149121412|NCT00768079|537921622|FG000|Overall Study|Participant incarcerated|0|||
149121413|NCT00768079|537921623|FG001|Overall Study|Participant incarcerated|1|||
149121414|NCT00768079|537921624|FG002|Overall Study|Participant incarcerated|0|||
149121415|NCT01498679|537921625|FG000|Overall Study|Adverse Event|1|||
149121416|NCT01498679|537921626|FG001|Overall Study|Adverse Event|4|||
149121417|NCT01498679|537921625|FG000|Overall Study|Lack of Efficacy|72|||
149121418|NCT01498679|537921626|FG001|Overall Study|Lack of Efficacy|12|||
149121419|NCT01498679|537921625|FG000|Overall Study|Protocol Violation|4|||
149121420|NCT01498679|537921626|FG001|Overall Study|Protocol Violation|0|||
149121421|NCT01498679|537921625|FG000|Overall Study|Physician Decision|0|||
149121422|NCT01498679|537921626|FG001|Overall Study|Physician Decision|2|||
149121423|NCT01498679|537921625|FG000|Overall Study|Withdrawal by Subject|12|||
149121424|NCT01498679|537921626|FG001|Overall Study|Withdrawal by Subject|4|||
149121425|NCT00158860|537921630|FG000|Overall Study|Adverse Event|3|||
149121426|NCT00158860|537921631|FG001|Overall Study|Adverse Event|6|||
149121427|NCT00158860|537921630|FG000|Overall Study|Lost to Follow-up|11|||
149121428|NCT00158860|537921631|FG001|Overall Study|Lost to Follow-up|17|||
149121429|NCT00158860|537921630|FG000|Overall Study|Protocol Violation|8|||
149121430|NCT00158860|537921631|FG001|Overall Study|Protocol Violation|23|||
149121431|NCT00158860|537921630|FG000|Overall Study|Withdrawal by Subject|7|||
149121432|NCT00158860|537921631|FG001|Overall Study|Withdrawal by Subject|17|||
149121433|NCT00158860|537921630|FG000|Overall Study|MOVING OUT OF STATE|1|||
149121434|NCT00158860|537921631|FG001|Overall Study|MOVING OUT OF STATE|0|||
149121435|NCT00158860|537921630|FG000|Overall Study|Pregnancy|3|||
149121436|NCT00158860|537921631|FG001|Overall Study|Pregnancy|3|||
149121437|NCT00158860|537921630|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
149121438|NCT00158860|537921631|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
149121439|NCT00158860|537921630|FG000|Overall Study|SPONSOR REQUEST|0|||
149121440|NCT00158860|537921631|FG001|Overall Study|SPONSOR REQUEST|1|||
149121441|NCT00158860|537921630|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
149121442|NCT00158860|537921631|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
149121443|NCT00158860|537921630|FG000|Overall Study|Closed per sponsor|0|||
149121444|NCT00158860|537921631|FG001|Overall Study|Closed per sponsor|1|||
149121445|NCT03047395|537921632|FG000|Overall Study|Adverse Event|142|||
149121446|NCT03047395|537921632|FG000|Overall Study|Withdrawal by Subject|155|||
149121447|NCT03047395|537921632|FG000|Overall Study|Lost to Follow-up|144|||
149121448|NCT03047395|537921632|FG000|Overall Study|COVID-19 Infection|2|||
149121449|NCT03047395|537921632|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
149121450|NCT03047395|537921632|FG000|Overall Study|Other, Not Specified|117|||
149121451|NCT01146782|537921635|FG000|Screening Cohort|Screen Failure|187|||
149121452|NCT01146782|537921635|FG000|Screening Cohort|Lost to Follow-up|4|||
149121453|NCT01146782|537921635|FG000|Screening Cohort|Physician Decision|1|||
149121454|NCT01146782|537921635|FG000|Screening Cohort|Withdrawal by Subject|29|||
149121455|NCT01146782|537921635|FG000|Safety Cohort|Screen Failure|61|||
149121456|NCT01146782|537921635|FG000|Safety Cohort|Withdrawal by Subject|4|||
149121457|NCT01146782|537921635|FG000|Safety Cohort|Control AHI <5|4|||
149121458|NCT01146782|537921635|FG000|Safety Cohort|TST <4 hrs|14|||
149121459|NCT01146782|537921635|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
149121460|NCT01146782|537921635|FG000|Primary Endpoint Cohort|Physician Decision|1|||
149121461|NCT02414932|537921636|FG000|Overall Study|Withdrawal by Subject|2|||
149121462|NCT02414932|537921637|FG001|Overall Study|Withdrawal by Subject|3|||
149121463|NCT02414932|537921636|FG000|Overall Study|Adverse Event|1|||
149121464|NCT02414932|537921637|FG001|Overall Study|Adverse Event|0|||
149121465|NCT00470366|537921638|FG000|Overall Study|Adverse Event|3|||
149121466|NCT00470366|537921638|FG000|Overall Study|Poor compliance|1|||
149121467|NCT01011387|537921639|FG000|Overall Study|Withdrawal by Subject|3|||
149121468|NCT01011387|537921639|FG000|Overall Study|Adverse Event|2|||
149121469|NCT01011387|537921639|FG000|Overall Study|Protocol Violation|1|||
149121470|NCT00438672|537921641|FG000|Overall Study|Lost to Follow-up|7|||
149121471|NCT00438672|537921642|FG001|Overall Study|Lost to Follow-up|9|||
149121472|NCT01942785|537921655|FG000|Overall Study|Adverse Event|2|||
149121473|NCT01942785|537921655|FG000|Overall Study|Withdrawal by Subject|1|||
149121474|NCT01942785|537921655|FG000|Overall Study|Protocol Violation|1|||
149121475|NCT05038163|537921659|FG000|Stage 1|Did not complete survey|374|||
149121476|NCT05038163|537921660|FG001|Stage 1|Did not complete survey|0|||
149121477|NCT05038163|537921661|FG002|Stage 1|Did not complete survey|0|||
148782609|NCT03046056|536679011|FG000|Overall Study|Adverse Event|1|||
148782610|NCT03046056|536679012|FG001|Overall Study|Adverse Event|5|||
148782611|NCT03046056|536679013|FG002|Overall Study|Adverse Event|0|||
148782612|NCT03046056|536679011|FG000|Overall Study|Non-compliance With Study Drug|0|||
148782613|NCT03046056|536679012|FG001|Overall Study|Non-compliance With Study Drug|0|||
148782614|NCT03046056|536679013|FG002|Overall Study|Non-compliance With Study Drug|2|||
148782615|NCT03046056|536679011|FG000|Overall Study|Protocol Violation|1|||
148782616|NCT03046056|536679012|FG001|Overall Study|Protocol Violation|1|||
148782617|NCT03046056|536679013|FG002|Overall Study|Protocol Violation|0|||
149121478|NCT05038163|537921662|FG003|Stage 1|Did not complete survey|0|||
148782618|NCT03046056|536679011|FG000|Overall Study|Investigator's Discretion|0|||
148782619|NCT03046056|536679012|FG001|Overall Study|Investigator's Discretion|1|||
148782620|NCT03046056|536679013|FG002|Overall Study|Investigator's Discretion|0|||
148782621|NCT03046056|536679011|FG000|Overall Study|Withdrew Consent|1|||
148782622|NCT03046056|536679012|FG001|Overall Study|Withdrew Consent|0|||
148782623|NCT03046056|536679013|FG002|Overall Study|Withdrew Consent|0|||
148782624|NCT03089853|536679014|FG000|Overall Study|Lost to Follow-up|2|||
148782625|NCT03089853|536679015|FG001|Overall Study|Lost to Follow-up|1|||
148782626|NCT00642954|536679016|FG000|Overall Study|Progressive Disease|3|||
148782627|NCT00642954|536679017|FG001|Overall Study|Progressive Disease|3|||
148782628|NCT00642954|536679018|FG002|Overall Study|Progressive Disease|3|||
148782629|NCT00642954|536679019|FG003|Overall Study|Progressive Disease|3|||
148782630|NCT00642954|536679020|FG004|Overall Study|Progressive Disease|9|||
148782631|NCT00642954|536679016|FG000|Overall Study|Withdrawal by Subject|0|||
148782632|NCT00642954|536679017|FG001|Overall Study|Withdrawal by Subject|0|||
149121479|NCT05038163|537921663|FG004|Stage 1|Did not complete survey|0|||
149121480|NCT05038163|537921664|FG005|Stage 1|Did not complete survey|0|||
149121481|NCT05038163|537921659|FG000|Stage 2|Did not complete Stage 2 survey|0|||
149121482|NCT05038163|537921660|FG001|Stage 2|Did not complete Stage 2 survey|29|||
149121483|NCT05038163|537921661|FG002|Stage 2|Did not complete Stage 2 survey|30|||
149121484|NCT05038163|537921662|FG003|Stage 2|Did not complete Stage 2 survey|24|||
149121485|NCT05038163|537921663|FG004|Stage 2|Did not complete Stage 2 survey|21|||
149121486|NCT05038163|537921664|FG005|Stage 2|Did not complete Stage 2 survey|100|||
149121487|NCT05453201|537921665|FG000|Overall Study|Withdrawal by Subject|1|||
149121488|NCT03562975|537921666|FG000|Overall Study|Death|1|||
149121489|NCT03562975|537921666|FG000|Overall Study|Lost to Follow-up|1|||
149121490|NCT03562975|537921666|FG000|Overall Study|Withdrawal by Subject|1|||
149121491|NCT01934790|537921667|FG000|Treatment|Adverse Event|3|||
148782633|NCT00642954|536679018|FG002|Overall Study|Withdrawal by Subject|0|||
148782634|NCT00642954|536679019|FG003|Overall Study|Withdrawal by Subject|0|||
148782635|NCT00642954|536679020|FG004|Overall Study|Withdrawal by Subject|1|||
149121492|NCT01934790|537921667|FG000|Treatment|Clinical progression|6|||
149121493|NCT01934790|537921667|FG000|Treatment|Radiological progression|4|||
149121494|NCT01934790|537921667|FG000|Treatment|Withdrawal by Subject|2|||
149121495|NCT01934790|537921667|FG000|Treatment|Study drug never administered|1|||
149121496|NCT01934790|537921667|FG000|Active Follow up|Death|20|||
149121497|NCT01934790|537921667|FG000|Active Follow up|Physician Decision|2|||
149121498|NCT01934790|537921667|FG000|Active Follow up|Progressive disease|1|||
149121499|NCT01934790|537921667|FG000|Active Follow up|Other reason|1|||
149121500|NCT03798691|537921670|FG000|Overall Study|Lost to Follow-up|2|||
149121501|NCT03798691|537921671|FG001|Overall Study|Lost to Follow-up|2|||
149121502|NCT00552929|537921672|FG000|Overall Study|Lost to Follow-up|0|||
149121503|NCT00552929|537921673|FG001|Overall Study|Lost to Follow-up|0|||
149121504|NCT00552929|537921674|FG002|Overall Study|Lost to Follow-up|0|||
149121505|NCT00552929|537921675|FG003|Overall Study|Lost to Follow-up|0|||
149121506|NCT00552929|537921676|FG004|Overall Study|Lost to Follow-up|0|||
149121507|NCT00552929|537921677|FG005|Overall Study|Lost to Follow-up|0|||
149121508|NCT00552929|537921678|FG006|Overall Study|Lost to Follow-up|0|||
149121509|NCT00552929|537921679|FG007|Overall Study|Lost to Follow-up|0|||
149121510|NCT00552929|537921680|FG008|Overall Study|Lost to Follow-up|1|||
149121511|NCT00552929|537921681|FG009|Overall Study|Lost to Follow-up|0|||
149121512|NCT00552929|537921672|FG000|Overall Study|Not Eligible|0|||
149121513|NCT00552929|537921673|FG001|Overall Study|Not Eligible|0|||
149121514|NCT00552929|537921674|FG002|Overall Study|Not Eligible|0|||
149121515|NCT00552929|537921675|FG003|Overall Study|Not Eligible|0|||
149121516|NCT00552929|537921676|FG004|Overall Study|Not Eligible|0|||
149121517|NCT00552929|537921677|FG005|Overall Study|Not Eligible|1|||
148782636|NCT00642954|536679016|FG000|Overall Study|Adverse Event|1|||
148782637|NCT00642954|536679017|FG001|Overall Study|Adverse Event|1|||
148782638|NCT00642954|536679018|FG002|Overall Study|Adverse Event|0|||
148782639|NCT00642954|536679019|FG003|Overall Study|Adverse Event|0|||
148782640|NCT00642954|536679020|FG004|Overall Study|Adverse Event|6|||
148782641|NCT02913105|536679021|FG000|Overall Study|Adverse Event|11|||
148782642|NCT02913105|536679022|FG001|Overall Study|Adverse Event|0|||
148782643|NCT02913105|536679023|FG002|Overall Study|Adverse Event|4|||
148782644|NCT02913105|536679021|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149121518|NCT00552929|537921678|FG006|Overall Study|Not Eligible|0|||
149121519|NCT00552929|537921679|FG007|Overall Study|Not Eligible|0|||
149121520|NCT00552929|537921680|FG008|Overall Study|Not Eligible|0|||
149121521|NCT00552929|537921681|FG009|Overall Study|Not Eligible|0|||
149121522|NCT01147536|537921692|FG000|Overall Study|Administrative study close|2|||
149121523|NCT01147536|537921692|FG000|Overall Study|Death|1|||
149121524|NCT01758900|537921695|FG000|Overall Study|difficulty for further intubation|7|||
149121525|NCT01758900|537921696|FG001|Overall Study|difficulty for further intubation|8|||
149121526|NCT00935818|537921698|FG000|Overall Study|Withdrawal by Subject|45|||
149121527|NCT00935818|537921699|FG001|Overall Study|Withdrawal by Subject|50|||
149121528|NCT00935818|537921698|FG000|Overall Study|Lost to Follow-up|40|||
149121529|NCT00935818|537921699|FG001|Overall Study|Lost to Follow-up|42|||
149121530|NCT00935818|537921698|FG000|Overall Study|Adverse Event|6|||
149121531|NCT00935818|537921699|FG001|Overall Study|Adverse Event|7|||
149121532|NCT00935818|537921698|FG000|Overall Study|Physician Decision|0|||
149121533|NCT00935818|537921699|FG001|Overall Study|Physician Decision|1|||
149121534|NCT03762200|537921700|FG000|Overall Study|Death|2|||
149121535|NCT00867308|537921703|FG000|Overall Study|Death|1|||
149121536|NCT00867308|537921704|FG001|Overall Study|Death|0|||
149121537|NCT00867308|537921703|FG000|Overall Study|Adverse Event|1|||
149121538|NCT00867308|537921704|FG001|Overall Study|Adverse Event|4|||
149121539|NCT00867308|537921703|FG000|Overall Study|Lack of Efficacy|6|||
149121540|NCT00867308|537921704|FG001|Overall Study|Lack of Efficacy|12|||
149121541|NCT00867308|537921703|FG000|Overall Study|Withdrawal by Subject|1|||
149121542|NCT00867308|537921704|FG001|Overall Study|Withdrawal by Subject|2|||
149121543|NCT00604825|537921705|FG000|Overall Study|Adverse Event|2|||
149121544|NCT00604825|537921706|FG001|Overall Study|Adverse Event|6|||
149121545|NCT00604825|537921707|FG002|Overall Study|Adverse Event|7|||
149121546|NCT00604825|537921708|FG003|Overall Study|Adverse Event|4|||
149121547|NCT00604825|537921705|FG000|Overall Study|Lost to Follow-up|0|||
149121548|NCT00604825|537921706|FG001|Overall Study|Lost to Follow-up|3|||
149121549|NCT00604825|537921707|FG002|Overall Study|Lost to Follow-up|1|||
149121550|NCT00604825|537921708|FG003|Overall Study|Lost to Follow-up|0|||
149121551|NCT00604825|537921705|FG000|Overall Study|Protocol Violation|0|||
149121552|NCT00604825|537921706|FG001|Overall Study|Protocol Violation|1|||
149121553|NCT00604825|537921707|FG002|Overall Study|Protocol Violation|0|||
149121554|NCT00604825|537921708|FG003|Overall Study|Protocol Violation|0|||
149121555|NCT00604825|537921705|FG000|Overall Study|Withdrawal by Subject|4|||
149121556|NCT00604825|537921706|FG001|Overall Study|Withdrawal by Subject|3|||
149121557|NCT00604825|537921707|FG002|Overall Study|Withdrawal by Subject|5|||
149121558|NCT00604825|537921708|FG003|Overall Study|Withdrawal by Subject|5|||
149121559|NCT00604825|537921705|FG000|Overall Study|Lack of Efficacy|3|||
149121560|NCT00604825|537921706|FG001|Overall Study|Lack of Efficacy|2|||
149121561|NCT00604825|537921707|FG002|Overall Study|Lack of Efficacy|1|||
149121562|NCT00604825|537921708|FG003|Overall Study|Lack of Efficacy|0|||
149121563|NCT00604825|537921705|FG000|Overall Study|Did not meet eligibility criteria|0|||
149121564|NCT00604825|537921706|FG001|Overall Study|Did not meet eligibility criteria|0|||
149121565|NCT00604825|537921707|FG002|Overall Study|Did not meet eligibility criteria|2|||
149121566|NCT00604825|537921708|FG003|Overall Study|Did not meet eligibility criteria|0|||
149121567|NCT00604825|537921705|FG000|Overall Study|Physician Decision|0|||
149121568|NCT00604825|537921706|FG001|Overall Study|Physician Decision|0|||
149121569|NCT00604825|537921707|FG002|Overall Study|Physician Decision|0|||
149121570|NCT00604825|537921708|FG003|Overall Study|Physician Decision|1|||
149121571|NCT00604825|537921705|FG000|Overall Study|Exclusion criterion met|0|||
149121572|NCT00604825|537921706|FG001|Overall Study|Exclusion criterion met|0|||
149121573|NCT00604825|537921707|FG002|Overall Study|Exclusion criterion met|0|||
149121574|NCT00604825|537921708|FG003|Overall Study|Exclusion criterion met|1|||
149121575|NCT05593445|537921713|FG000|12-Week DBVC Period|Adverse Event|1|||
149121576|NCT05593445|537921714|FG001|12-Week DBVC Period|Adverse Event|0|||
149121577|NCT05593445|537921715|FG002|12-Week DBVC Period|Adverse Event|0|||
149121578|NCT05593445|537921716|FG003|12-Week DBVC Period|Adverse Event|0|||
149121579|NCT05593445|537921713|FG000|12-Week DBVC Period|Physician Decision|0|||
149121580|NCT05593445|537921714|FG001|12-Week DBVC Period|Physician Decision|1|||
149121581|NCT05593445|537921715|FG002|12-Week DBVC Period|Physician Decision|0|||
149121582|NCT05593445|537921716|FG003|12-Week DBVC Period|Physician Decision|0|||
149121583|NCT05593445|537921713|FG000|12-Week DBVC Period|Protocol Violation|0|||
149121584|NCT05593445|537921714|FG001|12-Week DBVC Period|Protocol Violation|1|||
149121585|NCT05593445|537921715|FG002|12-Week DBVC Period|Protocol Violation|0|||
149121586|NCT05593445|537921716|FG003|12-Week DBVC Period|Protocol Violation|0|||
149121587|NCT05593445|537921713|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
149121588|NCT05593445|537921714|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
149121589|NCT05593445|537921715|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
149121590|NCT05593445|537921716|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
149121591|NCT05593445|537921713|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
149121592|NCT05593445|537921714|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
149121593|NCT05593445|537921715|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
149121594|NCT05593445|537921716|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
149121595|NCT05593445|537921713|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
149121596|NCT05593445|537921714|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
148782645|NCT02913105|536679022|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148782646|NCT02913105|536679023|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148782647|NCT02913105|536679021|FG000|Overall Study|Reason Not Specified|3|||
148782648|NCT02913105|536679022|FG001|Overall Study|Reason Not Specified|1|||
148782649|NCT02913105|536679023|FG002|Overall Study|Reason Not Specified|1|||
148782650|NCT02913105|536679021|FG000|Overall Study|Physician Decision|1|||
148782651|NCT02913105|536679022|FG001|Overall Study|Physician Decision|1|||
148782652|NCT02913105|536679023|FG002|Overall Study|Physician Decision|0|||
148782653|NCT02913105|536679021|FG000|Overall Study|Withdrawal by Subject|0|||
148782654|NCT02913105|536679022|FG001|Overall Study|Withdrawal by Subject|3|||
148782655|NCT02913105|536679023|FG002|Overall Study|Withdrawal by Subject|1|||
148782656|NCT01317004|536679024|FG000|Overall Study|Withdrawal by Subject|1|||
148782657|NCT01317004|536679025|FG001|Overall Study|Withdrawal by Subject|4|||
148782658|NCT01317004|536679024|FG000|Overall Study|Protocol Violation|0|||
148782659|NCT01317004|536679025|FG001|Overall Study|Protocol Violation|2|||
148782660|NCT01317004|536679024|FG000|Overall Study|Adverse Event|3|||
148782661|NCT01317004|536679025|FG001|Overall Study|Adverse Event|3|||
148782662|NCT05243563|536679026|FG000|Overall Study|Withdrawal by Subject|1|||
148782663|NCT05243563|536679027|FG001|Overall Study|Withdrawal by Subject|0|||
148782664|NCT05243563|536679026|FG000|Overall Study|Physician Decision|1|||
148782665|NCT05243563|536679027|FG001|Overall Study|Physician Decision|0|||
148782666|NCT04114656|536679028|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
148782667|NCT04114656|536679029|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
148782668|NCT04114656|536679028|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
148782669|NCT04114656|536679029|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
148782670|NCT04114656|536679028|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
148782671|NCT04114656|536679029|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
148782672|NCT04114656|536679028|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
148782673|NCT04114656|536679029|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
148782674|NCT04114656|536679028|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
148782675|NCT04114656|536679029|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
148782676|NCT02661061|536679030|FG000|Overall Study|Lack of Efficacy|1|||
148782677|NCT02661061|536679031|FG001|Overall Study|Lack of Efficacy|1|||
148782678|NCT02661061|536679030|FG000|Overall Study|Withdrawal by Subject|1|||
148782679|NCT02661061|536679031|FG001|Overall Study|Withdrawal by Subject|1|||
148782680|NCT03052920|536679032|FG000|Overall Study|Withdrawal by Subject|1|||
148782681|NCT01980628|536679033|FG000|Overall Study|Adverse Event|12|||
148782682|NCT01980628|536679033|FG000|Overall Study|Physician Decision|5|||
148782683|NCT01980628|536679033|FG000|Overall Study|Withdrawal by Subject|4|||
148782684|NCT01980628|536679033|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
148782685|NCT02578940|536679034|FG000|Overall Study|Screening failure|5|||
148782686|NCT02578940|536679034|FG000|Overall Study|Lost to Follow-up|1|||
148782687|NCT06226649|536679047|FG000|Overall Study|Withdrawal by Subject|4|||
148782688|NCT06226649|536679048|FG001|Overall Study|Withdrawal by Subject|1|||
148782689|NCT04767529|536679049|FG000|Overall Study|Adverse Event|0|||
148782690|NCT04767529|536679050|FG001|Overall Study|Adverse Event|4|||
148782691|NCT04767529|536679051|FG002|Overall Study|Adverse Event|3|||
148782692|NCT04767529|536679049|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
148782693|NCT04767529|536679050|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
148782694|NCT04767529|536679051|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
148782695|NCT04767529|536679049|FG000|Overall Study|Required use of a prohibited medication|0|||
148782696|NCT04767529|536679050|FG001|Overall Study|Required use of a prohibited medication|1|||
148782697|NCT04767529|536679051|FG002|Overall Study|Required use of a prohibited medication|0|||
148782698|NCT04767529|536679049|FG000|Overall Study|Withdrawal by Subject|7|||
148782699|NCT04767529|536679050|FG001|Overall Study|Withdrawal by Subject|5|||
148782700|NCT04767529|536679051|FG002|Overall Study|Withdrawal by Subject|4|||
148782701|NCT04767529|536679049|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
148782702|NCT04767529|536679050|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
149021124|NCT04423393|537557189|FG008|Overall Study|Sponsor Decision|0|||
149021125|NCT04423393|537557190|FG009|Overall Study|Sponsor Decision|0|||
149021126|NCT04423393|537557191|FG010|Overall Study|Sponsor Decision|0|||
149021127|NCT04423393|537557192|FG011|Overall Study|Sponsor Decision|0|||
149021128|NCT04423393|537557193|FG012|Overall Study|Sponsor Decision|0|||
149021129|NCT04423393|537557194|FG013|Overall Study|Sponsor Decision|1|||
149021130|NCT04423393|537557195|FG014|Overall Study|Sponsor Decision|0|||
149021131|NCT04423393|537557196|FG015|Overall Study|Sponsor Decision|0|||
149021132|NCT04423393|537557197|FG016|Overall Study|Sponsor Decision|0|||
149021133|NCT04423393|537557198|FG017|Overall Study|Sponsor Decision|0|||
149021134|NCT05220501|537557199|FG000|Overall Study|Withdrawal by Subject|11|||
149021135|NCT05220501|537557200|FG001|Overall Study|Withdrawal by Subject|21|||
149021136|NCT05220501|537557201|FG002|Overall Study|Withdrawal by Subject|32|||
149121597|NCT05593445|537921715|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
149121598|NCT05593445|537921716|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
149121599|NCT05593445|537921713|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
149121600|NCT05593445|537921714|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
149121601|NCT05593445|537921715|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
149121602|NCT05593445|537921716|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
149121603|NCT05593445|537921713|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
149121604|NCT05593445|537921714|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
149121605|NCT05593445|537921715|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
149121606|NCT05593445|537921716|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
149121607|NCT05559476|537921717|FG000|Overall Study|Adverse Event|2|||
149121608|NCT05559476|537921718|FG001|Overall Study|Adverse Event|0|||
149121609|NCT05559476|537921717|FG000|Overall Study|Lost to Follow-up|13|||
149121610|NCT05559476|537921718|FG001|Overall Study|Lost to Follow-up|12|||
149121611|NCT05559476|537921717|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
149121612|NCT05559476|537921718|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
149121613|NCT05559476|537921717|FG000|Overall Study|Other|0|||
149121614|NCT05559476|537921718|FG001|Overall Study|Other|2|||
149121615|NCT05110690|537921719|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
149121616|NCT05110690|537921719|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
149121617|NCT05110690|537921719|FG000|Completion of Intervention|Lost to Follow-up|1|||
149121618|NCT05110690|537921719|FG000|Completion of Intervention|Death|1|||
149121619|NCT05110690|537921719|FG000|Completion of Intervention|Withdrawal by Subject|2|||
149233794|NCT05182840|538324920|FG001|Treatment Period|No reason available|0|||
149233795|NCT05182840|538324921|FG002|Treatment Period|No reason available|0|||
149233796|NCT05182840|538324922|FG003|Treatment Period|No reason available|1|||
149233797|NCT05182840|538324923|FG004|Treatment Period|No reason available|0|||
149233798|NCT05182840|538324924|FG005|Treatment Period|No reason available|2|||
149233799|NCT05182840|538324925|FG006|Treatment Period|No reason available|0|||
149233800|NCT05182840|538324926|FG007|Treatment Period|No reason available|1|||
149233801|NCT05182840|538324927|FG008|Treatment Period|No reason available|0|||
149233802|NCT05182840|538324928|FG009|Treatment Period|No reason available|0|||
149233803|NCT05182840|538324919|FG000|Treatment Period|Burden of study procedures|0|||
149233804|NCT05182840|538324920|FG001|Treatment Period|Burden of study procedures|0|||
149233805|NCT05182840|538324921|FG002|Treatment Period|Burden of study procedures|0|||
149233806|NCT05182840|538324922|FG003|Treatment Period|Burden of study procedures|0|||
149233807|NCT05182840|538324923|FG004|Treatment Period|Burden of study procedures|1|||
149233808|NCT05182840|538324924|FG005|Treatment Period|Burden of study procedures|0|||
149233809|NCT05182840|538324925|FG006|Treatment Period|Burden of study procedures|0|||
149233810|NCT05182840|538324926|FG007|Treatment Period|Burden of study procedures|0|||
149233811|NCT05182840|538324927|FG008|Treatment Period|Burden of study procedures|0|||
149233812|NCT05182840|538324928|FG009|Treatment Period|Burden of study procedures|0|||
149233813|NCT05182840|538324919|FG000|Treatment Period|Change of residence|0|||
149233814|NCT05182840|538324920|FG001|Treatment Period|Change of residence|0|||
149233815|NCT05182840|538324921|FG002|Treatment Period|Change of residence|0|||
149233816|NCT05182840|538324922|FG003|Treatment Period|Change of residence|0|||
149233817|NCT05182840|538324923|FG004|Treatment Period|Change of residence|0|||
149233818|NCT05182840|538324924|FG005|Treatment Period|Change of residence|1|||
149233819|NCT05182840|538324925|FG006|Treatment Period|Change of residence|0|||
149233820|NCT05182840|538324926|FG007|Treatment Period|Change of residence|0|||
149233821|NCT05182840|538324927|FG008|Treatment Period|Change of residence|0|||
149233822|NCT05182840|538324928|FG009|Treatment Period|Change of residence|0|||
149233823|NCT05182840|538324919|FG000|Treatment Period|Adverse Event|0|||
149233824|NCT05182840|538324920|FG001|Treatment Period|Adverse Event|0|||
149233825|NCT05182840|538324921|FG002|Treatment Period|Adverse Event|4|||
149233826|NCT05182840|538324922|FG003|Treatment Period|Adverse Event|16|||
149233827|NCT05182840|538324923|FG004|Treatment Period|Adverse Event|12|||
149233828|NCT05182840|538324924|FG005|Treatment Period|Adverse Event|6|||
149233829|NCT05182840|538324925|FG006|Treatment Period|Adverse Event|4|||
149233830|NCT05182840|538324926|FG007|Treatment Period|Adverse Event|8|||
149233831|NCT05182840|538324927|FG008|Treatment Period|Adverse Event|16|||
149233832|NCT05182840|538324928|FG009|Treatment Period|Adverse Event|5|||
149233833|NCT05182840|538324919|FG000|Treatment Period|Not treated with study drug|0|||
149233834|NCT05182840|538324920|FG001|Treatment Period|Not treated with study drug|0|||
149233835|NCT05182840|538324921|FG002|Treatment Period|Not treated with study drug|0|||
149233836|NCT05182840|538324922|FG003|Treatment Period|Not treated with study drug|1|||
148782703|NCT04767529|536679051|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
148782704|NCT04767529|536679049|FG000|Overall Study|Lost to Follow-up|0|||
149233837|NCT05182840|538324923|FG004|Treatment Period|Not treated with study drug|0|||
149233838|NCT05182840|538324924|FG005|Treatment Period|Not treated with study drug|0|||
149233839|NCT05182840|538324925|FG006|Treatment Period|Not treated with study drug|1|||
149233840|NCT05182840|538324926|FG007|Treatment Period|Not treated with study drug|1|||
149233841|NCT05182840|538324927|FG008|Treatment Period|Not treated with study drug|0|||
148782705|NCT04767529|536679050|FG001|Overall Study|Lost to Follow-up|2|||
148782706|NCT04767529|536679051|FG002|Overall Study|Lost to Follow-up|3|||
149121620|NCT01506453|537923502|FG000|Overall Study|Withdrawal prior to treatment|0|||
149121621|NCT01506453|537923503|FG001|Overall Study|Withdrawal prior to treatment|2|||
149121622|NCT00117845|537923504|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
149121623|NCT00645801|537923505|FG000|Overall Study|unclear if patient took all the medication.|1|||
149121624|NCT00645801|537923506|FG001|Overall Study|unclear if patient took all the medication.|0|||
149121625|NCT00645801|537923505|FG000|Overall Study|Lost to Follow-up|19|||
149121626|NCT00645801|537923506|FG001|Overall Study|Lost to Follow-up|15|||
149121627|NCT03527173|537923507|FG000|Overall Study|Lost to Follow-up|4|||
149121628|NCT03527173|537923508|FG001|Overall Study|Lost to Follow-up|2|||
149121629|NCT03527173|537923507|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
149121630|NCT03527173|537923508|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
149121631|NCT03527173|537923507|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
149121632|NCT03527173|537923508|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
149121633|NCT03527173|537923507|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
149121634|NCT03527173|537923508|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149121635|NCT01248780|537923509|FG000|Overall Study|Lack of Efficacy|2|||
149121636|NCT01248780|537923510|FG001|Overall Study|Lack of Efficacy|0|||
149121637|NCT01248780|537923509|FG000|Overall Study|Lost to Follow-up|0|||
149121638|NCT01248780|537923510|FG001|Overall Study|Lost to Follow-up|1|||
149121639|NCT01248780|537923509|FG000|Overall Study|Death|0|||
148782707|NCT01716520|536679053|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
148782708|NCT01716520|536679054|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
148782709|NCT01716520|536679055|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
148782710|NCT01716520|536679056|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
148782711|NCT01716520|536679057|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
148782712|NCT01716520|536679058|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
148782713|NCT01716520|536679053|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
148782714|NCT01716520|536679054|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782715|NCT01716520|536679055|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
148782716|NCT01716520|536679056|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
148782717|NCT01716520|536679057|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782718|NCT01716520|536679058|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
148782719|NCT01716520|536679053|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148782720|NCT01716520|536679054|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148782721|NCT01716520|536679055|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148782722|NCT01716520|536679056|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148782723|NCT01716520|536679057|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148782724|NCT01716520|536679058|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148782725|NCT01716520|536679053|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
148782726|NCT01716520|536679054|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
148782727|NCT01716520|536679055|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
148782728|NCT01716520|536679056|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
148782729|NCT01716520|536679057|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
148782730|NCT01716520|536679058|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
148782731|NCT01716520|536679053|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148782732|NCT01716520|536679054|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148782733|NCT01716520|536679055|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148782734|NCT01716520|536679056|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148782735|NCT01716520|536679057|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148782736|NCT01716520|536679058|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
148782737|NCT01716520|536679053|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
148782738|NCT01716520|536679054|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
149121640|NCT01248780|537923510|FG001|Overall Study|Death|1|||
149121641|NCT01248780|537923509|FG000|Overall Study|Adverse Event|2|||
149121642|NCT01248780|537923510|FG001|Overall Study|Adverse Event|7|||
149121643|NCT01248780|537923509|FG000|Overall Study|Protocol Violation|1|||
149121644|NCT01248780|537923510|FG001|Overall Study|Protocol Violation|1|||
149121645|NCT01248780|537923509|FG000|Overall Study|Withdrawal by Subject|4|||
149121646|NCT01248780|537923510|FG001|Overall Study|Withdrawal by Subject|4|||
149121647|NCT01248780|537923509|FG000|Overall Study|Not treated|0|||
149121648|NCT01248780|537923510|FG001|Overall Study|Not treated|1|||
149121649|NCT04097301|537923511|FG000|Overall Study|Death|1|||
149121650|NCT04097301|537923511|FG000|Overall Study|Withdrawal by Subject|1|||
148782739|NCT01716520|536679055|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
148782740|NCT01716520|536679056|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
148782741|NCT01716520|536679057|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
148782742|NCT01716520|536679058|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
148782743|NCT01716520|536679053|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
148782744|NCT01716520|536679054|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
149121651|NCT04097301|537923511|FG000|Overall Study|Screening Failure|5|||
149121652|NCT00896051|537923513|FG000|Overall Study|Adverse Event|2|||
149121653|NCT00896051|537923514|FG001|Overall Study|Adverse Event|1|||
149121654|NCT00896051|537923513|FG000|Overall Study|Lost to Follow-up|3|||
149121655|NCT00896051|537923514|FG001|Overall Study|Lost to Follow-up|2|||
149121656|NCT00896051|537923513|FG000|Overall Study|Withdrawal by Subject|3|||
149121657|NCT00896051|537923514|FG001|Overall Study|Withdrawal by Subject|2|||
149121658|NCT00896051|537923513|FG000|Overall Study|Subject noncompliant|1|||
149121659|NCT00896051|537923514|FG001|Overall Study|Subject noncompliant|3|||
149121660|NCT00896051|537923513|FG000|Overall Study|Other|1|||
149121661|NCT00896051|537923514|FG001|Overall Study|Other|1|||
149121662|NCT01813929|537923521|FG000|Overall Study|Withdrawal by Subject|0|||
149121663|NCT01813929|537923522|FG001|Overall Study|Withdrawal by Subject|1|||
149121664|NCT00007345|537923523|FG000|Overall Study|Refused further treatment|0|||
149121665|NCT00007345|537923524|FG001|Overall Study|Refused further treatment|7|||
149121666|NCT00007345|537923523|FG000|Overall Study|Switched to alternative treatment|0|||
149121667|NCT00007345|537923524|FG001|Overall Study|Switched to alternative treatment|3|||
149121668|NCT00007345|537923523|FG000|Overall Study|Intercurrent illness|1|||
149121669|NCT00007345|537923524|FG001|Overall Study|Intercurrent illness|0|||
149121670|NCT00007345|537923523|FG000|Overall Study|Death on study|1|||
149121671|NCT00007345|537923524|FG001|Overall Study|Death on study|1|||
149121672|NCT04433585|537923525|FG000|Overall Study|Withdrawal by Subject|15|||
149121673|NCT04433585|537923526|FG001|Overall Study|Withdrawal by Subject|3|||
149121674|NCT04433585|537923527|FG002|Overall Study|Withdrawal by Subject|15|||
149121675|NCT04433585|537923528|FG003|Overall Study|Withdrawal by Subject|6|||
149121676|NCT04433585|537923525|FG000|Overall Study|Adverse Event|10|||
149121677|NCT04433585|537923526|FG001|Overall Study|Adverse Event|4|||
149121678|NCT04433585|537923527|FG002|Overall Study|Adverse Event|1|||
149121679|NCT04433585|537923528|FG003|Overall Study|Adverse Event|0|||
149121680|NCT04433585|537923525|FG000|Overall Study|Due to the conflict in Ukraine|2|||
148782745|NCT01716520|536679055|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
148782746|NCT01716520|536679056|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
149121681|NCT04433585|537923526|FG001|Overall Study|Due to the conflict in Ukraine|1|||
149121682|NCT04433585|537923527|FG002|Overall Study|Due to the conflict in Ukraine|1|||
149121683|NCT04433585|537923528|FG003|Overall Study|Due to the conflict in Ukraine|2|||
149121684|NCT04433585|537923525|FG000|Overall Study|Physician Decision|1|||
149121685|NCT04433585|537923526|FG001|Overall Study|Physician Decision|2|||
149121686|NCT04433585|537923527|FG002|Overall Study|Physician Decision|0|||
149121687|NCT04433585|537923528|FG003|Overall Study|Physician Decision|0|||
149121688|NCT04433585|537923525|FG000|Overall Study|Lost to Follow-up|1|||
149121689|NCT04433585|537923526|FG001|Overall Study|Lost to Follow-up|1|||
149121690|NCT04433585|537923527|FG002|Overall Study|Lost to Follow-up|1|||
149121691|NCT04433585|537923528|FG003|Overall Study|Lost to Follow-up|0|||
149121692|NCT04433585|537923525|FG000|Overall Study|Lack of Efficacy|0|||
149121693|NCT04433585|537923526|FG001|Overall Study|Lack of Efficacy|1|||
149121694|NCT04433585|537923527|FG002|Overall Study|Lack of Efficacy|1|||
149121695|NCT04433585|537923528|FG003|Overall Study|Lack of Efficacy|1|||
149121696|NCT04433585|537923525|FG000|Overall Study|Death|0|||
149121697|NCT04433585|537923526|FG001|Overall Study|Death|1|||
149121698|NCT04433585|537923527|FG002|Overall Study|Death|0|||
149121699|NCT04433585|537923528|FG003|Overall Study|Death|0|||
149121700|NCT02074553|537923529|FG000|Intervention Period 1|Family Emergency|0|||
149121701|NCT02074553|537923530|FG001|Intervention Period 1|Family Emergency|0|||
149121702|NCT02074553|537923531|FG002|Intervention Period 1|Family Emergency|0|||
149121703|NCT02074553|537923532|FG003|Intervention Period 1|Family Emergency|1|||
149121704|NCT02074553|537923533|FG004|Intervention Period 1|Family Emergency|0|||
149121705|NCT02074553|537923534|FG005|Intervention Period 1|Family Emergency|0|||
149121706|NCT02074553|537923535|FG006|Intervention Period 1|Family Emergency|0|||
149121707|NCT02074553|537923536|FG007|Intervention Period 1|Family Emergency|0|||
149121708|NCT02074553|537923529|FG000|Washout Period 1|Adverse Event|1|||
149121709|NCT02074553|537923530|FG001|Washout Period 1|Adverse Event|0|||
149121710|NCT02074553|537923531|FG002|Washout Period 1|Adverse Event|0|||
149121711|NCT02074553|537923532|FG003|Washout Period 1|Adverse Event|0|||
149121712|NCT02074553|537923533|FG004|Washout Period 1|Adverse Event|0|||
149121713|NCT02074553|537923534|FG005|Washout Period 1|Adverse Event|0|||
149121714|NCT02074553|537923535|FG006|Washout Period 1|Adverse Event|0|||
149121715|NCT02074553|537923536|FG007|Washout Period 1|Adverse Event|0|||
149121716|NCT02074553|537923529|FG000|Washout Period 1|Physician Decision|0|||
149121717|NCT02074553|537923530|FG001|Washout Period 1|Physician Decision|0|||
149121718|NCT02074553|537923531|FG002|Washout Period 1|Physician Decision|0|||
149121719|NCT02074553|537923532|FG003|Washout Period 1|Physician Decision|1|||
149121720|NCT02074553|537923533|FG004|Washout Period 1|Physician Decision|0|||
149121721|NCT02074553|537923534|FG005|Washout Period 1|Physician Decision|0|||
149121722|NCT02074553|537923535|FG006|Washout Period 1|Physician Decision|0|||
149121723|NCT02074553|537923536|FG007|Washout Period 1|Physician Decision|0|||
149121724|NCT02074553|537923529|FG000|Washout Period 1|Other|0|||
149121725|NCT02074553|537923530|FG001|Washout Period 1|Other|0|||
149121726|NCT02074553|537923531|FG002|Washout Period 1|Other|0|||
148782747|NCT01716520|536679057|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
148782748|NCT01716520|536679058|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
148782749|NCT01716520|536679053|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148782750|NCT01716520|536679054|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148782751|NCT01716520|536679055|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148782752|NCT01716520|536679056|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148782753|NCT01716520|536679057|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
148782754|NCT01716520|536679058|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148782755|NCT01716520|536679053|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782756|NCT01716520|536679054|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782757|NCT01716520|536679055|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782758|NCT01716520|536679056|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
148782759|NCT01716520|536679057|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782760|NCT01716520|536679058|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
148782761|NCT01716520|536679053|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
148782762|NCT01716520|536679054|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
148782763|NCT01716520|536679055|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
148782764|NCT01716520|536679056|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
148782765|NCT01716520|536679057|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
148782766|NCT01716520|536679058|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
148782767|NCT01716520|536679053|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
148782768|NCT01716520|536679054|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
148782769|NCT01716520|536679055|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
148782770|NCT01716520|536679056|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
148782771|NCT01716520|536679057|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
148782772|NCT01716520|536679058|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
148782773|NCT01716520|536679053|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
148782774|NCT01716520|536679054|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
148782775|NCT01716520|536679055|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
148782776|NCT01716520|536679056|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
148782777|NCT01716520|536679057|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
148782778|NCT01716520|536679058|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
148782779|NCT01716520|536679053|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
148782780|NCT01716520|536679054|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
148782781|NCT01716520|536679055|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
148782782|NCT01716520|536679056|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
148782783|NCT01716520|536679057|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
148782784|NCT01716520|536679058|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
148782785|NCT01716520|536679053|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148782786|NCT01716520|536679054|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148782787|NCT01716520|536679055|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148782788|NCT01716520|536679056|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148782789|NCT01716520|536679057|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
149121727|NCT02074553|537923532|FG003|Washout Period 1|Other|0|||
149121728|NCT02074553|537923533|FG004|Washout Period 1|Other|0|||
149121729|NCT02074553|537923534|FG005|Washout Period 1|Other|1|||
149121730|NCT02074553|537923535|FG006|Washout Period 1|Other|0|||
149121731|NCT02074553|537923536|FG007|Washout Period 1|Other|0|||
149121732|NCT02074553|537923529|FG000|Washout Period 2|Adverse Event|0|||
149121733|NCT02074553|537923530|FG001|Washout Period 2|Adverse Event|0|||
149121734|NCT02074553|537923531|FG002|Washout Period 2|Adverse Event|0|||
149121735|NCT02074553|537923532|FG003|Washout Period 2|Adverse Event|0|||
149121736|NCT02074553|537923533|FG004|Washout Period 2|Adverse Event|0|||
149121737|NCT02074553|537923534|FG005|Washout Period 2|Adverse Event|0|||
149121738|NCT02074553|537923535|FG006|Washout Period 2|Adverse Event|1|||
149121739|NCT02074553|537923536|FG007|Washout Period 2|Adverse Event|0|||
149121740|NCT02074553|537923529|FG000|Washout Period 2|Physician Decision|0|||
149121741|NCT02074553|537923530|FG001|Washout Period 2|Physician Decision|0|||
149121742|NCT02074553|537923531|FG002|Washout Period 2|Physician Decision|0|||
149121743|NCT02074553|537923532|FG003|Washout Period 2|Physician Decision|0|||
149121744|NCT02074553|537923533|FG004|Washout Period 2|Physician Decision|0|||
149121745|NCT02074553|537923534|FG005|Washout Period 2|Physician Decision|1|||
149121746|NCT02074553|537923535|FG006|Washout Period 2|Physician Decision|0|||
149121747|NCT02074553|537923536|FG007|Washout Period 2|Physician Decision|0|||
149121748|NCT02074553|537923529|FG000|Washout Period 2|Lost to Follow-up|0|||
149121749|NCT02074553|537923530|FG001|Washout Period 2|Lost to Follow-up|0|||
149121750|NCT02074553|537923531|FG002|Washout Period 2|Lost to Follow-up|1|||
149121751|NCT02074553|537923532|FG003|Washout Period 2|Lost to Follow-up|0|||
149121752|NCT02074553|537923533|FG004|Washout Period 2|Lost to Follow-up|0|||
149121753|NCT02074553|537923534|FG005|Washout Period 2|Lost to Follow-up|0|||
149121754|NCT02074553|537923535|FG006|Washout Period 2|Lost to Follow-up|0|||
149121755|NCT02074553|537923536|FG007|Washout Period 2|Lost to Follow-up|0|||
149121756|NCT02074553|537923529|FG000|Washout Period 3|Physician Decision|0|||
149121757|NCT02074553|537923530|FG001|Washout Period 3|Physician Decision|0|||
149121758|NCT02074553|537923531|FG002|Washout Period 3|Physician Decision|0|||
149121759|NCT02074553|537923532|FG003|Washout Period 3|Physician Decision|0|||
149121760|NCT02074553|537923533|FG004|Washout Period 3|Physician Decision|0|||
149121761|NCT02074553|537923534|FG005|Washout Period 3|Physician Decision|0|||
149121762|NCT02074553|537923535|FG006|Washout Period 3|Physician Decision|0|||
149121763|NCT02074553|537923536|FG007|Washout Period 3|Physician Decision|1|||
149121764|NCT00194987|537923537|FG000|Overall Study|Withdrawal by Subject|0|||
149121765|NCT00194987|537923538|FG001|Overall Study|Withdrawal by Subject|3|||
149121766|NCT01664598|537923539|FG000|Overall Study|Sponsor Decision|1|||
149121767|NCT01664598|537923539|FG000|Overall Study|Withdrawal of Informed Consent|4|||
149121768|NCT01664598|537923539|FG000|Overall Study|Adverse Event|1|||
149121769|NCT02342743|537923540|FG000|Baseline Period|Withdrawal by Subject|3|||
149121770|NCT02342743|537923540|FG000|Baseline Period|Lost to Follow-up|2|||
149121771|NCT02342743|537923540|FG000|Baseline Period|Change in prophylactic medication|3|||
149121772|NCT02342743|537923540|FG000|Baseline Period|Screening failure regarding baseline|7|||
149121773|NCT02342743|537923540|FG000|Treatment Period|Withdrawal by Subject|2|||
149121774|NCT02342743|537923540|FG000|Treatment Period|Lost to Follow-up|8|||
149121775|NCT02342743|537923540|FG000|Treatment Period|Change in prophylactic medication|1|||
149121776|NCT04875676|537923541|FG000|Overall Study|Lost to Follow-up|1|||
149121777|NCT04875676|537923542|FG001|Overall Study|Lost to Follow-up|0|||
149121778|NCT04875676|537923543|FG002|Overall Study|Lost to Follow-up|0|||
149121779|NCT03103763|537923548|FG000|Overall Study|Death|15|||
149121780|NCT03103763|537923549|FG001|Overall Study|Death|5|||
149121781|NCT03103763|537923550|FG002|Overall Study|Death|5|||
149121782|NCT03103763|537923548|FG000|Overall Study|Withdrawal by Subject|0|||
149121783|NCT03103763|537923549|FG001|Overall Study|Withdrawal by Subject|3|||
149121784|NCT03103763|537923550|FG002|Overall Study|Withdrawal by Subject|2|||
149121785|NCT00938470|537923551|FG000|Overall Study|Disease Progression|3|||
149121786|NCT00938470|537923552|FG001|Overall Study|Disease Progression|0|||
149121787|NCT00938470|537923551|FG000|Overall Study|Alternate Treatment|1|||
149121788|NCT00938470|537923552|FG001|Overall Study|Alternate Treatment|0|||
149121789|NCT00938470|537923551|FG000|Overall Study|Death|3|||
149121790|NCT00938470|537923552|FG001|Overall Study|Death|2|||
149121791|NCT00938470|537923551|FG000|Overall Study|Other Reason|0|||
149121792|NCT00938470|537923552|FG001|Overall Study|Other Reason|1|||
149121793|NCT03245151|537923553|FG000|Overall Study|Withdrawal by Subject|2|||
149121794|NCT03245151|537923554|FG001|Overall Study|Withdrawal by Subject|0|||
149121795|NCT03245151|537923555|FG002|Overall Study|Withdrawal by Subject|0|||
149121796|NCT03245151|537923556|FG003|Overall Study|Withdrawal by Subject|2|||
149121797|NCT03245151|537923557|FG004|Overall Study|Withdrawal by Subject|1|||
149121798|NCT03245151|537923553|FG000|Overall Study|Death|3|||
149121799|NCT03245151|537923554|FG001|Overall Study|Death|14|||
149121800|NCT03245151|537923555|FG002|Overall Study|Death|9|||
149121801|NCT03245151|537923556|FG003|Overall Study|Death|16|||
149121802|NCT03245151|537923557|FG004|Overall Study|Death|7|||
149121803|NCT03245151|537923553|FG000|Overall Study|Sponsor's decision|0|||
149121804|NCT03245151|537923554|FG001|Overall Study|Sponsor's decision|1|||
149121805|NCT03245151|537923555|FG002|Overall Study|Sponsor's decision|0|||
149121806|NCT03245151|537923556|FG003|Overall Study|Sponsor's decision|0|||
148782790|NCT01716520|536679058|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
148782791|NCT01716520|536679053|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148782792|NCT01716520|536679054|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148782793|NCT01716520|536679055|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
148782794|NCT01716520|536679056|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148782795|NCT01716520|536679057|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148782796|NCT01716520|536679058|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148782797|NCT00981058|536679064|FG000|Overall Study|Progressive Disease|38|||
148782798|NCT00981058|536679065|FG001|Overall Study|Progressive Disease|31|||
148782799|NCT00981058|536679064|FG000|Overall Study|Lost to Follow-up|3|||
148782800|NCT00981058|536679065|FG001|Overall Study|Lost to Follow-up|2|||
148782801|NCT00981058|536679064|FG000|Overall Study|Physician Decision|4|||
148782802|NCT00981058|536679065|FG001|Overall Study|Physician Decision|5|||
148782803|NCT00981058|536679064|FG000|Overall Study|Randomization Error|0|||
148782804|NCT00981058|536679065|FG001|Overall Study|Randomization Error|1|||
148782805|NCT00981058|536679064|FG000|Overall Study|Withdrawal by Subject|24|||
148782806|NCT00981058|536679065|FG001|Overall Study|Withdrawal by Subject|22|||
148782807|NCT05916131|536679066|FG000|Overall Study|Lost to Follow-up|0|||
149121807|NCT03245151|537923557|FG004|Overall Study|Sponsor's decision|0|||
148782808|NCT05916131|536679067|FG001|Overall Study|Lost to Follow-up|0|||
149121808|NCT01970345|537923558|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
148782809|NCT05916131|536679068|FG002|Overall Study|Lost to Follow-up|1|||
148782810|NCT05916131|536679069|FG003|Overall Study|Lost to Follow-up|0|||
149121809|NCT01970345|537923559|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
149121810|NCT01970345|537923558|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
148782811|NCT01636947|536679078|FG000|Overall Study|Not Treated|2|||
148782812|NCT01636947|536679079|FG001|Overall Study|Not Treated|2|||
148782813|NCT01636947|536679078|FG000|Overall Study|Lost to Follow-up|4|||
148782814|NCT01636947|536679079|FG001|Overall Study|Lost to Follow-up|0|||
148782815|NCT01636947|536679078|FG000|Overall Study|Protocol Violation|1|||
148782816|NCT01636947|536679079|FG001|Overall Study|Protocol Violation|1|||
148782817|NCT01636947|536679078|FG000|Overall Study|Withdrawal by Subject|3|||
148782818|NCT01636947|536679079|FG001|Overall Study|Withdrawal by Subject|3|||
148782819|NCT01636947|536679078|FG000|Overall Study|Adverse Event|1|||
148782820|NCT01636947|536679079|FG001|Overall Study|Adverse Event|1|||
148782821|NCT01636947|536679078|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
148782822|NCT01636947|536679079|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
148782823|NCT01955109|536679087|FG000|Overall Study|Adverse Event|2|||
148782824|NCT01955109|536679088|FG001|Overall Study|Adverse Event|0|||
148782825|NCT01955109|536679087|FG000|Overall Study|Participant unwilling to continue|35|||
149121811|NCT01970345|537923559|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
149121812|NCT01346475|537923561|FG000|First Intervention|Lost to Follow-up|4|||
149121813|NCT01346475|537923562|FG001|First Intervention|Lost to Follow-up|3|||
149121814|NCT01552603|537923563|FG000|Overall Study|Physician Decision|1|||
149121815|NCT00618618|537923564|FG000|Overall Study|Patient Request|0|||
149121816|NCT00618618|537923565|FG001|Overall Study|Patient Request|0|||
149121817|NCT00618618|537923566|FG002|Overall Study|Patient Request|2|||
149121818|NCT00618618|537923567|FG003|Overall Study|Patient Request|0|||
149121819|NCT00618618|537923564|FG000|Overall Study|Inability to Complete Study Procedures|0|||
149121820|NCT00618618|537923565|FG001|Overall Study|Inability to Complete Study Procedures|1|||
149121821|NCT00618618|537923566|FG002|Overall Study|Inability to Complete Study Procedures|0|||
149121822|NCT00618618|537923567|FG003|Overall Study|Inability to Complete Study Procedures|0|||
149121823|NCT00618618|537923564|FG000|Overall Study|Lost to Follow-up|3|||
149121824|NCT00618618|537923565|FG001|Overall Study|Lost to Follow-up|0|||
149121825|NCT00618618|537923566|FG002|Overall Study|Lost to Follow-up|0|||
149121826|NCT00618618|537923567|FG003|Overall Study|Lost to Follow-up|1|||
149121827|NCT00618618|537923564|FG000|Overall Study|Non-compliance|1|||
149121828|NCT00618618|537923565|FG001|Overall Study|Non-compliance|1|||
149121829|NCT00618618|537923566|FG002|Overall Study|Non-compliance|0|||
149121830|NCT00618618|537923567|FG003|Overall Study|Non-compliance|0|||
149121831|NCT00618618|537923564|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
149121832|NCT00618618|537923565|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
149121833|NCT00618618|537923566|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
149121834|NCT00618618|537923567|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
149121835|NCT00618618|537923564|FG000|Overall Study|Death|0|||
149121836|NCT00618618|537923565|FG001|Overall Study|Death|1|||
149121837|NCT00618618|537923566|FG002|Overall Study|Death|0|||
149121838|NCT00618618|537923567|FG003|Overall Study|Death|0|||
149121839|NCT04797650|537923573|FG000|Overall Study|Reason Not Specified|5|||
149121840|NCT04797650|537923574|FG001|Overall Study|Reason Not Specified|12|||
149121841|NCT04797650|537923575|FG002|Overall Study|Reason Not Specified|5|||
149121842|NCT04797650|537923573|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
149121843|NCT04797650|537923574|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
149121844|NCT04797650|537923575|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
149121845|NCT04797650|537923573|FG000|Overall Study|Lack of Efficacy|1|||
149121846|NCT04797650|537923574|FG001|Overall Study|Lack of Efficacy|0|||
149121847|NCT04797650|537923575|FG002|Overall Study|Lack of Efficacy|1|||
149121848|NCT04797650|537923573|FG000|Overall Study|Non-compliance with Study Drug|0|||
149121849|NCT04797650|537923574|FG001|Overall Study|Non-compliance with Study Drug|0|||
149121850|NCT04797650|537923575|FG002|Overall Study|Non-compliance with Study Drug|2|||
149121851|NCT04797650|537923573|FG000|Overall Study|Lost to Follow-up|4|||
149121852|NCT04797650|537923574|FG001|Overall Study|Lost to Follow-up|6|||
149121853|NCT04797650|537923575|FG002|Overall Study|Lost to Follow-up|1|||
149121854|NCT00309959|537923576|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
149121855|NCT02947087|537923578|FG000|Overall Study|Withdrawal by Subject|3|||
149121856|NCT02947087|537923579|FG001|Overall Study|Withdrawal by Subject|2|||
149121857|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
149121858|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
149121859|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
149121860|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
149121861|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
149121862|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
149121863|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
149121864|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
149121865|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
148782826|NCT01955109|536679088|FG001|Overall Study|Participant unwilling to continue|7|||
148782827|NCT01955109|536679087|FG000|Overall Study|Physician Decision|2|||
148782828|NCT01955109|536679088|FG001|Overall Study|Physician Decision|0|||
148782829|NCT01955109|536679087|FG000|Overall Study|Lost to Follow-up|3|||
149121866|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
149121867|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
149121868|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
149121869|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
149121870|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
149121871|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
149121872|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
149121873|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
149121874|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
149121875|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
149121876|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
149121877|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
149121878|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
149121879|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
149121880|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
149121881|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
149121882|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
149121883|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
149121884|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
149121885|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
149121886|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
149121887|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
149121888|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
149121889|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
149121890|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
149121891|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
149121892|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
149121893|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
149121894|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
149121895|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
149121896|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
149121897|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
149121898|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
149121899|NCT01160289|537923584|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
149121900|NCT01160289|537923585|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
149121901|NCT01160289|537923586|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
149121902|NCT01160289|537923587|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
149121903|NCT01160289|537923588|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
149121904|NCT01160289|537923589|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
149121905|NCT01160289|537923584|FG000|Post-Randomization Period|Adverse Event|0|||
149121906|NCT01160289|537923585|FG001|Post-Randomization Period|Adverse Event|4|||
149121907|NCT01160289|537923586|FG002|Post-Randomization Period|Adverse Event|4|||
149121908|NCT01160289|537923587|FG003|Post-Randomization Period|Adverse Event|2|||
149121909|NCT01160289|537923588|FG004|Post-Randomization Period|Adverse Event|0|||
149121910|NCT01160289|537923589|FG005|Post-Randomization Period|Adverse Event|0|||
149121911|NCT01160289|537923584|FG000|Post-Randomization Period|Death|0|||
149121912|NCT01160289|537923585|FG001|Post-Randomization Period|Death|0|||
149121913|NCT01160289|537923586|FG002|Post-Randomization Period|Death|0|||
149121914|NCT01160289|537923587|FG003|Post-Randomization Period|Death|1|||
149121915|NCT01160289|537923588|FG004|Post-Randomization Period|Death|0|||
149121916|NCT01160289|537923589|FG005|Post-Randomization Period|Death|0|||
149121917|NCT01160289|537923584|FG000|Post-Randomization Period|Lack of Efficacy|0|||
149121918|NCT01160289|537923585|FG001|Post-Randomization Period|Lack of Efficacy|1|||
149121919|NCT01160289|537923586|FG002|Post-Randomization Period|Lack of Efficacy|0|||
149121920|NCT01160289|537923587|FG003|Post-Randomization Period|Lack of Efficacy|3|||
149121921|NCT01160289|537923588|FG004|Post-Randomization Period|Lack of Efficacy|0|||
149121922|NCT01160289|537923589|FG005|Post-Randomization Period|Lack of Efficacy|0|||
149121923|NCT01160289|537923584|FG000|Post-Randomization Period|Lost to Follow-up|0|||
149121924|NCT01160289|537923585|FG001|Post-Randomization Period|Lost to Follow-up|3|||
149121925|NCT01160289|537923586|FG002|Post-Randomization Period|Lost to Follow-up|2|||
149121926|NCT01160289|537923587|FG003|Post-Randomization Period|Lost to Follow-up|5|||
149121927|NCT01160289|537923588|FG004|Post-Randomization Period|Lost to Follow-up|3|||
149121928|NCT01160289|537923589|FG005|Post-Randomization Period|Lost to Follow-up|4|||
149121929|NCT01160289|537923584|FG000|Post-Randomization Period|Physician Decision|0|||
149121930|NCT01160289|537923585|FG001|Post-Randomization Period|Physician Decision|0|||
149121931|NCT01160289|537923586|FG002|Post-Randomization Period|Physician Decision|1|||
149121932|NCT01160289|537923587|FG003|Post-Randomization Period|Physician Decision|0|||
148782830|NCT01955109|536679088|FG001|Overall Study|Lost to Follow-up|1|||
148782831|NCT01955109|536679087|FG000|Overall Study|Non-compliance|3|||
148782832|NCT01955109|536679088|FG001|Overall Study|Non-compliance|1|||
148782833|NCT02614131|536679089|FG000|Overall Study|Withdrawal by Subject|1|||
148782834|NCT02614131|536679090|FG001|Overall Study|Withdrawal by Subject|0|||
148782835|NCT02614131|536679091|FG002|Overall Study|Withdrawal by Subject|0|||
148782836|NCT02614131|536679092|FG003|Overall Study|Withdrawal by Subject|0|||
148782837|NCT02614131|536679093|FG004|Overall Study|Withdrawal by Subject|0|||
148782838|NCT02614131|536679094|FG005|Overall Study|Withdrawal by Subject|0|||
148782839|NCT02614131|536679095|FG006|Overall Study|Withdrawal by Subject|0|||
148782840|NCT02614131|536679089|FG000|Overall Study|Adverse Event|0|||
148782841|NCT02614131|536679090|FG001|Overall Study|Adverse Event|0|||
148782842|NCT02614131|536679091|FG002|Overall Study|Adverse Event|0|||
148782843|NCT02614131|536679092|FG003|Overall Study|Adverse Event|0|||
148782844|NCT02614131|536679093|FG004|Overall Study|Adverse Event|0|||
148782845|NCT02614131|536679094|FG005|Overall Study|Adverse Event|0|||
148782846|NCT02614131|536679095|FG006|Overall Study|Adverse Event|1|||
148782847|NCT00089635|536679096|FG000|Overall Study|Adverse Event|2|||
148782848|NCT00089635|536679096|FG000|Overall Study|Death|17|||
148782849|NCT00089635|536679096|FG000|Overall Study|Disease Progression|12|||
148782850|NCT00089635|536679096|FG000|Overall Study|Lost to Follow-up|3|||
148782851|NCT00089635|536679096|FG000|Overall Study|Withdrawal by Subject|6|||
148782852|NCT00089635|536679096|FG000|Overall Study|Ineligibility determined|1|||
148782853|NCT00089635|536679096|FG000|Overall Study|Other|2|||
148782854|NCT02603107|536679097|FG000|Randomized Phase|Withdrew consent|8|||
148782855|NCT02603107|536679098|FG001|Randomized Phase|Withdrew consent|15|||
148782856|NCT02603107|536679097|FG000|Randomized Phase|Lost to Follow-up|1|||
148782857|NCT02603107|536679098|FG001|Randomized Phase|Lost to Follow-up|3|||
148782858|NCT02603107|536679097|FG000|Randomized Phase|Adverse Event|2|||
148782859|NCT02603107|536679098|FG001|Randomized Phase|Adverse Event|0|||
148782860|NCT02603107|536679097|FG000|Randomized Phase|Death|1|||
148782861|NCT02603107|536679098|FG001|Randomized Phase|Death|1|||
148782862|NCT02603107|536679097|FG000|Randomized Phase|Non-compliance with study drug|1|||
148782863|NCT02603107|536679098|FG001|Randomized Phase|Non-compliance with study drug|1|||
148782864|NCT02603107|536679097|FG000|Randomized Phase|Investigator's discretion|0|||
148782865|NCT02603107|536679098|FG001|Randomized Phase|Investigator's discretion|1|||
148782866|NCT02603107|536679097|FG000|Randomized Phase|Lack of Efficacy|1|||
149121933|NCT01160289|537923588|FG004|Post-Randomization Period|Physician Decision|0|||
149121934|NCT01160289|537923589|FG005|Post-Randomization Period|Physician Decision|0|||
149121935|NCT01160289|537923584|FG000|Post-Randomization Period|Protocol Violation|0|||
149121936|NCT01160289|537923585|FG001|Post-Randomization Period|Protocol Violation|4|||
149121937|NCT01160289|537923586|FG002|Post-Randomization Period|Protocol Violation|2|||
149121938|NCT01160289|537923587|FG003|Post-Randomization Period|Protocol Violation|0|||
149121939|NCT01160289|537923588|FG004|Post-Randomization Period|Protocol Violation|1|||
149121940|NCT01160289|537923589|FG005|Post-Randomization Period|Protocol Violation|3|||
149121941|NCT01160289|537923584|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
149121942|NCT01160289|537923585|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
149121943|NCT01160289|537923586|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
149121944|NCT01160289|537923587|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
149121945|NCT01160289|537923588|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
149121946|NCT01160289|537923589|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
149121947|NCT01160289|537923584|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
149121948|NCT01160289|537923585|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
149121949|NCT01160289|537923586|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
149121950|NCT01160289|537923587|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
149121951|NCT01160289|537923588|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
149121952|NCT01160289|537923589|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
149121953|NCT01160289|537923584|FG000|Post-Randomization Period|Sponsor Decision|0|||
149121954|NCT01160289|537923585|FG001|Post-Randomization Period|Sponsor Decision|1|||
149121955|NCT01160289|537923586|FG002|Post-Randomization Period|Sponsor Decision|0|||
149121956|NCT01160289|537923587|FG003|Post-Randomization Period|Sponsor Decision|0|||
149121957|NCT01160289|537923588|FG004|Post-Randomization Period|Sponsor Decision|0|||
148782867|NCT02603107|536679098|FG001|Randomized Phase|Lack of Efficacy|0|||
149121958|NCT01160289|537923589|FG005|Post-Randomization Period|Sponsor Decision|0|||
148782868|NCT02603107|536679097|FG000|Randomized Phase|Protocol Violation|1|||
148782869|NCT02603107|536679098|FG001|Randomized Phase|Protocol Violation|0|||
148782870|NCT02603107|536679097|FG000|Optional Extension Phase|Lost to Follow-up|3|||
148782871|NCT02603107|536679098|FG001|Optional Extension Phase|Lost to Follow-up|3|||
148782872|NCT02603107|536679097|FG000|Optional Extension Phase|Withdrew consent|3|||
148782873|NCT02603107|536679098|FG001|Optional Extension Phase|Withdrew consent|2|||
149121959|NCT01156792|537923590|FG000|Overall Study|Adverse Event|1|||
149121960|NCT01156792|537923590|FG000|Overall Study|Lack of Efficacy|36|||
149121961|NCT01156792|537923590|FG000|Overall Study|Protocol Violation|6|||
149121962|NCT01156792|537923590|FG000|Overall Study|Lost to Follow-up|3|||
148782874|NCT02603107|536679097|FG000|Optional Extension Phase|Investigator's discretion|2|||
148782875|NCT02603107|536679098|FG001|Optional Extension Phase|Investigator's discretion|2|||
148782876|NCT02603107|536679097|FG000|Optional Extension Phase|Pregnancy|0|||
148782877|NCT02603107|536679098|FG001|Optional Extension Phase|Pregnancy|3|||
148782878|NCT02603107|536679097|FG000|Optional Extension Phase|Adverse Event|0|||
148782879|NCT02603107|536679098|FG001|Optional Extension Phase|Adverse Event|2|||
148782880|NCT02603107|536679097|FG000|Optional Extension Phase|Not treated in extension phase|0|||
148782881|NCT02603107|536679098|FG001|Optional Extension Phase|Not treated in extension phase|1|||
148782882|NCT02603107|536679097|FG000|Optional Extension Phase|Protocol Violation|1|||
148782883|NCT02603107|536679098|FG001|Optional Extension Phase|Protocol Violation|0|||
148782884|NCT00821015|536679103|FG000|Overall Study|Lost to Follow-up|12|||
148782885|NCT01887678|536679104|FG000|Overall Study|Adverse Event|4|||
148782886|NCT01887678|536679105|FG001|Overall Study|Adverse Event|6|||
148782887|NCT01887678|536679104|FG000|Overall Study|Exceeded rescue medication dosage|4|||
148782888|NCT01887678|536679105|FG001|Overall Study|Exceeded rescue medication dosage|5|||
148782889|NCT01887678|536679104|FG000|Overall Study|Withdrawal of consent|3|||
148782890|NCT01887678|536679105|FG001|Overall Study|Withdrawal of consent|4|||
148782891|NCT01887678|536679104|FG000|Overall Study|Lost to Follow-up|4|||
148782892|NCT01887678|536679105|FG001|Overall Study|Lost to Follow-up|2|||
148782893|NCT01887678|536679104|FG000|Overall Study|Deterioration of clinical condition|0|||
148782894|NCT01887678|536679105|FG001|Overall Study|Deterioration of clinical condition|4|||
148782895|NCT01887678|536679104|FG000|Overall Study|Lack of Efficacy|1|||
148782896|NCT01887678|536679105|FG001|Overall Study|Lack of Efficacy|2|||
148782897|NCT01887678|536679104|FG000|Overall Study|Non-compliance|0|||
148782898|NCT01887678|536679105|FG001|Overall Study|Non-compliance|3|||
148782899|NCT01887678|536679104|FG000|Overall Study|Specified|1|||
148782900|NCT01887678|536679105|FG001|Overall Study|Specified|2|||
148782901|NCT00932698|536679107|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
148782902|NCT00932698|536679108|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
148782903|NCT00932698|536679109|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
148782904|NCT00932698|536679110|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
148782905|NCT00932698|536679111|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
148782906|NCT00932698|536679112|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
148782907|NCT00932698|536679113|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
148782908|NCT00932698|536679114|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
148782909|NCT00932698|536679115|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
148782910|NCT00932698|536679116|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
148782911|NCT00932698|536679117|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
148782912|NCT00932698|536679107|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782913|NCT00932698|536679108|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
148782914|NCT00932698|536679109|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782915|NCT00932698|536679110|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
148782916|NCT00932698|536679111|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782917|NCT00932698|536679112|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
148782918|NCT00932698|536679113|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
148782919|NCT00932698|536679114|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782920|NCT00932698|536679115|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782921|NCT00932698|536679116|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782922|NCT00932698|536679117|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
148782923|NCT00932698|536679107|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
148782924|NCT00932698|536679108|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
148782925|NCT00932698|536679109|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
148782926|NCT00932698|536679110|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
148782927|NCT00932698|536679111|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
148782928|NCT00932698|536679112|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
148782929|NCT00932698|536679113|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
148782930|NCT00932698|536679114|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
148782931|NCT00932698|536679115|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
148782932|NCT00932698|536679116|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
148782933|NCT00932698|536679117|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
148782934|NCT00932698|536679107|FG000|Part 1 (Dose Escalation)|Other|0|||
148782935|NCT00932698|536679108|FG001|Part 1 (Dose Escalation)|Other|0|||
148782936|NCT00932698|536679109|FG002|Part 1 (Dose Escalation)|Other|1|||
148782937|NCT00932698|536679110|FG003|Part 1 (Dose Escalation)|Other|0|||
148782938|NCT00932698|536679111|FG004|Part 1 (Dose Escalation)|Other|0|||
148782939|NCT00932698|536679112|FG005|Part 1 (Dose Escalation)|Other|0|||
148782940|NCT00932698|536679113|FG006|Part 1 (Dose Escalation)|Other|1|||
148782941|NCT00932698|536679114|FG007|Part 1 (Dose Escalation)|Other|0|||
148782942|NCT00932698|536679115|FG008|Part 1 (Dose Escalation)|Other|0|||
148782943|NCT00932698|536679116|FG009|Part 1 (Dose Escalation)|Other|0|||
148782944|NCT00932698|536679117|FG010|Part 1 (Dose Escalation)|Other|0|||
148782945|NCT00932698|536679107|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
148782946|NCT00932698|536679108|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
148782947|NCT00932698|536679109|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
149121963|NCT01156792|537923590|FG000|Overall Study|Physician Decision|3|||
149121964|NCT01156792|537923590|FG000|Overall Study|Withdrawal by Subject|9|||
149121965|NCT01156792|537923590|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
149121966|NCT01097707|537923591|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149121967|NCT01097707|537923592|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149121968|NCT01097707|537923593|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
149121969|NCT01097707|537923594|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
149121970|NCT01097707|537923595|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
149121971|NCT01097707|537923591|FG000|Overall Study|Adverse Event|4|||
149121972|NCT01097707|537923592|FG001|Overall Study|Adverse Event|2|||
149121973|NCT01097707|537923593|FG002|Overall Study|Adverse Event|3|||
149121974|NCT01097707|537923594|FG003|Overall Study|Adverse Event|1|||
149121975|NCT01097707|537923595|FG004|Overall Study|Adverse Event|3|||
149121976|NCT01097707|537923591|FG000|Overall Study|Entry Criteria Not Met|2|||
149121977|NCT01097707|537923592|FG001|Overall Study|Entry Criteria Not Met|1|||
149121978|NCT01097707|537923593|FG002|Overall Study|Entry Criteria Not Met|1|||
149121979|NCT01097707|537923594|FG003|Overall Study|Entry Criteria Not Met|0|||
149121980|NCT01097707|537923595|FG004|Overall Study|Entry Criteria Not Met|1|||
149121981|NCT01097707|537923591|FG000|Overall Study|Lack of Efficacy|1|||
149121982|NCT01097707|537923592|FG001|Overall Study|Lack of Efficacy|0|||
149121983|NCT01097707|537923593|FG002|Overall Study|Lack of Efficacy|0|||
149121984|NCT01097707|537923594|FG003|Overall Study|Lack of Efficacy|1|||
149121985|NCT01097707|537923595|FG004|Overall Study|Lack of Efficacy|0|||
149121986|NCT01097707|537923591|FG000|Overall Study|Lost to Follow-up|1|||
149121987|NCT01097707|537923592|FG001|Overall Study|Lost to Follow-up|1|||
149121988|NCT01097707|537923593|FG002|Overall Study|Lost to Follow-up|2|||
149121989|NCT01097707|537923594|FG003|Overall Study|Lost to Follow-up|0|||
149121990|NCT01097707|537923595|FG004|Overall Study|Lost to Follow-up|3|||
149121991|NCT01097707|537923591|FG000|Overall Study|Protocol Violation|2|||
149121992|NCT01097707|537923592|FG001|Overall Study|Protocol Violation|2|||
149121993|NCT01097707|537923593|FG002|Overall Study|Protocol Violation|3|||
149121994|NCT01097707|537923594|FG003|Overall Study|Protocol Violation|2|||
149121995|NCT01097707|537923595|FG004|Overall Study|Protocol Violation|2|||
149121996|NCT01097707|537923591|FG000|Overall Study|Sponsor Decision|31|||
149121997|NCT01097707|537923592|FG001|Overall Study|Sponsor Decision|31|||
149121998|NCT01097707|537923593|FG002|Overall Study|Sponsor Decision|34|||
149121999|NCT01097707|537923594|FG003|Overall Study|Sponsor Decision|35|||
149122000|NCT01097707|537923595|FG004|Overall Study|Sponsor Decision|36|||
149122001|NCT01097707|537923591|FG000|Overall Study|Withdrawal by Subject|3|||
149122002|NCT01097707|537923592|FG001|Overall Study|Withdrawal by Subject|6|||
149122003|NCT01097707|537923593|FG002|Overall Study|Withdrawal by Subject|1|||
149122004|NCT01097707|537923594|FG003|Overall Study|Withdrawal by Subject|4|||
149122005|NCT01097707|537923595|FG004|Overall Study|Withdrawal by Subject|3|||
149122006|NCT01097707|537923591|FG000|Overall Study|Reason unknown|0|||
149122007|NCT01097707|537923592|FG001|Overall Study|Reason unknown|0|||
149122008|NCT01097707|537923593|FG002|Overall Study|Reason unknown|0|||
149122009|NCT01097707|537923594|FG003|Overall Study|Reason unknown|0|||
149122010|NCT01097707|537923595|FG004|Overall Study|Reason unknown|1|||
149122011|NCT03212989|537923596|FG000|Overall Study|Physician Decision|8|||
149122012|NCT01236534|537923599|FG000|Overall Study|Adverse Event|3|||
149122013|NCT01236534|537923600|FG001|Overall Study|Adverse Event|0|||
149122014|NCT01844687|537923601|FG000|Visit 1|Protocol Violation|3|||
149122015|NCT01844687|537923601|FG000|Visit 1|Lost to Follow-up|5|||
149122016|NCT01844687|537923601|FG000|Visit 2|Withdrawal by Subject|1|||
149122017|NCT01844687|537923601|FG000|Visit 2|Protocol Violation|1|||
149122018|NCT01844687|537923601|FG000|Visit 3|Lost to Follow-up|1|||
149122019|NCT01844687|537923601|FG000|Visit 3|Withdrawal by Subject|3|||
149122020|NCT01844687|537923601|FG000|Visit 3|child care problems|1|||
149122021|NCT01844687|537923601|FG000|Visit 4|Pregnancy|1|||
149122022|NCT01844687|537923601|FG000|Visit 4|Lost to Follow-up|1|||
149122023|NCT01844687|537923601|FG000|Visit 4|Withdrawal by Subject|2|||
149122024|NCT03775434|537923613|FG000|Overall Study|Adverse Event|2|||
149122025|NCT03775434|537923613|FG000|Overall Study|Withdrawal by Subject|1|||
149122026|NCT01621568|537923614|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
149122027|NCT01621568|537923615|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
149122028|NCT01621568|537923614|FG000|Week 5-6 No Treatment|Death|1|||
149122029|NCT01621568|537923615|FG001|Week 5-6 No Treatment|Death|0|||
149122030|NCT00564889|537923616|FG000|Overall Study|Death|7|||
149122031|NCT00564889|537923616|FG000|Overall Study|Adverse Event|12|||
149122032|NCT00564889|537923616|FG000|Overall Study|Alternative treatment|3|||
149122033|NCT00564889|537923616|FG000|Overall Study|Disease progression|3|||
149122034|NCT00564889|537923616|FG000|Overall Study|Other, not specified|4|||
149122035|NCT00635427|537923617|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
149122036|NCT00635427|537923618|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
149122037|NCT00635427|537923619|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
149122038|NCT00635427|537923620|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
148782948|NCT00932698|536679110|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
148782949|NCT00932698|536679111|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
148782950|NCT00932698|536679112|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
148782951|NCT00932698|536679113|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
148782952|NCT00932698|536679114|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
148782953|NCT00932698|536679115|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
148782954|NCT00932698|536679116|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
148782955|NCT00932698|536679117|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
148782956|NCT00932698|536679107|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782957|NCT00932698|536679108|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782958|NCT00932698|536679109|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782959|NCT00932698|536679110|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782960|NCT00932698|536679111|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782961|NCT00932698|536679112|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782962|NCT00932698|536679113|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782963|NCT00932698|536679114|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
148782964|NCT00932698|536679115|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
148782965|NCT00932698|536679116|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
148782966|NCT00932698|536679117|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
148782967|NCT00932698|536679107|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
148782968|NCT00932698|536679108|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
148782969|NCT00932698|536679109|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
148782970|NCT00932698|536679110|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
148782971|NCT00932698|536679111|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
148782972|NCT00932698|536679112|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
148782973|NCT00932698|536679113|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
148782974|NCT00932698|536679114|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
148782975|NCT00932698|536679115|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
148782976|NCT00932698|536679116|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
148782977|NCT00932698|536679117|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
148782978|NCT05249127|536679118|FG000|Overall Study|Protocol Violation|13|||
148782979|NCT05249127|536679118|FG000|Overall Study|Physician Decision|4|||
148782980|NCT05249127|536679118|FG000|Overall Study|Withdrawal by Subject|2|||
148782981|NCT05249127|536679118|FG000|Overall Study|Participant Non-compliance|1|||
148782982|NCT03646305|536679119|FG000|Overall Study|Lost to Follow-up|4|||
148782983|NCT03646305|536679120|FG001|Overall Study|Lost to Follow-up|2|||
148782984|NCT03646305|536679121|FG002|Overall Study|Lost to Follow-up|2|||
148782985|NCT03646305|536679122|FG003|Overall Study|Lost to Follow-up|1|||
148782986|NCT03646305|536679119|FG000|Overall Study|Withdrawal by Subject|1|||
148782987|NCT03646305|536679120|FG001|Overall Study|Withdrawal by Subject|0|||
148782988|NCT03646305|536679121|FG002|Overall Study|Withdrawal by Subject|0|||
148782989|NCT03646305|536679122|FG003|Overall Study|Withdrawal by Subject|1|||
148782990|NCT01554176|536679123|FG000|Treatment Phase|Protocol Violation|1|||
148782991|NCT01554176|536679124|FG001|Treatment Phase|Protocol Violation|2|||
148782992|NCT01554176|536679125|FG002|Treatment Phase|Protocol Violation|0|||
148782993|NCT01554176|536679126|FG003|Treatment Phase|Protocol Violation|0|||
148782994|NCT01554176|536679127|FG004|Treatment Phase|Protocol Violation|0|||
148782995|NCT01554176|536679123|FG000|Treatment Phase|Physician Decision|1|||
148782996|NCT01554176|536679124|FG001|Treatment Phase|Physician Decision|1|||
148782997|NCT01554176|536679125|FG002|Treatment Phase|Physician Decision|0|||
148782998|NCT01554176|536679126|FG003|Treatment Phase|Physician Decision|0|||
148782999|NCT01554176|536679127|FG004|Treatment Phase|Physician Decision|0|||
148783000|NCT01554176|536679123|FG000|Treatment Phase|Lack of Efficacy|0|||
148783001|NCT01554176|536679124|FG001|Treatment Phase|Lack of Efficacy|1|||
148783002|NCT01554176|536679125|FG002|Treatment Phase|Lack of Efficacy|0|||
148783003|NCT01554176|536679126|FG003|Treatment Phase|Lack of Efficacy|0|||
148783004|NCT01554176|536679127|FG004|Treatment Phase|Lack of Efficacy|0|||
148783005|NCT01554176|536679123|FG000|Treatment Phase|Adverse event, non-fatal|1|||
148783006|NCT01554176|536679124|FG001|Treatment Phase|Adverse event, non-fatal|1|||
148783007|NCT01554176|536679125|FG002|Treatment Phase|Adverse event, non-fatal|0|||
148783008|NCT01554176|536679126|FG003|Treatment Phase|Adverse event, non-fatal|0|||
148783009|NCT01554176|536679127|FG004|Treatment Phase|Adverse event, non-fatal|0|||
148783010|NCT01554176|536679123|FG000|Treatment Phase|Non-compliance with study drug|1|||
148783011|NCT01554176|536679124|FG001|Treatment Phase|Non-compliance with study drug|0|||
148783012|NCT01554176|536679125|FG002|Treatment Phase|Non-compliance with study drug|0|||
148783013|NCT01554176|536679126|FG003|Treatment Phase|Non-compliance with study drug|0|||
148783014|NCT01554176|536679127|FG004|Treatment Phase|Non-compliance with study drug|0|||
148783015|NCT01554176|536679123|FG000|Treatment Phase|Withdrawal by Subject|1|||
148783016|NCT01554176|536679124|FG001|Treatment Phase|Withdrawal by Subject|0|||
148783017|NCT01554176|536679125|FG002|Treatment Phase|Withdrawal by Subject|0|||
148783018|NCT01554176|536679126|FG003|Treatment Phase|Withdrawal by Subject|0|||
148783019|NCT01554176|536679127|FG004|Treatment Phase|Withdrawal by Subject|0|||
148783020|NCT01554176|536679123|FG000|Treatment Phase|Lost to Follow-up|3|||
148783021|NCT01554176|536679124|FG001|Treatment Phase|Lost to Follow-up|0|||
149122039|NCT00635427|537923621|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
149122040|NCT00635427|537923617|FG000|Overall Study|Death|0|||
149122041|NCT00635427|537923618|FG001|Overall Study|Death|0|||
149122042|NCT00635427|537923619|FG002|Overall Study|Death|0|||
149122043|NCT00635427|537923620|FG003|Overall Study|Death|1|||
149122044|NCT00635427|537923621|FG004|Overall Study|Death|0|||
148783022|NCT01554176|536679125|FG002|Treatment Phase|Lost to Follow-up|0|||
148783023|NCT01554176|536679126|FG003|Treatment Phase|Lost to Follow-up|0|||
148783024|NCT01554176|536679127|FG004|Treatment Phase|Lost to Follow-up|0|||
148783025|NCT01554176|536679123|FG000|Run-out Phase|Protocol Violation|0|||
148783026|NCT01554176|536679124|FG001|Run-out Phase|Protocol Violation|0|||
148783027|NCT01554176|536679125|FG002|Run-out Phase|Protocol Violation|0|||
148783028|NCT01554176|536679126|FG003|Run-out Phase|Protocol Violation|1|||
148783029|NCT01554176|536679127|FG004|Run-out Phase|Protocol Violation|0|||
148783030|NCT02607306|536679130|FG000|Overall Study|Adverse Event|8|||
148783031|NCT02607306|536679131|FG001|Overall Study|Adverse Event|6|||
148783032|NCT02607306|536679132|FG002|Overall Study|Adverse Event|6|||
148783033|NCT02607306|536679130|FG000|Overall Study|Unclassified|1|||
148783034|NCT02607306|536679131|FG001|Overall Study|Unclassified|4|||
148783035|NCT02607306|536679132|FG002|Overall Study|Unclassified|0|||
148783036|NCT02607306|536679130|FG000|Overall Study|Withdrawal by Subject|8|||
148783037|NCT02607306|536679131|FG001|Overall Study|Withdrawal by Subject|10|||
148783038|NCT02607306|536679132|FG002|Overall Study|Withdrawal by Subject|2|||
148783039|NCT02607306|536679130|FG000|Overall Study|Lack of Efficacy|0|||
148783040|NCT02607306|536679131|FG001|Overall Study|Lack of Efficacy|1|||
148783041|NCT02607306|536679132|FG002|Overall Study|Lack of Efficacy|1|||
148783042|NCT02607306|536679130|FG000|Overall Study|Protocol Violation|4|||
148783043|NCT02607306|536679131|FG001|Overall Study|Protocol Violation|2|||
148783044|NCT02607306|536679132|FG002|Overall Study|Protocol Violation|1|||
148783045|NCT00463840|536679133|FG000|Overall Study|Disease progression|7|||
148783046|NCT00463840|536679133|FG000|Overall Study|Withdrawal by Subject|2|||
148783047|NCT00463840|536679133|FG000|Overall Study|Adverse Event|3|||
148783048|NCT01653327|536679134|FG000|Overall Study|Withdrawal by Subject|1|||
148783049|NCT04683939|536679141|FG000|Overall Study|Study termination by the sponsor|0|||
148783050|NCT04683939|536679142|FG001|Overall Study|Study termination by the sponsor|1|||
148783051|NCT04683939|536679143|FG002|Overall Study|Study termination by the sponsor|2|||
148783052|NCT04683939|536679144|FG003|Overall Study|Study termination by the sponsor|2|||
148783053|NCT04683939|536679141|FG000|Overall Study|Death|1|||
148783054|NCT04683939|536679142|FG001|Overall Study|Death|1|||
149122045|NCT00635427|537923617|FG000|Overall Study|Termination Of Study By Sponsor|12|||
149122046|NCT00635427|537923618|FG001|Overall Study|Termination Of Study By Sponsor|6|||
149122047|NCT00635427|537923619|FG002|Overall Study|Termination Of Study By Sponsor|10|||
149122048|NCT00635427|537923620|FG003|Overall Study|Termination Of Study By Sponsor|6|||
149122049|NCT00635427|537923621|FG004|Overall Study|Termination Of Study By Sponsor|6|||
149122050|NCT00635427|537923617|FG000|Overall Study|Withdrawal Of Consent|0|||
149122051|NCT00635427|537923618|FG001|Overall Study|Withdrawal Of Consent|0|||
149122052|NCT00635427|537923619|FG002|Overall Study|Withdrawal Of Consent|0|||
149122053|NCT00635427|537923620|FG003|Overall Study|Withdrawal Of Consent|2|||
149122054|NCT00635427|537923621|FG004|Overall Study|Withdrawal Of Consent|2|||
149122055|NCT00938860|537923622|FG000|Overall Study|Adverse Event|2|||
149122056|NCT00938860|537923623|FG001|Overall Study|Adverse Event|1|||
149122057|NCT00938860|537923622|FG000|Overall Study|Abnormal laboratory values|2|||
149122058|NCT00938860|537923623|FG001|Overall Study|Abnormal laboratory values|2|||
149122059|NCT00938860|537923622|FG000|Overall Study|Withdrawal by Subject|11|||
149122060|NCT00938860|537923623|FG001|Overall Study|Withdrawal by Subject|8|||
149122061|NCT00938860|537923622|FG000|Overall Study|Lost to Follow-up|4|||
149122062|NCT00938860|537923623|FG001|Overall Study|Lost to Follow-up|4|||
149122063|NCT00938860|537923622|FG000|Overall Study|Administration problems|2|||
149122064|NCT00938860|537923623|FG001|Overall Study|Administration problems|0|||
149122065|NCT00938860|537923622|FG000|Overall Study|Death|1|||
149122066|NCT00938860|537923623|FG001|Overall Study|Death|1|||
149122067|NCT00938860|537923622|FG000|Overall Study|Protocol Violation|3|||
149122068|NCT00938860|537923623|FG001|Overall Study|Protocol Violation|1|||
149122069|NCT01605019|537923624|FG000|Overall Study|pt did not meet transplant endpoint|3|||
149122070|NCT01605019|537923625|FG001|Overall Study|pt did not meet transplant endpoint|0|||
149122071|NCT00468559|537923629|FG000|Open-label Treatment Phase|Adverse Event|5|||
148783055|NCT04683939|536679143|FG002|Overall Study|Death|2|||
148783056|NCT04683939|536679144|FG003|Overall Study|Death|1|||
148783057|NCT04683939|536679141|FG000|Overall Study|Withdrawal by Subject|1|||
148783058|NCT04683939|536679142|FG001|Overall Study|Withdrawal by Subject|0|||
148783059|NCT04683939|536679143|FG002|Overall Study|Withdrawal by Subject|0|||
148783060|NCT04683939|536679144|FG003|Overall Study|Withdrawal by Subject|0|||
149122072|NCT00468559|537923630|FG001|Open-label Treatment Phase|Adverse Event|0|||
149122073|NCT00468559|537923631|FG002|Open-label Treatment Phase|Adverse Event|0|||
149122074|NCT00468559|537923629|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
148783061|NCT04683939|536679141|FG000|Overall Study|Physician Decision|1|||
148783062|NCT04683939|536679142|FG001|Overall Study|Physician Decision|0|||
149122075|NCT00468559|537923630|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
149122076|NCT00468559|537923631|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
149122077|NCT00468559|537923629|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
149122078|NCT00468559|537923630|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
149122079|NCT00468559|537923631|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
149122080|NCT00468559|537923629|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
149122081|NCT00468559|537923630|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
149122082|NCT00468559|537923631|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
149122083|NCT00468559|537923629|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
149122084|NCT00468559|537923630|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
149122085|NCT00468559|537923631|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
149122086|NCT00324116|537923632|FG000|Overall Study|Adverse Event|5|||
149122087|NCT00324116|537923632|FG000|Overall Study|Lack of Efficacy|17|||
148783063|NCT04683939|536679143|FG002|Overall Study|Physician Decision|0|||
148783064|NCT04683939|536679144|FG003|Overall Study|Physician Decision|0|||
148783065|NCT04683939|536679141|FG000|Overall Study|Lost to Follow-up|0|||
148783066|NCT04683939|536679142|FG001|Overall Study|Lost to Follow-up|1|||
148783067|NCT04683939|536679143|FG002|Overall Study|Lost to Follow-up|0|||
148783068|NCT04683939|536679144|FG003|Overall Study|Lost to Follow-up|0|||
148783069|NCT01937715|536680781|FG000|Overall Study|Death|0|||
148783070|NCT01937715|536680782|FG001|Overall Study|Death|0|||
148783071|NCT01937715|536680783|FG002|Overall Study|Death|0|||
148783072|NCT01937715|536680784|FG003|Overall Study|Death|1|||
148783073|NCT01937715|536680785|FG004|Overall Study|Death|0|||
148783074|NCT01937715|536680781|FG000|Overall Study|Withdrawal by Subject|0|||
148783075|NCT01937715|536680782|FG001|Overall Study|Withdrawal by Subject|1|||
148783076|NCT01937715|536680783|FG002|Overall Study|Withdrawal by Subject|0|||
148783077|NCT01937715|536680784|FG003|Overall Study|Withdrawal by Subject|0|||
148783078|NCT01937715|536680785|FG004|Overall Study|Withdrawal by Subject|2|||
148783079|NCT01937715|536680781|FG000|Overall Study|Other|0|||
148783080|NCT01937715|536680782|FG001|Overall Study|Other|0|||
148783081|NCT01937715|536680783|FG002|Overall Study|Other|0|||
148783082|NCT01937715|536680784|FG003|Overall Study|Other|3|||
148783083|NCT01937715|536680785|FG004|Overall Study|Other|0|||
148783084|NCT01698268|536680788|FG000|Overall Study|Physician Decision|2|||
148783085|NCT01698268|536680789|FG001|Overall Study|Physician Decision|1|||
148783086|NCT00298363|536680791|FG000|Overall Study|Lost to Follow-up|0|||
148783087|NCT00298363|536680792|FG001|Overall Study|Lost to Follow-up|0|||
148783088|NCT00298363|536680793|FG002|Overall Study|Lost to Follow-up|1|||
148783089|NCT00298363|536680791|FG000|Overall Study|Physician Decision|4|||
148783090|NCT00298363|536680792|FG001|Overall Study|Physician Decision|1|||
148783091|NCT00298363|536680793|FG002|Overall Study|Physician Decision|0|||
148783092|NCT00298363|536680791|FG000|Overall Study|Protocol Violation|1|||
148783093|NCT00298363|536680792|FG001|Overall Study|Protocol Violation|1|||
148783094|NCT00298363|536680793|FG002|Overall Study|Protocol Violation|0|||
148783095|NCT00298363|536680791|FG000|Overall Study|Withdrawal by Subject|5|||
148783096|NCT00298363|536680792|FG001|Overall Study|Withdrawal by Subject|1|||
148783097|NCT00298363|536680793|FG002|Overall Study|Withdrawal by Subject|3|||
148783098|NCT00298363|536680791|FG000|Overall Study|Adverse Event|5|||
148783099|NCT00298363|536680792|FG001|Overall Study|Adverse Event|2|||
148783100|NCT00298363|536680793|FG002|Overall Study|Adverse Event|2|||
148783101|NCT00298363|536680791|FG000|Overall Study|Lack of Efficacy|2|||
148783102|NCT00298363|536680792|FG001|Overall Study|Lack of Efficacy|3|||
148783103|NCT00298363|536680793|FG002|Overall Study|Lack of Efficacy|0|||
148783104|NCT00135356|536680794|FG000|Overall Study|Adverse Event|6|||
148783105|NCT00135356|536680795|FG001|Overall Study|Adverse Event|2|||
148783106|NCT00135356|536680794|FG000|Overall Study|Lack of Efficacy|2|||
148783107|NCT00135356|536680795|FG001|Overall Study|Lack of Efficacy|0|||
148783108|NCT00135356|536680794|FG000|Overall Study|Lost to Follow-up|3|||
148783109|NCT00135356|536680795|FG001|Overall Study|Lost to Follow-up|1|||
148783110|NCT00135356|536680794|FG000|Overall Study|Surgery for abdominal fat|1|||
148783111|NCT00135356|536680795|FG001|Overall Study|Surgery for abdominal fat|0|||
148783112|NCT00135356|536680794|FG000|Overall Study|Change in antiviral regimen|0|||
148783113|NCT00135356|536680795|FG001|Overall Study|Change in antiviral regimen|1|||
148783114|NCT00135356|536680794|FG000|Overall Study|Poor/noncompliance|1|||
148783115|NCT00135356|536680795|FG001|Overall Study|Poor/noncompliance|1|||
148783116|NCT00135356|536680794|FG000|Overall Study|No longer meets study criteria|2|||
148783117|NCT00135356|536680795|FG001|Overall Study|No longer meets study criteria|0|||
148783118|NCT00135356|536680794|FG000|Overall Study|Withdrawal by Subject|2|||
148783119|NCT00135356|536680795|FG001|Overall Study|Withdrawal by Subject|4|||
148783120|NCT00153816|536680796|FG000|Overall Study|Death|6|||
148783121|NCT00153816|536680797|FG001|Overall Study|Death|5|||
148783122|NCT00153816|536680798|FG002|Overall Study|Death|4|||
148783123|NCT00153816|536680799|FG003|Overall Study|Death|6|||
148783124|NCT00153816|536680800|FG004|Overall Study|Death|0|||
148783125|NCT00153816|536680801|FG005|Overall Study|Death|2|||
148783126|NCT00153816|536680796|FG000|Overall Study|Lost to Follow-up|7|||
148783127|NCT00153816|536680797|FG001|Overall Study|Lost to Follow-up|8|||
148783128|NCT00153816|536680798|FG002|Overall Study|Lost to Follow-up|5|||
148783129|NCT00153816|536680799|FG003|Overall Study|Lost to Follow-up|8|||
149122088|NCT00324116|537923632|FG000|Overall Study|Withdrawal by Subject|5|||
149122089|NCT00324116|537923632|FG000|Overall Study|Other|5|||
149122090|NCT02703259|537923633|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
149122091|NCT02703259|537923634|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
149122092|NCT02703259|537923633|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
149122093|NCT02703259|537923634|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
149122094|NCT02703259|537923633|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
149122095|NCT02703259|537923634|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
148783130|NCT00153816|536680800|FG004|Overall Study|Lost to Follow-up|7|||
148783131|NCT00153816|536680801|FG005|Overall Study|Lost to Follow-up|9|||
148783132|NCT00153816|536680796|FG000|Overall Study|Withdrawal by Subject|9|||
148783133|NCT00153816|536680797|FG001|Overall Study|Withdrawal by Subject|9|||
149122096|NCT02624791|537923635|FG000|Overall Study|Withdrawal by Subject|2|||
149122097|NCT02624791|537923636|FG001|Overall Study|Withdrawal by Subject|0|||
149122098|NCT02624791|537923637|FG002|Overall Study|Withdrawal by Subject|0|||
149122099|NCT02624791|537923638|FG003|Overall Study|Withdrawal by Subject|0|||
149122100|NCT02624791|537923639|FG004|Overall Study|Withdrawal by Subject|0|||
149122101|NCT02624791|537923640|FG005|Overall Study|Withdrawal by Subject|0|||
149122102|NCT00998790|537923643|FG000|Overall Study|Withdrawal by Subject|21|||
149122103|NCT01993927|537923645|FG000|Overall Study|Case Report Forms Uncollected|18|||
149122104|NCT01993927|537923645|FG000|Overall Study|Protocol Violation|11|||
149122105|NCT00895154|537923646|FG000|Overall Study|Lost to Follow-up|1|||
149122106|NCT00895154|537923647|FG001|Overall Study|Lost to Follow-up|1|||
149122107|NCT00895154|537923646|FG000|Overall Study|Withdrawal by Subject|0|||
149122108|NCT00895154|537923647|FG001|Overall Study|Withdrawal by Subject|1|||
149122109|NCT00287690|537923650|FG000|Overall Study|Protocol Violation|20|||
149122110|NCT00287690|537923651|FG001|Overall Study|Protocol Violation|26|||
149122111|NCT01021215|537923654|FG000|Overall Study|Lost to Follow-up|3|||
149122112|NCT01021215|537923655|FG001|Overall Study|Lost to Follow-up|0|||
149122113|NCT01942590|537923656|FG000|Overall Study|Withdrawal by Subject|0|||
149122114|NCT01942590|537923657|FG001|Overall Study|Withdrawal by Subject|1|||
149122115|NCT01942590|537923656|FG000|Overall Study|Adverse Event|1|||
149122116|NCT01942590|537923657|FG001|Overall Study|Adverse Event|0|||
148783134|NCT00153816|536680798|FG002|Overall Study|Withdrawal by Subject|9|||
148783135|NCT00153816|536680799|FG003|Overall Study|Withdrawal by Subject|4|||
149122117|NCT01688830|537923658|FG000|Overall Study|Lost to Follow-up|0|||
149122118|NCT01688830|537923659|FG001|Overall Study|Lost to Follow-up|0|||
149122119|NCT01688830|537923660|FG002|Overall Study|Lost to Follow-up|0|||
149122120|NCT01688830|537923661|FG003|Overall Study|Lost to Follow-up|0|||
149122121|NCT01688830|537923662|FG004|Overall Study|Lost to Follow-up|0|||
149122122|NCT01688830|537923663|FG005|Overall Study|Lost to Follow-up|0|||
149122123|NCT01688830|537923664|FG006|Overall Study|Lost to Follow-up|0|||
149122124|NCT01688830|537923665|FG007|Overall Study|Lost to Follow-up|0|||
149122125|NCT01688830|537923666|FG008|Overall Study|Lost to Follow-up|0|||
149122126|NCT01688830|537923667|FG009|Overall Study|Lost to Follow-up|0|||
149122127|NCT01688830|537923668|FG010|Overall Study|Lost to Follow-up|1|||
149122128|NCT01688830|537923669|FG011|Overall Study|Lost to Follow-up|0|||
149122129|NCT01688830|537923670|FG012|Overall Study|Lost to Follow-up|0|||
149122130|NCT01688830|537923671|FG013|Overall Study|Lost to Follow-up|0|||
149122131|NCT01688830|537923672|FG014|Overall Study|Lost to Follow-up|0|||
149122132|NCT01688830|537923673|FG015|Overall Study|Lost to Follow-up|0|||
149122133|NCT01688830|537923674|FG016|Overall Study|Lost to Follow-up|0|||
149122134|NCT01688830|537923675|FG017|Overall Study|Lost to Follow-up|0|||
149122135|NCT01688830|537923676|FG018|Overall Study|Lost to Follow-up|0|||
149122136|NCT01688830|537923677|FG019|Overall Study|Lost to Follow-up|0|||
149122137|NCT01688830|537923678|FG020|Overall Study|Lost to Follow-up|0|||
149122138|NCT04822597|537923679|FG000|Overall Study|Withdrawal by Subject|0|||
149122139|NCT04822597|537923680|FG001|Overall Study|Withdrawal by Subject|1|||
149122140|NCT04822597|537923681|FG002|Overall Study|Withdrawal by Subject|1|||
149122141|NCT04822597|537923682|FG003|Overall Study|Withdrawal by Subject|0|||
149122142|NCT04822597|537923679|FG000|Overall Study|Physician Decision|0|||
149122143|NCT04822597|537923680|FG001|Overall Study|Physician Decision|0|||
149122144|NCT04822597|537923681|FG002|Overall Study|Physician Decision|1|||
149122145|NCT04822597|537923682|FG003|Overall Study|Physician Decision|1|||
149122146|NCT04822597|537923679|FG000|Overall Study|Subject withdrawn after enrollment|0|||
149122147|NCT04822597|537923680|FG001|Overall Study|Subject withdrawn after enrollment|1|||
149122148|NCT04822597|537923681|FG002|Overall Study|Subject withdrawn after enrollment|0|||
149122149|NCT04822597|537923682|FG003|Overall Study|Subject withdrawn after enrollment|1|||
149122150|NCT04822597|537923679|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
148783136|NCT00153816|536680800|FG004|Overall Study|Withdrawal by Subject|1|||
149122151|NCT04822597|537923680|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
149122152|NCT04822597|537923681|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
149122153|NCT04822597|537923682|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
149122154|NCT01285609|537923683|FG000|Randomized|Progressive Disease|41|||
148783137|NCT00153816|536680801|FG005|Overall Study|Withdrawal by Subject|5|||
148783138|NCT00153816|536680796|FG000|Overall Study|Follow-up exam not done|8|||
148783139|NCT00153816|536680797|FG001|Overall Study|Follow-up exam not done|7|||
148783140|NCT00153816|536680798|FG002|Overall Study|Follow-up exam not done|11|||
148783141|NCT00153816|536680799|FG003|Overall Study|Follow-up exam not done|10|||
148783142|NCT00153816|536680800|FG004|Overall Study|Follow-up exam not done|8|||
148783143|NCT00153816|536680801|FG005|Overall Study|Follow-up exam not done|9|||
148783144|NCT00153816|536680796|FG000|Overall Study|Follow-up exam done, histology missing|2|||
148783145|NCT00153816|536680797|FG001|Overall Study|Follow-up exam done, histology missing|3|||
148783146|NCT00153816|536680798|FG002|Overall Study|Follow-up exam done, histology missing|3|||
148783147|NCT00153816|536680799|FG003|Overall Study|Follow-up exam done, histology missing|3|||
148783148|NCT00153816|536680800|FG004|Overall Study|Follow-up exam done, histology missing|1|||
148783149|NCT00153816|536680801|FG005|Overall Study|Follow-up exam done, histology missing|2|||
148783150|NCT01533688|536680802|FG000|Overall Study|Withdrawal by Subject|5|||
148783151|NCT01533688|536680803|FG001|Overall Study|Withdrawal by Subject|4|||
148783152|NCT01533688|536680804|FG002|Overall Study|Withdrawal by Subject|3|||
148783153|NCT01533688|536680802|FG000|Overall Study|Medically unstable|1|||
148783154|NCT01533688|536680803|FG001|Overall Study|Medically unstable|3|||
148783155|NCT01533688|536680804|FG002|Overall Study|Medically unstable|3|||
148783156|NCT01533688|536680802|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
148783157|NCT01533688|536680803|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
148783158|NCT01533688|536680804|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
148783159|NCT02263729|536680805|FG000|Overall Study|Lost to Follow-up|1|||
148783160|NCT02263729|536680806|FG001|Overall Study|Lost to Follow-up|1|||
148783161|NCT04591015|536680807|FG000|Overall Study|Death|6|||
148783162|NCT04591015|536680808|FG001|Overall Study|Death|4|||
148783163|NCT04591015|536680807|FG000|Overall Study|Withdrawal by Subject|6|||
148783164|NCT04591015|536680808|FG001|Overall Study|Withdrawal by Subject|3|||
148783165|NCT04591015|536680807|FG000|Overall Study|Lost to Follow-up|16|||
148783166|NCT04591015|536680808|FG001|Overall Study|Lost to Follow-up|11|||
148783167|NCT00253370|536680809|FG000|Overall Study|Adverse Event|18|||
148783168|NCT00253370|536680809|FG000|Overall Study|Disease progression|13|||
148783169|NCT00253370|536680809|FG000|Overall Study|Death|2|||
148783170|NCT00253370|536680809|FG000|Overall Study|Withdrawal by Subject|6|||
148783171|NCT00253370|536680809|FG000|Overall Study|Non-protocol therapy|1|||
148783172|NCT00253370|536680809|FG000|Overall Study|Physician Decision|1|||
148783173|NCT00253370|536680809|FG000|Overall Study|Protocol Violation|1|||
148783174|NCT00253370|536680809|FG000|Overall Study|Abdominal pain due to disease|1|||
148783175|NCT00004088|536680812|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
148783176|NCT00004088|536680812|FG000|Overall Study|Withdrawal by Subject|1|||
148783177|NCT00004088|536680812|FG000|Overall Study|Protocol Violation|3|||
148783178|NCT00004088|536680812|FG000|Overall Study|Physician Decision|1|||
148783179|NCT01167634|536680819|FG000|Overall Study|Lost to Follow-up|1|||
148783180|NCT01167634|536680820|FG001|Overall Study|Lost to Follow-up|3|||
148783181|NCT01167634|536680821|FG002|Overall Study|Lost to Follow-up|3|||
148783182|NCT01167634|536680822|FG003|Overall Study|Lost to Follow-up|4|||
148783183|NCT01167634|536680819|FG000|Overall Study|Withdrawal by Subject|1|||
148783184|NCT01167634|536680820|FG001|Overall Study|Withdrawal by Subject|1|||
148783185|NCT01167634|536680821|FG002|Overall Study|Withdrawal by Subject|0|||
148783186|NCT01167634|536680822|FG003|Overall Study|Withdrawal by Subject|0|||
148783187|NCT00419159|536680832|FG000|Overall Study|Adverse Event|7|||
149122155|NCT01285609|537923684|FG001|Randomized|Progressive Disease|61|||
149122156|NCT01285609|537923683|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
149122157|NCT01285609|537923684|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
149122158|NCT01285609|537923683|FG000|Randomized|Study Drug Toxicity|13|||
149122159|NCT01285609|537923684|FG001|Randomized|Study Drug Toxicity|14|||
149122160|NCT01285609|537923683|FG000|Randomized|Death|5|||
149122161|NCT01285609|537923684|FG001|Randomized|Death|7|||
149122162|NCT01285609|537923683|FG000|Randomized|Withdrawal by Subject|8|||
149122163|NCT01285609|537923684|FG001|Randomized|Withdrawal by Subject|11|||
149122164|NCT01285609|537923683|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
148783188|NCT00419159|536680833|FG001|Overall Study|Adverse Event|15|||
148783189|NCT00419159|536680832|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148783190|NCT00419159|536680833|FG001|Overall Study|Abnormal laboratory value(s)|2|||
148783191|NCT00419159|536680832|FG000|Overall Study|Subject's no longer requires study drug|0|||
148783192|NCT00419159|536680833|FG001|Overall Study|Subject's no longer requires study drug|1|||
148783193|NCT00419159|536680832|FG000|Overall Study|Protocol Violation|1|||
148783194|NCT00419159|536680833|FG001|Overall Study|Protocol Violation|0|||
148783195|NCT00419159|536680832|FG000|Overall Study|Withdrawal by Subject|10|||
148783196|NCT00419159|536680833|FG001|Overall Study|Withdrawal by Subject|3|||
148783197|NCT00419159|536680832|FG000|Overall Study|Lost to Follow-up|0|||
148783198|NCT00419159|536680833|FG001|Overall Study|Lost to Follow-up|1|||
149122165|NCT01285609|537923684|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
149122166|NCT01285609|537923683|FG000|Randomized|Undisclosed Reasons|1|||
149122167|NCT01285609|537923684|FG001|Randomized|Undisclosed Reasons|0|||
148783199|NCT00419159|536680832|FG000|Overall Study|Death|2|||
148783200|NCT00419159|536680833|FG001|Overall Study|Death|2|||
148783201|NCT00419159|536680832|FG000|Overall Study|Disease progression|79|||
148783202|NCT00419159|536680833|FG001|Overall Study|Disease progression|76|||
149122168|NCT01285609|537923683|FG000|Randomized|Randomized but not Treated|4|||
149122169|NCT01285609|537923684|FG001|Randomized|Randomized but not Treated|4|||
149122170|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
149122171|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
149122172|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
149122173|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
149122174|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
149122175|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
149122176|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
149122177|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
149122178|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Death|11|||
149122179|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Death|3|||
149122180|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
149122181|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
149122182|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Not Reported|0|||
149122183|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Not Reported|2|||
149122184|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
149122185|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
149122186|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
149122187|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
149122188|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
149122189|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
149122190|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
149122191|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
149122192|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
149122193|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
149122194|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
149122195|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
149122196|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
149122197|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
149122198|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
149122199|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
149122200|NCT01285609|537923683|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
149122201|NCT01285609|537923684|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
149122202|NCT01285609|537923683|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
149122203|NCT01285609|537923684|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
149122204|NCT03406078|537923685|FG000|Overall Study|Death|1|||
149122205|NCT03406078|537923686|FG001|Overall Study|Death|0|||
149122206|NCT03406078|537923685|FG000|Overall Study|Lost to Follow-up|0|||
149122207|NCT03406078|537923686|FG001|Overall Study|Lost to Follow-up|1|||
149122208|NCT03406078|537923685|FG000|Overall Study|Withdrawal by Subject|5|||
149122209|NCT03406078|537923686|FG001|Overall Study|Withdrawal by Subject|2|||
149122210|NCT00591851|537923687|FG000|Overall Study|Withdrawal by Subject|3|||
149122211|NCT00591851|537923687|FG000|Overall Study|Adverse Event|2|||
149122212|NCT00591851|537923687|FG000|Overall Study|Progressive Disease|1|||
149122213|NCT03647488|537925389|FG000|Overall Study|Progressive disease|10|||
149122214|NCT03647488|537925390|FG001|Overall Study|Progressive disease|0|||
149122215|NCT03647488|537925391|FG002|Overall Study|Progressive disease|0|||
149122216|NCT03647488|537925389|FG000|Overall Study|Adverse Event|5|||
149122217|NCT03647488|537925390|FG001|Overall Study|Adverse Event|0|||
149122218|NCT03647488|537925391|FG002|Overall Study|Adverse Event|0|||
149122219|NCT03647488|537925389|FG000|Overall Study|Clinical progression|2|||
149122220|NCT03647488|537925390|FG001|Overall Study|Clinical progression|0|||
149122221|NCT03647488|537925391|FG002|Overall Study|Clinical progression|0|||
149122222|NCT03647488|537925389|FG000|Overall Study|Participant refused to take investigational product|1|||
149122223|NCT03647488|537925390|FG001|Overall Study|Participant refused to take investigational product|0|||
149122224|NCT03647488|537925391|FG002|Overall Study|Participant refused to take investigational product|0|||
149122225|NCT00812331|537925392|FG000|Overall Study|Adverse Event|1|||
149122226|NCT00812331|537925393|FG001|Overall Study|Adverse Event|0|||
149122227|NCT00812331|537925394|FG002|Overall Study|Adverse Event|0|||
149122228|NCT00812331|537925395|FG003|Overall Study|Adverse Event|0|||
149122229|NCT00812331|537925396|FG004|Overall Study|Adverse Event|0|||
148783203|NCT01017601|536680834|FG000|Overall Study|Disease Progression|12|||
149122230|NCT03694275|537925397|FG000|Overall Study|Adverse Event|0|||
149122231|NCT03694275|537925398|FG001|Overall Study|Adverse Event|1|||
149122232|NCT03694275|537925397|FG000|Overall Study|Reason not Specified|0|||
149122233|NCT03694275|537925398|FG001|Overall Study|Reason not Specified|1|||
149122234|NCT02502799|537925399|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
148783204|NCT01017601|536680835|FG001|Overall Study|Disease Progression|12|||
148783205|NCT01017601|536680834|FG000|Overall Study|Withdrawal by Subject|0|||
149122235|NCT02502799|537925400|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
149122236|NCT02502799|537925401|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
149122237|NCT02502799|537925402|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
149122238|NCT02502799|537925399|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
149122239|NCT02502799|537925400|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
149122240|NCT02502799|537925401|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
149122241|NCT02502799|537925402|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
149122242|NCT02502799|537925399|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
149122243|NCT02502799|537925400|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
149122244|NCT02502799|537925401|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
149122245|NCT02502799|537925402|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
149122246|NCT02502799|537925399|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
149122247|NCT02502799|537925400|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
149122248|NCT02502799|537925401|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
149122249|NCT02502799|537925402|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
149122250|NCT02502799|537925399|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
149122251|NCT02502799|537925400|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
149122252|NCT02502799|537925401|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
149122253|NCT02502799|537925402|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
149122254|NCT00153062|537925408|FG000|Overall Study|Death|360|||
149122255|NCT00153062|537925409|FG001|Overall Study|Death|352|||
149122256|NCT00153062|537925410|FG002|Overall Study|Death|369|||
149122257|NCT00153062|537925411|FG003|Overall Study|Death|365|||
149122258|NCT00153062|537925408|FG000|Overall Study|Withdrawal by Subject|14|||
149122259|NCT00153062|537925409|FG001|Overall Study|Withdrawal by Subject|30|||
149122260|NCT00153062|537925410|FG002|Overall Study|Withdrawal by Subject|27|||
149122261|NCT00153062|537925411|FG003|Overall Study|Withdrawal by Subject|28|||
149122262|NCT00153062|537925408|FG000|Overall Study|Lost to Follow-up|12|||
149122263|NCT00153062|537925409|FG001|Overall Study|Lost to Follow-up|20|||
149122264|NCT00153062|537925410|FG002|Overall Study|Lost to Follow-up|15|||
149122265|NCT00153062|537925411|FG003|Overall Study|Lost to Follow-up|16|||
149122266|NCT00153062|537925408|FG000|Overall Study|Adverse Event|0|||
149122267|NCT00153062|537925409|FG001|Overall Study|Adverse Event|1|||
149122268|NCT00153062|537925410|FG002|Overall Study|Adverse Event|1|||
149122269|NCT00153062|537925411|FG003|Overall Study|Adverse Event|0|||
149122270|NCT00153062|537925408|FG000|Overall Study|Protocol Violation|0|||
149122271|NCT00153062|537925409|FG001|Overall Study|Protocol Violation|2|||
149122272|NCT00153062|537925410|FG002|Overall Study|Protocol Violation|1|||
149122273|NCT00153062|537925411|FG003|Overall Study|Protocol Violation|1|||
149122274|NCT00153062|537925408|FG000|Overall Study|No disposition data available|1|||
149122275|NCT00153062|537925409|FG001|Overall Study|No disposition data available|1|||
149122276|NCT00153062|537925410|FG002|Overall Study|No disposition data available|1|||
149122277|NCT00153062|537925411|FG003|Overall Study|No disposition data available|1|||
149122278|NCT00153062|537925408|FG000|Overall Study|Other|0|||
149122279|NCT00153062|537925409|FG001|Overall Study|Other|0|||
149122280|NCT00153062|537925410|FG002|Overall Study|Other|1|||
149122281|NCT00153062|537925411|FG003|Overall Study|Other|0|||
149122282|NCT01589237|537925433|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
149122283|NCT01589237|537925434|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
149122284|NCT01589237|537925435|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
149122285|NCT01589237|537925436|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
149122286|NCT01589237|537925433|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
149122287|NCT01589237|537925434|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
149122288|NCT01589237|537925435|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
149122289|NCT01589237|537925436|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
149122290|NCT01589237|537925433|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
149122291|NCT01589237|537925434|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
149122292|NCT01589237|537925435|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
148783206|NCT01017601|536680835|FG001|Overall Study|Withdrawal by Subject|1|||
148783207|NCT00187278|536680836|FG000|Overall Study|Protocol Violation|10|||
149122293|NCT01589237|537925436|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
149122294|NCT01589237|537925433|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
149122295|NCT01589237|537925434|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
149122296|NCT01589237|537925435|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
149122297|NCT01589237|537925436|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
149122298|NCT01022268|537925438|FG000|Overall Study|Withdrawal by Subject|1|||
149122299|NCT01022268|537925439|FG001|Overall Study|Withdrawal by Subject|0|||
149122300|NCT01022268|537925438|FG000|Overall Study|Withdrawal by Subject|1|||
149122301|NCT01022268|537925439|FG001|Overall Study|Withdrawal by Subject|0|||
148783208|NCT00187278|536680837|FG001|Overall Study|Protocol Violation|13|||
148783209|NCT01857102|536680838|FG000|Period 1|No longer meets Eligibility Criteria|0|||
149122302|NCT00734097|537925440|FG000|Screening|Protocol Violation|12|||
149122303|NCT00734097|537925440|FG000|Screening|Withdrawal by Subject|5|||
149122304|NCT00734097|537925440|FG000|Screening|Lost to Follow-up|2|||
149122305|NCT00734097|537925440|FG000|Screening|Unconfirmed pregnancy|1|||
149122306|NCT00734097|537925440|FG000|Open Label|Lost to Follow-up|7|||
149122307|NCT00734097|537925440|FG000|Open Label|Withdrawal by Subject|5|||
149122308|NCT00734097|537925440|FG000|Open Label|Protocol Violation|4|||
149122309|NCT00910689|537925441|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
149122310|NCT00910689|537925442|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
149122311|NCT00910689|537925443|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
149122312|NCT00910689|537925444|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
149122313|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
149122314|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
149122315|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
149122316|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
149122317|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
149122318|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
149122319|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
149122320|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
149122321|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
149122322|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
149122323|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
149122324|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
149122325|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
149122326|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
149122327|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
149122328|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
149122329|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
149122330|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
149122331|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
149122332|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
149122333|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
149122334|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
149122335|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
149122336|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
149122337|NCT00910689|537925441|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
149122338|NCT00910689|537925442|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
149122339|NCT00910689|537925443|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
149122340|NCT00910689|537925444|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
149122341|NCT00910689|537925441|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
149122342|NCT00910689|537925442|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
149122343|NCT00910689|537925443|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
149122344|NCT00910689|537925444|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
149122345|NCT00910689|537925441|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
149122346|NCT00910689|537925442|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
149122347|NCT00910689|537925443|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
149122348|NCT00910689|537925444|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
149122349|NCT00910689|537925441|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
149122350|NCT00910689|537925442|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
149122351|NCT00910689|537925443|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
149122352|NCT00910689|537925444|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
149122353|NCT00910689|537925441|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
149122354|NCT00910689|537925442|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
149122355|NCT00910689|537925443|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
149122356|NCT00910689|537925444|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
149122357|NCT00910689|537925441|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
149122358|NCT00910689|537925442|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
149122359|NCT00910689|537925443|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
149122360|NCT00910689|537925444|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
149122361|NCT00910689|537925441|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
149122362|NCT00910689|537925442|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
149122363|NCT00910689|537925443|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
149122364|NCT00910689|537925444|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
149122365|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
149122366|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
149122367|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
149122368|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
149122369|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
149122370|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
149122371|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
148783210|NCT01857102|536680839|FG001|Period 1|No longer meets Eligibility Criteria|2|||
148783211|NCT01857102|536680838|FG000|Period 1|Lost to Follow-up|0|||
148783212|NCT01857102|536680839|FG001|Period 1|Lost to Follow-up|3|||
148783213|NCT01857102|536680838|FG000|Period 1|Unsatisfactory Lens Fit|1|||
148783214|NCT01857102|536680839|FG001|Period 1|Unsatisfactory Lens Fit|0|||
148783215|NCT01857102|536680838|FG000|Period 1|Unsatisfactory Visual Response|1|||
148783216|NCT01857102|536680839|FG001|Period 1|Unsatisfactory Visual Response|0|||
148783217|NCT01857102|536680838|FG000|Period 1|Physician Decision|1|||
148783218|NCT01857102|536680839|FG001|Period 1|Physician Decision|0|||
148783219|NCT01857102|536680838|FG000|Period 2|Lens Discomfort|1|||
148783220|NCT01857102|536680839|FG001|Period 2|Lens Discomfort|0|||
148783221|NCT01857102|536680838|FG000|Period 2|Unsatisfactory Lens Fit|1|||
148783222|NCT01857102|536680839|FG001|Period 2|Unsatisfactory Lens Fit|0|||
148783223|NCT00090584|536680845|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
148783224|NCT00090584|536680846|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
148783225|NCT00090584|536680845|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
148783226|NCT00090584|536680846|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
148783227|NCT02735096|536680847|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
148783228|NCT01080391|536680855|FG000|Overall Study|Randomized but not treated|7|||
148783229|NCT01080391|536680856|FG001|Overall Study|Randomized but not treated|4|||
148783230|NCT02117713|536680858|FG000|Week 48|Adverse Event|4|||
148783231|NCT02117713|536680858|FG000|Week 48|Withdrawal by caregiver|2|||
148783232|NCT02117713|536680858|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
148783233|NCT02117713|536680858|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
148783234|NCT02117713|536680858|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
148783235|NCT02117713|536680858|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
148783236|NCT01094782|536680859|FG000|Overall Study|Withdrawal by Subject|5|||
148783237|NCT01094782|536680860|FG001|Overall Study|Withdrawal by Subject|5|||
148783238|NCT01094782|536680861|FG002|Overall Study|Withdrawal by Subject|1|||
148783239|NCT01094782|536680862|FG003|Overall Study|Withdrawal by Subject|5|||
148783240|NCT01094782|536680863|FG004|Overall Study|Withdrawal by Subject|5|||
148783241|NCT01094782|536680864|FG005|Overall Study|Withdrawal by Subject|0|||
148783242|NCT01094782|536680859|FG000|Overall Study|Lost to Follow-up|1|||
148783243|NCT01094782|536680860|FG001|Overall Study|Lost to Follow-up|0|||
148783244|NCT01094782|536680861|FG002|Overall Study|Lost to Follow-up|0|||
148783245|NCT01094782|536680862|FG003|Overall Study|Lost to Follow-up|2|||
148783246|NCT01094782|536680863|FG004|Overall Study|Lost to Follow-up|1|||
148783247|NCT01094782|536680864|FG005|Overall Study|Lost to Follow-up|4|||
148783248|NCT01094782|536680859|FG000|Overall Study|Positive Drug Screen|2|||
148783249|NCT01094782|536680860|FG001|Overall Study|Positive Drug Screen|2|||
148783250|NCT01094782|536680861|FG002|Overall Study|Positive Drug Screen|1|||
148783251|NCT01094782|536680862|FG003|Overall Study|Positive Drug Screen|1|||
148783252|NCT01094782|536680863|FG004|Overall Study|Positive Drug Screen|3|||
148783253|NCT01094782|536680864|FG005|Overall Study|Positive Drug Screen|2|||
148783254|NCT01094782|536680859|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
148783255|NCT01094782|536680860|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
148783256|NCT01094782|536680861|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
148783257|NCT01094782|536680862|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
148783258|NCT01094782|536680863|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
148783259|NCT01094782|536680864|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
148783260|NCT01094782|536680859|FG000|Overall Study|Unable to Complete Questionnaires|0|||
148783261|NCT01094782|536680860|FG001|Overall Study|Unable to Complete Questionnaires|1|||
148783262|NCT01094782|536680861|FG002|Overall Study|Unable to Complete Questionnaires|0|||
148783263|NCT01094782|536680862|FG003|Overall Study|Unable to Complete Questionnaires|0|||
148783264|NCT01094782|536680863|FG004|Overall Study|Unable to Complete Questionnaires|0|||
148783265|NCT01094782|536680864|FG005|Overall Study|Unable to Complete Questionnaires|0|||
148783266|NCT01094782|536680859|FG000|Overall Study|Healthy Subject Had Pain|0|||
148783267|NCT01094782|536680860|FG001|Overall Study|Healthy Subject Had Pain|1|||
148783268|NCT01094782|536680861|FG002|Overall Study|Healthy Subject Had Pain|0|||
148893350|NCT00683878|537088679|FG001|Overall Study|Withdrawal by Subject|8|||
148783269|NCT01094782|536680862|FG003|Overall Study|Healthy Subject Had Pain|0|||
148783270|NCT01094782|536680863|FG004|Overall Study|Healthy Subject Had Pain|0|||
148783271|NCT01094782|536680864|FG005|Overall Study|Healthy Subject Had Pain|0|||
148783272|NCT01094782|536680859|FG000|Overall Study|Hypertension|0|||
148783273|NCT01094782|536680860|FG001|Overall Study|Hypertension|0|||
148783274|NCT01094782|536680861|FG002|Overall Study|Hypertension|1|||
148783275|NCT01094782|536680862|FG003|Overall Study|Hypertension|0|||
148783276|NCT01094782|536680863|FG004|Overall Study|Hypertension|0|||
148783277|NCT01094782|536680864|FG005|Overall Study|Hypertension|0|||
148783278|NCT01094782|536680859|FG000|Overall Study|Wrong Pain Condition|0|||
148783279|NCT01094782|536680860|FG001|Overall Study|Wrong Pain Condition|0|||
148783280|NCT01094782|536680861|FG002|Overall Study|Wrong Pain Condition|0|||
148783281|NCT01094782|536680862|FG003|Overall Study|Wrong Pain Condition|2|||
148783282|NCT01094782|536680863|FG004|Overall Study|Wrong Pain Condition|1|||
148783283|NCT01094782|536680864|FG005|Overall Study|Wrong Pain Condition|1|||
148893351|NCT00683878|537088680|FG002|Overall Study|Withdrawal by Subject|6|||
148783284|NCT01094782|536680859|FG000|Overall Study|Recent Interventional Injection|0|||
148783285|NCT01094782|536680860|FG001|Overall Study|Recent Interventional Injection|0|||
148783286|NCT01094782|536680861|FG002|Overall Study|Recent Interventional Injection|0|||
148783287|NCT01094782|536680862|FG003|Overall Study|Recent Interventional Injection|0|||
148783288|NCT01094782|536680863|FG004|Overall Study|Recent Interventional Injection|0|||
148783289|NCT01094782|536680864|FG005|Overall Study|Recent Interventional Injection|1|||
148783290|NCT01094782|536680859|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
148783291|NCT01094782|536680860|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
148783292|NCT01094782|536680861|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
148783293|NCT01094782|536680862|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
148783294|NCT01094782|536680863|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
148783295|NCT01094782|536680864|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
148783296|NCT01094782|536680859|FG000|Overall Study|Noncompliance With Study Schedule|0|||
148783297|NCT01094782|536680860|FG001|Overall Study|Noncompliance With Study Schedule|0|||
148783298|NCT01094782|536680861|FG002|Overall Study|Noncompliance With Study Schedule|0|||
148783299|NCT01094782|536680862|FG003|Overall Study|Noncompliance With Study Schedule|1|||
148783300|NCT01094782|536680863|FG004|Overall Study|Noncompliance With Study Schedule|0|||
148783301|NCT01094782|536680864|FG005|Overall Study|Noncompliance With Study Schedule|0|||
148783302|NCT02083653|536680866|FG000|Overall Study|Randomized but not Treated|0|||
148783303|NCT02083653|536680867|FG001|Overall Study|Randomized but not Treated|2|||
148783304|NCT02083653|536680868|FG002|Overall Study|Randomized but not Treated|7|||
148783305|NCT02083653|536680866|FG000|Overall Study|Adverse Event|12|||
148783306|NCT02083653|536680867|FG001|Overall Study|Adverse Event|5|||
148783307|NCT02083653|536680868|FG002|Overall Study|Adverse Event|4|||
148783308|NCT02083653|536680866|FG000|Overall Study|Lost to Follow-up|1|||
148783309|NCT02083653|536680867|FG001|Overall Study|Lost to Follow-up|0|||
148783310|NCT02083653|536680868|FG002|Overall Study|Lost to Follow-up|0|||
148783311|NCT02083653|536680866|FG000|Overall Study|Death|2|||
148783312|NCT02083653|536680867|FG001|Overall Study|Death|2|||
148783313|NCT02083653|536680868|FG002|Overall Study|Death|2|||
148783314|NCT02083653|536680866|FG000|Overall Study|Progressive Disease|65|||
148783315|NCT02083653|536680867|FG001|Overall Study|Progressive Disease|73|||
148783316|NCT02083653|536680868|FG002|Overall Study|Progressive Disease|63|||
148783317|NCT02083653|536680866|FG000|Overall Study|Withdrawal by Subject|2|||
148783318|NCT02083653|536680867|FG001|Overall Study|Withdrawal by Subject|1|||
148783319|NCT02083653|536680868|FG002|Overall Study|Withdrawal by Subject|2|||
148783320|NCT02083653|536680866|FG000|Overall Study|Other Events|0|||
148783321|NCT02083653|536680867|FG001|Overall Study|Other Events|2|||
148783322|NCT02083653|536680868|FG002|Overall Study|Other Events|2|||
148783323|NCT02083653|536680866|FG000|Overall Study|Reason Missing|0|||
148783324|NCT02083653|536680867|FG001|Overall Study|Reason Missing|0|||
148783325|NCT02083653|536680868|FG002|Overall Study|Reason Missing|4|||
148783326|NCT00957905|536680869|FG000|Part B|Not Treated|0|||
148783327|NCT00957905|536680870|FG001|Part B|Not Treated|1|||
148783328|NCT00957905|536680869|FG000|Part B|Physician Decision|0|||
148783329|NCT00957905|536680870|FG001|Part B|Physician Decision|1|||
148783330|NCT00957905|536680869|FG000|Part B|Death|0|||
148783331|NCT00957905|536680870|FG001|Part B|Death|1|||
148783332|NCT00957905|536680869|FG000|Part B|Protocol Violation|0|||
148783333|NCT00957905|536680870|FG001|Part B|Protocol Violation|1|||
148783334|NCT02073656|536680873|FG000|Primary Study|Lost to Follow-up|6|||
148783335|NCT02073656|536680873|FG000|Primary Study|Death|1|||
148783336|NCT02073656|536680873|FG000|Primary Study|Withdrew Consent|1|||
148783337|NCT02028169|536680876|FG000|Overall Study|Lost to Follow-up|21|||
148783338|NCT02028169|536680876|FG000|Overall Study|Lack of Efficacy|2|||
148783339|NCT02028169|536680876|FG000|Overall Study|Withdrawal by Subject|2|||
148783340|NCT02028169|536680876|FG000|Overall Study|Adverse Event|1|||
148783341|NCT02028169|536680876|FG000|Overall Study|Cessation of Drug|1|||
148783342|NCT02028169|536680876|FG000|Overall Study|Concomitant Medication Usage|1|||
148783343|NCT01969084|536680879|FG000|Overall Study|Adverse Event|0|||
148783344|NCT01969084|536680880|FG001|Overall Study|Adverse Event|1|||
148783345|NCT02054910|536680881|FG000|Overall Study|Lost to Follow-up|4|||
148783346|NCT02054910|536680882|FG001|Overall Study|Lost to Follow-up|1|||
148783347|NCT02920177|536680883|FG000|Overall Study|Withdrawal by Subject|1|||
148783348|NCT02920177|536680884|FG001|Overall Study|Withdrawal by Subject|1|||
148783349|NCT02920177|536680883|FG000|Overall Study|Physician Decision|1|||
148783350|NCT02920177|536680884|FG001|Overall Study|Physician Decision|0|||
148783351|NCT02920177|536680883|FG000|Overall Study|Lost to Follow-up|0|||
148783352|NCT02920177|536680884|FG001|Overall Study|Lost to Follow-up|1|||
148783353|NCT04907227|536680885|FG000|Overall Study|Death|12|||
148783354|NCT04907227|536680886|FG001|Overall Study|Death|8|||
148783355|NCT04907227|536680885|FG000|Overall Study|Withdrawal by Subject|2|||
148783356|NCT04907227|536680886|FG001|Overall Study|Withdrawal by Subject|2|||
148783357|NCT04907227|536680885|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
148783358|NCT04907227|536680886|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
148783359|NCT04907227|536680885|FG000|Overall Study|Sponsor Decision|25|||
148783360|NCT04907227|536680886|FG001|Overall Study|Sponsor Decision|30|||
148783361|NCT04907227|536680885|FG000|Overall Study|Physician Decision|1|||
148783362|NCT04907227|536680886|FG001|Overall Study|Physician Decision|0|||
148783363|NCT03723070|536680887|FG000|Overall Study|Lost to Follow-up|2|||
149122372|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
149122373|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
149122374|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
149122375|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
149122376|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
149122377|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
149122378|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
149122379|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
149122380|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
149122381|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
149122382|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
149122383|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
149122384|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
149122385|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
149122386|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
149122387|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
149122388|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
149122389|NCT00910689|537925441|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
149122390|NCT00910689|537925442|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
149122391|NCT00910689|537925443|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
149122392|NCT00910689|537925444|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
149122393|NCT03207009|537925447|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
149122394|NCT01877837|537925448|FG000|Overall Study|Lost to Follow-up|1|||
149122395|NCT01877837|537925448|FG000|Overall Study|Ineligible|4|||
149122396|NCT00932113|537925451|FG000|Overall Study|Lost to Follow-up|1|||
149122397|NCT00932113|537925452|FG001|Overall Study|Lost to Follow-up|0|||
149122398|NCT01773291|537925453|FG000|Overall Study|Protocol Violation|1|||
149122399|NCT01773291|537925454|FG001|Overall Study|Protocol Violation|0|||
149122400|NCT01773291|537925455|FG002|Overall Study|Protocol Violation|0|||
149122401|NCT01773291|537925453|FG000|Overall Study|Withdrawal by Subject|0|||
149122402|NCT01773291|537925454|FG001|Overall Study|Withdrawal by Subject|0|||
149122403|NCT01773291|537925455|FG002|Overall Study|Withdrawal by Subject|1|||
149122404|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
149122405|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
149122406|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
149122407|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
149122408|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
149122409|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
149122410|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
149122411|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
149122412|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
149122413|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
149122414|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
149122415|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
149122416|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
149122417|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
149122418|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
149122419|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
149122420|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
149122421|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
149122422|NCT02480153|537925456|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
149122423|NCT02480153|537925457|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
149122424|NCT02480153|537925458|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
149122425|NCT02480153|537925456|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
149122426|NCT02480153|537925457|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
149122427|NCT02480153|537925458|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
149122428|NCT02480153|537925456|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
149122429|NCT02480153|537925457|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
149122430|NCT02480153|537925458|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
149122431|NCT02480153|537925456|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
149122432|NCT02480153|537925457|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
148783364|NCT03723070|536680887|FG000|Overall Study|Physician Decision|1|||
148783365|NCT03723070|536680887|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
148783366|NCT02678000|536680888|FG000|PART 2|Adverse Event|0|||
148783367|NCT02678000|536680889|FG001|PART 2|Adverse Event|0|||
148783368|NCT02678000|536680890|FG002|PART 2|Adverse Event|2|||
148783369|NCT02678000|536680891|FG003|PART 2|Adverse Event|1|||
148783370|NCT02678000|536680892|FG004|PART 2|Adverse Event|0|||
148783371|NCT02678000|536680888|FG000|PART 2|Withdrawal by Subject|0|||
148783372|NCT02678000|536680889|FG001|PART 2|Withdrawal by Subject|0|||
148783373|NCT02678000|536680890|FG002|PART 2|Withdrawal by Subject|1|||
148783374|NCT02678000|536680891|FG003|PART 2|Withdrawal by Subject|0|||
148783375|NCT02678000|536680892|FG004|PART 2|Withdrawal by Subject|0|||
148783376|NCT03053427|536680893|FG000|Overall Study|Adverse Event|4|||
148783377|NCT03053427|536680894|FG001|Overall Study|Adverse Event|4|||
148783378|NCT03053427|536680893|FG000|Overall Study|Lack of Efficacy|1|||
148783379|NCT03053427|536680894|FG001|Overall Study|Lack of Efficacy|3|||
148783380|NCT03053427|536680893|FG000|Overall Study|Lost to Follow-up|2|||
148783381|NCT03053427|536680894|FG001|Overall Study|Lost to Follow-up|2|||
148783382|NCT03053427|536680893|FG000|Overall Study|Worsening of the target disease|0|||
148783383|NCT03053427|536680894|FG001|Overall Study|Worsening of the target disease|1|||
148783384|NCT03053427|536680893|FG000|Overall Study|Protocol Deviation|3|||
148783385|NCT03053427|536680894|FG001|Overall Study|Protocol Deviation|3|||
148783386|NCT03053427|536680893|FG000|Overall Study|Withdrawal by Subject|3|||
148783387|NCT03053427|536680894|FG001|Overall Study|Withdrawal by Subject|2|||
148783388|NCT03053427|536680893|FG000|Overall Study|Miscellaneous|0|||
148783389|NCT03053427|536680894|FG001|Overall Study|Miscellaneous|1|||
148783390|NCT02360475|536680903|FG000|Overall Study|Lost to Follow-up|4|||
148783391|NCT02360475|536680904|FG001|Overall Study|Lost to Follow-up|12|||
148783392|NCT02360475|536680905|FG002|Overall Study|Lost to Follow-up|6|||
148783393|NCT02360475|536680906|FG003|Overall Study|Lost to Follow-up|4|||
148783394|NCT02360475|536680903|FG000|Overall Study|Withdrawal by Subject|0|||
148783395|NCT02360475|536680904|FG001|Overall Study|Withdrawal by Subject|1|||
148783396|NCT02360475|536680905|FG002|Overall Study|Withdrawal by Subject|2|||
148783397|NCT02360475|536680906|FG003|Overall Study|Withdrawal by Subject|0|||
148783398|NCT02360475|536680903|FG000|Overall Study|Migrated/moved from study area|0|||
148783399|NCT02360475|536680904|FG001|Overall Study|Migrated/moved from study area|0|||
148783400|NCT02360475|536680905|FG002|Overall Study|Migrated/moved from study area|0|||
148783401|NCT02360475|536680906|FG003|Overall Study|Migrated/moved from study area|1|||
148783402|NCT00207727|536680908|FG000|Overall Study|Withdrawal by Subject|0|||
148783403|NCT00207727|536680909|FG001|Overall Study|Withdrawal by Subject|0|||
148783404|NCT00207727|536680910|FG002|Overall Study|Withdrawal by Subject|0|||
148783405|NCT00207727|536680911|FG003|Overall Study|Withdrawal by Subject|0|||
148783406|NCT00207727|536680912|FG004|Overall Study|Withdrawal by Subject|1|||
148783407|NCT00207727|536680908|FG000|Overall Study|Lost to Follow-up|0|||
148783408|NCT00207727|536680909|FG001|Overall Study|Lost to Follow-up|1|||
148783409|NCT00207727|536680910|FG002|Overall Study|Lost to Follow-up|0|||
148783410|NCT00207727|536680911|FG003|Overall Study|Lost to Follow-up|0|||
148783411|NCT00207727|536680912|FG004|Overall Study|Lost to Follow-up|0|||
148783412|NCT00207727|536680908|FG000|Overall Study|Other|38|||
148783413|NCT00207727|536680909|FG001|Overall Study|Other|41|||
148783414|NCT00207727|536680910|FG002|Overall Study|Other|41|||
148783415|NCT00207727|536680911|FG003|Overall Study|Other|37|||
148783416|NCT00207727|536680912|FG004|Overall Study|Other|33|||
148783417|NCT03759366|536680913|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
148783418|NCT03759366|536680913|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
148783419|NCT03759366|536680913|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
148783420|NCT03759366|536680913|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
148783421|NCT03759366|536680913|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
148783422|NCT03759366|536680913|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
148783423|NCT03759366|536680913|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
148783424|NCT00539032|536680917|FG000|Overall Study|Withdrawal by Subject|2|||
148783425|NCT00539032|536680918|FG001|Overall Study|Withdrawal by Subject|1|||
148783426|NCT02333383|536680919|FG000|Overall Study|Adalimumab discontinuation|21|||
148783427|NCT02333383|536680919|FG000|Overall Study|Lost to Follow-up|15|||
148783428|NCT02333383|536680919|FG000|Overall Study|Withdrawal by Subject|3|||
148783429|NCT02333383|536680919|FG000|Overall Study|Transfer to another hospital|2|||
148783430|NCT00866333|536680926|FG000|Overall Study|Withdrawal of consent|0|||
148783431|NCT00866333|536680927|FG001|Overall Study|Withdrawal of consent|1|||
148783432|NCT00866333|536680928|FG002|Overall Study|Withdrawal of consent|2|||
148783433|NCT00866333|536680926|FG000|Overall Study|Reason not Specified|3|||
148783434|NCT00866333|536680927|FG001|Overall Study|Reason not Specified|1|||
148783435|NCT00866333|536680928|FG002|Overall Study|Reason not Specified|1|||
148783436|NCT00866333|536680926|FG000|Overall Study|Study Terminated by Sponsor|2|||
148783437|NCT00866333|536680927|FG001|Overall Study|Study Terminated by Sponsor|5|||
148783438|NCT00866333|536680928|FG002|Overall Study|Study Terminated by Sponsor|9|||
148783439|NCT02669082|536680929|FG000|Overall Study|Adverse Event|1|||
148783440|NCT04918355|536680930|FG000|Overall Study|no qualifying health encounter|497|||
148783441|NCT04918355|536680931|FG001|Overall Study|no qualifying health encounter|192|||
148783442|NCT04918355|536680932|FG002|Overall Study|no qualifying health encounter|438|||
148783443|NCT04918355|536680933|FG003|Overall Study|no qualifying health encounter|424|||
148783444|NCT04852276|536680934|FG000|Overall Study|Death|2|||
148783445|NCT04852276|536680935|FG001|Overall Study|Death|0|||
148783446|NCT04852276|536680934|FG000|Overall Study|Lost to Follow-up|15|||
148783447|NCT04852276|536680935|FG001|Overall Study|Lost to Follow-up|9|||
148783448|NCT04852276|536680934|FG000|Overall Study|Withdrawal by Subject|26|||
148783449|NCT04852276|536680935|FG001|Overall Study|Withdrawal by Subject|6|||
148783450|NCT00703326|536682365|FG000|Overall Study|Lost to Follow-up|47|||
148783451|NCT00703326|536682366|FG001|Overall Study|Lost to Follow-up|18|||
148783452|NCT00703326|536682365|FG000|Overall Study|Withdrawal by Subject|54|||
148783453|NCT00703326|536682366|FG001|Overall Study|Withdrawal by Subject|20|||
148783454|NCT00703326|536682365|FG000|Overall Study|Adverse Event|1|||
148783455|NCT00703326|536682366|FG001|Overall Study|Adverse Event|0|||
148783456|NCT01393106|536682368|FG000|Overall Study|Adverse Event|3|||
148783457|NCT01393106|536682368|FG000|Overall Study|Withdrawal by Subject|1|||
148783458|NCT01393106|536682368|FG000|Overall Study|Lack of Efficacy|1|||
148783459|NCT03041467|536682369|FG000|Overall Study|Death|46|||
148783460|NCT03041467|536682370|FG001|Overall Study|Death|39|||
148783461|NCT03041467|536682369|FG000|Overall Study|Withdrawal by Subject|36|||
148783462|NCT03041467|536682370|FG001|Overall Study|Withdrawal by Subject|37|||
148783463|NCT03041467|536682369|FG000|Overall Study|Lost to Follow-up|6|||
148783464|NCT03041467|536682370|FG001|Overall Study|Lost to Follow-up|8|||
148783465|NCT03041467|536682369|FG000|Overall Study|Declined consent for study extension|21|||
148783466|NCT03041467|536682370|FG001|Overall Study|Declined consent for study extension|33|||
148783467|NCT03041467|536682369|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
148783468|NCT03041467|536682370|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
148783469|NCT02732015|536682372|FG000|Overall Study|Lost to Follow-up|0|||
148783470|NCT02732015|536682373|FG001|Overall Study|Lost to Follow-up|1|||
148783471|NCT05437640|536682376|FG000|Washout (1 Week)|Adverse Event|1|||
148783472|NCT05437640|536682377|FG001|Washout (1 Week)|Adverse Event|0|||
148783473|NCT02474355|536682378|FG000|Overall Study|Other|43|||
148783474|NCT02474355|536682378|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
148783475|NCT02474355|536682378|FG000|Overall Study|Lost to Follow-up|98|||
148783476|NCT02474355|536682378|FG000|Overall Study|Withdrawal by Subject|124|||
148783477|NCT02474355|536682378|FG000|Overall Study|Death|1361|||
148783478|NCT04228965|536682381|FG000|Overall Study|Lost to Follow-up|26|||
148783479|NCT04228965|536682382|FG001|Overall Study|Lost to Follow-up|11|||
148783480|NCT04228965|536682381|FG000|Overall Study|Withdrawal by Subject|18|||
148783481|NCT04228965|536682382|FG001|Overall Study|Withdrawal by Subject|5|||
148783482|NCT00734656|536682385|FG000|Lab Session 1|Withdrawal by Subject|2|||
148783483|NCT00734656|536682386|FG001|Lab Session 1|Withdrawal by Subject|0|||
148783484|NCT00734656|536682387|FG002|Lab Session 1|Withdrawal by Subject|0|||
148783485|NCT00734656|536682388|FG003|Lab Session 1|Withdrawal by Subject|0|||
148783486|NCT00734656|536682385|FG000|Washout 1|Withdrawal by Subject|1|||
148783487|NCT00734656|536682386|FG001|Washout 1|Withdrawal by Subject|5|||
148783488|NCT00734656|536682387|FG002|Washout 1|Withdrawal by Subject|2|||
148783489|NCT00734656|536682388|FG003|Washout 1|Withdrawal by Subject|3|||
148783490|NCT00734656|536682385|FG000|Lab Session 2|Withdrawal by Subject|1|||
148783491|NCT00734656|536682386|FG001|Lab Session 2|Withdrawal by Subject|0|||
148783492|NCT00734656|536682387|FG002|Lab Session 2|Withdrawal by Subject|0|||
148783493|NCT00734656|536682388|FG003|Lab Session 2|Withdrawal by Subject|1|||
148783494|NCT00734656|536682385|FG000|Washout 2|Withdrawal by Subject|1|||
148783495|NCT00734656|536682386|FG001|Washout 2|Withdrawal by Subject|1|||
148783496|NCT00734656|536682387|FG002|Washout 2|Withdrawal by Subject|1|||
148783497|NCT00734656|536682388|FG003|Washout 2|Withdrawal by Subject|0|||
148783498|NCT00734656|536682385|FG000|Washout 3|Withdrawal by Subject|1|||
148783499|NCT00734656|536682386|FG001|Washout 3|Withdrawal by Subject|0|||
148783500|NCT00734656|536682387|FG002|Washout 3|Withdrawal by Subject|0|||
148783501|NCT00734656|536682388|FG003|Washout 3|Withdrawal by Subject|1|||
148783502|NCT00734656|536682385|FG000|Lab Session 4|Withdrawal by Subject|0|||
148783503|NCT00734656|536682386|FG001|Lab Session 4|Withdrawal by Subject|0|||
148783504|NCT00734656|536682387|FG002|Lab Session 4|Withdrawal by Subject|0|||
148783505|NCT00734656|536682388|FG003|Lab Session 4|Withdrawal by Subject|1|||
148783506|NCT03214679|536682390|FG000|Overall Study|Lost to Follow-up|12|||
148783507|NCT03214679|536682391|FG001|Overall Study|Lost to Follow-up|14|||
148783508|NCT03214679|536682390|FG000|Overall Study|not eligible|2|||
148783509|NCT03214679|536682391|FG001|Overall Study|not eligible|0|||
148783510|NCT03015194|536682394|FG000|Overall Study|Death|10|||
148783511|NCT03015194|536682394|FG000|Overall Study|Withdrawal by Subject|2|||
148783512|NCT01754766|536682401|FG000|Overall Study|Personal reasons|1|||
148783513|NCT01754766|536682402|FG001|Overall Study|Personal reasons|1|||
148783514|NCT01754766|536682403|FG002|Overall Study|Personal reasons|0|||
148783515|NCT02469168|536682404|FG000|Overall Study|Trial closed|1|||
148783516|NCT02469168|536682405|FG001|Overall Study|Trial closed|0|||
148783517|NCT00433017|536682406|FG000|Overall Study|Adverse Event|5|||
148783518|NCT00433017|536682407|FG001|Overall Study|Adverse Event|3|||
148783519|NCT00433017|536682406|FG000|Overall Study|Withdrawal by Subject|4|||
148783520|NCT00433017|536682407|FG001|Overall Study|Withdrawal by Subject|5|||
148783521|NCT00433017|536682406|FG000|Overall Study|Lost to Follow-up|3|||
148783522|NCT00433017|536682407|FG001|Overall Study|Lost to Follow-up|4|||
148783523|NCT00433017|536682406|FG000|Overall Study|Administrative problems|80|||
148783524|NCT00433017|536682407|FG001|Overall Study|Administrative problems|86|||
148783525|NCT00433017|536682406|FG000|Overall Study|Protocol Violation|1|||
148783526|NCT00433017|536682407|FG001|Overall Study|Protocol Violation|0|||
148783527|NCT00433017|536682406|FG000|Overall Study|Death|2|||
148783528|NCT00433017|536682407|FG001|Overall Study|Death|2|||
148783529|NCT00433017|536682406|FG000|Overall Study|Subject no longer requires study drug|1|||
148783530|NCT00433017|536682407|FG001|Overall Study|Subject no longer requires study drug|1|||
148783531|NCT01306214|536682408|FG000|Overall Study|Death|0|||
148783532|NCT01306214|536682409|FG001|Overall Study|Death|0|||
148783533|NCT01306214|536682410|FG002|Overall Study|Death|1|||
148783534|NCT01306214|536682408|FG000|Overall Study|Lost to Follow-up|3|||
148783535|NCT01306214|536682409|FG001|Overall Study|Lost to Follow-up|5|||
148783536|NCT01306214|536682410|FG002|Overall Study|Lost to Follow-up|4|||
148783537|NCT01306214|536682408|FG000|Overall Study|Withdrawal by Subject|24|||
148783538|NCT01306214|536682409|FG001|Overall Study|Withdrawal by Subject|22|||
148783539|NCT01306214|536682410|FG002|Overall Study|Withdrawal by Subject|16|||
148783540|NCT01306214|536682408|FG000|Overall Study|Not treated|1|||
148783541|NCT01306214|536682409|FG001|Overall Study|Not treated|1|||
148783542|NCT01306214|536682410|FG002|Overall Study|Not treated|1|||
148783543|NCT02509078|536682411|FG000|Overall Study|Protocol Violation|1|||
148783544|NCT02509078|536682412|FG001|Overall Study|Protocol Violation|1|||
148783545|NCT02686814|536682415|FG000|Overall Study|Physician Decision|14|||
148783546|NCT02686814|536682415|FG000|Overall Study|Withdrawal by Subject|4|||
148783547|NCT02686814|536682415|FG000|Overall Study|Death|1|||
148783548|NCT01760447|536682416|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
148783549|NCT01760447|536682417|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
148783550|NCT01760447|536682418|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
148783551|NCT01760447|536682419|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
148783552|NCT01760447|536682416|FG000|Weeks 0-20|Withdrawal by Subject|2|||
148783553|NCT01760447|536682417|FG001|Weeks 0-20|Withdrawal by Subject|0|||
148783554|NCT01760447|536682418|FG002|Weeks 0-20|Withdrawal by Subject|1|||
148783555|NCT01760447|536682419|FG003|Weeks 0-20|Withdrawal by Subject|0|||
148783556|NCT01760447|536682416|FG000|Weeks 0-20|Lost to Follow-up|1|||
148783557|NCT01760447|536682417|FG001|Weeks 0-20|Lost to Follow-up|0|||
148783558|NCT01760447|536682418|FG002|Weeks 0-20|Lost to Follow-up|1|||
148783559|NCT01760447|536682419|FG003|Weeks 0-20|Lost to Follow-up|1|||
148783560|NCT01760447|536682416|FG000|Weeks 0-20|Randomized but not treated|0|||
148783561|NCT01760447|536682417|FG001|Weeks 0-20|Randomized but not treated|0|||
148783562|NCT01760447|536682418|FG002|Weeks 0-20|Randomized but not treated|2|||
148783563|NCT01760447|536682419|FG003|Weeks 0-20|Randomized but not treated|0|||
148783564|NCT01760447|536682416|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
148783565|NCT01760447|536682417|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
148783566|NCT01760447|536682418|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
148783567|NCT01760447|536682419|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
148783568|NCT01760447|536682416|FG000|Weeks 20-54|Withdrawal by Subject|2|||
148783569|NCT01760447|536682417|FG001|Weeks 20-54|Withdrawal by Subject|1|||
148783570|NCT01760447|536682418|FG002|Weeks 20-54|Withdrawal by Subject|1|||
148783571|NCT01760447|536682419|FG003|Weeks 20-54|Withdrawal by Subject|2|||
148783572|NCT01760447|536682416|FG000|Weeks 20-54|Lost to Follow-up|0|||
148783573|NCT01760447|536682417|FG001|Weeks 20-54|Lost to Follow-up|0|||
148783574|NCT01760447|536682418|FG002|Weeks 20-54|Lost to Follow-up|1|||
148783575|NCT01760447|536682419|FG003|Weeks 20-54|Lost to Follow-up|2|||
148783576|NCT03341936|536682422|FG000|Overall Study|Ineligible|1|||
148783577|NCT03341936|536682422|FG000|Overall Study|Disease Progression|2|||
148783578|NCT03341936|536682422|FG000|Overall Study|Withdrew Consent|4|||
148783579|NCT03341936|536682422|FG000|Overall Study|Non-Compliance|1|||
149122433|NCT02480153|537925458|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
149122434|NCT02480153|537925456|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
149122435|NCT02480153|537925457|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
149122436|NCT02480153|537925458|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
149122437|NCT02480153|537925456|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
149122438|NCT02480153|537925457|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
149122439|NCT02480153|537925458|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
149122440|NCT02480153|537925456|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
149122441|NCT02480153|537925457|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
149122442|NCT02480153|537925458|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
149122443|NCT02480153|537925456|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
148783580|NCT03341936|536682422|FG000|Overall Study|Physician Decision|1|||
148783581|NCT03341936|536682422|FG000|Overall Study|Withdrawal by Subject|1|||
148783582|NCT03341936|536682422|FG000|Overall Study|Other|1|||
148783583|NCT02368886|536682423|FG000|Overall Study|Cancel|1|||
148783584|NCT02368886|536682424|FG001|Overall Study|Cancel|1|||
148783585|NCT02368886|536682425|FG002|Overall Study|Cancel|1|||
148783586|NCT02368886|536682426|FG003|Overall Study|Cancel|3|||
148783587|NCT02368886|536682423|FG000|Overall Study|Ineligible|0|||
148783588|NCT02368886|536682424|FG001|Overall Study|Ineligible|0|||
149122444|NCT02480153|537925457|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
149122445|NCT02480153|537925458|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
149122446|NCT02480153|537925456|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
149122447|NCT02480153|537925457|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
149122448|NCT02480153|537925458|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
149122449|NCT02480153|537925456|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
149122450|NCT02480153|537925457|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
149122451|NCT02480153|537925458|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
149122452|NCT02480153|537925456|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
149122453|NCT02480153|537925457|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
149122454|NCT02480153|537925458|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
149122455|NCT02480153|537925456|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
149122456|NCT02480153|537925457|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
149122457|NCT02480153|537925458|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
149122458|NCT01403610|537925459|FG000|Overall Study|Withdrawal by Subject|2|||
149122459|NCT01403610|537925460|FG001|Overall Study|Withdrawal by Subject|0|||
149122460|NCT01403610|537925461|FG002|Overall Study|Withdrawal by Subject|0|||
149122461|NCT01403610|537925462|FG003|Overall Study|Withdrawal by Subject|0|||
149122462|NCT01403610|537925459|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
149122463|NCT01403610|537925460|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
149122464|NCT01403610|537925461|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
149122465|NCT01403610|537925462|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
149122466|NCT00203476|537925463|FG000|Overall Study|Lost to Follow-up|1|||
149122467|NCT00203476|537925464|FG001|Overall Study|Lost to Follow-up|0|||
149122468|NCT00203476|537925465|FG002|Overall Study|Lost to Follow-up|0|||
149122469|NCT00203476|537925463|FG000|Overall Study|Withdrawal by Subject|0|||
149122470|NCT00203476|537925464|FG001|Overall Study|Withdrawal by Subject|1|||
149122471|NCT00203476|537925465|FG002|Overall Study|Withdrawal by Subject|0|||
149122472|NCT01190514|537925466|FG000|First Intervention (Period 1)|Adverse Event|1|||
149122473|NCT01190514|537925467|FG001|First Intervention (Period 1)|Adverse Event|0|||
149122474|NCT01190514|537925468|FG002|First Intervention (Period 1)|Adverse Event|0|||
149122475|NCT01190514|537925469|FG003|First Intervention (Period 1)|Adverse Event|0|||
149122476|NCT01190514|537925466|FG000|Third Intervention (Period 3)|Adverse Event|1|||
149122477|NCT01190514|537925467|FG001|Third Intervention (Period 3)|Adverse Event|0|||
149122478|NCT01190514|537925468|FG002|Third Intervention (Period 3)|Adverse Event|0|||
149122479|NCT01190514|537925469|FG003|Third Intervention (Period 3)|Adverse Event|0|||
149122480|NCT01775475|537925474|FG000|Overall Study|Death|3|||
149122481|NCT01775475|537925475|FG001|Overall Study|Death|3|||
149122482|NCT01183234|537925478|FG000|First Intervention|Adverse Event|1|||
149122483|NCT01183234|537925479|FG001|First Intervention|Adverse Event|0|||
149122484|NCT00822172|537925484|FG000|Overall Study|Adverse Event|10|||
149122485|NCT00822172|537925485|FG001|Overall Study|Adverse Event|12|||
149122486|NCT00822172|537925484|FG000|Overall Study|Death|1|||
149122487|NCT00822172|537925485|FG001|Overall Study|Death|0|||
149122488|NCT00822172|537925484|FG000|Overall Study|Lost to Follow-up|3|||
149122489|NCT00822172|537925485|FG001|Overall Study|Lost to Follow-up|1|||
149122490|NCT00822172|537925484|FG000|Overall Study|Withdrawal by Subject|1|||
149122491|NCT00822172|537925485|FG001|Overall Study|Withdrawal by Subject|4|||
149122492|NCT00822172|537925484|FG000|Overall Study|site closed|0|||
149122493|NCT00822172|537925485|FG001|Overall Study|site closed|1|||
149122494|NCT00822172|537925484|FG000|Overall Study|Other|0|||
149122495|NCT00822172|537925485|FG001|Overall Study|Other|1|||
149122496|NCT00700258|537925486|FG000|Overall Study|Premature discontinuation of documentation|136|||
149122497|NCT00700258|537925486|FG000|Overall Study|Type of study end not documented|1|||
149122498|NCT00700258|537925486|FG000|Overall Study|Lost to Follow-up|81|||
149122499|NCT00700258|537925486|FG000|Overall Study|Premature discontinuation of therapy|1013|||
149122500|NCT00473265|537925487|FG000|Overall Study|Unrelated adverse event|5|||
149122501|NCT00473265|537925487|FG000|Overall Study|Off treatment early|15|||
149122502|NCT04638920|537925492|FG000|Overall Study|Withdrawal by Subject|5|||
149122503|NCT05383508|537925493|FG000|Overall Study|Withdrawal by Subject|1|||
149122504|NCT05383508|537925494|FG001|Overall Study|Withdrawal by Subject|0|||
149122505|NCT05383508|537925495|FG002|Overall Study|Withdrawal by Subject|1|||
149122506|NCT05383508|537925496|FG003|Overall Study|Withdrawal by Subject|1|||
148783589|NCT02368886|536682425|FG002|Overall Study|Ineligible|0|||
148783590|NCT02368886|536682426|FG003|Overall Study|Ineligible|1|||
149122507|NCT05383508|537925497|FG004|Overall Study|Withdrawal by Subject|2|||
149122508|NCT05383508|537925498|FG005|Overall Study|Withdrawal by Subject|0|||
149122509|NCT01859988|537925499|FG000|Overall Study|Withdrawal by Subject|6|||
149122510|NCT01859988|537925500|FG001|Overall Study|Withdrawal by Subject|3|||
149122511|NCT01859988|537925501|FG002|Overall Study|Withdrawal by Subject|4|||
149122512|NCT01859988|537925502|FG003|Overall Study|Withdrawal by Subject|3|||
148783591|NCT02131636|536682430|FG000|Overall Study|Personal Reasons|4|||
148783592|NCT02131636|536682431|FG001|Overall Study|Personal Reasons|4|||
149122513|NCT01859988|537925503|FG004|Overall Study|Withdrawal by Subject|2|||
149122514|NCT01859988|537925504|FG005|Overall Study|Withdrawal by Subject|2|||
149122515|NCT01859988|537925499|FG000|Overall Study|Lack of Efficacy|1|||
149122516|NCT01859988|537925500|FG001|Overall Study|Lack of Efficacy|1|||
149122517|NCT01859988|537925501|FG002|Overall Study|Lack of Efficacy|5|||
149122518|NCT01859988|537925502|FG003|Overall Study|Lack of Efficacy|0|||
149122519|NCT01859988|537925503|FG004|Overall Study|Lack of Efficacy|7|||
149122520|NCT01859988|537925504|FG005|Overall Study|Lack of Efficacy|9|||
149122521|NCT01859988|537925499|FG000|Overall Study|Physician Decision|1|||
149122522|NCT01859988|537925500|FG001|Overall Study|Physician Decision|3|||
149122523|NCT01859988|537925501|FG002|Overall Study|Physician Decision|1|||
149122524|NCT01859988|537925502|FG003|Overall Study|Physician Decision|3|||
149122525|NCT01859988|537925503|FG004|Overall Study|Physician Decision|4|||
149122526|NCT01859988|537925504|FG005|Overall Study|Physician Decision|1|||
149122527|NCT01859988|537925499|FG000|Overall Study|Adverse Event|2|||
149122528|NCT01859988|537925500|FG001|Overall Study|Adverse Event|1|||
149122529|NCT01859988|537925501|FG002|Overall Study|Adverse Event|3|||
149122530|NCT01859988|537925502|FG003|Overall Study|Adverse Event|1|||
149122531|NCT01859988|537925503|FG004|Overall Study|Adverse Event|2|||
149122532|NCT01859988|537925504|FG005|Overall Study|Adverse Event|2|||
149122533|NCT01859988|537925499|FG000|Overall Study|Lost to Follow-up|1|||
149122534|NCT01859988|537925500|FG001|Overall Study|Lost to Follow-up|2|||
149122535|NCT01859988|537925501|FG002|Overall Study|Lost to Follow-up|3|||
149122536|NCT01859988|537925502|FG003|Overall Study|Lost to Follow-up|0|||
149122537|NCT01859988|537925503|FG004|Overall Study|Lost to Follow-up|3|||
149122538|NCT01859988|537925504|FG005|Overall Study|Lost to Follow-up|2|||
149122539|NCT01859988|537925499|FG000|Overall Study|Protocol Violation|0|||
149122540|NCT01859988|537925500|FG001|Overall Study|Protocol Violation|0|||
149122541|NCT01859988|537925501|FG002|Overall Study|Protocol Violation|1|||
149122542|NCT01859988|537925502|FG003|Overall Study|Protocol Violation|0|||
149122543|NCT01859988|537925503|FG004|Overall Study|Protocol Violation|0|||
149122544|NCT01859988|537925504|FG005|Overall Study|Protocol Violation|0|||
149122545|NCT01859988|537925499|FG000|Overall Study|Other than specified above|0|||
149122546|NCT01859988|537925500|FG001|Overall Study|Other than specified above|2|||
149122547|NCT01859988|537925501|FG002|Overall Study|Other than specified above|11|||
149122548|NCT01859988|537925502|FG003|Overall Study|Other than specified above|3|||
149122549|NCT01859988|537925503|FG004|Overall Study|Other than specified above|5|||
149122550|NCT01859988|537925504|FG005|Overall Study|Other than specified above|3|||
149122551|NCT01157676|537925510|FG000|Randomization|Death|1|||
149122552|NCT01157676|537925511|FG001|Randomization|Death|1|||
149122553|NCT01157676|537925510|FG000|Randomization|unresectable|2|||
149122554|NCT01157676|537925511|FG001|Randomization|unresectable|3|||
149122555|NCT01157676|537925510|FG000|Randomization|Withdrawal by Subject|17|||
149122556|NCT01157676|537925511|FG001|Randomization|Withdrawal by Subject|13|||
149122557|NCT01157676|537925510|FG000|Randomization|Physician Decision|1|||
149122558|NCT01157676|537925511|FG001|Randomization|Physician Decision|0|||
149122559|NCT01157676|537925510|FG000|Surgery|underwent open cystectomy|0|||
149122560|NCT01157676|537925511|FG001|Surgery|underwent open cystectomy|4|||
149122561|NCT01157676|537925510|FG000|Surgery|converted to open procedure|0|||
149122562|NCT01157676|537925511|FG001|Surgery|converted to open procedure|5|||
149122563|NCT01157676|537925510|FG000|Surgery|underwent robotic cystectomy|1|||
149122564|NCT01157676|537925511|FG001|Surgery|underwent robotic cystectomy|0|||
149122565|NCT00682890|537925512|FG000|Overall Study|Lost to Follow-up|1|||
149122566|NCT00682890|537925513|FG001|Overall Study|Lost to Follow-up|1|||
149122567|NCT00682890|537925512|FG000|Overall Study|subject moved away|0|||
149122568|NCT00682890|537925513|FG001|Overall Study|subject moved away|1|||
149122569|NCT00682890|537925512|FG000|Overall Study|heavy menstrual bleeding|1|||
149122570|NCT00682890|537925513|FG001|Overall Study|heavy menstrual bleeding|0|||
149122571|NCT00141219|537925517|FG000|Overall Study|Protocol violations|5|||
149122572|NCT00141219|537925518|FG001|Overall Study|Protocol violations|4|||
149122573|NCT00141219|537925517|FG000|Overall Study|Adverse Event|8|||
149122574|NCT00141219|537925518|FG001|Overall Study|Adverse Event|6|||
149122575|NCT00141219|537925517|FG000|Overall Study|Lack of Efficacy|5|||
149122576|NCT00141219|537925518|FG001|Overall Study|Lack of Efficacy|4|||
149122577|NCT00141219|537925517|FG000|Overall Study|Withdrawal by Subject|6|||
149122578|NCT00141219|537925518|FG001|Overall Study|Withdrawal by Subject|2|||
149122579|NCT01506609|537925519|FG000|Overall Study|Adverse Event Related to Progression|0|||
149122580|NCT01506609|537925520|FG001|Overall Study|Adverse Event Related to Progression|0|||
149122581|NCT01506609|537925521|FG002|Overall Study|Adverse Event Related to Progression|0|||
149122582|NCT01506609|537925522|FG003|Overall Study|Adverse Event Related to Progression|3|||
149122583|NCT01506609|537925523|FG004|Overall Study|Adverse Event Related to Progression|7|||
149122584|NCT01506609|537925524|FG005|Overall Study|Adverse Event Related to Progression|3|||
149122585|NCT01506609|537925519|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
149122586|NCT01506609|537925520|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
148783593|NCT02131636|536682430|FG000|Overall Study|Lost to Follow-up|4|||
149122587|NCT01506609|537925521|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
149122588|NCT01506609|537925522|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
148783594|NCT02131636|536682431|FG001|Overall Study|Lost to Follow-up|0|||
148783595|NCT02131636|536682430|FG000|Overall Study|Adverse Event|4|||
148783596|NCT02131636|536682431|FG001|Overall Study|Adverse Event|1|||
148783597|NCT02173379|536682432|FG000|Overall Study|Lost to Follow-up|89|||
148783598|NCT02173379|536682433|FG001|Overall Study|Lost to Follow-up|81|||
148783599|NCT02173379|536682432|FG000|Overall Study|Withdrawal by Subject|24|||
148783600|NCT02173379|536682433|FG001|Overall Study|Withdrawal by Subject|29|||
148783601|NCT02173379|536682432|FG000|Overall Study|Physician Decision|8|||
148783602|NCT02173379|536682433|FG001|Overall Study|Physician Decision|8|||
148783603|NCT02173379|536682432|FG000|Overall Study|Death|75|||
148783604|NCT02173379|536682433|FG001|Overall Study|Death|72|||
148783605|NCT02173379|536682432|FG000|Overall Study|Other Reason|1|||
148783606|NCT02173379|536682433|FG001|Overall Study|Other Reason|0|||
148783607|NCT00631163|536682437|FG000|Number of Participants in Year 1|Adverse Event|12|||
148783608|NCT00631163|536682437|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
148783609|NCT00631163|536682437|FG000|Number of Participants in Year 1|Death|6|||
148783610|NCT00631163|536682437|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
148783611|NCT00631163|536682437|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
148783612|NCT00631163|536682437|FG000|Number of Participants in Year 1|Administrative problems|6|||
148783613|NCT00631163|536682437|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
148783614|NCT00631163|536682437|FG000|Number of Participants in Year 2|Adverse Event|1|||
148783615|NCT00631163|536682437|FG000|Number of Participants in Year 2|Protocol Violation|1|||
148783616|NCT00631163|536682437|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
148783617|NCT01937884|536682438|FG000|Overall Study|Withdrawal by Subject|1|||
148783618|NCT01937884|536682439|FG001|Overall Study|Withdrawal by Subject|0|||
148783619|NCT03003000|536682447|FG000|Overall Study|Adverse Event|1|||
148783620|NCT03003000|536682448|FG001|Overall Study|Adverse Event|2|||
148783621|NCT03003000|536682449|FG002|Overall Study|Adverse Event|3|||
148783622|NCT03003000|536682447|FG000|Overall Study|Lack of Efficacy|1|||
148783623|NCT03003000|536682448|FG001|Overall Study|Lack of Efficacy|0|||
148783624|NCT03003000|536682449|FG002|Overall Study|Lack of Efficacy|0|||
148783625|NCT03003000|536682447|FG000|Overall Study|Non-compliant with protocol|0|||
148783626|NCT03003000|536682448|FG001|Overall Study|Non-compliant with protocol|1|||
148783627|NCT03003000|536682449|FG002|Overall Study|Non-compliant with protocol|1|||
148783628|NCT03003000|536682447|FG000|Overall Study|Refused to continue medication|2|||
148783629|NCT03003000|536682448|FG001|Overall Study|Refused to continue medication|0|||
148783630|NCT03003000|536682449|FG002|Overall Study|Refused to continue medication|0|||
148783631|NCT03003000|536682447|FG000|Overall Study|Other than listed|1|||
148783632|NCT03003000|536682448|FG001|Overall Study|Other than listed|1|||
148783633|NCT03003000|536682449|FG002|Overall Study|Other than listed|1|||
148783634|NCT04933617|536682451|FG000|Dose Escalation|Early closure of study|0|||
148783635|NCT04933617|536682452|FG001|Dose Escalation|Early closure of study|3|||
148783636|NCT04933617|536682453|FG002|Dose Escalation|Early closure of study|0|||
148783637|NCT04933617|536682454|FG003|Dose Escalation|Early closure of study|0|||
148783638|NCT04933617|536682455|FG004|Dose Escalation|Early closure of study|0|||
148783639|NCT02191046|536682456|FG000|Overall Study|low compliance|5|||
148783640|NCT02191046|536682457|FG001|Overall Study|low compliance|1|||
148783641|NCT02147067|536682458|FG000|Overall Study|Withdrawal by Subject|2|||
148783642|NCT02147067|536682459|FG001|Overall Study|Withdrawal by Subject|2|||
148783643|NCT02536781|536682462|FG000|Overall Study|Lost to Follow-up|2|||
148783644|NCT02536781|536682463|FG001|Overall Study|Lost to Follow-up|0|||
148783645|NCT01952080|536682465|FG000|Overall Study|Withdrawal by Subject|0|||
148783646|NCT01952080|536682466|FG001|Overall Study|Withdrawal by Subject|0|||
148783647|NCT01952080|536682467|FG002|Overall Study|Withdrawal by Subject|0|||
148783648|NCT01952080|536682468|FG003|Overall Study|Withdrawal by Subject|1|||
148783649|NCT01952080|536682465|FG000|Overall Study|Protocol Non-compliance|0|||
148783650|NCT01952080|536682466|FG001|Overall Study|Protocol Non-compliance|1|||
148783651|NCT01952080|536682467|FG002|Overall Study|Protocol Non-compliance|0|||
148783652|NCT01952080|536682468|FG003|Overall Study|Protocol Non-compliance|0|||
148783653|NCT02258334|536682469|FG000|Overall Study|Adverse Event|1|||
148783654|NCT02258334|536682470|FG001|Overall Study|Adverse Event|0|||
148783655|NCT02258334|536682471|FG002|Overall Study|Adverse Event|0|||
148783656|NCT02258334|536682472|FG003|Overall Study|Adverse Event|0|||
148783657|NCT03564795|536682475|FG000|Overall Study|Withdrawal by Subject|3|||
148783658|NCT03564795|536682475|FG000|Overall Study|Lost to Follow-up|6|||
148783659|NCT03564795|536682475|FG000|Overall Study|Physician Decision|2|||
148893352|NCT00683878|537088678|FG000|Overall Study|Death|0|||
148783660|NCT02208050|536682478|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
148783661|NCT02208050|536682479|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
148783662|NCT00477607|536682480|FG000|Overall Study|Lost to Follow-up|7|||
148783663|NCT00477607|536682481|FG001|Overall Study|Lost to Follow-up|7|||
148783664|NCT00432276|536682482|FG000|Overall Study|Hyperglycemic Rescue|44|||
148783665|NCT00432276|536682483|FG001|Overall Study|Hyperglycemic Rescue|87|||
148783666|NCT00432276|536682482|FG000|Overall Study|Adverse Event|13|||
148783667|NCT00432276|536682483|FG001|Overall Study|Adverse Event|16|||
148783668|NCT00432276|536682482|FG000|Overall Study|Protocol Violation|25|||
148783669|NCT00432276|536682483|FG001|Overall Study|Protocol Violation|20|||
149122589|NCT01506609|537925523|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
149122590|NCT01506609|537925524|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
149122591|NCT01506609|537925519|FG000|Overall Study|Withdrawal by Subject|0|||
149122592|NCT01506609|537925520|FG001|Overall Study|Withdrawal by Subject|0|||
149122593|NCT01506609|537925521|FG002|Overall Study|Withdrawal by Subject|0|||
149122594|NCT01506609|537925522|FG003|Overall Study|Withdrawal by Subject|9|||
149122595|NCT01506609|537925523|FG004|Overall Study|Withdrawal by Subject|7|||
149122596|NCT01506609|537925524|FG005|Overall Study|Withdrawal by Subject|7|||
149122597|NCT01506609|537925519|FG000|Overall Study|Lost to Follow-up|0|||
149122598|NCT01506609|537925520|FG001|Overall Study|Lost to Follow-up|0|||
149122599|NCT01506609|537925521|FG002|Overall Study|Lost to Follow-up|0|||
149122600|NCT01506609|537925522|FG003|Overall Study|Lost to Follow-up|1|||
149122601|NCT01506609|537925523|FG004|Overall Study|Lost to Follow-up|2|||
149122602|NCT01506609|537925524|FG005|Overall Study|Lost to Follow-up|0|||
149122603|NCT01506609|537925519|FG000|Overall Study|Sponsor Discontinued Study|0|||
149122604|NCT01506609|537925520|FG001|Overall Study|Sponsor Discontinued Study|0|||
149122605|NCT01506609|537925521|FG002|Overall Study|Sponsor Discontinued Study|0|||
149122606|NCT01506609|537925522|FG003|Overall Study|Sponsor Discontinued Study|2|||
149122607|NCT01506609|537925523|FG004|Overall Study|Sponsor Discontinued Study|2|||
149122608|NCT01506609|537925524|FG005|Overall Study|Sponsor Discontinued Study|0|||
149122609|NCT01506609|537925519|FG000|Overall Study|Progressive Disease per Protocol|1|||
149122610|NCT01506609|537925520|FG001|Overall Study|Progressive Disease per Protocol|0|||
149122611|NCT01506609|537925521|FG002|Overall Study|Progressive Disease per Protocol|0|||
149122612|NCT01506609|537925522|FG003|Overall Study|Progressive Disease per Protocol|64|||
149122613|NCT01506609|537925523|FG004|Overall Study|Progressive Disease per Protocol|57|||
149122614|NCT01506609|537925524|FG005|Overall Study|Progressive Disease per Protocol|74|||
149122615|NCT01506609|537925519|FG000|Overall Study|Other, Not Specified|0|||
149122616|NCT01506609|537925520|FG001|Overall Study|Other, Not Specified|0|||
149122617|NCT01506609|537925521|FG002|Overall Study|Other, Not Specified|0|||
149122618|NCT01506609|537925522|FG003|Overall Study|Other, Not Specified|10|||
149122619|NCT01506609|537925523|FG004|Overall Study|Other, Not Specified|7|||
149122620|NCT01506609|537925524|FG005|Overall Study|Other, Not Specified|3|||
149122621|NCT01506609|537925519|FG000|Overall Study|Missing / Unknown Reason|1|||
149122622|NCT01506609|537925520|FG001|Overall Study|Missing / Unknown Reason|0|||
149122623|NCT01506609|537925521|FG002|Overall Study|Missing / Unknown Reason|1|||
149122624|NCT01506609|537925522|FG003|Overall Study|Missing / Unknown Reason|4|||
149122625|NCT01506609|537925523|FG004|Overall Study|Missing / Unknown Reason|4|||
149122626|NCT01506609|537925524|FG005|Overall Study|Missing / Unknown Reason|2|||
149122627|NCT01324440|537925529|FG000|Overall Study|Subject moved|0|||
149122628|NCT01324440|537925530|FG001|Overall Study|Subject moved|1|||
149122629|NCT02884908|537925531|FG000|Overall Study|Lost to Follow-up|13|||
149122630|NCT02884908|537925532|FG001|Overall Study|Lost to Follow-up|18|||
149122631|NCT01642251|537925533|FG000|Overall Study|Progressive disease|0|||
149122632|NCT01642251|537925534|FG001|Overall Study|Progressive disease|0|||
149122633|NCT01642251|537925535|FG002|Overall Study|Progressive disease|3|||
149122634|NCT01642251|537925536|FG003|Overall Study|Progressive disease|3|||
149122635|NCT01642251|537925533|FG000|Overall Study|Adverse Event|0|||
149122636|NCT01642251|537925534|FG001|Overall Study|Adverse Event|0|||
149122637|NCT01642251|537925535|FG002|Overall Study|Adverse Event|5|||
149122638|NCT01642251|537925536|FG003|Overall Study|Adverse Event|4|||
149122639|NCT01642251|537925533|FG000|Overall Study|Death|0|||
149122640|NCT01642251|537925534|FG001|Overall Study|Death|0|||
149122641|NCT01642251|537925535|FG002|Overall Study|Death|1|||
149122642|NCT01642251|537925536|FG003|Overall Study|Death|3|||
149122643|NCT01642251|537925533|FG000|Overall Study|Withdrawal by Subject|0|||
149122644|NCT01642251|537925534|FG001|Overall Study|Withdrawal by Subject|0|||
149122645|NCT01642251|537925535|FG002|Overall Study|Withdrawal by Subject|1|||
149122646|NCT01642251|537925536|FG003|Overall Study|Withdrawal by Subject|3|||
149122647|NCT01642251|537925533|FG000|Overall Study|Alternative therapy|0|||
149122648|NCT01642251|537925534|FG001|Overall Study|Alternative therapy|0|||
149122649|NCT01642251|537925535|FG002|Overall Study|Alternative therapy|0|||
149122650|NCT01642251|537925536|FG003|Overall Study|Alternative therapy|2|||
149122651|NCT01642251|537925533|FG000|Overall Study|Other complicating disease|0|||
149122652|NCT01642251|537925534|FG001|Overall Study|Other complicating disease|0|||
149122653|NCT01642251|537925535|FG002|Overall Study|Other complicating disease|1|||
149122654|NCT01642251|537925536|FG003|Overall Study|Other complicating disease|0|||
149122655|NCT01642251|537925533|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
149122656|NCT01642251|537925534|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
149122657|NCT01642251|537925535|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
149122658|NCT01642251|537925536|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
149122659|NCT01605916|537925537|FG000|Overall Study|Adverse Event|1|||
149122660|NCT01605916|537925538|FG001|Overall Study|Adverse Event|0|||
149122661|NCT01605916|537925539|FG002|Overall Study|Adverse Event|0|||
149122662|NCT01605916|537925540|FG003|Overall Study|Adverse Event|1|||
149122663|NCT01605916|537925541|FG004|Overall Study|Adverse Event|0|||
149122664|NCT01605916|537925537|FG000|Overall Study|Lack of Efficacy|2|||
148783670|NCT00432276|536682482|FG000|Overall Study|Lost to Follow-up|6|||
148783671|NCT00432276|536682483|FG001|Overall Study|Lost to Follow-up|2|||
148783672|NCT00432276|536682482|FG000|Overall Study|Withdrawal by Subject|25|||
148783673|NCT00432276|536682483|FG001|Overall Study|Withdrawal by Subject|20|||
148783674|NCT00432276|536682482|FG000|Overall Study|Physician Decision|6|||
148783675|NCT00432276|536682483|FG001|Overall Study|Physician Decision|8|||
148783676|NCT00432276|536682482|FG000|Overall Study|Other|2|||
148783677|NCT00432276|536682483|FG001|Overall Study|Other|3|||
148783678|NCT00467961|536682484|FG000|Overall Study|Technical Failures|5|||
148783679|NCT00467961|536682484|FG000|Overall Study|Disease Progression|2|||
148783680|NCT01324570|536682488|FG000|Overall Study|Adverse Event|4|||
148783681|NCT01324570|536682489|FG001|Overall Study|Adverse Event|7|||
148783682|NCT01324570|536682488|FG000|Overall Study|Withdrawal by Subject|0|||
148783683|NCT01324570|536682489|FG001|Overall Study|Withdrawal by Subject|3|||
148783684|NCT01324570|536682488|FG000|Overall Study|Lack of Efficacy|0|||
148783685|NCT01324570|536682489|FG001|Overall Study|Lack of Efficacy|1|||
148783686|NCT01324570|536682488|FG000|Overall Study|Confirmed or suspected diversion|0|||
148783687|NCT01324570|536682489|FG001|Overall Study|Confirmed or suspected diversion|1|||
148783688|NCT01324570|536682488|FG000|Overall Study|Administrative|0|||
148783689|NCT01324570|536682489|FG001|Overall Study|Administrative|2|||
148783690|NCT04459598|536682490|FG000|Overall Study|Adverse Event|1|||
148783691|NCT04459598|536682491|FG001|Overall Study|Adverse Event|1|||
148783692|NCT01853696|536684273|FG000|Overall Study|Withdrawal by Subject|1|||
148783693|NCT01853696|536684274|FG001|Overall Study|Withdrawal by Subject|1|||
148783694|NCT01853696|536684273|FG000|Overall Study|Lost to Follow-up|5|||
148783695|NCT01853696|536684274|FG001|Overall Study|Lost to Follow-up|4|||
148783696|NCT00438256|536684277|FG000|Overall Study|Ineligible for Resection|2|||
148783697|NCT00438256|536684278|FG001|Overall Study|Ineligible for Resection|1|||
148783698|NCT00438256|536684279|FG002|Overall Study|Ineligible for Resection|1|||
149122665|NCT01605916|537925538|FG001|Overall Study|Lack of Efficacy|3|||
149122666|NCT01605916|537925539|FG002|Overall Study|Lack of Efficacy|3|||
149122667|NCT01605916|537925540|FG003|Overall Study|Lack of Efficacy|5|||
149122668|NCT01605916|537925541|FG004|Overall Study|Lack of Efficacy|4|||
149122669|NCT01605916|537925537|FG000|Overall Study|Withdrawal by Subject|1|||
149122670|NCT01605916|537925538|FG001|Overall Study|Withdrawal by Subject|1|||
149122671|NCT01605916|537925539|FG002|Overall Study|Withdrawal by Subject|0|||
149122672|NCT01605916|537925540|FG003|Overall Study|Withdrawal by Subject|0|||
149122673|NCT01605916|537925541|FG004|Overall Study|Withdrawal by Subject|2|||
149122674|NCT00540046|537925542|FG000|Overall Study|Lost to Follow-up|33|||
149122675|NCT00540046|537925543|FG001|Overall Study|Lost to Follow-up|23|||
149122676|NCT02533531|537925544|FG000|Overall Study|Device did not turn on|1|||
149122677|NCT01103362|537925545|FG000|Overall Study|study terminated|596|||
149122678|NCT02047903|537925546|FG000|Overall Study|Adverse Event|14|||
149122679|NCT02047903|537925546|FG000|Overall Study|Serious adverse event|10|||
149122680|NCT02047903|537925546|FG000|Overall Study|Withdrawal by Subject|16|||
149122681|NCT02047903|537925546|FG000|Overall Study|Lost to Follow-up|4|||
149122682|NCT02047903|537925546|FG000|Overall Study|Reason not listed|6|||
149122683|NCT02047903|537925546|FG000|Overall Study|Not Treated|9|||
149122684|NCT00911768|537925551|FG000|Overall Study|Protocol Violation|5|||
149122685|NCT00911768|537925552|FG001|Overall Study|Protocol Violation|4|||
149122686|NCT00911768|537925551|FG000|Overall Study|Withdrawal by Subject|1|||
149122687|NCT00911768|537925552|FG001|Overall Study|Withdrawal by Subject|0|||
149122688|NCT02631577|537925554|FG000|Overall Study|Death|1|||
149122689|NCT02631577|537925555|FG001|Overall Study|Death|7|||
149122690|NCT02631577|537925554|FG000|Overall Study|Withdrawal by Subject|0|||
149122691|NCT02631577|537925555|FG001|Overall Study|Withdrawal by Subject|3|||
149122692|NCT00979134|537925556|FG000|Overall Study|Disease progression|18|||
149122693|NCT00979134|537925557|FG001|Overall Study|Disease progression|2|||
149122694|NCT00979134|537925558|FG002|Overall Study|Disease progression|5|||
149122695|NCT00979134|537925556|FG000|Overall Study|Adverse Event|0|||
148783699|NCT00438256|536684280|FG003|Overall Study|Ineligible for Resection|7|||
149122696|NCT00979134|537925557|FG001|Overall Study|Adverse Event|0|||
149122697|NCT00979134|537925558|FG002|Overall Study|Adverse Event|2|||
149122698|NCT00979134|537925556|FG000|Overall Study|Withdrawal by Subject|1|||
149122699|NCT00979134|537925557|FG001|Overall Study|Withdrawal by Subject|1|||
149122700|NCT00979134|537925558|FG002|Overall Study|Withdrawal by Subject|2|||
149122701|NCT00979134|537925556|FG000|Overall Study|Lost to Follow-up|2|||
148783700|NCT00438256|536684277|FG000|Overall Study|Excluded final Diagnosis|0|||
148783701|NCT00438256|536684278|FG001|Overall Study|Excluded final Diagnosis|0|||
148783702|NCT00438256|536684279|FG002|Overall Study|Excluded final Diagnosis|0|||
148783703|NCT00438256|536684280|FG003|Overall Study|Excluded final Diagnosis|2|||
148783704|NCT01964716|536684290|FG000|Overall Study|Withdrawal by Subject|2|||
148783705|NCT01964716|536684291|FG001|Overall Study|Withdrawal by Subject|3|||
148783706|NCT01964716|536684290|FG000|Overall Study|Lost to Follow-up|1|||
149122702|NCT00979134|537925557|FG001|Overall Study|Lost to Follow-up|2|||
149122703|NCT00979134|537925558|FG002|Overall Study|Lost to Follow-up|0|||
149122704|NCT00979134|537925556|FG000|Overall Study|Death|4|||
149122705|NCT00979134|537925557|FG001|Overall Study|Death|0|||
149122706|NCT00979134|537925558|FG002|Overall Study|Death|26|||
148783707|NCT01964716|536684291|FG001|Overall Study|Lost to Follow-up|2|||
148783708|NCT01964716|536684290|FG000|Overall Study|No longer met eligibility criteria|1|||
148783709|NCT01964716|536684291|FG001|Overall Study|No longer met eligibility criteria|1|||
148783710|NCT01964716|536684290|FG000|Overall Study|Death|1|||
148783711|NCT01964716|536684291|FG001|Overall Study|Death|0|||
148783712|NCT03913104|536684296|FG000|Overall Study|Lost to Follow-up|20|||
148783713|NCT03913104|536684296|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
148783714|NCT03913104|536684296|FG000|Overall Study|Withdrawal by Subject|2|||
148783715|NCT01370616|536684297|FG000|Overall Study|Adverse Event|11|||
148783716|NCT01370616|536684298|FG001|Overall Study|Adverse Event|16|||
148783717|NCT01370616|536684297|FG000|Overall Study|Death|1|||
148783718|NCT01370616|536684298|FG001|Overall Study|Death|0|||
148783719|NCT01370616|536684297|FG000|Overall Study|Lack of Efficacy|6|||
148783720|NCT01370616|536684298|FG001|Overall Study|Lack of Efficacy|2|||
148783721|NCT01370616|536684297|FG000|Overall Study|Lost to Follow-up|0|||
148783722|NCT01370616|536684298|FG001|Overall Study|Lost to Follow-up|3|||
148783723|NCT01370616|536684297|FG000|Overall Study|Physician Decision|6|||
148783724|NCT01370616|536684298|FG001|Overall Study|Physician Decision|6|||
148783725|NCT01370616|536684297|FG000|Overall Study|Progressive Disease|0|||
148783726|NCT01370616|536684298|FG001|Overall Study|Progressive Disease|1|||
148783727|NCT01370616|536684297|FG000|Overall Study|Recovery|1|||
148783728|NCT01370616|536684298|FG001|Overall Study|Recovery|0|||
148783729|NCT01370616|536684297|FG000|Overall Study|Technical Problems|3|||
148783730|NCT01370616|536684298|FG001|Overall Study|Technical Problems|5|||
148783731|NCT01370616|536684297|FG000|Overall Study|Withdrawal by Subject|34|||
148783732|NCT01370616|536684298|FG001|Overall Study|Withdrawal by Subject|34|||
148783733|NCT01693185|536684301|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
148783734|NCT01693185|536684302|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
148783735|NCT03742258|536684312|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
148783736|NCT03742258|536684313|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
148783737|NCT03742258|536684314|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
148783738|NCT03742258|536684312|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
148783739|NCT03742258|536684313|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
148783740|NCT03742258|536684314|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
148783741|NCT03742258|536684312|FG000|Survival Follow-Up|Still in Follow-up|0|||
148783742|NCT03742258|536684313|FG001|Survival Follow-Up|Still in Follow-up|0|||
148783743|NCT03742258|536684314|FG002|Survival Follow-Up|Still in Follow-up|2|||
148783744|NCT01380691|536684320|FG000|Washout (7 Days)|Protocol Violation|0|||
148783745|NCT01380691|536684321|FG001|Washout (7 Days)|Protocol Violation|0|||
148783746|NCT01380691|536684322|FG002|Washout (7 Days)|Protocol Violation|0|||
148783747|NCT01380691|536684323|FG003|Washout (7 Days)|Protocol Violation|1|||
148783748|NCT01380691|536684320|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
148783749|NCT01380691|536684321|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
148783750|NCT01380691|536684322|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
148783751|NCT01380691|536684323|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
148783752|NCT03423147|536684324|FG000|Overall Study|Lost to Follow-up|5|||
148783753|NCT03423147|536684325|FG001|Overall Study|Lost to Follow-up|8|||
148783754|NCT03423147|536684324|FG000|Overall Study|Withdrawal by Subject|1|||
148783755|NCT03423147|536684325|FG001|Overall Study|Withdrawal by Subject|0|||
148783756|NCT03423147|536684324|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
148783757|NCT03423147|536684325|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
148783758|NCT03423147|536684324|FG000|Overall Study|Age < 18|1|||
148783759|NCT03423147|536684325|FG001|Overall Study|Age < 18|0|||
148783760|NCT03423147|536684324|FG000|Overall Study|No Trial of Labor|0|||
148783761|NCT03423147|536684325|FG001|Overall Study|No Trial of Labor|1|||
148783762|NCT01048099|536684326|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
148783763|NCT01048099|536684326|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
148783764|NCT00508157|536684327|FG000|Overall Study|Adverse Event|0|||
148783765|NCT00508157|536684328|FG001|Overall Study|Adverse Event|1|||
148783766|NCT00508157|536684327|FG000|Overall Study|Subject Withdrew Consent|1|||
148783767|NCT00508157|536684328|FG001|Overall Study|Subject Withdrew Consent|0|||
148783768|NCT00508157|536684327|FG000|Overall Study|Lost to Follow-up|1|||
148783769|NCT00508157|536684328|FG001|Overall Study|Lost to Follow-up|0|||
148783770|NCT00508157|536684327|FG000|Overall Study|Subject no longer met study criteria|0|||
148783771|NCT00508157|536684328|FG001|Overall Study|Subject no longer met study criteria|1|||
148783772|NCT00508157|536684327|FG000|Overall Study|Other known cause|0|||
148783773|NCT00508157|536684328|FG001|Overall Study|Other known cause|1|||
148783774|NCT01987232|536684329|FG000|Overall Study|Ongoing in Study|0|||
148783775|NCT01987232|536684330|FG001|Overall Study|Ongoing in Study|0|||
148783776|NCT01987232|536684331|FG002|Overall Study|Ongoing in Study|0|||
148783777|NCT01987232|536684332|FG003|Overall Study|Ongoing in Study|1|||
148783778|NCT01987232|536684333|FG004|Overall Study|Ongoing in Study|0|||
148783779|NCT01731470|536684334|FG000|Overall Study|Withdrawal by Subject|1|||
148783780|NCT01731470|536684334|FG000|Overall Study|Did not meet study criteria|1|||
148783781|NCT00862459|536684335|FG000|Overall Study|Lost to Follow-up|1|||
148783782|NCT00862459|536684336|FG001|Overall Study|Lost to Follow-up|2|||
148783783|NCT00862459|536684337|FG002|Overall Study|Lost to Follow-up|2|||
148783784|NCT00862459|536684335|FG000|Overall Study|Protocol Violation|1|||
148783785|NCT00862459|536684336|FG001|Overall Study|Protocol Violation|0|||
148783786|NCT00862459|536684337|FG002|Overall Study|Protocol Violation|0|||
148783787|NCT00862459|536684335|FG000|Overall Study|Withdrawal by Subject|1|||
148783788|NCT00862459|536684336|FG001|Overall Study|Withdrawal by Subject|1|||
148783789|NCT00862459|536684337|FG002|Overall Study|Withdrawal by Subject|3|||
148783790|NCT00862459|536684335|FG000|Overall Study|Adverse Event|0|||
148783791|NCT00862459|536684336|FG001|Overall Study|Adverse Event|1|||
148783792|NCT00862459|536684337|FG002|Overall Study|Adverse Event|0|||
148783793|NCT00862459|536684335|FG000|Overall Study|Personal reasons|1|||
148783794|NCT00862459|536684336|FG001|Overall Study|Personal reasons|0|||
148783795|NCT00862459|536684337|FG002|Overall Study|Personal reasons|0|||
148783796|NCT00862459|536684335|FG000|Overall Study|Operation|1|||
148783797|NCT00862459|536684336|FG001|Overall Study|Operation|1|||
148783798|NCT00862459|536684337|FG002|Overall Study|Operation|0|||
148783799|NCT00862459|536684335|FG000|Overall Study|Intravenous (IV) site problems|1|||
148783800|NCT00862459|536684336|FG001|Overall Study|Intravenous (IV) site problems|0|||
148783801|NCT00862459|536684337|FG002|Overall Study|Intravenous (IV) site problems|1|||
148783802|NCT00862459|536684335|FG000|Overall Study|Unable to hold still for imaging|0|||
148783803|NCT00862459|536684336|FG001|Overall Study|Unable to hold still for imaging|1|||
148783804|NCT00862459|536684337|FG002|Overall Study|Unable to hold still for imaging|0|||
148783805|NCT00862459|536684335|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
148783806|NCT00862459|536684336|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
148783807|NCT00862459|536684337|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
148783808|NCT00862459|536684335|FG000|Overall Study|Administrative problems|0|||
148783809|NCT00862459|536684336|FG001|Overall Study|Administrative problems|1|||
148783810|NCT00862459|536684337|FG002|Overall Study|Administrative problems|0|||
148783811|NCT01625689|536684346|FG000|Overall Study|Migration|2|||
148783812|NCT01625689|536684347|FG001|Overall Study|Migration|1|||
148783813|NCT02134353|536684358|FG000|Overall Study|Adverse Event|10|||
148783814|NCT02134353|536684359|FG001|Overall Study|Adverse Event|6|||
149122707|NCT00979134|537925556|FG000|Overall Study|Other|8|||
149122708|NCT00979134|537925557|FG001|Overall Study|Other|1|||
149122709|NCT00979134|537925558|FG002|Overall Study|Other|5|||
149122710|NCT05917470|537925559|FG000|Overall Study|Progressive Disease|1|||
149122711|NCT05917470|537925560|FG001|Overall Study|Progressive Disease|1|||
149122712|NCT05917470|537925561|FG002|Overall Study|Progressive Disease|2|||
149122713|NCT05917470|537925562|FG003|Overall Study|Progressive Disease|3|||
149122714|NCT05917470|537925563|FG004|Overall Study|Progressive Disease|1|||
149122715|NCT05917470|537925564|FG005|Overall Study|Progressive Disease|1|||
149122716|NCT05917470|537925565|FG006|Overall Study|Progressive Disease|0|||
149122717|NCT05917470|537925566|FG007|Overall Study|Progressive Disease|0|||
149122718|NCT05917470|537925559|FG000|Overall Study|Withdrawal by Subject|0|||
149122719|NCT05917470|537925560|FG001|Overall Study|Withdrawal by Subject|0|||
149122720|NCT05917470|537925561|FG002|Overall Study|Withdrawal by Subject|1|||
149122721|NCT05917470|537925562|FG003|Overall Study|Withdrawal by Subject|0|||
149122722|NCT05917470|537925563|FG004|Overall Study|Withdrawal by Subject|0|||
149122723|NCT05917470|537925564|FG005|Overall Study|Withdrawal by Subject|0|||
149122724|NCT05917470|537925565|FG006|Overall Study|Withdrawal by Subject|0|||
149122725|NCT05917470|537925566|FG007|Overall Study|Withdrawal by Subject|0|||
149122726|NCT05917470|537925559|FG000|Overall Study|Sponsor Decision|0|||
149122727|NCT05917470|537925560|FG001|Overall Study|Sponsor Decision|0|||
149122728|NCT05917470|537925561|FG002|Overall Study|Sponsor Decision|1|||
149122729|NCT05917470|537925562|FG003|Overall Study|Sponsor Decision|0|||
149122730|NCT05917470|537925563|FG004|Overall Study|Sponsor Decision|2|||
149122731|NCT05917470|537925564|FG005|Overall Study|Sponsor Decision|1|||
149122732|NCT05917470|537925565|FG006|Overall Study|Sponsor Decision|3|||
149122733|NCT05917470|537925566|FG007|Overall Study|Sponsor Decision|3|||
149122734|NCT05917470|537925559|FG000|Overall Study|Adverse Event|0|||
149122735|NCT05917470|537925560|FG001|Overall Study|Adverse Event|0|||
149122736|NCT05917470|537925561|FG002|Overall Study|Adverse Event|0|||
149122737|NCT05917470|537925562|FG003|Overall Study|Adverse Event|0|||
149122738|NCT05917470|537925563|FG004|Overall Study|Adverse Event|0|||
149122739|NCT05917470|537925564|FG005|Overall Study|Adverse Event|1|||
149122740|NCT05917470|537925565|FG006|Overall Study|Adverse Event|0|||
148783815|NCT02134353|536684358|FG000|Overall Study|Lost to Follow-up|1|||
148783816|NCT02134353|536684359|FG001|Overall Study|Lost to Follow-up|1|||
148783817|NCT02134353|536684358|FG000|Overall Study|Lack of Efficacy|2|||
148783818|NCT02134353|536684359|FG001|Overall Study|Lack of Efficacy|1|||
148783819|NCT02134353|536684358|FG000|Overall Study|Withdrawal by Subject|12|||
148783820|NCT02134353|536684359|FG001|Overall Study|Withdrawal by Subject|13|||
148783821|NCT02134353|536684358|FG000|Overall Study|Death|0|||
149122741|NCT05917470|537925566|FG007|Overall Study|Adverse Event|0|||
149122742|NCT01290029|537927589|FG000|Overall Study|Other|2|||
149122743|NCT02924428|537927590|FG000|Overall Study|Adverse Event|1|||
149122744|NCT02924428|537927591|FG001|Overall Study|Adverse Event|0|||
149122745|NCT02924428|537927590|FG000|Overall Study|Physician Decision|1|||
149122746|NCT02924428|537927591|FG001|Overall Study|Physician Decision|0|||
148783822|NCT02134353|536684359|FG001|Overall Study|Death|1|||
148783823|NCT02134353|536684358|FG000|Overall Study|Pregnancy|0|||
148783824|NCT02134353|536684359|FG001|Overall Study|Pregnancy|1|||
148783825|NCT02134353|536684358|FG000|Overall Study|Relocation|1|||
148783826|NCT02134353|536684359|FG001|Overall Study|Relocation|0|||
148783827|NCT02134353|536684358|FG000|Overall Study|Other - Patient's Choice|0|||
148783828|NCT02134353|536684359|FG001|Overall Study|Other - Patient's Choice|1|||
148783829|NCT01732471|536684362|FG000|Overall Study|Withdrawal by Subject|1|||
148783830|NCT00474786|536684363|FG000|Overall Study|Not Meeting Study Criteria|0|||
148783831|NCT00474786|536684364|FG001|Overall Study|Not Meeting Study Criteria|1|||
148783832|NCT00474786|536684363|FG000|Overall Study|Investigator Request|2|||
148783833|NCT00474786|536684364|FG001|Overall Study|Investigator Request|1|||
148783834|NCT00474786|536684363|FG000|Overall Study|Death|189|||
148783835|NCT00474786|536684364|FG001|Overall Study|Death|170|||
148783836|NCT00474786|536684363|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
148783837|NCT00474786|536684364|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
148783838|NCT00474786|536684363|FG000|Overall Study|Lost to Follow-up|4|||
148783839|NCT00474786|536684364|FG001|Overall Study|Lost to Follow-up|7|||
148783840|NCT00474786|536684363|FG000|Overall Study|Protocol Violation|2|||
148783841|NCT00474786|536684364|FG001|Overall Study|Protocol Violation|0|||
148783842|NCT00474786|536684363|FG000|Overall Study|Withdrawal by Subject|15|||
148783843|NCT00474786|536684364|FG001|Overall Study|Withdrawal by Subject|15|||
148783844|NCT00474786|536684363|FG000|Overall Study|Other|5|||
148783845|NCT00474786|536684364|FG001|Overall Study|Other|0|||
148783846|NCT02892513|536684365|FG000|Overall Study|Withdrawal by Subject|0|||
148783847|NCT02892513|536684366|FG001|Overall Study|Withdrawal by Subject|1|||
148783848|NCT03426436|536684367|FG000|Overall Study|Incorrect lead placement|12|||
148783849|NCT03426436|536684367|FG000|Overall Study|Withdrawal by Subject|2|||
148783850|NCT03426436|536684367|FG000|Overall Study|Consent issue|1|||
148783851|NCT03426436|536684367|FG000|Overall Study|ECGs not saved|4|||
148783852|NCT00358956|536684368|FG000|Overall Study|Adverse Event|3|||
148783853|NCT00358956|536684368|FG000|Overall Study|condition under investigation worsened|4|||
148783854|NCT00358956|536684368|FG000|Overall Study|Withdrawal by Subject|1|||
148783855|NCT00655681|536684369|FG000|Overall Study|Lost to Follow-up|1|||
148783856|NCT00655681|536684370|FG001|Overall Study|Lost to Follow-up|1|||
148783857|NCT04776018|536684372|FG000|Overall Study|Death|0|||
148783858|NCT04776018|536684373|FG001|Overall Study|Death|1|||
148783859|NCT04776018|536684374|FG002|Overall Study|Death|4|||
148783860|NCT04776018|536684375|FG003|Overall Study|Death|1|||
148783861|NCT04776018|536684376|FG004|Overall Study|Death|4|||
148783862|NCT04776018|536684377|FG005|Overall Study|Death|0|||
148783863|NCT04776018|536684378|FG006|Overall Study|Death|0|||
148783864|NCT04776018|536684372|FG000|Overall Study|Study terminated by sponsor|2|||
148783865|NCT04776018|536684373|FG001|Overall Study|Study terminated by sponsor|1|||
148783866|NCT04776018|536684374|FG002|Overall Study|Study terminated by sponsor|4|||
148783867|NCT04776018|536684375|FG003|Overall Study|Study terminated by sponsor|0|||
148783868|NCT04776018|536684376|FG004|Overall Study|Study terminated by sponsor|3|||
148783869|NCT04776018|536684377|FG005|Overall Study|Study terminated by sponsor|0|||
148783870|NCT04776018|536684378|FG006|Overall Study|Study terminated by sponsor|0|||
148783871|NCT04776018|536684372|FG000|Overall Study|Withdrawal by Subject|1|||
148783872|NCT04776018|536684373|FG001|Overall Study|Withdrawal by Subject|0|||
148783873|NCT04776018|536684374|FG002|Overall Study|Withdrawal by Subject|0|||
148783874|NCT04776018|536684375|FG003|Overall Study|Withdrawal by Subject|2|||
148783875|NCT04776018|536684376|FG004|Overall Study|Withdrawal by Subject|1|||
148783876|NCT04776018|536684377|FG005|Overall Study|Withdrawal by Subject|0|||
148783877|NCT04776018|536684378|FG006|Overall Study|Withdrawal by Subject|0|||
148783878|NCT04776018|536684372|FG000|Overall Study|Other|0|||
148783879|NCT04776018|536684373|FG001|Overall Study|Other|1|||
148783880|NCT04776018|536684374|FG002|Overall Study|Other|1|||
148783881|NCT04776018|536684375|FG003|Overall Study|Other|0|||
148783882|NCT04776018|536684376|FG004|Overall Study|Other|0|||
148783883|NCT04776018|536684377|FG005|Overall Study|Other|0|||
148783884|NCT04776018|536684378|FG006|Overall Study|Other|0|||
148783885|NCT04776018|536684372|FG000|Overall Study|Lost to Follow-up|0|||
148783886|NCT04776018|536684373|FG001|Overall Study|Lost to Follow-up|0|||
148783887|NCT04776018|536684374|FG002|Overall Study|Lost to Follow-up|1|||
148783888|NCT04776018|536684375|FG003|Overall Study|Lost to Follow-up|0|||
148783889|NCT04776018|536684376|FG004|Overall Study|Lost to Follow-up|0|||
148783890|NCT04776018|536684377|FG005|Overall Study|Lost to Follow-up|0|||
148783891|NCT04776018|536684378|FG006|Overall Study|Lost to Follow-up|0|||
148783892|NCT02429310|536684380|FG000|Overall Study|Lost to Follow-up|1|||
148783893|NCT02429310|536684381|FG001|Overall Study|Lost to Follow-up|2|||
148783894|NCT02429310|536684380|FG000|Overall Study|Protocol Violation|1|||
148783895|NCT02429310|536684381|FG001|Overall Study|Protocol Violation|1|||
148783896|NCT00394433|536684382|FG000|Overall Study|Adverse Event|2|||
148783897|NCT00394433|536684382|FG000|Overall Study|Alternative Therapy|1|||
148783898|NCT00594386|536684385|FG000|Overall Study|Major protocol violation|2|||
148783899|NCT00594386|536684385|FG000|Overall Study|Lack of Efficacy|12|||
148783900|NCT00594386|536684385|FG000|Overall Study|Adverse Event|68|||
148783901|NCT00594386|536684385|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
149122747|NCT02924428|537927590|FG000|Overall Study|Lost to Follow-up|2|||
149122748|NCT02924428|537927591|FG001|Overall Study|Lost to Follow-up|4|||
149122749|NCT02924428|537927590|FG000|Overall Study|Pregnancy|0|||
149122750|NCT02924428|537927591|FG001|Overall Study|Pregnancy|1|||
149122751|NCT00512317|537927594|FG000|Overall Study|Insufficient clinical response|36|||
149122752|NCT00512317|537927594|FG000|Overall Study|Withdrawal by Subject|23|||
149122753|NCT00512317|537927594|FG000|Overall Study|Sponsor closure of study|21|||
149122754|NCT00512317|537927594|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
149122755|NCT00512317|537927594|FG000|Overall Study|Adverse Event|13|||
149122756|NCT00512317|537927594|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
149122757|NCT00512317|537927594|FG000|Overall Study|Lost to Follow-up|2|||
149122758|NCT00512317|537927594|FG000|Overall Study|Other|2|||
149122759|NCT01491672|537927595|FG000|Overall Study|Lost to Follow-up|0|||
149122760|NCT01491672|537927596|FG001|Overall Study|Lost to Follow-up|4|||
149122761|NCT01491672|537927597|FG002|Overall Study|Lost to Follow-up|1|||
149122762|NCT01491672|537927595|FG000|Overall Study|Withdrawal by Subject|6|||
149122763|NCT01491672|537927596|FG001|Overall Study|Withdrawal by Subject|7|||
149122764|NCT01491672|537927597|FG002|Overall Study|Withdrawal by Subject|0|||
149122765|NCT01491672|537927595|FG000|Overall Study|Adverse Event|8|||
149122766|NCT01491672|537927596|FG001|Overall Study|Adverse Event|10|||
149122767|NCT01491672|537927597|FG002|Overall Study|Adverse Event|4|||
149122768|NCT01491672|537927595|FG000|Overall Study|Disease progression|42|||
149122769|NCT01491672|537927596|FG001|Overall Study|Disease progression|34|||
149122770|NCT01491672|537927597|FG002|Overall Study|Disease progression|6|||
149122771|NCT01491672|537927595|FG000|Overall Study|Protocol deviation|0|||
149122772|NCT01491672|537927596|FG001|Overall Study|Protocol deviation|1|||
149122773|NCT01491672|537927597|FG002|Overall Study|Protocol deviation|0|||
149122774|NCT01491672|537927595|FG000|Overall Study|Death|0|||
149122775|NCT01491672|537927596|FG001|Overall Study|Death|4|||
149122776|NCT01491672|537927597|FG002|Overall Study|Death|0|||
149122777|NCT03064035|537927600|FG000|Overall Study|Did not receive allocated intervention|4|||
149122778|NCT03064035|537927601|FG001|Overall Study|Did not receive allocated intervention|2|||
149122779|NCT03064035|537927600|FG000|Overall Study|Lost to Follow-up|1|||
149122780|NCT03064035|537927601|FG001|Overall Study|Lost to Follow-up|1|||
149122781|NCT01143038|537927602|FG000|Overall Study|Withdrawal by Subject|4|||
149122782|NCT01143038|537927602|FG000|Overall Study|Requirement for alternative therapy|5|||
149122783|NCT01143038|537927602|FG000|Overall Study|Adverse Event|3|||
149122784|NCT01143038|537927602|FG000|Overall Study|Lost to Follow-up|2|||
149122785|NCT01143038|537927602|FG000|Overall Study|Protocol Deviation|1|||
149122786|NCT01143038|537927602|FG000|Overall Study|Death|1|||
149122787|NCT02336178|537927603|FG000|Overall Study|Lost to Follow-up|1|||
149122788|NCT02336178|537927603|FG000|Overall Study|Protocol Violation|1|||
149122789|NCT02336178|537927603|FG000|Overall Study|Withdrawal by Subject|1|||
149122790|NCT02336178|537927603|FG000|Overall Study|Other|1|||
149122791|NCT03310268|537927604|FG000|Overall Study|(Not specified)|1|||
149122792|NCT03310268|537927605|FG001|Overall Study|(Not specified)|5|||
149122793|NCT03310268|537927606|FG002|Overall Study|(Not specified)|0|||
149122794|NCT00618982|537927607|FG000|Overall Study|Adverse Event|23|||
149122795|NCT00618982|537927607|FG000|Overall Study|Withdrawal by Subject|1|||
149122796|NCT00618982|537927607|FG000|Overall Study|Protocol Violation|1|||
149122797|NCT00618982|537927607|FG000|Overall Study|ongoing, still treated with study med.|25|||
149122798|NCT00706433|537927613|FG000|Overall Study|Lost to Follow-up|3|||
149122799|NCT00706433|537927614|FG001|Overall Study|Lost to Follow-up|1|||
149122800|NCT00706433|537927615|FG002|Overall Study|Lost to Follow-up|6|||
149122801|NCT00706433|537927616|FG003|Overall Study|Lost to Follow-up|0|||
149122802|NCT00706433|537927613|FG000|Overall Study|Withdrawal by Subject|1|||
149122803|NCT00706433|537927614|FG001|Overall Study|Withdrawal by Subject|2|||
149122804|NCT00706433|537927615|FG002|Overall Study|Withdrawal by Subject|3|||
149122805|NCT00706433|537927616|FG003|Overall Study|Withdrawal by Subject|1|||
149122806|NCT00706433|537927613|FG000|Overall Study|Adverse Event|0|||
149122807|NCT00706433|537927614|FG001|Overall Study|Adverse Event|0|||
149122808|NCT00706433|537927615|FG002|Overall Study|Adverse Event|1|||
149122809|NCT00706433|537927616|FG003|Overall Study|Adverse Event|0|||
149122810|NCT00706433|537927613|FG000|Overall Study|Protocol Violation|1|||
149122811|NCT00706433|537927614|FG001|Overall Study|Protocol Violation|0|||
149122812|NCT00706433|537927615|FG002|Overall Study|Protocol Violation|0|||
149122813|NCT00706433|537927616|FG003|Overall Study|Protocol Violation|0|||
149122814|NCT00706433|537927613|FG000|Overall Study|new job|0|||
149122815|NCT00706433|537927614|FG001|Overall Study|new job|0|||
149122816|NCT00706433|537927615|FG002|Overall Study|new job|0|||
149122817|NCT00706433|537927616|FG003|Overall Study|new job|1|||
149122818|NCT01236365|537927618|FG000|Overall Study|Lost to Follow-up|0|||
149122819|NCT01236365|537927619|FG001|Overall Study|Lost to Follow-up|2|||
149122820|NCT01236365|537927618|FG000|Overall Study|Moved Out of State|1|||
149122821|NCT01236365|537927619|FG001|Overall Study|Moved Out of State|0|||
149122822|NCT01236365|537927618|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
149122823|NCT01236365|537927619|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
149122824|NCT04289051|537927620|FG000|Overall Study|Lost to Follow-up|0|||
149122825|NCT04289051|537927621|FG001|Overall Study|Lost to Follow-up|0|||
148783902|NCT00594386|536684385|FG000|Overall Study|Subject withdrew consent|35|||
148783903|NCT00594386|536684385|FG000|Overall Study|Study ended per sponsor|115|||
148783904|NCT00594386|536684385|FG000|Overall Study|Lost to Follow-up|6|||
148783905|NCT00594386|536684385|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
148783906|NCT00594386|536684385|FG000|Overall Study|Other: Subject moved to Seattle|1|||
148783907|NCT00594386|536684385|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
148783908|NCT00594386|536684385|FG000|Overall Study|Other: Study terminated per investigator|2|||
148783909|NCT00594386|536684385|FG000|Overall Study|Other: Sponsor closure of study|1|||
148783910|NCT00594386|536684385|FG000|Overall Study|Other: Site terminated participation|1|||
148783911|NCT00594386|536684385|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
148783912|NCT00594386|536684385|FG000|Overall Study|Other: Loss of drivers license|1|||
148783913|NCT03417024|536684386|FG000|Overall Study|Study Termination prior to follow-up|11|||
148783914|NCT03417024|536684386|FG000|Overall Study|Physician Decision|2|||
148783915|NCT03168919|536684387|FG000|Overall Study|Withdrawal by Subject|2|||
148783916|NCT01085136|536684388|FG000|Part A|Other Adverse event|223|||
148783917|NCT01085136|536684389|FG001|Part A|Other Adverse event|0|||
148783918|NCT01085136|536684390|FG002|Part A|Other Adverse event|0|||
148783919|NCT01085136|536684388|FG000|Part A|Protocol Violation|3|||
148783920|NCT01085136|536684389|FG001|Part A|Protocol Violation|0|||
148783921|NCT01085136|536684390|FG002|Part A|Protocol Violation|0|||
148783922|NCT01085136|536684388|FG000|Part A|Lost to Follow-up|3|||
148783923|NCT01085136|536684389|FG001|Part A|Lost to Follow-up|0|||
148783924|NCT01085136|536684390|FG002|Part A|Lost to Follow-up|0|||
148783925|NCT01085136|536684388|FG000|Part A|Refusal to continue trial medication|64|||
148783926|NCT01085136|536684389|FG001|Part A|Refusal to continue trial medication|0|||
148783927|NCT01085136|536684390|FG002|Part A|Refusal to continue trial medication|0|||
148783928|NCT01085136|536684388|FG000|Part A|Other reason not defined above|30|||
148783929|NCT01085136|536684389|FG001|Part A|Other reason not defined above|0|||
148783930|NCT01085136|536684390|FG002|Part A|Other reason not defined above|0|||
148783931|NCT01085136|536684388|FG000|Part B|Other AE|0|||
148783932|NCT01085136|536684389|FG001|Part B|Other AE|29|||
148783933|NCT01085136|536684390|FG002|Part B|Other AE|8|||
148783934|NCT01085136|536684388|FG000|Part B|Refusal to continue trial medication|0|||
148783935|NCT01085136|536684389|FG001|Part B|Refusal to continue trial medication|12|||
148783936|NCT01085136|536684390|FG002|Part B|Refusal to continue trial medication|7|||
148783937|NCT01085136|536684388|FG000|Part B|Not treated|0|||
148783938|NCT01085136|536684389|FG001|Part B|Not treated|4|||
148783939|NCT01085136|536684390|FG002|Part B|Not treated|8|||
148783940|NCT01085136|536684388|FG000|Part B|Other reason not defined above|0|||
148783941|NCT01085136|536684389|FG001|Part B|Other reason not defined above|6|||
148783942|NCT01085136|536684390|FG002|Part B|Other reason not defined above|3|||
148783943|NCT02195427|536684391|FG000|Overall Study|Did not consent to study extension|13|||
148783944|NCT02195427|536684392|FG001|Overall Study|Did not consent to study extension|9|||
148783945|NCT02195427|536684391|FG000|Overall Study|Withdrawal by Subject|4|||
148783946|NCT02195427|536684392|FG001|Overall Study|Withdrawal by Subject|2|||
148783947|NCT02195427|536684391|FG000|Overall Study|Lost to Follow-up|0|||
148783948|NCT02195427|536684392|FG001|Overall Study|Lost to Follow-up|1|||
148783949|NCT02195427|536684391|FG000|Overall Study|Protocol Violation|7|||
148783950|NCT02195427|536684392|FG001|Overall Study|Protocol Violation|14|||
148783951|NCT02195427|536684391|FG000|Overall Study|Conditional re-treatment at W52|2|||
148783952|NCT02195427|536684392|FG001|Overall Study|Conditional re-treatment at W52|1|||
148783953|NCT01210144|536684396|FG000|Overall Study|Lack of ovarian response|1|||
148783954|NCT01210144|536684397|FG001|Overall Study|Lack of ovarian response|0|||
148783955|NCT01210144|536684396|FG000|Overall Study|No fertilization|1|||
148783956|NCT01210144|536684397|FG001|Overall Study|No fertilization|0|||
148783957|NCT01210144|536684396|FG000|Overall Study|No transfer|1|||
148783958|NCT01210144|536684397|FG001|Overall Study|No transfer|0|||
148783959|NCT00386425|536684398|FG000|Overall Study|Physician Decision|3|||
148783960|NCT00386425|536684399|FG001|Overall Study|Physician Decision|0|||
148783961|NCT00386425|536684400|FG002|Overall Study|Physician Decision|0|||
148783962|NCT00386425|536684398|FG000|Overall Study|Withdrawal by Subject|0|||
148783963|NCT00386425|536684399|FG001|Overall Study|Withdrawal by Subject|1|||
148783964|NCT00386425|536684400|FG002|Overall Study|Withdrawal by Subject|0|||
148783965|NCT04226495|536684401|FG000|Overall Study|Withdrawal by Subject|3|||
148783966|NCT04226495|536684402|FG001|Overall Study|Withdrawal by Subject|3|||
148783967|NCT04226495|536684401|FG000|Overall Study|PI discretion|3|||
148783968|NCT04226495|536684402|FG001|Overall Study|PI discretion|4|||
148783969|NCT00505661|536684407|FG000|Overall Study|Not Eligible|4|||
148783970|NCT03611582|536684410|FG000|Overall Study|Adverse Event|26|||
148783971|NCT03611582|536684411|FG001|Overall Study|Adverse Event|6|||
148783972|NCT03611582|536684410|FG000|Overall Study|Protocol Violation|0|||
148783973|NCT03611582|536684411|FG001|Overall Study|Protocol Violation|1|||
148783974|NCT03611582|536684410|FG000|Overall Study|Pregnancy|1|||
148783975|NCT03611582|536684411|FG001|Overall Study|Pregnancy|2|||
148783976|NCT03611582|536684410|FG000|Overall Study|Lack of Efficacy|0|||
148783977|NCT03611582|536684411|FG001|Overall Study|Lack of Efficacy|1|||
148783978|NCT03611582|536684410|FG000|Overall Study|At the discretion of the investigator|1|||
148893353|NCT00683878|537088679|FG001|Overall Study|Death|1|||
148783979|NCT03611582|536684411|FG001|Overall Study|At the discretion of the investigator|0|||
148783980|NCT03611582|536684410|FG000|Overall Study|Safety concern as judged by the investigator|1|||
148783981|NCT03611582|536684411|FG001|Overall Study|Safety concern as judged by the investigator|2|||
148783982|NCT03611582|536684410|FG000|Overall Study|Withdrawal by Subject|4|||
148783983|NCT03611582|536684411|FG001|Overall Study|Withdrawal by Subject|3|||
148783984|NCT03611582|536684410|FG000|Overall Study|Lost to Follow-up|18|||
148783985|NCT03611582|536684411|FG001|Overall Study|Lost to Follow-up|7|||
148783986|NCT03611582|536684410|FG000|Overall Study|other|17|||
148783987|NCT03611582|536684411|FG001|Overall Study|other|16|||
148783988|NCT01783821|536684412|FG000|Overall Study|Screen Failure|1|||
148783989|NCT01783821|536684413|FG001|Overall Study|Screen Failure|1|||
148783990|NCT01907217|536684414|FG000|Overall Study|Withdrawal by Subject|0|||
148783991|NCT01907217|536684415|FG001|Overall Study|Withdrawal by Subject|2|||
148783992|NCT01764659|536684416|FG000|Overall Study|Death|1|||
148783993|NCT01764659|536684416|FG000|Overall Study|Physician Decision|1|||
148783994|NCT01210352|536684417|FG000|Overall Study|Adverse Event|0|||
148783995|NCT01210352|536684418|FG001|Overall Study|Adverse Event|0|||
148783996|NCT01210352|536684419|FG002|Overall Study|Adverse Event|0|||
148783997|NCT01210352|536684420|FG003|Overall Study|Adverse Event|0|||
148783998|NCT01210352|536684421|FG004|Overall Study|Adverse Event|0|||
148783999|NCT01210352|536684422|FG005|Overall Study|Adverse Event|0|||
148784000|NCT01210352|536684423|FG006|Overall Study|Adverse Event|0|||
148784001|NCT01210352|536684424|FG007|Overall Study|Adverse Event|2|||
148784002|NCT01210352|536684425|FG008|Overall Study|Adverse Event|1|||
148784003|NCT01210352|536684417|FG000|Overall Study|Lack of Efficacy|0|||
148784004|NCT01210352|536684418|FG001|Overall Study|Lack of Efficacy|0|||
148784005|NCT01210352|536684419|FG002|Overall Study|Lack of Efficacy|0|||
149122826|NCT04289051|537927622|FG002|Overall Study|Lost to Follow-up|2|||
149122827|NCT00545051|537927623|FG000|Overall Study|Adverse Event|7|||
149122828|NCT00545051|537927624|FG001|Overall Study|Adverse Event|3|||
149122829|NCT00545051|537927623|FG000|Overall Study|Death|1|||
149122830|NCT00545051|537927624|FG001|Overall Study|Death|0|||
149122831|NCT00545051|537927623|FG000|Overall Study|Violation of inclusion/exclusion|0|||
149122832|NCT00545051|537927624|FG001|Overall Study|Violation of inclusion/exclusion|2|||
149122833|NCT00545051|537927623|FG000|Overall Study|Protocol Violation|1|||
149122834|NCT00545051|537927624|FG001|Overall Study|Protocol Violation|0|||
149122835|NCT00545051|537927623|FG000|Overall Study|Withdrawal by Subject|0|||
149122836|NCT00545051|537927624|FG001|Overall Study|Withdrawal by Subject|1|||
149122837|NCT00545051|537927623|FG000|Overall Study|Administrative reasons|0|||
149122838|NCT00545051|537927624|FG001|Overall Study|Administrative reasons|1|||
149122839|NCT01375114|537927625|FG000|Overall Study|Lost to Follow-up|1|||
149122840|NCT01375114|537927626|FG001|Overall Study|Lost to Follow-up|0|||
149122841|NCT01375114|537927627|FG002|Overall Study|Lost to Follow-up|1|||
149122842|NCT01375114|537927625|FG000|Overall Study|Disease Progression|3|||
149122843|NCT01375114|537927626|FG001|Overall Study|Disease Progression|2|||
149122844|NCT01375114|537927627|FG002|Overall Study|Disease Progression|2|||
149122845|NCT01375114|537927625|FG000|Overall Study|Patient Changed Mind|0|||
149122846|NCT01375114|537927626|FG001|Overall Study|Patient Changed Mind|0|||
149122847|NCT01375114|537927627|FG002|Overall Study|Patient Changed Mind|2|||
149122848|NCT01375114|537927625|FG000|Overall Study|Pruritus|0|||
149122849|NCT01375114|537927626|FG001|Overall Study|Pruritus|0|||
149122850|NCT01375114|537927627|FG002|Overall Study|Pruritus|1|||
149122851|NCT01375114|537927625|FG000|Overall Study|Restlessness|0|||
149122852|NCT01375114|537927626|FG001|Overall Study|Restlessness|0|||
149122853|NCT01375114|537927627|FG002|Overall Study|Restlessness|1|||
149122854|NCT01375114|537927625|FG000|Overall Study|Diarrhea|0|||
149122855|NCT01375114|537927626|FG001|Overall Study|Diarrhea|0|||
149122856|NCT01375114|537927627|FG002|Overall Study|Diarrhea|1|||
149122857|NCT01375114|537927625|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
149122858|NCT01375114|537927626|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
149122859|NCT01375114|537927627|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
149122860|NCT01375114|537927625|FG000|Overall Study|Nausea|0|||
149122861|NCT01375114|537927626|FG001|Overall Study|Nausea|1|||
149122862|NCT01375114|537927627|FG002|Overall Study|Nausea|0|||
149122863|NCT01375114|537927625|FG000|Overall Study|Increased AST/ALT|0|||
149122864|NCT01375114|537927626|FG001|Overall Study|Increased AST/ALT|1|||
149122865|NCT01375114|537927627|FG002|Overall Study|Increased AST/ALT|0|||
149122866|NCT01375114|537927625|FG000|Overall Study|Vaginal Hemorrhage|0|||
148784006|NCT01210352|536684420|FG003|Overall Study|Lack of Efficacy|0|||
148784007|NCT01210352|536684421|FG004|Overall Study|Lack of Efficacy|0|||
148784008|NCT01210352|536684422|FG005|Overall Study|Lack of Efficacy|0|||
148784009|NCT01210352|536684423|FG006|Overall Study|Lack of Efficacy|1|||
148784010|NCT01210352|536684424|FG007|Overall Study|Lack of Efficacy|0|||
149122867|NCT01375114|537927626|FG001|Overall Study|Vaginal Hemorrhage|1|||
148784011|NCT01210352|536684425|FG008|Overall Study|Lack of Efficacy|0|||
148784012|NCT01210352|536684417|FG000|Overall Study|Physician Decision|0|||
149122868|NCT01375114|537927627|FG002|Overall Study|Vaginal Hemorrhage|0|||
149122869|NCT01375114|537927625|FG000|Overall Study|Family problem|0|||
149122870|NCT01375114|537927626|FG001|Overall Study|Family problem|1|||
149122871|NCT01375114|537927627|FG002|Overall Study|Family problem|0|||
149122872|NCT01375114|537927625|FG000|Overall Study|Protocol Violation|2|||
149122873|NCT01375114|537927626|FG001|Overall Study|Protocol Violation|0|||
149122874|NCT01375114|537927627|FG002|Overall Study|Protocol Violation|0|||
149122875|NCT01888900|537927628|FG000|Overall Study|failed treatment|0|||
149122876|NCT01888900|537927629|FG001|Overall Study|failed treatment|2|||
149122877|NCT03271021|537927630|FG000|Overall Study|Adverse Event|3|||
149122878|NCT03271021|537927631|FG001|Overall Study|Adverse Event|2|||
149122879|NCT03271021|537927630|FG000|Overall Study|Withdrawal by Subject|36|||
149122880|NCT03271021|537927631|FG001|Overall Study|Withdrawal by Subject|53|||
149122881|NCT03271021|537927630|FG000|Overall Study|Lost to Follow-up|34|||
149122882|NCT03271021|537927631|FG001|Overall Study|Lost to Follow-up|39|||
149122883|NCT03271021|537927630|FG000|Overall Study|Protocol Violation|6|||
149122884|NCT03271021|537927631|FG001|Overall Study|Protocol Violation|4|||
149122885|NCT03271021|537927630|FG000|Overall Study|Abnormal Lab Results|1|||
149122886|NCT03271021|537927631|FG001|Overall Study|Abnormal Lab Results|0|||
149122887|NCT03271021|537927630|FG000|Overall Study|Miscellaneous|9|||
149122888|NCT03271021|537927631|FG001|Overall Study|Miscellaneous|8|||
149122889|NCT03606668|537927634|FG000|Overall Study|Screen Failure|1|||
149122890|NCT03606668|537927634|FG000|Overall Study|Lost to Follow-up|1|||
149122891|NCT00495586|537927638|FG000|Overall Study|Withdrawal by Subject|4|||
149122892|NCT00495586|537927639|FG001|Overall Study|Withdrawal by Subject|4|||
149122893|NCT03038438|537927640|FG000|Overall Study|Death|3|||
149122894|NCT03038438|537927640|FG000|Overall Study|Lost to Follow-up|8|||
149122895|NCT03038438|537927640|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
149122896|NCT03038438|537927640|FG000|Overall Study|Withdrawal by Subject|5|||
149122897|NCT03038438|537927640|FG000|Overall Study|No 36-Month Follow-Up|18|||
149122898|NCT03215810|537927641|FG000|Overall Study|Still responding to nivolumab|1|||
149122899|NCT03215810|537927641|FG000|Overall Study|Insufficient TIL growth|1|||
149122900|NCT03215810|537927641|FG000|Overall Study|Decline in performance status|1|||
149122901|NCT03215810|537927641|FG000|Overall Study|Withdrawal by Subject|1|||
149122902|NCT02038543|537927644|FG000|Overall Study|Screen Failure|0|||
149122903|NCT02038543|537927645|FG001|Overall Study|Screen Failure|0|||
149122904|NCT02038543|537927646|FG002|Overall Study|Screen Failure|0|||
149122905|NCT02038543|537927647|FG003|Overall Study|Screen Failure|1|||
149122906|NCT02038543|537927644|FG000|Overall Study|Withdrawal by Subject|0|||
149122907|NCT02038543|537927645|FG001|Overall Study|Withdrawal by Subject|0|||
149122908|NCT02038543|537927646|FG002|Overall Study|Withdrawal by Subject|0|||
149122909|NCT02038543|537927647|FG003|Overall Study|Withdrawal by Subject|1|||
149122910|NCT03406260|537927648|FG000|Period 1|Adverse Event|0|||
149122911|NCT03406260|537927649|FG001|Period 1|Adverse Event|0|||
149122912|NCT03406260|537927650|FG002|Period 1|Adverse Event|0|||
149122913|NCT03406260|537927651|FG003|Period 1|Adverse Event|0|||
149122914|NCT03406260|537927652|FG004|Period 1|Adverse Event|1|||
149122915|NCT03406260|537927653|FG005|Period 1|Adverse Event|0|||
149122916|NCT02647866|537927654|FG000|Overall Study|Adverse Event|0|||
149122917|NCT02647866|537927655|FG001|Overall Study|Adverse Event|0|||
149122918|NCT02647866|537927656|FG002|Overall Study|Adverse Event|2|||
149122919|NCT02647866|537927657|FG003|Overall Study|Adverse Event|2|||
149122920|NCT02647866|537927658|FG004|Overall Study|Adverse Event|1|||
149122921|NCT02647866|537927654|FG000|Overall Study|Disease Worsening|3|||
149122922|NCT02647866|537927655|FG001|Overall Study|Disease Worsening|1|||
149122923|NCT02647866|537927656|FG002|Overall Study|Disease Worsening|0|||
149122924|NCT02647866|537927657|FG003|Overall Study|Disease Worsening|0|||
149122925|NCT02647866|537927658|FG004|Overall Study|Disease Worsening|1|||
149122926|NCT02647866|537927654|FG000|Overall Study|Withdrawal by Subject|1|||
149122927|NCT02647866|537927655|FG001|Overall Study|Withdrawal by Subject|1|||
149122928|NCT02647866|537927656|FG002|Overall Study|Withdrawal by Subject|2|||
149122929|NCT02647866|537927657|FG003|Overall Study|Withdrawal by Subject|4|||
149122930|NCT02647866|537927658|FG004|Overall Study|Withdrawal by Subject|4|||
149122931|NCT02647866|537927654|FG000|Overall Study|Physician Decision|0|||
149122932|NCT02647866|537927655|FG001|Overall Study|Physician Decision|1|||
149122933|NCT02647866|537927656|FG002|Overall Study|Physician Decision|1|||
149122934|NCT02647866|537927657|FG003|Overall Study|Physician Decision|0|||
149122935|NCT02647866|537927658|FG004|Overall Study|Physician Decision|2|||
149122936|NCT02647866|537927654|FG000|Overall Study|Death|0|||
149122937|NCT02647866|537927655|FG001|Overall Study|Death|1|||
149122938|NCT02647866|537927656|FG002|Overall Study|Death|0|||
149122939|NCT02647866|537927657|FG003|Overall Study|Death|0|||
149122940|NCT02647866|537927658|FG004|Overall Study|Death|0|||
149122941|NCT02647866|537927654|FG000|Overall Study|Subject moved to different country|1|||
149122942|NCT02647866|537927655|FG001|Overall Study|Subject moved to different country|0|||
149122943|NCT02647866|537927656|FG002|Overall Study|Subject moved to different country|0|||
149122944|NCT02647866|537927657|FG003|Overall Study|Subject moved to different country|0|||
149122945|NCT02647866|537927658|FG004|Overall Study|Subject moved to different country|0|||
149122946|NCT01029652|537927662|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
149122947|NCT01029652|537927663|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
149122948|NCT01029652|537927662|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
149122949|NCT01029652|537927663|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
148784013|NCT01210352|536684418|FG001|Overall Study|Physician Decision|0|||
148784014|NCT01210352|536684419|FG002|Overall Study|Physician Decision|0|||
148784015|NCT01210352|536684420|FG003|Overall Study|Physician Decision|0|||
148784016|NCT01210352|536684421|FG004|Overall Study|Physician Decision|0|||
148784017|NCT01210352|536684422|FG005|Overall Study|Physician Decision|0|||
148784018|NCT01210352|536684423|FG006|Overall Study|Physician Decision|0|||
148784019|NCT01210352|536684424|FG007|Overall Study|Physician Decision|1|||
148784020|NCT01210352|536684425|FG008|Overall Study|Physician Decision|2|||
148784021|NCT01210352|536684417|FG000|Overall Study|Withdrawal by Subject|0|||
148784022|NCT01210352|536684418|FG001|Overall Study|Withdrawal by Subject|0|||
148784023|NCT01210352|536684419|FG002|Overall Study|Withdrawal by Subject|1|||
148784024|NCT01210352|536684420|FG003|Overall Study|Withdrawal by Subject|0|||
148784025|NCT01210352|536684421|FG004|Overall Study|Withdrawal by Subject|0|||
148784026|NCT01210352|536684422|FG005|Overall Study|Withdrawal by Subject|0|||
148784027|NCT01210352|536684423|FG006|Overall Study|Withdrawal by Subject|1|||
148784028|NCT01210352|536684424|FG007|Overall Study|Withdrawal by Subject|0|||
148784029|NCT01210352|536684425|FG008|Overall Study|Withdrawal by Subject|1|||
148784030|NCT01210352|536684417|FG000|Overall Study|Patient Discharged Early|0|||
148784031|NCT01210352|536684418|FG001|Overall Study|Patient Discharged Early|0|||
148784032|NCT01210352|536684419|FG002|Overall Study|Patient Discharged Early|1|||
148784033|NCT01210352|536684420|FG003|Overall Study|Patient Discharged Early|0|||
148784034|NCT01210352|536684421|FG004|Overall Study|Patient Discharged Early|0|||
148784035|NCT01210352|536684422|FG005|Overall Study|Patient Discharged Early|0|||
148784036|NCT01210352|536684423|FG006|Overall Study|Patient Discharged Early|0|||
148784037|NCT01210352|536684424|FG007|Overall Study|Patient Discharged Early|0|||
148784038|NCT01210352|536684425|FG008|Overall Study|Patient Discharged Early|0|||
148784039|NCT00422292|536684426|FG000|Overall Study|Serious adverse events|1|||
148784040|NCT00422292|536684427|FG001|Overall Study|Serious adverse events|4|||
148784041|NCT00422292|536684428|FG002|Overall Study|Serious adverse events|0|||
148784042|NCT00422292|536684429|FG003|Overall Study|Serious adverse events|0|||
148784043|NCT00422292|536684426|FG000|Overall Study|Adverse Event|1|||
148784044|NCT00422292|536684427|FG001|Overall Study|Adverse Event|0|||
148784045|NCT00422292|536684428|FG002|Overall Study|Adverse Event|1|||
148784046|NCT00422292|536684429|FG003|Overall Study|Adverse Event|0|||
148784047|NCT00422292|536684426|FG000|Overall Study|Protocol Violation|4|||
148784048|NCT00422292|536684427|FG001|Overall Study|Protocol Violation|25|||
148784049|NCT00422292|536684428|FG002|Overall Study|Protocol Violation|8|||
148784050|NCT00422292|536684429|FG003|Overall Study|Protocol Violation|5|||
148784051|NCT00422292|536684426|FG000|Overall Study|Lost to Follow-up|6|||
148784052|NCT00422292|536684427|FG001|Overall Study|Lost to Follow-up|12|||
148784053|NCT00422292|536684428|FG002|Overall Study|Lost to Follow-up|6|||
148784054|NCT00422292|536684429|FG003|Overall Study|Lost to Follow-up|6|||
148784055|NCT00422292|536684426|FG000|Overall Study|Withdrawal by Subject|6|||
148784056|NCT00422292|536684427|FG001|Overall Study|Withdrawal by Subject|25|||
148784057|NCT00422292|536684428|FG002|Overall Study|Withdrawal by Subject|7|||
148784058|NCT00422292|536684429|FG003|Overall Study|Withdrawal by Subject|13|||
148784059|NCT02440854|536684430|FG000|Overall Study|Relocation of patient|1|||
148784060|NCT02440854|536684430|FG000|Overall Study|Death|6|||
148784061|NCT02440854|536684430|FG000|Overall Study|Lost to Follow-up|10|||
148784062|NCT02440854|536684430|FG000|Overall Study|Afatinib discontinuation|46|||
148784063|NCT02440854|536684430|FG000|Overall Study|stopped study at earlier timepoint|14|||
148784064|NCT02440854|536684430|FG000|Overall Study|Study medication not received|1|||
148784065|NCT02440854|536684430|FG000|Overall Study|Violation of inclusion criteria|2|||
148784066|NCT02243046|536684431|FG000|Overall Study|Lost to Follow-up|1|||
148784067|NCT02243046|536684432|FG001|Overall Study|Lost to Follow-up|1|||
148784068|NCT02243046|536684433|FG002|Overall Study|Lost to Follow-up|4|||
148784069|NCT03338569|536684434|FG000|Overall Study|Physician Decision|8|||
148784070|NCT03338569|536684435|FG001|Overall Study|Physician Decision|3|||
148784071|NCT03338569|536684434|FG000|Overall Study|Withdrawal by Subject|0|||
148784072|NCT03338569|536684435|FG001|Overall Study|Withdrawal by Subject|1|||
148784073|NCT03338569|536684434|FG000|Overall Study|Lost to Follow-up|0|||
148784074|NCT03338569|536684435|FG001|Overall Study|Lost to Follow-up|1|||
148784075|NCT04607980|536684436|FG000|Overall Study|Adverse Event|3|||
148784076|NCT04607980|536684437|FG001|Overall Study|Adverse Event|4|||
148784077|NCT04607980|536684436|FG000|Overall Study|Death|0|||
148784078|NCT04607980|536684437|FG001|Overall Study|Death|1|||
148784079|NCT04607980|536684436|FG000|Overall Study|Withdrawal by Subject|2|||
148784080|NCT04607980|536684437|FG001|Overall Study|Withdrawal by Subject|5|||
148784081|NCT04607980|536684436|FG000|Overall Study|Lost to Follow-up|4|||
148784082|NCT04607980|536684437|FG001|Overall Study|Lost to Follow-up|8|||
148893354|NCT00683878|537088680|FG002|Overall Study|Death|0|||
148784083|NCT04607980|536684436|FG000|Overall Study|Protocol Violation|0|||
148784084|NCT04607980|536684437|FG001|Overall Study|Protocol Violation|3|||
148784085|NCT04607980|536684436|FG000|Overall Study|Other|3|||
148784086|NCT04607980|536684437|FG001|Overall Study|Other|0|||
148784087|NCT01854879|536684438|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
148784088|NCT01854879|536684438|FG000|Overall Study|screen fail|3|||
148784089|NCT01854879|536684438|FG000|Overall Study|incomplete data set|1|||
148784090|NCT02012959|536684439|FG000|Treatment Phase A|Adverse Event|2|||
148784091|NCT02012959|536684440|FG001|Treatment Phase A|Adverse Event|0|||
148784092|NCT02012959|536684441|FG002|Treatment Phase A|Adverse Event|0|||
148784093|NCT02012959|536684442|FG003|Treatment Phase A|Adverse Event|0|||
148784094|NCT02012959|536684443|FG004|Treatment Phase A|Adverse Event|0|||
148784095|NCT01859949|536687293|FG000|Overall Study|Family Matters|0|||
148784096|NCT01859949|536687294|FG001|Overall Study|Family Matters|1|||
148784097|NCT01859949|536687293|FG000|Overall Study|Physician Decision|2|||
148784098|NCT01859949|536687294|FG001|Overall Study|Physician Decision|4|||
149122950|NCT01029652|537927662|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
149122951|NCT01029652|537927663|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
149122952|NCT01029652|537927662|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
149122953|NCT01029652|537927663|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
149122954|NCT01029652|537927662|FG000|Core Study (0-12 Weeks)|Death|0|||
149122955|NCT01029652|537927663|FG001|Core Study (0-12 Weeks)|Death|1|||
149122956|NCT01029652|537927662|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
149122957|NCT01029652|537927663|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
149122958|NCT01029652|537927662|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
149122959|NCT01029652|537927663|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
149122960|NCT01029652|537927662|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
149122961|NCT01029652|537927663|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
149122962|NCT01029652|537927662|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
149122963|NCT01029652|537927663|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
149122964|NCT01029652|537927662|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
149122965|NCT01029652|537927663|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
149122966|NCT01029652|537927662|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
149122967|NCT01029652|537927663|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
149122968|NCT01029652|537927662|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
149122969|NCT01029652|537927663|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
149122970|NCT02313233|537927667|FG000|Overall Study|Withdrawal by Subject|1|||
149122971|NCT02313233|537927668|FG001|Overall Study|Withdrawal by Subject|2|||
149122972|NCT02313233|537927667|FG000|Overall Study|Administrative reason|1|||
149122973|NCT02313233|537927668|FG001|Overall Study|Administrative reason|1|||
149122974|NCT02095951|537927669|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
149122975|NCT02095951|537927670|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
149122976|NCT03618823|537927671|FG000|Overall Study|Lost to Follow-up|63|||
149122977|NCT03618823|537927672|FG001|Overall Study|Lost to Follow-up|61|||
149122978|NCT02399254|537927673|FG000|Overall Study|Physician Decision|2|||
149122979|NCT02930226|537927674|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
149122980|NCT02930226|537927675|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
149122981|NCT02930226|537927676|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
149122982|NCT02930226|537927677|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
149122983|NCT02930226|537927678|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
149122984|NCT02930226|537927679|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
149122985|NCT00577473|537927682|FG000|Overall Study|Protocol Violation|1|||
149122986|NCT00577473|537927683|FG001|Overall Study|Protocol Violation|4|||
149122987|NCT00577473|537927682|FG000|Overall Study|Adverse Event|8|||
149122988|NCT00577473|537927683|FG001|Overall Study|Adverse Event|5|||
149122989|NCT00577473|537927682|FG000|Overall Study|Withdrawal by Subject|2|||
149122990|NCT00577473|537927683|FG001|Overall Study|Withdrawal by Subject|6|||
149122991|NCT00577473|537927682|FG000|Overall Study|Physician Decision|2|||
149122992|NCT00577473|537927683|FG001|Overall Study|Physician Decision|2|||
149122993|NCT00577473|537927682|FG000|Overall Study|Lack of Efficacy|8|||
149122994|NCT00577473|537927683|FG001|Overall Study|Lack of Efficacy|7|||
149122995|NCT02595073|537927686|FG000|Overall Study|Progressive Disease|0|||
149122996|NCT02595073|537927687|FG001|Overall Study|Progressive Disease|1|||
149122997|NCT02595073|537927686|FG000|Overall Study|Protocol Violation|2|||
149122998|NCT02595073|537927687|FG001|Overall Study|Protocol Violation|0|||
149122999|NCT01990560|537927688|FG000|Overall Study|Withdrawal by Subject|1|||
149123000|NCT01801735|537927694|FG000|Overall Study|Adverse Event|79|||
149123001|NCT01801735|537927694|FG000|Overall Study|Lack of Efficacy|28|||
149123002|NCT01801735|537927694|FG000|Overall Study|Withdrawal by Subject|27|||
149123003|NCT01801735|537927694|FG000|Overall Study|Protocol Violation|25|||
149123004|NCT01801735|537927694|FG000|Overall Study|Lost to Follow-up|15|||
149123005|NCT01801735|537927694|FG000|Overall Study|Non-compliance with Trial Drug|13|||
149123006|NCT01801735|537927694|FG000|Overall Study|Physician Decision|3|||
149123007|NCT01801735|537927694|FG000|Overall Study|Death|1|||
149123008|NCT01801735|537927694|FG000|Overall Study|Other, including site closure|19|||
149123009|NCT02084056|537927695|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
149123010|NCT02084056|537927696|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
148784099|NCT01859949|536687293|FG000|Overall Study|Withdrawal by Subject|11|||
148784100|NCT01859949|536687294|FG001|Overall Study|Withdrawal by Subject|10|||
148784101|NCT01859949|536687293|FG000|Overall Study|Protocol Violation|1|||
148784102|NCT01859949|536687294|FG001|Overall Study|Protocol Violation|1|||
149123011|NCT02084056|537927697|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149123012|NCT02084056|537927698|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149123013|NCT02084056|537927695|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
149123014|NCT02084056|537927696|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149123015|NCT02084056|537927697|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149123016|NCT02084056|537927698|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149123017|NCT01293487|537927700|FG000|Overall Study|Lost to Follow-up|0|||
149123018|NCT01293487|537927701|FG001|Overall Study|Lost to Follow-up|0|||
149123019|NCT01293487|537927702|FG002|Overall Study|Lost to Follow-up|0|||
149123020|NCT01293487|537927703|FG003|Overall Study|Lost to Follow-up|1|||
149123021|NCT01293487|537927704|FG004|Overall Study|Lost to Follow-up|0|||
149123022|NCT01293487|537927705|FG005|Overall Study|Lost to Follow-up|0|||
149123023|NCT01293487|537927706|FG006|Overall Study|Lost to Follow-up|0|||
149123024|NCT01293487|537927707|FG007|Overall Study|Lost to Follow-up|0|||
149123025|NCT01293487|537927700|FG000|Overall Study|Withdrawal by Subject|0|||
149123026|NCT01293487|537927701|FG001|Overall Study|Withdrawal by Subject|0|||
149123027|NCT01293487|537927702|FG002|Overall Study|Withdrawal by Subject|0|||
149123028|NCT01293487|537927703|FG003|Overall Study|Withdrawal by Subject|0|||
149123029|NCT01293487|537927704|FG004|Overall Study|Withdrawal by Subject|0|||
149123030|NCT01293487|537927705|FG005|Overall Study|Withdrawal by Subject|0|||
149123031|NCT01293487|537927706|FG006|Overall Study|Withdrawal by Subject|0|||
149123032|NCT01293487|537927707|FG007|Overall Study|Withdrawal by Subject|2|||
149123033|NCT01451827|537927709|FG000|Overall Study|Adverse Event|2|||
149123034|NCT01451827|537927710|FG001|Overall Study|Adverse Event|0|||
149123035|NCT01451827|537927711|FG002|Overall Study|Adverse Event|1|||
149123036|NCT01451827|537927712|FG003|Overall Study|Adverse Event|1|||
149123037|NCT01451827|537927709|FG000|Overall Study|Protocol deviation|1|||
149123038|NCT01451827|537927710|FG001|Overall Study|Protocol deviation|0|||
149123039|NCT01451827|537927711|FG002|Overall Study|Protocol deviation|0|||
149123040|NCT01451827|537927712|FG003|Overall Study|Protocol deviation|0|||
149123041|NCT01451827|537927709|FG000|Overall Study|Lost to Follow-up|0|||
149123042|NCT01451827|537927710|FG001|Overall Study|Lost to Follow-up|3|||
149123043|NCT01451827|537927711|FG002|Overall Study|Lost to Follow-up|0|||
149123044|NCT01451827|537927712|FG003|Overall Study|Lost to Follow-up|2|||
149123045|NCT01451827|537927709|FG000|Overall Study|Participant met withdrawal criteria|0|||
149123046|NCT01451827|537927710|FG001|Overall Study|Participant met withdrawal criteria|2|||
149123047|NCT01451827|537927711|FG002|Overall Study|Participant met withdrawal criteria|0|||
149123048|NCT01451827|537927712|FG003|Overall Study|Participant met withdrawal criteria|0|||
149123049|NCT01451827|537927709|FG000|Overall Study|Withdrawal by Subject|0|||
149123050|NCT01451827|537927710|FG001|Overall Study|Withdrawal by Subject|0|||
149123051|NCT01451827|537927711|FG002|Overall Study|Withdrawal by Subject|1|||
149123052|NCT01451827|537927712|FG003|Overall Study|Withdrawal by Subject|1|||
149123053|NCT01153958|537927713|FG000|Overall Study|Study Terminated|36|||
149123054|NCT01153958|537927714|FG001|Overall Study|Study Terminated|32|||
149123055|NCT01034163|537927716|FG000|Overall Study|Treatment completed as per protocol|8|||
149123056|NCT01034163|537927717|FG001|Overall Study|Treatment completed as per protocol|7|||
149123057|NCT01034163|537927716|FG000|Overall Study|Withdrawal by Subject|8|||
149123058|NCT01034163|537927717|FG001|Overall Study|Withdrawal by Subject|2|||
149123059|NCT01034163|537927716|FG000|Overall Study|Protocol deviation|1|||
149123060|NCT01034163|537927717|FG001|Overall Study|Protocol deviation|0|||
149123061|NCT01034163|537927716|FG000|Overall Study|Disease progression|3|||
149123062|NCT01034163|537927717|FG001|Overall Study|Disease progression|4|||
149123063|NCT01034163|537927716|FG000|Overall Study|Adverse Event|6|||
149123064|NCT01034163|537927717|FG001|Overall Study|Adverse Event|0|||
149123065|NCT01034163|537927716|FG000|Overall Study|Administrative problems|0|||
149123066|NCT01034163|537927717|FG001|Overall Study|Administrative problems|1|||
149123067|NCT01034163|537927716|FG000|Overall Study|Abnormal laboratory value|1|||
149123068|NCT01034163|537927717|FG001|Overall Study|Abnormal laboratory value|0|||
149123069|NCT01465347|537927718|FG000|Overall Study|Withdrawal by Subject|1|||
149123070|NCT01465347|537927719|FG001|Overall Study|Withdrawal by Subject|1|||
149123071|NCT01465347|537927718|FG000|Overall Study|Physician Decision|0|||
149123072|NCT01465347|537927719|FG001|Overall Study|Physician Decision|1|||
149123073|NCT01465347|537927718|FG000|Overall Study|Admitted to hospice|0|||
149123074|NCT01465347|537927719|FG001|Overall Study|Admitted to hospice|1|||
149123075|NCT02996474|537927720|FG000|Overall Study|Physician Decision|5|||
149123076|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
149123077|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
149123078|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
149123079|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
149123080|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
149123081|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
149123082|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
149123083|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
149123084|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
149123085|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
148784103|NCT01859949|536687293|FG000|Overall Study|Adverse Event|0|||
148784104|NCT01859949|536687294|FG001|Overall Study|Adverse Event|1|||
148784105|NCT01890759|536687295|FG000|Overall Study|Protocol Violation|0|||
148784106|NCT01890759|536687296|FG001|Overall Study|Protocol Violation|2|||
148784107|NCT01890759|536687295|FG000|Overall Study|Lost to Follow-up|0|||
148784108|NCT01890759|536687296|FG001|Overall Study|Lost to Follow-up|2|||
148784109|NCT01890759|536687295|FG000|Overall Study|Withdrawal by Subject|2|||
148784110|NCT01890759|536687296|FG001|Overall Study|Withdrawal by Subject|8|||
148784111|NCT01344759|536687297|FG000|Overall Study|Patients failed to reach sedation level|0|||
148784112|NCT01344759|536687298|FG001|Overall Study|Patients failed to reach sedation level|2|||
148784113|NCT04494425|536687303|FG000|Overall Study|Death|160|||
148784114|NCT04494425|536687304|FG001|Overall Study|Death|166|||
148784115|NCT04494425|536687303|FG000|Overall Study|Withdrawal by Subject|10|||
148784116|NCT04494425|536687304|FG001|Overall Study|Withdrawal by Subject|40|||
148784117|NCT04494425|536687303|FG000|Overall Study|Other|1|||
148784118|NCT04494425|536687304|FG001|Overall Study|Other|1|||
148784119|NCT04494425|536687303|FG000|Overall Study|Ongoing at the time of PCD|265|||
148784120|NCT04494425|536687304|FG001|Overall Study|Ongoing at the time of PCD|223|||
148784121|NCT01270321|536687305|FG000|Overall Study|Death|3|||
148784122|NCT01270321|536687306|FG001|Overall Study|Death|1|||
148784123|NCT01270321|536687307|FG002|Overall Study|Death|4|||
148784124|NCT01270321|536687305|FG000|Overall Study|Adverse Event|7|||
148784125|NCT01270321|536687306|FG001|Overall Study|Adverse Event|9|||
148784126|NCT01270321|536687307|FG002|Overall Study|Adverse Event|5|||
148784127|NCT04003623|536687311|FG000|Overall Study|Withdrawal by Subject|1|||
148784128|NCT04003623|536687312|FG001|Overall Study|Withdrawal by Subject|0|||
148784129|NCT01744483|536687318|FG000|Overall Study|Death|9|||
148784130|NCT01744483|536687319|FG001|Overall Study|Death|4|||
148784131|NCT01744483|536687320|FG002|Overall Study|Death|11|||
148784132|NCT01744483|536687318|FG000|Overall Study|Lost to Follow-up|8|||
148784133|NCT01744483|536687319|FG001|Overall Study|Lost to Follow-up|9|||
148784134|NCT01744483|536687320|FG002|Overall Study|Lost to Follow-up|11|||
148784135|NCT01744483|536687318|FG000|Overall Study|Protocol Violation|1|||
148784136|NCT01744483|536687319|FG001|Overall Study|Protocol Violation|2|||
148784137|NCT01744483|536687320|FG002|Overall Study|Protocol Violation|1|||
148784138|NCT01744483|536687318|FG000|Overall Study|Withdrawal by Subject|4|||
148784139|NCT01744483|536687319|FG001|Overall Study|Withdrawal by Subject|6|||
148784140|NCT01744483|536687320|FG002|Overall Study|Withdrawal by Subject|2|||
148784141|NCT01744483|536687318|FG000|Overall Study|No ICU Admit|5|||
148784142|NCT01744483|536687319|FG001|Overall Study|No ICU Admit|1|||
148784143|NCT01744483|536687320|FG002|Overall Study|No ICU Admit|2|||
148784144|NCT01744483|536687318|FG000|Overall Study|Routed to OSH|2|||
148784145|NCT01744483|536687319|FG001|Overall Study|Routed to OSH|0|||
148784146|NCT01744483|536687320|FG002|Overall Study|Routed to OSH|1|||
148784147|NCT01190189|536687321|FG000|Overall Study|Lost to Follow-up|4|||
148784148|NCT01190189|536687321|FG000|Overall Study|Withdrawal by Subject|1|||
148784149|NCT01190189|536687321|FG000|Overall Study|Migrated/moved from study area|1|||
148784150|NCT03915626|536687322|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
148784151|NCT05025332|536687323|FG000|Screening|Screen failure|12|||
148784152|NCT05025332|536687323|FG000|Treatment & Follow Up|Protocol Violation|1|||
148784153|NCT05025332|536687323|FG000|Treatment & Follow Up|Adverse Event|4|||
148784154|NCT01026818|536687324|FG000|Screening Period|Entry Criteria Not Met|105|||
148784155|NCT01026818|536687325|FG001|Screening Period|Entry Criteria Not Met|0|||
148784156|NCT01026818|536687326|FG002|Screening Period|Entry Criteria Not Met|0|||
148784157|NCT01026818|536687327|FG003|Screening Period|Entry Criteria Not Met|0|||
148784158|NCT01026818|536687324|FG000|Screening Period|Withdrawal by Subject|49|||
148784159|NCT01026818|536687325|FG001|Screening Period|Withdrawal by Subject|0|||
148784160|NCT01026818|536687326|FG002|Screening Period|Withdrawal by Subject|0|||
148784161|NCT01026818|536687327|FG003|Screening Period|Withdrawal by Subject|0|||
148784162|NCT01026818|536687324|FG000|Screening Period|Protocol Deviation|3|||
148784163|NCT01026818|536687325|FG001|Screening Period|Protocol Deviation|0|||
148784164|NCT01026818|536687326|FG002|Screening Period|Protocol Deviation|0|||
148784165|NCT01026818|536687327|FG003|Screening Period|Protocol Deviation|0|||
148784166|NCT01026818|536687324|FG000|Screening Period|Adverse Event|2|||
148784167|NCT01026818|536687325|FG001|Screening Period|Adverse Event|0|||
148784168|NCT01026818|536687326|FG002|Screening Period|Adverse Event|0|||
148784169|NCT01026818|536687327|FG003|Screening Period|Adverse Event|0|||
148784170|NCT01026818|536687324|FG000|Screening Period|Physician Decision|1|||
148784171|NCT01026818|536687325|FG001|Screening Period|Physician Decision|0|||
148784172|NCT01026818|536687326|FG002|Screening Period|Physician Decision|0|||
148784173|NCT01026818|536687327|FG003|Screening Period|Physician Decision|0|||
148784174|NCT01026818|536687324|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
148784175|NCT01026818|536687325|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
148784176|NCT01026818|536687326|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
148784177|NCT01026818|536687327|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
148784178|NCT01026818|536687324|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
148784179|NCT01026818|536687325|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
148784180|NCT01026818|536687326|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
149123086|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
149123087|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
149123088|NCT04493502|537927721|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
149123089|NCT04493502|537927722|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
149123090|NCT04493502|537927721|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
149123091|NCT04493502|537927722|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
149123092|NCT04493502|537927721|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
149123093|NCT04493502|537927722|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
148784181|NCT01026818|536687327|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
148784182|NCT01026818|536687324|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
148784183|NCT01026818|536687325|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
148784184|NCT01026818|536687326|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
148784185|NCT01026818|536687327|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
148784186|NCT01026818|536687324|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
148784187|NCT01026818|536687325|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
148784188|NCT01026818|536687326|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
148784189|NCT01026818|536687327|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
148784190|NCT01026818|536687324|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
148784191|NCT01026818|536687325|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
148784192|NCT01026818|536687326|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
148784193|NCT01026818|536687327|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
148784194|NCT01026818|536687324|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
148784195|NCT01026818|536687325|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
148784196|NCT01026818|536687326|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
148784197|NCT01026818|536687327|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
148784198|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
148784199|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
148784200|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
148784201|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
148784202|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
148784203|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
148784204|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
148784205|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
148784206|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
148784207|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
148784208|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
148784209|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
148784210|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
148784211|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
148784212|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
148784213|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
148784214|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
148784215|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
148784216|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
148784217|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
148784218|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
148784219|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
148784220|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
148784221|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
148784222|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
148784223|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
148784224|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
148784225|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
148784226|NCT01026818|536687324|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
148784227|NCT01026818|536687325|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
148784228|NCT01026818|536687326|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
148784229|NCT01026818|536687327|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
148784230|NCT01026818|536687324|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
148784231|NCT01026818|536687325|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
148784232|NCT01026818|536687326|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
148784233|NCT01026818|536687327|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
148784234|NCT01026818|536687324|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
148784235|NCT01026818|536687325|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
148893355|NCT00683878|537088678|FG000|Overall Study|Lost to Follow-up|4|||
148784236|NCT01026818|536687326|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
148784237|NCT01026818|536687327|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
148784238|NCT01026818|536687324|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
148784239|NCT01026818|536687325|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
148784240|NCT01026818|536687326|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
148784241|NCT01026818|536687327|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
148784242|NCT01026818|536687324|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
148784243|NCT01026818|536687325|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
148784244|NCT01026818|536687326|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
148784245|NCT01026818|536687327|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
148784246|NCT01026818|536687324|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
148784247|NCT01026818|536687325|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
148784248|NCT01026818|536687326|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
148784249|NCT01026818|536687327|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
148784250|NCT04575584|536687328|FG000|Overall Study|Death|6|||
148784251|NCT04575584|536687329|FG001|Overall Study|Death|4|||
148784252|NCT04575584|536687330|FG002|Overall Study|Death|6|||
148784253|NCT04575584|536687331|FG003|Overall Study|Death|2|||
148784254|NCT04575584|536687332|FG004|Overall Study|Death|0|||
148784255|NCT04575584|536687333|FG005|Overall Study|Death|0|||
148784256|NCT04575584|536687328|FG000|Overall Study|Lost to Follow-up|1|||
148784257|NCT04575584|536687329|FG001|Overall Study|Lost to Follow-up|1|||
148784258|NCT04575584|536687330|FG002|Overall Study|Lost to Follow-up|1|||
148784259|NCT04575584|536687331|FG003|Overall Study|Lost to Follow-up|1|||
148784260|NCT04575584|536687332|FG004|Overall Study|Lost to Follow-up|0|||
148784261|NCT04575584|536687333|FG005|Overall Study|Lost to Follow-up|0|||
148784262|NCT04575584|536687328|FG000|Overall Study|Physician Decision|0|||
148784263|NCT04575584|536687329|FG001|Overall Study|Physician Decision|1|||
148784264|NCT04575584|536687330|FG002|Overall Study|Physician Decision|1|||
148784265|NCT04575584|536687331|FG003|Overall Study|Physician Decision|1|||
148784266|NCT04575584|536687332|FG004|Overall Study|Physician Decision|0|||
148784267|NCT04575584|536687333|FG005|Overall Study|Physician Decision|0|||
148784268|NCT04575584|536687328|FG000|Overall Study|Withdrawal by Subject|7|||
148784269|NCT04575584|536687329|FG001|Overall Study|Withdrawal by Subject|9|||
148784270|NCT04575584|536687330|FG002|Overall Study|Withdrawal by Subject|5|||
148784271|NCT04575584|536687331|FG003|Overall Study|Withdrawal by Subject|3|||
148784272|NCT04575584|536687332|FG004|Overall Study|Withdrawal by Subject|0|||
148784273|NCT04575584|536687333|FG005|Overall Study|Withdrawal by Subject|0|||
148784274|NCT04575584|536687328|FG000|Overall Study|Not recorded|0|||
148784275|NCT04575584|536687329|FG001|Overall Study|Not recorded|0|||
148784276|NCT04575584|536687330|FG002|Overall Study|Not recorded|0|||
148784277|NCT04575584|536687331|FG003|Overall Study|Not recorded|1|||
148784278|NCT04575584|536687332|FG004|Overall Study|Not recorded|0|||
148784279|NCT04575584|536687333|FG005|Overall Study|Not recorded|0|||
148784280|NCT02634801|536687334|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
148784281|NCT02634801|536687335|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
148784282|NCT02634801|536687336|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
148784283|NCT02634801|536687334|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
148784284|NCT02634801|536687335|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
148784285|NCT02634801|536687336|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
148784286|NCT02634801|536687334|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
148784287|NCT02634801|536687335|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
148784288|NCT02634801|536687336|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
148784289|NCT02634801|536687334|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
148784290|NCT02634801|536687335|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
148784291|NCT02634801|536687336|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
148784292|NCT02634801|536687334|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
148784293|NCT02634801|536687335|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
148784294|NCT02634801|536687336|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
148784295|NCT02634801|536687334|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
148784296|NCT02634801|536687335|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
149123094|NCT04493502|537927721|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
149123095|NCT04493502|537927722|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
148784297|NCT02634801|536687336|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
148784298|NCT02634801|536687334|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
148784299|NCT02634801|536687335|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
148784300|NCT02634801|536687336|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
148784301|NCT02634801|536687334|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
148784302|NCT02634801|536687335|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
148784303|NCT02634801|536687336|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
148784304|NCT02634801|536687334|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
148784305|NCT02634801|536687335|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
148784306|NCT02634801|536687336|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
148784307|NCT02634801|536687334|FG000|Follow-up Period|Lost to Follow-up|3|||
148784308|NCT02634801|536687335|FG001|Follow-up Period|Lost to Follow-up|1|||
148784309|NCT02634801|536687336|FG002|Follow-up Period|Lost to Follow-up|2|||
148784310|NCT02634801|536687334|FG000|Follow-up Period|Physician Decision|0|||
148784311|NCT02634801|536687335|FG001|Follow-up Period|Physician Decision|0|||
148784312|NCT02634801|536687336|FG002|Follow-up Period|Physician Decision|1|||
148784313|NCT02634801|536687334|FG000|Follow-up Period|Withdrawal by Subject|1|||
148784314|NCT02634801|536687335|FG001|Follow-up Period|Withdrawal by Subject|2|||
148784315|NCT02634801|536687336|FG002|Follow-up Period|Withdrawal by Subject|5|||
148784316|NCT02634801|536687334|FG000|Follow-up Period|Adverse Event|1|||
148784317|NCT02634801|536687335|FG001|Follow-up Period|Adverse Event|5|||
148784318|NCT02634801|536687336|FG002|Follow-up Period|Adverse Event|0|||
148784319|NCT02335346|536687359|FG000|Overall Study|Adverse Event|11|||
148784320|NCT02335346|536687359|FG000|Overall Study|Withdrawal by Subject|1|||
148784321|NCT01548768|536687360|FG000|Overall Study|Withdrawal by Subject|0|||
148784322|NCT01548768|536687361|FG001|Overall Study|Withdrawal by Subject|2|||
148784323|NCT01548768|536687362|FG002|Overall Study|Withdrawal by Subject|1|||
148784324|NCT01548768|536687363|FG003|Overall Study|Withdrawal by Subject|0|||
148784325|NCT01548768|536687360|FG000|Overall Study|Physician Decision|1|||
148784326|NCT01548768|536687361|FG001|Overall Study|Physician Decision|0|||
148784327|NCT01548768|536687362|FG002|Overall Study|Physician Decision|0|||
148784328|NCT01548768|536687363|FG003|Overall Study|Physician Decision|0|||
148784329|NCT01548768|536687360|FG000|Overall Study|Adverse Event|0|||
148784330|NCT01548768|536687361|FG001|Overall Study|Adverse Event|0|||
148784331|NCT01548768|536687362|FG002|Overall Study|Adverse Event|0|||
148784332|NCT01548768|536687363|FG003|Overall Study|Adverse Event|1|||
148784333|NCT01548768|536687360|FG000|Overall Study|Non-Compliance|0|||
148784334|NCT01548768|536687361|FG001|Overall Study|Non-Compliance|0|||
148784335|NCT01548768|536687362|FG002|Overall Study|Non-Compliance|0|||
148784336|NCT01548768|536687363|FG003|Overall Study|Non-Compliance|3|||
148784337|NCT03300050|536687364|FG000|Overall Study|Lost to Follow-up|2|||
148784338|NCT03300050|536687365|FG001|Overall Study|Lost to Follow-up|1|||
148784339|NCT03300050|536687366|FG002|Overall Study|Lost to Follow-up|0|||
148784340|NCT03300050|536687367|FG003|Overall Study|Lost to Follow-up|0|||
148784341|NCT03300050|536687368|FG004|Overall Study|Lost to Follow-up|1|||
148784342|NCT03300050|536687364|FG000|Overall Study|Withdrawal by Subject|1|||
148784343|NCT03300050|536687365|FG001|Overall Study|Withdrawal by Subject|1|||
148784344|NCT03300050|536687366|FG002|Overall Study|Withdrawal by Subject|1|||
148784345|NCT03300050|536687367|FG003|Overall Study|Withdrawal by Subject|0|||
148784346|NCT03300050|536687368|FG004|Overall Study|Withdrawal by Subject|0|||
148784347|NCT03300050|536687364|FG000|Overall Study|Death|0|||
148784348|NCT03300050|536687365|FG001|Overall Study|Death|0|||
148784349|NCT03300050|536687366|FG002|Overall Study|Death|1|||
148784350|NCT03300050|536687367|FG003|Overall Study|Death|0|||
148784351|NCT03300050|536687368|FG004|Overall Study|Death|0|||
148784352|NCT03300050|536687364|FG000|Overall Study|Not Eligible at Randomization|0|||
148784353|NCT03300050|536687365|FG001|Overall Study|Not Eligible at Randomization|0|||
148784354|NCT03300050|536687366|FG002|Overall Study|Not Eligible at Randomization|1|||
148784355|NCT03300050|536687367|FG003|Overall Study|Not Eligible at Randomization|1|||
148784356|NCT03300050|536687368|FG004|Overall Study|Not Eligible at Randomization|0|||
148784357|NCT02907619|536687369|FG000|Overall Study|Study terminated by sponsor|18|||
148784358|NCT02907619|536687370|FG001|Overall Study|Study terminated by sponsor|18|||
148784359|NCT02907619|536687371|FG002|Overall Study|Study terminated by sponsor|19|||
148784360|NCT02907619|536687369|FG000|Overall Study|Death|0|||
148784361|NCT02907619|536687370|FG001|Overall Study|Death|0|||
148784362|NCT02907619|536687371|FG002|Overall Study|Death|1|||
148784363|NCT02907619|536687369|FG000|Overall Study|Withdrawal by Subject|1|||
148784364|NCT02907619|536687370|FG001|Overall Study|Withdrawal by Subject|1|||
148784365|NCT02907619|536687371|FG002|Overall Study|Withdrawal by Subject|0|||
148784366|NCT02907619|536687369|FG000|Overall Study|Other|0|||
148784367|NCT02907619|536687370|FG001|Overall Study|Other|1|||
148784368|NCT02907619|536687371|FG002|Overall Study|Other|0|||
148784369|NCT03326518|536687372|FG000|Overall Study|Protocol Violation|1|||
148784370|NCT03326518|536687373|FG001|Overall Study|Protocol Violation|0|||
148784371|NCT03326518|536687374|FG002|Overall Study|Protocol Violation|0|||
148784372|NCT03326518|536687372|FG000|Overall Study|Withdrawal by Subject|1|||
148784373|NCT03326518|536687373|FG001|Overall Study|Withdrawal by Subject|0|||
148784374|NCT03326518|536687374|FG002|Overall Study|Withdrawal by Subject|0|||
148784375|NCT03326518|536687372|FG000|Overall Study|Lost to Follow-up|1|||
148784376|NCT03326518|536687373|FG001|Overall Study|Lost to Follow-up|0|||
148784377|NCT03326518|536687374|FG002|Overall Study|Lost to Follow-up|1|||
148784378|NCT01375374|536687375|FG000|Overall Study|Adverse Event|1|||
148784379|NCT01908582|536687376|FG000|Period 2|Physician Decision|1|||
148784380|NCT01908582|536687376|FG000|Period 2|Withdrawal by Subject|1|||
148784381|NCT03594955|536687377|FG000|Overall Study|Adverse Event|1|||
148784382|NCT03594955|536687377|FG000|Overall Study|Progressive disease|5|||
148784383|NCT03594955|536687377|FG000|Overall Study|Sponsor's decision|1|||
148784384|NCT02065518|536687379|FG000|Overall Study|Lost to Follow-up|3|||
148784385|NCT02065518|536687380|FG001|Overall Study|Lost to Follow-up|4|||
148784386|NCT02065518|536687381|FG002|Overall Study|Lost to Follow-up|0|||
148784387|NCT02065518|536687382|FG003|Overall Study|Lost to Follow-up|3|||
148784388|NCT02065518|536687379|FG000|Overall Study|Withdrawal by Subject|3|||
148784389|NCT02065518|536687380|FG001|Overall Study|Withdrawal by Subject|4|||
148784390|NCT02065518|536687381|FG002|Overall Study|Withdrawal by Subject|9|||
148784391|NCT02065518|536687382|FG003|Overall Study|Withdrawal by Subject|2|||
148784392|NCT01066663|536687384|FG000|Overall Study|Adverse Event|0|||
148784393|NCT01066663|536687385|FG001|Overall Study|Adverse Event|0|||
148784394|NCT01066663|536687386|FG002|Overall Study|Adverse Event|1|||
148784395|NCT01090050|536687387|FG000|Overall Study|Lost to Follow-up|0|||
148784396|NCT01090050|536687388|FG001|Overall Study|Lost to Follow-up|1|||
148784397|NCT01090050|536687387|FG000|Overall Study|Lack of Efficacy|1|||
148784398|NCT01090050|536687388|FG001|Overall Study|Lack of Efficacy|5|||
148784399|NCT01090050|536687387|FG000|Overall Study|Physician Decision|0|||
148784400|NCT01090050|536687388|FG001|Overall Study|Physician Decision|1|||
148784401|NCT03539484|536687389|FG000|Overall Study|Death|1|||
148784402|NCT03539484|536687390|FG001|Overall Study|Death|0|||
148784403|NCT03539484|536687391|FG002|Overall Study|Death|0|||
148784404|NCT03539484|536687392|FG003|Overall Study|Death|2|||
148784405|NCT03539484|536687393|FG004|Overall Study|Death|8|||
148784406|NCT03539484|536687394|FG005|Overall Study|Death|3|||
148784407|NCT03539484|536687395|FG006|Overall Study|Death|0|||
148784408|NCT03539484|536687389|FG000|Overall Study|Lost to Follow-up|0|||
148784409|NCT03539484|536687390|FG001|Overall Study|Lost to Follow-up|1|||
148784410|NCT03539484|536687391|FG002|Overall Study|Lost to Follow-up|0|||
148784411|NCT03539484|536687392|FG003|Overall Study|Lost to Follow-up|0|||
148784412|NCT03539484|536687393|FG004|Overall Study|Lost to Follow-up|1|||
148784413|NCT03539484|536687394|FG005|Overall Study|Lost to Follow-up|0|||
148784414|NCT03539484|536687395|FG006|Overall Study|Lost to Follow-up|0|||
148784415|NCT03539484|536687389|FG000|Overall Study|Withdrawal by Subject|0|||
148784416|NCT03539484|536687390|FG001|Overall Study|Withdrawal by Subject|0|||
148784417|NCT03539484|536687391|FG002|Overall Study|Withdrawal by Subject|0|||
148784418|NCT03539484|536687392|FG003|Overall Study|Withdrawal by Subject|0|||
148784419|NCT03539484|536687393|FG004|Overall Study|Withdrawal by Subject|2|||
148784420|NCT03539484|536687394|FG005|Overall Study|Withdrawal by Subject|0|||
148784421|NCT03539484|536687395|FG006|Overall Study|Withdrawal by Subject|1|||
148784422|NCT03539484|536687389|FG000|Overall Study|Study Terminated by Sponsor|0|||
148784423|NCT03539484|536687390|FG001|Overall Study|Study Terminated by Sponsor|0|||
148784424|NCT03539484|536687391|FG002|Overall Study|Study Terminated by Sponsor|1|||
148784425|NCT03539484|536687392|FG003|Overall Study|Study Terminated by Sponsor|1|||
148784426|NCT03539484|536687393|FG004|Overall Study|Study Terminated by Sponsor|2|||
148784427|NCT03539484|536687394|FG005|Overall Study|Study Terminated by Sponsor|2|||
148784428|NCT03539484|536687395|FG006|Overall Study|Study Terminated by Sponsor|1|||
148784429|NCT02232061|536687396|FG000|Overall Study|Administrative problems|1|||
148784430|NCT02232061|536687396|FG000|Overall Study|Withdrawal by Subject|1|||
148784431|NCT00571103|536687397|FG000|Overall Study|Withdrawal by Subject|1|||
148784432|NCT00571103|536687397|FG000|Overall Study|Lost to Follow-up|1|||
148784433|NCT00564278|536687399|FG000|Overall Study|Lost to Follow-up|35|||
148784434|NCT00564278|536687400|FG001|Overall Study|Lost to Follow-up|33|||
148784435|NCT00564278|536687399|FG000|Overall Study|Physician Decision|1|||
148784436|NCT00564278|536687400|FG001|Overall Study|Physician Decision|2|||
148784437|NCT00564278|536687399|FG000|Overall Study|Withdrawal by Subject|11|||
148784438|NCT00564278|536687400|FG001|Overall Study|Withdrawal by Subject|7|||
148784439|NCT00560703|536687401|FG000|Overall Study|Adverse Event|0|||
148784440|NCT00560703|536687402|FG001|Overall Study|Adverse Event|2|||
148784441|NCT00560703|536687401|FG000|Overall Study|Protocol Violation|0|||
148784442|NCT00560703|536687402|FG001|Overall Study|Protocol Violation|2|||
148784443|NCT00560703|536687401|FG000|Overall Study|Withdrawal by Subject|0|||
148784444|NCT00560703|536687402|FG001|Overall Study|Withdrawal by Subject|1|||
148784445|NCT00560703|536687401|FG000|Overall Study|non-compliance|0|||
148784446|NCT00560703|536687402|FG001|Overall Study|non-compliance|1|||
148784447|NCT06439095|536687403|FG000|Overall Study|Lost to Follow-up|2|||
148784448|NCT03484403|536687405|FG000|Overall Study|Withdrawal by Subject|6|||
148784449|NCT03484403|536687406|FG001|Overall Study|Withdrawal by Subject|4|||
148784450|NCT04278924|536687407|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
148784451|NCT04278924|536687408|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
148784452|NCT04278924|536687409|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
148784453|NCT04278924|536687410|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
148784454|NCT04278924|536687411|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
148784455|NCT04278924|536687412|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
148784456|NCT04278924|536687413|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
148784457|NCT04278924|536687407|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
148784458|NCT04278924|536687408|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
148784459|NCT04278924|536687409|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
148784460|NCT04278924|536687410|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
148784461|NCT04278924|536687411|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
148893356|NCT00683878|537088679|FG001|Overall Study|Lost to Follow-up|2|||
148784462|NCT04278924|536687412|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
148784463|NCT04278924|536687413|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
148784464|NCT02476916|536687414|FG000|Core Period|Adverse Event|2|||
148784465|NCT02476916|536687415|FG001|Core Period|Adverse Event|2|||
148784466|NCT02476916|536687414|FG000|Core Period|Investigator decision|1|||
148784467|NCT02476916|536687415|FG001|Core Period|Investigator decision|1|||
148784468|NCT02476916|536687414|FG000|Core Period|Withdrawal by Subject|3|||
148784469|NCT02476916|536687415|FG001|Core Period|Withdrawal by Subject|0|||
148784470|NCT02476916|536687414|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
148784471|NCT02476916|536687415|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
148784472|NCT02476916|536687414|FG000|Extension Period|On Treatment|12|||
148784473|NCT02476916|536687415|FG001|Extension Period|On Treatment|17|||
148784474|NCT05600036|536687417|FG000|Overall Study|Adverse Event|0|||
148784475|NCT05600036|536687418|FG001|Overall Study|Adverse Event|2|||
148784476|NCT05600036|536687419|FG002|Overall Study|Adverse Event|1|||
148784477|NCT05600036|536687420|FG003|Overall Study|Adverse Event|0|||
148784478|NCT05600036|536687421|FG004|Overall Study|Adverse Event|1|||
148784479|NCT05600036|536687422|FG005|Overall Study|Adverse Event|0|||
148784480|NCT05600036|536687417|FG000|Overall Study|Lost to Follow-up|0|||
148784481|NCT05600036|536687418|FG001|Overall Study|Lost to Follow-up|2|||
148784482|NCT05600036|536687419|FG002|Overall Study|Lost to Follow-up|1|||
148784483|NCT05600036|536687420|FG003|Overall Study|Lost to Follow-up|1|||
148784484|NCT05600036|536687421|FG004|Overall Study|Lost to Follow-up|0|||
148784485|NCT05600036|536687422|FG005|Overall Study|Lost to Follow-up|0|||
148784486|NCT05600036|536687417|FG000|Overall Study|Protocol Violation|0|||
148784487|NCT05600036|536687418|FG001|Overall Study|Protocol Violation|0|||
148784488|NCT05600036|536687419|FG002|Overall Study|Protocol Violation|2|||
148784489|NCT05600036|536687420|FG003|Overall Study|Protocol Violation|0|||
148784490|NCT05600036|536687421|FG004|Overall Study|Protocol Violation|0|||
148784491|NCT05600036|536687422|FG005|Overall Study|Protocol Violation|0|||
148784492|NCT05600036|536687417|FG000|Overall Study|Withdrawal by Subject|0|||
148784493|NCT05600036|536687418|FG001|Overall Study|Withdrawal by Subject|1|||
148784494|NCT05600036|536687419|FG002|Overall Study|Withdrawal by Subject|2|||
148784495|NCT05600036|536687420|FG003|Overall Study|Withdrawal by Subject|0|||
148784496|NCT05600036|536687421|FG004|Overall Study|Withdrawal by Subject|3|||
148784497|NCT05600036|536687422|FG005|Overall Study|Withdrawal by Subject|5|||
148784498|NCT05600036|536687417|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
148784499|NCT05600036|536687418|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
148784500|NCT05600036|536687419|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
148784501|NCT05600036|536687420|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
148784502|NCT05600036|536687421|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
148784503|NCT05600036|536687422|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
148784504|NCT05600036|536687417|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
148784505|NCT05600036|536687418|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
148784506|NCT05600036|536687419|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
148784507|NCT05600036|536687420|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
148784508|NCT05600036|536687421|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
148784509|NCT05600036|536687422|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
148784510|NCT05600036|536687417|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
148784511|NCT05600036|536687418|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
148784512|NCT05600036|536687419|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
148784513|NCT05600036|536687420|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
148784514|NCT05600036|536687421|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
148784515|NCT05600036|536687422|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
148784516|NCT06010732|536687423|FG000|Crossover Period 1|Protocol Violation|0|||
148784517|NCT06010732|536687424|FG001|Crossover Period 1|Protocol Violation|0|||
148784518|NCT06010732|536687425|FG002|Crossover Period 1|Protocol Violation|1|||
148784519|NCT06010732|536687426|FG003|Crossover Period 1|Protocol Violation|0|||
148784520|NCT06010732|536687427|FG004|Crossover Period 1|Protocol Violation|1|||
148784521|NCT06010732|536687428|FG005|Crossover Period 1|Protocol Violation|0|||
148784522|NCT06010732|536687423|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
148784523|NCT06010732|536687424|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
148784524|NCT06010732|536687425|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
148784525|NCT06010732|536687426|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
148784526|NCT06010732|536687427|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
148784527|NCT06010732|536687428|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
148784528|NCT06010732|536687423|FG000|Crossover Period 2|Adverse Event|0|||
148784529|NCT06010732|536687424|FG001|Crossover Period 2|Adverse Event|1|||
148784530|NCT06010732|536687425|FG002|Crossover Period 2|Adverse Event|0|||
148784531|NCT06010732|536687426|FG003|Crossover Period 2|Adverse Event|0|||
148784532|NCT06010732|536687427|FG004|Crossover Period 2|Adverse Event|0|||
148784533|NCT06010732|536687428|FG005|Crossover Period 2|Adverse Event|0|||
148784534|NCT06010732|536687423|FG000|Crossover Period 2|broken denture|0|||
148784535|NCT06010732|536687424|FG001|Crossover Period 2|broken denture|0|||
148784536|NCT06010732|536687425|FG002|Crossover Period 2|broken denture|1|||
148784537|NCT06010732|536687426|FG003|Crossover Period 2|broken denture|0|||
148784538|NCT06010732|536687427|FG004|Crossover Period 2|broken denture|0|||
148784539|NCT06010732|536687428|FG005|Crossover Period 2|broken denture|0|||
148784540|NCT04401202|536687429|FG000|Overall Study|Lost to Follow-up|2|||
148784541|NCT04401202|536687430|FG001|Overall Study|Lost to Follow-up|2|||
148784542|NCT04401202|536687429|FG000|Overall Study|Adverse Event|0|||
148784543|NCT04401202|536687430|FG001|Overall Study|Adverse Event|1|||
148784544|NCT04401202|536687429|FG000|Overall Study|Hospitalized|4|||
148784545|NCT04401202|536687430|FG001|Overall Study|Hospitalized|1|||
148784546|NCT02714036|536687432|FG000|Overall Study|Adverse Event|9|||
148784547|NCT02714036|536687433|FG001|Overall Study|Adverse Event|2|||
148784548|NCT02714036|536687432|FG000|Overall Study|Withdrawal by Subject|3|||
148784549|NCT02714036|536687433|FG001|Overall Study|Withdrawal by Subject|2|||
148784550|NCT00715520|536687435|FG000|Overall Study|Screen failure|8|||
148784551|NCT00715520|536687436|FG001|Overall Study|Screen failure|1|||
148784552|NCT00715520|536687437|FG002|Overall Study|Screen failure|1|||
148784553|NCT00715520|536687435|FG000|Overall Study|Withdrawal by Subject|2|||
148784554|NCT00715520|536687436|FG001|Overall Study|Withdrawal by Subject|0|||
148784555|NCT00715520|536687437|FG002|Overall Study|Withdrawal by Subject|1|||
148784556|NCT01006590|536687438|FG000|Overall Study|Adverse Event|2|||
148784557|NCT01006590|536687439|FG001|Overall Study|Adverse Event|3|||
148784558|NCT01006590|536687438|FG000|Overall Study|Death|1|||
148784559|NCT01006590|536687439|FG001|Overall Study|Death|1|||
148784560|NCT01006590|536687438|FG000|Overall Study|Lost to Follow-up|1|||
148784561|NCT01006590|536687439|FG001|Overall Study|Lost to Follow-up|1|||
148784562|NCT01006590|536687438|FG000|Overall Study|Protocol Violation|1|||
148784563|NCT01006590|536687439|FG001|Overall Study|Protocol Violation|0|||
148784564|NCT01006590|536687438|FG000|Overall Study|Withdrawal by Subject|4|||
148784565|NCT01006590|536687439|FG001|Overall Study|Withdrawal by Subject|2|||
148784566|NCT01006590|536687438|FG000|Overall Study|Study specific discontinuation criteria|16|||
148784567|NCT01006590|536687439|FG001|Overall Study|Study specific discontinuation criteria|23|||
148784568|NCT01006590|536687438|FG000|Overall Study|Other|3|||
148784569|NCT01006590|536687439|FG001|Overall Study|Other|2|||
148784570|NCT03332095|536687440|FG000|Overall Study|Lost to Follow-up|1|||
148784571|NCT03332095|536687441|FG001|Overall Study|Lost to Follow-up|0|||
148784572|NCT03332095|536687440|FG000|Overall Study|Pregnancy|0|||
148784573|NCT03332095|536687441|FG001|Overall Study|Pregnancy|1|||
148784574|NCT04942210|536687445|FG000|Overall Study|Adverse Event|0|||
148784575|NCT04942210|536687446|FG001|Overall Study|Adverse Event|1|||
148784576|NCT04942210|536687445|FG000|Overall Study|Protocol Deviation|4|||
148784577|NCT04942210|536687446|FG001|Overall Study|Protocol Deviation|1|||
148784578|NCT04942210|536687445|FG000|Overall Study|Withdrawal by Subject|5|||
148784579|NCT04942210|536687446|FG001|Overall Study|Withdrawal by Subject|2|||
148784580|NCT04942210|536687445|FG000|Overall Study|Lost to Follow-up|16|||
148784581|NCT04942210|536687446|FG001|Overall Study|Lost to Follow-up|7|||
148784582|NCT04942210|536687445|FG000|Overall Study|Ongoing at the time of DBL date|60|||
148784583|NCT04942210|536687446|FG001|Overall Study|Ongoing at the time of DBL date|25|||
148784584|NCT04942210|536687445|FG000|Overall Study|Randomized but did not receive vaccination|3|||
148784585|NCT04942210|536687446|FG001|Overall Study|Randomized but did not receive vaccination|0|||
148784586|NCT02570750|536687449|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
148784587|NCT02570750|536687450|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
148784588|NCT02570750|536687449|FG000|Overall Study|Protocol deviation|4|||
148784589|NCT02570750|536687450|FG001|Overall Study|Protocol deviation|2|||
148784590|NCT02570750|536687449|FG000|Overall Study|Withdrawal by Subject|5|||
148784591|NCT02570750|536687450|FG001|Overall Study|Withdrawal by Subject|0|||
148784592|NCT02570750|536687449|FG000|Overall Study|Lost to Follow-up|2|||
148784593|NCT02570750|536687450|FG001|Overall Study|Lost to Follow-up|2|||
148784594|NCT02570750|536687449|FG000|Overall Study|Adverse Event|2|||
148784595|NCT02570750|536687450|FG001|Overall Study|Adverse Event|1|||
148784596|NCT04122625|536687451|FG000|Part A (up to 2.92 Years)|Death|2|||
148784597|NCT04122625|536687452|FG001|Part A (up to 2.92 Years)|Death|4|||
148784598|NCT04122625|536687453|FG002|Part A (up to 2.92 Years)|Death|0|||
148784599|NCT04122625|536687454|FG003|Part A (up to 2.92 Years)|Death|0|||
148784600|NCT04122625|536687455|FG004|Part A (up to 2.92 Years)|Death|0|||
148784601|NCT04122625|536687456|FG005|Part A (up to 2.92 Years)|Death|0|||
148784602|NCT04122625|536687451|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
148784603|NCT04122625|536687452|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
148784604|NCT04122625|536687453|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
148784605|NCT04122625|536687454|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
148784606|NCT04122625|536687455|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
148784607|NCT04122625|536687456|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
148784608|NCT04122625|536687451|FG000|Part B (up to 2.33 Years)|Death|0|||
148784609|NCT04122625|536687452|FG001|Part B (up to 2.33 Years)|Death|0|||
148784610|NCT04122625|536687453|FG002|Part B (up to 2.33 Years)|Death|5|||
148784611|NCT04122625|536687454|FG003|Part B (up to 2.33 Years)|Death|7|||
148784612|NCT04122625|536687455|FG004|Part B (up to 2.33 Years)|Death|6|||
148784613|NCT04122625|536687456|FG005|Part B (up to 2.33 Years)|Death|7|||
148784614|NCT01410240|536687457|FG000|Overall Study|Physician Decision|0|||
148784615|NCT01410240|536687458|FG001|Overall Study|Physician Decision|0|||
148784616|NCT01410240|536687459|FG002|Overall Study|Physician Decision|1|||
148784617|NCT01410240|536687457|FG000|Overall Study|Missed week 6 assessments|1|||
148784618|NCT01410240|536687458|FG001|Overall Study|Missed week 6 assessments|1|||
148784619|NCT01410240|536687459|FG002|Overall Study|Missed week 6 assessments|1|||
148784620|NCT04348500|536687460|FG000|Overall Study|Death|2|||
148784621|NCT04348500|536687461|FG001|Overall Study|Death|2|||
148784622|NCT04348500|536687460|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
148784623|NCT04348500|536687461|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
148784624|NCT03699540|536687462|FG000|Overall Study|Lost to Follow-up|1|||
148784625|NCT02697591|536687467|FG000|Overall Study|Lost to Follow-up|0|||
148784626|NCT02697591|536687468|FG001|Overall Study|Lost to Follow-up|0|||
148784627|NCT02697591|536687469|FG002|Overall Study|Lost to Follow-up|0|||
148784628|NCT02697591|536687470|FG003|Overall Study|Lost to Follow-up|0|||
148784629|NCT02697591|536687471|FG004|Overall Study|Lost to Follow-up|0|||
148784630|NCT02697591|536687472|FG005|Overall Study|Lost to Follow-up|1|||
148784631|NCT02697591|536687473|FG006|Overall Study|Lost to Follow-up|1|||
148784632|NCT02697591|536687474|FG007|Overall Study|Lost to Follow-up|0|||
148784633|NCT02697591|536687475|FG008|Overall Study|Lost to Follow-up|0|||
148784634|NCT02697591|536687476|FG009|Overall Study|Lost to Follow-up|1|||
148784635|NCT02697591|536687467|FG000|Overall Study|Withdrawal by Subject|1|||
148784636|NCT02697591|536687468|FG001|Overall Study|Withdrawal by Subject|1|||
148784637|NCT02697591|536687469|FG002|Overall Study|Withdrawal by Subject|2|||
148784638|NCT02697591|536687470|FG003|Overall Study|Withdrawal by Subject|1|||
148784639|NCT02697591|536687471|FG004|Overall Study|Withdrawal by Subject|7|||
148784640|NCT02697591|536687472|FG005|Overall Study|Withdrawal by Subject|6|||
148784641|NCT02697591|536687473|FG006|Overall Study|Withdrawal by Subject|9|||
148784642|NCT02697591|536687474|FG007|Overall Study|Withdrawal by Subject|1|||
148784643|NCT02697591|536687475|FG008|Overall Study|Withdrawal by Subject|6|||
148784644|NCT02697591|536687476|FG009|Overall Study|Withdrawal by Subject|10|||
148784645|NCT02697591|536687467|FG000|Overall Study|Physician Decision|1|||
148784646|NCT02697591|536687468|FG001|Overall Study|Physician Decision|0|||
148784647|NCT02697591|536687469|FG002|Overall Study|Physician Decision|0|||
148784648|NCT02697591|536687470|FG003|Overall Study|Physician Decision|0|||
148784649|NCT02697591|536687471|FG004|Overall Study|Physician Decision|1|||
148784650|NCT02697591|536687472|FG005|Overall Study|Physician Decision|2|||
148784651|NCT02697591|536687473|FG006|Overall Study|Physician Decision|0|||
148784652|NCT02697591|536687474|FG007|Overall Study|Physician Decision|0|||
148784653|NCT02697591|536687475|FG008|Overall Study|Physician Decision|1|||
148784654|NCT02697591|536687476|FG009|Overall Study|Physician Decision|1|||
148784655|NCT02697591|536687467|FG000|Overall Study|Death|2|||
148784656|NCT02697591|536687468|FG001|Overall Study|Death|3|||
148784657|NCT02697591|536687469|FG002|Overall Study|Death|1|||
148784658|NCT02697591|536687470|FG003|Overall Study|Death|1|||
148784659|NCT02697591|536687471|FG004|Overall Study|Death|4|||
148784660|NCT02697591|536687472|FG005|Overall Study|Death|5|||
148784661|NCT02697591|536687473|FG006|Overall Study|Death|3|||
148784662|NCT02697591|536687474|FG007|Overall Study|Death|1|||
148784663|NCT02697591|536687475|FG008|Overall Study|Death|1|||
148784664|NCT02697591|536687476|FG009|Overall Study|Death|5|||
148784665|NCT02697591|536687467|FG000|Overall Study|Reason not Specified|0|||
148784666|NCT02697591|536687468|FG001|Overall Study|Reason not Specified|0|||
148784667|NCT02697591|536687469|FG002|Overall Study|Reason not Specified|0|||
148784668|NCT02697591|536687470|FG003|Overall Study|Reason not Specified|1|||
148784669|NCT02697591|536687471|FG004|Overall Study|Reason not Specified|1|||
148784670|NCT02697591|536687472|FG005|Overall Study|Reason not Specified|2|||
148784671|NCT02697591|536687473|FG006|Overall Study|Reason not Specified|3|||
148784672|NCT02697591|536687474|FG007|Overall Study|Reason not Specified|1|||
148784673|NCT02697591|536687475|FG008|Overall Study|Reason not Specified|1|||
148784674|NCT02697591|536687476|FG009|Overall Study|Reason not Specified|3|||
148784675|NCT02722746|536687477|FG000|Overall Study|Withdrawal by Subject|0|||
148784676|NCT02722746|536687478|FG001|Overall Study|Withdrawal by Subject|1|||
148784677|NCT02722746|536687479|FG002|Overall Study|Withdrawal by Subject|0|||
148784678|NCT02722746|536687477|FG000|Overall Study|Protocol Violation|8|||
148784679|NCT02722746|536687478|FG001|Overall Study|Protocol Violation|4|||
148784680|NCT02722746|536687479|FG002|Overall Study|Protocol Violation|6|||
148784681|NCT01939223|536687486|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
148784682|NCT01939223|536687487|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
148784683|NCT01939223|536687486|FG000|Overall Study|Disease recurrence (radiological)|1|||
148784684|NCT01939223|536687487|FG001|Overall Study|Disease recurrence (radiological)|3|||
148784685|NCT01939223|536687486|FG000|Overall Study|Study stopped by Sponsor|5|||
148784686|NCT01939223|536687487|FG001|Overall Study|Study stopped by Sponsor|7|||
148784687|NCT01939223|536687486|FG000|Overall Study|Withdrawal by Subject|6|||
148893357|NCT00683878|537088680|FG002|Overall Study|Lost to Follow-up|4|||
148784688|NCT01939223|536687487|FG001|Overall Study|Withdrawal by Subject|0|||
148784689|NCT05053035|536687488|FG000|Overall Study|Withdrawal by Subject|1|||
148784690|NCT05053035|536687489|FG001|Overall Study|Withdrawal by Subject|0|||
148784691|NCT01618916|536687490|FG000|Overall Study|Adverse Event|1|||
148784692|NCT01618916|536687491|FG001|Overall Study|Adverse Event|0|||
148784693|NCT01618916|536687492|FG002|Overall Study|Adverse Event|0|||
148784694|NCT01618916|536687493|FG003|Overall Study|Adverse Event|0|||
148784695|NCT01618916|536687494|FG004|Overall Study|Adverse Event|0|||
148784696|NCT01618916|536687495|FG005|Overall Study|Adverse Event|0|||
148784697|NCT01618916|536687490|FG000|Overall Study|Withdrawal by Subject|0|||
148784698|NCT01618916|536687491|FG001|Overall Study|Withdrawal by Subject|1|||
148784699|NCT01618916|536687492|FG002|Overall Study|Withdrawal by Subject|1|||
148784700|NCT01618916|536687493|FG003|Overall Study|Withdrawal by Subject|0|||
148784701|NCT01618916|536687494|FG004|Overall Study|Withdrawal by Subject|1|||
148784702|NCT01618916|536687495|FG005|Overall Study|Withdrawal by Subject|0|||
148784703|NCT01618916|536687490|FG000|Overall Study|Lost to Follow-up|1|||
148784704|NCT01618916|536687491|FG001|Overall Study|Lost to Follow-up|0|||
148784705|NCT01618916|536687492|FG002|Overall Study|Lost to Follow-up|0|||
148784706|NCT01618916|536687493|FG003|Overall Study|Lost to Follow-up|2|||
148784707|NCT01618916|536687494|FG004|Overall Study|Lost to Follow-up|0|||
148784708|NCT01618916|536687495|FG005|Overall Study|Lost to Follow-up|0|||
148784709|NCT03004924|536687496|FG000|Overall Study|Adverse Event|6|||
148784710|NCT03004924|536687497|FG001|Overall Study|Adverse Event|5|||
148784711|NCT03004924|536687498|FG002|Overall Study|Adverse Event|10|||
148784712|NCT03004924|536687496|FG000|Overall Study|Protocol Violation|4|||
148784713|NCT03004924|536687497|FG001|Overall Study|Protocol Violation|0|||
148784714|NCT03004924|536687498|FG002|Overall Study|Protocol Violation|1|||
148784715|NCT03004924|536687496|FG000|Overall Study|Withdrawal by Subject|5|||
148784716|NCT03004924|536687497|FG001|Overall Study|Withdrawal by Subject|3|||
148784717|NCT03004924|536687498|FG002|Overall Study|Withdrawal by Subject|5|||
148784718|NCT03004924|536687496|FG000|Overall Study|Lost to Follow-up|6|||
148784719|NCT03004924|536687497|FG001|Overall Study|Lost to Follow-up|1|||
148784720|NCT03004924|536687498|FG002|Overall Study|Lost to Follow-up|4|||
148784721|NCT03004924|536687496|FG000|Overall Study|Lack of Efficacy|2|||
148784722|NCT03004924|536687497|FG001|Overall Study|Lack of Efficacy|4|||
148784723|NCT03004924|536687498|FG002|Overall Study|Lack of Efficacy|2|||
148784724|NCT03004924|536687496|FG000|Overall Study|Physician Decision|1|||
148784725|NCT03004924|536687497|FG001|Overall Study|Physician Decision|0|||
148784726|NCT03004924|536687498|FG002|Overall Study|Physician Decision|1|||
148784727|NCT03004924|536687496|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148784728|NCT03004924|536687497|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148784729|NCT03004924|536687498|FG002|Overall Study|Withdrawal by parent/guardian|2|||
148784730|NCT03004924|536687496|FG000|Overall Study|Screen Failure|1|||
148784731|NCT03004924|536687497|FG001|Overall Study|Screen Failure|0|||
148784732|NCT03004924|536687498|FG002|Overall Study|Screen Failure|0|||
148784733|NCT03004924|536687496|FG000|Overall Study|Pregnancy|0|||
148784734|NCT03004924|536687497|FG001|Overall Study|Pregnancy|1|||
148784735|NCT03004924|536687498|FG002|Overall Study|Pregnancy|0|||
148784736|NCT03004924|536687496|FG000|Overall Study|Terminated by Sponsor|0|||
148784737|NCT03004924|536687497|FG001|Overall Study|Terminated by Sponsor|0|||
148784738|NCT03004924|536687498|FG002|Overall Study|Terminated by Sponsor|1|||
148784739|NCT03004924|536687496|FG000|Overall Study|Missed Study Visit|0|||
148784740|NCT03004924|536687497|FG001|Overall Study|Missed Study Visit|0|||
148784741|NCT03004924|536687498|FG002|Overall Study|Missed Study Visit|2|||
148784742|NCT03004924|536687496|FG000|Overall Study|HSV1 Positive|1|||
148784743|NCT03004924|536687497|FG001|Overall Study|HSV1 Positive|0|||
148784744|NCT03004924|536687498|FG002|Overall Study|HSV1 Positive|0|||
148784745|NCT00803205|536687505|FG000|Overall Study|Adverse Event|7|||
148784746|NCT00803205|536687506|FG001|Overall Study|Adverse Event|2|||
148784747|NCT00803205|536687505|FG000|Overall Study|Lost to Follow-up|1|||
148784748|NCT00803205|536687506|FG001|Overall Study|Lost to Follow-up|0|||
148784749|NCT00803205|536687505|FG000|Overall Study|Withdrawal by Subject|9|||
148784750|NCT00803205|536687506|FG001|Overall Study|Withdrawal by Subject|9|||
148784751|NCT00803205|536687505|FG000|Overall Study|Physician Decision|1|||
148784752|NCT00803205|536687506|FG001|Overall Study|Physician Decision|0|||
148784753|NCT00803205|536687505|FG000|Overall Study|Protocol Violation|1|||
148784754|NCT00803205|536687506|FG001|Overall Study|Protocol Violation|1|||
148784755|NCT00803205|536687505|FG000|Overall Study|Medical Monitor Decision|1|||
148784756|NCT00803205|536687506|FG001|Overall Study|Medical Monitor Decision|0|||
149123096|NCT04493502|537927721|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
149123097|NCT04493502|537927722|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
148784757|NCT00803205|536687505|FG000|Overall Study|Acquired a Lung Infection|0|||
148784758|NCT00803205|536687506|FG001|Overall Study|Acquired a Lung Infection|1|||
148784759|NCT00803205|536687505|FG000|Overall Study|Sponsor Decision|0|||
148784760|NCT00803205|536687506|FG001|Overall Study|Sponsor Decision|1|||
148784761|NCT01490697|536687509|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
148784762|NCT01490697|536687510|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
148784763|NCT00379808|536687511|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
148784764|NCT00379808|536687512|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
148784765|NCT00564395|536687516|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
148784766|NCT00564395|536687517|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
148784767|NCT00564395|536687516|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
148784768|NCT00564395|536687517|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
148784769|NCT01333956|536687522|FG000|Overall Study|Lost to Follow-up|1|||
148784770|NCT01333956|536687523|FG001|Overall Study|Lost to Follow-up|2|||
148784771|NCT01333956|536687524|FG002|Overall Study|Lost to Follow-up|0|||
148784772|NCT01333956|536687525|FG003|Overall Study|Lost to Follow-up|1|||
148784773|NCT01333956|536687522|FG000|Overall Study|Unable to complete study procedure|1|||
148784774|NCT01333956|536687523|FG001|Overall Study|Unable to complete study procedure|0|||
148784775|NCT01333956|536687524|FG002|Overall Study|Unable to complete study procedure|0|||
148784776|NCT01333956|536687525|FG003|Overall Study|Unable to complete study procedure|1|||
148784777|NCT01333956|536687522|FG000|Overall Study|Withdrawal by Subject|0|||
148784778|NCT01333956|536687523|FG001|Overall Study|Withdrawal by Subject|2|||
148784779|NCT01333956|536687524|FG002|Overall Study|Withdrawal by Subject|1|||
148784780|NCT01333956|536687525|FG003|Overall Study|Withdrawal by Subject|0|||
148784781|NCT00435019|536687526|FG000|Overall Study|Adverse Event|1|||
148784782|NCT00435019|536687527|FG001|Overall Study|Adverse Event|0|||
148784783|NCT00435019|536687526|FG000|Overall Study|Lack of Efficacy|1|||
148784784|NCT00435019|536687527|FG001|Overall Study|Lack of Efficacy|2|||
148784785|NCT00435019|536687526|FG000|Overall Study|Protocol Violation|3|||
148784786|NCT00435019|536687527|FG001|Overall Study|Protocol Violation|1|||
148784787|NCT00435019|536687526|FG000|Overall Study|Personal reasons for withdrawal|8|||
148784788|NCT00435019|536687527|FG001|Overall Study|Personal reasons for withdrawal|7|||
148784789|NCT02412878|536688945|FG000|Overall Study|Withdrawal by Subject|19|||
148784790|NCT02412878|536688946|FG001|Overall Study|Withdrawal by Subject|10|||
148784791|NCT02412878|536688945|FG000|Overall Study|Lost to Follow-up|2|||
148784792|NCT02412878|536688946|FG001|Overall Study|Lost to Follow-up|3|||
148784793|NCT04847232|536688954|FG000|Overall Study|Death|123|||
148784794|NCT04847232|536688955|FG001|Overall Study|Death|115|||
148784795|NCT04847232|536688954|FG000|Overall Study|Lost to Follow-up|3|||
148784796|NCT04847232|536688955|FG001|Overall Study|Lost to Follow-up|10|||
148784797|NCT04847232|536688954|FG000|Overall Study|Withdrawal by Subject|73|||
148784798|NCT04847232|536688955|FG001|Overall Study|Withdrawal by Subject|101|||
148784799|NCT04847232|536688954|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
148784800|NCT04847232|536688955|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
148784801|NCT05697627|536688960|FG000|Overall Study|Adverse Event|1|||
148784802|NCT02776670|536688961|FG000|Overall Study|Adverse Event|0|||
148784803|NCT02776670|536688962|FG001|Overall Study|Adverse Event|2|||
148784804|NCT02776670|536688961|FG000|Overall Study|Protocol Violation|0|||
148784805|NCT02776670|536688962|FG001|Overall Study|Protocol Violation|2|||
148784806|NCT02776670|536688961|FG000|Overall Study|Withdrawal by Subject|0|||
148784807|NCT02776670|536688962|FG001|Overall Study|Withdrawal by Subject|1|||
148784808|NCT02776670|536688961|FG000|Overall Study|Other - Reason not given|0|||
148784809|NCT02776670|536688962|FG001|Overall Study|Other - Reason not given|1|||
148784810|NCT02636699|536688967|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
148784811|NCT02636699|536688968|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
148784812|NCT02636699|536688969|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
148784813|NCT02636699|536688967|FG000|Screening Period|Withdrawal by Subject|0|||
148784814|NCT02636699|536688968|FG001|Screening Period|Withdrawal by Subject|0|||
148784815|NCT02636699|536688969|FG002|Screening Period|Withdrawal by Subject|23|||
148784816|NCT02636699|536688967|FG000|Screening Period|Adverse Event|0|||
148784817|NCT02636699|536688968|FG001|Screening Period|Adverse Event|0|||
148784818|NCT02636699|536688969|FG002|Screening Period|Adverse Event|1|||
148784819|NCT02636699|536688967|FG000|Screening Period|Other not specified|0|||
148784820|NCT02636699|536688968|FG001|Screening Period|Other not specified|0|||
148784821|NCT02636699|536688969|FG002|Screening Period|Other not specified|3|||
148784822|NCT02636699|536688967|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
148784823|NCT02636699|536688968|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
148784824|NCT02636699|536688969|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
148784825|NCT02636699|536688967|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
148784826|NCT02636699|536688968|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
148784827|NCT02636699|536688969|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
148784828|NCT02636699|536688967|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
148784829|NCT02636699|536688968|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
148784830|NCT02636699|536688969|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
148784831|NCT02636699|536688967|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
148784832|NCT02636699|536688968|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
148784833|NCT02636699|536688969|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
148784834|NCT02636699|536688967|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
148784835|NCT02636699|536688968|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
149123098|NCT04493502|537927721|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
148784836|NCT02636699|536688969|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
148784837|NCT02636699|536688967|FG000|Treatment and Follow-up Periods|Other|3|||
148784838|NCT02636699|536688968|FG001|Treatment and Follow-up Periods|Other|1|||
148784839|NCT02636699|536688969|FG002|Treatment and Follow-up Periods|Other|0|||
148784840|NCT00624832|536688970|FG000|Overall Study|Adverse Event|0|||
148784841|NCT00624832|536688971|FG001|Overall Study|Adverse Event|1|||
148784842|NCT00624832|536688972|FG002|Overall Study|Adverse Event|0|||
148784843|NCT00624832|536688973|FG003|Overall Study|Adverse Event|1|||
148784844|NCT00624832|536688970|FG000|Overall Study|Abnormal Laboratory Value|2|||
148784845|NCT00624832|536688971|FG001|Overall Study|Abnormal Laboratory Value|0|||
148784846|NCT00624832|536688972|FG002|Overall Study|Abnormal Laboratory Value|0|||
148784847|NCT00624832|536688973|FG003|Overall Study|Abnormal Laboratory Value|0|||
148784848|NCT04379700|536688974|FG000|Overall Study|Withdrawal by Subject|10|||
148784849|NCT04379700|536688974|FG000|Overall Study|Screen Fail|4|||
148784850|NCT04379700|536688974|FG000|Overall Study|Lost to Follow-up|3|||
148784851|NCT03624569|536688976|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
148784852|NCT03624569|536688977|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
148784853|NCT03624569|536688976|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
148784854|NCT03624569|536688977|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
148784855|NCT00957424|536688978|FG000|Overall Study|Lost to Follow-up|19|||
148784856|NCT00957424|536688978|FG000|Overall Study|Protocol Violation|3|||
148784857|NCT00957424|536688978|FG000|Overall Study|Withdrawal by Subject|1|||
148784858|NCT01038752|536688979|FG000|Overall Study|Tumor Progression|2|||
148784859|NCT01038752|536688980|FG001|Overall Study|Tumor Progression|2|||
148784860|NCT01038752|536688979|FG000|Overall Study|Lost to Follow-up|3|||
148784861|NCT01038752|536688980|FG001|Overall Study|Lost to Follow-up|3|||
148784862|NCT02700698|536688987|FG000|Overall Study|Withdrawal by Subject|1|||
148784863|NCT02700698|536688988|FG001|Overall Study|Withdrawal by Subject|0|||
148784864|NCT00703118|536688991|FG000|Overall Study|Adverse Event|1|||
148784865|NCT00703118|536688992|FG001|Overall Study|Adverse Event|2|||
148784866|NCT00703118|536688993|FG002|Overall Study|Adverse Event|2|||
148784867|NCT00703118|536688991|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
148784868|NCT00703118|536688992|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
148784869|NCT00703118|536688993|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
148784870|NCT00703118|536688991|FG000|Overall Study|Lost to Follow-up|6|||
148784871|NCT00703118|536688992|FG001|Overall Study|Lost to Follow-up|4|||
148784872|NCT00703118|536688993|FG002|Overall Study|Lost to Follow-up|4|||
148784873|NCT00703118|536688991|FG000|Overall Study|Withdrawal by Subject|8|||
148784874|NCT00703118|536688992|FG001|Overall Study|Withdrawal by Subject|7|||
148784875|NCT00703118|536688993|FG002|Overall Study|Withdrawal by Subject|13|||
148784876|NCT00703118|536688991|FG000|Overall Study|Other|0|||
148784877|NCT00703118|536688992|FG001|Overall Study|Other|0|||
148784878|NCT00703118|536688993|FG002|Overall Study|Other|1|||
148784879|NCT04165135|536688994|FG000|Overall Study|Protocol Violation|10|||
148784880|NCT04165135|536688994|FG000|Overall Study|Participants withdrawal of consent|5|||
148784881|NCT00530790|536688995|FG000|Overall Study|Adverse Event|2|||
148784882|NCT00530790|536688995|FG000|Overall Study|Withdrawal by Subject|2|||
148784883|NCT00530790|536688995|FG000|Overall Study|Physician Decision|1|||
148784884|NCT02005627|536689003|FG000|Overall Study|Lost to Follow-up|1|||
148784885|NCT02005627|536689004|FG001|Overall Study|Lost to Follow-up|2|||
148784886|NCT02005627|536689003|FG000|Overall Study|Withdrawal by Subject|1|||
148784887|NCT02005627|536689004|FG001|Overall Study|Withdrawal by Subject|2|||
148784888|NCT01119846|536689010|FG000|Overall Study|Adverse Event|1|||
148784889|NCT01119846|536689011|FG001|Overall Study|Adverse Event|0|||
148784890|NCT01119846|536689012|FG002|Overall Study|Adverse Event|6|||
148784891|NCT01119846|536689010|FG000|Overall Study|Physician Decision|1|||
148784892|NCT01119846|536689011|FG001|Overall Study|Physician Decision|0|||
148784893|NCT01119846|536689012|FG002|Overall Study|Physician Decision|0|||
148784894|NCT01119846|536689010|FG000|Overall Study|Protocol Violation|0|||
148784895|NCT01119846|536689011|FG001|Overall Study|Protocol Violation|0|||
148784896|NCT01119846|536689012|FG002|Overall Study|Protocol Violation|1|||
148784897|NCT01119846|536689010|FG000|Overall Study|Withdrawal by Subject|0|||
148784898|NCT01119846|536689011|FG001|Overall Study|Withdrawal by Subject|0|||
148784899|NCT01119846|536689012|FG002|Overall Study|Withdrawal by Subject|4|||
148784900|NCT00048997|536689015|FG000|Overall Study|Protocol Violation|7|||
148784901|NCT00048997|536689016|FG001|Overall Study|Protocol Violation|2|||
149123099|NCT04493502|537927722|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
148784902|NCT00048997|536689015|FG000|Overall Study|Withdrawal by Subject|6|||
148784903|NCT00048997|536689016|FG001|Overall Study|Withdrawal by Subject|1|||
148784904|NCT00048165|536689018|FG000|Completed 6 Months Study|Administration/Other|8|||
148784905|NCT00048165|536689019|FG001|Completed 6 Months Study|Administration/Other|8|||
148784906|NCT00048165|536689018|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
148784907|NCT00048165|536689019|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
148784908|NCT00048165|536689018|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
148784909|NCT00048165|536689019|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
148784910|NCT00048165|536689018|FG000|Completed 6 Months Study|Death|12|||
148784911|NCT00048165|536689019|FG001|Completed 6 Months Study|Death|6|||
148784912|NCT00048165|536689018|FG000|Completed 6 Months Study|Insufficient therapy|1|||
148784913|NCT00048165|536689019|FG001|Completed 6 Months Study|Insufficient therapy|4|||
148784914|NCT00048165|536689018|FG000|Completed 6 Months Study|Other violation|4|||
148784915|NCT00048165|536689019|FG001|Completed 6 Months Study|Other violation|6|||
148784916|NCT00048165|536689018|FG000|Completed 6 Months Study|Refused treatment|5|||
148784917|NCT00048165|536689019|FG001|Completed 6 Months Study|Refused treatment|5|||
148784918|NCT00048165|536689018|FG000|Completed 6 Months Study|Violation criteria|0|||
148784919|NCT00048165|536689019|FG001|Completed 6 Months Study|Violation criteria|2|||
148784920|NCT00048165|536689018|FG000|Completed 6 Months Study|Did not receive study drug|6|||
148784921|NCT00048165|536689019|FG001|Completed 6 Months Study|Did not receive study drug|6|||
148784922|NCT00048165|536689018|FG000|Completed 12 Months Study|Administration/Other|0|||
148784923|NCT00048165|536689019|FG001|Completed 12 Months Study|Administration/Other|2|||
148784924|NCT00048165|536689018|FG000|Completed 12 Months Study|Death|2|||
148784925|NCT00048165|536689019|FG001|Completed 12 Months Study|Death|1|||
148784926|NCT00048165|536689018|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
148784927|NCT00048165|536689019|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
148784928|NCT01084538|536689027|FG000|Overall Study|Drug not available|30|||
148784929|NCT01084538|536689027|FG000|Overall Study|Adverse Event|9|||
148784930|NCT01084538|536689027|FG000|Overall Study|Kidney transplant|6|||
148784931|NCT01084538|536689027|FG000|Overall Study|Serious Adverse Event|3|||
148784932|NCT01084538|536689027|FG000|Overall Study|Lack of effectiveness|2|||
148784933|NCT01084538|536689027|FG000|Overall Study|Patient noncompliance|2|||
148784934|NCT01084538|536689027|FG000|Overall Study|Hyperphosphatemia|2|||
148784935|NCT01084538|536689027|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
148784936|NCT01084538|536689027|FG000|Overall Study|Change of residence|2|||
148784937|NCT01084538|536689027|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
148784938|NCT01084538|536689027|FG000|Overall Study|Reason unknown|8|||
148784939|NCT02906033|536689030|FG000|Baseline|Protocol Violation|37|||
148784940|NCT02906033|536689031|FG001|Baseline|Protocol Violation|33|||
148784941|NCT02906033|536689030|FG000|Follow-up|Lost to Follow-up|46|||
148784942|NCT02906033|536689031|FG001|Follow-up|Lost to Follow-up|62|||
148784943|NCT00094536|536689036|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
148784944|NCT00094536|536689036|FG000|Treatment and Follow-up|Adverse Event|4|||
148784945|NCT00094536|536689036|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
148784946|NCT00094536|536689036|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
148784947|NCT00094536|536689036|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
148784948|NCT00094536|536689036|FG000|Treatment and Follow-up|Subject non-compliance|9|||
148784949|NCT00094536|536689036|FG000|Treatment and Follow-up|Unable to attend visits|1|||
148784950|NCT02655419|536689037|FG000|Overall Study|Enrolled but not treated|1|||
148784951|NCT02655419|536689038|FG001|Overall Study|Enrolled but not treated|5|||
148784952|NCT02655419|536689037|FG000|Overall Study|Withdrawal by Subject|4|||
148784953|NCT02655419|536689038|FG001|Overall Study|Withdrawal by Subject|1|||
148784954|NCT02655419|536689037|FG000|Overall Study|Other|0|||
148784955|NCT02655419|536689038|FG001|Overall Study|Other|1|||
148784956|NCT01900431|536689039|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
148784957|NCT01900431|536689040|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
148784958|NCT01900431|536689041|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
148784959|NCT01900431|536689039|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
148784960|NCT01900431|536689040|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
148784961|NCT01900431|536689041|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
148784962|NCT01900431|536689039|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
148784963|NCT01900431|536689040|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
148784964|NCT01900431|536689041|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
148784965|NCT01900431|536689039|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
148784966|NCT01900431|536689040|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
148784967|NCT01900431|536689041|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
148784968|NCT01900431|536689039|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
148784969|NCT01900431|536689040|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
148784970|NCT01900431|536689041|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
148784971|NCT01900431|536689039|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
148784972|NCT01900431|536689040|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
148784973|NCT01900431|536689041|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
148784974|NCT01900431|536689039|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
148784975|NCT01900431|536689040|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
148784976|NCT01900431|536689041|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
148784977|NCT01900431|536689039|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
148784978|NCT01900431|536689040|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
148784979|NCT01900431|536689041|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
148784980|NCT01900431|536689039|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
148784981|NCT01900431|536689040|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
148784982|NCT01900431|536689041|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
148784983|NCT03782974|536689044|FG000|Overall Study|Withdrawal by Subject|7|||
148784984|NCT03782974|536689045|FG001|Overall Study|Withdrawal by Subject|7|||
148784985|NCT03782974|536689044|FG000|Overall Study|Pregnancy|1|||
148784986|NCT03782974|536689045|FG001|Overall Study|Pregnancy|0|||
148784987|NCT00448812|536689052|FG000|Year 2|Missed visit but remained in study|4|||
148784988|NCT00448812|536689053|FG001|Year 2|Missed visit but remained in study|1|||
148784989|NCT00448812|536689052|FG000|Year 3|Withdrawal by Subject|1|||
148784990|NCT00448812|536689053|FG001|Year 3|Withdrawal by Subject|3|||
148784991|NCT00448812|536689052|FG000|Year 3|Lost to Follow-up|1|||
148784992|NCT00448812|536689053|FG001|Year 3|Lost to Follow-up|0|||
148784993|NCT00448812|536689052|FG000|Year 3|Missed visit but remained in study|2|||
148784994|NCT00448812|536689053|FG001|Year 3|Missed visit but remained in study|0|||
148784995|NCT00448812|536689052|FG000|Year 5|Missed visit but remained in study|1|||
148784996|NCT00448812|536689053|FG001|Year 5|Missed visit but remained in study|0|||
148784997|NCT01687283|536690935|FG000|Overall Study|Adverse Event|11|||
148784998|NCT01687283|536690936|FG001|Overall Study|Adverse Event|4|||
148784999|NCT01687283|536690935|FG000|Overall Study|Lack of Efficacy|3|||
148785000|NCT01687283|536690936|FG001|Overall Study|Lack of Efficacy|1|||
148785001|NCT01687283|536690935|FG000|Overall Study|Protocol Violation|1|||
148785002|NCT01687283|536690936|FG001|Overall Study|Protocol Violation|3|||
148785003|NCT01687283|536690935|FG000|Overall Study|protocol defined stopping criteria|8|||
148785004|NCT01687283|536690936|FG001|Overall Study|protocol defined stopping criteria|10|||
148785005|NCT01687283|536690935|FG000|Overall Study|Lost to Follow-up|1|||
148785006|NCT01687283|536690936|FG001|Overall Study|Lost to Follow-up|1|||
148785007|NCT01687283|536690935|FG000|Overall Study|Investigator discretion|2|||
148785008|NCT01687283|536690936|FG001|Overall Study|Investigator discretion|0|||
148785009|NCT01687283|536690935|FG000|Overall Study|Withdrawal by Subject|9|||
148785010|NCT01687283|536690936|FG001|Overall Study|Withdrawal by Subject|8|||
148785011|NCT01153009|536690940|FG000|Overall Study|Adverse Event|4|||
148785012|NCT01153009|536690941|FG001|Overall Study|Adverse Event|14|||
148785013|NCT01153009|536690942|FG002|Overall Study|Adverse Event|14|||
148785014|NCT01153009|536690943|FG003|Overall Study|Adverse Event|10|||
148785015|NCT01153009|536690940|FG000|Overall Study|Lack of Efficacy|9|||
148785016|NCT01153009|536690941|FG001|Overall Study|Lack of Efficacy|0|||
148785017|NCT01153009|536690942|FG002|Overall Study|Lack of Efficacy|2|||
148785018|NCT01153009|536690943|FG003|Overall Study|Lack of Efficacy|1|||
148785019|NCT01153009|536690940|FG000|Overall Study|Noncompliance with Study Medication|1|||
148785020|NCT01153009|536690941|FG001|Overall Study|Noncompliance with Study Medication|3|||
148785021|NCT01153009|536690942|FG002|Overall Study|Noncompliance with Study Medication|4|||
148785022|NCT01153009|536690943|FG003|Overall Study|Noncompliance with Study Medication|1|||
148785023|NCT01153009|536690940|FG000|Overall Study|Protocol Deviations|4|||
148785024|NCT01153009|536690941|FG001|Overall Study|Protocol Deviations|3|||
148785025|NCT01153009|536690942|FG002|Overall Study|Protocol Deviations|3|||
148785026|NCT01153009|536690943|FG003|Overall Study|Protocol Deviations|2|||
148785027|NCT01153009|536690940|FG000|Overall Study|Withdrawal of Consent|5|||
148785028|NCT01153009|536690941|FG001|Overall Study|Withdrawal of Consent|5|||
148785029|NCT01153009|536690942|FG002|Overall Study|Withdrawal of Consent|4|||
148785030|NCT01153009|536690943|FG003|Overall Study|Withdrawal of Consent|6|||
148785031|NCT01153009|536690940|FG000|Overall Study|Lost to Follow-up|8|||
148785032|NCT01153009|536690941|FG001|Overall Study|Lost to Follow-up|8|||
148785033|NCT01153009|536690942|FG002|Overall Study|Lost to Follow-up|11|||
148785034|NCT01153009|536690943|FG003|Overall Study|Lost to Follow-up|15|||
148785035|NCT01153009|536690940|FG000|Overall Study|Other|1|||
148785036|NCT01153009|536690941|FG001|Overall Study|Other|1|||
148785037|NCT01153009|536690942|FG002|Overall Study|Other|3|||
148785038|NCT01153009|536690943|FG003|Overall Study|Other|2|||
148785039|NCT00410072|536690944|FG000|Day 1 to Week 48|Adverse Event|1|||
148785040|NCT00410072|536690945|FG001|Day 1 to Week 48|Adverse Event|2|||
148785041|NCT00410072|536690944|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
148785042|NCT00410072|536690945|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
148785043|NCT00410072|536690944|FG000|Day 1 to Week 48|Other|0|||
148785044|NCT00410072|536690945|FG001|Day 1 to Week 48|Other|1|||
148785045|NCT00410072|536690944|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
148785046|NCT00410072|536690945|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
148785047|NCT00410072|536690944|FG000|Day 1 to Week 48|Pregnancy|0|||
148785048|NCT00410072|536690945|FG001|Day 1 to Week 48|Pregnancy|2|||
148785049|NCT00410072|536690944|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
148785050|NCT00410072|536690945|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
148785051|NCT00410072|536690944|FG000|After Week 48 to Week 96|Adverse Event|1|||
148785052|NCT00410072|536690945|FG001|After Week 48 to Week 96|Adverse Event|2|||
148785053|NCT00410072|536690944|FG000|After Week 48 to Week 96|Death|0|||
148785054|NCT00410072|536690945|FG001|After Week 48 to Week 96|Death|1|||
148785055|NCT00410072|536690944|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
148785056|NCT00410072|536690945|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
148785057|NCT00410072|536690944|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
148785058|NCT00410072|536690945|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
148785059|NCT00410072|536690944|FG000|After Week 48 to Week 96|Other|2|||
148785060|NCT00410072|536690945|FG001|After Week 48 to Week 96|Other|0|||
148785061|NCT00410072|536690944|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
148785062|NCT00410072|536690945|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
148785063|NCT00410072|536690944|FG000|After Week 48 to Week 96|Pregnancy|0|||
148785064|NCT00410072|536690945|FG001|After Week 48 to Week 96|Pregnancy|2|||
148785065|NCT00410072|536690944|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
148785066|NCT00410072|536690945|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
148785067|NCT03307837|536690947|FG000|Overall Study|Withdrawal by Subject|0|||
148785068|NCT03307837|536690948|FG001|Overall Study|Withdrawal by Subject|0|||
148785069|NCT03307837|536690949|FG002|Overall Study|Withdrawal by Subject|1|||
148785070|NCT03307837|536690950|FG003|Overall Study|Withdrawal by Subject|0|||
148785071|NCT03307837|536690951|FG004|Overall Study|Withdrawal by Subject|0|||
148785072|NCT03307837|536690952|FG005|Overall Study|Withdrawal by Subject|1|||
148785073|NCT03307837|536690947|FG000|Overall Study|Lost to Follow-up|1|||
148785074|NCT03307837|536690948|FG001|Overall Study|Lost to Follow-up|1|||
148785075|NCT03307837|536690949|FG002|Overall Study|Lost to Follow-up|0|||
148785076|NCT03307837|536690950|FG003|Overall Study|Lost to Follow-up|0|||
148785077|NCT03307837|536690951|FG004|Overall Study|Lost to Follow-up|0|||
148785078|NCT03307837|536690952|FG005|Overall Study|Lost to Follow-up|1|||
148785079|NCT00904917|536690954|FG000|Overall Study|Lost to Follow-up|2|||
148785080|NCT00904917|536690955|FG001|Overall Study|Lost to Follow-up|2|||
148785081|NCT00904917|536690956|FG002|Overall Study|Lost to Follow-up|2|||
148785082|NCT00904917|536690957|FG003|Overall Study|Lost to Follow-up|2|||
148785083|NCT00762034|536690958|FG000|Induction Period|Protocol Violation|1|||
148785084|NCT00762034|536690959|FG001|Induction Period|Protocol Violation|2|||
148785085|NCT00762034|536690958|FG000|Induction Period|Entry Criterion Not Met|12|||
148785086|NCT00762034|536690959|FG001|Induction Period|Entry Criterion Not Met|11|||
148785087|NCT00762034|536690958|FG000|Induction Period|Adverse Event|27|||
148785088|NCT00762034|536690959|FG001|Induction Period|Adverse Event|38|||
148785089|NCT00762034|536690958|FG000|Induction Period|Lost to Follow-up|1|||
148785090|NCT00762034|536690959|FG001|Induction Period|Lost to Follow-up|1|||
148785091|NCT00762034|536690958|FG000|Induction Period|Progressive Disease|73|||
148785092|NCT00762034|536690959|FG001|Induction Period|Progressive Disease|55|||
148785093|NCT00762034|536690958|FG000|Induction Period|Physician Decision|21|||
148785094|NCT00762034|536690959|FG001|Induction Period|Physician Decision|20|||
148785095|NCT00762034|536690958|FG000|Induction Period|Withdrawal by Subject|15|||
148785096|NCT00762034|536690959|FG001|Induction Period|Withdrawal by Subject|19|||
148785097|NCT00762034|536690958|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
148785098|NCT00762034|536690959|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
148785099|NCT00762034|536690958|FG000|Induction Period|Deaths Due to Study Disease|9|||
148785100|NCT00762034|536690959|FG001|Induction Period|Deaths Due to Study Disease|9|||
148785101|NCT00762034|536690958|FG000|Maintenance Period|Protocol Violation|1|||
148785102|NCT00762034|536690959|FG001|Maintenance Period|Protocol Violation|3|||
148785103|NCT00762034|536690958|FG000|Maintenance Period|Entry Criterion Not Met|0|||
148785104|NCT00762034|536690959|FG001|Maintenance Period|Entry Criterion Not Met|2|||
148785105|NCT00762034|536690958|FG000|Maintenance Period|Adverse Event|42|||
148785106|NCT00762034|536690959|FG001|Maintenance Period|Adverse Event|26|||
148785107|NCT00762034|536690958|FG000|Maintenance Period|Progressive Disease|186|||
148785108|NCT00762034|536690959|FG001|Maintenance Period|Progressive Disease|224|||
148785109|NCT00762034|536690958|FG000|Maintenance Period|Physician Decision|25|||
148785110|NCT00762034|536690959|FG001|Maintenance Period|Physician Decision|20|||
148785111|NCT00762034|536690958|FG000|Maintenance Period|Withdrawal by Subject|34|||
148785112|NCT00762034|536690959|FG001|Maintenance Period|Withdrawal by Subject|14|||
148785113|NCT00762034|536690958|FG000|Maintenance Period|Death not due to study disease|2|||
148785114|NCT00762034|536690959|FG001|Maintenance Period|Death not due to study disease|5|||
148785115|NCT00762034|536690958|FG000|Maintenance Period|Death due to study disease|3|||
148785116|NCT00762034|536690959|FG001|Maintenance Period|Death due to study disease|3|||
148785117|NCT00762034|536690958|FG000|Maintenance Period|Other|1|||
148785118|NCT00762034|536690959|FG001|Maintenance Period|Other|1|||
148785119|NCT02442206|536690960|FG000|Period 1|Adverse Event|1|||
148785120|NCT02442206|536690961|FG001|Period 1|Adverse Event|1|||
148785121|NCT02442206|536690960|FG000|Period 1|withdrew consent|0|||
149011386|NCT01535274|537521460|FG000|Overall Study|Misallocated to propofol intervention|0|||
148785122|NCT02442206|536690961|FG001|Period 1|withdrew consent|1|||
148785123|NCT02442206|536690960|FG000|Period 1|COPD exacerbation|0|||
148785124|NCT02442206|536690961|FG001|Period 1|COPD exacerbation|1|||
148785125|NCT02442206|536690960|FG000|Period 2|Adverse Event|1|||
148785126|NCT02442206|536690961|FG001|Period 2|Adverse Event|0|||
148785127|NCT01709409|536690966|FG000|Overall Study|Protocol Violation|1|||
148785128|NCT01709409|536690967|FG001|Overall Study|Protocol Violation|0|||
148785129|NCT02190721|536690968|FG000|Overall Study|Patient was out of the city|0|||
148785130|NCT02190721|536690969|FG001|Overall Study|Patient was out of the city|1|||
148785131|NCT02190721|536690970|FG002|Overall Study|Patient was out of the city|0|||
148785132|NCT04571385|536690971|FG000|Overall Study|Participant non-compliance|1|||
148785133|NCT04571385|536690972|FG001|Overall Study|Participant non-compliance|0|||
148785134|NCT04571385|536690973|FG002|Overall Study|Participant non-compliance|0|||
148785135|NCT04571385|536690971|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
148785136|NCT04571385|536690972|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
148785137|NCT04571385|536690973|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
148785138|NCT04571385|536690971|FG000|Overall Study|Screen failure|0|||
148785139|NCT04571385|536690972|FG001|Overall Study|Screen failure|0|||
148785140|NCT04571385|536690973|FG002|Overall Study|Screen failure|1|||
148785141|NCT01212159|536690975|FG000|Overall Study|Withdrawal by Subject|12|||
148785142|NCT01212159|536690976|FG001|Overall Study|Withdrawal by Subject|12|||
148785143|NCT04676152|536690977|FG000|Overall Study|screen fail|9|||
148785144|NCT01928199|536690978|FG000|Overall Study|Lost to Follow-up|2|||
148785145|NCT01928199|536690979|FG001|Overall Study|Lost to Follow-up|1|||
148785146|NCT01928199|536690978|FG000|Overall Study|Withdrawal by Subject|3|||
148785147|NCT01928199|536690979|FG001|Overall Study|Withdrawal by Subject|5|||
148785148|NCT02107313|536690981|FG000|Overall Study|One participant did not do the FED cohor|0|||
148785149|NCT02107313|536690982|FG001|Overall Study|One participant did not do the FED cohor|1|||
148785150|NCT01031004|536690985|FG000|Overall Study|Protocol Violation|0|||
148785151|NCT01031004|536690986|FG001|Overall Study|Protocol Violation|1|||
148785152|NCT01031004|536690985|FG000|Overall Study|Lost to Follow-up|1|||
148785153|NCT01031004|536690986|FG001|Overall Study|Lost to Follow-up|0|||
148785154|NCT01641471|536690987|FG000|Overall Study|Withdrawal by Subject|19|||
148785155|NCT01641471|536690988|FG001|Overall Study|Withdrawal by Subject|19|||
148785156|NCT01641471|536690987|FG000|Overall Study|Lost to Follow-up|2|||
148785157|NCT01641471|536690988|FG001|Overall Study|Lost to Follow-up|4|||
148785158|NCT01641471|536690987|FG000|Overall Study|Protocol Violation|2|||
148785159|NCT01641471|536690988|FG001|Overall Study|Protocol Violation|4|||
148785160|NCT02815267|536690996|FG000|Double-Blind Phase|Adverse Event|0|||
148785161|NCT02815267|536690997|FG001|Double-Blind Phase|Adverse Event|3|||
148785162|NCT02815267|536690996|FG000|Double-Blind Phase|Lost to Follow-up|17|||
148785163|NCT02815267|536690997|FG001|Double-Blind Phase|Lost to Follow-up|9|||
148785164|NCT02815267|536690996|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
148785165|NCT02815267|536690997|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
148785166|NCT02815267|536690996|FG000|Double-Blind Phase|Protocol Violation|3|||
148785167|NCT02815267|536690997|FG001|Double-Blind Phase|Protocol Violation|2|||
148785168|NCT02815267|536690996|FG000|Double-Blind Phase|Site withdrawal|1|||
148785169|NCT02815267|536690997|FG001|Double-Blind Phase|Site withdrawal|6|||
148785170|NCT02815267|536690996|FG000|Double-Blind Phase|Received a disallowed medication|1|||
148785171|NCT02815267|536690997|FG001|Double-Blind Phase|Received a disallowed medication|1|||
148785172|NCT02815267|536690996|FG000|Open-Label Phase|Adverse Event|1|||
148785173|NCT02815267|536690997|FG001|Open-Label Phase|Adverse Event|1|||
148785174|NCT02815267|536690996|FG000|Open-Label Phase|Lost to Follow-up|23|||
148785175|NCT02815267|536690997|FG001|Open-Label Phase|Lost to Follow-up|9|||
148785176|NCT02815267|536690996|FG000|Open-Label Phase|Withdrawal by Subject|24|||
148785177|NCT02815267|536690997|FG001|Open-Label Phase|Withdrawal by Subject|13|||
148785178|NCT02815267|536690996|FG000|Open-Label Phase|Protocol Violation|0|||
148785179|NCT02815267|536690997|FG001|Open-Label Phase|Protocol Violation|1|||
148785180|NCT02815267|536690996|FG000|Open-Label Phase|Administrative|21|||
148785181|NCT02815267|536690997|FG001|Open-Label Phase|Administrative|12|||
148785182|NCT02815267|536690996|FG000|Open-Label Phase|Other|2|||
148785183|NCT02815267|536690997|FG001|Open-Label Phase|Other|5|||
148785184|NCT01108237|536690998|FG000|Overall Study|No alignment data|2|||
148785185|NCT01108237|536690999|FG001|Overall Study|No alignment data|15|||
148785186|NCT01108237|536690998|FG000|Overall Study|Did not meet criteria for analysis|7|||
148785187|NCT01108237|536690999|FG001|Overall Study|Did not meet criteria for analysis|0|||
148785188|NCT02178358|536691000|FG000|Overall Study|Withdrawal by Subject|0|||
148785189|NCT02178358|536691001|FG001|Overall Study|Withdrawal by Subject|2|||
148785190|NCT02178358|536691002|FG002|Overall Study|Withdrawal by Subject|2|||
148785191|NCT02178358|536691000|FG000|Overall Study|Lost to Follow-up|1|||
148785192|NCT02178358|536691001|FG001|Overall Study|Lost to Follow-up|0|||
148785193|NCT02178358|536691002|FG002|Overall Study|Lost to Follow-up|0|||
148785194|NCT00948922|536691003|FG000|Overall Study|Did not start study treatment|2|||
148785195|NCT00948922|536691004|FG001|Overall Study|Did not start study treatment|5|||
148785196|NCT00948922|536691005|FG002|Overall Study|Did not start study treatment|0|||
148785197|NCT00948922|536691003|FG000|Overall Study|Withdrawal by Subject|0|||
148785198|NCT00948922|536691004|FG001|Overall Study|Withdrawal by Subject|2|||
148785199|NCT00948922|536691005|FG002|Overall Study|Withdrawal by Subject|1|||
148785200|NCT00948922|536691003|FG000|Overall Study|Death|3|||
148785201|NCT00948922|536691004|FG001|Overall Study|Death|0|||
149123100|NCT04493502|537927721|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
148785202|NCT00948922|536691005|FG002|Overall Study|Death|0|||
148785203|NCT00948922|536691003|FG000|Overall Study|Disease progression|0|||
148785204|NCT00948922|536691004|FG001|Overall Study|Disease progression|1|||
148785205|NCT00948922|536691005|FG002|Overall Study|Disease progression|0|||
148785206|NCT00948922|536691003|FG000|Overall Study|Insurance issues|1|||
148785207|NCT00948922|536691004|FG001|Overall Study|Insurance issues|0|||
148785208|NCT00948922|536691005|FG002|Overall Study|Insurance issues|0|||
148785209|NCT00948922|536691003|FG000|Overall Study|Transplant eligibility issues|2|||
148785210|NCT00948922|536691004|FG001|Overall Study|Transplant eligibility issues|3|||
148785211|NCT00948922|536691005|FG002|Overall Study|Transplant eligibility issues|0|||
148785212|NCT00948922|536691003|FG000|Overall Study|Not evaluable at time of analysis|0|||
148785213|NCT00948922|536691004|FG001|Overall Study|Not evaluable at time of analysis|3|||
148785214|NCT00948922|536691005|FG002|Overall Study|Not evaluable at time of analysis|0|||
148785215|NCT02784288|536691006|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
148785216|NCT02757625|536691007|FG000|Overall Study|Investigator's discretion|0|||
148785217|NCT02757625|536691008|FG001|Overall Study|Investigator's discretion|0|||
148785218|NCT02757625|536691009|FG002|Overall Study|Investigator's discretion|1|||
148785219|NCT02757625|536691010|FG003|Overall Study|Investigator's discretion|0|||
148785220|NCT02757625|536691007|FG000|Overall Study|Adverse Event|0|||
148785221|NCT02757625|536691008|FG001|Overall Study|Adverse Event|0|||
148785222|NCT02757625|536691009|FG002|Overall Study|Adverse Event|1|||
148785223|NCT02757625|536691010|FG003|Overall Study|Adverse Event|0|||
148785224|NCT02131233|536691011|FG000|Overall Study|Not Treated|2|||
148785225|NCT02131233|536691012|FG001|Overall Study|Not Treated|3|||
148785226|NCT02131233|536691011|FG000|Overall Study|Adverse Event|7|||
148785227|NCT02131233|536691012|FG001|Overall Study|Adverse Event|6|||
148785228|NCT02131233|536691011|FG000|Overall Study|Death|0|||
148785229|NCT02131233|536691012|FG001|Overall Study|Death|1|||
148785230|NCT02131233|536691011|FG000|Overall Study|Lack of Efficacy|6|||
148785231|NCT02131233|536691012|FG001|Overall Study|Lack of Efficacy|3|||
148785232|NCT02131233|536691011|FG000|Overall Study|Lost to Follow-up|14|||
148785233|NCT02131233|536691012|FG001|Overall Study|Lost to Follow-up|13|||
148785234|NCT02131233|536691011|FG000|Overall Study|Non-Compliance With Study Drug|8|||
148785235|NCT02131233|536691012|FG001|Overall Study|Non-Compliance With Study Drug|5|||
148785236|NCT02131233|536691011|FG000|Overall Study|Physician Decision|7|||
148785237|NCT02131233|536691012|FG001|Overall Study|Physician Decision|0|||
148785238|NCT02131233|536691011|FG000|Overall Study|Pregnancy|4|||
148785239|NCT02131233|536691012|FG001|Overall Study|Pregnancy|0|||
148785240|NCT02131233|536691011|FG000|Overall Study|Withdrawal by Subject|18|||
148785241|NCT02131233|536691012|FG001|Overall Study|Withdrawal by Subject|11|||
148785242|NCT02095197|536691013|FG000|Overall Study|Lost to Follow-up|0|||
148785243|NCT02095197|536691014|FG001|Overall Study|Lost to Follow-up|3|||
148785244|NCT01597492|536691016|FG000|Overall Study|Withdrawal by Subject|1|||
148785245|NCT01597492|536691017|FG001|Overall Study|Withdrawal by Subject|2|||
148785246|NCT01597492|536691016|FG000|Overall Study|Adverse Event|3|||
148785247|NCT01597492|536691017|FG001|Overall Study|Adverse Event|0|||
148785248|NCT01597492|536691016|FG000|Overall Study|Lost to Follow-up|0|||
148785249|NCT01597492|536691017|FG001|Overall Study|Lost to Follow-up|2|||
148785250|NCT01597492|536691016|FG000|Overall Study|Other Reason|2|||
148785251|NCT01597492|536691017|FG001|Overall Study|Other Reason|0|||
148785252|NCT01204918|536691018|FG000|Overall Study|Withdrawal by Subject|4|||
148785253|NCT01204918|536691019|FG001|Overall Study|Withdrawal by Subject|10|||
148785254|NCT01204918|536691020|FG002|Overall Study|Withdrawal by Subject|5|||
148785255|NCT03517449|536691025|FG000|Overall Study|Death|184|||
148785256|NCT03517449|536691026|FG001|Overall Study|Death|236|||
148785257|NCT03517449|536691025|FG000|Overall Study|Lost to Follow-up|0|||
148785258|NCT03517449|536691026|FG001|Overall Study|Lost to Follow-up|2|||
148785259|NCT03517449|536691025|FG000|Overall Study|Withdrawal by Subject|7|||
148785260|NCT03517449|536691026|FG001|Overall Study|Withdrawal by Subject|26|||
148785261|NCT03517449|536691025|FG000|Overall Study|Participants Ongoing|220|||
148785262|NCT03517449|536691026|FG001|Overall Study|Participants Ongoing|152|||
148785263|NCT01280682|536691031|FG000|Overall Study|Lost to Follow-up|0|||
148785264|NCT01280682|536691032|FG001|Overall Study|Lost to Follow-up|6|||
148785265|NCT01280682|536691031|FG000|Overall Study|Withdrawal by Subject|0|||
148785266|NCT01280682|536691032|FG001|Overall Study|Withdrawal by Subject|7|||
148785267|NCT00269477|536691041|FG000|Overall Study|Protocol Violation|5|||
148785268|NCT00269477|536691042|FG001|Overall Study|Protocol Violation|5|||
148785269|NCT00269477|536691043|FG002|Overall Study|Protocol Violation|1|||
148785270|NCT00269477|536691044|FG003|Overall Study|Protocol Violation|0|||
148785271|NCT00269477|536691041|FG000|Overall Study|Missed post-vaccination blood draw|0|||
148785272|NCT00269477|536691042|FG001|Overall Study|Missed post-vaccination blood draw|1|||
148785273|NCT00269477|536691043|FG002|Overall Study|Missed post-vaccination blood draw|0|||
148785274|NCT00269477|536691044|FG003|Overall Study|Missed post-vaccination blood draw|0|||
148785275|NCT00431067|536691045|FG000|Overall Study|Other Adverse Event|9|||
148785276|NCT00431067|536691045|FG000|Overall Study|Progressive disease|30|||
148785277|NCT00431067|536691045|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
148785278|NCT00849290|536691046|FG000|Overall Study|Adverse Event|3|||
148785279|NCT00849290|536691046|FG000|Overall Study|Death|14|||
148785280|NCT00849290|536691046|FG000|Overall Study|Withdrawal by Subject|11|||
148785281|NCT00849290|536691046|FG000|Overall Study|Lost to Follow-up|2|||
148785282|NCT00849290|536691046|FG000|Overall Study|Protocol Violation|5|||
148785283|NCT00849290|536691046|FG000|Overall Study|Disease Progression|20|||
148785284|NCT00548249|536691047|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
148785285|NCT00548249|536691048|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
148785286|NCT00548249|536691049|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
148785287|NCT00548249|536691050|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
148785288|NCT00548249|536691051|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
148785289|NCT00548249|536691047|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
148785290|NCT00548249|536691048|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
148785291|NCT00548249|536691049|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
148785292|NCT00548249|536691050|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
148785293|NCT00548249|536691051|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
148785294|NCT00548249|536691047|FG000|Overall Study|Protocol Violation|1|||
148785295|NCT00548249|536691048|FG001|Overall Study|Protocol Violation|1|||
148785296|NCT00548249|536691049|FG002|Overall Study|Protocol Violation|4|||
148785297|NCT00548249|536691050|FG003|Overall Study|Protocol Violation|0|||
148785298|NCT00548249|536691051|FG004|Overall Study|Protocol Violation|3|||
148785299|NCT00548249|536691047|FG000|Overall Study|Miscellaneous|2|||
148785300|NCT00548249|536691048|FG001|Overall Study|Miscellaneous|3|||
148785301|NCT00548249|536691049|FG002|Overall Study|Miscellaneous|2|||
148785302|NCT00548249|536691050|FG003|Overall Study|Miscellaneous|0|||
148785303|NCT00548249|536691051|FG004|Overall Study|Miscellaneous|2|||
148785304|NCT00548249|536691047|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
148785305|NCT00548249|536691048|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
148785306|NCT00548249|536691049|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
148785307|NCT00548249|536691050|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
148785308|NCT00548249|536691051|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
148785309|NCT00548249|536691047|FG000|Overall Study|Adverse Event|2|||
148785310|NCT00548249|536691048|FG001|Overall Study|Adverse Event|2|||
148785311|NCT00548249|536691049|FG002|Overall Study|Adverse Event|0|||
148785312|NCT00548249|536691050|FG003|Overall Study|Adverse Event|1|||
148785313|NCT00548249|536691051|FG004|Overall Study|Adverse Event|1|||
148785314|NCT00548249|536691047|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
148785315|NCT00548249|536691048|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
148785316|NCT00548249|536691049|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
148785317|NCT00548249|536691050|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
148785318|NCT00548249|536691051|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
148785319|NCT00548249|536691047|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
148785320|NCT00548249|536691048|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
148785321|NCT00548249|536691049|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
148785322|NCT00548249|536691050|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
148785323|NCT00548249|536691051|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
148785324|NCT00548249|536691047|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
148785325|NCT00548249|536691048|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
148785326|NCT00548249|536691049|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
148785327|NCT00548249|536691050|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
148785328|NCT00548249|536691051|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
149123101|NCT04493502|537927722|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
149123102|NCT02891837|537927723|FG000|Overall Study|Lost to Follow-up|2|||
148785329|NCT00548249|536691047|FG000|Overall Study|Prolonged hospitalization|0|||
148785330|NCT00548249|536691048|FG001|Overall Study|Prolonged hospitalization|0|||
148785331|NCT00548249|536691049|FG002|Overall Study|Prolonged hospitalization|2|||
148785332|NCT00548249|536691050|FG003|Overall Study|Prolonged hospitalization|1|||
148785333|NCT00548249|536691051|FG004|Overall Study|Prolonged hospitalization|0|||
148785334|NCT00548249|536691047|FG000|Overall Study|Withdrawal by Subject|2|||
148785335|NCT00548249|536691048|FG001|Overall Study|Withdrawal by Subject|0|||
148785336|NCT00548249|536691049|FG002|Overall Study|Withdrawal by Subject|0|||
148785337|NCT00548249|536691050|FG003|Overall Study|Withdrawal by Subject|0|||
148785338|NCT00548249|536691051|FG004|Overall Study|Withdrawal by Subject|0|||
148785339|NCT00548249|536691047|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
148785340|NCT00548249|536691048|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
148785341|NCT00548249|536691049|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
148785342|NCT00548249|536691050|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
148785343|NCT00548249|536691051|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
148785344|NCT00548249|536691047|FG000|Overall Study|Sponsor's request|0|||
148785345|NCT00548249|536691048|FG001|Overall Study|Sponsor's request|0|||
148785346|NCT00548249|536691049|FG002|Overall Study|Sponsor's request|0|||
148785347|NCT00548249|536691050|FG003|Overall Study|Sponsor's request|1|||
148785348|NCT00548249|536691051|FG004|Overall Study|Sponsor's request|0|||
148785349|NCT00938587|536691052|FG000|Overall Study|Adverse Event|2|||
148785350|NCT00938587|536691053|FG001|Overall Study|Adverse Event|0|||
148785351|NCT00938587|536691054|FG002|Overall Study|Adverse Event|0|||
148785352|NCT00938587|536691055|FG003|Overall Study|Adverse Event|2|||
148785353|NCT00938587|536691052|FG000|Overall Study|Did not meet entrance criteria|0|||
148785354|NCT00938587|536691053|FG001|Overall Study|Did not meet entrance criteria|0|||
148785355|NCT00938587|536691054|FG002|Overall Study|Did not meet entrance criteria|1|||
148785356|NCT00938587|536691055|FG003|Overall Study|Did not meet entrance criteria|0|||
148785357|NCT00938587|536691052|FG000|Overall Study|Withdrawal by Subject|1|||
148785358|NCT00938587|536691053|FG001|Overall Study|Withdrawal by Subject|1|||
148785359|NCT00938587|536691054|FG002|Overall Study|Withdrawal by Subject|0|||
148785360|NCT00938587|536691055|FG003|Overall Study|Withdrawal by Subject|0|||
148785361|NCT03760458|536691061|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
148785362|NCT03760458|536691062|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
148785363|NCT03760458|536691063|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
148785364|NCT03760458|536691064|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
148785365|NCT03760458|536691065|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
149123103|NCT02891837|537927724|FG001|Overall Study|Lost to Follow-up|0|||
149123104|NCT02891837|537927723|FG000|Overall Study|Withdrawal by Subject|1|||
149123105|NCT02891837|537927724|FG001|Overall Study|Withdrawal by Subject|0|||
149123106|NCT01226095|537927730|FG000|Overall Study|Poor compliance|1|||
149123107|NCT03538301|537927735|FG000|Overall Study|Adverse Event|1|||
149123108|NCT03538301|537927736|FG001|Overall Study|Adverse Event|4|||
149123109|NCT03538301|537927737|FG002|Overall Study|Adverse Event|4|||
149123110|NCT03538301|537927735|FG000|Overall Study|Death|1|||
149123111|NCT03538301|537927736|FG001|Overall Study|Death|1|||
149123112|NCT03538301|537927737|FG002|Overall Study|Death|0|||
149123113|NCT03538301|537927735|FG000|Overall Study|Physician Decision|0|||
149123114|NCT03538301|537927736|FG001|Overall Study|Physician Decision|1|||
149123115|NCT03538301|537927737|FG002|Overall Study|Physician Decision|0|||
149123116|NCT03538301|537927735|FG000|Overall Study|Protocol Violation|0|||
149123117|NCT03538301|537927736|FG001|Overall Study|Protocol Violation|0|||
149123118|NCT03538301|537927737|FG002|Overall Study|Protocol Violation|1|||
149123119|NCT03538301|537927735|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
149123120|NCT03538301|537927736|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
149123121|NCT03538301|537927737|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
149123122|NCT03616977|537927738|FG000|Period 1|Physician Decision|0|||
149123123|NCT03616977|537927739|FG001|Period 1|Physician Decision|1|||
149123124|NCT03616977|537927738|FG000|Period 3|Adverse Event|1|||
149123125|NCT03616977|537927739|FG001|Period 3|Adverse Event|1|||
149123126|NCT00515853|537927740|FG000|Overall Study|Lost to Follow-up|9|||
149123127|NCT00515853|537927741|FG001|Overall Study|Lost to Follow-up|13|||
149123128|NCT00515853|537927740|FG000|Overall Study|Withdrawal by Subject|6|||
149123129|NCT00515853|537927741|FG001|Overall Study|Withdrawal by Subject|4|||
149123130|NCT02359877|537929659|FG000|Overall Study|Withdrawal by Subject|1|||
149123131|NCT02359877|537929660|FG001|Overall Study|Withdrawal by Subject|0|||
149123132|NCT02359877|537929661|FG002|Overall Study|Withdrawal by Subject|0|||
149123133|NCT02359877|537929662|FG003|Overall Study|Withdrawal by Subject|2|||
149123134|NCT02359877|537929659|FG000|Overall Study|Adverse Event|0|||
149123135|NCT02359877|537929660|FG001|Overall Study|Adverse Event|0|||
149123136|NCT02359877|537929661|FG002|Overall Study|Adverse Event|0|||
149123137|NCT02359877|537929662|FG003|Overall Study|Adverse Event|1|||
149123138|NCT00189488|537929664|FG000|Overall Study|Ineligibility determined|1|||
149123139|NCT00189488|537929665|FG001|Overall Study|Ineligibility determined|0|||
149123140|NCT00189488|537929664|FG000|Overall Study|Protocol deviation|2|||
149123141|NCT00189488|537929665|FG001|Overall Study|Protocol deviation|1|||
149123142|NCT00189488|537929664|FG000|Overall Study|Adverse Event|2|||
149123143|NCT00189488|537929665|FG001|Overall Study|Adverse Event|1|||
149123144|NCT00189488|537929664|FG000|Overall Study|Withdrawal by Subject|2|||
149123145|NCT00189488|537929665|FG001|Overall Study|Withdrawal by Subject|6|||
149123146|NCT00189488|537929664|FG000|Overall Study|Disease progression|2|||
149123147|NCT00189488|537929665|FG001|Overall Study|Disease progression|4|||
149123148|NCT00189488|537929664|FG000|Overall Study|Administrative Decision|0|||
149123149|NCT00189488|537929665|FG001|Overall Study|Administrative Decision|2|||
149123150|NCT00189488|537929664|FG000|Overall Study|Death|5|||
149123151|NCT00189488|537929665|FG001|Overall Study|Death|8|||
149123152|NCT00189488|537929664|FG000|Overall Study|Other|1|||
149123153|NCT00189488|537929665|FG001|Overall Study|Other|0|||
149123154|NCT02349425|537929666|FG000|Period 1|Adverse Event|1|||
149123155|NCT02349425|537929667|FG001|Period 1|Adverse Event|1|||
149123156|NCT02349425|537929668|FG002|Period 1|Adverse Event|0|||
149123157|NCT02349425|537929669|FG003|Period 1|Adverse Event|0|||
149123158|NCT02349425|537929666|FG000|Period 2|Adverse Event|0|||
149123159|NCT02349425|537929667|FG001|Period 2|Adverse Event|1|||
149123160|NCT02349425|537929668|FG002|Period 2|Adverse Event|1|||
148785366|NCT01404949|536691071|FG000|Overall Study|Not Treated|1|||
149123161|NCT02349425|537929669|FG003|Period 2|Adverse Event|0|||
149123162|NCT02186223|537929670|FG000|Overall Study|Not eligible for device placement|6|||
149123163|NCT02186223|537929670|FG000|Overall Study|Unable to obtain femoral access|3|||
149123164|NCT02186223|537929670|FG000|Overall Study|Death|3|||
149123165|NCT02186223|537929670|FG000|Overall Study|Device in place less than 48 hours|9|||
149123166|NCT00252733|537929671|FG000|Overall Study|Withdrawal by Subject|73|||
149123167|NCT00252733|537929672|FG001|Overall Study|Withdrawal by Subject|67|||
149123168|NCT00252733|537929671|FG000|Overall Study|Death|7|||
149123169|NCT00252733|537929672|FG001|Overall Study|Death|5|||
149123170|NCT00252733|537929671|FG000|Overall Study|Lost to Follow-up|12|||
149123171|NCT00252733|537929672|FG001|Overall Study|Lost to Follow-up|6|||
149123172|NCT00252733|537929671|FG000|Overall Study|Multiple Reasons|14|||
149123173|NCT00252733|537929672|FG001|Overall Study|Multiple Reasons|14|||
149123174|NCT00717067|537929673|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
149123175|NCT00717067|537929674|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
149123176|NCT00717067|537929675|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
149123177|NCT00717067|537929676|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
149123178|NCT00717067|537929677|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
149123179|NCT02090959|537929678|FG000|Overall Study|Withdrawal by Subject|10|||
149123180|NCT02090959|537929678|FG000|Overall Study|Adverse Event|1|||
148785367|NCT04527978|536691077|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
148785368|NCT04527978|536691078|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
148785369|NCT00055497|536691079|FG000|Overall Study|Adverse Event|1|||
148785370|NCT00055497|536691080|FG001|Overall Study|Adverse Event|1|||
148785371|NCT00055497|536691081|FG002|Overall Study|Adverse Event|1|||
148785372|NCT00055497|536691082|FG003|Overall Study|Adverse Event|28|||
148785373|NCT00055497|536691079|FG000|Overall Study|Withdrawal by Subject|3|||
148785374|NCT00055497|536691080|FG001|Overall Study|Withdrawal by Subject|1|||
148785375|NCT00055497|536691081|FG002|Overall Study|Withdrawal by Subject|1|||
148785376|NCT00055497|536691082|FG003|Overall Study|Withdrawal by Subject|15|||
148785377|NCT00055497|536691079|FG000|Overall Study|Lost to Follow-up|0|||
148785378|NCT00055497|536691080|FG001|Overall Study|Lost to Follow-up|1|||
148785379|NCT00055497|536691081|FG002|Overall Study|Lost to Follow-up|0|||
148785380|NCT00055497|536691082|FG003|Overall Study|Lost to Follow-up|5|||
148785381|NCT00055497|536691079|FG000|Overall Study|Protocol Violation|0|||
148785382|NCT00055497|536691080|FG001|Overall Study|Protocol Violation|0|||
148785383|NCT00055497|536691081|FG002|Overall Study|Protocol Violation|0|||
148785384|NCT00055497|536691082|FG003|Overall Study|Protocol Violation|3|||
148785385|NCT00055497|536691079|FG000|Overall Study|Lack of Efficacy|1|||
148785386|NCT00055497|536691080|FG001|Overall Study|Lack of Efficacy|0|||
148785387|NCT00055497|536691081|FG002|Overall Study|Lack of Efficacy|0|||
148785388|NCT00055497|536691082|FG003|Overall Study|Lack of Efficacy|27|||
148785389|NCT00055497|536691079|FG000|Overall Study|Administrative Reasons|0|||
148785390|NCT00055497|536691080|FG001|Overall Study|Administrative Reasons|0|||
148785391|NCT00055497|536691081|FG002|Overall Study|Administrative Reasons|0|||
148785392|NCT00055497|536691082|FG003|Overall Study|Administrative Reasons|1|||
148785393|NCT00055497|536691079|FG000|Overall Study|Other|0|||
148785394|NCT00055497|536691080|FG001|Overall Study|Other|0|||
148785395|NCT00055497|536691081|FG002|Overall Study|Other|0|||
148785396|NCT00055497|536691082|FG003|Overall Study|Other|11|||
148785397|NCT00731731|536691084|FG000|Overall Study|Protocol Violation|0|||
148785398|NCT00731731|536691085|FG001|Overall Study|Protocol Violation|0|||
148785399|NCT00731731|536691086|FG002|Overall Study|Protocol Violation|1|||
148785400|NCT00731731|536691084|FG000|Overall Study|Cancel prior to treatment|0|||
148785401|NCT00731731|536691085|FG001|Overall Study|Cancel prior to treatment|0|||
148785402|NCT00731731|536691086|FG002|Overall Study|Cancel prior to treatment|2|||
148785403|NCT02112877|536691087|FG000|Overall Study|Withdrawal by Subject|1|||
148785404|NCT02112877|536691088|FG001|Overall Study|Withdrawal by Subject|7|||
148785405|NCT02112877|536691087|FG000|Overall Study|Visit Missed|1|||
148785406|NCT02112877|536691088|FG001|Overall Study|Visit Missed|6|||
148785407|NCT01429441|536691089|FG000|Overall Study|Adverse Event|5|||
148785408|NCT01429441|536691090|FG001|Overall Study|Adverse Event|1|||
148785409|NCT01429441|536691089|FG000|Overall Study|Death|0|||
148785410|NCT01429441|536691090|FG001|Overall Study|Death|2|||
148785411|NCT01429441|536691089|FG000|Overall Study|Lost to Follow-up|5|||
148785412|NCT01429441|536691090|FG001|Overall Study|Lost to Follow-up|2|||
148785413|NCT01429441|536691089|FG000|Overall Study|Physician Decision|1|||
148785414|NCT01429441|536691090|FG001|Overall Study|Physician Decision|0|||
148785415|NCT01429441|536691089|FG000|Overall Study|Withdrawal by Subject|27|||
148785416|NCT01429441|536691090|FG001|Overall Study|Withdrawal by Subject|18|||
148785417|NCT01578499|536691095|FG000|Overall Study|Reason not Specified|0|||
148785418|NCT01578499|536691096|FG001|Overall Study|Reason not Specified|1|||
148785419|NCT01578499|536691095|FG000|Overall Study|Lost to Follow-up|2|||
148785420|NCT01578499|536691096|FG001|Overall Study|Lost to Follow-up|1|||
148785421|NCT01578499|536691095|FG000|Overall Study|Withdrawal by Subject|10|||
148785422|NCT01578499|536691096|FG001|Overall Study|Withdrawal by Subject|16|||
148785423|NCT01578499|536691095|FG000|Overall Study|Death|20|||
148785424|NCT01578499|536691096|FG001|Overall Study|Death|25|||
148785425|NCT01578499|536691095|FG000|Overall Study|Died and End of Study Page not Completed|2|||
148785426|NCT01578499|536691096|FG001|Overall Study|Died and End of Study Page not Completed|0|||
148785427|NCT01606748|536691097|FG000|Overall Study|Adverse Event|1|||
148785428|NCT01606748|536691098|FG001|Overall Study|Adverse Event|0|||
148785429|NCT01606748|536691097|FG000|Overall Study|Progressive Disease|1|||
148785430|NCT01606748|536691098|FG001|Overall Study|Progressive Disease|0|||
148785431|NCT01606748|536691097|FG000|Overall Study|Withdrawal by Subject|1|||
148785432|NCT01606748|536691098|FG001|Overall Study|Withdrawal by Subject|0|||
148785433|NCT00621517|536691102|FG000|Overall Study|Lost to Follow-up|3|||
148785434|NCT00621517|536691103|FG001|Overall Study|Lost to Follow-up|3|||
148785435|NCT00621517|536691102|FG000|Overall Study|Withdrawal by Subject|3|||
148785436|NCT00621517|536691103|FG001|Overall Study|Withdrawal by Subject|4|||
148785437|NCT00621517|536691102|FG000|Overall Study|Adverse Event|1|||
148785438|NCT00621517|536691103|FG001|Overall Study|Adverse Event|0|||
148785439|NCT01863732|536691104|FG000|Overall Study|Adverse Event|2|||
148785440|NCT01863732|536691105|FG001|Overall Study|Adverse Event|0|||
148785441|NCT01863732|536691106|FG002|Overall Study|Adverse Event|3|||
148785442|NCT01863732|536691107|FG003|Overall Study|Adverse Event|3|||
148785443|NCT01863732|536691104|FG000|Overall Study|Lack of Efficacy|1|||
148785444|NCT01863732|536691105|FG001|Overall Study|Lack of Efficacy|0|||
148785445|NCT01863732|536691106|FG002|Overall Study|Lack of Efficacy|2|||
148785446|NCT01863732|536691107|FG003|Overall Study|Lack of Efficacy|1|||
148785447|NCT01863732|536691104|FG000|Overall Study|Lost to Follow-up|2|||
148785448|NCT01863732|536691105|FG001|Overall Study|Lost to Follow-up|2|||
148785449|NCT01863732|536691106|FG002|Overall Study|Lost to Follow-up|1|||
148785450|NCT01863732|536691107|FG003|Overall Study|Lost to Follow-up|1|||
148785451|NCT01863732|536691104|FG000|Overall Study|Physician Decision|1|||
148785452|NCT01863732|536691105|FG001|Overall Study|Physician Decision|0|||
148785453|NCT01863732|536691106|FG002|Overall Study|Physician Decision|1|||
148785454|NCT01863732|536691107|FG003|Overall Study|Physician Decision|0|||
148785455|NCT01863732|536691104|FG000|Overall Study|Pregnancy|0|||
148785456|NCT01863732|536691105|FG001|Overall Study|Pregnancy|0|||
148785457|NCT01863732|536691106|FG002|Overall Study|Pregnancy|0|||
148785458|NCT01863732|536691107|FG003|Overall Study|Pregnancy|1|||
148785459|NCT01863732|536691104|FG000|Overall Study|Technical problems|0|||
148785460|NCT01863732|536691105|FG001|Overall Study|Technical problems|1|||
148785461|NCT01863732|536691106|FG002|Overall Study|Technical problems|1|||
148785462|NCT01863732|536691107|FG003|Overall Study|Technical problems|0|||
148785463|NCT01863732|536691104|FG000|Overall Study|Subject/guardian decision|6|||
148785464|NCT01863732|536691105|FG001|Overall Study|Subject/guardian decision|9|||
148785465|NCT01863732|536691106|FG002|Overall Study|Subject/guardian decision|3|||
148785466|NCT01863732|536691107|FG003|Overall Study|Subject/guardian decision|1|||
148785467|NCT01863732|536691104|FG000|Overall Study|Death|1|||
148785468|NCT01863732|536691105|FG001|Overall Study|Death|0|||
148785469|NCT01863732|536691106|FG002|Overall Study|Death|0|||
148785470|NCT01863732|536691107|FG003|Overall Study|Death|1|||
148785471|NCT03084315|536691108|FG000|Overall Study|Lost to Follow-up|8|||
148785472|NCT03084315|536691109|FG001|Overall Study|Lost to Follow-up|7|||
148785473|NCT03084315|536691108|FG000|Overall Study|Withdrawal by Subject|2|||
148785474|NCT03084315|536691109|FG001|Overall Study|Withdrawal by Subject|2|||
148785475|NCT01421147|536692395|FG000|Treatment Period|Adverse Event|2|||
148785476|NCT01421147|536692396|FG001|Treatment Period|Adverse Event|3|||
148785477|NCT01421147|536692395|FG000|Treatment Period|Lost to Follow-up|2|||
148785478|NCT01421147|536692396|FG001|Treatment Period|Lost to Follow-up|1|||
148785479|NCT01421147|536692395|FG000|Treatment Period|Physician Decision|2|||
148785480|NCT01421147|536692396|FG001|Treatment Period|Physician Decision|2|||
148785481|NCT01421147|536692395|FG000|Treatment Period|Withdrawal by Subject|10|||
148785482|NCT01421147|536692396|FG001|Treatment Period|Withdrawal by Subject|5|||
148785483|NCT01421147|536692395|FG000|Extension Period|Adverse Event|0|||
148785484|NCT01421147|536692396|FG001|Extension Period|Adverse Event|2|||
148785485|NCT01421147|536692395|FG000|Extension Period|Death|0|||
148785486|NCT01421147|536692396|FG001|Extension Period|Death|1|||
148785487|NCT01421147|536692395|FG000|Extension Period|Lost to Follow-up|2|||
148785488|NCT01421147|536692396|FG001|Extension Period|Lost to Follow-up|5|||
148785489|NCT01421147|536692395|FG000|Extension Period|Physician Decision|1|||
148785490|NCT01421147|536692396|FG001|Extension Period|Physician Decision|0|||
148785491|NCT01421147|536692395|FG000|Extension Period|Withdrawal by Subject|5|||
148785492|NCT01421147|536692396|FG001|Extension Period|Withdrawal by Subject|3|||
148785493|NCT00171158|536692399|FG000|Core Study|Death|27|||
148785494|NCT00171158|536692399|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
148785495|NCT00171158|536692399|FG000|Core Study|Protocol Violation|4|||
149123181|NCT02090959|537929678|FG000|Overall Study|Investigator decision|2|||
149123182|NCT02090959|537929678|FG000|Overall Study|Study termination|6|||
149123183|NCT02090959|537929678|FG000|Overall Study|Enrolled but not treated|1|||
149123184|NCT02090959|537929678|FG000|Overall Study|Transfer for compassionate use medicine|4|||
148785496|NCT00171158|536692399|FG000|Core Study|Administrative problems|1|||
148785497|NCT00171158|536692399|FG000|Core Study|Adverse event, non-fatal|21|||
148785498|NCT00171158|536692399|FG000|Core Study|Consent withdrawn by subject|6|||
148785499|NCT00171158|536692399|FG000|Core Study|No longer required drug (BMT)|14|||
148785500|NCT00171158|536692399|FG000|Core Study|Abnormal Laboratory Values|2|||
148785501|NCT00171158|536692399|FG000|Core Study|Lost to Follow-up|1|||
148785502|NCT00171158|536692399|FG000|E2 Extension|Other|7|||
148785503|NCT02757352|536692401|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
149123185|NCT02090959|537929678|FG000|Overall Study|Move to medical need program|3|||
148785504|NCT02757352|536692402|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
149123186|NCT02090959|537929678|FG000|Overall Study|Entered in to other study|34|||
148785505|NCT02757352|536692403|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
148785506|NCT02757352|536692404|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785507|NCT02757352|536692405|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785508|NCT02757352|536692406|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785509|NCT02757352|536692407|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785510|NCT02757352|536692408|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785511|NCT02757352|536692409|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785512|NCT02757352|536692410|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
148785513|NCT02757352|536692401|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785514|NCT02757352|536692402|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785515|NCT02757352|536692403|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
148785516|NCT02757352|536692404|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785517|NCT02757352|536692405|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785518|NCT02757352|536692406|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785519|NCT02757352|536692407|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785520|NCT02757352|536692408|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785521|NCT02757352|536692409|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785522|NCT02757352|536692410|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
148785523|NCT02757352|536692401|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
148785524|NCT02757352|536692402|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
148785525|NCT02757352|536692403|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
148785526|NCT02757352|536692404|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785527|NCT02757352|536692405|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785528|NCT02757352|536692406|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785529|NCT02757352|536692407|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785530|NCT02757352|536692408|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785531|NCT02757352|536692409|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785532|NCT02757352|536692410|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
148785533|NCT02757352|536692401|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785534|NCT02757352|536692402|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
148785535|NCT02757352|536692403|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785536|NCT02757352|536692404|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785537|NCT02757352|536692405|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785538|NCT02757352|536692406|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785539|NCT02757352|536692407|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785540|NCT02757352|536692408|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785541|NCT02757352|536692409|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785542|NCT02757352|536692410|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
148785543|NCT02757352|536692401|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785544|NCT02757352|536692402|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
148785545|NCT02757352|536692403|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785546|NCT02757352|536692404|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785547|NCT02757352|536692405|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785548|NCT02757352|536692406|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785549|NCT02757352|536692407|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785550|NCT02757352|536692408|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785551|NCT02757352|536692409|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785552|NCT02757352|536692410|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785553|NCT02757352|536692401|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
148785554|NCT02757352|536692402|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
148785555|NCT02757352|536692403|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
148785556|NCT02757352|536692404|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785557|NCT02757352|536692405|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785558|NCT02757352|536692406|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785559|NCT02757352|536692407|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
149123187|NCT02090959|537929678|FG000|Overall Study|Switched to commercial supply|88|||
148785560|NCT02757352|536692408|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148893358|NCT00683878|537088678|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
149123188|NCT02090959|537929678|FG000|Overall Study|Other than specified|2|||
149123189|NCT02808143|537929679|FG000|Maintenance Phase|Disease recurrence|1|||
149123190|NCT02808143|537929680|FG001|Maintenance Phase|Disease recurrence|3|||
149123191|NCT02808143|537929679|FG000|Maintenance Phase|Disease progression|1|||
149123192|NCT02808143|537929680|FG001|Maintenance Phase|Disease progression|2|||
149123193|NCT02808143|537929679|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
149123194|NCT02808143|537929680|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
149123195|NCT02808143|537929679|FG000|Survival Follow-Up|Disease recurrence|0|||
149123196|NCT02808143|537929680|FG001|Survival Follow-Up|Disease recurrence|2|||
149123197|NCT02808143|537929679|FG000|Survival Follow-Up|Adverse Event|0|||
149123198|NCT02808143|537929680|FG001|Survival Follow-Up|Adverse Event|1|||
149123199|NCT02808143|537929679|FG000|Survival Follow-Up|Death|1|||
149123200|NCT02808143|537929680|FG001|Survival Follow-Up|Death|0|||
149123201|NCT00522873|537929683|FG000|Overall Study|Adverse Event|41|||
149123202|NCT00522873|537929684|FG001|Overall Study|Adverse Event|26|||
149123203|NCT00522873|537929683|FG000|Overall Study|Withdrawal by Subject|20|||
148785561|NCT02757352|536692409|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785562|NCT02757352|536692410|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785563|NCT02757352|536692401|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
148785564|NCT02757352|536692402|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
148785565|NCT02757352|536692403|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
148785566|NCT02757352|536692404|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785567|NCT02757352|536692405|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785568|NCT02757352|536692406|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785569|NCT02757352|536692407|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785570|NCT02757352|536692408|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785571|NCT02757352|536692409|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785572|NCT02757352|536692410|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
148785573|NCT02757352|536692401|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785574|NCT02757352|536692402|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785575|NCT02757352|536692403|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785576|NCT02757352|536692404|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
148785577|NCT02757352|536692405|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785578|NCT02757352|536692406|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
148785579|NCT02757352|536692407|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785580|NCT02757352|536692408|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785581|NCT02757352|536692409|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785582|NCT02757352|536692410|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
148785583|NCT02757352|536692401|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785584|NCT02757352|536692402|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785585|NCT02757352|536692403|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785586|NCT02757352|536692404|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
148785587|NCT02757352|536692405|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
148785588|NCT02757352|536692406|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
148785589|NCT02757352|536692407|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785590|NCT02757352|536692408|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785591|NCT02757352|536692409|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785592|NCT02757352|536692410|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148785593|NCT02757352|536692401|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785594|NCT02757352|536692402|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785595|NCT02757352|536692403|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785596|NCT02757352|536692404|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785597|NCT02757352|536692405|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
148785598|NCT02757352|536692406|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785599|NCT02757352|536692407|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785600|NCT02757352|536692408|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785601|NCT02757352|536692409|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785602|NCT02757352|536692410|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
148785603|NCT02757352|536692401|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785604|NCT02757352|536692402|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785605|NCT02757352|536692403|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785606|NCT02757352|536692404|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785607|NCT02757352|536692405|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785608|NCT02757352|536692406|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
148785609|NCT02757352|536692407|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785610|NCT02757352|536692408|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785611|NCT02757352|536692409|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785612|NCT02757352|536692410|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
148785613|NCT02757352|536692401|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785614|NCT02757352|536692402|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785615|NCT02757352|536692403|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785616|NCT02757352|536692404|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
148785617|NCT02757352|536692405|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
149123204|NCT00522873|537929684|FG001|Overall Study|Withdrawal by Subject|9|||
148785618|NCT02757352|536692406|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
148785619|NCT02757352|536692407|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785620|NCT02757352|536692408|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785621|NCT02757352|536692409|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785622|NCT02757352|536692410|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148785623|NCT02757352|536692401|FG000|Follow-Up Period|Adverse Event|0|||
148785624|NCT02757352|536692402|FG001|Follow-Up Period|Adverse Event|0|||
148785625|NCT02757352|536692403|FG002|Follow-Up Period|Adverse Event|0|||
148785626|NCT02757352|536692404|FG003|Follow-Up Period|Adverse Event|0|||
148785627|NCT02757352|536692405|FG004|Follow-Up Period|Adverse Event|0|||
148785628|NCT02757352|536692406|FG005|Follow-Up Period|Adverse Event|0|||
148785629|NCT02757352|536692407|FG006|Follow-Up Period|Adverse Event|1|||
148785630|NCT02757352|536692408|FG007|Follow-Up Period|Adverse Event|0|||
148785631|NCT02757352|536692409|FG008|Follow-Up Period|Adverse Event|2|||
148785632|NCT02757352|536692410|FG009|Follow-Up Period|Adverse Event|0|||
148785633|NCT02757352|536692401|FG000|Follow-Up Period|Lost to Follow-up|0|||
148785634|NCT02757352|536692402|FG001|Follow-Up Period|Lost to Follow-up|0|||
148785635|NCT02757352|536692403|FG002|Follow-Up Period|Lost to Follow-up|0|||
148785636|NCT02757352|536692404|FG003|Follow-Up Period|Lost to Follow-up|0|||
148785637|NCT02757352|536692405|FG004|Follow-Up Period|Lost to Follow-up|0|||
148785638|NCT02757352|536692406|FG005|Follow-Up Period|Lost to Follow-up|0|||
148785639|NCT02757352|536692407|FG006|Follow-Up Period|Lost to Follow-up|0|||
148785640|NCT02757352|536692408|FG007|Follow-Up Period|Lost to Follow-up|0|||
148785641|NCT02757352|536692409|FG008|Follow-Up Period|Lost to Follow-up|1|||
148785642|NCT02757352|536692410|FG009|Follow-Up Period|Lost to Follow-up|0|||
148785643|NCT02757352|536692401|FG000|Follow-Up Period|Lack of Efficacy|0|||
148785644|NCT02757352|536692402|FG001|Follow-Up Period|Lack of Efficacy|0|||
148785645|NCT02757352|536692403|FG002|Follow-Up Period|Lack of Efficacy|0|||
148785646|NCT02757352|536692404|FG003|Follow-Up Period|Lack of Efficacy|0|||
148785647|NCT02757352|536692405|FG004|Follow-Up Period|Lack of Efficacy|0|||
148785648|NCT02757352|536692406|FG005|Follow-Up Period|Lack of Efficacy|0|||
148785649|NCT02757352|536692407|FG006|Follow-Up Period|Lack of Efficacy|0|||
148785650|NCT02757352|536692408|FG007|Follow-Up Period|Lack of Efficacy|0|||
148785651|NCT02757352|536692409|FG008|Follow-Up Period|Lack of Efficacy|1|||
148785652|NCT02757352|536692410|FG009|Follow-Up Period|Lack of Efficacy|1|||
148785653|NCT02757352|536692401|FG000|Follow-Up Period|Withdrawal by Subject|0|||
148785654|NCT02757352|536692402|FG001|Follow-Up Period|Withdrawal by Subject|0|||
148785655|NCT02757352|536692403|FG002|Follow-Up Period|Withdrawal by Subject|0|||
148785656|NCT02757352|536692404|FG003|Follow-Up Period|Withdrawal by Subject|0|||
149123205|NCT00522873|537929683|FG000|Overall Study|Protocol Violation|14|||
149123206|NCT00522873|537929684|FG001|Overall Study|Protocol Violation|4|||
149123207|NCT00522873|537929683|FG000|Overall Study|Lost to Follow-up|11|||
149123208|NCT00522873|537929684|FG001|Overall Study|Lost to Follow-up|3|||
149123209|NCT00522873|537929683|FG000|Overall Study|Personal Reasons|8|||
149123210|NCT00522873|537929684|FG001|Overall Study|Personal Reasons|1|||
148785657|NCT02757352|536692405|FG004|Follow-Up Period|Withdrawal by Subject|0|||
148785658|NCT02757352|536692406|FG005|Follow-Up Period|Withdrawal by Subject|0|||
148785659|NCT02757352|536692407|FG006|Follow-Up Period|Withdrawal by Subject|0|||
148785660|NCT02757352|536692408|FG007|Follow-Up Period|Withdrawal by Subject|1|||
148785661|NCT02757352|536692409|FG008|Follow-Up Period|Withdrawal by Subject|6|||
148785662|NCT02757352|536692410|FG009|Follow-Up Period|Withdrawal by Subject|2|||
148785663|NCT00497146|536692412|FG000|Treatment Period|Adverse Event|6|||
148785664|NCT00497146|536692413|FG001|Treatment Period|Adverse Event|2|||
148785665|NCT00497146|536692412|FG000|Treatment Period|Withdrawal by Subject|5|||
148785666|NCT00497146|536692413|FG001|Treatment Period|Withdrawal by Subject|9|||
148785667|NCT00497146|536692412|FG000|Treatment Period|Lost to Follow-up|1|||
148785668|NCT00497146|536692413|FG001|Treatment Period|Lost to Follow-up|3|||
148785669|NCT00497146|536692412|FG000|Treatment Period|Required dialysis|4|||
148785670|NCT00497146|536692413|FG001|Treatment Period|Required dialysis|1|||
148785671|NCT00497146|536692412|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
148785672|NCT00497146|536692413|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
148785673|NCT00497146|536692412|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
148785674|NCT00497146|536692413|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
148785675|NCT00497146|536692412|FG000|Treatment Period|Other Reason|2|||
148785676|NCT00497146|536692413|FG001|Treatment Period|Other Reason|3|||
148785677|NCT00497146|536692412|FG000|Long-term Follow-up Period|Adverse Event|2|||
149123211|NCT00522873|537929683|FG000|Overall Study|Medication Errors|1|||
149123212|NCT00522873|537929684|FG001|Overall Study|Medication Errors|1|||
148785678|NCT00497146|536692413|FG001|Long-term Follow-up Period|Adverse Event|2|||
148785679|NCT00497146|536692412|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
148785680|NCT00497146|536692413|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
148785681|NCT00497146|536692412|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
148785682|NCT00497146|536692413|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
148785683|NCT00497146|536692412|FG000|Long-term Follow-up Period|Other|0|||
148785684|NCT00497146|536692413|FG001|Long-term Follow-up Period|Other|1|||
148785685|NCT01471444|536692414|FG000|Overall Study|Physician Decision|3|||
149123213|NCT00522873|537929683|FG000|Overall Study|Never Received Medication|1|||
148785686|NCT01471444|536692415|FG001|Overall Study|Physician Decision|2|||
148785687|NCT01471444|536692414|FG000|Overall Study|Withdrawal by Subject|0|||
148785688|NCT01471444|536692415|FG001|Overall Study|Withdrawal by Subject|1|||
148785689|NCT01214668|536692421|FG000|Overall Study|Adverse Event|0|||
148785690|NCT01214668|536692422|FG001|Overall Study|Adverse Event|1|||
148785691|NCT01214668|536692423|FG002|Overall Study|Adverse Event|0|||
148785692|NCT01214668|536692424|FG003|Overall Study|Adverse Event|2|||
148785693|NCT01214668|536692425|FG004|Overall Study|Adverse Event|1|||
148785694|NCT01214668|536692426|FG005|Overall Study|Adverse Event|1|||
148785695|NCT01214668|536692421|FG000|Overall Study|Death|0|||
148785696|NCT01214668|536692422|FG001|Overall Study|Death|0|||
148785697|NCT01214668|536692423|FG002|Overall Study|Death|1|||
148785698|NCT01214668|536692424|FG003|Overall Study|Death|0|||
148785699|NCT01214668|536692425|FG004|Overall Study|Death|0|||
148785700|NCT01214668|536692426|FG005|Overall Study|Death|0|||
148785701|NCT01214668|536692421|FG000|Overall Study|Progressive Disease|4|||
148785702|NCT01214668|536692422|FG001|Overall Study|Progressive Disease|2|||
148785703|NCT01214668|536692423|FG002|Overall Study|Progressive Disease|5|||
148785704|NCT01214668|536692424|FG003|Overall Study|Progressive Disease|4|||
148785705|NCT01214668|536692425|FG004|Overall Study|Progressive Disease|4|||
148785706|NCT01214668|536692426|FG005|Overall Study|Progressive Disease|5|||
148785707|NCT01214668|536692421|FG000|Overall Study|Withdrawal by Subject|0|||
148785708|NCT01214668|536692422|FG001|Overall Study|Withdrawal by Subject|0|||
148785709|NCT01214668|536692423|FG002|Overall Study|Withdrawal by Subject|0|||
148785710|NCT01214668|536692424|FG003|Overall Study|Withdrawal by Subject|0|||
148785711|NCT01214668|536692425|FG004|Overall Study|Withdrawal by Subject|1|||
148785712|NCT01214668|536692426|FG005|Overall Study|Withdrawal by Subject|0|||
148785713|NCT02769312|536692427|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
148785714|NCT02769312|536692428|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
148785715|NCT02769312|536692427|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
148785716|NCT02769312|536692428|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
148785717|NCT02769312|536692427|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
148785718|NCT02769312|536692428|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
148785719|NCT02769312|536692427|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
148785720|NCT02769312|536692428|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
148785721|NCT02769312|536692427|FG000|Follow-up|Lost to Follow-up|1|||
148785722|NCT02769312|536692428|FG001|Follow-up|Lost to Follow-up|1|||
148785723|NCT02496039|536692433|FG000|Overall Study|Adverse Event|3|||
148785724|NCT02496039|536692433|FG000|Overall Study|Protocol Violation|1|||
148785725|NCT03297021|536692434|FG000|Overall Study|Incomplete/illegible data sheet|4|||
148785726|NCT03297021|536692435|FG001|Overall Study|Incomplete/illegible data sheet|2|||
148785727|NCT03297021|536692436|FG002|Overall Study|Incomplete/illegible data sheet|3|||
148785728|NCT03297021|536692434|FG000|Overall Study|Missing Post-Op Data|1|||
148785729|NCT03297021|536692435|FG001|Overall Study|Missing Post-Op Data|2|||
148785730|NCT03297021|536692436|FG002|Overall Study|Missing Post-Op Data|1|||
148785731|NCT02734862|536692437|FG000|Part A|Death|3|||
148785732|NCT02734862|536692438|FG001|Part A|Death|4|||
148785733|NCT02734862|536692439|FG002|Part A|Death|6|||
148785734|NCT02734862|536692437|FG000|Part A|Lost to Follow-up|2|||
148785735|NCT02734862|536692438|FG001|Part A|Lost to Follow-up|1|||
148785736|NCT02734862|536692439|FG002|Part A|Lost to Follow-up|1|||
148785737|NCT02734862|536692437|FG000|Part A|Withdrawal by Subject|1|||
148785738|NCT02734862|536692438|FG001|Part A|Withdrawal by Subject|1|||
148785739|NCT02734862|536692439|FG002|Part A|Withdrawal by Subject|2|||
148785740|NCT02734862|536692437|FG000|Part A|Physician Decision|2|||
148785741|NCT02734862|536692438|FG001|Part A|Physician Decision|0|||
149123214|NCT00522873|537929684|FG001|Overall Study|Never Received Medication|0|||
149123215|NCT00657020|537929685|FG000|PERIOD 1|Adverse Event|0|||
148785742|NCT02734862|536692439|FG002|Part A|Physician Decision|1|||
149123216|NCT00657020|537929686|FG001|PERIOD 1|Adverse Event|1|||
149123217|NCT02029846|537929689|FG000|Overall Study|n=1 each arm|1|||
148785743|NCT02734862|536692437|FG000|Part A|Adverse Event|2|||
148785744|NCT02734862|536692438|FG001|Part A|Adverse Event|0|||
148785745|NCT02734862|536692439|FG002|Part A|Adverse Event|1|||
148785746|NCT02734862|536692437|FG000|Part A|Noncompliance|1|||
148785747|NCT02734862|536692438|FG001|Part A|Noncompliance|1|||
148785748|NCT02734862|536692439|FG002|Part A|Noncompliance|0|||
148785749|NCT02734862|536692437|FG000|Part A|Other|1|||
148785750|NCT02734862|536692438|FG001|Part A|Other|1|||
148785751|NCT02734862|536692439|FG002|Part A|Other|3|||
148785752|NCT02734862|536692437|FG000|Part B|Death|8|||
148785753|NCT02734862|536692438|FG001|Part B|Death|3|||
148785754|NCT02734862|536692439|FG002|Part B|Death|5|||
148785755|NCT02734862|536692437|FG000|Part B|Lost to Follow-up|2|||
149123218|NCT02029846|537929690|FG001|Overall Study|n=1 each arm|1|||
148785756|NCT02734862|536692438|FG001|Part B|Lost to Follow-up|2|||
148785757|NCT02734862|536692439|FG002|Part B|Lost to Follow-up|0|||
148785758|NCT02734862|536692437|FG000|Part B|Withdrawal by Subject|3|||
148785759|NCT02734862|536692438|FG001|Part B|Withdrawal by Subject|1|||
148785760|NCT02734862|536692439|FG002|Part B|Withdrawal by Subject|0|||
149123219|NCT02966301|537929691|FG000|Overall Study|Death|2|||
148785761|NCT02734862|536692437|FG000|Part B|Other|0|||
148785762|NCT02734862|536692438|FG001|Part B|Other|1|||
148785763|NCT02734862|536692439|FG002|Part B|Other|0|||
148785764|NCT00645671|536692440|FG000|Overall Study|Protocol Violation|1|||
148785765|NCT00645671|536692441|FG001|Overall Study|Protocol Violation|0|||
148785766|NCT00645671|536692440|FG000|Overall Study|Withdrawal by Subject|0|||
148785767|NCT00645671|536692441|FG001|Overall Study|Withdrawal by Subject|4|||
148785768|NCT00645671|536692440|FG000|Overall Study|Adverse Event|0|||
148785769|NCT00645671|536692441|FG001|Overall Study|Adverse Event|1|||
148785770|NCT00645671|536692440|FG000|Overall Study|Physician Decision|0|||
148785771|NCT00645671|536692441|FG001|Overall Study|Physician Decision|1|||
148785772|NCT00790556|536692442|FG000|Treatment Period 1|Physician Decision|1|||
148785773|NCT00790556|536692443|FG001|Treatment Period 1|Physician Decision|0|||
148785774|NCT00790556|536692442|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148785775|NCT00790556|536692443|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148785776|NCT00255840|536692444|FG000|Overall Study|Lost to Follow-up|10|||
148785777|NCT00255840|536692445|FG001|Overall Study|Lost to Follow-up|14|||
148785778|NCT00255840|536692444|FG000|Overall Study|Discontinued intervention|53|||
148785779|NCT00255840|536692445|FG001|Overall Study|Discontinued intervention|56|||
148785780|NCT00339833|536692448|FG000|Overall Study|Withdrawal by Subject|1|||
148785781|NCT00339833|536692449|FG001|Overall Study|Withdrawal by Subject|2|||
148785782|NCT00339833|536692448|FG000|Overall Study|toothache|0|||
148785783|NCT00339833|536692449|FG001|Overall Study|toothache|1|||
149123220|NCT02966301|537929691|FG000|Overall Study|Withdrawal by Subject|1|||
149123221|NCT00370331|537929697|FG000|Overall Study|Adverse Event|4|||
149123222|NCT00370331|537929698|FG001|Overall Study|Adverse Event|13|||
149123223|NCT00370331|537929697|FG000|Overall Study|Withdrawal by Subject|2|||
149123224|NCT00370331|537929698|FG001|Overall Study|Withdrawal by Subject|4|||
149123225|NCT00370331|537929697|FG000|Overall Study|Lost to Follow-up|0|||
149123226|NCT00370331|537929698|FG001|Overall Study|Lost to Follow-up|3|||
149123227|NCT00370331|537929697|FG000|Overall Study|Lack of Efficacy|0|||
149123228|NCT00370331|537929698|FG001|Overall Study|Lack of Efficacy|1|||
149123229|NCT00370331|537929697|FG000|Overall Study|Non-compliance|0|||
149123230|NCT00370331|537929698|FG001|Overall Study|Non-compliance|1|||
149123231|NCT00370331|537929697|FG000|Overall Study|Protocol Violation|1|||
149123232|NCT00370331|537929698|FG001|Overall Study|Protocol Violation|1|||
149123233|NCT01874431|537929699|FG000|Overall Study|Physician Decision|0|||
149123234|NCT01874431|537929700|FG001|Overall Study|Physician Decision|0|||
149123235|NCT01874431|537929701|FG002|Overall Study|Physician Decision|1|||
149123236|NCT01874431|537929702|FG003|Overall Study|Physician Decision|0|||
149123237|NCT01874431|537929703|FG004|Overall Study|Physician Decision|0|||
149123238|NCT01874431|537929704|FG005|Overall Study|Physician Decision|0|||
149123239|NCT01874431|537929705|FG006|Overall Study|Physician Decision|0|||
149123240|NCT01874431|537929706|FG007|Overall Study|Physician Decision|0|||
149123241|NCT01874431|537929699|FG000|Overall Study|Adverse Event|5|||
149123242|NCT01874431|537929700|FG001|Overall Study|Adverse Event|4|||
149123243|NCT01874431|537929701|FG002|Overall Study|Adverse Event|6|||
149123244|NCT01874431|537929702|FG003|Overall Study|Adverse Event|5|||
149123245|NCT01874431|537929703|FG004|Overall Study|Adverse Event|2|||
149123246|NCT01874431|537929704|FG005|Overall Study|Adverse Event|8|||
149123247|NCT01874431|537929705|FG006|Overall Study|Adverse Event|2|||
149123248|NCT01874431|537929706|FG007|Overall Study|Adverse Event|3|||
149123249|NCT01874431|537929699|FG000|Overall Study|Protocol Violation|1|||
149123250|NCT01874431|537929700|FG001|Overall Study|Protocol Violation|1|||
149123251|NCT01874431|537929701|FG002|Overall Study|Protocol Violation|1|||
149123252|NCT01874431|537929702|FG003|Overall Study|Protocol Violation|0|||
149123253|NCT01874431|537929703|FG004|Overall Study|Protocol Violation|3|||
149123254|NCT01874431|537929704|FG005|Overall Study|Protocol Violation|2|||
149123255|NCT01874431|537929705|FG006|Overall Study|Protocol Violation|1|||
149123256|NCT01874431|537929706|FG007|Overall Study|Protocol Violation|1|||
149123257|NCT01874431|537929699|FG000|Overall Study|Non-compliance|0|||
149123258|NCT01874431|537929700|FG001|Overall Study|Non-compliance|0|||
149123259|NCT01874431|537929701|FG002|Overall Study|Non-compliance|0|||
149123260|NCT01874431|537929702|FG003|Overall Study|Non-compliance|0|||
148785784|NCT00339833|536692448|FG000|Overall Study|indigestion|0|||
148785785|NCT00339833|536692449|FG001|Overall Study|indigestion|1|||
149123261|NCT01874431|537929703|FG004|Overall Study|Non-compliance|1|||
149123262|NCT01874431|537929704|FG005|Overall Study|Non-compliance|0|||
149123263|NCT01874431|537929705|FG006|Overall Study|Non-compliance|1|||
149123264|NCT01874431|537929706|FG007|Overall Study|Non-compliance|0|||
148785786|NCT00339833|536692448|FG000|Overall Study|Chest pain|0|||
148785787|NCT00339833|536692449|FG001|Overall Study|Chest pain|1|||
148785788|NCT00339833|536692448|FG000|Overall Study|minor infection|0|||
148893359|NCT00683878|537088679|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
149123265|NCT01874431|537929699|FG000|Overall Study|Logistical difficulties|0|||
148893360|NCT00683878|537088680|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
149123266|NCT01874431|537929700|FG001|Overall Study|Logistical difficulties|0|||
149123267|NCT01874431|537929701|FG002|Overall Study|Logistical difficulties|0|||
148785789|NCT00339833|536692449|FG001|Overall Study|minor infection|1|||
149123268|NCT01874431|537929702|FG003|Overall Study|Logistical difficulties|0|||
149123269|NCT01874431|537929703|FG004|Overall Study|Logistical difficulties|0|||
149123270|NCT01874431|537929704|FG005|Overall Study|Logistical difficulties|0|||
149123271|NCT01874431|537929705|FG006|Overall Study|Logistical difficulties|1|||
149123272|NCT01874431|537929706|FG007|Overall Study|Logistical difficulties|0|||
149123273|NCT01874431|537929699|FG000|Overall Study|Withdrawal by Subject|0|||
149123274|NCT01874431|537929700|FG001|Overall Study|Withdrawal by Subject|0|||
149123275|NCT01874431|537929701|FG002|Overall Study|Withdrawal by Subject|1|||
149123276|NCT01874431|537929702|FG003|Overall Study|Withdrawal by Subject|2|||
149123277|NCT01874431|537929703|FG004|Overall Study|Withdrawal by Subject|1|||
149123278|NCT01874431|537929704|FG005|Overall Study|Withdrawal by Subject|1|||
149123279|NCT01874431|537929705|FG006|Overall Study|Withdrawal by Subject|3|||
149123280|NCT01874431|537929706|FG007|Overall Study|Withdrawal by Subject|0|||
149123281|NCT01874431|537929699|FG000|Overall Study|Sponsor decision|0|||
149123282|NCT01874431|537929700|FG001|Overall Study|Sponsor decision|0|||
149123283|NCT01874431|537929701|FG002|Overall Study|Sponsor decision|0|||
149123284|NCT01874431|537929702|FG003|Overall Study|Sponsor decision|0|||
149123285|NCT01874431|537929703|FG004|Overall Study|Sponsor decision|1|||
149123286|NCT01874431|537929704|FG005|Overall Study|Sponsor decision|0|||
149123287|NCT01874431|537929705|FG006|Overall Study|Sponsor decision|0|||
149123288|NCT01874431|537929706|FG007|Overall Study|Sponsor decision|0|||
149123289|NCT01874431|537929699|FG000|Overall Study|Lost to Follow-up|0|||
149123290|NCT01874431|537929700|FG001|Overall Study|Lost to Follow-up|0|||
149123291|NCT01874431|537929701|FG002|Overall Study|Lost to Follow-up|1|||
149123292|NCT01874431|537929702|FG003|Overall Study|Lost to Follow-up|0|||
149123293|NCT01874431|537929703|FG004|Overall Study|Lost to Follow-up|0|||
149123294|NCT01874431|537929704|FG005|Overall Study|Lost to Follow-up|0|||
149123295|NCT01874431|537929705|FG006|Overall Study|Lost to Follow-up|0|||
149123296|NCT01874431|537929706|FG007|Overall Study|Lost to Follow-up|0|||
149123297|NCT02937454|537929709|FG000|Overall Study|Adverse Event|0|||
149123298|NCT02937454|537929710|FG001|Overall Study|Adverse Event|1|||
149123299|NCT02937454|537929709|FG000|Overall Study|Death|98|||
149123300|NCT02937454|537929710|FG001|Overall Study|Death|95|||
149123301|NCT02937454|537929709|FG000|Overall Study|Lost to Follow-up|1|||
149123302|NCT02937454|537929710|FG001|Overall Study|Lost to Follow-up|1|||
149123303|NCT02937454|537929709|FG000|Overall Study|Physician Decision|0|||
149123304|NCT02937454|537929710|FG001|Overall Study|Physician Decision|1|||
149123305|NCT02937454|537929709|FG000|Overall Study|Protocol Violation|6|||
149123306|NCT02937454|537929710|FG001|Overall Study|Protocol Violation|10|||
149123307|NCT02937454|537929709|FG000|Overall Study|Withdrawal by Subject|27|||
149123308|NCT02937454|537929710|FG001|Overall Study|Withdrawal by Subject|15|||
149123309|NCT02937454|537929709|FG000|Overall Study|Other|8|||
149123310|NCT02937454|537929710|FG001|Overall Study|Other|5|||
149123311|NCT01474434|537929712|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
149123312|NCT01474434|537929713|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
149123313|NCT01474434|537929714|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
149123314|NCT01474434|537929715|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
149123315|NCT01474434|537929712|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
149123316|NCT01474434|537929713|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
149123317|NCT01474434|537929714|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
149123318|NCT01474434|537929715|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
149123319|NCT01474434|537929712|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
149123320|NCT01474434|537929713|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
149123321|NCT01474434|537929714|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
149123322|NCT01474434|537929715|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
149123323|NCT00993668|537929719|FG000|Single-Blind Period|Adverse Event|1|||
149123324|NCT00993668|537929720|FG001|Single-Blind Period|Adverse Event|1|||
149123325|NCT00993668|537929719|FG000|Single-Blind Period|Lack of Efficacy|0|||
149123326|NCT00993668|537929720|FG001|Single-Blind Period|Lack of Efficacy|1|||
149123327|NCT00993668|537929719|FG000|Single-Blind Period|Lost to Follow-up|3|||
149123328|NCT00993668|537929720|FG001|Single-Blind Period|Lost to Follow-up|1|||
149123329|NCT00993668|537929719|FG000|Open-Label Period|Adverse Event|9|||
149123330|NCT00993668|537929720|FG001|Open-Label Period|Adverse Event|8|||
149123331|NCT00993668|537929719|FG000|Open-Label Period|Lack of Efficacy|4|||
149123332|NCT00993668|537929720|FG001|Open-Label Period|Lack of Efficacy|3|||
149123333|NCT00993668|537929719|FG000|Open-Label Period|Withdrawal by Subject|4|||
149123334|NCT00993668|537929720|FG001|Open-Label Period|Withdrawal by Subject|3|||
149123335|NCT00993668|537929719|FG000|Open-Label Period|Lost to Follow-up|6|||
149123336|NCT00993668|537929720|FG001|Open-Label Period|Lost to Follow-up|1|||
149123337|NCT02207569|537929721|FG000|1-Month|Death|6|||
149123338|NCT02207569|537929721|FG000|1-Month|Withdrawal by Subject|2|||
149123339|NCT02207569|537929721|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
149123340|NCT02207569|537929721|FG000|6-Month|Death|8|||
149123341|NCT02207569|537929721|FG000|6-Month|Withdrawal by Subject|2|||
149123342|NCT02207569|537929721|FG000|12-Month|Death|14|||
149123343|NCT02207569|537929721|FG000|12-Month|Withdrawal by Subject|2|||
149123344|NCT02207569|537929721|FG000|24-Month|Death|23|||
149123345|NCT02207569|537929721|FG000|24-Month|Withdrawal by Subject|3|||
149123346|NCT02207569|537929721|FG000|36-Month|Death|23|||
149123347|NCT02207569|537929721|FG000|36-Month|Withdrawal by Subject|4|||
149123348|NCT02207569|537929721|FG000|48-Month|Death|25|||
149123349|NCT02207569|537929721|FG000|48-Month|Withdrawal by Subject|2|||
149123350|NCT02207569|537929721|FG000|48-Month|Lost to Follow-up|4|||
149123351|NCT02207569|537929721|FG000|60-Month|Death|1|||
149123352|NCT02207569|537929721|FG000|60-Month|Lost to Follow-up|1|||
149123353|NCT02207569|537929721|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
149123354|NCT02207569|537929721|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
149123355|NCT01014143|537929723|FG000|Second Intervention|Lost to Follow-up|2|||
149123356|NCT01014143|537929724|FG001|Second Intervention|Lost to Follow-up|0|||
149123357|NCT01014143|537929725|FG002|Second Intervention|Lost to Follow-up|0|||
149123358|NCT00523640|537929728|FG000|Overall Study|Death|1|||
149123359|NCT02334423|537929729|FG000|Overall Study|Protocol Violation|10|||
149123360|NCT02334423|537929730|FG001|Overall Study|Protocol Violation|3|||
149123361|NCT00652327|537929731|FG000|Overall Study|Adverse Event|0|||
149123362|NCT00652327|537929732|FG001|Overall Study|Adverse Event|2|||
149123363|NCT00652327|537929731|FG000|Overall Study|Lost to Follow-up|0|||
149123364|NCT00652327|537929732|FG001|Overall Study|Lost to Follow-up|3|||
149123365|NCT01076647|537929733|FG000|Overall Study|Adverse Event|4|||
149123366|NCT01076647|537929734|FG001|Overall Study|Adverse Event|1|||
149123367|NCT01076647|537929733|FG000|Overall Study|Lack of Efficacy|0|||
149123368|NCT01076647|537929734|FG001|Overall Study|Lack of Efficacy|1|||
149123369|NCT01076647|537929733|FG000|Overall Study|Protocol Violation|7|||
149123370|NCT01076647|537929734|FG001|Overall Study|Protocol Violation|9|||
149123371|NCT01076647|537929733|FG000|Overall Study|Withdrawal criteria|2|||
149123372|NCT01076647|537929734|FG001|Overall Study|Withdrawal criteria|2|||
149123373|NCT01076647|537929733|FG000|Overall Study|Unclassified|12|||
149123374|NCT01076647|537929734|FG001|Overall Study|Unclassified|12|||
149123375|NCT02081417|537929742|FG000|Overall Study|Lost to Follow-up|26|||
149123376|NCT02081417|537929743|FG001|Overall Study|Lost to Follow-up|23|||
149123377|NCT02081417|537929742|FG000|Overall Study|Moved Away|1|||
149123378|NCT02081417|537929743|FG001|Overall Study|Moved Away|2|||
149123379|NCT02081417|537929742|FG000|Overall Study|Incarcerated|2|||
149123380|NCT02081417|537929743|FG001|Overall Study|Incarcerated|2|||
149123381|NCT02081417|537929742|FG000|Overall Study|Death|4|||
149123382|NCT02081417|537929743|FG001|Overall Study|Death|3|||
149123383|NCT02081417|537929742|FG000|Overall Study|Withdrawal by Subject|4|||
149123384|NCT02081417|537929743|FG001|Overall Study|Withdrawal by Subject|0|||
149123385|NCT02081417|537929742|FG000|Overall Study|Admitted to Residential Treatment|2|||
149123386|NCT02081417|537929743|FG001|Overall Study|Admitted to Residential Treatment|0|||
149123387|NCT02081417|537929742|FG000|Overall Study|Did not start treatment|17|||
149123388|NCT02081417|537929743|FG001|Overall Study|Did not start treatment|21|||
149123389|NCT01577745|537929745|FG000|Overall Study|Withdrawal by Subject|0|||
149123390|NCT01577745|537929746|FG001|Overall Study|Withdrawal by Subject|1|||
149123391|NCT01577745|537929747|FG002|Overall Study|Withdrawal by Subject|0|||
149123392|NCT01577745|537929748|FG003|Overall Study|Withdrawal by Subject|3|||
149123393|NCT01577745|537929749|FG004|Overall Study|Withdrawal by Subject|2|||
149123394|NCT01577745|537929750|FG005|Overall Study|Withdrawal by Subject|0|||
149123395|NCT01577745|537929745|FG000|Overall Study|Death|3|||
149123396|NCT01577745|537929746|FG001|Overall Study|Death|2|||
149123397|NCT01577745|537929747|FG002|Overall Study|Death|2|||
149123398|NCT01577745|537929748|FG003|Overall Study|Death|1|||
149123399|NCT01577745|537929749|FG004|Overall Study|Death|1|||
149123400|NCT01577745|537929750|FG005|Overall Study|Death|3|||
149123401|NCT01577745|537929745|FG000|Overall Study|Physician Decision|0|||
149123402|NCT01577745|537929746|FG001|Overall Study|Physician Decision|0|||
149123403|NCT01577745|537929747|FG002|Overall Study|Physician Decision|0|||
149123404|NCT01577745|537929748|FG003|Overall Study|Physician Decision|1|||
149123405|NCT01577745|537929749|FG004|Overall Study|Physician Decision|1|||
149123406|NCT01577745|537929750|FG005|Overall Study|Physician Decision|0|||
149123407|NCT01577745|537929745|FG000|Overall Study|Lost to Follow-up|0|||
149123408|NCT01577745|537929746|FG001|Overall Study|Lost to Follow-up|0|||
149123409|NCT01577745|537929747|FG002|Overall Study|Lost to Follow-up|0|||
149123410|NCT01577745|537929748|FG003|Overall Study|Lost to Follow-up|0|||
149123411|NCT01577745|537929749|FG004|Overall Study|Lost to Follow-up|0|||
149123412|NCT01577745|537929750|FG005|Overall Study|Lost to Follow-up|1|||
149123413|NCT01577745|537929745|FG000|Overall Study|Alternative Therapy|0|||
149123414|NCT01577745|537929746|FG001|Overall Study|Alternative Therapy|0|||
149123415|NCT01577745|537929747|FG002|Overall Study|Alternative Therapy|0|||
149123416|NCT01577745|537929748|FG003|Overall Study|Alternative Therapy|1|||
149123417|NCT01577745|537929749|FG004|Overall Study|Alternative Therapy|1|||
149123418|NCT01577745|537929750|FG005|Overall Study|Alternative Therapy|0|||
149123419|NCT00862719|537929754|FG000|Overall Study|Disease Progression|5|||
149123420|NCT00862719|537929755|FG001|Overall Study|Disease Progression|0|||
149123421|NCT00862719|537929756|FG002|Overall Study|Disease Progression|1|||
149123422|NCT00862719|537929757|FG003|Overall Study|Disease Progression|0|||
149123423|NCT00862719|537929754|FG000|Overall Study|Death|5|||
149123424|NCT00862719|537929755|FG001|Overall Study|Death|6|||
149123425|NCT00862719|537929756|FG002|Overall Study|Death|1|||
149123426|NCT00862719|537929757|FG003|Overall Study|Death|1|||
149123427|NCT00862719|537929754|FG000|Overall Study|Engraftment failure|0|||
149123428|NCT00862719|537929755|FG001|Overall Study|Engraftment failure|0|||
149123429|NCT00862719|537929756|FG002|Overall Study|Engraftment failure|1|||
149123430|NCT00862719|537929757|FG003|Overall Study|Engraftment failure|0|||
149123431|NCT00862719|537929754|FG000|Overall Study|Veno-Occlusive Disease|0|||
149123432|NCT00862719|537929755|FG001|Overall Study|Veno-Occlusive Disease|0|||
149123433|NCT00862719|537929756|FG002|Overall Study|Veno-Occlusive Disease|1|||
149123434|NCT00862719|537929757|FG003|Overall Study|Veno-Occlusive Disease|0|||
149123435|NCT01806623|537929758|FG000|Overall Study|Withdrawal by Subject|1|||
149123436|NCT01806623|537929758|FG000|Overall Study|Adverse Event|1|||
149123437|NCT01806623|537929758|FG000|Overall Study|Did not meet the inclusion criteria|56|||
149123438|NCT01737827|537929759|FG000|Overall Study|Adverse Event|3|||
149123439|NCT01737827|537929760|FG001|Overall Study|Adverse Event|6|||
149123440|NCT01737827|537929761|FG002|Overall Study|Adverse Event|0|||
149123441|NCT01737827|537929759|FG000|Overall Study|Lost to Follow-up|0|||
149123442|NCT01737827|537929760|FG001|Overall Study|Lost to Follow-up|1|||
149123443|NCT01737827|537929761|FG002|Overall Study|Lost to Follow-up|0|||
149123444|NCT01737827|537929759|FG000|Overall Study|Physician Decision|0|||
149123445|NCT01737827|537929760|FG001|Overall Study|Physician Decision|2|||
149123446|NCT01737827|537929761|FG002|Overall Study|Physician Decision|0|||
149123447|NCT01737827|537929759|FG000|Overall Study|Progressive Disease|5|||
149123448|NCT01737827|537929760|FG001|Overall Study|Progressive Disease|16|||
149123449|NCT01737827|537929761|FG002|Overall Study|Progressive Disease|2|||
149123450|NCT01737827|537929759|FG000|Overall Study|Study Terminated by Sponsor|0|||
149123451|NCT01737827|537929760|FG001|Overall Study|Study Terminated by Sponsor|1|||
149123452|NCT01737827|537929761|FG002|Overall Study|Study Terminated by Sponsor|0|||
149123453|NCT01737827|537929759|FG000|Overall Study|Subject/Guardian Decision|0|||
149123454|NCT01737827|537929760|FG001|Overall Study|Subject/Guardian Decision|2|||
149123455|NCT01737827|537929761|FG002|Overall Study|Subject/Guardian Decision|0|||
149123456|NCT01964924|537929762|FG000|Trametinib Monotherapy|Progression|19|||
149123457|NCT01964924|537929763|FG001|Trametinib Monotherapy|Progression|0|||
149123458|NCT01528345|537929764|FG000|Overall Study|Adverse Event|10|||
149123459|NCT01528345|537929765|FG001|Overall Study|Adverse Event|1|||
149123460|NCT01528345|537929764|FG000|Overall Study|Death|1|||
149123461|NCT01528345|537929765|FG001|Overall Study|Death|1|||
149123462|NCT01528345|537929764|FG000|Overall Study|Non-compliance with study treatment|1|||
149123463|NCT01528345|537929765|FG001|Overall Study|Non-compliance with study treatment|0|||
149123464|NCT01528345|537929764|FG000|Overall Study|Progressive Disease|26|||
149123465|NCT01528345|537929765|FG001|Overall Study|Progressive Disease|40|||
149123466|NCT01528345|537929764|FG000|Overall Study|Study Terminated by Sponsor|4|||
149123467|NCT01528345|537929765|FG001|Overall Study|Study Terminated by Sponsor|8|||
149123468|NCT01528345|537929764|FG000|Overall Study|Subject/Guardian Decision|5|||
149123469|NCT01528345|537929765|FG001|Overall Study|Subject/Guardian Decision|0|||
149123470|NCT02424734|537929766|FG000|Overall Study|Treatment stopped to be discharged home|2|||
149123471|NCT02424734|537929767|FG001|Overall Study|Treatment stopped to be discharged home|2|||
149123472|NCT02424734|537929768|FG002|Overall Study|Treatment stopped to be discharged home|0|||
149123473|NCT00528645|537929769|FG000|Overall Study|Adverse Event|3|||
149123474|NCT01445301|537929770|FG000|Overall Study|Adverse Event|15|||
149123475|NCT01445301|537929771|FG001|Overall Study|Adverse Event|25|||
149123476|NCT01445301|537929772|FG002|Overall Study|Adverse Event|4|||
149123477|NCT01445301|537929770|FG000|Overall Study|Lack of Efficacy|0|||
149123478|NCT01445301|537929771|FG001|Overall Study|Lack of Efficacy|1|||
149123479|NCT01445301|537929772|FG002|Overall Study|Lack of Efficacy|0|||
149123480|NCT01445301|537929770|FG000|Overall Study|Protocol Violation|1|||
149123481|NCT01445301|537929771|FG001|Overall Study|Protocol Violation|0|||
149123482|NCT01445301|537929772|FG002|Overall Study|Protocol Violation|0|||
149123483|NCT01445301|537929770|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
149123484|NCT01445301|537929771|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
149123485|NCT01445301|537929772|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
149123486|NCT01445301|537929770|FG000|Overall Study|Physician Decision|0|||
149123487|NCT01445301|537929771|FG001|Overall Study|Physician Decision|2|||
149123488|NCT01445301|537929772|FG002|Overall Study|Physician Decision|0|||
149123489|NCT01445301|537929770|FG000|Overall Study|Withdrawal by Subject|5|||
149123490|NCT01445301|537929771|FG001|Overall Study|Withdrawal by Subject|6|||
149123491|NCT01445301|537929772|FG002|Overall Study|Withdrawal by Subject|4|||
149123492|NCT00752557|537929773|FG000|Overall Study|Withdrawal by Subject|4|||
149123493|NCT00752557|537929774|FG001|Overall Study|Withdrawal by Subject|3|||
149123494|NCT00752557|537929775|FG002|Overall Study|Withdrawal by Subject|3|||
149123495|NCT00752557|537929773|FG000|Overall Study|Unspecified resaons|0|||
149123496|NCT00752557|537929774|FG001|Overall Study|Unspecified resaons|2|||
149123497|NCT00752557|537929775|FG002|Overall Study|Unspecified resaons|2|||
148785790|NCT00339833|536692448|FG000|Overall Study|Poor venous access|2|||
149123498|NCT00752557|537929773|FG000|Overall Study|Lost to Follow-up|1|||
149123499|NCT00752557|537929774|FG001|Overall Study|Lost to Follow-up|0|||
149123500|NCT00752557|537929775|FG002|Overall Study|Lost to Follow-up|1|||
149123501|NCT02150343|537929780|FG000|Overall Study|Adverse Event|2|||
149123502|NCT02150343|537929781|FG001|Overall Study|Adverse Event|0|||
149123503|NCT02150343|537929782|FG002|Overall Study|Adverse Event|1|||
149123504|NCT02150343|537929783|FG003|Overall Study|Adverse Event|1|||
149123505|NCT02150343|537929780|FG000|Overall Study|Withdrawal by Subject|13|||
149123506|NCT02150343|537929781|FG001|Overall Study|Withdrawal by Subject|10|||
149123507|NCT02150343|537929782|FG002|Overall Study|Withdrawal by Subject|9|||
149123508|NCT02150343|537929783|FG003|Overall Study|Withdrawal by Subject|4|||
149123509|NCT02150343|537929780|FG000|Overall Study|Lost to Follow-up|4|||
149123510|NCT02150343|537929781|FG001|Overall Study|Lost to Follow-up|4|||
149123511|NCT02150343|537929782|FG002|Overall Study|Lost to Follow-up|2|||
149123512|NCT02150343|537929783|FG003|Overall Study|Lost to Follow-up|3|||
149123513|NCT02150343|537929780|FG000|Overall Study|Other|2|||
149123514|NCT02150343|537929781|FG001|Overall Study|Other|6|||
149123515|NCT02150343|537929782|FG002|Overall Study|Other|0|||
149123516|NCT02150343|537929783|FG003|Overall Study|Other|2|||
149123517|NCT00190749|537929784|FG000|Overall Study|Lost to Follow-up|8|||
149123518|NCT00190749|537929785|FG001|Overall Study|Lost to Follow-up|11|||
149123519|NCT00190749|537929784|FG000|Overall Study|Withdrawal by Subject|10|||
149123520|NCT00190749|537929785|FG001|Overall Study|Withdrawal by Subject|6|||
149123521|NCT00190749|537929784|FG000|Overall Study|Protocol Violation|5|||
149123522|NCT00190749|537929785|FG001|Overall Study|Protocol Violation|4|||
149123523|NCT00190749|537929784|FG000|Overall Study|Adverse Event|0|||
149123524|NCT00190749|537929785|FG001|Overall Study|Adverse Event|5|||
149123525|NCT00190749|537929784|FG000|Overall Study|Lack of Efficacy|2|||
149123526|NCT00190749|537929785|FG001|Overall Study|Lack of Efficacy|3|||
149123527|NCT00190749|537929784|FG000|Overall Study|Reason Not Specified|0|||
149123528|NCT00190749|537929785|FG001|Overall Study|Reason Not Specified|2|||
149123529|NCT00190749|537929784|FG000|Overall Study|Sponsor Decision|1|||
149123530|NCT00190749|537929785|FG001|Overall Study|Sponsor Decision|0|||
149123531|NCT02729753|537929786|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
149123532|NCT02729753|537929787|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
149123533|NCT01090427|537929788|FG000|After Controlled Period|Death|0|||
149123534|NCT01090427|537929789|FG001|After Controlled Period|Death|0|||
149123535|NCT01090427|537929790|FG002|After Controlled Period|Death|0|||
149123536|NCT01090427|537929791|FG003|After Controlled Period|Death|0|||
149123537|NCT01090427|537929792|FG004|After Controlled Period|Death|0|||
149123538|NCT01090427|537929793|FG005|After Controlled Period|Death|1|||
149123539|NCT01090427|537929794|FG006|After Controlled Period|Death|0|||
149123540|NCT01090427|537929788|FG000|After Controlled Period|Lack of Efficacy|0|||
149123541|NCT01090427|537929789|FG001|After Controlled Period|Lack of Efficacy|0|||
149123542|NCT01090427|537929790|FG002|After Controlled Period|Lack of Efficacy|0|||
149123543|NCT01090427|537929791|FG003|After Controlled Period|Lack of Efficacy|0|||
149123544|NCT01090427|537929792|FG004|After Controlled Period|Lack of Efficacy|0|||
149123545|NCT01090427|537929793|FG005|After Controlled Period|Lack of Efficacy|3|||
149123546|NCT01090427|537929794|FG006|After Controlled Period|Lack of Efficacy|2|||
149123547|NCT01090427|537929788|FG000|After Controlled Period|Adverse Event|0|||
149123548|NCT01090427|537929789|FG001|After Controlled Period|Adverse Event|0|||
149123549|NCT01090427|537929790|FG002|After Controlled Period|Adverse Event|0|||
149123550|NCT01090427|537929791|FG003|After Controlled Period|Adverse Event|2|||
149123551|NCT01090427|537929792|FG004|After Controlled Period|Adverse Event|0|||
149123552|NCT01090427|537929793|FG005|After Controlled Period|Adverse Event|1|||
149123553|NCT01090427|537929794|FG006|After Controlled Period|Adverse Event|0|||
149123554|NCT01154010|537929795|FG000|Overall Study|Lost to Follow-up|0|||
149123555|NCT01154010|537929796|FG001|Overall Study|Lost to Follow-up|1|||
149123556|NCT00439231|537929797|FG000|Overall Study|Lack of Efficacy|28|||
149123557|NCT02413333|537929803|FG000|Period 1|Adverse Event|1|||
149123558|NCT02413333|537929804|FG001|Period 1|Adverse Event|0|||
149123559|NCT02413333|537929803|FG000|Period 1|Reason Not Specified|0|||
149123560|NCT02413333|537929804|FG001|Period 1|Reason Not Specified|1|||
149123561|NCT02413333|537929803|FG000|Period 2|Protocol Deviation|1|||
149123562|NCT02413333|537929804|FG001|Period 2|Protocol Deviation|0|||
149123563|NCT01048671|537929811|FG000|Overall Study|Protocol Violation|0|||
149123564|NCT01048671|537929812|FG001|Overall Study|Protocol Violation|1|||
149123565|NCT01048671|537929813|FG002|Overall Study|Protocol Violation|1|||
149123566|NCT02689518|537929815|FG000|Overall Study|Withdrawal by Subject|3|||
149123567|NCT03965351|537929816|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
149123568|NCT03965351|537929817|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
149123569|NCT03965351|537929816|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
149123570|NCT03965351|537929817|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
149123571|NCT00943111|537929818|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
149123572|NCT00943111|537929819|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
149123573|NCT00943111|537929820|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
149123574|NCT00943111|537929818|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
149123575|NCT00943111|537929819|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
149123576|NCT00943111|537929820|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
149123577|NCT00943111|537929818|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
149123578|NCT00943111|537929819|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
149123579|NCT00943111|537929820|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
149123580|NCT00943111|537929818|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
149123581|NCT00943111|537929819|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
149123582|NCT00943111|537929820|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
149123583|NCT00943111|537929818|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
149123584|NCT00943111|537929819|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
149123585|NCT00943111|537929820|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
149123586|NCT00943111|537929818|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
149123587|NCT00943111|537929819|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
149123588|NCT00943111|537929820|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
149123589|NCT00943111|537929818|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
149123590|NCT00943111|537929819|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
149123591|NCT00943111|537929820|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
149123592|NCT00943111|537929818|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
149123593|NCT00943111|537929819|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
149123594|NCT00943111|537929820|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
149123595|NCT02859324|537929821|FG000|Overall Study|Death|4|||
149123596|NCT02859324|537929822|FG001|Overall Study|Death|6|||
149123597|NCT02859324|537929823|FG002|Overall Study|Death|5|||
149123598|NCT02859324|537929821|FG000|Overall Study|Other reasons|3|||
149123599|NCT02859324|537929822|FG001|Overall Study|Other reasons|3|||
149123600|NCT02859324|537929823|FG002|Overall Study|Other reasons|0|||
149123601|NCT02665338|537929824|FG000|Overall Study|Withdrawal by Subject|0|||
149123602|NCT02665338|537929825|FG001|Overall Study|Withdrawal by Subject|1|||
149123603|NCT05326815|537929827|FG000|Overall Study|Withdrawal by Subject|3|||
149123604|NCT05326815|537929827|FG000|Overall Study|Did not complete required labs|6|||
149123605|NCT05326815|537929827|FG000|Overall Study|Screen fail- abnormal labs|5|||
149123606|NCT02292927|537932659|FG000|Overall Study|Protocol Violation|13|||
149123607|NCT02292927|537932660|FG001|Overall Study|Protocol Violation|7|||
149123608|NCT01656733|537932662|FG000|Overall Study|No permission to collect birth outcomes|0|||
149123609|NCT01656733|537932663|FG001|Overall Study|No permission to collect birth outcomes|1|||
149123610|NCT01656733|537932662|FG000|Overall Study|Delivery at another hospital|0|||
149123611|NCT01656733|537932663|FG001|Overall Study|Delivery at another hospital|2|||
149123612|NCT01656733|537932662|FG000|Overall Study|Spontaneous abortion|0|||
149123613|NCT01656733|537932663|FG001|Overall Study|Spontaneous abortion|1|||
149123614|NCT01065844|537932664|FG000|Overall Study|Adverse Event|5|||
149123615|NCT02224690|537932665|FG000|Overall Study|Adverse Event|8|||
149123616|NCT02224690|537932666|FG001|Overall Study|Adverse Event|1|||
149123617|NCT02224690|537932665|FG000|Overall Study|Met Withdrawal Criteria|4|||
149123618|NCT02224690|537932666|FG001|Overall Study|Met Withdrawal Criteria|0|||
149123619|NCT02224690|537932665|FG000|Overall Study|Use of G-tube|1|||
149123620|NCT02224690|537932666|FG001|Overall Study|Use of G-tube|0|||
149123621|NCT02224690|537932665|FG000|Overall Study|Did not meet eligibility criteria|1|||
149123622|NCT02224690|537932666|FG001|Overall Study|Did not meet eligibility criteria|0|||
149123623|NCT00122460|537932667|FG000|Overall Study|investigational study phase ongoing|7|||
149123624|NCT00122460|537932668|FG001|Overall Study|investigational study phase ongoing|1|||
149123625|NCT00825916|537932669|FG000|Overall Study|Lost to Follow-up|4|||
149123626|NCT00825916|537932670|FG001|Overall Study|Lost to Follow-up|2|||
149123627|NCT00825916|537932671|FG002|Overall Study|Lost to Follow-up|1|||
149123628|NCT02962960|537932672|FG000|Overall Study|Withdrawal by Subject|1|||
149123629|NCT02962960|537932673|FG001|Overall Study|Withdrawal by Subject|1|||
149123630|NCT02962960|537932674|FG002|Overall Study|Withdrawal by Subject|0|||
149123631|NCT02962960|537932672|FG000|Overall Study|Adverse Event|1|||
149123632|NCT02962960|537932673|FG001|Overall Study|Adverse Event|1|||
149123633|NCT02962960|537932674|FG002|Overall Study|Adverse Event|0|||
149123634|NCT02962960|537932672|FG000|Overall Study|Protocol Violation|1|||
149123635|NCT02962960|537932673|FG001|Overall Study|Protocol Violation|0|||
149123636|NCT02962960|537932674|FG002|Overall Study|Protocol Violation|0|||
149123637|NCT02054741|537932675|FG000|Overall Study|Protocol Violation|13|||
149123638|NCT02054741|537932676|FG001|Overall Study|Protocol Violation|2|||
149123639|NCT02054741|537932675|FG000|Overall Study|Withdrawal by Subject|10|||
149123640|NCT02054741|537932676|FG001|Overall Study|Withdrawal by Subject|5|||
149123641|NCT02054741|537932675|FG000|Overall Study|Death|94|||
149123642|NCT02054741|537932676|FG001|Overall Study|Death|90|||
149123643|NCT02054741|537932675|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
149123644|NCT02054741|537932676|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
149123645|NCT02325557|537932682|FG000|Overall Study|Progressive disease|1|||
149123646|NCT02325557|537932683|FG001|Overall Study|Progressive disease|0|||
149123647|NCT02325557|537932684|FG002|Overall Study|Progressive disease|0|||
149123648|NCT02325557|537932685|FG003|Overall Study|Progressive disease|0|||
149123649|NCT02325557|537932682|FG000|Overall Study|Withdrawal by Subject|4|||
149123650|NCT02325557|537932683|FG001|Overall Study|Withdrawal by Subject|0|||
149123651|NCT02325557|537932684|FG002|Overall Study|Withdrawal by Subject|0|||
149123652|NCT02325557|537932685|FG003|Overall Study|Withdrawal by Subject|15|||
149123653|NCT02325557|537932682|FG000|Overall Study|Death|5|||
149123654|NCT02325557|537932683|FG001|Overall Study|Death|1|||
149123655|NCT02325557|537932684|FG002|Overall Study|Death|1|||
149123656|NCT02325557|537932685|FG003|Overall Study|Death|16|||
149123657|NCT02325557|537932682|FG000|Overall Study|Lost to Follow-up|0|||
149123658|NCT02325557|537932683|FG001|Overall Study|Lost to Follow-up|0|||
149123659|NCT02325557|537932684|FG002|Overall Study|Lost to Follow-up|1|||
149123660|NCT02325557|537932685|FG003|Overall Study|Lost to Follow-up|1|||
149123661|NCT02325557|537932682|FG000|Overall Study|Other|0|||
149123662|NCT02325557|537932683|FG001|Overall Study|Other|0|||
149123663|NCT02325557|537932684|FG002|Overall Study|Other|0|||
149123664|NCT02325557|537932685|FG003|Overall Study|Other|5|||
149123665|NCT02344004|537932686|FG000|Overall Study|Adverse Event|11|||
149123666|NCT02344004|537932687|FG001|Overall Study|Adverse Event|1|||
149123667|NCT02344004|537932686|FG000|Overall Study|Death|9|||
149123668|NCT02344004|537932687|FG001|Overall Study|Death|7|||
149123669|NCT02344004|537932686|FG000|Overall Study|Physician Decision|4|||
149123670|NCT02344004|537932687|FG001|Overall Study|Physician Decision|1|||
149123671|NCT02344004|537932686|FG000|Overall Study|Withdrawal by Subject|22|||
149123672|NCT02344004|537932687|FG001|Overall Study|Withdrawal by Subject|5|||
149123673|NCT02344004|537932686|FG000|Overall Study|Rescue Medication|2|||
149123674|NCT02344004|537932687|FG001|Overall Study|Rescue Medication|0|||
149123675|NCT02344004|537932686|FG000|Overall Study|Other Not Specified|12|||
149123676|NCT02344004|537932687|FG001|Overall Study|Other Not Specified|0|||
149123677|NCT02344004|537932686|FG000|Overall Study|Protocol Violation|1|||
149123678|NCT02344004|537932687|FG001|Overall Study|Protocol Violation|0|||
149123679|NCT01502631|537932688|FG000|Overall Study|Adverse Event|5|||
149123680|NCT01502631|537932689|FG001|Overall Study|Adverse Event|8|||
149123681|NCT01502631|537932688|FG000|Overall Study|Lost to Follow-up|2|||
149123682|NCT01502631|537932689|FG001|Overall Study|Lost to Follow-up|2|||
149123683|NCT01502631|537932688|FG000|Overall Study|Participant withdrew consent|2|||
149123684|NCT01502631|537932689|FG001|Overall Study|Participant withdrew consent|4|||
149123685|NCT01502631|537932688|FG000|Overall Study|Participant non-compliant|1|||
149123686|NCT01502631|537932689|FG001|Overall Study|Participant non-compliant|0|||
149123687|NCT01502631|537932688|FG000|Overall Study|Investigator's decision|0|||
149123688|NCT01502631|537932689|FG001|Overall Study|Investigator's decision|1|||
149123689|NCT01502631|537932688|FG000|Overall Study|Other|10|||
149123690|NCT01502631|537932689|FG001|Overall Study|Other|5|||
149123691|NCT01488487|537932690|FG000|Overall Study|Adverse Event|6|||
149123692|NCT01488487|537932690|FG000|Overall Study|Death|1|||
149123693|NCT01488487|537932690|FG000|Overall Study|Withdrawal by Subject|2|||
149123694|NCT00395460|537932693|FG000|Overall Study|Withdrawal by Subject|1|||
149123695|NCT00395460|537932694|FG001|Overall Study|Withdrawal by Subject|0|||
149123696|NCT02319525|537932695|FG000|Overall Study|Withdrawal by Subject|2|||
149123697|NCT02319525|537932696|FG001|Overall Study|Withdrawal by Subject|1|||
149123698|NCT04223830|537932700|FG000|Overall Study|Lost to Follow-up|9|||
149123699|NCT04223830|537932700|FG000|Overall Study|Adverse Event|1|||
149123700|NCT00709852|537932701|FG000|Period 1|Adverse Event|2|||
149123701|NCT00709852|537932702|FG001|Period 1|Adverse Event|0|||
149123702|NCT00709852|537932701|FG000|Period 1|Withdrawal by Subject|4|||
149123703|NCT00709852|537932702|FG001|Period 1|Withdrawal by Subject|2|||
149123704|NCT00709852|537932701|FG000|Period 1|Protocol Violation|1|||
149123705|NCT00709852|537932702|FG001|Period 1|Protocol Violation|0|||
149123706|NCT00709852|537932701|FG000|Period 1|Defective scanner|0|||
149123707|NCT00709852|537932702|FG001|Period 1|Defective scanner|1|||
149123708|NCT00709852|537932701|FG000|Period 1|Lost to Follow-up|1|||
149123709|NCT00709852|537932702|FG001|Period 1|Lost to Follow-up|0|||
149123710|NCT00709852|537932701|FG000|Period 2|Protocol Violation|4|||
149123711|NCT00709852|537932702|FG001|Period 2|Protocol Violation|1|||
149123712|NCT00709852|537932701|FG000|Period 2|Adverse Event|1|||
149123713|NCT00709852|537932702|FG001|Period 2|Adverse Event|1|||
149123714|NCT00709852|537932701|FG000|Period 2|Lost to Follow-up|1|||
149123715|NCT00709852|537932702|FG001|Period 2|Lost to Follow-up|0|||
149123716|NCT00709852|537932701|FG000|Period 2|No 72-hour follow-up|3|||
149123717|NCT00709852|537932702|FG001|Period 2|No 72-hour follow-up|0|||
149123718|NCT03814187|537932703|FG000|Overall Study|Sponsor's Administrative Decision|0|||
149123719|NCT03814187|537932704|FG001|Overall Study|Sponsor's Administrative Decision|0|||
149123720|NCT03814187|537932705|FG002|Overall Study|Sponsor's Administrative Decision|272|||
149123721|NCT03814187|537932703|FG000|Overall Study|Death|80|||
149123722|NCT03814187|537932704|FG001|Overall Study|Death|81|||
149123723|NCT03814187|537932705|FG002|Overall Study|Death|4|||
149123724|NCT03814187|537932703|FG000|Overall Study|Withdrew Consent|77|||
148785791|NCT00339833|536692449|FG001|Overall Study|Poor venous access|2|||
149123725|NCT03814187|537932704|FG001|Overall Study|Withdrew Consent|78|||
149123726|NCT03814187|537932705|FG002|Overall Study|Withdrew Consent|2|||
149123727|NCT03814187|537932703|FG000|Overall Study|Lost to Follow-up|47|||
149123728|NCT03814187|537932704|FG001|Overall Study|Lost to Follow-up|52|||
149123729|NCT03814187|537932705|FG002|Overall Study|Lost to Follow-up|1|||
149123730|NCT03814187|537932703|FG000|Overall Study|Adverse Event|22|||
149123731|NCT03814187|537932704|FG001|Overall Study|Adverse Event|23|||
149123732|NCT03814187|537932705|FG002|Overall Study|Adverse Event|0|||
149123733|NCT03814187|537932703|FG000|Overall Study|Physician Decision|7|||
149123734|NCT03814187|537932704|FG001|Overall Study|Physician Decision|4|||
149123735|NCT03814187|537932705|FG002|Overall Study|Physician Decision|2|||
149123736|NCT03814187|537932703|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
149123737|NCT03814187|537932704|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
149123738|NCT03814187|537932705|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
149123739|NCT03814187|537932703|FG000|Overall Study|Other reasons|34|||
149123740|NCT03814187|537932704|FG001|Overall Study|Other reasons|40|||
149123741|NCT03814187|537932705|FG002|Overall Study|Other reasons|2|||
149123742|NCT01014533|537932706|FG000|Overall Study|Protocol Violation|3|||
149123743|NCT01014533|537932707|FG001|Overall Study|Protocol Violation|2|||
149123744|NCT01014533|537932706|FG000|Overall Study|Withdrawal by Subject|2|||
149123745|NCT01014533|537932707|FG001|Overall Study|Withdrawal by Subject|0|||
149123746|NCT01014533|537932706|FG000|Overall Study|unable to come to appointment|0|||
149123747|NCT01014533|537932707|FG001|Overall Study|unable to come to appointment|3|||
149123748|NCT00296400|537932711|FG000|Overall Study|Adverse Event|7|||
149123749|NCT00296400|537932712|FG001|Overall Study|Adverse Event|7|||
149123750|NCT00296400|537932713|FG002|Overall Study|Adverse Event|7|||
149123751|NCT00296400|537932711|FG000|Overall Study|Withdrawal by Subject|5|||
149123752|NCT00296400|537932712|FG001|Overall Study|Withdrawal by Subject|6|||
149123753|NCT00296400|537932713|FG002|Overall Study|Withdrawal by Subject|2|||
149123754|NCT00296400|537932711|FG000|Overall Study|Incorrect enrollment|2|||
149123755|NCT00296400|537932712|FG001|Overall Study|Incorrect enrollment|0|||
149123756|NCT00296400|537932713|FG002|Overall Study|Incorrect enrollment|0|||
149123757|NCT00296400|537932711|FG000|Overall Study|Protocol Violation|1|||
149123758|NCT00296400|537932712|FG001|Overall Study|Protocol Violation|1|||
149123759|NCT00296400|537932713|FG002|Overall Study|Protocol Violation|1|||
149123760|NCT00296400|537932711|FG000|Overall Study|Lost to Follow-up|1|||
149123761|NCT00296400|537932712|FG001|Overall Study|Lost to Follow-up|1|||
149123762|NCT00296400|537932713|FG002|Overall Study|Lost to Follow-up|2|||
149123763|NCT00296400|537932711|FG000|Overall Study|Study specific discontinuation criteria|0|||
149123764|NCT00296400|537932712|FG001|Overall Study|Study specific discontinuation criteria|0|||
149123765|NCT00296400|537932713|FG002|Overall Study|Study specific discontinuation criteria|1|||
149123766|NCT00296400|537932711|FG000|Overall Study|Visit 10 was performed earlier|0|||
149123767|NCT00296400|537932712|FG001|Overall Study|Visit 10 was performed earlier|1|||
149123768|NCT00296400|537932713|FG002|Overall Study|Visit 10 was performed earlier|0|||
149123769|NCT00296400|537932711|FG000|Overall Study|Pregnancy|1|||
149123770|NCT00296400|537932712|FG001|Overall Study|Pregnancy|2|||
149123771|NCT00296400|537932713|FG002|Overall Study|Pregnancy|0|||
149123772|NCT00412061|537932715|FG000|Double Blind Phase|Disease Progression|101|||
149123773|NCT00412061|537932716|FG001|Double Blind Phase|Disease Progression|154|||
149123774|NCT00412061|537932715|FG000|Double Blind Phase|Adverse Event|61|||
149123775|NCT00412061|537932716|FG001|Double Blind Phase|Adverse Event|16|||
149123776|NCT00412061|537932715|FG000|Double Blind Phase|Final Primary Analysis|26|||
149123777|NCT00412061|537932716|FG001|Double Blind Phase|Final Primary Analysis|14|||
149123778|NCT00412061|537932715|FG000|Double Blind Phase|Withdrawal by Subject|18|||
149123779|NCT00412061|537932716|FG001|Double Blind Phase|Withdrawal by Subject|20|||
149123780|NCT00412061|537932715|FG000|Double Blind Phase|Death|6|||
149123781|NCT00412061|537932716|FG001|Double Blind Phase|Death|3|||
149123782|NCT00412061|537932715|FG000|Double Blind Phase|Protocol Violation|3|||
149123783|NCT00412061|537932716|FG001|Double Blind Phase|Protocol Violation|4|||
149123784|NCT00412061|537932715|FG000|Double Blind Phase|New Cander Therapy|1|||
149123785|NCT00412061|537932716|FG001|Double Blind Phase|New Cander Therapy|1|||
149123786|NCT00412061|537932715|FG000|Double Blind Phase|Lost to Follow-up|0|||
149123787|NCT00412061|537932716|FG001|Double Blind Phase|Lost to Follow-up|1|||
149123788|NCT00412061|537932715|FG000|Open Label Phase|Disease Progression|0|||
149123789|NCT00412061|537932716|FG001|Open Label Phase|Disease Progression|86|||
149123790|NCT00412061|537932715|FG000|Open Label Phase|Adverse Event|0|||
149123791|NCT00412061|537932716|FG001|Open Label Phase|Adverse Event|46|||
149123792|NCT00412061|537932715|FG000|Open Label Phase|Withdrawal by Subject|0|||
149123793|NCT00412061|537932716|FG001|Open Label Phase|Withdrawal by Subject|15|||
149123794|NCT00412061|537932715|FG000|Open Label Phase|Administrative Problems|0|||
149123795|NCT00412061|537932716|FG001|Open Label Phase|Administrative Problems|13|||
149123796|NCT00412061|537932715|FG000|Open Label Phase|Death|0|||
149123797|NCT00412061|537932716|FG001|Open Label Phase|Death|7|||
149123798|NCT00412061|537932715|FG000|Open Label Phase|Lost to Follow-up|0|||
149123799|NCT00412061|537932716|FG001|Open Label Phase|Lost to Follow-up|2|||
149123800|NCT00412061|537932715|FG000|Open Label Phase|New Cancer Therapy|0|||
149123801|NCT00412061|537932716|FG001|Open Label Phase|New Cancer Therapy|1|||
149123802|NCT02433340|537932721|FG000|Overall Study|Adverse Event|0|||
149123803|NCT02433340|537932722|FG001|Overall Study|Adverse Event|0|||
149123804|NCT02433340|537932723|FG002|Overall Study|Adverse Event|1|||
149123805|NCT02433340|537932724|FG003|Overall Study|Adverse Event|0|||
149123806|NCT02433340|537932721|FG000|Overall Study|Withdrawal by Subject|1|||
149123807|NCT02433340|537932722|FG001|Overall Study|Withdrawal by Subject|0|||
149123808|NCT02433340|537932723|FG002|Overall Study|Withdrawal by Subject|1|||
149123809|NCT02433340|537932724|FG003|Overall Study|Withdrawal by Subject|2|||
149123810|NCT02433340|537932721|FG000|Overall Study|Lost to Follow-up|0|||
149123811|NCT02433340|537932722|FG001|Overall Study|Lost to Follow-up|1|||
149123812|NCT02433340|537932723|FG002|Overall Study|Lost to Follow-up|0|||
149123813|NCT02433340|537932724|FG003|Overall Study|Lost to Follow-up|0|||
149123814|NCT02433340|537932721|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
149123815|NCT02433340|537932722|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
149123816|NCT02433340|537932723|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
149123817|NCT02433340|537932724|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
149123818|NCT02433340|537932721|FG000|Overall Study|Other|0|||
149123819|NCT02433340|537932722|FG001|Overall Study|Other|1|||
149123820|NCT02433340|537932723|FG002|Overall Study|Other|0|||
149123821|NCT02433340|537932724|FG003|Overall Study|Other|0|||
149123822|NCT01920854|537932725|FG000|Overall Study|Withdrawal by Subject|1|||
149123823|NCT01920854|537932726|FG001|Overall Study|Withdrawal by Subject|0|||
149123824|NCT01920854|537932727|FG002|Overall Study|Withdrawal by Subject|0|||
149123825|NCT01920854|537932728|FG003|Overall Study|Withdrawal by Subject|0|||
149123826|NCT01920854|537932729|FG004|Overall Study|Withdrawal by Subject|1|||
149123827|NCT01920854|537932730|FG005|Overall Study|Withdrawal by Subject|0|||
149123828|NCT01920854|537932731|FG006|Overall Study|Withdrawal by Subject|1|||
149123829|NCT01178385|537932732|FG000|Overall Study|Withdrawal by Subject|2|||
149123830|NCT01178385|537932733|FG001|Overall Study|Withdrawal by Subject|0|||
149123831|NCT00985946|537932740|FG000|Overall Study|Lost to Follow-up|6|||
149123832|NCT00985946|537932740|FG000|Overall Study|Withdrawal by Subject|1|||
149123833|NCT02679508|537932744|FG000|Healing Phase|Protocol Violation|1|||
149123834|NCT02679508|537932745|FG001|Healing Phase|Protocol Violation|1|||
149123835|NCT02679508|537932744|FG000|Healing Phase|Lost to Follow-up|1|||
149123836|NCT02679508|537932745|FG001|Healing Phase|Lost to Follow-up|0|||
149123837|NCT02679508|537932744|FG000|Maintenance Phase|Adverse Event|12|||
149123838|NCT02679508|537932745|FG001|Maintenance Phase|Adverse Event|2|||
149123839|NCT02679508|537932744|FG000|Maintenance Phase|Lost to Follow-up|0|||
149123840|NCT02679508|537932745|FG001|Maintenance Phase|Lost to Follow-up|1|||
149123841|NCT02679508|537932744|FG000|Maintenance Phase|Withdrawal by Subject|15|||
149123842|NCT02679508|537932745|FG001|Maintenance Phase|Withdrawal by Subject|8|||
149123843|NCT02679508|537932744|FG000|Maintenance Phase|Other|5|||
149123844|NCT02679508|537932745|FG001|Maintenance Phase|Other|4|||
149123845|NCT00928018|537932748|FG000|Overall Study|Withdrawal by Subject|1|||
149123846|NCT00928018|537932749|FG001|Overall Study|Withdrawal by Subject|0|||
149123847|NCT02008877|537932750|FG000|Overall Study|Inevaluable|0|||
149123848|NCT02008877|537932751|FG001|Overall Study|Inevaluable|1|||
149123849|NCT02008877|537932752|FG002|Overall Study|Inevaluable|0|||
149123850|NCT01049217|537932753|FG000|Overall Study|Adverse Event|2|||
149123851|NCT01049217|537932754|FG001|Overall Study|Adverse Event|1|||
149123852|NCT01049217|537932753|FG000|Overall Study|Lack of Efficacy|1|||
149123853|NCT01049217|537932754|FG001|Overall Study|Lack of Efficacy|1|||
149123854|NCT01049217|537932753|FG000|Overall Study|Lost to Follow-up|3|||
149123855|NCT01049217|537932754|FG001|Overall Study|Lost to Follow-up|8|||
149123856|NCT01049217|537932753|FG000|Overall Study|Withdrawal by Subject|4|||
149123857|NCT01049217|537932754|FG001|Overall Study|Withdrawal by Subject|3|||
149123858|NCT01049217|537932753|FG000|Overall Study|Protocol Violation|1|||
149123859|NCT01049217|537932754|FG001|Overall Study|Protocol Violation|3|||
149123860|NCT01049217|537932753|FG000|Overall Study|Pregnancy|1|||
148785792|NCT00339833|536692448|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
149123861|NCT01049217|537932754|FG001|Overall Study|Pregnancy|0|||
149123862|NCT01049217|537932753|FG000|Overall Study|Study Terminated by Sponsor|43|||
149123863|NCT01049217|537932754|FG001|Overall Study|Study Terminated by Sponsor|43|||
149123864|NCT01049217|537932753|FG000|Overall Study|Other|1|||
149123865|NCT01049217|537932754|FG001|Overall Study|Other|2|||
149123866|NCT01049217|537932753|FG000|Overall Study|Randomized but not Treated|0|||
149123867|NCT01049217|537932754|FG001|Overall Study|Randomized but not Treated|2|||
149123868|NCT00998335|537932755|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
149123869|NCT00998335|537932756|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
149123870|NCT05000931|537932757|FG000|Overall Study|Lost to Follow-up|1|||
149123871|NCT03149549|537932758|FG000|Study Discontinuation--Treatment Period|Death|0|||
149123872|NCT03149549|537932759|FG001|Study Discontinuation--Treatment Period|Death|0|||
149123873|NCT03149549|537932760|FG002|Study Discontinuation--Treatment Period|Death|0|||
149123874|NCT03149549|537932761|FG003|Study Discontinuation--Treatment Period|Death|1|||
149123875|NCT03149549|537932762|FG004|Study Discontinuation--Treatment Period|Death|2|||
149123876|NCT03149549|537932763|FG005|Study Discontinuation--Treatment Period|Death|1|||
149123877|NCT03149549|537932764|FG006|Study Discontinuation--Treatment Period|Death|1|||
149123878|NCT03149549|537932765|FG007|Study Discontinuation--Treatment Period|Death|2|||
149123879|NCT03149549|537932766|FG008|Study Discontinuation--Treatment Period|Death|4|||
149123880|NCT03149549|537932767|FG009|Study Discontinuation--Treatment Period|Death|1|||
149123881|NCT03149549|537932768|FG010|Study Discontinuation--Treatment Period|Death|0|||
149123882|NCT03149549|537932769|FG011|Study Discontinuation--Treatment Period|Death|0|||
149123883|NCT03149549|537932770|FG012|Study Discontinuation--Treatment Period|Death|1|||
149123884|NCT03149549|537932758|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123885|NCT03149549|537932759|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123886|NCT03149549|537932760|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123887|NCT03149549|537932761|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123888|NCT03149549|537932762|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123889|NCT03149549|537932763|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123890|NCT03149549|537932764|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123891|NCT03149549|537932765|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
149123892|NCT03149549|537932766|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123893|NCT03149549|537932767|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123894|NCT03149549|537932768|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123895|NCT03149549|537932769|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
149123896|NCT03149549|537932770|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
149123897|NCT03149549|537932758|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123898|NCT03149549|537932759|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123899|NCT03149549|537932760|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123900|NCT03149549|537932761|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
149123901|NCT03149549|537932762|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
149123902|NCT03149549|537932763|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
149123903|NCT03149549|537932764|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
149123904|NCT03149549|537932765|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123905|NCT03149549|537932766|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
149123906|NCT03149549|537932767|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123907|NCT03149549|537932768|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123908|NCT03149549|537932769|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123909|NCT03149549|537932770|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
149123910|NCT03149549|537932758|FG000|Study Discontinuation--Treatment Period|Other|0|||
149123911|NCT03149549|537932759|FG001|Study Discontinuation--Treatment Period|Other|0|||
149123912|NCT03149549|537932760|FG002|Study Discontinuation--Treatment Period|Other|0|||
149123913|NCT03149549|537932761|FG003|Study Discontinuation--Treatment Period|Other|0|||
149123914|NCT03149549|537932762|FG004|Study Discontinuation--Treatment Period|Other|0|||
149123915|NCT03149549|537932763|FG005|Study Discontinuation--Treatment Period|Other|0|||
149123916|NCT03149549|537932764|FG006|Study Discontinuation--Treatment Period|Other|0|||
149123917|NCT03149549|537932765|FG007|Study Discontinuation--Treatment Period|Other|1|||
149123918|NCT03149549|537932766|FG008|Study Discontinuation--Treatment Period|Other|0|||
149123919|NCT03149549|537932767|FG009|Study Discontinuation--Treatment Period|Other|1|||
149123920|NCT03149549|537932768|FG010|Study Discontinuation--Treatment Period|Other|0|||
149123921|NCT03149549|537932769|FG011|Study Discontinuation--Treatment Period|Other|0|||
149123922|NCT03149549|537932770|FG012|Study Discontinuation--Treatment Period|Other|0|||
149123923|NCT03149549|537932758|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123924|NCT03149549|537932759|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123925|NCT03149549|537932760|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123926|NCT03149549|537932761|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123927|NCT03149549|537932762|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123928|NCT03149549|537932763|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
149123929|NCT03149549|537932764|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
149123930|NCT03149549|537932765|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123931|NCT03149549|537932766|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
149123932|NCT03149549|537932767|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123933|NCT03149549|537932768|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123934|NCT03149549|537932769|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123935|NCT03149549|537932770|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
149123936|NCT03149549|537932758|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123937|NCT03149549|537932759|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123938|NCT03149549|537932760|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123939|NCT03149549|537932761|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123940|NCT03149549|537932762|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
149123941|NCT03149549|537932763|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123942|NCT03149549|537932764|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123943|NCT03149549|537932765|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
149123944|NCT03149549|537932766|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
149123945|NCT03149549|537932767|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123946|NCT03149549|537932768|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
149123947|NCT03149549|537932769|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
149123948|NCT03149549|537932770|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
149123949|NCT03149549|537932758|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123950|NCT03149549|537932759|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123951|NCT03149549|537932760|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123952|NCT03149549|537932761|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123953|NCT03149549|537932762|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
149123954|NCT03149549|537932763|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123955|NCT03149549|537932764|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123956|NCT03149549|537932765|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
149123957|NCT03149549|537932766|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
149123958|NCT03149549|537932767|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
149123959|NCT03149549|537932768|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
149123960|NCT03149549|537932769|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
149123961|NCT03149549|537932770|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
149123962|NCT03149549|537932758|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
149123963|NCT03149549|537932759|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
149123964|NCT03149549|537932760|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
149123965|NCT03149549|537932761|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
149123966|NCT03149549|537932762|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
149123967|NCT03149549|537932763|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
149123968|NCT03149549|537932764|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
149123969|NCT03149549|537932765|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
149123970|NCT03149549|537932766|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
149123971|NCT03149549|537932767|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
149123972|NCT03149549|537932768|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
149123973|NCT03149549|537932769|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
149123974|NCT03149549|537932770|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
149123975|NCT03149549|537932758|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
149123976|NCT03149549|537932759|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
149123977|NCT03149549|537932760|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
149123978|NCT03149549|537932761|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
149123979|NCT03149549|537932762|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
149123980|NCT03149549|537932763|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
149123981|NCT03149549|537932764|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
149123982|NCT03149549|537932765|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
149123983|NCT03149549|537932766|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
149123984|NCT03149549|537932767|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
149123985|NCT03149549|537932768|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
149123986|NCT03149549|537932769|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
149123987|NCT03149549|537932770|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
149123988|NCT01892540|537932773|FG000|Overall Study|Did not complete PET/MRI|0|||
149123989|NCT01892540|537932774|FG001|Overall Study|Did not complete PET/MRI|0|||
149123990|NCT01892540|537932775|FG002|Overall Study|Did not complete PET/MRI|2|||
149123991|NCT01892540|537932773|FG000|Overall Study|Did not fit in scanner|0|||
149123992|NCT01892540|537932774|FG001|Overall Study|Did not fit in scanner|0|||
149123993|NCT01892540|537932775|FG002|Overall Study|Did not fit in scanner|1|||
149123994|NCT01370590|537932776|FG000|Period 1|Adverse Event|8|||
149123995|NCT01370590|537932777|FG001|Period 1|Adverse Event|4|||
149123996|NCT01370590|537932776|FG000|Period 1|Lost to Follow-up|2|||
149123997|NCT01370590|537932777|FG001|Period 1|Lost to Follow-up|2|||
149123998|NCT01370590|537932776|FG000|Period 1|Protocol Violation|2|||
149123999|NCT01370590|537932777|FG001|Period 1|Protocol Violation|2|||
149124000|NCT01370590|537932776|FG000|Period 1|Withdrawal by Subject|4|||
149124001|NCT01370590|537932777|FG001|Period 1|Withdrawal by Subject|2|||
149124002|NCT01370590|537932776|FG000|Period 1|Could not access randomization system|0|||
149124003|NCT01370590|537932777|FG001|Period 1|Could not access randomization system|1|||
149124004|NCT01370590|537932776|FG000|Crossover Washout Period|Adverse Event|1|||
149124005|NCT01370590|537932777|FG001|Crossover Washout Period|Adverse Event|4|||
149124006|NCT01370590|537932776|FG000|Crossover Washout Period|Lost to Follow-up|2|||
149124007|NCT01370590|537932777|FG001|Crossover Washout Period|Lost to Follow-up|0|||
149124008|NCT01370590|537932776|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
149124009|NCT01370590|537932777|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
149124010|NCT01370590|537932776|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
149124011|NCT01370590|537932777|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
149124012|NCT01370590|537932776|FG000|Period 2|Adverse Event|0|||
149124013|NCT01370590|537932777|FG001|Period 2|Adverse Event|1|||
148785793|NCT00339833|536692449|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
149124014|NCT01370590|537932776|FG000|Period 2|Withdrawal by Subject|1|||
149124015|NCT01370590|537932777|FG001|Period 2|Withdrawal by Subject|1|||
149124016|NCT05172050|537932778|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
149124017|NCT05172050|537932779|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
149124018|NCT05172050|537932780|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
149124019|NCT05172050|537932778|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
149124020|NCT05172050|537932779|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
149124021|NCT05172050|537932780|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
149124022|NCT05172050|537932778|FG000|Overall Study|Other|2|||
149124023|NCT05172050|537932779|FG001|Overall Study|Other|2|||
149124024|NCT05172050|537932780|FG002|Overall Study|Other|1|||
149124025|NCT03141905|537932783|FG000|Overall Study|Death|3|||
149124026|NCT03141905|537932784|FG001|Overall Study|Death|2|||
149124027|NCT03141905|537932783|FG000|Overall Study|Withdrawal by Subject|1|||
149124028|NCT03141905|537932784|FG001|Overall Study|Withdrawal by Subject|0|||
149124029|NCT03141905|537932783|FG000|Overall Study|Lost to Follow-up|3|||
149124030|NCT03141905|537932784|FG001|Overall Study|Lost to Follow-up|7|||
149124031|NCT03141905|537932783|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
149124032|NCT03141905|537932784|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
149124033|NCT05180500|537932786|FG000|Overall Study|Adverse Event|1|||
149124034|NCT05180500|537932787|FG001|Overall Study|Adverse Event|0|||
149124035|NCT05180500|537932786|FG000|Overall Study|Withdrawal by Subject|2|||
149124036|NCT05180500|537932787|FG001|Overall Study|Withdrawal by Subject|0|||
149124037|NCT04617275|537932792|FG000|Treatment Period|Adverse Event|1|||
149124038|NCT04617275|537932793|FG001|Treatment Period|Adverse Event|6|||
149124039|NCT04617275|537932794|FG002|Treatment Period|Adverse Event|4|||
149124040|NCT04617275|537932795|FG003|Treatment Period|Adverse Event|6|||
149124041|NCT04617275|537932796|FG004|Treatment Period|Adverse Event|7|||
149124042|NCT04617275|537932797|FG005|Treatment Period|Adverse Event|8|||
149124043|NCT04617275|537932798|FG006|Treatment Period|Adverse Event|0|||
149124044|NCT04617275|537932799|FG007|Treatment Period|Adverse Event|12|||
149124045|NCT04617275|537932792|FG000|Treatment Period|Lost to Follow-up|0|||
149124046|NCT04617275|537932793|FG001|Treatment Period|Lost to Follow-up|0|||
149124047|NCT04617275|537932794|FG002|Treatment Period|Lost to Follow-up|2|||
149124048|NCT04617275|537932795|FG003|Treatment Period|Lost to Follow-up|0|||
149124049|NCT04617275|537932796|FG004|Treatment Period|Lost to Follow-up|0|||
149124050|NCT04617275|537932797|FG005|Treatment Period|Lost to Follow-up|3|||
149124051|NCT04617275|537932798|FG006|Treatment Period|Lost to Follow-up|0|||
149124052|NCT04617275|537932799|FG007|Treatment Period|Lost to Follow-up|2|||
149124053|NCT04617275|537932792|FG000|Treatment Period|No longer meets eligibility criteria|0|||
149124054|NCT04617275|537932793|FG001|Treatment Period|No longer meets eligibility criteria|0|||
149124055|NCT04617275|537932794|FG002|Treatment Period|No longer meets eligibility criteria|0|||
149124056|NCT04617275|537932795|FG003|Treatment Period|No longer meets eligibility criteria|1|||
149124057|NCT04617275|537932796|FG004|Treatment Period|No longer meets eligibility criteria|0|||
149124058|NCT04617275|537932797|FG005|Treatment Period|No longer meets eligibility criteria|0|||
149124059|NCT04617275|537932798|FG006|Treatment Period|No longer meets eligibility criteria|0|||
149124060|NCT04617275|537932799|FG007|Treatment Period|No longer meets eligibility criteria|0|||
149124061|NCT04617275|537932792|FG000|Treatment Period|Other|0|||
149124062|NCT04617275|537932793|FG001|Treatment Period|Other|1|||
149124063|NCT04617275|537932794|FG002|Treatment Period|Other|0|||
149124064|NCT04617275|537932795|FG003|Treatment Period|Other|0|||
149124065|NCT04617275|537932796|FG004|Treatment Period|Other|0|||
149124066|NCT04617275|537932797|FG005|Treatment Period|Other|0|||
149124067|NCT04617275|537932798|FG006|Treatment Period|Other|0|||
149124068|NCT04617275|537932799|FG007|Treatment Period|Other|0|||
149124069|NCT04617275|537932792|FG000|Treatment Period|Withdrawal by Subject|2|||
149124070|NCT04617275|537932793|FG001|Treatment Period|Withdrawal by Subject|0|||
149124071|NCT04617275|537932794|FG002|Treatment Period|Withdrawal by Subject|0|||
149124072|NCT04617275|537932795|FG003|Treatment Period|Withdrawal by Subject|2|||
149124073|NCT04617275|537932796|FG004|Treatment Period|Withdrawal by Subject|2|||
149124074|NCT04617275|537932797|FG005|Treatment Period|Withdrawal by Subject|0|||
149124075|NCT04617275|537932798|FG006|Treatment Period|Withdrawal by Subject|1|||
149124076|NCT04617275|537932799|FG007|Treatment Period|Withdrawal by Subject|2|||
149124077|NCT04617275|537932792|FG000|Follow-up Period|Adverse Event|1|||
149124078|NCT04617275|537932793|FG001|Follow-up Period|Adverse Event|1|||
149124079|NCT04617275|537932794|FG002|Follow-up Period|Adverse Event|2|||
149124080|NCT04617275|537932795|FG003|Follow-up Period|Adverse Event|3|||
149124081|NCT04617275|537932796|FG004|Follow-up Period|Adverse Event|4|||
149124082|NCT04617275|537932797|FG005|Follow-up Period|Adverse Event|3|||
149124083|NCT04617275|537932798|FG006|Follow-up Period|Adverse Event|0|||
149124084|NCT04617275|537932799|FG007|Follow-up Period|Adverse Event|3|||
149124085|NCT04617275|537932792|FG000|Follow-up Period|Lost to Follow-up|0|||
149124086|NCT04617275|537932793|FG001|Follow-up Period|Lost to Follow-up|1|||
149124087|NCT04617275|537932794|FG002|Follow-up Period|Lost to Follow-up|2|||
149124088|NCT04617275|537932795|FG003|Follow-up Period|Lost to Follow-up|0|||
149124089|NCT04617275|537932796|FG004|Follow-up Period|Lost to Follow-up|0|||
149124090|NCT04617275|537932797|FG005|Follow-up Period|Lost to Follow-up|4|||
149124091|NCT04617275|537932798|FG006|Follow-up Period|Lost to Follow-up|0|||
149124092|NCT04617275|537932799|FG007|Follow-up Period|Lost to Follow-up|3|||
149124093|NCT04617275|537932792|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
149124094|NCT04617275|537932793|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
149124095|NCT04617275|537932794|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
149124096|NCT04617275|537932795|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
149124097|NCT04617275|537932796|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
149124098|NCT04617275|537932797|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
149124099|NCT04617275|537932798|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
149124100|NCT04617275|537932799|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
149124101|NCT04617275|537932792|FG000|Follow-up Period|Other|0|||
149124102|NCT04617275|537932793|FG001|Follow-up Period|Other|1|||
149124103|NCT04617275|537932794|FG002|Follow-up Period|Other|0|||
149124104|NCT04617275|537932795|FG003|Follow-up Period|Other|0|||
149124105|NCT04617275|537932796|FG004|Follow-up Period|Other|0|||
149124106|NCT04617275|537932797|FG005|Follow-up Period|Other|0|||
149124107|NCT04617275|537932798|FG006|Follow-up Period|Other|0|||
149124108|NCT04617275|537932799|FG007|Follow-up Period|Other|0|||
149124109|NCT04617275|537932792|FG000|Follow-up Period|Withdrawal by Subject|2|||
149124110|NCT04617275|537932793|FG001|Follow-up Period|Withdrawal by Subject|0|||
149124111|NCT04617275|537932794|FG002|Follow-up Period|Withdrawal by Subject|0|||
149124112|NCT04617275|537932795|FG003|Follow-up Period|Withdrawal by Subject|2|||
149124113|NCT04617275|537932796|FG004|Follow-up Period|Withdrawal by Subject|2|||
149124114|NCT04617275|537932797|FG005|Follow-up Period|Withdrawal by Subject|0|||
149124115|NCT04617275|537932798|FG006|Follow-up Period|Withdrawal by Subject|1|||
149124116|NCT04617275|537932799|FG007|Follow-up Period|Withdrawal by Subject|2|||
149124117|NCT04227704|537932800|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
149124118|NCT04227704|537932801|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
149124119|NCT04227704|537932802|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
149124120|NCT04227704|537932800|FG000|Overall Study|due to C/S being cancelled|1|||
149124121|NCT04227704|537932801|FG001|Overall Study|due to C/S being cancelled|0|||
149124122|NCT04227704|537932802|FG002|Overall Study|due to C/S being cancelled|0|||
149124123|NCT04927884|537932806|FG000|Overall Study|Progressive Disease|2|||
149124124|NCT02317432|537932807|FG000|Overall Study|Death|4|||
149124125|NCT02317432|537932808|FG001|Overall Study|Death|1|||
149124126|NCT02317432|537932807|FG000|Overall Study|Lost to Follow-up|0|||
149124127|NCT02317432|537932808|FG001|Overall Study|Lost to Follow-up|5|||
149124128|NCT02317432|537932807|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
149124129|NCT02317432|537932808|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
149124130|NCT00727311|537932813|FG000|Overall Study|Did not receive drug|316|||
149124131|NCT00727311|537932813|FG000|Overall Study|Missing end of therapy data|205|||
149124132|NCT00727311|537932813|FG000|Overall Study|Adverse Event|58|||
149124133|NCT00727311|537932813|FG000|Overall Study|Lack of Efficacy|242|||
149124134|NCT00727311|537932813|FG000|Overall Study|Lost to Follow-up|73|||
149124135|NCT00727311|537932813|FG000|Overall Study|Withdrawal by Subject|77|||
149124136|NCT00727311|537932813|FG000|Overall Study|Other|97|||
149124137|NCT00727311|537932813|FG000|Overall Study|Multiple reasons|39|||
149124138|NCT03992846|537932814|FG000|Overall Study|Adverse Event|8|||
149124139|NCT03992846|537932815|FG001|Overall Study|Adverse Event|6|||
149124140|NCT03992846|537932816|FG002|Overall Study|Adverse Event|3|||
149124141|NCT03992846|537932814|FG000|Overall Study|Lost to Follow-up|0|||
149124142|NCT03992846|537932815|FG001|Overall Study|Lost to Follow-up|1|||
149124143|NCT03992846|537932816|FG002|Overall Study|Lost to Follow-up|1|||
149124144|NCT03992846|537932814|FG000|Overall Study|Pregnancy|2|||
149124145|NCT03992846|537932815|FG001|Overall Study|Pregnancy|0|||
149124146|NCT03992846|537932816|FG002|Overall Study|Pregnancy|1|||
149124147|NCT03992846|537932814|FG000|Overall Study|Protocol Violation|1|||
149124148|NCT03992846|537932815|FG001|Overall Study|Protocol Violation|2|||
149124149|NCT03992846|537932816|FG002|Overall Study|Protocol Violation|0|||
149124150|NCT03992846|537932814|FG000|Overall Study|Withdrawal by Subject|8|||
149124151|NCT03992846|537932815|FG001|Overall Study|Withdrawal by Subject|10|||
149124152|NCT03992846|537932816|FG002|Overall Study|Withdrawal by Subject|20|||
149124153|NCT03992846|537932814|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
149124154|NCT03992846|537932815|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
149124155|NCT03992846|537932816|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
149124156|NCT01111474|537934673|FG000|Overall Study|Lost to Follow-up|12|||
149124157|NCT04101318|537934676|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
149124158|NCT04101318|537934677|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
149124159|NCT04101318|537934676|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
149124160|NCT04101318|537934677|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
149124161|NCT04101318|537934676|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
149124162|NCT04101318|537934677|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
149124163|NCT00558259|537934678|FG000|Overall Study|Adverse Event|50|||
149124164|NCT00558259|537934679|FG001|Overall Study|Adverse Event|81|||
149124165|NCT00558259|537934678|FG000|Overall Study|Protocol Violation|9|||
149124166|NCT00558259|537934679|FG001|Overall Study|Protocol Violation|5|||
149124167|NCT00558259|537934678|FG000|Overall Study|Withdrawal by Subject|12|||
149124168|NCT00558259|537934679|FG001|Overall Study|Withdrawal by Subject|13|||
149124169|NCT02874924|537934680|FG000|Overall Study|Adverse Event|2|||
149124170|NCT02874924|537934681|FG001|Overall Study|Adverse Event|0|||
149124171|NCT02874924|537934682|FG002|Overall Study|Adverse Event|0|||
149124172|NCT02874924|537934680|FG000|Overall Study|Withdrawal by Subject|1|||
149124173|NCT02874924|537934681|FG001|Overall Study|Withdrawal by Subject|0|||
149124174|NCT02874924|537934682|FG002|Overall Study|Withdrawal by Subject|0|||
149124175|NCT00156819|537934685|FG000|Overall Study|Lost to Follow-up|1|||
149124176|NCT00156819|537934686|FG001|Overall Study|Lost to Follow-up|1|||
149124177|NCT00156819|537934687|FG002|Overall Study|Lost to Follow-up|3|||
149124178|NCT03718533|537934688|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
149124179|NCT03718533|537934688|FG000|Overall Study|Protocol deviation|1|||
149124180|NCT03718533|537934688|FG000|Overall Study|Disease progression|1|||
149124181|NCT03718533|537934688|FG000|Overall Study|Relapse|1|||
149124182|NCT03718533|537934688|FG000|Overall Study|Physician Decision|2|||
149124183|NCT03718533|537934688|FG000|Overall Study|Physician Decision and Adverse Event|1|||
149124184|NCT05398237|537934692|FG000|Overall Study|Withdrawal by Subject|1|||
149124185|NCT01248065|537934698|FG000|Overall Study|Lost to Follow-up|3|||
149124186|NCT01248065|537934699|FG001|Overall Study|Lost to Follow-up|5|||
149124187|NCT01248065|537934698|FG000|Overall Study|Withdrawal by Subject|14|||
149124188|NCT01248065|537934699|FG001|Overall Study|Withdrawal by Subject|11|||
149124189|NCT01248065|537934698|FG000|Overall Study|Adverse Event|3|||
149124190|NCT01248065|537934699|FG001|Overall Study|Adverse Event|0|||
149124191|NCT01248065|537934698|FG000|Overall Study|Third treatment failure event|3|||
149124192|NCT01248065|537934699|FG001|Overall Study|Third treatment failure event|1|||
149124193|NCT01248065|537934698|FG000|Overall Study|Other|3|||
149124194|NCT01248065|537934699|FG001|Overall Study|Other|5|||
149124195|NCT00321373|537934708|FG000|Overall Study|Adverse Event|0|||
149124196|NCT00321373|537934709|FG001|Overall Study|Adverse Event|0|||
149124197|NCT00321373|537934710|FG002|Overall Study|Adverse Event|1|||
149124198|NCT00321373|537934708|FG000|Overall Study|Lost to Follow-up|1|||
149124199|NCT00321373|537934709|FG001|Overall Study|Lost to Follow-up|0|||
149124200|NCT00321373|537934710|FG002|Overall Study|Lost to Follow-up|1|||
149124201|NCT00321373|537934708|FG000|Overall Study|Withdrawal by Subject|1|||
149124202|NCT00321373|537934709|FG001|Overall Study|Withdrawal by Subject|0|||
149124203|NCT00321373|537934710|FG002|Overall Study|Withdrawal by Subject|0|||
149124204|NCT00321373|537934708|FG000|Overall Study|Other|0|||
149124205|NCT00321373|537934709|FG001|Overall Study|Other|0|||
149124206|NCT00321373|537934710|FG002|Overall Study|Other|1|||
149124207|NCT01774487|537934711|FG000|Overall Study|Did not tolerate taste|4|||
149124208|NCT01774487|537934712|FG001|Overall Study|Did not tolerate taste|4|||
149124209|NCT00346632|537934713|FG000|Overall Study|Progressive Disease|2|||
149124210|NCT00346632|537934714|FG001|Overall Study|Progressive Disease|2|||
149124211|NCT00346632|537934715|FG002|Overall Study|Progressive Disease|4|||
149124212|NCT00346632|537934716|FG003|Overall Study|Progressive Disease|3|||
149124213|NCT00346632|537934717|FG004|Overall Study|Progressive Disease|3|||
149124214|NCT00346632|537934718|FG005|Overall Study|Progressive Disease|1|||
149124215|NCT00346632|537934719|FG006|Overall Study|Progressive Disease|2|||
149124216|NCT00346632|537934720|FG007|Overall Study|Progressive Disease|2|||
149124217|NCT00346632|537934721|FG008|Overall Study|Progressive Disease|2|||
149124218|NCT00346632|537934722|FG009|Overall Study|Progressive Disease|2|||
149124219|NCT00346632|537934713|FG000|Overall Study|Adverse Event|0|||
149124220|NCT00346632|537934714|FG001|Overall Study|Adverse Event|0|||
149124221|NCT00346632|537934715|FG002|Overall Study|Adverse Event|0|||
149124222|NCT00346632|537934716|FG003|Overall Study|Adverse Event|0|||
149124223|NCT00346632|537934717|FG004|Overall Study|Adverse Event|1|||
149124224|NCT00346632|537934718|FG005|Overall Study|Adverse Event|1|||
149124225|NCT00346632|537934719|FG006|Overall Study|Adverse Event|1|||
149124226|NCT00346632|537934720|FG007|Overall Study|Adverse Event|0|||
149124227|NCT00346632|537934721|FG008|Overall Study|Adverse Event|0|||
149124228|NCT00346632|537934722|FG009|Overall Study|Adverse Event|0|||
149124229|NCT00346632|537934713|FG000|Overall Study|Death|0|||
149124230|NCT00346632|537934714|FG001|Overall Study|Death|0|||
149124231|NCT00346632|537934715|FG002|Overall Study|Death|1|||
149124232|NCT00346632|537934716|FG003|Overall Study|Death|0|||
149124233|NCT00346632|537934717|FG004|Overall Study|Death|0|||
149124234|NCT00346632|537934718|FG005|Overall Study|Death|0|||
149124235|NCT00346632|537934719|FG006|Overall Study|Death|0|||
149124236|NCT00346632|537934720|FG007|Overall Study|Death|0|||
149124237|NCT00346632|537934721|FG008|Overall Study|Death|0|||
149124238|NCT00346632|537934722|FG009|Overall Study|Death|0|||
149124239|NCT00346632|537934713|FG000|Overall Study|Protocol Violation|0|||
149124240|NCT00346632|537934714|FG001|Overall Study|Protocol Violation|0|||
149124241|NCT00346632|537934715|FG002|Overall Study|Protocol Violation|0|||
149124242|NCT00346632|537934716|FG003|Overall Study|Protocol Violation|0|||
149124243|NCT00346632|537934717|FG004|Overall Study|Protocol Violation|0|||
149124244|NCT00346632|537934718|FG005|Overall Study|Protocol Violation|0|||
149124245|NCT00346632|537934719|FG006|Overall Study|Protocol Violation|1|||
149124246|NCT00346632|537934720|FG007|Overall Study|Protocol Violation|0|||
149124247|NCT00346632|537934721|FG008|Overall Study|Protocol Violation|0|||
149124248|NCT00346632|537934722|FG009|Overall Study|Protocol Violation|0|||
149124249|NCT00346632|537934713|FG000|Overall Study|Withdrawal by Subject|0|||
149124250|NCT00346632|537934714|FG001|Overall Study|Withdrawal by Subject|0|||
149124251|NCT00346632|537934715|FG002|Overall Study|Withdrawal by Subject|0|||
149124252|NCT00346632|537934716|FG003|Overall Study|Withdrawal by Subject|0|||
149124253|NCT00346632|537934717|FG004|Overall Study|Withdrawal by Subject|0|||
149124254|NCT00346632|537934718|FG005|Overall Study|Withdrawal by Subject|0|||
149124255|NCT00346632|537934719|FG006|Overall Study|Withdrawal by Subject|1|||
149124256|NCT00346632|537934720|FG007|Overall Study|Withdrawal by Subject|0|||
149124257|NCT00346632|537934721|FG008|Overall Study|Withdrawal by Subject|0|||
149124258|NCT00346632|537934722|FG009|Overall Study|Withdrawal by Subject|0|||
149124259|NCT00346632|537934713|FG000|Overall Study|Switched to alternative treatment|0|||
149124260|NCT00346632|537934714|FG001|Overall Study|Switched to alternative treatment|0|||
149124261|NCT00346632|537934715|FG002|Overall Study|Switched to alternative treatment|1|||
149124262|NCT00346632|537934716|FG003|Overall Study|Switched to alternative treatment|0|||
149124263|NCT00346632|537934717|FG004|Overall Study|Switched to alternative treatment|0|||
149124264|NCT00346632|537934718|FG005|Overall Study|Switched to alternative treatment|0|||
149124265|NCT00346632|537934719|FG006|Overall Study|Switched to alternative treatment|0|||
149124266|NCT00346632|537934720|FG007|Overall Study|Switched to alternative treatment|0|||
149124267|NCT00346632|537934721|FG008|Overall Study|Switched to alternative treatment|0|||
149124268|NCT00346632|537934722|FG009|Overall Study|Switched to alternative treatment|0|||
149124269|NCT00346632|537934713|FG000|Overall Study|Not Stated|1|||
149124270|NCT00346632|537934714|FG001|Overall Study|Not Stated|1|||
149124271|NCT00346632|537934715|FG002|Overall Study|Not Stated|0|||
149124272|NCT00346632|537934716|FG003|Overall Study|Not Stated|0|||
149124273|NCT00346632|537934717|FG004|Overall Study|Not Stated|0|||
149124274|NCT00346632|537934718|FG005|Overall Study|Not Stated|0|||
149124275|NCT00346632|537934719|FG006|Overall Study|Not Stated|0|||
149124276|NCT00346632|537934720|FG007|Overall Study|Not Stated|2|||
149124277|NCT00346632|537934721|FG008|Overall Study|Not Stated|2|||
149124278|NCT00346632|537934722|FG009|Overall Study|Not Stated|1|||
149124279|NCT00477334|537934723|FG000|Overall Study|Discontinued prior to taking study drug|106|||
149124280|NCT00477334|537934724|FG001|Overall Study|Discontinued prior to taking study drug|53|||
149124281|NCT00477334|537934723|FG000|Overall Study|Adverse Event|1|||
149124282|NCT00477334|537934724|FG001|Overall Study|Adverse Event|2|||
149124283|NCT00477334|537934723|FG000|Overall Study|Withdrawal by Subject|2|||
149124284|NCT00477334|537934724|FG001|Overall Study|Withdrawal by Subject|1|||
149124285|NCT00477334|537934723|FG000|Overall Study|Lost to Follow-up|15|||
149124286|NCT00477334|537934724|FG001|Overall Study|Lost to Follow-up|4|||
149124287|NCT00477334|537934723|FG000|Overall Study|Administrative Problems|39|||
149124288|NCT00477334|537934724|FG001|Overall Study|Administrative Problems|15|||
149124289|NCT00477334|537934723|FG000|Overall Study|Protocol Violation|7|||
149124290|NCT00477334|537934724|FG001|Overall Study|Protocol Violation|1|||
149124291|NCT02354508|537934728|FG000|Period 1: Core Phase|Adverse Event|1|||
149124292|NCT02354508|537934729|FG001|Period 1: Core Phase|Adverse Event|1|||
149124293|NCT02354508|537934730|FG002|Period 1: Core Phase|Adverse Event|2|||
149124294|NCT02354508|537934728|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
149124295|NCT02354508|537934729|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
149124296|NCT02354508|537934730|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
149124297|NCT02354508|537934728|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
149124298|NCT02354508|537934729|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
149124299|NCT02354508|537934730|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
149124300|NCT02354508|537934728|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
149124301|NCT02354508|537934729|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
149124302|NCT02354508|537934730|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
149124303|NCT02354508|537934728|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
149124304|NCT02354508|537934729|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
149124305|NCT02354508|537934730|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
149124306|NCT02354508|537934728|FG000|Period 2: Extension Phase|Physician Decision|5|||
148785794|NCT00339833|536692448|FG000|Overall Study|Error in data records|1|||
148785795|NCT00339833|536692449|FG001|Overall Study|Error in data records|0|||
149124307|NCT02354508|537934729|FG001|Period 2: Extension Phase|Physician Decision|0|||
149124308|NCT02354508|537934730|FG002|Period 2: Extension Phase|Physician Decision|1|||
149124309|NCT02354508|537934728|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
149124310|NCT02354508|537934729|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
149124311|NCT02354508|537934730|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
149124312|NCT02354508|537934728|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
149124313|NCT02354508|537934729|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
149124314|NCT02354508|537934730|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
149124315|NCT02354508|537934728|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
149124316|NCT02354508|537934729|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
149124317|NCT02354508|537934730|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
149124318|NCT03587974|537934732|FG000|Overall Study|caregiver demented, care recipient died|3|||
149124319|NCT03587974|537934733|FG001|Overall Study|caregiver demented, care recipient died|3|||
149124320|NCT03587974|537934732|FG000|Overall Study|Withdrawal by Subject|2|||
149124321|NCT03587974|537934733|FG001|Overall Study|Withdrawal by Subject|1|||
149124322|NCT02585232|537934734|FG000|Overall Study|Lost to Follow-up|8|||
149124323|NCT02585232|537934735|FG001|Overall Study|Lost to Follow-up|8|||
149124324|NCT02585232|537934734|FG000|Overall Study|Withdrawal by Subject|4|||
149124325|NCT02585232|537934735|FG001|Overall Study|Withdrawal by Subject|8|||
149124326|NCT00461032|537934736|FG000|Overall Study|Adverse Event|5|||
149124327|NCT00461032|537934737|FG001|Overall Study|Adverse Event|6|||
149124328|NCT00461032|537934736|FG000|Overall Study|Lack of Efficacy|5|||
149124329|NCT00461032|537934737|FG001|Overall Study|Lack of Efficacy|1|||
149124330|NCT00461032|537934736|FG000|Overall Study|Lost to Follow-up|7|||
149124331|NCT00461032|537934737|FG001|Overall Study|Lost to Follow-up|12|||
149124332|NCT00461032|537934736|FG000|Overall Study|Protocol Violation|4|||
149124333|NCT00461032|537934737|FG001|Overall Study|Protocol Violation|4|||
149124334|NCT00461032|537934736|FG000|Overall Study|Withdrawal by Subject|7|||
149124335|NCT00461032|537934737|FG001|Overall Study|Withdrawal by Subject|15|||
149124336|NCT00461032|537934736|FG000|Overall Study|Patient Moved or Relocated|2|||
149124337|NCT00461032|537934737|FG001|Overall Study|Patient Moved or Relocated|1|||
149124338|NCT00461032|537934736|FG000|Overall Study|Other|7|||
149124339|NCT00461032|537934737|FG001|Overall Study|Other|5|||
149124340|NCT04447846|537934738|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
149124341|NCT00297232|537934742|FG000|Overall Study|Lack of Efficacy|7|||
149124342|NCT00297232|537934742|FG000|Overall Study|Lost to Follow-up|10|||
149124343|NCT00297232|537934742|FG000|Overall Study|Adverse Event|63|||
149124344|NCT00297232|537934742|FG000|Overall Study|Voluntary Withdrawal|120|||
149124345|NCT00297232|537934742|FG000|Overall Study|Subject was Noncompliant|9|||
149124346|NCT00297232|537934742|FG000|Overall Study|Death|9|||
149124347|NCT00297232|537934742|FG000|Overall Study|Anti-natalizumab Positive|8|||
149124348|NCT00297232|537934742|FG000|Overall Study|Switched to Commercial Tysabri|22|||
149124349|NCT00297232|537934742|FG000|Overall Study|Disease Progression|8|||
149124350|NCT00297232|537934742|FG000|Overall Study|Fear of PML|10|||
149124351|NCT00297232|537934742|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
149124352|NCT00297232|537934742|FG000|Overall Study|Miscellaneous|5|||
149124353|NCT00297232|537934742|FG000|Overall Study|Sponsor Decision|34|||
149124354|NCT00297232|537934742|FG000|Overall Study|Subject Relocated|7|||
149124355|NCT00297232|537934742|FG000|Overall Study|Subject Withdrew Consent|37|||
149124356|NCT00297232|537934742|FG000|Overall Study|Persistently Positive Antibodies|11|||
149124357|NCT00297232|537934742|FG000|Overall Study|Investigator Withdrew From Program|19|||
149124358|NCT00297232|537934742|FG000|Overall Study|Did Not Enroll to Week 264|34|||
149124359|NCT00297232|537934742|FG000|Overall Study|Did Not Enroll to Week 480|17|||
149124360|NCT00297232|537934742|FG000|Overall Study|No data available after Week 264|161|||
149124361|NCT00297232|537934742|FG000|Overall Study|Other|1|||
149124362|NCT02257567|537934743|FG000|Overall Study|Adverse Event|0|||
149124363|NCT02257567|537934744|FG001|Overall Study|Adverse Event|0|||
149124364|NCT02257567|537934745|FG002|Overall Study|Adverse Event|0|||
149124365|NCT02257567|537934746|FG003|Overall Study|Adverse Event|1|||
149124366|NCT02257567|537934747|FG004|Overall Study|Adverse Event|1|||
149124367|NCT02257567|537934748|FG005|Overall Study|Adverse Event|0|||
149124368|NCT02257567|537934749|FG006|Overall Study|Adverse Event|0|||
149124369|NCT02257567|537934750|FG007|Overall Study|Adverse Event|0|||
149124370|NCT02257567|537934751|FG008|Overall Study|Adverse Event|1|||
149124371|NCT02257567|537934752|FG009|Overall Study|Adverse Event|0|||
149124372|NCT02257567|537934753|FG010|Overall Study|Adverse Event|0|||
149124373|NCT02257567|537934743|FG000|Overall Study|Death|2|||
149124374|NCT02257567|537934744|FG001|Overall Study|Death|2|||
149124375|NCT02257567|537934745|FG002|Overall Study|Death|2|||
149124376|NCT02257567|537934746|FG003|Overall Study|Death|4|||
149124377|NCT02257567|537934747|FG004|Overall Study|Death|15|||
149124378|NCT02257567|537934748|FG005|Overall Study|Death|11|||
149124379|NCT02257567|537934749|FG006|Overall Study|Death|26|||
149124380|NCT02257567|537934750|FG007|Overall Study|Death|30|||
149124381|NCT02257567|537934751|FG008|Overall Study|Death|2|||
149124382|NCT02257567|537934752|FG009|Overall Study|Death|18|||
149124383|NCT02257567|537934753|FG010|Overall Study|Death|65|||
149124384|NCT02257567|537934743|FG000|Overall Study|Lost to Follow-up|0|||
149124385|NCT02257567|537934744|FG001|Overall Study|Lost to Follow-up|0|||
149124386|NCT02257567|537934745|FG002|Overall Study|Lost to Follow-up|0|||
149124387|NCT02257567|537934746|FG003|Overall Study|Lost to Follow-up|0|||
149124388|NCT02257567|537934747|FG004|Overall Study|Lost to Follow-up|2|||
149124389|NCT02257567|537934748|FG005|Overall Study|Lost to Follow-up|2|||
149124390|NCT02257567|537934749|FG006|Overall Study|Lost to Follow-up|0|||
149124391|NCT02257567|537934750|FG007|Overall Study|Lost to Follow-up|0|||
149124392|NCT02257567|537934751|FG008|Overall Study|Lost to Follow-up|0|||
149124393|NCT02257567|537934752|FG009|Overall Study|Lost to Follow-up|1|||
149124394|NCT02257567|537934753|FG010|Overall Study|Lost to Follow-up|1|||
149124395|NCT02257567|537934743|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
148785796|NCT02829047|536692450|FG000|Overall Study|Withdrawal by Subject|1|||
148785797|NCT01464619|536692451|FG000|Overall Study|Lost to Follow-up|3|||
148785798|NCT01464619|536692452|FG001|Overall Study|Lost to Follow-up|4|||
148785799|NCT00750919|536692453|FG000|Overall Study|Adverse Event|9|||
148785800|NCT00750919|536692453|FG000|Overall Study|Withdrawal by Subject|1|||
148785801|NCT00750919|536692453|FG000|Overall Study|Lack of Efficacy|8|||
148785802|NCT00750919|536692453|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
148785803|NCT00750919|536692453|FG000|Overall Study|Other|36|||
148785804|NCT00080483|536692458|FG000|Overall Study|Lost to Follow-up|1|||
148785805|NCT00080483|536692459|FG001|Overall Study|Lost to Follow-up|1|||
148785806|NCT00080483|536692458|FG000|Overall Study|Physician Decision|1|||
148785807|NCT00080483|536692459|FG001|Overall Study|Physician Decision|1|||
148785808|NCT00002525|536692461|FG000|Overall Study|Adverse Event|36|||
148785809|NCT00002525|536692462|FG001|Overall Study|Adverse Event|0|||
148785810|NCT00002525|536692461|FG000|Overall Study|Death|5|||
148785811|NCT00002525|536692462|FG001|Overall Study|Death|0|||
148785812|NCT00002525|536692461|FG000|Overall Study|Withdrawal by Subject|11|||
148785813|NCT00002525|536692462|FG001|Overall Study|Withdrawal by Subject|0|||
148785814|NCT00002525|536692461|FG000|Overall Study|Start non-protocol therapy|1|||
148785815|NCT00002525|536692462|FG001|Overall Study|Start non-protocol therapy|0|||
148785816|NCT00002525|536692461|FG000|Overall Study|Other complicating disease|1|||
148785817|NCT00002525|536692462|FG001|Overall Study|Other complicating disease|0|||
148785818|NCT00002525|536692461|FG000|Overall Study|Duke's A, B1, D disease|92|||
148785819|NCT00002525|536692462|FG001|Overall Study|Duke's A, B1, D disease|0|||
148785820|NCT00002525|536692461|FG000|Overall Study|Error|6|||
148785821|NCT00002525|536692462|FG001|Overall Study|Error|0|||
148785822|NCT00002525|536692461|FG000|Overall Study|Other|26|||
148785823|NCT00002525|536692462|FG001|Overall Study|Other|0|||
148785824|NCT00002525|536692461|FG000|Overall Study|Never start protocol therapy|8|||
148785825|NCT00002525|536692462|FG001|Overall Study|Never start protocol therapy|0|||
148785826|NCT03304184|536692463|FG000|Overall Study|Withdrawal by Subject|1|||
148785827|NCT03304184|536692464|FG001|Overall Study|Withdrawal by Subject|2|||
148785828|NCT02651688|536692467|FG000|Overall Study|Non-compliance|0|||
148785829|NCT02651688|536692468|FG001|Overall Study|Non-compliance|0|||
148785830|NCT02651688|536692469|FG002|Overall Study|Non-compliance|1|||
148785831|NCT02651688|536692467|FG000|Overall Study|Principal Investigator (PI) decision|0|||
148785832|NCT02651688|536692468|FG001|Overall Study|Principal Investigator (PI) decision|2|||
148785833|NCT02651688|536692469|FG002|Overall Study|Principal Investigator (PI) decision|0|||
148785834|NCT02651688|536692467|FG000|Overall Study|Lost to Follow-up|1|||
148785835|NCT02651688|536692468|FG001|Overall Study|Lost to Follow-up|3|||
148785836|NCT02651688|536692469|FG002|Overall Study|Lost to Follow-up|0|||
148785837|NCT02651688|536692467|FG000|Overall Study|Withdrawal by Subject|1|||
148785838|NCT02651688|536692468|FG001|Overall Study|Withdrawal by Subject|0|||
148785839|NCT02651688|536692469|FG002|Overall Study|Withdrawal by Subject|2|||
148785840|NCT00625183|536692470|FG000|Overall Study|Disease Progression|1|||
148785841|NCT02279745|536692473|FG000|Overall Study|Adverse Event|7|||
148785842|NCT02279745|536692473|FG000|Overall Study|Death|6|||
148785843|NCT02279745|536692473|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
148785844|NCT02279745|536692473|FG000|Overall Study|Withdrawal by Subject|2|||
148785845|NCT02279745|536692473|FG000|Overall Study|Pregnancy|1|||
148785846|NCT02279745|536692473|FG000|Overall Study|Study Non-compliance|1|||
148785847|NCT02279745|536692473|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
148785848|NCT00380718|536692474|FG000|Overall Study|Adverse Event|1|||
148785849|NCT00380718|536692474|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
148785850|NCT01706575|536692478|FG000|Overall Study|Participant Withdrew Consent|4|||
148785851|NCT01706575|536692478|FG000|Overall Study|Lost to Follow-up|2|||
148785852|NCT01706575|536692478|FG000|Overall Study|Started but not Treated|6|||
148785853|NCT02912455|536692479|FG000|Overall Study|Withdrawal by Subject|0|||
148785854|NCT02912455|536692480|FG001|Overall Study|Withdrawal by Subject|1|||
148785855|NCT02912455|536692479|FG000|Overall Study|Lack of Efficacy|0|||
148785856|NCT02912455|536692480|FG001|Overall Study|Lack of Efficacy|1|||
148785857|NCT02912455|536692479|FG000|Overall Study|Lost to Follow-up|2|||
148785858|NCT02912455|536692480|FG001|Overall Study|Lost to Follow-up|1|||
148785859|NCT02670382|536692481|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
148785860|NCT02670382|536692482|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
148785861|NCT01428115|536692486|FG000|Overall Study|Lack of Efficacy|3|||
148785862|NCT01428115|536692486|FG000|Overall Study|Lost to Follow-up|10|||
148785863|NCT01428115|536692486|FG000|Overall Study|Pregnancy|1|||
148785864|NCT01428115|536692486|FG000|Overall Study|Protocol Violation|3|||
148785865|NCT01428115|536692486|FG000|Overall Study|Withdrawal by Subject|4|||
148785866|NCT01810783|536692487|FG000|Overall Study|Adverse Event|32|||
148785867|NCT01810783|536692487|FG000|Overall Study|Withdrawal by Subject|22|||
148785868|NCT01810783|536692487|FG000|Overall Study|Lack of Efficacy|12|||
148785869|NCT01810783|536692487|FG000|Overall Study|Lost to Follow-up|10|||
148785870|NCT01810783|536692487|FG000|Overall Study|Protocol Violation|5|||
148785871|NCT01810783|536692487|FG000|Overall Study|Non-compliance with IMP|4|||
148785872|NCT01810783|536692487|FG000|Overall Study|Adminstrative or other reason(s)|23|||
148893361|NCT02869633|537088684|FG000|Overall Study|Death|2|||
149124396|NCT02257567|537934744|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124397|NCT02257567|537934745|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124398|NCT02257567|537934746|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124399|NCT02257567|537934747|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
149124400|NCT02257567|537934748|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124401|NCT02257567|537934749|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
149124402|NCT02257567|537934750|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124403|NCT02257567|537934751|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124404|NCT02257567|537934752|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124405|NCT02257567|537934753|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
149124406|NCT02257567|537934743|FG000|Overall Study|Physician Decision|0|||
149124407|NCT02257567|537934744|FG001|Overall Study|Physician Decision|0|||
149124408|NCT02257567|537934745|FG002|Overall Study|Physician Decision|0|||
149124409|NCT02257567|537934746|FG003|Overall Study|Physician Decision|0|||
149124410|NCT02257567|537934747|FG004|Overall Study|Physician Decision|0|||
149124411|NCT02257567|537934748|FG005|Overall Study|Physician Decision|0|||
149124412|NCT02257567|537934749|FG006|Overall Study|Physician Decision|0|||
149124413|NCT02257567|537934750|FG007|Overall Study|Physician Decision|2|||
149124414|NCT02257567|537934751|FG008|Overall Study|Physician Decision|0|||
149124415|NCT02257567|537934752|FG009|Overall Study|Physician Decision|1|||
149124416|NCT02257567|537934753|FG010|Overall Study|Physician Decision|0|||
149124417|NCT02257567|537934743|FG000|Overall Study|Withdrawal by Subject|0|||
149124418|NCT02257567|537934744|FG001|Overall Study|Withdrawal by Subject|0|||
149124419|NCT02257567|537934745|FG002|Overall Study|Withdrawal by Subject|2|||
149124420|NCT02257567|537934746|FG003|Overall Study|Withdrawal by Subject|0|||
149124421|NCT02257567|537934747|FG004|Overall Study|Withdrawal by Subject|0|||
149124422|NCT02257567|537934748|FG005|Overall Study|Withdrawal by Subject|6|||
149124423|NCT02257567|537934749|FG006|Overall Study|Withdrawal by Subject|6|||
149124424|NCT02257567|537934750|FG007|Overall Study|Withdrawal by Subject|6|||
149124425|NCT02257567|537934751|FG008|Overall Study|Withdrawal by Subject|1|||
149124426|NCT02257567|537934752|FG009|Overall Study|Withdrawal by Subject|1|||
149124427|NCT02257567|537934753|FG010|Overall Study|Withdrawal by Subject|10|||
149124428|NCT01878214|537934756|FG000|Overall Study|Withdrawal by Subject|18|||
149124429|NCT01878214|537934757|FG001|Overall Study|Withdrawal by Subject|7|||
149124430|NCT01878214|537934756|FG000|Overall Study|Death|0|||
149124431|NCT01878214|537934757|FG001|Overall Study|Death|1|||
149124432|NCT01878214|537934756|FG000|Overall Study|Lost to Follow-up|35|||
149124433|NCT01878214|537934757|FG001|Overall Study|Lost to Follow-up|36|||
149124434|NCT00946101|537934758|FG000|Overall Study|Lost to Follow-up|2|||
149124435|NCT00946101|537934759|FG001|Overall Study|Lost to Follow-up|1|||
149124436|NCT00946101|537934758|FG000|Overall Study|Withdrawal of consent|2|||
149124437|NCT00946101|537934759|FG001|Overall Study|Withdrawal of consent|0|||
149124438|NCT00946101|537934758|FG000|Overall Study|Physician Decision|0|||
149124439|NCT00946101|537934759|FG001|Overall Study|Physician Decision|1|||
149124440|NCT01174160|537934760|FG000|Overall Study|Adverse Event|1|||
149124441|NCT01174160|537934761|FG001|Overall Study|Adverse Event|0|||
149124442|NCT01174160|537934760|FG000|Overall Study|Lost to Follow-up|1|||
149124443|NCT01174160|537934761|FG001|Overall Study|Lost to Follow-up|0|||
149124444|NCT01174160|537934760|FG000|Overall Study|Physician Decision|1|||
149124445|NCT01174160|537934761|FG001|Overall Study|Physician Decision|0|||
149124446|NCT01174160|537934760|FG000|Overall Study|Protocol Violation|4|||
149124447|NCT01174160|537934761|FG001|Overall Study|Protocol Violation|6|||
149124448|NCT01174160|537934760|FG000|Overall Study|Withdrawal by Subject|1|||
149124449|NCT01174160|537934761|FG001|Overall Study|Withdrawal by Subject|0|||
149124450|NCT01590017|537934762|FG000|Overall Study|Adverse Event|1|||
149124451|NCT01590017|537934762|FG000|Overall Study|Withdrawal by Subject|1|||
149124452|NCT01590017|537934762|FG000|Overall Study|Lack of Efficacy|1|||
149124453|NCT01590017|537934762|FG000|Overall Study|Physician Decision|1|||
149124454|NCT06377488|537934765|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
149124455|NCT06377488|537934765|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
149124456|NCT06377488|537934765|FG000|Overall Study|Protocol Violation|1|||
149124457|NCT06377488|537934765|FG000|Overall Study|Lost to Follow-up|1|||
149124458|NCT06377488|537934765|FG000|Overall Study|Incorrect Lens Dispensed|2|||
149124459|NCT03625895|537934766|FG000|Overall Study|Protocol Violation|585|||
149124460|NCT00552240|537934769|FG000|Overall Study|Adverse Event|9|||
149124461|NCT00552240|537934770|FG001|Overall Study|Adverse Event|9|||
149124462|NCT00552240|537934769|FG000|Overall Study|Protocol Violation|1|||
149124463|NCT00552240|537934770|FG001|Overall Study|Protocol Violation|1|||
149124464|NCT00552240|537934769|FG000|Overall Study|Lost to Follow-up|5|||
148691434|NCT01325207|536344178|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
149124465|NCT00552240|537934770|FG001|Overall Study|Lost to Follow-up|6|||
149124466|NCT00552240|537934769|FG000|Overall Study|Withdrawal by Subject|2|||
149124467|NCT00552240|537934770|FG001|Overall Study|Withdrawal by Subject|2|||
149124468|NCT00552240|537934769|FG000|Overall Study|Lack of Efficacy|6|||
149124469|NCT00552240|537934770|FG001|Overall Study|Lack of Efficacy|0|||
149124470|NCT00552240|537934769|FG000|Overall Study|Other|1|||
149124471|NCT00552240|537934770|FG001|Overall Study|Other|0|||
149124472|NCT02679573|537934771|FG000|Overall Study|Adverse Event|13|||
149124473|NCT02679573|537934772|FG001|Overall Study|Adverse Event|6|||
149124474|NCT02679573|537934771|FG000|Overall Study|Lack of Efficacy|12|||
149124475|NCT02679573|537934772|FG001|Overall Study|Lack of Efficacy|15|||
149124476|NCT02679573|537934771|FG000|Overall Study|Could not complete required study visits|6|||
149124477|NCT02679573|537934772|FG001|Overall Study|Could not complete required study visits|2|||
149124478|NCT02679573|537934771|FG000|Overall Study|Withdrawal by Subject|2|||
149124479|NCT02679573|537934772|FG001|Overall Study|Withdrawal by Subject|9|||
149124480|NCT02679573|537934771|FG000|Overall Study|Death|2|||
149124481|NCT02679573|537934772|FG001|Overall Study|Death|0|||
149124482|NCT02679573|537934771|FG000|Overall Study|Physician Decision|2|||
149124483|NCT02679573|537934772|FG001|Overall Study|Physician Decision|4|||
149124484|NCT02679573|537934771|FG000|Overall Study|Lost to Follow-up|0|||
149124485|NCT02679573|537934772|FG001|Overall Study|Lost to Follow-up|3|||
149124486|NCT01415531|537934773|FG000|Overall Study|Adverse Event|7|||
149124487|NCT01415531|537934774|FG001|Overall Study|Adverse Event|10|||
149124488|NCT01415531|537934773|FG000|Overall Study|Lack of Efficacy|3|||
149124489|NCT01415531|537934774|FG001|Overall Study|Lack of Efficacy|2|||
149124490|NCT01415531|537934773|FG000|Overall Study|Protocol Violation|0|||
149124491|NCT01415531|537934774|FG001|Overall Study|Protocol Violation|1|||
149124492|NCT01415531|537934773|FG000|Overall Study|Withdrawal by Subject|5|||
149124493|NCT01415531|537934774|FG001|Overall Study|Withdrawal by Subject|4|||
149124494|NCT01415531|537934773|FG000|Overall Study|Lost to Follow-up|6|||
149124495|NCT01415531|537934774|FG001|Overall Study|Lost to Follow-up|14|||
149124496|NCT01415531|537934773|FG000|Overall Study|Lack of Compliance|1|||
149124497|NCT01415531|537934774|FG001|Overall Study|Lack of Compliance|4|||
149124498|NCT01415531|537934773|FG000|Overall Study|Other Reasons|3|||
149124499|NCT01415531|537934774|FG001|Overall Study|Other Reasons|2|||
149124500|NCT05753670|537934775|FG000|Overall Study|Withdrawal by Subject|6|||
149124501|NCT05753670|537934776|FG001|Overall Study|Withdrawal by Subject|8|||
149124502|NCT05753670|537934775|FG000|Overall Study|Protocol Violation|3|||
149124503|NCT05753670|537934776|FG001|Overall Study|Protocol Violation|1|||
149124504|NCT02483585|537934777|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
149124505|NCT02483585|537934778|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
149124506|NCT02483585|537934777|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
149124507|NCT02483585|537934778|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
149124508|NCT02483585|537934777|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
149124509|NCT02483585|537934778|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
149124510|NCT02483585|537934777|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
149124511|NCT02483585|537934778|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
149124512|NCT02483585|537934777|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
149124513|NCT02483585|537934778|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
149124514|NCT02483585|537934777|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
149124515|NCT02483585|537934778|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
149124516|NCT02483585|537934777|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
149124517|NCT02483585|537934778|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
149124518|NCT00116753|537934786|FG000|Overall Study|Adverse Event|16|||
149124519|NCT00116753|537934787|FG001|Overall Study|Adverse Event|10|||
149124520|NCT00116753|537934788|FG002|Overall Study|Adverse Event|7|||
149124521|NCT00116753|537934786|FG000|Overall Study|Withdrawal by Subject|11|||
149124522|NCT00116753|537934787|FG001|Overall Study|Withdrawal by Subject|12|||
149124523|NCT00116753|537934788|FG002|Overall Study|Withdrawal by Subject|8|||
149124524|NCT00116753|537934786|FG000|Overall Study|Lost to Follow-up|0|||
149124525|NCT00116753|537934787|FG001|Overall Study|Lost to Follow-up|2|||
149124526|NCT00116753|537934788|FG002|Overall Study|Lost to Follow-up|1|||
149124527|NCT00116753|537934786|FG000|Overall Study|Protocol Violation|0|||
149124528|NCT00116753|537934787|FG001|Overall Study|Protocol Violation|0|||
149124529|NCT00116753|537934788|FG002|Overall Study|Protocol Violation|1|||
149124530|NCT00116753|537934786|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
149124531|NCT00116753|537934787|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
149124532|NCT00116753|537934788|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
149124533|NCT00116753|537934786|FG000|Overall Study|Disease Progression|3|||
149124534|NCT00116753|537934787|FG001|Overall Study|Disease Progression|4|||
149124535|NCT00116753|537934788|FG002|Overall Study|Disease Progression|3|||
149124536|NCT00116753|537934786|FG000|Overall Study|Abnormal Echocardiogram|0|||
149124537|NCT00116753|537934787|FG001|Overall Study|Abnormal Echocardiogram|0|||
149124538|NCT00116753|537934788|FG002|Overall Study|Abnormal Echocardiogram|1|||
149124539|NCT00116753|537934786|FG000|Overall Study|Progressive Parkinson's Disease|1|||
149124540|NCT00116753|537934787|FG001|Overall Study|Progressive Parkinson's Disease|0|||
149124541|NCT00116753|537934788|FG002|Overall Study|Progressive Parkinson's Disease|0|||
149124542|NCT00116753|537934786|FG000|Overall Study|Dosing Error|0|||
149124543|NCT00116753|537934787|FG001|Overall Study|Dosing Error|1|||
149124544|NCT00116753|537934788|FG002|Overall Study|Dosing Error|0|||
149124545|NCT01200589|537934789|FG000|Overall Study|Withdrawal by Subject|13|||
149124546|NCT01200589|537934790|FG001|Overall Study|Withdrawal by Subject|11|||
149124547|NCT01200589|537934789|FG000|Overall Study|Physician Decision|2|||
149124548|NCT01200589|537934790|FG001|Overall Study|Physician Decision|2|||
149124549|NCT01200589|537934789|FG000|Overall Study|Lost to Follow-up|5|||
149124550|NCT01200589|537934790|FG001|Overall Study|Lost to Follow-up|4|||
149124551|NCT01200589|537934789|FG000|Overall Study|Study terminated|170|||
149124552|NCT01200589|537934790|FG001|Overall Study|Study terminated|172|||
149124553|NCT01590082|537934791|FG000|Overall Study|Withdrawal by Subject|1|||
149124554|NCT01590082|537934792|FG001|Overall Study|Withdrawal by Subject|0|||
149124555|NCT01590082|537934791|FG000|Overall Study|Ineligible|1|||
149124556|NCT01590082|537934792|FG001|Overall Study|Ineligible|0|||
149124557|NCT01853644|537934793|FG000|Registration and Treatment Start|Did not start treatment|1|||
149124558|NCT01853644|537934793|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
149124559|NCT01853644|537934793|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
149124560|NCT01853644|537934793|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
149124561|NCT01853644|537934793|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
149124562|NCT01853644|537934793|FG000|Continued Treatment After First Response|Adverse Event|2|||
149124563|NCT01853644|537934793|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
149124564|NCT02891408|537934794|FG000|Overall Study|Lost to Follow-up|0|||
149124565|NCT02891408|537934795|FG001|Overall Study|Lost to Follow-up|0|||
149124566|NCT02891408|537934796|FG002|Overall Study|Lost to Follow-up|1|||
149124567|NCT02891408|537934797|FG003|Overall Study|Lost to Follow-up|0|||
149124568|NCT02891408|537934798|FG004|Overall Study|Lost to Follow-up|0|||
149124569|NCT02891408|537934799|FG005|Overall Study|Lost to Follow-up|0|||
149124570|NCT02891408|537934800|FG006|Overall Study|Lost to Follow-up|0|||
149124571|NCT00185965|537934801|FG000|Overall Study|Adverse Event|0|||
149124572|NCT00185965|537934802|FG001|Overall Study|Adverse Event|1|||
149124573|NCT03265938|537934804|FG000|Overall Study|Withdrawal by Subject|1|||
149124574|NCT03265938|537934804|FG000|Overall Study|Physician Decision|1|||
149124575|NCT03265938|537934804|FG000|Overall Study|friable mass|6|||
149124576|NCT03143166|537934805|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
149124577|NCT02673515|537934806|FG000|Overall Study|Lack of motivation|2|||
149124578|NCT02673515|537934807|FG001|Overall Study|Lack of motivation|1|||
149124579|NCT03683823|537934808|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
149124580|NCT03683823|537934809|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
149124581|NCT03683823|537934808|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
149124582|NCT03683823|537934809|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
149124583|NCT03683823|537934808|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
149124584|NCT03683823|537934809|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
149124585|NCT01323972|537934810|FG000|Overall Study|Withdrawal by Subject|1|||
149124586|NCT01323972|537934811|FG001|Overall Study|Withdrawal by Subject|0|||
149124587|NCT01323972|537934812|FG002|Overall Study|Withdrawal by Subject|1|||
149124588|NCT01323972|537934813|FG003|Overall Study|Withdrawal by Subject|0|||
149124589|NCT01323972|537934810|FG000|Overall Study|Migrated/moved from study area|1|||
149124590|NCT01323972|537934811|FG001|Overall Study|Migrated/moved from study area|2|||
149124591|NCT01323972|537934812|FG002|Overall Study|Migrated/moved from study area|0|||
149124592|NCT01323972|537934813|FG003|Overall Study|Migrated/moved from study area|0|||
149124593|NCT01323972|537934810|FG000|Overall Study|Lost to Follow-up|0|||
149124594|NCT01323972|537934811|FG001|Overall Study|Lost to Follow-up|1|||
149124595|NCT01323972|537934812|FG002|Overall Study|Lost to Follow-up|1|||
149124596|NCT01323972|537934813|FG003|Overall Study|Lost to Follow-up|1|||
149124597|NCT00994682|537934814|FG000|Double Bilnd|Withdrawal by Subject|5|||
149124598|NCT00994682|537934815|FG001|Double Bilnd|Withdrawal by Subject|6|||
149124599|NCT00994682|537934814|FG000|Double Bilnd|Lost to Follow-up|3|||
149124600|NCT00994682|537934815|FG001|Double Bilnd|Lost to Follow-up|3|||
149124601|NCT00994682|537934814|FG000|Double Bilnd|Adverse Event|1|||
149124602|NCT00994682|537934815|FG001|Double Bilnd|Adverse Event|0|||
149124603|NCT00994682|537934814|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
149124604|NCT00994682|537934815|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
149124605|NCT00994682|537934814|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
149124606|NCT00994682|537934815|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
149124607|NCT00994682|537934814|FG000|Pioglitazone Open Label|Physician Decision|6|||
149124608|NCT00994682|537934815|FG001|Pioglitazone Open Label|Physician Decision|1|||
149124609|NCT01946438|537934820|FG000|Overall Study|Adverse Event|0|||
149124610|NCT01946438|537934821|FG001|Overall Study|Adverse Event|0|||
149124611|NCT01946438|537934822|FG002|Overall Study|Adverse Event|0|||
149124612|NCT01946438|537934823|FG003|Overall Study|Adverse Event|1|||
149124613|NCT01946438|537934820|FG000|Overall Study|Serious Adverse event|1|||
149124614|NCT01946438|537934821|FG001|Overall Study|Serious Adverse event|0|||
149124615|NCT01946438|537934822|FG002|Overall Study|Serious Adverse event|0|||
149124616|NCT01946438|537934823|FG003|Overall Study|Serious Adverse event|0|||
149124617|NCT01946438|537934820|FG000|Overall Study|Protocol Violation|0|||
149124618|NCT01946438|537934821|FG001|Overall Study|Protocol Violation|0|||
149124619|NCT01946438|537934822|FG002|Overall Study|Protocol Violation|1|||
149124620|NCT01946438|537934823|FG003|Overall Study|Protocol Violation|0|||
149124621|NCT01946438|537934820|FG000|Overall Study|Withdrawal by Subject|1|||
149124622|NCT01946438|537934821|FG001|Overall Study|Withdrawal by Subject|0|||
149124623|NCT01946438|537934822|FG002|Overall Study|Withdrawal by Subject|0|||
149124624|NCT01946438|537934823|FG003|Overall Study|Withdrawal by Subject|0|||
149124625|NCT00589121|537934824|FG000|Overall Study|Protocol Violation|2|||
149124626|NCT00589121|537934825|FG001|Overall Study|Protocol Violation|6|||
149124627|NCT00589121|537934824|FG000|Overall Study|No protocol treatment received|0|||
149124628|NCT00589121|537934825|FG001|Overall Study|No protocol treatment received|1|||
149124629|NCT02412371|537934826|FG000|Overall Study|Withdrawal by Subject|0|||
149124630|NCT02412371|537934827|FG001|Overall Study|Withdrawal by Subject|2|||
149124631|NCT02412371|537934828|FG002|Overall Study|Withdrawal by Subject|0|||
149124632|NCT02412371|537934829|FG003|Overall Study|Withdrawal by Subject|1|||
149124633|NCT02412371|537934830|FG004|Overall Study|Withdrawal by Subject|1|||
149124634|NCT02412371|537934831|FG005|Overall Study|Withdrawal by Subject|0|||
149124635|NCT02412371|537934826|FG000|Overall Study|Sponsor Discontinued Study|1|||
149124636|NCT02412371|537934827|FG001|Overall Study|Sponsor Discontinued Study|4|||
149124637|NCT02412371|537934828|FG002|Overall Study|Sponsor Discontinued Study|6|||
149124638|NCT02412371|537934829|FG003|Overall Study|Sponsor Discontinued Study|4|||
149124639|NCT02412371|537934830|FG004|Overall Study|Sponsor Discontinued Study|5|||
149124640|NCT02412371|537934831|FG005|Overall Study|Sponsor Discontinued Study|0|||
149124641|NCT02412371|537934826|FG000|Overall Study|Death|4|||
149124642|NCT02412371|537934827|FG001|Overall Study|Death|2|||
149124643|NCT02412371|537934828|FG002|Overall Study|Death|1|||
149124644|NCT02412371|537934829|FG003|Overall Study|Death|3|||
149124645|NCT02412371|537934830|FG004|Overall Study|Death|5|||
149124646|NCT02412371|537934831|FG005|Overall Study|Death|2|||
149124647|NCT02412371|537934826|FG000|Overall Study|Other|2|||
149124648|NCT02412371|537934827|FG001|Overall Study|Other|1|||
149124649|NCT02412371|537934828|FG002|Overall Study|Other|0|||
149124650|NCT02412371|537934829|FG003|Overall Study|Other|0|||
149124651|NCT02412371|537934830|FG004|Overall Study|Other|1|||
149124652|NCT02412371|537934831|FG005|Overall Study|Other|3|||
149124653|NCT00847808|537934832|FG000|Overall Study|Adverse Event|7|||
149124654|NCT00847808|537934832|FG000|Overall Study|Protocol Violation|1|||
149124655|NCT00847808|537934832|FG000|Overall Study|Lost to Follow-up|1|||
149124656|NCT00847808|537934832|FG000|Overall Study|Withdrawal by Subject|4|||
149124657|NCT00847808|537934832|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
149124658|NCT00847808|537934832|FG000|Overall Study|Participant Took Excluded Medication|1|||
149124659|NCT00925132|537934841|FG000|Overall Study|Withdrawal by Subject|2|||
149124660|NCT00925132|537934842|FG001|Overall Study|Withdrawal by Subject|0|||
149124661|NCT00925132|537934843|FG002|Overall Study|Withdrawal by Subject|0|||
149124662|NCT00925132|537934844|FG003|Overall Study|Withdrawal by Subject|0|||
149124663|NCT00925132|537934845|FG004|Overall Study|Withdrawal by Subject|1|||
149124664|NCT00925132|537934841|FG000|Overall Study|Removed due to disease progression|0|||
149124665|NCT00925132|537934842|FG001|Overall Study|Removed due to disease progression|0|||
149124666|NCT00925132|537934843|FG002|Overall Study|Removed due to disease progression|0|||
149124667|NCT00925132|537934844|FG003|Overall Study|Removed due to disease progression|0|||
149124668|NCT00925132|537934845|FG004|Overall Study|Removed due to disease progression|4|||
149124669|NCT02545933|537934846|FG000|Overall Study|Adverse Event|3|||
149124670|NCT02545933|537934847|FG001|Overall Study|Adverse Event|0|||
149124671|NCT02545933|537934848|FG002|Overall Study|Adverse Event|0|||
149124672|NCT02545933|537934846|FG000|Overall Study|Withdrawal by Subject|2|||
149124673|NCT02545933|537934847|FG001|Overall Study|Withdrawal by Subject|3|||
149124674|NCT02545933|537934848|FG002|Overall Study|Withdrawal by Subject|3|||
149124675|NCT02545933|537934846|FG000|Overall Study|Protocol Violation|1|||
149124676|NCT02545933|537934847|FG001|Overall Study|Protocol Violation|0|||
149124677|NCT02545933|537934848|FG002|Overall Study|Protocol Violation|1|||
149124678|NCT00729378|537936667|FG000|Baseline|Did not complete study measurements|72|||
149124679|NCT00729378|537936668|FG001|Baseline|Did not complete study measurements|33|||
149124680|NCT00729378|537936667|FG000|Baseline|Withdrawal by Subject|66|||
149124681|NCT00729378|537936668|FG001|Baseline|Withdrawal by Subject|59|||
149124682|NCT00729378|537936667|FG000|12-months|Lost to Follow-up|100|||
149124683|NCT00729378|537936668|FG001|12-months|Lost to Follow-up|65|||
149124684|NCT00729378|537936667|FG000|24-months|Lost to Follow-up|72|||
149124685|NCT00729378|537936668|FG001|24-months|Lost to Follow-up|51|||
149124686|NCT00729378|537936667|FG000|36-months|Lost to Follow-up|15|||
149124687|NCT00729378|537936668|FG001|36-months|Lost to Follow-up|6|||
149124688|NCT01586910|537936669|FG000|Overall Study|Death|4|||
149124689|NCT01586910|537936670|FG001|Overall Study|Death|4|||
149124690|NCT01586910|537936669|FG000|Overall Study|Withdrawal by Subject|6|||
149124691|NCT01586910|537936670|FG001|Overall Study|Withdrawal by Subject|43|||
149124692|NCT01586910|537936669|FG000|Overall Study|Physician withdrew Subject|5|||
149124693|NCT01586910|537936670|FG001|Overall Study|Physician withdrew Subject|24|||
149124694|NCT01328717|537936679|FG000|Overall Study|Adverse Event|1|||
149124695|NCT00346268|537936680|FG000|Overall Study|Adverse Event|1|||
149124696|NCT00346268|537936681|FG001|Overall Study|Adverse Event|0|||
149124697|NCT00346268|537936680|FG000|Overall Study|Protocol Violation|1|||
149124698|NCT00346268|537936681|FG001|Overall Study|Protocol Violation|0|||
149124699|NCT00346268|537936680|FG000|Overall Study|Participant refused|0|||
149124700|NCT00346268|537936681|FG001|Overall Study|Participant refused|3|||
149124701|NCT00031551|537936682|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
149124702|NCT00031551|537936683|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
149124703|NCT00743275|537936684|FG000|Overall Study|Protocol Violation|0|||
149124704|NCT00743275|537936685|FG001|Overall Study|Protocol Violation|1|||
149124705|NCT01672723|537936686|FG000|First Intervention|Adverse Event|3|||
149124706|NCT01672723|537936687|FG001|First Intervention|Adverse Event|0|||
149124707|NCT00484289|537936698|FG000|Long Term Phase|Adverse Event|1|||
149124708|NCT00484289|537936699|FG001|Long Term Phase|Adverse Event|17|||
149124709|NCT00484289|537936700|FG002|Long Term Phase|Adverse Event|5|||
149124710|NCT00484289|537936698|FG000|Long Term Phase|Withdrawal by Subject|0|||
149124711|NCT00484289|537936699|FG001|Long Term Phase|Withdrawal by Subject|7|||
149124712|NCT00484289|537936700|FG002|Long Term Phase|Withdrawal by Subject|6|||
149124713|NCT00484289|537936698|FG000|Long Term Phase|Inadequate response|2|||
149124714|NCT00484289|537936699|FG001|Long Term Phase|Inadequate response|7|||
149124715|NCT00484289|537936700|FG002|Long Term Phase|Inadequate response|4|||
149124716|NCT00484289|537936698|FG000|Long Term Phase|Other Reason|0|||
149124717|NCT00484289|537936699|FG001|Long Term Phase|Other Reason|5|||
149124718|NCT00484289|537936700|FG002|Long Term Phase|Other Reason|1|||
149124719|NCT00484289|537936698|FG000|Post Marketing Phase|Adverse Event|0|||
149124720|NCT00484289|537936699|FG001|Post Marketing Phase|Adverse Event|1|||
149124721|NCT00484289|537936700|FG002|Post Marketing Phase|Adverse Event|0|||
149124722|NCT02831387|537936701|FG000|Overall Study|Withdrawal by Subject|1|||
149124723|NCT02831387|537936702|FG001|Overall Study|Withdrawal by Subject|1|||
149124724|NCT02831387|537936701|FG000|Overall Study|Discontinued due to stock recovery|0|||
149124725|NCT02831387|537936702|FG001|Overall Study|Discontinued due to stock recovery|1|||
149124726|NCT00192647|537936703|FG000|Overall Study|Death|1|||
149124727|NCT00192647|537936704|FG001|Overall Study|Death|1|||
148785873|NCT01810783|536692487|FG000|Overall Study|Enrolled, not treated|1|||
148785874|NCT02620384|536692488|FG000|Overall Study|Adverse Event|2|||
148785875|NCT02620384|536692489|FG001|Overall Study|Adverse Event|1|||
148785876|NCT02620384|536692488|FG000|Overall Study|Discharged prior to 2nd dose|2|||
148785877|NCT02620384|536692489|FG001|Overall Study|Discharged prior to 2nd dose|5|||
148785878|NCT02620384|536692488|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
148785879|NCT02620384|536692489|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
148785880|NCT02071082|536692490|FG000|Overall Study|Enrolled and Never Treated|1|||
148785881|NCT02071082|536692491|FG001|Overall Study|Enrolled and Never Treated|1|||
148785882|NCT02071082|536692490|FG000|Overall Study|Adverse Event|0|||
148785883|NCT02071082|536692491|FG001|Overall Study|Adverse Event|1|||
148785884|NCT02071082|536692490|FG000|Overall Study|Withdrew Consent|0|||
148785885|NCT02071082|536692491|FG001|Overall Study|Withdrew Consent|4|||
148785886|NCT02071082|536692490|FG000|Overall Study|Lost to Follow-up|1|||
148785887|NCT02071082|536692491|FG001|Overall Study|Lost to Follow-up|1|||
148785888|NCT00630747|536692492|FG000|Overall Study|Death|1|||
148785889|NCT00630747|536692492|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
148785890|NCT00630747|536692492|FG000|Overall Study|Returned to country of origin|1|||
148785891|NCT04503668|536692495|FG000|Overall Study|Incomplete data|4|||
148785892|NCT04503668|536692496|FG001|Overall Study|Incomplete data|3|||
148785893|NCT04503668|536692495|FG000|Overall Study|Withdrawal by Subject|1|||
148785894|NCT04503668|536692496|FG001|Overall Study|Withdrawal by Subject|1|||
148785895|NCT04503668|536692495|FG000|Overall Study|Adverse Event|2|||
148785896|NCT04503668|536692496|FG001|Overall Study|Adverse Event|0|||
149124728|NCT00192647|537936703|FG000|Overall Study|Adverse Event|35|||
149124729|NCT00192647|537936704|FG001|Overall Study|Adverse Event|29|||
148785897|NCT03403621|536692497|FG000|Overall Study|Withdrawal by Subject|2|||
148785898|NCT03403621|536692498|FG001|Overall Study|Withdrawal by Subject|2|||
148785899|NCT00395642|536692499|FG000|Overall Study|Death|4|||
148785900|NCT00395642|536692499|FG000|Overall Study|Lost to Follow-up|1|||
148785901|NCT00395642|536692499|FG000|Overall Study|Physician Decision|7|||
148785902|NCT00395642|536692499|FG000|Overall Study|Withdrawal by Subject|1|||
148785903|NCT01078298|536692502|FG000|Overall Study|Lost to Follow-up|12|||
149124730|NCT00192647|537936703|FG000|Overall Study|Laboratory Test Abnormality|4|||
149124731|NCT00192647|537936704|FG001|Overall Study|Laboratory Test Abnormality|2|||
149124732|NCT00192647|537936703|FG000|Overall Study|Insufficient Therapeutic Response|53|||
148785904|NCT01078298|536692503|FG001|Overall Study|Lost to Follow-up|13|||
148785905|NCT01078298|536692502|FG000|Overall Study|Withdrawal by Subject|31|||
148785906|NCT01078298|536692503|FG001|Overall Study|Withdrawal by Subject|33|||
148785907|NCT01078298|536692502|FG000|Overall Study|Protocol Violation|6|||
148785908|NCT01078298|536692503|FG001|Overall Study|Protocol Violation|6|||
148785909|NCT01078298|536692502|FG000|Overall Study|Adverse Event|6|||
149124733|NCT00192647|537936704|FG001|Overall Study|Insufficient Therapeutic Response|83|||
149124734|NCT00192647|537936703|FG000|Overall Study|Entry Criteria Violation|6|||
149124735|NCT00192647|537936704|FG001|Overall Study|Entry Criteria Violation|6|||
149124736|NCT00192647|537936703|FG000|Overall Study|Protocol Violation|3|||
149124737|NCT00192647|537936704|FG001|Overall Study|Protocol Violation|1|||
149124738|NCT00192647|537936703|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
149124739|NCT00192647|537936704|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
149124740|NCT00192647|537936703|FG000|Overall Study|Failure to Return|11|||
149124741|NCT00192647|537936704|FG001|Overall Study|Failure to Return|13|||
149124742|NCT00192647|537936703|FG000|Overall Study|Other/Administrative|5|||
149124743|NCT00192647|537936704|FG001|Overall Study|Other/Administrative|3|||
149124744|NCT01828073|537936705|FG000|Overall Study|Lost to Follow-up|1|||
149124745|NCT01828073|537936706|FG001|Overall Study|Lost to Follow-up|2|||
149124746|NCT00690443|537936711|FG000|Overall Study|Adverse Event|1|||
149124747|NCT00690443|537936712|FG001|Overall Study|Adverse Event|2|||
149124748|NCT03057977|537936713|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
149124749|NCT03057977|537936714|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
149124750|NCT03057977|537936713|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
149124751|NCT03057977|537936714|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
149124752|NCT03057977|537936713|FG000|Discontinuation From Treatment|Protocol Violation|6|||
149124753|NCT03057977|537936714|FG001|Discontinuation From Treatment|Protocol Violation|5|||
149124754|NCT03057977|537936713|FG000|Discontinuation From Treatment|Not treated|4|||
149124755|NCT03057977|537936714|FG001|Discontinuation From Treatment|Not treated|0|||
149124756|NCT03057977|537936713|FG000|Discontinuation From Treatment|Adverse Event|343|||
149124757|NCT03057977|537936714|FG001|Discontinuation From Treatment|Adverse Event|337|||
149124758|NCT03057977|537936713|FG000|Discontinuation From Treatment|Reason Unknown|0|||
149124759|NCT03057977|537936714|FG001|Discontinuation From Treatment|Reason Unknown|1|||
149124760|NCT03057977|537936713|FG000|Discontinuation From Treatment|Personal Reasons|1|||
149124761|NCT03057977|537936714|FG001|Discontinuation From Treatment|Personal Reasons|1|||
149124762|NCT03057977|537936713|FG000|Discontinuation From Treatment|Unblinded medication|1|||
149124763|NCT03057977|537936714|FG001|Discontinuation From Treatment|Unblinded medication|0|||
149124764|NCT03057977|537936713|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
149124765|NCT03057977|537936714|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
149124766|NCT03057977|537936713|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
149124767|NCT03057977|537936714|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
149124768|NCT03057977|537936713|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
149124769|NCT03057977|537936714|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
149124770|NCT03057977|537936713|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
149124771|NCT03057977|537936714|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
149124772|NCT03057977|537936713|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
149124773|NCT03057977|537936714|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
149124774|NCT03057977|537936713|FG000|Discontinuation From Treatment|Not attending study visit|3|||
149124775|NCT03057977|537936714|FG001|Discontinuation From Treatment|Not attending study visit|10|||
149124776|NCT03057977|537936713|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
149124777|NCT03057977|537936714|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
149124778|NCT03057977|537936713|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
149124779|NCT03057977|537936714|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
149124780|NCT03057977|537936713|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
149124781|NCT03057977|537936714|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
149124782|NCT03057977|537936713|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
149124783|NCT03057977|537936714|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
149124784|NCT03057977|537936713|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
149124785|NCT03057977|537936714|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
149124786|NCT00953407|537936715|FG000|Overall Study|Failed inclusion criteria|1|||
149124787|NCT00953407|537936716|FG001|Overall Study|Failed inclusion criteria|1|||
149124788|NCT00953407|537936717|FG002|Overall Study|Failed inclusion criteria|1|||
149124789|NCT00953407|537936718|FG003|Overall Study|Failed inclusion criteria|1|||
149124790|NCT00953407|537936719|FG004|Overall Study|Failed inclusion criteria|1|||
149124791|NCT00953407|537936715|FG000|Overall Study|Lost to Follow-up|0|||
149124792|NCT00953407|537936716|FG001|Overall Study|Lost to Follow-up|0|||
149124793|NCT00953407|537936717|FG002|Overall Study|Lost to Follow-up|0|||
149124794|NCT00953407|537936718|FG003|Overall Study|Lost to Follow-up|1|||
149124795|NCT00953407|537936719|FG004|Overall Study|Lost to Follow-up|0|||
149124796|NCT02502097|537936720|FG000|Period 1|Adverse Event|0|||
149124797|NCT02502097|537936721|FG001|Period 1|Adverse Event|0|||
149124798|NCT02502097|537936722|FG002|Period 1|Adverse Event|1|||
149124799|NCT02502097|537936723|FG003|Period 1|Adverse Event|0|||
149124800|NCT02502097|537936720|FG000|Wash Out Period|Adverse Event|0|||
149124801|NCT02502097|537936721|FG001|Wash Out Period|Adverse Event|1|||
149124802|NCT02502097|537936722|FG002|Wash Out Period|Adverse Event|1|||
149124803|NCT02502097|537936723|FG003|Wash Out Period|Adverse Event|1|||
149124804|NCT02502097|537936720|FG000|Period 2|Adverse Event|0|||
149124805|NCT02502097|537936721|FG001|Period 2|Adverse Event|0|||
149124806|NCT02502097|537936722|FG002|Period 2|Adverse Event|1|||
149124807|NCT02502097|537936723|FG003|Period 2|Adverse Event|0|||
149124808|NCT00876928|537936724|FG000|Overall Study|Lost to Follow-up|2|||
149124809|NCT00876928|537936725|FG001|Overall Study|Lost to Follow-up|5|||
149124810|NCT00876928|537936724|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
149124811|NCT00876928|537936725|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
149124812|NCT01689337|537936726|FG000|Overall Study|Study Discontinuation|1|||
149124813|NCT00642772|537936728|FG000|Overall Study|Lost to Follow-up|3|||
149124814|NCT00642772|537936728|FG000|Overall Study|Withdrawal by Subject|7|||
149124815|NCT01312857|537936734|FG000|Overall Study|Adverse Event|1|||
149124816|NCT01312857|537936735|FG001|Overall Study|Adverse Event|1|||
149124817|NCT01312857|537936734|FG000|Overall Study|Lost to Follow-up|2|||
149124818|NCT01312857|537936735|FG001|Overall Study|Lost to Follow-up|0|||
149124819|NCT01312857|537936734|FG000|Overall Study|Physician Decision|3|||
149124820|NCT01312857|537936735|FG001|Overall Study|Physician Decision|0|||
149124821|NCT01312857|537936734|FG000|Overall Study|Withdrawal by Subject|2|||
149124822|NCT01312857|537936735|FG001|Overall Study|Withdrawal by Subject|0|||
149124823|NCT02781844|537936740|FG000|Treatment Period 1|Adverse Event|0|||
149124824|NCT02781844|537936741|FG001|Treatment Period 1|Adverse Event|0|||
149124825|NCT02781844|537936742|FG002|Treatment Period 1|Adverse Event|0|||
149124826|NCT02781844|537936743|FG003|Treatment Period 1|Adverse Event|0|||
149124827|NCT02781844|537936744|FG004|Treatment Period 1|Adverse Event|0|||
149124828|NCT02781844|537936745|FG005|Treatment Period 1|Adverse Event|1|||
149124829|NCT02781844|537936746|FG006|Treatment Period 1|Adverse Event|0|||
149124830|NCT02781844|537936747|FG007|Treatment Period 1|Adverse Event|0|||
149124831|NCT02518490|537936748|FG000|Overall Study|Withdrawal by Subject|1|||
149124832|NCT02518490|537936749|FG001|Overall Study|Withdrawal by Subject|1|||
149124833|NCT04256629|537936750|FG000|Overall Study|Adverse Event|0|||
149124834|NCT04256629|537936751|FG001|Overall Study|Adverse Event|0|||
149124835|NCT04256629|537936752|FG002|Overall Study|Adverse Event|0|||
149124836|NCT04256629|537936753|FG003|Overall Study|Adverse Event|0|||
149124837|NCT04256629|537936754|FG004|Overall Study|Adverse Event|0|||
149124838|NCT04256629|537936755|FG005|Overall Study|Adverse Event|1|||
149124839|NCT04256629|537936750|FG000|Overall Study|Protocol Violation|0|||
149124840|NCT04256629|537936751|FG001|Overall Study|Protocol Violation|1|||
149124841|NCT04256629|537936752|FG002|Overall Study|Protocol Violation|0|||
149124842|NCT04256629|537936753|FG003|Overall Study|Protocol Violation|0|||
149124843|NCT04256629|537936754|FG004|Overall Study|Protocol Violation|0|||
149124844|NCT04256629|537936755|FG005|Overall Study|Protocol Violation|0|||
149124845|NCT01383499|537936756|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
149124846|NCT01383499|537936757|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149124847|NCT01383499|537936758|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149124848|NCT01383499|537936759|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
149124849|NCT02572882|537936760|FG000|Overall Study|Withdrawal by Subject|1|||
149124850|NCT02572882|537936760|FG000|Overall Study|Participant received kidney transplant|1|||
149124851|NCT04275089|537936763|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
149124852|NCT01079663|537936764|FG000|Overall Study|Adverse Event|0|||
149124853|NCT01079663|537936765|FG001|Overall Study|Adverse Event|2|||
149124854|NCT01079663|537936764|FG000|Overall Study|Protocol Violation|0|||
149124855|NCT01079663|537936765|FG001|Overall Study|Protocol Violation|2|||
149124856|NCT03486457|537936768|FG000|Up to Month 3|Adverse Event|2|||
149124857|NCT03486457|537936769|FG001|Up to Month 3|Adverse Event|5|||
149124858|NCT03486457|537936768|FG000|Up to Month 3|Lack of Efficacy|1|||
149124859|NCT03486457|537936769|FG001|Up to Month 3|Lack of Efficacy|0|||
149124860|NCT03486457|537936768|FG000|Up to Month 3|Withdrawal by Subject|1|||
149124861|NCT03486457|537936769|FG001|Up to Month 3|Withdrawal by Subject|0|||
149124862|NCT03486457|537936768|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
149124863|NCT03486457|537936769|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
149124864|NCT03486457|537936768|FG000|Up to Month 3|Other|1|||
149124865|NCT03486457|537936769|FG001|Up to Month 3|Other|0|||
149124866|NCT03486457|537936768|FG000|Month 3 to Month 6|Adverse Event|2|||
149124867|NCT03486457|537936769|FG001|Month 3 to Month 6|Adverse Event|0|||
149124868|NCT03486457|537936768|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
149124869|NCT03486457|537936769|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
149124870|NCT03486457|537936768|FG000|Month 3 to Month 6|Pregnancy|0|||
148785910|NCT01078298|536692503|FG001|Overall Study|Adverse Event|5|||
149124871|NCT03486457|537936769|FG001|Month 3 to Month 6|Pregnancy|1|||
149124872|NCT03486457|537936768|FG000|Month 3 to Month 6|Other|1|||
149124873|NCT03486457|537936769|FG001|Month 3 to Month 6|Other|0|||
149124874|NCT00093808|537936770|FG000|Overall Study|Cancel participation before receiving tx|1|||
149124875|NCT00093808|537936770|FG000|Overall Study|Protocol Violation|1|||
149124876|NCT00871780|537936771|FG000|Overall Study|Enrolled But Not Treated|6|||
149124877|NCT00871780|537936771|FG000|Overall Study|Withdrawal by Subject|9|||
149124878|NCT00871780|537936771|FG000|Overall Study|Adverse Event|6|||
149124879|NCT00871780|537936771|FG000|Overall Study|Voluntary Discontinuation|4|||
149124880|NCT00871780|537936771|FG000|Overall Study|Death|1|||
149124881|NCT00871780|537936771|FG000|Overall Study|Physician Decision|1|||
149124882|NCT02527343|537936772|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
149124883|NCT02527343|537936773|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
149124884|NCT02527343|537936774|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
149124885|NCT02527343|537936775|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
149124886|NCT02527343|537936776|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
149124887|NCT02527343|537936777|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
149124888|NCT02527343|537936772|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
149124889|NCT02527343|537936773|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
149124890|NCT02527343|537936774|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
149124891|NCT02527343|537936775|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
149124892|NCT02527343|537936776|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
149124893|NCT02527343|537936777|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
149124894|NCT02527343|537936772|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149124895|NCT02527343|537936773|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
149124896|NCT02527343|537936774|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149124897|NCT02527343|537936775|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149124898|NCT02527343|537936776|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149124899|NCT02527343|537936777|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149124900|NCT02527343|537936772|FG000|RT Period: Weeks 1 to 52|Other|4|||
149124901|NCT02527343|537936773|FG001|RT Period: Weeks 1 to 52|Other|3|||
149124902|NCT02527343|537936774|FG002|RT Period: Weeks 1 to 52|Other|0|||
149124903|NCT02527343|537936775|FG003|RT Period: Weeks 1 to 52|Other|0|||
149124904|NCT02527343|537936776|FG004|RT Period: Weeks 1 to 52|Other|0|||
149124905|NCT02527343|537936777|FG005|RT Period: Weeks 1 to 52|Other|0|||
149124906|NCT02527343|537936772|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
149124907|NCT02527343|537936773|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
149124908|NCT02527343|537936774|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
149124909|NCT02527343|537936775|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
149124910|NCT02527343|537936776|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
149124911|NCT02527343|537936777|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
149124912|NCT02527343|537936772|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
149124913|NCT02527343|537936773|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
149124914|NCT02527343|537936774|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
149124915|NCT02527343|537936775|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
149124916|NCT02527343|537936776|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
149124917|NCT02527343|537936777|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
149124918|NCT02527343|537936772|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
149124919|NCT02527343|537936773|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
149124920|NCT02527343|537936774|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
149124921|NCT02527343|537936775|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
149124922|NCT02527343|537936776|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
149124923|NCT02527343|537936777|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
149124924|NCT02527343|537936772|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
149124925|NCT02527343|537936773|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
149124926|NCT02527343|537936774|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
149124927|NCT02527343|537936775|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
149124928|NCT02527343|537936776|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
149124929|NCT02527343|537936777|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
149124930|NCT02527343|537936772|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
149124931|NCT02527343|537936773|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
149124932|NCT02527343|537936774|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
149124933|NCT02527343|537936775|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
149124934|NCT02527343|537936776|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
149124935|NCT02527343|537936777|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
149124936|NCT02527343|537936772|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
149124937|NCT02527343|537936773|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
149124938|NCT02527343|537936774|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
149124939|NCT02527343|537936775|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
149124940|NCT02527343|537936776|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
149124941|NCT02527343|537936777|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
149124942|NCT02527343|537936772|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
149124943|NCT02527343|537936773|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
149124944|NCT02527343|537936774|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
149124945|NCT02527343|537936775|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
149124946|NCT02527343|537936776|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
149124947|NCT02527343|537936777|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
149124948|NCT02527343|537936772|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
149124949|NCT02527343|537936773|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
149124950|NCT02527343|537936774|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
149124951|NCT02527343|537936775|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
149124952|NCT02527343|537936776|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
149124953|NCT02527343|537936777|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
149124954|NCT02527343|537936772|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
149124955|NCT02527343|537936773|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
149124956|NCT02527343|537936774|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
149124957|NCT02527343|537936775|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
149124958|NCT02527343|537936776|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
149124959|NCT02527343|537936777|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
149124960|NCT00701220|537936778|FG000|Overall Study|Withdrawal by Subject|0|||
149124961|NCT00701220|537936779|FG001|Overall Study|Withdrawal by Subject|2|||
149124962|NCT00701220|537936778|FG000|Overall Study|Protocol Violation|2|||
149124963|NCT00701220|537936779|FG001|Overall Study|Protocol Violation|0|||
149124964|NCT05767021|537936780|FG000|Overall Study|Adverse Event|2|||
149124965|NCT05767021|537936780|FG000|Overall Study|Protocol Deviation|1|||
149124966|NCT05767021|537936780|FG000|Overall Study|Withdrawal by Subject|1|||
149124967|NCT05767021|537936780|FG000|Overall Study|Physician Decision|1|||
149124968|NCT05767021|537936780|FG000|Overall Study|Lack of Efficacy|11|||
149124969|NCT05767021|537936780|FG000|Overall Study|Assigned Treatment by Mistake|1|||
149124970|NCT03545503|537936782|FG000|Overall Study|Protocol Violation|14|||
149124971|NCT03545503|537936783|FG001|Overall Study|Protocol Violation|16|||
149124972|NCT01236339|537936788|FG000|Overall Study|Termination of study by sponsor|11|||
149124973|NCT01236339|537936789|FG001|Overall Study|Termination of study by sponsor|13|||
149124974|NCT01098097|537936790|FG000|Overall Study|Adverse Event|17|||
149124975|NCT01098097|537936790|FG000|Overall Study|Lost to Follow-up|18|||
149124976|NCT01098097|537936790|FG000|Overall Study|Status unknown|16|||
149124977|NCT01098097|537936790|FG000|Overall Study|No reason reported|31|||
149124978|NCT00394082|537936791|FG000|Overall Study|Unacceptable toxicity|15|||
149124979|NCT00394082|537936791|FG000|Overall Study|Adverse Event|4|||
149124980|NCT00394082|537936791|FG000|Overall Study|Physician Decision|4|||
149124981|NCT00394082|537936791|FG000|Overall Study|Withdrawal by Subject|2|||
149124982|NCT00394082|537936791|FG000|Overall Study|Other|1|||
149124983|NCT01945060|537936792|FG000|Overall Study|Lost to follow up|1|||
149124984|NCT01945060|537936793|FG001|Overall Study|Lost to follow up|0|||
149124985|NCT01945060|537936792|FG000|Overall Study|Distress related to IV access|0|||
149124986|NCT01945060|537936793|FG001|Overall Study|Distress related to IV access|1|||
149124987|NCT01831856|537936794|FG000|Overall Study|Adverse Event|5|||
149124988|NCT01831856|537936795|FG001|Overall Study|Adverse Event|8|||
149124989|NCT01831856|537936794|FG000|Overall Study|Lack of Efficacy|13|||
149124990|NCT01831856|537936795|FG001|Overall Study|Lack of Efficacy|11|||
149124991|NCT01831856|537936794|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
149124992|NCT01831856|537936795|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
149124993|NCT05208866|537936796|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
149124994|NCT00577577|537936798|FG000|Overall Study|Adverse Event|3|||
149124995|NCT00577577|537936799|FG001|Overall Study|Adverse Event|2|||
149124996|NCT00577577|537936798|FG000|Overall Study|Lost to Follow-up|1|||
149124997|NCT00577577|537936799|FG001|Overall Study|Lost to Follow-up|0|||
149124998|NCT00577577|537936798|FG000|Overall Study|Protocol Violation|0|||
149124999|NCT00577577|537936799|FG001|Overall Study|Protocol Violation|3|||
149125000|NCT00577577|537936798|FG000|Overall Study|Transportation|1|||
149125001|NCT00577577|537936799|FG001|Overall Study|Transportation|0|||
149125002|NCT00232544|537936800|FG000|Overall Study|Lost to Follow-up|20|||
149125003|NCT00232544|537936801|FG001|Overall Study|Lost to Follow-up|15|||
149125004|NCT00986973|537936802|FG000|Overall Study|Withdrawn by study team|1|||
149125005|NCT02009761|537936804|FG000|Overall Study|Adverse Event|4|||
149125006|NCT00825825|537936805|FG000|First Medication Period (14 Days)|Adverse Event|1|||
149125007|NCT00825825|537936806|FG001|First Medication Period (14 Days)|Adverse Event|0|||
149125008|NCT00825825|537936807|FG002|First Medication Period (14 Days)|Adverse Event|0|||
149125009|NCT00825825|537936808|FG003|First Medication Period (14 Days)|Adverse Event|0|||
149125010|NCT00825825|537936809|FG004|First Medication Period (14 Days)|Adverse Event|0|||
149125011|NCT00825825|537936810|FG005|First Medication Period (14 Days)|Adverse Event|1|||
149125012|NCT00825825|537936805|FG000|First Medication Period (14 Days)|Physician Decision|2|||
149125013|NCT00825825|537936806|FG001|First Medication Period (14 Days)|Physician Decision|0|||
149125014|NCT00825825|537936807|FG002|First Medication Period (14 Days)|Physician Decision|1|||
149125015|NCT00825825|537936808|FG003|First Medication Period (14 Days)|Physician Decision|0|||
149125016|NCT00825825|537936809|FG004|First Medication Period (14 Days)|Physician Decision|0|||
149125017|NCT00825825|537936810|FG005|First Medication Period (14 Days)|Physician Decision|1|||
149125018|NCT00825825|537936805|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
149125019|NCT00825825|537936806|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
149125020|NCT00825825|537936807|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
149125021|NCT00825825|537936808|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
149125022|NCT00825825|537936809|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
149125023|NCT00825825|537936810|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
149125024|NCT00825825|537936805|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
149125025|NCT00825825|537936806|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
149125026|NCT00825825|537936807|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
149125027|NCT00825825|537936808|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
149125028|NCT00825825|537936809|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
149125029|NCT00825825|537936810|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
149125030|NCT00825825|537936805|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
149125031|NCT00825825|537936806|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
149125032|NCT00825825|537936807|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
149125033|NCT00825825|537936808|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
149125034|NCT00825825|537936809|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
149125035|NCT00825825|537936810|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
149125036|NCT00825825|537936805|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
149125037|NCT00825825|537936806|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
149125038|NCT00825825|537936807|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
149125039|NCT00825825|537936808|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
149125040|NCT00825825|537936809|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
149125041|NCT00825825|537936810|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
149125042|NCT00825825|537936805|FG000|Third Medication Period (14 Days)|poor data quality|0|||
149125043|NCT00825825|537936806|FG001|Third Medication Period (14 Days)|poor data quality|1|||
149125044|NCT00825825|537936807|FG002|Third Medication Period (14 Days)|poor data quality|0|||
149125045|NCT00825825|537936808|FG003|Third Medication Period (14 Days)|poor data quality|0|||
149125046|NCT00825825|537936809|FG004|Third Medication Period (14 Days)|poor data quality|0|||
149125047|NCT00825825|537936810|FG005|Third Medication Period (14 Days)|poor data quality|0|||
149125048|NCT00950950|537936811|FG000|Overall Study|Adverse Event|1|||
149125049|NCT00950950|537936812|FG001|Overall Study|Adverse Event|0|||
149125050|NCT00950950|537936811|FG000|Overall Study|Withdrawal by Subject|0|||
149125051|NCT00950950|537936812|FG001|Overall Study|Withdrawal by Subject|1|||
149125052|NCT01047293|537936816|FG000|Overall Study|DLT criteria not fulfilled|1|||
149125053|NCT01047293|537936817|FG001|Overall Study|DLT criteria not fulfilled|1|||
149125054|NCT01047293|537936818|FG002|Overall Study|DLT criteria not fulfilled|0|||
149125055|NCT01047293|537936819|FG003|Overall Study|DLT criteria not fulfilled|0|||
149125056|NCT00757783|537936822|FG000|Overall Study|Adverse Event|0|||
149125057|NCT00757783|537936823|FG001|Overall Study|Adverse Event|2|||
149125058|NCT00757783|537936822|FG000|Overall Study|Lost to Follow-up|1|||
149125059|NCT00757783|537936823|FG001|Overall Study|Lost to Follow-up|1|||
149125060|NCT00757783|537936822|FG000|Overall Study|Protocol Violation|1|||
149125061|NCT00757783|537936823|FG001|Overall Study|Protocol Violation|0|||
149125062|NCT00757783|537936822|FG000|Overall Study|Withdrawal by Subject|2|||
149125063|NCT00757783|537936823|FG001|Overall Study|Withdrawal by Subject|1|||
149125064|NCT00757783|537936822|FG000|Overall Study|Other|1|||
149125065|NCT00757783|537936823|FG001|Overall Study|Other|2|||
149125066|NCT02372136|537936824|FG000|Overall Study|Death|3|||
149125067|NCT02372136|537936825|FG001|Overall Study|Death|1|||
149125068|NCT01775124|537936826|FG000|Core Period|Disease Progression|0|||
149125069|NCT01775124|537936827|FG001|Core Period|Disease Progression|1|||
149125070|NCT01775124|537936826|FG000|Core Period|Physician Decision|1|||
149125071|NCT01775124|537936827|FG001|Core Period|Physician Decision|1|||
149125072|NCT01775124|537936826|FG000|Core Period|Death|0|||
149125073|NCT01775124|537936827|FG001|Core Period|Death|1|||
149125074|NCT01775124|537936826|FG000|Core Period|Administrative problems|1|||
149125075|NCT01775124|537936827|FG001|Core Period|Administrative problems|0|||
149125076|NCT01775124|537936826|FG000|Core Period|Withdrawal by Subject|4|||
149125077|NCT01775124|537936827|FG001|Core Period|Withdrawal by Subject|2|||
149125078|NCT01775124|537936826|FG000|Core Period|Adverse Event|5|||
149125079|NCT01775124|537936827|FG001|Core Period|Adverse Event|5|||
149125080|NCT01775124|537936826|FG000|Extension Period|Adverse Event|3|||
149125081|NCT01775124|537936827|FG001|Extension Period|Adverse Event|2|||
149125082|NCT01775124|537936826|FG000|Extension Period|Physician Decision|0|||
149125083|NCT01775124|537936827|FG001|Extension Period|Physician Decision|2|||
149125084|NCT01775124|537936826|FG000|Extension Period|Administrative problems|0|||
149125085|NCT01775124|537936827|FG001|Extension Period|Administrative problems|1|||
149125086|NCT01775124|537936826|FG000|Extension Period|Lost to Follow-up|0|||
149125087|NCT01775124|537936827|FG001|Extension Period|Lost to Follow-up|1|||
149125088|NCT01775124|537936826|FG000|Extension Period|Withdrawal by Subject|9|||
149125089|NCT01775124|537936827|FG001|Extension Period|Withdrawal by Subject|12|||
149125090|NCT02164383|537939129|FG000|Overall Study|Lost to Follow-up|1|||
149125091|NCT02164383|537939130|FG001|Overall Study|Lost to Follow-up|0|||
149125092|NCT01350336|537939131|FG000|Overall Study|Lost to Follow-up|31|||
149125093|NCT01350336|537939131|FG000|Overall Study|Withdrawal by Subject|14|||
149125094|NCT01350336|537939131|FG000|Overall Study|Physician Decision|8|||
149125095|NCT01350336|537939131|FG000|Overall Study|Death|4|||
149125096|NCT01016977|537939139|FG000|Overall Study|Lost to Follow-up|1|||
149125097|NCT01016977|537939140|FG001|Overall Study|Lost to Follow-up|0|||
149125098|NCT01016977|537939139|FG000|Overall Study|Withdrawal by Subject|2|||
149125099|NCT01016977|537939140|FG001|Overall Study|Withdrawal by Subject|2|||
149125100|NCT05081388|537939143|FG000|Overall Study|Adverse Event|1|||
149125101|NCT05081388|537939144|FG001|Overall Study|Adverse Event|0|||
149125102|NCT05081388|537939145|FG002|Overall Study|Adverse Event|0|||
149125103|NCT05081388|537939146|FG003|Overall Study|Adverse Event|0|||
149125104|NCT05081388|537939147|FG004|Overall Study|Adverse Event|0|||
149125105|NCT05081388|537939143|FG000|Overall Study|Lost to Follow-up|0|||
149125106|NCT05081388|537939144|FG001|Overall Study|Lost to Follow-up|1|||
149125107|NCT05081388|537939145|FG002|Overall Study|Lost to Follow-up|0|||
149125108|NCT05081388|537939146|FG003|Overall Study|Lost to Follow-up|0|||
149125109|NCT05081388|537939147|FG004|Overall Study|Lost to Follow-up|0|||
149125110|NCT05081388|537939143|FG000|Overall Study|Subject decision|0|||
149125111|NCT05081388|537939144|FG001|Overall Study|Subject decision|0|||
149125112|NCT05081388|537939145|FG002|Overall Study|Subject decision|0|||
149125113|NCT05081388|537939146|FG003|Overall Study|Subject decision|1|||
149125114|NCT05081388|537939147|FG004|Overall Study|Subject decision|0|||
149125115|NCT01776541|537939148|FG000|Overall Study|Administrative Reason|6|||
149125116|NCT01776541|537939149|FG001|Overall Study|Administrative Reason|2|||
149125117|NCT01776541|537939148|FG000|Overall Study|Death|4|||
149125118|NCT01776541|537939149|FG001|Overall Study|Death|0|||
149125119|NCT01776541|537939148|FG000|Overall Study|Lost to Follow-up|27|||
149125120|NCT01776541|537939149|FG001|Overall Study|Lost to Follow-up|48|||
149125121|NCT01776541|537939148|FG000|Overall Study|Unclassified|5|||
149125122|NCT01776541|537939149|FG001|Overall Study|Unclassified|4|||
149125123|NCT01776541|537939148|FG000|Overall Study|Protocol Violation|2|||
149125124|NCT01776541|537939149|FG001|Overall Study|Protocol Violation|1|||
149125125|NCT01776541|537939148|FG000|Overall Study|Withdrawal by Subject|12|||
149125126|NCT01776541|537939149|FG001|Overall Study|Withdrawal by Subject|20|||
149125127|NCT04279392|537939150|FG000|Overall Study|Physician Decision|1|||
149125128|NCT04279392|537939151|FG001|Overall Study|Physician Decision|0|||
149125129|NCT01171807|537939152|FG000|Overall Study|Treatment failure|2|||
149125130|NCT01171807|537939153|FG001|Overall Study|Treatment failure|4|||
149125131|NCT01171807|537939152|FG000|Overall Study|Non compliance|1|||
149125132|NCT01171807|537939153|FG001|Overall Study|Non compliance|0|||
149125133|NCT01171807|537939152|FG000|Overall Study|Lost to Follow-up|3|||
149125134|NCT01171807|537939153|FG001|Overall Study|Lost to Follow-up|0|||
149125135|NCT01901341|537939154|FG000|Overall Study|Adverse Event|4|||
149125136|NCT01901341|537939155|FG001|Overall Study|Adverse Event|2|||
149125137|NCT01901341|537939154|FG000|Overall Study|Lack of Efficacy|0|||
149125138|NCT01901341|537939155|FG001|Overall Study|Lack of Efficacy|2|||
149125139|NCT01901341|537939154|FG000|Overall Study|Lost to Follow-up|0|||
149125140|NCT01901341|537939155|FG001|Overall Study|Lost to Follow-up|1|||
149125141|NCT01901341|537939154|FG000|Overall Study|Protocol Violation|2|||
149125142|NCT01901341|537939155|FG001|Overall Study|Protocol Violation|0|||
149125143|NCT01901341|537939154|FG000|Overall Study|Study Terminated by Sponsor|13|||
149125144|NCT01901341|537939155|FG001|Overall Study|Study Terminated by Sponsor|15|||
149125145|NCT01901341|537939154|FG000|Overall Study|Withdrawal by Subject|1|||
149125146|NCT01901341|537939155|FG001|Overall Study|Withdrawal by Subject|1|||
149125147|NCT01981473|537939156|FG000|Overall Study|Incorrect diagnosis of RA|0|||
149125148|NCT01981473|537939157|FG001|Overall Study|Incorrect diagnosis of RA|0|||
149125149|NCT01981473|537939158|FG002|Overall Study|Incorrect diagnosis of RA|1|||
149125150|NCT01981473|537939156|FG000|Overall Study|Received treatment for < 6 months|0|||
149125151|NCT01981473|537939157|FG001|Overall Study|Received treatment for < 6 months|0|||
149125152|NCT01981473|537939158|FG002|Overall Study|Received treatment for < 6 months|1|||
149125153|NCT01981473|537939156|FG000|Overall Study|Received treatment for >24 months|2|||
149125154|NCT01981473|537939157|FG001|Overall Study|Received treatment for >24 months|0|||
149125155|NCT01981473|537939158|FG002|Overall Study|Received treatment for >24 months|6|||
149125156|NCT00738582|537939159|FG000|Combination Therapy|Completed Combination Therapy|1|||
149125157|NCT00738582|537939160|FG001|Combination Therapy|Completed Combination Therapy|0|||
149125158|NCT00738582|537939159|FG000|Combination Therapy|Physician Decision|1|||
149125159|NCT00738582|537939160|FG001|Combination Therapy|Physician Decision|0|||
149125160|NCT00738582|537939159|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
149125161|NCT00738582|537939160|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
149125162|NCT00738582|537939159|FG000|Combination Therapy|Other|5|||
149125163|NCT00738582|537939160|FG001|Combination Therapy|Other|0|||
149125164|NCT00738582|537939159|FG000|Combination Therapy|Adverse Event|16|||
149125165|NCT00738582|537939160|FG001|Combination Therapy|Adverse Event|0|||
149125166|NCT00738582|537939159|FG000|Combination Therapy|Progressive Disease|9|||
149125167|NCT00738582|537939160|FG001|Combination Therapy|Progressive Disease|0|||
149125168|NCT00738582|537939159|FG000|Maintenance Therapy|Other|0|||
149125169|NCT00738582|537939160|FG001|Maintenance Therapy|Other|2|||
149125170|NCT00738582|537939159|FG000|Maintenance Therapy|Adverse Event|0|||
149125171|NCT00738582|537939160|FG001|Maintenance Therapy|Adverse Event|6|||
149125172|NCT00738582|537939159|FG000|Maintenance Therapy|Progressive Disease|0|||
149125173|NCT00738582|537939160|FG001|Maintenance Therapy|Progressive Disease|47|||
149125174|NCT00738582|537939159|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
149125175|NCT00738582|537939160|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
149125176|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
149125177|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
149125178|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
149125179|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
149125180|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
149125181|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
149125182|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
149125183|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
149125184|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
149125185|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
149125186|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
149125187|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
149125188|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
149125189|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
149125190|NCT00757588|537939161|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
149125191|NCT00757588|537939162|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
149125192|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
149125193|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
149125194|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
149125195|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
149125196|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
149125197|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
149125198|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
149125199|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
149125200|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
149125201|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
149125202|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
149125203|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
149125204|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
149125205|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
149125206|NCT00757588|537939161|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
149125207|NCT00757588|537939162|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
149125208|NCT00799513|537939167|FG000|Overall Study|Physician Decision|1|||
149125209|NCT00799513|537939167|FG000|Overall Study|Adverse Event|1|||
149125210|NCT05062759|537939168|FG000|Overall Study|Death|0|||
149125211|NCT05062759|537939169|FG001|Overall Study|Death|1|||
149125212|NCT05062759|537939168|FG000|Overall Study|Lost to Follow-up|1|||
149125213|NCT05062759|537939169|FG001|Overall Study|Lost to Follow-up|0|||
149125214|NCT00903006|537939170|FG000|Overall Study|Withdrawal by Subject|2|||
149125215|NCT00903006|537939171|FG001|Overall Study|Withdrawal by Subject|0|||
149125216|NCT00903006|537939172|FG002|Overall Study|Withdrawal by Subject|0|||
149125217|NCT00903006|537939173|FG003|Overall Study|Withdrawal by Subject|0|||
149125218|NCT00903006|537939170|FG000|Overall Study|Progressive Disease|0|||
149125219|NCT00903006|537939171|FG001|Overall Study|Progressive Disease|3|||
149125220|NCT00903006|537939172|FG002|Overall Study|Progressive Disease|1|||
149125221|NCT00903006|537939173|FG003|Overall Study|Progressive Disease|0|||
149125222|NCT03536143|537939176|FG000|Overall Study|Early termination, Sponsor decision|1|||
149125223|NCT04055090|537939179|FG000|Overall Study|screen failure|1|||
149125224|NCT04055090|537939180|FG001|Overall Study|screen failure|0|||
149125225|NCT04055090|537939179|FG000|Overall Study|Withdrawal by Subject|1|||
149125226|NCT04055090|537939180|FG001|Overall Study|Withdrawal by Subject|0|||
149125227|NCT04745026|537939181|FG000|Overall Study|Physician Decision|1|||
149125228|NCT04745026|537939182|FG001|Overall Study|Physician Decision|0|||
149125229|NCT04745026|537939181|FG000|Overall Study|Adverse Event|2|||
149125230|NCT04745026|537939182|FG001|Overall Study|Adverse Event|2|||
149125231|NCT04745026|537939181|FG000|Overall Study|Protocol Violation|1|||
149125232|NCT04745026|537939182|FG001|Overall Study|Protocol Violation|3|||
149125233|NCT04745026|537939181|FG000|Overall Study|Lost to Follow-up|4|||
149125234|NCT04745026|537939182|FG001|Overall Study|Lost to Follow-up|3|||
149125235|NCT04745026|537939181|FG000|Overall Study|Withdrawal by Subject|5|||
149125236|NCT04745026|537939182|FG001|Overall Study|Withdrawal by Subject|5|||
149125237|NCT05478499|537939183|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
149125238|NCT05478499|537939184|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
149125239|NCT05478499|537939183|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
149125240|NCT05478499|537939184|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
149125241|NCT05478499|537939183|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
149125242|NCT05478499|537939184|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
149125243|NCT05478499|537939183|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
149125244|NCT05478499|537939184|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
149125245|NCT05478499|537939183|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
149125246|NCT05478499|537939184|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
149125247|NCT05478499|537939183|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
149125248|NCT05478499|537939184|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
149125249|NCT05478499|537939183|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
149125250|NCT05478499|537939184|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
149125251|NCT05478499|537939183|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
149125252|NCT05478499|537939184|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
149125253|NCT05478499|537939183|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
149125254|NCT05478499|537939184|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
149125255|NCT05478499|537939183|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
149125256|NCT05478499|537939184|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
149125257|NCT05478499|537939183|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
149125258|NCT05478499|537939184|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
149125259|NCT04426851|537939185|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
149125260|NCT04426851|537939186|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
149125261|NCT04426851|537939185|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
149125262|NCT04426851|537939186|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
149125263|NCT03256851|537939190|FG000|Overall Study|Withdrawal by Subject|1|||
149125264|NCT03256851|537939191|FG001|Overall Study|Withdrawal by Subject|0|||
149125265|NCT02476279|537939193|FG000|Overall Study|Lost to Follow-up|1|||
149125266|NCT02476279|537939194|FG001|Overall Study|Lost to Follow-up|1|||
149125267|NCT02128542|537939195|FG000|Overall Study|Lost to Follow-up|3|||
149125268|NCT02128542|537939196|FG001|Overall Study|Lost to Follow-up|0|||
149125269|NCT02128542|537939195|FG000|Overall Study|Withdrew Consent|1|||
149125270|NCT02128542|537939196|FG001|Overall Study|Withdrew Consent|0|||
149125271|NCT00402597|537939197|FG000|Overall Study|Death|15|||
149125272|NCT00402597|537939198|FG001|Overall Study|Death|7|||
149125273|NCT00402597|537939199|FG002|Overall Study|Death|6|||
149125274|NCT00402597|537939200|FG003|Overall Study|Death|4|||
149125275|NCT00402597|537939201|FG004|Overall Study|Death|6|||
149125276|NCT00402597|537939197|FG000|Overall Study|Adverse Event|81|||
149125277|NCT00402597|537939198|FG001|Overall Study|Adverse Event|18|||
149125278|NCT00402597|537939199|FG002|Overall Study|Adverse Event|106|||
149125279|NCT00402597|537939200|FG003|Overall Study|Adverse Event|39|||
149125280|NCT00402597|537939201|FG004|Overall Study|Adverse Event|71|||
149125281|NCT00402597|537939197|FG000|Overall Study|Lost to Follow-up|8|||
149125282|NCT00402597|537939198|FG001|Overall Study|Lost to Follow-up|1|||
149125283|NCT00402597|537939199|FG002|Overall Study|Lost to Follow-up|8|||
149125284|NCT00402597|537939200|FG003|Overall Study|Lost to Follow-up|2|||
149125285|NCT00402597|537939201|FG004|Overall Study|Lost to Follow-up|3|||
149125286|NCT00402597|537939197|FG000|Overall Study|Withdrawal by Subject|57|||
149125287|NCT00402597|537939198|FG001|Overall Study|Withdrawal by Subject|16|||
149125288|NCT00402597|537939199|FG002|Overall Study|Withdrawal by Subject|65|||
149125289|NCT00402597|537939200|FG003|Overall Study|Withdrawal by Subject|15|||
149125290|NCT00402597|537939201|FG004|Overall Study|Withdrawal by Subject|24|||
149125291|NCT00402597|537939197|FG000|Overall Study|reason not specified|30|||
149125292|NCT00402597|537939198|FG001|Overall Study|reason not specified|4|||
149125293|NCT00402597|537939199|FG002|Overall Study|reason not specified|27|||
149125294|NCT00402597|537939200|FG003|Overall Study|reason not specified|14|||
149125295|NCT00402597|537939201|FG004|Overall Study|reason not specified|20|||
149125296|NCT00598273|537939205|FG000|Overall Study|Adverse Event|4|||
149125297|NCT00598273|537939206|FG001|Overall Study|Adverse Event|5|||
149125298|NCT00598273|537939207|FG002|Overall Study|Adverse Event|2|||
149125299|NCT00598273|537939205|FG000|Overall Study|Death|6|||
149125300|NCT00598273|537939206|FG001|Overall Study|Death|12|||
149125301|NCT00598273|537939207|FG002|Overall Study|Death|8|||
149125302|NCT00598273|537939205|FG000|Overall Study|Lost to Follow-up|8|||
149125303|NCT00598273|537939206|FG001|Overall Study|Lost to Follow-up|3|||
149125304|NCT00598273|537939207|FG002|Overall Study|Lost to Follow-up|5|||
149125305|NCT00598273|537939205|FG000|Overall Study|Physician Decision|0|||
149125306|NCT00598273|537939206|FG001|Overall Study|Physician Decision|0|||
149125307|NCT00598273|537939207|FG002|Overall Study|Physician Decision|1|||
149125308|NCT00598273|537939205|FG000|Overall Study|Withdrawal by Subject|12|||
149125309|NCT00598273|537939206|FG001|Overall Study|Withdrawal by Subject|10|||
149125310|NCT00598273|537939207|FG002|Overall Study|Withdrawal by Subject|10|||
149125311|NCT00598273|537939205|FG000|Overall Study|Noncompliance|3|||
149125312|NCT00598273|537939206|FG001|Overall Study|Noncompliance|2|||
149125313|NCT00598273|537939207|FG002|Overall Study|Noncompliance|3|||
149125314|NCT00598273|537939205|FG000|Overall Study|Relocation|0|||
149125315|NCT00598273|537939206|FG001|Overall Study|Relocation|2|||
149125316|NCT00598273|537939207|FG002|Overall Study|Relocation|4|||
149125317|NCT00598273|537939205|FG000|Overall Study|Renal transplant|1|||
149125318|NCT00598273|537939206|FG001|Overall Study|Renal transplant|0|||
149125319|NCT00598273|537939207|FG002|Overall Study|Renal transplant|1|||
149125320|NCT00598273|537939205|FG000|Overall Study|Site elected to close|1|||
149125321|NCT00598273|537939206|FG001|Overall Study|Site elected to close|0|||
149125322|NCT00598273|537939207|FG002|Overall Study|Site elected to close|0|||
149125323|NCT00598273|537939205|FG000|Overall Study|Started dialysis|6|||
149125324|NCT00598273|537939206|FG001|Overall Study|Started dialysis|4|||
149125325|NCT00598273|537939207|FG002|Overall Study|Started dialysis|5|||
149125326|NCT00906945|537939208|FG000|Overall Study|Found to be not eligible|0|||
149125327|NCT00906945|537939209|FG001|Overall Study|Found to be not eligible|0|||
149125328|NCT00906945|537939210|FG002|Overall Study|Found to be not eligible|0|||
149125329|NCT00906945|537939211|FG003|Overall Study|Found to be not eligible|1|||
149125330|NCT00906945|537939212|FG004|Overall Study|Found to be not eligible|1|||
149125331|NCT00906945|537939213|FG005|Overall Study|Found to be not eligible|1|||
149125332|NCT00906945|537939208|FG000|Overall Study|Physician Decision|0|||
149125333|NCT00906945|537939209|FG001|Overall Study|Physician Decision|0|||
149125334|NCT00906945|537939210|FG002|Overall Study|Physician Decision|0|||
149125335|NCT00906945|537939211|FG003|Overall Study|Physician Decision|0|||
149125336|NCT00906945|537939212|FG004|Overall Study|Physician Decision|0|||
149125337|NCT00906945|537939213|FG005|Overall Study|Physician Decision|1|||
149125338|NCT01210664|537939215|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
149125339|NCT01210664|537939216|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
149125340|NCT01210664|537939217|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
149125341|NCT01210664|537939218|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
149125342|NCT01210664|537939215|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
149125343|NCT01210664|537939216|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
149125344|NCT01210664|537939217|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
149125345|NCT01210664|537939218|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
149125346|NCT01210664|537939215|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
149125347|NCT01210664|537939216|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
149125348|NCT01210664|537939217|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
149125349|NCT01210664|537939218|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
149125350|NCT01054170|537939219|FG000|Overall Study|Protocol Violation|1|||
149125351|NCT01054170|537939220|FG001|Overall Study|Protocol Violation|0|||
149125352|NCT01054170|537939219|FG000|Overall Study|Withdrawal by Subject|3|||
149125353|NCT01054170|537939220|FG001|Overall Study|Withdrawal by Subject|2|||
149125354|NCT01054170|537939219|FG000|Overall Study|Adverse Event|0|||
149125355|NCT01054170|537939220|FG001|Overall Study|Adverse Event|4|||
149125356|NCT02951767|537939221|FG000|Overall Study|Study Terminated By Sponsor|9|||
149125357|NCT02951767|537939221|FG000|Overall Study|Withdrawal by Subject|11|||
149125358|NCT02951767|537939221|FG000|Overall Study|Death|96|||
149125359|NCT02951767|537939221|FG000|Overall Study|Lost to Follow-up|2|||
149125360|NCT02951767|537939221|FG000|Overall Study|Physician Decision|1|||
149125361|NCT02751320|537939222|FG000|Overall Study|Adverse Event|2|||
149125362|NCT02751320|537939222|FG000|Overall Study|Withdrawal by Subject|1|||
149125363|NCT02549196|537939223|FG000|Overall Study|Protocol Violation|0|||
149125364|NCT02549196|537939224|FG001|Overall Study|Protocol Violation|0|||
149125365|NCT02549196|537939225|FG002|Overall Study|Protocol Violation|0|||
149125366|NCT02549196|537939226|FG003|Overall Study|Protocol Violation|1|||
149125367|NCT02549196|537939223|FG000|Overall Study|Withdrawal by Subject|1|||
149125368|NCT02549196|537939224|FG001|Overall Study|Withdrawal by Subject|0|||
149125369|NCT02549196|537939225|FG002|Overall Study|Withdrawal by Subject|1|||
149125370|NCT02549196|537939226|FG003|Overall Study|Withdrawal by Subject|0|||
149125371|NCT01442779|537939227|FG000|Overall Study|Withdrawal by Subject|3|||
149125372|NCT01442779|537939227|FG000|Overall Study|Death|3|||
149125373|NCT01442779|537939227|FG000|Overall Study|Non-compliance|1|||
149125374|NCT05249829|537939228|FG000|Overall Study|Participant Relocation|0|||
149125375|NCT05249829|537939229|FG001|Overall Study|Participant Relocation|1|||
149125376|NCT05249829|537939230|FG002|Overall Study|Participant Relocation|2|||
149125377|NCT05249829|537939231|FG003|Overall Study|Participant Relocation|2|||
149125378|NCT05249829|537939228|FG000|Overall Study|Withdrawal by Subject|9|||
149125379|NCT05249829|537939229|FG001|Overall Study|Withdrawal by Subject|17|||
149125380|NCT05249829|537939230|FG002|Overall Study|Withdrawal by Subject|40|||
149125381|NCT05249829|537939231|FG003|Overall Study|Withdrawal by Subject|35|||
149125382|NCT05249829|537939228|FG000|Overall Study|Physician Decision|1|||
149125383|NCT05249829|537939229|FG001|Overall Study|Physician Decision|0|||
149125384|NCT05249829|537939230|FG002|Overall Study|Physician Decision|0|||
149125385|NCT05249829|537939231|FG003|Overall Study|Physician Decision|0|||
149125386|NCT05249829|537939228|FG000|Overall Study|Lost to Follow-up|16|||
149125387|NCT05249829|537939229|FG001|Overall Study|Lost to Follow-up|16|||
149125388|NCT05249829|537939230|FG002|Overall Study|Lost to Follow-up|57|||
149125389|NCT05249829|537939231|FG003|Overall Study|Lost to Follow-up|60|||
149125390|NCT05249829|537939228|FG000|Overall Study|Adverse Event|2|||
149125391|NCT05249829|537939229|FG001|Overall Study|Adverse Event|2|||
149125392|NCT05249829|537939230|FG002|Overall Study|Adverse Event|2|||
149125393|NCT05249829|537939231|FG003|Overall Study|Adverse Event|2|||
149125394|NCT05249829|537939228|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
149125395|NCT05249829|537939229|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
149125396|NCT05249829|537939230|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
149125397|NCT05249829|537939231|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
149125398|NCT05249829|537939228|FG000|Overall Study|Protocol Violation|2|||
149125399|NCT05249829|537939229|FG001|Overall Study|Protocol Violation|0|||
149125400|NCT05249829|537939230|FG002|Overall Study|Protocol Violation|5|||
149125401|NCT05249829|537939231|FG003|Overall Study|Protocol Violation|3|||
149125402|NCT05249829|537939228|FG000|Overall Study|Death|0|||
149125403|NCT05249829|537939229|FG001|Overall Study|Death|1|||
149125404|NCT05249829|537939230|FG002|Overall Study|Death|2|||
149125405|NCT05249829|537939231|FG003|Overall Study|Death|4|||
149125406|NCT00513604|537939232|FG000|Overall Study|Not treated|2|||
149125407|NCT00513604|537939233|FG001|Overall Study|Not treated|0|||
149125408|NCT00513604|537939234|FG002|Overall Study|Not treated|1|||
149125409|NCT00513604|537939235|FG003|Overall Study|Not treated|0|||
149125410|NCT00513604|537939236|FG004|Overall Study|Not treated|0|||
149125411|NCT00513604|537939232|FG000|Overall Study|Death during treatment|0|||
149125412|NCT00513604|537939233|FG001|Overall Study|Death during treatment|3|||
149125413|NCT00513604|537939234|FG002|Overall Study|Death during treatment|2|||
149125414|NCT00513604|537939235|FG003|Overall Study|Death during treatment|0|||
149125415|NCT00513604|537939236|FG004|Overall Study|Death during treatment|0|||
149125416|NCT00196976|537939237|FG000|Primary Study|Migrated from study area|0|||
149125417|NCT00196976|537939238|FG001|Primary Study|Migrated from study area|0|||
149125418|NCT00196976|537939239|FG002|Primary Study|Migrated from study area|0|||
149125419|NCT00196976|537939240|FG003|Primary Study|Migrated from study area|0|||
149125420|NCT00196976|537939241|FG004|Primary Study|Migrated from study area|0|||
149125421|NCT00196976|537939242|FG005|Primary Study|Migrated from study area|0|||
149125422|NCT00196976|537939243|FG006|Primary Study|Migrated from study area|0|||
149125423|NCT00196976|537939244|FG007|Primary Study|Migrated from study area|1|||
149125424|NCT00196976|537939245|FG008|Primary Study|Migrated from study area|0|||
149125425|NCT00196976|537939246|FG009|Primary Study|Migrated from study area|0|||
149125426|NCT00196976|537939247|FG010|Primary Study|Migrated from study area|0|||
149125427|NCT00196976|537939248|FG011|Primary Study|Migrated from study area|0|||
149125428|NCT00196976|537939249|FG012|Primary Study|Migrated from study area|0|||
149125429|NCT00196976|537939250|FG013|Primary Study|Migrated from study area|0|||
149125430|NCT00196976|537939237|FG000|Primary Study|Protocol Violation|0|||
149125431|NCT00196976|537939238|FG001|Primary Study|Protocol Violation|1|||
149125432|NCT00196976|537939239|FG002|Primary Study|Protocol Violation|1|||
149125433|NCT00196976|537939240|FG003|Primary Study|Protocol Violation|0|||
149125434|NCT00196976|537939241|FG004|Primary Study|Protocol Violation|0|||
149125435|NCT00196976|537939242|FG005|Primary Study|Protocol Violation|0|||
149125436|NCT00196976|537939243|FG006|Primary Study|Protocol Violation|0|||
149125437|NCT00196976|537939244|FG007|Primary Study|Protocol Violation|0|||
149125438|NCT00196976|537939245|FG008|Primary Study|Protocol Violation|0|||
149125439|NCT00196976|537939246|FG009|Primary Study|Protocol Violation|0|||
149125440|NCT00196976|537939247|FG010|Primary Study|Protocol Violation|0|||
149125441|NCT00196976|537939248|FG011|Primary Study|Protocol Violation|0|||
149125442|NCT00196976|537939249|FG012|Primary Study|Protocol Violation|0|||
149125443|NCT00196976|537939250|FG013|Primary Study|Protocol Violation|0|||
149125444|NCT00196976|537939237|FG000|Primary Study|Withdrawal by Subject|1|||
149125445|NCT00196976|537939238|FG001|Primary Study|Withdrawal by Subject|0|||
149125446|NCT00196976|537939239|FG002|Primary Study|Withdrawal by Subject|1|||
149125447|NCT00196976|537939240|FG003|Primary Study|Withdrawal by Subject|1|||
149125448|NCT00196976|537939241|FG004|Primary Study|Withdrawal by Subject|2|||
149125449|NCT00196976|537939242|FG005|Primary Study|Withdrawal by Subject|1|||
149125450|NCT00196976|537939243|FG006|Primary Study|Withdrawal by Subject|0|||
149125451|NCT00196976|537939244|FG007|Primary Study|Withdrawal by Subject|0|||
149125452|NCT00196976|537939245|FG008|Primary Study|Withdrawal by Subject|0|||
149125453|NCT00196976|537939246|FG009|Primary Study|Withdrawal by Subject|1|||
149125454|NCT00196976|537939247|FG010|Primary Study|Withdrawal by Subject|0|||
149125455|NCT00196976|537939248|FG011|Primary Study|Withdrawal by Subject|0|||
149125456|NCT00196976|537939249|FG012|Primary Study|Withdrawal by Subject|0|||
149125457|NCT00196976|537939250|FG013|Primary Study|Withdrawal by Subject|0|||
149125458|NCT00196976|537939237|FG000|Primary Study|Lost to Follow-up|0|||
149125459|NCT00196976|537939238|FG001|Primary Study|Lost to Follow-up|0|||
149125460|NCT00196976|537939239|FG002|Primary Study|Lost to Follow-up|0|||
149125461|NCT00196976|537939240|FG003|Primary Study|Lost to Follow-up|0|||
149125462|NCT00196976|537939241|FG004|Primary Study|Lost to Follow-up|1|||
149125463|NCT00196976|537939242|FG005|Primary Study|Lost to Follow-up|1|||
149125464|NCT00196976|537939243|FG006|Primary Study|Lost to Follow-up|0|||
149125465|NCT00196976|537939244|FG007|Primary Study|Lost to Follow-up|2|||
149125466|NCT00196976|537939245|FG008|Primary Study|Lost to Follow-up|0|||
149125467|NCT00196976|537939246|FG009|Primary Study|Lost to Follow-up|0|||
149125468|NCT00196976|537939247|FG010|Primary Study|Lost to Follow-up|0|||
149125469|NCT00196976|537939248|FG011|Primary Study|Lost to Follow-up|0|||
149125470|NCT00196976|537939249|FG012|Primary Study|Lost to Follow-up|0|||
149125471|NCT00196976|537939250|FG013|Primary Study|Lost to Follow-up|0|||
149125472|NCT00196976|537939237|FG000|Primary Study|Other|0|||
149125473|NCT00196976|537939238|FG001|Primary Study|Other|0|||
149125474|NCT00196976|537939239|FG002|Primary Study|Other|2|||
149125475|NCT00196976|537939240|FG003|Primary Study|Other|0|||
149125476|NCT00196976|537939241|FG004|Primary Study|Other|0|||
149125477|NCT00196976|537939242|FG005|Primary Study|Other|0|||
149125478|NCT00196976|537939243|FG006|Primary Study|Other|0|||
149125479|NCT00196976|537939244|FG007|Primary Study|Other|0|||
149125480|NCT00196976|537939245|FG008|Primary Study|Other|0|||
149125481|NCT00196976|537939246|FG009|Primary Study|Other|0|||
149125482|NCT00196976|537939247|FG010|Primary Study|Other|0|||
149125483|NCT00196976|537939248|FG011|Primary Study|Other|0|||
149125484|NCT00196976|537939249|FG012|Primary Study|Other|0|||
149125485|NCT00196976|537939250|FG013|Primary Study|Other|0|||
149125486|NCT00196976|537939237|FG000|Booster Study|Withdrawal by Subject|0|||
149125487|NCT00196976|537939238|FG001|Booster Study|Withdrawal by Subject|0|||
149125488|NCT00196976|537939239|FG002|Booster Study|Withdrawal by Subject|0|||
149125489|NCT00196976|537939240|FG003|Booster Study|Withdrawal by Subject|0|||
149125490|NCT00196976|537939241|FG004|Booster Study|Withdrawal by Subject|0|||
149125491|NCT00196976|537939242|FG005|Booster Study|Withdrawal by Subject|0|||
149125492|NCT00196976|537939243|FG006|Booster Study|Withdrawal by Subject|0|||
149125493|NCT00196976|537939244|FG007|Booster Study|Withdrawal by Subject|0|||
149125494|NCT00196976|537939245|FG008|Booster Study|Withdrawal by Subject|0|||
149125495|NCT00196976|537939246|FG009|Booster Study|Withdrawal by Subject|0|||
149125496|NCT00196976|537939247|FG010|Booster Study|Withdrawal by Subject|1|||
149125497|NCT00196976|537939248|FG011|Booster Study|Withdrawal by Subject|0|||
149125498|NCT00196976|537939249|FG012|Booster Study|Withdrawal by Subject|0|||
149125499|NCT00196976|537939250|FG013|Booster Study|Withdrawal by Subject|0|||
149125500|NCT00196976|537939237|FG000|Booster Study|Lost to Follow-up|0|||
149125501|NCT00196976|537939238|FG001|Booster Study|Lost to Follow-up|0|||
149125502|NCT00196976|537939239|FG002|Booster Study|Lost to Follow-up|0|||
149125503|NCT00196976|537939240|FG003|Booster Study|Lost to Follow-up|0|||
149125504|NCT00196976|537939241|FG004|Booster Study|Lost to Follow-up|0|||
149125505|NCT00196976|537939242|FG005|Booster Study|Lost to Follow-up|0|||
149125506|NCT00196976|537939243|FG006|Booster Study|Lost to Follow-up|0|||
149125507|NCT00196976|537939244|FG007|Booster Study|Lost to Follow-up|0|||
149125508|NCT00196976|537939245|FG008|Booster Study|Lost to Follow-up|0|||
149125509|NCT00196976|537939246|FG009|Booster Study|Lost to Follow-up|0|||
149125510|NCT00196976|537939247|FG010|Booster Study|Lost to Follow-up|1|||
149125511|NCT00196976|537939248|FG011|Booster Study|Lost to Follow-up|2|||
149125512|NCT00196976|537939249|FG012|Booster Study|Lost to Follow-up|0|||
149125513|NCT00196976|537939250|FG013|Booster Study|Lost to Follow-up|0|||
149125514|NCT01535560|537939251|FG000|Overall Study|Adverse Event|12|||
149125515|NCT01535560|537939252|FG001|Overall Study|Adverse Event|7|||
149125516|NCT01535560|537939251|FG000|Overall Study|Lost to Follow-up|1|||
149125517|NCT01535560|537939252|FG001|Overall Study|Lost to Follow-up|3|||
149125518|NCT01535560|537939251|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
149125519|NCT01535560|537939252|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
149125520|NCT01535560|537939251|FG000|Overall Study|Treatment Failure|21|||
149125521|NCT01535560|537939252|FG001|Overall Study|Treatment Failure|83|||
149125522|NCT01535560|537939251|FG000|Overall Study|Other|0|||
149125523|NCT01535560|537939252|FG001|Overall Study|Other|1|||
149125524|NCT01535560|537939251|FG000|Overall Study|Randomized in Error|0|||
149125525|NCT01535560|537939252|FG001|Overall Study|Randomized in Error|1|||
149125526|NCT02842827|537939255|FG000|Overall Study|Adverse Event|0|||
149125527|NCT02842827|537939256|FG001|Overall Study|Adverse Event|1|||
149125528|NCT02842827|537939257|FG002|Overall Study|Adverse Event|0|||
149125529|NCT02842827|537939258|FG003|Overall Study|Adverse Event|1|||
149125530|NCT02842827|537939259|FG004|Overall Study|Adverse Event|0|||
149125531|NCT02842827|537939260|FG005|Overall Study|Adverse Event|1|||
149125532|NCT02842827|537939261|FG006|Overall Study|Adverse Event|0|||
149125533|NCT02842827|537939262|FG007|Overall Study|Adverse Event|0|||
149125534|NCT02842827|537939255|FG000|Overall Study|Death|1|||
149125535|NCT02842827|537939256|FG001|Overall Study|Death|0|||
149125536|NCT02842827|537939257|FG002|Overall Study|Death|2|||
149125537|NCT02842827|537939258|FG003|Overall Study|Death|3|||
149125538|NCT02842827|537939259|FG004|Overall Study|Death|2|||
149125539|NCT02842827|537939260|FG005|Overall Study|Death|1|||
149125540|NCT02842827|537939261|FG006|Overall Study|Death|0|||
149125541|NCT02842827|537939262|FG007|Overall Study|Death|4|||
149125542|NCT02842827|537939255|FG000|Overall Study|Physician Decision|1|||
149125543|NCT02842827|537939256|FG001|Overall Study|Physician Decision|3|||
149125544|NCT02842827|537939257|FG002|Overall Study|Physician Decision|0|||
149125545|NCT02842827|537939258|FG003|Overall Study|Physician Decision|0|||
149125546|NCT02842827|537939259|FG004|Overall Study|Physician Decision|1|||
149125547|NCT02842827|537939260|FG005|Overall Study|Physician Decision|4|||
149125548|NCT02842827|537939261|FG006|Overall Study|Physician Decision|2|||
149125549|NCT02842827|537939262|FG007|Overall Study|Physician Decision|1|||
149125550|NCT02842827|537939255|FG000|Overall Study|Protocol Defined Disease Progression|0|||
149125551|NCT02842827|537939256|FG001|Overall Study|Protocol Defined Disease Progression|0|||
149125552|NCT02842827|537939257|FG002|Overall Study|Protocol Defined Disease Progression|0|||
149125553|NCT02842827|537939258|FG003|Overall Study|Protocol Defined Disease Progression|0|||
149125554|NCT02842827|537939259|FG004|Overall Study|Protocol Defined Disease Progression|0|||
149125555|NCT02842827|537939260|FG005|Overall Study|Protocol Defined Disease Progression|1|||
149125556|NCT02842827|537939261|FG006|Overall Study|Protocol Defined Disease Progression|0|||
149125557|NCT02842827|537939262|FG007|Overall Study|Protocol Defined Disease Progression|0|||
149125558|NCT02842827|537939255|FG000|Overall Study|Participant Withdrawal of Consent|1|||
149125559|NCT02842827|537939256|FG001|Overall Study|Participant Withdrawal of Consent|2|||
148785911|NCT01078298|536692502|FG000|Overall Study|Death|2|||
148785912|NCT01078298|536692503|FG001|Overall Study|Death|0|||
148785913|NCT01078298|536692502|FG000|Overall Study|Did not meet entrance criteria|0|||
148785914|NCT01078298|536692503|FG001|Overall Study|Did not meet entrance criteria|1|||
148785915|NCT01078298|536692502|FG000|Overall Study|Other|24|||
148785916|NCT01078298|536692503|FG001|Overall Study|Other|32|||
148785917|NCT00659776|536692507|FG000|Overall Study|Withdrawal by Subject|12|||
148785918|NCT00659776|536692508|FG001|Overall Study|Withdrawal by Subject|2|||
148785919|NCT00659776|536692509|FG002|Overall Study|Withdrawal by Subject|0|||
148785920|NCT00742027|536692510|FG000|Overall Study|Disease Progression|76|||
148785921|NCT00742027|536692510|FG000|Overall Study|New Cancer Therapy|19|||
148785922|NCT00742027|536692510|FG000|Overall Study|Withdrawal by Subject|18|||
148785923|NCT00742027|536692510|FG000|Overall Study|Death|7|||
148785924|NCT00742027|536692510|FG000|Overall Study|Lost to Follow-up|4|||
148785925|NCT00742027|536692510|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
148785926|NCT00742027|536692510|FG000|Overall Study|Missing|2|||
148785927|NCT00742027|536692510|FG000|Overall Study|Administrative Problems|1|||
148785928|NCT00628927|536692511|FG000|Overall Study|Problems performing blood draw|6|||
148785929|NCT00628927|536692512|FG001|Overall Study|Problems performing blood draw|0|||
148785930|NCT00628927|536692511|FG000|Overall Study|Lost to Follow-up|1|||
148785931|NCT00628927|536692512|FG001|Overall Study|Lost to Follow-up|0|||
148785932|NCT00628927|536692511|FG000|Overall Study|Equipment failure|1|||
148785933|NCT00628927|536692512|FG001|Overall Study|Equipment failure|0|||
148785934|NCT01298141|536692516|FG000|Overall Study|Adverse Event|3|||
148785935|NCT01298141|536692516|FG000|Overall Study|Refusal of Required Study Procedures|1|||
148785936|NCT01298141|536692516|FG000|Overall Study|Withdrawal by Subject|6|||
148785937|NCT01298141|536692516|FG000|Overall Study|Termination of Study by the Investigator|5|||
148785938|NCT01298141|536692516|FG000|Overall Study|Other|5|||
148785939|NCT01298141|536692516|FG000|Overall Study|Lost to Follow-up|1|||
148785940|NCT01298141|536692516|FG000|Overall Study|Death|6|||
148785941|NCT01298141|536692516|FG000|Overall Study|Not treated|4|||
148785942|NCT01964989|536694001|FG000|Overall Study|Protocol Violation|3|||
148785943|NCT01964989|536694002|FG001|Overall Study|Protocol Violation|4|||
148785944|NCT01964989|536694001|FG000|Overall Study|Administrative Reason|103|||
148785945|NCT01964989|536694002|FG001|Overall Study|Administrative Reason|95|||
148785946|NCT01964989|536694001|FG000|Overall Study|Adverse Event|0|||
148785947|NCT01964989|536694002|FG001|Overall Study|Adverse Event|1|||
148785948|NCT01964989|536694001|FG000|Overall Study|Death|1|||
148785949|NCT01964989|536694002|FG001|Overall Study|Death|3|||
148785950|NCT01964989|536694001|FG000|Overall Study|Withdrawal by Subject|156|||
148785951|NCT01964989|536694002|FG001|Overall Study|Withdrawal by Subject|160|||
148785952|NCT01964989|536694001|FG000|Overall Study|Lost to Follow-up|254|||
148785953|NCT01964989|536694002|FG001|Overall Study|Lost to Follow-up|232|||
148785954|NCT01964989|536694001|FG000|Overall Study|Other|267|||
148785955|NCT01964989|536694002|FG001|Overall Study|Other|252|||
148785956|NCT02499263|536694003|FG000|Overall Study|Lost to Follow-up|9|||
148785957|NCT02499263|536694003|FG000|Overall Study|Participant's withdrawal of consent|4|||
148785958|NCT02499263|536694003|FG000|Overall Study|Lack of Efficacy|22|||
148785959|NCT02499263|536694003|FG000|Overall Study|investigator's judgment|12|||
148785960|NCT02499263|536694003|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
148785961|NCT02499263|536694003|FG000|Overall Study|Participant's decision|3|||
148785962|NCT02499263|536694003|FG000|Overall Study|Pregnancy|1|||
148785963|NCT04126317|536694004|FG000|Overall Study|Adverse Event|0|||
148785964|NCT04126317|536694005|FG001|Overall Study|Adverse Event|1|||
148785965|NCT04126317|536694004|FG000|Overall Study|Withdrawal by Subject|4|||
148785966|NCT04126317|536694005|FG001|Overall Study|Withdrawal by Subject|1|||
148785967|NCT00424593|536694006|FG000|Acute Double-Blind Period|Adverse Event|16|||
148785968|NCT00424593|536694007|FG001|Acute Double-Blind Period|Adverse Event|7|||
148785969|NCT00424593|536694006|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
148785970|NCT00424593|536694007|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
148785971|NCT00424593|536694006|FG000|Acute Double-Blind Period|Protocol Violation|2|||
148785972|NCT00424593|536694007|FG001|Acute Double-Blind Period|Protocol Violation|2|||
148785973|NCT00424593|536694006|FG000|Acute Double-Blind Period|Physician Decision|1|||
148785974|NCT00424593|536694007|FG001|Acute Double-Blind Period|Physician Decision|2|||
148785975|NCT00424593|536694006|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
148785976|NCT00424593|536694007|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
148785977|NCT00424593|536694006|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
148785978|NCT00424593|536694007|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
148785979|NCT00424593|536694006|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
148785980|NCT00424593|536694007|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
148785981|NCT00424593|536694006|FG000|Dose-Blind Extension Period|Adverse Event|18|||
148785982|NCT00424593|536694007|FG001|Dose-Blind Extension Period|Adverse Event|0|||
148785983|NCT00424593|536694006|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
148785984|NCT00424593|536694007|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
148785985|NCT00424593|536694006|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
148785986|NCT00424593|536694007|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
148893362|NCT02869633|537088685|FG001|Overall Study|Death|1|||
149125560|NCT02842827|537939257|FG002|Overall Study|Participant Withdrawal of Consent|2|||
149125561|NCT02842827|537939258|FG003|Overall Study|Participant Withdrawal of Consent|2|||
149125562|NCT02842827|537939259|FG004|Overall Study|Participant Withdrawal of Consent|2|||
149125563|NCT02842827|537939260|FG005|Overall Study|Participant Withdrawal of Consent|1|||
149125564|NCT02842827|537939261|FG006|Overall Study|Participant Withdrawal of Consent|2|||
149125565|NCT02842827|537939262|FG007|Overall Study|Participant Withdrawal of Consent|1|||
149125566|NCT01815138|537939263|FG000|Overall Study|Withdrawal by Subject|0|||
149125567|NCT01815138|537939264|FG001|Overall Study|Withdrawal by Subject|1|||
149125568|NCT01815138|537939263|FG000|Overall Study|Physician Decision|8|||
149125569|NCT01815138|537939264|FG001|Overall Study|Physician Decision|5|||
149125570|NCT00609765|537939267|FG000|Overall Study|Study ended prior to 12 months|1|||
149125571|NCT02649946|537939273|FG000|Overall Study|Withdrawal by Subject|1|||
149125572|NCT02649946|537939274|FG001|Overall Study|Withdrawal by Subject|1|||
149125573|NCT02649946|537939273|FG000|Overall Study|Death|7|||
149125574|NCT02649946|537939274|FG001|Overall Study|Death|9|||
149125575|NCT02649946|537939273|FG000|Overall Study|Physician Decision|1|||
149125576|NCT02649946|537939274|FG001|Overall Study|Physician Decision|0|||
149125577|NCT02649946|537939273|FG000|Overall Study|Lost to Follow-up|2|||
149125578|NCT02649946|537939274|FG001|Overall Study|Lost to Follow-up|1|||
149125579|NCT02649946|537939273|FG000|Overall Study|Erroneously enrolled|1|||
149125580|NCT02649946|537939274|FG001|Overall Study|Erroneously enrolled|0|||
149125581|NCT02649946|537939273|FG000|Overall Study|Missed 6-month follow-up visit|0|||
149125582|NCT02649946|537939274|FG001|Overall Study|Missed 6-month follow-up visit|4|||
149125583|NCT02054520|537939275|FG000|Overall Study|Adverse Event|1|||
149125584|NCT02054520|537939276|FG001|Overall Study|Adverse Event|4|||
149125585|NCT02054520|537939277|FG002|Overall Study|Adverse Event|2|||
149125586|NCT02054520|537939278|FG003|Overall Study|Adverse Event|1|||
149125587|NCT02054520|537939279|FG004|Overall Study|Adverse Event|1|||
149125588|NCT02054520|537939280|FG005|Overall Study|Adverse Event|0|||
149125589|NCT02054520|537939275|FG000|Overall Study|Lack of Efficacy|7|||
149125590|NCT02054520|537939276|FG001|Overall Study|Lack of Efficacy|0|||
149125591|NCT02054520|537939277|FG002|Overall Study|Lack of Efficacy|2|||
149125592|NCT02054520|537939278|FG003|Overall Study|Lack of Efficacy|1|||
149125593|NCT02054520|537939279|FG004|Overall Study|Lack of Efficacy|3|||
149125594|NCT02054520|537939280|FG005|Overall Study|Lack of Efficacy|2|||
149125595|NCT02054520|537939275|FG000|Overall Study|Withdrawal by Subject|1|||
149125596|NCT02054520|537939276|FG001|Overall Study|Withdrawal by Subject|0|||
149125597|NCT02054520|537939277|FG002|Overall Study|Withdrawal by Subject|0|||
149125598|NCT02054520|537939278|FG003|Overall Study|Withdrawal by Subject|2|||
149125599|NCT02054520|537939279|FG004|Overall Study|Withdrawal by Subject|1|||
149125600|NCT02054520|537939280|FG005|Overall Study|Withdrawal by Subject|0|||
149125601|NCT02054520|537939275|FG000|Overall Study|Physician Decision|0|||
149125602|NCT02054520|537939276|FG001|Overall Study|Physician Decision|1|||
149125603|NCT02054520|537939277|FG002|Overall Study|Physician Decision|0|||
149125604|NCT02054520|537939278|FG003|Overall Study|Physician Decision|1|||
149125605|NCT02054520|537939279|FG004|Overall Study|Physician Decision|0|||
149125606|NCT02054520|537939280|FG005|Overall Study|Physician Decision|1|||
149125607|NCT02054520|537939275|FG000|Overall Study|Study terminated by Sponsor|0|||
149125608|NCT02054520|537939276|FG001|Overall Study|Study terminated by Sponsor|0|||
149125609|NCT02054520|537939277|FG002|Overall Study|Study terminated by Sponsor|2|||
149125610|NCT02054520|537939278|FG003|Overall Study|Study terminated by Sponsor|1|||
149125611|NCT02054520|537939279|FG004|Overall Study|Study terminated by Sponsor|0|||
149125612|NCT02054520|537939280|FG005|Overall Study|Study terminated by Sponsor|0|||
149125613|NCT01272804|537939281|FG000|Overall Study|Adverse Event|1|||
149125614|NCT01272804|537939282|FG001|Overall Study|Adverse Event|0|||
149125615|NCT01272804|537939283|FG002|Overall Study|Adverse Event|0|||
149125616|NCT01272804|537939284|FG003|Overall Study|Adverse Event|0|||
148785987|NCT00424593|536694006|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
148785988|NCT00424593|536694007|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
148785989|NCT00424593|536694006|FG000|Dose-Blind Extension Period|Physician Decision|3|||
148785990|NCT00424593|536694007|FG001|Dose-Blind Extension Period|Physician Decision|0|||
148785991|NCT05114564|536694010|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
148785992|NCT05114564|536694011|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
148785993|NCT05114564|536694010|FG000|First Intervention|Adverse Event|0|||
148785994|NCT05114564|536694011|FG001|First Intervention|Adverse Event|1|||
148785995|NCT00493311|536694012|FG000|Overall Study|Need for rescue medication|2|||
148785996|NCT00493311|536694013|FG001|Overall Study|Need for rescue medication|2|||
149125617|NCT01272804|537939285|FG004|Overall Study|Adverse Event|2|||
149125618|NCT01272804|537939286|FG005|Overall Study|Adverse Event|1|||
149125619|NCT03801915|537939287|FG000|Overall Study|Screen failure|0|||
148785997|NCT02779075|536694014|FG000|Overall Study|Withdrawal by Subject|1|||
149125620|NCT03801915|537939288|FG001|Overall Study|Screen failure|0|||
149125621|NCT03801915|537939289|FG002|Overall Study|Screen failure|1|||
149125622|NCT03801915|537939287|FG000|Overall Study|Ineligible|1|||
149125623|NCT03801915|537939288|FG001|Overall Study|Ineligible|0|||
149125624|NCT03801915|537939289|FG002|Overall Study|Ineligible|0|||
149125625|NCT03801915|537939287|FG000|Overall Study|Physician Decision|2|||
149125626|NCT03801915|537939288|FG001|Overall Study|Physician Decision|1|||
149125627|NCT03801915|537939289|FG002|Overall Study|Physician Decision|0|||
149125628|NCT01588496|537939290|FG000|Overall Study|Withdrawal by Subject|0|||
149125629|NCT01588496|537939291|FG001|Overall Study|Withdrawal by Subject|1|||
149125630|NCT01588496|537939292|FG002|Overall Study|Withdrawal by Subject|0|||
149125631|NCT01551212|537939293|FG000|Overall Study|Graft loss/Retransplantation|0|||
149125632|NCT01551212|537939294|FG001|Overall Study|Graft loss/Retransplantation|1|||
149125633|NCT01551212|537939293|FG000|Overall Study|Administrative problems|1|||
149125634|NCT01551212|537939294|FG001|Overall Study|Administrative problems|2|||
149125635|NCT01551212|537939293|FG000|Overall Study|Lost to Follow-up|0|||
149125636|NCT01551212|537939294|FG001|Overall Study|Lost to Follow-up|1|||
149125637|NCT01551212|537939293|FG000|Overall Study|Protocol Violation|0|||
149125638|NCT01551212|537939294|FG001|Overall Study|Protocol Violation|1|||
149125639|NCT01551212|537939293|FG000|Overall Study|Withdrawal by Subject|0|||
149125640|NCT01551212|537939294|FG001|Overall Study|Withdrawal by Subject|7|||
149125641|NCT01551212|537939293|FG000|Overall Study|Death|2|||
149125642|NCT01551212|537939294|FG001|Overall Study|Death|4|||
149125643|NCT01551212|537939293|FG000|Overall Study|Never Received Study Treatment|2|||
149125644|NCT01551212|537939294|FG001|Overall Study|Never Received Study Treatment|4|||
149125645|NCT05924945|537939295|FG000|Overall Study|Withdrawal by Subject|3|||
149125646|NCT05924945|537939296|FG001|Overall Study|Withdrawal by Subject|4|||
149125647|NCT02471833|537939297|FG000|Overall Study|Lost to Follow-up|1|||
149125648|NCT02471833|537939298|FG001|Overall Study|Lost to Follow-up|0|||
149125649|NCT02471833|537939299|FG002|Overall Study|Lost to Follow-up|0|||
149125650|NCT02471833|537939297|FG000|Overall Study|Withdrawal by Subject|2|||
149125651|NCT02471833|537939298|FG001|Overall Study|Withdrawal by Subject|1|||
149125652|NCT02471833|537939299|FG002|Overall Study|Withdrawal by Subject|5|||
149125653|NCT02232243|537939304|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
149125654|NCT02232243|537939305|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
149125655|NCT02232243|537939306|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
149125656|NCT00490724|537939307|FG000|Period I|Physician Decision|0|||
149125657|NCT00490724|537939308|FG001|Period I|Physician Decision|0|||
149125658|NCT00490724|537939309|FG002|Period I|Physician Decision|1|||
149125659|NCT00490724|537939307|FG000|Period II|Treatment Discontinuation|3|||
149125660|NCT00490724|537939308|FG001|Period II|Treatment Discontinuation|1|||
149125661|NCT00490724|537939309|FG002|Period II|Treatment Discontinuation|3|||
149125662|NCT05026710|537939310|FG000|Overall Study|No longer met eligibility criteria|3|||
149125663|NCT05026710|537939311|FG001|Overall Study|No longer met eligibility criteria|1|||
149125664|NCT01395888|537939312|FG000|2-week Run-in Period|Adverse Event|2|||
149125665|NCT01395888|537939313|FG001|2-week Run-in Period|Adverse Event|0|||
149125666|NCT01395888|537939314|FG002|2-week Run-in Period|Adverse Event|0|||
149125667|NCT01395888|537939312|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
149125668|NCT01395888|537939313|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
149125669|NCT01395888|537939314|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
149125670|NCT01395888|537939312|FG000|2-week Run-in Period|Lost to Follow-up|1|||
149125671|NCT01395888|537939313|FG001|2-week Run-in Period|Lost to Follow-up|0|||
149125672|NCT01395888|537939314|FG002|2-week Run-in Period|Lost to Follow-up|0|||
149125673|NCT01395888|537939312|FG000|2-week Run-in Period|Protocol Violation|2|||
149125674|NCT01395888|537939313|FG001|2-week Run-in Period|Protocol Violation|0|||
149125675|NCT01395888|537939314|FG002|2-week Run-in Period|Protocol Violation|0|||
149125676|NCT01395888|537939312|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
149125677|NCT01395888|537939313|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149125678|NCT01395888|537939314|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
149125679|NCT01395888|537939312|FG000|Treatment Period (TP)|Adverse Event|0|||
149125680|NCT01395888|537939313|FG001|Treatment Period (TP)|Adverse Event|7|||
149125681|NCT01395888|537939314|FG002|Treatment Period (TP)|Adverse Event|6|||
149125682|NCT01395888|537939312|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
149125683|NCT01395888|537939313|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
149125684|NCT01395888|537939314|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
149125685|NCT01395888|537939312|FG000|Treatment Period (TP)|Protocol Violation|0|||
149125686|NCT01395888|537939313|FG001|Treatment Period (TP)|Protocol Violation|1|||
149125687|NCT01395888|537939314|FG002|Treatment Period (TP)|Protocol Violation|5|||
149125688|NCT01395888|537939312|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
149125689|NCT01395888|537939313|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
149125690|NCT01395888|537939314|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
149125691|NCT01395888|537939312|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
149125692|NCT01395888|537939313|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
149125693|NCT01395888|537939314|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
149125694|NCT03218397|537939315|FG000|Overall Study|Prior positive blood culture|8|||
149125695|NCT03218397|537939316|FG001|Overall Study|Prior positive blood culture|13|||
149125696|NCT03218397|537939315|FG000|Overall Study|Comfort care|8|||
149125697|NCT03218397|537939316|FG001|Overall Study|Comfort care|5|||
149125698|NCT03218397|537939315|FG000|Overall Study|Comfort care and positive blood culture|1|||
149125699|NCT03218397|537939316|FG001|Overall Study|Comfort care and positive blood culture|0|||
149125700|NCT03218397|537939315|FG000|Overall Study|Comfort care and mixed culture|0|||
149125701|NCT03218397|537939316|FG001|Overall Study|Comfort care and mixed culture|1|||
149125702|NCT03218397|537939315|FG000|Overall Study|Mixed culture|2|||
149125703|NCT03218397|537939316|FG001|Overall Study|Mixed culture|2|||
149125704|NCT03218397|537939315|FG000|Overall Study|Inaccessible hospital records|2|||
149125705|NCT03218397|537939316|FG001|Overall Study|Inaccessible hospital records|5|||
149125706|NCT03218397|537939315|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
149125707|NCT03218397|537939316|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
149125708|NCT03218397|537939315|FG000|Overall Study|Randomized during laboratory off hours|2|||
149125709|NCT03218397|537939316|FG001|Overall Study|Randomized during laboratory off hours|1|||
149125710|NCT01796548|537939317|FG000|Overall Study|Lost to Follow-up|1|||
149125711|NCT01796548|537939317|FG000|Overall Study|Other|2|||
149125712|NCT00126503|537939318|FG000|Overall Study|disease progression|23|||
149125713|NCT00126503|537939319|FG001|Overall Study|disease progression|14|||
149125714|NCT00126503|537939318|FG000|Overall Study|Withdrawal by Subject|0|||
149125715|NCT00126503|537939319|FG001|Overall Study|Withdrawal by Subject|1|||
149125716|NCT00126503|537939318|FG000|Overall Study|alternative therapy|1|||
149125717|NCT00126503|537939319|FG001|Overall Study|alternative therapy|1|||
149125718|NCT00126503|537939318|FG000|Overall Study|other complicating disease|4|||
149125719|NCT00126503|537939319|FG001|Overall Study|other complicating disease|1|||
149125720|NCT00126503|537939318|FG000|Overall Study|Death|3|||
149125721|NCT00126503|537939319|FG001|Overall Study|Death|0|||
149125722|NCT00126503|537939318|FG000|Overall Study|Adverse Event|13|||
149125723|NCT00126503|537939319|FG001|Overall Study|Adverse Event|3|||
149125724|NCT00126503|537939318|FG000|Overall Study|non-compliant|1|||
149125725|NCT00126503|537939319|FG001|Overall Study|non-compliant|0|||
149125726|NCT00126503|537939318|FG000|Overall Study|Physician Decision|2|||
149125727|NCT00126503|537939319|FG001|Overall Study|Physician Decision|1|||
149125728|NCT04964388|537941114|FG000|Overall Study|Lost to Follow-up|3|||
149125729|NCT04964388|537941115|FG001|Overall Study|Lost to Follow-up|2|||
149125730|NCT02563522|537941117|FG000|Overall Study|Adverse Event|2|||
149125731|NCT02563522|537941118|FG001|Overall Study|Adverse Event|3|||
149125732|NCT02563522|537941117|FG000|Overall Study|Lost to Follow-up|1|||
149125733|NCT02563522|537941118|FG001|Overall Study|Lost to Follow-up|0|||
149125734|NCT02563522|537941117|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
149125735|NCT02563522|537941118|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
149125736|NCT01052103|537941119|FG000|Overall Study|Adverse Event|10|||
149125737|NCT01052103|537941120|FG001|Overall Study|Adverse Event|6|||
149125738|NCT01052103|537941119|FG000|Overall Study|Entry Criteria Not Met|3|||
149125739|NCT01052103|537941120|FG001|Overall Study|Entry Criteria Not Met|1|||
149125740|NCT01052103|537941119|FG000|Overall Study|Lost to Follow-up|3|||
149125741|NCT01052103|537941120|FG001|Overall Study|Lost to Follow-up|5|||
149125742|NCT01052103|537941119|FG000|Overall Study|Protocol Violation|10|||
149125743|NCT01052103|537941120|FG001|Overall Study|Protocol Violation|4|||
149125744|NCT01052103|537941119|FG000|Overall Study|Scheduling conflict|2|||
149125745|NCT01052103|537941120|FG001|Overall Study|Scheduling conflict|1|||
149125746|NCT01052103|537941119|FG000|Overall Study|Sponsor Decision|2|||
149125747|NCT01052103|537941120|FG001|Overall Study|Sponsor Decision|0|||
149125748|NCT01052103|537941119|FG000|Overall Study|Withdrawal by Subject|3|||
149125749|NCT01052103|537941120|FG001|Overall Study|Withdrawal by Subject|6|||
149125750|NCT01052103|537941119|FG000|Overall Study|Perceived Lack of Efficacy|1|||
149125751|NCT01052103|537941120|FG001|Overall Study|Perceived Lack of Efficacy|0|||
149125752|NCT04874415|537941121|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125753|NCT04874415|537941122|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125754|NCT04874415|537941123|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125755|NCT04874415|537941124|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125756|NCT04874415|537941125|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125757|NCT04874415|537941126|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125758|NCT04874415|537941127|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
149125759|NCT04874415|537941128|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125760|NCT04874415|537941129|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
148785998|NCT02779075|536694015|FG001|Overall Study|Withdrawal by Subject|3|||
148785999|NCT02779075|536694014|FG000|Overall Study|IV lost during 2nd study|1|||
149125761|NCT04874415|537941130|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
149125762|NCT04874415|537941131|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125763|NCT04874415|537941132|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
149125764|NCT04874415|537941133|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
149125765|NCT04874415|537941134|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
149125766|NCT04874415|537941135|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
149125767|NCT04874415|537941136|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
149125768|NCT04874415|537941121|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125769|NCT04874415|537941122|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125770|NCT04874415|537941123|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125771|NCT04874415|537941124|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125772|NCT04874415|537941125|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125773|NCT04874415|537941126|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125774|NCT04874415|537941127|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125775|NCT04874415|537941128|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125776|NCT04874415|537941129|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125777|NCT04874415|537941130|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
149125778|NCT04874415|537941131|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125779|NCT04874415|537941132|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125780|NCT04874415|537941133|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125781|NCT04874415|537941134|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125782|NCT04874415|537941135|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
149125783|NCT04874415|537941136|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
149125784|NCT04874415|537941121|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125785|NCT04874415|537941122|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125786|NCT04874415|537941123|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125787|NCT04874415|537941124|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125788|NCT04874415|537941125|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
149125789|NCT04874415|537941126|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125790|NCT04874415|537941127|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125791|NCT04874415|537941128|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125792|NCT04874415|537941129|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125793|NCT04874415|537941130|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125794|NCT04874415|537941131|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125795|NCT04874415|537941132|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125796|NCT04874415|537941133|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125797|NCT04874415|537941134|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125798|NCT04874415|537941135|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125799|NCT04874415|537941136|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
149125800|NCT03405792|537941137|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
149125801|NCT03405792|537941138|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
149125802|NCT03405792|537941137|FG000|Overall Study|o Did not receive pembrolizumab|1|||
149125803|NCT03405792|537941138|FG001|Overall Study|o Did not receive pembrolizumab|0|||
149125804|NCT00918580|537941139|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
149125805|NCT00918580|537941139|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
149125806|NCT00918580|537941139|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
149125807|NCT00918580|537941139|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
149125808|NCT00918580|537941139|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
149125809|NCT00918580|537941139|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
149125810|NCT00918580|537941139|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
149125811|NCT00372229|537941140|FG000|Study Phase|Graft loss|0|||
149125812|NCT00372229|537941141|FG001|Study Phase|Graft loss|3|||
149125813|NCT00372229|537941140|FG000|Study Phase|Protocol Violation|3|||
149125814|NCT00372229|537941141|FG001|Study Phase|Protocol Violation|4|||
149125815|NCT00372229|537941140|FG000|Study Phase|Consent withdrawn|16|||
149125816|NCT00372229|537941141|FG001|Study Phase|Consent withdrawn|14|||
149125817|NCT00372229|537941140|FG000|Study Phase|Refused treatment/did not cooperate|3|||
149125818|NCT00372229|537941141|FG001|Study Phase|Refused treatment/did not cooperate|1|||
149125819|NCT00372229|537941140|FG000|Study Phase|Death|3|||
149125820|NCT00372229|537941141|FG001|Study Phase|Death|2|||
149125821|NCT00372229|537941140|FG000|Study Phase|Reason not specified|3|||
149125822|NCT00372229|537941141|FG001|Study Phase|Reason not specified|2|||
149125823|NCT00372229|537941140|FG000|Study Phase|Lost to Follow-up|3|||
149125824|NCT00372229|537941141|FG001|Study Phase|Lost to Follow-up|3|||
149125825|NCT00372229|537941140|FG000|Follow-Up Phase|Graft loss|8|||
149125826|NCT00372229|537941141|FG001|Follow-Up Phase|Graft loss|7|||
149125827|NCT00372229|537941140|FG000|Follow-Up Phase|Consent withdrawn|13|||
149125828|NCT00372229|537941141|FG001|Follow-Up Phase|Consent withdrawn|19|||
149125829|NCT00372229|537941140|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
149125830|NCT00372229|537941141|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
149125831|NCT00372229|537941140|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
149125832|NCT00372229|537941141|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
149125833|NCT00372229|537941140|FG000|Follow-Up Phase|Death|9|||
149125834|NCT00372229|537941141|FG001|Follow-Up Phase|Death|12|||
149125835|NCT00372229|537941140|FG000|Follow-Up Phase|Administrative|1|||
149125836|NCT00372229|537941141|FG001|Follow-Up Phase|Administrative|0|||
149125837|NCT00372229|537941140|FG000|Follow-Up Phase|Reason not specified|2|||
149125838|NCT00372229|537941141|FG001|Follow-Up Phase|Reason not specified|3|||
149125839|NCT00372229|537941140|FG000|Follow-Up Phase|Lost to Follow-up|12|||
149125840|NCT00372229|537941141|FG001|Follow-Up Phase|Lost to Follow-up|10|||
149125841|NCT01347762|537941142|FG000|Overall Study|Lost to Follow-up|0|||
149125842|NCT01347762|537941143|FG001|Overall Study|Lost to Follow-up|1|||
149125843|NCT01347762|537941144|FG002|Overall Study|Lost to Follow-up|6|||
149125844|NCT01347762|537941145|FG003|Overall Study|Lost to Follow-up|5|||
149125845|NCT01347762|537941142|FG000|Overall Study|Withdrawal by Subject|4|||
149125846|NCT01347762|537941143|FG001|Overall Study|Withdrawal by Subject|1|||
149125847|NCT01347762|537941144|FG002|Overall Study|Withdrawal by Subject|3|||
149125848|NCT01347762|537941145|FG003|Overall Study|Withdrawal by Subject|3|||
148786000|NCT02779075|536694015|FG001|Overall Study|IV lost during 2nd study|0|||
149125849|NCT03235284|537941146|FG000|Overall Study|Adverse Event|1|||
149125850|NCT03235284|537941147|FG001|Overall Study|Adverse Event|2|||
149125851|NCT03235284|537941148|FG002|Overall Study|Adverse Event|1|||
149125852|NCT00310037|537941149|FG000|Overall Study|Adverse Event|7|||
149125853|NCT00310037|537941150|FG001|Overall Study|Adverse Event|14|||
149125854|NCT00310037|537941149|FG000|Overall Study|Withdrawal by Subject|4|||
149125855|NCT00310037|537941150|FG001|Overall Study|Withdrawal by Subject|3|||
149125856|NCT00310037|537941149|FG000|Overall Study|Progression|6|||
149125857|NCT00310037|537941150|FG001|Overall Study|Progression|0|||
149125858|NCT00310037|537941149|FG000|Overall Study|Non-protocol treatment|1|||
149125859|NCT00310037|537941150|FG001|Overall Study|Non-protocol treatment|0|||
149125860|NCT01382706|537941153|FG000|Overall Study|Adverse Event|1|||
149125861|NCT01382706|537941153|FG000|Overall Study|Withdrawal by Subject|1|||
149125862|NCT05559099|537941154|FG000|Overall Study|Death|5|||
149125863|NCT05559099|537941155|FG001|Overall Study|Death|4|||
149125864|NCT05559099|537941154|FG000|Overall Study|Lost to Follow-up|0|||
149125865|NCT05559099|537941155|FG001|Overall Study|Lost to Follow-up|2|||
149125866|NCT05559099|537941154|FG000|Overall Study|Adverse Event|1|||
149125867|NCT05559099|537941155|FG001|Overall Study|Adverse Event|1|||
149125868|NCT04018092|537941156|FG000|Overall Study|Withdrawal by Subject|1|||
149125869|NCT04018092|537941157|FG001|Overall Study|Withdrawal by Subject|1|||
149125870|NCT04018092|537941156|FG000|Overall Study|Withdrawal by Subject|1|||
149125871|NCT04018092|537941157|FG001|Overall Study|Withdrawal by Subject|1|||
149125872|NCT02208999|537941160|FG000|Overall Study|Lost to Follow-up|1|||
149125873|NCT00319839|537941161|FG000|Overall Study|Adverse Event|5|||
149125874|NCT00319839|537941161|FG000|Overall Study|Withdrawal by Subject|1|||
149125875|NCT04494256|537941162|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
149125876|NCT04494256|537941163|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
149125877|NCT04494256|537941164|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
149125878|NCT04494256|537941165|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
149125879|NCT04494256|537941166|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
149125880|NCT04494256|537941167|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
149125881|NCT04494256|537941168|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
149125882|NCT04494256|537941162|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
149125883|NCT04494256|537941163|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
149125884|NCT04494256|537941164|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
149125885|NCT04494256|537941165|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
149125886|NCT04494256|537941166|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
149125887|NCT04494256|537941167|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
149125888|NCT04494256|537941168|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
149125889|NCT04494256|537941162|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
149125890|NCT04494256|537941163|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
149125891|NCT04494256|537941164|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
149125892|NCT04494256|537941165|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
149125893|NCT04494256|537941166|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
149125894|NCT04494256|537941167|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
149125895|NCT04494256|537941168|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
149125896|NCT04494256|537941162|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
148786001|NCT00217581|536694016|FG000|Overall Study|Withdrawal by Subject|1|||
149125897|NCT04494256|537941163|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125898|NCT04494256|537941164|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
148786002|NCT01005901|536694017|FG000|Overall Study|Withdrawal by Subject|38|||
149125899|NCT04494256|537941165|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
149125900|NCT04494256|537941166|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
149125901|NCT04494256|537941167|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125902|NCT04494256|537941168|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125903|NCT04494256|537941162|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
148786003|NCT01005901|536694018|FG001|Overall Study|Withdrawal by Subject|14|||
149125904|NCT04494256|537941163|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
149125905|NCT04494256|537941164|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
149125906|NCT04494256|537941165|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
149125907|NCT04494256|537941166|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
149125908|NCT04494256|537941167|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
149125909|NCT04494256|537941168|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
149125910|NCT04494256|537941162|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
149125911|NCT04494256|537941163|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
149125912|NCT04494256|537941164|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
149125913|NCT04494256|537941165|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
149125914|NCT04494256|537941166|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
149125915|NCT04494256|537941167|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
149125916|NCT04494256|537941168|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
149125917|NCT04494256|537941162|FG000|Part 2: Open Label Period|Death|0|||
149125918|NCT04494256|537941163|FG001|Part 2: Open Label Period|Death|0|||
149125919|NCT04494256|537941164|FG002|Part 2: Open Label Period|Death|0|||
149125920|NCT04494256|537941165|FG003|Part 2: Open Label Period|Death|0|||
149125921|NCT04494256|537941166|FG004|Part 2: Open Label Period|Death|0|||
149125922|NCT04494256|537941167|FG005|Part 2: Open Label Period|Death|4|||
149125923|NCT04494256|537941168|FG006|Part 2: Open Label Period|Death|2|||
149125924|NCT04494256|537941162|FG000|Part 2: Open Label Period|Adverse Event|0|||
149125925|NCT04494256|537941163|FG001|Part 2: Open Label Period|Adverse Event|0|||
149125926|NCT04494256|537941164|FG002|Part 2: Open Label Period|Adverse Event|0|||
149125927|NCT04494256|537941165|FG003|Part 2: Open Label Period|Adverse Event|0|||
149125928|NCT04494256|537941166|FG004|Part 2: Open Label Period|Adverse Event|0|||
149125929|NCT04494256|537941167|FG005|Part 2: Open Label Period|Adverse Event|0|||
149125930|NCT04494256|537941168|FG006|Part 2: Open Label Period|Adverse Event|2|||
149125931|NCT04494256|537941162|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
149125932|NCT04494256|537941163|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
149125933|NCT04494256|537941164|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
149125934|NCT04494256|537941165|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
149125935|NCT04494256|537941166|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
149125936|NCT04494256|537941167|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
149125937|NCT04494256|537941168|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
149125938|NCT04494256|537941162|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
149125939|NCT04494256|537941163|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
149125940|NCT04494256|537941164|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
149125941|NCT04494256|537941165|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
149125942|NCT04494256|537941166|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
149125943|NCT04494256|537941167|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
149125944|NCT04494256|537941168|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
149125945|NCT04494256|537941162|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
149125946|NCT04494256|537941163|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
149125947|NCT04494256|537941164|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
149125948|NCT04494256|537941165|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
149125949|NCT04494256|537941166|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
149125950|NCT04494256|537941167|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
149125951|NCT04494256|537941168|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
149125952|NCT04494256|537941162|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125953|NCT04494256|537941163|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125954|NCT04494256|537941164|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125955|NCT04494256|537941165|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125956|NCT04494256|537941166|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
149125957|NCT04494256|537941167|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
149125958|NCT04494256|537941168|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
149125959|NCT04494256|537941162|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
149125960|NCT04494256|537941163|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
149125961|NCT04494256|537941164|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
149125962|NCT04494256|537941165|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
149125963|NCT04494256|537941166|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
149125964|NCT04494256|537941167|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
149125965|NCT04494256|537941168|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
149125966|NCT00262951|537941169|FG000|Overall Study|Progressive disease/relapse|3|||
149125967|NCT00262951|537941169|FG000|Overall Study|Adverse Event|7|||
149125968|NCT00262951|537941169|FG000|Overall Study|Death|1|||
149125969|NCT00262951|537941169|FG000|Overall Study|Withdrawal by Subject|1|||
149125970|NCT00262951|537941169|FG000|Overall Study|Alternative treatment|3|||
149125971|NCT00262951|537941169|FG000|Overall Study|Off treatment for other disease|1|||
149125972|NCT01778023|537941170|FG000|Overall Study|Withdrawal by Subject|0|||
149125973|NCT01778023|537941171|FG001|Overall Study|Withdrawal by Subject|3|||
149125974|NCT00903630|537941172|FG000|Phase 2|Adverse Event|0|||
149125975|NCT00903630|537941173|FG001|Phase 2|Adverse Event|0|||
149125976|NCT00903630|537941174|FG002|Phase 2|Adverse Event|1|||
149125977|NCT04025580|537941175|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
149125978|NCT04025580|537941176|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
149125979|NCT04025580|537941177|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
149125980|NCT01768117|537941180|FG000|Overall Study|Lost to Follow-up|1|||
149125981|NCT01768117|537941180|FG000|Overall Study|Withdrawal by Subject|2|||
149125982|NCT01768117|537941180|FG000|Overall Study|Protocol Violation|3|||
149125983|NCT01249274|537941184|FG000|Overall Study|Lost to Follow-up|3|||
149125984|NCT01249274|537941185|FG001|Overall Study|Lost to Follow-up|4|||
149125985|NCT01249274|537941184|FG000|Overall Study|Received inpatient substance treatment|1|||
149125986|NCT01249274|537941185|FG001|Overall Study|Received inpatient substance treatment|2|||
149125987|NCT01000636|537941186|FG000|Overall Study|Withdrawal by Subject|1|||
149125988|NCT01000636|537941186|FG000|Overall Study|Adverse Event|1|||
149125989|NCT00138671|537941187|FG000|Overall Study|Death|0|||
149125990|NCT00138671|537941188|FG001|Overall Study|Death|3|||
149125991|NCT00138671|537941187|FG000|Overall Study|Adverse Event|6|||
149125992|NCT00138671|537941188|FG001|Overall Study|Adverse Event|3|||
149125993|NCT00138671|537941187|FG000|Overall Study|Lost to Follow-up|1|||
149125994|NCT00138671|537941188|FG001|Overall Study|Lost to Follow-up|2|||
149125995|NCT00138671|537941187|FG000|Overall Study|Withdrawal by Subject|3|||
149125996|NCT00138671|537941188|FG001|Overall Study|Withdrawal by Subject|5|||
149125997|NCT00138671|537941187|FG000|Overall Study|Other|3|||
149125998|NCT00138671|537941188|FG001|Overall Study|Other|3|||
149125999|NCT03658668|537941189|FG000|Overall Study|Time Commitment|1|||
149126000|NCT03658668|537941190|FG001|Overall Study|Time Commitment|1|||
149126001|NCT04634825|537941191|FG000|Overall Study|Death|10|||
149126002|NCT04634825|537941192|FG001|Overall Study|Death|3|||
149126003|NCT04634825|537941191|FG000|Overall Study|Lost to Follow-up|1|||
149126004|NCT04634825|537941192|FG001|Overall Study|Lost to Follow-up|0|||
149126005|NCT04634825|537941191|FG000|Overall Study|Study terminated by sponsor|35|||
149126006|NCT04634825|537941192|FG001|Overall Study|Study terminated by sponsor|11|||
149126007|NCT04634825|537941191|FG000|Overall Study|Withdrawal by Subject|2|||
149126008|NCT04634825|537941192|FG001|Overall Study|Withdrawal by Subject|0|||
149126009|NCT02581631|537941198|FG000|Overall Study|Disease progression|29|||
149126010|NCT02581631|537941199|FG001|Overall Study|Disease progression|19|||
149126011|NCT02581631|537941200|FG002|Overall Study|Disease progression|13|||
149126012|NCT02581631|537941201|FG003|Overall Study|Disease progression|5|||
149126013|NCT02581631|537941202|FG004|Overall Study|Disease progression|8|||
149126014|NCT02581631|537941198|FG000|Overall Study|Study drug toxicity|4|||
149126015|NCT02581631|537941199|FG001|Overall Study|Study drug toxicity|6|||
149126016|NCT02581631|537941200|FG002|Overall Study|Study drug toxicity|7|||
149126017|NCT02581631|537941201|FG003|Overall Study|Study drug toxicity|0|||
149126018|NCT02581631|537941202|FG004|Overall Study|Study drug toxicity|3|||
149126019|NCT02581631|537941198|FG000|Overall Study|AE unrelated to study drug|3|||
149126020|NCT02581631|537941199|FG001|Overall Study|AE unrelated to study drug|1|||
149126021|NCT02581631|537941200|FG002|Overall Study|AE unrelated to study drug|1|||
149126022|NCT02581631|537941201|FG003|Overall Study|AE unrelated to study drug|0|||
149126023|NCT02581631|537941202|FG004|Overall Study|AE unrelated to study drug|2|||
149126024|NCT02581631|537941198|FG000|Overall Study|Request to discontinue|1|||
149126025|NCT02581631|537941199|FG001|Overall Study|Request to discontinue|0|||
149126026|NCT02581631|537941200|FG002|Overall Study|Request to discontinue|3|||
149126027|NCT02581631|537941201|FG003|Overall Study|Request to discontinue|0|||
149126028|NCT02581631|537941202|FG004|Overall Study|Request to discontinue|1|||
149126029|NCT02581631|537941198|FG000|Overall Study|participant withdrew consent|3|||
149126030|NCT02581631|537941199|FG001|Overall Study|participant withdrew consent|0|||
149126031|NCT02581631|537941200|FG002|Overall Study|participant withdrew consent|1|||
149126032|NCT02581631|537941201|FG003|Overall Study|participant withdrew consent|0|||
149126033|NCT02581631|537941202|FG004|Overall Study|participant withdrew consent|0|||
149126034|NCT02581631|537941198|FG000|Overall Study|Maximum clinical benefit|1|||
148691435|NCT01325207|536344179|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
149126035|NCT02581631|537941199|FG001|Overall Study|Maximum clinical benefit|7|||
149126036|NCT02581631|537941200|FG002|Overall Study|Maximum clinical benefit|1|||
149126037|NCT02581631|537941201|FG003|Overall Study|Maximum clinical benefit|3|||
149126038|NCT02581631|537941202|FG004|Overall Study|Maximum clinical benefit|13|||
149126039|NCT02581631|537941198|FG000|Overall Study|Other Reasons|1|||
149126040|NCT02581631|537941199|FG001|Overall Study|Other Reasons|0|||
149126041|NCT02581631|537941200|FG002|Overall Study|Other Reasons|2|||
149126042|NCT02581631|537941201|FG003|Overall Study|Other Reasons|2|||
149126043|NCT02581631|537941202|FG004|Overall Study|Other Reasons|3|||
149126044|NCT02581631|537941198|FG000|Overall Study|Poor/Non-Compliance|0|||
149126045|NCT02581631|537941199|FG001|Overall Study|Poor/Non-Compliance|0|||
148786004|NCT01005901|536694017|FG000|Overall Study|Adverse Event|30|||
148786005|NCT01005901|536694018|FG001|Overall Study|Adverse Event|16|||
148786006|NCT01005901|536694017|FG000|Overall Study|Administrative problems|21|||
148786007|NCT01005901|536694018|FG001|Overall Study|Administrative problems|13|||
148786008|NCT01005901|536694017|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
148786009|NCT01005901|536694018|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
148786010|NCT01005901|536694017|FG000|Overall Study|Protocol Violation|4|||
148786011|NCT01005901|536694018|FG001|Overall Study|Protocol Violation|3|||
148786012|NCT01005901|536694017|FG000|Overall Study|Death|2|||
148786013|NCT01005901|536694018|FG001|Overall Study|Death|3|||
148786014|NCT01005901|536694017|FG000|Overall Study|Lost to Follow-up|1|||
148786015|NCT01005901|536694018|FG001|Overall Study|Lost to Follow-up|2|||
148786016|NCT01005901|536694017|FG000|Overall Study|Patient's inability to use the device|1|||
148786017|NCT01005901|536694018|FG001|Overall Study|Patient's inability to use the device|1|||
148786018|NCT01005901|536694017|FG000|Overall Study|No longer requires study drug|0|||
148786019|NCT01005901|536694018|FG001|Overall Study|No longer requires study drug|1|||
148786020|NCT00496587|536694019|FG000|Overall Study|Adverse Event|2|||
148786021|NCT00496587|536694019|FG000|Overall Study|Progressive Disease|24|||
148786022|NCT00496587|536694019|FG000|Overall Study|Withdrawal by Subject|2|||
148786023|NCT00496587|536694019|FG000|Overall Study|Death|1|||
148786024|NCT00496587|536694019|FG000|Overall Study|Complications unrelated|2|||
148786025|NCT00482170|536694020|FG000|Overall Study|Adverse Event|5|||
148786026|NCT00482170|536694021|FG001|Overall Study|Adverse Event|14|||
148786027|NCT00482170|536694020|FG000|Overall Study|Withdrawal by Subject|6|||
148786028|NCT00482170|536694021|FG001|Overall Study|Withdrawal by Subject|1|||
148786029|NCT00482170|536694020|FG000|Overall Study|Protocol Violation|2|||
148786030|NCT00482170|536694021|FG001|Overall Study|Protocol Violation|3|||
148786031|NCT00482170|536694020|FG000|Overall Study|Lost to Follow-up|2|||
148786032|NCT00482170|536694021|FG001|Overall Study|Lost to Follow-up|0|||
148786033|NCT00482170|536694020|FG000|Overall Study|Unspecified reason|0|||
148893363|NCT02869633|537088684|FG000|Overall Study|Patient refused follow-up|1|||
148893364|NCT02869633|537088685|FG001|Overall Study|Patient refused follow-up|0|||
148893365|NCT02869633|537088684|FG000|Overall Study|Provider discretion|1|||
148893366|NCT02869633|537088685|FG001|Overall Study|Provider discretion|0|||
148893367|NCT02869633|537088684|FG000|Overall Study|Investigator decision|1|||
148893368|NCT02869633|537088685|FG001|Overall Study|Investigator decision|0|||
148893369|NCT02869633|537088684|FG000|Overall Study|Lost to Follow-up|0|||
148893370|NCT02869633|537088685|FG001|Overall Study|Lost to Follow-up|1|||
148893371|NCT02869633|537088684|FG000|Overall Study|Not eligible|6|||
148893372|NCT02869633|537088685|FG001|Overall Study|Not eligible|1|||
148893373|NCT02869633|537088684|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
148893374|NCT02869633|537088685|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
148893375|NCT02869633|537088684|FG000|Overall Study|Withdrawal by Subject|0|||
148893376|NCT02869633|537088685|FG001|Overall Study|Withdrawal by Subject|1|||
148893377|NCT04024891|537088686|FG000|Overall Study|Pregnancy|0|||
148893378|NCT04024891|537088687|FG001|Overall Study|Pregnancy|1|||
148893379|NCT02891174|537088698|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
148893380|NCT02891174|537088699|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
148893381|NCT02891174|537088698|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
148893382|NCT02891174|537088699|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
148893383|NCT02891174|537088698|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
148893384|NCT02891174|537088699|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
148893385|NCT02891174|537088698|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
148893386|NCT02891174|537088699|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
148893387|NCT02891174|537088698|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
148893388|NCT02891174|537088699|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
148893389|NCT02891174|537088698|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
148893390|NCT02891174|537088699|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
148893391|NCT02891174|537088698|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
148893392|NCT02891174|537088699|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
148893393|NCT01693029|537088700|FG000|Overall Study|Withdrawal by Subject|15|||
148893394|NCT01693029|537088701|FG001|Overall Study|Withdrawal by Subject|22|||
148893395|NCT01693029|537088700|FG000|Overall Study|Kidney transplantation|7|||
148893396|NCT01693029|537088701|FG001|Overall Study|Kidney transplantation|7|||
148893397|NCT01693029|537088700|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
148893398|NCT01693029|537088701|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
148893399|NCT01693029|537088700|FG000|Overall Study|Protocol Violation|6|||
149126046|NCT02581631|537941200|FG002|Overall Study|Poor/Non-Compliance|1|||
149126047|NCT02581631|537941201|FG003|Overall Study|Poor/Non-Compliance|0|||
149126048|NCT02581631|537941202|FG004|Overall Study|Poor/Non-Compliance|0|||
148786034|NCT00482170|536694021|FG001|Overall Study|Unspecified reason|2|||
148786035|NCT01134263|536694022|FG000|Overall Study|Serious adverse event|2|||
149126049|NCT00705523|537941203|FG000|Overall Study|Lost to Follow-up|2|||
149126050|NCT00705523|537941204|FG001|Overall Study|Lost to Follow-up|3|||
149126051|NCT01013285|537941205|FG000|Overall Study|Death|48|||
149126052|NCT01013285|537941206|FG001|Overall Study|Death|89|||
149126053|NCT02003573|537941221|FG000|Overall Study|Progressive disease|2|||
149126054|NCT02003573|537941222|FG001|Overall Study|Progressive disease|0|||
149126055|NCT02003573|537941223|FG002|Overall Study|Progressive disease|1|||
149126056|NCT02003573|537941221|FG000|Overall Study|Other Adverse event|0|||
149126057|NCT02003573|537941222|FG001|Overall Study|Other Adverse event|1|||
149126058|NCT02003573|537941223|FG002|Overall Study|Other Adverse event|1|||
149126059|NCT02003573|537941221|FG000|Overall Study|Refuse to take trial medication|0|||
149126060|NCT02003573|537941222|FG001|Overall Study|Refuse to take trial medication|1|||
149126061|NCT02003573|537941223|FG002|Overall Study|Refuse to take trial medication|1|||
149126062|NCT02003573|537941221|FG000|Overall Study|Other than specified|1|||
149126063|NCT02003573|537941222|FG001|Overall Study|Other than specified|2|||
149126064|NCT02003573|537941223|FG002|Overall Study|Other than specified|3|||
149126065|NCT02457559|537941226|FG000|Overall Study|Progressive Disease|1|||
149126066|NCT02457559|537941227|FG001|Overall Study|Progressive Disease|2|||
149126067|NCT02457559|537941228|FG002|Overall Study|Progressive Disease|3|||
149126068|NCT02457559|537941229|FG003|Overall Study|Progressive Disease|0|||
149126069|NCT02457559|537941230|FG004|Overall Study|Progressive Disease|0|||
149126070|NCT02457559|537941231|FG005|Overall Study|Progressive Disease|2|||
149126071|NCT02457559|537941232|FG006|Overall Study|Progressive Disease|1|||
149126072|NCT02457559|537941233|FG007|Overall Study|Progressive Disease|0|||
149126073|NCT02457559|537941234|FG008|Overall Study|Progressive Disease|1|||
149126074|NCT02457559|537941235|FG009|Overall Study|Progressive Disease|1|||
149126075|NCT02457559|537941236|FG010|Overall Study|Progressive Disease|1|||
149126076|NCT02457559|537941226|FG000|Overall Study|Investigator's Discretion|0|||
149126077|NCT02457559|537941227|FG001|Overall Study|Investigator's Discretion|0|||
149126078|NCT02457559|537941228|FG002|Overall Study|Investigator's Discretion|2|||
149126079|NCT02457559|537941229|FG003|Overall Study|Investigator's Discretion|0|||
149126080|NCT02457559|537941230|FG004|Overall Study|Investigator's Discretion|1|||
149126081|NCT02457559|537941231|FG005|Overall Study|Investigator's Discretion|0|||
149126082|NCT02457559|537941232|FG006|Overall Study|Investigator's Discretion|1|||
149126083|NCT02457559|537941233|FG007|Overall Study|Investigator's Discretion|0|||
149126084|NCT02457559|537941234|FG008|Overall Study|Investigator's Discretion|1|||
149126085|NCT02457559|537941235|FG009|Overall Study|Investigator's Discretion|0|||
149126086|NCT02457559|537941236|FG010|Overall Study|Investigator's Discretion|1|||
149126087|NCT02457559|537941226|FG000|Overall Study|Adverse Event|0|||
149126088|NCT02457559|537941227|FG001|Overall Study|Adverse Event|1|||
149126089|NCT02457559|537941228|FG002|Overall Study|Adverse Event|2|||
149126090|NCT02457559|537941229|FG003|Overall Study|Adverse Event|0|||
149126091|NCT02457559|537941230|FG004|Overall Study|Adverse Event|0|||
149126092|NCT02457559|537941231|FG005|Overall Study|Adverse Event|0|||
149126093|NCT02457559|537941232|FG006|Overall Study|Adverse Event|0|||
149126094|NCT02457559|537941233|FG007|Overall Study|Adverse Event|0|||
149126095|NCT02457559|537941234|FG008|Overall Study|Adverse Event|0|||
149126096|NCT02457559|537941235|FG009|Overall Study|Adverse Event|0|||
149126097|NCT02457559|537941236|FG010|Overall Study|Adverse Event|0|||
149126098|NCT02457559|537941226|FG000|Overall Study|Reason not Specified|1|||
149126099|NCT02457559|537941227|FG001|Overall Study|Reason not Specified|0|||
149126100|NCT02457559|537941228|FG002|Overall Study|Reason not Specified|0|||
149126101|NCT02457559|537941229|FG003|Overall Study|Reason not Specified|0|||
149126102|NCT02457559|537941230|FG004|Overall Study|Reason not Specified|0|||
149126103|NCT02457559|537941231|FG005|Overall Study|Reason not Specified|0|||
149126104|NCT02457559|537941232|FG006|Overall Study|Reason not Specified|0|||
149126105|NCT02457559|537941233|FG007|Overall Study|Reason not Specified|0|||
149126106|NCT02457559|537941234|FG008|Overall Study|Reason not Specified|0|||
149126107|NCT02457559|537941235|FG009|Overall Study|Reason not Specified|2|||
149126108|NCT02457559|537941236|FG010|Overall Study|Reason not Specified|0|||
149126109|NCT02457559|537941226|FG000|Overall Study|Death|0|||
149126110|NCT02457559|537941227|FG001|Overall Study|Death|0|||
149126111|NCT02457559|537941228|FG002|Overall Study|Death|0|||
149126112|NCT02457559|537941229|FG003|Overall Study|Death|0|||
149126113|NCT02457559|537941230|FG004|Overall Study|Death|0|||
149126114|NCT02457559|537941231|FG005|Overall Study|Death|0|||
149126115|NCT02457559|537941232|FG006|Overall Study|Death|0|||
149126116|NCT02457559|537941233|FG007|Overall Study|Death|0|||
149126117|NCT02457559|537941234|FG008|Overall Study|Death|1|||
149126118|NCT02457559|537941235|FG009|Overall Study|Death|1|||
149126119|NCT02457559|537941236|FG010|Overall Study|Death|0|||
149126120|NCT02374671|537941237|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
149126121|NCT02374671|537941238|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
149126122|NCT02374671|537941239|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
149126123|NCT02374671|537941237|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
149126124|NCT02374671|537941238|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
149126125|NCT02374671|537941239|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
149126126|NCT02374671|537941237|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
149126127|NCT02374671|537941238|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
149126128|NCT02374671|537941239|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
149126129|NCT02374671|537941237|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
149126130|NCT02374671|537941238|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
149126131|NCT02374671|537941239|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
149126132|NCT02374671|537941237|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
149126133|NCT02374671|537941238|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
149126134|NCT02374671|537941239|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
149126135|NCT00903682|537941240|FG000|Overall Study|Adverse Event|6|||
149126136|NCT00903682|537941241|FG001|Overall Study|Adverse Event|13|||
149126137|NCT00903682|537941240|FG000|Overall Study|Lost to Follow-up|1|||
149126138|NCT00903682|537941241|FG001|Overall Study|Lost to Follow-up|0|||
149126139|NCT00903682|537941240|FG000|Overall Study|Withdrawal by Subject|5|||
149126140|NCT00903682|537941241|FG001|Overall Study|Withdrawal by Subject|0|||
149126141|NCT00903682|537941240|FG000|Overall Study|Pregnancy|0|||
149126142|NCT00903682|537941241|FG001|Overall Study|Pregnancy|1|||
149126143|NCT00903682|537941240|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
149126144|NCT00903682|537941241|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
149126145|NCT00903682|537941240|FG000|Overall Study|Subject Non-Compliant|1|||
149126146|NCT00903682|537941241|FG001|Overall Study|Subject Non-Compliant|0|||
149126147|NCT00903682|537941240|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
149126148|NCT00903682|537941241|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
149126149|NCT00903682|537941240|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
149126150|NCT00903682|537941241|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
149126151|NCT03866473|537941244|FG000|Phase 1|Death|1|||
149126152|NCT03866473|537941245|FG001|Phase 1|Death|0|||
149126153|NCT03866473|537941244|FG000|Phase 2|Death|0|||
149126154|NCT03866473|537941245|FG001|Phase 2|Death|2|||
149126155|NCT03866473|537941244|FG000|Phase 2|Dropped|1|||
149126156|NCT03866473|537941245|FG001|Phase 2|Dropped|1|||
149126157|NCT03866473|537941244|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
149126158|NCT03866473|537941245|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
149126159|NCT02495792|537941246|FG000|Overall Study|Lost to Follow-up|5|||
149126160|NCT02495792|537941247|FG001|Overall Study|Lost to Follow-up|9|||
149126161|NCT02495792|537941246|FG000|Overall Study|Protocol Violation|32|||
149126162|NCT02495792|537941247|FG001|Overall Study|Protocol Violation|31|||
149126163|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
149126164|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
149126165|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
149126166|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
149126167|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
149126168|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
149126169|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
149126170|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
149126171|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
149126172|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
149126173|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
149126174|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
149126175|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
149126176|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
149126177|NCT00600886|537941248|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
149126178|NCT00600886|537941249|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
149126179|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
149126180|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
149126181|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
149126182|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
149126183|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
149126184|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
149126185|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
149126186|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
149126187|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
149126188|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
149126189|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
149126190|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
149126191|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Death|1|||
149126192|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Death|1|||
149126193|NCT00600886|537941248|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
149126194|NCT00600886|537941249|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
149126195|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
149126196|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
149126197|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
149126198|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
149126199|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
149126200|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
149126201|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
149126202|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
149126203|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
149126204|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
149126205|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
149126206|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
149126207|NCT00600886|537941248|FG000|Extension - After Crossover (CAS)|Death|1|||
149126208|NCT00600886|537941249|FG001|Extension - After Crossover (CAS)|Death|0|||
149126209|NCT02523599|537941250|FG000|Overall Study|Adverse Event|1|||
149126210|NCT02523599|537941251|FG001|Overall Study|Adverse Event|0|||
149126211|NCT02523599|537941250|FG000|Overall Study|Physician Decision|1|||
149126212|NCT02523599|537941251|FG001|Overall Study|Physician Decision|0|||
149126213|NCT02523599|537941250|FG000|Overall Study|Lost to Follow-up|4|||
149126214|NCT02523599|537941251|FG001|Overall Study|Lost to Follow-up|1|||
149126215|NCT02523599|537941250|FG000|Overall Study|Did not return for Day 30 visit|2|||
149126216|NCT02523599|537941251|FG001|Overall Study|Did not return for Day 30 visit|0|||
149126217|NCT05590884|537941252|FG000|Overall Study|Withdrawal by Subject|1|||
149126218|NCT05590884|537941253|FG001|Overall Study|Withdrawal by Subject|0|||
149126219|NCT05590884|537941254|FG002|Overall Study|Withdrawal by Subject|0|||
149126220|NCT04976621|537941258|FG000|Overall Study|Lost to Follow-up|2|||
149126221|NCT04976621|537941259|FG001|Overall Study|Lost to Follow-up|2|||
149126222|NCT04976621|537941258|FG000|Overall Study|Withdrawal by Subject|1|||
149126223|NCT04976621|537941259|FG001|Overall Study|Withdrawal by Subject|1|||
149126224|NCT04443153|537941261|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
149126225|NCT04443153|537941262|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
149126226|NCT04443153|537941261|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
149126227|NCT04443153|537941262|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
149126228|NCT04443153|537941261|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
149126229|NCT04443153|537941262|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
149126230|NCT04443153|537941261|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
149126231|NCT04443153|537941262|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
149126232|NCT05182125|537941263|FG000|Overall Study|Withdrawal by Subject|0|||
149126233|NCT05182125|537941264|FG001|Overall Study|Withdrawal by Subject|0|||
149126234|NCT05182125|537941265|FG002|Overall Study|Withdrawal by Subject|0|||
149126235|NCT05182125|537941266|FG003|Overall Study|Withdrawal by Subject|0|||
149126236|NCT05182125|537941267|FG004|Overall Study|Withdrawal by Subject|2|||
149126237|NCT05182125|537941268|FG005|Overall Study|Withdrawal by Subject|0|||
149126238|NCT05182125|537941263|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
148786036|NCT01134263|536694023|FG001|Overall Study|Serious adverse event|1|||
148786037|NCT01134263|536694024|FG002|Overall Study|Serious adverse event|1|||
148786038|NCT01134263|536694025|FG003|Overall Study|Serious adverse event|1|||
148786039|NCT01134263|536694026|FG004|Overall Study|Serious adverse event|1|||
148786040|NCT01134263|536694022|FG000|Overall Study|Other adverse event|1|||
148786041|NCT01134263|536694023|FG001|Overall Study|Other adverse event|2|||
148786042|NCT01134263|536694024|FG002|Overall Study|Other adverse event|5|||
148786043|NCT01134263|536694025|FG003|Overall Study|Other adverse event|3|||
148786044|NCT01134263|536694026|FG004|Overall Study|Other adverse event|0|||
148786045|NCT01134263|536694022|FG000|Overall Study|Protocol Violation|8|||
148786046|NCT01134263|536694023|FG001|Overall Study|Protocol Violation|7|||
148786047|NCT01134263|536694024|FG002|Overall Study|Protocol Violation|2|||
148786048|NCT01134263|536694025|FG003|Overall Study|Protocol Violation|4|||
148786049|NCT01134263|536694026|FG004|Overall Study|Protocol Violation|2|||
148786050|NCT01134263|536694022|FG000|Overall Study|Lost to Follow-up|4|||
148786051|NCT01134263|536694023|FG001|Overall Study|Lost to Follow-up|3|||
148786052|NCT01134263|536694024|FG002|Overall Study|Lost to Follow-up|5|||
148786053|NCT01134263|536694025|FG003|Overall Study|Lost to Follow-up|3|||
148786054|NCT01134263|536694026|FG004|Overall Study|Lost to Follow-up|1|||
148786055|NCT01134263|536694022|FG000|Overall Study|Withdrawal by Subject|8|||
148786056|NCT01134263|536694023|FG001|Overall Study|Withdrawal by Subject|6|||
148786057|NCT01134263|536694024|FG002|Overall Study|Withdrawal by Subject|16|||
148786058|NCT01134263|536694025|FG003|Overall Study|Withdrawal by Subject|7|||
149126239|NCT05182125|537941264|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
149126240|NCT05182125|537941265|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
149126241|NCT05182125|537941266|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
148786059|NCT01134263|536694026|FG004|Overall Study|Withdrawal by Subject|5|||
148786060|NCT01134263|536694022|FG000|Overall Study|Enrolled, but not treated|1|||
148786061|NCT01134263|536694023|FG001|Overall Study|Enrolled, but not treated|1|||
148786062|NCT01134263|536694024|FG002|Overall Study|Enrolled, but not treated|0|||
149126242|NCT05182125|537941267|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
149126243|NCT05182125|537941268|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
149126244|NCT05182125|537941263|FG000|Overall Study|Death|0|||
149126245|NCT05182125|537941264|FG001|Overall Study|Death|0|||
149126246|NCT05182125|537941265|FG002|Overall Study|Death|0|||
149126247|NCT05182125|537941266|FG003|Overall Study|Death|0|||
149126248|NCT05182125|537941267|FG004|Overall Study|Death|1|||
149126249|NCT05182125|537941268|FG005|Overall Study|Death|0|||
149126250|NCT03519971|537941269|FG000|Overall Study|Death|142|||
149126251|NCT03519971|537941270|FG001|Overall Study|Death|69|||
149126252|NCT03519971|537941269|FG000|Overall Study|Lost to Follow-up|0|||
149126253|NCT03519971|537941270|FG001|Overall Study|Lost to Follow-up|1|||
149126254|NCT03519971|537941269|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
149126255|NCT03519971|537941270|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
149126256|NCT03519971|537941269|FG000|Overall Study|Withdrawal by Subject|3|||
149126257|NCT03519971|537941270|FG001|Overall Study|Withdrawal by Subject|2|||
149126258|NCT03519971|537941269|FG000|Overall Study|Other|1|||
149126259|NCT03519971|537941270|FG001|Overall Study|Other|0|||
149126260|NCT04134845|537941274|FG000|Overall Study|withdrawl by PI|12|||
149126261|NCT04134845|537941275|FG001|Overall Study|withdrawl by PI|5|||
149126262|NCT03110224|537941276|FG000|Overall Study|Death|3|||
149126263|NCT03110224|537941276|FG000|Overall Study|Lost to Follow-up|132|||
149126264|NCT03110224|537941276|FG000|Overall Study|Physician Decision|2|||
149126265|NCT03110224|537941276|FG000|Overall Study|Site Closed by Physician|35|||
149126266|NCT03110224|537941276|FG000|Overall Study|Site Closed by Sponsor|202|||
149126267|NCT03110224|537941276|FG000|Overall Study|Withdrawal by Subject|9|||
149126268|NCT05328167|537941277|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
149126269|NCT05328167|537941277|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
149126270|NCT06729606|537941278|FG000|Overall Study|Adverse Event|0|||
149126271|NCT06729606|537941279|FG001|Overall Study|Adverse Event|2|||
149126272|NCT06729606|537941278|FG000|Overall Study|Death|1|||
149126273|NCT06729606|537941279|FG001|Overall Study|Death|0|||
149126274|NCT06729606|537941278|FG000|Overall Study|Physician Decision|0|||
149126275|NCT06729606|537941279|FG001|Overall Study|Physician Decision|1|||
149126276|NCT06729606|537941278|FG000|Overall Study|Withdrawal by Subject|2|||
149126277|NCT06729606|537941279|FG001|Overall Study|Withdrawal by Subject|4|||
149126278|NCT05195489|537943092|FG000|Overall Study|Lost to Follow-up|1|||
149126279|NCT05195489|537943093|FG001|Overall Study|Lost to Follow-up|0|||
149126280|NCT05195489|537943092|FG000|Overall Study|Protocol Violation|0|||
149126281|NCT05195489|537943093|FG001|Overall Study|Protocol Violation|2|||
149126282|NCT05195489|537943092|FG000|Overall Study|Withdrawal by Subject|1|||
149126283|NCT05195489|537943093|FG001|Overall Study|Withdrawal by Subject|1|||
149126284|NCT05195489|537943092|FG000|Overall Study|Removed|0|||
149126285|NCT05195489|537943093|FG001|Overall Study|Removed|1|||
149126286|NCT03440320|537943095|FG000|Overall Study|Withdrawal by Subject|0|||
149126287|NCT03440320|537943096|FG001|Overall Study|Withdrawal by Subject|1|||
149126288|NCT00409773|537943097|FG000|Overall Study|Adverse Event|3|||
149126289|NCT00409773|537943098|FG001|Overall Study|Adverse Event|4|||
149126290|NCT00409773|537943099|FG002|Overall Study|Adverse Event|4|||
149126291|NCT00409773|537943100|FG003|Overall Study|Adverse Event|2|||
149126292|NCT00409773|537943101|FG004|Overall Study|Adverse Event|6|||
149126293|NCT00409773|537943097|FG000|Overall Study|Lost to Follow-up|6|||
149126294|NCT00409773|537943098|FG001|Overall Study|Lost to Follow-up|1|||
149126295|NCT00409773|537943099|FG002|Overall Study|Lost to Follow-up|2|||
149126296|NCT00409773|537943100|FG003|Overall Study|Lost to Follow-up|3|||
149126297|NCT00409773|537943101|FG004|Overall Study|Lost to Follow-up|1|||
149126298|NCT00409773|537943097|FG000|Overall Study|Physician Decision|0|||
149126299|NCT00409773|537943098|FG001|Overall Study|Physician Decision|0|||
149126300|NCT00409773|537943099|FG002|Overall Study|Physician Decision|0|||
149126301|NCT00409773|537943100|FG003|Overall Study|Physician Decision|2|||
149126302|NCT00409773|537943101|FG004|Overall Study|Physician Decision|0|||
149126303|NCT00409773|537943097|FG000|Overall Study|Protocol Violation|0|||
149126304|NCT00409773|537943098|FG001|Overall Study|Protocol Violation|2|||
149126305|NCT00409773|537943099|FG002|Overall Study|Protocol Violation|3|||
149126306|NCT00409773|537943100|FG003|Overall Study|Protocol Violation|3|||
149126307|NCT00409773|537943101|FG004|Overall Study|Protocol Violation|1|||
149126308|NCT00409773|537943097|FG000|Overall Study|Withdrawal by Subject|0|||
149126309|NCT00409773|537943098|FG001|Overall Study|Withdrawal by Subject|0|||
149126310|NCT00409773|537943099|FG002|Overall Study|Withdrawal by Subject|0|||
149126311|NCT00409773|537943100|FG003|Overall Study|Withdrawal by Subject|2|||
149126312|NCT00409773|537943101|FG004|Overall Study|Withdrawal by Subject|1|||
149126313|NCT00409773|537943097|FG000|Overall Study|Lack of Eligibility|0|||
149126314|NCT00409773|537943098|FG001|Overall Study|Lack of Eligibility|0|||
149126315|NCT00409773|537943099|FG002|Overall Study|Lack of Eligibility|0|||
149126316|NCT00409773|537943100|FG003|Overall Study|Lack of Eligibility|0|||
149126317|NCT00409773|537943101|FG004|Overall Study|Lack of Eligibility|1|||
149126318|NCT01201343|537943102|FG000|Overall Study|Adverse Event|6|||
149126319|NCT01201343|537943102|FG000|Overall Study|Withdrawal by Subject|5|||
149126320|NCT01201343|537943102|FG000|Overall Study|Lost to Follow-up|2|||
149126321|NCT01201343|537943102|FG000|Overall Study|Lack of Efficacy|2|||
149126322|NCT01201343|537943102|FG000|Overall Study|Participant wrongly included in trial|1|||
149126323|NCT01201343|537943102|FG000|Overall Study|Randomized, not treated|3|||
149126324|NCT01919814|537943103|FG000|Overall Study|Adverse Event|1|||
149126325|NCT01919814|537943104|FG001|Overall Study|Adverse Event|0|||
149126326|NCT01919814|537943103|FG000|Overall Study|Protocol Violation|1|||
149126327|NCT01919814|537943104|FG001|Overall Study|Protocol Violation|0|||
149126328|NCT01919814|537943103|FG000|Overall Study|Withdrawal by Subject|1|||
149126329|NCT01919814|537943104|FG001|Overall Study|Withdrawal by Subject|0|||
149126330|NCT01440374|537943106|FG000|Part 1: Open-label Phase|Adverse Event|5|||
149126331|NCT01440374|537943107|FG001|Part 1: Open-label Phase|Adverse Event|0|||
149126332|NCT01440374|537943108|FG002|Part 1: Open-label Phase|Adverse Event|0|||
149126333|NCT01440374|537943109|FG003|Part 1: Open-label Phase|Adverse Event|0|||
149126334|NCT01440374|537943106|FG000|Part 1: Open-label Phase|Physician Decision|1|||
149126335|NCT01440374|537943107|FG001|Part 1: Open-label Phase|Physician Decision|0|||
149126336|NCT01440374|537943108|FG002|Part 1: Open-label Phase|Physician Decision|0|||
149126337|NCT01440374|537943109|FG003|Part 1: Open-label Phase|Physician Decision|0|||
149126338|NCT01440374|537943106|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
149126339|NCT01440374|537943107|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
149126340|NCT01440374|537943108|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
149126341|NCT01440374|537943109|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
149126342|NCT01440374|537943106|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
149126343|NCT01440374|537943107|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
149126344|NCT01440374|537943108|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
149126345|NCT01440374|537943109|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
149126346|NCT01440374|537943106|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
149126347|NCT01440374|537943107|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
149126348|NCT01440374|537943108|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
149126349|NCT01440374|537943109|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
149126350|NCT01440374|537943106|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
149126351|NCT01440374|537943107|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
149126352|NCT01440374|537943108|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
149126353|NCT01440374|537943109|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
149126354|NCT01440374|537943106|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
149126355|NCT01440374|537943107|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
149126356|NCT01440374|537943108|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
149126357|NCT01440374|537943109|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
149126358|NCT01440374|537943106|FG000|Part 2; Double-blind Phase|Not treated|0|||
149126359|NCT01440374|537943107|FG001|Part 2; Double-blind Phase|Not treated|0|||
149126360|NCT01440374|537943108|FG002|Part 2; Double-blind Phase|Not treated|1|||
149126361|NCT01440374|537943109|FG003|Part 2; Double-blind Phase|Not treated|0|||
149126362|NCT01440374|537943106|FG000|Part 3: Extension|Withdrawal by Subject|0|||
149126363|NCT01440374|537943107|FG001|Part 3: Extension|Withdrawal by Subject|0|||
149126364|NCT01440374|537943108|FG002|Part 3: Extension|Withdrawal by Subject|0|||
149126365|NCT01440374|537943109|FG003|Part 3: Extension|Withdrawal by Subject|5|||
149126366|NCT01440374|537943106|FG000|Part 3: Extension|Adverse Event|0|||
149126367|NCT01440374|537943107|FG001|Part 3: Extension|Adverse Event|0|||
149126368|NCT01440374|537943108|FG002|Part 3: Extension|Adverse Event|0|||
149126369|NCT01440374|537943109|FG003|Part 3: Extension|Adverse Event|13|||
149126370|NCT01440374|537943106|FG000|Part 3: Extension|Physician Decision|0|||
149126371|NCT01440374|537943107|FG001|Part 3: Extension|Physician Decision|0|||
149126372|NCT01440374|537943108|FG002|Part 3: Extension|Physician Decision|0|||
149126373|NCT01440374|537943109|FG003|Part 3: Extension|Physician Decision|14|||
149126374|NCT01036763|537943110|FG000|Overall Study|Adverse Event|25|||
149126375|NCT01036763|537943110|FG000|Overall Study|Lost to Follow-up|28|||
149126376|NCT01036763|537943110|FG000|Overall Study|Other reason (not specified)|40|||
149126377|NCT04812548|537943112|FG000|Overall Study|Adverse Event|2|||
149126378|NCT04812548|537943113|FG001|Overall Study|Adverse Event|7|||
149126379|NCT04812548|537943112|FG000|Overall Study|HSCT Planned|2|||
149126380|NCT04812548|537943113|FG001|Overall Study|HSCT Planned|3|||
149126381|NCT04812548|537943112|FG000|Overall Study|Progressive Disease|0|||
149126382|NCT04812548|537943113|FG001|Overall Study|Progressive Disease|2|||
149126383|NCT04812548|537943112|FG000|Overall Study|Death|0|||
149126384|NCT04812548|537943113|FG001|Overall Study|Death|1|||
149126385|NCT04812548|537943112|FG000|Overall Study|Post Study Access to Treatment|0|||
149126386|NCT04812548|537943113|FG001|Overall Study|Post Study Access to Treatment|1|||
149126387|NCT04812548|537943112|FG000|Overall Study|Withdrawal by Subject|0|||
149126388|NCT04812548|537943113|FG001|Overall Study|Withdrawal by Subject|1|||
149126389|NCT04812548|537943112|FG000|Overall Study|Physician Decision|1|||
149126390|NCT04812548|537943113|FG001|Overall Study|Physician Decision|0|||
149126391|NCT02141984|537943119|FG000|Overall Study|Lack of Efficacy|2|||
149126392|NCT01177722|537943120|FG000|Overall Study|Serious Adverse Event|0|||
149126393|NCT01177722|537943121|FG001|Overall Study|Serious Adverse Event|0|||
149126394|NCT01177722|537943122|FG002|Overall Study|Serious Adverse Event|1|||
149126395|NCT01177722|537943123|FG003|Overall Study|Serious Adverse Event|0|||
149126396|NCT01177722|537943120|FG000|Overall Study|Protocol Violation|0|||
149126397|NCT01177722|537943121|FG001|Overall Study|Protocol Violation|0|||
149126398|NCT01177722|537943122|FG002|Overall Study|Protocol Violation|1|||
149126399|NCT01177722|537943123|FG003|Overall Study|Protocol Violation|0|||
149126400|NCT01177722|537943120|FG000|Overall Study|Lost to Follow-up|3|||
149126401|NCT01177722|537943121|FG001|Overall Study|Lost to Follow-up|4|||
149126402|NCT01177722|537943122|FG002|Overall Study|Lost to Follow-up|3|||
149126403|NCT01177722|537943123|FG003|Overall Study|Lost to Follow-up|1|||
149126404|NCT01177722|537943120|FG000|Overall Study|Withdrawal by Subject|10|||
149126405|NCT01177722|537943121|FG001|Overall Study|Withdrawal by Subject|6|||
149126406|NCT01177722|537943122|FG002|Overall Study|Withdrawal by Subject|4|||
149126407|NCT01177722|537943123|FG003|Overall Study|Withdrawal by Subject|6|||
149126408|NCT01201317|537943126|FG000|Overall Study|Withdrawal by Subject|5|||
149126409|NCT01201317|537943127|FG001|Overall Study|Withdrawal by Subject|0|||
149126410|NCT01201317|537943128|FG002|Overall Study|Withdrawal by Subject|3|||
149126411|NCT01201317|537943126|FG000|Overall Study|Adverse Event|2|||
149126412|NCT01201317|537943127|FG001|Overall Study|Adverse Event|2|||
149126413|NCT01201317|537943128|FG002|Overall Study|Adverse Event|2|||
149126414|NCT01201317|537943126|FG000|Overall Study|Screen failure|1|||
149126415|NCT01201317|537943127|FG001|Overall Study|Screen failure|1|||
149126416|NCT01201317|537943128|FG002|Overall Study|Screen failure|0|||
149126417|NCT01201317|537943126|FG000|Overall Study|Protocol Violation|0|||
149126418|NCT01201317|537943127|FG001|Overall Study|Protocol Violation|1|||
149126419|NCT01201317|537943128|FG002|Overall Study|Protocol Violation|1|||
149126420|NCT01201317|537943126|FG000|Overall Study|Death|0|||
149126421|NCT01201317|537943127|FG001|Overall Study|Death|1|||
149126422|NCT01201317|537943128|FG002|Overall Study|Death|0|||
149126423|NCT01201317|537943126|FG000|Overall Study|Study-specific withdrawal criteria|0|||
149126424|NCT01201317|537943127|FG001|Overall Study|Study-specific withdrawal criteria|0|||
149126425|NCT01201317|537943128|FG002|Overall Study|Study-specific withdrawal criteria|1|||
149126426|NCT01201317|537943126|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
149126427|NCT01201317|537943127|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
149126428|NCT01201317|537943128|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
149126429|NCT01201317|537943126|FG000|Overall Study|Decrease in renal function|0|||
149126430|NCT01201317|537943127|FG001|Overall Study|Decrease in renal function|1|||
149126431|NCT01201317|537943128|FG002|Overall Study|Decrease in renal function|0|||
149126432|NCT01201317|537943126|FG000|Overall Study|Lack of Efficacy|1|||
149126433|NCT01201317|537943127|FG001|Overall Study|Lack of Efficacy|0|||
149126434|NCT01201317|537943128|FG002|Overall Study|Lack of Efficacy|0|||
149126435|NCT01201317|537943126|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
149126436|NCT01201317|537943127|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
149126437|NCT01201317|537943128|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
149126438|NCT02079610|537943129|FG000|Overall Study|Withdrawal by Subject|1|||
149126439|NCT02079610|537943130|FG001|Overall Study|Withdrawal by Subject|1|||
149126440|NCT05220254|537943131|FG000|Overall Study|Withdrawal by Subject|4|||
149126441|NCT05220254|537943131|FG000|Overall Study|Removed due to ineligibility|1|||
149126442|NCT05220254|537943131|FG000|Overall Study|Lost to Follow-up|7|||
149126443|NCT02080221|537943135|FG000|Overall Study|Withdrawal by Subject|1|||
149126444|NCT02080221|537943135|FG000|Overall Study|Clinical Progression of Disease|1|||
149126445|NCT03184870|537943139|FG000|Initial Treatment|Death|6|||
149126446|NCT03184870|537943140|FG001|Initial Treatment|Death|6|||
149126447|NCT03184870|537943141|FG002|Initial Treatment|Death|8|||
149126448|NCT03184870|537943142|FG003|Initial Treatment|Death|8|||
149126449|NCT03184870|537943143|FG004|Initial Treatment|Death|6|||
149126450|NCT03184870|537943144|FG005|Initial Treatment|Death|6|||
149126451|NCT03184870|537943145|FG006|Initial Treatment|Death|6|||
149126452|NCT03184870|537943146|FG007|Initial Treatment|Death|7|||
149126453|NCT03184870|537943147|FG008|Initial Treatment|Death|1|||
149126454|NCT03184870|537943148|FG009|Initial Treatment|Death|2|||
149126455|NCT03184870|537943149|FG010|Initial Treatment|Death|26|||
149126456|NCT03184870|537943150|FG011|Initial Treatment|Death|28|||
149126457|NCT03184870|537943151|FG012|Initial Treatment|Death|10|||
149126458|NCT03184870|537943152|FG013|Initial Treatment|Death|33|||
149126459|NCT03184870|537943153|FG014|Initial Treatment|Death|34|||
149126460|NCT03184870|537943154|FG015|Initial Treatment|Death|26|||
149126461|NCT03184870|537943155|FG016|Initial Treatment|Death|20|||
149126462|NCT03184870|537943156|FG017|Initial Treatment|Death|18|||
149126463|NCT03184870|537943139|FG000|Initial Treatment|Other Reasons|2|||
149126464|NCT03184870|537943140|FG001|Initial Treatment|Other Reasons|2|||
149126465|NCT03184870|537943141|FG002|Initial Treatment|Other Reasons|0|||
149126466|NCT03184870|537943142|FG003|Initial Treatment|Other Reasons|1|||
149126467|NCT03184870|537943143|FG004|Initial Treatment|Other Reasons|0|||
149126468|NCT03184870|537943144|FG005|Initial Treatment|Other Reasons|0|||
149126469|NCT03184870|537943145|FG006|Initial Treatment|Other Reasons|0|||
149126470|NCT03184870|537943146|FG007|Initial Treatment|Other Reasons|2|||
149126471|NCT03184870|537943147|FG008|Initial Treatment|Other Reasons|0|||
149126472|NCT03184870|537943148|FG009|Initial Treatment|Other Reasons|0|||
149126473|NCT03184870|537943149|FG010|Initial Treatment|Other Reasons|4|||
149126474|NCT03184870|537943150|FG011|Initial Treatment|Other Reasons|2|||
149126475|NCT03184870|537943151|FG012|Initial Treatment|Other Reasons|2|||
149126476|NCT03184870|537943152|FG013|Initial Treatment|Other Reasons|0|||
149126477|NCT03184870|537943153|FG014|Initial Treatment|Other Reasons|0|||
149126478|NCT03184870|537943154|FG015|Initial Treatment|Other Reasons|1|||
149126479|NCT03184870|537943155|FG016|Initial Treatment|Other Reasons|0|||
149126480|NCT03184870|537943156|FG017|Initial Treatment|Other Reasons|2|||
149126481|NCT03184870|537943139|FG000|Initial Treatment|Lost to Follow-up|2|||
149126482|NCT03184870|537943140|FG001|Initial Treatment|Lost to Follow-up|0|||
149126483|NCT03184870|537943141|FG002|Initial Treatment|Lost to Follow-up|0|||
149126484|NCT03184870|537943142|FG003|Initial Treatment|Lost to Follow-up|1|||
149126485|NCT03184870|537943143|FG004|Initial Treatment|Lost to Follow-up|1|||
149126486|NCT03184870|537943144|FG005|Initial Treatment|Lost to Follow-up|1|||
149126487|NCT03184870|537943145|FG006|Initial Treatment|Lost to Follow-up|0|||
149126488|NCT03184870|537943146|FG007|Initial Treatment|Lost to Follow-up|2|||
149126489|NCT03184870|537943147|FG008|Initial Treatment|Lost to Follow-up|0|||
149126490|NCT03184870|537943148|FG009|Initial Treatment|Lost to Follow-up|0|||
149126491|NCT03184870|537943149|FG010|Initial Treatment|Lost to Follow-up|2|||
149126492|NCT03184870|537943150|FG011|Initial Treatment|Lost to Follow-up|0|||
149126493|NCT03184870|537943151|FG012|Initial Treatment|Lost to Follow-up|2|||
149126494|NCT03184870|537943152|FG013|Initial Treatment|Lost to Follow-up|2|||
149126495|NCT03184870|537943153|FG014|Initial Treatment|Lost to Follow-up|0|||
149126496|NCT03184870|537943154|FG015|Initial Treatment|Lost to Follow-up|0|||
149126497|NCT03184870|537943155|FG016|Initial Treatment|Lost to Follow-up|2|||
149126498|NCT03184870|537943156|FG017|Initial Treatment|Lost to Follow-up|2|||
149126499|NCT03184870|537943139|FG000|Initial Treatment|Withdrawal by Subject|0|||
149126500|NCT03184870|537943140|FG001|Initial Treatment|Withdrawal by Subject|0|||
149126501|NCT03184870|537943141|FG002|Initial Treatment|Withdrawal by Subject|2|||
149126502|NCT03184870|537943142|FG003|Initial Treatment|Withdrawal by Subject|1|||
149126503|NCT03184870|537943143|FG004|Initial Treatment|Withdrawal by Subject|1|||
149126504|NCT03184870|537943144|FG005|Initial Treatment|Withdrawal by Subject|0|||
149126505|NCT03184870|537943145|FG006|Initial Treatment|Withdrawal by Subject|1|||
149126506|NCT03184870|537943146|FG007|Initial Treatment|Withdrawal by Subject|0|||
149126507|NCT03184870|537943147|FG008|Initial Treatment|Withdrawal by Subject|0|||
149126508|NCT03184870|537943148|FG009|Initial Treatment|Withdrawal by Subject|0|||
149126509|NCT03184870|537943149|FG010|Initial Treatment|Withdrawal by Subject|0|||
149126510|NCT03184870|537943150|FG011|Initial Treatment|Withdrawal by Subject|2|||
149126511|NCT03184870|537943151|FG012|Initial Treatment|Withdrawal by Subject|3|||
149126512|NCT03184870|537943152|FG013|Initial Treatment|Withdrawal by Subject|0|||
149126513|NCT03184870|537943153|FG014|Initial Treatment|Withdrawal by Subject|1|||
149126514|NCT03184870|537943154|FG015|Initial Treatment|Withdrawal by Subject|5|||
149126515|NCT03184870|537943155|FG016|Initial Treatment|Withdrawal by Subject|2|||
149126516|NCT03184870|537943156|FG017|Initial Treatment|Withdrawal by Subject|2|||
149126517|NCT03184870|537943139|FG000|Initial Treatment|Moved to crossover treatment|0|||
149126518|NCT03184870|537943140|FG001|Initial Treatment|Moved to crossover treatment|0|||
149126519|NCT03184870|537943141|FG002|Initial Treatment|Moved to crossover treatment|0|||
149126520|NCT03184870|537943142|FG003|Initial Treatment|Moved to crossover treatment|0|||
149126521|NCT03184870|537943143|FG004|Initial Treatment|Moved to crossover treatment|0|||
149126522|NCT03184870|537943144|FG005|Initial Treatment|Moved to crossover treatment|0|||
149126523|NCT03184870|537943145|FG006|Initial Treatment|Moved to crossover treatment|0|||
149126524|NCT03184870|537943146|FG007|Initial Treatment|Moved to crossover treatment|0|||
149126525|NCT03184870|537943147|FG008|Initial Treatment|Moved to crossover treatment|0|||
149126526|NCT03184870|537943148|FG009|Initial Treatment|Moved to crossover treatment|0|||
149126527|NCT03184870|537943149|FG010|Initial Treatment|Moved to crossover treatment|0|||
149126528|NCT03184870|537943150|FG011|Initial Treatment|Moved to crossover treatment|0|||
149126529|NCT03184870|537943151|FG012|Initial Treatment|Moved to crossover treatment|9|||
149126530|NCT03184870|537943152|FG013|Initial Treatment|Moved to crossover treatment|0|||
149126531|NCT03184870|537943153|FG014|Initial Treatment|Moved to crossover treatment|0|||
149126532|NCT03184870|537943154|FG015|Initial Treatment|Moved to crossover treatment|0|||
149126533|NCT03184870|537943155|FG016|Initial Treatment|Moved to crossover treatment|0|||
149126534|NCT03184870|537943156|FG017|Initial Treatment|Moved to crossover treatment|0|||
149126535|NCT03184870|537943139|FG000|Crossover Treatment|Other reasons|0|||
149126536|NCT03184870|537943140|FG001|Crossover Treatment|Other reasons|0|||
149126537|NCT03184870|537943141|FG002|Crossover Treatment|Other reasons|0|||
149126538|NCT03184870|537943142|FG003|Crossover Treatment|Other reasons|0|||
149126539|NCT03184870|537943143|FG004|Crossover Treatment|Other reasons|0|||
149126540|NCT03184870|537943144|FG005|Crossover Treatment|Other reasons|0|||
149126541|NCT03184870|537943145|FG006|Crossover Treatment|Other reasons|0|||
149126542|NCT03184870|537943146|FG007|Crossover Treatment|Other reasons|0|||
149126543|NCT03184870|537943147|FG008|Crossover Treatment|Other reasons|0|||
149126544|NCT03184870|537943148|FG009|Crossover Treatment|Other reasons|0|||
149126545|NCT03184870|537943149|FG010|Crossover Treatment|Other reasons|0|||
149126546|NCT03184870|537943150|FG011|Crossover Treatment|Other reasons|0|||
149126547|NCT03184870|537943151|FG012|Crossover Treatment|Other reasons|0|||
149126548|NCT03184870|537943152|FG013|Crossover Treatment|Other reasons|0|||
149126549|NCT03184870|537943153|FG014|Crossover Treatment|Other reasons|0|||
149126550|NCT03184870|537943154|FG015|Crossover Treatment|Other reasons|0|||
149126551|NCT03184870|537943155|FG016|Crossover Treatment|Other reasons|0|||
149126552|NCT03184870|537943156|FG017|Crossover Treatment|Other reasons|2|||
149126553|NCT03184870|537943139|FG000|Crossover Treatment|Death|0|||
149126554|NCT03184870|537943140|FG001|Crossover Treatment|Death|0|||
149126555|NCT03184870|537943141|FG002|Crossover Treatment|Death|0|||
149126556|NCT03184870|537943142|FG003|Crossover Treatment|Death|0|||
149126557|NCT03184870|537943143|FG004|Crossover Treatment|Death|0|||
149126558|NCT03184870|537943144|FG005|Crossover Treatment|Death|0|||
149126559|NCT03184870|537943145|FG006|Crossover Treatment|Death|0|||
149126560|NCT03184870|537943146|FG007|Crossover Treatment|Death|0|||
149126561|NCT03184870|537943147|FG008|Crossover Treatment|Death|0|||
149126562|NCT03184870|537943148|FG009|Crossover Treatment|Death|0|||
149126563|NCT03184870|537943149|FG010|Crossover Treatment|Death|0|||
149126564|NCT03184870|537943150|FG011|Crossover Treatment|Death|0|||
149126565|NCT03184870|537943151|FG012|Crossover Treatment|Death|0|||
149126566|NCT03184870|537943152|FG013|Crossover Treatment|Death|0|||
149126567|NCT03184870|537943153|FG014|Crossover Treatment|Death|0|||
149126568|NCT03184870|537943154|FG015|Crossover Treatment|Death|0|||
149126569|NCT03184870|537943155|FG016|Crossover Treatment|Death|0|||
149126570|NCT03184870|537943156|FG017|Crossover Treatment|Death|7|||
149126571|NCT03786783|537943158|FG000|Overall Study|Death|1|||
149126572|NCT03786783|537943158|FG000|Overall Study|Physician Decision|6|||
149126573|NCT03786783|537943158|FG000|Overall Study|Withdrawal by Subject|2|||
149126574|NCT03786783|537943158|FG000|Overall Study|Disease Progression|7|||
149126575|NCT03786783|537943158|FG000|Overall Study|Patient/Parent Refusal|4|||
149126576|NCT04363801|537943159|FG000|Overall Study|Death|18|||
149126577|NCT04363801|537943160|FG001|Overall Study|Death|14|||
149126578|NCT04363801|537943161|FG002|Overall Study|Death|16|||
149126579|NCT04363801|537943162|FG003|Overall Study|Death|48|||
149126580|NCT04363801|537943163|FG004|Overall Study|Death|38|||
149126581|NCT04363801|537943159|FG000|Overall Study|Withdrawal by Subject|1|||
149126582|NCT04363801|537943160|FG001|Overall Study|Withdrawal by Subject|6|||
149126583|NCT04363801|537943161|FG002|Overall Study|Withdrawal by Subject|1|||
149126584|NCT04363801|537943162|FG003|Overall Study|Withdrawal by Subject|4|||
149126585|NCT04363801|537943163|FG004|Overall Study|Withdrawal by Subject|14|||
149126586|NCT04363801|537943159|FG000|Overall Study|Sponsor Decision|6|||
149126587|NCT04363801|537943160|FG001|Overall Study|Sponsor Decision|4|||
149126588|NCT04363801|537943161|FG002|Overall Study|Sponsor Decision|10|||
149126589|NCT04363801|537943162|FG003|Overall Study|Sponsor Decision|33|||
149126590|NCT04363801|537943163|FG004|Overall Study|Sponsor Decision|32|||
149126591|NCT04363801|537943159|FG000|Overall Study|Lost to Follow-up|0|||
149126592|NCT04363801|537943160|FG001|Overall Study|Lost to Follow-up|0|||
149126593|NCT04363801|537943161|FG002|Overall Study|Lost to Follow-up|1|||
149126594|NCT04363801|537943162|FG003|Overall Study|Lost to Follow-up|0|||
149126595|NCT04363801|537943163|FG004|Overall Study|Lost to Follow-up|1|||
149126596|NCT00250679|537943166|FG000|Overall Study|Adverse Event|12|||
149126597|NCT00250679|537943167|FG001|Overall Study|Adverse Event|15|||
149126598|NCT00250679|537943168|FG002|Overall Study|Adverse Event|16|||
149126599|NCT00250679|537943166|FG000|Overall Study|Protocol Violation|2|||
149126600|NCT00250679|537943167|FG001|Overall Study|Protocol Violation|4|||
149126601|NCT00250679|537943168|FG002|Overall Study|Protocol Violation|3|||
149126602|NCT00250679|537943166|FG000|Overall Study|Withdrawal by Subject|15|||
149126603|NCT00250679|537943167|FG001|Overall Study|Withdrawal by Subject|18|||
149126604|NCT00250679|537943168|FG002|Overall Study|Withdrawal by Subject|15|||
149126605|NCT00250679|537943166|FG000|Overall Study|Lost to Follow-up|3|||
149126606|NCT00250679|537943167|FG001|Overall Study|Lost to Follow-up|4|||
149126607|NCT00250679|537943168|FG002|Overall Study|Lost to Follow-up|2|||
149126608|NCT00250679|537943166|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
149126609|NCT00250679|537943167|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
149126610|NCT00250679|537943168|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
149126611|NCT00250679|537943166|FG000|Overall Study|Lack of Efficacy|0|||
149126612|NCT00250679|537943167|FG001|Overall Study|Lack of Efficacy|1|||
149126613|NCT00250679|537943168|FG002|Overall Study|Lack of Efficacy|3|||
149126614|NCT00250679|537943166|FG000|Overall Study|Technical Holter issues|1|||
149126615|NCT00250679|537943167|FG001|Overall Study|Technical Holter issues|0|||
149126616|NCT00250679|537943168|FG002|Overall Study|Technical Holter issues|2|||
149126617|NCT00250679|537943166|FG000|Overall Study|Moved|1|||
149126618|NCT00250679|537943167|FG001|Overall Study|Moved|1|||
149126619|NCT00250679|537943168|FG002|Overall Study|Moved|0|||
149126620|NCT00250679|537943166|FG000|Overall Study|Non-compliance|1|||
149126621|NCT00250679|537943167|FG001|Overall Study|Non-compliance|1|||
149126622|NCT00250679|537943168|FG002|Overall Study|Non-compliance|0|||
149126623|NCT00250679|537943166|FG000|Overall Study|various single events: hip surgery,diary|3|||
149126624|NCT00250679|537943167|FG001|Overall Study|various single events: hip surgery,diary|1|||
149126625|NCT00250679|537943168|FG002|Overall Study|various single events: hip surgery,diary|1|||
149126626|NCT00448279|537943169|FG000|Overall Study|Lost to Follow-up|2|||
149126627|NCT00448279|537943170|FG001|Overall Study|Lost to Follow-up|2|||
149126628|NCT00448279|537943169|FG000|Overall Study|Adverse Event|1|||
149126629|NCT00448279|537943170|FG001|Overall Study|Adverse Event|1|||
149126630|NCT00448279|537943169|FG000|Overall Study|Disease progression|16|||
149126631|NCT00448279|537943170|FG001|Overall Study|Disease progression|18|||
149126632|NCT00448279|537943169|FG000|Overall Study|Withdrawal by Subject|4|||
149126633|NCT00448279|537943170|FG001|Overall Study|Withdrawal by Subject|3|||
149126634|NCT00448279|537943169|FG000|Overall Study|Other|6|||
149126635|NCT00448279|537943170|FG001|Overall Study|Other|4|||
149126636|NCT00448279|537943169|FG000|Overall Study|Protocol Violation|0|||
149126637|NCT00448279|537943170|FG001|Overall Study|Protocol Violation|1|||
149126638|NCT03907410|537943171|FG000|Overall Study|Lost to Follow-up|4|||
149126639|NCT03907410|537943172|FG001|Overall Study|Lost to Follow-up|1|||
149126640|NCT03907410|537943173|FG002|Overall Study|Lost to Follow-up|1|||
149126641|NCT03907410|537943171|FG000|Overall Study|Lost to follow-up and research burden|0|||
149126642|NCT03907410|537943172|FG001|Overall Study|Lost to follow-up and research burden|0|||
149126643|NCT03907410|537943173|FG002|Overall Study|Lost to follow-up and research burden|1|||
149126644|NCT04776148|537943174|FG000|Overall Study|Death|249|||
149126645|NCT04776148|537943175|FG001|Overall Study|Death|260|||
149126646|NCT04776148|537943174|FG000|Overall Study|Lost to Follow-up|0|||
149126647|NCT04776148|537943175|FG001|Overall Study|Lost to Follow-up|1|||
149126648|NCT04776148|537943174|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149126649|NCT04776148|537943175|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149126650|NCT04776148|537943174|FG000|Overall Study|Withdrawal by Subject|3|||
149126651|NCT04776148|537943175|FG001|Overall Study|Withdrawal by Subject|4|||
149126652|NCT04776148|537943174|FG000|Overall Study|Sponsor Decision|30|||
149126653|NCT04776148|537943175|FG001|Overall Study|Sponsor Decision|15|||
149126654|NCT00666679|537943179|FG000|First Intervention|Lost to Follow-up|1|||
149126655|NCT00666679|537943180|FG001|First Intervention|Lost to Follow-up|0|||
149126656|NCT00666679|537943179|FG000|First Intervention|Protocol Violation|1|||
149126657|NCT00666679|537943180|FG001|First Intervention|Protocol Violation|0|||
149126658|NCT00666679|537943179|FG000|First Intervention|Withdrawal by Subject|1|||
149126659|NCT00666679|537943180|FG001|First Intervention|Withdrawal by Subject|0|||
149126660|NCT00666679|537943179|FG000|First Intervention|Randomized did not start treatment|1|||
149126661|NCT00666679|537943180|FG001|First Intervention|Randomized did not start treatment|1|||
149126662|NCT00666679|537943179|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
149126663|NCT00666679|537943180|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
149126664|NCT00666679|537943179|FG000|Washout Period of 1 Week|Protocol Violation|0|||
149126665|NCT00666679|537943180|FG001|Washout Period of 1 Week|Protocol Violation|1|||
149126666|NCT00666679|537943179|FG000|Second Intervention|Adverse Event|1|||
149126667|NCT00666679|537943180|FG001|Second Intervention|Adverse Event|0|||
149126668|NCT00666679|537943179|FG000|Second Intervention|Death|0|||
149126669|NCT00666679|537943180|FG001|Second Intervention|Death|1|||
149126670|NCT04882995|537943183|FG000|Overall Study|Withdrawal by Subject|1|||
149126671|NCT04882995|537943184|FG001|Overall Study|Withdrawal by Subject|2|||
149126672|NCT04882995|537943183|FG000|Overall Study|Protocol Violation|4|||
149126673|NCT04882995|537943184|FG001|Overall Study|Protocol Violation|4|||
149126674|NCT04882995|537943183|FG000|Overall Study|Surgery postponed due to COVID|1|||
149126675|NCT04882995|537943184|FG001|Overall Study|Surgery postponed due to COVID|1|||
149126676|NCT04371198|537943185|FG000|Overall Study|inadequate sample|4|||
149126677|NCT04754477|537943186|FG000|Overall Study|Withdrawal by Subject|1|||
149126678|NCT00655486|537943191|FG000|Overall Study|Adverse Event|10|||
149126679|NCT00655486|537943191|FG000|Overall Study|Lack of Efficacy|8|||
149126680|NCT00655486|537943191|FG000|Overall Study|Withdrawal by Subject|4|||
149126681|NCT00655486|537943191|FG000|Overall Study|Protocol Violation|1|||
149126682|NCT00655486|537943191|FG000|Overall Study|Unsatisfactory compliance|2|||
149126683|NCT00655486|537943191|FG000|Overall Study|Other: Pregnancy|1|||
149126684|NCT00655486|537943191|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
149126685|NCT00655486|537943191|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
149126686|NCT00440999|537943202|FG000|Overall Study|Adverse Event|0|||
149126687|NCT00440999|537943203|FG001|Overall Study|Adverse Event|2|||
149126688|NCT00440999|537943202|FG000|Overall Study|Lack of Efficacy|6|||
149126689|NCT00440999|537943203|FG001|Overall Study|Lack of Efficacy|7|||
149126690|NCT00440999|537943202|FG000|Overall Study|Lost to Follow-up|19|||
149126691|NCT00440999|537943203|FG001|Overall Study|Lost to Follow-up|12|||
149126692|NCT00440999|537943202|FG000|Overall Study|Protocol Violation|1|||
149126693|NCT00440999|537943203|FG001|Overall Study|Protocol Violation|0|||
149126694|NCT00440999|537943202|FG000|Overall Study|Withdrawal by Subject|2|||
149126695|NCT00440999|537943203|FG001|Overall Study|Withdrawal by Subject|5|||
149126696|NCT00440999|537943202|FG000|Overall Study|Subjets missed the visit|1|||
149126697|NCT00440999|537943203|FG001|Overall Study|Subjets missed the visit|0|||
149126698|NCT00440999|537943202|FG000|Overall Study|Mixed infection at entry|1|||
149126699|NCT00440999|537943203|FG001|Overall Study|Mixed infection at entry|0|||
149126700|NCT00440999|537943202|FG000|Overall Study|P. falciparum malaria|5|||
149126701|NCT00440999|537943203|FG001|Overall Study|P. falciparum malaria|14|||
149126702|NCT00440999|537943202|FG000|Overall Study|Subj left hosp without inform staff|0|||
149126703|NCT00440999|537943203|FG001|Overall Study|Subj left hosp without inform staff|1|||
149126704|NCT04218084|537943204|FG000|Overall Study|Adverse Event|7|||
149126705|NCT04218084|537943205|FG001|Overall Study|Adverse Event|2|||
149126706|NCT04218084|537943204|FG000|Overall Study|Withdrawal of Consent|4|||
149126707|NCT04218084|537943205|FG001|Overall Study|Withdrawal of Consent|5|||
149126708|NCT04218084|537943204|FG000|Overall Study|Physician Decision|1|||
149126709|NCT04218084|537943205|FG001|Overall Study|Physician Decision|1|||
149126710|NCT04218084|537943204|FG000|Overall Study|Lost to Follow-up|1|||
149126711|NCT04218084|537943205|FG001|Overall Study|Lost to Follow-up|1|||
149126712|NCT04218084|537943204|FG000|Overall Study|Non-compliance with study drug|1|||
149126713|NCT04218084|537943205|FG001|Overall Study|Non-compliance with study drug|1|||
149126714|NCT04218084|537943204|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
149126715|NCT04218084|537943205|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
149126716|NCT04218084|537943204|FG000|Overall Study|Other|0|||
149126717|NCT04218084|537943205|FG001|Overall Study|Other|1|||
149126718|NCT04218084|537943204|FG000|Overall Study|Ongoing at data cut-off date|62|||
149126719|NCT04218084|537943205|FG001|Overall Study|Ongoing at data cut-off date|58|||
149126720|NCT01100034|537943206|FG000|Overall Study|Lost to Follow-up|11|||
149126721|NCT01100034|537943206|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
149126722|NCT01100034|537943206|FG000|Overall Study|Withdrawal by Subject|4|||
149126723|NCT01100034|537943206|FG000|Overall Study|Sponsor decision|21|||
149126724|NCT01100034|537943206|FG000|Overall Study|Participated in another clinical trial|1|||
149126725|NCT01100034|537943206|FG000|Overall Study|Participants moved to another hospital|4|||
149126726|NCT01100034|537943206|FG000|Overall Study|Site closed due to non-responsiveness|1|||
149126727|NCT00836095|537943213|FG000|Overall Study|Physician Decision|0|||
149126728|NCT00836095|537943214|FG001|Overall Study|Physician Decision|3|||
149126729|NCT01602562|537943216|FG000|Overall Study|Adverse Event|3|||
149126730|NCT01602562|537943217|FG001|Overall Study|Adverse Event|1|||
149126731|NCT01602562|537943216|FG000|Overall Study|Physician Decision|1|||
149126732|NCT01602562|537943217|FG001|Overall Study|Physician Decision|1|||
149126733|NCT01602562|537943216|FG000|Overall Study|Withdrawal by Subject|1|||
149126734|NCT01602562|537943217|FG001|Overall Study|Withdrawal by Subject|1|||
149126735|NCT04964414|537943218|FG000|Overall Study|Lost to Follow-up|10|||
149126736|NCT04964414|537943219|FG001|Overall Study|Lost to Follow-up|8|||
149126737|NCT04964414|537943218|FG000|Overall Study|Withdrawal by Subject|1|||
149126738|NCT04964414|537943219|FG001|Overall Study|Withdrawal by Subject|1|||
149126739|NCT01718353|537943220|FG000|Overall Study|Lost to Follow-up|0|||
149126740|NCT01718353|537943221|FG001|Overall Study|Lost to Follow-up|1|||
149126741|NCT01718353|537943220|FG000|Overall Study|Principal Investigator's Decision|10|||
149126742|NCT01718353|537943221|FG001|Overall Study|Principal Investigator's Decision|4|||
149126743|NCT01718353|537943220|FG000|Overall Study|Randomized but not treated|2|||
149126744|NCT01718353|537943221|FG001|Overall Study|Randomized but not treated|0|||
149126745|NCT03426605|537943226|FG000|Overall Study|AML relapse or progression|2|||
149126746|NCT03426605|537943227|FG001|Overall Study|AML relapse or progression|1|||
149126747|NCT03426605|537943228|FG002|Overall Study|AML relapse or progression|2|||
149126748|NCT03426605|537943229|FG003|Overall Study|AML relapse or progression|2|||
149126749|NCT03426605|537943226|FG000|Overall Study|Treatment failure|3|||
149126750|NCT03426605|537943227|FG001|Overall Study|Treatment failure|2|||
149126751|NCT03426605|537943228|FG002|Overall Study|Treatment failure|0|||
149126752|NCT03426605|537943229|FG003|Overall Study|Treatment failure|0|||
149126753|NCT03426605|537943226|FG000|Overall Study|Adverse Event|1|||
149126754|NCT03426605|537943227|FG001|Overall Study|Adverse Event|0|||
149126755|NCT03426605|537943228|FG002|Overall Study|Adverse Event|1|||
149126756|NCT03426605|537943229|FG003|Overall Study|Adverse Event|1|||
149126757|NCT03426605|537943226|FG000|Overall Study|Withdrawal by Subject|0|||
149126758|NCT03426605|537943227|FG001|Overall Study|Withdrawal by Subject|0|||
149126759|NCT03426605|537943228|FG002|Overall Study|Withdrawal by Subject|1|||
149126760|NCT03426605|537943229|FG003|Overall Study|Withdrawal by Subject|1|||
149126761|NCT02308020|537943234|FG000|Overall Study|Lost to Follow-up|1|||
149126762|NCT02308020|537943235|FG001|Overall Study|Lost to Follow-up|7|||
149126763|NCT02308020|537943236|FG002|Overall Study|Lost to Follow-up|0|||
149126764|NCT02308020|537943237|FG003|Overall Study|Lost to Follow-up|0|||
149126765|NCT02308020|537943238|FG004|Overall Study|Lost to Follow-up|1|||
149126766|NCT02308020|537943239|FG005|Overall Study|Lost to Follow-up|2|||
149126767|NCT02308020|537943234|FG000|Overall Study|Sponsor Decision|0|||
149126768|NCT02308020|537943235|FG001|Overall Study|Sponsor Decision|8|||
149126769|NCT02308020|537943236|FG002|Overall Study|Sponsor Decision|0|||
149126770|NCT02308020|537943237|FG003|Overall Study|Sponsor Decision|2|||
149126771|NCT02308020|537943238|FG004|Overall Study|Sponsor Decision|2|||
149126772|NCT02308020|537943239|FG005|Overall Study|Sponsor Decision|1|||
149126773|NCT02308020|537943234|FG000|Overall Study|Withdrawal by Subject|3|||
149126774|NCT02308020|537943235|FG001|Overall Study|Withdrawal by Subject|5|||
149126775|NCT02308020|537943236|FG002|Overall Study|Withdrawal by Subject|3|||
149126776|NCT02308020|537943237|FG003|Overall Study|Withdrawal by Subject|2|||
149126777|NCT02308020|537943238|FG004|Overall Study|Withdrawal by Subject|1|||
149126778|NCT02308020|537943239|FG005|Overall Study|Withdrawal by Subject|2|||
149126779|NCT01211288|537943240|FG000|Overall Study|Lost to Follow-up|1|||
149126780|NCT01211288|537943241|FG001|Overall Study|Lost to Follow-up|1|||
149126781|NCT03333837|537943246|FG000|Overall Study|Adverse Event|2|||
149126782|NCT03333837|537943247|FG001|Overall Study|Adverse Event|1|||
149126783|NCT03333837|537943248|FG002|Overall Study|Adverse Event|1|||
149126784|NCT03333837|537943249|FG003|Overall Study|Adverse Event|1|||
149126785|NCT03333837|537943250|FG004|Overall Study|Adverse Event|0|||
149126786|NCT03333837|537943246|FG000|Overall Study|Caregiver withdrew|0|||
149126787|NCT03333837|537943247|FG001|Overall Study|Caregiver withdrew|2|||
149126788|NCT03333837|537943248|FG002|Overall Study|Caregiver withdrew|1|||
149126789|NCT03333837|537943249|FG003|Overall Study|Caregiver withdrew|0|||
149126790|NCT03333837|537943250|FG004|Overall Study|Caregiver withdrew|0|||
149126791|NCT03333837|537943246|FG000|Overall Study|Withdrawal by Subject|0|||
149126792|NCT03333837|537943247|FG001|Overall Study|Withdrawal by Subject|0|||
149126793|NCT03333837|537943248|FG002|Overall Study|Withdrawal by Subject|1|||
149126794|NCT03333837|537943249|FG003|Overall Study|Withdrawal by Subject|1|||
149126795|NCT03333837|537943250|FG004|Overall Study|Withdrawal by Subject|3|||
149126796|NCT03333837|537943246|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
149126797|NCT03333837|537943247|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
149126798|NCT03333837|537943248|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
149126799|NCT03333837|537943249|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
149126800|NCT03333837|537943250|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
149126801|NCT04217590|537943252|FG000|Overall Study|Other|1|||
149126802|NCT04217590|537943253|FG001|Overall Study|Other|1|||
149126803|NCT04217590|537943252|FG000|Overall Study|Withdrawal by Subject|3|||
149126804|NCT04217590|537943253|FG001|Overall Study|Withdrawal by Subject|1|||
149126805|NCT04217590|537943252|FG000|Overall Study|Death|0|||
149126806|NCT04217590|537943253|FG001|Overall Study|Death|1|||
149126807|NCT02401867|537945368|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
149126808|NCT02401867|537945368|FG000|Analysis|Cervical assay could not be conducted|9|||
149126809|NCT02795429|537945378|FG000|Overall Study|Adverse Event|1|||
149126810|NCT02795429|537945379|FG001|Overall Study|Adverse Event|2|||
149126811|NCT02795429|537945380|FG002|Overall Study|Adverse Event|1|||
149126812|NCT02795429|537945381|FG003|Overall Study|Adverse Event|2|||
149126813|NCT02795429|537945382|FG004|Overall Study|Adverse Event|1|||
149126814|NCT02795429|537945378|FG000|Overall Study|Death|1|||
149126815|NCT02795429|537945379|FG001|Overall Study|Death|0|||
149126816|NCT02795429|537945380|FG002|Overall Study|Death|1|||
149126817|NCT02795429|537945381|FG003|Overall Study|Death|2|||
149126818|NCT02795429|537945382|FG004|Overall Study|Death|1|||
149126819|NCT02795429|537945378|FG000|Overall Study|Physician Decision|0|||
149126820|NCT02795429|537945379|FG001|Overall Study|Physician Decision|0|||
149126821|NCT02795429|537945380|FG002|Overall Study|Physician Decision|2|||
149126822|NCT02795429|537945381|FG003|Overall Study|Physician Decision|1|||
149126823|NCT02795429|537945382|FG004|Overall Study|Physician Decision|5|||
149126824|NCT02795429|537945378|FG000|Overall Study|Progressive disease|3|||
149126825|NCT02795429|537945379|FG001|Overall Study|Progressive disease|7|||
149126826|NCT02795429|537945380|FG002|Overall Study|Progressive disease|6|||
149126827|NCT02795429|537945381|FG003|Overall Study|Progressive disease|26|||
149126828|NCT02795429|537945382|FG004|Overall Study|Progressive disease|20|||
149126829|NCT02795429|537945378|FG000|Overall Study|Subject/guardian decision|1|||
149126830|NCT02795429|537945379|FG001|Overall Study|Subject/guardian decision|1|||
149126831|NCT02795429|537945380|FG002|Overall Study|Subject/guardian decision|1|||
149126832|NCT02795429|537945381|FG003|Overall Study|Subject/guardian decision|1|||
149126833|NCT02795429|537945382|FG004|Overall Study|Subject/guardian decision|3|||
149126834|NCT05041101|537945385|FG000|Overall Study|Adverse Event|1|||
149126835|NCT05041101|537945386|FG001|Overall Study|Adverse Event|0|||
149126836|NCT05041101|537945387|FG002|Overall Study|Adverse Event|0|||
149126837|NCT05041101|537945385|FG000|Overall Study|Diease Progression|5|||
149126838|NCT05041101|537945386|FG001|Overall Study|Diease Progression|0|||
149126839|NCT05041101|537945387|FG002|Overall Study|Diease Progression|0|||
149126840|NCT00249002|537945388|FG000|Overall Study|Adverse Event|2|||
149126841|NCT00249002|537945388|FG000|Overall Study|Study cancellation|3|||
149126842|NCT00249002|537945388|FG000|Overall Study|Other|2|||
149126843|NCT00069108|537945389|FG000|Overall Study|Withdrawal by Subject|5|||
149126844|NCT00069108|537945390|FG001|Overall Study|Withdrawal by Subject|9|||
149126845|NCT00069108|537945389|FG000|Overall Study|Adverse Event|64|||
149126846|NCT00069108|537945390|FG001|Overall Study|Adverse Event|42|||
149126847|NCT00069108|537945389|FG000|Overall Study|Death|6|||
149126848|NCT00069108|537945390|FG001|Overall Study|Death|6|||
149126849|NCT00069108|537945389|FG000|Overall Study|Administration|15|||
149126850|NCT00069108|537945390|FG001|Overall Study|Administration|4|||
149126851|NCT00069108|537945389|FG000|Overall Study|Insufficient therapy|117|||
149126852|NCT00069108|537945390|FG001|Overall Study|Insufficient therapy|144|||
149126853|NCT00069108|537945389|FG000|Overall Study|Violation criteria|1|||
149126854|NCT00069108|537945390|FG001|Overall Study|Violation criteria|4|||
149126855|NCT00069108|537945389|FG000|Overall Study|Refused treatment|5|||
149126856|NCT00069108|537945390|FG001|Overall Study|Refused treatment|10|||
149126857|NCT01853137|537945391|FG000|Overall Study|Lost to Follow-up|4|||
149126858|NCT01853137|537945392|FG001|Overall Study|Lost to Follow-up|1|||
149126859|NCT03401229|537945393|FG000|Overall Study|Lost to Follow-up|2|||
149126860|NCT03401229|537945394|FG001|Overall Study|Lost to Follow-up|1|||
149126861|NCT03401229|537945393|FG000|Overall Study|Other|1|||
149126862|NCT03401229|537945394|FG001|Overall Study|Other|3|||
149126863|NCT03401229|537945393|FG000|Overall Study|Adverse Event|8|||
149126864|NCT03401229|537945394|FG001|Overall Study|Adverse Event|6|||
149126865|NCT03401229|537945393|FG000|Overall Study|Withdrawal by Subject|29|||
149126866|NCT03401229|537945394|FG001|Overall Study|Withdrawal by Subject|26|||
149126867|NCT03401229|537945393|FG000|Overall Study|COVID-19|0|||
149126868|NCT03401229|537945394|FG001|Overall Study|COVID-19|1|||
149126869|NCT00690820|537945395|FG000|Period 1|Withdrawal by Subject|0|||
149126870|NCT00690820|537945396|FG001|Period 1|Withdrawal by Subject|1|||
149126871|NCT05333224|537945397|FG000|Overall Study - Infants|Lost to Follow-up|1|||
149126872|NCT05333224|537945398|FG001|Overall Study - Infants|Lost to Follow-up|1|||
149126873|NCT01411215|537945400|FG000|Overall Study|Adverse Event|1|||
149126874|NCT01411215|537945401|FG001|Overall Study|Adverse Event|2|||
149126875|NCT01411215|537945400|FG000|Overall Study|Lack of Efficacy|2|||
149126876|NCT01411215|537945401|FG001|Overall Study|Lack of Efficacy|4|||
149126877|NCT01411215|537945400|FG000|Overall Study|Lost to Follow-up|12|||
149126878|NCT01411215|537945401|FG001|Overall Study|Lost to Follow-up|18|||
149126879|NCT01411215|537945400|FG000|Overall Study|Did not meet entrance criteria|0|||
149126880|NCT01411215|537945401|FG001|Overall Study|Did not meet entrance criteria|1|||
149126881|NCT01411215|537945400|FG000|Overall Study|Study terminated by sponsor|2|||
149126882|NCT01411215|537945401|FG001|Overall Study|Study terminated by sponsor|15|||
149126883|NCT01411215|537945400|FG000|Overall Study|Protocol Violation|3|||
149126884|NCT01411215|537945401|FG001|Overall Study|Protocol Violation|5|||
149126885|NCT01411215|537945400|FG000|Overall Study|Withdrawal by Subject|34|||
149126886|NCT01411215|537945401|FG001|Overall Study|Withdrawal by Subject|21|||
149126887|NCT01411215|537945400|FG000|Overall Study|Other|12|||
149126888|NCT01411215|537945401|FG001|Overall Study|Other|17|||
149126889|NCT01411215|537945400|FG000|Overall Study|Screen failure|0|||
149126890|NCT01411215|537945401|FG001|Overall Study|Screen failure|1|||
149126891|NCT00848926|537945402|FG000|Treatment Period|Progressive disease|45|||
149126892|NCT00848926|537945402|FG000|Treatment Period|Adverse Event|20|||
149126893|NCT00848926|537945402|FG000|Treatment Period|Physician Decision|12|||
149126894|NCT00848926|537945402|FG000|Treatment Period|Withdrawal by Subject|7|||
149126895|NCT00848926|537945402|FG000|Follow-up Period|Lost to Follow-up|7|||
149126896|NCT00848926|537945402|FG000|Follow-up Period|Withdrawal by Subject|3|||
149126897|NCT00848926|537945402|FG000|Follow-up Period|Other|2|||
149126898|NCT02203695|537945403|FG000|Overall Study|Patient withdrew consent|1|||
149126899|NCT02203695|537945404|FG001|Overall Study|Patient withdrew consent|1|||
149126900|NCT02203695|537945403|FG000|Overall Study|Started non-study treatment|1|||
149126901|NCT02203695|537945404|FG001|Overall Study|Started non-study treatment|0|||
149126902|NCT00966277|537945406|FG000|Overall Study|Withdrawal by Subject|3|||
149126903|NCT00966277|537945407|FG001|Overall Study|Withdrawal by Subject|0|||
149126904|NCT00966277|537945406|FG000|Overall Study|Ineligible|1|||
149126905|NCT00966277|537945407|FG001|Overall Study|Ineligible|3|||
149126906|NCT00966277|537945406|FG000|Overall Study|Treatment Plan Changed|0|||
149126907|NCT00966277|537945407|FG001|Overall Study|Treatment Plan Changed|1|||
149126908|NCT03451162|537945409|FG000|Overall Study|Lost to Follow-up|1|||
149126909|NCT03451162|537945410|FG001|Overall Study|Lost to Follow-up|0|||
149126910|NCT03451162|537945411|FG002|Overall Study|Lost to Follow-up|0|||
149126911|NCT03451162|537945412|FG003|Overall Study|Lost to Follow-up|0|||
149126912|NCT03451162|537945413|FG004|Overall Study|Lost to Follow-up|0|||
149126913|NCT03451162|537945409|FG000|Overall Study|Physician Decision|0|||
149126914|NCT03451162|537945410|FG001|Overall Study|Physician Decision|1|||
149126915|NCT03451162|537945411|FG002|Overall Study|Physician Decision|0|||
149126916|NCT03451162|537945412|FG003|Overall Study|Physician Decision|0|||
149126917|NCT03451162|537945413|FG004|Overall Study|Physician Decision|0|||
149126918|NCT03451162|537945409|FG000|Overall Study|Withdrawal by Subject|1|||
149126919|NCT03451162|537945410|FG001|Overall Study|Withdrawal by Subject|1|||
149126920|NCT03451162|537945411|FG002|Overall Study|Withdrawal by Subject|0|||
149126921|NCT03451162|537945412|FG003|Overall Study|Withdrawal by Subject|0|||
149126922|NCT03451162|537945413|FG004|Overall Study|Withdrawal by Subject|0|||
149126923|NCT03305731|537945414|FG000|Overall Study|Protocol Violation|1|||
149126924|NCT01952054|537945415|FG000|Overall Study|Physician Decision|1|||
149126925|NCT01127139|537945416|FG000|Overall Study|Adverse Event|40|||
149126926|NCT01127139|537945416|FG000|Overall Study|Incompliance|12|||
149126927|NCT01127139|537945416|FG000|Overall Study|Lack of Efficacy|4|||
149126928|NCT01127139|537945416|FG000|Overall Study|Reason not specified|1|||
149126929|NCT01136772|537945417|FG000|Overall Study|Adverse Event|15|||
149126930|NCT01136772|537945418|FG001|Overall Study|Adverse Event|14|||
149126931|NCT01136772|537945417|FG000|Overall Study|Lack of Efficacy|42|||
149126932|NCT01136772|537945418|FG001|Overall Study|Lack of Efficacy|39|||
149126933|NCT01136772|537945417|FG000|Overall Study|Administrative|14|||
149126934|NCT01136772|537945418|FG001|Overall Study|Administrative|12|||
149126935|NCT01136772|537945417|FG000|Overall Study|Withdrawal by Subject|33|||
149126936|NCT01136772|537945418|FG001|Overall Study|Withdrawal by Subject|36|||
149126937|NCT01136772|537945417|FG000|Overall Study|Did not receive injection|10|||
149126938|NCT01136772|537945418|FG001|Overall Study|Did not receive injection|7|||
149126939|NCT01136772|537945417|FG000|Overall Study|Did not follow up after first injection|2|||
149126940|NCT01136772|537945418|FG001|Overall Study|Did not follow up after first injection|2|||
149126941|NCT01498653|537945419|FG000|Overall Study|Adverse Event|2|||
149126942|NCT01498653|537945420|FG001|Overall Study|Adverse Event|2|||
149126943|NCT01498653|537945419|FG000|Overall Study|Lack of Efficacy|12|||
149126944|NCT01498653|537945420|FG001|Overall Study|Lack of Efficacy|26|||
149126945|NCT01498653|537945419|FG000|Overall Study|Protocol Violation|0|||
149126946|NCT01498653|537945420|FG001|Overall Study|Protocol Violation|4|||
149126947|NCT01498653|537945419|FG000|Overall Study|Lost to Follow-up|1|||
149126948|NCT01498653|537945420|FG001|Overall Study|Lost to Follow-up|0|||
149126949|NCT01498653|537945419|FG000|Overall Study|Physician Decision|2|||
149126950|NCT01498653|537945420|FG001|Overall Study|Physician Decision|0|||
149126951|NCT01498653|537945419|FG000|Overall Study|Withdrawal by Subject|2|||
149126952|NCT01498653|537945420|FG001|Overall Study|Withdrawal by Subject|3|||
149126953|NCT03881553|537945422|FG000|Overall Study|Discharged prior to participation|1|||
149126954|NCT03881553|537945423|FG001|Overall Study|Discharged prior to participation|1|||
149126955|NCT03881553|537945424|FG002|Overall Study|Discharged prior to participation|0|||
149126956|NCT03881553|537945422|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
149126957|NCT03881553|537945423|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
149126958|NCT03881553|537945424|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
149126959|NCT01477333|537945425|FG000|Overall Study|Adverse Event|1|||
149126960|NCT01477333|537945425|FG000|Overall Study|Withdrawal by Subject|1|||
149126961|NCT01477333|537945425|FG000|Overall Study|Clinical Deterioration|1|||
149126962|NCT00455325|537945426|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
149126963|NCT00455325|537945427|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
149126964|NCT00455325|537945428|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
149126965|NCT00455325|537945429|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
149126966|NCT00455325|537945426|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
149126967|NCT00455325|537945427|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
149126968|NCT00455325|537945428|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
149126969|NCT00455325|537945429|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
149126970|NCT00455325|537945426|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
149126971|NCT00455325|537945427|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
149126972|NCT00455325|537945428|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
149126973|NCT00455325|537945429|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
149126974|NCT00455325|537945426|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
149126975|NCT00455325|537945427|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
149126976|NCT00455325|537945428|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
149126977|NCT00455325|537945429|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
149126978|NCT00455325|537945426|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
149126979|NCT00455325|537945427|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
149126980|NCT00455325|537945428|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
149126981|NCT00455325|537945429|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
149126982|NCT00455325|537945426|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
149126983|NCT00455325|537945427|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
149126984|NCT00455325|537945428|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
149126985|NCT00455325|537945429|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
149126986|NCT00455325|537945426|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
149126987|NCT00455325|537945427|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
148786063|NCT01134263|536694025|FG003|Overall Study|Enrolled, but not treated|1|||
148786064|NCT01134263|536694026|FG004|Overall Study|Enrolled, but not treated|0|||
148786065|NCT01557517|536694027|FG000|Overall Study|Death|1|||
148786066|NCT01557517|536694028|FG001|Overall Study|Death|0|||
148786067|NCT01557517|536694027|FG000|Overall Study|Refused further treatment|0|||
148786068|NCT01557517|536694028|FG001|Overall Study|Refused further treatment|2|||
148786069|NCT01557517|536694027|FG000|Overall Study|Adverse Event|0|||
148786070|NCT01557517|536694028|FG001|Overall Study|Adverse Event|2|||
148786071|NCT01557517|536694027|FG000|Overall Study|Pt declined before treatment started|1|||
148786072|NCT01557517|536694028|FG001|Overall Study|Pt declined before treatment started|0|||
148786073|NCT00162097|536694029|FG000|Overall Study|Participant no longer met study criteria|0|||
148786074|NCT00162097|536694030|FG001|Overall Study|Participant no longer met study criteria|0|||
148786075|NCT00162097|536694031|FG002|Overall Study|Participant no longer met study criteria|0|||
148786076|NCT00162097|536694032|FG003|Overall Study|Participant no longer met study criteria|1|||
148786077|NCT02819440|536694033|FG000|Overall Study|Adverse Event|3|||
148786078|NCT02819440|536694034|FG001|Overall Study|Adverse Event|1|||
148786079|NCT02819440|536694033|FG000|Overall Study|Lost to Follow-up|1|||
148786080|NCT02819440|536694034|FG001|Overall Study|Lost to Follow-up|3|||
148786081|NCT02819440|536694033|FG000|Overall Study|Withdrawal by Subject|9|||
148786082|NCT02819440|536694034|FG001|Overall Study|Withdrawal by Subject|8|||
149126988|NCT00455325|537945428|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
149126989|NCT00455325|537945429|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
149126990|NCT00819390|537945433|FG000|Overall Study|Lost to Follow-up|1|||
149126991|NCT00819390|537945434|FG001|Overall Study|Lost to Follow-up|1|||
149126992|NCT00819390|537945435|FG002|Overall Study|Lost to Follow-up|0|||
149126993|NCT00819390|537945436|FG003|Overall Study|Lost to Follow-up|0|||
149126994|NCT00819390|537945433|FG000|Overall Study|Withdrawal by Subject|2|||
149126995|NCT00819390|537945434|FG001|Overall Study|Withdrawal by Subject|0|||
149126996|NCT00819390|537945435|FG002|Overall Study|Withdrawal by Subject|0|||
149126997|NCT00819390|537945436|FG003|Overall Study|Withdrawal by Subject|0|||
149126998|NCT00819390|537945433|FG000|Overall Study|Adverse Event|0|||
149126999|NCT00819390|537945434|FG001|Overall Study|Adverse Event|0|||
149127000|NCT00819390|537945435|FG002|Overall Study|Adverse Event|1|||
149127001|NCT00819390|537945436|FG003|Overall Study|Adverse Event|0|||
149127002|NCT01759368|537945437|FG000|Overall Study|Lost to Follow-up|1|||
149127003|NCT01759368|537945438|FG001|Overall Study|Lost to Follow-up|0|||
149127004|NCT01191268|537945445|FG000|Overall Study|Withdrawal by Subject|19|||
149127005|NCT01191268|537945446|FG001|Overall Study|Withdrawal by Subject|25|||
149127006|NCT01191268|537945447|FG002|Overall Study|Withdrawal by Subject|21|||
149127007|NCT01191268|537945445|FG000|Overall Study|Adverse Event|21|||
149127008|NCT01191268|537945446|FG001|Overall Study|Adverse Event|13|||
149127009|NCT01191268|537945447|FG002|Overall Study|Adverse Event|8|||
149127010|NCT01191268|537945445|FG000|Overall Study|Physician Decision|6|||
149127011|NCT01191268|537945446|FG001|Overall Study|Physician Decision|8|||
149127012|NCT01191268|537945447|FG002|Overall Study|Physician Decision|9|||
149127013|NCT01191268|537945445|FG000|Overall Study|Lost to Follow-up|8|||
149127014|NCT01191268|537945446|FG001|Overall Study|Lost to Follow-up|5|||
149127015|NCT01191268|537945447|FG002|Overall Study|Lost to Follow-up|9|||
149127016|NCT01191268|537945445|FG000|Overall Study|Entry Criteria Not Met|3|||
149127017|NCT01191268|537945446|FG001|Overall Study|Entry Criteria Not Met|1|||
149127018|NCT01191268|537945447|FG002|Overall Study|Entry Criteria Not Met|1|||
149127019|NCT01191268|537945445|FG000|Overall Study|Death|0|||
149127020|NCT01191268|537945446|FG001|Overall Study|Death|1|||
149127021|NCT01191268|537945447|FG002|Overall Study|Death|3|||
149127022|NCT01191268|537945445|FG000|Overall Study|Protocol Violation|1|||
149127023|NCT01191268|537945446|FG001|Overall Study|Protocol Violation|0|||
149127024|NCT01191268|537945447|FG002|Overall Study|Protocol Violation|1|||
149127025|NCT01191268|537945445|FG000|Overall Study|Sponsor Decision|0|||
149127026|NCT01191268|537945446|FG001|Overall Study|Sponsor Decision|2|||
149127027|NCT01191268|537945447|FG002|Overall Study|Sponsor Decision|0|||
149127028|NCT00336895|537945448|FG000|Overall Study|diarrhea|1|||
149127029|NCT00336895|537945448|FG000|Overall Study|nausea and upset stomach|1|||
149127030|NCT00336895|537945448|FG000|Overall Study|Physician Decision|1|||
149127031|NCT00336895|537945448|FG000|Overall Study|screen failed|1|||
149127032|NCT01959334|537945449|FG000|Second Dose|Adverse Event|1|||
149127033|NCT01959334|537945450|FG001|Second Dose|Adverse Event|0|||
149127034|NCT01959334|537945449|FG000|Third Dose|Adverse Event|0|||
149127035|NCT01959334|537945450|FG001|Third Dose|Adverse Event|1|||
149127036|NCT01313689|537945451|FG000|24-Week Randomization 1|Adverse Event|10|||
149127037|NCT01313689|537945452|FG001|24-Week Randomization 1|Adverse Event|5|||
149127038|NCT01313689|537945453|FG002|24-Week Randomization 1|Adverse Event|0|||
149127039|NCT01313689|537945454|FG003|24-Week Randomization 1|Adverse Event|0|||
149127040|NCT01313689|537945455|FG004|24-Week Randomization 1|Adverse Event|0|||
149127041|NCT01313689|537945451|FG000|24-Week Randomization 1|Physician Decision|4|||
149127042|NCT01313689|537945452|FG001|24-Week Randomization 1|Physician Decision|5|||
149127043|NCT01313689|537945453|FG002|24-Week Randomization 1|Physician Decision|0|||
149127044|NCT01313689|537945454|FG003|24-Week Randomization 1|Physician Decision|0|||
149127045|NCT01313689|537945455|FG004|24-Week Randomization 1|Physician Decision|0|||
149127046|NCT01313689|537945451|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
149127047|NCT01313689|537945452|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
149127048|NCT01313689|537945453|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
149127049|NCT01313689|537945454|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
149127050|NCT01313689|537945455|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
149127051|NCT01313689|537945451|FG000|24-Week Randomization 2|Adverse Event|0|||
149127052|NCT01313689|537945452|FG001|24-Week Randomization 2|Adverse Event|0|||
149127053|NCT01313689|537945453|FG002|24-Week Randomization 2|Adverse Event|2|||
149127054|NCT01313689|537945454|FG003|24-Week Randomization 2|Adverse Event|0|||
149127055|NCT01313689|537945455|FG004|24-Week Randomization 2|Adverse Event|8|||
149127056|NCT01313689|537945451|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
149127057|NCT01313689|537945452|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
149127058|NCT01313689|537945453|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
149127059|NCT01313689|537945454|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
149127060|NCT01313689|537945455|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
149127061|NCT01313689|537945451|FG000|24-Week Randomization 2|Physician Decision|0|||
149127062|NCT01313689|537945452|FG001|24-Week Randomization 2|Physician Decision|0|||
149127063|NCT01313689|537945453|FG002|24-Week Randomization 2|Physician Decision|0|||
149127064|NCT01313689|537945454|FG003|24-Week Randomization 2|Physician Decision|0|||
149127065|NCT01313689|537945455|FG004|24-Week Randomization 2|Physician Decision|4|||
149127066|NCT01768637|537945456|FG000|Overall Study|Lost to Follow-up|2|||
149127067|NCT01768637|537945457|FG001|Overall Study|Lost to Follow-up|7|||
148786083|NCT02007278|536694043|FG000|Overall Study|Failure to comply with an eligibility|0|||
148786084|NCT02007278|536694044|FG001|Overall Study|Failure to comply with an eligibility|1|||
148786085|NCT02007278|536694043|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
148786086|NCT02007278|536694044|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
148786087|NCT02007278|536694043|FG000|Overall Study|Incorrect medication administration|1|||
148786088|NCT02007278|536694044|FG001|Overall Study|Incorrect medication administration|0|||
148786089|NCT02007278|536694043|FG000|Overall Study|Mis-randomization|1|||
148786090|NCT02007278|536694044|FG001|Overall Study|Mis-randomization|1|||
148786091|NCT03230838|536694048|FG000|Overall Study|Withdrawal by Subject|3|||
148786092|NCT03230838|536694049|FG001|Overall Study|Withdrawal by Subject|0|||
148786093|NCT03230838|536694048|FG000|Overall Study|Temperature excursion|1|||
148786094|NCT03230838|536694049|FG001|Overall Study|Temperature excursion|0|||
148786095|NCT00435188|536694051|FG000|Overall Study|Death|1|||
148786096|NCT00435188|536694052|FG001|Overall Study|Death|6|||
148786097|NCT00435188|536694051|FG000|Overall Study|Withdrawal by Subject|16|||
148786098|NCT00435188|536694052|FG001|Overall Study|Withdrawal by Subject|11|||
148786099|NCT00435188|536694051|FG000|Overall Study|Lost to Follow-up|5|||
148786100|NCT00435188|536694052|FG001|Overall Study|Lost to Follow-up|6|||
148786101|NCT01915771|536694055|FG000|Day 1|Withdrawal by Subject|1|||
148786102|NCT01915771|536694055|FG000|Day 15|Withdrawal by Subject|1|||
148786103|NCT00575510|536694058|FG000|Overall Study|Lost to Follow-up|4|||
148786104|NCT00575510|536694059|FG001|Overall Study|Lost to Follow-up|6|||
148786105|NCT00575510|536694060|FG002|Overall Study|Lost to Follow-up|9|||
148786106|NCT00575510|536694058|FG000|Overall Study|Withdrawal by Subject|1|||
148786107|NCT00575510|536694059|FG001|Overall Study|Withdrawal by Subject|0|||
148786108|NCT00575510|536694060|FG002|Overall Study|Withdrawal by Subject|0|||
148786109|NCT00575510|536694058|FG000|Overall Study|Clinic Called Patient|7|||
148786110|NCT00575510|536694059|FG001|Overall Study|Clinic Called Patient|7|||
148786111|NCT00575510|536694060|FG002|Overall Study|Clinic Called Patient|7|||
148786112|NCT00575510|536694058|FG000|Overall Study|Pregnancy|0|||
148786113|NCT00575510|536694059|FG001|Overall Study|Pregnancy|0|||
148786114|NCT00575510|536694060|FG002|Overall Study|Pregnancy|1|||
148786115|NCT03420222|536694061|FG000|Overall Study|Withdrawal by Subject|5|||
148786116|NCT03420222|536694062|FG001|Overall Study|Withdrawal by Subject|0|||
148786117|NCT03420222|536694061|FG000|Overall Study|Physician Decision|0|||
148786118|NCT03420222|536694062|FG001|Overall Study|Physician Decision|1|||
148786119|NCT02334384|536694063|FG000|Overall Study|Lost to Follow-up|1|||
148786120|NCT02334384|536694064|FG001|Overall Study|Lost to Follow-up|1|||
148786121|NCT03244618|536694066|FG000|Overall Study|Lost to Follow-up|3|||
148786122|NCT03244618|536694067|FG001|Overall Study|Lost to Follow-up|4|||
148786123|NCT03244618|536694066|FG000|Overall Study|Protocol Violation|4|||
148786124|NCT03244618|536694067|FG001|Overall Study|Protocol Violation|3|||
148786125|NCT03244618|536694066|FG000|Overall Study|Withdrawal by Subject|0|||
148786126|NCT03244618|536694067|FG001|Overall Study|Withdrawal by Subject|2|||
148786127|NCT03469999|536694068|FG000|Overall Study|Lost to Follow-up|2|||
148786128|NCT04424914|536694072|FG000|Overall Study|Other|0|||
148786129|NCT04424914|536694073|FG001|Overall Study|Other|0|||
148786130|NCT04424914|536694074|FG002|Overall Study|Other|28|||
148786131|NCT04424914|536694072|FG000|Overall Study|Withdrawal by Subject|3|||
148786132|NCT04424914|536694073|FG001|Overall Study|Withdrawal by Subject|0|||
148786133|NCT04424914|536694074|FG002|Overall Study|Withdrawal by Subject|0|||
148786134|NCT04424914|536694072|FG000|Overall Study|Study terminated by sponsor|23|||
148786135|NCT04424914|536694073|FG001|Overall Study|Study terminated by sponsor|7|||
148786136|NCT04424914|536694074|FG002|Overall Study|Study terminated by sponsor|0|||
148786137|NCT04424914|536694072|FG000|Overall Study|Lost to Follow-up|0|||
148786138|NCT04424914|536694073|FG001|Overall Study|Lost to Follow-up|0|||
148786139|NCT04424914|536694074|FG002|Overall Study|Lost to Follow-up|1|||
148786140|NCT04424914|536694072|FG000|Overall Study|Death|3|||
148786141|NCT04424914|536694073|FG001|Overall Study|Death|1|||
148786142|NCT04424914|536694074|FG002|Overall Study|Death|0|||
148786143|NCT00460746|536694077|FG000|Overall Study|Adverse Event|1|||
148786144|NCT00460746|536694077|FG000|Overall Study|Lost to Follow-up|1|||
148786145|NCT01778751|536694080|FG000|Overall Study|Lost to Follow-up|1|||
148786146|NCT01778751|536694081|FG001|Overall Study|Lost to Follow-up|0|||
148786147|NCT01778751|536694080|FG000|Overall Study|Withdrawal by Subject|0|||
148786148|NCT01778751|536694081|FG001|Overall Study|Withdrawal by Subject|2|||
148786149|NCT01778751|536694080|FG000|Overall Study|Transfered care|1|||
148786150|NCT01778751|536694081|FG001|Overall Study|Transfered care|0|||
148786151|NCT02791438|536694086|FG000|Treatment Period|Adverse Event|1|||
149127068|NCT01768637|537945456|FG000|Overall Study|Difficult blood draw|1|||
149127069|NCT01768637|537945457|FG001|Overall Study|Difficult blood draw|0|||
148786152|NCT02791438|536694087|FG001|Treatment Period|Adverse Event|0|||
148786153|NCT02791438|536694086|FG000|Treatment Period|Withdrawal by Subject|0|||
148786154|NCT02791438|536694087|FG001|Treatment Period|Withdrawal by Subject|1|||
148786155|NCT02791438|536694086|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
148786156|NCT02791438|536694087|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
148786157|NCT02669667|536694088|FG000|Overall Study|Lost to Follow-up|0|||
148786158|NCT02669667|536694089|FG001|Overall Study|Lost to Follow-up|0|||
148786159|NCT02669667|536694090|FG002|Overall Study|Lost to Follow-up|0|||
148786160|NCT02669667|536694091|FG003|Overall Study|Lost to Follow-up|0|||
148786161|NCT02669667|536694092|FG004|Overall Study|Lost to Follow-up|0|||
148786162|NCT02669667|536694093|FG005|Overall Study|Lost to Follow-up|1|||
148786163|NCT02669667|536694094|FG006|Overall Study|Lost to Follow-up|0|||
148786164|NCT01603394|536694095|FG000|Overall Study|Adverse Event|1|||
148786165|NCT01215435|536694096|FG000|Overall Study|Adverse Event|1|||
148786166|NCT01215435|536694097|FG001|Overall Study|Adverse Event|0|||
148786167|NCT01215435|536694096|FG000|Overall Study|Protocol Violation|2|||
148786168|NCT01215435|536694097|FG001|Overall Study|Protocol Violation|0|||
148786169|NCT01215435|536694096|FG000|Overall Study|Withdrawal Criteria|8|||
148786170|NCT01215435|536694097|FG001|Overall Study|Withdrawal Criteria|11|||
148786171|NCT01215435|536694096|FG000|Overall Study|Lost to Follow-up|3|||
148786172|NCT01215435|536694097|FG001|Overall Study|Lost to Follow-up|0|||
148786173|NCT01215435|536694096|FG000|Overall Study|Unclassified|5|||
148786174|NCT01215435|536694097|FG001|Overall Study|Unclassified|5|||
148786175|NCT00840034|536694098|FG000|Acute Treatment Phase|Adverse Event|6|||
148786176|NCT00840034|536694099|FG001|Acute Treatment Phase|Adverse Event|8|||
148786177|NCT00840034|536694098|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
148786178|NCT00840034|536694099|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
148786179|NCT00840034|536694098|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
148786180|NCT00840034|536694099|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
148786181|NCT00840034|536694098|FG000|Acute Treatment Phase|Physician Decision|0|||
148786182|NCT00840034|536694099|FG001|Acute Treatment Phase|Physician Decision|1|||
148786183|NCT00840034|536694098|FG000|Acute Treatment Phase|Protocol Violation|2|||
148786184|NCT00840034|536694099|FG001|Acute Treatment Phase|Protocol Violation|4|||
148786185|NCT00840034|536694098|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
148786186|NCT00840034|536694099|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
148786187|NCT00840034|536694098|FG000|Taper Phase|Adverse Event|1|||
148786188|NCT00840034|536694099|FG001|Taper Phase|Adverse Event|0|||
148786189|NCT00840034|536694098|FG000|Taper Phase|Lost to Follow-up|1|||
148786190|NCT00840034|536694099|FG001|Taper Phase|Lost to Follow-up|1|||
148786191|NCT00840034|536694098|FG000|Taper Phase|Withdrawal by Subject|1|||
148786192|NCT00840034|536694099|FG001|Taper Phase|Withdrawal by Subject|1|||
148786193|NCT00394771|536694106|FG000|Overall Study|Did not meet protocol requirements|1|||
148786194|NCT00394771|536694107|FG001|Overall Study|Did not meet protocol requirements|0|||
148786195|NCT00394771|536694108|FG002|Overall Study|Did not meet protocol requirements|2|||
148786196|NCT00394771|536694109|FG003|Overall Study|Did not meet protocol requirements|0|||
148786197|NCT00394771|536694106|FG000|Overall Study|Protocol Violation|2|||
148786198|NCT00394771|536694107|FG001|Overall Study|Protocol Violation|4|||
148786199|NCT00394771|536694108|FG002|Overall Study|Protocol Violation|9|||
148786200|NCT00394771|536694109|FG003|Overall Study|Protocol Violation|7|||
148786201|NCT00394771|536694106|FG000|Overall Study|Withdrawal by Subject|10|||
148786202|NCT00394771|536694107|FG001|Overall Study|Withdrawal by Subject|6|||
148786203|NCT00394771|536694108|FG002|Overall Study|Withdrawal by Subject|8|||
148786204|NCT00394771|536694109|FG003|Overall Study|Withdrawal by Subject|12|||
148786205|NCT00394771|536694106|FG000|Overall Study|Adverse Event|10|||
148786206|NCT00394771|536694107|FG001|Overall Study|Adverse Event|5|||
148786207|NCT00394771|536694108|FG002|Overall Study|Adverse Event|12|||
148786208|NCT00394771|536694109|FG003|Overall Study|Adverse Event|8|||
148786209|NCT00394771|536694106|FG000|Overall Study|Participant pregnant|0|||
148786210|NCT00394771|536694107|FG001|Overall Study|Participant pregnant|1|||
148786211|NCT00394771|536694108|FG002|Overall Study|Participant pregnant|2|||
148786212|NCT00394771|536694109|FG003|Overall Study|Participant pregnant|2|||
148786213|NCT00394771|536694106|FG000|Overall Study|Lost to Follow-up|15|||
148786214|NCT00394771|536694107|FG001|Overall Study|Lost to Follow-up|15|||
148786215|NCT00394771|536694108|FG002|Overall Study|Lost to Follow-up|13|||
148786216|NCT00394771|536694109|FG003|Overall Study|Lost to Follow-up|10|||
148786217|NCT00394771|536694106|FG000|Overall Study|Other|3|||
148786218|NCT00394771|536694107|FG001|Overall Study|Other|3|||
148786219|NCT00394771|536694108|FG002|Overall Study|Other|1|||
148786220|NCT00394771|536694109|FG003|Overall Study|Other|0|||
148786221|NCT02839876|536694116|FG000|Overall Study|Protocol Violation|10|||
148786222|NCT02839876|536694117|FG001|Overall Study|Protocol Violation|11|||
148786223|NCT03383692|536694122|FG000|Overall Study|Progressive disease as per RECIST|3|||
148786224|NCT03383692|536694123|FG001|Overall Study|Progressive disease as per RECIST|3|||
148786225|NCT03383692|536694122|FG000|Overall Study|Clinical progression|0|||
148786226|NCT03383692|536694123|FG001|Overall Study|Clinical progression|1|||
148786227|NCT03383692|536694122|FG000|Overall Study|Adverse Event|3|||
148786228|NCT03383692|536694123|FG001|Overall Study|Adverse Event|0|||
148786229|NCT01156051|536694126|FG000|Overall Study|Lost to Follow-up|1|||
148786230|NCT01156051|536694127|FG001|Overall Study|Lost to Follow-up|0|||
148786231|NCT01156051|536694126|FG000|Overall Study|patient not compliant with protocol|0|||
148786232|NCT01156051|536694127|FG001|Overall Study|patient not compliant with protocol|1|||
148786233|NCT03816007|536694128|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
148786234|NCT03816007|536694129|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
148786235|NCT03816007|536694128|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
148786236|NCT03816007|536694129|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
148786237|NCT03816007|536694128|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
148786238|NCT03816007|536694129|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
148786239|NCT00793546|536694131|FG000|Overall Study|Death|3|||
148786240|NCT00793546|536694132|FG001|Overall Study|Death|0|||
148786241|NCT00793546|536694131|FG000|Overall Study|Lost to Follow-up|1|||
148786242|NCT00793546|536694132|FG001|Overall Study|Lost to Follow-up|0|||
148786243|NCT00793546|536694131|FG000|Overall Study|Withdrawal by Subject|1|||
148786244|NCT00793546|536694132|FG001|Overall Study|Withdrawal by Subject|1|||
148786245|NCT00793546|536694131|FG000|Overall Study|Study Terminated by Sponsor|8|||
148786246|NCT00793546|536694132|FG001|Overall Study|Study Terminated by Sponsor|27|||
148786247|NCT00793546|536694131|FG000|Overall Study|Other|1|||
148786248|NCT00793546|536694132|FG001|Overall Study|Other|0|||
148786249|NCT02101359|536694133|FG000|Overall Study|Not included|23|||
148786250|NCT02101359|536694134|FG001|Overall Study|Not included|13|||
148786251|NCT02101359|536694133|FG000|Overall Study|Withdrawal by Subject|5|||
148786252|NCT02101359|536694134|FG001|Overall Study|Withdrawal by Subject|4|||
148786253|NCT02101359|536694133|FG000|Overall Study|Lost to Follow-up|1|||
148786254|NCT02101359|536694134|FG001|Overall Study|Lost to Follow-up|0|||
148786255|NCT02101359|536694133|FG000|Overall Study|Protocol Violation|0|||
148786256|NCT02101359|536694134|FG001|Overall Study|Protocol Violation|2|||
148786257|NCT03172364|536694136|FG000|Overall Study|Adverse Event|1|||
148786258|NCT03172364|536694137|FG001|Overall Study|Adverse Event|1|||
148786259|NCT03172364|536694136|FG000|Overall Study|Protocol Violation|1|||
148786260|NCT03172364|536694137|FG001|Overall Study|Protocol Violation|0|||
148786261|NCT03755518|536694138|FG000|Overall Study|Lack of Efficacy|10|||
148786262|NCT03755518|536694138|FG000|Overall Study|Adverse Event|7|||
148786263|NCT03755518|536694138|FG000|Overall Study|Study Terminated by Sponsor|5|||
148786264|NCT03755518|536694138|FG000|Overall Study|Death|1|||
148786265|NCT03755518|536694138|FG000|Overall Study|Withdrawal by Subject|3|||
148786266|NCT03755518|536694138|FG000|Overall Study|Progressive Disease|4|||
148786267|NCT03755518|536694138|FG000|Overall Study|Bone Marrow Transplant|4|||
148786268|NCT03755518|536694138|FG000|Overall Study|Physicians Decision|1|||
148786269|NCT03755518|536694138|FG000|Overall Study|Relapse|1|||
148786270|NCT03755518|536694138|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
148786271|NCT03755518|536694138|FG000|Overall Study|Withdrawal by PI|1|||
148786272|NCT01714609|536694139|FG000|Overall Study|Protocol Violation|1|||
148786273|NCT01714609|536694140|FG001|Overall Study|Protocol Violation|0|||
148786274|NCT00385827|536696035|FG000|Part 1|Adverse Event|1|||
148786275|NCT00385827|536696036|FG001|Part 1|Adverse Event|0|||
148786276|NCT00385827|536696037|FG002|Part 1|Adverse Event|0|||
148786277|NCT00385827|536696035|FG000|Part 1|Death|2|||
148786278|NCT00385827|536696036|FG001|Part 1|Death|0|||
148786279|NCT00385827|536696037|FG002|Part 1|Death|0|||
148786280|NCT00385827|536696035|FG000|Part 1|Lack of Efficacy|5|||
148786281|NCT00385827|536696036|FG001|Part 1|Lack of Efficacy|0|||
148786282|NCT00385827|536696037|FG002|Part 1|Lack of Efficacy|0|||
148786283|NCT00385827|536696035|FG000|Part 1|Other|1|||
148786284|NCT00385827|536696036|FG001|Part 1|Other|0|||
148786285|NCT00385827|536696037|FG002|Part 1|Other|0|||
148786286|NCT00385827|536696035|FG000|Part 2|Adverse Event|0|||
148786287|NCT00385827|536696036|FG001|Part 2|Adverse Event|6|||
148786288|NCT00385827|536696037|FG002|Part 2|Adverse Event|10|||
148786289|NCT00385827|536696035|FG000|Part 2|Death|0|||
148786290|NCT00385827|536696036|FG001|Part 2|Death|0|||
148786291|NCT00385827|536696037|FG002|Part 2|Death|2|||
148786292|NCT00385827|536696035|FG000|Part 2|Lack of Efficacy|0|||
148786293|NCT00385827|536696036|FG001|Part 2|Lack of Efficacy|14|||
148786294|NCT00385827|536696037|FG002|Part 2|Lack of Efficacy|13|||
148786295|NCT00385827|536696035|FG000|Part 2|Randomized but not treated|0|||
148786296|NCT00385827|536696036|FG001|Part 2|Randomized but not treated|2|||
148786297|NCT00385827|536696037|FG002|Part 2|Randomized but not treated|2|||
148786298|NCT00385827|536696035|FG000|Part 2|Other|0|||
149127070|NCT01007448|537945458|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
148786299|NCT00385827|536696036|FG001|Part 2|Other|11|||
148786300|NCT00385827|536696037|FG002|Part 2|Other|21|||
148786301|NCT04227405|536696038|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
148786302|NCT04227405|536696039|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
148786303|NCT04227405|536696038|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
149127071|NCT01007448|537945459|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
148786304|NCT04227405|536696039|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
148786305|NCT04227405|536696038|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
149127072|NCT01007448|537945458|FG000|Overall Study|Staph Skin Infection Flare|1|||
148786306|NCT04227405|536696039|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
148786307|NCT04985942|536696040|FG000|Overall Study|Adverse Event|14|||
149127073|NCT01007448|537945459|FG001|Overall Study|Staph Skin Infection Flare|0|||
148786308|NCT04985942|536696041|FG001|Overall Study|Adverse Event|2|||
148786309|NCT04985942|536696040|FG000|Overall Study|Lack of Efficacy|0|||
148786310|NCT04985942|536696041|FG001|Overall Study|Lack of Efficacy|3|||
148786311|NCT04985942|536696040|FG000|Overall Study|Lost to Follow-up|1|||
148786312|NCT04985942|536696041|FG001|Overall Study|Lost to Follow-up|1|||
148786313|NCT04985942|536696040|FG000|Overall Study|Protocol Violation|1|||
148786314|NCT04985942|536696041|FG001|Overall Study|Protocol Violation|1|||
148786315|NCT04985942|536696040|FG000|Overall Study|Withdrawal by Subject|5|||
148786316|NCT04985942|536696041|FG001|Overall Study|Withdrawal by Subject|4|||
148786317|NCT03536663|536696046|FG000|Endexo|Protocol Violation|1|||
148786318|NCT00885378|536696047|FG000|Overall Study|Lack of Efficacy|2|||
148786319|NCT00885378|536696048|FG001|Overall Study|Lack of Efficacy|2|||
148786320|NCT00885378|536696047|FG000|Overall Study|Withdrawal by Subject|1|||
148786321|NCT00885378|536696048|FG001|Overall Study|Withdrawal by Subject|2|||
148786322|NCT00885378|536696047|FG000|Overall Study|Lost to Follow-up|1|||
148786323|NCT00885378|536696048|FG001|Overall Study|Lost to Follow-up|2|||
148786324|NCT00885378|536696047|FG000|Overall Study|Poor/Noncompliance|2|||
148786325|NCT00885378|536696048|FG001|Overall Study|Poor/Noncompliance|2|||
148786326|NCT00885378|536696047|FG000|Overall Study|Protocol Violation|2|||
148786327|NCT00885378|536696048|FG001|Overall Study|Protocol Violation|0|||
148786328|NCT04076319|536696050|FG000|Overall Study|Withdrawal by Subject|2|||
148786329|NCT04076319|536696051|FG001|Overall Study|Withdrawal by Subject|0|||
148786330|NCT04076319|536696050|FG000|Overall Study|Death|1|||
148786331|NCT04076319|536696051|FG001|Overall Study|Death|0|||
148786332|NCT03252145|536696055|FG000|Overall Study|Withdrawal by Subject|1|||
148786333|NCT03252145|536696056|FG001|Overall Study|Withdrawal by Subject|0|||
148786334|NCT03252145|536696055|FG000|Overall Study|Complicating Disease|1|||
148786335|NCT03252145|536696056|FG001|Overall Study|Complicating Disease|2|||
148786336|NCT03488563|536696057|FG000|Overall Study|Lost to Follow-up|7|||
148786337|NCT03488563|536696058|FG001|Overall Study|Lost to Follow-up|6|||
148786338|NCT03488563|536696059|FG002|Overall Study|Lost to Follow-up|7|||
148786339|NCT03488563|536696057|FG000|Overall Study|Withdrawal by Subject|8|||
148786340|NCT03488563|536696058|FG001|Overall Study|Withdrawal by Subject|7|||
148786341|NCT03488563|536696059|FG002|Overall Study|Withdrawal by Subject|7|||
148786342|NCT03488563|536696057|FG000|Overall Study|Physician Decision|0|||
148786343|NCT03488563|536696058|FG001|Overall Study|Physician Decision|0|||
148786344|NCT03488563|536696059|FG002|Overall Study|Physician Decision|1|||
148786345|NCT03488563|536696057|FG000|Overall Study|Protocol Violation|3|||
148786346|NCT03488563|536696058|FG001|Overall Study|Protocol Violation|2|||
148786347|NCT03488563|536696059|FG002|Overall Study|Protocol Violation|6|||
148786348|NCT03488563|536696057|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
148786349|NCT03488563|536696058|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
148786350|NCT03488563|536696059|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
148786351|NCT03488563|536696057|FG000|Overall Study|Use of prohibited medication|2|||
148786352|NCT03488563|536696058|FG001|Overall Study|Use of prohibited medication|0|||
148786353|NCT03488563|536696059|FG002|Overall Study|Use of prohibited medication|0|||
148786354|NCT03488563|536696057|FG000|Overall Study|Adverse Event|1|||
148786355|NCT03488563|536696058|FG001|Overall Study|Adverse Event|0|||
148786356|NCT03488563|536696059|FG002|Overall Study|Adverse Event|1|||
148786357|NCT03488563|536696057|FG000|Overall Study|Subject returned for ET visit|0|||
148786358|NCT03488563|536696058|FG001|Overall Study|Subject returned for ET visit|1|||
148786359|NCT03488563|536696059|FG002|Overall Study|Subject returned for ET visit|0|||
148786360|NCT03488563|536696057|FG000|Overall Study|Sponsor's decision|0|||
148786361|NCT03488563|536696058|FG001|Overall Study|Sponsor's decision|0|||
149127074|NCT01007448|537945458|FG000|Overall Study|Participant Leaving the Country|1|||
149127075|NCT01007448|537945459|FG001|Overall Study|Participant Leaving the Country|0|||
149127076|NCT01007448|537945458|FG000|Overall Study|Participant Given Prohibited Medication|1|||
149127077|NCT01007448|537945459|FG001|Overall Study|Participant Given Prohibited Medication|0|||
149127078|NCT01007448|537945458|FG000|Overall Study|Progressive Disease|1|||
149127079|NCT01007448|537945459|FG001|Overall Study|Progressive Disease|2|||
149127080|NCT01007448|537945458|FG000|Overall Study|Lack of Efficacy|2|||
149127081|NCT01007448|537945459|FG001|Overall Study|Lack of Efficacy|0|||
149127082|NCT01007448|537945458|FG000|Overall Study|Withdrawal by Subject|2|||
148786362|NCT03488563|536696059|FG002|Overall Study|Sponsor's decision|1|||
148786363|NCT00582426|536696066|FG000|Overall Study|Lost to Follow-up|0|||
148786364|NCT00582426|536696067|FG001|Overall Study|Lost to Follow-up|2|||
148786365|NCT00582426|536696066|FG000|Overall Study|Adverse Event|4|||
148786366|NCT00582426|536696067|FG001|Overall Study|Adverse Event|2|||
148786367|NCT00582426|536696066|FG000|Overall Study|Protocol Violation|6|||
148786368|NCT00582426|536696067|FG001|Overall Study|Protocol Violation|2|||
148786369|NCT00582426|536696066|FG000|Overall Study|Death|4|||
148786370|NCT00582426|536696067|FG001|Overall Study|Death|3|||
148786371|NCT00582426|536696066|FG000|Overall Study|Withdrawal by Subject|3|||
148786372|NCT00582426|536696067|FG001|Overall Study|Withdrawal by Subject|2|||
148786373|NCT00582426|536696066|FG000|Overall Study|Disease Progression|2|||
148786374|NCT00582426|536696067|FG001|Overall Study|Disease Progression|2|||
148786375|NCT00582426|536696066|FG000|Overall Study|Use of illicit drugs|1|||
148786376|NCT00582426|536696067|FG001|Overall Study|Use of illicit drugs|0|||
148786377|NCT02626000|536696070|FG000|Overall Study|Decision by Sponsor|1|||
148786378|NCT02626000|536696070|FG000|Overall Study|Death|29|||
148786379|NCT00662311|536696071|FG000|Overall Study|Respiratory Infection|1|||
148893400|NCT01693029|537088701|FG001|Overall Study|Protocol Violation|7|||
148786380|NCT00662311|536696072|FG001|Overall Study|Respiratory Infection|0|||
148786381|NCT00662311|536696073|FG002|Overall Study|Respiratory Infection|0|||
148786382|NCT02164318|536696074|FG000|Overall Study|Withdrawal by Subject|0|||
148786383|NCT02164318|536696075|FG001|Overall Study|Withdrawal by Subject|1|||
148786384|NCT02164318|536696076|FG002|Overall Study|Withdrawal by Subject|0|||
148786385|NCT02164318|536696077|FG003|Overall Study|Withdrawal by Subject|1|||
148786386|NCT00660595|536696098|FG000|Overall Study|Lost to Follow-up|0|||
148786387|NCT00660595|536696099|FG001|Overall Study|Lost to Follow-up|1|||
148786388|NCT00660595|536696098|FG000|Overall Study|Did not consent to participate in study|12|||
148786389|NCT00660595|536696099|FG001|Overall Study|Did not consent to participate in study|8|||
148786390|NCT00660595|536696098|FG000|Overall Study|Participant left hospital|1|||
148786391|NCT00660595|536696099|FG001|Overall Study|Participant left hospital|0|||
148786392|NCT00660595|536696098|FG000|Overall Study|Non Specified reasons|5|||
148786393|NCT00660595|536696099|FG001|Overall Study|Non Specified reasons|0|||
148786394|NCT01148459|536696100|FG000|Overall Study|Serious Adverse Event|5|||
148786395|NCT01148459|536696101|FG001|Overall Study|Serious Adverse Event|4|||
148786396|NCT01148459|536696100|FG000|Overall Study|Withdrawal by Subject|1|||
148786397|NCT01148459|536696101|FG001|Overall Study|Withdrawal by Subject|0|||
148786398|NCT01148459|536696100|FG000|Overall Study|Migrated/moved from study area|3|||
148786399|NCT01148459|536696101|FG001|Overall Study|Migrated/moved from study area|6|||
148786400|NCT01148459|536696100|FG000|Overall Study|Lost to Follow-up|2|||
148786401|NCT01148459|536696101|FG001|Overall Study|Lost to Follow-up|0|||
148786402|NCT01148459|536696100|FG000|Overall Study|Refusal|1|||
148786403|NCT01148459|536696101|FG001|Overall Study|Refusal|0|||
148786404|NCT01148459|536696100|FG000|Overall Study|Failure to comply with study procedures|0|||
148786405|NCT01148459|536696101|FG001|Overall Study|Failure to comply with study procedures|1|||
148786406|NCT04854057|536696102|FG000|Overall Study|Adverse Event|0|||
148786407|NCT04854057|536696103|FG001|Overall Study|Adverse Event|1|||
148786408|NCT01951573|536696112|FG000|Washout Period|Adverse Event|0|||
148786409|NCT01951573|536696113|FG001|Washout Period|Adverse Event|1|||
148786410|NCT01152996|536696117|FG000|Overall Study|Withdrawal by Subject|142|||
148786411|NCT01152996|536696117|FG000|Overall Study|Adverse Event|115|||
148786412|NCT01152996|536696117|FG000|Overall Study|Lost to Follow-up|112|||
148786413|NCT01152996|536696117|FG000|Overall Study|Lack of Efficacy|68|||
148786414|NCT01152996|536696117|FG000|Overall Study|Noncompliance|41|||
148786415|NCT01152996|536696117|FG000|Overall Study|Other|36|||
148786416|NCT01152996|536696117|FG000|Overall Study|Protocol Violation|22|||
148786417|NCT01152996|536696117|FG000|Overall Study|Elevated liver enzymes|1|||
148786418|NCT03077607|536696118|FG000|Period 1 (15 Days)|Adverse Event|1|||
148786419|NCT03077607|536696119|FG001|Period 1 (15 Days)|Adverse Event|0|||
148786420|NCT03077607|536696118|FG000|Period 1 (15 Days)|Death|1|||
148786421|NCT03077607|536696119|FG001|Period 1 (15 Days)|Death|0|||
148786422|NCT03077607|536696118|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
148786423|NCT03077607|536696119|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
148786424|NCT03077607|536696118|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
148786425|NCT03077607|536696119|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
148786426|NCT00460239|536696120|FG000|Overall Study|Physician Decision|0|||
148786427|NCT00460239|536696121|FG001|Overall Study|Physician Decision|1|||
148786428|NCT00460239|536696122|FG002|Overall Study|Physician Decision|0|||
148786429|NCT00460239|536696123|FG003|Overall Study|Physician Decision|0|||
148786430|NCT00460239|536696124|FG004|Overall Study|Physician Decision|0|||
148786431|NCT00460239|536696125|FG005|Overall Study|Physician Decision|2|||
148786432|NCT00460239|536696126|FG006|Overall Study|Physician Decision|0|||
148786433|NCT00460239|536696127|FG007|Overall Study|Physician Decision|0|||
148786434|NCT00460239|536696128|FG008|Overall Study|Physician Decision|0|||
148786435|NCT00460239|536696120|FG000|Overall Study|Withdrawal by Subject|0|||
148786436|NCT00460239|536696121|FG001|Overall Study|Withdrawal by Subject|0|||
148786437|NCT00460239|536696122|FG002|Overall Study|Withdrawal by Subject|0|||
148786438|NCT00460239|536696123|FG003|Overall Study|Withdrawal by Subject|0|||
148786439|NCT00460239|536696124|FG004|Overall Study|Withdrawal by Subject|0|||
148786440|NCT00460239|536696125|FG005|Overall Study|Withdrawal by Subject|1|||
148786441|NCT00460239|536696126|FG006|Overall Study|Withdrawal by Subject|0|||
148786442|NCT00460239|536696127|FG007|Overall Study|Withdrawal by Subject|0|||
149127083|NCT01007448|537945459|FG001|Overall Study|Withdrawal by Subject|3|||
148786443|NCT00460239|536696128|FG008|Overall Study|Withdrawal by Subject|0|||
148786444|NCT00760487|536696147|FG000|Overall Study|Unilateral implantation|3|||
148786445|NCT05259917|536696155|FG000|Overall Study|Protocol Violation|0|||
148786446|NCT05259917|536696156|FG001|Overall Study|Protocol Violation|0|||
148786447|NCT05259917|536696157|FG002|Overall Study|Protocol Violation|1|||
148786448|NCT05259917|536696158|FG003|Overall Study|Protocol Violation|0|||
148786449|NCT05259917|536696159|FG004|Overall Study|Protocol Violation|0|||
148786450|NCT05259917|536696160|FG005|Overall Study|Protocol Violation|0|||
148786451|NCT05259917|536696155|FG000|Overall Study|Lost to Follow-up|0|||
148786452|NCT05259917|536696156|FG001|Overall Study|Lost to Follow-up|0|||
148786453|NCT05259917|536696157|FG002|Overall Study|Lost to Follow-up|1|||
148786454|NCT05259917|536696158|FG003|Overall Study|Lost to Follow-up|0|||
148786455|NCT05259917|536696159|FG004|Overall Study|Lost to Follow-up|0|||
149127084|NCT01007448|537945458|FG000|Overall Study|Adverse Event|1|||
149127085|NCT01007448|537945459|FG001|Overall Study|Adverse Event|4|||
149127086|NCT02481947|537945460|FG000|Overall Study|Withdrawal by Subject|24|||
149127087|NCT02481947|537945461|FG001|Overall Study|Withdrawal by Subject|10|||
149127088|NCT02481947|537945460|FG000|Overall Study|Lost to Follow-up|11|||
149127089|NCT02481947|537945461|FG001|Overall Study|Lost to Follow-up|5|||
149127090|NCT02481947|537945460|FG000|Overall Study|Adverse Event|6|||
149127091|NCT02481947|537945461|FG001|Overall Study|Adverse Event|11|||
149127092|NCT02481947|537945460|FG000|Overall Study|Physician Decision|4|||
149127093|NCT02481947|537945461|FG001|Overall Study|Physician Decision|5|||
149127094|NCT02481947|537945460|FG000|Overall Study|Protocol Violation|1|||
149127095|NCT02481947|537945461|FG001|Overall Study|Protocol Violation|5|||
149127096|NCT01270971|537945470|FG000|Overall Study|Withdrawal by Subject|24|||
149127097|NCT01270971|537945471|FG001|Overall Study|Withdrawal by Subject|11|||
149127098|NCT01270971|537945470|FG000|Overall Study|Lost to Follow-up|18|||
149127099|NCT01270971|537945471|FG001|Overall Study|Lost to Follow-up|5|||
149127100|NCT01270971|537945470|FG000|Overall Study|Adverse Event|1|||
149127101|NCT01270971|537945471|FG001|Overall Study|Adverse Event|2|||
149127102|NCT01270971|537945470|FG000|Overall Study|Non compliance|2|||
149127103|NCT01270971|537945471|FG001|Overall Study|Non compliance|2|||
149127104|NCT01270971|537945470|FG000|Overall Study|Non-specific|7|||
149127105|NCT01270971|537945471|FG001|Overall Study|Non-specific|3|||
149127106|NCT02112708|537945474|FG000|Baseline|Physician Decision|16|||
149127107|NCT02112708|537945475|FG001|Baseline|Physician Decision|11|||
149127108|NCT02112708|537945474|FG000|Baseline|Lost to Follow-up|12|||
149127109|NCT02112708|537945475|FG001|Baseline|Lost to Follow-up|0|||
149127110|NCT02112708|537945474|FG000|4 Month|Death|0|||
149127111|NCT02112708|537945475|FG001|4 Month|Death|1|||
149127112|NCT02112708|537945474|FG000|4 Month|Withdrawal by Subject|12|||
149127113|NCT02112708|537945475|FG001|4 Month|Withdrawal by Subject|0|||
149127114|NCT00704405|537945476|FG000|Overall Study (NC Population)|Adverse Event|1|||
149127115|NCT00704405|537945477|FG001|Overall Study (NC Population)|Adverse Event|0|||
149127116|NCT00704405|537945478|FG002|Overall Study (NC Population)|Adverse Event|0|||
149127117|NCT00704405|537945479|FG003|Overall Study (NC Population)|Adverse Event|0|||
149127118|NCT00704405|537945480|FG004|Overall Study (NC Population)|Adverse Event|0|||
149127119|NCT00704405|537945476|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
149127120|NCT00704405|537945477|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
149127121|NCT00704405|537945478|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
149127122|NCT00704405|537945479|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
149127123|NCT00704405|537945480|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
149127124|NCT00704405|537945476|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
149127125|NCT00704405|537945477|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
149127126|NCT00704405|537945478|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
149127127|NCT00704405|537945479|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
149127128|NCT00704405|537945480|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
149127129|NCT00704405|537945476|FG000|Overall Study (NC Population)|Other|0|||
149127130|NCT00704405|537945477|FG001|Overall Study (NC Population)|Other|0|||
149127131|NCT00704405|537945478|FG002|Overall Study (NC Population)|Other|0|||
149127132|NCT00704405|537945479|FG003|Overall Study (NC Population)|Other|0|||
149127133|NCT00704405|537945480|FG004|Overall Study (NC Population)|Other|1|||
149127134|NCT00704405|537945476|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
149127135|NCT00704405|537945477|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
149127136|NCT00704405|537945478|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
149127137|NCT00704405|537945479|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
149127138|NCT00704405|537945480|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
149127139|NCT00704405|537945476|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
149127140|NCT00704405|537945477|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
149127141|NCT00704405|537945478|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
149127142|NCT00704405|537945479|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
149127143|NCT00704405|537945480|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
149127144|NCT03169101|537945481|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
149127145|NCT03169101|537945482|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
148786456|NCT05259917|536696160|FG005|Overall Study|Lost to Follow-up|1|||
149127146|NCT03169101|537945483|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
148786457|NCT05259917|536696155|FG000|Overall Study|Physician Decision|0|||
149127147|NCT03169101|537945484|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
149127148|NCT02641496|537945485|FG000|Overall Study|Lost to Follow-up|13|||
149127149|NCT02641496|537945486|FG001|Overall Study|Lost to Follow-up|12|||
149127150|NCT02641496|537945485|FG000|Overall Study|Withdrawal by Subject|1|||
149127151|NCT02641496|537945486|FG001|Overall Study|Withdrawal by Subject|0|||
149127152|NCT02053792|537945487|FG000|Overall Study|Physician Decision|0|||
149127153|NCT02053792|537945488|FG001|Overall Study|Physician Decision|1|||
148786458|NCT05259917|536696156|FG001|Overall Study|Physician Decision|1|||
148786459|NCT05259917|536696157|FG002|Overall Study|Physician Decision|0|||
148786460|NCT05259917|536696158|FG003|Overall Study|Physician Decision|0|||
149127154|NCT02053792|537945487|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
149127155|NCT02053792|537945488|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
149127156|NCT02053792|537945487|FG000|Overall Study|Lack of Efficacy|1|||
149127157|NCT02053792|537945488|FG001|Overall Study|Lack of Efficacy|0|||
149127158|NCT02053792|537945487|FG000|Overall Study|Adverse Event|1|||
149127159|NCT02053792|537945488|FG001|Overall Study|Adverse Event|0|||
149127160|NCT02053792|537945487|FG000|Overall Study|Withdrawal by Subject|2|||
149127161|NCT02053792|537945488|FG001|Overall Study|Withdrawal by Subject|2|||
149127162|NCT02053792|537945487|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
149127163|NCT02053792|537945488|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
149127164|NCT02053792|537945487|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
149127165|NCT02053792|537945488|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
149127166|NCT01028027|537945489|FG000|Overall Study|Lost to Follow-up|4|||
149127167|NCT01028027|537945490|FG001|Overall Study|Lost to Follow-up|1|||
149127168|NCT01028027|537945489|FG000|Overall Study|Withdrawal by Subject|5|||
149127169|NCT01028027|537945490|FG001|Overall Study|Withdrawal by Subject|3|||
149127170|NCT01028027|537945489|FG000|Overall Study|Adverse Event|4|||
149127171|NCT01028027|537945490|FG001|Overall Study|Adverse Event|7|||
149127172|NCT01028027|537945489|FG000|Overall Study|Protocol Violation|3|||
149127173|NCT01028027|537945490|FG001|Overall Study|Protocol Violation|1|||
149127174|NCT01028027|537945489|FG000|Overall Study|Lack of Efficacy|0|||
149127175|NCT01028027|537945490|FG001|Overall Study|Lack of Efficacy|1|||
149127176|NCT00790751|537945499|FG000|Overall Study|Protocol non-compliance|16|||
149127177|NCT00790751|537945500|FG001|Overall Study|Protocol non-compliance|16|||
149127178|NCT00790751|537945501|FG002|Overall Study|Protocol non-compliance|10|||
149127179|NCT00790751|537945502|FG003|Overall Study|Protocol non-compliance|11|||
149127180|NCT00790751|537945499|FG000|Overall Study|Lost to Follow-up|4|||
149127181|NCT00790751|537945500|FG001|Overall Study|Lost to Follow-up|9|||
149127182|NCT00790751|537945501|FG002|Overall Study|Lost to Follow-up|4|||
149127183|NCT00790751|537945502|FG003|Overall Study|Lost to Follow-up|5|||
149127184|NCT00790751|537945499|FG000|Overall Study|Adverse Event|5|||
149127185|NCT00790751|537945500|FG001|Overall Study|Adverse Event|3|||
149127186|NCT00790751|537945501|FG002|Overall Study|Adverse Event|5|||
149127187|NCT00790751|537945502|FG003|Overall Study|Adverse Event|4|||
149127188|NCT00790751|537945499|FG000|Overall Study|Requirement for restricted medication|0|||
149127189|NCT00790751|537945500|FG001|Overall Study|Requirement for restricted medication|2|||
149127190|NCT00790751|537945501|FG002|Overall Study|Requirement for restricted medication|0|||
149127191|NCT00790751|537945502|FG003|Overall Study|Requirement for restricted medication|0|||
149127192|NCT00790751|537945499|FG000|Overall Study|Death|0|||
149127193|NCT00790751|537945500|FG001|Overall Study|Death|0|||
149127194|NCT00790751|537945501|FG002|Overall Study|Death|1|||
149127195|NCT00790751|537945502|FG003|Overall Study|Death|0|||
149127196|NCT00790751|537945499|FG000|Overall Study|Physician Decision|0|||
149127197|NCT00790751|537945500|FG001|Overall Study|Physician Decision|0|||
149127198|NCT00790751|537945501|FG002|Overall Study|Physician Decision|0|||
149127199|NCT00790751|537945502|FG003|Overall Study|Physician Decision|1|||
149127200|NCT04948333|537945505|FG000|Overall Study|Adverse Event|6|||
149127201|NCT04948333|537945506|FG001|Overall Study|Adverse Event|4|||
149127202|NCT04948333|537945507|FG002|Overall Study|Adverse Event|0|||
149127203|NCT04948333|537945508|FG003|Overall Study|Adverse Event|2|||
149127204|NCT04948333|537945505|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
149127205|NCT04948333|537945506|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149127206|NCT04948333|537945507|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149127207|NCT04948333|537945508|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149127208|NCT04948333|537945505|FG000|Overall Study|Progressive Disease|1|||
149127209|NCT04948333|537945506|FG001|Overall Study|Progressive Disease|5|||
149127210|NCT04948333|537945507|FG002|Overall Study|Progressive Disease|0|||
149127211|NCT04948333|537945508|FG003|Overall Study|Progressive Disease|0|||
149127212|NCT04948333|537945505|FG000|Overall Study|Physician Decision|2|||
149127213|NCT04948333|537945506|FG001|Overall Study|Physician Decision|2|||
149127214|NCT04948333|537945507|FG002|Overall Study|Physician Decision|0|||
149127215|NCT04948333|537945508|FG003|Overall Study|Physician Decision|0|||
149127216|NCT04948333|537945505|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
149127217|NCT04948333|537945506|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
149127218|NCT04948333|537945507|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
149127219|NCT04948333|537945508|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
149127220|NCT04948333|537945505|FG000|Overall Study|Withdrawal by Subject|2|||
149127221|NCT04948333|537945506|FG001|Overall Study|Withdrawal by Subject|0|||
149127222|NCT04948333|537945507|FG002|Overall Study|Withdrawal by Subject|0|||
149127223|NCT04948333|537945508|FG003|Overall Study|Withdrawal by Subject|1|||
149127224|NCT04948333|537945505|FG000|Overall Study|Protocol Violation|0|||
149127225|NCT04948333|537945506|FG001|Overall Study|Protocol Violation|1|||
149127226|NCT04948333|537945507|FG002|Overall Study|Protocol Violation|0|||
149127227|NCT04948333|537945508|FG003|Overall Study|Protocol Violation|0|||
149127228|NCT04948333|537945505|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
149127229|NCT04948333|537945506|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
149127230|NCT04948333|537945507|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
149127231|NCT04948333|537945508|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
149127232|NCT05330312|537945513|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
149127233|NCT05330312|537945514|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
149127234|NCT05330312|537945515|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
149127235|NCT05330312|537945513|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
149127236|NCT05330312|537945514|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
149127237|NCT05330312|537945515|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
149127238|NCT05330312|537945513|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
149127239|NCT05330312|537945514|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
149127240|NCT05330312|537945515|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
149127241|NCT05330312|537945513|FG000|Pivotal Investigation - Part 2|Death|1|||
149127242|NCT05330312|537945514|FG001|Pivotal Investigation - Part 2|Death|4|||
149127243|NCT05330312|537945515|FG002|Pivotal Investigation - Part 2|Death|0|||
149127244|NCT02572843|537945516|FG000|Accrual|Brain metastasis retrospectively detected|1|||
149127245|NCT02572843|537945516|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
149127246|NCT02572843|537945516|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
149127247|NCT02572843|537945516|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
149127248|NCT02572843|537945516|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
149127249|NCT02572843|537945516|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
149127250|NCT02572843|537945516|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
149127251|NCT02572843|537945516|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
149127252|NCT02572843|537945516|FG000|Surgery|lost to follow up|7|||
149127253|NCT02572843|537945516|FG000|Surgery|Death|1|||
149127254|NCT01078454|537945519|FG000|Overall Study|Adverse Event|1|||
149127255|NCT01078454|537945520|FG001|Overall Study|Adverse Event|1|||
149127256|NCT01078454|537945519|FG000|Overall Study|Death|0|||
149127257|NCT01078454|537945520|FG001|Overall Study|Death|1|||
149127258|NCT05227703|537945521|FG000|Overall Study|Adverse Event|2|||
149127259|NCT05227703|537945522|FG001|Overall Study|Adverse Event|6|||
149127260|NCT05227703|537945523|FG002|Overall Study|Adverse Event|4|||
149127261|NCT05227703|537945521|FG000|Overall Study|Lack of Efficacy|4|||
149127262|NCT05227703|537945522|FG001|Overall Study|Lack of Efficacy|0|||
149127263|NCT05227703|537945523|FG002|Overall Study|Lack of Efficacy|1|||
149127264|NCT05227703|537945521|FG000|Overall Study|Physician Decision|2|||
149127265|NCT05227703|537945522|FG001|Overall Study|Physician Decision|2|||
149127266|NCT05227703|537945523|FG002|Overall Study|Physician Decision|1|||
149127267|NCT05227703|537945521|FG000|Overall Study|Protocol Violation|2|||
149127268|NCT05227703|537945522|FG001|Overall Study|Protocol Violation|1|||
149127269|NCT05227703|537945523|FG002|Overall Study|Protocol Violation|0|||
149127270|NCT05227703|537945521|FG000|Overall Study|Withdrawal by Subject|17|||
149127271|NCT05227703|537945522|FG001|Overall Study|Withdrawal by Subject|26|||
149127272|NCT05227703|537945523|FG002|Overall Study|Withdrawal by Subject|32|||
149127273|NCT05227703|537945521|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
149127274|NCT05227703|537945522|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
149127275|NCT05227703|537945523|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
149127276|NCT05227703|537945521|FG000|Overall Study|Other|1|||
149127277|NCT05227703|537945522|FG001|Overall Study|Other|1|||
149127278|NCT05227703|537945523|FG002|Overall Study|Other|0|||
149127279|NCT03464097|537945528|FG000|Overall Study|Withdrawal by Subject|15|||
149127280|NCT03464097|537945529|FG001|Overall Study|Withdrawal by Subject|13|||
149127281|NCT03464097|537945530|FG002|Overall Study|Withdrawal by Subject|11|||
149127282|NCT03464097|537945528|FG000|Overall Study|Study terminated by sponsor|47|||
149127283|NCT03464097|537945529|FG001|Overall Study|Study terminated by sponsor|44|||
149127284|NCT03464097|537945530|FG002|Overall Study|Study terminated by sponsor|40|||
149127285|NCT03464097|537945528|FG000|Overall Study|Pregnancy|0|||
148786461|NCT05259917|536696159|FG004|Overall Study|Physician Decision|0|||
148786462|NCT05259917|536696160|FG005|Overall Study|Physician Decision|0|||
148786463|NCT05259917|536696155|FG000|Overall Study|Withdrawal by Subject|0|||
148786464|NCT05259917|536696156|FG001|Overall Study|Withdrawal by Subject|1|||
148786465|NCT05259917|536696157|FG002|Overall Study|Withdrawal by Subject|0|||
148786466|NCT05259917|536696158|FG003|Overall Study|Withdrawal by Subject|0|||
149127286|NCT03464097|537945529|FG001|Overall Study|Pregnancy|1|||
149127287|NCT03464097|537945530|FG002|Overall Study|Pregnancy|0|||
149127288|NCT03464097|537945528|FG000|Overall Study|Other reasons|5|||
149127289|NCT03464097|537945529|FG001|Overall Study|Other reasons|12|||
149127290|NCT03464097|537945530|FG002|Overall Study|Other reasons|14|||
149127291|NCT03464097|537945528|FG000|Overall Study|Lost to Follow-up|0|||
148786467|NCT05259917|536696159|FG004|Overall Study|Withdrawal by Subject|1|||
149127292|NCT03464097|537945529|FG001|Overall Study|Lost to Follow-up|1|||
149127293|NCT03464097|537945530|FG002|Overall Study|Lost to Follow-up|1|||
149127294|NCT03464097|537945528|FG000|Overall Study|Lack of Efficacy|11|||
149127295|NCT03464097|537945529|FG001|Overall Study|Lack of Efficacy|18|||
149127296|NCT03464097|537945530|FG002|Overall Study|Lack of Efficacy|30|||
149127297|NCT03464097|537945528|FG000|Overall Study|Death|1|||
149127298|NCT03464097|537945529|FG001|Overall Study|Death|0|||
149127299|NCT03464097|537945530|FG002|Overall Study|Death|0|||
149127300|NCT03464097|537945528|FG000|Overall Study|Adverse Event|13|||
149127301|NCT03464097|537945529|FG001|Overall Study|Adverse Event|6|||
149127302|NCT03464097|537945530|FG002|Overall Study|Adverse Event|8|||
149127303|NCT03035201|537945531|FG000|Overall Study|Death|9|||
149127304|NCT03035201|537945532|FG001|Overall Study|Death|12|||
149127305|NCT03035201|537945533|FG002|Overall Study|Death|9|||
149127306|NCT03035201|537945534|FG003|Overall Study|Death|10|||
149127307|NCT03035201|537945531|FG000|Overall Study|Withdrawal by Subject|51|||
149127308|NCT03035201|537945532|FG001|Overall Study|Withdrawal by Subject|49|||
149127309|NCT03035201|537945533|FG002|Overall Study|Withdrawal by Subject|37|||
149127310|NCT03035201|537945534|FG003|Overall Study|Withdrawal by Subject|46|||
149127311|NCT03035201|537945531|FG000|Overall Study|Lost to Follow-up|67|||
149127312|NCT03035201|537945532|FG001|Overall Study|Lost to Follow-up|51|||
149127313|NCT03035201|537945533|FG002|Overall Study|Lost to Follow-up|64|||
149127314|NCT03035201|537945534|FG003|Overall Study|Lost to Follow-up|69|||
149127315|NCT00112047|537945541|FG000|Randomized Phase|Lost to Follow-up|26|||
149127316|NCT00112047|537945542|FG001|Randomized Phase|Lost to Follow-up|33|||
149127317|NCT00112047|537945541|FG000|Randomized Phase|Adverse Event|10|||
149127318|NCT00112047|537945542|FG001|Randomized Phase|Adverse Event|10|||
149127319|NCT00112047|537945541|FG000|Randomized Phase|Withrawal of consent|10|||
149127320|NCT00112047|537945542|FG001|Randomized Phase|Withrawal of consent|18|||
149127321|NCT00112047|537945541|FG000|Randomized Phase|Sub-optimal virological response|3|||
149127322|NCT00112047|537945542|FG001|Randomized Phase|Sub-optimal virological response|13|||
149127323|NCT00112047|537945541|FG000|Randomized Phase|Noncompliance|8|||
149127324|NCT00112047|537945542|FG001|Randomized Phase|Noncompliance|4|||
149127325|NCT00112047|537945541|FG000|Randomized Phase|Protocol Violation|2|||
149127326|NCT00112047|537945542|FG001|Randomized Phase|Protocol Violation|0|||
149127327|NCT00112047|537945541|FG000|Randomized Phase|Pregnancy|3|||
149127328|NCT00112047|537945542|FG001|Randomized Phase|Pregnancy|1|||
149127329|NCT00112047|537945541|FG000|Randomized Phase|Death|1|||
149127330|NCT00112047|537945542|FG001|Randomized Phase|Death|3|||
149127331|NCT00112047|537945541|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
149127332|NCT00112047|537945542|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
149127333|NCT00112047|537945541|FG000|Randomized Phase|Inability to swallow pills|0|||
149127334|NCT00112047|537945542|FG001|Randomized Phase|Inability to swallow pills|1|||
149127335|NCT00112047|537945541|FG000|Randomized Phase|Incarceration|3|||
149127336|NCT00112047|537945542|FG001|Randomized Phase|Incarceration|2|||
149127337|NCT00112047|537945541|FG000|Randomized Phase|Moved out of State|0|||
149127338|NCT00112047|537945542|FG001|Randomized Phase|Moved out of State|1|||
149127339|NCT00112047|537945541|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
149127340|NCT00112047|537945542|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
149127341|NCT00112047|537945541|FG000|Randomized Phase|High Hepatitis B DNA|0|||
149127342|NCT00112047|537945542|FG001|Randomized Phase|High Hepatitis B DNA|1|||
149127343|NCT00112047|537945541|FG000|Atripla Phase|Adverse Event|2|||
149127344|NCT00112047|537945542|FG001|Atripla Phase|Adverse Event|1|||
149127345|NCT00112047|537945541|FG000|Atripla Phase|Lost to Follow-up|5|||
149127346|NCT00112047|537945542|FG001|Atripla Phase|Lost to Follow-up|7|||
149127347|NCT00112047|537945541|FG000|Atripla Phase|Pregnancy|0|||
149127348|NCT00112047|537945542|FG001|Atripla Phase|Pregnancy|1|||
149127349|NCT00112047|537945541|FG000|Atripla Phase|Death|0|||
149127350|NCT00112047|537945542|FG001|Atripla Phase|Death|2|||
149127351|NCT00112047|537945541|FG000|Atripla Phase|Withdrew consent|7|||
149127352|NCT00112047|537945542|FG001|Atripla Phase|Withdrew consent|7|||
149127353|NCT00112047|537945541|FG000|Atripla Phase|Sub-optimal virological response|0|||
149127354|NCT00112047|537945542|FG001|Atripla Phase|Sub-optimal virological response|1|||
149127355|NCT00112047|537945541|FG000|Atripla Phase|Non-compliance|1|||
149127356|NCT00112047|537945542|FG001|Atripla Phase|Non-compliance|0|||
149127357|NCT00112047|537945541|FG000|Atripla Phase|Other|3|||
149127358|NCT00112047|537945542|FG001|Atripla Phase|Other|1|||
148786468|NCT05259917|536696160|FG005|Overall Study|Withdrawal by Subject|1|||
149127359|NCT01307579|537945543|FG000|Overall Study|Death|3|||
149127360|NCT01307579|537945544|FG001|Overall Study|Death|6|||
149127361|NCT01307579|537945543|FG000|Overall Study|Physician Decision|26|||
149127362|NCT01307579|537945544|FG001|Overall Study|Physician Decision|29|||
149127363|NCT01307579|537945543|FG000|Overall Study|Withdrawal by Subject|7|||
149127364|NCT01307579|537945544|FG001|Overall Study|Withdrawal by Subject|3|||
149127365|NCT01307579|537945543|FG000|Overall Study|Institutional diagnosis of IFD|21|||
149127366|NCT01307579|537945544|FG001|Overall Study|Institutional diagnosis of IFD|36|||
149127367|NCT01307579|537945543|FG000|Overall Study|Begin conditioning for HSCT|42|||
149127368|NCT01307579|537945544|FG001|Overall Study|Begin conditioning for HSCT|44|||
149127369|NCT01307579|537945543|FG000|Overall Study|Refractory or relapsed AML|38|||
149127370|NCT01307579|537945544|FG001|Overall Study|Refractory or relapsed AML|23|||
149127371|NCT01307579|537945543|FG000|Overall Study|Ineligible|3|||
149127372|NCT01307579|537945544|FG001|Overall Study|Ineligible|4|||
149127373|NCT03727438|537945545|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
149127374|NCT03727438|537945546|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
149127375|NCT03727438|537945545|FG000|Intervention Period|Excluded (health)|1|||
149127376|NCT03727438|537945546|FG001|Intervention Period|Excluded (health)|0|||
149127377|NCT03727438|537945545|FG000|Intervention Period|Withdrawal by Subject|3|||
149127378|NCT03727438|537945546|FG001|Intervention Period|Withdrawal by Subject|1|||
149127379|NCT03727438|537945545|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
149127380|NCT03727438|537945546|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
149127381|NCT03727438|537945545|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
149127382|NCT03727438|537945546|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
149127383|NCT03727438|537945545|FG000|8 Week Assessment|Withdrawal by Subject|6|||
149127384|NCT03727438|537945546|FG001|8 Week Assessment|Withdrawal by Subject|1|||
149127385|NCT03727438|537945545|FG000|6 mo Assessment|did not complete assessment|10|||
149127386|NCT03727438|537945546|FG001|6 mo Assessment|did not complete assessment|11|||
149127387|NCT03170349|537945547|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
149127388|NCT03170349|537945547|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
149127389|NCT03170349|537945547|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
149127390|NCT03170349|537945547|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
149127391|NCT03170349|537945547|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
149127392|NCT03170349|537945547|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
149127393|NCT03170349|537945547|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
149127394|NCT03170349|537945547|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
149127395|NCT03170349|537945547|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
149127396|NCT03170349|537945547|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
149127397|NCT03170349|537945547|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
149127398|NCT03170349|537945547|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
149127399|NCT03170349|537945547|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
149127400|NCT03170349|537945547|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
149127401|NCT03170349|537945547|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
149127402|NCT03170349|537945547|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
149127403|NCT01912456|537947342|FG000|Period 1|Physician Decision|0|||
149127404|NCT01912456|537947343|FG001|Period 1|Physician Decision|0|||
149127405|NCT01912456|537947344|FG002|Period 1|Physician Decision|1|||
149127406|NCT01912456|537947345|FG003|Period 1|Physician Decision|0|||
149127407|NCT01912456|537947342|FG000|Period 1|non-compliance|1|||
149127408|NCT01912456|537947343|FG001|Period 1|non-compliance|0|||
149127409|NCT01912456|537947344|FG002|Period 1|non-compliance|0|||
149127410|NCT01912456|537947345|FG003|Period 1|non-compliance|1|||
149127411|NCT01912456|537947342|FG000|Period 1|Adverse Event|1|||
149127412|NCT01912456|537947343|FG001|Period 1|Adverse Event|0|||
149127413|NCT01912456|537947344|FG002|Period 1|Adverse Event|0|||
149127414|NCT01912456|537947345|FG003|Period 1|Adverse Event|1|||
149127415|NCT01912456|537947342|FG000|Period 1|Withdrawal by Subject|0|||
149127416|NCT01912456|537947343|FG001|Period 1|Withdrawal by Subject|1|||
149127417|NCT01912456|537947344|FG002|Period 1|Withdrawal by Subject|1|||
149127418|NCT01912456|537947345|FG003|Period 1|Withdrawal by Subject|1|||
149127419|NCT01912456|537947342|FG000|Period 2|Lack of Efficacy|0|||
149127420|NCT01912456|537947343|FG001|Period 2|Lack of Efficacy|2|||
149127421|NCT01912456|537947344|FG002|Period 2|Lack of Efficacy|0|||
149127422|NCT01912456|537947345|FG003|Period 2|Lack of Efficacy|0|||
149127423|NCT01912456|537947342|FG000|Period 2|Adverse Event|0|||
149127424|NCT01912456|537947343|FG001|Period 2|Adverse Event|0|||
149127425|NCT01912456|537947344|FG002|Period 2|Adverse Event|0|||
149127426|NCT01912456|537947345|FG003|Period 2|Adverse Event|1|||
149127427|NCT03442985|537947346|FG000|Overall Study|Sponsor Request|55|||
149127428|NCT03442985|537947347|FG001|Overall Study|Sponsor Request|60|||
149127429|NCT03442985|537947348|FG002|Overall Study|Sponsor Request|54|||
149127430|NCT03442985|537947346|FG000|Overall Study|Lost to Follow-up|5|||
149127431|NCT03442985|537947347|FG001|Overall Study|Lost to Follow-up|2|||
149127432|NCT03442985|537947348|FG002|Overall Study|Lost to Follow-up|7|||
149127433|NCT03442985|537947346|FG000|Overall Study|Withdrawal by Subject|2|||
149127434|NCT03442985|537947347|FG001|Overall Study|Withdrawal by Subject|3|||
149127435|NCT03442985|537947348|FG002|Overall Study|Withdrawal by Subject|4|||
149127436|NCT03442985|537947346|FG000|Overall Study|Adverse Event|0|||
149127437|NCT03442985|537947347|FG001|Overall Study|Adverse Event|1|||
149127438|NCT03442985|537947348|FG002|Overall Study|Adverse Event|0|||
149127439|NCT01640054|537947349|FG000|Overall Study|Study-specific disc criteria|1|||
149127440|NCT01640054|537947349|FG000|Overall Study|Lack of Efficacy|3|||
148786469|NCT05259917|536696155|FG000|Overall Study|Trial Termination by Sponsor|7|||
149127441|NCT01640054|537947349|FG000|Overall Study|Adverse Event|2|||
149127442|NCT01620255|537947351|FG000|Overall Study|Withdrawal by Subject|4|||
149127443|NCT01620255|537947352|FG001|Overall Study|Withdrawal by Subject|1|||
149127444|NCT01620255|537947353|FG002|Overall Study|Withdrawal by Subject|1|||
149127445|NCT01620255|537947354|FG003|Overall Study|Withdrawal by Subject|2|||
149127446|NCT01620255|537947355|FG004|Overall Study|Withdrawal by Subject|4|||
149127447|NCT01620255|537947351|FG000|Overall Study|Participant underwent fecal transplant|0|||
149127448|NCT01620255|537947352|FG001|Overall Study|Participant underwent fecal transplant|0|||
149127449|NCT01620255|537947353|FG002|Overall Study|Participant underwent fecal transplant|1|||
149127450|NCT01620255|537947354|FG003|Overall Study|Participant underwent fecal transplant|0|||
149127451|NCT01620255|537947355|FG004|Overall Study|Participant underwent fecal transplant|0|||
149127452|NCT01620255|537947351|FG000|Overall Study|Non-compliance|0|||
149127453|NCT01620255|537947352|FG001|Overall Study|Non-compliance|1|||
149127454|NCT01620255|537947353|FG002|Overall Study|Non-compliance|0|||
149127455|NCT01620255|537947354|FG003|Overall Study|Non-compliance|0|||
149127456|NCT01620255|537947355|FG004|Overall Study|Non-compliance|0|||
149127457|NCT01620255|537947351|FG000|Overall Study|Adverse Event|0|||
149127458|NCT01620255|537947352|FG001|Overall Study|Adverse Event|4|||
149127459|NCT01620255|537947353|FG002|Overall Study|Adverse Event|0|||
149127460|NCT01620255|537947354|FG003|Overall Study|Adverse Event|1|||
149127461|NCT01620255|537947355|FG004|Overall Study|Adverse Event|1|||
149127462|NCT01620255|537947351|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
149127463|NCT01620255|537947352|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
149127464|NCT01620255|537947353|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
149127465|NCT01620255|537947354|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
149127466|NCT01620255|537947355|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
149127467|NCT01557283|537947359|FG000|Overall Study|Lost to Follow-up|7|||
149127468|NCT01557283|537947359|FG000|Overall Study|Non-responder|19|||
149127469|NCT01557283|537947359|FG000|Overall Study|Adverse Event|7|||
149127470|NCT01557283|537947359|FG000|Overall Study|Lack of Efficacy|1|||
149127471|NCT01557283|537947359|FG000|Overall Study|Non-compliance|1|||
149127472|NCT01557283|537947359|FG000|Overall Study|Withdrawal by Subject|1|||
149127473|NCT01557283|537947359|FG000|Overall Study|Participant's weight too high for dose|1|||
149127474|NCT01557283|537947359|FG000|Overall Study|Worsening of psoriasis|1|||
149127475|NCT01557283|537947359|FG000|Overall Study|Other|6|||
149127476|NCT01716117|537947360|FG000|Overall Study|Death|5|||
149127477|NCT01716117|537947361|FG001|Overall Study|Death|2|||
149127478|NCT01716117|537947360|FG000|Overall Study|Withdrawal by Subject|2|||
149127479|NCT01716117|537947361|FG001|Overall Study|Withdrawal by Subject|0|||
149127480|NCT03645057|537947362|FG000|Randomization to Baseline|Lost to Follow-up|1|||
149127481|NCT03645057|537947363|FG001|Randomization to Baseline|Lost to Follow-up|0|||
149127482|NCT03645057|537947364|FG002|Randomization to Baseline|Lost to Follow-up|1|||
149127483|NCT03645057|537947365|FG003|Randomization to Baseline|Lost to Follow-up|0|||
149127484|NCT03645057|537947362|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
149127485|NCT03645057|537947363|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
149127486|NCT03645057|537947364|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
149127487|NCT03645057|537947365|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
149127488|NCT03645057|537947362|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
149127489|NCT03645057|537947363|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
149127490|NCT03645057|537947364|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
149127491|NCT03645057|537947365|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
149127492|NCT03645057|537947362|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
149127493|NCT03645057|537947363|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
149127494|NCT03645057|537947364|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
149127495|NCT03645057|537947365|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
149127496|NCT01873495|537947366|FG000|Overall Study|Withdrawal by Subject|1|||
149127497|NCT01873495|537947366|FG000|Overall Study|Physician Decision|3|||
149127498|NCT01873495|537947366|FG000|Overall Study|Adverse Event|1|||
149127499|NCT01873495|537947366|FG000|Overall Study|Removed for Transplantation|1|||
149127500|NCT01873495|537947366|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
149127501|NCT01206777|537947367|FG000|Overall Study|Death|1|||
149127502|NCT01206777|537947367|FG000|Overall Study|Adverse Event|1|||
149127503|NCT01155375|537947372|FG000|Overall Study|Adverse Event|1|||
149127504|NCT01155375|537947373|FG001|Overall Study|Adverse Event|0|||
149127505|NCT00975507|537947374|FG000|Overall Study|Adverse Event|1|||
149127506|NCT00975507|537947375|FG001|Overall Study|Adverse Event|0|||
149127507|NCT00975507|537947374|FG000|Overall Study|Lost to Follow-up|7|||
149127508|NCT00975507|537947375|FG001|Overall Study|Lost to Follow-up|1|||
149127509|NCT00975507|537947374|FG000|Overall Study|Protocol Violation|2|||
148786470|NCT05259917|536696156|FG001|Overall Study|Trial Termination by Sponsor|2|||
148786471|NCT05259917|536696157|FG002|Overall Study|Trial Termination by Sponsor|3|||
148786472|NCT05259917|536696158|FG003|Overall Study|Trial Termination by Sponsor|5|||
148786473|NCT05259917|536696159|FG004|Overall Study|Trial Termination by Sponsor|11|||
148786474|NCT05259917|536696160|FG005|Overall Study|Trial Termination by Sponsor|4|||
148786475|NCT05259917|536696155|FG000|Overall Study|Other|1|||
148786476|NCT05259917|536696156|FG001|Overall Study|Other|0|||
148786477|NCT05259917|536696157|FG002|Overall Study|Other|2|||
149127510|NCT00975507|537947375|FG001|Overall Study|Protocol Violation|0|||
149127511|NCT00975507|537947374|FG000|Overall Study|Withdrawal by Subject|10|||
149127512|NCT00975507|537947375|FG001|Overall Study|Withdrawal by Subject|3|||
149127513|NCT01295034|537947376|FG000|Overall Study|Lost to Follow-up|5|||
149127514|NCT01295034|537947377|FG001|Overall Study|Lost to Follow-up|5|||
149127515|NCT03818204|537947378|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127516|NCT03818204|537947379|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127517|NCT03818204|537947380|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127518|NCT03818204|537947381|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
148786478|NCT05259917|536696158|FG003|Overall Study|Other|0|||
148786479|NCT05259917|536696159|FG004|Overall Study|Other|0|||
148786480|NCT05259917|536696160|FG005|Overall Study|Other|0|||
148786481|NCT00592592|536696161|FG000|Overall Study|Patient found ineligible upon chart review|1|||
149127519|NCT03818204|537947382|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
149127520|NCT03818204|537947383|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127521|NCT03818204|537947384|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127522|NCT03818204|537947385|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127523|NCT03818204|537947386|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127524|NCT03818204|537947387|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127525|NCT03818204|537947388|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127526|NCT03818204|537947389|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127527|NCT03818204|537947390|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127528|NCT03818204|537947391|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
149127529|NCT03818204|537947392|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127530|NCT03818204|537947393|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127531|NCT03818204|537947394|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127532|NCT03818204|537947395|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127533|NCT03818204|537947396|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
149127534|NCT03818204|537947378|FG000|Overall Study|Physician Decision|0|||
149127535|NCT03818204|537947379|FG001|Overall Study|Physician Decision|0|||
149127536|NCT03818204|537947380|FG002|Overall Study|Physician Decision|0|||
149127537|NCT03818204|537947381|FG003|Overall Study|Physician Decision|0|||
149127538|NCT03818204|537947382|FG004|Overall Study|Physician Decision|0|||
149127539|NCT03818204|537947383|FG005|Overall Study|Physician Decision|0|||
149127540|NCT03818204|537947384|FG006|Overall Study|Physician Decision|0|||
149127541|NCT03818204|537947385|FG007|Overall Study|Physician Decision|0|||
149127542|NCT03818204|537947386|FG008|Overall Study|Physician Decision|0|||
149127543|NCT03818204|537947387|FG009|Overall Study|Physician Decision|0|||
149127544|NCT03818204|537947388|FG010|Overall Study|Physician Decision|0|||
149127545|NCT03818204|537947389|FG011|Overall Study|Physician Decision|0|||
149127546|NCT03818204|537947390|FG012|Overall Study|Physician Decision|0|||
149127547|NCT03818204|537947391|FG013|Overall Study|Physician Decision|0|||
149127548|NCT03818204|537947392|FG014|Overall Study|Physician Decision|1|||
148786482|NCT02886884|536696162|FG000|Follow-up|Withdrawal by Subject|0|||
148786483|NCT02886884|536696163|FG001|Follow-up|Withdrawal by Subject|0|||
148786484|NCT02886884|536696164|FG002|Follow-up|Withdrawal by Subject|0|||
148786485|NCT02886884|536696165|FG003|Follow-up|Withdrawal by Subject|1|||
148786486|NCT00494221|536696166|FG000|Overall Study|Death|15|||
148786487|NCT00494221|536696167|FG001|Overall Study|Death|9|||
149127549|NCT03818204|537947393|FG015|Overall Study|Physician Decision|0|||
149127550|NCT03818204|537947394|FG016|Overall Study|Physician Decision|0|||
149127551|NCT03818204|537947395|FG017|Overall Study|Physician Decision|0|||
149127552|NCT03818204|537947396|FG018|Overall Study|Physician Decision|0|||
149127553|NCT00887250|537947397|FG000|Overall Study|Adverse Event|3|||
149127554|NCT00887250|537947398|FG001|Overall Study|Adverse Event|0|||
149127555|NCT00887250|537947399|FG002|Overall Study|Adverse Event|7|||
149127556|NCT00887250|537947397|FG000|Overall Study|Lack of Efficacy|9|||
148786488|NCT00494221|536696168|FG002|Overall Study|Death|14|||
148786489|NCT00494221|536696166|FG000|Overall Study|Withdrawal by Subject|1|||
149127557|NCT00887250|537947398|FG001|Overall Study|Lack of Efficacy|6|||
149127558|NCT00887250|537947399|FG002|Overall Study|Lack of Efficacy|1|||
149127559|NCT00887250|537947397|FG000|Overall Study|Lost to Follow-up|2|||
149127560|NCT00887250|537947398|FG001|Overall Study|Lost to Follow-up|3|||
149127561|NCT00887250|537947399|FG002|Overall Study|Lost to Follow-up|1|||
148786490|NCT00494221|536696167|FG001|Overall Study|Withdrawal by Subject|2|||
148786491|NCT00494221|536696168|FG002|Overall Study|Withdrawal by Subject|0|||
149127562|NCT00887250|537947397|FG000|Overall Study|Protocol Violation|2|||
149127563|NCT00887250|537947398|FG001|Overall Study|Protocol Violation|2|||
149127564|NCT00887250|537947399|FG002|Overall Study|Protocol Violation|1|||
149127565|NCT00887250|537947397|FG000|Overall Study|Withdrawal by Subject|2|||
149127566|NCT00887250|537947398|FG001|Overall Study|Withdrawal by Subject|1|||
149127567|NCT00887250|537947399|FG002|Overall Study|Withdrawal by Subject|2|||
149127568|NCT00887250|537947397|FG000|Overall Study|Patient uncooperative|0|||
149127569|NCT00887250|537947398|FG001|Overall Study|Patient uncooperative|0|||
149127570|NCT00887250|537947399|FG002|Overall Study|Patient uncooperative|1|||
149127571|NCT05754333|537947400|FG000|Overall Study|Miscellaneous|3|||
149127572|NCT05754333|537947401|FG001|Overall Study|Miscellaneous|0|||
149127573|NCT05754333|537947402|FG002|Overall Study|Miscellaneous|0|||
149127574|NCT05754333|537947403|FG003|Overall Study|Miscellaneous|0|||
149127575|NCT05754333|537947400|FG000|Overall Study|Lost to Follow-up|2|||
149127576|NCT05754333|537947401|FG001|Overall Study|Lost to Follow-up|1|||
149127577|NCT05754333|537947402|FG002|Overall Study|Lost to Follow-up|0|||
149127578|NCT05754333|537947403|FG003|Overall Study|Lost to Follow-up|1|||
149127579|NCT03864146|537947404|FG000|Overall Study|Lost to Follow-up|14|||
149127580|NCT03864146|537947405|FG001|Overall Study|Lost to Follow-up|23|||
149127581|NCT03864146|537947404|FG000|Overall Study|Withdrawal by Subject|3|||
149127582|NCT03864146|537947405|FG001|Overall Study|Withdrawal by Subject|2|||
149127583|NCT00824161|537947406|FG000|Overall Study|Withdrawal by Subject|1|||
149127584|NCT00824161|537947406|FG000|Overall Study|Screen Failure|1|||
149127585|NCT04981366|537947407|FG000|Overall Study|Withdrawal by Subject|5|||
149127586|NCT04981366|537947408|FG001|Overall Study|Withdrawal by Subject|4|||
149127587|NCT04981366|537947409|FG002|Overall Study|Withdrawal by Subject|8|||
149127588|NCT04981366|537947407|FG000|Overall Study|Health issues unrelated to the trial|1|||
149127589|NCT04981366|537947408|FG001|Overall Study|Health issues unrelated to the trial|2|||
149127590|NCT04981366|537947409|FG002|Overall Study|Health issues unrelated to the trial|0|||
149127591|NCT01112306|537947410|FG000|Overall Study|Death|175|||
149127592|NCT01112306|537947410|FG000|Overall Study|Lost to Follow-up|9|||
149127593|NCT01112306|537947410|FG000|Overall Study|Withdrawal by Subject|31|||
149127594|NCT01112306|537947410|FG000|Overall Study|Other|70|||
149127595|NCT00881608|537947411|FG000|Overall Study|Study prematurely terminated|11|||
149127596|NCT03214094|537947412|FG000|Overall Study|Case Report Forms Uncollected|14|||
149127597|NCT03214094|537947412|FG000|Overall Study|Protocol Deviation|46|||
149127598|NCT00795951|537947413|FG000|Overall Study|Lost to Follow-up|1|||
149127599|NCT00795951|537947413|FG000|Overall Study|Withdrawal by Subject|1|||
149127600|NCT04572841|537947414|FG000|Overall Study|Adverse Event|1|||
149127601|NCT04572841|537947415|FG001|Overall Study|Adverse Event|1|||
149127602|NCT04572841|537947414|FG000|Overall Study|Withdrawal by Subject|2|||
149127603|NCT04572841|537947415|FG001|Overall Study|Withdrawal by Subject|1|||
149127604|NCT06469242|537947416|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
149127605|NCT06469242|537947417|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
149127606|NCT06469242|537947416|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
149127607|NCT06469242|537947417|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
149127608|NCT01205152|537947418|FG000|Overall Study|Death|1|||
149127609|NCT02783768|537947419|FG000|Overall Study|Lost to Follow-up|1|||
149127610|NCT02783768|537947420|FG001|Overall Study|Lost to Follow-up|0|||
149127611|NCT01323647|537947421|FG000|Overall Study|Migrated/moved from study area|2|||
149127612|NCT01323647|537947422|FG001|Overall Study|Migrated/moved from study area|0|||
149127613|NCT01323647|537947421|FG000|Overall Study|Withdrawal by Subject|5|||
149127614|NCT01323647|537947422|FG001|Overall Study|Withdrawal by Subject|0|||
149127615|NCT01323647|537947421|FG000|Overall Study|Lost to Follow-up|2|||
149127616|NCT01323647|537947422|FG001|Overall Study|Lost to Follow-up|0|||
149127617|NCT02070588|537947425|FG000|Overall Study|Withdrawal by Subject|29|||
149127618|NCT02070588|537947426|FG001|Overall Study|Withdrawal by Subject|1|||
148786492|NCT02732327|536696172|FG000|Overall Study|Protocol Violation|0|||
149127619|NCT02070588|537947427|FG002|Overall Study|Withdrawal by Subject|0|||
149127620|NCT02070588|537947425|FG000|Overall Study|Writhdrawal due to early termination|9|||
149127621|NCT02070588|537947426|FG001|Overall Study|Writhdrawal due to early termination|0|||
149127622|NCT02070588|537947427|FG002|Overall Study|Writhdrawal due to early termination|0|||
149127623|NCT02070588|537947425|FG000|Overall Study|Adverse Event|1|||
149127624|NCT02070588|537947426|FG001|Overall Study|Adverse Event|0|||
149127625|NCT02070588|537947427|FG002|Overall Study|Adverse Event|0|||
149127626|NCT03421431|537947428|FG000|Overall Study|Adverse Event|2|||
149127627|NCT03421431|537947429|FG001|Overall Study|Adverse Event|1|||
149127628|NCT03421431|537947430|FG002|Overall Study|Adverse Event|12|||
149127629|NCT03421431|537947428|FG000|Overall Study|Lost to Follow-up|1|||
148786493|NCT02732327|536696173|FG001|Overall Study|Protocol Violation|1|||
149127630|NCT03421431|537947429|FG001|Overall Study|Lost to Follow-up|1|||
149127631|NCT03421431|537947430|FG002|Overall Study|Lost to Follow-up|1|||
149127632|NCT03421431|537947428|FG000|Overall Study|Withdrawal by Subject|3|||
149127633|NCT03421431|537947429|FG001|Overall Study|Withdrawal by Subject|2|||
149127634|NCT03421431|537947430|FG002|Overall Study|Withdrawal by Subject|1|||
149127635|NCT03421431|537947428|FG000|Overall Study|Protocol Violation|0|||
149127636|NCT03421431|537947429|FG001|Overall Study|Protocol Violation|1|||
149127637|NCT03421431|537947430|FG002|Overall Study|Protocol Violation|0|||
149127638|NCT03421431|537947428|FG000|Overall Study|Participant met Stopping Rules|0|||
149127639|NCT03421431|537947429|FG001|Overall Study|Participant met Stopping Rules|1|||
149127640|NCT03421431|537947430|FG002|Overall Study|Participant met Stopping Rules|0|||
149127641|NCT00141726|537947434|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
149127642|NCT02216357|537947435|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
149127643|NCT02216357|537947436|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
149127644|NCT00235326|537947441|FG000|Overall Study|Lost to Follow-up|746|||
149127645|NCT00235326|537947442|FG001|Overall Study|Lost to Follow-up|1400|||
149127646|NCT01959516|537947443|FG000|Epoch 1|Adverse Event|4|||
149127647|NCT01959516|537947444|FG001|Epoch 1|Adverse Event|1|||
149127648|NCT01959516|537947443|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
149127649|NCT01959516|537947444|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
149127650|NCT01959516|537947443|FG000|Epoch 1|Subject withdrew consent|3|||
149127651|NCT01959516|537947444|FG001|Epoch 1|Subject withdrew consent|2|||
149127652|NCT01959516|537947443|FG000|Epoch 1|Administrative problems|1|||
149127653|NCT01959516|537947444|FG001|Epoch 1|Administrative problems|0|||
149127654|NCT01959516|537947443|FG000|Epoch 1|Use of prohibited treatment|1|||
149127655|NCT01959516|537947444|FG001|Epoch 1|Use of prohibited treatment|0|||
149127656|NCT01959516|537947443|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
149127657|NCT01959516|537947444|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
149127658|NCT01959516|537947443|FG000|Epoch 1|Protocol deviation|0|||
149127659|NCT01959516|537947444|FG001|Epoch 1|Protocol deviation|1|||
149127660|NCT01959516|537947443|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
149127661|NCT01959516|537947444|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
149127662|NCT01959516|537947443|FG000|Epoch 2|Subject withdrew consent|1|||
149127663|NCT01959516|537947444|FG001|Epoch 2|Subject withdrew consent|0|||
149127664|NCT01959516|537947443|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
149127665|NCT01959516|537947444|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
149127666|NCT01178671|537947445|FG000|Overall Study|Adverse Event|4|||
149127667|NCT01178671|537947446|FG001|Overall Study|Adverse Event|6|||
149127668|NCT01178671|537947445|FG000|Overall Study|Protocol Violation|1|||
149127669|NCT01178671|537947446|FG001|Overall Study|Protocol Violation|1|||
149127670|NCT01178671|537947445|FG000|Overall Study|Lack of Efficacy|0|||
149127671|NCT01178671|537947446|FG001|Overall Study|Lack of Efficacy|1|||
149127672|NCT01178671|537947445|FG000|Overall Study|Lost to Follow-up|3|||
149127673|NCT01178671|537947446|FG001|Overall Study|Lost to Follow-up|1|||
149127674|NCT01178671|537947445|FG000|Overall Study|Physician Decision|4|||
149127675|NCT01178671|537947446|FG001|Overall Study|Physician Decision|6|||
149127676|NCT02435966|537947447|FG000|Overall Study|Withdrawal by Subject|0|||
149127677|NCT02435966|537947448|FG001|Overall Study|Withdrawal by Subject|1|||
149127678|NCT02435966|537947449|FG002|Overall Study|Withdrawal by Subject|0|||
149127679|NCT04620811|537947450|FG000|Overall Study|Withdrawal by Subject|18|||
149127680|NCT04620811|537947451|FG001|Overall Study|Withdrawal by Subject|15|||
149127681|NCT04620811|537947450|FG000|Overall Study|Adverse Event|6|||
149127682|NCT04620811|537947451|FG001|Overall Study|Adverse Event|11|||
149127683|NCT04620811|537947450|FG000|Overall Study|Lost to Follow-up|4|||
149127684|NCT04620811|537947451|FG001|Overall Study|Lost to Follow-up|8|||
149127685|NCT04620811|537947450|FG000|Overall Study|Physician Decision|1|||
149127686|NCT04620811|537947451|FG001|Overall Study|Physician Decision|4|||
149127687|NCT04620811|537947450|FG000|Overall Study|Sponsor Decision|0|||
149127688|NCT04620811|537947451|FG001|Overall Study|Sponsor Decision|1|||
149127689|NCT04620811|537947450|FG000|Overall Study|Elevation of ALT or AST|1|||
149127690|NCT04620811|537947451|FG001|Overall Study|Elevation of ALT or AST|0|||
149127691|NCT04620811|537947450|FG000|Overall Study|Other|3|||
149127692|NCT04620811|537947451|FG001|Overall Study|Other|5|||
149127693|NCT01078675|537947453|FG000|Overall Study|Withdrawal by Subject|7|||
149127694|NCT01078675|537947454|FG001|Overall Study|Withdrawal by Subject|3|||
148786494|NCT02306694|536696174|FG000|Overall Study|Withdrawal by Subject|3|||
149127695|NCT01078675|537947453|FG000|Overall Study|Protocol Violation|56|||
149127696|NCT01078675|537947454|FG001|Overall Study|Protocol Violation|0|||
149127697|NCT01078675|537947453|FG000|Overall Study|Provided in CRF for specific reasons|2|||
149127698|NCT01078675|537947454|FG001|Overall Study|Provided in CRF for specific reasons|3|||
148786495|NCT02306694|536696174|FG000|Overall Study|Lost to Follow-up|1|||
149127699|NCT01078675|537947453|FG000|Overall Study|Adverse Event|3|||
149127700|NCT01078675|537947454|FG001|Overall Study|Adverse Event|0|||
149127701|NCT00928746|537947463|FG000|Overall Study|Adverse Event|2|||
149127702|NCT00928746|537947463|FG000|Overall Study|Protocol Violation|1|||
149127703|NCT00928746|537947463|FG000|Overall Study|Withdrawal by Subject|1|||
149127704|NCT00928746|537947463|FG000|Overall Study|Other|2|||
149127705|NCT02745392|537947468|FG000|Overall Study|Lost to Follow-up|0|||
149127706|NCT02745392|537947469|FG001|Overall Study|Lost to Follow-up|1|||
148786496|NCT00603382|536696175|FG000|Overall Study|Adverse Event|0|||
149127707|NCT02745392|537947470|FG002|Overall Study|Lost to Follow-up|0|||
149127708|NCT02745392|537947471|FG003|Overall Study|Lost to Follow-up|0|||
149127709|NCT02513303|537947473|FG000|Overall Study|Withdrawal by Subject|9|||
149127710|NCT02513303|537947474|FG001|Overall Study|Withdrawal by Subject|7|||
149127711|NCT02513303|537947475|FG002|Overall Study|Withdrawal by Subject|2|||
149127712|NCT02513303|537947473|FG000|Overall Study|Lost to Follow-up|2|||
149127713|NCT02513303|537947474|FG001|Overall Study|Lost to Follow-up|4|||
149127714|NCT02513303|537947475|FG002|Overall Study|Lost to Follow-up|0|||
149127715|NCT02513303|537947473|FG000|Overall Study|Adverse Event|0|||
149127716|NCT02513303|537947474|FG001|Overall Study|Adverse Event|1|||
149127717|NCT02513303|537947475|FG002|Overall Study|Adverse Event|0|||
149127718|NCT02513303|537947473|FG000|Overall Study|Physician Decision|1|||
149127719|NCT02513303|537947474|FG001|Overall Study|Physician Decision|1|||
149127720|NCT02513303|537947475|FG002|Overall Study|Physician Decision|0|||
149127721|NCT02513303|537947473|FG000|Overall Study|Death|8|||
149127722|NCT02513303|537947474|FG001|Overall Study|Death|4|||
149127723|NCT02513303|537947475|FG002|Overall Study|Death|2|||
149127724|NCT02004353|537947476|FG000|Overall Study|Voluntary participation|1334|||
149127725|NCT01691768|537947477|FG000|Overall Study|Death|0|||
149127726|NCT01691768|537947478|FG001|Overall Study|Death|2|||
149127727|NCT01691768|537947477|FG000|Overall Study|Lost to Follow-up|4|||
149127728|NCT01691768|537947478|FG001|Overall Study|Lost to Follow-up|3|||
149127729|NCT01691768|537947477|FG000|Overall Study|Withdrawal by Subject|10|||
149127730|NCT01691768|537947478|FG001|Overall Study|Withdrawal by Subject|9|||
149127731|NCT01691768|537947477|FG000|Overall Study|Relocated|0|||
149127732|NCT01691768|537947478|FG001|Overall Study|Relocated|1|||
149127733|NCT01691768|537947477|FG000|Overall Study|Investigator decision|1|||
149127734|NCT01691768|537947478|FG001|Overall Study|Investigator decision|1|||
149127735|NCT00887432|537947480|FG000|Overall Study|Start Excluded Therapy|3|||
149127736|NCT00887432|537947481|FG001|Overall Study|Start Excluded Therapy|0|||
149127737|NCT00887432|537947480|FG000|Overall Study|Did not complete treatment|6|||
149127738|NCT00887432|537947481|FG001|Overall Study|Did not complete treatment|8|||
149127739|NCT00887432|537947480|FG000|Overall Study|Protocol Violation|2|||
149127740|NCT00887432|537947481|FG001|Overall Study|Protocol Violation|3|||
149127741|NCT00887432|537947480|FG000|Overall Study|Withdrawal by Subject|3|||
149127742|NCT00887432|537947481|FG001|Overall Study|Withdrawal by Subject|2|||
149127743|NCT00887432|537947480|FG000|Overall Study|Lost to Follow-up|1|||
149127744|NCT00887432|537947481|FG001|Overall Study|Lost to Follow-up|0|||
149127745|NCT00887432|537947480|FG000|Overall Study|No reason provided|0|||
149127746|NCT00887432|537947481|FG001|Overall Study|No reason provided|1|||
149127747|NCT00899548|537947482|FG000|Overall Study|Physician Decision|3|||
149127748|NCT01337115|537947483|FG000|Overall Study|Protocol Violation|2|||
149127749|NCT01337115|537947484|FG001|Overall Study|Protocol Violation|0|||
149127750|NCT03426267|537947485|FG000|Overall Study|Physician Decision|1|||
149127751|NCT03426267|537947486|FG001|Overall Study|Physician Decision|4|||
149127752|NCT03426267|537947485|FG000|Overall Study|Lost to Follow-up|1|||
149127753|NCT03426267|537947486|FG001|Overall Study|Lost to Follow-up|0|||
149127754|NCT03426267|537947485|FG000|Overall Study|Withdrawal by Subject|4|||
149127755|NCT03426267|537947486|FG001|Overall Study|Withdrawal by Subject|10|||
149127756|NCT03426267|537947485|FG000|Overall Study|Protocol Violation|1|||
149127757|NCT03426267|537947486|FG001|Overall Study|Protocol Violation|3|||
149127758|NCT03426267|537947485|FG000|Overall Study|Adverse Event|9|||
149127759|NCT03426267|537947486|FG001|Overall Study|Adverse Event|27|||
149127760|NCT03426267|537947485|FG000|Overall Study|Prohibited Treatment Intake|2|||
149127761|NCT03426267|537947486|FG001|Overall Study|Prohibited Treatment Intake|3|||
149127762|NCT03426267|537947485|FG000|Overall Study|Lack of Efficacy|0|||
149127763|NCT03426267|537947486|FG001|Overall Study|Lack of Efficacy|25|||
149127764|NCT03426267|537947485|FG000|Overall Study|other|3|||
149127765|NCT03426267|537947486|FG001|Overall Study|other|0|||
149127766|NCT01636960|537947489|FG000|Induction Phase|Adverse Event|2|||
149127767|NCT01636960|537947489|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
149127768|NCT01636960|537947489|FG000|Maintenance Phase|Adverse Event|3|||
149127769|NCT01636960|537947489|FG000|Maintenance Phase|Progressive disease|1|||
148786497|NCT00603382|536696176|FG001|Overall Study|Adverse Event|1|||
148786498|NCT00603382|536696177|FG002|Overall Study|Adverse Event|1|||
148786499|NCT00603382|536696178|FG003|Overall Study|Adverse Event|2|||
149127770|NCT01209780|537947490|FG000|Overall Study|Adverse Event|0|||
148786500|NCT00603382|536696179|FG004|Overall Study|Adverse Event|1|||
149127771|NCT01209780|537947491|FG001|Overall Study|Adverse Event|1|||
149127772|NCT01209780|537947492|FG002|Overall Study|Adverse Event|0|||
149127773|NCT01209780|537947493|FG003|Overall Study|Adverse Event|0|||
149127774|NCT01209780|537947494|FG004|Overall Study|Adverse Event|0|||
149127775|NCT01209780|537947490|FG000|Overall Study|Withdrawal by Subject|9|||
149127776|NCT01209780|537947491|FG001|Overall Study|Withdrawal by Subject|2|||
149127777|NCT01209780|537947492|FG002|Overall Study|Withdrawal by Subject|1|||
149127778|NCT01209780|537947493|FG003|Overall Study|Withdrawal by Subject|1|||
149127779|NCT01209780|537947494|FG004|Overall Study|Withdrawal by Subject|0|||
149127780|NCT01209780|537947490|FG000|Overall Study|Lost to Follow-up|17|||
149127781|NCT01209780|537947491|FG001|Overall Study|Lost to Follow-up|12|||
149127782|NCT01209780|537947492|FG002|Overall Study|Lost to Follow-up|3|||
149127783|NCT01209780|537947493|FG003|Overall Study|Lost to Follow-up|9|||
149127784|NCT01209780|537947494|FG004|Overall Study|Lost to Follow-up|4|||
149127785|NCT01209780|537947490|FG000|Overall Study|Protocol Violation|0|||
149127786|NCT01209780|537947491|FG001|Overall Study|Protocol Violation|1|||
149127787|NCT01209780|537947492|FG002|Overall Study|Protocol Violation|0|||
149127788|NCT01209780|537947493|FG003|Overall Study|Protocol Violation|0|||
149127789|NCT01209780|537947494|FG004|Overall Study|Protocol Violation|0|||
149127790|NCT01209780|537947490|FG000|Overall Study|Inappropriate enrollment|0|||
149127791|NCT01209780|537947491|FG001|Overall Study|Inappropriate enrollment|2|||
149127792|NCT01209780|537947492|FG002|Overall Study|Inappropriate enrollment|0|||
149127793|NCT01209780|537947493|FG003|Overall Study|Inappropriate enrollment|0|||
149127794|NCT01209780|537947494|FG004|Overall Study|Inappropriate enrollment|1|||
149127795|NCT03110185|537947495|FG000|Overall Study|Death|0|||
149127796|NCT03110185|537947496|FG001|Overall Study|Death|1|||
149127797|NCT03110185|537947495|FG000|Overall Study|Withdrawal by Subject|2|||
149127798|NCT03110185|537947496|FG001|Overall Study|Withdrawal by Subject|7|||
149127799|NCT03110185|537947495|FG000|Overall Study|Time Constraints|0|||
149127800|NCT03110185|537947496|FG001|Overall Study|Time Constraints|6|||
149127801|NCT03110185|537947495|FG000|Overall Study|Conflict with care|5|||
149127802|NCT03110185|537947496|FG001|Overall Study|Conflict with care|12|||
149127803|NCT03110185|537947495|FG000|Overall Study|Protocol Violation|1|||
149127804|NCT03110185|537947496|FG001|Overall Study|Protocol Violation|4|||
149127805|NCT03110185|537947495|FG000|Overall Study|MRI Incompatible|2|||
149127806|NCT03110185|537947496|FG001|Overall Study|MRI Incompatible|0|||
149127807|NCT03110185|537947495|FG000|Overall Study|Patient Refusal|0|||
149127808|NCT03110185|537947496|FG001|Overall Study|Patient Refusal|1|||
149127809|NCT03075410|537947499|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
149127810|NCT03075410|537947500|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127811|NCT03075410|537947501|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
149127812|NCT03075410|537947502|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127813|NCT03075410|537947503|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127814|NCT03075410|537947504|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127815|NCT03075410|537947505|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127816|NCT03075410|537947506|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127817|NCT03075410|537947507|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
149127818|NCT03075410|537947499|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
149127819|NCT03075410|537947500|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127820|NCT03075410|537947501|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127821|NCT03075410|537947502|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127822|NCT03075410|537947503|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127823|NCT03075410|537947504|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127824|NCT03075410|537947505|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127825|NCT03075410|537947506|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127826|NCT03075410|537947507|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
149127827|NCT01427751|537947508|FG000|Overall Study|Adverse Event|18|||
149127828|NCT01427751|537947509|FG001|Overall Study|Adverse Event|2|||
149127829|NCT01427751|537947508|FG000|Overall Study|No further treatment benefit expected|5|||
149127830|NCT01427751|537947509|FG001|Overall Study|No further treatment benefit expected|1|||
149127831|NCT01427751|537947508|FG000|Overall Study|Lost to Follow-up|3|||
149127832|NCT01427751|537947509|FG001|Overall Study|Lost to Follow-up|1|||
149127833|NCT01427751|537947508|FG000|Overall Study|Withdrawal of consent|2|||
149127834|NCT01427751|537947509|FG001|Overall Study|Withdrawal of consent|2|||
149127835|NCT01427751|537947508|FG000|Overall Study|Protocol Violation|6|||
149127836|NCT01427751|537947509|FG001|Overall Study|Protocol Violation|4|||
149127837|NCT01427751|537947508|FG000|Overall Study|Death|2|||
149127838|NCT01427751|537947509|FG001|Overall Study|Death|0|||
149127839|NCT01427751|537947508|FG000|Overall Study|Other miscellaneous reasons|6|||
149127840|NCT01427751|537947509|FG001|Overall Study|Other miscellaneous reasons|4|||
149127841|NCT05572021|537947510|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
149127842|NCT05572021|537947511|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
149127843|NCT04576455|537947512|FG000|Overall Study|Ongoing in the Study|48|||
148786501|NCT00603382|536696180|FG005|Overall Study|Adverse Event|2|||
148786502|NCT00603382|536696175|FG000|Overall Study|Lack of Efficacy|14|||
148786503|NCT00603382|536696176|FG001|Overall Study|Lack of Efficacy|9|||
148786504|NCT00603382|536696177|FG002|Overall Study|Lack of Efficacy|3|||
148786505|NCT00603382|536696178|FG003|Overall Study|Lack of Efficacy|6|||
148786506|NCT00603382|536696179|FG004|Overall Study|Lack of Efficacy|6|||
149127844|NCT04576455|537947513|FG001|Overall Study|Ongoing in the Study|58|||
149127845|NCT04576455|537947512|FG000|Overall Study|Death|83|||
149127846|NCT04576455|537947513|FG001|Overall Study|Death|77|||
149127847|NCT04576455|537947512|FG000|Overall Study|Lost to Follow-up|4|||
149127848|NCT04576455|537947513|FG001|Overall Study|Lost to Follow-up|5|||
149127849|NCT04576455|537947512|FG000|Overall Study|Withdrawal by Subject|16|||
149127850|NCT04576455|537947513|FG001|Overall Study|Withdrawal by Subject|12|||
149127851|NCT03432260|537947514|FG000|Overall Study|Lost to Follow-up|1|||
149127852|NCT03432260|537947515|FG001|Overall Study|Lost to Follow-up|1|||
149127853|NCT03432260|537947516|FG002|Overall Study|Lost to Follow-up|0|||
149127854|NCT03432260|537947517|FG003|Overall Study|Lost to Follow-up|0|||
149127855|NCT03432260|537947518|FG004|Overall Study|Lost to Follow-up|1|||
149127856|NCT02186847|537947519|FG000|Overall Study|Protocol Violation|3|||
149127857|NCT02186847|537947520|FG001|Overall Study|Protocol Violation|0|||
149127858|NCT04873232|537947524|FG000|Overall Study|Lost to Follow-up|1|||
149127859|NCT04873232|537947525|FG001|Overall Study|Lost to Follow-up|4|||
149127860|NCT04873232|537947524|FG000|Overall Study|Withdrawal by Subject|1|||
149127861|NCT04873232|537947525|FG001|Overall Study|Withdrawal by Subject|0|||
149127862|NCT00001962|537949073|FG000|Overall Study|Lack of Efficacy|18|||
149127863|NCT00001962|537949073|FG000|Overall Study|Lack of Accrual|6|||
149127864|NCT00001962|537949073|FG000|Overall Study|Death|1|||
149127865|NCT00001962|537949073|FG000|Overall Study|Lost to Follow-up|2|||
149127866|NCT00001962|537949073|FG000|Overall Study|Adverse Event|1|||
149127867|NCT00171704|537949074|FG000|Overall Study|Adverse Event|24|||
149127868|NCT00171704|537949075|FG001|Overall Study|Adverse Event|33|||
149127869|NCT00171704|537949074|FG000|Overall Study|Disease Progression|14|||
149127870|NCT00171704|537949075|FG001|Overall Study|Disease Progression|9|||
149127871|NCT00171704|537949074|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
149127872|NCT00171704|537949075|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
149127873|NCT00171704|537949074|FG000|Overall Study|Administrative Problems|2|||
149127874|NCT00171704|537949075|FG001|Overall Study|Administrative Problems|1|||
149127875|NCT00171704|537949074|FG000|Overall Study|Death|2|||
149127876|NCT00171704|537949075|FG001|Overall Study|Death|2|||
149127877|NCT00171704|537949074|FG000|Overall Study|Withdrawal by Subject|1|||
149127878|NCT00171704|537949075|FG001|Overall Study|Withdrawal by Subject|3|||
149127879|NCT00171704|537949074|FG000|Overall Study|Protocol Violation|0|||
149127880|NCT00171704|537949075|FG001|Overall Study|Protocol Violation|1|||
149127881|NCT03938545|537949078|FG000|Overall Study|Lost to Follow-up|0|||
149127882|NCT03938545|537949079|FG001|Overall Study|Lost to Follow-up|0|||
149127883|NCT03938545|537949080|FG002|Overall Study|Lost to Follow-up|0|||
149127884|NCT03938545|537949081|FG003|Overall Study|Lost to Follow-up|1|||
149127885|NCT03938545|537949078|FG000|Overall Study|Non-compliance with study drug|0|||
149127886|NCT03938545|537949079|FG001|Overall Study|Non-compliance with study drug|0|||
149127887|NCT03938545|537949080|FG002|Overall Study|Non-compliance with study drug|1|||
149127888|NCT03938545|537949081|FG003|Overall Study|Non-compliance with study drug|0|||
149127889|NCT03938545|537949078|FG000|Overall Study|Pregnancy|1|||
149127890|NCT03938545|537949079|FG001|Overall Study|Pregnancy|0|||
149127891|NCT03938545|537949080|FG002|Overall Study|Pregnancy|0|||
149127892|NCT03938545|537949081|FG003|Overall Study|Pregnancy|0|||
149127893|NCT03938545|537949078|FG000|Overall Study|Study terminated by sponsor|6|||
149127894|NCT03938545|537949079|FG001|Overall Study|Study terminated by sponsor|4|||
149127895|NCT03938545|537949080|FG002|Overall Study|Study terminated by sponsor|2|||
149127896|NCT03938545|537949081|FG003|Overall Study|Study terminated by sponsor|4|||
149127897|NCT03938545|537949078|FG000|Overall Study|Withdrawal by Subject|0|||
149127898|NCT03938545|537949079|FG001|Overall Study|Withdrawal by Subject|1|||
149127899|NCT03938545|537949080|FG002|Overall Study|Withdrawal by Subject|0|||
149127900|NCT03938545|537949081|FG003|Overall Study|Withdrawal by Subject|0|||
149127901|NCT03938545|537949078|FG000|Overall Study|Adverse Event|1|||
149127902|NCT03938545|537949079|FG001|Overall Study|Adverse Event|0|||
149127903|NCT03938545|537949080|FG002|Overall Study|Adverse Event|0|||
149127904|NCT03938545|537949081|FG003|Overall Study|Adverse Event|0|||
149127905|NCT01060540|537949082|FG000|Overall Study|Withdrawal by Subject|10|||
149127906|NCT01060540|537949083|FG001|Overall Study|Withdrawal by Subject|20|||
149127907|NCT01060540|537949082|FG000|Overall Study|Lost to Follow-up|52|||
149127908|NCT01060540|537949083|FG001|Overall Study|Lost to Follow-up|43|||
149127909|NCT01060540|537949082|FG000|Overall Study|Death|2|||
149127910|NCT01060540|537949083|FG001|Overall Study|Death|1|||
149127911|NCT01060540|537949082|FG000|Overall Study|Physician Decision|0|||
149127912|NCT01060540|537949083|FG001|Overall Study|Physician Decision|1|||
149127913|NCT01222507|537949087|FG000|Overall Study|Physician Decision|1|||
149127914|NCT01222507|537949087|FG000|Overall Study|Withdrawal by Subject|1|||
149127915|NCT02647320|537949088|FG000|Overall Study|Adverse Event|0|||
149127916|NCT02647320|537949089|FG001|Overall Study|Adverse Event|1|||
148786507|NCT00603382|536696180|FG005|Overall Study|Lack of Efficacy|11|||
149127917|NCT02647320|537949090|FG002|Overall Study|Adverse Event|3|||
149127918|NCT02647320|537949091|FG003|Overall Study|Adverse Event|2|||
149127919|NCT02647320|537949092|FG004|Overall Study|Adverse Event|1|||
149127920|NCT02647320|537949088|FG000|Overall Study|Protocol Violation|0|||
149127921|NCT02647320|537949089|FG001|Overall Study|Protocol Violation|0|||
149127922|NCT02647320|537949090|FG002|Overall Study|Protocol Violation|3|||
149127923|NCT02647320|537949091|FG003|Overall Study|Protocol Violation|0|||
149127924|NCT02647320|537949092|FG004|Overall Study|Protocol Violation|0|||
149127925|NCT02647320|537949088|FG000|Overall Study|Withdrawal by Subject|7|||
149127926|NCT02647320|537949089|FG001|Overall Study|Withdrawal by Subject|4|||
149127927|NCT02647320|537949090|FG002|Overall Study|Withdrawal by Subject|2|||
149127928|NCT02647320|537949091|FG003|Overall Study|Withdrawal by Subject|2|||
149127929|NCT02647320|537949092|FG004|Overall Study|Withdrawal by Subject|7|||
149127930|NCT02647320|537949088|FG000|Overall Study|Persistent hyperglycemia|0|||
149127931|NCT02647320|537949089|FG001|Overall Study|Persistent hyperglycemia|1|||
149127932|NCT02647320|537949090|FG002|Overall Study|Persistent hyperglycemia|1|||
149127933|NCT02647320|537949091|FG003|Overall Study|Persistent hyperglycemia|1|||
149127934|NCT02647320|537949092|FG004|Overall Study|Persistent hyperglycemia|1|||
149127935|NCT02647320|537949088|FG000|Overall Study|Study terminated by sponsor|1|||
149127936|NCT02647320|537949089|FG001|Overall Study|Study terminated by sponsor|1|||
149127937|NCT02647320|537949090|FG002|Overall Study|Study terminated by sponsor|1|||
149127938|NCT02647320|537949091|FG003|Overall Study|Study terminated by sponsor|1|||
149127939|NCT02647320|537949092|FG004|Overall Study|Study terminated by sponsor|2|||
149127940|NCT02647320|537949088|FG000|Overall Study|Reason not provided|0|||
149127941|NCT02647320|537949089|FG001|Overall Study|Reason not provided|0|||
149127942|NCT02647320|537949090|FG002|Overall Study|Reason not provided|1|||
149127943|NCT02647320|537949091|FG003|Overall Study|Reason not provided|0|||
149127944|NCT02647320|537949092|FG004|Overall Study|Reason not provided|2|||
149127945|NCT02647320|537949088|FG000|Overall Study|Lost to Follow-up|1|||
149127946|NCT02647320|537949089|FG001|Overall Study|Lost to Follow-up|1|||
149127947|NCT02647320|537949090|FG002|Overall Study|Lost to Follow-up|0|||
149127948|NCT02647320|537949091|FG003|Overall Study|Lost to Follow-up|0|||
149127949|NCT02647320|537949092|FG004|Overall Study|Lost to Follow-up|0|||
149127950|NCT02647320|537949088|FG000|Overall Study|Develop anemia|1|||
149127951|NCT02647320|537949089|FG001|Overall Study|Develop anemia|0|||
149127952|NCT02647320|537949090|FG002|Overall Study|Develop anemia|0|||
149127953|NCT02647320|537949091|FG003|Overall Study|Develop anemia|0|||
149127954|NCT02647320|537949092|FG004|Overall Study|Develop anemia|0|||
149127955|NCT02647320|537949088|FG000|Overall Study|Lack of Efficacy|0|||
149127956|NCT02647320|537949089|FG001|Overall Study|Lack of Efficacy|0|||
149127957|NCT02647320|537949090|FG002|Overall Study|Lack of Efficacy|0|||
149127958|NCT02647320|537949091|FG003|Overall Study|Lack of Efficacy|1|||
149127959|NCT02647320|537949092|FG004|Overall Study|Lack of Efficacy|0|||
149127960|NCT02647320|537949088|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
149127961|NCT02647320|537949089|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
149127962|NCT02647320|537949090|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
149127963|NCT02647320|537949091|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
149127964|NCT02647320|537949092|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
149127965|NCT00596427|537949093|FG000|Overall Study|Withdrawal by Subject|2|||
149127966|NCT00596427|537949094|FG001|Overall Study|Withdrawal by Subject|2|||
149127967|NCT00596427|537949093|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
149127968|NCT00596427|537949094|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
149127969|NCT00596427|537949093|FG000|Overall Study|Protocol Violation|1|||
149127970|NCT00596427|537949094|FG001|Overall Study|Protocol Violation|0|||
149127971|NCT00320541|537949095|FG000|Overall Study|Adverse Event|21|||
149127972|NCT00320541|537949096|FG001|Overall Study|Adverse Event|19|||
149127973|NCT00320541|537949095|FG000|Overall Study|Protocol Violation|0|||
149127974|NCT00320541|537949096|FG001|Overall Study|Protocol Violation|1|||
149127975|NCT00320541|537949095|FG000|Overall Study|Withdrawal by Subject|12|||
149127976|NCT00320541|537949096|FG001|Overall Study|Withdrawal by Subject|16|||
149127977|NCT00320541|537949095|FG000|Overall Study|Physician Decision|9|||
149127978|NCT00320541|537949096|FG001|Overall Study|Physician Decision|13|||
149127979|NCT00320541|537949095|FG000|Overall Study|Other|3|||
149127980|NCT00320541|537949096|FG001|Overall Study|Other|4|||
149127981|NCT00320541|537949095|FG000|Overall Study|Sponsor Decision|2|||
149127982|NCT00320541|537949096|FG001|Overall Study|Sponsor Decision|1|||
149127983|NCT00320541|537949095|FG000|Overall Study|Death due to Study Disease|1|||
149127984|NCT00320541|537949096|FG001|Overall Study|Death due to Study Disease|3|||
149127985|NCT00320541|537949095|FG000|Overall Study|Death due to Adverse Event(s)|1|||
149127986|NCT00320541|537949096|FG001|Overall Study|Death due to Adverse Event(s)|0|||
149127987|NCT00320541|537949095|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
149127988|NCT00320541|537949096|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
149127989|NCT01650246|537949101|FG000|Overall Study|Adverse Event|23|||
149127990|NCT01650246|537949101|FG000|Overall Study|Protocol Violation|5|||
149127991|NCT01650246|537949101|FG000|Overall Study|Sponsor terminated study|53|||
149127992|NCT01650246|537949101|FG000|Overall Study|Lost to Follow-up|5|||
149127993|NCT01650246|537949101|FG000|Overall Study|Withdrawal by Subject|26|||
149127994|NCT01650246|537949101|FG000|Overall Study|Death|1|||
149127995|NCT01650246|537949101|FG000|Overall Study|Lack of Efficacy|30|||
149127996|NCT00081770|537949102|FG000|Overall Study|Adverse Event|130|||
149127997|NCT00081770|537949103|FG001|Overall Study|Adverse Event|98|||
149127998|NCT00081770|537949104|FG002|Overall Study|Adverse Event|136|||
149127999|NCT00081770|537949102|FG000|Overall Study|Lack of Efficacy|262|||
149128000|NCT00081770|537949103|FG001|Overall Study|Lack of Efficacy|357|||
149128001|NCT00081770|537949104|FG002|Overall Study|Lack of Efficacy|211|||
149128002|NCT00081770|537949102|FG000|Overall Study|Lost to Follow-up|45|||
149128003|NCT00081770|537949103|FG001|Overall Study|Lost to Follow-up|34|||
149128004|NCT00081770|537949104|FG002|Overall Study|Lost to Follow-up|45|||
149128005|NCT00081770|537949102|FG000|Overall Study|Protocol Violation|15|||
149128006|NCT00081770|537949103|FG001|Overall Study|Protocol Violation|10|||
149128007|NCT00081770|537949104|FG002|Overall Study|Protocol Violation|10|||
149128008|NCT00081770|537949102|FG000|Overall Study|Withdrawal by Subject|45|||
149128009|NCT00081770|537949103|FG001|Overall Study|Withdrawal by Subject|40|||
149128010|NCT00081770|537949104|FG002|Overall Study|Withdrawal by Subject|42|||
149128011|NCT00081770|537949102|FG000|Overall Study|Did not meet protocol eligibility|2|||
149128012|NCT00081770|537949103|FG001|Overall Study|Did not meet protocol eligibility|0|||
149128013|NCT00081770|537949104|FG002|Overall Study|Did not meet protocol eligibility|3|||
149128014|NCT00081770|537949102|FG000|Overall Study|Administrative|1|||
149128015|NCT00081770|537949103|FG001|Overall Study|Administrative|0|||
149128016|NCT00081770|537949104|FG002|Overall Study|Administrative|1|||
149128017|NCT00081770|537949102|FG000|Overall Study|Other|2|||
149128018|NCT00081770|537949103|FG001|Overall Study|Other|7|||
149128019|NCT00081770|537949104|FG002|Overall Study|Other|8|||
149128020|NCT03435497|537949106|FG000|Overall Study|Lost to Follow-up|1|||
149128021|NCT03435497|537949107|FG001|Overall Study|Lost to Follow-up|0|||
149128022|NCT03435497|537949106|FG000|Overall Study|Death|1|||
149128023|NCT03435497|537949107|FG001|Overall Study|Death|0|||
149128024|NCT03435497|537949106|FG000|Overall Study|Withdrawal by Subject|0|||
149128025|NCT03435497|537949107|FG001|Overall Study|Withdrawal by Subject|4|||
149128026|NCT03435497|537949106|FG000|Overall Study|Wrong survey administered|0|||
149128027|NCT03435497|537949107|FG001|Overall Study|Wrong survey administered|2|||
149128028|NCT04281004|537949108|FG000|Overall Study|Physician Decision|1|||
149128029|NCT04281004|537949109|FG001|Overall Study|Physician Decision|0|||
149128030|NCT00701779|537949110|FG000|Overall Study|Adverse Event|6|||
149128031|NCT00701779|537949110|FG000|Overall Study|Lost to Follow-up|1|||
149128032|NCT00701779|537949110|FG000|Overall Study|Withdrawal by Subject|2|||
149128033|NCT00876694|537949115|FG000|Overall Study|Adverse Event|10|||
149128034|NCT00876694|537949116|FG001|Overall Study|Adverse Event|7|||
149128035|NCT00876694|537949115|FG000|Overall Study|Subject withdrew consent|6|||
149128036|NCT00876694|537949116|FG001|Overall Study|Subject withdrew consent|4|||
149128037|NCT00876694|537949115|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149128038|NCT00876694|537949116|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149128039|NCT00876694|537949115|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149128040|NCT00876694|537949116|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149128041|NCT00876694|537949115|FG000|Overall Study|Administrative problems|1|||
149128042|NCT00876694|537949116|FG001|Overall Study|Administrative problems|1|||
149128043|NCT00876694|537949115|FG000|Overall Study|Death|1|||
149128044|NCT00876694|537949116|FG001|Overall Study|Death|0|||
149128045|NCT00288509|537949117|FG000|Treatment Cycle 1|Adverse Event|1|||
149128046|NCT00288509|537949117|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
149128047|NCT00288509|537949117|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
149128048|NCT00288509|537949117|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
149128049|NCT00288509|537949117|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
149128050|NCT00288509|537949117|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
149128051|NCT00288509|537949117|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
149128052|NCT00288509|537949117|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
149128053|NCT00288509|537949117|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
149128054|NCT00288509|537949117|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
149128055|NCT00288509|537949117|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
149128056|NCT00288509|537949117|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
149128057|NCT00288509|537949117|FG000|Treatment Cycle 4|Physician Decision|4|||
149128058|NCT00288509|537949117|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
149128059|NCT02382016|537949118|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
149128060|NCT02382016|537949119|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
149128061|NCT02382016|537949118|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
149128062|NCT02382016|537949119|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
149128063|NCT02382016|537949118|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
149128064|NCT02382016|537949119|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
149128065|NCT02382016|537949118|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
149128066|NCT02382016|537949119|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
149128067|NCT02382016|537949118|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
149128068|NCT02382016|537949119|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
149128069|NCT02382016|537949118|FG000|Open-label (OL) Treatment Period|Death|4|||
149128070|NCT02382016|537949119|FG001|Open-label (OL) Treatment Period|Death|0|||
148786508|NCT00603382|536696175|FG000|Overall Study|Protocol Violation|1|||
148786509|NCT00603382|536696176|FG001|Overall Study|Protocol Violation|0|||
149128071|NCT02382016|537949118|FG000|OL Extension Period|Physician Decision|3|||
149128072|NCT02382016|537949119|FG001|OL Extension Period|Physician Decision|0|||
149128073|NCT02382016|537949118|FG000|OL Extension Period|Death|2|||
149128074|NCT02382016|537949119|FG001|OL Extension Period|Death|0|||
148786510|NCT00603382|536696177|FG002|Overall Study|Protocol Violation|1|||
149128075|NCT02382016|537949118|FG000|OL Extension Period|Withdrawal by Subject|1|||
149128076|NCT02382016|537949119|FG001|OL Extension Period|Withdrawal by Subject|0|||
149128077|NCT00084266|537949120|FG000|Overall Study|Death|42|||
149128078|NCT00084266|537949121|FG001|Overall Study|Death|39|||
149128079|NCT00084266|537949120|FG000|Overall Study|Adverse Event|8|||
149128080|NCT00084266|537949121|FG001|Overall Study|Adverse Event|5|||
149128081|NCT00084266|537949120|FG000|Overall Study|Lack of Efficacy|2|||
149128082|NCT00084266|537949121|FG001|Overall Study|Lack of Efficacy|4|||
149128083|NCT00084266|537949120|FG000|Overall Study|Lost to Follow-up|5|||
149128084|NCT00084266|537949121|FG001|Overall Study|Lost to Follow-up|3|||
149128085|NCT00084266|537949120|FG000|Overall Study|Participant not willing to participate|3|||
149128086|NCT00084266|537949121|FG001|Overall Study|Participant not willing to participate|8|||
149128087|NCT00084266|537949120|FG000|Overall Study|Other|360|||
149128088|NCT00084266|537949121|FG001|Overall Study|Other|344|||
149128089|NCT00084266|537949120|FG000|Overall Study|Randomized not treated|21|||
149128090|NCT00084266|537949121|FG001|Overall Study|Randomized not treated|20|||
149128091|NCT00730171|537949126|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
149128092|NCT00730171|537949126|FG000|Overall Study|Adverse Event|193|||
149128093|NCT00730171|537949126|FG000|Overall Study|Protocol Violation|48|||
149128094|NCT00730171|537949126|FG000|Overall Study|Withdrawal by Subject|202|||
149128095|NCT00730171|537949126|FG000|Overall Study|Lost to Follow-up|121|||
149128096|NCT00730171|537949126|FG000|Overall Study|Insufficient Therapeutic Response|141|||
149128097|NCT00730171|537949126|FG000|Overall Study|Other|61|||
149128098|NCT01386788|537949129|FG000|Overall Study|Lost to Follow-up|2|||
149128099|NCT00120406|537949132|FG000|Overall Study|Death|9|||
149128100|NCT00120406|537949133|FG001|Overall Study|Death|4|||
149128101|NCT00120406|537949132|FG000|Overall Study|Withdrawal by Subject|5|||
149128102|NCT00120406|537949133|FG001|Overall Study|Withdrawal by Subject|7|||
149128103|NCT00120406|537949132|FG000|Overall Study|Lost to Follow-up|5|||
149128104|NCT00120406|537949133|FG001|Overall Study|Lost to Follow-up|2|||
149128105|NCT00120406|537949132|FG000|Overall Study|received non-study stent|0|||
149128106|NCT00120406|537949133|FG001|Overall Study|received non-study stent|2|||
148786511|NCT00603382|536696178|FG003|Overall Study|Protocol Violation|2|||
148786512|NCT00603382|536696179|FG004|Overall Study|Protocol Violation|1|||
148786513|NCT00603382|536696180|FG005|Overall Study|Protocol Violation|0|||
148786514|NCT00603382|536696175|FG000|Overall Study|Lost to Follow-up|0|||
148786515|NCT00603382|536696176|FG001|Overall Study|Lost to Follow-up|1|||
148786516|NCT00603382|536696177|FG002|Overall Study|Lost to Follow-up|1|||
148786517|NCT00603382|536696178|FG003|Overall Study|Lost to Follow-up|1|||
148786518|NCT00603382|536696179|FG004|Overall Study|Lost to Follow-up|0|||
148786519|NCT00603382|536696180|FG005|Overall Study|Lost to Follow-up|1|||
148786520|NCT00603382|536696175|FG000|Overall Study|Physician Decision|0|||
148786521|NCT00603382|536696176|FG001|Overall Study|Physician Decision|0|||
148786522|NCT00603382|536696177|FG002|Overall Study|Physician Decision|2|||
148786523|NCT00603382|536696178|FG003|Overall Study|Physician Decision|0|||
148786524|NCT00603382|536696179|FG004|Overall Study|Physician Decision|1|||
148786525|NCT00603382|536696180|FG005|Overall Study|Physician Decision|3|||
148786526|NCT00603382|536696175|FG000|Overall Study|Withdrawal by Subject|3|||
148786527|NCT00603382|536696176|FG001|Overall Study|Withdrawal by Subject|3|||
148786528|NCT00603382|536696177|FG002|Overall Study|Withdrawal by Subject|1|||
148786529|NCT00603382|536696178|FG003|Overall Study|Withdrawal by Subject|1|||
148786530|NCT00603382|536696179|FG004|Overall Study|Withdrawal by Subject|0|||
148786531|NCT00603382|536696180|FG005|Overall Study|Withdrawal by Subject|1|||
148786532|NCT00583102|536696181|FG000|Overall Study|Adverse Event|3|||
148786533|NCT01180049|536696186|FG000|Overall Study|Other|9|||
148786534|NCT01180049|536696187|FG001|Overall Study|Other|7|||
148786535|NCT01180049|536696186|FG000|Overall Study|Lost to Follow-up|8|||
148786536|NCT01180049|536696187|FG001|Overall Study|Lost to Follow-up|6|||
148786537|NCT01180049|536696186|FG000|Overall Study|Death|36|||
148786538|NCT01180049|536696187|FG001|Overall Study|Death|35|||
148786539|NCT01738191|536696188|FG000|Overall Study|Withdrawal by Subject|4|||
148786540|NCT01738191|536696189|FG001|Overall Study|Withdrawal by Subject|1|||
148786541|NCT02483572|536696190|FG000|Overall Study|Withdrawal by Subject|1|||
148786542|NCT02483572|536696191|FG001|Overall Study|Withdrawal by Subject|0|||
148786543|NCT02483572|536696190|FG000|Overall Study|Lost to Follow-up|1|||
148786544|NCT02483572|536696191|FG001|Overall Study|Lost to Follow-up|0|||
148786545|NCT02483572|536696190|FG000|Overall Study|Physician Decision|0|||
148786546|NCT02483572|536696191|FG001|Overall Study|Physician Decision|1|||
149128107|NCT00120406|537949132|FG000|Overall Study|patient moved but has not withdrawn|0|||
148786547|NCT00350779|536696192|FG000|Overall Study|Adverse Event|4|||
148786548|NCT00350779|536696193|FG001|Overall Study|Adverse Event|2|||
148786549|NCT00350779|536696192|FG000|Overall Study|Lack of Efficacy|0|||
148786550|NCT00350779|536696193|FG001|Overall Study|Lack of Efficacy|4|||
148786551|NCT00350779|536696192|FG000|Overall Study|Lost to Follow-up|2|||
148786552|NCT00350779|536696193|FG001|Overall Study|Lost to Follow-up|0|||
148786553|NCT00350779|536696192|FG000|Overall Study|Physician Decision|2|||
148786554|NCT00350779|536696193|FG001|Overall Study|Physician Decision|4|||
148786555|NCT00350779|536696192|FG000|Overall Study|Protocol Violation|3|||
148786556|NCT00350779|536696193|FG001|Overall Study|Protocol Violation|1|||
149128108|NCT00120406|537949133|FG001|Overall Study|patient moved but has not withdrawn|1|||
149128109|NCT00762970|537949134|FG000|Overall Study|Withdrawal by Subject|7|||
149128110|NCT00762970|537949135|FG001|Overall Study|Withdrawal by Subject|4|||
149128111|NCT00762970|537949136|FG002|Overall Study|Withdrawal by Subject|0|||
149128112|NCT00762970|537949134|FG000|Overall Study|Protocol Violation|3|||
149128113|NCT00762970|537949135|FG001|Overall Study|Protocol Violation|1|||
149128114|NCT00762970|537949136|FG002|Overall Study|Protocol Violation|1|||
149128115|NCT00762970|537949134|FG000|Overall Study|Lost to Follow-up|1|||
149128116|NCT00762970|537949135|FG001|Overall Study|Lost to Follow-up|2|||
149128117|NCT00762970|537949136|FG002|Overall Study|Lost to Follow-up|0|||
149128118|NCT00762970|537949134|FG000|Overall Study|Difficulty of handling lens|1|||
149128119|NCT00762970|537949135|FG001|Overall Study|Difficulty of handling lens|2|||
149128120|NCT00762970|537949136|FG002|Overall Study|Difficulty of handling lens|0|||
149128121|NCT00879762|537949137|FG000|Overall Study|Lost to Follow-up|3|||
149128122|NCT00879762|537949138|FG001|Overall Study|Lost to Follow-up|1|||
149128123|NCT01313637|537949141|FG000|Overall Study|Adverse Event|17|||
149128124|NCT01313637|537949142|FG001|Overall Study|Adverse Event|24|||
149128125|NCT01313637|537949143|FG002|Overall Study|Adverse Event|25|||
149128126|NCT01313637|537949144|FG003|Overall Study|Adverse Event|18|||
149128127|NCT01313637|537949141|FG000|Overall Study|Lack of Efficacy|44|||
149128128|NCT01313637|537949142|FG001|Overall Study|Lack of Efficacy|38|||
149128129|NCT01313637|537949143|FG002|Overall Study|Lack of Efficacy|37|||
149128130|NCT01313637|537949144|FG003|Overall Study|Lack of Efficacy|24|||
149128131|NCT01313637|537949141|FG000|Overall Study|Protocol Violation|4|||
149128132|NCT01313637|537949142|FG001|Overall Study|Protocol Violation|3|||
149128133|NCT01313637|537949143|FG002|Overall Study|Protocol Violation|11|||
149128134|NCT01313637|537949144|FG003|Overall Study|Protocol Violation|5|||
149128135|NCT01313637|537949141|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
149128136|NCT01313637|537949142|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
149128137|NCT01313637|537949143|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
149128138|NCT01313637|537949144|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
149128139|NCT01313637|537949141|FG000|Overall Study|Lost to Follow-up|0|||
149128140|NCT01313637|537949142|FG001|Overall Study|Lost to Follow-up|2|||
149128141|NCT01313637|537949143|FG002|Overall Study|Lost to Follow-up|1|||
149128142|NCT01313637|537949144|FG003|Overall Study|Lost to Follow-up|3|||
149128143|NCT01313637|537949141|FG000|Overall Study|Withdrawal by Subject|11|||
149128144|NCT01313637|537949142|FG001|Overall Study|Withdrawal by Subject|13|||
149128145|NCT01313637|537949143|FG002|Overall Study|Withdrawal by Subject|18|||
149128146|NCT01313637|537949144|FG003|Overall Study|Withdrawal by Subject|15|||
149128147|NCT05580588|537949152|FG000|Overall Study|Lack of Efficacy|12|||
149128148|NCT00211185|537949155|FG000|Overall Study|Death|2|||
149128149|NCT00211185|537949155|FG000|Overall Study|Disease progression|7|||
149128150|NCT00211185|537949155|FG000|Overall Study|Withdrawal by Subject|6|||
149128151|NCT00211185|537949155|FG000|Overall Study|Physician Decision|5|||
149128152|NCT00986674|537949156|FG000|Overall Study|Lack of Efficacy|28|||
149128153|NCT00986674|537949157|FG001|Overall Study|Lack of Efficacy|25|||
149128154|NCT00986674|537949158|FG002|Overall Study|Lack of Efficacy|23|||
149128155|NCT00986674|537949156|FG000|Overall Study|Adverse Event|4|||
149128156|NCT00986674|537949157|FG001|Overall Study|Adverse Event|8|||
149128157|NCT00986674|537949158|FG002|Overall Study|Adverse Event|9|||
149128158|NCT00986674|537949156|FG000|Overall Study|Death|5|||
149128159|NCT00986674|537949157|FG001|Overall Study|Death|0|||
149128160|NCT00986674|537949158|FG002|Overall Study|Death|4|||
149128161|NCT00986674|537949156|FG000|Overall Study|Withdrawal by Subject|6|||
149128162|NCT00986674|537949157|FG001|Overall Study|Withdrawal by Subject|2|||
149128163|NCT00986674|537949158|FG002|Overall Study|Withdrawal by Subject|1|||
149128164|NCT00986674|537949156|FG000|Overall Study|alternative therapy|0|||
149128165|NCT00986674|537949157|FG001|Overall Study|alternative therapy|0|||
149128166|NCT00986674|537949158|FG002|Overall Study|alternative therapy|1|||
149128167|NCT00986674|537949156|FG000|Overall Study|not start protocol therapy|4|||
149128168|NCT00986674|537949157|FG001|Overall Study|not start protocol therapy|3|||
149128169|NCT00986674|537949158|FG002|Overall Study|not start protocol therapy|1|||
149128170|NCT00986674|537949156|FG000|Overall Study|unknown/not specify|0|||
149128171|NCT00986674|537949157|FG001|Overall Study|unknown/not specify|7|||
148786557|NCT00350779|536696192|FG000|Overall Study|Withdrawal by Subject|9|||
148786558|NCT00350779|536696193|FG001|Overall Study|Withdrawal by Subject|8|||
148786559|NCT00350779|536696192|FG000|Overall Study|Patient Moved|2|||
148786560|NCT00350779|536696193|FG001|Overall Study|Patient Moved|1|||
148786561|NCT00350779|536696192|FG000|Overall Study|Non-compliance with study procedures|0|||
148786562|NCT00350779|536696193|FG001|Overall Study|Non-compliance with study procedures|1|||
149128172|NCT00986674|537949158|FG002|Overall Study|unknown/not specify|9|||
149128173|NCT00842985|537949161|FG000|Screening|Did not meet entrance requirements|27|||
149128174|NCT00842985|537949161|FG000|First Intervention|Withdrawal by Subject|3|||
149128175|NCT00842985|537949161|FG000|First Intervention|Protocol Violation|3|||
149128176|NCT00842985|537949161|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
149128177|NCT00842985|537949161|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
149128178|NCT01037244|537949162|FG000|Overall Study|Adverse Event|3|||
148786563|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
149128179|NCT01037244|537949163|FG001|Overall Study|Adverse Event|2|||
149128180|NCT01037244|537949164|FG002|Overall Study|Adverse Event|6|||
149128181|NCT01037244|537949165|FG003|Overall Study|Adverse Event|3|||
149128182|NCT01037244|537949162|FG000|Overall Study|Lack of Efficacy|1|||
149128183|NCT01037244|537949163|FG001|Overall Study|Lack of Efficacy|1|||
149128184|NCT01037244|537949164|FG002|Overall Study|Lack of Efficacy|0|||
149128185|NCT01037244|537949165|FG003|Overall Study|Lack of Efficacy|1|||
149128186|NCT01037244|537949162|FG000|Overall Study|Lost to Follow-up|3|||
149128187|NCT01037244|537949163|FG001|Overall Study|Lost to Follow-up|3|||
149128188|NCT01037244|537949164|FG002|Overall Study|Lost to Follow-up|4|||
149128189|NCT01037244|537949165|FG003|Overall Study|Lost to Follow-up|4|||
149128190|NCT01037244|537949162|FG000|Overall Study|Withdrawal by Subject|1|||
149128191|NCT01037244|537949163|FG001|Overall Study|Withdrawal by Subject|5|||
149128192|NCT01037244|537949164|FG002|Overall Study|Withdrawal by Subject|3|||
149128193|NCT01037244|537949165|FG003|Overall Study|Withdrawal by Subject|5|||
149128194|NCT01037244|537949162|FG000|Overall Study|Partner Withdrew Consent|2|||
149128195|NCT01037244|537949163|FG001|Overall Study|Partner Withdrew Consent|1|||
149128196|NCT01037244|537949164|FG002|Overall Study|Partner Withdrew Consent|0|||
149128197|NCT01037244|537949165|FG003|Overall Study|Partner Withdrew Consent|0|||
149128198|NCT01037244|537949162|FG000|Overall Study|Various|3|||
149128199|NCT01037244|537949163|FG001|Overall Study|Various|2|||
149128200|NCT01037244|537949164|FG002|Overall Study|Various|1|||
149128201|NCT01037244|537949165|FG003|Overall Study|Various|1|||
149128202|NCT04507126|537949166|FG000|Overall Study|Withdrawal by Subject|1|||
149128203|NCT04507126|537949166|FG000|Overall Study|Protocol Violation|2|||
149128204|NCT04507126|537949166|FG000|Overall Study|Physician Decision|1|||
149128205|NCT02294227|537949170|FG000|Overall Study|Death|0|||
149128206|NCT02294227|537949171|FG001|Overall Study|Death|0|||
149128207|NCT02294227|537949172|FG002|Overall Study|Death|1|||
149128208|NCT02294227|537949170|FG000|Overall Study|Subject/Guardian Decision|6|||
149128209|NCT02294227|537949171|FG001|Overall Study|Subject/Guardian Decision|3|||
149128210|NCT02294227|537949172|FG002|Overall Study|Subject/Guardian Decision|7|||
149128211|NCT02294227|537949170|FG000|Overall Study|Physician Decision|1|||
149128212|NCT02294227|537949171|FG001|Overall Study|Physician Decision|2|||
149128213|NCT02294227|537949172|FG002|Overall Study|Physician Decision|1|||
149128214|NCT02294227|537949170|FG000|Overall Study|Lost to Follow-up|1|||
149128215|NCT02294227|537949171|FG001|Overall Study|Lost to Follow-up|0|||
149128216|NCT02294227|537949172|FG002|Overall Study|Lost to Follow-up|0|||
149128217|NCT02294227|537949170|FG000|Overall Study|Lack of Efficacy|11|||
149128218|NCT02294227|537949171|FG001|Overall Study|Lack of Efficacy|12|||
149128219|NCT02294227|537949172|FG002|Overall Study|Lack of Efficacy|8|||
149128220|NCT02294227|537949170|FG000|Overall Study|Adverse Event|6|||
149128221|NCT02294227|537949171|FG001|Overall Study|Adverse Event|8|||
149128222|NCT02294227|537949172|FG002|Overall Study|Adverse Event|2|||
149128223|NCT00551460|537949173|FG000|Overall Study|Adverse Event|1|||
149128224|NCT00551460|537949173|FG000|Overall Study|Withdrawal by Subject|1|||
149128225|NCT00551460|537949173|FG000|Overall Study|Physician Decision|1|||
149128226|NCT00551460|537949173|FG000|Overall Study|Death|7|||
149128227|NCT00551460|537949173|FG000|Overall Study|Ineligible|4|||
149128228|NCT00551460|537949173|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
149128229|NCT01580969|537949174|FG000|Overall Study|Physician Decision|3|||
149128230|NCT01580969|537949175|FG001|Overall Study|Physician Decision|0|||
149128231|NCT01580969|537949176|FG002|Overall Study|Physician Decision|0|||
149128232|NCT01745848|537949177|FG000|Overall Study|Adverse Event|6|||
149128233|NCT02027623|537949179|FG000|Overall Study|Lost to Follow-up|3|||
149128234|NCT02027623|537949180|FG001|Overall Study|Lost to Follow-up|3|||
149128235|NCT02027623|537949179|FG000|Overall Study|Withdrawal by Subject|6|||
149128236|NCT02027623|537949180|FG001|Overall Study|Withdrawal by Subject|9|||
149128237|NCT01886378|537949183|FG000|Overall Study|Adverse Event|1|||
149128238|NCT01886378|537949183|FG000|Overall Study|Withdrawal by Subject|4|||
149128239|NCT00505284|537949193|FG000|Overall Study|Adverse Event|3|||
149128240|NCT00505284|537949194|FG001|Overall Study|Adverse Event|7|||
149128241|NCT00505284|537949195|FG002|Overall Study|Adverse Event|9|||
149128242|NCT00505284|537949196|FG003|Overall Study|Adverse Event|14|||
149128243|NCT00505284|537949197|FG004|Overall Study|Adverse Event|22|||
149128244|NCT00505284|537949193|FG000|Overall Study|Protocol Violation|0|||
149128245|NCT00505284|537949194|FG001|Overall Study|Protocol Violation|1|||
149128246|NCT00505284|537949195|FG002|Overall Study|Protocol Violation|1|||
149128247|NCT00505284|537949196|FG003|Overall Study|Protocol Violation|0|||
149128248|NCT00505284|537949197|FG004|Overall Study|Protocol Violation|0|||
149128249|NCT00505284|537949193|FG000|Overall Study|Withdrawal by Subject|2|||
149128250|NCT00505284|537949194|FG001|Overall Study|Withdrawal by Subject|6|||
149128251|NCT00505284|537949195|FG002|Overall Study|Withdrawal by Subject|1|||
149128252|NCT00505284|537949196|FG003|Overall Study|Withdrawal by Subject|0|||
149128253|NCT00505284|537949197|FG004|Overall Study|Withdrawal by Subject|6|||
149128254|NCT00505284|537949193|FG000|Overall Study|Lack of Efficacy|0|||
149128255|NCT00505284|537949194|FG001|Overall Study|Lack of Efficacy|1|||
149128256|NCT00505284|537949195|FG002|Overall Study|Lack of Efficacy|1|||
149128257|NCT00505284|537949196|FG003|Overall Study|Lack of Efficacy|1|||
149128258|NCT00505284|537949197|FG004|Overall Study|Lack of Efficacy|1|||
149128259|NCT00505284|537949193|FG000|Overall Study|Physician Decision|0|||
149128260|NCT00505284|537949194|FG001|Overall Study|Physician Decision|1|||
149128261|NCT00505284|537949195|FG002|Overall Study|Physician Decision|0|||
149128262|NCT00505284|537949196|FG003|Overall Study|Physician Decision|0|||
149128263|NCT00505284|537949197|FG004|Overall Study|Physician Decision|0|||
149128264|NCT00505284|537949193|FG000|Overall Study|Other|5|||
149128265|NCT00505284|537949194|FG001|Overall Study|Other|0|||
148786564|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786565|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786566|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786567|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786568|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786569|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786570|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786571|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
148786572|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
148786573|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
148786574|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
148786575|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
148786576|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
148786577|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
148786578|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
148786579|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
148786580|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
148786581|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
148786582|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
148786583|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
148786584|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
148786585|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
148786586|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
148786587|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
148786588|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
148786589|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
148786590|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
148786591|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
149128266|NCT00505284|537949195|FG002|Overall Study|Other|0|||
149128267|NCT00505284|537949196|FG003|Overall Study|Other|4|||
149128268|NCT00505284|537949197|FG004|Overall Study|Other|4|||
149128269|NCT03513588|537949198|FG000|Overall Study|Lost to Follow-up|0|||
149128270|NCT03513588|537949199|FG001|Overall Study|Lost to Follow-up|1|||
149128271|NCT03513588|537949200|FG002|Overall Study|Lost to Follow-up|1|||
149128272|NCT03513588|537949198|FG000|Overall Study|Study dosing paused by sponsor|1|||
149128273|NCT03513588|537949199|FG001|Overall Study|Study dosing paused by sponsor|1|||
149128274|NCT03513588|537949200|FG002|Overall Study|Study dosing paused by sponsor|0|||
149128275|NCT03513588|537949198|FG000|Overall Study|Death|0|||
149128276|NCT03513588|537949199|FG001|Overall Study|Death|0|||
149128277|NCT03513588|537949200|FG002|Overall Study|Death|1|||
149128278|NCT00940108|537949201|FG000|Overall Study|Adverse Event|2|||
148786592|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
149128279|NCT00940108|537949202|FG001|Overall Study|Adverse Event|4|||
149128280|NCT00940108|537949203|FG002|Overall Study|Adverse Event|0|||
149128281|NCT00940108|537949204|FG003|Overall Study|Adverse Event|2|||
149128282|NCT00940108|537949201|FG000|Overall Study|Withdrew Consent|2|||
149128283|NCT00940108|537949202|FG001|Overall Study|Withdrew Consent|1|||
149128284|NCT00940108|537949203|FG002|Overall Study|Withdrew Consent|0|||
149128285|NCT00940108|537949204|FG003|Overall Study|Withdrew Consent|1|||
149128286|NCT00940108|537949201|FG000|Overall Study|Dose 2 contraindicated|1|||
149128287|NCT00940108|537949202|FG001|Overall Study|Dose 2 contraindicated|1|||
149128288|NCT00940108|537949203|FG002|Overall Study|Dose 2 contraindicated|0|||
149128289|NCT00940108|537949204|FG003|Overall Study|Dose 2 contraindicated|1|||
149128290|NCT00940108|537949201|FG000|Overall Study|Declined further vaccination|0|||
149128291|NCT00940108|537949202|FG001|Overall Study|Declined further vaccination|1|||
149128292|NCT00940108|537949203|FG002|Overall Study|Declined further vaccination|3|||
149128293|NCT00940108|537949204|FG003|Overall Study|Declined further vaccination|0|||
149128294|NCT00940108|537949201|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
149128295|NCT00940108|537949202|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
149128296|NCT00940108|537949203|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
149128297|NCT00940108|537949204|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
149128298|NCT00940108|537949201|FG000|Overall Study|Viral illness after Dose 1|0|||
149128299|NCT00940108|537949202|FG001|Overall Study|Viral illness after Dose 1|1|||
149128300|NCT00940108|537949203|FG002|Overall Study|Viral illness after Dose 1|0|||
149128301|NCT00940108|537949204|FG003|Overall Study|Viral illness after Dose 1|0|||
149128302|NCT00940108|537949201|FG000|Overall Study|Diagnosed with H1N1|0|||
149128303|NCT00940108|537949202|FG001|Overall Study|Diagnosed with H1N1|0|||
149128304|NCT00940108|537949203|FG002|Overall Study|Diagnosed with H1N1|0|||
149128305|NCT00940108|537949204|FG003|Overall Study|Diagnosed with H1N1|1|||
149128306|NCT01275131|537949205|FG000|Period 1|Withdrawal by Subject|1|||
149128307|NCT01275131|537949206|FG001|Period 1|Withdrawal by Subject|0|||
148786593|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
148786594|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
148786595|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
148786596|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
148786597|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
148786598|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
149128308|NCT01275131|537949207|FG002|Period 1|Withdrawal by Subject|3|||
149128309|NCT01275131|537949208|FG003|Period 1|Withdrawal by Subject|2|||
149128310|NCT01275131|537949205|FG000|Period 1|Physician Decision|1|||
149128311|NCT01275131|537949206|FG001|Period 1|Physician Decision|0|||
149128312|NCT01275131|537949207|FG002|Period 1|Physician Decision|0|||
149128313|NCT01275131|537949208|FG003|Period 1|Physician Decision|0|||
149128314|NCT01275131|537949205|FG000|Period 2 (Crossover)|Adverse Event|0|||
149128315|NCT01275131|537949206|FG001|Period 2 (Crossover)|Adverse Event|1|||
149128316|NCT01275131|537949207|FG002|Period 2 (Crossover)|Adverse Event|0|||
149128317|NCT01275131|537949208|FG003|Period 2 (Crossover)|Adverse Event|0|||
149128318|NCT01275131|537949205|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
149128319|NCT01275131|537949206|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
149128320|NCT01275131|537949207|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
149128321|NCT01275131|537949208|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
149128322|NCT01740323|537949212|FG000|Overall Study|Adverse Event|1|||
149128323|NCT01740323|537949213|FG001|Overall Study|Adverse Event|0|||
149128324|NCT01740323|537949212|FG000|Overall Study|Randomized but did not take study drug|1|||
149128325|NCT01740323|537949213|FG001|Overall Study|Randomized but did not take study drug|0|||
149128326|NCT00953745|537949220|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
149128327|NCT00953745|537949221|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
149128328|NCT00953745|537949220|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
149128329|NCT00953745|537949221|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
149128330|NCT00953745|537949220|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
149128331|NCT00953745|537949221|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
149128332|NCT00953745|537949220|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
149128333|NCT00953745|537949221|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
149128334|NCT00953745|537949220|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
149128335|NCT00953745|537949221|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
149128336|NCT00953745|537949220|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
149128337|NCT00953745|537949221|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
149128338|NCT01340196|537950896|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
149128339|NCT00816400|537950899|FG000|Overall Study|Death|2|||
149128340|NCT00816400|537950900|FG001|Overall Study|Death|3|||
149128341|NCT00816400|537950901|FG002|Overall Study|Death|3|||
149128342|NCT00816400|537950902|FG003|Overall Study|Death|3|||
149128343|NCT00816400|537950903|FG004|Overall Study|Death|2|||
149128344|NCT00816400|537950904|FG005|Overall Study|Death|3|||
149128345|NCT00816400|537950905|FG006|Overall Study|Death|2|||
149128346|NCT00816400|537950906|FG007|Overall Study|Death|5|||
149128347|NCT00816400|537950907|FG008|Overall Study|Death|6|||
149128348|NCT00816400|537950899|FG000|Overall Study|In hospice care at the end of the study|0|||
149128349|NCT00816400|537950900|FG001|Overall Study|In hospice care at the end of the study|0|||
149128350|NCT00816400|537950901|FG002|Overall Study|In hospice care at the end of the study|2|||
149128351|NCT00816400|537950902|FG003|Overall Study|In hospice care at the end of the study|0|||
149128352|NCT00816400|537950903|FG004|Overall Study|In hospice care at the end of the study|0|||
149128353|NCT00816400|537950904|FG005|Overall Study|In hospice care at the end of the study|0|||
149128354|NCT00816400|537950905|FG006|Overall Study|In hospice care at the end of the study|0|||
149128355|NCT00816400|537950906|FG007|Overall Study|In hospice care at the end of the study|0|||
149128356|NCT00816400|537950907|FG008|Overall Study|In hospice care at the end of the study|0|||
149128357|NCT01217957|537950910|FG000|Phase 1|Withdrawal by Patient|1|||
149128358|NCT01217957|537950911|FG001|Phase 1|Withdrawal by Patient|0|||
149128359|NCT01217957|537950912|FG002|Phase 1|Withdrawal by Patient|1|||
149128360|NCT01217957|537950913|FG003|Phase 1|Withdrawal by Patient|1|||
149128361|NCT01217957|537950914|FG004|Phase 1|Withdrawal by Patient|0|||
149128362|NCT01217957|537950910|FG000|Phase 2|Withdrawal by Patient|0|||
149128363|NCT01217957|537950911|FG001|Phase 2|Withdrawal by Patient|0|||
149128364|NCT01217957|537950912|FG002|Phase 2|Withdrawal by Patient|0|||
149128365|NCT01217957|537950913|FG003|Phase 2|Withdrawal by Patient|0|||
148786599|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
148786600|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
149128366|NCT01217957|537950914|FG004|Phase 2|Withdrawal by Patient|1|||
149128367|NCT00971932|537950915|FG000|Overall Study|Withdrawal by Subject|1|||
149128368|NCT00971932|537950915|FG000|Overall Study|Investigator's decision|2|||
149128369|NCT00971932|537950915|FG000|Overall Study|Ongoing|4|||
149128370|NCT01765192|537950916|FG000|Treatment Period 1|Adverse Event|0|||
149128371|NCT01765192|537950917|FG001|Treatment Period 1|Adverse Event|1|||
149128372|NCT01765192|537950916|FG000|Washout Period|Voluntary Withdrawal|1|||
149128373|NCT01765192|537950917|FG001|Washout Period|Voluntary Withdrawal|1|||
149128374|NCT01765192|537950916|FG000|Washout Period|Reason not specified|1|||
149128375|NCT01765192|537950917|FG001|Washout Period|Reason not specified|0|||
149128376|NCT01765192|537950916|FG000|Treatment Period 2|Reason not specified|0|||
149128377|NCT01765192|537950917|FG001|Treatment Period 2|Reason not specified|2|||
149128378|NCT01765192|537950916|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
149128379|NCT01765192|537950917|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
149128380|NCT01729156|537950920|FG000|Overall Study|Withdrawal by Subject|1|||
149128381|NCT01729156|537950921|FG001|Overall Study|Withdrawal by Subject|0|||
149128382|NCT01729156|537950922|FG002|Overall Study|Withdrawal by Subject|0|||
149128383|NCT01215422|537950923|FG000|Overall Study|Relocation|1|||
149128384|NCT01215422|537950924|FG001|Overall Study|Relocation|0|||
149128385|NCT01215422|537950925|FG002|Overall Study|Relocation|0|||
149128386|NCT01215422|537950926|FG003|Overall Study|Relocation|0|||
149128387|NCT01215422|537950923|FG000|Overall Study|Failed intubations|0|||
149128388|NCT01215422|537950924|FG001|Overall Study|Failed intubations|0|||
149128389|NCT01215422|537950925|FG002|Overall Study|Failed intubations|3|||
149128390|NCT01215422|537950926|FG003|Overall Study|Failed intubations|8|||
149128391|NCT01215422|537950923|FG000|Overall Study|Did not complete all intubations|7|||
149128392|NCT01215422|537950924|FG001|Overall Study|Did not complete all intubations|0|||
149128393|NCT01215422|537950925|FG002|Overall Study|Did not complete all intubations|0|||
149128394|NCT01215422|537950926|FG003|Overall Study|Did not complete all intubations|0|||
149128395|NCT06336603|537950927|FG000|Overall Study|Withdrawal by Subject|1|||
149128396|NCT06336603|537950927|FG000|Overall Study|Lost to Follow-up|2|||
149128397|NCT01146054|537950930|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
149128398|NCT01146054|537950930|FG000|Overall Study|Rapid tumor progression|2|||
149128399|NCT01146054|537950930|FG000|Overall Study|Other illness precluded treatment|2|||
149128400|NCT01146054|537950930|FG000|Overall Study|Lost to Follow-up|1|||
149128401|NCT04335812|537950931|FG000|Overall Study|Withdrawal by Subject|1|||
149128402|NCT04335812|537950932|FG001|Overall Study|Withdrawal by Subject|3|||
149128403|NCT04335812|537950931|FG000|Overall Study|Lost to Follow-up|12|||
149128404|NCT04335812|537950932|FG001|Overall Study|Lost to Follow-up|12|||
149128405|NCT04335812|537950931|FG000|Overall Study|Did not engage in the intervention|22|||
149128406|NCT04335812|537950932|FG001|Overall Study|Did not engage in the intervention|18|||
149128407|NCT02901041|537950938|FG000|Overall Study|Withdrawal by PI|4|||
149128408|NCT02901041|537950939|FG001|Overall Study|Withdrawal by PI|8|||
149128409|NCT02901041|537950938|FG000|Overall Study|Withdrawal by Subject|7|||
149128410|NCT02901041|537950939|FG001|Overall Study|Withdrawal by Subject|3|||
149128411|NCT01480674|537950940|FG000|Overall Study|Death|23|||
149128412|NCT01480674|537950940|FG000|Overall Study|Lost to Follow-up|2|||
149128413|NCT01480674|537950940|FG000|Overall Study|visit not done|10|||
149128414|NCT03249714|537950944|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
149128415|NCT03249714|537950945|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
149128416|NCT03249714|537950944|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
148786601|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
148786602|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
148786603|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
148786604|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
148786605|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
148786606|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
148786607|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
148786608|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
148786609|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
148786610|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
148786611|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
148786612|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
148786613|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
148786614|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149128417|NCT03249714|537950945|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
149128418|NCT03249714|537950944|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
149128419|NCT03249714|537950945|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
148786615|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
148786616|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
149128420|NCT03249714|537950944|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
149128421|NCT03249714|537950945|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
149128422|NCT00655863|537950953|FG000|Overall Study|Lost to Follow-up|0|||
149128423|NCT00655863|537950954|FG001|Overall Study|Lost to Follow-up|0|||
149128424|NCT00655863|537950955|FG002|Overall Study|Lost to Follow-up|1|||
149128425|NCT00712673|537950958|FG000|Overall Study|Adverse Event|3|||
149128426|NCT00712673|537950959|FG001|Overall Study|Adverse Event|3|||
149128427|NCT00712673|537950960|FG002|Overall Study|Adverse Event|21|||
149128428|NCT00712673|537950961|FG003|Overall Study|Adverse Event|26|||
149128429|NCT00712673|537950958|FG000|Overall Study|Lack of Efficacy|2|||
149128430|NCT00712673|537950959|FG001|Overall Study|Lack of Efficacy|8|||
149128431|NCT00712673|537950960|FG002|Overall Study|Lack of Efficacy|8|||
149128432|NCT00712673|537950961|FG003|Overall Study|Lack of Efficacy|6|||
149128433|NCT00712673|537950958|FG000|Overall Study|Poor Compliance to Protocol|3|||
149128434|NCT00712673|537950959|FG001|Overall Study|Poor Compliance to Protocol|3|||
149128435|NCT00712673|537950960|FG002|Overall Study|Poor Compliance to Protocol|4|||
149128436|NCT00712673|537950961|FG003|Overall Study|Poor Compliance to Protocol|16|||
149128437|NCT00712673|537950958|FG000|Overall Study|Lost to Follow-up|1|||
149128438|NCT00712673|537950959|FG001|Overall Study|Lost to Follow-up|0|||
149128439|NCT00712673|537950960|FG002|Overall Study|Lost to Follow-up|2|||
149128440|NCT00712673|537950961|FG003|Overall Study|Lost to Follow-up|0|||
149128441|NCT00712673|537950958|FG000|Overall Study|Withdrawal by Subject|6|||
149128442|NCT00712673|537950959|FG001|Overall Study|Withdrawal by Subject|7|||
149128443|NCT00712673|537950960|FG002|Overall Study|Withdrawal by Subject|15|||
149128444|NCT00712673|537950961|FG003|Overall Study|Withdrawal by Subject|20|||
149128445|NCT00712673|537950958|FG000|Overall Study|Familial and Personal Reasons|5|||
149128446|NCT00712673|537950959|FG001|Overall Study|Familial and Personal Reasons|0|||
149128447|NCT00712673|537950960|FG002|Overall Study|Familial and Personal Reasons|5|||
149128448|NCT00712673|537950961|FG003|Overall Study|Familial and Personal Reasons|2|||
149128449|NCT00712673|537950958|FG000|Overall Study|Investigator's Decision|1|||
149128450|NCT00712673|537950959|FG001|Overall Study|Investigator's Decision|0|||
149128451|NCT00712673|537950960|FG002|Overall Study|Investigator's Decision|0|||
149128452|NCT00712673|537950961|FG003|Overall Study|Investigator's Decision|0|||
149128453|NCT00712673|537950958|FG000|Overall Study|Protocol Violation|0|||
149128454|NCT00712673|537950959|FG001|Overall Study|Protocol Violation|0|||
149128455|NCT00712673|537950960|FG002|Overall Study|Protocol Violation|2|||
149128456|NCT00712673|537950961|FG003|Overall Study|Protocol Violation|0|||
149128457|NCT03603028|537950962|FG000|Overall Study|Withdrawal by Subject|1|||
149128458|NCT02963610|537950963|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
149128459|NCT00063154|537950964|FG000|Overall Study|Disease progression|27|||
149128460|NCT00063154|537950964|FG000|Overall Study|Adverse Event|2|||
149128461|NCT00063154|537950964|FG000|Overall Study|Physician Decision|10|||
149128462|NCT00063154|537950964|FG000|Overall Study|Death|3|||
149128463|NCT00063154|537950964|FG000|Overall Study|Reason unspecified|1|||
149128464|NCT00063154|537950964|FG000|Overall Study|Did not receive treatment|8|||
149128465|NCT01122862|537950965|FG000|Period 1|Protocol Violation|0|||
149128466|NCT01122862|537950966|FG001|Period 1|Protocol Violation|1|||
149128467|NCT01122862|537950967|FG002|Period 1|Protocol Violation|0|||
149128468|NCT01122862|537950965|FG000|Period 2|Adverse Event|0|||
149128469|NCT01122862|537950966|FG001|Period 2|Adverse Event|0|||
149128470|NCT01122862|537950967|FG002|Period 2|Adverse Event|1|||
149128471|NCT00846391|537950969|FG000|Overall Study|Physician Decision|0|||
149128472|NCT00846391|537950970|FG001|Overall Study|Physician Decision|0|||
149128473|NCT00846391|537950971|FG002|Overall Study|Physician Decision|1|||
149128474|NCT00846391|537950969|FG000|Overall Study|Study Terminated by Sponsor|1|||
149128475|NCT00846391|537950970|FG001|Overall Study|Study Terminated by Sponsor|2|||
149128476|NCT00846391|537950971|FG002|Overall Study|Study Terminated by Sponsor|2|||
149128477|NCT02924064|537950972|FG000|Overall Study|Adverse Event|2|||
149128478|NCT02924064|537950973|FG001|Overall Study|Adverse Event|2|||
149128479|NCT02924064|537950972|FG000|Overall Study|Lost to Follow-up|0|||
149128480|NCT02924064|537950973|FG001|Overall Study|Lost to Follow-up|2|||
149128481|NCT02924064|537950972|FG000|Overall Study|Physician Decision|0|||
149128482|NCT02924064|537950973|FG001|Overall Study|Physician Decision|2|||
149128483|NCT02924064|537950972|FG000|Overall Study|Protocol Violation|1|||
149128484|NCT02924064|537950973|FG001|Overall Study|Protocol Violation|3|||
149128485|NCT02924064|537950972|FG000|Overall Study|Withdrawal by Subject|4|||
149128486|NCT02924064|537950973|FG001|Overall Study|Withdrawal by Subject|5|||
149128487|NCT02924064|537950972|FG000|Overall Study|Other|17|||
149128488|NCT02924064|537950973|FG001|Overall Study|Other|29|||
149128489|NCT02699983|537950974|FG000|Overall Study|Withdrawal by Subject|1|||
149128490|NCT02699983|537950975|FG001|Overall Study|Withdrawal by Subject|0|||
149128491|NCT03575143|537950976|FG000|Overall Study|Lost to Follow-up|0|||
149128492|NCT03575143|537950977|FG001|Overall Study|Lost to Follow-up|0|||
149128493|NCT03575143|537950978|FG002|Overall Study|Lost to Follow-up|4|||
149128494|NCT03575143|537950976|FG000|Overall Study|Withdrawal by Subject|0|||
148893401|NCT01693029|537088700|FG000|Overall Study|Change in dialysis modality|2|||
149128495|NCT03575143|537950977|FG001|Overall Study|Withdrawal by Subject|0|||
149128496|NCT03575143|537950978|FG002|Overall Study|Withdrawal by Subject|5|||
149128497|NCT03575143|537950976|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
149128498|NCT03575143|537950977|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
149128499|NCT03575143|537950978|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
149128500|NCT02875977|537950981|FG000|Overall Study|Lost to Follow-up|42|||
149128501|NCT02875977|537950982|FG001|Overall Study|Lost to Follow-up|29|||
149128502|NCT01790126|537950986|FG000|Overall Study|PSA Progression|12|||
148786617|NCT00528372|536696194|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
148786618|NCT00528372|536696195|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
148786619|NCT00528372|536696196|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
148786620|NCT00528372|536696197|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
148786621|NCT00528372|536696198|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
148786622|NCT00528372|536696199|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
148786623|NCT00528372|536696200|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
148786624|NCT00528372|536696201|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
148786625|NCT00528372|536696202|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
148786626|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
148786627|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
148786628|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
149128503|NCT01790126|537950987|FG001|Overall Study|PSA Progression|16|||
149128504|NCT01790126|537950988|FG002|Overall Study|PSA Progression|16|||
149128505|NCT01790126|537950986|FG000|Overall Study|Other|5|||
149128506|NCT01790126|537950987|FG001|Overall Study|Other|4|||
149128507|NCT01790126|537950988|FG002|Overall Study|Other|8|||
149128508|NCT01790126|537950986|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
149128509|NCT01790126|537950987|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
149128510|NCT01790126|537950988|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
149128511|NCT01790126|537950986|FG000|Overall Study|Withdrawal by Physician|1|||
148786629|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
148786630|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
149128512|NCT01790126|537950987|FG001|Overall Study|Withdrawal by Physician|1|||
148786631|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
148786632|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
149128513|NCT01790126|537950988|FG002|Overall Study|Withdrawal by Physician|2|||
149128514|NCT01790126|537950986|FG000|Overall Study|Withdrawal by Subject|3|||
149128515|NCT01790126|537950987|FG001|Overall Study|Withdrawal by Subject|1|||
149128516|NCT01790126|537950988|FG002|Overall Study|Withdrawal by Subject|2|||
149128517|NCT01790126|537950986|FG000|Overall Study|Lost to Follow-up|1|||
149128518|NCT01790126|537950987|FG001|Overall Study|Lost to Follow-up|0|||
149128519|NCT01790126|537950988|FG002|Overall Study|Lost to Follow-up|1|||
149128520|NCT01790126|537950986|FG000|Overall Study|Adverse Event|0|||
149128521|NCT01790126|537950987|FG001|Overall Study|Adverse Event|2|||
149128522|NCT01790126|537950988|FG002|Overall Study|Adverse Event|0|||
149128523|NCT01790126|537950986|FG000|Overall Study|Death|2|||
149128524|NCT01790126|537950987|FG001|Overall Study|Death|0|||
149128525|NCT01790126|537950988|FG002|Overall Study|Death|0|||
149128526|NCT01790126|537950986|FG000|Overall Study|Radiographic Progression|3|||
149128527|NCT01790126|537950987|FG001|Overall Study|Radiographic Progression|1|||
149128528|NCT01790126|537950988|FG002|Overall Study|Radiographic Progression|0|||
148786633|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
148786634|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
148786635|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
148786636|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
149128529|NCT04781387|537950996|FG000|Overall Study|Withdrawal by Subject|1|||
149128530|NCT04781387|537950997|FG001|Overall Study|Withdrawal by Subject|0|||
149128531|NCT04781387|537950998|FG002|Overall Study|Withdrawal by Subject|1|||
149128532|NCT04781387|537950996|FG000|Overall Study|Lost to Follow-up|1|||
149128533|NCT04781387|537950997|FG001|Overall Study|Lost to Follow-up|0|||
149128534|NCT04781387|537950998|FG002|Overall Study|Lost to Follow-up|0|||
148786637|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
148786638|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
148786639|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
148786640|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
148786641|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
148786642|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
148786643|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
149128535|NCT00679627|537950999|FG000|Overall Study|Death|41|||
149128536|NCT00679627|537951000|FG001|Overall Study|Death|29|||
149128537|NCT00679627|537950999|FG000|Overall Study|Adverse Event|43|||
149128538|NCT00679627|537951000|FG001|Overall Study|Adverse Event|53|||
149128539|NCT00679627|537950999|FG000|Overall Study|Withdrawal by Subject|168|||
149128540|NCT00679627|537951000|FG001|Overall Study|Withdrawal by Subject|172|||
148786644|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
149128541|NCT00679627|537950999|FG000|Overall Study|Lost to Follow-up|22|||
149128542|NCT00679627|537951000|FG001|Overall Study|Lost to Follow-up|26|||
149128543|NCT00679627|537950999|FG000|Overall Study|Early Study Closure|425|||
149128544|NCT00679627|537951000|FG001|Overall Study|Early Study Closure|405|||
149128545|NCT00448123|537951001|FG000|Overall Study|Lost to Follow-up|9|||
149128546|NCT00448123|537951002|FG001|Overall Study|Lost to Follow-up|6|||
149128547|NCT00448123|537951001|FG000|Overall Study|Physician Decision|6|||
149128548|NCT00448123|537951002|FG001|Overall Study|Physician Decision|6|||
148786645|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
148786646|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
148786647|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
148786648|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
148786649|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
148786650|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
149128549|NCT02318797|537951003|FG000|Overall Study|Death|3|||
149128550|NCT02318797|537951004|FG001|Overall Study|Death|6|||
148786651|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
148786652|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
148786653|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
148786654|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
149128551|NCT02318797|537951003|FG000|Overall Study|Lost to Follow-up|85|||
149128552|NCT02318797|537951004|FG001|Overall Study|Lost to Follow-up|96|||
149128553|NCT02709096|537951007|FG000|Overall Study|non-compliance|1|||
149128554|NCT02709096|537951008|FG001|Overall Study|non-compliance|1|||
149128555|NCT01079741|537951009|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
149128556|NCT01079741|537951010|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
149128557|NCT01079741|537951011|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
149128558|NCT01079741|537951012|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
149128559|NCT01079741|537951013|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
149128560|NCT01079741|537951009|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
149128561|NCT01079741|537951010|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
149128562|NCT01079741|537951011|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
149128563|NCT01079741|537951012|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
149128564|NCT01079741|537951013|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
149128565|NCT00511472|537951014|FG000|Overall Study|Clinical Adverse Event|1|||
149128566|NCT00511472|537951015|FG001|Overall Study|Clinical Adverse Event|2|||
149128567|NCT00511472|537951014|FG000|Overall Study|Laboratory Adverse Event|0|||
149128568|NCT00511472|537951015|FG001|Overall Study|Laboratory Adverse Event|2|||
149128569|NCT00511472|537951014|FG000|Overall Study|Not reported|2|||
149128570|NCT00511472|537951015|FG001|Overall Study|Not reported|2|||
149128571|NCT00406653|537951016|FG000|Induction Period|Adverse Event|1|||
149128572|NCT00406653|537951017|FG001|Induction Period|Adverse Event|10|||
149128573|NCT00406653|537951018|FG002|Induction Period|Adverse Event|4|||
148786655|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
148786656|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
148786657|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
148786658|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
148786659|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
148786660|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
148786661|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
148786662|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
148786663|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
148786664|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
148786665|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
148786666|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
148786667|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
148786668|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
148786669|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
148786670|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
148786671|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
148786672|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
148786673|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
148786674|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
149128574|NCT00406653|537951019|FG003|Induction Period|Adverse Event|11|||
149128575|NCT00406653|537951020|FG004|Induction Period|Adverse Event|0|||
149128576|NCT00406653|537951021|FG005|Induction Period|Adverse Event|0|||
148786675|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
149128577|NCT00406653|537951022|FG006|Induction Period|Adverse Event|0|||
149128578|NCT00406653|537951016|FG000|Induction Period|Lack of Efficacy|11|||
149128579|NCT00406653|537951017|FG001|Induction Period|Lack of Efficacy|14|||
149128580|NCT00406653|537951018|FG002|Induction Period|Lack of Efficacy|8|||
149128581|NCT00406653|537951019|FG003|Induction Period|Lack of Efficacy|10|||
149128582|NCT00406653|537951020|FG004|Induction Period|Lack of Efficacy|0|||
149128583|NCT00406653|537951021|FG005|Induction Period|Lack of Efficacy|0|||
149128584|NCT00406653|537951022|FG006|Induction Period|Lack of Efficacy|0|||
149128585|NCT00406653|537951016|FG000|Induction Period|Lost to Follow-up|0|||
149128586|NCT00406653|537951017|FG001|Induction Period|Lost to Follow-up|2|||
149128587|NCT00406653|537951018|FG002|Induction Period|Lost to Follow-up|0|||
149128588|NCT00406653|537951019|FG003|Induction Period|Lost to Follow-up|0|||
149128589|NCT00406653|537951020|FG004|Induction Period|Lost to Follow-up|0|||
149128590|NCT00406653|537951021|FG005|Induction Period|Lost to Follow-up|0|||
149128591|NCT00406653|537951022|FG006|Induction Period|Lost to Follow-up|0|||
149128592|NCT00406653|537951016|FG000|Induction Period|Withdrawal of Consent|2|||
149128593|NCT00406653|537951017|FG001|Induction Period|Withdrawal of Consent|5|||
149128594|NCT00406653|537951018|FG002|Induction Period|Withdrawal of Consent|1|||
149128595|NCT00406653|537951019|FG003|Induction Period|Withdrawal of Consent|2|||
149128596|NCT00406653|537951020|FG004|Induction Period|Withdrawal of Consent|0|||
149128597|NCT00406653|537951021|FG005|Induction Period|Withdrawal of Consent|0|||
149128598|NCT00406653|537951022|FG006|Induction Period|Withdrawal of Consent|0|||
149128599|NCT00406653|537951016|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
149128600|NCT00406653|537951017|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
149128601|NCT00406653|537951018|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
149128602|NCT00406653|537951019|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
149128603|NCT00406653|537951020|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
149128604|NCT00406653|537951021|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
149128605|NCT00406653|537951022|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
149128606|NCT00406653|537951016|FG000|Induction Period|Pregnancy|1|||
149128607|NCT00406653|537951017|FG001|Induction Period|Pregnancy|0|||
149128608|NCT00406653|537951018|FG002|Induction Period|Pregnancy|0|||
149128609|NCT00406653|537951019|FG003|Induction Period|Pregnancy|0|||
149128610|NCT00406653|537951020|FG004|Induction Period|Pregnancy|0|||
149128611|NCT00406653|537951021|FG005|Induction Period|Pregnancy|0|||
149128612|NCT00406653|537951022|FG006|Induction Period|Pregnancy|0|||
149128613|NCT00406653|537951016|FG000|Induction Period|Declined participation but followup done|0|||
149128614|NCT00406653|537951017|FG001|Induction Period|Declined participation but followup done|2|||
149128615|NCT00406653|537951018|FG002|Induction Period|Declined participation but followup done|1|||
149128616|NCT00406653|537951019|FG003|Induction Period|Declined participation but followup done|1|||
149128617|NCT00406653|537951020|FG004|Induction Period|Declined participation but followup done|0|||
149128618|NCT00406653|537951021|FG005|Induction Period|Declined participation but followup done|0|||
149128619|NCT00406653|537951022|FG006|Induction Period|Declined participation but followup done|0|||
149128620|NCT00406653|537951016|FG000|Induction Period|Given prohibited drug|0|||
149128621|NCT00406653|537951017|FG001|Induction Period|Given prohibited drug|1|||
149128622|NCT00406653|537951018|FG002|Induction Period|Given prohibited drug|2|||
149128623|NCT00406653|537951019|FG003|Induction Period|Given prohibited drug|0|||
149128624|NCT00406653|537951020|FG004|Induction Period|Given prohibited drug|0|||
149128625|NCT00406653|537951021|FG005|Induction Period|Given prohibited drug|0|||
149128626|NCT00406653|537951022|FG006|Induction Period|Given prohibited drug|0|||
149128627|NCT00406653|537951016|FG000|Induction Period|Incarcerated|0|||
149128628|NCT00406653|537951017|FG001|Induction Period|Incarcerated|0|||
149128629|NCT00406653|537951018|FG002|Induction Period|Incarcerated|1|||
149128630|NCT00406653|537951019|FG003|Induction Period|Incarcerated|0|||
149128631|NCT00406653|537951020|FG004|Induction Period|Incarcerated|0|||
149128632|NCT00406653|537951021|FG005|Induction Period|Incarcerated|0|||
149128633|NCT00406653|537951022|FG006|Induction Period|Incarcerated|0|||
149128634|NCT00406653|537951016|FG000|Induction Period|Patient relocated|0|||
149128635|NCT00406653|537951017|FG001|Induction Period|Patient relocated|0|||
149128636|NCT00406653|537951018|FG002|Induction Period|Patient relocated|1|||
149128637|NCT00406653|537951019|FG003|Induction Period|Patient relocated|0|||
149128638|NCT00406653|537951020|FG004|Induction Period|Patient relocated|0|||
149128639|NCT00406653|537951021|FG005|Induction Period|Patient relocated|0|||
149128640|NCT00406653|537951022|FG006|Induction Period|Patient relocated|0|||
149128641|NCT00406653|537951016|FG000|Maintenance Period|Adverse Event|0|||
149128642|NCT00406653|537951017|FG001|Maintenance Period|Adverse Event|0|||
149128643|NCT00406653|537951018|FG002|Maintenance Period|Adverse Event|0|||
149128644|NCT00406653|537951019|FG003|Maintenance Period|Adverse Event|0|||
149128645|NCT00406653|537951020|FG004|Maintenance Period|Adverse Event|1|||
149128646|NCT00406653|537951021|FG005|Maintenance Period|Adverse Event|1|||
149128647|NCT00406653|537951022|FG006|Maintenance Period|Adverse Event|0|||
149128648|NCT00406653|537951016|FG000|Maintenance Period|Lack of Efficacy|0|||
149128649|NCT00406653|537951017|FG001|Maintenance Period|Lack of Efficacy|0|||
149128650|NCT00406653|537951018|FG002|Maintenance Period|Lack of Efficacy|0|||
149128651|NCT00406653|537951019|FG003|Maintenance Period|Lack of Efficacy|0|||
149128652|NCT00406653|537951020|FG004|Maintenance Period|Lack of Efficacy|20|||
149128653|NCT00406653|537951021|FG005|Maintenance Period|Lack of Efficacy|26|||
149128654|NCT00406653|537951022|FG006|Maintenance Period|Lack of Efficacy|0|||
149128655|NCT00406653|537951016|FG000|Maintenance Period|Lost to Follow-up|0|||
149128656|NCT00406653|537951017|FG001|Maintenance Period|Lost to Follow-up|0|||
149128657|NCT00406653|537951018|FG002|Maintenance Period|Lost to Follow-up|0|||
149128658|NCT00406653|537951019|FG003|Maintenance Period|Lost to Follow-up|0|||
149128659|NCT00406653|537951020|FG004|Maintenance Period|Lost to Follow-up|2|||
149128660|NCT00406653|537951021|FG005|Maintenance Period|Lost to Follow-up|1|||
149128661|NCT00406653|537951022|FG006|Maintenance Period|Lost to Follow-up|0|||
149128662|NCT00406653|537951016|FG000|Maintenance Period|Withdrawal of Consent|0|||
149128663|NCT00406653|537951017|FG001|Maintenance Period|Withdrawal of Consent|0|||
149128664|NCT00406653|537951018|FG002|Maintenance Period|Withdrawal of Consent|0|||
149128665|NCT00406653|537951019|FG003|Maintenance Period|Withdrawal of Consent|0|||
149128666|NCT00406653|537951020|FG004|Maintenance Period|Withdrawal of Consent|2|||
149128667|NCT00406653|537951021|FG005|Maintenance Period|Withdrawal of Consent|0|||
149128668|NCT00406653|537951022|FG006|Maintenance Period|Withdrawal of Consent|0|||
149128669|NCT00406653|537951016|FG000|Maintenance Period|Pregnancy|0|||
149128670|NCT00406653|537951017|FG001|Maintenance Period|Pregnancy|0|||
149128671|NCT00406653|537951018|FG002|Maintenance Period|Pregnancy|0|||
149128672|NCT00406653|537951019|FG003|Maintenance Period|Pregnancy|0|||
149128673|NCT00406653|537951020|FG004|Maintenance Period|Pregnancy|0|||
149128674|NCT00406653|537951021|FG005|Maintenance Period|Pregnancy|1|||
149128675|NCT00406653|537951022|FG006|Maintenance Period|Pregnancy|0|||
149128676|NCT00406653|537951016|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
149128677|NCT00406653|537951017|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
149128678|NCT00406653|537951018|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
149128679|NCT00406653|537951019|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
149128680|NCT00406653|537951020|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
149128681|NCT00406653|537951021|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
149128682|NCT00406653|537951022|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
149128683|NCT00406653|537951016|FG000|Maintenance Period|Error in disease score evaluation|0|||
149128684|NCT00406653|537951017|FG001|Maintenance Period|Error in disease score evaluation|0|||
149128685|NCT00406653|537951018|FG002|Maintenance Period|Error in disease score evaluation|0|||
149128686|NCT00406653|537951019|FG003|Maintenance Period|Error in disease score evaluation|0|||
149128687|NCT00406653|537951020|FG004|Maintenance Period|Error in disease score evaluation|1|||
149128688|NCT00406653|537951021|FG005|Maintenance Period|Error in disease score evaluation|0|||
149128689|NCT00406653|537951022|FG006|Maintenance Period|Error in disease score evaluation|0|||
149128690|NCT00406653|537951016|FG000|Open-Label Period|Death|0|||
149128691|NCT00406653|537951017|FG001|Open-Label Period|Death|0|||
149128692|NCT00406653|537951018|FG002|Open-Label Period|Death|0|||
149128693|NCT00406653|537951019|FG003|Open-Label Period|Death|0|||
149128694|NCT00406653|537951020|FG004|Open-Label Period|Death|0|||
149128695|NCT00406653|537951021|FG005|Open-Label Period|Death|0|||
149128696|NCT00406653|537951022|FG006|Open-Label Period|Death|1|||
149128697|NCT00406653|537951016|FG000|Open-Label Period|Adverse Event|0|||
149128698|NCT00406653|537951017|FG001|Open-Label Period|Adverse Event|0|||
149128699|NCT00406653|537951018|FG002|Open-Label Period|Adverse Event|0|||
149128700|NCT00406653|537951019|FG003|Open-Label Period|Adverse Event|0|||
149128701|NCT00406653|537951020|FG004|Open-Label Period|Adverse Event|0|||
149128702|NCT00406653|537951021|FG005|Open-Label Period|Adverse Event|0|||
149128703|NCT00406653|537951022|FG006|Open-Label Period|Adverse Event|18|||
149128704|NCT00406653|537951016|FG000|Open-Label Period|Lack of Efficacy|0|||
149128705|NCT00406653|537951017|FG001|Open-Label Period|Lack of Efficacy|0|||
149128706|NCT00406653|537951018|FG002|Open-Label Period|Lack of Efficacy|0|||
149128707|NCT00406653|537951019|FG003|Open-Label Period|Lack of Efficacy|0|||
149128708|NCT00406653|537951020|FG004|Open-Label Period|Lack of Efficacy|0|||
149128709|NCT00406653|537951021|FG005|Open-Label Period|Lack of Efficacy|0|||
149128710|NCT00406653|537951022|FG006|Open-Label Period|Lack of Efficacy|160|||
149128711|NCT00406653|537951016|FG000|Open-Label Period|Lost to Follow-up|0|||
149128712|NCT00406653|537951017|FG001|Open-Label Period|Lost to Follow-up|0|||
149128713|NCT00406653|537951018|FG002|Open-Label Period|Lost to Follow-up|0|||
149128714|NCT00406653|537951019|FG003|Open-Label Period|Lost to Follow-up|0|||
149128715|NCT00406653|537951020|FG004|Open-Label Period|Lost to Follow-up|0|||
149128716|NCT00406653|537951021|FG005|Open-Label Period|Lost to Follow-up|0|||
149128717|NCT00406653|537951022|FG006|Open-Label Period|Lost to Follow-up|6|||
149128718|NCT00406653|537951016|FG000|Open-Label Period|Withdrawal of Consent|0|||
149128719|NCT00406653|537951017|FG001|Open-Label Period|Withdrawal of Consent|0|||
149128720|NCT00406653|537951018|FG002|Open-Label Period|Withdrawal of Consent|0|||
149128721|NCT00406653|537951019|FG003|Open-Label Period|Withdrawal of Consent|0|||
149128722|NCT00406653|537951020|FG004|Open-Label Period|Withdrawal of Consent|0|||
149128723|NCT00406653|537951021|FG005|Open-Label Period|Withdrawal of Consent|0|||
148786676|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
149128724|NCT00406653|537951022|FG006|Open-Label Period|Withdrawal of Consent|11|||
149128725|NCT00406653|537951016|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149128726|NCT00406653|537951017|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149128727|NCT00406653|537951018|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149128728|NCT00406653|537951019|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149128729|NCT00406653|537951020|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149128730|NCT00406653|537951021|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
149128731|NCT00406653|537951022|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
149128732|NCT00406653|537951016|FG000|Open-Label Period|Pregnancy|0|||
149128733|NCT00406653|537951017|FG001|Open-Label Period|Pregnancy|0|||
149128734|NCT00406653|537951018|FG002|Open-Label Period|Pregnancy|0|||
149128735|NCT00406653|537951019|FG003|Open-Label Period|Pregnancy|0|||
149128736|NCT00406653|537951020|FG004|Open-Label Period|Pregnancy|0|||
149128737|NCT00406653|537951021|FG005|Open-Label Period|Pregnancy|0|||
149128738|NCT00406653|537951022|FG006|Open-Label Period|Pregnancy|2|||
149128739|NCT00406653|537951016|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
149128740|NCT00406653|537951017|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
149128741|NCT00406653|537951018|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
149128742|NCT00406653|537951019|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
149128743|NCT00406653|537951020|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
149128744|NCT00406653|537951021|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
149128745|NCT00406653|537951022|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
149128746|NCT00406653|537951016|FG000|Open-Label Period|Declined participation but followup done|0|||
149128747|NCT00406653|537951017|FG001|Open-Label Period|Declined participation but followup done|0|||
149128748|NCT00406653|537951018|FG002|Open-Label Period|Declined participation but followup done|0|||
149128749|NCT00406653|537951019|FG003|Open-Label Period|Declined participation but followup done|0|||
149128750|NCT00406653|537951020|FG004|Open-Label Period|Declined participation but followup done|0|||
149128751|NCT00406653|537951021|FG005|Open-Label Period|Declined participation but followup done|0|||
149128752|NCT00406653|537951022|FG006|Open-Label Period|Declined participation but followup done|8|||
149128753|NCT00406653|537951016|FG000|Open-Label Period|Discontinued by Sponsor|0|||
149128754|NCT00406653|537951017|FG001|Open-Label Period|Discontinued by Sponsor|0|||
149128755|NCT00406653|537951018|FG002|Open-Label Period|Discontinued by Sponsor|0|||
149128756|NCT00406653|537951019|FG003|Open-Label Period|Discontinued by Sponsor|0|||
149128757|NCT00406653|537951020|FG004|Open-Label Period|Discontinued by Sponsor|0|||
149128758|NCT00406653|537951021|FG005|Open-Label Period|Discontinued by Sponsor|0|||
149128759|NCT00406653|537951022|FG006|Open-Label Period|Discontinued by Sponsor|1|||
149128760|NCT00406653|537951016|FG000|Open-Label Period|Refused followup|0|||
149128761|NCT00406653|537951017|FG001|Open-Label Period|Refused followup|0|||
149128762|NCT00406653|537951018|FG002|Open-Label Period|Refused followup|0|||
149128763|NCT00406653|537951019|FG003|Open-Label Period|Refused followup|0|||
149128764|NCT00406653|537951020|FG004|Open-Label Period|Refused followup|0|||
149128765|NCT00406653|537951021|FG005|Open-Label Period|Refused followup|0|||
149128766|NCT00406653|537951022|FG006|Open-Label Period|Refused followup|1|||
149128767|NCT00446992|537951023|FG000|Overall Study|Adverse Event|11|||
149128768|NCT00446992|537951023|FG000|Overall Study|Lost to Follow-up|5|||
149128769|NCT00818649|537951024|FG000|Overall Study|Declining performance status|2|||
149128770|NCT00818649|537951024|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
149128771|NCT00818649|537951024|FG000|Overall Study|Adverse Event|1|||
149128772|NCT06338462|537951025|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
149128773|NCT00069238|537951029|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
149128774|NCT00069238|537951030|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
149128775|NCT00069238|537951031|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
149128776|NCT00069238|537951029|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
149128777|NCT00069238|537951030|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
149128778|NCT00069238|537951031|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
149128779|NCT00069238|537951029|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
149128780|NCT00069238|537951030|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
149128781|NCT00069238|537951031|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
149128782|NCT01001832|537951032|FG000|Short-term Period|Adverse Event|2|||
149128783|NCT01001832|537951033|FG001|Short-term Period|Adverse Event|3|||
149128784|NCT01001832|537951032|FG000|Long-term Period|Adverse Event|2|||
149128785|NCT01001832|537951033|FG001|Long-term Period|Adverse Event|1|||
149128786|NCT01001832|537951032|FG000|Long-term Period|Withdrawal by Subject|1|||
149128787|NCT01001832|537951033|FG001|Long-term Period|Withdrawal by Subject|0|||
149128788|NCT01001832|537951032|FG000|Long-term Period|Lack of Efficacy|0|||
149128789|NCT01001832|537951033|FG001|Long-term Period|Lack of Efficacy|2|||
149128790|NCT01001832|537951032|FG000|Long-term Period|Other|1|||
149128791|NCT01001832|537951033|FG001|Long-term Period|Other|2|||
149128792|NCT01001832|537951032|FG000|Follow-up Period|Withdrawal by Subject|1|||
149128793|NCT01001832|537951033|FG001|Follow-up Period|Withdrawal by Subject|0|||
149128794|NCT01001832|537951032|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
149128795|NCT01001832|537951033|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
149128796|NCT01001832|537951032|FG000|Follow-up Period|Other|2|||
149128797|NCT01001832|537951033|FG001|Follow-up Period|Other|1|||
149128798|NCT02427464|537951038|FG000|Overall Study|Adverse Event|6|||
149128799|NCT02427464|537951039|FG001|Overall Study|Adverse Event|1|||
149128800|NCT02427464|537951038|FG000|Overall Study|Lost to Follow-up|16|||
148893402|NCT01693029|537088701|FG001|Overall Study|Change in dialysis modality|1|||
149128801|NCT02427464|537951039|FG001|Overall Study|Lost to Follow-up|5|||
149128802|NCT02427464|537951038|FG000|Overall Study|Physician Decision|2|||
149128803|NCT02427464|537951039|FG001|Overall Study|Physician Decision|0|||
149128804|NCT02427464|537951038|FG000|Overall Study|Withdrawal by Subject|10|||
149128805|NCT02427464|537951039|FG001|Overall Study|Withdrawal by Subject|8|||
149128806|NCT02427464|537951038|FG000|Overall Study|Noncompliance|16|||
149128807|NCT02427464|537951039|FG001|Overall Study|Noncompliance|10|||
148786677|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
148786678|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
148786679|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
148786680|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
148786681|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
148786682|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
148786683|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
148786684|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
148786685|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
148786686|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
148786687|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
148786688|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
148786689|NCT00528372|536696194|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
148786690|NCT00528372|536696195|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
149128808|NCT03756129|537951041|FG000|Overall Study|Adverse Event|1|||
149128809|NCT03756129|537951042|FG001|Overall Study|Adverse Event|1|||
149128810|NCT03756129|537951043|FG002|Overall Study|Adverse Event|0|||
149128811|NCT03756129|537951044|FG003|Overall Study|Adverse Event|2|||
149128812|NCT03756129|537951045|FG004|Overall Study|Adverse Event|0|||
149128813|NCT03756129|537951046|FG005|Overall Study|Adverse Event|0|||
149128814|NCT03756129|537951041|FG000|Overall Study|Withdrawal by Subject|2|||
149128815|NCT03756129|537951042|FG001|Overall Study|Withdrawal by Subject|1|||
149128816|NCT03756129|537951043|FG002|Overall Study|Withdrawal by Subject|3|||
149128817|NCT03756129|537951044|FG003|Overall Study|Withdrawal by Subject|1|||
149128818|NCT03756129|537951045|FG004|Overall Study|Withdrawal by Subject|1|||
149128819|NCT03756129|537951046|FG005|Overall Study|Withdrawal by Subject|3|||
149128820|NCT03756129|537951041|FG000|Overall Study|Lost to Follow-up|0|||
149128821|NCT03756129|537951042|FG001|Overall Study|Lost to Follow-up|0|||
149128822|NCT03756129|537951043|FG002|Overall Study|Lost to Follow-up|0|||
149128823|NCT03756129|537951044|FG003|Overall Study|Lost to Follow-up|0|||
149128824|NCT03756129|537951045|FG004|Overall Study|Lost to Follow-up|0|||
149128825|NCT03756129|537951046|FG005|Overall Study|Lost to Follow-up|1|||
149128826|NCT03756129|537951041|FG000|Overall Study|Physician Decision|0|||
149128827|NCT03756129|537951042|FG001|Overall Study|Physician Decision|0|||
149128828|NCT03756129|537951043|FG002|Overall Study|Physician Decision|0|||
149128829|NCT03756129|537951044|FG003|Overall Study|Physician Decision|0|||
149128830|NCT03756129|537951045|FG004|Overall Study|Physician Decision|0|||
149128831|NCT03756129|537951046|FG005|Overall Study|Physician Decision|1|||
149128832|NCT01439360|537951047|FG000|Overall Study|Adverse Event|4|||
149128833|NCT01439360|537951048|FG001|Overall Study|Adverse Event|16|||
149128834|NCT01439360|537951047|FG000|Overall Study|Lost to Follow-up|43|||
149128835|NCT01439360|537951048|FG001|Overall Study|Lost to Follow-up|58|||
149128836|NCT01439360|537951047|FG000|Overall Study|Others|10|||
149128837|NCT01439360|537951048|FG001|Overall Study|Others|5|||
149128838|NCT01439360|537951047|FG000|Overall Study|Protocol Violation|1|||
149128839|NCT01439360|537951048|FG001|Overall Study|Protocol Violation|0|||
148786691|NCT00528372|536696196|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
148786692|NCT00528372|536696197|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
148786693|NCT00528372|536696198|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
148786694|NCT00528372|536696199|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
148786695|NCT00528372|536696200|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
148786696|NCT00528372|536696201|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
148786697|NCT00528372|536696202|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
148786698|NCT02432144|536696207|FG000|Overall Study|Participant Non-Compliance|1|||
148786699|NCT01483599|536696209|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
148786700|NCT01483599|536696210|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786701|NCT01483599|536696211|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786702|NCT01483599|536696212|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
148786703|NCT01483599|536696213|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
149128840|NCT01439360|537951047|FG000|Overall Study|Withdrawal by Subject|140|||
149128841|NCT01439360|537951048|FG001|Overall Study|Withdrawal by Subject|129|||
149128842|NCT00345293|537951049|FG000|Overall Study|Unable to access line for sample|1|||
149128843|NCT00345293|537951050|FG001|Overall Study|Unable to access line for sample|0|||
149128844|NCT00345293|537951049|FG000|Overall Study|Withdrawal by Subject|1|||
149128845|NCT00345293|537951050|FG001|Overall Study|Withdrawal by Subject|0|||
149128846|NCT03319849|537951051|FG000|Overall Study|Adverse Event|1|||
149128847|NCT03319849|537951052|FG001|Overall Study|Adverse Event|0|||
149128848|NCT03319849|537951051|FG000|Overall Study|Physician Decision|0|||
149128849|NCT03319849|537951052|FG001|Overall Study|Physician Decision|1|||
149128850|NCT03319849|537951051|FG000|Overall Study|Withdrawal by Subject|0|||
149128851|NCT03319849|537951052|FG001|Overall Study|Withdrawal by Subject|1|||
149128852|NCT03319849|537951051|FG000|Overall Study|COVID-19|0|||
149128853|NCT03319849|537951052|FG001|Overall Study|COVID-19|1|||
149128854|NCT03319849|537951051|FG000|Overall Study|Other|1|||
149128855|NCT03319849|537951052|FG001|Overall Study|Other|2|||
149128856|NCT03319849|537951051|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
149128857|NCT03319849|537951052|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
149128858|NCT03319849|537951051|FG000|Overall Study|Lost to Follow-up|0|||
149128859|NCT03319849|537951052|FG001|Overall Study|Lost to Follow-up|2|||
149128860|NCT00604279|537952485|FG000|Overall Study|Lack of Efficacy|22|||
149128861|NCT00604279|537952486|FG001|Overall Study|Lack of Efficacy|9|||
149128862|NCT00604279|537952485|FG000|Overall Study|Lost to Follow-up|9|||
149128863|NCT00604279|537952486|FG001|Overall Study|Lost to Follow-up|14|||
149128864|NCT00604279|537952485|FG000|Overall Study|Pregnancy|2|||
149128865|NCT00604279|537952486|FG001|Overall Study|Pregnancy|0|||
149128866|NCT00604279|537952485|FG000|Overall Study|Protocol Violation|3|||
149128867|NCT00604279|537952486|FG001|Overall Study|Protocol Violation|1|||
149128868|NCT00604279|537952485|FG000|Overall Study|Withdrawal by Subject|16|||
149128869|NCT00604279|537952486|FG001|Overall Study|Withdrawal by Subject|5|||
149128870|NCT00604279|537952485|FG000|Overall Study|Adverse Event|4|||
149128871|NCT00604279|537952486|FG001|Overall Study|Adverse Event|5|||
149128872|NCT00604279|537952485|FG000|Overall Study|Other|8|||
149128873|NCT00604279|537952486|FG001|Overall Study|Other|4|||
149128874|NCT00601419|537952487|FG000|Overall Study|Lost to Follow-up|3|||
149128875|NCT00601419|537952487|FG000|Overall Study|Missed Visits|1|||
149128876|NCT01786174|537952488|FG000|Overall Study|Discontinued Study Drug|2|||
149128877|NCT01786174|537952489|FG001|Overall Study|Discontinued Study Drug|0|||
149128878|NCT01614197|537952490|FG000|Overall Study|Withdrawal by Subject|0|||
149128879|NCT01614197|537952491|FG001|Overall Study|Withdrawal by Subject|1|||
149128880|NCT01614197|537952492|FG002|Overall Study|Withdrawal by Subject|0|||
149128881|NCT01614197|537952493|FG003|Overall Study|Withdrawal by Subject|0|||
149128882|NCT03628898|537952495|FG000|Overall Study|Device deficiency|1|||
149128883|NCT02245672|537952496|FG000|Overall Study|Adverse Event|4|||
149128884|NCT02245672|537952497|FG001|Overall Study|Adverse Event|4|||
149128885|NCT02245672|537952498|FG002|Overall Study|Adverse Event|4|||
149128886|NCT02245672|537952496|FG000|Overall Study|Lost to Follow-up|3|||
149128887|NCT02245672|537952497|FG001|Overall Study|Lost to Follow-up|5|||
149128888|NCT02245672|537952498|FG002|Overall Study|Lost to Follow-up|1|||
149128889|NCT02245672|537952496|FG000|Overall Study|Withdrawal by Subject|6|||
149128890|NCT02245672|537952497|FG001|Overall Study|Withdrawal by Subject|3|||
149128891|NCT02245672|537952498|FG002|Overall Study|Withdrawal by Subject|0|||
149128892|NCT02245672|537952496|FG000|Overall Study|Randomized in error (not treated)|0|||
149128893|NCT02245672|537952497|FG001|Overall Study|Randomized in error (not treated)|1|||
149128894|NCT02245672|537952498|FG002|Overall Study|Randomized in error (not treated)|0|||
149128895|NCT02434939|537952503|FG000|Overall Study|Lack of Efficacy|34|||
149128896|NCT02434939|537952504|FG001|Overall Study|Lack of Efficacy|48|||
149128897|NCT02434939|537952503|FG000|Overall Study|Withdrawal by Subject|3|||
149128898|NCT02434939|537952504|FG001|Overall Study|Withdrawal by Subject|0|||
149128899|NCT02434939|537952503|FG000|Overall Study|Adverse Event|0|||
149128900|NCT02434939|537952504|FG001|Overall Study|Adverse Event|1|||
149128901|NCT03581825|537952505|FG000|Period 1|Lens Discomfort|1|||
149128902|NCT03581825|537952506|FG001|Period 1|Lens Discomfort|0|||
149128903|NCT03581825|537952505|FG000|Period 2|Unsatisfactory Vision to Test|0|||
149128904|NCT03581825|537952506|FG001|Period 2|Unsatisfactory Vision to Test|1|||
149128905|NCT01668667|537952507|FG000|Overall Study|Adverse Event|3|||
149128906|NCT01668667|537952508|FG001|Overall Study|Adverse Event|6|||
149128907|NCT01668667|537952509|FG002|Overall Study|Adverse Event|4|||
149128908|NCT01668667|537952510|FG003|Overall Study|Adverse Event|4|||
149128909|NCT01668667|537952507|FG000|Overall Study|Lack of Efficacy|3|||
149128910|NCT01668667|537952508|FG001|Overall Study|Lack of Efficacy|2|||
149128911|NCT01668667|537952509|FG002|Overall Study|Lack of Efficacy|2|||
148786704|NCT01483599|536696214|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
148786705|NCT01483599|536696215|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
148786706|NCT01483599|536696216|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786707|NCT01483599|536696217|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
149128912|NCT01668667|537952510|FG003|Overall Study|Lack of Efficacy|3|||
149128913|NCT01668667|537952507|FG000|Overall Study|Protocol Violation|6|||
148786708|NCT01483599|536696218|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148893403|NCT01693029|537088700|FG000|Overall Study|Physician Decision|0|||
149128914|NCT01668667|537952508|FG001|Overall Study|Protocol Violation|10|||
149128915|NCT01668667|537952509|FG002|Overall Study|Protocol Violation|12|||
149128916|NCT01668667|537952510|FG003|Overall Study|Protocol Violation|5|||
149128917|NCT01668667|537952507|FG000|Overall Study|Lost to Follow-up|9|||
149128918|NCT01668667|537952508|FG001|Overall Study|Lost to Follow-up|4|||
149128919|NCT01668667|537952509|FG002|Overall Study|Lost to Follow-up|7|||
149128920|NCT01668667|537952510|FG003|Overall Study|Lost to Follow-up|6|||
149128921|NCT01668667|537952507|FG000|Overall Study|Physician Decision|3|||
149128922|NCT01668667|537952508|FG001|Overall Study|Physician Decision|0|||
149128923|NCT01668667|537952509|FG002|Overall Study|Physician Decision|1|||
149128924|NCT01668667|537952510|FG003|Overall Study|Physician Decision|0|||
149128925|NCT01668667|537952507|FG000|Overall Study|Withdrawal by Subject|7|||
149128926|NCT01668667|537952508|FG001|Overall Study|Withdrawal by Subject|4|||
149128927|NCT01668667|537952509|FG002|Overall Study|Withdrawal by Subject|5|||
149128928|NCT01668667|537952510|FG003|Overall Study|Withdrawal by Subject|5|||
149128929|NCT00511901|537952512|FG000|Overall Study|Withdrawal by Subject|1|||
149128930|NCT00511901|537952513|FG001|Overall Study|Withdrawal by Subject|3|||
149128931|NCT02447172|537952514|FG000|Overall Study|Adverse Event|11|||
149128932|NCT02447172|537952515|FG001|Overall Study|Adverse Event|8|||
149128933|NCT02447172|537952516|FG002|Overall Study|Adverse Event|7|||
149128934|NCT02447172|537952514|FG000|Overall Study|Death|3|||
149128935|NCT02447172|537952515|FG001|Overall Study|Death|1|||
149128936|NCT02447172|537952516|FG002|Overall Study|Death|0|||
149128937|NCT02447172|537952514|FG000|Overall Study|Protocol Violation|2|||
149128938|NCT02447172|537952515|FG001|Overall Study|Protocol Violation|1|||
149128939|NCT02447172|537952516|FG002|Overall Study|Protocol Violation|2|||
149128940|NCT02447172|537952514|FG000|Overall Study|Lost to Follow-up|7|||
149128941|NCT02447172|537952515|FG001|Overall Study|Lost to Follow-up|4|||
149128942|NCT02447172|537952516|FG002|Overall Study|Lost to Follow-up|4|||
149128943|NCT02447172|537952514|FG000|Overall Study|Withdrawal by Subject|5|||
149128944|NCT02447172|537952515|FG001|Overall Study|Withdrawal by Subject|1|||
149128945|NCT02447172|537952516|FG002|Overall Study|Withdrawal by Subject|3|||
149128946|NCT02447172|537952514|FG000|Overall Study|protocol specific treatment unrelated|3|||
149128947|NCT02447172|537952515|FG001|Overall Study|protocol specific treatment unrelated|0|||
149128948|NCT02447172|537952516|FG002|Overall Study|protocol specific treatment unrelated|2|||
149128949|NCT03562247|537952520|FG000|Overall Study|Lost to Follow-up|3|||
149128950|NCT03562247|537952521|FG001|Overall Study|Lost to Follow-up|1|||
149128951|NCT03562247|537952522|FG002|Overall Study|Lost to Follow-up|1|||
149128952|NCT01204398|537952523|FG000|Overall Study|Adverse Event|1|||
149128953|NCT03261700|537952524|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
149128954|NCT03261700|537952525|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
149128955|NCT01723254|537952527|FG000|Overall Study|Conflict with work schedule|0|||
149128956|NCT01723254|537952528|FG001|Overall Study|Conflict with work schedule|0|||
149128957|NCT01723254|537952529|FG002|Overall Study|Conflict with work schedule|0|||
149128958|NCT01723254|537952530|FG003|Overall Study|Conflict with work schedule|0|||
149128959|NCT01723254|537952531|FG004|Overall Study|Conflict with work schedule|0|||
149128960|NCT01723254|537952532|FG005|Overall Study|Conflict with work schedule|0|||
149128961|NCT01723254|537952533|FG006|Overall Study|Conflict with work schedule|0|||
149128962|NCT01723254|537952534|FG007|Overall Study|Conflict with work schedule|1|||
149128963|NCT01723254|537952527|FG000|Overall Study|Personal issues|0|||
149128964|NCT01723254|537952528|FG001|Overall Study|Personal issues|0|||
149128965|NCT01723254|537952529|FG002|Overall Study|Personal issues|0|||
149128966|NCT01723254|537952530|FG003|Overall Study|Personal issues|0|||
149128967|NCT01723254|537952531|FG004|Overall Study|Personal issues|0|||
149128968|NCT01723254|537952532|FG005|Overall Study|Personal issues|1|||
149128969|NCT01723254|537952533|FG006|Overall Study|Personal issues|0|||
149128970|NCT01723254|537952534|FG007|Overall Study|Personal issues|0|||
149128971|NCT01723254|537952527|FG000|Overall Study|No longer have time to participate|0|||
149128972|NCT01723254|537952528|FG001|Overall Study|No longer have time to participate|0|||
149128973|NCT01723254|537952529|FG002|Overall Study|No longer have time to participate|0|||
149128974|NCT01723254|537952530|FG003|Overall Study|No longer have time to participate|1|||
149128975|NCT01723254|537952531|FG004|Overall Study|No longer have time to participate|0|||
149128976|NCT01723254|537952532|FG005|Overall Study|No longer have time to participate|0|||
149128977|NCT01723254|537952533|FG006|Overall Study|No longer have time to participate|0|||
149128978|NCT01723254|537952534|FG007|Overall Study|No longer have time to participate|0|||
149128979|NCT01723254|537952527|FG000|Overall Study|Move/Left to another country/city|0|||
149128980|NCT01723254|537952528|FG001|Overall Study|Move/Left to another country/city|0|||
149128981|NCT01723254|537952529|FG002|Overall Study|Move/Left to another country/city|2|||
149128982|NCT01723254|537952530|FG003|Overall Study|Move/Left to another country/city|1|||
149128983|NCT01723254|537952531|FG004|Overall Study|Move/Left to another country/city|1|||
149128984|NCT01723254|537952532|FG005|Overall Study|Move/Left to another country/city|0|||
149128985|NCT01723254|537952533|FG006|Overall Study|Move/Left to another country/city|0|||
149128986|NCT01723254|537952534|FG007|Overall Study|Move/Left to another country/city|0|||
149128987|NCT01723254|537952527|FG000|Overall Study|Protocol Violation|0|||
149128988|NCT01723254|537952528|FG001|Overall Study|Protocol Violation|1|||
149128989|NCT01723254|537952529|FG002|Overall Study|Protocol Violation|0|||
149128990|NCT01723254|537952530|FG003|Overall Study|Protocol Violation|0|||
149128991|NCT01723254|537952531|FG004|Overall Study|Protocol Violation|0|||
149128992|NCT01723254|537952532|FG005|Overall Study|Protocol Violation|0|||
149128993|NCT01723254|537952533|FG006|Overall Study|Protocol Violation|0|||
149128994|NCT01723254|537952534|FG007|Overall Study|Protocol Violation|0|||
149128995|NCT01723254|537952527|FG000|Overall Study|Withdrawal by Subject|1|||
149128996|NCT01723254|537952528|FG001|Overall Study|Withdrawal by Subject|2|||
149128997|NCT01723254|537952529|FG002|Overall Study|Withdrawal by Subject|1|||
149128998|NCT01723254|537952530|FG003|Overall Study|Withdrawal by Subject|0|||
149128999|NCT01723254|537952531|FG004|Overall Study|Withdrawal by Subject|1|||
149129000|NCT01723254|537952532|FG005|Overall Study|Withdrawal by Subject|1|||
149129001|NCT01723254|537952533|FG006|Overall Study|Withdrawal by Subject|1|||
149129002|NCT01723254|537952534|FG007|Overall Study|Withdrawal by Subject|2|||
149129003|NCT04640077|537952538|FG000|Period 1|Withdrawal by Subject|4|||
148786709|NCT01483599|536696219|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786710|NCT01483599|536696220|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786711|NCT01483599|536696221|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786712|NCT01483599|536696222|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
148786713|NCT01483599|536696209|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786714|NCT01483599|536696210|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
148786715|NCT01483599|536696211|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786716|NCT01483599|536696212|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
148786717|NCT01483599|536696213|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786718|NCT01483599|536696214|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786719|NCT01483599|536696215|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
148786720|NCT01483599|536696216|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149129004|NCT04640077|537952539|FG001|Period 1|Withdrawal by Subject|5|||
149129005|NCT04640077|537952540|FG002|Period 1|Withdrawal by Subject|0|||
149129006|NCT04640077|537952538|FG000|Period 1|Adverse Event|1|||
149129007|NCT04640077|537952539|FG001|Period 1|Adverse Event|1|||
149129008|NCT04640077|537952540|FG002|Period 1|Adverse Event|0|||
149129009|NCT04640077|537952538|FG000|Period 1|Screen Failure|2|||
149129010|NCT04640077|537952539|FG001|Period 1|Screen Failure|0|||
149129011|NCT04640077|537952540|FG002|Period 1|Screen Failure|0|||
149129012|NCT04640077|537952538|FG000|Period 2|Withdrawal by Subject|0|||
149129013|NCT04640077|537952539|FG001|Period 2|Withdrawal by Subject|0|||
149129014|NCT04640077|537952540|FG002|Period 2|Withdrawal by Subject|18|||
149129015|NCT04640077|537952538|FG000|Period 2|Adverse Event|0|||
149129016|NCT04640077|537952539|FG001|Period 2|Adverse Event|0|||
149129017|NCT04640077|537952540|FG002|Period 2|Adverse Event|6|||
149129018|NCT04640077|537952538|FG000|Period 2|Lost to Follow-up|0|||
149129019|NCT04640077|537952539|FG001|Period 2|Lost to Follow-up|0|||
149129020|NCT04640077|537952540|FG002|Period 2|Lost to Follow-up|2|||
149129021|NCT04640077|537952538|FG000|Period 2|Death|0|||
149129022|NCT04640077|537952539|FG001|Period 2|Death|0|||
149129023|NCT04640077|537952540|FG002|Period 2|Death|2|||
149129024|NCT04640077|537952538|FG000|Period 2|Progressive Disease|0|||
149129025|NCT04640077|537952539|FG001|Period 2|Progressive Disease|0|||
149129026|NCT04640077|537952540|FG002|Period 2|Progressive Disease|1|||
149129027|NCT04640077|537952538|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
149129028|NCT04640077|537952539|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
149129029|NCT04640077|537952540|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
149129030|NCT01257425|537952541|FG000|Overall Study|Lack of Efficacy|3|||
149129031|NCT01257425|537952542|FG001|Overall Study|Lack of Efficacy|3|||
149129032|NCT01257425|537952541|FG000|Overall Study|Adverse Event|1|||
149129033|NCT01257425|537952542|FG001|Overall Study|Adverse Event|1|||
149129034|NCT01257425|537952541|FG000|Overall Study|Protocol Violation|1|||
149129035|NCT01257425|537952542|FG001|Overall Study|Protocol Violation|1|||
149129036|NCT01257425|537952541|FG000|Overall Study|Withdrawal by Subject|0|||
149129037|NCT01257425|537952542|FG001|Overall Study|Withdrawal by Subject|1|||
149129038|NCT01257425|537952541|FG000|Overall Study|Death|1|||
149129039|NCT01257425|537952542|FG001|Overall Study|Death|0|||
149129040|NCT00368992|537952547|FG000|Overall Study|Ineligible|5|||
149129041|NCT00368992|537952547|FG000|Overall Study|Refused treatment|3|||
149129042|NCT00368992|537952547|FG000|Overall Study|Lack of Efficacy|63|||
149129043|NCT00368992|537952547|FG000|Overall Study|Adverse Event|26|||
149129044|NCT00368992|537952547|FG000|Overall Study|Death|4|||
149129045|NCT00368992|537952547|FG000|Overall Study|Other|9|||
149129046|NCT02668185|537952554|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
148786721|NCT01483599|536696217|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786722|NCT01483599|536696218|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786723|NCT01483599|536696219|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
149129047|NCT02668185|537952555|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
149129048|NCT02668185|537952554|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
149129049|NCT02668185|537952555|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
149129050|NCT02668185|537952554|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
149129051|NCT02668185|537952555|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
149129052|NCT02668185|537952554|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
149129053|NCT02668185|537952555|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
149129054|NCT01013597|537952556|FG000|Overall Study|Withdrawal by Subject|1|||
149129055|NCT00427895|537952557|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129056|NCT00427895|537952558|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129057|NCT00427895|537952559|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129058|NCT00427895|537952560|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
149129059|NCT00427895|537952561|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129060|NCT00427895|537952562|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129061|NCT00427895|537952563|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129062|NCT00427895|537952564|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
149129063|NCT00427895|537952557|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129064|NCT00427895|537952558|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129065|NCT00427895|537952559|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129066|NCT00427895|537952560|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129067|NCT00427895|537952561|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129068|NCT00427895|537952562|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129069|NCT00427895|537952563|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
149129070|NCT00427895|537952564|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
149129071|NCT00427895|537952557|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129072|NCT00427895|537952558|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129073|NCT00427895|537952559|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129074|NCT00427895|537952560|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129075|NCT00427895|537952561|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129076|NCT00427895|537952562|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129077|NCT00427895|537952563|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
149129078|NCT00427895|537952564|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
149129079|NCT00427895|537952557|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
149129080|NCT00427895|537952558|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
149129081|NCT00427895|537952559|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
149129082|NCT00427895|537952560|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
149129083|NCT00427895|537952561|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
149129084|NCT00427895|537952562|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
149129085|NCT00427895|537952563|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
149129086|NCT00427895|537952564|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
149129087|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
149129088|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
149129089|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
149129090|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
149129091|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
149129092|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
149129093|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
149129094|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
149129095|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
149129096|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
149129097|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
149129098|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
149129099|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
149129100|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
149129101|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
149129102|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
149129103|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
149129104|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
149129105|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149129106|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149129107|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149129108|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149129109|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149129110|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
149129111|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
149129112|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
149129113|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
149129114|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
149129115|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
149129116|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
149129117|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
149129118|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
149129119|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129120|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129121|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129122|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
149129123|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129124|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129125|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129126|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
149129127|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
149129128|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
149129129|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
149129130|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
149129131|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
149129132|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
149129133|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
149129134|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
149129135|NCT00427895|537952557|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
149129136|NCT00427895|537952558|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
149129137|NCT00427895|537952559|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
149129138|NCT00427895|537952560|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
149129139|NCT00427895|537952561|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
149129140|NCT00427895|537952562|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
149129141|NCT00427895|537952563|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
149129142|NCT00427895|537952564|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
149129143|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
149129144|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
149129145|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
149129146|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
149129147|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
149129148|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
149129149|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
149129150|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
149129151|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
149129152|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
149129153|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
149129154|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
149129155|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
149129156|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
149129157|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
149129158|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
149129159|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
148786724|NCT01483599|536696220|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786725|NCT01483599|536696221|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786726|NCT01483599|536696222|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
148786727|NCT01483599|536696209|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
148786728|NCT01483599|536696210|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786729|NCT01483599|536696211|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786730|NCT01483599|536696212|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786731|NCT01483599|536696213|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786732|NCT01483599|536696214|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786733|NCT01483599|536696215|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786734|NCT01483599|536696216|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786735|NCT01483599|536696217|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786736|NCT01483599|536696218|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786737|NCT01483599|536696219|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786738|NCT01483599|536696220|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786739|NCT01483599|536696221|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786740|NCT01483599|536696222|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
148786741|NCT01483599|536696209|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
148786742|NCT01483599|536696210|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
148786743|NCT01483599|536696211|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
148786744|NCT01483599|536696212|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
148786745|NCT01483599|536696213|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
148786746|NCT01483599|536696214|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
148786747|NCT01483599|536696215|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
148786748|NCT01483599|536696216|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
148786749|NCT01483599|536696217|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
148786750|NCT01483599|536696218|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
148786751|NCT01483599|536696219|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
148786752|NCT01483599|536696220|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
148786753|NCT01483599|536696221|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
149129160|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
149129161|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
149129162|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
149129163|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
149129164|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
149129165|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
149129166|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
149129167|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
148786754|NCT01483599|536696222|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
148786755|NCT01483599|536696209|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
148786756|NCT01483599|536696210|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
148786757|NCT01483599|536696211|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
148786758|NCT01483599|536696212|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
148786759|NCT01483599|536696213|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
148786760|NCT01483599|536696214|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
148786761|NCT01483599|536696215|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
148786762|NCT01483599|536696216|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
148786763|NCT01483599|536696217|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
148786764|NCT01483599|536696218|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
148786765|NCT01483599|536696219|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
148786766|NCT01483599|536696220|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
148786767|NCT01483599|536696221|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
148786768|NCT01483599|536696222|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
148786769|NCT01483599|536696209|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786770|NCT01483599|536696210|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786771|NCT01483599|536696211|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786772|NCT01483599|536696212|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786773|NCT01483599|536696213|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786774|NCT01483599|536696214|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786775|NCT01483599|536696215|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786776|NCT01483599|536696216|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
148786777|NCT01483599|536696217|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
148786778|NCT01483599|536696218|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786779|NCT01483599|536696219|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786780|NCT01483599|536696220|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
148786781|NCT01483599|536696221|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
148786782|NCT01483599|536696222|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
148786783|NCT01483599|536696209|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786784|NCT01483599|536696210|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786785|NCT01483599|536696211|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149129168|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
149129169|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149129170|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149129171|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149129172|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149129173|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149129174|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
149129175|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Death|1|||
149129176|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Death|0|||
149129177|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Death|0|||
149129178|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Death|0|||
149129179|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Death|0|||
149129180|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Death|0|||
149129181|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Death|0|||
149129182|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Death|0|||
149129183|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
149129184|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
149129185|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
149129186|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
149129187|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
149129188|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
149129189|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
149129190|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
149129191|NCT00427895|537952557|FG000|Vax 1/Year 1 Follow-up|Other|0|||
149129192|NCT00427895|537952558|FG001|Vax 1/Year 1 Follow-up|Other|0|||
149129193|NCT00427895|537952559|FG002|Vax 1/Year 1 Follow-up|Other|0|||
149129194|NCT00427895|537952560|FG003|Vax 1/Year 1 Follow-up|Other|2|||
149129195|NCT00427895|537952561|FG004|Vax 1/Year 1 Follow-up|Other|0|||
149129196|NCT00427895|537952562|FG005|Vax 1/Year 1 Follow-up|Other|0|||
149129197|NCT00427895|537952563|FG006|Vax 1/Year 1 Follow-up|Other|0|||
149129198|NCT00427895|537952564|FG007|Vax 1/Year 1 Follow-up|Other|0|||
149129199|NCT00427895|537952557|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
148786786|NCT01483599|536696212|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786787|NCT01483599|536696213|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
149129200|NCT00427895|537952558|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
149129201|NCT00427895|537952559|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
149129202|NCT00427895|537952560|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
149129203|NCT00427895|537952561|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
149129204|NCT00427895|537952562|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
149129205|NCT00427895|537952563|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
149129206|NCT00427895|537952564|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
149129207|NCT00585195|537952566|FG000|Overall Study|Adverse Event|0|||
149129208|NCT00585195|537952567|FG001|Overall Study|Adverse Event|0|||
149129209|NCT00585195|537952568|FG002|Overall Study|Adverse Event|0|||
149129210|NCT00585195|537952569|FG003|Overall Study|Adverse Event|0|||
149129211|NCT00585195|537952570|FG004|Overall Study|Adverse Event|2|||
149129212|NCT00585195|537952571|FG005|Overall Study|Adverse Event|1|||
149129213|NCT00585195|537952572|FG006|Overall Study|Adverse Event|0|||
149129214|NCT00585195|537952573|FG007|Overall Study|Adverse Event|1|||
149129215|NCT00585195|537952574|FG008|Overall Study|Adverse Event|0|||
149129216|NCT00585195|537952575|FG009|Overall Study|Adverse Event|0|||
149129217|NCT00585195|537952576|FG010|Overall Study|Adverse Event|3|||
149129218|NCT00585195|537952577|FG011|Overall Study|Adverse Event|0|||
149129219|NCT00585195|537952578|FG012|Overall Study|Adverse Event|8|||
149129220|NCT00585195|537952579|FG013|Overall Study|Adverse Event|6|||
149129221|NCT00585195|537952580|FG014|Overall Study|Adverse Event|4|||
149129222|NCT00585195|537952581|FG015|Overall Study|Adverse Event|1|||
149129223|NCT00585195|537952582|FG016|Overall Study|Adverse Event|14|||
149129224|NCT00585195|537952583|FG017|Overall Study|Adverse Event|9|||
149129225|NCT00585195|537952584|FG018|Overall Study|Adverse Event|2|||
149129226|NCT00585195|537952585|FG019|Overall Study|Adverse Event|3|||
149129227|NCT00585195|537952586|FG020|Overall Study|Adverse Event|1|||
149129228|NCT00585195|537952566|FG000|Overall Study|Progressive Disease|2|||
149129229|NCT00585195|537952567|FG001|Overall Study|Progressive Disease|2|||
149129230|NCT00585195|537952568|FG002|Overall Study|Progressive Disease|5|||
149129231|NCT00585195|537952569|FG003|Overall Study|Progressive Disease|4|||
149129232|NCT00585195|537952570|FG004|Overall Study|Progressive Disease|6|||
149129233|NCT00585195|537952571|FG005|Overall Study|Progressive Disease|4|||
149129234|NCT00585195|537952572|FG006|Overall Study|Progressive Disease|6|||
149129235|NCT00585195|537952573|FG007|Overall Study|Progressive Disease|3|||
149129236|NCT00585195|537952574|FG008|Overall Study|Progressive Disease|0|||
149129237|NCT00585195|537952575|FG009|Overall Study|Progressive Disease|5|||
149129238|NCT00585195|537952576|FG010|Overall Study|Progressive Disease|2|||
149129239|NCT00585195|537952577|FG011|Overall Study|Progressive Disease|25|||
149129240|NCT00585195|537952578|FG012|Overall Study|Progressive Disease|29|||
149129241|NCT00585195|537952579|FG013|Overall Study|Progressive Disease|26|||
149129242|NCT00585195|537952580|FG014|Overall Study|Progressive Disease|21|||
149129243|NCT00585195|537952581|FG015|Overall Study|Progressive Disease|12|||
149129244|NCT00585195|537952582|FG016|Overall Study|Progressive Disease|94|||
149129245|NCT00585195|537952583|FG017|Overall Study|Progressive Disease|42|||
149129246|NCT00585195|537952584|FG018|Overall Study|Progressive Disease|4|||
149129247|NCT00585195|537952585|FG019|Overall Study|Progressive Disease|9|||
149129248|NCT00585195|537952586|FG020|Overall Study|Progressive Disease|8|||
149129249|NCT00585195|537952566|FG000|Overall Study|Withdrawal by Subject|1|||
149129250|NCT00585195|537952567|FG001|Overall Study|Withdrawal by Subject|1|||
149129251|NCT00585195|537952568|FG002|Overall Study|Withdrawal by Subject|2|||
149129252|NCT00585195|537952569|FG003|Overall Study|Withdrawal by Subject|2|||
149129253|NCT00585195|537952570|FG004|Overall Study|Withdrawal by Subject|0|||
149129254|NCT00585195|537952571|FG005|Overall Study|Withdrawal by Subject|0|||
149129255|NCT00585195|537952572|FG006|Overall Study|Withdrawal by Subject|0|||
149129256|NCT00585195|537952573|FG007|Overall Study|Withdrawal by Subject|1|||
149129257|NCT00585195|537952574|FG008|Overall Study|Withdrawal by Subject|0|||
149129258|NCT00585195|537952575|FG009|Overall Study|Withdrawal by Subject|0|||
149129259|NCT00585195|537952576|FG010|Overall Study|Withdrawal by Subject|3|||
149129260|NCT00585195|537952577|FG011|Overall Study|Withdrawal by Subject|8|||
149129261|NCT00585195|537952578|FG012|Overall Study|Withdrawal by Subject|15|||
149129262|NCT00585195|537952579|FG013|Overall Study|Withdrawal by Subject|0|||
149129263|NCT00585195|537952580|FG014|Overall Study|Withdrawal by Subject|3|||
149129264|NCT00585195|537952581|FG015|Overall Study|Withdrawal by Subject|0|||
149129265|NCT00585195|537952582|FG016|Overall Study|Withdrawal by Subject|7|||
149129266|NCT00585195|537952583|FG017|Overall Study|Withdrawal by Subject|1|||
149129267|NCT00585195|537952584|FG018|Overall Study|Withdrawal by Subject|2|||
149129268|NCT00585195|537952585|FG019|Overall Study|Withdrawal by Subject|2|||
149129269|NCT00585195|537952586|FG020|Overall Study|Withdrawal by Subject|0|||
149129270|NCT00585195|537952566|FG000|Overall Study|Other|0|||
149129271|NCT00585195|537952567|FG001|Overall Study|Other|1|||
149129272|NCT00585195|537952568|FG002|Overall Study|Other|1|||
149129273|NCT00585195|537952569|FG003|Overall Study|Other|1|||
149129274|NCT00585195|537952570|FG004|Overall Study|Other|0|||
149129275|NCT00585195|537952571|FG005|Overall Study|Other|1|||
149129276|NCT00585195|537952572|FG006|Overall Study|Other|0|||
149129277|NCT00585195|537952573|FG007|Overall Study|Other|0|||
149129278|NCT00585195|537952574|FG008|Overall Study|Other|2|||
149129279|NCT00585195|537952575|FG009|Overall Study|Other|1|||
149129280|NCT00585195|537952576|FG010|Overall Study|Other|0|||
149129281|NCT00585195|537952577|FG011|Overall Study|Other|19|||
149129282|NCT00585195|537952578|FG012|Overall Study|Other|24|||
149129283|NCT00585195|537952579|FG013|Overall Study|Other|7|||
149129284|NCT00585195|537952580|FG014|Overall Study|Other|11|||
149129285|NCT00585195|537952581|FG015|Overall Study|Other|3|||
149129286|NCT00585195|537952582|FG016|Overall Study|Other|28|||
149129287|NCT00585195|537952583|FG017|Overall Study|Other|12|||
149129288|NCT00585195|537952584|FG018|Overall Study|Other|10|||
149129289|NCT00585195|537952585|FG019|Overall Study|Other|4|||
149129290|NCT00585195|537952586|FG020|Overall Study|Other|2|||
149129291|NCT00585195|537952566|FG000|Overall Study|Randomized not treated|0|||
149129292|NCT00585195|537952567|FG001|Overall Study|Randomized not treated|0|||
149129293|NCT00585195|537952568|FG002|Overall Study|Randomized not treated|1|||
149129294|NCT00585195|537952569|FG003|Overall Study|Randomized not treated|0|||
149129295|NCT00585195|537952570|FG004|Overall Study|Randomized not treated|1|||
149129296|NCT00585195|537952571|FG005|Overall Study|Randomized not treated|0|||
149129297|NCT00585195|537952572|FG006|Overall Study|Randomized not treated|1|||
149129298|NCT00585195|537952573|FG007|Overall Study|Randomized not treated|0|||
149129299|NCT00585195|537952574|FG008|Overall Study|Randomized not treated|0|||
149129300|NCT00585195|537952575|FG009|Overall Study|Randomized not treated|0|||
149129301|NCT00585195|537952576|FG010|Overall Study|Randomized not treated|2|||
149129302|NCT00585195|537952577|FG011|Overall Study|Randomized not treated|0|||
149129303|NCT00585195|537952578|FG012|Overall Study|Randomized not treated|0|||
149129304|NCT00585195|537952579|FG013|Overall Study|Randomized not treated|0|||
149129305|NCT00585195|537952580|FG014|Overall Study|Randomized not treated|0|||
149129306|NCT00585195|537952581|FG015|Overall Study|Randomized not treated|1|||
149129307|NCT00585195|537952582|FG016|Overall Study|Randomized not treated|0|||
149129308|NCT00585195|537952583|FG017|Overall Study|Randomized not treated|1|||
149129309|NCT00585195|537952584|FG018|Overall Study|Randomized not treated|3|||
149129310|NCT00585195|537952585|FG019|Overall Study|Randomized not treated|0|||
149129311|NCT00585195|537952586|FG020|Overall Study|Randomized not treated|2|||
149129312|NCT00585195|537952566|FG000|Overall Study|Death|0|||
149129313|NCT00585195|537952567|FG001|Overall Study|Death|0|||
149129314|NCT00585195|537952568|FG002|Overall Study|Death|0|||
149129315|NCT00585195|537952569|FG003|Overall Study|Death|0|||
149129316|NCT00585195|537952570|FG004|Overall Study|Death|0|||
149129317|NCT00585195|537952571|FG005|Overall Study|Death|0|||
149129318|NCT00585195|537952572|FG006|Overall Study|Death|0|||
149129319|NCT00585195|537952573|FG007|Overall Study|Death|0|||
149129320|NCT00585195|537952574|FG008|Overall Study|Death|1|||
149129321|NCT00585195|537952575|FG009|Overall Study|Death|0|||
149129322|NCT00585195|537952576|FG010|Overall Study|Death|1|||
149129323|NCT00585195|537952577|FG011|Overall Study|Death|1|||
149129324|NCT00585195|537952578|FG012|Overall Study|Death|7|||
149129325|NCT00585195|537952579|FG013|Overall Study|Death|2|||
149129326|NCT00585195|537952580|FG014|Overall Study|Death|8|||
149129327|NCT00585195|537952581|FG015|Overall Study|Death|2|||
149129328|NCT00585195|537952582|FG016|Overall Study|Death|11|||
149129329|NCT00585195|537952583|FG017|Overall Study|Death|0|||
149129330|NCT00585195|537952584|FG018|Overall Study|Death|0|||
149129331|NCT00585195|537952585|FG019|Overall Study|Death|0|||
149129332|NCT00585195|537952586|FG020|Overall Study|Death|1|||
149129333|NCT00585195|537952566|FG000|Overall Study|Lost to Follow-up|0|||
149129334|NCT00585195|537952567|FG001|Overall Study|Lost to Follow-up|0|||
149129335|NCT00585195|537952568|FG002|Overall Study|Lost to Follow-up|0|||
149129336|NCT00585195|537952569|FG003|Overall Study|Lost to Follow-up|0|||
149129337|NCT00585195|537952570|FG004|Overall Study|Lost to Follow-up|0|||
149129338|NCT00585195|537952571|FG005|Overall Study|Lost to Follow-up|0|||
149129339|NCT00585195|537952572|FG006|Overall Study|Lost to Follow-up|0|||
149129340|NCT00585195|537952573|FG007|Overall Study|Lost to Follow-up|0|||
149129341|NCT00585195|537952574|FG008|Overall Study|Lost to Follow-up|0|||
149129342|NCT00585195|537952575|FG009|Overall Study|Lost to Follow-up|0|||
149129343|NCT00585195|537952576|FG010|Overall Study|Lost to Follow-up|0|||
149129344|NCT00585195|537952577|FG011|Overall Study|Lost to Follow-up|0|||
149129345|NCT00585195|537952578|FG012|Overall Study|Lost to Follow-up|1|||
149129346|NCT00585195|537952579|FG013|Overall Study|Lost to Follow-up|0|||
149129347|NCT00585195|537952580|FG014|Overall Study|Lost to Follow-up|0|||
149129348|NCT00585195|537952581|FG015|Overall Study|Lost to Follow-up|0|||
149129349|NCT00585195|537952582|FG016|Overall Study|Lost to Follow-up|0|||
149129350|NCT00585195|537952583|FG017|Overall Study|Lost to Follow-up|2|||
149129351|NCT00585195|537952584|FG018|Overall Study|Lost to Follow-up|0|||
149129352|NCT00585195|537952585|FG019|Overall Study|Lost to Follow-up|0|||
149129353|NCT00585195|537952586|FG020|Overall Study|Lost to Follow-up|0|||
149129354|NCT00585195|537952566|FG000|Overall Study|Site Terminated by Sponsor|0|||
149129355|NCT00585195|537952567|FG001|Overall Study|Site Terminated by Sponsor|0|||
149129356|NCT00585195|537952568|FG002|Overall Study|Site Terminated by Sponsor|0|||
149129357|NCT00585195|537952569|FG003|Overall Study|Site Terminated by Sponsor|0|||
149129358|NCT00585195|537952570|FG004|Overall Study|Site Terminated by Sponsor|0|||
149129359|NCT00585195|537952571|FG005|Overall Study|Site Terminated by Sponsor|0|||
149129360|NCT00585195|537952572|FG006|Overall Study|Site Terminated by Sponsor|0|||
149129361|NCT00585195|537952573|FG007|Overall Study|Site Terminated by Sponsor|0|||
149129362|NCT00585195|537952574|FG008|Overall Study|Site Terminated by Sponsor|0|||
149129363|NCT00585195|537952575|FG009|Overall Study|Site Terminated by Sponsor|0|||
149129364|NCT00585195|537952576|FG010|Overall Study|Site Terminated by Sponsor|0|||
149129365|NCT00585195|537952577|FG011|Overall Study|Site Terminated by Sponsor|0|||
149129366|NCT00585195|537952578|FG012|Overall Study|Site Terminated by Sponsor|1|||
149129367|NCT00585195|537952579|FG013|Overall Study|Site Terminated by Sponsor|0|||
149129368|NCT00585195|537952580|FG014|Overall Study|Site Terminated by Sponsor|0|||
149129369|NCT00585195|537952581|FG015|Overall Study|Site Terminated by Sponsor|0|||
149129370|NCT00585195|537952582|FG016|Overall Study|Site Terminated by Sponsor|0|||
149129371|NCT00585195|537952583|FG017|Overall Study|Site Terminated by Sponsor|0|||
149129372|NCT00585195|537952584|FG018|Overall Study|Site Terminated by Sponsor|0|||
149129373|NCT00585195|537952585|FG019|Overall Study|Site Terminated by Sponsor|0|||
149129374|NCT00585195|537952586|FG020|Overall Study|Site Terminated by Sponsor|0|||
149129375|NCT00585195|537952566|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
149129376|NCT00585195|537952567|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
149129377|NCT00585195|537952568|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
149129378|NCT00585195|537952569|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
149129379|NCT00585195|537952570|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
149129380|NCT00585195|537952571|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
149129381|NCT00585195|537952572|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
149129382|NCT00585195|537952573|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
149129383|NCT00585195|537952574|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
149129384|NCT00585195|537952575|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
149129385|NCT00585195|537952576|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
149129386|NCT00585195|537952577|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
149129387|NCT00585195|537952578|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
149129388|NCT00585195|537952579|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
149129389|NCT00585195|537952580|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
149129390|NCT00585195|537952581|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
149129391|NCT00585195|537952582|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
149129392|NCT00585195|537952583|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
149129393|NCT00585195|537952584|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
149129394|NCT00585195|537952585|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
149129395|NCT00585195|537952586|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
149129396|NCT02796560|537952592|FG000|Overall Study|Adverse Event|2|||
149129397|NCT02796560|537952593|FG001|Overall Study|Adverse Event|0|||
149129398|NCT02796560|537952592|FG000|Overall Study|Withdrawal by Subject|2|||
149129399|NCT02796560|537952593|FG001|Overall Study|Withdrawal by Subject|2|||
149129400|NCT03534284|537952594|FG000|Overall Study|Death|2|||
149129401|NCT03534284|537952595|FG001|Overall Study|Death|3|||
149129402|NCT03534284|537952596|FG002|Overall Study|Death|3|||
149129403|NCT03534284|537952594|FG000|Overall Study|Withdrawal by Subject|5|||
149129404|NCT03534284|537952595|FG001|Overall Study|Withdrawal by Subject|0|||
149129405|NCT03534284|537952596|FG002|Overall Study|Withdrawal by Subject|0|||
149129406|NCT03316300|537952597|FG000|Overall Study|Withdrawal by Subject|3|||
149129407|NCT03316300|537952598|FG001|Overall Study|Withdrawal by Subject|2|||
149129408|NCT03316300|537952597|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
149129409|NCT03316300|537952598|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
149129410|NCT03316300|537952597|FG000|Overall Study|Adverse Event|1|||
149129411|NCT03316300|537952598|FG001|Overall Study|Adverse Event|0|||
149129412|NCT03316300|537952597|FG000|Overall Study|COVID-19|0|||
149129413|NCT03316300|537952598|FG001|Overall Study|COVID-19|1|||
149129414|NCT04737187|537952599|FG000|Overall Study|Switched to marketed drug|32|||
149129415|NCT04737187|537952600|FG001|Overall Study|Switched to marketed drug|4|||
149129416|NCT04737187|537952599|FG000|Overall Study|Radiological Progressive Disease|145|||
149129417|NCT04737187|537952600|FG001|Overall Study|Radiological Progressive Disease|146|||
149129418|NCT04737187|537952599|FG000|Overall Study|Clinical Progressive Disease|20|||
149129419|NCT04737187|537952600|FG001|Overall Study|Clinical Progressive Disease|20|||
149129420|NCT04737187|537952599|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
149129421|NCT04737187|537952600|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
149129422|NCT04737187|537952599|FG000|Overall Study|Adverse Event|16|||
149129423|NCT04737187|537952600|FG001|Overall Study|Adverse Event|16|||
149129424|NCT04737187|537952599|FG000|Overall Study|Physician Decision|2|||
149129425|NCT04737187|537952600|FG001|Overall Study|Physician Decision|0|||
149129426|NCT04737187|537952599|FG000|Overall Study|Withdrawal by Subject|5|||
149129427|NCT04737187|537952600|FG001|Overall Study|Withdrawal by Subject|8|||
149129428|NCT01910181|537952603|FG000|Overall Study|Death|37|||
149129429|NCT01910181|537952603|FG000|Overall Study|Lost to Follow-up|3|||
149129430|NCT01910181|537952603|FG000|Overall Study|Study Terminated by Sponsor|6|||
149129431|NCT02656823|537952604|FG000|Overall Study|Adverse Event|3|||
149129432|NCT02656823|537952604|FG000|Overall Study|Lost to Follow-up|2|||
149129433|NCT01340651|537952608|FG000|Overall Study|Adverse Event|3|||
149129434|NCT01340651|537952608|FG000|Overall Study|Consent Withdrawn|2|||
149129435|NCT01340651|537952608|FG000|Overall Study|Commercial Supply per Sponsor|12|||
149129436|NCT01315353|537952609|FG000|Overall Study|Death|2|||
149129437|NCT01315353|537952610|FG001|Overall Study|Death|1|||
149129438|NCT01315353|537952611|FG002|Overall Study|Death|0|||
148786788|NCT01483599|536696214|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786789|NCT01483599|536696215|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786790|NCT01483599|536696216|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786791|NCT01483599|536696217|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
148786792|NCT01483599|536696218|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786793|NCT01483599|536696219|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786794|NCT01483599|536696220|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
148786795|NCT01483599|536696221|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
148786796|NCT01483599|536696222|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
148786797|NCT01483599|536696209|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786798|NCT01483599|536696210|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786799|NCT01483599|536696211|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786800|NCT01483599|536696212|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786801|NCT01483599|536696213|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786802|NCT01483599|536696214|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786803|NCT01483599|536696215|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786804|NCT01483599|536696216|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786805|NCT01483599|536696217|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
148786806|NCT01483599|536696218|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786807|NCT01483599|536696219|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
148786808|NCT01483599|536696220|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786809|NCT01483599|536696221|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
148786810|NCT01483599|536696222|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
148786811|NCT01483599|536696209|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786812|NCT01483599|536696210|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786813|NCT01483599|536696211|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786814|NCT01483599|536696212|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786815|NCT01483599|536696213|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786816|NCT01483599|536696214|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786817|NCT01483599|536696215|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786818|NCT01483599|536696216|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786819|NCT01483599|536696217|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
148786820|NCT01483599|536696218|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786821|NCT01483599|536696219|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786822|NCT01483599|536696220|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
148786823|NCT01483599|536696221|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
148786824|NCT01483599|536696222|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
148786825|NCT01483599|536696209|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
148786826|NCT01483599|536696210|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
148786827|NCT01483599|536696211|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
148786828|NCT01483599|536696212|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
148786829|NCT01483599|536696213|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
148786830|NCT01483599|536696214|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
148786831|NCT01483599|536696215|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
148786832|NCT01483599|536696216|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
148786833|NCT01483599|536696217|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
148786834|NCT01483599|536696218|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
148786835|NCT01483599|536696219|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
148786836|NCT01483599|536696220|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
148786837|NCT01483599|536696221|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
148786838|NCT01483599|536696222|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
148786839|NCT02109445|536696223|FG000|Overall Study|Symptomatic deterioration|2|||
148786840|NCT02109445|536696223|FG000|Overall Study|Adverse Event|1|||
148786841|NCT00966355|536696226|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
148786842|NCT00966355|536696227|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
148786843|NCT00966355|536696228|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
148786844|NCT00966355|536696226|FG000|Overall Study|newly diagnosed advanced HCC|11|||
148786845|NCT00966355|536696227|FG001|Overall Study|newly diagnosed advanced HCC|12|||
148786846|NCT00966355|536696228|FG002|Overall Study|newly diagnosed advanced HCC|10|||
148786847|NCT00966355|536696226|FG000|Overall Study|Lost to Follow-up|5|||
148786848|NCT00966355|536696227|FG001|Overall Study|Lost to Follow-up|4|||
148786849|NCT00966355|536696228|FG002|Overall Study|Lost to Follow-up|3|||
149129439|NCT01315353|537952609|FG000|Overall Study|Withdrawal by Subject|2|||
149129440|NCT01315353|537952610|FG001|Overall Study|Withdrawal by Subject|6|||
149129441|NCT01315353|537952611|FG002|Overall Study|Withdrawal by Subject|1|||
149129442|NCT01315353|537952609|FG000|Overall Study|Lost to Follow-up|13|||
149129443|NCT01315353|537952610|FG001|Overall Study|Lost to Follow-up|6|||
148786850|NCT00958412|536696229|FG000|Overall Study|Study prematurely terminated|18|||
148786851|NCT02552888|536696230|FG000|Overall Study|Lost to Follow-up|1|||
148786852|NCT02552888|536696231|FG001|Overall Study|Lost to Follow-up|1|||
148786853|NCT04378569|536697947|FG000|Overall Study|Adverse Event|0|||
148786854|NCT04378569|536697948|FG001|Overall Study|Adverse Event|0|||
148786855|NCT04378569|536697949|FG002|Overall Study|Adverse Event|2|||
148786856|NCT04378569|536697950|FG003|Overall Study|Adverse Event|0|||
148786857|NCT04378569|536697951|FG004|Overall Study|Adverse Event|3|||
148786858|NCT04378569|536697952|FG005|Overall Study|Adverse Event|3|||
148786859|NCT04378569|536697947|FG000|Overall Study|Lost to Follow-up|0|||
148786860|NCT04378569|536697948|FG001|Overall Study|Lost to Follow-up|3|||
148786861|NCT04378569|536697949|FG002|Overall Study|Lost to Follow-up|1|||
148786862|NCT04378569|536697950|FG003|Overall Study|Lost to Follow-up|0|||
148786863|NCT04378569|536697951|FG004|Overall Study|Lost to Follow-up|1|||
148786864|NCT04378569|536697952|FG005|Overall Study|Lost to Follow-up|1|||
148786865|NCT04378569|536697947|FG000|Overall Study|Protocol Violation|0|||
148786866|NCT04378569|536697948|FG001|Overall Study|Protocol Violation|0|||
148786867|NCT04378569|536697949|FG002|Overall Study|Protocol Violation|0|||
148786868|NCT04378569|536697950|FG003|Overall Study|Protocol Violation|0|||
148786869|NCT04378569|536697951|FG004|Overall Study|Protocol Violation|0|||
148786870|NCT04378569|536697952|FG005|Overall Study|Protocol Violation|1|||
148786871|NCT04378569|536697947|FG000|Overall Study|Withdrawal by Subject|0|||
148786872|NCT04378569|536697948|FG001|Overall Study|Withdrawal by Subject|6|||
148786873|NCT04378569|536697949|FG002|Overall Study|Withdrawal by Subject|7|||
148786874|NCT04378569|536697950|FG003|Overall Study|Withdrawal by Subject|4|||
148786875|NCT04378569|536697951|FG004|Overall Study|Withdrawal by Subject|5|||
148786876|NCT04378569|536697952|FG005|Overall Study|Withdrawal by Subject|4|||
148786877|NCT04378569|536697947|FG000|Overall Study|Lack of response|0|||
148786878|NCT04378569|536697948|FG001|Overall Study|Lack of response|0|||
148786879|NCT04378569|536697949|FG002|Overall Study|Lack of response|1|||
148786880|NCT04378569|536697950|FG003|Overall Study|Lack of response|0|||
148786881|NCT04378569|536697951|FG004|Overall Study|Lack of response|1|||
148786882|NCT04378569|536697952|FG005|Overall Study|Lack of response|1|||
148786883|NCT01048944|536697953|FG000|Overall Study|Protocol Violation|8|||
148786884|NCT01048944|536697954|FG001|Overall Study|Protocol Violation|10|||
148786885|NCT01048944|536697955|FG002|Overall Study|Protocol Violation|10|||
148786886|NCT01048944|536697956|FG003|Overall Study|Protocol Violation|2|||
148786887|NCT01844817|536697957|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
148786888|NCT01844817|536697958|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
148786889|NCT01844817|536697957|FG000|Treatment|Progressive Disease|27|||
148786890|NCT01844817|536697958|FG001|Treatment|Progressive Disease|36|||
148786891|NCT01844817|536697957|FG000|Treatment|Adverse Event|17|||
148786892|NCT01844817|536697958|FG001|Treatment|Adverse Event|9|||
148786893|NCT01844817|536697957|FG000|Treatment|Withdrawal by Subject|10|||
148786894|NCT01844817|536697958|FG001|Treatment|Withdrawal by Subject|6|||
148786895|NCT01844817|536697957|FG000|Treatment|Death|10|||
148786896|NCT01844817|536697958|FG001|Treatment|Death|8|||
148786897|NCT01844817|536697957|FG000|Treatment|Lost to Follow-up|0|||
148786898|NCT01844817|536697958|FG001|Treatment|Lost to Follow-up|1|||
148786899|NCT01844817|536697957|FG000|Treatment|Other|0|||
148786900|NCT01844817|536697958|FG001|Treatment|Other|3|||
148786901|NCT03630705|536697959|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
148786902|NCT03630705|536697960|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
148786903|NCT03630705|536697961|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
148786904|NCT03630705|536697962|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
148786905|NCT03630705|536697959|FG000|Overall Study|Lost to Follow-up|1|||
148786906|NCT03630705|536697960|FG001|Overall Study|Lost to Follow-up|2|||
148786907|NCT03630705|536697961|FG002|Overall Study|Lost to Follow-up|0|||
149129444|NCT01315353|537952611|FG002|Overall Study|Lost to Follow-up|6|||
149129445|NCT01315353|537952609|FG000|Overall Study|Unwilling to adhere to requirements|5|||
149129446|NCT01315353|537952610|FG001|Overall Study|Unwilling to adhere to requirements|5|||
149129447|NCT01315353|537952611|FG002|Overall Study|Unwilling to adhere to requirements|4|||
148786908|NCT03630705|536697962|FG003|Overall Study|Lost to Follow-up|0|||
148786909|NCT01128400|536697963|FG000|Overall Study|Lost to Follow-up|1|||
148786910|NCT01128400|536697964|FG001|Overall Study|Lost to Follow-up|0|||
148786911|NCT01128400|536697965|FG002|Overall Study|Lost to Follow-up|1|||
148786912|NCT01128400|536697963|FG000|Overall Study|Screening failure|1|||
148786913|NCT01128400|536697964|FG001|Overall Study|Screening failure|0|||
148786914|NCT01128400|536697965|FG002|Overall Study|Screening failure|0|||
148786915|NCT01128400|536697963|FG000|Overall Study|were not invited to participate on taste|0|||
148786916|NCT01128400|536697964|FG001|Overall Study|were not invited to participate on taste|0|||
148786917|NCT01128400|536697965|FG002|Overall Study|were not invited to participate on taste|15|||
148786918|NCT01128400|536697963|FG000|Overall Study|Excluded due to sinus problems|0|||
148786919|NCT01128400|536697964|FG001|Overall Study|Excluded due to sinus problems|1|||
148786920|NCT01128400|536697965|FG002|Overall Study|Excluded due to sinus problems|0|||
148786921|NCT02362425|536697966|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
148786922|NCT02362425|536697967|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
148893404|NCT01693029|537088701|FG001|Overall Study|Physician Decision|2|||
148786923|NCT02362425|536697968|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
148786924|NCT02362425|536697969|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
148786925|NCT02362425|536697966|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
149129448|NCT01315353|537952609|FG000|Overall Study|Site closing|7|||
149129449|NCT01315353|537952610|FG001|Overall Study|Site closing|4|||
149129450|NCT01315353|537952611|FG002|Overall Study|Site closing|0|||
149129451|NCT01315353|537952609|FG000|Overall Study|Taken off study by site in error|0|||
149129452|NCT01315353|537952610|FG001|Overall Study|Taken off study by site in error|1|||
149129453|NCT01315353|537952611|FG002|Overall Study|Taken off study by site in error|0|||
149129454|NCT01315353|537952609|FG000|Overall Study|Inadvertent randomization/assignment|0|||
149129455|NCT01315353|537952610|FG001|Overall Study|Inadvertent randomization/assignment|0|||
149129456|NCT01315353|537952611|FG002|Overall Study|Inadvertent randomization/assignment|2|||
149129457|NCT03567434|537952612|FG000|Overall Study|Lost to Follow-up|1|||
149129458|NCT03567434|537952613|FG001|Overall Study|Lost to Follow-up|3|||
149129459|NCT01009580|537952614|FG000|Overall Study|Adverse Event|4|||
149129460|NCT01009580|537952615|FG001|Overall Study|Adverse Event|4|||
149129461|NCT01009580|537952614|FG000|Overall Study|Lack of Efficacy|0|||
149129462|NCT01009580|537952615|FG001|Overall Study|Lack of Efficacy|1|||
149129463|NCT01009580|537952614|FG000|Overall Study|Protocol Violation|2|||
149129464|NCT01009580|537952615|FG001|Overall Study|Protocol Violation|3|||
149129465|NCT01009580|537952614|FG000|Overall Study|Withdrawal Criteria|4|||
149129466|NCT01009580|537952615|FG001|Overall Study|Withdrawal Criteria|6|||
149129467|NCT01009580|537952614|FG000|Overall Study|Unclassified|17|||
149129468|NCT01009580|537952615|FG001|Overall Study|Unclassified|21|||
149129469|NCT04469270|537952616|FG000|Overall Study|Adverse Event|2|||
149129470|NCT04469270|537952617|FG001|Overall Study|Adverse Event|0|||
149129471|NCT04469270|537952616|FG000|Overall Study|Lost to Follow-up|4|||
149129472|NCT04469270|537952617|FG001|Overall Study|Lost to Follow-up|3|||
149129473|NCT04469270|537952616|FG000|Overall Study|Withdrawal by Subject|7|||
149129474|NCT04469270|537952617|FG001|Overall Study|Withdrawal by Subject|3|||
149129475|NCT04469270|537952616|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
149129476|NCT04469270|537952617|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
149129477|NCT04469270|537952616|FG000|Overall Study|missing|1|||
149129478|NCT04469270|537952617|FG001|Overall Study|missing|0|||
149129479|NCT05437510|537952618|FG000|Overall Study|Adverse Event|2|||
149129480|NCT05437510|537952619|FG001|Overall Study|Adverse Event|1|||
149129481|NCT05437510|537952618|FG000|Overall Study|Protocol Deviation|1|||
149129482|NCT05437510|537952619|FG001|Overall Study|Protocol Deviation|6|||
149129483|NCT05437510|537952618|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
149129484|NCT05437510|537952619|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
149129485|NCT05437510|537952618|FG000|Overall Study|Lost to Follow-up|265|||
149129486|NCT05437510|537952619|FG001|Overall Study|Lost to Follow-up|358|||
149129487|NCT03573401|537952620|FG000|Overall Study|Withdrawal by Subject|2|||
149129488|NCT03573401|537952621|FG001|Overall Study|Withdrawal by Subject|0|||
149129489|NCT03573401|537952620|FG000|Overall Study|Subject non-compliance with study schedule|1|||
149129490|NCT03573401|537952621|FG001|Overall Study|Subject non-compliance with study schedule|0|||
149129491|NCT03573401|537952620|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
149129492|NCT03573401|537952621|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
149129493|NCT03573401|537952620|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
149129494|NCT03573401|537952621|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
149129495|NCT00355056|537954469|FG000|Randomization Period|Early Termination|4|||
149129496|NCT00355056|537954470|FG001|Randomization Period|Early Termination|6|||
149129497|NCT01072877|537954471|FG000|Overall Study|Lost to Follow-up|1|||
149129498|NCT01072877|537954472|FG001|Overall Study|Lost to Follow-up|1|||
149129499|NCT01072877|537954473|FG002|Overall Study|Lost to Follow-up|0|||
149129500|NCT01072877|537954474|FG003|Overall Study|Lost to Follow-up|2|||
149129501|NCT01072877|537954475|FG004|Overall Study|Lost to Follow-up|0|||
149129502|NCT00995020|537954476|FG000|Overall Study|margin analysis not performed|2|||
149129503|NCT00995020|537954477|FG001|Overall Study|margin analysis not performed|5|||
149129504|NCT00995020|537954476|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
149129505|NCT00995020|537954477|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
149129506|NCT01256658|537954482|FG000|Period 1|Lost to Follow-up|837|||
149129507|NCT01256658|537954483|FG001|Period 1|Lost to Follow-up|661|||
149129508|NCT01256658|537954482|FG000|Period 1|Withdrawal by Subject|35|||
149129509|NCT01256658|537954483|FG001|Period 1|Withdrawal by Subject|43|||
149129510|NCT01256658|537954482|FG000|Period 1|Death|48|||
148786926|NCT02362425|536697967|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
149129511|NCT01256658|537954483|FG001|Period 1|Death|44|||
148786927|NCT02362425|536697968|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
149129512|NCT00719563|537954484|FG000|Overall Study|Adverse Event|16|||
149129513|NCT00719563|537954485|FG001|Overall Study|Adverse Event|13|||
149129514|NCT00719563|537954484|FG000|Overall Study|Medical condition changed|3|||
149129515|NCT00719563|537954485|FG001|Overall Study|Medical condition changed|5|||
149129516|NCT00719563|537954484|FG000|Overall Study|Lack of Efficacy|3|||
148786928|NCT02362425|536697969|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
148786929|NCT02362425|536697966|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
148786930|NCT02362425|536697967|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
148786931|NCT02362425|536697968|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
148786932|NCT02362425|536697969|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
148786933|NCT02362425|536697966|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
148786934|NCT02362425|536697967|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
148786935|NCT02362425|536697968|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
148786936|NCT02362425|536697969|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
148786937|NCT02362425|536697966|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
148786938|NCT02362425|536697967|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
148786939|NCT02362425|536697968|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
148786940|NCT02362425|536697969|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
148786941|NCT02362425|536697966|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
148786942|NCT02362425|536697967|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
148786943|NCT02362425|536697968|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
148786944|NCT02362425|536697969|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
148786945|NCT02362425|536697966|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
148786946|NCT02362425|536697967|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
148786947|NCT02362425|536697968|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
148786948|NCT02362425|536697969|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
148786949|NCT02362425|536697966|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
148786950|NCT02362425|536697967|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
148786951|NCT02362425|536697968|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
148786952|NCT02362425|536697969|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
148786953|NCT02688764|536697972|FG000|Overall Study|Adverse Event|3|||
148786954|NCT02688764|536697973|FG001|Overall Study|Adverse Event|3|||
148786955|NCT02688764|536697972|FG000|Overall Study|AE/Kidney transplant|1|||
148786956|NCT02688764|536697973|FG001|Overall Study|AE/Kidney transplant|0|||
148786957|NCT02688764|536697972|FG000|Overall Study|AE/Lack of efficacy|1|||
148786958|NCT02688764|536697973|FG001|Overall Study|AE/Lack of efficacy|0|||
148786959|NCT02688764|536697972|FG000|Overall Study|AE/Non-compl.|1|||
148786960|NCT02688764|536697973|FG001|Overall Study|AE/Non-compl.|0|||
148786961|NCT02688764|536697972|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
148786962|NCT02688764|536697973|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
148786963|NCT02688764|536697972|FG000|Overall Study|AE/Other|0|||
148786964|NCT02688764|536697973|FG001|Overall Study|AE/Other|1|||
148786965|NCT02688764|536697972|FG000|Overall Study|AE/Physician decision|1|||
148786966|NCT02688764|536697973|FG001|Overall Study|AE/Physician decision|0|||
148786967|NCT02688764|536697972|FG000|Overall Study|AE/Withd. parent|3|||
148786968|NCT02688764|536697973|FG001|Overall Study|AE/Withd. parent|0|||
148786969|NCT02688764|536697972|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
148786970|NCT02688764|536697973|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
148786971|NCT02688764|536697972|FG000|Overall Study|AE/Withd. subject|1|||
148786972|NCT02688764|536697973|FG001|Overall Study|AE/Withd. subject|0|||
148786973|NCT02688764|536697972|FG000|Overall Study|Kidney transplant|10|||
148786974|NCT02688764|536697973|FG001|Overall Study|Kidney transplant|4|||
148786975|NCT02688764|536697972|FG000|Overall Study|Lack of Efficacy|3|||
148786976|NCT02688764|536697973|FG001|Overall Study|Lack of Efficacy|2|||
148786977|NCT02688764|536697972|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
148786978|NCT02688764|536697973|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
148786979|NCT02688764|536697972|FG000|Overall Study|Non-compliance with study drug|4|||
148786980|NCT02688764|536697973|FG001|Overall Study|Non-compliance with study drug|0|||
148786981|NCT02688764|536697972|FG000|Overall Study|Non-compl./Physician decision|2|||
148786982|NCT02688764|536697973|FG001|Overall Study|Non-compl./Physician decision|0|||
149011387|NCT01535274|537521461|FG001|Overall Study|Misallocated to propofol intervention|1|||
148786983|NCT02688764|536697972|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
148786984|NCT02688764|536697973|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
148786985|NCT02688764|536697972|FG000|Overall Study|Non-compl./Withd. subject|0|||
148786986|NCT02688764|536697973|FG001|Overall Study|Non-compl./Withd. subject|2|||
148786987|NCT02688764|536697972|FG000|Overall Study|Phosphorus level outside safe range|0|||
148786988|NCT02688764|536697973|FG001|Overall Study|Phosphorus level outside safe range|1|||
149011388|NCT02690077|537521462|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
149011389|NCT02690077|537521463|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
149011390|NCT02690077|537521462|FG000|Overall Study|Withdrawal by Subject|0|||
149011391|NCT02690077|537521463|FG001|Overall Study|Withdrawal by Subject|5|||
149011392|NCT02690077|537521462|FG000|Overall Study|Excluded by IRB|0|||
149011393|NCT02690077|537521463|FG001|Overall Study|Excluded by IRB|2|||
149011394|NCT00594217|537521464|FG000|Overall Study|Withdrawal by Subject|1|||
149011395|NCT00594217|537521465|FG001|Overall Study|Withdrawal by Subject|3|||
148786989|NCT02688764|536697972|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
148786990|NCT02688764|536697973|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
148786991|NCT02688764|536697972|FG000|Overall Study|Study drug taste/Withd. parent|1|||
148786992|NCT02688764|536697973|FG001|Overall Study|Study drug taste/Withd. parent|0|||
148786993|NCT02688764|536697972|FG000|Overall Study|Subject moving out|2|||
148786994|NCT02688764|536697973|FG001|Overall Study|Subject moving out|0|||
148786995|NCT02688764|536697972|FG000|Overall Study|Subject taken off dialysis|1|||
148786996|NCT02688764|536697973|FG001|Overall Study|Subject taken off dialysis|0|||
148786997|NCT02688764|536697972|FG000|Overall Study|Withdrawal by parent|3|||
148786998|NCT02688764|536697973|FG001|Overall Study|Withdrawal by parent|0|||
148786999|NCT02113007|536697974|FG000|Overall Study|Progressive disease|2|||
148787000|NCT04750278|536697975|FG000|Overall Study|Death|9|||
148787001|NCT04750278|536697976|FG001|Overall Study|Death|10|||
148787002|NCT04750278|536697977|FG002|Overall Study|Death|10|||
148787003|NCT04750278|536697975|FG000|Overall Study|Withdrawal by Subject|4|||
148787004|NCT04750278|536697976|FG001|Overall Study|Withdrawal by Subject|1|||
148787005|NCT04750278|536697977|FG002|Overall Study|Withdrawal by Subject|2|||
148787006|NCT04750278|536697975|FG000|Overall Study|Lost to Follow-up|1|||
148787007|NCT04750278|536697976|FG001|Overall Study|Lost to Follow-up|1|||
148787008|NCT04750278|536697977|FG002|Overall Study|Lost to Follow-up|1|||
148787009|NCT04750278|536697975|FG000|Overall Study|Pregnancy|1|||
148787010|NCT04750278|536697976|FG001|Overall Study|Pregnancy|0|||
148787011|NCT04750278|536697977|FG002|Overall Study|Pregnancy|0|||
148787012|NCT04750278|536697975|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
148787013|NCT04750278|536697976|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
148787014|NCT04750278|536697977|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
148787015|NCT04750278|536697975|FG000|Overall Study|Non-compliance|0|||
148787016|NCT04750278|536697976|FG001|Overall Study|Non-compliance|0|||
148787017|NCT04750278|536697977|FG002|Overall Study|Non-compliance|1|||
148787018|NCT04750278|536697975|FG000|Overall Study|Transfer to Outside Facility|0|||
148787019|NCT04750278|536697976|FG001|Overall Study|Transfer to Outside Facility|2|||
148787020|NCT04750278|536697977|FG002|Overall Study|Transfer to Outside Facility|1|||
148787021|NCT04750278|536697975|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
148787022|NCT04750278|536697976|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
148787023|NCT04750278|536697977|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
148787024|NCT04750278|536697975|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
148787025|NCT04750278|536697976|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
148787026|NCT04750278|536697977|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
148787027|NCT03026283|536697978|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
148787028|NCT03026283|536697979|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
148787029|NCT03026283|536697980|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
148787030|NCT03026283|536697981|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
148787031|NCT03026283|536697982|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
148787032|NCT03026283|536697983|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
148787033|NCT03026283|536697984|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
148787034|NCT03026283|536697985|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
148787035|NCT03026283|536697978|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
148787036|NCT03026283|536697979|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
148787037|NCT03026283|536697980|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
148787038|NCT03026283|536697981|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
148787039|NCT03026283|536697982|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
148787040|NCT03026283|536697983|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
148787041|NCT03026283|536697984|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
148787042|NCT03026283|536697985|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
148787043|NCT03026283|536697978|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787044|NCT03026283|536697979|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
148787045|NCT03026283|536697980|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787046|NCT03026283|536697981|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787047|NCT03026283|536697982|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787048|NCT03026283|536697983|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787049|NCT03026283|536697984|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787050|NCT03026283|536697985|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
148787051|NCT03026283|536697978|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787052|NCT03026283|536697979|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787053|NCT03026283|536697980|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
148787054|NCT03026283|536697981|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787055|NCT03026283|536697982|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787056|NCT03026283|536697983|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787057|NCT03026283|536697984|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787058|NCT03026283|536697985|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
148787059|NCT03026283|536697978|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
148787060|NCT03026283|536697979|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
148787061|NCT03026283|536697980|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
148787062|NCT03026283|536697981|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
148787063|NCT03026283|536697982|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
148787064|NCT03026283|536697983|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
148787065|NCT03026283|536697984|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
148787066|NCT03026283|536697985|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
148787067|NCT03026283|536697978|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
148787068|NCT03026283|536697979|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
148787069|NCT03026283|536697980|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
148787070|NCT03026283|536697981|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
148787071|NCT03026283|536697982|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
148787072|NCT03026283|536697983|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
148787073|NCT03026283|536697984|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
148787074|NCT03026283|536697985|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
148787075|NCT03026283|536697978|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
148787076|NCT03026283|536697979|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
148787077|NCT03026283|536697980|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
148787078|NCT03026283|536697981|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
148787079|NCT03026283|536697982|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
148787080|NCT03026283|536697983|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
148787081|NCT03026283|536697984|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
148787082|NCT03026283|536697985|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
148787083|NCT03026283|536697978|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787084|NCT03026283|536697979|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787085|NCT03026283|536697980|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787086|NCT03026283|536697981|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
148787087|NCT03026283|536697982|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787088|NCT03026283|536697983|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787089|NCT03026283|536697984|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787090|NCT03026283|536697985|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
148787091|NCT03026283|536697978|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
148787092|NCT03026283|536697979|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
148787093|NCT03026283|536697980|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
148787094|NCT03026283|536697981|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
148787095|NCT03026283|536697982|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
148787096|NCT03026283|536697983|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
148787097|NCT03026283|536697984|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
148787098|NCT03026283|536697985|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
148787099|NCT01054222|536697990|FG000|Overall Study|Lack of Efficacy|1|||
148787100|NCT01054222|536697990|FG000|Overall Study|Lost to Follow-up|4|||
148787101|NCT01054222|536697990|FG000|Overall Study|Withdrawal by Subject|6|||
148787102|NCT00824655|536697991|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
148787103|NCT00824655|536697992|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
148787104|NCT00824655|536697991|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
148787105|NCT00824655|536697992|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
148787106|NCT03782571|536697993|FG000|Period 1|Withdrawal by Subject|1|||
148787107|NCT03782571|536697994|FG001|Period 1|Withdrawal by Subject|0|||
148787108|NCT03782571|536697995|FG002|Period 1|Withdrawal by Subject|0|||
148787109|NCT03782571|536697996|FG003|Period 1|Withdrawal by Subject|0|||
148787110|NCT03782571|536697993|FG000|Period 3|Subject Unable to Attend V5|1|||
148787111|NCT03782571|536697994|FG001|Period 3|Subject Unable to Attend V5|0|||
148787112|NCT03782571|536697995|FG002|Period 3|Subject Unable to Attend V5|0|||
148787113|NCT03782571|536697996|FG003|Period 3|Subject Unable to Attend V5|0|||
148787114|NCT03782571|536697993|FG000|Period 3|Adverse Event|1|||
148787115|NCT03782571|536697994|FG001|Period 3|Adverse Event|0|||
148787116|NCT03782571|536697995|FG002|Period 3|Adverse Event|0|||
148787117|NCT03782571|536697996|FG003|Period 3|Adverse Event|0|||
148787118|NCT03504189|536697997|FG000|Overall Study|Withdrawal by Subject|1|||
148787119|NCT03504189|536697997|FG000|Overall Study|Screening Failure|1|||
148787120|NCT03504189|536697997|FG000|Overall Study|Device Failure|2|||
149129517|NCT00719563|537954485|FG001|Overall Study|Lack of Efficacy|7|||
148787121|NCT03091738|536697998|FG000|Overall Study|Adverse Event|1|||
148787122|NCT03091738|536697998|FG000|Overall Study|Lost to Follow-up|1|||
149129518|NCT00719563|537954484|FG000|Overall Study|Personal reasons|6|||
149129519|NCT00719563|537954485|FG001|Overall Study|Personal reasons|7|||
148787123|NCT01826981|536698009|FG000|Overall Study|Lack of Efficacy|0|||
148787124|NCT01826981|536698010|FG001|Overall Study|Lack of Efficacy|1|||
148787125|NCT01826981|536698011|FG002|Overall Study|Lack of Efficacy|0|||
148787126|NCT01826981|536698012|FG003|Overall Study|Lack of Efficacy|0|||
148787127|NCT01826981|536698013|FG004|Overall Study|Lack of Efficacy|5|||
148787128|NCT01826981|536698014|FG005|Overall Study|Lack of Efficacy|0|||
148787129|NCT01826981|536698015|FG006|Overall Study|Lack of Efficacy|0|||
148787130|NCT01826981|536698016|FG007|Overall Study|Lack of Efficacy|8|||
148787131|NCT01826981|536698017|FG008|Overall Study|Lack of Efficacy|7|||
148787132|NCT01826981|536698018|FG009|Overall Study|Lack of Efficacy|0|||
148787133|NCT01826981|536698019|FG010|Overall Study|Lack of Efficacy|1|||
148787134|NCT01826981|536698020|FG011|Overall Study|Lack of Efficacy|0|||
148787135|NCT01826981|536698021|FG012|Overall Study|Lack of Efficacy|0|||
148787136|NCT01826981|536698022|FG013|Overall Study|Lack of Efficacy|3|||
148787137|NCT01826981|536698023|FG014|Overall Study|Lack of Efficacy|0|||
148787138|NCT01826981|536698009|FG000|Overall Study|Lost to Follow-up|0|||
148787139|NCT01826981|536698010|FG001|Overall Study|Lost to Follow-up|0|||
148787140|NCT01826981|536698011|FG002|Overall Study|Lost to Follow-up|0|||
148787141|NCT01826981|536698012|FG003|Overall Study|Lost to Follow-up|0|||
148787142|NCT01826981|536698013|FG004|Overall Study|Lost to Follow-up|1|||
148787143|NCT01826981|536698014|FG005|Overall Study|Lost to Follow-up|1|||
148787144|NCT01826981|536698015|FG006|Overall Study|Lost to Follow-up|0|||
148787145|NCT01826981|536698016|FG007|Overall Study|Lost to Follow-up|1|||
148787146|NCT01826981|536698017|FG008|Overall Study|Lost to Follow-up|0|||
148787147|NCT01826981|536698018|FG009|Overall Study|Lost to Follow-up|1|||
148787148|NCT01826981|536698019|FG010|Overall Study|Lost to Follow-up|1|||
148787149|NCT01826981|536698020|FG011|Overall Study|Lost to Follow-up|1|||
148787150|NCT01826981|536698021|FG012|Overall Study|Lost to Follow-up|1|||
148787151|NCT01826981|536698022|FG013|Overall Study|Lost to Follow-up|0|||
148787152|NCT01826981|536698023|FG014|Overall Study|Lost to Follow-up|0|||
148787153|NCT01826981|536698009|FG000|Overall Study|Withdrew Consent|0|||
148787154|NCT01826981|536698010|FG001|Overall Study|Withdrew Consent|0|||
148787155|NCT01826981|536698011|FG002|Overall Study|Withdrew Consent|0|||
148787156|NCT01826981|536698012|FG003|Overall Study|Withdrew Consent|0|||
148787157|NCT01826981|536698013|FG004|Overall Study|Withdrew Consent|0|||
148787158|NCT01826981|536698014|FG005|Overall Study|Withdrew Consent|0|||
148787159|NCT01826981|536698015|FG006|Overall Study|Withdrew Consent|1|||
148787160|NCT01826981|536698016|FG007|Overall Study|Withdrew Consent|1|||
148787161|NCT01826981|536698017|FG008|Overall Study|Withdrew Consent|0|||
148787162|NCT01826981|536698018|FG009|Overall Study|Withdrew Consent|0|||
148787163|NCT01826981|536698019|FG010|Overall Study|Withdrew Consent|0|||
148787164|NCT01826981|536698020|FG011|Overall Study|Withdrew Consent|1|||
148787165|NCT01826981|536698021|FG012|Overall Study|Withdrew Consent|0|||
148787166|NCT01826981|536698022|FG013|Overall Study|Withdrew Consent|1|||
148787167|NCT01826981|536698023|FG014|Overall Study|Withdrew Consent|0|||
148787168|NCT01826981|536698009|FG000|Overall Study|Adverse Event|0|||
148787169|NCT01826981|536698010|FG001|Overall Study|Adverse Event|0|||
148787170|NCT01826981|536698011|FG002|Overall Study|Adverse Event|0|||
148787171|NCT01826981|536698012|FG003|Overall Study|Adverse Event|0|||
148787172|NCT01826981|536698013|FG004|Overall Study|Adverse Event|1|||
148787173|NCT01826981|536698014|FG005|Overall Study|Adverse Event|0|||
148787174|NCT01826981|536698015|FG006|Overall Study|Adverse Event|0|||
148787175|NCT01826981|536698016|FG007|Overall Study|Adverse Event|0|||
148787176|NCT01826981|536698017|FG008|Overall Study|Adverse Event|0|||
148787177|NCT01826981|536698018|FG009|Overall Study|Adverse Event|0|||
148787178|NCT01826981|536698019|FG010|Overall Study|Adverse Event|0|||
148787179|NCT01826981|536698020|FG011|Overall Study|Adverse Event|0|||
148787180|NCT01826981|536698021|FG012|Overall Study|Adverse Event|0|||
148787181|NCT01826981|536698022|FG013|Overall Study|Adverse Event|0|||
148787182|NCT01826981|536698023|FG014|Overall Study|Adverse Event|0|||
148787183|NCT01826981|536698009|FG000|Overall Study|Upper G-I Haemorrhage|0|||
148787184|NCT01826981|536698010|FG001|Overall Study|Upper G-I Haemorrhage|0|||
148787185|NCT01826981|536698011|FG002|Overall Study|Upper G-I Haemorrhage|0|||
148787186|NCT01826981|536698012|FG003|Overall Study|Upper G-I Haemorrhage|0|||
148787187|NCT01826981|536698013|FG004|Overall Study|Upper G-I Haemorrhage|0|||
148787188|NCT01826981|536698014|FG005|Overall Study|Upper G-I Haemorrhage|0|||
148787189|NCT01826981|536698015|FG006|Overall Study|Upper G-I Haemorrhage|0|||
148787190|NCT01826981|536698016|FG007|Overall Study|Upper G-I Haemorrhage|0|||
148787191|NCT01826981|536698017|FG008|Overall Study|Upper G-I Haemorrhage|0|||
148787192|NCT01826981|536698018|FG009|Overall Study|Upper G-I Haemorrhage|0|||
148787193|NCT01826981|536698019|FG010|Overall Study|Upper G-I Haemorrhage|0|||
148787194|NCT01826981|536698020|FG011|Overall Study|Upper G-I Haemorrhage|0|||
148787195|NCT01826981|536698021|FG012|Overall Study|Upper G-I Haemorrhage|0|||
148787196|NCT01826981|536698022|FG013|Overall Study|Upper G-I Haemorrhage|1|||
148787197|NCT01826981|536698023|FG014|Overall Study|Upper G-I Haemorrhage|0|||
148787198|NCT01826981|536698009|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787199|NCT01826981|536698010|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787200|NCT01826981|536698011|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787201|NCT01826981|536698012|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787202|NCT01826981|536698013|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787203|NCT01826981|536698014|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787204|NCT01826981|536698015|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787205|NCT01826981|536698016|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
148787206|NCT01826981|536698017|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787207|NCT01826981|536698018|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787208|NCT01826981|536698019|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787209|NCT01826981|536698020|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787210|NCT01826981|536698021|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787211|NCT01826981|536698022|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787212|NCT01826981|536698023|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
148787213|NCT01467271|536698024|FG000|Overall Study|Death|84|||
148787214|NCT01467271|536698024|FG000|Overall Study|Lost to Follow-up|83|||
148787215|NCT01467271|536698024|FG000|Overall Study|Retraction of patient's consent|21|||
148787216|NCT01467271|536698024|FG000|Overall Study|Other reason|14|||
148787217|NCT03084302|536698031|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
148787218|NCT03084302|536698031|FG000|Overall Study|No valid objective monitor data|6|||
148787219|NCT01411319|536698032|FG000|Overall Study|Lost to Follow-up|1|||
148787220|NCT01796301|536698035|FG000|Overall Study|Withdrawal by Subject|15|||
148787221|NCT01796301|536698036|FG001|Overall Study|Withdrawal by Subject|15|||
148787222|NCT01796301|536698035|FG000|Overall Study|Lost to Follow-up|3|||
148787223|NCT01796301|536698036|FG001|Overall Study|Lost to Follow-up|3|||
148787224|NCT01796301|536698035|FG000|Overall Study|Death|0|||
148787225|NCT01796301|536698036|FG001|Overall Study|Death|1|||
148787226|NCT01796301|536698035|FG000|Overall Study|Decision by Sponsor|0|||
148787227|NCT01796301|536698036|FG001|Overall Study|Decision by Sponsor|1|||
148787228|NCT00667563|536698037|FG000|Overall Study|Protocol Violation|24|||
148787229|NCT02985021|536698054|FG000|Overall Study|Inability to comply with study procedures|1|||
148787230|NCT00264290|536698055|FG000|Intervention (8 Weeks)|Adverse Event|1|||
148787231|NCT00264290|536698056|FG001|Intervention (8 Weeks)|Adverse Event|0|||
148787232|NCT04399889|536698057|FG000|Overall Study|Death|5|||
148787233|NCT04399889|536698058|FG001|Overall Study|Death|1|||
148787234|NCT04399889|536698059|FG002|Overall Study|Death|1|||
148787235|NCT00707980|536698060|FG000|Overall Study|Adverse Event|49|||
148787236|NCT00707980|536698060|FG000|Overall Study|Lack of Efficacy|35|||
148787237|NCT00707980|536698060|FG000|Overall Study|Non-Compliance with Study Drug|28|||
148787238|NCT00707980|536698060|FG000|Overall Study|Protocol Deviations|19|||
148787239|NCT00707980|536698060|FG000|Overall Study|Withdrawal of Consent|81|||
148787240|NCT00707980|536698060|FG000|Overall Study|Lost to Follow-up|59|||
148787241|NCT00707980|536698060|FG000|Overall Study|Other|39|||
148787242|NCT03585712|536698066|FG000|Treatment Period 1|Protocol Violation|1|||
148787243|NCT03585712|536698067|FG001|Treatment Period 1|Protocol Violation|0|||
148787244|NCT03585712|536698068|FG002|Treatment Period 1|Protocol Violation|0|||
148787245|NCT03585712|536698066|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
148787246|NCT03585712|536698067|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
148787247|NCT03585712|536698068|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
148787248|NCT03585712|536698066|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
148787249|NCT03585712|536698067|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
148787250|NCT03585712|536698068|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
148787251|NCT03585712|536698066|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
148787252|NCT03585712|536698067|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
148787253|NCT03585712|536698068|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
148787254|NCT02697734|536698074|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
148787255|NCT02697734|536698075|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
148787256|NCT02697734|536698074|FG000|Core Phase - up to Week 48|Adverse Event|1|||
148787257|NCT02697734|536698075|FG001|Core Phase - up to Week 48|Adverse Event|2|||
148787258|NCT02697734|536698074|FG000|Core Phase - up to Week 48|Physician Decision|1|||
148787259|NCT02697734|536698075|FG001|Core Phase - up to Week 48|Physician Decision|0|||
148787260|NCT02697734|536698074|FG000|Optional Extension Phase|Adverse Event|5|||
148787261|NCT02697734|536698075|FG001|Optional Extension Phase|Adverse Event|1|||
148787262|NCT02697734|536698074|FG000|Optional Extension Phase|Physician Decision|0|||
148787263|NCT02697734|536698075|FG001|Optional Extension Phase|Physician Decision|1|||
148787264|NCT02324699|536698076|FG000|Overall Study|study terminated|1|||
148787265|NCT03970200|536698077|FG000|Overall Study|Death|2|||
148787266|NCT03970200|536698078|FG001|Overall Study|Death|2|||
148787267|NCT03970200|536698079|FG002|Overall Study|Death|1|||
148787268|NCT03970200|536698077|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
148787269|NCT03970200|536698078|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
148787270|NCT03970200|536698079|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
148787271|NCT01607346|536698080|FG000|Overall Study|Adverse Event|3|||
148787272|NCT01098162|536698081|FG000|Overall Study|Adverse Event|37|||
148787273|NCT01098162|536698081|FG000|Overall Study|Lack of Efficacy|4|||
148787274|NCT01098162|536698081|FG000|Overall Study|Wish of Patient|7|||
148787275|NCT01098162|536698081|FG000|Overall Study|Lost to Follow-up|9|||
148787276|NCT01098162|536698081|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
148787277|NCT01098162|536698081|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
148787278|NCT01098162|536698081|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
148787279|NCT01098162|536698081|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
148787280|NCT01098162|536698081|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
148787281|NCT01098162|536698081|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
148787282|NCT01098162|536698081|FG000|Overall Study|Other Reason|1|||
148787283|NCT01098162|536698081|FG000|Overall Study|Reason Unknown|26|||
148787284|NCT00830518|536698082|FG000|Overall Study|Progressive Disease|18|||
148787285|NCT00830518|536698083|FG001|Overall Study|Progressive Disease|8|||
148787286|NCT00830518|536698082|FG000|Overall Study|Symptomatic Deterioration|4|||
148787287|NCT00830518|536698083|FG001|Overall Study|Symptomatic Deterioration|1|||
148787288|NCT00830518|536698082|FG000|Overall Study|Adverse Event|14|||
148787289|NCT00830518|536698083|FG001|Overall Study|Adverse Event|1|||
148787290|NCT00830518|536698082|FG000|Overall Study|Withdrawal by Patient|2|||
148787291|NCT00830518|536698083|FG001|Overall Study|Withdrawal by Patient|0|||
148787292|NCT00830518|536698082|FG000|Overall Study|Reason not Specified|8|||
148787293|NCT00830518|536698083|FG001|Overall Study|Reason not Specified|1|||
148787294|NCT02155322|536698086|FG000|Overall Study|Adverse Event|1|||
148787295|NCT02155322|536698086|FG000|Overall Study|Physician Decision|1|||
148787296|NCT02155322|536698086|FG000|Overall Study|Relapse/Recurrence|8|||
148787297|NCT02155322|536698086|FG000|Overall Study|Withdrawal by Subject|4|||
148787298|NCT00586898|536698098|FG000|Overall Study|Adverse Event|1|||
148787299|NCT00586898|536698098|FG000|Overall Study|Patiemt Non-compliance|1|||
148787300|NCT00586898|536698098|FG000|Overall Study|Evaluable for Toxicity Only|5|||
148787301|NCT00636961|536698099|FG000|Period 1|Administrative problems|1|||
148787302|NCT00636961|536698100|FG001|Period 1|Administrative problems|1|||
148787303|NCT00636961|536698099|FG000|Period 2|Adverse Event|1|||
148787304|NCT00636961|536698100|FG001|Period 2|Adverse Event|0|||
148787305|NCT02179749|536698104|FG000|Overall Study|Adverse Event|0|||
148787306|NCT02179749|536698105|FG001|Overall Study|Adverse Event|0|||
148787307|NCT02179749|536698106|FG002|Overall Study|Adverse Event|1|||
148787308|NCT02179749|536698104|FG000|Overall Study|Withdrawal by Subject|0|||
148787309|NCT02179749|536698105|FG001|Overall Study|Withdrawal by Subject|0|||
148787310|NCT02179749|536698106|FG002|Overall Study|Withdrawal by Subject|1|||
148787311|NCT01841567|536698107|FG000|Overall Study|Adverse Event|3|||
148787312|NCT01573754|536698112|FG000|Overall Study|Noncompliance or remission not achieved|3|||
148787313|NCT01573754|536698113|FG001|Overall Study|Noncompliance or remission not achieved|15|||
148787314|NCT01994902|536698114|FG000|Test Period 1|Withdrawal by Subject|3|||
148787315|NCT01994902|536698115|FG001|Test Period 1|Withdrawal by Subject|0|||
148787316|NCT01994902|536698114|FG000|Test Period 1|device deficiency with adverse event|0|||
148787317|NCT01994902|536698115|FG001|Test Period 1|device deficiency with adverse event|1|||
148787318|NCT01994902|536698114|FG000|Test Period 1|Adverse Event|2|||
148787319|NCT01994902|536698115|FG001|Test Period 1|Adverse Event|1|||
148787320|NCT01994902|536698114|FG000|Test Period 1|Lack of Efficacy|0|||
148787321|NCT01994902|536698115|FG001|Test Period 1|Lack of Efficacy|1|||
148787322|NCT01994902|536698114|FG000|Test Period 1|bag too small|1|||
148787323|NCT01994902|536698115|FG001|Test Period 1|bag too small|0|||
148787324|NCT01994902|536698114|FG000|Test Period 2|Withdrawal by Subject|0|||
148787325|NCT01994902|536698115|FG001|Test Period 2|Withdrawal by Subject|2|||
148787326|NCT01994902|536698114|FG000|Test Period 2|Lack of Efficacy|0|||
148787327|NCT01994902|536698115|FG001|Test Period 2|Lack of Efficacy|1|||
148787328|NCT01994902|536698114|FG000|Test Period 2|Other|0|||
148787329|NCT01994902|536698115|FG001|Test Period 2|Other|3|||
148787330|NCT03951753|536698118|FG000|Overall Study|Adverse Event|1|||
148787331|NCT03951753|536698119|FG001|Overall Study|Adverse Event|0|||
148787332|NCT03951753|536698120|FG002|Overall Study|Adverse Event|3|||
148787333|NCT03951753|536698118|FG000|Overall Study|Withdrawal by Subject|3|||
148787334|NCT03951753|536698119|FG001|Overall Study|Withdrawal by Subject|1|||
148787335|NCT03951753|536698120|FG002|Overall Study|Withdrawal by Subject|0|||
148787336|NCT03951753|536698118|FG000|Overall Study|Lost to Follow-up|0|||
148787337|NCT03951753|536698119|FG001|Overall Study|Lost to Follow-up|0|||
148787338|NCT03951753|536698120|FG002|Overall Study|Lost to Follow-up|1|||
148787339|NCT01905592|536698123|FG000|Overall Study|Disease Progression|51|||
148787340|NCT01905592|536698124|FG001|Overall Study|Disease Progression|110|||
148787341|NCT01905592|536698123|FG000|Overall Study|Toxicity|1|||
148787342|NCT01905592|536698124|FG001|Overall Study|Toxicity|16|||
148787343|NCT01905592|536698123|FG000|Overall Study|Physician Decision|0|||
148787344|NCT01905592|536698124|FG001|Overall Study|Physician Decision|2|||
148787345|NCT01905592|536698123|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
148787346|NCT01905592|536698124|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
148787347|NCT01905592|536698123|FG000|Overall Study|Protocol Violation|0|||
148787348|NCT01905592|536698124|FG001|Overall Study|Protocol Violation|1|||
148787349|NCT01905592|536698123|FG000|Overall Study|Sponsor's decision|1|||
149129520|NCT00719563|537954484|FG000|Overall Study|Unknown reasons|4|||
149129521|NCT00719563|537954485|FG001|Overall Study|Unknown reasons|6|||
148787350|NCT01905592|536698124|FG001|Overall Study|Sponsor's decision|1|||
148787351|NCT01905592|536698123|FG000|Overall Study|Not treated|7|||
148787352|NCT01905592|536698124|FG001|Overall Study|Not treated|3|||
148787353|NCT01905592|536698123|FG000|Overall Study|Withdrawal by Subject|10|||
148787354|NCT01905592|536698124|FG001|Overall Study|Withdrawal by Subject|2|||
148787355|NCT00314808|536699547|FG000|Overall Study|Disease Progression without AE|4|||
148787356|NCT00314808|536699547|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
148787357|NCT04304508|536699548|FG000|Overall Study|Subject Decision|29|||
148787358|NCT04304508|536699549|FG001|Overall Study|Subject Decision|39|||
148787359|NCT04304508|536699550|FG002|Overall Study|Subject Decision|37|||
148787360|NCT04304508|536699551|FG003|Overall Study|Subject Decision|48|||
148787361|NCT04304508|536699548|FG000|Overall Study|Death|6|||
148787362|NCT04304508|536699549|FG001|Overall Study|Death|1|||
148787363|NCT04304508|536699550|FG002|Overall Study|Death|8|||
148787364|NCT04304508|536699551|FG003|Overall Study|Death|5|||
148787365|NCT04304508|536699548|FG000|Overall Study|Non-compliance With Study Drug|3|||
148787366|NCT04304508|536699549|FG001|Overall Study|Non-compliance With Study Drug|1|||
148787367|NCT04304508|536699550|FG002|Overall Study|Non-compliance With Study Drug|2|||
148787368|NCT04304508|536699551|FG003|Overall Study|Non-compliance With Study Drug|0|||
148787369|NCT04304508|536699548|FG000|Overall Study|Switching To Other Therapy|1|||
148787370|NCT04304508|536699549|FG001|Overall Study|Switching To Other Therapy|1|||
148787371|NCT04304508|536699550|FG002|Overall Study|Switching To Other Therapy|1|||
148787372|NCT04304508|536699551|FG003|Overall Study|Switching To Other Therapy|2|||
148787373|NCT04304508|536699548|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
148787374|NCT04304508|536699549|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
148787375|NCT04304508|536699550|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
148787376|NCT04304508|536699551|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
148787377|NCT04304508|536699548|FG000|Overall Study|Withdrawal by Subject|7|||
148787378|NCT04304508|536699549|FG001|Overall Study|Withdrawal by Subject|5|||
148787379|NCT04304508|536699550|FG002|Overall Study|Withdrawal by Subject|11|||
148787380|NCT04304508|536699551|FG003|Overall Study|Withdrawal by Subject|6|||
148787381|NCT04304508|536699548|FG000|Overall Study|Logistical Difficulties|2|||
148787382|NCT04304508|536699549|FG001|Overall Study|Logistical Difficulties|2|||
148787383|NCT04304508|536699550|FG002|Overall Study|Logistical Difficulties|3|||
148787384|NCT04304508|536699551|FG003|Overall Study|Logistical Difficulties|2|||
148787385|NCT04304508|536699548|FG000|Overall Study|Missing Information|1|||
148787386|NCT04304508|536699549|FG001|Overall Study|Missing Information|2|||
148787387|NCT04304508|536699550|FG002|Overall Study|Missing Information|1|||
148787388|NCT04304508|536699551|FG003|Overall Study|Missing Information|3|||
148787389|NCT04304508|536699548|FG000|Overall Study|Other|7|||
148787390|NCT04304508|536699549|FG001|Overall Study|Other|6|||
148787391|NCT04304508|536699550|FG002|Overall Study|Other|5|||
148787392|NCT04304508|536699551|FG003|Overall Study|Other|4|||
148787393|NCT04304508|536699548|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
148787394|NCT04304508|536699549|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
148787395|NCT04304508|536699550|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
148787396|NCT04304508|536699551|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
148787397|NCT04304508|536699548|FG000|Overall Study|Physician Decision|3|||
148787398|NCT04304508|536699549|FG001|Overall Study|Physician Decision|4|||
148787399|NCT04304508|536699550|FG002|Overall Study|Physician Decision|9|||
148787400|NCT04304508|536699551|FG003|Overall Study|Physician Decision|7|||
148787401|NCT04304508|536699548|FG000|Overall Study|Study drug never administered|10|||
148787402|NCT04304508|536699549|FG001|Overall Study|Study drug never administered|4|||
148787403|NCT04304508|536699550|FG002|Overall Study|Study drug never administered|4|||
149129522|NCT00719563|537954484|FG000|Overall Study|Noncompliant|1|||
149129523|NCT00719563|537954485|FG001|Overall Study|Noncompliant|1|||
149129524|NCT00719563|537954484|FG000|Overall Study|Lost to Follow-up|5|||
149129525|NCT00719563|537954485|FG001|Overall Study|Lost to Follow-up|3|||
149129526|NCT00294554|537954486|FG000|Overall Study|Lack of Efficacy|0|||
149129527|NCT00294554|537954487|FG001|Overall Study|Lack of Efficacy|1|||
149129528|NCT00294554|537954486|FG000|Overall Study|Physician Decision|0|||
149129529|NCT00294554|537954487|FG001|Overall Study|Physician Decision|1|||
149129530|NCT00462865|537954488|FG000|Overall Study|Adverse Event|1|||
149129531|NCT02864381|537954489|FG000|Overall Study|Death|58|||
149129532|NCT02864381|537954490|FG001|Overall Study|Death|61|||
149129533|NCT02864381|537954489|FG000|Overall Study|Withdrew Consent|5|||
148787404|NCT04304508|536699551|FG003|Overall Study|Study drug never administered|4|||
148787405|NCT04304508|536699548|FG000|Overall Study|Adverse Event|49|||
148787406|NCT04304508|536699549|FG001|Overall Study|Adverse Event|50|||
148787407|NCT04304508|536699550|FG002|Overall Study|Adverse Event|51|||
149129534|NCT02864381|537954490|FG001|Overall Study|Withdrew Consent|6|||
149129535|NCT02864381|537954489|FG000|Overall Study|Reason Unknown|7|||
148787408|NCT04304508|536699551|FG003|Overall Study|Adverse Event|56|||
148787409|NCT04304508|536699548|FG000|Overall Study|Lost to Follow-up|1|||
148787410|NCT04304508|536699549|FG001|Overall Study|Lost to Follow-up|5|||
149129536|NCT02864381|537954490|FG001|Overall Study|Reason Unknown|3|||
149129537|NCT02864381|537954489|FG000|Overall Study|Lost to Follow-up|1|||
149129538|NCT02864381|537954490|FG001|Overall Study|Lost to Follow-up|1|||
149129539|NCT02864381|537954489|FG000|Overall Study|Investigator's Discretion|1|||
149129540|NCT02864381|537954490|FG001|Overall Study|Investigator's Discretion|0|||
148787411|NCT04304508|536699550|FG002|Overall Study|Lost to Follow-up|2|||
148787412|NCT04304508|536699551|FG003|Overall Study|Lost to Follow-up|3|||
148787413|NCT01775787|536699558|FG000|First 7-10 Days|Adverse Event|0|||
148787414|NCT01775787|536699559|FG001|First 7-10 Days|Adverse Event|1|||
148787415|NCT01775787|536699558|FG000|First 7-10 Days|family emergency|0|||
148787416|NCT01775787|536699559|FG001|First 7-10 Days|family emergency|1|||
148787417|NCT01775787|536699558|FG000|First 7-10 Days|time commitment|0|||
148787418|NCT01775787|536699559|FG001|First 7-10 Days|time commitment|2|||
148787419|NCT01775787|536699558|FG000|First 7-10 Days|concerns with using IV|1|||
148787420|NCT01775787|536699559|FG001|First 7-10 Days|concerns with using IV|2|||
148787421|NCT01775787|536699558|FG000|Second 7-10 Days|time commitment|0|||
148787422|NCT01775787|536699559|FG001|Second 7-10 Days|time commitment|1|||
148787423|NCT01775787|536699558|FG000|Second 7-10 Days|concerns with using IV|0|||
148787424|NCT01775787|536699559|FG001|Second 7-10 Days|concerns with using IV|1|||
148787425|NCT01299896|536699560|FG000|Overall Study|Withdrawal by Subject|1|||
148787426|NCT01299896|536699561|FG001|Overall Study|Withdrawal by Subject|7|||
148787427|NCT01299896|536699560|FG000|Overall Study|Lost to Follow-up|0|||
148787428|NCT01299896|536699561|FG001|Overall Study|Lost to Follow-up|11|||
148787429|NCT01502956|536699566|FG000|Overall Study|Death|0|||
148787430|NCT01502956|536699567|FG001|Overall Study|Death|2|||
148787431|NCT01502956|536699566|FG000|Overall Study|Lost to Follow-up|14|||
148787432|NCT01502956|536699567|FG001|Overall Study|Lost to Follow-up|11|||
148787433|NCT01502956|536699566|FG000|Overall Study|Physician Decision|2|||
148787434|NCT01502956|536699567|FG001|Overall Study|Physician Decision|3|||
148787435|NCT01502956|536699566|FG000|Overall Study|Withdrawal by Subject|8|||
148787436|NCT01502956|536699567|FG001|Overall Study|Withdrawal by Subject|10|||
148787437|NCT01616758|536699568|FG000|Overall Study|Adverse Event|1|||
148787438|NCT01616758|536699568|FG000|Overall Study|Withdrawal by Subject|2|||
148787439|NCT01616758|536699568|FG000|Overall Study|Disease progression|18|||
148787440|NCT01616758|536699568|FG000|Overall Study|Study termination by Sponsor|1|||
148787441|NCT00199849|536699569|FG000|Overall Study|Unrelated illness or complication|0|||
148787442|NCT00199849|536699570|FG001|Overall Study|Unrelated illness or complication|1|||
148787443|NCT00199849|536699571|FG002|Overall Study|Unrelated illness or complication|0|||
148787444|NCT00199849|536699569|FG000|Overall Study|Progressive disease requiring intervention|0|||
148787445|NCT00199849|536699570|FG001|Overall Study|Progressive disease requiring intervention|0|||
148787446|NCT00199849|536699571|FG002|Overall Study|Progressive disease requiring intervention|1|||
148787447|NCT00199849|536699569|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
148787448|NCT00199849|536699570|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
148787449|NCT00199849|536699571|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
148787450|NCT04727528|536699572|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
148787451|NCT04727528|536699573|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
148787452|NCT04727528|536699572|FG000|Open-label Period|Randomized who did not receive treatment|1|||
148787453|NCT04727528|536699573|FG001|Open-label Period|Randomized who did not receive treatment|0|||
148787454|NCT04727528|536699572|FG000|Double-blind Treatment Phase|Adverse Event|0|||
148787455|NCT04727528|536699573|FG001|Double-blind Treatment Phase|Adverse Event|1|||
148787456|NCT04727528|536699572|FG000|Double-blind Treatment Phase|Death|0|||
148787457|NCT04727528|536699573|FG001|Double-blind Treatment Phase|Death|1|||
148787458|NCT04727528|536699572|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
148787459|NCT04727528|536699573|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
148787460|NCT04727528|536699572|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
148787461|NCT04727528|536699573|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
148787462|NCT04727528|536699572|FG000|Double-blind Treatment Phase|Physician Decision|0|||
148787463|NCT04727528|536699573|FG001|Double-blind Treatment Phase|Physician Decision|1|||
148787464|NCT04727528|536699572|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
148787465|NCT04727528|536699573|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148787466|NCT03479008|536699583|FG000|Overall Study|Withdrawal by Subject|3|||
148787467|NCT01704755|536699584|FG000|Overall Study|Adverse Event|4|||
148787468|NCT01704755|536699585|FG001|Overall Study|Adverse Event|1|||
148787469|NCT01704755|536699584|FG000|Overall Study|Lost to Follow-up|3|||
148787470|NCT01704755|536699585|FG001|Overall Study|Lost to Follow-up|4|||
148787471|NCT01704755|536699584|FG000|Overall Study|Withdrew consent|1|||
148787472|NCT01704755|536699585|FG001|Overall Study|Withdrew consent|1|||
148787473|NCT01704755|536699584|FG000|Overall Study|Other (not specified)|3|||
148787474|NCT01704755|536699585|FG001|Overall Study|Other (not specified)|1|||
148787475|NCT01704755|536699584|FG000|Overall Study|Withdrew consent and personal issues|1|||
148787476|NCT01704755|536699585|FG001|Overall Study|Withdrew consent and personal issues|0|||
148787477|NCT02187029|536699588|FG000|Overall Study|Adverse Event|0|||
148787478|NCT02187029|536699589|FG001|Overall Study|Adverse Event|1|||
148787479|NCT02187029|536699590|FG002|Overall Study|Adverse Event|1|||
148787480|NCT02187029|536699591|FG003|Overall Study|Adverse Event|0|||
148787481|NCT02187029|536699588|FG000|Overall Study|Study Terminated by Sponsor|0|||
148787482|NCT02187029|536699589|FG001|Overall Study|Study Terminated by Sponsor|0|||
148787483|NCT02187029|536699590|FG002|Overall Study|Study Terminated by Sponsor|10|||
148787484|NCT02187029|536699591|FG003|Overall Study|Study Terminated by Sponsor|3|||
148787485|NCT02187029|536699588|FG000|Overall Study|Withdrawal by Subject|1|||
148787486|NCT02187029|536699589|FG001|Overall Study|Withdrawal by Subject|0|||
148787487|NCT02187029|536699590|FG002|Overall Study|Withdrawal by Subject|0|||
148787488|NCT02187029|536699591|FG003|Overall Study|Withdrawal by Subject|0|||
148787489|NCT04217317|536699592|FG000|Overall Study|Lack of Efficacy|4|||
148787490|NCT04217317|536699592|FG000|Overall Study|Physician Decision|1|||
148787491|NCT03836209|536699593|FG000|Overall Study|Adverse Event|5|||
148787492|NCT03836209|536699594|FG001|Overall Study|Adverse Event|2|||
148787493|NCT03836209|536699593|FG000|Overall Study|Death|4|||
148787494|NCT03836209|536699594|FG001|Overall Study|Death|1|||
148787495|NCT03836209|536699593|FG000|Overall Study|Lack of Efficacy|7|||
148787496|NCT03836209|536699594|FG001|Overall Study|Lack of Efficacy|10|||
148787497|NCT03836209|536699593|FG000|Overall Study|Physician Decision|7|||
148787498|NCT03836209|536699594|FG001|Overall Study|Physician Decision|11|||
148787499|NCT03836209|536699593|FG000|Overall Study|Protocol Violation|0|||
148787500|NCT03836209|536699594|FG001|Overall Study|Protocol Violation|3|||
148787501|NCT03836209|536699593|FG000|Overall Study|Withdrawal by Subject|2|||
148787502|NCT03836209|536699594|FG001|Overall Study|Withdrawal by Subject|10|||
148787503|NCT03836209|536699593|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
148787504|NCT03836209|536699594|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
148787505|NCT03739710|536699595|FG000|Overall Study|Screen Failed|81|||
148787506|NCT01753115|536699596|FG000|Overall Study|Lost to Follow-up|3|||
148787507|NCT01753115|536699597|FG001|Overall Study|Lost to Follow-up|6|||
148787508|NCT01753115|536699598|FG002|Overall Study|Lost to Follow-up|8|||
148787509|NCT01753115|536699596|FG000|Overall Study|Withdrawal by Subject|6|||
148787510|NCT01753115|536699597|FG001|Overall Study|Withdrawal by Subject|5|||
148787511|NCT01753115|536699598|FG002|Overall Study|Withdrawal by Subject|6|||
148787512|NCT01753115|536699596|FG000|Overall Study|Subject non-compliant|3|||
148787513|NCT01753115|536699597|FG001|Overall Study|Subject non-compliant|3|||
148787514|NCT01753115|536699598|FG002|Overall Study|Subject non-compliant|0|||
148787515|NCT01753115|536699596|FG000|Overall Study|Used excluded drug|0|||
148787516|NCT01753115|536699597|FG001|Overall Study|Used excluded drug|1|||
148787517|NCT01753115|536699598|FG002|Overall Study|Used excluded drug|0|||
148787518|NCT04313400|536699604|FG000|Overall Study|Withdrawal by Subject|0|||
148787519|NCT04313400|536699605|FG001|Overall Study|Withdrawal by Subject|0|||
148787520|NCT04313400|536699606|FG002|Overall Study|Withdrawal by Subject|0|||
148787521|NCT04313400|536699607|FG003|Overall Study|Withdrawal by Subject|0|||
148787522|NCT04313400|536699608|FG004|Overall Study|Withdrawal by Subject|0|||
148787523|NCT04313400|536699609|FG005|Overall Study|Withdrawal by Subject|4|||
148787524|NCT04313400|536699610|FG006|Overall Study|Withdrawal by Subject|1|||
148787525|NCT04313400|536699604|FG000|Overall Study|Adverse Event|0|||
148787526|NCT04313400|536699605|FG001|Overall Study|Adverse Event|0|||
148787527|NCT04313400|536699606|FG002|Overall Study|Adverse Event|0|||
148787528|NCT04313400|536699607|FG003|Overall Study|Adverse Event|0|||
148787529|NCT04313400|536699608|FG004|Overall Study|Adverse Event|0|||
148787530|NCT04313400|536699609|FG005|Overall Study|Adverse Event|1|||
148787531|NCT04313400|536699610|FG006|Overall Study|Adverse Event|0|||
148787532|NCT04313400|536699604|FG000|Overall Study|Lost to Follow-up|0|||
149129541|NCT02864381|537954489|FG000|Overall Study|Protocol Violation|0|||
149129542|NCT02864381|537954490|FG001|Overall Study|Protocol Violation|1|||
149129543|NCT02986334|537954492|FG000|Overall Study|Withdrawal by Subject|0|||
149129544|NCT02986334|537954493|FG001|Overall Study|Withdrawal by Subject|1|||
149129545|NCT02986334|537954494|FG002|Overall Study|Withdrawal by Subject|2|||
149129546|NCT02986334|537954492|FG000|Overall Study|Lost to Follow-up|1|||
149129547|NCT02986334|537954493|FG001|Overall Study|Lost to Follow-up|2|||
149129548|NCT02986334|537954494|FG002|Overall Study|Lost to Follow-up|1|||
148787533|NCT04313400|536699605|FG001|Overall Study|Lost to Follow-up|0|||
148787534|NCT04313400|536699606|FG002|Overall Study|Lost to Follow-up|0|||
148787535|NCT04313400|536699607|FG003|Overall Study|Lost to Follow-up|0|||
148787536|NCT04313400|536699608|FG004|Overall Study|Lost to Follow-up|0|||
148787537|NCT04313400|536699609|FG005|Overall Study|Lost to Follow-up|1|||
149129549|NCT02986334|537954492|FG000|Overall Study|Adverse Event|0|||
149129550|NCT02986334|537954493|FG001|Overall Study|Adverse Event|2|||
149129551|NCT02986334|537954494|FG002|Overall Study|Adverse Event|1|||
149129552|NCT02986334|537954492|FG000|Overall Study|non compliance in phone ratings|2|||
149129553|NCT02986334|537954493|FG001|Overall Study|non compliance in phone ratings|1|||
149129554|NCT02986334|537954494|FG002|Overall Study|non compliance in phone ratings|2|||
149129555|NCT02986334|537954492|FG000|Overall Study|undisclosed comorbidities|0|||
149129556|NCT02986334|537954493|FG001|Overall Study|undisclosed comorbidities|1|||
149129557|NCT02986334|537954494|FG002|Overall Study|undisclosed comorbidities|1|||
148787538|NCT04313400|536699610|FG006|Overall Study|Lost to Follow-up|0|||
149129558|NCT04142450|537954495|FG000|Overall Study|Screen Failure|1|||
149129559|NCT04142450|537954495|FG000|Overall Study|Lost to Follow-up|1|||
148787539|NCT00329745|536699617|FG000|Overall Study|Protocol Violation|1|||
148787540|NCT00329745|536699618|FG001|Overall Study|Protocol Violation|0|||
148787541|NCT00329745|536699617|FG000|Overall Study|Withdrawal by Subject|0|||
148787542|NCT00329745|536699618|FG001|Overall Study|Withdrawal by Subject|1|||
148787543|NCT00329745|536699617|FG000|Overall Study|Lost to Follow-up|86|||
148787544|NCT00329745|536699618|FG001|Overall Study|Lost to Follow-up|101|||
148787545|NCT03224624|536699621|FG000|Overall Study|Lost to Follow-up|9|||
148787546|NCT03224624|536699622|FG001|Overall Study|Lost to Follow-up|4|||
148787547|NCT03224624|536699621|FG000|Overall Study|Death|1|||
148787548|NCT03224624|536699622|FG001|Overall Study|Death|0|||
148787549|NCT01884545|536699623|FG000|Overall Study|Lost to Follow-up|6|||
148787550|NCT01884545|536699624|FG001|Overall Study|Lost to Follow-up|4|||
148787551|NCT01884545|536699625|FG002|Overall Study|Lost to Follow-up|9|||
148787552|NCT01884545|536699626|FG003|Overall Study|Lost to Follow-up|4|||
149129560|NCT01138007|537954498|FG000|Overall Study|Adverse Event|4|||
148787553|NCT01884545|536699623|FG000|Overall Study|Patient withdrawn|7|||
148787554|NCT01884545|536699624|FG001|Overall Study|Patient withdrawn|12|||
148787555|NCT01884545|536699625|FG002|Overall Study|Patient withdrawn|5|||
148787556|NCT01884545|536699626|FG003|Overall Study|Patient withdrawn|5|||
148787557|NCT01884545|536699623|FG000|Overall Study|Non-adherence|0|||
148787558|NCT01884545|536699624|FG001|Overall Study|Non-adherence|2|||
148787559|NCT01884545|536699625|FG002|Overall Study|Non-adherence|0|||
148787560|NCT01884545|536699626|FG003|Overall Study|Non-adherence|0|||
148787561|NCT01424241|536699627|FG000|Overall Study|Withdrawal by Subject|1|||
148787562|NCT01424241|536699627|FG000|Overall Study|Time constraints|2|||
148787563|NCT02782377|536699628|FG000|Overall Study|Physician Decision|5|||
148787564|NCT01188668|536699630|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
148787565|NCT01188668|536699630|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
148787566|NCT01188668|536699630|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
148787567|NCT00303472|536699631|FG000|Treatment Period|Adverse Event|0|||
148787568|NCT00303472|536699632|FG001|Treatment Period|Adverse Event|0|||
148787569|NCT00303472|536699633|FG002|Treatment Period|Adverse Event|0|||
148787570|NCT00303472|536699634|FG003|Treatment Period|Adverse Event|0|||
148787571|NCT00303472|536699635|FG004|Treatment Period|Adverse Event|1|||
148787572|NCT00303472|536699636|FG005|Treatment Period|Adverse Event|0|||
148787573|NCT00303472|536699637|FG006|Treatment Period|Adverse Event|0|||
148787574|NCT00303472|536699631|FG000|Treatment Period|Death|0|||
148787575|NCT00303472|536699632|FG001|Treatment Period|Death|0|||
148787576|NCT00303472|536699633|FG002|Treatment Period|Death|0|||
148787577|NCT00303472|536699634|FG003|Treatment Period|Death|1|||
148787578|NCT00303472|536699635|FG004|Treatment Period|Death|0|||
148787579|NCT00303472|536699636|FG005|Treatment Period|Death|0|||
148787580|NCT00303472|536699637|FG006|Treatment Period|Death|1|||
148787581|NCT00303472|536699631|FG000|Treatment Period|Withdrawal by Subject|0|||
148787582|NCT00303472|536699632|FG001|Treatment Period|Withdrawal by Subject|0|||
148787583|NCT00303472|536699633|FG002|Treatment Period|Withdrawal by Subject|0|||
148787584|NCT00303472|536699634|FG003|Treatment Period|Withdrawal by Subject|1|||
148787585|NCT00303472|536699635|FG004|Treatment Period|Withdrawal by Subject|0|||
148787586|NCT00303472|536699636|FG005|Treatment Period|Withdrawal by Subject|1|||
148787587|NCT00303472|536699637|FG006|Treatment Period|Withdrawal by Subject|0|||
148787588|NCT00303472|536699631|FG000|Treatment Period|Other|0|||
148787589|NCT00303472|536699632|FG001|Treatment Period|Other|0|||
148787590|NCT00303472|536699633|FG002|Treatment Period|Other|0|||
148787591|NCT00303472|536699634|FG003|Treatment Period|Other|0|||
148787592|NCT00303472|536699635|FG004|Treatment Period|Other|1|||
148787593|NCT00303472|536699636|FG005|Treatment Period|Other|0|||
148787594|NCT00303472|536699637|FG006|Treatment Period|Other|1|||
148787595|NCT00303472|536699631|FG000|Treatment Period|Disease Progression (to AML)|0|||
148787596|NCT00303472|536699632|FG001|Treatment Period|Disease Progression (to AML)|0|||
148787597|NCT00303472|536699633|FG002|Treatment Period|Disease Progression (to AML)|0|||
148787598|NCT00303472|536699634|FG003|Treatment Period|Disease Progression (to AML)|0|||
148787599|NCT00303472|536699635|FG004|Treatment Period|Disease Progression (to AML)|1|||
148787600|NCT00303472|536699636|FG005|Treatment Period|Disease Progression (to AML)|0|||
148787601|NCT00303472|536699637|FG006|Treatment Period|Disease Progression (to AML)|0|||
148787602|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Adverse Event|1|||
148787603|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Adverse Event|0|||
148787604|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Adverse Event|1|||
148787605|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Adverse Event|0|||
148787606|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Adverse Event|0|||
148787607|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Adverse Event|0|||
149129561|NCT01138007|537954499|FG001|Overall Study|Adverse Event|12|||
148787608|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Adverse Event|0|||
148787609|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Death|2|||
148787610|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Death|0|||
149129562|NCT01138007|537954500|FG002|Overall Study|Adverse Event|9|||
148787611|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Death|1|||
148787612|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Death|0|||
148787613|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Death|0|||
148787614|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Death|0|||
148787615|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Death|0|||
148787616|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
148787617|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
148787618|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
148787619|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
148787620|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
148787621|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
148787622|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
148787623|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Physician Decision|0|||
148787624|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Physician Decision|4|||
148787625|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Physician Decision|2|||
148787626|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Physician Decision|3|||
148787627|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Physician Decision|2|||
148787628|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Physician Decision|0|||
148787629|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Physician Decision|0|||
148787630|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
148787631|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
148787632|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
148787633|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
148787634|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
148787635|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
148787636|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
148787637|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Other|0|||
148787638|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Other|2|||
148787639|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Other|4|||
148787640|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Other|2|||
148787641|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Other|1|||
148787642|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Other|0|||
148787643|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Other|0|||
148787644|NCT00303472|536699631|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
148787645|NCT00303472|536699632|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
148787646|NCT00303472|536699633|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
148787647|NCT00303472|536699634|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
148787648|NCT00303472|536699635|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
148787649|NCT00303472|536699636|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
148787650|NCT00303472|536699637|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
148787651|NCT02937636|536699641|FG000|Overall Study|Other (Not specified)|3|||
148787652|NCT02937636|536699642|FG001|Overall Study|Other (Not specified)|2|||
148787653|NCT00770913|536699643|FG000|Overall Study|Adverse Event|1|||
148787654|NCT00770913|536699644|FG001|Overall Study|Adverse Event|3|||
148787655|NCT00770913|536699645|FG002|Overall Study|Adverse Event|6|||
148787656|NCT00770913|536699643|FG000|Overall Study|Refusal to continue participation|6|||
148787657|NCT00770913|536699644|FG001|Overall Study|Refusal to continue participation|4|||
148787658|NCT00770913|536699645|FG002|Overall Study|Refusal to continue participation|5|||
148787659|NCT00770913|536699643|FG000|Overall Study|Physician Decision|0|||
148787660|NCT00770913|536699644|FG001|Overall Study|Physician Decision|1|||
148787661|NCT00770913|536699645|FG002|Overall Study|Physician Decision|1|||
148787662|NCT00770913|536699643|FG000|Overall Study|Protocol Violation|3|||
148787663|NCT00770913|536699644|FG001|Overall Study|Protocol Violation|0|||
148787664|NCT00770913|536699645|FG002|Overall Study|Protocol Violation|1|||
148787665|NCT00770913|536699643|FG000|Overall Study|Incorrect drug was allocated|1|||
148787666|NCT00770913|536699644|FG001|Overall Study|Incorrect drug was allocated|0|||
148787667|NCT00770913|536699645|FG002|Overall Study|Incorrect drug was allocated|0|||
148787668|NCT00359294|536699649|FG000|Overall Study|Progressive disease|1|||
148787669|NCT00359294|536699650|FG001|Overall Study|Progressive disease|1|||
148787670|NCT00359294|536699651|FG002|Overall Study|Progressive disease|2|||
148787671|NCT00359294|536699652|FG003|Overall Study|Progressive disease|3|||
148787672|NCT00359294|536699653|FG004|Overall Study|Progressive disease|2|||
148787673|NCT00359294|536699649|FG000|Overall Study|Withdrawal by Subject|0|||
148787674|NCT00359294|536699650|FG001|Overall Study|Withdrawal by Subject|0|||
148787675|NCT00359294|536699651|FG002|Overall Study|Withdrawal by Subject|0|||
148787676|NCT00359294|536699652|FG003|Overall Study|Withdrawal by Subject|0|||
148787677|NCT00359294|536699653|FG004|Overall Study|Withdrawal by Subject|1|||
148787678|NCT00359294|536699649|FG000|Overall Study|Not treated|0|||
148787679|NCT00359294|536699650|FG001|Overall Study|Not treated|0|||
148787680|NCT00359294|536699651|FG002|Overall Study|Not treated|0|||
148787681|NCT00359294|536699652|FG003|Overall Study|Not treated|1|||
148787682|NCT00359294|536699653|FG004|Overall Study|Not treated|0|||
148787683|NCT00359294|536699649|FG000|Overall Study|Physician Decision|0|||
148787684|NCT00359294|536699650|FG001|Overall Study|Physician Decision|0|||
148787685|NCT00359294|536699651|FG002|Overall Study|Physician Decision|1|||
148787686|NCT00359294|536699652|FG003|Overall Study|Physician Decision|0|||
148787687|NCT00359294|536699653|FG004|Overall Study|Physician Decision|0|||
148787688|NCT04208412|536699660|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
149129563|NCT01138007|537954498|FG000|Overall Study|Lack of Efficacy|2|||
149129564|NCT01138007|537954499|FG001|Overall Study|Lack of Efficacy|0|||
149129565|NCT01138007|537954500|FG002|Overall Study|Lack of Efficacy|6|||
149129566|NCT01138007|537954498|FG000|Overall Study|Protocol Violation|2|||
149129567|NCT01138007|537954499|FG001|Overall Study|Protocol Violation|3|||
149129568|NCT01138007|537954500|FG002|Overall Study|Protocol Violation|2|||
149129569|NCT01138007|537954498|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
149129570|NCT01138007|537954499|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
149129571|NCT01138007|537954500|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
149129572|NCT01138007|537954498|FG000|Overall Study|Lost to Follow-up|3|||
149129573|NCT01138007|537954499|FG001|Overall Study|Lost to Follow-up|3|||
149129574|NCT01138007|537954500|FG002|Overall Study|Lost to Follow-up|5|||
149129575|NCT01138007|537954498|FG000|Overall Study|Physician Decision|0|||
149129576|NCT01138007|537954499|FG001|Overall Study|Physician Decision|5|||
149129577|NCT01138007|537954500|FG002|Overall Study|Physician Decision|3|||
149129578|NCT01138007|537954498|FG000|Overall Study|Withdrawal by Subject|5|||
149129579|NCT01138007|537954499|FG001|Overall Study|Withdrawal by Subject|6|||
149129580|NCT01138007|537954500|FG002|Overall Study|Withdrawal by Subject|15|||
149129581|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
149129582|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
149129583|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
149129584|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
149129585|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
149129586|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
149129587|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
149129588|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
149129589|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
149129590|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
149129591|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
149129592|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
149129593|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
149129594|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
149129595|NCT03548987|537954501|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
149129596|NCT03548987|537954502|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
149129597|NCT03548987|537954501|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
149129598|NCT03548987|537954502|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
149129599|NCT03548987|537954501|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
149129600|NCT03548987|537954502|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
149129601|NCT03548987|537954501|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
149129602|NCT03548987|537954502|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
149129603|NCT03548987|537954501|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
149129604|NCT03548987|537954502|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
149129605|NCT03548987|537954501|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
149129606|NCT03548987|537954502|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
149129607|NCT03548987|537954501|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
149129608|NCT03548987|537954502|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
149129609|NCT04661878|537954503|FG000|Overall Study|Lost to Follow-up|6|||
149129610|NCT04661878|537954504|FG001|Overall Study|Lost to Follow-up|5|||
149129611|NCT02768870|537954509|FG000|Overall Study|Death|1|||
149129612|NCT02768870|537954509|FG000|Overall Study|Reoperation|6|||
149129613|NCT02768870|537954509|FG000|Overall Study|Lost to Follow-up|1|||
149129614|NCT02768870|537954509|FG000|Overall Study|Exit|4|||
149129615|NCT01774110|537954510|FG000|Overall Study|Lost to Follow-up|7|||
149129616|NCT00640016|537954511|FG000|Overall Study|Withdrawal by Subject|0|||
149129617|NCT00640016|537954512|FG001|Overall Study|Withdrawal by Subject|1|||
149129618|NCT00640016|537954513|FG002|Overall Study|Withdrawal by Subject|0|||
149129619|NCT00640016|537954514|FG003|Overall Study|Withdrawal by Subject|0|||
149129620|NCT00640016|537954511|FG000|Overall Study|Study termination|2|||
149129621|NCT00640016|537954512|FG001|Overall Study|Study termination|1|||
149129622|NCT00640016|537954513|FG002|Overall Study|Study termination|3|||
149129623|NCT00640016|537954514|FG003|Overall Study|Study termination|2|||
149129624|NCT00640016|537954511|FG000|Overall Study|Adverse Event|0|||
149129625|NCT00640016|537954512|FG001|Overall Study|Adverse Event|0|||
149129626|NCT00640016|537954513|FG002|Overall Study|Adverse Event|0|||
149129627|NCT00640016|537954514|FG003|Overall Study|Adverse Event|1|||
149129628|NCT01287065|537954515|FG000|Treatment Period 1|Adverse Event|0|||
149129629|NCT01287065|537954516|FG001|Treatment Period 1|Adverse Event|0|||
149129630|NCT01287065|537954517|FG002|Treatment Period 1|Adverse Event|0|||
149129631|NCT01287065|537954518|FG003|Treatment Period 1|Adverse Event|0|||
149129632|NCT01287065|537954519|FG004|Treatment Period 1|Adverse Event|1|||
149129633|NCT01287065|537954520|FG005|Treatment Period 1|Adverse Event|0|||
149129634|NCT01287065|537954515|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149129635|NCT01287065|537954516|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149129636|NCT01287065|537954517|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148787689|NCT04208412|536699661|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
148787690|NCT04208412|536699660|FG000|Overall Study|Withdrawal by Subject|1|||
148787691|NCT04208412|536699661|FG001|Overall Study|Withdrawal by Subject|0|||
148787692|NCT04208412|536699660|FG000|Overall Study|Lost to Follow-up|0|||
148787693|NCT04208412|536699661|FG001|Overall Study|Lost to Follow-up|1|||
148787694|NCT01605825|536699666|FG000|Overall Study|Adverse Event|4|||
148787695|NCT01605825|536699667|FG001|Overall Study|Adverse Event|2|||
148787696|NCT01605825|536699666|FG000|Overall Study|Withdrawal by Subject|0|||
148787697|NCT01605825|536699667|FG001|Overall Study|Withdrawal by Subject|1|||
148787698|NCT01605825|536699666|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
148787699|NCT01605825|536699667|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
148787700|NCT01605825|536699666|FG000|Overall Study|Non-Compliance with Protocol|3|||
148787701|NCT01605825|536699667|FG001|Overall Study|Non-Compliance with Protocol|0|||
148787702|NCT01249833|536699668|FG000|Overall Study|Lost to Follow-up|0|||
148787703|NCT01249833|536699669|FG001|Overall Study|Lost to Follow-up|1|||
148787704|NCT03796676|536699670|FG000|Overall Study|Adverse Event|2|||
148787705|NCT03796676|536699671|FG001|Overall Study|Adverse Event|1|||
148787706|NCT03796676|536699672|FG002|Overall Study|Adverse Event|2|||
148787707|NCT03796676|536699670|FG000|Overall Study|Lost to Follow-up|2|||
148787708|NCT03796676|536699671|FG001|Overall Study|Lost to Follow-up|1|||
148787709|NCT03796676|536699672|FG002|Overall Study|Lost to Follow-up|0|||
148787710|NCT03796676|536699670|FG000|Overall Study|Protocol Violation|0|||
148787711|NCT03796676|536699671|FG001|Overall Study|Protocol Violation|0|||
148787712|NCT03796676|536699672|FG002|Overall Study|Protocol Violation|1|||
148787713|NCT03796676|536699670|FG000|Overall Study|Withdrawal by Subject|1|||
148787714|NCT03796676|536699671|FG001|Overall Study|Withdrawal by Subject|1|||
148787715|NCT03796676|536699672|FG002|Overall Study|Withdrawal by Subject|0|||
148787716|NCT03796676|536699670|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
148787717|NCT03796676|536699671|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
148787718|NCT03796676|536699672|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
148787719|NCT00262002|536699677|FG000|Overall Study|Adverse Event|2|||
148787720|NCT00262002|536699678|FG001|Overall Study|Adverse Event|1|||
148787721|NCT00262002|536699679|FG002|Overall Study|Adverse Event|0|||
148787722|NCT00262002|536699680|FG003|Overall Study|Adverse Event|0|||
148787723|NCT00262002|536699681|FG004|Overall Study|Adverse Event|0|||
148787724|NCT00262002|536699682|FG005|Overall Study|Adverse Event|1|||
148787725|NCT00262002|536699683|FG006|Overall Study|Adverse Event|0|||
148787726|NCT00262002|536699677|FG000|Overall Study|Withdrawal by Subject|4|||
148787727|NCT00262002|536699678|FG001|Overall Study|Withdrawal by Subject|2|||
148787728|NCT00262002|536699679|FG002|Overall Study|Withdrawal by Subject|0|||
148787729|NCT00262002|536699680|FG003|Overall Study|Withdrawal by Subject|1|||
148787730|NCT00262002|536699681|FG004|Overall Study|Withdrawal by Subject|2|||
148787731|NCT00262002|536699682|FG005|Overall Study|Withdrawal by Subject|2|||
148787732|NCT00262002|536699683|FG006|Overall Study|Withdrawal by Subject|2|||
148787733|NCT00262002|536699677|FG000|Overall Study|Lost to Follow-up|2|||
148787734|NCT00262002|536699678|FG001|Overall Study|Lost to Follow-up|0|||
148787735|NCT00262002|536699679|FG002|Overall Study|Lost to Follow-up|0|||
148787736|NCT00262002|536699680|FG003|Overall Study|Lost to Follow-up|2|||
148787737|NCT00262002|536699681|FG004|Overall Study|Lost to Follow-up|0|||
148787738|NCT00262002|536699682|FG005|Overall Study|Lost to Follow-up|1|||
148787739|NCT00262002|536699683|FG006|Overall Study|Lost to Follow-up|0|||
148787740|NCT00262002|536699677|FG000|Overall Study|Inapropriate enrollment|0|||
148787741|NCT00262002|536699678|FG001|Overall Study|Inapropriate enrollment|1|||
148787742|NCT00262002|536699679|FG002|Overall Study|Inapropriate enrollment|0|||
148787743|NCT00262002|536699680|FG003|Overall Study|Inapropriate enrollment|0|||
148787744|NCT00262002|536699681|FG004|Overall Study|Inapropriate enrollment|0|||
148787745|NCT00262002|536699682|FG005|Overall Study|Inapropriate enrollment|0|||
148787746|NCT00262002|536699683|FG006|Overall Study|Inapropriate enrollment|0|||
148787747|NCT00262002|536699677|FG000|Overall Study|Protocol Violation|3|||
148787748|NCT00262002|536699678|FG001|Overall Study|Protocol Violation|2|||
148787749|NCT00262002|536699679|FG002|Overall Study|Protocol Violation|0|||
148787750|NCT00262002|536699680|FG003|Overall Study|Protocol Violation|2|||
148787751|NCT00262002|536699681|FG004|Overall Study|Protocol Violation|5|||
148787752|NCT00262002|536699682|FG005|Overall Study|Protocol Violation|3|||
148787753|NCT00262002|536699683|FG006|Overall Study|Protocol Violation|2|||
148787754|NCT00262002|536699677|FG000|Overall Study|Unable to classify|0|||
148787755|NCT00262002|536699678|FG001|Overall Study|Unable to classify|0|||
148787756|NCT00262002|536699679|FG002|Overall Study|Unable to classify|0|||
148787757|NCT00262002|536699680|FG003|Overall Study|Unable to classify|0|||
148787758|NCT00262002|536699681|FG004|Overall Study|Unable to classify|0|||
148787759|NCT00262002|536699682|FG005|Overall Study|Unable to classify|0|||
148787760|NCT00262002|536699683|FG006|Overall Study|Unable to classify|2|||
148787761|NCT01085084|536699684|FG000|Overall Study|Withdrawal by Subject|1|||
148893405|NCT01693029|537088700|FG000|Overall Study|Lost to Follow-up|0|||
148893406|NCT01693029|537088701|FG001|Overall Study|Lost to Follow-up|1|||
148787762|NCT01085084|536699685|FG001|Overall Study|Withdrawal by Subject|0|||
148893407|NCT01693029|537088700|FG000|Overall Study|Adverse Event|1|||
148787763|NCT01085084|536699686|FG002|Overall Study|Withdrawal by Subject|0|||
148787764|NCT01085084|536699684|FG000|Overall Study|Lost to Follow-up|2|||
148787765|NCT01085084|536699685|FG001|Overall Study|Lost to Follow-up|1|||
148787766|NCT01085084|536699686|FG002|Overall Study|Lost to Follow-up|1|||
148787767|NCT01085084|536699684|FG000|Overall Study|Adverse Event|4|||
148787768|NCT01085084|536699685|FG001|Overall Study|Adverse Event|3|||
148787769|NCT01085084|536699686|FG002|Overall Study|Adverse Event|6|||
148787770|NCT01085084|536699684|FG000|Overall Study|Treatment Failure|0|||
148787771|NCT01085084|536699685|FG001|Overall Study|Treatment Failure|1|||
148787772|NCT01085084|536699686|FG002|Overall Study|Treatment Failure|2|||
148787773|NCT02070978|536699687|FG000|Overall Study|Adverse Event|6|||
148787774|NCT02070978|536699688|FG001|Overall Study|Adverse Event|2|||
148787775|NCT02070978|536699689|FG002|Overall Study|Adverse Event|0|||
148787776|NCT02070978|536699687|FG000|Overall Study|Lost to Follow-up|1|||
148787777|NCT02070978|536699688|FG001|Overall Study|Lost to Follow-up|3|||
148787778|NCT02070978|536699689|FG002|Overall Study|Lost to Follow-up|4|||
148787779|NCT02070978|536699687|FG000|Overall Study|Withdrawal by Subject|3|||
148787780|NCT02070978|536699688|FG001|Overall Study|Withdrawal by Subject|5|||
148787781|NCT02070978|536699689|FG002|Overall Study|Withdrawal by Subject|3|||
148787782|NCT02070978|536699687|FG000|Overall Study|Protocol Violation|1|||
148787783|NCT02070978|536699688|FG001|Overall Study|Protocol Violation|0|||
148787784|NCT02070978|536699689|FG002|Overall Study|Protocol Violation|3|||
148787785|NCT02070978|536699687|FG000|Overall Study|Lack of Efficacy|0|||
148787786|NCT02070978|536699688|FG001|Overall Study|Lack of Efficacy|1|||
148787787|NCT02070978|536699689|FG002|Overall Study|Lack of Efficacy|0|||
148787788|NCT02070978|536699687|FG000|Overall Study|Death|0|||
148787789|NCT02070978|536699688|FG001|Overall Study|Death|0|||
148787790|NCT02070978|536699689|FG002|Overall Study|Death|2|||
148787791|NCT02070978|536699687|FG000|Overall Study|Un-specified|3|||
148787792|NCT02070978|536699688|FG001|Overall Study|Un-specified|2|||
148787793|NCT02070978|536699689|FG002|Overall Study|Un-specified|2|||
148787794|NCT02070978|536699687|FG000|Overall Study|Terminated by Sponsor|33|||
148787795|NCT02070978|536699688|FG001|Overall Study|Terminated by Sponsor|40|||
148787796|NCT02070978|536699689|FG002|Overall Study|Terminated by Sponsor|39|||
148787797|NCT00715299|536701852|FG000|Overall Study|Withdrawal by Subject|1|||
148787798|NCT00715299|536701852|FG000|Overall Study|Adverse Event|3|||
148787799|NCT00715299|536701852|FG000|Overall Study|failed the pre-screen exercise test|2|||
148787800|NCT02020889|536701853|FG000|Overall Study|Adverse Event|0|||
148787801|NCT02020889|536701854|FG001|Overall Study|Adverse Event|1|||
148787802|NCT02020889|536701853|FG000|Overall Study|Lack of Efficacy|1|||
148787803|NCT02020889|536701854|FG001|Overall Study|Lack of Efficacy|0|||
148787804|NCT02020889|536701853|FG000|Overall Study|Lost to Follow-up|1|||
148787805|NCT02020889|536701854|FG001|Overall Study|Lost to Follow-up|0|||
148787806|NCT02020889|536701853|FG000|Overall Study|Physician Decision|2|||
148787807|NCT02020889|536701854|FG001|Overall Study|Physician Decision|0|||
148787808|NCT02020889|536701853|FG000|Overall Study|Withdrawal by Subject|3|||
148787809|NCT02020889|536701854|FG001|Overall Study|Withdrawal by Subject|2|||
148787810|NCT01540981|536701855|FG000|Overall Study|Withdrawal by Subject|1|||
148787811|NCT01540981|536701856|FG001|Overall Study|Withdrawal by Subject|0|||
148787812|NCT00809094|536701858|FG000|Overall Study|Lost to Follow-up|0|||
148787813|NCT00809094|536701859|FG001|Overall Study|Lost to Follow-up|1|||
148787814|NCT01535443|536701862|FG000|Overall Study|Physician Decision|3|||
148787815|NCT00232557|536701863|FG000|Overall Study|Lost to Follow-up|3|||
148787816|NCT00232557|536701864|FG001|Overall Study|Lost to Follow-up|5|||
148787817|NCT02260817|536701866|FG000|Overall Study|Lost to Follow-up|0|||
148787818|NCT02260817|536701867|FG001|Overall Study|Lost to Follow-up|14|||
148787819|NCT02260817|536701866|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
148787820|NCT02260817|536701867|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
148787821|NCT02260817|536701866|FG000|Overall Study|Observation, no biopsy|0|||
148787822|NCT02260817|536701867|FG001|Overall Study|Observation, no biopsy|1|||
148787823|NCT02260817|536701866|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
148787824|NCT02260817|536701867|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
148787825|NCT02260817|536701866|FG000|Overall Study|Protocol Violation|0|||
148787826|NCT02260817|536701867|FG001|Overall Study|Protocol Violation|14|||
148787827|NCT04435808|536701870|FG000|Overall Study|Study stopped by DSMB|0|||
148787828|NCT04435808|536701871|FG001|Overall Study|Study stopped by DSMB|1|||
148787829|NCT02087943|536701874|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
148787830|NCT02087943|536701875|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
148787831|NCT02087943|536701876|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
148787832|NCT02087943|536701877|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
148787833|NCT02087943|536701878|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
148787834|NCT02087943|536701874|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
148787835|NCT02087943|536701875|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
148787836|NCT02087943|536701876|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
148787837|NCT02087943|536701877|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
148787838|NCT02087943|536701878|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
148787839|NCT02087943|536701874|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
148787840|NCT02087943|536701875|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
148787841|NCT02087943|536701876|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
148787842|NCT02087943|536701877|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
148787843|NCT02087943|536701878|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
148787844|NCT02087943|536701874|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
148787845|NCT02087943|536701875|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
148787846|NCT02087943|536701876|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
148787847|NCT02087943|536701877|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
148787848|NCT02087943|536701878|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
148787849|NCT02087943|536701874|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
148787850|NCT02087943|536701875|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
148787851|NCT02087943|536701876|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
148787852|NCT02087943|536701877|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
148787853|NCT02087943|536701878|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
148787854|NCT02087943|536701874|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
148787855|NCT02087943|536701875|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
148787856|NCT02087943|536701876|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
148787857|NCT02087943|536701877|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
148787858|NCT02087943|536701878|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
148787859|NCT02087943|536701874|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
148787860|NCT02087943|536701875|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
148787861|NCT02087943|536701876|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
148787862|NCT02087943|536701877|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
148787863|NCT02087943|536701878|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
148787864|NCT02087943|536701874|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
148787865|NCT02087943|536701875|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
148787866|NCT02087943|536701876|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
148787867|NCT02087943|536701877|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
148787868|NCT02087943|536701878|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
148787869|NCT02087943|536701874|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
148787870|NCT02087943|536701875|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
148787871|NCT02087943|536701876|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
148787872|NCT02087943|536701877|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
148787873|NCT02087943|536701878|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
148787874|NCT02087943|536701874|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
148787875|NCT02087943|536701875|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
148787876|NCT02087943|536701876|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
148787877|NCT02087943|536701877|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
148787878|NCT02087943|536701878|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
148787879|NCT01348100|536701882|FG000|Overall Study|Subject Withdrew Consent|0|||
148787880|NCT01348100|536701883|FG001|Overall Study|Subject Withdrew Consent|0|||
148787881|NCT01348100|536701884|FG002|Overall Study|Subject Withdrew Consent|2|||
148787882|NCT01348100|536701885|FG003|Overall Study|Subject Withdrew Consent|0|||
148787883|NCT01348100|536701886|FG004|Overall Study|Subject Withdrew Consent|1|||
148787884|NCT01348100|536701887|FG005|Overall Study|Subject Withdrew Consent|0|||
148787885|NCT01348100|536701888|FG006|Overall Study|Subject Withdrew Consent|1|||
148787886|NCT01348100|536701882|FG000|Overall Study|Protocol Deviation|0|||
148787887|NCT01348100|536701883|FG001|Overall Study|Protocol Deviation|0|||
148787888|NCT01348100|536701884|FG002|Overall Study|Protocol Deviation|0|||
148787889|NCT01348100|536701885|FG003|Overall Study|Protocol Deviation|1|||
148787890|NCT01348100|536701886|FG004|Overall Study|Protocol Deviation|0|||
148787891|NCT01348100|536701887|FG005|Overall Study|Protocol Deviation|0|||
148787892|NCT01348100|536701888|FG006|Overall Study|Protocol Deviation|0|||
148787893|NCT01348100|536701882|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148787894|NCT01348100|536701883|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148787895|NCT01348100|536701884|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148787896|NCT01348100|536701885|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148787897|NCT01348100|536701886|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148787898|NCT01348100|536701887|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
149129637|NCT01287065|537954518|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149129638|NCT01287065|537954519|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149129639|NCT01287065|537954520|FG005|Treatment Period 1|Withdrawal by Subject|1|||
149129640|NCT01259726|537954521|FG000|Overall Study|Death|1|||
149129641|NCT01259726|537954522|FG001|Overall Study|Death|0|||
149129642|NCT01259726|537954523|FG002|Overall Study|Death|0|||
149129643|NCT01259726|537954524|FG003|Overall Study|Death|0|||
149129644|NCT01259726|537954521|FG000|Overall Study|Physician Decision|2|||
148787899|NCT01348100|536701888|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149129645|NCT01259726|537954522|FG001|Overall Study|Physician Decision|0|||
149129646|NCT01259726|537954523|FG002|Overall Study|Physician Decision|1|||
149129647|NCT01259726|537954524|FG003|Overall Study|Physician Decision|1|||
148787900|NCT01348100|536701882|FG000|Overall Study|Lost to Follow-up|0|||
148787901|NCT01348100|536701883|FG001|Overall Study|Lost to Follow-up|0|||
148787902|NCT01348100|536701884|FG002|Overall Study|Lost to Follow-up|0|||
148787903|NCT01348100|536701885|FG003|Overall Study|Lost to Follow-up|0|||
148787904|NCT01348100|536701886|FG004|Overall Study|Lost to Follow-up|0|||
148787905|NCT01348100|536701887|FG005|Overall Study|Lost to Follow-up|0|||
148787906|NCT01348100|536701888|FG006|Overall Study|Lost to Follow-up|1|||
148787907|NCT01348100|536701882|FG000|Overall Study|Administrative Problems|0|||
148787908|NCT01348100|536701883|FG001|Overall Study|Administrative Problems|0|||
148787909|NCT01348100|536701884|FG002|Overall Study|Administrative Problems|0|||
148787910|NCT01348100|536701885|FG003|Overall Study|Administrative Problems|0|||
148787911|NCT01348100|536701886|FG004|Overall Study|Administrative Problems|0|||
148787912|NCT01348100|536701887|FG005|Overall Study|Administrative Problems|1|||
148787913|NCT01348100|536701888|FG006|Overall Study|Administrative Problems|1|||
148787914|NCT03882957|536701891|FG000|Overall Study|Did not complete all three arms|1|||
148787915|NCT02347072|536701892|FG000|Overall Study|Adverse Event|2|||
148787916|NCT02347072|536701892|FG000|Overall Study|Withdrawal by Subject|6|||
148787917|NCT02347072|536701892|FG000|Overall Study|Physician Decision|1|||
148787918|NCT02347072|536701892|FG000|Overall Study|Lost to Follow-up|2|||
148787919|NCT02347072|536701892|FG000|Overall Study|Protocol Violation|1|||
148787920|NCT02347072|536701892|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
148787921|NCT01134393|536701898|FG000|Overall Study|Adverse Event|18|||
148787922|NCT01134393|536701898|FG000|Overall Study|Lack of Efficacy|2|||
148787923|NCT01134393|536701898|FG000|Overall Study|Protocol Violation|12|||
148787924|NCT01134393|536701898|FG000|Overall Study|Lost to Follow-up|3|||
148787925|NCT01134393|536701898|FG000|Overall Study|Withdrawal by Subject|11|||
148787926|NCT01134393|536701898|FG000|Overall Study|Other|6|||
148787927|NCT01808222|536701902|FG000|Overall Study|mpMR scan was not performed|1|||
148787928|NCT03762681|536701905|FG000|Part 1|Withdrawal by Subject|0|||
148787929|NCT03762681|536701906|FG001|Part 1|Withdrawal by Subject|0|||
148787930|NCT03762681|536701907|FG002|Part 1|Withdrawal by Subject|0|||
148787931|NCT03762681|536701908|FG003|Part 1|Withdrawal by Subject|1|||
148787932|NCT03762681|536701909|FG004|Part 1|Withdrawal by Subject|0|||
148787933|NCT03762681|536701910|FG005|Part 1|Withdrawal by Subject|0|||
148787934|NCT03762681|536701911|FG006|Part 1|Withdrawal by Subject|0|||
148787935|NCT03762681|536701912|FG007|Part 1|Withdrawal by Subject|0|||
148787936|NCT03762681|536701905|FG000|Part 2a|Pandemic Travel Restrictions|0|||
148787937|NCT03762681|536701906|FG001|Part 2a|Pandemic Travel Restrictions|0|||
148787938|NCT03762681|536701907|FG002|Part 2a|Pandemic Travel Restrictions|0|||
148787939|NCT03762681|536701908|FG003|Part 2a|Pandemic Travel Restrictions|0|||
148787940|NCT03762681|536701909|FG004|Part 2a|Pandemic Travel Restrictions|0|||
148787941|NCT03762681|536701910|FG005|Part 2a|Pandemic Travel Restrictions|0|||
148787942|NCT03762681|536701911|FG006|Part 2a|Pandemic Travel Restrictions|0|||
148787943|NCT03762681|536701912|FG007|Part 2a|Pandemic Travel Restrictions|1|||
148787944|NCT00524680|536701915|FG000|Overall Study|progression|0|||
148787945|NCT00524680|536701916|FG001|Overall Study|progression|0|||
148787946|NCT00524680|536701917|FG002|Overall Study|progression|0|||
148787947|NCT00524680|536701918|FG003|Overall Study|progression|1|||
148787948|NCT00524680|536701915|FG000|Overall Study|Adverse Event|2|||
148787949|NCT00524680|536701916|FG001|Overall Study|Adverse Event|0|||
148787950|NCT00524680|536701917|FG002|Overall Study|Adverse Event|0|||
148787951|NCT00524680|536701918|FG003|Overall Study|Adverse Event|1|||
148787952|NCT00524680|536701915|FG000|Overall Study|Other|0|||
148787953|NCT00524680|536701916|FG001|Overall Study|Other|1|||
148787954|NCT00524680|536701917|FG002|Overall Study|Other|2|||
148787955|NCT00524680|536701918|FG003|Overall Study|Other|3|||
148787956|NCT00524680|536701915|FG000|Overall Study|Withdrawal by Subject|1|||
148787957|NCT00524680|536701916|FG001|Overall Study|Withdrawal by Subject|0|||
148787958|NCT00524680|536701917|FG002|Overall Study|Withdrawal by Subject|1|||
148787959|NCT00524680|536701918|FG003|Overall Study|Withdrawal by Subject|1|||
148787960|NCT01146561|536701919|FG000|Overall Study|Withdrawal by Subject|1|||
148787961|NCT01146561|536701919|FG000|Overall Study|Lost to Follow-up|1|||
148787962|NCT04318132|536701922|FG000|Overall Study|Protocol Violation|0|||
148787963|NCT04318132|536701923|FG001|Overall Study|Protocol Violation|0|||
148787964|NCT04318132|536701924|FG002|Overall Study|Protocol Violation|3|||
148787965|NCT04318132|536701925|FG003|Overall Study|Protocol Violation|0|||
148787966|NCT00073008|536701927|FG000|Overall Study|Missing|6|||
148787967|NCT00073008|536701928|FG001|Overall Study|Missing|6|||
148787968|NCT00073008|536701927|FG000|Overall Study|Withdrawal by Subject|2|||
148787969|NCT00073008|536701928|FG001|Overall Study|Withdrawal by Subject|2|||
148787970|NCT00073008|536701927|FG000|Overall Study|Lost to Follow-up|1|||
148787971|NCT00073008|536701928|FG001|Overall Study|Lost to Follow-up|3|||
148787972|NCT00073008|536701927|FG000|Overall Study|Death|46|||
148787973|NCT00073008|536701928|FG001|Overall Study|Death|47|||
148787974|NCT00073008|536701927|FG000|Overall Study|"Other selected on Case Report Form"|7|||
148787975|NCT00073008|536701928|FG001|Overall Study|"Other selected on Case Report Form"|5|||
148787976|NCT03337048|536701929|FG000|Overall Study|Withdrawal by Subject|2|||
148787977|NCT03337048|536701930|FG001|Overall Study|Withdrawal by Subject|0|||
148787978|NCT03337048|536701931|FG002|Overall Study|Withdrawal by Subject|0|||
148787979|NCT00893971|536701933|FG000|Overall Study|Physician Decision|3|||
148787980|NCT01926197|536701934|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
148787981|NCT01926197|536701935|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
148787982|NCT01926197|536701934|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
148787983|NCT01926197|536701935|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
148787984|NCT03628716|536701936|FG000|Overall Study|Adverse Event|1|||
148787985|NCT03628716|536701937|FG001|Overall Study|Adverse Event|1|||
148787986|NCT03628716|536701936|FG000|Overall Study|Death|1|||
148787987|NCT03628716|536701937|FG001|Overall Study|Death|0|||
148787988|NCT03628716|536701936|FG000|Overall Study|Lack of Efficacy|15|||
148787989|NCT03628716|536701937|FG001|Overall Study|Lack of Efficacy|20|||
148787990|NCT03628716|536701936|FG000|Overall Study|Withdrawal by Subject|1|||
148787991|NCT03628716|536701937|FG001|Overall Study|Withdrawal by Subject|2|||
148787992|NCT03628716|536701936|FG000|Overall Study|Study Terminated by Sponsor|1|||
148787993|NCT03628716|536701937|FG001|Overall Study|Study Terminated by Sponsor|0|||
148787994|NCT00856843|536701939|FG000|Overall Study|Withdrawal by Subject|1|||
148787995|NCT00856843|536701940|FG001|Overall Study|Withdrawal by Subject|5|||
148787996|NCT00856843|536701939|FG000|Overall Study|Lack of Efficacy|1|||
148787997|NCT00856843|536701940|FG001|Overall Study|Lack of Efficacy|0|||
148787998|NCT02223364|536701941|FG000|Overall Study|Protocol Violation|3|||
148787999|NCT02223364|536701942|FG001|Overall Study|Protocol Violation|0|||
148788000|NCT02223364|536701943|FG002|Overall Study|Protocol Violation|3|||
148788001|NCT02223364|536701941|FG000|Overall Study|subject expired before surgery|1|||
148788002|NCT02223364|536701942|FG001|Overall Study|subject expired before surgery|0|||
148788003|NCT02223364|536701943|FG002|Overall Study|subject expired before surgery|0|||
148788004|NCT02223364|536701941|FG000|Overall Study|Physician Decision|1|||
148788005|NCT02223364|536701942|FG001|Overall Study|Physician Decision|0|||
148788006|NCT02223364|536701943|FG002|Overall Study|Physician Decision|0|||
148788007|NCT01416155|536701944|FG000|Overall Study|Adverse Event|8|||
148788008|NCT01416155|536701944|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
148788009|NCT01416155|536701944|FG000|Overall Study|Withdrawal by Subject|33|||
148788010|NCT01416155|536701944|FG000|Overall Study|Investigator decision|8|||
148788011|NCT01416155|536701944|FG000|Overall Study|Other|7|||
148788012|NCT00829829|536701948|FG000|Overall Study|Protocol Violation|0|||
148788013|NCT00829829|536701949|FG001|Overall Study|Protocol Violation|3|||
148788014|NCT00829829|536701950|FG002|Overall Study|Protocol Violation|0|||
148788015|NCT00829829|536701948|FG000|Overall Study|Adverse Event|4|||
148788016|NCT00829829|536701949|FG001|Overall Study|Adverse Event|4|||
148788017|NCT00829829|536701950|FG002|Overall Study|Adverse Event|3|||
148788018|NCT00829829|536701948|FG000|Overall Study|Withdrawal by Subject|8|||
148788019|NCT00829829|536701949|FG001|Overall Study|Withdrawal by Subject|4|||
148788020|NCT00829829|536701950|FG002|Overall Study|Withdrawal by Subject|2|||
148788021|NCT00829829|536701948|FG000|Overall Study|Decision by the Sponsor|1|||
148788022|NCT00829829|536701949|FG001|Overall Study|Decision by the Sponsor|0|||
148788023|NCT00829829|536701950|FG002|Overall Study|Decision by the Sponsor|2|||
148788024|NCT00829829|536701948|FG000|Overall Study|Lost to Follow-up|7|||
148788025|NCT00829829|536701949|FG001|Overall Study|Lost to Follow-up|3|||
148788026|NCT00829829|536701950|FG002|Overall Study|Lost to Follow-up|3|||
148788027|NCT00829829|536701948|FG000|Overall Study|Other than specified above|2|||
148788028|NCT00829829|536701949|FG001|Overall Study|Other than specified above|2|||
148788029|NCT00829829|536701950|FG002|Overall Study|Other than specified above|1|||
148788030|NCT02984267|536701951|FG000|Overall Study|Protocol Violation|1|||
148788031|NCT02984267|536701952|FG001|Overall Study|Protocol Violation|0|||
148788032|NCT02984267|536701951|FG000|Overall Study|Withdrawal by Subject|0|||
148788033|NCT02984267|536701952|FG001|Overall Study|Withdrawal by Subject|1|||
148788034|NCT02685072|536701953|FG000|Treatment Period|Lost to Follow-up|12|||
148788035|NCT02685072|536701954|FG001|Treatment Period|Lost to Follow-up|6|||
148788036|NCT02685072|536701953|FG000|Treatment Period|Withdrawal by Subject|1|||
148788037|NCT02685072|536701954|FG001|Treatment Period|Withdrawal by Subject|3|||
148788038|NCT02685072|536701953|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
148788039|NCT02685072|536701954|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
148788040|NCT03597139|536701955|FG000|Overall Study|Adverse Event|3|||
148788041|NCT03597139|536701956|FG001|Overall Study|Adverse Event|0|||
148788042|NCT03597139|536701955|FG000|Overall Study|Protocol Non-compliance|1|||
148788043|NCT03597139|536701956|FG001|Overall Study|Protocol Non-compliance|0|||
149129648|NCT01259726|537954521|FG000|Overall Study|Withdrawal by Subject|1|||
148788044|NCT05052697|536701960|FG000|Substudy A|Lost to Follow-up|0|||
148788045|NCT05052697|536701961|FG001|Substudy A|Lost to Follow-up|0|||
148788046|NCT05052697|536701962|FG002|Substudy A|Lost to Follow-up|0|||
148788047|NCT05052697|536701963|FG003|Substudy A|Lost to Follow-up|0|||
148788048|NCT05052697|536701964|FG004|Substudy A|Lost to Follow-up|0|||
148788049|NCT05052697|536701965|FG005|Substudy A|Lost to Follow-up|1|||
148788050|NCT05052697|536701966|FG006|Substudy A|Lost to Follow-up|0|||
148788051|NCT05052697|536701967|FG007|Substudy A|Lost to Follow-up|0|||
148788052|NCT05052697|536701968|FG008|Substudy A|Lost to Follow-up|0|||
149129649|NCT01259726|537954522|FG001|Overall Study|Withdrawal by Subject|3|||
149129650|NCT01259726|537954523|FG002|Overall Study|Withdrawal by Subject|2|||
148788053|NCT05052697|536701969|FG009|Substudy A|Lost to Follow-up|0|||
148788054|NCT05052697|536701970|FG010|Substudy A|Lost to Follow-up|0|||
148788055|NCT05052697|536701971|FG011|Substudy A|Lost to Follow-up|0|||
148788056|NCT05052697|536701972|FG012|Substudy A|Lost to Follow-up|0|||
148788057|NCT05052697|536701973|FG013|Substudy A|Lost to Follow-up|0|||
148788058|NCT05052697|536701974|FG014|Substudy A|Lost to Follow-up|0|||
148788059|NCT05052697|536701975|FG015|Substudy A|Lost to Follow-up|2|||
148788060|NCT05052697|536701976|FG016|Substudy A|Lost to Follow-up|0|||
148788061|NCT05052697|536701977|FG017|Substudy A|Lost to Follow-up|0|||
148788062|NCT05052697|536701978|FG018|Substudy A|Lost to Follow-up|0|||
148788063|NCT05052697|536701979|FG019|Substudy A|Lost to Follow-up|0|||
148788064|NCT05052697|536701980|FG020|Substudy A|Lost to Follow-up|0|||
148788065|NCT05052697|536701981|FG021|Substudy A|Lost to Follow-up|0|||
148788066|NCT05052697|536701982|FG022|Substudy A|Lost to Follow-up|0|||
148788067|NCT05052697|536701983|FG023|Substudy A|Lost to Follow-up|0|||
148788068|NCT05052697|536701984|FG024|Substudy A|Lost to Follow-up|0|||
148788069|NCT05052697|536701985|FG025|Substudy A|Lost to Follow-up|0|||
148788070|NCT05052697|536701986|FG026|Substudy A|Lost to Follow-up|0|||
148788071|NCT05052697|536701987|FG027|Substudy A|Lost to Follow-up|0|||
148788072|NCT05052697|536701988|FG028|Substudy A|Lost to Follow-up|0|||
148788073|NCT05052697|536701989|FG029|Substudy A|Lost to Follow-up|0|||
148788074|NCT05052697|536701990|FG030|Substudy A|Lost to Follow-up|0|||
148788075|NCT05052697|536701991|FG031|Substudy A|Lost to Follow-up|0|||
148788076|NCT05052697|536701992|FG032|Substudy A|Lost to Follow-up|0|||
148788077|NCT05052697|536701993|FG033|Substudy A|Lost to Follow-up|0|||
148788078|NCT05052697|536701960|FG000|Substudy A|No longer met eligibility criteria|0|||
148788079|NCT05052697|536701961|FG001|Substudy A|No longer met eligibility criteria|0|||
148788080|NCT05052697|536701962|FG002|Substudy A|No longer met eligibility criteria|0|||
148788081|NCT05052697|536701963|FG003|Substudy A|No longer met eligibility criteria|0|||
148788082|NCT05052697|536701964|FG004|Substudy A|No longer met eligibility criteria|0|||
148788083|NCT05052697|536701965|FG005|Substudy A|No longer met eligibility criteria|0|||
148788084|NCT05052697|536701966|FG006|Substudy A|No longer met eligibility criteria|0|||
148788085|NCT05052697|536701967|FG007|Substudy A|No longer met eligibility criteria|0|||
148788086|NCT05052697|536701968|FG008|Substudy A|No longer met eligibility criteria|0|||
148788087|NCT05052697|536701969|FG009|Substudy A|No longer met eligibility criteria|0|||
148788088|NCT05052697|536701970|FG010|Substudy A|No longer met eligibility criteria|0|||
148788089|NCT05052697|536701971|FG011|Substudy A|No longer met eligibility criteria|0|||
148788090|NCT05052697|536701972|FG012|Substudy A|No longer met eligibility criteria|0|||
148788091|NCT05052697|536701973|FG013|Substudy A|No longer met eligibility criteria|1|||
148788092|NCT05052697|536701974|FG014|Substudy A|No longer met eligibility criteria|0|||
148788093|NCT05052697|536701975|FG015|Substudy A|No longer met eligibility criteria|0|||
148788094|NCT05052697|536701976|FG016|Substudy A|No longer met eligibility criteria|0|||
148788095|NCT05052697|536701977|FG017|Substudy A|No longer met eligibility criteria|0|||
148788096|NCT05052697|536701978|FG018|Substudy A|No longer met eligibility criteria|0|||
148788097|NCT05052697|536701979|FG019|Substudy A|No longer met eligibility criteria|0|||
148788098|NCT05052697|536701980|FG020|Substudy A|No longer met eligibility criteria|0|||
148788099|NCT05052697|536701981|FG021|Substudy A|No longer met eligibility criteria|0|||
148788100|NCT05052697|536701982|FG022|Substudy A|No longer met eligibility criteria|0|||
148788101|NCT05052697|536701983|FG023|Substudy A|No longer met eligibility criteria|0|||
148788102|NCT05052697|536701984|FG024|Substudy A|No longer met eligibility criteria|0|||
148788103|NCT05052697|536701985|FG025|Substudy A|No longer met eligibility criteria|0|||
148788104|NCT05052697|536701986|FG026|Substudy A|No longer met eligibility criteria|0|||
148788105|NCT05052697|536701987|FG027|Substudy A|No longer met eligibility criteria|0|||
148788106|NCT05052697|536701988|FG028|Substudy A|No longer met eligibility criteria|0|||
148788107|NCT05052697|536701989|FG029|Substudy A|No longer met eligibility criteria|0|||
148788108|NCT05052697|536701990|FG030|Substudy A|No longer met eligibility criteria|0|||
148788109|NCT05052697|536701991|FG031|Substudy A|No longer met eligibility criteria|0|||
148788110|NCT05052697|536701992|FG032|Substudy A|No longer met eligibility criteria|0|||
148788111|NCT05052697|536701993|FG033|Substudy A|No longer met eligibility criteria|0|||
148788112|NCT05052697|536701960|FG000|Substudy A|Not vaccinated|0|||
148788113|NCT05052697|536701961|FG001|Substudy A|Not vaccinated|0|||
148788114|NCT05052697|536701962|FG002|Substudy A|Not vaccinated|0|||
148788115|NCT05052697|536701963|FG003|Substudy A|Not vaccinated|1|||
148788116|NCT05052697|536701964|FG004|Substudy A|Not vaccinated|0|||
148788117|NCT05052697|536701965|FG005|Substudy A|Not vaccinated|0|||
148788118|NCT05052697|536701966|FG006|Substudy A|Not vaccinated|0|||
148788119|NCT05052697|536701967|FG007|Substudy A|Not vaccinated|0|||
148788120|NCT05052697|536701968|FG008|Substudy A|Not vaccinated|1|||
148788121|NCT05052697|536701969|FG009|Substudy A|Not vaccinated|0|||
148788122|NCT05052697|536701970|FG010|Substudy A|Not vaccinated|0|||
148788123|NCT05052697|536701971|FG011|Substudy A|Not vaccinated|0|||
148788124|NCT05052697|536701972|FG012|Substudy A|Not vaccinated|0|||
148788125|NCT05052697|536701973|FG013|Substudy A|Not vaccinated|0|||
148788126|NCT05052697|536701974|FG014|Substudy A|Not vaccinated|0|||
148788127|NCT05052697|536701975|FG015|Substudy A|Not vaccinated|0|||
148788128|NCT05052697|536701976|FG016|Substudy A|Not vaccinated|0|||
148788129|NCT05052697|536701977|FG017|Substudy A|Not vaccinated|0|||
148788130|NCT05052697|536701978|FG018|Substudy A|Not vaccinated|0|||
148788131|NCT05052697|536701979|FG019|Substudy A|Not vaccinated|0|||
148788132|NCT05052697|536701980|FG020|Substudy A|Not vaccinated|0|||
148788133|NCT05052697|536701981|FG021|Substudy A|Not vaccinated|0|||
148788134|NCT05052697|536701982|FG022|Substudy A|Not vaccinated|0|||
148788135|NCT05052697|536701983|FG023|Substudy A|Not vaccinated|0|||
148788136|NCT05052697|536701984|FG024|Substudy A|Not vaccinated|0|||
148788137|NCT05052697|536701985|FG025|Substudy A|Not vaccinated|0|||
148788138|NCT05052697|536701986|FG026|Substudy A|Not vaccinated|0|||
148788139|NCT05052697|536701987|FG027|Substudy A|Not vaccinated|0|||
148788140|NCT05052697|536701988|FG028|Substudy A|Not vaccinated|0|||
148788141|NCT05052697|536701989|FG029|Substudy A|Not vaccinated|0|||
148788142|NCT05052697|536701990|FG030|Substudy A|Not vaccinated|0|||
148788143|NCT05052697|536701991|FG031|Substudy A|Not vaccinated|0|||
148788144|NCT05052697|536701992|FG032|Substudy A|Not vaccinated|0|||
148788145|NCT05052697|536701993|FG033|Substudy A|Not vaccinated|0|||
148788146|NCT05052697|536701960|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788147|NCT05052697|536701961|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
149129651|NCT01259726|537954524|FG003|Overall Study|Withdrawal by Subject|1|||
149129652|NCT01259726|537954521|FG000|Overall Study|Lost to Follow-up|1|||
149129653|NCT01259726|537954522|FG001|Overall Study|Lost to Follow-up|1|||
148788148|NCT05052697|536701962|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788149|NCT05052697|536701963|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788150|NCT05052697|536701964|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788151|NCT05052697|536701965|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788152|NCT05052697|536701966|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788153|NCT05052697|536701967|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788154|NCT05052697|536701968|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788155|NCT05052697|536701969|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788156|NCT05052697|536701970|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788157|NCT05052697|536701971|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788158|NCT05052697|536701972|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788159|NCT05052697|536701973|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788160|NCT05052697|536701974|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788161|NCT05052697|536701975|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788162|NCT05052697|536701976|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788163|NCT05052697|536701977|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788164|NCT05052697|536701978|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
148788165|NCT05052697|536701979|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
148788166|NCT05052697|536701980|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788167|NCT05052697|536701981|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
148788168|NCT05052697|536701982|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
148788169|NCT05052697|536701983|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788170|NCT05052697|536701984|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788171|NCT05052697|536701985|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788172|NCT05052697|536701986|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788173|NCT05052697|536701987|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788174|NCT05052697|536701988|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788175|NCT05052697|536701989|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788176|NCT05052697|536701990|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788177|NCT05052697|536701991|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788178|NCT05052697|536701992|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788179|NCT05052697|536701993|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
148788180|NCT05052697|536701960|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788181|NCT05052697|536701961|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
149129654|NCT01259726|537954523|FG002|Overall Study|Lost to Follow-up|1|||
149129655|NCT01259726|537954524|FG003|Overall Study|Lost to Follow-up|3|||
149129656|NCT01211197|537954526|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149129657|NCT01211197|537954527|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149129658|NCT01211197|537954528|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
149129659|NCT01211197|537954529|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149129660|NCT01211197|537954530|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149129661|NCT01211197|537954531|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148788182|NCT05052697|536701962|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788183|NCT05052697|536701963|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788184|NCT05052697|536701964|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788185|NCT05052697|536701965|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788186|NCT05052697|536701966|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
149129662|NCT01211197|537954526|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
149129663|NCT01211197|537954527|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
149129664|NCT01211197|537954528|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
149129665|NCT01211197|537954529|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
148788187|NCT05052697|536701967|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788188|NCT05052697|536701968|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788189|NCT05052697|536701969|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788190|NCT05052697|536701970|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788191|NCT05052697|536701971|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788192|NCT05052697|536701972|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788193|NCT05052697|536701973|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788194|NCT05052697|536701974|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788195|NCT05052697|536701975|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788196|NCT05052697|536701976|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788197|NCT05052697|536701977|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
148788198|NCT05052697|536701978|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788199|NCT05052697|536701979|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788200|NCT05052697|536701980|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788201|NCT05052697|536701981|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788202|NCT05052697|536701982|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788203|NCT05052697|536701983|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788204|NCT05052697|536701984|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788205|NCT05052697|536701985|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788206|NCT05052697|536701986|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788207|NCT05052697|536701987|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788208|NCT05052697|536701988|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788209|NCT05052697|536701989|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788210|NCT05052697|536701990|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788211|NCT05052697|536701991|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788212|NCT05052697|536701992|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788213|NCT05052697|536701993|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
148788214|NCT05052697|536701960|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788215|NCT05052697|536701961|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788216|NCT05052697|536701962|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788217|NCT05052697|536701963|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788218|NCT05052697|536701964|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788219|NCT05052697|536701965|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788220|NCT05052697|536701966|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788221|NCT05052697|536701967|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788222|NCT05052697|536701968|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788223|NCT05052697|536701969|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149129666|NCT01211197|537954530|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
149129667|NCT01211197|537954531|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
149129668|NCT00887679|537954532|FG000|Overall Study|Withdrawal by Subject|1|||
149129669|NCT00887679|537954532|FG000|Overall Study|Lost to Follow-up|4|||
149129670|NCT00887679|537954532|FG000|Overall Study|Physician Decision|5|||
149129671|NCT02683941|537954533|FG000|Double-blind Phase|Adverse Event|0|||
149129672|NCT02683941|537954534|FG001|Double-blind Phase|Adverse Event|1|||
148788224|NCT05052697|536701970|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788225|NCT05052697|536701971|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788226|NCT05052697|536701972|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788227|NCT05052697|536701973|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788228|NCT05052697|536701974|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788229|NCT05052697|536701975|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788230|NCT05052697|536701976|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788231|NCT05052697|536701977|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788232|NCT05052697|536701978|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788233|NCT05052697|536701979|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
148788234|NCT05052697|536701980|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
149129673|NCT02683941|537954533|FG000|Double-blind Phase|Withdrawal by Subject|4|||
149129674|NCT02683941|537954534|FG001|Double-blind Phase|Withdrawal by Subject|2|||
149129675|NCT02683941|537954533|FG000|Double-blind Phase|Lost to Follow-up|1|||
149129676|NCT02683941|537954534|FG001|Double-blind Phase|Lost to Follow-up|0|||
149129677|NCT02683941|537954533|FG000|Double-blind Phase|Disease Progression|5|||
149129678|NCT02683941|537954534|FG001|Double-blind Phase|Disease Progression|2|||
149129679|NCT02683941|537954533|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
149129680|NCT02683941|537954534|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
149129681|NCT02683941|537954533|FG000|Open-label Treatment Phase|Disease Progression|1|||
149129682|NCT02683941|537954534|FG001|Open-label Treatment Phase|Disease Progression|2|||
149129683|NCT02683941|537954533|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
149129684|NCT02683941|537954534|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
149129685|NCT02683941|537954533|FG000|Open-label Treatment Phase|Other|1|||
149129686|NCT02683941|537954534|FG001|Open-label Treatment Phase|Other|0|||
149129687|NCT02683941|537954533|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
149129688|NCT02683941|537954534|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
148788235|NCT05052697|536701981|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788236|NCT05052697|536701982|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788237|NCT05052697|536701983|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788238|NCT05052697|536701984|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788239|NCT05052697|536701985|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788240|NCT05052697|536701986|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788241|NCT05052697|536701987|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788242|NCT05052697|536701988|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788243|NCT05052697|536701989|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788244|NCT05052697|536701990|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788245|NCT05052697|536701991|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788246|NCT05052697|536701992|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788247|NCT05052697|536701993|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
148788248|NCT05052697|536701960|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788249|NCT05052697|536701961|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788250|NCT05052697|536701962|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788251|NCT05052697|536701963|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788252|NCT05052697|536701964|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788253|NCT05052697|536701965|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788254|NCT05052697|536701966|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788255|NCT05052697|536701967|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788256|NCT05052697|536701968|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788257|NCT05052697|536701969|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788258|NCT05052697|536701970|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788259|NCT05052697|536701971|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788260|NCT05052697|536701972|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788261|NCT05052697|536701973|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788262|NCT05052697|536701974|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788263|NCT05052697|536701975|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788264|NCT05052697|536701976|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788265|NCT05052697|536701977|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
148788266|NCT05052697|536701978|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788267|NCT05052697|536701979|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788268|NCT05052697|536701980|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788269|NCT05052697|536701981|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788270|NCT05052697|536701982|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788271|NCT05052697|536701983|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788272|NCT05052697|536701984|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788273|NCT05052697|536701985|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
148788274|NCT05052697|536701986|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788275|NCT05052697|536701987|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
148788276|NCT05052697|536701988|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788277|NCT05052697|536701989|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788278|NCT05052697|536701990|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788279|NCT05052697|536701991|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788280|NCT05052697|536701992|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788281|NCT05052697|536701993|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
148788282|NCT05052697|536701960|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788283|NCT05052697|536701961|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788284|NCT05052697|536701962|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788285|NCT05052697|536701963|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788286|NCT05052697|536701964|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788287|NCT05052697|536701965|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788288|NCT05052697|536701966|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788289|NCT05052697|536701967|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788290|NCT05052697|536701968|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788291|NCT05052697|536701969|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788292|NCT05052697|536701970|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788293|NCT05052697|536701971|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788294|NCT05052697|536701972|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788295|NCT05052697|536701973|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788296|NCT05052697|536701974|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788297|NCT05052697|536701975|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788298|NCT05052697|536701976|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788299|NCT05052697|536701977|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788300|NCT05052697|536701978|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788301|NCT05052697|536701979|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788302|NCT05052697|536701980|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788303|NCT05052697|536701981|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788304|NCT05052697|536701982|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788305|NCT05052697|536701983|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788306|NCT05052697|536701984|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788307|NCT05052697|536701985|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788308|NCT05052697|536701986|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788309|NCT05052697|536701987|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788310|NCT05052697|536701988|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
148788311|NCT05052697|536701989|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788312|NCT05052697|536701990|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
148788313|NCT05052697|536701991|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
148788314|NCT05052697|536701992|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
148788315|NCT05052697|536701993|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
148788316|NCT05052697|536701960|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788317|NCT05052697|536701961|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788318|NCT05052697|536701962|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788319|NCT05052697|536701963|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788320|NCT05052697|536701964|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788321|NCT05052697|536701965|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788322|NCT05052697|536701966|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788323|NCT05052697|536701967|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788324|NCT05052697|536701968|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788325|NCT05052697|536701969|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788326|NCT05052697|536701970|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788327|NCT05052697|536701971|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788328|NCT05052697|536701972|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788329|NCT05052697|536701973|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788330|NCT05052697|536701974|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788331|NCT05052697|536701975|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788332|NCT05052697|536701976|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788333|NCT05052697|536701977|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788334|NCT05052697|536701978|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788335|NCT05052697|536701979|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788336|NCT05052697|536701980|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788337|NCT05052697|536701981|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788338|NCT05052697|536701982|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788339|NCT05052697|536701983|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788340|NCT05052697|536701984|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788341|NCT05052697|536701985|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788342|NCT05052697|536701986|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788343|NCT05052697|536701987|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788344|NCT05052697|536701988|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
148788345|NCT05052697|536701989|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
148788346|NCT05052697|536701990|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
148788347|NCT05052697|536701991|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
148788348|NCT05052697|536701992|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
148788349|NCT05052697|536701993|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
148788350|NCT05052697|536701960|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788351|NCT05052697|536701961|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788352|NCT05052697|536701962|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788353|NCT05052697|536701963|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788354|NCT05052697|536701964|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788355|NCT05052697|536701965|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788356|NCT05052697|536701966|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788357|NCT05052697|536701967|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788358|NCT05052697|536701968|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788359|NCT05052697|536701969|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788360|NCT05052697|536701970|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788361|NCT05052697|536701971|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788362|NCT05052697|536701972|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788363|NCT05052697|536701973|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788364|NCT05052697|536701974|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788365|NCT05052697|536701975|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788366|NCT05052697|536701976|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788367|NCT05052697|536701977|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788368|NCT05052697|536701978|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788369|NCT05052697|536701979|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788370|NCT05052697|536701980|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788371|NCT05052697|536701981|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788372|NCT05052697|536701982|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788373|NCT05052697|536701983|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788374|NCT05052697|536701984|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788375|NCT05052697|536701985|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788376|NCT05052697|536701986|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788377|NCT05052697|536701987|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788378|NCT05052697|536701988|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788379|NCT05052697|536701989|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788380|NCT05052697|536701990|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788381|NCT05052697|536701991|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788382|NCT05052697|536701992|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
148788383|NCT05052697|536701993|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
148788384|NCT05052697|536701960|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788385|NCT05052697|536701961|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788386|NCT05052697|536701962|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788387|NCT05052697|536701963|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788388|NCT05052697|536701964|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788389|NCT05052697|536701965|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788390|NCT05052697|536701966|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788391|NCT05052697|536701967|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788392|NCT05052697|536701968|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788393|NCT05052697|536701969|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788394|NCT05052697|536701970|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788395|NCT05052697|536701971|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788396|NCT05052697|536701972|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788397|NCT05052697|536701973|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788398|NCT05052697|536701974|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788399|NCT05052697|536701975|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788400|NCT05052697|536701976|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788401|NCT05052697|536701977|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788402|NCT05052697|536701978|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788403|NCT05052697|536701979|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788404|NCT05052697|536701980|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788405|NCT05052697|536701981|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788406|NCT05052697|536701982|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788407|NCT05052697|536701983|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788408|NCT05052697|536701984|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788409|NCT05052697|536701985|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788410|NCT05052697|536701986|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788411|NCT05052697|536701987|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788412|NCT05052697|536701988|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
148788413|NCT05052697|536701989|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
148788414|NCT05052697|536701990|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
148788415|NCT05052697|536701991|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788416|NCT05052697|536701992|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788417|NCT05052697|536701993|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
148788418|NCT01900899|536701994|FG000|Overall Study|Withdrawal by Subject|7|||
148788419|NCT01900899|536701995|FG001|Overall Study|Withdrawal by Subject|1|||
148788420|NCT01900899|536701994|FG000|Overall Study|Migrated from study area|2|||
148788421|NCT01900899|536701995|FG001|Overall Study|Migrated from study area|0|||
148788422|NCT02772809|536701996|FG000|Overall Study|not completed some tasks|6|||
148788423|NCT00534105|536701999|FG000|Overall Study|Lost to Follow-up|23|||
148788424|NCT00534105|536702000|FG001|Overall Study|Lost to Follow-up|39|||
148788425|NCT00723697|536702001|FG000|Overall Study|Physician questionnaires not received|2|||
148788426|NCT00723697|536702001|FG000|Overall Study|Missing Informed Consent Form|10|||
148788427|NCT00723697|536702001|FG000|Overall Study|Other exclusion criteria applied|6|||
148788428|NCT01289574|536702002|FG000|Overall Study|Lack of Efficacy|4|||
148788429|NCT01289574|536702003|FG001|Overall Study|Lack of Efficacy|0|||
148788430|NCT01289574|536702004|FG002|Overall Study|Lack of Efficacy|1|||
148788431|NCT01289574|536702002|FG000|Overall Study|Lost to Follow-up|2|||
148788432|NCT01289574|536702003|FG001|Overall Study|Lost to Follow-up|0|||
148788433|NCT01289574|536702004|FG002|Overall Study|Lost to Follow-up|1|||
148788434|NCT01289574|536702002|FG000|Overall Study|Withdrawal by Subject|1|||
148788435|NCT01289574|536702003|FG001|Overall Study|Withdrawal by Subject|1|||
148788436|NCT01289574|536702004|FG002|Overall Study|Withdrawal by Subject|1|||
148788437|NCT01289574|536702002|FG000|Overall Study|Adverse Event|0|||
148788438|NCT01289574|536702003|FG001|Overall Study|Adverse Event|1|||
148788439|NCT01289574|536702004|FG002|Overall Study|Adverse Event|0|||
148788440|NCT01289574|536702002|FG000|Overall Study|Subject wanted alternate treatment|0|||
148788441|NCT01289574|536702003|FG001|Overall Study|Subject wanted alternate treatment|1|||
148788442|NCT01289574|536702004|FG002|Overall Study|Subject wanted alternate treatment|0|||
148788443|NCT00978341|536702007|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
148788444|NCT00978341|536702008|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
148788445|NCT03035916|536702009|FG000|Overall Study|Puncture failed|0|||
148788446|NCT03035916|536702010|FG001|Overall Study|Puncture failed|2|||
148788447|NCT03035916|536702011|FG002|Overall Study|Puncture failed|0|||
148788448|NCT03885999|536702012|FG000|Overall Study|Adverse Event|1|||
148788449|NCT02452554|536702013|FG000|Overall Study|Death|2|||
148788450|NCT02452554|536702014|FG001|Overall Study|Death|1|||
148788451|NCT02452554|536702015|FG002|Overall Study|Death|0|||
148788452|NCT02452554|536702016|FG003|Overall Study|Death|0|||
148788453|NCT02452554|536702017|FG004|Overall Study|Death|0|||
148788454|NCT02452554|536702018|FG005|Overall Study|Death|0|||
148788455|NCT02452554|536702013|FG000|Overall Study|Lack of Efficacy|13|||
148788456|NCT02452554|536702014|FG001|Overall Study|Lack of Efficacy|14|||
148788457|NCT02452554|536702015|FG002|Overall Study|Lack of Efficacy|9|||
148788458|NCT02452554|536702016|FG003|Overall Study|Lack of Efficacy|1|||
148788459|NCT02452554|536702017|FG004|Overall Study|Lack of Efficacy|5|||
148788460|NCT02452554|536702018|FG005|Overall Study|Lack of Efficacy|8|||
148788461|NCT02452554|536702013|FG000|Overall Study|Physician Decision|0|||
148788462|NCT02452554|536702014|FG001|Overall Study|Physician Decision|1|||
148788463|NCT02452554|536702015|FG002|Overall Study|Physician Decision|0|||
148788464|NCT02452554|536702016|FG003|Overall Study|Physician Decision|0|||
148788465|NCT02452554|536702017|FG004|Overall Study|Physician Decision|0|||
148788466|NCT02452554|536702018|FG005|Overall Study|Physician Decision|0|||
148788467|NCT02452554|536702013|FG000|Overall Study|Withdrawal by Subject|1|||
148788468|NCT02452554|536702014|FG001|Overall Study|Withdrawal by Subject|0|||
148788469|NCT02452554|536702015|FG002|Overall Study|Withdrawal by Subject|2|||
148788470|NCT02452554|536702016|FG003|Overall Study|Withdrawal by Subject|0|||
148788471|NCT02452554|536702017|FG004|Overall Study|Withdrawal by Subject|0|||
148788472|NCT02452554|536702018|FG005|Overall Study|Withdrawal by Subject|1|||
148788473|NCT02452554|536702013|FG000|Overall Study|Ineligible|0|||
148788474|NCT02452554|536702014|FG001|Overall Study|Ineligible|1|||
148788475|NCT02452554|536702015|FG002|Overall Study|Ineligible|0|||
148788476|NCT02452554|536702016|FG003|Overall Study|Ineligible|0|||
148788477|NCT02452554|536702017|FG004|Overall Study|Ineligible|0|||
148788478|NCT02452554|536702018|FG005|Overall Study|Ineligible|0|||
148788479|NCT02452554|536702013|FG000|Overall Study|Never Received Treatment|1|||
148788480|NCT02452554|536702014|FG001|Overall Study|Never Received Treatment|0|||
148788481|NCT02452554|536702015|FG002|Overall Study|Never Received Treatment|0|||
148788482|NCT02452554|536702016|FG003|Overall Study|Never Received Treatment|0|||
148788483|NCT02452554|536702017|FG004|Overall Study|Never Received Treatment|0|||
148788484|NCT02452554|536702018|FG005|Overall Study|Never Received Treatment|0|||
148788485|NCT02749799|536702019|FG000|Overall Study|Adverse Event|2|||
148788486|NCT02749799|536702019|FG000|Overall Study|Lost to Follow-up|4|||
148788487|NCT02749799|536702019|FG000|Overall Study|Protocol Violation|1|||
148788488|NCT02749799|536702019|FG000|Overall Study|Withdrawal by Subject|1|||
148788489|NCT02669043|536702020|FG000|Overall Study|Didn't meet I/E criteria|4|||
148788490|NCT00467558|536702022|FG000|Overall Study|Lost to Follow-up|2|||
148788491|NCT00467558|536702023|FG001|Overall Study|Lost to Follow-up|0|||
148788492|NCT05188729|536702025|FG000|Overall Study|Withdrawal by Subject|0|||
148788493|NCT05188729|536702026|FG001|Overall Study|Withdrawal by Subject|0|||
148788494|NCT05188729|536702027|FG002|Overall Study|Withdrawal by Subject|0|||
148788495|NCT05188729|536702028|FG003|Overall Study|Withdrawal by Subject|0|||
148788496|NCT05188729|536702029|FG004|Overall Study|Withdrawal by Subject|0|||
148788497|NCT05188729|536702030|FG005|Overall Study|Withdrawal by Subject|0|||
148788498|NCT05188729|536702031|FG006|Overall Study|Withdrawal by Subject|0|||
148788499|NCT05188729|536702032|FG007|Overall Study|Withdrawal by Subject|0|||
148788500|NCT05188729|536702033|FG008|Overall Study|Withdrawal by Subject|0|||
148788501|NCT05188729|536702034|FG009|Overall Study|Withdrawal by Subject|1|||
148788502|NCT05188729|536702035|FG010|Overall Study|Withdrawal by Subject|0|||
148788503|NCT05188729|536702036|FG011|Overall Study|Withdrawal by Subject|0|||
148788504|NCT05188729|536702037|FG012|Overall Study|Withdrawal by Subject|0|||
148788505|NCT05188729|536702025|FG000|Overall Study|Lost to Follow-up|0|||
148788506|NCT05188729|536702026|FG001|Overall Study|Lost to Follow-up|0|||
148788507|NCT05188729|536702027|FG002|Overall Study|Lost to Follow-up|0|||
148788508|NCT05188729|536702028|FG003|Overall Study|Lost to Follow-up|0|||
148788509|NCT05188729|536702029|FG004|Overall Study|Lost to Follow-up|0|||
148788510|NCT05188729|536702030|FG005|Overall Study|Lost to Follow-up|0|||
148788511|NCT05188729|536702031|FG006|Overall Study|Lost to Follow-up|0|||
148788512|NCT05188729|536702032|FG007|Overall Study|Lost to Follow-up|0|||
148788513|NCT05188729|536702033|FG008|Overall Study|Lost to Follow-up|0|||
148788514|NCT05188729|536702034|FG009|Overall Study|Lost to Follow-up|0|||
148788515|NCT05188729|536702035|FG010|Overall Study|Lost to Follow-up|1|||
148788516|NCT05188729|536702036|FG011|Overall Study|Lost to Follow-up|1|||
148788517|NCT05188729|536702037|FG012|Overall Study|Lost to Follow-up|0|||
148788518|NCT00520767|536702041|FG000|Overall Study|Death|2|||
148788519|NCT00401193|536704072|FG000|Overall Study|Adverse Event|1|||
148788520|NCT00401193|536704073|FG001|Overall Study|Adverse Event|3|||
148788521|NCT00401193|536704074|FG002|Overall Study|Adverse Event|1|||
148788522|NCT00401193|536704072|FG000|Overall Study|Protocol Violation|3|||
148788523|NCT00401193|536704073|FG001|Overall Study|Protocol Violation|1|||
148788524|NCT00401193|536704074|FG002|Overall Study|Protocol Violation|1|||
148788525|NCT00401193|536704072|FG000|Overall Study|Lost to Follow-up|6|||
148788526|NCT00401193|536704073|FG001|Overall Study|Lost to Follow-up|5|||
148788527|NCT00401193|536704074|FG002|Overall Study|Lost to Follow-up|1|||
148788528|NCT00401193|536704072|FG000|Overall Study|Withdrawal by Subject|2|||
148788529|NCT00401193|536704073|FG001|Overall Study|Withdrawal by Subject|0|||
148788530|NCT00401193|536704074|FG002|Overall Study|Withdrawal by Subject|1|||
148788531|NCT00401193|536704072|FG000|Overall Study|Other Event|3|||
148788532|NCT00401193|536704073|FG001|Overall Study|Other Event|2|||
148788533|NCT00401193|536704074|FG002|Overall Study|Other Event|2|||
148788534|NCT02526160|536704075|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
148788535|NCT02526160|536704076|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
148788536|NCT02526160|536704075|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
148788537|NCT02526160|536704076|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
148788538|NCT02526160|536704075|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
148788539|NCT02526160|536704076|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
148788540|NCT02526160|536704075|FG000|Open-Label Treatment Extension Period I|Death|0|||
148788541|NCT02526160|536704076|FG001|Open-Label Treatment Extension Period I|Death|1|||
148788542|NCT02526160|536704075|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
148788543|NCT02526160|536704076|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
148788544|NCT02526160|536704075|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
148788545|NCT02526160|536704076|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
148788546|NCT02526160|536704075|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
148788547|NCT02526160|536704076|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
148788548|NCT02526160|536704075|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
148788549|NCT02526160|536704076|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
148788550|NCT00398216|536704077|FG000|Overall Study|Adverse Event|4|||
148788551|NCT00398216|536704078|FG001|Overall Study|Adverse Event|2|||
148788552|NCT00398216|536704079|FG002|Overall Study|Adverse Event|5|||
148788553|NCT00398216|536704080|FG003|Overall Study|Adverse Event|7|||
148788554|NCT00398216|536704081|FG004|Overall Study|Adverse Event|2|||
148788555|NCT00398216|536704077|FG000|Overall Study|Protocol Violation|2|||
148788556|NCT00398216|536704078|FG001|Overall Study|Protocol Violation|4|||
148788557|NCT00398216|536704079|FG002|Overall Study|Protocol Violation|5|||
148788558|NCT00398216|536704080|FG003|Overall Study|Protocol Violation|7|||
148788559|NCT00398216|536704081|FG004|Overall Study|Protocol Violation|5|||
148788560|NCT00398216|536704077|FG000|Overall Study|Lost to Follow-up|1|||
148788561|NCT00398216|536704078|FG001|Overall Study|Lost to Follow-up|6|||
148788562|NCT00398216|536704079|FG002|Overall Study|Lost to Follow-up|4|||
148788563|NCT00398216|536704080|FG003|Overall Study|Lost to Follow-up|4|||
148788564|NCT00398216|536704081|FG004|Overall Study|Lost to Follow-up|1|||
148788565|NCT00398216|536704077|FG000|Overall Study|Death|0|||
148788566|NCT00398216|536704078|FG001|Overall Study|Death|3|||
148788567|NCT00398216|536704079|FG002|Overall Study|Death|0|||
148788568|NCT00398216|536704080|FG003|Overall Study|Death|0|||
148788569|NCT00398216|536704081|FG004|Overall Study|Death|0|||
148788570|NCT00398216|536704077|FG000|Overall Study|Withdrawal by Subject|1|||
148788571|NCT00398216|536704078|FG001|Overall Study|Withdrawal by Subject|0|||
148788572|NCT00398216|536704079|FG002|Overall Study|Withdrawal by Subject|3|||
148788573|NCT00398216|536704080|FG003|Overall Study|Withdrawal by Subject|1|||
148788574|NCT00398216|536704081|FG004|Overall Study|Withdrawal by Subject|2|||
148788575|NCT00398216|536704077|FG000|Overall Study|administrative reasons|3|||
148788576|NCT00398216|536704078|FG001|Overall Study|administrative reasons|4|||
148788577|NCT00398216|536704079|FG002|Overall Study|administrative reasons|4|||
148788578|NCT00398216|536704080|FG003|Overall Study|administrative reasons|3|||
148788579|NCT00398216|536704081|FG004|Overall Study|administrative reasons|3|||
148788580|NCT00398216|536704077|FG000|Overall Study|entrance criteria|0|||
148788581|NCT00398216|536704078|FG001|Overall Study|entrance criteria|0|||
148788582|NCT00398216|536704079|FG002|Overall Study|entrance criteria|0|||
148788583|NCT00398216|536704080|FG003|Overall Study|entrance criteria|0|||
148788584|NCT00398216|536704081|FG004|Overall Study|entrance criteria|2|||
149129689|NCT02683941|537954533|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
148788585|NCT01962948|536704084|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
148788586|NCT01962948|536704085|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
148788587|NCT01962948|536704086|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
148788588|NCT01962948|536704087|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
148788589|NCT00376532|536704088|FG000|Overall Study|Lack sufficient blood sample|6|||
148788590|NCT00376532|536704089|FG001|Overall Study|Lack sufficient blood sample|6|||
148788591|NCT01133704|536704090|FG000|Overall Study|Death|44|||
148788592|NCT01133704|536704091|FG001|Overall Study|Death|26|||
148788593|NCT01133704|536704090|FG000|Overall Study|Patient refused to continue|4|||
148788594|NCT01133704|536704091|FG001|Overall Study|Patient refused to continue|0|||
148788595|NCT01133704|536704090|FG000|Overall Study|Study Closure|1|||
148788596|NCT01133704|536704091|FG001|Overall Study|Study Closure|0|||
148788597|NCT02207400|536704092|FG000|Overall Study|Adverse Event|1|||
148788598|NCT02207400|536704093|FG001|Overall Study|Adverse Event|1|||
148788599|NCT02207400|536704092|FG000|Overall Study|Lost to Follow-up|6|||
148788600|NCT02207400|536704093|FG001|Overall Study|Lost to Follow-up|7|||
148788601|NCT02207400|536704092|FG000|Overall Study|Protocol Violation|1|||
148788602|NCT02207400|536704093|FG001|Overall Study|Protocol Violation|1|||
148788603|NCT02207400|536704092|FG000|Overall Study|Withdrawal by Subject|8|||
148788604|NCT02207400|536704093|FG001|Overall Study|Withdrawal by Subject|4|||
148788605|NCT02207400|536704092|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
148788606|NCT02207400|536704093|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
148788607|NCT03396822|536704094|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
148788608|NCT03396822|536704094|FG000|Overall Study|Physician Decision|1|||
148788609|NCT02849704|536704097|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
148788610|NCT02849704|536704098|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
148788611|NCT02849704|536704097|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
148788612|NCT02849704|536704098|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
148788613|NCT02849704|536704097|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
148788614|NCT02849704|536704098|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
148788615|NCT03638466|536704099|FG000|Overall Study|Early Termination|0|||
148788616|NCT03638466|536704100|FG001|Overall Study|Early Termination|1|||
148788617|NCT03251482|536704101|FG000|Overall Study|Withdrawal by Subject|0|||
148788618|NCT03251482|536704102|FG001|Overall Study|Withdrawal by Subject|1|||
148788619|NCT03251482|536704103|FG002|Overall Study|Withdrawal by Subject|0|||
148788620|NCT03251482|536704104|FG003|Overall Study|Withdrawal by Subject|0|||
148788621|NCT03251482|536704105|FG004|Overall Study|Withdrawal by Subject|0|||
148788622|NCT02447328|536704108|FG000|Overall Study|Withdrawal by Subject|1|||
148788623|NCT02155309|536704112|FG000|Overall Study|Protocol Violation|0|||
148788624|NCT02155309|536704113|FG001|Overall Study|Protocol Violation|0|||
148788625|NCT02155309|536704114|FG002|Overall Study|Protocol Violation|1|||
148788626|NCT02579382|536704118|FG000|Main Study Phase|Lost to Follow-up|0|||
148788627|NCT02579382|536704119|FG001|Main Study Phase|Lost to Follow-up|0|||
148788628|NCT02579382|536704120|FG002|Main Study Phase|Lost to Follow-up|2|||
148788629|NCT02579382|536704121|FG003|Main Study Phase|Lost to Follow-up|0|||
148788630|NCT02579382|536704118|FG000|Main Study Phase|Withdrew Consent|0|||
148788631|NCT02579382|536704119|FG001|Main Study Phase|Withdrew Consent|0|||
148788632|NCT02579382|536704120|FG002|Main Study Phase|Withdrew Consent|0|||
148788633|NCT02579382|536704121|FG003|Main Study Phase|Withdrew Consent|2|||
148788634|NCT02579382|536704118|FG000|Main Study Phase|Lack of Efficacy|0|||
148788635|NCT02579382|536704119|FG001|Main Study Phase|Lack of Efficacy|0|||
148788636|NCT02579382|536704120|FG002|Main Study Phase|Lack of Efficacy|0|||
148788637|NCT02579382|536704121|FG003|Main Study Phase|Lack of Efficacy|1|||
148788638|NCT02579382|536704118|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
148788639|NCT02579382|536704119|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
148788640|NCT02579382|536704120|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
148788641|NCT02579382|536704121|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
148788642|NCT02579382|536704118|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
148788643|NCT02579382|536704119|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
148788644|NCT02579382|536704120|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
148788645|NCT02579382|536704121|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
148788646|NCT02579382|536704118|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
148788647|NCT02579382|536704119|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
148788648|NCT02579382|536704120|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
148788649|NCT02579382|536704121|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
148788650|NCT02579382|536704118|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
148788651|NCT02579382|536704119|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
148788652|NCT02579382|536704120|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
148788653|NCT02579382|536704121|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
148788654|NCT02579382|536704118|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
148788655|NCT02579382|536704119|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
148788656|NCT02579382|536704120|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
148788657|NCT02579382|536704121|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
148788658|NCT02579382|536704118|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
148788659|NCT02579382|536704119|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
148788660|NCT02579382|536704120|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
148788661|NCT02579382|536704121|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
148788662|NCT02030119|536704133|FG000|Overall Study|Withdrawal by Subject|3|||
148788663|NCT02030119|536704134|FG001|Overall Study|Withdrawal by Subject|1|||
148788664|NCT02030119|536704135|FG002|Overall Study|Withdrawal by Subject|5|||
148788665|NCT02030119|536704136|FG003|Overall Study|Withdrawal by Subject|3|||
148788666|NCT02030119|536704133|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
148788667|NCT02030119|536704134|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
148788668|NCT02030119|536704135|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
148788669|NCT02030119|536704136|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
148788670|NCT03746405|536704137|FG000|Overall Study|Withdrawal by Subject|3|||
148788671|NCT03746405|536704138|FG001|Overall Study|Withdrawal by Subject|0|||
148788672|NCT03746405|536704137|FG000|Overall Study|technical difficulties|0|||
148788673|NCT03746405|536704138|FG001|Overall Study|technical difficulties|2|||
148788674|NCT00412932|536704139|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
148788675|NCT00412932|536704139|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
148788676|NCT00412932|536704139|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
148788677|NCT00412932|536704139|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
148788678|NCT00412932|536704139|FG000|Olmesartan (Olm) 20 mg|Other|1|||
148788679|NCT00412932|536704139|FG000|Olmesartan 40 mg|Adverse Event|4|||
148788680|NCT00412932|536704139|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
148788681|NCT00412932|536704139|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
148788682|NCT00412932|536704139|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
148788683|NCT00412932|536704139|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
148788684|NCT00412932|536704139|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
148788685|NCT00412932|536704139|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
148788686|NCT02753816|536704140|FG000|Overall Study|Protocol Violation|0|||
148788687|NCT02753816|536704141|FG001|Overall Study|Protocol Violation|1|||
148788688|NCT02753816|536704142|FG002|Overall Study|Protocol Violation|0|||
148788689|NCT02259400|536704143|FG000|Overall Study|Death|0|||
148788690|NCT02259400|536704144|FG001|Overall Study|Death|2|||
148788691|NCT02372383|536704148|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
148788692|NCT02372383|536704149|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
148788693|NCT02372383|536704150|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
148788694|NCT03130959|536704154|FG000|Overall Study|Disease progression|19|||
148788695|NCT03130959|536704155|FG001|Overall Study|Disease progression|7|||
148788696|NCT03130959|536704156|FG002|Overall Study|Disease progression|12|||
148788697|NCT03130959|536704157|FG003|Overall Study|Disease progression|7|||
148788698|NCT03130959|536704158|FG004|Overall Study|Disease progression|12|||
148788699|NCT03130959|536704159|FG005|Overall Study|Disease progression|3|||
148788700|NCT03130959|536704160|FG006|Overall Study|Disease progression|6|||
148788701|NCT03130959|536704161|FG007|Overall Study|Disease progression|3|||
148788702|NCT03130959|536704162|FG008|Overall Study|Disease progression|15|||
148788703|NCT03130959|536704163|FG009|Overall Study|Disease progression|8|||
148788704|NCT03130959|536704154|FG000|Overall Study|Study drug toxicity|2|||
148788705|NCT03130959|536704155|FG001|Overall Study|Study drug toxicity|2|||
148788706|NCT03130959|536704156|FG002|Overall Study|Study drug toxicity|1|||
148788707|NCT03130959|536704157|FG003|Overall Study|Study drug toxicity|2|||
148788708|NCT03130959|536704158|FG004|Overall Study|Study drug toxicity|1|||
148788709|NCT03130959|536704159|FG005|Overall Study|Study drug toxicity|1|||
148788710|NCT03130959|536704160|FG006|Overall Study|Study drug toxicity|3|||
148788711|NCT03130959|536704161|FG007|Overall Study|Study drug toxicity|0|||
148788712|NCT03130959|536704162|FG008|Overall Study|Study drug toxicity|3|||
148788713|NCT03130959|536704163|FG009|Overall Study|Study drug toxicity|3|||
148788714|NCT03130959|536704154|FG000|Overall Study|Other reasons|0|||
148788715|NCT03130959|536704155|FG001|Overall Study|Other reasons|0|||
148788716|NCT03130959|536704156|FG002|Overall Study|Other reasons|0|||
148788717|NCT03130959|536704157|FG003|Overall Study|Other reasons|0|||
148788718|NCT03130959|536704158|FG004|Overall Study|Other reasons|0|||
148788719|NCT03130959|536704159|FG005|Overall Study|Other reasons|1|||
148788720|NCT03130959|536704160|FG006|Overall Study|Other reasons|1|||
148788721|NCT03130959|536704161|FG007|Overall Study|Other reasons|0|||
148788722|NCT03130959|536704162|FG008|Overall Study|Other reasons|0|||
148788723|NCT03130959|536704163|FG009|Overall Study|Other reasons|0|||
148788724|NCT03130959|536704154|FG000|Overall Study|Subject request to discontinue therapy|0|||
148788725|NCT03130959|536704155|FG001|Overall Study|Subject request to discontinue therapy|0|||
148788726|NCT03130959|536704156|FG002|Overall Study|Subject request to discontinue therapy|1|||
148788727|NCT03130959|536704157|FG003|Overall Study|Subject request to discontinue therapy|1|||
148788728|NCT03130959|536704158|FG004|Overall Study|Subject request to discontinue therapy|0|||
148788729|NCT03130959|536704159|FG005|Overall Study|Subject request to discontinue therapy|0|||
148788730|NCT03130959|536704160|FG006|Overall Study|Subject request to discontinue therapy|1|||
148788731|NCT03130959|536704161|FG007|Overall Study|Subject request to discontinue therapy|1|||
148788732|NCT03130959|536704162|FG008|Overall Study|Subject request to discontinue therapy|0|||
148788733|NCT03130959|536704163|FG009|Overall Study|Subject request to discontinue therapy|0|||
148788734|NCT03130959|536704154|FG000|Overall Study|Not reported|0|||
148788735|NCT03130959|536704155|FG001|Overall Study|Not reported|0|||
148788736|NCT03130959|536704156|FG002|Overall Study|Not reported|0|||
148788737|NCT03130959|536704157|FG003|Overall Study|Not reported|1|||
148788738|NCT03130959|536704158|FG004|Overall Study|Not reported|0|||
148788739|NCT03130959|536704159|FG005|Overall Study|Not reported|1|||
148788740|NCT03130959|536704160|FG006|Overall Study|Not reported|0|||
148788741|NCT03130959|536704161|FG007|Overall Study|Not reported|0|||
148788742|NCT03130959|536704162|FG008|Overall Study|Not reported|0|||
148788743|NCT03130959|536704163|FG009|Overall Study|Not reported|1|||
148788744|NCT03130959|536704154|FG000|Overall Study|Adverse Event unrelated to drug|0|||
148788745|NCT03130959|536704155|FG001|Overall Study|Adverse Event unrelated to drug|0|||
148788746|NCT03130959|536704156|FG002|Overall Study|Adverse Event unrelated to drug|1|||
148788747|NCT03130959|536704157|FG003|Overall Study|Adverse Event unrelated to drug|1|||
148788748|NCT03130959|536704158|FG004|Overall Study|Adverse Event unrelated to drug|1|||
148788749|NCT03130959|536704159|FG005|Overall Study|Adverse Event unrelated to drug|0|||
148788750|NCT03130959|536704160|FG006|Overall Study|Adverse Event unrelated to drug|1|||
148788751|NCT03130959|536704161|FG007|Overall Study|Adverse Event unrelated to drug|0|||
148788752|NCT03130959|536704162|FG008|Overall Study|Adverse Event unrelated to drug|1|||
148788753|NCT03130959|536704163|FG009|Overall Study|Adverse Event unrelated to drug|1|||
148788754|NCT03130959|536704154|FG000|Overall Study|Participant withdrew consent|0|||
148788755|NCT03130959|536704155|FG001|Overall Study|Participant withdrew consent|1|||
148788756|NCT03130959|536704156|FG002|Overall Study|Participant withdrew consent|0|||
148788757|NCT03130959|536704157|FG003|Overall Study|Participant withdrew consent|2|||
148788758|NCT03130959|536704158|FG004|Overall Study|Participant withdrew consent|1|||
148788759|NCT03130959|536704159|FG005|Overall Study|Participant withdrew consent|0|||
148788760|NCT03130959|536704160|FG006|Overall Study|Participant withdrew consent|0|||
148788761|NCT03130959|536704161|FG007|Overall Study|Participant withdrew consent|0|||
148788762|NCT03130959|536704162|FG008|Overall Study|Participant withdrew consent|0|||
148788763|NCT03130959|536704163|FG009|Overall Study|Participant withdrew consent|2|||
148788764|NCT03130959|536704154|FG000|Overall Study|Administrative reason by sponsor|1|||
148788765|NCT03130959|536704155|FG001|Overall Study|Administrative reason by sponsor|0|||
148788766|NCT03130959|536704156|FG002|Overall Study|Administrative reason by sponsor|1|||
148788767|NCT03130959|536704157|FG003|Overall Study|Administrative reason by sponsor|0|||
148788768|NCT03130959|536704158|FG004|Overall Study|Administrative reason by sponsor|0|||
148788769|NCT03130959|536704159|FG005|Overall Study|Administrative reason by sponsor|0|||
148788770|NCT03130959|536704160|FG006|Overall Study|Administrative reason by sponsor|0|||
148788771|NCT03130959|536704161|FG007|Overall Study|Administrative reason by sponsor|0|||
148788772|NCT03130959|536704162|FG008|Overall Study|Administrative reason by sponsor|0|||
148788773|NCT03130959|536704163|FG009|Overall Study|Administrative reason by sponsor|0|||
148788774|NCT03130959|536704154|FG000|Overall Study|Lost to Follow-up|1|||
148788775|NCT03130959|536704155|FG001|Overall Study|Lost to Follow-up|0|||
148788776|NCT03130959|536704156|FG002|Overall Study|Lost to Follow-up|0|||
148788777|NCT03130959|536704157|FG003|Overall Study|Lost to Follow-up|0|||
148788778|NCT03130959|536704158|FG004|Overall Study|Lost to Follow-up|0|||
148788779|NCT03130959|536704159|FG005|Overall Study|Lost to Follow-up|0|||
148788780|NCT03130959|536704160|FG006|Overall Study|Lost to Follow-up|0|||
148788781|NCT03130959|536704161|FG007|Overall Study|Lost to Follow-up|0|||
148788782|NCT03130959|536704162|FG008|Overall Study|Lost to Follow-up|0|||
148788783|NCT03130959|536704163|FG009|Overall Study|Lost to Follow-up|0|||
148788784|NCT02384538|536704164|FG000|Overall Study|Adverse Event|1|||
148788785|NCT02384538|536704165|FG001|Overall Study|Adverse Event|4|||
148788786|NCT02384538|536704164|FG000|Overall Study|Lack of Efficacy|4|||
148788787|NCT02384538|536704165|FG001|Overall Study|Lack of Efficacy|4|||
148788788|NCT02384538|536704164|FG000|Overall Study|Withdrew Consent|0|||
148788789|NCT02384538|536704165|FG001|Overall Study|Withdrew Consent|4|||
148788790|NCT02384538|536704164|FG000|Overall Study|Other|1|||
148788791|NCT02384538|536704165|FG001|Overall Study|Other|3|||
148788792|NCT03042910|536704170|FG000|Overall Study|Adverse Event|1|||
148788793|NCT03042910|536704170|FG000|Overall Study|Disease Progression|2|||
148788794|NCT03042910|536704170|FG000|Overall Study|Withdrawal by Subject|3|||
148788795|NCT03042910|536704170|FG000|Overall Study|Enrolled but not treated|1|||
148788796|NCT01763203|536704173|FG000|Overall Study|Death|4|||
148788797|NCT01763203|536704174|FG001|Overall Study|Death|7|||
148788798|NCT01763203|536704173|FG000|Overall Study|Lost to Follow-up|12|||
148788799|NCT01763203|536704174|FG001|Overall Study|Lost to Follow-up|12|||
148788800|NCT01763203|536704173|FG000|Overall Study|Withdrawal by Subject|8|||
148788801|NCT01763203|536704174|FG001|Overall Study|Withdrawal by Subject|12|||
148788802|NCT01763203|536704173|FG000|Overall Study|Moved out of study region|7|||
148788803|NCT01763203|536704174|FG001|Overall Study|Moved out of study region|10|||
149129690|NCT02683941|537954534|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
149129691|NCT02683941|537954533|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
148788804|NCT01763203|536704173|FG000|Overall Study|Physician Decision|2|||
148788805|NCT01763203|536704174|FG001|Overall Study|Physician Decision|1|||
148788806|NCT02187861|536704175|FG000|Overall Study|Adverse Event|2|||
148788807|NCT02187861|536704176|FG001|Overall Study|Adverse Event|1|||
148788808|NCT02187861|536704177|FG002|Overall Study|Adverse Event|2|||
148788809|NCT02187861|536704178|FG003|Overall Study|Adverse Event|1|||
149129692|NCT02683941|537954534|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
148788810|NCT02187861|536704175|FG000|Overall Study|Death|0|||
148788811|NCT02187861|536704176|FG001|Overall Study|Death|3|||
148788812|NCT02187861|536704177|FG002|Overall Study|Death|1|||
148788813|NCT02187861|536704178|FG003|Overall Study|Death|2|||
148788814|NCT02187861|536704175|FG000|Overall Study|Physician Decision|0|||
148788815|NCT02187861|536704176|FG001|Overall Study|Physician Decision|1|||
148788816|NCT02187861|536704177|FG002|Overall Study|Physician Decision|0|||
148788817|NCT02187861|536704178|FG003|Overall Study|Physician Decision|3|||
148788818|NCT02187861|536704175|FG000|Overall Study|Progressive Disease|4|||
148788819|NCT02187861|536704176|FG001|Overall Study|Progressive Disease|42|||
148788820|NCT02187861|536704177|FG002|Overall Study|Progressive Disease|19|||
148788821|NCT02187861|536704178|FG003|Overall Study|Progressive Disease|22|||
148788822|NCT02187861|536704175|FG000|Overall Study|Withdrawal by Subject|0|||
148788823|NCT02187861|536704176|FG001|Overall Study|Withdrawal by Subject|0|||
148788824|NCT02187861|536704177|FG002|Overall Study|Withdrawal by Subject|3|||
148788825|NCT02187861|536704178|FG003|Overall Study|Withdrawal by Subject|3|||
148788826|NCT02187861|536704175|FG000|Overall Study|Other|0|||
148788827|NCT02187861|536704176|FG001|Overall Study|Other|1|||
148788828|NCT02187861|536704177|FG002|Overall Study|Other|7|||
148788829|NCT02187861|536704178|FG003|Overall Study|Other|1|||
148788830|NCT02756819|536704179|FG000|Overall Study|Lost for observation|23|||
148788831|NCT02756819|536704179|FG000|Overall Study|Patient's unwillingness|16|||
148788832|NCT02756819|536704179|FG000|Overall Study|Insufficient efficacy|2|||
148788833|NCT02756819|536704179|FG000|Overall Study|Adverse Event|2|||
148788834|NCT02756819|536704179|FG000|Overall Study|Reason not Specified|9|||
148788835|NCT01491841|536704181|FG000|Overall Study|Screen Failure|10|||
148788836|NCT01491841|536704181|FG000|Overall Study|Withdrawal by Subject|1|||
148788837|NCT00741598|536704182|FG000|Overall Study|Lost to Follow-up|3|||
148788838|NCT00741598|536704183|FG001|Overall Study|Lost to Follow-up|4|||
148788839|NCT00741598|536704182|FG000|Overall Study|Lack of Efficacy|1|||
148788840|NCT00741598|536704183|FG001|Overall Study|Lack of Efficacy|2|||
148788841|NCT00741598|536704182|FG000|Overall Study|Physician Decision|1|||
148788842|NCT00741598|536704183|FG001|Overall Study|Physician Decision|1|||
148788843|NCT00741598|536704182|FG000|Overall Study|Pregnancy|1|||
148788844|NCT00741598|536704183|FG001|Overall Study|Pregnancy|0|||
148788845|NCT00741598|536704182|FG000|Overall Study|Withdrawal by Subject|3|||
148788846|NCT00741598|536704183|FG001|Overall Study|Withdrawal by Subject|2|||
148788847|NCT04105842|536704184|FG000|Overall Study|Withdrawal by Subject|2|||
148788848|NCT00313586|536704187|FG000|Overall Study|Disease progression|14|||
148788849|NCT00313586|536704188|FG001|Overall Study|Disease progression|19|||
148788850|NCT00313586|536704189|FG002|Overall Study|Disease progression|10|||
148788851|NCT00313586|536704190|FG003|Overall Study|Disease progression|3|||
148788852|NCT00313586|536704187|FG000|Overall Study|Adverse Event|12|||
148788853|NCT00313586|536704188|FG001|Overall Study|Adverse Event|18|||
148788854|NCT00313586|536704189|FG002|Overall Study|Adverse Event|3|||
148788855|NCT00313586|536704190|FG003|Overall Study|Adverse Event|10|||
148788856|NCT00313586|536704187|FG000|Overall Study|Death|11|||
148788857|NCT00313586|536704188|FG001|Overall Study|Death|8|||
148788858|NCT00313586|536704189|FG002|Overall Study|Death|1|||
148788859|NCT00313586|536704190|FG003|Overall Study|Death|7|||
148788860|NCT00313586|536704187|FG000|Overall Study|Withdrawal by Subject|13|||
148788861|NCT00313586|536704188|FG001|Overall Study|Withdrawal by Subject|6|||
148788862|NCT00313586|536704189|FG002|Overall Study|Withdrawal by Subject|6|||
148788863|NCT00313586|536704190|FG003|Overall Study|Withdrawal by Subject|2|||
148788864|NCT00313586|536704187|FG000|Overall Study|Alternative therapy|3|||
148788865|NCT00313586|536704188|FG001|Overall Study|Alternative therapy|6|||
148788866|NCT00313586|536704189|FG002|Overall Study|Alternative therapy|2|||
148788867|NCT00313586|536704190|FG003|Overall Study|Alternative therapy|0|||
148788868|NCT00313586|536704187|FG000|Overall Study|Other complicating disease|2|||
148788869|NCT00313586|536704188|FG001|Overall Study|Other complicating disease|2|||
148788870|NCT00313586|536704189|FG002|Overall Study|Other complicating disease|0|||
148788871|NCT00313586|536704190|FG003|Overall Study|Other complicating disease|0|||
148788872|NCT00313586|536704187|FG000|Overall Study|Did not achieve HI-major/better response|10|||
148788873|NCT00313586|536704188|FG001|Overall Study|Did not achieve HI-major/better response|7|||
148788874|NCT00313586|536704189|FG002|Overall Study|Did not achieve HI-major/better response|2|||
148788875|NCT00313586|536704190|FG003|Overall Study|Did not achieve HI-major/better response|1|||
148788876|NCT00313586|536704187|FG000|Overall Study|Physician Decision|2|||
148788877|NCT00313586|536704188|FG001|Overall Study|Physician Decision|1|||
148788878|NCT00313586|536704189|FG002|Overall Study|Physician Decision|0|||
148788879|NCT00313586|536704190|FG003|Overall Study|Physician Decision|0|||
148788880|NCT00313586|536704187|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
148788881|NCT00313586|536704188|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
148788882|NCT00313586|536704189|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
148788883|NCT00313586|536704190|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
148788884|NCT00313586|536704187|FG000|Overall Study|Lost insurance|0|||
148788885|NCT00313586|536704188|FG001|Overall Study|Lost insurance|1|||
148788886|NCT00313586|536704189|FG002|Overall Study|Lost insurance|0|||
148788887|NCT00313586|536704190|FG003|Overall Study|Lost insurance|0|||
148788888|NCT00313586|536704187|FG000|Overall Study|Moved|0|||
148788889|NCT00313586|536704188|FG001|Overall Study|Moved|1|||
148788890|NCT00313586|536704189|FG002|Overall Study|Moved|0|||
148788891|NCT00313586|536704190|FG003|Overall Study|Moved|0|||
148788892|NCT00313586|536704187|FG000|Overall Study|Death before starting treatment|1|||
148788893|NCT00313586|536704188|FG001|Overall Study|Death before starting treatment|0|||
148788894|NCT00313586|536704189|FG002|Overall Study|Death before starting treatment|0|||
148788895|NCT00313586|536704190|FG003|Overall Study|Death before starting treatment|0|||
148788896|NCT02087670|536704191|FG000|Overall Study|Withdrawal by Subject|3|||
148788897|NCT02087670|536704192|FG001|Overall Study|Withdrawal by Subject|2|||
148788898|NCT04472494|536704194|FG000|Pre-treatment|Other reasons|2|||
148788899|NCT04472494|536704195|FG001|Pre-treatment|Other reasons|0|||
148788900|NCT04472494|536704194|FG000|Treatment|Death|5|||
148788901|NCT04472494|536704195|FG001|Treatment|Death|2|||
148788902|NCT04472494|536704194|FG000|Treatment|Hospital discharge|1|||
148788903|NCT04472494|536704195|FG001|Treatment|Hospital discharge|1|||
148788904|NCT03519919|536704196|FG000|Overall Study|Withdrawal by Subject|1|||
148788905|NCT03519919|536704196|FG000|Overall Study|Lack of Efficacy|1|||
148788906|NCT03519919|536704196|FG000|Overall Study|Screen Failure|1|||
148788907|NCT03076996|536704197|FG000|Overall Study|Withdrawal by Subject|2|||
148788908|NCT03076996|536704197|FG000|Overall Study|Lost to Follow-up|3|||
148788909|NCT03076996|536704197|FG000|Overall Study|Literacy precluded participation|1|||
148788910|NCT02144077|536704202|FG000|Overall Study|Withdrawal by Subject|3|||
148788911|NCT02144077|536704203|FG001|Overall Study|Withdrawal by Subject|3|||
148788912|NCT02144077|536704202|FG000|Overall Study|Adverse Event|2|||
148788913|NCT02144077|536704203|FG001|Overall Study|Adverse Event|3|||
148788914|NCT02144077|536704202|FG000|Overall Study|Lost to Follow-up|2|||
148788915|NCT02144077|536704203|FG001|Overall Study|Lost to Follow-up|2|||
148788916|NCT02144077|536704202|FG000|Overall Study|Protocol Violation|1|||
148788917|NCT02144077|536704203|FG001|Overall Study|Protocol Violation|2|||
148788918|NCT02144077|536704202|FG000|Overall Study|Death|0|||
148788919|NCT02144077|536704203|FG001|Overall Study|Death|1|||
148788920|NCT02144077|536704202|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
148788921|NCT02144077|536704203|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
148788922|NCT01909973|536704204|FG000|Overall Study|Lost to Follow-up|1|||
148788923|NCT01909973|536704205|FG001|Overall Study|Lost to Follow-up|0|||
148788924|NCT00169104|536704208|FG000|Overall Study|Withdrawal by Subject|2|||
148788925|NCT00169104|536704209|FG001|Overall Study|Withdrawal by Subject|0|||
148788926|NCT00169104|536704208|FG000|Overall Study|Protocol Violation|0|||
148788927|NCT00169104|536704209|FG001|Overall Study|Protocol Violation|1|||
148788928|NCT00169104|536704208|FG000|Overall Study|Physician Decision|0|||
148788929|NCT00169104|536704209|FG001|Overall Study|Physician Decision|1|||
148788930|NCT03299101|536704212|FG000|Overall Study|Lost to Follow-up|1|||
148788931|NCT03299101|536704212|FG000|Overall Study|Withdrawal by Subject|5|||
148788932|NCT03299101|536704212|FG000|Overall Study|Surgery was changed|3|||
148788933|NCT03299101|536704212|FG000|Overall Study|Not enough time to complete prehab|1|||
148788934|NCT02768792|536704213|FG000|Overall Study|Adverse Event|1|||
148788935|NCT01690299|536704214|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
148788936|NCT01690299|536704215|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
148788937|NCT01690299|536704216|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
148788938|NCT01690299|536704217|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
148788939|NCT01690299|536704218|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
148788940|NCT01690299|536704219|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
148788941|NCT01690299|536704214|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
148788942|NCT01690299|536704215|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148788943|NCT01690299|536704216|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148788944|NCT01690299|536704217|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148788945|NCT01690299|536704218|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148788946|NCT01690299|536704219|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148788947|NCT01690299|536704214|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
148788948|NCT01690299|536704215|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
148788949|NCT01690299|536704216|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
149129693|NCT02683941|537954533|FG000|Open-label Follow-up Phase|Other|8|||
149129694|NCT02683941|537954534|FG001|Open-label Follow-up Phase|Other|1|||
149129695|NCT00261846|537954535|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
149129696|NCT00261846|537954536|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
149129697|NCT00261846|537954537|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
149129698|NCT00261846|537954538|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
148788950|NCT01690299|536704217|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148788951|NCT01690299|536704218|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148788952|NCT01690299|536704219|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148788953|NCT01690299|536704214|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
148788954|NCT01690299|536704215|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
148788955|NCT01690299|536704216|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
148788956|NCT01690299|536704217|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
149129699|NCT00261846|537954539|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
148788957|NCT01690299|536704218|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
148788958|NCT01690299|536704219|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
148788959|NCT01690299|536704214|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
148788960|NCT01690299|536704215|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
148788961|NCT01690299|536704216|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
148788962|NCT01690299|536704217|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
148788963|NCT01690299|536704218|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
148788964|NCT01690299|536704219|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
148788965|NCT01690299|536704214|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
148788966|NCT01690299|536704215|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
148788967|NCT01690299|536704216|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
148788968|NCT01690299|536704217|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
148788969|NCT01690299|536704218|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
148788970|NCT01690299|536704219|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
148788971|NCT01690299|536704214|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
148788972|NCT01690299|536704215|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
148788973|NCT01690299|536704216|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
148788974|NCT01690299|536704217|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
148788975|NCT01690299|536704218|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
148788976|NCT01690299|536704219|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
148788977|NCT01690299|536704214|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
148788978|NCT01690299|536704215|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
148788979|NCT01690299|536704216|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
148788980|NCT01690299|536704217|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
148788981|NCT01690299|536704218|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
148788982|NCT01690299|536704219|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
148788983|NCT01690299|536704214|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
148788984|NCT01690299|536704215|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
148788985|NCT01690299|536704216|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
148788986|NCT01690299|536704217|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
148788987|NCT01690299|536704218|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
148788988|NCT01690299|536704219|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
148788989|NCT01690299|536704214|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
148788990|NCT01690299|536704215|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
148788991|NCT01690299|536704216|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
148788992|NCT01690299|536704217|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
148788993|NCT01690299|536704218|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
148788994|NCT01690299|536704219|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
148788995|NCT01882803|536704220|FG000|Overall Study|Disease Progression|1|||
148788996|NCT01882803|536704220|FG000|Overall Study|Withdrawal by Subject|9|||
148788997|NCT01882803|536704220|FG000|Overall Study|Death|68|||
148788998|NCT01882803|536704220|FG000|Overall Study|Physician Decision|3|||
148788999|NCT01882803|536704220|FG000|Overall Study|Lost to Follow-up|3|||
148789000|NCT01882803|536704220|FG000|Overall Study|Follow-up Completed|39|||
148789001|NCT01882803|536704220|FG000|Overall Study|Study Terminated by the Sponsor|6|||
148789002|NCT01563913|536704221|FG000|Overall Study|Physician Decision|1|||
148789003|NCT01563913|536704222|FG001|Overall Study|Physician Decision|0|||
148789004|NCT01563913|536704221|FG000|Overall Study|Spouse Passed Away|1|||
148789005|NCT01563913|536704222|FG001|Overall Study|Spouse Passed Away|0|||
148789006|NCT04399538|536704226|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
148789007|NCT04399538|536704227|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
148789008|NCT04399538|536704228|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
148789009|NCT04399538|536704229|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
148789010|NCT04399538|536704230|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
148789011|NCT04399538|536704226|FG000|Double-Blind Treatment|Adverse Event|0|||
148789012|NCT04399538|536704227|FG001|Double-Blind Treatment|Adverse Event|0|||
148789013|NCT04399538|536704228|FG002|Double-Blind Treatment|Adverse Event|0|||
148789014|NCT04399538|536704229|FG003|Double-Blind Treatment|Adverse Event|0|||
148789015|NCT04399538|536704230|FG004|Double-Blind Treatment|Adverse Event|1|||
148789016|NCT04399538|536704226|FG000|Follow-Up|Adverse Event|0|||
148789017|NCT04399538|536704227|FG001|Follow-Up|Adverse Event|0|||
148789018|NCT04399538|536704228|FG002|Follow-Up|Adverse Event|0|||
148789019|NCT04399538|536704229|FG003|Follow-Up|Adverse Event|0|||
148789020|NCT04399538|536704230|FG004|Follow-Up|Adverse Event|1|||
148789021|NCT04399538|536704226|FG000|Follow-Up|Withdrawal by Subject|0|||
148789022|NCT04399538|536704227|FG001|Follow-Up|Withdrawal by Subject|0|||
148789023|NCT04399538|536704228|FG002|Follow-Up|Withdrawal by Subject|0|||
148789024|NCT04399538|536704229|FG003|Follow-Up|Withdrawal by Subject|2|||
148789025|NCT04399538|536704230|FG004|Follow-Up|Withdrawal by Subject|0|||
148789026|NCT00492232|536704231|FG000|Placebo Run-in|Adverse Event|0|||
148789027|NCT00492232|536704232|FG001|Placebo Run-in|Adverse Event|2|||
148789028|NCT00492232|536704231|FG000|Placebo Run-in|Protocol Violation|0|||
148789029|NCT00492232|536704232|FG001|Placebo Run-in|Protocol Violation|3|||
148789030|NCT00492232|536704231|FG000|Placebo Run-in|Lost to Follow-up|0|||
148789031|NCT00492232|536704232|FG001|Placebo Run-in|Lost to Follow-up|3|||
148789032|NCT00492232|536704231|FG000|Placebo Run-in|Withdrawal by Subject|0|||
148789033|NCT00492232|536704232|FG001|Placebo Run-in|Withdrawal by Subject|8|||
148789034|NCT00492232|536704231|FG000|Placebo Run-in|Pregnancy|0|||
148789035|NCT00492232|536704232|FG001|Placebo Run-in|Pregnancy|1|||
148789036|NCT00492232|536704231|FG000|Placebo Run-in|Entrance criteria not met|0|||
148789037|NCT00492232|536704232|FG001|Placebo Run-in|Entrance criteria not met|45|||
148789038|NCT00492232|536704231|FG000|Placebo Run-in|Other|0|||
148789039|NCT00492232|536704232|FG001|Placebo Run-in|Other|6|||
148789040|NCT00492232|536704231|FG000|Placebo Run-in|Missing|0|||
148789041|NCT00492232|536704232|FG001|Placebo Run-in|Missing|2|||
148789042|NCT00492232|536704231|FG000|Double-Blind Treatment|Adverse Event|1|||
148789043|NCT00492232|536704232|FG001|Double-Blind Treatment|Adverse Event|2|||
148789044|NCT00492232|536704231|FG000|Double-Blind Treatment|Protocol Violation|3|||
148789045|NCT00492232|536704232|FG001|Double-Blind Treatment|Protocol Violation|7|||
148789046|NCT00492232|536704231|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
148789047|NCT00492232|536704232|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
148789048|NCT00492232|536704231|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
148789049|NCT00492232|536704232|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
148789050|NCT00492232|536704231|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
148789051|NCT00492232|536704232|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
148789052|NCT00492232|536704231|FG000|Double-Blind Treatment|Other|6|||
148789053|NCT00492232|536704232|FG001|Double-Blind Treatment|Other|5|||
148789054|NCT00492232|536704231|FG000|Double-Blind Treatment|Randomized not treated|1|||
148789055|NCT00492232|536704232|FG001|Double-Blind Treatment|Randomized not treated|0|||
148789056|NCT00492232|536704231|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
148789057|NCT00492232|536704232|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
148789058|NCT02756364|536704233|FG000|Overall Study|Site Terminated by Sponsor|24|||
148789059|NCT02756364|536704234|FG001|Overall Study|Site Terminated by Sponsor|30|||
148789060|NCT02756364|536704235|FG002|Overall Study|Site Terminated by Sponsor|21|||
148789061|NCT02756364|536704233|FG000|Overall Study|Death|20|||
148789062|NCT02756364|536704234|FG001|Overall Study|Death|15|||
148789063|NCT02756364|536704235|FG002|Overall Study|Death|18|||
148789064|NCT02756364|536704233|FG000|Overall Study|Withdrawal by Patient|2|||
148789065|NCT02756364|536704234|FG001|Overall Study|Withdrawal by Patient|1|||
148789066|NCT02756364|536704235|FG002|Overall Study|Withdrawal by Patient|8|||
148789067|NCT02756364|536704233|FG000|Overall Study|Lost to Follow-up|0|||
148789068|NCT02756364|536704234|FG001|Overall Study|Lost to Follow-up|1|||
148789069|NCT02756364|536704235|FG002|Overall Study|Lost to Follow-up|1|||
148789070|NCT04811664|536704236|FG000|Overall Study|Lost to Follow-up|78|||
148789071|NCT04811664|536704237|FG001|Overall Study|Lost to Follow-up|125|||
148789072|NCT04811664|536704238|FG002|Overall Study|Lost to Follow-up|46|||
148789073|NCT04811664|536704236|FG000|Overall Study|Withdrawal by Subject|39|||
148789074|NCT04811664|536704237|FG001|Overall Study|Withdrawal by Subject|76|||
148789075|NCT04811664|536704238|FG002|Overall Study|Withdrawal by Subject|12|||
148789076|NCT04811664|536704236|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
148789077|NCT04811664|536704237|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
148789078|NCT04811664|536704238|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
148789079|NCT04811664|536704236|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
148789080|NCT04811664|536704237|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
148789081|NCT04811664|536704238|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
148789082|NCT04811664|536704236|FG000|Overall Study|Protocol Violation|0|||
148789083|NCT04811664|536704237|FG001|Overall Study|Protocol Violation|5|||
148789084|NCT04811664|536704238|FG002|Overall Study|Protocol Violation|11|||
148789085|NCT04811664|536704236|FG000|Overall Study|Study Terminated by Sponsor|4|||
148789086|NCT04811664|536704237|FG001|Overall Study|Study Terminated by Sponsor|3|||
148789087|NCT04811664|536704238|FG002|Overall Study|Study Terminated by Sponsor|34|||
148789088|NCT04811664|536704236|FG000|Overall Study|Early Study Closure|3|||
148789089|NCT04811664|536704237|FG001|Overall Study|Early Study Closure|7|||
148789090|NCT04811664|536704238|FG002|Overall Study|Early Study Closure|79|||
148789091|NCT04811664|536704236|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
148789092|NCT04811664|536704237|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
148789093|NCT04811664|536704238|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
148789094|NCT00382109|536704239|FG000|Overall Study|Adverse Event|3|||
148789095|NCT00382109|536704240|FG001|Overall Study|Adverse Event|0|||
148789096|NCT00382109|536704239|FG000|Overall Study|Physician Decision|6|||
148789097|NCT00382109|536704240|FG001|Overall Study|Physician Decision|1|||
148789098|NCT00382109|536704239|FG000|Overall Study|Withdrawal by Subject|1|||
148789099|NCT00382109|536704240|FG001|Overall Study|Withdrawal by Subject|0|||
148789100|NCT00382109|536704239|FG000|Overall Study|ineligible|2|||
148789101|NCT00382109|536704240|FG001|Overall Study|ineligible|0|||
148789102|NCT00382109|536704239|FG000|Overall Study|Other|0|||
148789103|NCT00382109|536704240|FG001|Overall Study|Other|2|||
148789104|NCT00382109|536704239|FG000|Overall Study|consent withdrawal|0|||
148789105|NCT00382109|536704240|FG001|Overall Study|consent withdrawal|1|||
148789106|NCT02717442|536704241|FG000|Overall Study|Study Terminated by Sponsor|31|||
148789107|NCT02717442|536704242|FG001|Overall Study|Study Terminated by Sponsor|29|||
148789108|NCT02717442|536704241|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
148789109|NCT02717442|536704242|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
148789110|NCT02717442|536704241|FG000|Overall Study|Other - Not Specified|2|||
148789111|NCT02717442|536704242|FG001|Overall Study|Other - Not Specified|0|||
148789112|NCT02774005|536704245|FG000|Overall Study|Adverse Event|8|||
148789113|NCT02774005|536704245|FG000|Overall Study|Withdrawal by Subject|23|||
148789114|NCT02774005|536704245|FG000|Overall Study|Lost to Follow-up|7|||
148789115|NCT02774005|536704245|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
148789116|NCT02774005|536704245|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
148789117|NCT02774005|536704245|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
148789118|NCT02774005|536704245|FG000|Overall Study|Death|1|||
148789119|NCT02774005|536704245|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
148789120|NCT02774005|536704245|FG000|Overall Study|Lack of compliance with study medication|4|||
148789121|NCT02774005|536704245|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
148789122|NCT02774005|536704245|FG000|Overall Study|another study|1|||
148789123|NCT02774005|536704245|FG000|Overall Study|cardiologist imposed travel restriction|1|||
148789124|NCT01451554|536704246|FG000|Overall Study|Withdrawal by Subject|14|||
148789125|NCT01451554|536704247|FG001|Overall Study|Withdrawal by Subject|9|||
148789126|NCT01402986|536704248|FG000|Overall Study|Withdrawal by Subject|7|||
148789127|NCT01402986|536704249|FG001|Overall Study|Withdrawal by Subject|10|||
148789128|NCT01402986|536704250|FG002|Overall Study|Withdrawal by Subject|7|||
148789129|NCT01402986|536704251|FG003|Overall Study|Withdrawal by Subject|13|||
148789130|NCT01402986|536704248|FG000|Overall Study|Death|0|||
148789131|NCT01402986|536704249|FG001|Overall Study|Death|0|||
148789132|NCT01402986|536704250|FG002|Overall Study|Death|0|||
148789133|NCT01402986|536704251|FG003|Overall Study|Death|2|||
148789134|NCT01402986|536704248|FG000|Overall Study|Lost to Follow-up|0|||
148789135|NCT01402986|536704249|FG001|Overall Study|Lost to Follow-up|0|||
148789136|NCT01402986|536704250|FG002|Overall Study|Lost to Follow-up|0|||
148789137|NCT01402986|536704251|FG003|Overall Study|Lost to Follow-up|1|||
148789138|NCT01402986|536704248|FG000|Overall Study|Other|2|||
148789139|NCT01402986|536704249|FG001|Overall Study|Other|5|||
148789140|NCT01402986|536704250|FG002|Overall Study|Other|1|||
148789141|NCT01402986|536704251|FG003|Overall Study|Other|6|||
148789142|NCT02634983|536704252|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
148789143|NCT02634983|536704253|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
148789144|NCT03178851|536704254|FG000|Overall Study|Death|48|||
148789145|NCT03178851|536704255|FG001|Overall Study|Death|2|||
148789146|NCT03178851|536704256|FG002|Overall Study|Death|25|||
148789147|NCT03178851|536704254|FG000|Overall Study|Withdrawal by Subject|8|||
148789148|NCT03178851|536704255|FG001|Overall Study|Withdrawal by Subject|0|||
148789149|NCT03178851|536704256|FG002|Overall Study|Withdrawal by Subject|0|||
148789150|NCT03178851|536704254|FG000|Overall Study|Lost to Follow-up|5|||
148789151|NCT03178851|536704255|FG001|Overall Study|Lost to Follow-up|2|||
148789152|NCT03178851|536704256|FG002|Overall Study|Lost to Follow-up|0|||
148789153|NCT03178851|536704254|FG000|Overall Study|Adverse Event|0|||
148789154|NCT03178851|536704255|FG001|Overall Study|Adverse Event|0|||
148789155|NCT03178851|536704256|FG002|Overall Study|Adverse Event|1|||
148789156|NCT03178851|536704254|FG000|Overall Study|Study Termination by Sponsor|31|||
148789157|NCT03178851|536704255|FG001|Overall Study|Study Termination by Sponsor|7|||
148789158|NCT03178851|536704256|FG002|Overall Study|Study Termination by Sponsor|26|||
148789159|NCT02226120|536704257|FG000|Overall Study|Adverse Event|60|||
148789160|NCT02226120|536704257|FG000|Overall Study|Death|172|||
148789161|NCT02226120|536704257|FG000|Overall Study|Study terminated by sponsor|1|||
148789162|NCT02226120|536704257|FG000|Overall Study|Technical problems|4|||
148789163|NCT02226120|536704257|FG000|Overall Study|Lost to Follow-up|13|||
148789164|NCT02226120|536704257|FG000|Overall Study|Physician Decision|21|||
148789165|NCT02226120|536704257|FG000|Overall Study|Withdrawal by parent/guardian|36|||
148789166|NCT02226120|536704257|FG000|Overall Study|Non-compliance with study drug|10|||
148789167|NCT02226120|536704257|FG000|Overall Study|Protocol deviation|1|||
148789168|NCT02226120|536704257|FG000|Overall Study|missing treatment disposition pages|2|||
148789169|NCT02636439|536704264|FG000|Overall Study|Adverse Event|2|||
148789170|NCT02636439|536704265|FG001|Overall Study|Adverse Event|2|||
148789171|NCT02636439|536704264|FG000|Overall Study|Lost to Follow-up|1|||
148789172|NCT02636439|536704265|FG001|Overall Study|Lost to Follow-up|0|||
148789173|NCT02636439|536704264|FG000|Overall Study|Non-compliance|1|||
148789174|NCT02636439|536704265|FG001|Overall Study|Non-compliance|1|||
148789175|NCT02636439|536704264|FG000|Overall Study|Personal reasons|2|||
148789176|NCT02636439|536704265|FG001|Overall Study|Personal reasons|0|||
148789177|NCT02494401|536704266|FG000|Overall Study|Lost to Follow-up|22|||
148789178|NCT02494401|536704267|FG001|Overall Study|Lost to Follow-up|25|||
148789179|NCT02494401|536704266|FG000|Overall Study|Withdrawal by Subject|3|||
148789180|NCT02494401|536704267|FG001|Overall Study|Withdrawal by Subject|2|||
148789181|NCT00802672|536706504|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
148789182|NCT00802672|536706505|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
148789183|NCT00802672|536706506|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
148789184|NCT00802672|536706504|FG000|Overall Study|Adverse Event|1|||
148789185|NCT00802672|536706505|FG001|Overall Study|Adverse Event|1|||
148789186|NCT00802672|536706506|FG002|Overall Study|Adverse Event|1|||
148789187|NCT00802672|536706504|FG000|Overall Study|Protocol Violation|2|||
148789188|NCT00802672|536706505|FG001|Overall Study|Protocol Violation|1|||
148789189|NCT00802672|536706506|FG002|Overall Study|Protocol Violation|1|||
148789190|NCT00802672|536706504|FG000|Overall Study|Lost to Follow-up|5|||
148789191|NCT00802672|536706505|FG001|Overall Study|Lost to Follow-up|5|||
148789192|NCT00802672|536706506|FG002|Overall Study|Lost to Follow-up|3|||
148789193|NCT00802672|536706504|FG000|Overall Study|Withdrawal by Subject|1|||
148789194|NCT00802672|536706505|FG001|Overall Study|Withdrawal by Subject|1|||
148789195|NCT00802672|536706506|FG002|Overall Study|Withdrawal by Subject|2|||
148789196|NCT00802672|536706504|FG000|Overall Study|other|3|||
148789197|NCT00802672|536706505|FG001|Overall Study|other|1|||
148789198|NCT00802672|536706506|FG002|Overall Study|other|2|||
148789199|NCT04336475|536706507|FG000|Overall Study|pain|1|||
148789200|NCT04336475|536706508|FG001|Overall Study|pain|0|||
148789201|NCT04336475|536706507|FG000|Overall Study|upper respiratory infection|1|||
148789202|NCT04336475|536706508|FG001|Overall Study|upper respiratory infection|0|||
148789203|NCT04336475|536706507|FG000|Overall Study|Lost to Follow-up|0|||
148789204|NCT04336475|536706508|FG001|Overall Study|Lost to Follow-up|2|||
148789205|NCT01990573|536706511|FG000|Overall Study|Physician Decision|0|||
148789206|NCT01990573|536706512|FG001|Overall Study|Physician Decision|0|||
148789207|NCT01990573|536706513|FG002|Overall Study|Physician Decision|1|||
148789208|NCT01763827|536706518|FG000|Overall Study|Withdrawal by Subject|1|||
148789209|NCT01763827|536706519|FG001|Overall Study|Withdrawal by Subject|0|||
148789210|NCT01763827|536706520|FG002|Overall Study|Withdrawal by Subject|0|||
148789211|NCT01763827|536706521|FG003|Overall Study|Withdrawal by Subject|0|||
148789212|NCT01763827|536706522|FG004|Overall Study|Withdrawal by Subject|2|||
148789213|NCT01763827|536706523|FG005|Overall Study|Withdrawal by Subject|0|||
148789214|NCT01763827|536706518|FG000|Overall Study|Decision by sponsor|2|||
148789215|NCT01763827|536706519|FG001|Overall Study|Decision by sponsor|0|||
148789216|NCT01763827|536706520|FG002|Overall Study|Decision by sponsor|3|||
148789217|NCT01763827|536706521|FG003|Overall Study|Decision by sponsor|0|||
148789218|NCT01763827|536706522|FG004|Overall Study|Decision by sponsor|2|||
148789219|NCT01763827|536706523|FG005|Overall Study|Decision by sponsor|1|||
148789220|NCT01763827|536706518|FG000|Overall Study|Lost to Follow-up|0|||
148789221|NCT01763827|536706519|FG001|Overall Study|Lost to Follow-up|1|||
148789222|NCT01763827|536706520|FG002|Overall Study|Lost to Follow-up|1|||
148789223|NCT01763827|536706521|FG003|Overall Study|Lost to Follow-up|1|||
148789224|NCT01763827|536706522|FG004|Overall Study|Lost to Follow-up|2|||
148789225|NCT01763827|536706523|FG005|Overall Study|Lost to Follow-up|1|||
148789226|NCT02906579|536706524|FG000|Overall Study|Adverse Event|1|||
148789227|NCT02906579|536706524|FG000|Overall Study|Physician Decision|1|||
148789228|NCT00759655|536706525|FG000|Overall Study|Termination of the study by sponsor|1|||
148789229|NCT02933528|536706526|FG000|Overall Study|Lost to Follow-up|2|||
148789230|NCT01301079|536706527|FG000|Overall Study|Lost to Follow-up|2|||
148789231|NCT01301079|536706528|FG001|Overall Study|Lost to Follow-up|2|||
148789232|NCT01639703|536706529|FG000|Overall Study|Withdrawal by Subject|5|||
148789233|NCT01639703|536706529|FG000|Overall Study|Other reason|7|||
148789234|NCT02091414|536706530|FG000|Overall Study|Withdrawal by Subject|2|||
148789235|NCT02091414|536706530|FG000|Overall Study|Death|2|||
148789236|NCT03146741|536706531|FG000|Overall Study|Txp with non-HCV+ heart|4|||
148789237|NCT03146741|536706531|FG000|Overall Study|Listeted for MOT|2|||
148789238|NCT03146741|536706531|FG000|Overall Study|Physician Decision|2|||
148789239|NCT03146741|536706531|FG000|Overall Study|Awaiting txp|2|||
148789240|NCT00551525|536706534|FG000|Overall Study|Protocol Violation|5|||
148789241|NCT04676724|536706535|FG000|Overall Study|Adverse Event|2|||
148789242|NCT04676724|536706536|FG001|Overall Study|Adverse Event|0|||
148789243|NCT04676724|536706535|FG000|Overall Study|Lost to Follow-up|1|||
149129700|NCT00261846|537954540|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
149129701|NCT00261846|537954541|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
148789244|NCT04676724|536706536|FG001|Overall Study|Lost to Follow-up|0|||
148789245|NCT04676724|536706535|FG000|Overall Study|Physician Decision|0|||
148789246|NCT04676724|536706536|FG001|Overall Study|Physician Decision|1|||
148789247|NCT04676724|536706535|FG000|Overall Study|Withdrawal by Subject|3|||
148789248|NCT04676724|536706536|FG001|Overall Study|Withdrawal by Subject|2|||
148789249|NCT00398047|536706542|FG000|Overall Study|all patient progressed before completion|3|||
148789250|NCT02521792|536706543|FG000|Overall Study|Study Terminated|6|||
148789251|NCT00237692|536706544|FG000|Overall Study|Lost to Follow-up|9|||
148789252|NCT00237692|536706545|FG001|Overall Study|Lost to Follow-up|3|||
148789253|NCT00237692|536706546|FG002|Overall Study|Lost to Follow-up|5|||
148789254|NCT00237692|536706547|FG003|Overall Study|Lost to Follow-up|3|||
148789255|NCT00237692|536706544|FG000|Overall Study|Death|1|||
148789256|NCT00237692|536706545|FG001|Overall Study|Death|2|||
148789257|NCT00237692|536706546|FG002|Overall Study|Death|2|||
148789258|NCT00237692|536706547|FG003|Overall Study|Death|3|||
148789259|NCT00237692|536706544|FG000|Overall Study|Excluded - did not meet criteria|4|||
148789260|NCT00237692|536706545|FG001|Overall Study|Excluded - did not meet criteria|3|||
148789261|NCT00237692|536706546|FG002|Overall Study|Excluded - did not meet criteria|5|||
148789262|NCT00237692|536706547|FG003|Overall Study|Excluded - did not meet criteria|9|||
148789263|NCT00237692|536706544|FG000|Overall Study|Withdrawal by Subject|4|||
148789264|NCT00237692|536706545|FG001|Overall Study|Withdrawal by Subject|6|||
148789265|NCT00237692|536706546|FG002|Overall Study|Withdrawal by Subject|10|||
148789266|NCT00237692|536706547|FG003|Overall Study|Withdrawal by Subject|4|||
148789267|NCT00902746|536706548|FG000|Overall Study|Protocol Violation|7|||
148789268|NCT00902746|536706548|FG000|Overall Study|Withdrawal by Subject|16|||
148789269|NCT00902746|536706548|FG000|Overall Study|Adverse Event|8|||
148789270|NCT00902746|536706548|FG000|Overall Study|Lost to Follow-up|3|||
148789271|NCT00902746|536706548|FG000|Overall Study|Physician Decision|2|||
148789272|NCT02081001|536706553|FG000|Overall Study|Adverse Event|0|||
148789273|NCT02081001|536706554|FG001|Overall Study|Adverse Event|0|||
148789274|NCT02081001|536706555|FG002|Overall Study|Adverse Event|0|||
148789275|NCT02081001|536706556|FG003|Overall Study|Adverse Event|0|||
148789276|NCT02081001|536706557|FG004|Overall Study|Adverse Event|1|||
148789277|NCT02081001|536706558|FG005|Overall Study|Adverse Event|0|||
148789278|NCT02081001|536706559|FG006|Overall Study|Adverse Event|0|||
148789279|NCT02081001|536706560|FG007|Overall Study|Adverse Event|0|||
148789280|NCT02081001|536706561|FG008|Overall Study|Adverse Event|0|||
148789281|NCT02081001|536706562|FG009|Overall Study|Adverse Event|0|||
148789282|NCT02081001|536706563|FG010|Overall Study|Adverse Event|0|||
148789283|NCT02081001|536706564|FG011|Overall Study|Adverse Event|0|||
148789284|NCT01151345|536706577|FG000|First Intervention Period|Protocol Violation|0|||
148789285|NCT01151345|536706578|FG001|First Intervention Period|Protocol Violation|1|||
148789286|NCT01765569|536706579|FG000|Period B|Withdrawal by Subject|1|||
148789287|NCT01765569|536706579|FG000|Period C|Death|1|||
148789288|NCT02588092|536706580|FG000|Overall Study|Death|4|||
148789289|NCT02588092|536706581|FG001|Overall Study|Death|3|||
148789290|NCT02588092|536706582|FG002|Overall Study|Death|3|||
148789291|NCT02588092|536706583|FG003|Overall Study|Death|3|||
148789292|NCT02588092|536706584|FG004|Overall Study|Death|2|||
148789293|NCT02588092|536706585|FG005|Overall Study|Death|2|||
148789294|NCT02588092|536706586|FG006|Overall Study|Death|2|||
148789295|NCT02588092|536706587|FG007|Overall Study|Death|1|||
148789296|NCT02588092|536706588|FG008|Overall Study|Death|5|||
148789297|NCT02588092|536706589|FG009|Overall Study|Death|2|||
148789298|NCT02588092|536706580|FG000|Overall Study|Withdrawal by Subject|0|||
148789299|NCT02588092|536706581|FG001|Overall Study|Withdrawal by Subject|0|||
148789300|NCT02588092|536706582|FG002|Overall Study|Withdrawal by Subject|0|||
148789301|NCT02588092|536706583|FG003|Overall Study|Withdrawal by Subject|0|||
148789302|NCT02588092|536706584|FG004|Overall Study|Withdrawal by Subject|0|||
148789303|NCT02588092|536706585|FG005|Overall Study|Withdrawal by Subject|1|||
148789304|NCT02588092|536706586|FG006|Overall Study|Withdrawal by Subject|1|||
148789305|NCT02588092|536706587|FG007|Overall Study|Withdrawal by Subject|2|||
148789306|NCT02588092|536706588|FG008|Overall Study|Withdrawal by Subject|0|||
148789307|NCT02588092|536706589|FG009|Overall Study|Withdrawal by Subject|0|||
148789308|NCT02588092|536706580|FG000|Overall Study|Started Another Treatment|0|||
148789309|NCT02588092|536706581|FG001|Overall Study|Started Another Treatment|0|||
148789310|NCT02588092|536706582|FG002|Overall Study|Started Another Treatment|0|||
148789311|NCT02588092|536706583|FG003|Overall Study|Started Another Treatment|0|||
148789312|NCT02588092|536706584|FG004|Overall Study|Started Another Treatment|1|||
148789313|NCT02588092|536706585|FG005|Overall Study|Started Another Treatment|0|||
148789314|NCT02588092|536706586|FG006|Overall Study|Started Another Treatment|0|||
148789315|NCT02588092|536706587|FG007|Overall Study|Started Another Treatment|1|||
148789316|NCT02588092|536706588|FG008|Overall Study|Started Another Treatment|0|||
148789317|NCT02588092|536706589|FG009|Overall Study|Started Another Treatment|0|||
148789318|NCT02588092|536706580|FG000|Overall Study|Sponsor Decision|0|||
148789319|NCT02588092|536706581|FG001|Overall Study|Sponsor Decision|0|||
148789320|NCT02588092|536706582|FG002|Overall Study|Sponsor Decision|0|||
148789321|NCT02588092|536706583|FG003|Overall Study|Sponsor Decision|0|||
148789322|NCT02588092|536706584|FG004|Overall Study|Sponsor Decision|0|||
148789323|NCT02588092|536706585|FG005|Overall Study|Sponsor Decision|0|||
148789324|NCT02588092|536706586|FG006|Overall Study|Sponsor Decision|0|||
148789325|NCT02588092|536706587|FG007|Overall Study|Sponsor Decision|0|||
148789326|NCT02588092|536706588|FG008|Overall Study|Sponsor Decision|1|||
148789327|NCT02588092|536706589|FG009|Overall Study|Sponsor Decision|1|||
148789328|NCT01030718|536706590|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
148789329|NCT01030718|536706591|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
148789330|NCT01030718|536706592|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
148789331|NCT01030718|536706590|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
148789332|NCT01030718|536706591|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
148789333|NCT01030718|536706592|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
148789334|NCT01030718|536706590|FG000|Studies CA180-031 and -036 Combined|Death|0|||
148789335|NCT01030718|536706591|FG001|Studies CA180-031 and -036 Combined|Death|1|||
148789336|NCT01030718|536706592|FG002|Studies CA180-031 and -036 Combined|Death|0|||
148789337|NCT01030718|536706590|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
148789338|NCT01030718|536706591|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
148789339|NCT01030718|536706592|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
148789340|NCT01030718|536706590|FG000|Study CA180-036 Only|insufficient effect|1|||
148789341|NCT01030718|536706591|FG001|Study CA180-036 Only|insufficient effect|1|||
148789342|NCT01030718|536706592|FG002|Study CA180-036 Only|insufficient effect|5|||
148789343|NCT01030718|536706590|FG000|Study CA180-036 Only|Adverse Event|2|||
148789344|NCT01030718|536706591|FG001|Study CA180-036 Only|Adverse Event|3|||
148789345|NCT01030718|536706592|FG002|Study CA180-036 Only|Adverse Event|0|||
148789346|NCT01030718|536706590|FG000|Study CA180-036 Only|Death|0|||
148789347|NCT01030718|536706591|FG001|Study CA180-036 Only|Death|1|||
148789348|NCT01030718|536706592|FG002|Study CA180-036 Only|Death|0|||
148789349|NCT01030718|536706590|FG000|Study CA180-036 Only|Other Reasons|0|||
148789350|NCT01030718|536706591|FG001|Study CA180-036 Only|Other Reasons|2|||
148789351|NCT01030718|536706592|FG002|Study CA180-036 Only|Other Reasons|0|||
148789352|NCT00423813|536706593|FG000|Overall Study|Adverse Event|11|||
148789353|NCT00423813|536706594|FG001|Overall Study|Adverse Event|30|||
148789354|NCT00423813|536706595|FG002|Overall Study|Adverse Event|40|||
148789355|NCT00423813|536706593|FG000|Overall Study|Withdrawal by Subject|6|||
148789356|NCT00423813|536706594|FG001|Overall Study|Withdrawal by Subject|8|||
148789357|NCT00423813|536706595|FG002|Overall Study|Withdrawal by Subject|5|||
148789358|NCT00423813|536706593|FG000|Overall Study|Lost to Follow-up|5|||
148789359|NCT00423813|536706594|FG001|Overall Study|Lost to Follow-up|4|||
148789360|NCT00423813|536706595|FG002|Overall Study|Lost to Follow-up|4|||
148789361|NCT00423813|536706593|FG000|Overall Study|Lack of Efficacy|23|||
148789362|NCT00423813|536706594|FG001|Overall Study|Lack of Efficacy|18|||
148789363|NCT00423813|536706595|FG002|Overall Study|Lack of Efficacy|19|||
148789364|NCT00423813|536706593|FG000|Overall Study|Physician Decision|2|||
148789365|NCT00423813|536706594|FG001|Overall Study|Physician Decision|0|||
148789366|NCT00423813|536706595|FG002|Overall Study|Physician Decision|0|||
148789367|NCT00423813|536706593|FG000|Overall Study|Sponsor Decision|0|||
148789368|NCT00423813|536706594|FG001|Overall Study|Sponsor Decision|1|||
148789369|NCT00423813|536706595|FG002|Overall Study|Sponsor Decision|0|||
148789370|NCT00423813|536706593|FG000|Overall Study|Protocol Violation|9|||
148789371|NCT00423813|536706594|FG001|Overall Study|Protocol Violation|4|||
148789372|NCT00423813|536706595|FG002|Overall Study|Protocol Violation|4|||
148789373|NCT00423813|536706593|FG000|Overall Study|Pregnancy|0|||
148789374|NCT00423813|536706594|FG001|Overall Study|Pregnancy|0|||
148789375|NCT00423813|536706595|FG002|Overall Study|Pregnancy|1|||
148789376|NCT00423813|536706593|FG000|Overall Study|Subject started night shift work|1|||
148789377|NCT00423813|536706594|FG001|Overall Study|Subject started night shift work|0|||
148789378|NCT00423813|536706595|FG002|Overall Study|Subject started night shift work|0|||
148789379|NCT00423813|536706593|FG000|Overall Study|Will start exclusionary medications|0|||
148789380|NCT00423813|536706594|FG001|Overall Study|Will start exclusionary medications|1|||
148789381|NCT00423813|536706595|FG002|Overall Study|Will start exclusionary medications|0|||
148789382|NCT00423813|536706593|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
148789383|NCT00423813|536706594|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
148789384|NCT00423813|536706595|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
148789385|NCT01386944|536706596|FG000|Overall Study|Adverse Event|26|||
148789386|NCT01386944|536706596|FG000|Overall Study|Lack of Efficacy|14|||
148789387|NCT01386944|536706596|FG000|Overall Study|Lost to Follow-up|8|||
148789388|NCT01386944|536706596|FG000|Overall Study|Unspecified reason|8|||
148789389|NCT03883477|536706597|FG000|Overall Study|Death|1|||
148789390|NCT03883477|536706598|FG001|Overall Study|Death|0|||
148789391|NCT03883477|536706597|FG000|Overall Study|Protocol Violation|0|||
148789392|NCT03883477|536706598|FG001|Overall Study|Protocol Violation|1|||
148789393|NCT03853291|536706599|FG000|Overall Study|Lost to Follow-up|1|||
149129702|NCT00261846|537954542|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
148789394|NCT03853291|536706600|FG001|Overall Study|Lost to Follow-up|2|||
148789395|NCT03853291|536706601|FG002|Overall Study|Lost to Follow-up|0|||
148789396|NCT03853291|536706602|FG003|Overall Study|Lost to Follow-up|0|||
148789397|NCT03853291|536706603|FG004|Overall Study|Lost to Follow-up|0|||
148789398|NCT03853291|536706604|FG005|Overall Study|Lost to Follow-up|0|||
149129703|NCT00261846|537954543|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
148789399|NCT03853291|536706599|FG000|Overall Study|Determined to be ineligible|1|||
148789400|NCT03853291|536706600|FG001|Overall Study|Determined to be ineligible|1|||
148789401|NCT03853291|536706601|FG002|Overall Study|Determined to be ineligible|0|||
148789402|NCT03853291|536706602|FG003|Overall Study|Determined to be ineligible|0|||
148789403|NCT03853291|536706603|FG004|Overall Study|Determined to be ineligible|0|||
148789404|NCT03853291|536706604|FG005|Overall Study|Determined to be ineligible|0|||
148789405|NCT01904032|536706606|FG000|Overall Study|Adverse Event|3|||
148789406|NCT01904032|536706607|FG001|Overall Study|Adverse Event|1|||
148789407|NCT01904032|536706606|FG000|Overall Study|Lost to Follow-up|4|||
148789408|NCT01904032|536706607|FG001|Overall Study|Lost to Follow-up|2|||
148789409|NCT01658904|536706608|FG000|Overall Study|Principal Investigator discretion|2|||
148789410|NCT01658904|536706609|FG001|Overall Study|Principal Investigator discretion|0|||
148789411|NCT01658904|536706610|FG002|Overall Study|Principal Investigator discretion|0|||
148789412|NCT00531947|536706611|FG000|Overall Study|Adverse Event|5|||
148789413|NCT00531947|536706612|FG001|Overall Study|Adverse Event|10|||
148789414|NCT00531947|536706611|FG000|Overall Study|Lost to Follow-up|12|||
148789415|NCT00531947|536706612|FG001|Overall Study|Lost to Follow-up|9|||
148789416|NCT00531947|536706611|FG000|Overall Study|Withdrawal by Subject|14|||
148789417|NCT00531947|536706612|FG001|Overall Study|Withdrawal by Subject|19|||
148789418|NCT00531947|536706611|FG000|Overall Study|Protocol Violation|2|||
148789419|NCT00531947|536706612|FG001|Overall Study|Protocol Violation|1|||
148789420|NCT00531947|536706611|FG000|Overall Study|Non-Compliance|4|||
148789421|NCT00531947|536706612|FG001|Overall Study|Non-Compliance|7|||
148789422|NCT00531947|536706611|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
148789423|NCT00531947|536706612|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
148789424|NCT03148067|536706617|FG000|Overall Study|Lost to Follow-up|3|||
148789425|NCT03148067|536706617|FG000|Overall Study|Death|1|||
148789426|NCT04074330|536706629|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
148789427|NCT04074330|536706630|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
148789428|NCT04074330|536706631|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
148789429|NCT04074330|536706632|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
148789430|NCT04074330|536706633|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
148789431|NCT04074330|536706634|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
148789432|NCT04074330|536706635|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
148789433|NCT04074330|536706636|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
148789434|NCT04074330|536706637|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
148789435|NCT04074330|536706638|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
148789436|NCT04074330|536706629|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
148789437|NCT04074330|536706630|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
148789438|NCT04074330|536706631|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
148789439|NCT04074330|536706632|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
148789440|NCT04074330|536706633|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
148789441|NCT04074330|536706634|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
148789442|NCT04074330|536706635|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
148789443|NCT04074330|536706636|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
148789444|NCT04074330|536706637|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
148789445|NCT04074330|536706638|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
148789446|NCT04074330|536706629|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789447|NCT04074330|536706630|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789448|NCT04074330|536706631|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
148789449|NCT04074330|536706632|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789450|NCT04074330|536706633|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789451|NCT04074330|536706634|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789452|NCT04074330|536706635|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789453|NCT04074330|536706636|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789454|NCT04074330|536706637|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789455|NCT04074330|536706638|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
148789456|NCT04074330|536706629|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789457|NCT04074330|536706630|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789458|NCT04074330|536706631|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789459|NCT04074330|536706632|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789460|NCT04074330|536706633|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789461|NCT04074330|536706634|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
148789462|NCT04074330|536706635|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789463|NCT04074330|536706636|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
148789464|NCT04074330|536706637|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789465|NCT04074330|536706638|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
148789466|NCT04074330|536706629|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
148789467|NCT04074330|536706630|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
148789468|NCT04074330|536706631|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
148789469|NCT04074330|536706632|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
148789470|NCT04074330|536706633|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
148789471|NCT04074330|536706634|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
148789472|NCT04074330|536706635|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
148789473|NCT04074330|536706636|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
148893408|NCT01693029|537088701|FG001|Overall Study|Adverse Event|6|||
148789474|NCT04074330|536706637|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
148789475|NCT04074330|536706638|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
148789476|NCT04074330|536706629|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
148789477|NCT04074330|536706630|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
148789478|NCT04074330|536706631|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
148789479|NCT04074330|536706632|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
148789480|NCT04074330|536706633|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
148789481|NCT04074330|536706634|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
148789482|NCT04074330|536706635|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
148789483|NCT04074330|536706636|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
148789484|NCT04074330|536706637|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
148789485|NCT04074330|536706638|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
148789486|NCT04074330|536706629|FG000|Dose Expansion (up to 42 Months)|Death|0|||
148789487|NCT04074330|536706630|FG001|Dose Expansion (up to 42 Months)|Death|0|||
148789488|NCT04074330|536706631|FG002|Dose Expansion (up to 42 Months)|Death|0|||
148789489|NCT04074330|536706632|FG003|Dose Expansion (up to 42 Months)|Death|0|||
148789490|NCT04074330|536706633|FG004|Dose Expansion (up to 42 Months)|Death|0|||
148789491|NCT04074330|536706634|FG005|Dose Expansion (up to 42 Months)|Death|0|||
148789492|NCT04074330|536706635|FG006|Dose Expansion (up to 42 Months)|Death|0|||
148789493|NCT04074330|536706636|FG007|Dose Expansion (up to 42 Months)|Death|0|||
148789494|NCT04074330|536706637|FG008|Dose Expansion (up to 42 Months)|Death|1|||
148789495|NCT04074330|536706638|FG009|Dose Expansion (up to 42 Months)|Death|0|||
148789496|NCT04074330|536706629|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789497|NCT04074330|536706630|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789498|NCT04074330|536706631|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789499|NCT04074330|536706632|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789500|NCT04074330|536706633|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789501|NCT04074330|536706634|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789502|NCT04074330|536706635|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789503|NCT04074330|536706636|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
148789504|NCT04074330|536706637|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
148789505|NCT04074330|536706638|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
148789506|NCT03124537|536706639|FG000|Overall Study|Lost to Follow-up|3|||
148789507|NCT03124537|536706640|FG001|Overall Study|Lost to Follow-up|5|||
148789508|NCT03124537|536706639|FG000|Overall Study|App Crash, Incomplete Data|7|||
148789509|NCT03124537|536706640|FG001|Overall Study|App Crash, Incomplete Data|8|||
148789510|NCT03301831|536706643|FG000|Overall Study|Lost to Follow-up|5|||
148789511|NCT03301831|536706644|FG001|Overall Study|Lost to Follow-up|3|||
148789512|NCT03301831|536706643|FG000|Overall Study|Protocol Violation|4|||
148789513|NCT03301831|536706644|FG001|Overall Study|Protocol Violation|0|||
148789514|NCT03301831|536706643|FG000|Overall Study|Withdrawal by Subject|11|||
148789515|NCT03301831|536706644|FG001|Overall Study|Withdrawal by Subject|0|||
148789516|NCT00913770|536706648|FG000|Overall Study|Unable to contact|24|||
148789517|NCT00913770|536706649|FG001|Overall Study|Unable to contact|19|||
148789518|NCT00913770|536706650|FG002|Overall Study|Unable to contact|13|||
148789519|NCT00913770|536706648|FG000|Overall Study|Refused|11|||
148789520|NCT00913770|536706649|FG001|Overall Study|Refused|10|||
148789521|NCT00913770|536706650|FG002|Overall Study|Refused|8|||
148789522|NCT02348008|536706651|FG000|Overall Study|Adverse Event|2|||
148789523|NCT02348008|536706652|FG001|Overall Study|Adverse Event|3|||
148789524|NCT02348008|536706653|FG002|Overall Study|Adverse Event|3|||
148789525|NCT02348008|536706651|FG000|Overall Study|Disease Progression|1|||
148789526|NCT02348008|536706652|FG001|Overall Study|Disease Progression|5|||
148789527|NCT02348008|536706653|FG002|Overall Study|Disease Progression|16|||
148789528|NCT02348008|536706651|FG000|Overall Study|Withdrawal by Subject|0|||
148789529|NCT02348008|536706652|FG001|Overall Study|Withdrawal by Subject|1|||
148789530|NCT02348008|536706653|FG002|Overall Study|Withdrawal by Subject|0|||
148789531|NCT02348008|536706651|FG000|Overall Study|Symptomatic Deterioration|0|||
148789532|NCT02348008|536706652|FG001|Overall Study|Symptomatic Deterioration|1|||
148789533|NCT02348008|536706653|FG002|Overall Study|Symptomatic Deterioration|0|||
148789534|NCT03268005|536706659|FG000|Overall Study|Death|2|||
148789535|NCT03268005|536706660|FG001|Overall Study|Death|1|||
148789536|NCT03268005|536706659|FG000|Overall Study|Lost to Follow-up|2|||
148789537|NCT03268005|536706660|FG001|Overall Study|Lost to Follow-up|2|||
148789538|NCT03268005|536706659|FG000|Overall Study|Withdrawal by Subject|11|||
148789539|NCT03268005|536706660|FG001|Overall Study|Withdrawal by Subject|11|||
148789540|NCT00980655|536706661|FG000|Overall Study|Adverse Event|13|||
148789541|NCT00980655|536706662|FG001|Overall Study|Adverse Event|31|||
148789542|NCT00980655|536706661|FG000|Overall Study|Death|0|||
148789543|NCT00980655|536706662|FG001|Overall Study|Death|7|||
148789544|NCT00980655|536706661|FG000|Overall Study|Protocol Violation|2|||
148789545|NCT00980655|536706662|FG001|Overall Study|Protocol Violation|7|||
148789546|NCT00980655|536706661|FG000|Overall Study|Withdrawal by Subject|0|||
148789547|NCT00980655|536706662|FG001|Overall Study|Withdrawal by Subject|4|||
148789548|NCT00980655|536706661|FG000|Overall Study|Lost to Follow-up|0|||
148789549|NCT00980655|536706662|FG001|Overall Study|Lost to Follow-up|1|||
148789550|NCT00980655|536706661|FG000|Overall Study|Parent/legal guardian request|1|||
148789551|NCT00980655|536706662|FG001|Overall Study|Parent/legal guardian request|0|||
148789552|NCT00980655|536706661|FG000|Overall Study|Other|0|||
148789553|NCT00980655|536706662|FG001|Overall Study|Other|1|||
148789554|NCT00248833|536706668|FG000|Overall Study|Adverse Event|2|||
148789555|NCT00248833|536706669|FG001|Overall Study|Adverse Event|0|||
148789556|NCT00248833|536706670|FG002|Overall Study|Adverse Event|0|||
148789557|NCT00248833|536706668|FG000|Overall Study|Withdrawal by Subject|0|||
148789558|NCT00248833|536706669|FG001|Overall Study|Withdrawal by Subject|1|||
148789559|NCT00248833|536706670|FG002|Overall Study|Withdrawal by Subject|1|||
148789560|NCT00248833|536706668|FG000|Overall Study|Lost to Follow-up|1|||
148789561|NCT00248833|536706669|FG001|Overall Study|Lost to Follow-up|1|||
148789562|NCT00248833|536706670|FG002|Overall Study|Lost to Follow-up|1|||
148789563|NCT00248833|536706668|FG000|Overall Study|Other|0|||
148789564|NCT00248833|536706669|FG001|Overall Study|Other|1|||
148789565|NCT00248833|536706670|FG002|Overall Study|Other|0|||
148789566|NCT02427802|536706671|FG000|Overall Study|Adverse Event|11|||
148789567|NCT02427802|536706672|FG001|Overall Study|Adverse Event|3|||
148789568|NCT02427802|536706673|FG002|Overall Study|Adverse Event|7|||
148789569|NCT02427802|536706671|FG000|Overall Study|Death|0|||
148789570|NCT02427802|536706672|FG001|Overall Study|Death|4|||
148789571|NCT02427802|536706673|FG002|Overall Study|Death|1|||
148789572|NCT02427802|536706671|FG000|Overall Study|Lost to Follow-up|13|||
148789573|NCT02427802|536706672|FG001|Overall Study|Lost to Follow-up|8|||
149129704|NCT00261846|537954544|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
149129705|NCT00261846|537954545|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
149129706|NCT00261846|537954546|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
149129707|NCT00261846|537954535|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129708|NCT00261846|537954536|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129709|NCT00261846|537954537|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
148789574|NCT02427802|536706673|FG002|Overall Study|Lost to Follow-up|8|||
148789575|NCT02427802|536706671|FG000|Overall Study|Physician Decision|4|||
148789576|NCT02427802|536706672|FG001|Overall Study|Physician Decision|2|||
148789577|NCT02427802|536706673|FG002|Overall Study|Physician Decision|4|||
148789578|NCT02427802|536706671|FG000|Overall Study|Withdrawal by Subject|10|||
148789579|NCT02427802|536706672|FG001|Overall Study|Withdrawal by Subject|5|||
148789580|NCT02427802|536706673|FG002|Overall Study|Withdrawal by Subject|11|||
148789581|NCT02427802|536706671|FG000|Overall Study|Protocol Violation|3|||
148789582|NCT02427802|536706672|FG001|Overall Study|Protocol Violation|1|||
148789583|NCT02427802|536706673|FG002|Overall Study|Protocol Violation|1|||
148789584|NCT02427802|536706671|FG000|Overall Study|protocol specific treatment unrelated|18|||
148789585|NCT02427802|536706672|FG001|Overall Study|protocol specific treatment unrelated|11|||
148789586|NCT02427802|536706673|FG002|Overall Study|protocol specific treatment unrelated|11|||
148789587|NCT02213380|536708390|FG000|Underwent Randomization|Withdrawal by Subject|2|||
148789588|NCT02213380|536708391|FG001|Underwent Randomization|Withdrawal by Subject|0|||
148789589|NCT02213380|536708390|FG000|Underwent Randomization|Not treated|3|||
148789590|NCT02213380|536708391|FG001|Underwent Randomization|Not treated|3|||
148789591|NCT02213380|536708390|FG000|Per-protocol Analysis|Protocol Violation|32|||
148789592|NCT02213380|536708391|FG001|Per-protocol Analysis|Protocol Violation|36|||
148789593|NCT01490840|536708396|FG000|Phase 1|Lost to Follow-up|1|||
148789594|NCT01490840|536708397|FG001|Phase 1|Lost to Follow-up|0|||
148789595|NCT01490840|536708396|FG000|Phase 1|Adverse Event|2|||
148789596|NCT01490840|536708397|FG001|Phase 1|Adverse Event|1|||
149129710|NCT00261846|537954538|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
149129711|NCT00261846|537954539|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129712|NCT00261846|537954540|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129713|NCT00261846|537954541|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129714|NCT00261846|537954542|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129715|NCT00261846|537954543|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
148789597|NCT01490840|536708396|FG000|Phase 1|Withdrawal by Subject|6|||
148789598|NCT01490840|536708397|FG001|Phase 1|Withdrawal by Subject|5|||
148789599|NCT01490840|536708396|FG000|Phase 1|Visit 6a omitted|1|||
148789600|NCT01490840|536708397|FG001|Phase 1|Visit 6a omitted|0|||
148789601|NCT01490840|536708396|FG000|Phase 2|Withdrawal by Subject|4|||
148789602|NCT01490840|536708397|FG001|Phase 2|Withdrawal by Subject|3|||
148789603|NCT01490840|536708396|FG000|Phase 2|Permanent interruption of fingolimod|0|||
148789604|NCT01490840|536708397|FG001|Phase 2|Permanent interruption of fingolimod|1|||
148789605|NCT01490840|536708396|FG000|Phase 2|Lost to Follow-up|1|||
148789606|NCT01490840|536708397|FG001|Phase 2|Lost to Follow-up|1|||
148789607|NCT01490840|536708396|FG000|Phase 2|Adverse Event|1|||
148789608|NCT01490840|536708397|FG001|Phase 2|Adverse Event|1|||
149011396|NCT04186403|537521466|FG000|Overall Study|Adverse Event|1|||
148789609|NCT01025284|536708404|FG000|Overall Study|Investigator Decision|0|||
148789610|NCT01025284|536708405|FG001|Overall Study|Investigator Decision|1|||
148789611|NCT01025284|536708406|FG002|Overall Study|Investigator Decision|0|||
148789612|NCT01025284|536708404|FG000|Overall Study|Withdrawal by Subject|0|||
148789613|NCT01025284|536708405|FG001|Overall Study|Withdrawal by Subject|1|||
148789614|NCT01025284|536708406|FG002|Overall Study|Withdrawal by Subject|0|||
148789615|NCT01465230|536708408|FG000|Overall Study|Withdrawal by Subject|2|||
148789616|NCT00905567|536708409|FG000|Washout|Withdrawal by Subject|0|||
148789617|NCT00905567|536708410|FG001|Washout|Withdrawal by Subject|1|||
148789618|NCT02542397|536708411|FG000|Overall Study|Death|2|||
148789619|NCT02542397|536708411|FG000|Overall Study|Physician Decision|6|||
148789620|NCT02542397|536708411|FG000|Overall Study|Withdrawal by Subject|6|||
148789621|NCT02542397|536708411|FG000|Overall Study|Lost to Follow-up|2|||
148789622|NCT01738919|536708418|FG000|Overall Study|Lost to Follow-up|1|||
148789623|NCT01738919|536708419|FG001|Overall Study|Lost to Follow-up|0|||
148789624|NCT01738919|536708418|FG000|Overall Study|Immigrated|0|||
148789625|NCT01738919|536708419|FG001|Overall Study|Immigrated|1|||
148789626|NCT01738919|536708418|FG000|Overall Study|Withdrawal by Subject|0|||
148789627|NCT01738919|536708419|FG001|Overall Study|Withdrawal by Subject|1|||
148789628|NCT01738919|536708418|FG000|Overall Study|Not treated in accordance to guidelines|0|||
148789629|NCT01738919|536708419|FG001|Overall Study|Not treated in accordance to guidelines|1|||
148789630|NCT01473940|536708420|FG000|Induction Therapy|Death|0|||
148789631|NCT01473940|536708421|FG001|Induction Therapy|Death|0|||
148789632|NCT01473940|536708422|FG002|Induction Therapy|Death|1|||
148789633|NCT01473940|536708423|FG003|Induction Therapy|Death|1|||
148789634|NCT01473940|536708420|FG000|Induction Therapy|Progressive Disease|0|||
148789635|NCT01473940|536708421|FG001|Induction Therapy|Progressive Disease|1|||
148789636|NCT01473940|536708422|FG002|Induction Therapy|Progressive Disease|1|||
148789637|NCT01473940|536708423|FG003|Induction Therapy|Progressive Disease|0|||
148789638|NCT01473940|536708420|FG000|Maintenance Therapy|Progressive Disease|1|||
148789639|NCT01473940|536708421|FG001|Maintenance Therapy|Progressive Disease|2|||
148789640|NCT01473940|536708422|FG002|Maintenance Therapy|Progressive Disease|1|||
148789641|NCT01473940|536708423|FG003|Maintenance Therapy|Progressive Disease|4|||
148789642|NCT00547248|536708424|FG000|Overall Study|Protocol Violation|0|||
148789643|NCT00547248|536708425|FG001|Overall Study|Protocol Violation|0|||
148789644|NCT00547248|536708426|FG002|Overall Study|Protocol Violation|1|||
148789645|NCT00547248|536708427|FG003|Overall Study|Protocol Violation|1|||
148789646|NCT00547248|536708424|FG000|Overall Study|Migrated/moved from study area|0|||
148789647|NCT00547248|536708425|FG001|Overall Study|Migrated/moved from study area|0|||
148789648|NCT00547248|536708426|FG002|Overall Study|Migrated/moved from study area|2|||
148789649|NCT00547248|536708427|FG003|Overall Study|Migrated/moved from study area|0|||
148789650|NCT00547248|536708424|FG000|Overall Study|Withdrawal by Subject|0|||
148789651|NCT00547248|536708425|FG001|Overall Study|Withdrawal by Subject|0|||
148789652|NCT00547248|536708426|FG002|Overall Study|Withdrawal by Subject|7|||
148789653|NCT00547248|536708427|FG003|Overall Study|Withdrawal by Subject|1|||
148789654|NCT00534248|536708430|FG000|Overall Study|Adverse Event|19|||
148789655|NCT00534248|536708431|FG001|Overall Study|Adverse Event|29|||
148789656|NCT00534248|536708430|FG000|Overall Study|Lost to Follow-up|353|||
148789657|NCT00534248|536708431|FG001|Overall Study|Lost to Follow-up|375|||
148789658|NCT00534248|536708430|FG000|Overall Study|Other protocol specified criteria|13|||
148789659|NCT00534248|536708431|FG001|Overall Study|Other protocol specified criteria|3|||
148789660|NCT00534248|536708430|FG000|Overall Study|Physician Decision|10|||
148789661|NCT00534248|536708431|FG001|Overall Study|Physician Decision|7|||
148789662|NCT00534248|536708430|FG000|Overall Study|Protocol Violation|3|||
148789663|NCT00534248|536708431|FG001|Overall Study|Protocol Violation|4|||
148789664|NCT00534248|536708430|FG000|Overall Study|Withdrawal by Subject|263|||
148789665|NCT00534248|536708431|FG001|Overall Study|Withdrawal by Subject|255|||
148789666|NCT02532257|536708432|FG000|Overall Study|Adverse Event|2|||
148789667|NCT02532257|536708432|FG000|Overall Study|Physician Decision|4|||
148789668|NCT02532257|536708432|FG000|Overall Study|Withdrawal by Subject|3|||
148789669|NCT02532257|536708432|FG000|Overall Study|Progressive Disease|10|||
148789670|NCT02849171|536708433|FG000|Overall Study|Withdrawal by Subject|1|||
148789671|NCT02849171|536708433|FG000|Overall Study|Not treated|1|||
148789672|NCT02090283|536708434|FG000|Overall Study|Withdrawal by Subject|6|||
148789673|NCT02090283|536708435|FG001|Overall Study|Withdrawal by Subject|6|||
148789674|NCT02090283|536708436|FG002|Overall Study|Withdrawal by Subject|6|||
148789675|NCT02090283|536708434|FG000|Overall Study|Sponsor Terminated Study|6|||
148789676|NCT02090283|536708435|FG001|Overall Study|Sponsor Terminated Study|6|||
148789677|NCT02090283|536708436|FG002|Overall Study|Sponsor Terminated Study|1|||
148789678|NCT02090283|536708434|FG000|Overall Study|Lost to Follow-up|2|||
148789679|NCT02090283|536708435|FG001|Overall Study|Lost to Follow-up|2|||
148789680|NCT02090283|536708436|FG002|Overall Study|Lost to Follow-up|3|||
148789681|NCT02090283|536708434|FG000|Overall Study|Adverse Event|1|||
148789682|NCT02090283|536708435|FG001|Overall Study|Adverse Event|1|||
148789683|NCT02090283|536708436|FG002|Overall Study|Adverse Event|0|||
148789684|NCT02090283|536708434|FG000|Overall Study|Protocol Violation|2|||
148789685|NCT02090283|536708435|FG001|Overall Study|Protocol Violation|0|||
148789686|NCT02090283|536708436|FG002|Overall Study|Protocol Violation|0|||
148789687|NCT00697593|536708443|FG000|Overall Study|Adverse Event|3|||
148789688|NCT00697593|536708443|FG000|Overall Study|Protocol Violation|1|||
148789689|NCT00697593|536708443|FG000|Overall Study|Lack of Efficacy|3|||
148789690|NCT00697593|536708443|FG000|Overall Study|Suspension of the study by sponsor|12|||
148789691|NCT03498313|536708444|FG000|Experimental Period 1|Adverse Event|1|||
148789692|NCT03498313|536708445|FG001|Experimental Period 1|Adverse Event|0|||
148789693|NCT03498313|536708446|FG002|Experimental Period 1|Adverse Event|0|||
148789694|NCT03498313|536708447|FG003|Experimental Period 1|Adverse Event|1|||
148789695|NCT03498313|536708448|FG004|Experimental Period 1|Adverse Event|0|||
148789696|NCT03498313|536708449|FG005|Experimental Period 1|Adverse Event|0|||
148789697|NCT03498313|536708444|FG000|Experimental Period 1|Withdrawal by Subject|0|||
148789698|NCT03498313|536708445|FG001|Experimental Period 1|Withdrawal by Subject|1|||
148789699|NCT03498313|536708446|FG002|Experimental Period 1|Withdrawal by Subject|0|||
148789700|NCT03498313|536708447|FG003|Experimental Period 1|Withdrawal by Subject|0|||
148789701|NCT03498313|536708448|FG004|Experimental Period 1|Withdrawal by Subject|0|||
148789702|NCT03498313|536708449|FG005|Experimental Period 1|Withdrawal by Subject|0|||
148789703|NCT03498313|536708444|FG000|Washout Period 1|Anovulation|1|||
148789704|NCT03498313|536708445|FG001|Washout Period 1|Anovulation|0|||
148789705|NCT03498313|536708446|FG002|Washout Period 1|Anovulation|0|||
148789706|NCT03498313|536708447|FG003|Washout Period 1|Anovulation|0|||
148789707|NCT03498313|536708448|FG004|Washout Period 1|Anovulation|0|||
148789708|NCT03498313|536708449|FG005|Washout Period 1|Anovulation|0|||
148789709|NCT03498313|536708444|FG000|Washout Period 1|Withdrawal by Subject|0|||
148789710|NCT03498313|536708445|FG001|Washout Period 1|Withdrawal by Subject|3|||
148789711|NCT03498313|536708446|FG002|Washout Period 1|Withdrawal by Subject|0|||
148789712|NCT03498313|536708447|FG003|Washout Period 1|Withdrawal by Subject|1|||
148789713|NCT03498313|536708448|FG004|Washout Period 1|Withdrawal by Subject|0|||
148789714|NCT03498313|536708449|FG005|Washout Period 1|Withdrawal by Subject|1|||
148789715|NCT03498313|536708444|FG000|Experimental Period 2|Adverse Event|0|||
148789716|NCT03498313|536708445|FG001|Experimental Period 2|Adverse Event|0|||
148789717|NCT03498313|536708446|FG002|Experimental Period 2|Adverse Event|0|||
148789718|NCT03498313|536708447|FG003|Experimental Period 2|Adverse Event|0|||
148789719|NCT03498313|536708448|FG004|Experimental Period 2|Adverse Event|1|||
148789720|NCT03498313|536708449|FG005|Experimental Period 2|Adverse Event|2|||
148789721|NCT03498313|536708444|FG000|Washout Period 2|Physician Decision|1|||
148789722|NCT03498313|536708445|FG001|Washout Period 2|Physician Decision|0|||
148789723|NCT03498313|536708446|FG002|Washout Period 2|Physician Decision|0|||
148789724|NCT03498313|536708447|FG003|Washout Period 2|Physician Decision|1|||
148789725|NCT03498313|536708448|FG004|Washout Period 2|Physician Decision|0|||
148789726|NCT03498313|536708449|FG005|Washout Period 2|Physician Decision|1|||
148789727|NCT03498313|536708444|FG000|Washout Period 2|Withdrawal by Subject|3|||
148789728|NCT03498313|536708445|FG001|Washout Period 2|Withdrawal by Subject|2|||
148789729|NCT03498313|536708446|FG002|Washout Period 2|Withdrawal by Subject|0|||
148789730|NCT03498313|536708447|FG003|Washout Period 2|Withdrawal by Subject|0|||
148789731|NCT03498313|536708448|FG004|Washout Period 2|Withdrawal by Subject|2|||
148789732|NCT03498313|536708449|FG005|Washout Period 2|Withdrawal by Subject|0|||
148789733|NCT03498313|536708444|FG000|Washout Period 2|Anovulation|0|||
148789734|NCT03498313|536708445|FG001|Washout Period 2|Anovulation|0|||
148789735|NCT03498313|536708446|FG002|Washout Period 2|Anovulation|0|||
148789736|NCT03498313|536708447|FG003|Washout Period 2|Anovulation|0|||
148789737|NCT03498313|536708448|FG004|Washout Period 2|Anovulation|0|||
148789738|NCT03498313|536708449|FG005|Washout Period 2|Anovulation|1|||
148789739|NCT02964338|536708452|FG000|Overall Study|Sponsor terminated study for futility|12|||
148789740|NCT02964338|536708453|FG001|Overall Study|Sponsor terminated study for futility|15|||
148789741|NCT02964338|536708454|FG002|Overall Study|Sponsor terminated study for futility|14|||
148789742|NCT02964338|536708452|FG000|Overall Study|Lack of Efficacy|0|||
148789743|NCT02964338|536708453|FG001|Overall Study|Lack of Efficacy|3|||
148789744|NCT02964338|536708454|FG002|Overall Study|Lack of Efficacy|0|||
148789745|NCT02964338|536708452|FG000|Overall Study|Lost to Follow-up|1|||
148789746|NCT02964338|536708453|FG001|Overall Study|Lost to Follow-up|0|||
148789747|NCT02964338|536708454|FG002|Overall Study|Lost to Follow-up|3|||
148789748|NCT02964338|536708452|FG000|Overall Study|Protocol Violation|0|||
148789749|NCT02964338|536708453|FG001|Overall Study|Protocol Violation|1|||
148789750|NCT02964338|536708454|FG002|Overall Study|Protocol Violation|0|||
148789751|NCT02964338|536708452|FG000|Overall Study|Withdrawal by Subject|1|||
148789752|NCT02964338|536708453|FG001|Overall Study|Withdrawal by Subject|3|||
148789753|NCT02964338|536708454|FG002|Overall Study|Withdrawal by Subject|1|||
148789754|NCT02964338|536708452|FG000|Overall Study|Adverse Event|2|||
148789755|NCT02964338|536708453|FG001|Overall Study|Adverse Event|1|||
148789756|NCT02964338|536708454|FG002|Overall Study|Adverse Event|1|||
148789757|NCT02964338|536708452|FG000|Overall Study|Non-compliant with e-diary|0|||
148789758|NCT02964338|536708453|FG001|Overall Study|Non-compliant with e-diary|1|||
148789759|NCT02964338|536708454|FG002|Overall Study|Non-compliant with e-diary|0|||
148789760|NCT02964338|536708452|FG000|Overall Study|Did not meet criteria|1|||
148789761|NCT02964338|536708453|FG001|Overall Study|Did not meet criteria|0|||
148789762|NCT02964338|536708454|FG002|Overall Study|Did not meet criteria|0|||
148789763|NCT02630563|536708455|FG000|Overall Study|Administrative|1|||
148789764|NCT02239640|536708456|FG000|Overall Study|Withdrawal by Subject|3|||
148789765|NCT02239640|536708456|FG000|Overall Study|Lost to Follow-up|72|||
148789766|NCT02239640|536708456|FG000|Overall Study|Death|142|||
148789767|NCT00929994|536708459|FG000|Overall Study|Withdrawal by Subject|1|||
148789768|NCT00929994|536708459|FG000|Overall Study|medical issue unrelated to intervention|4|||
148789769|NCT00929994|536708459|FG000|Overall Study|employment|1|||
148789770|NCT00621257|536708460|FG000|Overall Study|Lost to Follow-up|4|||
148789771|NCT00621257|536708461|FG001|Overall Study|Lost to Follow-up|0|||
148789772|NCT00621257|536708462|FG002|Overall Study|Lost to Follow-up|2|||
148789773|NCT00621257|536708463|FG003|Overall Study|Lost to Follow-up|4|||
148789774|NCT00621257|536708464|FG004|Overall Study|Lost to Follow-up|7|||
148789775|NCT00621257|536708460|FG000|Overall Study|Adverse Event|0|||
148789776|NCT00621257|536708461|FG001|Overall Study|Adverse Event|1|||
148789777|NCT00621257|536708462|FG002|Overall Study|Adverse Event|1|||
148789778|NCT00621257|536708463|FG003|Overall Study|Adverse Event|0|||
148789779|NCT00621257|536708464|FG004|Overall Study|Adverse Event|0|||
148789780|NCT00621257|536708460|FG000|Overall Study|Physician Decision|0|||
148789781|NCT00621257|536708461|FG001|Overall Study|Physician Decision|2|||
148789782|NCT00621257|536708462|FG002|Overall Study|Physician Decision|0|||
148789783|NCT00621257|536708463|FG003|Overall Study|Physician Decision|1|||
148789784|NCT00621257|536708464|FG004|Overall Study|Physician Decision|1|||
148789785|NCT00621257|536708460|FG000|Overall Study|Withdrawal by Subject|0|||
148789786|NCT00621257|536708461|FG001|Overall Study|Withdrawal by Subject|0|||
148789787|NCT00621257|536708462|FG002|Overall Study|Withdrawal by Subject|0|||
148789788|NCT00621257|536708463|FG003|Overall Study|Withdrawal by Subject|1|||
148789789|NCT00621257|536708464|FG004|Overall Study|Withdrawal by Subject|1|||
148789790|NCT01255904|536708467|FG000|Overall Study|Physician Decision|1|||
148789791|NCT01255904|536708468|FG001|Overall Study|Physician Decision|4|||
148789792|NCT00184002|536708470|FG000|Overall Study|Adverse Event|9|||
148789793|NCT00184002|536708470|FG000|Overall Study|Death|3|||
148789794|NCT00184002|536708470|FG000|Overall Study|Physician Decision|1|||
148789795|NCT00184002|536708470|FG000|Overall Study|Withdrawal by Subject|4|||
148789796|NCT02061813|536708471|FG000|Overall Study|Withdrawal by Subject|1|||
148789797|NCT02061813|536708471|FG000|Overall Study|Protocol Violation|2|||
148789798|NCT01724177|536708474|FG000|Overall Study|Adverse Event|8|||
148789799|NCT01724177|536708474|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
148789800|NCT01724177|536708474|FG000|Overall Study|Nervous participant|1|||
148789801|NCT01724177|536708474|FG000|Overall Study|Serious Adverse Event Related|1|||
148789802|NCT01705080|536708475|FG000|Overall Study|Missed visit|10|||
148789803|NCT01705080|536708476|FG001|Overall Study|Missed visit|4|||
148789804|NCT01705080|536708477|FG002|Overall Study|Missed visit|1|||
148789805|NCT01705080|536708475|FG000|Overall Study|Death|4|||
148789806|NCT01705080|536708476|FG001|Overall Study|Death|4|||
148789807|NCT01705080|536708477|FG002|Overall Study|Death|6|||
148789808|NCT01705080|536708475|FG000|Overall Study|Withdrawal by Subject|61|||
148789809|NCT01705080|536708476|FG001|Overall Study|Withdrawal by Subject|44|||
148789810|NCT01705080|536708477|FG002|Overall Study|Withdrawal by Subject|9|||
148789811|NCT00206427|536708478|FG000|Overall Study|Adverse Event|2|||
148789812|NCT00281697|536708480|FG000|Overall Study|> 60 days since last dose of study drug|4|||
148789813|NCT00281697|536708481|FG001|Overall Study|> 60 days since last dose of study drug|4|||
148789814|NCT00281697|536708480|FG000|Overall Study|Adverse Event|54|||
148789815|NCT00281697|536708481|FG001|Overall Study|Adverse Event|15|||
148789816|NCT00281697|536708480|FG000|Overall Study|Death|8|||
148789817|NCT00281697|536708481|FG001|Overall Study|Death|3|||
148789818|NCT00281697|536708480|FG000|Overall Study|Disease progression|279|||
148789819|NCT00281697|536708481|FG001|Overall Study|Disease progression|149|||
148789820|NCT00281697|536708480|FG000|Overall Study|Other|5|||
148789821|NCT00281697|536708481|FG001|Overall Study|Other|6|||
148789822|NCT00281697|536708480|FG000|Overall Study|Physician's decision to withdraw|15|||
148789823|NCT00281697|536708481|FG001|Overall Study|Physician's decision to withdraw|12|||
148789824|NCT00281697|536708480|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
148789825|NCT00281697|536708481|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
148789826|NCT00281697|536708480|FG000|Overall Study|Did not receive study drug|3|||
148789827|NCT00281697|536708481|FG001|Overall Study|Did not receive study drug|2|||
148789828|NCT02075008|536708494|FG000|Overall Study|Technical problems|1|||
148789829|NCT02075008|536708494|FG000|Overall Study|Pregnancy|1|||
148789830|NCT02075008|536708494|FG000|Overall Study|Physician Decision|1|||
148789831|NCT02075008|536708494|FG000|Overall Study|Lost to Follow-up|1|||
148789832|NCT02075008|536708494|FG000|Overall Study|Lack of Efficacy|1|||
148789833|NCT02075008|536708494|FG000|Overall Study|Death|1|||
148789834|NCT02075008|536708494|FG000|Overall Study|Adverse Event|5|||
148789835|NCT02075008|536708494|FG000|Overall Study|Withdrawal by Subject|6|||
148789836|NCT02075008|536708494|FG000|Overall Study|Study terminated by Sponsor|159|||
148789837|NCT00572455|536708495|FG000|Stage I (14 Days)|Adverse Event|0|||
148789838|NCT00572455|536708496|FG001|Stage I (14 Days)|Adverse Event|0|||
148789839|NCT00572455|536708497|FG002|Stage I (14 Days)|Adverse Event|0|||
148789840|NCT00572455|536708498|FG003|Stage I (14 Days)|Adverse Event|0|||
148789841|NCT00572455|536708499|FG004|Stage I (14 Days)|Adverse Event|0|||
148789842|NCT00572455|536708500|FG005|Stage I (14 Days)|Adverse Event|3|||
148789843|NCT00572455|536708501|FG006|Stage I (14 Days)|Adverse Event|0|||
148789844|NCT00572455|536708502|FG007|Stage I (14 Days)|Adverse Event|0|||
148789845|NCT00572455|536708503|FG008|Stage I (14 Days)|Adverse Event|0|||
148789846|NCT00572455|536708504|FG009|Stage I (14 Days)|Adverse Event|0|||
148789847|NCT00572455|536708505|FG010|Stage I (14 Days)|Adverse Event|0|||
148789848|NCT00572455|536708506|FG011|Stage I (14 Days)|Adverse Event|0|||
148789849|NCT00572455|536708507|FG012|Stage I (14 Days)|Adverse Event|0|||
148789850|NCT00572455|536708508|FG013|Stage I (14 Days)|Adverse Event|0|||
148789851|NCT00572455|536708495|FG000|Stage I (14 Days)|Other|0|||
148789852|NCT00572455|536708496|FG001|Stage I (14 Days)|Other|0|||
148789853|NCT00572455|536708497|FG002|Stage I (14 Days)|Other|0|||
148789854|NCT00572455|536708498|FG003|Stage I (14 Days)|Other|0|||
148789855|NCT00572455|536708499|FG004|Stage I (14 Days)|Other|1|||
148789856|NCT00572455|536708500|FG005|Stage I (14 Days)|Other|0|||
148789857|NCT00572455|536708501|FG006|Stage I (14 Days)|Other|0|||
148789858|NCT00572455|536708502|FG007|Stage I (14 Days)|Other|0|||
148789859|NCT00572455|536708503|FG008|Stage I (14 Days)|Other|0|||
148789860|NCT00572455|536708504|FG009|Stage I (14 Days)|Other|0|||
148789861|NCT00572455|536708505|FG010|Stage I (14 Days)|Other|0|||
148789862|NCT00572455|536708506|FG011|Stage I (14 Days)|Other|0|||
148789863|NCT00572455|536708507|FG012|Stage I (14 Days)|Other|0|||
148789864|NCT00572455|536708508|FG013|Stage I (14 Days)|Other|0|||
148789865|NCT00572455|536708495|FG000|Stage II (28 Days)|Adverse Event|0|||
148789866|NCT00572455|536708496|FG001|Stage II (28 Days)|Adverse Event|0|||
148789867|NCT00572455|536708497|FG002|Stage II (28 Days)|Adverse Event|0|||
148789868|NCT00572455|536708498|FG003|Stage II (28 Days)|Adverse Event|0|||
148789869|NCT00572455|536708499|FG004|Stage II (28 Days)|Adverse Event|0|||
148789870|NCT00572455|536708500|FG005|Stage II (28 Days)|Adverse Event|0|||
148789871|NCT00572455|536708501|FG006|Stage II (28 Days)|Adverse Event|0|||
148789872|NCT00572455|536708502|FG007|Stage II (28 Days)|Adverse Event|0|||
148789873|NCT00572455|536708503|FG008|Stage II (28 Days)|Adverse Event|1|||
148789874|NCT00572455|536708504|FG009|Stage II (28 Days)|Adverse Event|3|||
148789875|NCT00572455|536708505|FG010|Stage II (28 Days)|Adverse Event|3|||
148789876|NCT00572455|536708506|FG011|Stage II (28 Days)|Adverse Event|4|||
148789877|NCT00572455|536708507|FG012|Stage II (28 Days)|Adverse Event|5|||
148789878|NCT00572455|536708508|FG013|Stage II (28 Days)|Adverse Event|1|||
148789879|NCT00572455|536708495|FG000|Stage II (28 Days)|Death|0|||
148789880|NCT00572455|536708496|FG001|Stage II (28 Days)|Death|0|||
148789881|NCT00572455|536708497|FG002|Stage II (28 Days)|Death|0|||
148789882|NCT00572455|536708498|FG003|Stage II (28 Days)|Death|0|||
148789883|NCT00572455|536708499|FG004|Stage II (28 Days)|Death|0|||
148789884|NCT00572455|536708500|FG005|Stage II (28 Days)|Death|0|||
148789885|NCT00572455|536708501|FG006|Stage II (28 Days)|Death|0|||
148789886|NCT00572455|536708502|FG007|Stage II (28 Days)|Death|0|||
148789887|NCT00572455|536708503|FG008|Stage II (28 Days)|Death|1|||
148789888|NCT00572455|536708504|FG009|Stage II (28 Days)|Death|0|||
148789889|NCT00572455|536708505|FG010|Stage II (28 Days)|Death|0|||
148789890|NCT00572455|536708506|FG011|Stage II (28 Days)|Death|0|||
148789891|NCT00572455|536708507|FG012|Stage II (28 Days)|Death|0|||
148789892|NCT00572455|536708508|FG013|Stage II (28 Days)|Death|0|||
148789893|NCT00572455|536708495|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
148789894|NCT00572455|536708496|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
148789895|NCT00572455|536708497|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
148789896|NCT00572455|536708498|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
148789897|NCT00572455|536708499|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
148789898|NCT00572455|536708500|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
148789899|NCT00572455|536708501|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
148789900|NCT00572455|536708502|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
148789901|NCT00572455|536708503|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
148789902|NCT00572455|536708504|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
148789903|NCT00572455|536708505|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
148789904|NCT00572455|536708506|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
148789905|NCT00572455|536708507|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
148789906|NCT00572455|536708508|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
148789907|NCT00572455|536708495|FG000|Stage II (28 Days)|Other|0|||
148789908|NCT00572455|536708496|FG001|Stage II (28 Days)|Other|0|||
148789909|NCT00572455|536708497|FG002|Stage II (28 Days)|Other|0|||
148789910|NCT00572455|536708498|FG003|Stage II (28 Days)|Other|0|||
148789911|NCT00572455|536708499|FG004|Stage II (28 Days)|Other|0|||
148789912|NCT00572455|536708500|FG005|Stage II (28 Days)|Other|0|||
148789913|NCT00572455|536708501|FG006|Stage II (28 Days)|Other|0|||
148789914|NCT00572455|536708502|FG007|Stage II (28 Days)|Other|0|||
148789915|NCT00572455|536708503|FG008|Stage II (28 Days)|Other|1|||
148789916|NCT00572455|536708504|FG009|Stage II (28 Days)|Other|0|||
148789917|NCT00572455|536708505|FG010|Stage II (28 Days)|Other|0|||
148789918|NCT00572455|536708506|FG011|Stage II (28 Days)|Other|0|||
148789919|NCT00572455|536708507|FG012|Stage II (28 Days)|Other|0|||
148789920|NCT00572455|536708508|FG013|Stage II (28 Days)|Other|0|||
148789921|NCT00572455|536708495|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
148789922|NCT00572455|536708496|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
148789923|NCT00572455|536708497|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
148789924|NCT00572455|536708498|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
148789925|NCT00572455|536708499|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
148893409|NCT01693029|537088700|FG000|Overall Study|Death|5|||
148789926|NCT00572455|536708500|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
148789927|NCT00572455|536708501|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
148789928|NCT00572455|536708502|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
148789929|NCT00572455|536708503|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
148789930|NCT00572455|536708504|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
148789931|NCT00572455|536708505|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
148789932|NCT00572455|536708506|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
148789933|NCT00572455|536708507|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
148789934|NCT00572455|536708508|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
148789935|NCT04446429|536708509|FG000|Overall Study|Lost to Follow-up|6|||
148789936|NCT04446429|536708510|FG001|Overall Study|Lost to Follow-up|0|||
148789937|NCT05205005|536708511|FG000|Overall Study|Withdrawal by Subject|1|||
148789938|NCT05205005|536708512|FG001|Overall Study|Withdrawal by Subject|0|||
148789939|NCT05205005|536708511|FG000|Overall Study|Adverse Event|1|||
148789940|NCT05205005|536708512|FG001|Overall Study|Adverse Event|0|||
148789941|NCT02821416|536708515|FG000|Overall Study|Adverse Event|0|||
148789942|NCT02821416|536708516|FG001|Overall Study|Adverse Event|1|||
148789943|NCT02821416|536708515|FG000|Overall Study|Withdrawal by Subject|2|||
148789944|NCT02821416|536708516|FG001|Overall Study|Withdrawal by Subject|0|||
148789945|NCT02821416|536708515|FG000|Overall Study|Lost to Follow-up|1|||
148789946|NCT02821416|536708516|FG001|Overall Study|Lost to Follow-up|0|||
148789947|NCT00694356|536708518|FG000|Overall Study|Adverse Event|1|||
148789948|NCT00694356|536708519|FG001|Overall Study|Adverse Event|0|||
148789949|NCT00694356|536708520|FG002|Overall Study|Adverse Event|0|||
148789950|NCT00694356|536708518|FG000|Overall Study|Progressive Disease|2|||
148789951|NCT00694356|536708519|FG001|Overall Study|Progressive Disease|6|||
148789952|NCT00694356|536708520|FG002|Overall Study|Progressive Disease|6|||
148789953|NCT02256917|536708521|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
148789954|NCT02256917|536708521|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
148789955|NCT02256917|536708521|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
148789956|NCT02256917|536708521|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
148789957|NCT02256917|536708521|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
148789958|NCT01308463|536708525|FG000|Overall Study|Study Discontinued|23|||
148789959|NCT01308463|536708525|FG000|Overall Study|Death|4|||
148789960|NCT01308463|536708525|FG000|Overall Study|Revision|2|||
148789961|NCT01042392|536708526|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
148789962|NCT01042392|536708527|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
148789963|NCT01042392|536708528|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
148789964|NCT01042392|536708529|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
148789965|NCT01042392|536708526|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
148789966|NCT01042392|536708527|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
148789967|NCT01042392|536708528|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
148789968|NCT01042392|536708529|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
148789969|NCT01042392|536708526|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
148789970|NCT01042392|536708527|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
148789971|NCT01042392|536708528|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
148789972|NCT01042392|536708529|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
148789973|NCT01042392|536708526|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
148789974|NCT01042392|536708527|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
148789975|NCT01042392|536708528|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
148789976|NCT01042392|536708529|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
148789977|NCT01042392|536708526|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
148789978|NCT01042392|536708527|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
148789979|NCT01042392|536708528|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
148789980|NCT01042392|536708529|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
148789981|NCT01042392|536708526|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
148789982|NCT01042392|536708527|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
148789983|NCT01042392|536708528|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
148789984|NCT01042392|536708529|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
148789985|NCT01042392|536708526|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
148789986|NCT01042392|536708527|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
148789987|NCT01042392|536708528|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
148789988|NCT01042392|536708529|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
148789989|NCT01042392|536708526|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
148789990|NCT01042392|536708527|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
148789991|NCT01042392|536708528|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
148789992|NCT01042392|536708529|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
148789993|NCT01042392|536708526|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
149129716|NCT00261846|537954544|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129717|NCT00261846|537954545|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129718|NCT00261846|537954546|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
149129719|NCT00261846|537954535|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
149129720|NCT00261846|537954536|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
149129721|NCT00261846|537954537|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
149129722|NCT00261846|537954538|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
149129723|NCT00261846|537954539|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
149129724|NCT00261846|537954540|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
149129725|NCT00261846|537954541|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
148789994|NCT01042392|536708527|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
149129726|NCT00261846|537954542|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
149129727|NCT00261846|537954543|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
149129728|NCT00261846|537954544|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
149129729|NCT00261846|537954545|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
149129730|NCT00261846|537954546|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
149129731|NCT00261846|537954535|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
149129732|NCT00261846|537954536|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
149129733|NCT00261846|537954537|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
149129734|NCT00261846|537954538|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
149129735|NCT00261846|537954539|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
149129736|NCT00261846|537954540|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
149129737|NCT00261846|537954541|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
149129738|NCT00261846|537954542|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
149129739|NCT00261846|537954543|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
149129740|NCT00261846|537954544|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
149129741|NCT00261846|537954545|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
149129742|NCT00261846|537954546|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
149129743|NCT00261846|537954535|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
149129744|NCT00261846|537954536|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
149129745|NCT00261846|537954537|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
149129746|NCT00261846|537954538|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
149129747|NCT00261846|537954539|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
149129748|NCT00261846|537954540|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
149129749|NCT00261846|537954541|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
149129750|NCT00261846|537954542|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
149129751|NCT00261846|537954543|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
149129752|NCT00261846|537954544|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
149129753|NCT00261846|537954545|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
149129754|NCT00261846|537954546|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
149129755|NCT00261846|537954535|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
149129756|NCT00261846|537954536|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
149129757|NCT00261846|537954537|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
149129758|NCT00261846|537954538|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
149129759|NCT00261846|537954539|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
149129760|NCT00261846|537954540|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
149129761|NCT00261846|537954541|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
149129762|NCT00261846|537954542|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
149129763|NCT00261846|537954543|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
149129764|NCT00261846|537954544|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
149129765|NCT00261846|537954545|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
149129766|NCT00261846|537954546|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
149129767|NCT00261846|537954535|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
149129768|NCT00261846|537954536|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
149129769|NCT00261846|537954537|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
148789995|NCT01042392|536708528|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
148789996|NCT01042392|536708529|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
148789997|NCT03117361|536708530|FG000|Overall Study|Progressive disease|5|||
148789998|NCT03117361|536708530|FG000|Overall Study|Death|1|||
148789999|NCT03117361|536708530|FG000|Overall Study|Physician Decision|2|||
148790000|NCT03117361|536708530|FG000|Overall Study|On study treatment at the end of study|1|||
148790001|NCT03117361|536708530|FG000|Overall Study|Treatment-related adverse event|1|||
148790002|NCT00587795|536708531|FG000|Overall Study|Withdrawal by Subject|1|||
148790003|NCT00587795|536708532|FG001|Overall Study|Withdrawal by Subject|0|||
148790004|NCT00540644|536708533|FG000|Overall Study|Adverse Event|3|||
148790005|NCT00540644|536708534|FG001|Overall Study|Adverse Event|1|||
149129770|NCT00261846|537954538|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
149129771|NCT00261846|537954539|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
149129772|NCT00261846|537954540|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
149129773|NCT00261846|537954541|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
149129774|NCT00261846|537954542|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
149129775|NCT00261846|537954543|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
149129776|NCT00261846|537954544|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
148790006|NCT00540644|536708533|FG000|Overall Study|Disease Progression|3|||
148790007|NCT00540644|536708534|FG001|Overall Study|Disease Progression|1|||
148790008|NCT00540644|536708533|FG000|Overall Study|Physician Decision|0|||
148790009|NCT00540644|536708534|FG001|Overall Study|Physician Decision|5|||
148790010|NCT00540644|536708533|FG000|Overall Study|Withdrawal by Subject|2|||
148790011|NCT00540644|536708534|FG001|Overall Study|Withdrawal by Subject|2|||
148790012|NCT00540644|536708533|FG000|Overall Study|Noncomplilance|1|||
148790013|NCT00540644|536708534|FG001|Overall Study|Noncomplilance|0|||
148790014|NCT01869777|536708535|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
148790015|NCT00943592|536708536|FG000|Overall Study|Death|3|||
148790016|NCT02072941|536708537|FG000|Overall Study|Withdrawal by Subject|29|||
148790017|NCT02072941|536708538|FG001|Overall Study|Withdrawal by Subject|21|||
148790018|NCT02072941|536708537|FG000|Overall Study|Lost to Follow-up|4|||
148790019|NCT02072941|536708538|FG001|Overall Study|Lost to Follow-up|4|||
148790020|NCT02072941|536708537|FG000|Overall Study|Death|3|||
148790021|NCT02072941|536708538|FG001|Overall Study|Death|2|||
148790022|NCT02072941|536708537|FG000|Overall Study|Removed by Study Staff|2|||
148790023|NCT02072941|536708538|FG001|Overall Study|Removed by Study Staff|2|||
148790024|NCT02438280|536708541|FG000|Overall Study|Physician Decision|1|||
148790025|NCT02438280|536708542|FG001|Overall Study|Physician Decision|0|||
148790026|NCT02982863|536708543|FG000|Overall Study|Not eligible patients|809|||
148790027|NCT02982863|536708544|FG001|Overall Study|Not eligible patients|4261|||
148790028|NCT02982863|536708545|FG002|Overall Study|Not eligible patients|1852|||
148790029|NCT02982863|536708546|FG003|Overall Study|Not eligible patients|1400|||
148790030|NCT02982863|536708547|FG004|Overall Study|Not eligible patients|492|||
148790031|NCT02457195|536708548|FG000|Overall Study|Adverse Event|3|||
148790032|NCT02457195|536708548|FG000|Overall Study|Protocol Violation|2|||
148790033|NCT02457195|536708548|FG000|Overall Study|Withdrawal by Subject|4|||
148790034|NCT04819438|536708550|FG000|Overall Study|Withdrawal by Subject|1|||
148790035|NCT04819438|536708551|FG001|Overall Study|Withdrawal by Subject|0|||
148790036|NCT04819438|536708550|FG000|Overall Study|Adverse Event|0|||
148790037|NCT04819438|536708551|FG001|Overall Study|Adverse Event|1|||
148790038|NCT04819438|536708550|FG000|Overall Study|Protocol Violation|0|||
148790039|NCT04819438|536708551|FG001|Overall Study|Protocol Violation|1|||
148790040|NCT05359952|536708552|FG000|Overall Study|Lost to Follow-up|1|||
148790041|NCT05359952|536708553|FG001|Overall Study|Lost to Follow-up|0|||
148790042|NCT05980013|536708554|FG000|Overall Study|Withdrawal by Subject|0|||
148790043|NCT05980013|536708555|FG001|Overall Study|Withdrawal by Subject|1|||
148790044|NCT05980013|536708554|FG000|Overall Study|Device Error|0|||
148790045|NCT05980013|536708555|FG001|Overall Study|Device Error|1|||
148790046|NCT02869893|536708556|FG000|Overall Study|participant aversion to IV|5|||
148790047|NCT02869893|536708556|FG000|Overall Study|participant fear of MRI scanner|2|||
148790048|NCT03066778|536708557|FG000|Overall Study|Death|195|||
148790049|NCT03066778|536708558|FG001|Overall Study|Death|205|||
148790050|NCT03066778|536708557|FG000|Overall Study|Withdrawal by Subject|5|||
148790051|NCT03066778|536708558|FG001|Overall Study|Withdrawal by Subject|7|||
148790052|NCT00705341|536708559|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
148790053|NCT00705341|536708560|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
148790054|NCT00705341|536708561|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
148790055|NCT00705341|536708562|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
148790056|NCT00705341|536708559|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
148790057|NCT00705341|536708560|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
148790058|NCT00705341|536708561|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
148790059|NCT00705341|536708562|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
148790060|NCT03665077|536708565|FG000|Overall Study|Lost to Follow-up|2|||
148790061|NCT03665077|536708565|FG000|Overall Study|Physician Decision|2|||
148790062|NCT00435461|536708566|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
148790063|NCT00435461|536708567|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
148790064|NCT00435461|536708568|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
148790065|NCT00435461|536708566|FG000|Overall Study|Protocol Violation|6|||
148790066|NCT00435461|536708567|FG001|Overall Study|Protocol Violation|9|||
148790067|NCT00435461|536708568|FG002|Overall Study|Protocol Violation|10|||
148790068|NCT00435461|536708566|FG000|Overall Study|Participant randomized(inadequate score)|1|||
148790069|NCT00435461|536708567|FG001|Overall Study|Participant randomized(inadequate score)|0|||
148790070|NCT00435461|536708568|FG002|Overall Study|Participant randomized(inadequate score)|0|||
149011397|NCT04186403|537521467|FG001|Overall Study|Adverse Event|8|||
148790071|NCT00435461|536708566|FG000|Overall Study|Compliance less than 80 percent|1|||
148790072|NCT00435461|536708567|FG001|Overall Study|Compliance less than 80 percent|0|||
148790073|NCT00435461|536708568|FG002|Overall Study|Compliance less than 80 percent|0|||
148790074|NCT00435461|536708566|FG000|Overall Study|In error, two study medications switched|1|||
148790075|NCT00435461|536708567|FG001|Overall Study|In error, two study medications switched|0|||
148790076|NCT00435461|536708568|FG002|Overall Study|In error, two study medications switched|0|||
148790077|NCT00435461|536708566|FG000|Overall Study|Lack of Efficacy|2|||
148790078|NCT00435461|536708567|FG001|Overall Study|Lack of Efficacy|1|||
148790079|NCT00435461|536708568|FG002|Overall Study|Lack of Efficacy|0|||
148790080|NCT00435461|536708566|FG000|Overall Study|Withdrawal by Subject|1|||
148790081|NCT00435461|536708567|FG001|Overall Study|Withdrawal by Subject|0|||
148790082|NCT00435461|536708568|FG002|Overall Study|Withdrawal by Subject|2|||
148790083|NCT00435461|536708566|FG000|Overall Study|Randomized in error|1|||
148790084|NCT00435461|536708567|FG001|Overall Study|Randomized in error|0|||
148790085|NCT00435461|536708568|FG002|Overall Study|Randomized in error|0|||
148790086|NCT00435461|536708566|FG000|Overall Study|Participant could not tolerate symptoms|0|||
148790087|NCT00435461|536708567|FG001|Overall Study|Participant could not tolerate symptoms|0|||
148790088|NCT00435461|536708568|FG002|Overall Study|Participant could not tolerate symptoms|1|||
149129777|NCT00261846|537954545|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
149129778|NCT00261846|537954546|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
149129779|NCT00928447|537954554|FG000|Overall Study|Withdrawal by Subject|1|||
149129780|NCT00928447|537954554|FG000|Overall Study|Investigator's decision|1|||
149129781|NCT01259284|537954555|FG000|Overall Study|Study Termination|2|||
149129782|NCT01259284|537954556|FG001|Overall Study|Study Termination|0|||
149129783|NCT01259284|537954557|FG002|Overall Study|Study Termination|0|||
149129784|NCT00307125|537954561|FG000|Screening Phase|Adverse Event|1|||
149129785|NCT00307125|537954562|FG001|Screening Phase|Adverse Event|0|||
149129786|NCT00307125|537954563|FG002|Screening Phase|Adverse Event|0|||
149129787|NCT00307125|537954561|FG000|Screening Phase|Protocol Violation|27|||
149129788|NCT00307125|537954562|FG001|Screening Phase|Protocol Violation|0|||
149129789|NCT00307125|537954563|FG002|Screening Phase|Protocol Violation|0|||
149129790|NCT00307125|537954561|FG000|Screening Phase|Lost to Follow-up|87|||
149129791|NCT00307125|537954562|FG001|Screening Phase|Lost to Follow-up|0|||
149129792|NCT00307125|537954563|FG002|Screening Phase|Lost to Follow-up|0|||
149129793|NCT00307125|537954561|FG000|Screening Phase|Death|10|||
149129794|NCT00307125|537954562|FG001|Screening Phase|Death|0|||
149129795|NCT00307125|537954563|FG002|Screening Phase|Death|0|||
149129796|NCT00307125|537954561|FG000|Screening Phase|Withdrawal by Subject|77|||
149129797|NCT00307125|537954562|FG001|Screening Phase|Withdrawal by Subject|0|||
149129798|NCT00307125|537954563|FG002|Screening Phase|Withdrawal by Subject|0|||
149129799|NCT00307125|537954561|FG000|Screening Phase|Physician Decision|26|||
149129800|NCT00307125|537954562|FG001|Screening Phase|Physician Decision|0|||
149129801|NCT00307125|537954563|FG002|Screening Phase|Physician Decision|0|||
149129802|NCT00307125|537954561|FG000|Screening Phase|Sponsor Decision|4|||
149129803|NCT00307125|537954562|FG001|Screening Phase|Sponsor Decision|0|||
149129804|NCT00307125|537954563|FG002|Screening Phase|Sponsor Decision|0|||
149129805|NCT00307125|537954561|FG000|Screening Phase|Study Terminated|17|||
149129806|NCT00307125|537954562|FG001|Screening Phase|Study Terminated|0|||
149129807|NCT00307125|537954563|FG002|Screening Phase|Study Terminated|0|||
149129808|NCT00307125|537954561|FG000|Screening Phase|Graft Loss|3|||
149129809|NCT00307125|537954562|FG001|Screening Phase|Graft Loss|0|||
149129810|NCT00307125|537954563|FG002|Screening Phase|Graft Loss|0|||
149129811|NCT00307125|537954561|FG000|Screening Phase|Graft Failure|8|||
149129812|NCT00307125|537954562|FG001|Screening Phase|Graft Failure|0|||
149129813|NCT00307125|537954563|FG002|Screening Phase|Graft Failure|0|||
149129814|NCT00307125|537954561|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
149129815|NCT00307125|537954562|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
149129816|NCT00307125|537954563|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
149129817|NCT00307125|537954561|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
149129818|NCT00307125|537954562|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
149129819|NCT00307125|537954563|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
148790089|NCT00435461|536708566|FG000|Overall Study|Participant could not swallow capsule|0|||
148790090|NCT00435461|536708567|FG001|Overall Study|Participant could not swallow capsule|0|||
148790091|NCT00435461|536708568|FG002|Overall Study|Participant could not swallow capsule|1|||
148790092|NCT00435461|536708566|FG000|Overall Study|Pregnancy|2|||
148790093|NCT00435461|536708567|FG001|Overall Study|Pregnancy|0|||
148790094|NCT00435461|536708568|FG002|Overall Study|Pregnancy|0|||
149129820|NCT00307125|537954561|FG000|Screening Phase|Moved or transferred facilities|34|||
149129821|NCT00307125|537954562|FG001|Screening Phase|Moved or transferred facilities|0|||
149129822|NCT00307125|537954563|FG002|Screening Phase|Moved or transferred facilities|0|||
149129823|NCT00307125|537954561|FG000|Screening Phase|Received Pancreas Transplant|8|||
149129824|NCT00307125|537954562|FG001|Screening Phase|Received Pancreas Transplant|0|||
149129825|NCT00307125|537954563|FG002|Screening Phase|Received Pancreas Transplant|0|||
149129826|NCT00307125|537954561|FG000|Screening Phase|Ineligible for pilot|4|||
149129827|NCT00307125|537954562|FG001|Screening Phase|Ineligible for pilot|0|||
149129828|NCT00307125|537954563|FG002|Screening Phase|Ineligible for pilot|0|||
149129829|NCT00307125|537954561|FG000|Screening Phase|Try to get pregnant|1|||
149129830|NCT00307125|537954562|FG001|Screening Phase|Try to get pregnant|0|||
149129831|NCT00307125|537954563|FG002|Screening Phase|Try to get pregnant|0|||
149129832|NCT00307125|537954561|FG000|Screening Phase|Developed acute leukemia|1|||
149129833|NCT00307125|537954562|FG001|Screening Phase|Developed acute leukemia|0|||
148790095|NCT00435461|536708566|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
148790096|NCT00435461|536708567|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
148790097|NCT00435461|536708568|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
148790098|NCT00435461|536708566|FG000|Overall Study|Participant ended study one day early|1|||
148790099|NCT00435461|536708567|FG001|Overall Study|Participant ended study one day early|0|||
148790100|NCT00435461|536708568|FG002|Overall Study|Participant ended study one day early|0|||
148790101|NCT00435461|536708566|FG000|Overall Study|Noncompliance with study requirements|1|||
148790102|NCT00435461|536708567|FG001|Overall Study|Noncompliance with study requirements|1|||
148790103|NCT00435461|536708568|FG002|Overall Study|Noncompliance with study requirements|1|||
148790104|NCT00435461|536708566|FG000|Overall Study|Adverse Event|1|||
148790105|NCT00435461|536708567|FG001|Overall Study|Adverse Event|2|||
148790106|NCT00435461|536708568|FG002|Overall Study|Adverse Event|6|||
148790107|NCT00435461|536708566|FG000|Overall Study|Non-Compliance of diary|2|||
148790108|NCT00435461|536708567|FG001|Overall Study|Non-Compliance of diary|0|||
148790109|NCT00435461|536708568|FG002|Overall Study|Non-Compliance of diary|1|||
148790110|NCT00435461|536708566|FG000|Overall Study|Lost to Follow-up|1|||
148790111|NCT00435461|536708567|FG001|Overall Study|Lost to Follow-up|1|||
148790112|NCT00435461|536708568|FG002|Overall Study|Lost to Follow-up|2|||
148790113|NCT01768559|536708573|FG000|Overall Study|Randomized but not treated|0|||
148790114|NCT01768559|536708574|FG001|Overall Study|Randomized but not treated|0|||
148790115|NCT01768559|536708575|FG002|Overall Study|Randomized but not treated|1|||
148790116|NCT01768559|536708573|FG000|Overall Study|Adverse Event|15|||
148790117|NCT01768559|536708574|FG001|Overall Study|Adverse Event|2|||
148790118|NCT01768559|536708575|FG002|Overall Study|Adverse Event|5|||
148790119|NCT01768559|536708573|FG000|Overall Study|Lack of Efficacy|6|||
148790120|NCT01768559|536708574|FG001|Overall Study|Lack of Efficacy|4|||
148790121|NCT01768559|536708575|FG002|Overall Study|Lack of Efficacy|0|||
148790122|NCT01768559|536708573|FG000|Overall Study|Poor compliance to protocol|0|||
148790123|NCT01768559|536708574|FG001|Overall Study|Poor compliance to protocol|3|||
148790124|NCT01768559|536708575|FG002|Overall Study|Poor compliance to protocol|2|||
148790125|NCT01768559|536708573|FG000|Overall Study|Other than specified|9|||
148790126|NCT01768559|536708574|FG001|Overall Study|Other than specified|8|||
148790127|NCT01768559|536708575|FG002|Overall Study|Other than specified|5|||
148790128|NCT02383355|536708576|FG000|Overall Study|Adverse Event|2|||
148790129|NCT02383355|536708577|FG001|Overall Study|Adverse Event|0|||
148790130|NCT03681184|536708579|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
148790131|NCT03681184|536708580|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
148790132|NCT02787083|536708581|FG000|Overall Study|Adverse Event|1|||
148790133|NCT02787083|536708582|FG001|Overall Study|Adverse Event|0|||
148790134|NCT02787083|536708581|FG000|Overall Study|Withdrawal by Subject|2|||
148790135|NCT02787083|536708582|FG001|Overall Study|Withdrawal by Subject|2|||
148790136|NCT03162328|536708583|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
148790137|NCT03162328|536708584|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
148790138|NCT03162328|536708585|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
148790139|NCT03162328|536708583|FG000|Screening Period|Withdrawal by Subject|1|||
148790140|NCT03162328|536708584|FG001|Screening Period|Withdrawal by Subject|0|||
148790141|NCT03162328|536708585|FG002|Screening Period|Withdrawal by Subject|0|||
148790142|NCT03162328|536708583|FG000|Study Period|Withdrawal by Subject|0|||
148790143|NCT03162328|536708584|FG001|Study Period|Withdrawal by Subject|0|||
148790144|NCT03162328|536708585|FG002|Study Period|Withdrawal by Subject|1|||
148790145|NCT02576977|536710701|FG000|Overall Study|Adverse Event|13|||
148790146|NCT02576977|536710702|FG001|Overall Study|Adverse Event|2|||
148790147|NCT02576977|536710701|FG000|Overall Study|Death|73|||
148790148|NCT02576977|536710702|FG001|Overall Study|Death|60|||
148790149|NCT02576977|536710701|FG000|Overall Study|Screen failure|1|||
148790150|NCT02576977|536710702|FG001|Overall Study|Screen failure|0|||
148790151|NCT02576977|536710701|FG000|Overall Study|Study Terminated at Selected Sites|27|||
148790152|NCT02576977|536710702|FG001|Overall Study|Study Terminated at Selected Sites|50|||
148790153|NCT02576977|536710701|FG000|Overall Study|Withdrawal by Subject|11|||
148790154|NCT02576977|536710702|FG001|Overall Study|Withdrawal by Subject|11|||
148790155|NCT02576977|536710701|FG000|Overall Study|Final Disposition Unknown|0|||
148790156|NCT02576977|536710702|FG001|Overall Study|Final Disposition Unknown|1|||
148790157|NCT02576977|536710701|FG000|Overall Study|Lost to Follow-up|1|||
148790158|NCT02576977|536710702|FG001|Overall Study|Lost to Follow-up|0|||
149129834|NCT00307125|537954563|FG002|Screening Phase|Developed acute leukemia|0|||
149129835|NCT00307125|537954561|FG000|Screening Phase|Metastatic colon cancer|1|||
148790159|NCT02576977|536710701|FG000|Overall Study|Progressive Disease|0|||
148790160|NCT02576977|536710702|FG001|Overall Study|Progressive Disease|1|||
148790161|NCT02823470|536710709|FG000|Overall Study|Adverse Event|1|||
148790162|NCT02823470|536710710|FG001|Overall Study|Adverse Event|0|||
148790163|NCT02823470|536710709|FG000|Overall Study|Study terminated by sponsor|8|||
148790164|NCT02823470|536710710|FG001|Overall Study|Study terminated by sponsor|15|||
148790165|NCT01073163|536710712|FG000|Overall Study|Adverse Event|1|||
148790166|NCT01073163|536710712|FG000|Overall Study|Disease Progression|1|||
148790167|NCT01073163|536710712|FG000|Overall Study|Early termination|1|||
148790168|NCT00703677|536710713|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
148790169|NCT04441788|536710714|FG000|Overall Study|Voluntary Withdrawl|0|||
148790170|NCT04441788|536710715|FG001|Overall Study|Voluntary Withdrawl|1|||
148790171|NCT04441788|536710716|FG002|Overall Study|Voluntary Withdrawl|0|||
148790172|NCT04441788|536710714|FG000|Overall Study|Ineligibility|1|||
148790173|NCT04441788|536710715|FG001|Overall Study|Ineligibility|0|||
148790174|NCT04441788|536710716|FG002|Overall Study|Ineligibility|0|||
148790175|NCT04441788|536710714|FG000|Overall Study|Adverse Event|0|||
148790176|NCT04441788|536710715|FG001|Overall Study|Adverse Event|0|||
148790177|NCT04441788|536710716|FG002|Overall Study|Adverse Event|4|||
148790178|NCT04441788|536710714|FG000|Overall Study|Study Terminated by Sponsor|16|||
148790179|NCT04441788|536710715|FG001|Overall Study|Study Terminated by Sponsor|16|||
148790180|NCT04441788|536710716|FG002|Overall Study|Study Terminated by Sponsor|12|||
148790181|NCT03859648|536710723|FG000|Overall Study|Lost to Follow-up|1|||
148790182|NCT03859648|536710723|FG000|Overall Study|Adverse Event|1|||
148790183|NCT02315664|536710724|FG000|Overall Study|Lost to Follow-up|1|||
148790184|NCT02315664|536710725|FG001|Overall Study|Lost to Follow-up|1|||
148790185|NCT02315664|536710724|FG000|Overall Study|Withdrawal by Subject|0|||
148790186|NCT02315664|536710725|FG001|Overall Study|Withdrawal by Subject|3|||
148790187|NCT01677182|536710726|FG000|Overall Study|Adverse Event|2|||
148790188|NCT01677182|536710727|FG001|Overall Study|Adverse Event|1|||
148790189|NCT01677182|536710728|FG002|Overall Study|Adverse Event|8|||
148790190|NCT01677182|536710726|FG000|Overall Study|Protocol Violation|5|||
148790191|NCT01677182|536710727|FG001|Overall Study|Protocol Violation|1|||
148790192|NCT01677182|536710728|FG002|Overall Study|Protocol Violation|4|||
148790193|NCT01677182|536710726|FG000|Overall Study|Lost to Follow-up|4|||
148790194|NCT01677182|536710727|FG001|Overall Study|Lost to Follow-up|0|||
148790195|NCT01677182|536710728|FG002|Overall Study|Lost to Follow-up|3|||
148790196|NCT01677182|536710726|FG000|Overall Study|Withdrawal by Subject|7|||
148790197|NCT01677182|536710727|FG001|Overall Study|Withdrawal by Subject|12|||
148790198|NCT01677182|536710728|FG002|Overall Study|Withdrawal by Subject|10|||
148790199|NCT01677182|536710726|FG000|Overall Study|Study termination|12|||
148790200|NCT01677182|536710727|FG001|Overall Study|Study termination|9|||
148790201|NCT01677182|536710728|FG002|Overall Study|Study termination|11|||
148790202|NCT01677182|536710726|FG000|Overall Study|Lack of Efficacy|3|||
148790203|NCT01677182|536710727|FG001|Overall Study|Lack of Efficacy|0|||
148790204|NCT01677182|536710728|FG002|Overall Study|Lack of Efficacy|1|||
148790205|NCT01677182|536710726|FG000|Overall Study|Other reasons|1|||
148790206|NCT01677182|536710727|FG001|Overall Study|Other reasons|5|||
148790207|NCT01677182|536710728|FG002|Overall Study|Other reasons|2|||
148790208|NCT02501161|536710731|FG000|Overall Study|Adverse Event|2|||
148790209|NCT02501161|536710732|FG001|Overall Study|Adverse Event|6|||
148790210|NCT02501161|536710731|FG000|Overall Study|Lost to Follow-up|7|||
148790211|NCT02501161|536710732|FG001|Overall Study|Lost to Follow-up|4|||
148790212|NCT02501161|536710731|FG000|Overall Study|Withdrawal by Subject|10|||
148790213|NCT02501161|536710732|FG001|Overall Study|Withdrawal by Subject|15|||
148790214|NCT02501161|536710731|FG000|Overall Study|Other|3|||
148790215|NCT02501161|536710732|FG001|Overall Study|Other|0|||
148790216|NCT00667992|536710735|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
148790217|NCT00667992|536710736|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
148790218|NCT00667992|536710735|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
148790219|NCT00667992|536710736|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
148790220|NCT00667992|536710735|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
148790221|NCT00667992|536710736|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
148790222|NCT00667992|536710735|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
148790223|NCT00667992|536710736|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
148790224|NCT00667992|536710735|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
148790225|NCT00667992|536710736|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
148790226|NCT00667992|536710735|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
148790227|NCT00667992|536710736|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
148790228|NCT00667992|536710735|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
148790229|NCT00667992|536710736|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
148790230|NCT00667992|536710735|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
148790231|NCT00667992|536710736|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
148790232|NCT00667992|536710735|FG000|Wash-out|Not within one doubling dilution|4|||
148790233|NCT00667992|536710736|FG001|Wash-out|Not within one doubling dilution|3|||
148790234|NCT00667992|536710735|FG000|Wash-out|Failure to wash-out|2|||
148790235|NCT00667992|536710736|FG001|Wash-out|Failure to wash-out|2|||
148790236|NCT00667992|536710735|FG000|Wash-out|Withdrawal by Subject|1|||
148790237|NCT00667992|536710736|FG001|Wash-out|Withdrawal by Subject|0|||
148790238|NCT00667992|536710735|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
148790239|NCT00667992|536710736|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
148790240|NCT00667992|536710735|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
148790241|NCT00667992|536710736|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
148790242|NCT00762762|536710737|FG000|Overall Study|Did not return for appointments|6|||
148790243|NCT00762762|536710738|FG001|Overall Study|Did not return for appointments|8|||
148790244|NCT02489448|536710739|FG000|Overall Study|Death|3|||
148790245|NCT02489448|536710739|FG000|Overall Study|Withdrawal by Subject|2|||
148790246|NCT02748057|536710740|FG000|Overall Study|Adverse Event|1|||
148790247|NCT02748057|536710741|FG001|Overall Study|Adverse Event|0|||
148790248|NCT02748057|536710740|FG000|Overall Study|Physician Decision|0|||
148790249|NCT02748057|536710741|FG001|Overall Study|Physician Decision|1|||
148790250|NCT02748057|536710740|FG000|Overall Study|Protocol Violation|2|||
148790251|NCT02748057|536710741|FG001|Overall Study|Protocol Violation|1|||
148790252|NCT02748057|536710740|FG000|Overall Study|Participant Moved|1|||
148790253|NCT02748057|536710741|FG001|Overall Study|Participant Moved|0|||
148790254|NCT02748057|536710740|FG000|Overall Study|Withdrawal by Subject|1|||
148790255|NCT02748057|536710741|FG001|Overall Study|Withdrawal by Subject|0|||
148790256|NCT02793947|536710742|FG000|Overall Study|Death|1|||
148790257|NCT02793947|536710743|FG001|Overall Study|Death|0|||
148790258|NCT02793947|536710742|FG000|Overall Study|Physician Decision|1|||
148790259|NCT02793947|536710743|FG001|Overall Study|Physician Decision|5|||
148790260|NCT01310127|536710744|FG000|Overall Study|Protocol Violation|1|||
148790261|NCT01310127|536710745|FG001|Overall Study|Protocol Violation|1|||
148790262|NCT01310127|536710744|FG000|Overall Study|advanced psc cataract outlier|1|||
148790263|NCT01310127|536710745|FG001|Overall Study|advanced psc cataract outlier|0|||
148790264|NCT02171429|536710753|FG000|Overall Study|Other|0|||
148790265|NCT02171429|536710754|FG001|Overall Study|Other|1|||
148790266|NCT02171429|536710755|FG002|Overall Study|Other|1|||
148790267|NCT02171429|536710753|FG000|Overall Study|Non-Compliance|0|||
148790268|NCT02171429|536710754|FG001|Overall Study|Non-Compliance|0|||
148790269|NCT02171429|536710755|FG002|Overall Study|Non-Compliance|1|||
148790270|NCT02171429|536710753|FG000|Overall Study|Physician Decision|0|||
148790271|NCT02171429|536710754|FG001|Overall Study|Physician Decision|0|||
148790272|NCT02171429|536710755|FG002|Overall Study|Physician Decision|1|||
148790273|NCT02171429|536710753|FG000|Overall Study|Withdrawal by Subject|1|||
148790274|NCT02171429|536710754|FG001|Overall Study|Withdrawal by Subject|1|||
148790275|NCT02171429|536710755|FG002|Overall Study|Withdrawal by Subject|1|||
148790276|NCT02171429|536710753|FG000|Overall Study|Lost to Follow-up|0|||
148790277|NCT02171429|536710754|FG001|Overall Study|Lost to Follow-up|1|||
148790278|NCT02171429|536710755|FG002|Overall Study|Lost to Follow-up|0|||
148790279|NCT02171429|536710753|FG000|Overall Study|Death|0|||
148790280|NCT02171429|536710754|FG001|Overall Study|Death|0|||
148790281|NCT02171429|536710755|FG002|Overall Study|Death|1|||
148790282|NCT00632125|536710761|FG000|Overall Study|Death|82|||
148790283|NCT00632125|536710761|FG000|Overall Study|Withdrawal by Subject|44|||
148790284|NCT00632125|536710761|FG000|Overall Study|Adverse Event|36|||
148790285|NCT00632125|536710761|FG000|Overall Study|Renal transplantation|17|||
148790286|NCT00632125|536710761|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
148790287|NCT00632125|536710761|FG000|Overall Study|Non-compliance|8|||
148790288|NCT00632125|536710761|FG000|Overall Study|Development of uncontrolled hypertension|5|||
148790289|NCT00632125|536710761|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
148790290|NCT04152083|536710762|FG000|Overall Study|Lost to Follow-up|2|||
148790291|NCT04152083|536710763|FG001|Overall Study|Lost to Follow-up|1|||
148790292|NCT04152083|536710762|FG000|Overall Study|Adverse Event|1|||
148790293|NCT04152083|536710763|FG001|Overall Study|Adverse Event|0|||
148790294|NCT04152083|536710762|FG000|Overall Study|Randomized but not treated|3|||
148790295|NCT04152083|536710763|FG001|Overall Study|Randomized but not treated|2|||
148790296|NCT03280056|536710764|FG000|Overall Study|Withdrawal by Subject|12|||
148790297|NCT03280056|536710765|FG001|Overall Study|Withdrawal by Subject|14|||
148790298|NCT03280056|536710764|FG000|Overall Study|Death|9|||
148790299|NCT03280056|536710765|FG001|Overall Study|Death|2|||
148790300|NCT03280056|536710764|FG000|Overall Study|Adverse Event|1|||
148790301|NCT03280056|536710765|FG001|Overall Study|Adverse Event|3|||
148790302|NCT03280056|536710764|FG000|Overall Study|Lost to Follow-up|1|||
148790303|NCT03280056|536710765|FG001|Overall Study|Lost to Follow-up|1|||
148790304|NCT03280056|536710764|FG000|Overall Study|Physician Decision|0|||
148790305|NCT03280056|536710765|FG001|Overall Study|Physician Decision|1|||
148790306|NCT03280056|536710764|FG000|Overall Study|Early Discontinuation|1|||
148790307|NCT03280056|536710765|FG001|Overall Study|Early Discontinuation|0|||
148790308|NCT01135524|536710768|FG000|Overall Study|Withdrawal by Subject|14|||
148790309|NCT01135524|536710768|FG000|Overall Study|Adverse Event|20|||
148790310|NCT01135524|536710768|FG000|Overall Study|Lost to Follow-up|3|||
148790311|NCT01135524|536710768|FG000|Overall Study|Administrative|151|||
148790312|NCT01135524|536710768|FG000|Overall Study|Lack of Efficacy|8|||
148790313|NCT01247350|536710769|FG000|Overall Study|Adverse Event|0|||
148790314|NCT01247350|536710770|FG001|Overall Study|Adverse Event|0|||
148790315|NCT01247350|536710771|FG002|Overall Study|Adverse Event|1|||
148790316|NCT01247350|536710772|FG003|Overall Study|Adverse Event|0|||
148790317|NCT01247350|536710773|FG004|Overall Study|Adverse Event|0|||
148790318|NCT01247350|536710769|FG000|Overall Study|Withdrawal by Subject|0|||
148790319|NCT01247350|536710770|FG001|Overall Study|Withdrawal by Subject|0|||
148790320|NCT01247350|536710771|FG002|Overall Study|Withdrawal by Subject|0|||
148790321|NCT01247350|536710772|FG003|Overall Study|Withdrawal by Subject|1|||
148790322|NCT01247350|536710773|FG004|Overall Study|Withdrawal by Subject|0|||
148790323|NCT01247350|536710769|FG000|Overall Study|Entry criteria not met|0|||
148790324|NCT01247350|536710770|FG001|Overall Study|Entry criteria not met|0|||
148790325|NCT01247350|536710771|FG002|Overall Study|Entry criteria not met|0|||
148790326|NCT01247350|536710772|FG003|Overall Study|Entry criteria not met|0|||
148790327|NCT01247350|536710773|FG004|Overall Study|Entry criteria not met|1|||
149129836|NCT00307125|537954562|FG001|Screening Phase|Metastatic colon cancer|0|||
149129837|NCT00307125|537954563|FG002|Screening Phase|Metastatic colon cancer|0|||
149129838|NCT00307125|537954561|FG000|Screening Phase|Malignancy|1|||
149129839|NCT00307125|537954562|FG001|Screening Phase|Malignancy|0|||
149129840|NCT00307125|537954563|FG002|Screening Phase|Malignancy|0|||
149129841|NCT00307125|537954561|FG000|Screening Phase|PAK|1|||
149129842|NCT00307125|537954562|FG001|Screening Phase|PAK|0|||
149129843|NCT00307125|537954563|FG002|Screening Phase|PAK|0|||
149129844|NCT00307125|537954561|FG000|Screening Phase|Ineligible|1|||
149129845|NCT00307125|537954562|FG001|Screening Phase|Ineligible|0|||
149129846|NCT00307125|537954563|FG002|Screening Phase|Ineligible|0|||
149129847|NCT00307125|537954561|FG000|Screening Phase|Screen Error|1|||
149129848|NCT00307125|537954562|FG001|Screening Phase|Screen Error|0|||
149129849|NCT00307125|537954563|FG002|Screening Phase|Screen Error|0|||
149129850|NCT00307125|537954561|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
149129851|NCT00307125|537954562|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
149129852|NCT00307125|537954563|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
149129853|NCT00307125|537954561|FG000|Screening Phase|AMR and treated with rituximab|1|||
149129854|NCT00307125|537954562|FG001|Screening Phase|AMR and treated with rituximab|0|||
149129855|NCT00307125|537954563|FG002|Screening Phase|AMR and treated with rituximab|0|||
149129856|NCT00307125|537954561|FG000|Screening Phase|Coronary artery bypass|1|||
149129857|NCT00307125|537954562|FG001|Screening Phase|Coronary artery bypass|0|||
149129858|NCT00307125|537954563|FG002|Screening Phase|Coronary artery bypass|0|||
148790328|NCT00807612|536710776|FG000|Overall Study|Death|8|||
148790329|NCT00807612|536710776|FG000|Overall Study|Study early termination|5|||
148790330|NCT00807612|536710776|FG000|Overall Study|Withdrawal by Subject|1|||
149129859|NCT00307125|537954561|FG000|Pilot Phase|Lost to Follow-up|0|||
149129860|NCT00307125|537954562|FG001|Pilot Phase|Lost to Follow-up|1|||
149129861|NCT00307125|537954563|FG002|Pilot Phase|Lost to Follow-up|0|||
149129862|NCT00307125|537954561|FG000|Pilot Phase|Withdrawal by Subject|0|||
149129863|NCT00307125|537954562|FG001|Pilot Phase|Withdrawal by Subject|1|||
149129864|NCT00307125|537954563|FG002|Pilot Phase|Withdrawal by Subject|1|||
149129865|NCT00051363|537954565|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
149129866|NCT00051363|537954566|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
149129867|NCT00051363|537954565|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
149129868|NCT00051363|537954566|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
149129869|NCT00051363|537954565|FG000|Overall Study|Death|2|||
149129870|NCT00051363|537954566|FG001|Overall Study|Death|2|||
149129871|NCT00051363|537954565|FG000|Overall Study|Excluded Pre-Randomization|2|||
149129872|NCT00051363|537954566|FG001|Overall Study|Excluded Pre-Randomization|5|||
149129873|NCT00926211|537954567|FG000|Overall Study|Lost to Follow-up|1|||
149129874|NCT01032382|537954570|FG000|Overall Study|Disease dissemination|1|||
149129875|NCT01032382|537954571|FG001|Overall Study|Disease dissemination|1|||
149129876|NCT01032382|537954570|FG000|Overall Study|Treatment failure|3|||
149129877|NCT01032382|537954571|FG001|Overall Study|Treatment failure|1|||
149129878|NCT01032382|537954570|FG000|Overall Study|Index lesion relapse|1|||
149129879|NCT01032382|537954571|FG001|Overall Study|Index lesion relapse|3|||
149129880|NCT01242800|537954572|FG000|Overall Study|Patient refusal|0|||
149129881|NCT01242800|537954573|FG001|Overall Study|Patient refusal|10|||
149129882|NCT01242800|537954572|FG000|Overall Study|Physician Decision|0|||
149129883|NCT01242800|537954573|FG001|Overall Study|Physician Decision|1|||
149129884|NCT01242800|537954572|FG000|Overall Study|Disease progression|0|||
149129885|NCT01242800|537954573|FG001|Overall Study|Disease progression|3|||
149129886|NCT01242800|537954572|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
149129887|NCT01242800|537954573|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
149129888|NCT01242800|537954572|FG000|Overall Study|Reasons not reported|0|||
149129889|NCT01242800|537954573|FG001|Overall Study|Reasons not reported|4|||
149129890|NCT02640157|537954576|FG000|Overall Study|Adverse Event|2|||
149129891|NCT02640157|537954577|FG001|Overall Study|Adverse Event|2|||
149129892|NCT02640157|537954578|FG002|Overall Study|Adverse Event|1|||
149129893|NCT02640157|537954576|FG000|Overall Study|Withdrew consent|2|||
149129894|NCT02640157|537954577|FG001|Overall Study|Withdrew consent|0|||
149129895|NCT02640157|537954578|FG002|Overall Study|Withdrew consent|2|||
149129896|NCT02640157|537954576|FG000|Overall Study|Lost to Follow-up|9|||
149129897|NCT02640157|537954577|FG001|Overall Study|Lost to Follow-up|2|||
149129898|NCT02640157|537954578|FG002|Overall Study|Lost to Follow-up|7|||
149129899|NCT02640157|537954576|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
149129900|NCT02640157|537954577|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
149129901|NCT02640157|537954578|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
149129902|NCT00710021|537954579|FG000|Overall Study|Lost to Follow-up|1|||
149129903|NCT00710021|537954580|FG001|Overall Study|Lost to Follow-up|0|||
149129904|NCT00710021|537954581|FG002|Overall Study|Lost to Follow-up|0|||
148790331|NCT04607135|536710777|FG000|Overall Study|Physician Decision|1|||
149129905|NCT00710021|537954579|FG000|Overall Study|Subject's Decision|0|||
148790332|NCT04607135|536710777|FG000|Overall Study|Withdrawal by Subject|1|||
149129906|NCT00710021|537954580|FG001|Overall Study|Subject's Decision|1|||
149129907|NCT00710021|537954581|FG002|Overall Study|Subject's Decision|0|||
149129908|NCT00710021|537954579|FG000|Overall Study|Subject misrandomized|0|||
149129909|NCT00710021|537954580|FG001|Overall Study|Subject misrandomized|1|||
149129910|NCT00710021|537954581|FG002|Overall Study|Subject misrandomized|1|||
149129911|NCT00710021|537954579|FG000|Overall Study|Physician Decision|0|||
149129912|NCT00710021|537954580|FG001|Overall Study|Physician Decision|1|||
149129913|NCT00710021|537954581|FG002|Overall Study|Physician Decision|0|||
149129914|NCT01679405|537954582|FG000|Overall Study|Death|2|||
149129915|NCT01679405|537954583|FG001|Overall Study|Death|5|||
149129916|NCT04677179|537954584|FG000|Induction Treatment Period|Adverse Event|1|||
149129917|NCT04677179|537954585|FG001|Induction Treatment Period|Adverse Event|0|||
149129918|NCT04677179|537954586|FG002|Induction Treatment Period|Adverse Event|0|||
149129919|NCT04677179|537954587|FG003|Induction Treatment Period|Adverse Event|0|||
149129920|NCT04677179|537954588|FG004|Induction Treatment Period|Adverse Event|0|||
149129921|NCT04677179|537954589|FG005|Induction Treatment Period|Adverse Event|0|||
149129922|NCT04677179|537954590|FG006|Induction Treatment Period|Adverse Event|0|||
149129923|NCT04677179|537954591|FG007|Induction Treatment Period|Adverse Event|0|||
149129924|NCT04677179|537954592|FG008|Induction Treatment Period|Adverse Event|0|||
149129925|NCT04677179|537954593|FG009|Induction Treatment Period|Adverse Event|0|||
149129926|NCT04677179|537954584|FG000|Induction Treatment Period|Physician Decision|1|||
149129927|NCT04677179|537954585|FG001|Induction Treatment Period|Physician Decision|0|||
149129928|NCT04677179|537954586|FG002|Induction Treatment Period|Physician Decision|1|||
149129929|NCT04677179|537954587|FG003|Induction Treatment Period|Physician Decision|0|||
149129930|NCT04677179|537954588|FG004|Induction Treatment Period|Physician Decision|0|||
149129931|NCT04677179|537954589|FG005|Induction Treatment Period|Physician Decision|0|||
149129932|NCT04677179|537954590|FG006|Induction Treatment Period|Physician Decision|0|||
149129933|NCT04677179|537954591|FG007|Induction Treatment Period|Physician Decision|0|||
149129934|NCT04677179|537954592|FG008|Induction Treatment Period|Physician Decision|0|||
149129935|NCT04677179|537954593|FG009|Induction Treatment Period|Physician Decision|0|||
149129936|NCT04677179|537954584|FG000|Induction Treatment Period|Protocol Violation|0|||
149129937|NCT04677179|537954585|FG001|Induction Treatment Period|Protocol Violation|1|||
149129938|NCT04677179|537954586|FG002|Induction Treatment Period|Protocol Violation|0|||
149129939|NCT04677179|537954587|FG003|Induction Treatment Period|Protocol Violation|0|||
149129940|NCT04677179|537954588|FG004|Induction Treatment Period|Protocol Violation|0|||
149129941|NCT04677179|537954589|FG005|Induction Treatment Period|Protocol Violation|0|||
149129942|NCT04677179|537954590|FG006|Induction Treatment Period|Protocol Violation|0|||
149129943|NCT04677179|537954591|FG007|Induction Treatment Period|Protocol Violation|0|||
149129944|NCT04677179|537954592|FG008|Induction Treatment Period|Protocol Violation|0|||
149129945|NCT04677179|537954593|FG009|Induction Treatment Period|Protocol Violation|0|||
149129946|NCT04677179|537954584|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
149129947|NCT04677179|537954585|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
149129948|NCT04677179|537954586|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
149129949|NCT04677179|537954587|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
149129950|NCT04677179|537954588|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
149129951|NCT04677179|537954589|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
149129952|NCT04677179|537954590|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
149129953|NCT04677179|537954591|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
149129954|NCT04677179|537954592|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
149129955|NCT04677179|537954593|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
149129956|NCT04677179|537954584|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
149129957|NCT04677179|537954585|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
149129958|NCT04677179|537954586|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
149129959|NCT04677179|537954587|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
149129960|NCT04677179|537954588|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
149129961|NCT04677179|537954589|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
149129962|NCT04677179|537954590|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
149129963|NCT04677179|537954591|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
149129964|NCT04677179|537954592|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
149129965|NCT04677179|537954593|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
149129966|NCT04677179|537954584|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
149129967|NCT04677179|537954585|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
149129968|NCT04677179|537954586|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
149129969|NCT04677179|537954587|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
149129970|NCT04677179|537954588|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
149129971|NCT04677179|537954589|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
149129972|NCT04677179|537954590|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
149129973|NCT04677179|537954591|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
149129974|NCT04677179|537954592|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
149129975|NCT04677179|537954593|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
149129976|NCT04677179|537954584|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
148790333|NCT04607135|536710777|FG000|Overall Study|Equipment not working|3|||
148790334|NCT03465709|536710778|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
148790335|NCT03465709|536710778|FG000|Overall Study|Withdrawal by Subject|3|||
148790336|NCT04892446|536710779|FG000|Overall Study|Death|4|||
148790337|NCT04892446|536710780|FG001|Overall Study|Death|4|||
148790338|NCT04892446|536710781|FG002|Overall Study|Death|0|||
148790339|NCT04892446|536710779|FG000|Overall Study|Withdrew consent|3|||
148790340|NCT04892446|536710780|FG001|Overall Study|Withdrew consent|0|||
148790341|NCT04892446|536710781|FG002|Overall Study|Withdrew consent|1|||
148790342|NCT04892446|536710779|FG000|Overall Study|Investigator's discretion|1|||
148790343|NCT04892446|536710780|FG001|Overall Study|Investigator's discretion|1|||
148790344|NCT04892446|536710781|FG002|Overall Study|Investigator's discretion|0|||
148790345|NCT04892446|536710779|FG000|Overall Study|Study terminated by sponsor|0|||
148790346|NCT04892446|536710780|FG001|Overall Study|Study terminated by sponsor|0|||
148790347|NCT04892446|536710781|FG002|Overall Study|Study terminated by sponsor|2|||
148790348|NCT03193047|536710783|FG000|Overall Study|Physician Decision|1|||
148790349|NCT03193047|536710784|FG001|Overall Study|Physician Decision|0|||
148790350|NCT03193047|536710783|FG000|Overall Study|Participant Left State|1|||
148790351|NCT03193047|536710784|FG001|Overall Study|Participant Left State|0|||
148790352|NCT02328937|536710785|FG000|Period 1|Lost to Follow-up|0|||
148790353|NCT02328937|536710786|FG001|Period 1|Lost to Follow-up|0|||
148790354|NCT02328937|536710787|FG002|Period 1|Lost to Follow-up|0|||
148790355|NCT02328937|536710788|FG003|Period 1|Lost to Follow-up|1|||
148790356|NCT02328937|536710789|FG004|Period 1|Lost to Follow-up|0|||
148790357|NCT02328937|536710790|FG005|Period 1|Lost to Follow-up|0|||
148790358|NCT02328937|536710785|FG000|Period 2|Adverse Event|0|||
148790359|NCT02328937|536710786|FG001|Period 2|Adverse Event|0|||
148790360|NCT02328937|536710787|FG002|Period 2|Adverse Event|1|||
149129977|NCT04677179|537954585|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129978|NCT04677179|537954586|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129979|NCT04677179|537954587|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
149129980|NCT04677179|537954588|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129981|NCT04677179|537954589|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129982|NCT04677179|537954590|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129983|NCT04677179|537954591|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129984|NCT04677179|537954592|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129985|NCT04677179|537954593|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
149129986|NCT04677179|537954584|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129987|NCT04677179|537954585|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129988|NCT04677179|537954586|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129989|NCT04677179|537954587|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
149129990|NCT04677179|537954588|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
149129991|NCT04677179|537954589|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
149129992|NCT04677179|537954590|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129993|NCT04677179|537954591|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129994|NCT04677179|537954592|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129995|NCT04677179|537954593|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
149129996|NCT04677179|537954584|FG000|Extension Treatment Period|Lack of Efficacy|0|||
149129997|NCT04677179|537954585|FG001|Extension Treatment Period|Lack of Efficacy|0|||
149129998|NCT04677179|537954586|FG002|Extension Treatment Period|Lack of Efficacy|0|||
149129999|NCT04677179|537954587|FG003|Extension Treatment Period|Lack of Efficacy|0|||
149130000|NCT04677179|537954588|FG004|Extension Treatment Period|Lack of Efficacy|0|||
149130001|NCT04677179|537954589|FG005|Extension Treatment Period|Lack of Efficacy|0|||
149130002|NCT04677179|537954590|FG006|Extension Treatment Period|Lack of Efficacy|6|||
149130003|NCT04677179|537954591|FG007|Extension Treatment Period|Lack of Efficacy|0|||
149130004|NCT04677179|537954592|FG008|Extension Treatment Period|Lack of Efficacy|0|||
149130005|NCT04677179|537954593|FG009|Extension Treatment Period|Lack of Efficacy|0|||
149130006|NCT04677179|537954584|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
149130007|NCT04677179|537954585|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
149130008|NCT04677179|537954586|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
149130009|NCT04677179|537954587|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
149130010|NCT04677179|537954588|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
149130011|NCT04677179|537954589|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
149130012|NCT04677179|537954590|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
149130013|NCT04677179|537954591|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
149130014|NCT04677179|537954592|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
149130015|NCT04677179|537954593|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
149130016|NCT04677179|537954584|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
149130017|NCT04677179|537954585|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
148790361|NCT02328937|536710788|FG003|Period 2|Adverse Event|0|||
148790362|NCT02328937|536710789|FG004|Period 2|Adverse Event|0|||
148790363|NCT02328937|536710790|FG005|Period 2|Adverse Event|0|||
149130018|NCT04677179|537954586|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
149130019|NCT04677179|537954587|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
149130020|NCT04677179|537954588|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
149130021|NCT04677179|537954589|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
149130022|NCT04677179|537954590|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
149130023|NCT04677179|537954591|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
149130024|NCT04677179|537954592|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
149130025|NCT04677179|537954593|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
149130026|NCT04677179|537954584|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
149130027|NCT04677179|537954585|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
149130028|NCT04677179|537954586|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
149130029|NCT04677179|537954587|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
149130030|NCT04677179|537954588|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
149130031|NCT04677179|537954589|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
149130032|NCT04677179|537954590|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
149130033|NCT04677179|537954591|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
149130034|NCT04677179|537954592|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
149130035|NCT04677179|537954593|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
149130036|NCT04677179|537954584|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130037|NCT04677179|537954585|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130038|NCT04677179|537954586|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130039|NCT04677179|537954587|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130040|NCT04677179|537954588|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130041|NCT04677179|537954589|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130042|NCT04677179|537954590|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130043|NCT04677179|537954591|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
149130044|NCT04677179|537954592|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
149130045|NCT04677179|537954593|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
149130046|NCT04677179|537954584|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130047|NCT04677179|537954585|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130048|NCT04677179|537954586|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130049|NCT04677179|537954587|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130050|NCT04677179|537954588|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130051|NCT04677179|537954589|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130052|NCT04677179|537954590|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130053|NCT04677179|537954591|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
149130054|NCT04677179|537954592|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
149130055|NCT04677179|537954593|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
148790364|NCT00837967|536710791|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
148790365|NCT00837967|536710792|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
148790366|NCT02504320|536710795|FG000|Treatment Period 1|Positive Drug Screen|0|||
148790367|NCT02504320|536710796|FG001|Treatment Period 1|Positive Drug Screen|0|||
148790368|NCT02504320|536710797|FG002|Treatment Period 1|Positive Drug Screen|1|||
148790369|NCT02504320|536710798|FG003|Treatment Period 1|Positive Drug Screen|0|||
148790370|NCT02504320|536710795|FG000|Treatment Period 2|Positive Drug Screen|0|||
148790371|NCT02504320|536710796|FG001|Treatment Period 2|Positive Drug Screen|1|||
148790372|NCT02504320|536710797|FG002|Treatment Period 2|Positive Drug Screen|0|||
148790373|NCT02504320|536710798|FG003|Treatment Period 2|Positive Drug Screen|0|||
148790374|NCT02504320|536710795|FG000|Treatment Period 3|Positive Drug Screen|0|||
148790375|NCT02504320|536710796|FG001|Treatment Period 3|Positive Drug Screen|0|||
148790376|NCT02504320|536710797|FG002|Treatment Period 3|Positive Drug Screen|0|||
148790377|NCT02504320|536710798|FG003|Treatment Period 3|Positive Drug Screen|1|||
148790378|NCT02504320|536710795|FG000|Treatment Period 3|Adverse Event|0|||
148790379|NCT02504320|536710796|FG001|Treatment Period 3|Adverse Event|0|||
148790380|NCT02504320|536710797|FG002|Treatment Period 3|Adverse Event|1|||
148790381|NCT02504320|536710798|FG003|Treatment Period 3|Adverse Event|0|||
148790382|NCT01210222|536710799|FG000|Overall Study|Ineligible|2|||
148790383|NCT01210222|536710799|FG000|Overall Study|Never treated|1|||
148790384|NCT01737879|536710800|FG000|Overall Study|Death|1|||
148790385|NCT01737879|536710800|FG000|Overall Study|Sponsor decision|40|||
149130056|NCT04677179|537954584|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130057|NCT04677179|537954585|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130058|NCT04677179|537954586|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130059|NCT04677179|537954587|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130060|NCT04677179|537954588|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
148790386|NCT00685360|536710801|FG000|Overall Study|Lost to Follow-up|0|||
148790387|NCT00685360|536710802|FG001|Overall Study|Lost to Follow-up|1|||
148790388|NCT00685360|536710803|FG002|Overall Study|Lost to Follow-up|2|||
148790389|NCT00685360|536710801|FG000|Overall Study|Adverse Event|4|||
148790390|NCT00685360|536710802|FG001|Overall Study|Adverse Event|6|||
148790391|NCT00685360|536710803|FG002|Overall Study|Adverse Event|4|||
148893410|NCT01693029|537088701|FG001|Overall Study|Death|8|||
149130061|NCT04677179|537954589|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130062|NCT04677179|537954590|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130063|NCT04677179|537954591|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
149130064|NCT04677179|537954592|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
149130065|NCT04677179|537954593|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
149130066|NCT04677179|537954584|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130067|NCT04677179|537954585|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130068|NCT04677179|537954586|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130069|NCT04677179|537954587|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130070|NCT04677179|537954588|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130071|NCT04677179|537954589|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130072|NCT04677179|537954590|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
149130073|NCT04677179|537954591|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
149130074|NCT04677179|537954592|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
149130075|NCT04677179|537954593|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
149130076|NCT01536015|537954594|FG000|Overall Study|Adverse Event|1|||
149130077|NCT01536015|537954595|FG001|Overall Study|Adverse Event|4|||
149130078|NCT01536015|537954594|FG000|Overall Study|Lost to Follow-up|0|||
149130079|NCT01536015|537954595|FG001|Overall Study|Lost to Follow-up|1|||
149130080|NCT01536015|537954594|FG000|Overall Study|Inclusion Criterion not met|2|||
149130081|NCT01536015|537954595|FG001|Overall Study|Inclusion Criterion not met|0|||
149130082|NCT01536015|537954594|FG000|Overall Study|Study closure|5|||
149130083|NCT01536015|537954595|FG001|Overall Study|Study closure|5|||
149130084|NCT04508023|537954596|FG000|Overall Study|Withdrawal by Subject|1|||
149130085|NCT04508023|537954597|FG001|Overall Study|Withdrawal by Subject|2|||
149130086|NCT00983931|537954607|FG000|14 Day Washout Period|Physician Decision|1|||
149130087|NCT00770341|537954608|FG000|Overall Study|Did not meet eligibility criteria|1|||
149130088|NCT00770341|537954609|FG001|Overall Study|Did not meet eligibility criteria|0|||
149130089|NCT00770341|537954610|FG002|Overall Study|Did not meet eligibility criteria|0|||
149130090|NCT00770341|537954608|FG000|Overall Study|Withdrawal by Subject|0|||
149130091|NCT00770341|537954609|FG001|Overall Study|Withdrawal by Subject|1|||
149130092|NCT00770341|537954610|FG002|Overall Study|Withdrawal by Subject|0|||
149130093|NCT00770341|537954608|FG000|Overall Study|Clinical Adverse Event|3|||
149130094|NCT00770341|537954609|FG001|Overall Study|Clinical Adverse Event|1|||
149130095|NCT00770341|537954610|FG002|Overall Study|Clinical Adverse Event|2|||
149130096|NCT00770341|537954608|FG000|Overall Study|Laboratory adverse event|3|||
149130097|NCT00770341|537954609|FG001|Overall Study|Laboratory adverse event|3|||
149130098|NCT00770341|537954610|FG002|Overall Study|Laboratory adverse event|0|||
149130099|NCT00770341|537954608|FG000|Overall Study|Lack of Efficacy|3|||
149130100|NCT00770341|537954609|FG001|Overall Study|Lack of Efficacy|0|||
149130101|NCT00770341|537954610|FG002|Overall Study|Lack of Efficacy|1|||
149130102|NCT00770341|537954608|FG000|Overall Study|Other|1|||
149130103|NCT00770341|537954609|FG001|Overall Study|Other|0|||
149130104|NCT00770341|537954610|FG002|Overall Study|Other|0|||
149130105|NCT00770341|537954608|FG000|Overall Study|Not treated|1|||
149130106|NCT00770341|537954609|FG001|Overall Study|Not treated|0|||
149130107|NCT00770341|537954610|FG002|Overall Study|Not treated|0|||
149130108|NCT02533570|537954611|FG000|Overall Study|Adverse Event|0|||
149130109|NCT02533570|537954612|FG001|Overall Study|Adverse Event|1|||
149130110|NCT02533570|537954613|FG002|Overall Study|Adverse Event|1|||
149130111|NCT00529958|537954615|FG000|2-Year Follow-up|Lost to Follow-up|1|||
149130112|NCT00529958|537954616|FG001|2-Year Follow-up|Lost to Follow-up|2|||
149130113|NCT00529958|537954617|FG002|2-Year Follow-up|Lost to Follow-up|2|||
149130114|NCT00529958|537954615|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
149130115|NCT00529958|537954616|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
149130116|NCT00529958|537954617|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
149130117|NCT00529958|537954615|FG000|5-Year Follow-up|Lost to Follow-up|2|||
149130118|NCT00529958|537954616|FG001|5-Year Follow-up|Lost to Follow-up|3|||
149130119|NCT00529958|537954617|FG002|5-Year Follow-up|Lost to Follow-up|1|||
149130120|NCT00529958|537954615|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
149130121|NCT00529958|537954616|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
149130122|NCT00529958|537954617|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
149130123|NCT03816332|537954618|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
149130124|NCT03816332|537954618|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
149130125|NCT03164564|537954621|FG000|Overall Study|Death|3|||
149130126|NCT03164564|537954622|FG001|Overall Study|Death|0|||
149130127|NCT03164564|537954621|FG000|Overall Study|Withdrawal by Subject|20|||
149130128|NCT03164564|537954622|FG001|Overall Study|Withdrawal by Subject|15|||
149130129|NCT03164564|537954621|FG000|Overall Study|Lost to Follow-up|2|||
149130130|NCT03164564|537954622|FG001|Overall Study|Lost to Follow-up|0|||
149130131|NCT03164564|537954621|FG000|Overall Study|Physician Decision|0|||
149130132|NCT03164564|537954622|FG001|Overall Study|Physician Decision|1|||
149130133|NCT03164564|537954621|FG000|Overall Study|Adverse Event|0|||
149130134|NCT03164564|537954622|FG001|Overall Study|Adverse Event|1|||
149130135|NCT03164564|537954621|FG000|Overall Study|Ongoing|1586|||
149130136|NCT03164564|537954622|FG001|Overall Study|Ongoing|1586|||
149130137|NCT05269355|537954625|FG000|Overall Study|Progressive Disease|104|||
149130138|NCT05269355|537954626|FG001|Overall Study|Progressive Disease|68|||
149130139|NCT05269355|537954625|FG000|Overall Study|Study Terminated by Sponsor|87|||
149130140|NCT05269355|537954626|FG001|Overall Study|Study Terminated by Sponsor|29|||
149130141|NCT05269355|537954625|FG000|Overall Study|Adverse Event|15|||
149130142|NCT05269355|537954626|FG001|Overall Study|Adverse Event|8|||
149130143|NCT05269355|537954625|FG000|Overall Study|Withdrawal by Subject|18|||
149130144|NCT05269355|537954626|FG001|Overall Study|Withdrawal by Subject|5|||
149130145|NCT05269355|537954625|FG000|Overall Study|Physician Decision|6|||
149130146|NCT05269355|537954626|FG001|Overall Study|Physician Decision|4|||
149130147|NCT05269355|537954625|FG000|Overall Study|Death|3|||
149130148|NCT05269355|537954626|FG001|Overall Study|Death|5|||
149130149|NCT05269355|537954625|FG000|Overall Study|Other Than Specified|5|||
149130150|NCT05269355|537954626|FG001|Overall Study|Other Than Specified|1|||
149130151|NCT05269355|537954625|FG000|Overall Study|Randomized But Not Treated|1|||
149130152|NCT05269355|537954626|FG001|Overall Study|Randomized But Not Treated|0|||
149130153|NCT01050790|537954627|FG000|Overall Study|Adverse Event|1|||
149130154|NCT01880528|537954628|FG000|Overall Study|Other|1|||
149130155|NCT01880528|537954629|FG001|Overall Study|Other|1|||
149130156|NCT00081497|537954630|FG000|Overall Study|Adverse Event|2|||
149130157|NCT00081497|537954631|FG001|Overall Study|Adverse Event|0|||
149130158|NCT00081497|537954630|FG000|Overall Study|Death|0|||
149130159|NCT00081497|537954631|FG001|Overall Study|Death|1|||
149130160|NCT00081497|537954630|FG000|Overall Study|Withdrawal by Subject|1|||
149130161|NCT00081497|537954631|FG001|Overall Study|Withdrawal by Subject|0|||
149130162|NCT00081497|537954630|FG000|Overall Study|Non-compliance|0|||
149130163|NCT00081497|537954631|FG001|Overall Study|Non-compliance|1|||
149130164|NCT02254278|537954632|FG000|Overall Study|Protocol Violation|1|||
149130165|NCT02254278|537954633|FG001|Overall Study|Protocol Violation|1|||
149130166|NCT02120625|537956203|FG000|Overall Study|Physician Decision|2|||
149130167|NCT00325039|537956206|FG000|Overall Study|Lost to Follow-up|18|||
149130168|NCT00325039|537956207|FG001|Overall Study|Lost to Follow-up|14|||
149130169|NCT01009203|537956209|FG000|Overall Study|Withdrawal by Subject|1|||
149130170|NCT01009203|537956209|FG000|Overall Study|Adverse Event|5|||
149130171|NCT01009203|537956209|FG000|Overall Study|Treatment-unrelated death|1|||
148790392|NCT00685360|536710801|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
148790393|NCT00685360|536710802|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
148790394|NCT00685360|536710803|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
149130172|NCT01776424|537956210|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
149130173|NCT01776424|537956211|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
149130174|NCT01776424|537956212|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
149130175|NCT01776424|537956210|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
149130176|NCT01776424|537956211|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
149130177|NCT01776424|537956212|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
149130178|NCT01776424|537956210|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
149130179|NCT01776424|537956211|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
149130180|NCT01776424|537956212|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
149130181|NCT01776424|537956210|FG000|LTOLE Part (Open Label)|Refused|5|||
149130182|NCT01776424|537956211|FG001|LTOLE Part (Open Label)|Refused|2|||
149130183|NCT01776424|537956212|FG002|LTOLE Part (Open Label)|Refused|11|||
149130184|NCT01776424|537956210|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
149130185|NCT01776424|537956211|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
149130186|NCT01776424|537956212|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
149130187|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
149130188|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
149130189|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
149130190|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
149130191|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
149130192|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
149130193|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
149130194|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
149130195|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
149130196|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
149130197|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
149130198|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
149130199|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
149130200|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
149130201|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
149130202|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
149130203|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
149130204|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
149130205|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
149130206|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
149130207|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
149130208|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
149130209|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
149130210|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
149130211|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
149130212|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
149130213|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
149130214|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
149130215|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
149130216|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
149130217|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Other|10|||
149130218|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Other|7|||
149130219|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Other|8|||
149130220|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Other|8|||
149130221|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Other|0|||
149130222|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
149130223|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
149130224|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
149130225|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
149130226|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
149130227|NCT00615836|537956215|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
149130228|NCT00615836|537956216|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
149130229|NCT00615836|537956217|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
149130230|NCT00615836|537956218|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
149130231|NCT00615836|537956219|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
149130232|NCT01630434|537956220|FG000|Overall Study|Donor lungs turned down|1|||
149130233|NCT01630434|537956221|FG001|Overall Study|Donor lungs turned down|0|||
149130234|NCT01630434|537956220|FG000|Overall Study|Protocol Violation|9|||
149130235|NCT01630434|537956221|FG001|Overall Study|Protocol Violation|4|||
149130236|NCT01630434|537956220|FG000|Overall Study|Death|20|||
149130237|NCT01630434|537956221|FG001|Overall Study|Death|26|||
149130238|NCT00687973|537956222|FG000|Overall Study|Adverse Event|18|||
149130239|NCT00687973|537956223|FG001|Overall Study|Adverse Event|28|||
149130240|NCT00687973|537956222|FG000|Overall Study|Lack of Efficacy|2|||
149130241|NCT00687973|537956223|FG001|Overall Study|Lack of Efficacy|3|||
149130242|NCT00687973|537956222|FG000|Overall Study|Protocol Violation|1|||
149130243|NCT00687973|537956223|FG001|Overall Study|Protocol Violation|2|||
149130244|NCT00687973|537956222|FG000|Overall Study|Administrative Reasons|0|||
149130245|NCT00687973|537956223|FG001|Overall Study|Administrative Reasons|2|||
149130246|NCT00687973|537956222|FG000|Overall Study|Withdrawal by Subject|3|||
149130247|NCT00687973|537956223|FG001|Overall Study|Withdrawal by Subject|3|||
149130248|NCT02121834|537956225|FG000|Overall Study|Protocol Violation|0|||
149130249|NCT02121834|537956226|FG001|Overall Study|Protocol Violation|1|||
149130250|NCT02121834|537956227|FG002|Overall Study|Protocol Violation|0|||
148790395|NCT00685360|536710801|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
148790396|NCT00685360|536710802|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
148790397|NCT00685360|536710803|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
148790398|NCT00685360|536710801|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
148790399|NCT00685360|536710802|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
148790400|NCT00685360|536710803|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
148790401|NCT00685360|536710801|FG000|Overall Study|Protocol Deviation|0|||
148790402|NCT00685360|536710802|FG001|Overall Study|Protocol Deviation|1|||
148790403|NCT00685360|536710803|FG002|Overall Study|Protocol Deviation|1|||
148790404|NCT01408901|536710806|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
148790405|NCT01408901|536710807|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
148790406|NCT01408901|536710808|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
149130251|NCT02121834|537956228|FG003|Overall Study|Protocol Violation|0|||
149130252|NCT02121834|537956229|FG004|Overall Study|Protocol Violation|0|||
149130253|NCT02121834|537956230|FG005|Overall Study|Protocol Violation|0|||
149130254|NCT02121834|537956231|FG006|Overall Study|Protocol Violation|0|||
149130255|NCT02121834|537956225|FG000|Overall Study|Withdrawal by Subject|0|||
149130256|NCT02121834|537956226|FG001|Overall Study|Withdrawal by Subject|1|||
149130257|NCT02121834|537956227|FG002|Overall Study|Withdrawal by Subject|1|||
149130258|NCT02121834|537956228|FG003|Overall Study|Withdrawal by Subject|0|||
149130259|NCT02121834|537956229|FG004|Overall Study|Withdrawal by Subject|0|||
149130260|NCT02121834|537956230|FG005|Overall Study|Withdrawal by Subject|0|||
149130261|NCT02121834|537956231|FG006|Overall Study|Withdrawal by Subject|0|||
149130262|NCT02121834|537956225|FG000|Overall Study|Lost to Follow-up|0|||
149130263|NCT02121834|537956226|FG001|Overall Study|Lost to Follow-up|0|||
148790407|NCT01408901|536710809|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
148790408|NCT01408901|536710806|FG000|6-Week Follow-Up|Death|1|||
148790409|NCT01408901|536710807|FG001|6-Week Follow-Up|Death|0|||
148790410|NCT01408901|536710808|FG002|6-Week Follow-Up|Death|0|||
148790411|NCT01408901|536710809|FG003|6-Week Follow-Up|Death|0|||
148790412|NCT01408901|536710806|FG000|6-Week Follow-Up|Cancelled visit|0|||
148790413|NCT01408901|536710807|FG001|6-Week Follow-Up|Cancelled visit|1|||
148790414|NCT01408901|536710808|FG002|6-Week Follow-Up|Cancelled visit|0|||
148790415|NCT01408901|536710809|FG003|6-Week Follow-Up|Cancelled visit|2|||
148790416|NCT01408901|536710806|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
148790417|NCT01408901|536710807|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
148790418|NCT01408901|536710808|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
148790419|NCT01408901|536710809|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
148790420|NCT01408901|536710806|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
148790421|NCT01408901|536710807|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
148790422|NCT01408901|536710808|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
148790423|NCT01408901|536710809|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
148790424|NCT01408901|536710806|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
148790425|NCT01408901|536710807|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
148790426|NCT01408901|536710808|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
148790427|NCT01408901|536710809|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
148790428|NCT01408901|536710806|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
148790429|NCT01408901|536710807|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
148790430|NCT01408901|536710808|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
148790431|NCT01408901|536710809|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
148790432|NCT01408901|536710806|FG000|26-Week Follow-Up|Death|0|||
148790433|NCT01408901|536710807|FG001|26-Week Follow-Up|Death|1|||
148790434|NCT01408901|536710808|FG002|26-Week Follow-Up|Death|0|||
148790435|NCT01408901|536710809|FG003|26-Week Follow-Up|Death|0|||
148790436|NCT02497404|536710810|FG000|Overall Study|Adverse Event|1|||
148790437|NCT04978337|536710811|FG000|Overall Study|Withdrawal by Subject|0|||
148790438|NCT04978337|536710812|FG001|Overall Study|Withdrawal by Subject|1|||
148790439|NCT04865419|536710817|FG000|Overall Study|Other|1|||
148790440|NCT04865419|536710818|FG001|Overall Study|Other|2|||
148790441|NCT04865419|536710819|FG002|Overall Study|Other|2|||
148790442|NCT04865419|536710820|FG003|Overall Study|Other|1|||
148790443|NCT04865419|536710821|FG004|Overall Study|Other|3|||
148790444|NCT04865419|536710822|FG005|Overall Study|Other|0|||
148790445|NCT04865419|536710823|FG006|Overall Study|Other|0|||
148790446|NCT04865419|536710824|FG007|Overall Study|Other|1|||
148790447|NCT04865419|536710825|FG008|Overall Study|Other|0|||
148790448|NCT04865419|536710826|FG009|Overall Study|Other|0|||
148790449|NCT04865419|536710827|FG010|Overall Study|Other|0|||
148790450|NCT04865419|536710817|FG000|Overall Study|Withdrawal by Subject|0|||
148790451|NCT04865419|536710818|FG001|Overall Study|Withdrawal by Subject|1|||
148790452|NCT04865419|536710819|FG002|Overall Study|Withdrawal by Subject|1|||
148790453|NCT04865419|536710820|FG003|Overall Study|Withdrawal by Subject|0|||
148790454|NCT04865419|536710821|FG004|Overall Study|Withdrawal by Subject|0|||
148790455|NCT04865419|536710822|FG005|Overall Study|Withdrawal by Subject|0|||
148790456|NCT04865419|536710823|FG006|Overall Study|Withdrawal by Subject|0|||
148790457|NCT04865419|536710824|FG007|Overall Study|Withdrawal by Subject|1|||
148790458|NCT04865419|536710825|FG008|Overall Study|Withdrawal by Subject|2|||
148790459|NCT04865419|536710826|FG009|Overall Study|Withdrawal by Subject|1|||
148790460|NCT04865419|536710827|FG010|Overall Study|Withdrawal by Subject|0|||
148790461|NCT04865419|536710817|FG000|Overall Study|Study terminated by Sponsor|0|||
148790462|NCT04865419|536710818|FG001|Overall Study|Study terminated by Sponsor|0|||
148790463|NCT04865419|536710819|FG002|Overall Study|Study terminated by Sponsor|0|||
148790464|NCT04865419|536710820|FG003|Overall Study|Study terminated by Sponsor|2|||
148790465|NCT04865419|536710821|FG004|Overall Study|Study terminated by Sponsor|2|||
148790466|NCT04865419|536710822|FG005|Overall Study|Study terminated by Sponsor|0|||
148790467|NCT04865419|536710823|FG006|Overall Study|Study terminated by Sponsor|0|||
148790468|NCT04865419|536710824|FG007|Overall Study|Study terminated by Sponsor|0|||
148893411|NCT01693029|537088700|FG000|Overall Study|Non-compliance|2|||
148893412|NCT01693029|537088701|FG001|Overall Study|Non-compliance|1|||
148790469|NCT04865419|536710825|FG008|Overall Study|Study terminated by Sponsor|0|||
148790470|NCT04865419|536710826|FG009|Overall Study|Study terminated by Sponsor|0|||
148790471|NCT04865419|536710827|FG010|Overall Study|Study terminated by Sponsor|1|||
148790472|NCT04865419|536710817|FG000|Overall Study|Death|3|||
148790473|NCT04865419|536710818|FG001|Overall Study|Death|1|||
148893413|NCT01329263|537088702|FG000|Overall Study|Lost to Follow-up|4|||
148790474|NCT04865419|536710819|FG002|Overall Study|Death|4|||
148790475|NCT04865419|536710820|FG003|Overall Study|Death|2|||
148790476|NCT04865419|536710821|FG004|Overall Study|Death|5|||
148790477|NCT04865419|536710822|FG005|Overall Study|Death|2|||
148790478|NCT04865419|536710823|FG006|Overall Study|Death|1|||
148790479|NCT04865419|536710824|FG007|Overall Study|Death|1|||
148790480|NCT04865419|536710825|FG008|Overall Study|Death|2|||
148790481|NCT04865419|536710826|FG009|Overall Study|Death|2|||
148790482|NCT04865419|536710827|FG010|Overall Study|Death|1|||
148893414|NCT01329263|537088703|FG001|Overall Study|Lost to Follow-up|21|||
148893415|NCT01329263|537088702|FG000|Overall Study|Withdrawal by Subject|1|||
148790483|NCT04865419|536710817|FG000|Overall Study|Lost to Follow-up|0|||
148790484|NCT04865419|536710818|FG001|Overall Study|Lost to Follow-up|0|||
148790485|NCT04865419|536710819|FG002|Overall Study|Lost to Follow-up|0|||
148790486|NCT04865419|536710820|FG003|Overall Study|Lost to Follow-up|0|||
148790487|NCT04865419|536710821|FG004|Overall Study|Lost to Follow-up|0|||
148790488|NCT04865419|536710822|FG005|Overall Study|Lost to Follow-up|0|||
148790489|NCT04865419|536710823|FG006|Overall Study|Lost to Follow-up|0|||
148790490|NCT04865419|536710824|FG007|Overall Study|Lost to Follow-up|0|||
148790491|NCT04865419|536710825|FG008|Overall Study|Lost to Follow-up|0|||
148790492|NCT04865419|536710826|FG009|Overall Study|Lost to Follow-up|1|||
148790493|NCT04865419|536710827|FG010|Overall Study|Lost to Follow-up|0|||
148790494|NCT00547157|536710828|FG000|Overall Study|Other|1|||
148790495|NCT00547157|536710829|FG001|Overall Study|Other|0|||
148790496|NCT00547157|536710828|FG000|Overall Study|Death|38|||
148790497|NCT00547157|536710829|FG001|Overall Study|Death|18|||
148790498|NCT00547157|536710828|FG000|Overall Study|Withdrawal by Subject|3|||
148790499|NCT00547157|536710829|FG001|Overall Study|Withdrawal by Subject|1|||
148790500|NCT00547157|536710828|FG000|Overall Study|Administrative decision|3|||
148790501|NCT00547157|536710829|FG001|Overall Study|Administrative decision|2|||
148790502|NCT00547157|536710828|FG000|Overall Study|Lost to Follow-up|4|||
148790503|NCT00547157|536710829|FG001|Overall Study|Lost to Follow-up|2|||
148790504|NCT04186221|536710830|FG000|Overall Study|Death|1|||
148790505|NCT00845676|536710837|FG000|Overall Study|Virologic breakthrough at week 20|1|||
148790506|NCT00845676|536710837|FG000|Overall Study|Adverse Event|1|||
148790507|NCT03275389|536710839|FG000|Overall Study|Lost to Follow-up|10|||
148790508|NCT03275389|536710840|FG001|Overall Study|Lost to Follow-up|10|||
148790509|NCT03275389|536710841|FG002|Overall Study|Lost to Follow-up|19|||
148790510|NCT03275389|536710842|FG003|Overall Study|Lost to Follow-up|12|||
148790511|NCT03275389|536710843|FG004|Overall Study|Lost to Follow-up|11|||
148790512|NCT03275389|536710844|FG005|Overall Study|Lost to Follow-up|12|||
148790513|NCT03275389|536710845|FG006|Overall Study|Lost to Follow-up|21|||
148790514|NCT03275389|536710846|FG007|Overall Study|Lost to Follow-up|15|||
148790515|NCT03275389|536710847|FG008|Overall Study|Lost to Follow-up|12|||
148790516|NCT03275389|536710848|FG009|Overall Study|Lost to Follow-up|14|||
148790517|NCT03275389|536710839|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790518|NCT03275389|536710840|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790519|NCT03275389|536710841|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790520|NCT03275389|536710842|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790521|NCT03275389|536710843|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790522|NCT03275389|536710844|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
148790523|NCT03275389|536710845|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790524|NCT03275389|536710846|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790525|NCT03275389|536710847|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
148790526|NCT03275389|536710848|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
148790527|NCT03275389|536710839|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
148790528|NCT03275389|536710840|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
148790529|NCT03275389|536710841|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
148790530|NCT03275389|536710842|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
148790531|NCT03275389|536710843|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
148790532|NCT03275389|536710844|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
148790533|NCT03275389|536710845|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
148790534|NCT03275389|536710846|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
148790535|NCT03275389|536710847|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
148790536|NCT03275389|536710848|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
148790537|NCT03275389|536710839|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148790538|NCT03275389|536710840|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
148790539|NCT03275389|536710841|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148790540|NCT03275389|536710842|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
148790541|NCT03275389|536710843|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148790542|NCT03275389|536710844|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148790543|NCT03275389|536710845|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148790544|NCT03275389|536710846|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148790545|NCT03275389|536710847|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148790546|NCT03275389|536710848|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148893416|NCT01329263|537088703|FG001|Overall Study|Withdrawal by Subject|2|||
148893417|NCT00791388|537088707|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
148790547|NCT03275389|536710839|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790548|NCT03275389|536710840|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790549|NCT03275389|536710841|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
148790550|NCT03275389|536710842|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790551|NCT03275389|536710843|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790552|NCT03275389|536710844|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790553|NCT03275389|536710845|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148893418|NCT00791388|537088708|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
148893419|NCT00791388|537088709|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
148893420|NCT00791388|537088710|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
148893421|NCT00791388|537088711|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
148893422|NCT00791388|537088707|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
148893423|NCT00791388|537088708|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
148790554|NCT03275389|536710846|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790555|NCT03275389|536710847|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
148790556|NCT03275389|536710848|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
148790557|NCT03275389|536710839|FG000|Overall Study|Other|0|||
148790558|NCT03275389|536710840|FG001|Overall Study|Other|4|||
148790559|NCT03275389|536710841|FG002|Overall Study|Other|3|||
148790560|NCT03275389|536710842|FG003|Overall Study|Other|2|||
148790561|NCT03275389|536710843|FG004|Overall Study|Other|2|||
148790562|NCT03275389|536710844|FG005|Overall Study|Other|2|||
148790563|NCT03275389|536710845|FG006|Overall Study|Other|0|||
148790564|NCT03275389|536710846|FG007|Overall Study|Other|0|||
148790565|NCT03275389|536710847|FG008|Overall Study|Other|1|||
148790566|NCT03275389|536710848|FG009|Overall Study|Other|0|||
148790567|NCT01790516|536710849|FG000|Overall Study|Physician Decision|1|||
148790568|NCT01790516|536710850|FG001|Overall Study|Physician Decision|0|||
148790569|NCT03749109|536710851|FG000|Overall Study|Adverse Event|2|||
148790570|NCT03749109|536710852|FG001|Overall Study|Adverse Event|0|||
148790571|NCT03034135|536710853|FG000|Overall Study|Withdrawal by Subject|2|||
148790572|NCT00878800|536712611|FG000|Overall Study|Adverse Event|0|||
148790573|NCT00878800|536712612|FG001|Overall Study|Adverse Event|0|||
148790574|NCT00878800|536712613|FG002|Overall Study|Adverse Event|2|||
148790575|NCT00878800|536712614|FG003|Overall Study|Adverse Event|0|||
148790576|NCT00878800|536712615|FG004|Overall Study|Adverse Event|1|||
148790577|NCT00878800|536712611|FG000|Overall Study|Progressive disease|1|||
148790578|NCT00878800|536712612|FG001|Overall Study|Progressive disease|5|||
148790579|NCT00878800|536712613|FG002|Overall Study|Progressive disease|6|||
148790580|NCT00878800|536712614|FG003|Overall Study|Progressive disease|5|||
148790581|NCT00878800|536712615|FG004|Overall Study|Progressive disease|13|||
148790582|NCT00878800|536712611|FG000|Overall Study|Withdrew consent|1|||
148790583|NCT00878800|536712612|FG001|Overall Study|Withdrew consent|1|||
148790584|NCT00878800|536712613|FG002|Overall Study|Withdrew consent|0|||
148790585|NCT00878800|536712614|FG003|Overall Study|Withdrew consent|1|||
148790586|NCT00878800|536712615|FG004|Overall Study|Withdrew consent|1|||
148790587|NCT00878800|536712611|FG000|Overall Study|Death|0|||
148790588|NCT00878800|536712612|FG001|Overall Study|Death|0|||
148790589|NCT00878800|536712613|FG002|Overall Study|Death|1|||
148790590|NCT00878800|536712614|FG003|Overall Study|Death|0|||
148790591|NCT00878800|536712615|FG004|Overall Study|Death|0|||
148790592|NCT00878800|536712611|FG000|Overall Study|Other|1|||
148790593|NCT00878800|536712612|FG001|Overall Study|Other|1|||
148790594|NCT00878800|536712613|FG002|Overall Study|Other|0|||
148790595|NCT00878800|536712614|FG003|Overall Study|Other|0|||
148790596|NCT00878800|536712615|FG004|Overall Study|Other|1|||
148790597|NCT03318003|536712616|FG000|Overall Study|Withdrawal by Subject|1|||
148790598|NCT03318003|536712617|FG001|Overall Study|Withdrawal by Subject|1|||
148790599|NCT03318003|536712616|FG000|Overall Study|fetal loss|0|||
148790600|NCT03318003|536712617|FG001|Overall Study|fetal loss|1|||
148790601|NCT01029262|536712621|FG000|Overall Study|Adverse Event|9|||
148790602|NCT01029262|536712622|FG001|Overall Study|Adverse Event|52|||
148790603|NCT01029262|536712621|FG000|Overall Study|Lack of therapeutic effect|57|||
148790604|NCT01029262|536712622|FG001|Overall Study|Lack of therapeutic effect|76|||
148790605|NCT01029262|536712621|FG000|Overall Study|Withdrawal by Subject|10|||
148790606|NCT01029262|536712622|FG001|Overall Study|Withdrawal by Subject|17|||
148893424|NCT00791388|537088709|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
148893425|NCT00791388|537088710|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
148893426|NCT00791388|537088711|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
148790607|NCT01029262|536712621|FG000|Overall Study|Protocol Violation|2|||
148790608|NCT01029262|536712622|FG001|Overall Study|Protocol Violation|3|||
148893427|NCT00791388|537088707|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
149130264|NCT02121834|537956227|FG002|Overall Study|Lost to Follow-up|1|||
149130265|NCT02121834|537956228|FG003|Overall Study|Lost to Follow-up|0|||
148790609|NCT01029262|536712621|FG000|Overall Study|Miscellaneous|1|||
148790610|NCT01029262|536712622|FG001|Overall Study|Miscellaneous|9|||
148790611|NCT01029262|536712621|FG000|Overall Study|Death|0|||
148790612|NCT01029262|536712622|FG001|Overall Study|Death|3|||
148790613|NCT02620787|536712625|FG000|Overall Study|Adverse Event|1|||
148790614|NCT02620787|536712626|FG001|Overall Study|Adverse Event|0|||
148790615|NCT02620787|536712625|FG000|Overall Study|Eligibility Criteria Not Met|1|||
148790616|NCT02620787|536712626|FG001|Overall Study|Eligibility Criteria Not Met|0|||
148790617|NCT01896193|536712627|FG000|Overall Study|Lack of Efficacy|20|||
148790618|NCT01896193|536712628|FG001|Overall Study|Lack of Efficacy|11|||
148790619|NCT01896193|536712627|FG000|Overall Study|Protocol Violation|0|||
148790620|NCT01896193|536712628|FG001|Overall Study|Protocol Violation|1|||
149130266|NCT02121834|537956229|FG004|Overall Study|Lost to Follow-up|0|||
149130267|NCT02121834|537956230|FG005|Overall Study|Lost to Follow-up|0|||
148790621|NCT01896193|536712627|FG000|Overall Study|Withdrew Consent|1|||
148790622|NCT01896193|536712628|FG001|Overall Study|Withdrew Consent|0|||
148790623|NCT02959918|536712630|FG000|Overall Study|Adverse Event|1|||
148790624|NCT02959918|536712631|FG001|Overall Study|Adverse Event|1|||
148790625|NCT02959918|536712632|FG002|Overall Study|Adverse Event|2|||
148790626|NCT02959918|536712633|FG003|Overall Study|Adverse Event|0|||
148790627|NCT02959918|536712634|FG004|Overall Study|Adverse Event|0|||
148790628|NCT02959918|536712635|FG005|Overall Study|Adverse Event|2|||
148790629|NCT02959918|536712636|FG006|Overall Study|Adverse Event|2|||
148790630|NCT02959918|536712637|FG007|Overall Study|Adverse Event|1|||
148790631|NCT02959918|536712638|FG008|Overall Study|Adverse Event|2|||
148790632|NCT02959918|536712639|FG009|Overall Study|Adverse Event|1|||
148790633|NCT02959918|536712640|FG010|Overall Study|Adverse Event|1|||
148790634|NCT02959918|536712641|FG011|Overall Study|Adverse Event|3|||
148790635|NCT02959918|536712642|FG012|Overall Study|Adverse Event|2|||
148790636|NCT02959918|536712643|FG013|Overall Study|Adverse Event|4|||
148790637|NCT02959918|536712630|FG000|Overall Study|Lost to Follow-up|0|||
148790638|NCT02959918|536712631|FG001|Overall Study|Lost to Follow-up|0|||
148790639|NCT02959918|536712632|FG002|Overall Study|Lost to Follow-up|0|||
148790640|NCT02959918|536712633|FG003|Overall Study|Lost to Follow-up|0|||
148790641|NCT02959918|536712634|FG004|Overall Study|Lost to Follow-up|0|||
148790642|NCT02959918|536712635|FG005|Overall Study|Lost to Follow-up|0|||
148790643|NCT02959918|536712636|FG006|Overall Study|Lost to Follow-up|0|||
148790644|NCT02959918|536712637|FG007|Overall Study|Lost to Follow-up|0|||
148790645|NCT02959918|536712638|FG008|Overall Study|Lost to Follow-up|0|||
148790646|NCT02959918|536712639|FG009|Overall Study|Lost to Follow-up|1|||
148790647|NCT02959918|536712640|FG010|Overall Study|Lost to Follow-up|0|||
148790648|NCT02959918|536712641|FG011|Overall Study|Lost to Follow-up|0|||
148790649|NCT02959918|536712642|FG012|Overall Study|Lost to Follow-up|1|||
148790650|NCT02959918|536712643|FG013|Overall Study|Lost to Follow-up|0|||
148790651|NCT02959918|536712630|FG000|Overall Study|Withdrawal by Subject|0|||
148790652|NCT02959918|536712631|FG001|Overall Study|Withdrawal by Subject|0|||
148790653|NCT02959918|536712632|FG002|Overall Study|Withdrawal by Subject|1|||
148790654|NCT02959918|536712633|FG003|Overall Study|Withdrawal by Subject|2|||
148790655|NCT02959918|536712634|FG004|Overall Study|Withdrawal by Subject|0|||
148790656|NCT02959918|536712635|FG005|Overall Study|Withdrawal by Subject|0|||
148790657|NCT02959918|536712636|FG006|Overall Study|Withdrawal by Subject|1|||
148790658|NCT02959918|536712637|FG007|Overall Study|Withdrawal by Subject|0|||
148790659|NCT02959918|536712638|FG008|Overall Study|Withdrawal by Subject|1|||
148790660|NCT02959918|536712639|FG009|Overall Study|Withdrawal by Subject|1|||
148790661|NCT02959918|536712640|FG010|Overall Study|Withdrawal by Subject|2|||
148790662|NCT02959918|536712641|FG011|Overall Study|Withdrawal by Subject|3|||
148790663|NCT02959918|536712642|FG012|Overall Study|Withdrawal by Subject|1|||
148790664|NCT02959918|536712643|FG013|Overall Study|Withdrawal by Subject|1|||
148790665|NCT02959918|536712630|FG000|Overall Study|Protocol Violation|0|||
148790666|NCT02959918|536712631|FG001|Overall Study|Protocol Violation|0|||
148790667|NCT02959918|536712632|FG002|Overall Study|Protocol Violation|1|||
148790668|NCT02959918|536712633|FG003|Overall Study|Protocol Violation|0|||
148790669|NCT02959918|536712634|FG004|Overall Study|Protocol Violation|0|||
148790670|NCT02959918|536712635|FG005|Overall Study|Protocol Violation|1|||
148790671|NCT02959918|536712636|FG006|Overall Study|Protocol Violation|0|||
148790672|NCT02959918|536712637|FG007|Overall Study|Protocol Violation|0|||
148790673|NCT02959918|536712638|FG008|Overall Study|Protocol Violation|2|||
148790674|NCT02959918|536712639|FG009|Overall Study|Protocol Violation|1|||
148790675|NCT02959918|536712640|FG010|Overall Study|Protocol Violation|0|||
148790676|NCT02959918|536712641|FG011|Overall Study|Protocol Violation|1|||
148790677|NCT02959918|536712642|FG012|Overall Study|Protocol Violation|1|||
148790678|NCT02959918|536712643|FG013|Overall Study|Protocol Violation|0|||
148790679|NCT02959918|536712630|FG000|Overall Study|Stopping Rule Met|1|||
149130268|NCT02121834|537956231|FG006|Overall Study|Lost to Follow-up|0|||
149130269|NCT02578862|537956232|FG000|Overall Study|Withdrawal by Subject|0|||
148790680|NCT02959918|536712631|FG001|Overall Study|Stopping Rule Met|0|||
148790681|NCT02959918|536712632|FG002|Overall Study|Stopping Rule Met|3|||
148790682|NCT02959918|536712633|FG003|Overall Study|Stopping Rule Met|4|||
148790683|NCT02959918|536712634|FG004|Overall Study|Stopping Rule Met|5|||
148790684|NCT02959918|536712635|FG005|Overall Study|Stopping Rule Met|3|||
148790685|NCT02959918|536712636|FG006|Overall Study|Stopping Rule Met|2|||
148790686|NCT02959918|536712637|FG007|Overall Study|Stopping Rule Met|4|||
148790687|NCT02959918|536712638|FG008|Overall Study|Stopping Rule Met|1|||
149130270|NCT02578862|537956233|FG001|Overall Study|Withdrawal by Subject|1|||
149130271|NCT02578862|537956232|FG000|Overall Study|Unplanned unilateral procedure|0|||
149130272|NCT02578862|537956233|FG001|Overall Study|Unplanned unilateral procedure|1|||
149130273|NCT02075541|537956241|FG000|Overall Study|Serious Adverse Event|1|||
148790688|NCT02959918|536712639|FG009|Overall Study|Stopping Rule Met|1|||
148790689|NCT02959918|536712640|FG010|Overall Study|Stopping Rule Met|3|||
148790690|NCT02959918|536712641|FG011|Overall Study|Stopping Rule Met|5|||
148790691|NCT02959918|536712642|FG012|Overall Study|Stopping Rule Met|2|||
148790692|NCT02959918|536712643|FG013|Overall Study|Stopping Rule Met|1|||
148790693|NCT02959918|536712630|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
148790694|NCT02959918|536712631|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
148790695|NCT02959918|536712632|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
148790696|NCT02959918|536712633|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
148790697|NCT02959918|536712634|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790698|NCT02959918|536712635|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790699|NCT02959918|536712636|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790700|NCT02959918|536712637|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790701|NCT02959918|536712638|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790702|NCT02959918|536712639|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790703|NCT02959918|536712640|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790704|NCT02959918|536712641|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790705|NCT02959918|536712642|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790706|NCT02959918|536712643|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
148790707|NCT02959918|536712630|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790708|NCT02959918|536712631|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790709|NCT02959918|536712632|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790710|NCT02959918|536712633|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790711|NCT02959918|536712634|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790712|NCT02959918|536712635|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790713|NCT02959918|536712636|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790714|NCT02959918|536712637|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
148790715|NCT02959918|536712638|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790716|NCT02959918|536712639|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790717|NCT02959918|536712640|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790718|NCT02959918|536712641|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148893428|NCT00791388|537088708|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
149130274|NCT02075541|537956242|FG001|Overall Study|Serious Adverse Event|4|||
149130275|NCT02075541|537956241|FG000|Overall Study|Protocol Violation|1|||
149130276|NCT02075541|537956242|FG001|Overall Study|Protocol Violation|0|||
149130277|NCT02075541|537956241|FG000|Overall Study|Withdrawal by Subject|1|||
149130278|NCT02075541|537956242|FG001|Overall Study|Withdrawal by Subject|3|||
149130279|NCT02075541|537956241|FG000|Overall Study|Sponsor study termination|0|||
149130280|NCT02075541|537956242|FG001|Overall Study|Sponsor study termination|1|||
149130281|NCT02075541|537956241|FG000|Overall Study|Other- unable to perform study procedure|1|||
149130282|NCT02075541|537956242|FG001|Overall Study|Other- unable to perform study procedure|0|||
149130283|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
149130284|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
149130285|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Death|0|||
149130286|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Death|2|||
149130287|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
148790719|NCT02959918|536712642|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148893429|NCT00791388|537088709|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
148893430|NCT00791388|537088710|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
148893431|NCT00791388|537088711|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
148893432|NCT00443040|537088719|FG000|Overall Study|Withdrawal by Subject|1|||
148893433|NCT00443040|537088720|FG001|Overall Study|Withdrawal by Subject|0|||
148893434|NCT00443040|537088721|FG002|Overall Study|Withdrawal by Subject|0|||
148893435|NCT00443040|537088719|FG000|Overall Study|Converted to an open laparotomy|3|||
148893436|NCT00443040|537088720|FG001|Overall Study|Converted to an open laparotomy|0|||
148893437|NCT00443040|537088721|FG002|Overall Study|Converted to an open laparotomy|1|||
148893438|NCT02469623|537088722|FG000|Overall Study|Not consented for long-term follow-up|4|||
148893439|NCT02469623|537088722|FG000|Overall Study|Lost to Follow-up|4|||
148893440|NCT02469623|537088722|FG000|Overall Study|Withdrawal by Subject|2|||
148893441|NCT02469623|537088722|FG000|Overall Study|Death|3|||
148893442|NCT03309878|537088723|FG000|Overall Study|Adverse Event|1|||
148893443|NCT03309878|537088724|FG001|Overall Study|Adverse Event|0|||
148893444|NCT03309878|537088725|FG002|Overall Study|Adverse Event|0|||
148893445|NCT03309878|537088726|FG003|Overall Study|Adverse Event|0|||
148893446|NCT03309878|537088723|FG000|Overall Study|Did not maintain eligibility|2|||
148893447|NCT03309878|537088724|FG001|Overall Study|Did not maintain eligibility|1|||
148893448|NCT03309878|537088725|FG002|Overall Study|Did not maintain eligibility|0|||
148790720|NCT02959918|536712643|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
148790721|NCT02959918|536712630|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148893449|NCT03309878|537088726|FG003|Overall Study|Did not maintain eligibility|0|||
148893450|NCT03309878|537088723|FG000|Overall Study|Withdrawal by Subject|0|||
148893451|NCT03309878|537088724|FG001|Overall Study|Withdrawal by Subject|1|||
148790722|NCT02959918|536712631|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790723|NCT02959918|536712632|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790724|NCT02959918|536712633|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790725|NCT02959918|536712634|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790726|NCT02959918|536712635|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790727|NCT02959918|536712636|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790728|NCT02959918|536712637|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790729|NCT02959918|536712638|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
148790730|NCT02959918|536712639|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790731|NCT02959918|536712640|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790732|NCT02959918|536712641|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790733|NCT02959918|536712642|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790734|NCT02959918|536712643|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
148790735|NCT02959918|536712630|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790736|NCT02959918|536712631|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790737|NCT02959918|536712632|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790738|NCT02959918|536712633|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790739|NCT02959918|536712634|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790740|NCT02959918|536712635|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790741|NCT02959918|536712636|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790742|NCT02959918|536712637|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790743|NCT02959918|536712638|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790744|NCT02959918|536712639|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
148790745|NCT02959918|536712640|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790746|NCT02959918|536712641|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790747|NCT02959918|536712642|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790748|NCT02959918|536712643|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
148790749|NCT03173456|536712645|FG000|Baseline|Medication dispensing system malfunction'|0|||
148790750|NCT03173456|536712646|FG001|Baseline|Medication dispensing system malfunction'|1|||
148790751|NCT03173456|536712647|FG002|Baseline|Medication dispensing system malfunction'|0|||
148790752|NCT03173456|536712648|FG003|Baseline|Medication dispensing system malfunction'|0|||
148790753|NCT03173456|536712649|FG004|Baseline|Medication dispensing system malfunction'|2|||
148790754|NCT03173456|536712645|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
148790755|NCT03173456|536712646|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
148790756|NCT03173456|536712647|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
148790757|NCT03173456|536712648|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
148790758|NCT03173456|536712649|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
148790759|NCT01733121|536712650|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
148790760|NCT01733121|536712651|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
148790761|NCT01733121|536712650|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
148790762|NCT01733121|536712651|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
148790763|NCT01733121|536712650|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
148790764|NCT01733121|536712651|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
148790765|NCT01733121|536712650|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
148790766|NCT01733121|536712651|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
148790767|NCT03061188|536712652|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
148790768|NCT03061188|536712653|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
148790769|NCT03061188|536712654|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
148790770|NCT03061188|536712655|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
148790771|NCT03061188|536712652|FG000|On Follow-up for 3 Years|Death|0|||
148790772|NCT03061188|536712653|FG001|On Follow-up for 3 Years|Death|3|||
148790773|NCT03061188|536712654|FG002|On Follow-up for 3 Years|Death|5|||
148790774|NCT03061188|536712655|FG003|On Follow-up for 3 Years|Death|4|||
148790775|NCT03061188|536712652|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
148790776|NCT03061188|536712653|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
148790777|NCT03061188|536712654|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
148790778|NCT03061188|536712655|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
148790779|NCT02609984|536712656|FG000|Overall Study|Death|29|||
148790780|NCT02609984|536712657|FG001|Overall Study|Death|26|||
148790781|NCT02609984|536712656|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
148790782|NCT02609984|536712657|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
148790783|NCT02609984|536712656|FG000|Overall Study|Lost to Follow-up|1|||
148790784|NCT02609984|536712657|FG001|Overall Study|Lost to Follow-up|2|||
148790785|NCT02609984|536712656|FG000|Overall Study|Withdrawal by Subject|0|||
148790786|NCT02609984|536712657|FG001|Overall Study|Withdrawal by Subject|1|||
148790787|NCT02609984|536712656|FG000|Overall Study|Disease Progression|2|||
149130288|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
148790788|NCT02609984|536712657|FG001|Overall Study|Disease Progression|0|||
148790789|NCT02306850|536712663|FG000|Overall Study|Lack of Efficacy|2|||
148790790|NCT02420262|536712664|FG000|Overall Study|Adverse Event|1|||
148790791|NCT02420262|536712665|FG001|Overall Study|Adverse Event|0|||
148790792|NCT02420262|536712664|FG000|Overall Study|Withdrawal by Subject|1|||
148790793|NCT02420262|536712665|FG001|Overall Study|Withdrawal by Subject|4|||
148790794|NCT02420262|536712664|FG000|Overall Study|Unclassified|0|||
148790795|NCT02420262|536712665|FG001|Overall Study|Unclassified|1|||
148790796|NCT00941304|536712666|FG000|Overall Study|Lost to Follow-up|1|||
148790797|NCT00941304|536712667|FG001|Overall Study|Lost to Follow-up|0|||
148790798|NCT00941304|536712668|FG002|Overall Study|Lost to Follow-up|0|||
148790799|NCT00941304|536712669|FG003|Overall Study|Lost to Follow-up|0|||
148790800|NCT00941304|536712670|FG004|Overall Study|Lost to Follow-up|0|||
148790801|NCT03293394|536712671|FG000|Follow-up (6 Months)|Adverse Event|4|||
148790802|NCT03293394|536712672|FG001|Follow-up (6 Months)|Adverse Event|2|||
148790803|NCT00784719|536712675|FG000|Overall Study|Adverse Event|0|||
148790804|NCT00784719|536712676|FG001|Overall Study|Adverse Event|2|||
148790805|NCT00784719|536712677|FG002|Overall Study|Adverse Event|0|||
148790806|NCT00784719|536712678|FG003|Overall Study|Adverse Event|0|||
148790807|NCT00784719|536712679|FG004|Overall Study|Adverse Event|1|||
148790808|NCT00784719|536712680|FG005|Overall Study|Adverse Event|1|||
148790809|NCT00784719|536712681|FG006|Overall Study|Adverse Event|1|||
148790810|NCT00784719|536712675|FG000|Overall Study|Lost to Follow-up|0|||
148790811|NCT00784719|536712676|FG001|Overall Study|Lost to Follow-up|0|||
148790812|NCT00784719|536712677|FG002|Overall Study|Lost to Follow-up|0|||
148790813|NCT00784719|536712678|FG003|Overall Study|Lost to Follow-up|0|||
148790814|NCT00784719|536712679|FG004|Overall Study|Lost to Follow-up|1|||
148790815|NCT00784719|536712680|FG005|Overall Study|Lost to Follow-up|1|||
148790816|NCT00784719|536712681|FG006|Overall Study|Lost to Follow-up|0|||
148790817|NCT00784719|536712675|FG000|Overall Study|Other|2|||
148790818|NCT00784719|536712676|FG001|Overall Study|Other|1|||
148790819|NCT00784719|536712677|FG002|Overall Study|Other|1|||
148790820|NCT00784719|536712678|FG003|Overall Study|Other|0|||
148790821|NCT00784719|536712679|FG004|Overall Study|Other|2|||
148790822|NCT00784719|536712680|FG005|Overall Study|Other|1|||
148790823|NCT00784719|536712681|FG006|Overall Study|Other|3|||
148790824|NCT00784719|536712675|FG000|Overall Study|Withdrawal by Subject|1|||
148790825|NCT00784719|536712676|FG001|Overall Study|Withdrawal by Subject|0|||
148790826|NCT00784719|536712677|FG002|Overall Study|Withdrawal by Subject|0|||
148790827|NCT00784719|536712678|FG003|Overall Study|Withdrawal by Subject|0|||
148790828|NCT00784719|536712679|FG004|Overall Study|Withdrawal by Subject|2|||
148790829|NCT00784719|536712680|FG005|Overall Study|Withdrawal by Subject|0|||
148790830|NCT00784719|536712681|FG006|Overall Study|Withdrawal by Subject|1|||
148790831|NCT01436227|536712685|FG000|Overall Study|Adverse Event|7|||
148790832|NCT01436227|536712685|FG000|Overall Study|Death|1|||
148790833|NCT01436227|536712685|FG000|Overall Study|Lack of Efficacy|1|||
148790834|NCT01436227|536712685|FG000|Overall Study|Lost to Follow-up|3|||
148790835|NCT01436227|536712685|FG000|Overall Study|Physician Decision|1|||
148790836|NCT01436227|536712685|FG000|Overall Study|Withdrawal by Subject|7|||
148790837|NCT01436227|536712685|FG000|Overall Study|Disease progression, relapse|6|||
148790838|NCT05446142|536712686|FG000|Period 2|Adverse Event|1|||
148790839|NCT05446142|536712687|FG001|Period 2|Adverse Event|0|||
149130289|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
149130290|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
149130291|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
149130292|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
149130293|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
149130294|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
149130295|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
149130296|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
149130297|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
149130298|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
149130299|NCT00343252|537956243|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
149130300|NCT00343252|537956244|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
149130301|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
149130302|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
149130303|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Death|3|||
148790840|NCT05446142|536712688|FG002|Period 2|Adverse Event|0|||
148790841|NCT05446142|536712689|FG003|Period 2|Adverse Event|0|||
148790842|NCT05446142|536712690|FG004|Period 2|Adverse Event|0|||
148790843|NCT05446142|536712691|FG005|Period 2|Adverse Event|0|||
148790844|NCT04633226|536712704|FG000|Overall Study|Withdrawal by parent/guardian|4|||
148790845|NCT04633226|536712704|FG000|Overall Study|Randomized by mistake without study treatment|1|||
148790846|NCT05415462|536712708|FG000|Overall Study|Death|18|||
148790847|NCT05415462|536712709|FG001|Overall Study|Death|10|||
148790848|NCT05415462|536712708|FG000|Overall Study|Lost to Follow-up|72|||
148790849|NCT05415462|536712709|FG001|Overall Study|Lost to Follow-up|64|||
149130304|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Death|3|||
149130305|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
149130306|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
149130307|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
149130308|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
149130309|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
149130310|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
149130311|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
149130312|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
149130313|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
149130314|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
149130315|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
149130316|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
149130317|NCT00343252|537956243|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
149130318|NCT00343252|537956244|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
149130319|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
149130320|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
149130321|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Death|4|||
149130322|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Death|5|||
149130323|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
149130324|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
149130325|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
149130326|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
149130327|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
149130328|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
149130329|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
149130330|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
149130331|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
149130332|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
149130333|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
149130334|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
149130335|NCT00343252|537956243|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
149130336|NCT00343252|537956244|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
149130337|NCT02076178|537956245|FG000|Oral Phase|Adverse Event|0|||
149130338|NCT02076178|537956246|FG001|Oral Phase|Adverse Event|7|||
149130339|NCT02076178|537956245|FG000|Oral Phase|Withdrawal by Subject|0|||
149130340|NCT02076178|537956246|FG001|Oral Phase|Withdrawal by Subject|4|||
149130341|NCT02076178|537956245|FG000|Oral Phase|Physician Decision|0|||
149130342|NCT02076178|537956246|FG001|Oral Phase|Physician Decision|1|||
149130343|NCT02076178|537956245|FG000|Injection Phase|Protocol defined stopping criteria|1|||
149130344|NCT02076178|537956246|FG001|Injection Phase|Protocol defined stopping criteria|0|||
149130345|NCT02076178|537956245|FG000|Injection Phase|Withdrawal by Subject|0|||
149130346|NCT02076178|537956246|FG001|Injection Phase|Withdrawal by Subject|3|||
149130347|NCT02076178|537956245|FG000|Injection Phase|Physician Decision|0|||
149130348|NCT02076178|537956246|FG001|Injection Phase|Physician Decision|3|||
149130349|NCT02076178|537956245|FG000|Injection Phase|Lost to Follow-up|0|||
149130350|NCT02076178|537956246|FG001|Injection Phase|Lost to Follow-up|1|||
149130351|NCT00731120|537956247|FG000|Overall Study|Adverse Event|7|||
149130352|NCT00731120|537956248|FG001|Overall Study|Adverse Event|6|||
149130353|NCT00731120|537956249|FG002|Overall Study|Adverse Event|8|||
149130354|NCT00731120|537956247|FG000|Overall Study|Lack of Efficacy|4|||
149130355|NCT00731120|537956248|FG001|Overall Study|Lack of Efficacy|5|||
149130356|NCT00731120|537956249|FG002|Overall Study|Lack of Efficacy|4|||
149130357|NCT00731120|537956247|FG000|Overall Study|Noncompliance with Study Drug|3|||
149130358|NCT00731120|537956248|FG001|Overall Study|Noncompliance with Study Drug|3|||
149130359|NCT00731120|537956249|FG002|Overall Study|Noncompliance with Study Drug|1|||
149130360|NCT00731120|537956247|FG000|Overall Study|Protocol Deviations|1|||
149130361|NCT00731120|537956248|FG001|Overall Study|Protocol Deviations|6|||
149130362|NCT00731120|537956249|FG002|Overall Study|Protocol Deviations|1|||
149130363|NCT00731120|537956247|FG000|Overall Study|Withdrawal of Consent|13|||
149130364|NCT00731120|537956248|FG001|Overall Study|Withdrawal of Consent|8|||
149130365|NCT00731120|537956249|FG002|Overall Study|Withdrawal of Consent|4|||
149130366|NCT00731120|537956247|FG000|Overall Study|Lost to Follow-up|10|||
149130367|NCT00731120|537956248|FG001|Overall Study|Lost to Follow-up|15|||
149130368|NCT00731120|537956249|FG002|Overall Study|Lost to Follow-up|17|||
149130369|NCT00731120|537956247|FG000|Overall Study|Other|4|||
149130370|NCT00731120|537956248|FG001|Overall Study|Other|0|||
149130371|NCT00731120|537956249|FG002|Overall Study|Other|1|||
149130372|NCT01142596|537956252|FG000|Overall Study|Withdrawal by Subject|9|||
149130373|NCT01142596|537956253|FG001|Overall Study|Withdrawal by Subject|35|||
149130374|NCT01142596|537956252|FG000|Overall Study|Adverse Event|8|||
149130375|NCT01142596|537956253|FG001|Overall Study|Adverse Event|35|||
149130376|NCT01142596|537956252|FG000|Overall Study|Lack of Efficacy|5|||
149130377|NCT01142596|537956253|FG001|Overall Study|Lack of Efficacy|9|||
149130378|NCT01142596|537956252|FG000|Overall Study|Lost to Follow-up|2|||
149130379|NCT01142596|537956253|FG001|Overall Study|Lost to Follow-up|3|||
149130380|NCT01142596|537956252|FG000|Overall Study|Other reason (not specified)|5|||
149130381|NCT01142596|537956253|FG001|Overall Study|Other reason (not specified)|4|||
149130382|NCT02019927|537956254|FG000|Overall Study|Lost to Follow-up|2|||
149130383|NCT02019927|537956255|FG001|Overall Study|Lost to Follow-up|4|||
149130384|NCT02019927|537956256|FG002|Overall Study|Lost to Follow-up|1|||
149130385|NCT02019927|537956257|FG003|Overall Study|Lost to Follow-up|2|||
149130386|NCT02019927|537956258|FG004|Overall Study|Lost to Follow-up|3|||
149130387|NCT02019927|537956259|FG005|Overall Study|Lost to Follow-up|1|||
149130388|NCT00394953|537956260|FG000|First Treatment Period|Adverse Event|1|||
148893452|NCT03309878|537088725|FG002|Overall Study|Withdrawal by Subject|0|||
148893453|NCT03309878|537088726|FG003|Overall Study|Withdrawal by Subject|0|||
148893454|NCT01096316|537088727|FG000|Overall Study|Lost to Follow-up|15|||
148893455|NCT01096316|537088728|FG001|Overall Study|Lost to Follow-up|9|||
148893456|NCT02763644|537088729|FG000|Overall Study|Patient/guardian decision|1|||
148893457|NCT02763644|537088730|FG001|Overall Study|Patient/guardian decision|0|||
148893458|NCT02763644|537088729|FG000|Overall Study|Death|1|||
148893459|NCT02763644|537088730|FG001|Overall Study|Death|1|||
148893460|NCT02763644|537088729|FG000|Overall Study|Adverse Event|1|||
148893461|NCT02763644|537088730|FG001|Overall Study|Adverse Event|1|||
148893462|NCT01884077|537088731|FG000|Overall Study|screen fail|0|||
148893463|NCT01884077|537088732|FG001|Overall Study|screen fail|2|||
148893464|NCT01884077|537088731|FG000|Overall Study|canceled surgery|2|||
148893465|NCT01884077|537088732|FG001|Overall Study|canceled surgery|0|||
148893466|NCT01884077|537088731|FG000|Overall Study|Lost to Follow-up|0|||
148893467|NCT01884077|537088732|FG001|Overall Study|Lost to Follow-up|4|||
148893468|NCT01884077|537088731|FG000|Overall Study|study closed|6|||
148893469|NCT01884077|537088732|FG001|Overall Study|study closed|4|||
148893470|NCT02836652|537088733|FG000|Overall Study|Death|3|||
148893471|NCT02836652|537088734|FG001|Overall Study|Death|3|||
148893472|NCT02836652|537088733|FG000|Overall Study|Transplant/Explant|3|||
148893473|NCT02836652|537088734|FG001|Overall Study|Transplant/Explant|4|||
148893474|NCT02836652|537088733|FG000|Overall Study|Withdrawn|9|||
148893475|NCT02836652|537088734|FG001|Overall Study|Withdrawn|9|||
148893476|NCT02836652|537088733|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
148893477|NCT02836652|537088734|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
148893478|NCT02648204|537088736|FG000|Overall Study|Withdrawal by Subject|12|||
148893479|NCT02648204|537088737|FG001|Overall Study|Withdrawal by Subject|8|||
148893480|NCT02648204|537088738|FG002|Overall Study|Withdrawal by Subject|2|||
148893481|NCT02648204|537088739|FG003|Overall Study|Withdrawal by Subject|6|||
148893482|NCT02648204|537088736|FG000|Overall Study|Lost to Follow-up|5|||
148893483|NCT02648204|537088737|FG001|Overall Study|Lost to Follow-up|8|||
148893484|NCT02648204|537088738|FG002|Overall Study|Lost to Follow-up|4|||
148893485|NCT02648204|537088739|FG003|Overall Study|Lost to Follow-up|6|||
148893486|NCT02648204|537088736|FG000|Overall Study|Missing follow-up information|4|||
148893487|NCT02648204|537088737|FG001|Overall Study|Missing follow-up information|4|||
148893488|NCT02648204|537088738|FG002|Overall Study|Missing follow-up information|4|||
148893489|NCT02648204|537088739|FG003|Overall Study|Missing follow-up information|2|||
148893490|NCT02648204|537088736|FG000|Overall Study|Death|1|||
148893491|NCT02648204|537088737|FG001|Overall Study|Death|1|||
148893492|NCT02648204|537088738|FG002|Overall Study|Death|2|||
148893493|NCT02648204|537088739|FG003|Overall Study|Death|2|||
148893494|NCT02648204|537088736|FG000|Overall Study|Adverse Event|0|||
148893495|NCT02648204|537088737|FG001|Overall Study|Adverse Event|0|||
148893496|NCT02648204|537088738|FG002|Overall Study|Adverse Event|1|||
148893497|NCT02648204|537088739|FG003|Overall Study|Adverse Event|0|||
148893498|NCT01008943|537088744|FG000|Overall Study|Withdrawal by Subject|1|||
149130389|NCT00394953|537956261|FG001|First Treatment Period|Adverse Event|2|||
148893499|NCT02356159|537088745|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
148893500|NCT02356159|537088746|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
148893501|NCT02356159|537088747|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
149130390|NCT00394953|537956260|FG000|First Treatment Period|Death|6|||
149130391|NCT00394953|537956261|FG001|First Treatment Period|Death|7|||
148893502|NCT02356159|537088748|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
148893503|NCT02356159|537088749|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
148893504|NCT02356159|537088750|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
148893505|NCT00861705|537088751|FG000|Overall Study|Never Began Treatment|7|||
149130392|NCT00394953|537956260|FG000|First Treatment Period|Lack of Efficacy|1|||
148893506|NCT00861705|537088752|FG001|Overall Study|Never Began Treatment|3|||
148893507|NCT00861705|537088753|FG002|Overall Study|Never Began Treatment|0|||
148893508|NCT00861705|537088754|FG003|Overall Study|Never Began Treatment|1|||
148893509|NCT06418152|537088755|FG000|Overall Study|Frequent DBS setting changes|1|||
149130393|NCT00394953|537956261|FG001|First Treatment Period|Lack of Efficacy|1|||
149130394|NCT00394953|537956260|FG000|First Treatment Period|Withdrawal by Subject|6|||
149130395|NCT00394953|537956261|FG001|First Treatment Period|Withdrawal by Subject|3|||
149130396|NCT00394953|537956260|FG000|First Treatment Period|Lost to Follow-up|0|||
149130397|NCT00394953|537956261|FG001|First Treatment Period|Lost to Follow-up|1|||
149130398|NCT00394953|537956260|FG000|First Treatment Period|Renal transplant|11|||
149130399|NCT00394953|537956261|FG001|First Treatment Period|Renal transplant|7|||
149130400|NCT00394953|537956260|FG000|First Treatment Period|Not defined|4|||
149130401|NCT00394953|537956261|FG001|First Treatment Period|Not defined|1|||
149130402|NCT00394953|537956260|FG000|Second Treatment Period|Adverse Event|2|||
149130403|NCT00394953|537956261|FG001|Second Treatment Period|Adverse Event|5|||
149130404|NCT00394953|537956260|FG000|Second Treatment Period|Death|8|||
149130405|NCT00394953|537956261|FG001|Second Treatment Period|Death|4|||
149130406|NCT00394953|537956260|FG000|Second Treatment Period|Lack of Efficacy|9|||
149130407|NCT00394953|537956261|FG001|Second Treatment Period|Lack of Efficacy|47|||
149130408|NCT00394953|537956260|FG000|Second Treatment Period|Withdrawal by Subject|3|||
149130409|NCT00394953|537956261|FG001|Second Treatment Period|Withdrawal by Subject|3|||
149130410|NCT00394953|537956260|FG000|Second Treatment Period|Lost to Follow-up|0|||
149130411|NCT00394953|537956261|FG001|Second Treatment Period|Lost to Follow-up|1|||
149130412|NCT00394953|537956260|FG000|Second Treatment Period|Renal transplant|4|||
149130413|NCT00394953|537956261|FG001|Second Treatment Period|Renal transplant|6|||
149130414|NCT00394953|537956260|FG000|Second Treatment Period|Not defined|3|||
149130415|NCT00394953|537956261|FG001|Second Treatment Period|Not defined|8|||
149130416|NCT03181451|537956262|FG000|Overall Study|Adverse Event|0|||
149130417|NCT03181451|537956263|FG001|Overall Study|Adverse Event|1|||
149130418|NCT03181451|537956264|FG002|Overall Study|Adverse Event|0|||
149130419|NCT03181451|537956262|FG000|Overall Study|Withdrawal by Subject|0|||
149130420|NCT03181451|537956263|FG001|Overall Study|Withdrawal by Subject|1|||
149130421|NCT03181451|537956264|FG002|Overall Study|Withdrawal by Subject|0|||
149130422|NCT03021954|537956280|FG000|Overall Study|Lost to Follow-up|10|||
149130423|NCT03021954|537956281|FG001|Overall Study|Lost to Follow-up|43|||
149130424|NCT03021954|537956280|FG000|Overall Study|Subjects had avulsion trauma|4|||
149130425|NCT03021954|537956281|FG001|Overall Study|Subjects had avulsion trauma|1|||
149130426|NCT02196714|537956284|FG000|Overall Study|Protocol Violation|0|||
149130427|NCT02196714|537956285|FG001|Overall Study|Protocol Violation|0|||
149130428|NCT02196714|537956286|FG002|Overall Study|Protocol Violation|1|||
149130429|NCT02196714|537956287|FG003|Overall Study|Protocol Violation|0|||
149130430|NCT01592864|537956289|FG000|Overall Study|Withdrawal by Subject|0|||
149130431|NCT01592864|537956290|FG001|Overall Study|Withdrawal by Subject|1|||
149130432|NCT01326533|537956293|FG000|Overall Study|Lost to Follow-up|2|||
149130433|NCT01326533|537956294|FG001|Overall Study|Lost to Follow-up|0|||
149130434|NCT01326533|537956293|FG000|Overall Study|Withdrawal by Subject|1|||
149130435|NCT01326533|537956294|FG001|Overall Study|Withdrawal by Subject|0|||
149130436|NCT01326533|537956293|FG000|Overall Study|Adverse Event|1|||
149130437|NCT01326533|537956294|FG001|Overall Study|Adverse Event|0|||
149130438|NCT04079803|537956295|FG000|Overall Study|Withdrawal by Subject|0|||
149130439|NCT04079803|537956296|FG001|Overall Study|Withdrawal by Subject|0|||
149130440|NCT04079803|537956297|FG002|Overall Study|Withdrawal by Subject|1|||
149130441|NCT03037619|537956298|FG000|Overall Study|Lost to Follow-up|0|||
149130442|NCT03037619|537956299|FG001|Overall Study|Lost to Follow-up|1|||
149130443|NCT00807235|537956302|FG000|Overall Study|Adverse Event|1|||
149130444|NCT00807235|537956303|FG001|Overall Study|Adverse Event|0|||
149130445|NCT01012713|537956304|FG000|Overall Study|Lack of Efficacy|3|||
149130446|NCT01596621|537956305|FG000|Overall Study|Death|4|||
149130447|NCT01596621|537956305|FG000|Overall Study|Withdrawal by Subject|9|||
149130448|NCT01596621|537956305|FG000|Overall Study|Disease Progression|49|||
149130449|NCT01596621|537956305|FG000|Overall Study|Lost to Follow-up|3|||
149130450|NCT01596621|537956305|FG000|Overall Study|Other than specified|13|||
149130451|NCT02988622|537956306|FG000|Overall Study|Lost to Follow-up|17|||
149130452|NCT01201265|537956307|FG000|Overall Study|Death|14|||
149130453|NCT01201265|537956307|FG000|Overall Study|Insufficient Therapeutic Response|3|||
149130454|NCT01201265|537956307|FG000|Overall Study|Lost to Follow-up|10|||
149130455|NCT01201265|537956307|FG000|Overall Study|Withdrawal by Subject|7|||
149130456|NCT01201265|537956307|FG000|Overall Study|Disease Progression|4|||
149130457|NCT01575028|537956308|FG000|Overall Study|Physician Decision|0|||
149130458|NCT01575028|537956309|FG001|Overall Study|Physician Decision|1|||
149130459|NCT02409368|537956310|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
149130460|NCT02409368|537956311|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
149130461|NCT02409368|537956312|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
149130462|NCT02409368|537956313|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
149130463|NCT02409368|537956310|FG000|ECOG Reclassification|Death|1|||
149130464|NCT02409368|537956311|FG001|ECOG Reclassification|Death|5|||
149130465|NCT02409368|537956312|FG002|ECOG Reclassification|Death|0|||
149130466|NCT02409368|537956313|FG003|ECOG Reclassification|Death|0|||
149130467|NCT02409368|537956310|FG000|ECOG Reclassification|Disease Progression|113|||
149130468|NCT02409368|537956311|FG001|ECOG Reclassification|Disease Progression|382|||
149130469|NCT02409368|537956312|FG002|ECOG Reclassification|Disease Progression|70|||
149130470|NCT02409368|537956313|FG003|ECOG Reclassification|Disease Progression|1|||
149130471|NCT02409368|537956310|FG000|ECOG Reclassification|Lost to Follow-up|1|||
149130472|NCT02409368|537956311|FG001|ECOG Reclassification|Lost to Follow-up|5|||
149130473|NCT02409368|537956312|FG002|ECOG Reclassification|Lost to Follow-up|0|||
149130474|NCT02409368|537956313|FG003|ECOG Reclassification|Lost to Follow-up|0|||
149130475|NCT02409368|537956310|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
149130476|NCT02409368|537956311|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
149130477|NCT02409368|537956312|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
149130478|NCT02409368|537956313|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
149130479|NCT02409368|537956310|FG000|ECOG Reclassification|Poor/non-compliance|0|||
149130480|NCT02409368|537956311|FG001|ECOG Reclassification|Poor/non-compliance|3|||
149130481|NCT02409368|537956312|FG002|ECOG Reclassification|Poor/non-compliance|2|||
149130482|NCT02409368|537956313|FG003|ECOG Reclassification|Poor/non-compliance|0|||
149130483|NCT02409368|537956310|FG000|ECOG Reclassification|Study drug toxicity|17|||
149130484|NCT02409368|537956311|FG001|ECOG Reclassification|Study drug toxicity|42|||
149130485|NCT02409368|537956312|FG002|ECOG Reclassification|Study drug toxicity|7|||
149130486|NCT02409368|537956313|FG003|ECOG Reclassification|Study drug toxicity|0|||
149130487|NCT02409368|537956310|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
149130488|NCT02409368|537956311|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
149130489|NCT02409368|537956312|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
149130490|NCT02409368|537956313|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
149130491|NCT02409368|537956310|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
149130492|NCT02409368|537956311|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
149130493|NCT02409368|537956312|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
149130494|NCT02409368|537956313|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
149130495|NCT02409368|537956310|FG000|ECOG Reclassification|Participant withdrew consent|2|||
149130496|NCT02409368|537956311|FG001|ECOG Reclassification|Participant withdrew consent|3|||
149130497|NCT02409368|537956312|FG002|ECOG Reclassification|Participant withdrew consent|4|||
149130498|NCT02409368|537956313|FG003|ECOG Reclassification|Participant withdrew consent|0|||
149130499|NCT02409368|537956310|FG000|ECOG Reclassification|Other Reasons|5|||
149130500|NCT02409368|537956311|FG001|ECOG Reclassification|Other Reasons|26|||
149130501|NCT02409368|537956312|FG002|ECOG Reclassification|Other Reasons|2|||
149130502|NCT02409368|537956313|FG003|ECOG Reclassification|Other Reasons|0|||
149130503|NCT02409368|537956310|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
149130504|NCT02409368|537956311|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
149130505|NCT02409368|537956312|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
149130506|NCT02409368|537956313|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
149130507|NCT01296347|537956314|FG000|Allocation|Withdrawal by Subject|1|||
149130508|NCT01296347|537956315|FG001|Allocation|Withdrawal by Subject|2|||
149130509|NCT01296347|537956314|FG000|Allocation|Lack of Efficacy|1|||
149130510|NCT01296347|537956315|FG001|Allocation|Lack of Efficacy|2|||
149130511|NCT01296347|537956314|FG000|Allocation|not received infusion|1|||
149130512|NCT01296347|537956315|FG001|Allocation|not received infusion|0|||
149130513|NCT01296347|537956314|FG000|6 Week Follow up|Death|0|||
149130514|NCT01296347|537956315|FG001|6 Week Follow up|Death|1|||
149130515|NCT01296347|537956314|FG000|3 Month Follow up|Death|1|||
149130516|NCT01296347|537956315|FG001|3 Month Follow up|Death|0|||
149130517|NCT01296347|537956314|FG000|3 Month Follow up|Lost to Follow-up|0|||
149130518|NCT01296347|537956315|FG001|3 Month Follow up|Lost to Follow-up|1|||
149130519|NCT01296347|537956314|FG000|6 Month Follow up|Death|2|||
149130520|NCT01296347|537956315|FG001|6 Month Follow up|Death|1|||
149130521|NCT01296347|537956314|FG000|6 Month Follow up|Lost to Follow-up|0|||
149130522|NCT01296347|537956315|FG001|6 Month Follow up|Lost to Follow-up|1|||
149130523|NCT01296347|537956314|FG000|12 Month Follow up|Lost to Follow-up|3|||
149130524|NCT01296347|537956315|FG001|12 Month Follow up|Lost to Follow-up|1|||
149130525|NCT01296347|537956314|FG000|12 Month Follow up|Death|1|||
149130526|NCT01296347|537956315|FG001|12 Month Follow up|Death|1|||
149130527|NCT01296347|537956314|FG000|12 Month Follow up|Withdrawal by Subject|0|||
149130528|NCT01296347|537956315|FG001|12 Month Follow up|Withdrawal by Subject|1|||
149130529|NCT02240693|537956316|FG000|Overall Study|Adverse Event|0|||
149130530|NCT02240693|537956317|FG001|Overall Study|Adverse Event|0|||
149130531|NCT02240693|537956318|FG002|Overall Study|Adverse Event|0|||
149130532|NCT02240693|537956319|FG003|Overall Study|Adverse Event|0|||
149130533|NCT02240693|537956320|FG004|Overall Study|Adverse Event|1|||
149130534|NCT02240693|537956316|FG000|Overall Study|Withdrawal by Subject|0|||
148790850|NCT05415462|536712708|FG000|Overall Study|Physician Decision|5|||
149130535|NCT02240693|537956317|FG001|Overall Study|Withdrawal by Subject|0|||
149130536|NCT02240693|537956318|FG002|Overall Study|Withdrawal by Subject|2|||
149130537|NCT02240693|537956319|FG003|Overall Study|Withdrawal by Subject|1|||
149130538|NCT02240693|537956320|FG004|Overall Study|Withdrawal by Subject|0|||
149130539|NCT02240693|537956316|FG000|Overall Study|Other than specified|0|||
149130540|NCT02240693|537956317|FG001|Overall Study|Other than specified|0|||
149130541|NCT02240693|537956318|FG002|Overall Study|Other than specified|2|||
149130542|NCT02240693|537956319|FG003|Overall Study|Other than specified|0|||
149130543|NCT02240693|537956320|FG004|Overall Study|Other than specified|0|||
149130544|NCT03343301|537956321|FG000|Overall Study|Withdrawal by Subject|1|||
149130545|NCT03343301|537956322|FG001|Overall Study|Withdrawal by Subject|1|||
149130546|NCT03343301|537956321|FG000|Overall Study|Death|0|||
149130547|NCT03343301|537956322|FG001|Overall Study|Death|2|||
149130548|NCT03343301|537956321|FG000|Overall Study|Other|0|||
149130549|NCT03343301|537956322|FG001|Overall Study|Other|6|||
149130550|NCT03343301|537956321|FG000|Overall Study|Missing|2|||
149130551|NCT03343301|537956322|FG001|Overall Study|Missing|0|||
149130552|NCT01585987|537956323|FG000|Randomized|Withdrawal by Subject|0|||
149130553|NCT01585987|537956324|FG001|Randomized|Withdrawal by Subject|4|||
149130554|NCT01585987|537956323|FG000|Randomized|No longer met criteria|0|||
149130555|NCT01585987|537956324|FG001|Randomized|No longer met criteria|2|||
149130556|NCT01585987|537956323|FG000|Treated|Disease Progression|39|||
149130557|NCT01585987|537956324|FG001|Treated|Disease Progression|36|||
149130558|NCT01585987|537956323|FG000|Treated|Study Drug Toxicity|9|||
149130559|NCT01585987|537956324|FG001|Treated|Study Drug Toxicity|5|||
149130560|NCT01585987|537956323|FG000|Treated|Adverse Event|3|||
149130561|NCT01585987|537956324|FG001|Treated|Adverse Event|0|||
149130562|NCT01585987|537956323|FG000|Treated|Withdrawal by Subject|1|||
149130563|NCT01585987|537956324|FG001|Treated|Withdrawal by Subject|2|||
149130564|NCT01585987|537956323|FG000|Treated|Death|1|||
149130565|NCT01585987|537956324|FG001|Treated|Death|0|||
149130566|NCT01585987|537956323|FG000|Treated|Lost to Follow-up|0|||
149130567|NCT01585987|537956324|FG001|Treated|Lost to Follow-up|1|||
149130568|NCT01585987|537956323|FG000|Treated|Maximum Clinical Benefit|0|||
149130569|NCT01585987|537956324|FG001|Treated|Maximum Clinical Benefit|1|||
149130570|NCT01585987|537956323|FG000|Treated|Non-Specified|1|||
149130571|NCT01585987|537956324|FG001|Treated|Non-Specified|2|||
149130572|NCT01585987|537956323|FG000|Treated|Subject Request|0|||
149130573|NCT01585987|537956324|FG001|Treated|Subject Request|1|||
149130574|NCT01585987|537956323|FG000|Treated|Poor/Non-Compliance|0|||
149130575|NCT01585987|537956324|FG001|Treated|Poor/Non-Compliance|1|||
149130576|NCT02041520|537956325|FG000|Overall Study|Adverse Event|2|||
149130577|NCT02041520|537956326|FG001|Overall Study|Adverse Event|1|||
149130578|NCT02041520|537956325|FG000|Overall Study|Withdrawal by Subject|3|||
149130579|NCT02041520|537956326|FG001|Overall Study|Withdrawal by Subject|4|||
149130580|NCT02041520|537956325|FG000|Overall Study|Protocol Violation|1|||
149130581|NCT02041520|537956326|FG001|Overall Study|Protocol Violation|0|||
149130582|NCT02041520|537956325|FG000|Overall Study|Lost to Follow-up|0|||
149130583|NCT02041520|537956326|FG001|Overall Study|Lost to Follow-up|1|||
149130584|NCT02041520|537956325|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
149130585|NCT02041520|537956326|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
149130586|NCT00413972|537956327|FG000|Overall Study|Adverse Event|2|||
149130587|NCT00413972|537956328|FG001|Overall Study|Adverse Event|1|||
149130588|NCT00413972|537956329|FG002|Overall Study|Adverse Event|0|||
149130589|NCT00413972|537956330|FG003|Overall Study|Adverse Event|0|||
149130590|NCT00413972|537956327|FG000|Overall Study|Lost to Follow-up|1|||
149130591|NCT00413972|537956328|FG001|Overall Study|Lost to Follow-up|2|||
149130592|NCT00413972|537956329|FG002|Overall Study|Lost to Follow-up|1|||
149130593|NCT00413972|537956330|FG003|Overall Study|Lost to Follow-up|0|||
149130594|NCT00413972|537956327|FG000|Overall Study|Withdrawal by Subject|4|||
149130595|NCT00413972|537956328|FG001|Overall Study|Withdrawal by Subject|5|||
149130596|NCT00413972|537956329|FG002|Overall Study|Withdrawal by Subject|7|||
149130597|NCT00413972|537956330|FG003|Overall Study|Withdrawal by Subject|2|||
149130598|NCT00413972|537956327|FG000|Overall Study|Protocol Violation|0|||
149130599|NCT00413972|537956328|FG001|Overall Study|Protocol Violation|0|||
149130600|NCT00413972|537956329|FG002|Overall Study|Protocol Violation|2|||
149130601|NCT00413972|537956330|FG003|Overall Study|Protocol Violation|0|||
149130602|NCT00413972|537956327|FG000|Overall Study|Other|0|||
149130603|NCT00413972|537956328|FG001|Overall Study|Other|0|||
149130604|NCT00413972|537956329|FG002|Overall Study|Other|0|||
149130605|NCT00413972|537956330|FG003|Overall Study|Other|1|||
149130606|NCT03705832|537956336|FG000|Overall Study|Physician Decision|0|||
149130607|NCT03705832|537956337|FG001|Overall Study|Physician Decision|1|||
149130608|NCT03705832|537956336|FG000|Overall Study|Withdrawal by Subject|1|||
149130609|NCT03705832|537956337|FG001|Overall Study|Withdrawal by Subject|0|||
149130610|NCT05677893|537957584|FG000|Overall Study|Withdrawal by Subject|0|||
149130611|NCT05677893|537957585|FG001|Overall Study|Withdrawal by Subject|0|||
149130612|NCT05677893|537957586|FG002|Overall Study|Withdrawal by Subject|0|||
149130613|NCT05677893|537957587|FG003|Overall Study|Withdrawal by Subject|0|||
149130614|NCT05677893|537957588|FG004|Overall Study|Withdrawal by Subject|1|||
149130615|NCT05677893|537957589|FG005|Overall Study|Withdrawal by Subject|1|||
149130616|NCT05677893|537957590|FG006|Overall Study|Withdrawal by Subject|0|||
149130617|NCT05677893|537957584|FG000|Overall Study|Others|1|||
149130618|NCT05677893|537957585|FG001|Overall Study|Others|0|||
149130619|NCT05677893|537957586|FG002|Overall Study|Others|0|||
149130620|NCT05677893|537957587|FG003|Overall Study|Others|0|||
149130621|NCT05677893|537957588|FG004|Overall Study|Others|0|||
149130622|NCT05677893|537957589|FG005|Overall Study|Others|0|||
149130623|NCT05677893|537957590|FG006|Overall Study|Others|0|||
149130624|NCT01101477|537957591|FG000|Overall Study|Protocol Violation|5|||
149130625|NCT01101477|537957592|FG001|Overall Study|Protocol Violation|3|||
149130626|NCT01101477|537957593|FG002|Overall Study|Protocol Violation|1|||
149130627|NCT00720941|537957594|FG000|Overall Study|Protocol Violation|1|||
149130628|NCT00720941|537957595|FG001|Overall Study|Protocol Violation|2|||
149130629|NCT00720941|537957594|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
149130630|NCT00720941|537957595|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
149130631|NCT00720941|537957594|FG000|Overall Study|Lost to Follow-up|20|||
149130632|NCT00720941|537957595|FG001|Overall Study|Lost to Follow-up|15|||
149130633|NCT00720941|537957594|FG000|Overall Study|Physician Decision|14|||
149130634|NCT00720941|537957595|FG001|Overall Study|Physician Decision|12|||
149130635|NCT00720941|537957594|FG000|Overall Study|Withdrawal by Subject|29|||
149130636|NCT00720941|537957595|FG001|Overall Study|Withdrawal by Subject|36|||
149130637|NCT03437278|537957600|FG000|Overall Study|Adverse Event|0|||
149130638|NCT03437278|537957601|FG001|Overall Study|Adverse Event|0|||
149130639|NCT03437278|537957602|FG002|Overall Study|Adverse Event|1|||
149130640|NCT03437278|537957600|FG000|Overall Study|Progressive disease|1|||
149130641|NCT03437278|537957601|FG001|Overall Study|Progressive disease|0|||
149130642|NCT03437278|537957602|FG002|Overall Study|Progressive disease|0|||
149130643|NCT03437278|537957600|FG000|Overall Study|Physician Decision|1|||
149130644|NCT03437278|537957601|FG001|Overall Study|Physician Decision|0|||
149130645|NCT03437278|537957602|FG002|Overall Study|Physician Decision|1|||
149130646|NCT01128738|537957603|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
149130647|NCT01128738|537957604|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
149130648|NCT01128738|537957603|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
149130649|NCT01128738|537957604|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
149130650|NCT01128738|537957603|FG000|Second TP|Lost to Follow-up|0|||
148893510|NCT06418152|537088755|FG000|Overall Study|Withdrawal by Subject|2|||
148893511|NCT05789745|537088756|FG000|Overall Study|Withdrawal by Subject|0|||
148893512|NCT05789745|537088757|FG001|Overall Study|Withdrawal by Subject|0|||
148893513|NCT05789745|537088758|FG002|Overall Study|Withdrawal by Subject|0|||
149130651|NCT01128738|537957604|FG001|Second TP|Lost to Follow-up|1|||
149130652|NCT01128738|537957603|FG000|Second TP|Withdrawal by Subject|0|||
149130653|NCT01128738|537957604|FG001|Second TP|Withdrawal by Subject|2|||
148893514|NCT05789745|537088759|FG003|Overall Study|Withdrawal by Subject|0|||
149130654|NCT00973362|537957605|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
149130655|NCT00973362|537957606|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
149130656|NCT00973362|537957605|FG000|Baseline Evaluation|No colposcopy visit|62|||
149130657|NCT00973362|537957606|FG001|Baseline Evaluation|No colposcopy visit|0|||
149130658|NCT00973362|537957605|FG000|Baseline Evaluation|Inevaluable|686|||
149130659|NCT00973362|537957606|FG001|Baseline Evaluation|Inevaluable|223|||
149130660|NCT00973362|537957605|FG000|3-Year Follow-up|Lost to Follow-up|17|||
149130661|NCT00973362|537957606|FG001|3-Year Follow-up|Lost to Follow-up|0|||
149130662|NCT00892723|537957612|FG000|Overall Study|Lost to Follow-up|1|||
149130663|NCT00892723|537957613|FG001|Overall Study|Lost to Follow-up|3|||
149130664|NCT00892723|537957614|FG002|Overall Study|Lost to Follow-up|1|||
149130665|NCT00892723|537957612|FG000|Overall Study|Withdrawal by Subject|1|||
149130666|NCT00892723|537957613|FG001|Overall Study|Withdrawal by Subject|1|||
149130667|NCT00892723|537957614|FG002|Overall Study|Withdrawal by Subject|1|||
149130668|NCT01026454|537957616|FG000|Second Intervention|Pregnancy|1|||
149130669|NCT01026454|537957617|FG001|Second Intervention|Pregnancy|1|||
149130670|NCT01054846|537957618|FG000|Overall Study|Lost to Follow-up|76|||
149130671|NCT01054846|537957619|FG001|Overall Study|Lost to Follow-up|17|||
149130672|NCT03353350|537957620|FG000|30-week Core Treatment Period|Protocol Violation|1|||
149130673|NCT03353350|537957621|FG001|30-week Core Treatment Period|Protocol Violation|1|||
149130674|NCT03353350|537957622|FG002|30-week Core Treatment Period|Protocol Violation|1|||
149130675|NCT03353350|537957623|FG003|30-week Core Treatment Period|Protocol Violation|0|||
149130676|NCT03353350|537957620|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
149130677|NCT03353350|537957621|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
149130678|NCT03353350|537957622|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
149130679|NCT03353350|537957623|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
149130680|NCT03353350|537957620|FG000|30-week Core Treatment Period|Adverse Event|0|||
149130681|NCT03353350|537957621|FG001|30-week Core Treatment Period|Adverse Event|4|||
149130682|NCT03353350|537957622|FG002|30-week Core Treatment Period|Adverse Event|2|||
149130683|NCT03353350|537957623|FG003|30-week Core Treatment Period|Adverse Event|3|||
149130684|NCT03353350|537957620|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
149130685|NCT03353350|537957621|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
149130686|NCT03353350|537957622|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
149130687|NCT03353350|537957623|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
149130688|NCT03353350|537957620|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
149130689|NCT03353350|537957621|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
149130690|NCT03353350|537957622|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
149130691|NCT03353350|537957623|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
148893515|NCT05789745|537088760|FG004|Overall Study|Withdrawal by Subject|1|||
149130692|NCT03353350|537957620|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
149130693|NCT03353350|537957621|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
149130694|NCT03353350|537957622|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
149130695|NCT03353350|537957623|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
149130696|NCT03353350|537957620|FG000|26-week Treatment Extension Period|Adverse Event|1|||
149130697|NCT03353350|537957621|FG001|26-week Treatment Extension Period|Adverse Event|0|||
149130698|NCT03353350|537957622|FG002|26-week Treatment Extension Period|Adverse Event|0|||
149130699|NCT03353350|537957623|FG003|26-week Treatment Extension Period|Adverse Event|1|||
149130700|NCT03353350|537957620|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
149130701|NCT03353350|537957621|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
149130702|NCT03353350|537957622|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
149130703|NCT03353350|537957623|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
149130704|NCT01881750|537957630|FG000|Overall Study|Changes in concomitant therapies|2|||
149130705|NCT01881750|537957631|FG001|Overall Study|Changes in concomitant therapies|3|||
149130706|NCT01881750|537957630|FG000|Overall Study|Lost to Follow-up|0|||
149130707|NCT01881750|537957631|FG001|Overall Study|Lost to Follow-up|1|||
149130708|NCT00178126|537957632|FG000|Overall Study|Lost to Follow-up|21|||
149130709|NCT00178126|537957633|FG001|Overall Study|Lost to Follow-up|21|||
149130710|NCT00178126|537957632|FG000|Overall Study|did not receive intervention|4|||
149130711|NCT00178126|537957633|FG001|Overall Study|did not receive intervention|6|||
149130712|NCT01281969|537957636|FG000|Overall Study|not randomized didn't meet criteria|0|||
149130713|NCT01281969|537957637|FG001|Overall Study|not randomized didn't meet criteria|0|||
149130714|NCT01281969|537957638|FG002|Overall Study|not randomized didn't meet criteria|7|||
149130715|NCT01281969|537957636|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
149130716|NCT01281969|537957637|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
149130717|NCT01281969|537957638|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
149130718|NCT01281969|537957636|FG000|Overall Study|not randomized, child consent not given|0|||
149130719|NCT01281969|537957637|FG001|Overall Study|not randomized, child consent not given|0|||
149130720|NCT01281969|537957638|FG002|Overall Study|not randomized, child consent not given|2|||
149130721|NCT02520284|537957641|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
149130722|NCT02520284|537957642|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
149130723|NCT02520284|537957643|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
149130724|NCT02520284|537957641|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
149130725|NCT02520284|537957642|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
149130726|NCT02520284|537957643|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
149130727|NCT02520284|537957641|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
149130728|NCT02520284|537957642|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
149130729|NCT02520284|537957643|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
149130730|NCT02520284|537957641|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
149130731|NCT02520284|537957642|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
149130732|NCT02520284|537957643|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
149130733|NCT02520284|537957641|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
149130734|NCT02520284|537957642|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
149130735|NCT02520284|537957643|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
149130736|NCT02520284|537957641|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
149130737|NCT02520284|537957642|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
149130738|NCT02520284|537957643|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
149130739|NCT02520284|537957641|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
149130740|NCT02520284|537957642|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
149130741|NCT02520284|537957643|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
149130742|NCT02520284|537957641|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
149130743|NCT02520284|537957642|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
149130744|NCT02520284|537957643|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
149130745|NCT02520284|537957641|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
149130746|NCT02520284|537957642|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
149130747|NCT02520284|537957643|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
149130748|NCT02520284|537957641|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
149130749|NCT02520284|537957642|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
149130750|NCT02520284|537957643|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
149130751|NCT02520284|537957641|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
149130752|NCT02520284|537957642|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
149130753|NCT02520284|537957643|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
149130754|NCT01898923|537957644|FG000|Overall Study|Lack of Efficacy|5|||
149130755|NCT01898923|537957645|FG001|Overall Study|Lack of Efficacy|6|||
149130756|NCT01898923|537957644|FG000|Overall Study|Adverse Event|3|||
148893516|NCT02055898|537088765|FG000|First Intervention (5 Days)|Physician Decision|2|||
149130757|NCT01898923|537957645|FG001|Overall Study|Adverse Event|1|||
149130758|NCT01898923|537957644|FG000|Overall Study|Lost to Follow-up|0|||
149130759|NCT01898923|537957645|FG001|Overall Study|Lost to Follow-up|1|||
149130760|NCT01898923|537957644|FG000|Overall Study|Withdrawal by Subject|4|||
149130761|NCT01898923|537957645|FG001|Overall Study|Withdrawal by Subject|7|||
149130762|NCT01898923|537957644|FG000|Overall Study|Physician Decision|3|||
149130763|NCT01898923|537957645|FG001|Overall Study|Physician Decision|4|||
149130764|NCT01898923|537957644|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
149130765|NCT01898923|537957645|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
149130766|NCT02678247|537957648|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
149130767|NCT02678247|537957649|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
149130768|NCT02678247|537957648|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
149130769|NCT02678247|537957649|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
149130770|NCT02678247|537957648|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
149130771|NCT02678247|537957649|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
149130772|NCT02678247|537957648|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
149130773|NCT02678247|537957649|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
149130774|NCT02678247|537957648|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
149130775|NCT02678247|537957649|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
149130776|NCT02678247|537957648|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
149130777|NCT02678247|537957649|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
149130778|NCT00723021|537957654|FG000|Intervention Period 4|Adverse Event|0|||
149130779|NCT00723021|537957655|FG001|Intervention Period 4|Adverse Event|0|||
149130780|NCT00723021|537957656|FG002|Intervention Period 4|Adverse Event|0|||
149130781|NCT00723021|537957657|FG003|Intervention Period 4|Adverse Event|0|||
149130782|NCT00723021|537957658|FG004|Intervention Period 4|Adverse Event|1|||
149130783|NCT02739360|537957660|FG000|Overall Study|Adverse Event|1|||
149130784|NCT02739360|537957660|FG000|Overall Study|Study terminated by Sponsor|2|||
149130785|NCT01163916|537957663|FG000|Overall Study|Withdrawal by Subject|2|||
149130786|NCT01163916|537957664|FG001|Overall Study|Withdrawal by Subject|0|||
149130787|NCT01163916|537957665|FG002|Overall Study|Withdrawal by Subject|2|||
149130788|NCT01163916|537957663|FG000|Overall Study|Adverse Event|2|||
149130789|NCT01163916|537957664|FG001|Overall Study|Adverse Event|0|||
149130790|NCT01163916|537957665|FG002|Overall Study|Adverse Event|1|||
149130791|NCT01163916|537957663|FG000|Overall Study|Lack of Efficacy|2|||
149130792|NCT01163916|537957664|FG001|Overall Study|Lack of Efficacy|0|||
149130793|NCT01163916|537957665|FG002|Overall Study|Lack of Efficacy|1|||
149130794|NCT01163916|537957663|FG000|Overall Study|Other|24|||
149130795|NCT01163916|537957664|FG001|Overall Study|Other|4|||
149130796|NCT01163916|537957665|FG002|Overall Study|Other|16|||
149130797|NCT00026208|537957666|FG000|Overall Study|Complications of auto accident|1|||
149130798|NCT00026208|537957667|FG001|Overall Study|Complications of auto accident|0|||
149130799|NCT04002401|537957669|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
149130800|NCT04002401|537957669|FG000|Overall Study|Death|10|||
149130801|NCT04002401|537957669|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
149130802|NCT04002401|537957669|FG000|Overall Study|Enrolled but Never Treated|1|||
149130803|NCT04002401|537957669|FG000|Overall Study|Lost to Follow-up|1|||
149130804|NCT00423930|537957670|FG000|Overall Study|Withdrawal by Subject|2|||
149130805|NCT02337751|537957671|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
149130806|NCT02337751|537957672|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
149130807|NCT02337751|537957671|FG000|Overall Study|Voluntary Withdrawal|6|||
149130808|NCT02337751|537957672|FG001|Overall Study|Voluntary Withdrawal|8|||
149130809|NCT02337751|537957671|FG000|Overall Study|Lack of Efficacy|2|||
149130810|NCT02337751|537957672|FG001|Overall Study|Lack of Efficacy|5|||
149130811|NCT02337751|537957671|FG000|Overall Study|Investigator's Judgement|1|||
149130812|NCT02337751|537957672|FG001|Overall Study|Investigator's Judgement|0|||
149130813|NCT02881957|537957679|FG000|Overall Study|Comfort care|0|||
149130814|NCT02881957|537957680|FG001|Overall Study|Comfort care|1|||
149130815|NCT02881957|537957679|FG000|Overall Study|Concurrent trial enrollment|0|||
149130816|NCT02881957|537957680|FG001|Overall Study|Concurrent trial enrollment|1|||
149130817|NCT02881957|537957679|FG000|Overall Study|Discharged within 48 hours|0|||
149130818|NCT02881957|537957680|FG001|Overall Study|Discharged within 48 hours|1|||
149130819|NCT02881957|537957679|FG000|Overall Study|Withdrawal by Subject|2|||
149130820|NCT02881957|537957680|FG001|Overall Study|Withdrawal by Subject|1|||
149130821|NCT02881957|537957679|FG000|Overall Study|Protocol Violation|1|||
149130822|NCT02881957|537957680|FG001|Overall Study|Protocol Violation|0|||
149130823|NCT02390245|537957686|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
149130824|NCT02390245|537957687|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
149130825|NCT02390245|537957688|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
149130826|NCT02390245|537957686|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
149130827|NCT02390245|537957687|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
149130828|NCT02390245|537957688|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
149130829|NCT00959647|537957690|FG000|Overall Study|Adverse Event|2|||
149130830|NCT00959647|537957690|FG000|Overall Study|Progressive disease|6|||
149130831|NCT00959647|537957690|FG000|Overall Study|Study terminated by sponsor|4|||
149130832|NCT00959647|537957690|FG000|Overall Study|Withdrawal by Subject|7|||
149130833|NCT02903368|537957691|FG000|Part 1|Adverse Event|3|||
149130834|NCT02903368|537957692|FG001|Part 1|Adverse Event|0|||
149130835|NCT02903368|537957693|FG002|Part 1|Adverse Event|0|||
149130836|NCT02903368|537957694|FG003|Part 1|Adverse Event|0|||
149130837|NCT02903368|537957691|FG000|Part 1|Withdrawal by Subject|1|||
149130838|NCT02903368|537957692|FG001|Part 1|Withdrawal by Subject|0|||
149130839|NCT02903368|537957693|FG002|Part 1|Withdrawal by Subject|0|||
149130840|NCT02903368|537957694|FG003|Part 1|Withdrawal by Subject|0|||
149130841|NCT02903368|537957691|FG000|Part 2|Adverse Event|0|||
149130842|NCT02903368|537957692|FG001|Part 2|Adverse Event|0|||
149130843|NCT02903368|537957693|FG002|Part 2|Adverse Event|5|||
149130844|NCT02903368|537957694|FG003|Part 2|Adverse Event|0|||
149130845|NCT02903368|537957691|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
149130846|NCT02903368|537957692|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
149130847|NCT02903368|537957693|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
149130848|NCT02903368|537957694|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
149130849|NCT02903368|537957691|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
149130850|NCT02903368|537957692|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
149130851|NCT02903368|537957693|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
149130852|NCT02903368|537957694|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
149130853|NCT02903368|537957691|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
149130854|NCT02903368|537957692|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
149130855|NCT02903368|537957693|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
149130856|NCT02903368|537957694|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
149130857|NCT06515483|537957697|FG000|Overall Study|Subject withdraw due to family issues|1|||
149130858|NCT06515483|537957698|FG001|Overall Study|Subject withdraw due to family issues|0|||
149130859|NCT05959629|537957701|FG000|Overall Study|partially necrotic/technical issues|2|||
149130860|NCT05959629|537957702|FG001|Overall Study|partially necrotic/technical issues|2|||
149130861|NCT00147823|537957706|FG000|Overall Study|Lost to Follow-up|6|||
149130862|NCT00147823|537957707|FG001|Overall Study|Lost to Follow-up|12|||
149130863|NCT00147823|537957706|FG000|Overall Study|Physician Decision|1|||
149130864|NCT00147823|537957707|FG001|Overall Study|Physician Decision|0|||
149130865|NCT00147823|537957706|FG000|Overall Study|Withdrawal by Subject|0|||
149130866|NCT00147823|537957707|FG001|Overall Study|Withdrawal by Subject|1|||
149130867|NCT00147823|537957706|FG000|Overall Study|Did not receive vitoss due to infection|6|||
149130868|NCT00147823|537957707|FG001|Overall Study|Did not receive vitoss due to infection|2|||
149130869|NCT02101034|537960005|FG000|Overall Study|Enrolled but did not start treatment|0|||
149130870|NCT02101034|537960006|FG001|Overall Study|Enrolled but did not start treatment|0|||
149130871|NCT02101034|537960007|FG002|Overall Study|Enrolled but did not start treatment|1|||
149130872|NCT02101034|537960008|FG003|Overall Study|Enrolled but did not start treatment|0|||
149130873|NCT02101034|537960009|FG004|Overall Study|Enrolled but did not start treatment|0|||
149130874|NCT02720536|537960014|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
149130875|NCT02720536|537960014|FG000|Overall Study|PR - pregnancy|2|||
149130876|NCT02720536|537960014|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
149130877|NCT02720536|537960014|FG000|Overall Study|PR - death|1|||
149130878|NCT02720536|537960014|FG000|Overall Study|PR - adverse event|1|||
149130879|NCT02720536|537960014|FG000|Overall Study|PR - abnormal lab value(s)|1|||
149130880|NCT02720536|537960014|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
149130881|NCT01028222|537960015|FG000|Overall Study|Protocol deviation|1|||
149130882|NCT01028222|537960016|FG001|Overall Study|Protocol deviation|0|||
149130883|NCT01028222|537960015|FG000|Overall Study|Disease progression|33|||
149130884|NCT01028222|537960016|FG001|Overall Study|Disease progression|9|||
149130885|NCT01028222|537960015|FG000|Overall Study|Administrative problems|1|||
149130886|NCT01028222|537960016|FG001|Overall Study|Administrative problems|1|||
149130887|NCT01028222|537960015|FG000|Overall Study|Lost to Follow-up|0|||
149130888|NCT01028222|537960016|FG001|Overall Study|Lost to Follow-up|1|||
149130889|NCT01028222|537960015|FG000|Overall Study|Withdrawal by Subject|1|||
149130890|NCT01028222|537960016|FG001|Overall Study|Withdrawal by Subject|0|||
149130891|NCT01028222|537960015|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
149130892|NCT01028222|537960016|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
149130893|NCT01028222|537960015|FG000|Overall Study|Adverse Event|2|||
149130894|NCT01028222|537960016|FG001|Overall Study|Adverse Event|0|||
149130895|NCT00146328|537960017|FG000|Overall Study|Adverse Event|39|||
149130896|NCT00146328|537960018|FG001|Overall Study|Adverse Event|48|||
149130897|NCT00146328|537960019|FG002|Overall Study|Adverse Event|79|||
149130898|NCT00146328|537960017|FG000|Overall Study|Protocol Violation|11|||
149130899|NCT00146328|537960018|FG001|Overall Study|Protocol Violation|6|||
149130900|NCT00146328|537960019|FG002|Overall Study|Protocol Violation|12|||
149130901|NCT00146328|537960017|FG000|Overall Study|Lost to Follow-up|7|||
149130902|NCT00146328|537960018|FG001|Overall Study|Lost to Follow-up|4|||
149130903|NCT00146328|537960019|FG002|Overall Study|Lost to Follow-up|7|||
149130904|NCT00146328|537960017|FG000|Overall Study|Withdrawal by Subject|16|||
149130905|NCT00146328|537960018|FG001|Overall Study|Withdrawal by Subject|16|||
149130906|NCT00146328|537960019|FG002|Overall Study|Withdrawal by Subject|22|||
149130907|NCT00146328|537960017|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
149130908|NCT00146328|537960018|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
149130909|NCT00146328|537960019|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
149130910|NCT00146328|537960017|FG000|Overall Study|Trial ended/site closed|8|||
149130911|NCT00146328|537960018|FG001|Overall Study|Trial ended/site closed|2|||
149130912|NCT00146328|537960019|FG002|Overall Study|Trial ended/site closed|19|||
149130913|NCT00146328|537960017|FG000|Overall Study|Patient decision to end|0|||
149130914|NCT00146328|537960018|FG001|Overall Study|Patient decision to end|1|||
149130915|NCT00146328|537960019|FG002|Overall Study|Patient decision to end|6|||
149130916|NCT00146328|537960017|FG000|Overall Study|Enroll into other trial|2|||
149130917|NCT00146328|537960018|FG001|Overall Study|Enroll into other trial|4|||
149130918|NCT00146328|537960019|FG002|Overall Study|Enroll into other trial|2|||
149130919|NCT00146328|537960017|FG000|Overall Study|Death|0|||
149130920|NCT00146328|537960018|FG001|Overall Study|Death|1|||
149130921|NCT00146328|537960019|FG002|Overall Study|Death|1|||
149130922|NCT00146328|537960017|FG000|Overall Study|Moved|2|||
149130923|NCT00146328|537960018|FG001|Overall Study|Moved|0|||
149130924|NCT00146328|537960019|FG002|Overall Study|Moved|0|||
149130925|NCT00146328|537960017|FG000|Overall Study|Interaction with other medication|2|||
149130926|NCT00146328|537960018|FG001|Overall Study|Interaction with other medication|0|||
149130927|NCT00146328|537960019|FG002|Overall Study|Interaction with other medication|1|||
149130928|NCT00300781|537960020|FG000|Overall Study|Disease Progression|55|||
149130929|NCT00300781|537960021|FG001|Overall Study|Disease Progression|52|||
149130930|NCT00300781|537960020|FG000|Overall Study|Adverse Event|5|||
149130931|NCT00300781|537960021|FG001|Overall Study|Adverse Event|6|||
149130932|NCT00300781|537960020|FG000|Overall Study|Withdrawal by Subject|1|||
149130933|NCT00300781|537960021|FG001|Overall Study|Withdrawal by Subject|2|||
149130934|NCT00300781|537960020|FG000|Overall Study|Physician Decision|1|||
149130935|NCT00300781|537960021|FG001|Overall Study|Physician Decision|0|||
149130936|NCT00300781|537960020|FG000|Overall Study|Not Recorded|0|||
149130937|NCT00300781|537960021|FG001|Overall Study|Not Recorded|1|||
149130938|NCT00300781|537960020|FG000|Overall Study|Symptomatic Deterioration|1|||
149130939|NCT00300781|537960021|FG001|Overall Study|Symptomatic Deterioration|0|||
149130940|NCT00300781|537960020|FG000|Overall Study|Lost to Follow-up|0|||
149130941|NCT00300781|537960021|FG001|Overall Study|Lost to Follow-up|1|||
149130942|NCT01717989|537960022|FG000|Overall Study|Ineligibility determined|6|||
149130943|NCT01717989|537960022|FG000|Overall Study|Protocol deviation|6|||
149130944|NCT01717989|537960022|FG000|Overall Study|Withdrawal by Subject|11|||
149130945|NCT01717989|537960022|FG000|Overall Study|Physician Decision|2|||
149130946|NCT01717989|537960022|FG000|Overall Study|Lost to Follow-up|11|||
149130947|NCT01717989|537960022|FG000|Overall Study|Death|439|||
149130948|NCT01717989|537960022|FG000|Overall Study|Protocol-specified criteria|551|||
149130949|NCT01717989|537960022|FG000|Overall Study|Other|40|||
149130950|NCT03224325|537960023|FG000|Overall Study|Adverse Event|1|||
149130951|NCT03224325|537960024|FG001|Overall Study|Adverse Event|0|||
149130952|NCT03224325|537960025|FG002|Overall Study|Adverse Event|0|||
149130953|NCT03224325|537960026|FG003|Overall Study|Adverse Event|0|||
149130954|NCT03224325|537960027|FG004|Overall Study|Adverse Event|0|||
149130955|NCT03224325|537960028|FG005|Overall Study|Adverse Event|0|||
149130956|NCT03224325|537960029|FG006|Overall Study|Adverse Event|1|||
149130957|NCT03224325|537960023|FG000|Overall Study|Withdrawal by Subject|0|||
149130958|NCT03224325|537960024|FG001|Overall Study|Withdrawal by Subject|0|||
149130959|NCT03224325|537960025|FG002|Overall Study|Withdrawal by Subject|0|||
149130960|NCT03224325|537960026|FG003|Overall Study|Withdrawal by Subject|1|||
149130961|NCT03224325|537960027|FG004|Overall Study|Withdrawal by Subject|0|||
149130962|NCT03224325|537960028|FG005|Overall Study|Withdrawal by Subject|0|||
149130963|NCT03224325|537960029|FG006|Overall Study|Withdrawal by Subject|0|||
149130964|NCT02525861|537960030|FG000|Overall Study|Adverse Event|1|||
149130965|NCT02525861|537960031|FG001|Overall Study|Adverse Event|0|||
149130966|NCT02525861|537960030|FG000|Overall Study|Withdrawal by Subject|0|||
149130967|NCT02525861|537960031|FG001|Overall Study|Withdrawal by Subject|1|||
149130968|NCT02525861|537960030|FG000|Overall Study|Physician Decision|0|||
149130969|NCT02525861|537960031|FG001|Overall Study|Physician Decision|1|||
149130970|NCT02544217|537960032|FG000|Overall Study|Withdrawal by Subject|1|||
149130971|NCT02544217|537960033|FG001|Overall Study|Withdrawal by Subject|1|||
149130972|NCT02544217|537960034|FG002|Overall Study|Withdrawal by Subject|0|||
149130973|NCT02544217|537960035|FG003|Overall Study|Withdrawal by Subject|0|||
149130974|NCT02544217|537960036|FG004|Overall Study|Withdrawal by Subject|0|||
149130975|NCT02544217|537960037|FG005|Overall Study|Withdrawal by Subject|0|||
149130976|NCT00667355|537960039|FG000|Overall Study|Adverse Event|5|||
149130977|NCT00667355|537960039|FG000|Overall Study|Lost to Follow-up|1|||
149130978|NCT00667355|537960039|FG000|Overall Study|Other reason was not specified|5|||
149130979|NCT00937833|537960040|FG000|Overall Study|Protocol Violation|1|||
149130980|NCT00937833|537960041|FG001|Overall Study|Protocol Violation|2|||
149130981|NCT00937833|537960040|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
149130982|NCT00937833|537960041|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
149130983|NCT00937833|537960040|FG000|Overall Study|Lost to Follow-up|10|||
149130984|NCT00937833|537960041|FG001|Overall Study|Lost to Follow-up|8|||
149130985|NCT00937833|537960040|FG000|Overall Study|Withdrawal by Subject|4|||
149130986|NCT00937833|537960041|FG001|Overall Study|Withdrawal by Subject|6|||
149130987|NCT03278106|537960043|FG000|Overall Study|No protocol treatment|1|||
149130988|NCT02175004|537960044|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
149130989|NCT02175004|537960045|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
149130990|NCT02175004|537960044|FG000|Overall Study|Investigator Judgment|1|||
149130991|NCT02175004|537960045|FG001|Overall Study|Investigator Judgment|4|||
149130992|NCT02175004|537960044|FG000|Overall Study|Voluntary Withdrawal|6|||
149130993|NCT02175004|537960045|FG001|Overall Study|Voluntary Withdrawal|19|||
149130994|NCT02175004|537960044|FG000|Overall Study|Liver Transplant|1|||
149130995|NCT02175004|537960045|FG001|Overall Study|Liver Transplant|0|||
149130996|NCT02175004|537960044|FG000|Overall Study|Disease Progression|1|||
149130997|NCT02175004|537960045|FG001|Overall Study|Disease Progression|0|||
149130998|NCT02175004|537960044|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
149130999|NCT02175004|537960045|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
149131000|NCT01607554|537960047|FG000|Overall Study|Disease progression|2|||
149131001|NCT03952806|537960048|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
149131002|NCT03952806|537960049|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
149131003|NCT03952806|537960048|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
149131004|NCT03952806|537960049|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
149131005|NCT03952806|537960048|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
149131006|NCT03952806|537960049|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
149131007|NCT03952806|537960048|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
149131008|NCT03952806|537960049|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
149131009|NCT03952806|537960048|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
149131010|NCT03952806|537960049|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
149131011|NCT03952806|537960048|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
149131012|NCT03952806|537960049|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
149131013|NCT03952806|537960048|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
149131014|NCT03952806|537960049|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
149131015|NCT03952806|537960048|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
149131016|NCT03952806|537960049|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
149131017|NCT03952806|537960048|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
149131018|NCT03952806|537960049|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
149131019|NCT03952806|537960048|FG000|OLE Phase (48 Weeks)|Other|16|||
149131020|NCT03952806|537960049|FG001|OLE Phase (48 Weeks)|Other|13|||
149131021|NCT01137955|537960050|FG000|Overall Study|Withdrawal by Subject|5|||
149131022|NCT01137955|537960051|FG001|Overall Study|Withdrawal by Subject|4|||
149131023|NCT02027701|537960055|FG000|Overall Study|Adverse Event|3|||
149131024|NCT02027701|537960055|FG000|Overall Study|Lack of Efficacy|8|||
149131025|NCT02027701|537960055|FG000|Overall Study|Physician Decision|2|||
149131026|NCT02027701|537960055|FG000|Overall Study|Withdrawal by Subject|3|||
149131027|NCT00756470|537960056|FG000|Overall Study|Withdrawal by Subject|1|||
149131028|NCT00756470|537960056|FG000|Overall Study|Adverse Event|4|||
149131029|NCT00820027|537960057|FG000|Overall Study|Adverse Event|15|||
149131030|NCT00820027|537960058|FG001|Overall Study|Adverse Event|8|||
149131031|NCT00820027|537960059|FG002|Overall Study|Adverse Event|10|||
149131032|NCT00820027|537960060|FG003|Overall Study|Adverse Event|5|||
149131033|NCT00820027|537960057|FG000|Overall Study|Lack of Efficacy|2|||
149131034|NCT00820027|537960058|FG001|Overall Study|Lack of Efficacy|1|||
149131035|NCT00820027|537960059|FG002|Overall Study|Lack of Efficacy|2|||
149131036|NCT00820027|537960060|FG003|Overall Study|Lack of Efficacy|2|||
149131037|NCT00820027|537960057|FG000|Overall Study|Physician Decision|0|||
149131038|NCT00820027|537960058|FG001|Overall Study|Physician Decision|1|||
149131039|NCT00820027|537960059|FG002|Overall Study|Physician Decision|1|||
149131040|NCT00820027|537960060|FG003|Overall Study|Physician Decision|0|||
149131041|NCT00820027|537960057|FG000|Overall Study|Protocol Violation|3|||
149131042|NCT00820027|537960058|FG001|Overall Study|Protocol Violation|0|||
149131043|NCT00820027|537960059|FG002|Overall Study|Protocol Violation|4|||
149131044|NCT00820027|537960060|FG003|Overall Study|Protocol Violation|0|||
149131045|NCT00820027|537960057|FG000|Overall Study|Withdrawal by Subject|6|||
149131046|NCT00820027|537960058|FG001|Overall Study|Withdrawal by Subject|4|||
149131047|NCT00820027|537960059|FG002|Overall Study|Withdrawal by Subject|4|||
149131048|NCT00820027|537960060|FG003|Overall Study|Withdrawal by Subject|6|||
149131049|NCT01978262|537960061|FG000|Overall Study|Withdrawal by Subject|9|||
149131050|NCT01978262|537960061|FG000|Overall Study|Lost to Follow-up|2|||
149131051|NCT02982187|537960062|FG000|Overall Study|Withdrawal by Subject|0|||
149131052|NCT02982187|537960063|FG001|Overall Study|Withdrawal by Subject|0|||
149131053|NCT02982187|537960064|FG002|Overall Study|Withdrawal by Subject|0|||
149131054|NCT02982187|537960065|FG003|Overall Study|Withdrawal by Subject|0|||
149131055|NCT02982187|537960066|FG004|Overall Study|Withdrawal by Subject|0|||
149131056|NCT02982187|537960067|FG005|Overall Study|Withdrawal by Subject|0|||
149131057|NCT02982187|537960068|FG006|Overall Study|Withdrawal by Subject|1|||
149131058|NCT02982187|537960069|FG007|Overall Study|Withdrawal by Subject|0|||
149131059|NCT02604433|537960070|FG000|Overall Study|Withdrawal by Subject|37|||
149131060|NCT02604433|537960071|FG001|Overall Study|Withdrawal by Subject|16|||
149131061|NCT02604433|537960070|FG000|Overall Study|Adverse Event|4|||
149131062|NCT02604433|537960071|FG001|Overall Study|Adverse Event|0|||
149131063|NCT02604433|537960070|FG000|Overall Study|Other reasons|3|||
149131064|NCT02604433|537960071|FG001|Overall Study|Other reasons|5|||
149131065|NCT02604433|537960070|FG000|Overall Study|Death|4|||
149131066|NCT02604433|537960071|FG001|Overall Study|Death|1|||
149131067|NCT02604433|537960070|FG000|Overall Study|Transition to Rollover Protocol|169|||
149131068|NCT02604433|537960071|FG001|Overall Study|Transition to Rollover Protocol|82|||
149131069|NCT02604433|537960070|FG000|Overall Study|Physician Decision|1|||
149131070|NCT02604433|537960071|FG001|Overall Study|Physician Decision|1|||
149131071|NCT02604433|537960070|FG000|Overall Study|Lack of Efficacy|0|||
149131072|NCT02604433|537960071|FG001|Overall Study|Lack of Efficacy|1|||
149131073|NCT03285178|537960072|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
149131074|NCT03285178|537960073|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
149131075|NCT03285178|537960074|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
149131076|NCT03285178|537960075|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
149131077|NCT03285178|537960076|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
149131078|NCT03285178|537960077|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
149131079|NCT03285178|537960078|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
149131080|NCT03285178|537960072|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
149131081|NCT03285178|537960073|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
149131082|NCT03285178|537960074|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
149131083|NCT03285178|537960075|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
149131084|NCT03285178|537960076|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
149131085|NCT03285178|537960077|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
149131086|NCT03285178|537960078|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
149131087|NCT03285178|537960072|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
149131088|NCT03285178|537960073|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
149131089|NCT03285178|537960074|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
149131090|NCT03285178|537960075|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
149131091|NCT03285178|537960076|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
149131092|NCT03285178|537960077|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
149131093|NCT03285178|537960078|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
149131094|NCT03285178|537960072|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
149131095|NCT03285178|537960073|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
149131096|NCT03285178|537960074|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
149131097|NCT03285178|537960075|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
149131098|NCT03285178|537960076|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
149131099|NCT03285178|537960077|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
149131100|NCT03285178|537960078|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
149131101|NCT03285178|537960072|FG000|Single-Blind Run-In Period|Physician Decision|2|||
149131102|NCT03285178|537960073|FG001|Single-Blind Run-In Period|Physician Decision|0|||
149131103|NCT03285178|537960074|FG002|Single-Blind Run-In Period|Physician Decision|0|||
149131104|NCT03285178|537960075|FG003|Single-Blind Run-In Period|Physician Decision|0|||
149131105|NCT03285178|537960076|FG004|Single-Blind Run-In Period|Physician Decision|0|||
149131106|NCT03285178|537960077|FG005|Single-Blind Run-In Period|Physician Decision|0|||
149131107|NCT03285178|537960078|FG006|Single-Blind Run-In Period|Physician Decision|0|||
149131108|NCT03285178|537960072|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
149131109|NCT03285178|537960073|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
149131110|NCT03285178|537960074|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
149131111|NCT03285178|537960075|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
149131112|NCT03285178|537960076|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
149131113|NCT03285178|537960077|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
149131114|NCT03285178|537960078|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
149131115|NCT03285178|537960072|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149131116|NCT03285178|537960073|FG001|Double-Blind Treatment Period|Adverse Event|0|||
149131117|NCT03285178|537960074|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149131118|NCT03285178|537960075|FG003|Double-Blind Treatment Period|Adverse Event|0|||
149131119|NCT03285178|537960076|FG004|Double-Blind Treatment Period|Adverse Event|0|||
149131120|NCT03285178|537960077|FG005|Double-Blind Treatment Period|Adverse Event|0|||
149131121|NCT03285178|537960078|FG006|Double-Blind Treatment Period|Adverse Event|2|||
149131122|NCT03285178|537960072|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149131123|NCT03285178|537960073|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149131124|NCT03285178|537960074|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
149131125|NCT03285178|537960075|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
149131126|NCT03285178|537960076|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
149131127|NCT03285178|537960077|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
149131128|NCT03285178|537960078|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
149131129|NCT03285178|537960072|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149131130|NCT03285178|537960073|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149131131|NCT03285178|537960074|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149131132|NCT03285178|537960075|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149131133|NCT03285178|537960076|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149131134|NCT03285178|537960077|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
149131135|NCT03285178|537960078|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149131136|NCT03285178|537960072|FG000|Double-Blind Treatment Period|COVID-19|0|||
149131137|NCT03285178|537960073|FG001|Double-Blind Treatment Period|COVID-19|0|||
149131138|NCT03285178|537960074|FG002|Double-Blind Treatment Period|COVID-19|1|||
149131139|NCT03285178|537960075|FG003|Double-Blind Treatment Period|COVID-19|0|||
149131140|NCT03285178|537960076|FG004|Double-Blind Treatment Period|COVID-19|0|||
149131141|NCT03285178|537960077|FG005|Double-Blind Treatment Period|COVID-19|0|||
149131142|NCT03285178|537960078|FG006|Double-Blind Treatment Period|COVID-19|0|||
149131143|NCT01128894|537960079|FG000|Overall Study|Adverse Event|31|||
149131144|NCT01128894|537960080|FG001|Overall Study|Adverse Event|41|||
149131145|NCT01128894|537960079|FG000|Overall Study|Protocol Violation|2|||
149131146|NCT01128894|537960080|FG001|Overall Study|Protocol Violation|1|||
149131147|NCT01128894|537960079|FG000|Overall Study|Noncompliance|4|||
149131148|NCT01128894|537960080|FG001|Overall Study|Noncompliance|5|||
149131149|NCT01128894|537960079|FG000|Overall Study|Lost to Follow-up|8|||
149131150|NCT01128894|537960080|FG001|Overall Study|Lost to Follow-up|8|||
149131151|NCT01128894|537960079|FG000|Overall Study|Withdrawal by Subject|10|||
149131152|NCT01128894|537960080|FG001|Overall Study|Withdrawal by Subject|12|||
149131153|NCT01128894|537960079|FG000|Overall Study|Physician Decision|2|||
149131154|NCT01128894|537960080|FG001|Overall Study|Physician Decision|1|||
149131155|NCT01128894|537960079|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
149131156|NCT01128894|537960080|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
149131157|NCT05116046|537960081|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149131158|NCT05116046|537960082|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149131159|NCT05116046|537960083|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149131160|NCT05116046|537960081|FG000|Overall Study|Study terminated by sponsor|14|||
149131161|NCT05116046|537960082|FG001|Overall Study|Study terminated by sponsor|16|||
149131162|NCT05116046|537960083|FG002|Overall Study|Study terminated by sponsor|1|||
149131163|NCT02168842|537960084|FG000|Overall Study|Withdrawal by Subject|5|||
149131164|NCT02168842|537960085|FG001|Overall Study|Withdrawal by Subject|3|||
149131165|NCT02168842|537960084|FG000|Overall Study|Lost to Follow-up|0|||
149131166|NCT02168842|537960085|FG001|Overall Study|Lost to Follow-up|2|||
149131167|NCT02168842|537960084|FG000|Overall Study|Death|2|||
149131168|NCT02168842|537960085|FG001|Overall Study|Death|1|||
149131169|NCT02168842|537960084|FG000|Overall Study|Physician Decision|1|||
149131170|NCT02168842|537960085|FG001|Overall Study|Physician Decision|2|||
149131171|NCT02147353|537960086|FG000|Overall Study|Lost to Follow-up|2|||
149131172|NCT02147353|537960087|FG001|Overall Study|Lost to Follow-up|0|||
149131173|NCT02147353|537960086|FG000|Overall Study|unable to make visits|4|||
149131174|NCT02147353|537960087|FG001|Overall Study|unable to make visits|0|||
149131175|NCT02147353|537960086|FG000|Overall Study|medication noncompliance|3|||
149131176|NCT02147353|537960087|FG001|Overall Study|medication noncompliance|0|||
149131177|NCT02974088|537960088|FG000|Overall Study|Lost to Follow-up|0|||
149131178|NCT02974088|537960089|FG001|Overall Study|Lost to Follow-up|2|||
149131179|NCT02974088|537960088|FG000|Overall Study|Adverse Event|0|||
149131180|NCT02974088|537960089|FG001|Overall Study|Adverse Event|1|||
149131181|NCT00150969|537960090|FG000|24 Month Main Study|Adverse Event|3|||
149131182|NCT00150969|537960091|FG001|24 Month Main Study|Adverse Event|4|||
148893517|NCT02055898|537088766|FG001|First Intervention (5 Days)|Physician Decision|0|||
149131183|NCT00150969|537960090|FG000|24 Month Main Study|Death|1|||
149131184|NCT00150969|537960091|FG001|24 Month Main Study|Death|1|||
149131185|NCT00150969|537960090|FG000|24 Month Main Study|Lack of Efficacy|1|||
149131186|NCT00150969|537960091|FG001|24 Month Main Study|Lack of Efficacy|8|||
149131187|NCT00150969|537960090|FG000|24 Month Main Study|Lost to Follow-up|3|||
149131188|NCT00150969|537960091|FG001|24 Month Main Study|Lost to Follow-up|2|||
149131189|NCT00150969|537960090|FG000|24 Month Main Study|Protocol Violation|4|||
149131190|NCT00150969|537960091|FG001|24 Month Main Study|Protocol Violation|2|||
149131191|NCT00150969|537960090|FG000|24 Month Main Study|Withdrawal by Subject|7|||
149131192|NCT00150969|537960091|FG001|24 Month Main Study|Withdrawal by Subject|4|||
149131193|NCT00150969|537960090|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
149131194|NCT00150969|537960091|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
149131195|NCT00150969|537960090|FG000|24-48 Month Extension|Lack of Efficacy|0|||
149131196|NCT00150969|537960091|FG001|24-48 Month Extension|Lack of Efficacy|1|||
149131197|NCT00150969|537960090|FG000|24-48 Month Extension|Adverse Event|1|||
149131198|NCT00150969|537960091|FG001|24-48 Month Extension|Adverse Event|3|||
149131199|NCT00150969|537960090|FG000|24-48 Month Extension|Other Reason|81|||
149131200|NCT00150969|537960091|FG001|24-48 Month Extension|Other Reason|91|||
149131201|NCT00146757|537960092|FG000|Overall Study|Death|1|||
149131202|NCT00146757|537960093|FG001|Overall Study|Death|0|||
149131203|NCT00146757|537960092|FG000|Overall Study|Adverse Event|1|||
149131204|NCT00146757|537960093|FG001|Overall Study|Adverse Event|0|||
149131205|NCT02893930|537960099|FG000|Overall Study|Adverse Event|3|||
149131206|NCT02893930|537960099|FG000|Overall Study|Death|1|||
149131207|NCT02893930|537960099|FG000|Overall Study|Disease progression|5|||
149131208|NCT02893930|537960099|FG000|Overall Study|Withdrawal by Subject|2|||
149131209|NCT02893930|537960099|FG000|Overall Study|Physician Decision|1|||
149131210|NCT02893930|537960099|FG000|Overall Study|Ineligible|1|||
149131211|NCT02349360|537960100|FG000|Overall Study|Withdrawal by Subject|0|||
149131212|NCT02349360|537960101|FG001|Overall Study|Withdrawal by Subject|1|||
149131213|NCT02446886|537960110|FG000|Overall Study|Adverse Event|1|||
149131214|NCT02446886|537960111|FG001|Overall Study|Adverse Event|3|||
149131215|NCT02446886|537960110|FG000|Overall Study|Withdrawal by Subject|1|||
149131216|NCT02446886|537960111|FG001|Overall Study|Withdrawal by Subject|1|||
149131217|NCT01971203|537960121|FG000|Overall Study|Protocol Violation|3|||
149131218|NCT01971203|537960122|FG001|Overall Study|Protocol Violation|2|||
149131219|NCT01971203|537960121|FG000|Overall Study|Withdrawal by Subject|5|||
149131220|NCT01971203|537960122|FG001|Overall Study|Withdrawal by Subject|6|||
149131221|NCT01971203|537960121|FG000|Overall Study|Adverse Event|1|||
149131222|NCT01971203|537960122|FG001|Overall Study|Adverse Event|0|||
149131223|NCT01498289|537960124|FG000|Overall Study|Adverse Event|16|||
149131224|NCT01498289|537960125|FG001|Overall Study|Adverse Event|18|||
149131225|NCT01498289|537960124|FG000|Overall Study|Death|6|||
149131226|NCT01498289|537960125|FG001|Overall Study|Death|8|||
149131227|NCT01498289|537960124|FG000|Overall Study|Withdrawal unrelated to AE|16|||
149131228|NCT01498289|537960125|FG001|Overall Study|Withdrawal unrelated to AE|16|||
149131229|NCT01498289|537960124|FG000|Overall Study|Progression/relapse|53|||
149131230|NCT01498289|537960125|FG001|Overall Study|Progression/relapse|59|||
149131231|NCT01498289|537960124|FG000|Overall Study|Not protocol specified|7|||
149131232|NCT01498289|537960125|FG001|Overall Study|Not protocol specified|2|||
149131233|NCT01498289|537960124|FG000|Overall Study|Reason under review|0|||
149131234|NCT01498289|537960125|FG001|Overall Study|Reason under review|1|||
149131235|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
149131236|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
149131237|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
149131238|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
149131239|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
149131240|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
149131241|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
149131242|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
149131243|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
149131244|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
149131245|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
149131246|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
149131247|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
149131248|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
149131249|NCT01294683|537960126|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
149131250|NCT01294683|537960127|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
149131251|NCT01294683|537960126|FG000|Post Crossover (Period III)|Adverse Event|6|||
149131252|NCT01294683|537960127|FG001|Post Crossover (Period III)|Adverse Event|6|||
149131253|NCT01294683|537960126|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
149131254|NCT01294683|537960127|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
149131255|NCT01294683|537960126|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
149131256|NCT01294683|537960127|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
149131257|NCT01294683|537960126|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
149131258|NCT01294683|537960127|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
149131259|NCT01290601|537960128|FG000|Overall Study|Adverse Event|0|||
149131260|NCT01290601|537960129|FG001|Overall Study|Adverse Event|2|||
149131261|NCT01290601|537960130|FG002|Overall Study|Adverse Event|0|||
149131262|NCT01290601|537960131|FG003|Overall Study|Adverse Event|0|||
149131263|NCT01290601|537960128|FG000|Overall Study|Lack of Efficacy|2|||
149131264|NCT01290601|537960129|FG001|Overall Study|Lack of Efficacy|1|||
149131265|NCT01290601|537960130|FG002|Overall Study|Lack of Efficacy|0|||
149131266|NCT01290601|537960131|FG003|Overall Study|Lack of Efficacy|0|||
149131267|NCT01290601|537960128|FG000|Overall Study|Lost to Follow-up|7|||
149131268|NCT01290601|537960129|FG001|Overall Study|Lost to Follow-up|2|||
149131269|NCT01290601|537960130|FG002|Overall Study|Lost to Follow-up|0|||
149131270|NCT01290601|537960131|FG003|Overall Study|Lost to Follow-up|0|||
149131271|NCT01290601|537960128|FG000|Overall Study|Other|1|||
149131272|NCT01290601|537960129|FG001|Overall Study|Other|0|||
149131273|NCT01290601|537960130|FG002|Overall Study|Other|0|||
149131274|NCT01290601|537960131|FG003|Overall Study|Other|0|||
149131275|NCT01290601|537960128|FG000|Overall Study|Protocol Violation|1|||
149131276|NCT01290601|537960129|FG001|Overall Study|Protocol Violation|0|||
149131277|NCT01290601|537960130|FG002|Overall Study|Protocol Violation|0|||
149131278|NCT01290601|537960131|FG003|Overall Study|Protocol Violation|0|||
149131279|NCT02571049|537960132|FG000|Screening|Did not meet entry criteria|2|||
149131280|NCT02571049|537960133|FG001|Screening|Did not meet entry criteria|2|||
149131281|NCT02571049|537960132|FG000|Randomization|No migraine attack|0|||
149131282|NCT02571049|537960133|FG001|Randomization|No migraine attack|1|||
149131283|NCT02571049|537960132|FG000|Randomization|Adverse Event|0|||
149131284|NCT02571049|537960133|FG001|Randomization|Adverse Event|1|||
149131285|NCT00985153|537960134|FG000|Overall Study|Lost to Follow-up|16|||
149131286|NCT00985153|537960135|FG001|Overall Study|Lost to Follow-up|19|||
149131287|NCT00985153|537960136|FG002|Overall Study|Lost to Follow-up|17|||
149131288|NCT00985153|537960137|FG003|Overall Study|Lost to Follow-up|20|||
149131289|NCT00985153|537960134|FG000|Overall Study|Protocol Violation|3|||
149131290|NCT00985153|537960135|FG001|Overall Study|Protocol Violation|2|||
149131291|NCT00985153|537960136|FG002|Overall Study|Protocol Violation|4|||
149131292|NCT00985153|537960137|FG003|Overall Study|Protocol Violation|3|||
149131293|NCT00985153|537960134|FG000|Overall Study|Withdrawal by Subject|6|||
149131294|NCT00985153|537960135|FG001|Overall Study|Withdrawal by Subject|11|||
149131295|NCT00985153|537960136|FG002|Overall Study|Withdrawal by Subject|11|||
149131296|NCT00985153|537960137|FG003|Overall Study|Withdrawal by Subject|10|||
149131297|NCT00985153|537960134|FG000|Overall Study|Missed One or More Bleeds|7|||
149131298|NCT00985153|537960135|FG001|Overall Study|Missed One or More Bleeds|7|||
149131299|NCT00985153|537960136|FG002|Overall Study|Missed One or More Bleeds|8|||
149131300|NCT00985153|537960137|FG003|Overall Study|Missed One or More Bleeds|10|||
149131301|NCT00985153|537960134|FG000|Overall Study|Incomplete Safety Follow-up|3|||
149131302|NCT00985153|537960135|FG001|Overall Study|Incomplete Safety Follow-up|5|||
149131303|NCT00985153|537960136|FG002|Overall Study|Incomplete Safety Follow-up|4|||
149131304|NCT00985153|537960137|FG003|Overall Study|Incomplete Safety Follow-up|4|||
149131305|NCT03370471|537960141|FG000|Overall Study|Withdrawal by Subject|6|||
149131306|NCT03370471|537960142|FG001|Overall Study|Withdrawal by Subject|1|||
149131307|NCT03370471|537960141|FG000|Overall Study|Unable to access veins for blood draw|0|||
149131308|NCT03370471|537960142|FG001|Overall Study|Unable to access veins for blood draw|1|||
149131309|NCT03370471|537960141|FG000|Overall Study|Screen fail|1|||
149131310|NCT03370471|537960142|FG001|Overall Study|Screen fail|0|||
149131311|NCT00561951|537960143|FG000|Overall Study|Adverse Event|11|||
149131312|NCT00561951|537960144|FG001|Overall Study|Adverse Event|14|||
149131313|NCT00561951|537960145|FG002|Overall Study|Adverse Event|14|||
149131314|NCT00561951|537960143|FG000|Overall Study|Lack of Efficacy|5|||
149131315|NCT00561951|537960144|FG001|Overall Study|Lack of Efficacy|3|||
149131316|NCT00561951|537960145|FG002|Overall Study|Lack of Efficacy|2|||
149131317|NCT00561951|537960143|FG000|Overall Study|Lost to Follow-up|1|||
149131318|NCT00561951|537960144|FG001|Overall Study|Lost to Follow-up|1|||
149131319|NCT00561951|537960145|FG002|Overall Study|Lost to Follow-up|0|||
149131320|NCT00561951|537960143|FG000|Overall Study|Withdrawal by Subject|10|||
149011398|NCT04186403|537521466|FG000|Overall Study|Lost to Follow-up|7|||
149011399|NCT04186403|537521467|FG001|Overall Study|Lost to Follow-up|3|||
149011400|NCT04186403|537521466|FG000|Overall Study|Physician Decision|1|||
149011401|NCT04186403|537521467|FG001|Overall Study|Physician Decision|0|||
149011402|NCT04186403|537521466|FG000|Overall Study|Withdrawal by Subject|7|||
149011403|NCT04186403|537521467|FG001|Overall Study|Withdrawal by Subject|8|||
149131321|NCT00561951|537960144|FG001|Overall Study|Withdrawal by Subject|9|||
149131322|NCT00561951|537960145|FG002|Overall Study|Withdrawal by Subject|10|||
149011404|NCT04186403|537521466|FG000|Overall Study|Other: Not Related to Covid-19|3|||
149131323|NCT00561951|537960143|FG000|Overall Study|Protocol Violation|4|||
149131324|NCT00561951|537960144|FG001|Overall Study|Protocol Violation|3|||
149131325|NCT00561951|537960145|FG002|Overall Study|Protocol Violation|4|||
149131326|NCT00561951|537960143|FG000|Overall Study|Physician Decision|1|||
149131327|NCT00561951|537960144|FG001|Overall Study|Physician Decision|0|||
149131328|NCT00561951|537960145|FG002|Overall Study|Physician Decision|0|||
149131329|NCT00561951|537960143|FG000|Overall Study|Pregnancy|0|||
149131330|NCT00561951|537960144|FG001|Overall Study|Pregnancy|1|||
149131331|NCT00561951|537960145|FG002|Overall Study|Pregnancy|0|||
149131332|NCT00561951|537960143|FG000|Overall Study|Meet Withdrawal Criterion|0|||
149131333|NCT00561951|537960144|FG001|Overall Study|Meet Withdrawal Criterion|1|||
149131334|NCT00561951|537960145|FG002|Overall Study|Meet Withdrawal Criterion|1|||
149131335|NCT00561951|537960143|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
149131336|NCT00561951|537960144|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
149131337|NCT00561951|537960145|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
149131338|NCT01765179|537960146|FG000|Overall Study|Adverse Event|3|||
149131339|NCT01765179|537960146|FG000|Overall Study|Lost to Follow-up|5|||
149131340|NCT01765179|537960146|FG000|Overall Study|Non-compliance with study drug|2|||
149131341|NCT01765179|537960146|FG000|Overall Study|Protocol Violation|1|||
149131342|NCT01765179|537960146|FG000|Overall Study|Withdrawal by Subject|8|||
149131343|NCT01765179|537960146|FG000|Overall Study|Hematocrit >54%|3|||
149131344|NCT01765179|537960146|FG000|Overall Study|prohibited med|1|||
149131345|NCT01765179|537960146|FG000|Overall Study|Out of country unable to finish study|1|||
149131346|NCT01765179|537960146|FG000|Overall Study|lack of venous access|1|||
149131347|NCT01765179|537960146|FG000|Overall Study|work conflict|1|||
149131348|NCT01765179|537960146|FG000|Overall Study|Ca elevated 10.6|1|||
149131349|NCT01323634|537960147|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
149131350|NCT01323634|537960148|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
149131351|NCT01323634|537960149|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
149131352|NCT01323634|537960147|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
149131353|NCT01323634|537960148|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
149131354|NCT01323634|537960149|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
149131355|NCT01323634|537960147|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
149131356|NCT01323634|537960148|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149131357|NCT01323634|537960149|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
149131358|NCT01323634|537960147|FG000|2-week Run-in Period|Physician Decision|5|||
149131359|NCT01323634|537960148|FG001|2-week Run-in Period|Physician Decision|0|||
149131360|NCT01323634|537960149|FG002|2-week Run-in Period|Physician Decision|0|||
149131361|NCT01323634|537960147|FG000|2-week Run-in Period|Protocol Violation|1|||
149131362|NCT01323634|537960148|FG001|2-week Run-in Period|Protocol Violation|0|||
149131363|NCT01323634|537960149|FG002|2-week Run-in Period|Protocol Violation|0|||
149131364|NCT01323634|537960147|FG000|2-week Run-in Period|Adverse Event|1|||
149131365|NCT01323634|537960148|FG001|2-week Run-in Period|Adverse Event|0|||
149131366|NCT01323634|537960149|FG002|2-week Run-in Period|Adverse Event|0|||
149131367|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
149131368|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
149131369|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
149131370|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149131371|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
149131372|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
149131373|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
149131374|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
149131375|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
149131376|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149131377|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149131378|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149131379|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
149131380|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
149131381|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
149131382|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149131383|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
149131384|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
149131385|NCT01323634|537960147|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
149131386|NCT01323634|537960148|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
149131387|NCT01323634|537960149|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
149131388|NCT05056987|537960150|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
149131389|NCT05056987|537960151|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
149131390|NCT05056987|537960150|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
149131391|NCT05056987|537960151|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
149131392|NCT01759407|537960152|FG000|Overall Study|Protocol Violation|0|||
149131393|NCT01759407|537960153|FG001|Overall Study|Protocol Violation|2|||
149131394|NCT03442114|537960156|FG000|Overall Study|Lost to Follow-up|13|||
149131395|NCT03442114|537960157|FG001|Overall Study|Lost to Follow-up|13|||
149131396|NCT03442114|537960156|FG000|Overall Study|Physician Decision|2|||
149131397|NCT03442114|537960157|FG001|Overall Study|Physician Decision|2|||
149131398|NCT03442114|537960156|FG000|Overall Study|Protocol Violation|0|||
149131399|NCT03442114|537960157|FG001|Overall Study|Protocol Violation|2|||
149131400|NCT03442114|537960156|FG000|Overall Study|Withdrawal by Subject|1|||
149131401|NCT03442114|537960157|FG001|Overall Study|Withdrawal by Subject|3|||
149131402|NCT03442114|537960156|FG000|Overall Study|Guardianship Change|0|||
149131403|NCT03442114|537960157|FG001|Overall Study|Guardianship Change|1|||
149131404|NCT03217266|537961831|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
149131405|NCT03217266|537961832|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
149131406|NCT03217266|537961833|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
149131407|NCT03217266|537961834|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
149131408|NCT03217266|537961831|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
149131409|NCT03217266|537961832|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
149131410|NCT03217266|537961833|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
149131411|NCT03217266|537961834|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
149131412|NCT03217266|537961831|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
149131413|NCT03217266|537961832|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
149131414|NCT03217266|537961833|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
149131415|NCT03217266|537961834|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
149131416|NCT01390181|537961835|FG000|Overall Study|Lost to Follow-up|1|||
149131417|NCT01390181|537961835|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
149131418|NCT00792805|537961842|FG000|Overall Study|Adverse Event|12|||
149131419|NCT00792805|537961843|FG001|Overall Study|Adverse Event|10|||
149131420|NCT00792805|537961844|FG002|Overall Study|Adverse Event|10|||
149131421|NCT00792805|537961842|FG000|Overall Study|Subject withdrew consent|5|||
149131422|NCT00792805|537961843|FG001|Overall Study|Subject withdrew consent|6|||
149131423|NCT00792805|537961844|FG002|Overall Study|Subject withdrew consent|5|||
149131424|NCT00792805|537961842|FG000|Overall Study|Administrative problems|2|||
149131425|NCT00792805|537961843|FG001|Overall Study|Administrative problems|0|||
149131426|NCT00792805|537961844|FG002|Overall Study|Administrative problems|4|||
149131427|NCT00792805|537961842|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149131428|NCT00792805|537961843|FG001|Overall Study|Abnormal test procedure result(s)|2|||
149131429|NCT00792805|537961844|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149131430|NCT00792805|537961842|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149131431|NCT00792805|537961843|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
149131432|NCT00792805|537961844|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
149131433|NCT00792805|537961842|FG000|Overall Study|Lost to Follow-up|1|||
149131434|NCT00792805|537961843|FG001|Overall Study|Lost to Follow-up|1|||
149131435|NCT00792805|537961844|FG002|Overall Study|Lost to Follow-up|6|||
149131436|NCT00792805|537961842|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149131437|NCT00792805|537961843|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149131438|NCT00792805|537961844|FG002|Overall Study|Abnormal laboratory value(s)|1|||
149131439|NCT00792805|537961842|FG000|Overall Study|Protocol deviation|0|||
149131440|NCT00792805|537961843|FG001|Overall Study|Protocol deviation|1|||
149131441|NCT00792805|537961844|FG002|Overall Study|Protocol deviation|1|||
149131442|NCT02598557|537961845|FG000|Overall Study|Withdrawal by Subject|1|||
149131443|NCT02598557|537961846|FG001|Overall Study|Withdrawal by Subject|0|||
149131444|NCT02598557|537961847|FG002|Overall Study|Withdrawal by Subject|1|||
149131445|NCT02598557|537961845|FG000|Overall Study|Participant did not start treatment|2|||
149131446|NCT02598557|537961846|FG001|Overall Study|Participant did not start treatment|1|||
149131447|NCT02598557|537961847|FG002|Overall Study|Participant did not start treatment|1|||
149131448|NCT02598557|537961845|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
149131449|NCT02598557|537961846|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
149131450|NCT02598557|537961847|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
149131451|NCT02598557|537961845|FG000|Overall Study|Adverse Event|1|||
149131452|NCT02598557|537961846|FG001|Overall Study|Adverse Event|1|||
149131453|NCT02598557|537961847|FG002|Overall Study|Adverse Event|0|||
149131454|NCT02072434|537961851|FG000|Overall Study|Protocol Violation|10|||
149131455|NCT02072434|537961852|FG001|Overall Study|Protocol Violation|9|||
149131456|NCT02072434|537961851|FG000|Overall Study|Physician Decision|5|||
149131457|NCT02072434|537961852|FG001|Overall Study|Physician Decision|10|||
149131458|NCT02072434|537961851|FG000|Overall Study|Adverse event, serious fatal|1|||
149131459|NCT02072434|537961852|FG001|Overall Study|Adverse event, serious fatal|6|||
149131460|NCT02072434|537961851|FG000|Overall Study|Adverse Event|7|||
149131461|NCT02072434|537961852|FG001|Overall Study|Adverse Event|6|||
149131462|NCT02072434|537961851|FG000|Overall Study|Withdrawal by Subject|17|||
149131463|NCT02072434|537961852|FG001|Overall Study|Withdrawal by Subject|29|||
149131464|NCT02072434|537961851|FG000|Overall Study|Other|14|||
149131465|NCT02072434|537961852|FG001|Overall Study|Other|29|||
149131466|NCT02072434|537961851|FG000|Overall Study|Lost to Follow-up|0|||
149131467|NCT02072434|537961852|FG001|Overall Study|Lost to Follow-up|1|||
149131468|NCT00402363|537961855|FG000|Overall Study|Adverse Event|9|||
149131469|NCT00402363|537961856|FG001|Overall Study|Adverse Event|14|||
149131470|NCT00402363|537961857|FG002|Overall Study|Adverse Event|2|||
149131471|NCT00402363|537961858|FG003|Overall Study|Adverse Event|2|||
149131472|NCT00402363|537961855|FG000|Overall Study|Withdrew Consent|10|||
149131473|NCT00402363|537961856|FG001|Overall Study|Withdrew Consent|5|||
149131474|NCT00402363|537961857|FG002|Overall Study|Withdrew Consent|2|||
149131475|NCT00402363|537961858|FG003|Overall Study|Withdrew Consent|1|||
149131476|NCT00402363|537961855|FG000|Overall Study|Protocol Violation|3|||
149131477|NCT00402363|537961856|FG001|Overall Study|Protocol Violation|5|||
149131478|NCT00402363|537961857|FG002|Overall Study|Protocol Violation|0|||
149131479|NCT00402363|537961858|FG003|Overall Study|Protocol Violation|3|||
149131480|NCT00402363|537961855|FG000|Overall Study|Lost to Follow-up|5|||
149131481|NCT00402363|537961856|FG001|Overall Study|Lost to Follow-up|4|||
149131482|NCT00402363|537961857|FG002|Overall Study|Lost to Follow-up|0|||
149131483|NCT00402363|537961858|FG003|Overall Study|Lost to Follow-up|2|||
149131484|NCT00402363|537961855|FG000|Overall Study|"Captured as Other"|6|||
149131485|NCT00402363|537961856|FG001|Overall Study|"Captured as Other"|2|||
149131486|NCT00402363|537961857|FG002|Overall Study|"Captured as Other"|2|||
149131487|NCT00402363|537961858|FG003|Overall Study|"Captured as Other"|2|||
149131488|NCT00162032|537961867|FG000|Overall Study|Lost to Follow-up|4|||
149131489|NCT00162032|537961868|FG001|Overall Study|Lost to Follow-up|2|||
149131490|NCT00162032|537961867|FG000|Overall Study|Reason not specified|1|||
149131491|NCT00162032|537961868|FG001|Overall Study|Reason not specified|0|||
149131492|NCT00818389|537961869|FG000|Overall Study|Death|1|||
149131493|NCT00818389|537961870|FG001|Overall Study|Death|3|||
149131494|NCT00818389|537961869|FG000|Overall Study|ALS Disease Progression|1|||
149131495|NCT00818389|537961870|FG001|Overall Study|ALS Disease Progression|0|||
149131496|NCT00818389|537961869|FG000|Overall Study|Withdrawal by Subject|2|||
149131497|NCT00818389|537961870|FG001|Overall Study|Withdrawal by Subject|2|||
149131498|NCT00818389|537961869|FG000|Overall Study|Adverse Event|0|||
149131499|NCT00818389|537961870|FG001|Overall Study|Adverse Event|1|||
149131500|NCT01794923|537961878|FG000|Overall Study|Adverse Event|0|||
149131501|NCT01794923|537961879|FG001|Overall Study|Adverse Event|0|||
149131502|NCT01794923|537961880|FG002|Overall Study|Adverse Event|1|||
149131503|NCT01423253|537961881|FG000|Overall Study|Adverse Event|2|||
149131504|NCT01423253|537961881|FG000|Overall Study|Lack of Efficacy|2|||
149131505|NCT01423253|537961881|FG000|Overall Study|Lost to Follow-up|1|||
149131506|NCT01423253|537961881|FG000|Overall Study|Protocol Violation|2|||
149131507|NCT01423253|537961881|FG000|Overall Study|Withdrawal by Subject|2|||
149131508|NCT02804178|537961884|FG000|Overall Study|Adverse Event|1|||
149131509|NCT01055262|537961889|FG000|Overall Study|Adverse Event|5|||
149131510|NCT01055262|537961889|FG000|Overall Study|Protocol Violation|3|||
149131511|NCT01055262|537961889|FG000|Overall Study|Uncooperativeness|1|||
149131512|NCT00752622|537961901|FG000|Induction Phase|Adverse Event|3|||
149131513|NCT00752622|537961901|FG000|Induction Phase|Other|3|||
149131514|NCT00752622|537961901|FG000|Induction Phase|Non-responder|14|||
149131515|NCT00752622|537961901|FG000|Induction Phase|Withdrawal by Subject|1|||
149131516|NCT00752622|537961901|FG000|Induction Phase|Premature study termination|14|||
149131517|NCT00752622|537961901|FG000|Observational Phase|Premature Study Termination|36|||
149131518|NCT00752622|537961901|FG000|Observational Phase|Non-responder|2|||
149131519|NCT00752622|537961901|FG000|Observational Phase|Withdrawal by Subject|2|||
149131520|NCT00752622|537961901|FG000|Observational Phase|Adverse Event|1|||
149131521|NCT00752622|537961901|FG000|Observational Phase|Other|2|||
149131522|NCT00752622|537961901|FG000|Interventional Phase|Non-responder|2|||
149131523|NCT00752622|537961901|FG000|Interventional Phase|Physician Decision|1|||
149131524|NCT00752622|537961901|FG000|Interventional Phase|Premature Study Termination|5|||
149131525|NCT00576836|537961902|FG000|Overall Study|Death|0|||
149131526|NCT00576836|537961903|FG001|Overall Study|Death|1|||
149131527|NCT00576836|537961902|FG000|Overall Study|Physician Decision|0|||
149131528|NCT00576836|537961903|FG001|Overall Study|Physician Decision|1|||
149131529|NCT00392327|537961906|FG000|Overall Study|Death|1|||
149131530|NCT00392327|537961907|FG001|Overall Study|Death|0|||
149131531|NCT00392327|537961908|FG002|Overall Study|Death|1|||
149131532|NCT00392327|537961909|FG003|Overall Study|Death|0|||
149131533|NCT00392327|537961910|FG004|Overall Study|Death|0|||
149131534|NCT00392327|537961911|FG005|Overall Study|Death|0|||
149131535|NCT00392327|537961912|FG006|Overall Study|Death|0|||
149131536|NCT00392327|537961913|FG007|Overall Study|Death|0|||
149131537|NCT00392327|537961906|FG000|Overall Study|Lack of Efficacy|8|||
149131538|NCT00392327|537961907|FG001|Overall Study|Lack of Efficacy|8|||
149131539|NCT00392327|537961908|FG002|Overall Study|Lack of Efficacy|9|||
149131540|NCT00392327|537961909|FG003|Overall Study|Lack of Efficacy|6|||
149131541|NCT00392327|537961910|FG004|Overall Study|Lack of Efficacy|3|||
149131542|NCT00392327|537961911|FG005|Overall Study|Lack of Efficacy|3|||
149131543|NCT00392327|537961912|FG006|Overall Study|Lack of Efficacy|3|||
149131544|NCT00392327|537961913|FG007|Overall Study|Lack of Efficacy|3|||
149131545|NCT00392327|537961906|FG000|Overall Study|Physician Decision|3|||
149131546|NCT00392327|537961907|FG001|Overall Study|Physician Decision|5|||
149131547|NCT00392327|537961908|FG002|Overall Study|Physician Decision|2|||
149131548|NCT00392327|537961909|FG003|Overall Study|Physician Decision|2|||
149131549|NCT00392327|537961910|FG004|Overall Study|Physician Decision|0|||
149131550|NCT00392327|537961911|FG005|Overall Study|Physician Decision|1|||
149131551|NCT00392327|537961912|FG006|Overall Study|Physician Decision|5|||
149131552|NCT00392327|537961913|FG007|Overall Study|Physician Decision|3|||
149131553|NCT00392327|537961906|FG000|Overall Study|Protocol Violation|0|||
149131554|NCT00392327|537961907|FG001|Overall Study|Protocol Violation|0|||
149131555|NCT00392327|537961908|FG002|Overall Study|Protocol Violation|1|||
149131556|NCT00392327|537961909|FG003|Overall Study|Protocol Violation|0|||
149131557|NCT00392327|537961910|FG004|Overall Study|Protocol Violation|0|||
149131558|NCT00392327|537961911|FG005|Overall Study|Protocol Violation|0|||
149131559|NCT00392327|537961912|FG006|Overall Study|Protocol Violation|0|||
148790851|NCT05415462|536712709|FG001|Overall Study|Physician Decision|5|||
148790852|NCT05415462|536712708|FG000|Overall Study|Protocol Deviation|1|||
148790853|NCT05415462|536712709|FG001|Overall Study|Protocol Deviation|0|||
149131560|NCT00392327|537961913|FG007|Overall Study|Protocol Violation|0|||
149131561|NCT00392327|537961906|FG000|Overall Study|Withdrawal by Subject|3|||
149131562|NCT00392327|537961907|FG001|Overall Study|Withdrawal by Subject|2|||
149131563|NCT00392327|537961908|FG002|Overall Study|Withdrawal by Subject|4|||
149131564|NCT00392327|537961909|FG003|Overall Study|Withdrawal by Subject|6|||
149131565|NCT00392327|537961910|FG004|Overall Study|Withdrawal by Subject|0|||
149131566|NCT00392327|537961911|FG005|Overall Study|Withdrawal by Subject|1|||
149131567|NCT00392327|537961912|FG006|Overall Study|Withdrawal by Subject|1|||
149131568|NCT00392327|537961913|FG007|Overall Study|Withdrawal by Subject|5|||
149131569|NCT00392327|537961906|FG000|Overall Study|Ineligible|0|||
149131570|NCT00392327|537961907|FG001|Overall Study|Ineligible|4|||
149131571|NCT00392327|537961908|FG002|Overall Study|Ineligible|3|||
149131572|NCT00392327|537961909|FG003|Overall Study|Ineligible|2|||
149131573|NCT00392327|537961910|FG004|Overall Study|Ineligible|0|||
149131574|NCT00392327|537961911|FG005|Overall Study|Ineligible|0|||
149131575|NCT00392327|537961912|FG006|Overall Study|Ineligible|0|||
149131576|NCT00392327|537961913|FG007|Overall Study|Ineligible|0|||
149131577|NCT00894686|537961914|FG000|Overall Study|Withdrawal by Subject|50|||
149131578|NCT00894686|537961914|FG000|Overall Study|Physician Decision|1|||
149131579|NCT00894686|537961914|FG000|Overall Study|Other|5|||
149131580|NCT00564018|537961917|FG000|Overall Study|Withdrawal by Subject|2|||
149131581|NCT00564018|537961918|FG001|Overall Study|Withdrawal by Subject|3|||
149131582|NCT00564018|537961919|FG002|Overall Study|Withdrawal by Subject|1|||
149131583|NCT00986440|537961920|FG000|Overall Study|Progressive disease|27|||
149131584|NCT00986440|537961921|FG001|Overall Study|Progressive disease|37|||
149131585|NCT00986440|537961920|FG000|Overall Study|Serious adverse event or adverse event|9|||
149131586|NCT00986440|537961921|FG001|Overall Study|Serious adverse event or adverse event|2|||
149131587|NCT00986440|537961920|FG000|Overall Study|Withdrawal by Subject|1|||
149131588|NCT00986440|537961921|FG001|Overall Study|Withdrawal by Subject|2|||
149131589|NCT00986440|537961920|FG000|Overall Study|Screen failure (not dosed)|4|||
149131590|NCT00986440|537961921|FG001|Overall Study|Screen failure (not dosed)|2|||
149131591|NCT03267940|537961922|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
149131592|NCT03267940|537961923|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
149131593|NCT03267940|537961924|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
149131594|NCT03267940|537961925|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
149131595|NCT03267940|537961926|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
149131596|NCT03267940|537961927|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
149131597|NCT03267940|537961922|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
149131598|NCT03267940|537961923|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
149131599|NCT03267940|537961924|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
149131600|NCT03267940|537961925|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
149131601|NCT03267940|537961926|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
149131602|NCT03267940|537961927|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
149131603|NCT03267940|537961922|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
149131604|NCT03267940|537961923|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
149131605|NCT03267940|537961924|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
149131606|NCT03267940|537961925|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
149131607|NCT03267940|537961926|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
149131608|NCT03267940|537961927|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
149131609|NCT03267940|537961922|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
149131610|NCT03267940|537961923|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
149131611|NCT03267940|537961924|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
149131612|NCT03267940|537961925|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
149131613|NCT03267940|537961926|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
149131614|NCT03267940|537961927|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
149131615|NCT03267940|537961922|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
149131616|NCT03267940|537961923|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
149131617|NCT03267940|537961924|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
149131618|NCT03267940|537961925|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
149131619|NCT03267940|537961926|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
149131620|NCT03267940|537961927|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
149131621|NCT03267940|537961922|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
149131622|NCT03267940|537961923|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
149131623|NCT03267940|537961924|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
149131624|NCT03267940|537961925|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
149131625|NCT03267940|537961926|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
149131626|NCT03267940|537961927|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
149131627|NCT03267940|537961922|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
149131628|NCT03267940|537961923|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
149131629|NCT03267940|537961924|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
149131630|NCT03267940|537961925|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
149131631|NCT03267940|537961926|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
149131632|NCT03267940|537961927|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
149131633|NCT03267940|537961922|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
149131634|NCT03267940|537961923|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
149131635|NCT03267940|537961924|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
149131636|NCT03267940|537961925|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
149131637|NCT03267940|537961926|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
149131638|NCT03267940|537961927|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
149131639|NCT03267940|537961922|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
149131640|NCT03267940|537961923|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
149131641|NCT03267940|537961924|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
149131642|NCT03267940|537961925|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
149131643|NCT03267940|537961926|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
149131644|NCT03267940|537961927|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
149131645|NCT00388154|537961934|FG000|Overall Study|Withdrawal by Subject|1|||
149131646|NCT00421707|537961935|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
149131647|NCT00421707|537961936|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
149131648|NCT00421707|537961935|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
149131649|NCT00421707|537961936|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
149131650|NCT00421707|537961935|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
149131651|NCT00421707|537961936|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
149131652|NCT00421707|537961935|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
149131653|NCT00421707|537961936|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
149131654|NCT00421707|537961935|FG000|Period 2: Washout|Adverse Event|1|||
149131655|NCT00421707|537961936|FG001|Period 2: Washout|Adverse Event|1|||
149131656|NCT00421707|537961935|FG000|Period 2: Washout|Withdrawal by Subject|0|||
149131657|NCT00421707|537961936|FG001|Period 2: Washout|Withdrawal by Subject|1|||
149131658|NCT00421707|537961935|FG000|Period 2: Washout|Lost to Follow-up|0|||
149131659|NCT00421707|537961936|FG001|Period 2: Washout|Lost to Follow-up|1|||
149131660|NCT00421707|537961935|FG000|Period 2: Washout|Other: Pregnancy|0|||
149131661|NCT00421707|537961936|FG001|Period 2: Washout|Other: Pregnancy|1|||
149131662|NCT00421707|537961935|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
149131663|NCT00421707|537961936|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
149131664|NCT00421707|537961935|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
149131665|NCT00421707|537961936|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
149131666|NCT00421707|537961935|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
149131667|NCT00421707|537961936|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
149131668|NCT01074216|537961937|FG000|Overall Study|Physician Decision|1|||
149131669|NCT01074216|537961937|FG000|Overall Study|Not Treated|12|||
149131670|NCT01182194|537961940|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
149131671|NCT01182194|537961941|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
149131672|NCT01948908|537961942|FG000|Overall Study|Protocol Violation|1|||
149131673|NCT01948908|537961943|FG001|Overall Study|Protocol Violation|0|||
149131674|NCT01948908|537961944|FG002|Overall Study|Protocol Violation|2|||
149131675|NCT00796120|537961945|FG000|Overall Study|Death|3|||
149131676|NCT00796120|537961946|FG001|Overall Study|Death|0|||
149131677|NCT00796120|537961945|FG000|Overall Study|Adverse Event|11|||
149131678|NCT00796120|537961946|FG001|Overall Study|Adverse Event|6|||
149131679|NCT00796120|537961945|FG000|Overall Study|Progressive disease|22|||
149131680|NCT00796120|537961946|FG001|Overall Study|Progressive disease|13|||
149131681|NCT00796120|537961945|FG000|Overall Study|Participant refusal|3|||
149131682|NCT00796120|537961946|FG001|Overall Study|Participant refusal|4|||
149131683|NCT00796120|537961945|FG000|Overall Study|Other|6|||
149131684|NCT00796120|537961946|FG001|Overall Study|Other|17|||
149131685|NCT00796120|537961945|FG000|Overall Study|Physician Decision|16|||
149131686|NCT00796120|537961946|FG001|Overall Study|Physician Decision|17|||
149131687|NCT00796120|537961945|FG000|Overall Study|Randomized but not treated|0|||
149131688|NCT00796120|537961946|FG001|Overall Study|Randomized but not treated|3|||
149131689|NCT03737474|537961950|FG000|Overall Study|Adverse Event|18|||
149131690|NCT03737474|537961951|FG001|Overall Study|Adverse Event|48|||
149131691|NCT03737474|537961950|FG000|Overall Study|Lack of Efficacy|1|||
149131692|NCT03737474|537961951|FG001|Overall Study|Lack of Efficacy|3|||
149131693|NCT03737474|537961950|FG000|Overall Study|Protocol Violation|0|||
149131694|NCT03737474|537961951|FG001|Overall Study|Protocol Violation|8|||
149131695|NCT03737474|537961950|FG000|Overall Study|Withdrawal by Subject|5|||
149131696|NCT03737474|537961951|FG001|Overall Study|Withdrawal by Subject|20|||
149131697|NCT03737474|537961950|FG000|Overall Study|Non-compliance With Study Drug|0|||
149131698|NCT03737474|537961951|FG001|Overall Study|Non-compliance With Study Drug|1|||
149131699|NCT03737474|537961950|FG000|Overall Study|Physician Decision|1|||
149131700|NCT03737474|537961951|FG001|Overall Study|Physician Decision|4|||
149131701|NCT00803270|537961952|FG000|Overall Study|Lost to Follow-up|1|||
149131702|NCT00803270|537961953|FG001|Overall Study|Lost to Follow-up|2|||
149131703|NCT00971243|537961954|FG000|Double Blind Period|Adverse Event|2|||
149131704|NCT00971243|537961955|FG001|Double Blind Period|Adverse Event|3|||
149131705|NCT00971243|537961956|FG002|Double Blind Period|Adverse Event|2|||
149131706|NCT00971243|537961957|FG003|Double Blind Period|Adverse Event|2|||
149131707|NCT00971243|537961958|FG004|Double Blind Period|Adverse Event|3|||
149131708|NCT00971243|537961954|FG000|Double Blind Period|Lost to Follow-up|0|||
149131709|NCT00971243|537961955|FG001|Double Blind Period|Lost to Follow-up|1|||
149131710|NCT00971243|537961956|FG002|Double Blind Period|Lost to Follow-up|1|||
149131711|NCT00971243|537961957|FG003|Double Blind Period|Lost to Follow-up|0|||
149131712|NCT00971243|537961958|FG004|Double Blind Period|Lost to Follow-up|1|||
149131713|NCT00971243|537961954|FG000|Double Blind Period|Physician Decision|10|||
149131714|NCT00971243|537961955|FG001|Double Blind Period|Physician Decision|6|||
149131715|NCT00971243|537961956|FG002|Double Blind Period|Physician Decision|7|||
149131716|NCT00971243|537961957|FG003|Double Blind Period|Physician Decision|6|||
149131717|NCT00971243|537961958|FG004|Double Blind Period|Physician Decision|7|||
149131718|NCT00971243|537961954|FG000|Double Blind Period|Protocol Violation|2|||
149131719|NCT00971243|537961955|FG001|Double Blind Period|Protocol Violation|0|||
149131720|NCT00971243|537961956|FG002|Double Blind Period|Protocol Violation|3|||
149131721|NCT00971243|537961957|FG003|Double Blind Period|Protocol Violation|2|||
149131722|NCT00971243|537961958|FG004|Double Blind Period|Protocol Violation|2|||
149131723|NCT00971243|537961954|FG000|Double Blind Period|Withdrawal by Subject|4|||
149131724|NCT00971243|537961955|FG001|Double Blind Period|Withdrawal by Subject|1|||
149131725|NCT00971243|537961956|FG002|Double Blind Period|Withdrawal by Subject|4|||
149131726|NCT00971243|537961957|FG003|Double Blind Period|Withdrawal by Subject|4|||
149131727|NCT00971243|537961958|FG004|Double Blind Period|Withdrawal by Subject|4|||
149131728|NCT00971243|537961954|FG000|Double Blind Period|Other reasons|1|||
149131729|NCT00971243|537961955|FG001|Double Blind Period|Other reasons|0|||
149131730|NCT00971243|537961956|FG002|Double Blind Period|Other reasons|2|||
149131731|NCT00971243|537961957|FG003|Double Blind Period|Other reasons|0|||
149131732|NCT00971243|537961958|FG004|Double Blind Period|Other reasons|1|||
149131733|NCT00971243|537961954|FG000|Open-label Period|Adverse Event|1|||
149131734|NCT00971243|537961955|FG001|Open-label Period|Adverse Event|0|||
149131735|NCT00971243|537961956|FG002|Open-label Period|Adverse Event|1|||
149131736|NCT00971243|537961957|FG003|Open-label Period|Adverse Event|1|||
149131737|NCT00971243|537961958|FG004|Open-label Period|Adverse Event|0|||
149131738|NCT00971243|537961954|FG000|Open-label Period|Physician Decision|5|||
149131739|NCT00971243|537961955|FG001|Open-label Period|Physician Decision|9|||
149131740|NCT00971243|537961956|FG002|Open-label Period|Physician Decision|3|||
149131741|NCT00971243|537961957|FG003|Open-label Period|Physician Decision|7|||
149131742|NCT00971243|537961958|FG004|Open-label Period|Physician Decision|2|||
149131743|NCT00971243|537961954|FG000|Open-label Period|Protocol Violation|1|||
149131744|NCT00971243|537961955|FG001|Open-label Period|Protocol Violation|1|||
149131745|NCT00971243|537961956|FG002|Open-label Period|Protocol Violation|1|||
149131746|NCT00971243|537961957|FG003|Open-label Period|Protocol Violation|0|||
149131747|NCT00971243|537961958|FG004|Open-label Period|Protocol Violation|1|||
149131748|NCT00971243|537961954|FG000|Open-label Period|Withdrawal by Subject|1|||
149131749|NCT00971243|537961955|FG001|Open-label Period|Withdrawal by Subject|0|||
149131750|NCT00971243|537961956|FG002|Open-label Period|Withdrawal by Subject|0|||
149131751|NCT00971243|537961957|FG003|Open-label Period|Withdrawal by Subject|2|||
149131752|NCT00971243|537961958|FG004|Open-label Period|Withdrawal by Subject|1|||
149131753|NCT00971243|537961954|FG000|Open-label Period|Other reason|0|||
149131754|NCT00971243|537961955|FG001|Open-label Period|Other reason|0|||
149131755|NCT00971243|537961956|FG002|Open-label Period|Other reason|0|||
149131756|NCT00971243|537961957|FG003|Open-label Period|Other reason|0|||
149131757|NCT00971243|537961958|FG004|Open-label Period|Other reason|2|||
149131758|NCT00494481|537961962|FG000|Overall Study|Condition under investigation worsened|11|||
149131759|NCT00494481|537961963|FG001|Overall Study|Condition under investigation worsened|13|||
149131760|NCT00494481|537961962|FG000|Overall Study|Adverse Event|15|||
149131761|NCT00494481|537961963|FG001|Overall Study|Adverse Event|11|||
149131762|NCT00494481|537961962|FG000|Overall Study|Other|1|||
149131763|NCT00494481|537961963|FG001|Overall Study|Other|0|||
149131764|NCT00494481|537961962|FG000|Overall Study|Never received IP|2|||
149131765|NCT00494481|537961963|FG001|Overall Study|Never received IP|0|||
149131766|NCT02370043|537961964|FG000|Overall Study|Withdrawal by Subject|0|||
149131767|NCT02370043|537961965|FG001|Overall Study|Withdrawal by Subject|0|||
149131768|NCT02370043|537961966|FG002|Overall Study|Withdrawal by Subject|0|||
149131769|NCT02370043|537961967|FG003|Overall Study|Withdrawal by Subject|0|||
149131770|NCT02370043|537961968|FG004|Overall Study|Withdrawal by Subject|1|||
149131771|NCT02370043|537961969|FG005|Overall Study|Withdrawal by Subject|1|||
149131772|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
149131773|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
149131774|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
149131775|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
149131776|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
149131777|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
149131778|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
149131779|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
149131780|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
149131781|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
149131782|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
149131783|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
149131784|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
149131785|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
149131786|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
149131787|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
149131788|NCT01231516|537961970|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
149131789|NCT01231516|537961971|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
149131790|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
149131791|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
149131792|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
149131793|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
149131794|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
149131795|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
149131796|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
149131797|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
149131798|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
149131799|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
149131800|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
149131801|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
149131802|NCT01231516|537961970|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
149131803|NCT01231516|537961971|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
149131804|NCT05266586|537961972|FG000|Overall Study|Adverse Event|2|||
149131805|NCT05266586|537961973|FG001|Overall Study|Adverse Event|2|||
149131806|NCT05266586|537961974|FG002|Overall Study|Adverse Event|1|||
149131807|NCT05266586|537961972|FG000|Overall Study|Withdrawal by Subject|1|||
149131808|NCT05266586|537961973|FG001|Overall Study|Withdrawal by Subject|0|||
149131809|NCT05266586|537961974|FG002|Overall Study|Withdrawal by Subject|1|||
149131810|NCT05266586|537961972|FG000|Overall Study|Non-compliance with study drug|0|||
149131811|NCT05266586|537961973|FG001|Overall Study|Non-compliance with study drug|1|||
149131812|NCT05266586|537961974|FG002|Overall Study|Non-compliance with study drug|0|||
149131813|NCT05266586|537961972|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
149131814|NCT05266586|537961973|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
149131815|NCT05266586|537961974|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
149131816|NCT02225353|537961975|FG000|Overall Study|Lost to Follow-up|0|||
149131817|NCT02225353|537961976|FG001|Overall Study|Lost to Follow-up|1|||
149131818|NCT02225353|537961977|FG002|Overall Study|Lost to Follow-up|3|||
149131819|NCT02225353|537961975|FG000|Overall Study|Protocol Violation|4|||
149131820|NCT02225353|537961976|FG001|Overall Study|Protocol Violation|5|||
149131821|NCT02225353|537961977|FG002|Overall Study|Protocol Violation|12|||
149131822|NCT01193920|537961978|FG000|Overall Study|Withdrawal by Subject|1|||
149131823|NCT01193920|537961979|FG001|Overall Study|Withdrawal by Subject|0|||
149131824|NCT01193920|537961980|FG002|Overall Study|Withdrawal by Subject|5|||
149131825|NCT01193920|537961981|FG003|Overall Study|Withdrawal by Subject|1|||
149131826|NCT01193920|537961982|FG004|Overall Study|Withdrawal by Subject|3|||
149131827|NCT01193920|537961983|FG005|Overall Study|Withdrawal by Subject|1|||
149131828|NCT01193920|537961984|FG006|Overall Study|Withdrawal by Subject|3|||
149131829|NCT01193920|537961985|FG007|Overall Study|Withdrawal by Subject|0|||
149131830|NCT01193920|537961986|FG008|Overall Study|Withdrawal by Subject|1|||
149131831|NCT01193920|537961987|FG009|Overall Study|Withdrawal by Subject|0|||
149131832|NCT01193920|537961978|FG000|Overall Study|Lost to Follow-up|1|||
149131833|NCT01193920|537961979|FG001|Overall Study|Lost to Follow-up|0|||
149131834|NCT01193920|537961980|FG002|Overall Study|Lost to Follow-up|1|||
149131835|NCT01193920|537961981|FG003|Overall Study|Lost to Follow-up|1|||
149131836|NCT01193920|537961982|FG004|Overall Study|Lost to Follow-up|3|||
149131837|NCT01193920|537961983|FG005|Overall Study|Lost to Follow-up|3|||
149131838|NCT01193920|537961984|FG006|Overall Study|Lost to Follow-up|1|||
149131839|NCT01193920|537961985|FG007|Overall Study|Lost to Follow-up|0|||
149131840|NCT01193920|537961986|FG008|Overall Study|Lost to Follow-up|2|||
149131841|NCT01193920|537961987|FG009|Overall Study|Lost to Follow-up|3|||
149131842|NCT01193920|537961978|FG000|Overall Study|Protocol Violation|1|||
149131843|NCT01193920|537961979|FG001|Overall Study|Protocol Violation|0|||
149131844|NCT01193920|537961980|FG002|Overall Study|Protocol Violation|0|||
149131845|NCT01193920|537961981|FG003|Overall Study|Protocol Violation|0|||
149131846|NCT01193920|537961982|FG004|Overall Study|Protocol Violation|0|||
149131847|NCT01193920|537961983|FG005|Overall Study|Protocol Violation|0|||
149131848|NCT01193920|537961984|FG006|Overall Study|Protocol Violation|0|||
149131849|NCT01193920|537961985|FG007|Overall Study|Protocol Violation|0|||
149131850|NCT01193920|537961986|FG008|Overall Study|Protocol Violation|0|||
149131851|NCT01193920|537961987|FG009|Overall Study|Protocol Violation|0|||
149131852|NCT01193920|537961978|FG000|Overall Study|Death|0|||
149131853|NCT01193920|537961979|FG001|Overall Study|Death|0|||
149131854|NCT01193920|537961980|FG002|Overall Study|Death|0|||
149131855|NCT01193920|537961981|FG003|Overall Study|Death|1|||
149131856|NCT01193920|537961982|FG004|Overall Study|Death|0|||
149131857|NCT01193920|537961983|FG005|Overall Study|Death|0|||
149131858|NCT01193920|537961984|FG006|Overall Study|Death|2|||
149131859|NCT01193920|537961985|FG007|Overall Study|Death|3|||
149131860|NCT01193920|537961986|FG008|Overall Study|Death|2|||
149131861|NCT01193920|537961987|FG009|Overall Study|Death|4|||
149131862|NCT01193920|537961978|FG000|Overall Study|Unable to classify|0|||
149131863|NCT01193920|537961979|FG001|Overall Study|Unable to classify|0|||
149131864|NCT01193920|537961980|FG002|Overall Study|Unable to classify|0|||
149131865|NCT01193920|537961981|FG003|Overall Study|Unable to classify|1|||
149131866|NCT01193920|537961982|FG004|Overall Study|Unable to classify|0|||
149131867|NCT01193920|537961983|FG005|Overall Study|Unable to classify|0|||
149131868|NCT01193920|537961984|FG006|Overall Study|Unable to classify|0|||
149131869|NCT01193920|537961985|FG007|Overall Study|Unable to classify|1|||
149131870|NCT01193920|537961986|FG008|Overall Study|Unable to classify|0|||
149131871|NCT01193920|537961987|FG009|Overall Study|Unable to classify|0|||
149131872|NCT04683731|537961989|FG000|Overall Study|Withdrawal by Subject|1|||
149131873|NCT04683731|537961990|FG001|Overall Study|Withdrawal by Subject|0|||
149131874|NCT04683731|537961991|FG002|Overall Study|Withdrawal by Subject|3|||
149131875|NCT04683731|537961992|FG003|Overall Study|Withdrawal by Subject|2|||
149131876|NCT04683731|537961989|FG000|Overall Study|Determined patient was not eligible|3|||
149131877|NCT04683731|537961990|FG001|Overall Study|Determined patient was not eligible|3|||
149131878|NCT04683731|537961991|FG002|Overall Study|Determined patient was not eligible|12|||
149131879|NCT04683731|537961992|FG003|Overall Study|Determined patient was not eligible|3|||
149131880|NCT02910739|537961993|FG000|Overall Study|Adverse Event|1|||
149131881|NCT02910739|537961994|FG001|Overall Study|Adverse Event|0|||
149131882|NCT02910739|537961995|FG002|Overall Study|Adverse Event|0|||
149131883|NCT02910739|537961996|FG003|Overall Study|Adverse Event|0|||
149131884|NCT03226275|537961999|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
149131885|NCT03226275|537962000|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
149131886|NCT03226275|537962001|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
149131887|NCT03226275|537962002|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
149131888|NCT03226275|537961999|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
149131889|NCT03226275|537962000|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
149131890|NCT03226275|537962001|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
149131891|NCT03226275|537962002|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
149131892|NCT03769181|537963839|FG000|Overall Study|Adverse Event|1|||
149131893|NCT03769181|537963840|FG001|Overall Study|Adverse Event|0|||
149131894|NCT03769181|537963841|FG002|Overall Study|Adverse Event|2|||
149131895|NCT03769181|537963842|FG003|Overall Study|Adverse Event|4|||
149131896|NCT03769181|537963839|FG000|Overall Study|Withdrawal by Subject|1|||
149131897|NCT03769181|537963840|FG001|Overall Study|Withdrawal by Subject|0|||
149131898|NCT03769181|537963841|FG002|Overall Study|Withdrawal by Subject|2|||
149131899|NCT03769181|537963842|FG003|Overall Study|Withdrawal by Subject|1|||
149131900|NCT03769181|537963839|FG000|Overall Study|Progressive disease|9|||
149131901|NCT03769181|537963840|FG001|Overall Study|Progressive disease|7|||
149131902|NCT03769181|537963841|FG002|Overall Study|Progressive disease|13|||
149131903|NCT03769181|537963842|FG003|Overall Study|Progressive disease|6|||
149131904|NCT03769181|537963839|FG000|Overall Study|Other - Unspecified|2|||
149131905|NCT03769181|537963840|FG001|Overall Study|Other - Unspecified|1|||
149131906|NCT03769181|537963841|FG002|Overall Study|Other - Unspecified|0|||
149131907|NCT03769181|537963842|FG003|Overall Study|Other - Unspecified|0|||
149131908|NCT03971422|537963843|FG000|Overall Study|Lost to Follow-up|0|||
149131909|NCT03971422|537963844|FG001|Overall Study|Lost to Follow-up|1|||
149131910|NCT03971422|537963845|FG002|Overall Study|Lost to Follow-up|0|||
149131911|NCT03971422|537963843|FG000|Overall Study|Lack of Efficacy|5|||
149131912|NCT03971422|537963844|FG001|Overall Study|Lack of Efficacy|1|||
149131913|NCT03971422|537963845|FG002|Overall Study|Lack of Efficacy|1|||
149131914|NCT03971422|537963843|FG000|Overall Study|Adverse event, not fatal|2|||
149131915|NCT03971422|537963844|FG001|Overall Study|Adverse event, not fatal|2|||
149131916|NCT03971422|537963845|FG002|Overall Study|Adverse event, not fatal|5|||
149131917|NCT03971422|537963843|FG000|Overall Study|Worsening of MG Symptoms|1|||
149131918|NCT03971422|537963844|FG001|Overall Study|Worsening of MG Symptoms|4|||
149131919|NCT03971422|537963845|FG002|Overall Study|Worsening of MG Symptoms|2|||
149131920|NCT03971422|537963843|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
149131921|NCT03971422|537963844|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
149131922|NCT03971422|537963845|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
149131923|NCT03971422|537963843|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
149131924|NCT03971422|537963844|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
149131925|NCT03971422|537963845|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
149131926|NCT03971422|537963843|FG000|Overall Study|Due to COVID-19 pandemic|0|||
149131927|NCT03971422|537963844|FG001|Overall Study|Due to COVID-19 pandemic|1|||
149131928|NCT03971422|537963845|FG002|Overall Study|Due to COVID-19 pandemic|1|||
149131929|NCT04751656|537963848|FG000|Overall Study|Lost to Follow-up|1|||
149131930|NCT01485354|537963851|FG000|Overall Study|Withdrawal by Subject|5|||
149131931|NCT03566810|537963852|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
149131932|NCT03566810|537963853|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
149131933|NCT03566810|537963854|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
149131934|NCT03566810|537963855|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
149131935|NCT01103245|537963856|FG000|Overall Study|Withdrawal by Subject|1|||
149131936|NCT01103245|537963857|FG001|Overall Study|Withdrawal by Subject|0|||
149131937|NCT01103245|537963858|FG002|Overall Study|Withdrawal by Subject|3|||
149131938|NCT01103245|537963859|FG003|Overall Study|Withdrawal by Subject|0|||
149131939|NCT01103245|537963856|FG000|Overall Study|Inadequate IV access|1|||
149131940|NCT01103245|537963857|FG001|Overall Study|Inadequate IV access|0|||
149131941|NCT01103245|537963858|FG002|Overall Study|Inadequate IV access|0|||
149131942|NCT01103245|537963859|FG003|Overall Study|Inadequate IV access|0|||
149131943|NCT01103245|537963856|FG000|Overall Study|Adverse Event|0|||
149131944|NCT01103245|537963857|FG001|Overall Study|Adverse Event|2|||
149131945|NCT01103245|537963858|FG002|Overall Study|Adverse Event|1|||
149131946|NCT01103245|537963859|FG003|Overall Study|Adverse Event|0|||
149131947|NCT01103245|537963856|FG000|Overall Study|Physician Decision|1|||
149131948|NCT01103245|537963857|FG001|Overall Study|Physician Decision|0|||
149131949|NCT01103245|537963858|FG002|Overall Study|Physician Decision|0|||
149131950|NCT01103245|537963859|FG003|Overall Study|Physician Decision|0|||
149131951|NCT00826111|537963860|FG000|Overall Study|Lost to Follow-up|0|||
149131952|NCT00826111|537963861|FG001|Overall Study|Lost to Follow-up|1|||
149131953|NCT00826111|537963860|FG000|Overall Study|Protocol Violation|1|||
149131954|NCT00826111|537963861|FG001|Overall Study|Protocol Violation|0|||
149131955|NCT00826111|537963860|FG000|Overall Study|Withdrawal by Subject|5|||
149131956|NCT00826111|537963861|FG001|Overall Study|Withdrawal by Subject|0|||
149131957|NCT00826111|537963860|FG000|Overall Study|Physician Decision|1|||
149131958|NCT00826111|537963861|FG001|Overall Study|Physician Decision|1|||
149131959|NCT02805725|537963862|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
149131960|NCT02805725|537963863|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
149131961|NCT02805725|537963864|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
149131962|NCT02805725|537963865|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
149131963|NCT02805725|537963866|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
149131964|NCT02805725|537963862|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
149131965|NCT02805725|537963863|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
149131966|NCT02805725|537963864|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
149131967|NCT02805725|537963865|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
149131968|NCT02805725|537963866|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
149131969|NCT02805725|537963862|FG000|Phase II|Protocol Violation|0|||
149131970|NCT02805725|537963863|FG001|Phase II|Protocol Violation|0|||
149131971|NCT02805725|537963864|FG002|Phase II|Protocol Violation|0|||
149131972|NCT02805725|537963865|FG003|Phase II|Protocol Violation|0|||
149131973|NCT02805725|537963866|FG004|Phase II|Protocol Violation|6|||
149131974|NCT01195545|537963867|FG000|Overall Study|Protocol Violation|4|||
149131975|NCT03511053|537963871|FG000|Overall Study|Withdrawal by Subject|1|||
149131976|NCT02425644|537963872|FG000|Overall Study|Lost to Follow-up|2|||
149131977|NCT02425644|537963873|FG001|Overall Study|Lost to Follow-up|3|||
149131978|NCT02425644|537963872|FG000|Overall Study|Withdrawal by Subject|41|||
149131979|NCT02425644|537963873|FG001|Overall Study|Withdrawal by Subject|36|||
149131980|NCT02425644|537963872|FG000|Overall Study|Lack of Efficacy|3|||
149131981|NCT02425644|537963873|FG001|Overall Study|Lack of Efficacy|10|||
149131982|NCT02425644|537963872|FG000|Overall Study|Adverse Event|13|||
149131983|NCT02425644|537963873|FG001|Overall Study|Adverse Event|3|||
149131984|NCT02425644|537963872|FG000|Overall Study|Death|0|||
149131985|NCT02425644|537963873|FG001|Overall Study|Death|2|||
149131986|NCT02425644|537963872|FG000|Overall Study|Other|18|||
149131987|NCT02425644|537963873|FG001|Overall Study|Other|17|||
149131988|NCT00567268|537963874|FG000|Overall Study|Protocol Violation|7|||
149131989|NCT00567268|537963874|FG000|Overall Study|Lost to Follow-up|36|||
149131990|NCT00567268|537963874|FG000|Overall Study|No Visit After First Day of Treatment|2|||
149131991|NCT00567268|537963874|FG000|Overall Study|No Drug Administration|4|||
149131992|NCT00567268|537963874|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
149131993|NCT00888433|537963881|FG000|Overall Study|Withdrawal by Subject|1|||
149131994|NCT00888433|537963882|FG001|Overall Study|Withdrawal by Subject|2|||
149131995|NCT00888433|537963881|FG000|Overall Study|Missed Visit|2|||
149131996|NCT00888433|537963882|FG001|Overall Study|Missed Visit|1|||
149131997|NCT04356183|537963884|FG000|Overall Study|Lost to Follow-up|1|||
149131998|NCT04356183|537963885|FG001|Overall Study|Lost to Follow-up|0|||
149131999|NCT04356183|537963884|FG000|Overall Study|Withdrawal by Subject|1|||
149132000|NCT04356183|537963885|FG001|Overall Study|Withdrawal by Subject|1|||
149132001|NCT04263909|537963886|FG000|Overall Study|Physician Decision|1|||
149132002|NCT04263909|537963887|FG001|Overall Study|Physician Decision|0|||
149132003|NCT04263909|537963888|FG002|Overall Study|Physician Decision|0|||
149132004|NCT04263909|537963886|FG000|Overall Study|Adverse Event|3|||
149132005|NCT04263909|537963887|FG001|Overall Study|Adverse Event|0|||
149132006|NCT04263909|537963888|FG002|Overall Study|Adverse Event|0|||
149132007|NCT04263909|537963886|FG000|Overall Study|Protocol Violation|5|||
149132008|NCT04263909|537963887|FG001|Overall Study|Protocol Violation|0|||
149132009|NCT04263909|537963888|FG002|Overall Study|Protocol Violation|0|||
149132010|NCT05193500|537963889|FG000|Overall Study|Withdrawal by Subject|7|||
149132011|NCT05193500|537963890|FG001|Overall Study|Withdrawal by Subject|4|||
149132012|NCT05193500|537963891|FG002|Overall Study|Withdrawal by Subject|3|||
149132013|NCT05193500|537963892|FG003|Overall Study|Withdrawal by Subject|5|||
149132014|NCT03840486|537963893|FG000|Overall Study|Withdrawal by Subject|0|||
149132015|NCT03840486|537963894|FG001|Overall Study|Withdrawal by Subject|1|||
149132016|NCT03840486|537963895|FG002|Overall Study|Withdrawal by Subject|0|||
149132017|NCT03840486|537963896|FG003|Overall Study|Withdrawal by Subject|0|||
149132018|NCT03840486|537963897|FG004|Overall Study|Withdrawal by Subject|0|||
149132019|NCT03840486|537963898|FG005|Overall Study|Withdrawal by Subject|0|||
149132020|NCT03840486|537963899|FG006|Overall Study|Withdrawal by Subject|0|||
149132021|NCT03840486|537963900|FG007|Overall Study|Withdrawal by Subject|0|||
149132022|NCT03840486|537963901|FG008|Overall Study|Withdrawal by Subject|0|||
149132023|NCT03840486|537963902|FG009|Overall Study|Withdrawal by Subject|0|||
149132024|NCT03840486|537963903|FG010|Overall Study|Withdrawal by Subject|0|||
149132025|NCT03840486|537963904|FG011|Overall Study|Withdrawal by Subject|0|||
149132026|NCT04442737|537963907|FG000|Overall Study|Lost to Follow-up|1|||
149132027|NCT04442737|537963908|FG001|Overall Study|Lost to Follow-up|3|||
149132028|NCT04442737|537963907|FG000|Overall Study|Withdrawal by Subject|3|||
149132029|NCT04442737|537963908|FG001|Overall Study|Withdrawal by Subject|2|||
149132030|NCT04442737|537963907|FG000|Overall Study|Adverse Event|3|||
149132031|NCT04442737|537963908|FG001|Overall Study|Adverse Event|2|||
149132032|NCT04442737|537963907|FG000|Overall Study|Death|0|||
149132033|NCT04442737|537963908|FG001|Overall Study|Death|1|||
149132034|NCT04442737|537963907|FG000|Overall Study|Protocol Violation|0|||
149132035|NCT04442737|537963908|FG001|Overall Study|Protocol Violation|2|||
149132036|NCT04442737|537963907|FG000|Overall Study|Other|1|||
149132037|NCT04442737|537963908|FG001|Overall Study|Other|1|||
149132038|NCT01139021|537963909|FG000|Overall Study|Adverse Event|0|||
149132039|NCT01139021|537963910|FG001|Overall Study|Adverse Event|0|||
149132040|NCT01139021|537963911|FG002|Overall Study|Adverse Event|0|||
149132041|NCT01139021|537963912|FG003|Overall Study|Adverse Event|0|||
149132042|NCT01139021|537963913|FG004|Overall Study|Adverse Event|1|||
149132043|NCT01139021|537963914|FG005|Overall Study|Adverse Event|0|||
149132044|NCT01139021|537963909|FG000|Overall Study|Lost to Follow-up|0|||
149132045|NCT01139021|537963910|FG001|Overall Study|Lost to Follow-up|0|||
149132046|NCT01139021|537963911|FG002|Overall Study|Lost to Follow-up|0|||
149132047|NCT01139021|537963912|FG003|Overall Study|Lost to Follow-up|0|||
149132048|NCT01139021|537963913|FG004|Overall Study|Lost to Follow-up|2|||
149132049|NCT01139021|537963914|FG005|Overall Study|Lost to Follow-up|0|||
149132050|NCT01139021|537963909|FG000|Overall Study|Protocol Violation|1|||
149132051|NCT01139021|537963910|FG001|Overall Study|Protocol Violation|0|||
149132052|NCT01139021|537963911|FG002|Overall Study|Protocol Violation|0|||
149132053|NCT01139021|537963912|FG003|Overall Study|Protocol Violation|0|||
149132054|NCT01139021|537963913|FG004|Overall Study|Protocol Violation|2|||
149132055|NCT01139021|537963914|FG005|Overall Study|Protocol Violation|0|||
149132056|NCT01139021|537963909|FG000|Overall Study|Withdrawal by Subject|0|||
149132057|NCT01139021|537963910|FG001|Overall Study|Withdrawal by Subject|0|||
149132058|NCT01139021|537963911|FG002|Overall Study|Withdrawal by Subject|0|||
149132059|NCT01139021|537963912|FG003|Overall Study|Withdrawal by Subject|1|||
149132060|NCT01139021|537963913|FG004|Overall Study|Withdrawal by Subject|4|||
149132061|NCT01139021|537963914|FG005|Overall Study|Withdrawal by Subject|0|||
149132062|NCT03588728|537963918|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
149132063|NCT03588728|537963919|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
149132064|NCT03588728|537963920|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
149132065|NCT03588728|537963921|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
149132066|NCT03588728|537963918|FG000|Overall Study|Lab shut down due to COVID-19|0|||
149132067|NCT03588728|537963919|FG001|Overall Study|Lab shut down due to COVID-19|0|||
149132068|NCT03588728|537963920|FG002|Overall Study|Lab shut down due to COVID-19|0|||
149132069|NCT03588728|537963921|FG003|Overall Study|Lab shut down due to COVID-19|1|||
149132070|NCT03588728|537963918|FG000|Overall Study|multiple technical issues|1|||
149132071|NCT03588728|537963919|FG001|Overall Study|multiple technical issues|0|||
149132072|NCT03588728|537963920|FG002|Overall Study|multiple technical issues|0|||
149132073|NCT03588728|537963921|FG003|Overall Study|multiple technical issues|0|||
149132074|NCT03588728|537963918|FG000|Overall Study|Hospitalized for COVID|1|||
149132075|NCT03588728|537963919|FG001|Overall Study|Hospitalized for COVID|0|||
149132076|NCT03588728|537963920|FG002|Overall Study|Hospitalized for COVID|0|||
149132077|NCT03588728|537963921|FG003|Overall Study|Hospitalized for COVID|0|||
149132078|NCT03588728|537963918|FG000|Overall Study|Schedule change unable to attend sessions|1|||
149132079|NCT03588728|537963919|FG001|Overall Study|Schedule change unable to attend sessions|0|||
149132080|NCT03588728|537963920|FG002|Overall Study|Schedule change unable to attend sessions|0|||
149132081|NCT03588728|537963921|FG003|Overall Study|Schedule change unable to attend sessions|0|||
149132082|NCT01388790|537963922|FG000|Overall Study|Ongoing at data cut-off date|8|||
149132083|NCT00195507|537963923|FG000|Overall Study|Adverse Event|24|||
149132084|NCT00195507|537963924|FG001|Overall Study|Adverse Event|13|||
149132085|NCT00195507|537963923|FG000|Overall Study|Death|0|||
149132086|NCT00195507|537963924|FG001|Overall Study|Death|1|||
149132087|NCT00195507|537963923|FG000|Overall Study|Failed to Return|4|||
149132088|NCT00195507|537963924|FG001|Overall Study|Failed to Return|3|||
149132089|NCT00195507|537963923|FG000|Overall Study|Physician Decision|1|||
149132090|NCT00195507|537963924|FG001|Overall Study|Physician Decision|2|||
149132091|NCT00195507|537963923|FG000|Overall Study|Lost to Follow-up|3|||
149132092|NCT00195507|537963924|FG001|Overall Study|Lost to Follow-up|2|||
149132093|NCT00195507|537963923|FG000|Overall Study|Protocol Violation|5|||
149132094|NCT00195507|537963924|FG001|Overall Study|Protocol Violation|4|||
149132095|NCT00195507|537963923|FG000|Overall Study|Lack of Efficacy|40|||
149132096|NCT00195507|537963924|FG001|Overall Study|Lack of Efficacy|67|||
149132097|NCT00195507|537963923|FG000|Overall Study|Withdrawal by Subject|16|||
149132098|NCT00195507|537963924|FG001|Overall Study|Withdrawal by Subject|23|||
149132099|NCT00195507|537963923|FG000|Overall Study|Protocol Deviation|6|||
149132100|NCT00195507|537963924|FG001|Overall Study|Protocol Deviation|3|||
149132101|NCT02202551|537963925|FG000|Overall Study|Adverse Event|8|||
149132102|NCT02202551|537963926|FG001|Overall Study|Adverse Event|19|||
149132103|NCT02202551|537963927|FG002|Overall Study|Adverse Event|5|||
149132104|NCT02202551|537963928|FG003|Overall Study|Adverse Event|9|||
149132105|NCT02202551|537963925|FG000|Overall Study|Death|3|||
149132106|NCT02202551|537963926|FG001|Overall Study|Death|2|||
149132107|NCT02202551|537963927|FG002|Overall Study|Death|1|||
149132108|NCT02202551|537963928|FG003|Overall Study|Death|1|||
149132109|NCT02202551|537963925|FG000|Overall Study|Lost to Follow-up|0|||
149132110|NCT02202551|537963926|FG001|Overall Study|Lost to Follow-up|1|||
149132111|NCT02202551|537963927|FG002|Overall Study|Lost to Follow-up|0|||
149132112|NCT02202551|537963928|FG003|Overall Study|Lost to Follow-up|1|||
149132113|NCT02202551|537963925|FG000|Overall Study|Needed to take excluded medication|0|||
149132114|NCT02202551|537963926|FG001|Overall Study|Needed to take excluded medication|2|||
149132115|NCT02202551|537963927|FG002|Overall Study|Needed to take excluded medication|0|||
149132116|NCT02202551|537963928|FG003|Overall Study|Needed to take excluded medication|1|||
149132117|NCT02202551|537963925|FG000|Overall Study|Subject moved away|0|||
149132118|NCT02202551|537963926|FG001|Overall Study|Subject moved away|1|||
149132119|NCT02202551|537963927|FG002|Overall Study|Subject moved away|0|||
149132120|NCT02202551|537963928|FG003|Overall Study|Subject moved away|0|||
149132121|NCT02202551|537963925|FG000|Overall Study|DBS surgery|3|||
149132122|NCT02202551|537963926|FG001|Overall Study|DBS surgery|0|||
149132123|NCT02202551|537963927|FG002|Overall Study|DBS surgery|0|||
149132124|NCT02202551|537963928|FG003|Overall Study|DBS surgery|0|||
149132125|NCT02202551|537963925|FG000|Overall Study|Dyskinesia upon taper|1|||
149132126|NCT02202551|537963926|FG001|Overall Study|Dyskinesia upon taper|0|||
149132127|NCT02202551|537963927|FG002|Overall Study|Dyskinesia upon taper|0|||
149132128|NCT02202551|537963928|FG003|Overall Study|Dyskinesia upon taper|0|||
149132129|NCT02202551|537963925|FG000|Overall Study|Lack of Efficacy|0|||
149132130|NCT02202551|537963926|FG001|Overall Study|Lack of Efficacy|1|||
149132131|NCT02202551|537963927|FG002|Overall Study|Lack of Efficacy|0|||
149132132|NCT02202551|537963928|FG003|Overall Study|Lack of Efficacy|0|||
149132133|NCT02202551|537963925|FG000|Overall Study|Physician Decision|1|||
149132134|NCT02202551|537963926|FG001|Overall Study|Physician Decision|0|||
149132135|NCT02202551|537963927|FG002|Overall Study|Physician Decision|0|||
149132136|NCT02202551|537963928|FG003|Overall Study|Physician Decision|0|||
149132137|NCT02202551|537963925|FG000|Overall Study|Site closure|3|||
149132138|NCT02202551|537963926|FG001|Overall Study|Site closure|0|||
149132139|NCT02202551|537963927|FG002|Overall Study|Site closure|0|||
149132140|NCT02202551|537963928|FG003|Overall Study|Site closure|1|||
149132141|NCT02202551|537963925|FG000|Overall Study|Unable to complete visits per protocol|1|||
149132142|NCT02202551|537963926|FG001|Overall Study|Unable to complete visits per protocol|0|||
149132143|NCT02202551|537963927|FG002|Overall Study|Unable to complete visits per protocol|0|||
149132144|NCT02202551|537963928|FG003|Overall Study|Unable to complete visits per protocol|0|||
149132145|NCT02202551|537963925|FG000|Overall Study|Worsening Dyskinesia|0|||
149132146|NCT02202551|537963926|FG001|Overall Study|Worsening Dyskinesia|0|||
149132147|NCT02202551|537963927|FG002|Overall Study|Worsening Dyskinesia|0|||
149132148|NCT02202551|537963928|FG003|Overall Study|Worsening Dyskinesia|1|||
149132149|NCT02202551|537963925|FG000|Overall Study|Protocol Violation|0|||
149132150|NCT02202551|537963926|FG001|Overall Study|Protocol Violation|1|||
149132151|NCT02202551|537963927|FG002|Overall Study|Protocol Violation|0|||
149132152|NCT02202551|537963928|FG003|Overall Study|Protocol Violation|0|||
149132153|NCT02202551|537963925|FG000|Overall Study|Sponsor's decision|2|||
149132154|NCT02202551|537963926|FG001|Overall Study|Sponsor's decision|0|||
149132155|NCT02202551|537963927|FG002|Overall Study|Sponsor's decision|0|||
149132156|NCT02202551|537963928|FG003|Overall Study|Sponsor's decision|0|||
149132157|NCT02202551|537963925|FG000|Overall Study|Subject unwilling to proceed|1|||
149132158|NCT02202551|537963926|FG001|Overall Study|Subject unwilling to proceed|5|||
149132159|NCT02202551|537963927|FG002|Overall Study|Subject unwilling to proceed|3|||
149132160|NCT02202551|537963928|FG003|Overall Study|Subject unwilling to proceed|5|||
149132161|NCT02202551|537963925|FG000|Overall Study|Subject consent withdrawn|0|||
149132162|NCT02202551|537963926|FG001|Overall Study|Subject consent withdrawn|3|||
149132163|NCT02202551|537963927|FG002|Overall Study|Subject consent withdrawn|1|||
149132164|NCT02202551|537963928|FG003|Overall Study|Subject consent withdrawn|2|||
149132165|NCT02202551|537963925|FG000|Overall Study|eGFR<50mL/min/m2|2|||
149132166|NCT02202551|537963926|FG001|Overall Study|eGFR<50mL/min/m2|2|||
149132167|NCT02202551|537963927|FG002|Overall Study|eGFR<50mL/min/m2|0|||
149132168|NCT02202551|537963928|FG003|Overall Study|eGFR<50mL/min/m2|1|||
149132169|NCT02349451|537963929|FG000|Overall Study|Withdrawal by Subject|0|||
149132170|NCT02349451|537963930|FG001|Overall Study|Withdrawal by Subject|1|||
149132171|NCT02349451|537963931|FG002|Overall Study|Withdrawal by Subject|2|||
149132172|NCT02349451|537963932|FG003|Overall Study|Withdrawal by Subject|1|||
149132173|NCT01176773|537963939|FG000|Overall Study|Screen Failure|2|||
149132174|NCT01176773|537963939|FG000|Overall Study|Withdrew consent|1|||
149132175|NCT03291587|537963948|FG000|Overall Study|Lost to Follow-up|62|||
149132176|NCT03291587|537963949|FG001|Overall Study|Lost to Follow-up|43|||
149132177|NCT03291587|537963948|FG000|Overall Study|Refused to Answer|5|||
149132178|NCT03291587|537963949|FG001|Overall Study|Refused to Answer|2|||
149132179|NCT03291587|537963948|FG000|Overall Study|Death|2|||
149132180|NCT03291587|537963949|FG001|Overall Study|Death|4|||
149132181|NCT03291587|537963948|FG000|Overall Study|Not interested in participating|8|||
149132182|NCT03291587|537963949|FG001|Overall Study|Not interested in participating|6|||
149132183|NCT03291587|537963948|FG000|Overall Study|Too busy to participate|4|||
149132184|NCT03291587|537963949|FG001|Overall Study|Too busy to participate|2|||
149132185|NCT02513745|537963952|FG000|Overall Study|Criteria at time of surgery not met.|3|||
149132186|NCT02513745|537963953|FG001|Overall Study|Criteria at time of surgery not met.|3|||
149132187|NCT01116882|537963954|FG000|30-day|Lost to Follow-up|50|||
149132188|NCT01116882|537963955|FG001|30-day|Lost to Follow-up|21|||
149132189|NCT01116882|537963954|FG000|30-day|Withdrawal by Subject|2|||
149132190|NCT01116882|537963955|FG001|30-day|Withdrawal by Subject|4|||
149132191|NCT01116882|537963954|FG000|30-day|Other Reasons|16|||
149132192|NCT01116882|537963955|FG001|30-day|Other Reasons|6|||
149132193|NCT01116882|537963954|FG000|12-month|Lost to Follow-up|111|||
149132194|NCT01116882|537963955|FG001|12-month|Lost to Follow-up|42|||
149132195|NCT01116882|537963954|FG000|12-month|Other Reasons|151|||
149132196|NCT01116882|537963955|FG001|12-month|Other Reasons|49|||
149132197|NCT01116882|537963954|FG000|12-month|Withdrawal by Subject|5|||
149132198|NCT01116882|537963955|FG001|12-month|Withdrawal by Subject|8|||
149132199|NCT00547365|537963956|FG000|Overall Study|Physician Decision|1|||
149132200|NCT00547365|537963956|FG000|Overall Study|Lost to Follow-up|1|||
149132201|NCT00547365|537963956|FG000|Overall Study|Protocol Violation|2|||
149132202|NCT00547365|537963956|FG000|Overall Study|death (not related to study)|4|||
149132203|NCT01139658|537963957|FG000|Overall Study|Adverse Event|10|||
149132204|NCT01139658|537963958|FG001|Overall Study|Adverse Event|27|||
149132205|NCT01139658|537963957|FG000|Overall Study|Lack of Efficacy|15|||
149132206|NCT01139658|537963958|FG001|Overall Study|Lack of Efficacy|7|||
149132207|NCT01139658|537963957|FG000|Overall Study|Withdrawal by Subject|2|||
149132208|NCT01139658|537963958|FG001|Overall Study|Withdrawal by Subject|4|||
149132209|NCT01139658|537963957|FG000|Overall Study|No documentation of treatment|1|||
149132210|NCT01139658|537963958|FG001|Overall Study|No documentation of treatment|0|||
148893518|NCT02055898|537088765|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
148893519|NCT02055898|537088766|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
148893520|NCT00718510|537088768|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
148893521|NCT00718510|537088769|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
148893522|NCT00718510|537088768|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
148893523|NCT00718510|537088769|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
148893524|NCT02201524|537088770|FG000|Overall Study|Adverse Event|0|||
148893525|NCT02201524|537088771|FG001|Overall Study|Adverse Event|2|||
148893526|NCT02201524|537088772|FG002|Overall Study|Adverse Event|1|||
148893527|NCT02201524|537088773|FG003|Overall Study|Adverse Event|0|||
148893528|NCT02201524|537088770|FG000|Overall Study|Insufficient clinical response|1|||
149132211|NCT01139658|537963957|FG000|Overall Study|Other|28|||
149132212|NCT01139658|537963958|FG001|Overall Study|Other|75|||
149132213|NCT00504881|537963961|FG000|Overall Study|Lack of Efficacy|1|||
149132214|NCT00504881|537963962|FG001|Overall Study|Lack of Efficacy|5|||
149132215|NCT00504881|537963961|FG000|Overall Study|Lost to Follow-up|0|||
149132216|NCT00504881|537963962|FG001|Overall Study|Lost to Follow-up|2|||
149132217|NCT00504881|537963961|FG000|Overall Study|Withdrawal by Subject|1|||
149132218|NCT00504881|537963962|FG001|Overall Study|Withdrawal by Subject|4|||
149132219|NCT00504881|537963961|FG000|Overall Study|Non-Compliance|1|||
149132220|NCT00504881|537963962|FG001|Overall Study|Non-Compliance|0|||
149132221|NCT00504881|537963961|FG000|Overall Study|No Birth Control|0|||
149132222|NCT00504881|537963962|FG001|Overall Study|No Birth Control|1|||
149132223|NCT00504881|537963961|FG000|Overall Study|Safety Visit not performed|0|||
149132224|NCT00504881|537963962|FG001|Overall Study|Safety Visit not performed|1|||
149132225|NCT00504881|537963961|FG000|Overall Study|AE, serious fatal|0|||
149132226|NCT00504881|537963962|FG001|Overall Study|AE, serious fatal|1|||
149132227|NCT00504881|537963961|FG000|Overall Study|SAE, non-fatal|2|||
149132228|NCT00504881|537963962|FG001|Overall Study|SAE, non-fatal|6|||
149132229|NCT00504881|537963961|FG000|Overall Study|AE, non-serious non-fatal|4|||
149132230|NCT00504881|537963962|FG001|Overall Study|AE, non-serious non-fatal|14|||
149132231|NCT00504881|537963961|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
149132232|NCT00504881|537963962|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
149132233|NCT00504881|537963961|FG000|Overall Study|AE of unknown type|1|||
149132234|NCT00504881|537963962|FG001|Overall Study|AE of unknown type|0|||
149132235|NCT01777269|537963963|FG000|Overall Study|Adverse Event|24|||
149132236|NCT01777269|537963964|FG001|Overall Study|Adverse Event|33|||
149132237|NCT01777269|537963963|FG000|Overall Study|Lack of Efficacy|8|||
149132238|NCT01777269|537963964|FG001|Overall Study|Lack of Efficacy|10|||
149132239|NCT01777269|537963963|FG000|Overall Study|Protocol Violation|4|||
149132240|NCT01777269|537963964|FG001|Overall Study|Protocol Violation|4|||
149132241|NCT01777269|537963963|FG000|Overall Study|Participants reached stopping criteria|1|||
149132242|NCT01777269|537963964|FG001|Overall Study|Participants reached stopping criteria|1|||
149132243|NCT01777269|537963963|FG000|Overall Study|Lost to Follow-up|4|||
149132244|NCT01777269|537963964|FG001|Overall Study|Lost to Follow-up|0|||
149132245|NCT01777269|537963963|FG000|Overall Study|Physician Decision|5|||
149132246|NCT01777269|537963964|FG001|Overall Study|Physician Decision|2|||
149132247|NCT01777269|537963963|FG000|Overall Study|Withdrawal by Subject|9|||
149132248|NCT01777269|537963964|FG001|Overall Study|Withdrawal by Subject|9|||
149132249|NCT00753272|537963972|FG000|Overall Study|Adverse Event|878|||
149132250|NCT00753272|537963973|FG001|Overall Study|Adverse Event|869|||
149132251|NCT00753272|537963972|FG000|Overall Study|Protocol Violation|28|||
149132252|NCT00753272|537963973|FG001|Overall Study|Protocol Violation|46|||
149132253|NCT00753272|537963972|FG000|Overall Study|Withdrawal by Subject|2481|||
149132254|NCT00753272|537963973|FG001|Overall Study|Withdrawal by Subject|2407|||
149132255|NCT00753272|537963972|FG000|Overall Study|Lost to Follow-up|491|||
149132256|NCT00753272|537963973|FG001|Overall Study|Lost to Follow-up|497|||
149132257|NCT00753272|537963972|FG000|Overall Study|Other|1104|||
149132258|NCT00753272|537963973|FG001|Overall Study|Other|1088|||
149132259|NCT02092220|537963975|FG000|Period 1|Unrelated Illness|0|||
149132260|NCT02092220|537963976|FG001|Period 1|Unrelated Illness|2|||
149132261|NCT02092220|537963975|FG000|Period 2|Severe Hypoglycaemia|1|||
149132262|NCT02092220|537963976|FG001|Period 2|Severe Hypoglycaemia|0|||
149132263|NCT02092220|537963975|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
149132264|NCT02092220|537963976|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
149132265|NCT00960531|537963977|FG000|Overall Study|Lack of Efficacy|1|||
149132266|NCT00960531|537963978|FG001|Overall Study|Lack of Efficacy|0|||
149132267|NCT00960531|537963979|FG002|Overall Study|Lack of Efficacy|0|||
149132268|NCT00960531|537963980|FG003|Overall Study|Lack of Efficacy|0|||
149132269|NCT00960531|537963981|FG004|Overall Study|Lack of Efficacy|0|||
149132270|NCT00960531|537963982|FG005|Overall Study|Lack of Efficacy|0|||
149132271|NCT00960531|537963983|FG006|Overall Study|Lack of Efficacy|0|||
149132272|NCT00960531|537963984|FG007|Overall Study|Lack of Efficacy|0|||
149132273|NCT00960531|537963985|FG008|Overall Study|Lack of Efficacy|0|||
149132274|NCT00960531|537963986|FG009|Overall Study|Lack of Efficacy|0|||
149132275|NCT00960531|537963977|FG000|Overall Study|Withdrawal by Subject|1|||
149132276|NCT00960531|537963978|FG001|Overall Study|Withdrawal by Subject|0|||
149132277|NCT00960531|537963979|FG002|Overall Study|Withdrawal by Subject|5|||
149132278|NCT00960531|537963980|FG003|Overall Study|Withdrawal by Subject|2|||
149132279|NCT00960531|537963981|FG004|Overall Study|Withdrawal by Subject|0|||
149132280|NCT00960531|537963982|FG005|Overall Study|Withdrawal by Subject|0|||
149132281|NCT00960531|537963983|FG006|Overall Study|Withdrawal by Subject|2|||
149132282|NCT00960531|537963984|FG007|Overall Study|Withdrawal by Subject|0|||
149132283|NCT00960531|537963985|FG008|Overall Study|Withdrawal by Subject|1|||
149132284|NCT00960531|537963986|FG009|Overall Study|Withdrawal by Subject|0|||
149132285|NCT00960531|537963977|FG000|Overall Study|Caregiver Request|2|||
149132286|NCT00960531|537963978|FG001|Overall Study|Caregiver Request|0|||
149132287|NCT00960531|537963979|FG002|Overall Study|Caregiver Request|6|||
149132288|NCT00960531|537963980|FG003|Overall Study|Caregiver Request|5|||
149132289|NCT00960531|537963981|FG004|Overall Study|Caregiver Request|0|||
149132290|NCT00960531|537963982|FG005|Overall Study|Caregiver Request|2|||
149132291|NCT00960531|537963983|FG006|Overall Study|Caregiver Request|3|||
149132292|NCT00960531|537963984|FG007|Overall Study|Caregiver Request|1|||
149132293|NCT00960531|537963985|FG008|Overall Study|Caregiver Request|3|||
149132294|NCT00960531|537963986|FG009|Overall Study|Caregiver Request|0|||
149132295|NCT00960531|537963977|FG000|Overall Study|Investigator Request|0|||
149132296|NCT00960531|537963978|FG001|Overall Study|Investigator Request|0|||
149132297|NCT00960531|537963979|FG002|Overall Study|Investigator Request|1|||
149132298|NCT00960531|537963980|FG003|Overall Study|Investigator Request|0|||
149132299|NCT00960531|537963981|FG004|Overall Study|Investigator Request|0|||
149132300|NCT00960531|537963982|FG005|Overall Study|Investigator Request|0|||
149132301|NCT00960531|537963983|FG006|Overall Study|Investigator Request|0|||
149132302|NCT00960531|537963984|FG007|Overall Study|Investigator Request|0|||
149132303|NCT00960531|537963985|FG008|Overall Study|Investigator Request|0|||
149132304|NCT00960531|537963986|FG009|Overall Study|Investigator Request|0|||
149132305|NCT00960531|537963977|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
149132306|NCT00960531|537963978|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
149132307|NCT00960531|537963979|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
149132308|NCT00960531|537963980|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
149132309|NCT00960531|537963981|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
149132310|NCT00960531|537963982|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
149132311|NCT00960531|537963983|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
149132312|NCT00960531|537963984|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
149132313|NCT00960531|537963985|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
149132314|NCT00960531|537963986|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
149132315|NCT00960531|537963977|FG000|Overall Study|Lost to Follow-up|0|||
149132316|NCT00960531|537963978|FG001|Overall Study|Lost to Follow-up|0|||
149132317|NCT00960531|537963979|FG002|Overall Study|Lost to Follow-up|1|||
149132318|NCT00960531|537963980|FG003|Overall Study|Lost to Follow-up|0|||
149132319|NCT00960531|537963981|FG004|Overall Study|Lost to Follow-up|0|||
149132320|NCT00960531|537963982|FG005|Overall Study|Lost to Follow-up|0|||
149132321|NCT00960531|537963983|FG006|Overall Study|Lost to Follow-up|1|||
149132322|NCT00960531|537963984|FG007|Overall Study|Lost to Follow-up|0|||
149132323|NCT00960531|537963985|FG008|Overall Study|Lost to Follow-up|0|||
149132324|NCT00960531|537963986|FG009|Overall Study|Lost to Follow-up|0|||
149132325|NCT00960531|537963977|FG000|Overall Study|Failed to Return|2|||
149132326|NCT00960531|537963978|FG001|Overall Study|Failed to Return|0|||
149132327|NCT00960531|537963979|FG002|Overall Study|Failed to Return|0|||
149132328|NCT00960531|537963980|FG003|Overall Study|Failed to Return|0|||
149132329|NCT00960531|537963981|FG004|Overall Study|Failed to Return|0|||
149132330|NCT00960531|537963982|FG005|Overall Study|Failed to Return|0|||
149132331|NCT00960531|537963983|FG006|Overall Study|Failed to Return|0|||
149132332|NCT00960531|537963984|FG007|Overall Study|Failed to Return|2|||
149132333|NCT00960531|537963985|FG008|Overall Study|Failed to Return|0|||
149132334|NCT00960531|537963986|FG009|Overall Study|Failed to Return|0|||
149132335|NCT00960531|537963977|FG000|Overall Study|Adverse Event (AE)|2|||
149132336|NCT00960531|537963978|FG001|Overall Study|Adverse Event (AE)|0|||
149132337|NCT00960531|537963979|FG002|Overall Study|Adverse Event (AE)|0|||
149132338|NCT00960531|537963980|FG003|Overall Study|Adverse Event (AE)|0|||
149132339|NCT00960531|537963981|FG004|Overall Study|Adverse Event (AE)|0|||
149132340|NCT00960531|537963982|FG005|Overall Study|Adverse Event (AE)|1|||
149132341|NCT00960531|537963983|FG006|Overall Study|Adverse Event (AE)|2|||
149132342|NCT00960531|537963984|FG007|Overall Study|Adverse Event (AE)|0|||
149132343|NCT00960531|537963985|FG008|Overall Study|Adverse Event (AE)|2|||
149132344|NCT00960531|537963986|FG009|Overall Study|Adverse Event (AE)|0|||
149132345|NCT00960531|537963977|FG000|Overall Study|Reason not Specified|2|||
149132346|NCT00960531|537963978|FG001|Overall Study|Reason not Specified|1|||
149132347|NCT00960531|537963979|FG002|Overall Study|Reason not Specified|13|||
149132348|NCT00960531|537963980|FG003|Overall Study|Reason not Specified|1|||
149132349|NCT00960531|537963981|FG004|Overall Study|Reason not Specified|2|||
149132350|NCT00960531|537963982|FG005|Overall Study|Reason not Specified|0|||
149132351|NCT00960531|537963983|FG006|Overall Study|Reason not Specified|16|||
149132352|NCT00960531|537963984|FG007|Overall Study|Reason not Specified|0|||
149132353|NCT00960531|537963985|FG008|Overall Study|Reason not Specified|8|||
149132354|NCT00960531|537963986|FG009|Overall Study|Reason not Specified|1|||
149132355|NCT00593957|537963987|FG000|Overall Study|Physician Decision|0|||
149132356|NCT00593957|537963988|FG001|Overall Study|Physician Decision|1|||
149132357|NCT00593957|537963989|FG002|Overall Study|Physician Decision|2|||
149132358|NCT02411578|537963992|FG000|Crossover Trial Phase|Pregnancy|0|||
149132359|NCT02411578|537963993|FG001|Crossover Trial Phase|Pregnancy|1|||
149132360|NCT01030198|537963994|FG000|Overall Study|Could not measure efficacy accurately|0|||
149132361|NCT01030198|537963995|FG001|Overall Study|Could not measure efficacy accurately|7|||
149132362|NCT00332189|537963996|FG000|Overall Study|Adverse Event|3|||
149132363|NCT00332189|537963996|FG000|Overall Study|Uncooperative/Noncompliant|3|||
149132364|NCT00332189|537963996|FG000|Overall Study|Withdrawal by Subject|9|||
149132365|NCT00332189|537963996|FG000|Overall Study|Lack of Efficacy|4|||
149132366|NCT00332189|537963996|FG000|Overall Study|Moved out of country|2|||
148893529|NCT02201524|537088771|FG001|Overall Study|Insufficient clinical response|0|||
148893530|NCT02201524|537088772|FG002|Overall Study|Insufficient clinical response|0|||
149132367|NCT03707925|537963997|FG000|Overall Study|Inevaluable|1|||
149132368|NCT02876835|537963999|FG000|Treatment Period (51.1 Month)|Other|1|||
149132369|NCT02876835|537964000|FG001|Treatment Period (51.1 Month)|Other|0|||
149132370|NCT02876835|537963999|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
149132371|NCT02876835|537964000|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
149132372|NCT02876835|537963999|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
149132373|NCT02876835|537964000|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
149132374|NCT02876835|537963999|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
149132375|NCT02876835|537964000|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
149132376|NCT01117857|537964001|FG000|Overall Study|Lost to Follow-up|4|||
149132377|NCT01117857|537964001|FG000|Overall Study|Withdrawal by Subject|4|||
149132378|NCT01117857|537964001|FG000|Overall Study|Physician Decision|1|||
149132379|NCT00883051|537964003|FG000|Overall Study|Lost to Follow-up|0|||
149132380|NCT00883051|537964004|FG001|Overall Study|Lost to Follow-up|0|||
149132381|NCT00883051|537964005|FG002|Overall Study|Lost to Follow-up|0|||
149132382|NCT00883051|537964006|FG003|Overall Study|Lost to Follow-up|0|||
149132383|NCT00883051|537964007|FG004|Overall Study|Lost to Follow-up|1|||
149132384|NCT00883051|537964003|FG000|Overall Study|Did not use study medication|24|||
149132385|NCT00883051|537964004|FG001|Overall Study|Did not use study medication|22|||
149132386|NCT00883051|537964005|FG002|Overall Study|Did not use study medication|29|||
149132387|NCT00883051|537964006|FG003|Overall Study|Did not use study medication|29|||
149132388|NCT00883051|537964007|FG004|Overall Study|Did not use study medication|17|||
149132389|NCT01411839|537964008|FG000|Overall Study|Lost to Follow-up|4|||
149132390|NCT01411839|537964009|FG001|Overall Study|Lost to Follow-up|3|||
149132391|NCT03282240|537964010|FG000|Overall Study|Adverse Event|2|||
149132392|NCT03282240|537964011|FG001|Overall Study|Adverse Event|2|||
149132393|NCT03282240|537964012|FG002|Overall Study|Adverse Event|0|||
149132394|NCT03282240|537964010|FG000|Overall Study|Lost to Follow-up|3|||
149132395|NCT03282240|537964011|FG001|Overall Study|Lost to Follow-up|0|||
149132396|NCT03282240|537964012|FG002|Overall Study|Lost to Follow-up|0|||
149132397|NCT03282240|537964010|FG000|Overall Study|Protocol Deviation|4|||
149132398|NCT03282240|537964011|FG001|Overall Study|Protocol Deviation|1|||
149132399|NCT03282240|537964012|FG002|Overall Study|Protocol Deviation|2|||
149132400|NCT03282240|537964010|FG000|Overall Study|Withdrawal by Subject|1|||
149132401|NCT03282240|537964011|FG001|Overall Study|Withdrawal by Subject|0|||
149132402|NCT03282240|537964012|FG002|Overall Study|Withdrawal by Subject|1|||
149132403|NCT01675479|537964013|FG000|Overall Study|Lost to Follow-up|11|||
149132404|NCT04223856|537964014|FG000|Overall Study|Progressive disease|153|||
149132405|NCT04223856|537964015|FG001|Overall Study|Progressive disease|73|||
149132406|NCT04223856|537964014|FG000|Overall Study|Adverse Event|97|||
149132407|NCT04223856|537964015|FG001|Overall Study|Adverse Event|62|||
149132408|NCT04223856|537964014|FG000|Overall Study|Physician Decision|9|||
149132409|NCT04223856|537964015|FG001|Overall Study|Physician Decision|28|||
149132410|NCT04223856|537964014|FG000|Overall Study|Withdrawal by Subject|22|||
149132411|NCT04223856|537964015|FG001|Overall Study|Withdrawal by Subject|24|||
149132412|NCT04223856|537964014|FG000|Overall Study|Other|7|||
149132413|NCT04223856|537964015|FG001|Overall Study|Other|2|||
149132414|NCT04223856|537964014|FG000|Overall Study|Randomized but not treated|2|||
149132415|NCT04223856|537964015|FG001|Overall Study|Randomized but not treated|11|||
149132416|NCT04223856|537964014|FG000|Overall Study|On-treatment|144|||
149132417|NCT04223856|537964015|FG001|Overall Study|On-treatment|0|||
149132418|NCT01444651|537966320|FG000|Overall Study|Adverse Event|3|||
149132419|NCT01444651|537966321|FG001|Overall Study|Adverse Event|2|||
149132420|NCT01444651|537966320|FG000|Overall Study|Lost to Follow-up|5|||
149132421|NCT01444651|537966321|FG001|Overall Study|Lost to Follow-up|5|||
149132422|NCT01444651|537966320|FG000|Overall Study|Non-fasting|2|||
149132423|NCT01444651|537966321|FG001|Overall Study|Non-fasting|1|||
149132424|NCT01444651|537966320|FG000|Overall Study|Missing data|1|||
149132425|NCT01444651|537966321|FG001|Overall Study|Missing data|1|||
149132426|NCT03338192|537966324|FG000|Year One to Year Two|High Blood Pressure|7|||
149132427|NCT03338192|537966325|FG001|Year One to Year Two|High Blood Pressure|1|||
149132428|NCT03338192|537966324|FG000|Year One to Year Two|HIV +|1|||
149132429|NCT03338192|537966325|FG001|Year One to Year Two|HIV +|0|||
149132430|NCT03338192|537966324|FG000|Year Two to Year Four|High Blood Pressure|1|||
149132431|NCT03338192|537966325|FG001|Year Two to Year Four|High Blood Pressure|0|||
149132432|NCT03338192|537966324|FG000|Year Two to Year Four|HIV +|2|||
149132433|NCT03338192|537966325|FG001|Year Two to Year Four|HIV +|0|||
149132434|NCT03338192|537966324|FG000|Year Four to Year Six|High Blood Pressure|2|||
149132435|NCT03338192|537966325|FG001|Year Four to Year Six|High Blood Pressure|1|||
149132436|NCT01929980|537966328|FG000|Overall Study|Physician Decision|1|||
149132437|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
149132438|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
149132439|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
149132440|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
149132441|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
149132442|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
149132443|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
149132444|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
149132445|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
149132446|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
149132447|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
149132448|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
149132449|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Death|3|||
149132450|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Death|1|||
149132451|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
149132452|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
149132453|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Adverse Event|7|||
149132454|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Adverse Event|8|||
149132455|NCT03236246|537966329|FG000|24-Week Dose Titration Period|Captured as Other|1|||
149132456|NCT03236246|537966330|FG001|24-Week Dose Titration Period|Captured as Other|2|||
149132457|NCT03236246|537966329|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
149132458|NCT03236246|537966330|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
149132459|NCT03236246|537966329|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
149132460|NCT03236246|537966330|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
149132461|NCT03236246|537966329|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
149132462|NCT03236246|537966330|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
149132463|NCT03236246|537966329|FG000|24-Week Dose Maintenance Period|Death|0|||
149132464|NCT03236246|537966330|FG001|24-Week Dose Maintenance Period|Death|1|||
149132465|NCT03236246|537966329|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
149132466|NCT03236246|537966330|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
149132467|NCT02952001|537966331|FG000|Overall Study|Adverse Event|3|||
149132468|NCT02952001|537966332|FG001|Overall Study|Adverse Event|0|||
149132469|NCT02952001|537966331|FG000|Overall Study|Prohibited therapy|10|||
149132470|NCT02952001|537966332|FG001|Overall Study|Prohibited therapy|3|||
149132471|NCT02952001|537966331|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
149132472|NCT02952001|537966332|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
149132473|NCT01794520|537966333|FG000|Overall Study|Adverse events- related to progression|0|||
149132474|NCT01794520|537966334|FG001|Overall Study|Adverse events- related to progression|0|||
149132475|NCT01794520|537966335|FG002|Overall Study|Adverse events- related to progression|1|||
149132476|NCT01794520|537966336|FG003|Overall Study|Adverse events- related to progression|2|||
149132477|NCT01794520|537966337|FG004|Overall Study|Adverse events- related to progression|0|||
149132478|NCT01794520|537966338|FG005|Overall Study|Adverse events- related to progression|1|||
149132479|NCT01794520|537966339|FG006|Overall Study|Adverse events- related to progression|0|||
149132480|NCT01794520|537966333|FG000|Overall Study|Adverse event- not related to progression|1|||
149132481|NCT01794520|537966334|FG001|Overall Study|Adverse event- not related to progression|1|||
149132482|NCT01794520|537966335|FG002|Overall Study|Adverse event- not related to progression|0|||
149132483|NCT01794520|537966336|FG003|Overall Study|Adverse event- not related to progression|0|||
149132484|NCT01794520|537966337|FG004|Overall Study|Adverse event- not related to progression|2|||
149132485|NCT01794520|537966338|FG005|Overall Study|Adverse event- not related to progression|0|||
149132486|NCT01794520|537966339|FG006|Overall Study|Adverse event- not related to progression|0|||
149132487|NCT01794520|537966333|FG000|Overall Study|Progressive disease|5|||
149132488|NCT01794520|537966334|FG001|Overall Study|Progressive disease|6|||
149132489|NCT01794520|537966335|FG002|Overall Study|Progressive disease|2|||
149132490|NCT01794520|537966336|FG003|Overall Study|Progressive disease|5|||
149132491|NCT01794520|537966337|FG004|Overall Study|Progressive disease|27|||
149132492|NCT01794520|537966338|FG005|Overall Study|Progressive disease|18|||
149132493|NCT01794520|537966339|FG006|Overall Study|Progressive disease|0|||
149132494|NCT01794520|537966333|FG000|Overall Study|Withdrew consent|0|||
149132495|NCT01794520|537966334|FG001|Overall Study|Withdrew consent|0|||
149132496|NCT01794520|537966335|FG002|Overall Study|Withdrew consent|1|||
149132497|NCT01794520|537966336|FG003|Overall Study|Withdrew consent|1|||
149132498|NCT01794520|537966337|FG004|Overall Study|Withdrew consent|0|||
149132499|NCT01794520|537966338|FG005|Overall Study|Withdrew consent|0|||
149132500|NCT01794520|537966339|FG006|Overall Study|Withdrew consent|0|||
149132501|NCT01794520|537966333|FG000|Overall Study|Lost to Follow-up|0|||
149132502|NCT01794520|537966334|FG001|Overall Study|Lost to Follow-up|0|||
149132503|NCT01794520|537966335|FG002|Overall Study|Lost to Follow-up|0|||
149132504|NCT01794520|537966336|FG003|Overall Study|Lost to Follow-up|0|||
149132505|NCT01794520|537966337|FG004|Overall Study|Lost to Follow-up|1|||
149132506|NCT01794520|537966338|FG005|Overall Study|Lost to Follow-up|0|||
149132507|NCT01794520|537966339|FG006|Overall Study|Lost to Follow-up|0|||
149132508|NCT01794520|537966333|FG000|Overall Study|Toxicity|0|||
149132509|NCT01794520|537966334|FG001|Overall Study|Toxicity|2|||
149132510|NCT01794520|537966335|FG002|Overall Study|Toxicity|0|||
149132511|NCT01794520|537966336|FG003|Overall Study|Toxicity|0|||
149132512|NCT01794520|537966337|FG004|Overall Study|Toxicity|0|||
149132513|NCT01794520|537966338|FG005|Overall Study|Toxicity|0|||
149132514|NCT01794520|537966339|FG006|Overall Study|Toxicity|0|||
149132515|NCT01794520|537966333|FG000|Overall Study|Study terminated by sponsor|0|||
149132516|NCT01794520|537966334|FG001|Overall Study|Study terminated by sponsor|0|||
149132517|NCT01794520|537966335|FG002|Overall Study|Study terminated by sponsor|1|||
149132518|NCT01794520|537966336|FG003|Overall Study|Study terminated by sponsor|0|||
149132519|NCT01794520|537966337|FG004|Overall Study|Study terminated by sponsor|1|||
149132520|NCT01794520|537966338|FG005|Overall Study|Study terminated by sponsor|0|||
149132521|NCT01794520|537966339|FG006|Overall Study|Study terminated by sponsor|7|||
149132522|NCT01794520|537966333|FG000|Overall Study|Death|0|||
149132523|NCT01794520|537966334|FG001|Overall Study|Death|0|||
149132524|NCT01794520|537966335|FG002|Overall Study|Death|0|||
149132525|NCT01794520|537966336|FG003|Overall Study|Death|0|||
149132526|NCT01794520|537966337|FG004|Overall Study|Death|1|||
149132527|NCT01794520|537966338|FG005|Overall Study|Death|0|||
149132528|NCT01794520|537966339|FG006|Overall Study|Death|22|||
149132529|NCT01794520|537966333|FG000|Overall Study|Other, not specified|0|||
149132530|NCT01794520|537966334|FG001|Overall Study|Other, not specified|0|||
149132531|NCT01794520|537966335|FG002|Overall Study|Other, not specified|1|||
149132532|NCT01794520|537966336|FG003|Overall Study|Other, not specified|1|||
149132533|NCT01794520|537966337|FG004|Overall Study|Other, not specified|4|||
149132534|NCT01794520|537966338|FG005|Overall Study|Other, not specified|1|||
149132535|NCT01794520|537966339|FG006|Overall Study|Other, not specified|2|||
148893531|NCT02201524|537088773|FG003|Overall Study|Insufficient clinical response|0|||
148893532|NCT02201524|537088770|FG000|Overall Study|Lost to Follow-up|0|||
148893533|NCT02201524|537088771|FG001|Overall Study|Lost to Follow-up|0|||
148893534|NCT02201524|537088772|FG002|Overall Study|Lost to Follow-up|2|||
148893535|NCT02201524|537088773|FG003|Overall Study|Lost to Follow-up|0|||
148893536|NCT02201524|537088770|FG000|Overall Study|No longer meets eligibility criteria|0|||
148893537|NCT02201524|537088771|FG001|Overall Study|No longer meets eligibility criteria|0|||
148893538|NCT02201524|537088772|FG002|Overall Study|No longer meets eligibility criteria|0|||
148893539|NCT02201524|537088773|FG003|Overall Study|No longer meets eligibility criteria|2|||
148893540|NCT02201524|537088770|FG000|Overall Study|Protocol Violation|0|||
148893541|NCT02201524|537088771|FG001|Overall Study|Protocol Violation|0|||
148893542|NCT02201524|537088772|FG002|Overall Study|Protocol Violation|0|||
148893543|NCT02201524|537088773|FG003|Overall Study|Protocol Violation|1|||
148893544|NCT02201524|537088770|FG000|Overall Study|Withdrawal by Subject|0|||
148893545|NCT02201524|537088771|FG001|Overall Study|Withdrawal by Subject|0|||
148893546|NCT02201524|537088772|FG002|Overall Study|Withdrawal by Subject|1|||
148893547|NCT02201524|537088773|FG003|Overall Study|Withdrawal by Subject|1|||
148893548|NCT02201524|537088770|FG000|Overall Study|Other|1|||
148893549|NCT02201524|537088771|FG001|Overall Study|Other|1|||
148893550|NCT02201524|537088772|FG002|Overall Study|Other|0|||
148893551|NCT02201524|537088773|FG003|Overall Study|Other|0|||
148893552|NCT02314052|537088774|FG000|Cycle One|Adverse Event|0|||
148893553|NCT02314052|537088775|FG001|Cycle One|Adverse Event|0|||
148893554|NCT02314052|537088776|FG002|Cycle One|Adverse Event|0|||
148893555|NCT02314052|537088777|FG003|Cycle One|Adverse Event|1|||
148893556|NCT02314052|537088778|FG004|Cycle One|Adverse Event|0|||
148893557|NCT02314052|537088779|FG005|Cycle One|Adverse Event|0|||
148893558|NCT01960140|537088787|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
148893559|NCT00472108|537088790|FG000|Overall Study|Lost to Follow-up|0|||
148893560|NCT00472108|537088791|FG001|Overall Study|Lost to Follow-up|1|||
148893561|NCT00005906|537088792|FG000|Overall Study|Lack of Efficacy|3|||
148893562|NCT04551989|537088793|FG000|Overall Study|Adverse Event|4|||
148893563|NCT04551989|537088793|FG000|Overall Study|Protocol Violation|3|||
148893564|NCT04551989|537088793|FG000|Overall Study|Lost to Follow-up|1|||
148893565|NCT04551989|537088793|FG000|Overall Study|Physician Decision|3|||
148893566|NCT02694744|537088794|FG000|Overall Study|Adverse Event|2|||
148893567|NCT02694744|537088795|FG001|Overall Study|Adverse Event|1|||
148893568|NCT02694744|537088794|FG000|Overall Study|Withdrawal by Subject|2|||
148893569|NCT02694744|537088795|FG001|Overall Study|Withdrawal by Subject|1|||
148893570|NCT02694744|537088794|FG000|Overall Study|Physician Decision|1|||
148893571|NCT02694744|537088795|FG001|Overall Study|Physician Decision|2|||
148893572|NCT02694744|537088794|FG000|Overall Study|Lost to Follow-up|1|||
148893573|NCT02694744|537088795|FG001|Overall Study|Lost to Follow-up|0|||
148893574|NCT02694744|537088794|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
148893575|NCT02694744|537088795|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
148893576|NCT00686777|537088796|FG000|Overall Study|Adverse Event|2|||
148893577|NCT00686777|537088796|FG000|Overall Study|Pregnancy|1|||
148893578|NCT00686777|537088796|FG000|Overall Study|Withdrawal by Subject|2|||
148893579|NCT00686777|537088796|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
148893580|NCT00686777|537088796|FG000|Overall Study|No Visit|1|||
148893581|NCT00883779|537088797|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
148893582|NCT00883779|537088798|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
148893583|NCT00883779|537088797|FG000|Primary Study Treatment Phase|Disease progression|75|||
148893584|NCT00883779|537088798|FG001|Primary Study Treatment Phase|Disease progression|59|||
148893585|NCT00883779|537088797|FG000|Primary Study Treatment Phase|Adverse Event|16|||
148893586|NCT00883779|537088798|FG001|Primary Study Treatment Phase|Adverse Event|16|||
148893587|NCT00883779|537088797|FG000|Primary Study Treatment Phase|Death|2|||
148893588|NCT00883779|537088798|FG001|Primary Study Treatment Phase|Death|3|||
148893589|NCT00883779|537088797|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
148893590|NCT00883779|537088798|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
148893591|NCT00883779|537088797|FG000|Primary Study Treatment Phase|Other|3|||
148893592|NCT00883779|537088798|FG001|Primary Study Treatment Phase|Other|0|||
148893593|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Adverse Event|2|||
149132536|NCT02276872|537966340|FG000|Overall Study|Adverse Event|1|||
149011405|NCT04186403|537521467|FG001|Overall Study|Other: Not Related to Covid-19|0|||
149132537|NCT02276872|537966341|FG001|Overall Study|Adverse Event|0|||
148893594|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Adverse Event|3|||
148893595|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Death|1|||
149132538|NCT02276872|537966342|FG002|Overall Study|Adverse Event|0|||
149132539|NCT04175808|537966343|FG000|Part A|Miscellaneous|2|||
149132540|NCT04175808|537966344|FG001|Part A|Miscellaneous|0|||
149132541|NCT04175808|537966345|FG002|Part A|Miscellaneous|0|||
149132542|NCT04175808|537966346|FG003|Part A|Miscellaneous|0|||
149132543|NCT04175808|537966347|FG004|Part A|Miscellaneous|0|||
149132544|NCT04175808|537966348|FG005|Part A|Miscellaneous|0|||
149132545|NCT04175808|537966349|FG006|Part A|Miscellaneous|0|||
149132546|NCT02021292|537966351|FG000|Overall Study|Physician Decision|0|||
149132547|NCT02021292|537966352|FG001|Overall Study|Physician Decision|1|||
149132548|NCT02021292|537966351|FG000|Overall Study|Lost to Follow-up|0|||
149132549|NCT02021292|537966352|FG001|Overall Study|Lost to Follow-up|1|||
149132550|NCT02021292|537966351|FG000|Overall Study|Death|0|||
149132551|NCT02021292|537966352|FG001|Overall Study|Death|1|||
149132552|NCT05972733|537966355|FG000|Overall Study|Lost to Follow-up|2|||
149132553|NCT05972733|537966355|FG000|Overall Study|Withdrawal by Subject|1|||
149132554|NCT01637623|537966358|FG000|Overall Study|Lost to Follow-up|0|||
149132555|NCT01637623|537966359|FG001|Overall Study|Lost to Follow-up|0|||
149132556|NCT01637623|537966360|FG002|Overall Study|Lost to Follow-up|2|||
149132557|NCT01637623|537966358|FG000|Overall Study|Physician Decision|1|||
149132558|NCT01637623|537966359|FG001|Overall Study|Physician Decision|0|||
149132559|NCT01637623|537966360|FG002|Overall Study|Physician Decision|1|||
149132560|NCT00568321|537966365|FG000|Overall Study|Adverse Event|1|||
149132561|NCT00568321|537966366|FG001|Overall Study|Adverse Event|0|||
149132562|NCT00568321|537966367|FG002|Overall Study|Adverse Event|0|||
149132563|NCT00568321|537966365|FG000|Overall Study|Lack of Efficacy|8|||
149132564|NCT00568321|537966366|FG001|Overall Study|Lack of Efficacy|5|||
149132565|NCT00568321|537966367|FG002|Overall Study|Lack of Efficacy|6|||
149132566|NCT00568321|537966365|FG000|Overall Study|Lost to Follow-up|0|||
149132567|NCT00568321|537966366|FG001|Overall Study|Lost to Follow-up|0|||
149132568|NCT00568321|537966367|FG002|Overall Study|Lost to Follow-up|1|||
149132569|NCT00568321|537966365|FG000|Overall Study|Withdrawal by Subject|2|||
149132570|NCT00568321|537966366|FG001|Overall Study|Withdrawal by Subject|0|||
149132571|NCT00568321|537966367|FG002|Overall Study|Withdrawal by Subject|0|||
149132572|NCT00568321|537966365|FG000|Overall Study|Protocol Violation|0|||
149132573|NCT00568321|537966366|FG001|Overall Study|Protocol Violation|0|||
149132574|NCT00568321|537966367|FG002|Overall Study|Protocol Violation|1|||
149132575|NCT00568321|537966365|FG000|Overall Study|Randomized, not treated|2|||
149132576|NCT00568321|537966366|FG001|Overall Study|Randomized, not treated|0|||
149132577|NCT00568321|537966367|FG002|Overall Study|Randomized, not treated|1|||
149132578|NCT00823901|537966369|FG000|Overall Study|Adverse Event|1|||
149132579|NCT00823901|537966370|FG001|Overall Study|Adverse Event|1|||
149132580|NCT00823901|537966369|FG000|Overall Study|Lack of Efficacy|1|||
149132581|NCT00823901|537966370|FG001|Overall Study|Lack of Efficacy|0|||
149132582|NCT00823901|537966369|FG000|Overall Study|Lost to Follow-up|2|||
149132583|NCT00823901|537966370|FG001|Overall Study|Lost to Follow-up|1|||
149132584|NCT01369511|537966371|FG000|Overall Study|Adverse Event|1|||
149132585|NCT01369511|537966372|FG001|Overall Study|Adverse Event|1|||
149132586|NCT01369511|537966373|FG002|Overall Study|Adverse Event|5|||
149132587|NCT01369511|537966374|FG003|Overall Study|Adverse Event|0|||
149132588|NCT01369511|537966371|FG000|Overall Study|Entry criteria not met|2|||
149132589|NCT01369511|537966372|FG001|Overall Study|Entry criteria not met|0|||
149132590|NCT01369511|537966373|FG002|Overall Study|Entry criteria not met|0|||
149132591|NCT01369511|537966374|FG003|Overall Study|Entry criteria not met|1|||
149132592|NCT01369511|537966371|FG000|Overall Study|Lost to Follow-up|0|||
149132593|NCT01369511|537966372|FG001|Overall Study|Lost to Follow-up|1|||
149132594|NCT01369511|537966373|FG002|Overall Study|Lost to Follow-up|1|||
149132595|NCT01369511|537966374|FG003|Overall Study|Lost to Follow-up|2|||
149132596|NCT01369511|537966371|FG000|Overall Study|Protocol Violation|0|||
149132597|NCT01369511|537966372|FG001|Overall Study|Protocol Violation|1|||
149132598|NCT01369511|537966373|FG002|Overall Study|Protocol Violation|0|||
149132599|NCT01369511|537966374|FG003|Overall Study|Protocol Violation|2|||
149132600|NCT01369511|537966371|FG000|Overall Study|Physician Decision|3|||
149132601|NCT01369511|537966372|FG001|Overall Study|Physician Decision|4|||
149132602|NCT01369511|537966373|FG002|Overall Study|Physician Decision|0|||
149132603|NCT01369511|537966374|FG003|Overall Study|Physician Decision|0|||
149132604|NCT01369511|537966371|FG000|Overall Study|Sponsor decision|2|||
149132605|NCT01369511|537966372|FG001|Overall Study|Sponsor decision|0|||
149132606|NCT01369511|537966373|FG002|Overall Study|Sponsor decision|1|||
149132607|NCT01369511|537966374|FG003|Overall Study|Sponsor decision|0|||
149132608|NCT01369511|537966371|FG000|Overall Study|Withdrawal by Subject|5|||
148893596|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Death|3|||
149132609|NCT01369511|537966372|FG001|Overall Study|Withdrawal by Subject|6|||
149132610|NCT01369511|537966373|FG002|Overall Study|Withdrawal by Subject|4|||
149132611|NCT01369511|537966374|FG003|Overall Study|Withdrawal by Subject|6|||
149132612|NCT01180998|537966376|FG000|Overall Study|Poor Vision|0|||
149132613|NCT01180998|537966377|FG001|Overall Study|Poor Vision|2|||
149132614|NCT01180998|537966378|FG002|Overall Study|Poor Vision|2|||
149132615|NCT01180998|537966376|FG000|Overall Study|Lost to Follow-up|0|||
149132616|NCT01180998|537966377|FG001|Overall Study|Lost to Follow-up|0|||
149132617|NCT01180998|537966378|FG002|Overall Study|Lost to Follow-up|1|||
149132618|NCT01180998|537966376|FG000|Overall Study|Protocol Violation|1|||
149132619|NCT01180998|537966377|FG001|Overall Study|Protocol Violation|2|||
149132620|NCT01180998|537966378|FG002|Overall Study|Protocol Violation|0|||
149132621|NCT01180998|537966376|FG000|Overall Study|Withdrawal by Subject|0|||
149132622|NCT01180998|537966377|FG001|Overall Study|Withdrawal by Subject|0|||
149132623|NCT01180998|537966378|FG002|Overall Study|Withdrawal by Subject|1|||
149132624|NCT01180998|537966376|FG000|Overall Study|Poor comfort|3|||
149132625|NCT01180998|537966377|FG001|Overall Study|Poor comfort|0|||
149132626|NCT01180998|537966378|FG002|Overall Study|Poor comfort|4|||
149132627|NCT01180998|537966376|FG000|Overall Study|Poor lens handling|0|||
149132628|NCT01180998|537966377|FG001|Overall Study|Poor lens handling|0|||
149132629|NCT01180998|537966378|FG002|Overall Study|Poor lens handling|2|||
149132630|NCT01376349|537966379|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
149132631|NCT01376349|537966380|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
149132632|NCT01376349|537966381|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
149132633|NCT01376349|537966379|FG000|Raondomized Treatment|Adverse Event|13|||
149132634|NCT01376349|537966380|FG001|Raondomized Treatment|Adverse Event|17|||
149132635|NCT01376349|537966381|FG002|Raondomized Treatment|Adverse Event|14|||
149132636|NCT01376349|537966379|FG000|Raondomized Treatment|Unkown|1|||
149132637|NCT01376349|537966380|FG001|Raondomized Treatment|Unkown|2|||
149132638|NCT01376349|537966381|FG002|Raondomized Treatment|Unkown|1|||
149132639|NCT01376349|537966379|FG000|Raondomized Treatment|Alternative Treatment|0|||
149132640|NCT01376349|537966380|FG001|Raondomized Treatment|Alternative Treatment|0|||
149132641|NCT01376349|537966381|FG002|Raondomized Treatment|Alternative Treatment|1|||
149132642|NCT01176968|537966382|FG000|Overall Study|Adverse Event|10|||
149132643|NCT01176968|537966383|FG001|Overall Study|Adverse Event|11|||
149132644|NCT01176968|537966382|FG000|Overall Study|Death|2|||
149132645|NCT01176968|537966383|FG001|Overall Study|Death|3|||
149132646|NCT01176968|537966382|FG000|Overall Study|Lack of Efficacy|0|||
149132647|NCT01176968|537966383|FG001|Overall Study|Lack of Efficacy|1|||
149132648|NCT01176968|537966382|FG000|Overall Study|Lost to Follow-up|16|||
149132649|NCT01176968|537966383|FG001|Overall Study|Lost to Follow-up|14|||
149132650|NCT01176968|537966382|FG000|Overall Study|Withdrawal by Subject|48|||
149132651|NCT01176968|537966383|FG001|Overall Study|Withdrawal by Subject|48|||
149132652|NCT01176968|537966382|FG000|Overall Study|Protocol Violation|2|||
149132653|NCT01176968|537966383|FG001|Overall Study|Protocol Violation|1|||
149132654|NCT01176968|537966382|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
149132655|NCT01176968|537966383|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
149132656|NCT01176968|537966382|FG000|Overall Study|Study terminated by sponsor|0|||
149132657|NCT01176968|537966383|FG001|Overall Study|Study terminated by sponsor|1|||
149132658|NCT01176968|537966382|FG000|Overall Study|Reason not defined|5|||
149132659|NCT01176968|537966383|FG001|Overall Study|Reason not defined|3|||
149132660|NCT00718640|537966384|FG000|Overall Study|Adverse Event|4|||
149132661|NCT00718640|537966384|FG000|Overall Study|Death|1|||
149132662|NCT00718640|537966384|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
149132663|NCT00068588|537966387|FG000|Overall Study|Adverse Event|0|||
149132664|NCT00068588|537966388|FG001|Overall Study|Adverse Event|0|||
149132665|NCT00068588|537966389|FG002|Overall Study|Adverse Event|2|||
149132666|NCT00068588|537966387|FG000|Overall Study|Withdrawal by Subject|0|||
149132667|NCT00068588|537966388|FG001|Overall Study|Withdrawal by Subject|0|||
149132668|NCT00068588|537966389|FG002|Overall Study|Withdrawal by Subject|1|||
149132669|NCT00068588|537966387|FG000|Overall Study|Poor KPS|0|||
149132670|NCT00068588|537966388|FG001|Overall Study|Poor KPS|0|||
149132671|NCT00068588|537966389|FG002|Overall Study|Poor KPS|1|||
149132672|NCT04098068|537966390|FG000|Overall Study|Disease Progression|7|||
149132673|NCT04098068|537966390|FG000|Overall Study|Withdrawal by Subject|2|||
149132674|NCT04098068|537966390|FG000|Overall Study|New Cancer Diagnosis|1|||
149132675|NCT03871829|537966391|FG000|Overall Study|Lost to Follow-up|0|||
149132676|NCT03871829|537966392|FG001|Overall Study|Lost to Follow-up|1|||
149132677|NCT03871829|537966391|FG000|Overall Study|Withdrawal by Subject|1|||
149132678|NCT03871829|537966392|FG001|Overall Study|Withdrawal by Subject|1|||
149132679|NCT03871829|537966391|FG000|Overall Study|Death|12|||
149132680|NCT03871829|537966392|FG001|Overall Study|Death|8|||
149132681|NCT03871829|537966391|FG000|Overall Study|Study terminated by sponsor|31|||
149132682|NCT03871829|537966392|FG001|Overall Study|Study terminated by sponsor|34|||
149132683|NCT02993523|537966393|FG000|Overall Study|Withdrew Consent|0|||
149132684|NCT02993523|537966394|FG001|Overall Study|Withdrew Consent|0|||
149132685|NCT02993523|537966395|FG002|Overall Study|Withdrew Consent|2|||
149132686|NCT02993523|537966396|FG003|Overall Study|Withdrew Consent|9|||
149132687|NCT02993523|537966397|FG004|Overall Study|Withdrew Consent|0|||
149132688|NCT02993523|537966393|FG000|Overall Study|Lost to Follow-up|0|||
149132689|NCT02993523|537966394|FG001|Overall Study|Lost to Follow-up|0|||
149132690|NCT02993523|537966395|FG002|Overall Study|Lost to Follow-up|3|||
149132691|NCT02993523|537966396|FG003|Overall Study|Lost to Follow-up|6|||
149132692|NCT02993523|537966397|FG004|Overall Study|Lost to Follow-up|0|||
149132693|NCT02993523|537966393|FG000|Overall Study|Death|1|||
149132694|NCT02993523|537966394|FG001|Overall Study|Death|1|||
149132695|NCT02993523|537966395|FG002|Overall Study|Death|138|||
149132696|NCT02993523|537966396|FG003|Overall Study|Death|222|||
149132697|NCT02993523|537966397|FG004|Overall Study|Death|6|||
149132698|NCT02993523|537966393|FG000|Overall Study|Reason not Specified|0|||
149132699|NCT02993523|537966394|FG001|Overall Study|Reason not Specified|0|||
149132700|NCT02993523|537966395|FG002|Overall Study|Reason not Specified|1|||
149132701|NCT02993523|537966396|FG003|Overall Study|Reason not Specified|1|||
149132702|NCT02993523|537966397|FG004|Overall Study|Reason not Specified|0|||
149132703|NCT03694418|537966398|FG000|Overall Study|Lost to Follow-up|115|||
149132704|NCT03694418|537966399|FG001|Overall Study|Lost to Follow-up|23|||
149132705|NCT03694418|537966400|FG002|Overall Study|Lost to Follow-up|12|||
149132706|NCT03694418|537966401|FG003|Overall Study|Lost to Follow-up|12|||
149132707|NCT03694418|537966402|FG004|Overall Study|Lost to Follow-up|13|||
149132708|NCT04288778|537966403|FG000|Overall Study|Withdrawal by Subject|2|||
149132709|NCT04288778|537966403|FG000|Overall Study|Adverse Event|5|||
149132710|NCT04288778|537966403|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149132711|NCT04288778|537966403|FG000|Overall Study|Other|1|||
149132712|NCT04288778|537966403|FG000|Overall Study|Started but not treated|2|||
149132713|NCT00744523|537966404|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
149132714|NCT00744523|537966405|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
149132715|NCT05458479|537966406|FG000|Overall Study|Lost to Follow-up|1|||
149132716|NCT00784693|537966407|FG000|Overall Study|Lost to Follow-up|0|||
149132717|NCT00784693|537966408|FG001|Overall Study|Lost to Follow-up|1|||
149132718|NCT00784693|537966407|FG000|Overall Study|Lack of Efficacy|1|||
149132719|NCT00784693|537966408|FG001|Overall Study|Lack of Efficacy|1|||
149132720|NCT00784693|537966407|FG000|Overall Study|Withdrawal by Subject|0|||
149132721|NCT00784693|537966408|FG001|Overall Study|Withdrawal by Subject|4|||
149132722|NCT00784693|537966407|FG000|Overall Study|Randomized but not Treated|1|||
149132723|NCT00784693|537966408|FG001|Overall Study|Randomized but not Treated|0|||
149132724|NCT00784693|537966407|FG000|Overall Study|Other|1|||
149132725|NCT00784693|537966408|FG001|Overall Study|Other|0|||
149132726|NCT00528866|537966409|FG000|Overall Study|Protocol Violation|6|||
149132727|NCT00993915|537966413|FG000|Overall Study|Insufficient clinical response|3|||
149132728|NCT00993915|537966413|FG000|Overall Study|Withdrawal by Subject|2|||
149132729|NCT00993915|537966413|FG000|Overall Study|Other|1|||
149132730|NCT00993915|537966413|FG000|Overall Study|Ongoing|3|||
149132731|NCT01386658|537966414|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
149132732|NCT01386658|537966415|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
149132733|NCT01386658|537966414|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
149132734|NCT01386658|537966415|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
149132735|NCT02465463|537966418|FG000|Overall Study|Lost to Follow-up|2|||
149132736|NCT02465463|537966419|FG001|Overall Study|Lost to Follow-up|1|||
149132737|NCT02465463|537966418|FG000|Overall Study|Death|1|||
149132738|NCT02465463|537966419|FG001|Overall Study|Death|0|||
149132739|NCT02465463|537966418|FG000|Overall Study|Protocol Violation|1|||
149132740|NCT02465463|537966419|FG001|Overall Study|Protocol Violation|0|||
149132741|NCT00769860|537966424|FG000|Overall Study|Withdrawal by Subject|2|||
149132742|NCT00769860|537966425|FG001|Overall Study|Withdrawal by Subject|0|||
149132743|NCT00412971|537966430|FG000|Overall Study|Lost to Follow-up|17|||
149132744|NCT00412971|537966431|FG001|Overall Study|Lost to Follow-up|9|||
149132745|NCT00412971|537966430|FG000|Overall Study|Protocol Violation|13|||
149132746|NCT00412971|537966431|FG001|Overall Study|Protocol Violation|1|||
149132747|NCT01106404|537966432|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
149132748|NCT01106404|537966433|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
149132749|NCT01106404|537966432|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
149132750|NCT01106404|537966433|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
149132751|NCT01106404|537966432|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
149132752|NCT01106404|537966433|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
149132753|NCT01106404|537966432|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
149132754|NCT01106404|537966433|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
149132755|NCT00775450|537966434|FG000|Overall Study|Serious Adverse Event|2|||
149132756|NCT00775450|537966435|FG001|Overall Study|Serious Adverse Event|0|||
149132757|NCT00775450|537966436|FG002|Overall Study|Serious Adverse Event|0|||
149132758|NCT00775450|537966437|FG003|Overall Study|Serious Adverse Event|0|||
149132759|NCT00775450|537966438|FG004|Overall Study|Serious Adverse Event|0|||
149132760|NCT00775450|537966434|FG000|Overall Study|Protocol Violation|0|||
149132761|NCT00775450|537966435|FG001|Overall Study|Protocol Violation|0|||
149132762|NCT00775450|537966436|FG002|Overall Study|Protocol Violation|0|||
149132763|NCT00775450|537966437|FG003|Overall Study|Protocol Violation|0|||
149132764|NCT00775450|537966438|FG004|Overall Study|Protocol Violation|1|||
149132765|NCT00775450|537966434|FG000|Overall Study|Withdrawal by Subject|1|||
149132766|NCT00775450|537966435|FG001|Overall Study|Withdrawal by Subject|0|||
149132767|NCT00775450|537966436|FG002|Overall Study|Withdrawal by Subject|0|||
149132768|NCT00775450|537966437|FG003|Overall Study|Withdrawal by Subject|0|||
149132769|NCT00775450|537966438|FG004|Overall Study|Withdrawal by Subject|1|||
149132770|NCT01749540|537966439|FG000|Overall Study|Protocol Violation|0|||
149132771|NCT01749540|537966440|FG001|Overall Study|Protocol Violation|0|||
149132772|NCT01749540|537966441|FG002|Overall Study|Protocol Violation|0|||
149132773|NCT01749540|537966442|FG003|Overall Study|Protocol Violation|0|||
149132774|NCT01749540|537966443|FG004|Overall Study|Protocol Violation|0|||
149132775|NCT01749540|537966444|FG005|Overall Study|Protocol Violation|1|||
149132776|NCT01749540|537966445|FG006|Overall Study|Protocol Violation|1|||
149132777|NCT01749540|537966439|FG000|Overall Study|Withdrawal by Subject|0|||
149132778|NCT01749540|537966440|FG001|Overall Study|Withdrawal by Subject|0|||
149132779|NCT01749540|537966441|FG002|Overall Study|Withdrawal by Subject|0|||
149132780|NCT01749540|537966442|FG003|Overall Study|Withdrawal by Subject|1|||
149132781|NCT01749540|537966443|FG004|Overall Study|Withdrawal by Subject|0|||
149132782|NCT01749540|537966444|FG005|Overall Study|Withdrawal by Subject|0|||
149132783|NCT01749540|537966445|FG006|Overall Study|Withdrawal by Subject|0|||
149132784|NCT01749540|537966439|FG000|Overall Study|Initiated into extension study A536-06|0|||
149132785|NCT01749540|537966440|FG001|Overall Study|Initiated into extension study A536-06|0|||
149132786|NCT01749540|537966441|FG002|Overall Study|Initiated into extension study A536-06|0|||
149132787|NCT01749540|537966442|FG003|Overall Study|Initiated into extension study A536-06|0|||
149132788|NCT01749540|537966443|FG004|Overall Study|Initiated into extension study A536-06|0|||
149132789|NCT01749540|537966444|FG005|Overall Study|Initiated into extension study A536-06|2|||
149132790|NCT01749540|537966445|FG006|Overall Study|Initiated into extension study A536-06|24|||
149132791|NCT01209143|537966449|FG000|Overall Study|Adverse Event|2|||
149132792|NCT01209143|537966450|FG001|Overall Study|Adverse Event|1|||
149132793|NCT01209143|537966449|FG000|Overall Study|Death|0|||
149132794|NCT01209143|537966450|FG001|Overall Study|Death|1|||
149132795|NCT01209143|537966449|FG000|Overall Study|Physician Decision|3|||
149132796|NCT01209143|537966450|FG001|Overall Study|Physician Decision|1|||
149132797|NCT01209143|537966449|FG000|Overall Study|Lost to Follow-up|1|||
149132798|NCT01209143|537966450|FG001|Overall Study|Lost to Follow-up|0|||
149132799|NCT01209143|537966449|FG000|Overall Study|Withdrawal by Subject|2|||
149132800|NCT01209143|537966450|FG001|Overall Study|Withdrawal by Subject|1|||
149132801|NCT01209143|537966449|FG000|Overall Study|Disease progression|11|||
149132802|NCT01209143|537966450|FG001|Overall Study|Disease progression|16|||
149132803|NCT01145755|537966451|FG000|Overall Study|Adverse Event|2|||
149132804|NCT01145755|537966452|FG001|Overall Study|Adverse Event|4|||
149132805|NCT01145755|537966453|FG002|Overall Study|Adverse Event|2|||
149132806|NCT01145755|537966451|FG000|Overall Study|Withdrawal by Subject|2|||
149132807|NCT01145755|537966452|FG001|Overall Study|Withdrawal by Subject|2|||
149132808|NCT01145755|537966453|FG002|Overall Study|Withdrawal by Subject|2|||
149132809|NCT01145755|537966451|FG000|Overall Study|Lost to Follow-up|2|||
149132810|NCT01145755|537966452|FG001|Overall Study|Lost to Follow-up|3|||
149132811|NCT01145755|537966453|FG002|Overall Study|Lost to Follow-up|1|||
149132812|NCT01145755|537966451|FG000|Overall Study|Protocol Violation|0|||
149132813|NCT01145755|537966452|FG001|Overall Study|Protocol Violation|3|||
149132814|NCT01145755|537966453|FG002|Overall Study|Protocol Violation|1|||
149132815|NCT01145755|537966451|FG000|Overall Study|Study Closure|14|||
149132816|NCT01145755|537966452|FG001|Overall Study|Study Closure|14|||
149132817|NCT01145755|537966453|FG002|Overall Study|Study Closure|17|||
149132818|NCT01145755|537966451|FG000|Overall Study|Lack of Efficacy|0|||
149132819|NCT01145755|537966452|FG001|Overall Study|Lack of Efficacy|1|||
149132820|NCT01145755|537966453|FG002|Overall Study|Lack of Efficacy|0|||
149132821|NCT01145755|537966451|FG000|Overall Study|Patient could not swollow medication|0|||
149132822|NCT01145755|537966452|FG001|Overall Study|Patient could not swollow medication|0|||
149132823|NCT01145755|537966453|FG002|Overall Study|Patient could not swollow medication|1|||
149132824|NCT01145755|537966451|FG000|Overall Study|Withdrawal by Subject|0|||
149132825|NCT01145755|537966452|FG001|Overall Study|Withdrawal by Subject|0|||
149132826|NCT01145755|537966453|FG002|Overall Study|Withdrawal by Subject|1|||
149132827|NCT01145755|537966451|FG000|Overall Study|Positive urine ethanol|0|||
149132828|NCT01145755|537966452|FG001|Overall Study|Positive urine ethanol|1|||
149132829|NCT01145755|537966453|FG002|Overall Study|Positive urine ethanol|0|||
149132830|NCT05245097|537966456|FG000|Overall Study|Adverse Event|13|||
149132831|NCT05245097|537966457|FG001|Overall Study|Adverse Event|2|||
149132832|NCT05245097|537966456|FG000|Overall Study|Protocol Violation|8|||
149132833|NCT05245097|537966457|FG001|Overall Study|Protocol Violation|6|||
149132834|NCT05245097|537966456|FG000|Overall Study|Withdrawal by Subject|18|||
149132835|NCT05245097|537966457|FG001|Overall Study|Withdrawal by Subject|0|||
149132836|NCT05245097|537966456|FG000|Overall Study|Death|6|||
149132837|NCT05245097|537966457|FG001|Overall Study|Death|7|||
149132838|NCT05245097|537966456|FG000|Overall Study|Physician Decision|6|||
149132839|NCT05245097|537966457|FG001|Overall Study|Physician Decision|0|||
149132840|NCT05245097|537966456|FG000|Overall Study|Relocation|4|||
149132841|NCT05245097|537966457|FG001|Overall Study|Relocation|3|||
149132842|NCT03254485|537966464|FG000|Overall Study|Adverse Event|3|||
149132843|NCT03254485|537966465|FG001|Overall Study|Adverse Event|0|||
149132844|NCT03254485|537966466|FG002|Overall Study|Adverse Event|0|||
149132845|NCT03254485|537966467|FG003|Overall Study|Adverse Event|6|||
149132846|NCT03254485|537966464|FG000|Overall Study|Protocol Violation|6|||
149132847|NCT03254485|537966465|FG001|Overall Study|Protocol Violation|0|||
149132848|NCT03254485|537966466|FG002|Overall Study|Protocol Violation|0|||
149132849|NCT03254485|537966467|FG003|Overall Study|Protocol Violation|2|||
149132850|NCT03254485|537966464|FG000|Overall Study|Withdrawal by Subject|1|||
149132851|NCT03254485|537966465|FG001|Overall Study|Withdrawal by Subject|0|||
149132852|NCT03254485|537966466|FG002|Overall Study|Withdrawal by Subject|0|||
149132853|NCT03254485|537966467|FG003|Overall Study|Withdrawal by Subject|4|||
149132854|NCT03254485|537966464|FG000|Overall Study|Death|0|||
149132855|NCT03254485|537966465|FG001|Overall Study|Death|0|||
149132856|NCT03254485|537966466|FG002|Overall Study|Death|0|||
149132857|NCT03254485|537966467|FG003|Overall Study|Death|1|||
149132858|NCT03254485|537966464|FG000|Overall Study|Lost to Follow-up|1|||
149132859|NCT03254485|537966465|FG001|Overall Study|Lost to Follow-up|0|||
149132860|NCT03254485|537966466|FG002|Overall Study|Lost to Follow-up|0|||
149132861|NCT03254485|537966467|FG003|Overall Study|Lost to Follow-up|0|||
149132862|NCT03254485|537966464|FG000|Overall Study|Other|1|||
149132863|NCT03254485|537966465|FG001|Overall Study|Other|0|||
149132864|NCT03254485|537966466|FG002|Overall Study|Other|0|||
149132865|NCT03254485|537966467|FG003|Overall Study|Other|2|||
149132866|NCT00475033|537966470|FG000|Infant Series|Failed to return|3|||
149132867|NCT00475033|537966471|FG001|Infant Series|Failed to return|4|||
149132868|NCT00475033|537966470|FG000|Infant Series|Parent or legal guardian request|1|||
149132869|NCT00475033|537966471|FG001|Infant Series|Parent or legal guardian request|5|||
149132870|NCT00475033|537966470|FG000|Infant Series|Protocol Violation|1|||
149132871|NCT00475033|537966471|FG001|Infant Series|Protocol Violation|2|||
149132872|NCT00475033|537966470|FG000|Infant Series|Lost to Follow-up|2|||
149132873|NCT00475033|537966471|FG001|Infant Series|Lost to Follow-up|0|||
149132874|NCT00475033|537966470|FG000|Infant Series|Adverse Event|0|||
149132875|NCT00475033|537966471|FG001|Infant Series|Adverse Event|2|||
149132876|NCT00475033|537966470|FG000|After the Infant Series|Adverse Event|0|||
149132877|NCT00475033|537966471|FG001|After the Infant Series|Adverse Event|4|||
149132878|NCT00475033|537966470|FG000|After the Infant Series|Parent or legal guardian request|2|||
149132879|NCT00475033|537966471|FG001|After the Infant Series|Parent or legal guardian request|2|||
149132880|NCT00475033|537966470|FG000|After the Infant Series|Failed to return|2|||
149132881|NCT00475033|537966471|FG001|After the Infant Series|Failed to return|1|||
149132882|NCT00475033|537966470|FG000|After the Infant Series|Protocol Violation|1|||
149132883|NCT00475033|537966471|FG001|After the Infant Series|Protocol Violation|0|||
149132884|NCT00475033|537966470|FG000|After the Infant Series|Lost to Follow-up|1|||
149132885|NCT00475033|537966471|FG001|After the Infant Series|Lost to Follow-up|0|||
149132886|NCT00475033|537966470|FG000|After the Infant Series|Other|0|||
149132887|NCT00475033|537966471|FG001|After the Infant Series|Other|1|||
149132888|NCT00475033|537966470|FG000|Toddler Dose|Parent or legal guardian request|2|||
149132889|NCT00475033|537966471|FG001|Toddler Dose|Parent or legal guardian request|0|||
149132890|NCT00475033|537966470|FG000|Toddler Dose|Failed to return|1|||
149132891|NCT00475033|537966471|FG001|Toddler Dose|Failed to return|0|||
149132892|NCT00475033|537966470|FG000|Toddler Dose|Lost to Follow-up|1|||
149132893|NCT00475033|537966471|FG001|Toddler Dose|Lost to Follow-up|0|||
149132894|NCT03231943|537966473|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132895|NCT03231943|537966474|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
149132896|NCT03231943|537966475|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
149132897|NCT03231943|537966476|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132898|NCT03231943|537966477|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132899|NCT03231943|537966478|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132900|NCT03231943|537966479|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132901|NCT03231943|537966480|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132902|NCT03231943|537966481|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132903|NCT03231943|537966482|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132904|NCT03231943|537966483|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132905|NCT03231943|537966484|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132906|NCT03231943|537966485|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
149132907|NCT03231943|537966473|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132908|NCT03231943|537966474|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
149132909|NCT03231943|537966475|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132910|NCT03231943|537966476|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132911|NCT03231943|537966477|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132912|NCT03231943|537966478|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132913|NCT03231943|537966479|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132914|NCT03231943|537966480|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132915|NCT03231943|537966481|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132916|NCT03231943|537966482|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132917|NCT03231943|537966483|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132918|NCT03231943|537966484|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132919|NCT03231943|537966485|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
149132920|NCT03231943|537966473|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
149132921|NCT03231943|537966474|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132922|NCT03231943|537966475|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132923|NCT03231943|537966476|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132924|NCT03231943|537966477|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132925|NCT03231943|537966478|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132926|NCT03231943|537966479|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132927|NCT03231943|537966480|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132928|NCT03231943|537966481|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132929|NCT03231943|537966482|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132930|NCT03231943|537966483|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132931|NCT03231943|537966484|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132932|NCT03231943|537966485|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
149132933|NCT03231943|537966473|FG000|Part 2|Adverse Event|0|||
149132934|NCT03231943|537966474|FG001|Part 2|Adverse Event|0|||
149132935|NCT03231943|537966475|FG002|Part 2|Adverse Event|0|||
149132936|NCT03231943|537966476|FG003|Part 2|Adverse Event|0|||
149132937|NCT03231943|537966477|FG004|Part 2|Adverse Event|0|||
149132938|NCT03231943|537966478|FG005|Part 2|Adverse Event|0|||
149132939|NCT03231943|537966479|FG006|Part 2|Adverse Event|0|||
149132940|NCT03231943|537966480|FG007|Part 2|Adverse Event|0|||
149132941|NCT03231943|537966481|FG008|Part 2|Adverse Event|0|||
149132942|NCT03231943|537966482|FG009|Part 2|Adverse Event|0|||
149132943|NCT03231943|537966483|FG010|Part 2|Adverse Event|1|||
149132944|NCT03231943|537966484|FG011|Part 2|Adverse Event|0|||
149132945|NCT03231943|537966485|FG012|Part 2|Adverse Event|0|||
149132946|NCT03231943|537966473|FG000|Part 2|Withdrawal by Subject|0|||
149132947|NCT03231943|537966474|FG001|Part 2|Withdrawal by Subject|0|||
149132948|NCT03231943|537966475|FG002|Part 2|Withdrawal by Subject|0|||
149132949|NCT03231943|537966476|FG003|Part 2|Withdrawal by Subject|0|||
149132950|NCT03231943|537966477|FG004|Part 2|Withdrawal by Subject|0|||
149132951|NCT03231943|537966478|FG005|Part 2|Withdrawal by Subject|0|||
149132952|NCT03231943|537966479|FG006|Part 2|Withdrawal by Subject|0|||
149132953|NCT03231943|537966480|FG007|Part 2|Withdrawal by Subject|0|||
149132954|NCT03231943|537966481|FG008|Part 2|Withdrawal by Subject|0|||
149132955|NCT03231943|537966482|FG009|Part 2|Withdrawal by Subject|0|||
149132956|NCT03231943|537966483|FG010|Part 2|Withdrawal by Subject|0|||
149132957|NCT03231943|537966484|FG011|Part 2|Withdrawal by Subject|1|||
149132958|NCT03231943|537966485|FG012|Part 2|Withdrawal by Subject|0|||
149132959|NCT01572922|537966486|FG000|Overall Study|Adverse Event|1|||
149132960|NCT01572922|537966486|FG000|Overall Study|Protocol Violation|1|||
149132961|NCT01572922|537966486|FG000|Overall Study|Death|1|||
149132962|NCT01335009|537966487|FG000|Overall Study|Too ill to travel to study sites|1|||
149132963|NCT01335009|537966488|FG001|Overall Study|Too ill to travel to study sites|0|||
149132964|NCT01335009|537966487|FG000|Overall Study|Death|28|||
149132965|NCT01335009|537966488|FG001|Overall Study|Death|32|||
149132966|NCT01335009|537966487|FG000|Overall Study|Withdrawal by Subject|1|||
149132967|NCT01335009|537966488|FG001|Overall Study|Withdrawal by Subject|1|||
149132968|NCT01335009|537966487|FG000|Overall Study|Lost to Follow-up|1|||
149132969|NCT01335009|537966488|FG001|Overall Study|Lost to Follow-up|0|||
149132970|NCT02818920|537966489|FG000|Overall Study|Unresectable|4|||
149132971|NCT02818920|537966489|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
149132972|NCT02818920|537966489|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
149132973|NCT02818920|537966489|FG000|Overall Study|Adverse Event|3|||
149132974|NCT02818920|537966489|FG000|Overall Study|Developed Other Disease|1|||
149132975|NCT02818920|537966489|FG000|Overall Study|Refused Further Treatment|1|||
149132976|NCT00445068|537966490|FG000|Overall Study|Disease progression|26|||
149132977|NCT00445068|537966490|FG000|Overall Study|Adverse Event|5|||
149132978|NCT00445068|537966490|FG000|Overall Study|Abnormal laboratory value|2|||
149132979|NCT00445068|537966490|FG000|Overall Study|Withdrawal by Subject|2|||
149132980|NCT00445068|537966490|FG000|Overall Study|Death|1|||
149132981|NCT04824521|537966491|FG000|Overall Study|Lost to Follow-up|1|||
149132982|NCT04821869|537966492|FG000|Overall Study|Adverse Event|4|||
149132983|NCT04821869|537966492|FG000|Overall Study|Withdrawal by Subject|2|||
149132984|NCT04821869|537966492|FG000|Overall Study|Did not meet FEV1 criteria|1|||
149132985|NCT03444324|537966493|FG000|Overall Study|Withdrawal by Subject|0|||
149132986|NCT03444324|537966494|FG001|Overall Study|Withdrawal by Subject|1|||
149132987|NCT03444324|537966493|FG000|Overall Study|Lost to Follow-up|4|||
149132988|NCT03444324|537966494|FG001|Overall Study|Lost to Follow-up|2|||
149132989|NCT03444324|537966493|FG000|Overall Study|Protocol Violation|0|||
149132990|NCT03444324|537966494|FG001|Overall Study|Protocol Violation|1|||
149132991|NCT03444324|537966493|FG000|Overall Study|Lack of Trial Compliance|1|||
149132992|NCT03444324|537966494|FG001|Overall Study|Lack of Trial Compliance|1|||
149132993|NCT03444324|537966493|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
149132994|NCT03444324|537966494|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
149132995|NCT01117454|537968107|FG000|Overall Study|Pregnancy|0|||
149132996|NCT01117454|537968108|FG001|Overall Study|Pregnancy|1|||
149132997|NCT04796896|537968111|FG000|Overall Study|Adverse Event|1|||
149132998|NCT04796896|537968112|FG001|Overall Study|Adverse Event|0|||
149132999|NCT04796896|537968113|FG002|Overall Study|Adverse Event|0|||
149133000|NCT04796896|537968114|FG003|Overall Study|Adverse Event|0|||
149133001|NCT04796896|537968115|FG004|Overall Study|Adverse Event|0|||
149133002|NCT04796896|537968116|FG005|Overall Study|Adverse Event|1|||
149133003|NCT04796896|537968117|FG006|Overall Study|Adverse Event|1|||
149133004|NCT04796896|537968118|FG007|Overall Study|Adverse Event|0|||
149133005|NCT04796896|537968119|FG008|Overall Study|Adverse Event|1|||
149133006|NCT04796896|537968120|FG009|Overall Study|Adverse Event|1|||
149133007|NCT04796896|537968121|FG010|Overall Study|Adverse Event|1|||
149133008|NCT04796896|537968122|FG011|Overall Study|Adverse Event|0|||
149133009|NCT04796896|537968111|FG000|Overall Study|Lost to Follow-up|24|||
149133010|NCT04796896|537968112|FG001|Overall Study|Lost to Follow-up|15|||
149133011|NCT04796896|537968113|FG002|Overall Study|Lost to Follow-up|6|||
149133012|NCT04796896|537968114|FG003|Overall Study|Lost to Follow-up|4|||
149133013|NCT04796896|537968115|FG004|Overall Study|Lost to Follow-up|21|||
149133014|NCT04796896|537968116|FG005|Overall Study|Lost to Follow-up|55|||
149133015|NCT04796896|537968117|FG006|Overall Study|Lost to Follow-up|237|||
149133016|NCT04796896|537968118|FG007|Overall Study|Lost to Follow-up|52|||
149133017|NCT04796896|537968119|FG008|Overall Study|Lost to Follow-up|221|||
149133018|NCT04796896|537968120|FG009|Overall Study|Lost to Follow-up|43|||
149133019|NCT04796896|537968121|FG010|Overall Study|Lost to Follow-up|142|||
149133020|NCT04796896|537968122|FG011|Overall Study|Lost to Follow-up|18|||
149133021|NCT04796896|537968111|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
149133022|NCT04796896|537968112|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
149133023|NCT04796896|537968113|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
149133024|NCT04796896|537968114|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
149133025|NCT04796896|537968115|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
149133026|NCT04796896|537968116|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
149133027|NCT04796896|537968117|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
149133028|NCT04796896|537968118|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
149133029|NCT04796896|537968119|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
149133030|NCT04796896|537968120|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
149133031|NCT04796896|537968121|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
149133032|NCT04796896|537968122|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
149133033|NCT04796896|537968111|FG000|Overall Study|Physician Decision|1|||
149133034|NCT04796896|537968112|FG001|Overall Study|Physician Decision|0|||
149133035|NCT04796896|537968113|FG002|Overall Study|Physician Decision|0|||
149133036|NCT04796896|537968114|FG003|Overall Study|Physician Decision|0|||
149133037|NCT04796896|537968115|FG004|Overall Study|Physician Decision|0|||
149133038|NCT04796896|537968116|FG005|Overall Study|Physician Decision|3|||
149133039|NCT04796896|537968117|FG006|Overall Study|Physician Decision|18|||
149133040|NCT04796896|537968118|FG007|Overall Study|Physician Decision|1|||
149133041|NCT04796896|537968119|FG008|Overall Study|Physician Decision|7|||
149133042|NCT04796896|537968120|FG009|Overall Study|Physician Decision|0|||
149133043|NCT04796896|537968121|FG010|Overall Study|Physician Decision|5|||
149133044|NCT04796896|537968122|FG011|Overall Study|Physician Decision|0|||
149133045|NCT04796896|537968111|FG000|Overall Study|Withdrawal by Subject|36|||
149133046|NCT04796896|537968112|FG001|Overall Study|Withdrawal by Subject|31|||
149133047|NCT04796896|537968113|FG002|Overall Study|Withdrawal by Subject|11|||
149133048|NCT04796896|537968114|FG003|Overall Study|Withdrawal by Subject|8|||
149133049|NCT04796896|537968115|FG004|Overall Study|Withdrawal by Subject|16|||
149133050|NCT04796896|537968116|FG005|Overall Study|Withdrawal by Subject|162|||
149133051|NCT04796896|537968117|FG006|Overall Study|Withdrawal by Subject|299|||
149133052|NCT04796896|537968118|FG007|Overall Study|Withdrawal by Subject|149|||
149133053|NCT04796896|537968119|FG008|Overall Study|Withdrawal by Subject|303|||
149133054|NCT04796896|537968120|FG009|Overall Study|Withdrawal by Subject|94|||
149133055|NCT04796896|537968121|FG010|Overall Study|Withdrawal by Subject|192|||
149133056|NCT04796896|537968122|FG011|Overall Study|Withdrawal by Subject|16|||
149133057|NCT04796896|537968111|FG000|Overall Study|Other Than Specified|6|||
149133058|NCT04796896|537968112|FG001|Overall Study|Other Than Specified|5|||
149133059|NCT04796896|537968113|FG002|Overall Study|Other Than Specified|3|||
149133060|NCT04796896|537968114|FG003|Overall Study|Other Than Specified|2|||
149133061|NCT04796896|537968115|FG004|Overall Study|Other Than Specified|6|||
149133062|NCT04796896|537968116|FG005|Overall Study|Other Than Specified|31|||
149133063|NCT04796896|537968117|FG006|Overall Study|Other Than Specified|86|||
149133064|NCT04796896|537968118|FG007|Overall Study|Other Than Specified|66|||
149133065|NCT04796896|537968119|FG008|Overall Study|Other Than Specified|388|||
149133066|NCT04796896|537968120|FG009|Overall Study|Other Than Specified|48|||
149133067|NCT04796896|537968121|FG010|Overall Study|Other Than Specified|258|||
149133068|NCT04796896|537968122|FG011|Overall Study|Other Than Specified|4|||
149133069|NCT04796896|537968111|FG000|Overall Study|Protocol Deviation|0|||
149133070|NCT04796896|537968112|FG001|Overall Study|Protocol Deviation|0|||
149133071|NCT04796896|537968113|FG002|Overall Study|Protocol Deviation|0|||
149133072|NCT04796896|537968114|FG003|Overall Study|Protocol Deviation|1|||
149133073|NCT04796896|537968115|FG004|Overall Study|Protocol Deviation|1|||
149133074|NCT04796896|537968116|FG005|Overall Study|Protocol Deviation|2|||
149133075|NCT04796896|537968117|FG006|Overall Study|Protocol Deviation|2|||
149133076|NCT04796896|537968118|FG007|Overall Study|Protocol Deviation|2|||
149133077|NCT04796896|537968119|FG008|Overall Study|Protocol Deviation|2|||
149133078|NCT04796896|537968120|FG009|Overall Study|Protocol Deviation|1|||
149133079|NCT04796896|537968121|FG010|Overall Study|Protocol Deviation|0|||
149133080|NCT04796896|537968122|FG011|Overall Study|Protocol Deviation|0|||
149133081|NCT04796896|537968111|FG000|Overall Study|Missing|0|||
149133082|NCT04796896|537968112|FG001|Overall Study|Missing|0|||
149133083|NCT04796896|537968113|FG002|Overall Study|Missing|0|||
149133084|NCT04796896|537968114|FG003|Overall Study|Missing|0|||
149133085|NCT04796896|537968115|FG004|Overall Study|Missing|0|||
149133086|NCT04796896|537968116|FG005|Overall Study|Missing|0|||
149133087|NCT04796896|537968117|FG006|Overall Study|Missing|2|||
149133088|NCT04796896|537968118|FG007|Overall Study|Missing|1|||
149133089|NCT04796896|537968119|FG008|Overall Study|Missing|2|||
149133090|NCT04796896|537968120|FG009|Overall Study|Missing|1|||
149133091|NCT04796896|537968121|FG010|Overall Study|Missing|1|||
149133092|NCT04796896|537968122|FG011|Overall Study|Missing|0|||
149133093|NCT04796896|537968111|FG000|Overall Study|Death|0|||
149133094|NCT04796896|537968112|FG001|Overall Study|Death|0|||
149133095|NCT04796896|537968113|FG002|Overall Study|Death|0|||
149133096|NCT04796896|537968114|FG003|Overall Study|Death|0|||
149133097|NCT04796896|537968115|FG004|Overall Study|Death|0|||
149133098|NCT04796896|537968116|FG005|Overall Study|Death|0|||
149133099|NCT04796896|537968117|FG006|Overall Study|Death|0|||
149133100|NCT04796896|537968118|FG007|Overall Study|Death|0|||
149133101|NCT04796896|537968119|FG008|Overall Study|Death|1|||
149133102|NCT04796896|537968120|FG009|Overall Study|Death|0|||
149133103|NCT04796896|537968121|FG010|Overall Study|Death|0|||
149133104|NCT04796896|537968122|FG011|Overall Study|Death|0|||
149133105|NCT01177787|537968123|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
149133106|NCT01177787|537968123|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
149133107|NCT01177787|537968123|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
149133108|NCT02824263|537968124|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
149133109|NCT02824263|537968125|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
149133110|NCT02824263|537968124|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
149133111|NCT02824263|537968125|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
149133112|NCT00992511|537968127|FG000|Overall Study|Migrated/moved from study area|1|||
149133113|NCT00992511|537968128|FG001|Overall Study|Migrated/moved from study area|0|||
149133114|NCT00992511|537968129|FG002|Overall Study|Migrated/moved from study area|1|||
149133115|NCT00992511|537968130|FG003|Overall Study|Migrated/moved from study area|2|||
149133116|NCT00992511|537968127|FG000|Overall Study|Lost to Follow-up|1|||
149133117|NCT00992511|537968128|FG001|Overall Study|Lost to Follow-up|0|||
149133118|NCT00992511|537968129|FG002|Overall Study|Lost to Follow-up|0|||
149133119|NCT00992511|537968130|FG003|Overall Study|Lost to Follow-up|2|||
149133120|NCT00992511|537968127|FG000|Overall Study|Withdrawal by Subject|0|||
149133121|NCT00992511|537968128|FG001|Overall Study|Withdrawal by Subject|0|||
149133122|NCT00992511|537968129|FG002|Overall Study|Withdrawal by Subject|1|||
149133123|NCT00992511|537968130|FG003|Overall Study|Withdrawal by Subject|1|||
149133124|NCT01676909|537968131|FG000|Overall Study|Withdrawal by Subject|3|||
149133125|NCT01676909|537968132|FG001|Overall Study|Withdrawal by Subject|5|||
149133126|NCT01676909|537968131|FG000|Overall Study|Lost to Follow-up|15|||
149133127|NCT01676909|537968132|FG001|Overall Study|Lost to Follow-up|9|||
149133128|NCT04615247|537968133|FG000|Overall Study|Adverse Event|0|||
149133129|NCT04615247|537968134|FG001|Overall Study|Adverse Event|2|||
149133130|NCT04615247|537968133|FG000|Overall Study|Withdrawal by Subject|1|||
149133131|NCT04615247|537968134|FG001|Overall Study|Withdrawal by Subject|1|||
149133132|NCT02076113|537968139|FG000|Overall Study|Lost to Follow-up|4|||
149133133|NCT02076113|537968140|FG001|Overall Study|Lost to Follow-up|1|||
149133134|NCT02076113|537968139|FG000|Overall Study|Withdrawal by Subject|2|||
149133135|NCT02076113|537968140|FG001|Overall Study|Withdrawal by Subject|3|||
149133136|NCT02076113|537968139|FG000|Overall Study|Death|1|||
149133137|NCT02076113|537968140|FG001|Overall Study|Death|3|||
149133138|NCT04485104|537968160|FG000|Overall Study|Physician Decision|2|||
149133139|NCT04485104|537968161|FG001|Overall Study|Physician Decision|0|||
149133140|NCT04485104|537968160|FG000|Overall Study|Decision by sponsor|0|||
149133141|NCT04485104|537968161|FG001|Overall Study|Decision by sponsor|1|||
149133142|NCT05057247|537968166|FG000|Overall Study|Death|4|||
149133143|NCT05057247|537968166|FG000|Overall Study|Physician Decision|3|||
149133144|NCT05057247|537968166|FG000|Overall Study|Progressive Disease|7|||
149133145|NCT05057247|537968166|FG000|Overall Study|Withdrawal by Subject|3|||
149133146|NCT05057247|537968166|FG000|Overall Study|Adverse Event|6|||
149133147|NCT05057247|537968166|FG000|Overall Study|Subject Non-Compliance|1|||
149133148|NCT05057247|537968166|FG000|Overall Study|On treatment|2|||
149133149|NCT01067326|537968167|FG000|Overall Study|Adverse Event|0|||
148893597|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
149133150|NCT01067326|537968168|FG001|Overall Study|Adverse Event|2|||
149133151|NCT01067326|537968167|FG000|Overall Study|Withdrawal by Subject|1|||
149133152|NCT01067326|537968168|FG001|Overall Study|Withdrawal by Subject|0|||
149133153|NCT01067326|537968167|FG000|Overall Study|Early Study Termination|1|||
149133154|NCT01067326|537968168|FG001|Overall Study|Early Study Termination|1|||
149133155|NCT02430051|537968170|FG000|Overall Study|Withdrawal by Subject|6|||
149133156|NCT02430051|537968171|FG001|Overall Study|Withdrawal by Subject|3|||
149133157|NCT02430051|537968170|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
149133158|NCT02430051|537968171|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
149133159|NCT02430051|537968170|FG000|Overall Study|Protocol Violation|1|||
149133160|NCT02430051|537968171|FG001|Overall Study|Protocol Violation|0|||
149133161|NCT02030405|537968177|FG000|Overall Study|Withdrawal by Subject|1|||
149133162|NCT02030405|537968177|FG000|Overall Study|Lost to Follow-up|1|||
149133163|NCT04526197|537968178|FG000|Period 1|Adverse Event|0|||
149133164|NCT04526197|537968179|FG001|Period 1|Adverse Event|1|||
149133165|NCT04526197|537968178|FG000|Period 1|Withdrawal by Subject|1|||
149133166|NCT04526197|537968179|FG001|Period 1|Withdrawal by Subject|0|||
149133167|NCT04526197|537968178|FG000|Period 2|Adverse Event|0|||
149133168|NCT04526197|537968179|FG001|Period 2|Adverse Event|1|||
149133169|NCT04526197|537968178|FG000|Period 2|Withdrawal by Subject|0|||
149133170|NCT04526197|537968179|FG001|Period 2|Withdrawal by Subject|1|||
149133171|NCT00381303|537968180|FG000|Overall Study|Lost to Follow-up|25|||
149133172|NCT00381303|537968181|FG001|Overall Study|Lost to Follow-up|9|||
149133173|NCT00381303|537968180|FG000|Overall Study|AE/HIV-related event|22|||
149133174|NCT00381303|537968181|FG001|Overall Study|AE/HIV-related event|6|||
149133175|NCT00381303|537968180|FG000|Overall Study|Non-Adherence|13|||
149133176|NCT00381303|537968181|FG001|Overall Study|Non-Adherence|6|||
149133177|NCT00381303|537968180|FG000|Overall Study|Withdrawal by Subject|13|||
149133178|NCT00381303|537968181|FG001|Overall Study|Withdrawal by Subject|6|||
149133179|NCT00381303|537968180|FG000|Overall Study|Virologic failure|6|||
149133180|NCT00381303|537968181|FG001|Overall Study|Virologic failure|4|||
149133181|NCT00381303|537968180|FG000|Overall Study|Ineligible to continue the trial|2|||
149133182|NCT00381303|537968181|FG001|Overall Study|Ineligible to continue the trial|1|||
149133183|NCT00381303|537968180|FG000|Overall Study|Pregnancy|2|||
149133184|NCT00381303|537968181|FG001|Overall Study|Pregnancy|0|||
149133185|NCT00381303|537968180|FG000|Overall Study|Physician Decision|1|||
149133186|NCT00381303|537968181|FG001|Overall Study|Physician Decision|0|||
149133187|NCT00381303|537968180|FG000|Overall Study|Physician's decision to close the site|3|||
149133188|NCT00381303|537968181|FG001|Overall Study|Physician's decision to close the site|1|||
149133189|NCT00381303|537968180|FG000|Overall Study|Subject moved out of state|2|||
149133190|NCT00381303|537968181|FG001|Overall Study|Subject moved out of state|0|||
149133191|NCT00381303|537968180|FG000|Overall Study|Subject taking too many different meds|1|||
149133192|NCT00381303|537968181|FG001|Overall Study|Subject taking too many different meds|0|||
149133193|NCT00381303|537968180|FG000|Overall Study|No virologic response by week 12|1|||
149133194|NCT00381303|537968181|FG001|Overall Study|No virologic response by week 12|0|||
149133195|NCT00381303|537968180|FG000|Overall Study|Subject was too busy for appointments|1|||
149133196|NCT00381303|537968181|FG001|Overall Study|Subject was too busy for appointments|0|||
149133197|NCT00381303|537968180|FG000|Overall Study|Subject did not continue visits|1|||
149133198|NCT00381303|537968181|FG001|Overall Study|Subject did not continue visits|0|||
149133199|NCT00381303|537968180|FG000|Overall Study|Subject primary physician's decision|1|||
149133200|NCT00381303|537968181|FG001|Overall Study|Subject primary physician's decision|0|||
149133201|NCT01136811|537968184|FG000|Overall Study|Physician Decision|11|||
149133202|NCT01211522|537968186|FG000|Overall Study|Withdrawal by Subject|3|||
149133203|NCT01211522|537968187|FG001|Overall Study|Withdrawal by Subject|7|||
149133204|NCT01211522|537968188|FG002|Overall Study|Withdrawal by Subject|5|||
149133205|NCT00372385|537968194|FG000|Overall Study|Adverse Event|6|||
149133206|NCT00372385|537968195|FG001|Overall Study|Adverse Event|11|||
149133207|NCT00372385|537968196|FG002|Overall Study|Adverse Event|9|||
149133208|NCT00372385|537968197|FG003|Overall Study|Adverse Event|7|||
149133209|NCT00372385|537968194|FG000|Overall Study|Noncompliance|0|||
149133210|NCT00372385|537968195|FG001|Overall Study|Noncompliance|1|||
149133211|NCT00372385|537968196|FG002|Overall Study|Noncompliance|1|||
149133212|NCT00372385|537968197|FG003|Overall Study|Noncompliance|1|||
149133213|NCT00372385|537968194|FG000|Overall Study|Physician Decision|1|||
149133214|NCT00372385|537968195|FG001|Overall Study|Physician Decision|0|||
149133215|NCT00372385|537968196|FG002|Overall Study|Physician Decision|0|||
149133216|NCT00372385|537968197|FG003|Overall Study|Physician Decision|0|||
149133217|NCT00372385|537968194|FG000|Overall Study|Lost to Follow-up|2|||
149133218|NCT00372385|537968195|FG001|Overall Study|Lost to Follow-up|0|||
149133219|NCT00372385|537968196|FG002|Overall Study|Lost to Follow-up|0|||
149133220|NCT00372385|537968197|FG003|Overall Study|Lost to Follow-up|0|||
149133221|NCT00372385|537968194|FG000|Overall Study|Withdrawal by Subject|2|||
149133222|NCT00372385|537968195|FG001|Overall Study|Withdrawal by Subject|1|||
149133223|NCT00372385|537968196|FG002|Overall Study|Withdrawal by Subject|0|||
149133224|NCT00372385|537968197|FG003|Overall Study|Withdrawal by Subject|0|||
149133225|NCT00372385|537968194|FG000|Overall Study|Refusal of Treatment|3|||
149133226|NCT00372385|537968195|FG001|Overall Study|Refusal of Treatment|6|||
149133227|NCT00372385|537968196|FG002|Overall Study|Refusal of Treatment|0|||
149133228|NCT00372385|537968197|FG003|Overall Study|Refusal of Treatment|0|||
149133229|NCT00372385|537968194|FG000|Overall Study|No Response|1|||
149133230|NCT00372385|537968195|FG001|Overall Study|No Response|1|||
149133231|NCT00372385|537968196|FG002|Overall Study|No Response|0|||
149133232|NCT00372385|537968197|FG003|Overall Study|No Response|0|||
149133233|NCT00372385|537968194|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
149133234|NCT00372385|537968195|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
149133235|NCT00372385|537968196|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
149133236|NCT00372385|537968197|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
149133237|NCT00372385|537968194|FG000|Overall Study|Virologic Stopping Rule|17|||
149133238|NCT00372385|537968195|FG001|Overall Study|Virologic Stopping Rule|0|||
149133239|NCT00372385|537968196|FG002|Overall Study|Virologic Stopping Rule|0|||
149133240|NCT00372385|537968197|FG003|Overall Study|Virologic Stopping Rule|0|||
149133241|NCT01966471|537968198|FG000|Overall Study|Death|44|||
149133242|NCT01966471|537968199|FG001|Overall Study|Death|56|||
149133243|NCT01966471|537968198|FG000|Overall Study|Lost to Follow-up|46|||
149133244|NCT01966471|537968199|FG001|Overall Study|Lost to Follow-up|39|||
149133245|NCT01966471|537968198|FG000|Overall Study|Various reasons|4|||
149133246|NCT01966471|537968199|FG001|Overall Study|Various reasons|4|||
149133247|NCT01966471|537968198|FG000|Overall Study|Physician Decision|7|||
149133248|NCT01966471|537968199|FG001|Overall Study|Physician Decision|5|||
149133249|NCT01966471|537968198|FG000|Overall Study|Study Terminated By Sponsor|758|||
149133250|NCT01966471|537968199|FG001|Overall Study|Study Terminated By Sponsor|773|||
149133251|NCT01966471|537968198|FG000|Overall Study|Withdrawal by Subject|59|||
149133252|NCT01966471|537968199|FG001|Overall Study|Withdrawal by Subject|51|||
149133253|NCT02279862|537968200|FG000|Overall Study|Study drug toxicity|3|||
149133254|NCT02279862|537968201|FG001|Overall Study|Study drug toxicity|6|||
149133255|NCT02279862|537968200|FG000|Overall Study|No longer meets criteria|0|||
149133256|NCT02279862|537968201|FG001|Overall Study|No longer meets criteria|1|||
149133257|NCT02279862|537968200|FG000|Overall Study|Administrative reason by sponsor|0|||
149133258|NCT02279862|537968201|FG001|Overall Study|Administrative reason by sponsor|1|||
149133259|NCT02279862|537968200|FG000|Overall Study|Disease progression|5|||
149133260|NCT02279862|537968201|FG001|Overall Study|Disease progression|2|||
149133261|NCT02279862|537968200|FG000|Overall Study|Study closed by sponsor|16|||
149133262|NCT02279862|537968201|FG001|Overall Study|Study closed by sponsor|13|||
149133263|NCT02279862|537968200|FG000|Overall Study|Other|1|||
149133264|NCT02279862|537968201|FG001|Overall Study|Other|2|||
149133265|NCT02279862|537968200|FG000|Overall Study|Withdrawal by Subject|1|||
149133266|NCT02279862|537968201|FG001|Overall Study|Withdrawal by Subject|0|||
149133267|NCT03431857|537968202|FG000|Overall Study|Death|6|||
149133268|NCT03431857|537968202|FG000|Overall Study|Lost to Follow-up|41|||
149133269|NCT03431857|537968202|FG000|Overall Study|Adverse Event|6|||
149133270|NCT03431857|537968202|FG000|Overall Study|Withdrawal by Subject|1|||
149133271|NCT01323621|537968203|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
149133272|NCT01323621|537968204|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
149133273|NCT01323621|537968205|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
149133274|NCT01323621|537968203|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
149133275|NCT01323621|537968204|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
149133276|NCT01323621|537968205|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
149133277|NCT01323621|537968203|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
149133278|NCT01323621|537968204|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
149133279|NCT01323621|537968205|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
149133280|NCT01323621|537968203|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
149133281|NCT01323621|537968204|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
149133282|NCT01323621|537968205|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
149133283|NCT01323621|537968203|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
149133284|NCT01323621|537968204|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
149133285|NCT01323621|537968205|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
149133286|NCT01323621|537968203|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
149133287|NCT01323621|537968204|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
148893598|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
148893599|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
148893600|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
148893601|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Disease progression|103|||
148893602|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Disease progression|122|||
148893603|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Other|3|||
148893604|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Other|0|||
148893605|NCT00883779|537088797|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
148893606|NCT00883779|537088798|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
148893607|NCT00883779|537088797|FG000|Off-study Phase|Death|185|||
148893608|NCT00883779|537088798|FG001|Off-study Phase|Death|174|||
148893609|NCT00883779|537088797|FG000|Off-study Phase|Refused treatment|1|||
149133288|NCT01323621|537968205|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
149133289|NCT01323621|537968203|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
148893610|NCT00883779|537088798|FG001|Off-study Phase|Refused treatment|1|||
148893611|NCT00883779|537088797|FG000|Off-study Phase|Failure to return|5|||
148893612|NCT00883779|537088798|FG001|Off-study Phase|Failure to return|6|||
148893613|NCT00883779|537088797|FG000|Off-study Phase|Other|18|||
148893614|NCT00883779|537088798|FG001|Off-study Phase|Other|21|||
148893615|NCT00647296|537088803|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
149133290|NCT01323621|537968204|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
149133291|NCT01323621|537968205|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
149133292|NCT01323621|537968203|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149133293|NCT01323621|537968204|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
149133294|NCT01323621|537968205|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
149133295|NCT01323621|537968203|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
149133296|NCT01323621|537968204|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
149133297|NCT01323621|537968205|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
149133298|NCT01323621|537968203|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149133299|NCT01323621|537968204|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
149133300|NCT01323621|537968205|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149133301|NCT01323621|537968203|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
149133302|NCT01323621|537968204|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
149133303|NCT01323621|537968205|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
149133304|NCT01323621|537968203|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149133305|NCT01323621|537968204|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
149133306|NCT01323621|537968205|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
149133307|NCT00651157|537968206|FG000|Overall Study|Death|1|||
149133308|NCT00651157|537968206|FG000|Overall Study|Protocol Violation|1|||
149133309|NCT01119001|537968208|FG000|Overall Study|Withdrawal by Subject|2|||
149133310|NCT04343248|537968209|FG000|Overall Study|Withdrawal by Subject|5|||
149133311|NCT04343248|537968210|FG001|Overall Study|Withdrawal by Subject|6|||
149133312|NCT04343248|537968209|FG000|Overall Study|Death|1|||
149133313|NCT04343248|537968210|FG001|Overall Study|Death|2|||
149133314|NCT04343248|537968209|FG000|Overall Study|Lost to Follow-up|9|||
149133315|NCT04343248|537968210|FG001|Overall Study|Lost to Follow-up|6|||
149133316|NCT04343248|537968209|FG000|Overall Study|Physician Decision|0|||
149133317|NCT04343248|537968210|FG001|Overall Study|Physician Decision|1|||
149133318|NCT04343248|537968209|FG000|Overall Study|Adverse Event|1|||
149133319|NCT04343248|537968210|FG001|Overall Study|Adverse Event|0|||
149133320|NCT03604523|537968211|FG000|Overall Study|Physician Decision|1|||
149133321|NCT03604523|537968212|FG001|Overall Study|Physician Decision|0|||
149133322|NCT00458341|537968213|FG000|Cycle 1|Adverse Event|1|||
149133323|NCT00458341|537968214|FG001|Cycle 1|Adverse Event|0|||
149133324|NCT05461794|537968215|FG000|Overall Study|Withdrawal by Subject|1|||
149133325|NCT05461794|537968216|FG001|Overall Study|Withdrawal by Subject|1|||
149133326|NCT05461794|537968217|FG002|Overall Study|Withdrawal by Subject|3|||
149133327|NCT05461794|537968215|FG000|Overall Study|Study Terminated By Sponsor|18|||
149133328|NCT05461794|537968216|FG001|Overall Study|Study Terminated By Sponsor|13|||
149133329|NCT05461794|537968217|FG002|Overall Study|Study Terminated By Sponsor|16|||
149133330|NCT05461794|537968215|FG000|Overall Study|Death|20|||
149133331|NCT05461794|537968216|FG001|Overall Study|Death|5|||
149133332|NCT05461794|537968217|FG002|Overall Study|Death|19|||
149133333|NCT02730598|537968224|FG000|Overall Study|Withdrawal by Subject|3|||
149133334|NCT02730598|537968225|FG001|Overall Study|Withdrawal by Subject|3|||
149133335|NCT02730598|537968224|FG000|Overall Study|Protocol Violation|0|||
149133336|NCT02730598|537968225|FG001|Overall Study|Protocol Violation|1|||
149133337|NCT02730598|537968224|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
149133338|NCT02730598|537968225|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
149133339|NCT00810394|537968226|FG000|Overall Study|Withdrawal by Subject|3|||
149133340|NCT00467285|537968227|FG000|Overall Study|Lost to Follow-up|4|||
149133341|NCT00467285|537968228|FG001|Overall Study|Lost to Follow-up|4|||
149133342|NCT03891524|537968229|FG000|Overall Study|Death|0|||
149133343|NCT03891524|537968230|FG001|Overall Study|Death|0|||
149133344|NCT03891524|537968231|FG002|Overall Study|Death|0|||
149133345|NCT03891524|537968232|FG003|Overall Study|Death|0|||
149133346|NCT03891524|537968233|FG004|Overall Study|Death|0|||
149133347|NCT03891524|537968234|FG005|Overall Study|Death|0|||
149133348|NCT03891524|537968235|FG006|Overall Study|Death|0|||
149133349|NCT03891524|537968236|FG007|Overall Study|Death|1|||
149133350|NCT03891524|537968229|FG000|Overall Study|Withdrawal by Subject|0|||
149133351|NCT03891524|537968230|FG001|Overall Study|Withdrawal by Subject|1|||
149133352|NCT03891524|537968231|FG002|Overall Study|Withdrawal by Subject|2|||
149133353|NCT03891524|537968232|FG003|Overall Study|Withdrawal by Subject|1|||
149133354|NCT03891524|537968233|FG004|Overall Study|Withdrawal by Subject|2|||
149133355|NCT03891524|537968234|FG005|Overall Study|Withdrawal by Subject|2|||
149133356|NCT03891524|537968235|FG006|Overall Study|Withdrawal by Subject|2|||
149133357|NCT03891524|537968236|FG007|Overall Study|Withdrawal by Subject|1|||
149133358|NCT01696942|537968237|FG000|Overall Study|Withdrawal by Subject|1|||
149133359|NCT01696942|537968238|FG001|Overall Study|Withdrawal by Subject|0|||
149133360|NCT01696942|537968237|FG000|Overall Study|Protocol Violation|1|||
149133361|NCT01696942|537968238|FG001|Overall Study|Protocol Violation|2|||
149133362|NCT01696942|537968237|FG000|Overall Study|screen failure|0|||
149133363|NCT01696942|537968238|FG001|Overall Study|screen failure|1|||
149133364|NCT04484831|537968239|FG000|Overall Study|Withdrawal by Subject|1|||
149133365|NCT04484831|537968240|FG001|Overall Study|Withdrawal by Subject|0|||
149133366|NCT01598311|537968242|FG000|Overall Study|Physician Decision|4|||
149133367|NCT01598311|537968243|FG001|Overall Study|Physician Decision|5|||
149133368|NCT01598311|537968242|FG000|Overall Study|Adverse Event|9|||
149133369|NCT01598311|537968243|FG001|Overall Study|Adverse Event|13|||
149133370|NCT01598311|537968242|FG000|Overall Study|Lost to Follow-up|7|||
149133371|NCT01598311|537968243|FG001|Overall Study|Lost to Follow-up|12|||
149133372|NCT01598311|537968242|FG000|Overall Study|Withdrawal by Subject|9|||
149133373|NCT01598311|537968243|FG001|Overall Study|Withdrawal by Subject|13|||
149133374|NCT01598311|537968242|FG000|Overall Study|No reason provided.|0|||
149133375|NCT01598311|537968243|FG001|Overall Study|No reason provided.|5|||
149133376|NCT01598311|537968242|FG000|Overall Study|Randomized but never treated|8|||
149133377|NCT01598311|537968243|FG001|Overall Study|Randomized but never treated|5|||
149133378|NCT01598311|537968242|FG000|Overall Study|Treated but no confirmed CDAD|9|||
149133379|NCT01598311|537968243|FG001|Overall Study|Treated but no confirmed CDAD|8|||
149133380|NCT01598311|537968242|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
149133381|NCT01598311|537968243|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
149133382|NCT00658684|537968244|FG000|Overall Study|Adverse Event|10|||
149133383|NCT00658684|537968245|FG001|Overall Study|Adverse Event|8|||
149133384|NCT00658684|537968246|FG002|Overall Study|Adverse Event|2|||
149133385|NCT00658684|537968247|FG003|Overall Study|Adverse Event|0|||
149133386|NCT00658684|537968244|FG000|Overall Study|Withdrawal by Subject|6|||
149133387|NCT00658684|537968245|FG001|Overall Study|Withdrawal by Subject|4|||
149133388|NCT00658684|537968246|FG002|Overall Study|Withdrawal by Subject|1|||
149133389|NCT00658684|537968247|FG003|Overall Study|Withdrawal by Subject|1|||
149133390|NCT00658684|537968244|FG000|Overall Study|Lack of Efficacy|1|||
149133391|NCT00658684|537968245|FG001|Overall Study|Lack of Efficacy|1|||
149133392|NCT00658684|537968246|FG002|Overall Study|Lack of Efficacy|0|||
149133393|NCT00658684|537968247|FG003|Overall Study|Lack of Efficacy|0|||
149133394|NCT00658684|537968244|FG000|Overall Study|Protocol Violation|1|||
149133395|NCT00658684|537968245|FG001|Overall Study|Protocol Violation|1|||
149133396|NCT00658684|537968246|FG002|Overall Study|Protocol Violation|0|||
149133397|NCT00658684|537968247|FG003|Overall Study|Protocol Violation|0|||
149133398|NCT00658684|537968244|FG000|Overall Study|Pregnancy|1|||
149133399|NCT00658684|537968245|FG001|Overall Study|Pregnancy|1|||
149133400|NCT00658684|537968246|FG002|Overall Study|Pregnancy|0|||
149133401|NCT00658684|537968247|FG003|Overall Study|Pregnancy|0|||
149133402|NCT00688103|537968248|FG000|Overall Study|Adverse Event|4|||
149133403|NCT00688103|537968249|FG001|Overall Study|Adverse Event|1|||
149133404|NCT00688103|537968248|FG000|Overall Study|Lack of Efficacy|11|||
149133405|NCT00688103|537968249|FG001|Overall Study|Lack of Efficacy|1|||
149133406|NCT00688103|537968248|FG000|Overall Study|Withdrawal by Subject|4|||
149133407|NCT00688103|537968249|FG001|Overall Study|Withdrawal by Subject|2|||
149133408|NCT00688103|537968248|FG000|Overall Study|complex reasons|11|||
149133409|NCT00688103|537968249|FG001|Overall Study|complex reasons|9|||
149133410|NCT03144804|537968251|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
149133411|NCT03078907|537969209|FG000|Overall Study|Adverse Event|2|||
149133412|NCT03078907|537969210|FG001|Overall Study|Adverse Event|0|||
149133413|NCT03078907|537969209|FG000|Overall Study|Other|1|||
149133414|NCT03078907|537969210|FG001|Overall Study|Other|0|||
149133415|NCT03078907|537969209|FG000|Overall Study|Protocol Violation|0|||
149133416|NCT03078907|537969210|FG001|Overall Study|Protocol Violation|1|||
149133417|NCT01955122|537969211|FG000|Overall Study|Physician Decision|5|||
149133418|NCT01955122|537969212|FG001|Overall Study|Physician Decision|5|||
149133419|NCT01672788|537969213|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
149133420|NCT01672788|537969214|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
149133421|NCT01672788|537969215|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
149133422|NCT01672788|537969216|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
149133423|NCT03329196|537969219|FG000|Overall Study|Adverse Event|10|||
149133424|NCT03329196|537969220|FG001|Overall Study|Adverse Event|5|||
149133425|NCT03329196|537969219|FG000|Overall Study|Physician Decision|2|||
149133426|NCT03329196|537969220|FG001|Overall Study|Physician Decision|2|||
149133427|NCT03329196|537969219|FG000|Overall Study|Withdrawal by Subject|11|||
149133428|NCT03329196|537969220|FG001|Overall Study|Withdrawal by Subject|3|||
149133429|NCT03329196|537969219|FG000|Overall Study|Hepatic function abnormalities|0|||
149133430|NCT03329196|537969220|FG001|Overall Study|Hepatic function abnormalities|1|||
149133431|NCT03329196|537969219|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
149133432|NCT03329196|537969220|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
149133433|NCT03329196|537969219|FG000|Overall Study|Difficult to control Hb|2|||
149133434|NCT03329196|537969220|FG001|Overall Study|Difficult to control Hb|3|||
149133435|NCT03329196|537969219|FG000|Overall Study|Dialysis or renal transplant|13|||
149133436|NCT03329196|537969220|FG001|Overall Study|Dialysis or renal transplant|15|||
149133437|NCT01128361|537969221|FG000|Overall Study|Lost to Follow-up|0|||
149133438|NCT01128361|537969222|FG001|Overall Study|Lost to Follow-up|1|||
149133439|NCT01128361|537969221|FG000|Overall Study|Withdrawal by Subject|5|||
149133440|NCT01128361|537969222|FG001|Overall Study|Withdrawal by Subject|2|||
149133441|NCT00985166|537969223|FG000|Overall Study|Lost to Follow-up|3|||
149133442|NCT00985166|537969224|FG001|Overall Study|Lost to Follow-up|2|||
149133443|NCT00985166|537969225|FG002|Overall Study|Lost to Follow-up|2|||
149133444|NCT00985166|537969223|FG000|Overall Study|Withdrawal by Subject|3|||
149133445|NCT00985166|537969224|FG001|Overall Study|Withdrawal by Subject|2|||
149133446|NCT00985166|537969225|FG002|Overall Study|Withdrawal by Subject|0|||
149133447|NCT00985166|537969223|FG000|Overall Study|Test not done|2|||
149133448|NCT00985166|537969224|FG001|Overall Study|Test not done|0|||
149133449|NCT00985166|537969225|FG002|Overall Study|Test not done|4|||
149133450|NCT00985166|537969223|FG000|Overall Study|Other|1|||
149133451|NCT00985166|537969224|FG001|Overall Study|Other|0|||
149133452|NCT00985166|537969225|FG002|Overall Study|Other|1|||
149133453|NCT02464228|537969226|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
149133454|NCT02464228|537969227|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
149133455|NCT02464228|537969228|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
149133456|NCT02464228|537969229|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
149133457|NCT02464228|537969226|FG000|Overall Study|Physician Decision|2|||
149133458|NCT02464228|537969227|FG001|Overall Study|Physician Decision|0|||
149133459|NCT02464228|537969228|FG002|Overall Study|Physician Decision|1|||
149133460|NCT02464228|537969229|FG003|Overall Study|Physician Decision|0|||
149133461|NCT02464228|537969226|FG000|Overall Study|Miscellaneous|1|||
149133462|NCT02464228|537969227|FG001|Overall Study|Miscellaneous|0|||
149133463|NCT02464228|537969228|FG002|Overall Study|Miscellaneous|1|||
149133464|NCT02464228|537969229|FG003|Overall Study|Miscellaneous|0|||
149133465|NCT02464228|537969226|FG000|Overall Study|Adverse Event|9|||
149133466|NCT02464228|537969227|FG001|Overall Study|Adverse Event|0|||
149133467|NCT02464228|537969228|FG002|Overall Study|Adverse Event|3|||
149133468|NCT02464228|537969229|FG003|Overall Study|Adverse Event|0|||
149133469|NCT02464228|537969226|FG000|Overall Study|Withdrawal by Subject|1|||
149133470|NCT02464228|537969227|FG001|Overall Study|Withdrawal by Subject|1|||
149133471|NCT02464228|537969228|FG002|Overall Study|Withdrawal by Subject|1|||
149133472|NCT02464228|537969229|FG003|Overall Study|Withdrawal by Subject|0|||
149133473|NCT02464228|537969226|FG000|Overall Study|Disease Progression|22|||
149133474|NCT02464228|537969227|FG001|Overall Study|Disease Progression|12|||
149133475|NCT02464228|537969228|FG002|Overall Study|Disease Progression|5|||
149133476|NCT02464228|537969229|FG003|Overall Study|Disease Progression|2|||
149133477|NCT01681628|537969234|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
149133478|NCT01681628|537969235|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
149133479|NCT01681628|537969234|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
149133480|NCT01681628|537969235|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
149133481|NCT01681628|537969234|FG000|19 Months Follow-up|Death|1|||
149133482|NCT01681628|537969235|FG001|19 Months Follow-up|Death|0|||
149133483|NCT01681628|537969234|FG000|19 Months Follow-up|Lost to Follow-up|61|||
149133484|NCT01681628|537969235|FG001|19 Months Follow-up|Lost to Follow-up|43|||
149133485|NCT05736211|537969249|FG000|Overall Study|Lost to Follow-up|6|||
149133486|NCT05736211|537969250|FG001|Overall Study|Lost to Follow-up|0|||
149133487|NCT02634346|537969251|FG000|Overall Study|Withdrawal by Subject|8|||
149133488|NCT02634346|537969252|FG001|Overall Study|Withdrawal by Subject|9|||
149133489|NCT02634346|537969253|FG002|Overall Study|Withdrawal by Subject|8|||
149133490|NCT02634346|537969251|FG000|Overall Study|Adverse Event|2|||
149133491|NCT02634346|537969252|FG001|Overall Study|Adverse Event|2|||
149133492|NCT02634346|537969253|FG002|Overall Study|Adverse Event|7|||
149133493|NCT02634346|537969251|FG000|Overall Study|Lack of Efficacy|1|||
149133494|NCT02634346|537969252|FG001|Overall Study|Lack of Efficacy|2|||
149133495|NCT02634346|537969253|FG002|Overall Study|Lack of Efficacy|8|||
149133496|NCT02634346|537969251|FG000|Overall Study|Lost to Follow-up|1|||
149133497|NCT02634346|537969252|FG001|Overall Study|Lost to Follow-up|0|||
149133498|NCT02634346|537969253|FG002|Overall Study|Lost to Follow-up|0|||
149133499|NCT02634346|537969251|FG000|Overall Study|Protocol Violation|0|||
149133500|NCT02634346|537969252|FG001|Overall Study|Protocol Violation|1|||
149133501|NCT02634346|537969253|FG002|Overall Study|Protocol Violation|0|||
149133502|NCT00908232|537969254|FG000|Cycle 1 to 4|Death|5|||
149133503|NCT00908232|537969255|FG001|Cycle 1 to 4|Death|0|||
149133504|NCT00908232|537969256|FG002|Cycle 1 to 4|Death|0|||
149133505|NCT00908232|537969257|FG003|Cycle 1 to 4|Death|0|||
149133506|NCT00908232|537969254|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
149133507|NCT00908232|537969255|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
149133508|NCT00908232|537969256|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
149133509|NCT00908232|537969257|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
149133510|NCT00908232|537969254|FG000|Cycle 1 to 4|Progressive Disease|6|||
149133511|NCT00908232|537969255|FG001|Cycle 1 to 4|Progressive Disease|0|||
149133512|NCT00908232|537969256|FG002|Cycle 1 to 4|Progressive Disease|0|||
149133513|NCT00908232|537969257|FG003|Cycle 1 to 4|Progressive Disease|0|||
149133514|NCT00908232|537969254|FG000|Cycle 1 to 4|Adverse Event|12|||
149133515|NCT00908232|537969255|FG001|Cycle 1 to 4|Adverse Event|0|||
149133516|NCT00908232|537969256|FG002|Cycle 1 to 4|Adverse Event|0|||
149133517|NCT00908232|537969257|FG003|Cycle 1 to 4|Adverse Event|0|||
149133518|NCT00908232|537969254|FG000|Cycle 1 to 4|Other|1|||
149133519|NCT00908232|537969255|FG001|Cycle 1 to 4|Other|0|||
149133520|NCT00908232|537969256|FG002|Cycle 1 to 4|Other|0|||
149133521|NCT00908232|537969257|FG003|Cycle 1 to 4|Other|0|||
149133522|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
149133523|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
149133524|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
149133525|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
149133526|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
149133527|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
149133528|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
149133529|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
149133530|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
149133531|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
149133532|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
149133533|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
149133534|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
149133535|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
149133536|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
149133537|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
149133538|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
149133539|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
148893616|NCT00647296|537088804|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
149133540|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
149133541|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
149133542|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
149133543|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
149133544|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
149133545|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
149133546|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
149133547|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
149133548|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
149133549|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
149133550|NCT00908232|537969254|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
149133551|NCT00908232|537969255|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
149133552|NCT00908232|537969256|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
149133553|NCT00908232|537969257|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
149133554|NCT00132496|537969258|FG000|Overall Study|Withdrawal by Subject|1|||
149133555|NCT00132496|537969259|FG001|Overall Study|Withdrawal by Subject|2|||
149133556|NCT00132496|537969258|FG000|Overall Study|Physician Decision|1|||
149133557|NCT00132496|537969259|FG001|Overall Study|Physician Decision|0|||
149133558|NCT03170154|537969262|FG000|Overall Study|Lost to Follow-up|4|||
149133559|NCT03170154|537969262|FG000|Overall Study|Death|2|||
149133560|NCT03170154|537969262|FG000|Overall Study|Withdrawal by Subject|2|||
149133561|NCT01163721|537969264|FG000|Overall Study|Adverse Event|5|||
149133562|NCT01163721|537969265|FG001|Overall Study|Adverse Event|6|||
149133563|NCT01163721|537969264|FG000|Overall Study|Withdrawal by Subject|3|||
149133564|NCT01163721|537969265|FG001|Overall Study|Withdrawal by Subject|4|||
149133565|NCT01163721|537969264|FG000|Overall Study|Lost to Follow-up|0|||
149133566|NCT01163721|537969265|FG001|Overall Study|Lost to Follow-up|1|||
149133567|NCT01163721|537969264|FG000|Overall Study|Physician Decision|0|||
149133568|NCT01163721|537969265|FG001|Overall Study|Physician Decision|1|||
149133569|NCT01295281|537969268|FG000|First Intervention (7 Days)|Death|0|||
149133570|NCT01295281|537969269|FG001|First Intervention (7 Days)|Death|1|||
149133571|NCT00292461|537969270|FG000|Overall Study|Adverse Event|4|||
149133572|NCT00292461|537969271|FG001|Overall Study|Adverse Event|2|||
149133573|NCT00292461|537969270|FG000|Overall Study|Lack of Efficacy|1|||
149133574|NCT00292461|537969271|FG001|Overall Study|Lack of Efficacy|0|||
149133575|NCT00292461|537969270|FG000|Overall Study|Withdrawal by Subject|0|||
149133576|NCT00292461|537969271|FG001|Overall Study|Withdrawal by Subject|1|||
149133577|NCT00292461|537969270|FG000|Overall Study|Protocol Violation|4|||
149133578|NCT00292461|537969271|FG001|Overall Study|Protocol Violation|3|||
149133579|NCT00292461|537969270|FG000|Overall Study|Lost to Follow-up|1|||
149133580|NCT00292461|537969271|FG001|Overall Study|Lost to Follow-up|0|||
149133581|NCT00954421|537969275|FG000|Screening|screen failures|3|||
149133582|NCT00954421|537969275|FG000|6 Months of DBS|Withdrawal by Subject|1|||
149133583|NCT00954421|537969275|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
149133584|NCT01891721|537969276|FG000|Overall Study|Lost to Follow-up|10|||
149133585|NCT01891721|537969277|FG001|Overall Study|Lost to Follow-up|5|||
149133586|NCT01891721|537969278|FG002|Overall Study|Lost to Follow-up|1|||
149133587|NCT02958267|537969302|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
149133588|NCT02958267|537969303|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
149133589|NCT02958267|537969302|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
149133590|NCT02958267|537969303|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
149133591|NCT02958267|537969302|FG000|Follow-up Visits|Additional treatment pursued|2|||
149133592|NCT02958267|537969303|FG001|Follow-up Visits|Additional treatment pursued|1|||
149133593|NCT00777946|537969304|FG000|Overall Study|Adverse Event|11|||
149133594|NCT00777946|537969305|FG001|Overall Study|Adverse Event|1|||
149133595|NCT00777946|537969306|FG002|Overall Study|Adverse Event|3|||
149133596|NCT00777946|537969304|FG000|Overall Study|Lack of Efficacy|0|||
149133597|NCT00777946|537969305|FG001|Overall Study|Lack of Efficacy|0|||
149133598|NCT00777946|537969306|FG002|Overall Study|Lack of Efficacy|9|||
149133599|NCT00777946|537969304|FG000|Overall Study|Condition no longer required study drug|1|||
149133600|NCT00777946|537969305|FG001|Overall Study|Condition no longer required study drug|0|||
149133601|NCT00777946|537969306|FG002|Overall Study|Condition no longer required study drug|0|||
149133602|NCT00777946|537969304|FG000|Overall Study|Patient withdrew consent|3|||
149133603|NCT00777946|537969305|FG001|Overall Study|Patient withdrew consent|2|||
149133604|NCT00777946|537969306|FG002|Overall Study|Patient withdrew consent|3|||
149133605|NCT00777946|537969304|FG000|Overall Study|Lost to Follow-up|3|||
149133606|NCT00777946|537969305|FG001|Overall Study|Lost to Follow-up|1|||
149133607|NCT00777946|537969306|FG002|Overall Study|Lost to Follow-up|0|||
149133608|NCT00777946|537969304|FG000|Overall Study|Protocol deviation|2|||
149133609|NCT00777946|537969305|FG001|Overall Study|Protocol deviation|1|||
149133610|NCT00777946|537969306|FG002|Overall Study|Protocol deviation|1|||
149133611|NCT00777946|537969304|FG000|Overall Study|Randomized in error|1|||
149133612|NCT00777946|537969305|FG001|Overall Study|Randomized in error|1|||
149133613|NCT00777946|537969306|FG002|Overall Study|Randomized in error|0|||
149133614|NCT01422850|537969312|FG000|Overall Study|Physician Decision|3|||
149133615|NCT02244996|537969314|FG000|Overall Study|Lack of Efficacy|2|||
149133616|NCT02244996|537969315|FG001|Overall Study|Lack of Efficacy|6|||
149133617|NCT00174265|537969317|FG000|Overall Study|Adverse Event|7|||
149133618|NCT00174265|537969318|FG001|Overall Study|Adverse Event|4|||
149133619|NCT00174265|537969317|FG000|Overall Study|Lack of Efficacy|2|||
149133620|NCT00174265|537969318|FG001|Overall Study|Lack of Efficacy|2|||
149133621|NCT00174265|537969317|FG000|Overall Study|Withdrawal by Subject|3|||
149133622|NCT00174265|537969318|FG001|Overall Study|Withdrawal by Subject|5|||
149133623|NCT00174265|537969317|FG000|Overall Study|Lost to Follow-up|1|||
149133624|NCT00174265|537969318|FG001|Overall Study|Lost to Follow-up|0|||
149133625|NCT00174265|537969317|FG000|Overall Study|Other (Not specified)|16|||
149133626|NCT00174265|537969318|FG001|Overall Study|Other (Not specified)|10|||
149133627|NCT00047320|537969319|FG000|Overall Study|Lack of Efficacy|8|||
149133628|NCT00047320|537969319|FG000|Overall Study|Lost to Follow-up|1|||
149133629|NCT00047320|537969319|FG000|Overall Study|Physician Decision|8|||
149133630|NCT00047320|537969319|FG000|Overall Study|Withdrawal by Subject|9|||
149133631|NCT00047320|537969319|FG000|Overall Study|Ineligible|2|||
149133632|NCT03471871|537969320|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
149133633|NCT03471871|537969321|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
149133634|NCT03471871|537969322|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
149133635|NCT03471871|537969323|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
149133636|NCT03471871|537969324|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
149133637|NCT03471871|537969320|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
149133638|NCT03471871|537969321|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
149133639|NCT03471871|537969322|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
149133640|NCT03471871|537969323|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
149133641|NCT03471871|537969324|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
149133642|NCT03471871|537969320|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
149133643|NCT03471871|537969321|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
149133644|NCT03471871|537969322|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
149133645|NCT03471871|537969323|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
149133646|NCT03471871|537969324|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
149133647|NCT03471871|537969320|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
149133648|NCT03471871|537969321|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
149133649|NCT03471871|537969322|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
148790854|NCT05415462|536712708|FG000|Overall Study|Withdrawal by Subject|129|||
148790855|NCT05415462|536712709|FG001|Overall Study|Withdrawal by Subject|101|||
148790856|NCT05415462|536712708|FG000|Overall Study|Other Than Specified|8|||
148790857|NCT05415462|536712709|FG001|Overall Study|Other Than Specified|8|||
148790858|NCT00972283|536712735|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
148790859|NCT00972283|536712736|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
148790860|NCT00972283|536712735|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
148790861|NCT00972283|536712736|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
148790862|NCT00972283|536712735|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
149133650|NCT03471871|537969323|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
149133651|NCT03471871|537969324|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
149133652|NCT03471871|537969320|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
148790863|NCT00972283|536712736|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
148790864|NCT00972283|536712735|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
148790865|NCT00972283|536712736|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
148790866|NCT00972283|536712735|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
148790867|NCT00972283|536712736|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
148790868|NCT00972283|536712735|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
148790869|NCT00972283|536712736|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
148790870|NCT00972283|536712735|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
148790871|NCT00972283|536712736|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
148790872|NCT00972283|536712735|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
148790873|NCT00972283|536712736|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
148790874|NCT00972283|536712735|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
148790875|NCT00972283|536712736|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
148790876|NCT00972283|536712735|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
148790877|NCT00972283|536712736|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
148790878|NCT00282152|536712737|FG000|Overall Study|Withdrawal by Subject|1|||
148790879|NCT00282152|536712738|FG001|Overall Study|Withdrawal by Subject|0|||
148790880|NCT00585325|536712739|FG000|Overall Study|Withdrawal by Subject|1|||
148790881|NCT00585325|536712740|FG001|Overall Study|Withdrawal by Subject|1|||
148790882|NCT03092791|536712741|FG000|Overall Study|Lost to Follow-up|0|||
148790883|NCT03092791|536712742|FG001|Overall Study|Lost to Follow-up|0|||
148790884|NCT03092791|536712743|FG002|Overall Study|Lost to Follow-up|0|||
148790885|NCT03092791|536712744|FG003|Overall Study|Lost to Follow-up|0|||
148790886|NCT03092791|536712745|FG004|Overall Study|Lost to Follow-up|0|||
148790887|NCT03092791|536712746|FG005|Overall Study|Lost to Follow-up|0|||
148790888|NCT03092791|536712747|FG006|Overall Study|Lost to Follow-up|1|||
148790889|NCT03092791|536712748|FG007|Overall Study|Lost to Follow-up|0|||
148790890|NCT03092791|536712741|FG000|Overall Study|Withdrawal of Consent|0|||
148790891|NCT03092791|536712742|FG001|Overall Study|Withdrawal of Consent|0|||
148790892|NCT03092791|536712743|FG002|Overall Study|Withdrawal of Consent|0|||
148790893|NCT03092791|536712744|FG003|Overall Study|Withdrawal of Consent|0|||
148790894|NCT03092791|536712745|FG004|Overall Study|Withdrawal of Consent|4|||
148790895|NCT03092791|536712746|FG005|Overall Study|Withdrawal of Consent|12|||
148790896|NCT03092791|536712747|FG006|Overall Study|Withdrawal of Consent|6|||
148790897|NCT03092791|536712748|FG007|Overall Study|Withdrawal of Consent|4|||
148790898|NCT03092791|536712741|FG000|Overall Study|Study Termination|0|||
148790899|NCT03092791|536712742|FG001|Overall Study|Study Termination|0|||
149133653|NCT03471871|537969321|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
149133654|NCT03471871|537969322|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
149133655|NCT03471871|537969323|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
149133656|NCT03471871|537969324|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
149133657|NCT03040622|537969325|FG000|Overall Study|unable to implant device|3|||
149133658|NCT03434353|537970840|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
148790900|NCT03092791|536712743|FG002|Overall Study|Study Termination|0|||
148790901|NCT03092791|536712744|FG003|Overall Study|Study Termination|0|||
148790902|NCT03092791|536712745|FG004|Overall Study|Study Termination|55|||
148790903|NCT03092791|536712746|FG005|Overall Study|Study Termination|46|||
148790904|NCT03092791|536712747|FG006|Overall Study|Study Termination|53|||
148790905|NCT03092791|536712748|FG007|Overall Study|Study Termination|55|||
148790906|NCT03092791|536712741|FG000|Overall Study|Death|0|||
148790907|NCT03092791|536712742|FG001|Overall Study|Death|0|||
148790908|NCT03092791|536712743|FG002|Overall Study|Death|0|||
148790909|NCT03092791|536712744|FG003|Overall Study|Death|0|||
148790910|NCT03092791|536712745|FG004|Overall Study|Death|0|||
148790911|NCT03092791|536712746|FG005|Overall Study|Death|1|||
148790912|NCT03092791|536712747|FG006|Overall Study|Death|0|||
148790913|NCT03092791|536712748|FG007|Overall Study|Death|1|||
148790914|NCT03092791|536712741|FG000|Overall Study|Reason Not Specified|0|||
148790915|NCT03092791|536712742|FG001|Overall Study|Reason Not Specified|0|||
148790916|NCT03092791|536712743|FG002|Overall Study|Reason Not Specified|0|||
148790917|NCT03092791|536712744|FG003|Overall Study|Reason Not Specified|0|||
148790918|NCT03092791|536712745|FG004|Overall Study|Reason Not Specified|1|||
148790919|NCT03092791|536712746|FG005|Overall Study|Reason Not Specified|1|||
148790920|NCT03092791|536712747|FG006|Overall Study|Reason Not Specified|0|||
148790921|NCT03092791|536712748|FG007|Overall Study|Reason Not Specified|0|||
148790922|NCT02182830|536712749|FG000|Overall Study|Not Treated|1|||
148790923|NCT02182830|536712750|FG001|Overall Study|Not Treated|1|||
148790924|NCT02182830|536712749|FG000|Overall Study|Trial stopped, reason missing|3|||
148790925|NCT02182830|536712750|FG001|Overall Study|Trial stopped, reason missing|3|||
148790926|NCT02182830|536712749|FG000|Overall Study|Consent withdrawn|8|||
148790927|NCT02182830|536712750|FG001|Overall Study|Consent withdrawn|8|||
148790928|NCT02182830|536712749|FG000|Overall Study|Lost to Follow-up|3|||
148790929|NCT02182830|536712750|FG001|Overall Study|Lost to Follow-up|3|||
148790930|NCT01990768|536712751|FG000|Intervention Started|Found to be ineligible|14|||
148790931|NCT01990768|536712752|FG001|Intervention Started|Found to be ineligible|13|||
148790932|NCT01990768|536712753|FG002|Intervention Started|Found to be ineligible|11|||
148790933|NCT01990768|536712751|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
148790934|NCT01990768|536712752|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
148790935|NCT01990768|536712753|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
148790936|NCT01990768|536712751|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
148790937|NCT01990768|536712752|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
148790938|NCT01990768|536712753|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
149133659|NCT03434353|537970841|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
149133660|NCT03434353|537970842|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
149133661|NCT03434353|537970843|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
149133662|NCT03434353|537970844|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
149133663|NCT03434353|537970840|FG000|Overall Study|Withdrew consent|1|||
149133664|NCT03434353|537970841|FG001|Overall Study|Withdrew consent|0|||
149133665|NCT03434353|537970842|FG002|Overall Study|Withdrew consent|3|||
149133666|NCT03434353|537970843|FG003|Overall Study|Withdrew consent|0|||
149133667|NCT03434353|537970844|FG004|Overall Study|Withdrew consent|0|||
149133668|NCT03434353|537970840|FG000|Overall Study|Adverse Event|1|||
149133669|NCT03434353|537970841|FG001|Overall Study|Adverse Event|0|||
149133670|NCT03434353|537970842|FG002|Overall Study|Adverse Event|0|||
149133671|NCT03434353|537970843|FG003|Overall Study|Adverse Event|0|||
149133672|NCT03434353|537970844|FG004|Overall Study|Adverse Event|1|||
149133673|NCT03434353|537970840|FG000|Overall Study|Lost to Follow-up|2|||
149133674|NCT03434353|537970841|FG001|Overall Study|Lost to Follow-up|0|||
149133675|NCT03434353|537970842|FG002|Overall Study|Lost to Follow-up|0|||
149133676|NCT03434353|537970843|FG003|Overall Study|Lost to Follow-up|0|||
149133677|NCT03434353|537970844|FG004|Overall Study|Lost to Follow-up|0|||
149133678|NCT01990534|537970845|FG000|Overall Study|Death|22|||
149133679|NCT01990534|537970845|FG000|Overall Study|Progressive disease|3|||
149133680|NCT01990534|537970845|FG000|Overall Study|Protocol Violation|1|||
149133681|NCT01990534|537970845|FG000|Overall Study|Withdrawal of Informed Consent|2|||
149133682|NCT01990534|537970845|FG000|Overall Study|Symptomatic Deterioration|1|||
149133683|NCT01990534|537970845|FG000|Overall Study|Withdrawal by Subject|3|||
149133684|NCT01990534|537970845|FG000|Overall Study|Reason not Specified|2|||
149133685|NCT01990534|537970845|FG000|Overall Study|Lost to Follow-up|1|||
149133686|NCT00234494|537970846|FG000|Overall Study|Protocol Violation|2|||
149133687|NCT01831544|537970847|FG000|Overall Study|Death|1|||
149133688|NCT01831544|537970847|FG000|Overall Study|Still on original MVAD device|2|||
148790939|NCT01990768|536712751|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
148790940|NCT01990768|536712752|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
149133689|NCT01521897|537970848|FG000|Overall Study|Protocol Violation|18|||
149133690|NCT01521897|537970848|FG000|Overall Study|Lost to Follow-up|5|||
149133691|NCT02194062|537970849|FG000|Overall Study|Lost to Follow-up|2|||
149133692|NCT02194062|537970850|FG001|Overall Study|Lost to Follow-up|2|||
149133693|NCT02194062|537970851|FG002|Overall Study|Lost to Follow-up|5|||
149133694|NCT03422172|537970852|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
149133695|NCT03422172|537970852|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
149133696|NCT03422172|537970852|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
149133697|NCT00293722|537970855|FG000|Overall Study|Other|427|||
149133698|NCT04658186|537970858|FG000|Overall Study|Adverse Event|4|||
149133699|NCT04658186|537970859|FG001|Overall Study|Adverse Event|18|||
149133700|NCT04658186|537970860|FG002|Overall Study|Adverse Event|15|||
149133701|NCT04658186|537970858|FG000|Overall Study|Lack of Efficacy|1|||
149133702|NCT04658186|537970859|FG001|Overall Study|Lack of Efficacy|1|||
149133703|NCT04658186|537970860|FG002|Overall Study|Lack of Efficacy|0|||
149133704|NCT04658186|537970858|FG000|Overall Study|Protocol Violation|0|||
149133705|NCT04658186|537970859|FG001|Overall Study|Protocol Violation|0|||
148790941|NCT01990768|536712753|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
148790942|NCT01990768|536712751|FG000|Intervention Started|Patient care priority|1|||
148790943|NCT01990768|536712752|FG001|Intervention Started|Patient care priority|2|||
148790944|NCT01990768|536712753|FG002|Intervention Started|Patient care priority|3|||
148790945|NCT01990768|536712751|FG000|Intervention Started|IV lost|2|||
149133706|NCT04658186|537970860|FG002|Overall Study|Protocol Violation|1|||
149133707|NCT04658186|537970858|FG000|Overall Study|Lost to Follow-up|0|||
149133708|NCT04658186|537970859|FG001|Overall Study|Lost to Follow-up|0|||
149133709|NCT04658186|537970860|FG002|Overall Study|Lost to Follow-up|2|||
149133710|NCT04658186|537970858|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
148790946|NCT01990768|536712752|FG001|Intervention Started|IV lost|2|||
149133711|NCT04658186|537970859|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
149133712|NCT04658186|537970860|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
149133713|NCT04658186|537970858|FG000|Overall Study|Participant is Moving in Another Province|0|||
149133714|NCT04658186|537970859|FG001|Overall Study|Participant is Moving in Another Province|1|||
149133715|NCT04658186|537970860|FG002|Overall Study|Participant is Moving in Another Province|0|||
149133716|NCT04658186|537970858|FG000|Overall Study|Non-Compliance|0|||
149133717|NCT04658186|537970859|FG001|Overall Study|Non-Compliance|1|||
149133718|NCT04658186|537970860|FG002|Overall Study|Non-Compliance|1|||
148790947|NCT01990768|536712753|FG002|Intervention Started|IV lost|2|||
148790948|NCT01990768|536712751|FG000|Intervention Started|Required CPR|1|||
148790949|NCT01990768|536712752|FG001|Intervention Started|Required CPR|1|||
148790950|NCT01990768|536712753|FG002|Intervention Started|Required CPR|0|||
148790951|NCT01990768|536712751|FG000|Intervention Started|Seizure or hx of seizure|0|||
148790952|NCT01990768|536712752|FG001|Intervention Started|Seizure or hx of seizure|0|||
148790953|NCT01990768|536712753|FG002|Intervention Started|Seizure or hx of seizure|2|||
148790954|NCT01990768|536712751|FG000|Intervention Started|Discovered to be pregnant|0|||
148790955|NCT01990768|536712752|FG001|Intervention Started|Discovered to be pregnant|1|||
148790956|NCT01990768|536712753|FG002|Intervention Started|Discovered to be pregnant|0|||
148790957|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
148790958|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
148790959|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
148790960|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
148790961|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
148790962|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
148790963|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
148790964|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
148790965|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
148790966|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
148790967|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
148790968|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
148790969|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Death|3|||
148790970|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Death|1|||
148790971|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Death|1|||
148790972|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Discharged|2|||
148790973|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Discharged|1|||
148790974|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Discharged|0|||
148790975|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
148790976|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
148790977|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
149133719|NCT04658186|537970858|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
149133720|NCT04658186|537970859|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
149133721|NCT04658186|537970860|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
149133722|NCT04658186|537970858|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
149133723|NCT04658186|537970859|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
149133724|NCT04658186|537970860|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
149133725|NCT04658186|537970858|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
149133726|NCT04658186|537970859|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
149133727|NCT04658186|537970860|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
149133728|NCT04658186|537970858|FG000|Overall Study|PI Decision due to Participant Safety|0|||
149133729|NCT04658186|537970859|FG001|Overall Study|PI Decision due to Participant Safety|0|||
149133730|NCT04658186|537970860|FG002|Overall Study|PI Decision due to Participant Safety|1|||
149133731|NCT04658186|537970858|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
149133732|NCT04658186|537970859|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
149133733|NCT04658186|537970860|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
149133734|NCT03153137|537970864|FG000|Overall Study|Lost to Follow-up|1|||
149133735|NCT03153137|537970865|FG001|Overall Study|Lost to Follow-up|0|||
149133736|NCT03153137|537970864|FG000|Overall Study|Withdrawal by Subject|2|||
149133737|NCT03153137|537970865|FG001|Overall Study|Withdrawal by Subject|1|||
149133738|NCT03153137|537970864|FG000|Overall Study|Physician Decision|0|||
149133739|NCT03153137|537970865|FG001|Overall Study|Physician Decision|3|||
149133740|NCT00954174|537970878|FG000|Overall Study|Adverse Event|28|||
149133741|NCT00954174|537970879|FG001|Overall Study|Adverse Event|23|||
149133742|NCT00954174|537970880|FG002|Overall Study|Adverse Event|4|||
149133743|NCT00954174|537970881|FG003|Overall Study|Adverse Event|9|||
149133744|NCT00954174|537970878|FG000|Overall Study|Death|4|||
149133745|NCT00954174|537970879|FG001|Overall Study|Death|2|||
149133746|NCT00954174|537970880|FG002|Overall Study|Death|0|||
149133747|NCT00954174|537970881|FG003|Overall Study|Death|0|||
148790978|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
148790979|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
148790980|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
148790981|NCT01990768|536712751|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
148790982|NCT01990768|536712752|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
148790983|NCT01990768|536712753|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
148790984|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
148790985|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
149133748|NCT00954174|537970878|FG000|Overall Study|Lack of Efficacy|32|||
149133749|NCT00954174|537970879|FG001|Overall Study|Lack of Efficacy|22|||
148790986|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
148790987|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
148790988|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
148790989|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
148790990|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
148790991|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
148790992|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
148790993|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
148790994|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
148790995|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
148790996|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
148790997|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
148790998|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
148790999|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
148791000|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
148791001|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
148791002|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
148791003|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
148791004|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
148791005|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
148791006|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
149133750|NCT00954174|537970880|FG002|Overall Study|Lack of Efficacy|8|||
149133751|NCT00954174|537970881|FG003|Overall Study|Lack of Efficacy|6|||
149133752|NCT00954174|537970878|FG000|Overall Study|Withdrawal by Subject|14|||
149133753|NCT00954174|537970879|FG001|Overall Study|Withdrawal by Subject|10|||
149133754|NCT00954174|537970880|FG002|Overall Study|Withdrawal by Subject|4|||
149133755|NCT00954174|537970881|FG003|Overall Study|Withdrawal by Subject|3|||
149133756|NCT00954174|537970878|FG000|Overall Study|Medical Reason|4|||
149133757|NCT00954174|537970879|FG001|Overall Study|Medical Reason|2|||
149133758|NCT00954174|537970880|FG002|Overall Study|Medical Reason|1|||
149133759|NCT00954174|537970881|FG003|Overall Study|Medical Reason|0|||
149133760|NCT00954174|537970878|FG000|Overall Study|Ineligible|40|||
149133761|NCT00954174|537970879|FG001|Overall Study|Ineligible|47|||
149133762|NCT00954174|537970880|FG002|Overall Study|Ineligible|7|||
149133763|NCT00954174|537970881|FG003|Overall Study|Ineligible|4|||
149133764|NCT00954174|537970878|FG000|Overall Study|Never Treated|4|||
149133765|NCT00954174|537970879|FG001|Overall Study|Never Treated|17|||
149133766|NCT00954174|537970880|FG002|Overall Study|Never Treated|0|||
149133767|NCT00954174|537970881|FG003|Overall Study|Never Treated|3|||
149133768|NCT02234323|537970882|FG000|All Enrolled|Not Treated: Completed study in database|2|||
149133769|NCT02234323|537970882|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
149133770|NCT02234323|537970882|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
149133771|NCT02234323|537970882|FG000|All Treated|Death|1|||
149133772|NCT02234323|537970882|FG000|All Treated|Physician Decision|5|||
149133773|NCT02234323|537970882|FG000|All Treated|Lack of Efficacy|3|||
149133774|NCT02234323|537970882|FG000|All Treated|Exceeded lab value limit|2|||
149133775|NCT02234323|537970882|FG000|All Treated|Other|7|||
149133776|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
149133777|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
149133778|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
149133779|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
149133780|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
149133781|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
149133782|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
149133783|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
149133784|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Death|1|||
148791007|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
148791008|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
148791009|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
148893617|NCT00647296|537088805|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
149133785|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Death|1|||
149133786|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
149133787|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
149133788|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
149133789|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
149133790|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
149133791|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
149133792|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
149133793|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
149133794|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
148791010|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
148791011|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
148791012|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
148791013|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
148791014|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
148791015|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
148791016|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
148791017|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
148791018|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
148791019|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
148791020|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
148791021|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
148791022|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
148791023|NCT01990768|536712751|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
148791024|NCT01990768|536712752|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
148791025|NCT01990768|536712753|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
148791026|NCT01990768|536712751|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
148791027|NCT01990768|536712752|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
148791028|NCT01990768|536712753|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
148791029|NCT01990768|536712751|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
148791030|NCT01990768|536712752|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
148791031|NCT01990768|536712753|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
148791032|NCT01990768|536712751|FG000|6-Month Follow-up|No contact information|5|||
148791033|NCT01990768|536712752|FG001|6-Month Follow-up|No contact information|6|||
148791034|NCT01990768|536712753|FG002|6-Month Follow-up|No contact information|5|||
148791035|NCT01990768|536712751|FG000|6-Month Follow-up|Homeless|4|||
148791036|NCT01990768|536712752|FG001|6-Month Follow-up|Homeless|3|||
148791037|NCT01990768|536712753|FG002|6-Month Follow-up|Homeless|6|||
148791038|NCT01990768|536712751|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
148791039|NCT01990768|536712752|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
148791040|NCT01990768|536712753|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
148791041|NCT01990768|536712751|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
148791042|NCT01990768|536712752|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
148791043|NCT01990768|536712753|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
148791044|NCT01990768|536712751|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
148791045|NCT01990768|536712752|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
148791046|NCT01990768|536712753|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
148791047|NCT00154375|536712754|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
148791048|NCT00154375|536712755|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
148791049|NCT00154375|536712754|FG000|Overall Study|Adverse Event|18|||
148791050|NCT00154375|536712755|FG001|Overall Study|Adverse Event|20|||
148791051|NCT00154375|536712754|FG000|Overall Study|Withdrawal by Subject|14|||
148791052|NCT00154375|536712755|FG001|Overall Study|Withdrawal by Subject|10|||
148791053|NCT00154375|536712754|FG000|Overall Study|Death|5|||
148791054|NCT00154375|536712755|FG001|Overall Study|Death|13|||
148791055|NCT00154375|536712754|FG000|Overall Study|Study drug no longer required|5|||
148791056|NCT00154375|536712755|FG001|Overall Study|Study drug no longer required|3|||
148791057|NCT00154375|536712754|FG000|Overall Study|Lost to Follow-up|2|||
148791058|NCT00154375|536712755|FG001|Overall Study|Lost to Follow-up|1|||
148791059|NCT00154375|536712754|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148791060|NCT00154375|536712755|FG001|Overall Study|Abnormal laboratory value(s)|2|||
148791061|NCT00154375|536712754|FG000|Overall Study|Protocol Violation|0|||
148791062|NCT00154375|536712755|FG001|Overall Study|Protocol Violation|1|||
148791063|NCT00154375|536712754|FG000|Overall Study|Suspected progression of disease|44|||
148791064|NCT00154375|536712755|FG001|Overall Study|Suspected progression of disease|30|||
148791065|NCT00334295|536712758|FG000|Overall Study|Patients received fewer than 3 injection|5|||
148791066|NCT01588405|536712759|FG000|Overall Study|Adverse Event|1|||
148791067|NCT01588405|536712759|FG000|Overall Study|Clinical Worsening|1|||
148791068|NCT00792116|536712761|FG000|Overall Study|Lost to Follow-up|0|||
148791069|NCT00792116|536712762|FG001|Overall Study|Lost to Follow-up|1|||
148791070|NCT00792116|536712761|FG000|Overall Study|Discontnued intervention|1|||
148791071|NCT00792116|536712762|FG001|Overall Study|Discontnued intervention|0|||
148791072|NCT02453256|536712763|FG000|Double Blind Period|Death|1|||
148791073|NCT02453256|536712764|FG001|Double Blind Period|Death|1|||
148893618|NCT00647296|537088806|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
148893619|NCT00647296|537088803|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
148791074|NCT02453256|536712763|FG000|Double Blind Period|Adverse Event|3|||
148791075|NCT02453256|536712764|FG001|Double Blind Period|Adverse Event|2|||
148791076|NCT02453256|536712763|FG000|Double Blind Period|Withdrawal by Subject|9|||
148791077|NCT02453256|536712764|FG001|Double Blind Period|Withdrawal by Subject|5|||
148791078|NCT02453256|536712763|FG000|Double Blind Period|Other|0|||
148791079|NCT02453256|536712764|FG001|Double Blind Period|Other|1|||
148791080|NCT02453256|536712763|FG000|Open Label Period|Adverse Event|1|||
148791081|NCT02453256|536712764|FG001|Open Label Period|Adverse Event|3|||
148791082|NCT02453256|536712763|FG000|Open Label Period|Death|0|||
148791083|NCT02453256|536712764|FG001|Open Label Period|Death|1|||
148791084|NCT02453256|536712763|FG000|Open Label Period|Lost to Follow-up|1|||
148791085|NCT02453256|536712764|FG001|Open Label Period|Lost to Follow-up|0|||
148791086|NCT02453256|536712763|FG000|Open Label Period|Other|0|||
148791087|NCT02453256|536712764|FG001|Open Label Period|Other|2|||
148791088|NCT02453256|536712763|FG000|Open Label Period|Withdrawal by Subject|5|||
148791089|NCT02453256|536712764|FG001|Open Label Period|Withdrawal by Subject|1|||
148791090|NCT01216332|536712765|FG000|Overall Study|Withdrawal by Subject|4|||
148791091|NCT01216332|536712766|FG001|Overall Study|Withdrawal by Subject|0|||
148791092|NCT01066871|536712770|FG000|Overall Study|Lost to Follow-up|0|||
148791093|NCT01066871|536712771|FG001|Overall Study|Lost to Follow-up|2|||
148791094|NCT01066871|536712772|FG002|Overall Study|Lost to Follow-up|2|||
148791095|NCT01066871|536712773|FG003|Overall Study|Lost to Follow-up|0|||
148791096|NCT01066871|536712770|FG000|Overall Study|Protocol Violation|1|||
148791097|NCT01066871|536712771|FG001|Overall Study|Protocol Violation|0|||
148791098|NCT01066871|536712772|FG002|Overall Study|Protocol Violation|3|||
148791099|NCT01066871|536712773|FG003|Overall Study|Protocol Violation|2|||
148791100|NCT01066871|536712770|FG000|Overall Study|Lack of Efficacy|0|||
148791101|NCT01066871|536712771|FG001|Overall Study|Lack of Efficacy|0|||
148791102|NCT01066871|536712772|FG002|Overall Study|Lack of Efficacy|0|||
148791103|NCT01066871|536712773|FG003|Overall Study|Lack of Efficacy|1|||
148791104|NCT01066871|536712770|FG000|Overall Study|Withdrawal by Subject|3|||
148791105|NCT01066871|536712771|FG001|Overall Study|Withdrawal by Subject|1|||
148791106|NCT01066871|536712772|FG002|Overall Study|Withdrawal by Subject|0|||
148791107|NCT01066871|536712773|FG003|Overall Study|Withdrawal by Subject|0|||
148791108|NCT01066871|536712770|FG000|Overall Study|Other|0|||
148791109|NCT01066871|536712771|FG001|Overall Study|Other|2|||
148791110|NCT01066871|536712772|FG002|Overall Study|Other|1|||
148791111|NCT01066871|536712773|FG003|Overall Study|Other|2|||
148791112|NCT04162795|536712774|FG000|Overall Study|Other|16|||
148791113|NCT04162795|536712774|FG000|Overall Study|Screen failures|10|||
148791114|NCT02029274|536712777|FG000|Overall Study|Adverse Event|1|||
148791115|NCT02029274|536712778|FG001|Overall Study|Adverse Event|0|||
148791116|NCT02029274|536712779|FG002|Overall Study|Adverse Event|2|||
148791117|NCT02029274|536712780|FG003|Overall Study|Adverse Event|2|||
148791118|NCT01124292|536712781|FG000|Overall Study|Lost to Follow-up|2|||
148791119|NCT01124292|536712782|FG001|Overall Study|Lost to Follow-up|4|||
148791120|NCT01124292|536712783|FG002|Overall Study|Lost to Follow-up|3|||
148791121|NCT01124292|536712781|FG000|Overall Study|Physician Decision|0|||
148791122|NCT01124292|536712782|FG001|Overall Study|Physician Decision|3|||
148791123|NCT01124292|536712783|FG002|Overall Study|Physician Decision|2|||
148791124|NCT01124292|536712781|FG000|Overall Study|Withdrawal by Subject|0|||
148791125|NCT01124292|536712782|FG001|Overall Study|Withdrawal by Subject|6|||
148791126|NCT01124292|536712783|FG002|Overall Study|Withdrawal by Subject|2|||
148791127|NCT01124292|536712781|FG000|Overall Study|medical issue unrelated to the study|0|||
148791128|NCT01124292|536712782|FG001|Overall Study|medical issue unrelated to the study|0|||
148791129|NCT01124292|536712783|FG002|Overall Study|medical issue unrelated to the study|2|||
148791130|NCT01124292|536712781|FG000|Overall Study|piercing track closed|0|||
148791131|NCT01124292|536712782|FG001|Overall Study|piercing track closed|2|||
148791132|NCT01124292|536712783|FG002|Overall Study|piercing track closed|1|||
148791133|NCT03373461|536712785|FG000|Part 2|Adverse Event|0|||
148791134|NCT03373461|536712786|FG001|Part 2|Adverse Event|1|||
148791135|NCT03373461|536712787|FG002|Part 2|Adverse Event|0|||
148791136|NCT03373461|536712788|FG003|Part 2|Adverse Event|0|||
148791137|NCT03373461|536712789|FG004|Part 2|Adverse Event|1|||
148791138|NCT01972464|536712792|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
148791139|NCT01972464|536712793|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
148791140|NCT01972464|536712792|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
148791141|NCT01972464|536712793|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
148791142|NCT01972464|536712792|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
148791143|NCT01972464|536712793|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
148791144|NCT01972464|536712792|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
148791145|NCT01972464|536712793|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
148791146|NCT04530838|536714658|FG000|Overall Study|Other|2|||
148791147|NCT04530838|536714659|FG001|Overall Study|Other|1|||
148791148|NCT04530838|536714660|FG002|Overall Study|Other|0|||
148791149|NCT04530838|536714658|FG000|Overall Study|Physician Decision|0|||
148791150|NCT04530838|536714659|FG001|Overall Study|Physician Decision|0|||
148791151|NCT04530838|536714660|FG002|Overall Study|Physician Decision|1|||
148791152|NCT04530838|536714658|FG000|Overall Study|Death|0|||
148791153|NCT04530838|536714659|FG001|Overall Study|Death|0|||
148791154|NCT04530838|536714660|FG002|Overall Study|Death|1|||
148791155|NCT04530838|536714658|FG000|Overall Study|Adverse Event|0|||
148791156|NCT04530838|536714659|FG001|Overall Study|Adverse Event|1|||
148791157|NCT04530838|536714660|FG002|Overall Study|Adverse Event|0|||
148791158|NCT04530838|536714658|FG000|Overall Study|No longer meets eligibility criteria|1|||
148791159|NCT04530838|536714659|FG001|Overall Study|No longer meets eligibility criteria|0|||
148791160|NCT04530838|536714660|FG002|Overall Study|No longer meets eligibility criteria|2|||
148791161|NCT04530838|536714658|FG000|Overall Study|Withdrawal by parent/guardian|5|||
148791162|NCT04530838|536714659|FG001|Overall Study|Withdrawal by parent/guardian|2|||
148791163|NCT04530838|536714660|FG002|Overall Study|Withdrawal by parent/guardian|2|||
148791164|NCT00803712|536714661|FG000|Overall Study|Noncompliance|3|||
148791165|NCT00803712|536714662|FG001|Overall Study|Noncompliance|0|||
148791166|NCT00803712|536714661|FG000|Overall Study|Adverse Event|5|||
148791167|NCT00803712|536714662|FG001|Overall Study|Adverse Event|0|||
148791168|NCT00803712|536714661|FG000|Overall Study|Death|8|||
148791169|NCT00803712|536714662|FG001|Overall Study|Death|7|||
148791170|NCT00803712|536714661|FG000|Overall Study|Lost to Follow-up|3|||
148791171|NCT00803712|536714662|FG001|Overall Study|Lost to Follow-up|1|||
148791172|NCT00803712|536714661|FG000|Overall Study|Withdrawal by Subject|2|||
148791173|NCT00803712|536714662|FG001|Overall Study|Withdrawal by Subject|4|||
148791174|NCT00803712|536714661|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
148791175|NCT00803712|536714662|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
148791176|NCT00803712|536714661|FG000|Overall Study|Protocol criteria (other)|0|||
148791177|NCT00803712|536714662|FG001|Overall Study|Protocol criteria (other)|2|||
148791178|NCT00803712|536714661|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
148791179|NCT00803712|536714662|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
148791180|NCT00803712|536714661|FG000|Overall Study|Administrative decision|2|||
148791181|NCT00803712|536714662|FG001|Overall Study|Administrative decision|3|||
148791182|NCT00803712|536714661|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
148791183|NCT00803712|536714662|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
148791184|NCT03335813|536714664|FG000|Overall Study|Withdrawal by Subject|1|||
148791185|NCT02861664|536714665|FG000|Overall Study|Withdrawal of Consent|0|||
148791186|NCT02861664|536714666|FG001|Overall Study|Withdrawal of Consent|1|||
148791187|NCT00905632|536714667|FG000|Overall Study|Adverse Event|0|||
148791188|NCT00905632|536714668|FG001|Overall Study|Adverse Event|0|||
148791189|NCT00905632|536714669|FG002|Overall Study|Adverse Event|0|||
149133795|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
149133796|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
149133797|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
149133798|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
149133799|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
149133800|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
149133801|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
148791190|NCT00905632|536714670|FG003|Overall Study|Adverse Event|0|||
148791191|NCT00905632|536714671|FG004|Overall Study|Adverse Event|0|||
148791192|NCT00905632|536714672|FG005|Overall Study|Adverse Event|1|||
148791193|NCT00905632|536714673|FG006|Overall Study|Adverse Event|4|||
148791194|NCT00305227|536714676|FG000|Overall Study|Lost to Follow-up|7|||
148791195|NCT00305227|536714677|FG001|Overall Study|Lost to Follow-up|6|||
148791196|NCT03492437|536714679|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148791197|NCT03492437|536714680|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148791198|NCT03872843|536714681|FG000|Overall Study|Lost to Follow-up|5|||
148791199|NCT03872843|536714682|FG001|Overall Study|Lost to Follow-up|7|||
148791200|NCT05133323|536714683|FG000|Overall Study|Lack of Efficacy|0|||
148791201|NCT05133323|536714684|FG001|Overall Study|Lack of Efficacy|0|||
148791202|NCT05133323|536714685|FG002|Overall Study|Lack of Efficacy|1|||
148791203|NCT05133323|536714683|FG000|Overall Study|Withdrawal by Subject|2|||
148791204|NCT05133323|536714684|FG001|Overall Study|Withdrawal by Subject|1|||
148791205|NCT05133323|536714685|FG002|Overall Study|Withdrawal by Subject|0|||
148791206|NCT00577772|536714694|FG000|Overall Study|Lost to Follow-up|0|||
149133802|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
148791207|NCT00577772|536714695|FG001|Overall Study|Lost to Follow-up|1|||
148791208|NCT00856999|536714698|FG000|Overall Study|Withdrawal by Subject|5|||
148893620|NCT00647296|537088804|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
148791209|NCT02465437|536714699|FG000|Overall Study|Physician Decision|0|||
148791210|NCT02465437|536714700|FG001|Overall Study|Physician Decision|0|||
148791211|NCT02465437|536714701|FG002|Overall Study|Physician Decision|1|||
148791212|NCT02465437|536714702|FG003|Overall Study|Physician Decision|0|||
148791213|NCT02465437|536714699|FG000|Overall Study|Withdrawal by Subject|1|||
148791214|NCT02465437|536714700|FG001|Overall Study|Withdrawal by Subject|0|||
148791215|NCT02465437|536714701|FG002|Overall Study|Withdrawal by Subject|0|||
148791216|NCT02465437|536714702|FG003|Overall Study|Withdrawal by Subject|1|||
148791217|NCT02465437|536714699|FG000|Overall Study|Adverse Event|0|||
148791218|NCT02465437|536714700|FG001|Overall Study|Adverse Event|1|||
148791219|NCT02465437|536714701|FG002|Overall Study|Adverse Event|0|||
148791220|NCT02465437|536714702|FG003|Overall Study|Adverse Event|0|||
148791221|NCT02609386|536714703|FG000|Overall Study|Withdrawal by Subject|6|||
149133803|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
149133804|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
149133805|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
149133806|NCT00559585|537970883|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
149133807|NCT00559585|537970884|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
149133808|NCT00559585|537970883|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
149133809|NCT00559585|537970884|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
149133810|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
149133811|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
149133812|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
149133813|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
149133814|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
149133815|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
149133816|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
149133817|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
149133818|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
149133819|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
149133820|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
149133821|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
149133822|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
149133823|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
149133824|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
149133825|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
149133826|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
149133827|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
149133828|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
149133829|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
149133830|NCT00559585|537970883|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
149133831|NCT00559585|537970884|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
149133832|NCT04209621|537970885|FG000|Overall Study|Death|1|||
149133833|NCT04209621|537970885|FG000|Overall Study|Study Terminated Early|2|||
149133834|NCT02249767|537970886|FG000|Overall Study|Did not use medication|8|||
149133835|NCT02249767|537970887|FG001|Overall Study|Did not use medication|9|||
149133836|NCT02249767|537970888|FG002|Overall Study|Did not use medication|8|||
149133837|NCT01372410|537970889|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
149133838|NCT01372410|537970890|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
149133839|NCT01372410|537970891|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
149133840|NCT01372410|537970892|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
149133841|NCT01372410|537970893|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
149133842|NCT01372410|537970894|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
149133843|NCT01372410|537970895|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
149133844|NCT01372410|537970896|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
149133845|NCT01372410|537970889|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
149133846|NCT01372410|537970890|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
149133847|NCT01372410|537970891|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
149133848|NCT01372410|537970892|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
149133849|NCT01372410|537970893|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
149133850|NCT01372410|537970894|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
149133851|NCT01372410|537970895|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
149133852|NCT01372410|537970896|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
149133853|NCT01372410|537970889|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149133854|NCT01372410|537970890|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149133855|NCT01372410|537970891|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149133856|NCT01372410|537970892|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149133857|NCT01372410|537970893|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
149133858|NCT01372410|537970894|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
148791222|NCT02609386|536714704|FG001|Overall Study|Withdrawal by Subject|1|||
148791223|NCT02609386|536714703|FG000|Overall Study|Lost to Follow-up|3|||
148791224|NCT02609386|536714704|FG001|Overall Study|Lost to Follow-up|5|||
149133859|NCT01372410|537970895|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149133860|NCT01372410|537970896|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
149133861|NCT01372410|537970889|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
149133862|NCT01372410|537970890|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
149133863|NCT01372410|537970891|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
149133864|NCT01372410|537970892|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
149133865|NCT01372410|537970893|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
148791225|NCT02609386|536714703|FG000|Overall Study|Death|19|||
148791226|NCT02609386|536714704|FG001|Overall Study|Death|9|||
149133866|NCT01372410|537970894|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
148791227|NCT02609386|536714703|FG000|Overall Study|Physician Decision|0|||
148791228|NCT02609386|536714704|FG001|Overall Study|Physician Decision|2|||
148791229|NCT00103662|536714705|FG000|Overall Study|Entered Rescue Procedure|0|||
148791230|NCT00103662|536714706|FG001|Overall Study|Entered Rescue Procedure|7|||
148791231|NCT00103662|536714705|FG000|Overall Study|Death|7|||
148791232|NCT00103662|536714706|FG001|Overall Study|Death|7|||
148791233|NCT00103662|536714705|FG000|Overall Study|Elective Withdrawal|5|||
148791234|NCT00103662|536714706|FG001|Overall Study|Elective Withdrawal|5|||
148791235|NCT00103662|536714705|FG000|Overall Study|Lost to Follow-up|0|||
148791236|NCT00103662|536714706|FG001|Overall Study|Lost to Follow-up|1|||
148791237|NCT00103662|536714705|FG000|Overall Study|Other|6|||
148791238|NCT00103662|536714706|FG001|Overall Study|Other|9|||
148791239|NCT00103662|536714705|FG000|Overall Study|Failed mobilization|0|||
148791240|NCT00103662|536714706|FG001|Overall Study|Failed mobilization|4|||
148791241|NCT00103662|536714705|FG000|Overall Study|Intercurrent illness|1|||
148791242|NCT00103662|536714706|FG001|Overall Study|Intercurrent illness|0|||
148791243|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
148791244|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
148791245|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
148791246|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
148791247|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
148791248|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
148791249|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
148791250|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
148791251|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
148791252|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
148791253|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
148791254|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
148791255|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
148791256|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
148791257|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Death|1|||
148791258|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Death|0|||
148791259|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
148791260|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
148791261|NCT00105989|536714708|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
148791262|NCT00105989|536714709|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
148791263|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
148791264|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
148791265|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
148791266|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
148791267|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
148791268|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
148791269|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
148791270|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
148791271|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
148791272|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
148791273|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
148791274|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
148791275|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
148791276|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
148791277|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Death|0|||
148791278|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Death|0|||
148791279|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
148791280|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
148791281|NCT00105989|536714708|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
148791282|NCT00105989|536714709|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
148791283|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
148791284|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
148791285|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
148791286|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
148791287|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
148791288|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
149133867|NCT01372410|537970895|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
148791289|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
148791290|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
148791291|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
148791292|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
148893621|NCT00647296|537088805|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
148791293|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
148791294|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
148791295|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
148791296|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
148791297|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
148791298|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
148791299|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
148791300|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
148791301|NCT00105989|536714708|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
148791302|NCT00105989|536714709|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
148791303|NCT00610168|536714710|FG000|Overall Study|Withdrawal by Subject|2|||
148791304|NCT00610168|536714711|FG001|Overall Study|Withdrawal by Subject|0|||
148791305|NCT00613821|536714722|FG000|Overall Study|Withdrawal by Subject|1|||
148791306|NCT00613821|536714723|FG001|Overall Study|Withdrawal by Subject|0|||
148791307|NCT00613821|536714722|FG000|Overall Study|Physician Decision|1|||
148791308|NCT00613821|536714723|FG001|Overall Study|Physician Decision|1|||
148791309|NCT01266824|536714725|FG000|Overall Study|Study terminated prior to completion|2|||
148791310|NCT01266824|536714726|FG001|Overall Study|Study terminated prior to completion|3|||
148791311|NCT02302846|536714727|FG000|Overall Study|Withdrawal by Subject|1|||
148791312|NCT00397189|536714728|FG000|3 Weeks Period|Lost to Follow-up|5|||
148791313|NCT00397189|536714729|FG001|3 Weeks Period|Lost to Follow-up|4|||
148791314|NCT00397189|536714728|FG000|3 Weeks Period|Adverse Event|3|||
148791315|NCT00397189|536714729|FG001|3 Weeks Period|Adverse Event|2|||
148791316|NCT00397189|536714728|FG000|3 Weeks Period|Withdrawal by Subject|13|||
148791317|NCT00397189|536714729|FG001|3 Weeks Period|Withdrawal by Subject|9|||
148791318|NCT00397189|536714728|FG000|3 Weeks Period|Physician Decision|0|||
148791319|NCT00397189|536714729|FG001|3 Weeks Period|Physician Decision|2|||
148791320|NCT00397189|536714728|FG000|3 Weeks Period|Protocol Violation|0|||
148791321|NCT00397189|536714729|FG001|3 Weeks Period|Protocol Violation|3|||
148791322|NCT00397189|536714728|FG000|3 Weeks Period|Other|0|||
148791323|NCT00397189|536714729|FG001|3 Weeks Period|Other|2|||
148791324|NCT00411450|536714730|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
148791325|NCT01059773|536714731|FG000|Overall Study|Adverse Event|2|||
148791326|NCT01059773|536714732|FG001|Overall Study|Adverse Event|2|||
148791327|NCT01059773|536714731|FG000|Overall Study|Withdrawal by Subject|1|||
148791328|NCT01059773|536714732|FG001|Overall Study|Withdrawal by Subject|5|||
148791329|NCT01059773|536714731|FG000|Overall Study|Lost to Follow-up|1|||
148791330|NCT01059773|536714732|FG001|Overall Study|Lost to Follow-up|1|||
148791331|NCT01059773|536714731|FG000|Overall Study|Pregnancy|1|||
148791332|NCT01059773|536714732|FG001|Overall Study|Pregnancy|1|||
148791333|NCT01059773|536714731|FG000|Overall Study|Protocol Violation|6|||
148791334|NCT01059773|536714732|FG001|Overall Study|Protocol Violation|2|||
148791335|NCT01059773|536714731|FG000|Overall Study|Physician Decision|5|||
148791336|NCT01059773|536714732|FG001|Overall Study|Physician Decision|4|||
148791337|NCT01059773|536714731|FG000|Overall Study|Lack of Efficacy|3|||
148791338|NCT01059773|536714732|FG001|Overall Study|Lack of Efficacy|3|||
148791339|NCT01059773|536714731|FG000|Overall Study|Death|0|||
148791340|NCT01059773|536714732|FG001|Overall Study|Death|1|||
148791341|NCT01059773|536714731|FG000|Overall Study|Malignancy including squamous cell skin|0|||
148791342|NCT01059773|536714732|FG001|Overall Study|Malignancy including squamous cell skin|1|||
148791343|NCT01059773|536714731|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
148791344|NCT01059773|536714732|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
148791345|NCT01059773|536714731|FG000|Overall Study|Other|1|||
148791346|NCT01059773|536714732|FG001|Overall Study|Other|3|||
148791347|NCT00141518|536714735|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
148791348|NCT00141518|536714736|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
148791349|NCT00141518|536714737|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
148791350|NCT00141518|536714735|FG000|Overall Study|Adverse Event|7|||
148791351|NCT00141518|536714736|FG001|Overall Study|Adverse Event|5|||
148791352|NCT00141518|536714737|FG002|Overall Study|Adverse Event|2|||
148791353|NCT00141518|536714735|FG000|Overall Study|Withdrawal by Subject|2|||
148791354|NCT00141518|536714736|FG001|Overall Study|Withdrawal by Subject|0|||
148791355|NCT00141518|536714737|FG002|Overall Study|Withdrawal by Subject|2|||
148791356|NCT00141518|536714735|FG000|Overall Study|Protocol Violation|1|||
148791357|NCT00141518|536714736|FG001|Overall Study|Protocol Violation|1|||
148791358|NCT00141518|536714737|FG002|Overall Study|Protocol Violation|2|||
148791359|NCT00141518|536714735|FG000|Overall Study|Lack of Efficacy|5|||
148791360|NCT00141518|536714736|FG001|Overall Study|Lack of Efficacy|0|||
148791361|NCT00141518|536714737|FG002|Overall Study|Lack of Efficacy|0|||
148791362|NCT01806168|536714738|FG000|Overall Study|Adverse Event|1|||
148791363|NCT01806168|536714739|FG001|Overall Study|Adverse Event|0|||
148791364|NCT01806168|536714740|FG002|Overall Study|Adverse Event|0|||
148791365|NCT01806168|536714738|FG000|Overall Study|Withdrawal by Subject|0|||
148791366|NCT01806168|536714739|FG001|Overall Study|Withdrawal by Subject|1|||
148791367|NCT01806168|536714740|FG002|Overall Study|Withdrawal by Subject|2|||
148791368|NCT01806168|536714738|FG000|Overall Study|Protocol Violation|0|||
148791369|NCT01806168|536714739|FG001|Overall Study|Protocol Violation|0|||
148791370|NCT01806168|536714740|FG002|Overall Study|Protocol Violation|1|||
148791371|NCT03410992|536714741|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149133868|NCT01372410|537970896|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
148791372|NCT03410992|536714742|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
148791373|NCT03410992|536714743|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791374|NCT03410992|536714744|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791375|NCT03410992|536714745|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791376|NCT03410992|536714746|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791377|NCT03410992|536714747|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791378|NCT03410992|536714748|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791379|NCT03410992|536714749|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791380|NCT03410992|536714750|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
149133869|NCT01372410|537970889|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
149133870|NCT01372410|537970890|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
149133871|NCT01372410|537970891|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
149133872|NCT01372410|537970892|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
149133873|NCT01372410|537970893|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
149133874|NCT01372410|537970894|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
149133875|NCT01372410|537970895|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
149133876|NCT01372410|537970896|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
149133877|NCT01372410|537970889|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133878|NCT01372410|537970890|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133879|NCT01372410|537970891|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133880|NCT01372410|537970892|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133881|NCT01372410|537970893|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
149133882|NCT01372410|537970894|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133883|NCT01372410|537970895|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133884|NCT01372410|537970896|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
149133885|NCT01372410|537970889|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
149133886|NCT01372410|537970890|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
149133887|NCT01372410|537970891|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
149133888|NCT01372410|537970892|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
149133889|NCT01372410|537970893|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
148791381|NCT03410992|536714751|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
148791382|NCT03410992|536714741|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
148791383|NCT03410992|536714742|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
148791384|NCT03410992|536714743|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791385|NCT03410992|536714744|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791386|NCT03410992|536714745|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791387|NCT03410992|536714746|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791388|NCT03410992|536714747|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791389|NCT03410992|536714748|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791390|NCT03410992|536714749|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791391|NCT03410992|536714750|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148791392|NCT03410992|536714751|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
148893622|NCT00647296|537088806|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
149133890|NCT01372410|537970894|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
149133891|NCT01372410|537970895|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
149133892|NCT01372410|537970896|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
149133893|NCT01372410|537970889|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133894|NCT01372410|537970890|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133895|NCT01372410|537970891|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133896|NCT01372410|537970892|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133897|NCT01372410|537970893|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133898|NCT01372410|537970894|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133899|NCT01372410|537970895|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
149133900|NCT01372410|537970896|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
149133901|NCT01372410|537970889|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133902|NCT01372410|537970890|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133903|NCT01372410|537970891|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
149133904|NCT01372410|537970892|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133905|NCT01372410|537970893|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133906|NCT01372410|537970894|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133907|NCT01372410|537970895|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133908|NCT01372410|537970896|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
149133909|NCT01372410|537970889|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
148791393|NCT03410992|536714741|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
148791394|NCT03410992|536714742|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
148791395|NCT03410992|536714743|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791396|NCT03410992|536714744|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791397|NCT03410992|536714745|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791398|NCT03410992|536714746|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791399|NCT03410992|536714747|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791400|NCT03410992|536714748|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791401|NCT03410992|536714749|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791402|NCT03410992|536714750|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791403|NCT03410992|536714751|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
148791404|NCT03410992|536714741|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
148791405|NCT03410992|536714742|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791406|NCT03410992|536714743|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791407|NCT03410992|536714744|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791408|NCT03410992|536714745|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791409|NCT03410992|536714746|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791410|NCT03410992|536714747|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791411|NCT03410992|536714748|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791412|NCT03410992|536714749|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791413|NCT03410992|536714750|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791414|NCT03410992|536714751|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
148791415|NCT03410992|536714741|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
148791416|NCT03410992|536714742|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
148791417|NCT03410992|536714743|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791418|NCT03410992|536714744|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791419|NCT03410992|536714745|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791420|NCT03410992|536714746|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791421|NCT03410992|536714747|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791422|NCT03410992|536714748|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791423|NCT03410992|536714749|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791424|NCT03410992|536714750|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791425|NCT03410992|536714751|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
148791426|NCT03410992|536714741|FG000|Week 16 Assessment|Incorrect escapers|0|||
148791427|NCT03410992|536714742|FG001|Week 16 Assessment|Incorrect escapers|6|||
148791428|NCT03410992|536714743|FG002|Week 16 Assessment|Incorrect escapers|0|||
148791429|NCT03410992|536714744|FG003|Week 16 Assessment|Incorrect escapers|0|||
148791430|NCT03410992|536714745|FG004|Week 16 Assessment|Incorrect escapers|0|||
148791431|NCT03410992|536714746|FG005|Week 16 Assessment|Incorrect escapers|0|||
148791432|NCT03410992|536714747|FG006|Week 16 Assessment|Incorrect escapers|0|||
148791433|NCT03410992|536714748|FG007|Week 16 Assessment|Incorrect escapers|0|||
148791434|NCT03410992|536714749|FG008|Week 16 Assessment|Incorrect escapers|0|||
148791435|NCT03410992|536714750|FG009|Week 16 Assessment|Incorrect escapers|0|||
148791436|NCT03410992|536714751|FG010|Week 16 Assessment|Incorrect escapers|0|||
148791437|NCT03410992|536714741|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791438|NCT03410992|536714742|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791439|NCT03410992|536714743|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791440|NCT03410992|536714744|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
148791441|NCT03410992|536714745|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
148791442|NCT03410992|536714746|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791443|NCT03410992|536714747|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791444|NCT03410992|536714748|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791445|NCT03410992|536714749|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791446|NCT03410992|536714750|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791447|NCT03410992|536714751|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
148791448|NCT03410992|536714741|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791449|NCT03410992|536714742|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791450|NCT03410992|536714743|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148893623|NCT00647296|537088803|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
148893624|NCT00647296|537088804|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
148893625|NCT00647296|537088805|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
148893626|NCT00647296|537088806|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
148893627|NCT00647296|537088803|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
148893628|NCT00647296|537088804|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
149133910|NCT01372410|537970890|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
149133911|NCT01372410|537970891|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
148791451|NCT03410992|536714744|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
148791452|NCT03410992|536714745|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
148791453|NCT03410992|536714746|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
148791454|NCT03410992|536714747|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791455|NCT03410992|536714748|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791456|NCT03410992|536714749|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791457|NCT03410992|536714750|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791458|NCT03410992|536714751|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
148791459|NCT03410992|536714741|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791460|NCT03410992|536714742|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791461|NCT03410992|536714743|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791462|NCT03410992|536714744|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791463|NCT03410992|536714745|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791464|NCT03410992|536714746|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
148791465|NCT03410992|536714747|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791466|NCT03410992|536714748|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791467|NCT03410992|536714749|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791468|NCT03410992|536714750|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791469|NCT03410992|536714751|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
148791470|NCT03410992|536714741|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791471|NCT03410992|536714742|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791472|NCT03410992|536714743|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791473|NCT03410992|536714744|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
148791474|NCT03410992|536714745|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
148791475|NCT03410992|536714746|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
148791476|NCT03410992|536714747|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791477|NCT03410992|536714748|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148893629|NCT00647296|537088805|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
148893630|NCT00647296|537088806|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
148893631|NCT00647296|537088803|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
148893632|NCT00647296|537088804|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
148893633|NCT00647296|537088805|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
148791478|NCT03410992|536714749|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791479|NCT03410992|536714750|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791480|NCT03410992|536714751|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
148791481|NCT03410992|536714741|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791482|NCT03410992|536714742|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791483|NCT03410992|536714743|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791484|NCT03410992|536714744|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791485|NCT03410992|536714745|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791486|NCT03410992|536714746|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791487|NCT03410992|536714747|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791488|NCT03410992|536714748|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
148791489|NCT03410992|536714749|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791490|NCT03410992|536714750|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791491|NCT03410992|536714751|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
148791492|NCT03410992|536714741|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791493|NCT03410992|536714742|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791494|NCT03410992|536714743|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791495|NCT03410992|536714744|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791496|NCT03410992|536714745|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791497|NCT03410992|536714746|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791498|NCT03410992|536714747|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791499|NCT03410992|536714748|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791500|NCT03410992|536714749|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
149133912|NCT01372410|537970892|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
149133913|NCT01372410|537970893|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
149133914|NCT01372410|537970894|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
149133915|NCT01372410|537970895|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
149133916|NCT01372410|537970896|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
149133917|NCT04585646|537970897|FG000|First Intervention|Physician Decision|1|||
149133918|NCT04585646|537970898|FG001|First Intervention|Physician Decision|0|||
149133919|NCT04585646|537970897|FG000|First Intervention|Lost to Follow-up|0|||
149133920|NCT04585646|537970898|FG001|First Intervention|Lost to Follow-up|3|||
149133921|NCT04585646|537970897|FG000|First Intervention|Withdrawal by Subject|0|||
149133922|NCT04585646|537970898|FG001|First Intervention|Withdrawal by Subject|1|||
149133923|NCT00867113|537970899|FG000|Treatment Period|Adverse Event|15|||
149133924|NCT00867113|537970899|FG000|Treatment Period|Death|2|||
148791501|NCT03410992|536714750|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791502|NCT03410992|536714751|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
148791503|NCT03904420|536714752|FG000|Overall Study|Study terminated|2|||
148791504|NCT03904420|536714753|FG001|Overall Study|Study terminated|2|||
148791505|NCT01001910|536714754|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
148791506|NCT00614874|536714755|FG000|Overall Study|Protocol Violation|1|||
148791507|NCT00614874|536714755|FG000|Overall Study|Withdrawal by Subject|1|||
148791508|NCT01468454|536714756|FG000|Overall Study|Did not have surgery after PET|9|||
148791509|NCT01462630|536714759|FG000|Overall Study|Did not initiate therapy|3|||
148791510|NCT01462630|536714759|FG000|Overall Study|Death|1|||
148791511|NCT01462630|536714759|FG000|Overall Study|Protocol Violation|2|||
148791512|NCT01462630|536714759|FG000|Overall Study|Adverse Event|1|||
148791513|NCT02585713|536714760|FG000|Overall Study|Withdrew prior to treatment|2|||
148791514|NCT02585713|536714761|FG001|Overall Study|Withdrew prior to treatment|7|||
148791515|NCT02585713|536714760|FG000|Overall Study|Other|3|||
148791516|NCT02585713|536714761|FG001|Overall Study|Other|1|||
148791517|NCT02098395|536714767|FG000|Overall Study|Protocol Violation|2|||
148791518|NCT02098395|536714768|FG001|Overall Study|Protocol Violation|2|||
148791519|NCT02098395|536714769|FG002|Overall Study|Protocol Violation|0|||
148791520|NCT02098395|536714770|FG003|Overall Study|Protocol Violation|7|||
148791521|NCT02098395|536714767|FG000|Overall Study|Withdrawal by Subject|10|||
148791522|NCT02098395|536714768|FG001|Overall Study|Withdrawal by Subject|10|||
148791523|NCT02098395|536714769|FG002|Overall Study|Withdrawal by Subject|5|||
148791524|NCT02098395|536714770|FG003|Overall Study|Withdrawal by Subject|13|||
148791525|NCT02098395|536714767|FG000|Overall Study|Adverse Event|12|||
148791526|NCT02098395|536714768|FG001|Overall Study|Adverse Event|19|||
148791527|NCT02098395|536714769|FG002|Overall Study|Adverse Event|34|||
148791528|NCT02098395|536714770|FG003|Overall Study|Adverse Event|2|||
148791529|NCT02098395|536714767|FG000|Overall Study|Lost to Follow-up|2|||
148791530|NCT02098395|536714768|FG001|Overall Study|Lost to Follow-up|1|||
148791531|NCT02098395|536714769|FG002|Overall Study|Lost to Follow-up|0|||
148791532|NCT02098395|536714770|FG003|Overall Study|Lost to Follow-up|3|||
148791533|NCT02098395|536714767|FG000|Overall Study|Unclassified|0|||
148791534|NCT02098395|536714768|FG001|Overall Study|Unclassified|0|||
148791535|NCT02098395|536714769|FG002|Overall Study|Unclassified|3|||
148791536|NCT02098395|536714770|FG003|Overall Study|Unclassified|2|||
148791537|NCT02137226|536714774|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
148791538|NCT02137226|536714775|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
148791539|NCT02137226|536714776|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
148791540|NCT02137226|536714777|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
148791541|NCT02137226|536714778|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
148791542|NCT02137226|536714774|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
148791543|NCT02137226|536714775|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
148791544|NCT02137226|536714776|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
148791545|NCT02137226|536714777|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
148791546|NCT02137226|536714778|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
148791547|NCT02137226|536714774|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
148791548|NCT02137226|536714775|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
148791549|NCT02137226|536714776|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
148791550|NCT02137226|536714777|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
148791551|NCT02137226|536714778|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
148791552|NCT02137226|536714774|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
148791553|NCT02137226|536714775|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
148791554|NCT02137226|536714776|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
148791555|NCT02137226|536714777|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
148791556|NCT02137226|536714778|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
148791557|NCT02137226|536714774|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
148791558|NCT02137226|536714775|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
148791559|NCT02137226|536714776|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
148791560|NCT02137226|536714777|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
148791561|NCT02137226|536714778|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
148791562|NCT02137226|536714774|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
148791563|NCT02137226|536714775|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
148791564|NCT02137226|536714776|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
148791565|NCT02137226|536714777|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
148791566|NCT02137226|536714778|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
148791567|NCT02137226|536714774|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
148791568|NCT02137226|536714775|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
148791569|NCT02137226|536714776|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
148791570|NCT02137226|536714777|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
148791571|NCT02137226|536714778|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
148791572|NCT02137226|536714774|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
148791573|NCT02137226|536714775|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
148791574|NCT02137226|536714776|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
148791575|NCT02137226|536714777|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
148791576|NCT02137226|536714778|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
148791577|NCT02137226|536714774|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
148791578|NCT02137226|536714775|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
148791579|NCT02137226|536714776|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
148791580|NCT02137226|536714777|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
148791581|NCT02137226|536714778|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
148791582|NCT02137226|536714774|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
148791583|NCT02137226|536714775|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
148791584|NCT02137226|536714776|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
148791585|NCT02137226|536714777|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
148791586|NCT02137226|536714778|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
148791587|NCT02137226|536714774|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
148791588|NCT02137226|536714775|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
148791589|NCT02137226|536714776|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
148791590|NCT02137226|536714777|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
148791591|NCT02137226|536714778|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
148791592|NCT02137226|536714774|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
148791593|NCT02137226|536714775|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
148791594|NCT02137226|536714776|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
148791595|NCT02137226|536714777|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
148791596|NCT02137226|536714778|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
148791597|NCT02998996|536714779|FG000|Overall Study|Lost to Follow-up|0|||
148791598|NCT02998996|536714780|FG001|Overall Study|Lost to Follow-up|0|||
148791599|NCT02998996|536714781|FG002|Overall Study|Lost to Follow-up|1|||
148791600|NCT02998996|536714782|FG003|Overall Study|Lost to Follow-up|0|||
148791601|NCT02998996|536714783|FG004|Overall Study|Lost to Follow-up|0|||
148791602|NCT02998996|536714784|FG005|Overall Study|Lost to Follow-up|0|||
148791603|NCT02998996|536714779|FG000|Overall Study|Pregnancy|0|||
148791604|NCT02998996|536714780|FG001|Overall Study|Pregnancy|1|||
148791605|NCT02998996|536714781|FG002|Overall Study|Pregnancy|0|||
148791606|NCT02998996|536714782|FG003|Overall Study|Pregnancy|0|||
148791607|NCT02998996|536714783|FG004|Overall Study|Pregnancy|0|||
148791608|NCT02998996|536714784|FG005|Overall Study|Pregnancy|0|||
148791609|NCT02998996|536714779|FG000|Overall Study|Family reasons|0|||
148791610|NCT02998996|536714780|FG001|Overall Study|Family reasons|0|||
148791611|NCT02998996|536714781|FG002|Overall Study|Family reasons|0|||
148791612|NCT02998996|536714782|FG003|Overall Study|Family reasons|0|||
148791613|NCT02998996|536714783|FG004|Overall Study|Family reasons|1|||
148791614|NCT02998996|536714784|FG005|Overall Study|Family reasons|0|||
148791615|NCT00003896|536714787|FG000|Overall Study|Adverse Event|16|||
148791616|NCT00003896|536714787|FG000|Overall Study|Withdrawal by Subject|1|||
148791617|NCT00003896|536714787|FG000|Overall Study|Lack of Efficacy|1|||
148791618|NCT00003896|536714787|FG000|Overall Study|Death|3|||
148791619|NCT00003896|536714787|FG000|Overall Study|not protocol specified|3|||
148791620|NCT00003896|536714787|FG000|Overall Study|ineligible|5|||
148791621|NCT01398358|536714790|FG000|Overall Study|Lost to Follow-up|11|||
148791622|NCT01398358|536714791|FG001|Overall Study|Lost to Follow-up|21|||
148791623|NCT01398358|536714792|FG002|Overall Study|Lost to Follow-up|18|||
148791624|NCT01398358|536714790|FG000|Overall Study|Withdrawal by Subject|3|||
148791625|NCT01398358|536714791|FG001|Overall Study|Withdrawal by Subject|2|||
148791626|NCT01398358|536714792|FG002|Overall Study|Withdrawal by Subject|2|||
148791627|NCT01398358|536714790|FG000|Overall Study|no longer eligible|1|||
148791628|NCT01398358|536714791|FG001|Overall Study|no longer eligible|0|||
148791629|NCT01398358|536714792|FG002|Overall Study|no longer eligible|1|||
148791630|NCT00985686|536714794|FG000|Overall Study|Lost to Follow-up|1|||
148791631|NCT00985686|536714795|FG001|Overall Study|Lost to Follow-up|1|||
148791632|NCT00985686|536714796|FG002|Overall Study|Lost to Follow-up|0|||
148791633|NCT00985686|536714797|FG003|Overall Study|Lost to Follow-up|2|||
148791634|NCT01087203|536714798|FG000|Overall Study|Lost to Follow-up|2|||
148791635|NCT01087203|536714799|FG001|Overall Study|Lost to Follow-up|0|||
148791636|NCT01087203|536714798|FG000|Overall Study|Withdrawal by Subject|2|||
148791637|NCT01087203|536714799|FG001|Overall Study|Withdrawal by Subject|6|||
148791638|NCT01087203|536714798|FG000|Overall Study|Lack of Efficacy|1|||
148791639|NCT01087203|536714799|FG001|Overall Study|Lack of Efficacy|2|||
148791640|NCT01087203|536714798|FG000|Overall Study|Study terminated by sponsor|27|||
148791641|NCT01087203|536714799|FG001|Overall Study|Study terminated by sponsor|27|||
148791642|NCT03134911|536714800|FG000|Overall Study|Screen failure|31|||
148791643|NCT03134911|536714800|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
148791644|NCT02559570|536714802|FG000|Overall Study|Adverse Event|0|||
148791645|NCT02559570|536714803|FG001|Overall Study|Adverse Event|2|||
148791646|NCT02559570|536714804|FG002|Overall Study|Adverse Event|0|||
148791647|NCT02559570|536714805|FG003|Overall Study|Adverse Event|1|||
148791648|NCT02559570|536714806|FG004|Overall Study|Adverse Event|0|||
148791649|NCT02559570|536714802|FG000|Overall Study|Withdrawal of Consent|0|||
148791650|NCT02559570|536714803|FG001|Overall Study|Withdrawal of Consent|0|||
148791651|NCT02559570|536714804|FG002|Overall Study|Withdrawal of Consent|1|||
148791652|NCT02559570|536714805|FG003|Overall Study|Withdrawal of Consent|2|||
148791653|NCT02559570|536714806|FG004|Overall Study|Withdrawal of Consent|1|||
148791654|NCT02559570|536714802|FG000|Overall Study|Lost to Follow-up|1|||
148791655|NCT02559570|536714803|FG001|Overall Study|Lost to Follow-up|0|||
148791656|NCT02559570|536714804|FG002|Overall Study|Lost to Follow-up|0|||
148791657|NCT02559570|536714805|FG003|Overall Study|Lost to Follow-up|0|||
148791658|NCT02559570|536714806|FG004|Overall Study|Lost to Follow-up|0|||
148791659|NCT02559570|536714802|FG000|Overall Study|Protocol Violation|1|||
148791660|NCT02559570|536714803|FG001|Overall Study|Protocol Violation|0|||
148791661|NCT02559570|536714804|FG002|Overall Study|Protocol Violation|0|||
148791662|NCT02559570|536714805|FG003|Overall Study|Protocol Violation|0|||
148791663|NCT02559570|536714806|FG004|Overall Study|Protocol Violation|1|||
148791664|NCT02559570|536714802|FG000|Overall Study|Other Miscellaneous Reasons|0|||
148791665|NCT02559570|536714803|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148791666|NCT02559570|536714804|FG002|Overall Study|Other Miscellaneous Reasons|1|||
148791667|NCT02559570|536714805|FG003|Overall Study|Other Miscellaneous Reasons|0|||
148791668|NCT02559570|536714806|FG004|Overall Study|Other Miscellaneous Reasons|0|||
148791669|NCT00184093|536714815|FG000|Overall Study|Adverse Event|3|||
148791670|NCT00184093|536714815|FG000|Overall Study|Lost to Follow-up|3|||
148791671|NCT00184093|536714815|FG000|Overall Study|Physician Decision|1|||
148791672|NCT00184093|536714815|FG000|Overall Study|Withdrawal by Subject|2|||
148791673|NCT05095311|536714816|FG000|Overall Study|Lost to Follow-up|7|||
148791674|NCT05095311|536714817|FG001|Overall Study|Lost to Follow-up|0|||
148791675|NCT05095311|536714818|FG002|Overall Study|Lost to Follow-up|0|||
148791676|NCT02588664|536714819|FG000|Overall Study|Death|56|||
148791677|NCT02588664|536714820|FG001|Overall Study|Death|55|||
148791678|NCT02588664|536714819|FG000|Overall Study|Lost to Follow-up|1305|||
148791679|NCT02588664|536714820|FG001|Overall Study|Lost to Follow-up|990|||
148791680|NCT00534638|536714823|FG000|Overall Study|Withdrawal by Subject|3|||
148791681|NCT00534638|536714824|FG001|Overall Study|Withdrawal by Subject|4|||
148791682|NCT00534638|536714823|FG000|Overall Study|Migrated/moved from study area|13|||
148791683|NCT00534638|536714824|FG001|Overall Study|Migrated/moved from study area|11|||
148791684|NCT00534638|536714823|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
148791685|NCT00534638|536714824|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
148791686|NCT00534638|536714823|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
148791687|NCT00534638|536714824|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
148791688|NCT00534638|536714823|FG000|Overall Study|Other|1685|||
148791689|NCT00534638|536714824|FG001|Overall Study|Other|902|||
148791690|NCT02903420|536714827|FG000|Overall Study|Death|3|||
148791691|NCT02500719|536714830|FG000|Overall Study|Lost to Follow-up|2|||
148791692|NCT02500719|536714831|FG001|Overall Study|Lost to Follow-up|3|||
148791693|NCT02500719|536714830|FG000|Overall Study|Trauma history|1|||
148791694|NCT02500719|536714831|FG001|Overall Study|Trauma history|0|||
148791695|NCT02500719|536714830|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
148791696|NCT02500719|536714831|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
148791697|NCT02500719|536714830|FG000|Overall Study|Did not meet criteria for PTSD|0|||
148791698|NCT02500719|536714831|FG001|Overall Study|Did not meet criteria for PTSD|1|||
148791699|NCT02500719|536714830|FG000|Overall Study|Claustrophobia|0|||
148791700|NCT02500719|536714831|FG001|Overall Study|Claustrophobia|1|||
148791701|NCT02500719|536714830|FG000|Overall Study|History of head trauma|0|||
148791702|NCT02500719|536714831|FG001|Overall Study|History of head trauma|1|||
148791703|NCT02710084|536714834|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
148791704|NCT02710084|536714835|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
148791705|NCT00181883|536714836|FG000|Overall Study|Lack of Efficacy|2|||
148791706|NCT00181883|536714836|FG000|Overall Study|Treatment Limiting AEs|3|||
148791707|NCT00181883|536714836|FG000|Overall Study|Withdrawal by Subject|4|||
148791708|NCT00181883|536714836|FG000|Overall Study|Lost to Follow-up|1|||
148791709|NCT05305989|536714837|FG000|Overall Study|Other|3|||
148791710|NCT05305989|536714838|FG001|Overall Study|Other|2|||
148791711|NCT05305989|536714839|FG002|Overall Study|Other|0|||
148791712|NCT05305989|536714837|FG000|Overall Study|Sponsor decision|2|||
148791713|NCT05305989|536714838|FG001|Overall Study|Sponsor decision|1|||
148791714|NCT05305989|536714839|FG002|Overall Study|Sponsor decision|0|||
148791715|NCT05305989|536714837|FG000|Overall Study|Protocol Violation|0|||
148791716|NCT05305989|536714838|FG001|Overall Study|Protocol Violation|1|||
148791717|NCT05305989|536714839|FG002|Overall Study|Protocol Violation|0|||
148791718|NCT05305989|536714837|FG000|Overall Study|Investigator decision|1|||
148791719|NCT05305989|536714838|FG001|Overall Study|Investigator decision|2|||
148791720|NCT05305989|536714839|FG002|Overall Study|Investigator decision|0|||
148791721|NCT05305989|536714837|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
148791722|NCT05305989|536714838|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
149133925|NCT00867113|537970899|FG000|Treatment Period|Withdrawal by Subject|19|||
149133926|NCT00867113|537970899|FG000|Treatment Period|Lost to Follow-up|3|||
149133927|NCT00867113|537970899|FG000|Treatment Period|Administrative problems|1|||
148791723|NCT05305989|536714839|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
148791724|NCT05305989|536714837|FG000|Overall Study|Adverse Event|1|||
148791725|NCT05305989|536714838|FG001|Overall Study|Adverse Event|1|||
148791726|NCT05305989|536714839|FG002|Overall Study|Adverse Event|0|||
148791727|NCT05305989|536714837|FG000|Overall Study|Enrolled but never dosed|3|||
148791728|NCT05305989|536714838|FG001|Overall Study|Enrolled but never dosed|2|||
148791729|NCT05305989|536714839|FG002|Overall Study|Enrolled but never dosed|1|||
148791730|NCT00669318|536715737|FG000|Overall Study|Withdrawal by Subject|2|||
148791731|NCT01639144|536715744|FG000|Overall Study|Withdrawal by Subject|4|||
148791732|NCT01639144|536715745|FG001|Overall Study|Withdrawal by Subject|2|||
148791733|NCT01639144|536715744|FG000|Overall Study|Physician Decision|2|||
148791734|NCT01639144|536715745|FG001|Overall Study|Physician Decision|0|||
148791735|NCT01639144|536715744|FG000|Overall Study|Met postoperative exclusion criteria|4|||
148791736|NCT01639144|536715745|FG001|Overall Study|Met postoperative exclusion criteria|3|||
148791737|NCT00003483|536715750|FG000|Overall Study|Not evaluable|1|||
148791738|NCT01048541|536715754|FG000|Overall Study|Withdrawal by Subject|1|||
148791739|NCT01048541|536715755|FG001|Overall Study|Withdrawal by Subject|0|||
148791740|NCT02105285|536715758|FG000|Overall Study|Adverse Event|1|||
148791741|NCT02105285|536715759|FG001|Overall Study|Adverse Event|1|||
148791742|NCT02105285|536715760|FG002|Overall Study|Adverse Event|0|||
148791743|NCT02105285|536715758|FG000|Overall Study|Protocol Violation|0|||
148791744|NCT02105285|536715759|FG001|Overall Study|Protocol Violation|1|||
148791745|NCT02105285|536715760|FG002|Overall Study|Protocol Violation|0|||
148791746|NCT02105285|536715758|FG000|Overall Study|Withdrawal by Subject|1|||
148791747|NCT02105285|536715759|FG001|Overall Study|Withdrawal by Subject|0|||
148791748|NCT02105285|536715760|FG002|Overall Study|Withdrawal by Subject|0|||
148791749|NCT00656175|536715761|FG000|Overall Study|Adverse Event|1|||
148791750|NCT00656175|536715762|FG001|Overall Study|Adverse Event|0|||
148791751|NCT00656175|536715761|FG000|Overall Study|Transportation issues|0|||
148791752|NCT00656175|536715762|FG001|Overall Study|Transportation issues|1|||
148791753|NCT01903993|536715766|FG000|Overall Study|Death|118|||
148791754|NCT01903993|536715767|FG001|Overall Study|Death|121|||
148791755|NCT01903993|536715766|FG000|Overall Study|Withdrawal by Subject|15|||
148791756|NCT01903993|536715767|FG001|Overall Study|Withdrawal by Subject|4|||
148791757|NCT01903993|536715766|FG000|Overall Study|Lost to Follow-up|2|||
148791758|NCT01903993|536715767|FG001|Overall Study|Lost to Follow-up|3|||
148791759|NCT01903993|536715766|FG000|Overall Study|Study Terminated by Sponsor|8|||
148791760|NCT01903993|536715767|FG001|Overall Study|Study Terminated by Sponsor|14|||
148791761|NCT01903993|536715766|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
148791762|NCT01903993|536715767|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
148791763|NCT03283930|536715777|FG000|Overall Study|Scheduling conflict|8|||
148791764|NCT03283930|536715778|FG001|Overall Study|Scheduling conflict|10|||
148791765|NCT03283930|536715777|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
148791766|NCT03283930|536715778|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
148791767|NCT03283930|536715777|FG000|Overall Study|Technical software issue|2|||
148791768|NCT03283930|536715778|FG001|Overall Study|Technical software issue|2|||
148791769|NCT00805129|536715779|FG000|Overall Study|Not treated|1|||
148791770|NCT00571662|536715782|FG000|Overall Study|Withdrawal by Subject|2|||
148791771|NCT00571662|536715782|FG000|Overall Study|psychiatric instability|1|||
148791772|NCT00571662|536715782|FG000|Overall Study|Adverse Event|5|||
148791773|NCT01429298|536715785|FG000|Overall Study|Protocol Violation|4|||
148791774|NCT01429298|536715786|FG001|Overall Study|Protocol Violation|6|||
148791775|NCT00396383|536715787|FG000|Overall Study|Death|2|||
148791776|NCT00396383|536715787|FG000|Overall Study|Lost to Follow-up|1|||
148791777|NCT01839916|536715788|FG000|Overall Study|Death|9|||
148791778|NCT01839916|536715788|FG000|Overall Study|Physician Decision|17|||
148791779|NCT01839916|536715788|FG000|Overall Study|Relapse|12|||
148791780|NCT01839916|536715788|FG000|Overall Study|GVHD|2|||
148791781|NCT01839916|536715788|FG000|Overall Study|Graft Failure|1|||
148791782|NCT02385110|536715791|FG000|Overall Study|Early Death|1|||
148791783|NCT02385110|536715792|FG001|Overall Study|Early Death|0|||
148791784|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
148791785|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
149133928|NCT00867113|537970899|FG000|Treatment Period|Disease progression/relapse|1|||
148791786|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
148791787|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
148791788|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
148791789|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
148791790|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
148791791|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
148791792|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
148791793|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
148791794|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
148791795|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
148791796|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
148791797|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
148791798|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
148791799|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
148791800|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
148791801|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
148791802|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
148791803|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
148791804|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
148791805|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
148791806|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
148791807|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
148791808|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
148791809|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
148791810|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
148791811|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
148791812|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
148791813|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
148791814|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
148791815|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
148791816|NCT03538691|536715793|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
148791817|NCT03538691|536715794|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
148791818|NCT03538691|536715795|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
148791819|NCT03538691|536715796|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
148791820|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
148791821|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
148791822|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
148791823|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
148791824|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
148791825|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
148791826|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
148791827|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
148791828|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
148791829|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
148791830|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
148791831|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
148791832|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
148791833|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
148791834|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
148791835|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
148791836|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
148791837|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
148791838|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
148791839|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
148791840|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
148791841|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
148791842|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
148791843|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
148791844|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
148791845|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
148791846|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
148791847|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
148791848|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
148791849|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
148791850|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
148791851|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
148791852|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
148791853|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
148791854|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
148791855|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
148811196|NCT01431976|536787032|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
148811197|NCT01431976|536787032|FG000|Overall Study|Physician Decision|1|||
148791856|NCT03538691|536715793|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
148791857|NCT03538691|536715794|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
148791858|NCT03538691|536715795|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
148791859|NCT03538691|536715796|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
148791860|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
148791861|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
148791862|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
148791863|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
148791864|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
148791865|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
148791866|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
148791867|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
148791868|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
148791869|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
148791870|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
148791871|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
148791872|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
148791873|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
148791874|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
148791875|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
148791876|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
148791877|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
148791878|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
148791879|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
148791880|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
148791881|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
148791882|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
148791883|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
148791884|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
148791885|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
148791886|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
148791887|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
148791888|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
148791889|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
148791890|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
148791891|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
148791892|NCT03538691|536715793|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
148791893|NCT03538691|536715794|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
148791894|NCT03538691|536715795|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
148791895|NCT03538691|536715796|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
148791896|NCT00481767|536715800|FG000|Overall Study|Withdrawal by Subject|16|||
148791897|NCT00481767|536715801|FG001|Overall Study|Withdrawal by Subject|11|||
148791898|NCT00481767|536715800|FG000|Overall Study|Lost to Follow-up|16|||
148791899|NCT00481767|536715801|FG001|Overall Study|Lost to Follow-up|10|||
148791900|NCT01366638|536715802|FG000|Overall Study|Withdrawal by Subject|0|||
148791901|NCT01366638|536715803|FG001|Overall Study|Withdrawal by Subject|0|||
148791902|NCT01366638|536715804|FG002|Overall Study|Withdrawal by Subject|6|||
148791903|NCT01366638|536715802|FG000|Overall Study|Other|1|||
148791904|NCT01366638|536715803|FG001|Overall Study|Other|0|||
148791905|NCT01366638|536715804|FG002|Overall Study|Other|0|||
148791906|NCT00636636|536715805|FG000|Overall Study|Other reason|4|||
148791907|NCT00636636|536715806|FG001|Overall Study|Other reason|6|||
148791908|NCT00636636|536715805|FG000|Overall Study|Adverse Event|19|||
148791909|NCT00636636|536715806|FG001|Overall Study|Adverse Event|8|||
148791910|NCT00636636|536715805|FG000|Overall Study|Lack of Efficacy|7|||
148791911|NCT00636636|536715806|FG001|Overall Study|Lack of Efficacy|12|||
148791912|NCT00636636|536715805|FG000|Overall Study|Protocol Violation|2|||
148791913|NCT00636636|536715806|FG001|Overall Study|Protocol Violation|2|||
148791914|NCT00636636|536715805|FG000|Overall Study|Lost to Follow-up|0|||
148791915|NCT00636636|536715806|FG001|Overall Study|Lost to Follow-up|1|||
148791916|NCT00636636|536715805|FG000|Overall Study|Death|0|||
148791917|NCT00636636|536715806|FG001|Overall Study|Death|1|||
148791918|NCT00636636|536715805|FG000|Overall Study|Withdrawal by Subject|4|||
148791919|NCT00636636|536715806|FG001|Overall Study|Withdrawal by Subject|9|||
148791920|NCT01237327|536715807|FG000|Overall Study|Protocol Violation: Core Study|1|||
148791921|NCT01237327|536715808|FG001|Overall Study|Protocol Violation: Core Study|0|||
148791922|NCT01237327|536715807|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
148791923|NCT01237327|536715808|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
148791924|NCT01237327|536715807|FG000|Overall Study|Progression of Disease: Core Study|18|||
148791925|NCT01237327|536715808|FG001|Overall Study|Progression of Disease: Core Study|22|||
148791926|NCT01237327|536715807|FG000|Overall Study|Progression of Disease: Extension Study|15|||
148791927|NCT01237327|536715808|FG001|Overall Study|Progression of Disease: Extension Study|13|||
148791928|NCT01237327|536715807|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
148791929|NCT01237327|536715808|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
148791930|NCT01237327|536715807|FG000|Overall Study|Withdrawal by Subject|1|||
148791931|NCT01237327|536715808|FG001|Overall Study|Withdrawal by Subject|3|||
148791932|NCT01237327|536715807|FG000|Overall Study|Lost to Follow-up|3|||
148791933|NCT01237327|536715808|FG001|Overall Study|Lost to Follow-up|0|||
148791934|NCT00524173|536715809|FG000|Overall Study|Lost to Follow-up|0|||
148791935|NCT00524173|536715810|FG001|Overall Study|Lost to Follow-up|1|||
148791936|NCT00524173|536715809|FG000|Overall Study|Death|1|||
148791937|NCT00524173|536715810|FG001|Overall Study|Death|0|||
148791938|NCT00524173|536715809|FG000|Overall Study|Had not reached endpoint at study close|4|||
148791939|NCT00524173|536715810|FG001|Overall Study|Had not reached endpoint at study close|1|||
148791940|NCT03300180|536715811|FG000|Baseline|Withdrawal by Subject|4|||
148791941|NCT03300180|536715812|FG001|Baseline|Withdrawal by Subject|6|||
148791942|NCT03300180|536715813|FG002|Baseline|Withdrawal by Subject|4|||
148791943|NCT03300180|536715811|FG000|6 Month Outcome|Withdrawal by Subject|12|||
148791944|NCT03300180|536715812|FG001|6 Month Outcome|Withdrawal by Subject|12|||
148791945|NCT03300180|536715813|FG002|6 Month Outcome|Withdrawal by Subject|19|||
148791946|NCT03300180|536715811|FG000|6 Month Outcome|Death|2|||
148791947|NCT03300180|536715812|FG001|6 Month Outcome|Death|4|||
148791948|NCT03300180|536715813|FG002|6 Month Outcome|Death|3|||
148791949|NCT03300180|536715811|FG000|6 Month Outcome|Missed Assessment|43|||
148791950|NCT03300180|536715812|FG001|6 Month Outcome|Missed Assessment|52|||
148791951|NCT03300180|536715813|FG002|6 Month Outcome|Missed Assessment|46|||
148791952|NCT03300180|536715811|FG000|12 Month Outcome|Withdrawal by Subject|3|||
148791953|NCT03300180|536715812|FG001|12 Month Outcome|Withdrawal by Subject|6|||
148791954|NCT03300180|536715813|FG002|12 Month Outcome|Withdrawal by Subject|6|||
148791955|NCT03300180|536715811|FG000|12 Month Outcome|Death|9|||
148791956|NCT03300180|536715812|FG001|12 Month Outcome|Death|6|||
148791957|NCT03300180|536715813|FG002|12 Month Outcome|Death|6|||
148791958|NCT03300180|536715811|FG000|12 Month Outcome|Missed Assessment|62|||
148791959|NCT03300180|536715812|FG001|12 Month Outcome|Missed Assessment|59|||
148791960|NCT03300180|536715813|FG002|12 Month Outcome|Missed Assessment|58|||
148791961|NCT03300180|536715811|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
148791962|NCT03300180|536715812|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
148791963|NCT03300180|536715813|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
148791964|NCT03300180|536715811|FG000|18 Month Outcome Assessment|Death|8|||
148791965|NCT03300180|536715812|FG001|18 Month Outcome Assessment|Death|5|||
148791966|NCT03300180|536715813|FG002|18 Month Outcome Assessment|Death|5|||
148791967|NCT03300180|536715811|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
148791968|NCT03300180|536715812|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
148791969|NCT03300180|536715813|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
148791970|NCT03300180|536715811|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
148791971|NCT03300180|536715812|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
148791972|NCT03300180|536715813|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
148791973|NCT03300180|536715811|FG000|24 Month Outcome Assessment|Death|13|||
148791974|NCT03300180|536715812|FG001|24 Month Outcome Assessment|Death|13|||
149133929|NCT00867113|537970899|FG000|Treatment Period|Protocol Violation|4|||
149133930|NCT00867113|537970899|FG000|Post Treatment After Survival Follow-up|Death|1|||
149133931|NCT00867113|537970899|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
149133932|NCT00867113|537970899|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
149133933|NCT00867113|537970899|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
149133934|NCT01145495|537970900|FG000|Overall Study|Adverse Event|6|||
149133935|NCT01145495|537970900|FG000|Overall Study|Withdrawal by Subject|6|||
149133936|NCT01145495|537970900|FG000|Overall Study|Disease progression after respone|2|||
149133937|NCT01886313|537970903|FG000|Overall Study|Adverse Event|1|||
148791975|NCT03300180|536715813|FG002|24 Month Outcome Assessment|Death|3|||
148791976|NCT03300180|536715811|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
148791977|NCT03300180|536715812|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
148791978|NCT03300180|536715813|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
149133938|NCT01886313|537970904|FG001|Overall Study|Adverse Event|1|||
148791979|NCT01554163|536715818|FG000|Overall Study|Adverse Event|3|||
148791980|NCT01554163|536715819|FG001|Overall Study|Adverse Event|0|||
148791981|NCT01554163|536715818|FG000|Overall Study|Lack of Efficacy|1|||
148791982|NCT01554163|536715819|FG001|Overall Study|Lack of Efficacy|0|||
148791983|NCT01554163|536715818|FG000|Overall Study|Lost to Follow-up|1|||
148791984|NCT01554163|536715819|FG001|Overall Study|Lost to Follow-up|0|||
148791985|NCT01554163|536715818|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149133939|NCT04614662|537970905|FG000|Overall Study|Withdrawal by Subject|0|||
149133940|NCT04614662|537970906|FG001|Overall Study|Withdrawal by Subject|1|||
149133941|NCT01230788|537970909|FG000|Overall Study|Prescribed exclusion drug|1|||
149133942|NCT00323297|537970910|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
149133943|NCT00323297|537970911|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
149133944|NCT00323297|537970910|FG000|Part A (Double Blind Randomized)|Death|0|||
149133945|NCT00323297|537970911|FG001|Part A (Double Blind Randomized)|Death|1|||
149133946|NCT00323297|537970910|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
149133947|NCT00323297|537970911|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
149133948|NCT00323297|537970910|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
149133949|NCT00323297|537970911|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
149133950|NCT00323297|537970910|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
149133951|NCT00323297|537970911|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
149133952|NCT00323297|537970910|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
149133953|NCT00323297|537970911|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
149133954|NCT00323297|537970910|FG000|Part B (Open-label)|Death|0|||
149133955|NCT00323297|537970911|FG001|Part B (Open-label)|Death|1|||
149133956|NCT00323297|537970910|FG000|Part B (Open-label)|Reason unspecified|0|||
149133957|NCT00323297|537970911|FG001|Part B (Open-label)|Reason unspecified|1|||
149133958|NCT00323297|537970910|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
149133959|NCT00323297|537970911|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
149133960|NCT00323297|537970910|FG000|Part B (Open-label)|Lack of Efficacy|3|||
149133961|NCT00323297|537970911|FG001|Part B (Open-label)|Lack of Efficacy|1|||
149133962|NCT00323297|537970910|FG000|Part B (Open-label)|Adverse Event|5|||
149133963|NCT00323297|537970911|FG001|Part B (Open-label)|Adverse Event|5|||
149133964|NCT00323297|537970910|FG000|Part B (Open-label)|Protocol Violation|0|||
149133965|NCT00323297|537970911|FG001|Part B (Open-label)|Protocol Violation|1|||
149133966|NCT01774084|537970913|FG000|Overall Study|Personal reasons|1|||
149133967|NCT01774084|537970914|FG001|Overall Study|Personal reasons|0|||
149133968|NCT02973048|537970915|FG000|Overall Study|Epidural catheter insertion failure|1|||
149133969|NCT02973048|537970916|FG001|Overall Study|Epidural catheter insertion failure|0|||
149133970|NCT02973048|537970915|FG000|Overall Study|Withdrawal by Subject|0|||
149133971|NCT02973048|537970916|FG001|Overall Study|Withdrawal by Subject|3|||
149133972|NCT01906346|537970920|FG000|Overall Study|AEs|1|||
149133973|NCT04226833|537970921|FG000|Overall Study|Death|0|||
149133974|NCT04226833|537970922|FG001|Overall Study|Death|0|||
149133975|NCT04226833|537970923|FG002|Overall Study|Death|1|||
149133976|NCT04226833|537970924|FG003|Overall Study|Death|0|||
149133977|NCT00688181|537970927|FG000|Overall Study|Lost to Follow-up|17|||
149133978|NCT00688181|537970927|FG000|Overall Study|Unknown Reason|4|||
149133979|NCT00688181|537970927|FG000|Overall Study|Non-clinical Reason|2|||
149133980|NCT01050205|537970928|FG000|Overall Study|Lost to Follow-up|7|||
149133981|NCT01050205|537970929|FG001|Overall Study|Lost to Follow-up|1|||
149133982|NCT01050205|537970928|FG000|Overall Study|Withdrawal by Subject|1|||
149133983|NCT01050205|537970929|FG001|Overall Study|Withdrawal by Subject|1|||
149133984|NCT01050205|537970928|FG000|Overall Study|Relocated from area|1|||
149133985|NCT01050205|537970929|FG001|Overall Study|Relocated from area|2|||
149133986|NCT01050205|537970928|FG000|Overall Study|Discontinued Intervention|2|||
149133987|NCT01050205|537970929|FG001|Overall Study|Discontinued Intervention|0|||
149133988|NCT00364156|537970930|FG000|Overall Study|Withdrawal by Subject|73|||
149133989|NCT00364156|537970931|FG001|Overall Study|Withdrawal by Subject|80|||
149133990|NCT00364156|537970930|FG000|Overall Study|Protocol Violation|6|||
149133991|NCT00364156|537970931|FG001|Overall Study|Protocol Violation|1|||
149133992|NCT01472380|537970932|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
149133993|NCT01472380|537970932|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
149133994|NCT02511678|537970933|FG000|Overall Study|Withdrawal by Subject|2|||
148791986|NCT01554163|536715819|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148791987|NCT01554163|536715818|FG000|Overall Study|Protocol Violation|0|||
148791988|NCT01554163|536715819|FG001|Overall Study|Protocol Violation|4|||
148791989|NCT01554163|536715818|FG000|Overall Study|Withdrawal by Subject|1|||
148791990|NCT01554163|536715819|FG001|Overall Study|Withdrawal by Subject|5|||
148791991|NCT01554163|536715818|FG000|Overall Study|Not Treated|1|||
148791992|NCT01554163|536715819|FG001|Overall Study|Not Treated|0|||
148791993|NCT01941537|536715820|FG000|Overall Study|Lack of Efficacy|1|||
148791994|NCT01941537|536715821|FG001|Overall Study|Lack of Efficacy|2|||
148791995|NCT01941537|536715820|FG000|Overall Study|Lost to Follow-up|1|||
148791996|NCT01941537|536715821|FG001|Overall Study|Lost to Follow-up|0|||
148791997|NCT01941537|536715820|FG000|Overall Study|Pregnancy|1|||
148791998|NCT01941537|536715821|FG001|Overall Study|Pregnancy|0|||
149133995|NCT02511678|537970933|FG000|Overall Study|Lost to Follow-up|4|||
149133996|NCT02511678|537970933|FG000|Overall Study|Death|19|||
149133997|NCT02511678|537970933|FG000|Overall Study|Adverse Event|1|||
149133998|NCT02511678|537970933|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
148791999|NCT01941537|536715820|FG000|Overall Study|Adverse Event|1|||
148792000|NCT01941537|536715821|FG001|Overall Study|Adverse Event|0|||
148792001|NCT01941537|536715820|FG000|Overall Study|Withdrawal by Subject|0|||
148792002|NCT01941537|536715821|FG001|Overall Study|Withdrawal by Subject|1|||
148792003|NCT02557516|536715823|FG000|Overall Study|Adverse Event|1|||
148792004|NCT02557516|536715824|FG001|Overall Study|Adverse Event|0|||
148792005|NCT02557516|536715825|FG002|Overall Study|Adverse Event|2|||
148792006|NCT02557516|536715826|FG003|Overall Study|Adverse Event|1|||
148792007|NCT02557516|536715823|FG000|Overall Study|Disease progression|0|||
148792008|NCT02557516|536715824|FG001|Overall Study|Disease progression|2|||
148792009|NCT02557516|536715825|FG002|Overall Study|Disease progression|0|||
148792010|NCT02557516|536715826|FG003|Overall Study|Disease progression|0|||
148792011|NCT02557516|536715823|FG000|Overall Study|Physician Decision|0|||
148792012|NCT02557516|536715824|FG001|Overall Study|Physician Decision|2|||
148792013|NCT02557516|536715825|FG002|Overall Study|Physician Decision|0|||
148792014|NCT02557516|536715826|FG003|Overall Study|Physician Decision|0|||
148792015|NCT02557516|536715823|FG000|Overall Study|Sponsor decision|0|||
148792016|NCT02557516|536715824|FG001|Overall Study|Sponsor decision|1|||
148792017|NCT02557516|536715825|FG002|Overall Study|Sponsor decision|2|||
148792018|NCT02557516|536715826|FG003|Overall Study|Sponsor decision|8|||
148792019|NCT01243177|536715827|FG000|Overall Study|Lack of Efficacy|47|||
148792020|NCT01243177|536715828|FG001|Overall Study|Lack of Efficacy|31|||
148792021|NCT01243177|536715827|FG000|Overall Study|Protocol Violation|11|||
148792022|NCT01243177|536715828|FG001|Overall Study|Protocol Violation|10|||
148792023|NCT01243177|536715827|FG000|Overall Study|Lost to Follow-up|15|||
148792024|NCT01243177|536715828|FG001|Overall Study|Lost to Follow-up|18|||
148792025|NCT01243177|536715827|FG000|Overall Study|Withdrawal by Subject|46|||
148792026|NCT01243177|536715828|FG001|Overall Study|Withdrawal by Subject|38|||
148792027|NCT01243177|536715827|FG000|Overall Study|AE, serious fatal|0|||
148792028|NCT01243177|536715828|FG001|Overall Study|AE, serious fatal|1|||
148792029|NCT01243177|536715827|FG000|Overall Study|SAE, non-fatal|7|||
148792030|NCT01243177|536715828|FG001|Overall Study|SAE, non-fatal|9|||
148792031|NCT01243177|536715827|FG000|Overall Study|AE, non-serious non-fatal|40|||
148792032|NCT01243177|536715828|FG001|Overall Study|AE, non-serious non-fatal|58|||
148792033|NCT01243177|536715827|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
148792034|NCT01243177|536715828|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
148792035|NCT01243177|536715827|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
148792036|NCT01243177|536715828|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
148792037|NCT01243177|536715827|FG000|Overall Study|Other Reason|11|||
148792038|NCT01243177|536715828|FG001|Overall Study|Other Reason|12|||
148792039|NCT01239394|536717926|FG000|Overall Study|Adverse Event|1|||
148792040|NCT00524771|536717928|FG000|Overall Study|Protocol Violation|220|||
148792041|NCT00524771|536717929|FG001|Overall Study|Protocol Violation|585|||
148792042|NCT02915159|536717932|FG000|Overall Study|Participant no longer meets criteria|2|||
148792043|NCT02915159|536717933|FG001|Overall Study|Participant no longer meets criteria|0|||
148792044|NCT02915159|536717932|FG000|Overall Study|poor/non-compliance|1|||
148792045|NCT02915159|536717933|FG001|Overall Study|poor/non-compliance|0|||
148792046|NCT02915159|536717932|FG000|Overall Study|Participant withdrew consent|5|||
148792047|NCT02915159|536717933|FG001|Overall Study|Participant withdrew consent|1|||
148792048|NCT02915159|536717932|FG000|Overall Study|Request to discontinue treatment|1|||
148792049|NCT02915159|536717933|FG001|Overall Study|Request to discontinue treatment|2|||
148792050|NCT02915159|536717932|FG000|Overall Study|Adverse Event|2|||
148792051|NCT02915159|536717933|FG001|Overall Study|Adverse Event|2|||
148792052|NCT02915159|536717932|FG000|Overall Study|Lack of Efficacy|0|||
148792053|NCT02915159|536717933|FG001|Overall Study|Lack of Efficacy|3|||
148792054|NCT00823264|536717934|FG000|Overall Study|Protocol Violation|2|||
148792055|NCT00823264|536717935|FG001|Overall Study|Protocol Violation|0|||
148792056|NCT01968811|536717939|FG000|Overall Study|Protocol Violation|4|||
148792057|NCT01968811|536717939|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
148792058|NCT01716663|536717940|FG000|Overall Study|Withdrawn prior to procedure|4|||
148792059|NCT01716663|536717940|FG000|Overall Study|Treated with non-study catheter|2|||
148792060|NCT01300247|536717946|FG000|Overall Study|Death|1|||
148792061|NCT01300247|536717947|FG001|Overall Study|Death|1|||
148792062|NCT01300247|536717946|FG000|Overall Study|Lost to Follow-up|2|||
148792063|NCT01300247|536717947|FG001|Overall Study|Lost to Follow-up|0|||
148792064|NCT01300247|536717946|FG000|Overall Study|Withdrawal by Subject|1|||
148792065|NCT01300247|536717947|FG001|Overall Study|Withdrawal by Subject|0|||
148792066|NCT01300247|536717946|FG000|Overall Study|Non-Compliance|0|||
148792067|NCT01300247|536717947|FG001|Overall Study|Non-Compliance|1|||
148792068|NCT00922116|536717948|FG000|Overall Study|Adverse Event|4|||
148792069|NCT00922116|536717948|FG000|Overall Study|Death|1|||
148792070|NCT00922116|536717948|FG000|Overall Study|Lost to Follow-up|1|||
148792071|NCT00922116|536717948|FG000|Overall Study|Withdrawal by Subject|4|||
148792072|NCT00922116|536717948|FG000|Overall Study|Other|5|||
148792073|NCT06060496|536717949|FG000|Overall Study|Withdrawal by Subject|2|||
148792074|NCT06060496|536717949|FG000|Overall Study|Lost to Follow-up|2|||
148792075|NCT02028507|536717950|FG000|Overall Study|Progressive Disease|122|||
148792076|NCT02028507|536717951|FG001|Overall Study|Progressive Disease|90|||
148792077|NCT02028507|536717952|FG002|Overall Study|Progressive Disease|102|||
148792078|NCT02028507|536717953|FG003|Overall Study|Progressive Disease|89|||
148792079|NCT02028507|536717950|FG000|Overall Study|Adverse Event|8|||
148792080|NCT02028507|536717951|FG001|Overall Study|Adverse Event|25|||
148792081|NCT02028507|536717952|FG002|Overall Study|Adverse Event|3|||
148792082|NCT02028507|536717953|FG003|Overall Study|Adverse Event|16|||
148792083|NCT02028507|536717950|FG000|Overall Study|Withdrawal by Subject|6|||
148792084|NCT02028507|536717951|FG001|Overall Study|Withdrawal by Subject|8|||
148792085|NCT02028507|536717952|FG002|Overall Study|Withdrawal by Subject|5|||
148792086|NCT02028507|536717953|FG003|Overall Study|Withdrawal by Subject|9|||
148792087|NCT02028507|536717950|FG000|Overall Study|Protocol Violation|2|||
148792088|NCT02028507|536717951|FG001|Overall Study|Protocol Violation|4|||
148792089|NCT02028507|536717952|FG002|Overall Study|Protocol Violation|1|||
148792090|NCT02028507|536717953|FG003|Overall Study|Protocol Violation|3|||
148792091|NCT02028507|536717950|FG000|Overall Study|Physician Decision|0|||
148792092|NCT02028507|536717951|FG001|Overall Study|Physician Decision|4|||
148792093|NCT02028507|536717952|FG002|Overall Study|Physician Decision|0|||
148792094|NCT02028507|536717953|FG003|Overall Study|Physician Decision|0|||
148792095|NCT02028507|536717950|FG000|Overall Study|Death|1|||
148792096|NCT02028507|536717951|FG001|Overall Study|Death|0|||
148792097|NCT02028507|536717952|FG002|Overall Study|Death|1|||
148792098|NCT02028507|536717953|FG003|Overall Study|Death|3|||
148792099|NCT02028507|536717950|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
148792100|NCT02028507|536717951|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
148792101|NCT02028507|536717952|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
148792102|NCT02028507|536717953|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
148792103|NCT02028507|536717950|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
148792104|NCT02028507|536717951|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
148792105|NCT02028507|536717952|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
148792106|NCT02028507|536717953|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
148792107|NCT02028507|536717950|FG000|Overall Study|Randomized But Not Treated|3|||
148792108|NCT02028507|536717951|FG001|Overall Study|Randomized But Not Treated|6|||
148792109|NCT02028507|536717952|FG002|Overall Study|Randomized But Not Treated|0|||
148792110|NCT02028507|536717953|FG003|Overall Study|Randomized But Not Treated|4|||
148792111|NCT02028507|536717950|FG000|Overall Study|Enzyme defect|0|||
148792112|NCT02028507|536717951|FG001|Overall Study|Enzyme defect|0|||
148792113|NCT02028507|536717952|FG002|Overall Study|Enzyme defect|0|||
148792114|NCT02028507|536717953|FG003|Overall Study|Enzyme defect|1|||
148792115|NCT02028507|536717950|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
148792116|NCT02028507|536717951|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
148792117|NCT02028507|536717952|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
148792118|NCT02028507|536717953|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
148792119|NCT02028507|536717950|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
148792120|NCT02028507|536717951|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
148792121|NCT02028507|536717952|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
148792122|NCT02028507|536717953|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
148792123|NCT02258659|536717954|FG000|Overall Study|Withdrawal by Subject|1|||
148792124|NCT03990051|536717955|FG000|Masked Period|Lost to Follow-up|1|||
148792125|NCT03990051|536717956|FG001|Masked Period|Lost to Follow-up|0|||
148792126|NCT03990051|536717955|FG000|Long Term Period|Death|1|||
148792127|NCT03990051|536717956|FG001|Long Term Period|Death|1|||
148792128|NCT03990051|536717955|FG000|Long Term Period|Lost to Follow-up|7|||
148792129|NCT03990051|536717956|FG001|Long Term Period|Lost to Follow-up|2|||
148792130|NCT00272844|536717957|FG000|Overall Study|Withdrawal by Subject|5|||
148792131|NCT03060291|536717958|FG000|3-month Follow-up|Declined to respond|8|||
148792132|NCT03060291|536717959|FG001|3-month Follow-up|Declined to respond|10|||
148792133|NCT03060291|536717960|FG002|3-month Follow-up|Declined to respond|2|||
148792134|NCT03060291|536717958|FG000|6-month Follow-up|Declined to respond|7|||
148792135|NCT03060291|536717959|FG001|6-month Follow-up|Declined to respond|13|||
148792136|NCT03060291|536717960|FG002|6-month Follow-up|Declined to respond|4|||
148792137|NCT03060291|536717958|FG000|12-month Follow-up|Declined to respond|7|||
148792138|NCT03060291|536717959|FG001|12-month Follow-up|Declined to respond|16|||
148792139|NCT03060291|536717960|FG002|12-month Follow-up|Declined to respond|6|||
148792140|NCT00618826|536717961|FG000|Overall Study|Adverse Event|1|||
148792141|NCT01509664|536717963|FG000|Overall Study|Lost to Follow-up|15|||
148792142|NCT01509664|536717964|FG001|Overall Study|Lost to Follow-up|21|||
148792143|NCT01556932|536717965|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
148792144|NCT01556932|536717966|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
148792145|NCT03743025|536717967|FG000|Overall Study|Surgery was cancelled|2|||
148792146|NCT03743025|536717968|FG001|Overall Study|Surgery was cancelled|1|||
148792147|NCT00791700|536717971|FG000|Overall Study|Insufficient clinical response|1|||
148792148|NCT00791700|536717972|FG001|Overall Study|Insufficient clinical response|4|||
148792149|NCT00791700|536717973|FG002|Overall Study|Insufficient clinical response|1|||
148792150|NCT00791700|536717974|FG003|Overall Study|Insufficient clinical response|8|||
148792151|NCT00791700|536717971|FG000|Overall Study|No longer willing to participate|1|||
148792152|NCT00791700|536717972|FG001|Overall Study|No longer willing to participate|1|||
148792153|NCT00791700|536717973|FG002|Overall Study|No longer willing to participate|0|||
148792154|NCT00791700|536717974|FG003|Overall Study|No longer willing to participate|8|||
148792155|NCT00791700|536717971|FG000|Overall Study|Non-compliance with study treatment|0|||
148792156|NCT00791700|536717972|FG001|Overall Study|Non-compliance with study treatment|2|||
148792157|NCT00791700|536717973|FG002|Overall Study|Non-compliance with study treatment|0|||
148792158|NCT00791700|536717974|FG003|Overall Study|Non-compliance with study treatment|4|||
148792159|NCT00791700|536717971|FG000|Overall Study|Withdrawn due to pregnancy|0|||
148792160|NCT00791700|536717972|FG001|Overall Study|Withdrawn due to pregnancy|0|||
148792161|NCT00791700|536717973|FG002|Overall Study|Withdrawn due to pregnancy|0|||
148792162|NCT00791700|536717974|FG003|Overall Study|Withdrawn due to pregnancy|1|||
148792163|NCT00791700|536717971|FG000|Overall Study|Other|0|||
148792164|NCT00791700|536717972|FG001|Overall Study|Other|1|||
148792165|NCT00791700|536717973|FG002|Overall Study|Other|0|||
148792166|NCT00791700|536717974|FG003|Overall Study|Other|1|||
148792167|NCT00791700|536717971|FG000|Overall Study|Death|0|||
148792168|NCT00791700|536717972|FG001|Overall Study|Death|0|||
148792169|NCT00791700|536717973|FG002|Overall Study|Death|0|||
148792170|NCT00791700|536717974|FG003|Overall Study|Death|1|||
148792171|NCT00791700|536717971|FG000|Overall Study|Lost to Follow-up|4|||
148792172|NCT00791700|536717972|FG001|Overall Study|Lost to Follow-up|3|||
148792173|NCT00791700|536717973|FG002|Overall Study|Lost to Follow-up|4|||
148792174|NCT00791700|536717974|FG003|Overall Study|Lost to Follow-up|6|||
148792175|NCT00791700|536717971|FG000|Overall Study|Adverse Event|0|||
148792176|NCT00791700|536717972|FG001|Overall Study|Adverse Event|0|||
148792177|NCT00791700|536717973|FG002|Overall Study|Adverse Event|1|||
148792178|NCT00791700|536717974|FG003|Overall Study|Adverse Event|1|||
148792179|NCT01720524|536717977|FG000|Part A|Insufficient Clinical Response|2|||
148792180|NCT01720524|536717978|FG001|Part A|Insufficient Clinical Response|4|||
148792181|NCT01720524|536717977|FG000|Part A|Adverse Event|2|||
148792182|NCT01720524|536717978|FG001|Part A|Adverse Event|2|||
148792183|NCT01720524|536717977|FG000|Part A|Death|2|||
148792184|NCT01720524|536717978|FG001|Part A|Death|1|||
148792185|NCT01720524|536717977|FG000|Part A|Lost to Follow-up|0|||
148792186|NCT01720524|536717978|FG001|Part A|Lost to Follow-up|1|||
148792187|NCT01720524|536717977|FG000|Part A|Missed 28 day follow-up visit|1|||
148792188|NCT01720524|536717978|FG001|Part A|Missed 28 day follow-up visit|1|||
148792189|NCT01720524|536717977|FG000|Part A|Withdrawal by Subject|0|||
148792190|NCT01720524|536717978|FG001|Part A|Withdrawal by Subject|1|||
148792191|NCT01720524|536717977|FG000|Part A|Other|0|||
148792192|NCT01720524|536717978|FG001|Part A|Other|1|||
148792193|NCT01720524|536717977|FG000|Part A|Lost to Follow-up|0|||
148792194|NCT01720524|536717978|FG001|Part A|Lost to Follow-up|1|||
148792195|NCT01720524|536717977|FG000|Part B|No longer willing to participate in study|1|||
148792196|NCT01720524|536717978|FG001|Part B|No longer willing to participate in study|4|||
148792197|NCT01720524|536717977|FG000|Part B|Other|2|||
148792198|NCT01720524|536717978|FG001|Part B|Other|0|||
148792199|NCT01720524|536717977|FG000|Part B|Lost to Follow-up|2|||
148792200|NCT01720524|536717978|FG001|Part B|Lost to Follow-up|3|||
148792201|NCT01720524|536717977|FG000|Part B|Death|0|||
148792202|NCT01720524|536717978|FG001|Part B|Death|2|||
148792203|NCT00996034|536717979|FG000|Overall Study|Lost to Follow-up|2|||
148792204|NCT00996034|536717979|FG000|Overall Study|withdrawn by PI|1|||
148792205|NCT00158262|536717983|FG000|Overall Study|Lost to Follow-up|1|||
148792206|NCT00158262|536717984|FG001|Overall Study|Lost to Follow-up|1|||
149133999|NCT02511678|537970933|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
149134000|NCT02511678|537970933|FG000|Overall Study|Required Radiofrequency Ablation|1|||
149134001|NCT02511678|537970933|FG000|Overall Study|Biopsy was Negative|1|||
149134002|NCT02511678|537970933|FG000|Overall Study|Protocol Violation|1|||
149134003|NCT02511678|537970933|FG000|Overall Study|Received Radiation Treatment|1|||
149134004|NCT00633061|537970936|FG000|Overall Study|Study closed|86|||
149134005|NCT00633061|537970937|FG001|Overall Study|Study closed|0|||
149134006|NCT02708095|537970938|FG000|Overall Study|Adverse Event|4|||
149134007|NCT02708095|537970939|FG001|Overall Study|Adverse Event|10|||
149134008|NCT02708095|537970940|FG002|Overall Study|Adverse Event|11|||
149134009|NCT02708095|537970938|FG000|Overall Study|Lack of Efficacy|9|||
149134010|NCT02708095|537970939|FG001|Overall Study|Lack of Efficacy|3|||
149134011|NCT02708095|537970940|FG002|Overall Study|Lack of Efficacy|0|||
149134012|NCT02708095|537970938|FG000|Overall Study|Lost to Follow-up|2|||
148792207|NCT00527826|536717985|FG000|Overall Study|Adverse Event|10|||
148792208|NCT00527826|536717986|FG001|Overall Study|Adverse Event|10|||
148792209|NCT00527826|536717985|FG000|Overall Study|Lost to Follow-up|3|||
148792210|NCT00527826|536717986|FG001|Overall Study|Lost to Follow-up|2|||
148792211|NCT00527826|536717985|FG000|Overall Study|Withdrawal by Subject|5|||
149134013|NCT02708095|537970939|FG001|Overall Study|Lost to Follow-up|0|||
148792212|NCT00527826|536717986|FG001|Overall Study|Withdrawal by Subject|8|||
149134014|NCT02708095|537970940|FG002|Overall Study|Lost to Follow-up|0|||
149134015|NCT02708095|537970938|FG000|Overall Study|Physician Decision|2|||
148792213|NCT00527826|536717985|FG000|Overall Study|Inclusion Criteria Not Met|3|||
148792214|NCT00527826|536717986|FG001|Overall Study|Inclusion Criteria Not Met|3|||
148792215|NCT00527826|536717985|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
148792216|NCT00527826|536717986|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
148792217|NCT00527826|536717985|FG000|Overall Study|Additional Intake of Viani forte|0|||
148792218|NCT00527826|536717986|FG001|Overall Study|Additional Intake of Viani forte|1|||
148792219|NCT00527826|536717985|FG000|Overall Study|Participant moved away|0|||
148792220|NCT00527826|536717986|FG001|Overall Study|Participant moved away|1|||
148792221|NCT01421641|536717989|FG000|Overall Study|Protocol Violation|2|||
148792222|NCT01421641|536717990|FG001|Overall Study|Protocol Violation|2|||
148792223|NCT02420119|536717992|FG000|Overall Study|insufficient laboratory data|5|||
148792224|NCT02364388|536717993|FG000|Overall Study|Protocol Violation|1|||
148792225|NCT02364388|536717993|FG000|Overall Study|Technical Failure|3|||
148792226|NCT02364388|536717993|FG000|Overall Study|No OA/US data|2|||
148792227|NCT02364388|536717993|FG000|Overall Study|No Biopsy|2|||
148792228|NCT03231306|536717994|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
148792229|NCT03231306|536717994|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
148792230|NCT03231306|536717994|FG000|Overall Study|Treatment delay > 21 days|2|||
148792231|NCT03231306|536717994|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
148792232|NCT03231306|536717994|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
148792233|NCT03231306|536717994|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
148792234|NCT03231306|536717994|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
148792235|NCT03231306|536717994|FG000|Overall Study|More than 1 Reason|2|||
148792236|NCT01808261|536717995|FG000|Overall Study|Physician Decision|0|||
148792237|NCT01808261|536717996|FG001|Overall Study|Physician Decision|2|||
148792238|NCT01808261|536717995|FG000|Overall Study|Study Closed/Terminated|25|||
148792239|NCT01808261|536717996|FG001|Overall Study|Study Closed/Terminated|23|||
148792240|NCT01808261|536717995|FG000|Overall Study|Adverse event, non-fatal|2|||
148792241|NCT01808261|536717996|FG001|Overall Study|Adverse event, non-fatal|0|||
148792242|NCT01808261|536717995|FG000|Overall Study|Consent withdrawn by subject|6|||
148792243|NCT01808261|536717996|FG001|Overall Study|Consent withdrawn by subject|7|||
148792244|NCT01808261|536717995|FG000|Overall Study|Lost to Follow-up|3|||
148792245|NCT01808261|536717996|FG001|Overall Study|Lost to Follow-up|1|||
148792246|NCT04501952|536718001|FG000|Overall Study|Adverse Event|0|||
148792247|NCT04501952|536718002|FG001|Overall Study|Adverse Event|3|||
148792248|NCT04501952|536718001|FG000|Overall Study|Investigator's Discretion|0|||
148792249|NCT04501952|536718002|FG001|Overall Study|Investigator's Discretion|1|||
148792250|NCT04501952|536718001|FG000|Overall Study|Protocol Violation|1|||
148792251|NCT04501952|536718002|FG001|Overall Study|Protocol Violation|1|||
148792252|NCT04501952|536718001|FG000|Overall Study|Withdrew Consent|5|||
148792253|NCT04501952|536718002|FG001|Overall Study|Withdrew Consent|4|||
148792254|NCT04501952|536718001|FG000|Overall Study|Lost to Follow-up|7|||
148792255|NCT04501952|536718002|FG001|Overall Study|Lost to Follow-up|2|||
148792256|NCT04501952|536718001|FG000|Overall Study|Randomized and Never Treated|13|||
148792257|NCT04501952|536718002|FG001|Overall Study|Randomized and Never Treated|9|||
148792258|NCT02080364|536718003|FG000|Baseline Period|Protocol Violation|2|||
148792259|NCT02080364|536718004|FG001|Baseline Period|Protocol Violation|1|||
148792260|NCT02080364|536718005|FG002|Baseline Period|Protocol Violation|0|||
148792261|NCT02080364|536718006|FG003|Baseline Period|Protocol Violation|0|||
148792262|NCT02080364|536718003|FG000|Baseline Period|Other|0|||
148792263|NCT02080364|536718004|FG001|Baseline Period|Other|1|||
148792264|NCT02080364|536718005|FG002|Baseline Period|Other|1|||
148792265|NCT02080364|536718006|FG003|Baseline Period|Other|0|||
148792266|NCT02080364|536718003|FG000|Treatment Period|Adverse Event|10|||
148792267|NCT02080364|536718004|FG001|Treatment Period|Adverse Event|15|||
148792268|NCT02080364|536718005|FG002|Treatment Period|Adverse Event|11|||
148792269|NCT02080364|536718006|FG003|Treatment Period|Adverse Event|14|||
148792270|NCT02080364|536718003|FG000|Treatment Period|Lost to Follow-up|2|||
148792271|NCT02080364|536718004|FG001|Treatment Period|Lost to Follow-up|3|||
148792272|NCT02080364|536718005|FG002|Treatment Period|Lost to Follow-up|5|||
148792273|NCT02080364|536718006|FG003|Treatment Period|Lost to Follow-up|0|||
148792274|NCT02080364|536718003|FG000|Treatment Period|Protocol Violation|5|||
148792275|NCT02080364|536718004|FG001|Treatment Period|Protocol Violation|3|||
148792276|NCT02080364|536718005|FG002|Treatment Period|Protocol Violation|5|||
148792277|NCT02080364|536718006|FG003|Treatment Period|Protocol Violation|1|||
148792278|NCT02080364|536718003|FG000|Treatment Period|Withdrawal by Subject|16|||
148792279|NCT02080364|536718004|FG001|Treatment Period|Withdrawal by Subject|16|||
148792280|NCT02080364|536718005|FG002|Treatment Period|Withdrawal by Subject|15|||
148792281|NCT02080364|536718006|FG003|Treatment Period|Withdrawal by Subject|10|||
148792282|NCT02080364|536718003|FG000|Treatment Period|Study Terminated by Sponsor|0|||
148792283|NCT02080364|536718004|FG001|Treatment Period|Study Terminated by Sponsor|0|||
148792284|NCT02080364|536718005|FG002|Treatment Period|Study Terminated by Sponsor|180|||
148792285|NCT02080364|536718006|FG003|Treatment Period|Study Terminated by Sponsor|183|||
148792286|NCT02080364|536718003|FG000|Treatment Period|Other|14|||
148792287|NCT02080364|536718004|FG001|Treatment Period|Other|12|||
148792288|NCT02080364|536718005|FG002|Treatment Period|Other|21|||
148792289|NCT02080364|536718006|FG003|Treatment Period|Other|16|||
148792290|NCT00991289|536718007|FG000|Overall Study|Adverse Event|1|||
149134016|NCT02708095|537970939|FG001|Overall Study|Physician Decision|3|||
148792291|NCT00991289|536718007|FG000|Overall Study|Physician Decision|2|||
148792292|NCT00991289|536718007|FG000|Overall Study|Withdrawal by Subject|3|||
148792293|NCT00991289|536718007|FG000|Overall Study|Lost to Follow-up|4|||
148792294|NCT00991289|536718007|FG000|Overall Study|Protocol Violation|2|||
148792295|NCT02256839|536718009|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
148792296|NCT02256839|536718010|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
148792297|NCT01843803|536718011|FG000|Overall Study|not a Veteran, did not see provider|1|||
148792298|NCT01843803|536718012|FG001|Overall Study|not a Veteran, did not see provider|3|||
148792299|NCT00436826|536718016|FG000|Double Blind Period (DBP)|Adverse Event|2|||
148792300|NCT00436826|536718017|FG001|Double Blind Period (DBP)|Adverse Event|0|||
148792301|NCT00436826|536718018|FG002|Double Blind Period (DBP)|Adverse Event|0|||
148792302|NCT00436826|536718019|FG003|Double Blind Period (DBP)|Adverse Event|0|||
148792303|NCT00436826|536718020|FG004|Double Blind Period (DBP)|Adverse Event|0|||
148792304|NCT00436826|536718021|FG005|Double Blind Period (DBP)|Adverse Event|0|||
148792305|NCT00436826|536718016|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
148792306|NCT00436826|536718017|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
148792307|NCT00436826|536718018|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
148792308|NCT00436826|536718019|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
148792309|NCT00436826|536718020|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
148792310|NCT00436826|536718021|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
148792311|NCT00436826|536718016|FG000|Double Blind Period (DBP)|Other|10|||
148792312|NCT00436826|536718017|FG001|Double Blind Period (DBP)|Other|11|||
148792313|NCT00436826|536718018|FG002|Double Blind Period (DBP)|Other|0|||
148792314|NCT00436826|536718019|FG003|Double Blind Period (DBP)|Other|0|||
148792315|NCT00436826|536718020|FG004|Double Blind Period (DBP)|Other|0|||
148792316|NCT00436826|536718021|FG005|Double Blind Period (DBP)|Other|0|||
148792317|NCT00436826|536718016|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
148792318|NCT00436826|536718017|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
148792319|NCT00436826|536718018|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
148792320|NCT00436826|536718019|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
148792321|NCT00436826|536718020|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
148792322|NCT00436826|536718021|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
148792323|NCT00436826|536718016|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
148792324|NCT00436826|536718017|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
148792325|NCT00436826|536718018|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
148792326|NCT00436826|536718019|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
148792327|NCT00436826|536718020|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
148792328|NCT00436826|536718021|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
148792329|NCT00436826|536718016|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
148792330|NCT00436826|536718017|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
148792331|NCT00436826|536718018|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
148792332|NCT00436826|536718019|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
148792333|NCT00436826|536718020|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
148792334|NCT00436826|536718021|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
148792335|NCT00110357|536718028|FG000|Overall Study|Deterioration without progression|2|||
148792336|NCT00110357|536718029|FG001|Overall Study|Deterioration without progression|0|||
148792337|NCT00110357|536718028|FG000|Overall Study|Disease progression/relapse|20|||
148792338|NCT00110357|536718029|FG001|Overall Study|Disease progression/relapse|15|||
148792339|NCT00110357|536718028|FG000|Overall Study|Study Closure|1|||
148792340|NCT00110357|536718029|FG001|Overall Study|Study Closure|0|||
148792341|NCT00110357|536718028|FG000|Overall Study|Study Drug Toxicity|1|||
148792342|NCT00110357|536718029|FG001|Overall Study|Study Drug Toxicity|3|||
148792343|NCT00110357|536718028|FG000|Overall Study|Withdrawal by Subject|3|||
148792344|NCT00110357|536718029|FG001|Overall Study|Withdrawal by Subject|1|||
148792345|NCT05285787|536718030|FG000|Overall Study|Withdrawal by Subject|1|||
148792346|NCT04004260|536718031|FG000|Overall Study|Withdrawal by Subject|7|||
148792347|NCT04004260|536718032|FG001|Overall Study|Withdrawal by Subject|3|||
148792348|NCT04004260|536718031|FG000|Overall Study|Lost to Follow-up|22|||
148792349|NCT04004260|536718032|FG001|Overall Study|Lost to Follow-up|12|||
148792350|NCT04004260|536718031|FG000|Overall Study|Did not engage in intervention|13|||
148792351|NCT04004260|536718032|FG001|Overall Study|Did not engage in intervention|17|||
148792352|NCT03382418|536718033|FG000|Overall Study|Withdrawal by Subject|1|||
148792353|NCT03382418|536718034|FG001|Overall Study|Withdrawal by Subject|0|||
148792354|NCT03382418|536718035|FG002|Overall Study|Withdrawal by Subject|0|||
148792355|NCT03382418|536718033|FG000|Overall Study|Lost to Follow-up|2|||
148792356|NCT03382418|536718034|FG001|Overall Study|Lost to Follow-up|3|||
148792357|NCT03382418|536718035|FG002|Overall Study|Lost to Follow-up|0|||
148792358|NCT05464420|536718036|FG000|Overall Study|Death|0|||
148792359|NCT05464420|536718037|FG001|Overall Study|Death|0|||
148792360|NCT05464420|536718038|FG002|Overall Study|Death|0|||
148792361|NCT05464420|536718039|FG003|Overall Study|Death|1|||
148792362|NCT05464420|536718036|FG000|Overall Study|Lost to Follow-up|16|||
148792363|NCT05464420|536718037|FG001|Overall Study|Lost to Follow-up|11|||
148792364|NCT05464420|536718038|FG002|Overall Study|Lost to Follow-up|11|||
148792365|NCT05464420|536718039|FG003|Overall Study|Lost to Follow-up|11|||
148792366|NCT05464420|536718036|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
148792367|NCT05464420|536718037|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
148792368|NCT05464420|536718038|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
148792369|NCT05464420|536718039|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
148792370|NCT05464420|536718036|FG000|Overall Study|Withdrawal by Subject|4|||
148792371|NCT05464420|536718037|FG001|Overall Study|Withdrawal by Subject|8|||
148792372|NCT05464420|536718038|FG002|Overall Study|Withdrawal by Subject|3|||
148792373|NCT05464420|536718039|FG003|Overall Study|Withdrawal by Subject|1|||
148792374|NCT05464420|536718036|FG000|Overall Study|Protocol Violation|0|||
148792375|NCT05464420|536718037|FG001|Overall Study|Protocol Violation|0|||
148792376|NCT05464420|536718038|FG002|Overall Study|Protocol Violation|1|||
149134017|NCT02708095|537970940|FG002|Overall Study|Physician Decision|2|||
149134018|NCT02708095|537970938|FG000|Overall Study|Protocol Violation|0|||
149134019|NCT02708095|537970939|FG001|Overall Study|Protocol Violation|0|||
149134020|NCT02708095|537970940|FG002|Overall Study|Protocol Violation|1|||
149134021|NCT02708095|537970938|FG000|Overall Study|Withdrawal by Subject|5|||
149134022|NCT02708095|537970939|FG001|Overall Study|Withdrawal by Subject|3|||
149134023|NCT02708095|537970940|FG002|Overall Study|Withdrawal by Subject|4|||
149134024|NCT04540133|537970941|FG000|Overall Study|Lost to Follow-up|1|||
149134025|NCT04540133|537970942|FG001|Overall Study|Lost to Follow-up|0|||
149134026|NCT01210118|537970947|FG000|Overall Study|Lost to Follow-up|1|||
149134027|NCT01210118|537970948|FG001|Overall Study|Lost to Follow-up|1|||
149134028|NCT01210118|537970947|FG000|Overall Study|Protocol Violation|1|||
149134029|NCT01210118|537970948|FG001|Overall Study|Protocol Violation|1|||
149134030|NCT01210118|537970947|FG000|Overall Study|Spontaneous abortion|1|||
149134031|NCT01210118|537970948|FG001|Overall Study|Spontaneous abortion|3|||
149134032|NCT05066724|537970950|FG000|Overall Study|Adverse Event|1|||
149134033|NCT05066724|537970950|FG000|Overall Study|Non-Compliance With Study Drug|5|||
149134034|NCT05066724|537970950|FG000|Overall Study|Withdrawal by Subject|6|||
149134035|NCT05066724|537970950|FG000|Overall Study|Physician Decision|2|||
149134036|NCT02673619|537970964|FG000|Overall Study|Lost to Follow-up|1|||
149134037|NCT02673619|537970965|FG001|Overall Study|Lost to Follow-up|0|||
149134038|NCT02673619|537970966|FG002|Overall Study|Lost to Follow-up|0|||
149134039|NCT02673619|537970967|FG003|Overall Study|Lost to Follow-up|0|||
149134040|NCT02673619|537970964|FG000|Overall Study|Withdrawal by Subject|1|||
149134041|NCT02673619|537970965|FG001|Overall Study|Withdrawal by Subject|1|||
149134042|NCT02673619|537970966|FG002|Overall Study|Withdrawal by Subject|1|||
149134043|NCT02673619|537970967|FG003|Overall Study|Withdrawal by Subject|0|||
149134044|NCT02673619|537970964|FG000|Overall Study|Adverse Event|0|||
149134045|NCT02673619|537970965|FG001|Overall Study|Adverse Event|0|||
149134046|NCT02673619|537970966|FG002|Overall Study|Adverse Event|1|||
149134047|NCT02673619|537970967|FG003|Overall Study|Adverse Event|0|||
149134048|NCT02673619|537970964|FG000|Overall Study|Lack of Efficacy|0|||
149134049|NCT02673619|537970965|FG001|Overall Study|Lack of Efficacy|0|||
149134050|NCT02673619|537970966|FG002|Overall Study|Lack of Efficacy|1|||
149134051|NCT02673619|537970967|FG003|Overall Study|Lack of Efficacy|0|||
149134052|NCT01313117|537970971|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
149134053|NCT01313117|537970971|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
149134054|NCT03602261|537970976|FG000|Overall Study|Adverse Event|5|||
149134055|NCT03602261|537970977|FG001|Overall Study|Adverse Event|1|||
149134056|NCT03602261|537970976|FG000|Overall Study|Physician Decision|1|||
149134057|NCT03602261|537970977|FG001|Overall Study|Physician Decision|0|||
149134058|NCT03602261|537970976|FG000|Overall Study|Withdrawal by Subject|1|||
149134059|NCT03602261|537970977|FG001|Overall Study|Withdrawal by Subject|1|||
149134060|NCT03602261|537970976|FG000|Overall Study|Lack of Efficacy|0|||
149134061|NCT03602261|537970977|FG001|Overall Study|Lack of Efficacy|1|||
149134062|NCT03602261|537970976|FG000|Overall Study|Subject moving out of state|1|||
149134063|NCT03602261|537970977|FG001|Overall Study|Subject moving out of state|0|||
149134064|NCT00909792|537972844|FG000|Period 1|Did not meet inclusion criteria|0|||
149134065|NCT00909792|537972845|FG001|Period 1|Did not meet inclusion criteria|1|||
149134066|NCT00909792|537972844|FG000|Period 2|Biomicroscopy|1|||
149134067|NCT00909792|537972845|FG001|Period 2|Biomicroscopy|0|||
149134068|NCT00909792|537972844|FG000|Period 2|Lost to Follow-up|0|||
149134069|NCT00909792|537972845|FG001|Period 2|Lost to Follow-up|1|||
149134070|NCT04498169|537972847|FG000|Study Completion|Adverse Event|1|||
149134071|NCT04498169|537972848|FG001|Study Completion|Adverse Event|1|||
149134072|NCT01383161|537972849|FG000|Overall Study|Adverse Event|5|||
149134073|NCT01383161|537972850|FG001|Overall Study|Adverse Event|1|||
148792377|NCT05464420|536718039|FG003|Overall Study|Protocol Violation|1|||
148792378|NCT05464420|536718036|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
148792379|NCT05464420|536718037|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
148792380|NCT05464420|536718038|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
149134074|NCT01383161|537972849|FG000|Overall Study|Withdrawal by Subject|0|||
149134075|NCT01383161|537972850|FG001|Overall Study|Withdrawal by Subject|2|||
149134076|NCT01383161|537972849|FG000|Overall Study|Lack of Efficacy|0|||
149134077|NCT01383161|537972850|FG001|Overall Study|Lack of Efficacy|1|||
148792381|NCT05464420|536718039|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
148792382|NCT02360280|536718047|FG000|Overall Study|Withdrawal by Subject|2|||
148792383|NCT02360280|536718048|FG001|Overall Study|Withdrawal by Subject|0|||
148792384|NCT02360280|536718047|FG000|Overall Study|Adverse Event|0|||
148792385|NCT02360280|536718048|FG001|Overall Study|Adverse Event|1|||
148792386|NCT02360280|536718047|FG000|Overall Study|Lost to Follow-up|1|||
148792387|NCT02360280|536718048|FG001|Overall Study|Lost to Follow-up|0|||
148792388|NCT01383018|536718049|FG000|Overall Study|Adverse Event|14|||
148792389|NCT01383018|536718049|FG000|Overall Study|Death|10|||
148792390|NCT01383018|536718049|FG000|Overall Study|Lost to Follow-up|5|||
148792391|NCT01383018|536718049|FG000|Overall Study|Physician Decision|5|||
148792392|NCT01383018|536718049|FG000|Overall Study|Withdrawal by Subject|9|||
148792393|NCT01383018|536718049|FG000|Overall Study|Subject not implanted|76|||
148792394|NCT01383018|536718049|FG000|Overall Study|Missed Visit|247|||
148792395|NCT01383018|536718049|FG000|Overall Study|Site closed early-not compliance related|7|||
148792396|NCT01383018|536718049|FG000|Overall Study|Patient moved away from site|1|||
148792397|NCT01383018|536718049|FG000|Overall Study|Subject Incarcerated|1|||
148792398|NCT01051817|536718050|FG000|Overall Study|Adverse Event|0|||
148792399|NCT01051817|536718051|FG001|Overall Study|Adverse Event|2|||
148792400|NCT01051817|536718050|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
148792401|NCT01051817|536718051|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
148792402|NCT01051817|536718050|FG000|Overall Study|Withdrawal by Subject|3|||
148792403|NCT01051817|536718051|FG001|Overall Study|Withdrawal by Subject|5|||
148792404|NCT01051817|536718050|FG000|Overall Study|Protocol Violation|0|||
148792405|NCT01051817|536718051|FG001|Overall Study|Protocol Violation|1|||
148792406|NCT02472886|536718052|FG000|Overall Study|Lack of Efficacy|0|||
148792407|NCT02472886|536718053|FG001|Overall Study|Lack of Efficacy|2|||
148792408|NCT02472886|536718054|FG002|Overall Study|Lack of Efficacy|1|||
148792409|NCT00320788|536718056|FG000|Overall Study|Adverse Event|0|||
148792410|NCT00320788|536718057|FG001|Overall Study|Adverse Event|0|||
148792411|NCT00320788|536718058|FG002|Overall Study|Adverse Event|0|||
148792412|NCT00320788|536718059|FG003|Overall Study|Adverse Event|1|||
148792413|NCT00320788|536718060|FG004|Overall Study|Adverse Event|0|||
148792414|NCT00320788|536718056|FG000|Overall Study|Death|0|||
148792415|NCT00320788|536718057|FG001|Overall Study|Death|0|||
148792416|NCT00320788|536718058|FG002|Overall Study|Death|1|||
148792417|NCT00320788|536718059|FG003|Overall Study|Death|0|||
148792418|NCT00320788|536718060|FG004|Overall Study|Death|1|||
148792419|NCT00320788|536718056|FG000|Overall Study|Lost to Follow-up|0|||
148792420|NCT00320788|536718057|FG001|Overall Study|Lost to Follow-up|2|||
148792421|NCT00320788|536718058|FG002|Overall Study|Lost to Follow-up|1|||
148792422|NCT00320788|536718059|FG003|Overall Study|Lost to Follow-up|0|||
148792423|NCT00320788|536718060|FG004|Overall Study|Lost to Follow-up|0|||
148792424|NCT00320788|536718056|FG000|Overall Study|Decision by the Sponsor|1|||
148792425|NCT00320788|536718057|FG001|Overall Study|Decision by the Sponsor|1|||
148792426|NCT00320788|536718058|FG002|Overall Study|Decision by the Sponsor|0|||
148792427|NCT00320788|536718059|FG003|Overall Study|Decision by the Sponsor|0|||
148792428|NCT00320788|536718060|FG004|Overall Study|Decision by the Sponsor|1|||
148792429|NCT00320788|536718056|FG000|Overall Study|Other|1|||
148792430|NCT00320788|536718057|FG001|Overall Study|Other|2|||
148792431|NCT00320788|536718058|FG002|Overall Study|Other|1|||
148792432|NCT00320788|536718059|FG003|Overall Study|Other|1|||
148792433|NCT00320788|536718060|FG004|Overall Study|Other|1|||
148792434|NCT00320788|536718056|FG000|Overall Study|Physician Decision|1|||
148792435|NCT00320788|536718057|FG001|Overall Study|Physician Decision|1|||
148792436|NCT00320788|536718058|FG002|Overall Study|Physician Decision|0|||
148792437|NCT00320788|536718059|FG003|Overall Study|Physician Decision|0|||
148792438|NCT00320788|536718060|FG004|Overall Study|Physician Decision|0|||
148792439|NCT00320788|536718056|FG000|Overall Study|Protocol Violation|0|||
148792440|NCT00320788|536718057|FG001|Overall Study|Protocol Violation|0|||
148792441|NCT00320788|536718058|FG002|Overall Study|Protocol Violation|0|||
148792442|NCT00320788|536718059|FG003|Overall Study|Protocol Violation|0|||
148792443|NCT00320788|536718060|FG004|Overall Study|Protocol Violation|1|||
148792444|NCT00320788|536718056|FG000|Overall Study|Withdrawal by Subject|3|||
148792445|NCT00320788|536718057|FG001|Overall Study|Withdrawal by Subject|0|||
148792446|NCT00320788|536718058|FG002|Overall Study|Withdrawal by Subject|0|||
148792447|NCT00320788|536718059|FG003|Overall Study|Withdrawal by Subject|3|||
148792448|NCT00320788|536718060|FG004|Overall Study|Withdrawal by Subject|1|||
148792449|NCT04346199|536718061|FG000|Overall Study|Death|8|||
148792450|NCT04346199|536718062|FG001|Overall Study|Death|9|||
148792451|NCT04346199|536718061|FG000|Overall Study|Lost to Follow-up|0|||
148792452|NCT04346199|536718062|FG001|Overall Study|Lost to Follow-up|1|||
148792453|NCT04346199|536718061|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
148792454|NCT04346199|536718062|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
148792455|NCT04346199|536718061|FG000|Overall Study|Withdrawal by Subject|5|||
148792456|NCT04346199|536718062|FG001|Overall Study|Withdrawal by Subject|1|||
148792457|NCT00627926|536718063|FG000|Overall Study|Adverse Event|26|||
148792458|NCT00627926|536718064|FG001|Overall Study|Adverse Event|37|||
148792459|NCT00627926|536718065|FG002|Overall Study|Adverse Event|36|||
148792460|NCT00627926|536718063|FG000|Overall Study|Death|1|||
148792461|NCT00627926|536718064|FG001|Overall Study|Death|0|||
148792462|NCT00627926|536718065|FG002|Overall Study|Death|0|||
148792463|NCT00627926|536718063|FG000|Overall Study|Lost to Follow-up|4|||
148792464|NCT00627926|536718064|FG001|Overall Study|Lost to Follow-up|3|||
148792465|NCT00627926|536718065|FG002|Overall Study|Lost to Follow-up|4|||
148792466|NCT00627926|536718063|FG000|Overall Study|Withdrawal by Subject|2|||
148792467|NCT00627926|536718064|FG001|Overall Study|Withdrawal by Subject|1|||
148792468|NCT00627926|536718065|FG002|Overall Study|Withdrawal by Subject|0|||
148792469|NCT00627926|536718063|FG000|Overall Study|Lack of Efficacy|118|||
148792470|NCT00627926|536718064|FG001|Overall Study|Lack of Efficacy|40|||
148792471|NCT00627926|536718065|FG002|Overall Study|Lack of Efficacy|38|||
148792472|NCT00627926|536718063|FG000|Overall Study|Noncompliance/unspecified|8|||
148792473|NCT00627926|536718064|FG001|Overall Study|Noncompliance/unspecified|23|||
148792474|NCT00627926|536718065|FG002|Overall Study|Noncompliance/unspecified|17|||
148792475|NCT03414229|536718066|FG000|Overall Study|Adverse Event|1|||
148792476|NCT03414229|536718067|FG001|Overall Study|Adverse Event|0|||
148792477|NCT03414229|536718068|FG002|Overall Study|Adverse Event|2|||
148792478|NCT03414229|536718069|FG003|Overall Study|Adverse Event|1|||
148792479|NCT03414229|536718066|FG000|Overall Study|Lack of Efficacy|7|||
148792480|NCT03414229|536718067|FG001|Overall Study|Lack of Efficacy|4|||
148792481|NCT03414229|536718068|FG002|Overall Study|Lack of Efficacy|1|||
148792482|NCT03414229|536718069|FG003|Overall Study|Lack of Efficacy|9|||
148792483|NCT03414229|536718066|FG000|Overall Study|Change in therapy|1|||
148792484|NCT03414229|536718067|FG001|Overall Study|Change in therapy|0|||
148792485|NCT03414229|536718068|FG002|Overall Study|Change in therapy|0|||
148792486|NCT03414229|536718069|FG003|Overall Study|Change in therapy|0|||
148792487|NCT03414229|536718066|FG000|Overall Study|Pregnancy|0|||
148792488|NCT03414229|536718067|FG001|Overall Study|Pregnancy|0|||
148792489|NCT03414229|536718068|FG002|Overall Study|Pregnancy|1|||
148792490|NCT03414229|536718069|FG003|Overall Study|Pregnancy|0|||
148792491|NCT03414229|536718066|FG000|Overall Study|Withdrawal by Subject|0|||
148792492|NCT03414229|536718067|FG001|Overall Study|Withdrawal by Subject|1|||
148792493|NCT03414229|536718068|FG002|Overall Study|Withdrawal by Subject|1|||
148792494|NCT03414229|536718069|FG003|Overall Study|Withdrawal by Subject|0|||
148792495|NCT04533438|536718073|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
148792496|NCT04533438|536718074|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
148792497|NCT05568797|536718077|FG000|Overall Study|Adverse Event|0|||
148792498|NCT05568797|536718078|FG001|Overall Study|Adverse Event|8|||
148792499|NCT05568797|536718077|FG000|Overall Study|Lost to Follow-up|2|||
148792500|NCT05568797|536718078|FG001|Overall Study|Lost to Follow-up|3|||
148792501|NCT05568797|536718077|FG000|Overall Study|Withdrawal by Subject|1|||
148792502|NCT05568797|536718078|FG001|Overall Study|Withdrawal by Subject|10|||
148792503|NCT05568797|536718077|FG000|Overall Study|Other|2|||
148792504|NCT05568797|536718078|FG001|Overall Study|Other|2|||
148792505|NCT00099632|536718079|FG000|Overall Study|Lost to Follow-up|1|||
148792506|NCT00099632|536718080|FG001|Overall Study|Lost to Follow-up|0|||
148792507|NCT00099632|536718081|FG002|Overall Study|Lost to Follow-up|3|||
148792508|NCT00099632|536718082|FG003|Overall Study|Lost to Follow-up|1|||
148792509|NCT00099632|536718083|FG004|Overall Study|Lost to Follow-up|1|||
148792510|NCT00099632|536718084|FG005|Overall Study|Lost to Follow-up|0|||
148792511|NCT00099632|536718079|FG000|Overall Study|Withdrawal by Subject|0|||
148792512|NCT00099632|536718080|FG001|Overall Study|Withdrawal by Subject|1|||
148792513|NCT00099632|536718081|FG002|Overall Study|Withdrawal by Subject|0|||
148792514|NCT00099632|536718082|FG003|Overall Study|Withdrawal by Subject|0|||
148792515|NCT00099632|536718083|FG004|Overall Study|Withdrawal by Subject|0|||
148792516|NCT00099632|536718084|FG005|Overall Study|Withdrawal by Subject|1|||
148792517|NCT00099632|536718079|FG000|Overall Study|Protocol Violation|0|||
148792518|NCT00099632|536718080|FG001|Overall Study|Protocol Violation|0|||
148792519|NCT00099632|536718081|FG002|Overall Study|Protocol Violation|0|||
148792520|NCT00099632|536718082|FG003|Overall Study|Protocol Violation|0|||
148792521|NCT00099632|536718083|FG004|Overall Study|Protocol Violation|0|||
148792522|NCT00099632|536718084|FG005|Overall Study|Protocol Violation|1|||
148792523|NCT03131687|536718085|FG000|Overall Study|Adverse Event|0|||
148792524|NCT03131687|536718086|FG001|Overall Study|Adverse Event|1|||
148792525|NCT03131687|536718087|FG002|Overall Study|Adverse Event|0|||
148792526|NCT03131687|536718088|FG003|Overall Study|Adverse Event|1|||
148792527|NCT03131687|536718089|FG004|Overall Study|Adverse Event|2|||
148792528|NCT03131687|536718090|FG005|Overall Study|Adverse Event|2|||
148792529|NCT03131687|536718085|FG000|Overall Study|Death|1|||
148792530|NCT03131687|536718086|FG001|Overall Study|Death|0|||
148792531|NCT03131687|536718087|FG002|Overall Study|Death|0|||
148792532|NCT03131687|536718088|FG003|Overall Study|Death|0|||
148792533|NCT03131687|536718089|FG004|Overall Study|Death|0|||
148792534|NCT03131687|536718090|FG005|Overall Study|Death|0|||
148792535|NCT03131687|536718085|FG000|Overall Study|Withdrawal by Subject|3|||
148792536|NCT03131687|536718086|FG001|Overall Study|Withdrawal by Subject|3|||
148792537|NCT03131687|536718087|FG002|Overall Study|Withdrawal by Subject|3|||
148792538|NCT03131687|536718088|FG003|Overall Study|Withdrawal by Subject|1|||
148792539|NCT03131687|536718089|FG004|Overall Study|Withdrawal by Subject|2|||
148792540|NCT03131687|536718090|FG005|Overall Study|Withdrawal by Subject|1|||
148792541|NCT03131687|536718085|FG000|Overall Study|Lost to Follow-up|1|||
148792542|NCT03131687|536718086|FG001|Overall Study|Lost to Follow-up|4|||
148792543|NCT03131687|536718087|FG002|Overall Study|Lost to Follow-up|0|||
148792544|NCT03131687|536718088|FG003|Overall Study|Lost to Follow-up|1|||
148792545|NCT03131687|536718089|FG004|Overall Study|Lost to Follow-up|4|||
148792546|NCT03131687|536718090|FG005|Overall Study|Lost to Follow-up|2|||
148792547|NCT03131687|536718085|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
148792548|NCT03131687|536718086|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
148792549|NCT03131687|536718087|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
148792550|NCT03131687|536718088|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
148792551|NCT03131687|536718089|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
148792552|NCT03131687|536718090|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
148792553|NCT03131687|536718085|FG000|Overall Study|Principle Investigator Decision|0|||
148792554|NCT03131687|536718086|FG001|Overall Study|Principle Investigator Decision|1|||
148792555|NCT03131687|536718087|FG002|Overall Study|Principle Investigator Decision|0|||
148792556|NCT03131687|536718088|FG003|Overall Study|Principle Investigator Decision|0|||
148792557|NCT03131687|536718089|FG004|Overall Study|Principle Investigator Decision|0|||
148792558|NCT03131687|536718090|FG005|Overall Study|Principle Investigator Decision|0|||
148792559|NCT03131687|536718085|FG000|Overall Study|Inadvertent Enrollment|0|||
148792560|NCT03131687|536718086|FG001|Overall Study|Inadvertent Enrollment|0|||
148792561|NCT03131687|536718087|FG002|Overall Study|Inadvertent Enrollment|0|||
148792562|NCT03131687|536718088|FG003|Overall Study|Inadvertent Enrollment|1|||
148792563|NCT03131687|536718089|FG004|Overall Study|Inadvertent Enrollment|0|||
148792564|NCT03131687|536718090|FG005|Overall Study|Inadvertent Enrollment|0|||
148792565|NCT02797678|536718091|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
148792566|NCT02797678|536718092|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
148792567|NCT02797678|536718093|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
148792568|NCT02797678|536718094|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
148792569|NCT02797678|536718091|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
148792570|NCT02797678|536718092|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
148792571|NCT02797678|536718093|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
148792572|NCT02797678|536718094|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
148792573|NCT02797678|536718091|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
148792574|NCT02797678|536718092|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
148792575|NCT02797678|536718093|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
148792576|NCT02797678|536718094|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
148792577|NCT02401035|536718095|FG000|Overall Study|Withdrawal by Subject|1|||
148792578|NCT02401035|536718096|FG001|Overall Study|Withdrawal by Subject|0|||
148792579|NCT00869128|536718097|FG000|Overall Study|lack of Compliance|6|||
148792580|NCT00869128|536718098|FG001|Overall Study|lack of Compliance|6|||
148792581|NCT01670045|536718104|FG000|Overall Study|Withdrawal by Subject|3|||
148792582|NCT01670045|536718104|FG000|Overall Study|Adverse Event|1|||
148792583|NCT01670045|536718104|FG000|Overall Study|Death|1|||
148792584|NCT01670045|536718104|FG000|Overall Study|Lost to Follow-up|11|||
148792585|NCT03046953|536718111|FG000|Overall Study|Relapse/progressive disease|21|||
148792586|NCT03046953|536718111|FG000|Overall Study|Death|2|||
148792587|NCT03046953|536718111|FG000|Overall Study|Withdrawal by Subject|3|||
148792588|NCT00420628|536718114|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
148792589|NCT00420628|536718115|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
148792590|NCT00420628|536718114|FG000|Overall Study|Lost to Follow-up|3|||
148792591|NCT00420628|536718115|FG001|Overall Study|Lost to Follow-up|2|||
148792592|NCT00420628|536718114|FG000|Overall Study|Adverse Event|1|||
148792593|NCT00420628|536718115|FG001|Overall Study|Adverse Event|0|||
148792594|NCT02716584|536718116|FG000|Overall Study|Lost to Follow-up|8|||
148792595|NCT02716584|536718117|FG001|Overall Study|Lost to Follow-up|5|||
148792596|NCT01868165|536718120|FG000|Overall Study|Withdrawal by Subject|36|||
148792597|NCT01868165|536718120|FG000|Overall Study|Physician Decision|2|||
148792598|NCT01868165|536718120|FG000|Overall Study|Lost to Follow-up|3|||
148792599|NCT01868165|536718120|FG000|Overall Study|Death|4|||
148792600|NCT00452439|536719763|FG000|Overall Study|Lost to Follow-up|1|||
148792601|NCT00452439|536719764|FG001|Overall Study|Lost to Follow-up|1|||
148792602|NCT00452439|536719763|FG000|Overall Study|Refused Treatment|4|||
148792603|NCT00452439|536719764|FG001|Overall Study|Refused Treatment|3|||
148792604|NCT00452439|536719763|FG000|Overall Study|Death|3|||
148792605|NCT00452439|536719764|FG001|Overall Study|Death|1|||
148792606|NCT00452439|536719763|FG000|Overall Study|Bone Marrow Transplant|0|||
148792607|NCT00452439|536719764|FG001|Overall Study|Bone Marrow Transplant|1|||
148792608|NCT00452439|536719763|FG000|Overall Study|Too Ill to Continue|0|||
148792609|NCT00452439|536719764|FG001|Overall Study|Too Ill to Continue|1|||
148792610|NCT00452439|536719763|FG000|Overall Study|Failed to achieve complete response|2|||
148792611|NCT00452439|536719764|FG001|Overall Study|Failed to achieve complete response|0|||
148792612|NCT00452439|536719763|FG000|Overall Study|Relapse|3|||
148792613|NCT00452439|536719764|FG001|Overall Study|Relapse|0|||
148792614|NCT00452439|536719763|FG000|Overall Study|Fracture|1|||
148792615|NCT00452439|536719764|FG001|Overall Study|Fracture|0|||
148792616|NCT03654729|536719770|FG000|Overall Study|Death|9|||
148792617|NCT03654729|536719771|FG001|Overall Study|Death|9|||
148792618|NCT03654729|536719772|FG002|Overall Study|Death|16|||
148792619|NCT03654729|536719770|FG000|Overall Study|Withdrawal by Subject|8|||
148792620|NCT03654729|536719771|FG001|Overall Study|Withdrawal by Subject|6|||
148792621|NCT03654729|536719772|FG002|Overall Study|Withdrawal by Subject|4|||
148792622|NCT03654729|536719770|FG000|Overall Study|Study terminated by Sponsor|3|||
148792623|NCT03654729|536719771|FG001|Overall Study|Study terminated by Sponsor|5|||
148792624|NCT03654729|536719772|FG002|Overall Study|Study terminated by Sponsor|4|||
148792625|NCT03654729|536719770|FG000|Overall Study|Not reported|2|||
148792626|NCT03654729|536719771|FG001|Overall Study|Not reported|4|||
148792627|NCT03654729|536719772|FG002|Overall Study|Not reported|5|||
148792628|NCT03654729|536719770|FG000|Overall Study|Progressive disease|3|||
148792629|NCT03654729|536719771|FG001|Overall Study|Progressive disease|0|||
148792630|NCT03654729|536719772|FG002|Overall Study|Progressive disease|0|||
148792631|NCT03654729|536719770|FG000|Overall Study|Lost to Follow-up|2|||
148792632|NCT03654729|536719771|FG001|Overall Study|Lost to Follow-up|0|||
148792633|NCT03654729|536719772|FG002|Overall Study|Lost to Follow-up|0|||
148792634|NCT03654729|536719770|FG000|Overall Study|Physician Decision|2|||
148792635|NCT03654729|536719771|FG001|Overall Study|Physician Decision|0|||
148792636|NCT03654729|536719772|FG002|Overall Study|Physician Decision|0|||
148792637|NCT03654729|536719770|FG000|Overall Study|Protocol Violation|1|||
148792638|NCT03654729|536719771|FG001|Overall Study|Protocol Violation|1|||
148792639|NCT03654729|536719772|FG002|Overall Study|Protocol Violation|0|||
148792640|NCT03654729|536719770|FG000|Overall Study|Non-compliance with study drug|0|||
148792641|NCT03654729|536719771|FG001|Overall Study|Non-compliance with study drug|1|||
148792642|NCT03654729|536719772|FG002|Overall Study|Non-compliance with study drug|0|||
148792643|NCT03654729|536719770|FG000|Overall Study|Site terminated by Sponsor|1|||
148792644|NCT03654729|536719771|FG001|Overall Study|Site terminated by Sponsor|0|||
148792645|NCT03654729|536719772|FG002|Overall Study|Site terminated by Sponsor|0|||
148792646|NCT01971567|536719781|FG000|Overall Study|Withdrawal by Subject|3|||
148792647|NCT01971567|536719782|FG001|Overall Study|Withdrawal by Subject|2|||
148792648|NCT01971567|536719781|FG000|Overall Study|Lost to Follow-up|1|||
148792649|NCT01971567|536719782|FG001|Overall Study|Lost to Follow-up|0|||
148792650|NCT02250300|536719783|FG000|Expansion Phase|Death|6|||
148792651|NCT02250300|536719784|FG001|Expansion Phase|Death|7|||
148792652|NCT02250300|536719785|FG002|Expansion Phase|Death|0|||
148792653|NCT02250300|536719786|FG003|Expansion Phase|Death|0|||
148792654|NCT02581488|536719794|FG000|Overall Study|Adverse Event|6|||
148792655|NCT02581488|536719795|FG001|Overall Study|Adverse Event|7|||
148792656|NCT02581488|536719794|FG000|Overall Study|Lost to Follow-up|1|||
148792657|NCT02581488|536719795|FG001|Overall Study|Lost to Follow-up|0|||
148792658|NCT02581488|536719794|FG000|Overall Study|Withdrawal by Subject|1|||
148792659|NCT02581488|536719795|FG001|Overall Study|Withdrawal by Subject|0|||
148792660|NCT02581488|536719794|FG000|Overall Study|Non-Compliance|1|||
148792661|NCT02581488|536719795|FG001|Overall Study|Non-Compliance|0|||
148792662|NCT02581488|536719794|FG000|Overall Study|Protocol Violation|0|||
148792663|NCT02581488|536719795|FG001|Overall Study|Protocol Violation|4|||
148792664|NCT01223404|536719796|FG000|First Intervention (1 Day)|Adverse Event|0|||
148792665|NCT01223404|536719797|FG001|First Intervention (1 Day)|Adverse Event|0|||
148792666|NCT01223404|536719798|FG002|First Intervention (1 Day)|Adverse Event|0|||
148792667|NCT01223404|536719799|FG003|First Intervention (1 Day)|Adverse Event|1|||
148792668|NCT01223404|536719800|FG004|First Intervention (1 Day)|Adverse Event|0|||
148792669|NCT01223404|536719801|FG005|First Intervention (1 Day)|Adverse Event|0|||
148792670|NCT01223404|536719796|FG000|Second Intervention (1 Day)|Adverse Event|1|||
148792671|NCT01223404|536719797|FG001|Second Intervention (1 Day)|Adverse Event|0|||
148792672|NCT01223404|536719798|FG002|Second Intervention (1 Day)|Adverse Event|0|||
148792673|NCT01223404|536719799|FG003|Second Intervention (1 Day)|Adverse Event|0|||
148792674|NCT01223404|536719800|FG004|Second Intervention (1 Day)|Adverse Event|0|||
148792675|NCT01223404|536719801|FG005|Second Intervention (1 Day)|Adverse Event|0|||
149134078|NCT03942406|537972857|FG000|Overall Study|Lost to Follow-up|4|||
148792676|NCT01223404|536719796|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
148792677|NCT01223404|536719797|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
148792678|NCT01223404|536719798|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
148792679|NCT01223404|536719799|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
148792680|NCT01223404|536719800|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
148792681|NCT01223404|536719801|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
148792682|NCT00707057|536719802|FG000|Overall Study|Withdrawal by Subject|8|||
148792683|NCT00707057|536719803|FG001|Overall Study|Withdrawal by Subject|3|||
148792684|NCT00707057|536719802|FG000|Overall Study|Dosed incorrectly|0|||
148792685|NCT00707057|536719803|FG001|Overall Study|Dosed incorrectly|1|||
148792686|NCT02492165|536719804|FG000|Overall Study|Withdrawal by Subject|0|||
148792687|NCT02492165|536719805|FG001|Overall Study|Withdrawal by Subject|1|||
148792688|NCT02492165|536719806|FG002|Overall Study|Withdrawal by Subject|0|||
148792689|NCT02492165|536719807|FG003|Overall Study|Withdrawal by Subject|0|||
148792690|NCT01957579|536719813|FG000|Overall Study|Withdrawal of concent|0|||
148792691|NCT01957579|536719814|FG001|Overall Study|Withdrawal of concent|1|||
148792692|NCT01957579|536719815|FG002|Overall Study|Withdrawal of concent|0|||
148792693|NCT01957579|536719816|FG003|Overall Study|Withdrawal of concent|0|||
148792694|NCT01957579|536719813|FG000|Overall Study|Death|0|||
148792695|NCT01957579|536719814|FG001|Overall Study|Death|0|||
148792696|NCT01957579|536719815|FG002|Overall Study|Death|2|||
148792697|NCT01957579|536719816|FG003|Overall Study|Death|0|||
148792698|NCT01307891|536719818|FG000|Overall Study|Progressive Disease|3|||
148792699|NCT01307891|536719819|FG001|Overall Study|Progressive Disease|1|||
148792700|NCT03365934|536719820|FG000|Overall Study|Adverse Event|1|||
148792701|NCT03365934|536719820|FG000|Overall Study|Withdrawal by Subject|1|||
148792702|NCT02750332|536719821|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148792703|NCT02750332|536719822|FG001|Treatment Period 1|Withdrawal by Subject|1|||
148792704|NCT02937740|536719823|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
148792705|NCT02937740|536719824|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
148792706|NCT02937740|536719823|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
148792707|NCT02937740|536719824|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
148792708|NCT02937740|536719823|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
148792709|NCT02937740|536719824|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
148792710|NCT02937740|536719823|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
148792711|NCT02937740|536719824|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
148792712|NCT02937740|536719823|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
148792713|NCT02937740|536719824|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
148792714|NCT02937740|536719823|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
148792715|NCT02937740|536719824|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
148792716|NCT04194489|536719825|FG000|Overall Study|Withdrawal by Subject|5|||
148792717|NCT04194489|536719825|FG000|Overall Study|Lost to Follow-up|48|||
148792718|NCT00377637|536719830|FG000|Induction Phase|Adverse Event|12|||
148792719|NCT00377637|536719831|FG001|Induction Phase|Adverse Event|21|||
148792720|NCT00377637|536719832|FG002|Induction Phase|Adverse Event|0|||
148792721|NCT00377637|536719833|FG003|Induction Phase|Adverse Event|0|||
148792722|NCT00377637|536719830|FG000|Induction Phase|Deterioration/serum creatinine|2|||
148792723|NCT00377637|536719831|FG001|Induction Phase|Deterioration/serum creatinine|0|||
148792724|NCT00377637|536719832|FG002|Induction Phase|Deterioration/serum creatinine|0|||
148792725|NCT00377637|536719833|FG003|Induction Phase|Deterioration/serum creatinine|0|||
148893634|NCT00647296|537088806|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
148893635|NCT00647296|537088803|FG000|Part 2: 4-week Placebo Washout|Death|3|||
148893636|NCT00647296|537088804|FG001|Part 2: 4-week Placebo Washout|Death|0|||
148893637|NCT00647296|537088805|FG002|Part 2: 4-week Placebo Washout|Death|0|||
148893638|NCT00647296|537088806|FG003|Part 2: 4-week Placebo Washout|Death|0|||
148893639|NCT00647296|537088803|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
148893640|NCT00647296|537088804|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
148792726|NCT00377637|536719830|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
148792727|NCT00377637|536719831|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
148792728|NCT00377637|536719832|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
148792729|NCT00377637|536719833|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
148792730|NCT00377637|536719830|FG000|Induction Phase|Lost to Follow-up|2|||
148792731|NCT00377637|536719831|FG001|Induction Phase|Lost to Follow-up|1|||
148792732|NCT00377637|536719832|FG002|Induction Phase|Lost to Follow-up|0|||
148792733|NCT00377637|536719833|FG003|Induction Phase|Lost to Follow-up|0|||
148792734|NCT00377637|536719830|FG000|Induction Phase|Death|1|||
148792735|NCT00377637|536719831|FG001|Induction Phase|Death|3|||
148792736|NCT00377637|536719832|FG002|Induction Phase|Death|0|||
148792737|NCT00377637|536719833|FG003|Induction Phase|Death|0|||
148792738|NCT00377637|536719830|FG000|Induction Phase|Withdrawal by Subject|5|||
148792739|NCT00377637|536719831|FG001|Induction Phase|Withdrawal by Subject|6|||
148792740|NCT00377637|536719832|FG002|Induction Phase|Withdrawal by Subject|0|||
148792741|NCT00377637|536719833|FG003|Induction Phase|Withdrawal by Subject|0|||
148792742|NCT00377637|536719830|FG000|Induction Phase|Physician Decision|3|||
148792743|NCT00377637|536719831|FG001|Induction Phase|Physician Decision|1|||
148792744|NCT00377637|536719832|FG002|Induction Phase|Physician Decision|0|||
148792745|NCT00377637|536719833|FG003|Induction Phase|Physician Decision|0|||
148792746|NCT00377637|536719830|FG000|Induction Phase|Sponsor decision|1|||
148792747|NCT00377637|536719831|FG001|Induction Phase|Sponsor decision|2|||
148792748|NCT00377637|536719832|FG002|Induction Phase|Sponsor decision|0|||
148792749|NCT00377637|536719833|FG003|Induction Phase|Sponsor decision|0|||
148792750|NCT00377637|536719830|FG000|Induction Phase|Non-Compliance|1|||
148792751|NCT00377637|536719831|FG001|Induction Phase|Non-Compliance|0|||
148792752|NCT00377637|536719832|FG002|Induction Phase|Non-Compliance|0|||
148792753|NCT00377637|536719833|FG003|Induction Phase|Non-Compliance|0|||
148792754|NCT00377637|536719830|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
148893641|NCT00647296|537088805|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
148893642|NCT00647296|537088806|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
149134079|NCT03942406|537972858|FG001|Overall Study|Lost to Follow-up|5|||
149134080|NCT03942406|537972859|FG002|Overall Study|Lost to Follow-up|3|||
149134081|NCT03942406|537972860|FG003|Overall Study|Lost to Follow-up|7|||
149134082|NCT03942406|537972861|FG004|Overall Study|Lost to Follow-up|1|||
148792755|NCT00377637|536719831|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
148792756|NCT00377637|536719832|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
148792757|NCT00377637|536719833|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
148792758|NCT00377637|536719830|FG000|Maintenance Phase|Adverse Event|0|||
148792759|NCT00377637|536719831|FG001|Maintenance Phase|Adverse Event|0|||
148792760|NCT00377637|536719832|FG002|Maintenance Phase|Adverse Event|29|||
148792761|NCT00377637|536719833|FG003|Maintenance Phase|Adverse Event|43|||
148792762|NCT00377637|536719830|FG000|Maintenance Phase|Physician Decision|0|||
148792763|NCT00377637|536719831|FG001|Maintenance Phase|Physician Decision|0|||
148792764|NCT00377637|536719832|FG002|Maintenance Phase|Physician Decision|5|||
148792765|NCT00377637|536719833|FG003|Maintenance Phase|Physician Decision|4|||
148792766|NCT00377637|536719830|FG000|Maintenance Phase|Lost to Follow-up|0|||
148792767|NCT00377637|536719831|FG001|Maintenance Phase|Lost to Follow-up|0|||
148792768|NCT00377637|536719832|FG002|Maintenance Phase|Lost to Follow-up|3|||
148792769|NCT00377637|536719833|FG003|Maintenance Phase|Lost to Follow-up|1|||
148792770|NCT00377637|536719830|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148792771|NCT00377637|536719831|FG001|Maintenance Phase|Withdrawal by Subject|0|||
148792772|NCT00377637|536719832|FG002|Maintenance Phase|Withdrawal by Subject|3|||
148792773|NCT00377637|536719833|FG003|Maintenance Phase|Withdrawal by Subject|3|||
148792774|NCT00377637|536719830|FG000|Maintenance Phase|Sponsor decision|0|||
148792775|NCT00377637|536719831|FG001|Maintenance Phase|Sponsor decision|0|||
148792776|NCT00377637|536719832|FG002|Maintenance Phase|Sponsor decision|2|||
148792777|NCT00377637|536719833|FG003|Maintenance Phase|Sponsor decision|3|||
148792778|NCT00377637|536719830|FG000|Maintenance Phase|Non-compliance|0|||
148792779|NCT00377637|536719831|FG001|Maintenance Phase|Non-compliance|0|||
148792780|NCT00377637|536719832|FG002|Maintenance Phase|Non-compliance|1|||
148792781|NCT00377637|536719833|FG003|Maintenance Phase|Non-compliance|1|||
148792782|NCT00377637|536719830|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
148792783|NCT00377637|536719831|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
148792784|NCT00377637|536719832|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
148792785|NCT00377637|536719833|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
148792786|NCT00377637|536719830|FG000|Maintenance Phase|Death|0|||
148792787|NCT00377637|536719831|FG001|Maintenance Phase|Death|0|||
148792788|NCT00377637|536719832|FG002|Maintenance Phase|Death|0|||
148792789|NCT00377637|536719833|FG003|Maintenance Phase|Death|1|||
148792790|NCT00493012|536719835|FG000|Overall Study|Lost to Follow-up|18|||
148792791|NCT00493012|536719836|FG001|Overall Study|Lost to Follow-up|17|||
148792792|NCT04147247|536719837|FG000|Overall Study|Progressive disease|3|||
148792793|NCT04147247|536719838|FG001|Overall Study|Progressive disease|3|||
148792794|NCT04147247|536719839|FG002|Overall Study|Progressive disease|4|||
148792795|NCT04147247|536719840|FG003|Overall Study|Progressive disease|4|||
148792796|NCT04147247|536719841|FG004|Overall Study|Progressive disease|3|||
148792797|NCT04147247|536719837|FG000|Overall Study|Physician Decision|0|||
148792798|NCT04147247|536719838|FG001|Overall Study|Physician Decision|1|||
148792799|NCT04147247|536719839|FG002|Overall Study|Physician Decision|0|||
148792800|NCT04147247|536719840|FG003|Overall Study|Physician Decision|0|||
148792801|NCT04147247|536719841|FG004|Overall Study|Physician Decision|0|||
148792802|NCT04147247|536719837|FG000|Overall Study|Clinical Disease Progression|0|||
148792803|NCT04147247|536719838|FG001|Overall Study|Clinical Disease Progression|0|||
148792804|NCT04147247|536719839|FG002|Overall Study|Clinical Disease Progression|0|||
148792805|NCT04147247|536719840|FG003|Overall Study|Clinical Disease Progression|0|||
148792806|NCT04147247|536719841|FG004|Overall Study|Clinical Disease Progression|1|||
148792807|NCT04147247|536719837|FG000|Overall Study|Adverse Event|0|||
148792808|NCT04147247|536719838|FG001|Overall Study|Adverse Event|0|||
148792809|NCT04147247|536719839|FG002|Overall Study|Adverse Event|1|||
148792810|NCT04147247|536719840|FG003|Overall Study|Adverse Event|0|||
148792811|NCT04147247|536719841|FG004|Overall Study|Adverse Event|1|||
148792812|NCT00327340|536719844|FG000|Overall Study|Withdrawal by Subject|1|||
148792813|NCT00327340|536719845|FG001|Overall Study|Withdrawal by Subject|5|||
148792814|NCT00327340|536719844|FG000|Overall Study|Physician Decision|1|||
148792815|NCT00327340|536719845|FG001|Overall Study|Physician Decision|1|||
148792816|NCT00327340|536719844|FG000|Overall Study|Disease Progression|10|||
148792817|NCT00327340|536719845|FG001|Overall Study|Disease Progression|19|||
148792818|NCT00327340|536719844|FG000|Overall Study|Symptomatic Disease|0|||
148792819|NCT00327340|536719845|FG001|Overall Study|Symptomatic Disease|2|||
148792820|NCT00327340|536719844|FG000|Overall Study|Adverse Event|3|||
148792821|NCT00327340|536719845|FG001|Overall Study|Adverse Event|3|||
148792822|NCT04085601|536719846|FG000|Overall Study|Lost to Follow-up|1|||
148792823|NCT04085601|536719847|FG001|Overall Study|Lost to Follow-up|0|||
148792824|NCT04085601|536719846|FG000|Overall Study|Death|1|||
148792825|NCT04085601|536719847|FG001|Overall Study|Death|1|||
148792826|NCT04534517|536719849|FG000|Overall Study|Adverse Event|1|||
148792827|NCT04534517|536719849|FG000|Overall Study|Withdrawal by Subject|1|||
148792828|NCT04534517|536719849|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
148792829|NCT04534517|536719849|FG000|Overall Study|COVID-19 Related|1|||
148792830|NCT02121795|536719850|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
148792831|NCT02121795|536719851|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
148792832|NCT02121795|536719850|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
148792833|NCT02121795|536719851|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
148792834|NCT02121795|536719850|FG000|Double-Blind Phase|Lost to Follow-up|7|||
148792835|NCT02121795|536719851|FG001|Double-Blind Phase|Lost to Follow-up|4|||
148792836|NCT02121795|536719850|FG000|Double-Blind Phase|Physician Decision|2|||
148792837|NCT02121795|536719851|FG001|Double-Blind Phase|Physician Decision|5|||
148792838|NCT02121795|536719850|FG000|Double-Blind Phase|Adverse Event|5|||
148792839|NCT02121795|536719851|FG001|Double-Blind Phase|Adverse Event|0|||
148792840|NCT02121795|536719850|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
148792841|NCT02121795|536719851|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
148792842|NCT02121795|536719850|FG000|Double-Blind Phase|Protocol Violation|0|||
148792843|NCT02121795|536719851|FG001|Double-Blind Phase|Protocol Violation|3|||
148792844|NCT02121795|536719850|FG000|Double-Blind Phase|Death|1|||
148792845|NCT02121795|536719851|FG001|Double-Blind Phase|Death|1|||
148792846|NCT02121795|536719850|FG000|Open-Label Phase|Physician Decision|8|||
148792847|NCT02121795|536719851|FG001|Open-Label Phase|Physician Decision|8|||
148792848|NCT02121795|536719850|FG000|Open-Label Phase|Withdrawal by Subject|3|||
148792849|NCT02121795|536719851|FG001|Open-Label Phase|Withdrawal by Subject|2|||
148792850|NCT02121795|536719850|FG000|Open-Label Phase|Lost to Follow-up|1|||
148792851|NCT02121795|536719851|FG001|Open-Label Phase|Lost to Follow-up|0|||
148792852|NCT04155463|536719852|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
148792853|NCT04155463|536719853|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
148792854|NCT00113295|536719854|FG000|Overall Study|Adverse Event|4|||
148792855|NCT00113295|536719855|FG001|Overall Study|Adverse Event|1|||
148792856|NCT00113295|536719854|FG000|Overall Study|Unrelated Medical Illness|1|||
148792857|NCT00113295|536719855|FG001|Overall Study|Unrelated Medical Illness|0|||
148792858|NCT01714544|536719856|FG000|Overall Study|Lost to Follow-up|1|||
148792859|NCT01714544|536719856|FG000|Overall Study|Physician Decision|1|||
148792860|NCT01714544|536719856|FG000|Overall Study|Withdrawal by Subject|1|||
148792861|NCT03373760|536719860|FG000|Overall Study|Adverse Event|8|||
148792862|NCT03373760|536719860|FG000|Overall Study|Disease Progression|46|||
148792863|NCT03373760|536719860|FG000|Overall Study|Death|4|||
148792864|NCT01093586|536719861|FG000|Overall Study|Failed to engraft|3|||
148792865|NCT00613366|536719862|FG000|Overall Study|Withdrawal by Subject|3|||
148792866|NCT00613366|536719863|FG001|Overall Study|Withdrawal by Subject|2|||
148792867|NCT00872521|536719870|FG000|Completed PAD Induction|Patient choice|0|||
148792868|NCT00872521|536719871|FG001|Completed PAD Induction|Patient choice|1|||
148792869|NCT00872521|536719872|FG002|Completed PAD Induction|Patient choice|0|||
148792870|NCT00872521|536719870|FG000|Completed PAD Induction|Disease progression|0|||
148792871|NCT00872521|536719871|FG001|Completed PAD Induction|Disease progression|2|||
148792872|NCT00872521|536719872|FG002|Completed PAD Induction|Disease progression|0|||
148792873|NCT00872521|536719870|FG000|Completed PAD Induction|Adverse Event|4|||
148792874|NCT00872521|536719871|FG001|Completed PAD Induction|Adverse Event|0|||
148792875|NCT00872521|536719872|FG002|Completed PAD Induction|Adverse Event|0|||
148792876|NCT00872521|536719870|FG000|Completed PAD Induction|Death|1|||
148792877|NCT00872521|536719871|FG001|Completed PAD Induction|Death|1|||
148792878|NCT00872521|536719872|FG002|Completed PAD Induction|Death|0|||
148792879|NCT00872521|536719870|FG000|Primary Endpoint Analysis|Other|1|||
148792880|NCT00872521|536719871|FG001|Primary Endpoint Analysis|Other|2|||
148792881|NCT00872521|536719872|FG002|Primary Endpoint Analysis|Other|0|||
148792882|NCT00872521|536719870|FG000|Primary Endpoint Analysis|Patient choice|0|||
148792883|NCT00872521|536719871|FG001|Primary Endpoint Analysis|Patient choice|1|||
148792884|NCT00872521|536719872|FG002|Primary Endpoint Analysis|Patient choice|0|||
148792885|NCT00872521|536719870|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
148792886|NCT00872521|536719871|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
148792887|NCT00872521|536719872|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
148792888|NCT00872521|536719870|FG000|Primary Endpoint Analysis|Patient response missing|0|||
148792889|NCT00872521|536719871|FG001|Primary Endpoint Analysis|Patient response missing|0|||
148792890|NCT00872521|536719872|FG002|Primary Endpoint Analysis|Patient response missing|1|||
148792891|NCT00872521|536719870|FG000|Completed 3-month Follow up|Other|0|||
148792892|NCT00872521|536719871|FG001|Completed 3-month Follow up|Other|2|||
148792893|NCT00872521|536719872|FG002|Completed 3-month Follow up|Other|0|||
148792894|NCT00872521|536719870|FG000|Completed 3-month Follow up|Physician Decision|0|||
148792895|NCT00872521|536719871|FG001|Completed 3-month Follow up|Physician Decision|1|||
148792896|NCT00872521|536719872|FG002|Completed 3-month Follow up|Physician Decision|0|||
148792897|NCT00872521|536719870|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
148792898|NCT00872521|536719871|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
148792899|NCT00872521|536719872|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
148792900|NCT05225558|536719873|FG000|Overall Study|Withdrawal by Subject|4|||
148792901|NCT05225558|536719874|FG001|Overall Study|Withdrawal by Subject|3|||
148792902|NCT05225558|536719873|FG000|Overall Study|Adverse Event|1|||
148792903|NCT05225558|536719874|FG001|Overall Study|Adverse Event|0|||
148792904|NCT05225558|536719873|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
148792905|NCT05225558|536719874|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
148792906|NCT05225558|536719873|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
148792907|NCT05225558|536719874|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
148792908|NCT03006562|536719875|FG000|Overall Study|Lost to Follow-up|0|||
148792909|NCT03006562|536719876|FG001|Overall Study|Lost to Follow-up|1|||
148893643|NCT00647296|537088803|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
149134083|NCT03942406|537972862|FG005|Overall Study|Lost to Follow-up|0|||
149134084|NCT03942406|537972863|FG006|Overall Study|Lost to Follow-up|0|||
149134085|NCT03942406|537972857|FG000|Overall Study|Withdrawal by Subject|3|||
149134086|NCT03942406|537972858|FG001|Overall Study|Withdrawal by Subject|1|||
149134087|NCT03942406|537972859|FG002|Overall Study|Withdrawal by Subject|1|||
149134088|NCT03942406|537972860|FG003|Overall Study|Withdrawal by Subject|3|||
149134089|NCT03942406|537972861|FG004|Overall Study|Withdrawal by Subject|0|||
149134090|NCT03942406|537972862|FG005|Overall Study|Withdrawal by Subject|0|||
149134091|NCT03942406|537972863|FG006|Overall Study|Withdrawal by Subject|0|||
149134092|NCT03942406|537972857|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
149134093|NCT03942406|537972858|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
149134094|NCT03942406|537972859|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
149134095|NCT03942406|537972860|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
149134096|NCT03942406|537972861|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
149134097|NCT03942406|537972862|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
149134098|NCT03942406|537972863|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
149134099|NCT01423812|537972864|FG000|Overall Study|Lost to Follow-up|2|||
149134100|NCT01423812|537972865|FG001|Overall Study|Lost to Follow-up|2|||
149134101|NCT01423812|537972864|FG000|Overall Study|Withdrawal by Subject|1|||
149134102|NCT01423812|537972865|FG001|Overall Study|Withdrawal by Subject|2|||
149134103|NCT01207596|537972866|FG000|Overall Study|Physician Decision|4|||
149134104|NCT01207596|537972866|FG000|Overall Study|Lack of Efficacy|1|||
149134105|NCT01207596|537972866|FG000|Overall Study|Adverse Event|3|||
149134106|NCT01207596|537972866|FG000|Overall Study|Withdrawal by Subject|1|||
149134107|NCT00216203|537972867|FG000|Overall Study|Withdrawal by Subject|2|||
149134108|NCT02748018|537972868|FG000|Study Period|Adverse Event|1|||
149134109|NCT02748018|537972869|FG001|Study Period|Adverse Event|3|||
149134110|NCT02748018|537972870|FG002|Study Period|Adverse Event|4|||
149134111|NCT02748018|537972871|FG003|Study Period|Adverse Event|0|||
149134112|NCT02748018|537972872|FG004|Study Period|Adverse Event|3|||
149134113|NCT02748018|537972873|FG005|Study Period|Adverse Event|3|||
149134114|NCT02748018|537972868|FG000|Study Period|Withdrawal by Subject|7|||
149134115|NCT02748018|537972869|FG001|Study Period|Withdrawal by Subject|4|||
149134116|NCT02748018|537972870|FG002|Study Period|Withdrawal by Subject|4|||
149134117|NCT02748018|537972871|FG003|Study Period|Withdrawal by Subject|11|||
149134118|NCT02748018|537972872|FG004|Study Period|Withdrawal by Subject|12|||
149134119|NCT02748018|537972873|FG005|Study Period|Withdrawal by Subject|10|||
149134120|NCT02748018|537972868|FG000|Study Period|Pregnancy|0|||
149134121|NCT02748018|537972869|FG001|Study Period|Pregnancy|1|||
149134122|NCT02748018|537972870|FG002|Study Period|Pregnancy|0|||
149134123|NCT02748018|537972871|FG003|Study Period|Pregnancy|0|||
149134124|NCT02748018|537972872|FG004|Study Period|Pregnancy|1|||
149134125|NCT02748018|537972873|FG005|Study Period|Pregnancy|0|||
149134126|NCT02748018|537972868|FG000|Study Period|Physician Decision|2|||
149134127|NCT02748018|537972869|FG001|Study Period|Physician Decision|2|||
149134128|NCT02748018|537972870|FG002|Study Period|Physician Decision|1|||
149134129|NCT02748018|537972871|FG003|Study Period|Physician Decision|0|||
149134130|NCT02748018|537972872|FG004|Study Period|Physician Decision|2|||
149134131|NCT02748018|537972873|FG005|Study Period|Physician Decision|0|||
149134132|NCT02748018|537972868|FG000|Study Period|Lost to Follow-up|0|||
149134133|NCT02748018|537972869|FG001|Study Period|Lost to Follow-up|0|||
149134134|NCT02748018|537972870|FG002|Study Period|Lost to Follow-up|0|||
149134135|NCT02748018|537972871|FG003|Study Period|Lost to Follow-up|2|||
149134136|NCT02748018|537972872|FG004|Study Period|Lost to Follow-up|0|||
149134137|NCT02748018|537972873|FG005|Study Period|Lost to Follow-up|1|||
149134138|NCT02748018|537972868|FG000|Continuation Period|Adverse Event|2|||
149134139|NCT02748018|537972869|FG001|Continuation Period|Adverse Event|0|||
149134140|NCT02748018|537972870|FG002|Continuation Period|Adverse Event|1|||
149134141|NCT02748018|537972871|FG003|Continuation Period|Adverse Event|1|||
149134142|NCT02748018|537972872|FG004|Continuation Period|Adverse Event|1|||
149134143|NCT02748018|537972873|FG005|Continuation Period|Adverse Event|4|||
149134144|NCT02748018|537972868|FG000|Continuation Period|Withdrawal by Subject|3|||
149134145|NCT02748018|537972869|FG001|Continuation Period|Withdrawal by Subject|5|||
149134146|NCT02748018|537972870|FG002|Continuation Period|Withdrawal by Subject|3|||
149134147|NCT02748018|537972871|FG003|Continuation Period|Withdrawal by Subject|9|||
149134148|NCT02748018|537972872|FG004|Continuation Period|Withdrawal by Subject|11|||
149134149|NCT02748018|537972873|FG005|Continuation Period|Withdrawal by Subject|1|||
148893644|NCT00647296|537088804|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
148893645|NCT00647296|537088805|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
148893646|NCT00647296|537088806|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
148893647|NCT00647296|537088803|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
148893648|NCT00647296|537088804|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
148893649|NCT00647296|537088805|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
148893650|NCT00647296|537088806|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
148893651|NCT00647296|537088803|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
148893652|NCT00647296|537088804|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
148893653|NCT00647296|537088805|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
148893654|NCT00647296|537088806|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
148893655|NCT00647296|537088803|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
148893656|NCT00647296|537088804|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
148893657|NCT00647296|537088805|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
148893658|NCT00647296|537088806|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
148893659|NCT02922725|537088807|FG000|Overall Study|Withdrawal by Subject|1|||
148893660|NCT02922725|537088808|FG001|Overall Study|Withdrawal by Subject|0|||
148893661|NCT02922725|537088809|FG002|Overall Study|Withdrawal by Subject|0|||
148893662|NCT01300234|537088810|FG000|Overall Study|Adverse Event|1|||
148893663|NCT01300234|537088811|FG001|Overall Study|Adverse Event|1|||
148893664|NCT01300234|537088810|FG000|Overall Study|Protocol Violation|2|||
148893665|NCT01300234|537088811|FG001|Overall Study|Protocol Violation|3|||
148893666|NCT01300234|537088810|FG000|Overall Study|Withdrawal by Subject|5|||
148893667|NCT01300234|537088811|FG001|Overall Study|Withdrawal by Subject|9|||
148893668|NCT01300234|537088810|FG000|Overall Study|Lost to Follow-up|14|||
148893669|NCT01300234|537088811|FG001|Overall Study|Lost to Follow-up|12|||
148893670|NCT01300234|537088810|FG000|Overall Study|Pregnancy|2|||
148893671|NCT01300234|537088811|FG001|Overall Study|Pregnancy|1|||
148893672|NCT01300234|537088810|FG000|Overall Study|Participant reached stopping critera|2|||
148893673|NCT01300234|537088811|FG001|Overall Study|Participant reached stopping critera|0|||
148893674|NCT01300234|537088810|FG000|Overall Study|Participant stopped medication|1|||
148893675|NCT01300234|537088811|FG001|Overall Study|Participant stopped medication|1|||
148893676|NCT01300234|537088810|FG000|Overall Study|Participant refused return to hospital|1|||
148893677|NCT01300234|537088811|FG001|Overall Study|Participant refused return to hospital|0|||
148893678|NCT00360412|537088812|FG000|Overall Study|Adverse Event|37|||
148893679|NCT00360412|537088813|FG001|Overall Study|Adverse Event|65|||
148893680|NCT00360412|537088812|FG000|Overall Study|Protocol Violation|2|||
148893681|NCT00360412|537088813|FG001|Overall Study|Protocol Violation|5|||
148893682|NCT00360412|537088812|FG000|Overall Study|Patient withdrew consent|27|||
148893683|NCT00360412|537088813|FG001|Overall Study|Patient withdrew consent|52|||
148893684|NCT00360412|537088812|FG000|Overall Study|Lack of therapeutic efficacy|46|||
148893685|NCT00360412|537088813|FG001|Overall Study|Lack of therapeutic efficacy|61|||
148893686|NCT00360412|537088812|FG000|Overall Study|Physician Decision|2|||
148893687|NCT00360412|537088813|FG001|Overall Study|Physician Decision|4|||
148893688|NCT00360412|537088812|FG000|Overall Study|Other|5|||
148893689|NCT00360412|537088813|FG001|Overall Study|Other|6|||
148893690|NCT00360412|537088812|FG000|Overall Study|Study termination by Sponsor|214|||
148893691|NCT00360412|537088813|FG001|Overall Study|Study termination by Sponsor|469|||
148893692|NCT04612725|537088814|FG000|Overall Study|Adverse Event|1|||
148893693|NCT04612725|537088815|FG001|Overall Study|Adverse Event|3|||
148893694|NCT04612725|537088816|FG002|Overall Study|Adverse Event|1|||
148893695|NCT04612725|537088817|FG003|Overall Study|Adverse Event|0|||
148893696|NCT04612725|537088818|FG004|Overall Study|Adverse Event|1|||
148893697|NCT04612725|537088814|FG000|Overall Study|Lost to Follow-up|0|||
148893698|NCT04612725|537088815|FG001|Overall Study|Lost to Follow-up|1|||
148893699|NCT04612725|537088816|FG002|Overall Study|Lost to Follow-up|0|||
148792910|NCT01089127|536719881|FG000|Overall Study|Adverse Event|5|||
148792911|NCT01089127|536719882|FG001|Overall Study|Adverse Event|1|||
148792912|NCT01089127|536719883|FG002|Overall Study|Adverse Event|1|||
148792913|NCT01089127|536719884|FG003|Overall Study|Adverse Event|0|||
148792914|NCT01089127|536719885|FG004|Overall Study|Adverse Event|0|||
148792915|NCT01089127|536719886|FG005|Overall Study|Adverse Event|1|||
148792916|NCT01089127|536719881|FG000|Overall Study|Subject withdrew consent|0|||
148792917|NCT01089127|536719882|FG001|Overall Study|Subject withdrew consent|1|||
148893700|NCT04612725|537088817|FG003|Overall Study|Lost to Follow-up|0|||
148893701|NCT04612725|537088818|FG004|Overall Study|Lost to Follow-up|0|||
149134150|NCT02748018|537972868|FG000|Continuation Period|Lost to Follow-up|0|||
148792918|NCT01089127|536719883|FG002|Overall Study|Subject withdrew consent|1|||
148792919|NCT01089127|536719884|FG003|Overall Study|Subject withdrew consent|1|||
148792920|NCT01089127|536719885|FG004|Overall Study|Subject withdrew consent|0|||
148893702|NCT04612725|537088814|FG000|Overall Study|Physician Decision|2|||
148893703|NCT04612725|537088815|FG001|Overall Study|Physician Decision|0|||
148893704|NCT04612725|537088816|FG002|Overall Study|Physician Decision|0|||
148893705|NCT04612725|537088817|FG003|Overall Study|Physician Decision|0|||
148792921|NCT01089127|536719886|FG005|Overall Study|Subject withdrew consent|2|||
148792922|NCT01089127|536719881|FG000|Overall Study|Abnormal test procedure result(s)|2|||
148792923|NCT01089127|536719882|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148792924|NCT01089127|536719883|FG002|Overall Study|Abnormal test procedure result(s)|0|||
148792925|NCT01089127|536719884|FG003|Overall Study|Abnormal test procedure result(s)|0|||
148792926|NCT01089127|536719885|FG004|Overall Study|Abnormal test procedure result(s)|0|||
148792927|NCT01089127|536719886|FG005|Overall Study|Abnormal test procedure result(s)|0|||
148792928|NCT01089127|536719881|FG000|Overall Study|Lost to Follow-up|1|||
148792929|NCT01089127|536719882|FG001|Overall Study|Lost to Follow-up|1|||
148792930|NCT01089127|536719883|FG002|Overall Study|Lost to Follow-up|0|||
148792931|NCT01089127|536719884|FG003|Overall Study|Lost to Follow-up|0|||
148792932|NCT01089127|536719885|FG004|Overall Study|Lost to Follow-up|1|||
148792933|NCT01089127|536719886|FG005|Overall Study|Lost to Follow-up|0|||
148792934|NCT01089127|536719881|FG000|Overall Study|Protocol deviation|0|||
148792935|NCT01089127|536719882|FG001|Overall Study|Protocol deviation|1|||
148792936|NCT01089127|536719883|FG002|Overall Study|Protocol deviation|0|||
148792937|NCT01089127|536719884|FG003|Overall Study|Protocol deviation|0|||
148792938|NCT01089127|536719885|FG004|Overall Study|Protocol deviation|1|||
148792939|NCT01089127|536719886|FG005|Overall Study|Protocol deviation|0|||
148792940|NCT03200548|536719887|FG000|Overall Study|Withdrawal by Subject|5|||
148792941|NCT03200548|536719888|FG001|Overall Study|Withdrawal by Subject|11|||
148792942|NCT03200548|536719889|FG002|Overall Study|Withdrawal by Subject|7|||
148792943|NCT03200548|536719890|FG003|Overall Study|Withdrawal by Subject|6|||
148792944|NCT00875563|536719892|FG000|Overall Study|Death|4|||
148792945|NCT00875563|536719892|FG000|Overall Study|Withdrawal by Subject|7|||
148792946|NCT00875563|536719892|FG000|Overall Study|No long-term (3-5 year) consent|6|||
148792947|NCT00875563|536719892|FG000|Overall Study|Still be eligible for follow-up|7|||
148792948|NCT02427841|536719895|FG000|Overall Study|Lack of Efficacy|5|||
148792949|NCT02427841|536719895|FG000|Overall Study|Physician Decision|2|||
148792950|NCT02427841|536719895|FG000|Overall Study|Withdrawal by Subject|1|||
148792951|NCT00511810|536719896|FG000|Overall Study|Lost to Follow-up|1|||
148792952|NCT00511810|536719897|FG001|Overall Study|Lost to Follow-up|2|||
148792953|NCT00511810|536719896|FG000|Overall Study|Lack of Efficacy|0|||
148792954|NCT00511810|536719897|FG001|Overall Study|Lack of Efficacy|2|||
149134151|NCT02748018|537972869|FG001|Continuation Period|Lost to Follow-up|2|||
149134152|NCT02748018|537972870|FG002|Continuation Period|Lost to Follow-up|1|||
149134153|NCT02748018|537972871|FG003|Continuation Period|Lost to Follow-up|0|||
149134154|NCT02748018|537972872|FG004|Continuation Period|Lost to Follow-up|1|||
149134155|NCT02748018|537972873|FG005|Continuation Period|Lost to Follow-up|0|||
149134156|NCT02748018|537972868|FG000|Continuation Period|Pregnancy|1|||
149134157|NCT02748018|537972869|FG001|Continuation Period|Pregnancy|2|||
149134158|NCT02748018|537972870|FG002|Continuation Period|Pregnancy|0|||
149134159|NCT02748018|537972871|FG003|Continuation Period|Pregnancy|0|||
149134160|NCT02748018|537972872|FG004|Continuation Period|Pregnancy|0|||
149134161|NCT02748018|537972873|FG005|Continuation Period|Pregnancy|0|||
149134162|NCT02748018|537972868|FG000|Continuation Period|Physician Decision|0|||
149134163|NCT02748018|537972869|FG001|Continuation Period|Physician Decision|1|||
149134164|NCT02748018|537972870|FG002|Continuation Period|Physician Decision|2|||
149134165|NCT02748018|537972871|FG003|Continuation Period|Physician Decision|0|||
149134166|NCT02748018|537972872|FG004|Continuation Period|Physician Decision|2|||
149134167|NCT02748018|537972873|FG005|Continuation Period|Physician Decision|1|||
149134168|NCT02748018|537972868|FG000|Continuation Period|Protocol Violation|0|||
149134169|NCT02748018|537972869|FG001|Continuation Period|Protocol Violation|1|||
149134170|NCT02748018|537972870|FG002|Continuation Period|Protocol Violation|0|||
149134171|NCT02748018|537972871|FG003|Continuation Period|Protocol Violation|0|||
149134172|NCT02748018|537972872|FG004|Continuation Period|Protocol Violation|0|||
149134173|NCT02748018|537972873|FG005|Continuation Period|Protocol Violation|0|||
149134174|NCT06069778|537972874|FG000|Overall Study|Withdrawal by Subject|1|||
149134175|NCT02856893|537972875|FG000|Overall Study|Lack of Efficacy|27|||
149134176|NCT02856893|537972876|FG001|Overall Study|Lack of Efficacy|15|||
149134177|NCT02856893|537972877|FG002|Overall Study|Lack of Efficacy|19|||
149134178|NCT02856893|537972875|FG000|Overall Study|Death|1|||
149134179|NCT02856893|537972876|FG001|Overall Study|Death|0|||
149134180|NCT02856893|537972877|FG002|Overall Study|Death|0|||
149134181|NCT02856893|537972875|FG000|Overall Study|Adverse Event|2|||
148792955|NCT00511810|536719896|FG000|Overall Study|Refused second scn|0|||
149134182|NCT02856893|537972876|FG001|Overall Study|Adverse Event|0|||
149134183|NCT02856893|537972877|FG002|Overall Study|Adverse Event|0|||
148792956|NCT00511810|536719897|FG001|Overall Study|Refused second scn|1|||
148792957|NCT02896569|536719898|FG000|Overall Study|Lost to Follow-up|2|||
148792958|NCT02896569|536719899|FG001|Overall Study|Lost to Follow-up|1|||
148792959|NCT02896569|536719898|FG000|Overall Study|Physician Decision|1|||
148792960|NCT02896569|536719899|FG001|Overall Study|Physician Decision|3|||
148792961|NCT02896569|536719898|FG000|Overall Study|Adverse Event|0|||
149134184|NCT02856893|537972875|FG000|Overall Study|Physician Decision|0|||
149134185|NCT02856893|537972876|FG001|Overall Study|Physician Decision|2|||
149134186|NCT02856893|537972877|FG002|Overall Study|Physician Decision|3|||
149134187|NCT02856893|537972875|FG000|Overall Study|Withdrawal by Subject|1|||
148792962|NCT02896569|536719899|FG001|Overall Study|Adverse Event|1|||
148792963|NCT02896569|536719898|FG000|Overall Study|Withdrawal by Subject|1|||
148792964|NCT02896569|536719899|FG001|Overall Study|Withdrawal by Subject|0|||
148792965|NCT00313846|536719900|FG000|Overall Study|Withdrawal by Subject|2|||
148792966|NCT00313846|536719901|FG001|Overall Study|Withdrawal by Subject|0|||
148792967|NCT00313846|536719900|FG000|Overall Study|Adverse Event|1|||
148792968|NCT00313846|536719901|FG001|Overall Study|Adverse Event|8|||
148792969|NCT00313846|536719900|FG000|Overall Study|Administrative|2|||
148792970|NCT00313846|536719901|FG001|Overall Study|Administrative|3|||
148792971|NCT02592447|536719902|FG000|Overall Study|Lost to Follow-up|1|||
148792972|NCT02592447|536719903|FG001|Overall Study|Lost to Follow-up|0|||
148792973|NCT02592447|536719902|FG000|Overall Study|Ineligible after randomization|1|||
148792974|NCT02592447|536719903|FG001|Overall Study|Ineligible after randomization|0|||
148792975|NCT02592447|536719902|FG000|Overall Study|Withdrawal by Subject|0|||
148792976|NCT02592447|536719903|FG001|Overall Study|Withdrawal by Subject|1|||
148792977|NCT01096160|536719908|FG000|Overall Study|Adverse Event|0|||
148792978|NCT01096160|536719909|FG001|Overall Study|Adverse Event|0|||
148792979|NCT01096160|536719910|FG002|Overall Study|Adverse Event|1|||
148792980|NCT01096160|536719911|FG003|Overall Study|Adverse Event|0|||
148792981|NCT01096160|536719912|FG004|Overall Study|Adverse Event|0|||
148792982|NCT01096160|536719913|FG005|Overall Study|Adverse Event|0|||
148792983|NCT01096160|536719914|FG006|Overall Study|Adverse Event|0|||
148792984|NCT01096160|536719915|FG007|Overall Study|Adverse Event|0|||
148792985|NCT01096160|536719916|FG008|Overall Study|Adverse Event|0|||
148792986|NCT01096160|536719917|FG009|Overall Study|Adverse Event|1|||
148792987|NCT01096160|536719908|FG000|Overall Study|Met stopping criteria per protocol|0|||
148792988|NCT01096160|536719909|FG001|Overall Study|Met stopping criteria per protocol|0|||
148792989|NCT01096160|536719910|FG002|Overall Study|Met stopping criteria per protocol|0|||
148792990|NCT01096160|536719911|FG003|Overall Study|Met stopping criteria per protocol|0|||
148792991|NCT01096160|536719912|FG004|Overall Study|Met stopping criteria per protocol|1|||
148792992|NCT01096160|536719913|FG005|Overall Study|Met stopping criteria per protocol|0|||
148792993|NCT01096160|536719914|FG006|Overall Study|Met stopping criteria per protocol|2|||
148792994|NCT01096160|536719915|FG007|Overall Study|Met stopping criteria per protocol|0|||
148792995|NCT01096160|536719916|FG008|Overall Study|Met stopping criteria per protocol|2|||
148792996|NCT01096160|536719917|FG009|Overall Study|Met stopping criteria per protocol|0|||
148792997|NCT00627497|536719918|FG000|Overall Study|Lost to Follow-up|1|||
148792998|NCT00627497|536719919|FG001|Overall Study|Lost to Follow-up|1|||
148792999|NCT00627497|536719920|FG002|Overall Study|Lost to Follow-up|0|||
148793000|NCT00627497|536719921|FG003|Overall Study|Lost to Follow-up|0|||
148793001|NCT05259163|536721904|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
148793002|NCT05259163|536721905|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
148793003|NCT05251233|536721906|FG000|Overall Study|Disease progression - did not start treatment|0|||
148793004|NCT05251233|536721907|FG001|Overall Study|Disease progression - did not start treatment|0|||
148793005|NCT05251233|536721908|FG002|Overall Study|Disease progression - did not start treatment|5|||
148793006|NCT05251233|536721906|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
148793007|NCT05251233|536721907|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
148793008|NCT05251233|536721908|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
148793009|NCT05251233|536721906|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
148793010|NCT05251233|536721907|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
148793011|NCT05251233|536721908|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
148793012|NCT05251233|536721906|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
148793013|NCT05251233|536721907|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
148793014|NCT05251233|536721908|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
148793015|NCT05251233|536721906|FG000|Overall Study|Death - did not start treatment|3|||
148793016|NCT05251233|536721907|FG001|Overall Study|Death - did not start treatment|0|||
148793017|NCT05251233|536721908|FG002|Overall Study|Death - did not start treatment|0|||
148793018|NCT05251233|536721906|FG000|Overall Study|Withdrawal by Subject|2|||
148793019|NCT05251233|536721907|FG001|Overall Study|Withdrawal by Subject|2|||
148793020|NCT05251233|536721908|FG002|Overall Study|Withdrawal by Subject|0|||
148793021|NCT05251233|536721906|FG000|Overall Study|Other complicating disease|2|||
148793022|NCT05251233|536721907|FG001|Overall Study|Other complicating disease|1|||
148793023|NCT05251233|536721908|FG002|Overall Study|Other complicating disease|0|||
148793024|NCT05251233|536721906|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
148793025|NCT05251233|536721907|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
148793026|NCT05251233|536721908|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
148793027|NCT05251233|536721906|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
148793028|NCT05251233|536721907|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
148793029|NCT05251233|536721908|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
148793030|NCT00103285|536721909|FG000|Induction|Adverse Event|14|||
148793031|NCT00103285|536721910|FG001|Induction|Adverse Event|0|||
148793032|NCT00103285|536721911|FG002|Induction|Adverse Event|0|||
148793033|NCT00103285|536721912|FG003|Induction|Adverse Event|0|||
148793034|NCT00103285|536721913|FG004|Induction|Adverse Event|0|||
148793035|NCT00103285|536721914|FG005|Induction|Adverse Event|0|||
148793036|NCT00103285|536721915|FG006|Induction|Adverse Event|0|||
148793037|NCT00103285|536721916|FG007|Induction|Adverse Event|0|||
148793038|NCT00103285|536721909|FG000|Induction|Death|24|||
148793039|NCT00103285|536721910|FG001|Induction|Death|0|||
148793040|NCT00103285|536721911|FG002|Induction|Death|0|||
148793041|NCT00103285|536721912|FG003|Induction|Death|0|||
148793042|NCT00103285|536721913|FG004|Induction|Death|0|||
148793043|NCT00103285|536721914|FG005|Induction|Death|0|||
148793044|NCT00103285|536721915|FG006|Induction|Death|0|||
148793045|NCT00103285|536721916|FG007|Induction|Death|0|||
148793046|NCT00103285|536721909|FG000|Induction|Physician Decision|103|||
148793047|NCT00103285|536721910|FG001|Induction|Physician Decision|0|||
148793048|NCT00103285|536721911|FG002|Induction|Physician Decision|0|||
148793049|NCT00103285|536721912|FG003|Induction|Physician Decision|0|||
148793050|NCT00103285|536721913|FG004|Induction|Physician Decision|0|||
148793051|NCT00103285|536721914|FG005|Induction|Physician Decision|0|||
148793052|NCT00103285|536721915|FG006|Induction|Physician Decision|0|||
148793053|NCT00103285|536721916|FG007|Induction|Physician Decision|0|||
148793054|NCT00103285|536721909|FG000|Induction|Withdrawal by Subject|1|||
148793055|NCT00103285|536721910|FG001|Induction|Withdrawal by Subject|0|||
148793056|NCT00103285|536721911|FG002|Induction|Withdrawal by Subject|0|||
148793057|NCT00103285|536721912|FG003|Induction|Withdrawal by Subject|0|||
148793058|NCT00103285|536721913|FG004|Induction|Withdrawal by Subject|0|||
148793059|NCT00103285|536721914|FG005|Induction|Withdrawal by Subject|0|||
148793060|NCT00103285|536721915|FG006|Induction|Withdrawal by Subject|0|||
148793061|NCT00103285|536721916|FG007|Induction|Withdrawal by Subject|0|||
148793062|NCT00103285|536721909|FG000|Induction|Ineligible|43|||
148793063|NCT00103285|536721910|FG001|Induction|Ineligible|0|||
148793064|NCT00103285|536721911|FG002|Induction|Ineligible|0|||
148793065|NCT00103285|536721912|FG003|Induction|Ineligible|0|||
148793066|NCT00103285|536721913|FG004|Induction|Ineligible|0|||
148793067|NCT00103285|536721914|FG005|Induction|Ineligible|0|||
148793068|NCT00103285|536721915|FG006|Induction|Ineligible|0|||
148793069|NCT00103285|536721916|FG007|Induction|Ineligible|0|||
148793070|NCT00103285|536721909|FG000|Induction|Refusal|906|||
148793071|NCT00103285|536721910|FG001|Induction|Refusal|0|||
148793072|NCT00103285|536721911|FG002|Induction|Refusal|0|||
148793073|NCT00103285|536721912|FG003|Induction|Refusal|0|||
148793074|NCT00103285|536721913|FG004|Induction|Refusal|0|||
148793075|NCT00103285|536721914|FG005|Induction|Refusal|0|||
148793076|NCT00103285|536721915|FG006|Induction|Refusal|0|||
148793077|NCT00103285|536721916|FG007|Induction|Refusal|0|||
148793078|NCT00103285|536721909|FG000|Induction|Other|258|||
148793079|NCT00103285|536721910|FG001|Induction|Other|0|||
148793080|NCT00103285|536721911|FG002|Induction|Other|0|||
148793081|NCT00103285|536721912|FG003|Induction|Other|0|||
148793082|NCT00103285|536721913|FG004|Induction|Other|0|||
148793083|NCT00103285|536721914|FG005|Induction|Other|0|||
148793084|NCT00103285|536721915|FG006|Induction|Other|0|||
148793085|NCT00103285|536721916|FG007|Induction|Other|0|||
148793086|NCT00103285|536721909|FG000|Response Assignment|Adverse Event|0|||
148793087|NCT00103285|536721910|FG001|Response Assignment|Adverse Event|8|||
148793088|NCT00103285|536721911|FG002|Response Assignment|Adverse Event|3|||
148793089|NCT00103285|536721912|FG003|Response Assignment|Adverse Event|2|||
148793090|NCT00103285|536721913|FG004|Response Assignment|Adverse Event|3|||
148793091|NCT00103285|536721914|FG005|Response Assignment|Adverse Event|1|||
148793092|NCT00103285|536721915|FG006|Response Assignment|Adverse Event|1|||
148793093|NCT00103285|536721916|FG007|Response Assignment|Adverse Event|2|||
148793094|NCT00103285|536721909|FG000|Response Assignment|Death|0|||
148793095|NCT00103285|536721910|FG001|Response Assignment|Death|5|||
148793096|NCT00103285|536721911|FG002|Response Assignment|Death|2|||
148793097|NCT00103285|536721912|FG003|Response Assignment|Death|2|||
148793098|NCT00103285|536721913|FG004|Response Assignment|Death|3|||
148793099|NCT00103285|536721914|FG005|Response Assignment|Death|1|||
148793100|NCT00103285|536721915|FG006|Response Assignment|Death|0|||
148793101|NCT00103285|536721916|FG007|Response Assignment|Death|8|||
148793102|NCT00103285|536721909|FG000|Response Assignment|Lost to Follow-up|0|||
148793103|NCT00103285|536721910|FG001|Response Assignment|Lost to Follow-up|9|||
148793104|NCT00103285|536721911|FG002|Response Assignment|Lost to Follow-up|5|||
148793105|NCT00103285|536721912|FG003|Response Assignment|Lost to Follow-up|5|||
148793106|NCT00103285|536721913|FG004|Response Assignment|Lost to Follow-up|1|||
148793107|NCT00103285|536721914|FG005|Response Assignment|Lost to Follow-up|2|||
148793108|NCT00103285|536721915|FG006|Response Assignment|Lost to Follow-up|2|||
148793109|NCT00103285|536721916|FG007|Response Assignment|Lost to Follow-up|5|||
148793110|NCT00103285|536721909|FG000|Response Assignment|Physician Decision|0|||
148793111|NCT00103285|536721910|FG001|Response Assignment|Physician Decision|13|||
148793112|NCT00103285|536721911|FG002|Response Assignment|Physician Decision|14|||
148793113|NCT00103285|536721912|FG003|Response Assignment|Physician Decision|9|||
148793114|NCT00103285|536721913|FG004|Response Assignment|Physician Decision|13|||
148793115|NCT00103285|536721914|FG005|Response Assignment|Physician Decision|7|||
148893706|NCT04612725|537088818|FG004|Overall Study|Physician Decision|0|||
148893707|NCT04612725|537088814|FG000|Overall Study|Study terminated by sponsor|3|||
148893708|NCT04612725|537088815|FG001|Overall Study|Study terminated by sponsor|1|||
148893709|NCT04612725|537088816|FG002|Overall Study|Study terminated by sponsor|2|||
148893710|NCT04612725|537088817|FG003|Overall Study|Study terminated by sponsor|4|||
148893711|NCT04612725|537088818|FG004|Overall Study|Study terminated by sponsor|5|||
148893712|NCT04612725|537088814|FG000|Overall Study|Withdrawal by Subject|8|||
148893713|NCT04612725|537088815|FG001|Overall Study|Withdrawal by Subject|3|||
148893714|NCT04612725|537088816|FG002|Overall Study|Withdrawal by Subject|5|||
148893715|NCT04612725|537088817|FG003|Overall Study|Withdrawal by Subject|1|||
148893716|NCT04612725|537088818|FG004|Overall Study|Withdrawal by Subject|9|||
148893717|NCT04612725|537088814|FG000|Overall Study|Other|0|||
148893718|NCT04612725|537088815|FG001|Overall Study|Other|0|||
148893719|NCT04612725|537088816|FG002|Overall Study|Other|0|||
148893720|NCT04612725|537088817|FG003|Overall Study|Other|0|||
148893721|NCT04612725|537088818|FG004|Overall Study|Other|1|||
148893722|NCT03409796|537090115|FG000|Overall Study|Adverse Event|2|||
148793116|NCT00103285|536721915|FG006|Response Assignment|Physician Decision|4|||
148793117|NCT00103285|536721916|FG007|Response Assignment|Physician Decision|35|||
148793118|NCT00103285|536721909|FG000|Response Assignment|Protocol Violation|0|||
148793119|NCT00103285|536721910|FG001|Response Assignment|Protocol Violation|2|||
148793120|NCT00103285|536721911|FG002|Response Assignment|Protocol Violation|0|||
148793121|NCT00103285|536721912|FG003|Response Assignment|Protocol Violation|0|||
148793122|NCT00103285|536721913|FG004|Response Assignment|Protocol Violation|0|||
148793123|NCT00103285|536721914|FG005|Response Assignment|Protocol Violation|0|||
148793124|NCT00103285|536721915|FG006|Response Assignment|Protocol Violation|0|||
148793125|NCT00103285|536721916|FG007|Response Assignment|Protocol Violation|0|||
148793126|NCT00103285|536721909|FG000|Response Assignment|Withdrawal by Subject|0|||
148793127|NCT00103285|536721910|FG001|Response Assignment|Withdrawal by Subject|4|||
148793128|NCT00103285|536721911|FG002|Response Assignment|Withdrawal by Subject|1|||
148793129|NCT00103285|536721912|FG003|Response Assignment|Withdrawal by Subject|1|||
148793130|NCT00103285|536721913|FG004|Response Assignment|Withdrawal by Subject|2|||
148793131|NCT00103285|536721914|FG005|Response Assignment|Withdrawal by Subject|2|||
148793132|NCT00103285|536721915|FG006|Response Assignment|Withdrawal by Subject|0|||
148793133|NCT00103285|536721916|FG007|Response Assignment|Withdrawal by Subject|2|||
148793134|NCT00103285|536721909|FG000|Response Assignment|Ineligible|0|||
148793135|NCT00103285|536721910|FG001|Response Assignment|Ineligible|8|||
148793136|NCT00103285|536721911|FG002|Response Assignment|Ineligible|6|||
148793137|NCT00103285|536721912|FG003|Response Assignment|Ineligible|2|||
148793138|NCT00103285|536721913|FG004|Response Assignment|Ineligible|0|||
148793139|NCT00103285|536721914|FG005|Response Assignment|Ineligible|3|||
148793140|NCT00103285|536721915|FG006|Response Assignment|Ineligible|1|||
148793141|NCT00103285|536721916|FG007|Response Assignment|Ineligible|5|||
148793142|NCT00103285|536721909|FG000|Response Assignment|Refusal|0|||
148793143|NCT00103285|536721910|FG001|Response Assignment|Refusal|53|||
148793144|NCT00103285|536721911|FG002|Response Assignment|Refusal|5|||
148793145|NCT00103285|536721912|FG003|Response Assignment|Refusal|3|||
148793146|NCT00103285|536721913|FG004|Response Assignment|Refusal|25|||
148793147|NCT00103285|536721914|FG005|Response Assignment|Refusal|15|||
148793148|NCT00103285|536721915|FG006|Response Assignment|Refusal|30|||
148793149|NCT00103285|536721916|FG007|Response Assignment|Refusal|10|||
148793150|NCT00103285|536721909|FG000|Response Assignment|Other|0|||
148793151|NCT00103285|536721910|FG001|Response Assignment|Other|30|||
148793152|NCT00103285|536721911|FG002|Response Assignment|Other|48|||
148793153|NCT00103285|536721912|FG003|Response Assignment|Other|38|||
148793154|NCT00103285|536721913|FG004|Response Assignment|Other|37|||
148793155|NCT00103285|536721914|FG005|Response Assignment|Other|17|||
148793156|NCT00103285|536721915|FG006|Response Assignment|Other|11|||
148793157|NCT00103285|536721916|FG007|Response Assignment|Other|53|||
148793158|NCT01381926|536721917|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
148793159|NCT01381926|536721918|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
148793160|NCT01381926|536721917|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
148793161|NCT01381926|536721918|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
148793162|NCT02624947|536721919|FG000|Maternal Participants|Adverse Event|5|||
148793163|NCT02624947|536721920|FG001|Maternal Participants|Adverse Event|0|||
148793164|NCT02624947|536721919|FG000|Maternal Participants|Investigator Decision|5|||
148893723|NCT03409796|537090116|FG001|Overall Study|Adverse Event|0|||
148793165|NCT02624947|536721920|FG001|Maternal Participants|Investigator Decision|3|||
148793166|NCT02624947|536721919|FG000|Maternal Participants|Lost to Follow-up|54|||
148793167|NCT02624947|536721920|FG001|Maternal Participants|Lost to Follow-up|24|||
148793168|NCT02624947|536721919|FG000|Maternal Participants|Non Compliance|8|||
148793169|NCT02624947|536721920|FG001|Maternal Participants|Non Compliance|5|||
148793170|NCT02624947|536721919|FG000|Maternal Participants|Sponsor Request|1|||
148893724|NCT03409796|537090115|FG000|Overall Study|Other|0|||
148893725|NCT03409796|537090116|FG001|Overall Study|Other|1|||
148893726|NCT00644423|537090118|FG000|Overall Study|Lost to Follow-up|1|||
148893727|NCT00644423|537090119|FG001|Overall Study|Lost to Follow-up|1|||
148893728|NCT01453049|537090132|FG000|Overall Study|Protocol Violation|2|||
148893729|NCT01453049|537090133|FG001|Overall Study|Protocol Violation|5|||
148893730|NCT01453049|537090132|FG000|Overall Study|Lost to Follow-up|2|||
148893731|NCT01453049|537090133|FG001|Overall Study|Lost to Follow-up|1|||
148893732|NCT01453049|537090132|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
148893733|NCT01453049|537090133|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
148893734|NCT01453049|537090132|FG000|Overall Study|Withdrawal by Subject|1|||
148893735|NCT01453049|537090133|FG001|Overall Study|Withdrawal by Subject|0|||
148893736|NCT01453049|537090132|FG000|Overall Study|Randomized in Error|1|||
148893737|NCT01453049|537090133|FG001|Overall Study|Randomized in Error|0|||
148893738|NCT03287791|537090138|FG000|Overall Study|Insufficient Therapeutic Response|0|||
148893739|NCT03287791|537090139|FG001|Overall Study|Insufficient Therapeutic Response|0|||
148893740|NCT03287791|537090140|FG002|Overall Study|Insufficient Therapeutic Response|1|||
148893741|NCT03287791|537090138|FG000|Overall Study|Adverse Event|0|||
148893742|NCT03287791|537090139|FG001|Overall Study|Adverse Event|4|||
148893743|NCT03287791|537090140|FG002|Overall Study|Adverse Event|3|||
148893744|NCT03287791|537090138|FG000|Overall Study|Withdrawal by Subject|12|||
148893745|NCT03287791|537090139|FG001|Overall Study|Withdrawal by Subject|12|||
148893746|NCT03287791|537090140|FG002|Overall Study|Withdrawal by Subject|17|||
148893747|NCT03287791|537090138|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
148893748|NCT03287791|537090139|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
148893749|NCT03287791|537090140|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
148893750|NCT03287791|537090138|FG000|Overall Study|Lost to Follow-up|8|||
148893751|NCT03287791|537090139|FG001|Overall Study|Lost to Follow-up|14|||
148893752|NCT03287791|537090140|FG002|Overall Study|Lost to Follow-up|11|||
148893753|NCT03287791|537090138|FG000|Overall Study|Protocol Violation|7|||
148893754|NCT03287791|537090139|FG001|Overall Study|Protocol Violation|2|||
148893755|NCT03287791|537090140|FG002|Overall Study|Protocol Violation|1|||
148893756|NCT03287791|537090138|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
148893757|NCT03287791|537090139|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
148893758|NCT03287791|537090140|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
148893759|NCT03287791|537090138|FG000|Overall Study|Too much time between 2 visits|0|||
148893760|NCT03287791|537090139|FG001|Overall Study|Too much time between 2 visits|1|||
148893761|NCT03287791|537090140|FG002|Overall Study|Too much time between 2 visits|0|||
148893762|NCT03287791|537090138|FG000|Overall Study|Non-compliance|0|||
148893763|NCT03287791|537090139|FG001|Overall Study|Non-compliance|1|||
148893764|NCT03287791|537090140|FG002|Overall Study|Non-compliance|0|||
148893765|NCT03287791|537090138|FG000|Overall Study|Did not meet inclusion criteria|1|||
148893766|NCT03287791|537090139|FG001|Overall Study|Did not meet inclusion criteria|0|||
148893767|NCT03287791|537090140|FG002|Overall Study|Did not meet inclusion criteria|0|||
148893768|NCT03095651|537090142|FG000|Overall Study|Lost to Follow-up|1|||
148893769|NCT03095651|537090143|FG001|Overall Study|Lost to Follow-up|1|||
148893770|NCT03095651|537090144|FG002|Overall Study|Lost to Follow-up|0|||
148893771|NCT03095651|537090145|FG003|Overall Study|Lost to Follow-up|1|||
148893772|NCT03095651|537090146|FG004|Overall Study|Lost to Follow-up|0|||
148893773|NCT03095651|537090147|FG005|Overall Study|Lost to Follow-up|0|||
148893774|NCT03095651|537090148|FG006|Overall Study|Lost to Follow-up|0|||
148893775|NCT03095651|537090149|FG007|Overall Study|Lost to Follow-up|0|||
148893776|NCT03095651|537090142|FG000|Overall Study|Withdrawal by Subject|0|||
148893777|NCT03095651|537090143|FG001|Overall Study|Withdrawal by Subject|0|||
148893778|NCT03095651|537090144|FG002|Overall Study|Withdrawal by Subject|0|||
148893779|NCT03095651|537090145|FG003|Overall Study|Withdrawal by Subject|0|||
148893780|NCT03095651|537090146|FG004|Overall Study|Withdrawal by Subject|0|||
148893781|NCT03095651|537090147|FG005|Overall Study|Withdrawal by Subject|1|||
148893782|NCT03095651|537090148|FG006|Overall Study|Withdrawal by Subject|0|||
148893783|NCT03095651|537090149|FG007|Overall Study|Withdrawal by Subject|0|||
148893784|NCT04235140|537090158|FG000|Overall Study|Adverse Event|2|||
148893785|NCT04235140|537090158|FG000|Overall Study|Lost to Follow-up|1|||
148893786|NCT04235140|537090158|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
148893787|NCT04235140|537090158|FG000|Overall Study|Commercial drug is available for participants|7|||
148893788|NCT02210000|537090159|FG000|Overall Study|Study Terminated|11|||
148893789|NCT02210000|537090160|FG001|Overall Study|Study Terminated|12|||
148893790|NCT02210000|537090159|FG000|Overall Study|Withdrawal by Subject|7|||
148893791|NCT02210000|537090160|FG001|Overall Study|Withdrawal by Subject|1|||
148893792|NCT02210000|537090159|FG000|Overall Study|Adverse Event|1|||
148893793|NCT02210000|537090160|FG001|Overall Study|Adverse Event|5|||
148893794|NCT02210000|537090159|FG000|Overall Study|Lost to Follow-up|0|||
148893795|NCT02210000|537090160|FG001|Overall Study|Lost to Follow-up|2|||
148893796|NCT02210000|537090159|FG000|Overall Study|Physician Decision|0|||
149134188|NCT02856893|537972876|FG001|Overall Study|Withdrawal by Subject|1|||
148893797|NCT02210000|537090160|FG001|Overall Study|Physician Decision|1|||
148893798|NCT00866177|537090165|FG000|Overall Study|Withdrawal by Subject|1|||
148893799|NCT00866177|537090165|FG000|Overall Study|Not Treated|151|||
148893800|NCT03585660|537090166|FG000|Overall Study|operator error|1|||
148893801|NCT03585660|537090166|FG000|Overall Study|technical error|2|||
148893802|NCT03585660|537090166|FG000|Overall Study|hip prosthesis|2|||
148793171|NCT02624947|536721920|FG001|Maternal Participants|Sponsor Request|1|||
149134189|NCT02856893|537972877|FG002|Overall Study|Withdrawal by Subject|0|||
149134190|NCT02856893|537972875|FG000|Overall Study|Other reasons|2|||
149134191|NCT02856893|537972876|FG001|Overall Study|Other reasons|1|||
149134192|NCT02856893|537972877|FG002|Overall Study|Other reasons|2|||
149134193|NCT03801902|537972878|FG000|Overall Study|Did not receive protocol treatment.|1|||
149134194|NCT03801902|537972879|FG001|Overall Study|Did not receive protocol treatment.|0|||
149134195|NCT03801902|537972880|FG002|Overall Study|Did not receive protocol treatment.|0|||
149134196|NCT03801902|537972881|FG003|Overall Study|Did not receive protocol treatment.|0|||
149134197|NCT02310672|537972882|FG000|Overall Study|Death|1|||
149134198|NCT02310672|537972882|FG000|Overall Study|Lost to Follow-up|1|||
149134199|NCT02310672|537972882|FG000|Overall Study|Withdrawal by Subject|1|||
149134200|NCT02310672|537972882|FG000|Overall Study|Sponsor's decision|12|||
149134201|NCT04704336|537972886|FG000|Overall Study|Death|2|||
149134202|NCT04704336|537972887|FG001|Overall Study|Death|2|||
149134203|NCT04704336|537972886|FG000|Overall Study|Lost to Follow-up|33|||
149134204|NCT04704336|537972887|FG001|Overall Study|Lost to Follow-up|40|||
149134205|NCT03118674|537972895|FG000|Overall Study|Lost to Follow-up|2|||
149134206|NCT03118674|537972895|FG000|Overall Study|Screen Faliure|8|||
149134207|NCT03118674|537972895|FG000|Overall Study|Withdrawal by Subject|5|||
149134208|NCT02260882|537972896|FG000|Overall Study|Protocol Violation|0|||
149134209|NCT02260882|537972897|FG001|Overall Study|Protocol Violation|1|||
149134210|NCT02119325|537972898|FG000|Washout Period 1|Adverse Event|0|||
149134211|NCT02119325|537972899|FG001|Washout Period 1|Adverse Event|1|||
149134212|NCT02644941|537972904|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
149134213|NCT02644941|537972905|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
149134214|NCT01387230|537972912|FG000|Overall Study|Adverse Event|0|||
149134215|NCT01387230|537972913|FG001|Overall Study|Adverse Event|1|||
149134216|NCT01387230|537972914|FG002|Overall Study|Adverse Event|3|||
149134217|NCT01387230|537972912|FG000|Overall Study|Lack of Efficacy|8|||
149134218|NCT01387230|537972913|FG001|Overall Study|Lack of Efficacy|5|||
149134219|NCT01387230|537972914|FG002|Overall Study|Lack of Efficacy|4|||
149134220|NCT01387230|537972912|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
149134221|NCT01387230|537972913|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
149134222|NCT01387230|537972914|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
149134223|NCT01387230|537972912|FG000|Overall Study|Lost to Follow-up|0|||
149134224|NCT01387230|537972913|FG001|Overall Study|Lost to Follow-up|0|||
149134225|NCT01387230|537972914|FG002|Overall Study|Lost to Follow-up|1|||
149134226|NCT01387230|537972912|FG000|Overall Study|Withdrawal by Subject|4|||
149134227|NCT01387230|537972913|FG001|Overall Study|Withdrawal by Subject|1|||
149134228|NCT01387230|537972914|FG002|Overall Study|Withdrawal by Subject|0|||
149134229|NCT00403754|537972915|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
149134230|NCT00403754|537972916|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
149134231|NCT00403754|537972917|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
149134232|NCT00403754|537972918|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
149134233|NCT00403754|537972915|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
149134234|NCT00403754|537972916|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
149134235|NCT00403754|537972917|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
149134236|NCT00403754|537972918|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
149134237|NCT02000427|537972919|FG000|Overall Study|Death|22|||
149134238|NCT05125679|537972922|FG000|Overall Study|Study Terminated by Sponsor|2|||
149134239|NCT05125679|537972923|FG001|Overall Study|Study Terminated by Sponsor|5|||
149134240|NCT03829319|537972924|FG000|Overall Study|Sponsor's Decision|4|||
149134241|NCT03829319|537972925|FG001|Overall Study|Sponsor's Decision|90|||
149134242|NCT03829319|537972926|FG002|Overall Study|Sponsor's Decision|102|||
149134243|NCT03829319|537972924|FG000|Overall Study|Withdrawal by Subject|1|||
149134244|NCT03829319|537972925|FG001|Overall Study|Withdrawal by Subject|5|||
149134245|NCT03829319|537972926|FG002|Overall Study|Withdrawal by Subject|4|||
149134246|NCT03829319|537972924|FG000|Overall Study|Physician Decision|0|||
149134247|NCT03829319|537972925|FG001|Overall Study|Physician Decision|3|||
149134248|NCT03829319|537972926|FG002|Overall Study|Physician Decision|0|||
149134249|NCT03829319|537972924|FG000|Overall Study|Lost to Follow-up|0|||
149134250|NCT03829319|537972925|FG001|Overall Study|Lost to Follow-up|0|||
149134251|NCT03829319|537972926|FG002|Overall Study|Lost to Follow-up|1|||
149134252|NCT03829319|537972924|FG000|Overall Study|Death|8|||
149134253|NCT03829319|537972925|FG001|Overall Study|Death|277|||
149134254|NCT03829319|537972926|FG002|Overall Study|Death|266|||
148793172|NCT02624947|536721919|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
149134255|NCT02846532|537972927|FG000|Overall Study|Lost to Follow-up|0|||
149134256|NCT02846532|537972928|FG001|Overall Study|Lost to Follow-up|1|||
149134257|NCT02846532|537972929|FG002|Overall Study|Lost to Follow-up|1|||
149134258|NCT02846532|537972927|FG000|Overall Study|Withdrawal by Subject|1|||
149134259|NCT02846532|537972928|FG001|Overall Study|Withdrawal by Subject|2|||
149134260|NCT02846532|537972929|FG002|Overall Study|Withdrawal by Subject|0|||
149134261|NCT04484259|537972930|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
149134262|NCT04484259|537972931|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
149134263|NCT04484259|537972932|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
148893803|NCT03585660|537090166|FG000|Overall Study|did not undergo biopsy|8|||
148793173|NCT02624947|536721920|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
148793174|NCT02624947|536721919|FG000|Maternal Participants|Miscellaneous|23|||
148793175|NCT02624947|536721920|FG001|Maternal Participants|Miscellaneous|15|||
148793176|NCT02624947|536721919|FG000|Infant Participants|Adverse Event|18|||
148793177|NCT02624947|536721920|FG001|Infant Participants|Adverse Event|11|||
148793178|NCT02624947|536721919|FG000|Infant Participants|Investigator Decision|5|||
148793179|NCT02624947|536721920|FG001|Infant Participants|Investigator Decision|4|||
148793180|NCT02624947|536721919|FG000|Infant Participants|Lost to Follow-up|93|||
148793181|NCT02624947|536721920|FG001|Infant Participants|Lost to Follow-up|58|||
148793182|NCT02624947|536721919|FG000|Infant Participants|Non Compliance|17|||
148793183|NCT02624947|536721920|FG001|Infant Participants|Non Compliance|7|||
148793184|NCT02624947|536721919|FG000|Infant Participants|Sponsor Request|0|||
148793185|NCT02624947|536721920|FG001|Infant Participants|Sponsor Request|1|||
148793186|NCT02624947|536721919|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
149134264|NCT04484259|537972933|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
149134265|NCT04484259|537972934|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
149134266|NCT04484259|537972930|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
149134267|NCT04484259|537972931|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
149134268|NCT04484259|537972932|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
149134269|NCT04484259|537972933|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
149134270|NCT04484259|537972934|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
149134271|NCT04484259|537972930|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
149134272|NCT04484259|537972931|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
149134273|NCT04484259|537972932|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
149134274|NCT04484259|537972933|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
149134275|NCT04484259|537972934|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
149134276|NCT04484259|537972930|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
149134277|NCT04484259|537972931|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
149134278|NCT04484259|537972932|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
149134279|NCT04484259|537972933|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
149134280|NCT04484259|537972934|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
149134281|NCT04484259|537972930|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
149134282|NCT04484259|537972931|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
149134283|NCT04484259|537972932|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
149134284|NCT04484259|537972933|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
149134285|NCT04484259|537972934|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
149134286|NCT04484259|537972930|FG000|Randomized Treatment|Withdrawal by Subject|1|||
149134287|NCT04484259|537972931|FG001|Randomized Treatment|Withdrawal by Subject|0|||
149134288|NCT04484259|537972932|FG002|Randomized Treatment|Withdrawal by Subject|0|||
149134289|NCT04484259|537972933|FG003|Randomized Treatment|Withdrawal by Subject|0|||
149134290|NCT04484259|537972934|FG004|Randomized Treatment|Withdrawal by Subject|0|||
149134291|NCT03951220|537972935|FG000|Overall Study|Withdrawal by Subject|9|||
149134292|NCT03951220|537972936|FG001|Overall Study|Withdrawal by Subject|2|||
149134293|NCT03951220|537972937|FG002|Overall Study|Withdrawal by Subject|0|||
149134294|NCT04498832|537972938|FG000|Overall Study|Adverse Event|1|||
149134295|NCT04498832|537972939|FG001|Overall Study|Adverse Event|3|||
149134296|NCT04498832|537972938|FG000|Overall Study|Withdrawal by Subject|0|||
149134297|NCT04498832|537972939|FG001|Overall Study|Withdrawal by Subject|1|||
149134298|NCT04908189|537972940|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
149134299|NCT04908189|537972941|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
149134300|NCT04908189|537972942|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
149134301|NCT04908189|537972940|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
149134302|NCT04908189|537972941|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
149134303|NCT04908189|537972942|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
149134304|NCT04908189|537972940|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
149134305|NCT04908189|537972941|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
149134306|NCT04908189|537972942|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
149134307|NCT04908189|537972940|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
149134308|NCT04908189|537972941|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
149134309|NCT04908189|537972942|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
149233842|NCT05182840|538324928|FG009|Treatment Period|Not treated with study drug|0|||
148893804|NCT03585660|537090166|FG000|Overall Study|scanner problem|2|||
148893805|NCT05635461|537090167|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
148893806|NCT05635461|537090168|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
148793187|NCT02624947|536721920|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
148893807|NCT05635461|537090169|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
148893808|NCT05635461|537090170|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
148893809|NCT05635461|537090171|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
148893810|NCT05635461|537090172|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
148893811|NCT05635461|537090167|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
148893812|NCT05635461|537090168|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
148893813|NCT05635461|537090169|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
148893814|NCT05635461|537090170|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
148893815|NCT05635461|537090171|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
148893816|NCT05635461|537090172|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
148893817|NCT05635461|537090167|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
148893818|NCT05635461|537090168|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
148893819|NCT05635461|537090169|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
148893820|NCT05635461|537090170|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
148893821|NCT05635461|537090171|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
148893822|NCT05635461|537090172|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
148893823|NCT04201431|537090180|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
148893824|NCT04201431|537090181|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
148893825|NCT04201431|537090182|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
148893826|NCT01945021|537090183|FG000|Overall Study|Adverse Event|1|||
148893827|NCT01945021|537090183|FG000|Overall Study|Withdrawal of consent|12|||
148893828|NCT01945021|537090183|FG000|Overall Study|Lost to Follow-up|5|||
148893829|NCT01945021|537090183|FG000|Overall Study|Death|65|||
148893830|NCT02163902|537090184|FG000|Overall Study|Subject's Request|3|||
148893831|NCT02163902|537090185|FG001|Overall Study|Subject's Request|4|||
148893832|NCT02163902|537090184|FG000|Overall Study|Lost to Follow-up|6|||
148893833|NCT02163902|537090185|FG001|Overall Study|Lost to Follow-up|7|||
148893834|NCT02163902|537090184|FG000|Overall Study|Administrative Decision|2|||
148893835|NCT02163902|537090185|FG001|Overall Study|Administrative Decision|2|||
148893836|NCT02903160|537090186|FG000|Overall Study|Adverse Event|2|||
148893837|NCT02903160|537090186|FG000|Overall Study|Death|1|||
148893838|NCT02903160|537090186|FG000|Overall Study|Lost to Follow-up|2|||
148893839|NCT02903160|537090186|FG000|Overall Study|Withdrawal by Subject|1|||
148893840|NCT02903160|537090186|FG000|Overall Study|Medical Insurance Barriers|1|||
148893841|NCT01664910|537090189|FG000|Overall Study|Adverse Event|0|||
148893842|NCT01664910|537090190|FG001|Overall Study|Adverse Event|0|||
148893843|NCT01664910|537090191|FG002|Overall Study|Adverse Event|1|||
148893844|NCT00867165|537090196|FG000|Overall Study|Adverse Event|3|||
148893845|NCT00867165|537090197|FG001|Overall Study|Adverse Event|0|||
148893846|NCT00867165|537090196|FG000|Overall Study|Withdrawal by Subject|1|||
148893847|NCT00867165|537090197|FG001|Overall Study|Withdrawal by Subject|0|||
148893848|NCT02734693|537090198|FG000|Overall Study|Adverse Event|1|||
148893849|NCT02734693|537090199|FG001|Overall Study|Adverse Event|3|||
148893850|NCT02734693|537090200|FG002|Overall Study|Adverse Event|3|||
148893851|NCT02734693|537090198|FG000|Overall Study|Lack of Efficacy|1|||
148893852|NCT02734693|537090199|FG001|Overall Study|Lack of Efficacy|0|||
148893853|NCT02734693|537090200|FG002|Overall Study|Lack of Efficacy|0|||
148893854|NCT02734693|537090198|FG000|Overall Study|Lost to Follow-up|2|||
148893855|NCT02734693|537090199|FG001|Overall Study|Lost to Follow-up|0|||
148893856|NCT02734693|537090200|FG002|Overall Study|Lost to Follow-up|0|||
148893857|NCT02734693|537090198|FG000|Overall Study|Protocol Violation|1|||
148893858|NCT02734693|537090199|FG001|Overall Study|Protocol Violation|0|||
149134310|NCT04908189|537972940|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
149134311|NCT04908189|537972941|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
148793188|NCT02624947|536721919|FG000|Infant Participants|Miscellaneous|50|||
148793189|NCT02624947|536721920|FG001|Infant Participants|Miscellaneous|26|||
148793190|NCT01919164|536721936|FG000|Overall Study|Adverse Event|6|||
148793191|NCT01919164|536721937|FG001|Overall Study|Adverse Event|4|||
148793192|NCT01919164|536721938|FG002|Overall Study|Adverse Event|9|||
148793193|NCT01919164|536721939|FG003|Overall Study|Adverse Event|3|||
148793194|NCT01919164|536721940|FG004|Overall Study|Adverse Event|2|||
149134312|NCT04908189|537972942|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
149134313|NCT04908189|537972940|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
148793195|NCT01919164|536721936|FG000|Overall Study|Lost to Follow-up|2|||
149134314|NCT04908189|537972941|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
149134315|NCT04908189|537972942|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
149134316|NCT04908189|537972940|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
149134317|NCT04908189|537972941|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
148793196|NCT01919164|536721937|FG001|Overall Study|Lost to Follow-up|2|||
148793197|NCT01919164|536721938|FG002|Overall Study|Lost to Follow-up|2|||
148793198|NCT01919164|536721939|FG003|Overall Study|Lost to Follow-up|0|||
148893859|NCT02734693|537090200|FG002|Overall Study|Protocol Violation|0|||
148893860|NCT02734693|537090198|FG000|Overall Study|Withdrawal by Subject|1|||
148893861|NCT02734693|537090199|FG001|Overall Study|Withdrawal by Subject|0|||
148793199|NCT01919164|536721940|FG004|Overall Study|Lost to Follow-up|4|||
148893862|NCT02734693|537090200|FG002|Overall Study|Withdrawal by Subject|0|||
149134318|NCT04908189|537972942|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
149134319|NCT04908189|537972940|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
149134320|NCT04908189|537972941|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
149134321|NCT04908189|537972942|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
149134322|NCT04908189|537972940|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
149134323|NCT04908189|537972941|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
149134324|NCT04908189|537972942|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
149134325|NCT04908189|537972940|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
149134326|NCT04908189|537972941|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
149134327|NCT04908189|537972942|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
149134328|NCT04908189|537972940|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
149134329|NCT04908189|537972941|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
149134330|NCT04908189|537972942|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
149134331|NCT04908189|537972940|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
149134332|NCT04908189|537972941|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
149134333|NCT04908189|537972942|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
149134334|NCT05359003|537972943|FG000|Overall Study|Withdrawal by Subject|1|||
149134335|NCT05359003|537972944|FG001|Overall Study|Withdrawal by Subject|3|||
149134336|NCT00607022|537972948|FG000|Overall Study|Withdrawal by Subject|1|||
149134337|NCT00607022|537972949|FG001|Overall Study|Withdrawal by Subject|0|||
149134338|NCT00607022|537972950|FG002|Overall Study|Withdrawal by Subject|0|||
149134339|NCT06268288|537972951|FG000|Overall Study|Withdrawal by Subject|1|||
149134340|NCT06268288|537972952|FG001|Overall Study|Withdrawal by Subject|2|||
149134341|NCT03049735|537972953|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
149134342|NCT03049735|537972954|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
149134343|NCT03049735|537972955|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
149134344|NCT03049735|537972953|FG000|Overall Study|Other|5|||
149134345|NCT03049735|537972954|FG001|Overall Study|Other|3|||
149134346|NCT03049735|537972955|FG002|Overall Study|Other|1|||
149134347|NCT03049735|537972953|FG000|Overall Study|Lack of Efficacy|4|||
149134348|NCT03049735|537972954|FG001|Overall Study|Lack of Efficacy|0|||
149134349|NCT03049735|537972955|FG002|Overall Study|Lack of Efficacy|3|||
149134350|NCT03049735|537972953|FG000|Overall Study|Protocol deviation|1|||
149134351|NCT03049735|537972954|FG001|Overall Study|Protocol deviation|0|||
149134352|NCT03049735|537972955|FG002|Overall Study|Protocol deviation|0|||
149134353|NCT03049735|537972953|FG000|Overall Study|Pregnancy|0|||
149134354|NCT03049735|537972954|FG001|Overall Study|Pregnancy|0|||
149134355|NCT03049735|537972955|FG002|Overall Study|Pregnancy|1|||
149134356|NCT03049735|537972953|FG000|Overall Study|Adverse Event|7|||
149134357|NCT03049735|537972954|FG001|Overall Study|Adverse Event|18|||
148793200|NCT01919164|536721936|FG000|Overall Study|Death|1|||
148793201|NCT01919164|536721937|FG001|Overall Study|Death|0|||
148793202|NCT01919164|536721938|FG002|Overall Study|Death|0|||
148793203|NCT01919164|536721939|FG003|Overall Study|Death|0|||
148793204|NCT01919164|536721940|FG004|Overall Study|Death|0|||
148793205|NCT01919164|536721936|FG000|Overall Study|Protocol Violation|6|||
148793206|NCT01919164|536721937|FG001|Overall Study|Protocol Violation|0|||
148793207|NCT01919164|536721938|FG002|Overall Study|Protocol Violation|3|||
148793208|NCT01919164|536721939|FG003|Overall Study|Protocol Violation|2|||
148793209|NCT01919164|536721940|FG004|Overall Study|Protocol Violation|2|||
148793210|NCT01919164|536721936|FG000|Overall Study|Disease progression|2|||
148793211|NCT01919164|536721937|FG001|Overall Study|Disease progression|2|||
148793212|NCT01919164|536721938|FG002|Overall Study|Disease progression|1|||
148793213|NCT01919164|536721939|FG003|Overall Study|Disease progression|2|||
148793214|NCT01919164|536721940|FG004|Overall Study|Disease progression|1|||
148793215|NCT01919164|536721936|FG000|Overall Study|Withdrew consent|13|||
148793216|NCT01919164|536721937|FG001|Overall Study|Withdrew consent|13|||
148793217|NCT01919164|536721938|FG002|Overall Study|Withdrew consent|14|||
148793218|NCT01919164|536721939|FG003|Overall Study|Withdrew consent|14|||
148793219|NCT01919164|536721940|FG004|Overall Study|Withdrew consent|9|||
148793220|NCT01919164|536721936|FG000|Overall Study|Other Un-specified|13|||
148793221|NCT01919164|536721937|FG001|Overall Study|Other Un-specified|9|||
149134358|NCT03049735|537972955|FG002|Overall Study|Adverse Event|5|||
149134359|NCT03049735|537972953|FG000|Overall Study|Withdrawal by Subject|10|||
149134360|NCT03049735|537972954|FG001|Overall Study|Withdrawal by Subject|3|||
149134361|NCT03049735|537972955|FG002|Overall Study|Withdrawal by Subject|7|||
149134362|NCT03049735|537972953|FG000|Overall Study|Lost to Follow-up|1|||
149134363|NCT03049735|537972954|FG001|Overall Study|Lost to Follow-up|5|||
148793222|NCT01919164|536721938|FG002|Overall Study|Other Un-specified|8|||
148793223|NCT01919164|536721939|FG003|Overall Study|Other Un-specified|7|||
148793224|NCT01919164|536721940|FG004|Overall Study|Other Un-specified|15|||
149134364|NCT03049735|537972955|FG002|Overall Study|Lost to Follow-up|5|||
149134365|NCT02146326|537972956|FG000|Overall Study|Lost to Follow-up|3|||
148793225|NCT00588146|536721942|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
148893863|NCT02898454|537090203|FG000|Overall Study|Adverse Event|4|||
148793226|NCT00588146|536721943|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
148793227|NCT02100839|536721944|FG000|Multiple Ascending Dose|Adverse Event|2|||
148793228|NCT02100839|536721945|FG001|Multiple Ascending Dose|Adverse Event|0|||
148793229|NCT02100839|536721944|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
148793230|NCT02100839|536721945|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
148793231|NCT00463801|536721950|FG000|Overall Study|Protocol Violation|1|||
148793232|NCT00463801|536721950|FG000|Overall Study|Lack of Efficacy|2|||
148793233|NCT00463801|536721950|FG000|Overall Study|Adverse Event|4|||
148793234|NCT00463801|536721950|FG000|Overall Study|Lost to Follow-up|5|||
148793235|NCT00463801|536721950|FG000|Overall Study|No longer require therapy|1|||
148793236|NCT03272347|536721951|FG000|Overall Study|Death|0|||
148793237|NCT03272347|536721952|FG001|Overall Study|Death|0|||
148793238|NCT03272347|536721953|FG002|Overall Study|Death|0|||
148793239|NCT03272347|536721954|FG003|Overall Study|Death|1|||
148793240|NCT03272347|536721951|FG000|Overall Study|Lost to Follow-up|1|||
148793241|NCT03272347|536721952|FG001|Overall Study|Lost to Follow-up|3|||
148793242|NCT03272347|536721953|FG002|Overall Study|Lost to Follow-up|5|||
148793243|NCT03272347|536721954|FG003|Overall Study|Lost to Follow-up|1|||
148793244|NCT03272347|536721951|FG000|Overall Study|Physician Decision|4|||
148793245|NCT03272347|536721952|FG001|Overall Study|Physician Decision|2|||
148793246|NCT03272347|536721953|FG002|Overall Study|Physician Decision|5|||
148793247|NCT03272347|536721954|FG003|Overall Study|Physician Decision|4|||
148793248|NCT03272347|536721951|FG000|Overall Study|Screen Failure|1|||
148793249|NCT03272347|536721952|FG001|Overall Study|Screen Failure|0|||
148793250|NCT03272347|536721953|FG002|Overall Study|Screen Failure|0|||
148793251|NCT03272347|536721954|FG003|Overall Study|Screen Failure|0|||
148793252|NCT03272347|536721951|FG000|Overall Study|Withdrawal by Subject|5|||
148793253|NCT03272347|536721952|FG001|Overall Study|Withdrawal by Subject|1|||
148793254|NCT03272347|536721953|FG002|Overall Study|Withdrawal by Subject|2|||
148793255|NCT03272347|536721954|FG003|Overall Study|Withdrawal by Subject|1|||
148793256|NCT00940888|536721955|FG000|Overall Study|Unsuccessful Implant|4|||
148793257|NCT00940888|536721955|FG000|Overall Study|Death|461|||
148793258|NCT00940888|536721955|FG000|Overall Study|Withdrawn - Non-Death|364|||
148793259|NCT00940888|536721955|FG000|Overall Study|Lost to Follow-up|6|||
148793260|NCT01409915|536721959|FG000|Overall Study|Adverse Event|0|||
148793261|NCT01409915|536721960|FG001|Overall Study|Adverse Event|2|||
148793262|NCT01409915|536721959|FG000|Overall Study|Withdrawal by Subject|0|||
148793263|NCT01409915|536721960|FG001|Overall Study|Withdrawal by Subject|1|||
148793264|NCT01409915|536721959|FG000|Overall Study|Protocol Violation|1|||
148793265|NCT01409915|536721960|FG001|Overall Study|Protocol Violation|0|||
148793266|NCT00391872|536721961|FG000|Overall Study|Protocol Violation|7|||
148793267|NCT00391872|536721962|FG001|Overall Study|Protocol Violation|2|||
148793268|NCT00391872|536721961|FG000|Overall Study|Withdrawal by Subject|296|||
148793269|NCT00391872|536721962|FG001|Overall Study|Withdrawal by Subject|249|||
148793270|NCT00391872|536721961|FG000|Overall Study|Reason unknown|2|||
148793271|NCT00391872|536721962|FG001|Overall Study|Reason unknown|4|||
148793272|NCT00391872|536721961|FG000|Overall Study|Lost to Follow-up|2|||
148793273|NCT00391872|536721962|FG001|Overall Study|Lost to Follow-up|0|||
148793274|NCT04826484|536721963|FG000|Overall Study|Lost to Follow-up|2|||
148793275|NCT04826484|536721964|FG001|Overall Study|Lost to Follow-up|0|||
148793276|NCT00215644|536721966|FG000|Overall Study|Disease Progression|28|||
148793277|NCT00215644|536721967|FG001|Overall Study|Disease Progression|10|||
148793278|NCT00215644|536721966|FG000|Overall Study|Adverse Event|2|||
148793279|NCT00215644|536721967|FG001|Overall Study|Adverse Event|9|||
148793280|NCT00215644|536721966|FG000|Overall Study|Death|1|||
148793281|NCT00215644|536721967|FG001|Overall Study|Death|2|||
148793282|NCT00215644|536721966|FG000|Overall Study|Withdrawal by Subject|1|||
148793283|NCT00215644|536721967|FG001|Overall Study|Withdrawal by Subject|0|||
148793284|NCT00215644|536721966|FG000|Overall Study|Other|3|||
148793285|NCT00215644|536721967|FG001|Overall Study|Other|15|||
148793286|NCT00215644|536721966|FG000|Overall Study|Randomized but Not Treated|1|||
148793287|NCT00215644|536721967|FG001|Overall Study|Randomized but Not Treated|0|||
148793288|NCT03512353|536721971|FG000|Overall Study|Sponsor Decision|3|||
148793289|NCT03512353|536721971|FG000|Overall Study|Death|1|||
148793290|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
148793291|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
148793292|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
148793293|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
148793294|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
148793295|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
148793296|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
148793297|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
148793298|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
148793299|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
148793300|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
148793301|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
148793302|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
148893864|NCT02898454|537090204|FG001|Overall Study|Adverse Event|1|||
148893865|NCT02898454|537090205|FG002|Overall Study|Adverse Event|2|||
148893866|NCT02898454|537090203|FG000|Overall Study|Protocol Violation|1|||
148893867|NCT02898454|537090204|FG001|Overall Study|Protocol Violation|0|||
148893868|NCT02898454|537090205|FG002|Overall Study|Protocol Violation|1|||
148893869|NCT02898454|537090203|FG000|Overall Study|Lack of Efficacy|4|||
148893870|NCT02898454|537090204|FG001|Overall Study|Lack of Efficacy|1|||
148893871|NCT02898454|537090205|FG002|Overall Study|Lack of Efficacy|0|||
148893872|NCT02898454|537090203|FG000|Overall Study|Withdrawal by Subject|6|||
148893873|NCT02898454|537090204|FG001|Overall Study|Withdrawal by Subject|3|||
148893874|NCT02898454|537090205|FG002|Overall Study|Withdrawal by Subject|3|||
148893875|NCT02898454|537090203|FG000|Overall Study|Lost to Follow-up|1|||
148893876|NCT02898454|537090204|FG001|Overall Study|Lost to Follow-up|0|||
148893877|NCT02898454|537090205|FG002|Overall Study|Lost to Follow-up|0|||
148893878|NCT02898454|537090203|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
148893879|NCT02898454|537090204|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
148893880|NCT02898454|537090205|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
148893881|NCT00689390|537090206|FG000|Overall Study|Adverse Event|19|||
148893882|NCT00689390|537090207|FG001|Overall Study|Adverse Event|0|||
148893883|NCT00689390|537090206|FG000|Overall Study|Lost to Follow-up|179|||
148893884|NCT00689390|537090207|FG001|Overall Study|Lost to Follow-up|7|||
148893885|NCT00689390|537090206|FG000|Overall Study|Withdrawal by Subject|117|||
148893886|NCT00689390|537090207|FG001|Overall Study|Withdrawal by Subject|3|||
148893887|NCT00689390|537090206|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
148893888|NCT00689390|537090207|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
148893889|NCT00689390|537090206|FG000|Overall Study|Non-Compliance With Protocol|21|||
148893890|NCT00689390|537090207|FG001|Overall Study|Non-Compliance With Protocol|0|||
148893891|NCT00689390|537090206|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
148893892|NCT00689390|537090207|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
148893893|NCT00689390|537090206|FG000|Overall Study|Administrative|37|||
148893894|NCT00689390|537090207|FG001|Overall Study|Administrative|0|||
148893895|NCT02343263|537090208|FG000|Overall Study|Physician Decision|5|||
148893896|NCT02343263|537090209|FG001|Overall Study|Physician Decision|3|||
148893897|NCT02343263|537090210|FG002|Overall Study|Physician Decision|1|||
148893898|NCT04264442|537090214|FG000|Overall Study|Lack of Efficacy|6|||
148893899|NCT04264442|537090214|FG000|Overall Study|Lost to Follow-up|2|||
148893900|NCT04264442|537090214|FG000|Overall Study|Sponsor Decision|23|||
148893901|NCT04264442|537090214|FG000|Overall Study|Withdrawal by Subject|11|||
148893902|NCT04264442|537090214|FG000|Overall Study|Study Termination|5|||
148893903|NCT01384734|537090216|FG000|Overall Study|Adverse Event|0|||
148893904|NCT01384734|537090217|FG001|Overall Study|Adverse Event|3|||
148893905|NCT01384734|537090218|FG002|Overall Study|Adverse Event|0|||
148793303|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
148793304|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
148793305|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
148793306|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
148793307|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
148793308|NCT03569098|536721972|FG000|Double-Blind Treatment Cycle 1|Other|1|||
148793309|NCT03569098|536721973|FG001|Double-Blind Treatment Cycle 1|Other|0|||
148793310|NCT03569098|536721974|FG002|Double-Blind Treatment Cycle 1|Other|1|||
148793311|NCT03569098|536721972|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
148793312|NCT03569098|536721973|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
148793313|NCT03569098|536721974|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
148893906|NCT01384734|537090219|FG003|Overall Study|Adverse Event|2|||
148893907|NCT01384734|537090220|FG004|Overall Study|Adverse Event|7|||
148893908|NCT01384734|537090216|FG000|Overall Study|Death|1|||
148893909|NCT01384734|537090217|FG001|Overall Study|Death|0|||
148893910|NCT01384734|537090218|FG002|Overall Study|Death|1|||
148893911|NCT01384734|537090219|FG003|Overall Study|Death|0|||
148893912|NCT01384734|537090220|FG004|Overall Study|Death|0|||
148893913|NCT01384734|537090216|FG000|Overall Study|Continuation criteria not met|0|||
148893914|NCT01384734|537090217|FG001|Overall Study|Continuation criteria not met|0|||
148893915|NCT01384734|537090218|FG002|Overall Study|Continuation criteria not met|1|||
148893916|NCT01384734|537090219|FG003|Overall Study|Continuation criteria not met|1|||
148893917|NCT01384734|537090220|FG004|Overall Study|Continuation criteria not met|0|||
148893918|NCT01384734|537090216|FG000|Overall Study|Lack of Efficacy|3|||
148893919|NCT01384734|537090217|FG001|Overall Study|Lack of Efficacy|7|||
148893920|NCT01384734|537090218|FG002|Overall Study|Lack of Efficacy|4|||
148893921|NCT01384734|537090219|FG003|Overall Study|Lack of Efficacy|4|||
148893922|NCT01384734|537090220|FG004|Overall Study|Lack of Efficacy|2|||
148893923|NCT01384734|537090216|FG000|Overall Study|Lost to Follow-up|5|||
148893924|NCT01384734|537090217|FG001|Overall Study|Lost to Follow-up|3|||
148893925|NCT01384734|537090218|FG002|Overall Study|Lost to Follow-up|3|||
148893926|NCT01384734|537090219|FG003|Overall Study|Lost to Follow-up|8|||
148893927|NCT01384734|537090220|FG004|Overall Study|Lost to Follow-up|5|||
148893928|NCT01384734|537090216|FG000|Overall Study|Non-compliance with study drug|1|||
148893929|NCT01384734|537090217|FG001|Overall Study|Non-compliance with study drug|2|||
148893930|NCT01384734|537090218|FG002|Overall Study|Non-compliance with study drug|6|||
148893931|NCT01384734|537090219|FG003|Overall Study|Non-compliance with study drug|0|||
148893932|NCT01384734|537090220|FG004|Overall Study|Non-compliance with study drug|2|||
148893933|NCT01384734|537090216|FG000|Overall Study|Pregnancy|0|||
148893934|NCT01384734|537090217|FG001|Overall Study|Pregnancy|1|||
148893935|NCT01384734|537090218|FG002|Overall Study|Pregnancy|0|||
148893936|NCT01384734|537090219|FG003|Overall Study|Pregnancy|0|||
148893937|NCT01384734|537090220|FG004|Overall Study|Pregnancy|1|||
148893938|NCT01384734|537090216|FG000|Overall Study|Sponsor terminated|0|||
148893939|NCT01384734|537090217|FG001|Overall Study|Sponsor terminated|0|||
148893940|NCT01384734|537090218|FG002|Overall Study|Sponsor terminated|0|||
148893941|NCT01384734|537090219|FG003|Overall Study|Sponsor terminated|0|||
148893942|NCT01384734|537090220|FG004|Overall Study|Sponsor terminated|1|||
148893943|NCT01384734|537090216|FG000|Overall Study|Withdrawal by Subject|5|||
148893944|NCT01384734|537090217|FG001|Overall Study|Withdrawal by Subject|5|||
148893945|NCT01384734|537090218|FG002|Overall Study|Withdrawal by Subject|6|||
148893946|NCT01384734|537090219|FG003|Overall Study|Withdrawal by Subject|7|||
148893947|NCT01384734|537090220|FG004|Overall Study|Withdrawal by Subject|9|||
148893948|NCT01384734|537090216|FG000|Overall Study|Investigator relocating|0|||
148893949|NCT01384734|537090217|FG001|Overall Study|Investigator relocating|2|||
148893950|NCT01384734|537090218|FG002|Overall Study|Investigator relocating|0|||
148893951|NCT01384734|537090219|FG003|Overall Study|Investigator relocating|3|||
148893952|NCT01384734|537090220|FG004|Overall Study|Investigator relocating|1|||
148893953|NCT01384734|537090216|FG000|Overall Study|Unable to come back for visit|1|||
148893954|NCT01384734|537090217|FG001|Overall Study|Unable to come back for visit|0|||
148893955|NCT01384734|537090218|FG002|Overall Study|Unable to come back for visit|1|||
148893956|NCT01384734|537090219|FG003|Overall Study|Unable to come back for visit|1|||
148893957|NCT01384734|537090220|FG004|Overall Study|Unable to come back for visit|0|||
148893958|NCT01384734|537090216|FG000|Overall Study|Prison|0|||
148893959|NCT01384734|537090217|FG001|Overall Study|Prison|0|||
148893960|NCT01384734|537090218|FG002|Overall Study|Prison|1|||
148893961|NCT01384734|537090219|FG003|Overall Study|Prison|0|||
148893962|NCT01384734|537090220|FG004|Overall Study|Prison|0|||
148893963|NCT01384734|537090216|FG000|Overall Study|As per Exclusion criteria|0|||
148893964|NCT01384734|537090217|FG001|Overall Study|As per Exclusion criteria|1|||
148893965|NCT01384734|537090218|FG002|Overall Study|As per Exclusion criteria|0|||
148893966|NCT01384734|537090219|FG003|Overall Study|As per Exclusion criteria|0|||
148893967|NCT01384734|537090220|FG004|Overall Study|As per Exclusion criteria|0|||
148893968|NCT01384734|537090216|FG000|Overall Study|Missed End of treatment visit|0|||
148893969|NCT01384734|537090217|FG001|Overall Study|Missed End of treatment visit|0|||
148893970|NCT01384734|537090218|FG002|Overall Study|Missed End of treatment visit|0|||
148893971|NCT01384734|537090219|FG003|Overall Study|Missed End of treatment visit|1|||
148893972|NCT01384734|537090220|FG004|Overall Study|Missed End of treatment visit|0|||
148893973|NCT01384734|537090216|FG000|Overall Study|Adhesion problem|0|||
148893974|NCT01384734|537090217|FG001|Overall Study|Adhesion problem|0|||
148893975|NCT01384734|537090218|FG002|Overall Study|Adhesion problem|0|||
148893976|NCT01384734|537090219|FG003|Overall Study|Adhesion problem|1|||
148893977|NCT01384734|537090220|FG004|Overall Study|Adhesion problem|0|||
148893978|NCT01384734|537090216|FG000|Overall Study|Early termination|0|||
148893979|NCT01384734|537090217|FG001|Overall Study|Early termination|0|||
148893980|NCT01384734|537090218|FG002|Overall Study|Early termination|0|||
148893981|NCT01384734|537090219|FG003|Overall Study|Early termination|0|||
148893982|NCT01384734|537090220|FG004|Overall Study|Early termination|1|||
148893983|NCT01384734|537090216|FG000|Overall Study|Physician Decision|1|||
148893984|NCT01384734|537090217|FG001|Overall Study|Physician Decision|0|||
148893985|NCT01384734|537090218|FG002|Overall Study|Physician Decision|0|||
148893986|NCT01384734|537090219|FG003|Overall Study|Physician Decision|0|||
148893987|NCT01384734|537090220|FG004|Overall Study|Physician Decision|0|||
148893988|NCT01290523|537090221|FG000|Overall Study|Death|3|||
148893989|NCT03071263|537090222|FG000|Overall Study|Adverse Event|1|||
148893990|NCT03071263|537090223|FG001|Overall Study|Adverse Event|3|||
148893991|NCT03071263|537090222|FG000|Overall Study|Withdrawal by Subject|1|||
148893992|NCT03071263|537090223|FG001|Overall Study|Withdrawal by Subject|3|||
148893993|NCT03071263|537090222|FG000|Overall Study|Physician Decision|1|||
148893994|NCT03071263|537090223|FG001|Overall Study|Physician Decision|0|||
148893995|NCT03071263|537090222|FG000|Overall Study|Participant moved to another city|0|||
148893996|NCT03071263|537090223|FG001|Overall Study|Participant moved to another city|1|||
148893997|NCT02354235|537090225|FG000|Overall Study|Adverse Event|2|||
148893998|NCT02354235|537090226|FG001|Overall Study|Adverse Event|2|||
148893999|NCT02354235|537090225|FG000|Overall Study|Physician Decision|0|||
148894000|NCT02354235|537090226|FG001|Overall Study|Physician Decision|1|||
148894001|NCT02354235|537090225|FG000|Overall Study|Withdrawal by Subject|1|||
148894002|NCT02354235|537090226|FG001|Overall Study|Withdrawal by Subject|3|||
148894003|NCT02354235|537090225|FG000|Overall Study|Conflict with the stopping criteria|0|||
148894004|NCT02354235|537090226|FG001|Overall Study|Conflict with the stopping criteria|1|||
148894005|NCT03069352|537090227|FG000|Overall Study|Ongoing|12|||
148894006|NCT03069352|537090228|FG001|Overall Study|Ongoing|40|||
148894007|NCT02621424|537090229|FG000|Overall Study|Withdrawal by Subject|1|||
148894008|NCT02621424|537090230|FG001|Overall Study|Withdrawal by Subject|2|||
148894009|NCT05148234|537090232|FG000|Phase I|Ineligible|0|||
148894010|NCT05148234|537090233|FG001|Phase I|Ineligible|0|||
148894011|NCT05148234|537090234|FG002|Phase I|Ineligible|0|||
148894012|NCT05148234|537090235|FG003|Phase I|Ineligible|0|||
148894013|NCT05148234|537090236|FG004|Phase I|Ineligible|0|||
148894014|NCT05148234|537090237|FG005|Phase I|Ineligible|0|||
148894015|NCT05148234|537090238|FG006|Phase I|Ineligible|0|||
148894016|NCT05148234|537090239|FG007|Phase I|Ineligible|1|||
148894017|NCT05148234|537090232|FG000|Phase I|Company closed the trial.|0|||
148894018|NCT05148234|537090233|FG001|Phase I|Company closed the trial.|1|||
148894019|NCT05148234|537090234|FG002|Phase I|Company closed the trial.|0|||
148894020|NCT05148234|537090235|FG003|Phase I|Company closed the trial.|0|||
148894021|NCT05148234|537090236|FG004|Phase I|Company closed the trial.|0|||
148894022|NCT05148234|537090237|FG005|Phase I|Company closed the trial.|0|||
148894023|NCT05148234|537090238|FG006|Phase I|Company closed the trial.|0|||
148894024|NCT05148234|537090239|FG007|Phase I|Company closed the trial.|0|||
148956401|NCT00293254|537324410|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
148956402|NCT00293254|537324411|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
148956403|NCT00293254|537324410|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
148956404|NCT00293254|537324411|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
148956405|NCT00293254|537324410|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
148956406|NCT00293254|537324411|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
148956407|NCT00293254|537324410|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
148956408|NCT00293254|537324411|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
148956409|NCT00293254|537324410|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
148956410|NCT00293254|537324411|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
148956411|NCT00293254|537324410|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
148956412|NCT00293254|537324411|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
148956413|NCT00293254|537324410|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
148956414|NCT00293254|537324411|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
148956415|NCT00293254|537324410|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
148956416|NCT00293254|537324411|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
148956417|NCT00293254|537324410|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
148956418|NCT00293254|537324411|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
148956419|NCT00503308|537324412|FG000|Overall Study|Protocol Violation|2|||
148956420|NCT00503308|537324413|FG001|Overall Study|Protocol Violation|1|||
148956421|NCT04481750|537324414|FG000|Period 1 (Fasted)|Adverse Event|0|||
148956422|NCT04481750|537324415|FG001|Period 1 (Fasted)|Adverse Event|0|||
148956423|NCT04481750|537324416|FG002|Period 1 (Fasted)|Adverse Event|1|||
148956424|NCT04481750|537324417|FG003|Period 1 (Fasted)|Adverse Event|0|||
148956425|NCT04481750|537324418|FG004|Period 1 (Fasted)|Adverse Event|0|||
148956426|NCT04481750|537324419|FG005|Period 1 (Fasted)|Adverse Event|0|||
148956427|NCT04481750|537324420|FG006|Period 1 (Fasted)|Adverse Event|0|||
148956428|NCT04481750|537324421|FG007|Period 1 (Fasted)|Adverse Event|0|||
148956429|NCT04481750|537324422|FG008|Period 1 (Fasted)|Adverse Event|0|||
148956430|NCT04481750|537324423|FG009|Period 1 (Fasted)|Adverse Event|0|||
148956431|NCT04481750|537324424|FG010|Period 1 (Fasted)|Adverse Event|0|||
148956432|NCT01475331|537324425|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
148956433|NCT01475331|537324426|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
148956434|NCT01475331|537324425|FG000|Overall Study|excessive main duct communication|1|||
148956435|NCT01475331|537324426|FG001|Overall Study|excessive main duct communication|1|||
148956436|NCT01475331|537324425|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
148956437|NCT01475331|537324426|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
148956438|NCT01475331|537324425|FG000|Overall Study|Sign of malignancy during the procedure|2|||
148956439|NCT01475331|537324426|FG001|Overall Study|Sign of malignancy during the procedure|0|||
148956440|NCT01475331|537324425|FG000|Overall Study|cyst found to be prohibitively small|0|||
148956441|NCT01475331|537324426|FG001|Overall Study|cyst found to be prohibitively small|1|||
148956442|NCT00462761|537324427|FG000|Overall Study|Adverse Event|6|||
148956443|NCT00462761|537324427|FG000|Overall Study|Withdrawal by Subject|9|||
148956444|NCT00462761|537324427|FG000|Overall Study|Physician Decision|5|||
148956445|NCT00462761|537324427|FG000|Overall Study|Disease progression|43|||
148956446|NCT00462761|537324427|FG000|Overall Study|Death|12|||
148956447|NCT00462761|537324427|FG000|Overall Study|Other|1|||
148956448|NCT00723892|537324428|FG000|Overall Study|Participant not tracked|33|||
148956449|NCT00723892|537324429|FG001|Overall Study|Participant not tracked|35|||
148956450|NCT00723892|537324428|FG000|Overall Study|Virological criterion|24|||
148956451|NCT00723892|537324429|FG001|Overall Study|Virological criterion|9|||
148956452|NCT00723892|537324428|FG000|Overall Study|Withdrawal by Subject|6|||
148956453|NCT00723892|537324429|FG001|Overall Study|Withdrawal by Subject|9|||
148956454|NCT00723892|537324428|FG000|Overall Study|End planned|11|||
148956455|NCT00723892|537324429|FG001|Overall Study|End planned|7|||
148956456|NCT00723892|537324428|FG000|Overall Study|Bad tolerance|5|||
149134366|NCT02146326|537972957|FG001|Overall Study|Lost to Follow-up|3|||
148894025|NCT04607668|537091874|FG000|Overall Study|Death|49|||
148894026|NCT04607668|537091875|FG001|Overall Study|Death|26|||
148894027|NCT04607668|537091874|FG000|Overall Study|Lost to Follow-up|3|||
148894028|NCT04607668|537091875|FG001|Overall Study|Lost to Follow-up|4|||
148894029|NCT04607668|537091874|FG000|Overall Study|Study terminated by Sponsor|92|||
148793314|NCT03569098|536721972|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
148793315|NCT03569098|536721973|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
148793316|NCT03569098|536721974|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
148793317|NCT03569098|536721972|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
148894030|NCT04607668|537091875|FG001|Overall Study|Study terminated by Sponsor|114|||
148894031|NCT04607668|537091874|FG000|Overall Study|Withdrawal by Subject|12|||
148894032|NCT04607668|537091875|FG001|Overall Study|Withdrawal by Subject|11|||
148894033|NCT04607668|537091874|FG000|Overall Study|Other, unspecified|8|||
148894034|NCT04607668|537091875|FG001|Overall Study|Other, unspecified|7|||
148894035|NCT01751061|537091876|FG000|Overall Study|Death|1|||
148894036|NCT01751061|537091877|FG001|Overall Study|Death|0|||
148894037|NCT01751061|537091876|FG000|Overall Study|patient death|5|||
148894038|NCT01751061|537091877|FG001|Overall Study|patient death|0|||
148894039|NCT01751061|537091876|FG000|Overall Study|Lost to Follow-up|40|||
148894040|NCT01751061|537091877|FG001|Overall Study|Lost to Follow-up|25|||
148894041|NCT01751061|537091876|FG000|Overall Study|patient regained decisional capacity|4|||
148894042|NCT01751061|537091877|FG001|Overall Study|patient regained decisional capacity|8|||
148894043|NCT01751061|537091876|FG000|Overall Study|Withdrawal by Subject|4|||
148894044|NCT01751061|537091877|FG001|Overall Study|Withdrawal by Subject|1|||
148894045|NCT01751061|537091876|FG000|Overall Study|Physician Decision|2|||
148894046|NCT01751061|537091877|FG001|Overall Study|Physician Decision|0|||
148894047|NCT00768989|537091878|FG000|Prior to Week 24|Withdrawal by Subject|1|||
148894048|NCT00768989|537091879|FG001|Prior to Week 24|Withdrawal by Subject|0|||
148894049|NCT00768989|537091878|FG000|Prior to Week 24|Adverse Event|3|||
148894050|NCT00768989|537091879|FG001|Prior to Week 24|Adverse Event|0|||
148894051|NCT00768989|537091878|FG000|Prior to Week 24|Lost to Follow-up|0|||
148894052|NCT00768989|537091879|FG001|Prior to Week 24|Lost to Follow-up|1|||
148894053|NCT00768989|537091878|FG000|Prior to Week 24|Protocol Violation|0|||
148894054|NCT00768989|537091879|FG001|Prior to Week 24|Protocol Violation|2|||
148894055|NCT00768989|537091878|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
148894056|NCT00768989|537091879|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
148894057|NCT00768989|537091878|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
148894058|NCT00768989|537091879|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
148894059|NCT00768989|537091878|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
148894060|NCT00768989|537091879|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
148894061|NCT00768989|537091878|FG000|On or After Week 36|Lack of Efficacy|1|||
148894062|NCT00768989|537091879|FG001|On or After Week 36|Lack of Efficacy|0|||
148894063|NCT00768989|537091878|FG000|On or After Week 36|Adverse Event|0|||
148894064|NCT00768989|537091879|FG001|On or After Week 36|Adverse Event|1|||
148894065|NCT00768989|537091878|FG000|On or After Week 36|Lost to Follow-up|1|||
148894066|NCT00768989|537091879|FG001|On or After Week 36|Lost to Follow-up|0|||
148894067|NCT00768989|537091878|FG000|On or After Week 36|Poor Compliance|1|||
148894068|NCT00768989|537091879|FG001|On or After Week 36|Poor Compliance|0|||
148894069|NCT00768989|537091878|FG000|On or After Week 36|Protocol Violation|1|||
148894070|NCT00768989|537091879|FG001|On or After Week 36|Protocol Violation|0|||
148894071|NCT00768989|537091878|FG000|On or After Week 36|Did not attend termination visit|2|||
148894072|NCT00768989|537091879|FG001|On or After Week 36|Did not attend termination visit|0|||
148793318|NCT03569098|536721973|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
148793319|NCT03569098|536721974|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
148793320|NCT03569098|536721972|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
148793321|NCT03569098|536721973|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
148793322|NCT03569098|536721974|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
148793323|NCT03569098|536721972|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
148793324|NCT03569098|536721973|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
148793325|NCT03569098|536721974|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
148793326|NCT03569098|536721972|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
148793327|NCT03569098|536721973|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
148793328|NCT03569098|536721974|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
148793329|NCT00758498|536721975|FG000|Overall Study|Adverse Event|2|||
148793330|NCT00758498|536721976|FG001|Overall Study|Adverse Event|2|||
148793331|NCT00758498|536721977|FG002|Overall Study|Adverse Event|3|||
148793332|NCT00758498|536721975|FG000|Overall Study|Subject legally detained out of state|1|||
148894073|NCT00768989|537091878|FG000|On or After Week 36|Sponsor Termination|45|||
148894074|NCT00768989|537091879|FG001|On or After Week 36|Sponsor Termination|26|||
148894075|NCT03562195|537091885|FG000|Overall Study|Adverse Event|0|||
148894076|NCT03562195|537091886|FG001|Overall Study|Adverse Event|6|||
148894077|NCT03562195|537091885|FG000|Overall Study|Lack of Efficacy|0|||
148894078|NCT03562195|537091886|FG001|Overall Study|Lack of Efficacy|5|||
148894079|NCT03562195|537091885|FG000|Overall Study|Protocol Violation|0|||
148894080|NCT03562195|537091886|FG001|Overall Study|Protocol Violation|1|||
148793333|NCT00758498|536721976|FG001|Overall Study|Subject legally detained out of state|0|||
148793334|NCT00758498|536721977|FG002|Overall Study|Subject legally detained out of state|0|||
148793335|NCT00758498|536721975|FG000|Overall Study|Withdrawal by Subject|0|||
148793336|NCT00758498|536721976|FG001|Overall Study|Withdrawal by Subject|0|||
148793337|NCT00758498|536721977|FG002|Overall Study|Withdrawal by Subject|1|||
148793338|NCT00758498|536721975|FG000|Overall Study|Noncompliance to study procedures|0|||
148793339|NCT00758498|536721976|FG001|Overall Study|Noncompliance to study procedures|0|||
148793340|NCT00758498|536721977|FG002|Overall Study|Noncompliance to study procedures|1|||
148793341|NCT01516736|536721980|FG000|Overall Study|Withdrawal by Subject|10|||
148793342|NCT01516736|536721981|FG001|Overall Study|Withdrawal by Subject|4|||
148793343|NCT01516736|536721980|FG000|Overall Study|Adverse Event|4|||
148793344|NCT01516736|536721981|FG001|Overall Study|Adverse Event|5|||
148793345|NCT01516736|536721980|FG000|Overall Study|Death|3|||
148793346|NCT01516736|536721981|FG001|Overall Study|Death|1|||
148793347|NCT01516736|536721980|FG000|Overall Study|Physician Decision|2|||
148793348|NCT01516736|536721981|FG001|Overall Study|Physician Decision|1|||
148793349|NCT01516736|536721980|FG000|Overall Study|Lack of Efficacy|1|||
148793350|NCT01516736|536721981|FG001|Overall Study|Lack of Efficacy|0|||
148793351|NCT01516736|536721980|FG000|Overall Study|Protocol Violation|0|||
148793352|NCT01516736|536721981|FG001|Overall Study|Protocol Violation|1|||
148793353|NCT01516736|536721980|FG000|Overall Study|Other (not specified)|0|||
148793354|NCT01516736|536721981|FG001|Overall Study|Other (not specified)|1|||
148793355|NCT02781818|536721982|FG000|Overall Study|Lost to Follow-up|4|||
148793356|NCT02781818|536721983|FG001|Overall Study|Lost to Follow-up|2|||
148793357|NCT02781818|536721984|FG002|Overall Study|Lost to Follow-up|1|||
148793358|NCT01877668|536721985|FG000|Overall Study|Death|0|||
148793359|NCT01877668|536721986|FG001|Overall Study|Death|0|||
148793360|NCT01877668|536721987|FG002|Overall Study|Death|0|||
148793361|NCT01877668|536721988|FG003|Overall Study|Death|1|||
148793362|NCT01877668|536721989|FG004|Overall Study|Death|0|||
148793363|NCT01877668|536721985|FG000|Overall Study|No longer met study criteria|1|||
148793364|NCT01877668|536721986|FG001|Overall Study|No longer met study criteria|0|||
148793365|NCT01877668|536721987|FG002|Overall Study|No longer met study criteria|1|||
148793366|NCT01877668|536721988|FG003|Overall Study|No longer met study criteria|0|||
148793367|NCT01877668|536721989|FG004|Overall Study|No longer met study criteria|0|||
148793368|NCT01877668|536721985|FG000|Overall Study|Insufficient clinical response|0|||
148793369|NCT01877668|536721986|FG001|Overall Study|Insufficient clinical response|1|||
148793370|NCT01877668|536721987|FG002|Overall Study|Insufficient clinical response|2|||
148793371|NCT01877668|536721988|FG003|Overall Study|Insufficient clinical response|2|||
148793372|NCT01877668|536721989|FG004|Overall Study|Insufficient clinical response|0|||
148793373|NCT01877668|536721985|FG000|Overall Study|Lost to Follow-up|0|||
148793374|NCT01877668|536721986|FG001|Overall Study|Lost to Follow-up|2|||
148793375|NCT01877668|536721987|FG002|Overall Study|Lost to Follow-up|1|||
148793376|NCT01877668|536721988|FG003|Overall Study|Lost to Follow-up|0|||
148793377|NCT01877668|536721989|FG004|Overall Study|Lost to Follow-up|0|||
148793378|NCT01877668|536721985|FG000|Overall Study|Withdrawal by Subject|2|||
148793379|NCT01877668|536721986|FG001|Overall Study|Withdrawal by Subject|0|||
148793380|NCT01877668|536721987|FG002|Overall Study|Withdrawal by Subject|3|||
148793381|NCT01877668|536721988|FG003|Overall Study|Withdrawal by Subject|2|||
148793382|NCT01877668|536721989|FG004|Overall Study|Withdrawal by Subject|2|||
148793383|NCT01877668|536721985|FG000|Overall Study|Other|1|||
148793384|NCT01877668|536721986|FG001|Overall Study|Other|1|||
148793385|NCT01877668|536721987|FG002|Overall Study|Other|1|||
148793386|NCT01877668|536721988|FG003|Overall Study|Other|1|||
148793387|NCT01877668|536721989|FG004|Overall Study|Other|3|||
148793388|NCT01877668|536721985|FG000|Overall Study|Protocol Violation|1|||
148793389|NCT01877668|536721986|FG001|Overall Study|Protocol Violation|1|||
148793390|NCT01877668|536721987|FG002|Overall Study|Protocol Violation|0|||
148793391|NCT01877668|536721988|FG003|Overall Study|Protocol Violation|0|||
148793392|NCT01877668|536721989|FG004|Overall Study|Protocol Violation|3|||
148793393|NCT01877668|536721985|FG000|Overall Study|Adverse event related to study drug|2|||
148793394|NCT01877668|536721986|FG001|Overall Study|Adverse event related to study drug|2|||
148793395|NCT01877668|536721987|FG002|Overall Study|Adverse event related to study drug|2|||
148793396|NCT01877668|536721988|FG003|Overall Study|Adverse event related to study drug|2|||
148793397|NCT01877668|536721989|FG004|Overall Study|Adverse event related to study drug|1|||
148793398|NCT01877668|536721985|FG000|Overall Study|Adverse event unrelated to study drug|4|||
149134367|NCT02146326|537972958|FG002|Overall Study|Lost to Follow-up|11|||
149134368|NCT02146326|537972959|FG003|Overall Study|Lost to Follow-up|19|||
148793399|NCT01877668|536721986|FG001|Overall Study|Adverse event unrelated to study drug|1|||
148793400|NCT01877668|536721987|FG002|Overall Study|Adverse event unrelated to study drug|2|||
148793401|NCT01877668|536721988|FG003|Overall Study|Adverse event unrelated to study drug|0|||
148793402|NCT01877668|536721989|FG004|Overall Study|Adverse event unrelated to study drug|1|||
148793403|NCT01697800|536721990|FG000|Overall Study|Death|0|||
148793404|NCT01697800|536721991|FG001|Overall Study|Death|1|||
148793405|NCT01302418|536721992|FG000|Overall Study|Protocol Violation|9|||
148793406|NCT01302418|536721992|FG000|Overall Study|Non-evaluable|9|||
148793407|NCT00954122|536721993|FG000|Overall Study|Withdrawal by Subject|5|||
148793408|NCT00954122|536721993|FG000|Overall Study|Adverse Event|1|||
148793409|NCT00954122|536721993|FG000|Overall Study|Safety Reason|1|||
148793410|NCT01000974|536721994|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
148793411|NCT01000974|536721995|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
148793412|NCT01000974|536721996|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
148793413|NCT01000974|536721994|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
148793414|NCT01000974|536721995|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
148793415|NCT01000974|536721996|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
148793416|NCT01000974|536721994|FG000|Primary Vaccination Phase|Protocol Violation|40|||
148793417|NCT01000974|536721995|FG001|Primary Vaccination Phase|Protocol Violation|3|||
148793418|NCT01000974|536721996|FG002|Primary Vaccination Phase|Protocol Violation|2|||
148793419|NCT01000974|536721994|FG000|Primary Vaccination Phase|Adverse Event|14|||
148793420|NCT01000974|536721995|FG001|Primary Vaccination Phase|Adverse Event|2|||
148793421|NCT01000974|536721996|FG002|Primary Vaccination Phase|Adverse Event|2|||
148793422|NCT01000974|536721994|FG000|Primary Vaccination Phase|Other|4|||
148793423|NCT01000974|536721995|FG001|Primary Vaccination Phase|Other|9|||
148793424|NCT01000974|536721996|FG002|Primary Vaccination Phase|Other|12|||
148793425|NCT01000974|536721994|FG000|Booster Vaccination Phase|Protocol Violation|0|||
148793426|NCT01000974|536721995|FG001|Booster Vaccination Phase|Protocol Violation|0|||
148793427|NCT01000974|536721996|FG002|Booster Vaccination Phase|Protocol Violation|2|||
148793428|NCT01000974|536721994|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
148793429|NCT01000974|536721995|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
148793430|NCT01000974|536721996|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
148793431|NCT01000974|536721994|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
148793432|NCT01000974|536721995|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
148793433|NCT01000974|536721996|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
148793434|NCT01000974|536721994|FG000|Booster Vaccination Phase|Other|24|||
148793435|NCT01000974|536721995|FG001|Booster Vaccination Phase|Other|6|||
148793436|NCT01000974|536721996|FG002|Booster Vaccination Phase|Other|4|||
148793437|NCT02485483|536721999|FG000|Overall Study|Depression at baseline|15|||
148793438|NCT02485483|536722000|FG001|Overall Study|Depression at baseline|0|||
148793439|NCT02485483|536721999|FG000|Overall Study|Discontinued after baseline|39|||
148793440|NCT02485483|536722000|FG001|Overall Study|Discontinued after baseline|0|||
148793441|NCT02291029|536722001|FG000|Overall Study|Withdrawal by Subject|0|||
148793442|NCT02291029|536722002|FG001|Overall Study|Withdrawal by Subject|0|||
148793443|NCT02291029|536722003|FG002|Overall Study|Withdrawal by Subject|1|||
148793444|NCT02291029|536722004|FG003|Overall Study|Withdrawal by Subject|0|||
148793445|NCT02291029|536722005|FG004|Overall Study|Withdrawal by Subject|0|||
148793446|NCT02291029|536722006|FG005|Overall Study|Withdrawal by Subject|0|||
148793447|NCT02291029|536722001|FG000|Overall Study|Adverse Event|0|||
148793448|NCT02291029|536722002|FG001|Overall Study|Adverse Event|1|||
148793449|NCT02291029|536722003|FG002|Overall Study|Adverse Event|0|||
148793450|NCT02291029|536722004|FG003|Overall Study|Adverse Event|0|||
148793451|NCT02291029|536722005|FG004|Overall Study|Adverse Event|0|||
148793452|NCT02291029|536722006|FG005|Overall Study|Adverse Event|0|||
148793453|NCT00522548|536722007|FG000|Overall Study|Adverse Event|2|||
148793454|NCT00522548|536722008|FG001|Overall Study|Adverse Event|2|||
148793455|NCT00522548|536722007|FG000|Overall Study|Withdrawal by Subject|0|||
148793456|NCT00522548|536722008|FG001|Overall Study|Withdrawal by Subject|2|||
148793457|NCT00666211|536722009|FG000|Overall Study|Withdrawal by Subject|10|||
148793458|NCT00666211|536722010|FG001|Overall Study|Withdrawal by Subject|13|||
149134369|NCT02146326|537972956|FG000|Overall Study|Withdrawal by Subject|2|||
149134370|NCT02146326|537972957|FG001|Overall Study|Withdrawal by Subject|1|||
149134371|NCT02146326|537972958|FG002|Overall Study|Withdrawal by Subject|15|||
149134372|NCT02146326|537972959|FG003|Overall Study|Withdrawal by Subject|11|||
149134373|NCT02146326|537972956|FG000|Overall Study|Separated from mental health center|23|||
149134374|NCT02146326|537972957|FG001|Overall Study|Separated from mental health center|33|||
148793459|NCT00666211|536722009|FG000|Overall Study|went off medication, no more pain|1|||
148793460|NCT00666211|536722010|FG001|Overall Study|went off medication, no more pain|0|||
148793461|NCT00666211|536722009|FG000|Overall Study|patient non-compliant|6|||
148793462|NCT00666211|536722010|FG001|Overall Study|patient non-compliant|6|||
148793463|NCT00666211|536722009|FG000|Overall Study|disease progression|1|||
148793464|NCT00666211|536722010|FG001|Overall Study|disease progression|8|||
149134375|NCT02146326|537972958|FG002|Overall Study|Separated from mental health center|0|||
149134376|NCT02146326|537972959|FG003|Overall Study|Separated from mental health center|0|||
149134377|NCT02146326|537972956|FG000|Overall Study|Incarcerated|0|||
148793465|NCT00666211|536722009|FG000|Overall Study|Lost to Follow-up|2|||
148793466|NCT00666211|536722010|FG001|Overall Study|Lost to Follow-up|0|||
148793467|NCT00666211|536722009|FG000|Overall Study|toxicity|0|||
148793468|NCT00666211|536722010|FG001|Overall Study|toxicity|2|||
148793469|NCT00666211|536722009|FG000|Overall Study|hospital admission|0|||
148793470|NCT00666211|536722010|FG001|Overall Study|hospital admission|5|||
148793471|NCT00666211|536722009|FG000|Overall Study|Death|0|||
149134378|NCT02146326|537972957|FG001|Overall Study|Incarcerated|0|||
148793472|NCT00666211|536722010|FG001|Overall Study|Death|2|||
148894081|NCT03562195|537091885|FG000|Overall Study|Lost to Follow-up|0|||
148894082|NCT03562195|537091886|FG001|Overall Study|Lost to Follow-up|1|||
148894083|NCT03562195|537091885|FG000|Overall Study|Physician Decision|1|||
148894084|NCT03562195|537091886|FG001|Overall Study|Physician Decision|0|||
148894085|NCT03562195|537091885|FG000|Overall Study|Withdrawal by Subject|3|||
148894086|NCT03562195|537091886|FG001|Overall Study|Withdrawal by Subject|0|||
148894087|NCT02529852|537091887|FG000|Overall Study|Withdrawal by Subject|2|||
148894088|NCT00117637|537091888|FG000|First Intervention (Period 1)|Adverse Event|11|||
148894089|NCT00117637|537091889|FG001|First Intervention (Period 1)|Adverse Event|16|||
148894090|NCT00117637|537091888|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
148894091|NCT00117637|537091889|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
148894092|NCT00117637|537091888|FG000|First Intervention (Period 1)|Protocol Violation|1|||
148894093|NCT00117637|537091889|FG001|First Intervention (Period 1)|Protocol Violation|0|||
148894094|NCT00117637|537091888|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
148894095|NCT00117637|537091889|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
148894096|NCT00117637|537091888|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
148894097|NCT00117637|537091889|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
148894098|NCT00117637|537091888|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
148894099|NCT00117637|537091889|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
148894100|NCT00117637|537091888|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
148894101|NCT00117637|537091889|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
148894102|NCT00117637|537091888|FG000|First Intervention (Period 1)|reason not reported|0|||
148894103|NCT00117637|537091889|FG001|First Intervention (Period 1)|reason not reported|1|||
148894104|NCT00117637|537091888|FG000|Second Intervention (Period 2)|Adverse Event|0|||
148894105|NCT00117637|537091889|FG001|Second Intervention (Period 2)|Adverse Event|9|||
148894106|NCT00117637|537091888|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
148894107|NCT00117637|537091889|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
148894108|NCT00117637|537091888|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
148894109|NCT00117637|537091889|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
148894110|NCT00117637|537091888|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
148894111|NCT00117637|537091889|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
148894112|NCT00117637|537091888|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
148894113|NCT00117637|537091889|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
148894114|NCT00117637|537091888|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
148894115|NCT00117637|537091889|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
148894116|NCT00117637|537091888|FG000|Second Intervention (Period 2)|reason not reported|1|||
148894117|NCT00117637|537091889|FG001|Second Intervention (Period 2)|reason not reported|0|||
148894118|NCT01620060|537091890|FG000|Overall Study|Adverse Event|9|||
148894119|NCT01620060|537091890|FG000|Overall Study|Protocol Violation|1|||
148894120|NCT01620060|537091890|FG000|Overall Study|Withdrawal by Subject|1|||
148894121|NCT01620060|537091890|FG000|Overall Study|Did not comply with Study Produre|1|||
148894122|NCT01620060|537091890|FG000|Overall Study|Family emergency|1|||
148894123|NCT01620060|537091890|FG000|Overall Study|Per Sponsor Decision|2|||
148894124|NCT02269124|537091891|FG000|Overall Study|Lost to Follow-up|1|||
148894125|NCT02269124|537091892|FG001|Overall Study|Lost to Follow-up|0|||
148894126|NCT02269124|537091891|FG000|Overall Study|Withdrawal by Subject|0|||
148894127|NCT02269124|537091892|FG001|Overall Study|Withdrawal by Subject|2|||
148894128|NCT00614575|537091893|FG000|Overall Study|Adverse Event|106|||
148894129|NCT00614575|537091893|FG000|Overall Study|Lost to Follow-up|55|||
148894130|NCT00614575|537091893|FG000|Overall Study|Lack of Efficacy|14|||
148894131|NCT00614575|537091893|FG000|Overall Study|Withdrawal by Subject|6|||
148894132|NCT00614575|537091893|FG000|Overall Study|Death|3|||
148894133|NCT00614575|537091893|FG000|Overall Study|Physician Decision|2|||
148894134|NCT00614575|537091893|FG000|Overall Study|No data were collected.|18|||
148894135|NCT00614575|537091893|FG000|Overall Study|Irregularly enrolled patients|23|||
148894136|NCT00614575|537091893|FG000|Overall Study|No treatment|1|||
148894137|NCT03452540|537091895|FG000|Overall Study|Adverse Event|1|||
148894138|NCT03452540|537091895|FG000|Overall Study|Withdrawal by Subject|1|||
148894139|NCT03452540|537091895|FG000|Overall Study|Other SAE and AE|2|||
148894140|NCT01582061|537091896|FG000|Overall Study|Lack of Efficacy|3|||
148894141|NCT01582061|537091897|FG001|Overall Study|Lack of Efficacy|23|||
148894142|NCT01582061|537091896|FG000|Overall Study|Adverse Event|12|||
148894143|NCT01582061|537091897|FG001|Overall Study|Adverse Event|8|||
148894144|NCT01582061|537091896|FG000|Overall Study|Withdrawal by Subject|10|||
148894145|NCT01582061|537091897|FG001|Overall Study|Withdrawal by Subject|4|||
148894146|NCT01582061|537091896|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148894147|NCT01582061|537091897|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148894148|NCT01582061|537091896|FG000|Overall Study|Death|0|||
148894149|NCT01582061|537091897|FG001|Overall Study|Death|1|||
148894150|NCT01582061|537091896|FG000|Overall Study|condition no longer requires study drug|1|||
148894151|NCT01582061|537091897|FG001|Overall Study|condition no longer requires study drug|0|||
149011406|NCT01407354|537521468|FG000|First Intervention|Withdrawal by Subject|0|||
148894152|NCT01582061|537091896|FG000|Overall Study|Lost to Follow-up|1|||
148793473|NCT00666211|536722009|FG000|Overall Study|off tx for other complicating disease|0|||
148793474|NCT00666211|536722010|FG001|Overall Study|off tx for other complicating disease|1|||
148793475|NCT00666211|536722009|FG000|Overall Study|Physician Decision|0|||
148793476|NCT00666211|536722010|FG001|Overall Study|Physician Decision|1|||
148793477|NCT02999789|536722013|FG000|Overall Study|Withdrawal by Subject|0|||
148793478|NCT02999789|536722014|FG001|Overall Study|Withdrawal by Subject|1|||
148793479|NCT02999789|536722013|FG000|Overall Study|Became ineligible|1|||
148793480|NCT02999789|536722014|FG001|Overall Study|Became ineligible|2|||
148793481|NCT02907463|536722017|FG000|Overall Study|Lost to Follow-up|17|||
148793482|NCT02907463|536722017|FG000|Overall Study|Death|10|||
148793483|NCT02907463|536722017|FG000|Overall Study|Withdrawal by Subject|4|||
148793484|NCT02907463|536722017|FG000|Overall Study|MIS Approach was not used|2|||
148793485|NCT02907463|536722017|FG000|Overall Study|Not Implanted with Study Device|2|||
148793486|NCT02907463|536722017|FG000|Overall Study|Device Explanted|1|||
148793487|NCT02907463|536722017|FG000|Overall Study|Missing Exit Form|1|||
148793488|NCT04878055|536722018|FG000|Overall Study|Patient transferred in another department|0|||
148793489|NCT04878055|536722019|FG001|Overall Study|Patient transferred in another department|2|||
148793490|NCT04878055|536722018|FG000|Overall Study|Physician Decision|1|||
148793491|NCT04878055|536722019|FG001|Overall Study|Physician Decision|1|||
148793492|NCT04878055|536722018|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
148793493|NCT04878055|536722019|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
148793494|NCT04878055|536722018|FG000|Overall Study|Adverse Event|12|||
148793495|NCT04878055|536722019|FG001|Overall Study|Adverse Event|7|||
148793496|NCT04878055|536722018|FG000|Overall Study|Other|5|||
148793497|NCT04878055|536722019|FG001|Overall Study|Other|0|||
148793498|NCT04878055|536722018|FG000|Overall Study|Withdrawal by Subject|7|||
148793499|NCT04878055|536722019|FG001|Overall Study|Withdrawal by Subject|3|||
148793500|NCT04878055|536722018|FG000|Overall Study|Lost to Follow-up|10|||
148793501|NCT04878055|536722019|FG001|Overall Study|Lost to Follow-up|1|||
148793502|NCT03257436|536722020|FG000|Overall Study|Withdrawal by Subject|76|||
148793503|NCT03257436|536722020|FG000|Overall Study|Death|19|||
148793504|NCT00970489|536722021|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
148793505|NCT00970489|536722022|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
148793506|NCT02659943|536722023|FG000|Overall Study|Switched to alternative treatment|1|||
148793507|NCT02659943|536722024|FG001|Overall Study|Switched to alternative treatment|1|||
148793508|NCT02659943|536722025|FG002|Overall Study|Switched to alternative treatment|0|||
148793509|NCT02659943|536722026|FG003|Overall Study|Switched to alternative treatment|2|||
148793510|NCT02659943|536722027|FG004|Overall Study|Switched to alternative treatment|1|||
148793511|NCT02659943|536722028|FG005|Overall Study|Switched to alternative treatment|0|||
148793512|NCT02659943|536722029|FG006|Overall Study|Switched to alternative treatment|1|||
148793513|NCT02659943|536722023|FG000|Overall Study|Disease progression on study|0|||
148793514|NCT02659943|536722024|FG001|Overall Study|Disease progression on study|1|||
148793515|NCT02659943|536722025|FG002|Overall Study|Disease progression on study|1|||
148793516|NCT02659943|536722026|FG003|Overall Study|Disease progression on study|1|||
148793517|NCT02659943|536722027|FG004|Overall Study|Disease progression on study|1|||
148793518|NCT02659943|536722028|FG005|Overall Study|Disease progression on study|4|||
148793519|NCT02659943|536722029|FG006|Overall Study|Disease progression on study|0|||
148793520|NCT02659943|536722023|FG000|Overall Study|Patient's condition per principal investigator|0|||
148793521|NCT02659943|536722024|FG001|Overall Study|Patient's condition per principal investigator|0|||
148793522|NCT02659943|536722025|FG002|Overall Study|Patient's condition per principal investigator|0|||
148793523|NCT02659943|536722026|FG003|Overall Study|Patient's condition per principal investigator|0|||
148793524|NCT02659943|536722027|FG004|Overall Study|Patient's condition per principal investigator|0|||
148793525|NCT02659943|536722028|FG005|Overall Study|Patient's condition per principal investigator|1|||
148793526|NCT02659943|536722029|FG006|Overall Study|Patient's condition per principal investigator|0|||
148793527|NCT02659943|536722023|FG000|Overall Study|Ineligible|0|||
148793528|NCT02659943|536722024|FG001|Overall Study|Ineligible|0|||
148793529|NCT02659943|536722025|FG002|Overall Study|Ineligible|0|||
148793530|NCT02659943|536722026|FG003|Overall Study|Ineligible|0|||
148894153|NCT01582061|537091897|FG001|Overall Study|Lost to Follow-up|0|||
148894154|NCT01045460|537091900|FG000|Overall Study|Physician Decision|3|||
148894155|NCT01045460|537091901|FG001|Overall Study|Physician Decision|2|||
148793531|NCT02659943|536722027|FG004|Overall Study|Ineligible|0|||
148793532|NCT02659943|536722028|FG005|Overall Study|Ineligible|0|||
148793533|NCT02659943|536722029|FG006|Overall Study|Ineligible|1|||
148793534|NCT02659943|536722023|FG000|Overall Study|No longer meets eligibility|0|||
148793535|NCT02659943|536722024|FG001|Overall Study|No longer meets eligibility|0|||
148793536|NCT02659943|536722025|FG002|Overall Study|No longer meets eligibility|0|||
148793537|NCT02659943|536722026|FG003|Overall Study|No longer meets eligibility|0|||
148793538|NCT02659943|536722027|FG004|Overall Study|No longer meets eligibility|0|||
148793539|NCT02659943|536722028|FG005|Overall Study|No longer meets eligibility|0|||
148793540|NCT02659943|536722029|FG006|Overall Study|No longer meets eligibility|1|||
148793541|NCT02659943|536722023|FG000|Overall Study|No treatment, per protocol|0|||
148894156|NCT01045460|537091900|FG000|Overall Study|Lost to Follow-up|0|||
148894157|NCT01045460|537091901|FG001|Overall Study|Lost to Follow-up|1|||
148894158|NCT01045460|537091900|FG000|Overall Study|Lack of Efficacy|3|||
148894159|NCT01045460|537091901|FG001|Overall Study|Lack of Efficacy|0|||
148894160|NCT04664153|537091902|FG000|Overall Study|Lack of Efficacy|0|||
148894161|NCT04664153|537091903|FG001|Overall Study|Lack of Efficacy|0|||
148894162|NCT04664153|537091904|FG002|Overall Study|Lack of Efficacy|1|||
148894163|NCT04664153|537091905|FG003|Overall Study|Lack of Efficacy|0|||
148894164|NCT04664153|537091902|FG000|Overall Study|Physician Decision|0|||
148894165|NCT04664153|537091903|FG001|Overall Study|Physician Decision|0|||
148894166|NCT04664153|537091904|FG002|Overall Study|Physician Decision|1|||
148894167|NCT04664153|537091905|FG003|Overall Study|Physician Decision|0|||
148894168|NCT04664153|537091902|FG000|Overall Study|Withdrawal by Subject|3|||
148894169|NCT04664153|537091903|FG001|Overall Study|Withdrawal by Subject|2|||
148894170|NCT04664153|537091904|FG002|Overall Study|Withdrawal by Subject|1|||
148894171|NCT04664153|537091905|FG003|Overall Study|Withdrawal by Subject|2|||
148894172|NCT04664153|537091902|FG000|Overall Study|Other|0|||
148894173|NCT04664153|537091903|FG001|Overall Study|Other|1|||
148894174|NCT04664153|537091904|FG002|Overall Study|Other|0|||
148894175|NCT04664153|537091905|FG003|Overall Study|Other|0|||
148894176|NCT04664153|537091902|FG000|Overall Study|Adverse Event|4|||
148894177|NCT04664153|537091903|FG001|Overall Study|Adverse Event|0|||
148894178|NCT04664153|537091904|FG002|Overall Study|Adverse Event|1|||
148894179|NCT04664153|537091905|FG003|Overall Study|Adverse Event|0|||
148894180|NCT00097500|537091906|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
148894181|NCT00097500|537091907|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
148894182|NCT00097500|537091906|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
148894183|NCT00097500|537091907|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
148894184|NCT00097500|537091906|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
148894185|NCT00097500|537091907|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
148894186|NCT00097500|537091906|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
148793542|NCT02659943|536722024|FG001|Overall Study|No treatment, per protocol|0|||
148793543|NCT02659943|536722025|FG002|Overall Study|No treatment, per protocol|0|||
148793544|NCT02659943|536722026|FG003|Overall Study|No treatment, per protocol|0|||
148894187|NCT00097500|537091907|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
148894188|NCT00097500|537091906|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
148894189|NCT00097500|537091907|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
148793545|NCT02659943|536722027|FG004|Overall Study|No treatment, per protocol|0|||
148793546|NCT02659943|536722028|FG005|Overall Study|No treatment, per protocol|0|||
148793547|NCT02659943|536722029|FG006|Overall Study|No treatment, per protocol|3|||
148793548|NCT01723072|536722032|FG000|Overall Study|Withdrawal by Subject|7|||
148793549|NCT01723072|536722033|FG001|Overall Study|Withdrawal by Subject|13|||
148793550|NCT01723072|536722032|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
148793551|NCT01723072|536722033|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
148793552|NCT01723072|536722032|FG000|Overall Study|Other|4|||
148793553|NCT01723072|536722033|FG001|Overall Study|Other|3|||
148793554|NCT01841970|536722034|FG000|Overall Study|Withdrawal by Subject|1|||
148793555|NCT01841970|536722034|FG000|Overall Study|Physician Decision|2|||
148793556|NCT01841970|536722034|FG000|Overall Study|Lost to Follow-up|8|||
148793557|NCT03478371|536722035|FG000|Overall Study|non-compliance|1|||
148793558|NCT03478371|536722035|FG000|Overall Study|Lost to Follow-up|4|||
148793559|NCT03428100|536722036|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
148793560|NCT03428100|536722037|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793561|NCT03428100|536722038|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
148793562|NCT03428100|536722039|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
148793563|NCT03428100|536722040|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793564|NCT03428100|536722041|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793565|NCT03428100|536722042|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793566|NCT03428100|536722043|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793567|NCT03428100|536722044|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793568|NCT03428100|536722045|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793569|NCT03428100|536722046|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793570|NCT03428100|536722047|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793571|NCT03428100|536722048|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793572|NCT03428100|536722049|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793573|NCT03428100|536722050|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793574|NCT03428100|536722051|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148894190|NCT00097500|537091906|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
148894191|NCT00097500|537091907|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
148894192|NCT00097500|537091906|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
148894193|NCT00097500|537091907|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
148894194|NCT00524485|537091911|FG000|Overall Study|Withdrawal by Subject|5|||
148894195|NCT01600885|537091914|FG000|First Period|Adverse Event|1|||
148894196|NCT01600885|537091915|FG001|First Period|Adverse Event|1|||
148894197|NCT01600885|537091914|FG000|First Period|moved out of area|1|||
148793575|NCT03428100|536722052|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793576|NCT03428100|536722053|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793577|NCT03428100|536722054|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
148793578|NCT03428100|536722036|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
148793579|NCT03428100|536722037|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
148793580|NCT03428100|536722038|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
148793581|NCT03428100|536722039|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
148793582|NCT03428100|536722040|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793583|NCT03428100|536722041|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793584|NCT03428100|536722042|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793585|NCT03428100|536722043|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793586|NCT03428100|536722044|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793587|NCT03428100|536722045|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793588|NCT03428100|536722046|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793589|NCT03428100|536722047|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793590|NCT03428100|536722048|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793591|NCT03428100|536722049|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793592|NCT03428100|536722050|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793593|NCT03428100|536722051|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793594|NCT03428100|536722052|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793595|NCT03428100|536722053|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793596|NCT03428100|536722054|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
148793597|NCT03428100|536722036|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793598|NCT03428100|536722037|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
148793599|NCT03428100|536722038|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
148793600|NCT03428100|536722039|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793601|NCT03428100|536722040|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793602|NCT03428100|536722041|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793603|NCT03428100|536722042|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793604|NCT03428100|536722043|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793605|NCT03428100|536722044|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793606|NCT03428100|536722045|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793607|NCT03428100|536722046|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793608|NCT03428100|536722047|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793609|NCT03428100|536722048|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793610|NCT03428100|536722049|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793611|NCT03428100|536722050|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793612|NCT03428100|536722051|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793613|NCT03428100|536722052|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793614|NCT03428100|536722053|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793615|NCT03428100|536722054|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
148793616|NCT03428100|536722036|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
148793617|NCT03428100|536722037|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793618|NCT03428100|536722038|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793619|NCT03428100|536722039|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793620|NCT03428100|536722040|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793621|NCT03428100|536722041|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793622|NCT03428100|536722042|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793623|NCT03428100|536722043|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793624|NCT03428100|536722044|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793625|NCT03428100|536722045|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793626|NCT03428100|536722046|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793627|NCT03428100|536722047|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793628|NCT03428100|536722048|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793629|NCT03428100|536722049|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793630|NCT03428100|536722050|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793631|NCT03428100|536722051|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148894198|NCT01600885|537091915|FG001|First Period|moved out of area|0|||
148894199|NCT00642356|537091919|FG000|Overall Study|Adverse Event|1|||
148894200|NCT00642356|537091920|FG001|Overall Study|Adverse Event|0|||
148793632|NCT03428100|536722052|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793633|NCT03428100|536722053|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148793634|NCT03428100|536722054|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
148894201|NCT00642356|537091919|FG000|Overall Study|Protocol Violation|0|||
148894202|NCT00642356|537091920|FG001|Overall Study|Protocol Violation|3|||
148894203|NCT00642356|537091919|FG000|Overall Study|Lack of Efficacy|1|||
148894204|NCT00642356|537091920|FG001|Overall Study|Lack of Efficacy|0|||
148894205|NCT01009060|537091923|FG000|Overall Study|Adverse Event|1|||
148894206|NCT01009060|537091924|FG001|Overall Study|Adverse Event|2|||
148894207|NCT01009060|537091923|FG000|Overall Study|Protocol Violation|0|||
148894208|NCT01009060|537091924|FG001|Overall Study|Protocol Violation|1|||
148894209|NCT01009060|537091923|FG000|Overall Study|Lost to Follow-up|1|||
148894210|NCT01009060|537091924|FG001|Overall Study|Lost to Follow-up|0|||
148894211|NCT01009060|537091923|FG000|Overall Study|Physician Decision|1|||
148894212|NCT01009060|537091924|FG001|Overall Study|Physician Decision|1|||
148894213|NCT01009060|537091923|FG000|Overall Study|Withdrawal by Subject|1|||
148894214|NCT01009060|537091924|FG001|Overall Study|Withdrawal by Subject|1|||
148894215|NCT00088530|537091929|FG000|Overall Study|Progressive/Relapsed Disease|28|||
148894216|NCT00088530|537091930|FG001|Overall Study|Progressive/Relapsed Disease|39|||
148894217|NCT00088530|537091929|FG000|Overall Study|Adverse Event|15|||
148894218|NCT00088530|537091930|FG001|Overall Study|Adverse Event|9|||
148894219|NCT00088530|537091929|FG000|Overall Study|Withdrawal by Subject|2|||
148894220|NCT00088530|537091930|FG001|Overall Study|Withdrawal by Subject|5|||
148894221|NCT00088530|537091929|FG000|Overall Study|Lost to Follow-up|2|||
148894222|NCT00088530|537091930|FG001|Overall Study|Lost to Follow-up|0|||
148894223|NCT00088530|537091929|FG000|Overall Study|Physician Decision|2|||
148894224|NCT00088530|537091930|FG001|Overall Study|Physician Decision|0|||
148894225|NCT00088530|537091929|FG000|Overall Study|Sponsor decision|0|||
148894226|NCT00088530|537091930|FG001|Overall Study|Sponsor decision|1|||
148894227|NCT00088530|537091929|FG000|Overall Study|Patient never treated|1|||
148894228|NCT00088530|537091930|FG001|Overall Study|Patient never treated|0|||
148894229|NCT00300755|537091931|FG000|Overall Study|Adverse Event|1|||
148894230|NCT00300755|537091932|FG001|Overall Study|Adverse Event|2|||
148894231|NCT00300755|537091933|FG002|Overall Study|Adverse Event|1|||
148894232|NCT00300755|537091931|FG000|Overall Study|Withdrawal by Subject|0|||
148894233|NCT00300755|537091932|FG001|Overall Study|Withdrawal by Subject|2|||
148894234|NCT00300755|537091933|FG002|Overall Study|Withdrawal by Subject|0|||
148894235|NCT00300755|537091931|FG000|Overall Study|Protocol Violation|0|||
148894236|NCT00300755|537091932|FG001|Overall Study|Protocol Violation|0|||
148894237|NCT00300755|537091933|FG002|Overall Study|Protocol Violation|1|||
148894238|NCT04571944|537091934|FG000|Overall Study|Death|1|||
148894239|NCT04571944|537091935|FG001|Overall Study|Death|0|||
148894240|NCT04571944|537091934|FG000|Overall Study|Withdrawal by Subject|3|||
149011407|NCT01407354|537521469|FG001|First Intervention|Withdrawal by Subject|2|||
149011408|NCT01407354|537521468|FG000|First Intervention|Adverse Event|1|||
149011409|NCT01407354|537521469|FG001|First Intervention|Adverse Event|0|||
149011410|NCT01407354|537521468|FG000|First Intervention|Physician Decision|1|||
149011411|NCT01407354|537521469|FG001|First Intervention|Physician Decision|0|||
149011412|NCT02778399|537521470|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
149011413|NCT02778399|537521471|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
149011414|NCT02778399|537521472|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
149011415|NCT02778399|537521473|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
149011416|NCT02778399|537521474|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
149011417|NCT02778399|537521475|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
149011418|NCT02778399|537521470|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
149011419|NCT02778399|537521471|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
149011420|NCT02778399|537521472|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
149011421|NCT02778399|537521473|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
149011422|NCT02778399|537521474|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
149011423|NCT02778399|537521475|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
149011424|NCT02778399|537521470|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
149011425|NCT02778399|537521471|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
149011426|NCT02778399|537521472|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
149011427|NCT02778399|537521473|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
149011428|NCT02778399|537521474|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
149011429|NCT02778399|537521475|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
149011430|NCT02778399|537521470|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
149011431|NCT02778399|537521471|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
149011432|NCT02778399|537521472|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
149011433|NCT02778399|537521473|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
149011434|NCT02778399|537521474|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
148894241|NCT04571944|537091935|FG001|Overall Study|Withdrawal by Subject|0|||
148894242|NCT04571944|537091934|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
148894243|NCT04571944|537091935|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
148894244|NCT00667888|537091938|FG000|Overall Study|Death|1|||
148894245|NCT00667888|537091939|FG001|Overall Study|Death|1|||
148894246|NCT00667888|537091938|FG000|Overall Study|Withdrawal by Subject|6|||
149011435|NCT02778399|537521475|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
148793635|NCT03428100|536722036|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793636|NCT03428100|536722037|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
148793637|NCT03428100|536722038|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793638|NCT03428100|536722039|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793639|NCT03428100|536722040|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793640|NCT03428100|536722041|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793641|NCT03428100|536722042|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793642|NCT03428100|536722043|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793643|NCT03428100|536722044|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793644|NCT03428100|536722045|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793645|NCT03428100|536722046|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793646|NCT03428100|536722047|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793647|NCT03428100|536722048|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793648|NCT03428100|536722049|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793649|NCT03428100|536722050|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793650|NCT03428100|536722051|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793651|NCT03428100|536722052|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793652|NCT03428100|536722053|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793653|NCT03428100|536722054|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
148793654|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793655|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793656|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793657|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793658|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793659|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
148793660|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
148793661|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
148793662|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
148793663|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793664|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
148793665|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793666|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
148793667|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
148793668|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
148793669|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
148793670|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
148793671|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793672|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
148793673|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
148793674|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
148793675|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
148793676|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
148793677|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
148793678|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
148793679|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
148793680|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
148793681|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
148793682|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
148793683|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
148793684|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
148793685|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
148793686|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
148793687|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
148793688|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
148793689|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
148793690|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
148793691|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
148793692|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
148793693|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
148793694|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
148793695|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
148793696|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
148793697|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
148793698|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
148894247|NCT00667888|537091939|FG001|Overall Study|Withdrawal by Subject|3|||
148894248|NCT00667888|537091938|FG000|Overall Study|Proceed with other treatment|3|||
148793699|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
148793700|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
148793701|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
148793702|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
148793703|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
148793704|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
148793705|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
148793706|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
148793707|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
148793708|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
148793709|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
148793710|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
148793711|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793712|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793713|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793714|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793715|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793716|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793717|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793718|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
148793719|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793720|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793721|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793722|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
148793723|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
148793724|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793725|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
148793726|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793727|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793728|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
148793729|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
148793730|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
148793731|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
148894249|NCT00667888|537091939|FG001|Overall Study|Proceed with other treatment|3|||
148894250|NCT00667888|537091938|FG000|Overall Study|Ineligible after SIM|0|||
148894251|NCT00667888|537091939|FG001|Overall Study|Ineligible after SIM|2|||
148894252|NCT02174731|537091940|FG000|Overall Study|Participant decision|67|||
148894253|NCT02174731|537091941|FG001|Overall Study|Participant decision|64|||
148894254|NCT02174731|537091940|FG000|Overall Study|Incorrect enrolment before randomization|0|||
148793732|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
148793733|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
148793734|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
148793735|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
148793736|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
148793737|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
148793738|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
148894255|NCT02174731|537091941|FG001|Overall Study|Incorrect enrolment before randomization|1|||
148894256|NCT02174731|537091940|FG000|Overall Study|Missing|2|||
148894257|NCT02174731|537091941|FG001|Overall Study|Missing|0|||
148894258|NCT00079040|537091942|FG000|Overall Study|Withdrew before treatment|1|||
148894259|NCT00079040|537091942|FG000|Overall Study|Ineligible|1|||
148894260|NCT03119259|537091943|FG000|Overall Study|Withdrawn as no longer eligible|1|||
148894261|NCT03119259|537091944|FG001|Overall Study|Withdrawn as no longer eligible|0|||
148894262|NCT03119259|537091943|FG000|Overall Study|Withdrawal by Subject|4|||
148894263|NCT03119259|537091944|FG001|Overall Study|Withdrawal by Subject|2|||
148894264|NCT03119259|537091943|FG000|Overall Study|Lost to Follow-up|0|||
148894265|NCT03119259|537091944|FG001|Overall Study|Lost to Follow-up|1|||
148894266|NCT03535974|537091945|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
148894267|NCT03535974|537091946|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
148894268|NCT03535974|537091947|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
148894269|NCT03535974|537091945|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
148894270|NCT03535974|537091946|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
148894271|NCT03535974|537091947|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
148894272|NCT00626275|537091950|FG000|Part A - Treatment Period 1|Adverse Event|1|||
148894273|NCT00626275|537091951|FG001|Part A - Treatment Period 1|Adverse Event|0|||
148894274|NCT00626275|537091952|FG002|Part A - Treatment Period 1|Adverse Event|0|||
148894275|NCT00626275|537091953|FG003|Part A - Treatment Period 1|Adverse Event|0|||
148894276|NCT00626275|537091954|FG004|Part A - Treatment Period 1|Adverse Event|0|||
148793739|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
148894277|NCT00626275|537091955|FG005|Part A - Treatment Period 1|Adverse Event|0|||
148894278|NCT00626275|537091956|FG006|Part A - Treatment Period 1|Adverse Event|0|||
148894279|NCT00626275|537091957|FG007|Part A - Treatment Period 1|Adverse Event|0|||
148894280|NCT00626275|537091950|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894281|NCT00626275|537091951|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894282|NCT00626275|537091952|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
148894283|NCT00626275|537091953|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894284|NCT00626275|537091954|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894285|NCT00626275|537091955|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894286|NCT00626275|537091956|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894287|NCT00626275|537091957|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
148894288|NCT00626275|537091950|FG000|Part B|Lost to Follow-up|0|||
148894289|NCT00626275|537091951|FG001|Part B|Lost to Follow-up|0|||
148894290|NCT00626275|537091952|FG002|Part B|Lost to Follow-up|0|||
148894291|NCT00626275|537091953|FG003|Part B|Lost to Follow-up|0|||
148894292|NCT00626275|537091954|FG004|Part B|Lost to Follow-up|0|||
148894293|NCT00626275|537091955|FG005|Part B|Lost to Follow-up|0|||
148894294|NCT00626275|537091956|FG006|Part B|Lost to Follow-up|1|||
148894295|NCT00626275|537091957|FG007|Part B|Lost to Follow-up|0|||
148894296|NCT00626275|537091950|FG000|Part B|Withdrawal by Subject|0|||
148894297|NCT00626275|537091951|FG001|Part B|Withdrawal by Subject|0|||
148894298|NCT00626275|537091952|FG002|Part B|Withdrawal by Subject|0|||
148894299|NCT00626275|537091953|FG003|Part B|Withdrawal by Subject|0|||
148894300|NCT00626275|537091954|FG004|Part B|Withdrawal by Subject|0|||
148894301|NCT00626275|537091955|FG005|Part B|Withdrawal by Subject|0|||
148894302|NCT00626275|537091956|FG006|Part B|Withdrawal by Subject|0|||
148894303|NCT00626275|537091957|FG007|Part B|Withdrawal by Subject|1|||
148894304|NCT01362348|537091958|FG000|Overall Study|Protocol-defined stopping criteria|9|||
148894305|NCT01362348|537091958|FG000|Overall Study|Study closed/terminated|5|||
148894306|NCT00758771|537091959|FG000|Overall Study|Withdrawal by Subject|1|||
148894307|NCT00758771|537091960|FG001|Overall Study|Withdrawal by Subject|1|||
148894308|NCT00758771|537091959|FG000|Overall Study|Did not meet eligibility criteria|2|||
148894309|NCT00758771|537091960|FG001|Overall Study|Did not meet eligibility criteria|4|||
148894310|NCT00960063|537091961|FG000|Overall Study|Adverse Event|1|||
148894311|NCT00960063|537091962|FG001|Overall Study|Adverse Event|0|||
148894312|NCT00960063|537091963|FG002|Overall Study|Adverse Event|0|||
148894313|NCT00960063|537091961|FG000|Overall Study|Progression of Disease|0|||
148894314|NCT00960063|537091962|FG001|Overall Study|Progression of Disease|0|||
148894315|NCT00960063|537091963|FG002|Overall Study|Progression of Disease|3|||
148894316|NCT02675907|537091964|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
148894317|NCT02675907|537091965|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
148894318|NCT02675907|537091964|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
148894319|NCT02675907|537091965|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
148894320|NCT02675907|537091964|FG000|Study Overall|Lack of Efficacy|1|||
148894321|NCT02675907|537091965|FG001|Study Overall|Lack of Efficacy|0|||
148894322|NCT02675907|537091964|FG000|Study Overall|Withdrawal by Subject|2|||
148894323|NCT02675907|537091965|FG001|Study Overall|Withdrawal by Subject|2|||
149134379|NCT02146326|537972958|FG002|Overall Study|Incarcerated|3|||
149134380|NCT02146326|537972959|FG003|Overall Study|Incarcerated|8|||
148793740|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
148793741|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
148793742|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
148793743|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
148793744|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
148793745|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
148793746|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
148793747|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
148793748|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
148793749|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793750|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793751|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793752|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793753|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793754|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793755|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
148793756|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793757|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
149134381|NCT02146326|537972956|FG000|Overall Study|Death|0|||
149134382|NCT02146326|537972957|FG001|Overall Study|Death|0|||
148793758|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148894324|NCT02675907|537091964|FG000|Study Overall|Lost to Follow-up|0|||
148894325|NCT02675907|537091965|FG001|Study Overall|Lost to Follow-up|2|||
149134383|NCT02146326|537972958|FG002|Overall Study|Death|4|||
149134384|NCT02146326|537972959|FG003|Overall Study|Death|4|||
148793759|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793760|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793761|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793762|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793763|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793764|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793765|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793766|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
148793767|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
148793768|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
148793769|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
148793770|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
148793771|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
148793772|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
148793773|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
148793774|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
148793775|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
148793776|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
148793777|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
148793778|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
148793779|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
148793780|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
148793781|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
148793782|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
148793783|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
148793784|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
148793785|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
148793786|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
148793787|NCT03428100|536722036|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793788|NCT03428100|536722037|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793789|NCT03428100|536722038|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793790|NCT03428100|536722039|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793791|NCT03428100|536722040|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
148793792|NCT03428100|536722041|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793793|NCT03428100|536722042|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
148793794|NCT03428100|536722043|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
148793795|NCT03428100|536722044|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793796|NCT03428100|536722045|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
148793797|NCT03428100|536722046|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
148793798|NCT03428100|536722047|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
148793799|NCT03428100|536722048|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
148793800|NCT03428100|536722049|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
148793801|NCT03428100|536722050|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
148793802|NCT03428100|536722051|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793803|NCT03428100|536722052|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
148793804|NCT03428100|536722053|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
148793805|NCT03428100|536722054|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
148793806|NCT01411852|536722055|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
148793807|NCT01411852|536722056|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
148793808|NCT01411852|536722055|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
148793809|NCT01411852|536722056|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
148793810|NCT01411852|536722055|FG000|Prehospital Intervention Phase|Found to be under age|0|||
148793811|NCT01411852|536722056|FG001|Prehospital Intervention Phase|Found to be under age|1|||
148793812|NCT01411852|536722055|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
148793813|NCT01411852|536722056|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
148793814|NCT01411852|536722055|FG000|Hospital Intervention Phase|Severe head injury|5|||
148793815|NCT01411852|536722056|FG001|Hospital Intervention Phase|Severe head injury|4|||
148793816|NCT01411852|536722055|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
148793817|NCT01411852|536722056|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
148793818|NCT01411852|536722055|FG000|Hospital Intervention Phase|Miscommunication error|1|||
149134385|NCT02146326|537972956|FG000|Overall Study|Unable to complete interview|0|||
148894326|NCT00539981|537091966|FG000|Overall Study|Adverse events (AE)|3|||
148894327|NCT00539981|537091967|FG001|Overall Study|Adverse events (AE)|3|||
148894328|NCT00539981|537091966|FG000|Overall Study|Lost to Follow-up|260|||
148894329|NCT00539981|537091967|FG001|Overall Study|Lost to Follow-up|251|||
148894330|NCT00539981|537091966|FG000|Overall Study|Withdrew consent|22|||
148894331|NCT00539981|537091967|FG001|Overall Study|Withdrew consent|14|||
148894332|NCT00539981|537091966|FG000|Overall Study|Death|1|||
148894333|NCT00539981|537091967|FG001|Overall Study|Death|1|||
148894334|NCT00539981|537091966|FG000|Overall Study|Other reason-unspecified|9|||
148894335|NCT00539981|537091967|FG001|Overall Study|Other reason-unspecified|13|||
148894336|NCT01611792|537091968|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
148894337|NCT01611792|537091969|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
148894338|NCT01611792|537091968|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
148894339|NCT01611792|537091969|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
148894340|NCT01759420|537091973|FG000|Overall Study|Screen failure|5|||
148894341|NCT01759420|537091973|FG000|Overall Study|Inaccurate EKG machine readings|1|||
148894342|NCT01129622|537091976|FG000|Overall Study|Withdrawal by Subject|2|||
148894343|NCT02051764|537091977|FG000|Overall Study|Study terminated by sponsor|0|||
148894344|NCT02051764|537091978|FG001|Overall Study|Study terminated by sponsor|7|||
148894345|NCT00591006|537091979|FG000|Overall Study|Withdrawal by Subject|0|||
148894346|NCT00591006|537091980|FG001|Overall Study|Withdrawal by Subject|0|||
148894347|NCT00591006|537091981|FG002|Overall Study|Withdrawal by Subject|0|||
148894348|NCT00591006|537091982|FG003|Overall Study|Withdrawal by Subject|0|||
148894349|NCT00591006|537091983|FG004|Overall Study|Withdrawal by Subject|0|||
148894350|NCT00591006|537091984|FG005|Overall Study|Withdrawal by Subject|0|||
148894351|NCT00591006|537091985|FG006|Overall Study|Withdrawal by Subject|0|||
148894352|NCT00591006|537091986|FG007|Overall Study|Withdrawal by Subject|0|||
148894353|NCT00591006|537091987|FG008|Overall Study|Withdrawal by Subject|0|||
148894354|NCT00591006|537091988|FG009|Overall Study|Withdrawal by Subject|0|||
148894355|NCT00591006|537091989|FG010|Overall Study|Withdrawal by Subject|0|||
148894356|NCT00591006|537091990|FG011|Overall Study|Withdrawal by Subject|0|||
148894357|NCT00591006|537091991|FG012|Overall Study|Withdrawal by Subject|0|||
148894358|NCT00591006|537091992|FG013|Overall Study|Withdrawal by Subject|0|||
148894359|NCT00591006|537091993|FG014|Overall Study|Withdrawal by Subject|0|||
148894360|NCT00591006|537091994|FG015|Overall Study|Withdrawal by Subject|1|||
148894361|NCT00591006|537091995|FG016|Overall Study|Withdrawal by Subject|0|||
148894362|NCT00591006|537091996|FG017|Overall Study|Withdrawal by Subject|0|||
148894363|NCT00591006|537091997|FG018|Overall Study|Withdrawal by Subject|0|||
148894364|NCT00591006|537091998|FG019|Overall Study|Withdrawal by Subject|0|||
148894365|NCT00591006|537091999|FG020|Overall Study|Withdrawal by Subject|0|||
148894366|NCT00591006|537092000|FG021|Overall Study|Withdrawal by Subject|0|||
148894367|NCT00591006|537092001|FG022|Overall Study|Withdrawal by Subject|0|||
148894368|NCT00591006|537092002|FG023|Overall Study|Withdrawal by Subject|1|||
148894369|NCT00591006|537091979|FG000|Overall Study|Adverse Event|0|||
148894370|NCT00591006|537091980|FG001|Overall Study|Adverse Event|0|||
148894371|NCT00591006|537091981|FG002|Overall Study|Adverse Event|0|||
148894372|NCT00591006|537091982|FG003|Overall Study|Adverse Event|0|||
148894373|NCT00591006|537091983|FG004|Overall Study|Adverse Event|0|||
148894374|NCT00591006|537091984|FG005|Overall Study|Adverse Event|0|||
148894375|NCT00591006|537091985|FG006|Overall Study|Adverse Event|0|||
148894376|NCT00591006|537091986|FG007|Overall Study|Adverse Event|0|||
148894377|NCT00591006|537091987|FG008|Overall Study|Adverse Event|0|||
148894378|NCT00591006|537091988|FG009|Overall Study|Adverse Event|0|||
148894379|NCT00591006|537091989|FG010|Overall Study|Adverse Event|0|||
148894380|NCT00591006|537091990|FG011|Overall Study|Adverse Event|0|||
148894381|NCT00591006|537091991|FG012|Overall Study|Adverse Event|0|||
148894382|NCT00591006|537091992|FG013|Overall Study|Adverse Event|0|||
148894383|NCT00591006|537091993|FG014|Overall Study|Adverse Event|0|||
148894384|NCT00591006|537091994|FG015|Overall Study|Adverse Event|0|||
148894385|NCT00591006|537091995|FG016|Overall Study|Adverse Event|0|||
148894386|NCT00591006|537091996|FG017|Overall Study|Adverse Event|0|||
148894387|NCT00591006|537091997|FG018|Overall Study|Adverse Event|0|||
148894388|NCT00591006|537091998|FG019|Overall Study|Adverse Event|0|||
148894389|NCT00591006|537091999|FG020|Overall Study|Adverse Event|0|||
148894390|NCT00591006|537092000|FG021|Overall Study|Adverse Event|0|||
148894391|NCT00591006|537092001|FG022|Overall Study|Adverse Event|1|||
148894392|NCT00591006|537092002|FG023|Overall Study|Adverse Event|0|||
148894393|NCT03289208|537092006|FG000|Overall Study|Adverse Event|1|||
148894394|NCT03289208|537092007|FG001|Overall Study|Adverse Event|0|||
148894395|NCT03289208|537092008|FG002|Overall Study|Adverse Event|0|||
148894396|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
148894397|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
148894398|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
148894399|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
148894400|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
148894401|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
148956457|NCT00723892|537324429|FG001|Overall Study|Bad tolerance|5|||
148894402|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
149134386|NCT02146326|537972957|FG001|Overall Study|Unable to complete interview|0|||
149134387|NCT02146326|537972958|FG002|Overall Study|Unable to complete interview|10|||
149134388|NCT02146326|537972959|FG003|Overall Study|Unable to complete interview|6|||
149134389|NCT03153111|537972960|FG000|Overall Study|Death|2|||
149134390|NCT03153111|537972961|FG001|Overall Study|Death|5|||
149134391|NCT03153111|537972960|FG000|Overall Study|Lost to Follow-up|1|||
149134392|NCT03153111|537972961|FG001|Overall Study|Lost to Follow-up|0|||
149134393|NCT03153111|537972960|FG000|Overall Study|Physician Decision|5|||
149134394|NCT03153111|537972961|FG001|Overall Study|Physician Decision|1|||
149134395|NCT03153111|537972960|FG000|Overall Study|Withdrawal by Subject|3|||
149134396|NCT03153111|537972961|FG001|Overall Study|Withdrawal by Subject|3|||
149134397|NCT02684357|537972964|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
149134398|NCT02684357|537972965|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
149134399|NCT02684357|537972966|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
149134400|NCT02684357|537972967|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
149134401|NCT02684357|537972968|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
149134402|NCT02684357|537972969|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
149134403|NCT02684357|537972964|FG000|Part A|Lost to Follow-up|0|||
149134404|NCT02684357|537972965|FG001|Part A|Lost to Follow-up|2|||
149134405|NCT02684357|537972966|FG002|Part A|Lost to Follow-up|2|||
149134406|NCT02684357|537972967|FG003|Part A|Lost to Follow-up|0|||
149134407|NCT02684357|537972968|FG004|Part A|Lost to Follow-up|0|||
149134408|NCT02684357|537972969|FG005|Part A|Lost to Follow-up|0|||
149134409|NCT02684357|537972964|FG000|Part A|Withdrawal by Subject|3|||
149134410|NCT02684357|537972965|FG001|Part A|Withdrawal by Subject|0|||
149134411|NCT02684357|537972966|FG002|Part A|Withdrawal by Subject|0|||
149134412|NCT02684357|537972967|FG003|Part A|Withdrawal by Subject|0|||
149134413|NCT02684357|537972968|FG004|Part A|Withdrawal by Subject|0|||
149134414|NCT02684357|537972969|FG005|Part A|Withdrawal by Subject|0|||
149134415|NCT02684357|537972964|FG000|Part A|Other|0|||
149134416|NCT02684357|537972965|FG001|Part A|Other|1|||
149134417|NCT02684357|537972966|FG002|Part A|Other|0|||
148894403|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
148894404|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
148894405|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
148894406|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
148894407|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
148894408|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
148894409|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
148894410|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
148894411|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
148894412|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
148894413|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
148894414|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
148894415|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
148894416|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
148894417|NCT00550407|537092009|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
148894418|NCT00550407|537092010|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
148894419|NCT00550407|537092011|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
148894420|NCT00550407|537092009|FG000|26-Week Randomized Phase|Adverse Event|0|||
148894421|NCT00550407|537092010|FG001|26-Week Randomized Phase|Adverse Event|5|||
148894422|NCT00550407|537092011|FG002|26-Week Randomized Phase|Adverse Event|2|||
148894423|NCT00550407|537092009|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
148894424|NCT00550407|537092010|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
148894425|NCT00550407|537092011|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
148894426|NCT00550407|537092009|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
148894427|NCT00550407|537092010|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
148894428|NCT00550407|537092011|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
148894429|NCT00550407|537092009|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
148894430|NCT00550407|537092010|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
148894431|NCT00550407|537092011|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
148894432|NCT00584415|537092012|FG000|Overall Study|Adverse Event|7|||
148894433|NCT00556894|537092013|FG000|Overall Study|Adverse Event|2|||
148894434|NCT00556894|537092014|FG001|Overall Study|Adverse Event|3|||
148894435|NCT00556894|537092015|FG002|Overall Study|Adverse Event|3|||
148894436|NCT00556894|537092013|FG000|Overall Study|Death|1|||
148894437|NCT00556894|537092014|FG001|Overall Study|Death|0|||
148894438|NCT00556894|537092015|FG002|Overall Study|Death|0|||
148894439|NCT00556894|537092013|FG000|Overall Study|regulatory decision in Bulgaria|10|||
148894440|NCT00556894|537092014|FG001|Overall Study|regulatory decision in Bulgaria|14|||
148894441|NCT00556894|537092015|FG002|Overall Study|regulatory decision in Bulgaria|13|||
148894442|NCT00556894|537092013|FG000|Overall Study|Change in therapy|2|||
148894443|NCT00556894|537092014|FG001|Overall Study|Change in therapy|1|||
148894444|NCT00556894|537092015|FG002|Overall Study|Change in therapy|2|||
148894445|NCT00556894|537092013|FG000|Overall Study|Withdrawal by Subject|1|||
148894446|NCT00556894|537092014|FG001|Overall Study|Withdrawal by Subject|1|||
148894447|NCT00556894|537092015|FG002|Overall Study|Withdrawal by Subject|1|||
148894448|NCT03883581|537092016|FG000|Overall Study|Withdrawal by Subject|4|||
148894449|NCT04750642|537092020|FG000|Overall Study|Adverse Event|1|||
148894450|NCT04750642|537092021|FG001|Overall Study|Adverse Event|0|||
148894451|NCT04750642|537092020|FG000|Overall Study|Withdrawal by Subject|0|||
148894452|NCT04750642|537092021|FG001|Overall Study|Withdrawal by Subject|1|||
148894453|NCT04750642|537092020|FG000|Overall Study|Protocol Violation|0|||
148894454|NCT04750642|537092021|FG001|Overall Study|Protocol Violation|1|||
148894455|NCT01650194|537092022|FG000|Overall Study|Progressive Disease (PD)|35|||
148894456|NCT01650194|537092022|FG000|Overall Study|Withdrawal by Subject|2|||
148894457|NCT01650194|537092022|FG000|Overall Study|Miscellaneous|10|||
148894458|NCT01928927|537092023|FG000|Overall Study|Lost to Follow-up|1|||
148894459|NCT01928927|537092024|FG001|Overall Study|Lost to Follow-up|0|||
148894460|NCT01928927|537092023|FG000|Overall Study|Withdrawal by Subject|1|||
148894461|NCT01928927|537092024|FG001|Overall Study|Withdrawal by Subject|1|||
148894462|NCT04158583|537092025|FG000|Overall Study|Withdrawal by Subject|1|||
148894463|NCT04158583|537092026|FG001|Overall Study|Withdrawal by Subject|1|||
148894464|NCT04158583|537092027|FG002|Overall Study|Withdrawal by Subject|0|||
148894465|NCT04158583|537092028|FG003|Overall Study|Withdrawal by Subject|0|||
148894466|NCT04158583|537092029|FG004|Overall Study|Withdrawal by Subject|1|||
148894467|NCT04158583|537092030|FG005|Overall Study|Withdrawal by Subject|0|||
148894468|NCT04158583|537092031|FG006|Overall Study|Withdrawal by Subject|0|||
148894469|NCT04158583|537092032|FG007|Overall Study|Withdrawal by Subject|0|||
148894470|NCT04158583|537092033|FG008|Overall Study|Withdrawal by Subject|2|||
148894471|NCT04158583|537092034|FG009|Overall Study|Withdrawal by Subject|0|||
148894472|NCT04158583|537092025|FG000|Overall Study|Study Terminated by Sponsor|0|||
148894473|NCT04158583|537092026|FG001|Overall Study|Study Terminated by Sponsor|0|||
148894474|NCT04158583|537092027|FG002|Overall Study|Study Terminated by Sponsor|0|||
148793819|NCT01411852|536722056|FG001|Hospital Intervention Phase|Miscommunication error|2|||
148793820|NCT01411852|536722055|FG000|Hospital Intervention Phase|CPR administered|3|||
148793821|NCT01411852|536722056|FG001|Hospital Intervention Phase|CPR administered|1|||
148793822|NCT01411852|536722055|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
148793823|NCT01411852|536722056|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
148793824|NCT01411852|536722055|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
148793825|NCT01411852|536722056|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
149134418|NCT02684357|537972967|FG003|Part A|Other|0|||
149134419|NCT02684357|537972968|FG004|Part A|Other|0|||
149134420|NCT02684357|537972969|FG005|Part A|Other|0|||
149134421|NCT02684357|537972964|FG000|Part B|Adverse Event (Other)|0|||
149134422|NCT02684357|537972965|FG001|Part B|Adverse Event (Other)|0|||
149134423|NCT02684357|537972966|FG002|Part B|Adverse Event (Other)|0|||
149134424|NCT02684357|537972967|FG003|Part B|Adverse Event (Other)|1|||
149134425|NCT02684357|537972968|FG004|Part B|Adverse Event (Other)|1|||
149134426|NCT02684357|537972969|FG005|Part B|Adverse Event (Other)|1|||
149134427|NCT02684357|537972964|FG000|Part B|Lost to Follow-up|0|||
149134428|NCT02684357|537972965|FG001|Part B|Lost to Follow-up|0|||
149134429|NCT02684357|537972966|FG002|Part B|Lost to Follow-up|0|||
149134430|NCT02684357|537972967|FG003|Part B|Lost to Follow-up|1|||
149134431|NCT02684357|537972968|FG004|Part B|Lost to Follow-up|1|||
149134432|NCT02684357|537972969|FG005|Part B|Lost to Follow-up|7|||
149134433|NCT02684357|537972964|FG000|Part B|Withdrawal by Subject|0|||
149134434|NCT02684357|537972965|FG001|Part B|Withdrawal by Subject|0|||
149134435|NCT02684357|537972966|FG002|Part B|Withdrawal by Subject|0|||
149134436|NCT02684357|537972967|FG003|Part B|Withdrawal by Subject|0|||
149134437|NCT02684357|537972968|FG004|Part B|Withdrawal by Subject|2|||
149134438|NCT02684357|537972969|FG005|Part B|Withdrawal by Subject|4|||
149134439|NCT02684357|537972964|FG000|Part B|Other|0|||
149134440|NCT02684357|537972965|FG001|Part B|Other|0|||
149134441|NCT02684357|537972966|FG002|Part B|Other|0|||
149134442|NCT02684357|537972967|FG003|Part B|Other|1|||
149134443|NCT02684357|537972968|FG004|Part B|Other|0|||
149134444|NCT02684357|537972969|FG005|Part B|Other|1|||
149134445|NCT01079130|537972970|FG000|Overall Study|Adverse Event|1|||
149134446|NCT01079130|537972971|FG001|Overall Study|Adverse Event|1|||
149134447|NCT01079130|537972972|FG002|Overall Study|Adverse Event|0|||
149134448|NCT01079130|537972973|FG003|Overall Study|Adverse Event|1|||
149134449|NCT01079130|537972974|FG004|Overall Study|Adverse Event|5|||
149134450|NCT01079130|537972975|FG005|Overall Study|Adverse Event|1|||
149134451|NCT01079130|537972970|FG000|Overall Study|Administrative problems|1|||
149134452|NCT01079130|537972971|FG001|Overall Study|Administrative problems|3|||
149134453|NCT01079130|537972972|FG002|Overall Study|Administrative problems|0|||
149134454|NCT01079130|537972973|FG003|Overall Study|Administrative problems|0|||
149134455|NCT01079130|537972974|FG004|Overall Study|Administrative problems|0|||
149134456|NCT01079130|537972975|FG005|Overall Study|Administrative problems|1|||
149134457|NCT01079130|537972970|FG000|Overall Study|Withdrawal by Subject|0|||
149134458|NCT01079130|537972971|FG001|Overall Study|Withdrawal by Subject|1|||
149134459|NCT01079130|537972972|FG002|Overall Study|Withdrawal by Subject|0|||
149134460|NCT01079130|537972973|FG003|Overall Study|Withdrawal by Subject|0|||
149134461|NCT01079130|537972974|FG004|Overall Study|Withdrawal by Subject|1|||
149134462|NCT01079130|537972975|FG005|Overall Study|Withdrawal by Subject|3|||
149134463|NCT01079130|537972970|FG000|Overall Study|Protocol deviation|0|||
149134464|NCT01079130|537972971|FG001|Overall Study|Protocol deviation|2|||
149134465|NCT01079130|537972972|FG002|Overall Study|Protocol deviation|1|||
149134466|NCT01079130|537972973|FG003|Overall Study|Protocol deviation|2|||
149134467|NCT01079130|537972974|FG004|Overall Study|Protocol deviation|0|||
149134468|NCT01079130|537972975|FG005|Overall Study|Protocol deviation|0|||
149134469|NCT01079130|537972970|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149134470|NCT01079130|537972971|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149134471|NCT01079130|537972972|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149134472|NCT01079130|537972973|FG003|Overall Study|Abnormal test procedure result(s)|0|||
149134473|NCT01079130|537972974|FG004|Overall Study|Abnormal test procedure result(s)|1|||
149134474|NCT01079130|537972975|FG005|Overall Study|Abnormal test procedure result(s)|0|||
149134475|NCT01079130|537972970|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149134476|NCT01079130|537972971|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149134477|NCT01079130|537972972|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149134478|NCT01079130|537972973|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
149134479|NCT01079130|537972974|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
149134480|NCT01079130|537972975|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
149134481|NCT01079130|537972970|FG000|Overall Study|Lost to Follow-up|0|||
149134482|NCT01079130|537972971|FG001|Overall Study|Lost to Follow-up|0|||
149134483|NCT01079130|537972972|FG002|Overall Study|Lost to Follow-up|0|||
149134484|NCT01079130|537972973|FG003|Overall Study|Lost to Follow-up|0|||
149134485|NCT01079130|537972974|FG004|Overall Study|Lost to Follow-up|1|||
149134486|NCT01079130|537972975|FG005|Overall Study|Lost to Follow-up|0|||
149134487|NCT01853982|537972976|FG000|Overall Study|Withdrawal by Subject|1|||
149134488|NCT01853982|537972977|FG001|Overall Study|Withdrawal by Subject|0|||
149134489|NCT01853982|537972976|FG000|Overall Study|Death|1|||
148793826|NCT01411852|536722055|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
148793827|NCT01411852|536722056|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
148793828|NCT01411852|536722055|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
148793829|NCT01411852|536722056|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
148793830|NCT01411852|536722055|FG000|Hospital Intervention Phase|Other ineligible|2|||
148793831|NCT01411852|536722056|FG001|Hospital Intervention Phase|Other ineligible|2|||
148793832|NCT01411852|536722055|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
148793833|NCT01411852|536722056|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
148793834|NCT01411852|536722055|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
148793835|NCT01411852|536722056|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
148793836|NCT01411852|536722055|FG000|Hospital Intervention Phase|Vascular access failed|1|||
148793837|NCT01411852|536722056|FG001|Hospital Intervention Phase|Vascular access failed|0|||
148793838|NCT01118663|536722058|FG000|Overall Study|Adverse Event|2|||
148793839|NCT01118663|536722059|FG001|Overall Study|Adverse Event|1|||
148793840|NCT01118663|536722058|FG000|Overall Study|Withdrawal by Subject|0|||
148793841|NCT01118663|536722059|FG001|Overall Study|Withdrawal by Subject|1|||
148793842|NCT04039204|536722060|FG000|Overall Study|Withdrawal by Subject|0|||
148793843|NCT04039204|536722061|FG001|Overall Study|Withdrawal by Subject|2|||
148793844|NCT01189461|536722062|FG000|Overall Study|Lack of Efficacy|13|||
148793845|NCT01189461|536722062|FG000|Overall Study|Lost to Follow-up|1|||
148793846|NCT01189461|536722062|FG000|Overall Study|Withdrawal by Subject|6|||
148793847|NCT01189461|536722062|FG000|Overall Study|Protocol Violation|1|||
148793848|NCT01189461|536722062|FG000|Overall Study|Adverse Event|2|||
148793849|NCT01189461|536722062|FG000|Overall Study|Did not meet entrance criteria|3|||
148793850|NCT01189461|536722062|FG000|Overall Study|Other|8|||
148793851|NCT02282163|536722065|FG000|Overall Study|Protocol Violation|1|||
148793852|NCT03472521|536722066|FG000|Overall Study|Lost to Follow-up|3|||
148793853|NCT03472521|536722067|FG001|Overall Study|Lost to Follow-up|2|||
148793854|NCT03472521|536722066|FG000|Overall Study|Discontinued intervention|3|||
148793855|NCT03472521|536722067|FG001|Overall Study|Discontinued intervention|1|||
148793856|NCT05219968|536722068|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
148793857|NCT05219968|536722069|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
148793858|NCT05219968|536722070|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
148793859|NCT05219968|536722071|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
148793860|NCT05219968|536722072|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
148793861|NCT05219968|536722068|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
148793862|NCT05219968|536722069|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
148793863|NCT05219968|536722070|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
148793864|NCT05219968|536722071|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
148793865|NCT05219968|536722072|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
148793866|NCT05219968|536722068|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
148793867|NCT05219968|536722069|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
148793868|NCT05219968|536722070|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
148793869|NCT05219968|536722071|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
148793870|NCT05219968|536722072|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
148793871|NCT05219968|536722068|FG000|Week 24 Treatment Period|Adverse Event|3|||
148793872|NCT05219968|536722069|FG001|Week 24 Treatment Period|Adverse Event|0|||
148793873|NCT05219968|536722070|FG002|Week 24 Treatment Period|Adverse Event|0|||
148793874|NCT05219968|536722071|FG003|Week 24 Treatment Period|Adverse Event|0|||
148793875|NCT05219968|536722072|FG004|Week 24 Treatment Period|Adverse Event|0|||
148793876|NCT05219968|536722068|FG000|Week 24 Treatment Period|Physician Decision|0|||
148793877|NCT05219968|536722069|FG001|Week 24 Treatment Period|Physician Decision|1|||
148793878|NCT05219968|536722070|FG002|Week 24 Treatment Period|Physician Decision|0|||
148793879|NCT05219968|536722071|FG003|Week 24 Treatment Period|Physician Decision|0|||
148793880|NCT05219968|536722072|FG004|Week 24 Treatment Period|Physician Decision|0|||
148793881|NCT05219968|536722068|FG000|Week 24 Treatment Period|Other, not specified|3|||
148793882|NCT05219968|536722069|FG001|Week 24 Treatment Period|Other, not specified|0|||
148793883|NCT05219968|536722070|FG002|Week 24 Treatment Period|Other, not specified|0|||
148793884|NCT05219968|536722071|FG003|Week 24 Treatment Period|Other, not specified|0|||
148793885|NCT05219968|536722072|FG004|Week 24 Treatment Period|Other, not specified|0|||
148793886|NCT05219968|536722068|FG000|Safety Extension Period|Treatment administration failure|0|||
148793887|NCT05219968|536722069|FG001|Safety Extension Period|Treatment administration failure|0|||
148793888|NCT05219968|536722070|FG002|Safety Extension Period|Treatment administration failure|0|||
148793889|NCT05219968|536722071|FG003|Safety Extension Period|Treatment administration failure|1|||
148793890|NCT05219968|536722072|FG004|Safety Extension Period|Treatment administration failure|4|||
148793891|NCT05219968|536722068|FG000|Safety Extension Period|Bilateral dislodgement|0|||
148793892|NCT05219968|536722069|FG001|Safety Extension Period|Bilateral dislodgement|0|||
148793893|NCT05219968|536722070|FG002|Safety Extension Period|Bilateral dislodgement|4|||
148793894|NCT05219968|536722071|FG003|Safety Extension Period|Bilateral dislodgement|0|||
148894475|NCT04158583|537092028|FG003|Overall Study|Study Terminated by Sponsor|1|||
148894476|NCT04158583|537092029|FG004|Overall Study|Study Terminated by Sponsor|0|||
148894477|NCT04158583|537092030|FG005|Overall Study|Study Terminated by Sponsor|0|||
148894478|NCT04158583|537092031|FG006|Overall Study|Study Terminated by Sponsor|0|||
148894479|NCT04158583|537092032|FG007|Overall Study|Study Terminated by Sponsor|0|||
148894480|NCT04158583|537092033|FG008|Overall Study|Study Terminated by Sponsor|0|||
148894481|NCT04158583|537092034|FG009|Overall Study|Study Terminated by Sponsor|0|||
148793895|NCT05219968|536722072|FG004|Safety Extension Period|Bilateral dislodgement|1|||
148793896|NCT05219968|536722068|FG000|Safety Extension Period|Withdrawal by Subject|0|||
148793897|NCT05219968|536722069|FG001|Safety Extension Period|Withdrawal by Subject|0|||
148793898|NCT05219968|536722070|FG002|Safety Extension Period|Withdrawal by Subject|2|||
148793899|NCT05219968|536722071|FG003|Safety Extension Period|Withdrawal by Subject|0|||
148793900|NCT05219968|536722072|FG004|Safety Extension Period|Withdrawal by Subject|4|||
148793901|NCT05219968|536722068|FG000|Safety Extension Period|Adverse Event|0|||
148793902|NCT05219968|536722069|FG001|Safety Extension Period|Adverse Event|0|||
148793903|NCT05219968|536722070|FG002|Safety Extension Period|Adverse Event|2|||
148793904|NCT05219968|536722071|FG003|Safety Extension Period|Adverse Event|1|||
148793905|NCT05219968|536722072|FG004|Safety Extension Period|Adverse Event|1|||
149134490|NCT01853982|537972977|FG001|Overall Study|Death|0|||
149134491|NCT01853982|537972976|FG000|Overall Study|Lost to Follow-up|0|||
149134492|NCT01853982|537972977|FG001|Overall Study|Lost to Follow-up|1|||
149134493|NCT00390910|537972978|FG000|Overall Study|Adverse Event|1|||
149134494|NCT00390910|537972979|FG001|Overall Study|Adverse Event|0|||
149134495|NCT00390910|537972980|FG002|Overall Study|Adverse Event|0|||
149134496|NCT00390910|537972978|FG000|Overall Study|Lost to Follow-up|0|||
149134497|NCT00390910|537972979|FG001|Overall Study|Lost to Follow-up|1|||
149134498|NCT00390910|537972980|FG002|Overall Study|Lost to Follow-up|5|||
149134499|NCT00390910|537972978|FG000|Overall Study|Withdrawal by Subject|1|||
149134500|NCT00390910|537972979|FG001|Overall Study|Withdrawal by Subject|3|||
148793906|NCT05219968|536722068|FG000|Safety Extension Period|Lost to Follow-up|0|||
148894482|NCT04158583|537092025|FG000|Overall Study|Progressive Disease|1|||
148894483|NCT04158583|537092026|FG001|Overall Study|Progressive Disease|0|||
148793907|NCT05219968|536722069|FG001|Safety Extension Period|Lost to Follow-up|0|||
148793908|NCT05219968|536722070|FG002|Safety Extension Period|Lost to Follow-up|0|||
148793909|NCT05219968|536722071|FG003|Safety Extension Period|Lost to Follow-up|1|||
148793910|NCT05219968|536722072|FG004|Safety Extension Period|Lost to Follow-up|0|||
148793911|NCT04587336|536722073|FG000|Overall Study|Lost to Follow-up|1|||
148793912|NCT04587336|536722074|FG001|Overall Study|Lost to Follow-up|0|||
148793913|NCT00357877|536723411|FG000|Overall Study|Death|2|||
148793914|NCT00357877|536723412|FG001|Overall Study|Death|1|||
148793915|NCT00357877|536723411|FG000|Overall Study|Lost to Follow-up|20|||
148793916|NCT00357877|536723412|FG001|Overall Study|Lost to Follow-up|23|||
148793917|NCT00357877|536723411|FG000|Overall Study|Withdrawal by Subject|3|||
148793918|NCT00357877|536723412|FG001|Overall Study|Withdrawal by Subject|3|||
148793919|NCT00357877|536723411|FG000|Overall Study|Administrative withdrawal|1|||
148793920|NCT00357877|536723412|FG001|Overall Study|Administrative withdrawal|1|||
148793921|NCT00357877|536723411|FG000|Overall Study|Other|0|||
148793922|NCT00357877|536723412|FG001|Overall Study|Other|2|||
148793923|NCT00447772|536723417|FG000|Overall Study|Lack of Efficacy|3|||
148793924|NCT00447772|536723417|FG000|Overall Study|Insufficient compliance|6|||
148793925|NCT00447772|536723417|FG000|Overall Study|Discontinuation of drug therapy|1|||
148793926|NCT00447772|536723417|FG000|Overall Study|Lost to Follow-up|9|||
148793927|NCT00447772|536723417|FG000|Overall Study|Withdrawal by Subject|1|||
148793928|NCT00447772|536723417|FG000|Overall Study|Unable to attend all study visits|2|||
148793929|NCT00447772|536723417|FG000|Overall Study|Adverse Event|1|||
148793930|NCT00447772|536723417|FG000|Overall Study|Patient relocated|1|||
148793931|NCT00447772|536723417|FG000|Overall Study|Incomplete documentation at visit 1|1|||
148793932|NCT00447772|536723417|FG000|Overall Study|Chemotherapy for lung cancer|1|||
148793933|NCT00447772|536723417|FG000|Overall Study|Premature re-injection required|1|||
148793934|NCT02849743|536723424|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
148793935|NCT02849743|536723425|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
148793936|NCT02849743|536723424|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
148793937|NCT02849743|536723425|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
148793938|NCT03874013|536723432|FG000|Overall Study|Adverse Event|0|||
148793939|NCT03874013|536723433|FG001|Overall Study|Adverse Event|1|||
148894484|NCT04158583|537092027|FG002|Overall Study|Progressive Disease|3|||
149134501|NCT00390910|537972980|FG002|Overall Study|Withdrawal by Subject|2|||
149134502|NCT00390910|537972978|FG000|Overall Study|Migrated/moved from study area|0|||
148793940|NCT01026948|536723437|FG000|Overall Study|Physician Decision|8|||
148793941|NCT02989402|536723439|FG000|Overall Study|Adverse event, or serious adverse event|4|||
148793942|NCT02989402|536723439|FG000|Overall Study|Death|2|||
148793943|NCT02989402|536723439|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
148793944|NCT02989402|536723439|FG000|Overall Study|Lost to Follow-up|8|||
148793945|NCT02989402|536723439|FG000|Overall Study|Patient no longer on monotherapy|1|||
149134503|NCT00390910|537972979|FG001|Overall Study|Migrated/moved from study area|0|||
148793946|NCT02989402|536723439|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
149233843|NCT02161380|538324929|FG000|Overall Study|Lost to Follow-up|0|||
148894485|NCT04158583|537092028|FG003|Overall Study|Progressive Disease|5|||
148894486|NCT04158583|537092029|FG004|Overall Study|Progressive Disease|0|||
148894487|NCT04158583|537092030|FG005|Overall Study|Progressive Disease|1|||
148894488|NCT04158583|537092031|FG006|Overall Study|Progressive Disease|6|||
148894489|NCT04158583|537092032|FG007|Overall Study|Progressive Disease|2|||
148894490|NCT04158583|537092033|FG008|Overall Study|Progressive Disease|1|||
148894491|NCT04158583|537092034|FG009|Overall Study|Progressive Disease|2|||
148894492|NCT04158583|537092025|FG000|Overall Study|Lost to Follow-up|0|||
148894493|NCT04158583|537092026|FG001|Overall Study|Lost to Follow-up|0|||
148894494|NCT04158583|537092027|FG002|Overall Study|Lost to Follow-up|1|||
148894495|NCT04158583|537092028|FG003|Overall Study|Lost to Follow-up|1|||
148894496|NCT04158583|537092029|FG004|Overall Study|Lost to Follow-up|1|||
148894497|NCT04158583|537092030|FG005|Overall Study|Lost to Follow-up|0|||
148894498|NCT04158583|537092031|FG006|Overall Study|Lost to Follow-up|0|||
148894499|NCT04158583|537092032|FG007|Overall Study|Lost to Follow-up|0|||
148894500|NCT04158583|537092033|FG008|Overall Study|Lost to Follow-up|0|||
148894501|NCT04158583|537092034|FG009|Overall Study|Lost to Follow-up|0|||
148894502|NCT04158583|537092025|FG000|Overall Study|Due To Patient Status|0|||
148894503|NCT04158583|537092026|FG001|Overall Study|Due To Patient Status|0|||
148894504|NCT04158583|537092027|FG002|Overall Study|Due To Patient Status|0|||
148894505|NCT04158583|537092028|FG003|Overall Study|Due To Patient Status|0|||
148894506|NCT04158583|537092029|FG004|Overall Study|Due To Patient Status|0|||
148894507|NCT04158583|537092030|FG005|Overall Study|Due To Patient Status|0|||
148894508|NCT04158583|537092031|FG006|Overall Study|Due To Patient Status|0|||
148894509|NCT04158583|537092032|FG007|Overall Study|Due To Patient Status|0|||
148894510|NCT04158583|537092033|FG008|Overall Study|Due To Patient Status|1|||
148894511|NCT04158583|537092034|FG009|Overall Study|Due To Patient Status|0|||
148894512|NCT04158583|537092025|FG000|Overall Study|Death|3|||
148894513|NCT04158583|537092026|FG001|Overall Study|Death|4|||
148894514|NCT04158583|537092027|FG002|Overall Study|Death|2|||
148894515|NCT04158583|537092028|FG003|Overall Study|Death|2|||
148894516|NCT04158583|537092029|FG004|Overall Study|Death|4|||
148894517|NCT04158583|537092030|FG005|Overall Study|Death|3|||
148894518|NCT04158583|537092031|FG006|Overall Study|Death|5|||
148894519|NCT04158583|537092032|FG007|Overall Study|Death|2|||
148894520|NCT04158583|537092033|FG008|Overall Study|Death|0|||
148894521|NCT04158583|537092034|FG009|Overall Study|Death|1|||
148894522|NCT04158583|537092025|FG000|Overall Study|Clinical Progression Disease|0|||
148894523|NCT04158583|537092026|FG001|Overall Study|Clinical Progression Disease|0|||
148894524|NCT04158583|537092027|FG002|Overall Study|Clinical Progression Disease|0|||
148894525|NCT04158583|537092028|FG003|Overall Study|Clinical Progression Disease|1|||
148894526|NCT04158583|537092029|FG004|Overall Study|Clinical Progression Disease|0|||
148894527|NCT04158583|537092030|FG005|Overall Study|Clinical Progression Disease|0|||
148894528|NCT04158583|537092031|FG006|Overall Study|Clinical Progression Disease|0|||
148894529|NCT04158583|537092032|FG007|Overall Study|Clinical Progression Disease|0|||
148894530|NCT04158583|537092033|FG008|Overall Study|Clinical Progression Disease|0|||
148894531|NCT04158583|537092034|FG009|Overall Study|Clinical Progression Disease|0|||
148894532|NCT04158583|537092025|FG000|Overall Study|Clinical Progression|0|||
148894533|NCT04158583|537092026|FG001|Overall Study|Clinical Progression|0|||
148894534|NCT04158583|537092027|FG002|Overall Study|Clinical Progression|0|||
148894535|NCT04158583|537092028|FG003|Overall Study|Clinical Progression|0|||
148894536|NCT04158583|537092029|FG004|Overall Study|Clinical Progression|1|||
148894537|NCT04158583|537092030|FG005|Overall Study|Clinical Progression|0|||
149134504|NCT00390910|537972980|FG002|Overall Study|Migrated/moved from study area|3|||
149134505|NCT01839487|537972981|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
149134506|NCT01839487|537972982|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149134507|NCT01839487|537972983|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149134508|NCT01839487|537972984|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149134509|NCT01839487|537972985|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149134510|NCT01839487|537972986|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
149134511|NCT01839487|537972981|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
149134512|NCT01839487|537972982|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
149134513|NCT01839487|537972983|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
149134514|NCT01839487|537972984|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
149134515|NCT01839487|537972985|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
149134516|NCT01839487|537972986|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
149134517|NCT01839487|537972981|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
149134518|NCT01839487|537972982|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
148894538|NCT04158583|537092031|FG006|Overall Study|Clinical Progression|2|||
148894539|NCT04158583|537092032|FG007|Overall Study|Clinical Progression|0|||
148894540|NCT04158583|537092033|FG008|Overall Study|Clinical Progression|0|||
148894541|NCT04158583|537092034|FG009|Overall Study|Clinical Progression|0|||
148894542|NCT04158583|537092025|FG000|Overall Study|Clinical Deterioration|0|||
148894543|NCT04158583|537092026|FG001|Overall Study|Clinical Deterioration|0|||
148894544|NCT04158583|537092027|FG002|Overall Study|Clinical Deterioration|0|||
148793947|NCT02989402|536723439|FG000|Overall Study|Withdrawal by Subject|7|||
149134519|NCT01839487|537972983|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
149134520|NCT01839487|537972984|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
148793948|NCT02989402|536723439|FG000|Overall Study|Other|2|||
148793949|NCT01462110|536723452|FG000|Overall Study|Adverse Event|1|||
148793950|NCT01462110|536723453|FG001|Overall Study|Adverse Event|0|||
148793951|NCT00753675|536723454|FG000|Overall Study|other reason|11|||
148793952|NCT00753675|536723455|FG001|Overall Study|other reason|12|||
148793953|NCT00753675|536723456|FG002|Overall Study|other reason|13|||
148793954|NCT00753675|536723454|FG000|Overall Study|Death|1|||
148793955|NCT00753675|536723455|FG001|Overall Study|Death|2|||
148793956|NCT00753675|536723456|FG002|Overall Study|Death|4|||
148793957|NCT00753675|536723454|FG000|Overall Study|Adverse Event|11|||
148793958|NCT00753675|536723455|FG001|Overall Study|Adverse Event|9|||
148793959|NCT00753675|536723456|FG002|Overall Study|Adverse Event|4|||
148793960|NCT00753675|536723454|FG000|Overall Study|Objective progression of disease|35|||
148793961|NCT00753675|536723455|FG001|Overall Study|Objective progression of disease|35|||
148793962|NCT00753675|536723456|FG002|Overall Study|Objective progression of disease|35|||
148793963|NCT00753675|536723454|FG000|Overall Study|Withdrawal by Subject|0|||
148793964|NCT00753675|536723455|FG001|Overall Study|Withdrawal by Subject|1|||
148793965|NCT00753675|536723456|FG002|Overall Study|Withdrawal by Subject|0|||
148793966|NCT00753675|536723454|FG000|Overall Study|Lost to Follow-up|1|||
148793967|NCT00753675|536723455|FG001|Overall Study|Lost to Follow-up|0|||
148793968|NCT00753675|536723456|FG002|Overall Study|Lost to Follow-up|0|||
148793969|NCT05279131|536723458|FG000|Overall Study|Lost to Follow-up|1|||
148793970|NCT05279131|536723458|FG000|Overall Study|Death|1|||
148793971|NCT05279131|536723458|FG000|Overall Study|Physician Decision|1|||
148793972|NCT02149264|536723464|FG000|Overall Study|Withdrawal by Subject|9|||
148793973|NCT02149264|536723464|FG000|Overall Study|Adverse Event|7|||
148793974|NCT02149264|536723464|FG000|Overall Study|Physician Decision|3|||
148793975|NCT02149264|536723464|FG000|Overall Study|Protocol Violation|1|||
148793976|NCT02824627|536723471|FG000|Overall Study|Adverse Event|1|||
148793977|NCT02824627|536723472|FG001|Overall Study|Adverse Event|2|||
148793978|NCT02824627|536723471|FG000|Overall Study|Lost to Follow-up|2|||
148793979|NCT02824627|536723472|FG001|Overall Study|Lost to Follow-up|1|||
148793980|NCT00672633|536723473|FG000|Overall Study|Withdrawal by Subject|0|||
148793981|NCT00672633|536723474|FG001|Overall Study|Withdrawal by Subject|1|||
148793982|NCT01938846|536723475|FG000|Overall Study|Progressive disease|26|||
148793983|NCT01938846|536723476|FG001|Overall Study|Progressive disease|18|||
148793984|NCT01938846|536723477|FG002|Overall Study|Progressive disease|16|||
148793985|NCT01938846|536723475|FG000|Overall Study|Adverse Event|8|||
148793986|NCT01938846|536723476|FG001|Overall Study|Adverse Event|4|||
148793987|NCT01938846|536723477|FG002|Overall Study|Adverse Event|3|||
148793988|NCT01938846|536723475|FG000|Overall Study|Withdrawal by Subject|2|||
148793989|NCT01938846|536723476|FG001|Overall Study|Withdrawal by Subject|2|||
148793990|NCT01938846|536723477|FG002|Overall Study|Withdrawal by Subject|1|||
148793991|NCT01938846|536723475|FG000|Overall Study|Other than listed|5|||
148793992|NCT01938846|536723476|FG001|Overall Study|Other than listed|1|||
148793993|NCT01938846|536723477|FG002|Overall Study|Other than listed|4|||
148793994|NCT02499120|536723481|FG000|Overall Study|Death|52|||
148793995|NCT02499120|536723482|FG001|Overall Study|Death|43|||
148793996|NCT02499120|536723481|FG000|Overall Study|Lost to Follow-up|1|||
148894545|NCT04158583|537092028|FG003|Overall Study|Clinical Deterioration|1|||
148894546|NCT04158583|537092029|FG004|Overall Study|Clinical Deterioration|0|||
148793997|NCT02499120|536723482|FG001|Overall Study|Lost to Follow-up|2|||
148793998|NCT02499120|536723481|FG000|Overall Study|Participant refused further follow-up|1|||
148793999|NCT02499120|536723482|FG001|Overall Study|Participant refused further follow-up|0|||
148794000|NCT02499120|536723481|FG000|Overall Study|Withdrawal by Subject|2|||
148794001|NCT02499120|536723482|FG001|Overall Study|Withdrawal by Subject|5|||
148794002|NCT02499120|536723481|FG000|Overall Study|Other|9|||
148794003|NCT02499120|536723482|FG001|Overall Study|Other|10|||
148794004|NCT00964028|536723485|FG000|Overall Study|Withdrawal by Subject|0|||
148794005|NCT00964028|536723486|FG001|Overall Study|Withdrawal by Subject|1|||
148794006|NCT01603407|536723487|FG000|Overall Study|Adverse Event|1|||
148794007|NCT01603407|536723488|FG001|Overall Study|Adverse Event|1|||
148794008|NCT01603407|536723489|FG002|Overall Study|Adverse Event|1|||
148794009|NCT01603407|536723487|FG000|Overall Study|Protocol Violation|2|||
148794010|NCT01603407|536723488|FG001|Overall Study|Protocol Violation|2|||
148894547|NCT04158583|537092030|FG005|Overall Study|Clinical Deterioration|0|||
149233844|NCT02161380|538324930|FG001|Overall Study|Lost to Follow-up|1|||
148794011|NCT01603407|536723489|FG002|Overall Study|Protocol Violation|0|||
148794012|NCT01603407|536723487|FG000|Overall Study|Withdrawal by Subject|8|||
148794013|NCT01603407|536723488|FG001|Overall Study|Withdrawal by Subject|5|||
148794014|NCT01603407|536723489|FG002|Overall Study|Withdrawal by Subject|7|||
148794015|NCT01603407|536723487|FG000|Overall Study|Lost to Follow-up|0|||
148794016|NCT01603407|536723488|FG001|Overall Study|Lost to Follow-up|3|||
148794017|NCT01603407|536723489|FG002|Overall Study|Lost to Follow-up|2|||
148794018|NCT02106351|536723494|FG000|Treatment Cycle 1|Adverse Event|2|||
148794019|NCT02106351|536723495|FG001|Treatment Cycle 1|Adverse Event|0|||
149134521|NCT01839487|537972985|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
149134522|NCT01839487|537972986|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
149134523|NCT01839487|537972981|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
149134524|NCT01839487|537972982|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
149134525|NCT01839487|537972983|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
149134526|NCT01839487|537972984|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
149134527|NCT01839487|537972985|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
149134528|NCT01839487|537972986|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
149134529|NCT01839487|537972981|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
149134530|NCT01839487|537972982|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
149134531|NCT01839487|537972983|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
149134532|NCT01839487|537972984|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
149134533|NCT01839487|537972985|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
149134534|NCT01839487|537972986|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
149134535|NCT01839487|537972981|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
149134536|NCT01839487|537972982|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
149134537|NCT01839487|537972983|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
149134538|NCT01839487|537972984|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
149134539|NCT01839487|537972985|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
149134540|NCT01839487|537972986|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
149134541|NCT01839487|537972981|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
149134542|NCT01839487|537972982|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
149134543|NCT01839487|537972983|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
149134544|NCT01839487|537972984|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
149134545|NCT01839487|537972985|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
149134546|NCT01839487|537972986|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
149134547|NCT01839487|537972981|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
149134548|NCT01839487|537972982|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
149134549|NCT01839487|537972983|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
149134550|NCT01839487|537972984|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
149134551|NCT01839487|537972985|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
149134552|NCT01839487|537972986|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
149134553|NCT01839487|537972981|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
149134554|NCT01839487|537972982|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
149134555|NCT01839487|537972983|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
149134556|NCT01839487|537972984|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
149134557|NCT01839487|537972985|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
149134558|NCT01839487|537972986|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
149134559|NCT01658826|537972992|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
149134560|NCT01658826|537972993|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
149134561|NCT01658826|537972992|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
149134562|NCT01658826|537972993|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
149134563|NCT01658826|537972992|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
149134564|NCT01658826|537972993|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
149134565|NCT01658826|537972992|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
149134566|NCT01658826|537972993|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
149236140|NCT05681715|538334271|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
149236141|NCT05681715|538334269|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
149236142|NCT05681715|538334270|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
149236143|NCT05681715|538334271|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
149236144|NCT05116241|538334272|FG000|Study|Withdrawal by Subject|5|||
149236145|NCT05116241|538334273|FG001|Study|Withdrawal by Subject|2|||
149236146|NCT05116241|538334274|FG002|Study|Withdrawal by Subject|1|||
149236147|NCT05116241|538334272|FG000|Study|Lost to Follow-up|0|||
149236148|NCT05116241|538334273|FG001|Study|Lost to Follow-up|2|||
149236149|NCT05116241|538334274|FG002|Study|Lost to Follow-up|2|||
149236150|NCT02268214|538334278|FG000|Overall Study|Subject no longer meets study criteria|0|||
149236151|NCT02268214|538334279|FG001|Overall Study|Subject no longer meets study criteria|2|||
148794020|NCT02106351|536723496|FG002|Treatment Cycle 1|Adverse Event|0|||
148794021|NCT02106351|536723494|FG000|Treatment Cycle 1|Consent withdrawn|1|||
148794022|NCT02106351|536723495|FG001|Treatment Cycle 1|Consent withdrawn|0|||
148794023|NCT02106351|536723496|FG002|Treatment Cycle 1|Consent withdrawn|2|||
148794024|NCT02106351|536723494|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
148794025|NCT02106351|536723495|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
148794026|NCT02106351|536723496|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
148794027|NCT02106351|536723494|FG000|Treatment Cycle 1|Other|0|||
148794028|NCT02106351|536723495|FG001|Treatment Cycle 1|Other|3|||
148794029|NCT02106351|536723496|FG002|Treatment Cycle 1|Other|1|||
148794030|NCT02106351|536723494|FG000|Treatment Cycle 1|Randomised but not treated|1|||
148794031|NCT02106351|536723495|FG001|Treatment Cycle 1|Randomised but not treated|0|||
148794032|NCT02106351|536723496|FG002|Treatment Cycle 1|Randomised but not treated|1|||
148794033|NCT02106351|536723494|FG000|Treatment Cycle 2|Adverse Event|0|||
148794034|NCT02106351|536723495|FG001|Treatment Cycle 2|Adverse Event|2|||
149134567|NCT01658826|537972992|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
149134568|NCT01658826|537972993|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
149134569|NCT01658826|537972992|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
149134570|NCT01658826|537972993|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
149134571|NCT01658826|537972992|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
149134572|NCT01658826|537972993|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
149134573|NCT01658826|537972992|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
149134574|NCT01658826|537972993|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
149134575|NCT01658826|537972992|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
149134576|NCT01658826|537972993|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
149134577|NCT06071754|537972994|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
149134578|NCT04567615|537972995|FG000|Randomization|Participant withdrew consent|1|||
149134579|NCT04567615|537972996|FG001|Randomization|Participant withdrew consent|0|||
149134580|NCT04567615|537972997|FG002|Randomization|Participant withdrew consent|0|||
149134581|NCT04567615|537972995|FG000|Randomization|Adverse event unrelated to study drug|0|||
149134582|NCT04567615|537972996|FG001|Randomization|Adverse event unrelated to study drug|1|||
149134583|NCT04567615|537972997|FG002|Randomization|Adverse event unrelated to study drug|0|||
149134584|NCT04567615|537972995|FG000|Treatment Period|Participant Withdrew Consent|2|||
149134585|NCT04567615|537972996|FG001|Treatment Period|Participant Withdrew Consent|5|||
149134586|NCT04567615|537972997|FG002|Treatment Period|Participant Withdrew Consent|1|||
149134587|NCT04567615|537972995|FG000|Treatment Period|Death|1|||
149134588|NCT04567615|537972996|FG001|Treatment Period|Death|2|||
149134589|NCT04567615|537972997|FG002|Treatment Period|Death|0|||
149134590|NCT04567615|537972995|FG000|Treatment Period|Lost to Follow-up|0|||
149134591|NCT04567615|537972996|FG001|Treatment Period|Lost to Follow-up|1|||
149134592|NCT04567615|537972997|FG002|Treatment Period|Lost to Follow-up|0|||
149134593|NCT04567615|537972995|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
149134594|NCT04567615|537972996|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
149134595|NCT04567615|537972997|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
149134596|NCT04567615|537972995|FG000|Treatment Period|Disease Progression|85|||
149134597|NCT04567615|537972996|FG001|Treatment Period|Disease Progression|63|||
149134598|NCT04567615|537972997|FG002|Treatment Period|Disease Progression|16|||
149134599|NCT04567615|537972995|FG000|Treatment Period|Study Drug Toxicity|3|||
149134600|NCT04567615|537972996|FG001|Treatment Period|Study Drug Toxicity|10|||
149134601|NCT04567615|537972997|FG002|Treatment Period|Study Drug Toxicity|4|||
149134602|NCT04567615|537972995|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
149134603|NCT04567615|537972996|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
149134604|NCT04567615|537972997|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
149134605|NCT04567615|537972995|FG000|Treatment Period|Other Reasons|1|||
149134606|NCT04567615|537972996|FG001|Treatment Period|Other Reasons|2|||
149134607|NCT04567615|537972997|FG002|Treatment Period|Other Reasons|0|||
149134608|NCT04567615|537972995|FG000|Treatment Period|Still On-going Treatment|21|||
149134609|NCT04567615|537972996|FG001|Treatment Period|Still On-going Treatment|22|||
149134610|NCT04567615|537972997|FG002|Treatment Period|Still On-going Treatment|2|||
149134611|NCT05028517|537972998|FG000|Overall Study|Lost to Follow-up|13|||
149134612|NCT05028517|537972999|FG001|Overall Study|Lost to Follow-up|20|||
149134613|NCT05028517|537973000|FG002|Overall Study|Lost to Follow-up|12|||
149134614|NCT05028517|537972998|FG000|Overall Study|Withdrawal by Subject|0|||
149134615|NCT05028517|537972999|FG001|Overall Study|Withdrawal by Subject|0|||
149134616|NCT05028517|537973000|FG002|Overall Study|Withdrawal by Subject|1|||
149134617|NCT01306890|537974706|FG000|Overall Study|Adverse Event|2|||
149134618|NCT01306890|537974706|FG000|Overall Study|Death|1223|||
149134619|NCT01306890|537974706|FG000|Overall Study|Lost to Follow-up|58|||
149134620|NCT01306890|537974706|FG000|Overall Study|Withdrawal by Subject|88|||
149134621|NCT01306890|537974706|FG000|Overall Study|Unspecified reasons|104|||
149134622|NCT01306890|537974706|FG000|Overall Study|Study Termination|3|||
149134623|NCT01306890|537974706|FG000|Overall Study|No discontinuation documentation|41|||
149134624|NCT02217436|537974707|FG000|Overall Study|Protocol Violation|1|||
149134625|NCT02217436|537974708|FG001|Overall Study|Protocol Violation|1|||
149134626|NCT02217436|537974707|FG000|Overall Study|Incomplete data|0|||
149134627|NCT02217436|537974708|FG001|Overall Study|Incomplete data|1|||
149134628|NCT03739762|537974709|FG000|Overall Study|Lost to Follow-up|1|||
149134629|NCT03739762|537974710|FG001|Overall Study|Lost to Follow-up|1|||
149134630|NCT03739762|537974709|FG000|Overall Study|Withdrawal by Subject|2|||
149134631|NCT03739762|537974710|FG001|Overall Study|Withdrawal by Subject|6|||
149134632|NCT00607880|537974711|FG000|Overall Study|Unable to place port due to occlusion|1|||
149134633|NCT00607880|537974712|FG001|Overall Study|Unable to place port due to occlusion|0|||
149134634|NCT05104476|537974713|FG000|Overall Study|Randomized But Not Treated|1|||
149134635|NCT05104476|537974714|FG001|Overall Study|Randomized But Not Treated|2|||
149134636|NCT05104476|537974713|FG000|Overall Study|Adverse Event|2|||
149134637|NCT05104476|537974714|FG001|Overall Study|Adverse Event|2|||
149134638|NCT05104476|537974713|FG000|Overall Study|Withdrawal by Subject|3|||
149134639|NCT05104476|537974714|FG001|Overall Study|Withdrawal by Subject|3|||
149134640|NCT05104476|537974713|FG000|Overall Study|Other Than Specified|0|||
149134641|NCT05104476|537974714|FG001|Overall Study|Other Than Specified|3|||
149134642|NCT02170389|537974717|FG000|Overall Study|Study terminated prior to start of treat|1|||
149134643|NCT01008696|537974718|FG000|Overall Study|Participant's evasion of hospital visit|5|||
149134644|NCT01008696|537974719|FG001|Overall Study|Participant's evasion of hospital visit|4|||
149134645|NCT01008696|537974718|FG000|Overall Study|Withdrawal by Subject|2|||
149134646|NCT01008696|537974719|FG001|Overall Study|Withdrawal by Subject|4|||
149134647|NCT01008696|537974718|FG000|Overall Study|Physician Decision|5|||
149134648|NCT01008696|537974719|FG001|Overall Study|Physician Decision|1|||
149134649|NCT01008696|537974718|FG000|Overall Study|Adverse Event|1|||
149134650|NCT01008696|537974719|FG001|Overall Study|Adverse Event|0|||
149134651|NCT01008696|537974718|FG000|Overall Study|Participants' non-cooperation|2|||
149134652|NCT01008696|537974719|FG001|Overall Study|Participants' non-cooperation|3|||
149134653|NCT01008696|537974718|FG000|Overall Study|Other|2|||
149134654|NCT01008696|537974719|FG001|Overall Study|Other|3|||
149134655|NCT01008696|537974718|FG000|Overall Study|Other|0|||
149134656|NCT01008696|537974719|FG001|Overall Study|Other|2|||
149134657|NCT02366728|537974720|FG000|Overall Study|Death|0|||
149134658|NCT02366728|537974721|FG001|Overall Study|Death|0|||
149134659|NCT02366728|537974722|FG002|Overall Study|Death|1|||
149134660|NCT02366728|537974720|FG000|Overall Study|Adverse Event|1|||
149134661|NCT02366728|537974721|FG001|Overall Study|Adverse Event|0|||
149134662|NCT02366728|537974722|FG002|Overall Study|Adverse Event|0|||
149134663|NCT02366728|537974720|FG000|Overall Study|Screen Failure|2|||
149134664|NCT02366728|537974721|FG001|Overall Study|Screen Failure|1|||
149134665|NCT02366728|537974722|FG002|Overall Study|Screen Failure|0|||
149134666|NCT02366728|537974720|FG000|Overall Study|Only yielded 2 vaccines|1|||
149134667|NCT02366728|537974721|FG001|Overall Study|Only yielded 2 vaccines|0|||
149134668|NCT02366728|537974722|FG002|Overall Study|Only yielded 2 vaccines|0|||
149134669|NCT04964960|537974723|FG000|Overall Study|Withdrawal by Subject|1|||
149134670|NCT04964960|537974723|FG000|Overall Study|Did not complete cycles|1|||
149134671|NCT02960854|537974724|FG000|Overall Study|Not Disclosed|2|||
149134672|NCT02960854|537974725|FG001|Overall Study|Not Disclosed|2|||
149134673|NCT02960854|537974724|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
149134674|NCT02960854|537974725|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
149134675|NCT02960854|537974724|FG000|Overall Study|Subject Withdrew Consent|0|||
149134676|NCT02960854|537974725|FG001|Overall Study|Subject Withdrew Consent|1|||
149134677|NCT02960854|537974724|FG000|Overall Study|Death|4|||
149134678|NCT02960854|537974725|FG001|Overall Study|Death|6|||
149134679|NCT00221195|537974726|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
149134680|NCT00221195|537974727|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
149134681|NCT00221195|537974726|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
149134682|NCT00221195|537974727|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
149134683|NCT00221195|537974726|FG000|Washout Period (Months 7-9)|Death|0|||
149134684|NCT00221195|537974727|FG001|Washout Period (Months 7-9)|Death|1|||
149134685|NCT00221195|537974726|FG000|Therapy 2 (Months 10-15)|Death|1|||
149134686|NCT00221195|537974727|FG001|Therapy 2 (Months 10-15)|Death|0|||
149134687|NCT00221195|537974726|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
149134688|NCT00221195|537974727|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
149134689|NCT00833911|537974729|FG000|Titration|Adverse Event|18|||
149134690|NCT00833911|537974729|FG000|Titration|Withdrawal by Subject|3|||
149134691|NCT00833911|537974729|FG000|Maintenance Phase I|Adverse Event|73|||
149134692|NCT00833911|537974729|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
149134693|NCT00833911|537974729|FG000|Maintenance Phase I|Physician Decision|10|||
148794035|NCT02106351|536723496|FG002|Treatment Cycle 2|Adverse Event|0|||
149134694|NCT00833911|537974729|FG000|Maintenance Phase I|Lack of Efficacy|4|||
149134695|NCT00833911|537974729|FG000|Maintenance Phase II|Adverse Event|6|||
149134696|NCT00833911|537974729|FG000|Maintenance Phase II|Physician Decision|2|||
149134697|NCT00833911|537974729|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
149134698|NCT00833911|537974729|FG000|Maintenance Phase II|Lack of Efficacy|1|||
149134699|NCT02596620|537974734|FG000|Overall Study|Lost to Follow-up|1|||
149134700|NCT02596620|537974735|FG001|Overall Study|Lost to Follow-up|1|||
149134701|NCT03155373|537974736|FG000|Overall Study|No longer required surgery|1|||
149134702|NCT03155373|537974736|FG000|Overall Study|Protocol Violation|1|||
149134703|NCT03155373|537974736|FG000|Overall Study|Death|2|||
149134704|NCT03155373|537974736|FG000|Overall Study|Withdrawal by Subject|3|||
149134705|NCT01054144|537974737|FG000|Overall Study|Death|2|||
149134706|NCT02616614|537974738|FG000|Overall Study|Withdrawal by Subject|10|||
149134707|NCT02616614|537974739|FG001|Overall Study|Withdrawal by Subject|5|||
149134708|NCT02616614|537974740|FG002|Overall Study|Withdrawal by Subject|6|||
149134709|NCT02616614|537974738|FG000|Overall Study|Physician Decision|2|||
149134710|NCT02616614|537974739|FG001|Overall Study|Physician Decision|1|||
149134711|NCT02616614|537974740|FG002|Overall Study|Physician Decision|0|||
149134712|NCT02616614|537974738|FG000|Overall Study|Adverse Event|1|||
149134713|NCT02616614|537974739|FG001|Overall Study|Adverse Event|4|||
149134714|NCT02616614|537974740|FG002|Overall Study|Adverse Event|1|||
149134715|NCT02616614|537974738|FG000|Overall Study|Protocol Violation|0|||
149134716|NCT02616614|537974739|FG001|Overall Study|Protocol Violation|3|||
149134717|NCT02616614|537974740|FG002|Overall Study|Protocol Violation|1|||
149134718|NCT02616614|537974738|FG000|Overall Study|Prohibited Medication|12|||
149134719|NCT02616614|537974739|FG001|Overall Study|Prohibited Medication|9|||
149134720|NCT02616614|537974740|FG002|Overall Study|Prohibited Medication|5|||
149134721|NCT02616614|537974738|FG000|Overall Study|More than 3 applications missed|6|||
149134722|NCT02616614|537974739|FG001|Overall Study|More than 3 applications missed|8|||
149134723|NCT02616614|537974740|FG002|Overall Study|More than 3 applications missed|1|||
149134724|NCT02616614|537974738|FG000|Overall Study|Lost to Follow-up|31|||
149134725|NCT02616614|537974739|FG001|Overall Study|Lost to Follow-up|28|||
149134726|NCT02616614|537974740|FG002|Overall Study|Lost to Follow-up|13|||
149134727|NCT02616614|537974738|FG000|Overall Study|Pregnancy|2|||
149134728|NCT02616614|537974739|FG001|Overall Study|Pregnancy|0|||
149134729|NCT02616614|537974740|FG002|Overall Study|Pregnancy|1|||
149134730|NCT02616614|537974738|FG000|Overall Study|Other|1|||
149134731|NCT02616614|537974739|FG001|Overall Study|Other|2|||
149134732|NCT02616614|537974740|FG002|Overall Study|Other|1|||
149134733|NCT01324323|537974741|FG000|Overall Study|Withdrawal by Subject|1|||
149134734|NCT00537485|537974742|FG000|Overall Study|Adverse Event|10|||
149134735|NCT00537485|537974743|FG001|Overall Study|Adverse Event|5|||
149134736|NCT00537485|537974742|FG000|Overall Study|Withdrawal by Subject|3|||
149134737|NCT00537485|537974743|FG001|Overall Study|Withdrawal by Subject|2|||
149134738|NCT00537485|537974742|FG000|Overall Study|Withdrawal by Subject|1|||
149134739|NCT00537485|537974743|FG001|Overall Study|Withdrawal by Subject|3|||
149134740|NCT00537485|537974742|FG000|Overall Study|Physician Decision|1|||
149134741|NCT00537485|537974743|FG001|Overall Study|Physician Decision|0|||
149134742|NCT01601847|537974744|FG000|Overall Study|Death|1|||
149236152|NCT02268214|538334280|FG002|Overall Study|Subject no longer meets study criteria|0|||
149236153|NCT02268214|538334278|FG000|Overall Study|Pregnancy|2|||
149236154|NCT02268214|538334279|FG001|Overall Study|Pregnancy|2|||
148794036|NCT02106351|536723494|FG000|Treatment Cycle 2|Consent withdrawn|0|||
148794037|NCT02106351|536723495|FG001|Treatment Cycle 2|Consent withdrawn|1|||
148794038|NCT02106351|536723496|FG002|Treatment Cycle 2|Consent withdrawn|1|||
148794039|NCT02106351|536723494|FG000|Treatment Cycle 2|Other|0|||
148794040|NCT02106351|536723495|FG001|Treatment Cycle 2|Other|2|||
148794041|NCT02106351|536723496|FG002|Treatment Cycle 2|Other|2|||
148794042|NCT02106351|536723494|FG000|Treatment Cycle 3|Adverse Event|0|||
148794043|NCT02106351|536723495|FG001|Treatment Cycle 3|Adverse Event|1|||
148794044|NCT02106351|536723496|FG002|Treatment Cycle 3|Adverse Event|0|||
148794045|NCT02106351|536723494|FG000|Treatment Cycle 3|Consent withdrawn|0|||
148794046|NCT02106351|536723495|FG001|Treatment Cycle 3|Consent withdrawn|0|||
148794047|NCT02106351|536723496|FG002|Treatment Cycle 3|Consent withdrawn|2|||
148794048|NCT02106351|536723494|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
148794049|NCT02106351|536723495|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
148794050|NCT02106351|536723496|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
148794051|NCT02106351|536723494|FG000|Treatment Cycle 3|Other|0|||
148794052|NCT02106351|536723495|FG001|Treatment Cycle 3|Other|2|||
148794053|NCT02106351|536723496|FG002|Treatment Cycle 3|Other|3|||
148794054|NCT02106351|536723494|FG000|Treatment Cycle 4|Consent withdrawn|0|||
148794055|NCT02106351|536723495|FG001|Treatment Cycle 4|Consent withdrawn|0|||
148794056|NCT02106351|536723496|FG002|Treatment Cycle 4|Consent withdrawn|2|||
148794057|NCT02106351|536723494|FG000|Treatment Cycle 4|Other|0|||
148794058|NCT02106351|536723495|FG001|Treatment Cycle 4|Other|1|||
148794059|NCT02106351|536723496|FG002|Treatment Cycle 4|Other|0|||
148794060|NCT00069823|536723501|FG000|Overall Study|Did not have follow-up diary cards|6|||
148794061|NCT00069823|536723502|FG001|Overall Study|Did not have follow-up diary cards|3|||
148794062|NCT03560869|536723505|FG000|Overall Study|Withdrawal by Subject|3|||
148894548|NCT04158583|537092031|FG006|Overall Study|Clinical Deterioration|0|||
149134743|NCT01601847|537974745|FG001|Overall Study|Death|0|||
149134744|NCT01601847|537974744|FG000|Overall Study|Withdrawal by Subject|11|||
149134745|NCT01601847|537974745|FG001|Overall Study|Withdrawal by Subject|7|||
149134746|NCT01601847|537974744|FG000|Overall Study|Lost to Follow-up|1|||
148794063|NCT03560869|536723506|FG001|Overall Study|Withdrawal by Subject|4|||
148794064|NCT03560869|536723505|FG000|Overall Study|Screening failure|4|||
148894549|NCT04158583|537092032|FG007|Overall Study|Clinical Deterioration|0|||
149134747|NCT01601847|537974745|FG001|Overall Study|Lost to Follow-up|3|||
149134748|NCT01284062|537974746|FG000|Overall Study|Adverse Event|4|||
148794065|NCT03560869|536723506|FG001|Overall Study|Screening failure|4|||
149134749|NCT01284062|537974747|FG001|Overall Study|Adverse Event|5|||
149134750|NCT01284062|537974748|FG002|Overall Study|Adverse Event|0|||
149236155|NCT02268214|538334280|FG002|Overall Study|Pregnancy|1|||
149236156|NCT02268214|538334278|FG000|Overall Study|Lost to Follow-up|3|||
149236157|NCT02268214|538334279|FG001|Overall Study|Lost to Follow-up|3|||
149236158|NCT02268214|538334280|FG002|Overall Study|Lost to Follow-up|4|||
149236159|NCT02268214|538334278|FG000|Overall Study|Lack of Efficacy|1|||
149236160|NCT02268214|538334279|FG001|Overall Study|Lack of Efficacy|0|||
149236161|NCT02268214|538334280|FG002|Overall Study|Lack of Efficacy|2|||
149236162|NCT02268214|538334278|FG000|Overall Study|Adverse Event|11|||
149236163|NCT02268214|538334279|FG001|Overall Study|Adverse Event|14|||
149236164|NCT02268214|538334280|FG002|Overall Study|Adverse Event|9|||
149236165|NCT02268214|538334278|FG000|Overall Study|Withdrawal by Subject|4|||
149236166|NCT02268214|538334279|FG001|Overall Study|Withdrawal by Subject|5|||
149236167|NCT02268214|538334280|FG002|Overall Study|Withdrawal by Subject|10|||
149236168|NCT02268214|538334278|FG000|Overall Study|Subject request to discontinue treatment|10|||
149236169|NCT02268214|538334279|FG001|Overall Study|Subject request to discontinue treatment|8|||
149236170|NCT02268214|538334280|FG002|Overall Study|Subject request to discontinue treatment|6|||
149236171|NCT02268214|538334278|FG000|Overall Study|Poor/non-compliance|2|||
149236172|NCT02268214|538334279|FG001|Overall Study|Poor/non-compliance|1|||
149236173|NCT02268214|538334280|FG002|Overall Study|Poor/non-compliance|2|||
149236174|NCT02268214|538334278|FG000|Overall Study|Other reasons|7|||
149236175|NCT02268214|538334279|FG001|Overall Study|Other reasons|3|||
149236176|NCT02268214|538334280|FG002|Overall Study|Other reasons|3|||
149236177|NCT02268214|538334278|FG000|Overall Study|Not entering long-term period|2|||
149236178|NCT02268214|538334279|FG001|Overall Study|Not entering long-term period|3|||
148794066|NCT03560869|536723505|FG000|Overall Study|Withdrawal by PI|0|||
148794067|NCT03560869|536723506|FG001|Overall Study|Withdrawal by PI|1|||
148794068|NCT01801111|536723507|FG000|Overall Study|Adverse Event|12|||
148794069|NCT01801111|536723507|FG000|Overall Study|Death|8|||
148794070|NCT01801111|536723507|FG000|Overall Study|Physician Decision|5|||
148794071|NCT01801111|536723507|FG000|Overall Study|Other|1|||
148794072|NCT01801111|536723507|FG000|Overall Study|Withdrawal by Subject|4|||
148794073|NCT01801111|536723507|FG000|Overall Study|Study Terminated by Sponsor|27|||
148794074|NCT01801111|536723507|FG000|Overall Study|Progressive Disease|81|||
148794075|NCT01210482|536723508|FG000|Overall Study|Protocol Violation|1|||
148794076|NCT01210482|536723508|FG000|Overall Study|Case Report Forms were not collected|18|||
148794077|NCT01210482|536723508|FG000|Overall Study|Duplicated|2|||
148794078|NCT01210482|536723508|FG000|Overall Study|No Drug Administration|28|||
148794079|NCT01223937|536723509|FG000|Overall Study|Withdrawal by Subject|3|||
149134751|NCT01284062|537974749|FG003|Overall Study|Adverse Event|5|||
149134752|NCT01284062|537974746|FG000|Overall Study|Lack of Efficacy|3|||
149134753|NCT01284062|537974747|FG001|Overall Study|Lack of Efficacy|2|||
149134754|NCT01284062|537974748|FG002|Overall Study|Lack of Efficacy|2|||
149134755|NCT01284062|537974749|FG003|Overall Study|Lack of Efficacy|1|||
149134756|NCT01284062|537974746|FG000|Overall Study|Medication error without adverse event|0|||
149134757|NCT01284062|537974747|FG001|Overall Study|Medication error without adverse event|0|||
149134758|NCT01284062|537974748|FG002|Overall Study|Medication error without adverse event|1|||
149134759|NCT01284062|537974749|FG003|Overall Study|Medication error without adverse event|0|||
149134760|NCT01284062|537974746|FG000|Overall Study|Protocol Violation|1|||
149134761|NCT01284062|537974747|FG001|Overall Study|Protocol Violation|0|||
149134762|NCT01284062|537974748|FG002|Overall Study|Protocol Violation|0|||
149134763|NCT01284062|537974749|FG003|Overall Study|Protocol Violation|2|||
149134764|NCT01284062|537974746|FG000|Overall Study|Withdrawal by Subject|3|||
149134765|NCT01284062|537974747|FG001|Overall Study|Withdrawal by Subject|1|||
149134766|NCT01284062|537974748|FG002|Overall Study|Withdrawal by Subject|2|||
149134767|NCT01284062|537974749|FG003|Overall Study|Withdrawal by Subject|5|||
149134768|NCT01284062|537974746|FG000|Overall Study|Other|0|||
149134769|NCT01284062|537974747|FG001|Overall Study|Other|0|||
149134770|NCT01284062|537974748|FG002|Overall Study|Other|0|||
149134771|NCT01284062|537974749|FG003|Overall Study|Other|1|||
149134772|NCT01284062|537974746|FG000|Overall Study|Site Closed|0|||
149134773|NCT01284062|537974747|FG001|Overall Study|Site Closed|0|||
149134774|NCT01284062|537974748|FG002|Overall Study|Site Closed|1|||
149134775|NCT01284062|537974749|FG003|Overall Study|Site Closed|0|||
149134776|NCT01603082|537974755|FG000|Overall Study|Adverse Event|0|||
149134777|NCT01603082|537974756|FG001|Overall Study|Adverse Event|1|||
149134778|NCT01603082|537974755|FG000|Overall Study|Withdrawal by Subject|1|||
149134779|NCT01603082|537974756|FG001|Overall Study|Withdrawal by Subject|0|||
149236179|NCT02268214|538334280|FG002|Overall Study|Not entering long-term period|5|||
149236180|NCT04584294|538334283|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
149236181|NCT04584294|538334284|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
149236182|NCT04584294|538334283|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
149236183|NCT04584294|538334284|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
148794080|NCT01223937|536723510|FG001|Overall Study|Withdrawal by Subject|2|||
149134780|NCT01603082|537974755|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
149134781|NCT01603082|537974756|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
149134782|NCT00634010|537974762|FG000|Overall Study|Adverse Event|2|||
148794081|NCT01223937|536723509|FG000|Overall Study|Lost to Follow-up|1|||
148794082|NCT01223937|536723510|FG001|Overall Study|Lost to Follow-up|4|||
148794083|NCT01223937|536723509|FG000|Overall Study|Adverse Event|1|||
148794084|NCT01223937|536723510|FG001|Overall Study|Adverse Event|4|||
148794085|NCT01223937|536723509|FG000|Overall Study|Protocol Violation|8|||
148794086|NCT01223937|536723510|FG001|Overall Study|Protocol Violation|7|||
148794087|NCT01223937|536723509|FG000|Overall Study|Other|4|||
148794088|NCT01223937|536723510|FG001|Overall Study|Other|1|||
148794089|NCT03284853|536723511|FG000|Overall Study|Adverse Event|40|||
148794090|NCT03284853|536723512|FG001|Overall Study|Adverse Event|4|||
148794091|NCT03284853|536723511|FG000|Overall Study|Withdrawal by Subject|5|||
148794092|NCT03284853|536723512|FG001|Overall Study|Withdrawal by Subject|1|||
149011436|NCT02778399|537521470|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
149134783|NCT00634010|537974763|FG001|Overall Study|Adverse Event|5|||
149134784|NCT00634010|537974762|FG000|Overall Study|Withdrawal by Subject|5|||
149134785|NCT00634010|537974763|FG001|Overall Study|Withdrawal by Subject|6|||
149134786|NCT00634010|537974762|FG000|Overall Study|Physician Decision|1|||
149134787|NCT00634010|537974763|FG001|Overall Study|Physician Decision|1|||
149134788|NCT00634010|537974762|FG000|Overall Study|Disease Progression|1|||
149134789|NCT00634010|537974763|FG001|Overall Study|Disease Progression|1|||
149134790|NCT00634010|537974762|FG000|Overall Study|Non-Compliant|1|||
149134791|NCT00634010|537974763|FG001|Overall Study|Non-Compliant|1|||
149134792|NCT01026142|537974764|FG000|Overall Study|Death|136|||
149134793|NCT01026142|537974765|FG001|Overall Study|Death|134|||
149134794|NCT01026142|537974764|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
149134795|NCT01026142|537974765|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
149134796|NCT01862640|537974769|FG000|Overall Study|Adverse Event|4|||
149134797|NCT01862640|537974770|FG001|Overall Study|Adverse Event|10|||
149134798|NCT01862640|537974771|FG002|Overall Study|Adverse Event|6|||
149134799|NCT01862640|537974772|FG003|Overall Study|Adverse Event|8|||
149134800|NCT01862640|537974769|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
149134801|NCT01862640|537974770|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
149134802|NCT01862640|537974771|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
149134803|NCT01862640|537974772|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
149134804|NCT01862640|537974769|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
149134805|NCT01862640|537974770|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
149134806|NCT01862640|537974771|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
149134807|NCT01862640|537974772|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
149134808|NCT01862640|537974769|FG000|Overall Study|Withdrawal by Subject|2|||
149134809|NCT01862640|537974770|FG001|Overall Study|Withdrawal by Subject|4|||
149134810|NCT01862640|537974771|FG002|Overall Study|Withdrawal by Subject|8|||
149134811|NCT01862640|537974772|FG003|Overall Study|Withdrawal by Subject|5|||
149134812|NCT01862640|537974769|FG000|Overall Study|Protocol Deviation|0|||
149134813|NCT01862640|537974770|FG001|Overall Study|Protocol Deviation|0|||
149134814|NCT01862640|537974771|FG002|Overall Study|Protocol Deviation|1|||
149134815|NCT01862640|537974772|FG003|Overall Study|Protocol Deviation|0|||
149134816|NCT01019317|537974773|FG000|Overall Study|Not Eligible|4|||
149134817|NCT02178553|537974774|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
149134818|NCT02178553|537974775|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
149134819|NCT02178553|537974774|FG000|Overall Study|Physician Decision|0|||
149134820|NCT02178553|537974775|FG001|Overall Study|Physician Decision|4|||
149134821|NCT02178553|537974774|FG000|Overall Study|Technical problem with injection|1|||
149134822|NCT02178553|537974775|FG001|Overall Study|Technical problem with injection|3|||
149134823|NCT05085665|537974776|FG000|Overall Study|Physician Decision|2|||
149134824|NCT01641809|537974778|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
149134825|NCT01641809|537974779|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
149134826|NCT01641809|537974780|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
149134827|NCT01641809|537974781|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
149134828|NCT01641809|537974778|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
149134829|NCT01641809|537974779|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
149134830|NCT01641809|537974780|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
149134831|NCT01641809|537974781|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
149134832|NCT01641809|537974778|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
149134833|NCT01641809|537974779|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
149134834|NCT01641809|537974780|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
149134835|NCT01641809|537974781|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
149134836|NCT01641809|537974778|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
149134837|NCT01641809|537974779|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
149134838|NCT01641809|537974780|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
149134839|NCT01641809|537974781|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
149134840|NCT01641809|537974778|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
149233845|NCT02161380|538324931|FG002|Overall Study|Lost to Follow-up|0|||
148794093|NCT03284853|536723511|FG000|Overall Study|Lost to Follow-up|1|||
148794094|NCT03284853|536723512|FG001|Overall Study|Lost to Follow-up|0|||
148794095|NCT03284853|536723511|FG000|Overall Study|Lack of Efficacy|1|||
149236184|NCT04584294|538334283|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
149236185|NCT04584294|538334284|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
149236186|NCT04584294|538334283|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
149236187|NCT04584294|538334284|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
149236188|NCT04584294|538334283|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
149236189|NCT04584294|538334284|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
149236190|NCT04584294|538334283|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
149236191|NCT04584294|538334284|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
149236192|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
149236193|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
149236194|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
149236195|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149236196|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149236197|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149236198|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
149236199|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149236200|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149236201|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
149236202|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149236203|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149236204|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149236205|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
149236206|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
149236207|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
148794096|NCT03284853|536723512|FG001|Overall Study|Lack of Efficacy|0|||
148794097|NCT03284853|536723511|FG000|Overall Study|Disallowed Concurrent Medication|1|||
148894550|NCT04158583|537092033|FG008|Overall Study|Clinical Deterioration|0|||
148894551|NCT04158583|537092034|FG009|Overall Study|Clinical Deterioration|1|||
148894552|NCT00740220|537093934|FG000|Overall Study|screen failures (non-COPD patients)|9|||
149236208|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
148794098|NCT03284853|536723512|FG001|Overall Study|Disallowed Concurrent Medication|1|||
148794099|NCT03284853|536723511|FG000|Overall Study|Protocol Violation|3|||
148794100|NCT03284853|536723512|FG001|Overall Study|Protocol Violation|3|||
148794101|NCT03284853|536723511|FG000|Overall Study|Death|0|||
148794102|NCT03284853|536723512|FG001|Overall Study|Death|1|||
148794103|NCT03284853|536723511|FG000|Overall Study|Other - Reason not reported in CSR|4|||
148794104|NCT03284853|536723512|FG001|Overall Study|Other - Reason not reported in CSR|3|||
148794105|NCT05176717|536723513|FG000|Overall Study|Sponsor Decision|1|||
148794106|NCT05176717|536723514|FG001|Overall Study|Sponsor Decision|2|||
148794107|NCT05176717|536723515|FG002|Overall Study|Sponsor Decision|2|||
148794108|NCT00765817|536723517|FG000|Overall Study|Adverse Event|13|||
148794109|NCT00765817|536723518|FG001|Overall Study|Adverse Event|1|||
148794110|NCT00765817|536723517|FG000|Overall Study|Death|0|||
148794111|NCT00765817|536723518|FG001|Overall Study|Death|1|||
148794112|NCT00765817|536723517|FG000|Overall Study|Entry criteria not met|2|||
148794113|NCT00765817|536723518|FG001|Overall Study|Entry criteria not met|2|||
148794114|NCT00765817|536723517|FG000|Overall Study|Loss of glucose control|0|||
148794115|NCT00765817|536723518|FG001|Overall Study|Loss of glucose control|2|||
148794116|NCT00765817|536723517|FG000|Overall Study|Lost to Follow-up|1|||
148794117|NCT00765817|536723518|FG001|Overall Study|Lost to Follow-up|3|||
148794118|NCT00765817|536723517|FG000|Overall Study|Physician Decision|2|||
148794119|NCT00765817|536723518|FG001|Overall Study|Physician Decision|1|||
148794120|NCT00765817|536723517|FG000|Overall Study|Protocol Violation|1|||
148794121|NCT00765817|536723518|FG001|Overall Study|Protocol Violation|1|||
148794122|NCT00765817|536723517|FG000|Overall Study|Subject decision|7|||
148794123|NCT00765817|536723518|FG001|Overall Study|Subject decision|11|||
148794124|NCT02143024|536723519|FG000|Overall Study|Lost to Follow-up|1|||
148794125|NCT02143024|536723520|FG001|Overall Study|Lost to Follow-up|1|||
148794126|NCT02143024|536723519|FG000|Overall Study|Withdrawal by Subject|1|||
148794127|NCT02143024|536723520|FG001|Overall Study|Withdrawal by Subject|0|||
148794128|NCT06597084|536723521|FG000|Overall Study|Withdrawal by Subject|4|||
148794129|NCT06597084|536723522|FG001|Overall Study|Withdrawal by Subject|9|||
148794130|NCT06597084|536723521|FG000|Overall Study|Consent was not given by the patient until V2|0|||
148794131|NCT06597084|536723522|FG001|Overall Study|Consent was not given by the patient until V2|3|||
148794132|NCT06597084|536723521|FG000|Overall Study|Physician Decision|1|||
148794133|NCT06597084|536723522|FG001|Overall Study|Physician Decision|0|||
148794134|NCT06597084|536723521|FG000|Overall Study|Adverse Event|3|||
148794135|NCT06597084|536723522|FG001|Overall Study|Adverse Event|2|||
148794136|NCT06597084|536723521|FG000|Overall Study|Death|4|||
148794137|NCT06597084|536723522|FG001|Overall Study|Death|0|||
148794138|NCT06597084|536723521|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
148794139|NCT06597084|536723522|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
148794140|NCT06597084|536723521|FG000|Overall Study|Lost to Follow-up|4|||
149236209|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149236210|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149236211|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149236212|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
149236213|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
149236214|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149236215|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
149236216|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149236217|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149236218|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149236219|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
149236220|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
149236221|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
149236222|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
149236223|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149236224|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149236225|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149236226|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
149236227|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149236228|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149236229|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
149236230|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149236231|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149236232|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149236233|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
149236234|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149236235|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149236236|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
149236237|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149236238|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149236239|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149236240|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
149236241|NCT04242498|538334287|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149236242|NCT04242498|538334288|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
149236243|NCT04242498|538334289|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
149236244|NCT04242498|538334290|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149236245|NCT04242498|538334291|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149236246|NCT04242498|538334292|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149236247|NCT04242498|538334293|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
149236248|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
148794141|NCT06597084|536723522|FG001|Overall Study|Lost to Follow-up|2|||
148794142|NCT06597084|536723521|FG000|Overall Study|Other. Not specified|1|||
148794143|NCT06597084|536723522|FG001|Overall Study|Other. Not specified|0|||
148794144|NCT03999749|536723531|FG000|Overall Study|Toxicity|16|||
148794145|NCT03999749|536723531|FG000|Overall Study|Withdrawal by Subject|3|||
148794146|NCT03999749|536723531|FG000|Overall Study|Disease progression|26|||
148794147|NCT03999749|536723531|FG000|Overall Study|Physician Decision|4|||
148794148|NCT03999749|536723531|FG000|Overall Study|Death|5|||
148794149|NCT03999749|536723531|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
148794150|NCT00255164|536723532|FG000|Overall Study|Adverse Event|10|||
148794151|NCT00255164|536723533|FG001|Overall Study|Adverse Event|6|||
148794152|NCT00255164|536723534|FG002|Overall Study|Adverse Event|9|||
148794153|NCT00255164|536723532|FG000|Overall Study|Lost to Follow-up|4|||
148794154|NCT00255164|536723533|FG001|Overall Study|Lost to Follow-up|3|||
148794155|NCT00255164|536723534|FG002|Overall Study|Lost to Follow-up|4|||
148794156|NCT00255164|536723532|FG000|Overall Study|Withdrawal by Subject|18|||
148794157|NCT00255164|536723533|FG001|Overall Study|Withdrawal by Subject|17|||
148794158|NCT00255164|536723534|FG002|Overall Study|Withdrawal by Subject|8|||
148894553|NCT01602224|537093935|FG000|Overall Study|Adverse Event|0|||
148794159|NCT00255164|536723532|FG000|Overall Study|Noncompliance|0|||
148794160|NCT00255164|536723533|FG001|Overall Study|Noncompliance|1|||
148794161|NCT00255164|536723534|FG002|Overall Study|Noncompliance|2|||
148794162|NCT00255164|536723532|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
148794163|NCT00255164|536723533|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
149236249|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149236250|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149236251|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
149236252|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
148794164|NCT00255164|536723534|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
148794165|NCT00255164|536723532|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
148794166|NCT00255164|536723533|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
148794167|NCT00255164|536723534|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
148794168|NCT00255164|536723532|FG000|Overall Study|Possible Barrett's Esophagus|1|||
148794169|NCT00255164|536723533|FG001|Overall Study|Possible Barrett's Esophagus|3|||
148794170|NCT00255164|536723534|FG002|Overall Study|Possible Barrett's Esophagus|8|||
148794171|NCT00255164|536723532|FG000|Overall Study|Esophageal Stricture|0|||
148794172|NCT00255164|536723533|FG001|Overall Study|Esophageal Stricture|0|||
148794173|NCT00255164|536723534|FG002|Overall Study|Esophageal Stricture|1|||
148794174|NCT00255164|536723532|FG000|Overall Study|Therapeutic Failure|11|||
148794175|NCT00255164|536723533|FG001|Overall Study|Therapeutic Failure|2|||
148794176|NCT00255164|536723534|FG002|Overall Study|Therapeutic Failure|3|||
148794177|NCT03677869|536723535|FG000|Overall Study|Withdrawal by Subject|1|||
148794178|NCT03334188|536725593|FG000|Overall Study|Withdrawal by Subject|0|||
148794179|NCT03334188|536725594|FG001|Overall Study|Withdrawal by Subject|1|||
148794180|NCT03334188|536725593|FG000|Overall Study|Death|1|||
148794181|NCT03334188|536725594|FG001|Overall Study|Death|0|||
148794182|NCT03334188|536725593|FG000|Overall Study|Never had qualifying clinic visit|7|||
148794183|NCT03334188|536725594|FG001|Overall Study|Never had qualifying clinic visit|7|||
148794184|NCT03442088|536725601|FG000|Overall Study|Adverse Event|1|||
148794185|NCT03442088|536725601|FG000|Overall Study|Lack of Efficacy|2|||
148794186|NCT03442088|536725601|FG000|Overall Study|Lost to Follow-up|2|||
148794187|NCT01001520|536725602|FG000|Medication Period 1|Withdrawal by Subject|2|||
148794188|NCT01001520|536725603|FG001|Medication Period 1|Withdrawal by Subject|2|||
148794189|NCT01001520|536725602|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
148794190|NCT01001520|536725603|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
148794191|NCT01001520|536725602|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
148794192|NCT01001520|536725603|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
148794193|NCT01001520|536725602|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
148794194|NCT01001520|536725603|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
148794195|NCT01001520|536725602|FG000|Washout Period|Withdrawal by Subject|2|||
148794196|NCT01001520|536725603|FG001|Washout Period|Withdrawal by Subject|1|||
148794197|NCT01001520|536725602|FG000|Medication Period 2|Withdrawal by Subject|0|||
148794198|NCT01001520|536725603|FG001|Medication Period 2|Withdrawal by Subject|3|||
148794199|NCT04668209|536725606|FG000|Overall Study|Withdrawal by Subject|2|||
148794200|NCT04668209|536725607|FG001|Overall Study|Withdrawal by Subject|2|||
148794201|NCT04668209|536725606|FG000|Overall Study|Lost to Follow-up|3|||
148794202|NCT04668209|536725607|FG001|Overall Study|Lost to Follow-up|4|||
148794203|NCT04668209|536725606|FG000|Overall Study|Subject Expired|2|||
148794204|NCT04668209|536725607|FG001|Overall Study|Subject Expired|0|||
148794205|NCT04668209|536725606|FG000|Overall Study|Withdrawn from study|0|||
148794206|NCT04668209|536725607|FG001|Overall Study|Withdrawn from study|1|||
148794207|NCT04668209|536725606|FG000|Overall Study|Adverse Event|0|||
148794208|NCT04668209|536725607|FG001|Overall Study|Adverse Event|1|||
148794209|NCT00130689|536725617|FG000|Overall Study|Progressive Disease|29|||
148794210|NCT00130689|536725617|FG000|Overall Study|Death|1|||
148794211|NCT00130689|536725617|FG000|Overall Study|Clinical Deterioration|4|||
148794212|NCT00130689|536725617|FG000|Overall Study|Withdrawal by Subject|3|||
148794213|NCT00130689|536725617|FG000|Overall Study|Ineligible|6|||
148794214|NCT00766597|536725618|FG000|Overall Study|Unexpected closure of study|4|||
148794215|NCT00766597|536725618|FG000|Overall Study|Without CCR5-tropic virus|5|||
148794216|NCT00943397|536725619|FG000|Overall Study|Adverse Event|0|||
148794217|NCT00943397|536725620|FG001|Overall Study|Adverse Event|6|||
148794218|NCT00943397|536725619|FG000|Overall Study|Lost to Follow-up|0|||
148794219|NCT00943397|536725620|FG001|Overall Study|Lost to Follow-up|4|||
148794220|NCT00943397|536725619|FG000|Overall Study|Protocol Violation|2|||
148794221|NCT00943397|536725620|FG001|Overall Study|Protocol Violation|5|||
148794222|NCT00943397|536725619|FG000|Overall Study|Withdrawal by Subject|1|||
148894554|NCT01602224|537093936|FG001|Overall Study|Adverse Event|1|||
148794223|NCT00943397|536725620|FG001|Overall Study|Withdrawal by Subject|1|||
149236253|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
149236254|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
148794224|NCT00943397|536725619|FG000|Overall Study|Site terminated and other|12|||
148794225|NCT00943397|536725620|FG001|Overall Study|Site terminated and other|56|||
148794226|NCT01254656|536725621|FG000|Overall Study|Discontinued due to termination of study|40|||
148794227|NCT01254656|536725622|FG001|Overall Study|Discontinued due to termination of study|39|||
148794228|NCT01254656|536725623|FG002|Overall Study|Discontinued due to termination of study|13|||
148794229|NCT01254656|536725621|FG000|Overall Study|Lack of Efficacy|3|||
148894555|NCT01602224|537093937|FG002|Overall Study|Adverse Event|0|||
149134841|NCT01641809|537974779|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
149134842|NCT01641809|537974780|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
149134843|NCT01641809|537974781|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
149134844|NCT01641809|537974778|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
149134845|NCT01641809|537974779|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
149134846|NCT01641809|537974780|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
149134847|NCT01641809|537974781|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
149134848|NCT01641809|537974778|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
149134849|NCT01641809|537974779|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
149134850|NCT01641809|537974780|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
149134851|NCT01641809|537974781|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
148794230|NCT01254656|536725622|FG001|Overall Study|Lack of Efficacy|0|||
148794231|NCT01254656|536725623|FG002|Overall Study|Lack of Efficacy|0|||
148794232|NCT01254656|536725621|FG000|Overall Study|Lost to Follow-up|1|||
148794233|NCT01254656|536725622|FG001|Overall Study|Lost to Follow-up|0|||
148794234|NCT01254656|536725623|FG002|Overall Study|Lost to Follow-up|2|||
148794235|NCT01254656|536725621|FG000|Overall Study|Withdrawal by Subject|2|||
149134852|NCT01641809|537974778|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
149134853|NCT01641809|537974779|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
149134854|NCT01641809|537974780|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
149134855|NCT01641809|537974781|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
149134856|NCT01641809|537974778|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
149134857|NCT01641809|537974779|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
149134858|NCT01641809|537974780|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
149134859|NCT01641809|537974781|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
149134860|NCT01641809|537974778|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
149134861|NCT01641809|537974779|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
149134862|NCT01641809|537974780|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
149134863|NCT01641809|537974781|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
149134864|NCT01641809|537974778|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
149134865|NCT01641809|537974779|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
149134866|NCT01641809|537974780|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
149134867|NCT01641809|537974781|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
149134868|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
149134869|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
149134870|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
149134871|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
149134872|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
149134873|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
149134874|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
149134875|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
149134876|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
149134877|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
149134878|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
149134879|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
149134880|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
149134881|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
149134882|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
149134883|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
149134884|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
149134885|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
149134886|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
149134887|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
149134888|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
149134889|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
148794236|NCT01254656|536725622|FG001|Overall Study|Withdrawal by Subject|2|||
148794237|NCT01254656|536725623|FG002|Overall Study|Withdrawal by Subject|1|||
148794238|NCT01254656|536725621|FG000|Overall Study|Pregnancy|0|||
148794239|NCT01254656|536725622|FG001|Overall Study|Pregnancy|0|||
148794240|NCT01254656|536725623|FG002|Overall Study|Pregnancy|2|||
148794241|NCT01254656|536725621|FG000|Overall Study|Adverse Event|1|||
148794242|NCT01254656|536725622|FG001|Overall Study|Adverse Event|1|||
148794243|NCT01254656|536725623|FG002|Overall Study|Adverse Event|0|||
148794244|NCT01254656|536725621|FG000|Overall Study|Death|0|||
148794245|NCT01254656|536725622|FG001|Overall Study|Death|1|||
148794246|NCT01254656|536725623|FG002|Overall Study|Death|0|||
148794247|NCT01178125|536725624|FG000|Overall Study|Lost to Follow-up|397|||
148794248|NCT01178125|536725624|FG000|Overall Study|Adverse Event|244|||
148794249|NCT01178125|536725624|FG000|Overall Study|Withdrawal by Subject|209|||
148794250|NCT01178125|536725624|FG000|Overall Study|Noncompliance|184|||
148794251|NCT01178125|536725624|FG000|Overall Study|Pregnancy|55|||
148794252|NCT01178125|536725624|FG000|Overall Study|Other Reason|39|||
148794253|NCT01178125|536725624|FG000|Overall Study|Sponsor Decision|28|||
148794254|NCT01178125|536725624|FG000|Overall Study|Protocol Violation|17|||
148794255|NCT01178125|536725624|FG000|Overall Study|Investigator Decision|5|||
148794256|NCT02948829|536725625|FG000|Overall Study|Lost to Follow-up|2|||
148794257|NCT02948829|536725625|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
148794258|NCT02948829|536725625|FG000|Overall Study|Pregnancy|1|||
148794259|NCT02948829|536725625|FG000|Overall Study|Other: Reason not Specified|8|||
148794260|NCT01004978|536725626|FG000|Overall Study|Disease progression|31|||
148794261|NCT01004978|536725627|FG001|Overall Study|Disease progression|48|||
148794262|NCT01004978|536725626|FG000|Overall Study|Adverse Event|42|||
148794263|NCT01004978|536725627|FG001|Overall Study|Adverse Event|22|||
148794264|NCT01004978|536725626|FG000|Overall Study|Death|3|||
148794265|NCT01004978|536725627|FG001|Overall Study|Death|2|||
148794266|NCT01004978|536725626|FG000|Overall Study|Withdrawal by Subject|16|||
148794267|NCT01004978|536725627|FG001|Overall Study|Withdrawal by Subject|16|||
148794268|NCT01004978|536725626|FG000|Overall Study|Alternative therapy|4|||
148794269|NCT01004978|536725627|FG001|Overall Study|Alternative therapy|8|||
149236255|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149236256|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149236257|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149236258|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
149236259|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
149236260|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
149236261|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
148794270|NCT01004978|536725626|FG000|Overall Study|Physician Decision|6|||
148794271|NCT01004978|536725627|FG001|Overall Study|Physician Decision|3|||
149236262|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
148794272|NCT01004978|536725626|FG000|Overall Study|Other complicating disease|2|||
148794273|NCT01004978|536725627|FG001|Overall Study|Other complicating disease|2|||
148794274|NCT01004978|536725626|FG000|Overall Study|Protocol Violation|2|||
148794275|NCT01004978|536725627|FG001|Overall Study|Protocol Violation|3|||
149236263|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149236264|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
148794276|NCT01004978|536725626|FG000|Overall Study|Non-compliance|3|||
148794277|NCT01004978|536725627|FG001|Overall Study|Non-compliance|2|||
148794278|NCT01004978|536725626|FG000|Overall Study|Ineligible|1|||
148794279|NCT01004978|536725627|FG001|Overall Study|Ineligible|0|||
148794280|NCT01004978|536725626|FG000|Overall Study|Unblinded|0|||
148794281|NCT01004978|536725627|FG001|Overall Study|Unblinded|1|||
148794282|NCT01004978|536725626|FG000|Overall Study|Performance status worsening|0|||
148794283|NCT01004978|536725627|FG001|Overall Study|Performance status worsening|1|||
149236265|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149236266|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
149236267|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
149236268|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
149236269|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149236270|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149236271|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
149236272|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
149236273|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
149236274|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
149236275|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
149236276|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149236277|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149236278|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
149236279|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
148794284|NCT01004978|536725626|FG000|Overall Study|Never started treatment|8|||
148794285|NCT01004978|536725627|FG001|Overall Study|Never started treatment|9|||
148794286|NCT00369915|536725628|FG000|Overall Study|expected side effects|2|||
148794287|NCT00369915|536725629|FG001|Overall Study|expected side effects|1|||
148794288|NCT00369915|536725628|FG000|Overall Study|Withdrawal by Subject|4|||
148794289|NCT00369915|536725629|FG001|Overall Study|Withdrawal by Subject|1|||
148794290|NCT00369915|536725628|FG000|Overall Study|W/drawl by investigators|0|||
148894556|NCT01602224|537093935|FG000|Overall Study|Investigator Decison|1|||
148794291|NCT00369915|536725629|FG001|Overall Study|W/drawl by investigators|1|||
148794292|NCT01447407|536725652|FG000|Overall Study|Withdrawal by Subject|2|||
148794293|NCT01447407|536725653|FG001|Overall Study|Withdrawal by Subject|0|||
148794294|NCT01447407|536725654|FG002|Overall Study|Withdrawal by Subject|0|||
148794295|NCT01447407|536725655|FG003|Overall Study|Withdrawal by Subject|1|||
149236280|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
149236281|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
149236282|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
149236283|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149236284|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149236285|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149236286|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149236287|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
149236288|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149236289|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
149236290|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149236291|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149236292|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149236293|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149236294|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149236295|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
149236296|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
149236297|NCT04242498|538334287|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149236298|NCT04242498|538334288|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149236299|NCT04242498|538334289|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149236300|NCT04242498|538334290|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149236301|NCT04242498|538334291|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
149236302|NCT04242498|538334292|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
149236303|NCT04242498|538334293|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
149236304|NCT01003691|538334294|FG000|Overall Study|Adverse Event|0|||
149236305|NCT01003691|538334295|FG001|Overall Study|Adverse Event|0|||
149236306|NCT01003691|538334296|FG002|Overall Study|Adverse Event|0|||
149236307|NCT01003691|538334297|FG003|Overall Study|Adverse Event|1|||
149236308|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
149236309|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
149236310|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
149236311|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
149236312|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
149236313|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
149236314|NCT00828009|538334307|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
149236315|NCT00828009|538334307|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
149236316|NCT00828009|538334307|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
149236317|NCT00828009|538334307|FG000|Step 2 - Maintenance Therapy|Death|1|||
149236318|NCT00828009|538334307|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
149236319|NCT00828009|538334307|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
149236320|NCT00828009|538334307|FG000|Step 2 - Maintenance Therapy|Other|1|||
149236321|NCT04246372|538336610|FG000|Overall Study|Adverse Event|1|||
149236322|NCT04246372|538336610|FG000|Overall Study|Withdrawal by Subject|1|||
149236323|NCT04246372|538336610|FG000|Overall Study|Protocol Violation|2|||
149236324|NCT04246372|538336610|FG000|Overall Study|Physician Decision|1|||
149236325|NCT04145349|538336611|FG000|Overall Study|Withdrawal by Subject|3|||
149236326|NCT04145349|538336612|FG001|Overall Study|Withdrawal by Subject|0|||
149236327|NCT04145349|538336611|FG000|Overall Study|Lost to Follow-up|0|||
149236328|NCT04145349|538336612|FG001|Overall Study|Lost to Follow-up|1|||
149236329|NCT04145349|538336611|FG000|Overall Study|On study treatment (Ongoing)|0|||
149236330|NCT04145349|538336612|FG001|Overall Study|On study treatment (Ongoing)|1|||
149236331|NCT02328014|538336614|FG000|Overall Study|Adverse Event|1|||
149236332|NCT02328014|538336615|FG001|Overall Study|Adverse Event|0|||
149236333|NCT02328014|538336616|FG002|Overall Study|Adverse Event|0|||
148794296|NCT01447407|536725652|FG000|Overall Study|Physician Decision|0|||
148794297|NCT01447407|536725653|FG001|Overall Study|Physician Decision|0|||
148794298|NCT01447407|536725654|FG002|Overall Study|Physician Decision|1|||
148794299|NCT01447407|536725655|FG003|Overall Study|Physician Decision|1|||
148794300|NCT00268983|536725658|FG000|Overall Study|Death|3|||
148794301|NCT00268983|536725659|FG001|Overall Study|Death|0|||
148794302|NCT01719380|536725660|FG000|Overall Study|Adverse Event|0|||
148794303|NCT01719380|536725661|FG001|Overall Study|Adverse Event|0|||
148794304|NCT01719380|536725662|FG002|Overall Study|Adverse Event|1|||
148794305|NCT01719380|536725663|FG003|Overall Study|Adverse Event|2|||
148794306|NCT01719380|536725664|FG004|Overall Study|Adverse Event|0|||
148794307|NCT01719380|536725665|FG005|Overall Study|Adverse Event|1|||
148794308|NCT01719380|536725666|FG006|Overall Study|Adverse Event|0|||
148794309|NCT01719380|536725667|FG007|Overall Study|Adverse Event|1|||
148794310|NCT01719380|536725668|FG008|Overall Study|Adverse Event|4|||
148794311|NCT01719380|536725669|FG009|Overall Study|Adverse Event|3|||
148794312|NCT01719380|536725660|FG000|Overall Study|Death|0|||
148794313|NCT01719380|536725661|FG001|Overall Study|Death|1|||
148794314|NCT01719380|536725662|FG002|Overall Study|Death|0|||
148794315|NCT01719380|536725663|FG003|Overall Study|Death|0|||
148794316|NCT01719380|536725664|FG004|Overall Study|Death|0|||
148794317|NCT01719380|536725665|FG005|Overall Study|Death|0|||
148794318|NCT01719380|536725666|FG006|Overall Study|Death|0|||
148794319|NCT01719380|536725667|FG007|Overall Study|Death|0|||
148794320|NCT01719380|536725668|FG008|Overall Study|Death|3|||
148794321|NCT01719380|536725669|FG009|Overall Study|Death|3|||
148794322|NCT01719380|536725660|FG000|Overall Study|Participant/Guardian Decision|0|||
148794323|NCT01719380|536725661|FG001|Overall Study|Participant/Guardian Decision|0|||
148794324|NCT01719380|536725662|FG002|Overall Study|Participant/Guardian Decision|1|||
148794325|NCT01719380|536725663|FG003|Overall Study|Participant/Guardian Decision|0|||
148794326|NCT01719380|536725664|FG004|Overall Study|Participant/Guardian Decision|0|||
148794327|NCT01719380|536725665|FG005|Overall Study|Participant/Guardian Decision|0|||
148794328|NCT01719380|536725666|FG006|Overall Study|Participant/Guardian Decision|0|||
148794329|NCT01719380|536725667|FG007|Overall Study|Participant/Guardian Decision|0|||
148794330|NCT01719380|536725668|FG008|Overall Study|Participant/Guardian Decision|2|||
149134890|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
149134891|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
149134892|NCT01641809|537974778|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
149134893|NCT01641809|537974779|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
149134894|NCT01641809|537974780|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
149134895|NCT01641809|537974781|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
149134896|NCT03294109|537974784|FG000|Overall Study|Withdrawal by Subject|6|||
148794331|NCT01719380|536725669|FG009|Overall Study|Participant/Guardian Decision|2|||
148794332|NCT01719380|536725660|FG000|Overall Study|Physician Decision|0|||
148794333|NCT01719380|536725661|FG001|Overall Study|Physician Decision|0|||
148794334|NCT01719380|536725662|FG002|Overall Study|Physician Decision|2|||
148794335|NCT01719380|536725663|FG003|Overall Study|Physician Decision|0|||
148794336|NCT01719380|536725664|FG004|Overall Study|Physician Decision|0|||
148794337|NCT01719380|536725665|FG005|Overall Study|Physician Decision|0|||
148794338|NCT01719380|536725666|FG006|Overall Study|Physician Decision|0|||
148794339|NCT01719380|536725667|FG007|Overall Study|Physician Decision|0|||
148794340|NCT01719380|536725668|FG008|Overall Study|Physician Decision|1|||
148794341|NCT01719380|536725669|FG009|Overall Study|Physician Decision|1|||
148794342|NCT01719380|536725660|FG000|Overall Study|Lack of Efficacy|2|||
148794343|NCT01719380|536725661|FG001|Overall Study|Lack of Efficacy|6|||
148794344|NCT01719380|536725662|FG002|Overall Study|Lack of Efficacy|5|||
148894557|NCT01602224|537093936|FG001|Overall Study|Investigator Decison|0|||
148894558|NCT01602224|537093937|FG002|Overall Study|Investigator Decison|0|||
148794345|NCT01719380|536725663|FG003|Overall Study|Lack of Efficacy|6|||
148794346|NCT01719380|536725664|FG004|Overall Study|Lack of Efficacy|3|||
148894559|NCT01602224|537093935|FG000|Overall Study|Lost to Follow-up|0|||
148894560|NCT01602224|537093936|FG001|Overall Study|Lost to Follow-up|0|||
148894561|NCT01602224|537093937|FG002|Overall Study|Lost to Follow-up|1|||
149134897|NCT03294109|537974785|FG001|Overall Study|Withdrawal by Subject|5|||
148794347|NCT01719380|536725665|FG005|Overall Study|Lack of Efficacy|7|||
148794348|NCT01719380|536725666|FG006|Overall Study|Lack of Efficacy|10|||
148794349|NCT01719380|536725667|FG007|Overall Study|Lack of Efficacy|6|||
148794350|NCT01719380|536725668|FG008|Overall Study|Lack of Efficacy|39|||
148794351|NCT01719380|536725669|FG009|Overall Study|Lack of Efficacy|42|||
148794352|NCT01719380|536725660|FG000|Overall Study|Progressive Disease|0|||
148794353|NCT01719380|536725661|FG001|Overall Study|Progressive Disease|0|||
148794354|NCT01719380|536725662|FG002|Overall Study|Progressive Disease|0|||
149134898|NCT03690141|537974786|FG000|Overall Study|Adverse Event|5|||
149134899|NCT03690141|537974786|FG000|Overall Study|Withdrawal by Subject|3|||
149134900|NCT03690141|537974786|FG000|Overall Study|Physician Decision|4|||
148794355|NCT01719380|536725663|FG003|Overall Study|Progressive Disease|0|||
148794356|NCT01719380|536725664|FG004|Overall Study|Progressive Disease|0|||
148794357|NCT01719380|536725665|FG005|Overall Study|Progressive Disease|0|||
148894562|NCT01602224|537093935|FG000|Overall Study|Protocol Violation|0|||
149134901|NCT03690141|537974786|FG000|Overall Study|Disease progression|4|||
149134902|NCT04744285|537974787|FG000|Overall Study|Withdrawal by Subject|1|||
148794358|NCT01719380|536725666|FG006|Overall Study|Progressive Disease|0|||
148794359|NCT01719380|536725667|FG007|Overall Study|Progressive Disease|0|||
148794360|NCT01719380|536725668|FG008|Overall Study|Progressive Disease|1|||
148794361|NCT01719380|536725669|FG009|Overall Study|Progressive Disease|0|||
148794362|NCT01064414|536725672|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
148794363|NCT01064414|536725673|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
148794364|NCT01064414|536725674|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
148794365|NCT01064414|536725672|FG000|Core Period: Baseline to Week 26|Death|0|||
148794366|NCT01064414|536725673|FG001|Core Period: Baseline to Week 26|Death|1|||
148794367|NCT01064414|536725674|FG002|Core Period: Baseline to Week 26|Death|0|||
148794368|NCT01064414|536725672|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
148794369|NCT01064414|536725673|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
148794370|NCT01064414|536725674|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
148794371|NCT01064414|536725672|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
148794372|NCT01064414|536725673|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
148894563|NCT01602224|537093936|FG001|Overall Study|Protocol Violation|1|||
148894564|NCT01602224|537093937|FG002|Overall Study|Protocol Violation|0|||
148894565|NCT01602224|537093935|FG000|Overall Study|Sponsor Decision|2|||
148894566|NCT01602224|537093936|FG001|Overall Study|Sponsor Decision|3|||
148894567|NCT01602224|537093937|FG002|Overall Study|Sponsor Decision|2|||
148894568|NCT01602224|537093935|FG000|Overall Study|Withdrawal by Subject|5|||
148894569|NCT01602224|537093936|FG001|Overall Study|Withdrawal by Subject|3|||
148894570|NCT01602224|537093937|FG002|Overall Study|Withdrawal by Subject|3|||
148894571|NCT00633477|537093938|FG000|Overall Study|Death|1|||
148794373|NCT01064414|536725674|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
148794374|NCT01064414|536725672|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148794375|NCT01064414|536725673|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
148794376|NCT01064414|536725674|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148794377|NCT01064414|536725672|FG000|Core Period: Baseline to Week 26|Other|4|||
148794378|NCT01064414|536725673|FG001|Core Period: Baseline to Week 26|Other|7|||
148794379|NCT01064414|536725674|FG002|Core Period: Baseline to Week 26|Other|2|||
148794380|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
148794381|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
148794382|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
148794383|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Death|0|||
148794384|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Death|1|||
148794385|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Death|0|||
148794386|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
148794387|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148794388|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148794389|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
148794390|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148794391|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148794392|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
148794393|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
148794394|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
148794395|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
148794396|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
148794397|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
148794398|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
148794399|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
148794400|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
148794401|NCT01064414|536725672|FG000|Extension Period: Week 26 to Week 52|Other|5|||
148794402|NCT01064414|536725673|FG001|Extension Period: Week 26 to Week 52|Other|2|||
148794403|NCT01064414|536725674|FG002|Extension Period: Week 26 to Week 52|Other|1|||
148794404|NCT02532374|536725677|FG000|Overall Study|Withdrawal by Subject|1|||
148794405|NCT02532374|536725677|FG000|Overall Study|Physician Decision|1|||
148794406|NCT01348139|536725678|FG000|Period 1|Adverse Event|1|||
148794407|NCT01348139|536725679|FG001|Period 1|Adverse Event|0|||
148894572|NCT00633477|537093939|FG001|Overall Study|Death|0|||
148894573|NCT00633477|537093938|FG000|Overall Study|Randomized but not treated|1|||
148956458|NCT00723892|537324428|FG000|Overall Study|Multiple reasons|17|||
149011437|NCT02778399|537521471|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
149011438|NCT02778399|537521472|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
149011439|NCT02778399|537521473|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
149011440|NCT02778399|537521474|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
149011441|NCT02778399|537521475|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
149011442|NCT02778399|537521470|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
149011443|NCT02778399|537521471|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
148794408|NCT01348139|536725680|FG002|Period 1|Adverse Event|0|||
148794409|NCT01348139|536725681|FG003|Period 1|Adverse Event|0|||
148794410|NCT01348139|536725682|FG004|Period 1|Adverse Event|0|||
148956459|NCT00723892|537324429|FG001|Overall Study|Multiple reasons|12|||
148956460|NCT00723892|537324428|FG000|Overall Study|Other|6|||
148956461|NCT00723892|537324429|FG001|Overall Study|Other|3|||
148956462|NCT00723892|537324428|FG000|Overall Study|Study end|1|||
148956463|NCT00723892|537324429|FG001|Overall Study|Study end|3|||
148956464|NCT00723892|537324428|FG000|Overall Study|Weight loss|1|||
148956465|NCT00723892|537324429|FG001|Overall Study|Weight loss|3|||
148894574|NCT00633477|537093939|FG001|Overall Study|Randomized but not treated|0|||
148894575|NCT00770653|537093943|FG000|Overall Study|Adverse Event|13|||
148894576|NCT00770653|537093944|FG001|Overall Study|Adverse Event|5|||
148894577|NCT00770653|537093943|FG000|Overall Study|Protocol Violation|8|||
148894578|NCT00770653|537093944|FG001|Overall Study|Protocol Violation|6|||
148894579|NCT00770653|537093943|FG000|Overall Study|Withdrawal by Subject|4|||
148894580|NCT00770653|537093944|FG001|Overall Study|Withdrawal by Subject|7|||
148894581|NCT00770653|537093943|FG000|Overall Study|Lack of Compliance|1|||
148894582|NCT00770653|537093944|FG001|Overall Study|Lack of Compliance|4|||
148894583|NCT00770653|537093943|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
148894584|NCT00770653|537093944|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
148894585|NCT00770653|537093943|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
148894586|NCT00770653|537093944|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
148894587|NCT00770653|537093943|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
148894588|NCT00770653|537093944|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
148894589|NCT00770653|537093943|FG000|Overall Study|Lost to Follow-up|1|||
148894590|NCT00770653|537093944|FG001|Overall Study|Lost to Follow-up|2|||
148894591|NCT00770653|537093943|FG000|Overall Study|Physician Decision|1|||
148894592|NCT00770653|537093944|FG001|Overall Study|Physician Decision|0|||
149134903|NCT04744285|537974788|FG001|Overall Study|Withdrawal by Subject|1|||
149134904|NCT04744285|537974789|FG002|Overall Study|Withdrawal by Subject|2|||
148794411|NCT01348139|536725683|FG005|Period 1|Adverse Event|0|||
148794412|NCT02762084|536725686|FG000|Overall Study|Withdrawal by Subject|1|||
148794413|NCT02762084|536725687|FG001|Overall Study|Withdrawal by Subject|0|||
148794414|NCT02762084|536725688|FG002|Overall Study|Withdrawal by Subject|0|||
148794415|NCT02762084|536725686|FG000|Overall Study|Adverse Event|0|||
148794416|NCT02762084|536725687|FG001|Overall Study|Adverse Event|0|||
148794417|NCT02762084|536725688|FG002|Overall Study|Adverse Event|1|||
148794418|NCT02254772|536725689|FG000|Overall Study|Ineligible|1|||
148794419|NCT02254772|536725689|FG000|Overall Study|Withdrawal by Subject|1|||
148794420|NCT00716456|536725690|FG000|Overall Study|Adverse Event|0|||
148794421|NCT00716456|536725691|FG001|Overall Study|Adverse Event|2|||
148794422|NCT00716456|536725692|FG002|Overall Study|Adverse Event|0|||
148794423|NCT01765296|536725693|FG000|Overall Study|Protocol Violation|0|||
148794424|NCT01765296|536725694|FG001|Overall Study|Protocol Violation|5|||
148794425|NCT01765296|536725695|FG002|Overall Study|Protocol Violation|4|||
148794426|NCT01765296|536725693|FG000|Overall Study|Withdrawal by Subject|4|||
148794427|NCT01765296|536725694|FG001|Overall Study|Withdrawal by Subject|2|||
148794428|NCT01765296|536725695|FG002|Overall Study|Withdrawal by Subject|2|||
148794429|NCT01765296|536725693|FG000|Overall Study|Adverse Event|1|||
148794430|NCT01765296|536725694|FG001|Overall Study|Adverse Event|13|||
148794431|NCT01765296|536725695|FG002|Overall Study|Adverse Event|5|||
148794432|NCT01765296|536725693|FG000|Overall Study|Lack of Efficacy|0|||
148794433|NCT01765296|536725694|FG001|Overall Study|Lack of Efficacy|0|||
148794434|NCT01765296|536725695|FG002|Overall Study|Lack of Efficacy|2|||
148794435|NCT01619852|536725696|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
148794436|NCT01619852|536725697|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
148794437|NCT01619852|536725696|FG000|3 Month Follow up|Lost to Follow-up|31|||
148794438|NCT01619852|536725697|FG001|3 Month Follow up|Lost to Follow-up|34|||
148794439|NCT04556760|536725698|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
148794440|NCT04556760|536725699|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
148794441|NCT04556760|536725700|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
148794442|NCT04556760|536725701|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
148794443|NCT04556760|536725702|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
148794444|NCT04556760|536725703|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
148794445|NCT04556760|536725698|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
148794446|NCT04556760|536725699|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
148794447|NCT04556760|536725700|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
148794448|NCT04556760|536725701|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
148794449|NCT04556760|536725702|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
148794450|NCT04556760|536725703|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
148794451|NCT03075267|536725710|FG000|Overall Study|Protocol Violation|1|||
148794452|NCT03075267|536725711|FG001|Overall Study|Protocol Violation|0|||
148794453|NCT03075267|536725712|FG002|Overall Study|Protocol Violation|0|||
149134905|NCT04744285|537974790|FG003|Overall Study|Withdrawal by Subject|1|||
148794454|NCT02168491|536725713|FG000|Overall Study|Withdrawal by Subject|1|||
148894593|NCT04906499|537093950|FG000|Overall Study|Lack of time|1|||
148894594|NCT00179621|537093951|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
149233846|NCT02161380|538324932|FG003|Overall Study|Lost to Follow-up|0|||
148794455|NCT00809445|536725714|FG000|1 Month Follow-up|Lost contact|1|||
148894595|NCT00179621|537093952|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
148956466|NCT00723892|537324428|FG000|Overall Study|Alcohol abuse|0|||
148794456|NCT00809445|536725715|FG001|1 Month Follow-up|Lost contact|2|||
148794457|NCT00809445|536725716|FG002|1 Month Follow-up|Lost contact|1|||
148794458|NCT00809445|536725714|FG000|1 Month Follow-up|Withdrew consent|1|||
148794459|NCT00809445|536725715|FG001|1 Month Follow-up|Withdrew consent|1|||
148794460|NCT00809445|536725716|FG002|1 Month Follow-up|Withdrew consent|1|||
148794461|NCT00809445|536725714|FG000|1 Month Follow-up|Death|0|||
148794462|NCT00809445|536725715|FG001|1 Month Follow-up|Death|1|||
148794463|NCT00809445|536725716|FG002|1 Month Follow-up|Death|1|||
148794464|NCT00809445|536725714|FG000|1 Month Follow-up|Incarcerated|0|||
148794465|NCT00809445|536725715|FG001|1 Month Follow-up|Incarcerated|0|||
148794466|NCT00809445|536725716|FG002|1 Month Follow-up|Incarcerated|1|||
148794467|NCT00809445|536725714|FG000|6 Month Follow-up|Lost contact|16|||
148794468|NCT00809445|536725715|FG001|6 Month Follow-up|Lost contact|14|||
149134906|NCT01717768|537974791|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134907|NCT01717768|537974792|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
149134908|NCT01717768|537974793|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134909|NCT01717768|537974794|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134910|NCT01717768|537974795|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134911|NCT01717768|537974796|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134912|NCT01717768|537974797|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134913|NCT01717768|537974798|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134914|NCT01717768|537974799|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134915|NCT01717768|537974800|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134916|NCT01717768|537974801|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134917|NCT01717768|537974802|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
149134918|NCT01717768|537974791|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134919|NCT01717768|537974792|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134920|NCT01717768|537974793|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134921|NCT01717768|537974794|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134922|NCT01717768|537974795|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134923|NCT01717768|537974796|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134924|NCT01717768|537974797|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134925|NCT01717768|537974798|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134926|NCT01717768|537974799|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134927|NCT01717768|537974800|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134928|NCT01717768|537974801|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
149134929|NCT01717768|537974802|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
149134930|NCT01717768|537974791|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134931|NCT01717768|537974792|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134932|NCT01717768|537974793|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134933|NCT01717768|537974794|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134934|NCT01717768|537974795|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134935|NCT01717768|537974796|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134936|NCT01717768|537974797|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134937|NCT01717768|537974798|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
149134938|NCT01717768|537974799|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134939|NCT01717768|537974800|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134940|NCT01717768|537974801|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134941|NCT01717768|537974802|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
149134942|NCT01717768|537974791|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134943|NCT01717768|537974792|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134944|NCT01717768|537974793|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134945|NCT01717768|537974794|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134946|NCT01717768|537974795|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134947|NCT01717768|537974796|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134948|NCT01717768|537974797|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134949|NCT01717768|537974798|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134950|NCT01717768|537974799|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134951|NCT01717768|537974800|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
149134952|NCT01717768|537974801|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149236334|NCT02328014|538336617|FG003|Overall Study|Adverse Event|1|||
149236335|NCT02328014|538336614|FG000|Overall Study|Death|0|||
148794469|NCT00809445|536725716|FG002|6 Month Follow-up|Lost contact|14|||
148794470|NCT00809445|536725714|FG000|6 Month Follow-up|Death|2|||
148794471|NCT00809445|536725715|FG001|6 Month Follow-up|Death|1|||
148794472|NCT00809445|536725716|FG002|6 Month Follow-up|Death|1|||
148794473|NCT00809445|536725714|FG000|6 Month Follow-up|Incarcerated|6|||
148794474|NCT00809445|536725715|FG001|6 Month Follow-up|Incarcerated|8|||
149236336|NCT02328014|538336615|FG001|Overall Study|Death|0|||
149236337|NCT02328014|538336616|FG002|Overall Study|Death|0|||
149236338|NCT02328014|538336617|FG003|Overall Study|Death|4|||
148894596|NCT00179621|537093953|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
148894597|NCT00179621|537093954|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
148894598|NCT00179621|537093951|FG000|Double-Blind Period|Adverse Event|2|||
148894599|NCT00179621|537093952|FG001|Double-Blind Period|Adverse Event|7|||
148894600|NCT00179621|537093953|FG002|Double-Blind Period|Adverse Event|4|||
148894601|NCT00179621|537093954|FG003|Double-Blind Period|Adverse Event|0|||
148894602|NCT00179621|537093951|FG000|Double-Blind Period|Withdrawal by Subject|2|||
148894603|NCT00179621|537093952|FG001|Double-Blind Period|Withdrawal by Subject|1|||
148894604|NCT00179621|537093953|FG002|Double-Blind Period|Withdrawal by Subject|3|||
148894605|NCT00179621|537093954|FG003|Double-Blind Period|Withdrawal by Subject|0|||
148894606|NCT00179621|537093951|FG000|Double-Blind Period|Death|0|||
148894607|NCT00179621|537093952|FG001|Double-Blind Period|Death|1|||
148894608|NCT00179621|537093953|FG002|Double-Blind Period|Death|2|||
148894609|NCT00179621|537093954|FG003|Double-Blind Period|Death|0|||
148894610|NCT00179621|537093951|FG000|Double-Blind Period|Protocol Violation|1|||
148894611|NCT00179621|537093952|FG001|Double-Blind Period|Protocol Violation|0|||
148894612|NCT00179621|537093953|FG002|Double-Blind Period|Protocol Violation|0|||
148894613|NCT00179621|537093954|FG003|Double-Blind Period|Protocol Violation|0|||
148894614|NCT00179621|537093951|FG000|Double-Blind Period|Other|0|||
148894615|NCT00179621|537093952|FG001|Double-Blind Period|Other|2|||
148894616|NCT00179621|537093953|FG002|Double-Blind Period|Other|2|||
148894617|NCT00179621|537093954|FG003|Double-Blind Period|Other|0|||
148894618|NCT00179621|537093951|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
149236339|NCT02328014|538336614|FG000|Overall Study|Physician Decision|0|||
148794475|NCT00809445|536725716|FG002|6 Month Follow-up|Incarcerated|8|||
148794476|NCT00809445|536725714|FG000|6 Month Follow-up|Withdrew consent|0|||
148794477|NCT00809445|536725715|FG001|6 Month Follow-up|Withdrew consent|0|||
148794478|NCT00809445|536725716|FG002|6 Month Follow-up|Withdrew consent|1|||
148794479|NCT00807885|536725724|FG000|Overall Study|Lost to Follow-up|0|||
148794480|NCT00807885|536725725|FG001|Overall Study|Lost to Follow-up|0|||
148794481|NCT00807885|536725726|FG002|Overall Study|Lost to Follow-up|0|||
148794482|NCT00807885|536725727|FG003|Overall Study|Lost to Follow-up|0|||
148794483|NCT00807885|536725728|FG004|Overall Study|Lost to Follow-up|0|||
148794484|NCT00807885|536725729|FG005|Overall Study|Lost to Follow-up|1|||
148794485|NCT00807885|536725730|FG006|Overall Study|Lost to Follow-up|0|||
148794486|NCT00807885|536725731|FG007|Overall Study|Lost to Follow-up|0|||
148794487|NCT00807885|536725732|FG008|Overall Study|Lost to Follow-up|0|||
148794488|NCT03489343|536725733|FG000|Overall Study|Documented progressive disease|1|||
148794489|NCT03489343|536725734|FG001|Overall Study|Documented progressive disease|0|||
148794490|NCT03489343|536725735|FG002|Overall Study|Documented progressive disease|3|||
148794491|NCT03489343|536725736|FG003|Overall Study|Documented progressive disease|1|||
148794492|NCT03489343|536725737|FG004|Overall Study|Documented progressive disease|3|||
148794493|NCT03489343|536725738|FG005|Overall Study|Documented progressive disease|5|||
148794494|NCT03489343|536725739|FG006|Overall Study|Documented progressive disease|4|||
148794495|NCT03489343|536725733|FG000|Overall Study|Adverse Event|0|||
148794496|NCT03489343|536725734|FG001|Overall Study|Adverse Event|1|||
148794497|NCT03489343|536725735|FG002|Overall Study|Adverse Event|0|||
148794498|NCT03489343|536725736|FG003|Overall Study|Adverse Event|0|||
148794499|NCT03489343|536725737|FG004|Overall Study|Adverse Event|0|||
148794500|NCT03489343|536725738|FG005|Overall Study|Adverse Event|1|||
148794501|NCT03489343|536725739|FG006|Overall Study|Adverse Event|0|||
148794502|NCT03489343|536725733|FG000|Overall Study|Withdrawal by Subject|0|||
148794503|NCT03489343|536725734|FG001|Overall Study|Withdrawal by Subject|0|||
148794504|NCT03489343|536725735|FG002|Overall Study|Withdrawal by Subject|0|||
148794505|NCT03489343|536725736|FG003|Overall Study|Withdrawal by Subject|1|||
148794506|NCT03489343|536725737|FG004|Overall Study|Withdrawal by Subject|0|||
148794507|NCT03489343|536725738|FG005|Overall Study|Withdrawal by Subject|1|||
148794508|NCT03489343|536725739|FG006|Overall Study|Withdrawal by Subject|1|||
148794509|NCT03489343|536725733|FG000|Overall Study|Clinical progression|0|||
148794510|NCT03489343|536725734|FG001|Overall Study|Clinical progression|0|||
148794511|NCT03489343|536725735|FG002|Overall Study|Clinical progression|0|||
148794512|NCT03489343|536725736|FG003|Overall Study|Clinical progression|1|||
148794513|NCT03489343|536725737|FG004|Overall Study|Clinical progression|0|||
148794514|NCT03489343|536725738|FG005|Overall Study|Clinical progression|0|||
148794515|NCT03489343|536725739|FG006|Overall Study|Clinical progression|1|||
148794516|NCT00327717|536725740|FG000|Overall Study|Adverse Event|6|||
148794517|NCT00327717|536725741|FG001|Overall Study|Adverse Event|6|||
148794518|NCT00327717|536725740|FG000|Overall Study|Lack of Efficacy|0|||
148794519|NCT00327717|536725741|FG001|Overall Study|Lack of Efficacy|1|||
148794520|NCT00327717|536725740|FG000|Overall Study|Withdrawal by Subject|3|||
148894619|NCT00179621|537093952|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
148894620|NCT00179621|537093953|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
148894621|NCT00179621|537093954|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
148894622|NCT00179621|537093951|FG000|Open-Label Period|Adverse Event|0|||
148894623|NCT00179621|537093952|FG001|Open-Label Period|Adverse Event|6|||
148894624|NCT00179621|537093953|FG002|Open-Label Period|Adverse Event|5|||
148794521|NCT00327717|536725741|FG001|Overall Study|Withdrawal by Subject|7|||
148894625|NCT00179621|537093954|FG003|Open-Label Period|Adverse Event|6|||
149236340|NCT02328014|538336615|FG001|Overall Study|Physician Decision|0|||
149236341|NCT02328014|538336616|FG002|Overall Study|Physician Decision|0|||
149236342|NCT02328014|538336617|FG003|Overall Study|Physician Decision|1|||
149236343|NCT02328014|538336614|FG000|Overall Study|Disease Progression|1|||
149236344|NCT02328014|538336615|FG001|Overall Study|Disease Progression|0|||
149236345|NCT02328014|538336616|FG002|Overall Study|Disease Progression|1|||
149236346|NCT02328014|538336617|FG003|Overall Study|Disease Progression|3|||
149236347|NCT02328014|538336614|FG000|Overall Study|Study Terminated by Sponsor|4|||
149236348|NCT02328014|538336615|FG001|Overall Study|Study Terminated by Sponsor|1|||
149236349|NCT02328014|538336616|FG002|Overall Study|Study Terminated by Sponsor|1|||
149236350|NCT02328014|538336617|FG003|Overall Study|Study Terminated by Sponsor|0|||
149236351|NCT02328014|538336614|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
149236352|NCT02328014|538336615|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
149236353|NCT02328014|538336616|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
149236354|NCT02328014|538336617|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
149236355|NCT02328014|538336614|FG000|Overall Study|Withdrawal by Subject|0|||
149236356|NCT02328014|538336615|FG001|Overall Study|Withdrawal by Subject|0|||
149236357|NCT02328014|538336616|FG002|Overall Study|Withdrawal by Subject|0|||
149236358|NCT02328014|538336617|FG003|Overall Study|Withdrawal by Subject|1|||
149236359|NCT04338581|538336626|FG000|Overall Study|Lack of Efficacy|1|||
149236360|NCT04338581|538336627|FG001|Overall Study|Lack of Efficacy|0|||
149236361|NCT04338581|538336626|FG000|Overall Study|Withdrawal by Subject|4|||
149236362|NCT04338581|538336627|FG001|Overall Study|Withdrawal by Subject|4|||
149236363|NCT04338581|538336626|FG000|Overall Study|Prohibited Medication|1|||
149236364|NCT04338581|538336627|FG001|Overall Study|Prohibited Medication|0|||
149236365|NCT05028569|538336631|FG000|Double-Blind Phase|Death|0|||
149236366|NCT05028569|538336632|FG001|Double-Blind Phase|Death|0|||
149236367|NCT05028569|538336633|FG002|Double-Blind Phase|Death|0|||
149236368|NCT05028569|538336634|FG003|Double-Blind Phase|Death|1|||
149236369|NCT05028569|538336635|FG004|Double-Blind Phase|Death|0|||
149236370|NCT05028569|538336636|FG005|Double-Blind Phase|Death|0|||
149236371|NCT05028569|538336637|FG006|Double-Blind Phase|Death|0|||
149236372|NCT05028569|538336631|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149236373|NCT05028569|538336632|FG001|Double-Blind Phase|Lost to Follow-up|6|||
149236374|NCT05028569|538336633|FG002|Double-Blind Phase|Lost to Follow-up|3|||
149236375|NCT05028569|538336634|FG003|Double-Blind Phase|Lost to Follow-up|9|||
149236376|NCT05028569|538336635|FG004|Double-Blind Phase|Lost to Follow-up|0|||
149236377|NCT05028569|538336636|FG005|Double-Blind Phase|Lost to Follow-up|0|||
149236378|NCT05028569|538336637|FG006|Double-Blind Phase|Lost to Follow-up|0|||
149236379|NCT05028569|538336631|FG000|Double-Blind Phase|Protocol Deviation|0|||
149236380|NCT05028569|538336632|FG001|Double-Blind Phase|Protocol Deviation|2|||
149236381|NCT05028569|538336633|FG002|Double-Blind Phase|Protocol Deviation|0|||
149236382|NCT05028569|538336634|FG003|Double-Blind Phase|Protocol Deviation|0|||
149236383|NCT05028569|538336635|FG004|Double-Blind Phase|Protocol Deviation|0|||
149236384|NCT05028569|538336636|FG005|Double-Blind Phase|Protocol Deviation|0|||
149236385|NCT05028569|538336637|FG006|Double-Blind Phase|Protocol Deviation|0|||
149236386|NCT05028569|538336631|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
149236387|NCT05028569|538336632|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
149236388|NCT05028569|538336633|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
149236389|NCT05028569|538336634|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
149236390|NCT05028569|538336635|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
149236391|NCT05028569|538336636|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
149236392|NCT05028569|538336637|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
149236393|NCT05028569|538336631|FG000|Double-Blind Phase|Other, not specified|0|||
149236394|NCT05028569|538336632|FG001|Double-Blind Phase|Other, not specified|5|||
149236395|NCT05028569|538336633|FG002|Double-Blind Phase|Other, not specified|4|||
149236396|NCT05028569|538336634|FG003|Double-Blind Phase|Other, not specified|6|||
149236397|NCT05028569|538336635|FG004|Double-Blind Phase|Other, not specified|0|||
149236398|NCT05028569|538336636|FG005|Double-Blind Phase|Other, not specified|0|||
148794522|NCT01630135|536725743|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
148794523|NCT01630135|536725744|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
148794524|NCT04767373|536725746|FG000|Overall Study|Death|6|||
148794525|NCT04767373|536725747|FG001|Overall Study|Death|3|||
148794526|NCT04767373|536725746|FG000|Overall Study|Lost to Follow-up|67|||
148794527|NCT04767373|536725747|FG001|Overall Study|Lost to Follow-up|35|||
148794528|NCT04767373|536725746|FG000|Overall Study|Physician Decision|15|||
148794529|NCT04767373|536725747|FG001|Overall Study|Physician Decision|4|||
148794530|NCT04767373|536725746|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149236399|NCT05028569|538336637|FG006|Double-Blind Phase|Other, not specified|0|||
149236400|NCT05028569|538336631|FG000|Open-Label Phase|Death|0|||
149236401|NCT05028569|538336632|FG001|Open-Label Phase|Death|0|||
149236402|NCT05028569|538336633|FG002|Open-Label Phase|Death|0|||
148894626|NCT00179621|537093951|FG000|Open-Label Period|Withdrawal by Subject|0|||
149236403|NCT05028569|538336634|FG003|Open-Label Phase|Death|0|||
149236404|NCT05028569|538336635|FG004|Open-Label Phase|Death|0|||
149236405|NCT05028569|538336636|FG005|Open-Label Phase|Death|0|||
149236406|NCT05028569|538336637|FG006|Open-Label Phase|Death|1|||
149236407|NCT05028569|538336631|FG000|Open-Label Phase|Lost to Follow-up|0|||
149236408|NCT05028569|538336632|FG001|Open-Label Phase|Lost to Follow-up|0|||
149236409|NCT05028569|538336633|FG002|Open-Label Phase|Lost to Follow-up|0|||
149236410|NCT05028569|538336634|FG003|Open-Label Phase|Lost to Follow-up|0|||
149236411|NCT05028569|538336635|FG004|Open-Label Phase|Lost to Follow-up|5|||
149236412|NCT05028569|538336636|FG005|Open-Label Phase|Lost to Follow-up|5|||
149236413|NCT05028569|538336637|FG006|Open-Label Phase|Lost to Follow-up|4|||
149236414|NCT05028569|538336631|FG000|Open-Label Phase|Protocol Deviation|0|||
149236415|NCT05028569|538336632|FG001|Open-Label Phase|Protocol Deviation|0|||
149236416|NCT05028569|538336633|FG002|Open-Label Phase|Protocol Deviation|0|||
149236417|NCT05028569|538336634|FG003|Open-Label Phase|Protocol Deviation|0|||
149236418|NCT05028569|538336635|FG004|Open-Label Phase|Protocol Deviation|1|||
149236419|NCT05028569|538336636|FG005|Open-Label Phase|Protocol Deviation|0|||
149236420|NCT05028569|538336637|FG006|Open-Label Phase|Protocol Deviation|0|||
149236421|NCT05028569|538336631|FG000|Open-Label Phase|Pregnancy|0|||
149236422|NCT05028569|538336632|FG001|Open-Label Phase|Pregnancy|0|||
149236423|NCT05028569|538336633|FG002|Open-Label Phase|Pregnancy|0|||
149236424|NCT05028569|538336634|FG003|Open-Label Phase|Pregnancy|0|||
149236425|NCT05028569|538336635|FG004|Open-Label Phase|Pregnancy|0|||
149236426|NCT05028569|538336636|FG005|Open-Label Phase|Pregnancy|1|||
149236427|NCT05028569|538336637|FG006|Open-Label Phase|Pregnancy|0|||
149236428|NCT05028569|538336631|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149236429|NCT05028569|538336632|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149236430|NCT05028569|538336633|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149236431|NCT05028569|538336634|FG003|Open-Label Phase|Withdrawal by Subject|0|||
149236432|NCT05028569|538336635|FG004|Open-Label Phase|Withdrawal by Subject|15|||
149236433|NCT05028569|538336636|FG005|Open-Label Phase|Withdrawal by Subject|8|||
149236434|NCT05028569|538336637|FG006|Open-Label Phase|Withdrawal by Subject|13|||
149236435|NCT05028569|538336631|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
149236436|NCT05028569|538336632|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
149236437|NCT05028569|538336633|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
149236438|NCT05028569|538336634|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
149236439|NCT05028569|538336635|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
149236440|NCT05028569|538336636|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
149236441|NCT05028569|538336637|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
149236442|NCT05028569|538336631|FG000|Open-Label Phase|Other, not specified|0|||
149236443|NCT05028569|538336632|FG001|Open-Label Phase|Other, not specified|0|||
149236444|NCT05028569|538336633|FG002|Open-Label Phase|Other, not specified|0|||
149236445|NCT05028569|538336634|FG003|Open-Label Phase|Other, not specified|0|||
149236446|NCT05028569|538336635|FG004|Open-Label Phase|Other, not specified|6|||
149236447|NCT05028569|538336636|FG005|Open-Label Phase|Other, not specified|5|||
149236448|NCT05028569|538336637|FG006|Open-Label Phase|Other, not specified|7|||
149236449|NCT05028569|538336631|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149236450|NCT05028569|538336632|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149236451|NCT05028569|538336633|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149236452|NCT05028569|538336634|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149236453|NCT05028569|538336635|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149236454|NCT05028569|538336636|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
149236455|NCT05028569|538336637|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
149236456|NCT05028569|538336631|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149236457|NCT05028569|538336632|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149236458|NCT05028569|538336633|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149236459|NCT05028569|538336634|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149236460|NCT05028569|538336635|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149236461|NCT05028569|538336636|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
149236462|NCT05028569|538336637|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
149236463|NCT01314703|538336639|FG000|Overall Study|screen failure and closed enrollment|8|||
149236464|NCT04063384|538336640|FG000|Overall Study|placebo manipulation issue|1|||
149236465|NCT04063384|538336641|FG001|Overall Study|placebo manipulation issue|2|||
149236466|NCT04063384|538336642|FG002|Overall Study|placebo manipulation issue|1|||
149236467|NCT04063384|538336643|FG003|Overall Study|placebo manipulation issue|1|||
149236468|NCT04609553|538336647|FG000|Overall Study|Lost to Follow-up|27|||
148894627|NCT00179621|537093952|FG001|Open-Label Period|Withdrawal by Subject|2|||
148894628|NCT00179621|537093953|FG002|Open-Label Period|Withdrawal by Subject|2|||
148894629|NCT00179621|537093954|FG003|Open-Label Period|Withdrawal by Subject|2|||
149236469|NCT04609553|538336648|FG001|Overall Study|Lost to Follow-up|31|||
149236470|NCT04609553|538336649|FG002|Overall Study|Lost to Follow-up|24|||
149236471|NCT04609553|538336647|FG000|Overall Study|Discontinued|12|||
148894630|NCT00179621|537093951|FG000|Open-Label Period|Death|0|||
148894631|NCT00179621|537093952|FG001|Open-Label Period|Death|0|||
149134953|NCT01717768|537974802|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
149134954|NCT00448435|537974803|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
149134955|NCT00448435|537974804|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
149134956|NCT04195581|537974807|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
149134957|NCT04195581|537974807|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
149134958|NCT04195581|537974807|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
149134959|NCT04195581|537974807|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
149134960|NCT04195581|537974807|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
149134961|NCT04195581|537974807|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
149134962|NCT00821431|537974808|FG000|Overall Study|Adverse Event|6|||
149134963|NCT00821431|537974809|FG001|Overall Study|Adverse Event|3|||
149134964|NCT00821431|537974808|FG000|Overall Study|Withdrawal by Subject|5|||
149134965|NCT00821431|537974809|FG001|Overall Study|Withdrawal by Subject|0|||
149134966|NCT00821431|537974808|FG000|Overall Study|Lost to Follow-up|1|||
149134967|NCT00821431|537974809|FG001|Overall Study|Lost to Follow-up|0|||
149236472|NCT04609553|538336648|FG001|Overall Study|Discontinued|10|||
149236473|NCT04609553|538336649|FG002|Overall Study|Discontinued|9|||
149236474|NCT03595683|538336651|FG000|Overall Study|Adverse Event|1|||
149236475|NCT03595683|538336652|FG001|Overall Study|Adverse Event|0|||
149236476|NCT03595683|538336651|FG000|Overall Study|Pursue alternative therapy|1|||
149236477|NCT03595683|538336652|FG001|Overall Study|Pursue alternative therapy|1|||
149236478|NCT03595683|538336651|FG000|Overall Study|Progressive disease|1|||
149236479|NCT03595683|538336652|FG001|Overall Study|Progressive disease|3|||
149236480|NCT03215030|538336653|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
149236481|NCT03215030|538336654|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
149236482|NCT03215030|538336655|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236483|NCT03215030|538336656|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
149236484|NCT03215030|538336657|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236485|NCT03215030|538336658|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
148794531|NCT04767373|536725747|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148794532|NCT04767373|536725746|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
148794533|NCT04767373|536725747|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
148794534|NCT04767373|536725746|FG000|Overall Study|Other|1|||
148794535|NCT04767373|536725747|FG001|Overall Study|Other|2|||
148794536|NCT01502033|536725748|FG000|Overall Study|1 participant had scalp discomfort|1|||
148794537|NCT01502033|536725748|FG000|Overall Study|1 participant had worsening depression|1|||
148794538|NCT01502033|536725748|FG000|Overall Study|1 participant went back to school|1|||
148794539|NCT02658669|536725749|FG000|Overall Study|Lost to Follow-up|7|||
148794540|NCT02658669|536725750|FG001|Overall Study|Lost to Follow-up|5|||
148794541|NCT00186485|536725751|FG000|Overall Study|Lost to Follow-up|3|||
148794542|NCT03804268|536725764|FG000|Overall Study|Adverse Event|2|||
148794543|NCT03804268|536725765|FG001|Overall Study|Adverse Event|2|||
148794544|NCT03804268|536725764|FG000|Overall Study|Withdrawal by Subject|2|||
148794545|NCT03804268|536725765|FG001|Overall Study|Withdrawal by Subject|0|||
148794546|NCT03804268|536725764|FG000|Overall Study|Lost to Follow-up|1|||
148794547|NCT03804268|536725765|FG001|Overall Study|Lost to Follow-up|0|||
148794548|NCT03804268|536725764|FG000|Overall Study|Physician Decision|2|||
148794549|NCT03804268|536725765|FG001|Overall Study|Physician Decision|0|||
148794550|NCT00838097|536725766|FG000|Overall Study|Ineligibility determined|6|||
148794551|NCT00838097|536725766|FG000|Overall Study|Adverse Event|2|||
148794552|NCT00838097|536725766|FG000|Overall Study|Withdrawal by Subject|3|||
148794553|NCT00838097|536725766|FG000|Overall Study|Requirement for alternative therapy|2|||
148794554|NCT00838097|536725766|FG000|Overall Study|Physician Decision|4|||
148794555|NCT00838097|536725766|FG000|Overall Study|Lost to Follow-up|11|||
148794556|NCT00838097|536725766|FG000|Overall Study|Death|6|||
148794557|NCT00838097|536725766|FG000|Overall Study|Protocol-specified criteria|142|||
148794558|NCT03311841|536725769|FG000|14-day Wash-out|Adverse Event|0|||
148794559|NCT03311841|536725770|FG001|14-day Wash-out|Adverse Event|1|||
148794560|NCT03311841|536725771|FG002|14-day Wash-out|Adverse Event|0|||
148794561|NCT03311841|536725772|FG003|14-day Wash-out|Adverse Event|0|||
148794562|NCT03311841|536725773|FG004|14-day Wash-out|Adverse Event|0|||
148794563|NCT03311841|536725769|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
148794564|NCT03311841|536725770|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
148794565|NCT03311841|536725771|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
148794566|NCT03311841|536725772|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
148794567|NCT03311841|536725773|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
149134968|NCT00821431|537974808|FG000|Overall Study|Protocol Violation|3|||
149134969|NCT00821431|537974809|FG001|Overall Study|Protocol Violation|1|||
149134970|NCT00821431|537974808|FG000|Overall Study|Physician Decision|0|||
149236486|NCT03215030|538336659|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236487|NCT03215030|538336660|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
148794568|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
148794569|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
148794570|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Adverse Event|57|||
148794571|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Adverse Event|49|||
148794572|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
148794573|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
148794574|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Site closure|3|||
148794575|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Site closure|2|||
149134971|NCT00821431|537974809|FG001|Overall Study|Physician Decision|1|||
149134972|NCT03026127|537974812|FG000|CRISP R61|Adverse Event|5|||
149134973|NCT03026127|537974813|FG001|CRISP R61|Adverse Event|0|||
149134974|NCT03026127|537974814|FG002|CRISP R61|Adverse Event|0|||
149134975|NCT03026127|537974812|FG000|CRISP R61|Lost to Follow-up|2|||
149134976|NCT03026127|537974813|FG001|CRISP R61|Lost to Follow-up|0|||
149134977|NCT03026127|537974814|FG002|CRISP R61|Lost to Follow-up|0|||
149134978|NCT03026127|537974812|FG000|CRISP R61|Dropped before therapy|5|||
149134979|NCT03026127|537974813|FG001|CRISP R61|Dropped before therapy|0|||
148794576|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
148794577|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
148794578|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Physician Decision|48|||
148794579|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Physician Decision|38|||
148794580|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
148794581|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
148794582|NCT01705977|536725790|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
149134980|NCT03026127|537974814|FG002|CRISP R61|Dropped before therapy|0|||
149134981|NCT03026127|537974812|FG000|CRISP R33|Lost to Follow-up|0|||
149134982|NCT03026127|537974813|FG001|CRISP R33|Lost to Follow-up|5|||
149134983|NCT03026127|537974814|FG002|CRISP R33|Lost to Follow-up|4|||
149134984|NCT03026127|537974812|FG000|CRISP R33|Adverse Event|0|||
149134985|NCT03026127|537974813|FG001|CRISP R33|Adverse Event|9|||
149134986|NCT03026127|537974814|FG002|CRISP R33|Adverse Event|5|||
149134987|NCT03026127|537974812|FG000|CRISP R33|Withdrawal by Subject|0|||
149134988|NCT03026127|537974813|FG001|CRISP R33|Withdrawal by Subject|9|||
149134989|NCT03026127|537974814|FG002|CRISP R33|Withdrawal by Subject|1|||
149134990|NCT03026127|537974812|FG000|CRISP R33|Lack of Efficacy|0|||
149134991|NCT03026127|537974813|FG001|CRISP R33|Lack of Efficacy|3|||
149134992|NCT03026127|537974814|FG002|CRISP R33|Lack of Efficacy|2|||
149134993|NCT03026127|537974812|FG000|CRISP R33|Physician Decision|0|||
149134994|NCT03026127|537974813|FG001|CRISP R33|Physician Decision|3|||
149134995|NCT03026127|537974814|FG002|CRISP R33|Physician Decision|1|||
149134996|NCT03026127|537974812|FG000|CRISP R33|Transportation|0|||
149134997|NCT03026127|537974813|FG001|CRISP R33|Transportation|2|||
149134998|NCT03026127|537974814|FG002|CRISP R33|Transportation|1|||
149134999|NCT01182766|537974818|FG000|Overall Study|Lost to Follow-up|32|||
149135000|NCT01182766|537974819|FG001|Overall Study|Lost to Follow-up|36|||
149135001|NCT01182766|537974820|FG002|Overall Study|Lost to Follow-up|29|||
149135002|NCT01182766|537974818|FG000|Overall Study|Withdrawal by Subject|14|||
149135003|NCT01182766|537974819|FG001|Overall Study|Withdrawal by Subject|3|||
149135004|NCT01182766|537974820|FG002|Overall Study|Withdrawal by Subject|6|||
149135005|NCT01182766|537974818|FG000|Overall Study|Physician Decision|1|||
149135006|NCT01182766|537974819|FG001|Overall Study|Physician Decision|0|||
149135007|NCT01182766|537974820|FG002|Overall Study|Physician Decision|0|||
149135008|NCT01182766|537974818|FG000|Overall Study|Non-compliance|1|||
149135009|NCT01182766|537974819|FG001|Overall Study|Non-compliance|1|||
149135010|NCT01182766|537974820|FG002|Overall Study|Non-compliance|1|||
149135011|NCT03027557|537974821|FG000|Overall Study|Adverse Event|1|||
149135012|NCT03027557|537974822|FG001|Overall Study|Adverse Event|0|||
149135013|NCT03027557|537974823|FG002|Overall Study|Adverse Event|0|||
149135014|NCT02510560|537974826|FG000|Overall Study|Discontinued from Treatment|27|||
149135015|NCT02510560|537974827|FG001|Overall Study|Discontinued from Treatment|18|||
149135016|NCT02510560|537974828|FG002|Overall Study|Discontinued from Treatment|19|||
149135017|NCT02510560|537974826|FG000|Overall Study|Other|4|||
149135018|NCT02510560|537974827|FG001|Overall Study|Other|4|||
149135019|NCT02510560|537974828|FG002|Overall Study|Other|3|||
149135020|NCT01699789|537974829|FG000|Overall Study|Withdrawal by Subject|18|||
149135021|NCT01699789|537974830|FG001|Overall Study|Withdrawal by Subject|23|||
149135022|NCT01699789|537974829|FG000|Overall Study|Death|1|||
149135023|NCT01699789|537974830|FG001|Overall Study|Death|2|||
149135024|NCT01699789|537974829|FG000|Overall Study|Lost to Follow-up|83|||
149135025|NCT01699789|537974830|FG001|Overall Study|Lost to Follow-up|101|||
149135026|NCT01009554|537974831|FG000|Overall Study|Adverse Event|1|||
149135027|NCT01009554|537974832|FG001|Overall Study|Adverse Event|1|||
149135028|NCT01009554|537974831|FG000|Overall Study|Withdrawal by Subject|1|||
149135029|NCT01009554|537974832|FG001|Overall Study|Withdrawal by Subject|3|||
149135030|NCT01009554|537974831|FG000|Overall Study|Noncompliant with Study Product|0|||
149135031|NCT01009554|537974832|FG001|Overall Study|Noncompliant with Study Product|3|||
149135032|NCT01605253|537974833|FG000|Overall Study|Physician Decision|3|||
149135033|NCT01605253|537974834|FG001|Overall Study|Physician Decision|2|||
149135034|NCT01605253|537974833|FG000|Overall Study|Lost to Follow-up|3|||
149135035|NCT01605253|537974834|FG001|Overall Study|Lost to Follow-up|1|||
149135036|NCT02554903|537974835|FG000|Overall Study|Death|1|||
149135037|NCT02554903|537974836|FG001|Overall Study|Death|1|||
149135038|NCT02554903|537974835|FG000|Overall Study|Physician Decision|2|||
149135039|NCT02554903|537974836|FG001|Overall Study|Physician Decision|2|||
149236488|NCT03215030|538336661|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236489|NCT03215030|538336662|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236490|NCT03215030|538336663|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236491|NCT03215030|538336664|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
149236492|NCT03215030|538336653|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
149236493|NCT03215030|538336654|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236494|NCT03215030|538336655|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236495|NCT03215030|538336656|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
149236496|NCT03215030|538336657|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236497|NCT03215030|538336658|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236498|NCT03215030|538336659|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236499|NCT03215030|538336660|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236500|NCT03215030|538336661|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236501|NCT03215030|538336662|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236502|NCT03215030|538336663|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236503|NCT03215030|538336664|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149236504|NCT03215030|538336653|FG000|Part 1: Dose Escalation|Death|15|||
149236505|NCT03215030|538336654|FG001|Part 1: Dose Escalation|Death|6|||
149236506|NCT03215030|538336655|FG002|Part 1: Dose Escalation|Death|6|||
149236507|NCT03215030|538336656|FG003|Part 1: Dose Escalation|Death|8|||
149236508|NCT03215030|538336657|FG004|Part 1: Dose Escalation|Death|0|||
149236509|NCT03215030|538336658|FG005|Part 1: Dose Escalation|Death|0|||
149236510|NCT03215030|538336659|FG006|Part 1: Dose Escalation|Death|0|||
149236511|NCT03215030|538336660|FG007|Part 1: Dose Escalation|Death|0|||
149236512|NCT03215030|538336661|FG008|Part 1: Dose Escalation|Death|0|||
149236513|NCT03215030|538336662|FG009|Part 1: Dose Escalation|Death|0|||
149236514|NCT03215030|538336663|FG010|Part 1: Dose Escalation|Death|0|||
149236515|NCT03215030|538336664|FG011|Part 1: Dose Escalation|Death|0|||
149236516|NCT03215030|538336653|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
149236517|NCT03215030|538336654|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
149236518|NCT03215030|538336655|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
149236519|NCT03215030|538336656|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
149236520|NCT03215030|538336657|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
149236521|NCT03215030|538336658|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
149236522|NCT03215030|538336659|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
149236523|NCT03215030|538336660|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
149236524|NCT03215030|538336661|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
149236525|NCT03215030|538336662|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
149236526|NCT03215030|538336663|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
149236527|NCT03215030|538336664|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
149236528|NCT03215030|538336653|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236529|NCT03215030|538336654|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236530|NCT03215030|538336655|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236531|NCT03215030|538336656|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236532|NCT03215030|538336657|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236533|NCT03215030|538336658|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236534|NCT03215030|538336659|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236535|NCT03215030|538336660|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
149236536|NCT03215030|538336661|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236537|NCT03215030|538336662|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236538|NCT03215030|538336663|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236539|NCT03215030|538336664|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
149236540|NCT03215030|538336653|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236541|NCT03215030|538336654|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236542|NCT03215030|538336655|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236543|NCT03215030|538336656|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236544|NCT03215030|538336657|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
149236545|NCT03215030|538336658|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
149236546|NCT03215030|538336659|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
149236547|NCT03215030|538336660|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
149236548|NCT03215030|538336661|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236549|NCT03215030|538336662|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236550|NCT03215030|538336663|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236551|NCT03215030|538336664|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149236552|NCT03215030|538336653|FG000|Part 2: Dose Expansion|Death|0|||
149236553|NCT03215030|538336654|FG001|Part 2: Dose Expansion|Death|0|||
149236554|NCT03215030|538336655|FG002|Part 2: Dose Expansion|Death|0|||
149236555|NCT03215030|538336656|FG003|Part 2: Dose Expansion|Death|0|||
149236556|NCT03215030|538336657|FG004|Part 2: Dose Expansion|Death|3|||
149236557|NCT03215030|538336658|FG005|Part 2: Dose Expansion|Death|1|||
149236558|NCT03215030|538336659|FG006|Part 2: Dose Expansion|Death|5|||
149236559|NCT03215030|538336660|FG007|Part 2: Dose Expansion|Death|4|||
149236560|NCT03215030|538336661|FG008|Part 2: Dose Expansion|Death|0|||
149236561|NCT03215030|538336662|FG009|Part 2: Dose Expansion|Death|0|||
149236562|NCT03215030|538336663|FG010|Part 2: Dose Expansion|Death|0|||
149236563|NCT03215030|538336664|FG011|Part 2: Dose Expansion|Death|0|||
149236564|NCT03215030|538336653|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
149236565|NCT03215030|538336654|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
149236566|NCT03215030|538336655|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
149236567|NCT03215030|538336656|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
149236568|NCT03215030|538336657|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
149236569|NCT03215030|538336658|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
149236570|NCT03215030|538336659|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
149236571|NCT03215030|538336660|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
149236572|NCT03215030|538336661|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
149236573|NCT03215030|538336662|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
149236574|NCT03215030|538336663|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
149236575|NCT03215030|538336664|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
149236576|NCT03215030|538336653|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
149236577|NCT03215030|538336654|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
149236578|NCT03215030|538336655|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
149236579|NCT03215030|538336656|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
149236580|NCT03215030|538336657|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
149236581|NCT03215030|538336658|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
149236582|NCT03215030|538336659|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
149236583|NCT03215030|538336660|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
149236584|NCT03215030|538336661|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
149236585|NCT03215030|538336662|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
149236586|NCT03215030|538336663|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
149236587|NCT03215030|538336664|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
149236588|NCT03215030|538336653|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236589|NCT03215030|538336654|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236590|NCT03215030|538336655|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236591|NCT03215030|538336656|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236592|NCT03215030|538336657|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236593|NCT03215030|538336658|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236594|NCT03215030|538336659|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236595|NCT03215030|538336660|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236596|NCT03215030|538336661|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
149236597|NCT03215030|538336662|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
149236598|NCT03215030|538336663|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236599|NCT03215030|538336664|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
149236600|NCT03215030|538336653|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236601|NCT03215030|538336654|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236602|NCT03215030|538336655|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236603|NCT03215030|538336656|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236604|NCT03215030|538336657|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236605|NCT03215030|538336658|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236606|NCT03215030|538336659|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236607|NCT03215030|538336660|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236608|NCT03215030|538336661|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
149236609|NCT03215030|538336662|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
148794583|NCT01705977|536725791|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
148794584|NCT01705977|536725790|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
148794585|NCT01705977|536725791|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
148794586|NCT01705977|536725790|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
148794587|NCT01705977|536725791|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
148794588|NCT01705977|536725790|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
149236610|NCT03215030|538336663|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236611|NCT03215030|538336664|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
149236612|NCT03215030|538336653|FG000|Part 3: Dose Extension|Death|0|||
148794589|NCT01705977|536725791|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
148794590|NCT01705977|536725790|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
148794591|NCT01705977|536725791|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
149236613|NCT03215030|538336654|FG001|Part 3: Dose Extension|Death|0|||
149236614|NCT03215030|538336655|FG002|Part 3: Dose Extension|Death|0|||
148794592|NCT02039778|536725795|FG000|Overall Study|Death|2|||
148794593|NCT02039778|536725795|FG000|Overall Study|Withdrawal by Subject|1|||
148794594|NCT02039778|536725795|FG000|Overall Study|Never started the protocol treatment|1|||
149236615|NCT03215030|538336656|FG003|Part 3: Dose Extension|Death|0|||
149236616|NCT03215030|538336657|FG004|Part 3: Dose Extension|Death|0|||
149236617|NCT03215030|538336658|FG005|Part 3: Dose Extension|Death|0|||
149236618|NCT03215030|538336659|FG006|Part 3: Dose Extension|Death|0|||
149236619|NCT03215030|538336660|FG007|Part 3: Dose Extension|Death|0|||
149236620|NCT03215030|538336661|FG008|Part 3: Dose Extension|Death|19|||
149236621|NCT03215030|538336662|FG009|Part 3: Dose Extension|Death|20|||
149236622|NCT03215030|538336663|FG010|Part 3: Dose Extension|Death|0|||
149236623|NCT03215030|538336664|FG011|Part 3: Dose Extension|Death|0|||
149236624|NCT03215030|538336653|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
149236625|NCT03215030|538336654|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
149236626|NCT03215030|538336655|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
149236627|NCT03215030|538336656|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
149236628|NCT03215030|538336657|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
149236629|NCT03215030|538336658|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
149236630|NCT03215030|538336659|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
149236631|NCT03215030|538336660|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
149236632|NCT03215030|538336661|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
149236633|NCT03215030|538336662|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
149236634|NCT03215030|538336663|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
149236635|NCT03215030|538336664|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
149236636|NCT03215030|538336653|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236637|NCT03215030|538336654|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236638|NCT03215030|538336655|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236639|NCT03215030|538336656|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236640|NCT03215030|538336657|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236641|NCT03215030|538336658|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236642|NCT03215030|538336659|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236643|NCT03215030|538336660|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236644|NCT03215030|538336661|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236645|NCT03215030|538336662|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
149236646|NCT03215030|538336663|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
149236647|NCT03215030|538336664|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
149236648|NCT05416138|538336666|FG000|Overall Study|Withdrawal by Subject|2|||
149236649|NCT05416138|538336667|FG001|Overall Study|Withdrawal by Subject|1|||
149236650|NCT05675709|538336684|FG000|Overall Study|incomplete outcome data|2|||
149236651|NCT05675709|538336685|FG001|Overall Study|incomplete outcome data|8|||
149236652|NCT05804877|538336686|FG000|Overall Study|Lost to Follow-up|1|||
149236653|NCT05804877|538336687|FG001|Overall Study|Lost to Follow-up|3|||
149236654|NCT05804877|538336686|FG000|Overall Study|Withdrawal by Subject|1|||
149236655|NCT05804877|538336687|FG001|Overall Study|Withdrawal by Subject|0|||
149236656|NCT05804877|538336686|FG000|Overall Study|Withdrawal by Subject|1|||
149236657|NCT05804877|538336687|FG001|Overall Study|Withdrawal by Subject|0|||
149236658|NCT04190225|538336688|FG000|Overall Study|Lost to Follow-up|2|||
149236659|NCT04190225|538336689|FG001|Overall Study|Lost to Follow-up|3|||
149236660|NCT04190225|538336688|FG000|Overall Study|Withdrawal by Subject|3|||
149236661|NCT04190225|538336689|FG001|Overall Study|Withdrawal by Subject|2|||
149236662|NCT04190225|538336688|FG000|Overall Study|Unrelated health condition|2|||
149236663|NCT04190225|538336689|FG001|Overall Study|Unrelated health condition|0|||
149236664|NCT04429971|538336691|FG000|Overall Study|Lost to Follow-up|7|||
149236665|NCT04429971|538336692|FG001|Overall Study|Lost to Follow-up|8|||
149236666|NCT04540497|538336697|FG000|Overall Study|Adverse Event|0|||
149236667|NCT04540497|538336698|FG001|Overall Study|Adverse Event|2|||
149236668|NCT04540497|538336697|FG000|Overall Study|Lost to Follow-up|1|||
149236669|NCT04540497|538336698|FG001|Overall Study|Lost to Follow-up|0|||
149236670|NCT04540497|538336697|FG000|Overall Study|Withdrawal by Subject|1|||
149236671|NCT04540497|538336698|FG001|Overall Study|Withdrawal by Subject|1|||
149236672|NCT04540497|538336697|FG000|Overall Study|Miscellaneous|2|||
149236673|NCT04540497|538336698|FG001|Overall Study|Miscellaneous|1|||
149236674|NCT05274815|538336700|FG000|Overall Study|Adverse Event|1|||
149236675|NCT05274815|538336700|FG000|Overall Study|Death|2|||
149236676|NCT05274815|538336700|FG000|Overall Study|Lost to Follow-up|4|||
149236677|NCT05274815|538336700|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
149236678|NCT05274815|538336700|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
149236679|NCT05274815|538336700|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
149236680|NCT05274815|538336700|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
149236681|NCT05274815|538336700|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
149236682|NCT05274815|538336700|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
149236683|NCT05274815|538336700|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
149236684|NCT05274815|538336700|FG000|Overall Study|Withdrawal by Subject|11|||
149236685|NCT04044690|538336701|FG000|Period 1|Lack of Efficacy|1|||
149236686|NCT04044690|538336702|FG001|Period 1|Lack of Efficacy|1|||
149236687|NCT04044690|538336701|FG000|Period 1|Adverse Event|4|||
149135040|NCT02554903|537974835|FG000|Overall Study|Heart Transplant|1|||
149135041|NCT02554903|537974836|FG001|Overall Study|Heart Transplant|2|||
149135042|NCT04427501|537974841|FG000|Overall Study|Death|0|||
149135043|NCT04427501|537974842|FG001|Overall Study|Death|0|||
149135044|NCT04427501|537974843|FG002|Overall Study|Death|0|||
149135045|NCT04427501|537974844|FG003|Overall Study|Death|0|||
149135046|NCT04427501|537974845|FG004|Overall Study|Death|0|||
149135047|NCT04427501|537974846|FG005|Overall Study|Death|15|||
149135048|NCT04427501|537974847|FG006|Overall Study|Death|0|||
149135049|NCT04427501|537974848|FG007|Overall Study|Death|0|||
149135050|NCT04427501|537974849|FG008|Overall Study|Death|0|||
149135051|NCT04427501|537974850|FG009|Overall Study|Death|0|||
149135052|NCT04427501|537974851|FG010|Overall Study|Death|0|||
149135053|NCT04427501|537974852|FG011|Overall Study|Death|0|||
149135054|NCT04427501|537974841|FG000|Overall Study|Lost to Follow-up|5|||
149135055|NCT04427501|537974842|FG001|Overall Study|Lost to Follow-up|1|||
149135056|NCT04427501|537974843|FG002|Overall Study|Lost to Follow-up|2|||
149135057|NCT04427501|537974844|FG003|Overall Study|Lost to Follow-up|0|||
149135058|NCT04427501|537974845|FG004|Overall Study|Lost to Follow-up|2|||
149135059|NCT04427501|537974846|FG005|Overall Study|Lost to Follow-up|11|||
149135060|NCT04427501|537974847|FG006|Overall Study|Lost to Follow-up|10|||
149135061|NCT04427501|537974848|FG007|Overall Study|Lost to Follow-up|10|||
149135062|NCT04427501|537974849|FG008|Overall Study|Lost to Follow-up|2|||
149135063|NCT04427501|537974850|FG009|Overall Study|Lost to Follow-up|5|||
149135064|NCT04427501|537974851|FG010|Overall Study|Lost to Follow-up|2|||
149135065|NCT04427501|537974852|FG011|Overall Study|Lost to Follow-up|0|||
149135066|NCT04427501|537974841|FG000|Overall Study|Physician Decision|0|||
149135067|NCT04427501|537974842|FG001|Overall Study|Physician Decision|3|||
149135068|NCT04427501|537974843|FG002|Overall Study|Physician Decision|0|||
149135069|NCT04427501|537974844|FG003|Overall Study|Physician Decision|0|||
149135070|NCT04427501|537974845|FG004|Overall Study|Physician Decision|0|||
149135071|NCT04427501|537974846|FG005|Overall Study|Physician Decision|0|||
149135072|NCT04427501|537974847|FG006|Overall Study|Physician Decision|2|||
149135073|NCT04427501|537974848|FG007|Overall Study|Physician Decision|0|||
149135074|NCT04427501|537974849|FG008|Overall Study|Physician Decision|0|||
149135075|NCT04427501|537974850|FG009|Overall Study|Physician Decision|0|||
149135076|NCT04427501|537974851|FG010|Overall Study|Physician Decision|0|||
149135077|NCT04427501|537974852|FG011|Overall Study|Physician Decision|0|||
149135078|NCT04427501|537974841|FG000|Overall Study|Withdrawal by Subject|9|||
149135079|NCT04427501|537974842|FG001|Overall Study|Withdrawal by Subject|2|||
149135080|NCT04427501|537974843|FG002|Overall Study|Withdrawal by Subject|2|||
149135081|NCT04427501|537974844|FG003|Overall Study|Withdrawal by Subject|3|||
149135082|NCT04427501|537974845|FG004|Overall Study|Withdrawal by Subject|7|||
149135083|NCT04427501|537974846|FG005|Overall Study|Withdrawal by Subject|25|||
149135084|NCT04427501|537974847|FG006|Overall Study|Withdrawal by Subject|15|||
149135085|NCT04427501|537974848|FG007|Overall Study|Withdrawal by Subject|7|||
149135086|NCT04427501|537974849|FG008|Overall Study|Withdrawal by Subject|4|||
149135087|NCT04427501|537974850|FG009|Overall Study|Withdrawal by Subject|1|||
149135088|NCT04427501|537974851|FG010|Overall Study|Withdrawal by Subject|4|||
149135089|NCT04427501|537974852|FG011|Overall Study|Withdrawal by Subject|0|||
149135090|NCT04427501|537974841|FG000|Overall Study|Other - as reported by the investigator|1|||
149135091|NCT04427501|537974842|FG001|Overall Study|Other - as reported by the investigator|0|||
149135092|NCT04427501|537974843|FG002|Overall Study|Other - as reported by the investigator|0|||
149135093|NCT04427501|537974844|FG003|Overall Study|Other - as reported by the investigator|0|||
149135094|NCT04427501|537974845|FG004|Overall Study|Other - as reported by the investigator|0|||
149135095|NCT04427501|537974846|FG005|Overall Study|Other - as reported by the investigator|6|||
149135096|NCT04427501|537974847|FG006|Overall Study|Other - as reported by the investigator|6|||
149135097|NCT04427501|537974848|FG007|Overall Study|Other - as reported by the investigator|0|||
149135098|NCT04427501|537974849|FG008|Overall Study|Other - as reported by the investigator|0|||
149135099|NCT04427501|537974850|FG009|Overall Study|Other - as reported by the investigator|0|||
149135100|NCT04427501|537974851|FG010|Overall Study|Other - as reported by the investigator|0|||
149135101|NCT04427501|537974852|FG011|Overall Study|Other - as reported by the investigator|0|||
149135102|NCT04427501|537974841|FG000|Overall Study|Other|0|||
149135103|NCT04427501|537974842|FG001|Overall Study|Other|0|||
149135104|NCT04427501|537974843|FG002|Overall Study|Other|0|||
149135105|NCT04427501|537974844|FG003|Overall Study|Other|0|||
149135106|NCT04427501|537974845|FG004|Overall Study|Other|0|||
149135107|NCT04427501|537974846|FG005|Overall Study|Other|0|||
149135108|NCT04427501|537974847|FG006|Overall Study|Other|0|||
149135109|NCT04427501|537974848|FG007|Overall Study|Other|0|||
149135110|NCT04427501|537974849|FG008|Overall Study|Other|0|||
149135111|NCT04427501|537974850|FG009|Overall Study|Other|0|||
149135112|NCT04427501|537974851|FG010|Overall Study|Other|0|||
149135113|NCT04427501|537974852|FG011|Overall Study|Other|1|||
149135114|NCT04936841|537974855|FG000|Overall Study|Death|1|||
149135115|NCT00639223|537974856|FG000|Overall Study|Lost to Follow-up|0|||
149135116|NCT00639223|537974857|FG001|Overall Study|Lost to Follow-up|2|||
149135117|NCT04201821|537974862|FG000|Overall Study|Withdrawal by Subject|2|||
149135118|NCT01890148|537976349|FG000|Overall Study|Adverse Event|1|||
149236688|NCT04044690|538336702|FG001|Period 1|Adverse Event|2|||
149236689|NCT04044690|538336701|FG000|Period 1|Physician Decision|0|||
149236690|NCT04044690|538336702|FG001|Period 1|Physician Decision|1|||
149236691|NCT04044690|538336701|FG000|Period 1|Withdrawal by Subject|2|||
149236692|NCT04044690|538336702|FG001|Period 1|Withdrawal by Subject|5|||
149236693|NCT04044690|538336701|FG000|Period 1|Protocol Deviation|2|||
149236694|NCT04044690|538336702|FG001|Period 1|Protocol Deviation|0|||
149236695|NCT04044690|538336701|FG000|Period 1|Site Terminated by Sponsor|0|||
149236696|NCT04044690|538336702|FG001|Period 1|Site Terminated by Sponsor|1|||
149236697|NCT04044690|538336701|FG000|Period 1|Study Terminated by Sponsor|0|||
149236698|NCT04044690|538336702|FG001|Period 1|Study Terminated by Sponsor|1|||
149236699|NCT04044690|538336701|FG000|Period 1|Death|1|||
149236700|NCT04044690|538336702|FG001|Period 1|Death|1|||
149236701|NCT04044690|538336701|FG000|Period 1|Other: Unspecified|1|||
149236702|NCT04044690|538336702|FG001|Period 1|Other: Unspecified|0|||
149236703|NCT04044690|538336701|FG000|Period 2|Lack of Efficacy|0|||
149236704|NCT04044690|538336702|FG001|Period 2|Lack of Efficacy|1|||
149236705|NCT04044690|538336701|FG000|Period 2|Adverse Event|0|||
149236706|NCT04044690|538336702|FG001|Period 2|Adverse Event|1|||
149236707|NCT04044690|538336701|FG000|Period 2|Physician Decision|0|||
149236708|NCT04044690|538336702|FG001|Period 2|Physician Decision|2|||
149236709|NCT04044690|538336701|FG000|Period 2|Withdrawal by Subject|5|||
149236710|NCT04044690|538336702|FG001|Period 2|Withdrawal by Subject|5|||
149236711|NCT04044690|538336701|FG000|Period 2|Lost to Follow-up|0|||
149236712|NCT04044690|538336702|FG001|Period 2|Lost to Follow-up|1|||
149236713|NCT04044690|538336701|FG000|Period 2|Site Terminated by Sponsor|1|||
149236714|NCT04044690|538336702|FG001|Period 2|Site Terminated by Sponsor|3|||
149236715|NCT04044690|538336701|FG000|Period 2|Study Terminated by Sponsor|8|||
149236716|NCT04044690|538336702|FG001|Period 2|Study Terminated by Sponsor|3|||
149236717|NCT04044690|538336701|FG000|Period 2|Death|1|||
149236718|NCT04044690|538336702|FG001|Period 2|Death|0|||
149236719|NCT04044690|538336701|FG000|Period 2|Other: Unspecified|1|||
149236720|NCT04044690|538336702|FG001|Period 2|Other: Unspecified|1|||
149236721|NCT04044690|538336701|FG000|Period 3|Site Terminated by Sponsor|1|||
149236722|NCT04044690|538336702|FG001|Period 3|Site Terminated by Sponsor|2|||
149236723|NCT04044690|538336701|FG000|Period 3|Study Terminated by Sponsor|24|||
149236724|NCT04044690|538336702|FG001|Period 3|Study Terminated by Sponsor|18|||
149236725|NCT04044690|538336701|FG000|Period 3|Missing|0|||
149236726|NCT04044690|538336702|FG001|Period 3|Missing|2|||
149236727|NCT06132659|538336703|FG000|Overall Study|Lost to Follow-up|0|||
149236728|NCT06132659|538336704|FG001|Overall Study|Lost to Follow-up|1|||
149236729|NCT06132659|538336705|FG002|Overall Study|Lost to Follow-up|0|||
149236730|NCT05876351|538336708|FG000|Overall Study|Other than specified|2|||
149236731|NCT05876351|538336708|FG000|Overall Study|Study specific discontinuation criteria|1|||
149236732|NCT03914326|538336709|FG000|Overall Study|Withdrawal by Subject|27|||
149135119|NCT01215175|537976350|FG000|Overall Study|Lost to Follow-up|0|||
149135120|NCT01215175|537976351|FG001|Overall Study|Lost to Follow-up|1|||
149135121|NCT01215175|537976352|FG002|Overall Study|Lost to Follow-up|0|||
149135122|NCT01215175|537976353|FG003|Overall Study|Lost to Follow-up|1|||
149135123|NCT01215175|537976354|FG004|Overall Study|Lost to Follow-up|0|||
149135124|NCT03872453|537976355|FG000|Overall Study|Adverse Event|1|||
149135125|NCT03872453|537976356|FG001|Overall Study|Adverse Event|1|||
149135126|NCT03872453|537976357|FG002|Overall Study|Adverse Event|0|||
149135127|NCT03872453|537976358|FG003|Overall Study|Adverse Event|0|||
149135128|NCT03872453|537976355|FG000|Overall Study|Lost to Follow-up|8|||
149135129|NCT03872453|537976356|FG001|Overall Study|Lost to Follow-up|7|||
149135130|NCT03872453|537976357|FG002|Overall Study|Lost to Follow-up|4|||
149135131|NCT03872453|537976358|FG003|Overall Study|Lost to Follow-up|4|||
149135132|NCT03872453|537976355|FG000|Overall Study|Never Treated Migraine|19|||
149135133|NCT03872453|537976356|FG001|Overall Study|Never Treated Migraine|17|||
149135134|NCT03872453|537976357|FG002|Overall Study|Never Treated Migraine|13|||
149135135|NCT03872453|537976358|FG003|Overall Study|Never Treated Migraine|12|||
149135136|NCT03872453|537976355|FG000|Overall Study|Pregnancy|1|||
149135137|NCT03872453|537976356|FG001|Overall Study|Pregnancy|0|||
149135138|NCT03872453|537976357|FG002|Overall Study|Pregnancy|0|||
149135139|NCT03872453|537976358|FG003|Overall Study|Pregnancy|0|||
149135140|NCT03872453|537976355|FG000|Overall Study|Protocol Deviation|2|||
149135141|NCT03872453|537976356|FG001|Overall Study|Protocol Deviation|0|||
149135142|NCT03872453|537976357|FG002|Overall Study|Protocol Deviation|0|||
149135143|NCT03872453|537976358|FG003|Overall Study|Protocol Deviation|2|||
149135144|NCT03872453|537976355|FG000|Overall Study|Withdrawal by Subject|0|||
149135145|NCT03872453|537976356|FG001|Overall Study|Withdrawal by Subject|1|||
149135146|NCT03872453|537976357|FG002|Overall Study|Withdrawal by Subject|2|||
149135147|NCT03872453|537976358|FG003|Overall Study|Withdrawal by Subject|0|||
149236733|NCT03914326|538336710|FG001|Overall Study|Withdrawal by Subject|34|||
149236734|NCT03914326|538336709|FG000|Overall Study|Lost to Follow-up|43|||
149135148|NCT03872453|537976355|FG000|Overall Study|Other Than Specified|1|||
149236735|NCT03914326|538336710|FG001|Overall Study|Lost to Follow-up|51|||
149236736|NCT03914326|538336709|FG000|Overall Study|Randomised more than once|0|||
149236737|NCT03914326|538336710|FG001|Overall Study|Randomised more than once|1|||
149236738|NCT04478708|538336711|FG000|Overall Study|Lost to Follow-up|0|||
148794595|NCT02308228|536725800|FG000|Overall Study|Adverse Event|3|||
149236739|NCT04478708|538336712|FG001|Overall Study|Lost to Follow-up|0|||
149236740|NCT04478708|538336713|FG002|Overall Study|Lost to Follow-up|0|||
149236741|NCT04478708|538336714|FG003|Overall Study|Lost to Follow-up|0|||
149236742|NCT04478708|538336715|FG004|Overall Study|Lost to Follow-up|0|||
149236743|NCT04478708|538336716|FG005|Overall Study|Lost to Follow-up|0|||
149236744|NCT04478708|538336717|FG006|Overall Study|Lost to Follow-up|0|||
149236745|NCT04478708|538336718|FG007|Overall Study|Lost to Follow-up|0|||
149236746|NCT04478708|538336719|FG008|Overall Study|Lost to Follow-up|1|||
149236747|NCT04478708|538336720|FG009|Overall Study|Lost to Follow-up|1|||
149236748|NCT04478708|538336721|FG010|Overall Study|Lost to Follow-up|1|||
149236749|NCT04478708|538336722|FG011|Overall Study|Lost to Follow-up|2|||
149236750|NCT04478708|538336723|FG012|Overall Study|Lost to Follow-up|1|||
149236751|NCT04478708|538336724|FG013|Overall Study|Lost to Follow-up|0|||
149236752|NCT04478708|538336725|FG014|Overall Study|Lost to Follow-up|0|||
149236753|NCT04478708|538336726|FG015|Overall Study|Lost to Follow-up|0|||
149236754|NCT04478708|538336727|FG016|Overall Study|Lost to Follow-up|0|||
149236755|NCT04478708|538336711|FG000|Overall Study|Withdrawal of consent from study|0|||
149236756|NCT04478708|538336712|FG001|Overall Study|Withdrawal of consent from study|1|||
149236757|NCT04478708|538336713|FG002|Overall Study|Withdrawal of consent from study|2|||
149236758|NCT04478708|538336714|FG003|Overall Study|Withdrawal of consent from study|0|||
149236759|NCT04478708|538336715|FG004|Overall Study|Withdrawal of consent from study|1|||
149236760|NCT04478708|538336716|FG005|Overall Study|Withdrawal of consent from study|1|||
149236761|NCT04478708|538336717|FG006|Overall Study|Withdrawal of consent from study|1|||
149236762|NCT04478708|538336718|FG007|Overall Study|Withdrawal of consent from study|0|||
149236763|NCT04478708|538336719|FG008|Overall Study|Withdrawal of consent from study|0|||
149236764|NCT04478708|538336720|FG009|Overall Study|Withdrawal of consent from study|0|||
149236765|NCT04478708|538336721|FG010|Overall Study|Withdrawal of consent from study|4|||
149236766|NCT04478708|538336722|FG011|Overall Study|Withdrawal of consent from study|3|||
149236767|NCT04478708|538336723|FG012|Overall Study|Withdrawal of consent from study|0|||
149236768|NCT04478708|538336724|FG013|Overall Study|Withdrawal of consent from study|0|||
149236769|NCT04478708|538336725|FG014|Overall Study|Withdrawal of consent from study|1|||
149236770|NCT04478708|538336726|FG015|Overall Study|Withdrawal of consent from study|0|||
149236771|NCT04478708|538336727|FG016|Overall Study|Withdrawal of consent from study|4|||
149236772|NCT04168385|538336728|FG000|Overall Study|Withdrawal by Subject|1|||
149236773|NCT04168385|538336729|FG001|Overall Study|Withdrawal by Subject|0|||
149236774|NCT04168385|538336728|FG000|Overall Study|Adverse Event|2|||
149236775|NCT04168385|538336729|FG001|Overall Study|Adverse Event|1|||
149236776|NCT04168385|538336728|FG000|Overall Study|Liver transplant|3|||
149236777|NCT04168385|538336729|FG001|Overall Study|Liver transplant|1|||
149236778|NCT04168385|538336728|FG000|Overall Study|Listed for liver transplant|1|||
149236779|NCT04168385|538336729|FG001|Overall Study|Listed for liver transplant|0|||
149236780|NCT01869114|538336730|FG000|Overall Study|Death|19|||
149236781|NCT01869114|538336731|FG001|Overall Study|Death|18|||
149236782|NCT01869114|538336732|FG002|Overall Study|Death|8|||
149236783|NCT01869114|538336730|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
149236784|NCT01869114|538336731|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
149236785|NCT01869114|538336732|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
149236786|NCT01869114|538336730|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
149236787|NCT01869114|538336731|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
149236788|NCT01869114|538336732|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
149236789|NCT01869114|538336730|FG000|Overall Study|Withdrawal by Subject|0|||
149236790|NCT01869114|538336731|FG001|Overall Study|Withdrawal by Subject|3|||
148794596|NCT02308228|536725801|FG001|Overall Study|Adverse Event|4|||
148794597|NCT02308228|536725800|FG000|Overall Study|Withdrawal by Subject|5|||
148794598|NCT02308228|536725801|FG001|Overall Study|Withdrawal by Subject|3|||
148794599|NCT01845597|536727180|FG000|Overall Study|Death|8|||
148794600|NCT01845597|536727180|FG000|Overall Study|Lost to Follow-up|22|||
148794601|NCT00956839|536727187|FG000|Overall Study|Lost to Follow-up|3|||
148794602|NCT00956839|536727188|FG001|Overall Study|Lost to Follow-up|0|||
148794603|NCT00956839|536727189|FG002|Overall Study|Lost to Follow-up|3|||
148794604|NCT03506438|536727190|FG000|Overall Study|Lost to Follow-up|8|||
148794605|NCT03506438|536727191|FG001|Overall Study|Lost to Follow-up|7|||
148794606|NCT03506438|536727192|FG002|Overall Study|Lost to Follow-up|8|||
148794607|NCT03506438|536727193|FG003|Overall Study|Lost to Follow-up|7|||
148794608|NCT03506438|536727194|FG004|Overall Study|Lost to Follow-up|0|||
149011444|NCT02778399|537521472|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
149011445|NCT02778399|537521473|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
149236791|NCT01869114|538336732|FG002|Overall Study|Withdrawal by Subject|0|||
149236792|NCT01869114|538336730|FG000|Overall Study|Disease Progression|0|||
149236793|NCT01869114|538336731|FG001|Overall Study|Disease Progression|1|||
149236794|NCT01869114|538336732|FG002|Overall Study|Disease Progression|0|||
149236795|NCT03323502|538336733|FG000|Overall Study|Resident could not be linked to CMS data|594|||
149236796|NCT03323502|538336734|FG001|Overall Study|Resident could not be linked to CMS data|435|||
148794609|NCT03506438|536727195|FG005|Overall Study|Lost to Follow-up|0|||
149236797|NCT03323502|538336733|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
149236798|NCT03323502|538336734|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
149236799|NCT03323502|538336733|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
149236800|NCT03323502|538336734|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
148794610|NCT01128296|536727196|FG000|Overall Study|Physician Decision|0|||
148794611|NCT01128296|536727197|FG001|Overall Study|Physician Decision|0|||
148794612|NCT01128296|536727198|FG002|Overall Study|Physician Decision|0|||
149236801|NCT03323502|538336733|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
149236802|NCT03323502|538336734|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
149236803|NCT03323502|538336733|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
149236804|NCT03323502|538336734|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
149236805|NCT03615326|538336735|FG000|Overall Study|Death|266|||
149236806|NCT03615326|538336736|FG001|Overall Study|Death|286|||
149236807|NCT03615326|538336737|FG002|Overall Study|Death|14|||
149236808|NCT03615326|538336738|FG003|Overall Study|Death|17|||
149236809|NCT03615326|538336735|FG000|Overall Study|Lost to Follow-up|0|||
149236810|NCT03615326|538336736|FG001|Overall Study|Lost to Follow-up|1|||
149236811|NCT03615326|538336737|FG002|Overall Study|Lost to Follow-up|0|||
149236812|NCT03615326|538336738|FG003|Overall Study|Lost to Follow-up|0|||
149236813|NCT03615326|538336735|FG000|Overall Study|Withdrawal by Subject|1|||
149236814|NCT03615326|538336736|FG001|Overall Study|Withdrawal by Subject|3|||
149236815|NCT03615326|538336737|FG002|Overall Study|Withdrawal by Subject|0|||
149236816|NCT03615326|538336738|FG003|Overall Study|Withdrawal by Subject|0|||
149236817|NCT03615326|538336735|FG000|Overall Study|Participants Ongoing|83|||
149236818|NCT03615326|538336736|FG001|Overall Study|Participants Ongoing|58|||
149236819|NCT03615326|538336737|FG002|Overall Study|Participants Ongoing|6|||
149236820|NCT03615326|538336738|FG003|Overall Study|Participants Ongoing|3|||
149236821|NCT05472142|538336739|FG000|Total Participants|Lost to Follow-up|312|||
149236822|NCT05472142|538336740|FG001|Total Participants|Lost to Follow-up|0|||
149236823|NCT05472142|538336739|FG000|Clinic Patients|Lost to Follow-up|312|||
149236824|NCT05472142|538336740|FG001|Clinic Patients|Lost to Follow-up|0|||
149236825|NCT03794583|538336741|FG000|Overall Study|Death|8|||
149236826|NCT03794583|538336741|FG000|Overall Study|Study Terminated by Sponsor|24|||
149236827|NCT03794583|538336741|FG000|Overall Study|Withdrawal by Subject|9|||
149236828|NCT04703192|538336747|FG000|Overall Study|Withdrawal by Subject|2|||
149236829|NCT04703192|538336748|FG001|Overall Study|Withdrawal by Subject|0|||
149236830|NCT04703192|538336747|FG000|Overall Study|Death|3|||
149236831|NCT04703192|538336748|FG001|Overall Study|Death|1|||
149236832|NCT04703192|538336747|FG000|Overall Study|Adverse Event|13|||
149236833|NCT04703192|538336748|FG001|Overall Study|Adverse Event|2|||
149236834|NCT04703192|538336747|FG000|Overall Study|Progressive or Relapsed Disease|46|||
149236835|NCT04703192|538336748|FG001|Overall Study|Progressive or Relapsed Disease|7|||
149236836|NCT04703192|538336747|FG000|Overall Study|Clinical Progression|19|||
149236837|NCT04703192|538336748|FG001|Overall Study|Clinical Progression|8|||
149236838|NCT04703192|538336747|FG000|Overall Study|Lost to Follow-up|1|||
148794613|NCT01128296|536727199|FG003|Overall Study|Physician Decision|0|||
148794614|NCT01128296|536727200|FG004|Overall Study|Physician Decision|0|||
148794615|NCT01128296|536727201|FG005|Overall Study|Physician Decision|3|||
148794616|NCT01128296|536727196|FG000|Overall Study|Withdrawal by Subject|0|||
148794617|NCT01128296|536727197|FG001|Overall Study|Withdrawal by Subject|0|||
148794618|NCT01128296|536727198|FG002|Overall Study|Withdrawal by Subject|0|||
148794619|NCT01128296|536727199|FG003|Overall Study|Withdrawal by Subject|0|||
148794620|NCT01128296|536727200|FG004|Overall Study|Withdrawal by Subject|0|||
148794621|NCT01128296|536727201|FG005|Overall Study|Withdrawal by Subject|2|||
148794622|NCT00994110|536727204|FG000|Overall Study|Withdrawal by Subject|9|||
148794623|NCT00994110|536727205|FG001|Overall Study|Withdrawal by Subject|9|||
148794624|NCT00994110|536727204|FG000|Overall Study|Not Treated|4|||
148794625|NCT00994110|536727205|FG001|Overall Study|Not Treated|8|||
148794626|NCT00994110|536727204|FG000|Overall Study|Adverse Event|1|||
148794627|NCT00994110|536727205|FG001|Overall Study|Adverse Event|0|||
148794628|NCT00994110|536727204|FG000|Overall Study|Patient not resected|41|||
148794629|NCT00994110|536727205|FG001|Overall Study|Patient not resected|52|||
148794630|NCT00994110|536727204|FG000|Overall Study|Pt not eligible|10|||
148794631|NCT00994110|536727205|FG001|Overall Study|Pt not eligible|5|||
148794632|NCT01914393|536727206|FG000|Overall Study|Protocol Violation|11|||
148794633|NCT01914393|536727207|FG001|Overall Study|Protocol Violation|3|||
148794634|NCT01914393|536727208|FG002|Overall Study|Protocol Violation|19|||
149236839|NCT04703192|538336748|FG001|Overall Study|Lost to Follow-up|0|||
149236840|NCT04703192|538336747|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
148794635|NCT01914393|536727206|FG000|Overall Study|Lack of Efficacy|11|||
148794636|NCT01914393|536727207|FG001|Overall Study|Lack of Efficacy|16|||
148794637|NCT01914393|536727208|FG002|Overall Study|Lack of Efficacy|5|||
148794638|NCT01914393|536727206|FG000|Overall Study|no reason given|14|||
148794639|NCT01914393|536727207|FG001|Overall Study|no reason given|8|||
149236841|NCT04703192|538336748|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
149236842|NCT04703192|538336747|FG000|Overall Study|Other|5|||
149236843|NCT04703192|538336748|FG001|Overall Study|Other|1|||
149236844|NCT03207711|538336749|FG000|Overall Study|Withdrawal by Subject|1|||
149236845|NCT03207711|538336750|FG001|Overall Study|Withdrawal by Subject|2|||
149236846|NCT05108649|538336751|FG000|Overall Study|Lost to Follow-up|0|||
149236847|NCT05108649|538336752|FG001|Overall Study|Lost to Follow-up|4|||
149236848|NCT05108649|538336753|FG002|Overall Study|Lost to Follow-up|3|||
149236849|NCT05108649|538336754|FG003|Overall Study|Lost to Follow-up|6|||
149236850|NCT05108649|538336751|FG000|Overall Study|Not Interested|1|||
149236851|NCT05108649|538336752|FG001|Overall Study|Not Interested|1|||
149236852|NCT05108649|538336753|FG002|Overall Study|Not Interested|0|||
149236853|NCT05108649|538336754|FG003|Overall Study|Not Interested|1|||
149236854|NCT05108649|538336751|FG000|Overall Study|Out of area|0|||
149236855|NCT05108649|538336752|FG001|Overall Study|Out of area|0|||
149236856|NCT05108649|538336753|FG002|Overall Study|Out of area|0|||
149236857|NCT05108649|538336754|FG003|Overall Study|Out of area|1|||
149236858|NCT05108649|538336751|FG000|Overall Study|PI decision|1|||
149236859|NCT05108649|538336752|FG001|Overall Study|PI decision|0|||
148894632|NCT00179621|537093953|FG002|Open-Label Period|Death|1|||
149135149|NCT03872453|537976356|FG001|Overall Study|Other Than Specified|0|||
149135150|NCT03872453|537976357|FG002|Overall Study|Other Than Specified|0|||
149135151|NCT03872453|537976358|FG003|Overall Study|Other Than Specified|0|||
149135152|NCT01678209|537976359|FG000|Overall Study|could not scan twice|1|||
149135153|NCT01678209|537976360|FG001|Overall Study|could not scan twice|1|||
149135154|NCT01678209|537976361|FG002|Overall Study|could not scan twice|1|||
149135155|NCT01678209|537976359|FG000|Overall Study|scheduling conflicts|0|||
149135156|NCT01678209|537976360|FG001|Overall Study|scheduling conflicts|0|||
149135157|NCT01678209|537976361|FG002|Overall Study|scheduling conflicts|1|||
149135158|NCT01678209|537976359|FG000|Overall Study|screen fail|16|||
149135159|NCT01678209|537976360|FG001|Overall Study|screen fail|17|||
148894633|NCT00179621|537093954|FG003|Open-Label Period|Death|2|||
148894634|NCT00179621|537093951|FG000|Open-Label Period|Other|0|||
148894635|NCT00179621|537093952|FG001|Open-Label Period|Other|1|||
148894636|NCT00179621|537093953|FG002|Open-Label Period|Other|1|||
148894637|NCT00179621|537093954|FG003|Open-Label Period|Other|2|||
148894638|NCT01908426|537093956|FG000|Overall Study|Adverse Event|98|||
148894639|NCT01908426|537093957|FG001|Overall Study|Adverse Event|11|||
148894640|NCT01908426|537093956|FG000|Overall Study|Clinical Deterioration|72|||
148894641|NCT01908426|537093957|FG001|Overall Study|Clinical Deterioration|38|||
148894642|NCT01908426|537093956|FG000|Overall Study|Lack of Efficacy|3|||
148894643|NCT01908426|537093957|FG001|Overall Study|Lack of Efficacy|0|||
148894644|NCT01908426|537093956|FG000|Overall Study|Lost to Follow-up|0|||
148894645|NCT01908426|537093957|FG001|Overall Study|Lost to Follow-up|1|||
148894646|NCT01908426|537093956|FG000|Overall Study|Physician Decision|3|||
148894647|NCT01908426|537093957|FG001|Overall Study|Physician Decision|3|||
148894648|NCT01908426|537093956|FG000|Overall Study|Withdrawal by Subject|11|||
149236860|NCT05108649|538336753|FG002|Overall Study|PI decision|0|||
149236861|NCT05108649|538336754|FG003|Overall Study|PI decision|0|||
149236862|NCT05108649|538336751|FG000|Overall Study|Significant Non-Compliance|0|||
149236863|NCT05108649|538336752|FG001|Overall Study|Significant Non-Compliance|1|||
149236864|NCT05108649|538336753|FG002|Overall Study|Significant Non-Compliance|0|||
149236865|NCT05108649|538336754|FG003|Overall Study|Significant Non-Compliance|0|||
149236866|NCT05108649|538336751|FG000|Overall Study|Unable to adhere to study protocol|0|||
149236867|NCT05108649|538336752|FG001|Overall Study|Unable to adhere to study protocol|2|||
149236868|NCT05108649|538336753|FG002|Overall Study|Unable to adhere to study protocol|0|||
149236869|NCT05108649|538336754|FG003|Overall Study|Unable to adhere to study protocol|0|||
149236870|NCT04798781|538336759|FG000|Overall Study|Withdrawal by Subject|1|||
149236871|NCT03260504|538336760|FG000|Overall Study|Adverse Event|0|||
149236872|NCT03260504|538336761|FG001|Overall Study|Adverse Event|1|||
149236873|NCT00846742|538336763|FG000|Overall Study|Withdrawal by Subject|1|||
149236874|NCT05289830|538336768|FG000|Overall Study|Lost to Follow-up|1|||
149236875|NCT05289830|538336769|FG001|Overall Study|Lost to Follow-up|1|||
149236876|NCT05289830|538336768|FG000|Overall Study|Physician Decision|0|||
149236877|NCT05289830|538336769|FG001|Overall Study|Physician Decision|1|||
149236878|NCT02699697|538336770|FG000|Overall Study|Death|18|||
148894649|NCT01908426|537093957|FG001|Overall Study|Withdrawal by Subject|6|||
148894650|NCT01908426|537093956|FG000|Overall Study|Progressive Disease|206|||
148894651|NCT01908426|537093957|FG001|Overall Study|Progressive Disease|152|||
148894652|NCT01908426|537093956|FG000|Overall Study|Protocol Violation|1|||
148894653|NCT01908426|537093957|FG001|Overall Study|Protocol Violation|0|||
148894654|NCT01908426|537093956|FG000|Overall Study|No Study Treatment Given|3|||
148894655|NCT01908426|537093957|FG001|Overall Study|No Study Treatment Given|0|||
148894656|NCT03346434|537093958|FG000|Overall Study|Randomized in Error|0|||
149135160|NCT01678209|537976361|FG002|Overall Study|screen fail|16|||
149135161|NCT03756350|537976362|FG000|Overall Study|Lost to Follow-up|1|||
149135162|NCT01096342|537976365|FG000|Overall Study|Protocol Violation|1|||
149135163|NCT03083847|537976370|FG000|Main|Physician Decision|0|||
149135164|NCT03083847|537976371|FG001|Main|Physician Decision|0|||
149236879|NCT02699697|538336771|FG001|Overall Study|Death|15|||
149236880|NCT02699697|538336770|FG000|Overall Study|Physician Decision|0|||
149236881|NCT02699697|538336771|FG001|Overall Study|Physician Decision|1|||
149236882|NCT02699697|538336770|FG000|Overall Study|Lost to Follow-up|2|||
149236883|NCT02699697|538336771|FG001|Overall Study|Lost to Follow-up|3|||
149236884|NCT02699697|538336770|FG000|Overall Study|Refused to follow up|1|||
149236885|NCT02699697|538336771|FG001|Overall Study|Refused to follow up|1|||
149236886|NCT02699697|538336770|FG000|Overall Study|Entered hospice care|5|||
149236887|NCT02699697|538336771|FG001|Overall Study|Entered hospice care|2|||
149236888|NCT02699697|538336770|FG000|Overall Study|Missing reason for discontinuation|6|||
149236889|NCT02699697|538336771|FG001|Overall Study|Missing reason for discontinuation|5|||
149236890|NCT02362035|538336772|FG000|Overall Study|Death|67|||
149236891|NCT02362035|538336772|FG000|Overall Study|Lost to Follow-up|3|||
149236892|NCT02362035|538336772|FG000|Overall Study|Adverse Event|1|||
149236893|NCT02362035|538336772|FG000|Overall Study|Physician Decision|1|||
149236894|NCT02362035|538336772|FG000|Overall Study|Subject started another cancer therapy|10|||
149236895|NCT02362035|538336772|FG000|Overall Study|Study terminated by sponsor|45|||
149236896|NCT02362035|538336772|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
149236897|NCT02362035|538336772|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
149236898|NCT02362035|538336772|FG000|Overall Study|Disease progression|11|||
149236899|NCT02362035|538336772|FG000|Overall Study|Withdrawal by Subject|20|||
149236900|NCT01046825|538336775|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
149236901|NCT01046825|538336776|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
149236902|NCT01046825|538336777|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
149236903|NCT01046825|538336778|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
149236904|NCT01046825|538336779|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
149236905|NCT01046825|538336775|FG000|Overall Study|Physician Decision|0|||
149236906|NCT01046825|538336776|FG001|Overall Study|Physician Decision|1|||
149236907|NCT01046825|538336777|FG002|Overall Study|Physician Decision|2|||
149236908|NCT01046825|538336778|FG003|Overall Study|Physician Decision|0|||
149236909|NCT01046825|538336779|FG004|Overall Study|Physician Decision|0|||
149236910|NCT01046825|538336775|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
149236911|NCT01046825|538336776|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
149236912|NCT01046825|538336777|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
149236913|NCT01046825|538336778|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
149236914|NCT01046825|538336779|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
149236915|NCT01046825|538336775|FG000|Overall Study|Found to be ineligible|0|||
149236916|NCT01046825|538336776|FG001|Overall Study|Found to be ineligible|1|||
149236917|NCT01046825|538336777|FG002|Overall Study|Found to be ineligible|0|||
149236918|NCT01046825|538336778|FG003|Overall Study|Found to be ineligible|0|||
149236919|NCT01046825|538336779|FG004|Overall Study|Found to be ineligible|0|||
149236920|NCT01046825|538336775|FG000|Overall Study|Death|0|||
149236921|NCT01046825|538336776|FG001|Overall Study|Death|0|||
149135165|NCT03083847|537976372|FG002|Main|Physician Decision|0|||
149135166|NCT03083847|537976373|FG003|Main|Physician Decision|0|||
149135167|NCT03083847|537976374|FG004|Main|Physician Decision|0|||
149135168|NCT03083847|537976375|FG005|Main|Physician Decision|1|||
149135169|NCT03083847|537976376|FG006|Main|Physician Decision|0|||
149135170|NCT03083847|537976377|FG007|Main|Physician Decision|0|||
149135171|NCT03083847|537976378|FG008|Main|Physician Decision|0|||
149011446|NCT02778399|537521474|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
149011447|NCT02778399|537521475|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
149011448|NCT02778399|537521470|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
149011449|NCT02778399|537521471|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
149011450|NCT02778399|537521472|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
149011451|NCT02778399|537521473|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
149011452|NCT02778399|537521474|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
149011453|NCT02778399|537521475|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
149135172|NCT03083847|537976379|FG009|Main|Physician Decision|0|||
149135173|NCT03083847|537976370|FG000|Main|Pregnancy|0|||
149135174|NCT03083847|537976371|FG001|Main|Pregnancy|0|||
149135175|NCT03083847|537976372|FG002|Main|Pregnancy|0|||
149135176|NCT03083847|537976373|FG003|Main|Pregnancy|0|||
149135177|NCT03083847|537976374|FG004|Main|Pregnancy|0|||
149135178|NCT03083847|537976375|FG005|Main|Pregnancy|0|||
149236922|NCT01046825|538336777|FG002|Overall Study|Death|0|||
149236923|NCT01046825|538336778|FG003|Overall Study|Death|1|||
149236924|NCT01046825|538336779|FG004|Overall Study|Death|0|||
149236925|NCT01046825|538336775|FG000|Overall Study|Did not submit biology samples|0|||
149135179|NCT03083847|537976376|FG006|Main|Pregnancy|0|||
149135180|NCT03083847|537976377|FG007|Main|Pregnancy|1|||
149135181|NCT03083847|537976378|FG008|Main|Pregnancy|0|||
149135182|NCT03083847|537976379|FG009|Main|Pregnancy|0|||
149135183|NCT03083847|537976370|FG000|Main|Adverse Event|0|||
149135184|NCT03083847|537976371|FG001|Main|Adverse Event|0|||
149135185|NCT03083847|537976372|FG002|Main|Adverse Event|0|||
149135186|NCT03083847|537976373|FG003|Main|Adverse Event|0|||
149135187|NCT03083847|537976374|FG004|Main|Adverse Event|0|||
148794640|NCT01914393|536727208|FG002|Overall Study|no reason given|16|||
148794641|NCT01914393|536727206|FG000|Overall Study|Adverse Event|29|||
148794642|NCT01914393|536727207|FG001|Overall Study|Adverse Event|18|||
148794643|NCT01914393|536727208|FG002|Overall Study|Adverse Event|31|||
148794644|NCT01914393|536727206|FG000|Overall Study|Withdrawal by Subject|38|||
148794645|NCT01914393|536727207|FG001|Overall Study|Withdrawal by Subject|20|||
148794646|NCT01914393|536727208|FG002|Overall Study|Withdrawal by Subject|47|||
149135188|NCT03083847|537976375|FG005|Main|Adverse Event|0|||
149135189|NCT03083847|537976376|FG006|Main|Adverse Event|0|||
149135190|NCT03083847|537976377|FG007|Main|Adverse Event|2|||
149135191|NCT03083847|537976378|FG008|Main|Adverse Event|0|||
149135192|NCT03083847|537976379|FG009|Main|Adverse Event|0|||
149135193|NCT03083847|537976370|FG000|Main|Withdrawal by Subject|0|||
149135194|NCT03083847|537976371|FG001|Main|Withdrawal by Subject|0|||
149135195|NCT03083847|537976372|FG002|Main|Withdrawal by Subject|0|||
149135196|NCT03083847|537976373|FG003|Main|Withdrawal by Subject|0|||
149135197|NCT03083847|537976374|FG004|Main|Withdrawal by Subject|0|||
149135198|NCT03083847|537976375|FG005|Main|Withdrawal by Subject|0|||
149135199|NCT03083847|537976376|FG006|Main|Withdrawal by Subject|1|||
149135200|NCT03083847|537976377|FG007|Main|Withdrawal by Subject|1|||
149135201|NCT03083847|537976378|FG008|Main|Withdrawal by Subject|0|||
149135202|NCT03083847|537976379|FG009|Main|Withdrawal by Subject|0|||
149135203|NCT01807923|537976389|FG000|Overall Study|Adverse Event|2|||
149135204|NCT01807923|537976390|FG001|Overall Study|Adverse Event|1|||
149135205|NCT01807923|537976391|FG002|Overall Study|Adverse Event|2|||
149135206|NCT01807923|537976389|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
149135207|NCT01807923|537976390|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
149135208|NCT01807923|537976391|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
149135209|NCT01807923|537976389|FG000|Overall Study|Physician Decision|0|||
149135210|NCT01807923|537976390|FG001|Overall Study|Physician Decision|0|||
149135211|NCT01807923|537976391|FG002|Overall Study|Physician Decision|1|||
149135212|NCT01807923|537976389|FG000|Overall Study|Not Eligible (Genotype)|0|||
149135213|NCT01807923|537976390|FG001|Overall Study|Not Eligible (Genotype)|0|||
149135214|NCT01807923|537976391|FG002|Overall Study|Not Eligible (Genotype)|1|||
149135215|NCT01807923|537976389|FG000|Overall Study|Randomized But Not Treated|3|||
149135216|NCT01807923|537976390|FG001|Overall Study|Randomized But Not Treated|2|||
149135217|NCT01807923|537976391|FG002|Overall Study|Randomized But Not Treated|5|||
149135218|NCT03836807|537976393|FG000|Overall Study|Physician Decision|1|||
149135219|NCT03836807|537976394|FG001|Overall Study|Physician Decision|0|||
149135220|NCT00685685|537976395|FG000|Washout Period of 7 Days|Adverse Event|2|||
149135221|NCT00685685|537976396|FG001|Washout Period of 7 Days|Adverse Event|0|||
149135222|NCT00685685|537976395|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
149135223|NCT00685685|537976396|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149135224|NCT04029116|537976397|FG000|Overall Study|Adverse Event|0|||
149135225|NCT04029116|537976398|FG001|Overall Study|Adverse Event|2|||
149135226|NCT04029116|537976397|FG000|Overall Study|Lost to Follow-up|3|||
149135227|NCT04029116|537976398|FG001|Overall Study|Lost to Follow-up|5|||
149135228|NCT04029116|537976397|FG000|Overall Study|Physician Decision|2|||
149135229|NCT04029116|537976398|FG001|Overall Study|Physician Decision|0|||
149135230|NCT04029116|537976397|FG000|Overall Study|Pregnancy|1|||
149135231|NCT04029116|537976398|FG001|Overall Study|Pregnancy|2|||
149135232|NCT04029116|537976397|FG000|Overall Study|Withdrawal by Subject|4|||
149135233|NCT04029116|537976398|FG001|Overall Study|Withdrawal by Subject|6|||
149135234|NCT04029116|537976397|FG000|Overall Study|Other|2|||
149135235|NCT04029116|537976398|FG001|Overall Study|Other|1|||
149135236|NCT01272947|537976399|FG000|Overall Study|Abnormal Laboratory Value|2|||
149135237|NCT01272947|537976400|FG001|Overall Study|Abnormal Laboratory Value|2|||
149135238|NCT02469896|537976403|FG000|Overall Study|Withdrawal by Subject|2|||
149135239|NCT02469896|537976404|FG001|Overall Study|Withdrawal by Subject|0|||
149135240|NCT02019420|537976405|FG000|Overall Study|Did not receive study drug|2|||
149135241|NCT02019420|537976406|FG001|Overall Study|Did not receive study drug|2|||
149135242|NCT02019420|537976405|FG000|Overall Study|Withdrawal by Subject|1|||
149135243|NCT02019420|537976406|FG001|Overall Study|Withdrawal by Subject|3|||
149135244|NCT02019420|537976405|FG000|Overall Study|At request of sponsor or investigator|0|||
149135245|NCT02019420|537976406|FG001|Overall Study|At request of sponsor or investigator|1|||
149135246|NCT02019420|537976405|FG000|Overall Study|Death|104|||
149135247|NCT02019420|537976406|FG001|Overall Study|Death|99|||
149135248|NCT02019420|537976405|FG000|Overall Study|Transferred to other care facility|1|||
149135249|NCT02019420|537976406|FG001|Overall Study|Transferred to other care facility|1|||
149135250|NCT00882310|537976407|FG000|Overall Study|Screen Failure|10|||
149135251|NCT00882310|537976407|FG000|Overall Study|Never received treatment|1|||
149135252|NCT00882310|537976407|FG000|Overall Study|Death|6|||
149135253|NCT00882310|537976407|FG000|Overall Study|Progression of disease|4|||
148794647|NCT01914393|536727206|FG000|Overall Study|Lost to Follow-up|12|||
149135254|NCT00882310|537976407|FG000|Overall Study|Adverse Event|1|||
149135255|NCT01093625|537976408|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
149135256|NCT01093625|537976409|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
149135257|NCT01093625|537976408|FG000|2-Week Visit|Withdrawal by Subject|1|||
149236926|NCT01046825|538336776|FG001|Overall Study|Did not submit biology samples|0|||
149236927|NCT01046825|538336777|FG002|Overall Study|Did not submit biology samples|0|||
149236928|NCT01046825|538336778|FG003|Overall Study|Did not submit biology samples|0|||
149236929|NCT01046825|538336779|FG004|Overall Study|Did not submit biology samples|13|||
149236930|NCT05587296|538336786|FG000|Overall Study|Adverse Event|15|||
149236931|NCT05587296|538336787|FG001|Overall Study|Adverse Event|7|||
149236932|NCT05587296|538336786|FG000|Overall Study|Lack of Efficacy|2|||
149236933|NCT05587296|538336787|FG001|Overall Study|Lack of Efficacy|0|||
149236934|NCT05587296|538336786|FG000|Overall Study|Lost to Follow-up|1|||
149236935|NCT05587296|538336787|FG001|Overall Study|Lost to Follow-up|0|||
149236936|NCT05587296|538336786|FG000|Overall Study|Withdrawal by Subject|14|||
149236937|NCT05587296|538336787|FG001|Overall Study|Withdrawal by Subject|4|||
149236938|NCT05587296|538336786|FG000|Overall Study|miscellaneous|3|||
149236939|NCT05587296|538336787|FG001|Overall Study|miscellaneous|6|||
149236940|NCT05587296|538336786|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
149236941|NCT05587296|538336787|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
149236942|NCT05868954|538336788|FG000|Overall Study|Lost to Follow-up|0|||
149236943|NCT05868954|538336789|FG001|Overall Study|Lost to Follow-up|1|||
149236944|NCT05868954|538336788|FG000|Overall Study|Withdrawal by Subject|2|||
149236945|NCT05868954|538336789|FG001|Overall Study|Withdrawal by Subject|2|||
149236946|NCT05868954|538336788|FG000|Overall Study|Participant delivered|1|||
149236947|NCT05868954|538336789|FG001|Overall Study|Participant delivered|1|||
149236948|NCT05868954|538336788|FG000|Overall Study|Miscarriage|0|||
149236949|NCT05868954|538336789|FG001|Overall Study|Miscarriage|1|||
149236950|NCT05469113|538336790|FG000|Period 2|Adverse Event|0|||
149236951|NCT05469113|538336791|FG001|Period 2|Adverse Event|3|||
149236952|NCT02847624|538336796|FG000|Overall Study|Lost to Follow-up|28|||
149236953|NCT02847624|538336796|FG000|Overall Study|Protocol Violation|98|||
149236954|NCT02847624|538336796|FG000|Overall Study|Case report failures|4|||
149236955|NCT02872311|538336797|FG000|Overall Study|Death|2|||
149236956|NCT02872311|538336798|FG001|Overall Study|Death|0|||
149236957|NCT02872311|538336799|FG002|Overall Study|Death|0|||
149135258|NCT01093625|537976409|FG001|2-Week Visit|Withdrawal by Subject|0|||
149135259|NCT01093625|537976408|FG000|1-Month Visit|Lost to Follow-up|2|||
149135260|NCT01093625|537976409|FG001|1-Month Visit|Lost to Follow-up|0|||
149135261|NCT01093625|537976408|FG000|3-Month Visit|Lost to Follow-up|2|||
149135262|NCT01093625|537976409|FG001|3-Month Visit|Lost to Follow-up|0|||
149135263|NCT01093625|537976408|FG000|6-Month Visit|Withdrawal by Subject|6|||
149135264|NCT01093625|537976409|FG001|6-Month Visit|Withdrawal by Subject|7|||
149135265|NCT01093625|537976408|FG000|6-Month Visit|Lost to Follow-up|2|||
149135266|NCT01093625|537976409|FG001|6-Month Visit|Lost to Follow-up|2|||
149135267|NCT01093625|537976408|FG000|1-Year Visit|Lost to Follow-up|5|||
149135268|NCT01093625|537976409|FG001|1-Year Visit|Lost to Follow-up|3|||
149135269|NCT04233164|537976416|FG000|Overall Study|Unable to obtain specimen|0|||
149135270|NCT04233164|537976417|FG001|Overall Study|Unable to obtain specimen|1|||
149135271|NCT01843218|537976422|FG000|Overall Study|Withdrawal by Subject|5|||
149135272|NCT01431534|537976423|FG000|Treatment Phase|Adverse Event|0|||
149135273|NCT01431534|537976424|FG001|Treatment Phase|Adverse Event|0|||
149135274|NCT01431534|537976425|FG002|Treatment Phase|Adverse Event|1|||
149135275|NCT01431534|537976423|FG000|Treatment Phase|Progressive Disease|4|||
149135276|NCT01431534|537976424|FG001|Treatment Phase|Progressive Disease|3|||
149135277|NCT01431534|537976425|FG002|Treatment Phase|Progressive Disease|10|||
149135278|NCT02540538|537976427|FG000|Overall Study|Pregnancy|0|||
149135279|NCT02540538|537976428|FG001|Overall Study|Pregnancy|1|||
149135280|NCT02540538|537976429|FG002|Overall Study|Pregnancy|0|||
149135281|NCT01557348|537976430|FG000|Overall Study|Adverse Event|6|||
149135282|NCT01557348|537976431|FG001|Overall Study|Adverse Event|16|||
149135283|NCT01557348|537976430|FG000|Overall Study|Infusion reaction event|5|||
149135284|NCT01557348|537976431|FG001|Overall Study|Infusion reaction event|5|||
149135285|NCT01557348|537976430|FG000|Overall Study|Death|7|||
149135286|NCT01557348|537976431|FG001|Overall Study|Death|4|||
149135287|NCT01557348|537976430|FG000|Overall Study|Insufficient Therapeutic Response|13|||
149236958|NCT02872311|538336800|FG003|Overall Study|Death|0|||
149135288|NCT01557348|537976431|FG001|Overall Study|Insufficient Therapeutic Response|28|||
149135289|NCT01557348|537976430|FG000|Overall Study|Withdrawal by Subject|5|||
149135290|NCT01557348|537976431|FG001|Overall Study|Withdrawal by Subject|4|||
149135291|NCT01557348|537976430|FG000|Overall Study|Lost to Follow-up|26|||
149135292|NCT01557348|537976431|FG001|Overall Study|Lost to Follow-up|22|||
149135293|NCT01557348|537976430|FG000|Overall Study|Administrative|18|||
149135294|NCT01557348|537976431|FG001|Overall Study|Administrative|11|||
149135295|NCT04598477|537976434|FG000|Overall Study|Adverse Event|2|||
149236959|NCT02872311|538336801|FG004|Overall Study|Death|0|||
149236960|NCT02872311|538336797|FG000|Overall Study|Lost to Follow-up|2|||
149236961|NCT02872311|538336798|FG001|Overall Study|Lost to Follow-up|0|||
149236962|NCT02872311|538336799|FG002|Overall Study|Lost to Follow-up|0|||
149236963|NCT02872311|538336800|FG003|Overall Study|Lost to Follow-up|0|||
149236964|NCT02872311|538336801|FG004|Overall Study|Lost to Follow-up|0|||
149236965|NCT02872311|538336797|FG000|Overall Study|Protocol Violation|0|||
149236966|NCT02872311|538336798|FG001|Overall Study|Protocol Violation|2|||
149236967|NCT02872311|538336799|FG002|Overall Study|Protocol Violation|1|||
149236968|NCT02872311|538336800|FG003|Overall Study|Protocol Violation|0|||
149236969|NCT02872311|538336801|FG004|Overall Study|Protocol Violation|0|||
149236970|NCT03483584|538336802|FG000|Overall Study|Lost to Follow-up|40|||
149236971|NCT03483584|538336803|FG001|Overall Study|Lost to Follow-up|7|||
149236972|NCT03483584|538336802|FG000|Overall Study|Withdrawal by Subject|4|||
149236973|NCT03483584|538336803|FG001|Overall Study|Withdrawal by Subject|1|||
149236974|NCT01435798|538336804|FG000|Overall Study|Withdrawal by Subject|1|||
149236975|NCT04102098|538336805|FG000|Main Study Period|Ongoing in study|302|||
149236976|NCT04102098|538336806|FG001|Main Study Period|Ongoing in study|291|||
149236977|NCT04102098|538336805|FG000|Main Study Period|Death|20|||
149236978|NCT04102098|538336806|FG001|Main Study Period|Death|27|||
149236979|NCT04102098|538336805|FG000|Main Study Period|Lost to Follow-up|1|||
149236980|NCT04102098|538336806|FG001|Main Study Period|Lost to Follow-up|1|||
149236981|NCT04102098|538336805|FG000|Main Study Period|Physician Decision|0|||
149236982|NCT04102098|538336806|FG001|Main Study Period|Physician Decision|1|||
149236983|NCT04102098|538336805|FG000|Main Study Period|Withdrawal by Subject|11|||
149236984|NCT04102098|538336806|FG001|Main Study Period|Withdrawal by Subject|14|||
149236985|NCT04102098|538336805|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
149236986|NCT04102098|538336806|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
149236987|NCT04102098|538336805|FG000|Crossover: AS Who Crossed Over|Death|11|||
149236988|NCT04102098|538336806|FG001|Crossover: AS Who Crossed Over|Death|0|||
149236989|NCT04102098|538336805|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
149236990|NCT04102098|538336806|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
149236991|NCT04063163|538336807|FG000|Overall Study|Death|281|||
149236992|NCT04063163|538336808|FG001|Overall Study|Death|166|||
149236993|NCT04063163|538336807|FG000|Overall Study|Lost to Follow-up|12|||
149236994|NCT04063163|538336808|FG001|Overall Study|Lost to Follow-up|8|||
149236995|NCT04063163|538336807|FG000|Overall Study|Withdrawal by Subject|19|||
149236996|NCT04063163|538336808|FG001|Overall Study|Withdrawal by Subject|10|||
149236997|NCT05617911|538336809|FG000|Overall Study|Withdrawal by Subject|1|||
149236998|NCT05617911|538336810|FG001|Overall Study|Withdrawal by Subject|0|||
149236999|NCT04868903|538336821|FG000|Overall Study|Adverse Event|0|||
149237000|NCT04868903|538336822|FG001|Overall Study|Adverse Event|0|||
149237001|NCT04868903|538336823|FG002|Overall Study|Adverse Event|0|||
149237002|NCT04868903|538336824|FG003|Overall Study|Adverse Event|1|||
149237003|NCT04868903|538336821|FG000|Overall Study|Withdrawal by Subject|29|||
149237004|NCT04868903|538336822|FG001|Overall Study|Withdrawal by Subject|44|||
149237005|NCT04868903|538336823|FG002|Overall Study|Withdrawal by Subject|17|||
149237006|NCT04868903|538336824|FG003|Overall Study|Withdrawal by Subject|12|||
149237007|NCT04868903|538336821|FG000|Overall Study|Hyperparathyroidism|3|||
149237008|NCT04868903|538336822|FG001|Overall Study|Hyperparathyroidism|5|||
149237009|NCT04868903|538336823|FG002|Overall Study|Hyperparathyroidism|2|||
149237010|NCT04868903|538336824|FG003|Overall Study|Hyperparathyroidism|3|||
149237011|NCT03975647|538336825|FG000|Overall Study|Death|71|||
149237012|NCT03975647|538336826|FG001|Overall Study|Death|63|||
149237013|NCT03975647|538336825|FG000|Overall Study|Lost to Follow-up|2|||
149237014|NCT03975647|538336826|FG001|Overall Study|Lost to Follow-up|2|||
149237015|NCT03975647|538336825|FG000|Overall Study|Subject withdrawal of consent|7|||
149237016|NCT03975647|538336826|FG001|Overall Study|Subject withdrawal of consent|11|||
149237017|NCT03449901|538336827|FG000|Overall Study|Progression|57|||
149237018|NCT03449901|538336828|FG001|Overall Study|Progression|12|||
149237019|NCT03449901|538336827|FG000|Overall Study|Adverse Event|3|||
149237020|NCT03449901|538336828|FG001|Overall Study|Adverse Event|0|||
149237021|NCT03449901|538336827|FG000|Overall Study|Death|6|||
149237022|NCT03449901|538336828|FG001|Overall Study|Death|2|||
149237023|NCT03449901|538336827|FG000|Overall Study|Withdrawal by Subject|12|||
149237024|NCT03449901|538336828|FG001|Overall Study|Withdrawal by Subject|1|||
149237025|NCT03449901|538336827|FG000|Overall Study|Physician Decision|1|||
149237026|NCT03449901|538336828|FG001|Overall Study|Physician Decision|0|||
149237027|NCT03449901|538336827|FG000|Overall Study|Patient elected for surgical intervention|1|||
149237028|NCT03449901|538336828|FG001|Overall Study|Patient elected for surgical intervention|0|||
149237029|NCT03449901|538336827|FG000|Overall Study|Patient off for other complicating disease|1|||
149237030|NCT03449901|538336828|FG001|Overall Study|Patient off for other complicating disease|0|||
149237031|NCT03150173|538336829|FG000|Overall Study|Lost to Follow-up|13|||
149237032|NCT03150173|538336830|FG001|Overall Study|Lost to Follow-up|5|||
149237033|NCT02275533|538336831|FG000|Overall Study|Protocol Violation|2|||
149237034|NCT02275533|538336832|FG001|Overall Study|Protocol Violation|0|||
149237035|NCT02275533|538336831|FG000|Overall Study|Never received study treatment|1|||
149237036|NCT02275533|538336832|FG001|Overall Study|Never received study treatment|0|||
149237037|NCT03735667|538336833|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
149237038|NCT03735667|538336834|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
149237039|NCT03735667|538336835|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
149237040|NCT03735667|538336833|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
149237041|NCT03735667|538336834|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
149237042|NCT03735667|538336835|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
149237043|NCT03735667|538336833|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
149237044|NCT03735667|538336834|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
149237045|NCT03735667|538336835|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
149237046|NCT03735667|538336833|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
149237047|NCT03735667|538336834|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
149237048|NCT03735667|538336835|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
149237049|NCT03735667|538336833|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
149237050|NCT03735667|538336834|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
149237051|NCT03735667|538336835|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
149237052|NCT03735667|538336833|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
149237053|NCT03735667|538336834|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
149237054|NCT03735667|538336835|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
149237055|NCT03735667|538336833|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
149237056|NCT03735667|538336834|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
149237057|NCT03735667|538336835|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
149237058|NCT03735667|538336833|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
149237059|NCT03735667|538336834|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
149237060|NCT03735667|538336835|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
149237061|NCT03735667|538336833|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
149237062|NCT03735667|538336834|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
149237063|NCT03735667|538336835|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
149237064|NCT03735667|538336833|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
149237065|NCT03735667|538336834|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
149237066|NCT03735667|538336835|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
149237067|NCT03735667|538336833|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
149237068|NCT03735667|538336834|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
149237069|NCT03735667|538336835|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
149237070|NCT03735667|538336833|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
149237071|NCT03735667|538336834|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
149237072|NCT03735667|538336835|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
149237073|NCT00984399|538336836|FG000|Overall Study|Adverse Event|0|||
149237074|NCT00984399|538336837|FG001|Overall Study|Adverse Event|1|||
149237075|NCT00984399|538336836|FG000|Overall Study|Physician Decision|1|||
149237076|NCT00984399|538336837|FG001|Overall Study|Physician Decision|0|||
149237077|NCT00984399|538336836|FG000|Overall Study|Withdrawal by Subject|1|||
149237078|NCT00984399|538336837|FG001|Overall Study|Withdrawal by Subject|1|||
149237079|NCT00984399|538336836|FG000|Overall Study|Protocol Violation|0|||
149237080|NCT00984399|538336837|FG001|Overall Study|Protocol Violation|1|||
149237081|NCT00984399|538336836|FG000|Overall Study|Pts did not start treatment|2|||
149237082|NCT00984399|538336837|FG001|Overall Study|Pts did not start treatment|2|||
149237083|NCT01723774|538336839|FG000|Neoadjuvant|Ki67 > 10%|4|||
149237084|NCT01723774|538336840|FG001|Neoadjuvant|Ki67 > 10%|0|||
149237085|NCT01723774|538336841|FG002|Neoadjuvant|Ki67 > 10%|10|||
149237086|NCT01723774|538336842|FG003|Neoadjuvant|Ki67 > 10%|0|||
149237087|NCT01723774|538336839|FG000|Neoadjuvant|Withdrawal by Subject|3|||
149237088|NCT01723774|538336840|FG001|Neoadjuvant|Withdrawal by Subject|1|||
149237089|NCT01723774|538336841|FG002|Neoadjuvant|Withdrawal by Subject|0|||
149237090|NCT01723774|538336842|FG003|Neoadjuvant|Withdrawal by Subject|0|||
149237091|NCT01723774|538336839|FG000|Neoadjuvant|Disease progression|0|||
149237092|NCT01723774|538336840|FG001|Neoadjuvant|Disease progression|1|||
149237093|NCT01723774|538336841|FG002|Neoadjuvant|Disease progression|1|||
149237094|NCT01723774|538336842|FG003|Neoadjuvant|Disease progression|0|||
149237095|NCT01723774|538336839|FG000|Neoadjuvant|Adverse Event|0|||
149237096|NCT01723774|538336840|FG001|Neoadjuvant|Adverse Event|1|||
149237097|NCT01723774|538336841|FG002|Neoadjuvant|Adverse Event|2|||
149237098|NCT01723774|538336842|FG003|Neoadjuvant|Adverse Event|0|||
149237099|NCT01723774|538336839|FG000|Neoadjuvant|High estradiol|0|||
149237100|NCT01723774|538336840|FG001|Neoadjuvant|High estradiol|1|||
149237101|NCT01723774|538336841|FG002|Neoadjuvant|High estradiol|0|||
149237102|NCT01723774|538336842|FG003|Neoadjuvant|High estradiol|0|||
149237103|NCT02964182|538336843|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149237104|NCT02964182|538336844|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
149237105|NCT02964182|538336845|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149237106|NCT02964182|538336846|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149237107|NCT02964182|538336847|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149237108|NCT02964182|538336848|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
149237109|NCT02964182|538336849|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149237110|NCT02964182|538336850|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
149237111|NCT02964182|538336843|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149237112|NCT02964182|538336844|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149237113|NCT02964182|538336845|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149237114|NCT02964182|538336846|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
148794648|NCT01914393|536727207|FG001|Overall Study|Lost to Follow-up|6|||
148794649|NCT01914393|536727208|FG002|Overall Study|Lost to Follow-up|19|||
148894657|NCT03346434|537093959|FG001|Overall Study|Randomized in Error|0|||
149237115|NCT02964182|538336847|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149237116|NCT02964182|538336848|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
149237117|NCT02964182|538336849|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149237118|NCT02964182|538336850|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
149237119|NCT02964182|538336843|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149237120|NCT02964182|538336844|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
149237121|NCT02964182|538336845|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149237122|NCT02964182|538336846|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149237123|NCT02964182|538336847|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149237124|NCT02964182|538336848|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
149237125|NCT02964182|538336849|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149237126|NCT02964182|538336850|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
149237127|NCT02964182|538336843|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149237128|NCT02964182|538336844|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149237129|NCT02964182|538336845|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
149237130|NCT02964182|538336846|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
149237131|NCT02964182|538336847|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149237132|NCT02964182|538336848|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149237133|NCT02964182|538336849|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
149237134|NCT02964182|538336850|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
149237135|NCT02964182|538336843|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149237136|NCT02964182|538336844|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149237137|NCT02964182|538336845|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
149237138|NCT02964182|538336846|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
149237139|NCT02964182|538336847|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149237140|NCT02964182|538336848|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149237141|NCT02964182|538336849|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
149237142|NCT02964182|538336850|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
149237143|NCT02964182|538336843|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149237144|NCT02964182|538336844|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149237145|NCT02964182|538336845|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
149237146|NCT02964182|538336846|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
149237147|NCT02964182|538336847|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149237148|NCT02964182|538336848|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149237149|NCT02964182|538336849|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149237150|NCT02964182|538336850|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
149237151|NCT02964182|538336843|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149237152|NCT02964182|538336844|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149237153|NCT02964182|538336845|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
149237154|NCT02964182|538336846|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
149237155|NCT02964182|538336847|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149237156|NCT02964182|538336848|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149237157|NCT02964182|538336849|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
149237158|NCT02964182|538336850|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
149237159|NCT03755791|538337907|FG000|Overall Study|Did not receive any study treatment|3|||
149237160|NCT03755791|538337908|FG001|Overall Study|Did not receive any study treatment|0|||
149237161|NCT03755791|538337909|FG002|Overall Study|Did not receive any study treatment|10|||
149237162|NCT03755791|538337907|FG000|Overall Study|Radiographic progression|204|||
149237163|NCT03755791|538337908|FG001|Overall Study|Radiographic progression|92|||
149237164|NCT03755791|538337909|FG002|Overall Study|Radiographic progression|115|||
149237165|NCT03755791|538337907|FG000|Overall Study|Adverse Event|140|||
149237166|NCT03755791|538337908|FG001|Overall Study|Adverse Event|60|||
149237167|NCT03755791|538337909|FG002|Overall Study|Adverse Event|51|||
149237168|NCT03755791|538337907|FG000|Overall Study|Lack of Efficacy|12|||
149237169|NCT03755791|538337908|FG001|Overall Study|Lack of Efficacy|6|||
149237170|NCT03755791|538337909|FG002|Overall Study|Lack of Efficacy|6|||
149237171|NCT03755791|538337907|FG000|Overall Study|Withdrawal by Subject|26|||
148894658|NCT03346434|537093960|FG002|Overall Study|Randomized in Error|0|||
148894659|NCT03346434|537093961|FG003|Overall Study|Randomized in Error|0|||
148894660|NCT03346434|537093962|FG004|Overall Study|Randomized in Error|1|||
148894661|NCT03346434|537093963|FG005|Overall Study|Randomized in Error|0|||
149237172|NCT03755791|538337908|FG001|Overall Study|Withdrawal by Subject|23|||
149237173|NCT03755791|538337909|FG002|Overall Study|Withdrawal by Subject|24|||
149237174|NCT03755791|538337907|FG000|Overall Study|Sponsor decision,|41|||
149237175|NCT03755791|538337908|FG001|Overall Study|Sponsor decision,|5|||
149237176|NCT03755791|538337909|FG002|Overall Study|Sponsor decision,|7|||
149237177|NCT03755791|538337907|FG000|Overall Study|Lost to Follow-up|1|||
149237178|NCT03755791|538337908|FG001|Overall Study|Lost to Follow-up|0|||
149237179|NCT03755791|538337909|FG002|Overall Study|Lost to Follow-up|2|||
149237180|NCT03755791|538337907|FG000|Overall Study|Protocol Violation|0|||
149237181|NCT03755791|538337908|FG001|Overall Study|Protocol Violation|0|||
149237182|NCT03755791|538337909|FG002|Overall Study|Protocol Violation|2|||
149237183|NCT03755791|538337907|FG000|Overall Study|Other than specified|5|||
149237184|NCT03755791|538337908|FG001|Overall Study|Other than specified|2|||
148894662|NCT03346434|537093958|FG000|Overall Study|Withdrawal by Subject|0|||
148894663|NCT03346434|537093959|FG001|Overall Study|Withdrawal by Subject|0|||
148894664|NCT03346434|537093960|FG002|Overall Study|Withdrawal by Subject|1|||
148894665|NCT03346434|537093961|FG003|Overall Study|Withdrawal by Subject|0|||
148894666|NCT03346434|537093962|FG004|Overall Study|Withdrawal by Subject|1|||
148894667|NCT03346434|537093963|FG005|Overall Study|Withdrawal by Subject|0|||
148894668|NCT03346434|537093958|FG000|Overall Study|Lost to Follow-up|0|||
148894669|NCT03346434|537093959|FG001|Overall Study|Lost to Follow-up|0|||
148894670|NCT03346434|537093960|FG002|Overall Study|Lost to Follow-up|0|||
148894671|NCT03346434|537093961|FG003|Overall Study|Lost to Follow-up|0|||
148894672|NCT03346434|537093962|FG004|Overall Study|Lost to Follow-up|1|||
148894673|NCT03346434|537093963|FG005|Overall Study|Lost to Follow-up|1|||
148894674|NCT03346434|537093958|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
148894675|NCT03346434|537093959|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
148894676|NCT03346434|537093960|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
148894677|NCT03346434|537093961|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
148894678|NCT03346434|537093962|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
148894679|NCT03346434|537093963|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
148894680|NCT03525444|537093967|FG000|Overall Study|Adverse Event|0|||
148894681|NCT03525444|537093968|FG001|Overall Study|Adverse Event|1|||
148894682|NCT03525444|537093967|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
148894683|NCT03525444|537093968|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
148894684|NCT03525444|537093967|FG000|Overall Study|Other|0|||
148894685|NCT03525444|537093968|FG001|Overall Study|Other|1|||
148894686|NCT00262860|537093972|FG000|Overall Study|Adverse Event|2|||
148894687|NCT02741128|537093973|FG000|Overall Study|Protocol Violation|4|||
148894688|NCT02741128|537093974|FG001|Overall Study|Protocol Violation|1|||
148894689|NCT02741128|537093973|FG000|Overall Study|Withdrawal by Subject|2|||
148894690|NCT02741128|537093974|FG001|Overall Study|Withdrawal by Subject|0|||
148894691|NCT02741128|537093973|FG000|Overall Study|Lost to Follow-up|1|||
148894692|NCT02741128|537093974|FG001|Overall Study|Lost to Follow-up|0|||
148894693|NCT02973100|537093975|FG000|Overall Study|Adverse Event|1|||
148894694|NCT02973100|537093976|FG001|Overall Study|Adverse Event|2|||
148894695|NCT02973100|537093977|FG002|Overall Study|Adverse Event|1|||
148894696|NCT02973100|537093978|FG003|Overall Study|Adverse Event|2|||
148894697|NCT02973100|537093975|FG000|Overall Study|Lost to Follow-up|3|||
148894698|NCT02973100|537093976|FG001|Overall Study|Lost to Follow-up|1|||
148894699|NCT02973100|537093977|FG002|Overall Study|Lost to Follow-up|1|||
148894700|NCT02973100|537093978|FG003|Overall Study|Lost to Follow-up|0|||
148894701|NCT02973100|537093975|FG000|Overall Study|Withdrawal by Subject|3|||
148894702|NCT02973100|537093976|FG001|Overall Study|Withdrawal by Subject|5|||
148894703|NCT02973100|537093977|FG002|Overall Study|Withdrawal by Subject|1|||
148894704|NCT02973100|537093978|FG003|Overall Study|Withdrawal by Subject|4|||
148894705|NCT02973100|537093975|FG000|Overall Study|Notification of change in address|0|||
148894706|NCT02973100|537093976|FG001|Overall Study|Notification of change in address|0|||
148894707|NCT02973100|537093977|FG002|Overall Study|Notification of change in address|0|||
148894708|NCT02973100|537093978|FG003|Overall Study|Notification of change in address|1|||
148894709|NCT02973100|537093975|FG000|Overall Study|Failed to attend Safety followup period|0|||
148894710|NCT02973100|537093976|FG001|Overall Study|Failed to attend Safety followup period|0|||
148894711|NCT02973100|537093977|FG002|Overall Study|Failed to attend Safety followup period|1|||
148894712|NCT02973100|537093978|FG003|Overall Study|Failed to attend Safety followup period|0|||
148894713|NCT01419769|537093979|FG000|Overall Study|Did not receive the AXIOS stent|3|||
148894714|NCT01419769|537093979|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
148894715|NCT00878501|537093980|FG000|Overall Study|Adverse Event|11|||
148894716|NCT00878501|537093981|FG001|Overall Study|Adverse Event|3|||
148894717|NCT00878501|537093982|FG002|Overall Study|Adverse Event|3|||
148894718|NCT00878501|537093980|FG000|Overall Study|Lack of Efficacy|2|||
148894719|NCT00878501|537093981|FG001|Overall Study|Lack of Efficacy|1|||
148894720|NCT00878501|537093982|FG002|Overall Study|Lack of Efficacy|0|||
148894721|NCT00878501|537093980|FG000|Overall Study|Withdrawal by Subject|2|||
148894722|NCT00878501|537093981|FG001|Overall Study|Withdrawal by Subject|1|||
148894723|NCT00878501|537093982|FG002|Overall Study|Withdrawal by Subject|2|||
148894724|NCT00878501|537093980|FG000|Overall Study|Protocol Violation|0|||
148894725|NCT00878501|537093981|FG001|Overall Study|Protocol Violation|0|||
148894726|NCT00878501|537093982|FG002|Overall Study|Protocol Violation|1|||
148894727|NCT00878501|537093980|FG000|Overall Study|Incorrect enrolment|1|||
148894728|NCT00878501|537093981|FG001|Overall Study|Incorrect enrolment|2|||
148894729|NCT00878501|537093982|FG002|Overall Study|Incorrect enrolment|0|||
148894730|NCT00878501|537093980|FG000|Overall Study|Intake of prohibited concom. medication|0|||
148894731|NCT00878501|537093981|FG001|Overall Study|Intake of prohibited concom. medication|0|||
148894732|NCT00878501|537093982|FG002|Overall Study|Intake of prohibited concom. medication|1|||
148894733|NCT00878501|537093980|FG000|Overall Study|Mis-randomisation of patient|1|||
148894734|NCT00878501|537093981|FG001|Overall Study|Mis-randomisation of patient|0|||
148894735|NCT00878501|537093982|FG002|Overall Study|Mis-randomisation of patient|0|||
148894736|NCT00878501|537093980|FG000|Overall Study|Administrative|0|||
148894737|NCT00878501|537093981|FG001|Overall Study|Administrative|0|||
149237185|NCT03755791|538337909|FG002|Overall Study|Other than specified|0|||
149237186|NCT01964404|538337910|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
149237187|NCT01964404|538337911|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
149237188|NCT01964404|538337912|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
149237189|NCT01964404|538337913|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
149237190|NCT01964404|538337914|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
149237191|NCT01964404|538337915|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
149237192|NCT01964404|538337916|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
149237193|NCT01964404|538337917|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
149237194|NCT01964404|538337918|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
149237195|NCT01964404|538337919|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
149237196|NCT01964404|538337910|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
149237197|NCT01964404|538337911|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
149237198|NCT01964404|538337912|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
149237199|NCT01964404|538337913|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
149237200|NCT01964404|538337914|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237201|NCT01964404|538337915|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237202|NCT01964404|538337916|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237203|NCT01964404|538337917|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237204|NCT01964404|538337918|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237205|NCT01964404|538337919|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237206|NCT01964404|538337910|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
149237207|NCT01964404|538337911|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
149237208|NCT01964404|538337912|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237209|NCT01964404|538337913|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
149237210|NCT01964404|538337914|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237211|NCT01964404|538337915|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237212|NCT01964404|538337916|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237213|NCT01964404|538337917|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237214|NCT01964404|538337918|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237215|NCT01964404|538337919|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
149237216|NCT05528510|538337920|FG000|Overall Study|Death|1|||
149237217|NCT05528510|538337921|FG001|Overall Study|Death|0|||
149237218|NCT05528510|538337922|FG002|Overall Study|Death|0|||
149237219|NCT05528510|538337920|FG000|Overall Study|Lost to Follow-up|1|||
149237220|NCT05528510|538337921|FG001|Overall Study|Lost to Follow-up|0|||
149237221|NCT05528510|538337922|FG002|Overall Study|Lost to Follow-up|0|||
149237222|NCT05528510|538337920|FG000|Overall Study|Withdrawal by Subject|4|||
149237223|NCT05528510|538337921|FG001|Overall Study|Withdrawal by Subject|1|||
149237224|NCT05528510|538337922|FG002|Overall Study|Withdrawal by Subject|3|||
148794650|NCT01914393|536727206|FG000|Overall Study|subject never dosed|0|||
148794651|NCT01914393|536727207|FG001|Overall Study|subject never dosed|0|||
148794652|NCT01914393|536727208|FG002|Overall Study|subject never dosed|1|||
148794653|NCT02806713|536727209|FG000|Overall Study|Urethral injury during procedure|1|||
148794654|NCT02806713|536727210|FG001|Overall Study|Urethral injury during procedure|0|||
148794655|NCT02806713|536727209|FG000|Overall Study|cancelled surgery|1|||
148794656|NCT02806713|536727210|FG001|Overall Study|cancelled surgery|2|||
148794657|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
148794658|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
148794659|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
148794660|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
148794661|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
148794662|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
148794663|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
148794664|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
148794665|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
148794666|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
148794667|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
148794668|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
148794669|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
148794670|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
148794671|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
148794672|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
148794673|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
149237225|NCT05528510|538337920|FG000|Overall Study|Other|2|||
149237226|NCT05528510|538337921|FG001|Overall Study|Other|2|||
149237227|NCT05528510|538337922|FG002|Overall Study|Other|1|||
149237228|NCT03109847|538337928|FG000|Overall Study|Withdrawal by Subject|1|||
148794674|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
148794675|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
149237229|NCT03109847|538337929|FG001|Overall Study|Withdrawal by Subject|0|||
149237230|NCT03212170|538337930|FG000|Overall Study|Withdrawal by Subject|1|||
148894738|NCT00878501|537093982|FG002|Overall Study|Administrative|1|||
148894739|NCT04416204|537093983|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
148894740|NCT04416204|537093984|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
148894741|NCT04416204|537093985|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
148894742|NCT04416204|537093986|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
148894743|NCT00812708|537093987|FG000|Overall Study|Device could not be implanted|2|||
148894744|NCT00812708|537093987|FG000|Overall Study|Lack of medical insurance|1|||
148894745|NCT00812708|537093987|FG000|Overall Study|Switched to another study|1|||
148894746|NCT00812708|537093987|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
148894747|NCT00812708|537093987|FG000|Overall Study|Signed consent but later withdrew|3|||
148894748|NCT01959503|537093991|FG000|Overall Study|Death|2|||
148894749|NCT01959503|537093992|FG001|Overall Study|Death|1|||
148894750|NCT01959503|537093991|FG000|Overall Study|Randomized but not treated|1|||
148894751|NCT01959503|537093992|FG001|Overall Study|Randomized but not treated|1|||
148894752|NCT01419236|537093993|FG000|Overall Study|Adverse Event|1|||
148894753|NCT01419236|537093994|FG001|Overall Study|Adverse Event|0|||
148894754|NCT01419236|537093993|FG000|Overall Study|Lack of Efficacy|0|||
148894755|NCT01419236|537093994|FG001|Overall Study|Lack of Efficacy|1|||
148894756|NCT01419236|537093993|FG000|Overall Study|Lost to Follow-up|1|||
148894757|NCT01419236|537093994|FG001|Overall Study|Lost to Follow-up|0|||
148894758|NCT01419236|537093993|FG000|Overall Study|Physician Decision|1|||
148894759|NCT01419236|537093994|FG001|Overall Study|Physician Decision|0|||
148894760|NCT01419236|537093993|FG000|Overall Study|Withdrawal by Subject|1|||
148894761|NCT01419236|537093994|FG001|Overall Study|Withdrawal by Subject|4|||
148894762|NCT01419236|537093993|FG000|Overall Study|Entry Criteria Not Met|1|||
149135296|NCT04598477|537976435|FG001|Overall Study|Adverse Event|0|||
148894763|NCT01419236|537093994|FG001|Overall Study|Entry Criteria Not Met|0|||
148894764|NCT03224130|537093998|FG000|Overall Study|consent issue|0|||
148894765|NCT03224130|537093999|FG001|Overall Study|consent issue|1|||
148894766|NCT03598036|537094004|FG000|Overall Study|Withdrawal by Subject|1|||
148894767|NCT03598036|537094005|FG001|Overall Study|Withdrawal by Subject|0|||
149135297|NCT04598477|537976434|FG000|Overall Study|Death|0|||
149135298|NCT04598477|537976435|FG001|Overall Study|Death|1|||
149135299|NCT04598477|537976434|FG000|Overall Study|Lost to Follow-up|1|||
149135300|NCT04598477|537976435|FG001|Overall Study|Lost to Follow-up|0|||
149135301|NCT04598477|537976434|FG000|Overall Study|Physician Decision|7|||
149135302|NCT04598477|537976435|FG001|Overall Study|Physician Decision|2|||
149135303|NCT04598477|537976434|FG000|Overall Study|Pregnancy|0|||
149135304|NCT04598477|537976435|FG001|Overall Study|Pregnancy|1|||
149135305|NCT04598477|537976434|FG000|Overall Study|Requires Prohibited Medication|0|||
149135306|NCT04598477|537976435|FG001|Overall Study|Requires Prohibited Medication|1|||
149135307|NCT04598477|537976434|FG000|Overall Study|Study Terminated by Sponsor|18|||
149135308|NCT04598477|537976435|FG001|Overall Study|Study Terminated by Sponsor|12|||
149135309|NCT04598477|537976434|FG000|Overall Study|Withdrawal by Subject|16|||
149135310|NCT04598477|537976435|FG001|Overall Study|Withdrawal by Subject|12|||
149135311|NCT04598477|537976434|FG000|Overall Study|Other|15|||
149135312|NCT04598477|537976435|FG001|Overall Study|Other|8|||
149135313|NCT05579990|537976441|FG000|Overall Study|Lost to Follow-up|3|||
149135314|NCT05118204|537976442|FG000|Overall Study|Lost to Follow-up|3|||
149135315|NCT05118204|537976443|FG001|Overall Study|Lost to Follow-up|2|||
149135316|NCT05118204|537976442|FG000|Overall Study|Withdrawal by Subject|0|||
149135317|NCT05118204|537976443|FG001|Overall Study|Withdrawal by Subject|2|||
149135318|NCT01313650|537976445|FG000|Overall Study|Adverse Event|9|||
149135319|NCT01313650|537976446|FG001|Overall Study|Adverse Event|34|||
149135320|NCT01313650|537976447|FG002|Overall Study|Adverse Event|24|||
149135321|NCT01313650|537976448|FG003|Overall Study|Adverse Event|23|||
149135322|NCT01313650|537976445|FG000|Overall Study|Lack of Efficacy|37|||
149135323|NCT01313650|537976446|FG001|Overall Study|Lack of Efficacy|20|||
149135324|NCT01313650|537976447|FG002|Overall Study|Lack of Efficacy|32|||
149135325|NCT01313650|537976448|FG003|Overall Study|Lack of Efficacy|20|||
149135326|NCT01313650|537976445|FG000|Overall Study|Lost to Follow-up|1|||
149135327|NCT01313650|537976446|FG001|Overall Study|Lost to Follow-up|0|||
149135328|NCT01313650|537976447|FG002|Overall Study|Lost to Follow-up|3|||
149135329|NCT01313650|537976448|FG003|Overall Study|Lost to Follow-up|2|||
149135330|NCT01313650|537976445|FG000|Overall Study|Withdrawal by Subject|16|||
149135331|NCT01313650|537976446|FG001|Overall Study|Withdrawal by Subject|20|||
149135332|NCT01313650|537976447|FG002|Overall Study|Withdrawal by Subject|15|||
149135333|NCT01313650|537976448|FG003|Overall Study|Withdrawal by Subject|15|||
149237231|NCT01570868|538337944|FG000|Overall Study|Adverse Event|8|||
148894768|NCT04124939|537094008|FG000|Overall Study|Lost to Follow-up|1|||
148894769|NCT04124939|537094009|FG001|Overall Study|Lost to Follow-up|3|||
149135334|NCT01313650|537976445|FG000|Overall Study|Protocol Violation|4|||
149135335|NCT01313650|537976446|FG001|Overall Study|Protocol Violation|7|||
149135336|NCT01313650|537976447|FG002|Overall Study|Protocol Violation|5|||
149135337|NCT01313650|537976448|FG003|Overall Study|Protocol Violation|6|||
149135338|NCT01313650|537976445|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
149135339|NCT01313650|537976446|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
149135340|NCT01313650|537976447|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
149135341|NCT01313650|537976448|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
149135342|NCT05393037|537976451|FG000|Part A|Death|1|||
149135343|NCT05393037|537976452|FG001|Part A|Death|0|||
149237232|NCT01570868|538337945|FG001|Overall Study|Adverse Event|1|||
149237233|NCT01570868|538337944|FG000|Overall Study|FDA Recommendation|23|||
149237234|NCT01570868|538337945|FG001|Overall Study|FDA Recommendation|3|||
149237235|NCT01570868|538337944|FG000|Overall Study|Physician Decision|10|||
149237236|NCT01570868|538337945|FG001|Overall Study|Physician Decision|4|||
149237237|NCT01570868|538337944|FG000|Overall Study|Lost to Follow-up|1|||
149237238|NCT01570868|538337945|FG001|Overall Study|Lost to Follow-up|0|||
149237239|NCT01570868|538337944|FG000|Overall Study|Withdrawal by Subject|1|||
149237240|NCT01570868|538337945|FG001|Overall Study|Withdrawal by Subject|0|||
149237241|NCT03205995|538337946|FG000|Overall Study|Adverse Event|1|||
149237242|NCT03205995|538337946|FG000|Overall Study|Death|1|||
149237243|NCT03205995|538337946|FG000|Overall Study|Physician Decision|2|||
149237244|NCT03205995|538337946|FG000|Overall Study|Protocol Violation|2|||
149237245|NCT05567172|538337947|FG000|Overall Study|Death|3|||
149237246|NCT04936308|538337948|FG000|Overall Study|Death|0|||
149237247|NCT04936308|538337949|FG001|Overall Study|Death|0|||
149237248|NCT04936308|538337950|FG002|Overall Study|Death|1|||
149237249|NCT04936308|538337948|FG000|Overall Study|Withdrawal by Subject|6|||
149237250|NCT04936308|538337949|FG001|Overall Study|Withdrawal by Subject|3|||
149237251|NCT04936308|538337950|FG002|Overall Study|Withdrawal by Subject|0|||
149237252|NCT04936308|538337948|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
149237253|NCT04936308|538337949|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
149237254|NCT04936308|538337950|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
149237255|NCT04936308|538337948|FG000|Overall Study|Completed protocol-required follow-up|1|||
149237256|NCT04936308|538337949|FG001|Overall Study|Completed protocol-required follow-up|2|||
149237257|NCT04936308|538337950|FG002|Overall Study|Completed protocol-required follow-up|2|||
149237258|NCT04936308|538337948|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
149237259|NCT04936308|538337949|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
149237260|NCT04936308|538337950|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
149237261|NCT04936308|538337948|FG000|Overall Study|Other|3|||
149237262|NCT04936308|538337949|FG001|Overall Study|Other|0|||
149237263|NCT04936308|538337950|FG002|Overall Study|Other|2|||
149237264|NCT03892746|538337951|FG000|Overall Study|Withdrawal by Subject|2|||
149237265|NCT03892746|538337952|FG001|Overall Study|Withdrawal by Subject|1|||
149237266|NCT03892746|538337951|FG000|Overall Study|Lost to Follow-up|2|||
149237267|NCT03892746|538337952|FG001|Overall Study|Lost to Follow-up|0|||
149237268|NCT04068610|538337953|FG000|Overall Study|Death|4|||
149237269|NCT04068610|538337954|FG001|Overall Study|Death|8|||
149237270|NCT04068610|538337955|FG002|Overall Study|Death|13|||
149237271|NCT04068610|538337953|FG000|Overall Study|Lost to Follow-up|0|||
149237272|NCT04068610|538337954|FG001|Overall Study|Lost to Follow-up|2|||
149237273|NCT04068610|538337955|FG002|Overall Study|Lost to Follow-up|0|||
149237274|NCT04068610|538337953|FG000|Overall Study|Withdrawal by Subject|0|||
149237275|NCT04068610|538337954|FG001|Overall Study|Withdrawal by Subject|4|||
149237276|NCT04068610|538337955|FG002|Overall Study|Withdrawal by Subject|2|||
149237277|NCT04068610|538337953|FG000|Overall Study|Other|3|||
149237278|NCT04068610|538337954|FG001|Overall Study|Other|12|||
149237279|NCT04068610|538337955|FG002|Overall Study|Other|11|||
149237280|NCT05535972|538337956|FG000|Overall Study|Withdrawal by Subject|31|||
149237281|NCT05535972|538337956|FG000|Overall Study|Lost to Follow-up|5|||
149237282|NCT05535972|538337956|FG000|Overall Study|Adverse Event|6|||
149237283|NCT05535972|538337956|FG000|Overall Study|Protocol Deviation|2|||
149237284|NCT03370276|538337957|FG000|Overall Study|Death|0|||
149237285|NCT03370276|538337958|FG001|Overall Study|Death|2|||
149237286|NCT03370276|538337959|FG002|Overall Study|Death|5|||
149237287|NCT03594994|538337961|FG000|Overall Study|Adverse Event|1|||
149237288|NCT03594994|538337962|FG001|Overall Study|Adverse Event|0|||
149237289|NCT03594994|538337961|FG000|Overall Study|Withdrawal by Subject|0|||
149237290|NCT03594994|538337962|FG001|Overall Study|Withdrawal by Subject|1|||
149237291|NCT02649894|538337963|FG000|Overall Study|Adverse Event|1|||
149237292|NCT02649894|538337964|FG001|Overall Study|Adverse Event|0|||
149237293|NCT02649894|538337963|FG000|Overall Study|Physician Decision|0|||
149237294|NCT02649894|538337964|FG001|Overall Study|Physician Decision|1|||
149237295|NCT02649894|538337963|FG000|Overall Study|Withdrawal by Subject|5|||
148794676|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
148794677|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
148794678|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
148794679|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
148794680|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
148794681|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
149237296|NCT02649894|538337964|FG001|Overall Study|Withdrawal by Subject|2|||
149237297|NCT02649894|538337963|FG000|Overall Study|Lost to Follow-up|2|||
149237298|NCT02649894|538337964|FG001|Overall Study|Lost to Follow-up|1|||
149237299|NCT02649894|538337963|FG000|Overall Study|Death|30|||
149237300|NCT02649894|538337964|FG001|Overall Study|Death|7|||
149237301|NCT02649894|538337963|FG000|Overall Study|Other, not specified|6|||
149237302|NCT02649894|538337964|FG001|Overall Study|Other, not specified|0|||
148894770|NCT02250326|537094014|FG000|Treatment|Death|1|||
148894771|NCT02250326|537094015|FG001|Treatment|Death|13|||
148894772|NCT02250326|537094016|FG002|Treatment|Death|2|||
148894773|NCT02250326|537094014|FG000|Treatment|Adverse Event|8|||
148894774|NCT02250326|537094015|FG001|Treatment|Adverse Event|8|||
148894775|NCT02250326|537094016|FG002|Treatment|Adverse Event|9|||
148894776|NCT02250326|537094014|FG000|Treatment|Progressive Disease|42|||
148894777|NCT02250326|537094015|FG001|Treatment|Progressive Disease|40|||
148894778|NCT02250326|537094016|FG002|Treatment|Progressive Disease|47|||
148894779|NCT02250326|537094014|FG000|Treatment|Symptomatic Deterioration|9|||
148894780|NCT02250326|537094015|FG001|Treatment|Symptomatic Deterioration|4|||
148894781|NCT02250326|537094016|FG002|Treatment|Symptomatic Deterioration|10|||
148894782|NCT02250326|537094014|FG000|Treatment|Withdrawal by Subject|11|||
148894783|NCT02250326|537094015|FG001|Treatment|Withdrawal by Subject|6|||
148894784|NCT02250326|537094016|FG002|Treatment|Withdrawal by Subject|4|||
148894785|NCT02250326|537094014|FG000|Treatment|Other reasons|8|||
148894786|NCT02250326|537094015|FG001|Treatment|Other reasons|7|||
148894787|NCT02250326|537094016|FG002|Treatment|Other reasons|7|||
148894788|NCT02250326|537094014|FG000|Extension Period|Progressive Disease|0|||
148894789|NCT02250326|537094015|FG001|Extension Period|Progressive Disease|2|||
148894790|NCT02250326|537094016|FG002|Extension Period|Progressive Disease|0|||
148894791|NCT02250326|537094014|FG000|Extension Period|Withdrawal by Subject|0|||
148894792|NCT02250326|537094015|FG001|Extension Period|Withdrawal by Subject|1|||
148894793|NCT02250326|537094016|FG002|Extension Period|Withdrawal by Subject|0|||
148894794|NCT02250326|537094014|FG000|Extension Period|Withdrawal by investigator|0|||
148894795|NCT02250326|537094015|FG001|Extension Period|Withdrawal by investigator|1|||
148894796|NCT02250326|537094016|FG002|Extension Period|Withdrawal by investigator|0|||
148894797|NCT04516746|537094017|FG000|Overall Study|Randomized but not Treated|51|||
148894798|NCT04516746|537094018|FG001|Overall Study|Randomized but not Treated|19|||
148894799|NCT04516746|537094017|FG000|Overall Study|Adverse Event|0|||
148894800|NCT04516746|537094018|FG001|Overall Study|Adverse Event|1|||
149135344|NCT05393037|537976451|FG000|Part A|Lost to Follow-up|1|||
149135345|NCT05393037|537976452|FG001|Part A|Lost to Follow-up|1|||
149135346|NCT05393037|537976451|FG000|Part A|Withdrawal by Subject|2|||
149135347|NCT05393037|537976452|FG001|Part A|Withdrawal by Subject|4|||
148894801|NCT04516746|537094017|FG000|Overall Study|Death|62|||
148894802|NCT04516746|537094018|FG001|Overall Study|Death|32|||
148894803|NCT04516746|537094017|FG000|Overall Study|Lost to Follow-up|3431|||
148894804|NCT04516746|537094018|FG001|Overall Study|Lost to Follow-up|1831|||
148894805|NCT04516746|537094017|FG000|Overall Study|Withdrawal by Subject|1946|||
148894806|NCT04516746|537094018|FG001|Overall Study|Withdrawal by Subject|1696|||
148894807|NCT04516746|537094017|FG000|Overall Study|Physician Decision|10|||
148894808|NCT04516746|537094018|FG001|Overall Study|Physician Decision|8|||
148894809|NCT04516746|537094017|FG000|Overall Study|Other|35|||
148894810|NCT04516746|537094018|FG001|Overall Study|Other|16|||
148894811|NCT01194830|537094022|FG000|Overall Study|Adverse Event|3|||
148894812|NCT01194830|537094023|FG001|Overall Study|Adverse Event|2|||
148894813|NCT01194830|537094022|FG000|Overall Study|Protocol Violation|5|||
148894814|NCT01194830|537094023|FG001|Overall Study|Protocol Violation|4|||
148894815|NCT01194830|537094022|FG000|Overall Study|Lost to Follow-up|9|||
148894816|NCT01194830|537094023|FG001|Overall Study|Lost to Follow-up|7|||
148894817|NCT01194830|537094022|FG000|Overall Study|Withdrawal by Subject|2|||
148894818|NCT01194830|537094023|FG001|Overall Study|Withdrawal by Subject|1|||
148894819|NCT01194830|537094022|FG000|Overall Study|Lack of Efficacy|1|||
148894820|NCT01194830|537094023|FG001|Overall Study|Lack of Efficacy|1|||
148894821|NCT01194830|537094022|FG000|Overall Study|Non-compliance issues|4|||
148894822|NCT01194830|537094023|FG001|Overall Study|Non-compliance issues|4|||
149011454|NCT02778399|537521470|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
148894823|NCT01194830|537094022|FG000|Overall Study|Other Reason|12|||
148894824|NCT01194830|537094023|FG001|Overall Study|Other Reason|8|||
148894825|NCT00435409|537094026|FG000|Overall Study|Protocol Violation|1|||
148894826|NCT00435409|537094027|FG001|Overall Study|Protocol Violation|2|||
148894827|NCT00435409|537094028|FG002|Overall Study|Protocol Violation|0|||
149135348|NCT05393037|537976451|FG000|Part B|Lost to Follow-up|1|||
149135349|NCT05393037|537976452|FG001|Part B|Lost to Follow-up|0|||
149135350|NCT01012739|537976453|FG000|Treatment Period 1|Adverse Event|0|||
149135351|NCT01012739|537976454|FG001|Treatment Period 1|Adverse Event|0|||
149135352|NCT01012739|537976455|FG002|Treatment Period 1|Adverse Event|0|||
149135353|NCT01012739|537976456|FG003|Treatment Period 1|Adverse Event|1|||
148894828|NCT00435409|537094026|FG000|Overall Study|Lost to Follow-up|1|||
148894829|NCT00435409|537094027|FG001|Overall Study|Lost to Follow-up|2|||
148894830|NCT00435409|537094028|FG002|Overall Study|Lost to Follow-up|0|||
148894831|NCT00435409|537094026|FG000|Overall Study|Death|8|||
148894832|NCT00435409|537094027|FG001|Overall Study|Death|6|||
148894833|NCT00435409|537094028|FG002|Overall Study|Death|6|||
148894834|NCT00435409|537094026|FG000|Overall Study|Objective progression or relapse|158|||
148894835|NCT00435409|537094027|FG001|Overall Study|Objective progression or relapse|93|||
148894836|NCT00435409|537094028|FG002|Overall Study|Objective progression or relapse|58|||
149135354|NCT01012739|537976453|FG000|Treatment Period 2|Abnormal test procedure results|0|||
149135355|NCT01012739|537976454|FG001|Treatment Period 2|Abnormal test procedure results|0|||
149237303|NCT04590963|538337965|FG000|Overall Study|Death|118|||
149237304|NCT04590963|538337966|FG001|Overall Study|Death|59|||
149237305|NCT04590963|538337965|FG000|Overall Study|Lost to Follow-up|1|||
149237306|NCT04590963|538337966|FG001|Overall Study|Lost to Follow-up|1|||
149237307|NCT04590963|538337965|FG000|Overall Study|Progressive disease|0|||
149237308|NCT04590963|538337966|FG001|Overall Study|Progressive disease|1|||
149237309|NCT04590963|538337965|FG000|Overall Study|Study terminated by sponsor|103|||
149237310|NCT04590963|538337966|FG001|Overall Study|Study terminated by sponsor|50|||
149237311|NCT04590963|538337965|FG000|Overall Study|Withdrawal by Subject|15|||
149237312|NCT04590963|538337966|FG001|Overall Study|Withdrawal by Subject|8|||
149237313|NCT04590963|538337965|FG000|Overall Study|Ongoing at data cut-off|9|||
149237314|NCT04590963|538337966|FG001|Overall Study|Ongoing at data cut-off|4|||
149237315|NCT04590963|538337965|FG000|Overall Study|Screen failure|1|||
149237316|NCT04590963|538337966|FG001|Overall Study|Screen failure|0|||
149237317|NCT04430738|538337967|FG000|Phase 1: Dose Escalation|Death|1|||
149237318|NCT04430738|538337968|FG001|Phase 1: Dose Escalation|Death|4|||
149237319|NCT04430738|538337969|FG002|Phase 1: Dose Escalation|Death|4|||
149237320|NCT04430738|538337970|FG003|Phase 1: Dose Escalation|Death|1|||
149237321|NCT04430738|538337971|FG004|Phase 1: Dose Escalation|Death|6|||
149237322|NCT04430738|538337972|FG005|Phase 1: Dose Escalation|Death|0|||
149237323|NCT04430738|538337967|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
149237324|NCT04430738|538337968|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
149237325|NCT04430738|538337969|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
149237326|NCT04430738|538337970|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
148794682|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
148794683|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
148794684|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
148794685|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
148794686|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
148794687|NCT01111565|536727211|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
148794688|NCT01111565|536727212|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
148794689|NCT01111565|536727213|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
148794690|NCT01111565|536727214|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
148794691|NCT01111565|536727215|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
148794692|NCT01111565|536727211|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
148794693|NCT01111565|536727212|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
148794694|NCT01111565|536727213|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
148794695|NCT01111565|536727214|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
148794696|NCT01111565|536727215|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
148794697|NCT01111565|536727211|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148794698|NCT01111565|536727212|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148794699|NCT01111565|536727213|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
148794700|NCT01111565|536727214|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148794701|NCT01111565|536727215|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148794702|NCT01111565|536727211|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
148794703|NCT01111565|536727212|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
148794704|NCT01111565|536727213|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
148794705|NCT01111565|536727214|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
148794706|NCT01111565|536727215|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
148794707|NCT01111565|536727211|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
148794708|NCT01111565|536727212|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
148794709|NCT01111565|536727213|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
148794710|NCT01111565|536727214|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
148794711|NCT01111565|536727215|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
148794712|NCT01111565|536727211|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
148794713|NCT01111565|536727212|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
148794714|NCT01111565|536727213|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
148794715|NCT01111565|536727214|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
148894837|NCT00435409|537094026|FG000|Overall Study|Global deterioration of health status|0|||
149237327|NCT04430738|538337971|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
149237328|NCT04430738|538337972|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
149237329|NCT04430738|538337967|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
149237330|NCT04430738|538337968|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
149237331|NCT04430738|538337969|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
149237332|NCT04430738|538337970|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
149237333|NCT04430738|538337971|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
148894838|NCT00435409|537094027|FG001|Overall Study|Global deterioration of health status|0|||
149237334|NCT04430738|538337972|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
149237335|NCT04430738|538337967|FG000|Phase 1: Dose Escalation|Other|1|||
149237336|NCT04430738|538337968|FG001|Phase 1: Dose Escalation|Other|0|||
149237337|NCT04430738|538337969|FG002|Phase 1: Dose Escalation|Other|0|||
149237338|NCT04430738|538337970|FG003|Phase 1: Dose Escalation|Other|0|||
149237339|NCT04430738|538337971|FG004|Phase 1: Dose Escalation|Other|0|||
149237340|NCT04430738|538337972|FG005|Phase 1: Dose Escalation|Other|0|||
149237341|NCT04430738|538337967|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
149237342|NCT04430738|538337968|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
149237343|NCT04430738|538337969|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
149237344|NCT04430738|538337970|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
149237345|NCT04430738|538337971|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
149237346|NCT04430738|538337972|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
149237347|NCT04430738|538337967|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
149237348|NCT04430738|538337968|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
149237349|NCT04430738|538337969|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
149237350|NCT04430738|538337970|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
149237351|NCT04430738|538337971|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
149237352|NCT04430738|538337972|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
149237353|NCT04707469|538337974|FG000|Overall Study|Site closure|0|||
149237354|NCT04707469|538337975|FG001|Overall Study|Site closure|2|||
149237355|NCT04707469|538337976|FG002|Overall Study|Site closure|0|||
149237356|NCT04707469|538337974|FG000|Overall Study|Physician Decision|2|||
149237357|NCT04707469|538337975|FG001|Overall Study|Physician Decision|2|||
149237358|NCT04707469|538337976|FG002|Overall Study|Physician Decision|2|||
149237359|NCT04707469|538337974|FG000|Overall Study|Death|1|||
149237360|NCT04707469|538337975|FG001|Overall Study|Death|6|||
149237361|NCT04707469|538337976|FG002|Overall Study|Death|2|||
149237362|NCT04707469|538337974|FG000|Overall Study|Lost to Follow-up|9|||
149237363|NCT04707469|538337975|FG001|Overall Study|Lost to Follow-up|19|||
149237364|NCT04707469|538337976|FG002|Overall Study|Lost to Follow-up|14|||
149237365|NCT04707469|538337974|FG000|Overall Study|Withdrawal by Subject|17|||
149237366|NCT04707469|538337975|FG001|Overall Study|Withdrawal by Subject|16|||
149237367|NCT04707469|538337976|FG002|Overall Study|Withdrawal by Subject|12|||
149237368|NCT03500172|538337978|FG000|Period 1: Baseline Randomization|Death|0|||
149237369|NCT03500172|538337979|FG001|Period 1: Baseline Randomization|Death|0|||
149237370|NCT03500172|538337980|FG002|Period 1: Baseline Randomization|Death|0|||
149237371|NCT03500172|538337981|FG003|Period 1: Baseline Randomization|Death|0|||
149237372|NCT03500172|538337982|FG004|Period 1: Baseline Randomization|Death|0|||
149237373|NCT03500172|538337983|FG005|Period 1: Baseline Randomization|Death|0|||
149237374|NCT03500172|538337984|FG006|Period 1: Baseline Randomization|Death|0|||
149237375|NCT03500172|538337985|FG007|Period 1: Baseline Randomization|Death|0|||
149237376|NCT03500172|538337986|FG008|Period 1: Baseline Randomization|Death|0|||
149237377|NCT03500172|538337987|FG009|Period 1: Baseline Randomization|Death|2|||
149237378|NCT03500172|538337988|FG010|Period 1: Baseline Randomization|Death|0|||
149237379|NCT03500172|538337978|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
149237380|NCT03500172|538337979|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
149237381|NCT03500172|538337980|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
149237382|NCT03500172|538337981|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
149237383|NCT03500172|538337982|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
149237384|NCT03500172|538337983|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
149237385|NCT03500172|538337984|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
149237386|NCT03500172|538337985|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
149237387|NCT03500172|538337986|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
149237388|NCT03500172|538337987|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
149237389|NCT03500172|538337988|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
149237390|NCT03500172|538337978|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
149237391|NCT03500172|538337979|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
149237392|NCT03500172|538337980|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
149237393|NCT03500172|538337981|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
149237394|NCT03500172|538337982|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
149237395|NCT03500172|538337983|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
149237396|NCT03500172|538337984|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
149237397|NCT03500172|538337985|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
149237398|NCT03500172|538337986|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
149237399|NCT03500172|538337987|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
149237400|NCT03500172|538337988|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
149237401|NCT03500172|538337978|FG000|Period 2: Re-Randomization|Death|0|||
149237402|NCT03500172|538337979|FG001|Period 2: Re-Randomization|Death|0|||
149237403|NCT03500172|538337980|FG002|Period 2: Re-Randomization|Death|0|||
149237404|NCT03500172|538337981|FG003|Period 2: Re-Randomization|Death|4|||
149237405|NCT03500172|538337982|FG004|Period 2: Re-Randomization|Death|2|||
149237406|NCT03500172|538337983|FG005|Period 2: Re-Randomization|Death|0|||
149237407|NCT03500172|538337984|FG006|Period 2: Re-Randomization|Death|5|||
149237408|NCT03500172|538337985|FG007|Period 2: Re-Randomization|Death|2|||
149237409|NCT03500172|538337986|FG008|Period 2: Re-Randomization|Death|0|||
149237410|NCT03500172|538337987|FG009|Period 2: Re-Randomization|Death|0|||
149237411|NCT03500172|538337988|FG010|Period 2: Re-Randomization|Death|0|||
149237412|NCT00309985|538337991|FG000|Overall Study|Disease progression|12|||
149237413|NCT00309985|538337992|FG001|Overall Study|Disease progression|0|||
149237414|NCT00309985|538337991|FG000|Overall Study|Adverse Event|30|||
149237415|NCT00309985|538337992|FG001|Overall Study|Adverse Event|0|||
149237416|NCT00309985|538337991|FG000|Overall Study|Death|2|||
149237417|NCT00309985|538337992|FG001|Overall Study|Death|0|||
149237418|NCT00309985|538337991|FG000|Overall Study|Withdrawal by Subject|5|||
149237419|NCT00309985|538337992|FG001|Overall Study|Withdrawal by Subject|1|||
149237420|NCT00309985|538337991|FG000|Overall Study|Physician Decision|3|||
149237421|NCT00309985|538337992|FG001|Overall Study|Physician Decision|0|||
149237422|NCT00309985|538337991|FG000|Overall Study|Never started treatment|7|||
149237423|NCT00309985|538337992|FG001|Overall Study|Never started treatment|0|||
149237424|NCT00309985|538337991|FG000|Overall Study|Complicating disease|1|||
149237425|NCT00309985|538337992|FG001|Overall Study|Complicating disease|0|||
149237426|NCT00309985|538337991|FG000|Overall Study|Non-compliance|1|||
149237427|NCT00309985|538337992|FG001|Overall Study|Non-compliance|0|||
149237428|NCT00309985|538337991|FG000|Overall Study|Chemotherapy discontinued only|1|||
149237429|NCT00309985|538337992|FG001|Overall Study|Chemotherapy discontinued only|0|||
149237430|NCT03659916|538339482|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
149237431|NCT03659916|538339483|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
149237432|NCT03659916|538339484|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
149237433|NCT03659916|538339482|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
149237434|NCT03659916|538339483|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
149237435|NCT03659916|538339484|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
149237436|NCT03659916|538339482|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
149237437|NCT03659916|538339483|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
149237438|NCT03659916|538339484|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
149237439|NCT03659916|538339482|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
149237440|NCT03659916|538339483|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
149237441|NCT03659916|538339484|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
149237442|NCT03659916|538339482|FG000|Treatment Period (72 Weeks)|Other|1|||
149237443|NCT03659916|538339483|FG001|Treatment Period (72 Weeks)|Other|3|||
149237444|NCT03659916|538339484|FG002|Treatment Period (72 Weeks)|Other|9|||
149237445|NCT03659916|538339482|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
149237446|NCT03659916|538339483|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
149237447|NCT03659916|538339484|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
149237448|NCT03659916|538339482|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
149237449|NCT03659916|538339483|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
149237450|NCT03659916|538339484|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
149237451|NCT03659916|538339482|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
149237452|NCT03659916|538339483|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
149237453|NCT03659916|538339484|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
149237454|NCT03659916|538339482|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
149237455|NCT03659916|538339483|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
149135356|NCT01012739|537976455|FG002|Treatment Period 2|Abnormal test procedure results|0|||
149135357|NCT01012739|537976456|FG003|Treatment Period 2|Abnormal test procedure results|1|||
149135358|NCT04029480|537976457|FG000|Overall Study|Physician Decision|0|||
149135359|NCT04029480|537976458|FG001|Overall Study|Physician Decision|0|||
149135360|NCT04029480|537976459|FG002|Overall Study|Physician Decision|2|||
149135361|NCT04029480|537976460|FG003|Overall Study|Physician Decision|1|||
149135362|NCT04029480|537976457|FG000|Overall Study|Withdrawal by Subject|2|||
149135363|NCT04029480|537976458|FG001|Overall Study|Withdrawal by Subject|0|||
149135364|NCT04029480|537976459|FG002|Overall Study|Withdrawal by Subject|1|||
149135365|NCT04029480|537976460|FG003|Overall Study|Withdrawal by Subject|1|||
149135366|NCT04786119|537976461|FG000|Overall Study|Withdrawal by Subject|4|||
149135367|NCT04786119|537976462|FG001|Overall Study|Withdrawal by Subject|5|||
149135368|NCT04786119|537976461|FG000|Overall Study|Lost to Follow-up|5|||
149135369|NCT04786119|537976462|FG001|Overall Study|Lost to Follow-up|5|||
149135370|NCT04786119|537976461|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
149135371|NCT04786119|537976462|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
149237456|NCT03659916|538339484|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
149011455|NCT02778399|537521471|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
149135372|NCT02593786|537976467|FG000|Overall Study|Disease progression|12|||
149135373|NCT02593786|537976468|FG001|Overall Study|Disease progression|16|||
149237457|NCT03659916|538339482|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
149237458|NCT03659916|538339483|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
149237459|NCT03659916|538339484|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
149237460|NCT03659916|538339482|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
149237461|NCT03659916|538339483|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
149237462|NCT03659916|538339484|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
149237463|NCT04759885|538339485|FG000|Overall Study|Other|1|||
149237464|NCT04759885|538339486|FG001|Overall Study|Other|0|||
149237465|NCT04759885|538339487|FG002|Overall Study|Other|2|||
149237466|NCT04759885|538339488|FG003|Overall Study|Other|0|||
149237467|NCT04759885|538339489|FG004|Overall Study|Other|0|||
149237468|NCT04759885|538339485|FG000|Overall Study|Withdrawal by Subject|0|||
149237469|NCT04759885|538339486|FG001|Overall Study|Withdrawal by Subject|0|||
149237470|NCT04759885|538339487|FG002|Overall Study|Withdrawal by Subject|1|||
149237471|NCT04759885|538339488|FG003|Overall Study|Withdrawal by Subject|9|||
149237472|NCT04759885|538339489|FG004|Overall Study|Withdrawal by Subject|6|||
149237473|NCT04759885|538339485|FG000|Overall Study|Adverse Event|0|||
149237474|NCT04759885|538339486|FG001|Overall Study|Adverse Event|0|||
149237475|NCT04759885|538339487|FG002|Overall Study|Adverse Event|0|||
148794716|NCT01111565|536727215|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
148794717|NCT02824224|536727218|FG000|Overall Study|Discontinued, IUS expulsion|0|||
148794718|NCT02824224|536727219|FG001|Overall Study|Discontinued, IUS expulsion|1|||
148794719|NCT02824224|536727218|FG000|Overall Study|Did not show up for allocation visit|2|||
148794720|NCT02824224|536727219|FG001|Overall Study|Did not show up for allocation visit|0|||
148794721|NCT02683239|536727220|FG000|Overall Study|Protocol Violation|35|||
148794722|NCT02683239|536727221|FG001|Overall Study|Protocol Violation|23|||
148794723|NCT02683239|536727222|FG002|Overall Study|Protocol Violation|26|||
148794724|NCT02683239|536727223|FG003|Overall Study|Protocol Violation|4|||
148794725|NCT02683239|536727224|FG004|Overall Study|Protocol Violation|35|||
148794726|NCT02683239|536727225|FG005|Overall Study|Protocol Violation|4|||
148794727|NCT02683239|536727226|FG006|Overall Study|Protocol Violation|5|||
148794728|NCT02683239|536727220|FG000|Overall Study|Adverse Event|64|||
148794729|NCT02683239|536727221|FG001|Overall Study|Adverse Event|39|||
148794730|NCT02683239|536727222|FG002|Overall Study|Adverse Event|42|||
148794731|NCT02683239|536727223|FG003|Overall Study|Adverse Event|16|||
148794732|NCT02683239|536727224|FG004|Overall Study|Adverse Event|189|||
148794733|NCT02683239|536727225|FG005|Overall Study|Adverse Event|9|||
148794734|NCT02683239|536727226|FG006|Overall Study|Adverse Event|9|||
148794735|NCT02683239|536727220|FG000|Overall Study|Physician Decision|38|||
148794736|NCT02683239|536727221|FG001|Overall Study|Physician Decision|19|||
148794737|NCT02683239|536727222|FG002|Overall Study|Physician Decision|14|||
148794738|NCT02683239|536727223|FG003|Overall Study|Physician Decision|73|||
148794739|NCT02683239|536727224|FG004|Overall Study|Physician Decision|143|||
148794740|NCT02683239|536727225|FG005|Overall Study|Physician Decision|14|||
148794741|NCT02683239|536727226|FG006|Overall Study|Physician Decision|15|||
148794742|NCT02683239|536727220|FG000|Overall Study|Withdrawal by Subject|187|||
148794743|NCT02683239|536727221|FG001|Overall Study|Withdrawal by Subject|99|||
148794744|NCT02683239|536727222|FG002|Overall Study|Withdrawal by Subject|91|||
148794745|NCT02683239|536727223|FG003|Overall Study|Withdrawal by Subject|18|||
148794746|NCT02683239|536727224|FG004|Overall Study|Withdrawal by Subject|248|||
148794747|NCT02683239|536727225|FG005|Overall Study|Withdrawal by Subject|22|||
148794748|NCT02683239|536727226|FG006|Overall Study|Withdrawal by Subject|28|||
148794749|NCT02683239|536727220|FG000|Overall Study|Lost to Follow-up|77|||
149237476|NCT04759885|538339488|FG003|Overall Study|Adverse Event|3|||
149237477|NCT04759885|538339489|FG004|Overall Study|Adverse Event|0|||
149237478|NCT04759885|538339485|FG000|Overall Study|Physician Decision|0|||
149237479|NCT04759885|538339486|FG001|Overall Study|Physician Decision|0|||
149237480|NCT04759885|538339487|FG002|Overall Study|Physician Decision|0|||
149237481|NCT04759885|538339488|FG003|Overall Study|Physician Decision|2|||
149237482|NCT04759885|538339489|FG004|Overall Study|Physician Decision|0|||
149237483|NCT04941456|538339490|FG000|Overall Study|Withdrawal by Subject|1|||
149237484|NCT04941456|538339491|FG001|Overall Study|Withdrawal by Subject|0|||
149237485|NCT04941456|538339490|FG000|Overall Study|Protocol Violation|1|||
149237486|NCT04941456|538339491|FG001|Overall Study|Protocol Violation|0|||
149237487|NCT02296684|538339492|FG000|Overall Study|Withdrawal by Subject|0|||
149237488|NCT02296684|538339493|FG001|Overall Study|Withdrawal by Subject|1|||
149237489|NCT02296684|538339494|FG002|Overall Study|Withdrawal by Subject|1|||
149237490|NCT02296684|538339492|FG000|Overall Study|Death|2|||
149237491|NCT02296684|538339493|FG001|Overall Study|Death|0|||
148794750|NCT02683239|536727221|FG001|Overall Study|Lost to Follow-up|24|||
148794751|NCT02683239|536727222|FG002|Overall Study|Lost to Follow-up|25|||
148794752|NCT02683239|536727223|FG003|Overall Study|Lost to Follow-up|7|||
148794753|NCT02683239|536727224|FG004|Overall Study|Lost to Follow-up|88|||
149237492|NCT02296684|538339494|FG002|Overall Study|Death|0|||
149237493|NCT04452344|538339496|FG000|Overall Study|Withdrawal by Subject|3|||
148794754|NCT02683239|536727225|FG005|Overall Study|Lost to Follow-up|8|||
148794755|NCT02683239|536727226|FG006|Overall Study|Lost to Follow-up|11|||
148794756|NCT02683239|536727220|FG000|Overall Study|Death|9|||
148794757|NCT02683239|536727221|FG001|Overall Study|Death|5|||
148794758|NCT02683239|536727222|FG002|Overall Study|Death|8|||
148794759|NCT02683239|536727223|FG003|Overall Study|Death|0|||
149135374|NCT02593786|537976469|FG002|Overall Study|Disease progression|10|||
148894839|NCT00435409|537094028|FG002|Overall Study|Global deterioration of health status|4|||
148894840|NCT00435409|537094026|FG000|Overall Study|Withdrawal by Subject|8|||
148894841|NCT00435409|537094027|FG001|Overall Study|Withdrawal by Subject|7|||
148894842|NCT00435409|537094028|FG002|Overall Study|Withdrawal by Subject|1|||
148894843|NCT00435409|537094026|FG000|Overall Study|Other|45|||
148894844|NCT00435409|537094027|FG001|Overall Study|Other|30|||
148894845|NCT00435409|537094028|FG002|Overall Study|Other|1|||
148894846|NCT00435409|537094026|FG000|Overall Study|Adverse Event|0|||
148894847|NCT00435409|537094027|FG001|Overall Study|Adverse Event|0|||
148894848|NCT00435409|537094028|FG002|Overall Study|Adverse Event|8|||
148894849|NCT00435409|537094026|FG000|Overall Study|Sponsor decision|0|||
148894850|NCT00435409|537094027|FG001|Overall Study|Sponsor decision|3|||
148894851|NCT00435409|537094028|FG002|Overall Study|Sponsor decision|0|||
148894852|NCT03661723|537094033|FG000|Overall Study|Disease Progression|4|||
148894853|NCT03661723|537094034|FG001|Overall Study|Disease Progression|24|||
148894854|NCT03661723|537094035|FG002|Overall Study|Disease Progression|4|||
148894855|NCT03661723|537094036|FG003|Overall Study|Disease Progression|19|||
148894856|NCT03661723|537094033|FG000|Overall Study|Withdrawal by Subject|1|||
149135375|NCT02593786|537976470|FG003|Overall Study|Disease progression|7|||
149135376|NCT02593786|537976467|FG000|Overall Study|Study drug toxicity|1|||
149135377|NCT02593786|537976468|FG001|Overall Study|Study drug toxicity|0|||
149135378|NCT02593786|537976469|FG002|Overall Study|Study drug toxicity|0|||
149135379|NCT02593786|537976470|FG003|Overall Study|Study drug toxicity|0|||
149135380|NCT02593786|537976467|FG000|Overall Study|Adverse event unrelated to study drug|1|||
149135381|NCT02593786|537976468|FG001|Overall Study|Adverse event unrelated to study drug|1|||
149135382|NCT02593786|537976469|FG002|Overall Study|Adverse event unrelated to study drug|1|||
149135383|NCT02593786|537976470|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149135384|NCT02593786|537976467|FG000|Overall Study|Participant request to discontinue study therapy|0|||
149135385|NCT02593786|537976468|FG001|Overall Study|Participant request to discontinue study therapy|2|||
149135386|NCT02593786|537976469|FG002|Overall Study|Participant request to discontinue study therapy|0|||
149135387|NCT02593786|537976470|FG003|Overall Study|Participant request to discontinue study therapy|0|||
149135388|NCT02593786|537976467|FG000|Overall Study|Other reasons|1|||
149135389|NCT02593786|537976468|FG001|Overall Study|Other reasons|1|||
149135390|NCT02593786|537976469|FG002|Overall Study|Other reasons|0|||
149135391|NCT02593786|537976470|FG003|Overall Study|Other reasons|5|||
149135392|NCT02383589|537976480|FG000|Treatment Period|Adverse Event|1|||
149135393|NCT02383589|537976481|FG001|Treatment Period|Adverse Event|3|||
149135394|NCT02383589|537976480|FG000|Treatment Period|Lost to Follow-up|0|||
149135395|NCT02383589|537976481|FG001|Treatment Period|Lost to Follow-up|1|||
149135396|NCT02383589|537976480|FG000|Treatment Period|Withdrawal by Subject|0|||
149135397|NCT02383589|537976481|FG001|Treatment Period|Withdrawal by Subject|5|||
149135398|NCT02383589|537976480|FG000|Treatment Period|Non-compliance with study drug|0|||
149135399|NCT02383589|537976481|FG001|Treatment Period|Non-compliance with study drug|1|||
149135400|NCT02383589|537976480|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
149135401|NCT02383589|537976481|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
149135402|NCT02383589|537976480|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
149135403|NCT02383589|537976481|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
149135404|NCT02383589|537976480|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
148794760|NCT02683239|536727224|FG004|Overall Study|Death|12|||
148794761|NCT02683239|536727225|FG005|Overall Study|Death|1|||
148794762|NCT02683239|536727226|FG006|Overall Study|Death|0|||
148794763|NCT02683239|536727220|FG000|Overall Study|Lack of Efficacy|50|||
148794764|NCT02683239|536727221|FG001|Overall Study|Lack of Efficacy|23|||
148794765|NCT02683239|536727222|FG002|Overall Study|Lack of Efficacy|12|||
148794766|NCT02683239|536727223|FG003|Overall Study|Lack of Efficacy|2|||
148794767|NCT02683239|536727224|FG004|Overall Study|Lack of Efficacy|29|||
148794768|NCT02683239|536727225|FG005|Overall Study|Lack of Efficacy|2|||
148794769|NCT02683239|536727226|FG006|Overall Study|Lack of Efficacy|3|||
148794770|NCT02683239|536727220|FG000|Overall Study|Missing data|0|||
148794771|NCT02683239|536727221|FG001|Overall Study|Missing data|1|||
148794772|NCT02683239|536727222|FG002|Overall Study|Missing data|1|||
148794773|NCT02683239|536727223|FG003|Overall Study|Missing data|0|||
148794774|NCT02683239|536727224|FG004|Overall Study|Missing data|1|||
148794775|NCT02683239|536727225|FG005|Overall Study|Missing data|0|||
148794776|NCT02683239|536727226|FG006|Overall Study|Missing data|0|||
148794777|NCT00368108|536727229|FG000|Overall Study|Adverse Event|38|||
148794778|NCT00368108|536727230|FG001|Overall Study|Adverse Event|26|||
148794779|NCT00368108|536727231|FG002|Overall Study|Adverse Event|44|||
148894857|NCT03661723|537094034|FG001|Overall Study|Withdrawal by Subject|0|||
149135405|NCT02383589|537976481|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
149135406|NCT00866697|537976482|FG000|Overall Study|Study closed/terminated|156|||
148794780|NCT00368108|536727229|FG000|Overall Study|Abnormal Laboratory Value|0|||
148794781|NCT00368108|536727230|FG001|Overall Study|Abnormal Laboratory Value|0|||
148794782|NCT00368108|536727231|FG002|Overall Study|Abnormal Laboratory Value|3|||
148794783|NCT00368108|536727229|FG000|Overall Study|Protocol Violation|5|||
148894858|NCT03661723|537094035|FG002|Overall Study|Withdrawal by Subject|2|||
149135407|NCT00866697|537976483|FG001|Overall Study|Study closed/terminated|138|||
149135408|NCT00866697|537976482|FG000|Overall Study|Lost to Follow-up|22|||
149135409|NCT00866697|537976483|FG001|Overall Study|Lost to Follow-up|28|||
149135410|NCT00866697|537976482|FG000|Overall Study|Physician Decision|3|||
149135411|NCT00866697|537976483|FG001|Overall Study|Physician Decision|5|||
149135412|NCT00866697|537976482|FG000|Overall Study|Withdrawal by Subject|33|||
149135413|NCT00866697|537976483|FG001|Overall Study|Withdrawal by Subject|57|||
149135414|NCT00447382|537976486|FG000|Overall Study|Adverse Event|1|||
149135415|NCT00447382|537976487|FG001|Overall Study|Adverse Event|1|||
149135416|NCT00447382|537976486|FG000|Overall Study|Lack of Efficacy|1|||
148794784|NCT00368108|536727230|FG001|Overall Study|Protocol Violation|9|||
148794785|NCT00368108|536727231|FG002|Overall Study|Protocol Violation|9|||
148794786|NCT00368108|536727229|FG000|Overall Study|Withdrawal by Subject|9|||
148794787|NCT00368108|536727230|FG001|Overall Study|Withdrawal by Subject|3|||
148794788|NCT00368108|536727231|FG002|Overall Study|Withdrawal by Subject|5|||
148794789|NCT00368108|536727229|FG000|Overall Study|Lack of Efficacy|7|||
148794790|NCT00368108|536727230|FG001|Overall Study|Lack of Efficacy|8|||
148794791|NCT00368108|536727231|FG002|Overall Study|Lack of Efficacy|5|||
148794792|NCT00368108|536727229|FG000|Overall Study|Physician Decision|2|||
148794793|NCT00368108|536727230|FG001|Overall Study|Physician Decision|0|||
148794794|NCT00368108|536727231|FG002|Overall Study|Physician Decision|1|||
148794795|NCT00368108|536727229|FG000|Overall Study|Other|3|||
148794796|NCT00368108|536727230|FG001|Overall Study|Other|7|||
148794797|NCT00368108|536727231|FG002|Overall Study|Other|1|||
148794798|NCT04131712|536727234|FG000|Overall Study|COVID related|0|||
148794799|NCT04131712|536727235|FG001|Overall Study|COVID related|0|||
148794800|NCT04131712|536727236|FG002|Overall Study|COVID related|2|||
148794801|NCT04131712|536727237|FG003|Overall Study|COVID related|0|||
148794802|NCT04131712|536727234|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
148794803|NCT04131712|536727235|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
148794804|NCT04131712|536727236|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
148794805|NCT04131712|536727237|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
148794806|NCT02299388|536727240|FG000|Overall Study|Withdrawal by Subject|0|||
148794807|NCT02299388|536727241|FG001|Overall Study|Withdrawal by Subject|1|||
148794808|NCT04613739|536727242|FG000|Overall Study|Lost to Follow-up|6|||
148794809|NCT04613739|536727243|FG001|Overall Study|Lost to Follow-up|9|||
148794810|NCT04613739|536727242|FG000|Overall Study|potentially duplicative/fraudulent|1|||
148794811|NCT04613739|536727243|FG001|Overall Study|potentially duplicative/fraudulent|3|||
148794812|NCT00003537|536727244|FG000|Overall Study|Not evalauable|1|||
148794813|NCT01051557|536727245|FG000|Overall Study|Physician Decision|1|||
148794814|NCT01051557|536727246|FG001|Overall Study|Physician Decision|0|||
148794815|NCT01051557|536727247|FG002|Overall Study|Physician Decision|0|||
148794816|NCT01051557|536727248|FG003|Overall Study|Physician Decision|0|||
148794817|NCT01051557|536727249|FG004|Overall Study|Physician Decision|0|||
148794818|NCT01051557|536727250|FG005|Overall Study|Physician Decision|0|||
148794819|NCT01051557|536727251|FG006|Overall Study|Physician Decision|0|||
148794820|NCT01051557|536727245|FG000|Overall Study|disease progression|3|||
148794821|NCT01051557|536727246|FG001|Overall Study|disease progression|3|||
148794822|NCT01051557|536727247|FG002|Overall Study|disease progression|5|||
148794823|NCT01051557|536727248|FG003|Overall Study|disease progression|2|||
148794824|NCT01051557|536727249|FG004|Overall Study|disease progression|4|||
148794825|NCT01051557|536727250|FG005|Overall Study|disease progression|3|||
148794826|NCT01051557|536727251|FG006|Overall Study|disease progression|1|||
148794827|NCT01051557|536727245|FG000|Overall Study|Withdrawal by Subject|0|||
148794828|NCT01051557|536727246|FG001|Overall Study|Withdrawal by Subject|0|||
148794829|NCT01051557|536727247|FG002|Overall Study|Withdrawal by Subject|1|||
148794830|NCT01051557|536727248|FG003|Overall Study|Withdrawal by Subject|0|||
148794831|NCT01051557|536727249|FG004|Overall Study|Withdrawal by Subject|2|||
148794832|NCT01051557|536727250|FG005|Overall Study|Withdrawal by Subject|0|||
148794833|NCT01051557|536727251|FG006|Overall Study|Withdrawal by Subject|1|||
148794834|NCT01051557|536727245|FG000|Overall Study|Adverse Event|0|||
148794835|NCT01051557|536727246|FG001|Overall Study|Adverse Event|0|||
148794836|NCT01051557|536727247|FG002|Overall Study|Adverse Event|0|||
148794837|NCT01051557|536727248|FG003|Overall Study|Adverse Event|1|||
148794838|NCT01051557|536727249|FG004|Overall Study|Adverse Event|1|||
149135417|NCT00447382|537976487|FG001|Overall Study|Lack of Efficacy|0|||
149135418|NCT00447382|537976486|FG000|Overall Study|Protocol Violation|2|||
148794839|NCT01051557|536727250|FG005|Overall Study|Adverse Event|3|||
148794840|NCT01051557|536727251|FG006|Overall Study|Adverse Event|4|||
148794841|NCT01265394|536727253|FG000|Overall Study|Subjects withdrawn|37|||
148794842|NCT00249873|536727254|FG000|Overall Study|Not treated|7|||
148794843|NCT00249873|536727255|FG001|Overall Study|Not treated|8|||
148794844|NCT00249873|536727254|FG000|Overall Study|Significant thrombocytopenia|9|||
148794845|NCT00249873|536727255|FG001|Overall Study|Significant thrombocytopenia|8|||
148794846|NCT00249873|536727254|FG000|Overall Study|Severe allergic reaction|8|||
148794847|NCT00249873|536727255|FG001|Overall Study|Severe allergic reaction|1|||
149135419|NCT00447382|537976487|FG001|Overall Study|Protocol Violation|0|||
149135420|NCT00447382|537976486|FG000|Overall Study|Unclassified|2|||
148794848|NCT00249873|536727254|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
148794849|NCT00249873|536727255|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
148794850|NCT00249873|536727254|FG000|Overall Study|Other Serious Adverse Event|86|||
148794851|NCT00249873|536727255|FG001|Overall Study|Other Serious Adverse Event|97|||
148794852|NCT00249873|536727254|FG000|Overall Study|Qualifying condition not present|20|||
148794853|NCT00249873|536727255|FG001|Overall Study|Qualifying condition not present|23|||
148794854|NCT00249873|536727254|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
148794855|NCT00249873|536727255|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
148794856|NCT00249873|536727254|FG000|Overall Study|Withdrawal by Subject|504|||
148794857|NCT00249873|536727255|FG001|Overall Study|Withdrawal by Subject|466|||
148794858|NCT00249873|536727254|FG000|Overall Study|Lost to Follow-up|4|||
148794859|NCT00249873|536727255|FG001|Overall Study|Lost to Follow-up|7|||
148794860|NCT00249873|536727254|FG000|Overall Study|Minor bleeding|99|||
148794861|NCT00249873|536727255|FG001|Overall Study|Minor bleeding|37|||
148794862|NCT00249873|536727254|FG000|Overall Study|Non-compliance|41|||
148794863|NCT00249873|536727255|FG001|Overall Study|Non-compliance|46|||
148794864|NCT00249873|536727254|FG000|Overall Study|Other non serious Adverse Event|112|||
148794865|NCT00249873|536727255|FG001|Overall Study|Other non serious Adverse Event|108|||
148794866|NCT00249873|536727254|FG000|Overall Study|Other contraindicated medication|1|||
148794867|NCT00249873|536727255|FG001|Overall Study|Other contraindicated medication|0|||
148794868|NCT00249873|536727254|FG000|Overall Study|Patient not wish to continue after May08|3|||
148794869|NCT00249873|536727255|FG001|Overall Study|Patient not wish to continue after May08|4|||
148794870|NCT00249873|536727254|FG000|Overall Study|Physician withdrew consent|59|||
148794871|NCT00249873|536727255|FG001|Overall Study|Physician withdrew consent|60|||
148794872|NCT00249873|536727254|FG000|Overall Study|Open label clopidogrel required|31|||
148794873|NCT00249873|536727255|FG001|Overall Study|Open label clopidogrel required|42|||
148794874|NCT00249873|536727254|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
148794875|NCT00249873|536727255|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
148794876|NCT00249873|536727254|FG000|Overall Study|Oral anticoagulant required|159|||
148794877|NCT00249873|536727255|FG001|Overall Study|Oral anticoagulant required|157|||
148794878|NCT00249873|536727254|FG000|Overall Study|Study drug intolerance|5|||
148794879|NCT00249873|536727255|FG001|Overall Study|Study drug intolerance|0|||
148794880|NCT00249873|536727254|FG000|Overall Study|Surgery/ procedure|9|||
148794881|NCT00249873|536727255|FG001|Overall Study|Surgery/ procedure|9|||
148794882|NCT00249873|536727254|FG000|Overall Study|Event related to cardiac condition|12|||
148794883|NCT00249873|536727255|FG001|Overall Study|Event related to cardiac condition|21|||
148794884|NCT00249873|536727254|FG000|Overall Study|Thromboembolic/outcome event|82|||
148794885|NCT00249873|536727255|FG001|Overall Study|Thromboembolic/outcome event|122|||
148794886|NCT01781962|536727258|FG000|Overall Study|Other Miscellaneous Reasons|5|||
148794887|NCT05417412|536727261|FG000|Overall Study|Lost to Follow-up|2|||
148794888|NCT01576575|536727262|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
148794889|NCT01576575|536727262|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
148794890|NCT01576575|536727262|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
148794891|NCT01566604|536727263|FG000|Overall Study|Patient's inability to use the device|1|||
148794892|NCT01566604|536727264|FG001|Overall Study|Patient's inability to use the device|0|||
148894859|NCT03661723|537094036|FG003|Overall Study|Withdrawal by Subject|4|||
149135421|NCT00447382|537976487|FG001|Overall Study|Unclassified|5|||
149135422|NCT03901053|537976490|FG000|Overall Study|Lost to Follow-up|6|||
149135423|NCT03901053|537976491|FG001|Overall Study|Lost to Follow-up|2|||
149135424|NCT03901053|537976490|FG000|Overall Study|Withdrawal by Subject|4|||
149135425|NCT03901053|537976491|FG001|Overall Study|Withdrawal by Subject|3|||
149135426|NCT03901053|537976490|FG000|Overall Study|Unsatisfactory Device|1|||
149135427|NCT03901053|537976491|FG001|Overall Study|Unsatisfactory Device|2|||
149135428|NCT03901053|537976490|FG000|Overall Study|No longer meets study criteria|1|||
149135429|NCT03901053|537976491|FG001|Overall Study|No longer meets study criteria|3|||
149135430|NCT03901053|537976490|FG000|Overall Study|Subject's Medical Status|0|||
149135431|NCT03901053|537976491|FG001|Overall Study|Subject's Medical Status|1|||
149135432|NCT03901053|537976490|FG000|Overall Study|Screening Failure|1|||
149135433|NCT03901053|537976491|FG001|Overall Study|Screening Failure|0|||
149135434|NCT02408861|537976494|FG000|Overall Study|Death|0|||
149135435|NCT02408861|537976495|FG001|Overall Study|Death|3|||
149135436|NCT02408861|537976496|FG002|Overall Study|Death|1|||
149135437|NCT02408861|537976497|FG003|Overall Study|Death|2|||
149135438|NCT02408861|537976498|FG004|Overall Study|Death|4|||
149135439|NCT02408861|537976499|FG005|Overall Study|Death|1|||
149135440|NCT02408861|537976500|FG006|Overall Study|Death|0|||
148794893|NCT01566604|536727263|FG000|Overall Study|Administrative problems|1|||
148794894|NCT01566604|536727264|FG001|Overall Study|Administrative problems|0|||
148794895|NCT01566604|536727263|FG000|Overall Study|Lack of Efficacy|1|||
148794896|NCT01566604|536727264|FG001|Overall Study|Lack of Efficacy|2|||
148794897|NCT01566604|536727263|FG000|Overall Study|Protocol deviation|2|||
148794898|NCT01566604|536727264|FG001|Overall Study|Protocol deviation|0|||
149135441|NCT02408861|537976494|FG000|Overall Study|Lost to Follow-up|0|||
149135442|NCT02408861|537976495|FG001|Overall Study|Lost to Follow-up|0|||
149135443|NCT02408861|537976496|FG002|Overall Study|Lost to Follow-up|1|||
149237494|NCT04452344|538339497|FG001|Overall Study|Withdrawal by Subject|6|||
149237495|NCT04452344|538339496|FG000|Overall Study|Adverse Event|1|||
149237496|NCT04452344|538339497|FG001|Overall Study|Adverse Event|2|||
149237497|NCT04452344|538339496|FG000|Overall Study|Lost to Follow-up|2|||
149237498|NCT04452344|538339497|FG001|Overall Study|Lost to Follow-up|2|||
149237499|NCT04452344|538339496|FG000|Overall Study|No Post-Op Visit|6|||
149237500|NCT04452344|538339497|FG001|Overall Study|No Post-Op Visit|7|||
149237501|NCT05171777|538339498|FG000|Treatment Crossover Period|Adverse Event|9|||
149237502|NCT05171777|538339499|FG001|Treatment Crossover Period|Adverse Event|6|||
149237503|NCT05171777|538339500|FG002|Treatment Crossover Period|Adverse Event|0|||
149237504|NCT05171777|538339501|FG003|Treatment Crossover Period|Adverse Event|0|||
149237505|NCT05171777|538339498|FG000|Treatment Crossover Period|Death|5|||
149237506|NCT05171777|538339499|FG001|Treatment Crossover Period|Death|5|||
149237507|NCT05171777|538339500|FG002|Treatment Crossover Period|Death|0|||
149237508|NCT05171777|538339501|FG003|Treatment Crossover Period|Death|0|||
149237509|NCT05171777|538339498|FG000|Treatment Crossover Period|Disease Relapse|1|||
149237510|NCT05171777|538339499|FG001|Treatment Crossover Period|Disease Relapse|0|||
149237511|NCT05171777|538339500|FG002|Treatment Crossover Period|Disease Relapse|0|||
149237512|NCT05171777|538339501|FG003|Treatment Crossover Period|Disease Relapse|0|||
149237513|NCT05171777|538339498|FG000|Treatment Crossover Period|Reason not Specified|1|||
149237514|NCT05171777|538339499|FG001|Treatment Crossover Period|Reason not Specified|1|||
149237515|NCT05171777|538339500|FG002|Treatment Crossover Period|Reason not Specified|0|||
149237516|NCT05171777|538339501|FG003|Treatment Crossover Period|Reason not Specified|0|||
149237517|NCT05171777|538339498|FG000|Treatment Crossover Period|Physician Decision|0|||
149237518|NCT05171777|538339499|FG001|Treatment Crossover Period|Physician Decision|1|||
149237519|NCT05171777|538339500|FG002|Treatment Crossover Period|Physician Decision|0|||
149237520|NCT05171777|538339501|FG003|Treatment Crossover Period|Physician Decision|0|||
149237521|NCT05171777|538339498|FG000|Treatment Crossover Period|Progressive Disease|14|||
149237522|NCT05171777|538339499|FG001|Treatment Crossover Period|Progressive Disease|10|||
149237523|NCT05171777|538339500|FG002|Treatment Crossover Period|Progressive Disease|0|||
149237524|NCT05171777|538339501|FG003|Treatment Crossover Period|Progressive Disease|0|||
149237525|NCT05171777|538339498|FG000|Treatment Crossover Period|Protocol Violation|0|||
149237526|NCT05171777|538339499|FG001|Treatment Crossover Period|Protocol Violation|2|||
149237527|NCT05171777|538339500|FG002|Treatment Crossover Period|Protocol Violation|0|||
149237528|NCT05171777|538339501|FG003|Treatment Crossover Period|Protocol Violation|0|||
149237529|NCT05171777|538339498|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
149237530|NCT05171777|538339499|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
149237531|NCT05171777|538339500|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
149237532|NCT05171777|538339501|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
149237533|NCT05171777|538339498|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
149237534|NCT05171777|538339499|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
149237535|NCT05171777|538339500|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
149237536|NCT05171777|538339501|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
149237537|NCT05171777|538339498|FG000|Treatment Continuation Period|Adverse Event|0|||
149237538|NCT05171777|538339499|FG001|Treatment Continuation Period|Adverse Event|0|||
149237539|NCT05171777|538339500|FG002|Treatment Continuation Period|Adverse Event|3|||
149237540|NCT05171777|538339501|FG003|Treatment Continuation Period|Adverse Event|6|||
149237541|NCT05171777|538339498|FG000|Treatment Continuation Period|Death|0|||
149237542|NCT05171777|538339499|FG001|Treatment Continuation Period|Death|0|||
149237543|NCT05171777|538339500|FG002|Treatment Continuation Period|Death|1|||
149237544|NCT05171777|538339501|FG003|Treatment Continuation Period|Death|3|||
149237545|NCT05171777|538339498|FG000|Treatment Continuation Period|Disease Relapse|0|||
149237546|NCT05171777|538339499|FG001|Treatment Continuation Period|Disease Relapse|0|||
149237547|NCT05171777|538339500|FG002|Treatment Continuation Period|Disease Relapse|1|||
149237548|NCT05171777|538339501|FG003|Treatment Continuation Period|Disease Relapse|0|||
149237549|NCT05171777|538339498|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
149237550|NCT05171777|538339499|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
149237551|NCT05171777|538339500|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
149237552|NCT05171777|538339501|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
149237553|NCT05171777|538339498|FG000|Treatment Continuation Period|Physician Decision|0|||
149237554|NCT05171777|538339499|FG001|Treatment Continuation Period|Physician Decision|0|||
149237555|NCT05171777|538339500|FG002|Treatment Continuation Period|Physician Decision|0|||
149237556|NCT05171777|538339501|FG003|Treatment Continuation Period|Physician Decision|4|||
149237557|NCT05171777|538339498|FG000|Treatment Continuation Period|Progressive Disease|0|||
149237558|NCT05171777|538339499|FG001|Treatment Continuation Period|Progressive Disease|0|||
149237559|NCT05171777|538339500|FG002|Treatment Continuation Period|Progressive Disease|6|||
149237560|NCT05171777|538339501|FG003|Treatment Continuation Period|Progressive Disease|20|||
149237561|NCT05171777|538339498|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
149237562|NCT05171777|538339499|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
149237563|NCT05171777|538339500|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
149237564|NCT05171777|538339501|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
149237565|NCT05171777|538339498|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
149237566|NCT05171777|538339499|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
149237567|NCT05171777|538339500|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
149237568|NCT05171777|538339501|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
149237569|NCT05171777|538339498|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
149237570|NCT05171777|538339499|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
149237571|NCT05171777|538339500|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
149237572|NCT05171777|538339501|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
149237573|NCT02364713|538339502|FG000|Overall Study|Ineligible|2|||
149237574|NCT02364713|538339503|FG001|Overall Study|Ineligible|2|||
149237575|NCT05294419|538339504|FG000|Overall Study|Protocol Violation|4|||
149237576|NCT05294419|538339505|FG001|Overall Study|Protocol Violation|0|||
149237577|NCT05294419|538339506|FG002|Overall Study|Protocol Violation|0|||
149237578|NCT05294419|538339504|FG000|Overall Study|Lost to Follow-up|6|||
149237579|NCT05294419|538339505|FG001|Overall Study|Lost to Follow-up|0|||
149237580|NCT05294419|538339506|FG002|Overall Study|Lost to Follow-up|0|||
149237581|NCT05294419|538339504|FG000|Overall Study|Results voided after publishing|2|||
149237582|NCT05294419|538339505|FG001|Overall Study|Results voided after publishing|0|||
149237583|NCT05294419|538339506|FG002|Overall Study|Results voided after publishing|0|||
149237584|NCT04364646|538339507|FG000|Overall Study|Lost to Follow-up|1|||
149237585|NCT04364646|538339508|FG001|Overall Study|Lost to Follow-up|0|||
149237586|NCT04364646|538339507|FG000|Overall Study|Withdrawal by Subject|7|||
149237587|NCT04364646|538339508|FG001|Overall Study|Withdrawal by Subject|14|||
149237588|NCT04364646|538339507|FG000|Overall Study|Protocol Violation|4|||
149237589|NCT04364646|538339508|FG001|Overall Study|Protocol Violation|5|||
149237590|NCT04686786|538339509|FG000|Overall Study|Adverse Event|9|||
149237591|NCT04686786|538339509|FG000|Overall Study|Death|1|||
149237592|NCT04686786|538339509|FG000|Overall Study|Lack of Efficacy|25|||
149237593|NCT04686786|538339509|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
149237594|NCT04686786|538339509|FG000|Overall Study|Study Terminated by Sponsor|14|||
148794899|NCT01566604|536727263|FG000|Overall Study|Abnormal laboratory value|2|||
149237595|NCT04686786|538339509|FG000|Overall Study|Withdrawal by Subject|15|||
148794900|NCT01566604|536727264|FG001|Overall Study|Abnormal laboratory value|0|||
148794901|NCT01566604|536727263|FG000|Overall Study|Death|4|||
148794902|NCT01566604|536727264|FG001|Overall Study|Death|1|||
148794903|NCT01566604|536727263|FG000|Overall Study|Adverse Event|4|||
148794904|NCT01566604|536727264|FG001|Overall Study|Adverse Event|2|||
148794905|NCT01566604|536727263|FG000|Overall Study|Withdrawal by Subject|9|||
148794906|NCT01566604|536727264|FG001|Overall Study|Withdrawal by Subject|6|||
148794907|NCT01610037|536727266|FG000|All Patients|Adverse Event|27|||
148794908|NCT01610037|536727267|FG001|All Patients|Adverse Event|22|||
148794909|NCT01610037|536727268|FG002|All Patients|Adverse Event|26|||
148794910|NCT01610037|536727266|FG000|All Patients|Withdrawal by Subject|12|||
148794911|NCT01610037|536727267|FG001|All Patients|Withdrawal by Subject|10|||
148794912|NCT01610037|536727268|FG002|All Patients|Withdrawal by Subject|20|||
148794913|NCT01610037|536727266|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
148794914|NCT01610037|536727267|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
148794915|NCT01610037|536727268|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
148794916|NCT01610037|536727266|FG000|All Patients|Death|4|||
148794917|NCT01610037|536727267|FG001|All Patients|Death|2|||
148794918|NCT01610037|536727268|FG002|All Patients|Death|1|||
148794919|NCT01610037|536727266|FG000|All Patients|Protocol deviation|4|||
148794920|NCT01610037|536727267|FG001|All Patients|Protocol deviation|3|||
148794921|NCT01610037|536727268|FG002|All Patients|Protocol deviation|3|||
148794922|NCT01610037|536727266|FG000|All Patients|Abnormal laboratory value|1|||
148794923|NCT01610037|536727267|FG001|All Patients|Abnormal laboratory value|1|||
148794924|NCT01610037|536727268|FG002|All Patients|Abnormal laboratory value|0|||
148794925|NCT01610037|536727266|FG000|All Patients|Administrative problems|1|||
148794926|NCT01610037|536727267|FG001|All Patients|Administrative problems|4|||
148794927|NCT01610037|536727268|FG002|All Patients|Administrative problems|4|||
148794928|NCT01610037|536727266|FG000|All Patients|Lost to Follow-up|1|||
148794929|NCT01610037|536727267|FG001|All Patients|Lost to Follow-up|0|||
148794930|NCT01610037|536727268|FG002|All Patients|Lost to Follow-up|0|||
148794931|NCT01610037|536727266|FG000|All Patients|Abnormal test procedure result(s)|0|||
148794932|NCT01610037|536727267|FG001|All Patients|Abnormal test procedure result(s)|1|||
148794933|NCT01610037|536727268|FG002|All Patients|Abnormal test procedure result(s)|3|||
149237596|NCT04686786|538339509|FG000|Overall Study|Other than specified|1|||
149237597|NCT05628103|538339510|FG000|Overall Study|Adverse Event|7|||
149237598|NCT05628103|538339510|FG000|Overall Study|Withdrawal by Subject|3|||
149237599|NCT05628103|538339510|FG000|Overall Study|Lost to Follow-up|3|||
149237600|NCT05628103|538339510|FG000|Overall Study|Lack of Efficacy|1|||
149237601|NCT05628103|538339510|FG000|Overall Study|Non-Compliance With Study Drug|4|||
149237602|NCT04840888|538339511|FG000|Period 1|Withdrawal by Subject|0|||
148794934|NCT01610037|536727266|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
148794935|NCT01610037|536727267|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
148894860|NCT03661723|537094033|FG000|Overall Study|Physician Decision|1|||
148794936|NCT01610037|536727268|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
148794937|NCT01610037|536727266|FG000|Treatment and Follow up Period|Death|10|||
148794938|NCT01610037|536727267|FG001|Treatment and Follow up Period|Death|5|||
148794939|NCT01610037|536727268|FG002|Treatment and Follow up Period|Death|4|||
148794940|NCT01610037|536727266|FG000|Treatment and Follow up Period|Administrative problems|1|||
148794941|NCT01610037|536727267|FG001|Treatment and Follow up Period|Administrative problems|3|||
148794942|NCT01610037|536727268|FG002|Treatment and Follow up Period|Administrative problems|2|||
148794943|NCT01610037|536727266|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
148794944|NCT01610037|536727267|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
148794945|NCT01610037|536727268|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
148794946|NCT00705757|536727276|FG000|Overall Study|Lack of Efficacy|5|||
148794947|NCT00705757|536727277|FG001|Overall Study|Lack of Efficacy|1|||
148794948|NCT00705757|536727278|FG002|Overall Study|Lack of Efficacy|3|||
148794949|NCT00705757|536727276|FG000|Overall Study|Lost to Follow-up|7|||
148794950|NCT00705757|536727277|FG001|Overall Study|Lost to Follow-up|6|||
148794951|NCT00705757|536727278|FG002|Overall Study|Lost to Follow-up|6|||
148794952|NCT00705757|536727276|FG000|Overall Study|Withdrawal by Subject|1|||
148794953|NCT00705757|536727277|FG001|Overall Study|Withdrawal by Subject|1|||
148794954|NCT00705757|536727278|FG002|Overall Study|Withdrawal by Subject|2|||
148794955|NCT00661089|536727279|FG000|Overall Study|1 subject withdrawal|0|||
148794956|NCT00661089|536727280|FG001|Overall Study|1 subject withdrawal|1|||
148794957|NCT00661089|536727279|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
148794958|NCT00661089|536727280|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
148794959|NCT00274742|536727281|FG000|Overall Study|Adverse Event|0|||
148794960|NCT00274742|536727282|FG001|Overall Study|Adverse Event|4|||
148794961|NCT00274742|536727283|FG002|Overall Study|Adverse Event|1|||
148794962|NCT00274742|536727284|FG003|Overall Study|Adverse Event|4|||
148794963|NCT00274742|536727285|FG004|Overall Study|Adverse Event|12|||
148794964|NCT00274742|536727286|FG005|Overall Study|Adverse Event|3|||
148794965|NCT00274742|536727281|FG000|Overall Study|Lost to Follow-up|0|||
148794966|NCT00274742|536727282|FG001|Overall Study|Lost to Follow-up|0|||
148794967|NCT00274742|536727283|FG002|Overall Study|Lost to Follow-up|0|||
148794968|NCT00274742|536727284|FG003|Overall Study|Lost to Follow-up|0|||
148794969|NCT00274742|536727285|FG004|Overall Study|Lost to Follow-up|1|||
148794970|NCT00274742|536727286|FG005|Overall Study|Lost to Follow-up|0|||
148794971|NCT00274742|536727281|FG000|Overall Study|End of Study|0|||
148794972|NCT00274742|536727282|FG001|Overall Study|End of Study|0|||
148794973|NCT00274742|536727283|FG002|Overall Study|End of Study|0|||
148794974|NCT00274742|536727284|FG003|Overall Study|End of Study|1|||
148794975|NCT00274742|536727285|FG004|Overall Study|End of Study|0|||
148794976|NCT00274742|536727286|FG005|Overall Study|End of Study|0|||
148794977|NCT00274742|536727281|FG000|Overall Study|Disease Progression|0|||
148794978|NCT00274742|536727282|FG001|Overall Study|Disease Progression|1|||
148794979|NCT00274742|536727283|FG002|Overall Study|Disease Progression|1|||
148794980|NCT00274742|536727284|FG003|Overall Study|Disease Progression|0|||
148794981|NCT00274742|536727285|FG004|Overall Study|Disease Progression|1|||
148794982|NCT00274742|536727286|FG005|Overall Study|Disease Progression|0|||
148794983|NCT00274742|536727281|FG000|Overall Study|Other|0|||
148794984|NCT00274742|536727282|FG001|Overall Study|Other|3|||
148794985|NCT00274742|536727283|FG002|Overall Study|Other|0|||
148794986|NCT00274742|536727284|FG003|Overall Study|Other|0|||
148794987|NCT00274742|536727285|FG004|Overall Study|Other|2|||
148794988|NCT00274742|536727286|FG005|Overall Study|Other|0|||
148794989|NCT01443858|536727297|FG000|Overall Study|Withdrawal by Subject|9|||
148794990|NCT01443858|536727298|FG001|Overall Study|Withdrawal by Subject|8|||
148794991|NCT01443858|536727299|FG002|Overall Study|Withdrawal by Subject|5|||
148794992|NCT01443858|536727297|FG000|Overall Study|Lack of Efficacy|1|||
148794993|NCT01443858|536727298|FG001|Overall Study|Lack of Efficacy|0|||
148794994|NCT01443858|536727299|FG002|Overall Study|Lack of Efficacy|0|||
148794995|NCT01443858|536727297|FG000|Overall Study|Lost to Follow-up|5|||
148794996|NCT01443858|536727298|FG001|Overall Study|Lost to Follow-up|5|||
148794997|NCT01443858|536727299|FG002|Overall Study|Lost to Follow-up|2|||
148794998|NCT03361306|536727300|FG000|Overall Study|Death|6|||
148794999|NCT00321906|536727301|FG000|Overall Study|Adverse Event|36|||
148795000|NCT00321906|536727302|FG001|Overall Study|Adverse Event|44|||
148795001|NCT00321906|536727301|FG000|Overall Study|Death|9|||
148795002|NCT00321906|536727302|FG001|Overall Study|Death|6|||
148795003|NCT00321906|536727301|FG000|Overall Study|Lost to Follow-up|1|||
148795004|NCT00321906|536727302|FG001|Overall Study|Lost to Follow-up|2|||
148795005|NCT00321906|536727301|FG000|Overall Study|Withdrawal by Subject|0|||
148795006|NCT00321906|536727302|FG001|Overall Study|Withdrawal by Subject|4|||
148795007|NCT01272908|536727304|FG000|Initial Treatment Period|Adverse Event|1|||
148795008|NCT01272908|536727304|FG000|Initial Treatment Period|Lack of Efficacy|5|||
148795009|NCT01272908|536727304|FG000|Initial Treatment Period|Protocol Violation|1|||
148795010|NCT01272908|536727304|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
148795011|NCT01272908|536727304|FG000|Re-Treatment Period|Adverse Event|2|||
148795012|NCT01272908|536727304|FG000|Re-Treatment Period|Lack of Efficacy|3|||
148795013|NCT01272908|536727304|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
149237603|NCT04840888|538339512|FG001|Period 1|Withdrawal by Subject|0|||
149237604|NCT04840888|538339513|FG002|Period 1|Withdrawal by Subject|0|||
149237605|NCT04840888|538339514|FG003|Period 1|Withdrawal by Subject|0|||
149237606|NCT04840888|538339515|FG004|Period 1|Withdrawal by Subject|1|||
149237607|NCT04840888|538339516|FG005|Period 1|Withdrawal by Subject|0|||
149237608|NCT04840888|538339511|FG000|Period 1|Adverse Event|0|||
149237609|NCT04840888|538339512|FG001|Period 1|Adverse Event|0|||
149237610|NCT04840888|538339513|FG002|Period 1|Adverse Event|1|||
149237611|NCT04840888|538339514|FG003|Period 1|Adverse Event|1|||
149237612|NCT04840888|538339515|FG004|Period 1|Adverse Event|10|||
149237613|NCT04840888|538339516|FG005|Period 1|Adverse Event|1|||
149237614|NCT02003924|538339517|FG000|Double-blind Phase|Lost to Follow-up|2|||
149237615|NCT02003924|538339518|FG001|Double-blind Phase|Lost to Follow-up|1|||
149237616|NCT02003924|538339519|FG002|Double-blind Phase|Lost to Follow-up|0|||
149237617|NCT02003924|538339517|FG000|Double-blind Phase|Protocol Violation|1|||
149237618|NCT02003924|538339518|FG001|Double-blind Phase|Protocol Violation|2|||
149237619|NCT02003924|538339519|FG002|Double-blind Phase|Protocol Violation|0|||
149237620|NCT02003924|538339517|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
149237621|NCT02003924|538339518|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
149237622|NCT02003924|538339519|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
149237623|NCT02003924|538339517|FG000|Double-blind Phase|Disease Progression|229|||
149237624|NCT02003924|538339518|FG001|Double-blind Phase|Disease Progression|247|||
149237625|NCT02003924|538339519|FG002|Double-blind Phase|Disease Progression|0|||
149237626|NCT02003924|538339517|FG000|Double-blind Phase|Adverse Event|120|||
149237627|NCT02003924|538339518|FG001|Double-blind Phase|Adverse Event|31|||
149237628|NCT02003924|538339519|FG002|Double-blind Phase|Adverse Event|0|||
149237629|NCT02003924|538339517|FG000|Double-blind Phase|Randomized But not Treated|3|||
149237630|NCT02003924|538339518|FG001|Double-blind Phase|Randomized But not Treated|3|||
149237631|NCT02003924|538339519|FG002|Double-blind Phase|Randomized But not Treated|0|||
149237632|NCT02003924|538339517|FG000|Double-blind Phase|Other|29|||
149237633|NCT02003924|538339518|FG001|Double-blind Phase|Other|50|||
149237634|NCT02003924|538339519|FG002|Double-blind Phase|Other|0|||
149237635|NCT02003924|538339517|FG000|Open-label Phase|Lost to Follow-up|0|||
149237636|NCT02003924|538339518|FG001|Open-label Phase|Lost to Follow-up|0|||
149237637|NCT02003924|538339519|FG002|Open-label Phase|Lost to Follow-up|1|||
149237638|NCT02003924|538339517|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
149237639|NCT02003924|538339518|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
149237640|NCT02003924|538339519|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
149237641|NCT02003924|538339517|FG000|Open-label Phase|Disease Progression|59|||
149237642|NCT02003924|538339518|FG001|Open-label Phase|Disease Progression|0|||
149237643|NCT02003924|538339519|FG002|Open-label Phase|Disease Progression|5|||
149237644|NCT02003924|538339517|FG000|Open-label Phase|Adverse Event|25|||
149237645|NCT02003924|538339518|FG001|Open-label Phase|Adverse Event|0|||
149237646|NCT02003924|538339519|FG002|Open-label Phase|Adverse Event|10|||
149237647|NCT02003924|538339517|FG000|Open-label Phase|Other|7|||
149237648|NCT02003924|538339518|FG001|Open-label Phase|Other|0|||
149237649|NCT02003924|538339519|FG002|Open-label Phase|Other|0|||
149237650|NCT02003924|538339517|FG000|Long-term Follow-up Phase|Death|288|||
149237651|NCT02003924|538339518|FG001|Long-term Follow-up Phase|Death|174|||
149237652|NCT02003924|538339519|FG002|Long-term Follow-up Phase|Death|4|||
149237653|NCT02003924|538339517|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
149237654|NCT02003924|538339518|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
149237655|NCT02003924|538339519|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
149237656|NCT02003924|538339517|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
149237657|NCT02003924|538339518|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
149237658|NCT02003924|538339519|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
148894861|NCT03661723|537094034|FG001|Overall Study|Physician Decision|0|||
148894862|NCT03661723|537094035|FG002|Overall Study|Physician Decision|0|||
149237659|NCT02003924|538339517|FG000|Long-term Follow-up Phase|Other|5|||
149237660|NCT02003924|538339518|FG001|Long-term Follow-up Phase|Other|2|||
149237661|NCT02003924|538339519|FG002|Long-term Follow-up Phase|Other|1|||
148894863|NCT03661723|537094036|FG003|Overall Study|Physician Decision|0|||
149237662|NCT04684914|538339521|FG000|Overall Study|Withdrawal by Subject|1|||
149237663|NCT04684914|538339522|FG001|Overall Study|Withdrawal by Subject|0|||
149237664|NCT04684914|538339521|FG000|Overall Study|Discontinued before receiving study treatment|1|||
149237665|NCT04684914|538339522|FG001|Overall Study|Discontinued before receiving study treatment|2|||
149237666|NCT03924869|538339523|FG000|Overall Study|Death|73|||
149237667|NCT03924869|538339524|FG001|Overall Study|Death|62|||
149237668|NCT03924869|538339523|FG000|Overall Study|Lost to Follow-up|3|||
149237669|NCT03924869|538339524|FG001|Overall Study|Lost to Follow-up|0|||
149237670|NCT03924869|538339523|FG000|Overall Study|Physician Decision|0|||
149237671|NCT03924869|538339524|FG001|Overall Study|Physician Decision|3|||
149237672|NCT03924869|538339523|FG000|Overall Study|Withdrawal by Subject|7|||
149237673|NCT03924869|538339524|FG001|Overall Study|Withdrawal by Subject|3|||
148894864|NCT03661723|537094033|FG000|Overall Study|Clinical Deterioration|0|||
148894865|NCT03661723|537094034|FG001|Overall Study|Clinical Deterioration|0|||
148894866|NCT03661723|537094035|FG002|Overall Study|Clinical Deterioration|0|||
148894867|NCT03661723|537094036|FG003|Overall Study|Clinical Deterioration|1|||
148894868|NCT00286442|537094037|FG000|Overall Study|Hyperglycemic Rescue|19|||
149237674|NCT03924869|538339523|FG000|Overall Study|Study Terminated By Sponsor|144|||
149237675|NCT03924869|538339524|FG001|Overall Study|Study Terminated By Sponsor|153|||
149237676|NCT03359759|538339525|FG000|Overall Study|Death|3|||
149237677|NCT03359759|538339525|FG000|Overall Study|Lost to Follow-up|2|||
149237678|NCT06081829|538339526|FG000|Overall Study|Participants still on-study|8|||
149237679|NCT06081829|538339526|FG000|Overall Study|Death|4|||
148894869|NCT00286442|537094038|FG001|Overall Study|Hyperglycemic Rescue|17|||
148894870|NCT00286442|537094039|FG002|Overall Study|Hyperglycemic Rescue|25|||
148894871|NCT00286442|537094037|FG000|Overall Study|Adverse Event|7|||
148894872|NCT00286442|537094038|FG001|Overall Study|Adverse Event|6|||
148894873|NCT00286442|537094039|FG002|Overall Study|Adverse Event|1|||
148894874|NCT00286442|537094037|FG000|Overall Study|Protocol Violation|2|||
148894875|NCT00286442|537094038|FG001|Overall Study|Protocol Violation|4|||
148894876|NCT00286442|537094039|FG002|Overall Study|Protocol Violation|2|||
148894877|NCT00286442|537094037|FG000|Overall Study|Lost to Follow-up|5|||
148894878|NCT00286442|537094038|FG001|Overall Study|Lost to Follow-up|2|||
148894879|NCT00286442|537094039|FG002|Overall Study|Lost to Follow-up|1|||
148894880|NCT00286442|537094037|FG000|Overall Study|Physician Decision|1|||
148894881|NCT00286442|537094038|FG001|Overall Study|Physician Decision|1|||
148894882|NCT00286442|537094039|FG002|Overall Study|Physician Decision|1|||
148894883|NCT00286442|537094037|FG000|Overall Study|Administrative Error|1|||
148894884|NCT00286442|537094038|FG001|Overall Study|Administrative Error|1|||
148894885|NCT00286442|537094039|FG002|Overall Study|Administrative Error|0|||
148894886|NCT00286442|537094037|FG000|Overall Study|Withdrawal by Subject|2|||
148894887|NCT00286442|537094038|FG001|Overall Study|Withdrawal by Subject|14|||
148894888|NCT00286442|537094039|FG002|Overall Study|Withdrawal by Subject|2|||
148894889|NCT02140047|537094040|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148894890|NCT02140047|537094041|FG001|Overall Study|Withdrawal by parent/guardian|1|||
148894891|NCT02140047|537094042|FG002|Overall Study|Withdrawal by parent/guardian|0|||
148894892|NCT00325897|537094043|FG000|Overall Study|Lost to Follow-up|12|||
148894893|NCT00325897|537094044|FG001|Overall Study|Lost to Follow-up|13|||
148894894|NCT04079296|537094045|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
148894895|NCT04079296|537094046|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
148894896|NCT04079296|537094047|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
148894897|NCT04079296|537094048|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
149135444|NCT02408861|537976497|FG003|Overall Study|Lost to Follow-up|1|||
149135445|NCT02408861|537976498|FG004|Overall Study|Lost to Follow-up|4|||
149135446|NCT02408861|537976499|FG005|Overall Study|Lost to Follow-up|2|||
149135447|NCT02408861|537976500|FG006|Overall Study|Lost to Follow-up|1|||
149135448|NCT02408861|537976494|FG000|Overall Study|Disease Progression|0|||
149135449|NCT02408861|537976495|FG001|Overall Study|Disease Progression|0|||
149135450|NCT02408861|537976496|FG002|Overall Study|Disease Progression|1|||
149135451|NCT02408861|537976497|FG003|Overall Study|Disease Progression|0|||
149135452|NCT02408861|537976498|FG004|Overall Study|Disease Progression|3|||
149135453|NCT02408861|537976499|FG005|Overall Study|Disease Progression|1|||
149135454|NCT02408861|537976500|FG006|Overall Study|Disease Progression|1|||
149135455|NCT02408861|537976494|FG000|Overall Study|Adverse Event|1|||
149135456|NCT02408861|537976495|FG001|Overall Study|Adverse Event|0|||
149135457|NCT02408861|537976496|FG002|Overall Study|Adverse Event|1|||
149135458|NCT02408861|537976497|FG003|Overall Study|Adverse Event|0|||
149135459|NCT02408861|537976498|FG004|Overall Study|Adverse Event|2|||
149135460|NCT02408861|537976499|FG005|Overall Study|Adverse Event|0|||
149135461|NCT02408861|537976500|FG006|Overall Study|Adverse Event|0|||
149135462|NCT02408861|537976494|FG000|Overall Study|Physician Decision|1|||
149135463|NCT02408861|537976495|FG001|Overall Study|Physician Decision|1|||
149135464|NCT02408861|537976496|FG002|Overall Study|Physician Decision|1|||
149135465|NCT02408861|537976497|FG003|Overall Study|Physician Decision|0|||
149135466|NCT02408861|537976498|FG004|Overall Study|Physician Decision|0|||
149135467|NCT02408861|537976499|FG005|Overall Study|Physician Decision|1|||
149135468|NCT02408861|537976500|FG006|Overall Study|Physician Decision|0|||
149135469|NCT02408861|537976494|FG000|Overall Study|Protocol Violation|1|||
148894898|NCT04079296|537094049|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
148894899|NCT04079296|537094045|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
148894900|NCT04079296|537094046|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
148894901|NCT04079296|537094047|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
148894902|NCT04079296|537094048|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
148894903|NCT04079296|537094049|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
148894904|NCT04079296|537094045|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
149135470|NCT02408861|537976495|FG001|Overall Study|Protocol Violation|0|||
149135471|NCT02408861|537976496|FG002|Overall Study|Protocol Violation|0|||
149135472|NCT02408861|537976497|FG003|Overall Study|Protocol Violation|0|||
149135473|NCT02408861|537976498|FG004|Overall Study|Protocol Violation|0|||
149237680|NCT05568888|538339527|FG000|Overall Study|Physician Decision|1|||
149237681|NCT05568888|538339528|FG001|Overall Study|Physician Decision|0|||
148795014|NCT02221648|536727305|FG000|Overall Study|Withdrawal by Subject|3|||
148795015|NCT02221648|536727306|FG001|Overall Study|Withdrawal by Subject|3|||
148795016|NCT00149396|536727307|FG000|Overall Study|Death|15|||
148795017|NCT00149396|536727307|FG000|Overall Study|Withdrawal by Subject|1|||
148795018|NCT00149396|536727307|FG000|Overall Study|Subject noncompliance|2|||
148795019|NCT00149396|536727307|FG000|Overall Study|other treatment|5|||
148795020|NCT00810069|536727310|FG000|Lead-in Period I|Adverse Event|43|||
148795021|NCT00810069|536727311|FG001|Lead-in Period I|Adverse Event|0|||
148795022|NCT00810069|536727312|FG002|Lead-in Period I|Adverse Event|0|||
148795023|NCT00810069|536727310|FG000|Lead-in Period I|Lack of Efficacy|1|||
148795024|NCT00810069|536727311|FG001|Lead-in Period I|Lack of Efficacy|0|||
148795025|NCT00810069|536727312|FG002|Lead-in Period I|Lack of Efficacy|0|||
148795026|NCT00810069|536727310|FG000|Lead-in Period I|Lost to Follow-up|19|||
148795027|NCT00810069|536727311|FG001|Lead-in Period I|Lost to Follow-up|0|||
148795028|NCT00810069|536727312|FG002|Lead-in Period I|Lost to Follow-up|0|||
148795029|NCT00810069|536727310|FG000|Lead-in Period I|Physician Decision|1|||
148795030|NCT00810069|536727311|FG001|Lead-in Period I|Physician Decision|0|||
148795031|NCT00810069|536727312|FG002|Lead-in Period I|Physician Decision|0|||
148795032|NCT00810069|536727310|FG000|Lead-in Period I|Protocol Violation|1|||
148795033|NCT00810069|536727311|FG001|Lead-in Period I|Protocol Violation|0|||
148795034|NCT00810069|536727312|FG002|Lead-in Period I|Protocol Violation|0|||
148795035|NCT00810069|536727310|FG000|Lead-in Period I|Withdrawal by Subject|46|||
148795036|NCT00810069|536727311|FG001|Lead-in Period I|Withdrawal by Subject|0|||
148795037|NCT00810069|536727312|FG002|Lead-in Period I|Withdrawal by Subject|0|||
148795038|NCT00810069|536727310|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
148795039|NCT00810069|536727311|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
148795040|NCT00810069|536727312|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
148795041|NCT00810069|536727310|FG000|Lead-in Period I|Randomization criteria not met|158|||
148795042|NCT00810069|536727311|FG001|Lead-in Period I|Randomization criteria not met|0|||
148795043|NCT00810069|536727312|FG002|Lead-in Period I|Randomization criteria not met|0|||
148795044|NCT00810069|536727310|FG000|Double-Blind Period II|Adverse Event|0|||
148795045|NCT00810069|536727311|FG001|Double-Blind Period II|Adverse Event|9|||
148795046|NCT00810069|536727312|FG002|Double-Blind Period II|Adverse Event|8|||
148795047|NCT00810069|536727310|FG000|Double-Blind Period II|Lack of Efficacy|0|||
148795048|NCT00810069|536727311|FG001|Double-Blind Period II|Lack of Efficacy|7|||
148795049|NCT00810069|536727312|FG002|Double-Blind Period II|Lack of Efficacy|12|||
148795050|NCT00810069|536727310|FG000|Double-Blind Period II|Lost to Follow-up|0|||
148795051|NCT00810069|536727311|FG001|Double-Blind Period II|Lost to Follow-up|9|||
148795052|NCT00810069|536727312|FG002|Double-Blind Period II|Lost to Follow-up|9|||
148795053|NCT00810069|536727310|FG000|Double-Blind Period II|Physician Decision|0|||
148795054|NCT00810069|536727311|FG001|Double-Blind Period II|Physician Decision|0|||
148795055|NCT00810069|536727312|FG002|Double-Blind Period II|Physician Decision|1|||
148795056|NCT00810069|536727310|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
148795057|NCT00810069|536727311|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
148795058|NCT00810069|536727312|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
148795059|NCT00810069|536727310|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
148795060|NCT00810069|536727311|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
148795061|NCT00810069|536727312|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
148795062|NCT00810069|536727310|FG000|Double-Blind Period II|Clinical relapse|0|||
148795063|NCT00810069|536727311|FG001|Double-Blind Period II|Clinical relapse|3|||
148795064|NCT00810069|536727312|FG002|Double-Blind Period II|Clinical relapse|0|||
148795065|NCT00810069|536727310|FG000|Double-Blind Period II|Protocol Violation|0|||
148795066|NCT00810069|536727311|FG001|Double-Blind Period II|Protocol Violation|7|||
148795067|NCT00810069|536727312|FG002|Double-Blind Period II|Protocol Violation|6|||
148795068|NCT01951417|536727315|FG000|Overall Study|Withdrawal by Subject|1|||
148795069|NCT01951417|536727315|FG000|Overall Study|Protocol Violation|2|||
148795070|NCT01951417|536727315|FG000|Overall Study|Lost to Follow-up|6|||
148795071|NCT00977613|536727316|FG000|Overall Study|Lost to Follow-up|16|||
148795072|NCT03360019|536727323|FG000|Overall Study|Withdrawal by Subject|2|||
148795073|NCT03360019|536727324|FG001|Overall Study|Withdrawal by Subject|0|||
148795074|NCT03360019|536727325|FG002|Overall Study|Withdrawal by Subject|0|||
148795075|NCT03360019|536727323|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
148795076|NCT03360019|536727324|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
148795077|NCT03360019|536727325|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
148795078|NCT00520039|536727328|FG000|Overall Study|Exclusion criteria met at first visit|7|||
148795079|NCT00520039|536727329|FG001|Overall Study|Exclusion criteria met at first visit|5|||
148795080|NCT02058589|536727331|FG000|Overall Study|Serious Adverse Event|1|||
148795081|NCT02058589|536727332|FG001|Overall Study|Serious Adverse Event|1|||
148795082|NCT02058589|536727331|FG000|Overall Study|Non-Serious Adverse Event|1|||
148795083|NCT02058589|536727332|FG001|Overall Study|Non-Serious Adverse Event|0|||
148795084|NCT02058589|536727331|FG000|Overall Study|Withdrawal by Subject|0|||
148795085|NCT02058589|536727332|FG001|Overall Study|Withdrawal by Subject|1|||
148795086|NCT00490971|536727334|FG000|Acute/Continuation|Adverse Event|62|||
148795087|NCT00490971|536727335|FG001|Acute/Continuation|Adverse Event|13|||
149135474|NCT02408861|537976499|FG005|Overall Study|Protocol Violation|0|||
149135475|NCT02408861|537976500|FG006|Overall Study|Protocol Violation|0|||
149135476|NCT02408861|537976494|FG000|Overall Study|Withdrawal by Subject|0|||
149135477|NCT02408861|537976495|FG001|Overall Study|Withdrawal by Subject|0|||
149135478|NCT02408861|537976496|FG002|Overall Study|Withdrawal by Subject|0|||
149135479|NCT02408861|537976497|FG003|Overall Study|Withdrawal by Subject|0|||
149237682|NCT05568888|538339527|FG000|Overall Study|Protocol Deviation|2|||
149237683|NCT05568888|538339528|FG001|Overall Study|Protocol Deviation|1|||
149237684|NCT05568888|538339527|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
149237685|NCT05568888|538339528|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
149237686|NCT05568888|538339527|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
149237687|NCT05568888|538339528|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
149237688|NCT05568888|538339527|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
149237689|NCT05568888|538339528|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
149237690|NCT02406781|538339530|FG000|Overall Study|Protocol Violation|2|||
149237691|NCT02406781|538339531|FG001|Overall Study|Protocol Violation|2|||
149237692|NCT02406781|538339532|FG002|Overall Study|Protocol Violation|2|||
149237693|NCT02406781|538339533|FG003|Overall Study|Protocol Violation|2|||
149237694|NCT02406781|538339534|FG004|Overall Study|Protocol Violation|1|||
149237695|NCT02406781|538339535|FG005|Overall Study|Protocol Violation|5|||
149237696|NCT02406781|538339536|FG006|Overall Study|Protocol Violation|3|||
149237697|NCT03608033|538339540|FG000|Treatment Period|Death|0|||
149237698|NCT03608033|538339541|FG001|Treatment Period|Death|1|||
148795088|NCT00490971|536727336|FG002|Acute/Continuation|Adverse Event|0|||
148795089|NCT00490971|536727337|FG003|Acute/Continuation|Adverse Event|0|||
148795090|NCT00490971|536727338|FG004|Acute/Continuation|Adverse Event|0|||
149135480|NCT02408861|537976498|FG004|Overall Study|Withdrawal by Subject|1|||
149135481|NCT02408861|537976499|FG005|Overall Study|Withdrawal by Subject|1|||
149135482|NCT02408861|537976500|FG006|Overall Study|Withdrawal by Subject|0|||
149135483|NCT02408861|537976494|FG000|Overall Study|Other Treatment|0|||
149135484|NCT02408861|537976495|FG001|Overall Study|Other Treatment|0|||
149135485|NCT02408861|537976496|FG002|Overall Study|Other Treatment|0|||
149135486|NCT02408861|537976497|FG003|Overall Study|Other Treatment|0|||
149135487|NCT02408861|537976498|FG004|Overall Study|Other Treatment|0|||
149135488|NCT02408861|537976499|FG005|Overall Study|Other Treatment|1|||
149135489|NCT02408861|537976500|FG006|Overall Study|Other Treatment|1|||
149135490|NCT03808688|537978426|FG000|Overall Study|Adverse Event|13|||
149135491|NCT03808688|537978427|FG001|Overall Study|Adverse Event|17|||
149135492|NCT03808688|537978426|FG000|Overall Study|Lack of Efficacy|2|||
149135493|NCT03808688|537978427|FG001|Overall Study|Lack of Efficacy|0|||
149135494|NCT03808688|537978426|FG000|Overall Study|Lost to Follow-up|0|||
149135495|NCT03808688|537978427|FG001|Overall Study|Lost to Follow-up|2|||
149135496|NCT03808688|537978426|FG000|Overall Study|Withdrawal by Subject|1|||
149135497|NCT03808688|537978427|FG001|Overall Study|Withdrawal by Subject|0|||
149135498|NCT03808688|537978426|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
149135499|NCT03808688|537978427|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
149135500|NCT03808688|537978426|FG000|Overall Study|IOP Too High|1|||
149135501|NCT03808688|537978427|FG001|Overall Study|IOP Too High|1|||
149135502|NCT03808688|537978426|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
149135503|NCT03808688|537978427|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
149135504|NCT03808688|537978426|FG000|Overall Study|Visit Out of Window|0|||
149135505|NCT03808688|537978427|FG001|Overall Study|Visit Out of Window|1|||
149135506|NCT03808688|537978426|FG000|Overall Study|Medication Non-Compliance|0|||
149135507|NCT03808688|537978427|FG001|Overall Study|Medication Non-Compliance|1|||
149135508|NCT04641299|537978434|FG000|Overall Study|Adverse Event|0|||
149135509|NCT04641299|537978435|FG001|Overall Study|Adverse Event|0|||
149135510|NCT04641299|537978436|FG002|Overall Study|Adverse Event|2|||
149135511|NCT04641299|537978437|FG003|Overall Study|Adverse Event|0|||
149135512|NCT04641299|537978434|FG000|Overall Study|Lost to Follow-up|0|||
149135513|NCT04641299|537978435|FG001|Overall Study|Lost to Follow-up|1|||
149135514|NCT04641299|537978436|FG002|Overall Study|Lost to Follow-up|0|||
149135515|NCT04641299|537978437|FG003|Overall Study|Lost to Follow-up|0|||
149135516|NCT04641299|537978434|FG000|Overall Study|Withdrawal by Subject|1|||
149135517|NCT04641299|537978435|FG001|Overall Study|Withdrawal by Subject|0|||
149135518|NCT04641299|537978436|FG002|Overall Study|Withdrawal by Subject|0|||
149237699|NCT03608033|538339540|FG000|Treatment Period|Adverse Event|1|||
149237700|NCT03608033|538339541|FG001|Treatment Period|Adverse Event|5|||
148795091|NCT00490971|536727334|FG000|Acute/Continuation|Death|2|||
148795092|NCT00490971|536727335|FG001|Acute/Continuation|Death|0|||
148795093|NCT00490971|536727336|FG002|Acute/Continuation|Death|0|||
148795094|NCT00490971|536727337|FG003|Acute/Continuation|Death|0|||
148795095|NCT00490971|536727338|FG004|Acute/Continuation|Death|0|||
149135519|NCT04641299|537978437|FG003|Overall Study|Withdrawal by Subject|0|||
149135520|NCT04641299|537978434|FG000|Overall Study|Reason not given|1|||
149135521|NCT04641299|537978435|FG001|Overall Study|Reason not given|0|||
149135522|NCT04641299|537978436|FG002|Overall Study|Reason not given|0|||
149237701|NCT03608033|538339540|FG000|Treatment Period|Lack of Efficacy|4|||
149237702|NCT03608033|538339541|FG001|Treatment Period|Lack of Efficacy|3|||
149237703|NCT03608033|538339540|FG000|Treatment Period|Lost to Follow-up|2|||
149237704|NCT03608033|538339541|FG001|Treatment Period|Lost to Follow-up|6|||
149237705|NCT03608033|538339540|FG000|Treatment Period|Physician Decision|6|||
149237706|NCT03608033|538339541|FG001|Treatment Period|Physician Decision|10|||
149237707|NCT03608033|538339540|FG000|Treatment Period|Pregnancy|1|||
149237708|NCT03608033|538339541|FG001|Treatment Period|Pregnancy|0|||
149237709|NCT03608033|538339540|FG000|Treatment Period|Protocol Violation|1|||
149237710|NCT03608033|538339541|FG001|Treatment Period|Protocol Violation|2|||
149237711|NCT03608033|538339540|FG000|Treatment Period|Withdrawal by Subject|46|||
149237712|NCT03608033|538339541|FG001|Treatment Period|Withdrawal by Subject|45|||
149237713|NCT03608033|538339540|FG000|Treatment Period|Study terminated by sponsor|82|||
149237714|NCT03608033|538339541|FG001|Treatment Period|Study terminated by sponsor|68|||
149237715|NCT03608033|538339540|FG000|Treatment Period|Site Terminated by Sponsor|1|||
149237716|NCT03608033|538339541|FG001|Treatment Period|Site Terminated by Sponsor|0|||
149237717|NCT03608033|538339540|FG000|Open-Label Period: OMS721|Adverse Event|1|||
149237718|NCT03608033|538339541|FG001|Open-Label Period: OMS721|Adverse Event|0|||
149237719|NCT03608033|538339540|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
149237720|NCT03608033|538339541|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
149237721|NCT03608033|538339540|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
149237722|NCT03608033|538339541|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
149237723|NCT03608033|538339540|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
149237724|NCT03608033|538339541|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
149237725|NCT03608033|538339540|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
149237726|NCT03608033|538339541|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
149237727|NCT04026711|538339542|FG000|Overall Study|Withdrawal by Subject|1|||
149237728|NCT04026711|538339543|FG001|Overall Study|Withdrawal by Subject|0|||
149237729|NCT04026711|538339542|FG000|Overall Study|mental health crisis|1|||
149237730|NCT04026711|538339543|FG001|Overall Study|mental health crisis|0|||
149237731|NCT03483012|538339544|FG000|Overall Study|Lack of Efficacy|6|||
149237732|NCT02900976|538339546|FG000|Overall Study|Adverse Event|0|||
149237733|NCT02900976|538339547|FG001|Overall Study|Adverse Event|1|||
149237734|NCT02900976|538339546|FG000|Overall Study|Physician Decision|0|||
149237735|NCT02900976|538339547|FG001|Overall Study|Physician Decision|2|||
149237736|NCT02900976|538339546|FG000|Overall Study|Progressive disease|0|||
149237737|NCT02900976|538339547|FG001|Overall Study|Progressive disease|6|||
149237738|NCT05985395|538339550|FG000|Overall Study|Physician Decision|2|||
149237739|NCT05985395|538339551|FG001|Overall Study|Physician Decision|1|||
149237740|NCT05985395|538339550|FG000|Overall Study|Withdrawal by Subject|1|||
149237741|NCT05985395|538339551|FG001|Overall Study|Withdrawal by Subject|0|||
149237742|NCT02360579|538339553|FG000|Initial|Death|16|||
149237743|NCT02360579|538339554|FG001|Initial|Death|49|||
149237744|NCT02360579|538339555|FG002|Initial|Death|0|||
149237745|NCT02360579|538339556|FG003|Initial|Death|71|||
149237746|NCT02360579|538339553|FG000|Initial|Lost to Follow-up|0|||
149237747|NCT02360579|538339554|FG001|Initial|Lost to Follow-up|4|||
149237748|NCT02360579|538339555|FG002|Initial|Lost to Follow-up|0|||
149237749|NCT02360579|538339556|FG003|Initial|Lost to Follow-up|1|||
148795096|NCT00490971|536727334|FG000|Acute/Continuation|Lack of Efficacy|106|||
148795097|NCT00490971|536727335|FG001|Acute/Continuation|Lack of Efficacy|12|||
148795098|NCT00490971|536727336|FG002|Acute/Continuation|Lack of Efficacy|0|||
148795099|NCT00490971|536727337|FG003|Acute/Continuation|Lack of Efficacy|0|||
148795100|NCT00490971|536727338|FG004|Acute/Continuation|Lack of Efficacy|0|||
148795101|NCT00490971|536727334|FG000|Acute/Continuation|Lost to Follow-up|23|||
148795102|NCT00490971|536727335|FG001|Acute/Continuation|Lost to Follow-up|7|||
148795103|NCT00490971|536727336|FG002|Acute/Continuation|Lost to Follow-up|0|||
148795104|NCT00490971|536727337|FG003|Acute/Continuation|Lost to Follow-up|0|||
148795105|NCT00490971|536727338|FG004|Acute/Continuation|Lost to Follow-up|0|||
148795106|NCT00490971|536727334|FG000|Acute/Continuation|Protocol Violation|10|||
148795107|NCT00490971|536727335|FG001|Acute/Continuation|Protocol Violation|2|||
148795108|NCT00490971|536727336|FG002|Acute/Continuation|Protocol Violation|0|||
148795109|NCT00490971|536727337|FG003|Acute/Continuation|Protocol Violation|0|||
148795110|NCT00490971|536727338|FG004|Acute/Continuation|Protocol Violation|0|||
148795111|NCT00490971|536727334|FG000|Acute/Continuation|Withdrawal by Subject|92|||
148795112|NCT00490971|536727335|FG001|Acute/Continuation|Withdrawal by Subject|24|||
148795113|NCT00490971|536727336|FG002|Acute/Continuation|Withdrawal by Subject|0|||
148795114|NCT00490971|536727337|FG003|Acute/Continuation|Withdrawal by Subject|0|||
148795115|NCT00490971|536727338|FG004|Acute/Continuation|Withdrawal by Subject|0|||
148795116|NCT00490971|536727334|FG000|Acute/Continuation|Other|11|||
148795117|NCT00490971|536727335|FG001|Acute/Continuation|Other|4|||
148795118|NCT00490971|536727336|FG002|Acute/Continuation|Other|0|||
148795119|NCT00490971|536727337|FG003|Acute/Continuation|Other|0|||
148795120|NCT00490971|536727338|FG004|Acute/Continuation|Other|0|||
149237750|NCT02360579|538339553|FG000|Initial|Withdrawal by Subject|0|||
149237751|NCT02360579|538339554|FG001|Initial|Withdrawal by Subject|0|||
149237752|NCT02360579|538339555|FG002|Initial|Withdrawal by Subject|0|||
149237753|NCT02360579|538339556|FG003|Initial|Withdrawal by Subject|3|||
149237754|NCT02360579|538339553|FG000|Initial|Other|7|||
149237755|NCT02360579|538339554|FG001|Initial|Other|0|||
148795121|NCT00490971|536727334|FG000|Maintenance|Adverse Event|0|||
148795122|NCT00490971|536727335|FG001|Maintenance|Adverse Event|0|||
148795123|NCT00490971|536727336|FG002|Maintenance|Adverse Event|4|||
148795124|NCT00490971|536727337|FG003|Maintenance|Adverse Event|5|||
148795125|NCT00490971|536727338|FG004|Maintenance|Adverse Event|7|||
148795126|NCT00490971|536727334|FG000|Maintenance|Death|0|||
148795127|NCT00490971|536727335|FG001|Maintenance|Death|0|||
148795128|NCT00490971|536727336|FG002|Maintenance|Death|0|||
148795129|NCT00490971|536727337|FG003|Maintenance|Death|2|||
148795130|NCT00490971|536727338|FG004|Maintenance|Death|0|||
148795131|NCT00490971|536727334|FG000|Maintenance|Lost to Follow-up|0|||
148795132|NCT00490971|536727335|FG001|Maintenance|Lost to Follow-up|0|||
148795133|NCT00490971|536727336|FG002|Maintenance|Lost to Follow-up|5|||
148795134|NCT00490971|536727337|FG003|Maintenance|Lost to Follow-up|8|||
148795135|NCT00490971|536727338|FG004|Maintenance|Lost to Follow-up|10|||
148795136|NCT00490971|536727334|FG000|Maintenance|Pregnancy|0|||
148795137|NCT00490971|536727335|FG001|Maintenance|Pregnancy|0|||
148795138|NCT00490971|536727336|FG002|Maintenance|Pregnancy|1|||
148795139|NCT00490971|536727337|FG003|Maintenance|Pregnancy|0|||
148795140|NCT00490971|536727338|FG004|Maintenance|Pregnancy|0|||
148795141|NCT00490971|536727334|FG000|Maintenance|Protocol Violation|0|||
148795142|NCT00490971|536727335|FG001|Maintenance|Protocol Violation|0|||
148795143|NCT00490971|536727336|FG002|Maintenance|Protocol Violation|4|||
148795144|NCT00490971|536727337|FG003|Maintenance|Protocol Violation|1|||
148795145|NCT00490971|536727338|FG004|Maintenance|Protocol Violation|1|||
148795146|NCT00490971|536727334|FG000|Maintenance|Withdrawal by Subject|0|||
148795147|NCT00490971|536727335|FG001|Maintenance|Withdrawal by Subject|0|||
148795148|NCT00490971|536727336|FG002|Maintenance|Withdrawal by Subject|26|||
148795149|NCT00490971|536727337|FG003|Maintenance|Withdrawal by Subject|28|||
148795150|NCT00490971|536727338|FG004|Maintenance|Withdrawal by Subject|18|||
148795151|NCT00490971|536727334|FG000|Maintenance|Other|0|||
148795152|NCT00490971|536727335|FG001|Maintenance|Other|0|||
148795153|NCT00490971|536727336|FG002|Maintenance|Other|11|||
148795154|NCT00490971|536727337|FG003|Maintenance|Other|9|||
148795155|NCT00490971|536727338|FG004|Maintenance|Other|3|||
148795156|NCT02358031|536729038|FG000|Overall Study|Death|253|||
148795157|NCT02358031|536729039|FG001|Overall Study|Death|237|||
148795158|NCT02358031|536729040|FG002|Overall Study|Death|266|||
148795159|NCT02358031|536729038|FG000|Overall Study|Lost to Follow-up|1|||
148795160|NCT02358031|536729039|FG001|Overall Study|Lost to Follow-up|1|||
148795161|NCT02358031|536729040|FG002|Overall Study|Lost to Follow-up|0|||
148795162|NCT02358031|536729038|FG000|Overall Study|Withdrawal by Subject|19|||
148795163|NCT02358031|536729039|FG001|Overall Study|Withdrawal by Subject|14|||
148795164|NCT02358031|536729040|FG002|Overall Study|Withdrawal by Subject|18|||
148795165|NCT02358031|536729038|FG000|Overall Study|Sponsor Decision|26|||
148795166|NCT02358031|536729039|FG001|Overall Study|Sponsor Decision|28|||
148795167|NCT02358031|536729040|FG002|Overall Study|Sponsor Decision|16|||
148795168|NCT01212094|536729041|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
148795169|NCT01212094|536729042|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
148795170|NCT01212094|536729043|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
148795171|NCT01212094|536729041|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
148795172|NCT01212094|536729042|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
148795173|NCT01212094|536729043|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
148795174|NCT01212094|536729041|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
148795175|NCT01212094|536729042|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
148795176|NCT01212094|536729043|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
148795177|NCT01212094|536729041|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
148795178|NCT01212094|536729042|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
148795179|NCT01212094|536729043|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
148795180|NCT01212094|536729041|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
148795181|NCT01212094|536729042|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
148795182|NCT01212094|536729043|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
148795183|NCT01212094|536729041|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
148795184|NCT01212094|536729042|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
148795185|NCT01212094|536729043|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
148795186|NCT05664581|536729047|FG000|Overall Study|Withdrawal by Subject|2|||
148795187|NCT03101150|536729050|FG000|Overall Study|Lost to Follow-up|2|||
148795188|NCT03101150|536729051|FG001|Overall Study|Lost to Follow-up|4|||
149135523|NCT04641299|537978437|FG003|Overall Study|Reason not given|0|||
149135524|NCT01940354|537978442|FG000|Overall Study|Withdrawal by Subject|4|||
149135525|NCT01940354|537978443|FG001|Overall Study|Withdrawal by Subject|2|||
149135526|NCT02020863|537978444|FG000|Overall Study|Discovery of Metastatic disease|4|||
148795189|NCT03101150|536729050|FG000|Overall Study|Miscarriage|3|||
148795190|NCT03101150|536729051|FG001|Overall Study|Miscarriage|6|||
148795191|NCT01317641|536729057|FG000|Overall Study|Not treated|0|||
148795192|NCT01317641|536729058|FG001|Overall Study|Not treated|0|||
148795193|NCT01317641|536729059|FG002|Overall Study|Not treated|0|||
148795194|NCT01317641|536729060|FG003|Overall Study|Not treated|0|||
148795195|NCT01317641|536729061|FG004|Overall Study|Not treated|0|||
148795196|NCT01317641|536729062|FG005|Overall Study|Not treated|0|||
149135527|NCT02020863|537978444|FG000|Overall Study|Team chose not to place an a line|1|||
149135528|NCT01016964|537978445|FG000|Overall Study|Lost to Follow-up|3|||
149135529|NCT01016964|537978446|FG001|Overall Study|Lost to Follow-up|3|||
149135530|NCT00352885|537978447|FG000|Overall Study|Withdrawal by Subject|0|||
149135531|NCT00352885|537978448|FG001|Overall Study|Withdrawal by Subject|3|||
149135532|NCT00352885|537978447|FG000|Overall Study|Development of major depression|0|||
148795197|NCT01317641|536729063|FG006|Overall Study|Not treated|0|||
148795198|NCT01317641|536729064|FG007|Overall Study|Not treated|1|||
148795199|NCT01317641|536729065|FG008|Overall Study|Not treated|1|||
148795200|NCT01317641|536729057|FG000|Overall Study|Adverse Event|0|||
148795201|NCT01317641|536729058|FG001|Overall Study|Adverse Event|1|||
148795202|NCT01317641|536729059|FG002|Overall Study|Adverse Event|0|||
148795203|NCT01317641|536729060|FG003|Overall Study|Adverse Event|1|||
148795204|NCT01317641|536729061|FG004|Overall Study|Adverse Event|0|||
148795205|NCT01317641|536729062|FG005|Overall Study|Adverse Event|0|||
148795206|NCT01317641|536729063|FG006|Overall Study|Adverse Event|2|||
148795207|NCT01317641|536729064|FG007|Overall Study|Adverse Event|1|||
148795208|NCT01317641|536729065|FG008|Overall Study|Adverse Event|0|||
148795209|NCT01317641|536729057|FG000|Overall Study|Protocol Violation|1|||
148795210|NCT01317641|536729058|FG001|Overall Study|Protocol Violation|0|||
148795211|NCT01317641|536729059|FG002|Overall Study|Protocol Violation|0|||
148795212|NCT01317641|536729060|FG003|Overall Study|Protocol Violation|0|||
148795213|NCT01317641|536729061|FG004|Overall Study|Protocol Violation|0|||
148795214|NCT01317641|536729062|FG005|Overall Study|Protocol Violation|0|||
148795215|NCT01317641|536729063|FG006|Overall Study|Protocol Violation|0|||
148795216|NCT01317641|536729064|FG007|Overall Study|Protocol Violation|0|||
148795217|NCT01317641|536729065|FG008|Overall Study|Protocol Violation|0|||
148795218|NCT01317641|536729057|FG000|Overall Study|Disease progression|0|||
148795219|NCT01317641|536729058|FG001|Overall Study|Disease progression|0|||
148795220|NCT01317641|536729059|FG002|Overall Study|Disease progression|0|||
148795221|NCT01317641|536729060|FG003|Overall Study|Disease progression|0|||
148795222|NCT01317641|536729061|FG004|Overall Study|Disease progression|0|||
148795223|NCT01317641|536729062|FG005|Overall Study|Disease progression|0|||
148795224|NCT01317641|536729063|FG006|Overall Study|Disease progression|0|||
148795225|NCT01317641|536729064|FG007|Overall Study|Disease progression|3|||
148795226|NCT01317641|536729065|FG008|Overall Study|Disease progression|4|||
148795227|NCT01317641|536729057|FG000|Overall Study|Withdrawal by Subject|0|||
148795228|NCT01317641|536729058|FG001|Overall Study|Withdrawal by Subject|0|||
148795229|NCT01317641|536729059|FG002|Overall Study|Withdrawal by Subject|0|||
148795230|NCT01317641|536729060|FG003|Overall Study|Withdrawal by Subject|0|||
148795231|NCT01317641|536729061|FG004|Overall Study|Withdrawal by Subject|0|||
148795232|NCT01317641|536729062|FG005|Overall Study|Withdrawal by Subject|0|||
148795233|NCT01317641|536729063|FG006|Overall Study|Withdrawal by Subject|1|||
148795234|NCT01317641|536729064|FG007|Overall Study|Withdrawal by Subject|0|||
148795235|NCT01317641|536729065|FG008|Overall Study|Withdrawal by Subject|0|||
148795236|NCT04980014|536729066|FG000|Overall Study|Participants who are Duplicated|1|||
148795237|NCT04980014|536729066|FG000|Overall Study|Follow-up Failure|13|||
148795238|NCT04980014|536729066|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
148795239|NCT04980014|536729066|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
148795240|NCT04980014|536729066|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
148795241|NCT00715559|536729067|FG000|Overall Study|medication not tolerated - nausea|1|||
148795242|NCT02317991|536729068|FG000|Overall Study|Adverse Event|12|||
148795243|NCT02317991|536729068|FG000|Overall Study|Death|4|||
148795244|NCT02317991|536729068|FG000|Overall Study|Withdrawal by Subject|8|||
148795245|NCT02317991|536729068|FG000|Overall Study|Progressive Disease|41|||
148795246|NCT02019550|536729069|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
148795247|NCT02019550|536729070|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
148795248|NCT02787304|536729073|FG000|Overall Study|Adverse Event|9|||
148795249|NCT02787304|536729074|FG001|Overall Study|Adverse Event|3|||
148795250|NCT02787304|536729075|FG002|Overall Study|Adverse Event|8|||
148795251|NCT02787304|536729076|FG003|Overall Study|Adverse Event|1|||
148795252|NCT02787304|536729073|FG000|Overall Study|Withdrawal by Subject|1|||
148795253|NCT02787304|536729074|FG001|Overall Study|Withdrawal by Subject|4|||
148795254|NCT02787304|536729075|FG002|Overall Study|Withdrawal by Subject|0|||
148795255|NCT02787304|536729076|FG003|Overall Study|Withdrawal by Subject|0|||
148795256|NCT02787304|536729073|FG000|Overall Study|Lost to Follow-up|1|||
148795257|NCT02787304|536729074|FG001|Overall Study|Lost to Follow-up|0|||
148795258|NCT02787304|536729075|FG002|Overall Study|Lost to Follow-up|0|||
148795259|NCT02787304|536729076|FG003|Overall Study|Lost to Follow-up|1|||
148795260|NCT02787304|536729073|FG000|Overall Study|Noncompliance with study drug|0|||
148795261|NCT02787304|536729074|FG001|Overall Study|Noncompliance with study drug|0|||
148795262|NCT02787304|536729075|FG002|Overall Study|Noncompliance with study drug|1|||
148795263|NCT02787304|536729076|FG003|Overall Study|Noncompliance with study drug|0|||
148795264|NCT02787304|536729073|FG000|Overall Study|Physician Decision|0|||
148795265|NCT02787304|536729074|FG001|Overall Study|Physician Decision|0|||
148795266|NCT02787304|536729075|FG002|Overall Study|Physician Decision|1|||
149135533|NCT00352885|537978448|FG001|Overall Study|Development of major depression|1|||
149237756|NCT02360579|538339555|FG002|Initial|Other|0|||
149237757|NCT02360579|538339556|FG003|Initial|Other|0|||
149237758|NCT02360579|538339553|FG000|Initial|Did not receive TIL|8|||
149237759|NCT02360579|538339554|FG001|Initial|Did not receive TIL|11|||
149237760|NCT02360579|538339555|FG002|Initial|Did not receive TIL|0|||
149237761|NCT02360579|538339556|FG003|Initial|Did not receive TIL|22|||
149237762|NCT02360579|538339553|FG000|Retreatment|Death|0|||
149237763|NCT02360579|538339554|FG001|Retreatment|Death|0|||
149237764|NCT02360579|538339555|FG002|Retreatment|Death|11|||
149237765|NCT02360579|538339556|FG003|Retreatment|Death|0|||
149237766|NCT04745689|538339560|FG000|Overall Study|Death|9|||
149237767|NCT04745689|538339561|FG001|Overall Study|Death|6|||
149237768|NCT04745689|538339560|FG000|Overall Study|Lost to Follow-up|1|||
149237769|NCT04745689|538339561|FG001|Overall Study|Lost to Follow-up|0|||
149237770|NCT04745689|538339560|FG000|Overall Study|Withdrawal by Subject|2|||
149237771|NCT04745689|538339561|FG001|Overall Study|Withdrawal by Subject|0|||
149237772|NCT04745689|538339560|FG000|Overall Study|Study terminated by sponsor|10|||
149237773|NCT04745689|538339561|FG001|Overall Study|Study terminated by sponsor|3|||
149237774|NCT05741528|538339562|FG000|Overall Study|Withdrawal by Subject|11|||
149237775|NCT05741528|538339562|FG000|Overall Study|Lost to Follow-up|3|||
149237776|NCT05741528|538339562|FG000|Overall Study|Adverse Event|2|||
149237777|NCT05741528|538339562|FG000|Overall Study|Non-Compliance With Study Drug|2|||
149237778|NCT05741528|538339562|FG000|Overall Study|Reason Not Specified|1|||
149237779|NCT03682848|538339563|FG000|Overall Study|Withdrawal by Subject|3|||
149237780|NCT03682848|538339563|FG000|Overall Study|Site closed|5|||
149237781|NCT03682848|538339563|FG000|Overall Study|Protocol Deviation|1|||
149237782|NCT03682848|538339563|FG000|Overall Study|Adverse Event|2|||
149237783|NCT03682848|538339563|FG000|Overall Study|Lack of Efficacy|1|||
149237784|NCT04102189|538339564|FG000|Overall Study|Withdrawal by Subject|1|||
149237785|NCT04102189|538339565|FG001|Overall Study|Withdrawal by Subject|2|||
149237786|NCT04102189|538339564|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149237787|NCT04102189|538339565|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149237788|NCT04102189|538339564|FG000|Overall Study|Lost to Follow-up|1|||
149237789|NCT04102189|538339565|FG001|Overall Study|Lost to Follow-up|0|||
149237790|NCT03774082|538339568|FG000|Overall Study|Death|6|||
149237791|NCT03774082|538339569|FG001|Overall Study|Death|3|||
149237792|NCT03774082|538339570|FG002|Overall Study|Death|2|||
149237793|NCT03774082|538339568|FG000|Overall Study|Subject decision|0|||
149237794|NCT03774082|538339569|FG001|Overall Study|Subject decision|3|||
149237795|NCT03774082|538339570|FG002|Overall Study|Subject decision|0|||
149237796|NCT03774082|538339568|FG000|Overall Study|Lost to Follow-up|2|||
149237797|NCT03774082|538339569|FG001|Overall Study|Lost to Follow-up|0|||
149237798|NCT03774082|538339570|FG002|Overall Study|Lost to Follow-up|0|||
149237799|NCT03774082|538339568|FG000|Overall Study|Guardian decision|0|||
149237800|NCT03774082|538339569|FG001|Overall Study|Guardian decision|0|||
149237801|NCT03774082|538339570|FG002|Overall Study|Guardian decision|1|||
149237802|NCT03774082|538339568|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
149237803|NCT03774082|538339569|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
149237804|NCT03774082|538339570|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
149237805|NCT02553460|538339572|FG000|Overall Study|Death|3|||
149237806|NCT02553460|538339572|FG000|Overall Study|Withdrawal by Subject|1|||
149237807|NCT02553460|538339572|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
149237808|NCT02553460|538339572|FG000|Overall Study|Relapse or Transplant|14|||
149237809|NCT02553460|538339572|FG000|Overall Study|No response to treatment|2|||
149237810|NCT02553460|538339572|FG000|Overall Study|CAR T cells|2|||
149237811|NCT02483429|538339573|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
149237812|NCT02483429|538339574|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
149237813|NCT04823650|538339577|FG000|Overall Study|Withdrawal by Subject|0|||
149237814|NCT04823650|538339578|FG001|Overall Study|Withdrawal by Subject|0|||
149237815|NCT04823650|538339579|FG002|Overall Study|Withdrawal by Subject|0|||
149237816|NCT04823650|538339580|FG003|Overall Study|Withdrawal by Subject|0|||
149237817|NCT04823650|538339581|FG004|Overall Study|Withdrawal by Subject|1|||
149237818|NCT04823650|538339582|FG005|Overall Study|Withdrawal by Subject|0|||
149237819|NCT01844986|538339583|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
149237820|NCT01844986|538339584|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
149237821|NCT01844986|538339583|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
149237822|NCT01844986|538339584|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
149237823|NCT01844986|538339583|FG000|Overall Study (Global Cohort)|Death|55|||
149237824|NCT01844986|538339584|FG001|Overall Study (Global Cohort)|Death|26|||
149237825|NCT01844986|538339583|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
149237826|NCT01844986|538339584|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
149237827|NCT01844986|538339583|FG000|Overall Study (China Cohort)|Death|10|||
149237828|NCT01844986|538339584|FG001|Overall Study (China Cohort)|Death|6|||
149237829|NCT07083843|538339585|FG000|Intervention period.|Withdrawal by Subject|1|||
149237830|NCT07083843|538339586|FG001|Intervention period.|Withdrawal by Subject|0|||
149237831|NCT07083843|538339585|FG000|Intervention period.|Death|0|||
149237832|NCT07083843|538339586|FG001|Intervention period.|Death|1|||
149237833|NCT04988477|538339589|FG000|Overall Study|Death|1|||
148894905|NCT04079296|537094046|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
148894906|NCT04079296|537094047|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
148894907|NCT04079296|537094048|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
148894908|NCT04079296|537094049|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
148894909|NCT04079296|537094045|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
148894910|NCT04079296|537094046|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
148894911|NCT04079296|537094047|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
148894912|NCT04079296|537094048|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
148894913|NCT04079296|537094049|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
148894914|NCT04079296|537094045|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
148894915|NCT04079296|537094046|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
148894916|NCT04079296|537094047|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
148894917|NCT04079296|537094048|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
148894918|NCT04079296|537094049|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
148894919|NCT04079296|537094045|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
148894920|NCT04079296|537094046|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
148894921|NCT04079296|537094047|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
149237834|NCT04988477|538339590|FG001|Overall Study|Death|0|||
149237835|NCT04988477|538339591|FG002|Overall Study|Death|0|||
149237836|NCT04988477|538339589|FG000|Overall Study|Lost to Follow-up|5|||
149237837|NCT04988477|538339590|FG001|Overall Study|Lost to Follow-up|2|||
149237838|NCT04988477|538339591|FG002|Overall Study|Lost to Follow-up|0|||
149237839|NCT04988477|538339589|FG000|Overall Study|Withdrawal by Subject|2|||
149237840|NCT04988477|538339590|FG001|Overall Study|Withdrawal by Subject|0|||
149237841|NCT04988477|538339591|FG002|Overall Study|Withdrawal by Subject|0|||
149237842|NCT07099521|538339594|FG000|Overall Study|Incompeleted stimulus program|1|||
149237843|NCT07099521|538339595|FG001|Overall Study|Incompeleted stimulus program|0|||
149237844|NCT07099521|538339594|FG000|Overall Study|Non-social anxiety symtpoms|0|||
149237845|NCT07099521|538339595|FG001|Overall Study|Non-social anxiety symtpoms|1|||
149237846|NCT07099521|538339594|FG000|Overall Study|Extreme values|2|||
149237847|NCT07099521|538339595|FG001|Overall Study|Extreme values|4|||
149237848|NCT01950390|538339597|FG000|Overall Study|Never started treatment|3|||
149237849|NCT01950390|538339598|FG001|Overall Study|Never started treatment|2|||
149237850|NCT01950390|538339597|FG000|Overall Study|Disease progression|45|||
149237851|NCT01950390|538339598|FG001|Overall Study|Disease progression|52|||
149237852|NCT01950390|538339597|FG000|Overall Study|Adverse Event|22|||
149237853|NCT01950390|538339598|FG001|Overall Study|Adverse Event|16|||
148894922|NCT04079296|537094048|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
148894923|NCT04079296|537094049|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
148894924|NCT04079296|537094045|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
148894925|NCT04079296|537094046|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
148894926|NCT04079296|537094047|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
148894927|NCT04079296|537094048|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
148894928|NCT04079296|537094049|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
148894929|NCT04079296|537094045|FG000|Dose Expansion Phase (168 Days)|Death|0|||
148894930|NCT04079296|537094046|FG001|Dose Expansion Phase (168 Days)|Death|0|||
148894931|NCT04079296|537094047|FG002|Dose Expansion Phase (168 Days)|Death|0|||
148894932|NCT04079296|537094048|FG003|Dose Expansion Phase (168 Days)|Death|1|||
148894933|NCT04079296|537094049|FG004|Dose Expansion Phase (168 Days)|Death|0|||
148894934|NCT04059549|537094050|FG000|Overall Study|Withdrawal by Subject|2|||
148894935|NCT04059549|537094051|FG001|Overall Study|Withdrawal by Subject|0|||
148894936|NCT01919229|537094053|FG000|Overall Study|Subject/guardian decision|0|||
148894937|NCT01919229|537094054|FG001|Overall Study|Subject/guardian decision|0|||
148894938|NCT01919229|537094055|FG002|Overall Study|Subject/guardian decision|1|||
148894939|NCT01011673|537094056|FG000|Randomized|Secondary headache|2|||
148894940|NCT01011673|537094057|FG001|Randomized|Secondary headache|1|||
148894941|NCT01011673|537094056|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
148894942|NCT01011673|537094057|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
148894943|NCT00549640|537094059|FG000|Overall Study|Withdrawal by Subject|6|||
149237854|NCT01950390|538339597|FG000|Overall Study|Death|5|||
148894944|NCT00549640|537094060|FG001|Overall Study|Withdrawal by Subject|12|||
148894945|NCT00549640|537094059|FG000|Overall Study|Adverse Event|5|||
149237855|NCT01950390|538339598|FG001|Overall Study|Death|3|||
148894946|NCT00549640|537094060|FG001|Overall Study|Adverse Event|0|||
149237856|NCT01950390|538339597|FG000|Overall Study|Withdrawal by Subject|5|||
149237857|NCT01950390|538339598|FG001|Overall Study|Withdrawal by Subject|1|||
149237858|NCT01950390|538339597|FG000|Overall Study|Alternative therapy|0|||
148894947|NCT00549640|537094059|FG000|Overall Study|Lost to Follow-up|7|||
148894948|NCT00549640|537094060|FG001|Overall Study|Lost to Follow-up|4|||
148894949|NCT03261336|537094061|FG000|Overall Study|Adverse Event|1|||
148894950|NCT00292942|537094063|FG000|Overall Study|Withdrawal by Subject|0|||
149237859|NCT01950390|538339598|FG001|Overall Study|Alternative therapy|3|||
149237860|NCT01950390|538339597|FG000|Overall Study|Complicating disease|1|||
149237861|NCT01950390|538339598|FG001|Overall Study|Complicating disease|0|||
149237862|NCT01950390|538339597|FG000|Overall Study|On treatment|1|||
149237863|NCT01950390|538339598|FG001|Overall Study|On treatment|0|||
149237864|NCT01950390|538339597|FG000|Overall Study|Symptomatic deterioration|2|||
149237865|NCT01950390|538339598|FG001|Overall Study|Symptomatic deterioration|1|||
149237866|NCT01950390|538339597|FG000|Overall Study|Physician Decision|0|||
149237867|NCT01950390|538339598|FG001|Overall Study|Physician Decision|4|||
149237868|NCT01950390|538339597|FG000|Overall Study|Lack of clinical benefit|0|||
149237869|NCT01950390|538339598|FG001|Overall Study|Lack of clinical benefit|1|||
149237870|NCT01950390|538339597|FG000|Overall Study|Maintained PR and moved to observation only|0|||
149237871|NCT01950390|538339598|FG001|Overall Study|Maintained PR and moved to observation only|1|||
149237872|NCT05938920|538339599|FG000|Overall Study|Adverse Event|1|||
149237873|NCT05938920|538339600|FG001|Overall Study|Adverse Event|3|||
149237874|NCT05938920|538339601|FG002|Overall Study|Adverse Event|2|||
149237875|NCT05938920|538339602|FG003|Overall Study|Adverse Event|1|||
149237876|NCT05938920|538339599|FG000|Overall Study|Death|0|||
149237877|NCT05938920|538339600|FG001|Overall Study|Death|1|||
149237878|NCT05938920|538339601|FG002|Overall Study|Death|0|||
149237879|NCT05938920|538339602|FG003|Overall Study|Death|0|||
149237880|NCT05938920|538339599|FG000|Overall Study|Lost to Follow-up|0|||
149237881|NCT05938920|538339600|FG001|Overall Study|Lost to Follow-up|0|||
149237882|NCT05938920|538339601|FG002|Overall Study|Lost to Follow-up|1|||
149237883|NCT05938920|538339602|FG003|Overall Study|Lost to Follow-up|0|||
149237884|NCT05938920|538339599|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
149237885|NCT05938920|538339600|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
149237886|NCT05938920|538339601|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
149237887|NCT05938920|538339602|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
149237888|NCT05938920|538339599|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
149237889|NCT05938920|538339600|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
149237890|NCT05938920|538339601|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
149237891|NCT05938920|538339602|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
149237892|NCT05938920|538339599|FG000|Overall Study|Participant Refused to Come In|0|||
149237893|NCT05938920|538339600|FG001|Overall Study|Participant Refused to Come In|0|||
149237894|NCT05938920|538339601|FG002|Overall Study|Participant Refused to Come In|1|||
149237895|NCT05938920|538339602|FG003|Overall Study|Participant Refused to Come In|0|||
149237896|NCT01251861|538340083|FG000|Overall Study|Disease progression|6|||
149237897|NCT01251861|538340084|FG001|Overall Study|Disease progression|6|||
149237898|NCT01251861|538340083|FG000|Overall Study|Adverse Event|2|||
149237899|NCT01251861|538340084|FG001|Overall Study|Adverse Event|17|||
149237900|NCT01251861|538340083|FG000|Overall Study|Withdrawal by Subject|2|||
149237901|NCT01251861|538340084|FG001|Overall Study|Withdrawal by Subject|2|||
149237902|NCT01251861|538340083|FG000|Overall Study|Alternative therapy|1|||
149237903|NCT01251861|538340084|FG001|Overall Study|Alternative therapy|0|||
149237904|NCT01251861|538340083|FG000|Overall Study|Other complicating disease|0|||
149237905|NCT01251861|538340084|FG001|Overall Study|Other complicating disease|1|||
149237906|NCT01251861|538340083|FG000|Overall Study|Physician Decision|1|||
149237907|NCT01251861|538340084|FG001|Overall Study|Physician Decision|0|||
149237908|NCT01251861|538340083|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
149237909|NCT01251861|538340084|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
149237910|NCT01251861|538340083|FG000|Overall Study|Other|1|||
149237911|NCT01251861|538340084|FG001|Overall Study|Other|0|||
149237912|NCT01251861|538340083|FG000|Overall Study|Never started therapy|4|||
149237913|NCT01251861|538340084|FG001|Overall Study|Never started therapy|1|||
149237914|NCT01251861|538340083|FG000|Overall Study|Potential interaction of drugs|0|||
149237915|NCT01251861|538340084|FG001|Overall Study|Potential interaction of drugs|1|||
148795267|NCT02787304|536729076|FG003|Overall Study|Physician Decision|0|||
148795268|NCT02787304|536729073|FG000|Overall Study|Study terminated by sponsor|25|||
148795269|NCT02787304|536729074|FG001|Overall Study|Study terminated by sponsor|31|||
148795270|NCT02787304|536729075|FG002|Overall Study|Study terminated by sponsor|31|||
148795271|NCT02787304|536729076|FG003|Overall Study|Study terminated by sponsor|32|||
148795272|NCT04771013|536729077|FG000|Overall Study|Withdrawal by Subject|2|||
148795273|NCT04771013|536729078|FG001|Overall Study|Withdrawal by Subject|0|||
148795274|NCT04771013|536729077|FG000|Overall Study|Death|0|||
148795275|NCT04771013|536729078|FG001|Overall Study|Death|5|||
148795276|NCT04771013|536729077|FG000|Overall Study|Referred to another hospital before day 20|0|||
148795277|NCT04771013|536729078|FG001|Overall Study|Referred to another hospital before day 20|1|||
148795278|NCT00823134|536729081|FG000|Overall Study|Invalid measurement|1|||
148894951|NCT00292942|537094064|FG001|Overall Study|Withdrawal by Subject|0|||
149237916|NCT05089656|538340085|FG000|Period 1 - First Intervention (52 Weeks)|Physician Decision|1|||
149237917|NCT05089656|538340086|FG001|Period 1 - First Intervention (52 Weeks)|Physician Decision|0|||
148795279|NCT00419757|536729085|FG000|Overall Study|Adverse Event|1|||
148795280|NCT00419757|536729086|FG001|Overall Study|Adverse Event|4|||
148894952|NCT00292942|537094065|FG002|Overall Study|Withdrawal by Subject|1|||
148894953|NCT00292942|537094066|FG003|Overall Study|Withdrawal by Subject|0|||
148894954|NCT00292942|537094063|FG000|Overall Study|Adverse Event|0|||
148894955|NCT00292942|537094064|FG001|Overall Study|Adverse Event|0|||
148894956|NCT00292942|537094065|FG002|Overall Study|Adverse Event|0|||
148894957|NCT00292942|537094066|FG003|Overall Study|Adverse Event|1|||
148894958|NCT00644358|537094067|FG000|Overall Study|Adverse Event|124|||
148894959|NCT00644358|537094067|FG000|Overall Study|Lost to Follow-up|105|||
148894960|NCT00644358|537094067|FG000|Overall Study|Consent Withdrawal|64|||
148894961|NCT00644358|537094067|FG000|Overall Study|Lack of Effectiveness|39|||
148894962|NCT00644358|537094067|FG000|Overall Study|Protocol Violation|5|||
148894963|NCT00644358|537094067|FG000|Overall Study|Noncompliance|14|||
148894964|NCT00644358|537094067|FG000|Overall Study|Other Unspecified|11|||
148894965|NCT00651924|537094073|FG000|Overall Study|Withdrawal by PI|0|||
148894966|NCT00651924|537094074|FG001|Overall Study|Withdrawal by PI|2|||
148894967|NCT00651924|537094073|FG000|Overall Study|Withdrawal by Subject|0|||
148894968|NCT00651924|537094074|FG001|Overall Study|Withdrawal by Subject|5|||
149135534|NCT00352885|537978447|FG000|Overall Study|Progression of metastatic melanoma|5|||
149135535|NCT00352885|537978448|FG001|Overall Study|Progression of metastatic melanoma|3|||
149135536|NCT00352885|537978447|FG000|Overall Study|Side effects of IL-2 administration|1|||
148894969|NCT05190120|537094075|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
148894970|NCT05190120|537094076|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
148894971|NCT05190120|537094077|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
148894972|NCT05190120|537094078|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
148894973|NCT05190120|537094075|FG000|Overall Study|Lost to Follow-up|5|||
149237918|NCT05089656|538340085|FG000|Period 1 - First Intervention (52 Weeks)|Guardian decision|1|||
149237919|NCT05089656|538340086|FG001|Period 1 - First Intervention (52 Weeks)|Guardian decision|0|||
149237920|NCT05089656|538340085|FG000|Period 1 - First Intervention (52 Weeks)|Adverse Event|0|||
149237921|NCT05089656|538340086|FG001|Period 1 - First Intervention (52 Weeks)|Adverse Event|1|||
149237922|NCT05089656|538340085|FG000|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|6|||
149237923|NCT05089656|538340086|FG001|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|4|||
149237924|NCT04191135|538340087|FG000|Induction Treatment|Not Treated|2|||
149237925|NCT04191135|538340088|FG001|Induction Treatment|Not Treated|0|||
149237926|NCT04191135|538340089|FG002|Induction Treatment|Not Treated|0|||
149237927|NCT04191135|538340087|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
149237928|NCT04191135|538340088|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
149237929|NCT04191135|538340089|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
149237930|NCT04191135|538340087|FG000|Induction Treatment|Adverse Event|25|||
149237931|NCT04191135|538340088|FG001|Induction Treatment|Adverse Event|0|||
149237932|NCT04191135|538340089|FG002|Induction Treatment|Adverse Event|0|||
149237933|NCT04191135|538340087|FG000|Induction Treatment|Clinical Progression|8|||
149237934|NCT04191135|538340088|FG001|Induction Treatment|Clinical Progression|0|||
149237935|NCT04191135|538340089|FG002|Induction Treatment|Clinical Progression|0|||
148894974|NCT05190120|537094076|FG001|Overall Study|Lost to Follow-up|0|||
148894975|NCT05190120|537094077|FG002|Overall Study|Lost to Follow-up|2|||
148894976|NCT05190120|537094078|FG003|Overall Study|Lost to Follow-up|3|||
148894977|NCT03062358|537094080|FG000|Overall Study|Death|269|||
148894978|NCT03062358|537094081|FG001|Overall Study|Death|145|||
148894979|NCT03062358|537094080|FG000|Overall Study|Withdrawal by Subject|2|||
149135537|NCT00352885|537978448|FG001|Overall Study|Side effects of IL-2 administration|0|||
149237936|NCT04191135|538340087|FG000|Induction Treatment|Excluded Medication|1|||
149237937|NCT04191135|538340088|FG001|Induction Treatment|Excluded Medication|0|||
149237938|NCT04191135|538340089|FG002|Induction Treatment|Excluded Medication|0|||
149237939|NCT04191135|538340087|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
149237940|NCT04191135|538340088|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
149237941|NCT04191135|538340089|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
149237942|NCT04191135|538340087|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
149237943|NCT04191135|538340088|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
149135538|NCT01920594|537978449|FG000|Overall Study|Adverse Event|4|||
149135539|NCT01920594|537978450|FG001|Overall Study|Adverse Event|2|||
149135540|NCT01920594|537978449|FG000|Overall Study|Lost to Follow-up|1|||
149135541|NCT01920594|537978450|FG001|Overall Study|Lost to Follow-up|0|||
149135542|NCT01920594|537978449|FG000|Overall Study|Recovery|2|||
149135543|NCT01920594|537978450|FG001|Overall Study|Recovery|0|||
149135544|NCT01920594|537978449|FG000|Overall Study|Investigator discretion|0|||
149135545|NCT01920594|537978450|FG001|Overall Study|Investigator discretion|1|||
148894980|NCT03062358|537094081|FG001|Overall Study|Withdrawal by Subject|1|||
148894981|NCT03062358|537094080|FG000|Overall Study|Sponsor Decision|29|||
148894982|NCT03062358|537094081|FG001|Overall Study|Sponsor Decision|7|||
148894983|NCT00410956|537094084|FG000|Overall Study|Adverse Event|1|||
149135546|NCT00928564|537978451|FG000|Overall Study|Lost to Follow-up|6|||
149135547|NCT00928564|537978452|FG001|Overall Study|Lost to Follow-up|0|||
148894984|NCT00410956|537094084|FG000|Overall Study|Death|2|||
148894985|NCT00410956|537094084|FG000|Overall Study|Lack of Efficacy|10|||
148894986|NCT00410956|537094084|FG000|Overall Study|Physician Decision|6|||
148894987|NCT01838694|537096101|FG000|Overall Study|Adverse Event|0|||
148894988|NCT01838694|537096102|FG001|Overall Study|Adverse Event|1|||
148894989|NCT02587520|537096104|FG000|Overall Study|Protocol Violation|2|||
148894990|NCT02587520|537096105|FG001|Overall Study|Protocol Violation|0|||
148894991|NCT02587520|537096106|FG002|Overall Study|Protocol Violation|0|||
148894992|NCT02587520|537096107|FG003|Overall Study|Protocol Violation|2|||
149237944|NCT04191135|538340089|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
149237945|NCT04191135|538340087|FG000|Induction Treatment|Physician Decision|2|||
149237946|NCT04191135|538340088|FG001|Induction Treatment|Physician Decision|0|||
149237947|NCT04191135|538340089|FG002|Induction Treatment|Physician Decision|0|||
149237948|NCT04191135|538340087|FG000|Induction Treatment|Progressive Disease|135|||
149237949|NCT04191135|538340088|FG001|Induction Treatment|Progressive Disease|0|||
149237950|NCT04191135|538340089|FG002|Induction Treatment|Progressive Disease|0|||
149237951|NCT04191135|538340087|FG000|Induction Treatment|Protocol Violation|10|||
149237952|NCT04191135|538340088|FG001|Induction Treatment|Protocol Violation|0|||
149237953|NCT04191135|538340089|FG002|Induction Treatment|Protocol Violation|0|||
149237954|NCT04191135|538340087|FG000|Induction Treatment|Withdrawal by Subject|4|||
149237955|NCT04191135|538340088|FG001|Induction Treatment|Withdrawal by Subject|0|||
149237956|NCT04191135|538340089|FG002|Induction Treatment|Withdrawal by Subject|0|||
149237957|NCT04191135|538340087|FG000|Randomized Treatment|Death|0|||
149237958|NCT04191135|538340088|FG001|Randomized Treatment|Death|50|||
149237959|NCT04191135|538340089|FG002|Randomized Treatment|Death|54|||
149237960|NCT04191135|538340087|FG000|Randomized Treatment|Lost to Follow-up|0|||
149237961|NCT04191135|538340088|FG001|Randomized Treatment|Lost to Follow-up|0|||
149237962|NCT04191135|538340089|FG002|Randomized Treatment|Lost to Follow-up|1|||
149237963|NCT04191135|538340087|FG000|Randomized Treatment|Withdrawal by Subject|0|||
149237964|NCT04191135|538340088|FG001|Randomized Treatment|Withdrawal by Subject|2|||
149237965|NCT04191135|538340089|FG002|Randomized Treatment|Withdrawal by Subject|0|||
149237966|NCT04191135|538340087|FG000|Randomized Treatment|Ongoing in Trial|0|||
149237967|NCT04191135|538340088|FG001|Randomized Treatment|Ongoing in Trial|83|||
149237968|NCT04191135|538340089|FG002|Randomized Treatment|Ongoing in Trial|81|||
149237969|NCT04381650|538340095|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237970|NCT04381650|538340096|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237971|NCT04381650|538340097|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237972|NCT04381650|538340098|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
149237973|NCT04381650|538340099|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237974|NCT04381650|538340100|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237975|NCT04381650|538340101|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237976|NCT04381650|538340102|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237977|NCT04381650|538340103|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237978|NCT04381650|538340104|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237979|NCT04381650|538340105|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
149237980|NCT04381650|538340095|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237981|NCT04381650|538340096|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237982|NCT04381650|538340097|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237983|NCT04381650|538340098|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
149237984|NCT04381650|538340099|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237985|NCT04381650|538340100|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237986|NCT04381650|538340101|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237987|NCT04381650|538340102|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237988|NCT04381650|538340103|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237989|NCT04381650|538340104|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237990|NCT04381650|538340105|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
149237991|NCT04381650|538340095|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
149237992|NCT04381650|538340096|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
149237993|NCT04381650|538340097|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
149237994|NCT04381650|538340098|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
149237995|NCT04381650|538340099|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149237996|NCT04381650|538340100|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149237997|NCT04381650|538340101|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149237998|NCT04381650|538340102|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149237999|NCT04381650|538340103|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149238000|NCT04381650|538340104|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149238001|NCT04381650|538340105|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
149238002|NCT04381650|538340095|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238003|NCT04381650|538340096|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238004|NCT04381650|538340097|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
148894993|NCT02587520|537096108|FG004|Overall Study|Protocol Violation|0|||
148894994|NCT02587520|537096109|FG005|Overall Study|Protocol Violation|1|||
149238005|NCT04381650|538340098|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
149238006|NCT04381650|538340099|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238007|NCT04381650|538340100|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238008|NCT04381650|538340101|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
148894995|NCT02587520|537096110|FG006|Overall Study|Protocol Violation|1|||
148894996|NCT02587520|537096111|FG007|Overall Study|Protocol Violation|1|||
148894997|NCT02587520|537096112|FG008|Overall Study|Protocol Violation|3|||
148894998|NCT02587520|537096113|FG009|Overall Study|Protocol Violation|3|||
148894999|NCT02587520|537096114|FG010|Overall Study|Protocol Violation|1|||
148895000|NCT02587520|537096115|FG011|Overall Study|Protocol Violation|2|||
148895001|NCT02587520|537096116|FG012|Overall Study|Protocol Violation|0|||
148895002|NCT02587520|537096117|FG013|Overall Study|Protocol Violation|0|||
148895003|NCT02587520|537096118|FG014|Overall Study|Protocol Violation|0|||
148895004|NCT02587520|537096119|FG015|Overall Study|Protocol Violation|0|||
148895005|NCT02587520|537096120|FG016|Overall Study|Protocol Violation|0|||
148895006|NCT02587520|537096121|FG017|Overall Study|Protocol Violation|0|||
149135548|NCT04906616|537978454|FG000|Overall Study|Divorce|3|||
149135549|NCT04906616|537978455|FG001|Overall Study|Divorce|2|||
149238009|NCT04381650|538340102|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238010|NCT04381650|538340103|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238011|NCT04381650|538340104|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238012|NCT04381650|538340105|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
149238013|NCT04381650|538340095|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238014|NCT04381650|538340096|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
149135550|NCT00929656|537978456|FG000|Overall Study|Lost to Follow-up|0|||
149135551|NCT00929656|537978457|FG001|Overall Study|Lost to Follow-up|1|||
149135552|NCT00385203|537978460|FG000|Overall Study|Adverse Event|5|||
149135553|NCT00385203|537978461|FG001|Overall Study|Adverse Event|4|||
149135554|NCT00385203|537978460|FG000|Overall Study|Death|1|||
149135555|NCT00385203|537978461|FG001|Overall Study|Death|0|||
149135556|NCT00385203|537978460|FG000|Overall Study|Condition under investigation worsened|18|||
149135557|NCT00385203|537978461|FG001|Overall Study|Condition under investigation worsened|3|||
149135558|NCT00385203|537978460|FG000|Overall Study|Incorrect enrollment|2|||
149135559|NCT00385203|537978461|FG001|Overall Study|Incorrect enrollment|0|||
149135560|NCT03308942|537978462|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
149135561|NCT03308942|537978463|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
149135562|NCT03308942|537978464|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
149135563|NCT03308942|537978465|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
149135564|NCT03308942|537978466|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
149135565|NCT03308942|537978462|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
149135566|NCT03308942|537978463|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
149135567|NCT03308942|537978464|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
149135568|NCT03308942|537978465|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
149135569|NCT03308942|537978466|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
149135570|NCT03308942|537978462|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
149135571|NCT03308942|537978463|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
149135572|NCT03308942|537978464|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
149135573|NCT03308942|537978465|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
149135574|NCT03308942|537978466|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
149135575|NCT03308942|537978462|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
149135576|NCT03308942|537978463|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
149135577|NCT03308942|537978464|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
149135578|NCT03308942|537978465|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
149135579|NCT03308942|537978466|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
149135580|NCT03308942|537978462|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
149135581|NCT03308942|537978463|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
149135582|NCT03308942|537978464|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
149135583|NCT03308942|537978465|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
149135584|NCT03308942|537978466|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
149135585|NCT03308942|537978462|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
149135586|NCT03308942|537978463|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
149135587|NCT03308942|537978464|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
149135588|NCT03308942|537978465|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
149135589|NCT03308942|537978466|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
149135590|NCT03308942|537978462|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
149135591|NCT03308942|537978463|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
149135592|NCT03308942|537978464|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
149135593|NCT03308942|537978465|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
149135594|NCT03308942|537978466|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
148895007|NCT02587520|537096104|FG000|Overall Study|Adverse Event|0|||
149238015|NCT04381650|538340097|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
149238016|NCT04381650|538340098|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
149238017|NCT04381650|538340099|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238018|NCT04381650|538340100|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238019|NCT04381650|538340101|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238020|NCT04381650|538340102|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238021|NCT04381650|538340103|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238022|NCT04381650|538340104|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238023|NCT04381650|538340105|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
149238024|NCT04381650|538340095|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238025|NCT04381650|538340096|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238026|NCT04381650|538340097|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238027|NCT04381650|538340098|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238028|NCT04381650|538340099|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
149238029|NCT04381650|538340100|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
149238030|NCT04381650|538340101|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238031|NCT04381650|538340102|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238032|NCT04381650|538340103|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238033|NCT04381650|538340104|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
149238034|NCT04381650|538340105|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
149238035|NCT04381650|538340095|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238036|NCT04381650|538340096|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238037|NCT04381650|538340097|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238038|NCT04381650|538340098|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238039|NCT04381650|538340099|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238040|NCT04381650|538340100|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238041|NCT04381650|538340101|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238042|NCT04381650|538340102|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149238043|NCT04381650|538340103|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149238044|NCT04381650|538340104|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149238045|NCT04381650|538340105|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149238046|NCT04381650|538340095|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
149238047|NCT04381650|538340096|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
149238048|NCT04381650|538340097|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
149238049|NCT04381650|538340098|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
149238050|NCT04381650|538340099|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
149238051|NCT04381650|538340100|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
149238052|NCT04381650|538340101|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
149238053|NCT04381650|538340102|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
149238054|NCT04381650|538340103|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
149238055|NCT04381650|538340104|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
149238056|NCT04381650|538340105|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
149238057|NCT04381650|538340095|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
149238058|NCT04381650|538340096|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
149238059|NCT04381650|538340097|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
149238060|NCT04381650|538340098|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
149238061|NCT04381650|538340099|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
149238062|NCT04381650|538340100|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
149238063|NCT04381650|538340101|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
149238064|NCT04381650|538340102|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
149238065|NCT04381650|538340103|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
149238066|NCT04381650|538340104|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
149238067|NCT04381650|538340105|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
149238068|NCT04381650|538340095|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238069|NCT04381650|538340096|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238070|NCT04381650|538340097|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238071|NCT04381650|538340098|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238072|NCT04381650|538340099|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238073|NCT04381650|538340100|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238074|NCT04381650|538340101|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238075|NCT04381650|538340102|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
149238076|NCT04381650|538340103|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238077|NCT04381650|538340104|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
149238078|NCT04381650|538340105|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
148895008|NCT02587520|537096105|FG001|Overall Study|Adverse Event|0|||
149135595|NCT01131351|537978467|FG000|Overall Study|Adverse Event|0|||
149135596|NCT01131351|537978468|FG001|Overall Study|Adverse Event|2|||
149135597|NCT01131351|537978467|FG000|Overall Study|Protocol Deviation|0|||
149135598|NCT01131351|537978468|FG001|Overall Study|Protocol Deviation|1|||
149135599|NCT04147234|537978469|FG000|Overall Study|Clinical deterioration|0|||
149135600|NCT04147234|537978470|FG001|Overall Study|Clinical deterioration|0|||
149135601|NCT04147234|537978471|FG002|Overall Study|Clinical deterioration|1|||
149135602|NCT04147234|537978472|FG003|Overall Study|Clinical deterioration|0|||
149135603|NCT04147234|537978473|FG004|Overall Study|Clinical deterioration|0|||
149135604|NCT04147234|537978474|FG005|Overall Study|Clinical deterioration|0|||
149135605|NCT04147234|537978475|FG006|Overall Study|Clinical deterioration|0|||
149135606|NCT04147234|537978469|FG000|Overall Study|Withdrawal by Subject|0|||
149135607|NCT04147234|537978470|FG001|Overall Study|Withdrawal by Subject|1|||
149135608|NCT04147234|537978471|FG002|Overall Study|Withdrawal by Subject|1|||
149135609|NCT04147234|537978472|FG003|Overall Study|Withdrawal by Subject|0|||
149135610|NCT04147234|537978473|FG004|Overall Study|Withdrawal by Subject|0|||
149135611|NCT04147234|537978474|FG005|Overall Study|Withdrawal by Subject|0|||
149135612|NCT04147234|537978475|FG006|Overall Study|Withdrawal by Subject|0|||
149135613|NCT04147234|537978469|FG000|Overall Study|Clinical disease progression|1|||
149135614|NCT04147234|537978470|FG001|Overall Study|Clinical disease progression|3|||
149135615|NCT04147234|537978471|FG002|Overall Study|Clinical disease progression|1|||
149135616|NCT04147234|537978472|FG003|Overall Study|Clinical disease progression|1|||
149135617|NCT04147234|537978473|FG004|Overall Study|Clinical disease progression|0|||
149135618|NCT04147234|537978474|FG005|Overall Study|Clinical disease progression|1|||
149135619|NCT04147234|537978475|FG006|Overall Study|Clinical disease progression|0|||
149135620|NCT04147234|537978469|FG000|Overall Study|Objective disease progression|6|||
149135621|NCT04147234|537978470|FG001|Overall Study|Objective disease progression|4|||
149135622|NCT04147234|537978471|FG002|Overall Study|Objective disease progression|3|||
149135623|NCT04147234|537978472|FG003|Overall Study|Objective disease progression|3|||
149135624|NCT04147234|537978473|FG004|Overall Study|Objective disease progression|5|||
149135625|NCT04147234|537978474|FG005|Overall Study|Objective disease progression|2|||
149135626|NCT04147234|537978475|FG006|Overall Study|Objective disease progression|3|||
149135627|NCT04147234|537978469|FG000|Overall Study|Adverse Event|0|||
149135628|NCT04147234|537978470|FG001|Overall Study|Adverse Event|0|||
149135629|NCT04147234|537978471|FG002|Overall Study|Adverse Event|0|||
149135630|NCT04147234|537978472|FG003|Overall Study|Adverse Event|0|||
149135631|NCT04147234|537978473|FG004|Overall Study|Adverse Event|1|||
149135632|NCT04147234|537978474|FG005|Overall Study|Adverse Event|0|||
149135633|NCT04147234|537978475|FG006|Overall Study|Adverse Event|0|||
149135634|NCT01524133|537978484|FG000|Treatment Phase|Withdrawal by Subject|13|||
149135635|NCT01524133|537978485|FG001|Treatment Phase|Withdrawal by Subject|28|||
149135636|NCT01524133|537978486|FG002|Treatment Phase|Withdrawal by Subject|31|||
149135637|NCT01524133|537978484|FG000|Treatment Phase|Physician Decision|6|||
149135638|NCT01524133|537978485|FG001|Treatment Phase|Physician Decision|3|||
149135639|NCT01524133|537978486|FG002|Treatment Phase|Physician Decision|3|||
149135640|NCT01524133|537978484|FG000|Treatment Phase|Lost to Follow-up|0|||
149135641|NCT01524133|537978485|FG001|Treatment Phase|Lost to Follow-up|1|||
149135642|NCT01524133|537978486|FG002|Treatment Phase|Lost to Follow-up|2|||
149135643|NCT01524133|537978484|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
149135644|NCT01524133|537978485|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
149135645|NCT01524133|537978486|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
149135646|NCT01524133|537978484|FG000|Overall Study 52 Weeks|Physician Decision|1|||
149135647|NCT01524133|537978485|FG001|Overall Study 52 Weeks|Physician Decision|0|||
149135648|NCT01524133|537978486|FG002|Overall Study 52 Weeks|Physician Decision|2|||
149135649|NCT01524133|537978484|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
149135650|NCT01524133|537978485|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
149135651|NCT01524133|537978486|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
149135652|NCT05352048|537978490|FG000|Overall Study|Lost to Follow-up|1|||
149135653|NCT05352048|537978490|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
149135654|NCT01214187|537978491|FG000|Overall Study|Adverse Event|6|||
149135655|NCT01214187|537978492|FG001|Overall Study|Adverse Event|2|||
148795281|NCT00419757|536729085|FG000|Overall Study|Lost to Follow-up|1|||
148795282|NCT00419757|536729086|FG001|Overall Study|Lost to Follow-up|4|||
148795283|NCT00419757|536729085|FG000|Overall Study|Withdrawal by Subject|7|||
148795284|NCT00419757|536729086|FG001|Overall Study|Withdrawal by Subject|1|||
148795285|NCT00419757|536729085|FG000|Overall Study|Protocol Violation|2|||
148795286|NCT00419757|536729086|FG001|Overall Study|Protocol Violation|3|||
148795287|NCT00419757|536729085|FG000|Overall Study|Study specific discontinuation criteria|4|||
148795288|NCT00419757|536729086|FG001|Overall Study|Study specific discontinuation criteria|8|||
148795289|NCT00419757|536729085|FG000|Overall Study|Multiple reasons|3|||
148795290|NCT00419757|536729086|FG001|Overall Study|Multiple reasons|1|||
148795291|NCT00379834|536729091|FG000|Overall Study|Time constraints|2|||
148895009|NCT02587520|537096106|FG002|Overall Study|Adverse Event|0|||
149135656|NCT01214187|537978491|FG000|Overall Study|Death|1|||
149135657|NCT01214187|537978492|FG001|Overall Study|Death|1|||
149135658|NCT01214187|537978491|FG000|Overall Study|Withdrawal by Subject|0|||
149135659|NCT01214187|537978492|FG001|Overall Study|Withdrawal by Subject|3|||
149135660|NCT01233869|537978493|FG000|Initial Treatment Period (24 Months)|Death|1|||
149135661|NCT01233869|537978494|FG001|Initial Treatment Period (24 Months)|Death|0|||
149135662|NCT01233869|537978495|FG002|Initial Treatment Period (24 Months)|Death|0|||
149135663|NCT01233869|537978496|FG003|Initial Treatment Period (24 Months)|Death|0|||
149135664|NCT01233869|537978493|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
149135665|NCT01233869|537978494|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
149135666|NCT01233869|537978495|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
149135667|NCT01233869|537978496|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
149135668|NCT01233869|537978493|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
149135669|NCT01233869|537978494|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
149135670|NCT01233869|537978495|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
149135671|NCT01233869|537978496|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
149135672|NCT01233869|537978493|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
149135673|NCT01233869|537978494|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
149135674|NCT01233869|537978495|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
149135675|NCT01233869|537978496|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
148895010|NCT02587520|537096107|FG003|Overall Study|Adverse Event|0|||
148895011|NCT02587520|537096108|FG004|Overall Study|Adverse Event|0|||
148895012|NCT02587520|537096109|FG005|Overall Study|Adverse Event|0|||
148895013|NCT02587520|537096110|FG006|Overall Study|Adverse Event|0|||
148895014|NCT02587520|537096111|FG007|Overall Study|Adverse Event|0|||
148895015|NCT02587520|537096112|FG008|Overall Study|Adverse Event|0|||
148895016|NCT02587520|537096113|FG009|Overall Study|Adverse Event|0|||
148895017|NCT02587520|537096114|FG010|Overall Study|Adverse Event|0|||
148895018|NCT02587520|537096115|FG011|Overall Study|Adverse Event|1|||
148895019|NCT02587520|537096116|FG012|Overall Study|Adverse Event|0|||
148895020|NCT02587520|537096117|FG013|Overall Study|Adverse Event|0|||
148895021|NCT02587520|537096118|FG014|Overall Study|Adverse Event|0|||
148895022|NCT02587520|537096119|FG015|Overall Study|Adverse Event|0|||
148895023|NCT02587520|537096120|FG016|Overall Study|Adverse Event|0|||
148895024|NCT02587520|537096121|FG017|Overall Study|Adverse Event|0|||
148895025|NCT02587520|537096104|FG000|Overall Study|Withdrawal by Subject|0|||
148895026|NCT02587520|537096105|FG001|Overall Study|Withdrawal by Subject|0|||
148895027|NCT02587520|537096106|FG002|Overall Study|Withdrawal by Subject|1|||
148895028|NCT02587520|537096107|FG003|Overall Study|Withdrawal by Subject|1|||
148895029|NCT02587520|537096108|FG004|Overall Study|Withdrawal by Subject|0|||
148895030|NCT02587520|537096109|FG005|Overall Study|Withdrawal by Subject|1|||
148895031|NCT02587520|537096110|FG006|Overall Study|Withdrawal by Subject|1|||
148895032|NCT02587520|537096111|FG007|Overall Study|Withdrawal by Subject|0|||
148895033|NCT02587520|537096112|FG008|Overall Study|Withdrawal by Subject|0|||
148895034|NCT02587520|537096113|FG009|Overall Study|Withdrawal by Subject|0|||
148895035|NCT02587520|537096114|FG010|Overall Study|Withdrawal by Subject|0|||
148895036|NCT02587520|537096115|FG011|Overall Study|Withdrawal by Subject|0|||
148895037|NCT02587520|537096116|FG012|Overall Study|Withdrawal by Subject|0|||
148895038|NCT02587520|537096117|FG013|Overall Study|Withdrawal by Subject|1|||
148895039|NCT02587520|537096118|FG014|Overall Study|Withdrawal by Subject|0|||
148895040|NCT02587520|537096119|FG015|Overall Study|Withdrawal by Subject|0|||
148895041|NCT02587520|537096120|FG016|Overall Study|Withdrawal by Subject|0|||
148895042|NCT02587520|537096121|FG017|Overall Study|Withdrawal by Subject|0|||
148895043|NCT02587520|537096104|FG000|Overall Study|Lost to Follow-up|0|||
148895044|NCT02587520|537096105|FG001|Overall Study|Lost to Follow-up|2|||
148895045|NCT02587520|537096106|FG002|Overall Study|Lost to Follow-up|0|||
148895046|NCT02587520|537096107|FG003|Overall Study|Lost to Follow-up|2|||
148895047|NCT02587520|537096108|FG004|Overall Study|Lost to Follow-up|0|||
148895048|NCT02587520|537096109|FG005|Overall Study|Lost to Follow-up|1|||
148895049|NCT02587520|537096110|FG006|Overall Study|Lost to Follow-up|1|||
148895050|NCT02587520|537096111|FG007|Overall Study|Lost to Follow-up|1|||
148895051|NCT02587520|537096112|FG008|Overall Study|Lost to Follow-up|0|||
148895052|NCT02587520|537096113|FG009|Overall Study|Lost to Follow-up|2|||
148895053|NCT02587520|537096114|FG010|Overall Study|Lost to Follow-up|2|||
148895054|NCT02587520|537096115|FG011|Overall Study|Lost to Follow-up|1|||
148895055|NCT02587520|537096116|FG012|Overall Study|Lost to Follow-up|0|||
148895056|NCT02587520|537096117|FG013|Overall Study|Lost to Follow-up|0|||
148895057|NCT02587520|537096118|FG014|Overall Study|Lost to Follow-up|0|||
148895058|NCT02587520|537096119|FG015|Overall Study|Lost to Follow-up|0|||
148895059|NCT02587520|537096120|FG016|Overall Study|Lost to Follow-up|0|||
148895060|NCT02587520|537096121|FG017|Overall Study|Lost to Follow-up|0|||
148895061|NCT00672555|537096122|FG000|Overall Study|Lost to Follow-up|4|||
148895062|NCT00672555|537096122|FG000|Overall Study|Did not want to answer questionnaire|2|||
148895063|NCT02153086|537096128|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
148895064|NCT02153086|537096128|FG000|Overall Study|Other|2|||
148895065|NCT00446849|537096129|FG000|Acute Phase|Lack of Efficacy|64|||
148895066|NCT00446849|537096129|FG000|Acute Phase|Protocol Violation|10|||
148895067|NCT00446849|537096129|FG000|Acute Phase|Consent withdrawn|4|||
148895068|NCT00446849|537096129|FG000|Acute Phase|Lost to Follow-up|2|||
148895069|NCT00446849|537096129|FG000|Acute Phase|Physician Decision|1|||
148895070|NCT00446849|537096129|FG000|Acute Phase|noncompliance|1|||
148895071|NCT00446849|537096129|FG000|Maintenance Phase|Lack of Efficacy|40|||
148895072|NCT00446849|537096129|FG000|Maintenance Phase|Protocol Violation|7|||
148895073|NCT00446849|537096129|FG000|Maintenance Phase|Adverse Event|6|||
148895074|NCT00446849|537096129|FG000|Maintenance Phase|Consent withdrawn|5|||
148895075|NCT00446849|537096129|FG000|Maintenance Phase|Lost to Follow-up|3|||
148895076|NCT00446849|537096129|FG000|Maintenance Phase|Pregnancy|1|||
148895077|NCT00446849|537096129|FG000|Maintenance Phase|noncompliance|2|||
148895078|NCT00446849|537096129|FG000|Maintenance Phase|prohibited medication use|2|||
148895079|NCT00446849|537096129|FG000|Maintenance Phase|antibiotic use|1|||
148895080|NCT00446849|537096129|FG000|Maintenance Phase|study closure|1|||
148895081|NCT00446849|537096129|FG000|Maintenance Phase|hydrocodone use|1|||
148895082|NCT00446849|537096129|FG000|Maintenance Phase|concomitant medication use|1|||
148895083|NCT03115359|537096130|FG000|Overall Study|Withdrawal by Subject|29|||
148895084|NCT03115359|537096131|FG001|Overall Study|Withdrawal by Subject|39|||
148895085|NCT03115359|537096130|FG000|Overall Study|Scheduling conflict|25|||
148895086|NCT03115359|537096131|FG001|Overall Study|Scheduling conflict|23|||
148895087|NCT03115359|537096130|FG000|Overall Study|Personal reasons including health|12|||
148895088|NCT03115359|537096131|FG001|Overall Study|Personal reasons including health|9|||
148895089|NCT03115359|537096130|FG000|Overall Study|Transportation barriers|3|||
148895090|NCT03115359|537096131|FG001|Overall Study|Transportation barriers|0|||
148895091|NCT03115359|537096130|FG000|Overall Study|No longer interested|5|||
148895092|NCT03115359|537096131|FG001|Overall Study|No longer interested|4|||
148895093|NCT03115359|537096130|FG000|Overall Study|No reason provided|45|||
148895094|NCT03115359|537096131|FG001|Overall Study|No reason provided|47|||
148895095|NCT01317472|537096134|FG000|Overall Study|Withdrawal by Subject|1|||
148895096|NCT01317472|537096135|FG001|Overall Study|Withdrawal by Subject|0|||
148895097|NCT01317472|537096134|FG000|Overall Study|Unrelated hospitalization|1|||
148895098|NCT01317472|537096135|FG001|Overall Study|Unrelated hospitalization|0|||
148895099|NCT01815918|537096136|FG000|Overall Study|Patient samples not analyzable|3|||
148895100|NCT01815918|537096137|FG001|Overall Study|Patient samples not analyzable|4|||
148895101|NCT01815918|537096136|FG000|Overall Study|Lack of Efficacy|15|||
148895102|NCT01815918|537096137|FG001|Overall Study|Lack of Efficacy|15|||
148895103|NCT03284710|537096140|FG000|Overall Study|Withdrawal by Subject|1|||
148895104|NCT03284710|537096141|FG001|Overall Study|Withdrawal by Subject|0|||
148895105|NCT03284710|537096142|FG002|Overall Study|Withdrawal by Subject|1|||
148895106|NCT03284710|537096143|FG003|Overall Study|Withdrawal by Subject|6|||
148895107|NCT03284710|537096140|FG000|Overall Study|Lost to Follow-up|3|||
148895108|NCT03284710|537096141|FG001|Overall Study|Lost to Follow-up|3|||
148895109|NCT03284710|537096142|FG002|Overall Study|Lost to Follow-up|1|||
148895110|NCT03284710|537096143|FG003|Overall Study|Lost to Follow-up|0|||
148895111|NCT03284710|537096140|FG000|Overall Study|Physician Decision|1|||
148895112|NCT03284710|537096141|FG001|Overall Study|Physician Decision|0|||
148895113|NCT03284710|537096142|FG002|Overall Study|Physician Decision|0|||
148895114|NCT03284710|537096143|FG003|Overall Study|Physician Decision|0|||
148895115|NCT03284710|537096140|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
148895116|NCT03284710|537096141|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
148895117|NCT03284710|537096142|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
148895118|NCT03284710|537096143|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
149135676|NCT01233869|537978493|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
148895119|NCT03284710|537096140|FG000|Overall Study|HIV Infection|0|||
149135677|NCT01233869|537978494|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
149135678|NCT01233869|537978495|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
149135679|NCT01233869|537978496|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
149135680|NCT01233869|537978493|FG000|Extended Treatment Period (46 Months)|Other|3|||
148895120|NCT03284710|537096141|FG001|Overall Study|HIV Infection|2|||
149135681|NCT01233869|537978494|FG001|Extended Treatment Period (46 Months)|Other|0|||
149135682|NCT01233869|537978495|FG002|Extended Treatment Period (46 Months)|Other|0|||
149135683|NCT01233869|537978496|FG003|Extended Treatment Period (46 Months)|Other|3|||
149135684|NCT01233869|537978493|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
149135685|NCT01233869|537978494|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
149135686|NCT01233869|537978495|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
149135687|NCT01233869|537978496|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
149135688|NCT00631189|537978505|FG000|Initial Phase|Protocol Violation|347|||
149135689|NCT00631189|537978506|FG001|Initial Phase|Protocol Violation|0|||
149135690|NCT00631189|537978507|FG002|Initial Phase|Protocol Violation|0|||
149135691|NCT00631189|537978508|FG003|Initial Phase|Protocol Violation|0|||
149135692|NCT00631189|537978505|FG000|Initial Phase|Withdrawal by Subject|4|||
149135693|NCT00631189|537978506|FG001|Initial Phase|Withdrawal by Subject|0|||
149135694|NCT00631189|537978507|FG002|Initial Phase|Withdrawal by Subject|0|||
149135695|NCT00631189|537978508|FG003|Initial Phase|Withdrawal by Subject|0|||
149135696|NCT00631189|537978505|FG000|Treatment Phase|Withdrawal by Subject|0|||
149135697|NCT00631189|537978506|FG001|Treatment Phase|Withdrawal by Subject|2|||
149135698|NCT00631189|537978507|FG002|Treatment Phase|Withdrawal by Subject|1|||
149135699|NCT00631189|537978508|FG003|Treatment Phase|Withdrawal by Subject|1|||
149135700|NCT00631189|537978505|FG000|Treatment Phase|Protocol Violation|0|||
149135701|NCT00631189|537978506|FG001|Treatment Phase|Protocol Violation|1|||
149135702|NCT00631189|537978507|FG002|Treatment Phase|Protocol Violation|6|||
149135703|NCT00631189|537978508|FG003|Treatment Phase|Protocol Violation|2|||
149135704|NCT00631189|537978505|FG000|Treatment Phase|Adverse Event|0|||
149135705|NCT00631189|537978506|FG001|Treatment Phase|Adverse Event|3|||
149135706|NCT00631189|537978507|FG002|Treatment Phase|Adverse Event|2|||
149135707|NCT00631189|537978508|FG003|Treatment Phase|Adverse Event|4|||
149135708|NCT00631189|537978505|FG000|Treatment Phase|Lost to Follow-up|0|||
149135709|NCT00631189|537978506|FG001|Treatment Phase|Lost to Follow-up|1|||
149135710|NCT00631189|537978507|FG002|Treatment Phase|Lost to Follow-up|0|||
149135711|NCT00631189|537978508|FG003|Treatment Phase|Lost to Follow-up|0|||
149135712|NCT00631189|537978505|FG000|Treatment Phase|Pregnancy|0|||
149135713|NCT00631189|537978506|FG001|Treatment Phase|Pregnancy|0|||
149135714|NCT00631189|537978507|FG002|Treatment Phase|Pregnancy|1|||
149135715|NCT00631189|537978508|FG003|Treatment Phase|Pregnancy|0|||
149135716|NCT00631189|537978505|FG000|Treatment Phase|patient did not take pravastatin|0|||
149135717|NCT00631189|537978506|FG001|Treatment Phase|patient did not take pravastatin|0|||
149135718|NCT00631189|537978507|FG002|Treatment Phase|patient did not take pravastatin|1|||
149135719|NCT00631189|537978508|FG003|Treatment Phase|patient did not take pravastatin|0|||
149135720|NCT04464265|537978509|FG000|Overall Study|Physician Decision|2|||
149135721|NCT00974090|537978510|FG000|Period 1: Double Blind Period|Adverse Event|2|||
149135722|NCT00974090|537978511|FG001|Period 1: Double Blind Period|Adverse Event|1|||
149135723|NCT00974090|537978510|FG000|Period 1: Double Blind Period|Physician Decision|1|||
149135724|NCT00974090|537978511|FG001|Period 1: Double Blind Period|Physician Decision|0|||
149135725|NCT00974090|537978510|FG000|Period 2: Open-label Period|Adverse Event|4|||
149135726|NCT00974090|537978511|FG001|Period 2: Open-label Period|Adverse Event|6|||
149135727|NCT00974090|537978510|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
149135728|NCT00974090|537978511|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
149135729|NCT00974090|537978510|FG000|Period 2: Open-label Period|Physician Decision|0|||
149135730|NCT00974090|537978511|FG001|Period 2: Open-label Period|Physician Decision|3|||
149135731|NCT00974090|537978510|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
149135732|NCT00974090|537978511|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
149135733|NCT00056862|537978512|FG000|Overall Study|Protocol Violation|1|||
149135734|NCT00056862|537978513|FG001|Overall Study|Protocol Violation|0|||
149135735|NCT02378220|537978517|FG000|Overall Study|Death|6|||
149135736|NCT02378220|537978518|FG001|Overall Study|Death|1|||
149135737|NCT00866723|537978519|FG000|Overall Study|Withdrawal by Subject|1|||
149135738|NCT00866723|537978519|FG000|Overall Study|Disease Progression|4|||
149135739|NCT01975428|537978523|FG000|Overall Study|Lost to Follow-up|17|||
149135740|NCT01975428|537978524|FG001|Overall Study|Lost to Follow-up|4|||
149135741|NCT01975428|537978523|FG000|Overall Study|Withdrawal by Subject|3|||
149135742|NCT01975428|537978524|FG001|Overall Study|Withdrawal by Subject|10|||
149135743|NCT00628251|537978525|FG000|Randomised Part|Withdrawal by Subject|0|||
149135744|NCT00628251|537978526|FG001|Randomised Part|Withdrawal by Subject|0|||
149135745|NCT00628251|537978527|FG002|Randomised Part|Withdrawal by Subject|1|||
148895121|NCT03284710|537096142|FG002|Overall Study|HIV Infection|2|||
149135746|NCT00628251|537978525|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
149135747|NCT00628251|537978526|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
149135748|NCT00628251|537978527|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
149135749|NCT00628251|537978525|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
149135750|NCT00628251|537978526|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
149135751|NCT00628251|537978527|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
149135752|NCT00628251|537978525|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
149135753|NCT00628251|537978526|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
148895122|NCT03284710|537096143|FG003|Overall Study|HIV Infection|1|||
148895123|NCT02412306|537096146|FG000|Overall Study|Lost to Follow-up|0|||
148895124|NCT02412306|537096147|FG001|Overall Study|Lost to Follow-up|1|||
148895125|NCT02412306|537096148|FG002|Overall Study|Lost to Follow-up|0|||
148895126|NCT02412306|537096149|FG003|Overall Study|Lost to Follow-up|0|||
148895127|NCT02412306|537096150|FG004|Overall Study|Lost to Follow-up|0|||
148895128|NCT02412306|537096146|FG000|Overall Study|Withdrawal by Subject|0|||
148956467|NCT00723892|537324429|FG001|Overall Study|Alcohol abuse|1|||
149011456|NCT02778399|537521472|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
148795292|NCT01519817|536729092|FG000|Overall Study|Withdrawal by Subject|1|||
148795293|NCT01519817|536729093|FG001|Overall Study|Withdrawal by Subject|0|||
148795294|NCT01519817|536729094|FG002|Overall Study|Withdrawal by Subject|0|||
148795295|NCT01519817|536729095|FG003|Overall Study|Withdrawal by Subject|0|||
148795296|NCT01519817|536729092|FG000|Overall Study|Off study due to infection|0|||
148795297|NCT01519817|536729093|FG001|Overall Study|Off study due to infection|0|||
148795298|NCT01519817|536729094|FG002|Overall Study|Off study due to infection|0|||
148795299|NCT01519817|536729095|FG003|Overall Study|Off study due to infection|1|||
148795300|NCT02922153|536729096|FG000|Overall Study|Death|8|||
148795301|NCT02922153|536729097|FG001|Overall Study|Death|1|||
148795302|NCT02922153|536729096|FG000|Overall Study|Lost to Follow-up|1|||
148795303|NCT02922153|536729097|FG001|Overall Study|Lost to Follow-up|0|||
148795304|NCT02922153|536729096|FG000|Overall Study|Physician Decision|1|||
148795305|NCT02922153|536729097|FG001|Overall Study|Physician Decision|1|||
148795306|NCT01325350|536729102|FG000|Overall Study|Adverse Event|3|||
148795307|NCT01325350|536729103|FG001|Overall Study|Adverse Event|3|||
148795308|NCT01325350|536729104|FG002|Overall Study|Adverse Event|3|||
148795309|NCT01325350|536729105|FG003|Overall Study|Adverse Event|1|||
148795310|NCT01325350|536729106|FG004|Overall Study|Adverse Event|2|||
148795311|NCT01325350|536729102|FG000|Overall Study|Pregnancy|0|||
148795312|NCT01325350|536729103|FG001|Overall Study|Pregnancy|0|||
148795313|NCT01325350|536729104|FG002|Overall Study|Pregnancy|1|||
148795314|NCT01325350|536729105|FG003|Overall Study|Pregnancy|0|||
148795315|NCT01325350|536729106|FG004|Overall Study|Pregnancy|1|||
148795316|NCT01325350|536729102|FG000|Overall Study|Lost to Follow-up|1|||
148795317|NCT01325350|536729103|FG001|Overall Study|Lost to Follow-up|0|||
148795318|NCT01325350|536729104|FG002|Overall Study|Lost to Follow-up|5|||
148795319|NCT01325350|536729105|FG003|Overall Study|Lost to Follow-up|1|||
148795320|NCT01325350|536729106|FG004|Overall Study|Lost to Follow-up|5|||
148795321|NCT01325350|536729102|FG000|Overall Study|Personal Reasons|2|||
148795322|NCT01325350|536729103|FG001|Overall Study|Personal Reasons|1|||
148795323|NCT01325350|536729104|FG002|Overall Study|Personal Reasons|6|||
148795324|NCT01325350|536729105|FG003|Overall Study|Personal Reasons|5|||
148795325|NCT01325350|536729106|FG004|Overall Study|Personal Reasons|3|||
148795326|NCT01325350|536729102|FG000|Overall Study|Protocol Violation|0|||
148795327|NCT01325350|536729103|FG001|Overall Study|Protocol Violation|0|||
148795328|NCT01325350|536729104|FG002|Overall Study|Protocol Violation|0|||
148795329|NCT01325350|536729105|FG003|Overall Study|Protocol Violation|1|||
148795330|NCT01325350|536729106|FG004|Overall Study|Protocol Violation|0|||
148795331|NCT01325350|536729102|FG000|Overall Study|Withdrawal by Subject|0|||
148795332|NCT01325350|536729103|FG001|Overall Study|Withdrawal by Subject|0|||
148795333|NCT01325350|536729104|FG002|Overall Study|Withdrawal by Subject|1|||
148795334|NCT01325350|536729105|FG003|Overall Study|Withdrawal by Subject|1|||
148795335|NCT01325350|536729106|FG004|Overall Study|Withdrawal by Subject|0|||
148795336|NCT01325350|536729102|FG000|Overall Study|Did Not Receive Treatment|0|||
148795337|NCT01325350|536729103|FG001|Overall Study|Did Not Receive Treatment|1|||
148795338|NCT01325350|536729104|FG002|Overall Study|Did Not Receive Treatment|1|||
148795339|NCT01325350|536729105|FG003|Overall Study|Did Not Receive Treatment|0|||
148795340|NCT01325350|536729106|FG004|Overall Study|Did Not Receive Treatment|1|||
148795341|NCT01716806|536729111|FG000|Overall Study|Patient withdrawal of consent|4|||
148795342|NCT01716806|536729112|FG001|Overall Study|Patient withdrawal of consent|2|||
148795343|NCT01716806|536729113|FG002|Overall Study|Patient withdrawal of consent|4|||
148795344|NCT01716806|536729114|FG003|Overall Study|Patient withdrawal of consent|3|||
148795345|NCT01716806|536729115|FG004|Overall Study|Patient withdrawal of consent|2|||
148795346|NCT01716806|536729116|FG005|Overall Study|Patient withdrawal of consent|0|||
148795347|NCT01716806|536729111|FG000|Overall Study|Lost to Follow-up|3|||
148795348|NCT01716806|536729112|FG001|Overall Study|Lost to Follow-up|3|||
148795349|NCT01716806|536729113|FG002|Overall Study|Lost to Follow-up|0|||
148795350|NCT01716806|536729114|FG003|Overall Study|Lost to Follow-up|2|||
148795351|NCT01716806|536729115|FG004|Overall Study|Lost to Follow-up|1|||
148795352|NCT01716806|536729116|FG005|Overall Study|Lost to Follow-up|0|||
148795353|NCT01716806|536729111|FG000|Overall Study|Death|13|||
148795354|NCT01716806|536729112|FG001|Overall Study|Death|9|||
148795355|NCT01716806|536729113|FG002|Overall Study|Death|12|||
148795356|NCT01716806|536729114|FG003|Overall Study|Death|4|||
148795357|NCT01716806|536729115|FG004|Overall Study|Death|10|||
148795358|NCT01716806|536729116|FG005|Overall Study|Death|5|||
148795359|NCT01716806|536729111|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
148795360|NCT01716806|536729112|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
148795361|NCT01716806|536729113|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
148795362|NCT01716806|536729114|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
148795363|NCT01716806|536729115|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
148795364|NCT01716806|536729116|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
148795365|NCT01716806|536729111|FG000|Overall Study|PI decision|0|||
148795366|NCT01716806|536729112|FG001|Overall Study|PI decision|0|||
148795367|NCT01716806|536729113|FG002|Overall Study|PI decision|0|||
148795368|NCT01716806|536729114|FG003|Overall Study|PI decision|0|||
148795369|NCT01716806|536729115|FG004|Overall Study|PI decision|1|||
148795370|NCT01716806|536729116|FG005|Overall Study|PI decision|0|||
148795371|NCT01716806|536729111|FG000|Overall Study|Change in performance status|1|||
148795372|NCT01716806|536729112|FG001|Overall Study|Change in performance status|0|||
148795373|NCT01716806|536729113|FG002|Overall Study|Change in performance status|0|||
148795374|NCT01716806|536729114|FG003|Overall Study|Change in performance status|0|||
148795375|NCT01716806|536729115|FG004|Overall Study|Change in performance status|0|||
148795376|NCT01716806|536729116|FG005|Overall Study|Change in performance status|0|||
148795377|NCT01716806|536729111|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
148795378|NCT01716806|536729112|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
148795379|NCT01716806|536729113|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
148795380|NCT01716806|536729114|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
148795381|NCT01716806|536729115|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
148795382|NCT01716806|536729116|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
148795383|NCT01716806|536729111|FG000|Overall Study|Sponsor direction|7|||
148795384|NCT01716806|536729112|FG001|Overall Study|Sponsor direction|8|||
148795385|NCT01716806|536729113|FG002|Overall Study|Sponsor direction|5|||
148795386|NCT01716806|536729114|FG003|Overall Study|Sponsor direction|12|||
148795387|NCT01716806|536729115|FG004|Overall Study|Sponsor direction|16|||
148795388|NCT01716806|536729116|FG005|Overall Study|Sponsor direction|1|||
148795389|NCT02692586|536729117|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
148795390|NCT02692586|536729117|FG000|Overall Study|Received adjunctive thrombolytics|2|||
148795391|NCT03316586|536729123|FG000|Overall Study|Adverse Event|2|||
149011457|NCT02778399|537521473|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
149011458|NCT02778399|537521474|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
148795392|NCT03316586|536729123|FG000|Overall Study|Physician Decision|3|||
148795393|NCT03316586|536729123|FG000|Overall Study|Lack of Efficacy|10|||
148795394|NCT03316586|536729123|FG000|Overall Study|still on treatment|1|||
148795395|NCT03316586|536729123|FG000|Overall Study|Patient needed radiation therapy|1|||
148795396|NCT03316586|536729123|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
148795397|NCT00619827|536729124|FG000|Overall Study|Adverse Event|1|||
148795398|NCT00619827|536729125|FG001|Overall Study|Adverse Event|2|||
148795399|NCT00619827|536729124|FG000|Overall Study|Withdrawal by Subject|2|||
148795400|NCT00619827|536729125|FG001|Overall Study|Withdrawal by Subject|2|||
148795401|NCT01396083|536729127|FG000|Overall Study|Adverse Event|2|||
148795402|NCT01396083|536729128|FG001|Overall Study|Adverse Event|28|||
148795403|NCT01396083|536729127|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148795404|NCT01396083|536729128|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
148795405|NCT01396083|536729127|FG000|Overall Study|Consent withdrawn|4|||
148795406|NCT01396083|536729128|FG001|Overall Study|Consent withdrawn|5|||
148795407|NCT01396083|536729127|FG000|Overall Study|Protocol deviation(s)|0|||
148795408|NCT01396083|536729128|FG001|Overall Study|Protocol deviation(s)|1|||
148795409|NCT01396083|536729127|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148795410|NCT01396083|536729128|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148795411|NCT01396083|536729127|FG000|Overall Study|Administrative problems|1|||
148795412|NCT01396083|536729128|FG001|Overall Study|Administrative problems|0|||
148795413|NCT01396083|536729127|FG000|Overall Study|Lost to Follow-up|1|||
148795414|NCT01396083|536729128|FG001|Overall Study|Lost to Follow-up|0|||
148795415|NCT00735709|536729129|FG000|Overall Study|Adverse Event|2|||
148795416|NCT00735709|536729130|FG001|Overall Study|Adverse Event|3|||
148795417|NCT00735709|536729131|FG002|Overall Study|Adverse Event|1|||
148795418|NCT00735709|536729132|FG003|Overall Study|Adverse Event|5|||
148795419|NCT00735709|536729129|FG000|Overall Study|Lack of Efficacy|8|||
148795420|NCT00735709|536729130|FG001|Overall Study|Lack of Efficacy|4|||
148795421|NCT00735709|536729131|FG002|Overall Study|Lack of Efficacy|2|||
148795422|NCT00735709|536729132|FG003|Overall Study|Lack of Efficacy|3|||
148795423|NCT00735709|536729129|FG000|Overall Study|Noncompliance|0|||
148795424|NCT00735709|536729130|FG001|Overall Study|Noncompliance|0|||
148795425|NCT00735709|536729131|FG002|Overall Study|Noncompliance|1|||
148795426|NCT00735709|536729132|FG003|Overall Study|Noncompliance|0|||
148795427|NCT00735709|536729129|FG000|Overall Study|Protocol deviations|1|||
148795428|NCT00735709|536729130|FG001|Overall Study|Protocol deviations|2|||
148795429|NCT00735709|536729131|FG002|Overall Study|Protocol deviations|1|||
148795430|NCT00735709|536729132|FG003|Overall Study|Protocol deviations|1|||
148795431|NCT00735709|536729129|FG000|Overall Study|Voluntary Withdrawal|1|||
148795432|NCT00735709|536729130|FG001|Overall Study|Voluntary Withdrawal|3|||
148795433|NCT00735709|536729131|FG002|Overall Study|Voluntary Withdrawal|5|||
148795434|NCT00735709|536729132|FG003|Overall Study|Voluntary Withdrawal|7|||
148795435|NCT00735709|536729129|FG000|Overall Study|Lost to Follow-up|0|||
148795436|NCT00735709|536729130|FG001|Overall Study|Lost to Follow-up|1|||
148795437|NCT00735709|536729131|FG002|Overall Study|Lost to Follow-up|1|||
148795438|NCT00735709|536729132|FG003|Overall Study|Lost to Follow-up|1|||
148795439|NCT00735709|536729129|FG000|Overall Study|Excluded medication|1|||
148795440|NCT00735709|536729130|FG001|Overall Study|Excluded medication|0|||
148795441|NCT00735709|536729131|FG002|Overall Study|Excluded medication|0|||
148795442|NCT00735709|536729132|FG003|Overall Study|Excluded medication|1|||
148795443|NCT00521365|536729150|FG000|Overall Study|Adverse Event|3|||
148795444|NCT00521365|536729150|FG000|Overall Study|Lost to Follow-up|6|||
148795445|NCT00521365|536729150|FG000|Overall Study|Protocol deviation|2|||
148795446|NCT00521365|536729150|FG000|Overall Study|Drug compliance|3|||
148795447|NCT00521365|536729150|FG000|Overall Study|Usage of not allowed drugs|6|||
148795448|NCT03150082|536729151|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
148795449|NCT03150082|536729152|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
148795450|NCT01718483|536729153|FG000|Overall Study|Withdrawal by Subject|14|||
148795451|NCT01718483|536729154|FG001|Overall Study|Withdrawal by Subject|12|||
148795452|NCT01718483|536729153|FG000|Overall Study|Adverse Event|5|||
148795453|NCT01718483|536729154|FG001|Overall Study|Adverse Event|12|||
148795454|NCT01718483|536729153|FG000|Overall Study|Lost to Follow-up|8|||
148795455|NCT01718483|536729154|FG001|Overall Study|Lost to Follow-up|3|||
148795456|NCT01718483|536729153|FG000|Overall Study|Protocol Violation|4|||
148795457|NCT01718483|536729154|FG001|Overall Study|Protocol Violation|2|||
148795458|NCT01718483|536729153|FG000|Overall Study|Other|1|||
148795459|NCT01718483|536729154|FG001|Overall Study|Other|4|||
148795460|NCT01718483|536729153|FG000|Overall Study|Pregnancy|1|||
148795461|NCT01718483|536729154|FG001|Overall Study|Pregnancy|1|||
148795462|NCT01718483|536729153|FG000|Overall Study|Lack of Efficacy|1|||
148795463|NCT01718483|536729154|FG001|Overall Study|Lack of Efficacy|0|||
148795464|NCT04547140|536729157|FG000|Overall Study|Adverse Event|0|||
148795465|NCT04547140|536729158|FG001|Overall Study|Adverse Event|1|||
148795466|NCT04547140|536729157|FG000|Overall Study|Withdrawal by Subject|0|||
148795467|NCT04547140|536729158|FG001|Overall Study|Withdrawal by Subject|1|||
148795468|NCT04547140|536729157|FG000|Overall Study|Lost to Follow-up|3|||
148795469|NCT04547140|536729158|FG001|Overall Study|Lost to Follow-up|1|||
148795470|NCT04547140|536729157|FG000|Overall Study|Death|2|||
148795471|NCT04547140|536729158|FG001|Overall Study|Death|1|||
148795472|NCT04547140|536729157|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
148795473|NCT04547140|536729158|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
148795474|NCT04547140|536729157|FG000|Overall Study|Pregnancy|1|||
148795475|NCT04547140|536729158|FG001|Overall Study|Pregnancy|0|||
148795476|NCT04547140|536729157|FG000|Overall Study|Reason Not Specified|4|||
148795477|NCT04547140|536729158|FG001|Overall Study|Reason Not Specified|1|||
148795478|NCT02119299|536729159|FG000|Overall Study|Withdrawal by Subject|7|||
148795479|NCT02119299|536729159|FG000|Overall Study|Lack of Efficacy|1|||
148795480|NCT02119299|536729159|FG000|Overall Study|Pregnancy|1|||
148795481|NCT00873730|536729160|FG000|Overall Study|Protocol Deviation|5|||
148795482|NCT00873730|536729161|FG001|Overall Study|Protocol Deviation|2|||
148795483|NCT00873730|536729160|FG000|Overall Study|Adverse Event|0|||
148795484|NCT00873730|536729161|FG001|Overall Study|Adverse Event|2|||
148895129|NCT02412306|537096147|FG001|Overall Study|Withdrawal by Subject|0|||
148895130|NCT02412306|537096148|FG002|Overall Study|Withdrawal by Subject|1|||
148895131|NCT02412306|537096149|FG003|Overall Study|Withdrawal by Subject|0|||
148895132|NCT02412306|537096150|FG004|Overall Study|Withdrawal by Subject|0|||
148895133|NCT02412306|537096146|FG000|Overall Study|Death|5|||
148895134|NCT02412306|537096147|FG001|Overall Study|Death|7|||
148895135|NCT02412306|537096148|FG002|Overall Study|Death|15|||
148895136|NCT02412306|537096149|FG003|Overall Study|Death|0|||
148895137|NCT02412306|537096150|FG004|Overall Study|Death|2|||
148895138|NCT03760029|537096160|FG000|Overall Study|Death|1|||
148895139|NCT03760029|537096161|FG001|Overall Study|Death|0|||
148895140|NCT03760029|537096162|FG002|Overall Study|Death|0|||
148895141|NCT03760029|537096160|FG000|Overall Study|Lost to Follow-up|0|||
148895142|NCT03760029|537096161|FG001|Overall Study|Lost to Follow-up|2|||
148895143|NCT03760029|537096162|FG002|Overall Study|Lost to Follow-up|1|||
148895144|NCT03760029|537096160|FG000|Overall Study|Withdrawal by Subject|1|||
148895145|NCT03760029|537096161|FG001|Overall Study|Withdrawal by Subject|4|||
148895146|NCT03760029|537096162|FG002|Overall Study|Withdrawal by Subject|1|||
148895147|NCT03760029|537096160|FG000|Overall Study|Withdrawal by parent/guardian|4|||
148895148|NCT03760029|537096161|FG001|Overall Study|Withdrawal by parent/guardian|4|||
148895149|NCT03760029|537096162|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148895150|NCT03760029|537096160|FG000|Overall Study|Other|2|||
148895151|NCT03760029|537096161|FG001|Overall Study|Other|1|||
148895152|NCT03760029|537096162|FG002|Overall Study|Other|0|||
148895153|NCT04750824|537096166|FG000|Overall Study|Toxicity/intolerability|3|||
148895154|NCT04750824|537096167|FG001|Overall Study|Toxicity/intolerability|1|||
148895155|NCT04750824|537096166|FG000|Overall Study|Death|1|||
148895156|NCT04750824|537096167|FG001|Overall Study|Death|3|||
148895157|NCT04750824|537096166|FG000|Overall Study|Scheduled duration of therapy complete|1|||
148895158|NCT04750824|537096167|FG001|Overall Study|Scheduled duration of therapy complete|9|||
148895159|NCT04750824|537096166|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
148895160|NCT04750824|537096167|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
148895161|NCT00807911|537096168|FG000|Overall Study|Withdrawal by Subject|12|||
149135754|NCT00628251|537978527|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
149135755|NCT00628251|537978525|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
149135756|NCT00628251|537978526|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
149135757|NCT00628251|537978527|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
149135758|NCT00628251|537978525|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
149135759|NCT00628251|537978526|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
149135760|NCT00628251|537978527|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
149135761|NCT01822522|537978528|FG000|Overall Study|Adverse Event|1|||
149135762|NCT01822522|537978529|FG001|Overall Study|Adverse Event|1|||
149135763|NCT01822522|537978530|FG002|Overall Study|Adverse Event|1|||
149135764|NCT01822522|537978531|FG003|Overall Study|Adverse Event|0|||
149135765|NCT01822522|537978532|FG004|Overall Study|Adverse Event|0|||
149135766|NCT01822522|537978533|FG005|Overall Study|Adverse Event|1|||
149135767|NCT01822522|537978528|FG000|Overall Study|Death|3|||
149135768|NCT01822522|537978529|FG001|Overall Study|Death|0|||
149135769|NCT01822522|537978530|FG002|Overall Study|Death|2|||
149135770|NCT01822522|537978531|FG003|Overall Study|Death|0|||
149135771|NCT01822522|537978532|FG004|Overall Study|Death|0|||
149135772|NCT01822522|537978533|FG005|Overall Study|Death|0|||
149135773|NCT01822522|537978528|FG000|Overall Study|Lost to Follow-up|0|||
149135774|NCT01822522|537978529|FG001|Overall Study|Lost to Follow-up|0|||
149135775|NCT01822522|537978530|FG002|Overall Study|Lost to Follow-up|1|||
149135776|NCT01822522|537978531|FG003|Overall Study|Lost to Follow-up|1|||
149135777|NCT01822522|537978532|FG004|Overall Study|Lost to Follow-up|0|||
149135778|NCT01822522|537978533|FG005|Overall Study|Lost to Follow-up|1|||
149135779|NCT01822522|537978528|FG000|Overall Study|Withdrawal by Subject|0|||
149135780|NCT01822522|537978529|FG001|Overall Study|Withdrawal by Subject|0|||
149135781|NCT01822522|537978530|FG002|Overall Study|Withdrawal by Subject|0|||
149135782|NCT01822522|537978531|FG003|Overall Study|Withdrawal by Subject|1|||
149135783|NCT01822522|537978532|FG004|Overall Study|Withdrawal by Subject|0|||
149135784|NCT01822522|537978533|FG005|Overall Study|Withdrawal by Subject|0|||
149135785|NCT01822522|537978528|FG000|Overall Study|Lack of Efficacy|0|||
149135786|NCT01822522|537978529|FG001|Overall Study|Lack of Efficacy|0|||
149135787|NCT01822522|537978530|FG002|Overall Study|Lack of Efficacy|0|||
149135788|NCT01822522|537978531|FG003|Overall Study|Lack of Efficacy|0|||
149135789|NCT01822522|537978532|FG004|Overall Study|Lack of Efficacy|0|||
148895162|NCT00807911|537096169|FG001|Overall Study|Withdrawal by Subject|10|||
148895163|NCT00807911|537096168|FG000|Overall Study|Ineligible|0|||
148895164|NCT00807911|537096169|FG001|Overall Study|Ineligible|4|||
148895165|NCT04349891|537096172|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
148895166|NCT04349891|537096173|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
148895167|NCT04349891|537096172|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
148895168|NCT04349891|537096173|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
149135790|NCT01822522|537978533|FG005|Overall Study|Lack of Efficacy|2|||
149135791|NCT02558231|537978534|FG000|Overall Study|Death|4|||
148795485|NCT00873730|536729160|FG000|Overall Study|Withdrawal by Subject|0|||
148795486|NCT00873730|536729161|FG001|Overall Study|Withdrawal by Subject|1|||
148795487|NCT00873730|536729160|FG000|Overall Study|Sponsor decision|1|||
148795488|NCT00873730|536729161|FG001|Overall Study|Sponsor decision|0|||
148795489|NCT00115778|536729162|FG000|Overall Study|Withdrawal by Subject|0|||
148795490|NCT00115778|536729163|FG001|Overall Study|Withdrawal by Subject|1|||
148795491|NCT02185417|536729166|FG000|Overall Study|Death|448|||
148795492|NCT02185417|536729167|FG001|Overall Study|Death|446|||
148795493|NCT02185417|536729168|FG002|Overall Study|Death|0|||
148795494|NCT02185417|536729166|FG000|Overall Study|Withdrawal by Subject|7|||
148795495|NCT02185417|536729167|FG001|Overall Study|Withdrawal by Subject|12|||
148795496|NCT02185417|536729168|FG002|Overall Study|Withdrawal by Subject|0|||
148795497|NCT01598610|536729173|FG000|Overall Study|Adverse Event|1|||
148795498|NCT00325819|536729175|FG000|Overall Study|Study product lost in mail|2|||
148795499|NCT00325819|536729176|FG001|Overall Study|Study product lost in mail|1|||
148795500|NCT00325819|536729175|FG000|Overall Study|Did not take a dose of study product|4|||
148795501|NCT00325819|536729176|FG001|Overall Study|Did not take a dose of study product|9|||
148795502|NCT00325819|536729175|FG000|Overall Study|Lost to Follow-up|3|||
148795503|NCT00325819|536729176|FG001|Overall Study|Lost to Follow-up|3|||
148795504|NCT04754542|536729177|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
148795505|NCT04754542|536729178|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
148795506|NCT01051921|536730763|FG000|Overall Study|Physician Decision|9|||
148795507|NCT01051921|536730763|FG000|Overall Study|Adverse Event|8|||
148795508|NCT01051921|536730763|FG000|Overall Study|Withdrawal by Subject|7|||
148795509|NCT01051921|536730763|FG000|Overall Study|Lost to Follow-up|4|||
148795510|NCT01051921|536730763|FG000|Overall Study|virological failure|1|||
148795511|NCT01051921|536730763|FG000|Overall Study|patient moved|1|||
148795512|NCT03934216|536730768|FG000|Overall Study|Other Reasons|5|||
148795513|NCT03934216|536730769|FG001|Overall Study|Other Reasons|5|||
148795514|NCT03934216|536730768|FG000|Overall Study|Adverse Event|22|||
148795515|NCT03934216|536730769|FG001|Overall Study|Adverse Event|11|||
148795516|NCT03934216|536730768|FG000|Overall Study|Lack of Efficacy|8|||
148795517|NCT03934216|536730769|FG001|Overall Study|Lack of Efficacy|7|||
148795518|NCT03934216|536730768|FG000|Overall Study|Lost to Follow-up|2|||
148795519|NCT03934216|536730769|FG001|Overall Study|Lost to Follow-up|0|||
148795520|NCT03934216|536730768|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148795521|NCT03934216|536730769|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148795522|NCT03934216|536730768|FG000|Overall Study|Pregnancy|1|||
148795523|NCT03934216|536730769|FG001|Overall Study|Pregnancy|0|||
148795524|NCT03934216|536730768|FG000|Overall Study|Withdrawal by Subject|18|||
148795525|NCT03934216|536730769|FG001|Overall Study|Withdrawal by Subject|6|||
148795526|NCT03934216|536730768|FG000|Overall Study|Randomized but not treated|1|||
148795527|NCT03934216|536730769|FG001|Overall Study|Randomized but not treated|1|||
148795528|NCT01053741|536730770|FG000|2nd Study Intervention|Physician Decision|0|||
148795529|NCT01053741|536730771|FG001|2nd Study Intervention|Physician Decision|1|||
148795530|NCT01063855|536730772|FG000|Overall Study|Adverse Event|4|||
148795531|NCT01063855|536730773|FG001|Overall Study|Adverse Event|4|||
148795532|NCT01063855|536730772|FG000|Overall Study|Death|0|||
148795533|NCT01063855|536730773|FG001|Overall Study|Death|1|||
148795534|NCT01063855|536730772|FG000|Overall Study|Lost to Follow-up|8|||
148795535|NCT01063855|536730773|FG001|Overall Study|Lost to Follow-up|4|||
148795536|NCT01063855|536730772|FG000|Overall Study|Pregnancy|1|||
148795537|NCT01063855|536730773|FG001|Overall Study|Pregnancy|0|||
148795538|NCT01063855|536730772|FG000|Overall Study|Lack of Efficacy|0|||
148795539|NCT01063855|536730773|FG001|Overall Study|Lack of Efficacy|1|||
148795540|NCT01063855|536730772|FG000|Overall Study|Withdrawal by Subject|11|||
148795541|NCT01063855|536730773|FG001|Overall Study|Withdrawal by Subject|8|||
148795542|NCT01063855|536730772|FG000|Overall Study|Reason not specified|13|||
148795543|NCT01063855|536730773|FG001|Overall Study|Reason not specified|11|||
148795544|NCT01165307|536730774|FG000|Overall Study|Lost to Follow-up|11|||
148795545|NCT01165307|536730775|FG001|Overall Study|Lost to Follow-up|3|||
148795546|NCT01165307|536730774|FG000|Overall Study|Withdrawal by Subject|2|||
148795547|NCT01165307|536730775|FG001|Overall Study|Withdrawal by Subject|0|||
148795548|NCT01165307|536730774|FG000|Overall Study|Subject not available for contact|1|||
148795549|NCT01165307|536730775|FG001|Overall Study|Subject not available for contact|0|||
148795550|NCT03627832|536730780|FG000|Overall Study|Withdrawal by Subject|10|||
148795551|NCT03627832|536730781|FG001|Overall Study|Withdrawal by Subject|1|||
148795552|NCT00048035|536730787|FG000|Core Period|Early Withdrawals|4|||
148795553|NCT00048035|536730788|FG001|Core Period|Early Withdrawals|2|||
148795554|NCT00048035|536730789|FG002|Core Period|Early Withdrawals|1|||
148795555|NCT00048035|536730790|FG003|Core Period|Early Withdrawals|1|||
148795556|NCT00048035|536730791|FG004|Core Period|Early Withdrawals|1|||
148795557|NCT00048035|536730792|FG005|Core Period|Early Withdrawals|1|||
148795558|NCT00048035|536730793|FG006|Core Period|Early Withdrawals|0|||
148795559|NCT00048035|536730794|FG007|Core Period|Early Withdrawals|0|||
148795560|NCT00048035|536730787|FG000|Extension Year 1|Early Withdrawals|0|||
148795561|NCT00048035|536730788|FG001|Extension Year 1|Early Withdrawals|0|||
148795562|NCT00048035|536730789|FG002|Extension Year 1|Early Withdrawals|0|||
148795563|NCT00048035|536730790|FG003|Extension Year 1|Early Withdrawals|0|||
148795564|NCT00048035|536730791|FG004|Extension Year 1|Early Withdrawals|0|||
148795565|NCT00048035|536730792|FG005|Extension Year 1|Early Withdrawals|0|||
148795566|NCT00048035|536730793|FG006|Extension Year 1|Early Withdrawals|11|||
148795567|NCT00048035|536730794|FG007|Extension Year 1|Early Withdrawals|11|||
148795568|NCT00048035|536730787|FG000|Extension Year 2|Early Withdrawals|0|||
149135792|NCT02558231|537978535|FG001|Overall Study|Death|12|||
149135793|NCT02558231|537978534|FG000|Overall Study|Lost to Follow-up|7|||
149135794|NCT02558231|537978535|FG001|Overall Study|Lost to Follow-up|4|||
149135795|NCT02558231|537978534|FG000|Overall Study|Withdrawal by Subject|7|||
149135796|NCT02558231|537978535|FG001|Overall Study|Withdrawal by Subject|4|||
149135797|NCT02558231|537978534|FG000|Overall Study|Physician Decision|7|||
149135798|NCT02558231|537978535|FG001|Overall Study|Physician Decision|5|||
149135799|NCT02558231|537978534|FG000|Overall Study|Sponsor Decision|0|||
149135800|NCT02558231|537978535|FG001|Overall Study|Sponsor Decision|1|||
149135801|NCT00995007|537978536|FG000|Overall Study|Withdrew consent|1|||
149135802|NCT00995007|537978537|FG001|Overall Study|Withdrew consent|0|||
149135803|NCT00995007|537978536|FG000|Overall Study|Refused further treatment|8|||
149135804|NCT00995007|537978537|FG001|Overall Study|Refused further treatment|2|||
149135805|NCT00995007|537978536|FG000|Overall Study|Toxicity|8|||
149135806|NCT00995007|537978537|FG001|Overall Study|Toxicity|0|||
149135807|NCT03933397|537978538|FG000|Overall Study|No emergency department visit|65|||
149135808|NCT03933397|537978539|FG001|Overall Study|No emergency department visit|71|||
149135809|NCT03933397|537978538|FG000|Overall Study|Missed emergency department visit|25|||
149135810|NCT03933397|537978539|FG001|Overall Study|Missed emergency department visit|30|||
149135811|NCT03933397|537978538|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
149135812|NCT03933397|537978539|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
149135813|NCT03933397|537978538|FG000|Overall Study|Withdrawal by Subject|1|||
149135814|NCT03933397|537978539|FG001|Overall Study|Withdrawal by Subject|0|||
149135815|NCT03933397|537978538|FG000|Overall Study|Physician Decision|1|||
149135816|NCT03933397|537978539|FG001|Overall Study|Physician Decision|1|||
149135817|NCT03933397|537978538|FG000|Overall Study|missing pain score|1|||
149135818|NCT03933397|537978539|FG001|Overall Study|missing pain score|1|||
149135819|NCT03933397|537978538|FG000|Overall Study|Confirmed COVID-19|1|||
149135820|NCT03933397|537978539|FG001|Overall Study|Confirmed COVID-19|2|||
148895169|NCT04349891|537096172|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
148895170|NCT04349891|537096173|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
148895171|NCT04349891|537096172|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
148895172|NCT04349891|537096173|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
148895173|NCT03532542|537096178|FG000|Overall Study|Death|1|||
148895174|NCT03532542|537096179|FG001|Overall Study|Death|0|||
148895175|NCT03532542|537096178|FG000|Overall Study|Study Terminated by Sponsor|41|||
148895176|NCT03532542|537096179|FG001|Overall Study|Study Terminated by Sponsor|65|||
148895177|NCT03532542|537096178|FG000|Overall Study|Withdrawal by Subject|6|||
148895178|NCT03532542|537096179|FG001|Overall Study|Withdrawal by Subject|5|||
148895179|NCT00836589|537096180|FG000|Overall Study|Lost to Follow-up|246|||
148895180|NCT00836589|537096180|FG000|Overall Study|Death|429|||
148895181|NCT00836589|537096180|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
148895182|NCT02914639|537096182|FG000|Overall Study|Withdrawal by Subject|0|||
148895183|NCT02914639|537096183|FG001|Overall Study|Withdrawal by Subject|2|||
148895184|NCT01018030|537096185|FG000|Overall Study|Adverse Event|10|||
148895185|NCT01018030|537096186|FG001|Overall Study|Adverse Event|5|||
148895186|NCT01018030|537096187|FG002|Overall Study|Adverse Event|5|||
148895187|NCT01018030|537096185|FG000|Overall Study|Withdrawal by Subject|2|||
148895188|NCT01018030|537096186|FG001|Overall Study|Withdrawal by Subject|2|||
148895189|NCT01018030|537096187|FG002|Overall Study|Withdrawal by Subject|4|||
148895190|NCT01018030|537096185|FG000|Overall Study|Lost to Follow-up|2|||
149135821|NCT02066051|537978544|FG000|Overall Study|Subject developed active GVHD|1|||
149135822|NCT01237340|537978549|FG000|Overall Study|Adverse Event|3|||
149135823|NCT01237340|537978549|FG000|Overall Study|Withdrawal by Subject|1|||
149135824|NCT01237340|537978549|FG000|Overall Study|Early termination of the trial|36|||
149135825|NCT01610687|537978550|FG000|Overall Study|Lack of Efficacy|26|||
149135826|NCT01610687|537978550|FG000|Overall Study|Adverse Event|18|||
149135827|NCT01610687|537978550|FG000|Overall Study|Moved out of area|6|||
149135828|NCT01610687|537978550|FG000|Overall Study|Withdrawal by Subject|7|||
149135829|NCT01610687|537978550|FG000|Overall Study|Lost to Follow-up|4|||
149135830|NCT01610687|537978550|FG000|Overall Study|Symptom control without study medication|2|||
149135831|NCT01610687|537978550|FG000|Overall Study|Unable to make journey|1|||
149135832|NCT01610687|537978550|FG000|Overall Study|Death|1|||
149135833|NCT01610687|537978550|FG000|Overall Study|Cannabis affecting job|1|||
149135834|NCT01610687|537978550|FG000|Overall Study|Felt more alter without study medication|1|||
149135835|NCT02401412|537978551|FG000|Overall Study|Lost to Follow-up|1|||
149135836|NCT02401412|537978552|FG001|Overall Study|Lost to Follow-up|0|||
149135837|NCT02401412|537978551|FG000|Overall Study|Discontinued Intervention|15|||
149135838|NCT02401412|537978552|FG001|Overall Study|Discontinued Intervention|21|||
149135839|NCT02401412|537978551|FG000|Overall Study|Withdrawal by Subject|4|||
149135840|NCT02401412|537978552|FG001|Overall Study|Withdrawal by Subject|4|||
149135841|NCT02401412|537978551|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
149135842|NCT02401412|537978552|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
149135843|NCT02401412|537978551|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
149135844|NCT02401412|537978552|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
149135845|NCT02742766|537978557|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135846|NCT02742766|537978558|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135847|NCT02742766|537978559|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135848|NCT02742766|537978560|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135849|NCT02742766|537978561|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135850|NCT02742766|537978562|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135851|NCT02742766|537978563|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135852|NCT02742766|537978564|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135853|NCT02742766|537978565|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135854|NCT02742766|537978566|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135855|NCT02742766|537978567|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135856|NCT02742766|537978568|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135857|NCT02742766|537978569|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135858|NCT02742766|537978570|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
149135859|NCT02742766|537978571|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135860|NCT02742766|537978572|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135861|NCT02742766|537978573|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135862|NCT02742766|537978574|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
149135863|NCT02742766|537978575|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
148895191|NCT01018030|537096186|FG001|Overall Study|Lost to Follow-up|0|||
148895192|NCT01018030|537096187|FG002|Overall Study|Lost to Follow-up|3|||
148895193|NCT01018030|537096185|FG000|Overall Study|Protocol Violation|2|||
148895194|NCT01018030|537096186|FG001|Overall Study|Protocol Violation|1|||
148895195|NCT01018030|537096187|FG002|Overall Study|Protocol Violation|0|||
148895196|NCT01018030|537096185|FG000|Overall Study|Physician Decision|1|||
148895197|NCT01018030|537096186|FG001|Overall Study|Physician Decision|0|||
148895198|NCT01018030|537096187|FG002|Overall Study|Physician Decision|1|||
148895199|NCT01018030|537096185|FG000|Overall Study|Lack of Efficacy|1|||
148895200|NCT01018030|537096186|FG001|Overall Study|Lack of Efficacy|0|||
148895201|NCT01018030|537096187|FG002|Overall Study|Lack of Efficacy|0|||
148895202|NCT01018030|537096185|FG000|Overall Study|Did Not Receive Study Drug|1|||
148895203|NCT01018030|537096186|FG001|Overall Study|Did Not Receive Study Drug|3|||
148895204|NCT01018030|537096187|FG002|Overall Study|Did Not Receive Study Drug|0|||
148895205|NCT00436332|537096188|FG000|Overall Study|Adverse Event|9|||
148895206|NCT00436332|537096188|FG000|Overall Study|Withdrawal by Subject|2|||
148895207|NCT00436332|537096188|FG000|Overall Study|Progression|59|||
148895208|NCT00436332|537096188|FG000|Overall Study|Death|2|||
148895209|NCT00436332|537096188|FG000|Overall Study|Not Protocol Specified|6|||
148895210|NCT00436332|537096188|FG000|Overall Study|Ineligible|2|||
148895211|NCT00436332|537096188|FG000|Overall Study|Never Received Treatment|3|||
148895212|NCT00062439|537096189|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
148795569|NCT00048035|536730788|FG001|Extension Year 2|Early Withdrawals|0|||
148795570|NCT00048035|536730789|FG002|Extension Year 2|Early Withdrawals|0|||
148795571|NCT00048035|536730790|FG003|Extension Year 2|Early Withdrawals|0|||
148795572|NCT00048035|536730791|FG004|Extension Year 2|Early Withdrawals|0|||
148795573|NCT00048035|536730792|FG005|Extension Year 2|Early Withdrawals|0|||
148795574|NCT00048035|536730793|FG006|Extension Year 2|Early Withdrawals|3|||
148795575|NCT00048035|536730794|FG007|Extension Year 2|Early Withdrawals|3|||
148795576|NCT04110314|536730795|FG000|Overall Study|Did not meet inclusion criteria|35255|||
148795577|NCT04110314|536730796|FG001|Overall Study|Did not meet inclusion criteria|35104|||
148795578|NCT04110314|536730797|FG002|Overall Study|Did not meet inclusion criteria|35636|||
148795579|NCT04110314|536730798|FG003|Overall Study|Did not meet inclusion criteria|35135|||
148795580|NCT04110314|536730799|FG004|Overall Study|Did not meet inclusion criteria|35247|||
148795581|NCT04110314|536730800|FG005|Overall Study|Did not meet inclusion criteria|35727|||
148795582|NCT05137717|536730801|FG000|Overall Study|Death|2|||
148795583|NCT05137717|536730801|FG000|Overall Study|Withdrawal by Subject|6|||
148795584|NCT02619617|536730802|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
148795585|NCT02619617|536730803|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
148795586|NCT02619617|536730802|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
148795587|NCT02619617|536730803|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
148795588|NCT00509899|536730805|FG000|Overall Study|Progressive disease|1|||
148795589|NCT00509899|536730806|FG001|Overall Study|Progressive disease|3|||
148795590|NCT00509899|536730807|FG002|Overall Study|Progressive disease|5|||
148795591|NCT00509899|536730808|FG003|Overall Study|Progressive disease|1|||
148795592|NCT00509899|536730809|FG004|Overall Study|Progressive disease|0|||
148795593|NCT00509899|536730810|FG005|Overall Study|Progressive disease|1|||
148795594|NCT00509899|536730811|FG006|Overall Study|Progressive disease|0|||
148795595|NCT00509899|536730812|FG007|Overall Study|Progressive disease|0|||
148795596|NCT00509899|536730805|FG000|Overall Study|Unacceptable Toxicity|1|||
148795597|NCT00509899|536730806|FG001|Overall Study|Unacceptable Toxicity|0|||
148795598|NCT00509899|536730807|FG002|Overall Study|Unacceptable Toxicity|0|||
148795599|NCT00509899|536730808|FG003|Overall Study|Unacceptable Toxicity|2|||
148795600|NCT00509899|536730809|FG004|Overall Study|Unacceptable Toxicity|0|||
148795601|NCT00509899|536730810|FG005|Overall Study|Unacceptable Toxicity|0|||
148795602|NCT00509899|536730811|FG006|Overall Study|Unacceptable Toxicity|0|||
148795603|NCT00509899|536730812|FG007|Overall Study|Unacceptable Toxicity|0|||
148795604|NCT00509899|536730805|FG000|Overall Study|Withdrawal by Subject|6|||
148795605|NCT00509899|536730806|FG001|Overall Study|Withdrawal by Subject|2|||
148795606|NCT00509899|536730807|FG002|Overall Study|Withdrawal by Subject|3|||
148795607|NCT00509899|536730808|FG003|Overall Study|Withdrawal by Subject|0|||
148795608|NCT00509899|536730809|FG004|Overall Study|Withdrawal by Subject|3|||
148795609|NCT00509899|536730810|FG005|Overall Study|Withdrawal by Subject|2|||
148795610|NCT00509899|536730811|FG006|Overall Study|Withdrawal by Subject|0|||
149011459|NCT02778399|537521475|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
149135864|NCT02742766|537978557|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135865|NCT02742766|537978558|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135866|NCT02742766|537978559|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135867|NCT02742766|537978560|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135868|NCT02742766|537978561|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135869|NCT02742766|537978562|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135870|NCT02742766|537978563|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135871|NCT02742766|537978564|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135872|NCT02742766|537978565|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135873|NCT02742766|537978566|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135874|NCT02742766|537978567|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135875|NCT02742766|537978568|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135876|NCT02742766|537978569|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
149135877|NCT02742766|537978570|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
149135878|NCT02742766|537978571|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135879|NCT02742766|537978572|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
149135880|NCT02742766|537978573|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135881|NCT02742766|537978574|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135882|NCT02742766|537978575|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
149135883|NCT01395316|537978577|FG000|Overall Study|Lost to Follow-up|2|||
149135884|NCT01395316|537978577|FG000|Overall Study|poor MRI quality|1|||
149135885|NCT00708175|537978584|FG000|Overall Study|Adverse Event|4|||
149135886|NCT00708175|537978585|FG001|Overall Study|Adverse Event|5|||
149135887|NCT00708175|537978584|FG000|Overall Study|Protocol Violation|2|||
148795611|NCT00509899|536730812|FG007|Overall Study|Withdrawal by Subject|0|||
148795612|NCT00509899|536730805|FG000|Overall Study|Physician Decision|4|||
148795613|NCT00509899|536730806|FG001|Overall Study|Physician Decision|2|||
148795614|NCT00509899|536730807|FG002|Overall Study|Physician Decision|7|||
148795615|NCT00509899|536730808|FG003|Overall Study|Physician Decision|0|||
149135888|NCT00708175|537978585|FG001|Overall Study|Protocol Violation|3|||
149135889|NCT00708175|537978584|FG000|Overall Study|Lost to Follow-up|5|||
148795616|NCT00509899|536730809|FG004|Overall Study|Physician Decision|1|||
148795617|NCT00509899|536730810|FG005|Overall Study|Physician Decision|4|||
148795618|NCT00509899|536730811|FG006|Overall Study|Physician Decision|0|||
148795619|NCT00509899|536730812|FG007|Overall Study|Physician Decision|0|||
148795620|NCT00509899|536730805|FG000|Overall Study|Intercurrent Illness|1|||
148795621|NCT00509899|536730806|FG001|Overall Study|Intercurrent Illness|0|||
148795622|NCT00509899|536730807|FG002|Overall Study|Intercurrent Illness|0|||
148795623|NCT00509899|536730808|FG003|Overall Study|Intercurrent Illness|1|||
148795624|NCT00509899|536730809|FG004|Overall Study|Intercurrent Illness|0|||
148795625|NCT00509899|536730810|FG005|Overall Study|Intercurrent Illness|1|||
148795626|NCT00509899|536730811|FG006|Overall Study|Intercurrent Illness|0|||
148795627|NCT00509899|536730812|FG007|Overall Study|Intercurrent Illness|0|||
148795628|NCT00509899|536730805|FG000|Overall Study|Death|2|||
148795629|NCT00509899|536730806|FG001|Overall Study|Death|2|||
148795630|NCT00509899|536730807|FG002|Overall Study|Death|3|||
148795631|NCT00509899|536730808|FG003|Overall Study|Death|0|||
148795632|NCT00509899|536730809|FG004|Overall Study|Death|1|||
148795633|NCT00509899|536730810|FG005|Overall Study|Death|1|||
148795634|NCT00509899|536730811|FG006|Overall Study|Death|1|||
148795635|NCT00509899|536730812|FG007|Overall Study|Death|1|||
148795636|NCT00509899|536730805|FG000|Overall Study|Lack of Efficacy|1|||
148795637|NCT00509899|536730806|FG001|Overall Study|Lack of Efficacy|0|||
148795638|NCT00509899|536730807|FG002|Overall Study|Lack of Efficacy|2|||
148795639|NCT00509899|536730808|FG003|Overall Study|Lack of Efficacy|0|||
148795640|NCT00509899|536730809|FG004|Overall Study|Lack of Efficacy|0|||
148795641|NCT00509899|536730810|FG005|Overall Study|Lack of Efficacy|1|||
148795642|NCT00509899|536730811|FG006|Overall Study|Lack of Efficacy|0|||
148795643|NCT00509899|536730812|FG007|Overall Study|Lack of Efficacy|0|||
148795644|NCT01711983|536730817|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
148795645|NCT01711983|536730817|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
148795646|NCT01711983|536730817|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
148795647|NCT01711983|536730817|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
148795648|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795649|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
148795650|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
148795651|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795652|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795653|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795654|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795655|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795656|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795657|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795658|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795659|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795660|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795661|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795662|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148795663|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
148795664|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
148795665|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795666|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795667|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795668|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795669|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795670|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795671|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795672|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795673|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795674|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795675|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795676|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148895213|NCT00062439|537096189|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
148895214|NCT00062439|537096189|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
148895215|NCT00062439|537096189|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
148895216|NCT00062439|537096189|FG000|Post Chemoradiation Assessment|Death|1|||
148895217|NCT00062439|537096189|FG000|Post Chemoradiation Assessment|Disease progression|2|||
148895218|NCT00062439|537096189|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
148895219|NCT00062439|537096189|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
148895220|NCT00062439|537096189|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
148895221|NCT00062439|537096189|FG000|Surgery|Physician Decision|4|||
148895222|NCT00062439|537096189|FG000|Surgery|Death|1|||
148895223|NCT00062439|537096189|FG000|Surgery|Adverse Event|2|||
148895224|NCT00062439|537096189|FG000|Consolidation Chemotherapy|Adverse Event|2|||
148895225|NCT01924845|537096190|FG000|Overall Study|Adverse Event|3|||
148895226|NCT01924845|537096190|FG000|Overall Study|Withdrawal by Subject|2|||
148895227|NCT01924845|537096190|FG000|Overall Study|Protocol Violation|1|||
148895228|NCT00265564|537096193|FG000|Overall Study|Lost to Follow-up|5|||
148895229|NCT00265564|537096194|FG001|Overall Study|Lost to Follow-up|7|||
148895230|NCT00265564|537096193|FG000|Overall Study|met exclusion criteria|5|||
148895231|NCT00265564|537096194|FG001|Overall Study|met exclusion criteria|2|||
148895232|NCT01553084|537096197|FG000|Overall Study|Withdrawal by Subject|15|||
148895233|NCT01553084|537096198|FG001|Overall Study|Withdrawal by Subject|13|||
148895234|NCT01553084|537096199|FG002|Overall Study|Withdrawal by Subject|35|||
148895235|NCT04698343|537096200|FG000|Overall Study|Withdrawal by Subject|6|||
148895236|NCT04698343|537096200|FG000|Overall Study|Physician Decision|2|||
148895237|NCT04698343|537096200|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
148895238|NCT04698343|537096200|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
148895239|NCT04698343|537096200|FG000|Overall Study|Personal reasons|3|||
148895240|NCT04698343|537096200|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
148895241|NCT02756338|537096201|FG000|Overall Study|Withdrawn by Investigator|1|||
148895242|NCT02756338|537096201|FG000|Overall Study|Device Replaced with Pacemaker|4|||
149135890|NCT00708175|537978585|FG001|Overall Study|Lost to Follow-up|3|||
149135891|NCT00708175|537978584|FG000|Overall Study|Withdrawal by Subject|5|||
149135892|NCT00708175|537978585|FG001|Overall Study|Withdrawal by Subject|7|||
149135893|NCT00708175|537978584|FG000|Overall Study|BMD loss >7%|2|||
149135894|NCT00708175|537978585|FG001|Overall Study|BMD loss >7%|3|||
149135895|NCT02038920|537978587|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
149135896|NCT02038920|537978588|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
149135897|NCT02038920|537978589|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
149135898|NCT02038920|537978590|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
149135899|NCT02038920|537978591|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
149135900|NCT02038920|537978592|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
149135901|NCT02038920|537978587|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
149135902|NCT02038920|537978588|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
149135903|NCT02038920|537978589|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
149135904|NCT02038920|537978590|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
149135905|NCT02038920|537978591|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
149135906|NCT02038920|537978592|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
149135907|NCT02038920|537978587|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
149135908|NCT02038920|537978588|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
149135909|NCT02038920|537978589|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
149135910|NCT02038920|537978590|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
149135911|NCT02038920|537978591|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
149135912|NCT02038920|537978592|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
149135913|NCT02038920|537978587|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
149135914|NCT02038920|537978588|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
149135915|NCT02038920|537978589|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
149135916|NCT02038920|537978590|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
149135917|NCT02038920|537978591|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
149135918|NCT02038920|537978592|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
149135919|NCT02038920|537978587|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
149135920|NCT02038920|537978588|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
149135921|NCT02038920|537978589|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
148895243|NCT01339689|537096204|FG000|Overall Study|Adverse Event|1|||
148895244|NCT01339689|537096205|FG001|Overall Study|Adverse Event|2|||
148895245|NCT01339689|537096204|FG000|Overall Study|Lost to Follow-up|9|||
148895246|NCT01339689|537096205|FG001|Overall Study|Lost to Follow-up|3|||
148895247|NCT01339689|537096204|FG000|Overall Study|Withdrawal by Subject|3|||
148895248|NCT01339689|537096205|FG001|Overall Study|Withdrawal by Subject|0|||
148895249|NCT01339689|537096204|FG000|Overall Study|Noncompliance|1|||
148895250|NCT01339689|537096205|FG001|Overall Study|Noncompliance|0|||
148795677|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148795678|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
148795679|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
148795680|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
148795681|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795682|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795683|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795684|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795685|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795686|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795687|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795688|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795689|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795690|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795691|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795692|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148795693|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795694|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795695|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
148795696|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795697|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795698|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795699|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795700|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795701|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795702|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795703|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795704|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795705|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795706|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795707|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
148795708|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795709|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795710|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
148795711|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795712|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795713|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795714|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795715|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795716|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795717|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795718|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795719|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795720|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795721|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795722|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
148795723|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795724|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795725|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
148795726|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795727|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795728|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795729|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148811198|NCT01431976|536787032|FG000|Overall Study|Withdrawal by Subject|1|||
149135922|NCT02038920|537978590|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
149135923|NCT02038920|537978591|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
149135924|NCT02038920|537978592|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
149135925|NCT02038920|537978587|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
149135926|NCT02038920|537978588|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
149135927|NCT02038920|537978589|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
149135928|NCT02038920|537978590|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
149135929|NCT02038920|537978591|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
149135930|NCT02038920|537978592|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
148895251|NCT01339689|537096204|FG000|Overall Study|Relocated out of area|0|||
148895252|NCT01339689|537096205|FG001|Overall Study|Relocated out of area|1|||
148895253|NCT01339689|537096204|FG000|Overall Study|Other|2|||
148895254|NCT01339689|537096205|FG001|Overall Study|Other|2|||
148895255|NCT01339689|537096204|FG000|Overall Study|multiple reasons|1|||
148895256|NCT01339689|537096205|FG001|Overall Study|multiple reasons|1|||
148895257|NCT00467740|537096208|FG000|Overall Study|Adverse Event|0|||
148895258|NCT00467740|537096209|FG001|Overall Study|Adverse Event|0|||
148895259|NCT00467740|537096210|FG002|Overall Study|Adverse Event|1|||
148895260|NCT00467740|537096211|FG003|Overall Study|Adverse Event|0|||
148895261|NCT00467740|537096212|FG004|Overall Study|Adverse Event|0|||
148895262|NCT00467740|537096208|FG000|Overall Study|Protocol Violation|0|||
148895263|NCT00467740|537096209|FG001|Overall Study|Protocol Violation|0|||
148895264|NCT00467740|537096210|FG002|Overall Study|Protocol Violation|1|||
148895265|NCT00467740|537096211|FG003|Overall Study|Protocol Violation|0|||
148895266|NCT00467740|537096212|FG004|Overall Study|Protocol Violation|0|||
148895267|NCT00467740|537096208|FG000|Overall Study|Lost to Follow-up|0|||
148895268|NCT00467740|537096209|FG001|Overall Study|Lost to Follow-up|1|||
148895269|NCT00467740|537096210|FG002|Overall Study|Lost to Follow-up|0|||
148895270|NCT00467740|537096211|FG003|Overall Study|Lost to Follow-up|0|||
148895271|NCT00467740|537096212|FG004|Overall Study|Lost to Follow-up|0|||
148795730|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795731|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795732|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795733|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795734|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795735|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795736|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795737|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
148795738|NCT02326272|536730818|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795739|NCT02326272|536730819|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795740|NCT02326272|536730820|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
148795741|NCT02326272|536730821|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795742|NCT02326272|536730822|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795743|NCT02326272|536730823|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795744|NCT02326272|536730824|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795745|NCT02326272|536730825|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795746|NCT02326272|536730826|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795747|NCT02326272|536730827|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795748|NCT02326272|536730828|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148895272|NCT00467740|537096208|FG000|Overall Study|Withdrawal by Subject|1|||
148795749|NCT02326272|536730829|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795750|NCT02326272|536730830|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795751|NCT02326272|536730831|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795752|NCT02326272|536730832|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
148795753|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795754|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795755|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795756|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795757|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
148795758|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
148795759|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
148795760|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
148795761|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
148795762|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795763|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795764|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795765|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795766|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149011460|NCT02778399|537521470|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
148795767|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148795768|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795769|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795770|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795771|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795772|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795773|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
148795774|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
148795775|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795776|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
148795777|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
148795778|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795779|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795780|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795781|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148895273|NCT00467740|537096209|FG001|Overall Study|Withdrawal by Subject|1|||
148895274|NCT00467740|537096210|FG002|Overall Study|Withdrawal by Subject|0|||
148895275|NCT00467740|537096211|FG003|Overall Study|Withdrawal by Subject|1|||
148895276|NCT00467740|537096212|FG004|Overall Study|Withdrawal by Subject|0|||
148895277|NCT00467740|537096208|FG000|Overall Study|Lack of Efficacy|0|||
148895278|NCT00467740|537096209|FG001|Overall Study|Lack of Efficacy|1|||
148895279|NCT00467740|537096210|FG002|Overall Study|Lack of Efficacy|0|||
148895280|NCT00467740|537096211|FG003|Overall Study|Lack of Efficacy|0|||
148895281|NCT00467740|537096212|FG004|Overall Study|Lack of Efficacy|0|||
148895282|NCT00730158|537096213|FG000|Overall Study|Withdrawal by Subject|1|||
148895283|NCT00730158|537096214|FG001|Overall Study|Withdrawal by Subject|1|||
148895284|NCT04999839|537096215|FG000|Overall Study|Adverse Event|1|||
148895285|NCT04999839|537096216|FG001|Overall Study|Adverse Event|1|||
148895286|NCT04999839|537096217|FG002|Overall Study|Adverse Event|1|||
148895287|NCT04999839|537096218|FG003|Overall Study|Adverse Event|1|||
148895288|NCT04999839|537096219|FG004|Overall Study|Adverse Event|1|||
148895289|NCT04999839|537096215|FG000|Overall Study|Lost to Follow-up|2|||
148895290|NCT04999839|537096216|FG001|Overall Study|Lost to Follow-up|0|||
148895291|NCT04999839|537096217|FG002|Overall Study|Lost to Follow-up|2|||
148795782|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148795783|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795784|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795785|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795786|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795787|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795788|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
148795789|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795790|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
148795791|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795792|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795793|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795794|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795795|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795796|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795797|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148795798|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148895292|NCT04999839|537096218|FG003|Overall Study|Lost to Follow-up|4|||
148895293|NCT04999839|537096219|FG004|Overall Study|Lost to Follow-up|1|||
148895294|NCT04999839|537096215|FG000|Overall Study|Withdrawal by Subject|6|||
148895295|NCT04999839|537096216|FG001|Overall Study|Withdrawal by Subject|5|||
148895296|NCT04999839|537096217|FG002|Overall Study|Withdrawal by Subject|3|||
148895297|NCT04999839|537096218|FG003|Overall Study|Withdrawal by Subject|2|||
148895298|NCT04999839|537096219|FG004|Overall Study|Withdrawal by Subject|2|||
148895299|NCT04999839|537096215|FG000|Overall Study|Lack of Efficacy|0|||
148895300|NCT04999839|537096216|FG001|Overall Study|Lack of Efficacy|1|||
148895301|NCT04999839|537096217|FG002|Overall Study|Lack of Efficacy|0|||
148895302|NCT04999839|537096218|FG003|Overall Study|Lack of Efficacy|0|||
148895303|NCT04999839|537096219|FG004|Overall Study|Lack of Efficacy|0|||
148895304|NCT04999839|537096215|FG000|Overall Study|Physician Decision|0|||
148895305|NCT04999839|537096216|FG001|Overall Study|Physician Decision|0|||
148895306|NCT04999839|537096217|FG002|Overall Study|Physician Decision|0|||
148895307|NCT04999839|537096218|FG003|Overall Study|Physician Decision|0|||
148895308|NCT04999839|537096219|FG004|Overall Study|Physician Decision|1|||
148895309|NCT04999839|537096215|FG000|Overall Study|Sponsor request|0|||
148895310|NCT04999839|537096216|FG001|Overall Study|Sponsor request|1|||
148895311|NCT04999839|537096217|FG002|Overall Study|Sponsor request|0|||
148895312|NCT04999839|537096218|FG003|Overall Study|Sponsor request|0|||
148895313|NCT04999839|537096219|FG004|Overall Study|Sponsor request|0|||
148895314|NCT04999839|537096215|FG000|Overall Study|Other|0|||
148895315|NCT04999839|537096216|FG001|Overall Study|Other|0|||
148895316|NCT04999839|537096217|FG002|Overall Study|Other|1|||
148895317|NCT04999839|537096218|FG003|Overall Study|Other|0|||
148895318|NCT04999839|537096219|FG004|Overall Study|Other|0|||
148895319|NCT03740048|537096220|FG000|Overall Study|Withdrawal by Subject|1|||
148895320|NCT03740048|537096221|FG001|Overall Study|Withdrawal by Subject|1|||
148895321|NCT03740048|537096220|FG000|Overall Study|Death|1|||
148895322|NCT03740048|537096221|FG001|Overall Study|Death|6|||
148795799|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795800|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795801|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148795802|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795803|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
148795804|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148795805|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148795806|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795807|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148795808|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795809|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795810|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795811|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795812|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148795813|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
149011461|NCT02778399|537521471|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
148795814|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795815|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795816|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795817|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795818|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795819|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795820|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
148795821|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795822|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795823|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795824|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795825|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795826|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795827|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
148795828|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795829|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795830|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795831|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795832|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795833|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795834|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
148795835|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795836|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795837|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148895323|NCT03740048|537096220|FG000|Overall Study|Switched to thrice-weekly HD|2|||
148895324|NCT03740048|537096221|FG001|Overall Study|Switched to thrice-weekly HD|0|||
148895325|NCT03740048|537096220|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
148895326|NCT03740048|537096221|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
148895327|NCT03740048|537096220|FG000|Overall Study|Lost to Follow-up|0|||
148895328|NCT03740048|537096221|FG001|Overall Study|Lost to Follow-up|1|||
148895329|NCT03740048|537096220|FG000|Overall Study|Non-compliance with HD|0|||
148895330|NCT03740048|537096221|FG001|Overall Study|Non-compliance with HD|1|||
148895331|NCT01476722|537096223|FG000|Overall Study|Adverse Event|1|||
148895332|NCT00528957|537096224|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
148895333|NCT00528957|537096225|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
148895334|NCT00528957|537096224|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
148895335|NCT00528957|537096225|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
148895336|NCT00528957|537096224|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
148895337|NCT00528957|537096225|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
148895338|NCT00528957|537096224|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
148895339|NCT00528957|537096225|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
148895340|NCT00528957|537096224|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
148795838|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795839|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795840|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795841|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795842|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148795843|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795844|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795845|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795846|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795847|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795848|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795849|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795850|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795851|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
148795852|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795853|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795854|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795855|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795856|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148811199|NCT02313155|536787039|FG000|Overall Study|Lost to Follow-up|0|||
148811200|NCT02313155|536787040|FG001|Overall Study|Lost to Follow-up|1|||
148811201|NCT04666298|536787041|FG000|Overall Study|Subject decision|1|||
148811202|NCT04666298|536787042|FG001|Overall Study|Subject decision|0|||
148811203|NCT04666298|536787043|FG002|Overall Study|Subject decision|0|||
148811204|NCT04666298|536787044|FG003|Overall Study|Subject decision|2|||
148811205|NCT04666298|536787041|FG000|Overall Study|Death|1|||
148811206|NCT04666298|536787042|FG001|Overall Study|Death|0|||
148811207|NCT04666298|536787043|FG002|Overall Study|Death|0|||
148811208|NCT04666298|536787044|FG003|Overall Study|Death|0|||
148811209|NCT04666298|536787041|FG000|Overall Study|Lost to Follow-up|0|||
148811210|NCT04666298|536787042|FG001|Overall Study|Lost to Follow-up|0|||
148811211|NCT04666298|536787043|FG002|Overall Study|Lost to Follow-up|0|||
148811212|NCT04666298|536787044|FG003|Overall Study|Lost to Follow-up|1|||
148811213|NCT04666298|536787041|FG000|Overall Study|Physician Decision|0|||
148811214|NCT04666298|536787042|FG001|Overall Study|Physician Decision|0|||
148795857|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
148795858|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795859|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795860|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795861|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795862|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795863|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
148795864|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
148795865|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
148795866|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
148795867|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795868|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795869|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795870|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795871|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795872|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148795873|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795874|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795875|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795876|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795877|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795878|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
148795879|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795880|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795881|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795882|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795883|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795884|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795885|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795886|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795887|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
148795888|NCT02326272|536730818|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795889|NCT02326272|536730819|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795890|NCT02326272|536730820|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795891|NCT02326272|536730821|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795892|NCT02326272|536730822|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795893|NCT02326272|536730823|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795894|NCT02326272|536730824|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
148795895|NCT02326272|536730825|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795896|NCT02326272|536730826|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795897|NCT02326272|536730827|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795898|NCT02326272|536730828|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795899|NCT02326272|536730829|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795900|NCT02326272|536730830|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795901|NCT02326272|536730831|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795902|NCT02326272|536730832|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
148795903|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
148795904|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
148795905|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
148795906|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
148795907|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
148795908|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
148795909|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
148795910|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
148795911|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
148795912|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
148795913|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
148795914|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
148795915|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
148795916|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
148795917|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
148795918|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795919|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795920|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795921|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795922|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795923|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795924|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795925|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795926|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795927|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795928|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
148795929|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
148795930|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
148795931|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148795932|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
148795933|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795934|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795935|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795936|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795937|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148895341|NCT00528957|537096225|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
148895342|NCT00528957|537096224|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
148895343|NCT00528957|537096225|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
148895344|NCT00528957|537096224|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
148895345|NCT00528957|537096225|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
148895346|NCT00528957|537096224|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
148895347|NCT00528957|537096225|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
148895348|NCT00528957|537096224|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
148895349|NCT00528957|537096225|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
148895350|NCT00528957|537096224|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
148895351|NCT00528957|537096225|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
149135931|NCT02038920|537978587|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
149135932|NCT02038920|537978588|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
149135933|NCT02038920|537978589|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
149135934|NCT02038920|537978590|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
149135935|NCT02038920|537978591|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
149135936|NCT02038920|537978592|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
149135937|NCT02038920|537978587|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
149135938|NCT02038920|537978588|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
149135939|NCT02038920|537978589|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
149135940|NCT02038920|537978590|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
149135941|NCT02038920|537978591|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
149135942|NCT02038920|537978592|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
149135943|NCT02038920|537978587|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
149135944|NCT02038920|537978588|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
149135945|NCT02038920|537978589|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
149135946|NCT02038920|537978590|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
149135947|NCT02038920|537978591|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
149135948|NCT02038920|537978592|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
149135949|NCT02038920|537978587|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
149135950|NCT02038920|537978588|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
149135951|NCT02038920|537978589|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
149135952|NCT02038920|537978590|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
149135953|NCT02038920|537978591|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
149135954|NCT02038920|537978592|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
149135955|NCT02038920|537978587|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
149135956|NCT02038920|537978588|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
149135957|NCT02038920|537978589|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
149135958|NCT02038920|537978590|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
149135959|NCT02038920|537978591|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
149135960|NCT02038920|537978592|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
149135961|NCT02038920|537978587|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
149135962|NCT02038920|537978588|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
149135963|NCT02038920|537978589|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
149135964|NCT02038920|537978590|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
149135965|NCT02038920|537978591|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
149135966|NCT02038920|537978592|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
149135967|NCT02906787|537978593|FG000|Overall Study|Withdrawal by Subject|12|||
149135968|NCT02906787|537978594|FG001|Overall Study|Withdrawal by Subject|10|||
149135969|NCT02906787|537978593|FG000|Overall Study|Missed|24|||
149135970|NCT02906787|537978594|FG001|Overall Study|Missed|22|||
149135971|NCT04600336|537978597|FG000|Initial Treatment|Withdrawal by Subject|1|||
149135972|NCT04600336|537978598|FG001|Initial Treatment|Withdrawal by Subject|2|||
149135973|NCT04600336|537978599|FG002|Initial Treatment|Withdrawal by Subject|0|||
149135974|NCT04600336|537978600|FG003|Initial Treatment|Withdrawal by Subject|0|||
149135975|NCT04600336|537978597|FG000|Initial Treatment|Adverse Event|0|||
149135976|NCT04600336|537978598|FG001|Initial Treatment|Adverse Event|2|||
149135977|NCT04600336|537978599|FG002|Initial Treatment|Adverse Event|0|||
149135978|NCT04600336|537978600|FG003|Initial Treatment|Adverse Event|0|||
149135979|NCT04600336|537978597|FG000|Initial Treatment|Other complicating disease|0|||
149135980|NCT04600336|537978598|FG001|Initial Treatment|Other complicating disease|0|||
149135981|NCT04600336|537978599|FG002|Initial Treatment|Other complicating disease|1|||
148895352|NCT00528957|537096224|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
148795938|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795939|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795940|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795941|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795942|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795943|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
148795944|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795945|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
148795946|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148795947|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148895353|NCT00528957|537096225|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
148895354|NCT00528957|537096224|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
148895355|NCT00528957|537096225|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
148895356|NCT00528957|537096224|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
148895357|NCT00528957|537096225|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
148895358|NCT00528957|537096224|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
148895359|NCT00528957|537096225|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
148895360|NCT00528957|537096224|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
148895361|NCT00528957|537096225|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
148895362|NCT00528957|537096224|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
148895363|NCT00528957|537096225|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
148895364|NCT01323582|537096228|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
148895365|NCT01323582|537096229|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
148895366|NCT01323582|537096228|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
148895367|NCT01323582|537096229|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
148895368|NCT01323582|537096228|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
148895369|NCT01323582|537096229|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
148895370|NCT03353675|537096241|FG000|Overall Study|Adverse Event|4|||
148895371|NCT00880698|537096244|FG000|Overall Study|Death|0|||
148895372|NCT00880698|537096245|FG001|Overall Study|Death|0|||
148895373|NCT00880698|537096246|FG002|Overall Study|Death|1|||
148895374|NCT00880698|537096247|FG003|Overall Study|Death|2|||
148895375|NCT00880698|537096244|FG000|Overall Study|Lost to Follow-up|1|||
148895376|NCT00880698|537096245|FG001|Overall Study|Lost to Follow-up|3|||
148895377|NCT00880698|537096246|FG002|Overall Study|Lost to Follow-up|0|||
148895378|NCT00880698|537096247|FG003|Overall Study|Lost to Follow-up|1|||
148895379|NCT04972162|537096248|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
148895380|NCT04972162|537096249|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
148895381|NCT05546476|537098441|FG000|Period 1: Part A|Adverse Event|2|||
148895382|NCT05546476|537098442|FG001|Period 1: Part A|Adverse Event|0|||
148895383|NCT05546476|537098443|FG002|Period 1: Part A|Adverse Event|0|||
148895384|NCT05546476|537098444|FG003|Period 1: Part A|Adverse Event|1|||
148895385|NCT05546476|537098441|FG000|Period 1: Part A|Death|4|||
148895386|NCT05546476|537098442|FG001|Period 1: Part A|Death|4|||
148795948|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795949|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795950|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795951|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795952|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795953|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148811215|NCT04666298|536787043|FG002|Overall Study|Physician Decision|0|||
148795954|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795955|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795956|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795957|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795958|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795959|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
148795960|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795961|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795962|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148795963|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795964|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795965|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795966|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148811216|NCT04666298|536787044|FG003|Overall Study|Physician Decision|1|||
149135982|NCT04600336|537978600|FG003|Initial Treatment|Other complicating disease|0|||
149135983|NCT04600336|537978597|FG000|Crossover Treatment|Withdrawal by Subject|0|||
149135984|NCT04600336|537978598|FG001|Crossover Treatment|Withdrawal by Subject|0|||
149135985|NCT04600336|537978599|FG002|Crossover Treatment|Withdrawal by Subject|2|||
149135986|NCT04600336|537978600|FG003|Crossover Treatment|Withdrawal by Subject|1|||
149135987|NCT04600336|537978597|FG000|Crossover Treatment|Adverse Event|0|||
149135988|NCT04600336|537978598|FG001|Crossover Treatment|Adverse Event|0|||
149135989|NCT04600336|537978599|FG002|Crossover Treatment|Adverse Event|1|||
149135990|NCT04600336|537978600|FG003|Crossover Treatment|Adverse Event|1|||
149135991|NCT04225806|537978601|FG000|Overall Study|Trial termination|15|||
149135992|NCT04313153|537980311|FG000|Overall Study|Adverse Event (includes Death)|14|||
149135993|NCT04313153|537980312|FG001|Overall Study|Adverse Event (includes Death)|19|||
149135994|NCT04313153|537980313|FG002|Overall Study|Adverse Event (includes Death)|10|||
149135995|NCT04313153|537980311|FG000|Overall Study|Physician Decision|4|||
149135996|NCT04313153|537980312|FG001|Overall Study|Physician Decision|2|||
149135997|NCT04313153|537980313|FG002|Overall Study|Physician Decision|1|||
149135998|NCT04313153|537980311|FG000|Overall Study|Withdrawal by Subject|7|||
149135999|NCT04313153|537980312|FG001|Overall Study|Withdrawal by Subject|6|||
149136000|NCT04313153|537980313|FG002|Overall Study|Withdrawal by Subject|2|||
149136001|NCT04313153|537980311|FG000|Overall Study|Lack of Efficacy|3|||
149136002|NCT04313153|537980312|FG001|Overall Study|Lack of Efficacy|3|||
149136003|NCT04313153|537980313|FG002|Overall Study|Lack of Efficacy|0|||
149136004|NCT04313153|537980311|FG000|Overall Study|Lost to Follow-up|1|||
149136005|NCT04313153|537980312|FG001|Overall Study|Lost to Follow-up|0|||
149136006|NCT04313153|537980313|FG002|Overall Study|Lost to Follow-up|2|||
149136007|NCT04313153|537980311|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
149136008|NCT04313153|537980312|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
149136009|NCT04313153|537980313|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
149136010|NCT04313153|537980311|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
149136011|NCT04313153|537980312|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
149136012|NCT04313153|537980313|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
149136013|NCT04313153|537980311|FG000|Overall Study|Change in Dialysis Modality|0|||
149136014|NCT04313153|537980312|FG001|Overall Study|Change in Dialysis Modality|1|||
149136015|NCT04313153|537980313|FG002|Overall Study|Change in Dialysis Modality|2|||
149136016|NCT04313153|537980311|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
149136017|NCT04313153|537980312|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
149136018|NCT04313153|537980313|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
149136019|NCT04313153|537980311|FG000|Overall Study|Other|5|||
149136020|NCT04313153|537980312|FG001|Overall Study|Other|3|||
149136021|NCT04313153|537980313|FG002|Overall Study|Other|2|||
149136022|NCT00523718|537980314|FG000|Overall Study|Withdrawal by Subject|1|||
149136023|NCT00523718|537980315|FG001|Overall Study|Withdrawal by Subject|0|||
149136024|NCT00523718|537980314|FG000|Overall Study|Protocol Violation|2|||
149136025|NCT00523718|537980315|FG001|Overall Study|Protocol Violation|0|||
149136026|NCT02113579|537980318|FG000|Overall Study|Adverse Event|1|||
149136027|NCT02113579|537980319|FG001|Overall Study|Adverse Event|0|||
149136028|NCT02113579|537980318|FG000|Overall Study|Withdrawal by Subject|3|||
149136029|NCT02113579|537980319|FG001|Overall Study|Withdrawal by Subject|2|||
149136030|NCT02113579|537980318|FG000|Overall Study|Lost to Follow-up|6|||
149136031|NCT02113579|537980319|FG001|Overall Study|Lost to Follow-up|2|||
149136032|NCT01436071|537980320|FG000|Overall Study|Adverse Event|1|||
149136033|NCT01436071|537980321|FG001|Overall Study|Adverse Event|0|||
149136034|NCT01436071|537980320|FG000|Overall Study|Lack of Efficacy|16|||
148811217|NCT04666298|536787041|FG000|Overall Study|Protocol deviation|0|||
148795967|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795968|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795969|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795970|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795971|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795972|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795973|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
148795974|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795975|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
148795976|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148795977|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
148795978|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795979|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795980|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795981|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795982|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795983|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795984|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795985|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795986|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795987|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795988|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795989|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
148795990|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795991|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148795992|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
148795993|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148795994|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148795995|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148795996|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148795997|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148811218|NCT04666298|536787042|FG001|Overall Study|Protocol deviation|0|||
148811219|NCT04666298|536787043|FG002|Overall Study|Protocol deviation|1|||
148895387|NCT05546476|537098443|FG002|Period 1: Part A|Death|5|||
148895388|NCT05546476|537098444|FG003|Period 1: Part A|Death|6|||
148895389|NCT05546476|537098441|FG000|Period 1: Part A|Lack of Efficacy|0|||
148895390|NCT05546476|537098442|FG001|Period 1: Part A|Lack of Efficacy|0|||
148895391|NCT05546476|537098443|FG002|Period 1: Part A|Lack of Efficacy|0|||
148895392|NCT05546476|537098444|FG003|Period 1: Part A|Lack of Efficacy|1|||
148895393|NCT05546476|537098441|FG000|Period 1: Part A|Lost to Follow-up|0|||
148895394|NCT05546476|537098442|FG001|Period 1: Part A|Lost to Follow-up|0|||
148895395|NCT05546476|537098443|FG002|Period 1: Part A|Lost to Follow-up|0|||
148895396|NCT05546476|537098444|FG003|Period 1: Part A|Lost to Follow-up|1|||
148895397|NCT05546476|537098441|FG000|Period 1: Part A|Physician Decision|1|||
148895398|NCT05546476|537098442|FG001|Period 1: Part A|Physician Decision|0|||
148895399|NCT05546476|537098443|FG002|Period 1: Part A|Physician Decision|0|||
148895400|NCT05546476|537098444|FG003|Period 1: Part A|Physician Decision|0|||
148895401|NCT05546476|537098441|FG000|Period 1: Part A|Progressive disease|3|||
148895402|NCT05546476|537098442|FG001|Period 1: Part A|Progressive disease|5|||
148895403|NCT05546476|537098443|FG002|Period 1: Part A|Progressive disease|0|||
148895404|NCT05546476|537098444|FG003|Period 1: Part A|Progressive disease|1|||
148895405|NCT05546476|537098441|FG000|Period 1: Part A|Withdrawal by Subject|1|||
148795998|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148795999|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148895406|NCT05546476|537098442|FG001|Period 1: Part A|Withdrawal by Subject|1|||
148895407|NCT05546476|537098443|FG002|Period 1: Part A|Withdrawal by Subject|1|||
148895408|NCT05546476|537098444|FG003|Period 1: Part A|Withdrawal by Subject|2|||
148895409|NCT05546476|537098441|FG000|Period 1: Part A|Global deterioration of health status|2|||
148895410|NCT05546476|537098442|FG001|Period 1: Part A|Global deterioration of health status|2|||
148895411|NCT05546476|537098443|FG002|Period 1: Part A|Global deterioration of health status|1|||
148895412|NCT05546476|537098444|FG003|Period 1: Part A|Global deterioration of health status|4|||
148895413|NCT05546476|537098441|FG000|Period 1: Part A|Other: Unspecified|0|||
148895414|NCT05546476|537098442|FG001|Period 1: Part A|Other: Unspecified|2|||
148895415|NCT05546476|537098443|FG002|Period 1: Part A|Other: Unspecified|0|||
148895416|NCT05546476|537098444|FG003|Period 1: Part A|Other: Unspecified|0|||
148895417|NCT05546476|537098441|FG000|Period 2: Part B|Ongoing|26|||
148895418|NCT05546476|537098442|FG001|Period 2: Part B|Ongoing|27|||
148895419|NCT05546476|537098443|FG002|Period 2: Part B|Ongoing|35|||
148895420|NCT05546476|537098444|FG003|Period 2: Part B|Ongoing|29|||
148895421|NCT04890652|537098454|FG000|Overall Study|Withdrawal by Subject|2|||
148895422|NCT01706458|537098458|FG000|Overall Study|Physician Decision|3|||
148895423|NCT01706458|537098459|FG001|Overall Study|Physician Decision|4|||
148796000|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148796001|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148796002|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148796003|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148796004|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
148796005|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
148796006|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148796007|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
148796008|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796009|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796010|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796011|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796012|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796013|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796014|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796015|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796016|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796017|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796018|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796019|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
148796020|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796021|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796022|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
148796023|NCT02326272|536730818|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796024|NCT02326272|536730819|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796025|NCT02326272|536730820|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796026|NCT02326272|536730821|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796027|NCT02326272|536730822|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796028|NCT02326272|536730823|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796029|NCT02326272|536730824|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796030|NCT02326272|536730825|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796031|NCT02326272|536730826|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796032|NCT02326272|536730827|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796033|NCT02326272|536730828|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796034|NCT02326272|536730829|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796035|NCT02326272|536730830|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
148796036|NCT02326272|536730831|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796037|NCT02326272|536730832|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
148796038|NCT00737100|536730834|FG000|Overall Study|Adverse Event|6|||
148796039|NCT00737100|536730835|FG001|Overall Study|Adverse Event|5|||
148796040|NCT00737100|536730836|FG002|Overall Study|Adverse Event|3|||
148796041|NCT00737100|536730834|FG000|Overall Study|Lost to Follow-up|0|||
148796042|NCT00737100|536730835|FG001|Overall Study|Lost to Follow-up|1|||
148796043|NCT00737100|536730836|FG002|Overall Study|Lost to Follow-up|0|||
148796044|NCT00737100|536730834|FG000|Overall Study|Withdrawal by Subject|0|||
148796045|NCT00737100|536730835|FG001|Overall Study|Withdrawal by Subject|0|||
148796046|NCT00737100|536730836|FG002|Overall Study|Withdrawal by Subject|3|||
148796047|NCT00737100|536730834|FG000|Overall Study|Reason discontinued not explained above|1|||
148796048|NCT00737100|536730835|FG001|Overall Study|Reason discontinued not explained above|1|||
148796049|NCT00737100|536730836|FG002|Overall Study|Reason discontinued not explained above|1|||
148796050|NCT00735943|536730841|FG000|Overall Study|Lost to Follow-up|1|||
148796051|NCT00735943|536730841|FG000|Overall Study|Adverse Event|1|||
148796052|NCT00528424|536730844|FG000|Overall Study|Lost to Follow-up|13|||
148796053|NCT00528424|536730844|FG000|Overall Study|Withdrew consent|2|||
148796054|NCT00528424|536730844|FG000|Overall Study|Administrative reason|2|||
148796055|NCT00528424|536730844|FG000|Overall Study|Other|12|||
148796056|NCT03713684|536730845|FG000|Overall Study|Adverse Event|1|||
148796057|NCT03713684|536730846|FG001|Overall Study|Adverse Event|3|||
148796058|NCT03713684|536730847|FG002|Overall Study|Adverse Event|1|||
148796059|NCT03713684|536730848|FG003|Overall Study|Adverse Event|0|||
148796060|NCT03713684|536730845|FG000|Overall Study|Poor compliance to protocol|2|||
148796061|NCT03713684|536730846|FG001|Overall Study|Poor compliance to protocol|1|||
148796062|NCT03713684|536730847|FG002|Overall Study|Poor compliance to protocol|0|||
148796063|NCT03713684|536730848|FG003|Overall Study|Poor compliance to protocol|1|||
148796064|NCT03713684|536730845|FG000|Overall Study|Withdrawal by Subject|14|||
148796065|NCT03713684|536730846|FG001|Overall Study|Withdrawal by Subject|6|||
148796066|NCT03713684|536730847|FG002|Overall Study|Withdrawal by Subject|14|||
148796067|NCT03713684|536730848|FG003|Overall Study|Withdrawal by Subject|16|||
148796068|NCT03713684|536730845|FG000|Overall Study|Other than specified|69|||
148796069|NCT03713684|536730846|FG001|Overall Study|Other than specified|77|||
148796070|NCT03713684|536730847|FG002|Overall Study|Other than specified|73|||
148796071|NCT03713684|536730848|FG003|Overall Study|Other than specified|70|||
148796072|NCT02595502|536730851|FG000|Period 1|Adverse Event|0|||
148796073|NCT02595502|536730852|FG001|Period 1|Adverse Event|1|||
148796074|NCT02595502|536730851|FG000|Period 1|Withdrawal by Subject|1|||
148796075|NCT02595502|536730852|FG001|Period 1|Withdrawal by Subject|0|||
148796076|NCT02595502|536730851|FG000|Period 1|Lost to Follow-up|0|||
148796077|NCT02595502|536730852|FG001|Period 1|Lost to Follow-up|1|||
148796078|NCT02595502|536730851|FG000|Period 2|Adverse Event|1|||
148796079|NCT02595502|536730852|FG001|Period 2|Adverse Event|1|||
148796080|NCT02595502|536730851|FG000|Period 2|Received incorrect lens at Period 1|0|||
148796081|NCT02595502|536730852|FG001|Period 2|Received incorrect lens at Period 1|1|||
148796082|NCT02595502|536730851|FG000|Period 3|Protocol Violation|0|||
148796083|NCT02595502|536730852|FG001|Period 3|Protocol Violation|1|||
148796084|NCT02595502|536730851|FG000|Period 3|Lost to Follow-up|1|||
148796085|NCT02595502|536730852|FG001|Period 3|Lost to Follow-up|0|||
148796086|NCT02595502|536730851|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
148796087|NCT02595502|536730852|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
148796088|NCT00974311|536730853|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
148796089|NCT00974311|536730854|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
148796090|NCT00974311|536730853|FG000|DB Phase (up to 24 Months)|Death|561|||
148796091|NCT00974311|536730854|FG001|DB Phase (up to 24 Months)|Death|298|||
148796092|NCT00974311|536730853|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
148796093|NCT00974311|536730854|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
148811220|NCT04666298|536787044|FG003|Overall Study|Protocol deviation|0|||
148796094|NCT00974311|536730853|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
148796095|NCT00974311|536730854|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
148796096|NCT00974311|536730853|FG000|DB Phase (up to 24 Months)|Other|1|||
148796097|NCT00974311|536730854|FG001|DB Phase (up to 24 Months)|Other|0|||
148796098|NCT00974311|536730853|FG000|OLE Phase (up to 77 Months)|Death|14|||
148796099|NCT00974311|536730854|FG001|OLE Phase (up to 77 Months)|Death|21|||
148796100|NCT00974311|536730853|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
148796101|NCT00974311|536730854|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
148796102|NCT00974311|536730853|FG000|OLE Phase (up to 77 Months)|Other|15|||
148796103|NCT00974311|536730854|FG001|OLE Phase (up to 77 Months)|Other|2|||
148796104|NCT00974311|536730853|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
148796105|NCT00974311|536730854|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
148796106|NCT03131167|536730855|FG000|Overall Study|Other (Unspecified)|0|||
148796107|NCT03131167|536730856|FG001|Overall Study|Other (Unspecified)|0|||
148796108|NCT03131167|536730857|FG002|Overall Study|Other (Unspecified)|0|||
148796109|NCT03131167|536730858|FG003|Overall Study|Other (Unspecified)|0|||
148796110|NCT03131167|536730859|FG004|Overall Study|Other (Unspecified)|0|||
148796111|NCT03131167|536730860|FG005|Overall Study|Other (Unspecified)|1|||
148796112|NCT03131167|536730861|FG006|Overall Study|Other (Unspecified)|0|||
148796113|NCT03131167|536730862|FG007|Overall Study|Other (Unspecified)|0|||
148796114|NCT03131167|536730863|FG008|Overall Study|Other (Unspecified)|0|||
148796115|NCT03131167|536730864|FG009|Overall Study|Other (Unspecified)|0|||
148796116|NCT03131167|536730865|FG010|Overall Study|Other (Unspecified)|0|||
148796117|NCT03131167|536730866|FG011|Overall Study|Other (Unspecified)|0|||
148796118|NCT03131167|536730867|FG012|Overall Study|Other (Unspecified)|0|||
148796119|NCT03286218|536730868|FG000|Qualification Phase Period 1|Adverse Event|1|||
148796120|NCT03286218|536730869|FG001|Qualification Phase Period 1|Adverse Event|0|||
148796121|NCT03286218|536730870|FG002|Qualification Phase Period 1|Adverse Event|0|||
148796122|NCT03286218|536730871|FG003|Qualification Phase Period 1|Adverse Event|0|||
148796123|NCT03286218|536730872|FG004|Qualification Phase Period 1|Adverse Event|0|||
148796124|NCT03286218|536730873|FG005|Qualification Phase Period 1|Adverse Event|0|||
148796125|NCT03286218|536730874|FG006|Qualification Phase Period 1|Adverse Event|0|||
148796126|NCT03286218|536730875|FG007|Qualification Phase Period 1|Adverse Event|0|||
148796127|NCT03286218|536730876|FG008|Qualification Phase Period 1|Adverse Event|0|||
148796128|NCT03286218|536730877|FG009|Qualification Phase Period 1|Adverse Event|0|||
148796129|NCT03286218|536730878|FG010|Qualification Phase Period 1|Adverse Event|0|||
148796130|NCT03286218|536730879|FG011|Qualification Phase Period 1|Adverse Event|0|||
148796131|NCT03286218|536730868|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796132|NCT03286218|536730869|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
148796133|NCT03286218|536730870|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796134|NCT03286218|536730871|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796135|NCT03286218|536730872|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796136|NCT03286218|536730873|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796137|NCT03286218|536730874|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796138|NCT03286218|536730875|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796139|NCT03286218|536730876|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796140|NCT03286218|536730877|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796141|NCT03286218|536730878|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796142|NCT03286218|536730879|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
148796143|NCT03286218|536730868|FG000|Qualification Phase Period 2|Adverse Event|0|||
148796144|NCT03286218|536730869|FG001|Qualification Phase Period 2|Adverse Event|1|||
148796145|NCT03286218|536730870|FG002|Qualification Phase Period 2|Adverse Event|0|||
148796146|NCT03286218|536730871|FG003|Qualification Phase Period 2|Adverse Event|0|||
148796147|NCT03286218|536730872|FG004|Qualification Phase Period 2|Adverse Event|0|||
148796148|NCT03286218|536730873|FG005|Qualification Phase Period 2|Adverse Event|0|||
148796149|NCT03286218|536730874|FG006|Qualification Phase Period 2|Adverse Event|0|||
148796150|NCT03286218|536730875|FG007|Qualification Phase Period 2|Adverse Event|0|||
148796151|NCT03286218|536730876|FG008|Qualification Phase Period 2|Adverse Event|0|||
148796152|NCT03286218|536730877|FG009|Qualification Phase Period 2|Adverse Event|0|||
148796153|NCT03286218|536730878|FG010|Qualification Phase Period 2|Adverse Event|0|||
148796154|NCT03286218|536730879|FG011|Qualification Phase Period 2|Adverse Event|0|||
148796155|NCT03286218|536730868|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
148796156|NCT03286218|536730869|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
148796157|NCT03286218|536730870|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796158|NCT03286218|536730871|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796159|NCT03286218|536730872|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796160|NCT03286218|536730873|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796161|NCT03286218|536730874|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148895424|NCT03192176|537098465|FG000|Overall Study|Adverse Event|1|||
148895425|NCT03192176|537098466|FG001|Overall Study|Adverse Event|0|||
148796162|NCT03286218|536730875|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796163|NCT03286218|536730876|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796164|NCT03286218|536730877|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796165|NCT03286218|536730878|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796166|NCT03286218|536730879|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
148796167|NCT03286218|536730868|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
148796168|NCT03286218|536730869|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
148796169|NCT03286218|536730870|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
148796170|NCT03286218|536730871|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
148796171|NCT03286218|536730872|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
148796172|NCT03286218|536730873|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
148796173|NCT03286218|536730874|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
148796174|NCT03286218|536730875|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
148796175|NCT03286218|536730876|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
148796176|NCT03286218|536730877|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
148796177|NCT03286218|536730878|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
148796178|NCT03286218|536730879|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
148796179|NCT03286218|536730868|FG000|Qualification Phase Period 2|Protocol Violation|2|||
148796180|NCT03286218|536730869|FG001|Qualification Phase Period 2|Protocol Violation|0|||
148796181|NCT03286218|536730870|FG002|Qualification Phase Period 2|Protocol Violation|0|||
148796182|NCT03286218|536730871|FG003|Qualification Phase Period 2|Protocol Violation|0|||
148796183|NCT03286218|536730872|FG004|Qualification Phase Period 2|Protocol Violation|0|||
148796184|NCT03286218|536730873|FG005|Qualification Phase Period 2|Protocol Violation|0|||
148796185|NCT03286218|536730874|FG006|Qualification Phase Period 2|Protocol Violation|0|||
148796186|NCT03286218|536730875|FG007|Qualification Phase Period 2|Protocol Violation|0|||
148796187|NCT03286218|536730876|FG008|Qualification Phase Period 2|Protocol Violation|0|||
148796188|NCT03286218|536730877|FG009|Qualification Phase Period 2|Protocol Violation|0|||
148796189|NCT03286218|536730878|FG010|Qualification Phase Period 2|Protocol Violation|0|||
148796190|NCT03286218|536730879|FG011|Qualification Phase Period 2|Protocol Violation|0|||
148796191|NCT03286218|536730868|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
148796192|NCT03286218|536730869|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
148796193|NCT03286218|536730870|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796194|NCT03286218|536730871|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796195|NCT03286218|536730872|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796196|NCT03286218|536730873|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796197|NCT03286218|536730874|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796198|NCT03286218|536730875|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796199|NCT03286218|536730876|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796200|NCT03286218|536730877|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796201|NCT03286218|536730878|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796202|NCT03286218|536730879|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
148796203|NCT03286218|536730868|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796204|NCT03286218|536730869|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796205|NCT03286218|536730870|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
148796206|NCT03286218|536730871|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
148796207|NCT03286218|536730872|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796208|NCT03286218|536730873|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
148796209|NCT03286218|536730874|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796210|NCT03286218|536730875|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796211|NCT03286218|536730876|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796212|NCT03286218|536730877|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
148796213|NCT03286218|536730878|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
148895426|NCT03192176|537098467|FG002|Overall Study|Adverse Event|4|||
148796214|NCT03286218|536730879|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
148796215|NCT03286218|536730868|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796216|NCT03286218|536730869|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796217|NCT03286218|536730870|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796218|NCT03286218|536730871|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796219|NCT03286218|536730872|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796220|NCT03286218|536730873|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796221|NCT03286218|536730874|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796222|NCT03286218|536730875|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796223|NCT03286218|536730876|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796224|NCT03286218|536730877|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796225|NCT03286218|536730878|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
148796226|NCT03286218|536730879|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
148796227|NCT00458003|536730880|FG000|Overall Study|Non protocol spinal anesthesia|1|||
148796228|NCT00458003|536730881|FG001|Overall Study|Non protocol spinal anesthesia|1|||
148796229|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Death|20|||
148796230|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Death|26|||
148796231|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
148796232|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
148796233|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
148796234|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
148796235|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
148796236|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
148796237|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
148796238|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
148796239|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
148796240|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
148796241|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
148796242|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
148796243|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
148796244|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
148796245|NCT00643201|536730884|FG000|Randomized, Completed 6 Months of Study|Other|107|||
148796246|NCT00643201|536730885|FG001|Randomized, Completed 6 Months of Study|Other|107|||
148691436|NCT01325207|536344180|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
148691437|NCT01325207|536344181|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
148796247|NCT00643201|536730884|FG000|Completed Study Follow Up|Death|28|||
149136035|NCT01436071|537980321|FG001|Overall Study|Lack of Efficacy|7|||
149136036|NCT01436071|537980320|FG000|Overall Study|Protocol Violation|0|||
149136037|NCT01436071|537980321|FG001|Overall Study|Protocol Violation|1|||
149136038|NCT01436071|537980320|FG000|Overall Study|Lost to Follow-up|3|||
149136039|NCT01436071|537980321|FG001|Overall Study|Lost to Follow-up|1|||
149136040|NCT01436071|537980320|FG000|Overall Study|Physician Decision|1|||
149136041|NCT01436071|537980321|FG001|Overall Study|Physician Decision|0|||
149136042|NCT01436071|537980320|FG000|Overall Study|Withdrawal by Subject|2|||
149136043|NCT01436071|537980321|FG001|Overall Study|Withdrawal by Subject|2|||
149136044|NCT01436071|537980320|FG000|Overall Study|Did Not Receive Trial Medication|3|||
149136045|NCT01436071|537980321|FG001|Overall Study|Did Not Receive Trial Medication|3|||
149136046|NCT00726622|537980324|FG000|Overall Study|Withdrawal by Subject|16|||
149136047|NCT00726622|537980325|FG001|Overall Study|Withdrawal by Subject|2|||
149136048|NCT00726622|537980324|FG000|Overall Study|Physician Decision|0|||
149136049|NCT00726622|537980325|FG001|Overall Study|Physician Decision|1|||
149136050|NCT00726622|537980324|FG000|Overall Study|Metastasis|2|||
149136051|NCT00726622|537980325|FG001|Overall Study|Metastasis|0|||
149136052|NCT03335163|537980329|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
149136053|NCT03335163|537980329|FG000|Overall Study|Withdrawal by Subject|18|||
149136054|NCT03873493|537980332|FG000|Overall Study|Withdrawal by Subject|1|||
149136055|NCT03873493|537980332|FG000|Overall Study|Death|9|||
149136056|NCT03873493|537980332|FG000|Overall Study|Lost to Follow-up|1|||
149136057|NCT03873493|537980332|FG000|Overall Study|Study Terminated by Sponsor|1|||
149136058|NCT03873493|537980332|FG000|Overall Study|Other|2|||
149136059|NCT00702845|537980334|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
149136060|NCT00702845|537980335|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
149136061|NCT00702845|537980334|FG000|Overall Study|Too high ovarian response|5|||
149136062|NCT00702845|537980335|FG001|Overall Study|Too high ovarian response|1|||
149136063|NCT00702845|537980334|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
149136064|NCT00702845|537980335|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
149136065|NCT00702845|537980334|FG000|Overall Study|Insufficient ovarian response|1|||
149136066|NCT00702845|537980335|FG001|Overall Study|Insufficient ovarian response|0|||
149136067|NCT00702845|537980334|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
149136068|NCT00702845|537980335|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
149136069|NCT00702845|537980334|FG000|Overall Study|No or abnormal fertilization|4|||
149136070|NCT00702845|537980335|FG001|Overall Study|No or abnormal fertilization|2|||
149136071|NCT00702845|537980334|FG000|Overall Study|Patient's decision|2|||
149136072|NCT00702845|537980335|FG001|Overall Study|Patient's decision|1|||
149136073|NCT00702845|537980334|FG000|Overall Study|Not randomized|0|||
149136074|NCT00702845|537980335|FG001|Overall Study|Not randomized|1|||
149136075|NCT01448213|537980339|FG000|Overall Study|Lost to Follow-up|12|||
149136076|NCT01448213|537980340|FG001|Overall Study|Lost to Follow-up|10|||
149136077|NCT01448213|537980339|FG000|Overall Study|Adverse Event|4|||
149136078|NCT01448213|537980340|FG001|Overall Study|Adverse Event|10|||
149136079|NCT01448213|537980339|FG000|Overall Study|Protocol Violation|1|||
149136080|NCT01448213|537980340|FG001|Overall Study|Protocol Violation|2|||
149136081|NCT04606771|537980345|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
149136082|NCT04606771|537980346|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
149136083|NCT04606771|537980345|FG000|Overall Study|Death|5|||
149136084|NCT04606771|537980346|FG001|Overall Study|Death|6|||
149136085|NCT04606771|537980345|FG000|Overall Study|Wrong randomisation|0|||
148895427|NCT03192176|537098468|FG003|Overall Study|Adverse Event|5|||
148895428|NCT03192176|537098469|FG004|Overall Study|Adverse Event|3|||
148895429|NCT03192176|537098470|FG005|Overall Study|Adverse Event|2|||
148796248|NCT00643201|536730885|FG001|Completed Study Follow Up|Death|34|||
148796249|NCT00643201|536730884|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
148796250|NCT00643201|536730885|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
148796251|NCT00643201|536730884|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
148796252|NCT00643201|536730885|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
148796253|NCT00643201|536730884|FG000|Completed Study Follow Up|non-specified|1|||
148796254|NCT00643201|536730885|FG001|Completed Study Follow Up|non-specified|0|||
148895430|NCT03192176|537098471|FG006|Overall Study|Adverse Event|3|||
149136086|NCT04606771|537980346|FG001|Overall Study|Wrong randomisation|1|||
149136087|NCT00733304|537980351|FG000|Overall Study|Adverse Event|3|||
149136088|NCT00733304|537980352|FG001|Overall Study|Adverse Event|0|||
149136089|NCT00733304|537980353|FG002|Overall Study|Adverse Event|0|||
149136090|NCT00733304|537980351|FG000|Overall Study|Lack of Efficacy|0|||
149136091|NCT00733304|537980352|FG001|Overall Study|Lack of Efficacy|0|||
149136092|NCT00733304|537980353|FG002|Overall Study|Lack of Efficacy|2|||
149136093|NCT00733304|537980351|FG000|Overall Study|Lost to Follow-up|0|||
149136094|NCT00733304|537980352|FG001|Overall Study|Lost to Follow-up|1|||
149136095|NCT00733304|537980353|FG002|Overall Study|Lost to Follow-up|0|||
149136096|NCT00733304|537980351|FG000|Overall Study|Physician Decision|3|||
149136097|NCT00733304|537980352|FG001|Overall Study|Physician Decision|1|||
149136098|NCT00733304|537980353|FG002|Overall Study|Physician Decision|3|||
149136099|NCT00733304|537980351|FG000|Overall Study|Withdrawal by Subject|1|||
149136100|NCT00733304|537980352|FG001|Overall Study|Withdrawal by Subject|1|||
149136101|NCT00733304|537980353|FG002|Overall Study|Withdrawal by Subject|0|||
149136102|NCT01187550|537980354|FG000|Overall Study|Protocol Violation|3|||
149136103|NCT01187550|537980355|FG001|Overall Study|Protocol Violation|1|||
149136104|NCT01187550|537980354|FG000|Overall Study|Other|3|||
149136105|NCT01187550|537980355|FG001|Overall Study|Other|0|||
149136106|NCT01187550|537980354|FG000|Overall Study|Randomized but not treated|8|||
149136107|NCT01187550|537980355|FG001|Overall Study|Randomized but not treated|0|||
149136108|NCT00129623|537980356|FG000|Overall Study|Adverse Event|3|||
149136109|NCT00129623|537980357|FG001|Overall Study|Adverse Event|7|||
149136110|NCT00129623|537980356|FG000|Overall Study|Refused Treatment|5|||
149136111|NCT00129623|537980357|FG001|Overall Study|Refused Treatment|3|||
149136112|NCT00129623|537980356|FG000|Overall Study|Failure to Return|1|||
149136113|NCT00129623|537980357|FG001|Overall Study|Failure to Return|1|||
149136114|NCT00129623|537980356|FG000|Overall Study|Relocated job out of state|1|||
149136115|NCT00129623|537980357|FG001|Overall Study|Relocated job out of state|0|||
149136116|NCT00129623|537980356|FG000|Overall Study|Uncertainty to return|0|||
149136117|NCT00129623|537980357|FG001|Overall Study|Uncertainty to return|1|||
149136118|NCT02445755|537980358|FG000|Overall Study|Withdrawal by Subject|2|||
149136119|NCT02445755|537980358|FG000|Overall Study|Protocol Violation|6|||
149136120|NCT02445755|537980358|FG000|Overall Study|Screen Failure|5|||
149136121|NCT03189862|537980359|FG000|Overall Study|Withdrawal by Subject|1|||
149136122|NCT03189862|537980360|FG001|Overall Study|Withdrawal by Subject|0|||
149136123|NCT03189862|537980359|FG000|Overall Study|Lost to Follow-up|54|||
149136124|NCT03189862|537980360|FG001|Overall Study|Lost to Follow-up|62|||
149136125|NCT03974334|537980362|FG000|Overall Study|Lost to Follow-up|1|||
149136126|NCT01109173|537980363|FG000|Overall Study|Adverse Event|15|||
149136127|NCT01109173|537980364|FG001|Overall Study|Adverse Event|17|||
149136128|NCT01109173|537980365|FG002|Overall Study|Adverse Event|9|||
149136129|NCT01109173|537980366|FG003|Overall Study|Adverse Event|6|||
149136130|NCT01109173|537980363|FG000|Overall Study|Lost to Follow-up|0|||
149136131|NCT01109173|537980364|FG001|Overall Study|Lost to Follow-up|1|||
149136132|NCT01109173|537980365|FG002|Overall Study|Lost to Follow-up|0|||
149136133|NCT01109173|537980366|FG003|Overall Study|Lost to Follow-up|0|||
149136134|NCT01109173|537980363|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
149136135|NCT01109173|537980364|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
149136136|NCT01109173|537980365|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
149136137|NCT01109173|537980366|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
148895431|NCT03192176|537098472|FG007|Overall Study|Adverse Event|3|||
148895432|NCT03192176|537098465|FG000|Overall Study|Lost to Follow-up|0|||
148895433|NCT03192176|537098466|FG001|Overall Study|Lost to Follow-up|0|||
148895434|NCT03192176|537098467|FG002|Overall Study|Lost to Follow-up|1|||
148895435|NCT03192176|537098468|FG003|Overall Study|Lost to Follow-up|2|||
148895436|NCT03192176|537098469|FG004|Overall Study|Lost to Follow-up|3|||
148895437|NCT03192176|537098470|FG005|Overall Study|Lost to Follow-up|1|||
148895438|NCT03192176|537098471|FG006|Overall Study|Lost to Follow-up|1|||
148895439|NCT03192176|537098472|FG007|Overall Study|Lost to Follow-up|1|||
148895440|NCT03192176|537098465|FG000|Overall Study|Physician Decision|1|||
148895441|NCT03192176|537098466|FG001|Overall Study|Physician Decision|0|||
148895442|NCT03192176|537098467|FG002|Overall Study|Physician Decision|0|||
148895443|NCT03192176|537098468|FG003|Overall Study|Physician Decision|0|||
148895444|NCT03192176|537098469|FG004|Overall Study|Physician Decision|0|||
148895445|NCT03192176|537098470|FG005|Overall Study|Physician Decision|2|||
148895446|NCT03192176|537098471|FG006|Overall Study|Physician Decision|1|||
148895447|NCT03192176|537098472|FG007|Overall Study|Physician Decision|0|||
148895448|NCT03192176|537098465|FG000|Overall Study|Protocol Deviation|1|||
148895449|NCT03192176|537098466|FG001|Overall Study|Protocol Deviation|1|||
148895450|NCT03192176|537098467|FG002|Overall Study|Protocol Deviation|0|||
148895451|NCT03192176|537098468|FG003|Overall Study|Protocol Deviation|0|||
148895452|NCT03192176|537098469|FG004|Overall Study|Protocol Deviation|2|||
148895453|NCT03192176|537098470|FG005|Overall Study|Protocol Deviation|0|||
148895454|NCT03192176|537098471|FG006|Overall Study|Protocol Deviation|0|||
148895455|NCT03192176|537098472|FG007|Overall Study|Protocol Deviation|0|||
148895456|NCT03192176|537098465|FG000|Overall Study|Withdrawal by Subject|3|||
148895457|NCT03192176|537098466|FG001|Overall Study|Withdrawal by Subject|4|||
148895458|NCT03192176|537098467|FG002|Overall Study|Withdrawal by Subject|0|||
148895459|NCT03192176|537098468|FG003|Overall Study|Withdrawal by Subject|4|||
148895460|NCT03192176|537098469|FG004|Overall Study|Withdrawal by Subject|3|||
149136138|NCT01109173|537980363|FG000|Overall Study|Noncompliance|0|||
149136139|NCT01109173|537980364|FG001|Overall Study|Noncompliance|1|||
149136140|NCT01109173|537980365|FG002|Overall Study|Noncompliance|0|||
149136141|NCT01109173|537980366|FG003|Overall Study|Noncompliance|0|||
149136142|NCT01109173|537980363|FG000|Overall Study|Treatment Failure|25|||
149136143|NCT01109173|537980364|FG001|Overall Study|Treatment Failure|32|||
149136144|NCT01109173|537980365|FG002|Overall Study|Treatment Failure|69|||
149136145|NCT01109173|537980366|FG003|Overall Study|Treatment Failure|64|||
149136146|NCT01109173|537980363|FG000|Overall Study|Protocol Violation|4|||
149136147|NCT01109173|537980364|FG001|Overall Study|Protocol Violation|5|||
149136148|NCT01109173|537980365|FG002|Overall Study|Protocol Violation|1|||
149136149|NCT01109173|537980366|FG003|Overall Study|Protocol Violation|2|||
149136150|NCT01109173|537980363|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
149136151|NCT01109173|537980364|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
149136152|NCT01109173|537980365|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
149136153|NCT01109173|537980366|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
149136154|NCT01109173|537980363|FG000|Overall Study|Not Specifiied|5|||
149136155|NCT01109173|537980364|FG001|Overall Study|Not Specifiied|4|||
149136156|NCT01109173|537980365|FG002|Overall Study|Not Specifiied|9|||
149136157|NCT01109173|537980366|FG003|Overall Study|Not Specifiied|14|||
149136158|NCT02252536|537980367|FG000|Overall Study|Lost to Follow-up|5|||
149136159|NCT02252536|537980368|FG001|Overall Study|Lost to Follow-up|3|||
149136160|NCT01438151|537980369|FG000|Overall Study|study terminated|8|||
149136161|NCT00006392|537980376|FG000|Overall Study|Ineligible|11|||
149136162|NCT00006392|537980377|FG001|Overall Study|Ineligible|3|||
149136163|NCT00006392|537980378|FG002|Overall Study|Ineligible|5|||
148796255|NCT01278342|536730888|FG000|Overall Study|Physician Decision|0|||
148796256|NCT01278342|536730889|FG001|Overall Study|Physician Decision|1|||
148796257|NCT01278342|536730890|FG002|Overall Study|Physician Decision|0|||
148796258|NCT01278342|536730888|FG000|Overall Study|Lost to Follow-up|1|||
148796259|NCT01278342|536730889|FG001|Overall Study|Lost to Follow-up|0|||
148796260|NCT01278342|536730890|FG002|Overall Study|Lost to Follow-up|0|||
148796261|NCT01278342|536730888|FG000|Overall Study|Administrative problems|2|||
148796262|NCT01278342|536730889|FG001|Overall Study|Administrative problems|0|||
148796263|NCT01278342|536730890|FG002|Overall Study|Administrative problems|0|||
148796264|NCT01278342|536730888|FG000|Overall Study|Other|1|||
148796265|NCT01278342|536730889|FG001|Overall Study|Other|0|||
148796266|NCT01278342|536730890|FG002|Overall Study|Other|0|||
148796267|NCT03933449|536730898|FG000|Overall Study|Adverse Event|6|||
148796268|NCT03933449|536730899|FG001|Overall Study|Adverse Event|4|||
148796269|NCT03933449|536730898|FG000|Overall Study|Death|55|||
148796270|NCT03933449|536730899|FG001|Overall Study|Death|57|||
148796271|NCT03933449|536730898|FG000|Overall Study|Sponsor Decision|1|||
148796272|NCT03933449|536730899|FG001|Overall Study|Sponsor Decision|0|||
148796273|NCT04742673|536730903|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
148796274|NCT04742673|536730904|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
148796275|NCT04073303|536730906|FG000|Overall Study|Adverse Event|0|||
148796276|NCT04073303|536730907|FG001|Overall Study|Adverse Event|2|||
148796277|NCT04073303|536730906|FG000|Overall Study|Withdrawal by Subject|16|||
148796278|NCT04073303|536730907|FG001|Overall Study|Withdrawal by Subject|36|||
148796279|NCT04073303|536730906|FG000|Overall Study|Lost to Follow-up|6|||
148796280|NCT04073303|536730907|FG001|Overall Study|Lost to Follow-up|1|||
148796281|NCT04073303|536730906|FG000|Overall Study|Protocol Deviation|0|||
148796282|NCT04073303|536730907|FG001|Overall Study|Protocol Deviation|4|||
148796283|NCT04073303|536730906|FG000|Overall Study|Other|1|||
148796284|NCT04073303|536730907|FG001|Overall Study|Other|1|||
148796285|NCT01158261|536730913|FG000|Overall Study|Lost to Follow-up|9|||
148796286|NCT01158261|536730913|FG000|Overall Study|Death|7|||
148796287|NCT01158261|536730913|FG000|Overall Study|Withdrawal by Subject|1|||
148796288|NCT02899065|536730914|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
148796289|NCT02899065|536730915|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
148796290|NCT02899065|536730914|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
148796291|NCT02899065|536730915|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
148796292|NCT02899065|536730914|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
148796293|NCT02899065|536730915|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
148796294|NCT00971867|536730916|FG000|Overall Study|Adverse Event|4|||
148796295|NCT00971867|536730916|FG000|Overall Study|Participant Withdrew Consent|1|||
148796296|NCT00971867|536730916|FG000|Overall Study|Disease Progression|6|||
148796297|NCT02983045|536730918|FG000|Overall Study|Withdrawal by Subject|0|||
148796298|NCT02983045|536730919|FG001|Overall Study|Withdrawal by Subject|1|||
148796299|NCT02983045|536730920|FG002|Overall Study|Withdrawal by Subject|0|||
148796300|NCT02983045|536730921|FG003|Overall Study|Withdrawal by Subject|5|||
148796301|NCT02983045|536730922|FG004|Overall Study|Withdrawal by Subject|0|||
148796302|NCT02983045|536730923|FG005|Overall Study|Withdrawal by Subject|72|||
148796303|NCT02983045|536730924|FG006|Overall Study|Withdrawal by Subject|0|||
149136164|NCT00006392|537980379|FG003|Overall Study|Ineligible|5|||
149136165|NCT00006392|537980376|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
149136166|NCT00006392|537980377|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
149136167|NCT00006392|537980378|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
149136168|NCT00006392|537980379|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
149136169|NCT02459769|537980380|FG000|Overall Study|Withdrawal by Subject|7|||
149136170|NCT02459769|537980381|FG001|Overall Study|Withdrawal by Subject|4|||
149136171|NCT02459769|537980382|FG002|Overall Study|Withdrawal by Subject|8|||
149136172|NCT02459769|537980383|FG003|Overall Study|Withdrawal by Subject|5|||
149136173|NCT02459769|537980380|FG000|Overall Study|Lost to Follow-up|1|||
149136174|NCT02459769|537980381|FG001|Overall Study|Lost to Follow-up|0|||
149136175|NCT02459769|537980382|FG002|Overall Study|Lost to Follow-up|1|||
149136176|NCT02459769|537980383|FG003|Overall Study|Lost to Follow-up|0|||
149136177|NCT00312221|537980384|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
149136178|NCT00312221|537980385|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
149136179|NCT00312221|537980386|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
149136180|NCT00312221|537980387|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
149136181|NCT00312221|537980384|FG000|Open-label Run-in Period|Adverse Event|74|||
149136182|NCT00312221|537980385|FG001|Open-label Run-in Period|Adverse Event|0|||
149136183|NCT00312221|537980386|FG002|Open-label Run-in Period|Adverse Event|0|||
149136184|NCT00312221|537980387|FG003|Open-label Run-in Period|Adverse Event|0|||
149136185|NCT00312221|537980384|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
149136186|NCT00312221|537980385|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
149136187|NCT00312221|537980386|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
149136188|NCT00312221|537980387|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
149136189|NCT00312221|537980384|FG000|Open-label Run-in Period|Administrative|42|||
149136190|NCT00312221|537980385|FG001|Open-label Run-in Period|Administrative|0|||
149136191|NCT00312221|537980386|FG002|Open-label Run-in Period|Administrative|0|||
149136192|NCT00312221|537980387|FG003|Open-label Run-in Period|Administrative|0|||
149136193|NCT00312221|537980384|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
149136194|NCT00312221|537980385|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
149136195|NCT00312221|537980386|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
149136196|NCT00312221|537980387|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
149136197|NCT00312221|537980384|FG000|Open-label Run-in Period|Did not qualify|5|||
149136198|NCT00312221|537980385|FG001|Open-label Run-in Period|Did not qualify|0|||
149136199|NCT00312221|537980386|FG002|Open-label Run-in Period|Did not qualify|0|||
149136200|NCT00312221|537980387|FG003|Open-label Run-in Period|Did not qualify|0|||
149136201|NCT00312221|537980384|FG000|Double-blind Phase|Withdrawal by Subject|0|||
149136202|NCT00312221|537980385|FG001|Double-blind Phase|Withdrawal by Subject|6|||
149136203|NCT00312221|537980386|FG002|Double-blind Phase|Withdrawal by Subject|8|||
149136204|NCT00312221|537980387|FG003|Double-blind Phase|Withdrawal by Subject|7|||
149136205|NCT00312221|537980384|FG000|Double-blind Phase|Adverse Event|0|||
149136206|NCT00312221|537980385|FG001|Double-blind Phase|Adverse Event|10|||
149136207|NCT00312221|537980386|FG002|Double-blind Phase|Adverse Event|19|||
149136208|NCT00312221|537980387|FG003|Double-blind Phase|Adverse Event|18|||
149136209|NCT00312221|537980384|FG000|Double-blind Phase|Lost to Follow-up|0|||
149136210|NCT00312221|537980385|FG001|Double-blind Phase|Lost to Follow-up|0|||
149136211|NCT00312221|537980386|FG002|Double-blind Phase|Lost to Follow-up|2|||
149136212|NCT00312221|537980387|FG003|Double-blind Phase|Lost to Follow-up|2|||
149136213|NCT00312221|537980384|FG000|Double-blind Phase|Administrative|0|||
149136214|NCT00312221|537980385|FG001|Double-blind Phase|Administrative|26|||
149136215|NCT00312221|537980386|FG002|Double-blind Phase|Administrative|37|||
149136216|NCT00312221|537980387|FG003|Double-blind Phase|Administrative|33|||
149136217|NCT00312221|537980384|FG000|Double-blind Phase|Lack of Efficacy|0|||
149136218|NCT00312221|537980385|FG001|Double-blind Phase|Lack of Efficacy|17|||
149136219|NCT00312221|537980386|FG002|Double-blind Phase|Lack of Efficacy|6|||
149136220|NCT00312221|537980387|FG003|Double-blind Phase|Lack of Efficacy|10|||
149136221|NCT05105789|537980388|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
149136222|NCT01271803|537980392|FG000|Overall Study|Progressive disease|0|||
149136223|NCT01271803|537980393|FG001|Overall Study|Progressive disease|0|||
149136224|NCT01271803|537980394|FG002|Overall Study|Progressive disease|2|||
149136225|NCT01271803|537980392|FG000|Overall Study|Death|53|||
149136226|NCT01271803|537980393|FG001|Overall Study|Death|34|||
149136227|NCT01271803|537980394|FG002|Overall Study|Death|0|||
149136228|NCT01271803|537980392|FG000|Overall Study|Withdrawal by Subject|1|||
149136229|NCT01271803|537980393|FG001|Overall Study|Withdrawal by Subject|5|||
149136230|NCT01271803|537980394|FG002|Overall Study|Withdrawal by Subject|0|||
149136231|NCT01271803|537980392|FG000|Overall Study|Lost to Follow-up|1|||
149136232|NCT01271803|537980393|FG001|Overall Study|Lost to Follow-up|0|||
149136233|NCT01271803|537980394|FG002|Overall Study|Lost to Follow-up|0|||
149136234|NCT04178967|537980395|FG000|Induction Period|Adverse Event|4|||
149136235|NCT04178967|537980396|FG001|Induction Period|Adverse Event|6|||
149136236|NCT04178967|537980397|FG002|Induction Period|Adverse Event|0|||
148895461|NCT03192176|537098470|FG005|Overall Study|Withdrawal by Subject|4|||
149011462|NCT02778399|537521472|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
148895462|NCT03192176|537098471|FG006|Overall Study|Withdrawal by Subject|4|||
149136237|NCT04178967|537980398|FG003|Induction Period|Adverse Event|0|||
149136238|NCT04178967|537980399|FG004|Induction Period|Adverse Event|0|||
149136239|NCT04178967|537980400|FG005|Induction Period|Adverse Event|0|||
149136240|NCT04178967|537980401|FG006|Induction Period|Adverse Event|0|||
149136241|NCT04178967|537980402|FG007|Induction Period|Adverse Event|0|||
149136242|NCT04178967|537980403|FG008|Induction Period|Adverse Event|0|||
149136243|NCT04178967|537980404|FG009|Induction Period|Adverse Event|0|||
149136244|NCT04178967|537980405|FG010|Induction Period|Adverse Event|0|||
149136245|NCT04178967|537980395|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
149136246|NCT04178967|537980396|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
149136247|NCT04178967|537980397|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
149136248|NCT04178967|537980398|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
149136249|NCT04178967|537980399|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
149136250|NCT04178967|537980400|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
149136251|NCT04178967|537980401|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
149136252|NCT04178967|537980402|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
148796304|NCT02983045|536730925|FG007|Overall Study|Withdrawal by Subject|0|||
148796305|NCT02983045|536730926|FG008|Overall Study|Withdrawal by Subject|0|||
148796306|NCT02983045|536730927|FG009|Overall Study|Withdrawal by Subject|2|||
148796307|NCT02983045|536730918|FG000|Overall Study|Lost to Follow-up|0|||
148796308|NCT02983045|536730919|FG001|Overall Study|Lost to Follow-up|0|||
148796309|NCT02983045|536730920|FG002|Overall Study|Lost to Follow-up|0|||
148796310|NCT02983045|536730921|FG003|Overall Study|Lost to Follow-up|0|||
148796311|NCT02983045|536730922|FG004|Overall Study|Lost to Follow-up|0|||
148796312|NCT02983045|536730923|FG005|Overall Study|Lost to Follow-up|10|||
149136253|NCT04178967|537980403|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
149136254|NCT04178967|537980404|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
149136255|NCT04178967|537980405|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
149136256|NCT04178967|537980395|FG000|Induction Period|Lack of Efficacy|4|||
149136257|NCT04178967|537980396|FG001|Induction Period|Lack of Efficacy|1|||
149136258|NCT04178967|537980397|FG002|Induction Period|Lack of Efficacy|0|||
149136259|NCT04178967|537980398|FG003|Induction Period|Lack of Efficacy|0|||
149136260|NCT04178967|537980399|FG004|Induction Period|Lack of Efficacy|0|||
149136261|NCT04178967|537980400|FG005|Induction Period|Lack of Efficacy|0|||
149136262|NCT04178967|537980401|FG006|Induction Period|Lack of Efficacy|0|||
149136263|NCT04178967|537980402|FG007|Induction Period|Lack of Efficacy|0|||
149136264|NCT04178967|537980403|FG008|Induction Period|Lack of Efficacy|0|||
149136265|NCT04178967|537980404|FG009|Induction Period|Lack of Efficacy|0|||
149136266|NCT04178967|537980405|FG010|Induction Period|Lack of Efficacy|0|||
149136267|NCT04178967|537980395|FG000|Induction Period|Protocol Violation|0|||
149136268|NCT04178967|537980396|FG001|Induction Period|Protocol Violation|6|||
149136269|NCT04178967|537980397|FG002|Induction Period|Protocol Violation|0|||
149136270|NCT04178967|537980398|FG003|Induction Period|Protocol Violation|0|||
149136271|NCT04178967|537980399|FG004|Induction Period|Protocol Violation|0|||
149136272|NCT04178967|537980400|FG005|Induction Period|Protocol Violation|0|||
149136273|NCT04178967|537980401|FG006|Induction Period|Protocol Violation|0|||
149136274|NCT04178967|537980402|FG007|Induction Period|Protocol Violation|0|||
149136275|NCT04178967|537980403|FG008|Induction Period|Protocol Violation|0|||
149136276|NCT04178967|537980404|FG009|Induction Period|Protocol Violation|0|||
149136277|NCT04178967|537980405|FG010|Induction Period|Protocol Violation|0|||
149136278|NCT04178967|537980395|FG000|Induction Period|Withdrawal by Subject|6|||
149136279|NCT04178967|537980396|FG001|Induction Period|Withdrawal by Subject|4|||
149136280|NCT04178967|537980397|FG002|Induction Period|Withdrawal by Subject|0|||
149136281|NCT04178967|537980398|FG003|Induction Period|Withdrawal by Subject|0|||
149136282|NCT04178967|537980399|FG004|Induction Period|Withdrawal by Subject|0|||
149136283|NCT04178967|537980400|FG005|Induction Period|Withdrawal by Subject|0|||
149136284|NCT04178967|537980401|FG006|Induction Period|Withdrawal by Subject|0|||
149136285|NCT04178967|537980402|FG007|Induction Period|Withdrawal by Subject|0|||
149136286|NCT04178967|537980403|FG008|Induction Period|Withdrawal by Subject|0|||
149136287|NCT04178967|537980404|FG009|Induction Period|Withdrawal by Subject|0|||
149136288|NCT04178967|537980405|FG010|Induction Period|Withdrawal by Subject|0|||
149136289|NCT04178967|537980395|FG000|Induction Period|Lost to Follow-up|2|||
149136290|NCT04178967|537980396|FG001|Induction Period|Lost to Follow-up|0|||
149136291|NCT04178967|537980397|FG002|Induction Period|Lost to Follow-up|0|||
149136292|NCT04178967|537980398|FG003|Induction Period|Lost to Follow-up|0|||
149136293|NCT04178967|537980399|FG004|Induction Period|Lost to Follow-up|0|||
149136294|NCT04178967|537980400|FG005|Induction Period|Lost to Follow-up|0|||
149136295|NCT04178967|537980401|FG006|Induction Period|Lost to Follow-up|0|||
149136296|NCT04178967|537980402|FG007|Induction Period|Lost to Follow-up|0|||
149136297|NCT04178967|537980403|FG008|Induction Period|Lost to Follow-up|0|||
149136298|NCT04178967|537980404|FG009|Induction Period|Lost to Follow-up|0|||
149136299|NCT04178967|537980405|FG010|Induction Period|Lost to Follow-up|0|||
149136300|NCT04178967|537980395|FG000|Induction Period|Participant Missed Study Visits|0|||
149136301|NCT04178967|537980396|FG001|Induction Period|Participant Missed Study Visits|1|||
149136302|NCT04178967|537980397|FG002|Induction Period|Participant Missed Study Visits|0|||
149136303|NCT04178967|537980398|FG003|Induction Period|Participant Missed Study Visits|0|||
149136304|NCT04178967|537980399|FG004|Induction Period|Participant Missed Study Visits|0|||
149136305|NCT04178967|537980400|FG005|Induction Period|Participant Missed Study Visits|0|||
149136306|NCT04178967|537980401|FG006|Induction Period|Participant Missed Study Visits|0|||
149136307|NCT04178967|537980402|FG007|Induction Period|Participant Missed Study Visits|0|||
149136308|NCT04178967|537980403|FG008|Induction Period|Participant Missed Study Visits|0|||
149136309|NCT04178967|537980404|FG009|Induction Period|Participant Missed Study Visits|0|||
149136310|NCT04178967|537980405|FG010|Induction Period|Participant Missed Study Visits|0|||
149136311|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136312|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136313|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136314|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136315|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136316|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
149136317|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
149136318|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
149136319|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136320|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136321|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
149136322|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136323|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136324|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136325|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136326|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136327|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
149136328|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136329|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136330|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136331|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136332|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
149136333|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136334|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136335|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136336|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
149136337|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136338|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136339|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136340|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136341|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136342|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136343|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
149136344|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136345|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136346|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136347|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136348|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136349|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136350|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
149136351|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136352|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136353|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136354|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
149136355|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136356|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136357|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136358|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136359|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
149136360|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
149136361|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136362|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
149136363|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136364|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136365|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
149136366|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
149136367|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
148895463|NCT03192176|537098472|FG007|Overall Study|Withdrawal by Subject|2|||
148895464|NCT03192176|537098465|FG000|Overall Study|Miscellaneous|1|||
148895465|NCT03192176|537098466|FG001|Overall Study|Miscellaneous|0|||
148895466|NCT03192176|537098467|FG002|Overall Study|Miscellaneous|1|||
148895467|NCT03192176|537098468|FG003|Overall Study|Miscellaneous|1|||
148895468|NCT03192176|537098469|FG004|Overall Study|Miscellaneous|1|||
148895469|NCT03192176|537098470|FG005|Overall Study|Miscellaneous|2|||
149136368|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
149136369|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
149136370|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
149136371|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
149136372|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
149136373|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
149136374|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
149136375|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
149136376|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
149136377|NCT04178967|537980395|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136378|NCT04178967|537980396|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136379|NCT04178967|537980397|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136380|NCT04178967|537980398|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
149136381|NCT04178967|537980399|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136382|NCT04178967|537980400|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
149136383|NCT04178967|537980401|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
149136384|NCT04178967|537980402|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
149136385|NCT04178967|537980403|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136386|NCT04178967|537980404|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136387|NCT04178967|537980405|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
149136388|NCT04178967|537980395|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136389|NCT04178967|537980396|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136390|NCT04178967|537980397|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136391|NCT04178967|537980398|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136392|NCT04178967|537980399|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136393|NCT04178967|537980400|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136394|NCT04178967|537980401|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136395|NCT04178967|537980402|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136396|NCT04178967|537980403|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
149136397|NCT04178967|537980404|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
149136398|NCT04178967|537980405|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
149136399|NCT04178967|537980395|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136400|NCT04178967|537980396|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136401|NCT04178967|537980397|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136402|NCT04178967|537980398|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136403|NCT04178967|537980399|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136404|NCT04178967|537980400|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136405|NCT04178967|537980401|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136406|NCT04178967|537980402|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149136407|NCT04178967|537980403|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
149136408|NCT04178967|537980404|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
149136409|NCT04178967|537980405|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
149136410|NCT04178967|537980395|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136411|NCT04178967|537980396|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136412|NCT04178967|537980397|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136413|NCT04178967|537980398|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136414|NCT04178967|537980399|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136415|NCT04178967|537980400|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136416|NCT04178967|537980401|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136417|NCT04178967|537980402|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136418|NCT04178967|537980403|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136419|NCT04178967|537980404|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
149136420|NCT04178967|537980405|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149136421|NCT04178967|537980395|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136422|NCT04178967|537980396|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136423|NCT04178967|537980397|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136424|NCT04178967|537980398|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148895470|NCT03192176|537098471|FG006|Overall Study|Miscellaneous|0|||
149136425|NCT04178967|537980399|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136426|NCT04178967|537980400|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136427|NCT04178967|537980401|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136428|NCT04178967|537980402|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149136429|NCT04178967|537980403|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
149136430|NCT04178967|537980404|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
149136431|NCT04178967|537980405|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149136432|NCT04178967|537980395|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136433|NCT04178967|537980396|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136434|NCT04178967|537980397|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136435|NCT04178967|537980398|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136436|NCT04178967|537980399|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136437|NCT04178967|537980400|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136438|NCT04178967|537980401|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136439|NCT04178967|537980402|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136440|NCT04178967|537980403|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136441|NCT04178967|537980404|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
149136442|NCT04178967|537980405|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
149136443|NCT04178967|537980395|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136444|NCT04178967|537980396|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136445|NCT04178967|537980397|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136446|NCT04178967|537980398|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136447|NCT04178967|537980399|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136448|NCT04178967|537980400|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136449|NCT04178967|537980401|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136450|NCT04178967|537980402|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136451|NCT04178967|537980403|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136452|NCT04178967|537980404|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
149136453|NCT04178967|537980405|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
149136454|NCT00728481|537980406|FG000|Overall Study|Withdrawal by Subject|0|||
149136455|NCT00728481|537980407|FG001|Overall Study|Withdrawal by Subject|1|||
149136456|NCT00728481|537980406|FG000|Overall Study|Adverse Event|0|||
149136457|NCT00728481|537980407|FG001|Overall Study|Adverse Event|1|||
149136458|NCT00728481|537980406|FG000|Overall Study|Study medication non-compliance|0|||
149136459|NCT00728481|537980407|FG001|Overall Study|Study medication non-compliance|2|||
149136460|NCT00728481|537980406|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
149136461|NCT00728481|537980407|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
149136462|NCT02545322|537980408|FG000|Overall Study|Withdrawal by Subject|3|||
149136463|NCT00041067|537980409|FG000|Overall Study|Adverse Event|20|||
149136464|NCT00041067|537980409|FG000|Overall Study|Progression|19|||
149136465|NCT00041067|537980409|FG000|Overall Study|Patient refusal|12|||
149136466|NCT00041067|537980409|FG000|Overall Study|Other reasons|23|||
149136467|NCT00041067|537980409|FG000|Overall Study|Ineligible|2|||
149136468|NCT00778622|537980410|FG000|Overall Study|Adverse Event|5|||
149136469|NCT00778622|537980411|FG001|Overall Study|Adverse Event|4|||
149136470|NCT00778622|537980412|FG002|Overall Study|Adverse Event|7|||
149136471|NCT00778622|537980410|FG000|Overall Study|Withdrawal by Subject|4|||
149136472|NCT00778622|537980411|FG001|Overall Study|Withdrawal by Subject|5|||
149136473|NCT00778622|537980412|FG002|Overall Study|Withdrawal by Subject|5|||
149136474|NCT00778622|537980410|FG000|Overall Study|Lost to Follow-up|3|||
149136475|NCT00778622|537980411|FG001|Overall Study|Lost to Follow-up|3|||
149136476|NCT00778622|537980412|FG002|Overall Study|Lost to Follow-up|2|||
149136477|NCT00778622|537980410|FG000|Overall Study|Protocol Violation|0|||
149136478|NCT00778622|537980411|FG001|Overall Study|Protocol Violation|3|||
149136479|NCT00778622|537980412|FG002|Overall Study|Protocol Violation|0|||
149136480|NCT00778622|537980410|FG000|Overall Study|Lack of Efficacy|2|||
149136481|NCT00778622|537980411|FG001|Overall Study|Lack of Efficacy|0|||
149136482|NCT00778622|537980412|FG002|Overall Study|Lack of Efficacy|0|||
149136483|NCT00778622|537980410|FG000|Overall Study|immigration|1|||
149136484|NCT00778622|537980411|FG001|Overall Study|immigration|0|||
149136485|NCT00778622|537980412|FG002|Overall Study|immigration|0|||
149136486|NCT00778622|537980410|FG000|Overall Study|Other|1|||
149136487|NCT00778622|537980411|FG001|Overall Study|Other|0|||
149136488|NCT00778622|537980412|FG002|Overall Study|Other|1|||
149136489|NCT01251120|537980414|FG000|Overall Study|Lack of Efficacy|0|||
149136490|NCT01251120|537980415|FG001|Overall Study|Lack of Efficacy|1|||
149136491|NCT01968070|537980416|FG000|Period 1|Withdrawal by Subject|0|||
149136492|NCT01968070|537980417|FG001|Period 1|Withdrawal by Subject|1|||
149136493|NCT01968070|537980418|FG002|Period 1|Withdrawal by Subject|0|||
149136494|NCT01968070|537980419|FG003|Period 1|Withdrawal by Subject|0|||
149136495|NCT01968070|537980420|FG004|Period 1|Withdrawal by Subject|0|||
149136496|NCT01968070|537980421|FG005|Period 1|Withdrawal by Subject|0|||
149136497|NCT01968070|537980422|FG006|Period 1|Withdrawal by Subject|1|||
148796313|NCT02983045|536730924|FG006|Overall Study|Lost to Follow-up|0|||
149136498|NCT01968070|537980423|FG007|Period 1|Withdrawal by Subject|0|||
149136499|NCT01968070|537980424|FG008|Period 1|Withdrawal by Subject|0|||
149136500|NCT01968070|537980425|FG009|Period 1|Withdrawal by Subject|0|||
149136501|NCT01968070|537980426|FG010|Period 1|Withdrawal by Subject|0|||
149136502|NCT01968070|537980427|FG011|Period 1|Withdrawal by Subject|0|||
149136503|NCT01968070|537980428|FG012|Period 1|Withdrawal by Subject|0|||
149136504|NCT01968070|537980429|FG013|Period 1|Withdrawal by Subject|0|||
149136505|NCT01968070|537980430|FG014|Period 1|Withdrawal by Subject|0|||
149136506|NCT01968070|537980431|FG015|Period 1|Withdrawal by Subject|1|||
149136507|NCT01968070|537980432|FG016|Period 1|Withdrawal by Subject|0|||
149136508|NCT01968070|537980433|FG017|Period 1|Withdrawal by Subject|0|||
149136509|NCT01968070|537980416|FG000|Period 1|Protocol Violation|0|||
149136510|NCT01968070|537980417|FG001|Period 1|Protocol Violation|0|||
149136511|NCT01968070|537980418|FG002|Period 1|Protocol Violation|0|||
149136512|NCT01968070|537980419|FG003|Period 1|Protocol Violation|1|||
149136513|NCT01968070|537980420|FG004|Period 1|Protocol Violation|1|||
149136514|NCT01968070|537980421|FG005|Period 1|Protocol Violation|0|||
149136515|NCT01968070|537980422|FG006|Period 1|Protocol Violation|0|||
149136516|NCT01968070|537980423|FG007|Period 1|Protocol Violation|0|||
149136517|NCT01968070|537980424|FG008|Period 1|Protocol Violation|0|||
149136518|NCT01968070|537980425|FG009|Period 1|Protocol Violation|0|||
149136519|NCT01968070|537980426|FG010|Period 1|Protocol Violation|0|||
149136520|NCT01968070|537980427|FG011|Period 1|Protocol Violation|0|||
149136521|NCT01968070|537980428|FG012|Period 1|Protocol Violation|0|||
149136522|NCT01968070|537980429|FG013|Period 1|Protocol Violation|0|||
149136523|NCT01968070|537980430|FG014|Period 1|Protocol Violation|0|||
149136524|NCT01968070|537980431|FG015|Period 1|Protocol Violation|0|||
149136525|NCT01968070|537980432|FG016|Period 1|Protocol Violation|0|||
149136526|NCT01968070|537980433|FG017|Period 1|Protocol Violation|0|||
149136527|NCT01968070|537980416|FG000|Period 1|Lost to Follow-up|0|||
149136528|NCT01968070|537980417|FG001|Period 1|Lost to Follow-up|0|||
149136529|NCT01968070|537980418|FG002|Period 1|Lost to Follow-up|0|||
149136530|NCT01968070|537980419|FG003|Period 1|Lost to Follow-up|1|||
149136531|NCT01968070|537980420|FG004|Period 1|Lost to Follow-up|0|||
149136532|NCT01968070|537980421|FG005|Period 1|Lost to Follow-up|0|||
149136533|NCT01968070|537980422|FG006|Period 1|Lost to Follow-up|0|||
149136534|NCT01968070|537980423|FG007|Period 1|Lost to Follow-up|0|||
149136535|NCT01968070|537980424|FG008|Period 1|Lost to Follow-up|0|||
149136536|NCT01968070|537980425|FG009|Period 1|Lost to Follow-up|0|||
149136537|NCT01968070|537980426|FG010|Period 1|Lost to Follow-up|0|||
149136538|NCT01968070|537980427|FG011|Period 1|Lost to Follow-up|0|||
149136539|NCT01968070|537980428|FG012|Period 1|Lost to Follow-up|0|||
149136540|NCT01968070|537980429|FG013|Period 1|Lost to Follow-up|0|||
149136541|NCT01968070|537980430|FG014|Period 1|Lost to Follow-up|0|||
149136542|NCT01968070|537980431|FG015|Period 1|Lost to Follow-up|0|||
149136543|NCT01968070|537980432|FG016|Period 1|Lost to Follow-up|0|||
149136544|NCT01968070|537980433|FG017|Period 1|Lost to Follow-up|0|||
149136545|NCT01968070|537980416|FG000|Period 1|Adverse Event|0|||
149136546|NCT01968070|537980417|FG001|Period 1|Adverse Event|0|||
149136547|NCT01968070|537980418|FG002|Period 1|Adverse Event|0|||
149136548|NCT01968070|537980419|FG003|Period 1|Adverse Event|0|||
149136549|NCT01968070|537980420|FG004|Period 1|Adverse Event|0|||
149136550|NCT01968070|537980421|FG005|Period 1|Adverse Event|0|||
149136551|NCT01968070|537980422|FG006|Period 1|Adverse Event|1|||
149136552|NCT01968070|537980423|FG007|Period 1|Adverse Event|0|||
149136553|NCT01968070|537980424|FG008|Period 1|Adverse Event|0|||
149136554|NCT01968070|537980425|FG009|Period 1|Adverse Event|0|||
149136555|NCT01968070|537980426|FG010|Period 1|Adverse Event|0|||
149136556|NCT01968070|537980427|FG011|Period 1|Adverse Event|0|||
149136557|NCT01968070|537980428|FG012|Period 1|Adverse Event|0|||
149136558|NCT01968070|537980429|FG013|Period 1|Adverse Event|0|||
149136559|NCT01968070|537980430|FG014|Period 1|Adverse Event|0|||
149136560|NCT01968070|537980431|FG015|Period 1|Adverse Event|0|||
149136561|NCT01968070|537980432|FG016|Period 1|Adverse Event|0|||
149136562|NCT01968070|537980433|FG017|Period 1|Adverse Event|0|||
149136563|NCT01968070|537980416|FG000|Period 1|Physician Decision|0|||
149136564|NCT01968070|537980417|FG001|Period 1|Physician Decision|0|||
149136565|NCT01968070|537980418|FG002|Period 1|Physician Decision|0|||
149136566|NCT01968070|537980419|FG003|Period 1|Physician Decision|0|||
149136567|NCT01968070|537980420|FG004|Period 1|Physician Decision|0|||
149136568|NCT01968070|537980421|FG005|Period 1|Physician Decision|0|||
149136569|NCT01968070|537980422|FG006|Period 1|Physician Decision|0|||
149136570|NCT01968070|537980423|FG007|Period 1|Physician Decision|0|||
149136571|NCT01968070|537980424|FG008|Period 1|Physician Decision|0|||
149136572|NCT01968070|537980425|FG009|Period 1|Physician Decision|0|||
149136573|NCT01968070|537980426|FG010|Period 1|Physician Decision|0|||
149136574|NCT01968070|537980427|FG011|Period 1|Physician Decision|1|||
149136575|NCT01968070|537980428|FG012|Period 1|Physician Decision|0|||
149136576|NCT01968070|537980429|FG013|Period 1|Physician Decision|0|||
149136577|NCT01968070|537980430|FG014|Period 1|Physician Decision|0|||
149136578|NCT01968070|537980431|FG015|Period 1|Physician Decision|0|||
149136579|NCT01968070|537980432|FG016|Period 1|Physician Decision|0|||
149136580|NCT01968070|537980433|FG017|Period 1|Physician Decision|0|||
148796314|NCT02983045|536730925|FG007|Overall Study|Lost to Follow-up|0|||
148796315|NCT02983045|536730926|FG008|Overall Study|Lost to Follow-up|0|||
148796316|NCT02983045|536730927|FG009|Overall Study|Lost to Follow-up|0|||
148796317|NCT00905424|536730928|FG000|Overall Study|Lost to Follow-up|3|||
149136581|NCT01968070|537980416|FG000|Period 2|Withdrawal by Subject|0|||
149136582|NCT01968070|537980417|FG001|Period 2|Withdrawal by Subject|0|||
149136583|NCT01968070|537980418|FG002|Period 2|Withdrawal by Subject|0|||
149136584|NCT01968070|537980419|FG003|Period 2|Withdrawal by Subject|0|||
149136585|NCT01968070|537980420|FG004|Period 2|Withdrawal by Subject|1|||
149136586|NCT01968070|537980421|FG005|Period 2|Withdrawal by Subject|0|||
149136587|NCT01968070|537980422|FG006|Period 2|Withdrawal by Subject|0|||
149136588|NCT01968070|537980423|FG007|Period 2|Withdrawal by Subject|0|||
149136589|NCT01968070|537980424|FG008|Period 2|Withdrawal by Subject|0|||
149136590|NCT01968070|537980425|FG009|Period 2|Withdrawal by Subject|0|||
149136591|NCT01968070|537980426|FG010|Period 2|Withdrawal by Subject|0|||
149136592|NCT01968070|537980427|FG011|Period 2|Withdrawal by Subject|0|||
149136593|NCT01968070|537980428|FG012|Period 2|Withdrawal by Subject|0|||
149136594|NCT01968070|537980429|FG013|Period 2|Withdrawal by Subject|0|||
149136595|NCT01968070|537980430|FG014|Period 2|Withdrawal by Subject|0|||
149136596|NCT01968070|537980431|FG015|Period 2|Withdrawal by Subject|0|||
148796318|NCT00905424|536730929|FG001|Overall Study|Lost to Follow-up|3|||
149136597|NCT01968070|537980432|FG016|Period 2|Withdrawal by Subject|0|||
149136598|NCT01968070|537980433|FG017|Period 2|Withdrawal by Subject|0|||
149136599|NCT00890929|537980434|FG000|Overall Study|Death before treatment|2|||
149136600|NCT00890929|537980434|FG000|Overall Study|Withdrawal by Subject|3|||
149136601|NCT00890929|537980434|FG000|Overall Study|Physician Decision|1|||
149136602|NCT00108069|537980435|FG000|Overall Study|Never rec'd study drug|0|||
149136603|NCT00108069|537980436|FG001|Overall Study|Never rec'd study drug|1|||
149136604|NCT00108069|537980435|FG000|Overall Study|Adverse Event|1|||
149136605|NCT00108069|537980436|FG001|Overall Study|Adverse Event|1|||
149136606|NCT00108069|537980435|FG000|Overall Study|Withdrawal by Subject|1|||
149136607|NCT00108069|537980436|FG001|Overall Study|Withdrawal by Subject|0|||
149136608|NCT00108069|537980435|FG000|Overall Study|Death|1|||
149136609|NCT00108069|537980436|FG001|Overall Study|Death|0|||
149136610|NCT00108069|537980435|FG000|Overall Study|Progessive disease|27|||
149136611|NCT00108069|537980436|FG001|Overall Study|Progessive disease|11|||
149136612|NCT02014740|537980437|FG000|Overall Study|Lost to Follow-up|4|||
149136613|NCT02014740|537980438|FG001|Overall Study|Lost to Follow-up|4|||
149136614|NCT02014740|537980437|FG000|Overall Study|Withdrawal by Subject|2|||
149136615|NCT02014740|537980438|FG001|Overall Study|Withdrawal by Subject|1|||
149136616|NCT03684642|537980439|FG000|Overall Study|Adverse Event|6|||
149136617|NCT03684642|537980440|FG001|Overall Study|Adverse Event|15|||
149136618|NCT03684642|537980441|FG002|Overall Study|Adverse Event|11|||
149136619|NCT03684642|537980439|FG000|Overall Study|Withdrawal by Subject|35|||
149136620|NCT03684642|537980440|FG001|Overall Study|Withdrawal by Subject|53|||
149136621|NCT03684642|537980441|FG002|Overall Study|Withdrawal by Subject|23|||
149136622|NCT03684642|537980439|FG000|Overall Study|Lack of Efficacy|0|||
149136623|NCT03684642|537980440|FG001|Overall Study|Lack of Efficacy|0|||
149136624|NCT03684642|537980441|FG002|Overall Study|Lack of Efficacy|1|||
149136625|NCT03684642|537980439|FG000|Overall Study|Poor compliance to protocol|0|||
149136626|NCT03684642|537980440|FG001|Overall Study|Poor compliance to protocol|4|||
149136627|NCT03684642|537980441|FG002|Overall Study|Poor compliance to protocol|1|||
149136628|NCT03684642|537980439|FG000|Overall Study|Other than specified|62|||
149136629|NCT03684642|537980440|FG001|Overall Study|Other than specified|60|||
149136630|NCT03684642|537980441|FG002|Overall Study|Other than specified|67|||
149136631|NCT03684642|537980439|FG000|Overall Study|Randomized and not treated|0|||
149136632|NCT03684642|537980440|FG001|Overall Study|Randomized and not treated|0|||
149136633|NCT03684642|537980441|FG002|Overall Study|Randomized and not treated|1|||
149136634|NCT03684642|537980439|FG000|Overall Study|Missing completion status but alive at last contact|0|||
149136635|NCT03684642|537980440|FG001|Overall Study|Missing completion status but alive at last contact|1|||
149136636|NCT03684642|537980441|FG002|Overall Study|Missing completion status but alive at last contact|2|||
149136637|NCT01840605|537980445|FG000|Overall Study|Adverse Event|0|||
149136638|NCT01840605|537980446|FG001|Overall Study|Adverse Event|1|||
149136639|NCT01840605|537980445|FG000|Overall Study|Physician Decision|2|||
149136640|NCT01840605|537980446|FG001|Overall Study|Physician Decision|1|||
149136641|NCT03739437|537980447|FG000|Overall Study|Lost to Follow-up|2|||
149136642|NCT03739437|537980448|FG001|Overall Study|Lost to Follow-up|5|||
149136643|NCT01351623|537980449|FG000|Overall Study|Protocol Violation|2|||
149136644|NCT01351623|537980449|FG000|Overall Study|Adverse Event|4|||
149136645|NCT01351623|537980449|FG000|Overall Study|Withdrawal by Subject|1|||
149136646|NCT01351623|537980449|FG000|Overall Study|Death|2|||
149136647|NCT01130974|537980450|FG000|Overall Study|Protocol Violation|10|||
149136648|NCT01130974|537980451|FG001|Overall Study|Protocol Violation|10|||
149136649|NCT01130974|537980450|FG000|Overall Study|Withdrawal by Subject|0|||
149136650|NCT01130974|537980451|FG001|Overall Study|Withdrawal by Subject|1|||
149136651|NCT01130974|537980450|FG000|Overall Study|Ineligibility criteria|5|||
149136652|NCT01130974|537980451|FG001|Overall Study|Ineligibility criteria|2|||
149136653|NCT03359590|537980452|FG000|First Intervention|Withdrawal by Subject|1|||
149136654|NCT03359590|537980453|FG001|First Intervention|Withdrawal by Subject|1|||
149136655|NCT03359590|537980452|FG000|First Intervention|Protocol Violation|0|||
148895471|NCT03192176|537098472|FG007|Overall Study|Miscellaneous|1|||
148895472|NCT02384551|537098475|FG000|Overall Study|Lost to Follow-up|13|||
148895473|NCT02384551|537098476|FG001|Overall Study|Lost to Follow-up|14|||
149136656|NCT03359590|537980453|FG001|First Intervention|Protocol Violation|1|||
149136657|NCT06132425|537980454|FG000|Overall Study|Withdrawal by Subject|3|||
149136658|NCT06132425|537980455|FG001|Overall Study|Withdrawal by Subject|0|||
149136659|NCT06132425|537980454|FG000|Overall Study|Did not follow study instructions|0|||
149136660|NCT06132425|537980455|FG001|Overall Study|Did not follow study instructions|2|||
149136661|NCT06132425|537980454|FG000|Overall Study|Lost to Follow-up|3|||
149136662|NCT06132425|537980455|FG001|Overall Study|Lost to Follow-up|5|||
149136663|NCT04409353|537980456|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
149136664|NCT04409353|537980457|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
149136665|NCT04409353|537980458|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
149136666|NCT04409353|537980456|FG000|Overall Study|Lost to Follow-up|6|||
149136667|NCT04409353|537980457|FG001|Overall Study|Lost to Follow-up|8|||
149136668|NCT04409353|537980458|FG002|Overall Study|Lost to Follow-up|7|||
149136669|NCT04409353|537980456|FG000|Overall Study|Major surgery during participation window|4|||
149136670|NCT04409353|537980457|FG001|Overall Study|Major surgery during participation window|3|||
149136671|NCT04409353|537980458|FG002|Overall Study|Major surgery during participation window|3|||
149136672|NCT04409353|537980456|FG000|Overall Study|Life event occurred during participation window|3|||
149136673|NCT04409353|537980457|FG001|Overall Study|Life event occurred during participation window|2|||
149136674|NCT04409353|537980458|FG002|Overall Study|Life event occurred during participation window|4|||
149136675|NCT04409353|537980456|FG000|Overall Study|Lack of Efficacy|4|||
149136676|NCT04409353|537980457|FG001|Overall Study|Lack of Efficacy|1|||
149136677|NCT04409353|537980458|FG002|Overall Study|Lack of Efficacy|3|||
149136678|NCT04409353|537980456|FG000|Overall Study|Adverse Event|2|||
149136679|NCT04409353|537980457|FG001|Overall Study|Adverse Event|1|||
149136680|NCT04409353|537980458|FG002|Overall Study|Adverse Event|1|||
149136681|NCT04409353|537980456|FG000|Overall Study|Disease burden - unable to participate|0|||
149136682|NCT04409353|537980457|FG001|Overall Study|Disease burden - unable to participate|1|||
149136683|NCT04409353|537980458|FG002|Overall Study|Disease burden - unable to participate|1|||
149136684|NCT04409353|537980456|FG000|Overall Study|Intervention too complicated|1|||
149136685|NCT04409353|537980457|FG001|Overall Study|Intervention too complicated|0|||
149136686|NCT04409353|537980458|FG002|Overall Study|Intervention too complicated|1|||
149136687|NCT06308666|537980459|FG000|Overall Study|Withdrawal by Subject|1|||
149136688|NCT06308666|537980459|FG000|Overall Study|Protocol Violation|2|||
149136689|NCT00835120|537980461|FG000|Overall Study|Lack of Efficacy|1|||
149136690|NCT00835120|537980461|FG000|Overall Study|Lost to Follow-up|3|||
149136691|NCT00835120|537980461|FG000|Overall Study|Adverse Event|2|||
149136692|NCT00835120|537980461|FG000|Overall Study|Withdrawal by Subject|2|||
149136693|NCT01019980|537980464|FG000|Overall Study|Drug not available.|2|||
149136694|NCT01019980|537980465|FG001|Overall Study|Drug not available.|0|||
149136695|NCT00671554|537980472|FG000|Overall Study|Disease progression|3|||
149136696|NCT04275297|537980474|FG000|Overall Study|Lost to Follow-up|1|||
149136697|NCT04275297|537980475|FG001|Overall Study|Lost to Follow-up|1|||
149136698|NCT04435782|537980478|FG000|Overall Study|Study terminated by sponsor|4|||
149136699|NCT03672461|537980479|FG000|Overall Study|COVID Related|4|||
149136700|NCT03672461|537980480|FG001|Overall Study|COVID Related|2|||
149136701|NCT03672461|537980479|FG000|Overall Study|Adverse Event|2|||
149136702|NCT03672461|537980480|FG001|Overall Study|Adverse Event|0|||
149136703|NCT03672461|537980479|FG000|Overall Study|Serious Adverse Event|0|||
149136704|NCT03672461|537980480|FG001|Overall Study|Serious Adverse Event|1|||
149136705|NCT03672461|537980479|FG000|Overall Study|Too Busy|3|||
149136706|NCT03672461|537980480|FG001|Overall Study|Too Busy|1|||
149136707|NCT03672461|537980479|FG000|Overall Study|Lost to Follow-up|1|||
149136708|NCT03672461|537980480|FG001|Overall Study|Lost to Follow-up|2|||
149136709|NCT03672461|537980479|FG000|Overall Study|Family|2|||
149136710|NCT03672461|537980480|FG001|Overall Study|Family|2|||
149136711|NCT03672461|537980479|FG000|Overall Study|No remote technology access|0|||
149136712|NCT03672461|537980480|FG001|Overall Study|No remote technology access|1|||
149136713|NCT03672461|537980479|FG000|Overall Study|Withdrawal by Subject|1|||
149136714|NCT03672461|537980480|FG001|Overall Study|Withdrawal by Subject|0|||
149136715|NCT03672461|537980479|FG000|Overall Study|Cannot tolerate intervention|1|||
149136716|NCT03672461|537980480|FG001|Overall Study|Cannot tolerate intervention|0|||
149136717|NCT03672461|537980479|FG000|Overall Study|Incomplete outcome data|6|||
149136718|NCT03672461|537980480|FG001|Overall Study|Incomplete outcome data|1|||
149136719|NCT04667247|537980483|FG000|Overall Study|Withdrawal by Subject|0|||
149136720|NCT04667247|537980484|FG001|Overall Study|Withdrawal by Subject|1|||
149136721|NCT04124614|537980485|FG000|Placebo Run-in Period|Not Randomized|34|||
149136722|NCT04124614|537980486|FG001|Placebo Run-in Period|Not Randomized|0|||
149136723|NCT04124614|537980487|FG002|Placebo Run-in Period|Not Randomized|0|||
149136724|NCT04124614|537980485|FG000|Double Blind Treatment Period|Adverse Event|0|||
149136725|NCT04124614|537980486|FG001|Double Blind Treatment Period|Adverse Event|7|||
149136726|NCT04124614|537980487|FG002|Double Blind Treatment Period|Adverse Event|22|||
149136727|NCT04124614|537980485|FG000|Double Blind Treatment Period|Death|0|||
149136728|NCT04124614|537980486|FG001|Double Blind Treatment Period|Death|0|||
149136729|NCT04124614|537980487|FG002|Double Blind Treatment Period|Death|1|||
149136730|NCT04124614|537980485|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
148895474|NCT02384551|537098477|FG002|Overall Study|Lost to Follow-up|14|||
148895475|NCT02384551|537098478|FG003|Overall Study|Lost to Follow-up|14|||
148895476|NCT02399215|537098492|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
148895477|NCT02399215|537098492|FG000|Overall Study|Withdrawal by Subject|1|||
149136731|NCT04124614|537980486|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
149136732|NCT04124614|537980487|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
149136733|NCT04124614|537980485|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
149136734|NCT04124614|537980486|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
149136735|NCT04124614|537980487|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
149136736|NCT04124614|537980485|FG000|Double Blind Treatment Period|Physician Decision|0|||
149136737|NCT04124614|537980486|FG001|Double Blind Treatment Period|Physician Decision|0|||
149136738|NCT04124614|537980487|FG002|Double Blind Treatment Period|Physician Decision|3|||
149136739|NCT04124614|537980485|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
149136740|NCT04124614|537980486|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
149136741|NCT04124614|537980487|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
149136742|NCT04124614|537980485|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
149136743|NCT04124614|537980486|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
149136744|NCT04124614|537980487|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
149136745|NCT04124614|537980485|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
149136746|NCT04124614|537980486|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
149136747|NCT04124614|537980487|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
149136748|NCT04890054|537982192|FG000|Overall Study|Lost to Follow-up|202|||
149136749|NCT04890054|537982193|FG001|Overall Study|Lost to Follow-up|219|||
149136750|NCT05586269|537982194|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
149136751|NCT05586269|537982195|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
149136752|NCT05586269|537982196|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
149136753|NCT05586269|537982197|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
149136754|NCT05586269|537982194|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
149136755|NCT05586269|537982195|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
149136756|NCT05586269|537982196|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
149136757|NCT05586269|537982197|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
149136758|NCT04752475|537982198|FG000|Overall Study|Withdrawal by Subject|1|||
149136759|NCT04752475|537982199|FG001|Overall Study|Withdrawal by Subject|1|||
149136760|NCT00440700|537982207|FG000|Overall Study|Withdrawal by Subject|8|||
149136761|NCT00440700|537982208|FG001|Overall Study|Withdrawal by Subject|8|||
149136762|NCT00440700|537982209|FG002|Overall Study|Withdrawal by Subject|4|||
149136763|NCT02973425|537982210|FG000|Overall Study|Lost to Follow-up|49|||
149136764|NCT02973425|537982211|FG001|Overall Study|Lost to Follow-up|53|||
149136765|NCT01754857|537982221|FG000|Overall Study|Adverse Event|7|||
149136766|NCT01754857|537982221|FG000|Overall Study|Disease progression|3|||
149136767|NCT01754857|537982221|FG000|Overall Study|Physician Decision|2|||
149136768|NCT01754857|537982221|FG000|Overall Study|Withdrawal by Subject|3|||
149136769|NCT01754857|537982221|FG000|Overall Study|other complicating disease|1|||
149136770|NCT01754857|537982221|FG000|Overall Study|ineligible to continue onto maintenance|1|||
149136771|NCT01754857|537982221|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
149136772|NCT01754857|537982221|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
149136773|NCT00059839|537982224|FG000|Overall Study|Death|1|||
149136774|NCT00059839|537982225|FG001|Overall Study|Death|1|||
149136775|NCT00059839|537982224|FG000|Overall Study|Lack of Efficacy|6|||
149136776|NCT00059839|537982225|FG001|Overall Study|Lack of Efficacy|5|||
149136777|NCT00059839|537982224|FG000|Overall Study|Lost to Follow-up|2|||
149136778|NCT00059839|537982225|FG001|Overall Study|Lost to Follow-up|0|||
149136779|NCT00059839|537982224|FG000|Overall Study|Physician Decision|1|||
149136780|NCT00059839|537982225|FG001|Overall Study|Physician Decision|2|||
149136781|NCT00059839|537982224|FG000|Overall Study|Withdrawal by Subject|1|||
149136782|NCT00059839|537982225|FG001|Overall Study|Withdrawal by Subject|6|||
149136783|NCT00059839|537982224|FG000|Overall Study|Ineligible|1|||
149136784|NCT00059839|537982225|FG001|Overall Study|Ineligible|3|||
149136785|NCT03842163|537982226|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
149136786|NCT03842163|537982226|FG000|Overall Study|Scintigraphy was not performed|44|||
149136787|NCT03829241|537982230|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
149136788|NCT03829241|537982231|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
149136789|NCT03829241|537982230|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
149136790|NCT03829241|537982231|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
149136791|NCT03829241|537982230|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
149136792|NCT03829241|537982231|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
149136793|NCT03829241|537982230|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
149136794|NCT03829241|537982231|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
149136795|NCT03829241|537982230|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
149136796|NCT03829241|537982231|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
149136797|NCT03829241|537982230|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
149136798|NCT03829241|537982231|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
149136799|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
149136800|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
149136801|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
149136802|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
149136803|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
149136804|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
149136805|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
149136806|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
149136807|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
149136808|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
149136809|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
149136810|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
149136811|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
149136812|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
149136813|NCT03829241|537982230|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
149136814|NCT03829241|537982231|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
149136815|NCT00698451|537982232|FG000|Overall Study|Adverse Event|22|||
149136816|NCT00698451|537982232|FG000|Overall Study|Physician Decision|2|||
149136817|NCT00698451|537982232|FG000|Overall Study|Protocol Violation|6|||
149136818|NCT00698451|537982232|FG000|Overall Study|Withdrawal by Subject|6|||
149136819|NCT00698451|537982232|FG000|Overall Study|Disease progression|3|||
149136820|NCT02224599|537982235|FG000|Overall Study|Physician Decision|1|||
149136821|NCT02224599|537982235|FG000|Overall Study|Progression of Disease|1|||
149136822|NCT00596934|537982236|FG000|Overall Study|Protocol Violation|1|||
149136823|NCT00596934|537982236|FG000|Overall Study|Withdrawal by Subject|1|||
149136824|NCT02315898|537982239|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
149136825|NCT02315898|537982240|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
149136826|NCT02315898|537982241|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
149136827|NCT02315898|537982242|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
149136828|NCT01330914|537982243|FG000|Overall Study|Withdrawal by Subject|4|||
149136829|NCT01330914|537982243|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
149136830|NCT02308007|537982256|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
149136831|NCT02308007|537982257|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
149136832|NCT02308007|537982258|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
149136833|NCT02308007|537982256|FG000|Overall Study|Positive for STD at Baseline|7|||
149136834|NCT02308007|537982257|FG001|Overall Study|Positive for STD at Baseline|11|||
149136835|NCT02308007|537982258|FG002|Overall Study|Positive for STD at Baseline|7|||
149136836|NCT02308007|537982256|FG000|Overall Study|Lost to Follow-up|3|||
149136837|NCT02308007|537982257|FG001|Overall Study|Lost to Follow-up|0|||
149136838|NCT02308007|537982258|FG002|Overall Study|Lost to Follow-up|1|||
149136839|NCT00528567|537982259|FG000|Overall Study|Death|4|||
149136840|NCT00528567|537982260|FG001|Overall Study|Death|5|||
149136841|NCT00528567|537982259|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
149136842|NCT00528567|537982260|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
149136843|NCT00528567|537982259|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
149136844|NCT00528567|537982260|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
149136845|NCT00528567|537982259|FG000|Overall Study|Violation Criteria at Entry|3|||
149136846|NCT00528567|537982260|FG001|Overall Study|Violation Criteria at Entry|17|||
149136847|NCT00528567|537982259|FG000|Overall Study|Withdrew Consent|59|||
149136848|NCT00528567|537982260|FG001|Overall Study|Withdrew Consent|55|||
149136849|NCT00528567|537982259|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
149136850|NCT00528567|537982260|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
149136851|NCT00528567|537982259|FG000|Overall Study|Failure to Return|1|||
149136852|NCT00528567|537982260|FG001|Overall Study|Failure to Return|4|||
149136853|NCT00528567|537982259|FG000|Overall Study|Other Protocol Violation|5|||
149136854|NCT00528567|537982260|FG001|Overall Study|Other Protocol Violation|21|||
149136855|NCT00528567|537982259|FG000|Overall Study|Administrative/Other|22|||
149136856|NCT00528567|537982260|FG001|Overall Study|Administrative/Other|75|||
149136857|NCT03085758|537982265|FG000|Overall Study|Death|26|||
149136858|NCT03085758|537982266|FG001|Overall Study|Death|24|||
149136859|NCT03085758|537982267|FG002|Overall Study|Death|53|||
149136860|NCT03085758|537982265|FG000|Overall Study|Lost to Follow-up|1|||
149136861|NCT03085758|537982266|FG001|Overall Study|Lost to Follow-up|1|||
149136862|NCT03085758|537982267|FG002|Overall Study|Lost to Follow-up|1|||
149136863|NCT03085758|537982265|FG000|Overall Study|Withdrawal by Subject|2|||
149136864|NCT03085758|537982266|FG001|Overall Study|Withdrawal by Subject|2|||
149136865|NCT03085758|537982267|FG002|Overall Study|Withdrawal by Subject|1|||
149136866|NCT03085758|537982265|FG000|Overall Study|Refusal to recall it up to day 90|0|||
149136867|NCT03085758|537982266|FG001|Overall Study|Refusal to recall it up to day 90|0|||
148895478|NCT00772538|537098493|FG000|Overall Study|Adverse Event|6|||
149136868|NCT03085758|537982267|FG002|Overall Study|Refusal to recall it up to day 90|1|||
149136869|NCT03085758|537982265|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
149136870|NCT03085758|537982266|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
149136871|NCT03085758|537982267|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
149136872|NCT01122576|537982268|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
149136873|NCT01122576|537982269|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
149136874|NCT01122576|537982270|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
149136875|NCT01122576|537982268|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
149136876|NCT01122576|537982269|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
149136877|NCT01122576|537982270|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
149136878|NCT01122576|537982268|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
149136879|NCT01122576|537982269|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
149136880|NCT01122576|537982270|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
149136881|NCT05696236|537982271|FG000|Overall Study|Lost to Follow-up|1|||
149136882|NCT05696236|537982272|FG001|Overall Study|Lost to Follow-up|0|||
149136883|NCT05696236|537982271|FG000|Overall Study|Later determined to not be eligible for participation|0|||
149136884|NCT05696236|537982272|FG001|Overall Study|Later determined to not be eligible for participation|1|||
149136885|NCT05696236|537982271|FG000|Overall Study|Withdrawal by Subject|2|||
149136886|NCT05696236|537982272|FG001|Overall Study|Withdrawal by Subject|2|||
149136887|NCT01829360|537982273|FG000|Overall Study|Protocol Violation|0|||
149136888|NCT01829360|537982274|FG001|Overall Study|Protocol Violation|0|||
149136889|NCT01829360|537982275|FG002|Overall Study|Protocol Violation|1|||
149136890|NCT01829360|537982276|FG003|Overall Study|Protocol Violation|0|||
149136891|NCT00931944|537982281|FG000|Overall Study|Adverse Event|4|||
149136892|NCT00931944|537982281|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
149136893|NCT00931944|537982281|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
149136894|NCT00931944|537982281|FG000|Overall Study|Death|28|||
149136895|NCT00931944|537982281|FG000|Overall Study|Other|2|||
149136896|NCT01132612|537982285|FG000|Overall Study|Death|0|||
149136897|NCT01132612|537982286|FG001|Overall Study|Death|0|||
149136898|NCT01132612|537982287|FG002|Overall Study|Death|1|||
149136899|NCT01132612|537982285|FG000|Overall Study|Protocol deviation|0|||
149136900|NCT01132612|537982286|FG001|Overall Study|Protocol deviation|0|||
149136901|NCT01132612|537982287|FG002|Overall Study|Protocol deviation|3|||
149136902|NCT01132612|537982285|FG000|Overall Study|Lost to Follow-up|2|||
149136903|NCT01132612|537982286|FG001|Overall Study|Lost to Follow-up|2|||
149136904|NCT01132612|537982287|FG002|Overall Study|Lost to Follow-up|7|||
149136905|NCT01132612|537982285|FG000|Overall Study|Adverse Event|5|||
149136906|NCT01132612|537982286|FG001|Overall Study|Adverse Event|2|||
149136907|NCT01132612|537982287|FG002|Overall Study|Adverse Event|15|||
149136908|NCT01132612|537982285|FG000|Overall Study|Withdrawal by Subject|5|||
149136909|NCT01132612|537982286|FG001|Overall Study|Withdrawal by Subject|8|||
149136910|NCT01132612|537982287|FG002|Overall Study|Withdrawal by Subject|19|||
149136911|NCT01132612|537982285|FG000|Overall Study|Administrative problems|5|||
149136912|NCT01132612|537982286|FG001|Overall Study|Administrative problems|1|||
149136913|NCT01132612|537982287|FG002|Overall Study|Administrative problems|52|||
149136914|NCT01132612|537982285|FG000|Overall Study|Lack of Efficacy|23|||
149136915|NCT01132612|537982286|FG001|Overall Study|Lack of Efficacy|22|||
149136916|NCT01132612|537982287|FG002|Overall Study|Lack of Efficacy|73|||
149136917|NCT01186796|537982290|FG000|Overall Study|Adverse Event|3|||
149136918|NCT01186796|537982291|FG001|Overall Study|Adverse Event|0|||
149136919|NCT01186796|537982290|FG000|Overall Study|Withdrawal by Subject|1|||
149136920|NCT01186796|537982291|FG001|Overall Study|Withdrawal by Subject|1|||
149136921|NCT01186796|537982290|FG000|Overall Study|Protocol Violation|0|||
149136922|NCT01186796|537982291|FG001|Overall Study|Protocol Violation|1|||
149136923|NCT03838198|537982292|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
149136924|NCT03838198|537982293|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
149136925|NCT03838198|537982294|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
149136926|NCT03838198|537982295|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
149136927|NCT03838198|537982292|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
148796319|NCT00905424|536730928|FG000|Overall Study|Withdrawal by Subject|1|||
148796320|NCT00905424|536730929|FG001|Overall Study|Withdrawal by Subject|2|||
148796321|NCT00905424|536730928|FG000|Overall Study|Adverse Event|4|||
148796322|NCT00905424|536730929|FG001|Overall Study|Adverse Event|2|||
148796323|NCT00905424|536730928|FG000|Overall Study|Non-compliance with study medication|2|||
148796324|NCT00905424|536730929|FG001|Overall Study|Non-compliance with study medication|0|||
148796325|NCT00905424|536730928|FG000|Overall Study|Sponsor decision|1|||
148796326|NCT00905424|536730929|FG001|Overall Study|Sponsor decision|0|||
148796327|NCT00905424|536730928|FG000|Overall Study|Positive urine drug screen|0|||
148796328|NCT00905424|536730929|FG001|Overall Study|Positive urine drug screen|1|||
149136928|NCT03838198|537982293|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
149136929|NCT03838198|537982294|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
149136930|NCT03838198|537982295|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
149136931|NCT00578786|537982296|FG000|Overall Study|Adverse Event|27|||
149136932|NCT00578786|537982297|FG001|Overall Study|Adverse Event|37|||
149136933|NCT00578786|537982298|FG002|Overall Study|Adverse Event|17|||
149136934|NCT00578786|537982296|FG000|Overall Study|Lack of Efficacy|2|||
149136935|NCT00578786|537982297|FG001|Overall Study|Lack of Efficacy|5|||
149136936|NCT00578786|537982298|FG002|Overall Study|Lack of Efficacy|2|||
149136937|NCT00578786|537982296|FG000|Overall Study|Early Escape from Prior Study|2|||
149136938|NCT00578786|537982297|FG001|Overall Study|Early Escape from Prior Study|1|||
149136939|NCT00578786|537982298|FG002|Overall Study|Early Escape from Prior Study|2|||
149136940|NCT00578786|537982296|FG000|Overall Study|Withdrawal by Subject|7|||
149136941|NCT00578786|537982297|FG001|Overall Study|Withdrawal by Subject|8|||
149136942|NCT00578786|537982298|FG002|Overall Study|Withdrawal by Subject|5|||
149136943|NCT00578786|537982296|FG000|Overall Study|Protocol Violation|0|||
149136944|NCT00578786|537982297|FG001|Overall Study|Protocol Violation|3|||
149136945|NCT00578786|537982298|FG002|Overall Study|Protocol Violation|1|||
149136946|NCT00578786|537982296|FG000|Overall Study|Physician Decision|1|||
149136947|NCT00578786|537982297|FG001|Overall Study|Physician Decision|0|||
149136948|NCT00578786|537982298|FG002|Overall Study|Physician Decision|1|||
149136949|NCT00578786|537982296|FG000|Overall Study|Sponsor Decision|0|||
149136950|NCT00578786|537982297|FG001|Overall Study|Sponsor Decision|0|||
149136951|NCT00578786|537982298|FG002|Overall Study|Sponsor Decision|1|||
149136952|NCT00578786|537982296|FG000|Overall Study|Lost to Follow-up|0|||
149136953|NCT00578786|537982297|FG001|Overall Study|Lost to Follow-up|4|||
149136954|NCT00578786|537982298|FG002|Overall Study|Lost to Follow-up|0|||
149136955|NCT00578786|537982296|FG000|Overall Study|Pregnancy|0|||
149136956|NCT00578786|537982297|FG001|Overall Study|Pregnancy|1|||
149136957|NCT00578786|537982298|FG002|Overall Study|Pregnancy|0|||
149136958|NCT00578786|537982296|FG000|Overall Study|Not Otherwise Specified|0|||
149136959|NCT00578786|537982297|FG001|Overall Study|Not Otherwise Specified|4|||
148796329|NCT00905424|536730928|FG000|Overall Study|Non-adherence to visit schedule|0|||
148796330|NCT00905424|536730929|FG001|Overall Study|Non-adherence to visit schedule|1|||
148796331|NCT00379899|536730932|FG000|Overall Study|Adverse Event|7|||
148796332|NCT00379899|536730933|FG001|Overall Study|Adverse Event|3|||
148796333|NCT00379899|536730932|FG000|Overall Study|Death|10|||
148796334|NCT00379899|536730933|FG001|Overall Study|Death|10|||
148796335|NCT00379899|536730932|FG000|Overall Study|Lost to Follow-up|2|||
148796336|NCT00379899|536730933|FG001|Overall Study|Lost to Follow-up|4|||
148796337|NCT00379899|536730932|FG000|Overall Study|Physician Decision|3|||
148796338|NCT00379899|536730933|FG001|Overall Study|Physician Decision|4|||
148796339|NCT00379899|536730932|FG000|Overall Study|Withdrawal by Subject|5|||
148796340|NCT00379899|536730933|FG001|Overall Study|Withdrawal by Subject|5|||
148796341|NCT00379899|536730932|FG000|Overall Study|Ineligibility determined|0|||
148796342|NCT00379899|536730933|FG001|Overall Study|Ineligibility determined|1|||
148796343|NCT00379899|536730932|FG000|Overall Study|Noncompliance|1|||
148796344|NCT00379899|536730933|FG001|Overall Study|Noncompliance|1|||
148796345|NCT00379899|536730932|FG000|Overall Study|Parathyroidectomy|0|||
148796346|NCT00379899|536730933|FG001|Overall Study|Parathyroidectomy|2|||
149136960|NCT00578786|537982298|FG002|Overall Study|Not Otherwise Specified|1|||
148796347|NCT00379899|536730932|FG000|Overall Study|Renal transplantation|5|||
148796348|NCT00379899|536730933|FG001|Overall Study|Renal transplantation|4|||
148796349|NCT00379899|536730932|FG000|Overall Study|Coronary artery bypass graft|1|||
148796350|NCT00379899|536730933|FG001|Overall Study|Coronary artery bypass graft|1|||
148796351|NCT00379899|536730932|FG000|Overall Study|Other protocol-specified criteria|3|||
148796352|NCT00379899|536730933|FG001|Overall Study|Other protocol-specified criteria|4|||
148796353|NCT00379899|536730932|FG000|Overall Study|Other|3|||
148796354|NCT00379899|536730933|FG001|Overall Study|Other|1|||
148796355|NCT01922258|536730934|FG000|Overall Study|Lost to Follow-up|1|||
148796356|NCT01922258|536730935|FG001|Overall Study|Lost to Follow-up|1|||
148796357|NCT01922258|536730934|FG000|Overall Study|Adverse Event|9|||
148796358|NCT01922258|536730935|FG001|Overall Study|Adverse Event|2|||
148796359|NCT01922258|536730934|FG000|Overall Study|Met Withdrawal Criteria|0|||
148796360|NCT01922258|536730935|FG001|Overall Study|Met Withdrawal Criteria|4|||
148796361|NCT01922258|536730934|FG000|Overall Study|Withdrawn by the Investigator|1|||
148796362|NCT01922258|536730935|FG001|Overall Study|Withdrawn by the Investigator|4|||
148796363|NCT01922258|536730934|FG000|Overall Study|Withdrawal by participant|5|||
148796364|NCT01922258|536730935|FG001|Overall Study|Withdrawal by participant|5|||
148796365|NCT05225389|536730936|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
149136961|NCT00578786|537982296|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
149136962|NCT00578786|537982297|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
149136963|NCT00578786|537982298|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
149136964|NCT02060721|537982299|FG000|Overall Study|Lost to Follow-up|1|||
149136965|NCT02060721|537982299|FG000|Overall Study|Physician Decision|2|||
149136966|NCT02060721|537982299|FG000|Overall Study|Death|14|||
149136967|NCT02060721|537982299|FG000|Overall Study|Withdrawal by Subject|2|||
149136968|NCT02060721|537982299|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
149136969|NCT02608879|537982302|FG000|Overall Study|Lost to Follow-up|1|||
149136970|NCT02608879|537982303|FG001|Overall Study|Lost to Follow-up|0|||
149136971|NCT02608879|537982304|FG002|Overall Study|Lost to Follow-up|0|||
149136972|NCT02608879|537982302|FG000|Overall Study|Did not meet continuation criteria|0|||
149136973|NCT02608879|537982303|FG001|Overall Study|Did not meet continuation criteria|0|||
149136974|NCT02608879|537982304|FG002|Overall Study|Did not meet continuation criteria|3|||
149136975|NCT02499770|537982308|FG000|Overall Study|Death|17|||
149136976|NCT02499770|537982309|FG001|Overall Study|Death|56|||
149136977|NCT02499770|537982308|FG000|Overall Study|Study completion|1|||
149136978|NCT02499770|537982309|FG001|Overall Study|Study completion|10|||
149136979|NCT02499770|537982308|FG000|Overall Study|Withdrawal by Subject|0|||
149136980|NCT02499770|537982309|FG001|Overall Study|Withdrawal by Subject|7|||
149136981|NCT02499770|537982308|FG000|Overall Study|Lost to Follow-up|0|||
149136982|NCT02499770|537982309|FG001|Overall Study|Lost to Follow-up|2|||
149136983|NCT02499770|537982308|FG000|Overall Study|Subject declined further treatment|1|||
149136984|NCT02499770|537982309|FG001|Overall Study|Subject declined further treatment|0|||
149136985|NCT02499770|537982308|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
149136986|NCT02499770|537982309|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
149136987|NCT02499770|537982308|FG000|Overall Study|Randomized but not enrolled|0|||
149136988|NCT02499770|537982309|FG001|Overall Study|Randomized but not enrolled|1|||
149136989|NCT03610165|537982310|FG000|Overall Study|Device didn't work|0|||
149136990|NCT03610165|537982311|FG001|Overall Study|Device didn't work|1|||
149136991|NCT02129205|537982312|FG000|Overall Study|Withdrawal by Subject|0|||
149136992|NCT02129205|537982313|FG001|Overall Study|Withdrawal by Subject|0|||
149136993|NCT02129205|537982314|FG002|Overall Study|Withdrawal by Subject|0|||
149136994|NCT02129205|537982315|FG003|Overall Study|Withdrawal by Subject|0|||
148796366|NCT01585246|536730937|FG000|Overall Study|Lost to Follow-up|0|||
148796367|NCT01585246|536730938|FG001|Overall Study|Lost to Follow-up|0|||
148796368|NCT01585246|536730939|FG002|Overall Study|Lost to Follow-up|2|||
149136995|NCT02129205|537982316|FG004|Overall Study|Withdrawal by Subject|1|||
148895479|NCT00772538|537098494|FG001|Overall Study|Adverse Event|6|||
148895480|NCT00772538|537098493|FG000|Overall Study|Protocol Violation|3|||
148895481|NCT00772538|537098494|FG001|Overall Study|Protocol Violation|3|||
148895482|NCT00772538|537098493|FG000|Overall Study|Lost to Follow-up|1|||
148895483|NCT00772538|537098494|FG001|Overall Study|Lost to Follow-up|1|||
148895484|NCT00772538|537098493|FG000|Overall Study|Withdrawal by Subject|3|||
148895485|NCT00772538|537098494|FG001|Overall Study|Withdrawal by Subject|8|||
148895486|NCT00772538|537098493|FG000|Overall Study|Lack of Efficacy|0|||
148895487|NCT00772538|537098494|FG001|Overall Study|Lack of Efficacy|1|||
148895488|NCT00772538|537098493|FG000|Overall Study|Other|7|||
148895489|NCT00772538|537098494|FG001|Overall Study|Other|7|||
148895490|NCT00189540|537098495|FG000|Overall Study|Withdrawal by Subject|3|||
148895491|NCT00189540|537098496|FG001|Overall Study|Withdrawal by Subject|0|||
148895492|NCT00189540|537098495|FG000|Overall Study|Death|4|||
148895493|NCT00189540|537098496|FG001|Overall Study|Death|1|||
148895494|NCT01089504|537098497|FG000|Overall Study|Lost to Follow-up|1|||
148895495|NCT01089504|537098498|FG001|Overall Study|Lost to Follow-up|1|||
148895496|NCT01089504|537098497|FG000|Overall Study|Withdrawal by Subject|2|||
148895497|NCT01089504|537098498|FG001|Overall Study|Withdrawal by Subject|0|||
148895498|NCT00001832|537098499|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
148895499|NCT00001832|537098500|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
148895500|NCT00001832|537098501|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
148895501|NCT00001832|537098502|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
148895502|NCT00001832|537098503|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
148895503|NCT00001832|537098504|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
148895504|NCT00001832|537098505|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
148796369|NCT01585246|536730940|FG003|Overall Study|Lost to Follow-up|1|||
148796370|NCT01585246|536730941|FG004|Overall Study|Lost to Follow-up|0|||
148796371|NCT01585246|536730937|FG000|Overall Study|Protocol Violation|0|||
148796372|NCT01585246|536730938|FG001|Overall Study|Protocol Violation|0|||
148796373|NCT01585246|536730939|FG002|Overall Study|Protocol Violation|0|||
148796374|NCT01585246|536730940|FG003|Overall Study|Protocol Violation|0|||
148796375|NCT01585246|536730941|FG004|Overall Study|Protocol Violation|1|||
148796376|NCT01585246|536730937|FG000|Overall Study|Withdrawal by Subject|0|||
148796377|NCT01585246|536730938|FG001|Overall Study|Withdrawal by Subject|0|||
148796378|NCT01585246|536730939|FG002|Overall Study|Withdrawal by Subject|1|||
148895505|NCT00001832|537098506|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
148895506|NCT00001832|537098507|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
148895507|NCT00001832|537098508|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
148895508|NCT00001832|537098509|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
148895509|NCT00001832|537098510|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
148895510|NCT00001832|537098511|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
148895511|NCT00001832|537098512|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
148895512|NCT00001832|537098513|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
148895513|NCT00001832|537098499|FG000|Treatment Period|Death during treatment|0|||
149136996|NCT02129205|537982317|FG005|Overall Study|Withdrawal by Subject|1|||
148895514|NCT00001832|537098500|FG001|Treatment Period|Death during treatment|0|||
148895515|NCT00001832|537098501|FG002|Treatment Period|Death during treatment|0|||
148895516|NCT00001832|537098502|FG003|Treatment Period|Death during treatment|0|||
148895517|NCT00001832|537098503|FG004|Treatment Period|Death during treatment|0|||
148895518|NCT00001832|537098504|FG005|Treatment Period|Death during treatment|1|||
148895519|NCT00001832|537098505|FG006|Treatment Period|Death during treatment|0|||
148895520|NCT00001832|537098506|FG007|Treatment Period|Death during treatment|0|||
148895521|NCT00001832|537098507|FG008|Treatment Period|Death during treatment|0|||
148895522|NCT00001832|537098508|FG009|Treatment Period|Death during treatment|0|||
148895523|NCT00001832|537098509|FG010|Treatment Period|Death during treatment|0|||
148895524|NCT00001832|537098510|FG011|Treatment Period|Death during treatment|0|||
148895525|NCT00001832|537098511|FG012|Treatment Period|Death during treatment|0|||
148895526|NCT00001832|537098512|FG013|Treatment Period|Death during treatment|0|||
148895527|NCT00001832|537098513|FG014|Treatment Period|Death during treatment|0|||
148895528|NCT00001832|537098499|FG000|Treatment Period|Not treated|0|||
148895529|NCT00001832|537098500|FG001|Treatment Period|Not treated|0|||
148895530|NCT00001832|537098501|FG002|Treatment Period|Not treated|0|||
148895531|NCT00001832|537098502|FG003|Treatment Period|Not treated|0|||
148895532|NCT00001832|537098503|FG004|Treatment Period|Not treated|0|||
148895533|NCT00001832|537098504|FG005|Treatment Period|Not treated|0|||
148895534|NCT00001832|537098505|FG006|Treatment Period|Not treated|0|||
148895535|NCT00001832|537098506|FG007|Treatment Period|Not treated|1|||
148895536|NCT00001832|537098507|FG008|Treatment Period|Not treated|0|||
148895537|NCT00001832|537098508|FG009|Treatment Period|Not treated|0|||
148895538|NCT00001832|537098509|FG010|Treatment Period|Not treated|0|||
148895539|NCT00001832|537098510|FG011|Treatment Period|Not treated|0|||
148895540|NCT00001832|537098511|FG012|Treatment Period|Not treated|0|||
148895541|NCT00001832|537098512|FG013|Treatment Period|Not treated|0|||
148895542|NCT00001832|537098513|FG014|Treatment Period|Not treated|0|||
148895543|NCT01903356|537098514|FG000|Overall Study|Lost to Follow-up|7|||
149136997|NCT02129205|537982318|FG006|Overall Study|Withdrawal by Subject|1|||
149136998|NCT02129205|537982319|FG007|Overall Study|Withdrawal by Subject|0|||
149136999|NCT02129205|537982320|FG008|Overall Study|Withdrawal by Subject|1|||
149137000|NCT02129205|537982321|FG009|Overall Study|Withdrawal by Subject|0|||
149137001|NCT02129205|537982312|FG000|Overall Study|Other|1|||
149137002|NCT02129205|537982313|FG001|Overall Study|Other|0|||
149137003|NCT02129205|537982314|FG002|Overall Study|Other|0|||
149137004|NCT02129205|537982315|FG003|Overall Study|Other|0|||
149137005|NCT02129205|537982316|FG004|Overall Study|Other|2|||
149137006|NCT02129205|537982317|FG005|Overall Study|Other|3|||
149137007|NCT02129205|537982318|FG006|Overall Study|Other|3|||
149137008|NCT02129205|537982319|FG007|Overall Study|Other|2|||
149137009|NCT02129205|537982320|FG008|Overall Study|Other|1|||
149137010|NCT02129205|537982321|FG009|Overall Study|Other|0|||
149137011|NCT04376060|537982324|FG000|Overall Study|Physician Decision|1|||
149137012|NCT00977574|537982325|FG000|Overall Study|Never Treated|4|||
149137013|NCT00977574|537982326|FG001|Overall Study|Never Treated|2|||
149137014|NCT00977574|537982327|FG002|Overall Study|Never Treated|4|||
149137015|NCT07052682|537982328|FG000|Overall Study|Withdrawal by Subject|4|||
149137016|NCT04223791|537982329|FG000|Overall Study|Lost to Follow-up|0|||
149137017|NCT04223791|537982330|FG001|Overall Study|Lost to Follow-up|4|||
149137018|NCT04223791|537982329|FG000|Overall Study|Physician Decision|5|||
149137019|NCT04223791|537982330|FG001|Overall Study|Physician Decision|1|||
149137020|NCT04223791|537982329|FG000|Overall Study|Protocol Violation|1|||
149137021|NCT04223791|537982330|FG001|Overall Study|Protocol Violation|1|||
149137022|NCT04223791|537982329|FG000|Overall Study|Withdrawal by Subject|10|||
149137023|NCT04223791|537982330|FG001|Overall Study|Withdrawal by Subject|12|||
149137024|NCT04223791|537982329|FG000|Overall Study|Pregnancy|1|||
148895544|NCT01903356|537098514|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
149137025|NCT04223791|537982330|FG001|Overall Study|Pregnancy|1|||
149137026|NCT04223791|537982329|FG000|Overall Study|Ongoing in Study|305|||
149137027|NCT04223791|537982330|FG001|Overall Study|Ongoing in Study|302|||
149137028|NCT05460273|537982331|FG000|Overall Study|Death|43|||
149137029|NCT05460273|537982332|FG001|Overall Study|Death|9|||
149137030|NCT05460273|537982331|FG000|Overall Study|Lost to Follow-up|7|||
149137031|NCT05460273|537982332|FG001|Overall Study|Lost to Follow-up|0|||
149137032|NCT05460273|537982331|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
149137033|NCT05460273|537982332|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
148796379|NCT01585246|536730940|FG003|Overall Study|Withdrawal by Subject|2|||
148796380|NCT01585246|536730941|FG004|Overall Study|Withdrawal by Subject|1|||
148796381|NCT01585246|536730937|FG000|Overall Study|Other|0|||
148796382|NCT01585246|536730938|FG001|Overall Study|Other|1|||
148796383|NCT01585246|536730939|FG002|Overall Study|Other|1|||
148796384|NCT01585246|536730940|FG003|Overall Study|Other|1|||
148796385|NCT01585246|536730941|FG004|Overall Study|Other|0|||
148796386|NCT04552132|536730942|FG000|Overall Study|Lost to Follow-up|4|||
148796387|NCT04552132|536730943|FG001|Overall Study|Lost to Follow-up|3|||
148796388|NCT04552132|536730942|FG000|Overall Study|Protocol Violation|1|||
148796389|NCT04552132|536730943|FG001|Overall Study|Protocol Violation|0|||
148796390|NCT01657162|536730944|FG000|Overall Study|Adverse Event|26|||
148796391|NCT01657162|536730945|FG001|Overall Study|Adverse Event|36|||
148796392|NCT01657162|536730944|FG000|Overall Study|Withdrawal by Subject|13|||
148796393|NCT01657162|536730945|FG001|Overall Study|Withdrawal by Subject|13|||
148796394|NCT01657162|536730944|FG000|Overall Study|Continuing Significant Deterioration|9|||
148796395|NCT01657162|536730945|FG001|Overall Study|Continuing Significant Deterioration|3|||
148796396|NCT01657162|536730944|FG000|Overall Study|Refusal of Treatment|4|||
148796397|NCT01657162|536730945|FG001|Overall Study|Refusal of Treatment|6|||
148796398|NCT01657162|536730944|FG000|Overall Study|Lost to Follow-up|3|||
148796399|NCT01657162|536730945|FG001|Overall Study|Lost to Follow-up|4|||
148796400|NCT01657162|536730944|FG000|Overall Study|Death|2|||
148796401|NCT01657162|536730945|FG001|Overall Study|Death|3|||
148796402|NCT01657162|536730944|FG000|Overall Study|Inability to Complete Study Procedures|1|||
148796403|NCT01657162|536730945|FG001|Overall Study|Inability to Complete Study Procedures|7|||
148796404|NCT01657162|536730944|FG000|Overall Study|Protocol Violation|1|||
148796405|NCT01657162|536730945|FG001|Overall Study|Protocol Violation|0|||
148796406|NCT01657162|536730944|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
148796407|NCT01657162|536730945|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
148796408|NCT01657162|536730944|FG000|Overall Study|Other than Specified|0|||
148796409|NCT01657162|536730945|FG001|Overall Study|Other than Specified|2|||
148796410|NCT01261390|536730946|FG000|Overall Study|Significant Concurrent Illness|1|||
148796411|NCT01261390|536730947|FG001|Overall Study|Significant Concurrent Illness|0|||
148796412|NCT01261390|536730948|FG002|Overall Study|Significant Concurrent Illness|1|||
148796413|NCT01261390|536730949|FG003|Overall Study|Significant Concurrent Illness|0|||
148796414|NCT01261390|536730946|FG000|Overall Study|Dissatisfaction with Treatment|2|||
148796415|NCT01261390|536730947|FG001|Overall Study|Dissatisfaction with Treatment|1|||
148796416|NCT01261390|536730948|FG002|Overall Study|Dissatisfaction with Treatment|1|||
148796417|NCT01261390|536730949|FG003|Overall Study|Dissatisfaction with Treatment|2|||
148796418|NCT01261390|536730946|FG000|Overall Study|Relocation|0|||
148796419|NCT01261390|536730947|FG001|Overall Study|Relocation|1|||
148796420|NCT01261390|536730948|FG002|Overall Study|Relocation|0|||
148796421|NCT01261390|536730949|FG003|Overall Study|Relocation|0|||
148796422|NCT01261390|536730946|FG000|Overall Study|Loss of Interest in the Study|3|||
148796423|NCT01261390|536730947|FG001|Overall Study|Loss of Interest in the Study|1|||
148796424|NCT01261390|536730948|FG002|Overall Study|Loss of Interest in the Study|0|||
148796425|NCT01261390|536730949|FG003|Overall Study|Loss of Interest in the Study|0|||
148796426|NCT01261390|536730946|FG000|Overall Study|Lost to Follow-up|1|||
148796427|NCT01261390|536730947|FG001|Overall Study|Lost to Follow-up|6|||
148796428|NCT01261390|536730948|FG002|Overall Study|Lost to Follow-up|5|||
148796429|NCT01261390|536730949|FG003|Overall Study|Lost to Follow-up|6|||
148796430|NCT03421379|536730950|FG000|Period 1|Withdrawal by Subject|0|||
148796431|NCT03421379|536730951|FG001|Period 1|Withdrawal by Subject|1|||
148796432|NCT03421379|536730950|FG000|Period 1|Physician Decision|1|||
148796433|NCT03421379|536730951|FG001|Period 1|Physician Decision|1|||
148796434|NCT03421379|536730950|FG000|Period 1|Did not receive treatment|1|||
148796435|NCT03421379|536730951|FG001|Period 1|Did not receive treatment|2|||
148796436|NCT01497067|536730953|FG000|Overall Study|Lost to Follow-up|56|||
148796437|NCT01497067|536730953|FG000|Overall Study|Adverse Event|3|||
149137034|NCT05749952|537982333|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
149137035|NCT06950879|537982334|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
149137036|NCT03047551|537983327|FG000|Overall Study|Did not receive TAS|1|||
149137037|NCT03047551|537983328|FG001|Overall Study|Did not receive TAS|0|||
149137038|NCT03047551|537983327|FG000|Overall Study|Physician Decision|1|||
149137039|NCT03047551|537983328|FG001|Overall Study|Physician Decision|0|||
149137040|NCT03047551|537983327|FG000|Overall Study|Withdrawal by Subject|0|||
149137041|NCT03047551|537983328|FG001|Overall Study|Withdrawal by Subject|1|||
149137042|NCT03047551|537983327|FG000|Overall Study|Probe malfunction|0|||
149137043|NCT03047551|537983328|FG001|Overall Study|Probe malfunction|1|||
149137044|NCT03047551|537983327|FG000|Overall Study|Ineligible|0|||
149137045|NCT03047551|537983328|FG001|Overall Study|Ineligible|1|||
149137046|NCT02462928|537983329|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
149137047|NCT02462928|537983330|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
149137048|NCT02462928|537983331|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
149137049|NCT02462928|537983329|FG000|Overall Study|Adverse Event|47|||
149137050|NCT02462928|537983330|FG001|Overall Study|Adverse Event|51|||
149137051|NCT02462928|537983331|FG002|Overall Study|Adverse Event|25|||
149137052|NCT02462928|537983329|FG000|Overall Study|Lack of Efficacy|3|||
149137053|NCT02462928|537983330|FG001|Overall Study|Lack of Efficacy|8|||
149137054|NCT02462928|537983331|FG002|Overall Study|Lack of Efficacy|3|||
149137055|NCT02462928|537983329|FG000|Overall Study|Lost to Follow-up|4|||
149137056|NCT02462928|537983330|FG001|Overall Study|Lost to Follow-up|4|||
149137057|NCT02462928|537983331|FG002|Overall Study|Lost to Follow-up|1|||
149137058|NCT02462928|537983329|FG000|Overall Study|Withdrawal by Patient|31|||
149137059|NCT02462928|537983330|FG001|Overall Study|Withdrawal by Patient|21|||
149137060|NCT02462928|537983331|FG002|Overall Study|Withdrawal by Patient|21|||
149137061|NCT02462928|537983329|FG000|Overall Study|Protocol Violation|0|||
149137062|NCT02462928|537983330|FG001|Overall Study|Protocol Violation|1|||
149137063|NCT02462928|537983331|FG002|Overall Study|Protocol Violation|0|||
149137064|NCT02462928|537983329|FG000|Overall Study|Reason not Specified|4|||
149137065|NCT02462928|537983330|FG001|Overall Study|Reason not Specified|6|||
149137066|NCT02462928|537983331|FG002|Overall Study|Reason not Specified|5|||
149137067|NCT00395863|537983332|FG000|Overall Study|Patients did not complete both exams|2|||
149137068|NCT00395863|537983333|FG001|Overall Study|Patients did not complete both exams|3|||
149137069|NCT03503513|537983334|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
149137070|NCT03503513|537983334|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
149137071|NCT03503513|537983334|FG000|Overall Study|Physician Decision|3|||
149137072|NCT03503513|537983334|FG000|Overall Study|Withdrawal by Subject|2|||
149137073|NCT03503513|537983334|FG000|Overall Study|Lost to Follow-up|1|||
149137074|NCT01170039|537983335|FG000|Overall Study|Withdrawal by Subject|5|||
149137075|NCT01170039|537983336|FG001|Overall Study|Withdrawal by Subject|3|||
149137076|NCT01170039|537983335|FG000|Overall Study|Lack of funding, drug not available|3|||
149137077|NCT01170039|537983336|FG001|Overall Study|Lack of funding, drug not available|3|||
149137078|NCT00727649|537983337|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
149137079|NCT00727649|537983338|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
149137080|NCT00727649|537983337|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
149137081|NCT00727649|537983338|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
149137082|NCT00727649|537983337|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
149137083|NCT00727649|537983338|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
149137084|NCT00727649|537983337|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
149137085|NCT00727649|537983338|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
148895545|NCT01903356|537098514|FG000|Overall Study|Violated the dosage and administration|3|||
148895546|NCT00713609|537098515|FG000|Overall Study|Adverse Event|2|||
148895547|NCT00713609|537098516|FG001|Overall Study|Adverse Event|0|||
148895548|NCT00713609|537098517|FG002|Overall Study|Adverse Event|2|||
148895549|NCT00713609|537098518|FG003|Overall Study|Adverse Event|2|||
148895550|NCT00713609|537098519|FG004|Overall Study|Adverse Event|3|||
148895551|NCT00713609|537098520|FG005|Overall Study|Adverse Event|1|||
148895552|NCT00713609|537098515|FG000|Overall Study|Lost to Follow-up|5|||
148895553|NCT00713609|537098516|FG001|Overall Study|Lost to Follow-up|7|||
148895554|NCT00713609|537098517|FG002|Overall Study|Lost to Follow-up|5|||
148895555|NCT00713609|537098518|FG003|Overall Study|Lost to Follow-up|5|||
148895556|NCT00713609|537098519|FG004|Overall Study|Lost to Follow-up|7|||
148895557|NCT00713609|537098520|FG005|Overall Study|Lost to Follow-up|0|||
148895558|NCT00713609|537098515|FG000|Overall Study|Lack of Efficacy|1|||
148796438|NCT01497067|536730953|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
148796439|NCT01497067|536730953|FG000|Overall Study|Other|13|||
148796440|NCT03771963|536730954|FG000|Overall Study|Lost to Follow-up|22|||
148796441|NCT03771963|536730954|FG000|Overall Study|Withdrawal of Consent|10|||
148796442|NCT03066830|536730955|FG000|Overall Study|At the Participant's own Request|16|||
148796443|NCT03066830|536730956|FG001|Overall Study|At the Participant's own Request|17|||
148796444|NCT03066830|536730955|FG000|Overall Study|Other|3|||
148796445|NCT03066830|536730956|FG001|Overall Study|Other|0|||
148796446|NCT03066830|536730955|FG000|Overall Study|Poor Compliance to Protocol|1|||
148796447|NCT03066830|536730956|FG001|Overall Study|Poor Compliance to Protocol|0|||
148796448|NCT03066830|536730955|FG000|Overall Study|Adverse Event|2|||
148796449|NCT03066830|536730956|FG001|Overall Study|Adverse Event|2|||
148796450|NCT03066830|536730955|FG000|Overall Study|Lost to Follow-up|11|||
148796451|NCT03066830|536730956|FG001|Overall Study|Lost to Follow-up|3|||
148796452|NCT04888494|536730958|FG000|Overall Study|Lost to Follow-up|2|||
148796453|NCT04888494|536730959|FG001|Overall Study|Lost to Follow-up|3|||
148796454|NCT04888494|536730958|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
148796455|NCT04888494|536730959|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
148796456|NCT03430856|536730960|FG000|Overall Study|Adverse Event|0|||
148796457|NCT03430856|536730961|FG001|Overall Study|Adverse Event|1|||
148796458|NCT03430856|536730962|FG002|Overall Study|Adverse Event|0|||
148796459|NCT03430856|536730960|FG000|Overall Study|Rescue criteria|1|||
148796460|NCT03430856|536730961|FG001|Overall Study|Rescue criteria|1|||
148796461|NCT03430856|536730962|FG002|Overall Study|Rescue criteria|0|||
148796462|NCT03430856|536730960|FG000|Overall Study|Voluntary withdrawal of consent|1|||
148796463|NCT03430856|536730961|FG001|Overall Study|Voluntary withdrawal of consent|1|||
148796464|NCT03430856|536730962|FG002|Overall Study|Voluntary withdrawal of consent|1|||
148796465|NCT00565604|536730966|FG000|Overall Study|Failure to treat|2|||
148895559|NCT00713609|537098516|FG001|Overall Study|Lack of Efficacy|3|||
148895560|NCT00713609|537098517|FG002|Overall Study|Lack of Efficacy|0|||
148895561|NCT00713609|537098518|FG003|Overall Study|Lack of Efficacy|0|||
148895562|NCT00713609|537098519|FG004|Overall Study|Lack of Efficacy|1|||
148895563|NCT00713609|537098520|FG005|Overall Study|Lack of Efficacy|0|||
148895564|NCT00713609|537098515|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
149137086|NCT00727649|537983337|FG000|Second Intervention (4-weeks)|Death|1|||
149137087|NCT00727649|537983338|FG001|Second Intervention (4-weeks)|Death|0|||
149137088|NCT00727649|537983337|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
149137089|NCT00727649|537983338|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
149137090|NCT00727649|537983337|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
149137091|NCT00727649|537983338|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
149137092|NCT02953639|537983341|FG000|Overall Study|Adverse Event|2|||
149137093|NCT02953639|537983342|FG001|Overall Study|Adverse Event|0|||
149137094|NCT02953639|537983343|FG002|Overall Study|Adverse Event|1|||
149137095|NCT02953639|537983341|FG000|Overall Study|Lost to Follow-up|8|||
149137096|NCT02953639|537983342|FG001|Overall Study|Lost to Follow-up|4|||
149137097|NCT02953639|537983343|FG002|Overall Study|Lost to Follow-up|3|||
149137098|NCT02953639|537983341|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149137099|NCT02953639|537983342|FG001|Overall Study|Non-Compliance With Study Drug|2|||
149137100|NCT02953639|537983343|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149137101|NCT02953639|537983341|FG000|Overall Study|Multiple Reasons|1|||
149137102|NCT02953639|537983342|FG001|Overall Study|Multiple Reasons|0|||
149137103|NCT02953639|537983343|FG002|Overall Study|Multiple Reasons|1|||
149137104|NCT02953639|537983341|FG000|Overall Study|Physician Decision|1|||
149137105|NCT02953639|537983342|FG001|Overall Study|Physician Decision|0|||
149137106|NCT02953639|537983343|FG002|Overall Study|Physician Decision|0|||
149137107|NCT02953639|537983341|FG000|Overall Study|Withdrawal by Subject|7|||
149137108|NCT02953639|537983342|FG001|Overall Study|Withdrawal by Subject|8|||
149137109|NCT02953639|537983343|FG002|Overall Study|Withdrawal by Subject|10|||
149137110|NCT02953639|537983341|FG000|Overall Study|Completed or Discontinued information is missing|1|||
149137111|NCT02953639|537983342|FG001|Overall Study|Completed or Discontinued information is missing|0|||
149137112|NCT02953639|537983343|FG002|Overall Study|Completed or Discontinued information is missing|0|||
149137113|NCT01830855|537983344|FG000|Overall Study|Other|7|||
149137114|NCT01830855|537983345|FG001|Overall Study|Other|1|||
149137115|NCT01830855|537983346|FG002|Overall Study|Other|4|||
149137116|NCT01830855|537983347|FG003|Overall Study|Other|4|||
149137117|NCT01830855|537983344|FG000|Overall Study|Medication error without associated AE|1|||
149137118|NCT01830855|537983345|FG001|Overall Study|Medication error without associated AE|0|||
149137119|NCT01830855|537983346|FG002|Overall Study|Medication error without associated AE|0|||
149137120|NCT01830855|537983347|FG003|Overall Study|Medication error without associated AE|1|||
149137121|NCT01830855|537983344|FG000|Overall Study|Pregnancy|3|||
149137122|NCT01830855|537983345|FG001|Overall Study|Pregnancy|1|||
149137123|NCT01830855|537983346|FG002|Overall Study|Pregnancy|2|||
149137124|NCT01830855|537983347|FG003|Overall Study|Pregnancy|1|||
149137125|NCT01830855|537983344|FG000|Overall Study|No longer meets eligibility criteria|11|||
149137126|NCT01830855|537983345|FG001|Overall Study|No longer meets eligibility criteria|2|||
149137127|NCT01830855|537983346|FG002|Overall Study|No longer meets eligibility criteria|3|||
149137128|NCT01830855|537983347|FG003|Overall Study|No longer meets eligibility criteria|5|||
149137129|NCT01830855|537983344|FG000|Overall Study|Adverse Event|11|||
149137130|NCT01830855|537983345|FG001|Overall Study|Adverse Event|5|||
149137131|NCT01830855|537983346|FG002|Overall Study|Adverse Event|6|||
149137132|NCT01830855|537983347|FG003|Overall Study|Adverse Event|3|||
149137133|NCT01830855|537983344|FG000|Overall Study|Protocol deviation|10|||
149137134|NCT01830855|537983345|FG001|Overall Study|Protocol deviation|5|||
149137135|NCT01830855|537983346|FG002|Overall Study|Protocol deviation|6|||
149137136|NCT01830855|537983347|FG003|Overall Study|Protocol deviation|6|||
149137137|NCT01830855|537983344|FG000|Overall Study|Withdrawal by Subject|33|||
149137138|NCT01830855|537983345|FG001|Overall Study|Withdrawal by Subject|14|||
149137139|NCT01830855|537983346|FG002|Overall Study|Withdrawal by Subject|10|||
149137140|NCT01830855|537983347|FG003|Overall Study|Withdrawal by Subject|12|||
149137141|NCT01830855|537983344|FG000|Overall Study|No longer willing to participate|32|||
149137142|NCT01830855|537983345|FG001|Overall Study|No longer willing to participate|13|||
149137143|NCT01830855|537983346|FG002|Overall Study|No longer willing to participate|12|||
149137144|NCT01830855|537983347|FG003|Overall Study|No longer willing to participate|17|||
149137145|NCT01830855|537983344|FG000|Overall Study|Lost to Follow-up|47|||
149137146|NCT01830855|537983345|FG001|Overall Study|Lost to Follow-up|20|||
149137147|NCT01830855|537983346|FG002|Overall Study|Lost to Follow-up|23|||
149137148|NCT01830855|537983347|FG003|Overall Study|Lost to Follow-up|33|||
149137149|NCT00295633|537983350|FG000|Overall Study|Lack of Efficacy|19|||
149137150|NCT00295633|537983351|FG001|Overall Study|Lack of Efficacy|7|||
149137151|NCT00295633|537983352|FG002|Overall Study|Lack of Efficacy|16|||
149137152|NCT00295633|537983350|FG000|Overall Study|Withdrawal of consent by subject|16|||
149137153|NCT00295633|537983351|FG001|Overall Study|Withdrawal of consent by subject|16|||
148895565|NCT00713609|537098516|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
148895566|NCT00713609|537098517|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
148895567|NCT00713609|537098518|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
148895568|NCT00713609|537098519|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
148895569|NCT00713609|537098520|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
148895570|NCT00713609|537098515|FG000|Overall Study|Withdrawal by Subject|6|||
148895571|NCT00713609|537098516|FG001|Overall Study|Withdrawal by Subject|1|||
149137154|NCT00295633|537983352|FG002|Overall Study|Withdrawal of consent by subject|26|||
149137155|NCT00295633|537983350|FG000|Overall Study|Adverse Event|9|||
149137156|NCT00295633|537983351|FG001|Overall Study|Adverse Event|17|||
149137157|NCT00295633|537983352|FG002|Overall Study|Adverse Event|9|||
149137158|NCT00295633|537983350|FG000|Overall Study|Lost to Follow-up|6|||
149137159|NCT00295633|537983351|FG001|Overall Study|Lost to Follow-up|11|||
149137160|NCT00295633|537983352|FG002|Overall Study|Lost to Follow-up|7|||
149137161|NCT00295633|537983350|FG000|Overall Study|Physician Decision|9|||
149137162|NCT00295633|537983351|FG001|Overall Study|Physician Decision|10|||
149137163|NCT00295633|537983352|FG002|Overall Study|Physician Decision|8|||
149137164|NCT00295633|537983350|FG000|Overall Study|Poor/Noncompliance|2|||
149137165|NCT00295633|537983351|FG001|Overall Study|Poor/Noncompliance|2|||
149137166|NCT00295633|537983352|FG002|Overall Study|Poor/Noncompliance|6|||
149137167|NCT00295633|537983350|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
149137168|NCT00295633|537983351|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
149137169|NCT00295633|537983352|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
149137170|NCT00295633|537983350|FG000|Overall Study|Death|1|||
149137171|NCT00295633|537983351|FG001|Overall Study|Death|1|||
149137172|NCT00295633|537983352|FG002|Overall Study|Death|0|||
149137173|NCT00295633|537983350|FG000|Overall Study|Administrative reason by sponsor|0|||
149137174|NCT00295633|537983351|FG001|Overall Study|Administrative reason by sponsor|0|||
149137175|NCT00295633|537983352|FG002|Overall Study|Administrative reason by sponsor|1|||
149137176|NCT01798992|537983353|FG000|Overall Study|Administrative withdrawal|0|||
149137177|NCT01798992|537983354|FG001|Overall Study|Administrative withdrawal|1|||
149137178|NCT01798992|537983355|FG002|Overall Study|Administrative withdrawal|0|||
149137179|NCT01798992|537983356|FG003|Overall Study|Administrative withdrawal|1|||
149137180|NCT01798992|537983353|FG000|Overall Study|Lost to Follow-up|0|||
149137181|NCT01798992|537983354|FG001|Overall Study|Lost to Follow-up|1|||
149137182|NCT01798992|537983355|FG002|Overall Study|Lost to Follow-up|1|||
149137183|NCT01798992|537983356|FG003|Overall Study|Lost to Follow-up|0|||
149137184|NCT01798992|537983353|FG000|Overall Study|Insufficient biopsy tissue|0|||
149137185|NCT01798992|537983354|FG001|Overall Study|Insufficient biopsy tissue|0|||
149137186|NCT01798992|537983355|FG002|Overall Study|Insufficient biopsy tissue|1|||
149137187|NCT01798992|537983356|FG003|Overall Study|Insufficient biopsy tissue|0|||
149137188|NCT02294682|537983357|FG000|Overall Study|Could not swallow pills|1|||
149137189|NCT02294682|537983358|FG001|Overall Study|Could not swallow pills|0|||
149137190|NCT01516970|537983359|FG000|Overall Study|Lost to Follow-up|7|||
149137191|NCT01516970|537983360|FG001|Overall Study|Lost to Follow-up|8|||
149137192|NCT01516970|537983359|FG000|Overall Study|Adverse Event|1|||
149137193|NCT01516970|537983360|FG001|Overall Study|Adverse Event|5|||
149137194|NCT01516970|537983359|FG000|Overall Study|Withdrawal by Subject|1|||
149137195|NCT01516970|537983360|FG001|Overall Study|Withdrawal by Subject|1|||
149137196|NCT01516970|537983359|FG000|Overall Study|Other|9|||
149137197|NCT01516970|537983360|FG001|Overall Study|Other|7|||
149137198|NCT00434421|537983361|FG000|Overall Study|Withdrawal by Subject|1|||
149137199|NCT00434421|537983361|FG000|Overall Study|Non-compliance with study treatment|1|||
149137200|NCT00892177|537983368|FG000|Phase II|Ineligible|0|||
148796466|NCT00565604|536730966|FG000|Overall Study|Lost to Follow-up|2|||
148796467|NCT01001429|536733061|FG000|Overall Study|surgery cancelled|0|||
148796468|NCT01001429|536733062|FG001|Overall Study|surgery cancelled|1|||
148796469|NCT03234036|536733067|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
148796470|NCT03234036|536733068|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
148796471|NCT03234036|536733069|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
148796472|NCT03234036|536733070|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
148796473|NCT02163395|536733071|FG000|Overall Study|Withdrawal by Subject|1|||
148796474|NCT02163395|536733071|FG000|Overall Study|Lost to Follow-up|3|||
148796475|NCT02163395|536733071|FG000|Overall Study|Adverse Event|1|||
148796476|NCT00165503|536733076|FG000|Overall Study|Death|1|||
148796477|NCT00165503|536733076|FG000|Overall Study|Lost to Follow-up|12|||
148796478|NCT00165503|536733076|FG000|Overall Study|Unresectable|3|||
148796479|NCT02976519|536733077|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
148796480|NCT02976519|536733078|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
148796481|NCT02976519|536733079|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
148796482|NCT02976519|536733080|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
148796483|NCT02976519|536733081|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
149137201|NCT00892177|537983369|FG001|Phase II|Ineligible|0|||
149137202|NCT00892177|537983370|FG002|Phase II|Ineligible|0|||
149137203|NCT00892177|537983371|FG003|Phase II|Ineligible|0|||
149137204|NCT00892177|537983372|FG004|Phase II|Ineligible|1|||
148796484|NCT02976519|536733082|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
148796485|NCT02976519|536733083|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
148796486|NCT02976519|536733077|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
148796487|NCT02976519|536733078|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
148796488|NCT02976519|536733079|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
148796489|NCT02976519|536733080|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
148796490|NCT02976519|536733081|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
148796491|NCT02976519|536733082|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
148796492|NCT02976519|536733083|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
148796493|NCT02976519|536733077|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
148796494|NCT02976519|536733078|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
148796495|NCT02976519|536733079|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
148796496|NCT02976519|536733080|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
148796497|NCT02976519|536733081|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
148796498|NCT02976519|536733082|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
148796499|NCT02976519|536733083|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
148796500|NCT02976519|536733077|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
148796501|NCT02976519|536733078|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
148796502|NCT02976519|536733079|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
148796503|NCT02976519|536733080|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
148796504|NCT02976519|536733081|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
148796505|NCT02976519|536733082|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
148796506|NCT02976519|536733083|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
148796507|NCT02976519|536733077|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
148796508|NCT02976519|536733078|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
148796509|NCT02976519|536733079|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
148796510|NCT02976519|536733080|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
148796511|NCT02976519|536733081|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
148796512|NCT02976519|536733082|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
148796513|NCT02976519|536733083|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
148796514|NCT02346708|536733084|FG000|Overall Study|Adverse Event|2|||
148796515|NCT02346708|536733085|FG001|Overall Study|Adverse Event|0|||
148796516|NCT02346708|536733084|FG000|Overall Study|Protocol Violation|0|||
148796517|NCT02346708|536733085|FG001|Overall Study|Protocol Violation|1|||
148796518|NCT00928434|536733088|FG000|Overall Study|Adverse Event|14|||
148796519|NCT00928434|536733089|FG001|Overall Study|Adverse Event|5|||
148796520|NCT00928434|536733090|FG002|Overall Study|Adverse Event|18|||
148796521|NCT00928434|536733088|FG000|Overall Study|Protocol Violation|5|||
148796522|NCT00928434|536733089|FG001|Overall Study|Protocol Violation|0|||
148796523|NCT00928434|536733090|FG002|Overall Study|Protocol Violation|8|||
148796524|NCT00928434|536733088|FG000|Overall Study|Physician Decision|2|||
148796525|NCT00928434|536733089|FG001|Overall Study|Physician Decision|0|||
148796526|NCT00928434|536733090|FG002|Overall Study|Physician Decision|3|||
148796527|NCT00928434|536733088|FG000|Overall Study|Lost to Follow-up|1|||
148796528|NCT00928434|536733089|FG001|Overall Study|Lost to Follow-up|0|||
148796529|NCT00928434|536733090|FG002|Overall Study|Lost to Follow-up|3|||
148796530|NCT00928434|536733088|FG000|Overall Study|Withdrawal by Subject|5|||
148796531|NCT00928434|536733089|FG001|Overall Study|Withdrawal by Subject|3|||
148796532|NCT00928434|536733090|FG002|Overall Study|Withdrawal by Subject|2|||
148796533|NCT00928434|536733088|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
148796534|NCT00928434|536733089|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
148796535|NCT00928434|536733090|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
148796536|NCT00928434|536733088|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
148796537|NCT00928434|536733089|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
148796538|NCT00928434|536733090|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
148796539|NCT00928434|536733088|FG000|Overall Study|Other (not meeting above criteria)|5|||
148796540|NCT00928434|536733089|FG001|Overall Study|Other (not meeting above criteria)|1|||
148796541|NCT00928434|536733090|FG002|Overall Study|Other (not meeting above criteria)|2|||
148796542|NCT02154139|536733097|FG000|Overall Study|Injection not administered|2|||
148796543|NCT02154139|536733097|FG000|Overall Study|Other|2|||
148796544|NCT02154139|536733097|FG000|Overall Study|Investigator transferred|3|||
148796545|NCT00473655|536733098|FG000|Overall Study|Lost to Follow-up|9|||
148796546|NCT00473655|536733099|FG001|Overall Study|Lost to Follow-up|5|||
148796547|NCT00473655|536733100|FG002|Overall Study|Lost to Follow-up|8|||
148796548|NCT02087774|536733101|FG000|Overall Study|Were absent day of data collection|8|||
148796549|NCT02087774|536733102|FG001|Overall Study|Were absent day of data collection|20|||
148796550|NCT04176939|536733111|FG000|Overall Study|Withdrawal by Subject|5|||
148796551|NCT04176939|536733111|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
148796552|NCT04176939|536733111|FG000|Overall Study|Lost to Follow-up|2|||
148796553|NCT04176939|536733111|FG000|Overall Study|Unspecified reason|4|||
148796554|NCT04176939|536733111|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
148796555|NCT03225170|536733112|FG000|Overall Study|Lost to Follow-up|4|||
148796556|NCT03225170|536733113|FG001|Overall Study|Lost to Follow-up|4|||
148796557|NCT03225170|536733114|FG002|Overall Study|Lost to Follow-up|0|||
148796558|NCT03225170|536733112|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
148796559|NCT03225170|536733113|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
148796560|NCT03225170|536733114|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
148796561|NCT00227539|536733115|FG000|Overall Study|Protocol Violation|1|||
148796562|NCT00426764|536733116|FG000|Overall Study|Protocol Violation|1|||
148796563|NCT00426764|536733116|FG000|Overall Study|Withdrawal by Subject|4|||
148796564|NCT00426764|536733116|FG000|Overall Study|Physician Decision|6|||
148796565|NCT00426764|536733116|FG000|Overall Study|Compassionate Use|1|||
148796566|NCT00426764|536733116|FG000|Overall Study|Progressive Disease|83|||
148796567|NCT00426764|536733116|FG000|Overall Study|Adverse Event|24|||
148796568|NCT00426764|536733116|FG000|Overall Study|Other|1|||
148796569|NCT00426764|536733116|FG000|Overall Study|Death|1|||
148796570|NCT00426764|536733116|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
148796571|NCT04396626|536733117|FG000|Overall Study|Premature termination of study|975|||
148796572|NCT03380377|536733118|FG000|Overall Study|Physician Decision|1|||
148796573|NCT03380377|536733118|FG000|Overall Study|Withdrawal by Subject|1|||
148796574|NCT02600923|536733119|FG000|Overall Study|Death|10|||
148796575|NCT02600923|536733119|FG000|Overall Study|Adverse Event|3|||
148796576|NCT02600923|536733119|FG000|Overall Study|Global deterioration of health status|2|||
148796577|NCT02600923|536733119|FG000|Overall Study|Insufficient clinical response|6|||
148796578|NCT02600923|536733119|FG000|Overall Study|Lost to Follow-up|1|||
148796579|NCT02600923|536733119|FG000|Overall Study|Withdrawal by Subject|5|||
148796580|NCT02600923|536733119|FG000|Overall Study|Objective progression or relapse|50|||
148796581|NCT02600923|536733119|FG000|Overall Study|Study terminated by Sponsor|53|||
148796582|NCT02600923|536733119|FG000|Overall Study|Not treated|1|||
149137205|NCT00892177|537983373|FG005|Phase II|Ineligible|1|||
149137206|NCT00892177|537983368|FG000|Phase II|Withdrawal by Subject|0|||
149137207|NCT00892177|537983369|FG001|Phase II|Withdrawal by Subject|0|||
149137208|NCT00892177|537983370|FG002|Phase II|Withdrawal by Subject|0|||
149137209|NCT00892177|537983371|FG003|Phase II|Withdrawal by Subject|0|||
149137210|NCT00892177|537983372|FG004|Phase II|Withdrawal by Subject|4|||
149137211|NCT00892177|537983373|FG005|Phase II|Withdrawal by Subject|1|||
149137212|NCT01446016|537983374|FG000|Overall Study|Lost to Follow-up|3|||
149137213|NCT01446016|537983374|FG000|Overall Study|Withdrawal by Subject|1|||
149137214|NCT01446016|537983374|FG000|Overall Study|Toxicity|3|||
149137215|NCT00404066|537983381|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
149137216|NCT00404066|537983381|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
149137217|NCT01087957|537983382|FG000|Overall Study|Death|2|||
149137218|NCT01087957|537983383|FG001|Overall Study|Death|2|||
149137219|NCT01087957|537983382|FG000|Overall Study|Lost to Follow-up|3|||
149137220|NCT01087957|537983383|FG001|Overall Study|Lost to Follow-up|4|||
148895572|NCT00713609|537098517|FG002|Overall Study|Withdrawal by Subject|5|||
148895573|NCT00713609|537098518|FG003|Overall Study|Withdrawal by Subject|1|||
148895574|NCT00713609|537098519|FG004|Overall Study|Withdrawal by Subject|5|||
148895575|NCT00713609|537098520|FG005|Overall Study|Withdrawal by Subject|7|||
148895576|NCT00713609|537098515|FG000|Overall Study|Protocol Violation|6|||
148895577|NCT00713609|537098516|FG001|Overall Study|Protocol Violation|3|||
148895578|NCT00713609|537098517|FG002|Overall Study|Protocol Violation|1|||
148895579|NCT00713609|537098518|FG003|Overall Study|Protocol Violation|1|||
148895580|NCT00713609|537098519|FG004|Overall Study|Protocol Violation|2|||
148895581|NCT00713609|537098520|FG005|Overall Study|Protocol Violation|0|||
148895582|NCT04529083|537098521|FG000|Overall Study|Withdrawal by Subject|3|||
148895583|NCT04196686|537098526|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
148895584|NCT04196686|537098527|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
148895585|NCT03882021|537098534|FG000|Enrollment|Procedure aborted/cancelled|2|||
148895586|NCT03882021|537098534|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
148895587|NCT03882021|537098534|FG000|Enrollment to 3-Month|Death|1|||
148895588|NCT03882021|537098534|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
148895589|NCT03882021|537098534|FG000|Enrollment to 3-Month|Missed Visit|4|||
148895590|NCT03882021|537098534|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
148895591|NCT03882021|537098534|FG000|6-Month to 12-Month Visit|Death|1|||
148895592|NCT03882021|537098534|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
148895593|NCT00659061|537098535|FG000|Overall Study|Migration due to political unrest|21|||
148895594|NCT00659061|537098536|FG001|Overall Study|Migration due to political unrest|15|||
148895595|NCT00475670|537098540|FG000|Overall Study|Death|0|||
148895596|NCT00475670|537098541|FG001|Overall Study|Death|1|||
148895597|NCT00475670|537098540|FG000|Overall Study|Lack of Efficacy|3|||
148895598|NCT00475670|537098541|FG001|Overall Study|Lack of Efficacy|34|||
148895599|NCT00475670|537098540|FG000|Overall Study|Refused treatment|0|||
148895600|NCT00475670|537098541|FG001|Overall Study|Refused treatment|2|||
148895601|NCT00475670|537098540|FG000|Overall Study|Failure to Return|0|||
148895602|NCT00475670|537098541|FG001|Overall Study|Failure to Return|1|||
148895603|NCT00475670|537098540|FG000|Overall Study|Other|0|||
148796583|NCT00792909|536733120|FG000|Overall Study|Withdrawal by Subject|0|||
148796584|NCT00792909|536733121|FG001|Overall Study|Withdrawal by Subject|1|||
148796585|NCT00792909|536733122|FG002|Overall Study|Withdrawal by Subject|0|||
148796586|NCT00096538|536733130|FG000|Overall Study|Withdrawal by Subject|1|||
148796587|NCT02686164|536733132|FG000|Overall Study|Adverse Event|1|||
148796588|NCT02686164|536733132|FG000|Overall Study|Withdrawal of consent|1|||
148796589|NCT02686164|536733132|FG000|Overall Study|Clinical progression|1|||
148895604|NCT00475670|537098541|FG001|Overall Study|Other|3|||
148895605|NCT01168349|537098542|FG000|Overall Study|Death|157|||
148895606|NCT01168349|537098542|FG000|Overall Study|Lost to Follow-up|34|||
148895607|NCT01168349|537098542|FG000|Overall Study|Withdrawal by Subject|9|||
148796590|NCT01691378|536733133|FG000|Overall Study|Withdrawal by Subject|2|||
148796591|NCT01691378|536733134|FG001|Overall Study|Withdrawal by Subject|0|||
148796592|NCT01691378|536733133|FG000|Overall Study|Lost to Follow-up|5|||
148796593|NCT01691378|536733134|FG001|Overall Study|Lost to Follow-up|2|||
148796594|NCT02324361|536733137|FG000|Overall Study|Lost to Follow-up|5|||
148796595|NCT02324361|536733138|FG001|Overall Study|Lost to Follow-up|2|||
148796596|NCT00003471|536733143|FG000|Overall Study|Not evaluable|4|||
148796597|NCT00735007|536733148|FG000|Overall Study|Adverse Event|4|||
148796598|NCT00735007|536733148|FG000|Overall Study|Protocol Violation|1|||
148796599|NCT00715403|536733149|FG000|Overall Study|Progressive disease|0|||
148796600|NCT00715403|536733150|FG001|Overall Study|Progressive disease|1|||
148796601|NCT00715403|536733151|FG002|Overall Study|Progressive disease|3|||
148796602|NCT00715403|536733152|FG003|Overall Study|Progressive disease|9|||
148796603|NCT00715403|536733153|FG004|Overall Study|Progressive disease|5|||
148796604|NCT00715403|536733154|FG005|Overall Study|Progressive disease|14|||
148895608|NCT01168349|537098542|FG000|Overall Study|Kidney transplantation|3|||
148796605|NCT00715403|536733155|FG006|Overall Study|Progressive disease|1|||
148796606|NCT00715403|536733149|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
148796607|NCT00715403|536733150|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
148796608|NCT00715403|536733151|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
148796609|NCT00715403|536733152|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
148796610|NCT00715403|536733153|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
148796611|NCT00715403|536733154|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
148796612|NCT00715403|536733155|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
148796613|NCT00715403|536733149|FG000|Overall Study|Other Adverse Event than DLT|1|||
148796614|NCT00715403|536733150|FG001|Overall Study|Other Adverse Event than DLT|0|||
148796615|NCT00715403|536733151|FG002|Overall Study|Other Adverse Event than DLT|0|||
148796616|NCT00715403|536733152|FG003|Overall Study|Other Adverse Event than DLT|0|||
148796617|NCT00715403|536733153|FG004|Overall Study|Other Adverse Event than DLT|0|||
148796618|NCT00715403|536733154|FG005|Overall Study|Other Adverse Event than DLT|2|||
148796619|NCT00715403|536733155|FG006|Overall Study|Other Adverse Event than DLT|0|||
148796620|NCT00715403|536733149|FG000|Overall Study|Protocol Violation|0|||
148796621|NCT00715403|536733150|FG001|Overall Study|Protocol Violation|0|||
148796622|NCT00715403|536733151|FG002|Overall Study|Protocol Violation|0|||
148796623|NCT00715403|536733152|FG003|Overall Study|Protocol Violation|0|||
148796624|NCT00715403|536733153|FG004|Overall Study|Protocol Violation|0|||
148796625|NCT00715403|536733154|FG005|Overall Study|Protocol Violation|1|||
148796626|NCT00715403|536733155|FG006|Overall Study|Protocol Violation|0|||
148796627|NCT00715403|536733149|FG000|Overall Study|Other reason not defined above|0|||
148796628|NCT00715403|536733150|FG001|Overall Study|Other reason not defined above|0|||
148796629|NCT00715403|536733151|FG002|Overall Study|Other reason not defined above|1|||
148796630|NCT00715403|536733152|FG003|Overall Study|Other reason not defined above|0|||
148796631|NCT00715403|536733153|FG004|Overall Study|Other reason not defined above|1|||
148796632|NCT00715403|536733154|FG005|Overall Study|Other reason not defined above|1|||
148796633|NCT00715403|536733155|FG006|Overall Study|Other reason not defined above|0|||
148796634|NCT02104895|536733156|FG000|Overall Study|Withdrawal by Subject|0|||
148796635|NCT02104895|536733157|FG001|Overall Study|Withdrawal by Subject|14|||
148796636|NCT04235504|536733161|FG000|Study Phase|Withdrawal by Subject|5|||
148796637|NCT04235504|536733162|FG001|Study Phase|Withdrawal by Subject|2|||
148796638|NCT04235504|536733163|FG002|Study Phase|Withdrawal by Subject|0|||
148796639|NCT04235504|536733164|FG003|Study Phase|Withdrawal by Subject|0|||
148796640|NCT04235504|536733161|FG000|Continuation Phase|Withdrawal by Subject|0|||
148796641|NCT04235504|536733162|FG001|Continuation Phase|Withdrawal by Subject|4|||
148796642|NCT04235504|536733163|FG002|Continuation Phase|Withdrawal by Subject|0|||
148796643|NCT04235504|536733164|FG003|Continuation Phase|Withdrawal by Subject|0|||
148796644|NCT04235504|536733161|FG000|Continuation Phase|Adverse Event|0|||
148796645|NCT04235504|536733162|FG001|Continuation Phase|Adverse Event|1|||
148796646|NCT04235504|536733163|FG002|Continuation Phase|Adverse Event|0|||
148796647|NCT04235504|536733164|FG003|Continuation Phase|Adverse Event|0|||
148796648|NCT04235504|536733161|FG000|Continuation Phase|Physician Decision|1|||
148796649|NCT04235504|536733162|FG001|Continuation Phase|Physician Decision|2|||
148796650|NCT04235504|536733163|FG002|Continuation Phase|Physician Decision|1|||
148796651|NCT04235504|536733164|FG003|Continuation Phase|Physician Decision|0|||
148796652|NCT00101868|536733171|FG000|Overall Study|Death|10|||
148796653|NCT00101868|536733172|FG001|Overall Study|Death|10|||
148796654|NCT00101868|536733171|FG000|Overall Study|Withdrawal by Subject|8|||
148796655|NCT00101868|536733172|FG001|Overall Study|Withdrawal by Subject|9|||
148796656|NCT00101868|536733171|FG000|Overall Study|Protocol Violation|3|||
148796657|NCT00101868|536733172|FG001|Overall Study|Protocol Violation|0|||
148796658|NCT00101868|536733171|FG000|Overall Study|Lost to Follow-up|8|||
148796659|NCT00101868|536733172|FG001|Overall Study|Lost to Follow-up|13|||
148796660|NCT03839394|536733173|FG000|Overall Study|Lost to Follow-up|6|||
148796661|NCT03839394|536733174|FG001|Overall Study|Lost to Follow-up|8|||
148796662|NCT03839394|536733173|FG000|Overall Study|Withdrawal by Subject|0|||
148796663|NCT03839394|536733174|FG001|Overall Study|Withdrawal by Subject|2|||
148796664|NCT04001803|536733175|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
148796665|NCT04001803|536733175|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
148796666|NCT04001803|536733175|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
148796667|NCT04001803|536733175|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
148796668|NCT04001803|536733175|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
148796669|NCT04001803|536733175|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
148796670|NCT04001803|536733175|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
148796671|NCT04001803|536733175|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
148796672|NCT04001803|536733175|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
148796673|NCT04001803|536733175|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
148796674|NCT01931397|536733178|FG000|Overall Study|Physician Decision|2|||
148796675|NCT01931397|536733178|FG000|Overall Study|Withdrawal by Subject|8|||
148895609|NCT01168349|537098542|FG000|Overall Study|Other|22|||
148796676|NCT01931397|536733178|FG000|Overall Study|moved out of state|1|||
148796677|NCT02329327|536733182|FG000|Overall Study|Death|78|||
149137221|NCT01087957|537983382|FG000|Overall Study|Protocol Violation|13|||
149137222|NCT01087957|537983383|FG001|Overall Study|Protocol Violation|25|||
149137223|NCT01087957|537983382|FG000|Overall Study|Withdrawal by Subject|18|||
149137224|NCT01087957|537983383|FG001|Overall Study|Withdrawal by Subject|15|||
149137225|NCT01087957|537983382|FG000|Overall Study|Physician Decision|5|||
149137226|NCT01087957|537983383|FG001|Overall Study|Physician Decision|9|||
149137227|NCT01399190|537983384|FG000|Overall Study|Not Eligible for Final Analysis|5|||
149137228|NCT01399190|537983384|FG000|Overall Study|Adverse Event|8|||
149137229|NCT01399190|537983384|FG000|Overall Study|Participant's Request|5|||
149137230|NCT01399190|537983384|FG000|Overall Study|Physician Decision|2|||
149137231|NCT03239483|537983386|FG000|Overall Study|Lost to Follow-up|1|||
149137232|NCT03239483|537983387|FG001|Overall Study|Lost to Follow-up|0|||
149137233|NCT03239483|537983386|FG000|Overall Study|Withdrawal by Subject|1|||
149137234|NCT03239483|537983387|FG001|Overall Study|Withdrawal by Subject|0|||
149137235|NCT01296035|537983388|FG000|Overall Study|Withdrawal by Subject|1|||
149137236|NCT01674712|537983389|FG000|Overall Study|Adverse Event|5|||
149137237|NCT01674712|537983390|FG001|Overall Study|Adverse Event|6|||
149137238|NCT01674712|537983391|FG002|Overall Study|Adverse Event|3|||
149137239|NCT01674712|537983392|FG003|Overall Study|Adverse Event|4|||
149137240|NCT01674712|537983393|FG004|Overall Study|Adverse Event|6|||
149137241|NCT01674712|537983389|FG000|Overall Study|Lost to Follow-up|1|||
149137242|NCT01674712|537983390|FG001|Overall Study|Lost to Follow-up|0|||
149137243|NCT01674712|537983391|FG002|Overall Study|Lost to Follow-up|0|||
149137244|NCT01674712|537983392|FG003|Overall Study|Lost to Follow-up|0|||
149137245|NCT01674712|537983393|FG004|Overall Study|Lost to Follow-up|0|||
149137246|NCT01674712|537983389|FG000|Overall Study|Protocol Violation|2|||
149137247|NCT01674712|537983390|FG001|Overall Study|Protocol Violation|0|||
149137248|NCT01674712|537983391|FG002|Overall Study|Protocol Violation|0|||
149137249|NCT01674712|537983392|FG003|Overall Study|Protocol Violation|0|||
149137250|NCT01674712|537983393|FG004|Overall Study|Protocol Violation|0|||
149137251|NCT01674712|537983389|FG000|Overall Study|Withdrawal by Subject|2|||
149137252|NCT01674712|537983390|FG001|Overall Study|Withdrawal by Subject|2|||
149137253|NCT01674712|537983391|FG002|Overall Study|Withdrawal by Subject|5|||
149137254|NCT01674712|537983392|FG003|Overall Study|Withdrawal by Subject|4|||
149137255|NCT01674712|537983393|FG004|Overall Study|Withdrawal by Subject|3|||
149137256|NCT01674712|537983389|FG000|Overall Study|Administrative|0|||
149137257|NCT01674712|537983390|FG001|Overall Study|Administrative|1|||
149137258|NCT01674712|537983391|FG002|Overall Study|Administrative|0|||
149137259|NCT01674712|537983392|FG003|Overall Study|Administrative|0|||
149137260|NCT01674712|537983393|FG004|Overall Study|Administrative|1|||
149137261|NCT01674712|537983389|FG000|Overall Study|Lack of Efficacy|0|||
149137262|NCT01674712|537983390|FG001|Overall Study|Lack of Efficacy|0|||
149137263|NCT01674712|537983391|FG002|Overall Study|Lack of Efficacy|1|||
149137264|NCT01674712|537983392|FG003|Overall Study|Lack of Efficacy|0|||
149137265|NCT01674712|537983393|FG004|Overall Study|Lack of Efficacy|1|||
149137266|NCT01287364|537983395|FG000|Overall Study|Adverse Event|0|||
149137267|NCT01287364|537983396|FG001|Overall Study|Adverse Event|3|||
149137268|NCT01287364|537983395|FG000|Overall Study|Protocol Violation|5|||
149137269|NCT01287364|537983396|FG001|Overall Study|Protocol Violation|5|||
149137270|NCT01287364|537983395|FG000|Overall Study|Other Reason|4|||
149137271|NCT01287364|537983396|FG001|Overall Study|Other Reason|2|||
149137272|NCT05372653|537983405|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
149137273|NCT05372653|537983406|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
149137274|NCT05372653|537983405|FG000|Overall Study|Adverse Event|0|||
149137275|NCT05372653|537983406|FG001|Overall Study|Adverse Event|1|||
149137276|NCT01003990|537983409|FG000|Overall Study|Adverse Event|8|||
149137277|NCT01003990|537983410|FG001|Overall Study|Adverse Event|5|||
149137278|NCT01003990|537983411|FG002|Overall Study|Adverse Event|11|||
149137279|NCT01003990|537983409|FG000|Overall Study|Death|0|||
149137280|NCT01003990|537983410|FG001|Overall Study|Death|8|||
149137281|NCT01003990|537983411|FG002|Overall Study|Death|1|||
149137282|NCT01003990|537983409|FG000|Overall Study|Lack of Efficacy|10|||
149137283|NCT01003990|537983410|FG001|Overall Study|Lack of Efficacy|2|||
149137284|NCT01003990|537983411|FG002|Overall Study|Lack of Efficacy|3|||
149137285|NCT01003990|537983409|FG000|Overall Study|Lost to Follow-up|30|||
149137286|NCT01003990|537983410|FG001|Overall Study|Lost to Follow-up|12|||
149137287|NCT01003990|537983411|FG002|Overall Study|Lost to Follow-up|7|||
149137288|NCT01003990|537983409|FG000|Overall Study|Reasons Not Identified|14|||
149137289|NCT01003990|537983410|FG001|Overall Study|Reasons Not Identified|13|||
149137290|NCT01003990|537983411|FG002|Overall Study|Reasons Not Identified|8|||
149137291|NCT01003990|537983409|FG000|Overall Study|Poor/Non-compliance|4|||
149137292|NCT01003990|537983410|FG001|Overall Study|Poor/Non-compliance|3|||
149137293|NCT01003990|537983411|FG002|Overall Study|Poor/Non-compliance|2|||
149137294|NCT01003990|537983409|FG000|Overall Study|Pregnancy|10|||
149137295|NCT01003990|537983410|FG001|Overall Study|Pregnancy|2|||
149137296|NCT01003990|537983411|FG002|Overall Study|Pregnancy|4|||
149137297|NCT01003990|537983409|FG000|Overall Study|No Longer Met Study Criteria|4|||
149137298|NCT01003990|537983410|FG001|Overall Study|No Longer Met Study Criteria|1|||
149137299|NCT01003990|537983411|FG002|Overall Study|No Longer Met Study Criteria|0|||
148895610|NCT01168349|537098542|FG000|Overall Study|Protocol Violation|76|||
148895611|NCT02678351|537098543|FG000|Overall Study|Withdrawal by Subject|1|||
148895612|NCT01632020|537098544|FG000|Overall Study|Withdrawal by Subject|1|||
148895613|NCT01632020|537098545|FG001|Overall Study|Withdrawal by Subject|0|||
148895614|NCT01632020|537098544|FG000|Overall Study|Adverse Event|1|||
148895615|NCT01632020|537098545|FG001|Overall Study|Adverse Event|0|||
148895616|NCT02978417|537098549|FG000|Overall Study|Lost to Follow-up|2|||
148895617|NCT02978417|537098550|FG001|Overall Study|Lost to Follow-up|2|||
148895618|NCT03416868|537098558|FG000|Overall Study|Withdrawal by Subject|2|||
149011463|NCT02778399|537521473|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
149137300|NCT01003990|537983409|FG000|Overall Study|Subject Withdrew Consent|12|||
149137301|NCT01003990|537983410|FG001|Overall Study|Subject Withdrew Consent|5|||
149137302|NCT01003990|537983411|FG002|Overall Study|Subject Withdrew Consent|7|||
149137303|NCT01829425|537983412|FG000|Overall Study|Withdrawal by Subject|4|||
149137304|NCT01829425|537983413|FG001|Overall Study|Withdrawal by Subject|3|||
149137305|NCT01829425|537983412|FG000|Overall Study|Lost to Follow-up|2|||
149137306|NCT01829425|537983413|FG001|Overall Study|Lost to Follow-up|1|||
149137307|NCT05211739|537983414|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
149137308|NCT05211739|537983415|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
149137309|NCT05211739|537983414|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
149137310|NCT05211739|537983415|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
149137311|NCT05211739|537983414|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
149137312|NCT05211739|537983415|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
149137313|NCT05211739|537983414|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
149137314|NCT05211739|537983415|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
149137315|NCT03606980|537983416|FG000|Overall Study|Lost to Follow-up|3|||
149137316|NCT03606980|537983417|FG001|Overall Study|Lost to Follow-up|2|||
149137317|NCT03606980|537983418|FG002|Overall Study|Lost to Follow-up|3|||
149137318|NCT03606980|537983416|FG000|Overall Study|Withdrawal by Subject|1|||
149137319|NCT03606980|537983417|FG001|Overall Study|Withdrawal by Subject|0|||
149137320|NCT03606980|537983418|FG002|Overall Study|Withdrawal by Subject|4|||
149137321|NCT01294150|537983421|FG000|Overall Study|Physician Decision|2|||
149137322|NCT01294150|537983422|FG001|Overall Study|Physician Decision|2|||
149137323|NCT03675776|537983423|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
149137324|NCT03675776|537983424|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
149137325|NCT03675776|537983425|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
149137326|NCT03675776|537983423|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
149137327|NCT03675776|537983424|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
149137328|NCT03675776|537983425|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
149137329|NCT00999713|537983426|FG000|Overall Study|Physician Decision|2|||
149137330|NCT00999713|537983427|FG001|Overall Study|Physician Decision|0|||
149137331|NCT03427125|537983431|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
149137332|NCT03427125|537983432|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
149137333|NCT03427125|537983433|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
149137334|NCT05390580|537983436|FG000|Overall Study|Physician Decision|3|||
149137335|NCT05390580|537983437|FG001|Overall Study|Physician Decision|2|||
149137336|NCT04014361|537983438|FG000|Period 2|Physician Decision|0|||
149137337|NCT04014361|537983439|FG001|Period 2|Physician Decision|0|||
149137338|NCT04014361|537983440|FG002|Period 2|Physician Decision|0|||
149137339|NCT04014361|537983441|FG003|Period 2|Physician Decision|1|||
149137340|NCT04014361|537983442|FG004|Period 2|Physician Decision|0|||
149137341|NCT04014361|537983443|FG005|Period 2|Physician Decision|0|||
149137342|NCT04014361|537983444|FG006|Period 2|Physician Decision|0|||
149137343|NCT04014361|537983445|FG007|Period 2|Physician Decision|0|||
149137344|NCT01130051|537983447|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
149137345|NCT01130051|537983448|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
149137346|NCT01130051|537983447|FG000|Washout Period of 14 Days|Protocol Violation|1|||
149137347|NCT01130051|537983448|FG001|Washout Period of 14 Days|Protocol Violation|1|||
149137348|NCT04252287|537983451|FG000|Overall Study|Death|5|||
149137349|NCT04252287|537983452|FG001|Overall Study|Death|3|||
149137350|NCT04252287|537983451|FG000|Overall Study|Lost to Follow-up|4|||
149137351|NCT04252287|537983452|FG001|Overall Study|Lost to Follow-up|6|||
149137352|NCT04252287|537983451|FG000|Overall Study|Withdrawal by Subject|19|||
149137353|NCT04252287|537983452|FG001|Overall Study|Withdrawal by Subject|16|||
149137354|NCT04252287|537983451|FG000|Overall Study|Protocol Violation|3|||
149137355|NCT04252287|537983452|FG001|Overall Study|Protocol Violation|4|||
149137356|NCT01310803|537985103|FG000|Overall Study|Subject terminated by Sponsor|1|||
149137357|NCT01310803|537985104|FG001|Overall Study|Subject terminated by Sponsor|0|||
149137358|NCT00332839|537985105|FG000|Core (Months 0 - 12)|Administrative problems|1|||
149137359|NCT00332839|537985106|FG001|Core (Months 0 - 12)|Administrative problems|1|||
149137360|NCT00332839|537985105|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
149137361|NCT00332839|537985106|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
149137362|NCT00332839|537985105|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
148895619|NCT03416868|537098558|FG000|Overall Study|Lost to Follow-up|1|||
148895620|NCT03473236|537098573|FG000|Overall Study|Withdrawal by Subject|0|||
148895621|NCT03473236|537098574|FG001|Overall Study|Withdrawal by Subject|0|||
148895622|NCT03473236|537098575|FG002|Overall Study|Withdrawal by Subject|0|||
148895623|NCT03473236|537098576|FG003|Overall Study|Withdrawal by Subject|0|||
148895624|NCT03473236|537098577|FG004|Overall Study|Withdrawal by Subject|0|||
148895625|NCT03473236|537098578|FG005|Overall Study|Withdrawal by Subject|1|||
148895626|NCT03473236|537098579|FG006|Overall Study|Withdrawal by Subject|0|||
148895627|NCT03473236|537098580|FG007|Overall Study|Withdrawal by Subject|0|||
148895628|NCT03473236|537098581|FG008|Overall Study|Withdrawal by Subject|1|||
148895629|NCT03473236|537098582|FG009|Overall Study|Withdrawal by Subject|0|||
148895630|NCT03155724|537098585|FG000|Overall Study|Death|3|||
148895631|NCT03155724|537098585|FG000|Overall Study|Physician Decision|1|||
148895632|NCT03155724|537098585|FG000|Overall Study|Study closure|7|||
148895633|NCT00525512|537098586|FG000|Double-Blind Phase|Adverse Event|48|||
148895634|NCT00525512|537098587|FG001|Double-Blind Phase|Adverse Event|28|||
148895635|NCT00525512|537098588|FG002|Double-Blind Phase|Adverse Event|0|||
148895636|NCT00525512|537098589|FG003|Double-Blind Phase|Adverse Event|0|||
148895637|NCT00525512|537098586|FG000|Double-Blind Phase|Protocol Violation|3|||
148895638|NCT00525512|537098587|FG001|Double-Blind Phase|Protocol Violation|1|||
148895639|NCT00525512|537098588|FG002|Double-Blind Phase|Protocol Violation|0|||
148895640|NCT00525512|537098589|FG003|Double-Blind Phase|Protocol Violation|0|||
148895641|NCT00525512|537098586|FG000|Double-Blind Phase|Lost to Follow-up|3|||
148895642|NCT00525512|537098587|FG001|Double-Blind Phase|Lost to Follow-up|7|||
148895643|NCT00525512|537098588|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148895644|NCT00525512|537098589|FG003|Double-Blind Phase|Lost to Follow-up|0|||
148895645|NCT00525512|537098586|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
148895646|NCT00525512|537098587|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
148895647|NCT00525512|537098588|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
148895648|NCT00525512|537098589|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
148895649|NCT00525512|537098586|FG000|Double-Blind Phase|Lack of Efficacy|13|||
148895650|NCT00525512|537098587|FG001|Double-Blind Phase|Lack of Efficacy|5|||
148895651|NCT00525512|537098588|FG002|Double-Blind Phase|Lack of Efficacy|0|||
148895652|NCT00525512|537098589|FG003|Double-Blind Phase|Lack of Efficacy|0|||
148895653|NCT00525512|537098586|FG000|Double-Blind Phase|Other reason (not specified)|12|||
148895654|NCT00525512|537098587|FG001|Double-Blind Phase|Other reason (not specified)|13|||
148895655|NCT00525512|537098588|FG002|Double-Blind Phase|Other reason (not specified)|0|||
148895656|NCT00525512|537098589|FG003|Double-Blind Phase|Other reason (not specified)|0|||
148895657|NCT00525512|537098586|FG000|Open-Label Phase|Adverse Event|0|||
148895658|NCT00525512|537098587|FG001|Open-Label Phase|Adverse Event|0|||
148895659|NCT00525512|537098588|FG002|Open-Label Phase|Adverse Event|1|||
148895660|NCT00525512|537098589|FG003|Open-Label Phase|Adverse Event|0|||
148895661|NCT00525512|537098586|FG000|Open-Label Phase|Lost to Follow-up|0|||
148895662|NCT00525512|537098587|FG001|Open-Label Phase|Lost to Follow-up|0|||
148895663|NCT00525512|537098588|FG002|Open-Label Phase|Lost to Follow-up|1|||
148895664|NCT00525512|537098589|FG003|Open-Label Phase|Lost to Follow-up|0|||
148796678|NCT02329327|536733183|FG001|Overall Study|Death|0|||
148796679|NCT02329327|536733182|FG000|Overall Study|Withdrawal by Subject|3|||
148796680|NCT02329327|536733183|FG001|Overall Study|Withdrawal by Subject|0|||
148796681|NCT02329327|536733182|FG000|Overall Study|Lost to Follow-up|4|||
148796682|NCT02329327|536733183|FG001|Overall Study|Lost to Follow-up|0|||
148796683|NCT02493517|536733184|FG000|Overall Study|Protocol Violation|1|||
148796684|NCT02493517|536733185|FG001|Overall Study|Protocol Violation|2|||
148796685|NCT02493517|536733184|FG000|Overall Study|Withdrawal by Subject|1|||
148796686|NCT02493517|536733185|FG001|Overall Study|Withdrawal by Subject|2|||
148796687|NCT02493517|536733184|FG000|Overall Study|Adverse Event|0|||
148796688|NCT02493517|536733185|FG001|Overall Study|Adverse Event|2|||
148796689|NCT02493517|536733184|FG000|Overall Study|Missed study visit|0|||
148796690|NCT02493517|536733185|FG001|Overall Study|Missed study visit|1|||
148796691|NCT01367249|536733186|FG000|Overall Study|Withdrawal by Subject|6|||
148796692|NCT01367249|536733187|FG001|Overall Study|Withdrawal by Subject|6|||
148796693|NCT01367249|536733186|FG000|Overall Study|Other|3|||
148796694|NCT01367249|536733187|FG001|Overall Study|Other|10|||
148796695|NCT03718429|536733189|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
148796696|NCT03718429|536733190|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
148796697|NCT03718429|536733191|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
148796698|NCT03718429|536733192|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
148796699|NCT05404711|536733193|FG000|Completed Study Visit|Withdrawal by Subject|1|||
148796700|NCT05404711|536733193|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
148796701|NCT05404711|536733193|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
148895665|NCT00525512|537098586|FG000|Open-Label Phase|Other reason (not specified)|0|||
148895666|NCT00525512|537098587|FG001|Open-Label Phase|Other reason (not specified)|0|||
148895667|NCT00525512|537098588|FG002|Open-Label Phase|Other reason (not specified)|4|||
148895668|NCT00525512|537098589|FG003|Open-Label Phase|Other reason (not specified)|5|||
148895669|NCT03309020|537098591|FG000|Overall Study|Death|1|||
148895670|NCT03309020|537098592|FG001|Overall Study|Death|0|||
148895671|NCT03309020|537098591|FG000|Overall Study|Did not undergo surgery|2|||
148895672|NCT03309020|537098592|FG001|Overall Study|Did not undergo surgery|1|||
148895673|NCT00402168|537098593|FG000|Randomized|Lost to Follow-up|1|||
148895674|NCT00402168|537098594|FG001|Randomized|Lost to Follow-up|0|||
148895675|NCT00402168|537098593|FG000|Randomized|Withdrawal by Subject|0|||
148895676|NCT00402168|537098594|FG001|Randomized|Withdrawal by Subject|1|||
148895677|NCT00402168|537098593|FG000|Treatment (up to 12 Months)|Death|0|||
148895678|NCT00402168|537098594|FG001|Treatment (up to 12 Months)|Death|1|||
148895679|NCT00402168|537098593|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
148895680|NCT00402168|537098594|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
148895681|NCT00402168|537098593|FG000|Treatment (up to 12 Months)|non-specified|0|||
148895682|NCT00402168|537098594|FG001|Treatment (up to 12 Months)|non-specified|1|||
148895683|NCT00402168|537098593|FG000|Long Term (LT)|Adverse Event|1|||
148895684|NCT00402168|537098594|FG001|Long Term (LT)|Adverse Event|5|||
148895685|NCT00402168|537098593|FG000|Long Term (LT)|Withdrawal by Subject|4|||
148895686|NCT00402168|537098594|FG001|Long Term (LT)|Withdrawal by Subject|7|||
148895687|NCT00402168|537098593|FG000|Long Term (LT)|Pregnancy|0|||
148895688|NCT00402168|537098594|FG001|Long Term (LT)|Pregnancy|1|||
148895689|NCT00402168|537098593|FG000|Long Term (LT)|Lost to Follow-up|1|||
148895690|NCT00402168|537098594|FG001|Long Term (LT)|Lost to Follow-up|0|||
148895691|NCT00402168|537098593|FG000|Long Term (LT)|Death|4|||
148895692|NCT00402168|537098594|FG001|Long Term (LT)|Death|0|||
148895693|NCT00402168|537098593|FG000|Long Term (LT)|Lack of Efficacy|0|||
148895694|NCT00402168|537098594|FG001|Long Term (LT)|Lack of Efficacy|2|||
148895695|NCT00402168|537098593|FG000|Long Term (LT)|non-specified|1|||
148895696|NCT00402168|537098594|FG001|Long Term (LT)|non-specified|2|||
148895697|NCT00402168|537098593|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
148895698|NCT00402168|537098594|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
148895699|NCT00402168|537098593|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
148895700|NCT00402168|537098594|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
148895701|NCT00601835|537098598|FG000|Overall Study|Withdrawal by Subject|9|||
148895702|NCT00601835|537098599|FG001|Overall Study|Withdrawal by Subject|6|||
148895703|NCT00601835|537098598|FG000|Overall Study|Physician Decision|1|||
148895704|NCT00601835|537098599|FG001|Overall Study|Physician Decision|0|||
148895705|NCT00601835|537098598|FG000|Overall Study|Lost to Follow-up|37|||
148895706|NCT00601835|537098599|FG001|Overall Study|Lost to Follow-up|5|||
148895707|NCT00601835|537098598|FG000|Overall Study|Adverse Event|1|||
148895708|NCT00601835|537098599|FG001|Overall Study|Adverse Event|1|||
148895709|NCT00601835|537098598|FG000|Overall Study|Relocate|12|||
148895710|NCT00601835|537098599|FG001|Overall Study|Relocate|2|||
148895711|NCT02370420|537098602|FG000|Overall Study|Physician Decision|3|||
148895712|NCT02370420|537098603|FG001|Overall Study|Physician Decision|3|||
148895713|NCT02370420|537098602|FG000|Overall Study|Lost to Follow-up|11|||
148895714|NCT02370420|537098603|FG001|Overall Study|Lost to Follow-up|9|||
148895715|NCT00880620|537098604|FG000|Overall Study|Adverse Event|4|||
148895716|NCT00880620|537098605|FG001|Overall Study|Adverse Event|5|||
148895717|NCT00880620|537098606|FG002|Overall Study|Adverse Event|15|||
148895718|NCT00880620|537098607|FG003|Overall Study|Adverse Event|15|||
148895719|NCT00880620|537098604|FG000|Overall Study|Death|0|||
148895720|NCT00880620|537098605|FG001|Overall Study|Death|0|||
148895721|NCT00880620|537098606|FG002|Overall Study|Death|1|||
148895722|NCT00880620|537098607|FG003|Overall Study|Death|0|||
148895723|NCT00880620|537098604|FG000|Overall Study|Lack of Efficacy|12|||
148895724|NCT00880620|537098605|FG001|Overall Study|Lack of Efficacy|4|||
148895725|NCT00880620|537098606|FG002|Overall Study|Lack of Efficacy|0|||
148895726|NCT00880620|537098607|FG003|Overall Study|Lack of Efficacy|1|||
148895727|NCT00880620|537098604|FG000|Overall Study|Lost to Follow-up|0|||
148895728|NCT00880620|537098605|FG001|Overall Study|Lost to Follow-up|1|||
148895729|NCT00880620|537098606|FG002|Overall Study|Lost to Follow-up|1|||
148895730|NCT00880620|537098607|FG003|Overall Study|Lost to Follow-up|0|||
148895731|NCT00880620|537098604|FG000|Overall Study|Protocol Violation|0|||
148895732|NCT00880620|537098605|FG001|Overall Study|Protocol Violation|1|||
148895733|NCT00880620|537098606|FG002|Overall Study|Protocol Violation|0|||
148895734|NCT00880620|537098607|FG003|Overall Study|Protocol Violation|2|||
148895735|NCT00880620|537098604|FG000|Overall Study|Withdrawal by Subject|4|||
148895736|NCT00880620|537098605|FG001|Overall Study|Withdrawal by Subject|3|||
148895737|NCT00880620|537098606|FG002|Overall Study|Withdrawal by Subject|1|||
148895738|NCT00880620|537098607|FG003|Overall Study|Withdrawal by Subject|3|||
148895739|NCT00880620|537098604|FG000|Overall Study|Noncompliance|0|||
148895740|NCT00880620|537098605|FG001|Overall Study|Noncompliance|0|||
148895741|NCT00880620|537098606|FG002|Overall Study|Noncompliance|1|||
148895742|NCT00880620|537098607|FG003|Overall Study|Noncompliance|1|||
148895743|NCT00880620|537098604|FG000|Overall Study|Other|1|||
148895744|NCT00880620|537098605|FG001|Overall Study|Other|1|||
148895745|NCT00880620|537098606|FG002|Overall Study|Other|2|||
148895746|NCT00880620|537098607|FG003|Overall Study|Other|2|||
148895747|NCT05893862|537098608|FG000|Overall Study|Physician Decision|0|||
148895748|NCT05893862|537098609|FG001|Overall Study|Physician Decision|1|||
148895749|NCT05893862|537098610|FG002|Overall Study|Physician Decision|0|||
148895750|NCT05893862|537098611|FG003|Overall Study|Physician Decision|0|||
148796702|NCT05404711|536733193|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
148796703|NCT05404711|536733193|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
148796704|NCT05404711|536733193|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
148796705|NCT02346877|536733194|FG000|Overall Study|Adverse Event|1|||
148796706|NCT02346877|536733195|FG001|Overall Study|Adverse Event|0|||
148796707|NCT02346877|536733194|FG000|Overall Study|Administrative Decision|1|||
148796708|NCT02346877|536733195|FG001|Overall Study|Administrative Decision|0|||
148796709|NCT02346877|536733194|FG000|Overall Study|Sponsor Decision|12|||
148796710|NCT02346877|536733195|FG001|Overall Study|Sponsor Decision|0|||
148796711|NCT02346877|536733194|FG000|Overall Study|Missing|5|||
148796712|NCT02346877|536733195|FG001|Overall Study|Missing|0|||
148796713|NCT01817075|536733196|FG000|Overall Study|Adverse Event|7|||
148796714|NCT01817075|536733197|FG001|Overall Study|Adverse Event|5|||
148796715|NCT01817075|536733196|FG000|Overall Study|Physician Decision|9|||
148796716|NCT01817075|536733197|FG001|Overall Study|Physician Decision|12|||
148796717|NCT01817075|536733196|FG000|Overall Study|Withdrawal by Subject|31|||
148796718|NCT01817075|536733197|FG001|Overall Study|Withdrawal by Subject|15|||
148796719|NCT01817075|536733196|FG000|Overall Study|Received Sorafenib after enrollment|0|||
148796720|NCT01817075|536733197|FG001|Overall Study|Received Sorafenib after enrollment|1|||
148796721|NCT01817075|536733196|FG000|Overall Study|Ineligible|0|||
148796722|NCT01817075|536733197|FG001|Overall Study|Ineligible|2|||
148796723|NCT01683604|536733200|FG000|Overall Study|Adverse Event|2|||
148796724|NCT01683604|536733200|FG000|Overall Study|Lack of Efficacy|1|||
148796725|NCT01683604|536733200|FG000|Overall Study|Other|2|||
148796726|NCT01395810|536733207|FG000|Overall Study|Adverse Event|0|||
148796727|NCT01395810|536733208|FG001|Overall Study|Adverse Event|1|||
148796728|NCT01395810|536733209|FG002|Overall Study|Adverse Event|0|||
148796729|NCT01395810|536733210|FG003|Overall Study|Adverse Event|0|||
148796730|NCT01395810|536733207|FG000|Overall Study|Lack of Efficacy|0|||
148796731|NCT01395810|536733208|FG001|Overall Study|Lack of Efficacy|1|||
148796732|NCT01395810|536733209|FG002|Overall Study|Lack of Efficacy|0|||
148796733|NCT01395810|536733210|FG003|Overall Study|Lack of Efficacy|0|||
148796734|NCT01395810|536733207|FG000|Overall Study|Withdrawal criteria|0|||
148796735|NCT01395810|536733208|FG001|Overall Study|Withdrawal criteria|2|||
148796736|NCT01395810|536733209|FG002|Overall Study|Withdrawal criteria|0|||
148796737|NCT01395810|536733210|FG003|Overall Study|Withdrawal criteria|0|||
148796738|NCT01395810|536733207|FG000|Overall Study|Unclassified|2|||
148796739|NCT01395810|536733208|FG001|Overall Study|Unclassified|0|||
148796740|NCT01395810|536733209|FG002|Overall Study|Unclassified|0|||
148796741|NCT01395810|536733210|FG003|Overall Study|Unclassified|0|||
148796742|NCT03877224|536733211|FG000|Overall Study|Death|3|||
148796743|NCT03877224|536733212|FG001|Overall Study|Death|2|||
148796744|NCT03877224|536733211|FG000|Overall Study|Withdrawal by Subject|1|||
148796745|NCT03877224|536733212|FG001|Overall Study|Withdrawal by Subject|6|||
148796746|NCT03877224|536733211|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
148796747|NCT03877224|536733212|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
148796748|NCT02481050|536735021|FG000|Overall Study|Adverse Event|1|||
148796749|NCT02481050|536735021|FG000|Overall Study|Disease Progression|47|||
148796750|NCT02481050|536735021|FG000|Overall Study|Withdrawal by Subject|7|||
148796751|NCT02481050|536735021|FG000|Overall Study|Other|3|||
148796752|NCT01228591|536735022|FG000|Baseline|Lack of Efficacy|1|||
148796753|NCT01228591|536735023|FG001|Baseline|Lack of Efficacy|2|||
148796754|NCT01095835|536735024|FG000|Overall Study|Adverse Event|8|||
148796755|NCT01095835|536735025|FG001|Overall Study|Adverse Event|6|||
148796756|NCT01095835|536735026|FG002|Overall Study|Adverse Event|6|||
148796757|NCT01095835|536735024|FG000|Overall Study|Lack of Efficacy|0|||
148796758|NCT01095835|536735025|FG001|Overall Study|Lack of Efficacy|1|||
148796759|NCT01095835|536735026|FG002|Overall Study|Lack of Efficacy|0|||
148796760|NCT01095835|536735024|FG000|Overall Study|Physician Decision|0|||
148796761|NCT01095835|536735025|FG001|Overall Study|Physician Decision|0|||
148796762|NCT01095835|536735026|FG002|Overall Study|Physician Decision|1|||
148796763|NCT01095835|536735024|FG000|Overall Study|Withdrawal by Subject|1|||
148796764|NCT01095835|536735025|FG001|Overall Study|Withdrawal by Subject|3|||
148796765|NCT01095835|536735026|FG002|Overall Study|Withdrawal by Subject|0|||
148796766|NCT01095835|536735024|FG000|Overall Study|Non study compliance|0|||
148796767|NCT01095835|536735025|FG001|Overall Study|Non study compliance|0|||
148796768|NCT01095835|536735026|FG002|Overall Study|Non study compliance|1|||
148796769|NCT01095835|536735024|FG000|Overall Study|Protocol Violation|1|||
148796770|NCT01095835|536735025|FG001|Overall Study|Protocol Violation|2|||
148796771|NCT01095835|536735026|FG002|Overall Study|Protocol Violation|0|||
148796772|NCT03110354|536735027|FG000|Overall Study|Death|1|||
148796773|NCT03110354|536735028|FG001|Overall Study|Death|0|||
148796774|NCT03110354|536735029|FG002|Overall Study|Death|0|||
148796775|NCT03110354|536735030|FG003|Overall Study|Death|1|||
148796776|NCT03110354|536735031|FG004|Overall Study|Death|0|||
148796777|NCT03110354|536735027|FG000|Overall Study|Start of new therapy|0|||
148796778|NCT03110354|536735028|FG001|Overall Study|Start of new therapy|0|||
148796779|NCT03110354|536735029|FG002|Overall Study|Start of new therapy|0|||
148895751|NCT05893862|537098612|FG004|Overall Study|Physician Decision|1|||
148895752|NCT05893862|537098613|FG005|Overall Study|Physician Decision|0|||
148895753|NCT05893862|537098608|FG000|Overall Study|Withdrawal by Subject|1|||
148895754|NCT05893862|537098609|FG001|Overall Study|Withdrawal by Subject|7|||
148895755|NCT05893862|537098610|FG002|Overall Study|Withdrawal by Subject|1|||
148895756|NCT05893862|537098611|FG003|Overall Study|Withdrawal by Subject|3|||
148895757|NCT05893862|537098612|FG004|Overall Study|Withdrawal by Subject|3|||
148895758|NCT05893862|537098613|FG005|Overall Study|Withdrawal by Subject|2|||
148895759|NCT05893862|537098608|FG000|Overall Study|Adverse Event|1|||
148895760|NCT05893862|537098609|FG001|Overall Study|Adverse Event|4|||
148895761|NCT05893862|537098610|FG002|Overall Study|Adverse Event|2|||
148895762|NCT05893862|537098611|FG003|Overall Study|Adverse Event|2|||
148895763|NCT05893862|537098612|FG004|Overall Study|Adverse Event|1|||
148895764|NCT05893862|537098613|FG005|Overall Study|Adverse Event|0|||
148895765|NCT01400698|537098614|FG000|Overall Study|Lost to Follow-up|2|||
148895766|NCT01400698|537098615|FG001|Overall Study|Lost to Follow-up|5|||
148895767|NCT01400698|537098616|FG002|Overall Study|Lost to Follow-up|2|||
148895768|NCT01400698|537098617|FG003|Overall Study|Lost to Follow-up|1|||
148895769|NCT01400698|537098618|FG004|Overall Study|Lost to Follow-up|4|||
148895770|NCT01400698|537098619|FG005|Overall Study|Lost to Follow-up|3|||
148895771|NCT01400698|537098614|FG000|Overall Study|Withdrawal by Subject|8|||
148895772|NCT01400698|537098615|FG001|Overall Study|Withdrawal by Subject|2|||
148895773|NCT01400698|537098616|FG002|Overall Study|Withdrawal by Subject|0|||
148895774|NCT01400698|537098617|FG003|Overall Study|Withdrawal by Subject|4|||
148895775|NCT01400698|537098618|FG004|Overall Study|Withdrawal by Subject|1|||
148895776|NCT01400698|537098619|FG005|Overall Study|Withdrawal by Subject|3|||
148895777|NCT01400698|537098614|FG000|Overall Study|Protocol Violation|0|||
148895778|NCT01400698|537098615|FG001|Overall Study|Protocol Violation|1|||
148895779|NCT01400698|537098616|FG002|Overall Study|Protocol Violation|0|||
148895780|NCT01400698|537098617|FG003|Overall Study|Protocol Violation|0|||
148895781|NCT01400698|537098618|FG004|Overall Study|Protocol Violation|1|||
148895782|NCT01400698|537098619|FG005|Overall Study|Protocol Violation|0|||
148895783|NCT01400698|537098614|FG000|Overall Study|Non-compliance|0|||
148895784|NCT01400698|537098615|FG001|Overall Study|Non-compliance|1|||
148895785|NCT01400698|537098616|FG002|Overall Study|Non-compliance|0|||
148895786|NCT01400698|537098617|FG003|Overall Study|Non-compliance|1|||
148895787|NCT01400698|537098618|FG004|Overall Study|Non-compliance|0|||
148895788|NCT01400698|537098619|FG005|Overall Study|Non-compliance|0|||
148895789|NCT01400698|537098614|FG000|Overall Study|Adverse Event|1|||
148895790|NCT01400698|537098615|FG001|Overall Study|Adverse Event|0|||
148895791|NCT01400698|537098616|FG002|Overall Study|Adverse Event|0|||
148895792|NCT01400698|537098617|FG003|Overall Study|Adverse Event|0|||
148895793|NCT01400698|537098618|FG004|Overall Study|Adverse Event|0|||
148895794|NCT01400698|537098619|FG005|Overall Study|Adverse Event|0|||
148895795|NCT01400698|537098614|FG000|Overall Study|Other|4|||
148895796|NCT01400698|537098615|FG001|Overall Study|Other|2|||
148895797|NCT01400698|537098616|FG002|Overall Study|Other|0|||
148895798|NCT01400698|537098617|FG003|Overall Study|Other|2|||
148895799|NCT01400698|537098618|FG004|Overall Study|Other|1|||
148895800|NCT01400698|537098619|FG005|Overall Study|Other|0|||
148895801|NCT02919761|537098620|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
148895802|NCT02919761|537098621|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
148895803|NCT02919761|537098622|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
148895804|NCT02919761|537098620|FG000|Part 1: Open Label|Adverse Event|1|||
148895805|NCT02919761|537098621|FG001|Part 1: Open Label|Adverse Event|0|||
148895806|NCT02919761|537098622|FG002|Part 1: Open Label|Adverse Event|0|||
149137363|NCT00332839|537985106|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
148895807|NCT02919761|537098620|FG000|Part 1: Open Label|Lost to Follow-up|1|||
148895808|NCT02919761|537098621|FG001|Part 1: Open Label|Lost to Follow-up|0|||
148895809|NCT02919761|537098622|FG002|Part 1: Open Label|Lost to Follow-up|0|||
148895810|NCT02919761|537098620|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
148895811|NCT02919761|537098621|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
148895812|NCT02919761|537098622|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
148895813|NCT02919761|537098620|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
148895814|NCT02919761|537098621|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
148895815|NCT02919761|537098622|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
148895816|NCT02919761|537098620|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
148895817|NCT02919761|537098621|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
148895818|NCT02919761|537098622|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
148895819|NCT02919761|537098620|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
148895820|NCT02919761|537098621|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
148895821|NCT02919761|537098622|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
148895822|NCT02919761|537098620|FG000|Part 1: Open Label|Termination by Sponsor|1|||
148895823|NCT02919761|537098621|FG001|Part 1: Open Label|Termination by Sponsor|0|||
148895824|NCT02919761|537098622|FG002|Part 1: Open Label|Termination by Sponsor|0|||
148895825|NCT02919761|537098620|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
148895826|NCT02919761|537098621|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
148895827|NCT02919761|537098622|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
148895828|NCT02919761|537098620|FG000|Part 2: Double-blind|Adverse Event|0|||
148895829|NCT02919761|537098621|FG001|Part 2: Double-blind|Adverse Event|1|||
148895830|NCT02919761|537098622|FG002|Part 2: Double-blind|Adverse Event|0|||
148895831|NCT02919761|537098620|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
148895832|NCT02919761|537098621|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
148895833|NCT02919761|537098622|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
148895834|NCT02919761|537098620|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
148895835|NCT02919761|537098621|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
148895836|NCT02919761|537098622|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
148895837|NCT02919761|537098620|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
148895838|NCT02919761|537098621|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
148895839|NCT02919761|537098622|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
148895840|NCT02919761|537098620|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
148895841|NCT02919761|537098621|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
148895842|NCT02919761|537098622|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
148895843|NCT02919761|537098620|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
148895844|NCT02919761|537098621|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
148895845|NCT02919761|537098622|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
148895846|NCT02919761|537098620|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
148895847|NCT02919761|537098621|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
148895848|NCT02919761|537098622|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
148895849|NCT01352117|537100761|FG000|Overall Study|Death|15|||
148895850|NCT01352117|537100762|FG001|Overall Study|Death|16|||
148895851|NCT01352117|537100761|FG000|Overall Study|Withdrawal by Subject|1|||
148895852|NCT01352117|537100762|FG001|Overall Study|Withdrawal by Subject|0|||
148895853|NCT01352117|537100761|FG000|Overall Study|Lost to Follow-up|2|||
148895854|NCT01352117|537100762|FG001|Overall Study|Lost to Follow-up|7|||
148895855|NCT01352117|537100761|FG000|Overall Study|Non-adherent to study requirements|1|||
148895856|NCT01352117|537100762|FG001|Overall Study|Non-adherent to study requirements|1|||
148895857|NCT01352117|537100761|FG000|Overall Study|Did not initiate study treatment|1|||
148895858|NCT01352117|537100762|FG001|Overall Study|Did not initiate study treatment|0|||
148895859|NCT01352117|537100761|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
148895860|NCT01352117|537100762|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
148895861|NCT00385671|537100763|FG000|Overall Study|Adverse Event|14|||
148895862|NCT00385671|537100764|FG001|Overall Study|Adverse Event|27|||
148895863|NCT00385671|537100765|FG002|Overall Study|Adverse Event|18|||
148895864|NCT00385671|537100763|FG000|Overall Study|Lack of Efficacy|5|||
148895865|NCT00385671|537100764|FG001|Overall Study|Lack of Efficacy|9|||
148895866|NCT00385671|537100765|FG002|Overall Study|Lack of Efficacy|5|||
148895867|NCT00385671|537100763|FG000|Overall Study|Lost to Follow-up|6|||
148895868|NCT00385671|537100764|FG001|Overall Study|Lost to Follow-up|6|||
148895869|NCT00385671|537100765|FG002|Overall Study|Lost to Follow-up|5|||
148895870|NCT00385671|537100763|FG000|Overall Study|Physician Decision|2|||
148895871|NCT00385671|537100764|FG001|Overall Study|Physician Decision|1|||
148895872|NCT00385671|537100765|FG002|Overall Study|Physician Decision|2|||
148895873|NCT00385671|537100763|FG000|Overall Study|Protocol Violation|5|||
148895874|NCT00385671|537100764|FG001|Overall Study|Protocol Violation|2|||
148895875|NCT00385671|537100765|FG002|Overall Study|Protocol Violation|1|||
148895876|NCT00385671|537100763|FG000|Overall Study|Sponsor Decision|2|||
148895877|NCT00385671|537100764|FG001|Overall Study|Sponsor Decision|2|||
148895878|NCT00385671|537100765|FG002|Overall Study|Sponsor Decision|1|||
148895879|NCT00385671|537100763|FG000|Overall Study|Withdrawal by Subject|4|||
148895880|NCT00385671|537100764|FG001|Overall Study|Withdrawal by Subject|4|||
148895881|NCT00385671|537100765|FG002|Overall Study|Withdrawal by Subject|4|||
148895882|NCT03037385|537100768|FG000|Overall Study|Adverse Event|0|||
148895883|NCT03037385|537100769|FG001|Overall Study|Adverse Event|0|||
148895884|NCT03037385|537100770|FG002|Overall Study|Adverse Event|1|||
148895885|NCT03037385|537100771|FG003|Overall Study|Adverse Event|0|||
148895886|NCT03037385|537100772|FG004|Overall Study|Adverse Event|0|||
148895887|NCT03037385|537100773|FG005|Overall Study|Adverse Event|0|||
148895888|NCT03037385|537100774|FG006|Overall Study|Adverse Event|0|||
148895889|NCT03037385|537100775|FG007|Overall Study|Adverse Event|0|||
148895890|NCT03037385|537100776|FG008|Overall Study|Adverse Event|0|||
148895891|NCT03037385|537100777|FG009|Overall Study|Adverse Event|6|||
148895892|NCT03037385|537100768|FG000|Overall Study|Death|1|||
148895893|NCT03037385|537100769|FG001|Overall Study|Death|4|||
148895894|NCT03037385|537100770|FG002|Overall Study|Death|2|||
148895895|NCT03037385|537100771|FG003|Overall Study|Death|2|||
148895896|NCT03037385|537100772|FG004|Overall Study|Death|5|||
148895897|NCT03037385|537100773|FG005|Overall Study|Death|2|||
148895898|NCT03037385|537100774|FG006|Overall Study|Death|1|||
148895899|NCT03037385|537100775|FG007|Overall Study|Death|4|||
148895900|NCT03037385|537100776|FG008|Overall Study|Death|3|||
148895901|NCT03037385|537100777|FG009|Overall Study|Death|240|||
148895902|NCT03037385|537100768|FG000|Overall Study|Initiation of Another Therapy|1|||
148895903|NCT03037385|537100769|FG001|Overall Study|Initiation of Another Therapy|0|||
148895904|NCT03037385|537100770|FG002|Overall Study|Initiation of Another Therapy|0|||
148895905|NCT03037385|537100771|FG003|Overall Study|Initiation of Another Therapy|0|||
148895906|NCT03037385|537100772|FG004|Overall Study|Initiation of Another Therapy|0|||
148895907|NCT03037385|537100773|FG005|Overall Study|Initiation of Another Therapy|0|||
148895908|NCT03037385|537100774|FG006|Overall Study|Initiation of Another Therapy|0|||
148895909|NCT03037385|537100775|FG007|Overall Study|Initiation of Another Therapy|1|||
148895910|NCT03037385|537100776|FG008|Overall Study|Initiation of Another Therapy|0|||
148895911|NCT03037385|537100777|FG009|Overall Study|Initiation of Another Therapy|2|||
148895912|NCT03037385|537100768|FG000|Overall Study|Lost to Follow-up|0|||
148895913|NCT03037385|537100769|FG001|Overall Study|Lost to Follow-up|0|||
148895914|NCT03037385|537100770|FG002|Overall Study|Lost to Follow-up|0|||
148895915|NCT03037385|537100771|FG003|Overall Study|Lost to Follow-up|0|||
148895916|NCT03037385|537100772|FG004|Overall Study|Lost to Follow-up|0|||
148895917|NCT03037385|537100773|FG005|Overall Study|Lost to Follow-up|1|||
148895918|NCT03037385|537100774|FG006|Overall Study|Lost to Follow-up|0|||
148895919|NCT03037385|537100775|FG007|Overall Study|Lost to Follow-up|0|||
148895920|NCT03037385|537100776|FG008|Overall Study|Lost to Follow-up|0|||
148895921|NCT03037385|537100777|FG009|Overall Study|Lost to Follow-up|16|||
148895922|NCT03037385|537100768|FG000|Overall Study|Physician Decision|0|||
148895923|NCT03037385|537100769|FG001|Overall Study|Physician Decision|0|||
148895924|NCT03037385|537100770|FG002|Overall Study|Physician Decision|0|||
148895925|NCT03037385|537100771|FG003|Overall Study|Physician Decision|0|||
148895926|NCT03037385|537100772|FG004|Overall Study|Physician Decision|0|||
148895927|NCT03037385|537100773|FG005|Overall Study|Physician Decision|0|||
148895928|NCT03037385|537100774|FG006|Overall Study|Physician Decision|0|||
148895929|NCT03037385|537100775|FG007|Overall Study|Physician Decision|0|||
148895930|NCT03037385|537100776|FG008|Overall Study|Physician Decision|0|||
148895931|NCT03037385|537100777|FG009|Overall Study|Physician Decision|1|||
148895932|NCT03037385|537100768|FG000|Overall Study|Progressive Disease|0|||
148895933|NCT03037385|537100769|FG001|Overall Study|Progressive Disease|1|||
148895934|NCT03037385|537100770|FG002|Overall Study|Progressive Disease|1|||
148895935|NCT03037385|537100771|FG003|Overall Study|Progressive Disease|5|||
148895936|NCT03037385|537100772|FG004|Overall Study|Progressive Disease|2|||
148895937|NCT03037385|537100773|FG005|Overall Study|Progressive Disease|0|||
148895938|NCT03037385|537100774|FG006|Overall Study|Progressive Disease|1|||
148895939|NCT03037385|537100775|FG007|Overall Study|Progressive Disease|0|||
148895940|NCT03037385|537100776|FG008|Overall Study|Progressive Disease|0|||
148895941|NCT03037385|537100777|FG009|Overall Study|Progressive Disease|30|||
148895942|NCT03037385|537100768|FG000|Overall Study|Withdrawal by Subject|0|||
148895943|NCT03037385|537100769|FG001|Overall Study|Withdrawal by Subject|0|||
148895944|NCT03037385|537100770|FG002|Overall Study|Withdrawal by Subject|1|||
148895945|NCT03037385|537100771|FG003|Overall Study|Withdrawal by Subject|2|||
148895946|NCT03037385|537100772|FG004|Overall Study|Withdrawal by Subject|1|||
148895947|NCT03037385|537100773|FG005|Overall Study|Withdrawal by Subject|3|||
148895948|NCT03037385|537100774|FG006|Overall Study|Withdrawal by Subject|0|||
148895949|NCT03037385|537100775|FG007|Overall Study|Withdrawal by Subject|0|||
148895950|NCT03037385|537100776|FG008|Overall Study|Withdrawal by Subject|0|||
148895951|NCT03037385|537100777|FG009|Overall Study|Withdrawal by Subject|52|||
148895952|NCT03037385|537100768|FG000|Overall Study|Reason Not Specified|0|||
148895953|NCT03037385|537100769|FG001|Overall Study|Reason Not Specified|1|||
148895954|NCT03037385|537100770|FG002|Overall Study|Reason Not Specified|0|||
148895955|NCT03037385|537100771|FG003|Overall Study|Reason Not Specified|4|||
148895956|NCT03037385|537100772|FG004|Overall Study|Reason Not Specified|3|||
148895957|NCT03037385|537100773|FG005|Overall Study|Reason Not Specified|6|||
148895958|NCT03037385|537100774|FG006|Overall Study|Reason Not Specified|2|||
148895959|NCT03037385|537100775|FG007|Overall Study|Reason Not Specified|0|||
148895960|NCT03037385|537100776|FG008|Overall Study|Reason Not Specified|1|||
148895961|NCT03037385|537100777|FG009|Overall Study|Reason Not Specified|181|||
148895962|NCT04515771|537100778|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
148895963|NCT04515771|537100779|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
148895964|NCT04515771|537100778|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
148895965|NCT04515771|537100779|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
148895966|NCT04515771|537100778|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
148895967|NCT04515771|537100779|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
148895968|NCT01021020|537100781|FG000|Period I|Protocol Violation|1|||
148895969|NCT01021020|537100781|FG000|Period I|Withdrawal by Subject|1|||
148895970|NCT01021020|537100781|FG000|14 Day Washout Period A|Physician Decision|1|||
148895971|NCT05543265|537100785|FG000|Overall Study|Lost to Follow-up|3|||
148895972|NCT05543265|537100786|FG001|Overall Study|Lost to Follow-up|3|||
148895973|NCT05543265|537100785|FG000|Overall Study|Withdrawal by Subject|0|||
148895974|NCT05543265|537100786|FG001|Overall Study|Withdrawal by Subject|1|||
148895975|NCT02927301|537100787|FG000|Overall Study|Death|39|||
148895976|NCT02927301|537100787|FG000|Overall Study|Lost to Follow-up|8|||
148895977|NCT02927301|537100787|FG000|Overall Study|Physician Decision|2|||
148895978|NCT02927301|537100787|FG000|Overall Study|Withdrawal by Subject|12|||
148895979|NCT02927301|537100787|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
148895980|NCT03035032|537100788|FG000|Overall Study|Adverse Event|2|||
148895981|NCT03035032|537100788|FG000|Overall Study|Death|9|||
148895982|NCT03035032|537100788|FG000|Overall Study|Lost to Follow-up|1|||
148895983|NCT03035032|537100788|FG000|Overall Study|Progressive Disease|22|||
148895984|NCT03035032|537100788|FG000|Overall Study|Protocol Violation|2|||
148895985|NCT03035032|537100788|FG000|Overall Study|Withdrawal by Subject|2|||
148895986|NCT03035032|537100788|FG000|Overall Study|Physician Decision|5|||
148895987|NCT03780452|537100798|FG000|Overall Study|Screening failure|2|||
148895988|NCT00914849|537100799|FG000|Overall Study|Withdrawal by Subject|1|||
148895989|NCT00914849|537100800|FG001|Overall Study|Withdrawal by Subject|0|||
148895990|NCT00914849|537100799|FG000|Overall Study|Not eligible|0|||
148895991|NCT00914849|537100800|FG001|Overall Study|Not eligible|1|||
148895992|NCT01001221|537100801|FG000|Overall Study|Adverse Event|1|||
148895993|NCT01001221|537100802|FG001|Overall Study|Adverse Event|2|||
148895994|NCT01001221|537100803|FG002|Overall Study|Adverse Event|0|||
148895995|NCT01001221|537100804|FG003|Overall Study|Adverse Event|2|||
148895996|NCT01001221|537100805|FG004|Overall Study|Adverse Event|0|||
148895997|NCT01001221|537100801|FG000|Overall Study|Disease progression|3|||
148895998|NCT01001221|537100802|FG001|Overall Study|Disease progression|2|||
148895999|NCT01001221|537100803|FG002|Overall Study|Disease progression|2|||
148896000|NCT01001221|537100804|FG003|Overall Study|Disease progression|4|||
148896001|NCT01001221|537100805|FG004|Overall Study|Disease progression|0|||
148896002|NCT01001221|537100801|FG000|Overall Study|Other|1|||
148896003|NCT01001221|537100802|FG001|Overall Study|Other|1|||
148896004|NCT01001221|537100803|FG002|Overall Study|Other|0|||
148896005|NCT01001221|537100804|FG003|Overall Study|Other|0|||
148896006|NCT01001221|537100805|FG004|Overall Study|Other|0|||
148896007|NCT01001221|537100801|FG000|Overall Study|Not treated; protocol exclusion|0|||
148896008|NCT01001221|537100802|FG001|Overall Study|Not treated; protocol exclusion|0|||
148896009|NCT01001221|537100803|FG002|Overall Study|Not treated; protocol exclusion|1|||
148896010|NCT01001221|537100804|FG003|Overall Study|Not treated; protocol exclusion|0|||
148796780|NCT03110354|536735030|FG003|Overall Study|Start of new therapy|0|||
148796781|NCT03110354|536735031|FG004|Overall Study|Start of new therapy|1|||
148796782|NCT03110354|536735027|FG000|Overall Study|Failure to achieve response|2|||
148796783|NCT03110354|536735028|FG001|Overall Study|Failure to achieve response|3|||
148796784|NCT03110354|536735029|FG002|Overall Study|Failure to achieve response|0|||
148796785|NCT03110354|536735030|FG003|Overall Study|Failure to achieve response|2|||
148796786|NCT03110354|536735031|FG004|Overall Study|Failure to achieve response|1|||
148796787|NCT03110354|536735027|FG000|Overall Study|Progressive disease|1|||
148796788|NCT03110354|536735028|FG001|Overall Study|Progressive disease|1|||
148796789|NCT03110354|536735029|FG002|Overall Study|Progressive disease|3|||
148796790|NCT03110354|536735030|FG003|Overall Study|Progressive disease|4|||
148796791|NCT03110354|536735031|FG004|Overall Study|Progressive disease|2|||
148796792|NCT03110354|536735027|FG000|Overall Study|Adverse Event|0|||
148796793|NCT03110354|536735028|FG001|Overall Study|Adverse Event|0|||
148796794|NCT03110354|536735029|FG002|Overall Study|Adverse Event|0|||
148796795|NCT03110354|536735030|FG003|Overall Study|Adverse Event|2|||
148796796|NCT03110354|536735031|FG004|Overall Study|Adverse Event|2|||
148796797|NCT03110354|536735027|FG000|Overall Study|Other|0|||
148796798|NCT03110354|536735028|FG001|Overall Study|Other|0|||
148796799|NCT03110354|536735029|FG002|Overall Study|Other|0|||
148796800|NCT03110354|536735030|FG003|Overall Study|Other|1|||
148796801|NCT03110354|536735031|FG004|Overall Study|Other|1|||
148896011|NCT01001221|537100805|FG004|Overall Study|Not treated; protocol exclusion|0|||
148896012|NCT02388269|537100806|FG000|Overall Study|Adverse Event|2|||
148796802|NCT01298700|536735032|FG000|Overall Study|Adverse Event|50|||
148896013|NCT02388269|537100807|FG001|Overall Study|Adverse Event|0|||
148896014|NCT02388269|537100808|FG002|Overall Study|Adverse Event|0|||
148896015|NCT02388269|537100806|FG000|Overall Study|Withdrawal by Subject|1|||
149011464|NCT02778399|537521474|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
149011465|NCT02778399|537521475|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
148896016|NCT02388269|537100807|FG001|Overall Study|Withdrawal by Subject|2|||
148796803|NCT01298700|536735033|FG001|Overall Study|Adverse Event|51|||
148796804|NCT01298700|536735032|FG000|Overall Study|Lack of Efficacy|9|||
148796805|NCT01298700|536735033|FG001|Overall Study|Lack of Efficacy|14|||
148796806|NCT01298700|536735032|FG000|Overall Study|Lost to Follow-up|5|||
148796807|NCT01298700|536735033|FG001|Overall Study|Lost to Follow-up|2|||
148796808|NCT01298700|536735032|FG000|Overall Study|Withdrawal by Subject|12|||
148796809|NCT01298700|536735033|FG001|Overall Study|Withdrawal by Subject|9|||
148896017|NCT02388269|537100808|FG002|Overall Study|Withdrawal by Subject|0|||
148796810|NCT01298700|536735032|FG000|Overall Study|Protocol Violation|6|||
148796811|NCT01298700|536735033|FG001|Overall Study|Protocol Violation|4|||
148796812|NCT01298700|536735032|FG000|Overall Study|Other Miscellaneous Reasons|16|||
148796813|NCT01298700|536735033|FG001|Overall Study|Other Miscellaneous Reasons|15|||
148796814|NCT01298700|536735032|FG000|Overall Study|Did not Receive Study Drug|3|||
148796815|NCT01298700|536735033|FG001|Overall Study|Did not Receive Study Drug|5|||
148796816|NCT04006145|536735034|FG000|Overall Study|Lost to Follow-up|0|||
148796817|NCT04006145|536735035|FG001|Overall Study|Lost to Follow-up|1|||
148796818|NCT04006145|536735034|FG000|Overall Study|Other|1|||
148796819|NCT04006145|536735035|FG001|Overall Study|Other|2|||
148796820|NCT00010257|536735038|FG000|Overall Study|Withdrawal by Subject|1|||
148796821|NCT00010257|536735039|FG001|Overall Study|Withdrawal by Subject|0|||
148796822|NCT02063672|536735040|FG000|Overall Study|Ongoing Follow-up|27|||
148796823|NCT02063672|536735041|FG001|Overall Study|Ongoing Follow-up|14|||
148796824|NCT02063672|536735040|FG000|Overall Study|Death|5|||
148796825|NCT02063672|536735041|FG001|Overall Study|Death|3|||
148796826|NCT02063672|536735040|FG000|Overall Study|Lost to Follow-up|1|||
148796827|NCT02063672|536735041|FG001|Overall Study|Lost to Follow-up|3|||
148796828|NCT02063672|536735040|FG000|Overall Study|Withdrawal by Subject|2|||
148796829|NCT02063672|536735041|FG001|Overall Study|Withdrawal by Subject|2|||
148796830|NCT01965327|536735043|FG000|Overall Study|Physician Decision|2|||
148796831|NCT02498678|536735044|FG000|Overall Study|interference from the surgical team|0|||
148796832|NCT02498678|536735045|FG001|Overall Study|interference from the surgical team|2|||
148796833|NCT01145482|536735046|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
148796834|NCT01145482|536735047|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
148796835|NCT02452047|536735050|FG000|Overall Study|Adverse Event|0|||
148796836|NCT02452047|536735051|FG001|Overall Study|Adverse Event|1|||
148796837|NCT02452047|536735052|FG002|Overall Study|Adverse Event|1|||
148796838|NCT02452047|536735050|FG000|Overall Study|Death|1|||
148796839|NCT02452047|536735051|FG001|Overall Study|Death|3|||
148796840|NCT02452047|536735052|FG002|Overall Study|Death|1|||
148796841|NCT02452047|536735050|FG000|Overall Study|Physician Decision|1|||
148796842|NCT02452047|536735051|FG001|Overall Study|Physician Decision|0|||
148796843|NCT02452047|536735052|FG002|Overall Study|Physician Decision|0|||
148796844|NCT02452047|536735050|FG000|Overall Study|Lost to Follow-up|1|||
148796845|NCT02452047|536735051|FG001|Overall Study|Lost to Follow-up|1|||
148796846|NCT02452047|536735052|FG002|Overall Study|Lost to Follow-up|0|||
148796847|NCT02452047|536735050|FG000|Overall Study|Withdrawal by Subject|1|||
148796848|NCT02452047|536735051|FG001|Overall Study|Withdrawal by Subject|0|||
148796849|NCT02452047|536735052|FG002|Overall Study|Withdrawal by Subject|0|||
148796850|NCT01868646|536735053|FG000|Overall Study|Do not meet inclusion criteria|3|||
148796851|NCT01868646|536735054|FG001|Overall Study|Do not meet inclusion criteria|5|||
148796852|NCT02735980|536735055|FG000|Overall Study|Adverse Event|0|||
148796853|NCT02735980|536735056|FG001|Overall Study|Adverse Event|4|||
148796854|NCT02735980|536735057|FG002|Overall Study|Adverse Event|1|||
148796855|NCT02735980|536735055|FG000|Overall Study|Death|5|||
148796856|NCT02735980|536735056|FG001|Overall Study|Death|4|||
148796857|NCT02735980|536735057|FG002|Overall Study|Death|0|||
148796858|NCT02735980|536735055|FG000|Overall Study|Physician Decision|3|||
148796859|NCT02735980|536735056|FG001|Overall Study|Physician Decision|1|||
148796860|NCT02735980|536735057|FG002|Overall Study|Physician Decision|0|||
148796861|NCT02735980|536735055|FG000|Overall Study|Screen failure|1|||
148796862|NCT02735980|536735056|FG001|Overall Study|Screen failure|0|||
148796863|NCT02735980|536735057|FG002|Overall Study|Screen failure|0|||
148796864|NCT02735980|536735055|FG000|Overall Study|Withdrawal by Subject|1|||
148796865|NCT02735980|536735056|FG001|Overall Study|Withdrawal by Subject|2|||
148796866|NCT02735980|536735057|FG002|Overall Study|Withdrawal by Subject|0|||
148796867|NCT01854697|536735058|FG000|Overall Study|Adverse Event|1|||
148796868|NCT01854697|536735059|FG001|Overall Study|Adverse Event|0|||
148796869|NCT01854697|536735060|FG002|Overall Study|Adverse Event|0|||
148796870|NCT01854697|536735061|FG003|Overall Study|Adverse Event|0|||
148796871|NCT01854697|536735062|FG004|Overall Study|Adverse Event|1|||
148796872|NCT01854697|536735058|FG000|Overall Study|Lost to Follow-up|4|||
148796873|NCT01854697|536735059|FG001|Overall Study|Lost to Follow-up|1|||
148796874|NCT01854697|536735060|FG002|Overall Study|Lost to Follow-up|1|||
148796875|NCT01854697|536735061|FG003|Overall Study|Lost to Follow-up|2|||
148796876|NCT01854697|536735062|FG004|Overall Study|Lost to Follow-up|0|||
148796877|NCT01854697|536735058|FG000|Overall Study|To enter another AbbVie study|1|||
148796878|NCT01854697|536735059|FG001|Overall Study|To enter another AbbVie study|0|||
148796879|NCT01854697|536735060|FG002|Overall Study|To enter another AbbVie study|0|||
148796880|NCT01854697|536735061|FG003|Overall Study|To enter another AbbVie study|0|||
148796881|NCT01854697|536735062|FG004|Overall Study|To enter another AbbVie study|1|||
148796882|NCT01854697|536735058|FG000|Overall Study|Withdrew Consent|0|||
148796883|NCT01854697|536735059|FG001|Overall Study|Withdrew Consent|1|||
148796884|NCT01854697|536735060|FG002|Overall Study|Withdrew Consent|0|||
148796885|NCT01854697|536735061|FG003|Overall Study|Withdrew Consent|1|||
148796886|NCT01854697|536735062|FG004|Overall Study|Withdrew Consent|0|||
148796887|NCT01854697|536735058|FG000|Overall Study|Other|0|||
148796888|NCT01854697|536735059|FG001|Overall Study|Other|1|||
148796889|NCT01854697|536735060|FG002|Overall Study|Other|1|||
148796890|NCT01854697|536735061|FG003|Overall Study|Other|0|||
148796891|NCT01854697|536735062|FG004|Overall Study|Other|0|||
148796892|NCT01607593|536735068|FG000|Overall Study|Adverse Event|15|||
148796893|NCT01607593|536735068|FG000|Overall Study|Lack of Efficacy|16|||
148796894|NCT01607593|536735068|FG000|Overall Study|Lost to Follow-up|25|||
148796895|NCT01607593|536735068|FG000|Overall Study|Continuation|33|||
148796896|NCT01607593|536735068|FG000|Overall Study|Other|4|||
148796897|NCT02515630|536735071|FG000|Overall Study|Withdrawal by Subject|5|||
148796898|NCT02515630|536735071|FG000|Overall Study|Adverse Event|4|||
148796899|NCT02515630|536735071|FG000|Overall Study|Physician Decision|4|||
148796900|NCT02515630|536735071|FG000|Overall Study|Death|2|||
148796901|NCT02515630|536735071|FG000|Overall Study|Disease Progression|1|||
148796902|NCT00483652|536735072|FG000|Double-blind Treatment Period|Protocol Violation|2|||
148796903|NCT00483652|536735073|FG001|Double-blind Treatment Period|Protocol Violation|1|||
148796904|NCT00483652|536735072|FG000|Double-blind Treatment Period|Adverse Event|3|||
148796905|NCT00483652|536735073|FG001|Double-blind Treatment Period|Adverse Event|4|||
148796906|NCT00483652|536735072|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
148796907|NCT00483652|536735073|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
148796908|NCT00483652|536735072|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
148796909|NCT00483652|536735073|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
148796910|NCT00891813|536735075|FG000|Overall Study|Adverse Event|3|||
148796911|NCT00891813|536735075|FG000|Overall Study|Withdrawal by Subject|1|||
148796912|NCT00891813|536735075|FG000|Overall Study|Patient Noncompliance|6|||
148796913|NCT00891813|536735075|FG000|Overall Study|Protocol Violation|2|||
148796914|NCT02513550|536735078|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
148796915|NCT02513550|536735079|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
148796916|NCT02513550|536735080|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
148796917|NCT02513550|536735081|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
148796918|NCT02513550|536735082|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
148796919|NCT02513550|536735083|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
148796920|NCT02513550|536735078|FG000|Double Blind Treatment Period|Adverse Event|5|||
148796921|NCT02513550|536735079|FG001|Double Blind Treatment Period|Adverse Event|13|||
148796922|NCT02513550|536735080|FG002|Double Blind Treatment Period|Adverse Event|17|||
148796923|NCT02513550|536735081|FG003|Double Blind Treatment Period|Adverse Event|0|||
148796924|NCT02513550|536735082|FG004|Double Blind Treatment Period|Adverse Event|1|||
148796925|NCT02513550|536735083|FG005|Double Blind Treatment Period|Adverse Event|0|||
148796926|NCT02513550|536735078|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
148796927|NCT02513550|536735079|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
148796928|NCT02513550|536735080|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
148796929|NCT02513550|536735081|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
148796930|NCT02513550|536735082|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
148796931|NCT02513550|536735083|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
148796932|NCT02513550|536735078|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
148796933|NCT02513550|536735079|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
148796934|NCT02513550|536735080|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
148796935|NCT02513550|536735081|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
148796936|NCT02513550|536735082|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
148796937|NCT02513550|536735083|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
148796938|NCT02513550|536735078|FG000|Double Blind Treatment Period|Protocol Violation|1|||
148796939|NCT02513550|536735079|FG001|Double Blind Treatment Period|Protocol Violation|1|||
148796940|NCT02513550|536735080|FG002|Double Blind Treatment Period|Protocol Violation|4|||
148796941|NCT02513550|536735081|FG003|Double Blind Treatment Period|Protocol Violation|0|||
148796942|NCT02513550|536735082|FG004|Double Blind Treatment Period|Protocol Violation|0|||
148796943|NCT02513550|536735083|FG005|Double Blind Treatment Period|Protocol Violation|0|||
148796944|NCT02513550|536735078|FG000|Double Blind Treatment Period|Physician Decision|2|||
148796945|NCT02513550|536735079|FG001|Double Blind Treatment Period|Physician Decision|0|||
148796946|NCT02513550|536735080|FG002|Double Blind Treatment Period|Physician Decision|4|||
148796947|NCT02513550|536735081|FG003|Double Blind Treatment Period|Physician Decision|0|||
148796948|NCT02513550|536735082|FG004|Double Blind Treatment Period|Physician Decision|0|||
148796949|NCT02513550|536735083|FG005|Double Blind Treatment Period|Physician Decision|0|||
148796950|NCT02513550|536735078|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
148796951|NCT02513550|536735079|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
148796952|NCT02513550|536735080|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
148796953|NCT02513550|536735081|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
148796954|NCT02513550|536735082|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
148796955|NCT02513550|536735083|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
148796956|NCT02513550|536735078|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
148796957|NCT02513550|536735079|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
148796958|NCT02513550|536735080|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
148896018|NCT02388269|537100806|FG000|Overall Study|less than 50% stimulations|1|||
148896019|NCT02388269|537100807|FG001|Overall Study|less than 50% stimulations|0|||
148796959|NCT02513550|536735081|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
148796960|NCT02513550|536735082|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
148796961|NCT02513550|536735083|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
148796962|NCT02513550|536735078|FG000|Double Blind Treatment Period|Due to personal business|2|||
148796963|NCT02513550|536735079|FG001|Double Blind Treatment Period|Due to personal business|0|||
148796964|NCT02513550|536735080|FG002|Double Blind Treatment Period|Due to personal business|1|||
148796965|NCT02513550|536735081|FG003|Double Blind Treatment Period|Due to personal business|0|||
148796966|NCT02513550|536735082|FG004|Double Blind Treatment Period|Due to personal business|0|||
148796967|NCT02513550|536735083|FG005|Double Blind Treatment Period|Due to personal business|0|||
148796968|NCT02513550|536735078|FG000|Double Blind Treatment Period|Death|1|||
148796969|NCT02513550|536735079|FG001|Double Blind Treatment Period|Death|0|||
148796970|NCT02513550|536735080|FG002|Double Blind Treatment Period|Death|2|||
148796971|NCT02513550|536735081|FG003|Double Blind Treatment Period|Death|0|||
148796972|NCT02513550|536735082|FG004|Double Blind Treatment Period|Death|0|||
148796973|NCT02513550|536735083|FG005|Double Blind Treatment Period|Death|0|||
148796974|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
148796975|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
148796976|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
148796977|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
148796978|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
148796979|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
148796980|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
148796981|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
148796982|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
148796983|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
148796984|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
148796985|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
148796986|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
148796987|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
148796988|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
148796989|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
148796990|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
148796991|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
148796992|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
148796993|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
148796994|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
148796995|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
148796996|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
148796997|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
148796998|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
148796999|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
148797000|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
148797001|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
148797002|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
148797003|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
148797004|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Death|0|||
148797005|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Death|0|||
148797006|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Death|1|||
148797007|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Death|0|||
148797008|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Death|0|||
148797009|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Death|0|||
148797010|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
148797011|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
148797012|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
148797013|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
148797014|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
148797015|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
148797016|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
148797017|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
148797018|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
148896020|NCT02388269|537100808|FG002|Overall Study|less than 50% stimulations|0|||
148896021|NCT02388269|537100806|FG000|Overall Study|no diary data|3|||
148896022|NCT02388269|537100807|FG001|Overall Study|no diary data|0|||
148896023|NCT02388269|537100808|FG002|Overall Study|no diary data|0|||
148896024|NCT02388269|537100806|FG000|Overall Study|Protocol Violation|2|||
148797019|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
148797020|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
148797021|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
148797022|NCT02513550|536735078|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
148797023|NCT02513550|536735079|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
148797024|NCT02513550|536735080|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
148797025|NCT02513550|536735081|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
148797026|NCT02513550|536735082|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
148797027|NCT02513550|536735083|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
148797028|NCT00243919|536735084|FG000|Overall Study|Death|3|||
148797029|NCT00243919|536735085|FG001|Overall Study|Death|4|||
148797030|NCT00243919|536735086|FG002|Overall Study|Death|6|||
148797031|NCT00243919|536735084|FG000|Overall Study|Withdrawal by Subject|6|||
148797032|NCT00243919|536735085|FG001|Overall Study|Withdrawal by Subject|6|||
148797033|NCT00243919|536735086|FG002|Overall Study|Withdrawal by Subject|2|||
148797034|NCT00243919|536735084|FG000|Overall Study|Lost to Follow-up|6|||
148797035|NCT00243919|536735085|FG001|Overall Study|Lost to Follow-up|7|||
148797036|NCT00243919|536735086|FG002|Overall Study|Lost to Follow-up|3|||
148797037|NCT00243919|536735084|FG000|Overall Study|Administrative Error|1|||
148797038|NCT00243919|536735085|FG001|Overall Study|Administrative Error|0|||
148797039|NCT00243919|536735086|FG002|Overall Study|Administrative Error|0|||
148797040|NCT00243919|536735084|FG000|Overall Study|Physician Decision|1|||
148797041|NCT00243919|536735085|FG001|Overall Study|Physician Decision|1|||
148797042|NCT00243919|536735086|FG002|Overall Study|Physician Decision|0|||
148797043|NCT02157519|536735096|FG000|Overall Study|Death|3|||
148797044|NCT02157519|536735097|FG001|Overall Study|Death|1|||
148797045|NCT02157519|536735096|FG000|Overall Study|Withdrawal by Subject|7|||
148797046|NCT02157519|536735097|FG001|Overall Study|Withdrawal by Subject|0|||
148797047|NCT02157519|536735096|FG000|Overall Study|Lost to Follow-up|1|||
148797048|NCT02157519|536735097|FG001|Overall Study|Lost to Follow-up|0|||
148797049|NCT01656395|536735098|FG000|Overall Study|Adverse Event|1|||
148797050|NCT01656395|536735099|FG001|Overall Study|Adverse Event|14|||
148797051|NCT01656395|536735100|FG002|Overall Study|Adverse Event|5|||
148797052|NCT01656395|536735101|FG003|Overall Study|Adverse Event|4|||
148797053|NCT01656395|536735102|FG004|Overall Study|Adverse Event|5|||
148797054|NCT01656395|536735103|FG005|Overall Study|Adverse Event|7|||
148797055|NCT01656395|536735104|FG006|Overall Study|Adverse Event|0|||
148797056|NCT01656395|536735105|FG007|Overall Study|Adverse Event|0|||
148797057|NCT01656395|536735098|FG000|Overall Study|Lack of Efficacy|1|||
148797058|NCT01656395|536735099|FG001|Overall Study|Lack of Efficacy|8|||
148797059|NCT01656395|536735100|FG002|Overall Study|Lack of Efficacy|6|||
148797060|NCT01656395|536735101|FG003|Overall Study|Lack of Efficacy|1|||
148797061|NCT01656395|536735102|FG004|Overall Study|Lack of Efficacy|1|||
148797062|NCT01656395|536735103|FG005|Overall Study|Lack of Efficacy|6|||
148797063|NCT01656395|536735104|FG006|Overall Study|Lack of Efficacy|0|||
148797064|NCT01656395|536735105|FG007|Overall Study|Lack of Efficacy|0|||
148797065|NCT01656395|536735098|FG000|Overall Study|Lost to Follow-up|1|||
148797066|NCT01656395|536735099|FG001|Overall Study|Lost to Follow-up|0|||
148797067|NCT01656395|536735100|FG002|Overall Study|Lost to Follow-up|0|||
148797068|NCT01656395|536735101|FG003|Overall Study|Lost to Follow-up|0|||
148797069|NCT01656395|536735102|FG004|Overall Study|Lost to Follow-up|0|||
148797070|NCT01656395|536735103|FG005|Overall Study|Lost to Follow-up|0|||
148797071|NCT01656395|536735104|FG006|Overall Study|Lost to Follow-up|0|||
148797072|NCT01656395|536735105|FG007|Overall Study|Lost to Follow-up|0|||
148797073|NCT01656395|536735098|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148797074|NCT01656395|536735099|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148797075|NCT01656395|536735100|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148797076|NCT01656395|536735101|FG003|Overall Study|Non-Compliance with Study Drug|0|||
148797077|NCT01656395|536735102|FG004|Overall Study|Non-Compliance with Study Drug|1|||
148797078|NCT01656395|536735103|FG005|Overall Study|Non-Compliance with Study Drug|1|||
148797079|NCT01656395|536735104|FG006|Overall Study|Non-Compliance with Study Drug|0|||
148797080|NCT01656395|536735105|FG007|Overall Study|Non-Compliance with Study Drug|0|||
148797081|NCT01656395|536735098|FG000|Overall Study|Other|0|||
148797082|NCT01656395|536735099|FG001|Overall Study|Other|0|||
148797083|NCT01656395|536735100|FG002|Overall Study|Other|1|||
148797084|NCT01656395|536735101|FG003|Overall Study|Other|0|||
148797085|NCT01656395|536735102|FG004|Overall Study|Other|0|||
148797086|NCT01656395|536735103|FG005|Overall Study|Other|1|||
148797087|NCT01656395|536735104|FG006|Overall Study|Other|0|||
148797088|NCT01656395|536735105|FG007|Overall Study|Other|0|||
148797089|NCT01656395|536735098|FG000|Overall Study|Physician Decision|2|||
148797090|NCT01656395|536735099|FG001|Overall Study|Physician Decision|3|||
148797091|NCT01656395|536735100|FG002|Overall Study|Physician Decision|3|||
148797092|NCT01656395|536735101|FG003|Overall Study|Physician Decision|2|||
148797093|NCT01656395|536735102|FG004|Overall Study|Physician Decision|3|||
148797094|NCT01656395|536735103|FG005|Overall Study|Physician Decision|3|||
148797095|NCT01656395|536735104|FG006|Overall Study|Physician Decision|0|||
148896025|NCT02388269|537100807|FG001|Overall Study|Protocol Violation|0|||
148896026|NCT02388269|537100808|FG002|Overall Study|Protocol Violation|0|||
148896027|NCT02388269|537100806|FG000|Overall Study|Screen Failure|0|||
148896028|NCT02388269|537100807|FG001|Overall Study|Screen Failure|0|||
148896029|NCT02388269|537100808|FG002|Overall Study|Screen Failure|10|||
148896030|NCT05106959|537100809|FG000|Overall Study|Lost to Follow-up|1|||
148896031|NCT03448406|537100810|FG000|Overall Study|Noncompliance of scheduled visits|1|||
148896032|NCT03448406|537100811|FG001|Overall Study|Noncompliance of scheduled visits|2|||
148896033|NCT03448406|537100810|FG000|Overall Study|Withdrawal by Subject|1|||
148896034|NCT03448406|537100811|FG001|Overall Study|Withdrawal by Subject|2|||
148896035|NCT03448406|537100810|FG000|Overall Study|Protocol Violation|1|||
148896036|NCT03448406|537100811|FG001|Overall Study|Protocol Violation|0|||
148896037|NCT03448406|537100810|FG000|Overall Study|Adverse Event|8|||
148896038|NCT03448406|537100811|FG001|Overall Study|Adverse Event|9|||
148896039|NCT00087152|537100812|FG000|Overall Study|Ineligible|6|||
148896040|NCT01292486|537100813|FG000|Overall Study|Protocol Violation|2|||
148896041|NCT01292486|537100813|FG000|Overall Study|Did not meet screening criteria|2|||
148896042|NCT01292486|537100813|FG000|Overall Study|Adverse Event|1|||
148896043|NCT01292486|537100813|FG000|Overall Study|Physician Decision|1|||
148896044|NCT04602390|537100819|FG000|Overall Study|Withdrawal by Subject|0|||
148896045|NCT04602390|537100820|FG001|Overall Study|Withdrawal by Subject|0|||
148896046|NCT04602390|537100821|FG002|Overall Study|Withdrawal by Subject|0|||
148896047|NCT04602390|537100822|FG003|Overall Study|Withdrawal by Subject|0|||
148896048|NCT04602390|537100823|FG004|Overall Study|Withdrawal by Subject|1|||
148896049|NCT04602390|537100824|FG005|Overall Study|Withdrawal by Subject|0|||
148896050|NCT04602390|537100819|FG000|Overall Study|Adverse Event|0|||
148896051|NCT04602390|537100820|FG001|Overall Study|Adverse Event|0|||
148896052|NCT04602390|537100821|FG002|Overall Study|Adverse Event|0|||
148896053|NCT04602390|537100822|FG003|Overall Study|Adverse Event|0|||
148896054|NCT04602390|537100823|FG004|Overall Study|Adverse Event|0|||
148896055|NCT04602390|537100824|FG005|Overall Study|Adverse Event|1|||
148896056|NCT01546857|537100827|FG000|Overall Study|Withdrawal by Subject|2|||
148896057|NCT01546857|537100828|FG001|Overall Study|Withdrawal by Subject|3|||
148896058|NCT02542865|537100829|FG000|Overall Study|Identified as screen failure|1|||
148896059|NCT02542865|537100830|FG001|Overall Study|Identified as screen failure|0|||
148896060|NCT02542865|537100829|FG000|Overall Study|Withdrawal by Subject|16|||
148896061|NCT02542865|537100830|FG001|Overall Study|Withdrawal by Subject|0|||
148896062|NCT03582215|537100831|FG000|Overall Study|Adverse Event|1|||
148896063|NCT03582215|537100832|FG001|Overall Study|Adverse Event|0|||
148896064|NCT03582215|537100833|FG002|Overall Study|Adverse Event|0|||
148896065|NCT03582215|537100834|FG003|Overall Study|Adverse Event|0|||
148896066|NCT03582215|537100835|FG004|Overall Study|Adverse Event|0|||
148896067|NCT03582215|537100836|FG005|Overall Study|Adverse Event|0|||
148896068|NCT03582215|537100837|FG006|Overall Study|Adverse Event|2|||
148896069|NCT03582215|537100838|FG007|Overall Study|Adverse Event|2|||
148896070|NCT04913610|537100839|FG000|Randomized Participants|Did Not Receive Treatment|0|||
148896071|NCT04913610|537100840|FG001|Randomized Participants|Did Not Receive Treatment|0|||
148896072|NCT04913610|537100841|FG002|Randomized Participants|Did Not Receive Treatment|1|||
148896073|NCT04913610|537100842|FG003|Randomized Participants|Did Not Receive Treatment|1|||
148896074|NCT04913610|537100843|FG004|Randomized Participants|Did Not Receive Treatment|0|||
148896075|NCT04913610|537100839|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
148896076|NCT04913610|537100840|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
148896077|NCT04913610|537100841|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
148896078|NCT04913610|537100842|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
148896079|NCT04913610|537100843|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
148896080|NCT03186209|537100850|FG000|Overall Study|Withdrawal by Subject|11|||
148896081|NCT03186209|537100851|FG001|Overall Study|Withdrawal by Subject|22|||
148896082|NCT03186209|537100850|FG000|Overall Study|Pregnancy|1|||
148896083|NCT03186209|537100851|FG001|Overall Study|Pregnancy|0|||
148896084|NCT03186209|537100850|FG000|Overall Study|Adverse Event|4|||
148896085|NCT03186209|537100851|FG001|Overall Study|Adverse Event|0|||
148896086|NCT03186209|537100850|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
148896087|NCT03186209|537100851|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
148797096|NCT01656395|536735105|FG007|Overall Study|Physician Decision|0|||
148797097|NCT01656395|536735098|FG000|Overall Study|Pregnancy|0|||
148797098|NCT01656395|536735099|FG001|Overall Study|Pregnancy|0|||
148797099|NCT01656395|536735100|FG002|Overall Study|Pregnancy|1|||
148797100|NCT01656395|536735101|FG003|Overall Study|Pregnancy|0|||
148797101|NCT01656395|536735102|FG004|Overall Study|Pregnancy|0|||
148797102|NCT01656395|536735103|FG005|Overall Study|Pregnancy|0|||
148797103|NCT01656395|536735104|FG006|Overall Study|Pregnancy|0|||
148797104|NCT01656395|536735105|FG007|Overall Study|Pregnancy|0|||
148797105|NCT01656395|536735098|FG000|Overall Study|Progressive Disease|0|||
148797106|NCT01656395|536735099|FG001|Overall Study|Progressive Disease|0|||
148797107|NCT01656395|536735100|FG002|Overall Study|Progressive Disease|0|||
148797108|NCT01656395|536735101|FG003|Overall Study|Progressive Disease|0|||
148797109|NCT01656395|536735102|FG004|Overall Study|Progressive Disease|0|||
148797110|NCT01656395|536735103|FG005|Overall Study|Progressive Disease|1|||
148797111|NCT01656395|536735104|FG006|Overall Study|Progressive Disease|0|||
148797112|NCT01656395|536735105|FG007|Overall Study|Progressive Disease|0|||
148797113|NCT01656395|536735098|FG000|Overall Study|Protocol Violation|6|||
148797114|NCT01656395|536735099|FG001|Overall Study|Protocol Violation|6|||
148797115|NCT01656395|536735100|FG002|Overall Study|Protocol Violation|9|||
148797116|NCT01656395|536735101|FG003|Overall Study|Protocol Violation|2|||
148797117|NCT01656395|536735102|FG004|Overall Study|Protocol Violation|4|||
148797118|NCT01656395|536735103|FG005|Overall Study|Protocol Violation|10|||
148797119|NCT01656395|536735104|FG006|Overall Study|Protocol Violation|0|||
148797120|NCT01656395|536735105|FG007|Overall Study|Protocol Violation|0|||
148797121|NCT01656395|536735098|FG000|Overall Study|Screen Failure|2|||
148797122|NCT01656395|536735099|FG001|Overall Study|Screen Failure|1|||
148797123|NCT01656395|536735100|FG002|Overall Study|Screen Failure|7|||
148797124|NCT01656395|536735101|FG003|Overall Study|Screen Failure|1|||
148797125|NCT01656395|536735102|FG004|Overall Study|Screen Failure|0|||
148797126|NCT01656395|536735103|FG005|Overall Study|Screen Failure|8|||
148797127|NCT01656395|536735104|FG006|Overall Study|Screen Failure|0|||
148797128|NCT01656395|536735105|FG007|Overall Study|Screen Failure|0|||
148797129|NCT01656395|536735098|FG000|Overall Study|Withdrawal by Subject|3|||
148797130|NCT01656395|536735099|FG001|Overall Study|Withdrawal by Subject|1|||
148797131|NCT01656395|536735100|FG002|Overall Study|Withdrawal by Subject|4|||
148797132|NCT01656395|536735101|FG003|Overall Study|Withdrawal by Subject|2|||
148797133|NCT01656395|536735102|FG004|Overall Study|Withdrawal by Subject|0|||
148797134|NCT01656395|536735103|FG005|Overall Study|Withdrawal by Subject|3|||
148797135|NCT01656395|536735104|FG006|Overall Study|Withdrawal by Subject|0|||
148797136|NCT01656395|536735105|FG007|Overall Study|Withdrawal by Subject|0|||
148797137|NCT04919317|536735109|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
148797138|NCT04919317|536735110|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
148797139|NCT04919317|536735109|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
148797140|NCT04919317|536735110|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
148797141|NCT02869789|536735111|FG000|Overall Study|Disease progression|184|||
148797142|NCT02869789|536735112|FG001|Overall Study|Disease progression|109|||
148797143|NCT02869789|536735113|FG002|Overall Study|Disease progression|260|||
148797144|NCT02869789|536735114|FG003|Overall Study|Disease progression|19|||
148797145|NCT02869789|536735111|FG000|Overall Study|Study drug toxicity|90|||
148797146|NCT02869789|536735112|FG001|Overall Study|Study drug toxicity|32|||
148797147|NCT02869789|536735113|FG002|Overall Study|Study drug toxicity|55|||
148797148|NCT02869789|536735114|FG003|Overall Study|Study drug toxicity|14|||
148797149|NCT02869789|536735111|FG000|Overall Study|Death|7|||
148797150|NCT02869789|536735112|FG001|Overall Study|Death|3|||
148797151|NCT02869789|536735113|FG002|Overall Study|Death|5|||
148797152|NCT02869789|536735114|FG003|Overall Study|Death|1|||
148797153|NCT02869789|536735111|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
148797154|NCT02869789|536735112|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
148797155|NCT02869789|536735113|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
148797156|NCT02869789|536735114|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
148797157|NCT02869789|536735111|FG000|Overall Study|Participant request to discontinue study treatment|10|||
148797158|NCT02869789|536735112|FG001|Overall Study|Participant request to discontinue study treatment|5|||
148797159|NCT02869789|536735113|FG002|Overall Study|Participant request to discontinue study treatment|5|||
148797160|NCT02869789|536735114|FG003|Overall Study|Participant request to discontinue study treatment|3|||
148797161|NCT02869789|536735111|FG000|Overall Study|Withdrawal by Subject|5|||
148797162|NCT02869789|536735112|FG001|Overall Study|Withdrawal by Subject|2|||
148797163|NCT02869789|536735113|FG002|Overall Study|Withdrawal by Subject|7|||
148797164|NCT02869789|536735114|FG003|Overall Study|Withdrawal by Subject|2|||
148797165|NCT02869789|536735111|FG000|Overall Study|Lost to Follow-up|0|||
148797166|NCT02869789|536735112|FG001|Overall Study|Lost to Follow-up|0|||
148797167|NCT02869789|536735113|FG002|Overall Study|Lost to Follow-up|2|||
148797168|NCT02869789|536735114|FG003|Overall Study|Lost to Follow-up|0|||
148797169|NCT02869789|536735111|FG000|Overall Study|Maximum clinical benefit|5|||
148797170|NCT02869789|536735112|FG001|Overall Study|Maximum clinical benefit|2|||
148797171|NCT02869789|536735113|FG002|Overall Study|Maximum clinical benefit|1|||
148797172|NCT02869789|536735114|FG003|Overall Study|Maximum clinical benefit|0|||
148797173|NCT02869789|536735111|FG000|Overall Study|Poor/Non-compliance|0|||
148797174|NCT02869789|536735112|FG001|Overall Study|Poor/Non-compliance|2|||
148797175|NCT02869789|536735113|FG002|Overall Study|Poor/Non-compliance|1|||
148797176|NCT02869789|536735114|FG003|Overall Study|Poor/Non-compliance|0|||
148797177|NCT02869789|536735111|FG000|Overall Study|Participant no longer meets study criteria|0|||
148797178|NCT02869789|536735112|FG001|Overall Study|Participant no longer meets study criteria|1|||
148797179|NCT02869789|536735113|FG002|Overall Study|Participant no longer meets study criteria|1|||
148797180|NCT02869789|536735114|FG003|Overall Study|Participant no longer meets study criteria|0|||
148797181|NCT02869789|536735111|FG000|Overall Study|Administrative reason by sponsor|0|||
148797182|NCT02869789|536735112|FG001|Overall Study|Administrative reason by sponsor|0|||
148797183|NCT02869789|536735113|FG002|Overall Study|Administrative reason by sponsor|1|||
148797184|NCT02869789|536735114|FG003|Overall Study|Administrative reason by sponsor|0|||
148797185|NCT02869789|536735111|FG000|Overall Study|Other reasons|4|||
148797186|NCT02869789|536735112|FG001|Overall Study|Other reasons|8|||
148797187|NCT02869789|536735113|FG002|Overall Study|Other reasons|6|||
148797188|NCT02869789|536735114|FG003|Overall Study|Other reasons|0|||
148797189|NCT00230048|536735115|FG000|Overall Study|Lost to Follow-up|13|||
148797190|NCT00230048|536735116|FG001|Overall Study|Lost to Follow-up|18|||
148797191|NCT00676403|536735119|FG000|Overall Study|Adverse Event|1|||
148797192|NCT00676403|536735120|FG001|Overall Study|Adverse Event|2|||
148797193|NCT00676403|536735121|FG002|Overall Study|Adverse Event|0|||
148797194|NCT00676403|536735122|FG003|Overall Study|Adverse Event|5|||
148797195|NCT00676403|536735123|FG004|Overall Study|Adverse Event|1|||
148797196|NCT00676403|536735124|FG005|Overall Study|Adverse Event|2|||
148797197|NCT00676403|536735119|FG000|Overall Study|Lost to Follow-up|0|||
148797198|NCT00676403|536735120|FG001|Overall Study|Lost to Follow-up|0|||
148797199|NCT00676403|536735121|FG002|Overall Study|Lost to Follow-up|0|||
148797200|NCT00676403|536735122|FG003|Overall Study|Lost to Follow-up|0|||
148797201|NCT00676403|536735123|FG004|Overall Study|Lost to Follow-up|0|||
148797202|NCT00676403|536735124|FG005|Overall Study|Lost to Follow-up|1|||
148797203|NCT00676403|536735119|FG000|Overall Study|Reason Unspecified|1|||
148797204|NCT00676403|536735120|FG001|Overall Study|Reason Unspecified|0|||
148797205|NCT00676403|536735121|FG002|Overall Study|Reason Unspecified|1|||
148797206|NCT00676403|536735122|FG003|Overall Study|Reason Unspecified|0|||
148797207|NCT00676403|536735123|FG004|Overall Study|Reason Unspecified|0|||
148797208|NCT00676403|536735124|FG005|Overall Study|Reason Unspecified|1|||
148797209|NCT00676403|536735119|FG000|Overall Study|Withdrawal by Subject|0|||
148797210|NCT00676403|536735120|FG001|Overall Study|Withdrawal by Subject|0|||
148797211|NCT00676403|536735121|FG002|Overall Study|Withdrawal by Subject|0|||
148797212|NCT00676403|536735122|FG003|Overall Study|Withdrawal by Subject|0|||
148797213|NCT00676403|536735123|FG004|Overall Study|Withdrawal by Subject|0|||
148797214|NCT00676403|536735124|FG005|Overall Study|Withdrawal by Subject|1|||
148797215|NCT00297648|536735126|FG000|Overall Study|Adverse Event|13|||
148797216|NCT00297648|536735126|FG000|Overall Study|Lack of Efficacy|18|||
148797217|NCT00297648|536735126|FG000|Overall Study|Lost to Follow-up|1|||
148797218|NCT00297648|536735126|FG000|Overall Study|Withdrawal by Subject|3|||
148797219|NCT00297648|536735126|FG000|Overall Study|Other: Incompliance|1|||
148797220|NCT02048722|536735127|FG000|2 Cycles of Treatment|Adverse Event|2|||
148797221|NCT02048722|536735127|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
148797222|NCT02048722|536735127|FG000|2 Cycles of Treatment|Progressive Disease|2|||
148797223|NCT02048722|536735127|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
148896088|NCT03186209|537100850|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
148797224|NCT02048722|536735127|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
148797225|NCT02048722|536735127|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
148797226|NCT01529606|536735129|FG000|Overall Study|Lost to Follow-up|21|||
148797227|NCT01529606|536735130|FG001|Overall Study|Lost to Follow-up|18|||
148797228|NCT05209880|536735131|FG000|1-Month Follow-up|Spoke with Doctor|5|||
148797229|NCT05209880|536735132|FG001|1-Month Follow-up|Spoke with Doctor|5|||
148896089|NCT03186209|537100851|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
148896090|NCT03186209|537100850|FG000|Overall Study|Fail to meet randomization criteria|0|||
148896091|NCT03186209|537100851|FG001|Overall Study|Fail to meet randomization criteria|1|||
148896092|NCT03186209|537100850|FG000|Overall Study|Lost to Follow-up|0|||
148896093|NCT03186209|537100851|FG001|Overall Study|Lost to Follow-up|1|||
148896094|NCT01277744|537100852|FG000|Overall Study|Physician Decision|2|||
148896095|NCT01791244|537100853|FG000|Overall Study|Adverse Event|5|||
148896096|NCT01791244|537100854|FG001|Overall Study|Adverse Event|7|||
148896097|NCT01791244|537100853|FG000|Overall Study|Insufficient clinical response|10|||
148896098|NCT01791244|537100854|FG001|Overall Study|Insufficient clinical response|10|||
148896099|NCT01791244|537100853|FG000|Overall Study|Laboratory Abnormality|0|||
148896100|NCT01791244|537100854|FG001|Overall Study|Laboratory Abnormality|1|||
148896101|NCT02240485|537100859|FG000|3 Months Post-admission|Lost to Follow-up|1|||
148896102|NCT02240485|537100860|FG001|3 Months Post-admission|Lost to Follow-up|5|||
148896103|NCT02240485|537100859|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
148896104|NCT02240485|537100860|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
148896105|NCT02240485|537100859|FG000|9 Months Post-admission|Lost to Follow-up|3|||
148896106|NCT02240485|537100860|FG001|9 Months Post-admission|Lost to Follow-up|1|||
148896107|NCT02240485|537100859|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
148896108|NCT02240485|537100860|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
148896109|NCT02240485|537100859|FG000|18 Months Post-admission|Lost to Follow-up|1|||
148896110|NCT02240485|537100860|FG001|18 Months Post-admission|Lost to Follow-up|1|||
148896111|NCT02240485|537100859|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
148896112|NCT02240485|537100860|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
148896113|NCT04038359|537100861|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
148896114|NCT04038359|537100862|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
148896115|NCT04038359|537100861|FG000|Overall Study|Death|8|||
148896116|NCT04038359|537100862|FG001|Overall Study|Death|7|||
148896117|NCT04038359|537100861|FG000|Overall Study|Lost to Follow-up|3|||
148896118|NCT04038359|537100862|FG001|Overall Study|Lost to Follow-up|0|||
148896119|NCT04038359|537100861|FG000|Overall Study|Participant Moved|1|||
148896120|NCT04038359|537100862|FG001|Overall Study|Participant Moved|0|||
148896121|NCT04038359|537100861|FG000|Overall Study|Withdrawal by Subject|4|||
148896122|NCT04038359|537100862|FG001|Overall Study|Withdrawal by Subject|3|||
148896123|NCT04038359|537100861|FG000|Overall Study|Physician Decision|3|||
148896124|NCT04038359|537100862|FG001|Overall Study|Physician Decision|2|||
148896125|NCT04038359|537100861|FG000|Overall Study|Adverse Event|0|||
148896126|NCT04038359|537100862|FG001|Overall Study|Adverse Event|2|||
148896127|NCT04038359|537100861|FG000|Overall Study|Progressive Disease|0|||
148896128|NCT04038359|537100862|FG001|Overall Study|Progressive Disease|1|||
148896129|NCT04949191|537100863|FG000|Overall Study|Non-compliance with Study Drug|1|||
148896130|NCT04949191|537100864|FG001|Overall Study|Non-compliance with Study Drug|0|||
148896131|NCT04949191|537100865|FG002|Overall Study|Non-compliance with Study Drug|0|||
148896132|NCT04949191|537100866|FG003|Overall Study|Non-compliance with Study Drug|0|||
148896133|NCT04949191|537100863|FG000|Overall Study|Progressive Disease|0|||
148896134|NCT04949191|537100864|FG001|Overall Study|Progressive Disease|1|||
148896135|NCT04949191|537100865|FG002|Overall Study|Progressive Disease|0|||
148896136|NCT04949191|537100866|FG003|Overall Study|Progressive Disease|0|||
148896137|NCT04949191|537100863|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
148896138|NCT04949191|537100864|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
148896139|NCT04949191|537100865|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
148896140|NCT04949191|537100866|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
148896141|NCT04949191|537100863|FG000|Overall Study|Sponsor Terminated Study|0|||
148896142|NCT04949191|537100864|FG001|Overall Study|Sponsor Terminated Study|0|||
148896143|NCT04949191|537100865|FG002|Overall Study|Sponsor Terminated Study|1|||
148896144|NCT04949191|537100866|FG003|Overall Study|Sponsor Terminated Study|1|||
148896145|NCT03259230|537100867|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
148896146|NCT03259230|537100868|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
148896147|NCT05468814|537100869|FG000|Overall Study|Lost to Follow-up|5|||
148896148|NCT05468814|537100870|FG001|Overall Study|Lost to Follow-up|6|||
148896149|NCT04716426|537100874|FG000|Overall Study|Vaccination|1|||
148896150|NCT04716426|537100875|FG001|Overall Study|Vaccination|1|||
148896151|NCT04716426|537100874|FG000|Overall Study|Contamination|1|||
148896152|NCT04716426|537100875|FG001|Overall Study|Contamination|0|||
148896153|NCT01046565|537100878|FG000|Overall Study|Adverse Event|2|||
148896154|NCT01046565|537100878|FG000|Overall Study|Withdrawal by Subject|7|||
148896155|NCT01650558|537100879|FG000|Overall Study|Migration out of study area|61|||
148896156|NCT01650558|537100880|FG001|Overall Study|Migration out of study area|71|||
148896157|NCT01650558|537100881|FG002|Overall Study|Migration out of study area|56|||
148896158|NCT01650558|537100879|FG000|Overall Study|Lost to Follow-up|10|||
148896159|NCT01650558|537100880|FG001|Overall Study|Lost to Follow-up|13|||
148896160|NCT01650558|537100881|FG002|Overall Study|Lost to Follow-up|6|||
148896161|NCT01650558|537100879|FG000|Overall Study|Death|10|||
148896162|NCT01650558|537100880|FG001|Overall Study|Death|6|||
148896163|NCT01650558|537100881|FG002|Overall Study|Death|8|||
148896164|NCT01650558|537100879|FG000|Overall Study|Withdrawal by Subject|1|||
148896165|NCT01650558|537100880|FG001|Overall Study|Withdrawal by Subject|1|||
148896166|NCT01650558|537100881|FG002|Overall Study|Withdrawal by Subject|3|||
148896167|NCT01650558|537100879|FG000|Overall Study|Non-compliant participant|1|||
148896168|NCT01650558|537100880|FG001|Overall Study|Non-compliant participant|0|||
148896169|NCT01650558|537100881|FG002|Overall Study|Non-compliant participant|2|||
148896170|NCT01650558|537100879|FG000|Overall Study|Physician Decision|0|||
148896171|NCT01650558|537100880|FG001|Overall Study|Physician Decision|1|||
148896172|NCT01650558|537100881|FG002|Overall Study|Physician Decision|0|||
148896173|NCT02960217|537100882|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
148896174|NCT02960217|537100883|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
148896175|NCT02960217|537100882|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
148896176|NCT02960217|537100883|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
148896177|NCT02960217|537100882|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
148896178|NCT02960217|537100883|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
148896179|NCT02960217|537100882|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
148896180|NCT02960217|537100883|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
148896181|NCT02960217|537100882|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
148896182|NCT02960217|537100883|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
148896183|NCT02960217|537100882|FG000|Open-Label Extension Phase|Adverse Event|1|||
148896184|NCT02960217|537100883|FG001|Open-Label Extension Phase|Adverse Event|0|||
148896185|NCT02960217|537100882|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
148896186|NCT02960217|537100883|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
148896187|NCT02960217|537100882|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
148896188|NCT02960217|537100883|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
148896189|NCT02960217|537100882|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
148896190|NCT02960217|537100883|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
148896191|NCT01069484|537100884|FG000|Overall Study|Death-in-near-family|1|||
148896192|NCT01069484|537100885|FG001|Overall Study|Death-in-near-family|0|||
148896193|NCT01069484|537100884|FG000|Overall Study|No specific reason|8|||
148896194|NCT01069484|537100885|FG001|Overall Study|No specific reason|2|||
148896195|NCT01069484|537100884|FG000|Overall Study|Illness mother or child|3|||
148896196|NCT01069484|537100885|FG001|Overall Study|Illness mother or child|1|||
148896197|NCT05083351|537100888|FG000|Overall Study|Adverse Event|3|||
148896198|NCT05083351|537100888|FG000|Overall Study|Did not meet data inclusion criteria|8|||
148896199|NCT05083351|537100888|FG000|Overall Study|Did not meet eligibility criteria|19|||
148896200|NCT05083351|537100888|FG000|Overall Study|Study Staff Decision|19|||
148896201|NCT00960375|537100891|FG000|Overall Study|Lost to Follow-up|20|||
148896202|NCT00960375|537100892|FG001|Overall Study|Lost to Follow-up|22|||
148896203|NCT00083889|537100893|FG000|Overall Study|Adverse Event|76|||
148896204|NCT00083889|537100894|FG001|Overall Study|Adverse Event|86|||
148896205|NCT00083889|537100893|FG000|Overall Study|Protocol Violation|2|||
148896206|NCT00083889|537100894|FG001|Overall Study|Protocol Violation|2|||
148896207|NCT00083889|537100893|FG000|Overall Study|Withdrawal by Subject|22|||
148896208|NCT00083889|537100894|FG001|Overall Study|Withdrawal by Subject|24|||
148896209|NCT00083889|537100893|FG000|Overall Study|Lack of Efficacy|240|||
148896210|NCT00083889|537100894|FG001|Overall Study|Lack of Efficacy|219|||
148896211|NCT00083889|537100893|FG000|Overall Study|Decision of sponsor|32|||
148896212|NCT00083889|537100894|FG001|Overall Study|Decision of sponsor|4|||
148896213|NCT00083889|537100893|FG000|Overall Study|Randomized: did not take study drug|0|||
148896214|NCT00083889|537100894|FG001|Overall Study|Randomized: did not take study drug|15|||
148896215|NCT00083889|537100893|FG000|Overall Study|Completed on marketed sunitinub|3|||
148896216|NCT00083889|537100894|FG001|Overall Study|Completed on marketed sunitinub|0|||
148896217|NCT00083889|537100893|FG000|Overall Study|Crossover to SU011248|0|||
148896218|NCT00083889|537100894|FG001|Overall Study|Crossover to SU011248|25|||
148896219|NCT03624881|537100895|FG000|Overall Study|Screen Failure|14|||
148896220|NCT03624881|537100896|FG001|Overall Study|Screen Failure|0|||
148896221|NCT03624881|537100895|FG000|Overall Study|No Catheter Inserted|6|||
148896222|NCT03624881|537100896|FG001|Overall Study|No Catheter Inserted|1|||
148896223|NCT03624881|537100895|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
148896224|NCT03624881|537100896|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
148896225|NCT03624881|537100895|FG000|Overall Study|Death|2|||
148896226|NCT03624881|537100896|FG001|Overall Study|Death|0|||
148896227|NCT03624881|537100895|FG000|Overall Study|Lost to Follow-up|10|||
148896228|NCT03624881|537100896|FG001|Overall Study|Lost to Follow-up|4|||
148896229|NCT03624881|537100895|FG000|Overall Study|Withdrawal by Subject|12|||
148896230|NCT03624881|537100896|FG001|Overall Study|Withdrawal by Subject|1|||
148896231|NCT03019406|537100897|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
148896232|NCT03019406|537100898|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
148896233|NCT03019406|537100899|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
148896234|NCT03019406|537100900|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
148896235|NCT03668873|537100901|FG000|Overall Study|Lost to Follow-up|6|||
148896236|NCT03668873|537100902|FG001|Overall Study|Lost to Follow-up|3|||
148896237|NCT00849940|537100908|FG000|Overall Study|Physician Decision|4|||
148797230|NCT05209880|536735131|FG000|1-Month Follow-up|Lost to Follow-up|7|||
148797231|NCT05209880|536735132|FG001|1-Month Follow-up|Lost to Follow-up|9|||
148797232|NCT05209880|536735131|FG000|1-Month Follow-up|Discontinued|0|||
148797233|NCT05209880|536735132|FG001|1-Month Follow-up|Discontinued|1|||
148797234|NCT05209880|536735131|FG000|3-Month Follow-up|Spoke with Doctor|17|||
148797235|NCT05209880|536735132|FG001|3-Month Follow-up|Spoke with Doctor|7|||
148797236|NCT05209880|536735131|FG000|3-Month Follow-up|Lost to Follow-up|8|||
148797237|NCT05209880|536735132|FG001|3-Month Follow-up|Lost to Follow-up|10|||
148797238|NCT05209880|536735131|FG000|3-Month Follow-up|Discontinued|1|||
148797239|NCT05209880|536735132|FG001|3-Month Follow-up|Discontinued|3|||
148797240|NCT05209880|536735131|FG000|6-Month Follow-up|Spoke with Doctor|25|||
148797241|NCT05209880|536735132|FG001|6-Month Follow-up|Spoke with Doctor|14|||
148797242|NCT05209880|536735131|FG000|6-Month Follow-up|Lost to Follow-up|9|||
148797243|NCT05209880|536735132|FG001|6-Month Follow-up|Lost to Follow-up|14|||
148797244|NCT05209880|536735131|FG000|6-Month Follow-up|Discontinued|1|||
148797245|NCT05209880|536735132|FG001|6-Month Follow-up|Discontinued|3|||
148797246|NCT05635045|536735137|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
148797247|NCT05635045|536735138|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
148797248|NCT05635045|536735139|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
148797249|NCT05635045|536735140|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
148797250|NCT03143101|536735146|FG000|Overall Study|Withdrawal by Subject|0|||
148797251|NCT03143101|536735147|FG001|Overall Study|Withdrawal by Subject|1|||
148797252|NCT03143101|536735148|FG002|Overall Study|Withdrawal by Subject|0|||
148797253|NCT03143101|536735146|FG000|Overall Study|Lost to Follow-up|2|||
148797254|NCT03143101|536735147|FG001|Overall Study|Lost to Follow-up|2|||
148797255|NCT03143101|536735148|FG002|Overall Study|Lost to Follow-up|0|||
148797256|NCT05227118|536735149|FG000|Overall Study|Adverse Event|0|||
148797257|NCT05227118|536735150|FG001|Overall Study|Adverse Event|0|||
148797258|NCT05227118|536735151|FG002|Overall Study|Adverse Event|1|||
148797259|NCT05227118|536735152|FG003|Overall Study|Adverse Event|0|||
148797260|NCT05227118|536735149|FG000|Overall Study|Withdrawal by Subject|0|||
148797261|NCT05227118|536735150|FG001|Overall Study|Withdrawal by Subject|0|||
148797262|NCT05227118|536735151|FG002|Overall Study|Withdrawal by Subject|2|||
148797263|NCT05227118|536735152|FG003|Overall Study|Withdrawal by Subject|0|||
148797264|NCT01435759|536735153|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
148797265|NCT01435759|536735154|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
148797266|NCT01435759|536735155|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
148797267|NCT01435759|536735156|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
148797268|NCT01435759|536735157|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
148797269|NCT01435759|536735158|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
148797270|NCT01435759|536735153|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
148797271|NCT01435759|536735154|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
148797272|NCT01435759|536735155|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
148797273|NCT01435759|536735156|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
148797274|NCT01435759|536735157|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
148797275|NCT01435759|536735158|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
148797276|NCT01435759|536735153|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
148797277|NCT01435759|536735154|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148797278|NCT01435759|536735155|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148797279|NCT01435759|536735156|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148797280|NCT01435759|536735157|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148797281|NCT01435759|536735158|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148797282|NCT01435759|536735153|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
148797283|NCT01435759|536735154|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148797284|NCT01435759|536735155|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148797285|NCT01435759|536735156|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148797286|NCT01435759|536735157|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148797287|NCT01435759|536735158|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148797288|NCT01435759|536735153|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
148797289|NCT01435759|536735154|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797290|NCT01435759|536735155|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797291|NCT01435759|536735156|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797292|NCT01435759|536735157|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797293|NCT01435759|536735158|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797294|NCT01435759|536735153|FG000|Antidepressant Lead-in Phase|Other|119|||
148797295|NCT01435759|536735154|FG001|Antidepressant Lead-in Phase|Other|0|||
148896238|NCT04258423|537100909|FG000|Overall Study|Study Closure|2|||
148797296|NCT01435759|536735155|FG002|Antidepressant Lead-in Phase|Other|0|||
148797297|NCT01435759|536735156|FG003|Antidepressant Lead-in Phase|Other|0|||
148797298|NCT01435759|536735157|FG004|Antidepressant Lead-in Phase|Other|0|||
148797299|NCT01435759|536735158|FG005|Antidepressant Lead-in Phase|Other|0|||
148797300|NCT01435759|536735153|FG000|Double-blind Phase|Adverse Event|7|||
148797301|NCT01435759|536735154|FG001|Double-blind Phase|Adverse Event|0|||
148797302|NCT01435759|536735155|FG002|Double-blind Phase|Adverse Event|1|||
148797303|NCT01435759|536735156|FG003|Double-blind Phase|Adverse Event|1|||
148797304|NCT01435759|536735157|FG004|Double-blind Phase|Adverse Event|1|||
148797305|NCT01435759|536735158|FG005|Double-blind Phase|Adverse Event|3|||
148797306|NCT01435759|536735153|FG000|Double-blind Phase|Protocol Violation|2|||
148797307|NCT01435759|536735154|FG001|Double-blind Phase|Protocol Violation|0|||
148797308|NCT01435759|536735155|FG002|Double-blind Phase|Protocol Violation|1|||
148797309|NCT01435759|536735156|FG003|Double-blind Phase|Protocol Violation|2|||
148797310|NCT01435759|536735157|FG004|Double-blind Phase|Protocol Violation|0|||
148797311|NCT01435759|536735158|FG005|Double-blind Phase|Protocol Violation|1|||
148797312|NCT01435759|536735153|FG000|Double-blind Phase|Withdrawal by Subject|17|||
148797313|NCT01435759|536735154|FG001|Double-blind Phase|Withdrawal by Subject|4|||
148797314|NCT01435759|536735155|FG002|Double-blind Phase|Withdrawal by Subject|3|||
148797315|NCT01435759|536735156|FG003|Double-blind Phase|Withdrawal by Subject|4|||
148797316|NCT01435759|536735157|FG004|Double-blind Phase|Withdrawal by Subject|2|||
148797317|NCT01435759|536735158|FG005|Double-blind Phase|Withdrawal by Subject|2|||
148797318|NCT01435759|536735153|FG000|Double-blind Phase|Lost to Follow-up|31|||
148797319|NCT01435759|536735154|FG001|Double-blind Phase|Lost to Follow-up|1|||
148797320|NCT01435759|536735155|FG002|Double-blind Phase|Lost to Follow-up|2|||
148797321|NCT01435759|536735156|FG003|Double-blind Phase|Lost to Follow-up|0|||
148797322|NCT01435759|536735157|FG004|Double-blind Phase|Lost to Follow-up|3|||
148797323|NCT01435759|536735158|FG005|Double-blind Phase|Lost to Follow-up|3|||
148797324|NCT01435759|536735153|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
148797325|NCT01435759|536735154|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797326|NCT01435759|536735155|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797327|NCT01435759|536735156|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797328|NCT01435759|536735157|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
148797329|NCT01435759|536735158|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
148797330|NCT01435759|536735153|FG000|Double-blind Phase|Other|8|||
148797331|NCT01435759|536735154|FG001|Double-blind Phase|Other|2|||
148797332|NCT01435759|536735155|FG002|Double-blind Phase|Other|0|||
148797333|NCT01435759|536735156|FG003|Double-blind Phase|Other|2|||
148797334|NCT01435759|536735157|FG004|Double-blind Phase|Other|0|||
148797335|NCT01435759|536735158|FG005|Double-blind Phase|Other|0|||
148797336|NCT03727841|536735161|FG000|Overall Study|Physician Decision|3|||
148797337|NCT03727841|536735162|FG001|Overall Study|Physician Decision|1|||
148797338|NCT03126786|536735163|FG000|Overall Study|Adverse Event|3|||
148797339|NCT03126786|536735164|FG001|Overall Study|Adverse Event|0|||
148797340|NCT03126786|536735163|FG000|Overall Study|Lost to Follow-up|0|||
149137364|NCT00332839|537985105|FG000|Core (Months 0 - 12)|Adverse Event|5|||
149137365|NCT00332839|537985106|FG001|Core (Months 0 - 12)|Adverse Event|15|||
149137366|NCT00332839|537985105|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
149137367|NCT00332839|537985106|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
149137368|NCT00332839|537985105|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
149137369|NCT00332839|537985106|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
149137370|NCT00332839|537985105|FG000|Follow-up (Months 12 - 60)|Death|1|||
149137371|NCT00332839|537985106|FG001|Follow-up (Months 12 - 60)|Death|1|||
148797341|NCT03126786|536735164|FG001|Overall Study|Lost to Follow-up|1|||
148797342|NCT03126786|536735163|FG000|Overall Study|Withdrawal by Subject|3|||
148797343|NCT03126786|536735164|FG001|Overall Study|Withdrawal by Subject|1|||
148797344|NCT01601496|536735165|FG000|Overall Study|Physician Decision|1|||
148797345|NCT01601496|536735165|FG000|Overall Study|Withdrawal by Subject|1|||
148797346|NCT01601496|536735165|FG000|Overall Study|Lost to Follow-up|6|||
148797347|NCT01601496|536735165|FG000|Overall Study|Death|4|||
148896239|NCT04258423|537100910|FG001|Overall Study|Study Closure|2|||
148896240|NCT01601535|537100913|FG000|Phase 1|Adverse Event|1|||
148896241|NCT01601535|537100914|FG001|Phase 1|Adverse Event|0|||
148896242|NCT01601535|537100915|FG002|Phase 1|Adverse Event|2|||
148896243|NCT01601535|537100916|FG003|Phase 1|Adverse Event|1|||
148896244|NCT01601535|537100917|FG004|Phase 1|Adverse Event|0|||
148896245|NCT01601535|537100918|FG005|Phase 1|Adverse Event|0|||
148896246|NCT01601535|537100913|FG000|Phase 1|Withdrawal by Subject|2|||
148896247|NCT01601535|537100914|FG001|Phase 1|Withdrawal by Subject|1|||
148896248|NCT01601535|537100915|FG002|Phase 1|Withdrawal by Subject|1|||
148896249|NCT01601535|537100916|FG003|Phase 1|Withdrawal by Subject|2|||
148896250|NCT01601535|537100917|FG004|Phase 1|Withdrawal by Subject|0|||
148896251|NCT01601535|537100918|FG005|Phase 1|Withdrawal by Subject|0|||
148896252|NCT01601535|537100913|FG000|Phase 1|Progressive Disease|2|||
148896253|NCT01601535|537100914|FG001|Phase 1|Progressive Disease|3|||
148896254|NCT01601535|537100915|FG002|Phase 1|Progressive Disease|2|||
148896255|NCT01601535|537100916|FG003|Phase 1|Progressive Disease|1|||
148896256|NCT01601535|537100917|FG004|Phase 1|Progressive Disease|0|||
148797348|NCT01601496|536735165|FG000|Overall Study|Other: patient refusal to continue|3|||
148797349|NCT03243305|536735166|FG000|Overall Study|Lost to Follow-up|250|||
148797350|NCT03243305|536735166|FG000|Overall Study|Withdrawal by Subject|170|||
148797351|NCT03243305|536735166|FG000|Overall Study|Pregnancy|104|||
148797352|NCT03243305|536735166|FG000|Overall Study|Non-Compliance with Study Drug|38|||
148797353|NCT03243305|536735166|FG000|Overall Study|Adverse Event|23|||
148797354|NCT03243305|536735166|FG000|Overall Study|No sexually active|26|||
148797355|NCT03243305|536735166|FG000|Overall Study|Physician Decision|22|||
148797356|NCT03243305|536735166|FG000|Overall Study|Protocol Violation|22|||
148797357|NCT03243305|536735166|FG000|Overall Study|Study method no longer primary method|12|||
148797358|NCT03243305|536735166|FG000|Overall Study|Study Terminated by Sponsor|1|||
148797359|NCT03243305|536735166|FG000|Overall Study|Early terminations|267|||
148797360|NCT02689804|536735167|FG000|Overall Study|Withdrawal by Subject|2|||
148797361|NCT02689804|536735168|FG001|Overall Study|Withdrawal by Subject|0|||
148797362|NCT00673257|536735170|FG000|Overall Study|Withdrawal by Subject|4|||
148797363|NCT00673257|536735170|FG000|Overall Study|Unable to obtain specimen|1|||
148797364|NCT01166750|536735177|FG000|Overall Study|Lost to Follow-up|1|||
148797365|NCT01166750|536735178|FG001|Overall Study|Lost to Follow-up|0|||
148797366|NCT02417753|536735181|FG000|Overall Study|Death|1|||
148797367|NCT03113968|536735182|FG000|Overall Study|Withdrawal by Subject|31|||
148797368|NCT03113968|536735183|FG001|Overall Study|Withdrawal by Subject|4|||
148797369|NCT04805671|536735184|FG000|Overall Study|Death|2|||
148797370|NCT04805671|536735185|FG001|Overall Study|Death|7|||
148797371|NCT04805671|536735184|FG000|Overall Study|Lost to Follow-up|1|||
148797372|NCT04805671|536735185|FG001|Overall Study|Lost to Follow-up|0|||
148797373|NCT04805671|536735184|FG000|Overall Study|Withdrawal by Subject|9|||
148797374|NCT04805671|536735185|FG001|Overall Study|Withdrawal by Subject|7|||
148797375|NCT04805671|536735184|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
148797376|NCT04805671|536735185|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
148797377|NCT02111174|536735188|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
148797378|NCT02111174|536735189|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
148797379|NCT02111174|536735188|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
148797380|NCT02111174|536735189|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
148797381|NCT02111174|536735188|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
148797382|NCT02111174|536735189|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
148797383|NCT02111174|536735188|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
148797384|NCT02111174|536735189|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
148797385|NCT00901342|536735190|FG000|Overall Study|Adverse Event|1|||
148797386|NCT00901342|536735190|FG000|Overall Study|Death|4|||
148797387|NCT00901342|536735190|FG000|Overall Study|Disease progression|1|||
148797388|NCT00901342|536735190|FG000|Overall Study|Withdrawal by Subject|9|||
148797389|NCT02849587|536735191|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
148797390|NCT02849587|536735192|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
148797391|NCT02849587|536735193|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
148797392|NCT02849587|536735191|FG000|Overall Study|Withdrawal by Subject|0|||
148896257|NCT01601535|537100918|FG005|Phase 1|Progressive Disease|0|||
148797393|NCT02849587|536735192|FG001|Overall Study|Withdrawal by Subject|1|||
148797394|NCT02849587|536735193|FG002|Overall Study|Withdrawal by Subject|0|||
148797395|NCT02716779|536735196|FG000|Monotherapy|Adverse Event|0|||
148797396|NCT02716779|536735197|FG001|Monotherapy|Adverse Event|1|||
148797397|NCT02716779|536735198|FG002|Monotherapy|Adverse Event|1|||
148896258|NCT01601535|537100913|FG000|Phase 1|Started Another Treatment|1|||
148896259|NCT01601535|537100914|FG001|Phase 1|Started Another Treatment|2|||
148896260|NCT01601535|537100915|FG002|Phase 1|Started Another Treatment|0|||
148896261|NCT01601535|537100916|FG003|Phase 1|Started Another Treatment|0|||
148896262|NCT01601535|537100917|FG004|Phase 1|Started Another Treatment|0|||
148797398|NCT02716779|536735196|FG000|Combination Therapy|Adverse Event|0|||
148797399|NCT02716779|536735197|FG001|Combination Therapy|Adverse Event|2|||
148797400|NCT02716779|536735198|FG002|Combination Therapy|Adverse Event|1|||
148797401|NCT01386606|536736659|FG000|Overall Study|Adverse Event|0|||
148797402|NCT01386606|536736660|FG001|Overall Study|Adverse Event|1|||
148797403|NCT01386606|536736661|FG002|Overall Study|Adverse Event|0|||
148797404|NCT01386606|536736662|FG003|Overall Study|Adverse Event|0|||
148797405|NCT01386606|536736659|FG000|Overall Study|Withdrawal by Subject|0|||
148797406|NCT01386606|536736660|FG001|Overall Study|Withdrawal by Subject|1|||
148797407|NCT01386606|536736661|FG002|Overall Study|Withdrawal by Subject|1|||
148797408|NCT01386606|536736662|FG003|Overall Study|Withdrawal by Subject|0|||
148797409|NCT01386606|536736659|FG000|Overall Study|Protocol Violation|1|||
148797410|NCT01386606|536736660|FG001|Overall Study|Protocol Violation|0|||
148797411|NCT01386606|536736661|FG002|Overall Study|Protocol Violation|1|||
148797412|NCT01386606|536736662|FG003|Overall Study|Protocol Violation|1|||
148797413|NCT01386606|536736659|FG000|Overall Study|Lost to Follow-up|2|||
148797414|NCT01386606|536736660|FG001|Overall Study|Lost to Follow-up|0|||
148797415|NCT01386606|536736661|FG002|Overall Study|Lost to Follow-up|0|||
148797416|NCT01386606|536736662|FG003|Overall Study|Lost to Follow-up|0|||
148797417|NCT01386606|536736659|FG000|Overall Study|Subject incarcerated|0|||
148797418|NCT01386606|536736660|FG001|Overall Study|Subject incarcerated|1|||
148797419|NCT01386606|536736661|FG002|Overall Study|Subject incarcerated|0|||
148797420|NCT01386606|536736662|FG003|Overall Study|Subject incarcerated|0|||
148797421|NCT01386606|536736659|FG000|Overall Study|Unable to draw PK|1|||
148797422|NCT01386606|536736660|FG001|Overall Study|Unable to draw PK|0|||
148797423|NCT01386606|536736661|FG002|Overall Study|Unable to draw PK|0|||
148797424|NCT01386606|536736662|FG003|Overall Study|Unable to draw PK|0|||
148797425|NCT01386606|536736659|FG000|Overall Study|T levels too high|0|||
148797426|NCT01386606|536736660|FG001|Overall Study|T levels too high|1|||
148797427|NCT01386606|536736661|FG002|Overall Study|T levels too high|1|||
148797428|NCT01386606|536736662|FG003|Overall Study|T levels too high|0|||
148797429|NCT02357459|536736665|FG000|Overall Study|Adverse Event|0|||
148797430|NCT02357459|536736666|FG001|Overall Study|Adverse Event|1|||
148797431|NCT02357459|536736667|FG002|Overall Study|Adverse Event|1|||
148797432|NCT02357459|536736665|FG000|Overall Study|Withdrawal by Subject|5|||
148797433|NCT02357459|536736666|FG001|Overall Study|Withdrawal by Subject|3|||
148797434|NCT02357459|536736667|FG002|Overall Study|Withdrawal by Subject|3|||
148797435|NCT02357459|536736665|FG000|Overall Study|Physician Decision|0|||
148797436|NCT02357459|536736666|FG001|Overall Study|Physician Decision|2|||
148797437|NCT02357459|536736667|FG002|Overall Study|Physician Decision|0|||
148797438|NCT02357459|536736665|FG000|Overall Study|Protocol Violation|1|||
148797439|NCT02357459|536736666|FG001|Overall Study|Protocol Violation|1|||
148797440|NCT02357459|536736667|FG002|Overall Study|Protocol Violation|0|||
148797441|NCT02357459|536736665|FG000|Overall Study|Lost to Follow-up|1|||
148797442|NCT02357459|536736666|FG001|Overall Study|Lost to Follow-up|3|||
148797443|NCT02357459|536736667|FG002|Overall Study|Lost to Follow-up|0|||
148797444|NCT02357459|536736665|FG000|Overall Study|Lack of Efficacy|7|||
148797445|NCT02357459|536736666|FG001|Overall Study|Lack of Efficacy|4|||
148797446|NCT02357459|536736667|FG002|Overall Study|Lack of Efficacy|4|||
148797447|NCT02357459|536736665|FG000|Overall Study|Patient Relocated|2|||
148797448|NCT02357459|536736666|FG001|Overall Study|Patient Relocated|0|||
148797449|NCT02357459|536736667|FG002|Overall Study|Patient Relocated|0|||
148797450|NCT02357459|536736665|FG000|Overall Study|Instruction from PCP|1|||
148797451|NCT02357459|536736666|FG001|Overall Study|Instruction from PCP|0|||
148797452|NCT02357459|536736667|FG002|Overall Study|Instruction from PCP|0|||
149137372|NCT00594516|537985111|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
149137373|NCT00594516|537985112|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
149137374|NCT00594516|537985113|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
149137375|NCT00594516|537985111|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
149137376|NCT00594516|537985112|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
149137377|NCT00594516|537985113|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
149137378|NCT00594516|537985111|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
149137379|NCT00594516|537985112|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
149137380|NCT00594516|537985113|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
149137381|NCT00594516|537985111|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
149137382|NCT00594516|537985112|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
149137383|NCT00594516|537985113|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
149137384|NCT00594516|537985111|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
149137385|NCT00594516|537985112|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
148797453|NCT02357459|536736665|FG000|Overall Study|Incarceration|0|||
148797454|NCT02357459|536736666|FG001|Overall Study|Incarceration|0|||
149137386|NCT00594516|537985113|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
148797455|NCT02357459|536736667|FG002|Overall Study|Incarceration|1|||
148797456|NCT02357459|536736665|FG000|Overall Study|Pre-planned Knee surgery|0|||
148896263|NCT01601535|537100918|FG005|Phase 1|Started Another Treatment|0|||
148896264|NCT01601535|537100913|FG000|Phase 2|Adverse Event|0|||
148896265|NCT01601535|537100914|FG001|Phase 2|Adverse Event|0|||
148896266|NCT01601535|537100915|FG002|Phase 2|Adverse Event|0|||
148896267|NCT01601535|537100916|FG003|Phase 2|Adverse Event|0|||
148896268|NCT01601535|537100917|FG004|Phase 2|Adverse Event|5|||
148896269|NCT01601535|537100918|FG005|Phase 2|Adverse Event|1|||
148896270|NCT01601535|537100913|FG000|Phase 2|Withdrawal by Subject|0|||
148896271|NCT01601535|537100914|FG001|Phase 2|Withdrawal by Subject|0|||
148896272|NCT01601535|537100915|FG002|Phase 2|Withdrawal by Subject|0|||
148896273|NCT01601535|537100916|FG003|Phase 2|Withdrawal by Subject|0|||
148896274|NCT01601535|537100917|FG004|Phase 2|Withdrawal by Subject|8|||
148896275|NCT01601535|537100918|FG005|Phase 2|Withdrawal by Subject|2|||
148896276|NCT01601535|537100913|FG000|Phase 2|Progressive Disease|0|||
148896277|NCT01601535|537100914|FG001|Phase 2|Progressive Disease|0|||
148896278|NCT01601535|537100915|FG002|Phase 2|Progressive Disease|0|||
148896279|NCT01601535|537100916|FG003|Phase 2|Progressive Disease|0|||
148896280|NCT01601535|537100917|FG004|Phase 2|Progressive Disease|5|||
148896281|NCT01601535|537100918|FG005|Phase 2|Progressive Disease|7|||
148896282|NCT01601535|537100913|FG000|Phase 2|Started Another Treatment|0|||
148896283|NCT01601535|537100914|FG001|Phase 2|Started Another Treatment|0|||
148896284|NCT01601535|537100915|FG002|Phase 2|Started Another Treatment|0|||
148896285|NCT01601535|537100916|FG003|Phase 2|Started Another Treatment|0|||
148896286|NCT01601535|537100917|FG004|Phase 2|Started Another Treatment|1|||
148896287|NCT01601535|537100918|FG005|Phase 2|Started Another Treatment|2|||
148896288|NCT01766050|537103041|FG000|Overall Study|Adverse Event|1|||
148896289|NCT01766050|537103041|FG000|Overall Study|Lost to Follow-up|1|||
148896290|NCT01766050|537103041|FG000|Overall Study|Withdrawal by Subject|2|||
148896291|NCT02994108|537103043|FG000|Intervention Messages|Withdrawal by Subject|2|||
148896292|NCT02994108|537103044|FG001|Intervention Messages|Withdrawal by Subject|0|||
148896293|NCT02994108|537103043|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
148896294|NCT02994108|537103044|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
148896295|NCT02994108|537103043|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
148896296|NCT02994108|537103044|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
148896297|NCT02994108|537103043|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
148896298|NCT02994108|537103044|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
148896299|NCT02081677|537103045|FG000|Overall Study|Adverse Event|0|||
148896300|NCT02081677|537103046|FG001|Overall Study|Adverse Event|0|||
148896301|NCT02081677|537103047|FG002|Overall Study|Adverse Event|1|||
148896302|NCT02081677|537103048|FG003|Overall Study|Adverse Event|0|||
148896303|NCT02081677|537103045|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
148896304|NCT02081677|537103046|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148896305|NCT02081677|537103047|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
148896306|NCT02081677|537103048|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
148896307|NCT02081677|537103045|FG000|Overall Study|Not comfortable with lens care system|1|||
148896308|NCT02081677|537103046|FG001|Overall Study|Not comfortable with lens care system|0|||
148896309|NCT02081677|537103047|FG002|Overall Study|Not comfortable with lens care system|0|||
148896310|NCT02081677|537103048|FG003|Overall Study|Not comfortable with lens care system|0|||
148896311|NCT02081677|537103045|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
148896312|NCT02081677|537103046|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
148896313|NCT02081677|537103047|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
148896314|NCT02081677|537103048|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
148896315|NCT00089297|537103049|FG000|Overall Study|Adverse Event|9|||
148896316|NCT00089297|537103049|FG000|Overall Study|Death|1|||
148896317|NCT00089297|537103049|FG000|Overall Study|Withdrawal by Subject|12|||
148896318|NCT00089297|537103049|FG000|Overall Study|Disease progression|2|||
148896319|NCT00089297|537103049|FG000|Overall Study|Ineligible|11|||
148896320|NCT00089297|537103049|FG000|Overall Study|Secondary malignancy|1|||
148896321|NCT00089297|537103049|FG000|Overall Study|IRB approval not ready|1|||
148896322|NCT00089297|537103049|FG000|Overall Study|Non-compliance|1|||
148896323|NCT00904969|537103050|FG000|Overall Study|Lost to Follow-up|4|||
148896324|NCT00904969|537103050|FG000|Overall Study|Withdrawal by Subject|3|||
148896325|NCT00904969|537103050|FG000|Overall Study|Additional Treatments|11|||
148797457|NCT02357459|536736666|FG001|Overall Study|Pre-planned Knee surgery|0|||
148797458|NCT02357459|536736667|FG002|Overall Study|Pre-planned Knee surgery|2|||
148797459|NCT02357459|536736665|FG000|Overall Study|Job Commitments|0|||
148797460|NCT02357459|536736666|FG001|Overall Study|Job Commitments|0|||
148797461|NCT02357459|536736667|FG002|Overall Study|Job Commitments|1|||
148797462|NCT03246347|536736668|FG000|Overall Study|On Study|23|||
148797463|NCT01548599|536736669|FG000|Overall Study|Lost to Follow-up|0|||
148797464|NCT01548599|536736670|FG001|Overall Study|Lost to Follow-up|1|||
148797465|NCT01548599|536736669|FG000|Overall Study|Withdrawal by Subject|4|||
148797466|NCT01548599|536736670|FG001|Overall Study|Withdrawal by Subject|0|||
148797467|NCT01548599|536736669|FG000|Overall Study|Death|2|||
148797468|NCT01548599|536736670|FG001|Overall Study|Death|1|||
148797469|NCT02188160|536736671|FG000|Overall Study|Adverse Event|1|||
148797470|NCT02188160|536736672|FG001|Overall Study|Adverse Event|0|||
148797471|NCT02188160|536736671|FG000|Overall Study|Use of an excluded medication|0|||
148797472|NCT02188160|536736672|FG001|Overall Study|Use of an excluded medication|1|||
148797473|NCT04113694|536736673|FG000|Overall Study|Adverse Event|2|||
148797474|NCT04113694|536736673|FG000|Overall Study|Lost to Follow-up|2|||
148797475|NCT04113694|536736673|FG000|Overall Study|Withdrawal by Subject|6|||
148797476|NCT04113694|536736673|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
148797477|NCT00916578|536736676|FG000|Overall Study|Physician Decision|2|||
148797478|NCT00916578|536736676|FG000|Overall Study|Withdrawal by Subject|3|||
148797479|NCT00916578|536736676|FG000|Overall Study|Insurance Denial|2|||
148797480|NCT00754741|536736677|FG000|Overall Study|Died or disenrolled|57|||
148797481|NCT00754741|536736678|FG001|Overall Study|Died or disenrolled|69|||
148797482|NCT00754741|536736679|FG002|Overall Study|Died or disenrolled|54|||
148797483|NCT04152200|536736681|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
148797484|NCT04152200|536736682|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
148797485|NCT04969289|536736683|FG000|Overall Study|Lost to Follow-up|13|||
148797486|NCT04969289|536736684|FG001|Overall Study|Lost to Follow-up|9|||
148797487|NCT00593814|536736685|FG000|Overall Study|Death|7|||
148797488|NCT00593814|536736686|FG001|Overall Study|Death|0|||
148797489|NCT00593814|536736685|FG000|Overall Study|Withdrawal by Subject|7|||
148797490|NCT00593814|536736686|FG001|Overall Study|Withdrawal by Subject|0|||
148797491|NCT00593814|536736685|FG000|Overall Study|Lost to Follow-up|7|||
148797492|NCT00593814|536736686|FG001|Overall Study|Lost to Follow-up|0|||
148797493|NCT00593814|536736685|FG000|Overall Study|Physician Decision|3|||
148797494|NCT00593814|536736686|FG001|Overall Study|Physician Decision|0|||
148797495|NCT02699996|536736687|FG000|Overall Study|Withdrawal by Subject|5|||
148797496|NCT02699996|536736688|FG001|Overall Study|Withdrawal by Subject|2|||
148797497|NCT01921517|536736689|FG000|Overall Study|Lost to Follow-up|5|||
148797498|NCT01921517|536736690|FG001|Overall Study|Lost to Follow-up|0|||
148797499|NCT01921517|536736689|FG000|Overall Study|Newly diagnosed health concern|2|||
148797500|NCT01921517|536736690|FG001|Overall Study|Newly diagnosed health concern|0|||
148797501|NCT01921517|536736689|FG000|Overall Study|Physician Decision|0|||
148797502|NCT01921517|536736690|FG001|Overall Study|Physician Decision|2|||
148797503|NCT01921517|536736689|FG000|Overall Study|Withdrawal by Subject|7|||
148797504|NCT01921517|536736690|FG001|Overall Study|Withdrawal by Subject|3|||
148797505|NCT01921517|536736689|FG000|Overall Study|Subject missed final imaging|1|||
148797506|NCT01921517|536736690|FG001|Overall Study|Subject missed final imaging|4|||
148797507|NCT01307787|536736692|FG000|Overall Study|Withdrawal by Subject|2|||
148797508|NCT01307787|536736693|FG001|Overall Study|Withdrawal by Subject|0|||
148797509|NCT01294423|536736694|FG000|Overall Study|Adverse Event|1|||
148797510|NCT01294423|536736695|FG001|Overall Study|Adverse Event|2|||
148797511|NCT01294423|536736696|FG002|Overall Study|Adverse Event|3|||
148797512|NCT01294423|536736694|FG000|Overall Study|Withdrawal by Subject|1|||
148797513|NCT01294423|536736695|FG001|Overall Study|Withdrawal by Subject|2|||
148797514|NCT01294423|536736696|FG002|Overall Study|Withdrawal by Subject|2|||
148797515|NCT01294423|536736694|FG000|Overall Study|subject no longer meets study criteria|2|||
148797516|NCT01294423|536736695|FG001|Overall Study|subject no longer meets study criteria|5|||
148797517|NCT01294423|536736696|FG002|Overall Study|subject no longer meets study criteria|2|||
148797518|NCT01294423|536736694|FG000|Overall Study|poor/non-compliance|1|||
148896326|NCT00904969|537103050|FG000|Overall Study|Case Aborted; Subject Exited|1|||
148797519|NCT01294423|536736695|FG001|Overall Study|poor/non-compliance|0|||
148797520|NCT01294423|536736696|FG002|Overall Study|poor/non-compliance|1|||
148797521|NCT01405560|536736699|FG000|Overall Study|Physician Decision|1|||
148896327|NCT01097668|537103051|FG000|Overall Study|Withdrawal by Subject|1|||
148896328|NCT01097668|537103052|FG001|Overall Study|Withdrawal by Subject|2|||
148896329|NCT01097668|537103051|FG000|Overall Study|Lost to Follow-up|1|||
148896330|NCT01097668|537103052|FG001|Overall Study|Lost to Follow-up|0|||
148896331|NCT04199351|537103062|FG000|Overall Study|Decision by sponsor|0|||
148896332|NCT04199351|537103063|FG001|Overall Study|Decision by sponsor|0|||
148896333|NCT04199351|537103064|FG002|Overall Study|Decision by sponsor|0|||
148896334|NCT04199351|537103065|FG003|Overall Study|Decision by sponsor|2|||
148896335|NCT04199351|537103066|FG004|Overall Study|Decision by sponsor|0|||
148896336|NCT04199351|537103067|FG005|Overall Study|Decision by sponsor|0|||
148896337|NCT04199351|537103068|FG006|Overall Study|Decision by sponsor|0|||
148896338|NCT04199351|537103069|FG007|Overall Study|Decision by sponsor|0|||
148896339|NCT04199351|537103070|FG008|Overall Study|Decision by sponsor|0|||
148896340|NCT04199351|537103071|FG009|Overall Study|Decision by sponsor|6|||
148896341|NCT04199351|537103062|FG000|Overall Study|Lost to Follow-up|0|||
148896342|NCT04199351|537103063|FG001|Overall Study|Lost to Follow-up|0|||
148896343|NCT04199351|537103064|FG002|Overall Study|Lost to Follow-up|1|||
148896344|NCT04199351|537103065|FG003|Overall Study|Lost to Follow-up|0|||
148896345|NCT04199351|537103066|FG004|Overall Study|Lost to Follow-up|0|||
148896346|NCT04199351|537103067|FG005|Overall Study|Lost to Follow-up|1|||
148896347|NCT04199351|537103068|FG006|Overall Study|Lost to Follow-up|0|||
148896348|NCT04199351|537103069|FG007|Overall Study|Lost to Follow-up|0|||
148896349|NCT04199351|537103070|FG008|Overall Study|Lost to Follow-up|0|||
148896350|NCT04199351|537103071|FG009|Overall Study|Lost to Follow-up|0|||
148896351|NCT04199351|537103062|FG000|Overall Study|Withdrawal by Subject|0|||
148896352|NCT04199351|537103063|FG001|Overall Study|Withdrawal by Subject|1|||
148896353|NCT04199351|537103064|FG002|Overall Study|Withdrawal by Subject|0|||
148896354|NCT04199351|537103065|FG003|Overall Study|Withdrawal by Subject|0|||
148896355|NCT04199351|537103066|FG004|Overall Study|Withdrawal by Subject|1|||
148896356|NCT04199351|537103067|FG005|Overall Study|Withdrawal by Subject|4|||
148896357|NCT04199351|537103068|FG006|Overall Study|Withdrawal by Subject|2|||
148896358|NCT04199351|537103069|FG007|Overall Study|Withdrawal by Subject|0|||
148896359|NCT04199351|537103070|FG008|Overall Study|Withdrawal by Subject|3|||
148896360|NCT04199351|537103071|FG009|Overall Study|Withdrawal by Subject|0|||
148896361|NCT03623243|537103072|FG000|Overall Study|Adverse Event|15|||
148896362|NCT03623243|537103072|FG000|Overall Study|Guardian Decision|1|||
148896363|NCT03623243|537103072|FG000|Overall Study|New Therapy for Study Indication|1|||
148896364|NCT03623243|537103072|FG000|Overall Study|Protocol Deviation|3|||
148896365|NCT03623243|537103072|FG000|Overall Study|Physician Decision|4|||
148896366|NCT03623243|537103072|FG000|Overall Study|Patient Decision|15|||
148896367|NCT03007966|537103073|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
148896368|NCT03007966|537103074|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
148896369|NCT00474487|537103078|FG000|Overall Study|Withdrawal by Subject|6|||
148896370|NCT00474487|537103079|FG001|Overall Study|Withdrawal by Subject|0|||
148896371|NCT00474487|537103080|FG002|Overall Study|Withdrawal by Subject|0|||
148896372|NCT00474487|537103081|FG003|Overall Study|Withdrawal by Subject|0|||
148896373|NCT00474487|537103078|FG000|Overall Study|Lost to Follow-up|20|||
148896374|NCT00474487|537103079|FG001|Overall Study|Lost to Follow-up|1|||
148896375|NCT00474487|537103080|FG002|Overall Study|Lost to Follow-up|7|||
148896376|NCT00474487|537103081|FG003|Overall Study|Lost to Follow-up|0|||
148896377|NCT00474487|537103078|FG000|Overall Study|Inappropriate enrollment|4|||
148896378|NCT00474487|537103079|FG001|Overall Study|Inappropriate enrollment|0|||
148896379|NCT00474487|537103080|FG002|Overall Study|Inappropriate enrollment|7|||
148896380|NCT00474487|537103081|FG003|Overall Study|Inappropriate enrollment|0|||
148896381|NCT00474487|537103078|FG000|Overall Study|Death|0|||
148896382|NCT00474487|537103079|FG001|Overall Study|Death|1|||
148896383|NCT00474487|537103080|FG002|Overall Study|Death|0|||
148896384|NCT00474487|537103081|FG003|Overall Study|Death|0|||
148896385|NCT01428258|537103082|FG000|Intervention 1|Withdrawal by Subject|2|||
148896386|NCT01428258|537103083|FG001|Intervention 1|Withdrawal by Subject|0|||
148896387|NCT00419393|537103084|FG000|Overall Study|Adverse Event|5|||
148896388|NCT00419393|537103084|FG000|Overall Study|Protocol Violation|5|||
148896389|NCT00419393|537103084|FG000|Overall Study|Withdrawal by Subject|7|||
148896390|NCT00419393|537103084|FG000|Overall Study|Other: Sponsor request|3|||
148896391|NCT00419393|537103084|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
148896392|NCT00419393|537103084|FG000|Overall Study|Other: Site closure|1|||
148896393|NCT00419393|537103084|FG000|Overall Study|Other: Other health problems|1|||
148896394|NCT00419393|537103084|FG000|Overall Study|Other: Investigator decision|1|||
148896395|NCT00979901|537103085|FG000|Overall Study|Adverse Event|1|||
149137387|NCT00594516|537985111|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
149137388|NCT00594516|537985112|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
149137389|NCT00594516|537985113|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
149137390|NCT00594516|537985111|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
149137391|NCT00594516|537985112|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
149137392|NCT00594516|537985113|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
148896396|NCT00979901|537103086|FG001|Overall Study|Adverse Event|3|||
148896397|NCT00979901|537103087|FG002|Overall Study|Adverse Event|9|||
148896398|NCT00979901|537103088|FG003|Overall Study|Adverse Event|2|||
148896399|NCT00979901|537103085|FG000|Overall Study|Lack of Efficacy|8|||
148896400|NCT00979901|537103086|FG001|Overall Study|Lack of Efficacy|4|||
148896401|NCT00979901|537103087|FG002|Overall Study|Lack of Efficacy|9|||
148896402|NCT00979901|537103088|FG003|Overall Study|Lack of Efficacy|0|||
148896403|NCT00979901|537103085|FG000|Overall Study|Lost to Follow-up|1|||
148896404|NCT00979901|537103086|FG001|Overall Study|Lost to Follow-up|1|||
148896405|NCT00979901|537103087|FG002|Overall Study|Lost to Follow-up|2|||
148896406|NCT00979901|537103088|FG003|Overall Study|Lost to Follow-up|0|||
148896407|NCT00979901|537103085|FG000|Overall Study|Protocol Violation|2|||
148896408|NCT00979901|537103086|FG001|Overall Study|Protocol Violation|2|||
148896409|NCT00979901|537103087|FG002|Overall Study|Protocol Violation|7|||
148896410|NCT00979901|537103088|FG003|Overall Study|Protocol Violation|1|||
148896411|NCT00979901|537103085|FG000|Overall Study|Withdrawal by Subject|2|||
148896412|NCT00979901|537103086|FG001|Overall Study|Withdrawal by Subject|1|||
148896413|NCT00979901|537103087|FG002|Overall Study|Withdrawal by Subject|1|||
148896414|NCT00979901|537103088|FG003|Overall Study|Withdrawal by Subject|1|||
148896415|NCT00979901|537103085|FG000|Overall Study|Noncompliance|1|||
148896416|NCT00979901|537103086|FG001|Overall Study|Noncompliance|0|||
148896417|NCT00979901|537103087|FG002|Overall Study|Noncompliance|0|||
148896418|NCT00979901|537103088|FG003|Overall Study|Noncompliance|0|||
148896419|NCT00979901|537103085|FG000|Overall Study|out-of-state|1|||
148896420|NCT00979901|537103086|FG001|Overall Study|out-of-state|0|||
148896421|NCT00979901|537103087|FG002|Overall Study|out-of-state|0|||
148896422|NCT00979901|537103088|FG003|Overall Study|out-of-state|0|||
148896423|NCT00979901|537103085|FG000|Overall Study|vacation|1|||
148896424|NCT00979901|537103086|FG001|Overall Study|vacation|0|||
148896425|NCT00979901|537103087|FG002|Overall Study|vacation|0|||
148896426|NCT00979901|537103088|FG003|Overall Study|vacation|0|||
148896427|NCT00979901|537103085|FG000|Overall Study|elevated lab values pre-randomization|1|||
148896428|NCT00979901|537103086|FG001|Overall Study|elevated lab values pre-randomization|0|||
148896429|NCT00979901|537103087|FG002|Overall Study|elevated lab values pre-randomization|0|||
148896430|NCT00979901|537103088|FG003|Overall Study|elevated lab values pre-randomization|0|||
148896431|NCT00979901|537103085|FG000|Overall Study|Discontinued in Error|0|||
148896432|NCT00979901|537103086|FG001|Overall Study|Discontinued in Error|1|||
148896433|NCT00979901|537103087|FG002|Overall Study|Discontinued in Error|0|||
148896434|NCT00979901|537103088|FG003|Overall Study|Discontinued in Error|0|||
148896435|NCT00979901|537103085|FG000|Overall Study|Left Country|0|||
148896436|NCT00979901|537103086|FG001|Overall Study|Left Country|0|||
149137393|NCT00594516|537985111|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
149137394|NCT00594516|537985112|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
149137395|NCT00594516|537985113|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
149137396|NCT00594516|537985111|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
149137397|NCT00594516|537985112|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
149137398|NCT00594516|537985113|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
149137399|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
149137400|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
149137401|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
149137402|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
149137403|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
149137404|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
149137405|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
149137406|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
149137407|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
149137408|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
149137409|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
149137410|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
149137411|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
149137412|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
149137413|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
149137414|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
149137415|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
149137416|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
149137417|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Early termination|0|||
149137418|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Early termination|0|||
149137419|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Early termination|34|||
149137420|NCT01493557|537985114|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
148896437|NCT00979901|537103087|FG002|Overall Study|Left Country|1|||
148896438|NCT00979901|537103088|FG003|Overall Study|Left Country|0|||
148797522|NCT01699750|536736700|FG000|Overall Study|Withdrew Consent|0|||
148797523|NCT01699750|536736701|FG001|Overall Study|Withdrew Consent|1|||
148797524|NCT01699750|536736700|FG000|Overall Study|Other|0|||
148797525|NCT01699750|536736701|FG001|Overall Study|Other|2|||
148797526|NCT01484951|536736702|FG000|Overall Study|Adverse Event|3|||
148797527|NCT01484951|536736702|FG000|Overall Study|Personal Reasons|1|||
148797528|NCT01484951|536736702|FG000|Overall Study|Non-Compliance|1|||
148797529|NCT01831427|536736704|FG000|Overall Study|Adverse Event|0|||
148797530|NCT01831427|536736705|FG001|Overall Study|Adverse Event|1|||
149137421|NCT01493557|537985115|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
149137422|NCT01493557|537985116|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
149137423|NCT01493557|537985114|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
149137424|NCT01493557|537985115|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
149137425|NCT01493557|537985116|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
149137426|NCT01493557|537985114|FG000|Randomized to Management Strategies|Other adverse event|8|||
149137427|NCT01493557|537985115|FG001|Randomized to Management Strategies|Other adverse event|5|||
149137428|NCT01493557|537985116|FG002|Randomized to Management Strategies|Other adverse event|0|||
149137429|NCT01493557|537985114|FG000|Randomized to Management Strategies|Protocol Violation|3|||
149137430|NCT01493557|537985115|FG001|Randomized to Management Strategies|Protocol Violation|0|||
149137431|NCT01493557|537985116|FG002|Randomized to Management Strategies|Protocol Violation|0|||
149137432|NCT01493557|537985114|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
149137433|NCT01493557|537985115|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
149137434|NCT01493557|537985116|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
149137435|NCT01493557|537985114|FG000|Randomized to Management Strategies|Other than stated above|1|||
149137436|NCT01493557|537985115|FG001|Randomized to Management Strategies|Other than stated above|3|||
149137437|NCT01493557|537985116|FG002|Randomized to Management Strategies|Other than stated above|0|||
149137438|NCT01493557|537985114|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
149137439|NCT01493557|537985115|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
149137440|NCT01493557|537985116|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
149137441|NCT01493557|537985114|FG000|Adding the Second Strategy|Other adverse event|1|||
149137442|NCT01493557|537985115|FG001|Adding the Second Strategy|Other adverse event|2|||
149137443|NCT01493557|537985116|FG002|Adding the Second Strategy|Other adverse event|0|||
149137444|NCT01493557|537985114|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
149137445|NCT01493557|537985115|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
149137446|NCT01493557|537985116|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
149137447|NCT02592551|537985117|FG000|Overall Study|Not evaluable|1|||
149137448|NCT02592551|537985118|FG001|Overall Study|Not evaluable|3|||
149137449|NCT02592551|537985119|FG002|Overall Study|Not evaluable|0|||
149137450|NCT01876251|537985120|FG000|Overall Study|Clinical progression|1|||
149137451|NCT01876251|537985121|FG001|Overall Study|Clinical progression|0|||
149137452|NCT01876251|537985122|FG002|Overall Study|Clinical progression|0|||
149137453|NCT01876251|537985120|FG000|Overall Study|Death|2|||
149137454|NCT01876251|537985121|FG001|Overall Study|Death|0|||
149137455|NCT01876251|537985122|FG002|Overall Study|Death|1|||
149137456|NCT01876251|537985120|FG000|Overall Study|Participant started new treatment|1|||
149137457|NCT01876251|537985121|FG001|Overall Study|Participant started new treatment|0|||
149137458|NCT01876251|537985122|FG002|Overall Study|Participant started new treatment|1|||
149137459|NCT01876251|537985120|FG000|Overall Study|Participant refused further follow-up|0|||
149137460|NCT01876251|537985121|FG001|Overall Study|Participant refused further follow-up|0|||
149137461|NCT01876251|537985122|FG002|Overall Study|Participant refused further follow-up|1|||
149137462|NCT01876251|537985120|FG000|Overall Study|Study terminated|1|||
149137463|NCT01876251|537985121|FG001|Overall Study|Study terminated|0|||
149137464|NCT01876251|537985122|FG002|Overall Study|Study terminated|0|||
149137465|NCT01876251|537985120|FG000|Overall Study|Objective progression or relapse|10|||
149137466|NCT01876251|537985121|FG001|Overall Study|Objective progression or relapse|3|||
149137467|NCT01876251|537985122|FG002|Overall Study|Objective progression or relapse|8|||
149137468|NCT02460497|537985131|FG000|Overall Study|Participant Requested Withdrawal|4|||
149137469|NCT02460497|537985131|FG000|Overall Study|Non-Compliance|1|||
149137470|NCT02460497|537985131|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
149137471|NCT02460497|537985131|FG000|Overall Study|Lost to Follow-up|2|||
149137472|NCT02460497|537985131|FG000|Overall Study|Investigator Decision|1|||
149137473|NCT03876171|537985132|FG000|Overall Study|Withdrawal by Subject|3|||
149137474|NCT03876171|537985133|FG001|Overall Study|Withdrawal by Subject|3|||
149137475|NCT03876171|537985132|FG000|Overall Study|Re-arrest|0|||
149137476|NCT03876171|537985133|FG001|Overall Study|Re-arrest|4|||
149137477|NCT02012296|537985134|FG000|Overall Study|Lack of Efficacy|0|||
149137478|NCT02012296|537985135|FG001|Overall Study|Lack of Efficacy|0|||
149137479|NCT02012296|537985136|FG002|Overall Study|Lack of Efficacy|15|||
149137480|NCT02012296|537985134|FG000|Overall Study|Adverse Event|0|||
148797531|NCT01831427|536736706|FG002|Overall Study|Adverse Event|0|||
148797532|NCT01831427|536736707|FG003|Overall Study|Adverse Event|0|||
148797533|NCT01831427|536736708|FG004|Overall Study|Adverse Event|0|||
148896439|NCT00979901|537103085|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
148896440|NCT00979901|537103086|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
148896441|NCT00979901|537103087|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
148896442|NCT00979901|537103088|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
148896443|NCT02814916|537103093|FG000|Overall Study|Withdrawal of consent|0|||
148896444|NCT02814916|537103094|FG001|Overall Study|Withdrawal of consent|2|||
148896445|NCT02814916|537103095|FG002|Overall Study|Withdrawal of consent|0|||
148896446|NCT02814916|537103093|FG000|Overall Study|Lost to Follow-up|0|||
148896447|NCT02814916|537103094|FG001|Overall Study|Lost to Follow-up|1|||
148896448|NCT02814916|537103095|FG002|Overall Study|Lost to Follow-up|0|||
148896449|NCT02814916|537103093|FG000|Overall Study|Other, not specified|0|||
148896450|NCT02814916|537103094|FG001|Overall Study|Other, not specified|1|||
148896451|NCT02814916|537103095|FG002|Overall Study|Other, not specified|0|||
148896452|NCT05316597|537103097|FG000|First Session|Withdrawal by Subject|0|||
148896453|NCT05316597|537103098|FG001|First Session|Withdrawal by Subject|1|||
148896454|NCT05316597|537103097|FG000|Washout Period|Lost to Follow-up|1|||
148896455|NCT05316597|537103098|FG001|Washout Period|Lost to Follow-up|2|||
148896456|NCT05316597|537103097|FG000|Washout Period|Physician Decision|1|||
148896457|NCT05316597|537103098|FG001|Washout Period|Physician Decision|1|||
148896458|NCT05316597|537103097|FG000|Washout Period|Excluded before second session|1|||
148896459|NCT05316597|537103098|FG001|Washout Period|Excluded before second session|1|||
148896460|NCT05316597|537103097|FG000|Washout Period|Withdrawal by Subject|0|||
148896461|NCT05316597|537103098|FG001|Washout Period|Withdrawal by Subject|4|||
148896462|NCT03547518|537103099|FG000|Overall Study|Lost to Follow-up|2|||
148896463|NCT03547518|537103100|FG001|Overall Study|Lost to Follow-up|0|||
148896464|NCT02766023|537103101|FG000|Overall Study|Lost to Follow-up|23|||
148896465|NCT02766023|537103102|FG001|Overall Study|Lost to Follow-up|11|||
148896466|NCT02766023|537103101|FG000|Overall Study|Pregnancy|1|||
148896467|NCT02766023|537103102|FG001|Overall Study|Pregnancy|0|||
148896468|NCT02766023|537103101|FG000|Overall Study|Adverse Event|1|||
148896469|NCT02766023|537103102|FG001|Overall Study|Adverse Event|0|||
148896470|NCT02766023|537103101|FG000|Overall Study|Withdrawal by Subject|4|||
148896471|NCT02766023|537103102|FG001|Overall Study|Withdrawal by Subject|5|||
148896472|NCT02766023|537103101|FG000|Overall Study|Physician Decision|1|||
148896473|NCT02766023|537103102|FG001|Overall Study|Physician Decision|0|||
148896474|NCT02766023|537103101|FG000|Overall Study|Not Eligible at Enrollment|0|||
149137481|NCT02012296|537985135|FG001|Overall Study|Adverse Event|0|||
149137482|NCT02012296|537985136|FG002|Overall Study|Adverse Event|2|||
149137483|NCT02012296|537985134|FG000|Overall Study|Early study closure|0|||
149137484|NCT02012296|537985135|FG001|Overall Study|Early study closure|0|||
149137485|NCT02012296|537985136|FG002|Overall Study|Early study closure|5|||
149137486|NCT02012296|537985134|FG000|Overall Study|Protocol Violation|0|||
149137487|NCT02012296|537985135|FG001|Overall Study|Protocol Violation|1|||
149137488|NCT02012296|537985136|FG002|Overall Study|Protocol Violation|0|||
149137489|NCT00908583|537985139|FG000|Phase 1|Withdrawal by Subject|1|||
149137490|NCT00908583|537985139|FG000|Phase 1|Adverse Event|4|||
149137491|NCT00908583|537985139|FG000|Phase 2|Physician Decision|1|||
149137492|NCT00908583|537985139|FG000|Phase 2|Adverse Event|1|||
149137493|NCT00908583|537985139|FG000|Phase 3|Adverse Event|2|||
149137494|NCT00908583|537985139|FG000|Phase 4|Adverse Event|1|||
149137495|NCT00908583|537985139|FG000|Phase 4|Physician Decision|1|||
149137496|NCT00908583|537985139|FG000|Phase 5|Adverse Event|3|||
149137497|NCT00993954|537985140|FG000|Overall Study|Protocol Violation|21|||
149137498|NCT00993954|537985141|FG001|Overall Study|Protocol Violation|2|||
149137499|NCT00860951|537985142|FG000|Overall Study|Withdrawal by Subject|2|||
149137500|NCT00860951|537985142|FG000|Overall Study|Lost to Follow-up|5|||
149137501|NCT01667081|537985144|FG000|Overall Study|Death|43|||
149137502|NCT01667081|537985145|FG001|Overall Study|Death|3|||
149137503|NCT01667081|537985144|FG000|Overall Study|Lost to Follow-up|99|||
149137504|NCT01667081|537985145|FG001|Overall Study|Lost to Follow-up|48|||
149137505|NCT01667081|537985144|FG000|Overall Study|Physician Decision|16|||
149137506|NCT01667081|537985145|FG001|Overall Study|Physician Decision|2|||
149137507|NCT01667081|537985144|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
148896475|NCT02766023|537103102|FG001|Overall Study|Not Eligible at Enrollment|1|||
148896476|NCT00286468|537103105|FG000|Overall Study|Hyperglycemic Rescue|28|||
148896477|NCT00286468|537103106|FG001|Overall Study|Hyperglycemic Rescue|30|||
149011466|NCT02778399|537521470|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
149011467|NCT02778399|537521471|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
148896478|NCT00286468|537103107|FG002|Overall Study|Hyperglycemic Rescue|31|||
148896479|NCT00286468|537103105|FG000|Overall Study|Adverse Event|2|||
148896480|NCT00286468|537103106|FG001|Overall Study|Adverse Event|6|||
148896481|NCT00286468|537103107|FG002|Overall Study|Adverse Event|4|||
149137508|NCT01667081|537985145|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
149137509|NCT01667081|537985144|FG000|Overall Study|Withdrawal by Subject|90|||
148797534|NCT01831427|536736709|FG005|Overall Study|Adverse Event|1|||
148797535|NCT01831427|536736710|FG006|Overall Study|Adverse Event|0|||
148797536|NCT01831427|536736711|FG007|Overall Study|Adverse Event|1|||
148797537|NCT01831427|536736712|FG008|Overall Study|Adverse Event|0|||
148797538|NCT01831427|536736713|FG009|Overall Study|Adverse Event|0|||
148797539|NCT01831427|536736714|FG010|Overall Study|Adverse Event|2|||
148797540|NCT01831427|536736704|FG000|Overall Study|Investigator's Discretion|0|||
148797541|NCT01831427|536736705|FG001|Overall Study|Investigator's Discretion|0|||
148797542|NCT01831427|536736706|FG002|Overall Study|Investigator's Discretion|0|||
148797543|NCT01831427|536736707|FG003|Overall Study|Investigator's Discretion|1|||
148797544|NCT01831427|536736708|FG004|Overall Study|Investigator's Discretion|0|||
148797545|NCT01831427|536736709|FG005|Overall Study|Investigator's Discretion|0|||
148797546|NCT01831427|536736710|FG006|Overall Study|Investigator's Discretion|0|||
148797547|NCT01831427|536736711|FG007|Overall Study|Investigator's Discretion|0|||
148797548|NCT01831427|536736712|FG008|Overall Study|Investigator's Discretion|0|||
148797549|NCT01831427|536736713|FG009|Overall Study|Investigator's Discretion|0|||
148797550|NCT01831427|536736714|FG010|Overall Study|Investigator's Discretion|0|||
148797551|NCT01831427|536736704|FG000|Overall Study|Withdrew Consent|0|||
148797552|NCT01831427|536736705|FG001|Overall Study|Withdrew Consent|0|||
148797553|NCT01831427|536736706|FG002|Overall Study|Withdrew Consent|0|||
148797554|NCT01831427|536736707|FG003|Overall Study|Withdrew Consent|0|||
148797555|NCT01831427|536736708|FG004|Overall Study|Withdrew Consent|0|||
148797556|NCT01831427|536736709|FG005|Overall Study|Withdrew Consent|0|||
148797557|NCT01831427|536736710|FG006|Overall Study|Withdrew Consent|2|||
148797558|NCT01831427|536736711|FG007|Overall Study|Withdrew Consent|0|||
148797559|NCT01831427|536736712|FG008|Overall Study|Withdrew Consent|0|||
148797560|NCT01831427|536736713|FG009|Overall Study|Withdrew Consent|1|||
148797561|NCT01831427|536736714|FG010|Overall Study|Withdrew Consent|1|||
148797562|NCT02169505|536736715|FG000|Overall Study|Withdrawal by Subject|1|||
148797563|NCT02035553|536736716|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
148797564|NCT02035553|536736717|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
148797565|NCT02035553|536736716|FG000|Overall Study|Adverse Event|10|||
148797566|NCT02035553|536736717|FG001|Overall Study|Adverse Event|6|||
148797567|NCT02035553|536736716|FG000|Overall Study|Physician Decision|3|||
148797568|NCT02035553|536736717|FG001|Overall Study|Physician Decision|2|||
148797569|NCT02035553|536736716|FG000|Overall Study|Lack of Efficacy|1|||
148797570|NCT02035553|536736717|FG001|Overall Study|Lack of Efficacy|1|||
148797571|NCT02035553|536736716|FG000|Overall Study|Withdrawal by Subject|4|||
148797572|NCT02035553|536736717|FG001|Overall Study|Withdrawal by Subject|7|||
148797573|NCT02035553|536736716|FG000|Overall Study|Non-compliance with Study Drug|0|||
148797574|NCT02035553|536736717|FG001|Overall Study|Non-compliance with Study Drug|1|||
148797575|NCT02035553|536736716|FG000|Overall Study|Lost to Follow-up|0|||
148797576|NCT02035553|536736717|FG001|Overall Study|Lost to Follow-up|1|||
148797577|NCT02035553|536736716|FG000|Overall Study|Other Reason|0|||
148797578|NCT02035553|536736717|FG001|Overall Study|Other Reason|4|||
148797579|NCT00917124|536736718|FG000|Overall Study|Protocol Violation|4|||
148797580|NCT00917124|536736719|FG001|Overall Study|Protocol Violation|6|||
148797581|NCT03191799|536736725|FG000|Overall Study|Withdrawal by Subject|4|||
148797582|NCT03191799|536736725|FG000|Overall Study|Physician Decision|2|||
148797583|NCT03191799|536736725|FG000|Overall Study|Lost to Follow-up|1|||
148797584|NCT03191799|536736725|FG000|Overall Study|Death|2|||
148797585|NCT01746862|536736726|FG000|Overall Study|Withdrawal by Subject|1|||
148797586|NCT01746862|536736727|FG001|Overall Study|Withdrawal by Subject|1|||
148797587|NCT01746862|536736726|FG000|Overall Study|Protocol Violation|1|||
148797588|NCT01746862|536736727|FG001|Overall Study|Protocol Violation|0|||
148797589|NCT01746862|536736726|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
148797590|NCT01746862|536736727|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
148797591|NCT01746862|536736726|FG000|Overall Study|Entered puberty during the study|1|||
148797592|NCT01746862|536736727|FG001|Overall Study|Entered puberty during the study|0|||
148797593|NCT00385918|536736740|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
148797594|NCT00385918|536736741|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
148797595|NCT00385918|536736742|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
148797596|NCT00385918|536736740|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
148797597|NCT00385918|536736741|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
148797598|NCT00385918|536736742|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
148797599|NCT00385918|536736740|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
148797600|NCT00385918|536736741|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
148797601|NCT00385918|536736742|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
148797602|NCT00385918|536736740|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
148797603|NCT00385918|536736741|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
148797604|NCT00385918|536736742|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
148797605|NCT00385918|536736740|FG000|Intervention Phase After Randomization|Physician Decision|1|||
148797606|NCT00385918|536736741|FG001|Intervention Phase After Randomization|Physician Decision|0|||
148797607|NCT00385918|536736742|FG002|Intervention Phase After Randomization|Physician Decision|0|||
148797608|NCT00385918|536736740|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
148797609|NCT00385918|536736741|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
148797610|NCT00385918|536736742|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
148797611|NCT00128661|536736743|FG000|Overall Study|Adverse Event|14|||
148797612|NCT00128661|536736744|FG001|Overall Study|Adverse Event|11|||
148797613|NCT00128661|536736743|FG000|Overall Study|Lost to Follow-up|10|||
148797614|NCT00128661|536736744|FG001|Overall Study|Lost to Follow-up|7|||
148797615|NCT00128661|536736743|FG000|Overall Study|Withdrawal by Subject|243|||
148797616|NCT00128661|536736744|FG001|Overall Study|Withdrawal by Subject|232|||
148797617|NCT00128661|536736743|FG000|Overall Study|Other|7|||
148797618|NCT00128661|536736744|FG001|Overall Study|Other|8|||
148797619|NCT02782741|536736747|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
148797620|NCT02782741|536736748|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
148797621|NCT02782741|536736749|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
148797622|NCT02782741|536736747|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
148797623|NCT02782741|536736748|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
148797624|NCT02782741|536736749|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
148797625|NCT02782741|536736747|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
148797626|NCT02782741|536736748|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
148797627|NCT02782741|536736749|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
148797628|NCT02782741|536736747|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
148797629|NCT02782741|536736748|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
148797630|NCT02782741|536736749|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
148797631|NCT02782741|536736747|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
148797632|NCT02782741|536736748|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
148797633|NCT02782741|536736749|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
148797634|NCT04157088|536736750|FG000|Overall Study|Study terminated by sponsor|23|||
148797635|NCT04157088|536736750|FG000|Overall Study|Withdrawal by Subject|4|||
148797636|NCT04157088|536736750|FG000|Overall Study|Lost to Follow-up|2|||
148797637|NCT04157088|536736750|FG000|Overall Study|Death|1|||
148797638|NCT02421419|536736751|FG000|Overall Study|Physician Decision|0|||
148797639|NCT02421419|536736752|FG001|Overall Study|Physician Decision|0|||
148797640|NCT02421419|536736753|FG002|Overall Study|Physician Decision|1|||
148797641|NCT01676701|536736755|FG000|Overall Study|Protocol Violation|1|||
148797642|NCT01676701|536736756|FG001|Overall Study|Protocol Violation|0|||
148797643|NCT01676701|536736755|FG000|Overall Study|Sponsor Decision|3|||
148797644|NCT01676701|536736756|FG001|Overall Study|Sponsor Decision|4|||
148797645|NCT02115607|536736757|FG000|Overall Study|Withdrawal by Subject|1|||
148797646|NCT00196105|536736761|FG000|Overall Study|Lost to Follow-up|4|||
148797647|NCT00196105|536736762|FG001|Overall Study|Lost to Follow-up|5|||
148797648|NCT00196105|536736763|FG002|Overall Study|Lost to Follow-up|7|||
148797649|NCT04863872|536736764|FG000|Overall Study|Withdrawal by Subject|4|||
148797650|NCT04863872|536736765|FG001|Overall Study|Withdrawal by Subject|15|||
148797651|NCT04863872|536736764|FG000|Overall Study|Death|5|||
148797652|NCT04863872|536736765|FG001|Overall Study|Death|2|||
148797653|NCT04863872|536736764|FG000|Overall Study|Lost to Follow-up|2|||
148797654|NCT04863872|536736765|FG001|Overall Study|Lost to Follow-up|1|||
148797655|NCT04058028|536736769|FG000|Overall Study|Withdrawal of Consent from Study|12|||
148797656|NCT04058028|536736770|FG001|Overall Study|Withdrawal of Consent from Study|8|||
148797657|NCT04058028|536736771|FG002|Overall Study|Withdrawal of Consent from Study|6|||
148797658|NCT04058028|536736772|FG003|Overall Study|Withdrawal of Consent from Study|7|||
148797659|NCT04058028|536736769|FG000|Overall Study|Decision by Sponsor|13|||
148797660|NCT04058028|536736770|FG001|Overall Study|Decision by Sponsor|4|||
148797661|NCT04058028|536736771|FG002|Overall Study|Decision by Sponsor|1|||
148797662|NCT04058028|536736772|FG003|Overall Study|Decision by Sponsor|35|||
148797663|NCT04058028|536736769|FG000|Overall Study|Lost to Follow-up|1|||
148797664|NCT04058028|536736770|FG001|Overall Study|Lost to Follow-up|1|||
148797665|NCT04058028|536736771|FG002|Overall Study|Lost to Follow-up|1|||
148797666|NCT04058028|536736772|FG003|Overall Study|Lost to Follow-up|0|||
148797667|NCT04058028|536736769|FG000|Overall Study|Death|0|||
148797668|NCT04058028|536736770|FG001|Overall Study|Death|1|||
148797669|NCT04058028|536736771|FG002|Overall Study|Death|0|||
148797670|NCT04058028|536736772|FG003|Overall Study|Death|0|||
148797671|NCT04010461|536736773|FG000|Overall Study|COVID based withdrawal|5|||
148797672|NCT04010461|536736773|FG000|Overall Study|Withdrawal by Subject|5|||
148797673|NCT04010461|536736773|FG000|Overall Study|Adverse Event|1|||
148797674|NCT04010461|536736773|FG000|Overall Study|No Motor Threshold obtainable|1|||
148797675|NCT04010461|536736773|FG000|Overall Study|Physician Decision|1|||
148797676|NCT02227784|536736774|FG000|Double-Blind Phase|Adverse Event|3|||
148896482|NCT00286468|537103105|FG000|Overall Study|Protocol Violation|0|||
148896483|NCT00286468|537103106|FG001|Overall Study|Protocol Violation|3|||
148896484|NCT00286468|537103107|FG002|Overall Study|Protocol Violation|1|||
148896485|NCT00286468|537103105|FG000|Overall Study|Lost to Follow-up|1|||
148896486|NCT00286468|537103106|FG001|Overall Study|Lost to Follow-up|1|||
148896487|NCT00286468|537103107|FG002|Overall Study|Lost to Follow-up|2|||
148896488|NCT00286468|537103105|FG000|Overall Study|Withdrawal by Subject|3|||
148896489|NCT00286468|537103106|FG001|Overall Study|Withdrawal by Subject|8|||
148896490|NCT00286468|537103107|FG002|Overall Study|Withdrawal by Subject|11|||
148896491|NCT00286468|537103105|FG000|Overall Study|Physician Decision|3|||
148896492|NCT00286468|537103106|FG001|Overall Study|Physician Decision|2|||
148896493|NCT00286468|537103107|FG002|Overall Study|Physician Decision|1|||
148896494|NCT02953652|537103108|FG000|Overall Study|Adverse Event|18|||
148896495|NCT02953652|537103108|FG000|Overall Study|Withdrawal by Subject|6|||
148896496|NCT02953652|537103108|FG000|Overall Study|Protocol Violation|1|||
148896497|NCT02953652|537103108|FG000|Overall Study|Disease Progression|27|||
148896498|NCT04742556|537103109|FG000|Overall Study|Withdrawal by Subject|0|||
148896499|NCT04742556|537103110|FG001|Overall Study|Withdrawal by Subject|1|||
148896500|NCT04742556|537103111|FG002|Overall Study|Withdrawal by Subject|0|||
148896501|NCT04742556|537103109|FG000|Overall Study|Adverse Event|0|||
148896502|NCT04742556|537103110|FG001|Overall Study|Adverse Event|0|||
148896503|NCT04742556|537103111|FG002|Overall Study|Adverse Event|2|||
148896504|NCT04742556|537103109|FG000|Overall Study|Clinical disease progression|0|||
148896505|NCT04742556|537103110|FG001|Overall Study|Clinical disease progression|1|||
149011468|NCT02778399|537521472|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
148896506|NCT04742556|537103111|FG002|Overall Study|Clinical disease progression|2|||
148896507|NCT04742556|537103109|FG000|Overall Study|Objective disease progression|3|||
148896508|NCT04742556|537103110|FG001|Overall Study|Objective disease progression|2|||
148797677|NCT02227784|536736775|FG001|Double-Blind Phase|Adverse Event|2|||
148797678|NCT02227784|536736776|FG002|Double-Blind Phase|Adverse Event|1|||
148797679|NCT02227784|536736777|FG003|Double-Blind Phase|Adverse Event|3|||
148797680|NCT02227784|536736778|FG004|Double-Blind Phase|Adverse Event|0|||
148797681|NCT02227784|536736774|FG000|Double-Blind Phase|Physician Decision|1|||
148797682|NCT02227784|536736775|FG001|Double-Blind Phase|Physician Decision|0|||
148797683|NCT02227784|536736776|FG002|Double-Blind Phase|Physician Decision|0|||
148797684|NCT02227784|536736777|FG003|Double-Blind Phase|Physician Decision|1|||
148797685|NCT02227784|536736778|FG004|Double-Blind Phase|Physician Decision|0|||
148797686|NCT02227784|536736774|FG000|Double-Blind Phase|Protocol Violation|0|||
148797687|NCT02227784|536736775|FG001|Double-Blind Phase|Protocol Violation|0|||
148797688|NCT02227784|536736776|FG002|Double-Blind Phase|Protocol Violation|1|||
148797689|NCT02227784|536736777|FG003|Double-Blind Phase|Protocol Violation|1|||
148797690|NCT02227784|536736778|FG004|Double-Blind Phase|Protocol Violation|0|||
148797691|NCT02227784|536736774|FG000|Double-Blind Phase|Sponsor Decision|34|||
148797692|NCT02227784|536736775|FG001|Double-Blind Phase|Sponsor Decision|15|||
148797693|NCT02227784|536736776|FG002|Double-Blind Phase|Sponsor Decision|14|||
148797694|NCT02227784|536736777|FG003|Double-Blind Phase|Sponsor Decision|32|||
148797695|NCT02227784|536736778|FG004|Double-Blind Phase|Sponsor Decision|0|||
148797696|NCT02227784|536736774|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
148797697|NCT02227784|536736775|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
148797698|NCT02227784|536736776|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
148797699|NCT02227784|536736777|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
148797700|NCT02227784|536736778|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
148797701|NCT02227784|536736774|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
148797702|NCT02227784|536736775|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
148797703|NCT02227784|536736776|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
148797704|NCT02227784|536736777|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
148797705|NCT02227784|536736778|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
148797706|NCT02227784|536736774|FG000|Open-Label Extension Phase (OLE)|Death|0|||
148797707|NCT02227784|536736775|FG001|Open-Label Extension Phase (OLE)|Death|0|||
148797708|NCT02227784|536736776|FG002|Open-Label Extension Phase (OLE)|Death|0|||
148797709|NCT02227784|536736777|FG003|Open-Label Extension Phase (OLE)|Death|0|||
148797710|NCT02227784|536736778|FG004|Open-Label Extension Phase (OLE)|Death|1|||
148797711|NCT02227784|536736774|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
148797712|NCT02227784|536736775|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
148797713|NCT02227784|536736776|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
148797714|NCT02227784|536736777|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
148797715|NCT02227784|536736778|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
148797716|NCT02227784|536736774|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
148797717|NCT02227784|536736775|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
148797718|NCT02227784|536736776|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
148797719|NCT02227784|536736777|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
148797720|NCT02227784|536736778|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
148797721|NCT00102596|536736779|FG000|Part A|Screen failures|6|||
148797722|NCT00102596|536736780|FG001|Part A|Screen failures|0|||
148797723|NCT00102596|536736779|FG000|Part A|Adverse Event|1|||
148797724|NCT00102596|536736780|FG001|Part A|Adverse Event|0|||
148797725|NCT01275144|536736781|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
148797726|NCT01275144|536736782|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
148797727|NCT05607576|536736784|FG000|Overall Study|immediate sensor error|2|||
148797728|NCT05607576|536736784|FG000|Overall Study|Physician Decision|2|||
148797729|NCT01827592|536736785|FG000|Overall Study|Adverse Event|11|||
148797730|NCT01827592|536736786|FG001|Overall Study|Adverse Event|9|||
148797731|NCT01827592|536736787|FG002|Overall Study|Adverse Event|2|||
148797732|NCT01827592|536736785|FG000|Overall Study|Physician Decision|0|||
148797733|NCT01827592|536736786|FG001|Overall Study|Physician Decision|2|||
148797734|NCT01827592|536736787|FG002|Overall Study|Physician Decision|1|||
148797735|NCT01827592|536736785|FG000|Overall Study|Protocol Violation|2|||
148797736|NCT01827592|536736786|FG001|Overall Study|Protocol Violation|1|||
148797737|NCT01827592|536736787|FG002|Overall Study|Protocol Violation|0|||
148797738|NCT01827592|536736785|FG000|Overall Study|Lost to Follow-up|1|||
148896509|NCT04742556|537103111|FG002|Overall Study|Objective disease progression|4|||
148797739|NCT01827592|536736786|FG001|Overall Study|Lost to Follow-up|2|||
148797740|NCT01827592|536736787|FG002|Overall Study|Lost to Follow-up|2|||
148797741|NCT01827592|536736785|FG000|Overall Study|Withdrawal by Subject|12|||
148797742|NCT01827592|536736786|FG001|Overall Study|Withdrawal by Subject|11|||
148797743|NCT01827592|536736787|FG002|Overall Study|Withdrawal by Subject|11|||
148797744|NCT01827592|536736785|FG000|Overall Study|Patient's substantial non-compliance|1|||
148797745|NCT01827592|536736786|FG001|Overall Study|Patient's substantial non-compliance|1|||
148797746|NCT01827592|536736787|FG002|Overall Study|Patient's substantial non-compliance|6|||
148797747|NCT01827592|536736785|FG000|Overall Study|Trial terminated by Sponsor|47|||
148896510|NCT04247347|537103112|FG000|Overall Study|Withdrawal by Subject|2|||
148896511|NCT04247347|537103113|FG001|Overall Study|Withdrawal by Subject|3|||
148896512|NCT04247347|537103114|FG002|Overall Study|Withdrawal by Subject|3|||
148896513|NCT04247347|537103112|FG000|Overall Study|Lost to Follow-up|1|||
148896514|NCT04247347|537103113|FG001|Overall Study|Lost to Follow-up|1|||
148896515|NCT04247347|537103114|FG002|Overall Study|Lost to Follow-up|1|||
148896516|NCT03617172|537103126|FG000|Overall Study|Lost to Follow-up|1|||
148896517|NCT03617172|537103127|FG001|Overall Study|Lost to Follow-up|0|||
148896518|NCT03305666|537103128|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
148896519|NCT03305666|537103129|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
148896520|NCT02587221|537103132|FG000|Overall Study|Adverse Event|3|||
148896521|NCT02587221|537103133|FG001|Overall Study|Adverse Event|3|||
148896522|NCT02587221|537103132|FG000|Overall Study|Death|33|||
148896523|NCT02587221|537103133|FG001|Overall Study|Death|34|||
148896524|NCT02587221|537103132|FG000|Overall Study|Withdrawal by Subject|66|||
148896525|NCT02587221|537103133|FG001|Overall Study|Withdrawal by Subject|61|||
148896526|NCT02587221|537103132|FG000|Overall Study|Lost to Follow-up|21|||
148896527|NCT02587221|537103133|FG001|Overall Study|Lost to Follow-up|19|||
148896528|NCT02587221|537103132|FG000|Overall Study|Protocol Violation|6|||
148896529|NCT02587221|537103133|FG001|Overall Study|Protocol Violation|5|||
148896530|NCT02587221|537103132|FG000|Overall Study|Other Reason or Unspecified|2|||
148896531|NCT02587221|537103133|FG001|Overall Study|Other Reason or Unspecified|1|||
148896532|NCT02546609|537103134|FG000|Overall Study|Withdrawal by Subject|0|||
148896533|NCT02546609|537103135|FG001|Overall Study|Withdrawal by Subject|1|||
148896534|NCT02546609|537103136|FG002|Overall Study|Withdrawal by Subject|2|||
148896535|NCT02546609|537103134|FG000|Overall Study|Adverse Event|0|||
148896536|NCT02546609|537103135|FG001|Overall Study|Adverse Event|6|||
148896537|NCT02546609|537103136|FG002|Overall Study|Adverse Event|1|||
148896538|NCT02546609|537103134|FG000|Overall Study|Protocol Violation|0|||
148896539|NCT02546609|537103135|FG001|Overall Study|Protocol Violation|1|||
148896540|NCT02546609|537103136|FG002|Overall Study|Protocol Violation|1|||
148896541|NCT02546609|537103134|FG000|Overall Study|Lost to Follow-up|2|||
148896542|NCT02546609|537103135|FG001|Overall Study|Lost to Follow-up|3|||
148896543|NCT02546609|537103136|FG002|Overall Study|Lost to Follow-up|1|||
148896544|NCT02546609|537103134|FG000|Overall Study|travel or work schedule restriction|0|||
148896545|NCT02546609|537103135|FG001|Overall Study|travel or work schedule restriction|0|||
148896546|NCT02546609|537103136|FG002|Overall Study|travel or work schedule restriction|2|||
148896547|NCT03988400|537103138|FG000|Overall Study|Adverse Event|1|||
148896548|NCT03988400|537103139|FG001|Overall Study|Adverse Event|0|||
148896549|NCT03988400|537103138|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
148896550|NCT03988400|537103139|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
148896551|NCT03988400|537103138|FG000|Overall Study|Lost to Follow-up|0|||
148896552|NCT03988400|537103139|FG001|Overall Study|Lost to Follow-up|1|||
148896553|NCT00953667|537103144|FG000|Overall Study|Lost to Follow-up|11|||
148896554|NCT00953667|537103144|FG000|Overall Study|Physician Decision|35|||
148896555|NCT00953667|537103144|FG000|Overall Study|Withdrawal by Subject|63|||
148896556|NCT00953667|537103144|FG000|Overall Study|Adverse Event|10|||
148896557|NCT00953667|537103144|FG000|Overall Study|poor venous access,unable to draw blood|4|||
148896558|NCT04819945|537103145|FG000|Overall Study|Lost to Follow-up|1|||
148896559|NCT00703014|537103146|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
148896560|NCT00703014|537103147|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
148896561|NCT00703014|537103148|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
148896562|NCT00703014|537103149|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
148896563|NCT00703014|537103146|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
148896564|NCT00703014|537103147|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
148896565|NCT00703014|537103148|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
148896566|NCT00703014|537103149|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
148896567|NCT02004236|537103150|FG000|Overall Study|Lack of Efficacy|0|||
148896568|NCT02004236|537103151|FG001|Overall Study|Lack of Efficacy|0|||
148896569|NCT02004236|537103152|FG002|Overall Study|Lack of Efficacy|16|||
148896570|NCT05121766|537103153|FG000|Overall Study|Covid reinfection|3|||
148896571|NCT05121766|537103154|FG001|Overall Study|Covid reinfection|0|||
148896572|NCT05121766|537103153|FG000|Overall Study|Withdrawal by Subject|3|||
148896573|NCT05121766|537103154|FG001|Overall Study|Withdrawal by Subject|1|||
148896574|NCT05121766|537103153|FG000|Overall Study|Adverse Event|2|||
148896575|NCT05121766|537103154|FG001|Overall Study|Adverse Event|4|||
148896576|NCT05121766|537103153|FG000|Overall Study|Lost to Follow-up|0|||
148896577|NCT05121766|537103154|FG001|Overall Study|Lost to Follow-up|1|||
148896578|NCT01033240|537103156|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
148896579|NCT01033240|537103157|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
149137510|NCT01667081|537985145|FG001|Overall Study|Withdrawal by Subject|35|||
148896580|NCT01033240|537103158|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
148896581|NCT01033240|537103156|FG000|Overall Study|Death|2|||
148896582|NCT01033240|537103157|FG001|Overall Study|Death|0|||
148896583|NCT01033240|537103158|FG002|Overall Study|Death|0|||
148896584|NCT01033240|537103156|FG000|Overall Study|Withdrew Consent|2|||
148896585|NCT01033240|537103157|FG001|Overall Study|Withdrew Consent|9|||
148896586|NCT01033240|537103158|FG002|Overall Study|Withdrew Consent|2|||
148896587|NCT01033240|537103156|FG000|Overall Study|Disease Progression|35|||
148896588|NCT01033240|537103157|FG001|Overall Study|Disease Progression|32|||
148896589|NCT01033240|537103158|FG002|Overall Study|Disease Progression|41|||
148896590|NCT01033240|537103156|FG000|Overall Study|Investigator Discretion|0|||
148896591|NCT01033240|537103157|FG001|Overall Study|Investigator Discretion|0|||
148896592|NCT01033240|537103158|FG002|Overall Study|Investigator Discretion|2|||
148896593|NCT01033240|537103156|FG000|Overall Study|Other|0|||
148896594|NCT01033240|537103157|FG001|Overall Study|Other|1|||
148896595|NCT01033240|537103158|FG002|Overall Study|Other|2|||
148896596|NCT02913482|537103159|FG000|Overall Study|Death|0|||
148896597|NCT02913482|537103160|FG001|Overall Study|Death|2|||
148896598|NCT02913482|537103161|FG002|Overall Study|Death|2|||
148896599|NCT02913482|537103159|FG000|Overall Study|Progressive Disease|1|||
148896600|NCT02913482|537103160|FG001|Overall Study|Progressive Disease|1|||
148797748|NCT01827592|536736786|FG001|Overall Study|Trial terminated by Sponsor|53|||
148797749|NCT01827592|536736787|FG002|Overall Study|Trial terminated by Sponsor|51|||
148797750|NCT01827592|536736785|FG000|Overall Study|Others|0|||
148797751|NCT01827592|536736786|FG001|Overall Study|Others|1|||
148797752|NCT01827592|536736787|FG002|Overall Study|Others|3|||
148797753|NCT00689338|536736788|FG000|Overall Study|Death|65|||
148797754|NCT00689338|536736788|FG000|Overall Study|Adverse Event|13|||
148797755|NCT00689338|536736788|FG000|Overall Study|Insufficient Clinical Response|1|||
148797756|NCT00689338|536736788|FG000|Overall Study|Lack of Efficacy|6|||
148797757|NCT00689338|536736788|FG000|Overall Study|Other|8|||
148797758|NCT00689338|536736788|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
148797759|NCT00689338|536736788|FG000|Overall Study|Lost to Follow-up|5|||
148797760|NCT00689338|536736788|FG000|Overall Study|Withdrawal by Subject|3|||
148797761|NCT00689338|536736788|FG000|Overall Study|Protocol Violation|15|||
148797762|NCT00808067|536736789|FG000|Overall Study|Major/minor bleed|30|||
148797763|NCT00808067|536736790|FG001|Overall Study|Major/minor bleed|44|||
148797764|NCT00808067|536736789|FG000|Overall Study|Outcome event - other|33|||
148797765|NCT00808067|536736790|FG001|Overall Study|Outcome event - other|25|||
148797766|NCT00808067|536736789|FG000|Overall Study|Adverse Event|111|||
148797767|NCT00808067|536736790|FG001|Overall Study|Adverse Event|121|||
148797768|NCT00808067|536736789|FG000|Overall Study|Hospitalization (not including surgery)|18|||
148797769|NCT00808067|536736790|FG001|Overall Study|Hospitalization (not including surgery)|17|||
148797770|NCT00808067|536736789|FG000|Overall Study|Hospitalization due to surgery|37|||
148797771|NCT00808067|536736790|FG001|Overall Study|Hospitalization due to surgery|40|||
148797772|NCT00808067|536736789|FG000|Overall Study|Reduced creatinine clearance|53|||
148896601|NCT02913482|537103161|FG002|Overall Study|Progressive Disease|1|||
148896602|NCT02913482|537103159|FG000|Overall Study|Reason not specified|0|||
149137511|NCT03034460|537985146|FG000|Overall Study|Adverse Event|0|||
149137512|NCT03034460|537985147|FG001|Overall Study|Adverse Event|1|||
149137513|NCT03034460|537985146|FG000|Overall Study|Withdrawal by Subject|2|||
149137514|NCT03034460|537985147|FG001|Overall Study|Withdrawal by Subject|2|||
149137515|NCT03034460|537985146|FG000|Overall Study|Personal Reasons|1|||
149137516|NCT03034460|537985147|FG001|Overall Study|Personal Reasons|0|||
149137517|NCT01205438|537985148|FG000|Overall Study|Adverse Event|19|||
149137518|NCT01205438|537985149|FG001|Overall Study|Adverse Event|17|||
149137519|NCT01205438|537985150|FG002|Overall Study|Adverse Event|24|||
149137520|NCT01205438|537985148|FG000|Overall Study|Death|1|||
149137521|NCT01205438|537985149|FG001|Overall Study|Death|1|||
149137522|NCT01205438|537985150|FG002|Overall Study|Death|3|||
149137523|NCT01205438|537985148|FG000|Overall Study|Entry Criteria Not Met|16|||
149137524|NCT01205438|537985149|FG001|Overall Study|Entry Criteria Not Met|15|||
149137525|NCT01205438|537985150|FG002|Overall Study|Entry Criteria Not Met|13|||
149137526|NCT01205438|537985148|FG000|Overall Study|Lack of Efficacy|14|||
149137527|NCT01205438|537985149|FG001|Overall Study|Lack of Efficacy|11|||
149137528|NCT01205438|537985150|FG002|Overall Study|Lack of Efficacy|14|||
149137529|NCT01205438|537985148|FG000|Overall Study|Lost to Follow-up|6|||
149137530|NCT01205438|537985149|FG001|Overall Study|Lost to Follow-up|7|||
149137531|NCT01205438|537985150|FG002|Overall Study|Lost to Follow-up|8|||
149137532|NCT01205438|537985148|FG000|Overall Study|Withdrawal by Subject|19|||
149137533|NCT01205438|537985149|FG001|Overall Study|Withdrawal by Subject|25|||
149137534|NCT01205438|537985150|FG002|Overall Study|Withdrawal by Subject|19|||
149137535|NCT01205438|537985148|FG000|Overall Study|Physician Decision|0|||
148797773|NCT00808067|536736790|FG001|Overall Study|Reduced creatinine clearance|55|||
148896603|NCT02913482|537103160|FG001|Overall Study|Reason not specified|0|||
148896604|NCT02913482|537103161|FG002|Overall Study|Reason not specified|1|||
149137536|NCT01205438|537985149|FG001|Overall Study|Physician Decision|3|||
149137537|NCT01205438|537985150|FG002|Overall Study|Physician Decision|2|||
148896605|NCT02913482|537103159|FG000|Overall Study|Withdrawal by Subject|0|||
148896606|NCT02913482|537103160|FG001|Overall Study|Withdrawal by Subject|1|||
149137538|NCT01205438|537985148|FG000|Overall Study|Protocol Violation|2|||
148896607|NCT02913482|537103161|FG002|Overall Study|Withdrawal by Subject|1|||
148896608|NCT00918385|537103164|FG000|Monotherapy|Adverse Event|1|||
148896609|NCT00918385|537103165|FG001|Monotherapy|Adverse Event|6|||
148896610|NCT00918385|537103164|FG000|Monotherapy|Complicating illness|1|||
148896611|NCT00918385|537103165|FG001|Monotherapy|Complicating illness|0|||
148896612|NCT00918385|537103164|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
148896613|NCT00918385|537103165|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
148896614|NCT00918385|537103164|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
148896615|NCT00918385|537103165|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
148896616|NCT00918385|537103164|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
148896617|NCT00918385|537103165|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
148896618|NCT00918385|537103164|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
148896619|NCT00918385|537103165|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
148896620|NCT00625131|537103169|FG000|Overall Study|Lost to Follow-up|3|||
148896621|NCT00625131|537103170|FG001|Overall Study|Lost to Follow-up|2|||
148896622|NCT00625131|537103171|FG002|Overall Study|Lost to Follow-up|0|||
148896623|NCT00625131|537103169|FG000|Overall Study|Withdrawal by Subject|1|||
148896624|NCT00625131|537103170|FG001|Overall Study|Withdrawal by Subject|0|||
148896625|NCT00625131|537103171|FG002|Overall Study|Withdrawal by Subject|5|||
148896626|NCT00918281|537103174|FG000|Overall Study|Physician Decision|29|||
148896627|NCT00168844|537103175|FG000|Overall Study|Adverse Event|31|||
148896628|NCT00168844|537103176|FG001|Overall Study|Adverse Event|32|||
148896629|NCT00168844|537103177|FG002|Overall Study|Adverse Event|48|||
148896630|NCT00168844|537103175|FG000|Overall Study|Lost to Follow-up|4|||
148896631|NCT00168844|537103176|FG001|Overall Study|Lost to Follow-up|5|||
148896632|NCT00168844|537103177|FG002|Overall Study|Lost to Follow-up|11|||
148896633|NCT00168844|537103175|FG000|Overall Study|Withdrawal by Subject|12|||
148896634|NCT00168844|537103176|FG001|Overall Study|Withdrawal by Subject|9|||
148896635|NCT00168844|537103177|FG002|Overall Study|Withdrawal by Subject|19|||
148896636|NCT00168844|537103175|FG000|Overall Study|Protocol Violation|2|||
148896637|NCT00168844|537103176|FG001|Overall Study|Protocol Violation|2|||
148896638|NCT00168844|537103177|FG002|Overall Study|Protocol Violation|4|||
148896639|NCT00168844|537103175|FG000|Overall Study|Other|6|||
148896640|NCT00168844|537103176|FG001|Overall Study|Other|7|||
148896641|NCT00168844|537103177|FG002|Overall Study|Other|9|||
148896642|NCT03557970|537103180|FG000|Overall Study|Study closure|1|||
148896643|NCT03557970|537103181|FG001|Overall Study|Study closure|0|||
148896644|NCT03557970|537103180|FG000|Overall Study|Physician Decision|0|||
148896645|NCT03557970|537103181|FG001|Overall Study|Physician Decision|1|||
148896646|NCT03557970|537103180|FG000|Overall Study|Death|0|||
148896647|NCT03557970|537103181|FG001|Overall Study|Death|1|||
148896648|NCT02138890|537103184|FG000|Overall Study|Adverse Event|1|||
148896649|NCT02138890|537103185|FG001|Overall Study|Adverse Event|0|||
148896650|NCT00112736|537103186|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
148896651|NCT00112736|537103187|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
148896652|NCT05435339|537103188|FG000|Overall Study|Death|1|||
148896653|NCT05435339|537103189|FG001|Overall Study|Death|0|||
148896654|NCT05435339|537103190|FG002|Overall Study|Death|3|||
148896655|NCT05435339|537103191|FG003|Overall Study|Death|1|||
148896656|NCT05435339|537103192|FG004|Overall Study|Death|3|||
148896657|NCT05435339|537103193|FG005|Overall Study|Death|2|||
148896658|NCT05435339|537103194|FG006|Overall Study|Death|4|||
148896659|NCT05435339|537103195|FG007|Overall Study|Death|6|||
148896660|NCT05435339|537103188|FG000|Overall Study|Sponsor Decision|0|||
148896661|NCT05435339|537103189|FG001|Overall Study|Sponsor Decision|1|||
148896662|NCT05435339|537103190|FG002|Overall Study|Sponsor Decision|0|||
148896663|NCT05435339|537103191|FG003|Overall Study|Sponsor Decision|0|||
148896664|NCT05435339|537103192|FG004|Overall Study|Sponsor Decision|2|||
149137539|NCT01205438|537985149|FG001|Overall Study|Protocol Violation|7|||
149137540|NCT01205438|537985150|FG002|Overall Study|Protocol Violation|4|||
149137541|NCT01205438|537985148|FG000|Overall Study|Sponsor Decision|0|||
149137542|NCT01205438|537985149|FG001|Overall Study|Sponsor Decision|1|||
149137543|NCT01205438|537985150|FG002|Overall Study|Sponsor Decision|1|||
149137544|NCT03823404|537985151|FG000|Overall Study|Lost to Follow-up|1|||
149137545|NCT03823404|537985152|FG001|Overall Study|Lost to Follow-up|2|||
149137546|NCT03823404|537985153|FG002|Overall Study|Lost to Follow-up|3|||
148896665|NCT05435339|537103193|FG005|Overall Study|Sponsor Decision|1|||
148896666|NCT05435339|537103194|FG006|Overall Study|Sponsor Decision|2|||
148896667|NCT05435339|537103195|FG007|Overall Study|Sponsor Decision|2|||
148896668|NCT05435339|537103188|FG000|Overall Study|Withdrawal by Subject|0|||
148896669|NCT05435339|537103189|FG001|Overall Study|Withdrawal by Subject|0|||
148896670|NCT05435339|537103190|FG002|Overall Study|Withdrawal by Subject|0|||
148896671|NCT05435339|537103191|FG003|Overall Study|Withdrawal by Subject|0|||
148896672|NCT05435339|537103192|FG004|Overall Study|Withdrawal by Subject|1|||
148896673|NCT05435339|537103193|FG005|Overall Study|Withdrawal by Subject|0|||
148896674|NCT05435339|537103194|FG006|Overall Study|Withdrawal by Subject|1|||
148896675|NCT05435339|537103195|FG007|Overall Study|Withdrawal by Subject|1|||
148896676|NCT01446159|537103196|FG000|Overall Study|Withdrawal by Subject|1|||
148896677|NCT01446159|537103197|FG001|Overall Study|Withdrawal by Subject|0|||
148896678|NCT01446159|537103198|FG002|Overall Study|Withdrawal by Subject|14|||
148896679|NCT01446159|537103199|FG003|Overall Study|Withdrawal by Subject|11|||
148896680|NCT01446159|537103196|FG000|Overall Study|Lost to Follow-up|0|||
148896681|NCT01446159|537103197|FG001|Overall Study|Lost to Follow-up|0|||
148896682|NCT01446159|537103198|FG002|Overall Study|Lost to Follow-up|1|||
148896683|NCT01446159|537103199|FG003|Overall Study|Lost to Follow-up|2|||
148896684|NCT01446159|537103196|FG000|Overall Study|Death|2|||
148896685|NCT01446159|537103197|FG001|Overall Study|Death|3|||
148896686|NCT01446159|537103198|FG002|Overall Study|Death|43|||
148896687|NCT01446159|537103199|FG003|Overall Study|Death|36|||
148896688|NCT01446159|537103196|FG000|Overall Study|Other|0|||
148896689|NCT01446159|537103197|FG001|Overall Study|Other|0|||
148896690|NCT01446159|537103198|FG002|Overall Study|Other|13|||
148896691|NCT01446159|537103199|FG003|Overall Study|Other|13|||
148896692|NCT00537394|537103200|FG000|First Year of Follow-up|Death|7|||
148896693|NCT00537394|537103201|FG001|First Year of Follow-up|Death|0|||
148896694|NCT00537394|537103202|FG002|First Year of Follow-up|Death|0|||
148896695|NCT00537394|537103200|FG000|First Year of Follow-up|Severe debilitation|1|||
148896696|NCT00537394|537103201|FG001|First Year of Follow-up|Severe debilitation|0|||
148896697|NCT00537394|537103202|FG002|First Year of Follow-up|Severe debilitation|1|||
148896698|NCT00537394|537103200|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
148896699|NCT00537394|537103201|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
148896700|NCT00537394|537103202|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
148896701|NCT00537394|537103200|FG000|First Year of Follow-up|Lost to Follow-up|1|||
148896702|NCT00537394|537103201|FG001|First Year of Follow-up|Lost to Follow-up|5|||
148896703|NCT00537394|537103202|FG002|First Year of Follow-up|Lost to Follow-up|1|||
148896704|NCT00537394|537103200|FG000|2nd Year of Follow-up|Death|4|||
148896705|NCT00537394|537103201|FG001|2nd Year of Follow-up|Death|1|||
148896706|NCT00537394|537103202|FG002|2nd Year of Follow-up|Death|2|||
148896707|NCT00537394|537103200|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
148896708|NCT00537394|537103201|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
148896709|NCT00537394|537103202|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
148896710|NCT00537394|537103200|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
148896711|NCT00537394|537103201|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
148896712|NCT00537394|537103202|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
148896713|NCT00537394|537103200|FG000|2nd Year of Follow-up|Clinic site closure|1|||
148896714|NCT00537394|537103201|FG001|2nd Year of Follow-up|Clinic site closure|0|||
148896715|NCT00537394|537103202|FG002|2nd Year of Follow-up|Clinic site closure|0|||
148896716|NCT01283139|537103203|FG000|Overall Study|Lost to Follow-up|5|||
148896717|NCT01283139|537103204|FG001|Overall Study|Lost to Follow-up|2|||
148896718|NCT01283139|537103205|FG002|Overall Study|Lost to Follow-up|3|||
148896719|NCT01283139|537103206|FG003|Overall Study|Lost to Follow-up|1|||
148896720|NCT01283139|537103203|FG000|Overall Study|Withdrawal by Subject|8|||
148896721|NCT01283139|537103204|FG001|Overall Study|Withdrawal by Subject|8|||
148896722|NCT01283139|537103205|FG002|Overall Study|Withdrawal by Subject|6|||
148896723|NCT01283139|537103206|FG003|Overall Study|Withdrawal by Subject|8|||
148896724|NCT01283139|537103203|FG000|Overall Study|Death|2|||
148896725|NCT01283139|537103204|FG001|Overall Study|Death|0|||
148896726|NCT01283139|537103205|FG002|Overall Study|Death|2|||
148896727|NCT01283139|537103206|FG003|Overall Study|Death|2|||
148896728|NCT01283139|537103203|FG000|Overall Study|Lack of Efficacy|1|||
148896729|NCT01283139|537103204|FG001|Overall Study|Lack of Efficacy|2|||
148896730|NCT01283139|537103205|FG002|Overall Study|Lack of Efficacy|2|||
148896731|NCT01283139|537103206|FG003|Overall Study|Lack of Efficacy|1|||
148896732|NCT01283139|537103203|FG000|Overall Study|Early termination due to AE/SAE|1|||
148896733|NCT01283139|537103204|FG001|Overall Study|Early termination due to AE/SAE|1|||
148896734|NCT01283139|537103205|FG002|Overall Study|Early termination due to AE/SAE|0|||
148896735|NCT01283139|537103206|FG003|Overall Study|Early termination due to AE/SAE|0|||
148896736|NCT01283139|537103203|FG000|Overall Study|Participant's refusal to continue|0|||
148896737|NCT01283139|537103204|FG001|Overall Study|Participant's refusal to continue|3|||
148896738|NCT01283139|537103205|FG002|Overall Study|Participant's refusal to continue|1|||
148896739|NCT01283139|537103206|FG003|Overall Study|Participant's refusal to continue|1|||
148896740|NCT01283139|537103203|FG000|Overall Study|Pregnancy|0|||
148896741|NCT01283139|537103204|FG001|Overall Study|Pregnancy|1|||
148896742|NCT01283139|537103205|FG002|Overall Study|Pregnancy|1|||
148896743|NCT01283139|537103206|FG003|Overall Study|Pregnancy|0|||
148896744|NCT01283139|537103203|FG000|Overall Study|Missed follow-up visit|0|||
148896745|NCT01283139|537103204|FG001|Overall Study|Missed follow-up visit|1|||
148896746|NCT01283139|537103205|FG002|Overall Study|Missed follow-up visit|2|||
148896747|NCT01283139|537103206|FG003|Overall Study|Missed follow-up visit|2|||
148896748|NCT01283139|537103203|FG000|Overall Study|Participant randomized in error|0|||
148896749|NCT01283139|537103204|FG001|Overall Study|Participant randomized in error|0|||
148896750|NCT01283139|537103205|FG002|Overall Study|Participant randomized in error|1|||
148896751|NCT01283139|537103206|FG003|Overall Study|Participant randomized in error|0|||
148896752|NCT00004563|537103207|FG000|Overall Study|Withdrawal by Subject|20|||
148896753|NCT00004563|537103208|FG001|Overall Study|Withdrawal by Subject|16|||
148896754|NCT00004563|537103207|FG000|Overall Study|Lack of Efficacy|3|||
148896755|NCT00004563|537103208|FG001|Overall Study|Lack of Efficacy|5|||
148896756|NCT00004563|537103207|FG000|Overall Study|Death|2|||
148896757|NCT00004563|537103208|FG001|Overall Study|Death|3|||
148896758|NCT01910298|537104916|FG000|Overall Study|Adverse Event|1|||
148896759|NCT01910298|537104917|FG001|Overall Study|Adverse Event|0|||
148896760|NCT01910298|537104916|FG000|Overall Study|Withdrawal by Subject|2|||
148896761|NCT01910298|537104917|FG001|Overall Study|Withdrawal by Subject|7|||
148896762|NCT01910298|537104916|FG000|Overall Study|Protocol Deviation|0|||
148896763|NCT01910298|537104917|FG001|Overall Study|Protocol Deviation|5|||
148896764|NCT01910298|537104916|FG000|Overall Study|Lost to Follow-up|1|||
148896765|NCT01910298|537104917|FG001|Overall Study|Lost to Follow-up|1|||
148896766|NCT01910298|537104916|FG000|Overall Study|Study Terminated by Sponsor|1|||
148896767|NCT01910298|537104917|FG001|Overall Study|Study Terminated by Sponsor|17|||
148896768|NCT01910298|537104916|FG000|Overall Study|Other Miscellaneous Reasons|0|||
148896769|NCT01910298|537104917|FG001|Overall Study|Other Miscellaneous Reasons|2|||
148896770|NCT00755183|537104922|FG000|Overall Study|Adverse Event|5|||
148896771|NCT00755183|537104923|FG001|Overall Study|Adverse Event|2|||
148896772|NCT00755183|537104922|FG000|Overall Study|Protocol Violation|0|||
148896773|NCT00755183|537104923|FG001|Overall Study|Protocol Violation|1|||
148896774|NCT00755183|537104922|FG000|Overall Study|Withdrawal by Subject|0|||
148896775|NCT00755183|537104923|FG001|Overall Study|Withdrawal by Subject|2|||
148896776|NCT00755183|537104922|FG000|Overall Study|Administrative|2|||
148896777|NCT00755183|537104923|FG001|Overall Study|Administrative|1|||
148896778|NCT00948246|537104924|FG000|Overall Study|Lost to Follow-up|11|||
148896779|NCT00948246|537104924|FG000|Overall Study|Adverse Event|11|||
148896780|NCT00948246|537104924|FG000|Overall Study|Death|1|||
148896781|NCT00948246|537104924|FG000|Overall Study|Withdrawal by Subject|1|||
148896782|NCT00148317|537104925|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
148896783|NCT00148317|537104925|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
148896784|NCT00148317|537104925|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
148896785|NCT03924622|537104926|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
148896786|NCT03924622|537104927|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
148896787|NCT03924622|537104928|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
148896788|NCT03924622|537104929|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
148896789|NCT03924622|537104930|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
148896790|NCT03924622|537104931|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
148896791|NCT02923726|537104933|FG000|Overall Study|Death|196|||
148896792|NCT02923726|537104934|FG001|Overall Study|Death|175|||
148896793|NCT02923726|537104933|FG000|Overall Study|Withdrawal by Subject|337|||
148896794|NCT02923726|537104934|FG001|Overall Study|Withdrawal by Subject|307|||
148896795|NCT00671658|537104938|FG000|Overall Study|Physician Decision|5|||
148896796|NCT01176032|537104940|FG000|Overall Study|Adverse Event|1|||
148896797|NCT01176032|537104941|FG001|Overall Study|Adverse Event|0|||
148896798|NCT01176032|537104940|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148896799|NCT01176032|537104941|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148896800|NCT01176032|537104940|FG000|Overall Study|Protocol Violation|1|||
148896801|NCT01176032|537104941|FG001|Overall Study|Protocol Violation|0|||
148896802|NCT01176032|537104940|FG000|Overall Study|Informed consent withdrawn|3|||
148896803|NCT01176032|537104941|FG001|Overall Study|Informed consent withdrawn|0|||
148896804|NCT01176032|537104940|FG000|Overall Study|Other|1|||
148896805|NCT01176032|537104941|FG001|Overall Study|Other|0|||
148896806|NCT01469221|537104942|FG000|Double Blind Phase|Protocol Violation|1|||
148896807|NCT01469221|537104943|FG001|Double Blind Phase|Protocol Violation|0|||
148896808|NCT01469221|537104944|FG002|Double Blind Phase|Protocol Violation|0|||
148896809|NCT01469221|537104942|FG000|Double Blind Phase|Physician Decision|1|||
148896810|NCT01469221|537104943|FG001|Double Blind Phase|Physician Decision|1|||
148896811|NCT01469221|537104944|FG002|Double Blind Phase|Physician Decision|0|||
149011469|NCT02778399|537521473|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
148896812|NCT01469221|537104942|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
148896813|NCT01469221|537104943|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
148896814|NCT01469221|537104944|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
148896815|NCT01149096|537104947|FG000|Overall Study|Lost to Follow-up|0|||
148896816|NCT01149096|537104948|FG001|Overall Study|Lost to Follow-up|1|||
148896817|NCT02358473|537104951|FG000|Overall Study|Disease Progession|6|||
148896818|NCT02358473|537104951|FG000|Overall Study|Adverse Event|3|||
148896819|NCT02358473|537104951|FG000|Overall Study|Withdrawal by Subject|2|||
148896820|NCT02358473|537104951|FG000|Overall Study|Physician Decision|2|||
148896821|NCT00762164|537104968|FG000|Overall Study|Lost to Follow-up|1|||
148896822|NCT00762164|537104969|FG001|Overall Study|Lost to Follow-up|1|||
148896823|NCT00762164|537104968|FG000|Overall Study|Discontinued medication|2|||
148896824|NCT00762164|537104969|FG001|Overall Study|Discontinued medication|0|||
148896825|NCT00762164|537104968|FG000|Overall Study|Withdrawal by Subject|0|||
148896826|NCT00762164|537104969|FG001|Overall Study|Withdrawal by Subject|1|||
148896827|NCT00685165|537104976|FG000|Washout Period of 14 Days|Adverse Event|1|||
148896828|NCT00685165|537104977|FG001|Washout Period of 14 Days|Adverse Event|0|||
148896829|NCT00321789|537104979|FG000|Overall Study|Lost to Follow-up|4|||
148896830|NCT00321789|537104980|FG001|Overall Study|Lost to Follow-up|7|||
148896831|NCT00321789|537104979|FG000|Overall Study|Withdrawal by Subject|6|||
148896832|NCT00321789|537104980|FG001|Overall Study|Withdrawal by Subject|6|||
148896833|NCT00321789|537104979|FG000|Overall Study|Protocol Violation|5|||
148896834|NCT00321789|537104980|FG001|Overall Study|Protocol Violation|3|||
148896835|NCT04576988|537104981|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
148896836|NCT04576988|537104982|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
148896837|NCT04576988|537104981|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
148896838|NCT04576988|537104982|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
148896839|NCT04576988|537104981|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
148896840|NCT04576988|537104982|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
148896841|NCT04576988|537104981|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
148896842|NCT04576988|537104982|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
148896843|NCT04576988|537104981|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
148896844|NCT04576988|537104982|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
148896845|NCT04576988|537104981|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
148896846|NCT04576988|537104982|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
148896847|NCT04576988|537104981|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
148896848|NCT04576988|537104982|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
148896849|NCT04576988|537104981|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
148896850|NCT04576988|537104982|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
148896851|NCT04576988|537104981|FG000|Long Term Double Blind (LTDB)|Death|2|||
148896852|NCT04576988|537104982|FG001|Long Term Double Blind (LTDB)|Death|1|||
148896853|NCT04576988|537104981|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
148896854|NCT04576988|537104982|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
148896855|NCT02362724|537104993|FG000|Overall Study|Withdrawal by Subject|3|||
148896856|NCT02362724|537104994|FG001|Overall Study|Withdrawal by Subject|1|||
148896857|NCT02362724|537104993|FG000|Overall Study|Adverse Event|3|||
148896858|NCT02362724|537104994|FG001|Overall Study|Adverse Event|0|||
148896859|NCT02025179|537104995|FG000|Overall Study|Lost to Follow-up|0|||
148896860|NCT02025179|537104996|FG001|Overall Study|Lost to Follow-up|0|||
148896861|NCT02025179|537104997|FG002|Overall Study|Lost to Follow-up|1|||
148896862|NCT00556075|537104998|FG000|Overall Study|Lost to Follow-up|3|||
148896863|NCT00556075|537104999|FG001|Overall Study|Lost to Follow-up|0|||
148896864|NCT00556075|537105000|FG002|Overall Study|Lost to Follow-up|3|||
148896865|NCT00556075|537104998|FG000|Overall Study|Withdrawal by Subject|3|||
148896866|NCT00556075|537104999|FG001|Overall Study|Withdrawal by Subject|3|||
148896867|NCT00556075|537105000|FG002|Overall Study|Withdrawal by Subject|0|||
148896868|NCT00556075|537104998|FG000|Overall Study|Protocol Violation|1|||
149137547|NCT03823404|537985151|FG000|Overall Study|Protocol Violation|2|||
149137548|NCT03823404|537985152|FG001|Overall Study|Protocol Violation|0|||
149137549|NCT03823404|537985153|FG002|Overall Study|Protocol Violation|2|||
149137550|NCT03823404|537985151|FG000|Overall Study|Adverse Event|35|||
149137551|NCT03823404|537985152|FG001|Overall Study|Adverse Event|38|||
149137552|NCT03823404|537985153|FG002|Overall Study|Adverse Event|8|||
148896869|NCT00556075|537104999|FG001|Overall Study|Protocol Violation|1|||
148896870|NCT00556075|537105000|FG002|Overall Study|Protocol Violation|3|||
148896871|NCT00556075|537104998|FG000|Overall Study|Not eligible|1|||
148896872|NCT00556075|537104999|FG001|Overall Study|Not eligible|1|||
148896873|NCT00556075|537105000|FG002|Overall Study|Not eligible|2|||
148896874|NCT00556075|537104998|FG000|Overall Study|Adverse Event|1|||
148896875|NCT00556075|537104999|FG001|Overall Study|Adverse Event|2|||
148896876|NCT00556075|537105000|FG002|Overall Study|Adverse Event|0|||
148896877|NCT00556075|537104998|FG000|Overall Study|Personal issues|4|||
148896878|NCT00556075|537104999|FG001|Overall Study|Personal issues|1|||
149137553|NCT03823404|537985151|FG000|Overall Study|Withdrawal by Subject|38|||
148896879|NCT00556075|537105000|FG002|Overall Study|Personal issues|0|||
149137554|NCT03823404|537985152|FG001|Overall Study|Withdrawal by Subject|40|||
148896880|NCT00556075|537104998|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
148896881|NCT00556075|537104999|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
148896882|NCT00556075|537105000|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
148896883|NCT02485691|537105003|FG000|Overall Study|Adverse Event|25|||
148896884|NCT02485691|537105004|FG001|Overall Study|Adverse Event|11|||
148896885|NCT02485691|537105003|FG000|Overall Study|Poor compliance to protocol|0|||
148896886|NCT02485691|537105004|FG001|Overall Study|Poor compliance to protocol|1|||
148896887|NCT02485691|537105003|FG000|Overall Study|Disease progression|57|||
148896888|NCT02485691|537105004|FG001|Overall Study|Disease progression|92|||
148896889|NCT02485691|537105003|FG000|Overall Study|Investigator's decision|23|||
148896890|NCT02485691|537105004|FG001|Overall Study|Investigator's decision|5|||
148896891|NCT02485691|537105003|FG000|Overall Study|Participant's request|13|||
148896892|NCT02485691|537105004|FG001|Overall Study|Participant's request|6|||
148896893|NCT02485691|537105003|FG000|Overall Study|Other reason|8|||
148896894|NCT02485691|537105004|FG001|Overall Study|Other reason|9|||
148896895|NCT02485691|537105003|FG000|Overall Study|Randomized and not treated|3|||
148896896|NCT02485691|537105004|FG001|Overall Study|Randomized and not treated|2|||
148896897|NCT01927497|537105005|FG000|Overall Study|Death|0|||
148896898|NCT01927497|537105006|FG001|Overall Study|Death|1|||
148896899|NCT01927497|537105005|FG000|Overall Study|Protocol Violation|2|||
148896900|NCT01927497|537105006|FG001|Overall Study|Protocol Violation|0|||
148896901|NCT00395746|537105007|FG000|Overall Study|Adverse Event|5|||
148896902|NCT00395746|537105008|FG001|Overall Study|Adverse Event|2|||
148896903|NCT00395746|537105009|FG002|Overall Study|Adverse Event|2|||
148896904|NCT00395746|537105007|FG000|Overall Study|Protocol Violation|0|||
148896905|NCT00395746|537105008|FG001|Overall Study|Protocol Violation|1|||
148896906|NCT00395746|537105009|FG002|Overall Study|Protocol Violation|0|||
148896907|NCT00395746|537105007|FG000|Overall Study|Lack of Efficacy|2|||
148896908|NCT00395746|537105008|FG001|Overall Study|Lack of Efficacy|0|||
148896909|NCT00395746|537105009|FG002|Overall Study|Lack of Efficacy|17|||
148896910|NCT00395746|537105007|FG000|Overall Study|Hypoglycaemia|2|||
148896911|NCT00395746|537105008|FG001|Overall Study|Hypoglycaemia|1|||
148896912|NCT00395746|537105009|FG002|Overall Study|Hypoglycaemia|0|||
148896913|NCT00395746|537105007|FG000|Overall Study|Subject decision|0|||
148896914|NCT00395746|537105008|FG001|Overall Study|Subject decision|0|||
148896915|NCT00395746|537105009|FG002|Overall Study|Subject decision|1|||
148896916|NCT00395746|537105007|FG000|Overall Study|Withdrawal of consent|0|||
148896917|NCT00395746|537105008|FG001|Overall Study|Withdrawal of consent|0|||
148896918|NCT00395746|537105009|FG002|Overall Study|Withdrawal of consent|1|||
148896919|NCT00395746|537105007|FG000|Overall Study|Difficultulty in use of device|0|||
148896920|NCT00395746|537105008|FG001|Overall Study|Difficultulty in use of device|0|||
148896921|NCT00395746|537105009|FG002|Overall Study|Difficultulty in use of device|1|||
148896922|NCT00395746|537105007|FG000|Overall Study|Unable to visit site on schedule|1|||
148896923|NCT00395746|537105008|FG001|Overall Study|Unable to visit site on schedule|0|||
148896924|NCT00395746|537105009|FG002|Overall Study|Unable to visit site on schedule|0|||
148896925|NCT04528641|537105010|FG000|Overall Study|Withdrawal by Subject|0|||
148896926|NCT04528641|537105011|FG001|Overall Study|Withdrawal by Subject|0|||
148896927|NCT04528641|537105012|FG002|Overall Study|Withdrawal by Subject|0|||
148896928|NCT04528641|537105013|FG003|Overall Study|Withdrawal by Subject|1|||
148896929|NCT04528641|537105014|FG004|Overall Study|Withdrawal by Subject|0|||
148797774|NCT00808067|536736789|FG000|Overall Study|Elevated LFT results|7|||
148797775|NCT00808067|536736790|FG001|Overall Study|Elevated LFT results|3|||
148797776|NCT00808067|536736789|FG000|Overall Study|Patient refused to take study medication|65|||
148797777|NCT00808067|536736790|FG001|Overall Study|Patient refused to take study medication|76|||
148797778|NCT00808067|536736789|FG000|Overall Study|Missing|1|||
148797779|NCT00808067|536736790|FG001|Overall Study|Missing|0|||
148797780|NCT00808067|536736789|FG000|Overall Study|Death|1|||
148797781|NCT00808067|536736790|FG001|Overall Study|Death|1|||
148797782|NCT00808067|536736789|FG000|Overall Study|Procedure|6|||
148797783|NCT00808067|536736790|FG001|Overall Study|Procedure|7|||
148797784|NCT00808067|536736789|FG000|Overall Study|Withdrawal by Subject|21|||
148797785|NCT00808067|536736790|FG001|Overall Study|Withdrawal by Subject|25|||
148797786|NCT00808067|536736789|FG000|Overall Study|Site closed|4|||
148896930|NCT04528641|537105015|FG005|Overall Study|Withdrawal by Subject|1|||
148896931|NCT00517296|537105016|FG000|Overall Study|Withdrawal by Subject|1|||
148896932|NCT00517296|537105017|FG001|Overall Study|Withdrawal by Subject|0|||
148896933|NCT04764162|537105018|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
148896934|NCT04764162|537105019|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
148797787|NCT00808067|536736790|FG001|Overall Study|Site closed|3|||
148896935|NCT03361137|537105020|FG000|Overall Study|Reason not specified|1|||
148896936|NCT03361137|537105021|FG001|Overall Study|Reason not specified|0|||
148797788|NCT00808067|536736789|FG000|Overall Study|Physician Decision|47|||
148797789|NCT00808067|536736790|FG001|Overall Study|Physician Decision|38|||
148896937|NCT03361137|537105022|FG002|Overall Study|Reason not specified|0|||
148896938|NCT03361137|537105023|FG003|Overall Study|Reason not specified|0|||
148896939|NCT03361137|537105024|FG004|Overall Study|Reason not specified|0|||
148896940|NCT00791934|537105025|FG000|Overall Study|Withdrawal by Subject|2|||
148896941|NCT00791934|537105025|FG000|Overall Study|Did not consent for extended follow-up|13|||
148896942|NCT05556265|537105028|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
148896943|NCT05556265|537105029|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
148896944|NCT05556265|537105030|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
148896945|NCT05556265|537105031|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
148896946|NCT05556265|537105032|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
148896947|NCT05556265|537105028|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
148896948|NCT05556265|537105029|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
148896949|NCT05556265|537105030|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
148896950|NCT05556265|537105031|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
148896951|NCT05556265|537105032|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
148896952|NCT05556265|537105028|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
148896953|NCT05556265|537105029|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
148896954|NCT05556265|537105030|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
148896955|NCT05556265|537105031|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
148896956|NCT05556265|537105032|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
148896957|NCT05556265|537105028|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
148896958|NCT05556265|537105029|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
148896959|NCT05556265|537105030|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
148896960|NCT05556265|537105031|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
148896961|NCT05556265|537105032|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
148896962|NCT05556265|537105028|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
148896963|NCT05556265|537105029|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
148896964|NCT05556265|537105030|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
148896965|NCT05556265|537105031|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
148896966|NCT05556265|537105032|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
148896967|NCT05556265|537105028|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
148896968|NCT05556265|537105029|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
148896969|NCT05556265|537105030|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
148896970|NCT05556265|537105031|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
148896971|NCT05556265|537105032|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
148896972|NCT05556265|537105028|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
148896973|NCT05556265|537105029|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
148896974|NCT05556265|537105030|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
148896975|NCT05556265|537105031|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
148896976|NCT05556265|537105032|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
148896977|NCT05556265|537105028|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
148896978|NCT05556265|537105029|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
148896979|NCT05556265|537105030|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
148896980|NCT05556265|537105031|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
148896981|NCT05556265|537105032|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
148896982|NCT05556265|537105028|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
148896983|NCT05556265|537105029|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
148896984|NCT05556265|537105030|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
148896985|NCT05556265|537105031|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
148896986|NCT05556265|537105032|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
148896987|NCT03137992|537105033|FG000|Washout Period 1|Adverse Event|1|||
148896988|NCT03137992|537105034|FG001|Washout Period 1|Adverse Event|1|||
148896989|NCT03137992|537105035|FG002|Washout Period 1|Adverse Event|0|||
148896990|NCT03137992|537105036|FG003|Washout Period 1|Adverse Event|0|||
148896991|NCT03137992|537105037|FG004|Washout Period 1|Adverse Event|0|||
148896992|NCT03137992|537105038|FG005|Washout Period 1|Adverse Event|1|||
148896993|NCT03137992|537105033|FG000|Washout Period 1|Withdrawal by Subject|0|||
148896994|NCT03137992|537105034|FG001|Washout Period 1|Withdrawal by Subject|1|||
148896995|NCT03137992|537105035|FG002|Washout Period 1|Withdrawal by Subject|1|||
148896996|NCT03137992|537105036|FG003|Washout Period 1|Withdrawal by Subject|0|||
148896997|NCT03137992|537105037|FG004|Washout Period 1|Withdrawal by Subject|0|||
148896998|NCT03137992|537105038|FG005|Washout Period 1|Withdrawal by Subject|0|||
148896999|NCT03137992|537105033|FG000|Washout Period 1|Principal Investigator Discretion|0|||
148897000|NCT03137992|537105034|FG001|Washout Period 1|Principal Investigator Discretion|1|||
148897001|NCT03137992|537105035|FG002|Washout Period 1|Principal Investigator Discretion|0|||
148897002|NCT03137992|537105036|FG003|Washout Period 1|Principal Investigator Discretion|0|||
148797790|NCT00808067|536736789|FG000|Overall Study|Protocol Violation|3|||
148797791|NCT00808067|536736790|FG001|Overall Study|Protocol Violation|11|||
148797792|NCT00808067|536736789|FG000|Overall Study|Patient elected|7|||
148797793|NCT00808067|536736790|FG001|Overall Study|Patient elected|9|||
148797794|NCT00808067|536736789|FG000|Overall Study|Site closed for cause|19|||
148797795|NCT00808067|536736790|FG001|Overall Study|Site closed for cause|19|||
148797796|NCT00808067|536736789|FG000|Overall Study|Other reason not defined above|5|||
148797797|NCT00808067|536736790|FG001|Overall Study|Other reason not defined above|5|||
148797798|NCT00808067|536736789|FG000|Overall Study|Excluded from analysis|13|||
148797799|NCT00808067|536736790|FG001|Overall Study|Excluded from analysis|19|||
148797800|NCT02532283|536736795|FG000|Overall Study|Adverse Event|0|||
148797801|NCT02532283|536736796|FG001|Overall Study|Adverse Event|1|||
148797802|NCT02532283|536736795|FG000|Overall Study|Death|1|||
148797803|NCT02532283|536736796|FG001|Overall Study|Death|0|||
148797804|NCT02532283|536736795|FG000|Overall Study|Lost to Follow-up|0|||
148797805|NCT02532283|536736796|FG001|Overall Study|Lost to Follow-up|1|||
148797806|NCT02532283|536736795|FG000|Overall Study|Withdrawal by Subject|8|||
148797807|NCT02532283|536736796|FG001|Overall Study|Withdrawal by Subject|3|||
148797808|NCT01945944|536736797|FG000|Overall Study|Adverse Event|0|||
148797809|NCT01945944|536736798|FG001|Overall Study|Adverse Event|2|||
148797810|NCT01945944|536736797|FG000|Overall Study|Physician Decision|1|||
148797811|NCT01945944|536736798|FG001|Overall Study|Physician Decision|0|||
148797812|NCT01945944|536736797|FG000|Overall Study|Withdrawal by Subject|0|||
148797813|NCT01945944|536736798|FG001|Overall Study|Withdrawal by Subject|1|||
148797814|NCT04376515|536736799|FG000|Overall Study|Found to have been vaccinated before study start|6|||
148797815|NCT04376515|536736800|FG001|Overall Study|Found to have been vaccinated before study start|6|||
148797816|NCT03811821|536736801|FG000|Overall Study|Adverse Event|1|||
148797817|NCT03811821|536736802|FG001|Overall Study|Adverse Event|1|||
148797818|NCT03811821|536736801|FG000|Overall Study|Withdrawal by Subject|5|||
148797819|NCT03811821|536736802|FG001|Overall Study|Withdrawal by Subject|4|||
148797820|NCT03811821|536736801|FG000|Overall Study|Lost to Follow-up|2|||
148797821|NCT03811821|536736802|FG001|Overall Study|Lost to Follow-up|2|||
148797822|NCT03811821|536736801|FG000|Overall Study|Contraindication for treatment|0|||
148797823|NCT03811821|536736802|FG001|Overall Study|Contraindication for treatment|1|||
148797824|NCT03811821|536736801|FG000|Overall Study|Tolerability|0|||
148797825|NCT03811821|536736802|FG001|Overall Study|Tolerability|3|||
148797826|NCT03811821|536736801|FG000|Overall Study|Comorbidities|0|||
148797827|NCT03811821|536736802|FG001|Overall Study|Comorbidities|2|||
148797828|NCT05027815|536736805|FG000|Overall Study|Death|2|||
148797829|NCT05027815|536736806|FG001|Overall Study|Death|1|||
148797830|NCT01022203|536738713|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
148797831|NCT01022203|536738714|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
148797832|NCT01022203|536738713|FG000|Post Treatment Assessment|Physician Decision|2|||
148797833|NCT01022203|536738714|FG001|Post Treatment Assessment|Physician Decision|0|||
148797834|NCT01022203|536738713|FG000|Post Treatment Assessment|Adverse Event|0|||
148797835|NCT01022203|536738714|FG001|Post Treatment Assessment|Adverse Event|2|||
148797836|NCT01022203|536738713|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
148797837|NCT01022203|536738714|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
148797838|NCT03638128|536738717|FG000|Overall Study|Withdrawal by Subject|1|||
148797839|NCT03638128|536738718|FG001|Overall Study|Withdrawal by Subject|7|||
148797840|NCT03638128|536738719|FG002|Overall Study|Withdrawal by Subject|6|||
148797841|NCT03638128|536738717|FG000|Overall Study|Sponsor Decision|15|||
148797842|NCT03638128|536738718|FG001|Overall Study|Sponsor Decision|12|||
148797843|NCT03638128|536738719|FG002|Overall Study|Sponsor Decision|19|||
148797844|NCT03638128|536738717|FG000|Overall Study|Lost to Follow-up|0|||
148797845|NCT03638128|536738718|FG001|Overall Study|Lost to Follow-up|0|||
148797846|NCT03638128|536738719|FG002|Overall Study|Lost to Follow-up|1|||
148797847|NCT03163446|536738720|FG000|Overall Study|Unable to return for Day 180 visit|2|||
148797848|NCT03163446|536738721|FG001|Overall Study|Unable to return for Day 180 visit|0|||
148797849|NCT03163446|536738720|FG000|Overall Study|Withdrawal by Subject|2|||
148797850|NCT03163446|536738721|FG001|Overall Study|Withdrawal by Subject|6|||
148797851|NCT03163446|536738720|FG000|Overall Study|Death|16|||
148797852|NCT03163446|536738721|FG001|Overall Study|Death|5|||
148797853|NCT03163446|536738720|FG000|Overall Study|Lost to Follow-up|6|||
148797854|NCT03163446|536738721|FG001|Overall Study|Lost to Follow-up|5|||
148797855|NCT03163446|536738720|FG000|Overall Study|Physician Decision|1|||
148797856|NCT03163446|536738721|FG001|Overall Study|Physician Decision|1|||
148797857|NCT03163446|536738720|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
148797858|NCT03163446|536738721|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
148797859|NCT00611806|536738722|FG000|Overall Study|Withdrawal by Subject|8|||
148797860|NCT00611806|536738723|FG001|Overall Study|Withdrawal by Subject|2|||
148797861|NCT00611806|536738722|FG000|Overall Study|Adverse Event|2|||
148797862|NCT00611806|536738723|FG001|Overall Study|Adverse Event|1|||
148797863|NCT00611806|536738722|FG000|Overall Study|Lost to Follow-up|6|||
148897003|NCT03137992|537105037|FG004|Washout Period 1|Principal Investigator Discretion|0|||
148897004|NCT03137992|537105038|FG005|Washout Period 1|Principal Investigator Discretion|0|||
148897005|NCT03137992|537105033|FG000|Washout Period 1|COPD Exacerbation|1|||
148897006|NCT03137992|537105034|FG001|Washout Period 1|COPD Exacerbation|1|||
148897007|NCT03137992|537105035|FG002|Washout Period 1|COPD Exacerbation|1|||
148897008|NCT03137992|537105036|FG003|Washout Period 1|COPD Exacerbation|0|||
148897009|NCT03137992|537105037|FG004|Washout Period 1|COPD Exacerbation|1|||
148897010|NCT03137992|537105038|FG005|Washout Period 1|COPD Exacerbation|1|||
148897011|NCT03137992|537105033|FG000|Washout Period 1|Subject Noncompliance|1|||
148897012|NCT03137992|537105034|FG001|Washout Period 1|Subject Noncompliance|0|||
148897013|NCT03137992|537105035|FG002|Washout Period 1|Subject Noncompliance|0|||
148897014|NCT03137992|537105036|FG003|Washout Period 1|Subject Noncompliance|0|||
148897015|NCT03137992|537105037|FG004|Washout Period 1|Subject Noncompliance|1|||
148897016|NCT03137992|537105038|FG005|Washout Period 1|Subject Noncompliance|0|||
148897017|NCT03137992|537105033|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
148897018|NCT03137992|537105034|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
148897019|NCT03137992|537105035|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
148897020|NCT03137992|537105036|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
148897021|NCT03137992|537105037|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
148897022|NCT03137992|537105038|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
148897023|NCT03137992|537105033|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
148897024|NCT03137992|537105034|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
148897025|NCT03137992|537105035|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
148897026|NCT03137992|537105036|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
148897027|NCT03137992|537105037|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
148897028|NCT03137992|537105038|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
148897029|NCT03137992|537105033|FG000|Period 2 (Visit 3)|Adverse Event|0|||
148897030|NCT03137992|537105034|FG001|Period 2 (Visit 3)|Adverse Event|1|||
148897031|NCT03137992|537105035|FG002|Period 2 (Visit 3)|Adverse Event|0|||
148897032|NCT03137992|537105036|FG003|Period 2 (Visit 3)|Adverse Event|0|||
148897033|NCT03137992|537105037|FG004|Period 2 (Visit 3)|Adverse Event|0|||
148897034|NCT03137992|537105038|FG005|Period 2 (Visit 3)|Adverse Event|0|||
148897035|NCT03137992|537105033|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
148897036|NCT03137992|537105034|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
148897037|NCT03137992|537105035|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
148897038|NCT03137992|537105036|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
149011470|NCT02778399|537521474|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
148797864|NCT00611806|536738723|FG001|Overall Study|Lost to Follow-up|0|||
148797865|NCT00329108|536738725|FG000|Overall Study|Adverse Event|2|||
148797866|NCT00329108|536738726|FG001|Overall Study|Adverse Event|2|||
148797867|NCT00329108|536738725|FG000|Overall Study|Lack of Efficacy|3|||
148797868|NCT00329108|536738726|FG001|Overall Study|Lack of Efficacy|3|||
148797869|NCT00329108|536738725|FG000|Overall Study|Withdrawal by Subject|0|||
148797870|NCT00329108|536738726|FG001|Overall Study|Withdrawal by Subject|2|||
148797871|NCT00329108|536738725|FG000|Overall Study|symptomatic deterioration|1|||
148797872|NCT00329108|536738726|FG001|Overall Study|symptomatic deterioration|1|||
148797873|NCT00329108|536738725|FG000|Overall Study|Subject no longer willing to participate|2|||
148797874|NCT00329108|536738726|FG001|Overall Study|Subject no longer willing to participate|2|||
148797875|NCT00329108|536738725|FG000|Overall Study|study terminated by sponsor|1|||
148797876|NCT00329108|536738726|FG001|Overall Study|study terminated by sponsor|0|||
148797877|NCT00329108|536738725|FG000|Overall Study|withdrew patient after SAE resolved|1|||
148797878|NCT00329108|536738726|FG001|Overall Study|withdrew patient after SAE resolved|0|||
148797879|NCT00329108|536738725|FG000|Overall Study|Protocol Violation|0|||
148797880|NCT00329108|536738726|FG001|Overall Study|Protocol Violation|2|||
148797881|NCT02371616|536738727|FG000|Overall Study|Protocol Violation|2|||
148797882|NCT02371616|536738728|FG001|Overall Study|Protocol Violation|1|||
148797883|NCT02371616|536738727|FG000|Overall Study|Adverse Event|0|||
148797884|NCT02371616|536738728|FG001|Overall Study|Adverse Event|1|||
148797885|NCT02371616|536738727|FG000|Overall Study|Withdrawal of Consent|1|||
148797886|NCT02371616|536738728|FG001|Overall Study|Withdrawal of Consent|0|||
148797887|NCT02371616|536738727|FG000|Overall Study|Other (Not specified)|1|||
148797888|NCT02371616|536738728|FG001|Overall Study|Other (Not specified)|5|||
148797889|NCT04069715|536738733|FG000|Overall Study|Lost to Follow-up|1|||
148797890|NCT04069715|536738734|FG001|Overall Study|Lost to Follow-up|1|||
148797891|NCT04069715|536738733|FG000|Overall Study|Physician Decision|1|||
148797892|NCT04069715|536738734|FG001|Overall Study|Physician Decision|1|||
148797893|NCT04069715|536738733|FG000|Overall Study|Withdrawal by Subject|3|||
148797894|NCT04069715|536738734|FG001|Overall Study|Withdrawal by Subject|3|||
148897039|NCT03137992|537105037|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
148897040|NCT03137992|537105038|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
148897041|NCT03137992|537105033|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
148897042|NCT03137992|537105034|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
148897043|NCT03137992|537105035|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
148897044|NCT03137992|537105036|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
148897045|NCT03137992|537105037|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
148797895|NCT03205150|536738735|FG000|Overall Study|Protocol deviation|1|||
148797896|NCT03205150|536738736|FG001|Overall Study|Protocol deviation|3|||
148797897|NCT03205150|536738737|FG002|Overall Study|Protocol deviation|0|||
148797898|NCT03205150|536738735|FG000|Overall Study|Patient/guardian decision|0|||
148797899|NCT03205150|536738736|FG001|Overall Study|Patient/guardian decision|3|||
148797900|NCT03205150|536738737|FG002|Overall Study|Patient/guardian decision|0|||
148797901|NCT03205150|536738735|FG000|Overall Study|Adverse Event|1|||
148797902|NCT03205150|536738736|FG001|Overall Study|Adverse Event|1|||
148797903|NCT03205150|536738737|FG002|Overall Study|Adverse Event|1|||
148797904|NCT03205150|536738735|FG000|Overall Study|Lost to Follow-up|0|||
148797905|NCT03205150|536738736|FG001|Overall Study|Lost to Follow-up|0|||
148797906|NCT03205150|536738737|FG002|Overall Study|Lost to Follow-up|1|||
148797907|NCT02723188|536738738|FG000|Overall Study|Withdrawal by Subject|1|||
148797908|NCT02723188|536738739|FG001|Overall Study|Withdrawal by Subject|0|||
148797909|NCT02723188|536738740|FG002|Overall Study|Withdrawal by Subject|0|||
148797910|NCT02486692|536738746|FG000|Overall Study|did not login for randomization|4|||
148797911|NCT02486692|536738747|FG001|Overall Study|did not login for randomization|7|||
148797912|NCT00116688|536738756|FG000|Overall Study|Protocol deviation|1|||
148797913|NCT00116688|536738757|FG001|Overall Study|Protocol deviation|0|||
148797914|NCT00116688|536738756|FG000|Overall Study|Noncompliance|3|||
148797915|NCT00116688|536738757|FG001|Overall Study|Noncompliance|1|||
148797916|NCT00116688|536738756|FG000|Overall Study|Adverse Event|11|||
148797917|NCT00116688|536738757|FG001|Overall Study|Adverse Event|0|||
148797918|NCT00116688|536738756|FG000|Overall Study|Withdrawal by Subject|26|||
148797919|NCT00116688|536738757|FG001|Overall Study|Withdrawal by Subject|2|||
148797920|NCT00116688|536738756|FG000|Overall Study|Requirement for alternative therapy|11|||
148797921|NCT00116688|536738757|FG001|Overall Study|Requirement for alternative therapy|1|||
148797922|NCT00116688|536738756|FG000|Overall Study|Physician Decision|7|||
148797923|NCT00116688|536738757|FG001|Overall Study|Physician Decision|0|||
148797924|NCT00116688|536738756|FG000|Overall Study|Lost to Follow-up|3|||
148797925|NCT00116688|536738757|FG001|Overall Study|Lost to Follow-up|0|||
148797926|NCT00116688|536738756|FG000|Overall Study|Death|15|||
148797927|NCT00116688|536738757|FG001|Overall Study|Death|0|||
148797928|NCT00116688|536738756|FG000|Overall Study|Protocol-specified criteria|3|||
148797929|NCT00116688|536738757|FG001|Overall Study|Protocol-specified criteria|0|||
148797930|NCT00116688|536738756|FG000|Overall Study|Pregnancy|1|||
148797931|NCT00116688|536738757|FG001|Overall Study|Pregnancy|0|||
148797932|NCT00116688|536738756|FG000|Overall Study|Other|11|||
148797933|NCT00116688|536738757|FG001|Overall Study|Other|0|||
148797934|NCT01775670|536738761|FG000|Overall Study|Lost to Follow-up|1|||
148797935|NCT01775670|536738762|FG001|Overall Study|Lost to Follow-up|1|||
148797936|NCT00643760|536738765|FG000|Overall Study|Adverse Event|11|||
148797937|NCT00643760|536738766|FG001|Overall Study|Adverse Event|5|||
148797938|NCT00643760|536738767|FG002|Overall Study|Adverse Event|12|||
148797939|NCT00643760|536738768|FG003|Overall Study|Adverse Event|21|||
148797940|NCT00643760|536738769|FG004|Overall Study|Adverse Event|6|||
148797941|NCT00643760|536738765|FG000|Overall Study|Lack of Efficacy|3|||
148797942|NCT00643760|536738766|FG001|Overall Study|Lack of Efficacy|1|||
148797943|NCT00643760|536738767|FG002|Overall Study|Lack of Efficacy|0|||
148797944|NCT00643760|536738768|FG003|Overall Study|Lack of Efficacy|4|||
148797945|NCT00643760|536738769|FG004|Overall Study|Lack of Efficacy|3|||
148797946|NCT00643760|536738765|FG000|Overall Study|Protocol Violation|7|||
148797947|NCT00643760|536738766|FG001|Overall Study|Protocol Violation|6|||
148797948|NCT00643760|536738767|FG002|Overall Study|Protocol Violation|4|||
148797949|NCT00643760|536738768|FG003|Overall Study|Protocol Violation|4|||
148797950|NCT00643760|536738769|FG004|Overall Study|Protocol Violation|6|||
148797951|NCT00643760|536738765|FG000|Overall Study|Lost to Follow-up|6|||
148797952|NCT00643760|536738766|FG001|Overall Study|Lost to Follow-up|2|||
148797953|NCT00643760|536738767|FG002|Overall Study|Lost to Follow-up|1|||
148797954|NCT00643760|536738768|FG003|Overall Study|Lost to Follow-up|3|||
148797955|NCT00643760|536738769|FG004|Overall Study|Lost to Follow-up|3|||
148797956|NCT00643760|536738765|FG000|Overall Study|Investigator Discretion|0|||
148797957|NCT00643760|536738766|FG001|Overall Study|Investigator Discretion|0|||
148797958|NCT00643760|536738767|FG002|Overall Study|Investigator Discretion|0|||
148797959|NCT00643760|536738768|FG003|Overall Study|Investigator Discretion|2|||
148797960|NCT00643760|536738769|FG004|Overall Study|Investigator Discretion|0|||
148797961|NCT00643760|536738765|FG000|Overall Study|Withdrawal by Subject|3|||
148797962|NCT00643760|536738766|FG001|Overall Study|Withdrawal by Subject|1|||
148797963|NCT00643760|536738767|FG002|Overall Study|Withdrawal by Subject|2|||
148797964|NCT00643760|536738768|FG003|Overall Study|Withdrawal by Subject|4|||
148797965|NCT00643760|536738769|FG004|Overall Study|Withdrawal by Subject|1|||
148797966|NCT03353792|536738776|FG000|Overall Study|Lost to Follow-up|1|||
148797967|NCT03353792|536738777|FG001|Overall Study|Lost to Follow-up|0|||
148797968|NCT03353792|536738776|FG000|Overall Study|Participant Unable to Manage Device|1|||
148797969|NCT03353792|536738777|FG001|Overall Study|Participant Unable to Manage Device|0|||
148797970|NCT00789321|536738778|FG000|Overall Study|Adverse Event|0|||
148797971|NCT00789321|536738779|FG001|Overall Study|Adverse Event|1|||
148797972|NCT00104052|536738780|FG000|Overall Study|Adverse Event|1|||
148797973|NCT00104052|536738780|FG000|Overall Study|Lack of Efficacy|26|||
148897046|NCT03137992|537105038|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
148897047|NCT03137992|537105033|FG000|Washout Period 2|COPD Exacerbation|1|||
148897048|NCT03137992|537105034|FG001|Washout Period 2|COPD Exacerbation|1|||
148897049|NCT03137992|537105035|FG002|Washout Period 2|COPD Exacerbation|0|||
148897050|NCT03137992|537105036|FG003|Washout Period 2|COPD Exacerbation|0|||
148897051|NCT03137992|537105037|FG004|Washout Period 2|COPD Exacerbation|1|||
148897052|NCT03137992|537105038|FG005|Washout Period 2|COPD Exacerbation|0|||
148897053|NCT03137992|537105033|FG000|Washout Period 2|Subject Non-compliance|0|||
148897054|NCT03137992|537105034|FG001|Washout Period 2|Subject Non-compliance|1|||
148897055|NCT03137992|537105035|FG002|Washout Period 2|Subject Non-compliance|0|||
148897056|NCT03137992|537105036|FG003|Washout Period 2|Subject Non-compliance|0|||
148897057|NCT03137992|537105037|FG004|Washout Period 2|Subject Non-compliance|0|||
148897058|NCT03137992|537105038|FG005|Washout Period 2|Subject Non-compliance|0|||
148897059|NCT03137992|537105033|FG000|Washout Period 2|Adverse Event|0|||
148897060|NCT03137992|537105034|FG001|Washout Period 2|Adverse Event|0|||
148897061|NCT03137992|537105035|FG002|Washout Period 2|Adverse Event|0|||
148897062|NCT03137992|537105036|FG003|Washout Period 2|Adverse Event|1|||
148897063|NCT03137992|537105037|FG004|Washout Period 2|Adverse Event|1|||
148897064|NCT03137992|537105038|FG005|Washout Period 2|Adverse Event|0|||
148897065|NCT03137992|537105033|FG000|Washout Period 2|Withdrawal by Subject|1|||
148897066|NCT03137992|537105034|FG001|Washout Period 2|Withdrawal by Subject|0|||
148897067|NCT03137992|537105035|FG002|Washout Period 2|Withdrawal by Subject|0|||
148897068|NCT03137992|537105036|FG003|Washout Period 2|Withdrawal by Subject|0|||
148897069|NCT03137992|537105037|FG004|Washout Period 2|Withdrawal by Subject|1|||
148897070|NCT03137992|537105038|FG005|Washout Period 2|Withdrawal by Subject|0|||
148897071|NCT03137992|537105033|FG000|Washout Period 2|Sponsor Decision|0|||
148897072|NCT03137992|537105034|FG001|Washout Period 2|Sponsor Decision|0|||
148897073|NCT03137992|537105035|FG002|Washout Period 2|Sponsor Decision|0|||
148897074|NCT03137992|537105036|FG003|Washout Period 2|Sponsor Decision|0|||
148897075|NCT03137992|537105037|FG004|Washout Period 2|Sponsor Decision|0|||
148897076|NCT03137992|537105038|FG005|Washout Period 2|Sponsor Decision|1|||
148897077|NCT03137992|537105033|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
148897078|NCT03137992|537105034|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
148897079|NCT03137992|537105035|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
148897080|NCT03137992|537105036|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
148897081|NCT03137992|537105037|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
148897082|NCT03137992|537105038|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
148897083|NCT03137992|537105033|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
148897084|NCT03137992|537105034|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
148897085|NCT03137992|537105035|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
148897086|NCT03137992|537105036|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
148897087|NCT03137992|537105037|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
148897088|NCT03137992|537105038|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
148897089|NCT03137992|537105033|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
148897090|NCT03137992|537105034|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
148897091|NCT03137992|537105035|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
148897092|NCT03137992|537105036|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
148897093|NCT03137992|537105037|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
148897094|NCT03137992|537105038|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
148897095|NCT03137992|537105033|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
148897096|NCT03137992|537105034|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
148897097|NCT03137992|537105035|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
148897098|NCT03137992|537105036|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
148897099|NCT03137992|537105037|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
148897100|NCT03137992|537105038|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
148897101|NCT03137992|537105033|FG000|Part 2 (Open-label Extension)|Per study team|1|||
148897102|NCT03137992|537105034|FG001|Part 2 (Open-label Extension)|Per study team|0|||
148897103|NCT03137992|537105035|FG002|Part 2 (Open-label Extension)|Per study team|0|||
148897104|NCT03137992|537105036|FG003|Part 2 (Open-label Extension)|Per study team|0|||
148897105|NCT03137992|537105037|FG004|Part 2 (Open-label Extension)|Per study team|0|||
148897106|NCT03137992|537105038|FG005|Part 2 (Open-label Extension)|Per study team|0|||
148897107|NCT03137992|537105033|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
148897108|NCT03137992|537105034|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
148897109|NCT03137992|537105035|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
148897110|NCT03137992|537105036|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
148897111|NCT03137992|537105037|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
149011471|NCT02778399|537521475|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
148897112|NCT03137992|537105038|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
148897113|NCT03077542|537105041|FG000|Overall Study|Death|4|||
148897114|NCT03077542|537105042|FG001|Overall Study|Death|0|||
148897115|NCT03077542|537105041|FG000|Overall Study|Physician Decision|6|||
148897116|NCT03077542|537105042|FG001|Overall Study|Physician Decision|1|||
148897117|NCT03077542|537105041|FG000|Overall Study|Withdrawal by Subject|0|||
148897118|NCT03077542|537105042|FG001|Overall Study|Withdrawal by Subject|1|||
148897119|NCT00795704|537105043|FG000|Overall Study|Withdrawal by Subject|3|||
148897120|NCT00795704|537105044|FG001|Overall Study|Withdrawal by Subject|2|||
148897121|NCT00795704|537105043|FG000|Overall Study|Adverse Event|1|||
148897122|NCT00795704|537105044|FG001|Overall Study|Adverse Event|1|||
148897123|NCT03980730|537105045|FG000|Overall Study|Study Terminated by Sponsor|0|||
148897124|NCT03980730|537105046|FG001|Overall Study|Study Terminated by Sponsor|3|||
148897125|NCT03980730|537105045|FG000|Overall Study|Adverse Event|2|||
148897126|NCT03980730|537105046|FG001|Overall Study|Adverse Event|0|||
148897127|NCT03980730|537105045|FG000|Overall Study|Sponsor Request|0|||
148897128|NCT03980730|537105046|FG001|Overall Study|Sponsor Request|1|||
148897129|NCT01486966|537105047|FG000|Overall Study|Adverse Event|0|||
148897130|NCT01486966|537105048|FG001|Overall Study|Adverse Event|1|||
148897131|NCT01486966|537105047|FG000|Overall Study|Withdrawal by Subject|0|||
148897132|NCT01486966|537105048|FG001|Overall Study|Withdrawal by Subject|1|||
148897133|NCT01607957|537105056|FG000|Overall Study|Not treated|1|||
148897134|NCT01607957|537105057|FG001|Overall Study|Not treated|1|||
148897135|NCT01607957|537105056|FG000|Overall Study|Death|367|||
148897136|NCT01607957|537105057|FG001|Overall Study|Death|211|||
148897137|NCT01607957|537105056|FG000|Overall Study|Lost to Follow-up|3|||
148897138|NCT01607957|537105057|FG001|Overall Study|Lost to Follow-up|3|||
148897139|NCT01607957|537105056|FG000|Overall Study|Participant refusal|1|||
148897140|NCT01607957|537105057|FG001|Overall Study|Participant refusal|0|||
148897141|NCT03905096|537105060|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
148897142|NCT03905096|537105061|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
148897143|NCT02016781|537105063|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
148897144|NCT02016781|537105064|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
148897145|NCT02016781|537105063|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
148897146|NCT02016781|537105064|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
148897147|NCT02016781|537105063|FG000|Final Database Lock|Withdrawal by Subject|2|||
148897148|NCT02016781|537105064|FG001|Final Database Lock|Withdrawal by Subject|1|||
148897149|NCT02016781|537105063|FG000|Final Database Lock|Lost to Follow-up|11|||
148897150|NCT02016781|537105064|FG001|Final Database Lock|Lost to Follow-up|4|||
148897151|NCT02016781|537105063|FG000|Final Database Lock|Missing data|0|||
148897152|NCT02016781|537105064|FG001|Final Database Lock|Missing data|3|||
148897153|NCT03724942|537105070|FG000|Overall Study|Adverse Event|20|||
148897154|NCT03724942|537105071|FG001|Overall Study|Adverse Event|14|||
148897155|NCT03724942|537105070|FG000|Overall Study|Lack of Efficacy|0|||
148897156|NCT03724942|537105071|FG001|Overall Study|Lack of Efficacy|1|||
148897157|NCT03724942|537105070|FG000|Overall Study|Physician Decision|5|||
148897158|NCT03724942|537105071|FG001|Overall Study|Physician Decision|2|||
148897159|NCT03724942|537105070|FG000|Overall Study|Protocol Violation|1|||
148897160|NCT03724942|537105071|FG001|Overall Study|Protocol Violation|0|||
148897161|NCT03724942|537105070|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
148897162|NCT03724942|537105071|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
148897163|NCT03724942|537105070|FG000|Overall Study|Withdrawal by Legal Representative|3|||
148897164|NCT03724942|537105071|FG001|Overall Study|Withdrawal by Legal Representative|0|||
148897165|NCT02429830|537105072|FG000|Overall Study|Lost to Follow-up|1|||
148897166|NCT02429830|537105072|FG000|Overall Study|Device Explant|2|||
148897167|NCT03414983|537107010|FG000|Pre-Treatment|Other reasons|1|||
148897168|NCT03414983|537107011|FG001|Pre-Treatment|Other reasons|0|||
148897169|NCT03414983|537107010|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
148897170|NCT03414983|537107011|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
148897171|NCT03414983|537107010|FG000|Pre-Treatment|Participant withdrew consent|1|||
148897172|NCT03414983|537107011|FG001|Pre-Treatment|Participant withdrew consent|3|||
148897173|NCT03414983|537107010|FG000|Treatment|Participant withdrew consent|4|||
148897174|NCT03414983|537107011|FG001|Treatment|Participant withdrew consent|3|||
148897175|NCT03414983|537107010|FG000|Treatment|Participant request to discontinue study treatment|8|||
148897176|NCT03414983|537107011|FG001|Treatment|Participant request to discontinue study treatment|10|||
148897177|NCT03414983|537107010|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
148897178|NCT03414983|537107011|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
148897179|NCT03414983|537107010|FG000|Treatment|Death|0|||
148897180|NCT03414983|537107011|FG001|Treatment|Death|1|||
148897181|NCT03414983|537107010|FG000|Treatment|Study Drug Toxicity|10|||
148897182|NCT03414983|537107011|FG001|Treatment|Study Drug Toxicity|5|||
148897183|NCT03414983|537107010|FG000|Treatment|Disease Progression|75|||
148897184|NCT03414983|537107011|FG001|Treatment|Disease Progression|29|||
148897185|NCT03414983|537107010|FG000|Treatment|Not reported|1|||
148897186|NCT03414983|537107011|FG001|Treatment|Not reported|0|||
148897187|NCT03414983|537107010|FG000|Treatment|Other reasons|3|||
148897188|NCT03414983|537107011|FG001|Treatment|Other reasons|2|||
148897189|NCT03414983|537107010|FG000|Treatment|Poor/non-compliance|2|||
148897190|NCT03414983|537107011|FG001|Treatment|Poor/non-compliance|0|||
148897191|NCT03414983|537107010|FG000|Treatment|Maximum clinical benefit|5|||
148897192|NCT03414983|537107011|FG001|Treatment|Maximum clinical benefit|9|||
148897193|NCT03414983|537107010|FG000|Treatment|Lost to Follow-up|0|||
148897194|NCT03414983|537107011|FG001|Treatment|Lost to Follow-up|1|||
148897195|NCT03414983|537107010|FG000|Treatment|Administrative reasons by sponsor|1|||
148897196|NCT03414983|537107011|FG001|Treatment|Administrative reasons by sponsor|0|||
148897197|NCT02608684|537107012|FG000|Overall Study|Physician Decision|2|||
148897198|NCT02608684|537107012|FG000|Overall Study|Withdrawal by Subject|1|||
148897199|NCT00751296|537107013|FG000|Overall Study|Adverse Event|2|||
148897200|NCT04914364|537107014|FG000|Overall Study|No longer eligible for study|1|||
148897201|NCT04914364|537107014|FG000|Overall Study|Lost to Follow-up|2|||
148897202|NCT00702702|537107017|FG000|Overall Study|Study prematurely terminated|56|||
148897203|NCT00551759|537107020|FG000|Overall Study|Adverse Event|7|||
148897204|NCT00551759|537107020|FG000|Overall Study|Death|5|||
148897205|NCT00551759|537107020|FG000|Overall Study|Ineligible|1|||
148897206|NCT03279081|537107021|FG000|Overall Study|Withdrawal by Subject|12|||
148897207|NCT03279081|537107022|FG001|Overall Study|Withdrawal by Subject|20|||
148897208|NCT03279081|537107021|FG000|Overall Study|Physician Decision|4|||
148897209|NCT03279081|537107022|FG001|Overall Study|Physician Decision|1|||
148897210|NCT03279081|537107021|FG000|Overall Study|Lost to Follow-up|8|||
148897211|NCT03279081|537107022|FG001|Overall Study|Lost to Follow-up|8|||
148897212|NCT03279081|537107021|FG000|Overall Study|Death|0|||
148897213|NCT03279081|537107022|FG001|Overall Study|Death|1|||
148897214|NCT03279081|537107021|FG000|Overall Study|Adverse Event|1|||
148897215|NCT03279081|537107022|FG001|Overall Study|Adverse Event|0|||
148897216|NCT03279081|537107021|FG000|Overall Study|Reason not Specified|14|||
148897217|NCT03279081|537107022|FG001|Overall Study|Reason not Specified|4|||
148897218|NCT03521570|537107023|FG000|Overall Study|Not eligible|11|||
148897219|NCT00322881|537107024|FG000|Overall Study|Death|2|||
148897220|NCT00322881|537107024|FG000|Overall Study|Adverse Event|1|||
148897221|NCT00322881|537107024|FG000|Overall Study|Disease Progression|2|||
148897222|NCT01667900|537107027|FG000|Part B|Death|0|||
148897223|NCT01667900|537107028|FG001|Part B|Death|0|||
148897224|NCT01667900|537107029|FG002|Part B|Death|0|||
148897225|NCT01667900|537107030|FG003|Part B|Death|0|||
148897226|NCT01667900|537107031|FG004|Part B|Death|0|||
148897227|NCT01667900|537107032|FG005|Part B|Death|0|||
148897228|NCT01667900|537107033|FG006|Part B|Death|0|||
148897229|NCT01667900|537107034|FG007|Part B|Death|0|||
148897230|NCT01667900|537107035|FG008|Part B|Death|0|||
148897231|NCT01667900|537107036|FG009|Part B|Death|0|||
148897232|NCT01667900|537107037|FG010|Part B|Death|0|||
148897233|NCT01667900|537107038|FG011|Part B|Death|0|||
148897234|NCT01667900|537107039|FG012|Part B|Death|0|||
148897235|NCT01667900|537107040|FG013|Part B|Death|0|||
148897236|NCT01667900|537107041|FG014|Part B|Death|0|||
148897237|NCT01667900|537107042|FG015|Part B|Death|0|||
148897238|NCT01667900|537107043|FG016|Part B|Death|1|||
148897239|NCT01667900|537107044|FG017|Part B|Death|0|||
148897240|NCT01667900|537107045|FG018|Part B|Death|0|||
148897241|NCT01667900|537107046|FG019|Part B|Death|0|||
148897242|NCT00468169|537107049|FG000|Overall Study|Withdrawal by Subject|1|||
148897243|NCT00468169|537107050|FG001|Overall Study|Withdrawal by Subject|0|||
148897244|NCT00784563|537107051|FG000|Years 1 & 2|Withdrawal by Subject|3|||
148897245|NCT00784563|537107052|FG001|Years 1 & 2|Withdrawal by Subject|2|||
148897246|NCT00784563|537107053|FG002|Years 1 & 2|Withdrawal by Subject|0|||
148897247|NCT00784563|537107051|FG000|Years 1 & 2|Adverse Event|0|||
148897248|NCT00784563|537107052|FG001|Years 1 & 2|Adverse Event|3|||
148897249|NCT00784563|537107053|FG002|Years 1 & 2|Adverse Event|0|||
148897250|NCT00784563|537107051|FG000|Year 3|Withdrawal by Subject|0|||
148897251|NCT00784563|537107052|FG001|Year 3|Withdrawal by Subject|0|||
148897252|NCT00784563|537107053|FG002|Year 3|Withdrawal by Subject|2|||
148897253|NCT00784563|537107051|FG000|Year 3|Adverse Event|0|||
148897254|NCT00784563|537107052|FG001|Year 3|Adverse Event|0|||
148897255|NCT00784563|537107053|FG002|Year 3|Adverse Event|1|||
148897256|NCT02954536|537107054|FG000|Overall Study|Adverse Event|2|||
148897257|NCT02954536|537107054|FG000|Overall Study|Death|12|||
148897258|NCT02946580|537107055|FG000|Overall Study|Withdrawal by Subject|1|||
148897259|NCT02946580|537107056|FG001|Overall Study|Withdrawal by Subject|2|||
148897260|NCT02946580|537107055|FG000|Overall Study|Adverse Event|0|||
148897261|NCT02946580|537107056|FG001|Overall Study|Adverse Event|2|||
148897262|NCT02946580|537107055|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
148897263|NCT02946580|537107056|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
148897264|NCT01576341|537107066|FG000|Overall Study|Withdrawal by Subject|24|||
148897265|NCT01576341|537107066|FG000|Overall Study|Adverse Event|10|||
148897266|NCT01576341|537107066|FG000|Overall Study|Death|21|||
148897267|NCT01576341|537107066|FG000|Overall Study|Physician Decision|2|||
148897268|NCT01576341|537107066|FG000|Overall Study|Lost to Follow-up|2|||
148897269|NCT01576341|537107066|FG000|Overall Study|Kidney transplantation|10|||
148897270|NCT01576341|537107066|FG000|Overall Study|Protocol Violation|12|||
148897271|NCT01576341|537107066|FG000|Overall Study|Other|12|||
148897272|NCT01844765|537107067|FG000|Overall Study|Adverse Event|6|||
148897273|NCT01844765|537107068|FG001|Overall Study|Adverse Event|8|||
148897274|NCT01844765|537107067|FG000|Overall Study|Withdrawal by Subject|2|||
148897275|NCT01844765|537107068|FG001|Overall Study|Withdrawal by Subject|3|||
148897276|NCT01844765|537107067|FG000|Overall Study|Disease progression|1|||
148897277|NCT01844765|537107068|FG001|Overall Study|Disease progression|0|||
148897278|NCT01844765|537107067|FG000|Overall Study|Administrative problems|3|||
148897279|NCT01844765|537107068|FG001|Overall Study|Administrative problems|4|||
148897280|NCT01844765|537107067|FG000|Overall Study|Protocol deviation|2|||
148897281|NCT01844765|537107068|FG001|Overall Study|Protocol deviation|0|||
148897282|NCT01844765|537107067|FG000|Overall Study|Untreated|1|||
148897283|NCT01844765|537107068|FG001|Overall Study|Untreated|0|||
148897284|NCT04292535|537107069|FG000|Overall Study|Withdrawal by Subject|0|||
148897285|NCT04292535|537107070|FG001|Overall Study|Withdrawal by Subject|0|||
148897286|NCT04292535|537107071|FG002|Overall Study|Withdrawal by Subject|0|||
148897287|NCT04292535|537107072|FG003|Overall Study|Withdrawal by Subject|0|||
148897288|NCT04292535|537107073|FG004|Overall Study|Withdrawal by Subject|0|||
148897289|NCT04292535|537107074|FG005|Overall Study|Withdrawal by Subject|0|||
148897290|NCT04292535|537107075|FG006|Overall Study|Withdrawal by Subject|0|||
148897291|NCT04292535|537107076|FG007|Overall Study|Withdrawal by Subject|1|||
148897292|NCT04292535|537107077|FG008|Overall Study|Withdrawal by Subject|0|||
148897293|NCT04292535|537107078|FG009|Overall Study|Withdrawal by Subject|0|||
148897294|NCT04292535|537107079|FG010|Overall Study|Withdrawal by Subject|0|||
148897295|NCT04292535|537107080|FG011|Overall Study|Withdrawal by Subject|0|||
148897296|NCT04292535|537107081|FG012|Overall Study|Withdrawal by Subject|0|||
148897297|NCT04292535|537107082|FG013|Overall Study|Withdrawal by Subject|0|||
148897298|NCT04292535|537107069|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897299|NCT04292535|537107070|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897300|NCT04292535|537107071|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897301|NCT04292535|537107072|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897302|NCT04292535|537107073|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897303|NCT04292535|537107074|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897304|NCT04292535|537107075|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897305|NCT04292535|537107076|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
148897306|NCT04292535|537107077|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897307|NCT04292535|537107078|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897308|NCT04292535|537107079|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897309|NCT04292535|537107080|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
148897310|NCT04292535|537107081|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
148897311|NCT04292535|537107082|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
148897312|NCT04292535|537107069|FG000|Overall Study|Report of Dizziness|0|||
148897313|NCT04292535|537107070|FG001|Overall Study|Report of Dizziness|0|||
148897314|NCT04292535|537107071|FG002|Overall Study|Report of Dizziness|0|||
148897315|NCT04292535|537107072|FG003|Overall Study|Report of Dizziness|0|||
148897316|NCT04292535|537107073|FG004|Overall Study|Report of Dizziness|0|||
148897317|NCT04292535|537107074|FG005|Overall Study|Report of Dizziness|0|||
148897318|NCT04292535|537107075|FG006|Overall Study|Report of Dizziness|0|||
148897319|NCT04292535|537107076|FG007|Overall Study|Report of Dizziness|0|||
148897320|NCT04292535|537107077|FG008|Overall Study|Report of Dizziness|0|||
149011472|NCT02778399|537521470|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
148897321|NCT04292535|537107078|FG009|Overall Study|Report of Dizziness|0|||
148897322|NCT04292535|537107079|FG010|Overall Study|Report of Dizziness|0|||
148897323|NCT04292535|537107080|FG011|Overall Study|Report of Dizziness|0|||
148897324|NCT04292535|537107081|FG012|Overall Study|Report of Dizziness|0|||
148897325|NCT04292535|537107082|FG013|Overall Study|Report of Dizziness|1|||
148897326|NCT04292535|537107069|FG000|Overall Study|Equipment Failure|0|||
148897327|NCT04292535|537107070|FG001|Overall Study|Equipment Failure|0|||
148897328|NCT04292535|537107071|FG002|Overall Study|Equipment Failure|0|||
148897329|NCT04292535|537107072|FG003|Overall Study|Equipment Failure|0|||
148897330|NCT04292535|537107073|FG004|Overall Study|Equipment Failure|0|||
148897331|NCT04292535|537107074|FG005|Overall Study|Equipment Failure|0|||
148897332|NCT04292535|537107075|FG006|Overall Study|Equipment Failure|0|||
148897333|NCT04292535|537107076|FG007|Overall Study|Equipment Failure|0|||
148897334|NCT04292535|537107077|FG008|Overall Study|Equipment Failure|0|||
148897335|NCT04292535|537107078|FG009|Overall Study|Equipment Failure|0|||
148897336|NCT04292535|537107079|FG010|Overall Study|Equipment Failure|0|||
148897337|NCT04292535|537107080|FG011|Overall Study|Equipment Failure|1|||
148897338|NCT04292535|537107081|FG012|Overall Study|Equipment Failure|0|||
148897339|NCT04292535|537107082|FG013|Overall Study|Equipment Failure|0|||
148897340|NCT03914417|537107083|FG000|Overall Study|Withdrawal by Subject|2|||
148897341|NCT03836625|537107086|FG000|Overall Study|Lost to Follow-up|9|||
148897342|NCT03836625|537107087|FG001|Overall Study|Lost to Follow-up|9|||
148897343|NCT03836625|537107086|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
148897344|NCT03836625|537107087|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
148897345|NCT03836625|537107086|FG000|Overall Study|Death|0|||
148897346|NCT03836625|537107087|FG001|Overall Study|Death|1|||
148897347|NCT03836625|537107086|FG000|Overall Study|Refused follow-up|0|||
148897348|NCT03836625|537107087|FG001|Overall Study|Refused follow-up|1|||
148897349|NCT01420861|537107094|FG000|Overall Study|Adverse Event|2|||
148897350|NCT01420861|537107094|FG000|Overall Study|Study terminated by Sponsor|7|||
148897351|NCT01420861|537107094|FG000|Overall Study|Screen failure|7|||
148897352|NCT01420861|537107094|FG000|Overall Study|Randomized not Treated|2|||
148897353|NCT03413891|537107096|FG000|Overall Study|Lost to Follow-up|2|||
148897354|NCT03413891|537107097|FG001|Overall Study|Lost to Follow-up|1|||
148897355|NCT03413891|537107096|FG000|Overall Study|Protocol Violation|0|||
148897356|NCT03413891|537107097|FG001|Overall Study|Protocol Violation|1|||
148897357|NCT04905134|537107098|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
148897358|NCT04905134|537107098|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
148897359|NCT03009058|537107099|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
148897360|NCT03221556|537107102|FG000|Allocation|post-randomization exclusion|0|||
148897361|NCT03221556|537107103|FG001|Allocation|post-randomization exclusion|1|||
148897362|NCT03221556|537107102|FG000|Follow-Up|Withdrawal by Subject|0|||
148897363|NCT03221556|537107103|FG001|Follow-Up|Withdrawal by Subject|1|||
148897364|NCT01300728|537107106|FG000|Overall Study|Withdrawal by Subject|1|||
148897365|NCT01300728|537107107|FG001|Overall Study|Withdrawal by Subject|1|||
148897366|NCT01300728|537107106|FG000|Overall Study|Physician Decision|1|||
148897367|NCT01300728|537107107|FG001|Overall Study|Physician Decision|0|||
148897368|NCT01247324|537107108|FG000|Overall Study|Death|6|||
148897369|NCT01247324|537107109|FG001|Overall Study|Death|10|||
148897370|NCT01247324|537107108|FG000|Overall Study|Physician Decision|2|||
148897371|NCT01247324|537107109|FG001|Overall Study|Physician Decision|3|||
148897372|NCT01247324|537107108|FG000|Overall Study|Non-compliance with study drug|3|||
148897373|NCT01247324|537107109|FG001|Overall Study|Non-compliance with study drug|0|||
148897374|NCT01247324|537107108|FG000|Overall Study|Lack of Efficacy|24|||
148897375|NCT01247324|537107109|FG001|Overall Study|Lack of Efficacy|14|||
148897376|NCT01247324|537107108|FG000|Overall Study|Non-compliance|3|||
148897377|NCT01247324|537107109|FG001|Overall Study|Non-compliance|2|||
148897378|NCT01247324|537107108|FG000|Overall Study|Pregnancy|5|||
148897379|NCT01247324|537107109|FG001|Overall Study|Pregnancy|10|||
148897380|NCT01247324|537107108|FG000|Overall Study|Protocol Violation|1|||
148897381|NCT01247324|537107109|FG001|Overall Study|Protocol Violation|1|||
148897382|NCT01247324|537107108|FG000|Overall Study|Reason not specified|42|||
148897383|NCT01247324|537107109|FG001|Overall Study|Reason not specified|32|||
149137555|NCT03823404|537985153|FG002|Overall Study|Withdrawal by Subject|35|||
148897384|NCT01247324|537107108|FG000|Overall Study|Consent withdrawn by participant|41|||
148897385|NCT01247324|537107109|FG001|Overall Study|Consent withdrawn by participant|56|||
148897386|NCT01247324|537107108|FG000|Overall Study|Adverse Event|49|||
148897387|NCT01247324|537107109|FG001|Overall Study|Adverse Event|35|||
148897388|NCT01247324|537107108|FG000|Overall Study|Lost to Follow-up|3|||
148897389|NCT01247324|537107109|FG001|Overall Study|Lost to Follow-up|6|||
148897390|NCT01247324|537107108|FG000|Overall Study|Study Terminated by Sponsor|4|||
148897391|NCT01247324|537107109|FG001|Overall Study|Study Terminated by Sponsor|1|||
148897392|NCT01247324|537107108|FG000|Overall Study|Missing|2|||
148897393|NCT01247324|537107109|FG001|Overall Study|Missing|1|||
149137556|NCT03823404|537985151|FG000|Overall Study|Death|4|||
148897394|NCT00301808|537107117|FG000|Overall Study|Adverse Event|5|||
148897395|NCT00301808|537107117|FG000|Overall Study|Death|3|||
148897396|NCT00301808|537107117|FG000|Overall Study|Lack of Efficacy|4|||
148897397|NCT02234843|537107118|FG000|Overall Study|Death|1|||
149137557|NCT03823404|537985152|FG001|Overall Study|Death|0|||
148797974|NCT00104052|536738780|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
148797975|NCT03652818|536738784|FG000|Overall Study|Adverse Event|1|||
148797976|NCT03652818|536738785|FG001|Overall Study|Adverse Event|0|||
148797977|NCT03652818|536738786|FG002|Overall Study|Adverse Event|0|||
148797978|NCT03652818|536738787|FG003|Overall Study|Adverse Event|0|||
148797979|NCT03652818|536738788|FG004|Overall Study|Adverse Event|0|||
148797980|NCT03652818|536738784|FG000|Overall Study|Physician Decision|1|||
148797981|NCT03652818|536738785|FG001|Overall Study|Physician Decision|0|||
148797982|NCT03652818|536738786|FG002|Overall Study|Physician Decision|0|||
148797983|NCT03652818|536738787|FG003|Overall Study|Physician Decision|0|||
148797984|NCT03652818|536738788|FG004|Overall Study|Physician Decision|0|||
148797985|NCT03652818|536738784|FG000|Overall Study|Lost to Follow-up|0|||
148797986|NCT03652818|536738785|FG001|Overall Study|Lost to Follow-up|1|||
148797987|NCT03652818|536738786|FG002|Overall Study|Lost to Follow-up|2|||
148797988|NCT03652818|536738787|FG003|Overall Study|Lost to Follow-up|1|||
148797989|NCT03652818|536738788|FG004|Overall Study|Lost to Follow-up|1|||
148797990|NCT03964207|536738789|FG000|First Treatment|Withdrawal by Subject|1|||
148797991|NCT03964207|536738790|FG001|First Treatment|Withdrawal by Subject|2|||
148797992|NCT03964207|536738789|FG000|First Treatment|Protocol Violation|1|||
148797993|NCT03964207|536738790|FG001|First Treatment|Protocol Violation|0|||
148797994|NCT03964207|536738789|FG000|First Treatment|Lost to Follow-up|1|||
148797995|NCT03964207|536738790|FG001|First Treatment|Lost to Follow-up|0|||
148797996|NCT03964207|536738789|FG000|Second Treatment|Lost to Follow-up|0|||
148797997|NCT03964207|536738790|FG001|Second Treatment|Lost to Follow-up|1|||
148797998|NCT03964207|536738789|FG000|Second Treatment|Adverse Event|1|||
148797999|NCT03964207|536738790|FG001|Second Treatment|Adverse Event|2|||
148798000|NCT00830219|536738791|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
148798001|NCT00830219|536738792|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
148798002|NCT01241279|536738797|FG000|Overall Study|Lost to Follow-up|0|||
148798003|NCT01241279|536738798|FG001|Overall Study|Lost to Follow-up|1|||
148798004|NCT00239720|536738802|FG000|Overall Study|Adverse Event|1|||
148798005|NCT00239720|536738803|FG001|Overall Study|Adverse Event|0|||
148798006|NCT00239720|536738802|FG000|Overall Study|Lost to Follow-up|0|||
148798007|NCT00239720|536738803|FG001|Overall Study|Lost to Follow-up|1|||
148798008|NCT00126594|536738805|FG000|Overall Study|Ineligible|2|||
148798009|NCT00126594|536738806|FG001|Overall Study|Ineligible|0|||
148798010|NCT00126594|536738805|FG000|Overall Study|Withdrawal by Subject|0|||
148798011|NCT00126594|536738806|FG001|Overall Study|Withdrawal by Subject|4|||
148798012|NCT00126594|536738805|FG000|Overall Study|Physician Decision|1|||
148798013|NCT00126594|536738806|FG001|Overall Study|Physician Decision|3|||
148798014|NCT00126594|536738805|FG000|Overall Study|Adverse Event|7|||
148798015|NCT00126594|536738806|FG001|Overall Study|Adverse Event|5|||
148798016|NCT00126594|536738805|FG000|Overall Study|Non-compliance|0|||
148798017|NCT00126594|536738806|FG001|Overall Study|Non-compliance|1|||
148798018|NCT00126594|536738805|FG000|Overall Study|Disease Progression|29|||
148798019|NCT00126594|536738806|FG001|Overall Study|Disease Progression|24|||
148798020|NCT00468585|536738807|FG000|Overall Study|Patient not treated|1|||
148798021|NCT00468585|536738808|FG001|Overall Study|Patient not treated|0|||
148798022|NCT00468585|536738809|FG002|Overall Study|Patient not treated|1|||
148798023|NCT00468585|536738810|FG003|Overall Study|Patient not treated|0|||
148798024|NCT00468585|536738807|FG000|Overall Study|Patient found to be ineligible|0|||
148798025|NCT00468585|536738808|FG001|Overall Study|Patient found to be ineligible|0|||
148798026|NCT00468585|536738809|FG002|Overall Study|Patient found to be ineligible|1|||
148798027|NCT00468585|536738810|FG003|Overall Study|Patient found to be ineligible|0|||
148798028|NCT00468585|536738807|FG000|Overall Study|Adverse Event|0|||
148798029|NCT00468585|536738808|FG001|Overall Study|Adverse Event|0|||
148798030|NCT00468585|536738809|FG002|Overall Study|Adverse Event|1|||
148798031|NCT00468585|536738810|FG003|Overall Study|Adverse Event|0|||
148798032|NCT00468585|536738807|FG000|Overall Study|Withdrawal by Subject|0|||
148798033|NCT00468585|536738808|FG001|Overall Study|Withdrawal by Subject|0|||
148798034|NCT00468585|536738809|FG002|Overall Study|Withdrawal by Subject|2|||
148798035|NCT00468585|536738810|FG003|Overall Study|Withdrawal by Subject|1|||
148798036|NCT03769649|536738811|FG000|Overall Study|Lost to Follow-up|4|||
148798037|NCT00731822|536738815|FG000|Overall Study|Adverse Event|2|||
148798038|NCT00731822|536738816|FG001|Overall Study|Adverse Event|1|||
148798039|NCT00731822|536738815|FG000|Overall Study|Protocol Violation|1|||
148798040|NCT00731822|536738816|FG001|Overall Study|Protocol Violation|0|||
148798041|NCT00731822|536738815|FG000|Overall Study|Lost to Follow-up|1|||
148798042|NCT00731822|536738816|FG001|Overall Study|Lost to Follow-up|0|||
148798043|NCT02127658|536738817|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
148798044|NCT02127658|536738818|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
148798045|NCT02127658|536738817|FG000|Overall Study|Withdrawal by Subject|0|||
148798046|NCT02127658|536738818|FG001|Overall Study|Withdrawal by Subject|2|||
148798047|NCT02127658|536738817|FG000|Overall Study|Physician Decision|0|||
148798048|NCT02127658|536738818|FG001|Overall Study|Physician Decision|1|||
148798049|NCT03834493|536738819|FG000|Overall Study|Participants Ongoing|311|||
148897398|NCT02234843|537107119|FG001|Overall Study|Death|0|||
148897399|NCT02234843|537107120|FG002|Overall Study|Death|0|||
148897400|NCT02234843|537107121|FG003|Overall Study|Death|0|||
148897401|NCT02234843|537107122|FG004|Overall Study|Death|0|||
148897402|NCT02234843|537107123|FG005|Overall Study|Death|0|||
148897403|NCT02234843|537107124|FG006|Overall Study|Death|0|||
148897404|NCT02234843|537107125|FG007|Overall Study|Death|0|||
148897405|NCT02234843|537107126|FG008|Overall Study|Death|0|||
148897406|NCT02234843|537107127|FG009|Overall Study|Death|0|||
148897407|NCT02234843|537107118|FG000|Overall Study|Protocol Violation|1|||
148897408|NCT02234843|537107119|FG001|Overall Study|Protocol Violation|0|||
148897409|NCT02234843|537107120|FG002|Overall Study|Protocol Violation|1|||
148897410|NCT02234843|537107121|FG003|Overall Study|Protocol Violation|0|||
148897411|NCT02234843|537107122|FG004|Overall Study|Protocol Violation|0|||
148897412|NCT02234843|537107123|FG005|Overall Study|Protocol Violation|0|||
148897413|NCT02234843|537107124|FG006|Overall Study|Protocol Violation|0|||
148897414|NCT02234843|537107125|FG007|Overall Study|Protocol Violation|0|||
148897415|NCT02234843|537107126|FG008|Overall Study|Protocol Violation|0|||
148897416|NCT02234843|537107127|FG009|Overall Study|Protocol Violation|0|||
148897417|NCT02234843|537107118|FG000|Overall Study|Efficacy outcome reached|2|||
148897418|NCT02234843|537107119|FG001|Overall Study|Efficacy outcome reached|0|||
148897419|NCT02234843|537107120|FG002|Overall Study|Efficacy outcome reached|0|||
148897420|NCT02234843|537107121|FG003|Overall Study|Efficacy outcome reached|0|||
148897421|NCT02234843|537107122|FG004|Overall Study|Efficacy outcome reached|0|||
148897422|NCT02234843|537107123|FG005|Overall Study|Efficacy outcome reached|2|||
148897423|NCT02234843|537107124|FG006|Overall Study|Efficacy outcome reached|0|||
148897424|NCT02234843|537107125|FG007|Overall Study|Efficacy outcome reached|0|||
148897425|NCT02234843|537107126|FG008|Overall Study|Efficacy outcome reached|0|||
148897426|NCT02234843|537107127|FG009|Overall Study|Efficacy outcome reached|0|||
148897427|NCT02234843|537107118|FG000|Overall Study|Patient convenience|2|||
148897428|NCT02234843|537107119|FG001|Overall Study|Patient convenience|0|||
148897429|NCT02234843|537107120|FG002|Overall Study|Patient convenience|0|||
148897430|NCT02234843|537107121|FG003|Overall Study|Patient convenience|0|||
148897431|NCT02234843|537107122|FG004|Overall Study|Patient convenience|0|||
148897432|NCT02234843|537107123|FG005|Overall Study|Patient convenience|1|||
148897433|NCT02234843|537107124|FG006|Overall Study|Patient convenience|0|||
148897434|NCT02234843|537107125|FG007|Overall Study|Patient convenience|0|||
148897435|NCT02234843|537107126|FG008|Overall Study|Patient convenience|0|||
148897436|NCT02234843|537107127|FG009|Overall Study|Patient convenience|0|||
148897437|NCT02234843|537107118|FG000|Overall Study|Withdrawal by Subject|5|||
148897438|NCT02234843|537107119|FG001|Overall Study|Withdrawal by Subject|1|||
148897439|NCT02234843|537107120|FG002|Overall Study|Withdrawal by Subject|1|||
148897440|NCT02234843|537107121|FG003|Overall Study|Withdrawal by Subject|0|||
148897441|NCT02234843|537107122|FG004|Overall Study|Withdrawal by Subject|0|||
148897442|NCT02234843|537107123|FG005|Overall Study|Withdrawal by Subject|7|||
148897443|NCT02234843|537107124|FG006|Overall Study|Withdrawal by Subject|0|||
148897444|NCT02234843|537107125|FG007|Overall Study|Withdrawal by Subject|0|||
148897445|NCT02234843|537107126|FG008|Overall Study|Withdrawal by Subject|0|||
148897446|NCT02234843|537107127|FG009|Overall Study|Withdrawal by Subject|0|||
148897447|NCT02234843|537107118|FG000|Overall Study|Recovery|1|||
148897448|NCT02234843|537107119|FG001|Overall Study|Recovery|0|||
148897449|NCT02234843|537107120|FG002|Overall Study|Recovery|0|||
148897450|NCT02234843|537107121|FG003|Overall Study|Recovery|0|||
148897451|NCT02234843|537107122|FG004|Overall Study|Recovery|0|||
148897452|NCT02234843|537107123|FG005|Overall Study|Recovery|0|||
148897453|NCT02234843|537107124|FG006|Overall Study|Recovery|0|||
148897454|NCT02234843|537107125|FG007|Overall Study|Recovery|0|||
148897455|NCT02234843|537107126|FG008|Overall Study|Recovery|0|||
148897456|NCT02234843|537107127|FG009|Overall Study|Recovery|0|||
148897457|NCT02234843|537107118|FG000|Overall Study|Other|0|||
148897458|NCT02234843|537107119|FG001|Overall Study|Other|2|||
148897459|NCT02234843|537107120|FG002|Overall Study|Other|0|||
148897460|NCT02234843|537107121|FG003|Overall Study|Other|1|||
148897461|NCT02234843|537107122|FG004|Overall Study|Other|0|||
148897462|NCT02234843|537107123|FG005|Overall Study|Other|1|||
148897463|NCT02234843|537107124|FG006|Overall Study|Other|0|||
148897464|NCT02234843|537107125|FG007|Overall Study|Other|1|||
149011473|NCT02778399|537521471|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
149137558|NCT03823404|537985153|FG002|Overall Study|Death|0|||
148897465|NCT02234843|537107126|FG008|Overall Study|Other|0|||
148897466|NCT02234843|537107127|FG009|Overall Study|Other|0|||
148897467|NCT02234843|537107118|FG000|Overall Study|Physician Decision|4|||
148897468|NCT02234843|537107119|FG001|Overall Study|Physician Decision|1|||
148897469|NCT02234843|537107120|FG002|Overall Study|Physician Decision|0|||
148897470|NCT02234843|537107121|FG003|Overall Study|Physician Decision|1|||
148897471|NCT02234843|537107122|FG004|Overall Study|Physician Decision|0|||
148897472|NCT02234843|537107123|FG005|Overall Study|Physician Decision|0|||
148897473|NCT02234843|537107124|FG006|Overall Study|Physician Decision|0|||
148897474|NCT02234843|537107125|FG007|Overall Study|Physician Decision|1|||
148897475|NCT02234843|537107126|FG008|Overall Study|Physician Decision|0|||
148897476|NCT02234843|537107127|FG009|Overall Study|Physician Decision|0|||
148897477|NCT02234843|537107118|FG000|Overall Study|Adverse Event|5|||
148897478|NCT02234843|537107119|FG001|Overall Study|Adverse Event|1|||
148897479|NCT02234843|537107120|FG002|Overall Study|Adverse Event|1|||
148897480|NCT02234843|537107121|FG003|Overall Study|Adverse Event|3|||
148897481|NCT02234843|537107122|FG004|Overall Study|Adverse Event|2|||
148897482|NCT02234843|537107123|FG005|Overall Study|Adverse Event|1|||
148897483|NCT02234843|537107124|FG006|Overall Study|Adverse Event|0|||
148897484|NCT02234843|537107125|FG007|Overall Study|Adverse Event|0|||
148897485|NCT02234843|537107126|FG008|Overall Study|Adverse Event|1|||
148897486|NCT02234843|537107127|FG009|Overall Study|Adverse Event|0|||
148897487|NCT02234843|537107118|FG000|Overall Study|Non-compliance with study drug|1|||
148897488|NCT02234843|537107119|FG001|Overall Study|Non-compliance with study drug|0|||
148897489|NCT02234843|537107120|FG002|Overall Study|Non-compliance with study drug|0|||
148897490|NCT02234843|537107121|FG003|Overall Study|Non-compliance with study drug|0|||
148897491|NCT02234843|537107122|FG004|Overall Study|Non-compliance with study drug|0|||
148897492|NCT02234843|537107123|FG005|Overall Study|Non-compliance with study drug|1|||
148897493|NCT02234843|537107124|FG006|Overall Study|Non-compliance with study drug|1|||
148897494|NCT02234843|537107125|FG007|Overall Study|Non-compliance with study drug|0|||
148897495|NCT02234843|537107126|FG008|Overall Study|Non-compliance with study drug|0|||
148897496|NCT02234843|537107127|FG009|Overall Study|Non-compliance with study drug|0|||
148897497|NCT02234843|537107118|FG000|Overall Study|Lost to Follow-up|0|||
148897498|NCT02234843|537107119|FG001|Overall Study|Lost to Follow-up|1|||
148897499|NCT02234843|537107120|FG002|Overall Study|Lost to Follow-up|0|||
148897500|NCT02234843|537107121|FG003|Overall Study|Lost to Follow-up|0|||
148897501|NCT02234843|537107122|FG004|Overall Study|Lost to Follow-up|0|||
148897502|NCT02234843|537107123|FG005|Overall Study|Lost to Follow-up|0|||
148897503|NCT02234843|537107124|FG006|Overall Study|Lost to Follow-up|1|||
148897504|NCT02234843|537107125|FG007|Overall Study|Lost to Follow-up|0|||
148897505|NCT02234843|537107126|FG008|Overall Study|Lost to Follow-up|0|||
148897506|NCT02234843|537107127|FG009|Overall Study|Lost to Follow-up|0|||
148897507|NCT00506350|537107128|FG000|Overall Study|Serious Adverse Event|1|||
148897508|NCT00506350|537107129|FG001|Overall Study|Serious Adverse Event|0|||
148897509|NCT00506350|537107130|FG002|Overall Study|Serious Adverse Event|0|||
149137559|NCT03823404|537985151|FG000|Overall Study|Other: Various reasons provided|5|||
149137560|NCT03823404|537985152|FG001|Overall Study|Other: Various reasons provided|5|||
149137561|NCT03823404|537985153|FG002|Overall Study|Other: Various reasons provided|6|||
149137562|NCT03631667|537985154|FG000|Overall Study|Withdrawal by Subject|3|||
149137563|NCT01835015|537985157|FG000|Overall Study|Adverse Event|0|||
149137564|NCT01835015|537985158|FG001|Overall Study|Adverse Event|0|||
149137565|NCT01835015|537985159|FG002|Overall Study|Adverse Event|1|||
149137566|NCT01835015|537985160|FG003|Overall Study|Adverse Event|0|||
148897510|NCT00506350|537107131|FG003|Overall Study|Serious Adverse Event|0|||
148897511|NCT00506350|537107132|FG004|Overall Study|Serious Adverse Event|0|||
148897512|NCT00506350|537107133|FG005|Overall Study|Serious Adverse Event|0|||
148897513|NCT00506350|537107134|FG006|Overall Study|Serious Adverse Event|0|||
148897514|NCT00506350|537107135|FG007|Overall Study|Serious Adverse Event|0|||
148897515|NCT00506350|537107136|FG008|Overall Study|Serious Adverse Event|0|||
148897516|NCT00506350|537107128|FG000|Overall Study|Adverse Event|0|||
148897517|NCT00506350|537107129|FG001|Overall Study|Adverse Event|0|||
148897518|NCT00506350|537107130|FG002|Overall Study|Adverse Event|0|||
148897519|NCT00506350|537107131|FG003|Overall Study|Adverse Event|0|||
148897520|NCT00506350|537107132|FG004|Overall Study|Adverse Event|0|||
148897521|NCT00506350|537107133|FG005|Overall Study|Adverse Event|0|||
148897522|NCT00506350|537107134|FG006|Overall Study|Adverse Event|0|||
148897523|NCT00506350|537107135|FG007|Overall Study|Adverse Event|1|||
148897524|NCT00506350|537107136|FG008|Overall Study|Adverse Event|1|||
148897525|NCT00506350|537107128|FG000|Overall Study|Protocol Violation|0|||
148897526|NCT00506350|537107129|FG001|Overall Study|Protocol Violation|0|||
148897527|NCT00506350|537107130|FG002|Overall Study|Protocol Violation|1|||
148897528|NCT00506350|537107131|FG003|Overall Study|Protocol Violation|0|||
148897529|NCT00506350|537107132|FG004|Overall Study|Protocol Violation|0|||
148897530|NCT00506350|537107133|FG005|Overall Study|Protocol Violation|0|||
148897531|NCT00506350|537107134|FG006|Overall Study|Protocol Violation|1|||
149137567|NCT01835015|537985161|FG004|Overall Study|Adverse Event|0|||
149137568|NCT03678103|537985165|FG000|Overall Study|Withdrawn prior to completion|4|||
149137569|NCT01241552|537985167|FG000|Overall Study|Lack of Efficacy|1|||
149137570|NCT01241552|537985168|FG001|Overall Study|Lack of Efficacy|0|||
149137571|NCT01241552|537985169|FG002|Overall Study|Lack of Efficacy|0|||
149137572|NCT01241552|537985170|FG003|Overall Study|Lack of Efficacy|0|||
149137573|NCT01241552|537985167|FG000|Overall Study|Death|26|||
149137574|NCT01241552|537985168|FG001|Overall Study|Death|30|||
148897532|NCT00506350|537107135|FG007|Overall Study|Protocol Violation|0|||
148897533|NCT00506350|537107136|FG008|Overall Study|Protocol Violation|0|||
148897534|NCT00506350|537107128|FG000|Overall Study|Withdrawal by Subject|0|||
148897535|NCT00506350|537107129|FG001|Overall Study|Withdrawal by Subject|1|||
148897536|NCT00506350|537107130|FG002|Overall Study|Withdrawal by Subject|1|||
148897537|NCT00506350|537107131|FG003|Overall Study|Withdrawal by Subject|1|||
148897538|NCT00506350|537107132|FG004|Overall Study|Withdrawal by Subject|4|||
148897539|NCT00506350|537107133|FG005|Overall Study|Withdrawal by Subject|1|||
148897540|NCT00506350|537107134|FG006|Overall Study|Withdrawal by Subject|1|||
148897541|NCT00506350|537107135|FG007|Overall Study|Withdrawal by Subject|2|||
148897542|NCT00506350|537107136|FG008|Overall Study|Withdrawal by Subject|0|||
148897543|NCT00506350|537107128|FG000|Overall Study|Lost to Follow-up|1|||
148897544|NCT00506350|537107129|FG001|Overall Study|Lost to Follow-up|1|||
148897545|NCT00506350|537107130|FG002|Overall Study|Lost to Follow-up|1|||
148897546|NCT00506350|537107131|FG003|Overall Study|Lost to Follow-up|1|||
148897547|NCT00506350|537107132|FG004|Overall Study|Lost to Follow-up|2|||
148897548|NCT00506350|537107133|FG005|Overall Study|Lost to Follow-up|1|||
148897549|NCT00506350|537107134|FG006|Overall Study|Lost to Follow-up|0|||
148897550|NCT00506350|537107135|FG007|Overall Study|Lost to Follow-up|0|||
148897551|NCT00506350|537107136|FG008|Overall Study|Lost to Follow-up|2|||
148897552|NCT00506350|537107128|FG000|Overall Study|Medical Reason|0|||
148897553|NCT00506350|537107129|FG001|Overall Study|Medical Reason|0|||
148897554|NCT00506350|537107130|FG002|Overall Study|Medical Reason|0|||
148897555|NCT00506350|537107131|FG003|Overall Study|Medical Reason|0|||
148897556|NCT00506350|537107132|FG004|Overall Study|Medical Reason|1|||
148897557|NCT00506350|537107133|FG005|Overall Study|Medical Reason|0|||
148897558|NCT00506350|537107134|FG006|Overall Study|Medical Reason|0|||
148897559|NCT00506350|537107135|FG007|Overall Study|Medical Reason|0|||
148897560|NCT00506350|537107136|FG008|Overall Study|Medical Reason|0|||
148897561|NCT00506350|537107128|FG000|Overall Study|Other|1|||
148897562|NCT00506350|537107129|FG001|Overall Study|Other|1|||
148897563|NCT00506350|537107130|FG002|Overall Study|Other|3|||
148897564|NCT00506350|537107131|FG003|Overall Study|Other|0|||
148897565|NCT00506350|537107132|FG004|Overall Study|Other|3|||
148897566|NCT00506350|537107133|FG005|Overall Study|Other|0|||
148897567|NCT00506350|537107134|FG006|Overall Study|Other|0|||
148897568|NCT00506350|537107135|FG007|Overall Study|Other|2|||
148897569|NCT00506350|537107136|FG008|Overall Study|Other|2|||
148897570|NCT03474588|537107137|FG000|Overall Study|Withdrawal by Subject|4|||
148897571|NCT03474588|537107138|FG001|Overall Study|Withdrawal by Subject|3|||
148897572|NCT03474588|537107137|FG000|Overall Study|Death|0|||
148897573|NCT03474588|537107138|FG001|Overall Study|Death|1|||
148897574|NCT01691794|537107140|FG000|Overall Study|Poor/Non-Compliance|1|||
148897575|NCT01691794|537107141|FG001|Overall Study|Poor/Non-Compliance|4|||
148897576|NCT01691794|537107142|FG002|Overall Study|Poor/Non-Compliance|1|||
148897577|NCT01691794|537107140|FG000|Overall Study|Death|0|||
148897578|NCT01691794|537107141|FG001|Overall Study|Death|0|||
148897579|NCT01691794|537107142|FG002|Overall Study|Death|1|||
148897580|NCT01691794|537107140|FG000|Overall Study|Lack of Efficacy|0|||
148897581|NCT01691794|537107141|FG001|Overall Study|Lack of Efficacy|7|||
148897582|NCT01691794|537107142|FG002|Overall Study|Lack of Efficacy|1|||
148897583|NCT01691794|537107140|FG000|Overall Study|Participant request to discontinue|0|||
148897584|NCT01691794|537107141|FG001|Overall Study|Participant request to discontinue|1|||
148897585|NCT01691794|537107142|FG002|Overall Study|Participant request to discontinue|0|||
148897586|NCT01691794|537107140|FG000|Overall Study|Adverse Event|0|||
148897587|NCT01691794|537107141|FG001|Overall Study|Adverse Event|1|||
148897588|NCT01691794|537107142|FG002|Overall Study|Adverse Event|1|||
148897589|NCT01691794|537107140|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
149137575|NCT01241552|537985169|FG002|Overall Study|Death|20|||
149137576|NCT01241552|537985170|FG003|Overall Study|Death|25|||
149137577|NCT01241552|537985167|FG000|Overall Study|Adverse Event|1|||
149137578|NCT01241552|537985168|FG001|Overall Study|Adverse Event|1|||
149137579|NCT01241552|537985169|FG002|Overall Study|Adverse Event|0|||
149137580|NCT01241552|537985170|FG003|Overall Study|Adverse Event|0|||
149137581|NCT01241552|537985167|FG000|Overall Study|Technical Problems|2|||
149137582|NCT01241552|537985168|FG001|Overall Study|Technical Problems|0|||
149137583|NCT01241552|537985169|FG002|Overall Study|Technical Problems|2|||
149137584|NCT01241552|537985170|FG003|Overall Study|Technical Problems|2|||
149137585|NCT01241552|537985167|FG000|Overall Study|Progressive Disease|0|||
149137586|NCT01241552|537985168|FG001|Overall Study|Progressive Disease|0|||
149137587|NCT01241552|537985169|FG002|Overall Study|Progressive Disease|1|||
149137588|NCT01241552|537985170|FG003|Overall Study|Progressive Disease|2|||
149137589|NCT01241552|537985167|FG000|Overall Study|Protocol Violation|0|||
149137590|NCT01241552|537985168|FG001|Overall Study|Protocol Violation|2|||
148897590|NCT01691794|537107141|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
148897591|NCT01691794|537107142|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
148897592|NCT01691794|537107140|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
148897593|NCT01691794|537107141|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
148897594|NCT01691794|537107142|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
148897595|NCT04972786|537107143|FG000|First Intervention (1 Day)|Adverse Event|1|||
148897596|NCT04972786|537107144|FG001|First Intervention (1 Day)|Adverse Event|0|||
148897597|NCT00844844|537107145|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
148897598|NCT00844844|537107145|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
148897599|NCT00844844|537107145|FG000|Extension Treatment Period|Adverse Event|2|||
148897600|NCT00844844|537107145|FG000|Post Treatment Period|Withdrawal by Subject|1|||
149137591|NCT01241552|537985169|FG002|Overall Study|Protocol Violation|6|||
148897601|NCT00945009|537107148|FG000|Overall Study|Lack of Efficacy|10|||
149137592|NCT01241552|537985170|FG003|Overall Study|Protocol Violation|1|||
148897602|NCT00945009|537107149|FG001|Overall Study|Lack of Efficacy|0|||
148897603|NCT00945009|537107150|FG002|Overall Study|Lack of Efficacy|0|||
148897604|NCT00945009|537107148|FG000|Overall Study|Physician Decision|21|||
148897605|NCT00945009|537107149|FG001|Overall Study|Physician Decision|4|||
148897606|NCT00945009|537107150|FG002|Overall Study|Physician Decision|3|||
148897607|NCT00945009|537107148|FG000|Overall Study|Protocol Violation|6|||
148897608|NCT00945009|537107149|FG001|Overall Study|Protocol Violation|1|||
148897609|NCT00945009|537107150|FG002|Overall Study|Protocol Violation|0|||
148897610|NCT00945009|537107148|FG000|Overall Study|Withdrawal by Subject|1|||
148897611|NCT00945009|537107149|FG001|Overall Study|Withdrawal by Subject|0|||
148897612|NCT00945009|537107150|FG002|Overall Study|Withdrawal by Subject|0|||
148897613|NCT00945009|537107148|FG000|Overall Study|Ineligible|6|||
148897614|NCT00945009|537107149|FG001|Overall Study|Ineligible|1|||
148897615|NCT00945009|537107150|FG002|Overall Study|Ineligible|0|||
148897616|NCT00945009|537107148|FG000|Overall Study|Inevaluable|0|||
148897617|NCT00945009|537107149|FG001|Overall Study|Inevaluable|1|||
148897618|NCT00945009|537107150|FG002|Overall Study|Inevaluable|0|||
148897619|NCT00945009|537107148|FG000|Overall Study|Refusal of further protocol|1|||
148897620|NCT00945009|537107149|FG001|Overall Study|Refusal of further protocol|0|||
148897621|NCT00945009|537107150|FG002|Overall Study|Refusal of further protocol|0|||
148897622|NCT04886154|537107151|FG000|Overall Study|Adverse Event|0|||
148897623|NCT04886154|537107152|FG001|Overall Study|Adverse Event|0|||
148897624|NCT04886154|537107153|FG002|Overall Study|Adverse Event|0|||
148897625|NCT04886154|537107154|FG003|Overall Study|Adverse Event|0|||
148897626|NCT04886154|537107155|FG004|Overall Study|Adverse Event|1|||
148897627|NCT04886154|537107156|FG005|Overall Study|Adverse Event|0|||
148897628|NCT04886154|537107157|FG006|Overall Study|Adverse Event|0|||
148897629|NCT04886154|537107158|FG007|Overall Study|Adverse Event|1|||
148897630|NCT04886154|537107159|FG008|Overall Study|Adverse Event|1|||
148897631|NCT04886154|537107160|FG009|Overall Study|Adverse Event|0|||
148897632|NCT04886154|537107161|FG010|Overall Study|Adverse Event|0|||
148897633|NCT04886154|537107162|FG011|Overall Study|Adverse Event|1|||
148897634|NCT04886154|537107163|FG012|Overall Study|Adverse Event|0|||
148897635|NCT04886154|537107164|FG013|Overall Study|Adverse Event|0|||
148897636|NCT04886154|537107165|FG014|Overall Study|Adverse Event|3|||
148897637|NCT04886154|537107151|FG000|Overall Study|Lost to Follow-up|1|||
148897638|NCT04886154|537107152|FG001|Overall Study|Lost to Follow-up|0|||
148897639|NCT04886154|537107153|FG002|Overall Study|Lost to Follow-up|2|||
148897640|NCT04886154|537107154|FG003|Overall Study|Lost to Follow-up|0|||
148897641|NCT04886154|537107155|FG004|Overall Study|Lost to Follow-up|17|||
148897642|NCT04886154|537107156|FG005|Overall Study|Lost to Follow-up|7|||
148897643|NCT04886154|537107157|FG006|Overall Study|Lost to Follow-up|8|||
148897644|NCT04886154|537107158|FG007|Overall Study|Lost to Follow-up|7|||
148897645|NCT04886154|537107159|FG008|Overall Study|Lost to Follow-up|8|||
148897646|NCT04886154|537107160|FG009|Overall Study|Lost to Follow-up|0|||
148897647|NCT04886154|537107161|FG010|Overall Study|Lost to Follow-up|2|||
148897648|NCT04886154|537107162|FG011|Overall Study|Lost to Follow-up|0|||
148897649|NCT04886154|537107163|FG012|Overall Study|Lost to Follow-up|0|||
148897650|NCT04886154|537107164|FG013|Overall Study|Lost to Follow-up|0|||
148897651|NCT04886154|537107165|FG014|Overall Study|Lost to Follow-up|0|||
148897652|NCT04886154|537107151|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897653|NCT04886154|537107152|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897654|NCT04886154|537107153|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148798050|NCT03834493|536738820|FG001|Overall Study|Participants Ongoing|324|||
148798051|NCT03834493|536738819|FG000|Overall Study|Withdrawal by Subject|20|||
148798052|NCT03834493|536738820|FG001|Overall Study|Withdrawal by Subject|17|||
148798053|NCT03834493|536738819|FG000|Overall Study|Physician Decision|1|||
148798054|NCT03834493|536738820|FG001|Overall Study|Physician Decision|0|||
148798055|NCT03834493|536738819|FG000|Overall Study|Death|289|||
148798056|NCT03834493|536738820|FG001|Overall Study|Death|282|||
148798057|NCT04144322|536738822|FG000|Overall Study|Lack of Efficacy|2|||
148798058|NCT04144322|536738823|FG001|Overall Study|Lack of Efficacy|2|||
148798059|NCT02277028|536738824|FG000|Overall Study|Lost to Follow-up|1|||
148798060|NCT02277028|536738825|FG001|Overall Study|Lost to Follow-up|0|||
148897655|NCT04886154|537107154|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897656|NCT04886154|537107155|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897657|NCT04886154|537107156|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897658|NCT04886154|537107157|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
148897659|NCT04886154|537107158|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897660|NCT04886154|537107159|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897661|NCT04886154|537107160|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897662|NCT04886154|537107161|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897663|NCT04886154|537107162|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897664|NCT04886154|537107163|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897665|NCT04886154|537107164|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897666|NCT04886154|537107165|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
148897667|NCT04886154|537107151|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897668|NCT04886154|537107152|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897669|NCT04886154|537107153|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897670|NCT04886154|537107154|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897671|NCT04886154|537107155|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148897672|NCT04886154|537107156|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897673|NCT04886154|537107157|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
148897674|NCT04886154|537107158|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148897675|NCT04886154|537107159|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897676|NCT04886154|537107160|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897677|NCT04886154|537107161|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897678|NCT04886154|537107162|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897679|NCT04886154|537107163|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897680|NCT04886154|537107164|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148897681|NCT04886154|537107165|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148897682|NCT04886154|537107151|FG000|Overall Study|Other, Not Specified|0|||
148897683|NCT04886154|537107152|FG001|Overall Study|Other, Not Specified|0|||
148897684|NCT04886154|537107153|FG002|Overall Study|Other, Not Specified|0|||
148897685|NCT04886154|537107154|FG003|Overall Study|Other, Not Specified|0|||
148897686|NCT04886154|537107155|FG004|Overall Study|Other, Not Specified|11|||
148897687|NCT04886154|537107156|FG005|Overall Study|Other, Not Specified|8|||
148897688|NCT04886154|537107157|FG006|Overall Study|Other, Not Specified|9|||
148897689|NCT04886154|537107158|FG007|Overall Study|Other, Not Specified|10|||
148897690|NCT04886154|537107159|FG008|Overall Study|Other, Not Specified|6|||
148897691|NCT04886154|537107160|FG009|Overall Study|Other, Not Specified|1|||
148897692|NCT04886154|537107161|FG010|Overall Study|Other, Not Specified|1|||
148897693|NCT04886154|537107162|FG011|Overall Study|Other, Not Specified|2|||
148897694|NCT04886154|537107163|FG012|Overall Study|Other, Not Specified|1|||
148897695|NCT04886154|537107164|FG013|Overall Study|Other, Not Specified|2|||
148798061|NCT02277028|536738824|FG000|Overall Study|Withdrawal by Subject|0|||
148798062|NCT02277028|536738825|FG001|Overall Study|Withdrawal by Subject|1|||
148798063|NCT02718911|536738826|FG000|Overall Study|Adverse Event|0|||
148798064|NCT02718911|536738827|FG001|Overall Study|Adverse Event|0|||
148798065|NCT02718911|536738828|FG002|Overall Study|Adverse Event|0|||
148798066|NCT02718911|536738829|FG003|Overall Study|Adverse Event|0|||
148798067|NCT02718911|536738830|FG004|Overall Study|Adverse Event|0|||
148798068|NCT02718911|536738831|FG005|Overall Study|Adverse Event|0|||
148798069|NCT02718911|536738832|FG006|Overall Study|Adverse Event|0|||
148798070|NCT02718911|536738833|FG007|Overall Study|Adverse Event|0|||
148798071|NCT02718911|536738834|FG008|Overall Study|Adverse Event|0|||
148798072|NCT02718911|536738835|FG009|Overall Study|Adverse Event|2|||
148798073|NCT02718911|536738826|FG000|Overall Study|Death|2|||
148798074|NCT02718911|536738827|FG001|Overall Study|Death|3|||
148798075|NCT02718911|536738828|FG002|Overall Study|Death|1|||
148798076|NCT02718911|536738829|FG003|Overall Study|Death|0|||
148798077|NCT02718911|536738830|FG004|Overall Study|Death|1|||
148798078|NCT02718911|536738831|FG005|Overall Study|Death|3|||
148798079|NCT02718911|536738832|FG006|Overall Study|Death|1|||
148798080|NCT02718911|536738833|FG007|Overall Study|Death|1|||
148798081|NCT02718911|536738834|FG008|Overall Study|Death|4|||
148897696|NCT04886154|537107165|FG014|Overall Study|Other, Not Specified|3|||
148897697|NCT03919773|537107174|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
148798082|NCT02718911|536738835|FG009|Overall Study|Death|3|||
148798083|NCT02718911|536738826|FG000|Overall Study|Lost to Follow-up|0|||
148798084|NCT02718911|536738827|FG001|Overall Study|Lost to Follow-up|0|||
148798085|NCT02718911|536738828|FG002|Overall Study|Lost to Follow-up|0|||
148897698|NCT03919773|537107175|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
148897699|NCT03919773|537107174|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
148897700|NCT03919773|537107175|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
148897701|NCT04659044|537107176|FG000|Induction|Physician Decision|1|||
148897702|NCT04659044|537107176|FG000|Induction|Adverse Event|2|||
148897703|NCT04966013|537107177|FG000|Overall Study|Withdrawal by Subject|0|||
148897704|NCT04966013|537107178|FG001|Overall Study|Withdrawal by Subject|2|||
148897705|NCT04966013|537107179|FG002|Overall Study|Withdrawal by Subject|1|||
148897706|NCT04966013|537107177|FG000|Overall Study|Adverse Event|2|||
148897707|NCT04966013|537107178|FG001|Overall Study|Adverse Event|1|||
148897708|NCT04966013|537107179|FG002|Overall Study|Adverse Event|1|||
148897709|NCT02336282|537107186|FG000|Overall Study|Unrelated illness|1|||
148897710|NCT02336282|537107186|FG000|Overall Study|Uncomfortable with technology|1|||
148897711|NCT02336282|537107186|FG000|Overall Study|Lost to Follow-up|1|||
148897712|NCT02336282|537107186|FG000|Overall Study|Not enough time to complete sessions|2|||
148897713|NCT04875975|537107202|FG000|Overall Study|Adverse Event|1|||
148897714|NCT04875975|537107203|FG001|Overall Study|Adverse Event|2|||
148897715|NCT04875975|537107202|FG000|Overall Study|Lack of Efficacy|2|||
148897716|NCT04875975|537107203|FG001|Overall Study|Lack of Efficacy|2|||
148897717|NCT04875975|537107202|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
148897718|NCT04875975|537107203|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
148897719|NCT04875975|537107202|FG000|Overall Study|Relapse With Insults|0|||
148897720|NCT04875975|537107203|FG001|Overall Study|Relapse With Insults|1|||
148897721|NCT04875975|537107202|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
148897722|NCT04875975|537107203|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
148897723|NCT05472090|537107204|FG000|Overall Study|Adverse Event|2|||
148897724|NCT05472090|537107205|FG001|Overall Study|Adverse Event|3|||
148897725|NCT05472090|537107204|FG000|Overall Study|Lack of Efficacy|1|||
148897726|NCT05472090|537107205|FG001|Overall Study|Lack of Efficacy|0|||
148897727|NCT05472090|537107204|FG000|Overall Study|Physician Decision|1|||
148897728|NCT05472090|537107205|FG001|Overall Study|Physician Decision|0|||
148897729|NCT05472090|537107204|FG000|Overall Study|Withdrawal by Subject|2|||
148897730|NCT05472090|537107205|FG001|Overall Study|Withdrawal by Subject|0|||
148897731|NCT05472090|537107204|FG000|Overall Study|Lost to Follow-up|0|||
148897732|NCT05472090|537107205|FG001|Overall Study|Lost to Follow-up|3|||
148897733|NCT00781768|537108425|FG000|Overall Study|Not transplanted.|0|||
148897734|NCT00781768|537108426|FG001|Overall Study|Not transplanted.|2|||
148897735|NCT02458313|537108435|FG000|Overall Study|Withdrawal by Subject|6|||
148897736|NCT02458313|537108436|FG001|Overall Study|Withdrawal by Subject|8|||
148897737|NCT02458313|537108435|FG000|Overall Study|Excluded for motion during MRI|1|||
148897738|NCT02458313|537108436|FG001|Overall Study|Excluded for motion during MRI|2|||
148897739|NCT00199381|537108437|FG000|Overall Study|Withdrawal by Subject|38|||
148897740|NCT00199381|537108437|FG000|Overall Study|Adverse Event|73|||
148897741|NCT00199381|537108437|FG000|Overall Study|Protocol Violation|6|||
148897742|NCT00199381|537108437|FG000|Overall Study|Lack of Efficacy|27|||
148897743|NCT00199381|537108437|FG000|Overall Study|Not including due to early termination|37|||
148897744|NCT00199381|537108437|FG000|Overall Study|Study termination by Sponsor|323|||
148897745|NCT01775501|537108442|FG000|Overall Study|Discontinued prior to treatment|1|||
148897746|NCT02318706|537108443|FG000|Double-blind Phase|Adverse Event|7|||
148897747|NCT02318706|537108444|FG001|Double-blind Phase|Adverse Event|4|||
148897748|NCT02318706|537108445|FG002|Double-blind Phase|Adverse Event|3|||
148897749|NCT02318706|537108446|FG003|Double-blind Phase|Adverse Event|10|||
148897750|NCT02318706|537108447|FG004|Double-blind Phase|Adverse Event|0|||
148897751|NCT02318706|537108443|FG000|Double-blind Phase|Lost to Follow-up|1|||
148897752|NCT02318706|537108444|FG001|Double-blind Phase|Lost to Follow-up|0|||
148897753|NCT02318706|537108445|FG002|Double-blind Phase|Lost to Follow-up|0|||
148897754|NCT02318706|537108446|FG003|Double-blind Phase|Lost to Follow-up|0|||
148897755|NCT02318706|537108447|FG004|Double-blind Phase|Lost to Follow-up|0|||
148897756|NCT02318706|537108443|FG000|Double-blind Phase|Protocol Violation|4|||
148897757|NCT02318706|537108444|FG001|Double-blind Phase|Protocol Violation|2|||
148897758|NCT02318706|537108445|FG002|Double-blind Phase|Protocol Violation|4|||
148897759|NCT02318706|537108446|FG003|Double-blind Phase|Protocol Violation|3|||
148897760|NCT02318706|537108447|FG004|Double-blind Phase|Protocol Violation|0|||
148897761|NCT02318706|537108443|FG000|Double-blind Phase|Withdrawal by Subject|9|||
148897762|NCT02318706|537108444|FG001|Double-blind Phase|Withdrawal by Subject|5|||
148897763|NCT02318706|537108445|FG002|Double-blind Phase|Withdrawal by Subject|7|||
148897764|NCT02318706|537108446|FG003|Double-blind Phase|Withdrawal by Subject|10|||
148897765|NCT02318706|537108447|FG004|Double-blind Phase|Withdrawal by Subject|0|||
148897766|NCT02318706|537108443|FG000|Double-blind Phase|Other|4|||
148897767|NCT02318706|537108444|FG001|Double-blind Phase|Other|1|||
148897768|NCT02318706|537108445|FG002|Double-blind Phase|Other|2|||
148897769|NCT02318706|537108446|FG003|Double-blind Phase|Other|1|||
148897770|NCT02318706|537108447|FG004|Double-blind Phase|Other|0|||
148897771|NCT02318706|537108443|FG000|Double-blind Phase|Death|0|||
148897772|NCT02318706|537108444|FG001|Double-blind Phase|Death|0|||
148897773|NCT02318706|537108445|FG002|Double-blind Phase|Death|2|||
148897774|NCT02318706|537108446|FG003|Double-blind Phase|Death|0|||
148897775|NCT02318706|537108447|FG004|Double-blind Phase|Death|0|||
148897776|NCT02318706|537108443|FG000|Open-label Extension Phase|Adverse Event|0|||
148897777|NCT02318706|537108444|FG001|Open-label Extension Phase|Adverse Event|0|||
148897778|NCT02318706|537108445|FG002|Open-label Extension Phase|Adverse Event|0|||
148897779|NCT02318706|537108446|FG003|Open-label Extension Phase|Adverse Event|0|||
148897780|NCT02318706|537108447|FG004|Open-label Extension Phase|Adverse Event|21|||
148897781|NCT02318706|537108443|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
148897782|NCT02318706|537108444|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
148897783|NCT02318706|537108445|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
148897784|NCT02318706|537108446|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
148897785|NCT02318706|537108447|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
148897786|NCT02318706|537108443|FG000|Open-label Extension Phase|Death|0|||
148897787|NCT02318706|537108444|FG001|Open-label Extension Phase|Death|0|||
148897788|NCT02318706|537108445|FG002|Open-label Extension Phase|Death|0|||
148897789|NCT02318706|537108446|FG003|Open-label Extension Phase|Death|0|||
148897790|NCT02318706|537108447|FG004|Open-label Extension Phase|Death|1|||
148897791|NCT02318706|537108443|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
148897792|NCT02318706|537108444|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
148897793|NCT02318706|537108445|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
148897794|NCT02318706|537108446|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
148897795|NCT02318706|537108447|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
148897796|NCT01702311|537108448|FG000|Overall Study|Withdrawal by Subject|3|||
148897797|NCT01702311|537108449|FG001|Overall Study|Withdrawal by Subject|2|||
148897798|NCT01702311|537108448|FG000|Overall Study|Discharge less than 24 hours|10|||
148897799|NCT01702311|537108449|FG001|Overall Study|Discharge less than 24 hours|7|||
148897800|NCT01702311|537108448|FG000|Overall Study|Physician Decision|3|||
148897801|NCT01702311|537108449|FG001|Overall Study|Physician Decision|4|||
148897802|NCT03714672|537108454|FG000|Overall Study|Adverse Event|0|||
148897803|NCT03714672|537108455|FG001|Overall Study|Adverse Event|0|||
148897804|NCT03714672|537108456|FG002|Overall Study|Adverse Event|3|||
148897805|NCT03714672|537108457|FG003|Overall Study|Adverse Event|0|||
148897806|NCT03714672|537108454|FG000|Overall Study|Physician Decision|0|||
148897807|NCT03714672|537108455|FG001|Overall Study|Physician Decision|1|||
148897808|NCT03714672|537108456|FG002|Overall Study|Physician Decision|0|||
148897809|NCT03714672|537108457|FG003|Overall Study|Physician Decision|0|||
148897810|NCT03714672|537108454|FG000|Overall Study|Other Reason|1|||
148897811|NCT03714672|537108455|FG001|Overall Study|Other Reason|2|||
148897812|NCT03714672|537108456|FG002|Overall Study|Other Reason|1|||
148897813|NCT03714672|537108457|FG003|Overall Study|Other Reason|1|||
148897814|NCT03714672|537108454|FG000|Overall Study|Lost to Follow-up|1|||
148897815|NCT03714672|537108455|FG001|Overall Study|Lost to Follow-up|1|||
148897816|NCT03714672|537108456|FG002|Overall Study|Lost to Follow-up|0|||
148897817|NCT03714672|537108457|FG003|Overall Study|Lost to Follow-up|0|||
148897818|NCT01054885|537108460|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
148897819|NCT01054885|537108461|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148897820|NCT01054885|537108462|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148897821|NCT01054885|537108463|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148897822|NCT01054885|537108464|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148897823|NCT01054885|537108465|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148897824|NCT01054885|537108466|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148897825|NCT01054885|537108460|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
148897826|NCT01054885|537108461|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
148897827|NCT01054885|537108462|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
148897828|NCT01054885|537108463|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
148897829|NCT01054885|537108464|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
148897830|NCT01054885|537108465|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
148897831|NCT01054885|537108466|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
148897832|NCT01054885|537108460|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
148897833|NCT01054885|537108461|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148897834|NCT01054885|537108462|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148897835|NCT01054885|537108463|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148897836|NCT01054885|537108464|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148897837|NCT01054885|537108465|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148897838|NCT01054885|537108466|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148897839|NCT01054885|537108460|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
148897840|NCT01054885|537108461|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148897841|NCT01054885|537108462|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148897842|NCT01054885|537108463|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148897843|NCT01054885|537108464|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148897844|NCT01054885|537108465|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148897845|NCT01054885|537108466|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148897846|NCT01054885|537108460|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
148897847|NCT01054885|537108461|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
148897848|NCT01054885|537108462|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
148897849|NCT01054885|537108463|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
148897850|NCT01054885|537108464|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
148897851|NCT01054885|537108465|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
148897852|NCT01054885|537108466|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
148897853|NCT01054885|537108460|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
148897854|NCT01054885|537108461|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148897855|NCT01054885|537108462|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148897856|NCT01054885|537108463|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148897857|NCT01054885|537108464|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148897858|NCT01054885|537108465|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148897859|NCT01054885|537108466|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148897860|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
148897861|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
148897862|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
148897863|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
148897864|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
148897865|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
148897866|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
148897867|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148897868|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148897869|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
148897870|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
148897871|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148897872|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
148897873|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148897874|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
148897875|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
148897876|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
148897877|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
148897878|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
148897879|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
148897880|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
148897881|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
148897882|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
148897883|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
148897884|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
148897885|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
148897886|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
148897887|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
148897888|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
148897889|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
148897890|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
148897891|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
148897892|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
149011474|NCT02778399|537521472|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
149011475|NCT02778399|537521473|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
148897893|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
148897894|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
148897895|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
148897896|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
148897897|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
148897898|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
148897899|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
148897900|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
148897901|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
148897902|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148897903|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
148897904|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
148897905|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148897906|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148897907|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
148897908|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
148897909|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
148897910|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
148897911|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
148897912|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
148897913|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
148897914|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
148897915|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
148897916|NCT01054885|537108460|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
148897917|NCT01054885|537108461|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
148897918|NCT01054885|537108462|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
148897919|NCT01054885|537108463|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
148897920|NCT01054885|537108464|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
148897921|NCT01054885|537108465|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
148897922|NCT01054885|537108466|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
148897923|NCT00804908|537108467|FG000|Overall Study|Other|115|||
148897924|NCT00804908|537108468|FG001|Overall Study|Other|116|||
148897925|NCT00804908|537108469|FG002|Overall Study|Other|114|||
148897926|NCT01280903|537108470|FG000|Overall Study|Lost to Follow-up|23|||
148897927|NCT01280903|537108471|FG001|Overall Study|Lost to Follow-up|16|||
148897928|NCT03453164|537108472|FG000|Overall Study|Lack of Efficacy|16|||
148897929|NCT03453164|537108472|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
148897930|NCT02177695|537108475|FG000|ITT Analysis|Ineligible|5|||
148897931|NCT02177695|537108476|FG001|ITT Analysis|Ineligible|5|||
148897932|NCT02177695|537108475|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
148897933|NCT02177695|537108476|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
148897934|NCT02177695|537108475|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
148897935|NCT02177695|537108476|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
148897936|NCT02177695|537108475|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
148897937|NCT02177695|537108476|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
148897938|NCT00248625|537108479|FG000|Overall Study|Withdrawal by Subject|0|||
148897939|NCT00248625|537108480|FG001|Overall Study|Withdrawal by Subject|2|||
148897940|NCT01074502|537108483|FG000|Overall Study|Withdrawal by Subject|1|||
148897941|NCT02220920|537108491|FG000|Overall Study|Adverse Event|1|||
148897942|NCT02220920|537108492|FG001|Overall Study|Adverse Event|0|||
148897943|NCT02220920|537108491|FG000|Overall Study|Lack of Efficacy|0|||
148897944|NCT02220920|537108492|FG001|Overall Study|Lack of Efficacy|1|||
148897945|NCT02220920|537108491|FG000|Overall Study|Withdrawal by Subject|1|||
148897946|NCT02220920|537108492|FG001|Overall Study|Withdrawal by Subject|0|||
148897947|NCT02220920|537108491|FG000|Overall Study|Conflict with the stopping criteria|1|||
148897948|NCT02220920|537108492|FG001|Overall Study|Conflict with the stopping criteria|2|||
148897949|NCT05176314|537108498|FG000|Overall Study|Lost to Follow-up|2|||
148897950|NCT05176314|537108498|FG000|Overall Study|Physician Decision|1|||
149011476|NCT02778399|537521474|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
149137593|NCT01241552|537985167|FG000|Overall Study|Withdrawal by Subject|7|||
149137594|NCT01241552|537985168|FG001|Overall Study|Withdrawal by Subject|15|||
149137595|NCT01241552|537985169|FG002|Overall Study|Withdrawal by Subject|14|||
149137596|NCT01241552|537985170|FG003|Overall Study|Withdrawal by Subject|15|||
149137597|NCT01241552|537985167|FG000|Overall Study|Physician Decision|2|||
149137598|NCT01241552|537985168|FG001|Overall Study|Physician Decision|4|||
149137599|NCT01241552|537985169|FG002|Overall Study|Physician Decision|2|||
149137600|NCT01241552|537985170|FG003|Overall Study|Physician Decision|3|||
149137601|NCT01241552|537985167|FG000|Overall Study|Lost to Follow-up|2|||
149137602|NCT01241552|537985168|FG001|Overall Study|Lost to Follow-up|11|||
149137603|NCT01241552|537985169|FG002|Overall Study|Lost to Follow-up|15|||
149137604|NCT01241552|537985170|FG003|Overall Study|Lost to Follow-up|16|||
149137605|NCT05395104|537985173|FG000|Overall Study|Met Liver Stopping Criteria|1|||
149137606|NCT05395104|537985173|FG000|Overall Study|Withdrawal by Subject|1|||
148897951|NCT05176314|537108498|FG000|Overall Study|Adverse Event|1|||
148897952|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
148897953|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
148897954|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
148897955|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Death|9|||
148897956|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Death|0|||
148897957|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Death|0|||
148897958|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
148897959|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
148897960|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
148897961|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
148897962|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
148897963|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
148897964|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Other|135|||
148897965|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Other|0|||
148897966|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Other|0|||
148897967|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
148897968|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
148897969|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
148897970|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
148897971|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
148897972|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
148897973|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
148897974|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
148897975|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
148897976|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Other|3|||
148897977|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Other|0|||
148897978|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Other|0|||
148897979|NCT02118584|537108501|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
148897980|NCT02118584|537108502|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
148897981|NCT02118584|537108503|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
148897982|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
148897983|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
148897984|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
148897985|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
148897986|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
148897987|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
148897988|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
148897989|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
148897990|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
148897991|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
148897992|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
148897993|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
148897994|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
148897995|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
148897996|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
148897997|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
148897998|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
148897999|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
148898000|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
148898001|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
148898002|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
148898003|NCT02118584|537108501|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
148898004|NCT02118584|537108502|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
148898005|NCT02118584|537108503|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
148898006|NCT03103542|537108506|FG000|Overall Study|Physician Decision|2|||
148898007|NCT03103542|537108506|FG000|Overall Study|Adverse Event|2|||
148898008|NCT03103542|537108506|FG000|Overall Study|Other|2|||
148898009|NCT03103542|537108506|FG000|Overall Study|Withdrawal by Subject|1|||
148898010|NCT02939287|537108510|FG000|Overall Study|met exclusion criteria|1|||
148898011|NCT02939287|537108511|FG001|Overall Study|met exclusion criteria|1|||
148898012|NCT02939287|537108512|FG002|Overall Study|met exclusion criteria|1|||
148898013|NCT02939287|537108510|FG000|Overall Study|Did not complete survey|2|||
149137607|NCT00381563|537985174|FG000|Overall Study|Withdrawal by Subject|5|||
149137608|NCT00381563|537985175|FG001|Overall Study|Withdrawal by Subject|5|||
148898014|NCT02939287|537108511|FG001|Overall Study|Did not complete survey|2|||
148898015|NCT02939287|537108512|FG002|Overall Study|Did not complete survey|0|||
148898016|NCT02939287|537108510|FG000|Overall Study|Withdrawal by Subject|1|||
148898017|NCT02939287|537108511|FG001|Overall Study|Withdrawal by Subject|1|||
148898018|NCT02939287|537108512|FG002|Overall Study|Withdrawal by Subject|0|||
148898019|NCT01680341|537108518|FG000|Overall Study|Adverse Event|3|||
148898020|NCT01680341|537108519|FG001|Overall Study|Adverse Event|2|||
148898021|NCT01680341|537108518|FG000|Overall Study|Unclassified|18|||
148898022|NCT01680341|537108519|FG001|Overall Study|Unclassified|15|||
148898023|NCT00499486|537108521|FG000|Overall Study|Withdrawal by Subject|16|||
148898024|NCT03796728|537108522|FG000|Overall Study|Lost to Follow-up|8|||
148898025|NCT03796728|537108522|FG000|Overall Study|Reason not Specified|16|||
148898026|NCT00333775|537108523|FG000|Overall Study|Death|144|||
148798086|NCT02718911|536738829|FG003|Overall Study|Lost to Follow-up|0|||
148798087|NCT02718911|536738830|FG004|Overall Study|Lost to Follow-up|0|||
148798088|NCT02718911|536738831|FG005|Overall Study|Lost to Follow-up|0|||
148798089|NCT02718911|536738832|FG006|Overall Study|Lost to Follow-up|0|||
148798090|NCT02718911|536738833|FG007|Overall Study|Lost to Follow-up|0|||
148798091|NCT02718911|536738834|FG008|Overall Study|Lost to Follow-up|1|||
148798092|NCT02718911|536738835|FG009|Overall Study|Lost to Follow-up|0|||
148798093|NCT02718911|536738826|FG000|Overall Study|Physician Decision|2|||
148798094|NCT02718911|536738827|FG001|Overall Study|Physician Decision|0|||
148798095|NCT02718911|536738828|FG002|Overall Study|Physician Decision|1|||
148798096|NCT02718911|536738829|FG003|Overall Study|Physician Decision|1|||
148798097|NCT02718911|536738830|FG004|Overall Study|Physician Decision|0|||
148798098|NCT02718911|536738831|FG005|Overall Study|Physician Decision|0|||
148798099|NCT02718911|536738832|FG006|Overall Study|Physician Decision|0|||
148798100|NCT02718911|536738833|FG007|Overall Study|Physician Decision|1|||
148798101|NCT02718911|536738834|FG008|Overall Study|Physician Decision|2|||
148798102|NCT02718911|536738835|FG009|Overall Study|Physician Decision|1|||
148798103|NCT02718911|536738826|FG000|Overall Study|Withdrawal by Subject|0|||
148798104|NCT02718911|536738827|FG001|Overall Study|Withdrawal by Subject|0|||
148798105|NCT02718911|536738828|FG002|Overall Study|Withdrawal by Subject|0|||
148798106|NCT02718911|536738829|FG003|Overall Study|Withdrawal by Subject|0|||
148798107|NCT02718911|536738830|FG004|Overall Study|Withdrawal by Subject|1|||
148798108|NCT02718911|536738831|FG005|Overall Study|Withdrawal by Subject|0|||
148798109|NCT02718911|536738832|FG006|Overall Study|Withdrawal by Subject|0|||
148798110|NCT02718911|536738833|FG007|Overall Study|Withdrawal by Subject|0|||
148798111|NCT02718911|536738834|FG008|Overall Study|Withdrawal by Subject|1|||
148798112|NCT02718911|536738835|FG009|Overall Study|Withdrawal by Subject|4|||
148798113|NCT02718911|536738826|FG000|Overall Study|Reason Not Collected|0|||
148798114|NCT02718911|536738827|FG001|Overall Study|Reason Not Collected|0|||
148798115|NCT02718911|536738828|FG002|Overall Study|Reason Not Collected|1|||
148798116|NCT02718911|536738829|FG003|Overall Study|Reason Not Collected|0|||
148798117|NCT02718911|536738830|FG004|Overall Study|Reason Not Collected|0|||
148798118|NCT02718911|536738831|FG005|Overall Study|Reason Not Collected|0|||
148798119|NCT02718911|536738832|FG006|Overall Study|Reason Not Collected|2|||
148798120|NCT02718911|536738833|FG007|Overall Study|Reason Not Collected|1|||
148798121|NCT02718911|536738834|FG008|Overall Study|Reason Not Collected|4|||
148798122|NCT02718911|536738835|FG009|Overall Study|Reason Not Collected|9|||
148798123|NCT04817332|536738836|FG000|Overall Study|Lost to Follow-up|3|||
148798124|NCT04817332|536738837|FG001|Overall Study|Lost to Follow-up|3|||
148798125|NCT04817332|536738836|FG000|Overall Study|Protocol Violation|2|||
148798126|NCT04817332|536738837|FG001|Overall Study|Protocol Violation|0|||
148798127|NCT01867008|536738838|FG000|Overall Study|Withdrawal by Subject|1|||
148798128|NCT00983372|536738839|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
148798129|NCT00983372|536738839|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
148798130|NCT00983372|536738839|FG000|Diltiazem ER Alone|Adverse Event|1|||
148798131|NCT02131064|536738846|FG000|Overall Study|Death|5|||
148798132|NCT02131064|536738847|FG001|Overall Study|Death|6|||
148798133|NCT02131064|536738846|FG000|Overall Study|Lost to Follow-up|4|||
148798134|NCT02131064|536738847|FG001|Overall Study|Lost to Follow-up|8|||
148798135|NCT02131064|536738846|FG000|Overall Study|Withdrawal by Subject|14|||
148798136|NCT02131064|536738847|FG001|Overall Study|Withdrawal by Subject|18|||
148798137|NCT02131064|536738846|FG000|Overall Study|Other|2|||
148798138|NCT02131064|536738847|FG001|Overall Study|Other|2|||
148798139|NCT00871234|536738858|FG000|Overall Study|Adverse Event|2|||
148798140|NCT00871234|536738858|FG000|Overall Study|Lost to Follow-up|3|||
148798141|NCT01710020|536738859|FG000|Period 1|Protocol Violation|1|||
148798142|NCT01764841|536738860|FG000|Overall Study|Logistical Difficulties|0|||
148798143|NCT01764841|536738861|FG001|Overall Study|Logistical Difficulties|1|||
148798144|NCT01764841|536738862|FG002|Overall Study|Logistical Difficulties|0|||
148798145|NCT01764841|536738863|FG003|Overall Study|Logistical Difficulties|0|||
148798146|NCT01764841|536738860|FG000|Overall Study|Death|3|||
148798147|NCT01764841|536738861|FG001|Overall Study|Death|0|||
148798148|NCT01764841|536738862|FG002|Overall Study|Death|1|||
148798149|NCT01764841|536738863|FG003|Overall Study|Death|4|||
148798150|NCT01764841|536738860|FG000|Overall Study|No Follow Up|1|||
148798151|NCT01764841|536738861|FG001|Overall Study|No Follow Up|0|||
148798152|NCT01764841|536738862|FG002|Overall Study|No Follow Up|1|||
148798153|NCT01764841|536738863|FG003|Overall Study|No Follow Up|0|||
148798154|NCT01764841|536738860|FG000|Overall Study|Protocol Violation|0|||
148798155|NCT01764841|536738861|FG001|Overall Study|Protocol Violation|1|||
148798156|NCT01764841|536738862|FG002|Overall Study|Protocol Violation|0|||
148798157|NCT01764841|536738863|FG003|Overall Study|Protocol Violation|0|||
148798158|NCT01764841|536738860|FG000|Overall Study|Withdrawal by Subject|16|||
148798159|NCT01764841|536738861|FG001|Overall Study|Withdrawal by Subject|24|||
148798160|NCT01764841|536738862|FG002|Overall Study|Withdrawal by Subject|11|||
148798161|NCT01764841|536738863|FG003|Overall Study|Withdrawal by Subject|15|||
148798162|NCT01764841|536738860|FG000|Overall Study|Lost to Follow-up|3|||
148798163|NCT01764841|536738861|FG001|Overall Study|Lost to Follow-up|0|||
148798164|NCT01764841|536738862|FG002|Overall Study|Lost to Follow-up|1|||
148798165|NCT01764841|536738863|FG003|Overall Study|Lost to Follow-up|0|||
148798166|NCT00549549|536738864|FG000|Overall Study|Adverse Event|5|||
148798167|NCT00549549|536738865|FG001|Overall Study|Adverse Event|3|||
148798168|NCT00549549|536738866|FG002|Overall Study|Adverse Event|1|||
148798169|NCT00549549|536738867|FG003|Overall Study|Adverse Event|9|||
148798170|NCT00549549|536738864|FG000|Overall Study|Lack of Efficacy|9|||
148798171|NCT00549549|536738865|FG001|Overall Study|Lack of Efficacy|6|||
148798172|NCT00549549|536738866|FG002|Overall Study|Lack of Efficacy|4|||
148798173|NCT00549549|536738867|FG003|Overall Study|Lack of Efficacy|2|||
148798174|NCT00549549|536738864|FG000|Overall Study|Lost to Follow-up|1|||
148798175|NCT00549549|536738865|FG001|Overall Study|Lost to Follow-up|0|||
148798176|NCT00549549|536738866|FG002|Overall Study|Lost to Follow-up|1|||
148798177|NCT00549549|536738867|FG003|Overall Study|Lost to Follow-up|2|||
148798178|NCT00549549|536738864|FG000|Overall Study|Withdrawal by Subject|0|||
148798179|NCT00549549|536738865|FG001|Overall Study|Withdrawal by Subject|4|||
148798180|NCT00549549|536738866|FG002|Overall Study|Withdrawal by Subject|1|||
148798181|NCT00549549|536738867|FG003|Overall Study|Withdrawal by Subject|0|||
148798182|NCT00549549|536738864|FG000|Overall Study|Other|9|||
148798183|NCT00549549|536738865|FG001|Overall Study|Other|9|||
148798184|NCT00549549|536738866|FG002|Overall Study|Other|9|||
148798185|NCT00549549|536738867|FG003|Overall Study|Other|11|||
148798186|NCT00549549|536738864|FG000|Overall Study|Randomized but not treated|0|||
148798187|NCT00549549|536738865|FG001|Overall Study|Randomized but not treated|0|||
148798188|NCT00549549|536738866|FG002|Overall Study|Randomized but not treated|1|||
148798189|NCT00549549|536738867|FG003|Overall Study|Randomized but not treated|1|||
148798190|NCT02155699|536738868|FG000|Overall Study|Withdrawal by Subject|0|||
148798191|NCT02155699|536738869|FG001|Overall Study|Withdrawal by Subject|3|||
148798192|NCT02155699|536738870|FG002|Overall Study|Withdrawal by Subject|6|||
148798193|NCT02155699|536738871|FG003|Overall Study|Withdrawal by Subject|1|||
148798194|NCT02155699|536738868|FG000|Overall Study|Lost to Follow-up|0|||
148798195|NCT02155699|536738869|FG001|Overall Study|Lost to Follow-up|0|||
148798196|NCT02155699|536738870|FG002|Overall Study|Lost to Follow-up|0|||
148798197|NCT02155699|536738871|FG003|Overall Study|Lost to Follow-up|3|||
148798198|NCT02155699|536738868|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
148798199|NCT02155699|536738869|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
148798200|NCT02155699|536738870|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
148798201|NCT02155699|536738871|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
148798202|NCT02688933|536738874|FG000|Overall Study|Adverse Event|3|||
148798203|NCT02688933|536738875|FG001|Overall Study|Adverse Event|1|||
148798204|NCT02688933|536738874|FG000|Overall Study|Lack of Efficacy|2|||
148798205|NCT02688933|536738875|FG001|Overall Study|Lack of Efficacy|2|||
148798206|NCT02688933|536738874|FG000|Overall Study|Poor compliance to protocol|7|||
148798207|NCT02688933|536738875|FG001|Overall Study|Poor compliance to protocol|4|||
148798208|NCT02688933|536738874|FG000|Overall Study|Hypoglycemia|2|||
148798209|NCT02688933|536738875|FG001|Overall Study|Hypoglycemia|0|||
148798210|NCT02688933|536738874|FG000|Overall Study|Other than Specified|14|||
148798211|NCT02688933|536738875|FG001|Overall Study|Other than Specified|25|||
148798212|NCT02688933|536738874|FG000|Overall Study|Lost to Follow-up|1|||
148798213|NCT02688933|536738875|FG001|Overall Study|Lost to Follow-up|5|||
148798214|NCT00810199|536738876|FG000|Overall Study|Adverse Event|24|||
148798215|NCT00810199|536738877|FG001|Overall Study|Adverse Event|26|||
148798216|NCT00810199|536738876|FG000|Overall Study|Death|4|||
148798217|NCT00810199|536738877|FG001|Overall Study|Death|6|||
148798218|NCT00810199|536738876|FG000|Overall Study|Withdrew consent|9|||
148798219|NCT00810199|536738877|FG001|Overall Study|Withdrew consent|12|||
148798220|NCT00810199|536738876|FG000|Overall Study|Insufficient therapeutic response|5|||
148798221|NCT00810199|536738877|FG001|Overall Study|Insufficient therapeutic response|14|||
148798222|NCT00810199|536738876|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
148798223|NCT00810199|536738877|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
148798224|NCT00810199|536738876|FG000|Overall Study|Administrative/Other|5|||
148798225|NCT00810199|536738877|FG001|Overall Study|Administrative/Other|6|||
148798226|NCT00810199|536738876|FG000|Overall Study|Protocol Violation|2|||
148898027|NCT00333775|537108524|FG001|Overall Study|Death|149|||
148898028|NCT00333775|537108525|FG002|Overall Study|Death|143|||
148898029|NCT00333775|537108523|FG000|Overall Study|In Follow-up When Study Stopped|87|||
148898030|NCT00333775|537108524|FG001|Overall Study|In Follow-up When Study Stopped|92|||
148898031|NCT00333775|537108525|FG002|Overall Study|In Follow-up When Study Stopped|96|||
148898032|NCT00333775|537108523|FG000|Overall Study|Lost to Follow-up|10|||
148898033|NCT00333775|537108524|FG001|Overall Study|Lost to Follow-up|7|||
148898034|NCT00333775|537108525|FG002|Overall Study|Lost to Follow-up|8|||
148898035|NCT02476617|537108529|FG000|Overall Study|Adverse Event|1|||
148898036|NCT02476617|537108529|FG000|Overall Study|Lost to Follow-up|1|||
148898037|NCT01383928|537108530|FG000|Overall Study|Initiation of ASCT|2|||
148898038|NCT01383928|537108531|FG001|Overall Study|Initiation of ASCT|1|||
148898039|NCT01383928|537108532|FG002|Overall Study|Initiation of ASCT|18|||
148898040|NCT01383928|537108530|FG000|Overall Study|Adverse Event|1|||
148898041|NCT01383928|537108531|FG001|Overall Study|Adverse Event|2|||
148898042|NCT01383928|537108532|FG002|Overall Study|Adverse Event|8|||
148898043|NCT01383928|537108530|FG000|Overall Study|Other|1|||
148898044|NCT01383928|537108531|FG001|Overall Study|Other|3|||
148898045|NCT01383928|537108532|FG002|Overall Study|Other|4|||
148898046|NCT01383928|537108530|FG000|Overall Study|Progressive Disease|1|||
148898047|NCT01383928|537108531|FG001|Overall Study|Progressive Disease|1|||
148898048|NCT01383928|537108532|FG002|Overall Study|Progressive Disease|5|||
148898049|NCT01383928|537108530|FG000|Overall Study|Withdrawal by Subject|0|||
148898050|NCT01383928|537108531|FG001|Overall Study|Withdrawal by Subject|0|||
148898051|NCT01383928|537108532|FG002|Overall Study|Withdrawal by Subject|4|||
148898052|NCT01383928|537108530|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
148898053|NCT01383928|537108531|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
148898054|NCT01383928|537108532|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
148898055|NCT02491684|537108533|FG000|Treatment Phase|Adverse Event|2|||
148898056|NCT02491684|537108534|FG001|Treatment Phase|Adverse Event|2|||
148898057|NCT02491684|537108533|FG000|Treatment Phase|Incorrect randomisation|1|||
148898058|NCT02491684|537108534|FG001|Treatment Phase|Incorrect randomisation|0|||
148898059|NCT02491684|537108533|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
148898060|NCT02491684|537108534|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
148898061|NCT04739982|537108536|FG000|Overall Study|Lost to Follow-up|176|||
148898062|NCT04739982|537108537|FG001|Overall Study|Lost to Follow-up|65|||
148898063|NCT04739982|537108536|FG000|Overall Study|Withdrawal by Subject|19|||
148898064|NCT04739982|537108537|FG001|Overall Study|Withdrawal by Subject|0|||
148898065|NCT04739982|537108536|FG000|Overall Study|Protocol Violation|0|||
148898066|NCT04739982|537108537|FG001|Overall Study|Protocol Violation|5|||
148898067|NCT03651765|537108538|FG000|Overall Study|Adverse Event|6|||
148898068|NCT03651765|537108538|FG000|Overall Study|Lack of Efficacy|18|||
148898069|NCT03651765|537108538|FG000|Overall Study|Lost to Follow-up|5|||
148898070|NCT03651765|537108538|FG000|Overall Study|Non-Compliance with Study Drug|4|||
148898071|NCT03651765|537108538|FG000|Overall Study|Physician Decision|6|||
148898072|NCT03651765|537108538|FG000|Overall Study|Pregnancy|1|||
148898073|NCT03651765|537108538|FG000|Overall Study|Discontinued by Sponsor|40|||
148898074|NCT03651765|537108538|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
148898075|NCT03651765|537108538|FG000|Overall Study|Withdrawal by Subject|24|||
148898076|NCT03651765|537108538|FG000|Overall Study|Miscellaneous|6|||
148898077|NCT01263769|537108540|FG000|Overall Study|Non-Compliant with treatment|1|||
148898078|NCT01346358|537108541|FG000|Overall Study|Withdrawal by Subject|1|||
148898079|NCT01346358|537108542|FG001|Overall Study|Withdrawal by Subject|0|||
148898080|NCT01346358|537108543|FG002|Overall Study|Withdrawal by Subject|1|||
148898081|NCT01346358|537108544|FG003|Overall Study|Withdrawal by Subject|1|||
148898082|NCT01346358|537108545|FG004|Overall Study|Withdrawal by Subject|0|||
148898083|NCT01346358|537108546|FG005|Overall Study|Withdrawal by Subject|2|||
148898084|NCT01346358|537108547|FG006|Overall Study|Withdrawal by Subject|1|||
148898085|NCT01346358|537108548|FG007|Overall Study|Withdrawal by Subject|1|||
148898086|NCT01346358|537108549|FG008|Overall Study|Withdrawal by Subject|1|||
148898087|NCT01346358|537108541|FG000|Overall Study|Adverse Event|1|||
148898088|NCT01346358|537108542|FG001|Overall Study|Adverse Event|0|||
148898089|NCT01346358|537108543|FG002|Overall Study|Adverse Event|0|||
148898090|NCT01346358|537108544|FG003|Overall Study|Adverse Event|0|||
148898091|NCT01346358|537108545|FG004|Overall Study|Adverse Event|1|||
148898092|NCT01346358|537108546|FG005|Overall Study|Adverse Event|0|||
148898093|NCT01346358|537108547|FG006|Overall Study|Adverse Event|0|||
148898094|NCT01346358|537108548|FG007|Overall Study|Adverse Event|0|||
148898095|NCT01346358|537108549|FG008|Overall Study|Adverse Event|1|||
148898096|NCT01346358|537108541|FG000|Overall Study|Non-Compliance|0|||
148898097|NCT01346358|537108542|FG001|Overall Study|Non-Compliance|0|||
148898098|NCT01346358|537108543|FG002|Overall Study|Non-Compliance|0|||
148898099|NCT01346358|537108544|FG003|Overall Study|Non-Compliance|0|||
148898100|NCT01346358|537108545|FG004|Overall Study|Non-Compliance|0|||
148898101|NCT01346358|537108546|FG005|Overall Study|Non-Compliance|0|||
148898102|NCT01346358|537108547|FG006|Overall Study|Non-Compliance|0|||
148898103|NCT01346358|537108548|FG007|Overall Study|Non-Compliance|2|||
148898104|NCT01346358|537108549|FG008|Overall Study|Non-Compliance|0|||
148898105|NCT01346358|537108541|FG000|Overall Study|Physician Decision|0|||
148898106|NCT01346358|537108542|FG001|Overall Study|Physician Decision|1|||
148898107|NCT01346358|537108543|FG002|Overall Study|Physician Decision|0|||
148898108|NCT01346358|537108544|FG003|Overall Study|Physician Decision|0|||
148898109|NCT01346358|537108545|FG004|Overall Study|Physician Decision|0|||
148898110|NCT01346358|537108546|FG005|Overall Study|Physician Decision|0|||
148898111|NCT01346358|537108547|FG006|Overall Study|Physician Decision|0|||
148898112|NCT01346358|537108548|FG007|Overall Study|Physician Decision|1|||
148898113|NCT01346358|537108549|FG008|Overall Study|Physician Decision|1|||
148898114|NCT05058365|537108552|FG000|Overall Study|Migration|1|||
148898115|NCT05058365|537108553|FG001|Overall Study|Migration|1|||
148898116|NCT00771914|537108555|FG000|Overall Study|Physician Decision|0|||
148898117|NCT00771914|537108556|FG001|Overall Study|Physician Decision|0|||
148898118|NCT00771914|537108557|FG002|Overall Study|Physician Decision|0|||
148898119|NCT00771914|537108558|FG003|Overall Study|Physician Decision|1|||
148898120|NCT00771914|537108555|FG000|Overall Study|Lost to Follow-up|0|||
148898121|NCT00771914|537108556|FG001|Overall Study|Lost to Follow-up|0|||
148898122|NCT00771914|537108557|FG002|Overall Study|Lost to Follow-up|0|||
148898123|NCT00771914|537108558|FG003|Overall Study|Lost to Follow-up|1|||
148898124|NCT01521117|537108563|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
148898125|NCT01521117|537108564|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
148898126|NCT01521117|537108563|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
148898127|NCT01521117|537108564|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
148898128|NCT01521117|537108563|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
148898129|NCT01521117|537108564|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
148898130|NCT01056822|537108565|FG000|Overall Study|Adverse Event|0|||
148898131|NCT01056822|537108566|FG001|Overall Study|Adverse Event|1|||
148898132|NCT01056822|537108565|FG000|Overall Study|Protocol Violation|6|||
148898133|NCT01056822|537108566|FG001|Overall Study|Protocol Violation|5|||
148898134|NCT01056822|537108565|FG000|Overall Study|Withdrawal by Subject|1|||
148898135|NCT01056822|537108566|FG001|Overall Study|Withdrawal by Subject|1|||
148898136|NCT01056822|537108565|FG000|Overall Study|Lost to Follow-up|1|||
148898137|NCT01056822|537108566|FG001|Overall Study|Lost to Follow-up|0|||
148898138|NCT05135871|537108569|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
148898139|NCT05135871|537108570|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
148898140|NCT05135871|537108571|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
148898141|NCT05135871|537108572|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
148898142|NCT00617734|537108573|FG000|Overall Study|Withdrew Consent|2|||
148898143|NCT00617734|537108574|FG001|Overall Study|Withdrew Consent|0|||
148898144|NCT00617734|537108573|FG000|Overall Study|Adverse Event|4|||
148898145|NCT00617734|537108574|FG001|Overall Study|Adverse Event|1|||
148898146|NCT00617734|537108573|FG000|Overall Study|Protocol Violation|1|||
148898147|NCT00617734|537108574|FG001|Overall Study|Protocol Violation|0|||
148898148|NCT00617734|537108573|FG000|Overall Study|Found Ineligible After Randomization|1|||
148898149|NCT00617734|537108574|FG001|Overall Study|Found Ineligible After Randomization|4|||
148898150|NCT00617734|537108573|FG000|Overall Study|Lost to Follow-up|0|||
148898151|NCT00617734|537108574|FG001|Overall Study|Lost to Follow-up|1|||
148898152|NCT02892344|537110375|FG000|Overall Study|Protocol deviation|3|||
148898153|NCT02892344|537110376|FG001|Overall Study|Protocol deviation|4|||
148898154|NCT02892344|537110375|FG000|Overall Study|Adverse Event|1|||
148898155|NCT02892344|537110376|FG001|Overall Study|Adverse Event|8|||
148898156|NCT02892344|537110375|FG000|Overall Study|Lost to Follow-up|0|||
148898157|NCT02892344|537110376|FG001|Overall Study|Lost to Follow-up|1|||
148898158|NCT02892344|537110375|FG000|Overall Study|Non-compliance with study treatment|0|||
148898159|NCT02892344|537110376|FG001|Overall Study|Non-compliance with study treatment|1|||
148898160|NCT02892344|537110375|FG000|Overall Study|Physician Decision|0|||
148898161|NCT02892344|537110376|FG001|Overall Study|Physician Decision|2|||
148898162|NCT02892344|537110375|FG000|Overall Study|Subject/guardian decision|0|||
148898163|NCT02892344|537110376|FG001|Overall Study|Subject/guardian decision|4|||
148898164|NCT02892344|537110375|FG000|Overall Study|Technical problems|0|||
148898165|NCT02892344|537110376|FG001|Overall Study|Technical problems|1|||
148898166|NCT01295814|537110377|FG000|Overall Study|Lack of Efficacy|0|||
148898167|NCT01295814|537110378|FG001|Overall Study|Lack of Efficacy|2|||
148898168|NCT01295814|537110377|FG000|Overall Study|Withdrawal by Subject|2|||
148898169|NCT01295814|537110378|FG001|Overall Study|Withdrawal by Subject|0|||
148898170|NCT04106557|537110384|FG000|Overall Study|Physician Decision|0|||
148898171|NCT04106557|537110385|FG001|Overall Study|Physician Decision|1|||
148898172|NCT04106557|537110386|FG002|Overall Study|Physician Decision|0|||
148898173|NCT04106557|537110384|FG000|Overall Study|Protocol Violation|0|||
148898174|NCT04106557|537110385|FG001|Overall Study|Protocol Violation|1|||
148898175|NCT04106557|537110386|FG002|Overall Study|Protocol Violation|0|||
148898176|NCT02326155|537110387|FG000|Overall Study|Adverse Event|21|||
148898177|NCT02326155|537110388|FG001|Overall Study|Adverse Event|5|||
148898178|NCT02326155|537110387|FG000|Overall Study|Death|3|||
148898179|NCT02326155|537110388|FG001|Overall Study|Death|0|||
148898180|NCT02326155|537110387|FG000|Overall Study|Lack of Efficacy|49|||
148898181|NCT02326155|537110388|FG001|Overall Study|Lack of Efficacy|5|||
148898182|NCT02326155|537110387|FG000|Overall Study|Lost to Follow-up|14|||
148898183|NCT02326155|537110388|FG001|Overall Study|Lost to Follow-up|3|||
148898184|NCT02326155|537110387|FG000|Overall Study|Protocol Violation|2|||
148898185|NCT02326155|537110388|FG001|Overall Study|Protocol Violation|0|||
148898186|NCT02326155|537110387|FG000|Overall Study|Withdrawal by Subject|34|||
148898187|NCT02326155|537110388|FG001|Overall Study|Withdrawal by Subject|11|||
148898188|NCT02326155|537110387|FG000|Overall Study|Disease progression|37|||
148898189|NCT02326155|537110388|FG001|Overall Study|Disease progression|4|||
148898190|NCT02326155|537110387|FG000|Overall Study|Study close|188|||
148898191|NCT02326155|537110388|FG001|Overall Study|Study close|21|||
148898192|NCT02326155|537110387|FG000|Overall Study|except for study close|46|||
148898193|NCT02326155|537110388|FG001|Overall Study|except for study close|13|||
148898194|NCT05024032|537110389|FG000|Overall Study|Withdrawal by Subject|0|||
148898195|NCT05024032|537110390|FG001|Overall Study|Withdrawal by Subject|3|||
148898196|NCT05024032|537110391|FG002|Overall Study|Withdrawal by Subject|4|||
148898197|NCT05024032|537110389|FG000|Overall Study|Adverse Event|0|||
148898198|NCT05024032|537110390|FG001|Overall Study|Adverse Event|1|||
148898199|NCT05024032|537110391|FG002|Overall Study|Adverse Event|0|||
148898200|NCT05024032|537110389|FG000|Overall Study|Protocol Deviation|1|||
148898201|NCT05024032|537110390|FG001|Overall Study|Protocol Deviation|0|||
148898202|NCT05024032|537110391|FG002|Overall Study|Protocol Deviation|0|||
148898203|NCT01209689|537110392|FG000|Overall Study|Insufficient Therapeutic Response|7|||
148898204|NCT01209689|537110393|FG001|Overall Study|Insufficient Therapeutic Response|2|||
148898205|NCT01209689|537110392|FG000|Overall Study|Refused Treatment|8|||
148898206|NCT01209689|537110393|FG001|Overall Study|Refused Treatment|3|||
148898207|NCT01209689|537110392|FG000|Overall Study|Adverse Event|4|||
148898208|NCT01209689|537110393|FG001|Overall Study|Adverse Event|0|||
148898209|NCT01209689|537110392|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
148898210|NCT01209689|537110393|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
148898211|NCT01209689|537110392|FG000|Overall Study|Failure to Return|3|||
148898212|NCT01209689|537110393|FG001|Overall Study|Failure to Return|0|||
148898213|NCT01209689|537110392|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
148898214|NCT01209689|537110393|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
148898215|NCT03780244|537110394|FG000|Overall Study|Lost to Follow-up|1|||
148898216|NCT03780244|537110395|FG001|Overall Study|Lost to Follow-up|0|||
148898217|NCT03175367|537110396|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
148898218|NCT03175367|537110397|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
148898219|NCT03175367|537110398|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
148898220|NCT03175367|537110399|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
148898221|NCT03175367|537110400|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
148898222|NCT03175367|537110401|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
148898223|NCT03175367|537110402|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
148898224|NCT03175367|537110396|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
148898225|NCT03175367|537110397|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
148898226|NCT03175367|537110398|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
148898227|NCT03175367|537110399|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
148898228|NCT03175367|537110400|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
148898229|NCT03175367|537110401|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
148898230|NCT03175367|537110402|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
148898231|NCT03175367|537110396|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
148898232|NCT03175367|537110397|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
148898233|NCT03175367|537110398|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
148898234|NCT03175367|537110399|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
148898235|NCT03175367|537110400|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
148898236|NCT03175367|537110401|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
148898237|NCT03175367|537110402|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
148898238|NCT03175367|537110396|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
148898239|NCT03175367|537110397|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
148898240|NCT03175367|537110398|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
148898241|NCT03175367|537110399|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
148898242|NCT03175367|537110400|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
148898243|NCT03175367|537110401|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
148898244|NCT03175367|537110402|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
148898245|NCT03175367|537110396|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148898246|NCT03175367|537110397|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148898247|NCT03175367|537110398|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
148898248|NCT03175367|537110399|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148898249|NCT03175367|537110400|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
149011477|NCT02778399|537521475|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
148798227|NCT00810199|536738877|FG001|Overall Study|Protocol Violation|6|||
148798228|NCT00810199|536738876|FG000|Overall Study|Failure to return|1|||
148798229|NCT00810199|536738877|FG001|Overall Study|Failure to return|4|||
148798230|NCT00810199|536738876|FG000|Overall Study|Did not receive study drug|2|||
148798231|NCT00810199|536738877|FG001|Overall Study|Did not receive study drug|1|||
148798232|NCT00992017|536738879|FG000|Overall Study|Lost to Follow-up|2|||
148798233|NCT00992017|536738879|FG000|Overall Study|Withdrawal by Subject|2|||
148798234|NCT00992017|536738879|FG000|Overall Study|Unable to get to clinic|5|||
148798235|NCT00992017|536738879|FG000|Overall Study|Not adhere to study requirements|1|||
148798236|NCT02864407|536738880|FG000|Overall Study|Protocol Violation|3|||
148798237|NCT02864407|536738880|FG000|Overall Study|Lost to Follow-up|115|||
148798238|NCT02864407|536738880|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
148798239|NCT02864407|536738880|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
148798240|NCT02864407|536738880|FG000|Overall Study|Consent prior to the contract date|1|||
148798241|NCT02287038|536738890|FG000|Overall Study|Stopped attending appointments|3|||
148798242|NCT02287038|536738891|FG001|Overall Study|Stopped attending appointments|2|||
148798243|NCT02287038|536738890|FG000|Overall Study|Anxiety after starting medication|0|||
148798244|NCT02287038|536738891|FG001|Overall Study|Anxiety after starting medication|1|||
148798245|NCT02287038|536738890|FG000|Overall Study|Nausea after starting medication|1|||
148798246|NCT02287038|536738891|FG001|Overall Study|Nausea after starting medication|0|||
148798247|NCT02287038|536738890|FG000|Overall Study|Abnormal ECG after starting medication|1|||
148798248|NCT02287038|536738891|FG001|Overall Study|Abnormal ECG after starting medication|0|||
148798249|NCT05502302|536738899|FG000|Overall Study|Lost to Follow-up|6|||
148798250|NCT05502302|536738899|FG000|Overall Study|Death|2|||
148798251|NCT02998151|536738905|FG000|Overall Study|Withdrawal by Subject|3|||
148798252|NCT02998151|536738905|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
148798253|NCT02998151|536738905|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
148798254|NCT02155985|536738906|FG000|Overall Study|Withdrawal by Subject|0|||
148798255|NCT02155985|536738907|FG001|Overall Study|Withdrawal by Subject|0|||
148798256|NCT02155985|536738908|FG002|Overall Study|Withdrawal by Subject|1|||
148798257|NCT02155985|536738906|FG000|Overall Study|Lost to Follow-up|1|||
148798258|NCT02155985|536738907|FG001|Overall Study|Lost to Follow-up|0|||
148798259|NCT02155985|536738908|FG002|Overall Study|Lost to Follow-up|0|||
148798260|NCT04414787|536738916|FG000|Overall Study|Patient Death|18|||
148798261|NCT04414787|536738917|FG001|Overall Study|Patient Death|18|||
148798262|NCT04414787|536738918|FG002|Overall Study|Patient Death|15|||
148798263|NCT04414787|536738919|FG003|Overall Study|Patient Death|15|||
148798264|NCT04414787|536738916|FG000|Overall Study|Patient Hospitalization|1|||
148798265|NCT04414787|536738917|FG001|Overall Study|Patient Hospitalization|1|||
148798266|NCT04414787|536738918|FG002|Overall Study|Patient Hospitalization|2|||
148798267|NCT04414787|536738919|FG003|Overall Study|Patient Hospitalization|2|||
148798268|NCT04414787|536738916|FG000|Overall Study|Lost to Follow-up|7|||
148798269|NCT04414787|536738917|FG001|Overall Study|Lost to Follow-up|7|||
148798270|NCT04414787|536738918|FG002|Overall Study|Lost to Follow-up|5|||
148798271|NCT04414787|536738919|FG003|Overall Study|Lost to Follow-up|5|||
148798272|NCT04414787|536738916|FG000|Overall Study|Residence in post-acute care facility|3|||
148798273|NCT04414787|536738917|FG001|Overall Study|Residence in post-acute care facility|3|||
148798274|NCT04414787|536738918|FG002|Overall Study|Residence in post-acute care facility|5|||
148798275|NCT04414787|536738919|FG003|Overall Study|Residence in post-acute care facility|5|||
148798276|NCT00447902|536738921|FG000|Overall Study|Adverse Event|0|||
148798277|NCT00447902|536738922|FG001|Overall Study|Adverse Event|3|||
148798278|NCT00447902|536738921|FG000|Overall Study|Protocol Violation|1|||
148798279|NCT00447902|536738922|FG001|Overall Study|Protocol Violation|0|||
148798280|NCT00447902|536738921|FG000|Overall Study|Withdrawal by Subject|0|||
148798281|NCT00447902|536738922|FG001|Overall Study|Withdrawal by Subject|1|||
148798282|NCT00447902|536738921|FG000|Overall Study|included patients who discontinued|1|||
148798283|NCT00447902|536738922|FG001|Overall Study|included patients who discontinued|1|||
148798284|NCT00447902|536738921|FG000|Overall Study|Lack of Efficacy|2|||
148798285|NCT00447902|536738922|FG001|Overall Study|Lack of Efficacy|1|||
148798286|NCT01811732|536741256|FG000|Overall Study|Lost to Follow-up|24|||
148798287|NCT01811732|536741257|FG001|Overall Study|Lost to Follow-up|30|||
148798288|NCT01811732|536741256|FG000|Overall Study|Withdrawal by Subject|16|||
148798289|NCT01811732|536741257|FG001|Overall Study|Withdrawal by Subject|10|||
148798290|NCT01811732|536741256|FG000|Overall Study|Adverse Event|3|||
148798291|NCT01811732|536741257|FG001|Overall Study|Adverse Event|9|||
148798292|NCT01811732|536741256|FG000|Overall Study|Lack of Efficacy|3|||
148798293|NCT01811732|536741257|FG001|Overall Study|Lack of Efficacy|1|||
148798294|NCT01811732|536741256|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
148798295|NCT01811732|536741257|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
148798296|NCT01811732|536741256|FG000|Overall Study|Physician Decision|2|||
148798297|NCT01811732|536741257|FG001|Overall Study|Physician Decision|0|||
148798298|NCT01811732|536741256|FG000|Overall Study|Death|1|||
148798299|NCT01811732|536741257|FG001|Overall Study|Death|1|||
148798300|NCT01811732|536741256|FG000|Overall Study|Insufficient venous access|0|||
148798301|NCT01811732|536741257|FG001|Overall Study|Insufficient venous access|1|||
148798302|NCT01811732|536741256|FG000|Overall Study|Protocol Violation|0|||
148798303|NCT01811732|536741257|FG001|Overall Study|Protocol Violation|1|||
148798304|NCT01811732|536741256|FG000|Overall Study|Subject incarcerated|1|||
148798305|NCT01811732|536741257|FG001|Overall Study|Subject incarcerated|2|||
148798306|NCT01811732|536741256|FG000|Overall Study|Admitted to another facility|1|||
148798307|NCT01811732|536741257|FG001|Overall Study|Admitted to another facility|0|||
148798308|NCT01811732|536741256|FG000|Overall Study|Correct study drug not available on site|1|||
148798309|NCT01811732|536741257|FG001|Overall Study|Correct study drug not available on site|0|||
148798310|NCT01783743|536741258|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
148798311|NCT01783743|536741259|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
148798312|NCT01783743|536741258|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
148798313|NCT01783743|536741259|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
148798314|NCT01783743|536741258|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
148798315|NCT01783743|536741259|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
148798316|NCT02771275|536741260|FG000|Overall Study|Reoperation|3|||
148798317|NCT02771275|536741260|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
148798318|NCT05556148|536741261|FG000|Overall Study|Early Termination|29|||
148798319|NCT05556148|536741261|FG000|Overall Study|Baseline Tasks Expired|4|||
148798320|NCT05556148|536741261|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
148798321|NCT05556148|536741261|FG000|Overall Study|No Longer Wished to Participate|1|||
148798322|NCT05556148|536741261|FG000|Overall Study|Bacterial Conjunctivitis|1|||
148798323|NCT00728494|536741274|FG000|Overall Study|Adverse Event|7|||
148798324|NCT00728494|536741275|FG001|Overall Study|Adverse Event|0|||
148798325|NCT00728494|536741274|FG000|Overall Study|Withdrawal by Subject|0|||
148798326|NCT00728494|536741275|FG001|Overall Study|Withdrawal by Subject|2|||
148798327|NCT00728494|536741274|FG000|Overall Study|Lack of Efficacy|2|||
148798328|NCT00728494|536741275|FG001|Overall Study|Lack of Efficacy|4|||
148798329|NCT00728494|536741274|FG000|Overall Study|No data available|0|||
148798330|NCT00728494|536741275|FG001|Overall Study|No data available|1|||
148798331|NCT00853762|536741278|FG000|Overall Study|Premature Termination|16|||
148798332|NCT00853762|536741279|FG001|Overall Study|Premature Termination|15|||
148798333|NCT00853762|536741280|FG002|Overall Study|Premature Termination|14|||
148798334|NCT00853762|536741281|FG003|Overall Study|Premature Termination|21|||
148798335|NCT00853762|536741278|FG000|Overall Study|Protocol Violation|0|||
148798336|NCT00853762|536741279|FG001|Overall Study|Protocol Violation|0|||
148898250|NCT03175367|537110401|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148898251|NCT03175367|537110402|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148898252|NCT03175367|537110396|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
148798337|NCT00853762|536741280|FG002|Overall Study|Protocol Violation|0|||
148798338|NCT00853762|536741281|FG003|Overall Study|Protocol Violation|1|||
148798339|NCT00853762|536741278|FG000|Overall Study|Withdrawal by Subject|0|||
149011478|NCT00405639|537521477|FG000|Overall Study|Withdrawal by Subject|1|||
148798340|NCT00853762|536741279|FG001|Overall Study|Withdrawal by Subject|0|||
148798341|NCT00853762|536741280|FG002|Overall Study|Withdrawal by Subject|1|||
148798342|NCT00853762|536741281|FG003|Overall Study|Withdrawal by Subject|0|||
148798343|NCT00853762|536741278|FG000|Overall Study|Other|0|||
148798344|NCT00853762|536741279|FG001|Overall Study|Other|2|||
148798345|NCT00853762|536741280|FG002|Overall Study|Other|0|||
148798346|NCT00853762|536741281|FG003|Overall Study|Other|0|||
148798347|NCT00853762|536741278|FG000|Overall Study|Randomised but not Treated|0|||
148798348|NCT00853762|536741279|FG001|Overall Study|Randomised but not Treated|2|||
148798349|NCT00853762|536741280|FG002|Overall Study|Randomised but not Treated|2|||
148798350|NCT00853762|536741281|FG003|Overall Study|Randomised but not Treated|0|||
148798351|NCT01290718|536741284|FG000|Overall Study|Early termination of the study|4|||
148798352|NCT02456727|536741287|FG000|Overall Study|Lost to Follow-up|63|||
148798353|NCT02456727|536741288|FG001|Overall Study|Lost to Follow-up|65|||
148798354|NCT02456727|536741287|FG000|Overall Study|Death|2|||
148798355|NCT02456727|536741288|FG001|Overall Study|Death|1|||
148798356|NCT02456727|536741287|FG000|Overall Study|Withdrawal by Subject|1|||
148798357|NCT02456727|536741288|FG001|Overall Study|Withdrawal by Subject|10|||
148798358|NCT02456727|536741287|FG000|Overall Study|Never Initiated Treatment|43|||
148798359|NCT02456727|536741288|FG001|Overall Study|Never Initiated Treatment|30|||
148798360|NCT02059239|536741289|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
148798361|NCT02059239|536741290|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
148798362|NCT02059239|536741289|FG000|Overall Study|Physician Decision|1|||
148798363|NCT02059239|536741290|FG001|Overall Study|Physician Decision|0|||
148798364|NCT01268267|536741292|FG000|Overall Study|Protocol Violation|1|||
148798365|NCT01222104|536741293|FG000|Overall Study|Lost to Follow-up|37|||
148798366|NCT01222104|536741293|FG000|Overall Study|Death|10|||
148798367|NCT01418339|536741294|FG000|Overall Study|Adverse Event|5|||
148798368|NCT01418339|536741295|FG001|Overall Study|Adverse Event|2|||
148798369|NCT01418339|536741294|FG000|Overall Study|Subject Withdrew Consent|1|||
148798370|NCT01418339|536741295|FG001|Overall Study|Subject Withdrew Consent|2|||
148798371|NCT01418339|536741294|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
148798372|NCT01418339|536741295|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
148798373|NCT02204917|536741298|FG000|Overall Study|Protocol Violation|1|||
148798374|NCT00909844|536741299|FG000|Overall Study|Adverse Event|1|||
148798375|NCT00909844|536741299|FG000|Overall Study|Withdrawal by Subject|1|||
148798376|NCT00909844|536741299|FG000|Overall Study|Lost to Follow-up|2|||
148798377|NCT02219685|536741300|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
148798378|NCT02219685|536741301|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
148798379|NCT02219685|536741300|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
148798380|NCT02219685|536741301|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
148798381|NCT00698815|536741302|FG000|Overall Study|Death|1|||
148798382|NCT00698815|536741303|FG001|Overall Study|Death|2|||
148798383|NCT00698815|536741304|FG002|Overall Study|Death|4|||
148798384|NCT00698815|536741302|FG000|Overall Study|Withdrawal by Subject|6|||
148798385|NCT00698815|536741303|FG001|Overall Study|Withdrawal by Subject|3|||
148798386|NCT00698815|536741304|FG002|Overall Study|Withdrawal by Subject|2|||
148798387|NCT00698815|536741302|FG000|Overall Study|MD discretion|2|||
148798388|NCT00698815|536741303|FG001|Overall Study|MD discretion|7|||
148798389|NCT00698815|536741304|FG002|Overall Study|MD discretion|2|||
148798390|NCT00698815|536741302|FG000|Overall Study|Did not receive protocol treatment|1|||
148798391|NCT00698815|536741303|FG001|Overall Study|Did not receive protocol treatment|2|||
148798392|NCT00698815|536741304|FG002|Overall Study|Did not receive protocol treatment|2|||
148798393|NCT00706004|536741305|FG000|Overall Study|Did not meet eligibility criteria|2|||
148798394|NCT00490035|536741310|FG000|Overall Study|AE, non-serious non-fatal|3|||
148798395|NCT00490035|536741311|FG001|Overall Study|AE, non-serious non-fatal|4|||
148798396|NCT00490035|536741312|FG002|Overall Study|AE, non-serious non-fatal|4|||
148798397|NCT00490035|536741313|FG003|Overall Study|AE, non-serious non-fatal|5|||
148798398|NCT00490035|536741310|FG000|Overall Study|Lost to Follow-up|2|||
148798399|NCT00490035|536741311|FG001|Overall Study|Lost to Follow-up|0|||
148798400|NCT00490035|536741312|FG002|Overall Study|Lost to Follow-up|1|||
148798401|NCT00490035|536741313|FG003|Overall Study|Lost to Follow-up|0|||
148798402|NCT00490035|536741310|FG000|Overall Study|Withdrawal by Subject|2|||
148798403|NCT00490035|536741311|FG001|Overall Study|Withdrawal by Subject|1|||
148798404|NCT00490035|536741312|FG002|Overall Study|Withdrawal by Subject|1|||
148798405|NCT00490035|536741313|FG003|Overall Study|Withdrawal by Subject|0|||
148798406|NCT00490035|536741310|FG000|Overall Study|Other reason|0|||
148798407|NCT00490035|536741311|FG001|Overall Study|Other reason|1|||
148798408|NCT00490035|536741312|FG002|Overall Study|Other reason|3|||
148798409|NCT00490035|536741313|FG003|Overall Study|Other reason|1|||
148798410|NCT00490035|536741310|FG000|Overall Study|AE, serious fatal|1|||
148798411|NCT00490035|536741311|FG001|Overall Study|AE, serious fatal|0|||
148798412|NCT00490035|536741312|FG002|Overall Study|AE, serious fatal|0|||
148798413|NCT00490035|536741313|FG003|Overall Study|AE, serious fatal|0|||
148798414|NCT00490035|536741310|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
148798415|NCT00490035|536741311|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
148898253|NCT03175367|537110397|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
148898254|NCT03175367|537110398|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
148898255|NCT03175367|537110399|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
148898256|NCT03175367|537110400|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
148898257|NCT03175367|537110401|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
148898258|NCT03175367|537110402|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
148898259|NCT03175367|537110396|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898260|NCT03175367|537110397|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898261|NCT03175367|537110398|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898262|NCT03175367|537110399|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898263|NCT03175367|537110400|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898264|NCT03175367|537110401|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
148898265|NCT03175367|537110402|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
148898266|NCT03085095|537110407|FG000|Overall Study|Adverse Event|23|||
148898267|NCT03085095|537110408|FG001|Overall Study|Adverse Event|8|||
148898268|NCT03085095|537110407|FG000|Overall Study|Protocol Violation|0|||
148898269|NCT03085095|537110408|FG001|Overall Study|Protocol Violation|1|||
148898270|NCT03085095|537110407|FG000|Overall Study|Lost to Follow-up|2|||
148898271|NCT03085095|537110408|FG001|Overall Study|Lost to Follow-up|1|||
148898272|NCT03085095|537110407|FG000|Overall Study|Withdrawal by Subject|17|||
148898273|NCT03085095|537110408|FG001|Overall Study|Withdrawal by Subject|6|||
148898274|NCT03085095|537110407|FG000|Overall Study|Physician Decision|9|||
148898275|NCT03085095|537110408|FG001|Overall Study|Physician Decision|3|||
148898276|NCT03085095|537110407|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
148898277|NCT03085095|537110408|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
148898278|NCT03085095|537110407|FG000|Overall Study|Did not Receive Study Drug|2|||
148898279|NCT03085095|537110408|FG001|Overall Study|Did not Receive Study Drug|2|||
148898280|NCT03085095|537110407|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
148898281|NCT03085095|537110408|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
148798416|NCT00490035|536741312|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
148798417|NCT00490035|536741313|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
148798418|NCT00490035|536741310|FG000|Overall Study|AE of unknown type|0|||
148798419|NCT00490035|536741311|FG001|Overall Study|AE of unknown type|0|||
148798420|NCT00490035|536741312|FG002|Overall Study|AE of unknown type|2|||
148798421|NCT00490035|536741313|FG003|Overall Study|AE of unknown type|0|||
148798422|NCT00593918|536741314|FG000|Overall Study|Withdrawal by Subject|5|||
148798423|NCT00593918|536741315|FG001|Overall Study|Withdrawal by Subject|24|||
148798424|NCT01211145|536741319|FG000|Overall Study|Reason not specified|3|||
148798425|NCT01211145|536741320|FG001|Overall Study|Reason not specified|2|||
148798426|NCT01211145|536741321|FG002|Overall Study|Reason not specified|2|||
148798427|NCT01211145|536741322|FG003|Overall Study|Reason not specified|1|||
148798428|NCT01211145|536741319|FG000|Overall Study|Lost to Follow-up|3|||
148798429|NCT01211145|536741320|FG001|Overall Study|Lost to Follow-up|2|||
148798430|NCT01211145|536741321|FG002|Overall Study|Lost to Follow-up|1|||
148798431|NCT01211145|536741322|FG003|Overall Study|Lost to Follow-up|2|||
148798432|NCT01211145|536741319|FG000|Overall Study|Study-specific withdrawal criteria|1|||
148798433|NCT01211145|536741320|FG001|Overall Study|Study-specific withdrawal criteria|0|||
148798434|NCT01211145|536741321|FG002|Overall Study|Study-specific withdrawal criteria|0|||
148798435|NCT01211145|536741322|FG003|Overall Study|Study-specific withdrawal criteria|0|||
148798436|NCT01211145|536741319|FG000|Overall Study|Severe noncompliance to protocol|1|||
148798437|NCT01211145|536741320|FG001|Overall Study|Severe noncompliance to protocol|0|||
148798438|NCT01211145|536741321|FG002|Overall Study|Severe noncompliance to protocol|0|||
148798439|NCT01211145|536741322|FG003|Overall Study|Severe noncompliance to protocol|0|||
148798440|NCT01211145|536741319|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
148798441|NCT01211145|536741320|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
148798442|NCT01211145|536741321|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
148798443|NCT01211145|536741322|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
148798444|NCT01211145|536741319|FG000|Overall Study|Patient decision|2|||
148798445|NCT01211145|536741320|FG001|Overall Study|Patient decision|1|||
148798446|NCT01211145|536741321|FG002|Overall Study|Patient decision|0|||
148798447|NCT01211145|536741322|FG003|Overall Study|Patient decision|2|||
148798448|NCT00791999|536741323|FG000|Overall Study|Protocol planed withdrawal|14|||
148798449|NCT00791999|536741324|FG001|Overall Study|Protocol planed withdrawal|11|||
148798450|NCT00791999|536741325|FG002|Overall Study|Protocol planed withdrawal|11|||
148798451|NCT00791999|536741326|FG003|Overall Study|Protocol planed withdrawal|45|||
148798452|NCT00791999|536741323|FG000|Overall Study|Withdrawal by Subject|0|||
148798453|NCT00791999|536741324|FG001|Overall Study|Withdrawal by Subject|1|||
148798454|NCT00791999|536741325|FG002|Overall Study|Withdrawal by Subject|0|||
148798455|NCT00791999|536741326|FG003|Overall Study|Withdrawal by Subject|2|||
148798456|NCT00791999|536741323|FG000|Overall Study|Protocol Violation|3|||
148798457|NCT00791999|536741324|FG001|Overall Study|Protocol Violation|0|||
148798458|NCT00791999|536741325|FG002|Overall Study|Protocol Violation|1|||
148798459|NCT00791999|536741326|FG003|Overall Study|Protocol Violation|0|||
148798460|NCT00791999|536741323|FG000|Overall Study|Adverse Event|3|||
148798461|NCT00791999|536741324|FG001|Overall Study|Adverse Event|3|||
148798462|NCT00791999|536741325|FG002|Overall Study|Adverse Event|7|||
148798463|NCT00791999|536741326|FG003|Overall Study|Adverse Event|3|||
148798464|NCT00791999|536741323|FG000|Overall Study|Lack of Efficacy|0|||
148798465|NCT00791999|536741324|FG001|Overall Study|Lack of Efficacy|1|||
148798466|NCT00791999|536741325|FG002|Overall Study|Lack of Efficacy|0|||
148798467|NCT00791999|536741326|FG003|Overall Study|Lack of Efficacy|2|||
148798468|NCT00791999|536741323|FG000|Overall Study|Reason other than those above|1|||
148798469|NCT00791999|536741324|FG001|Overall Study|Reason other than those above|0|||
148798470|NCT00791999|536741325|FG002|Overall Study|Reason other than those above|1|||
148798471|NCT00791999|536741326|FG003|Overall Study|Reason other than those above|0|||
148798472|NCT00570401|536741331|FG000|Overall Study|Adverse Event|2|||
148798473|NCT00617357|536741332|FG000|Overall Study|Lost to Follow-up|7|||
148798474|NCT00617357|536741332|FG000|Overall Study|Death|5|||
148798475|NCT00617357|536741332|FG000|Overall Study|insurance concerns|2|||
148798476|NCT00617357|536741332|FG000|Overall Study|Withdrawal by Subject|1|||
148798477|NCT00617357|536741332|FG000|Overall Study|Physician Decision|1|||
148798478|NCT00427908|536741333|FG000|Primary Phase|Lost to Follow-up|4|||
148798479|NCT00427908|536741334|FG001|Primary Phase|Lost to Follow-up|0|||
148798480|NCT00427908|536741335|FG002|Primary Phase|Lost to Follow-up|2|||
148798481|NCT00427908|536741336|FG003|Primary Phase|Lost to Follow-up|0|||
148798482|NCT00427908|536741333|FG000|Primary Phase|Withdrawal by Subject|1|||
148798483|NCT00427908|536741334|FG001|Primary Phase|Withdrawal by Subject|2|||
148798484|NCT00427908|536741335|FG002|Primary Phase|Withdrawal by Subject|1|||
148798485|NCT00427908|536741336|FG003|Primary Phase|Withdrawal by Subject|0|||
148798486|NCT00427908|536741333|FG000|Primary Phase|Adverse Event|0|||
148798487|NCT00427908|536741334|FG001|Primary Phase|Adverse Event|1|||
148798488|NCT00427908|536741335|FG002|Primary Phase|Adverse Event|0|||
148898282|NCT03459079|537110410|FG000|Overall Study|Adverse Event|4|||
148898283|NCT03459079|537110411|FG001|Overall Study|Adverse Event|2|||
148898284|NCT03459079|537110412|FG002|Overall Study|Adverse Event|0|||
148898285|NCT03459079|537110410|FG000|Overall Study|Withdrawal by Subject|2|||
148898286|NCT03459079|537110411|FG001|Overall Study|Withdrawal by Subject|2|||
148898287|NCT03459079|537110412|FG002|Overall Study|Withdrawal by Subject|0|||
148898288|NCT00674817|537110413|FG000|Period 1|Withdrawal by Subject|2|||
148898289|NCT00674817|537110413|FG000|Period 1|Protocol Violation|1|||
148898290|NCT00674817|537110413|FG000|Period 3|Adverse Event|1|||
148898291|NCT00674817|537110413|FG000|Period 3|Protocol Violation|1|||
148898292|NCT00674817|537110413|FG000|Period 4|Adverse Event|1|||
148898293|NCT02379728|537110414|FG000|Overall Study|Lost to Follow-up|1|||
148898294|NCT02379728|537110415|FG001|Overall Study|Lost to Follow-up|0|||
148898295|NCT02379728|537110416|FG002|Overall Study|Lost to Follow-up|3|||
148898296|NCT02379728|537110417|FG003|Overall Study|Lost to Follow-up|0|||
148898297|NCT02379728|537110414|FG000|Overall Study|Withdrawal by Subject|5|||
148898298|NCT02379728|537110415|FG001|Overall Study|Withdrawal by Subject|0|||
148898299|NCT02379728|537110416|FG002|Overall Study|Withdrawal by Subject|5|||
148898300|NCT02379728|537110417|FG003|Overall Study|Withdrawal by Subject|3|||
148898301|NCT02379728|537110414|FG000|Overall Study|Protocol Violation|0|||
148898302|NCT02379728|537110415|FG001|Overall Study|Protocol Violation|0|||
148898303|NCT02379728|537110416|FG002|Overall Study|Protocol Violation|2|||
148898304|NCT02379728|537110417|FG003|Overall Study|Protocol Violation|0|||
148898305|NCT04945733|537110419|FG000|Overall Study|Physician Decision|1|||
148898306|NCT04945733|537110420|FG001|Overall Study|Physician Decision|3|||
148898307|NCT04945733|537110421|FG002|Overall Study|Physician Decision|0|||
148898308|NCT04945733|537110419|FG000|Overall Study|Withdrawal by Subject|3|||
148898309|NCT04945733|537110420|FG001|Overall Study|Withdrawal by Subject|3|||
148898310|NCT04945733|537110421|FG002|Overall Study|Withdrawal by Subject|0|||
148898311|NCT00726063|537110422|FG000|Overall Study|Adverse Event|9|||
148898312|NCT00726063|537110423|FG001|Overall Study|Adverse Event|7|||
148898313|NCT02007096|537110424|FG000|Overall Study|medication not available|2|||
148898314|NCT02007096|537110425|FG001|Overall Study|medication not available|0|||
148898315|NCT02007096|537110424|FG000|Overall Study|did not inject saline|0|||
148898316|NCT02007096|537110425|FG001|Overall Study|did not inject saline|3|||
148898317|NCT02007096|537110424|FG000|Overall Study|did not follow postoperative protocol|8|||
148898318|NCT02007096|537110425|FG001|Overall Study|did not follow postoperative protocol|11|||
148898319|NCT02007096|537110424|FG000|Overall Study|converted to open surgery|1|||
148898320|NCT02007096|537110425|FG001|Overall Study|converted to open surgery|1|||
148898321|NCT02007096|537110424|FG000|Overall Study|no mesh placed|0|||
148898322|NCT02007096|537110425|FG001|Overall Study|no mesh placed|1|||
148898323|NCT01231984|537110426|FG000|Study Period 1|Withdrawal by Subject|0|||
148898324|NCT01231984|537110427|FG001|Study Period 1|Withdrawal by Subject|0|||
148898325|NCT01231984|537110428|FG002|Study Period 1|Withdrawal by Subject|0|||
148898326|NCT01231984|537110429|FG003|Study Period 1|Withdrawal by Subject|1|||
148898327|NCT01231984|537110426|FG000|Study Period 1|Lost to Follow-up|1|||
148898328|NCT01231984|537110427|FG001|Study Period 1|Lost to Follow-up|1|||
148898329|NCT01231984|537110428|FG002|Study Period 1|Lost to Follow-up|1|||
148898330|NCT01231984|537110429|FG003|Study Period 1|Lost to Follow-up|0|||
148898331|NCT01231984|537110426|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
148898332|NCT01231984|537110427|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
148898333|NCT01231984|537110428|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
148898334|NCT01231984|537110429|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
148898335|NCT01231984|537110426|FG000|Study Period 1|Screen Failure|0|||
148898336|NCT01231984|537110427|FG001|Study Period 1|Screen Failure|0|||
148898337|NCT01231984|537110428|FG002|Study Period 1|Screen Failure|0|||
148898338|NCT01231984|537110429|FG003|Study Period 1|Screen Failure|1|||
148898339|NCT01231984|537110426|FG000|Study Period 1|Non-compliance with study requirements|5|||
148898340|NCT01231984|537110427|FG001|Study Period 1|Non-compliance with study requirements|0|||
148898341|NCT01231984|537110428|FG002|Study Period 1|Non-compliance with study requirements|2|||
148898342|NCT01231984|537110429|FG003|Study Period 1|Non-compliance with study requirements|1|||
148898343|NCT01231984|537110426|FG000|Study Period 1|Protocol Violation|3|||
148898344|NCT01231984|537110427|FG001|Study Period 1|Protocol Violation|4|||
148898345|NCT01231984|537110428|FG002|Study Period 1|Protocol Violation|2|||
149011479|NCT00405639|537521478|FG001|Overall Study|Withdrawal by Subject|0|||
148898346|NCT01231984|537110429|FG003|Study Period 1|Protocol Violation|3|||
148898347|NCT01231984|537110426|FG000|Study Period 1|Adverse Event|1|||
148898348|NCT01231984|537110427|FG001|Study Period 1|Adverse Event|0|||
148898349|NCT01231984|537110428|FG002|Study Period 1|Adverse Event|0|||
148898350|NCT01231984|537110429|FG003|Study Period 1|Adverse Event|0|||
148898351|NCT01231984|537110426|FG000|Study Period 1|Other|0|||
148898352|NCT01231984|537110427|FG001|Study Period 1|Other|0|||
148898353|NCT01231984|537110428|FG002|Study Period 1|Other|0|||
148898354|NCT01231984|537110429|FG003|Study Period 1|Other|1|||
148898355|NCT01231984|537110426|FG000|Study Period 2|Withdrawal by Subject|1|||
148898356|NCT01231984|537110427|FG001|Study Period 2|Withdrawal by Subject|1|||
148898357|NCT01231984|537110428|FG002|Study Period 2|Withdrawal by Subject|0|||
148898358|NCT01231984|537110429|FG003|Study Period 2|Withdrawal by Subject|0|||
148898359|NCT01231984|537110426|FG000|Study Period 2|Lost to Follow-up|1|||
148898360|NCT01231984|537110427|FG001|Study Period 2|Lost to Follow-up|0|||
148898361|NCT01231984|537110428|FG002|Study Period 2|Lost to Follow-up|0|||
148898362|NCT01231984|537110429|FG003|Study Period 2|Lost to Follow-up|3|||
148898363|NCT01231984|537110426|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
148898364|NCT01231984|537110427|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
148898365|NCT01231984|537110428|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
148898366|NCT01231984|537110429|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
148898367|NCT02182895|537110432|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
148898368|NCT02182895|537110433|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
148898369|NCT03566511|537110437|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
148898370|NCT03566511|537110438|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
148898371|NCT00981656|537110440|FG000|Overall Study|Protocol Violation|1|||
148898372|NCT00981656|537110440|FG000|Overall Study|Did not start protocol treatment|2|||
148898373|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
148898374|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
148898375|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
148898376|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
148898377|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
148898378|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
148898379|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
148898380|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
148898381|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
148898382|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148898383|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
148898384|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148898385|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
148898386|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
148898387|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
148798489|NCT00427908|536741336|FG003|Primary Phase|Adverse Event|0|||
148798490|NCT04202497|536741340|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
148798491|NCT04202497|536741341|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
148798492|NCT04202497|536741342|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
148798493|NCT04202497|536741343|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
148798494|NCT04344301|536741344|FG000|Overall Study|Withdrawal by Subject|1|||
148798495|NCT04344301|536741345|FG001|Overall Study|Withdrawal by Subject|0|||
148798496|NCT04344301|536741344|FG000|Overall Study|Death|0|||
148798497|NCT04344301|536741345|FG001|Overall Study|Death|1|||
148798498|NCT01747499|536741346|FG000|Overall Study|Steroid refractory aGvHD|1|||
148798499|NCT01747499|536741347|FG001|Overall Study|Steroid refractory aGvHD|0|||
148798500|NCT01747499|536741348|FG002|Overall Study|Steroid refractory aGvHD|0|||
148798501|NCT01747499|536741349|FG003|Overall Study|Steroid refractory aGvHD|1|||
148798502|NCT01747499|536741350|FG004|Overall Study|Steroid refractory aGvHD|4|||
148798503|NCT01747499|536741346|FG000|Overall Study|Physician Decision|0|||
148798504|NCT01747499|536741347|FG001|Overall Study|Physician Decision|1|||
148798505|NCT01747499|536741348|FG002|Overall Study|Physician Decision|0|||
148798506|NCT01747499|536741349|FG003|Overall Study|Physician Decision|0|||
148798507|NCT01747499|536741350|FG004|Overall Study|Physician Decision|2|||
148798508|NCT01747499|536741346|FG000|Overall Study|Death|0|||
148798509|NCT01747499|536741347|FG001|Overall Study|Death|0|||
148798510|NCT01747499|536741348|FG002|Overall Study|Death|0|||
148798511|NCT01747499|536741349|FG003|Overall Study|Death|1|||
148798512|NCT01747499|536741350|FG004|Overall Study|Death|1|||
148798513|NCT01747499|536741346|FG000|Overall Study|Withdrawal by Subject|0|||
148798514|NCT01747499|536741347|FG001|Overall Study|Withdrawal by Subject|0|||
148798515|NCT01747499|536741348|FG002|Overall Study|Withdrawal by Subject|0|||
148798516|NCT01747499|536741349|FG003|Overall Study|Withdrawal by Subject|0|||
148798517|NCT01747499|536741350|FG004|Overall Study|Withdrawal by Subject|6|||
148798518|NCT01747499|536741346|FG000|Overall Study|Developed AML and death|0|||
148798519|NCT01747499|536741347|FG001|Overall Study|Developed AML and death|0|||
148798520|NCT01747499|536741348|FG002|Overall Study|Developed AML and death|0|||
148798521|NCT01747499|536741349|FG003|Overall Study|Developed AML and death|0|||
148798522|NCT01747499|536741350|FG004|Overall Study|Developed AML and death|1|||
148798523|NCT01747499|536741346|FG000|Overall Study|Determined not to be eligible|0|||
148798524|NCT01747499|536741347|FG001|Overall Study|Determined not to be eligible|0|||
148798525|NCT01747499|536741348|FG002|Overall Study|Determined not to be eligible|0|||
148798526|NCT01747499|536741349|FG003|Overall Study|Determined not to be eligible|0|||
148798527|NCT01747499|536741350|FG004|Overall Study|Determined not to be eligible|1|||
148898388|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
148898389|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
148898390|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
148898391|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
148898392|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
148898393|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
148898394|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
148898395|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
148898396|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
148898397|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
148898398|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
148898399|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
148898400|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
148898401|NCT04026113|537110441|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
148898402|NCT04026113|537110442|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
148898403|NCT04026113|537110443|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
148898404|NCT04026113|537110444|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
148898405|NCT04026113|537110441|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
148898406|NCT04026113|537110442|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
148898407|NCT04026113|537110443|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
148898408|NCT04026113|537110444|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
148898409|NCT00687596|537110445|FG000|Overall Study|Adverse Event (AE)|10|||
148898410|NCT00687596|537110446|FG001|Overall Study|Adverse Event (AE)|3|||
148898411|NCT00687596|537110445|FG000|Overall Study|Radiological Disease Progression|6|||
148898412|NCT00687596|537110446|FG001|Overall Study|Radiological Disease Progression|2|||
148898413|NCT00687596|537110445|FG000|Overall Study|Clinical Disease Progression|1|||
148898414|NCT00687596|537110446|FG001|Overall Study|Clinical Disease Progression|3|||
148898415|NCT00687596|537110445|FG000|Overall Study|Investigator Discretion|3|||
148898416|NCT00687596|537110446|FG001|Overall Study|Investigator Discretion|1|||
148898417|NCT00687596|537110445|FG000|Overall Study|Sponsor Terminated Study|6|||
148898418|NCT00687596|537110446|FG001|Overall Study|Sponsor Terminated Study|17|||
148898419|NCT04613362|537110447|FG000|3 Month Follow-up|Lost to Follow-up|1|||
148898420|NCT04613362|537110448|FG001|3 Month Follow-up|Lost to Follow-up|2|||
148898421|NCT04613362|537110447|FG000|6 Month Follow-up|Lost to Follow-up|0|||
148898422|NCT04613362|537110448|FG001|6 Month Follow-up|Lost to Follow-up|1|||
148898423|NCT02903771|537110449|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
148898424|NCT02903771|537110450|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
148898425|NCT02903771|537110451|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
148898426|NCT02903771|537110452|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
148898427|NCT02903771|537110453|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
148898428|NCT02903771|537110454|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
148898429|NCT02903771|537110455|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
148898430|NCT02903771|537110449|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
148898431|NCT02903771|537110450|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
148898432|NCT02903771|537110451|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
148898433|NCT02903771|537110452|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
148898434|NCT02903771|537110453|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
148898435|NCT02903771|537110454|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
148898436|NCT02903771|537110455|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
148898437|NCT02903771|537110449|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
148898438|NCT02903771|537110450|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
148898439|NCT02903771|537110451|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
148898440|NCT02903771|537110452|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
148898441|NCT02903771|537110453|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
148898442|NCT02903771|537110454|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
148898443|NCT02903771|537110455|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
148898444|NCT02903771|537110449|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
148898445|NCT02903771|537110450|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
148898446|NCT02903771|537110451|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
148898447|NCT02903771|537110452|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
148898448|NCT02903771|537110453|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
149137609|NCT00381563|537985174|FG000|Overall Study|Lost to Follow-up|2|||
149137610|NCT00381563|537985175|FG001|Overall Study|Lost to Follow-up|0|||
148898449|NCT02903771|537110454|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
149137611|NCT00381563|537985174|FG000|Overall Study|Protocol Violation|0|||
149137612|NCT00381563|537985175|FG001|Overall Study|Protocol Violation|1|||
149137613|NCT00024167|537985176|FG000|Overall Study|Death|53|||
149137614|NCT00024167|537985177|FG001|Overall Study|Death|47|||
149137615|NCT00770770|537985182|FG000|Overall Study|Lost to Follow-up|1|||
149137616|NCT00770770|537985183|FG001|Overall Study|Lost to Follow-up|0|||
148798528|NCT00072410|536741351|FG000|Overall Study|Progressive disease|0|||
148798529|NCT00072410|536741352|FG001|Overall Study|Progressive disease|3|||
148798530|NCT00485069|536741355|FG000|Overall Study|Adverse Event|10|||
148798531|NCT00485069|536741356|FG001|Overall Study|Adverse Event|4|||
148798532|NCT00485069|536741355|FG000|Overall Study|Lack of Efficacy|2|||
148798533|NCT00485069|536741356|FG001|Overall Study|Lack of Efficacy|1|||
148798534|NCT00485069|536741355|FG000|Overall Study|Protocol Violation|0|||
148798535|NCT00485069|536741356|FG001|Overall Study|Protocol Violation|1|||
148798536|NCT00485069|536741355|FG000|Overall Study|Withdrawal by Subject|6|||
148798537|NCT00485069|536741356|FG001|Overall Study|Withdrawal by Subject|6|||
148798538|NCT00248651|536741357|FG000|Overall Study|Withdrawal by Subject|28|||
148798539|NCT00248651|536741358|FG001|Overall Study|Withdrawal by Subject|40|||
148798540|NCT00248651|536741359|FG002|Overall Study|Withdrawal by Subject|32|||
148798541|NCT00828113|536741360|FG000|Overall Study|Withdrawal by Subject|27|||
148798542|NCT00828113|536741361|FG001|Overall Study|Withdrawal by Subject|26|||
148798543|NCT00828113|536741360|FG000|Overall Study|Lost to Follow-up|3|||
148798544|NCT00828113|536741361|FG001|Overall Study|Lost to Follow-up|5|||
148798545|NCT01365130|536741362|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
148798546|NCT05547386|536741363|FG000|Overall Study|Withdrawal by Subject|7|||
148798547|NCT04622969|536741364|FG000|Overall Study|Withdrawal by Subject|2|||
148798548|NCT04622969|536741365|FG001|Overall Study|Withdrawal by Subject|3|||
148798549|NCT05616013|536741366|FG000|Overall Study|Adverse Event|6|||
148798550|NCT05616013|536741367|FG001|Overall Study|Adverse Event|12|||
148798551|NCT05616013|536741368|FG002|Overall Study|Adverse Event|8|||
148798552|NCT05616013|536741369|FG003|Overall Study|Adverse Event|4|||
148798553|NCT05616013|536741370|FG004|Overall Study|Adverse Event|6|||
148798554|NCT05616013|536741371|FG005|Overall Study|Adverse Event|8|||
148798555|NCT05616013|536741372|FG006|Overall Study|Adverse Event|3|||
148798556|NCT05616013|536741373|FG007|Overall Study|Adverse Event|6|||
148798557|NCT05616013|536741374|FG008|Overall Study|Adverse Event|1|||
148798558|NCT05616013|536741366|FG000|Overall Study|Lost to Follow-up|5|||
148798559|NCT05616013|536741367|FG001|Overall Study|Lost to Follow-up|4|||
148798560|NCT05616013|536741368|FG002|Overall Study|Lost to Follow-up|3|||
148798561|NCT05616013|536741369|FG003|Overall Study|Lost to Follow-up|2|||
148798562|NCT05616013|536741370|FG004|Overall Study|Lost to Follow-up|0|||
148798563|NCT05616013|536741371|FG005|Overall Study|Lost to Follow-up|5|||
148798564|NCT05616013|536741372|FG006|Overall Study|Lost to Follow-up|2|||
148798565|NCT05616013|536741373|FG007|Overall Study|Lost to Follow-up|1|||
148798566|NCT05616013|536741374|FG008|Overall Study|Lost to Follow-up|2|||
148798567|NCT05616013|536741366|FG000|Overall Study|Non-compliance with study requirements|2|||
148798568|NCT05616013|536741367|FG001|Overall Study|Non-compliance with study requirements|2|||
148798569|NCT05616013|536741368|FG002|Overall Study|Non-compliance with study requirements|2|||
148798570|NCT05616013|536741369|FG003|Overall Study|Non-compliance with study requirements|3|||
148798571|NCT05616013|536741370|FG004|Overall Study|Non-compliance with study requirements|0|||
148798572|NCT05616013|536741371|FG005|Overall Study|Non-compliance with study requirements|2|||
148798573|NCT05616013|536741372|FG006|Overall Study|Non-compliance with study requirements|1|||
148798574|NCT05616013|536741373|FG007|Overall Study|Non-compliance with study requirements|1|||
148798575|NCT05616013|536741374|FG008|Overall Study|Non-compliance with study requirements|4|||
148798576|NCT05616013|536741366|FG000|Overall Study|Withdrawal by Subject|11|||
148798577|NCT05616013|536741367|FG001|Overall Study|Withdrawal by Subject|9|||
148798578|NCT05616013|536741368|FG002|Overall Study|Withdrawal by Subject|8|||
148798579|NCT05616013|536741369|FG003|Overall Study|Withdrawal by Subject|6|||
148798580|NCT05616013|536741370|FG004|Overall Study|Withdrawal by Subject|3|||
148798581|NCT05616013|536741371|FG005|Overall Study|Withdrawal by Subject|4|||
148798582|NCT05616013|536741372|FG006|Overall Study|Withdrawal by Subject|6|||
148798583|NCT05616013|536741373|FG007|Overall Study|Withdrawal by Subject|5|||
148898450|NCT02903771|537110455|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
148898451|NCT02903771|537110449|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
148898452|NCT02903771|537110450|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
148898453|NCT02903771|537110451|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
148898454|NCT02903771|537110452|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
148898455|NCT02903771|537110453|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
148898456|NCT02903771|537110454|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
148898457|NCT02903771|537110455|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
148898458|NCT02903771|537110449|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
148898459|NCT02903771|537110450|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
148898460|NCT02903771|537110451|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
148898461|NCT02903771|537110452|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
148898462|NCT02903771|537110453|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
148898463|NCT02903771|537110454|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
148898464|NCT02903771|537110455|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
148898465|NCT02903771|537110449|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
148898466|NCT02903771|537110450|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
148898467|NCT02903771|537110451|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
148898468|NCT02903771|537110452|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
148898469|NCT02903771|537110453|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
148898470|NCT02903771|537110454|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
148898471|NCT02903771|537110455|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
148898472|NCT02903771|537110449|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
148898473|NCT02903771|537110450|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
148898474|NCT02903771|537110451|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
148898475|NCT02903771|537110452|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
148898476|NCT02903771|537110453|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
148898477|NCT02903771|537110454|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
148898478|NCT02903771|537110455|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
148898479|NCT02903771|537110449|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
148898480|NCT02903771|537110450|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
148898481|NCT02903771|537110451|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
148898482|NCT02903771|537110452|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
148898483|NCT02903771|537110453|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
148898484|NCT02903771|537110454|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
148898485|NCT02903771|537110455|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
148898486|NCT02903771|537110449|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
148898487|NCT02903771|537110450|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
148898488|NCT02903771|537110451|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
148898489|NCT02903771|537110452|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
148898490|NCT02903771|537110453|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
148898491|NCT02903771|537110454|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
148898492|NCT02903771|537110455|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
148898493|NCT02903771|537110449|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
148898494|NCT02903771|537110450|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
148898495|NCT02903771|537110451|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
148898496|NCT02903771|537110452|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
148898497|NCT02903771|537110453|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
148898498|NCT02903771|537110454|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
148898499|NCT02903771|537110455|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
148898500|NCT02218372|537110456|FG000|Overall Study|Adverse Event|1|||
148898501|NCT02218372|537110457|FG001|Overall Study|Adverse Event|1|||
148898502|NCT02218372|537110456|FG000|Overall Study|Miscellaneous|2|||
148898503|NCT02218372|537110457|FG001|Overall Study|Miscellaneous|1|||
148898504|NCT02218372|537110456|FG000|Overall Study|Randomized but did not receive treatment|2|||
148898505|NCT02218372|537110457|FG001|Overall Study|Randomized but did not receive treatment|3|||
148898506|NCT02218372|537110456|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148898507|NCT02218372|537110457|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
148898508|NCT03406780|537110462|FG000|Overall Study|Withdrawal by Subject|1|||
148898509|NCT03406780|537110463|FG001|Overall Study|Withdrawal by Subject|1|||
148898510|NCT03406780|537110462|FG000|Overall Study|Other|0|||
148898511|NCT03406780|537110463|FG001|Overall Study|Other|2|||
148898512|NCT01488045|537110468|FG000|Overall Study|Withdrawal by Subject|6|||
148898513|NCT01488045|537110469|FG001|Overall Study|Withdrawal by Subject|11|||
148898514|NCT01488045|537110468|FG000|Overall Study|Failure to present for colonoscopy|3|||
148898515|NCT01488045|537110469|FG001|Overall Study|Failure to present for colonoscopy|6|||
148898516|NCT01488045|537110468|FG000|Overall Study|Failure to report exclusion criteria|0|||
148898517|NCT01488045|537110469|FG001|Overall Study|Failure to report exclusion criteria|1|||
148898518|NCT05365217|537110471|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148898519|NCT05365217|537110472|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148898520|NCT01527149|537110473|FG000|Overall Study|Death|2|||
148898521|NCT03331315|537110474|FG000|Overall Study|Physician Decision|18|||
148898522|NCT03331315|537110475|FG001|Overall Study|Physician Decision|14|||
148898523|NCT02230410|537110476|FG000|Overall Study|Screen Failure|3|||
148898524|NCT00656513|537110482|FG000|Overall Study|Protocol Violation|1|||
148898525|NCT00656513|537110483|FG001|Overall Study|Protocol Violation|0|||
148898526|NCT00656513|537110484|FG002|Overall Study|Protocol Violation|2|||
148898527|NCT00656513|537110482|FG000|Overall Study|Withdrawal by Subject|0|||
148898528|NCT00656513|537110483|FG001|Overall Study|Withdrawal by Subject|11|||
148898529|NCT00656513|537110484|FG002|Overall Study|Withdrawal by Subject|4|||
148898530|NCT00656513|537110482|FG000|Overall Study|Death|0|||
148898531|NCT00656513|537110483|FG001|Overall Study|Death|0|||
149137617|NCT00770770|537985182|FG000|Overall Study|Withdrawal by Subject|1|||
149137618|NCT00770770|537985183|FG001|Overall Study|Withdrawal by Subject|0|||
149137619|NCT00770770|537985182|FG000|Overall Study|Death|0|||
149137620|NCT00770770|537985183|FG001|Overall Study|Death|1|||
149137621|NCT00770770|537985182|FG000|Overall Study|Study Terminated|8|||
149137622|NCT00770770|537985183|FG001|Overall Study|Study Terminated|0|||
149137623|NCT00117507|537985185|FG000|Overall Study|Adverse Event|4|||
149137624|NCT00117507|537985185|FG000|Overall Study|Abnormal laboratory values|3|||
149137625|NCT00117507|537985185|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149137626|NCT00117507|537985185|FG000|Overall Study|Patient withdrew consent|4|||
149137627|NCT00117507|537985185|FG000|Overall Study|Death|3|||
149137628|NCT01505010|537985186|FG000|Overall Study|Protocol Violation|0|||
149137629|NCT01505010|537985187|FG001|Overall Study|Protocol Violation|1|||
149137630|NCT01505010|537985186|FG000|Overall Study|Lost to Follow-up|0|||
149137631|NCT01505010|537985187|FG001|Overall Study|Lost to Follow-up|1|||
149137632|NCT04513665|537985194|FG000|Overall Study|Adverse Event|2|||
149137633|NCT04513665|537985195|FG001|Overall Study|Adverse Event|0|||
149137634|NCT04513665|537985194|FG000|Overall Study|Lack of Efficacy|14|||
148898532|NCT00656513|537110484|FG002|Overall Study|Death|1|||
148898533|NCT00656513|537110482|FG000|Overall Study|Missing data|0|||
148898534|NCT00656513|537110483|FG001|Overall Study|Missing data|11|||
148898535|NCT00656513|537110484|FG002|Overall Study|Missing data|9|||
148898536|NCT00656513|537110482|FG000|Overall Study|Incomplete treatment|3|||
148898537|NCT00656513|537110483|FG001|Overall Study|Incomplete treatment|0|||
148898538|NCT00656513|537110484|FG002|Overall Study|Incomplete treatment|0|||
149011480|NCT00405639|537521477|FG000|Overall Study|Adverse Event|1|||
149137635|NCT04513665|537985195|FG001|Overall Study|Lack of Efficacy|0|||
149137636|NCT01368042|537985196|FG000|Overall Study|Death|14|||
149137637|NCT01368042|537985196|FG000|Overall Study|Protocol Violation|11|||
149137638|NCT01368042|537985196|FG000|Overall Study|Lost to Follow-up|4|||
148898539|NCT00656513|537110482|FG000|Overall Study|Treatment completed outside of timeframe|0|||
148898540|NCT00656513|537110483|FG001|Overall Study|Treatment completed outside of timeframe|3|||
148898541|NCT00656513|537110484|FG002|Overall Study|Treatment completed outside of timeframe|1|||
148898542|NCT00656513|537110482|FG000|Overall Study|Missing baseline form|0|||
148898543|NCT00656513|537110483|FG001|Overall Study|Missing baseline form|5|||
148898544|NCT00656513|537110484|FG002|Overall Study|Missing baseline form|5|||
148898545|NCT04558125|537110485|FG000|Overall Study|Death|1|||
148898546|NCT03199976|537110486|FG000|Overall Study|Lack of Efficacy|3|||
148898547|NCT03199976|537110487|FG001|Overall Study|Lack of Efficacy|6|||
148898548|NCT03199976|537110488|FG002|Overall Study|Lack of Efficacy|13|||
148898549|NCT03199976|537110486|FG000|Overall Study|Withdrawal by Subject|1|||
148898550|NCT03199976|537110487|FG001|Overall Study|Withdrawal by Subject|0|||
148898551|NCT03199976|537110488|FG002|Overall Study|Withdrawal by Subject|0|||
148898552|NCT03199976|537110486|FG000|Overall Study|Lost to Follow-up|0|||
148898553|NCT03199976|537110487|FG001|Overall Study|Lost to Follow-up|1|||
148898554|NCT03199976|537110488|FG002|Overall Study|Lost to Follow-up|1|||
148898555|NCT01761877|537110489|FG000|Overall Study|Adverse Event|7|||
148898556|NCT01761877|537110490|FG001|Overall Study|Adverse Event|0|||
148898557|NCT01761877|537110489|FG000|Overall Study|Withdrawal by Subject|6|||
148898558|NCT01761877|537110490|FG001|Overall Study|Withdrawal by Subject|4|||
148898559|NCT01761877|537110489|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
148898560|NCT01761877|537110490|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
148898561|NCT01761877|537110489|FG000|Overall Study|Death|0|||
148898562|NCT01761877|537110490|FG001|Overall Study|Death|1|||
148898563|NCT01761877|537110489|FG000|Overall Study|MRI intolerant|1|||
148898564|NCT01761877|537110490|FG001|Overall Study|MRI intolerant|6|||
148898565|NCT03962491|537110491|FG000|Overall Study|Lost to Follow-up|4|||
148898566|NCT03962491|537110492|FG001|Overall Study|Lost to Follow-up|5|||
148898567|NCT03697252|537110499|FG000|Overall Study|Adverse Event|3|||
148898568|NCT03697252|537110500|FG001|Overall Study|Adverse Event|2|||
148898569|NCT03697252|537110499|FG000|Overall Study|Withdrawal by Subject|14|||
148898570|NCT03697252|537110500|FG001|Overall Study|Withdrawal by Subject|14|||
148898571|NCT03697252|537110499|FG000|Overall Study|Lost to Follow-up|0|||
148898572|NCT03697252|537110500|FG001|Overall Study|Lost to Follow-up|1|||
148898573|NCT03697252|537110499|FG000|Overall Study|Physician Decision|1|||
148898574|NCT03697252|537110500|FG001|Overall Study|Physician Decision|1|||
148898575|NCT03697252|537110499|FG000|Overall Study|Other|0|||
148898576|NCT03697252|537110500|FG001|Overall Study|Other|1|||
148898577|NCT00561652|537110506|FG000|Overall Study|Withdrawal by Subject|0|||
148898578|NCT00561652|537110507|FG001|Overall Study|Withdrawal by Subject|1|||
148898579|NCT04842747|537110508|FG000|Overall Study|Withdrawal by Subject|6|||
148898580|NCT04842747|537110509|FG001|Overall Study|Withdrawal by Subject|2|||
148898581|NCT04842747|537110508|FG000|Overall Study|Lost to Follow-up|1|||
148898582|NCT04842747|537110509|FG001|Overall Study|Lost to Follow-up|2|||
148898583|NCT04842747|537110508|FG000|Overall Study|Physician Decision|1|||
148898584|NCT04842747|537110509|FG001|Overall Study|Physician Decision|0|||
148898585|NCT04842747|537110508|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
148898586|NCT04842747|537110509|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
148898587|NCT01743469|537110510|FG000|Active Treatment Phase|Adverse Event|10|||
149011481|NCT00405639|537521478|FG001|Overall Study|Adverse Event|0|||
148798584|NCT05616013|536741374|FG008|Overall Study|Withdrawal by Subject|4|||
148798585|NCT05616013|536741366|FG000|Overall Study|Physician Decision|0|||
148798586|NCT05616013|536741367|FG001|Overall Study|Physician Decision|0|||
148798587|NCT05616013|536741368|FG002|Overall Study|Physician Decision|1|||
148798588|NCT05616013|536741369|FG003|Overall Study|Physician Decision|0|||
148798589|NCT05616013|536741370|FG004|Overall Study|Physician Decision|0|||
148798590|NCT05616013|536741371|FG005|Overall Study|Physician Decision|1|||
148798591|NCT05616013|536741372|FG006|Overall Study|Physician Decision|3|||
148798592|NCT05616013|536741373|FG007|Overall Study|Physician Decision|0|||
148798593|NCT05616013|536741374|FG008|Overall Study|Physician Decision|0|||
148798594|NCT05616013|536741366|FG000|Overall Study|Protocol Violation|0|||
148798595|NCT05616013|536741367|FG001|Overall Study|Protocol Violation|0|||
148798596|NCT05616013|536741368|FG002|Overall Study|Protocol Violation|0|||
148798597|NCT05616013|536741369|FG003|Overall Study|Protocol Violation|0|||
148798598|NCT05616013|536741370|FG004|Overall Study|Protocol Violation|0|||
148798599|NCT05616013|536741371|FG005|Overall Study|Protocol Violation|0|||
148798600|NCT05616013|536741372|FG006|Overall Study|Protocol Violation|1|||
148798601|NCT05616013|536741373|FG007|Overall Study|Protocol Violation|0|||
148798602|NCT05616013|536741374|FG008|Overall Study|Protocol Violation|2|||
148798603|NCT05616013|536741366|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
148798604|NCT05616013|536741367|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798605|NCT05616013|536741368|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798606|NCT05616013|536741369|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798607|NCT05616013|536741370|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798608|NCT05616013|536741371|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798609|NCT05616013|536741372|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798610|NCT05616013|536741373|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798611|NCT05616013|536741374|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
148798612|NCT05616013|536741366|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
148798613|NCT05616013|536741367|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798614|NCT05616013|536741368|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148811221|NCT01995201|536787047|FG000|From Baseline Until Week 24|Adverse Event|4|||
148811222|NCT01995201|536787048|FG001|From Baseline Until Week 24|Adverse Event|15|||
148811223|NCT01995201|536787049|FG002|From Baseline Until Week 24|Adverse Event|0|||
148811224|NCT01995201|536787050|FG003|From Baseline Until Week 24|Adverse Event|0|||
148811225|NCT01995201|536787051|FG004|From Baseline Until Week 24|Adverse Event|0|||
148811226|NCT01995201|536787052|FG005|From Baseline Until Week 24|Adverse Event|0|||
148811227|NCT01995201|536787053|FG006|From Baseline Until Week 24|Adverse Event|0|||
148811228|NCT01995201|536787047|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
148811229|NCT01995201|536787048|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
148811230|NCT01995201|536787049|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
148811231|NCT01995201|536787050|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
148811232|NCT01995201|536787051|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
148811233|NCT01995201|536787052|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
148811234|NCT01995201|536787053|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
148811235|NCT01995201|536787047|FG000|From Baseline Until Week 24|Death|0|||
148811236|NCT01995201|536787048|FG001|From Baseline Until Week 24|Death|1|||
148811237|NCT01995201|536787049|FG002|From Baseline Until Week 24|Death|0|||
148811238|NCT01995201|536787050|FG003|From Baseline Until Week 24|Death|0|||
148811239|NCT01995201|536787051|FG004|From Baseline Until Week 24|Death|0|||
148811240|NCT01995201|536787052|FG005|From Baseline Until Week 24|Death|0|||
148811241|NCT01995201|536787053|FG006|From Baseline Until Week 24|Death|0|||
148811242|NCT01995201|536787047|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
148811243|NCT01995201|536787048|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
148898588|NCT01743469|537110511|FG001|Active Treatment Phase|Adverse Event|5|||
148898589|NCT01743469|537110512|FG002|Active Treatment Phase|Adverse Event|8|||
148898590|NCT01743469|537110513|FG003|Active Treatment Phase|Adverse Event|1|||
148898591|NCT01743469|537110510|FG000|Active Treatment Phase|Disease Progression|40|||
148898592|NCT01743469|537110511|FG001|Active Treatment Phase|Disease Progression|47|||
148898593|NCT01743469|537110512|FG002|Active Treatment Phase|Disease Progression|30|||
148898594|NCT01743469|537110513|FG003|Active Treatment Phase|Disease Progression|20|||
148898595|NCT01743469|537110510|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
148898596|NCT01743469|537110511|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
148898597|NCT01743469|537110512|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
148898598|NCT01743469|537110513|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
148898599|NCT01743469|537110510|FG000|Active Treatment Phase|Missing|1|||
148898600|NCT01743469|537110511|FG001|Active Treatment Phase|Missing|0|||
148898601|NCT01743469|537110512|FG002|Active Treatment Phase|Missing|0|||
148898602|NCT01743469|537110513|FG003|Active Treatment Phase|Missing|0|||
148898603|NCT01743469|537110510|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
148898604|NCT01743469|537110511|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
148898605|NCT01743469|537110512|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
148898606|NCT01743469|537110513|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
148898607|NCT01743469|537110510|FG000|Follow-up Period - Post-Treatment|Death|43|||
148898608|NCT01743469|537110511|FG001|Follow-up Period - Post-Treatment|Death|47|||
148898609|NCT01743469|537110512|FG002|Follow-up Period - Post-Treatment|Death|22|||
148898610|NCT01743469|537110513|FG003|Follow-up Period - Post-Treatment|Death|16|||
148898611|NCT01743469|537110510|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
148898612|NCT01743469|537110511|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
148898613|NCT01743469|537110512|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
148898614|NCT01743469|537110513|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
148898615|NCT00317473|537110514|FG000|Overall Study|Withdrawal by Subject|2|||
148898616|NCT00317473|537110515|FG001|Overall Study|Withdrawal by Subject|1|||
148898617|NCT00317473|537110516|FG002|Overall Study|Withdrawal by Subject|2|||
148898618|NCT00317473|537110517|FG003|Overall Study|Withdrawal by Subject|1|||
148898619|NCT00317473|537110518|FG004|Overall Study|Withdrawal by Subject|3|||
148898620|NCT00317473|537110519|FG005|Overall Study|Withdrawal by Subject|1|||
148898621|NCT00317473|537110514|FG000|Overall Study|Relocation|1|||
148898622|NCT00317473|537110515|FG001|Overall Study|Relocation|0|||
148898623|NCT00317473|537110516|FG002|Overall Study|Relocation|1|||
148898624|NCT00317473|537110517|FG003|Overall Study|Relocation|1|||
148898625|NCT00317473|537110518|FG004|Overall Study|Relocation|5|||
148898626|NCT00317473|537110519|FG005|Overall Study|Relocation|2|||
148898627|NCT00317473|537110514|FG000|Overall Study|Death|1|||
148898628|NCT00317473|537110515|FG001|Overall Study|Death|0|||
148898629|NCT00317473|537110516|FG002|Overall Study|Death|0|||
148898630|NCT00317473|537110517|FG003|Overall Study|Death|0|||
148898631|NCT00317473|537110518|FG004|Overall Study|Death|0|||
148898632|NCT00317473|537110519|FG005|Overall Study|Death|0|||
148898633|NCT00317473|537110514|FG000|Overall Study|Other|0|||
148898634|NCT00317473|537110515|FG001|Overall Study|Other|2|||
148898635|NCT00317473|537110516|FG002|Overall Study|Other|0|||
148898636|NCT00317473|537110517|FG003|Overall Study|Other|0|||
148898637|NCT00317473|537110518|FG004|Overall Study|Other|0|||
148898638|NCT00317473|537110519|FG005|Overall Study|Other|0|||
148898639|NCT01502293|537110523|FG000|Overall Study|Progressive Disease|20|||
148898640|NCT01502293|537110524|FG001|Overall Study|Progressive Disease|12|||
148898641|NCT01502293|537110525|FG002|Overall Study|Progressive Disease|2|||
148898642|NCT01502293|537110523|FG000|Overall Study|Withdrawal by Subject|3|||
148898643|NCT01502293|537110524|FG001|Overall Study|Withdrawal by Subject|3|||
148898644|NCT01502293|537110525|FG002|Overall Study|Withdrawal by Subject|1|||
148898645|NCT01502293|537110523|FG000|Overall Study|Adverse Event|0|||
148898646|NCT01502293|537110524|FG001|Overall Study|Adverse Event|2|||
148898647|NCT01502293|537110525|FG002|Overall Study|Adverse Event|0|||
148898648|NCT01502293|537110523|FG000|Overall Study|Reason Not Specified|2|||
148898649|NCT01502293|537110524|FG001|Overall Study|Reason Not Specified|0|||
148898650|NCT01502293|537110525|FG002|Overall Study|Reason Not Specified|0|||
148898651|NCT01502293|537110523|FG000|Overall Study|Physician Decision|0|||
148898652|NCT01502293|537110524|FG001|Overall Study|Physician Decision|0|||
148898653|NCT01502293|537110525|FG002|Overall Study|Physician Decision|1|||
148898654|NCT01126749|537110529|FG000|Phase 1b|Other|0|||
148898655|NCT01126749|537110530|FG001|Phase 1b|Other|1|||
148898656|NCT01126749|537110531|FG002|Phase 1b|Other|0|||
148898657|NCT01126749|537110532|FG003|Phase 1b|Other|0|||
148898658|NCT01126749|537110529|FG000|Phase 1b|Withdrawal by Subject|0|||
148898659|NCT01126749|537110530|FG001|Phase 1b|Withdrawal by Subject|1|||
148898660|NCT01126749|537110531|FG002|Phase 1b|Withdrawal by Subject|0|||
148898661|NCT01126749|537110532|FG003|Phase 1b|Withdrawal by Subject|0|||
148898662|NCT01126749|537110529|FG000|Phase 1b|Death|3|||
148898663|NCT01126749|537110530|FG001|Phase 1b|Death|4|||
148898664|NCT01126749|537110531|FG002|Phase 1b|Death|0|||
148898665|NCT01126749|537110532|FG003|Phase 1b|Death|0|||
148898666|NCT01126749|537110529|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
148898667|NCT01126749|537110530|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
148898668|NCT01126749|537110531|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
148898669|NCT01126749|537110532|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
148898670|NCT01126749|537110529|FG000|Phase 2|Study Termination by Sponsor|0|||
148898671|NCT01126749|537110530|FG001|Phase 2|Study Termination by Sponsor|0|||
148898672|NCT01126749|537110531|FG002|Phase 2|Study Termination by Sponsor|12|||
148898673|NCT01126749|537110532|FG003|Phase 2|Study Termination by Sponsor|6|||
148898674|NCT01126749|537110529|FG000|Phase 2|Other|0|||
148898675|NCT01126749|537110530|FG001|Phase 2|Other|0|||
148898676|NCT01126749|537110531|FG002|Phase 2|Other|4|||
148898677|NCT01126749|537110532|FG003|Phase 2|Other|2|||
148898678|NCT01126749|537110529|FG000|Phase 2|Withdrawal by Subject|0|||
148898679|NCT01126749|537110530|FG001|Phase 2|Withdrawal by Subject|0|||
148898680|NCT01126749|537110531|FG002|Phase 2|Withdrawal by Subject|0|||
148898681|NCT01126749|537110532|FG003|Phase 2|Withdrawal by Subject|2|||
148898682|NCT01126749|537110529|FG000|Phase 2|Lost to Follow-up|0|||
148898683|NCT01126749|537110530|FG001|Phase 2|Lost to Follow-up|0|||
148898684|NCT01126749|537110531|FG002|Phase 2|Lost to Follow-up|0|||
148898685|NCT01126749|537110532|FG003|Phase 2|Lost to Follow-up|1|||
148898686|NCT01126749|537110529|FG000|Phase 2|Death|0|||
148898687|NCT01126749|537110530|FG001|Phase 2|Death|0|||
148898688|NCT01126749|537110531|FG002|Phase 2|Death|22|||
148898689|NCT01126749|537110532|FG003|Phase 2|Death|22|||
148898690|NCT01126749|537110529|FG000|Phase 2|Adverse Event|0|||
148898691|NCT01126749|537110530|FG001|Phase 2|Adverse Event|0|||
148898692|NCT01126749|537110531|FG002|Phase 2|Adverse Event|0|||
148898693|NCT01126749|537110532|FG003|Phase 2|Adverse Event|1|||
148898694|NCT00976274|537110534|FG000|Overall Study|Lost to Follow-up|5|||
148898695|NCT00976274|537110535|FG001|Overall Study|Lost to Follow-up|5|||
148898696|NCT00976274|537110534|FG000|Overall Study|Withdrawal by Subject|1|||
148898697|NCT00976274|537110535|FG001|Overall Study|Withdrawal by Subject|1|||
148898698|NCT00976274|537110534|FG000|Overall Study|Physician Decision|1|||
148898699|NCT00976274|537110535|FG001|Overall Study|Physician Decision|2|||
148898700|NCT02183675|537110536|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
148898701|NCT02183675|537110537|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
148898702|NCT02183675|537110538|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
148898703|NCT02183675|537110539|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
148898704|NCT02183675|537110540|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
148898705|NCT02183675|537110541|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
148898706|NCT00627393|537110542|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
148898707|NCT00627393|537110543|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
148898708|NCT00627393|537110542|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
148898709|NCT00627393|537110543|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
148898710|NCT00627393|537110542|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
148898711|NCT00627393|537110543|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
148898712|NCT00627393|537110542|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
148898713|NCT00627393|537110543|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
148898714|NCT03337308|537110544|FG000|Overall Study|Adverse Event|2|||
148898715|NCT03337308|537110545|FG001|Overall Study|Adverse Event|3|||
148898716|NCT03337308|537110546|FG002|Overall Study|Adverse Event|3|||
148898717|NCT03337308|537110547|FG003|Overall Study|Adverse Event|1|||
148898718|NCT03337308|537110544|FG000|Overall Study|Lost to Follow-up|1|||
148898719|NCT03337308|537110545|FG001|Overall Study|Lost to Follow-up|2|||
148898720|NCT03337308|537110546|FG002|Overall Study|Lost to Follow-up|0|||
148898721|NCT03337308|537110547|FG003|Overall Study|Lost to Follow-up|0|||
148898722|NCT03337308|537110544|FG000|Overall Study|Withdrawal by Subject|2|||
148898723|NCT03337308|537110545|FG001|Overall Study|Withdrawal by Subject|1|||
148898724|NCT03337308|537110546|FG002|Overall Study|Withdrawal by Subject|2|||
148898725|NCT03337308|537110547|FG003|Overall Study|Withdrawal by Subject|1|||
148898726|NCT03337308|537110544|FG000|Overall Study|Protocol Violation|0|||
148898727|NCT03337308|537110545|FG001|Overall Study|Protocol Violation|1|||
148898728|NCT03337308|537110546|FG002|Overall Study|Protocol Violation|0|||
148898729|NCT03337308|537110547|FG003|Overall Study|Protocol Violation|0|||
148898730|NCT01668784|537110549|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
148898731|NCT01668784|537110550|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
148898732|NCT01668784|537110549|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
148898733|NCT01668784|537110550|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
148898734|NCT01668784|537110549|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
148898735|NCT01668784|537110550|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
148898736|NCT01668784|537110549|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
148898737|NCT01668784|537110550|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
148898738|NCT01668784|537110549|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
148898739|NCT01668784|537110550|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
148898740|NCT01668784|537110549|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
149137639|NCT01368042|537985196|FG000|Overall Study|Transplanted|1|||
149137640|NCT02663271|537985197|FG000|Overall Study|Withdrawal by Subject|5|||
148798615|NCT05616013|536741369|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798616|NCT05616013|536741370|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798617|NCT05616013|536741371|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798618|NCT05616013|536741372|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798619|NCT05616013|536741373|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798620|NCT05616013|536741374|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
148798621|NCT05616013|536741366|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
148798622|NCT05616013|536741367|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798623|NCT05616013|536741368|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798624|NCT05616013|536741369|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798625|NCT05616013|536741370|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798626|NCT05616013|536741371|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798627|NCT05616013|536741372|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798628|NCT05616013|536741373|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798629|NCT05616013|536741374|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
148798630|NCT05616013|536741366|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798631|NCT05616013|536741367|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
148798632|NCT05616013|536741368|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798633|NCT05616013|536741369|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798634|NCT05616013|536741370|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798635|NCT05616013|536741371|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798636|NCT05616013|536741372|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798637|NCT05616013|536741373|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798638|NCT05616013|536741374|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
148798639|NCT05616013|536741366|FG000|Overall Study|Participant Decision, Time Constraints|0|||
148898741|NCT01668784|537110550|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
148898742|NCT01668784|537110549|FG000|Treatment Period|Disease Progression|316|||
148898743|NCT01668784|537110550|FG001|Treatment Period|Disease Progression|293|||
148898744|NCT01668784|537110549|FG000|Treatment Period|Study Drug Toxicity|46|||
148898745|NCT01668784|537110550|FG001|Treatment Period|Study Drug Toxicity|53|||
148898746|NCT01668784|537110549|FG000|Treatment Period|Death|1|||
148898747|NCT01668784|537110550|FG001|Treatment Period|Death|1|||
148898748|NCT01668784|537110549|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
148898749|NCT01668784|537110550|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
148898750|NCT01668784|537110549|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
148898751|NCT01668784|537110550|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
148898752|NCT01668784|537110549|FG000|Treatment Period|Withdrawal by Subject|5|||
148898753|NCT01668784|537110550|FG001|Treatment Period|Withdrawal by Subject|3|||
148898754|NCT01668784|537110549|FG000|Treatment Period|Maximal Clinical Benefit|3|||
148898755|NCT01668784|537110550|FG001|Treatment Period|Maximal Clinical Benefit|3|||
148898756|NCT01668784|537110549|FG000|Treatment Period|Other|2|||
148898757|NCT01668784|537110550|FG001|Treatment Period|Other|8|||
148898758|NCT01668784|537110549|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
148898759|NCT01668784|537110550|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
148898760|NCT00374140|537110553|FG000|Overall Study|Lost to Follow-up|1|||
148898761|NCT00374140|537110553|FG000|Overall Study|Protocol Violation|1|||
148898762|NCT00604565|537110554|FG000|Overall Study|Study terminated|0|||
148898763|NCT00604565|537110555|FG001|Overall Study|Study terminated|3|||
148898764|NCT02992288|537112458|FG000|Overall Study|Adverse Event|8|||
148898765|NCT02992288|537112459|FG001|Overall Study|Adverse Event|2|||
148898766|NCT02992288|537112460|FG002|Overall Study|Adverse Event|2|||
148898767|NCT02992288|537112461|FG003|Overall Study|Adverse Event|2|||
148898768|NCT02992288|537112462|FG004|Overall Study|Adverse Event|2|||
148898769|NCT02992288|537112463|FG005|Overall Study|Adverse Event|7|||
148898770|NCT02992288|537112458|FG000|Overall Study|Non-compliance with study drug|0|||
148898771|NCT02992288|537112459|FG001|Overall Study|Non-compliance with study drug|1|||
148898772|NCT02992288|537112460|FG002|Overall Study|Non-compliance with study drug|1|||
148898773|NCT02992288|537112461|FG003|Overall Study|Non-compliance with study drug|0|||
148898774|NCT02992288|537112462|FG004|Overall Study|Non-compliance with study drug|1|||
148898775|NCT02992288|537112463|FG005|Overall Study|Non-compliance with study drug|0|||
148898776|NCT02992288|537112458|FG000|Overall Study|Physician Decision|3|||
148898777|NCT02992288|537112459|FG001|Overall Study|Physician Decision|0|||
148898778|NCT02992288|537112460|FG002|Overall Study|Physician Decision|1|||
148898779|NCT02992288|537112461|FG003|Overall Study|Physician Decision|0|||
148898780|NCT02992288|537112462|FG004|Overall Study|Physician Decision|0|||
148898781|NCT02992288|537112463|FG005|Overall Study|Physician Decision|1|||
148898782|NCT02992288|537112458|FG000|Overall Study|Death|2|||
148898783|NCT02992288|537112459|FG001|Overall Study|Death|0|||
148898784|NCT02992288|537112460|FG002|Overall Study|Death|2|||
148898785|NCT02992288|537112461|FG003|Overall Study|Death|1|||
148898786|NCT02992288|537112462|FG004|Overall Study|Death|2|||
148898787|NCT02992288|537112463|FG005|Overall Study|Death|0|||
148898788|NCT02992288|537112458|FG000|Overall Study|Lost to Follow-up|0|||
148898789|NCT02992288|537112459|FG001|Overall Study|Lost to Follow-up|0|||
148898790|NCT02992288|537112460|FG002|Overall Study|Lost to Follow-up|0|||
148898791|NCT02992288|537112461|FG003|Overall Study|Lost to Follow-up|1|||
148898792|NCT02992288|537112462|FG004|Overall Study|Lost to Follow-up|0|||
148898793|NCT02992288|537112463|FG005|Overall Study|Lost to Follow-up|0|||
148898794|NCT02992288|537112458|FG000|Overall Study|Protocol Violation|0|||
148898795|NCT02992288|537112459|FG001|Overall Study|Protocol Violation|0|||
148898796|NCT02992288|537112460|FG002|Overall Study|Protocol Violation|0|||
148898797|NCT02992288|537112461|FG003|Overall Study|Protocol Violation|0|||
148898798|NCT02992288|537112462|FG004|Overall Study|Protocol Violation|0|||
148898799|NCT02992288|537112463|FG005|Overall Study|Protocol Violation|1|||
148898800|NCT02992288|537112458|FG000|Overall Study|Withdrawal by Subject|4|||
148898801|NCT02992288|537112459|FG001|Overall Study|Withdrawal by Subject|2|||
148898802|NCT02992288|537112460|FG002|Overall Study|Withdrawal by Subject|1|||
148898803|NCT02992288|537112461|FG003|Overall Study|Withdrawal by Subject|5|||
148898804|NCT02992288|537112462|FG004|Overall Study|Withdrawal by Subject|3|||
148898805|NCT02992288|537112463|FG005|Overall Study|Withdrawal by Subject|4|||
148898806|NCT01748292|537112464|FG000|Overall Study|Adverse Event|2|||
148898807|NCT01748292|537112465|FG001|Overall Study|Adverse Event|4|||
148898808|NCT01748292|537112464|FG000|Overall Study|Lost to Follow-up|0|||
148898809|NCT01748292|537112465|FG001|Overall Study|Lost to Follow-up|3|||
148898810|NCT01748292|537112464|FG000|Overall Study|Death|0|||
148898811|NCT01748292|537112465|FG001|Overall Study|Death|3|||
148898812|NCT01748292|537112464|FG000|Overall Study|Withdrawal by Subject|0|||
148898813|NCT01748292|537112465|FG001|Overall Study|Withdrawal by Subject|2|||
148898814|NCT03379818|537112466|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
148898815|NCT03379818|537112467|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
148898816|NCT03379818|537112466|FG000|Overall Study|Withdrawal by Subject|2|||
148898817|NCT03379818|537112467|FG001|Overall Study|Withdrawal by Subject|3|||
149137641|NCT02663271|537985197|FG000|Overall Study|Lack of Efficacy|1|||
148798640|NCT05616013|536741367|FG001|Overall Study|Participant Decision, Time Constraints|1|||
148798641|NCT05616013|536741368|FG002|Overall Study|Participant Decision, Time Constraints|0|||
148798642|NCT05616013|536741369|FG003|Overall Study|Participant Decision, Time Constraints|0|||
148798643|NCT05616013|536741370|FG004|Overall Study|Participant Decision, Time Constraints|0|||
148798644|NCT05616013|536741371|FG005|Overall Study|Participant Decision, Time Constraints|0|||
148798645|NCT05616013|536741372|FG006|Overall Study|Participant Decision, Time Constraints|0|||
148798646|NCT05616013|536741373|FG007|Overall Study|Participant Decision, Time Constraints|0|||
148798647|NCT05616013|536741374|FG008|Overall Study|Participant Decision, Time Constraints|0|||
148798648|NCT05616013|536741366|FG000|Overall Study|Prohibited Concomitant Medication|0|||
148798649|NCT05616013|536741367|FG001|Overall Study|Prohibited Concomitant Medication|0|||
148798650|NCT05616013|536741368|FG002|Overall Study|Prohibited Concomitant Medication|1|||
148798651|NCT05616013|536741369|FG003|Overall Study|Prohibited Concomitant Medication|0|||
148798652|NCT05616013|536741370|FG004|Overall Study|Prohibited Concomitant Medication|0|||
148798653|NCT05616013|536741371|FG005|Overall Study|Prohibited Concomitant Medication|0|||
148798654|NCT05616013|536741372|FG006|Overall Study|Prohibited Concomitant Medication|0|||
148798655|NCT05616013|536741373|FG007|Overall Study|Prohibited Concomitant Medication|0|||
148798656|NCT05616013|536741374|FG008|Overall Study|Prohibited Concomitant Medication|0|||
148798657|NCT05616013|536741366|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798658|NCT05616013|536741367|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798659|NCT05616013|536741368|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
148798660|NCT05616013|536741369|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798661|NCT05616013|536741370|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798662|NCT05616013|536741371|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798663|NCT05616013|536741372|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798664|NCT05616013|536741373|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798665|NCT05616013|536741374|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
148798666|NCT05616013|536741366|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798667|NCT05616013|536741367|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798668|NCT05616013|536741368|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798669|NCT05616013|536741369|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
148798670|NCT05616013|536741370|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798671|NCT05616013|536741371|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148898818|NCT03379818|537112466|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
148898819|NCT03379818|537112467|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
148898820|NCT01867671|537112475|FG000|Overall Study|Adverse Event|5|||
148898821|NCT01867671|537112476|FG001|Overall Study|Adverse Event|3|||
148898822|NCT01867671|537112475|FG000|Overall Study|Anaphylaxis|0|||
148898823|NCT01867671|537112476|FG001|Overall Study|Anaphylaxis|1|||
148898824|NCT01867671|537112475|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
148898825|NCT01867671|537112476|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
148898826|NCT01867671|537112475|FG000|Overall Study|Lost to Follow-up|0|||
148898827|NCT01867671|537112476|FG001|Overall Study|Lost to Follow-up|1|||
148898828|NCT01867671|537112475|FG000|Overall Study|Non-compliance with Study Drug|1|||
148898829|NCT01867671|537112476|FG001|Overall Study|Non-compliance with Study Drug|2|||
148898830|NCT01867671|537112475|FG000|Overall Study|Withdrawal by Subject|21|||
148898831|NCT01867671|537112476|FG001|Overall Study|Withdrawal by Subject|21|||
148898832|NCT05236270|537112479|FG000|Overall Study|Lost to Follow-up|3|||
148898833|NCT05236270|537112480|FG001|Overall Study|Lost to Follow-up|2|||
148898834|NCT05236270|537112481|FG002|Overall Study|Lost to Follow-up|0|||
148898835|NCT05236270|537112482|FG003|Overall Study|Lost to Follow-up|0|||
148898836|NCT05236270|537112483|FG004|Overall Study|Lost to Follow-up|2|||
148898837|NCT05236270|537112484|FG005|Overall Study|Lost to Follow-up|0|||
148898838|NCT05236270|537112485|FG006|Overall Study|Lost to Follow-up|1|||
148898839|NCT05236270|537112486|FG007|Overall Study|Lost to Follow-up|3|||
148898840|NCT01499940|537112487|FG000|Overall Study|Study was withdrawn before completion.|9|||
148898841|NCT04097678|537112488|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
148898842|NCT04097678|537112489|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
148898843|NCT03694678|537112490|FG000|Overall Study|Withdrawal by Subject|2|||
148898844|NCT03694678|537112491|FG001|Overall Study|Withdrawal by Subject|0|||
148898845|NCT03694678|537112490|FG000|Overall Study|Lost to Follow-up|2|||
148898846|NCT03694678|537112491|FG001|Overall Study|Lost to Follow-up|3|||
148898847|NCT02435212|537112492|FG000|Core Phase|Adverse Event|8|||
148898848|NCT02435212|537112493|FG001|Core Phase|Adverse Event|5|||
148898849|NCT02435212|537112492|FG000|Core Phase|Withdrawal by Subject|3|||
148898850|NCT02435212|537112493|FG001|Core Phase|Withdrawal by Subject|0|||
148898851|NCT02435212|537112492|FG000|Core Phase|Withdrawal by parent/guardian|9|||
148898852|NCT02435212|537112493|FG001|Core Phase|Withdrawal by parent/guardian|4|||
148898853|NCT02435212|537112492|FG000|Core Phase|Protocol Violation|1|||
148798672|NCT05616013|536741372|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798673|NCT05616013|536741373|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798674|NCT05616013|536741374|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
148798675|NCT05616013|536741366|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798676|NCT05616013|536741367|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798677|NCT05616013|536741368|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798678|NCT05616013|536741369|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798679|NCT05616013|536741370|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798680|NCT05616013|536741371|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798681|NCT05616013|536741372|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
148798682|NCT05616013|536741373|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798683|NCT05616013|536741374|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
148798684|NCT05616013|536741366|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798685|NCT05616013|536741367|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798686|NCT05616013|536741368|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798687|NCT05616013|536741369|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798688|NCT05616013|536741370|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798689|NCT05616013|536741371|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798690|NCT05616013|536741372|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798691|NCT05616013|536741373|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
148798692|NCT05616013|536741374|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
148798693|NCT05616013|536741366|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798694|NCT05616013|536741367|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798695|NCT05616013|536741368|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798696|NCT05616013|536741369|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798697|NCT05616013|536741370|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798698|NCT05616013|536741371|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798699|NCT05616013|536741372|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798700|NCT05616013|536741373|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
148798701|NCT05616013|536741374|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
148798702|NCT05116202|536741375|FG000|Overall Study|Study Terminated by Sponsor|21|||
148798703|NCT05116202|536741376|FG001|Overall Study|Study Terminated by Sponsor|38|||
148798704|NCT05116202|536741377|FG002|Overall Study|Study Terminated by Sponsor|17|||
148798705|NCT05116202|536741378|FG003|Overall Study|Study Terminated by Sponsor|18|||
148798706|NCT05116202|536741379|FG004|Overall Study|Study Terminated by Sponsor|0|||
148798707|NCT05116202|536741375|FG000|Overall Study|Withdrawal by Subject|0|||
148798708|NCT05116202|536741376|FG001|Overall Study|Withdrawal by Subject|1|||
148798709|NCT05116202|536741377|FG002|Overall Study|Withdrawal by Subject|1|||
148798710|NCT05116202|536741378|FG003|Overall Study|Withdrawal by Subject|1|||
148798711|NCT05116202|536741379|FG004|Overall Study|Withdrawal by Subject|1|||
148798712|NCT05116202|536741375|FG000|Overall Study|Lost to Follow-up|0|||
148798713|NCT05116202|536741376|FG001|Overall Study|Lost to Follow-up|0|||
148798714|NCT05116202|536741377|FG002|Overall Study|Lost to Follow-up|0|||
148798715|NCT05116202|536741378|FG003|Overall Study|Lost to Follow-up|0|||
148798716|NCT05116202|536741379|FG004|Overall Study|Lost to Follow-up|2|||
148798717|NCT05116202|536741375|FG000|Overall Study|Death|1|||
148798718|NCT05116202|536741376|FG001|Overall Study|Death|1|||
148798719|NCT05116202|536741377|FG002|Overall Study|Death|2|||
148798720|NCT05116202|536741378|FG003|Overall Study|Death|1|||
148798721|NCT05116202|536741379|FG004|Overall Study|Death|5|||
148798722|NCT03834506|536741380|FG000|Overall Study|Death|336|||
148798723|NCT03834506|536741381|FG001|Overall Study|Death|326|||
148798724|NCT03834506|536741380|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148798725|NCT03834506|536741381|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
148798726|NCT03834506|536741380|FG000|Overall Study|Withdrawal by Subject|10|||
148798727|NCT03834506|536741381|FG001|Overall Study|Withdrawal by Subject|8|||
148798728|NCT03834506|536741380|FG000|Overall Study|Sponsor decision|165|||
148798729|NCT03834506|536741381|FG001|Overall Study|Sponsor decision|178|||
148798730|NCT03834506|536741380|FG000|Overall Study|Physician Decision|3|||
148798731|NCT03834506|536741381|FG001|Overall Study|Physician Decision|1|||
148798732|NCT03834506|536741380|FG000|Overall Study|Lost to Follow-up|0|||
148798733|NCT03834506|536741381|FG001|Overall Study|Lost to Follow-up|1|||
148798734|NCT05067972|536741382|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
148798735|NCT05067972|536741383|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
148798736|NCT05067972|536741384|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
148898854|NCT02435212|537112493|FG001|Core Phase|Protocol Violation|2|||
148898855|NCT02435212|537112492|FG000|Core Phase|Physician Decision|3|||
148898856|NCT02435212|537112493|FG001|Core Phase|Physician Decision|0|||
148898857|NCT02435212|537112492|FG000|Core Phase|Lost to Follow-up|0|||
148898858|NCT02435212|537112493|FG001|Core Phase|Lost to Follow-up|1|||
148898859|NCT02435212|537112492|FG000|Core Phase|Lack of Efficacy|0|||
148898860|NCT02435212|537112493|FG001|Core Phase|Lack of Efficacy|1|||
148898861|NCT02435212|537112492|FG000|Core Phase|Recovery|1|||
148898862|NCT02435212|537112493|FG001|Core Phase|Recovery|0|||
148898863|NCT02435212|537112492|FG000|Optional Extension Phase|Adverse Event|3|||
148898864|NCT02435212|537112493|FG001|Optional Extension Phase|Adverse Event|9|||
148898865|NCT02435212|537112492|FG000|Optional Extension Phase|Physician Decision|6|||
148898866|NCT02435212|537112493|FG001|Optional Extension Phase|Physician Decision|8|||
148898867|NCT02435212|537112492|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
148898868|NCT02435212|537112493|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
148898869|NCT02435212|537112492|FG000|Optional Extension Phase|Lack of Efficacy|2|||
148898870|NCT02435212|537112493|FG001|Optional Extension Phase|Lack of Efficacy|3|||
148898871|NCT02435212|537112492|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
148898872|NCT02435212|537112493|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
148898873|NCT02435212|537112492|FG000|Optional Extension Phase|Protocol Violation|0|||
148898874|NCT02435212|537112493|FG001|Optional Extension Phase|Protocol Violation|1|||
148898875|NCT02435212|537112492|FG000|Optional Extension Phase|Recovery|1|||
148898876|NCT02435212|537112493|FG001|Optional Extension Phase|Recovery|1|||
148898877|NCT02435212|537112492|FG000|Optional Extension Phase|Death|1|||
148898878|NCT02435212|537112493|FG001|Optional Extension Phase|Death|0|||
148898879|NCT02435212|537112492|FG000|Optional Extension Phase|Technical problems|2|||
148898880|NCT02435212|537112493|FG001|Optional Extension Phase|Technical problems|0|||
148898881|NCT04711850|537112497|FG000|Overall Study|Graft loss|2|||
148898882|NCT04711850|537112498|FG001|Overall Study|Graft loss|1|||
148898883|NCT04711850|537112497|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
148898884|NCT04711850|537112498|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
148898885|NCT04711850|537112497|FG000|Overall Study|Study terminated by sponsor|5|||
148898886|NCT04711850|537112498|FG001|Overall Study|Study terminated by sponsor|3|||
148898887|NCT04711850|537112497|FG000|Overall Study|Sponsor decision|0|||
148898888|NCT04711850|537112498|FG001|Overall Study|Sponsor decision|2|||
148898889|NCT05249582|537112499|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
148898890|NCT05249582|537112500|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
148898891|NCT05249582|537112499|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
148898892|NCT05249582|537112500|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
148898893|NCT05249582|537112499|FG000|Overall Study|Declined to use virtual reality headset|1|||
148898894|NCT05249582|537112500|FG001|Overall Study|Declined to use virtual reality headset|0|||
148898895|NCT03267277|537112501|FG000|Overall Study|Withdrawal by Subject|1|||
148898896|NCT04531176|537112524|FG000|Overall Study|Study was stopped early|24|||
148898897|NCT04531176|537112525|FG001|Overall Study|Study was stopped early|26|||
148898898|NCT04531176|537112526|FG002|Overall Study|Study was stopped early|24|||
148898899|NCT02285855|537112527|FG000|Overall Study|Withdrawal by Subject|2|||
148898900|NCT02285855|537112528|FG001|Overall Study|Withdrawal by Subject|1|||
148898901|NCT01451606|537112531|FG000|Overall Study|Withdrawal by Subject|4|||
148898902|NCT01451606|537112532|FG001|Overall Study|Withdrawal by Subject|3|||
148898903|NCT02718898|537112533|FG000|Blinded Treatment Period|Adverse Event|5|||
148898904|NCT02718898|537112534|FG001|Blinded Treatment Period|Adverse Event|1|||
148898905|NCT02718898|537112535|FG002|Blinded Treatment Period|Adverse Event|0|||
148898906|NCT02718898|537112536|FG003|Blinded Treatment Period|Adverse Event|0|||
148898907|NCT02718898|537112537|FG004|Blinded Treatment Period|Adverse Event|0|||
148898908|NCT02718898|537112538|FG005|Blinded Treatment Period|Adverse Event|0|||
148898909|NCT02718898|537112539|FG006|Blinded Treatment Period|Adverse Event|0|||
148898910|NCT02718898|537112533|FG000|Blinded Treatment Period|Physician Decision|1|||
148898911|NCT02718898|537112534|FG001|Blinded Treatment Period|Physician Decision|0|||
148898912|NCT02718898|537112535|FG002|Blinded Treatment Period|Physician Decision|0|||
148898913|NCT02718898|537112536|FG003|Blinded Treatment Period|Physician Decision|0|||
148898914|NCT02718898|537112537|FG004|Blinded Treatment Period|Physician Decision|0|||
148898915|NCT02718898|537112538|FG005|Blinded Treatment Period|Physician Decision|0|||
148898916|NCT02718898|537112539|FG006|Blinded Treatment Period|Physician Decision|0|||
148898917|NCT02718898|537112533|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
148898918|NCT02718898|537112534|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
148898919|NCT02718898|537112535|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
148898920|NCT02718898|537112536|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
148898921|NCT02718898|537112537|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
148898922|NCT02718898|537112538|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
148898923|NCT02718898|537112539|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
148898924|NCT02718898|537112533|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
148898925|NCT02718898|537112534|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
148898926|NCT02718898|537112535|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
148898927|NCT02718898|537112536|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
148898928|NCT02718898|537112537|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
148898929|NCT02718898|537112538|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
148898930|NCT02718898|537112539|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
148898931|NCT02718898|537112533|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
148898932|NCT02718898|537112534|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
148898933|NCT02718898|537112535|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
148898934|NCT02718898|537112536|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
148898935|NCT02718898|537112537|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
148898936|NCT02718898|537112538|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
148898937|NCT02718898|537112539|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
148898938|NCT02718898|537112533|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
148898939|NCT02718898|537112534|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
148898940|NCT02718898|537112535|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
148898941|NCT02718898|537112536|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
148898942|NCT02718898|537112537|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
148898943|NCT02718898|537112538|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
148898944|NCT02718898|537112539|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
148898945|NCT02718898|537112533|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898946|NCT02718898|537112534|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898947|NCT02718898|537112535|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
148898948|NCT02718898|537112536|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
148898949|NCT02718898|537112537|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898950|NCT02718898|537112538|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898951|NCT02718898|537112539|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148898952|NCT02718898|537112533|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
148898953|NCT02718898|537112534|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
148898954|NCT02718898|537112535|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
148898955|NCT02718898|537112536|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
148898956|NCT02718898|537112537|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
148898957|NCT02718898|537112538|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
148898958|NCT02718898|537112539|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
148898959|NCT02718898|537112533|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
148898960|NCT02718898|537112534|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
148898961|NCT02718898|537112535|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
148898962|NCT02718898|537112536|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
148898963|NCT02718898|537112537|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
148898964|NCT02718898|537112538|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
148898965|NCT02718898|537112539|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
148898966|NCT02718898|537112533|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
148898967|NCT02718898|537112534|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
148898968|NCT02718898|537112535|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
148898969|NCT02718898|537112536|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
148898970|NCT02718898|537112537|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
148898971|NCT02718898|537112538|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
148898972|NCT02718898|537112539|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
148898973|NCT02718898|537112533|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
148898974|NCT02718898|537112534|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
148898975|NCT02718898|537112535|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
148898976|NCT02718898|537112536|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
148898977|NCT02718898|537112537|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
148898978|NCT02718898|537112538|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
148898979|NCT02718898|537112539|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
148898980|NCT02718898|537112533|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
148898981|NCT02718898|537112534|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
148898982|NCT02718898|537112535|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
148898983|NCT02718898|537112536|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
148898984|NCT02718898|537112537|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
148898985|NCT02718898|537112538|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
148898986|NCT02718898|537112539|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
148898987|NCT02718898|537112533|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
148898988|NCT02718898|537112534|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
148898989|NCT02718898|537112535|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
148898990|NCT02718898|537112536|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
148898991|NCT02718898|537112537|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
148898992|NCT02718898|537112538|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
148898993|NCT02718898|537112539|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
148898994|NCT02163538|537112542|FG000|Overall Study|Protocol Violation|1|||
148898995|NCT02163538|537112543|FG001|Overall Study|Protocol Violation|0|||
148898996|NCT02163538|537112542|FG000|Overall Study|Physician Decision|0|||
148898997|NCT02163538|537112543|FG001|Overall Study|Physician Decision|1|||
148898998|NCT04484961|537112546|FG000|Overall Study|Lost to Follow-up|9|||
148898999|NCT04484961|537112547|FG001|Overall Study|Lost to Follow-up|9|||
148899000|NCT00388349|537112548|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
148899001|NCT00388349|537112549|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
148899002|NCT01345240|537112553|FG000|Overall Study|Adverse Event|3|||
148899003|NCT01345240|537112554|FG001|Overall Study|Adverse Event|5|||
148899004|NCT01345240|537112555|FG002|Overall Study|Adverse Event|4|||
148899005|NCT01345240|537112556|FG003|Overall Study|Adverse Event|2|||
148899006|NCT01345240|537112557|FG004|Overall Study|Adverse Event|1|||
148899007|NCT01345240|537112553|FG000|Overall Study|Lost to Follow-up|8|||
148899008|NCT01345240|537112554|FG001|Overall Study|Lost to Follow-up|9|||
148899009|NCT01345240|537112555|FG002|Overall Study|Lost to Follow-up|14|||
149137642|NCT01572675|537985198|FG000|Overall Study|End of prescribed treatment|140|||
148899010|NCT01345240|537112556|FG003|Overall Study|Lost to Follow-up|7|||
148899011|NCT01345240|537112557|FG004|Overall Study|Lost to Follow-up|9|||
148899012|NCT04011540|537112558|FG000|Overall Study|Lost to Follow-up|9|||
148899013|NCT04011540|537112559|FG001|Overall Study|Lost to Follow-up|6|||
148899014|NCT01339832|537112564|FG000|Overall Study|Lost to Follow-up|3|||
149137643|NCT01572675|537985199|FG001|Overall Study|End of prescribed treatment|118|||
149137644|NCT01572675|537985198|FG000|Overall Study|Recovery|16|||
149137645|NCT01572675|537985199|FG001|Overall Study|Recovery|23|||
149137646|NCT01572675|537985198|FG000|Overall Study|Lack of Efficacy|31|||
149137647|NCT01572675|537985199|FG001|Overall Study|Lack of Efficacy|31|||
149137648|NCT01572675|537985198|FG000|Overall Study|Intolerance|6|||
149137649|NCT01572675|537985199|FG001|Overall Study|Intolerance|5|||
149137650|NCT01572675|537985198|FG000|Overall Study|Improved symptoms|8|||
149137651|NCT01572675|537985199|FG001|Overall Study|Improved symptoms|2|||
149137652|NCT01572675|537985198|FG000|Overall Study|Surgical intervention|3|||
149137653|NCT01572675|537985199|FG001|Overall Study|Surgical intervention|6|||
149137654|NCT01572675|537985198|FG000|Overall Study|Withdrawal by Subject|5|||
149137655|NCT01572675|537985199|FG001|Overall Study|Withdrawal by Subject|1|||
149137656|NCT01572675|537985198|FG000|Overall Study|Physician Decision|2|||
149137657|NCT01572675|537985199|FG001|Overall Study|Physician Decision|2|||
149137658|NCT01572675|537985198|FG000|Overall Study|Death unrelated to coxibs|1|||
149137659|NCT01572675|537985199|FG001|Overall Study|Death unrelated to coxibs|1|||
149137660|NCT01572675|537985198|FG000|Overall Study|Other disease detected|1|||
149137661|NCT01572675|537985199|FG001|Overall Study|Other disease detected|1|||
149137662|NCT01572675|537985198|FG000|Overall Study|Unknown reason|1|||
149137663|NCT01572675|537985199|FG001|Overall Study|Unknown reason|1|||
149137664|NCT01572675|537985198|FG000|Overall Study|Rheumatologist new evaluation|0|||
149137665|NCT01572675|537985199|FG001|Overall Study|Rheumatologist new evaluation|1|||
149137666|NCT01572675|537985198|FG000|Overall Study|Missing data|1|||
149137667|NCT01572675|537985199|FG001|Overall Study|Missing data|4|||
149137668|NCT01572675|537985198|FG000|Overall Study|Lost to Follow-up|22|||
149137669|NCT01572675|537985199|FG001|Overall Study|Lost to Follow-up|27|||
149137670|NCT00387764|537985201|FG000|Overall Study|Adverse Event|12|||
149137671|NCT00387764|537985201|FG000|Overall Study|Withdrawal by Subject|8|||
149137672|NCT00387764|537985201|FG000|Overall Study|Sponsor Terminated Study|1|||
149137673|NCT00387764|537985201|FG000|Overall Study|Physician Decision|1|||
149137674|NCT00387764|537985201|FG000|Overall Study|Other|2|||
149137675|NCT00387764|537985201|FG000|Overall Study|Death|7|||
149137676|NCT02966223|537985202|FG000|Overall Study|Physician Decision|3|||
149137677|NCT02966223|537985202|FG000|Overall Study|Withdrawal by Subject|11|||
149137678|NCT02966223|537985202|FG000|Overall Study|Lost to Follow-up|1|||
149137679|NCT01326728|537985203|FG000|Overall Study|Death|13|||
149137680|NCT01326728|537985204|FG001|Overall Study|Death|0|||
149137681|NCT01326728|537985203|FG000|Overall Study|Early closure of study|34|||
148798737|NCT05067972|536741385|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
148798738|NCT05067972|536741386|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
148798739|NCT05067972|536741387|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
148798740|NCT05067972|536741388|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
148798741|NCT05067972|536741382|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
148798742|NCT05067972|536741383|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
148798743|NCT05067972|536741384|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
148798744|NCT05067972|536741385|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
148798745|NCT05067972|536741386|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
148798746|NCT05067972|536741387|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
148798747|NCT05067972|536741388|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
148798748|NCT05067972|536741382|FG000|Part 1: Treatment|Progressive Disease|3|||
148798749|NCT05067972|536741383|FG001|Part 1: Treatment|Progressive Disease|3|||
148798750|NCT05067972|536741384|FG002|Part 1: Treatment|Progressive Disease|4|||
148798751|NCT05067972|536741385|FG003|Part 1: Treatment|Progressive Disease|2|||
148798752|NCT05067972|536741386|FG004|Part 1: Treatment|Progressive Disease|3|||
148798753|NCT05067972|536741387|FG005|Part 1: Treatment|Progressive Disease|0|||
148798754|NCT05067972|536741388|FG006|Part 1: Treatment|Progressive Disease|2|||
148798755|NCT05067972|536741382|FG000|Part 1: Treatment|Physician Decision|0|||
148798756|NCT05067972|536741383|FG001|Part 1: Treatment|Physician Decision|0|||
148798757|NCT05067972|536741384|FG002|Part 1: Treatment|Physician Decision|0|||
148798758|NCT05067972|536741385|FG003|Part 1: Treatment|Physician Decision|1|||
148798759|NCT05067972|536741386|FG004|Part 1: Treatment|Physician Decision|0|||
148798760|NCT05067972|536741387|FG005|Part 1: Treatment|Physician Decision|0|||
148798761|NCT05067972|536741388|FG006|Part 1: Treatment|Physician Decision|0|||
148798762|NCT05067972|536741382|FG000|Part 1: Treatment|Death|0|||
148798763|NCT05067972|536741383|FG001|Part 1: Treatment|Death|0|||
148798764|NCT05067972|536741384|FG002|Part 1: Treatment|Death|0|||
148798765|NCT05067972|536741385|FG003|Part 1: Treatment|Death|2|||
148798766|NCT05067972|536741386|FG004|Part 1: Treatment|Death|0|||
148798767|NCT05067972|536741387|FG005|Part 1: Treatment|Death|0|||
148798768|NCT05067972|536741388|FG006|Part 1: Treatment|Death|0|||
148798769|NCT05067972|536741382|FG000|Part 1: Treatment|Adverse Event|0|||
148798770|NCT05067972|536741383|FG001|Part 1: Treatment|Adverse Event|0|||
148798771|NCT05067972|536741384|FG002|Part 1: Treatment|Adverse Event|0|||
148798772|NCT05067972|536741385|FG003|Part 1: Treatment|Adverse Event|0|||
148798773|NCT05067972|536741386|FG004|Part 1: Treatment|Adverse Event|0|||
148798774|NCT05067972|536741387|FG005|Part 1: Treatment|Adverse Event|2|||
148798775|NCT05067972|536741388|FG006|Part 1: Treatment|Adverse Event|1|||
148798776|NCT05067972|536741382|FG000|Part 1: Follow-up|Adverse Event|0|||
148798777|NCT05067972|536741383|FG001|Part 1: Follow-up|Adverse Event|0|||
148798778|NCT05067972|536741384|FG002|Part 1: Follow-up|Adverse Event|0|||
148798779|NCT05067972|536741385|FG003|Part 1: Follow-up|Adverse Event|0|||
148798780|NCT05067972|536741386|FG004|Part 1: Follow-up|Adverse Event|0|||
148798781|NCT05067972|536741387|FG005|Part 1: Follow-up|Adverse Event|1|||
148798782|NCT05067972|536741388|FG006|Part 1: Follow-up|Adverse Event|0|||
148798783|NCT05067972|536741382|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
148798784|NCT05067972|536741383|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
148798785|NCT05067972|536741384|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
148798786|NCT05067972|536741385|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
148798787|NCT05067972|536741386|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
148798788|NCT05067972|536741387|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
148798789|NCT05067972|536741388|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
148798790|NCT05067972|536741382|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
148798791|NCT05067972|536741383|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
148798792|NCT05067972|536741384|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
148798793|NCT05067972|536741385|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
148798794|NCT05067972|536741386|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
148798795|NCT05067972|536741387|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
148798796|NCT05067972|536741388|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
148798797|NCT05067972|536741382|FG000|Part 1: Follow-up|Physician Decision|0|||
148798798|NCT05067972|536741383|FG001|Part 1: Follow-up|Physician Decision|0|||
148798799|NCT05067972|536741384|FG002|Part 1: Follow-up|Physician Decision|0|||
148798800|NCT05067972|536741385|FG003|Part 1: Follow-up|Physician Decision|1|||
148798801|NCT05067972|536741386|FG004|Part 1: Follow-up|Physician Decision|0|||
148798802|NCT05067972|536741387|FG005|Part 1: Follow-up|Physician Decision|0|||
148798803|NCT05067972|536741388|FG006|Part 1: Follow-up|Physician Decision|0|||
148798804|NCT05067972|536741382|FG000|Part 1: Follow-up|Death|1|||
148798805|NCT05067972|536741383|FG001|Part 1: Follow-up|Death|2|||
148798806|NCT05067972|536741384|FG002|Part 1: Follow-up|Death|1|||
148798807|NCT05067972|536741385|FG003|Part 1: Follow-up|Death|0|||
148798808|NCT05067972|536741386|FG004|Part 1: Follow-up|Death|1|||
148798809|NCT05067972|536741387|FG005|Part 1: Follow-up|Death|0|||
148798810|NCT05067972|536741388|FG006|Part 1: Follow-up|Death|1|||
148798811|NCT04391842|536741389|FG000|Overall Study|Withdrawal by Subject|2|||
148798812|NCT02573259|536741398|FG000|Overall Study|Death|1|||
148798813|NCT02573259|536741399|FG001|Overall Study|Death|6|||
148798814|NCT02573259|536741400|FG002|Overall Study|Death|5|||
148798815|NCT02573259|536741401|FG003|Overall Study|Death|6|||
148798816|NCT02573259|536741402|FG004|Overall Study|Death|9|||
148798817|NCT02573259|536741403|FG005|Overall Study|Death|32|||
148798818|NCT02573259|536741404|FG006|Overall Study|Death|21|||
148798819|NCT02573259|536741398|FG000|Overall Study|Lost to Follow-up|0|||
148798820|NCT02573259|536741399|FG001|Overall Study|Lost to Follow-up|0|||
148798821|NCT02573259|536741400|FG002|Overall Study|Lost to Follow-up|0|||
148798822|NCT02573259|536741401|FG003|Overall Study|Lost to Follow-up|0|||
148798823|NCT02573259|536741402|FG004|Overall Study|Lost to Follow-up|0|||
148798824|NCT02573259|536741403|FG005|Overall Study|Lost to Follow-up|2|||
148798825|NCT02573259|536741404|FG006|Overall Study|Lost to Follow-up|1|||
148798826|NCT02573259|536741398|FG000|Overall Study|Participant refused further follow-up|0|||
148798827|NCT02573259|536741399|FG001|Overall Study|Participant refused further follow-up|2|||
148798828|NCT02573259|536741400|FG002|Overall Study|Participant refused further follow-up|1|||
148798829|NCT02573259|536741401|FG003|Overall Study|Participant refused further follow-up|0|||
148798830|NCT02573259|536741402|FG004|Overall Study|Participant refused further follow-up|3|||
148798831|NCT02573259|536741403|FG005|Overall Study|Participant refused further follow-up|20|||
148798832|NCT02573259|536741404|FG006|Overall Study|Participant refused further follow-up|7|||
148798833|NCT02573259|536741398|FG000|Overall Study|Other|0|||
148798834|NCT02573259|536741399|FG001|Overall Study|Other|0|||
148798835|NCT02573259|536741400|FG002|Overall Study|Other|0|||
148798836|NCT02573259|536741401|FG003|Overall Study|Other|0|||
148798837|NCT02573259|536741402|FG004|Overall Study|Other|1|||
148798838|NCT02573259|536741403|FG005|Overall Study|Other|4|||
148798839|NCT02573259|536741404|FG006|Overall Study|Other|5|||
148798840|NCT00751140|536741405|FG000|Overall Study|benign angioma excluded from analysis|1|||
148798841|NCT03160716|536741406|FG000|Overall Study|Lost to Follow-up|1|||
148798842|NCT01628848|536741407|FG000|Overall Study|Adverse Event|9|||
148798843|NCT01628848|536741408|FG001|Overall Study|Adverse Event|7|||
148798844|NCT01628848|536741407|FG000|Overall Study|Lack of Efficacy|0|||
148798845|NCT01628848|536741408|FG001|Overall Study|Lack of Efficacy|4|||
148798846|NCT01628848|536741407|FG000|Overall Study|Withdrawal by Subject|0|||
148798847|NCT01628848|536741408|FG001|Overall Study|Withdrawal by Subject|2|||
148798848|NCT01628848|536741407|FG000|Overall Study|Physician Decision|3|||
148798849|NCT01628848|536741408|FG001|Overall Study|Physician Decision|1|||
148798850|NCT02667301|536741409|FG000|Overall Study|Adverse Event|1|||
148798851|NCT02667301|536741409|FG000|Overall Study|Lack of Efficacy|1|||
148798852|NCT01939314|536741410|FG000|Overall Study|Withdrawal by Subject|3|||
148798853|NCT01939314|536741411|FG001|Overall Study|Withdrawal by Subject|1|||
148798854|NCT01939314|536741410|FG000|Overall Study|Protocol Violation|1|||
148798855|NCT01939314|536741411|FG001|Overall Study|Protocol Violation|0|||
148798856|NCT01939314|536741410|FG000|Overall Study|Pregnancy|0|||
148798857|NCT01939314|536741411|FG001|Overall Study|Pregnancy|1|||
148798858|NCT01939314|536741410|FG000|Overall Study|Lost to Follow-up|5|||
148798859|NCT01939314|536741411|FG001|Overall Study|Lost to Follow-up|6|||
148798860|NCT01107925|536741419|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
148899015|NCT01339832|537112564|FG000|Overall Study|Death|11|||
148899016|NCT00231816|537112565|FG000|Overall Study|Adverse Event|1|||
148899017|NCT00231816|537112566|FG001|Overall Study|Adverse Event|0|||
148899018|NCT00231816|537112565|FG000|Overall Study|Lost to Follow-up|8|||
148899019|NCT00231816|537112566|FG001|Overall Study|Lost to Follow-up|5|||
148899020|NCT00231816|537112565|FG000|Overall Study|Protocol Violation|2|||
148899021|NCT00231816|537112566|FG001|Overall Study|Protocol Violation|3|||
148899022|NCT00231816|537112565|FG000|Overall Study|Withdrawal by Subject|3|||
148899023|NCT00231816|537112566|FG001|Overall Study|Withdrawal by Subject|3|||
148899024|NCT00231816|537112565|FG000|Overall Study|Other|2|||
148899025|NCT00231816|537112566|FG001|Overall Study|Other|1|||
148899026|NCT00774046|537112567|FG000|Screening|Not eligible|56|||
148899027|NCT00774046|537112567|FG000|Enrollment|Desired other therapy/refused|28|||
148899028|NCT00774046|537112567|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
148899029|NCT01614249|537112570|FG000|Overall Study|Lost to Follow-up|11|||
148899030|NCT01614249|537112571|FG001|Overall Study|Lost to Follow-up|23|||
148899031|NCT05498649|537112572|FG000|Overall Study|Lost to Follow-up|1|||
148899032|NCT02761330|537112584|FG000|Treatment Week 1|Withdrawal by Subject|0|||
148899033|NCT02761330|537112585|FG001|Treatment Week 1|Withdrawal by Subject|0|||
148899034|NCT02761330|537112586|FG002|Treatment Week 1|Withdrawal by Subject|0|||
148899035|NCT02761330|537112587|FG003|Treatment Week 1|Withdrawal by Subject|1|||
148899036|NCT02761330|537112588|FG004|Treatment Week 1|Withdrawal by Subject|0|||
148899037|NCT02761330|537112589|FG005|Treatment Week 1|Withdrawal by Subject|1|||
148899038|NCT00888134|537112590|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
148899039|NCT00888134|537112590|FG000|Follow-up|being followed for long-term survival|1|||
148899040|NCT03043313|537112591|FG000|Overall Study|Withdrawal by Subject|5|||
148899041|NCT03043313|537112592|FG001|Overall Study|Withdrawal by Subject|1|||
148899042|NCT03043313|537112593|FG002|Overall Study|Withdrawal by Subject|1|||
148899043|NCT03043313|537112591|FG000|Overall Study|Lost to Follow-up|1|||
148899044|NCT03043313|537112592|FG001|Overall Study|Lost to Follow-up|1|||
148899045|NCT03043313|537112593|FG002|Overall Study|Lost to Follow-up|0|||
148899046|NCT03043313|537112591|FG000|Overall Study|Death|28|||
148899047|NCT03043313|537112592|FG001|Overall Study|Death|26|||
148899048|NCT03043313|537112593|FG002|Overall Study|Death|17|||
148899049|NCT03043313|537112591|FG000|Overall Study|Participation terminated by sponsor|11|||
148899050|NCT03043313|537112592|FG001|Overall Study|Participation terminated by sponsor|13|||
148899051|NCT03043313|537112593|FG002|Overall Study|Participation terminated by sponsor|13|||
148899052|NCT02657889|537112594|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
148899053|NCT02657889|537112595|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
148899054|NCT02657889|537112596|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
148899055|NCT02657889|537112597|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
148899056|NCT02657889|537112594|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
148899057|NCT02657889|537112595|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
148899058|NCT02657889|537112596|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
148899059|NCT02657889|537112597|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
148899060|NCT02657889|537112594|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
148899061|NCT02657889|537112595|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
148899062|NCT02657889|537112596|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
148899063|NCT02657889|537112597|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
148899064|NCT02657889|537112594|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
148899065|NCT02657889|537112595|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
148899066|NCT02657889|537112596|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
148899067|NCT02657889|537112597|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
148899068|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
148899069|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
148899070|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
148899071|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
148899072|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
148899073|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
148899074|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
148899075|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
148899076|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
148899077|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
148899078|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
148899079|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
148899080|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
148899081|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
148899082|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
149011482|NCT00405639|537521477|FG000|Overall Study|Seizure prior to receiving BNP|1|||
148798861|NCT01107925|536741420|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
148798862|NCT01107925|536741421|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
148798863|NCT01107925|536741422|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
148798864|NCT01107925|536741423|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
148798865|NCT01107925|536741424|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
148798866|NCT01107925|536741419|FG000|Period 2|Withdrawal by Subject|0|||
148798867|NCT01107925|536741420|FG001|Period 2|Withdrawal by Subject|1|||
148798868|NCT01107925|536741421|FG002|Period 2|Withdrawal by Subject|0|||
148798869|NCT01107925|536741422|FG003|Period 2|Withdrawal by Subject|0|||
148798870|NCT01107925|536741423|FG004|Period 2|Withdrawal by Subject|0|||
148798871|NCT01107925|536741424|FG005|Period 2|Withdrawal by Subject|1|||
148798872|NCT04877990|536741425|FG000|Treatment|Other reasons|3|||
148798873|NCT04877990|536741426|FG001|Treatment|Other reasons|1|||
148798874|NCT04877990|536741425|FG000|Treatment|Administrative reasons by sponsor|17|||
148798875|NCT04877990|536741426|FG001|Treatment|Administrative reasons by sponsor|33|||
148798876|NCT04877990|536741425|FG000|Treatment|Withdrawal by Subject|2|||
148798877|NCT04877990|536741426|FG001|Treatment|Withdrawal by Subject|6|||
148798878|NCT04877990|536741425|FG000|Treatment|Adverse Event|2|||
148798879|NCT04877990|536741426|FG001|Treatment|Adverse Event|1|||
148798880|NCT02895295|536741427|FG000|Overall Study|Survey Non-response|71|||
148798881|NCT02895295|536741428|FG001|Overall Study|Survey Non-response|94|||
148798882|NCT02895295|536741429|FG002|Overall Study|Survey Non-response|92|||
148798883|NCT01949142|536741430|FG000|Overall Study|Withdrawal of consent|1|||
148798884|NCT01949142|536741431|FG001|Overall Study|Withdrawal of consent|0|||
148798885|NCT01949142|536741430|FG000|Overall Study|Lost to Follow-up|1|||
148798886|NCT01949142|536741431|FG001|Overall Study|Lost to Follow-up|1|||
148798887|NCT01949142|536741430|FG000|Overall Study|Parent changed their mind|1|||
148798888|NCT01949142|536741431|FG001|Overall Study|Parent changed their mind|0|||
148798889|NCT00490919|536741432|FG000|Open-label Run-in Period|Adverse Event|239|||
148798890|NCT00490919|536741433|FG001|Open-label Run-in Period|Adverse Event|0|||
148798891|NCT00490919|536741434|FG002|Open-label Run-in Period|Adverse Event|0|||
148798892|NCT00490919|536741432|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
148798893|NCT00490919|536741433|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
148798894|NCT00490919|536741434|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
148798895|NCT00490919|536741432|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
148798896|NCT00490919|536741433|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
148798897|NCT00490919|536741434|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
148798898|NCT00490919|536741432|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
148798899|NCT00490919|536741433|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
148798900|NCT00490919|536741434|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
148798901|NCT00490919|536741432|FG000|Open-label Run-in Period|Administrative|40|||
148798902|NCT00490919|536741433|FG001|Open-label Run-in Period|Administrative|0|||
148798903|NCT00490919|536741434|FG002|Open-label Run-in Period|Administrative|0|||
148798904|NCT00490919|536741432|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
148798905|NCT00490919|536741433|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
148798906|NCT00490919|536741434|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
148798907|NCT00490919|536741432|FG000|Double-blind Phase|Adverse Event|0|||
148798908|NCT00490919|536741433|FG001|Double-blind Phase|Adverse Event|40|||
148798909|NCT00490919|536741434|FG002|Double-blind Phase|Adverse Event|20|||
148899083|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
148798910|NCT00490919|536741432|FG000|Double-blind Phase|Withdrawal by Subject|0|||
148798911|NCT00490919|536741433|FG001|Double-blind Phase|Withdrawal by Subject|10|||
148899084|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
148798912|NCT00490919|536741434|FG002|Double-blind Phase|Withdrawal by Subject|11|||
148798913|NCT00490919|536741432|FG000|Double-blind Phase|Lost to Follow-up|0|||
148798914|NCT00490919|536741433|FG001|Double-blind Phase|Lost to Follow-up|8|||
148798915|NCT00490919|536741434|FG002|Double-blind Phase|Lost to Follow-up|11|||
148798916|NCT00490919|536741432|FG000|Double-blind Phase|Lack of Efficacy|0|||
148798917|NCT00490919|536741433|FG001|Double-blind Phase|Lack of Efficacy|22|||
148899085|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
148899086|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
148899087|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
148899088|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
148899089|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
148899090|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
148899091|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
148899092|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
148899093|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
148899094|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
148899095|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
148899096|NCT02657889|537112594|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
148899097|NCT02657889|537112595|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
148899098|NCT02657889|537112596|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
148899099|NCT02657889|537112597|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
148899100|NCT00795535|537112598|FG000|Overall Study|incomplete data and technical problems|20|||
148899101|NCT03341299|537112599|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
148899102|NCT03341299|537112600|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
148899103|NCT03341299|537112601|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
148899104|NCT03341299|537112602|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
148899105|NCT04609319|537112603|FG000|Overall Study|Death|64|||
148899106|NCT04609319|537112604|FG001|Overall Study|Death|49|||
148899107|NCT04609319|537112605|FG002|Overall Study|Death|1|||
148899108|NCT04609319|537112603|FG000|Overall Study|Withdrawal of consent|15|||
148899109|NCT04609319|537112604|FG001|Overall Study|Withdrawal of consent|3|||
148899110|NCT04609319|537112605|FG002|Overall Study|Withdrawal of consent|0|||
148899111|NCT04609319|537112603|FG000|Overall Study|Lost to Follow-up|20|||
148899112|NCT04609319|537112604|FG001|Overall Study|Lost to Follow-up|33|||
148899113|NCT04609319|537112605|FG002|Overall Study|Lost to Follow-up|0|||
148899114|NCT04609319|537112603|FG000|Overall Study|Alive until end of follow-up|60|||
148899115|NCT04609319|537112604|FG001|Overall Study|Alive until end of follow-up|53|||
148899116|NCT04609319|537112605|FG002|Overall Study|Alive until end of follow-up|1|||
148899117|NCT03804528|537112606|FG000|Overall Study|Time Commitment|18|||
148899118|NCT03804528|537112606|FG000|Overall Study|Health Reasons|5|||
148899119|NCT04607005|537112609|FG000|Overall Study|Adverse Event|0|||
148899120|NCT04607005|537112610|FG001|Overall Study|Adverse Event|1|||
148899121|NCT04607005|537112609|FG000|Overall Study|Lack of Efficacy|1|||
148899122|NCT04607005|537112610|FG001|Overall Study|Lack of Efficacy|6|||
148899123|NCT04607005|537112609|FG000|Overall Study|Withdrawal by Subject|4|||
148899124|NCT04607005|537112610|FG001|Overall Study|Withdrawal by Subject|9|||
148899125|NCT04607005|537112609|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
148899126|NCT04607005|537112610|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
148899127|NCT04825574|537112611|FG000|Overall Study|Commercial treatment became available|1|||
148899128|NCT04825574|537112611|FG000|Overall Study|Disease progression|1|||
148899129|NCT03518086|537112612|FG000|Overall Study|Adverse Event|23|||
148899130|NCT03518086|537112613|FG001|Overall Study|Adverse Event|15|||
148899131|NCT03518086|537112614|FG002|Overall Study|Adverse Event|3|||
148899132|NCT03518086|537112615|FG003|Overall Study|Adverse Event|2|||
148899133|NCT03518086|537112612|FG000|Overall Study|Withdrawal by Subject|8|||
148899134|NCT03518086|537112613|FG001|Overall Study|Withdrawal by Subject|5|||
148899135|NCT03518086|537112614|FG002|Overall Study|Withdrawal by Subject|1|||
148899136|NCT03518086|537112615|FG003|Overall Study|Withdrawal by Subject|0|||
148899137|NCT03518086|537112612|FG000|Overall Study|Lack of Efficacy|5|||
148899138|NCT03518086|537112613|FG001|Overall Study|Lack of Efficacy|5|||
148899139|NCT03518086|537112614|FG002|Overall Study|Lack of Efficacy|0|||
148899140|NCT03518086|537112615|FG003|Overall Study|Lack of Efficacy|2|||
148899141|NCT03518086|537112612|FG000|Overall Study|Protocol Violation|1|||
148899142|NCT03518086|537112613|FG001|Overall Study|Protocol Violation|5|||
148899143|NCT03518086|537112614|FG002|Overall Study|Protocol Violation|1|||
148899144|NCT03518086|537112615|FG003|Overall Study|Protocol Violation|3|||
148899145|NCT03518086|537112612|FG000|Overall Study|Lost to Follow-up|0|||
148899146|NCT03518086|537112613|FG001|Overall Study|Lost to Follow-up|3|||
148899147|NCT03518086|537112614|FG002|Overall Study|Lost to Follow-up|0|||
148899148|NCT03518086|537112615|FG003|Overall Study|Lost to Follow-up|0|||
148899149|NCT03518086|537112612|FG000|Overall Study|Insufficient Diary Data|0|||
148899150|NCT03518086|537112613|FG001|Overall Study|Insufficient Diary Data|2|||
148798918|NCT00490919|536741434|FG002|Double-blind Phase|Lack of Efficacy|36|||
148798919|NCT00490919|536741432|FG000|Double-blind Phase|Administrative|0|||
148798920|NCT00490919|536741433|FG001|Double-blind Phase|Administrative|6|||
148798921|NCT00490919|536741434|FG002|Double-blind Phase|Administrative|6|||
148798922|NCT00903201|536743968|FG000|Overall Study|Adverse Event|1|||
148798923|NCT00903201|536743969|FG001|Overall Study|Adverse Event|4|||
148798924|NCT00903201|536743970|FG002|Overall Study|Adverse Event|0|||
148798925|NCT00903201|536743968|FG000|Overall Study|Protocol Violation|2|||
148798926|NCT00903201|536743969|FG001|Overall Study|Protocol Violation|1|||
148798927|NCT00903201|536743970|FG002|Overall Study|Protocol Violation|0|||
148798928|NCT00903201|536743968|FG000|Overall Study|Lost to Follow-up|0|||
148798929|NCT00903201|536743969|FG001|Overall Study|Lost to Follow-up|1|||
148798930|NCT00903201|536743970|FG002|Overall Study|Lost to Follow-up|0|||
148798931|NCT00903201|536743968|FG000|Overall Study|Physician Decision|1|||
148798932|NCT00903201|536743969|FG001|Overall Study|Physician Decision|0|||
148798933|NCT00903201|536743970|FG002|Overall Study|Physician Decision|1|||
148798934|NCT00903201|536743968|FG000|Overall Study|Withdrawal by Subject|1|||
148798935|NCT00903201|536743969|FG001|Overall Study|Withdrawal by Subject|0|||
148798936|NCT00903201|536743970|FG002|Overall Study|Withdrawal by Subject|1|||
148798937|NCT01094288|536743971|FG000|Overall Study|Adverse Event|0|||
148798938|NCT01094288|536743972|FG001|Overall Study|Adverse Event|3|||
148798939|NCT01094288|536743973|FG002|Overall Study|Adverse Event|1|||
148798940|NCT01094288|536743974|FG003|Overall Study|Adverse Event|1|||
148798941|NCT01094288|536743975|FG004|Overall Study|Adverse Event|0|||
148798942|NCT01094288|536743976|FG005|Overall Study|Adverse Event|0|||
148798943|NCT01094288|536743977|FG006|Overall Study|Adverse Event|0|||
148798944|NCT01094288|536743978|FG007|Overall Study|Adverse Event|0|||
148798945|NCT01094288|536743971|FG000|Overall Study|Withdrawal by Subject|0|||
148798946|NCT01094288|536743972|FG001|Overall Study|Withdrawal by Subject|1|||
148798947|NCT01094288|536743973|FG002|Overall Study|Withdrawal by Subject|2|||
148798948|NCT01094288|536743974|FG003|Overall Study|Withdrawal by Subject|0|||
148798949|NCT01094288|536743975|FG004|Overall Study|Withdrawal by Subject|0|||
148798950|NCT01094288|536743976|FG005|Overall Study|Withdrawal by Subject|0|||
148798951|NCT01094288|536743977|FG006|Overall Study|Withdrawal by Subject|0|||
148798952|NCT01094288|536743978|FG007|Overall Study|Withdrawal by Subject|2|||
148798953|NCT01094288|536743971|FG000|Overall Study|Initiation of Alternative Therapy|0|||
148798954|NCT01094288|536743972|FG001|Overall Study|Initiation of Alternative Therapy|0|||
148798955|NCT01094288|536743973|FG002|Overall Study|Initiation of Alternative Therapy|1|||
148798956|NCT01094288|536743974|FG003|Overall Study|Initiation of Alternative Therapy|0|||
148798957|NCT01094288|536743975|FG004|Overall Study|Initiation of Alternative Therapy|0|||
148798958|NCT01094288|536743976|FG005|Overall Study|Initiation of Alternative Therapy|0|||
148798959|NCT01094288|536743977|FG006|Overall Study|Initiation of Alternative Therapy|0|||
148798960|NCT01094288|536743978|FG007|Overall Study|Initiation of Alternative Therapy|0|||
148798961|NCT01094288|536743971|FG000|Overall Study|Reason not Specified|2|||
148798962|NCT01094288|536743972|FG001|Overall Study|Reason not Specified|3|||
148798963|NCT01094288|536743973|FG002|Overall Study|Reason not Specified|0|||
148798964|NCT01094288|536743974|FG003|Overall Study|Reason not Specified|1|||
148798965|NCT01094288|536743975|FG004|Overall Study|Reason not Specified|0|||
148798966|NCT01094288|536743976|FG005|Overall Study|Reason not Specified|0|||
148798967|NCT01094288|536743977|FG006|Overall Study|Reason not Specified|0|||
148798968|NCT01094288|536743978|FG007|Overall Study|Reason not Specified|0|||
148798969|NCT01094288|536743971|FG000|Overall Study|Ongoing Participants|0|||
148798970|NCT01094288|536743972|FG001|Overall Study|Ongoing Participants|3|||
148798971|NCT01094288|536743973|FG002|Overall Study|Ongoing Participants|0|||
148798972|NCT01094288|536743974|FG003|Overall Study|Ongoing Participants|0|||
148798973|NCT01094288|536743975|FG004|Overall Study|Ongoing Participants|0|||
148798974|NCT01094288|536743976|FG005|Overall Study|Ongoing Participants|0|||
148798975|NCT01094288|536743977|FG006|Overall Study|Ongoing Participants|0|||
148798976|NCT01094288|536743978|FG007|Overall Study|Ongoing Participants|0|||
148798977|NCT02611882|536743981|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
148798978|NCT02611882|536743982|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
148798979|NCT02611882|536743983|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
148798980|NCT01389232|536743984|FG000|Overall Study|Had scaffold removed|15|||
148798981|NCT01389232|536743984|FG000|Overall Study|Personal reasons|2|||
148798982|NCT01389232|536743984|FG000|Overall Study|Adverse Event|1|||
148899151|NCT03518086|537112614|FG002|Overall Study|Insufficient Diary Data|0|||
148899152|NCT03518086|537112615|FG003|Overall Study|Insufficient Diary Data|0|||
148899153|NCT03518086|537112612|FG000|Overall Study|Non- compliance to Protocol|0|||
148899154|NCT03518086|537112613|FG001|Overall Study|Non- compliance to Protocol|1|||
148899155|NCT03518086|537112614|FG002|Overall Study|Non- compliance to Protocol|0|||
148899156|NCT03518086|537112615|FG003|Overall Study|Non- compliance to Protocol|0|||
148899157|NCT03518086|537112612|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
148899158|NCT03518086|537112613|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
148899159|NCT03518086|537112614|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
148899160|NCT03518086|537112615|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
148899161|NCT03518086|537112612|FG000|Overall Study|Site Terminated by Sponsor|0|||
148899162|NCT03518086|537112613|FG001|Overall Study|Site Terminated by Sponsor|1|||
148899163|NCT03518086|537112614|FG002|Overall Study|Site Terminated by Sponsor|0|||
148899164|NCT03518086|537112615|FG003|Overall Study|Site Terminated by Sponsor|0|||
148899165|NCT03518086|537112612|FG000|Overall Study|Pregnancy|0|||
148899166|NCT03518086|537112613|FG001|Overall Study|Pregnancy|0|||
148899167|NCT03518086|537112614|FG002|Overall Study|Pregnancy|0|||
148899168|NCT03518086|537112615|FG003|Overall Study|Pregnancy|2|||
148899169|NCT00668148|537112616|FG000|Overall Study|Adverse Event|5|||
148899170|NCT00668148|537112616|FG000|Overall Study|Subject Non-compliance|1|||
148899171|NCT00668148|537112616|FG000|Overall Study|Progressive Disease Before Treatment|2|||
148899172|NCT00668148|537112616|FG000|Overall Study|Withdrawal of Consent|2|||
148899173|NCT02702492|537112617|FG000|Overall Study|Disease progression|3|||
148899174|NCT02702492|537112618|FG001|Overall Study|Disease progression|3|||
148899175|NCT02702492|537112619|FG002|Overall Study|Disease progression|2|||
148899176|NCT02702492|537112620|FG003|Overall Study|Disease progression|4|||
148899177|NCT02702492|537112621|FG004|Overall Study|Disease progression|4|||
148899178|NCT02702492|537112622|FG005|Overall Study|Disease progression|1|||
148899179|NCT02702492|537112623|FG006|Overall Study|Disease progression|2|||
148899180|NCT02702492|537112624|FG007|Overall Study|Disease progression|8|||
148899181|NCT02702492|537112625|FG008|Overall Study|Disease progression|5|||
148899182|NCT02702492|537112626|FG009|Overall Study|Disease progression|1|||
148899183|NCT02702492|537112627|FG010|Overall Study|Disease progression|0|||
148899184|NCT02702492|537112628|FG011|Overall Study|Disease progression|3|||
148899185|NCT02702492|537112629|FG012|Overall Study|Disease progression|2|||
148899186|NCT02702492|537112617|FG000|Overall Study|Clinical progression|0|||
148899187|NCT02702492|537112618|FG001|Overall Study|Clinical progression|0|||
148899188|NCT02702492|537112619|FG002|Overall Study|Clinical progression|2|||
148899189|NCT02702492|537112620|FG003|Overall Study|Clinical progression|1|||
148899190|NCT02702492|537112621|FG004|Overall Study|Clinical progression|0|||
148899191|NCT02702492|537112622|FG005|Overall Study|Clinical progression|2|||
148899192|NCT02702492|537112623|FG006|Overall Study|Clinical progression|1|||
148899193|NCT02702492|537112624|FG007|Overall Study|Clinical progression|4|||
148899194|NCT02702492|537112625|FG008|Overall Study|Clinical progression|0|||
148899195|NCT02702492|537112626|FG009|Overall Study|Clinical progression|0|||
148899196|NCT02702492|537112627|FG010|Overall Study|Clinical progression|1|||
148899197|NCT02702492|537112628|FG011|Overall Study|Clinical progression|2|||
148899198|NCT02702492|537112629|FG012|Overall Study|Clinical progression|0|||
148899199|NCT02702492|537112617|FG000|Overall Study|Adverse Event|0|||
148899200|NCT02702492|537112618|FG001|Overall Study|Adverse Event|0|||
148899201|NCT02702492|537112619|FG002|Overall Study|Adverse Event|1|||
148899202|NCT02702492|537112620|FG003|Overall Study|Adverse Event|2|||
148899203|NCT02702492|537112621|FG004|Overall Study|Adverse Event|1|||
148899204|NCT02702492|537112622|FG005|Overall Study|Adverse Event|0|||
148899205|NCT02702492|537112623|FG006|Overall Study|Adverse Event|1|||
148899206|NCT02702492|537112624|FG007|Overall Study|Adverse Event|0|||
148899207|NCT02702492|537112625|FG008|Overall Study|Adverse Event|2|||
148899208|NCT02702492|537112626|FG009|Overall Study|Adverse Event|0|||
148899209|NCT02702492|537112627|FG010|Overall Study|Adverse Event|0|||
148899210|NCT02702492|537112628|FG011|Overall Study|Adverse Event|0|||
148899211|NCT02702492|537112629|FG012|Overall Study|Adverse Event|1|||
148899212|NCT02702492|537112617|FG000|Overall Study|Other|0|||
148899213|NCT02702492|537112618|FG001|Overall Study|Other|0|||
148899214|NCT02702492|537112619|FG002|Overall Study|Other|0|||
148899215|NCT02702492|537112620|FG003|Overall Study|Other|0|||
148899216|NCT02702492|537112621|FG004|Overall Study|Other|0|||
148899217|NCT02702492|537112622|FG005|Overall Study|Other|0|||
148899218|NCT02702492|537112623|FG006|Overall Study|Other|0|||
148899219|NCT02702492|537112624|FG007|Overall Study|Other|0|||
148899220|NCT02702492|537112625|FG008|Overall Study|Other|0|||
148899221|NCT02702492|537112626|FG009|Overall Study|Other|0|||
148899222|NCT02702492|537112627|FG010|Overall Study|Other|0|||
148899223|NCT02702492|537112628|FG011|Overall Study|Other|0|||
148899224|NCT02702492|537112629|FG012|Overall Study|Other|1|||
148899225|NCT03204188|537112639|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
148899226|NCT03204188|537112639|FG000|Immunotherapy Phase (1 Year)|Death|1|||
148899227|NCT03204188|537112639|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
148899228|NCT03204188|537112639|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
148899229|NCT04944992|537114589|FG000|Overall Study|Lost to Follow-up|1|||
148899230|NCT04944992|537114590|FG001|Overall Study|Lost to Follow-up|1|||
148899231|NCT04944992|537114589|FG000|Overall Study|Physician Decision|1|||
148899232|NCT04944992|537114590|FG001|Overall Study|Physician Decision|0|||
148899233|NCT04944992|537114589|FG000|Overall Study|Withdrawal by Subject|6|||
148899234|NCT04944992|537114590|FG001|Overall Study|Withdrawal by Subject|1|||
148899235|NCT00303069|537114591|FG000|Overall Study|Lost to Follow-up|1|||
148899236|NCT00303069|537114592|FG001|Overall Study|Lost to Follow-up|0|||
148899237|NCT00303069|537114593|FG002|Overall Study|Lost to Follow-up|0|||
148899238|NCT00303069|537114594|FG003|Overall Study|Lost to Follow-up|2|||
148899239|NCT00303069|537114591|FG000|Overall Study|subject moved|1|||
148899240|NCT00303069|537114592|FG001|Overall Study|subject moved|0|||
148899241|NCT00303069|537114593|FG002|Overall Study|subject moved|0|||
148899242|NCT00303069|537114594|FG003|Overall Study|subject moved|0|||
148899243|NCT00303069|537114591|FG000|Overall Study|Recruitment into Army Reserves|0|||
148899244|NCT00303069|537114592|FG001|Overall Study|Recruitment into Army Reserves|0|||
148899245|NCT00303069|537114593|FG002|Overall Study|Recruitment into Army Reserves|1|||
148899246|NCT00303069|537114594|FG003|Overall Study|Recruitment into Army Reserves|0|||
148899247|NCT01972217|537114599|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
148899248|NCT01972217|537114600|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
148899249|NCT01972217|537114601|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
148899250|NCT01972217|537114602|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
148899251|NCT01972217|537114599|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
148899252|NCT01972217|537114600|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
148899253|NCT01972217|537114601|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
148899254|NCT01972217|537114602|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
148899255|NCT01972217|537114599|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
148899256|NCT01972217|537114600|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
148899257|NCT01972217|537114601|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
148899258|NCT01972217|537114602|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
148899259|NCT01972217|537114599|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
148899260|NCT01972217|537114600|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
148899261|NCT01972217|537114601|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
148899262|NCT01972217|537114602|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
148899263|NCT01972217|537114599|FG000|Part B Double-blind, Randomised Period|Death|0|||
148899264|NCT01972217|537114600|FG001|Part B Double-blind, Randomised Period|Death|0|||
148899265|NCT01972217|537114601|FG002|Part B Double-blind, Randomised Period|Death|43|||
148899266|NCT01972217|537114602|FG003|Part B Double-blind, Randomised Period|Death|44|||
148899267|NCT01972217|537114599|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
148899268|NCT01972217|537114600|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
148899269|NCT01972217|537114601|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
148899270|NCT01972217|537114602|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
148899271|NCT01972217|537114599|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
148899272|NCT01972217|537114600|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
148899273|NCT01972217|537114601|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
148899274|NCT01972217|537114602|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
148899275|NCT01972217|537114599|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
148899276|NCT01972217|537114600|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
148899277|NCT01972217|537114601|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
148899278|NCT01972217|537114602|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
148899279|NCT01972217|537114599|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
148899280|NCT01972217|537114600|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
148899281|NCT01972217|537114601|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
148899282|NCT01972217|537114602|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
148899283|NCT04328077|537114604|FG000|Overall Study|Lost to Follow-up|0|||
148899284|NCT04328077|537114605|FG001|Overall Study|Lost to Follow-up|1|||
148899285|NCT04328077|537114606|FG002|Overall Study|Lost to Follow-up|0|||
148899286|NCT04328077|537114607|FG003|Overall Study|Lost to Follow-up|0|||
148899287|NCT04328077|537114604|FG000|Overall Study|Withdrawal by Subject|0|||
148899288|NCT04328077|537114605|FG001|Overall Study|Withdrawal by Subject|1|||
148899289|NCT04328077|537114606|FG002|Overall Study|Withdrawal by Subject|1|||
148899290|NCT04328077|537114607|FG003|Overall Study|Withdrawal by Subject|3|||
148899291|NCT01456039|537114608|FG000|Phase 1 (First Step)|Disease Progression|1|||
148899292|NCT01456039|537114609|FG001|Phase 1 (First Step)|Disease Progression|1|||
148899293|NCT01456039|537114610|FG002|Phase 1 (First Step)|Disease Progression|0|||
148899294|NCT01456039|537114608|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
148899295|NCT01456039|537114609|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
148899296|NCT01456039|537114610|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
148899297|NCT01456039|537114608|FG000|Phase 1 (First Step)|Adverse Event|0|||
148899298|NCT01456039|537114609|FG001|Phase 1 (First Step)|Adverse Event|3|||
148899299|NCT01456039|537114610|FG002|Phase 1 (First Step)|Adverse Event|0|||
148899300|NCT01456039|537114608|FG000|Phase 1 (First Step)|Other|0|||
148899301|NCT01456039|537114609|FG001|Phase 1 (First Step)|Other|1|||
148899302|NCT01456039|537114610|FG002|Phase 1 (First Step)|Other|0|||
148899303|NCT01456039|537114608|FG000|Phase 2 (Second Step)|Disease Progression|0|||
148899304|NCT01456039|537114609|FG001|Phase 2 (Second Step)|Disease Progression|0|||
148899305|NCT01456039|537114610|FG002|Phase 2 (Second Step)|Disease Progression|17|||
148899306|NCT01456039|537114608|FG000|Phase 2 (Second Step)|Adverse Event|0|||
148899307|NCT01456039|537114609|FG001|Phase 2 (Second Step)|Adverse Event|0|||
148899308|NCT01456039|537114610|FG002|Phase 2 (Second Step)|Adverse Event|10|||
148899309|NCT01456039|537114608|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
148899310|NCT01456039|537114609|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
148899311|NCT01456039|537114610|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
148899312|NCT01456039|537114608|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
148899313|NCT01456039|537114609|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
148899314|NCT01456039|537114610|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
148899315|NCT01456039|537114608|FG000|Phase 2 (Second Step)|Other|0|||
148899316|NCT01456039|537114609|FG001|Phase 2 (Second Step)|Other|0|||
148899317|NCT01456039|537114610|FG002|Phase 2 (Second Step)|Other|1|||
148899318|NCT00335777|537114613|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
148899319|NCT00335777|537114613|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
148899320|NCT00335777|537114613|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
148899321|NCT00335777|537114613|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
148899322|NCT00335777|537114613|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
148899323|NCT00939393|537114621|FG000|Overall Study|Withdrawal by Subject|1|||
148899324|NCT00939393|537114622|FG001|Overall Study|Withdrawal by Subject|0|||
148899325|NCT00939393|537114621|FG000|Overall Study|Lost to Follow-up|3|||
148899326|NCT00939393|537114622|FG001|Overall Study|Lost to Follow-up|0|||
148899327|NCT02851615|537114623|FG000|Overall Study|Cognitive Issue|1|||
148899328|NCT02851615|537114624|FG001|Overall Study|Cognitive Issue|0|||
148899329|NCT02851615|537114623|FG000|Overall Study|Lost to Follow-up|0|||
148899330|NCT02851615|537114624|FG001|Overall Study|Lost to Follow-up|4|||
148899331|NCT00313014|537114625|FG000|Overall Study|Withdrawal by Subject|11|||
148899332|NCT00313014|537114626|FG001|Overall Study|Withdrawal by Subject|7|||
148899333|NCT00313014|537114627|FG002|Overall Study|Withdrawal by Subject|5|||
148899334|NCT00313014|537114625|FG000|Overall Study|Adverse Event|14|||
148899335|NCT00313014|537114626|FG001|Overall Study|Adverse Event|29|||
148899336|NCT00313014|537114627|FG002|Overall Study|Adverse Event|16|||
148899337|NCT00313014|537114625|FG000|Overall Study|Lost to Follow-up|7|||
148899338|NCT00313014|537114626|FG001|Overall Study|Lost to Follow-up|6|||
148899339|NCT00313014|537114627|FG002|Overall Study|Lost to Follow-up|10|||
148899340|NCT00313014|537114625|FG000|Overall Study|Administrative|9|||
148899341|NCT00313014|537114626|FG001|Overall Study|Administrative|6|||
148899342|NCT00313014|537114627|FG002|Overall Study|Administrative|14|||
148899343|NCT00313014|537114625|FG000|Overall Study|Lack of Efficacy|52|||
148899344|NCT00313014|537114626|FG001|Overall Study|Lack of Efficacy|25|||
148899345|NCT00313014|537114627|FG002|Overall Study|Lack of Efficacy|16|||
148899346|NCT00371150|537114629|FG000|Overall Study|Lost to Follow-up|3|||
148899347|NCT00371150|537114630|FG001|Overall Study|Lost to Follow-up|2|||
148899348|NCT02345070|537114631|FG000|Overall Study|Adverse Event|12|||
148899349|NCT02345070|537114632|FG001|Overall Study|Adverse Event|8|||
148899350|NCT02345070|537114633|FG002|Overall Study|Adverse Event|16|||
148899351|NCT02345070|537114631|FG000|Overall Study|Poor compliance to protocol|2|||
148899352|NCT02345070|537114632|FG001|Overall Study|Poor compliance to protocol|0|||
148899353|NCT02345070|537114633|FG002|Overall Study|Poor compliance to protocol|0|||
148899354|NCT02345070|537114631|FG000|Overall Study|Other than specified above|6|||
148899355|NCT02345070|537114632|FG001|Overall Study|Other than specified above|3|||
148899356|NCT02345070|537114633|FG002|Overall Study|Other than specified above|7|||
148899357|NCT01112917|537114636|FG000|Overall Study|Death|2|||
148899358|NCT01112917|537114637|FG001|Overall Study|Death|11|||
148899359|NCT01112917|537114636|FG000|Overall Study|Lost to Follow-up|1|||
148899360|NCT01112917|537114637|FG001|Overall Study|Lost to Follow-up|1|||
148899361|NCT01112917|537114636|FG000|Overall Study|Withdrawal by Subject|1|||
148899362|NCT01112917|537114637|FG001|Overall Study|Withdrawal by Subject|3|||
148899363|NCT01112917|537114636|FG000|Overall Study|Unable to Convert Filter|3|||
148899364|NCT01112917|537114637|FG001|Overall Study|Unable to Convert Filter|0|||
148899365|NCT05101122|537114638|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
148798983|NCT01389232|536743984|FG000|Overall Study|Death|1|||
148798984|NCT01317940|536743985|FG000|Overall Study|Death|1|||
148798985|NCT01317940|536743986|FG001|Overall Study|Death|0|||
148798986|NCT01317940|536743987|FG002|Overall Study|Death|1|||
148798987|NCT01317940|536743988|FG003|Overall Study|Death|0|||
148798988|NCT01317940|536743989|FG004|Overall Study|Death|0|||
148798989|NCT01317940|536743990|FG005|Overall Study|Death|0|||
148798990|NCT01317940|536743985|FG000|Overall Study|Lost to Follow-up|0|||
148798991|NCT01317940|536743986|FG001|Overall Study|Lost to Follow-up|0|||
148798992|NCT01317940|536743987|FG002|Overall Study|Lost to Follow-up|1|||
148798993|NCT01317940|536743988|FG003|Overall Study|Lost to Follow-up|1|||
148798994|NCT01317940|536743989|FG004|Overall Study|Lost to Follow-up|1|||
148798995|NCT01317940|536743990|FG005|Overall Study|Lost to Follow-up|0|||
148798996|NCT01317940|536743985|FG000|Overall Study|Change in therapy plan|0|||
148798997|NCT01317940|536743986|FG001|Overall Study|Change in therapy plan|0|||
148798998|NCT01317940|536743987|FG002|Overall Study|Change in therapy plan|3|||
148798999|NCT01317940|536743988|FG003|Overall Study|Change in therapy plan|0|||
148799000|NCT01317940|536743989|FG004|Overall Study|Change in therapy plan|0|||
148799001|NCT01317940|536743990|FG005|Overall Study|Change in therapy plan|0|||
148799002|NCT00945243|536743992|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
148799003|NCT03256578|536743993|FG000|Overall Study|Excluded Post Randomization|66|||
148799004|NCT03256578|536743994|FG001|Overall Study|Excluded Post Randomization|56|||
148799005|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
148799006|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
148799007|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
148799008|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
148799009|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
148799010|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
148799011|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
148799012|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
148799013|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
148799014|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
148799015|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
148799016|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
148799017|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
148799018|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
148799019|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
148799020|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
148799021|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
148799022|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
148799023|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
148799024|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
148799025|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
148799026|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
148799027|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
148799028|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
148799029|NCT01198002|536743995|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
148799030|NCT01198002|536743996|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
148799031|NCT01198002|536743997|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
148799032|NCT01198002|536743995|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
148799033|NCT01198002|536743996|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
148799034|NCT01198002|536743997|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
148799035|NCT01198002|536743995|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
148799036|NCT01198002|536743996|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
148799037|NCT01198002|536743997|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
148799038|NCT01198002|536743995|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
148799039|NCT01198002|536743996|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
148799040|NCT01198002|536743997|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
148799041|NCT01198002|536743995|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
148799042|NCT01198002|536743996|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
148799043|NCT01198002|536743997|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
148799044|NCT01198002|536743995|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
148799045|NCT01198002|536743996|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
148799046|NCT01198002|536743997|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
148799047|NCT01198002|536743995|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
148799048|NCT01198002|536743996|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
148799049|NCT01198002|536743997|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
148799050|NCT00536510|536744001|FG000|Overall Study|Adverse Event|27|||
148899366|NCT05101122|537114638|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
148899367|NCT05101122|537114638|FG000|AD313 80/5|Withdrawal by Subject|1|||
148899368|NCT05101122|537114638|FG000|AD313 80/10|Physician Decision|1|||
148899369|NCT03131219|537114640|FG000|Initial Evaluation Period|Adverse Event|2|||
148899370|NCT03131219|537114641|FG001|Initial Evaluation Period|Adverse Event|0|||
148899371|NCT03131219|537114640|FG000|Initial Evaluation Period|Protocol Violation|1|||
148899372|NCT03131219|537114641|FG001|Initial Evaluation Period|Protocol Violation|0|||
148899373|NCT03131219|537114640|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
148899374|NCT03131219|537114641|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
148899375|NCT03131219|537114640|FG000|Initial Evaluation Period|Physician Decision|1|||
148899376|NCT03131219|537114641|FG001|Initial Evaluation Period|Physician Decision|0|||
148899377|NCT03131219|537114640|FG000|Extension Period|Physician Decision|1|||
148899378|NCT03131219|537114641|FG001|Extension Period|Physician Decision|0|||
148899379|NCT00616759|537114643|FG000|Overall Study|Physician Decision|2|||
148899380|NCT00616759|537114644|FG001|Overall Study|Physician Decision|0|||
148899381|NCT00616759|537114643|FG000|Overall Study|Withdrawal by Subject|1|||
148899382|NCT00616759|537114644|FG001|Overall Study|Withdrawal by Subject|2|||
148899383|NCT02177123|537114645|FG000|Overall Study|Lost to Follow-up|6|||
148899384|NCT02177123|537114645|FG000|Overall Study|Withdrawal by Subject|4|||
148899385|NCT02177123|537114645|FG000|Overall Study|Adverse Event|4|||
148899386|NCT02177123|537114645|FG000|Overall Study|Physician Decision|3|||
148899387|NCT02177123|537114645|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
148899388|NCT02177123|537114645|FG000|Overall Study|Excluded for medical reasons|2|||
148899389|NCT02177123|537114645|FG000|Overall Study|Death|1|||
148899390|NCT02177123|537114645|FG000|Overall Study|Other|1|||
148899391|NCT02177123|537114645|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
148899392|NCT05660577|537114647|FG000|Overall Study|Discontinued|9|||
148899393|NCT03363841|537114653|FG000|Overall Study|Adverse Event|1|||
148899394|NCT03363841|537114653|FG000|Overall Study|Withdrawal by Subject|1|||
148899395|NCT03363841|537114653|FG000|Overall Study|Death|7|||
148899396|NCT03363841|537114653|FG000|Overall Study|Physician Decision|1|||
148899397|NCT02156076|537114654|FG000|Treatment Period|no longer meets study criteria|0|||
148899398|NCT02156076|537114655|FG001|Treatment Period|no longer meets study criteria|0|||
148899399|NCT02156076|537114656|FG002|Treatment Period|no longer meets study criteria|1|||
148899400|NCT02156076|537114657|FG003|Treatment Period|no longer meets study criteria|0|||
148899401|NCT02156076|537114654|FG000|Treatment Period|Poor/non-compliance|0|||
148899402|NCT02156076|537114655|FG001|Treatment Period|Poor/non-compliance|1|||
148899403|NCT02156076|537114656|FG002|Treatment Period|Poor/non-compliance|0|||
148899404|NCT02156076|537114657|FG003|Treatment Period|Poor/non-compliance|0|||
148899405|NCT02156076|537114654|FG000|Treatment Period|Lost to Follow-up|0|||
148899406|NCT02156076|537114655|FG001|Treatment Period|Lost to Follow-up|0|||
148899407|NCT02156076|537114656|FG002|Treatment Period|Lost to Follow-up|0|||
148899408|NCT02156076|537114657|FG003|Treatment Period|Lost to Follow-up|1|||
148899409|NCT02156076|537114654|FG000|Treatment Period|Withdrawal by Subject|0|||
148899410|NCT02156076|537114655|FG001|Treatment Period|Withdrawal by Subject|0|||
148899411|NCT02156076|537114656|FG002|Treatment Period|Withdrawal by Subject|1|||
148899412|NCT02156076|537114657|FG003|Treatment Period|Withdrawal by Subject|0|||
148899413|NCT02156076|537114654|FG000|Treatment Period|Subject request to discontinue treatment|0|||
148899414|NCT02156076|537114655|FG001|Treatment Period|Subject request to discontinue treatment|1|||
148899415|NCT02156076|537114656|FG002|Treatment Period|Subject request to discontinue treatment|0|||
148899416|NCT02156076|537114657|FG003|Treatment Period|Subject request to discontinue treatment|0|||
148899417|NCT02156076|537114654|FG000|Treatment Period|Adverse Event|0|||
148899418|NCT02156076|537114655|FG001|Treatment Period|Adverse Event|0|||
148899419|NCT02156076|537114656|FG002|Treatment Period|Adverse Event|0|||
148899420|NCT02156076|537114657|FG003|Treatment Period|Adverse Event|1|||
148899421|NCT02156076|537114654|FG000|Follow-up Period|Withdrawal by Subject|1|||
148899422|NCT02156076|537114655|FG001|Follow-up Period|Withdrawal by Subject|0|||
148899423|NCT02156076|537114656|FG002|Follow-up Period|Withdrawal by Subject|0|||
148899424|NCT02156076|537114657|FG003|Follow-up Period|Withdrawal by Subject|0|||
148899425|NCT06271993|537114660|FG000|Overall Study|Not reactive to histamine|5|||
148899426|NCT06271993|537114661|FG001|Overall Study|Not reactive to histamine|5|||
148899427|NCT06271993|537114662|FG002|Overall Study|Not reactive to histamine|5|||
148899428|NCT01709721|537114671|FG000|Open Label Phase|Withdrawal by Subject|0|||
148899429|NCT01709721|537114672|FG001|Open Label Phase|Withdrawal by Subject|0|||
148899430|NCT01709721|537114673|FG002|Open Label Phase|Withdrawal by Subject|5|||
148899431|NCT01709721|537114671|FG000|Open Label Phase|Adverse Event|0|||
148899432|NCT01709721|537114672|FG001|Open Label Phase|Adverse Event|0|||
148899433|NCT01709721|537114673|FG002|Open Label Phase|Adverse Event|8|||
148899434|NCT01709721|537114671|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
148899435|NCT01709721|537114672|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
148899436|NCT01709721|537114673|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
148899437|NCT01709721|537114671|FG000|Open Label Phase|Investigator Decision|0|||
148899438|NCT01709721|537114672|FG001|Open Label Phase|Investigator Decision|0|||
148899439|NCT01709721|537114673|FG002|Open Label Phase|Investigator Decision|1|||
148799051|NCT00536510|536744002|FG001|Overall Study|Adverse Event|4|||
148799052|NCT00536510|536744001|FG000|Overall Study|Lost to Follow-up|11|||
148799053|NCT00536510|536744002|FG001|Overall Study|Lost to Follow-up|8|||
148799054|NCT00536510|536744001|FG000|Overall Study|Protocol Violation|4|||
148799055|NCT00536510|536744002|FG001|Overall Study|Protocol Violation|5|||
148799056|NCT00536510|536744001|FG000|Overall Study|Withdrawal by Subject|16|||
148799057|NCT00536510|536744002|FG001|Overall Study|Withdrawal by Subject|9|||
148799058|NCT00536510|536744001|FG000|Overall Study|Flushing with Product|20|||
148799059|NCT00536510|536744002|FG001|Overall Study|Flushing with Product|0|||
148799060|NCT00536510|536744001|FG000|Overall Study|Laboratory Adverse Event|2|||
148799061|NCT00536510|536744002|FG001|Overall Study|Laboratory Adverse Event|1|||
148799062|NCT00536510|536744001|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
148799063|NCT00536510|536744002|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
148799064|NCT01249417|536744003|FG000|Randomised Population|Study treatment not received|0|||
148799065|NCT01249417|536744004|FG001|Randomised Population|Study treatment not received|0|||
148799066|NCT01249417|536744005|FG002|Randomised Population|Study treatment not received|2|||
148799067|NCT01249417|536744003|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
148799068|NCT01249417|536744004|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
148799069|NCT01249417|536744005|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
148799070|NCT01249417|536744003|FG000|Treatment Phase - ITT Population|Other|0|||
148799071|NCT01249417|536744004|FG001|Treatment Phase - ITT Population|Other|0|||
148799072|NCT01249417|536744005|FG002|Treatment Phase - ITT Population|Other|1|||
148799073|NCT01249417|536744003|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
148799074|NCT01249417|536744004|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
148799075|NCT01249417|536744005|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
148799076|NCT01249417|536744003|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
148799077|NCT01249417|536744004|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
148799078|NCT01249417|536744005|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
148799079|NCT01249417|536744003|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
148799080|NCT01249417|536744004|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
148899440|NCT01709721|537114671|FG000|Open Label Phase|Sponsor Decision|0|||
148899441|NCT01709721|537114672|FG001|Open Label Phase|Sponsor Decision|0|||
148899442|NCT01709721|537114673|FG002|Open Label Phase|Sponsor Decision|2|||
148899443|NCT01709721|537114671|FG000|Open Label Phase|Protocol Violation|0|||
148899444|NCT01709721|537114672|FG001|Open Label Phase|Protocol Violation|0|||
148899445|NCT01709721|537114673|FG002|Open Label Phase|Protocol Violation|1|||
148899446|NCT01709721|537114671|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
148899447|NCT01709721|537114672|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
148899448|NCT01709721|537114673|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
148899449|NCT01709721|537114671|FG000|Open Label Phase|Inadequate Pain Control|0|||
148899450|NCT01709721|537114672|FG001|Open Label Phase|Inadequate Pain Control|0|||
148899451|NCT01709721|537114673|FG002|Open Label Phase|Inadequate Pain Control|37|||
148899452|NCT01709721|537114671|FG000|Open Label Phase|Other, Specify in text field in database|0|||
148899453|NCT01709721|537114672|FG001|Open Label Phase|Other, Specify in text field in database|0|||
148899454|NCT01709721|537114673|FG002|Open Label Phase|Other, Specify in text field in database|14|||
148899455|NCT01709721|537114671|FG000|Randomized Phase|Adverse Event|0|||
148899456|NCT01709721|537114672|FG001|Randomized Phase|Adverse Event|1|||
148899457|NCT01709721|537114673|FG002|Randomized Phase|Adverse Event|0|||
148899458|NCT01709721|537114671|FG000|Randomized Phase|Lost to Follow-up|1|||
148899459|NCT01709721|537114672|FG001|Randomized Phase|Lost to Follow-up|0|||
148899460|NCT01709721|537114673|FG002|Randomized Phase|Lost to Follow-up|0|||
148899461|NCT01709721|537114671|FG000|Randomized Phase|Inadequate Pain Control|1|||
148899462|NCT01709721|537114672|FG001|Randomized Phase|Inadequate Pain Control|2|||
148899463|NCT01709721|537114673|FG002|Randomized Phase|Inadequate Pain Control|0|||
148899464|NCT01709721|537114671|FG000|Randomized Phase|Other, Specify text field in database|1|||
148899465|NCT01709721|537114672|FG001|Randomized Phase|Other, Specify text field in database|3|||
148899466|NCT01709721|537114673|FG002|Randomized Phase|Other, Specify text field in database|0|||
148899467|NCT00481832|537114674|FG000|Enrollment|Physician Decision|8|||
148899468|NCT00481832|537114674|FG000|Enrollment|Unable to collect enough stem cells|2|||
148899469|NCT00481832|537114674|FG000|Inter-transplant Period|Adverse Event|4|||
148899470|NCT00481832|537114674|FG000|Inter-transplant Period|Death|3|||
148899471|NCT00481832|537114674|FG000|Inter-transplant Period|Physician Decision|4|||
148899472|NCT00481832|537114674|FG000|Inter-transplant Period|Disease relapse|11|||
148899473|NCT00481832|537114674|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
148899474|NCT02558894|537114675|FG000|Overall Study|Death; any cause, entire study duration|28|||
148899475|NCT02558894|537114676|FG001|Overall Study|Death; any cause, entire study duration|31|||
148899476|NCT02558894|537114675|FG000|Overall Study|Withdrawal by Subject|2|||
148899477|NCT02558894|537114676|FG001|Overall Study|Withdrawal by Subject|1|||
148899478|NCT02558894|537114675|FG000|Overall Study|Closure of Part A|2|||
148899479|NCT02558894|537114676|FG001|Overall Study|Closure of Part A|1|||
148899480|NCT00581308|537114677|FG000|Pre Discharge|Lost to Follow-up|1|||
148899481|NCT00581308|537114677|FG000|Pre Discharge|Device Removed|1|||
148899482|NCT00581308|537114677|FG000|Month 1|Lost to Follow-up|3|||
148899483|NCT00581308|537114677|FG000|Month 1|Withdrawal by Subject|2|||
148899484|NCT00581308|537114677|FG000|Month 1|Device Removed|2|||
148899485|NCT00581308|537114677|FG000|Month 1|Uknown|1|||
148899486|NCT00581308|537114677|FG000|Month 6|Lost to Follow-up|1|||
148899487|NCT00581308|537114677|FG000|Month 6|Withdrawal by Subject|2|||
148899488|NCT00581308|537114677|FG000|Month 12|Death|1|||
148899489|NCT00581308|537114677|FG000|Month 12|Lost to Follow-up|14|||
148899490|NCT00581308|537114677|FG000|Month 12|Withdrawal by Subject|3|||
148899491|NCT00581308|537114677|FG000|Month 12|Device Removed|1|||
148899492|NCT00581308|537114677|FG000|Month 12|Other|1|||
148899493|NCT03137381|537114678|FG000|Overall Study|Adverse Event|3|||
148899494|NCT03137381|537114679|FG001|Overall Study|Adverse Event|0|||
148899495|NCT03137381|537114680|FG002|Overall Study|Adverse Event|2|||
148899496|NCT03137381|537114681|FG003|Overall Study|Adverse Event|0|||
148899497|NCT03137381|537114678|FG000|Overall Study|Lost to Follow-up|2|||
148899498|NCT03137381|537114679|FG001|Overall Study|Lost to Follow-up|1|||
148899499|NCT03137381|537114680|FG002|Overall Study|Lost to Follow-up|1|||
148899500|NCT03137381|537114681|FG003|Overall Study|Lost to Follow-up|0|||
148899501|NCT03137381|537114678|FG000|Overall Study|Protocol deviation|1|||
148899502|NCT03137381|537114679|FG001|Overall Study|Protocol deviation|1|||
148899503|NCT03137381|537114680|FG002|Overall Study|Protocol deviation|0|||
148899504|NCT03137381|537114681|FG003|Overall Study|Protocol deviation|1|||
148899505|NCT03137381|537114678|FG000|Overall Study|Withdrawal by Investigator|0|||
148899506|NCT03137381|537114679|FG001|Overall Study|Withdrawal by Investigator|1|||
148899507|NCT03137381|537114680|FG002|Overall Study|Withdrawal by Investigator|1|||
148899508|NCT03137381|537114681|FG003|Overall Study|Withdrawal by Investigator|0|||
148899509|NCT03137381|537114678|FG000|Overall Study|Withdrawal by Subject|3|||
148899510|NCT03137381|537114679|FG001|Overall Study|Withdrawal by Subject|4|||
148899511|NCT03137381|537114680|FG002|Overall Study|Withdrawal by Subject|3|||
148899512|NCT03137381|537114681|FG003|Overall Study|Withdrawal by Subject|0|||
148899513|NCT03137381|537114678|FG000|Overall Study|Pregnancy|0|||
148899514|NCT03137381|537114679|FG001|Overall Study|Pregnancy|0|||
148899515|NCT03137381|537114680|FG002|Overall Study|Pregnancy|1|||
148899516|NCT03137381|537114681|FG003|Overall Study|Pregnancy|0|||
148899517|NCT01980017|537114686|FG000|Overall Study|Lost to Follow-up|30|||
148899518|NCT01980017|537114687|FG001|Overall Study|Lost to Follow-up|21|||
148899519|NCT01980017|537114686|FG000|Overall Study|Death|0|||
148899520|NCT01980017|537114687|FG001|Overall Study|Death|1|||
148899521|NCT03044106|537114688|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
148899522|NCT03044106|537114689|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
148899523|NCT01207414|537114691|FG000|Overall Study|Adverse Event|25|||
148899524|NCT01207414|537114692|FG001|Overall Study|Adverse Event|39|||
148899525|NCT01207414|537114691|FG000|Overall Study|Abnormal test procedure results|0|||
148899526|NCT01207414|537114692|FG001|Overall Study|Abnormal test procedure results|1|||
148899527|NCT01207414|537114691|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
148899528|NCT01207414|537114692|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
148899529|NCT01207414|537114691|FG000|Overall Study|Patient withdrew consent|14|||
148899530|NCT01207414|537114692|FG001|Overall Study|Patient withdrew consent|11|||
148899531|NCT01207414|537114691|FG000|Overall Study|Lost to Follow-up|15|||
148899532|NCT01207414|537114692|FG001|Overall Study|Lost to Follow-up|17|||
148899533|NCT01207414|537114691|FG000|Overall Study|Administrative problems|1|||
148899534|NCT01207414|537114692|FG001|Overall Study|Administrative problems|1|||
148899535|NCT01207414|537114691|FG000|Overall Study|Protocol deviation|12|||
148899536|NCT01207414|537114692|FG001|Overall Study|Protocol deviation|9|||
148899537|NCT01207414|537114691|FG000|Overall Study|Randomized in error|1|||
148899538|NCT01207414|537114692|FG001|Overall Study|Randomized in error|0|||
148899539|NCT02057250|537114693|FG000|AID Assessment Phase|Adverse Event|3|||
148899540|NCT02057250|537114694|FG001|AID Assessment Phase|Adverse Event|2|||
148899541|NCT02057250|537114695|FG002|AID Assessment Phase|Adverse Event|6|||
148899542|NCT02057250|537114696|FG003|AID Assessment Phase|Adverse Event|1|||
148899543|NCT02057250|537114697|FG004|AID Assessment Phase|Adverse Event|0|||
148899544|NCT02057250|537114693|FG000|AID Assessment Phase|Other than specified above|1|||
148899545|NCT02057250|537114694|FG001|AID Assessment Phase|Other than specified above|1|||
148899546|NCT02057250|537114695|FG002|AID Assessment Phase|Other than specified above|1|||
148899547|NCT02057250|537114696|FG003|AID Assessment Phase|Other than specified above|1|||
148899548|NCT02057250|537114697|FG004|AID Assessment Phase|Other than specified above|0|||
148899549|NCT02057250|537114693|FG000|Extension Phase|Adverse Event|0|||
148899550|NCT02057250|537114694|FG001|Extension Phase|Adverse Event|0|||
148899551|NCT02057250|537114695|FG002|Extension Phase|Adverse Event|0|||
148899552|NCT02057250|537114696|FG003|Extension Phase|Adverse Event|0|||
148899553|NCT02057250|537114697|FG004|Extension Phase|Adverse Event|15|||
148899554|NCT02057250|537114693|FG000|Extension Phase|Lack of Efficacy|0|||
148899555|NCT02057250|537114694|FG001|Extension Phase|Lack of Efficacy|0|||
148799081|NCT01249417|536744005|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
148799082|NCT03102762|536744006|FG000|Overall Study|Lost to Follow-up|1|||
148799083|NCT03102762|536744007|FG001|Overall Study|Lost to Follow-up|0|||
148799084|NCT03074695|536744012|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
148799085|NCT03074695|536744013|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
148799086|NCT03074695|536744012|FG000|Overall Study|Research staff not available|1|||
148799087|NCT03074695|536744013|FG001|Overall Study|Research staff not available|2|||
148799088|NCT03074695|536744012|FG000|Overall Study|Did not receive neuraxial block|2|||
148799089|NCT03074695|536744013|FG001|Overall Study|Did not receive neuraxial block|2|||
148799090|NCT01774981|536744014|FG000|Overall Study|Adverse Event|0|||
148799091|NCT01774981|536744015|FG001|Overall Study|Adverse Event|0|||
148799092|NCT01774981|536744016|FG002|Overall Study|Adverse Event|0|||
148799093|NCT01774981|536744017|FG003|Overall Study|Adverse Event|0|||
148799094|NCT01774981|536744018|FG004|Overall Study|Adverse Event|0|||
148799095|NCT01774981|536744019|FG005|Overall Study|Adverse Event|1|||
148799096|NCT01774981|536744020|FG006|Overall Study|Adverse Event|0|||
148799097|NCT01774981|536744021|FG007|Overall Study|Adverse Event|0|||
148799098|NCT01774981|536744014|FG000|Overall Study|Withdrawal by Subject|0|||
148799099|NCT01774981|536744015|FG001|Overall Study|Withdrawal by Subject|0|||
148799100|NCT01774981|536744016|FG002|Overall Study|Withdrawal by Subject|0|||
148799101|NCT01774981|536744017|FG003|Overall Study|Withdrawal by Subject|0|||
148799102|NCT01774981|536744018|FG004|Overall Study|Withdrawal by Subject|0|||
148799103|NCT01774981|536744019|FG005|Overall Study|Withdrawal by Subject|0|||
148799104|NCT01774981|536744020|FG006|Overall Study|Withdrawal by Subject|0|||
148799105|NCT01774981|536744021|FG007|Overall Study|Withdrawal by Subject|1|||
148799106|NCT01774981|536744014|FG000|Overall Study|Death|0|||
148799107|NCT01774981|536744015|FG001|Overall Study|Death|0|||
148799108|NCT01774981|536744016|FG002|Overall Study|Death|0|||
148799109|NCT01774981|536744017|FG003|Overall Study|Death|0|||
148799110|NCT01774981|536744018|FG004|Overall Study|Death|1|||
148799111|NCT01774981|536744019|FG005|Overall Study|Death|0|||
148799112|NCT01774981|536744020|FG006|Overall Study|Death|0|||
148799113|NCT01774981|536744021|FG007|Overall Study|Death|0|||
148799114|NCT00902577|536744026|FG000|Overall Study|Withdrawal by Subject|6|||
148799115|NCT00902577|536744026|FG000|Overall Study|FMISO production failure|2|||
148799116|NCT01232790|536744029|FG000|Randomization|Withdrawal by Subject|2|||
148799117|NCT01232790|536744030|FG001|Randomization|Withdrawal by Subject|0|||
148799118|NCT01232790|536744029|FG000|Randomization|Protocol Violation|0|||
148799119|NCT01232790|536744030|FG001|Randomization|Protocol Violation|1|||
148799120|NCT01232790|536744029|FG000|Randomization|Physician Decision|0|||
148799121|NCT01232790|536744030|FG001|Randomization|Physician Decision|1|||
148799122|NCT01232790|536744029|FG000|Initial Assessment|Withdrawal by Subject|0|||
148799123|NCT01232790|536744030|FG001|Initial Assessment|Withdrawal by Subject|1|||
148799124|NCT01232790|536744029|FG000|First Crossover|Withdrawal by Subject|1|||
148799125|NCT01232790|536744030|FG001|First Crossover|Withdrawal by Subject|0|||
148799126|NCT01232790|536744029|FG000|Second Crossover|Withdrawal by Subject|1|||
148799127|NCT01232790|536744030|FG001|Second Crossover|Withdrawal by Subject|2|||
148799128|NCT03322293|536744031|FG000|Overall Study|Lost to Follow-up|0|||
148799129|NCT03322293|536744032|FG001|Overall Study|Lost to Follow-up|0|||
148799130|NCT03322293|536744033|FG002|Overall Study|Lost to Follow-up|1|||
148799131|NCT00083915|536744034|FG000|Overall Study|Death|6|||
148799132|NCT00083915|536744035|FG001|Overall Study|Death|3|||
148799133|NCT00083915|536744034|FG000|Overall Study|Physician Decision|11|||
148799134|NCT00083915|536744035|FG001|Overall Study|Physician Decision|6|||
148799135|NCT00083915|536744034|FG000|Overall Study|Withdrawal by Subject|8|||
148799136|NCT00083915|536744035|FG001|Overall Study|Withdrawal by Subject|3|||
148899556|NCT02057250|537114695|FG002|Extension Phase|Lack of Efficacy|0|||
148799137|NCT00083915|536744034|FG000|Overall Study|disease progression|18|||
148799138|NCT00083915|536744035|FG001|Overall Study|disease progression|23|||
148799139|NCT00083915|536744034|FG000|Overall Study|Failure to collect|3|||
148799140|NCT00083915|536744035|FG001|Overall Study|Failure to collect|0|||
148799141|NCT00083915|536744034|FG000|Overall Study|No response|3|||
148799142|NCT00083915|536744035|FG001|Overall Study|No response|1|||
148799143|NCT00083915|536744034|FG000|Overall Study|Insurance issues|1|||
148799144|NCT00083915|536744035|FG001|Overall Study|Insurance issues|1|||
148899557|NCT02057250|537114696|FG003|Extension Phase|Lack of Efficacy|0|||
148899558|NCT02057250|537114697|FG004|Extension Phase|Lack of Efficacy|10|||
148899559|NCT02057250|537114693|FG000|Extension Phase|Entered in this period but not treated|0|||
148899560|NCT02057250|537114694|FG001|Extension Phase|Entered in this period but not treated|0|||
148899561|NCT02057250|537114695|FG002|Extension Phase|Entered in this period but not treated|0|||
148899562|NCT02057250|537114696|FG003|Extension Phase|Entered in this period but not treated|0|||
148899563|NCT02057250|537114697|FG004|Extension Phase|Entered in this period but not treated|4|||
148799145|NCT01239797|536744036|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
148799146|NCT01239797|536744037|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
148799147|NCT01239797|536744036|FG000|Randomized Participants|Participant withdrew consent|1|||
148799148|NCT01239797|536744037|FG001|Randomized Participants|Participant withdrew consent|7|||
148799149|NCT01239797|536744036|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
148799150|NCT01239797|536744037|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
148799151|NCT01239797|536744036|FG000|Treated Participants|Disease progression|185|||
148799152|NCT01239797|536744037|FG001|Treated Participants|Disease progression|185|||
148799153|NCT01239797|536744036|FG000|Treated Participants|Study drug toxicity|39|||
148799154|NCT01239797|536744037|FG001|Treated Participants|Study drug toxicity|45|||
148799155|NCT01239797|536744036|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
148799156|NCT01239797|536744037|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
148799157|NCT01239797|536744036|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
148799158|NCT01239797|536744037|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
148799159|NCT01239797|536744036|FG000|Treated Participants|Administrative reason by sponsor|13|||
148799160|NCT01239797|536744037|FG001|Treated Participants|Administrative reason by sponsor|4|||
148799161|NCT01239797|536744036|FG000|Treated Participants|Other reasons|14|||
148799162|NCT01239797|536744037|FG001|Treated Participants|Other reasons|14|||
148799163|NCT01239797|536744036|FG000|Treated Participants|Participant withdrew consent|6|||
148799164|NCT01239797|536744037|FG001|Treated Participants|Participant withdrew consent|11|||
148799165|NCT01239797|536744036|FG000|Treated Participants|Death|1|||
148799166|NCT01239797|536744037|FG001|Treated Participants|Death|1|||
148799167|NCT01239797|536744036|FG000|Treated Participants|Participant no longer meets study criteria|1|||
148799168|NCT01239797|536744037|FG001|Treated Participants|Participant no longer meets study criteria|1|||
148899564|NCT02057250|537114693|FG000|Extension Phase|Other than specified above|0|||
148899565|NCT02057250|537114694|FG001|Extension Phase|Other than specified above|0|||
148899566|NCT02057250|537114695|FG002|Extension Phase|Other than specified above|0|||
148899567|NCT02057250|537114696|FG003|Extension Phase|Other than specified above|0|||
148899568|NCT02057250|537114697|FG004|Extension Phase|Other than specified above|7|||
148899569|NCT01435382|537114700|FG000|Overall Study|Lost to Follow-up|1|||
148899570|NCT01435382|537114701|FG001|Overall Study|Lost to Follow-up|0|||
148899571|NCT01435382|537114702|FG002|Overall Study|Lost to Follow-up|1|||
148899572|NCT01435382|537114703|FG003|Overall Study|Lost to Follow-up|0|||
148899573|NCT01435382|537114700|FG000|Overall Study|Withdrawal by Subject|0|||
148899574|NCT01435382|537114701|FG001|Overall Study|Withdrawal by Subject|2|||
148899575|NCT01435382|537114702|FG002|Overall Study|Withdrawal by Subject|0|||
148899576|NCT01435382|537114703|FG003|Overall Study|Withdrawal by Subject|1|||
148899577|NCT03367793|537114704|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
148899578|NCT03367793|537114705|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
148899579|NCT03367793|537114706|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
148899580|NCT03367793|537114707|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
148899581|NCT03367793|537114708|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
148899582|NCT03367793|537114709|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
148899583|NCT00423579|537114710|FG000|Overall Study|Lost to Follow-up|3|||
148899584|NCT00423579|537114711|FG001|Overall Study|Lost to Follow-up|0|||
148899585|NCT00423579|537114710|FG000|Overall Study|Protocol Violation|1|||
148899586|NCT00423579|537114711|FG001|Overall Study|Protocol Violation|3|||
148899587|NCT00423579|537114710|FG000|Overall Study|Diagnosis of diabetes|0|||
148899588|NCT00423579|537114711|FG001|Overall Study|Diagnosis of diabetes|1|||
148899589|NCT00260533|537114712|FG000|Overall Study|Other|3|||
148899590|NCT00260533|537114713|FG001|Overall Study|Other|3|||
148899591|NCT01310777|537114715|FG000|Overall Study|Adverse Event|23|||
148899592|NCT01310777|537114716|FG001|Overall Study|Adverse Event|1|||
148899593|NCT01310777|537114717|FG002|Overall Study|Adverse Event|15|||
148899594|NCT01310777|537114715|FG000|Overall Study|Lost to Follow-up|0|||
148899595|NCT01310777|537114716|FG001|Overall Study|Lost to Follow-up|4|||
148899596|NCT01310777|537114717|FG002|Overall Study|Lost to Follow-up|1|||
148899597|NCT01310777|537114715|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
148899598|NCT01310777|537114716|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
148899599|NCT01310777|537114717|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
148899600|NCT01310777|537114715|FG000|Overall Study|Inadequate Control of IOP|5|||
148899601|NCT01310777|537114716|FG001|Overall Study|Inadequate Control of IOP|7|||
148899602|NCT01310777|537114717|FG002|Overall Study|Inadequate Control of IOP|10|||
148899603|NCT01310777|537114715|FG000|Overall Study|Other|4|||
148899604|NCT01310777|537114716|FG001|Overall Study|Other|1|||
148899605|NCT01310777|537114717|FG002|Overall Study|Other|2|||
148899606|NCT00003475|537114718|FG000|Overall Study|Not evaluable|13|||
148899607|NCT03125395|537114719|FG000|Overall Study|Adverse Event|2|||
148899608|NCT03125395|537114719|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
148899609|NCT03125395|537114719|FG000|Overall Study|Physician Decision|2|||
148899610|NCT03125395|537114719|FG000|Overall Study|Commercial drug is available|5|||
148899611|NCT00106704|537114720|FG000|Overall Study|Adverse Event|10|||
148899612|NCT00106704|537114721|FG001|Overall Study|Adverse Event|7|||
148899613|NCT00106704|537114720|FG000|Overall Study|Death|2|||
148899614|NCT00106704|537114721|FG001|Overall Study|Death|1|||
148899615|NCT00106704|537114720|FG000|Overall Study|Lack of Efficacy|67|||
148899616|NCT00106704|537114721|FG001|Overall Study|Lack of Efficacy|69|||
148899617|NCT00106704|537114720|FG000|Overall Study|Lost to Follow-up|7|||
148899618|NCT00106704|537114721|FG001|Overall Study|Lost to Follow-up|3|||
148899619|NCT00106704|537114720|FG000|Overall Study|Pregnancy|1|||
148899620|NCT00106704|537114721|FG001|Overall Study|Pregnancy|0|||
148899621|NCT00106704|537114720|FG000|Overall Study|Protocol Violation|4|||
148899622|NCT00106704|537114721|FG001|Overall Study|Protocol Violation|7|||
148899623|NCT00106704|537114720|FG000|Overall Study|Withdrawal by Subject|14|||
148899624|NCT00106704|537114721|FG001|Overall Study|Withdrawal by Subject|21|||
148899625|NCT00106704|537114720|FG000|Overall Study|Patient moved|1|||
148899626|NCT00106704|537114721|FG001|Overall Study|Patient moved|0|||
148899627|NCT00106704|537114720|FG000|Overall Study|Site terminated|0|||
148899628|NCT00106704|537114721|FG001|Overall Study|Site terminated|1|||
148899629|NCT00106704|537114720|FG000|Overall Study|Planned major surgery|1|||
148899630|NCT00106704|537114721|FG001|Overall Study|Planned major surgery|0|||
148899631|NCT00106704|537114720|FG000|Overall Study|Patient Received Glycemic Medication|22|||
148899632|NCT00106704|537114721|FG001|Overall Study|Patient Received Glycemic Medication|41|||
148899633|NCT00106704|537114720|FG000|Overall Study|Unable to re-enter US|1|||
148899634|NCT00106704|537114721|FG001|Overall Study|Unable to re-enter US|0|||
148899635|NCT00106704|537114720|FG000|Overall Study|Laboratory test|1|||
148899636|NCT00106704|537114721|FG001|Overall Study|Laboratory test|1|||
148899637|NCT01780506|537114722|FG000|Double-Blind Phase|Randomized but not Treated|3|||
148899638|NCT01780506|537114723|FG001|Double-Blind Phase|Randomized but not Treated|2|||
148899639|NCT01780506|537114722|FG000|Double-Blind Phase|Adverse Event|4|||
148899640|NCT01780506|537114723|FG001|Double-Blind Phase|Adverse Event|14|||
148899641|NCT01780506|537114722|FG000|Double-Blind Phase|Death|1|||
148899642|NCT01780506|537114723|FG001|Double-Blind Phase|Death|2|||
148899643|NCT01780506|537114722|FG000|Double-Blind Phase|Pregnancy|2|||
148899644|NCT01780506|537114723|FG001|Double-Blind Phase|Pregnancy|1|||
148899645|NCT01780506|537114722|FG000|Double-Blind Phase|Lack of Efficacy|1|||
148899646|NCT01780506|537114723|FG001|Double-Blind Phase|Lack of Efficacy|1|||
148899647|NCT01780506|537114722|FG000|Double-Blind Phase|Investigator's Discretion|5|||
148899648|NCT01780506|537114723|FG001|Double-Blind Phase|Investigator's Discretion|2|||
148899649|NCT01780506|537114722|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
148899650|NCT01780506|537114723|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
148899651|NCT01780506|537114722|FG000|Double-Blind Phase|Protocol Violation|4|||
148899652|NCT01780506|537114723|FG001|Double-Blind Phase|Protocol Violation|3|||
148899653|NCT01780506|537114722|FG000|Double-Blind Phase|Withdrew Consent|23|||
148899654|NCT01780506|537114723|FG001|Double-Blind Phase|Withdrew Consent|24|||
148899655|NCT01780506|537114722|FG000|Double-Blind Phase|Lost to Follow-up|23|||
148899656|NCT01780506|537114723|FG001|Double-Blind Phase|Lost to Follow-up|26|||
148899657|NCT01780506|537114722|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
148899658|NCT01780506|537114723|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
148899659|NCT03486912|537114730|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
148899660|NCT03486912|537114731|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
148899661|NCT03486912|537114732|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
148899662|NCT03486912|537114733|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
148899663|NCT03486912|537114730|FG000|Treatment Period|Withdrawal by Subject|3|||
148899664|NCT03486912|537114731|FG001|Treatment Period|Withdrawal by Subject|3|||
148899665|NCT03486912|537114732|FG002|Treatment Period|Withdrawal by Subject|3|||
148899666|NCT03486912|537114733|FG003|Treatment Period|Withdrawal by Subject|2|||
148899667|NCT03486912|537114730|FG000|Treatment Period|Other Reasons|0|||
148899668|NCT03486912|537114731|FG001|Treatment Period|Other Reasons|2|||
148899669|NCT03486912|537114732|FG002|Treatment Period|Other Reasons|1|||
148899670|NCT03486912|537114733|FG003|Treatment Period|Other Reasons|1|||
148899671|NCT03486912|537114730|FG000|Treatment Period|Adverse Event|0|||
148899672|NCT03486912|537114731|FG001|Treatment Period|Adverse Event|1|||
148899673|NCT03486912|537114732|FG002|Treatment Period|Adverse Event|1|||
148899674|NCT03486912|537114733|FG003|Treatment Period|Adverse Event|0|||
148899675|NCT03486912|537114730|FG000|Treatment Period|Lost to Follow-up|1|||
148899676|NCT03486912|537114731|FG001|Treatment Period|Lost to Follow-up|0|||
148899677|NCT03486912|537114732|FG002|Treatment Period|Lost to Follow-up|0|||
148899678|NCT03486912|537114733|FG003|Treatment Period|Lost to Follow-up|2|||
148899679|NCT00412984|537114735|FG000|Overall Study|Death|331|||
148899680|NCT00412984|537114736|FG001|Overall Study|Death|349|||
148899681|NCT00412984|537114735|FG000|Overall Study|Adverse Event|679|||
148899682|NCT00412984|537114736|FG001|Overall Study|Adverse Event|738|||
148899683|NCT00412984|537114735|FG000|Overall Study|Withdrawal by Subject|921|||
148899684|NCT00412984|537114736|FG001|Overall Study|Withdrawal by Subject|989|||
148899685|NCT00412984|537114735|FG000|Overall Study|Lost to Follow-up|51|||
148899686|NCT00412984|537114736|FG001|Overall Study|Lost to Follow-up|39|||
148899687|NCT00412984|537114735|FG000|Overall Study|Poor/Noncompliance|57|||
148899688|NCT00412984|537114736|FG001|Overall Study|Poor/Noncompliance|77|||
148899689|NCT00412984|537114735|FG000|Overall Study|Pregnancy|1|||
148899690|NCT00412984|537114736|FG001|Overall Study|Pregnancy|0|||
148899691|NCT00412984|537114735|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
148899692|NCT00412984|537114736|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
148799169|NCT01239797|536744036|FG000|Treated Participants|Poor/non-compliance|0|||
148799170|NCT01239797|536744037|FG001|Treated Participants|Poor/non-compliance|1|||
148799171|NCT02000921|536744043|FG000|Overall Study|Withdrawal by Subject|3|||
148799172|NCT02000921|536744044|FG001|Overall Study|Withdrawal by Subject|10|||
148799173|NCT02000921|536744045|FG002|Overall Study|Withdrawal by Subject|5|||
148799174|NCT02000921|536744043|FG000|Overall Study|Lost to Follow-up|2|||
148799175|NCT02000921|536744044|FG001|Overall Study|Lost to Follow-up|4|||
148799176|NCT02000921|536744045|FG002|Overall Study|Lost to Follow-up|5|||
148799177|NCT02000921|536744043|FG000|Overall Study|Physician Decision|0|||
148799178|NCT02000921|536744044|FG001|Overall Study|Physician Decision|2|||
148799179|NCT02000921|536744045|FG002|Overall Study|Physician Decision|0|||
148799180|NCT02914834|536744046|FG000|Overall Study|Study halted due to COVID|1|||
148799181|NCT02914834|536744047|FG001|Overall Study|Study halted due to COVID|1|||
148799182|NCT02914834|536744046|FG000|Overall Study|1 subject withdrew|0|||
148799183|NCT02914834|536744047|FG001|Overall Study|1 subject withdrew|1|||
148799184|NCT02631941|536744052|FG000|Overall Study|Physician Decision|0|||
148799185|NCT02631941|536744053|FG001|Overall Study|Physician Decision|1|||
148799186|NCT02631941|536744054|FG002|Overall Study|Physician Decision|0|||
148799187|NCT02631941|536744055|FG003|Overall Study|Physician Decision|0|||
148799188|NCT02631941|536744056|FG004|Overall Study|Physician Decision|0|||
148799189|NCT02631941|536744057|FG005|Overall Study|Physician Decision|0|||
148799190|NCT02631941|536744058|FG006|Overall Study|Physician Decision|0|||
148799191|NCT02631941|536744059|FG007|Overall Study|Physician Decision|0|||
148799192|NCT02631941|536744060|FG008|Overall Study|Physician Decision|0|||
148799193|NCT02631941|536744061|FG009|Overall Study|Physician Decision|0|||
148799194|NCT02631941|536744052|FG000|Overall Study|Adverse Event|0|||
148799195|NCT02631941|536744053|FG001|Overall Study|Adverse Event|1|||
148799196|NCT02631941|536744054|FG002|Overall Study|Adverse Event|0|||
148799197|NCT02631941|536744055|FG003|Overall Study|Adverse Event|0|||
148799198|NCT02631941|536744056|FG004|Overall Study|Adverse Event|0|||
148799199|NCT02631941|536744057|FG005|Overall Study|Adverse Event|0|||
148799200|NCT02631941|536744058|FG006|Overall Study|Adverse Event|0|||
148799201|NCT02631941|536744059|FG007|Overall Study|Adverse Event|0|||
148799202|NCT02631941|536744060|FG008|Overall Study|Adverse Event|0|||
148799203|NCT02631941|536744061|FG009|Overall Study|Adverse Event|0|||
148799204|NCT02631941|536744052|FG000|Overall Study|Withdrawal by Subject|0|||
148799205|NCT02631941|536744053|FG001|Overall Study|Withdrawal by Subject|0|||
148799206|NCT02631941|536744054|FG002|Overall Study|Withdrawal by Subject|0|||
148799207|NCT02631941|536744055|FG003|Overall Study|Withdrawal by Subject|0|||
148799208|NCT02631941|536744056|FG004|Overall Study|Withdrawal by Subject|1|||
148799209|NCT02631941|536744057|FG005|Overall Study|Withdrawal by Subject|0|||
148799210|NCT02631941|536744058|FG006|Overall Study|Withdrawal by Subject|0|||
148799211|NCT02631941|536744059|FG007|Overall Study|Withdrawal by Subject|1|||
148799212|NCT02631941|536744060|FG008|Overall Study|Withdrawal by Subject|0|||
148799213|NCT02631941|536744061|FG009|Overall Study|Withdrawal by Subject|0|||
148799214|NCT02631941|536744052|FG000|Overall Study|Lost to Follow-up|0|||
148799215|NCT02631941|536744053|FG001|Overall Study|Lost to Follow-up|0|||
148799216|NCT02631941|536744054|FG002|Overall Study|Lost to Follow-up|0|||
148799217|NCT02631941|536744055|FG003|Overall Study|Lost to Follow-up|0|||
148799218|NCT02631941|536744056|FG004|Overall Study|Lost to Follow-up|0|||
148799219|NCT02631941|536744057|FG005|Overall Study|Lost to Follow-up|0|||
148799220|NCT02631941|536744058|FG006|Overall Study|Lost to Follow-up|0|||
148799221|NCT02631941|536744059|FG007|Overall Study|Lost to Follow-up|0|||
148799222|NCT02631941|536744060|FG008|Overall Study|Lost to Follow-up|1|||
148799223|NCT02631941|536744061|FG009|Overall Study|Lost to Follow-up|0|||
148799224|NCT00719901|536744064|FG000|Overall Study|Adverse Event|5|||
148799225|NCT00719901|536744064|FG000|Overall Study|Withdrawal by Subject|1|||
148799226|NCT00719901|536744064|FG000|Overall Study|Alternate Treatment|1|||
148799227|NCT00719901|536744064|FG000|Overall Study|Disease Progression|3|||
148799228|NCT00719901|536744064|FG000|Overall Study|Availability of Study Drug|1|||
148799229|NCT04456686|536744067|FG000|Overall Study|Adverse Event|2|||
148799230|NCT04456686|536744068|FG001|Overall Study|Adverse Event|1|||
148799231|NCT04456686|536744067|FG000|Overall Study|Lack of Efficacy|3|||
148799232|NCT04456686|536744068|FG001|Overall Study|Lack of Efficacy|1|||
148799233|NCT04456686|536744067|FG000|Overall Study|Withdrew consent|3|||
148799234|NCT04456686|536744068|FG001|Overall Study|Withdrew consent|1|||
148799235|NCT04456686|536744067|FG000|Overall Study|Physician Decision|2|||
148799236|NCT04456686|536744068|FG001|Overall Study|Physician Decision|2|||
148799237|NCT04456686|536744067|FG000|Overall Study|Withdrawal by Subject|5|||
148799238|NCT04456686|536744068|FG001|Overall Study|Withdrawal by Subject|1|||
148799239|NCT04456686|536744067|FG000|Overall Study|Protocol Violation|0|||
148799240|NCT04456686|536744068|FG001|Overall Study|Protocol Violation|1|||
148799241|NCT02858401|536744072|FG000|Overall Study|Withdrew Consent|0|||
148799242|NCT02858401|536744073|FG001|Overall Study|Withdrew Consent|0|||
148799243|NCT02858401|536744074|FG002|Overall Study|Withdrew Consent|0|||
148799244|NCT02858401|536744075|FG003|Overall Study|Withdrew Consent|0|||
148799245|NCT02858401|536744076|FG004|Overall Study|Withdrew Consent|0|||
148799246|NCT02858401|536744077|FG005|Overall Study|Withdrew Consent|1|||
148799247|NCT02858401|536744078|FG006|Overall Study|Withdrew Consent|0|||
148799248|NCT02858401|536744072|FG000|Overall Study|Lost to Follow-up|0|||
148799249|NCT02858401|536744073|FG001|Overall Study|Lost to Follow-up|1|||
148799250|NCT02858401|536744074|FG002|Overall Study|Lost to Follow-up|0|||
148799251|NCT02858401|536744075|FG003|Overall Study|Lost to Follow-up|0|||
148799252|NCT02858401|536744076|FG004|Overall Study|Lost to Follow-up|0|||
148799253|NCT02858401|536744077|FG005|Overall Study|Lost to Follow-up|0|||
148799254|NCT02858401|536744078|FG006|Overall Study|Lost to Follow-up|0|||
148799255|NCT03722576|536744079|FG000|Overall Study|Withdrawal by Subject|3|||
148799256|NCT03722576|536744079|FG000|Overall Study|Adverse Event|2|||
148799257|NCT03722576|536744079|FG000|Overall Study|Physician Decision|1|||
148799258|NCT03722576|536744079|FG000|Overall Study|Lost to Follow-up|1|||
148799259|NCT00748241|536744080|FG000|Overall Study|Implant failure|1|||
148799260|NCT00748241|536744080|FG000|Overall Study|Lost to Follow-up|5|||
148799261|NCT00748241|536744080|FG000|Overall Study|Death|2|||
148799262|NCT01240382|536744081|FG000|Overall Study|Adverse Event|2|||
148799263|NCT01240382|536744082|FG001|Overall Study|Adverse Event|1|||
148799264|NCT01240382|536744081|FG000|Overall Study|Lack of Efficacy|0|||
148799265|NCT01240382|536744082|FG001|Overall Study|Lack of Efficacy|2|||
148799266|NCT01240382|536744081|FG000|Overall Study|Fear of adverse events|0|||
148799267|NCT01240382|536744082|FG001|Overall Study|Fear of adverse events|1|||
148799268|NCT02643693|536744083|FG000|Overall Study|Physician Decision|0|||
148799269|NCT02643693|536744084|FG001|Overall Study|Physician Decision|1|||
148799270|NCT02643693|536744085|FG002|Overall Study|Physician Decision|0|||
148799271|NCT02643693|536744086|FG003|Overall Study|Physician Decision|0|||
148799272|NCT02643693|536744087|FG004|Overall Study|Physician Decision|0|||
148799273|NCT02643693|536744088|FG005|Overall Study|Physician Decision|0|||
148799274|NCT02643693|536744083|FG000|Overall Study|Withdrawal by Subject|0|||
148799275|NCT02643693|536744084|FG001|Overall Study|Withdrawal by Subject|1|||
148799276|NCT02643693|536744085|FG002|Overall Study|Withdrawal by Subject|0|||
148799277|NCT02643693|536744086|FG003|Overall Study|Withdrawal by Subject|0|||
148799278|NCT02643693|536744087|FG004|Overall Study|Withdrawal by Subject|0|||
148799279|NCT02643693|536744088|FG005|Overall Study|Withdrawal by Subject|0|||
148799280|NCT02643693|536744083|FG000|Overall Study|Protocol Adherence Issues|2|||
148799281|NCT02643693|536744084|FG001|Overall Study|Protocol Adherence Issues|0|||
148799282|NCT02643693|536744085|FG002|Overall Study|Protocol Adherence Issues|1|||
148799283|NCT02643693|536744086|FG003|Overall Study|Protocol Adherence Issues|0|||
148799284|NCT02643693|536744087|FG004|Overall Study|Protocol Adherence Issues|0|||
148799285|NCT02643693|536744088|FG005|Overall Study|Protocol Adherence Issues|1|||
148799286|NCT00492297|536744089|FG000|Treatment|Death|2|||
148799287|NCT00492297|536744089|FG000|Treatment|Study terminated by sponsor|3|||
148799288|NCT00492297|536744089|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
148799289|NCT00492297|536744089|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
148799290|NCT00492297|536744089|FG000|Survival Only Follow-up|Death|46|||
148799291|NCT00492297|536744089|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
148799292|NCT00492297|536744089|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
148799293|NCT01408706|536744090|FG000|Overall Study|Physician Decision|1|||
148799294|NCT01408706|536744091|FG001|Overall Study|Physician Decision|0|||
148799295|NCT00888654|536744093|FG000|Overall Study|Problems swallowing oral meds.|1|||
148799296|NCT00888654|536744093|FG000|Overall Study|Not enough oral meds before surgery|3|||
148799297|NCT00888654|536744093|FG000|Overall Study|Surgery aborted|2|||
148799298|NCT00888654|536744093|FG000|Overall Study|Withdrawal by Subject|1|||
148799299|NCT00888654|536744093|FG000|Overall Study|Inelig. due to contraindication of med|1|||
148799300|NCT00888654|536744093|FG000|Overall Study|Change in surg date|1|||
148799301|NCT00888654|536744093|FG000|Overall Study|Stopped meds due to headaches|1|||
148799302|NCT03885908|536744094|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
148799303|NCT03885908|536744095|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
148799304|NCT03885908|536744094|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
148799305|NCT03885908|536744095|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
148799306|NCT03885908|536744094|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
148799307|NCT03885908|536744095|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
149011483|NCT00405639|537521478|FG001|Overall Study|Seizure prior to receiving BNP|0|||
148799308|NCT03885908|536744094|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
148799309|NCT03885908|536744095|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
148899693|NCT00412984|537114735|FG000|Overall Study|Administrative Reason by Sponsor|11|||
148899694|NCT00412984|537114736|FG001|Overall Study|Administrative Reason by Sponsor|8|||
148899695|NCT00412984|537114735|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
148899696|NCT00412984|537114736|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
148899697|NCT00412984|537114735|FG000|Overall Study|Other Reason|80|||
148899698|NCT00412984|537114736|FG001|Overall Study|Other Reason|92|||
148899699|NCT00412984|537114735|FG000|Overall Study|Not Reported|11|||
148899700|NCT00412984|537114736|FG001|Overall Study|Not Reported|12|||
148899701|NCT02383576|537114737|FG000|Overall Study|Death|53|||
148899702|NCT02383576|537114738|FG001|Overall Study|Death|33|||
148899703|NCT02383576|537114737|FG000|Overall Study|Lost to Follow-up|7|||
148899704|NCT02383576|537114738|FG001|Overall Study|Lost to Follow-up|1|||
148899705|NCT02383576|537114737|FG000|Overall Study|Withdrew Consent|1|||
148899706|NCT02383576|537114738|FG001|Overall Study|Withdrew Consent|6|||
148899707|NCT02383576|537114737|FG000|Overall Study|Investigator's Decision|0|||
148899708|NCT02383576|537114738|FG001|Overall Study|Investigator's Decision|1|||
148899709|NCT02383576|537114737|FG000|Overall Study|Administrative/Other|2|||
148899710|NCT02383576|537114738|FG001|Overall Study|Administrative/Other|4|||
148899711|NCT04852302|537114747|FG000|Overall Study|Withdrawal by Subject|2|||
148899712|NCT04852302|537114747|FG000|Overall Study|Did not complete CALM therapy.|2|||
148899713|NCT00528112|537114748|FG000|Treatment up to 3 Years|Adverse Event|313|||
148899714|NCT00528112|537114749|FG001|Treatment up to 3 Years|Adverse Event|278|||
148899715|NCT00528112|537114748|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
148899716|NCT00528112|537114749|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
148899717|NCT00528112|537114748|FG000|Treatment up to 3 Years|Protocol Violation|16|||
148899718|NCT00528112|537114749|FG001|Treatment up to 3 Years|Protocol Violation|16|||
148899719|NCT00528112|537114748|FG000|Treatment up to 3 Years|Death|0|||
148899720|NCT00528112|537114749|FG001|Treatment up to 3 Years|Death|1|||
148899721|NCT00528112|537114748|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
148899722|NCT00528112|537114749|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
148899723|NCT00528112|537114748|FG000|Treatment up to 3 Years|Pregnancy|9|||
148899724|NCT00528112|537114749|FG001|Treatment up to 3 Years|Pregnancy|10|||
148899725|NCT00528112|537114748|FG000|Treatment up to 3 Years|Other reasons|186|||
148899726|NCT00528112|537114749|FG001|Treatment up to 3 Years|Other reasons|186|||
148899727|NCT00528112|537114748|FG000|Extension Phase|Withdrawal by Subject|0|||
148899728|NCT00528112|537114749|FG001|Extension Phase|Withdrawal by Subject|3|||
148899729|NCT00528112|537114748|FG000|Extension Phase|Other reasons|0|||
148899730|NCT00528112|537114749|FG001|Extension Phase|Other reasons|100|||
148899731|NCT00528112|537114748|FG000|Extension Phase|Pregnancy|0|||
148899732|NCT00528112|537114749|FG001|Extension Phase|Pregnancy|3|||
148899733|NCT00528112|537114748|FG000|Extension Phase|Lost to Follow-up|0|||
148899734|NCT00528112|537114749|FG001|Extension Phase|Lost to Follow-up|12|||
148899735|NCT00528112|537114748|FG000|Extension Phase|Death|0|||
148899736|NCT00528112|537114749|FG001|Extension Phase|Death|1|||
148899737|NCT00528112|537114748|FG000|Extension Phase|Adverse Event|0|||
148899738|NCT00528112|537114749|FG001|Extension Phase|Adverse Event|36|||
148899739|NCT00528112|537114748|FG000|Extension Phase|Protocol Violation|0|||
148899740|NCT00528112|537114749|FG001|Extension Phase|Protocol Violation|2|||
148899741|NCT02559622|537114751|FG000|Overall Study|Progressive disease|0|||
148899742|NCT02559622|537114752|FG001|Overall Study|Progressive disease|1|||
148899743|NCT02559622|537114753|FG002|Overall Study|Progressive disease|0|||
148899744|NCT02559622|537114754|FG003|Overall Study|Progressive disease|0|||
148899745|NCT02559622|537114751|FG000|Overall Study|Adverse Event|0|||
148899746|NCT02559622|537114752|FG001|Overall Study|Adverse Event|2|||
148899747|NCT02559622|537114753|FG002|Overall Study|Adverse Event|2|||
148899748|NCT02559622|537114754|FG003|Overall Study|Adverse Event|2|||
148899749|NCT02559622|537114751|FG000|Overall Study|Patient/guardian decision|1|||
148899750|NCT02559622|537114752|FG001|Overall Study|Patient/guardian decision|2|||
148899751|NCT02559622|537114753|FG002|Overall Study|Patient/guardian decision|0|||
148899752|NCT02559622|537114754|FG003|Overall Study|Patient/guardian decision|1|||
148899753|NCT01075243|537114756|FG000|Overall Study|Lost to Follow-up|5|||
148899754|NCT01075243|537114757|FG001|Overall Study|Lost to Follow-up|2|||
148899755|NCT01075243|537114758|FG002|Overall Study|Lost to Follow-up|0|||
148899756|NCT01075243|537114756|FG000|Overall Study|Withdrawal by Subject|1|||
148899757|NCT01075243|537114757|FG001|Overall Study|Withdrawal by Subject|1|||
148899758|NCT01075243|537114758|FG002|Overall Study|Withdrawal by Subject|0|||
148899759|NCT03050801|537114763|FG000|Experiment 1|Lost to Follow-up|0|||
148899760|NCT03050801|537114764|FG001|Experiment 1|Lost to Follow-up|1|||
148899761|NCT03050801|537114765|FG002|Experiment 1|Lost to Follow-up|0|||
148899762|NCT03050801|537114766|FG003|Experiment 1|Lost to Follow-up|0|||
148899763|NCT03050801|537114767|FG004|Experiment 1|Lost to Follow-up|0|||
148899764|NCT03050801|537114768|FG005|Experiment 1|Lost to Follow-up|0|||
148899765|NCT03050801|537114763|FG000|Experiment 1|Physician Decision|0|||
148899766|NCT03050801|537114764|FG001|Experiment 1|Physician Decision|3|||
148899767|NCT03050801|537114765|FG002|Experiment 1|Physician Decision|0|||
148899768|NCT03050801|537114766|FG003|Experiment 1|Physician Decision|0|||
148899769|NCT03050801|537114767|FG004|Experiment 1|Physician Decision|0|||
148899770|NCT03050801|537114768|FG005|Experiment 1|Physician Decision|0|||
148899771|NCT03050801|537114763|FG000|Experiment 1|Change of experimental design|0|||
148899772|NCT03050801|537114764|FG001|Experiment 1|Change of experimental design|3|||
148899773|NCT03050801|537114765|FG002|Experiment 1|Change of experimental design|0|||
148899774|NCT03050801|537114766|FG003|Experiment 1|Change of experimental design|0|||
148899775|NCT03050801|537114767|FG004|Experiment 1|Change of experimental design|0|||
148899776|NCT03050801|537114768|FG005|Experiment 1|Change of experimental design|0|||
148899777|NCT03050801|537114763|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
148899778|NCT03050801|537114764|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
148899779|NCT03050801|537114765|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
148899780|NCT03050801|537114766|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
148899781|NCT03050801|537114767|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
148899782|NCT03050801|537114768|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
148899783|NCT03050801|537114763|FG000|Experiment 2|Lost to Follow-up|0|||
148899784|NCT03050801|537114764|FG001|Experiment 2|Lost to Follow-up|0|||
148899785|NCT03050801|537114765|FG002|Experiment 2|Lost to Follow-up|0|||
148899786|NCT03050801|537114766|FG003|Experiment 2|Lost to Follow-up|1|||
148899787|NCT03050801|537114767|FG004|Experiment 2|Lost to Follow-up|1|||
148899788|NCT03050801|537114768|FG005|Experiment 2|Lost to Follow-up|0|||
148899789|NCT03050801|537114763|FG000|Experiment 2|Physician Decision|0|||
148899790|NCT03050801|537114764|FG001|Experiment 2|Physician Decision|0|||
148899791|NCT03050801|537114765|FG002|Experiment 2|Physician Decision|0|||
148899792|NCT03050801|537114766|FG003|Experiment 2|Physician Decision|0|||
148899793|NCT03050801|537114767|FG004|Experiment 2|Physician Decision|1|||
148899794|NCT03050801|537114768|FG005|Experiment 2|Physician Decision|0|||
148899795|NCT03050801|537114763|FG000|Experiment 2|Pregnancy|0|||
148899796|NCT03050801|537114764|FG001|Experiment 2|Pregnancy|0|||
148899797|NCT03050801|537114765|FG002|Experiment 2|Pregnancy|0|||
148899798|NCT03050801|537114766|FG003|Experiment 2|Pregnancy|0|||
148899799|NCT03050801|537114767|FG004|Experiment 2|Pregnancy|1|||
148899800|NCT03050801|537114768|FG005|Experiment 2|Pregnancy|0|||
148899801|NCT03050801|537114763|FG000|Experiment 2|Withdrawal by Subject|0|||
148899802|NCT03050801|537114764|FG001|Experiment 2|Withdrawal by Subject|0|||
148899803|NCT03050801|537114765|FG002|Experiment 2|Withdrawal by Subject|0|||
148899804|NCT03050801|537114766|FG003|Experiment 2|Withdrawal by Subject|1|||
148899805|NCT03050801|537114767|FG004|Experiment 2|Withdrawal by Subject|0|||
148899806|NCT03050801|537114768|FG005|Experiment 2|Withdrawal by Subject|0|||
148899807|NCT03050801|537114763|FG000|Experiment 2|Poor data quality|0|||
148899808|NCT03050801|537114764|FG001|Experiment 2|Poor data quality|0|||
148899809|NCT03050801|537114765|FG002|Experiment 2|Poor data quality|0|||
148899810|NCT03050801|537114766|FG003|Experiment 2|Poor data quality|4|||
148899811|NCT03050801|537114767|FG004|Experiment 2|Poor data quality|1|||
148899812|NCT03050801|537114768|FG005|Experiment 2|Poor data quality|0|||
148899813|NCT03050801|537114763|FG000|Experiment 2|Discomfort during stimulation|0|||
148899814|NCT03050801|537114764|FG001|Experiment 2|Discomfort during stimulation|0|||
148899815|NCT03050801|537114765|FG002|Experiment 2|Discomfort during stimulation|0|||
148899816|NCT03050801|537114766|FG003|Experiment 2|Discomfort during stimulation|0|||
148899817|NCT03050801|537114767|FG004|Experiment 2|Discomfort during stimulation|0|||
148899818|NCT03050801|537114768|FG005|Experiment 2|Discomfort during stimulation|2|||
148899819|NCT03600909|537114769|FG000|Overall Study|Not treated|0|||
148899820|NCT03600909|537114770|FG001|Overall Study|Not treated|3|||
148899821|NCT03600909|537114771|FG002|Overall Study|Not treated|0|||
148899822|NCT01084655|537116759|FG000|Overall Study|Radiographic disease progression|3|||
148899823|NCT01084655|537116760|FG001|Overall Study|Radiographic disease progression|2|||
148899824|NCT01084655|537116761|FG002|Overall Study|Radiographic disease progression|8|||
148899825|NCT01084655|537116759|FG000|Overall Study|Withdrawal by Subject|1|||
148899826|NCT01084655|537116760|FG001|Overall Study|Withdrawal by Subject|0|||
148899827|NCT01084655|537116761|FG002|Overall Study|Withdrawal by Subject|4|||
148899828|NCT01084655|537116759|FG000|Overall Study|Adverse Event|2|||
148899829|NCT01084655|537116760|FG001|Overall Study|Adverse Event|1|||
148899830|NCT01084655|537116761|FG002|Overall Study|Adverse Event|2|||
148899831|NCT01084655|537116759|FG000|Overall Study|Other|0|||
148899832|NCT01084655|537116760|FG001|Overall Study|Other|3|||
148899833|NCT01084655|537116761|FG002|Overall Study|Other|2|||
148899834|NCT01084655|537116759|FG000|Overall Study|Symptomatic deterioration|0|||
148899835|NCT01084655|537116760|FG001|Overall Study|Symptomatic deterioration|0|||
148899836|NCT01084655|537116761|FG002|Overall Study|Symptomatic deterioration|2|||
148899837|NCT01084655|537116759|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
148899838|NCT01084655|537116760|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
148899839|NCT01084655|537116761|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
148899840|NCT03829228|537116762|FG000|Overall Study|Protocol Violation|1|||
148899841|NCT02443688|537116765|FG000|Overall Study|Adverse Event|2|||
148899842|NCT02443688|537116766|FG001|Overall Study|Adverse Event|3|||
148899843|NCT02443688|537116767|FG002|Overall Study|Adverse Event|2|||
148899844|NCT02443688|537116765|FG000|Overall Study|Lost to Follow-up|1|||
148899845|NCT02443688|537116766|FG001|Overall Study|Lost to Follow-up|0|||
148899846|NCT02443688|537116767|FG002|Overall Study|Lost to Follow-up|0|||
148899847|NCT02443688|537116765|FG000|Overall Study|Physician Decision|3|||
148799310|NCT03669549|536744096|FG000|Overall Study|Adverse Event|4|||
148799311|NCT03669549|536744096|FG000|Overall Study|Withdrawal by Subject|1|||
148799312|NCT03669549|536744096|FG000|Overall Study|Study terminated by the Sponsor|1|||
148799313|NCT02974868|536744098|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
148799314|NCT02974868|536744099|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
148799315|NCT02974868|536744100|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
148799316|NCT02974868|536744101|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
148799317|NCT02974868|536744098|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
148799318|NCT02974868|536744099|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
148799319|NCT02974868|536744100|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
148799320|NCT02974868|536744101|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
148799321|NCT02974868|536744098|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
148799322|NCT02974868|536744099|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
148799323|NCT02974868|536744100|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
148799324|NCT02974868|536744101|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
148799325|NCT02974868|536744098|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
148799326|NCT02974868|536744099|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
148799327|NCT02974868|536744100|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
148799328|NCT02974868|536744101|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
148799329|NCT02674516|536744102|FG000|Overall Study|Lost to Follow-up|3|||
148799330|NCT02674516|536744103|FG001|Overall Study|Lost to Follow-up|0|||
148799331|NCT02674516|536744102|FG000|Overall Study|Protocol Violation|0|||
148799332|NCT02674516|536744103|FG001|Overall Study|Protocol Violation|4|||
148799333|NCT02674516|536744102|FG000|Overall Study|Knowledge of study hypothesis|1|||
148799334|NCT02674516|536744103|FG001|Overall Study|Knowledge of study hypothesis|0|||
148799335|NCT01064479|536744104|FG000|Overall Study|Death|10|||
148799336|NCT01064479|536744105|FG001|Overall Study|Death|11|||
148799337|NCT01064479|536744104|FG000|Overall Study|Withdrawal by Subject|2|||
148799338|NCT01064479|536744105|FG001|Overall Study|Withdrawal by Subject|2|||
148799339|NCT01064479|536744104|FG000|Overall Study|Disease progression|1|||
148799340|NCT01064479|536744105|FG001|Overall Study|Disease progression|1|||
148799341|NCT01064479|536744104|FG000|Overall Study|Toxicity|1|||
148799342|NCT01064479|536744105|FG001|Overall Study|Toxicity|1|||
148799343|NCT01064479|536744104|FG000|Overall Study|Other|1|||
148799344|NCT01064479|536744105|FG001|Overall Study|Other|2|||
148799345|NCT01663402|536744109|FG000|Overall Study|Randomized but not treated|19|||
148799346|NCT01663402|536744110|FG001|Overall Study|Randomized but not treated|11|||
148799347|NCT01663402|536744109|FG000|Overall Study|Adverse Event|347|||
148799348|NCT01663402|536744110|FG001|Overall Study|Adverse Event|362|||
148799349|NCT01663402|536744109|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
148799350|NCT01663402|536744110|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
148799351|NCT01663402|536744109|FG000|Overall Study|Poor compliance to protocol|529|||
148799352|NCT01663402|536744110|FG001|Overall Study|Poor compliance to protocol|454|||
148799353|NCT01663402|536744109|FG000|Overall Study|Physician Decision|77|||
148799354|NCT01663402|536744110|FG001|Overall Study|Physician Decision|62|||
148799355|NCT01663402|536744109|FG000|Overall Study|Site terminated by sponsor|1|||
148799356|NCT01663402|536744110|FG001|Overall Study|Site terminated by sponsor|3|||
148799357|NCT01663402|536744109|FG000|Overall Study|Participant moved|139|||
148799358|NCT01663402|536744110|FG001|Overall Study|Participant moved|104|||
148799359|NCT01663402|536744109|FG000|Overall Study|Withdrawal by Subject|118|||
148799360|NCT01663402|536744110|FG001|Overall Study|Withdrawal by Subject|91|||
148799361|NCT01663402|536744109|FG000|Overall Study|Related to study drug administration|96|||
148799362|NCT01663402|536744110|FG001|Overall Study|Related to study drug administration|105|||
148799363|NCT01663402|536744109|FG000|Overall Study|Lost to Follow-up|17|||
148799364|NCT01663402|536744110|FG001|Overall Study|Lost to Follow-up|15|||
148799365|NCT01663402|536744109|FG000|Overall Study|Other than specified above|172|||
148799366|NCT01663402|536744110|FG001|Overall Study|Other than specified above|147|||
148799367|NCT03575702|536744113|FG000|Overall Study|Withdrawal by Subject|1|||
148799368|NCT03575702|536744114|FG001|Overall Study|Withdrawal by Subject|1|||
148799369|NCT03575702|536744113|FG000|Overall Study|Lost to Follow-up|1|||
148799370|NCT03575702|536744114|FG001|Overall Study|Lost to Follow-up|2|||
148799371|NCT03575702|536744113|FG000|Overall Study|Protocol Violation|0|||
149011484|NCT00612534|537521481|FG000|Overall Study|Adverse Event|0|||
148799372|NCT03575702|536744114|FG001|Overall Study|Protocol Violation|1|||
148799373|NCT03575702|536744113|FG000|Overall Study|Patient non compliance|4|||
148799374|NCT03575702|536744114|FG001|Overall Study|Patient non compliance|0|||
148799375|NCT03903172|536744115|FG000|Overall Study|screen fail|4|||
148799376|NCT03903172|536744116|FG001|Overall Study|screen fail|1|||
148799377|NCT01545388|536744117|FG000|Overall Study|Adverse Event|2|||
148799378|NCT01545388|536744118|FG001|Overall Study|Adverse Event|4|||
148799379|NCT01545388|536744119|FG002|Overall Study|Adverse Event|1|||
148799380|NCT01545388|536744117|FG000|Overall Study|Lack of Efficacy|3|||
148799381|NCT01545388|536744118|FG001|Overall Study|Lack of Efficacy|2|||
148799382|NCT01545388|536744119|FG002|Overall Study|Lack of Efficacy|5|||
148799383|NCT01545388|536744117|FG000|Overall Study|Participant moved or relocated|1|||
148899848|NCT02443688|537116766|FG001|Overall Study|Physician Decision|0|||
148899849|NCT02443688|537116767|FG002|Overall Study|Physician Decision|1|||
148899850|NCT02443688|537116765|FG000|Overall Study|Pregnancy|0|||
148899851|NCT02443688|537116766|FG001|Overall Study|Pregnancy|0|||
148899852|NCT02443688|537116767|FG002|Overall Study|Pregnancy|1|||
148899853|NCT02443688|537116765|FG000|Overall Study|Withdrawal by Subject|3|||
148899854|NCT02443688|537116766|FG001|Overall Study|Withdrawal by Subject|3|||
148899855|NCT02443688|537116767|FG002|Overall Study|Withdrawal by Subject|4|||
148899856|NCT02443688|537116765|FG000|Overall Study|Non-compliance with study drug|1|||
148899857|NCT02443688|537116766|FG001|Overall Study|Non-compliance with study drug|2|||
148899858|NCT02443688|537116767|FG002|Overall Study|Non-compliance with study drug|4|||
148899859|NCT02443688|537116765|FG000|Overall Study|Sponsor Request|2|||
148899860|NCT02443688|537116766|FG001|Overall Study|Sponsor Request|1|||
148899861|NCT02443688|537116767|FG002|Overall Study|Sponsor Request|0|||
148899862|NCT00408317|537116769|FG000|First Intervention Period|Adverse Event|0|||
148899863|NCT00408317|537116770|FG001|First Intervention Period|Adverse Event|1|||
148899864|NCT00408317|537116769|FG000|Second Intervention Period|Adverse Event|2|||
148899865|NCT00408317|537116770|FG001|Second Intervention Period|Adverse Event|0|||
148899866|NCT00408317|537116769|FG000|Second Intervention Period|Protocol Violation|0|||
148899867|NCT00408317|537116770|FG001|Second Intervention Period|Protocol Violation|1|||
148899868|NCT00408317|537116769|FG000|Second Intervention Period|Withdrawal of consent|0|||
148899869|NCT00408317|537116770|FG001|Second Intervention Period|Withdrawal of consent|1|||
148899870|NCT00473564|537116773|FG000|Overall Study|robot surgery aborted in OR|23|||
148899871|NCT00837434|537116778|FG000|Overall Study|Physician Decision|3|||
148899872|NCT00837434|537116779|FG001|Overall Study|Physician Decision|0|||
148899873|NCT00837434|537116778|FG000|Overall Study|Lost to Follow-up|1|||
148899874|NCT00837434|537116779|FG001|Overall Study|Lost to Follow-up|1|||
148899875|NCT00837434|537116778|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
148899876|NCT00837434|537116779|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
148899877|NCT00837434|537116778|FG000|Overall Study|Noncompliant|2|||
148899878|NCT00837434|537116779|FG001|Overall Study|Noncompliant|0|||
148899879|NCT00837434|537116778|FG000|Overall Study|Baseline assessments not done in time|1|||
148799384|NCT01545388|536744118|FG001|Overall Study|Participant moved or relocated|0|||
148799385|NCT01545388|536744119|FG002|Overall Study|Participant moved or relocated|0|||
148799386|NCT01545388|536744117|FG000|Overall Study|Withdrawal by Subject|1|||
148799387|NCT01545388|536744118|FG001|Overall Study|Withdrawal by Subject|4|||
148799388|NCT01545388|536744119|FG002|Overall Study|Withdrawal by Subject|2|||
148799389|NCT01545388|536744117|FG000|Overall Study|Other|1|||
148799390|NCT01545388|536744118|FG001|Overall Study|Other|1|||
148799391|NCT01545388|536744119|FG002|Overall Study|Other|0|||
148799392|NCT01900444|536744120|FG000|Overall Study|Protocol Violation|2|||
148799393|NCT01900444|536744120|FG000|Overall Study|Lost to Follow-up|1|||
148799394|NCT00072384|536744121|FG000|Overall Study|Physician Decision|1|||
148799395|NCT00072384|536744121|FG000|Overall Study|Ineligible|8|||
148799396|NCT01825200|536744122|FG000|Overall Study|Lost to Follow-up|5|||
148799397|NCT01825200|536744123|FG001|Overall Study|Lost to Follow-up|6|||
148799398|NCT01825200|536744122|FG000|Overall Study|Withdrawal by Subject|0|||
148799399|NCT01825200|536744123|FG001|Overall Study|Withdrawal by Subject|1|||
148799400|NCT01255163|536744124|FG000|Overall Study|Withdrawal by Subject|1|||
148799401|NCT01255163|536744125|FG001|Overall Study|Withdrawal by Subject|0|||
148799402|NCT01255163|536744124|FG000|Overall Study|Lost to Follow-up|2|||
148799403|NCT01255163|536744125|FG001|Overall Study|Lost to Follow-up|0|||
148799404|NCT01255163|536744124|FG000|Overall Study|Adverse Event|0|||
148799405|NCT01255163|536744125|FG001|Overall Study|Adverse Event|2|||
148799406|NCT01255163|536744124|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
148899880|NCT00837434|537116779|FG001|Overall Study|Baseline assessments not done in time|0|||
148899881|NCT00837434|537116778|FG000|Overall Study|Unable to obtain study drug|1|||
148899882|NCT00837434|537116779|FG001|Overall Study|Unable to obtain study drug|0|||
148899883|NCT01921205|537116780|FG000|Overall Study|Adverse Event|12|||
148799407|NCT01255163|536744125|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
148799408|NCT06058390|536744126|FG000|Overall Study|Lost to Follow-up|0|||
148799409|NCT06058390|536744127|FG001|Overall Study|Lost to Follow-up|0|||
148799410|NCT06058390|536744128|FG002|Overall Study|Lost to Follow-up|2|||
148799411|NCT06058390|536744129|FG003|Overall Study|Lost to Follow-up|1|||
148899884|NCT01921205|537116781|FG001|Overall Study|Adverse Event|7|||
148899885|NCT01921205|537116780|FG000|Overall Study|Lack of Efficacy|1|||
148899886|NCT01921205|537116781|FG001|Overall Study|Lack of Efficacy|0|||
148899887|NCT01921205|537116780|FG000|Overall Study|Protocol Violation|1|||
148899888|NCT01921205|537116781|FG001|Overall Study|Protocol Violation|3|||
148899889|NCT01921205|537116780|FG000|Overall Study|Lost to Follow-up|1|||
148899890|NCT01921205|537116781|FG001|Overall Study|Lost to Follow-up|1|||
148899891|NCT01921205|537116780|FG000|Overall Study|Withdrawal by Subject|6|||
148899892|NCT01921205|537116781|FG001|Overall Study|Withdrawal by Subject|5|||
148899893|NCT01921205|537116780|FG000|Overall Study|Use Of Prohibited Medication|0|||
148899894|NCT01921205|537116781|FG001|Overall Study|Use Of Prohibited Medication|1|||
148899895|NCT01921205|537116780|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
148899896|NCT01921205|537116781|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
148899897|NCT01921205|537116780|FG000|Overall Study|Non Compliance Of The Parent|0|||
148899898|NCT01921205|537116781|FG001|Overall Study|Non Compliance Of The Parent|1|||
148899899|NCT01921205|537116780|FG000|Overall Study|Non Compliance Of Child|0|||
148899900|NCT01921205|537116781|FG001|Overall Study|Non Compliance Of Child|1|||
148899901|NCT02006472|537116782|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
148899902|NCT02006472|537116783|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
148899903|NCT02006472|537116784|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
148899904|NCT02006472|537116785|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
148899905|NCT02006472|537116786|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
148899906|NCT02006472|537116782|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
148899907|NCT02006472|537116783|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
148899908|NCT02006472|537116784|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
148899909|NCT02006472|537116785|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
148899910|NCT02006472|537116786|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
148899911|NCT02006472|537116782|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
148899912|NCT02006472|537116783|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
148899913|NCT02006472|537116784|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
148899914|NCT02006472|537116785|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
148899915|NCT02006472|537116786|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
148899916|NCT02006472|537116782|FG000|Period 1 (Through Week 26)|Other|1|||
148899917|NCT02006472|537116783|FG001|Period 1 (Through Week 26)|Other|5|||
148899918|NCT02006472|537116784|FG002|Period 1 (Through Week 26)|Other|0|||
148899919|NCT02006472|537116785|FG003|Period 1 (Through Week 26)|Other|2|||
148899920|NCT02006472|537116786|FG004|Period 1 (Through Week 26)|Other|3|||
148899921|NCT02006472|537116782|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
148899922|NCT02006472|537116783|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
148899923|NCT02006472|537116784|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
148899924|NCT02006472|537116785|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
148899925|NCT02006472|537116786|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
148899926|NCT02006472|537116782|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
148899927|NCT02006472|537116783|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
148899928|NCT02006472|537116784|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
148899929|NCT02006472|537116785|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
148899930|NCT02006472|537116786|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
148899931|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
148899932|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
148899933|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
148899934|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
148899935|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
148899936|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
148899937|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
148899938|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
148899939|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
148899940|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
148899941|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
148899942|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
148899943|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
148899944|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
148899945|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
148899946|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Other|0|||
148899947|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Other|1|||
148899948|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Other|0|||
148899949|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Other|1|||
148899950|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Other|0|||
148899951|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Not treated|0|||
148899952|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Not treated|0|||
148899953|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Not treated|2|||
148899954|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Not treated|0|||
148899955|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Not treated|0|||
148899956|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
148899957|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
148899958|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
148899959|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
148899960|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
148899961|NCT02006472|537116782|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
148899962|NCT02006472|537116783|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
148899963|NCT02006472|537116784|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
148899964|NCT02006472|537116785|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
148899965|NCT02006472|537116786|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
148899966|NCT00886379|537116787|FG000|Overall Study|Transferred Schools|0|||
148899967|NCT00886379|537116788|FG001|Overall Study|Transferred Schools|0|||
148899968|NCT00886379|537116789|FG002|Overall Study|Transferred Schools|2|||
148899969|NCT00886379|537116790|FG003|Overall Study|Transferred Schools|1|||
148899970|NCT00886379|537116791|FG004|Overall Study|Transferred Schools|1|||
148899971|NCT00886379|537116787|FG000|Overall Study|Final blood draw not obtained|3|||
148899972|NCT00886379|537116788|FG001|Overall Study|Final blood draw not obtained|3|||
148899973|NCT00886379|537116789|FG002|Overall Study|Final blood draw not obtained|4|||
148899974|NCT00886379|537116790|FG003|Overall Study|Final blood draw not obtained|2|||
148899975|NCT00886379|537116791|FG004|Overall Study|Final blood draw not obtained|2|||
148899976|NCT03219723|537116792|FG000|Overall Study|Case Report Forms Uncollected|6|||
148899977|NCT03219723|537116792|FG000|Overall Study|Protocol Deviation|4|||
148899978|NCT00459316|537116793|FG000|Steps 1 & 2|Other eligibility failure|1|||
148899979|NCT00459316|537116794|FG001|Steps 1 & 2|Other eligibility failure|1|||
148899980|NCT00459316|537116795|FG002|Steps 1 & 2|Other eligibility failure|0|||
148899981|NCT00459316|537116793|FG000|Steps 1 & 2|Death|1|||
148899982|NCT00459316|537116794|FG001|Steps 1 & 2|Death|1|||
148899983|NCT00459316|537116795|FG002|Steps 1 & 2|Death|0|||
148899984|NCT00459316|537116793|FG000|Steps 1 & 2|Not able to get to clinic|7|||
148899985|NCT00459316|537116794|FG001|Steps 1 & 2|Not able to get to clinic|4|||
148899986|NCT00459316|537116795|FG002|Steps 1 & 2|Not able to get to clinic|0|||
148899987|NCT00459316|537116793|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
148899988|NCT00459316|537116794|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
148899989|NCT00459316|537116795|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
148899990|NCT00459316|537116793|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
148899991|NCT00459316|537116794|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
148899992|NCT00459316|537116795|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
148899993|NCT00459316|537116793|FG000|Steps 1 & 2|Lost to Follow-up|5|||
148899994|NCT00459316|537116794|FG001|Steps 1 & 2|Lost to Follow-up|0|||
148899995|NCT00459316|537116795|FG002|Steps 1 & 2|Lost to Follow-up|2|||
148899996|NCT00459316|537116793|FG000|Step 3|Withdrawal by Subject|3|||
148899997|NCT00459316|537116794|FG001|Step 3|Withdrawal by Subject|0|||
148899998|NCT00459316|537116795|FG002|Step 3|Withdrawal by Subject|1|||
148899999|NCT00910650|537116796|FG000|Overall Study|Death|2|||
148900000|NCT04682366|537116797|FG000|Overall Study|Lost to Follow-up|1|||
148900001|NCT04682366|537116798|FG001|Overall Study|Lost to Follow-up|1|||
148900002|NCT04218240|537116799|FG000|Overall Study|Withdrawal by Subject|6|||
148900003|NCT04218240|537116800|FG001|Overall Study|Withdrawal by Subject|0|||
148900004|NCT04218240|537116799|FG000|Overall Study|Lack of Efficacy|24|||
148900005|NCT04218240|537116800|FG001|Overall Study|Lack of Efficacy|19|||
148900006|NCT04218240|537116799|FG000|Overall Study|Physician Decision|0|||
148900007|NCT04218240|537116800|FG001|Overall Study|Physician Decision|1|||
148900008|NCT04218240|537116799|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
148900009|NCT04218240|537116800|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
148900010|NCT01436149|537116801|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
148900011|NCT01436149|537116802|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
148900012|NCT01436149|537116803|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
148900013|NCT01436149|537116801|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
148900014|NCT01436149|537116802|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
148900015|NCT01436149|537116803|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
148900016|NCT01436149|537116801|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
148900017|NCT01436149|537116802|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148900018|NCT01436149|537116803|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
148900019|NCT01436149|537116801|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
148900020|NCT01436149|537116802|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148900021|NCT01436149|537116803|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
148900022|NCT01436149|537116801|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
148900023|NCT01436149|537116802|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
148900024|NCT01436149|537116803|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
148900025|NCT01436149|537116801|FG000|Antidepressant Lead-in Phase|Other|119|||
148900026|NCT01436149|537116802|FG001|Antidepressant Lead-in Phase|Other|0|||
148900027|NCT01436149|537116803|FG002|Antidepressant Lead-in Phase|Other|0|||
148900028|NCT01436149|537116801|FG000|Randomized Phase|Adverse Event|9|||
148900029|NCT01436149|537116802|FG001|Randomized Phase|Adverse Event|10|||
148900030|NCT01436149|537116803|FG002|Randomized Phase|Adverse Event|11|||
148900031|NCT01436149|537116801|FG000|Randomized Phase|Protocol Violation|4|||
148900032|NCT01436149|537116802|FG001|Randomized Phase|Protocol Violation|5|||
148900033|NCT01436149|537116803|FG002|Randomized Phase|Protocol Violation|0|||
148900034|NCT01436149|537116801|FG000|Randomized Phase|Withdrawal by Subject|16|||
148900035|NCT01436149|537116802|FG001|Randomized Phase|Withdrawal by Subject|10|||
148900036|NCT01436149|537116803|FG002|Randomized Phase|Withdrawal by Subject|10|||
148900037|NCT01436149|537116801|FG000|Randomized Phase|Lost to Follow-up|34|||
148900038|NCT01436149|537116802|FG001|Randomized Phase|Lost to Follow-up|5|||
148900039|NCT01436149|537116803|FG002|Randomized Phase|Lost to Follow-up|6|||
148900040|NCT01436149|537116801|FG000|Randomized Phase|Lack of Efficacy|0|||
148900041|NCT01436149|537116802|FG001|Randomized Phase|Lack of Efficacy|0|||
148900042|NCT01436149|537116803|FG002|Randomized Phase|Lack of Efficacy|1|||
148900043|NCT01436149|537116801|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
148900044|NCT01436149|537116802|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
148900045|NCT01436149|537116803|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
148900046|NCT01436149|537116801|FG000|Randomized Phase|Other|12|||
148900047|NCT01436149|537116802|FG001|Randomized Phase|Other|5|||
148900048|NCT01436149|537116803|FG002|Randomized Phase|Other|11|||
148900049|NCT03094416|537116813|FG000|Run-in|Screening failure|8|||
148900050|NCT03094416|537116813|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
148900051|NCT03094416|537116813|FG000|Run-in|Withdrawal by Subject|3|||
148900052|NCT03094416|537116813|FG000|Treatment Period|Withdrawal by Subject|2|||
148900053|NCT02158442|537116816|FG000|Overall Study|Withdrawal by Subject|1|||
148900054|NCT02158442|537116817|FG001|Overall Study|Withdrawal by Subject|0|||
148900055|NCT02158442|537116816|FG000|Overall Study|Perfusion staff not available|1|||
148900056|NCT02158442|537116817|FG001|Overall Study|Perfusion staff not available|0|||
148900057|NCT05386329|537116818|FG000|Overall Study|Lost to Follow-up|3|||
148900058|NCT02651675|537116819|FG000|Overall Study|Death|0|||
148900059|NCT02651675|537116820|FG001|Overall Study|Death|0|||
148900060|NCT02651675|537116821|FG002|Overall Study|Death|1|||
148900061|NCT02246530|537116822|FG000|Overall Study|Lost to Follow-up|4|||
148900062|NCT02246530|537116823|FG001|Overall Study|Lost to Follow-up|0|||
148900063|NCT01506596|537116824|FG000|Overall Study|ineligible pathology|1|||
148900064|NCT01488890|537116828|FG000|Overall Study|Serious adverse event|2|||
148900065|NCT01488890|537116829|FG001|Overall Study|Serious adverse event|0|||
148900066|NCT01488890|537116830|FG002|Overall Study|Serious adverse event|0|||
148900067|NCT01488890|537116831|FG003|Overall Study|Serious adverse event|0|||
148900068|NCT01488890|537116828|FG000|Overall Study|Protocol Violation|3|||
148900069|NCT01488890|537116829|FG001|Overall Study|Protocol Violation|0|||
148900070|NCT01488890|537116830|FG002|Overall Study|Protocol Violation|4|||
148900071|NCT01488890|537116831|FG003|Overall Study|Protocol Violation|0|||
148900072|NCT01488890|537116828|FG000|Overall Study|Lost to Follow-up|13|||
148900073|NCT01488890|537116829|FG001|Overall Study|Lost to Follow-up|10|||
148900074|NCT01488890|537116830|FG002|Overall Study|Lost to Follow-up|20|||
148900075|NCT01488890|537116831|FG003|Overall Study|Lost to Follow-up|3|||
148900076|NCT01488890|537116828|FG000|Overall Study|Withdrawal by Subject|14|||
148900077|NCT01488890|537116829|FG001|Overall Study|Withdrawal by Subject|10|||
148900078|NCT01488890|537116830|FG002|Overall Study|Withdrawal by Subject|11|||
148900079|NCT01488890|537116831|FG003|Overall Study|Withdrawal by Subject|2|||
148900080|NCT05712460|537116832|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900081|NCT05712460|537116833|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900082|NCT05712460|537116834|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900083|NCT05712460|537116835|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900084|NCT05712460|537116836|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900085|NCT05712460|537116837|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148799412|NCT06058390|536744126|FG000|Overall Study|Physician Decision|0|||
148799413|NCT06058390|536744127|FG001|Overall Study|Physician Decision|0|||
148799414|NCT06058390|536744128|FG002|Overall Study|Physician Decision|0|||
148799415|NCT06058390|536744129|FG003|Overall Study|Physician Decision|1|||
148799416|NCT06058390|536744126|FG000|Overall Study|Participants did not receive any study intervention|0|||
148799417|NCT06058390|536744127|FG001|Overall Study|Participants did not receive any study intervention|0|||
148799418|NCT06058390|536744128|FG002|Overall Study|Participants did not receive any study intervention|0|||
148799419|NCT06058390|536744129|FG003|Overall Study|Participants did not receive any study intervention|1|||
148799420|NCT02495389|536744130|FG000|Overall Study|Withdrawal by Subject|40|||
148799421|NCT01802385|536744134|FG000|Overall Study|Death|106|||
148799422|NCT01802385|536744135|FG001|Overall Study|Death|120|||
148799423|NCT05559905|536744136|FG000|Overall Study|Withdrawal by Subject|1|||
148799424|NCT05559905|536744137|FG001|Overall Study|Withdrawal by Subject|0|||
148799425|NCT05559905|536744138|FG002|Overall Study|Withdrawal by Subject|0|||
148799426|NCT05559905|536744136|FG000|Overall Study|Not Reported|1|||
148799427|NCT05559905|536744137|FG001|Overall Study|Not Reported|0|||
148799428|NCT05559905|536744138|FG002|Overall Study|Not Reported|0|||
148799429|NCT04003103|536744139|FG000|Overall Study|Death|1|||
148799430|NCT04003103|536744140|FG001|Overall Study|Death|0|||
148799431|NCT04003103|536744141|FG002|Overall Study|Death|0|||
148799432|NCT04003103|536744139|FG000|Overall Study|Lost to Follow-up|4|||
148799433|NCT04003103|536744140|FG001|Overall Study|Lost to Follow-up|3|||
148799434|NCT04003103|536744141|FG002|Overall Study|Lost to Follow-up|2|||
148799435|NCT04003103|536744139|FG000|Overall Study|Withdrawal by Subject|10|||
148799436|NCT04003103|536744140|FG001|Overall Study|Withdrawal by Subject|1|||
148799437|NCT04003103|536744141|FG002|Overall Study|Withdrawal by Subject|1|||
148799438|NCT04003103|536744139|FG000|Overall Study|Status not recorded|0|||
148799439|NCT04003103|536744140|FG001|Overall Study|Status not recorded|2|||
148799440|NCT04003103|536744141|FG002|Overall Study|Status not recorded|0|||
148799441|NCT05518539|536744145|FG000|Overall Study|Lost to Follow-up|6|||
148799442|NCT03589807|536744148|FG000|Overall Study|Lost to Follow-up|0|||
148799443|NCT03589807|536744149|FG001|Overall Study|Lost to Follow-up|2|||
148799444|NCT03589807|536744150|FG002|Overall Study|Lost to Follow-up|2|||
148799445|NCT03589807|536744151|FG003|Overall Study|Lost to Follow-up|3|||
148799446|NCT03589807|536744152|FG004|Overall Study|Lost to Follow-up|1|||
148799447|NCT03589807|536744153|FG005|Overall Study|Lost to Follow-up|1|||
148799448|NCT03589807|536744148|FG000|Overall Study|Withdrawal by Subject|0|||
148799449|NCT03589807|536744149|FG001|Overall Study|Withdrawal by Subject|5|||
148799450|NCT03589807|536744150|FG002|Overall Study|Withdrawal by Subject|0|||
148799451|NCT03589807|536744151|FG003|Overall Study|Withdrawal by Subject|0|||
148799452|NCT03589807|536744152|FG004|Overall Study|Withdrawal by Subject|0|||
148799453|NCT03589807|536744153|FG005|Overall Study|Withdrawal by Subject|0|||
148799454|NCT03589807|536744148|FG000|Overall Study|Protocol Violation|0|||
148799455|NCT03589807|536744149|FG001|Overall Study|Protocol Violation|0|||
148799456|NCT03589807|536744150|FG002|Overall Study|Protocol Violation|0|||
148799457|NCT03589807|536744151|FG003|Overall Study|Protocol Violation|1|||
148799458|NCT03589807|536744152|FG004|Overall Study|Protocol Violation|0|||
148799459|NCT03589807|536744153|FG005|Overall Study|Protocol Violation|0|||
148799460|NCT03589807|536744148|FG000|Overall Study|Enrolled but treatment not administered|0|||
148799461|NCT03589807|536744149|FG001|Overall Study|Enrolled but treatment not administered|0|||
148799462|NCT03589807|536744150|FG002|Overall Study|Enrolled but treatment not administered|0|||
148799463|NCT03589807|536744151|FG003|Overall Study|Enrolled but treatment not administered|0|||
148799464|NCT03589807|536744152|FG004|Overall Study|Enrolled but treatment not administered|1|||
148799465|NCT03589807|536744153|FG005|Overall Study|Enrolled but treatment not administered|0|||
148799466|NCT00338741|536744154|FG000|Overall Study|Lost to Follow-up|2|||
148799467|NCT00338741|536744155|FG001|Overall Study|Lost to Follow-up|0|||
148799468|NCT01534273|536744156|FG000|Period 1|Physician Decision|0|||
148799469|NCT01534273|536744157|FG001|Period 1|Physician Decision|0|||
148799470|NCT01534273|536744158|FG002|Period 1|Physician Decision|0|||
148799471|NCT01534273|536744159|FG003|Period 1|Physician Decision|1|||
148799472|NCT01534273|536744160|FG004|Period 1|Physician Decision|0|||
148799473|NCT01534273|536744161|FG005|Period 1|Physician Decision|0|||
148799474|NCT01534273|536744162|FG006|Period 1|Physician Decision|0|||
148799475|NCT01619865|536744163|FG000|Overall Study|Adverse Event|1|||
148799476|NCT01619865|536744163|FG000|Overall Study|Death|2|||
148799477|NCT01619865|536744163|FG000|Overall Study|subject not able to comply|1|||
148799478|NCT03586050|536744164|FG000|Overall Study|Death|3|||
148799479|NCT03586050|536744164|FG000|Overall Study|Withdrawal by Subject|2|||
148799480|NCT01494818|536744165|FG000|Overall Study|Relocation|1|||
148799481|NCT01494818|536744166|FG001|Overall Study|Relocation|2|||
148799482|NCT01494818|536744165|FG000|Overall Study|Lost to Follow-up|1|||
148799483|NCT01494818|536744166|FG001|Overall Study|Lost to Follow-up|0|||
148799484|NCT01883895|536744167|FG000|Overall Study|Lost to Follow-up|2|||
148799485|NCT05630196|536745774|FG000|Overall Study|Adverse Event|2|||
148799486|NCT05630196|536745775|FG001|Overall Study|Adverse Event|1|||
148799487|NCT05630196|536745774|FG000|Overall Study|Lost to Follow-up|1|||
148799488|NCT05630196|536745775|FG001|Overall Study|Lost to Follow-up|1|||
148799489|NCT05630196|536745774|FG000|Overall Study|Protocol Violation|2|||
148799490|NCT05630196|536745775|FG001|Overall Study|Protocol Violation|3|||
148799491|NCT05630196|536745774|FG000|Overall Study|Physician Decision|1|||
148799492|NCT05630196|536745775|FG001|Overall Study|Physician Decision|0|||
148799493|NCT05630196|536745774|FG000|Overall Study|Withdrawal by Subject|3|||
148799494|NCT05630196|536745775|FG001|Overall Study|Withdrawal by Subject|4|||
148799495|NCT01655901|536745779|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
148799496|NCT01655901|536745780|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
148799497|NCT01655901|536745781|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
148799498|NCT01655901|536745782|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
148799499|NCT01655901|536745783|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
148799500|NCT01655901|536745784|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
148799501|NCT00352118|536745785|FG000|Overall Study|Physician Decision|4|||
148799502|NCT00870727|536745786|FG000|Overall Study|Lost to Follow-up|0|||
148799503|NCT00870727|536745787|FG001|Overall Study|Lost to Follow-up|1|||
148799504|NCT00870727|536745786|FG000|Overall Study|Lack of Efficacy|1|||
148799505|NCT00870727|536745787|FG001|Overall Study|Lack of Efficacy|3|||
148799506|NCT00870727|536745786|FG000|Overall Study|Adverse Event|0|||
148799507|NCT00870727|536745787|FG001|Overall Study|Adverse Event|1|||
148799508|NCT01712516|536745788|FG000|Overall Study|Technical problems|0|||
148799509|NCT01712516|536745789|FG001|Overall Study|Technical problems|0|||
148799510|NCT01712516|536745790|FG002|Overall Study|Technical problems|0|||
148799511|NCT01712516|536745791|FG003|Overall Study|Technical problems|2|||
148799512|NCT01712516|536745788|FG000|Overall Study|Lost to Follow-up|0|||
148799513|NCT01712516|536745789|FG001|Overall Study|Lost to Follow-up|0|||
148799514|NCT01712516|536745790|FG002|Overall Study|Lost to Follow-up|2|||
148799515|NCT01712516|536745791|FG003|Overall Study|Lost to Follow-up|1|||
148799516|NCT01712516|536745788|FG000|Overall Study|Death|0|||
148799517|NCT01712516|536745789|FG001|Overall Study|Death|1|||
148799518|NCT01712516|536745790|FG002|Overall Study|Death|0|||
148799519|NCT01712516|536745791|FG003|Overall Study|Death|0|||
148799520|NCT01712516|536745788|FG000|Overall Study|Protocol deviation|1|||
148799521|NCT01712516|536745789|FG001|Overall Study|Protocol deviation|0|||
148799522|NCT01712516|536745790|FG002|Overall Study|Protocol deviation|1|||
148799523|NCT01712516|536745791|FG003|Overall Study|Protocol deviation|0|||
148799524|NCT01712516|536745788|FG000|Overall Study|Physician Decision|2|||
148799525|NCT01712516|536745789|FG001|Overall Study|Physician Decision|0|||
148799526|NCT01712516|536745790|FG002|Overall Study|Physician Decision|0|||
148799527|NCT01712516|536745791|FG003|Overall Study|Physician Decision|1|||
148799528|NCT01712516|536745788|FG000|Overall Study|Withdrawal by Subject|3|||
148799529|NCT01712516|536745789|FG001|Overall Study|Withdrawal by Subject|9|||
148799530|NCT01712516|536745790|FG002|Overall Study|Withdrawal by Subject|3|||
148799531|NCT01712516|536745791|FG003|Overall Study|Withdrawal by Subject|9|||
148799532|NCT01251952|536745794|FG000|Overall Study|Adverse Event|1|||
148799533|NCT00496769|536745795|FG000|Double Blind|>=1 reason assigned per patient|558|||
148799534|NCT00496769|536745796|FG001|Double Blind|>=1 reason assigned per patient|649|||
148799535|NCT00496769|536745797|FG002|Double Blind|>=1 reason assigned per patient|0|||
148799536|NCT00496769|536745795|FG000|Open Label|>=1 reason assigned per patient|0|||
148799537|NCT00496769|536745796|FG001|Open Label|>=1 reason assigned per patient|0|||
148799538|NCT00496769|536745797|FG002|Open Label|>=1 reason assigned per patient|1011|||
148799539|NCT03028142|536745798|FG000|Overall Study|Adverse Event|1|||
148799540|NCT03028142|536745799|FG001|Overall Study|Adverse Event|1|||
148799541|NCT03028142|536745800|FG002|Overall Study|Adverse Event|0|||
148799542|NCT03028142|536745801|FG003|Overall Study|Adverse Event|0|||
148799543|NCT03028142|536745802|FG004|Overall Study|Adverse Event|0|||
148799544|NCT03028142|536745803|FG005|Overall Study|Adverse Event|1|||
148799545|NCT03028142|536745798|FG000|Overall Study|Withdrawal by Subject|0|||
148799546|NCT03028142|536745799|FG001|Overall Study|Withdrawal by Subject|0|||
148799547|NCT03028142|536745800|FG002|Overall Study|Withdrawal by Subject|0|||
148799548|NCT03028142|536745801|FG003|Overall Study|Withdrawal by Subject|0|||
148799549|NCT03028142|536745802|FG004|Overall Study|Withdrawal by Subject|1|||
148799550|NCT03028142|536745803|FG005|Overall Study|Withdrawal by Subject|0|||
148799551|NCT02810418|536745807|FG000|Arm A Dose Escalation|Adverse Event|2|||
148799552|NCT02810418|536745808|FG001|Arm A Dose Escalation|Adverse Event|1|||
148799553|NCT02810418|536745809|FG002|Arm A Dose Escalation|Adverse Event|0|||
148799554|NCT02810418|536745810|FG003|Arm A Dose Escalation|Adverse Event|0|||
148799555|NCT02810418|536745811|FG004|Arm A Dose Escalation|Adverse Event|0|||
148799556|NCT02810418|536745812|FG005|Arm A Dose Escalation|Adverse Event|0|||
148799557|NCT02810418|536745813|FG006|Arm A Dose Escalation|Adverse Event|0|||
148799558|NCT02810418|536745807|FG000|Dose Expansion|Adverse Event|0|||
148799559|NCT02810418|536745808|FG001|Dose Expansion|Adverse Event|1|||
148799560|NCT02810418|536745809|FG002|Dose Expansion|Adverse Event|1|||
148799561|NCT02810418|536745810|FG003|Dose Expansion|Adverse Event|0|||
148799562|NCT02810418|536745811|FG004|Dose Expansion|Adverse Event|0|||
148799563|NCT02810418|536745812|FG005|Dose Expansion|Adverse Event|0|||
148799564|NCT02810418|536745813|FG006|Dose Expansion|Adverse Event|0|||
148799565|NCT02810418|536745807|FG000|Dose Expansion|Physician Decision|0|||
148799566|NCT02810418|536745808|FG001|Dose Expansion|Physician Decision|0|||
148799567|NCT02810418|536745809|FG002|Dose Expansion|Physician Decision|2|||
148799568|NCT02810418|536745810|FG003|Dose Expansion|Physician Decision|0|||
148799569|NCT02810418|536745811|FG004|Dose Expansion|Physician Decision|0|||
148799570|NCT02810418|536745812|FG005|Dose Expansion|Physician Decision|0|||
148799571|NCT02810418|536745813|FG006|Dose Expansion|Physician Decision|0|||
148799572|NCT02810418|536745807|FG000|Arm B Dose Escalation|Adverse Event|0|||
148799573|NCT02810418|536745808|FG001|Arm B Dose Escalation|Adverse Event|0|||
148799574|NCT02810418|536745809|FG002|Arm B Dose Escalation|Adverse Event|0|||
148799575|NCT02810418|536745810|FG003|Arm B Dose Escalation|Adverse Event|0|||
148900086|NCT05712460|537116838|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900087|NCT05712460|537116839|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
148900088|NCT05712460|537116840|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900089|NCT05712460|537116841|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900090|NCT05712460|537116842|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900091|NCT05712460|537116843|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
148900092|NCT04408989|537116846|FG000|Overall Study|Lost to Follow-up|0|||
148900093|NCT04408989|537116847|FG001|Overall Study|Lost to Follow-up|0|||
148900094|NCT04408989|537116848|FG002|Overall Study|Lost to Follow-up|1|||
148900095|NCT04408989|537116846|FG000|Overall Study|Withdrawal by Subject|0|||
148900096|NCT04408989|537116847|FG001|Overall Study|Withdrawal by Subject|0|||
148900097|NCT04408989|537116848|FG002|Overall Study|Withdrawal by Subject|2|||
148900098|NCT05135767|537116849|FG000|Baseline|Lost to Follow-up|1|||
148900099|NCT05135767|537116850|FG001|Baseline|Lost to Follow-up|1|||
148900100|NCT05135767|537116849|FG000|Baseline|Withdrawal by Subject|0|||
148900101|NCT05135767|537116850|FG001|Baseline|Withdrawal by Subject|2|||
148900102|NCT05135767|537116849|FG000|Active Study Phase|Lost to Follow-up|2|||
148900103|NCT05135767|537116850|FG001|Active Study Phase|Lost to Follow-up|0|||
148900104|NCT02694185|537116851|FG000|Overall Study|Withdrawal by Subject|45|||
148900105|NCT02694185|537116852|FG001|Overall Study|Withdrawal by Subject|0|||
148900106|NCT05082857|537116853|FG000|Overall Study|participants relocated and could not continue|2|||
148900107|NCT05082857|537116854|FG001|Overall Study|participants relocated and could not continue|1|||
148900108|NCT05082857|537116853|FG000|Overall Study|Lost to Follow-up|1|||
148900109|NCT05082857|537116854|FG001|Overall Study|Lost to Follow-up|3|||
148900110|NCT04363320|537116855|FG000|Overall Study|Lost to Follow-up|43|||
148900111|NCT04363320|537116856|FG001|Overall Study|Lost to Follow-up|42|||
148900112|NCT04363320|537116857|FG002|Overall Study|Lost to Follow-up|24|||
148900113|NCT04363320|537116858|FG003|Overall Study|Lost to Follow-up|29|||
148900114|NCT04363320|537116855|FG000|Overall Study|Death|0|||
148900115|NCT04363320|537116856|FG001|Overall Study|Death|0|||
148900116|NCT04363320|537116857|FG002|Overall Study|Death|1|||
148900117|NCT04363320|537116858|FG003|Overall Study|Death|0|||
148900118|NCT02260934|537116868|FG000|Overall Study|Lost to Follow-up|2|||
148900119|NCT02260934|537116869|FG001|Overall Study|Lost to Follow-up|1|||
148900120|NCT02260934|537116868|FG000|Overall Study|Withdrawal by Subject|0|||
148900121|NCT02260934|537116869|FG001|Overall Study|Withdrawal by Subject|2|||
148900122|NCT02260934|537116868|FG000|Overall Study|Participant Relocated|1|||
148900123|NCT02260934|537116869|FG001|Overall Study|Participant Relocated|0|||
148900124|NCT02260934|537116868|FG000|Overall Study|Site error|0|||
148900125|NCT02260934|537116869|FG001|Overall Study|Site error|1|||
148900126|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
148900127|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
148900128|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
148900129|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
148900130|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
148900131|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
148900132|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
148900133|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
148900134|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
148900135|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
148900136|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
148900137|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
148900138|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
148900139|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
148900140|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
148900141|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
148900142|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
148900143|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
148900144|NCT03605667|537116872|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
148900145|NCT03605667|537116873|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
148900146|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
148900147|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
148900148|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Other|6|||
148900149|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Other|8|||
148900150|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
148900151|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
148900152|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
148900153|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
148900154|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
148900155|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
148900156|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
148900157|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
148900158|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
148900159|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
148900160|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
148900161|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
148900162|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Death|0|||
148900163|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Death|2|||
148900164|NCT03605667|537116872|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
148900165|NCT03605667|537116873|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
148900166|NCT05632211|537116874|FG000|Overall Study|Withdrawal by Subject|2|||
148900167|NCT05632211|537116875|FG001|Overall Study|Withdrawal by Subject|0|||
148900168|NCT05632211|537116876|FG002|Overall Study|Withdrawal by Subject|2|||
148900169|NCT05632211|537116874|FG000|Overall Study|Other reasons|1|||
148900170|NCT05632211|537116875|FG001|Overall Study|Other reasons|1|||
148900171|NCT05632211|537116876|FG002|Overall Study|Other reasons|1|||
148900172|NCT04366349|537116877|FG000|Overall Study|Withdrawal by Subject|1|||
148900173|NCT04366349|537116878|FG001|Overall Study|Withdrawal by Subject|0|||
148900174|NCT04366349|537116879|FG002|Overall Study|Withdrawal by Subject|0|||
148900175|NCT04366349|537116880|FG003|Overall Study|Withdrawal by Subject|0|||
148900176|NCT04366349|537116881|FG004|Overall Study|Withdrawal by Subject|0|||
148900177|NCT04366349|537116882|FG005|Overall Study|Withdrawal by Subject|0|||
148900178|NCT05194124|537116887|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900179|NCT05194124|537116888|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900180|NCT05194124|537116889|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900181|NCT05194124|537116890|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
148900182|NCT05194124|537116891|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900183|NCT05194124|537116892|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
148900184|NCT05194124|537116893|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900185|NCT05194124|537116894|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900186|NCT05194124|537116895|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900187|NCT05194124|537116896|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
148900188|NCT05194124|537116887|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900189|NCT05194124|537116888|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900190|NCT05194124|537116889|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900191|NCT05194124|537116890|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900192|NCT05194124|537116891|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900193|NCT05194124|537116892|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900194|NCT05194124|537116893|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900195|NCT05194124|537116894|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900196|NCT05194124|537116895|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
148900197|NCT05194124|537116896|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
148900198|NCT03642873|537116897|FG000|Third Intervention (1 Day)|Screen failure|0|||
148900199|NCT03642873|537116898|FG001|Third Intervention (1 Day)|Screen failure|0|||
148900200|NCT03642873|537116899|FG002|Third Intervention (1 Day)|Screen failure|0|||
148900201|NCT03642873|537116900|FG003|Third Intervention (1 Day)|Screen failure|0|||
148900202|NCT03642873|537116901|FG004|Third Intervention (1 Day)|Screen failure|1|||
148900203|NCT03642873|537116902|FG005|Third Intervention (1 Day)|Screen failure|0|||
148900204|NCT02532517|537116907|FG000|Overall Study|Did not complete 24-Month visit|4|||
148900205|NCT02532517|537116907|FG000|Overall Study|Failed Angiographic eligibility|1|||
148900206|NCT02532517|537116907|FG000|Overall Study|Lost to Follow-up|4|||
148900207|NCT02532517|537116907|FG000|Overall Study|Withdrawal by Subject|4|||
148900208|NCT02532517|537116907|FG000|Overall Study|Death|4|||
148900209|NCT03312231|537116908|FG000|Overall Study|Lost to Follow-up|2|||
148900210|NCT03312231|537116909|FG001|Overall Study|Lost to Follow-up|6|||
148900211|NCT03312231|537116910|FG002|Overall Study|Lost to Follow-up|1|||
148900212|NCT03312231|537116911|FG003|Overall Study|Lost to Follow-up|3|||
148900213|NCT03312231|537116912|FG004|Overall Study|Lost to Follow-up|1|||
148900214|NCT03312231|537116908|FG000|Overall Study|Withdrawal by Subject|0|||
148900215|NCT03312231|537116909|FG001|Overall Study|Withdrawal by Subject|3|||
148900216|NCT03312231|537116910|FG002|Overall Study|Withdrawal by Subject|1|||
148900217|NCT03312231|537116911|FG003|Overall Study|Withdrawal by Subject|0|||
149137682|NCT01326728|537985204|FG001|Overall Study|Early closure of study|9|||
148900218|NCT03312231|537116912|FG004|Overall Study|Withdrawal by Subject|0|||
148900219|NCT03312231|537116908|FG000|Overall Study|Death|0|||
148900220|NCT03312231|537116909|FG001|Overall Study|Death|1|||
148900221|NCT03312231|537116910|FG002|Overall Study|Death|1|||
148900222|NCT03312231|537116911|FG003|Overall Study|Death|0|||
148900223|NCT03312231|537116912|FG004|Overall Study|Death|0|||
148900224|NCT03312231|537116908|FG000|Overall Study|Study Vaccination not Received|1|||
149137683|NCT01184053|537985205|FG000|Overall Study|progression while on treatment|3|||
148799576|NCT02810418|536745811|FG004|Arm B Dose Escalation|Adverse Event|1|||
148799577|NCT02810418|536745812|FG005|Arm B Dose Escalation|Adverse Event|2|||
148799578|NCT02810418|536745813|FG006|Arm B Dose Escalation|Adverse Event|0|||
148799579|NCT02224625|536745814|FG000|Irritation|Adverse Event|6|||
148799580|NCT02224625|536745814|FG000|Sensitization|Adverse Event|55|||
148799581|NCT01573000|536745815|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
148799582|NCT01573000|536745816|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
148799583|NCT01573000|536745815|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
148799584|NCT01573000|536745816|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
148799585|NCT01573000|536745815|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
148799586|NCT01573000|536745816|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
148799587|NCT01573000|536745815|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
148799588|NCT01573000|536745816|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
148799589|NCT01573000|536745815|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
148799590|NCT01573000|536745816|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
148799591|NCT01573000|536745815|FG000|Crossover Phase|Lack of Efficacy|0|||
148799592|NCT01573000|536745816|FG001|Crossover Phase|Lack of Efficacy|13|||
148799593|NCT01573000|536745815|FG000|Crossover Phase|Lost to Follow-up|0|||
148799594|NCT01573000|536745816|FG001|Crossover Phase|Lost to Follow-up|2|||
148799595|NCT01573000|536745815|FG000|Crossover Phase|Death|0|||
148799596|NCT01573000|536745816|FG001|Crossover Phase|Death|3|||
148799597|NCT01573000|536745815|FG000|Long-Term Follow-Up|Death|3|||
148799598|NCT01573000|536745816|FG001|Long-Term Follow-Up|Death|0|||
148799599|NCT01573000|536745815|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
148799600|NCT01573000|536745816|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
148799601|NCT01100853|536745825|FG000|Overall Study|Lost to Follow-up|11|||
148799602|NCT01100853|536745826|FG001|Overall Study|Lost to Follow-up|6|||
148799603|NCT01100853|536745825|FG000|Overall Study|Received <4 study injections|10|||
148799604|NCT01100853|536745826|FG001|Overall Study|Received <4 study injections|13|||
148799605|NCT01100853|536745825|FG000|Overall Study|Withdrawal by Subject|6|||
148799606|NCT01100853|536745826|FG001|Overall Study|Withdrawal by Subject|4|||
148799607|NCT01384877|536745827|FG000|Treatment 2|Lost to Follow-up|2|||
148799608|NCT01384877|536745828|FG001|Treatment 2|Lost to Follow-up|2|||
148799609|NCT04161391|536745829|FG000|Overall Study|Adverse Event|0|||
148799610|NCT04161391|536745830|FG001|Overall Study|Adverse Event|1|||
148799611|NCT04161391|536745831|FG002|Overall Study|Adverse Event|0|||
148799612|NCT04161391|536745832|FG003|Overall Study|Adverse Event|1|||
148799613|NCT04161391|536745833|FG004|Overall Study|Adverse Event|0|||
148799614|NCT04161391|536745834|FG005|Overall Study|Adverse Event|0|||
148799615|NCT04161391|536745835|FG006|Overall Study|Adverse Event|0|||
148799616|NCT04161391|536745836|FG007|Overall Study|Adverse Event|3|||
148799617|NCT04161391|536745837|FG008|Overall Study|Adverse Event|0|||
148799618|NCT04161391|536745829|FG000|Overall Study|Death|0|||
148799619|NCT04161391|536745830|FG001|Overall Study|Death|0|||
148799620|NCT04161391|536745831|FG002|Overall Study|Death|0|||
148799621|NCT04161391|536745832|FG003|Overall Study|Death|0|||
148900225|NCT03312231|537116909|FG001|Overall Study|Study Vaccination not Received|1|||
148799622|NCT04161391|536745833|FG004|Overall Study|Death|0|||
148799623|NCT04161391|536745834|FG005|Overall Study|Death|0|||
148799624|NCT04161391|536745835|FG006|Overall Study|Death|0|||
148799625|NCT04161391|536745836|FG007|Overall Study|Death|1|||
148799626|NCT04161391|536745837|FG008|Overall Study|Death|0|||
148799627|NCT04161391|536745829|FG000|Overall Study|Physician Decision|0|||
148799628|NCT04161391|536745830|FG001|Overall Study|Physician Decision|0|||
148799629|NCT04161391|536745831|FG002|Overall Study|Physician Decision|1|||
148799630|NCT04161391|536745832|FG003|Overall Study|Physician Decision|2|||
148799631|NCT04161391|536745833|FG004|Overall Study|Physician Decision|0|||
148799632|NCT04161391|536745834|FG005|Overall Study|Physician Decision|0|||
148799633|NCT04161391|536745835|FG006|Overall Study|Physician Decision|2|||
148799634|NCT04161391|536745836|FG007|Overall Study|Physician Decision|0|||
148799635|NCT04161391|536745837|FG008|Overall Study|Physician Decision|0|||
148799636|NCT04161391|536745829|FG000|Overall Study|Progressive Disease|4|||
148799637|NCT04161391|536745830|FG001|Overall Study|Progressive Disease|3|||
148799638|NCT04161391|536745831|FG002|Overall Study|Progressive Disease|3|||
148799639|NCT04161391|536745832|FG003|Overall Study|Progressive Disease|5|||
148799640|NCT04161391|536745833|FG004|Overall Study|Progressive Disease|3|||
148799641|NCT04161391|536745834|FG005|Overall Study|Progressive Disease|3|||
148799642|NCT04161391|536745835|FG006|Overall Study|Progressive Disease|5|||
148799643|NCT04161391|536745836|FG007|Overall Study|Progressive Disease|2|||
148799644|NCT04161391|536745837|FG008|Overall Study|Progressive Disease|2|||
148799645|NCT01162343|536745840|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
148799646|NCT01162343|536745840|FG000|Overall Study|Refused psychiatrist assessment|12|||
148799647|NCT01130272|536745841|FG000|Overall Study|Adverse Event|2|||
148799648|NCT01130272|536745842|FG001|Overall Study|Adverse Event|5|||
148799649|NCT01130272|536745843|FG002|Overall Study|Adverse Event|6|||
148799650|NCT01130272|536745844|FG003|Overall Study|Adverse Event|22|||
148799651|NCT01130272|536745845|FG004|Overall Study|Adverse Event|7|||
148799652|NCT01130272|536745841|FG000|Overall Study|IVRS-confirmed constipation|0|||
148799653|NCT01130272|536745842|FG001|Overall Study|IVRS-confirmed constipation|1|||
148799654|NCT01130272|536745843|FG002|Overall Study|IVRS-confirmed constipation|1|||
148799655|NCT01130272|536745844|FG003|Overall Study|IVRS-confirmed constipation|2|||
148799656|NCT01130272|536745845|FG004|Overall Study|IVRS-confirmed constipation|0|||
148799657|NCT01130272|536745841|FG000|Overall Study|Rescue medications due to diarrhea|3|||
148799658|NCT01130272|536745842|FG001|Overall Study|Rescue medications due to diarrhea|5|||
148799659|NCT01130272|536745843|FG002|Overall Study|Rescue medications due to diarrhea|8|||
148799660|NCT01130272|536745844|FG003|Overall Study|Rescue medications due to diarrhea|8|||
148799661|NCT01130272|536745845|FG004|Overall Study|Rescue medications due to diarrhea|6|||
148799662|NCT01130272|536745841|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
148799663|NCT01130272|536745842|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
148799664|NCT01130272|536745843|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
148799665|NCT01130272|536745844|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
148799666|NCT01130272|536745845|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
148799667|NCT01130272|536745841|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
148799668|NCT01130272|536745842|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
148799669|NCT01130272|536745843|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
148799670|NCT01130272|536745844|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
148799671|NCT01130272|536745845|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
148799672|NCT01130272|536745841|FG000|Overall Study|Protocol Violation|0|||
148799673|NCT01130272|536745842|FG001|Overall Study|Protocol Violation|0|||
148799674|NCT01130272|536745843|FG002|Overall Study|Protocol Violation|3|||
148799675|NCT01130272|536745844|FG003|Overall Study|Protocol Violation|5|||
148799676|NCT01130272|536745845|FG004|Overall Study|Protocol Violation|5|||
148799677|NCT01130272|536745841|FG000|Overall Study|Lost to Follow-up|4|||
148799678|NCT01130272|536745842|FG001|Overall Study|Lost to Follow-up|3|||
148799679|NCT01130272|536745843|FG002|Overall Study|Lost to Follow-up|4|||
148799680|NCT01130272|536745844|FG003|Overall Study|Lost to Follow-up|7|||
148799681|NCT01130272|536745845|FG004|Overall Study|Lost to Follow-up|6|||
148799682|NCT01130272|536745841|FG000|Overall Study|Withdrawal by Subject|4|||
148799683|NCT01130272|536745842|FG001|Overall Study|Withdrawal by Subject|11|||
148799684|NCT01130272|536745843|FG002|Overall Study|Withdrawal by Subject|10|||
148799685|NCT01130272|536745844|FG003|Overall Study|Withdrawal by Subject|9|||
148799686|NCT01130272|536745845|FG004|Overall Study|Withdrawal by Subject|8|||
148799687|NCT01130272|536745841|FG000|Overall Study|Physician Decision|1|||
148799688|NCT01130272|536745842|FG001|Overall Study|Physician Decision|1|||
148799689|NCT01130272|536745843|FG002|Overall Study|Physician Decision|0|||
148799690|NCT01130272|536745844|FG003|Overall Study|Physician Decision|1|||
148799691|NCT01130272|536745845|FG004|Overall Study|Physician Decision|2|||
148799692|NCT01130272|536745841|FG000|Overall Study|Sponsor decision|6|||
148799693|NCT01130272|536745842|FG001|Overall Study|Sponsor decision|15|||
149137684|NCT03785678|537985208|FG000|Overall Study|Death|44|||
148799694|NCT01130272|536745843|FG002|Overall Study|Sponsor decision|16|||
148799695|NCT01130272|536745844|FG003|Overall Study|Sponsor decision|13|||
148799696|NCT01130272|536745845|FG004|Overall Study|Sponsor decision|16|||
149137685|NCT03785678|537985209|FG001|Overall Study|Death|42|||
149137686|NCT03785678|537985208|FG000|Overall Study|Lost to Follow-up|4|||
149137687|NCT03785678|537985209|FG001|Overall Study|Lost to Follow-up|2|||
148799697|NCT01130272|536745841|FG000|Overall Study|Study arm discontinued|38|||
148900226|NCT03312231|537116910|FG002|Overall Study|Study Vaccination not Received|1|||
148900227|NCT03312231|537116911|FG003|Overall Study|Study Vaccination not Received|0|||
148900228|NCT03312231|537116912|FG004|Overall Study|Study Vaccination not Received|0|||
148900229|NCT03157830|537116917|FG000|Overall Study|Lost to Follow-up|1|||
148900230|NCT03157830|537116917|FG000|Overall Study|Withdrawal by Subject|1|||
148900231|NCT03694353|537116918|FG000|Overall Study|Withdrawal by Subject|1|||
148900232|NCT03694353|537116918|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
148900233|NCT05138653|537116921|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
148900234|NCT05138653|537116922|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900235|NCT05138653|537116923|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900236|NCT05138653|537116924|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900237|NCT05138653|537116925|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900238|NCT05138653|537116926|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900239|NCT05138653|537116927|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900240|NCT05138653|537116928|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900241|NCT05138653|537116929|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900242|NCT05138653|537116930|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900243|NCT05138653|537116931|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900244|NCT05138653|537116932|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900245|NCT05138653|537116933|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900246|NCT05138653|537116934|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900247|NCT05138653|537116935|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900248|NCT05138653|537116936|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
148900249|NCT05138653|537116921|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900250|NCT05138653|537116922|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
148900251|NCT05138653|537116923|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900252|NCT05138653|537116924|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900253|NCT05138653|537116925|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900254|NCT05138653|537116926|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900255|NCT05138653|537116927|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900256|NCT05138653|537116928|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900257|NCT05138653|537116929|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
148900258|NCT05138653|537116930|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900259|NCT05138653|537116931|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900260|NCT05138653|537116932|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900261|NCT05138653|537116933|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900262|NCT05138653|537116934|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900263|NCT05138653|537116935|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900264|NCT05138653|537116936|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
148900265|NCT05138653|537116921|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900266|NCT05138653|537116922|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
148900267|NCT05138653|537116923|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900268|NCT05138653|537116924|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900269|NCT05138653|537116925|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
148900270|NCT05138653|537116926|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900271|NCT05138653|537116927|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900272|NCT05138653|537116928|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900273|NCT05138653|537116929|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900274|NCT05138653|537116930|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900275|NCT05138653|537116931|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900276|NCT05138653|537116932|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900277|NCT05138653|537116933|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900278|NCT05138653|537116934|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900279|NCT05138653|537116935|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900280|NCT05138653|537116936|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
148900281|NCT05138653|537116921|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900282|NCT05138653|537116922|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900283|NCT05138653|537116923|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900284|NCT05138653|537116924|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900285|NCT05138653|537116925|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900286|NCT05138653|537116926|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900287|NCT05138653|537116927|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
148900288|NCT05138653|537116928|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900289|NCT05138653|537116929|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900290|NCT05138653|537116930|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148799698|NCT01130272|536745842|FG001|Overall Study|Study arm discontinued|0|||
148799699|NCT01130272|536745843|FG002|Overall Study|Study arm discontinued|0|||
148799700|NCT01130272|536745844|FG003|Overall Study|Study arm discontinued|0|||
148799701|NCT01130272|536745845|FG004|Overall Study|Study arm discontinued|0|||
148799702|NCT01548404|536745846|FG000|Overall Study|Adverse Event|3|||
148799703|NCT01548404|536745847|FG001|Overall Study|Adverse Event|1|||
148799704|NCT01548404|536745846|FG000|Overall Study|Physician Decision|2|||
148799705|NCT01548404|536745847|FG001|Overall Study|Physician Decision|1|||
148799706|NCT01548404|536745846|FG000|Overall Study|Inadequate response to study treatment|23|||
148799707|NCT01548404|536745847|FG001|Overall Study|Inadequate response to study treatment|7|||
148799708|NCT01548404|536745846|FG000|Overall Study|Lost to Follow-up|2|||
148799709|NCT01548404|536745847|FG001|Overall Study|Lost to Follow-up|0|||
148799710|NCT01548404|536745846|FG000|Overall Study|Withdrawal by Subject|0|||
148799711|NCT01548404|536745847|FG001|Overall Study|Withdrawal by Subject|3|||
148799712|NCT01548404|536745846|FG000|Overall Study|Other than specified above|0|||
148900291|NCT05138653|537116931|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900292|NCT05138653|537116932|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148799713|NCT01548404|536745847|FG001|Overall Study|Other than specified above|2|||
148799714|NCT00641056|536745848|FG000|Overall Study|Adverse Event|12|||
148799715|NCT00641056|536745849|FG001|Overall Study|Adverse Event|2|||
148799716|NCT00641056|536745848|FG000|Overall Study|Lost to Follow-up|2|||
148900293|NCT05138653|537116933|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900294|NCT05138653|537116934|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900295|NCT05138653|537116935|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900296|NCT05138653|537116936|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
148900297|NCT05138653|537116921|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900298|NCT05138653|537116922|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900299|NCT05138653|537116923|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900300|NCT05138653|537116924|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900301|NCT05138653|537116925|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900302|NCT05138653|537116926|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900303|NCT05138653|537116927|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900304|NCT05138653|537116928|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900305|NCT05138653|537116929|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900306|NCT05138653|537116930|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900307|NCT05138653|537116931|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
148900308|NCT05138653|537116932|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900309|NCT05138653|537116933|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
148900310|NCT05138653|537116934|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900311|NCT05138653|537116935|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
148900312|NCT05138653|537116936|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
148900313|NCT05138653|537116921|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900314|NCT05138653|537116922|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900315|NCT05138653|537116923|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900316|NCT05138653|537116924|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900317|NCT05138653|537116925|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900318|NCT05138653|537116926|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900319|NCT05138653|537116927|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900320|NCT05138653|537116928|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900321|NCT05138653|537116929|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900322|NCT05138653|537116930|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900323|NCT05138653|537116931|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900324|NCT05138653|537116932|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900325|NCT05138653|537116933|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
149011485|NCT00612534|537521482|FG001|Overall Study|Adverse Event|4|||
148900326|NCT05138653|537116934|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900327|NCT05138653|537116935|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
148900328|NCT05138653|537116936|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
148900329|NCT05138653|537116921|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900330|NCT05138653|537116922|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900331|NCT05138653|537116923|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900332|NCT05138653|537116924|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900333|NCT05138653|537116925|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900334|NCT05138653|537116926|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900335|NCT05138653|537116927|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900336|NCT05138653|537116928|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900337|NCT05138653|537116929|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900338|NCT05138653|537116930|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900339|NCT05138653|537116931|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900340|NCT05138653|537116932|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900341|NCT05138653|537116933|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900342|NCT05138653|537116934|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
148900343|NCT05138653|537116935|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900344|NCT05138653|537116936|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
148900345|NCT02331134|537116937|FG000|Overall Study|Withdrawal by Subject|1|||
148900346|NCT05967260|537116938|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
148900347|NCT05967260|537116939|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
148900348|NCT02681523|537116942|FG000|Overall Study|Adverse Event|1|||
148900349|NCT02681523|537116942|FG000|Overall Study|Patient Non-compliance|1|||
148900350|NCT01350999|537116943|FG000|Overall Study|Adverse Event|4|||
148900351|NCT01350999|537116944|FG001|Overall Study|Adverse Event|9|||
148900352|NCT01350999|537116945|FG002|Overall Study|Adverse Event|10|||
148900353|NCT01350999|537116943|FG000|Overall Study|Voluntary withdrawal|3|||
148900354|NCT01350999|537116944|FG001|Overall Study|Voluntary withdrawal|4|||
148900355|NCT01350999|537116945|FG002|Overall Study|Voluntary withdrawal|6|||
148900356|NCT01350999|537116943|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
148900357|NCT01350999|537116944|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
148900358|NCT01350999|537116945|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
148900359|NCT00079417|537118927|FG000|Overall Study|Physician Decision|2|||
148900360|NCT00079417|537118927|FG000|Overall Study|Ineligible|7|||
148900361|NCT01615939|537118928|FG000|Overall Study|Lost to Follow-up|5|||
148900362|NCT01615939|537118929|FG001|Overall Study|Lost to Follow-up|0|||
148900363|NCT01586364|537118933|FG000|Overall Study|Withdrawal by Subject|40|||
148900364|NCT01586364|537118933|FG000|Overall Study|Adverse Event|37|||
148900365|NCT01586364|537118933|FG000|Overall Study|Lost to Follow-up|17|||
148900366|NCT01586364|537118933|FG000|Overall Study|Protocol Violation|16|||
148900367|NCT01586364|537118933|FG000|Overall Study|Lack of Efficacy|1|||
148900368|NCT01586364|537118933|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
148900369|NCT01586364|537118933|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
148900370|NCT01586364|537118933|FG000|Overall Study|Other-Site closure due to PI illness|1|||
148900371|NCT01586364|537118933|FG000|Overall Study|Other-PI discretion, site closing|2|||
148900372|NCT01586364|537118933|FG000|Overall Study|Other-Not specified|1|||
148900373|NCT02121535|537118934|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
148900374|NCT02121535|537118935|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
148900375|NCT02121535|537118934|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
148900376|NCT02121535|537118935|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
148900377|NCT00091949|537118936|FG000|Overall Study|Withdrawal by Subject|117|||
148900378|NCT00091949|537118937|FG001|Overall Study|Withdrawal by Subject|110|||
148900379|NCT00091949|537118936|FG000|Overall Study|Lost to Follow-up|58|||
148900380|NCT00091949|537118937|FG001|Overall Study|Lost to Follow-up|41|||
148900381|NCT00092417|537118938|FG000|Overall Study|Lost to Follow-up|2|||
148900382|NCT00092417|537118939|FG001|Overall Study|Lost to Follow-up|0|||
148900383|NCT00092417|537118938|FG000|Overall Study|Withdrawal by Subject|2|||
148900384|NCT00092417|537118939|FG001|Overall Study|Withdrawal by Subject|1|||
148900385|NCT00092417|537118938|FG000|Overall Study|Other|1|||
148900386|NCT00092417|537118939|FG001|Overall Study|Other|0|||
148900387|NCT01520506|537118940|FG000|Overall Study|Missed Visit|4|||
148900388|NCT01520506|537118940|FG000|Overall Study|Lost to Follow-up|1|||
148900389|NCT01520506|537118940|FG000|Overall Study|Withdrawal by Subject|1|||
148900390|NCT00425269|537118941|FG000|Overall Study|Pregnancy|5|||
148900391|NCT00425269|537118942|FG001|Overall Study|Pregnancy|7|||
148900392|NCT00425269|537118941|FG000|Overall Study|Lost to Follow-up|9|||
148900393|NCT00425269|537118942|FG001|Overall Study|Lost to Follow-up|9|||
148900394|NCT00425269|537118941|FG000|Overall Study|moved or medical reason|5|||
148900395|NCT00425269|537118942|FG001|Overall Study|moved or medical reason|4|||
148900396|NCT05366738|537118943|FG000|Overall Study|Adverse Event|0|||
148799717|NCT00641056|536745849|FG001|Overall Study|Lost to Follow-up|1|||
148799718|NCT00641056|536745848|FG000|Overall Study|Physician Decision|3|||
148799719|NCT00641056|536745849|FG001|Overall Study|Physician Decision|1|||
148799720|NCT00641056|536745848|FG000|Overall Study|Protocol Violation|2|||
148799721|NCT00641056|536745849|FG001|Overall Study|Protocol Violation|0|||
148799722|NCT00641056|536745848|FG000|Overall Study|Entry Criteria Not Met|3|||
148799723|NCT00641056|536745849|FG001|Overall Study|Entry Criteria Not Met|0|||
148799724|NCT00641056|536745848|FG000|Overall Study|Subject Decision|6|||
148799725|NCT00641056|536745849|FG001|Overall Study|Subject Decision|19|||
148799726|NCT00641056|536745848|FG000|Overall Study|Sponsor Decision|1|||
148799727|NCT00641056|536745849|FG001|Overall Study|Sponsor Decision|2|||
148799728|NCT00896493|536745852|FG000|Overall Study|Early disease relapse|3|||
148799729|NCT02026141|536745855|FG000|Overall Study|Protocol Violation|0|||
148799730|NCT02026141|536745856|FG001|Overall Study|Protocol Violation|1|||
148799731|NCT00960193|536745859|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
148799732|NCT01324102|536745860|FG000|Overall Study|illness|1|||
148799733|NCT01324102|536745861|FG001|Overall Study|illness|6|||
148799734|NCT03238417|536745862|FG000|Overall|non-response|955|||
148799735|NCT03238417|536745863|FG001|Overall|non-response|1920|||
148799736|NCT03238417|536745862|FG000|Overall|partial completion|48|||
148799737|NCT03238417|536745863|FG001|Overall|partial completion|68|||
148799738|NCT03238417|536745862|FG000|Baseline|Partial completion|17|||
148799739|NCT03238417|536745863|FG001|Baseline|Partial completion|48|||
148799740|NCT03238417|536745862|FG000|Baseline|non-response|372|||
148799741|NCT03238417|536745863|FG001|Baseline|non-response|669|||
148799742|NCT03238417|536745862|FG000|12-month|non-response|296|||
148799743|NCT03238417|536745863|FG001|12-month|non-response|669|||
148799744|NCT03238417|536745862|FG000|12-month|partial completion|23|||
148799745|NCT03238417|536745863|FG001|12-month|partial completion|37|||
148799746|NCT03238417|536745862|FG000|24-month|non-response|287|||
148799747|NCT03238417|536745863|FG001|24-month|non-response|594|||
148799748|NCT03238417|536745862|FG000|24-month|partial completion|8|||
148799749|NCT03238417|536745863|FG001|24-month|partial completion|31|||
148799750|NCT03585270|536745867|FG000|Overall Study|Withdrawal by Subject|2|||
148799751|NCT03585270|536745868|FG001|Overall Study|Withdrawal by Subject|6|||
148799752|NCT03585270|536745867|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
148799753|NCT03585270|536745868|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
148799754|NCT03585270|536745867|FG000|Overall Study|Adverse Event|5|||
148799755|NCT03585270|536745868|FG001|Overall Study|Adverse Event|2|||
148799756|NCT03585270|536745867|FG000|Overall Study|Lost to Follow-up|1|||
148799757|NCT03585270|536745868|FG001|Overall Study|Lost to Follow-up|4|||
148799758|NCT03585270|536745867|FG000|Overall Study|Death|5|||
148799759|NCT03585270|536745868|FG001|Overall Study|Death|3|||
148799760|NCT03585270|536745867|FG000|Overall Study|Other reasons|2|||
148799761|NCT03585270|536745868|FG001|Overall Study|Other reasons|2|||
148799762|NCT01664091|536745871|FG000|Overall Study|Death|1|||
148799763|NCT01664091|536745871|FG000|Overall Study|Disease Progression|2|||
148799764|NCT01664091|536745871|FG000|Overall Study|Lost to Follow-up|2|||
148799765|NCT01664091|536745871|FG000|Overall Study|Withdrawal by Subject|1|||
148799766|NCT01172873|536745872|FG000|Overall Study|Withdrawal by Subject|3|||
148799767|NCT01172873|536745873|FG001|Overall Study|Withdrawal by Subject|2|||
148799768|NCT02053493|536745874|FG000|Overall Study|Withdrawal by Subject|1|||
148799769|NCT02053493|536745875|FG001|Overall Study|Withdrawal by Subject|1|||
148799770|NCT01076543|536745876|FG000|Overall Study|Withdrawal by Subject|2|||
148799771|NCT01076543|536745877|FG001|Overall Study|Withdrawal by Subject|0|||
148799772|NCT01076543|536745878|FG002|Overall Study|Withdrawal by Subject|0|||
148799773|NCT01076543|536745879|FG003|Overall Study|Withdrawal by Subject|0|||
148799774|NCT01076543|536745880|FG004|Overall Study|Withdrawal by Subject|0|||
148799775|NCT01076543|536745881|FG005|Overall Study|Withdrawal by Subject|0|||
148799776|NCT01791985|536745882|FG000|Overall Study|Adverse Event|7|||
148799777|NCT01791985|536745882|FG000|Overall Study|Withdrawal by Subject|1|||
148799778|NCT03217591|536745895|FG000|Overall Study|Adverse Event|1|||
148799779|NCT03217591|536745896|FG001|Overall Study|Adverse Event|2|||
148799780|NCT03217591|536745897|FG002|Overall Study|Adverse Event|6|||
148799781|NCT03217591|536745895|FG000|Overall Study|Withdrawal by Subject|0|||
148799782|NCT03217591|536745896|FG001|Overall Study|Withdrawal by Subject|1|||
148799783|NCT03217591|536745897|FG002|Overall Study|Withdrawal by Subject|3|||
148799784|NCT03217591|536745895|FG000|Overall Study|Lost to Follow-up|1|||
148799785|NCT03217591|536745896|FG001|Overall Study|Lost to Follow-up|0|||
148799786|NCT03217591|536745897|FG002|Overall Study|Lost to Follow-up|0|||
149137688|NCT03785678|537985208|FG000|Overall Study|Physician Decision|0|||
148799787|NCT03217591|536745895|FG000|Overall Study|Protocol Violation|1|||
148799788|NCT03217591|536745896|FG001|Overall Study|Protocol Violation|0|||
148799789|NCT03217591|536745897|FG002|Overall Study|Protocol Violation|1|||
148799790|NCT00086190|536745898|FG000|Overall Study|Adverse Event|6|||
148799791|NCT00086190|536745899|FG001|Overall Study|Adverse Event|2|||
148799792|NCT00086190|536745900|FG002|Overall Study|Adverse Event|2|||
148799793|NCT00086190|536745898|FG000|Overall Study|Withdrawal by Subject|0|||
148799794|NCT00086190|536745899|FG001|Overall Study|Withdrawal by Subject|2|||
148799795|NCT00086190|536745900|FG002|Overall Study|Withdrawal by Subject|2|||
148799796|NCT00086190|536745898|FG000|Overall Study|Protocol Violation|1|||
148799797|NCT00086190|536745899|FG001|Overall Study|Protocol Violation|0|||
148799798|NCT00086190|536745900|FG002|Overall Study|Protocol Violation|0|||
148799799|NCT00086190|536745898|FG000|Overall Study|Moved|1|||
148799800|NCT00086190|536745899|FG001|Overall Study|Moved|0|||
148799801|NCT00086190|536745900|FG002|Overall Study|Moved|0|||
148799802|NCT00086190|536745898|FG000|Overall Study|Worsening depression|0|||
148799803|NCT00086190|536745899|FG001|Overall Study|Worsening depression|0|||
148799804|NCT00086190|536745900|FG002|Overall Study|Worsening depression|2|||
148799805|NCT03902613|536745903|FG000|Overall Study|Physician Decision|1|||
148799806|NCT04467515|536745907|FG000|Overall Study|Lost to Follow-up|1|||
148799807|NCT04467515|536745908|FG001|Overall Study|Lost to Follow-up|0|||
148799808|NCT04467515|536745909|FG002|Overall Study|Lost to Follow-up|0|||
148799809|NCT04467515|536745907|FG000|Overall Study|Withdrawal by Subject|1|||
148799810|NCT04467515|536745908|FG001|Overall Study|Withdrawal by Subject|0|||
148799811|NCT04467515|536745909|FG002|Overall Study|Withdrawal by Subject|1|||
148799812|NCT04467515|536745907|FG000|Overall Study|Progressive Disease|0|||
148799813|NCT04467515|536745908|FG001|Overall Study|Progressive Disease|1|||
148799814|NCT04467515|536745909|FG002|Overall Study|Progressive Disease|3|||
148799815|NCT04467515|536745907|FG000|Overall Study|Death|0|||
149137689|NCT03785678|537985209|FG001|Overall Study|Physician Decision|2|||
149137690|NCT03785678|537985208|FG000|Overall Study|Withdrawal by Subject|5|||
149137691|NCT03785678|537985209|FG001|Overall Study|Withdrawal by Subject|3|||
149137692|NCT02536755|537985211|FG000|Overall Study|Adverse Event|4|||
149137693|NCT02301936|537985212|FG000|Overall Study|Lost to Follow-up|1|||
149137694|NCT02301936|537985213|FG001|Overall Study|Lost to Follow-up|0|||
149137695|NCT00375219|537985215|FG000|Overall Study|Failure to achieve a response|16|||
149137696|NCT00375219|537985216|FG001|Overall Study|Failure to achieve a response|2|||
149137697|NCT00375219|537985217|FG002|Overall Study|Failure to achieve a response|0|||
149137698|NCT00375219|537985215|FG000|Overall Study|Adverse Event|8|||
149137699|NCT00375219|537985216|FG001|Overall Study|Adverse Event|2|||
149137700|NCT00375219|537985217|FG002|Overall Study|Adverse Event|1|||
149137701|NCT00375219|537985215|FG000|Overall Study|Protocol Violation|1|||
149137702|NCT00375219|537985216|FG001|Overall Study|Protocol Violation|0|||
149137703|NCT00375219|537985217|FG002|Overall Study|Protocol Violation|1|||
149137704|NCT00375219|537985215|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
149137705|NCT00375219|537985216|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
149137706|NCT00375219|537985217|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
149137707|NCT00375219|537985215|FG000|Overall Study|Lost to Follow-up|1|||
149137708|NCT00375219|537985216|FG001|Overall Study|Lost to Follow-up|1|||
149137709|NCT00375219|537985217|FG002|Overall Study|Lost to Follow-up|0|||
149137710|NCT00375219|537985215|FG000|Overall Study|Disease progression|18|||
149137711|NCT00375219|537985216|FG001|Overall Study|Disease progression|9|||
149137712|NCT00375219|537985217|FG002|Overall Study|Disease progression|12|||
149137713|NCT00375219|537985215|FG000|Overall Study|Death|4|||
149137714|NCT00375219|537985216|FG001|Overall Study|Death|3|||
149137715|NCT00375219|537985217|FG002|Overall Study|Death|7|||
149137716|NCT00375219|537985215|FG000|Overall Study|Hematologic resistance|1|||
149137717|NCT00375219|537985216|FG001|Overall Study|Hematologic resistance|0|||
149137718|NCT00375219|537985217|FG002|Overall Study|Hematologic resistance|0|||
149137719|NCT00375219|537985215|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
149137720|NCT00375219|537985216|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
149137721|NCT00375219|537985217|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
149137722|NCT00375219|537985215|FG000|Overall Study|Allograft|2|||
149137723|NCT00375219|537985216|FG001|Overall Study|Allograft|0|||
149137724|NCT00375219|537985217|FG002|Overall Study|Allograft|0|||
149137725|NCT00375219|537985215|FG000|Overall Study|Cord blood transplantation|1|||
149137726|NCT00375219|537985216|FG001|Overall Study|Cord blood transplantation|0|||
149137727|NCT00375219|537985217|FG002|Overall Study|Cord blood transplantation|0|||
149137728|NCT00375219|537985215|FG000|Overall Study|Withdrawal by Subject|1|||
149137729|NCT00375219|537985216|FG001|Overall Study|Withdrawal by Subject|0|||
149137730|NCT00375219|537985217|FG002|Overall Study|Withdrawal by Subject|0|||
149137731|NCT01667107|537985218|FG000|Overall Study|Adverse Event|4|||
148799816|NCT04467515|536745908|FG001|Overall Study|Death|1|||
148799817|NCT04467515|536745909|FG002|Overall Study|Death|0|||
148799818|NCT03014206|536745912|FG000|Overall Study|Registration Violation|12|||
149137732|NCT01667107|537985219|FG001|Overall Study|Adverse Event|3|||
148900397|NCT05366738|537118944|FG001|Overall Study|Adverse Event|1|||
148900398|NCT05366738|537118945|FG002|Overall Study|Adverse Event|0|||
148900399|NCT00906204|537118946|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
148900400|NCT00906204|537118947|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
148900401|NCT00906204|537118946|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
148900402|NCT00906204|537118947|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
148900403|NCT00906204|537118946|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
148900404|NCT00906204|537118947|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
148900405|NCT00906204|537118946|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
148900406|NCT00906204|537118947|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
148900407|NCT00906204|537118946|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
148900408|NCT00906204|537118947|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
148900409|NCT02151058|537118951|FG000|Overall Study|Withdrawal by Subject|1|||
148900410|NCT02151058|537118952|FG001|Overall Study|Withdrawal by Subject|1|||
148900411|NCT02151058|537118953|FG002|Overall Study|Withdrawal by Subject|3|||
148900412|NCT02151058|537118951|FG000|Overall Study|Lost to Follow-up|1|||
148900413|NCT02151058|537118952|FG001|Overall Study|Lost to Follow-up|0|||
148900414|NCT02151058|537118953|FG002|Overall Study|Lost to Follow-up|2|||
148900415|NCT00124943|537118954|FG000|Phase II|Adverse Event|0|||
148900416|NCT00124943|537118955|FG001|Phase II|Adverse Event|2|||
148900417|NCT00124943|537118956|FG002|Phase II|Adverse Event|0|||
148900418|NCT00124943|537118957|FG003|Phase II|Adverse Event|1|||
148900419|NCT00124943|537118954|FG000|Phase II|Protocol Violation|0|||
148900420|NCT00124943|537118955|FG001|Phase II|Protocol Violation|0|||
148900421|NCT00124943|537118956|FG002|Phase II|Protocol Violation|0|||
148900422|NCT00124943|537118957|FG003|Phase II|Protocol Violation|1|||
148900423|NCT00124943|537118954|FG000|Phase II|Lost to Follow-up|0|||
148900424|NCT00124943|537118955|FG001|Phase II|Lost to Follow-up|0|||
148900425|NCT00124943|537118956|FG002|Phase II|Lost to Follow-up|0|||
148900426|NCT00124943|537118957|FG003|Phase II|Lost to Follow-up|1|||
148900427|NCT00124943|537118954|FG000|Phase II|Withdrawal by Subject|0|||
148900428|NCT00124943|537118955|FG001|Phase II|Withdrawal by Subject|0|||
148900429|NCT00124943|537118956|FG002|Phase II|Withdrawal by Subject|0|||
148900430|NCT00124943|537118957|FG003|Phase II|Withdrawal by Subject|2|||
148900431|NCT03337477|537118958|FG000|Overall Study|not categorized into the listed ones|11|||
148900432|NCT03337477|537118959|FG001|Overall Study|not categorized into the listed ones|9|||
148900433|NCT03337477|537118958|FG000|Overall Study|Withdrawal by Subject|0|||
148900434|NCT03337477|537118959|FG001|Overall Study|Withdrawal by Subject|1|||
148900435|NCT03337477|537118958|FG000|Overall Study|Death|0|||
148900436|NCT03337477|537118959|FG001|Overall Study|Death|1|||
148900437|NCT03337477|537118958|FG000|Overall Study|Lost to Follow-up|0|||
148900438|NCT03337477|537118959|FG001|Overall Study|Lost to Follow-up|2|||
148900439|NCT03304626|537118960|FG000|Overall Study|Adverse Event|1|||
148900440|NCT03304626|537118961|FG001|Overall Study|Adverse Event|0|||
148900441|NCT03304626|537118960|FG000|Overall Study|Lack of Efficacy|1|||
148900442|NCT03304626|537118961|FG001|Overall Study|Lack of Efficacy|1|||
148900443|NCT00744497|537118962|FG000|Overall Study|Withdrawal by Subject|21|||
148900444|NCT00744497|537118963|FG001|Overall Study|Withdrawal by Subject|18|||
148900445|NCT00744497|537118962|FG000|Overall Study|Death|11|||
148900446|NCT00744497|537118963|FG001|Overall Study|Death|9|||
148900447|NCT00744497|537118962|FG000|Overall Study|Lost to Follow-up|4|||
148900448|NCT00744497|537118963|FG001|Overall Study|Lost to Follow-up|2|||
148900449|NCT00744497|537118962|FG000|Overall Study|Poor compliance/noncompliance|9|||
148900450|NCT00744497|537118963|FG001|Overall Study|Poor compliance/noncompliance|5|||
148900451|NCT00744497|537118962|FG000|Overall Study|No longer meets study criteria|7|||
148900452|NCT00744497|537118963|FG001|Overall Study|No longer meets study criteria|3|||
148900453|NCT00744497|537118962|FG000|Overall Study|Administrative Reason By Sponsor|25|||
148900454|NCT00744497|537118963|FG001|Overall Study|Administrative Reason By Sponsor|8|||
148900455|NCT00744497|537118962|FG000|Overall Study|Disease progression|312|||
148900456|NCT00744497|537118963|FG001|Overall Study|Disease progression|219|||
148900457|NCT00744497|537118962|FG000|Overall Study|Study drug toxicity|68|||
148900458|NCT00744497|537118963|FG001|Overall Study|Study drug toxicity|141|||
148900459|NCT00744497|537118962|FG000|Overall Study|Adverse event unrelated to study drug|78|||
148900460|NCT00744497|537118963|FG001|Overall Study|Adverse event unrelated to study drug|122|||
148900461|NCT00744497|537118962|FG000|Overall Study|Patient requested to stop study drug|65|||
148900462|NCT00744497|537118963|FG001|Overall Study|Patient requested to stop study drug|80|||
148900463|NCT00744497|537118962|FG000|Overall Study|Maximum clinical benefit|141|||
148900464|NCT00744497|537118963|FG001|Overall Study|Maximum clinical benefit|142|||
148799819|NCT01091246|536745913|FG000|Overall Study|Lost to Follow-up|23|||
148799820|NCT01091246|536745914|FG001|Overall Study|Lost to Follow-up|11|||
148799821|NCT01091246|536745915|FG002|Overall Study|Lost to Follow-up|7|||
148799822|NCT01091246|536745913|FG000|Overall Study|Adverse Event|1|||
148799823|NCT01091246|536745914|FG001|Overall Study|Adverse Event|0|||
148799824|NCT01091246|536745915|FG002|Overall Study|Adverse Event|1|||
148799825|NCT01091246|536745913|FG000|Overall Study|Withdrawal by Subject|9|||
148799826|NCT01091246|536745914|FG001|Overall Study|Withdrawal by Subject|5|||
148799827|NCT01091246|536745915|FG002|Overall Study|Withdrawal by Subject|4|||
148799828|NCT01091246|536745913|FG000|Overall Study|Subject not dosed|2|||
148900465|NCT00744497|537118962|FG000|Overall Study|Not defined|19|||
148900466|NCT00744497|537118963|FG001|Overall Study|Not defined|13|||
148900467|NCT03182374|537118968|FG000|Overall Study|Lost to Follow-up|3|||
148900468|NCT03182374|537118969|FG001|Overall Study|Lost to Follow-up|2|||
148900469|NCT03182374|537118968|FG000|Overall Study|Lack of Efficacy|8|||
148900470|NCT03182374|537118969|FG001|Overall Study|Lack of Efficacy|14|||
148900471|NCT03182374|537118968|FG000|Overall Study|Withdrawal by Subject|1|||
148900472|NCT03182374|537118969|FG001|Overall Study|Withdrawal by Subject|1|||
148900473|NCT03182374|537118968|FG000|Overall Study|exit for non-compliance|1|||
148900474|NCT03182374|537118969|FG001|Overall Study|exit for non-compliance|1|||
148900475|NCT03182374|537118968|FG000|Overall Study|one subject was randomized but not treated|1|||
148900476|NCT03182374|537118969|FG001|Overall Study|one subject was randomized but not treated|0|||
148900477|NCT03182374|537118968|FG000|Overall Study|Other reasons|0|||
148900478|NCT03182374|537118969|FG001|Overall Study|Other reasons|3|||
148900479|NCT01462370|537118970|FG000|Overall Study|Lack of Qualifying Event|1|||
148900480|NCT01462370|537118971|FG001|Overall Study|Lack of Qualifying Event|1|||
148900481|NCT01462370|537118970|FG000|Overall Study|Physician Decision|0|||
148900482|NCT01462370|537118971|FG001|Overall Study|Physician Decision|1|||
148900483|NCT01462370|537118970|FG000|Overall Study|Withdrawal by Subject|0|||
148900484|NCT01462370|537118971|FG001|Overall Study|Withdrawal by Subject|3|||
148900485|NCT03198715|537118972|FG000|Overall Study|Death|0|||
148900486|NCT03198715|537118973|FG001|Overall Study|Death|0|||
148900487|NCT03198715|537118974|FG002|Overall Study|Death|1|||
148900488|NCT03198715|537118975|FG003|Overall Study|Death|0|||
148900489|NCT03198715|537118976|FG004|Overall Study|Death|2|||
148900490|NCT03198715|537118972|FG000|Overall Study|Other|0|||
148900491|NCT03198715|537118973|FG001|Overall Study|Other|1|||
148900492|NCT03198715|537118974|FG002|Overall Study|Other|1|||
148900493|NCT03198715|537118975|FG003|Overall Study|Other|0|||
148900494|NCT03198715|537118976|FG004|Overall Study|Other|0|||
148900495|NCT00853307|537118979|FG000|Overall Study|Adverse Event|1|||
148900496|NCT00853307|537118980|FG001|Overall Study|Adverse Event|2|||
148900497|NCT00853307|537118979|FG000|Overall Study|Withdrawal by Subject|1|||
148900498|NCT00853307|537118980|FG001|Overall Study|Withdrawal by Subject|2|||
148900499|NCT00853307|537118979|FG000|Overall Study|Reason Not Specified|0|||
148900500|NCT00853307|537118980|FG001|Overall Study|Reason Not Specified|1|||
148900501|NCT00914316|537118981|FG000|Phase 1|Physician Decision|4|||
148900502|NCT00914316|537118982|FG001|Phase 1|Physician Decision|0|||
148900503|NCT00914316|537118983|FG002|Phase 1|Physician Decision|1|||
149011486|NCT00612534|537521483|FG002|Overall Study|Adverse Event|2|||
149011487|NCT00612534|537521484|FG003|Overall Study|Adverse Event|1|||
148900504|NCT00914316|537118984|FG003|Phase 1|Physician Decision|2|||
148900505|NCT00914316|537118981|FG000|Phase 1|Withdrawal by Subject|0|||
148900506|NCT00914316|537118982|FG001|Phase 1|Withdrawal by Subject|2|||
148900507|NCT00914316|537118983|FG002|Phase 1|Withdrawal by Subject|4|||
148900508|NCT00914316|537118984|FG003|Phase 1|Withdrawal by Subject|0|||
148900509|NCT00914316|537118981|FG000|Phase 1|Adverse Event|1|||
148900510|NCT00914316|537118982|FG001|Phase 1|Adverse Event|0|||
148900511|NCT00914316|537118983|FG002|Phase 1|Adverse Event|0|||
148900512|NCT00914316|537118984|FG003|Phase 1|Adverse Event|0|||
148900513|NCT00914316|537118981|FG000|Phase 2|Withdrawal by Subject|1|||
148900514|NCT00914316|537118982|FG001|Phase 2|Withdrawal by Subject|0|||
148900515|NCT00914316|537118983|FG002|Phase 2|Withdrawal by Subject|1|||
148900516|NCT00914316|537118984|FG003|Phase 2|Withdrawal by Subject|0|||
148900517|NCT02399163|537118987|FG000|Overall Study|Adverse Event|2|||
148900518|NCT02399163|537118987|FG000|Overall Study|Protocol Deviation|2|||
148900519|NCT02399163|537118987|FG000|Overall Study|Withdrawal by Participant|5|||
148900520|NCT01391546|537118993|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
148900521|NCT01391546|537118994|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
148900522|NCT04225897|537119000|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900523|NCT04225897|537119001|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
148900524|NCT04225897|537119002|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900525|NCT04225897|537119003|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900526|NCT04225897|537119004|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900527|NCT04225897|537119005|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900528|NCT04225897|537119006|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900529|NCT04225897|537119007|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900530|NCT04225897|537119008|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900531|NCT04225897|537119009|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900532|NCT04225897|537119010|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900533|NCT04225897|537119011|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
148900534|NCT04225897|537119000|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900535|NCT04225897|537119001|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900536|NCT04225897|537119002|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
148900537|NCT04225897|537119003|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900538|NCT04225897|537119004|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900539|NCT04225897|537119005|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900540|NCT04225897|537119006|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900541|NCT04225897|537119007|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900542|NCT04225897|537119008|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900543|NCT04225897|537119009|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900544|NCT04225897|537119010|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900545|NCT04225897|537119011|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
148900546|NCT04225897|537119000|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900547|NCT04225897|537119001|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900548|NCT04225897|537119002|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
148900549|NCT04225897|537119003|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900550|NCT04225897|537119004|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900551|NCT04225897|537119005|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900552|NCT04225897|537119006|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900553|NCT04225897|537119007|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900554|NCT04225897|537119008|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900555|NCT04225897|537119009|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900556|NCT04225897|537119010|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900557|NCT04225897|537119011|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
148900558|NCT04225897|537119000|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900559|NCT04225897|537119001|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900560|NCT04225897|537119002|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900561|NCT04225897|537119003|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900562|NCT04225897|537119004|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900563|NCT04225897|537119005|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900564|NCT04225897|537119006|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900565|NCT04225897|537119007|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
148900566|NCT04225897|537119008|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900567|NCT04225897|537119009|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900568|NCT04225897|537119010|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900569|NCT04225897|537119011|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
148900570|NCT00074711|537119012|FG000|Overall Study|Withdrawal by Subject|1|||
148900571|NCT00074711|537119013|FG001|Overall Study|Withdrawal by Subject|1|||
148900572|NCT00074711|537119012|FG000|Overall Study|Lost to Follow-up|10|||
148900573|NCT00074711|537119013|FG001|Overall Study|Lost to Follow-up|8|||
148900574|NCT00074711|537119012|FG000|Overall Study|Participant stopped study drug|4|||
148900575|NCT00074711|537119013|FG001|Overall Study|Participant stopped study drug|6|||
148900576|NCT03466658|537119014|FG000|Overall Study|Withdrawal by Subject|3|||
148900577|NCT00360230|537119015|FG000|Overall Study|Withdrawal by Subject|1|||
148900578|NCT00360230|537119016|FG001|Overall Study|Withdrawal by Subject|1|||
148900579|NCT00360230|537119017|FG002|Overall Study|Withdrawal by Subject|0|||
148900580|NCT00360230|537119018|FG003|Overall Study|Withdrawal by Subject|1|||
148900581|NCT00360230|537119019|FG004|Overall Study|Withdrawal by Subject|1|||
148900582|NCT00360230|537119020|FG005|Overall Study|Withdrawal by Subject|1|||
148900583|NCT00360230|537119021|FG006|Overall Study|Withdrawal by Subject|0|||
148900584|NCT00360230|537119015|FG000|Overall Study|Migrated|4|||
148900585|NCT00360230|537119016|FG001|Overall Study|Migrated|1|||
148900586|NCT00360230|537119017|FG002|Overall Study|Migrated|3|||
148900587|NCT00360230|537119018|FG003|Overall Study|Migrated|1|||
148900588|NCT00360230|537119019|FG004|Overall Study|Migrated|4|||
148900589|NCT00360230|537119020|FG005|Overall Study|Migrated|1|||
148900590|NCT00360230|537119021|FG006|Overall Study|Migrated|1|||
148900591|NCT00360230|537119015|FG000|Overall Study|Other|1|||
148900592|NCT00360230|537119016|FG001|Overall Study|Other|0|||
148900593|NCT00360230|537119017|FG002|Overall Study|Other|0|||
148900594|NCT00360230|537119018|FG003|Overall Study|Other|0|||
148900595|NCT00360230|537119019|FG004|Overall Study|Other|0|||
148900596|NCT00360230|537119020|FG005|Overall Study|Other|0|||
148900597|NCT00360230|537119021|FG006|Overall Study|Other|0|||
148900598|NCT00360230|537119015|FG000|Overall Study|Protocol Violation|0|||
148900599|NCT00360230|537119016|FG001|Overall Study|Protocol Violation|0|||
148900600|NCT00360230|537119017|FG002|Overall Study|Protocol Violation|0|||
148900601|NCT00360230|537119018|FG003|Overall Study|Protocol Violation|0|||
148900602|NCT00360230|537119019|FG004|Overall Study|Protocol Violation|0|||
148900603|NCT00360230|537119020|FG005|Overall Study|Protocol Violation|1|||
148900604|NCT00360230|537119021|FG006|Overall Study|Protocol Violation|0|||
148900605|NCT00360230|537119015|FG000|Overall Study|Death|0|||
148900606|NCT00360230|537119016|FG001|Overall Study|Death|1|||
148900607|NCT00360230|537119017|FG002|Overall Study|Death|0|||
148900608|NCT00360230|537119018|FG003|Overall Study|Death|0|||
148900609|NCT00360230|537119019|FG004|Overall Study|Death|0|||
148900610|NCT00360230|537119020|FG005|Overall Study|Death|1|||
148900611|NCT00360230|537119021|FG006|Overall Study|Death|1|||
148900612|NCT00456846|537119025|FG000|Overall Study|Adverse Event|2|||
148900613|NCT00456846|537119026|FG001|Overall Study|Adverse Event|15|||
148900614|NCT00456846|537119025|FG000|Overall Study|Physician Decision|11|||
148900615|NCT00456846|537119026|FG001|Overall Study|Physician Decision|6|||
148900616|NCT00456846|537119025|FG000|Overall Study|Protocol Deviation|2|||
148900617|NCT00456846|537119026|FG001|Overall Study|Protocol Deviation|0|||
148900618|NCT00456846|537119025|FG000|Overall Study|Participant Discretion|1|||
148900619|NCT00456846|537119026|FG001|Overall Study|Participant Discretion|5|||
148900620|NCT00456846|537119025|FG000|Overall Study|Other|0|||
148900621|NCT00456846|537119026|FG001|Overall Study|Other|2|||
148900622|NCT04543279|537119028|FG000|Overall Study|Withdrawal by Subject|1|||
148900623|NCT04543279|537119029|FG001|Overall Study|Withdrawal by Subject|0|||
148900624|NCT04543279|537119028|FG000|Overall Study|Adverse Event|1|||
148900625|NCT04543279|537119029|FG001|Overall Study|Adverse Event|0|||
148900626|NCT04543279|537119028|FG000|Overall Study|Physician Decision|1|||
148900627|NCT04543279|537119029|FG001|Overall Study|Physician Decision|0|||
148900628|NCT00929695|537119030|FG000|Overall Study|Death|2|||
148900629|NCT00929695|537119031|FG001|Overall Study|Death|1|||
148900630|NCT00929695|537119030|FG000|Overall Study|Withdrawal by Subject|0|||
148900631|NCT00929695|537119031|FG001|Overall Study|Withdrawal by Subject|2|||
148900632|NCT00929695|537119030|FG000|Overall Study|discharge home|4|||
148900633|NCT00929695|537119031|FG001|Overall Study|discharge home|3|||
148900634|NCT00929695|537119030|FG000|Overall Study|incorrect stratification|2|||
148900635|NCT00929695|537119031|FG001|Overall Study|incorrect stratification|0|||
148900636|NCT04030143|537119032|FG000|Overall Study|Adverse Event|5|||
148900637|NCT04030143|537119033|FG001|Overall Study|Adverse Event|10|||
148900638|NCT04030143|537119032|FG000|Overall Study|Lost to Follow-up|3|||
148900639|NCT04030143|537119033|FG001|Overall Study|Lost to Follow-up|7|||
148900640|NCT04030143|537119032|FG000|Overall Study|Protocol Deviation|2|||
148900641|NCT04030143|537119033|FG001|Overall Study|Protocol Deviation|2|||
148900642|NCT04030143|537119032|FG000|Overall Study|Withdrawal by Subject|16|||
148900643|NCT04030143|537119033|FG001|Overall Study|Withdrawal by Subject|18|||
148900644|NCT04030143|537119032|FG000|Overall Study|Physician Decision|1|||
148900645|NCT04030143|537119033|FG001|Overall Study|Physician Decision|1|||
148900646|NCT04030143|537119032|FG000|Overall Study|Due to Covid-19|2|||
148900647|NCT04030143|537119033|FG001|Overall Study|Due to Covid-19|3|||
148900648|NCT04030143|537119032|FG000|Overall Study|Not Due to Covid-19|1|||
148900649|NCT04030143|537119033|FG001|Overall Study|Not Due to Covid-19|1|||
148900650|NCT03216226|537119034|FG000|Overall Study|Adverse Event|3|||
148900651|NCT03216226|537119035|FG001|Overall Study|Adverse Event|0|||
148900652|NCT03216226|537119034|FG000|Overall Study|Protocol Violation|1|||
148900653|NCT03216226|537119035|FG001|Overall Study|Protocol Violation|3|||
148900654|NCT03216226|537119034|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
148900655|NCT03216226|537119035|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
148900656|NCT03216226|537119034|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
148900657|NCT03216226|537119035|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
148900658|NCT03216226|537119034|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
148900659|NCT03216226|537119035|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
148900660|NCT05966142|537119039|FG000|Overall Study|Death|3|||
148900661|NCT05966142|537119040|FG001|Overall Study|Death|3|||
148900662|NCT05966142|537119039|FG000|Overall Study|Lost to Follow-up|55|||
148900663|NCT05966142|537119040|FG001|Overall Study|Lost to Follow-up|52|||
148900664|NCT05966142|537119039|FG000|Overall Study|Physician Decision|1|||
148900665|NCT05966142|537119040|FG001|Overall Study|Physician Decision|0|||
148900666|NCT05966142|537119039|FG000|Overall Study|Withdrawal by Subject|9|||
148900667|NCT05966142|537119040|FG001|Overall Study|Withdrawal by Subject|8|||
148900668|NCT05966142|537119039|FG000|Overall Study|Duplicate Enrollment|1|||
148900669|NCT05966142|537119040|FG001|Overall Study|Duplicate Enrollment|0|||
148900670|NCT05966142|537119039|FG000|Overall Study|Study Logistical Reason|1|||
148900671|NCT05966142|537119040|FG001|Overall Study|Study Logistical Reason|0|||
148900672|NCT05966142|537119039|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
148900673|NCT05966142|537119040|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
148900674|NCT04849364|537119041|FG000|Overall Study|Eligibility criteria not meet|0|||
148900675|NCT04849364|537119042|FG001|Overall Study|Eligibility criteria not meet|1|||
148900676|NCT04849364|537119043|FG002|Overall Study|Eligibility criteria not meet|0|||
148900677|NCT02738801|537119047|FG000|Overall Study|Adverse Event|1|||
148900678|NCT02738801|537119048|FG001|Overall Study|Adverse Event|1|||
148900679|NCT02738801|537119047|FG000|Overall Study|Withdrawal by Subject|0|||
148900680|NCT02738801|537119048|FG001|Overall Study|Withdrawal by Subject|1|||
148900681|NCT01643668|537119049|FG000|Overall Study|Death|1|||
148900682|NCT03253796|537119058|FG000|Period 1: Run-In|Adverse Event|4|||
148900683|NCT03253796|537119059|FG001|Period 1: Run-In|Adverse Event|0|||
148900684|NCT03253796|537119060|FG002|Period 1: Run-In|Adverse Event|0|||
148900685|NCT03253796|537119061|FG003|Period 1: Run-In|Adverse Event|0|||
148900686|NCT03253796|537119062|FG004|Period 1: Run-In|Adverse Event|0|||
148900687|NCT03253796|537119058|FG000|Period 1: Run-In|Lack of Efficacy|1|||
148900688|NCT03253796|537119059|FG001|Period 1: Run-In|Lack of Efficacy|0|||
148900689|NCT03253796|537119060|FG002|Period 1: Run-In|Lack of Efficacy|0|||
148900690|NCT03253796|537119061|FG003|Period 1: Run-In|Lack of Efficacy|0|||
148900691|NCT03253796|537119062|FG004|Period 1: Run-In|Lack of Efficacy|0|||
148900692|NCT03253796|537119058|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
148900693|NCT03253796|537119059|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
148900694|NCT03253796|537119060|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
148900695|NCT03253796|537119061|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
148900696|NCT03253796|537119062|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
148900697|NCT03253796|537119058|FG000|Period 1: Run-In|Protocol Violation|5|||
148900698|NCT03253796|537119059|FG001|Period 1: Run-In|Protocol Violation|0|||
148900699|NCT03253796|537119060|FG002|Period 1: Run-In|Protocol Violation|0|||
148900700|NCT03253796|537119061|FG003|Period 1: Run-In|Protocol Violation|0|||
148900701|NCT03253796|537119062|FG004|Period 1: Run-In|Protocol Violation|0|||
148900702|NCT03253796|537119058|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
148900703|NCT03253796|537119059|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
148900704|NCT03253796|537119060|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
148900705|NCT03253796|537119061|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
148900706|NCT03253796|537119062|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
148900707|NCT03253796|537119058|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
148900708|NCT03253796|537119059|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
148900709|NCT03253796|537119060|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
148900710|NCT03253796|537119061|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
148900711|NCT03253796|537119062|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
149011488|NCT00612534|537521481|FG000|Overall Study|Lack of Efficacy|13|||
148900712|NCT03253796|537119058|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
148900713|NCT03253796|537119059|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
148900714|NCT03253796|537119060|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
148900715|NCT03253796|537119061|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
148900716|NCT03253796|537119062|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
148900717|NCT03253796|537119058|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
148900718|NCT03253796|537119059|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
148900719|NCT03253796|537119060|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
148900720|NCT03253796|537119061|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
148900721|NCT03253796|537119062|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
148900722|NCT03253796|537119058|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
148900723|NCT03253796|537119059|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
148900724|NCT03253796|537119060|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
148900725|NCT03253796|537119061|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
148900726|NCT03253796|537119062|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
148900727|NCT03253796|537119058|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
148900728|NCT03253796|537119059|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
148900729|NCT03253796|537119060|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
148900730|NCT03253796|537119061|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
148900731|NCT03253796|537119062|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
148900732|NCT03253796|537119058|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
148900733|NCT03253796|537119059|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
148900734|NCT03253796|537119060|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
148900735|NCT03253796|537119061|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
148900736|NCT03253796|537119062|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
148900737|NCT00894803|537119063|FG000|Overall Study|Death|20|||
148900738|NCT00894803|537119064|FG001|Overall Study|Death|4|||
148900739|NCT00894803|537119063|FG000|Overall Study|Lost to Follow-up|0|||
148900740|NCT00894803|537119064|FG001|Overall Study|Lost to Follow-up|1|||
148900741|NCT01409707|537119067|FG000|Overall Study|Withdrawal by Subject|5|||
148900742|NCT01409707|537119068|FG001|Overall Study|Withdrawal by Subject|17|||
148900743|NCT01409707|537119069|FG002|Overall Study|Withdrawal by Subject|16|||
148900744|NCT01217229|537119070|FG000|Overall Study|Adverse Event|1|||
148900745|NCT01217229|537119070|FG000|Overall Study|Disease progression, deterioration|2|||
148900746|NCT01217229|537119070|FG000|Overall Study|Disease progression, Cheson criteria|14|||
148900747|NCT01217229|537119070|FG000|Overall Study|Protocol Violation|1|||
148900748|NCT01217229|537119070|FG000|Overall Study|Disease progression not confirmed|2|||
148900749|NCT00521079|537119071|FG000|Overall Study|Adverse Event|7|||
148900750|NCT00521079|537119072|FG001|Overall Study|Adverse Event|1|||
148900751|NCT00521079|537119071|FG000|Overall Study|Lost to Follow-up|2|||
148900752|NCT00521079|537119072|FG001|Overall Study|Lost to Follow-up|1|||
148900753|NCT00521079|537119071|FG000|Overall Study|Withdrawal by Subject|5|||
148900754|NCT00521079|537119072|FG001|Overall Study|Withdrawal by Subject|3|||
148900755|NCT05720897|537119074|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
148900756|NCT05720897|537119075|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
148900757|NCT00400179|537119076|FG000|Overall Study|Adverse Event|2|||
148900758|NCT00400179|537119077|FG001|Overall Study|Adverse Event|2|||
148900759|NCT00400179|537119076|FG000|Overall Study|Death|1|||
148900760|NCT00400179|537119077|FG001|Overall Study|Death|2|||
148900761|NCT00400179|537119076|FG000|Overall Study|Withdrew Consent|1|||
148900762|NCT00400179|537119077|FG001|Overall Study|Withdrew Consent|5|||
148900763|NCT00400179|537119076|FG000|Overall Study|Disease progression|1|||
148900764|NCT00400179|537119077|FG001|Overall Study|Disease progression|1|||
148900765|NCT00400179|537119076|FG000|Overall Study|Intercurrent illness|0|||
148900766|NCT00400179|537119077|FG001|Overall Study|Intercurrent illness|1|||
148900767|NCT00400179|537119076|FG000|Overall Study|Investigator judgment|0|||
148900768|NCT00400179|537119077|FG001|Overall Study|Investigator judgment|1|||
148900769|NCT00400179|537119076|FG000|Overall Study|Randomization error/patient ineligible|1|||
148900770|NCT00400179|537119077|FG001|Overall Study|Randomization error/patient ineligible|6|||
148900771|NCT04780061|537119078|FG000|Overall Study|Withdrawal by Subject|5|||
148900772|NCT04780061|537119079|FG001|Overall Study|Withdrawal by Subject|8|||
148900773|NCT04780061|537119078|FG000|Overall Study|Adverse Event|2|||
148900774|NCT04780061|537119079|FG001|Overall Study|Adverse Event|2|||
148900775|NCT04780061|537119078|FG000|Overall Study|Lost to Follow-up|1|||
148900776|NCT04780061|537119079|FG001|Overall Study|Lost to Follow-up|5|||
148900777|NCT02023086|537119080|FG000|Overall Study|Withdrawal by Subject|2|||
148900778|NCT02023086|537119081|FG001|Overall Study|Withdrawal by Subject|0|||
148900779|NCT03589859|537119084|FG000|Overall Study|Withdrawal by Subject|0|||
148900780|NCT03589859|537119085|FG001|Overall Study|Withdrawal by Subject|6|||
148900781|NCT05565742|537119087|FG000|Overall Study|Withdrawal by Subject|0|||
148900782|NCT05565742|537119088|FG001|Overall Study|Withdrawal by Subject|0|||
148900783|NCT05565742|537119089|FG002|Overall Study|Withdrawal by Subject|2|||
148900784|NCT05565742|537119090|FG003|Overall Study|Withdrawal by Subject|2|||
148900785|NCT05565742|537119091|FG004|Overall Study|Withdrawal by Subject|2|||
148900786|NCT05565742|537119087|FG000|Overall Study|Death|1|||
148900787|NCT05565742|537119088|FG001|Overall Study|Death|0|||
148900788|NCT05565742|537119089|FG002|Overall Study|Death|0|||
148900789|NCT05565742|537119090|FG003|Overall Study|Death|0|||
148900790|NCT05565742|537119091|FG004|Overall Study|Death|0|||
148900791|NCT05565742|537119087|FG000|Overall Study|Participant Travelled Abroad|0|||
148900792|NCT05565742|537119088|FG001|Overall Study|Participant Travelled Abroad|0|||
148900793|NCT05565742|537119089|FG002|Overall Study|Participant Travelled Abroad|0|||
148900794|NCT05565742|537119090|FG003|Overall Study|Participant Travelled Abroad|0|||
148900795|NCT05565742|537119091|FG004|Overall Study|Participant Travelled Abroad|1|||
148900796|NCT04163341|537119092|FG000|Overall Study|Withdrawal by Subject|2|||
148900797|NCT04163341|537119093|FG001|Overall Study|Withdrawal by Subject|0|||
148900798|NCT04163341|537119092|FG000|Overall Study|Lost to Follow-up|3|||
148900799|NCT04163341|537119093|FG001|Overall Study|Lost to Follow-up|4|||
148900800|NCT05417438|537119094|FG000|Overall Study|Withdrawal by Subject|3|||
148900801|NCT04272242|537119095|FG000|Overall Study|Withdrawal by Subject|3|||
148900802|NCT04272242|537119095|FG000|Overall Study|Lost to Follow-up|1|||
148900803|NCT04272242|537119095|FG000|Overall Study|Adverse Event|1|||
148900804|NCT03253393|537119098|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
148900805|NCT03253393|537119099|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
148900806|NCT03253393|537119100|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
148900807|NCT01256788|537120387|FG000|Overall Study|Lost to Follow-up|5|||
148900808|NCT01256788|537120388|FG001|Overall Study|Lost to Follow-up|8|||
148900809|NCT01256788|537120389|FG002|Overall Study|Lost to Follow-up|3|||
148900810|NCT05291520|537120390|FG000|Overall Study|Lost to Follow-up|0|||
148900811|NCT05291520|537120391|FG001|Overall Study|Lost to Follow-up|0|||
148900812|NCT05291520|537120392|FG002|Overall Study|Lost to Follow-up|1|||
148900813|NCT01347112|537120393|FG000|Overall Study|Withdrawal by Subject|1|||
148900814|NCT01347112|537120394|FG001|Overall Study|Withdrawal by Subject|7|||
148900815|NCT01347112|537120393|FG000|Overall Study|Lost to Follow-up|3|||
148900816|NCT01347112|537120394|FG001|Overall Study|Lost to Follow-up|5|||
148900817|NCT00696072|537120395|FG000|Overall Study|continuing active treatment|10|||
148900818|NCT00696072|537120396|FG001|Overall Study|continuing active treatment|13|||
148900819|NCT00696072|537120395|FG000|Overall Study|Adverse Event|10|||
148900820|NCT00696072|537120396|FG001|Overall Study|Adverse Event|6|||
148900821|NCT00696072|537120395|FG000|Overall Study|Patient Request|3|||
148900822|NCT00696072|537120396|FG001|Overall Study|Patient Request|7|||
148900823|NCT00696072|537120395|FG000|Overall Study|Investigator Request|1|||
148900824|NCT00696072|537120396|FG001|Overall Study|Investigator Request|4|||
148900825|NCT00696072|537120395|FG000|Overall Study|Sponsor Request|0|||
148900826|NCT00696072|537120396|FG001|Overall Study|Sponsor Request|1|||
148900827|NCT00696072|537120395|FG000|Overall Study|Disease Progression|32|||
148900828|NCT00696072|537120396|FG001|Overall Study|Disease Progression|30|||
148900829|NCT00696072|537120395|FG000|Overall Study|Non-specified|1|||
148900830|NCT00696072|537120396|FG001|Overall Study|Non-specified|2|||
148900831|NCT01597596|537120397|FG000|Overall Study|Study terminated by sponsor|1|||
148900832|NCT01597596|537120398|FG001|Overall Study|Study terminated by sponsor|0|||
148900833|NCT01597596|537120397|FG000|Overall Study|Physician Decision|0|||
148900834|NCT01597596|537120398|FG001|Overall Study|Physician Decision|1|||
148900835|NCT00992108|537120405|FG000|Overall Study|Lost to Follow-up|0|||
148900836|NCT00992108|537120406|FG001|Overall Study|Lost to Follow-up|1|||
148900837|NCT04639245|537120407|FG000|Overall Study|Death|1|||
148900838|NCT02419001|537120410|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
148900839|NCT02419001|537120411|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
148900840|NCT00535496|537120412|FG000|Overall Study|Lost to Follow-up|0|||
148900841|NCT00535496|537120413|FG001|Overall Study|Lost to Follow-up|1|||
148900842|NCT00535496|537120414|FG002|Overall Study|Lost to Follow-up|0|||
148900843|NCT00535496|537120415|FG003|Overall Study|Lost to Follow-up|0|||
148900844|NCT00535496|537120412|FG000|Overall Study|Not treated with sugammadex|0|||
148900845|NCT00535496|537120413|FG001|Overall Study|Not treated with sugammadex|1|||
148900846|NCT00535496|537120414|FG002|Overall Study|Not treated with sugammadex|0|||
148900847|NCT00535496|537120415|FG003|Overall Study|Not treated with sugammadex|0|||
148900848|NCT03591406|537120417|FG000|Overall Study|Adverse Event|5|||
148900849|NCT03591406|537120418|FG001|Overall Study|Adverse Event|3|||
148900850|NCT03591406|537120417|FG000|Overall Study|Protocol Violation|2|||
148900851|NCT03591406|537120418|FG001|Overall Study|Protocol Violation|1|||
148900852|NCT03591406|537120417|FG000|Overall Study|Withdrawal by Subject|0|||
148900853|NCT03591406|537120418|FG001|Overall Study|Withdrawal by Subject|5|||
148900854|NCT01083771|537120419|FG000|Overall Study|non-compliant|2|||
148900855|NCT01083771|537120419|FG000|Overall Study|Withdrawal by Subject|3|||
148900856|NCT03181932|537120422|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
148900857|NCT03181932|537120423|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
148900858|NCT03181932|537120422|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
148900859|NCT03181932|537120423|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
148900860|NCT03181932|537120422|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
148900861|NCT03181932|537120423|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
148900862|NCT03181932|537120422|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
148900863|NCT03181932|537120423|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
148900864|NCT03181932|537120422|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
148900865|NCT03181932|537120423|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
148900866|NCT03181932|537120422|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
148900867|NCT03181932|537120423|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
148900868|NCT03181932|537120422|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
148900869|NCT03181932|537120423|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
148900870|NCT03181932|537120422|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
148900871|NCT03181932|537120423|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
148900872|NCT03181932|537120422|FG000|Period 2 (Open-label Period)|Reason missing|2|||
148900873|NCT03181932|537120423|FG001|Period 2 (Open-label Period)|Reason missing|0|||
148900874|NCT02703597|537120448|FG000|Assignment to Baseline|Lost to Follow-up|17|||
148900875|NCT02703597|537120449|FG001|Assignment to Baseline|Lost to Follow-up|16|||
148900876|NCT02703597|537120448|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
148900877|NCT02703597|537120449|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
148900878|NCT02703597|537120448|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
148900879|NCT02703597|537120449|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
148900880|NCT02703597|537120448|FG000|First Post-test to First Follow-up|Site drop out|0|||
148900881|NCT02703597|537120449|FG001|First Post-test to First Follow-up|Site drop out|58|||
148900882|NCT02703597|537120448|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
148900883|NCT02703597|537120449|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
148900884|NCT02703597|537120448|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
148900885|NCT02703597|537120449|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
148900886|NCT02703597|537120448|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
148900887|NCT02703597|537120449|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
148900888|NCT01614886|537120450|FG000|Overall Study|Adverse Event|15|||
148900889|NCT01614886|537120451|FG001|Overall Study|Adverse Event|20|||
148900890|NCT01614886|537120450|FG000|Overall Study|Withdrawal by Subject|4|||
148900891|NCT01614886|537120451|FG001|Overall Study|Withdrawal by Subject|4|||
148900892|NCT01614886|537120450|FG000|Overall Study|Death|1|||
148900893|NCT01614886|537120451|FG001|Overall Study|Death|0|||
148799829|NCT01091246|536745914|FG001|Overall Study|Subject not dosed|0|||
148799830|NCT01091246|536745915|FG002|Overall Study|Subject not dosed|1|||
148799831|NCT04577794|536745916|FG000|Overall Study|Adverse Event|1|||
148799832|NCT04577794|536745917|FG001|Overall Study|Adverse Event|1|||
148799833|NCT01676012|536745919|FG000|Overall Study|Adverse Event|2|||
148799834|NCT01676012|536745919|FG000|Overall Study|incomplete set of videos|1|||
148799835|NCT01819727|536745926|FG000|Overall Study|Adverse Event|8|||
148799836|NCT01819727|536745927|FG001|Overall Study|Adverse Event|9|||
148799837|NCT01819727|536745926|FG000|Overall Study|Death|1|||
148799838|NCT01819727|536745927|FG001|Overall Study|Death|0|||
148799839|NCT01819727|536745926|FG000|Overall Study|Lost to Follow-up|1|||
148799840|NCT01819727|536745927|FG001|Overall Study|Lost to Follow-up|1|||
148799841|NCT01819727|536745926|FG000|Overall Study|Physician Decision|3|||
148799842|NCT01819727|536745927|FG001|Overall Study|Physician Decision|2|||
148799843|NCT01819727|536745926|FG000|Overall Study|Pregnancy|1|||
148799844|NCT01819727|536745927|FG001|Overall Study|Pregnancy|0|||
148799845|NCT01819727|536745926|FG000|Overall Study|Protocol Violation|0|||
148799846|NCT01819727|536745927|FG001|Overall Study|Protocol Violation|2|||
148799847|NCT01819727|536745926|FG000|Overall Study|Study Terminated by Sponsor|0|||
148799848|NCT01819727|536745927|FG001|Overall Study|Study Terminated by Sponsor|1|||
148799849|NCT01819727|536745926|FG000|Overall Study|Withdrawal by Subject|6|||
148799850|NCT01819727|536745927|FG001|Overall Study|Withdrawal by Subject|11|||
148799851|NCT01819727|536745926|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
148799852|NCT01819727|536745927|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
148799853|NCT01819727|536745926|FG000|Overall Study|Quit due to lack of health benifits|0|||
148799854|NCT01819727|536745927|FG001|Overall Study|Quit due to lack of health benifits|1|||
148799855|NCT04460326|536745928|FG000|Completed at Least 4 Meals|Early discharge|5|||
148799856|NCT04460326|536745929|FG001|Completed at Least 4 Meals|Early discharge|5|||
148799857|NCT04460326|536745928|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
148799858|NCT04460326|536745929|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
148799859|NCT04460326|536745928|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
148799860|NCT04460326|536745929|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
148799861|NCT04460326|536745928|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
148799862|NCT04460326|536745929|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
148799863|NCT04460326|536745928|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
148799864|NCT04460326|536745929|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
148799865|NCT04460326|536745928|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
148799866|NCT04460326|536745929|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
148799867|NCT04794751|536745930|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
148799868|NCT04794751|536745931|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
148799869|NCT04794751|536745930|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
148799870|NCT04794751|536745931|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
148799871|NCT04794751|536745930|FG000|Period 1|Protocol Violation|0|||
148799872|NCT04794751|536745931|FG001|Period 1|Protocol Violation|2|||
148799873|NCT04794751|536745930|FG000|Period 1|Withdrawal by Subject|0|||
148799874|NCT04794751|536745931|FG001|Period 1|Withdrawal by Subject|1|||
148799875|NCT04794751|536745930|FG000|Period 2|Withdrawal by Subject|0|||
148799876|NCT04794751|536745931|FG001|Period 2|Withdrawal by Subject|1|||
148799877|NCT04794751|536745930|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
148799878|NCT04794751|536745931|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
148799879|NCT04794751|536745930|FG000|Period 2|Protocol Violation|1|||
148799880|NCT04794751|536745931|FG001|Period 2|Protocol Violation|0|||
148799881|NCT00969228|536745932|FG000|Overall Study|Adverse Event|1|||
148799882|NCT00969228|536745933|FG001|Overall Study|Adverse Event|0|||
148799883|NCT00969228|536745932|FG000|Overall Study|Withdrawal by Subject|4|||
148799884|NCT00969228|536745933|FG001|Overall Study|Withdrawal by Subject|0|||
148799885|NCT00969228|536745932|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
148799886|NCT00969228|536745933|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
148799887|NCT02007720|536745941|FG000|Overall Study|Withdrawal by Subject|9|||
148799888|NCT02007720|536745942|FG001|Overall Study|Withdrawal by Subject|11|||
148799889|NCT02007720|536745941|FG000|Overall Study|study terminated by sponsor|58|||
148799890|NCT02007720|536745942|FG001|Overall Study|study terminated by sponsor|54|||
148799891|NCT02007720|536745941|FG000|Overall Study|technical problem|4|||
148799892|NCT02007720|536745942|FG001|Overall Study|technical problem|2|||
148799893|NCT02007720|536745941|FG000|Overall Study|patient followd less than 165 days|11|||
148799894|NCT02007720|536745942|FG001|Overall Study|patient followd less than 165 days|5|||
148799895|NCT00922636|536747333|FG000|Overall Study|Adverse Event|3|||
148799896|NCT00922636|536747334|FG001|Overall Study|Adverse Event|3|||
148799897|NCT00922636|536747335|FG002|Overall Study|Adverse Event|2|||
148799898|NCT00922636|536747336|FG003|Overall Study|Adverse Event|3|||
148799899|NCT00922636|536747337|FG004|Overall Study|Adverse Event|2|||
148799900|NCT00922636|536747333|FG000|Overall Study|Lack of Efficacy|1|||
148799901|NCT00922636|536747334|FG001|Overall Study|Lack of Efficacy|7|||
148799902|NCT00922636|536747335|FG002|Overall Study|Lack of Efficacy|3|||
148799903|NCT00922636|536747336|FG003|Overall Study|Lack of Efficacy|2|||
148799904|NCT00922636|536747337|FG004|Overall Study|Lack of Efficacy|4|||
148799905|NCT00922636|536747333|FG000|Overall Study|Sponsor Decision|0|||
148799906|NCT00922636|536747334|FG001|Overall Study|Sponsor Decision|0|||
148799907|NCT00922636|536747335|FG002|Overall Study|Sponsor Decision|2|||
148799908|NCT00922636|536747336|FG003|Overall Study|Sponsor Decision|0|||
148799909|NCT00922636|536747337|FG004|Overall Study|Sponsor Decision|0|||
148799910|NCT00922636|536747333|FG000|Overall Study|Withdrawal by Subject|0|||
148799911|NCT00922636|536747334|FG001|Overall Study|Withdrawal by Subject|0|||
148799912|NCT00922636|536747335|FG002|Overall Study|Withdrawal by Subject|5|||
148799913|NCT00922636|536747336|FG003|Overall Study|Withdrawal by Subject|2|||
148799914|NCT00922636|536747337|FG004|Overall Study|Withdrawal by Subject|4|||
148799915|NCT00922636|536747333|FG000|Overall Study|Protocol Violation|0|||
148799916|NCT00922636|536747334|FG001|Overall Study|Protocol Violation|0|||
148799917|NCT00922636|536747335|FG002|Overall Study|Protocol Violation|2|||
148799918|NCT00922636|536747336|FG003|Overall Study|Protocol Violation|2|||
148799919|NCT00922636|536747337|FG004|Overall Study|Protocol Violation|0|||
148799920|NCT00922636|536747333|FG000|Overall Study|Entry Criteria Not Met|0|||
148799921|NCT00922636|536747334|FG001|Overall Study|Entry Criteria Not Met|0|||
148799922|NCT00922636|536747335|FG002|Overall Study|Entry Criteria Not Met|1|||
148799923|NCT00922636|536747336|FG003|Overall Study|Entry Criteria Not Met|1|||
148799924|NCT00922636|536747337|FG004|Overall Study|Entry Criteria Not Met|0|||
148799925|NCT00922636|536747333|FG000|Overall Study|Parent/Caregiver Decision|2|||
148799926|NCT00922636|536747334|FG001|Overall Study|Parent/Caregiver Decision|4|||
148799927|NCT00922636|536747335|FG002|Overall Study|Parent/Caregiver Decision|3|||
148799928|NCT00922636|536747336|FG003|Overall Study|Parent/Caregiver Decision|5|||
148799929|NCT00922636|536747337|FG004|Overall Study|Parent/Caregiver Decision|2|||
148799930|NCT00922636|536747333|FG000|Overall Study|Lost to Follow-up|1|||
148799931|NCT00922636|536747334|FG001|Overall Study|Lost to Follow-up|2|||
148799932|NCT00922636|536747335|FG002|Overall Study|Lost to Follow-up|2|||
148799933|NCT00922636|536747336|FG003|Overall Study|Lost to Follow-up|2|||
148799934|NCT00922636|536747337|FG004|Overall Study|Lost to Follow-up|4|||
148799935|NCT00557466|536747338|FG000|Overall Study|Adverse Event|3|||
148799936|NCT00557466|536747339|FG001|Overall Study|Adverse Event|1|||
148799937|NCT00557466|536747340|FG002|Overall Study|Adverse Event|4|||
148799938|NCT00557466|536747341|FG003|Overall Study|Adverse Event|1|||
148799939|NCT00557466|536747342|FG004|Overall Study|Adverse Event|2|||
148799940|NCT00557466|536747343|FG005|Overall Study|Adverse Event|4|||
148799941|NCT00557466|536747338|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148799942|NCT00557466|536747339|FG001|Overall Study|Abnormal laboratory value(s)|2|||
148799943|NCT00557466|536747340|FG002|Overall Study|Abnormal laboratory value(s)|0|||
148799944|NCT00557466|536747341|FG003|Overall Study|Abnormal laboratory value(s)|0|||
148799945|NCT00557466|536747342|FG004|Overall Study|Abnormal laboratory value(s)|0|||
148799946|NCT00557466|536747343|FG005|Overall Study|Abnormal laboratory value(s)|0|||
148799947|NCT00557466|536747338|FG000|Overall Study|Protocol deviation|0|||
148799948|NCT00557466|536747339|FG001|Overall Study|Protocol deviation|1|||
148799949|NCT00557466|536747340|FG002|Overall Study|Protocol deviation|0|||
148799950|NCT00557466|536747341|FG003|Overall Study|Protocol deviation|2|||
148799951|NCT00557466|536747342|FG004|Overall Study|Protocol deviation|0|||
148799952|NCT00557466|536747343|FG005|Overall Study|Protocol deviation|0|||
148799953|NCT00557466|536747338|FG000|Overall Study|Subject withdrew consent|0|||
148799954|NCT00557466|536747339|FG001|Overall Study|Subject withdrew consent|0|||
148799955|NCT00557466|536747340|FG002|Overall Study|Subject withdrew consent|0|||
148799956|NCT00557466|536747341|FG003|Overall Study|Subject withdrew consent|0|||
148799957|NCT00557466|536747342|FG004|Overall Study|Subject withdrew consent|1|||
148799958|NCT00557466|536747343|FG005|Overall Study|Subject withdrew consent|2|||
148799959|NCT00557466|536747338|FG000|Overall Study|Administrative problems|0|||
148799960|NCT00557466|536747339|FG001|Overall Study|Administrative problems|1|||
148799961|NCT00557466|536747340|FG002|Overall Study|Administrative problems|1|||
148799962|NCT00557466|536747341|FG003|Overall Study|Administrative problems|0|||
148799963|NCT00557466|536747342|FG004|Overall Study|Administrative problems|0|||
148799964|NCT00557466|536747343|FG005|Overall Study|Administrative problems|0|||
148799965|NCT00557466|536747338|FG000|Overall Study|Abnormal test procedure results|0|||
148799966|NCT00557466|536747339|FG001|Overall Study|Abnormal test procedure results|0|||
148799967|NCT00557466|536747340|FG002|Overall Study|Abnormal test procedure results|1|||
148799968|NCT00557466|536747341|FG003|Overall Study|Abnormal test procedure results|0|||
148799969|NCT00557466|536747342|FG004|Overall Study|Abnormal test procedure results|0|||
148799970|NCT00557466|536747343|FG005|Overall Study|Abnormal test procedure results|0|||
148799971|NCT00557466|536747338|FG000|Overall Study|Lost to Follow-up|0|||
148799972|NCT00557466|536747339|FG001|Overall Study|Lost to Follow-up|0|||
148799973|NCT00557466|536747340|FG002|Overall Study|Lost to Follow-up|0|||
148799974|NCT00557466|536747341|FG003|Overall Study|Lost to Follow-up|1|||
148799975|NCT00557466|536747342|FG004|Overall Study|Lost to Follow-up|0|||
148900894|NCT01614886|537120450|FG000|Overall Study|Protocol deviation|0|||
148900895|NCT01614886|537120451|FG001|Overall Study|Protocol deviation|2|||
148900896|NCT02224560|537120453|FG000|Overall Study|Protocol Deviation|1|||
148900897|NCT02224560|537120454|FG001|Overall Study|Protocol Deviation|0|||
148900898|NCT02224560|537120455|FG002|Overall Study|Protocol Deviation|0|||
148900899|NCT02224560|537120453|FG000|Overall Study|Withdrawal by Subject|2|||
148900900|NCT02224560|537120454|FG001|Overall Study|Withdrawal by Subject|0|||
148900901|NCT02224560|537120455|FG002|Overall Study|Withdrawal by Subject|1|||
148900902|NCT02224560|537120453|FG000|Overall Study|Met Withdrawal Criteria|1|||
148900903|NCT02224560|537120454|FG001|Overall Study|Met Withdrawal Criteria|0|||
148900904|NCT02224560|537120455|FG002|Overall Study|Met Withdrawal Criteria|0|||
148900905|NCT02224560|537120453|FG000|Overall Study|Adverse Event|4|||
148900906|NCT02224560|537120454|FG001|Overall Study|Adverse Event|1|||
148900907|NCT02224560|537120455|FG002|Overall Study|Adverse Event|1|||
148900908|NCT02224560|537120453|FG000|Overall Study|Withdrawn by Investigator|1|||
148900909|NCT02224560|537120454|FG001|Overall Study|Withdrawn by Investigator|1|||
148900910|NCT02224560|537120455|FG002|Overall Study|Withdrawn by Investigator|0|||
148900911|NCT01523366|537120456|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148900912|NCT01523366|537120457|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148900913|NCT01523366|537120456|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
148900914|NCT01523366|537120457|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
148900915|NCT02461758|537120458|FG000|Overall Study|Lost to Follow-up|0|||
148900916|NCT02461758|537120459|FG001|Overall Study|Lost to Follow-up|1|||
148900917|NCT02461758|537120460|FG002|Overall Study|Lost to Follow-up|1|||
148900918|NCT02461758|537120461|FG003|Overall Study|Lost to Follow-up|0|||
148900919|NCT01710345|537120462|FG000|Overall Study|Adverse Event|0|||
148900920|NCT01710345|537120463|FG001|Overall Study|Adverse Event|2|||
148900921|NCT01710345|537120464|FG002|Overall Study|Adverse Event|0|||
148900922|NCT01710345|537120462|FG000|Overall Study|Lack of Efficacy|2|||
148900923|NCT01710345|537120463|FG001|Overall Study|Lack of Efficacy|3|||
148900924|NCT01710345|537120464|FG002|Overall Study|Lack of Efficacy|1|||
148900925|NCT01710345|537120462|FG000|Overall Study|Drug Dosing Error|1|||
148900926|NCT01710345|537120463|FG001|Overall Study|Drug Dosing Error|0|||
148900927|NCT01710345|537120464|FG002|Overall Study|Drug Dosing Error|0|||
148900928|NCT00449696|537120466|FG000|Overall Study|Other Treatment Required|6|||
148900929|NCT00449696|537120467|FG001|Overall Study|Other Treatment Required|1|||
148900930|NCT00449696|537120466|FG000|Overall Study|Withdrawal by Subject|5|||
148900931|NCT00449696|537120467|FG001|Overall Study|Withdrawal by Subject|5|||
148900932|NCT00449696|537120466|FG000|Overall Study|Lost to Follow-up|2|||
148900933|NCT00449696|537120467|FG001|Overall Study|Lost to Follow-up|3|||
148900934|NCT00449696|537120466|FG000|Overall Study|Others|7|||
148900935|NCT00449696|537120467|FG001|Overall Study|Others|0|||
148900936|NCT01033019|537120468|FG000|Overall Study|Withdrawal by Subject|1|||
148900937|NCT01033019|537120469|FG001|Overall Study|Withdrawal by Subject|0|||
148900938|NCT00551642|537120475|FG000|Treatment Period|Protocol Deviation|6|||
148900939|NCT00551642|537120476|FG001|Treatment Period|Protocol Deviation|11|||
148900940|NCT00551642|537120475|FG000|Treatment Period|Delivery device failure|1|||
148900941|NCT00551642|537120476|FG001|Treatment Period|Delivery device failure|3|||
148900942|NCT00551642|537120475|FG000|Treatment Period|Physician Decision|0|||
148900943|NCT00551642|537120476|FG001|Treatment Period|Physician Decision|1|||
148900944|NCT00551642|537120475|FG000|Treatment Period|Death|33|||
148900945|NCT00551642|537120476|FG001|Treatment Period|Death|31|||
148900946|NCT00551642|537120475|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
148900947|NCT00551642|537120476|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
148900948|NCT00551642|537120475|FG000|Treatment Period|Adverse Event|15|||
148900949|NCT00551642|537120476|FG001|Treatment Period|Adverse Event|12|||
148900950|NCT00551642|537120475|FG000|Treatment Period|Withdrawal by Subject|2|||
148900951|NCT00551642|537120476|FG001|Treatment Period|Withdrawal by Subject|1|||
148900952|NCT03011099|537120477|FG000|Overall Study|Withdrawal by Subject|0|||
148900953|NCT03011099|537120478|FG001|Overall Study|Withdrawal by Subject|2|||
148900954|NCT01903460|537120481|FG000|Overall Study|Adverse Event|0|||
148900955|NCT01903460|537120482|FG001|Overall Study|Adverse Event|0|||
148900956|NCT01903460|537120483|FG002|Overall Study|Adverse Event|0|||
148900957|NCT01903460|537120484|FG003|Overall Study|Adverse Event|1|||
148900958|NCT03104868|537120485|FG000|6 Week Follow up|Lost to Follow-up|5|||
148900959|NCT03104868|537120486|FG001|6 Week Follow up|Lost to Follow-up|8|||
148900960|NCT03104868|537120485|FG000|6 Week Follow up|Death|1|||
148900961|NCT03104868|537120486|FG001|6 Week Follow up|Death|1|||
148900962|NCT03104868|537120485|FG000|6 Week Follow up|Withdrawal by Subject|7|||
148900963|NCT03104868|537120486|FG001|6 Week Follow up|Withdrawal by Subject|6|||
148900964|NCT03104868|537120485|FG000|6 Week Follow up|Completed Later Timepoint|24|||
148900965|NCT03104868|537120486|FG001|6 Week Follow up|Completed Later Timepoint|22|||
148900966|NCT03104868|537120485|FG000|6 Month Follow up|Lost to Follow-up|2|||
148900967|NCT03104868|537120486|FG001|6 Month Follow up|Lost to Follow-up|2|||
148900968|NCT03104868|537120485|FG000|6 Month Follow up|Death|0|||
148900969|NCT03104868|537120486|FG001|6 Month Follow up|Death|1|||
148900970|NCT03104868|537120485|FG000|6 Month Follow up|Completed Later Timepoint|22|||
148900971|NCT03104868|537120486|FG001|6 Month Follow up|Completed Later Timepoint|32|||
148900972|NCT03104868|537120485|FG000|12 Month Follow up|Lost to Follow-up|1|||
148900973|NCT03104868|537120486|FG001|12 Month Follow up|Lost to Follow-up|2|||
148900974|NCT03104868|537120485|FG000|12 Month Follow up|Death|0|||
148900975|NCT03104868|537120486|FG001|12 Month Follow up|Death|1|||
148900976|NCT03104868|537120485|FG000|12 Month Follow up|Withdrawal by Subject|0|||
148900977|NCT03104868|537120486|FG001|12 Month Follow up|Withdrawal by Subject|3|||
148900978|NCT03104868|537120485|FG000|12 Month Follow up|Completed Later Timepoint|32|||
148900979|NCT03104868|537120486|FG001|12 Month Follow up|Completed Later Timepoint|29|||
148900980|NCT03104868|537120485|FG000|18 Month Follow up|Lost to Follow-up|7|||
148900981|NCT03104868|537120486|FG001|18 Month Follow up|Lost to Follow-up|11|||
148900982|NCT03104868|537120485|FG000|18 Month Follow up|Death|2|||
148900983|NCT03104868|537120486|FG001|18 Month Follow up|Death|1|||
148900984|NCT03104868|537120485|FG000|18 Month Follow up|Withdrawal by Subject|1|||
148900985|NCT03104868|537120486|FG001|18 Month Follow up|Withdrawal by Subject|2|||
148900986|NCT03104868|537120485|FG000|18 Month Follow up|Graft Loss|1|||
148900987|NCT03104868|537120486|FG001|18 Month Follow up|Graft Loss|1|||
148900988|NCT03104868|537120485|FG000|18 Month Follow up|Completed Later Timepoint|19|||
148900989|NCT03104868|537120486|FG001|18 Month Follow up|Completed Later Timepoint|20|||
148900990|NCT03104868|537120485|FG000|24 Month Follow up|Lost to Follow-up|15|||
148900991|NCT03104868|537120486|FG001|24 Month Follow up|Lost to Follow-up|16|||
148900992|NCT03104868|537120485|FG000|24 Month Follow up|Death|3|||
148900993|NCT03104868|537120486|FG001|24 Month Follow up|Death|2|||
148900994|NCT03104868|537120485|FG000|24 Month Follow up|Withdrawal by Subject|1|||
148900995|NCT03104868|537120486|FG001|24 Month Follow up|Withdrawal by Subject|0|||
148900996|NCT03104868|537120485|FG000|24 Month Follow up|Graft Loss|2|||
148900997|NCT03104868|537120486|FG001|24 Month Follow up|Graft Loss|0|||
148900998|NCT04986904|537120489|FG000|Overall Study|Lost to Follow-up|11|||
148900999|NCT04986904|537120489|FG000|Overall Study|Withdrawal by Subject|1|||
148901000|NCT02018562|537120494|FG000|Overall Study|Withdrawal by Subject|2|||
148901001|NCT02018562|537120495|FG001|Overall Study|Withdrawal by Subject|0|||
148901002|NCT02018562|537120494|FG000|Overall Study|Discharged prior to study completion|1|||
148901003|NCT02018562|537120495|FG001|Overall Study|Discharged prior to study completion|0|||
148901004|NCT01253291|537120505|FG000|Overall Study|Withdrawal by Subject|1|||
148901005|NCT01253291|537120506|FG001|Overall Study|Withdrawal by Subject|1|||
148901006|NCT01253291|537120507|FG002|Overall Study|Withdrawal by Subject|0|||
148901007|NCT01253291|537120508|FG003|Overall Study|Withdrawal by Subject|0|||
148901008|NCT01253291|537120509|FG004|Overall Study|Withdrawal by Subject|0|||
148901009|NCT01253291|537120505|FG000|Overall Study|Adverse Event|0|||
148901010|NCT01253291|537120506|FG001|Overall Study|Adverse Event|1|||
148901011|NCT01253291|537120507|FG002|Overall Study|Adverse Event|0|||
148901012|NCT01253291|537120508|FG003|Overall Study|Adverse Event|0|||
148901013|NCT01253291|537120509|FG004|Overall Study|Adverse Event|0|||
148901014|NCT01253291|537120505|FG000|Overall Study|Lack of Efficacy|1|||
148901015|NCT01253291|537120506|FG001|Overall Study|Lack of Efficacy|0|||
148901016|NCT01253291|537120507|FG002|Overall Study|Lack of Efficacy|0|||
148901017|NCT01253291|537120508|FG003|Overall Study|Lack of Efficacy|0|||
148901018|NCT01253291|537120509|FG004|Overall Study|Lack of Efficacy|0|||
148901019|NCT01253291|537120505|FG000|Overall Study|Physician Decision|2|||
148901020|NCT01253291|537120506|FG001|Overall Study|Physician Decision|0|||
148901021|NCT01253291|537120507|FG002|Overall Study|Physician Decision|0|||
148901022|NCT01253291|537120508|FG003|Overall Study|Physician Decision|0|||
148901023|NCT01253291|537120509|FG004|Overall Study|Physician Decision|2|||
148901024|NCT01838395|537120513|FG000|Overall Study|Withdrawal by Subject|0|||
148901025|NCT01838395|537120514|FG001|Overall Study|Withdrawal by Subject|0|||
148901026|NCT01838395|537120515|FG002|Overall Study|Withdrawal by Subject|0|||
148901027|NCT01838395|537120516|FG003|Overall Study|Withdrawal by Subject|0|||
148901028|NCT01838395|537120517|FG004|Overall Study|Withdrawal by Subject|1|||
148901029|NCT01838395|537120518|FG005|Overall Study|Withdrawal by Subject|0|||
148901030|NCT01838395|537120513|FG000|Overall Study|Death|0|||
148901031|NCT01838395|537120514|FG001|Overall Study|Death|0|||
148901032|NCT01838395|537120515|FG002|Overall Study|Death|1|||
148901033|NCT01838395|537120516|FG003|Overall Study|Death|0|||
148901034|NCT01838395|537120517|FG004|Overall Study|Death|0|||
148901035|NCT01838395|537120518|FG005|Overall Study|Death|0|||
148901036|NCT01838395|537120513|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
148901037|NCT01838395|537120514|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
148901038|NCT01838395|537120515|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
148901039|NCT01838395|537120516|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
149011489|NCT00612534|537521482|FG001|Overall Study|Lack of Efficacy|12|||
148901040|NCT01838395|537120517|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
148901041|NCT01838395|537120518|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
148901042|NCT04050553|537120522|FG000|Period 1|Physician Decision|2|||
148901043|NCT04050553|537120523|FG001|Period 1|Physician Decision|2|||
148901044|NCT04050553|537120522|FG000|Period 1|Adverse Event|1|||
148901045|NCT04050553|537120523|FG001|Period 1|Adverse Event|1|||
148901046|NCT04050553|537120522|FG000|Period 1|Withdrawal by Subject|0|||
148901047|NCT04050553|537120523|FG001|Period 1|Withdrawal by Subject|1|||
148901048|NCT04050553|537120522|FG000|Wash-out|Adverse Event|0|||
148901049|NCT04050553|537120523|FG001|Wash-out|Adverse Event|1|||
148901050|NCT04050553|537120522|FG000|Wash-out|Withdrawal by Subject|0|||
148901051|NCT04050553|537120523|FG001|Wash-out|Withdrawal by Subject|1|||
148901052|NCT00734149|537120525|FG000|Overall Study|Withdrawal by Subject|1|||
148901053|NCT05430854|537120526|FG000|Overall Study|Trial terminated by Sponsor|39|||
148901054|NCT05430854|537120527|FG001|Overall Study|Trial terminated by Sponsor|50|||
148901055|NCT05430854|537120528|FG002|Overall Study|Trial terminated by Sponsor|46|||
148901056|NCT05430854|537120526|FG000|Overall Study|Withdrawal by Subject|0|||
148901057|NCT05430854|537120527|FG001|Overall Study|Withdrawal by Subject|3|||
148901058|NCT05430854|537120528|FG002|Overall Study|Withdrawal by Subject|0|||
148901059|NCT04314284|537120529|FG000|Overall Study|Withdrawal by Subject|4|||
148901060|NCT04314284|537120530|FG001|Overall Study|Withdrawal by Subject|7|||
148901061|NCT04314284|537120529|FG000|Overall Study|Consented but did not complete survey|0|||
148901062|NCT04314284|537120530|FG001|Overall Study|Consented but did not complete survey|6|||
148901063|NCT01652235|537120536|FG000|Overall Study|Death|9|||
148901064|NCT01652235|537120536|FG000|Overall Study|Lost to Follow-up|5|||
148901065|NCT01652235|537120536|FG000|Overall Study|Withdrawal by Subject|2|||
148901066|NCT00626106|537120539|FG000|Overall Study|Withdrawal by Subject|2|||
148901067|NCT00626106|537120540|FG001|Overall Study|Withdrawal by Subject|1|||
148901068|NCT00626106|537120539|FG000|Overall Study|Lost to Follow-up|1|||
148901069|NCT00626106|537120540|FG001|Overall Study|Lost to Follow-up|4|||
148901070|NCT00626106|537120539|FG000|Overall Study|Death|64|||
148901071|NCT00626106|537120540|FG001|Overall Study|Death|19|||
148901072|NCT03472885|537120541|FG000|24-Week Treatment Period|Adverse Event|1|||
148901073|NCT02201953|537120542|FG000|Overall Study|Randomized but Never Treated|1|||
148901074|NCT02201953|537120543|FG001|Overall Study|Randomized but Never Treated|5|||
148901075|NCT02201953|537120542|FG000|Overall Study|Lack of Efficacy|9|||
148901076|NCT02201953|537120543|FG001|Overall Study|Lack of Efficacy|30|||
148901077|NCT02201953|537120542|FG000|Overall Study|Lost to Follow-up|8|||
148901078|NCT02201953|537120543|FG001|Overall Study|Lost to Follow-up|8|||
148901079|NCT02201953|537120542|FG000|Overall Study|Withdrew Consent|2|||
148901080|NCT02201953|537120543|FG001|Overall Study|Withdrew Consent|5|||
148901081|NCT02201953|537120542|FG000|Overall Study|Adverse Event|0|||
148901082|NCT02201953|537120543|FG001|Overall Study|Adverse Event|5|||
148901083|NCT02201953|537120542|FG000|Overall Study|Death|0|||
148901084|NCT02201953|537120543|FG001|Overall Study|Death|3|||
148901085|NCT00321620|537121850|FG000|Overall Study|Death|269|||
148901086|NCT00321620|537121851|FG001|Overall Study|Death|294|||
148901087|NCT00321620|537121850|FG000|Overall Study|Withdrawal by Subject|164|||
148901088|NCT00321620|537121851|FG001|Overall Study|Withdrawal by Subject|147|||
148901089|NCT00321620|537121850|FG000|Overall Study|Disease progression|113|||
148901090|NCT00321620|537121851|FG001|Overall Study|Disease progression|117|||
148901091|NCT00321620|537121850|FG000|Overall Study|Adverse Event|43|||
148901092|NCT00321620|537121851|FG001|Overall Study|Adverse Event|56|||
148901093|NCT00321620|537121850|FG000|Overall Study|Lost to Follow-up|13|||
148901094|NCT00321620|537121851|FG001|Overall Study|Lost to Follow-up|9|||
148901095|NCT00321620|537121850|FG000|Overall Study|Physician Decision|4|||
148901096|NCT00321620|537121851|FG001|Overall Study|Physician Decision|1|||
148901097|NCT00321620|537121850|FG000|Overall Study|Noncompliance|14|||
148901098|NCT00321620|537121851|FG001|Overall Study|Noncompliance|7|||
148901099|NCT00321620|537121850|FG000|Overall Study|Protocol deviation|4|||
148901100|NCT00321620|537121851|FG001|Overall Study|Protocol deviation|3|||
148901101|NCT00321620|537121850|FG000|Overall Study|Ineligibility determined|2|||
148901102|NCT00321620|537121851|FG001|Overall Study|Ineligibility determined|3|||
148901103|NCT00321620|537121850|FG000|Overall Study|Participant request|75|||
148901104|NCT00321620|537121851|FG001|Overall Study|Participant request|52|||
148901105|NCT00321620|537121850|FG000|Overall Study|Other|42|||
148901106|NCT00321620|537121851|FG001|Overall Study|Other|33|||
148901107|NCT01747876|537121856|FG000|Overall Study|Adverse Event|1|||
148901108|NCT01747876|537121857|FG001|Overall Study|Adverse Event|0|||
148901109|NCT01747876|537121858|FG002|Overall Study|Adverse Event|2|||
148901110|NCT01747876|537121856|FG000|Overall Study|Withdrawal by Subject|0|||
148901111|NCT01747876|537121857|FG001|Overall Study|Withdrawal by Subject|1|||
148901112|NCT01747876|537121858|FG002|Overall Study|Withdrawal by Subject|1|||
148901113|NCT01747876|537121856|FG000|Overall Study|Disease progression|4|||
148901114|NCT01747876|537121857|FG001|Overall Study|Disease progression|13|||
148901115|NCT01747876|537121858|FG002|Overall Study|Disease progression|8|||
148901116|NCT01747876|537121856|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
148901117|NCT01747876|537121857|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
148901118|NCT01747876|537121858|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
148901119|NCT00129402|537121860|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
148901120|NCT00129402|537121861|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
148901121|NCT00129402|537121862|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
148901122|NCT00129402|537121863|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
148901123|NCT00129402|537121864|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
148901124|NCT00129402|537121865|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
148901125|NCT00129402|537121866|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
148901126|NCT00129402|537121860|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
148901127|NCT00129402|537121861|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
148901128|NCT00129402|537121862|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
148901129|NCT00129402|537121863|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
148901130|NCT00129402|537121864|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
148901131|NCT00129402|537121865|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
148901132|NCT00129402|537121866|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
148901133|NCT00129402|537121860|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
148799976|NCT00557466|536747343|FG005|Overall Study|Lost to Follow-up|0|||
148799977|NCT02308046|536747344|FG000|Overall Study|Negative yeast culture at Baseline|32|||
148799978|NCT02308046|536747345|FG001|Overall Study|Negative yeast culture at Baseline|33|||
148799979|NCT02308046|536747344|FG000|Overall Study|Positive for STD at Baseline|1|||
148799980|NCT02308046|536747345|FG001|Overall Study|Positive for STD at Baseline|2|||
148799981|NCT02308046|536747344|FG000|Overall Study|Lost to Follow-up|1|||
148799982|NCT02308046|536747345|FG001|Overall Study|Lost to Follow-up|3|||
148799983|NCT01181167|536747348|FG000|Overall Study|Adverse Event|11|||
148799984|NCT01181167|536747349|FG001|Overall Study|Adverse Event|21|||
148799985|NCT01181167|536747348|FG000|Overall Study|Lost to Follow-up|1|||
148799986|NCT01181167|536747349|FG001|Overall Study|Lost to Follow-up|0|||
148799987|NCT01181167|536747348|FG000|Overall Study|Physician Decision|2|||
148799988|NCT01181167|536747349|FG001|Overall Study|Physician Decision|3|||
148901134|NCT00129402|537121861|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
148901135|NCT00129402|537121862|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
148901136|NCT00129402|537121863|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
148901137|NCT00129402|537121864|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
148901138|NCT00129402|537121865|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
148901139|NCT00129402|537121866|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
148901140|NCT00129402|537121860|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
149011490|NCT00612534|537521483|FG002|Overall Study|Lack of Efficacy|5|||
148901141|NCT00129402|537121861|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
148901142|NCT00129402|537121862|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
148901143|NCT00129402|537121863|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
148901144|NCT00129402|537121864|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
148901145|NCT00129402|537121865|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
148901146|NCT00129402|537121866|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
148901147|NCT00129402|537121860|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
148901148|NCT00129402|537121861|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
148901149|NCT00129402|537121862|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
148901150|NCT00129402|537121863|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
148901151|NCT00129402|537121864|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
148901152|NCT00129402|537121865|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
148799989|NCT01181167|536747348|FG000|Overall Study|Protocol Violation|3|||
148799990|NCT01181167|536747349|FG001|Overall Study|Protocol Violation|0|||
148799991|NCT01181167|536747348|FG000|Overall Study|Withdrawal by Subject|6|||
148799992|NCT01181167|536747349|FG001|Overall Study|Withdrawal by Subject|8|||
148799993|NCT03342001|536747350|FG000|Overall Study|Adverse Event|1|||
148799994|NCT03342001|536747350|FG000|Overall Study|Lost to Follow-up|1|||
148799995|NCT01433159|536747351|FG000|Overall Study|Adverse Event|1|||
148799996|NCT01433159|536747352|FG001|Overall Study|Adverse Event|0|||
148799997|NCT01433159|536747351|FG000|Overall Study|Physician Decision|1|||
148799998|NCT01433159|536747352|FG001|Overall Study|Physician Decision|0|||
148799999|NCT01433159|536747351|FG000|Overall Study|Protocol Violation|0|||
148800000|NCT01433159|536747352|FG001|Overall Study|Protocol Violation|1|||
148800001|NCT01117870|536747357|FG000|Overall Study|Inability to place needle|1|||
148800002|NCT01117870|536747358|FG001|Overall Study|Inability to place needle|0|||
148800003|NCT01249131|536747361|FG000|Washout Period of 10 Days|Adverse Event|0|||
148800004|NCT01249131|536747362|FG001|Washout Period of 10 Days|Adverse Event|0|||
148800005|NCT01249131|536747363|FG002|Washout Period of 10 Days|Adverse Event|0|||
148800006|NCT01249131|536747364|FG003|Washout Period of 10 Days|Adverse Event|0|||
148800007|NCT01249131|536747365|FG004|Washout Period of 10 Days|Adverse Event|1|||
148800008|NCT01249131|536747366|FG005|Washout Period of 10 Days|Adverse Event|0|||
148800009|NCT00433836|536747367|FG000|Overall Study|Adverse Event|7|||
148800010|NCT00433836|536747368|FG001|Overall Study|Adverse Event|0|||
148901153|NCT00129402|537121866|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
148901154|NCT00129402|537121860|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
148901155|NCT00129402|537121861|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
148901156|NCT00129402|537121862|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
148901157|NCT00129402|537121863|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
148901158|NCT00129402|537121864|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
148901159|NCT00129402|537121865|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
148901160|NCT00129402|537121866|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
148901161|NCT00129402|537121860|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
148901162|NCT00129402|537121861|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
148901163|NCT00129402|537121862|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
148901164|NCT00129402|537121863|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
148901165|NCT00129402|537121864|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
148901166|NCT00129402|537121865|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
148901167|NCT00129402|537121866|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
148901168|NCT00129402|537121860|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
148901169|NCT00129402|537121861|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
148901170|NCT00129402|537121862|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
148901171|NCT00129402|537121863|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
148901172|NCT00129402|537121864|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
148800011|NCT00433836|536747367|FG000|Overall Study|Lost to Follow-up|3|||
148800012|NCT00433836|536747368|FG001|Overall Study|Lost to Follow-up|0|||
148800013|NCT00433836|536747367|FG000|Overall Study|Withdrawal by Subject|2|||
148800014|NCT00433836|536747368|FG001|Overall Study|Withdrawal by Subject|1|||
148800015|NCT00433836|536747367|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148800016|NCT00433836|536747368|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148800017|NCT00433836|536747367|FG000|Overall Study|Protocol Violation|0|||
148800018|NCT00433836|536747368|FG001|Overall Study|Protocol Violation|2|||
148800019|NCT00433836|536747367|FG000|Overall Study|Condition no longer requires study drug|0|||
148800020|NCT00433836|536747368|FG001|Overall Study|Condition no longer requires study drug|1|||
148800021|NCT00433836|536747367|FG000|Overall Study|Abnormal laboratory values|0|||
148800022|NCT00433836|536747368|FG001|Overall Study|Abnormal laboratory values|1|||
148800023|NCT00192114|536747369|FG000|Overall Study|Objective Tumor Progression|19|||
148800024|NCT00192114|536747369|FG000|Overall Study|Adverse Event|2|||
148800025|NCT00192114|536747369|FG000|Overall Study|Clinical Progression|2|||
148800026|NCT00192114|536747369|FG000|Overall Study|Death|1|||
148800027|NCT00113607|536747370|FG000|Overall Study|Adverse Event|40|||
148800028|NCT00113607|536747371|FG001|Overall Study|Adverse Event|71|||
148800029|NCT00113607|536747370|FG000|Overall Study|Death|8|||
148800030|NCT00113607|536747371|FG001|Overall Study|Death|8|||
148800031|NCT00113607|536747370|FG000|Overall Study|Withdrawal by Subject|50|||
148800032|NCT00113607|536747371|FG001|Overall Study|Withdrawal by Subject|58|||
148800033|NCT00113607|536747370|FG000|Overall Study|Lost to Follow-up|0|||
148800034|NCT00113607|536747371|FG001|Overall Study|Lost to Follow-up|2|||
148800035|NCT00113607|536747370|FG000|Overall Study|Disease Progression|180|||
148800036|NCT00113607|536747371|FG001|Overall Study|Disease Progression|142|||
148800037|NCT00113607|536747370|FG000|Overall Study|Complete Response (Confirmed)|14|||
148800038|NCT00113607|536747371|FG001|Overall Study|Complete Response (Confirmed)|24|||
148800039|NCT00113607|536747370|FG000|Overall Study|Other|43|||
148800040|NCT00113607|536747371|FG001|Overall Study|Other|32|||
148800041|NCT00749398|536747373|FG000|Overall Study|Lack of Efficacy|7|||
148800042|NCT00749398|536747373|FG000|Overall Study|Adverse Event|4|||
148800043|NCT00749398|536747373|FG000|Overall Study|Serious adverse event|11|||
148800044|NCT00749398|536747373|FG000|Overall Study|Withdrawal by Subject|17|||
148800045|NCT00749398|536747373|FG000|Overall Study|Lost to Follow-up|11|||
148800046|NCT00749398|536747373|FG000|Overall Study|Reason not specified|2|||
148800047|NCT00749398|536747373|FG000|Overall Study|Unknown reason|1|||
148800048|NCT05002972|536747376|FG000|Overall Study|Withdrawal by Subject|2|||
148800049|NCT00249834|536747383|FG000|Overall Study|Ovarian stimulation failed|1|||
148800050|NCT00249834|536747384|FG001|Overall Study|Ovarian stimulation failed|0|||
148800051|NCT00249834|536747385|FG002|Overall Study|Ovarian stimulation failed|0|||
148800052|NCT00249834|536747386|FG003|Overall Study|Ovarian stimulation failed|0|||
148800053|NCT00249834|536747387|FG004|Overall Study|Ovarian stimulation failed|0|||
148800054|NCT00249834|536747388|FG005|Overall Study|Ovarian stimulation failed|0|||
148800055|NCT00249834|536747389|FG006|Overall Study|Ovarian stimulation failed|0|||
148800056|NCT00249834|536747390|FG007|Overall Study|Ovarian stimulation failed|0|||
148800057|NCT00249834|536747383|FG000|Overall Study|Failure of down-regulation|0|||
148800058|NCT00249834|536747384|FG001|Overall Study|Failure of down-regulation|0|||
148800059|NCT00249834|536747385|FG002|Overall Study|Failure of down-regulation|0|||
148800060|NCT00249834|536747386|FG003|Overall Study|Failure of down-regulation|0|||
148800061|NCT00249834|536747387|FG004|Overall Study|Failure of down-regulation|0|||
148800062|NCT00249834|536747388|FG005|Overall Study|Failure of down-regulation|0|||
148800063|NCT00249834|536747389|FG006|Overall Study|Failure of down-regulation|1|||
148800064|NCT00249834|536747390|FG007|Overall Study|Failure of down-regulation|0|||
148800065|NCT00249834|536747383|FG000|Overall Study|Protocol Violation|0|||
148800066|NCT00249834|536747384|FG001|Overall Study|Protocol Violation|19|||
148800067|NCT00249834|536747385|FG002|Overall Study|Protocol Violation|14|||
148800068|NCT00249834|536747386|FG003|Overall Study|Protocol Violation|8|||
148901173|NCT00129402|537121865|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
148800069|NCT00249834|536747387|FG004|Overall Study|Protocol Violation|5|||
148800070|NCT00249834|536747388|FG005|Overall Study|Protocol Violation|2|||
148800071|NCT00249834|536747389|FG006|Overall Study|Protocol Violation|0|||
148800072|NCT00249834|536747390|FG007|Overall Study|Protocol Violation|0|||
148800073|NCT02849080|536747391|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
148800074|NCT02849080|536747392|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
148800075|NCT02849080|536747393|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
148901174|NCT00129402|537121866|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
148901175|NCT00129402|537121860|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
148901176|NCT00129402|537121861|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
148901177|NCT00129402|537121862|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
148901178|NCT00129402|537121863|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
148901179|NCT00129402|537121864|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
148901180|NCT00129402|537121865|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
148901181|NCT00129402|537121866|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
148901182|NCT00129402|537121860|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
148901183|NCT00129402|537121861|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
148901184|NCT00129402|537121862|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
148901185|NCT00129402|537121863|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
148901186|NCT00129402|537121864|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
148901187|NCT00129402|537121865|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
148901188|NCT00129402|537121866|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
148901189|NCT00129402|537121860|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
148901190|NCT00129402|537121861|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
148901191|NCT00129402|537121862|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
148901192|NCT00129402|537121863|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
148901193|NCT00129402|537121864|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
148901194|NCT00129402|537121865|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
148901195|NCT00129402|537121866|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
148901196|NCT00129402|537121860|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
148901197|NCT00129402|537121861|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
148901198|NCT00129402|537121862|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
148901199|NCT00129402|537121863|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
148901200|NCT00129402|537121864|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
148901201|NCT00129402|537121865|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
148901202|NCT00129402|537121866|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
148901203|NCT00129402|537121860|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
148901204|NCT00129402|537121861|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
148901205|NCT00129402|537121862|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
148901206|NCT00129402|537121863|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
148901207|NCT00129402|537121864|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
148901208|NCT00129402|537121865|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
148901209|NCT00129402|537121866|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
148901210|NCT03041038|537121867|FG000|Overall Study|Withdrawal by Subject|4|||
149137733|NCT01667107|537985218|FG000|Overall Study|Tolerability issues|0|||
149137734|NCT01667107|537985219|FG001|Overall Study|Tolerability issues|2|||
149137735|NCT01667107|537985218|FG000|Overall Study|Protocol Violation|0|||
149137736|NCT01667107|537985219|FG001|Overall Study|Protocol Violation|1|||
149137737|NCT01667107|537985218|FG000|Overall Study|Lack of Efficacy|0|||
149137738|NCT01667107|537985219|FG001|Overall Study|Lack of Efficacy|1|||
149137739|NCT01298518|537985220|FG000|Overall Study|Withdrawal by Subject|0|||
149137740|NCT01298518|537985221|FG001|Overall Study|Withdrawal by Subject|0|||
149137741|NCT01298518|537985222|FG002|Overall Study|Withdrawal by Subject|1|||
149137742|NCT01791803|537985223|FG000|Overall Study|Withdrawal by Subject|0|||
149137743|NCT01791803|537985224|FG001|Overall Study|Withdrawal by Subject|0|||
149137744|NCT01791803|537985225|FG002|Overall Study|Withdrawal by Subject|0|||
149137745|NCT01791803|537985226|FG003|Overall Study|Withdrawal by Subject|2|||
149137746|NCT01791803|537985223|FG000|Overall Study|Physician Decision|0|||
149137747|NCT01791803|537985224|FG001|Overall Study|Physician Decision|2|||
149137748|NCT01791803|537985225|FG002|Overall Study|Physician Decision|0|||
149137749|NCT01791803|537985226|FG003|Overall Study|Physician Decision|1|||
149137750|NCT01791803|537985223|FG000|Overall Study|Death|0|||
149137751|NCT01791803|537985224|FG001|Overall Study|Death|0|||
149137752|NCT01791803|537985225|FG002|Overall Study|Death|2|||
149137753|NCT01791803|537985226|FG003|Overall Study|Death|2|||
149137754|NCT04572854|537985227|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
149137755|NCT04572854|537985228|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
149137756|NCT04572854|537985229|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
149137757|NCT04572854|537985230|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
149137758|NCT04572854|537985227|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
149137759|NCT04572854|537985228|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
149137760|NCT04572854|537985229|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
149137761|NCT04572854|537985230|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
149137762|NCT00972777|537985231|FG000|Overall Study|Adverse Event|3|||
149137763|NCT00972777|537985232|FG001|Overall Study|Adverse Event|2|||
149137764|NCT00972777|537985231|FG000|Overall Study|Lost to Follow-up|0|||
149137765|NCT00972777|537985232|FG001|Overall Study|Lost to Follow-up|4|||
149137766|NCT00972777|537985231|FG000|Overall Study|Withdrawal by Subject|4|||
149137767|NCT00972777|537985232|FG001|Overall Study|Withdrawal by Subject|5|||
149137768|NCT00972777|537985231|FG000|Overall Study|Physician Decision|4|||
149137769|NCT00972777|537985232|FG001|Overall Study|Physician Decision|0|||
149137770|NCT00972777|537985231|FG000|Overall Study|Protocol Violation|0|||
149137771|NCT00972777|537985232|FG001|Overall Study|Protocol Violation|2|||
149137772|NCT00972777|537985231|FG000|Overall Study|Screening Failure|2|||
149137773|NCT00972777|537985232|FG001|Overall Study|Screening Failure|1|||
149137774|NCT00972777|537985231|FG000|Overall Study|Missed visit|1|||
149137775|NCT00972777|537985232|FG001|Overall Study|Missed visit|0|||
149137776|NCT01093326|537985233|FG000|Overall Study|Death|0|||
149137777|NCT01093326|537985234|FG001|Overall Study|Death|1|||
149137778|NCT01093326|537985235|FG002|Overall Study|Death|0|||
149137779|NCT01093326|537985233|FG000|Overall Study|Lack of Efficacy|7|||
149137780|NCT01093326|537985234|FG001|Overall Study|Lack of Efficacy|6|||
149137781|NCT01093326|537985235|FG002|Overall Study|Lack of Efficacy|3|||
149137782|NCT01093326|537985233|FG000|Overall Study|Lost to Follow-up|2|||
148800076|NCT02849080|536747394|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
148800077|NCT02849080|536747391|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
148800078|NCT02849080|536747392|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
148800079|NCT02849080|536747393|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
148800080|NCT02849080|536747394|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
148800081|NCT02849080|536747391|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
148800082|NCT02849080|536747392|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
148800083|NCT02849080|536747393|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
148800084|NCT02849080|536747394|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
148800085|NCT02849080|536747391|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
148800086|NCT02849080|536747392|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
148800087|NCT02849080|536747393|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
148800088|NCT02849080|536747394|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
148800089|NCT02849080|536747391|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
148800090|NCT02849080|536747392|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
148800091|NCT02849080|536747393|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
148800092|NCT02849080|536747394|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
148800093|NCT02849080|536747391|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
148800094|NCT02849080|536747392|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
148800095|NCT02849080|536747393|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
148800096|NCT02849080|536747394|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
148800097|NCT02283658|536747404|FG000|Overall Study|Withdrawal by Subject|1|||
148800098|NCT01687218|536747405|FG000|Overall Study|Withdrawal by Subject|2|||
148800099|NCT01687218|536747406|FG001|Overall Study|Withdrawal by Subject|3|||
148800100|NCT01687218|536747407|FG002|Overall Study|Withdrawal by Subject|0|||
148800101|NCT01687218|536747408|FG003|Overall Study|Withdrawal by Subject|1|||
148800102|NCT01687218|536747409|FG004|Overall Study|Withdrawal by Subject|1|||
148800103|NCT01687218|536747410|FG005|Overall Study|Withdrawal by Subject|0|||
148800104|NCT01687218|536747405|FG000|Overall Study|Relocated, no follow-up planned|1|||
148800105|NCT01687218|536747406|FG001|Overall Study|Relocated, no follow-up planned|0|||
148800106|NCT01687218|536747407|FG002|Overall Study|Relocated, no follow-up planned|1|||
148800107|NCT01687218|536747408|FG003|Overall Study|Relocated, no follow-up planned|1|||
148800108|NCT01687218|536747409|FG004|Overall Study|Relocated, no follow-up planned|0|||
148901211|NCT03041038|537121868|FG001|Overall Study|Withdrawal by Subject|0|||
148901212|NCT03041038|537121867|FG000|Overall Study|Lost to Follow-up|1|||
148901213|NCT03041038|537121868|FG001|Overall Study|Lost to Follow-up|1|||
148901214|NCT03041038|537121867|FG000|Overall Study|Protocol Violation|1|||
148800109|NCT01687218|536747410|FG005|Overall Study|Relocated, no follow-up planned|0|||
148800110|NCT03528551|536747412|FG000|Overall Study|Lost to Follow-up|0|||
148901215|NCT03041038|537121868|FG001|Overall Study|Protocol Violation|1|||
148901216|NCT02131259|537121869|FG000|Overall Study|Progressive disease|751|||
148901217|NCT02131259|537121869|FG000|Overall Study|Adverse Event|341|||
148901218|NCT02131259|537121869|FG000|Overall Study|Lost to Follow-up|7|||
148901219|NCT02131259|537121869|FG000|Overall Study|Relocation|32|||
148901220|NCT02131259|537121869|FG000|Overall Study|Other|63|||
148901221|NCT02131259|537121869|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
148901222|NCT02131259|537121869|FG000|Overall Study|Progressive disease/relocation|1|||
148901223|NCT02131259|537121869|FG000|Overall Study|Progressive disease/other|2|||
148901224|NCT02131259|537121869|FG000|Overall Study|AE/lost to follow-up|1|||
148901225|NCT02131259|537121869|FG000|Overall Study|AE/other|1|||
148901226|NCT02131259|537121869|FG000|Overall Study|Progressive disease/AE/other|1|||
148901227|NCT02131259|537121869|FG000|Overall Study|Missing|3|||
148901228|NCT02796170|537121870|FG000|Overall Study|Lost to Follow-up|3|||
148901229|NCT02796170|537121871|FG001|Overall Study|Lost to Follow-up|0|||
148901230|NCT01527370|537121874|FG000|Overall Study|Withdrawal by Subject|4|||
149011491|NCT00612534|537521484|FG003|Overall Study|Lack of Efficacy|16|||
149137783|NCT01093326|537985234|FG001|Overall Study|Lost to Follow-up|5|||
149137784|NCT01093326|537985235|FG002|Overall Study|Lost to Follow-up|4|||
149137785|NCT01093326|537985233|FG000|Overall Study|Physician Decision|3|||
149137786|NCT01093326|537985234|FG001|Overall Study|Physician Decision|1|||
149137787|NCT01093326|537985235|FG002|Overall Study|Physician Decision|3|||
149137788|NCT01093326|537985233|FG000|Overall Study|Withdrawal by Subject|30|||
149137789|NCT01093326|537985234|FG001|Overall Study|Withdrawal by Subject|27|||
149137790|NCT01093326|537985235|FG002|Overall Study|Withdrawal by Subject|26|||
149137791|NCT01093326|537985233|FG000|Overall Study|Adverse Event|2|||
149137792|NCT01093326|537985234|FG001|Overall Study|Adverse Event|1|||
149137793|NCT01093326|537985235|FG002|Overall Study|Adverse Event|4|||
149137794|NCT01093326|537985233|FG000|Overall Study|Other|0|||
149137795|NCT01093326|537985234|FG001|Overall Study|Other|0|||
149137796|NCT01093326|537985235|FG002|Overall Study|Other|1|||
149137797|NCT05162027|537986821|FG000|Overall Study|Adverse Event|1|||
149137798|NCT05162027|537986822|FG001|Overall Study|Adverse Event|0|||
149137799|NCT02553265|537986823|FG000|Enrollment|Death|0|||
149137800|NCT02553265|537986824|FG001|Enrollment|Death|0|||
149137801|NCT02553265|537986825|FG002|Enrollment|Death|1|||
149137802|NCT02553265|537986823|FG000|First Intervention (28 Days)|Adverse Event|1|||
149137803|NCT02553265|537986824|FG001|First Intervention (28 Days)|Adverse Event|0|||
149137804|NCT02553265|537986825|FG002|First Intervention (28 Days)|Adverse Event|0|||
149137805|NCT02553265|537986823|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
149137806|NCT02553265|537986824|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
149137807|NCT02553265|537986825|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
149137808|NCT02553265|537986823|FG000|Second Intervention (28 Days)|Adverse Event|1|||
149137809|NCT02553265|537986824|FG001|Second Intervention (28 Days)|Adverse Event|0|||
149137810|NCT02553265|537986825|FG002|Second Intervention (28 Days)|Adverse Event|0|||
149137811|NCT02553265|537986823|FG000|Third Intervention (28 Days)|Adverse Event|1|||
149137812|NCT02553265|537986824|FG001|Third Intervention (28 Days)|Adverse Event|0|||
149137813|NCT02553265|537986825|FG002|Third Intervention (28 Days)|Adverse Event|0|||
149137814|NCT02553265|537986823|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
149137815|NCT02553265|537986824|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
149137816|NCT02553265|537986825|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
149137817|NCT01650285|537986831|FG000|Overall Study|Adverse Event|1|||
149137818|NCT00659529|537986832|FG000|Overall Study|Withdrawal by Subject|4|||
149137819|NCT00659529|537986832|FG000|Overall Study|Protocol Violation|3|||
149137820|NCT00659529|537986832|FG000|Overall Study|Screen failure|9|||
149137821|NCT02023242|537986835|FG000|Overall Study|Lost to Follow-up|3|||
149137822|NCT02023242|537986836|FG001|Overall Study|Lost to Follow-up|1|||
149137823|NCT02023242|537986835|FG000|Overall Study|Death|0|||
149137824|NCT02023242|537986836|FG001|Overall Study|Death|1|||
149137825|NCT01950247|537986837|FG000|Overall Study|Withdrawal by Subject|28|||
149137826|NCT01950247|537986838|FG001|Overall Study|Withdrawal by Subject|13|||
149137827|NCT01950247|537986837|FG000|Overall Study|Lost to Follow-up|18|||
149137828|NCT01950247|537986838|FG001|Overall Study|Lost to Follow-up|16|||
149137829|NCT01950247|537986837|FG000|Overall Study|Physician Decision|3|||
149137830|NCT01950247|537986838|FG001|Overall Study|Physician Decision|4|||
149137831|NCT01950247|537986837|FG000|Overall Study|Adverse Event|3|||
149137832|NCT01950247|537986838|FG001|Overall Study|Adverse Event|2|||
149137833|NCT01950247|537986837|FG000|Overall Study|Death|1|||
149137834|NCT01950247|537986838|FG001|Overall Study|Death|1|||
149137835|NCT01950247|537986837|FG000|Overall Study|Not Defined|4|||
149137836|NCT01950247|537986838|FG001|Overall Study|Not Defined|10|||
149137837|NCT00763971|537986839|FG000|Overall Study|Adverse Event|5|||
149137838|NCT00763971|537986840|FG001|Overall Study|Adverse Event|2|||
149137839|NCT00763971|537986841|FG002|Overall Study|Adverse Event|4|||
149137840|NCT00763971|537986839|FG000|Overall Study|Protocol Violation|3|||
149137841|NCT00763971|537986840|FG001|Overall Study|Protocol Violation|3|||
149137842|NCT00763971|537986841|FG002|Overall Study|Protocol Violation|2|||
149137843|NCT00763971|537986839|FG000|Overall Study|Withdrawal by Subject|4|||
149137844|NCT00763971|537986840|FG001|Overall Study|Withdrawal by Subject|5|||
149137845|NCT00763971|537986841|FG002|Overall Study|Withdrawal by Subject|5|||
149137846|NCT00763971|537986839|FG000|Overall Study|Lost to Follow-up|0|||
149137847|NCT00763971|537986840|FG001|Overall Study|Lost to Follow-up|1|||
149137848|NCT00763971|537986841|FG002|Overall Study|Lost to Follow-up|0|||
149137849|NCT00763971|537986839|FG000|Overall Study|Lack of Efficacy|11|||
149137850|NCT00763971|537986840|FG001|Overall Study|Lack of Efficacy|22|||
149137851|NCT00763971|537986841|FG002|Overall Study|Lack of Efficacy|54|||
149137852|NCT00763971|537986839|FG000|Overall Study|Unable to swallow capsule|2|||
149137853|NCT00763971|537986840|FG001|Overall Study|Unable to swallow capsule|1|||
149137854|NCT00763971|537986841|FG002|Overall Study|Unable to swallow capsule|1|||
149137855|NCT00763971|537986839|FG000|Overall Study|Personal reason|3|||
149011492|NCT00612534|537521481|FG000|Overall Study|Other Reason|0|||
149137856|NCT00763971|537986840|FG001|Overall Study|Personal reason|0|||
149137857|NCT00763971|537986841|FG002|Overall Study|Personal reason|0|||
149137858|NCT00763971|537986839|FG000|Overall Study|Exclusion criteria met|1|||
149137859|NCT00763971|537986840|FG001|Overall Study|Exclusion criteria met|0|||
148901231|NCT01527370|537121874|FG000|Overall Study|Physician Decision|1|||
148901232|NCT01527370|537121874|FG000|Overall Study|Death|1|||
148901233|NCT03131570|537121877|FG000|Overall Study|Adverse Event|1|||
148901234|NCT03131570|537121878|FG001|Overall Study|Adverse Event|0|||
148901235|NCT01352715|537121879|FG000|Overall Study|Death|3|||
148901236|NCT01352715|537121880|FG001|Overall Study|Death|3|||
148901237|NCT01352715|537121879|FG000|Overall Study|Lost to Follow-up|5|||
148901238|NCT01352715|537121880|FG001|Overall Study|Lost to Follow-up|7|||
148901239|NCT01352715|537121879|FG000|Overall Study|Withdrawal by Subject|4|||
148901240|NCT01352715|537121880|FG001|Overall Study|Withdrawal by Subject|8|||
148901241|NCT01352715|537121879|FG000|Overall Study|site closure|16|||
148901242|NCT01352715|537121880|FG001|Overall Study|site closure|15|||
148901243|NCT01352715|537121879|FG000|Overall Study|no final visit in closeout period|15|||
148901244|NCT01352715|537121880|FG001|Overall Study|no final visit in closeout period|12|||
148901245|NCT01352715|537121879|FG000|Overall Study|major ineligibility|2|||
148901246|NCT01352715|537121880|FG001|Overall Study|major ineligibility|1|||
148901247|NCT04596267|537121881|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
148901248|NCT04596267|537121882|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
148901249|NCT04596267|537121881|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
148901250|NCT04596267|537121882|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
148901251|NCT00071058|537121883|FG000|Overall Study|brain tumor-removed from study|1|||
148901252|NCT02000440|537121889|FG000|Overall Study|Adverse Event|3|||
148901253|NCT02000440|537121889|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
148901254|NCT00871975|537121890|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
148901255|NCT00871975|537121890|FG000|Overall Study|Catheters could not be inserted|1|||
148901256|NCT00871975|537121890|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
148901257|NCT00871975|537121890|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
148901258|NCT01690143|537121891|FG000|Overall Study|Withdrawal by Subject|1|||
148901259|NCT01210313|537121895|FG000|Overall Study|Withdrawal by Subject|3|||
148901260|NCT01210313|537121895|FG000|Overall Study|Adverse Event|2|||
148901261|NCT01210313|537121895|FG000|Overall Study|Distant recurrence|4|||
148901262|NCT01210313|537121895|FG000|Overall Study|Non-compliance|7|||
148901263|NCT01052493|537121904|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
148901264|NCT01052493|537121905|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
148901265|NCT01052493|537121906|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
148901266|NCT03944577|537121907|FG000|Overall Study|Adverse Event|3|||
148901267|NCT00391586|537121908|FG000|Overall Study|Progressive disease|13|||
148901268|NCT00391586|537121908|FG000|Overall Study|Adverse Event|5|||
148800111|NCT03528551|536747413|FG001|Overall Study|Lost to Follow-up|1|||
148800112|NCT03528551|536747414|FG002|Overall Study|Lost to Follow-up|0|||
148800113|NCT03528551|536747412|FG000|Overall Study|Transferred to other arm/group|2|||
148800114|NCT03528551|536747413|FG001|Overall Study|Transferred to other arm/group|3|||
148800115|NCT03528551|536747414|FG002|Overall Study|Transferred to other arm/group|0|||
148800116|NCT03528551|536747412|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148800117|NCT03528551|536747413|FG001|Overall Study|Withdrawal by parent/guardian|5|||
148800118|NCT03528551|536747414|FG002|Overall Study|Withdrawal by parent/guardian|0|||
148800119|NCT03528551|536747412|FG000|Overall Study|Protocol Violation|0|||
148800120|NCT03528551|536747413|FG001|Overall Study|Protocol Violation|3|||
148800121|NCT03528551|536747414|FG002|Overall Study|Protocol Violation|0|||
148800122|NCT03528551|536747412|FG000|Overall Study|Withdrawal by Subject|0|||
148800123|NCT03528551|536747413|FG001|Overall Study|Withdrawal by Subject|7|||
148800124|NCT03528551|536747414|FG002|Overall Study|Withdrawal by Subject|0|||
148800125|NCT01789047|536747417|FG000|Overall Study|Adverse Event|3|||
148800126|NCT01789047|536747418|FG001|Overall Study|Adverse Event|2|||
148800127|NCT01789047|536747417|FG000|Overall Study|Withdrawal by Subject|1|||
148800128|NCT01789047|536747418|FG001|Overall Study|Withdrawal by Subject|2|||
148800129|NCT03644017|536747419|FG000|Overall Study|Access Abandonment|5|||
148800130|NCT03644017|536747419|FG000|Overall Study|Kidney Transplant|2|||
148800131|NCT02700048|536747420|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
148800132|NCT02700048|536747421|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
148800133|NCT02175225|536747422|FG000|Overall Study|Withdrawal by Subject|1|||
148800134|NCT02175225|536747423|FG001|Overall Study|Withdrawal by Subject|2|||
148800135|NCT02175225|536747422|FG000|Overall Study|Lost to Follow-up|6|||
148800136|NCT02175225|536747423|FG001|Overall Study|Lost to Follow-up|7|||
148800137|NCT02175225|536747422|FG000|Overall Study|Study drug not administered|1|||
148800138|NCT02175225|536747423|FG001|Overall Study|Study drug not administered|2|||
148800139|NCT02340000|536747424|FG000|Time Period 1|Withdrawal by Subject|6|||
148800140|NCT02340000|536747425|FG001|Time Period 1|Withdrawal by Subject|8|||
148800141|NCT02340000|536747424|FG000|Time Period 1|Lost to Follow-up|6|||
148800142|NCT02340000|536747425|FG001|Time Period 1|Lost to Follow-up|7|||
148800143|NCT02340000|536747424|FG000|Time Period 2|Withdrawal by Subject|9|||
148800144|NCT02340000|536747425|FG001|Time Period 2|Withdrawal by Subject|7|||
148800145|NCT02340000|536747424|FG000|Time Period 2|Lost to Follow-up|10|||
148800146|NCT02340000|536747425|FG001|Time Period 2|Lost to Follow-up|8|||
148800147|NCT02668640|536747426|FG000|Overall Study|Lost to Follow-up|13|||
148800148|NCT02668640|536747426|FG000|Overall Study|Other, not specified|1|||
148800149|NCT03311945|536747427|FG000|Overall Study|Adverse Event|2|||
148800150|NCT03311945|536747427|FG000|Overall Study|Lack of Efficacy|1|||
148800151|NCT01619878|536747428|FG000|6 Week Follow-up Phase|Adverse Event|1|||
148800152|NCT01619878|536747428|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
148800153|NCT01619878|536747428|FG000|Follow-up at 12 Months of Age|Death|2|||
148800154|NCT01305564|536747431|FG000|Overall Study|Death|21|||
148800155|NCT01305564|536747431|FG000|Overall Study|Lost to Follow-up|12|||
148800156|NCT01305564|536747431|FG000|Overall Study|Withdrawal by Subject|1|||
148800157|NCT01305564|536747431|FG000|Overall Study|Physician Decision|3|||
148800158|NCT02322749|536747432|FG000|Period 2|Adverse Event|0|||
148800159|NCT02322749|536747433|FG001|Period 2|Adverse Event|0|||
148800160|NCT02322749|536747434|FG002|Period 2|Adverse Event|0|||
148800161|NCT02322749|536747435|FG003|Period 2|Adverse Event|1|||
148800162|NCT02322749|536747436|FG004|Period 2|Adverse Event|0|||
148800163|NCT02322749|536747437|FG005|Period 2|Adverse Event|0|||
148800164|NCT02322749|536747432|FG000|Period 2|Withdrawal by Subject|0|||
148800165|NCT02322749|536747433|FG001|Period 2|Withdrawal by Subject|0|||
148800166|NCT02322749|536747434|FG002|Period 2|Withdrawal by Subject|0|||
148800167|NCT02322749|536747435|FG003|Period 2|Withdrawal by Subject|1|||
148800168|NCT02322749|536747436|FG004|Period 2|Withdrawal by Subject|0|||
148800169|NCT02322749|536747437|FG005|Period 2|Withdrawal by Subject|0|||
148800170|NCT02322749|536747432|FG000|Period 3|Withdrawal by Subject|0|||
148800171|NCT02322749|536747433|FG001|Period 3|Withdrawal by Subject|0|||
148800172|NCT02322749|536747434|FG002|Period 3|Withdrawal by Subject|1|||
148800173|NCT02322749|536747435|FG003|Period 3|Withdrawal by Subject|0|||
148800174|NCT02322749|536747436|FG004|Period 3|Withdrawal by Subject|0|||
148800175|NCT02322749|536747437|FG005|Period 3|Withdrawal by Subject|0|||
149011493|NCT00612534|537521482|FG001|Overall Study|Other Reason|1|||
148800176|NCT00073918|536747442|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
148800177|NCT00073918|536747442|FG000|Overall Study|Rapid disease progression|2|||
148800178|NCT00073918|536747442|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
148800179|NCT01190813|536747445|FG000|Overall Study|Lost to Follow-up|1|||
148800180|NCT01190813|536747446|FG001|Overall Study|Lost to Follow-up|2|||
148800181|NCT01190813|536747445|FG000|Overall Study|Withdrawal by Subject|2|||
148800182|NCT01190813|536747446|FG001|Overall Study|Withdrawal by Subject|1|||
148800183|NCT01190813|536747445|FG000|Overall Study|Refused study treatment after randomized|1|||
148800184|NCT01190813|536747446|FG001|Overall Study|Refused study treatment after randomized|0|||
149137860|NCT00763971|537986841|FG002|Overall Study|Exclusion criteria met|0|||
149137861|NCT00763971|537986839|FG000|Overall Study|Sponsor decision|1|||
149137862|NCT00763971|537986840|FG001|Overall Study|Sponsor decision|0|||
149137863|NCT00763971|537986841|FG002|Overall Study|Sponsor decision|0|||
149137864|NCT00763971|537986839|FG000|Overall Study|Due to holiday season|2|||
149137865|NCT00763971|537986840|FG001|Overall Study|Due to holiday season|0|||
149137866|NCT00763971|537986841|FG002|Overall Study|Due to holiday season|1|||
149137867|NCT00763971|537986839|FG000|Overall Study|Randomization error|0|||
149137868|NCT00763971|537986840|FG001|Overall Study|Randomization error|0|||
149137869|NCT00763971|537986841|FG002|Overall Study|Randomization error|1|||
149137870|NCT00763971|537986839|FG000|Overall Study|Medical monitor decision|0|||
149137871|NCT00763971|537986840|FG001|Overall Study|Medical monitor decision|0|||
149137872|NCT00763971|537986841|FG002|Overall Study|Medical monitor decision|1|||
149137873|NCT00763971|537986839|FG000|Overall Study|Moved to another country|0|||
149137874|NCT00763971|537986840|FG001|Overall Study|Moved to another country|1|||
149137875|NCT00763971|537986841|FG002|Overall Study|Moved to another country|0|||
149137876|NCT00763971|537986839|FG000|Overall Study|Subject wanted dose reduction|0|||
149137877|NCT00763971|537986840|FG001|Overall Study|Subject wanted dose reduction|1|||
149137878|NCT00763971|537986841|FG002|Overall Study|Subject wanted dose reduction|0|||
149137879|NCT00763971|537986839|FG000|Overall Study|Lack of availability|0|||
149137880|NCT00763971|537986840|FG001|Overall Study|Lack of availability|1|||
148800185|NCT01190813|536747445|FG000|Overall Study|Adverse Event|0|||
148800186|NCT01190813|536747446|FG001|Overall Study|Adverse Event|1|||
148800187|NCT02033759|536747447|FG000|Overall Study|Withdrawal by Subject|2|||
148800188|NCT02033759|536747448|FG001|Overall Study|Withdrawal by Subject|1|||
148800189|NCT02033759|536747447|FG000|Overall Study|Protocol Violation|1|||
148800190|NCT02033759|536747448|FG001|Overall Study|Protocol Violation|1|||
148800191|NCT00807365|536747453|FG000|Overall Study|Study Terminated|5|||
148800192|NCT04821830|536747456|FG000|Overall Study|Withdrawal by Subject|1|||
148800193|NCT04821830|536747457|FG001|Overall Study|Withdrawal by Subject|0|||
148800194|NCT00919633|536747459|FG000|Overall Study|Adverse Event|1|||
148800195|NCT00919633|536747460|FG001|Overall Study|Adverse Event|9|||
148800196|NCT00919633|536747461|FG002|Overall Study|Adverse Event|12|||
148800197|NCT00919633|536747462|FG003|Overall Study|Adverse Event|10|||
148800198|NCT00919633|536747459|FG000|Overall Study|Death|0|||
148800199|NCT00919633|536747460|FG001|Overall Study|Death|0|||
148800200|NCT00919633|536747461|FG002|Overall Study|Death|2|||
148800201|NCT00919633|536747462|FG003|Overall Study|Death|0|||
148800202|NCT00919633|536747459|FG000|Overall Study|Lack of Efficacy|17|||
148800203|NCT00919633|536747460|FG001|Overall Study|Lack of Efficacy|3|||
148800204|NCT00919633|536747461|FG002|Overall Study|Lack of Efficacy|2|||
148800205|NCT00919633|536747462|FG003|Overall Study|Lack of Efficacy|3|||
148800206|NCT00919633|536747459|FG000|Overall Study|Withdrawal by Subject|1|||
149137881|NCT00763971|537986841|FG002|Overall Study|Lack of availability|0|||
149137882|NCT00763971|537986839|FG000|Overall Study|Performed final visit on phone|0|||
149137883|NCT00763971|537986840|FG001|Overall Study|Performed final visit on phone|1|||
148800207|NCT00919633|536747460|FG001|Overall Study|Withdrawal by Subject|2|||
148800208|NCT00919633|536747461|FG002|Overall Study|Withdrawal by Subject|4|||
148800209|NCT00919633|536747462|FG003|Overall Study|Withdrawal by Subject|3|||
148800210|NCT00919633|536747459|FG000|Overall Study|Lost to Follow-up|3|||
148800211|NCT00919633|536747460|FG001|Overall Study|Lost to Follow-up|1|||
148901269|NCT00391586|537121908|FG000|Overall Study|Physician Decision|2|||
148901270|NCT00391586|537121908|FG000|Overall Study|Death|4|||
148901271|NCT00198822|537121909|FG000|Overall Study|Lost to Follow-up|14|||
148901272|NCT00198822|537121910|FG001|Overall Study|Lost to Follow-up|20|||
148901273|NCT00198822|537121911|FG002|Overall Study|Lost to Follow-up|21|||
148901274|NCT00283296|537121917|FG000|Overall Study|in-home trial not completed|5|||
148901275|NCT01353898|537121918|FG000|Overall Study|Study site terminated|0|||
148901276|NCT01353898|537121919|FG001|Overall Study|Study site terminated|0|||
148901277|NCT01353898|537121920|FG002|Overall Study|Study site terminated|0|||
148901278|NCT01353898|537121921|FG003|Overall Study|Study site terminated|0|||
148901279|NCT01353898|537121922|FG004|Overall Study|Study site terminated|0|||
148901280|NCT01353898|537121923|FG005|Overall Study|Study site terminated|1|||
148901281|NCT02668653|537121924|FG000|Overall Study|Refractory disease|41|||
148901282|NCT02668653|537121925|FG001|Overall Study|Refractory disease|70|||
148901283|NCT02668653|537121924|FG000|Overall Study|Relapse|44|||
148901284|NCT02668653|537121925|FG001|Overall Study|Relapse|65|||
148901285|NCT02668653|537121924|FG000|Overall Study|Adverse Event|58|||
148901286|NCT02668653|537121925|FG001|Overall Study|Adverse Event|23|||
148901287|NCT02668653|537121924|FG000|Overall Study|Subject decision to stop study drug|25|||
148901288|NCT02668653|537121925|FG001|Overall Study|Subject decision to stop study drug|23|||
148901289|NCT02668653|537121924|FG000|Overall Study|Other reasons not specified|16|||
148901290|NCT02668653|537121925|FG001|Overall Study|Other reasons not specified|11|||
148901291|NCT02668653|537121924|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
148901292|NCT02668653|537121925|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
148901293|NCT02668653|537121924|FG000|Overall Study|Investigator decision|10|||
148901294|NCT02668653|537121925|FG001|Overall Study|Investigator decision|7|||
148901295|NCT02668653|537121924|FG000|Overall Study|Failure to meet continuation criteria|5|||
148800212|NCT00919633|536747461|FG002|Overall Study|Lost to Follow-up|0|||
148800213|NCT00919633|536747462|FG003|Overall Study|Lost to Follow-up|2|||
148800214|NCT00919633|536747459|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
148800215|NCT00919633|536747460|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
148800216|NCT00919633|536747461|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
148800217|NCT00919633|536747462|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
148800218|NCT00919633|536747459|FG000|Overall Study|Protocol Violation|0|||
149011494|NCT00612534|537521483|FG002|Overall Study|Other Reason|0|||
149137884|NCT00763971|537986841|FG002|Overall Study|Performed final visit on phone|0|||
149137885|NCT00763971|537986839|FG000|Overall Study|Participation in 489-326 required|1|||
149137886|NCT00763971|537986840|FG001|Overall Study|Participation in 489-326 required|0|||
149137887|NCT00763971|537986841|FG002|Overall Study|Participation in 489-326 required|0|||
149137888|NCT03383289|537986844|FG000|Overall Study|Death|83|||
149137889|NCT03383289|537986845|FG001|Overall Study|Death|78|||
149137890|NCT03383289|537986844|FG000|Overall Study|discharge from facility|84|||
149137891|NCT03383289|537986845|FG001|Overall Study|discharge from facility|84|||
149137892|NCT03383289|537986844|FG000|Overall Study|Withdrawal by Subject|4|||
149137893|NCT03383289|537986845|FG001|Overall Study|Withdrawal by Subject|1|||
149137894|NCT00884325|537986846|FG000|Overall Study|Lost to Follow-up|1|||
149137895|NCT00884325|537986847|FG001|Overall Study|Lost to Follow-up|2|||
149137896|NCT00884325|537986846|FG000|Overall Study|Lack of Efficacy|0|||
149137897|NCT00884325|537986847|FG001|Overall Study|Lack of Efficacy|1|||
149137898|NCT00884325|537986846|FG000|Overall Study|Withdrawal by Subject|1|||
149137899|NCT00884325|537986847|FG001|Overall Study|Withdrawal by Subject|1|||
149137900|NCT00884325|537986846|FG000|Overall Study|Not provided|1|||
149137901|NCT00884325|537986847|FG001|Overall Study|Not provided|0|||
149137902|NCT00832117|537986848|FG000|Overall Study|Death|1|||
149137903|NCT00832117|537986848|FG000|Overall Study|Disease Progression|11|||
149137904|NCT04439071|537986849|FG000|Overall Study|Lost to Follow-up|0|||
149137905|NCT04439071|537986850|FG001|Overall Study|Lost to Follow-up|3|||
149137906|NCT04439071|537986849|FG000|Overall Study|Withdrawal by Subject|3|||
149137907|NCT04439071|537986850|FG001|Overall Study|Withdrawal by Subject|8|||
149137908|NCT04439071|537986849|FG000|Overall Study|Death|6|||
149137909|NCT04439071|537986850|FG001|Overall Study|Death|4|||
149137910|NCT04439071|537986849|FG000|Overall Study|Other than specified|3|||
149137911|NCT04439071|537986850|FG001|Overall Study|Other than specified|3|||
149137912|NCT04439071|537986849|FG000|Overall Study|Randomized but not treated|2|||
149137913|NCT04439071|537986850|FG001|Overall Study|Randomized but not treated|0|||
149137914|NCT01186939|537986851|FG000|Overall Study|Death|7|||
149137915|NCT01186939|537986851|FG000|Overall Study|Withdrawal by Subject|2|||
149137916|NCT01186939|537986851|FG000|Overall Study|No longer receiving clinical benefit|17|||
149137917|NCT01186939|537986851|FG000|Overall Study|Program closed|5|||
149137918|NCT01186939|537986851|FG000|Overall Study|Sponsor decision|4|||
149137919|NCT01186939|537986851|FG000|Overall Study|Started additional treatment|1|||
149137920|NCT01186939|537986851|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
149137921|NCT01186939|537986851|FG000|Overall Study|Myocardial infarction|1|||
149137922|NCT01186939|537986851|FG000|Overall Study|Bone marrow transplant|1|||
149137923|NCT01186939|537986851|FG000|Overall Study|Transformation to AML|1|||
149137924|NCT02606461|537986852|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
149137925|NCT02606461|537986853|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
149137926|NCT02606461|537986854|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
149137927|NCT02606461|537986855|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
149137928|NCT02606461|537986856|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
149137929|NCT02606461|537986857|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
149137930|NCT03740997|537986861|FG000|Overall Study|Withdrawal by Subject|1|||
149137931|NCT03740997|537986862|FG001|Overall Study|Withdrawal by Subject|0|||
149137932|NCT03740997|537986861|FG000|Overall Study|Participant was unable to complete study procedures|1|||
149137933|NCT03740997|537986862|FG001|Overall Study|Participant was unable to complete study procedures|0|||
149137934|NCT03681951|537986866|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
149137935|NCT03681951|537986867|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137936|NCT03681951|537986868|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137937|NCT03681951|537986869|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137938|NCT03681951|537986870|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137939|NCT03681951|537986871|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137940|NCT03681951|537986872|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137941|NCT03681951|537986873|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
149137942|NCT03681951|537986866|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
149137943|NCT03681951|537986867|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
149137944|NCT03681951|537986868|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
149137945|NCT03681951|537986869|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
149137946|NCT03681951|537986870|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
149137947|NCT03681951|537986871|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
148800219|NCT00919633|536747460|FG001|Overall Study|Protocol Violation|0|||
148800220|NCT00919633|536747461|FG002|Overall Study|Protocol Violation|0|||
148800221|NCT00919633|536747462|FG003|Overall Study|Protocol Violation|1|||
148800222|NCT00919633|536747459|FG000|Overall Study|Physician Decision|0|||
148800223|NCT00919633|536747460|FG001|Overall Study|Physician Decision|0|||
148800224|NCT00919633|536747461|FG002|Overall Study|Physician Decision|0|||
148800225|NCT00919633|536747462|FG003|Overall Study|Physician Decision|1|||
148800226|NCT00919633|536747459|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
148800227|NCT00919633|536747460|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
148800228|NCT00919633|536747461|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
148800229|NCT00919633|536747462|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
148800230|NCT00919633|536747459|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
149011495|NCT00612534|537521484|FG003|Overall Study|Other Reason|0|||
148800231|NCT00919633|536747460|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
148800232|NCT00919633|536747461|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
148800233|NCT00919633|536747462|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
148800234|NCT01526785|536747463|FG000|Overall Study|Study Terminated by Sponsor|8|||
148800235|NCT01526785|536747463|FG000|Overall Study|Death|2|||
148800236|NCT01526785|536747463|FG000|Overall Study|Physician Decision|1|||
148800237|NCT01526785|536747463|FG000|Overall Study|Withdrawal by Subject|2|||
148800238|NCT00960804|536747466|FG000|Overall Study|Adverse Event|1|||
148800239|NCT00960804|536747467|FG001|Overall Study|Adverse Event|0|||
148800240|NCT00960804|536747468|FG002|Overall Study|Adverse Event|0|||
148800241|NCT00960804|536747466|FG000|Overall Study|Withdrawal by Subject|1|||
148800242|NCT00960804|536747467|FG001|Overall Study|Withdrawal by Subject|0|||
148800243|NCT00960804|536747468|FG002|Overall Study|Withdrawal by Subject|0|||
148800244|NCT00960804|536747466|FG000|Overall Study|Study terminated by the sponsor|5|||
148800245|NCT00960804|536747467|FG001|Overall Study|Study terminated by the sponsor|4|||
148800246|NCT00960804|536747468|FG002|Overall Study|Study terminated by the sponsor|10|||
148800247|NCT01121263|536747469|FG000|Overall Study|Death|3|||
148800248|NCT01121263|536747470|FG001|Overall Study|Death|2|||
148800249|NCT01121263|536747469|FG000|Overall Study|Lost to Follow-up|22|||
148800250|NCT01121263|536747470|FG001|Overall Study|Lost to Follow-up|12|||
148800251|NCT01121263|536747469|FG000|Overall Study|Withdrawal by Subject|0|||
148800252|NCT01121263|536747470|FG001|Overall Study|Withdrawal by Subject|1|||
148800253|NCT03810456|536747472|FG000|Treatment|Urgent Family Matters|3|||
148800254|NCT03810456|536747473|FG001|Treatment|Urgent Family Matters|0|||
148800255|NCT03810456|536747474|FG002|Treatment|Urgent Family Matters|0|||
148800256|NCT03810456|536747472|FG000|Treatment|Scheduling Conflicts|0|||
148800257|NCT03810456|536747473|FG001|Treatment|Scheduling Conflicts|11|||
148800258|NCT03810456|536747474|FG002|Treatment|Scheduling Conflicts|0|||
148800259|NCT03810456|536747472|FG000|Treatment|No Longer Interested|0|||
148800260|NCT03810456|536747473|FG001|Treatment|No Longer Interested|12|||
148800261|NCT03810456|536747474|FG002|Treatment|No Longer Interested|0|||
148800262|NCT03810456|536747472|FG000|Treatment|Transportation Issues|0|||
148800263|NCT03810456|536747473|FG001|Treatment|Transportation Issues|1|||
148800264|NCT03810456|536747474|FG002|Treatment|Transportation Issues|0|||
148800265|NCT03810456|536747472|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
148800266|NCT03810456|536747473|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
148800267|NCT03810456|536747474|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
148901296|NCT02668653|537121925|FG001|Overall Study|Failure to meet continuation criteria|12|||
148901297|NCT02668653|537121924|FG000|Overall Study|Lost to Follow-up|1|||
148901298|NCT02668653|537121925|FG001|Overall Study|Lost to Follow-up|0|||
148901299|NCT02668653|537121924|FG000|Overall Study|Pregnancy|0|||
148901300|NCT02668653|537121925|FG001|Overall Study|Pregnancy|1|||
148901301|NCT02668653|537121924|FG000|Overall Study|Death|0|||
148901302|NCT02668653|537121925|FG001|Overall Study|Death|1|||
148901303|NCT03558737|537121926|FG000|Overall Study|Death|1|||
148901304|NCT03558737|537121927|FG001|Overall Study|Death|1|||
148901305|NCT01294553|537121928|FG000|Overall Study|Duplicated Participants|1|||
148901306|NCT01294553|537121928|FG000|Overall Study|Protocol Violation|268|||
148901307|NCT00453206|537121930|FG000|Overall Study|Death|1|||
148901308|NCT00577889|537121931|FG000|Overall Study|Withdrawal by Subject|1|||
148901309|NCT00577889|537121932|FG001|Overall Study|Withdrawal by Subject|0|||
148901310|NCT00577889|537121933|FG002|Overall Study|Withdrawal by Subject|0|||
148901311|NCT03041181|537121934|FG000|Overall Study|Disease Progression|1|||
148901312|NCT03041181|537121935|FG001|Overall Study|Disease Progression|2|||
148901313|NCT00005780|537121938|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
148901314|NCT04973449|537121939|FG000|Overall Study|Withdrawal by Subject|3|||
148901315|NCT04973449|537121940|FG001|Overall Study|Withdrawal by Subject|3|||
148901316|NCT04973449|537121941|FG002|Overall Study|Withdrawal by Subject|2|||
148901317|NCT04973449|537121942|FG003|Overall Study|Withdrawal by Subject|5|||
148901318|NCT04973449|537121943|FG004|Overall Study|Withdrawal by Subject|5|||
148901319|NCT04973449|537121944|FG005|Overall Study|Withdrawal by Subject|4|||
148901320|NCT04973449|537121945|FG006|Overall Study|Withdrawal by Subject|7|||
148901321|NCT04973449|537121946|FG007|Overall Study|Withdrawal by Subject|5|||
148901322|NCT04973449|537121939|FG000|Overall Study|Lost to Follow-up|15|||
149137948|NCT03681951|537986872|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
149137949|NCT03681951|537986873|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
149137950|NCT03681951|537986866|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
149137951|NCT03681951|537986867|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
149137952|NCT03681951|537986868|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
149137953|NCT03681951|537986869|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
149137954|NCT03681951|537986870|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
149137955|NCT03681951|537986871|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
149137956|NCT03681951|537986872|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
148800268|NCT03810456|536747472|FG000|1 Month Follow-Up|Relocated to Different State|1|||
148800269|NCT03810456|536747473|FG001|1 Month Follow-Up|Relocated to Different State|0|||
148800270|NCT03810456|536747474|FG002|1 Month Follow-Up|Relocated to Different State|1|||
148800271|NCT03810456|536747472|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
149137957|NCT03681951|537986873|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
149137958|NCT02187809|537986874|FG000|Overall Study|The study was terminated|3|||
149137959|NCT01020448|537986875|FG000|Pre-assignment|Adverse Event|6|||
149137960|NCT01020448|537986875|FG000|Pre-assignment|Withdrawal by Subject|5|||
149137961|NCT01020448|537986875|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
149137962|NCT01020448|537986875|FG000|Treatment|Adverse Event|11|||
149137963|NCT01020448|537986875|FG000|Treatment|Consent Withdrawn|3|||
149137964|NCT01020448|537986875|FG000|Treatment|Disease Progression|2|||
148800272|NCT03810456|536747473|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
148800273|NCT03810456|536747474|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
148800274|NCT03810456|536747472|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
148800275|NCT03810456|536747473|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
148800276|NCT03810456|536747474|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
148800277|NCT03810456|536747472|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
148800278|NCT03810456|536747473|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
148800279|NCT03810456|536747474|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
148800280|NCT03810456|536747472|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
149137965|NCT01020448|537986875|FG000|Treatment|Lack of Efficacy|8|||
149137966|NCT01020448|537986875|FG000|Treatment|Lost to Follow-up|2|||
149137967|NCT01230554|537986876|FG000|Overall Study|Lost to Follow-up|2|||
149137968|NCT01230554|537986876|FG000|Overall Study|Inability to maintain visit schedule|1|||
149137969|NCT01006265|537986879|FG000|Overall Study|Lost to Follow-up|1|||
149137970|NCT01006265|537986880|FG001|Overall Study|Lost to Follow-up|0|||
149137971|NCT01006265|537986881|FG002|Overall Study|Lost to Follow-up|1|||
149137972|NCT01006265|537986882|FG003|Overall Study|Lost to Follow-up|0|||
149137973|NCT01006265|537986879|FG000|Overall Study|Withdrawal by Subject|4|||
148800281|NCT03810456|536747473|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
148800282|NCT03810456|536747474|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
148800283|NCT03810456|536747472|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
148800284|NCT03810456|536747473|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
148800285|NCT03810456|536747474|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
148800286|NCT02100124|536747479|FG000|Overall Study|Lost to Follow-up|5|||
148800287|NCT02100124|536747480|FG001|Overall Study|Lost to Follow-up|11|||
148800288|NCT02100124|536747481|FG002|Overall Study|Lost to Follow-up|3|||
148800289|NCT02100124|536747479|FG000|Overall Study|Withdrawal by Subject|1|||
148800290|NCT02100124|536747480|FG001|Overall Study|Withdrawal by Subject|0|||
148800291|NCT02100124|536747481|FG002|Overall Study|Withdrawal by Subject|0|||
148800292|NCT04350827|536747486|FG000|Overall Study|Lost to Follow-up|1|||
148800293|NCT04350827|536747487|FG001|Overall Study|Lost to Follow-up|2|||
148800294|NCT04265261|536747488|FG000|Overall Study|Adverse Event|2|||
148800295|NCT04265261|536747489|FG001|Overall Study|Adverse Event|0|||
148800296|NCT04265261|536747490|FG002|Overall Study|Adverse Event|0|||
148800297|NCT04265261|536747488|FG000|Overall Study|Death|1|||
148800298|NCT04265261|536747489|FG001|Overall Study|Death|0|||
148800299|NCT04265261|536747490|FG002|Overall Study|Death|0|||
148800300|NCT04265261|536747488|FG000|Overall Study|Lost to Follow-up|4|||
148800301|NCT04265261|536747489|FG001|Overall Study|Lost to Follow-up|1|||
148800302|NCT04265261|536747490|FG002|Overall Study|Lost to Follow-up|3|||
148800303|NCT04265261|536747488|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148800304|NCT04265261|536747489|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148800305|NCT04265261|536747490|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148800306|NCT04265261|536747488|FG000|Overall Study|Physician Decision|0|||
148800307|NCT04265261|536747489|FG001|Overall Study|Physician Decision|0|||
148800308|NCT04265261|536747490|FG002|Overall Study|Physician Decision|1|||
148800309|NCT04265261|536747488|FG000|Overall Study|Protocol Deviation|0|||
148800310|NCT04265261|536747489|FG001|Overall Study|Protocol Deviation|2|||
148800311|NCT04265261|536747490|FG002|Overall Study|Protocol Deviation|0|||
148800312|NCT04265261|536747488|FG000|Overall Study|Withdrawal by Subject|2|||
148800313|NCT04265261|536747489|FG001|Overall Study|Withdrawal by Subject|1|||
148901323|NCT04973449|537121940|FG001|Overall Study|Lost to Follow-up|16|||
148901324|NCT04973449|537121941|FG002|Overall Study|Lost to Follow-up|16|||
148901325|NCT04973449|537121942|FG003|Overall Study|Lost to Follow-up|13|||
148901326|NCT04973449|537121943|FG004|Overall Study|Lost to Follow-up|5|||
148901327|NCT04973449|537121944|FG005|Overall Study|Lost to Follow-up|6|||
148901328|NCT04973449|537121945|FG006|Overall Study|Lost to Follow-up|10|||
148901329|NCT04973449|537121946|FG007|Overall Study|Lost to Follow-up|6|||
148901330|NCT04973449|537121939|FG000|Overall Study|Death|1|||
148901331|NCT04973449|537121940|FG001|Overall Study|Death|0|||
148901332|NCT04973449|537121941|FG002|Overall Study|Death|0|||
148901333|NCT04973449|537121942|FG003|Overall Study|Death|0|||
148901334|NCT04973449|537121943|FG004|Overall Study|Death|0|||
148901335|NCT04973449|537121944|FG005|Overall Study|Death|1|||
148901336|NCT04973449|537121945|FG006|Overall Study|Death|0|||
148901337|NCT04973449|537121946|FG007|Overall Study|Death|0|||
148901338|NCT04973449|537121939|FG000|Overall Study|Other|1|||
148901339|NCT04973449|537121940|FG001|Overall Study|Other|1|||
148901340|NCT04973449|537121941|FG002|Overall Study|Other|2|||
148901341|NCT04973449|537121942|FG003|Overall Study|Other|1|||
148901342|NCT04973449|537121943|FG004|Overall Study|Other|4|||
148901343|NCT04973449|537121944|FG005|Overall Study|Other|0|||
148901344|NCT04973449|537121945|FG006|Overall Study|Other|2|||
148901345|NCT04973449|537121946|FG007|Overall Study|Other|2|||
148901346|NCT01467960|537121947|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
148901347|NCT01467960|537121948|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
148901348|NCT01467960|537121949|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
148901349|NCT01467960|537121950|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
148901350|NCT01467960|537121951|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
148901351|NCT01467960|537121952|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
148901352|NCT00888173|537121953|FG000|Overall Study|Wrong Primary|1|||
149011496|NCT02487095|537521488|FG000|Dose Expansion|Unable to scan/restage participant|0|||
149011497|NCT02487095|537521489|FG001|Dose Expansion|Unable to scan/restage participant|0|||
148901353|NCT00888173|537121953|FG000|Overall Study|Ineligible: required test not done|1|||
148800314|NCT04265261|536747490|FG002|Overall Study|Withdrawal by Subject|4|||
148800315|NCT02997163|536749456|FG000|Overall Study|Adverse Event|1|||
148800316|NCT02997163|536749457|FG001|Overall Study|Adverse Event|0|||
148800317|NCT02997163|536749458|FG002|Overall Study|Adverse Event|0|||
148800318|NCT02997163|536749459|FG003|Overall Study|Adverse Event|1|||
148800319|NCT02812186|536749460|FG000|Period 1|Post randomization screen failure|5|||
148800320|NCT02812186|536749461|FG001|Period 1|Post randomization screen failure|9|||
148800321|NCT02812186|536749460|FG000|Period 1|nonevaluable data sets|6|||
148800322|NCT02812186|536749461|FG001|Period 1|nonevaluable data sets|6|||
148800323|NCT00161213|536749462|FG000|Overall Study|Withdrawal by Subject|1|||
148800324|NCT00161213|536749462|FG000|Overall Study|Evaluable for toxicity but not response|1|||
148800325|NCT03103503|536749463|FG000|Overall Study|Death|64|||
148800326|NCT03103503|536749463|FG000|Overall Study|Physician Decision|57|||
148800327|NCT03103503|536749463|FG000|Overall Study|Withdrawal by Subject|10|||
148800328|NCT03103503|536749463|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
148800329|NCT03103503|536749463|FG000|Overall Study|Lost to Follow-up|3|||
148800330|NCT03103503|536749463|FG000|Overall Study|Study Closure|757|||
148800331|NCT00301834|536749465|FG000|Overall Study|Death|1|||
148800332|NCT02870868|536749466|FG000|Overall Study|Withdrawal by Subject|2|||
148800333|NCT02870868|536749467|FG001|Overall Study|Withdrawal by Subject|1|||
148800334|NCT00183430|536749468|FG000|Overall Study|Adverse Event|1|||
148800335|NCT00183430|536749469|FG001|Overall Study|Adverse Event|0|||
148800336|NCT00183430|536749468|FG000|Overall Study|Lost to Follow-up|3|||
148800337|NCT00183430|536749469|FG001|Overall Study|Lost to Follow-up|0|||
148800338|NCT00183430|536749468|FG000|Overall Study|did not meet inclusion criteria|1|||
148800339|NCT00183430|536749469|FG001|Overall Study|did not meet inclusion criteria|0|||
148800340|NCT00183430|536749468|FG000|Overall Study|Withdrawal by Subject|1|||
148800341|NCT00183430|536749469|FG001|Overall Study|Withdrawal by Subject|0|||
148800342|NCT00883181|536749472|FG000|Overall Study|Hematological Adverse Event|26|||
148800343|NCT00883181|536749472|FG000|Overall Study|Non-hematological Adverse Event|55|||
148800344|NCT00883181|536749472|FG000|Overall Study|Disease Progression|94|||
148800345|NCT00883181|536749472|FG000|Overall Study|Administrative Reason|24|||
148800346|NCT00883181|536749472|FG000|Overall Study|Withdrawal by Subject|4|||
148800347|NCT00883181|536749472|FG000|Overall Study|Death|31|||
148800348|NCT00883181|536749472|FG000|Overall Study|Other|38|||
148800349|NCT00883181|536749472|FG000|Overall Study|Protocol Deviation|3|||
148800350|NCT00883181|536749472|FG000|Overall Study|Noncompliance|3|||
148800351|NCT04040439|536749473|FG000|Overall Study|Invalid registration|11|||
148800352|NCT04040439|536749473|FG000|Overall Study|No IC* on publication of study results|2|||
148800353|NCT01248455|536749476|FG000|Overall Study|switched to alternate treatment|1|||
148800354|NCT00426270|536749477|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
148800355|NCT00426270|536749477|FG000|Overall Study|Adverse Event|5|||
148800356|NCT01309386|536749478|FG000|Overall Study|Other|2|||
148800357|NCT01309386|536749479|FG001|Overall Study|Other|0|||
148800358|NCT01309386|536749478|FG000|Overall Study|Withdrawal by Subject|2|||
148800359|NCT01309386|536749479|FG001|Overall Study|Withdrawal by Subject|0|||
148800360|NCT01309386|536749478|FG000|Overall Study|Progressive disease|9|||
148800361|NCT01309386|536749479|FG001|Overall Study|Progressive disease|11|||
148800362|NCT01309386|536749478|FG000|Overall Study|Physician Decision|1|||
148800363|NCT01309386|536749479|FG001|Overall Study|Physician Decision|1|||
148800364|NCT01309386|536749478|FG000|Overall Study|Lack of Efficacy|3|||
148800365|NCT01309386|536749479|FG001|Overall Study|Lack of Efficacy|1|||
148800366|NCT01309386|536749478|FG000|Overall Study|Adverse Event|5|||
148800367|NCT01309386|536749479|FG001|Overall Study|Adverse Event|8|||
148800368|NCT00723229|536749480|FG000|First Intervention|Lost to Follow-up|7|||
148800369|NCT00723229|536749481|FG001|First Intervention|Lost to Follow-up|3|||
148800370|NCT01674725|536749482|FG000|Overall Study|Adverse Event|1|||
148800371|NCT01674725|536749483|FG001|Overall Study|Adverse Event|0|||
148800372|NCT01674725|536749482|FG000|Overall Study|Did not receive study drug|1|||
148800373|NCT01674725|536749483|FG001|Overall Study|Did not receive study drug|0|||
148800374|NCT01674725|536749482|FG000|Overall Study|Withdrawal by Subject|1|||
148800375|NCT01674725|536749483|FG001|Overall Study|Withdrawal by Subject|0|||
148800376|NCT01674725|536749482|FG000|Overall Study|Lost to Follow-up|0|||
148800377|NCT01674725|536749483|FG001|Overall Study|Lost to Follow-up|1|||
148800378|NCT02089347|536749484|FG000|Overall Study|Protocol Violation|1|||
148800379|NCT02089347|536749485|FG001|Overall Study|Protocol Violation|0|||
148800380|NCT00001566|536749486|FG000|Overall Study|patients' choice to discontinue protocol|3|||
148800381|NCT00001566|536749486|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
148800382|NCT00001566|536749486|FG000|Overall Study|Death|13|||
148800383|NCT00001566|536749486|FG000|Overall Study|Lost to Follow-up|1|||
148800384|NCT00001566|536749486|FG000|Overall Study|unable to complete initial apheresis|1|||
148800385|NCT03439137|536749491|FG000|Overall Study|Adverse Event|16|||
148800386|NCT03439137|536749492|FG001|Overall Study|Adverse Event|12|||
148800387|NCT03439137|536749491|FG000|Overall Study|Physician Decision|0|||
148800388|NCT03439137|536749492|FG001|Overall Study|Physician Decision|5|||
148800389|NCT03439137|536749491|FG000|Overall Study|Withdrawal by Subject|14|||
148800390|NCT03439137|536749492|FG001|Overall Study|Withdrawal by Subject|4|||
148800391|NCT03439137|536749491|FG000|Overall Study|Conducting rescue therapy|2|||
148800392|NCT03439137|536749492|FG001|Overall Study|Conducting rescue therapy|1|||
148800393|NCT03439137|536749491|FG000|Overall Study|Difficult to control Hb|10|||
148800394|NCT03439137|536749492|FG001|Overall Study|Difficult to control Hb|2|||
148800395|NCT03439137|536749491|FG000|Overall Study|Initiation of a renal transplant|0|||
148800396|NCT03439137|536749492|FG001|Overall Study|Initiation of a renal transplant|2|||
148800397|NCT01225549|536749495|FG000|Period 4 - Washout|Disallowed medication|0|||
148800398|NCT01225549|536749496|FG001|Period 4 - Washout|Disallowed medication|1|||
148800399|NCT01225549|536749497|FG002|Period 4 - Washout|Disallowed medication|0|||
148800400|NCT01225549|536749498|FG003|Period 4 - Washout|Disallowed medication|0|||
148800401|NCT01225549|536749499|FG004|Period 4 - Washout|Disallowed medication|0|||
148800402|NCT01225549|536749500|FG005|Period 4 - Washout|Disallowed medication|0|||
148800403|NCT01225549|536749501|FG006|Period 4 - Washout|Disallowed medication|0|||
148800404|NCT01225549|536749502|FG007|Period 4 - Washout|Disallowed medication|0|||
148800405|NCT01225549|536749503|FG008|Period 4 - Washout|Disallowed medication|0|||
148800406|NCT01225549|536749504|FG009|Period 4 - Washout|Disallowed medication|0|||
148800407|NCT01225549|536749495|FG000|Period 6 - Washout|Disallowed medication|0|||
148800408|NCT01225549|536749496|FG001|Period 6 - Washout|Disallowed medication|0|||
148800409|NCT01225549|536749497|FG002|Period 6 - Washout|Disallowed medication|0|||
148800410|NCT01225549|536749498|FG003|Period 6 - Washout|Disallowed medication|1|||
148800411|NCT01225549|536749499|FG004|Period 6 - Washout|Disallowed medication|0|||
148800412|NCT01225549|536749500|FG005|Period 6 - Washout|Disallowed medication|0|||
148800413|NCT01225549|536749501|FG006|Period 6 - Washout|Disallowed medication|0|||
148800414|NCT01225549|536749502|FG007|Period 6 - Washout|Disallowed medication|0|||
148800415|NCT01225549|536749503|FG008|Period 6 - Washout|Disallowed medication|0|||
148800416|NCT01225549|536749504|FG009|Period 6 - Washout|Disallowed medication|0|||
148800417|NCT00473083|536749507|FG000|Overall Study|Adverse Event|1|||
148800418|NCT00473083|536749508|FG001|Overall Study|Adverse Event|0|||
148800419|NCT00473083|536749509|FG002|Overall Study|Adverse Event|0|||
148800420|NCT02915835|536749510|FG000|Overall Study|Physician Decision|1|||
148800421|NCT02915835|536749511|FG001|Overall Study|Physician Decision|0|||
148800422|NCT02915835|536749510|FG000|Overall Study|Withdrawal by Subject|0|||
148901354|NCT00829426|537121958|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
148901355|NCT00829426|537121959|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
148901356|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
148901357|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
148901358|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
148800423|NCT02915835|536749511|FG001|Overall Study|Withdrawal by Subject|1|||
148800424|NCT01184872|536749512|FG000|Overall Study|Adverse Event|3|||
148800425|NCT01184872|536749513|FG001|Overall Study|Adverse Event|4|||
148800426|NCT01184872|536749512|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
148800427|NCT01184872|536749513|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148800428|NCT01184872|536749512|FG000|Overall Study|Withdrawal by Subject|2|||
148800429|NCT01184872|536749513|FG001|Overall Study|Withdrawal by Subject|0|||
148800430|NCT01184872|536749512|FG000|Overall Study|Lost to Follow-up|0|||
148800431|NCT01184872|536749513|FG001|Overall Study|Lost to Follow-up|1|||
148800432|NCT01184872|536749512|FG000|Overall Study|Administrative problems|1|||
148800433|NCT01184872|536749513|FG001|Overall Study|Administrative problems|1|||
148800434|NCT01184872|536749512|FG000|Overall Study|Protocol deviation|1|||
148800435|NCT01184872|536749513|FG001|Overall Study|Protocol deviation|0|||
148800436|NCT03426345|536749514|FG000|Overall Study|Adverse Event|4|||
148800437|NCT03426345|536749515|FG001|Overall Study|Adverse Event|4|||
148800438|NCT03426345|536749514|FG000|Overall Study|Lack of Efficacy|1|||
148800439|NCT03426345|536749515|FG001|Overall Study|Lack of Efficacy|0|||
148800440|NCT03426345|536749514|FG000|Overall Study|Withdrawal by Subject|5|||
148800441|NCT03426345|536749515|FG001|Overall Study|Withdrawal by Subject|6|||
148800442|NCT03426345|536749514|FG000|Overall Study|Lost to Follow-up|3|||
148800443|NCT03426345|536749515|FG001|Overall Study|Lost to Follow-up|1|||
148800444|NCT03426345|536749514|FG000|Overall Study|Protocol Deviation|3|||
148800445|NCT03426345|536749515|FG001|Overall Study|Protocol Deviation|4|||
148800446|NCT03426345|536749514|FG000|Overall Study|Reason Not Specified|1|||
148800447|NCT03426345|536749515|FG001|Overall Study|Reason Not Specified|2|||
148800448|NCT03426345|536749514|FG000|Overall Study|Missing Completion Status|1|||
148800449|NCT03426345|536749515|FG001|Overall Study|Missing Completion Status|0|||
148800450|NCT02446691|536749516|FG000|Overall Study|Withdrawal by Subject|2|||
148800451|NCT02446691|536749516|FG000|Overall Study|Lost to Follow-up|8|||
148800452|NCT02446691|536749516|FG000|Overall Study|Protocol Violation|1|||
148800453|NCT04210986|536749517|FG000|Overall Study|Lost to Follow-up|5|||
148800454|NCT04210986|536749518|FG001|Overall Study|Lost to Follow-up|2|||
148800455|NCT04210986|536749517|FG000|Overall Study|Withdrawal by Subject|3|||
148800456|NCT04210986|536749518|FG001|Overall Study|Withdrawal by Subject|1|||
148800457|NCT04210986|536749517|FG000|Overall Study|Protocol Violation|1|||
148800458|NCT04210986|536749518|FG001|Overall Study|Protocol Violation|1|||
148800459|NCT04210986|536749517|FG000|Overall Study|Physician Decision|0|||
148800460|NCT04210986|536749518|FG001|Overall Study|Physician Decision|1|||
148800461|NCT02378662|536749519|FG000|Overall Study|Early Discontinuation|2|||
148800462|NCT02378662|536749520|FG001|Overall Study|Early Discontinuation|0|||
148800463|NCT01474486|536749528|FG000|Overall Study|Death|2|||
148800464|NCT01474486|536749528|FG000|Overall Study|Withdrawal by Subject|4|||
148800465|NCT01474486|536749528|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
148800466|NCT04219189|536749533|FG000|Overall Study|Withdrawal by Subject|1|||
148800467|NCT04219189|536749534|FG001|Overall Study|Withdrawal by Subject|2|||
148800468|NCT04219189|536749533|FG000|Overall Study|Protocol Violation|0|||
148800469|NCT04219189|536749534|FG001|Overall Study|Protocol Violation|1|||
148800470|NCT04219189|536749533|FG000|Overall Study|Lost to Follow-up|0|||
148800471|NCT04219189|536749534|FG001|Overall Study|Lost to Follow-up|1|||
148800472|NCT04219189|536749533|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
148800473|NCT04219189|536749534|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
148800474|NCT03863353|536749535|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
148800475|NCT03863353|536749536|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
148800476|NCT04079790|536749537|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
148800477|NCT04079790|536749538|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
148800478|NCT04079790|536749539|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
148800479|NCT04079790|536749540|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
148800480|NCT04079790|536749537|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
148800481|NCT04079790|536749538|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
148800482|NCT04079790|536749539|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
148800483|NCT04079790|536749540|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
148800484|NCT04079790|536749537|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
148800485|NCT04079790|536749538|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
148800486|NCT04079790|536749539|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
148800487|NCT04079790|536749540|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
148800488|NCT05817669|536749541|FG000|Overall Study|Prohibited medication used|1|||
148800489|NCT05817669|536749542|FG001|Overall Study|Prohibited medication used|2|||
148800490|NCT05817669|536749541|FG000|Overall Study|Adverse Event|1|||
148901359|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
148901360|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Adverse Event|2|||
148901361|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Adverse Event|5|||
148901362|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Adverse Event|1|||
148901363|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Adverse Event|2|||
148901364|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Death|13|||
148901365|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Death|17|||
148901366|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Death|1|||
148901367|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Death|0|||
148901368|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
148901369|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
148901370|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
148901371|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
148901372|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Disease Progression|2|||
148901373|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Disease Progression|0|||
148901374|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Disease Progression|0|||
148901375|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Disease Progression|0|||
148901376|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
148901377|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
148901378|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
148901379|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
148901380|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
148901381|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
148901382|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
148901383|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
148901384|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
148901385|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
148901386|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
148901387|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
148901388|NCT03955146|537121960|FG000|DB Period (48 Weeks)|Participant Decision|9|||
148901389|NCT03955146|537121961|FG001|DB Period (48 Weeks)|Participant Decision|12|||
148901390|NCT03955146|537121962|FG002|DB Period (48 Weeks)|Participant Decision|1|||
148901391|NCT03955146|537121963|FG003|DB Period (48 Weeks)|Participant Decision|1|||
148901392|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
148901393|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
148901394|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
148901395|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
148901396|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
148901397|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
148901398|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
148901399|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
148901400|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
148901401|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
148901402|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
148901403|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
148901404|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
148901405|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
148901406|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
148901407|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
148901408|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
148901409|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
148901410|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
148901411|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
148901412|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
148901413|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
148901414|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
148901415|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
148901416|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
148800491|NCT05817669|536749542|FG001|Overall Study|Adverse Event|0|||
148800492|NCT05817669|536749541|FG000|Overall Study|Withdrawal by Subject|1|||
148800493|NCT05817669|536749542|FG001|Overall Study|Withdrawal by Subject|2|||
148800494|NCT00323063|536749544|FG000|Overall Study|Adverse Event|1|||
148800495|NCT00323063|536749545|FG001|Overall Study|Adverse Event|0|||
148800496|NCT00323063|536749544|FG000|Overall Study|brain mets discovered prior to treatment|1|||
148800497|NCT00323063|536749545|FG001|Overall Study|brain mets discovered prior to treatment|0|||
148901417|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
148800498|NCT03055936|536749546|FG000|Overall Study|Adverse Event|0|||
148800499|NCT03055936|536749547|FG001|Overall Study|Adverse Event|1|||
148901418|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
148800500|NCT03055936|536749548|FG002|Overall Study|Adverse Event|1|||
148800501|NCT03055936|536749549|FG003|Overall Study|Adverse Event|1|||
148800502|NCT03055936|536749546|FG000|Overall Study|Personal reason|2|||
148800503|NCT03055936|536749547|FG001|Overall Study|Personal reason|0|||
148800504|NCT03055936|536749548|FG002|Overall Study|Personal reason|1|||
148800505|NCT03055936|536749549|FG003|Overall Study|Personal reason|0|||
148800506|NCT04613518|536749553|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
148800507|NCT04613518|536749554|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
148800508|NCT04613518|536749555|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
148800509|NCT04613518|536749553|FG000|Double-Blind Treatment Period|Adverse Event|2|||
148800510|NCT04613518|536749554|FG001|Double-Blind Treatment Period|Adverse Event|0|||
148800511|NCT04613518|536749555|FG002|Double-Blind Treatment Period|Adverse Event|1|||
148800512|NCT04613518|536749553|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
148800513|NCT04613518|536749554|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
148800514|NCT04613518|536749555|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
148800515|NCT04613518|536749553|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
148800516|NCT04613518|536749554|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
148800517|NCT04613518|536749555|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
148800518|NCT04613518|536749553|FG000|Double-Blind Treatment Period|Other Reasons|2|||
148800519|NCT04613518|536749554|FG001|Double-Blind Treatment Period|Other Reasons|0|||
148800520|NCT04613518|536749555|FG002|Double-Blind Treatment Period|Other Reasons|0|||
148800521|NCT04613518|536749553|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
148800522|NCT04613518|536749554|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
148800523|NCT04613518|536749555|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
148800524|NCT04613518|536749553|FG000|Open-Label Treatment Period|Adverse Event|1|||
148800525|NCT04613518|536749554|FG001|Open-Label Treatment Period|Adverse Event|0|||
148800526|NCT04613518|536749555|FG002|Open-Label Treatment Period|Adverse Event|3|||
148800527|NCT04613518|536749553|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
148800528|NCT04613518|536749554|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
148800529|NCT04613518|536749555|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
148800530|NCT04613518|536749553|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
148800531|NCT04613518|536749554|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
148800532|NCT04613518|536749555|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
148800533|NCT04613518|536749553|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
148800534|NCT04613518|536749554|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
148800535|NCT04613518|536749555|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
148800536|NCT04613518|536749553|FG000|Open-Label Treatment Period|Other reasons|1|||
148800537|NCT04613518|536749554|FG001|Open-Label Treatment Period|Other reasons|0|||
148800538|NCT04613518|536749555|FG002|Open-Label Treatment Period|Other reasons|0|||
148800539|NCT05222880|536749557|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
148800540|NCT05222880|536749557|FG000|Overall Study|Withdrew Consent during Study|1|||
148800541|NCT05222880|536749557|FG000|Overall Study|COVID-19 Related|1|||
148800542|NCT01077323|536749560|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
148800543|NCT01077323|536749561|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
148800544|NCT01077323|536749562|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
148800545|NCT01077323|536749560|FG000|Overall Study|Dispensing of drug in baseline period|0|||
148800546|NCT01077323|536749561|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
148800547|NCT01077323|536749562|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
148800548|NCT01077323|536749560|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
148800549|NCT01077323|536749561|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
148800550|NCT01077323|536749562|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
148800551|NCT02984982|536749565|FG000|Overall Study|Adverse Event|2|||
148800552|NCT02984982|536749566|FG001|Overall Study|Adverse Event|5|||
148800553|NCT02984982|536749565|FG000|Overall Study|Poor Compliance to Protocol|4|||
148800554|NCT02984982|536749566|FG001|Overall Study|Poor Compliance to Protocol|4|||
148800555|NCT02984982|536749565|FG000|Overall Study|Withdrawal by Subject|2|||
148800556|NCT02984982|536749566|FG001|Overall Study|Withdrawal by Subject|0|||
148800557|NCT02984982|536749565|FG000|Overall Study|Randomized but not treated|0|||
148800558|NCT02984982|536749566|FG001|Overall Study|Randomized but not treated|1|||
148800559|NCT02153918|536749567|FG000|Overall Study|Refused further treatment|1|||
148800560|NCT02144701|536749568|FG000|Overall Study|development of relapse, GVHD or death|9|||
148800561|NCT02144701|536749569|FG001|Overall Study|development of relapse, GVHD or death|3|||
148800562|NCT02616783|536749570|FG000|Overall Study|Randomized but Not Treated|1|||
148800563|NCT02616783|536749571|FG001|Overall Study|Randomized but Not Treated|0|||
148800564|NCT02616783|536749570|FG000|Overall Study|Adverse Event|1|||
148800565|NCT02616783|536749571|FG001|Overall Study|Adverse Event|0|||
148800566|NCT02616783|536749570|FG000|Overall Study|Death|1|||
148800567|NCT02616783|536749571|FG001|Overall Study|Death|0|||
148800568|NCT02616783|536749570|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148901419|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
148901420|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
148901421|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
148901422|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
148901423|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
148901424|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
148901425|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
148901426|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
148901427|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
148901428|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
148901429|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
148901430|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
148901431|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
148901432|NCT03955146|537121960|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
148901433|NCT03955146|537121961|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
149011498|NCT02487095|537521490|FG002|Dose Expansion|Unable to scan/restage participant|0|||
149137974|NCT01006265|537986880|FG001|Overall Study|Withdrawal by Subject|7|||
149137975|NCT01006265|537986881|FG002|Overall Study|Withdrawal by Subject|5|||
149137976|NCT01006265|537986882|FG003|Overall Study|Withdrawal by Subject|5|||
149137977|NCT01006265|537986879|FG000|Overall Study|Administrative reason|1|||
148800569|NCT02616783|536749571|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148800570|NCT02616783|536749570|FG000|Overall Study|Protocol Violation|1|||
148800571|NCT02616783|536749571|FG001|Overall Study|Protocol Violation|1|||
148800572|NCT02616783|536749570|FG000|Overall Study|Withdrew Consent|1|||
148800573|NCT02616783|536749571|FG001|Overall Study|Withdrew Consent|1|||
148800574|NCT03327324|536749572|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800575|NCT03327324|536749573|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
148800576|NCT03327324|536749574|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800577|NCT03327324|536749575|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
148800578|NCT03327324|536749576|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800579|NCT03327324|536749577|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
148800580|NCT03327324|536749572|FG000|Baseline (Month 0-Month 3)|Refused|0|||
148800581|NCT03327324|536749573|FG001|Baseline (Month 0-Month 3)|Refused|0|||
148800582|NCT03327324|536749574|FG002|Baseline (Month 0-Month 3)|Refused|0|||
148800583|NCT03327324|536749575|FG003|Baseline (Month 0-Month 3)|Refused|0|||
148800584|NCT03327324|536749576|FG004|Baseline (Month 0-Month 3)|Refused|1|||
148800585|NCT03327324|536749577|FG005|Baseline (Month 0-Month 3)|Refused|0|||
148800586|NCT03327324|536749572|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
148800587|NCT03327324|536749573|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
148800588|NCT03327324|536749574|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
148800589|NCT03327324|536749575|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
148800590|NCT03327324|536749576|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
148800591|NCT03327324|536749577|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
148800592|NCT03327324|536749572|FG000|Baseline (Month 0-Month 3)|Death|0|||
148800593|NCT03327324|536749573|FG001|Baseline (Month 0-Month 3)|Death|0|||
148800594|NCT03327324|536749574|FG002|Baseline (Month 0-Month 3)|Death|0|||
148800595|NCT03327324|536749575|FG003|Baseline (Month 0-Month 3)|Death|0|||
148800596|NCT03327324|536749576|FG004|Baseline (Month 0-Month 3)|Death|1|||
148800597|NCT03327324|536749577|FG005|Baseline (Month 0-Month 3)|Death|0|||
148800598|NCT03327324|536749572|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800599|NCT03327324|536749573|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800600|NCT03327324|536749574|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800601|NCT03327324|536749575|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800602|NCT03327324|536749576|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800603|NCT03327324|536749577|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
148800604|NCT03327324|536749572|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800605|NCT03327324|536749573|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800606|NCT03327324|536749574|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
148800607|NCT03327324|536749575|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800608|NCT03327324|536749576|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800609|NCT03327324|536749577|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800610|NCT03327324|536749572|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
148901434|NCT03955146|537121962|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
148901435|NCT03955146|537121963|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
148901436|NCT02628873|537121966|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
148901437|NCT02628873|537121967|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
148901438|NCT02628873|537121966|FG000|Second Test (1 Hour)|Physician Decision|1|||
148901439|NCT02628873|537121967|FG001|Second Test (1 Hour)|Physician Decision|0|||
148901440|NCT03597347|537121969|FG000|Overall Study|Withdrawal by Subject|1|||
148901441|NCT03597347|537121970|FG001|Overall Study|Withdrawal by Subject|1|||
148901442|NCT03597347|537121971|FG002|Overall Study|Withdrawal by Subject|0|||
148901443|NCT03597347|537121969|FG000|Overall Study|Withdrawal due to Covid-19|3|||
149137978|NCT01006265|537986880|FG001|Overall Study|Administrative reason|2|||
149137979|NCT01006265|537986881|FG002|Overall Study|Administrative reason|3|||
149137980|NCT01006265|537986882|FG003|Overall Study|Administrative reason|0|||
149137981|NCT00307333|537986883|FG000|Overall Study|Lost to Follow-up|11|||
149137982|NCT00307333|537986884|FG001|Overall Study|Lost to Follow-up|3|||
149137983|NCT00698932|537986885|FG000|Overall Study|Adverse Event|0|||
149137984|NCT00698932|537986886|FG001|Overall Study|Adverse Event|2|||
149137985|NCT00698932|537986885|FG000|Overall Study|Incorrect enrollment|0|||
149137986|NCT00698932|537986886|FG001|Overall Study|Incorrect enrollment|2|||
149137987|NCT00698932|537986885|FG000|Overall Study|Study specific discontinuation criteria|3|||
149137988|NCT00698932|537986886|FG001|Overall Study|Study specific discontinuation criteria|4|||
149137989|NCT00698932|537986885|FG000|Overall Study|Withdrawal by Subject|11|||
149137990|NCT00698932|537986886|FG001|Overall Study|Withdrawal by Subject|23|||
149137991|NCT00698932|537986885|FG000|Overall Study|Lost to Follow-up|6|||
149137992|NCT00698932|537986886|FG001|Overall Study|Lost to Follow-up|1|||
149137993|NCT00698932|537986885|FG000|Overall Study|Severe non-compliance to protocol|1|||
148901444|NCT03597347|537121970|FG001|Overall Study|Withdrawal due to Covid-19|0|||
148901445|NCT03597347|537121971|FG002|Overall Study|Withdrawal due to Covid-19|0|||
148901446|NCT03597347|537121969|FG000|Overall Study|Sponsor decision to terminate study|3|||
148901447|NCT03597347|537121970|FG001|Overall Study|Sponsor decision to terminate study|2|||
148901448|NCT03597347|537121971|FG002|Overall Study|Sponsor decision to terminate study|4|||
148901449|NCT00107653|537121972|FG000|Overall Study|Adverse Event|24|||
148901450|NCT00107653|537121973|FG001|Overall Study|Adverse Event|43|||
148901451|NCT00107653|537121972|FG000|Overall Study|Insufficient Therapeutic Response|25|||
148901452|NCT00107653|537121973|FG001|Overall Study|Insufficient Therapeutic Response|11|||
148901453|NCT00107653|537121972|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
148901454|NCT00107653|537121973|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
148901455|NCT00107653|537121972|FG000|Overall Study|Protocol Violation|1|||
148901456|NCT00107653|537121973|FG001|Overall Study|Protocol Violation|0|||
148901457|NCT00107653|537121972|FG000|Overall Study|Withdrawal by Subject|12|||
148901458|NCT00107653|537121973|FG001|Overall Study|Withdrawal by Subject|13|||
148901459|NCT00107653|537121972|FG000|Overall Study|Lost to Follow-up|13|||
148901460|NCT00107653|537121973|FG001|Overall Study|Lost to Follow-up|5|||
148901461|NCT00107653|537121972|FG000|Overall Study|Administrative Reasons|3|||
148901462|NCT00107653|537121973|FG001|Overall Study|Administrative Reasons|3|||
148901463|NCT00541658|537121975|FG000|Overall Study|Adverse Event|28|||
148901464|NCT00541658|537121976|FG001|Overall Study|Adverse Event|37|||
148901465|NCT00541658|537121977|FG002|Overall Study|Adverse Event|25|||
148901466|NCT00541658|537121975|FG000|Overall Study|Physician Decision|0|||
148901467|NCT00541658|537121976|FG001|Overall Study|Physician Decision|0|||
148901468|NCT00541658|537121977|FG002|Overall Study|Physician Decision|4|||
148901469|NCT00541658|537121975|FG000|Overall Study|Lost to Follow-up|3|||
148901470|NCT00541658|537121976|FG001|Overall Study|Lost to Follow-up|3|||
148901471|NCT00541658|537121977|FG002|Overall Study|Lost to Follow-up|6|||
148901472|NCT00541658|537121975|FG000|Overall Study|Protocol Violation|0|||
148901473|NCT00541658|537121976|FG001|Overall Study|Protocol Violation|1|||
148901474|NCT00541658|537121977|FG002|Overall Study|Protocol Violation|1|||
148901475|NCT00541658|537121975|FG000|Overall Study|Withdrawal by Subject|28|||
148901476|NCT00541658|537121976|FG001|Overall Study|Withdrawal by Subject|32|||
148901477|NCT00541658|537121977|FG002|Overall Study|Withdrawal by Subject|32|||
148901478|NCT00541658|537121975|FG000|Overall Study|Took No Study Drug|1|||
148901479|NCT00541658|537121976|FG001|Overall Study|Took No Study Drug|0|||
148901480|NCT00541658|537121977|FG002|Overall Study|Took No Study Drug|0|||
148901481|NCT01074970|537121979|FG000|Overall Study|Never Treated|0|||
148901482|NCT01074970|537121980|FG001|Overall Study|Never Treated|0|||
148901483|NCT01074970|537121981|FG002|Overall Study|Never Treated|8|||
148901484|NCT01074970|537121982|FG003|Overall Study|Never Treated|1|||
148901485|NCT01074970|537121979|FG000|Overall Study|Adverse Event|1|||
148901486|NCT01074970|537121980|FG001|Overall Study|Adverse Event|0|||
149137994|NCT00698932|537986886|FG001|Overall Study|Severe non-compliance to protocol|2|||
148901487|NCT01074970|537121981|FG002|Overall Study|Adverse Event|4|||
148901488|NCT01074970|537121982|FG003|Overall Study|Adverse Event|3|||
149137995|NCT00698932|537986885|FG000|Overall Study|Safety reasons|0|||
148901489|NCT01074970|537121979|FG000|Overall Study|Disease progression during treatment|3|||
148901490|NCT01074970|537121980|FG001|Overall Study|Disease progression during treatment|1|||
148901491|NCT01074970|537121981|FG002|Overall Study|Disease progression during treatment|2|||
148901492|NCT01074970|537121982|FG003|Overall Study|Disease progression during treatment|9|||
148901493|NCT01074970|537121979|FG000|Overall Study|Lost to Follow-up|0|||
148901494|NCT01074970|537121980|FG001|Overall Study|Lost to Follow-up|0|||
148901495|NCT01074970|537121981|FG002|Overall Study|Lost to Follow-up|1|||
148901496|NCT01074970|537121982|FG003|Overall Study|Lost to Follow-up|0|||
148901497|NCT01074970|537121979|FG000|Overall Study|Withdrawal by Subject|0|||
148901498|NCT01074970|537121980|FG001|Overall Study|Withdrawal by Subject|0|||
148901499|NCT01074970|537121981|FG002|Overall Study|Withdrawal by Subject|6|||
148901500|NCT01074970|537121982|FG003|Overall Study|Withdrawal by Subject|4|||
148901501|NCT02536976|537124488|FG000|Overall Study|Physician Decision|0|||
148901502|NCT02536976|537124489|FG001|Overall Study|Physician Decision|1|||
148901503|NCT01354899|537124490|FG000|Overall Study|discharge from the hospital|2|||
148901504|NCT01354899|537124490|FG000|Overall Study|Protocol Violation|1|||
148901505|NCT00463567|537124491|FG000|Overall Study|Adverse Event|29|||
148901506|NCT00463567|537124492|FG001|Overall Study|Adverse Event|26|||
148901507|NCT00463567|537124493|FG002|Overall Study|Adverse Event|17|||
148901508|NCT00463567|537124494|FG003|Overall Study|Adverse Event|46|||
148901509|NCT00463567|537124495|FG004|Overall Study|Adverse Event|10|||
148901510|NCT00463567|537124496|FG005|Overall Study|Adverse Event|10|||
148901511|NCT00463567|537124497|FG006|Overall Study|Adverse Event|4|||
148901512|NCT00463567|537124491|FG000|Overall Study|Withdrawal by Subject|29|||
148901513|NCT00463567|537124492|FG001|Overall Study|Withdrawal by Subject|22|||
148901514|NCT00463567|537124493|FG002|Overall Study|Withdrawal by Subject|20|||
148901515|NCT00463567|537124494|FG003|Overall Study|Withdrawal by Subject|37|||
148901516|NCT00463567|537124495|FG004|Overall Study|Withdrawal by Subject|6|||
148901517|NCT00463567|537124496|FG005|Overall Study|Withdrawal by Subject|5|||
148901518|NCT00463567|537124497|FG006|Overall Study|Withdrawal by Subject|1|||
148901519|NCT00463567|537124491|FG000|Overall Study|Protocol Deviation|13|||
148901520|NCT00463567|537124492|FG001|Overall Study|Protocol Deviation|9|||
148901521|NCT00463567|537124493|FG002|Overall Study|Protocol Deviation|14|||
148901522|NCT00463567|537124494|FG003|Overall Study|Protocol Deviation|11|||
148901523|NCT00463567|537124495|FG004|Overall Study|Protocol Deviation|1|||
148901524|NCT00463567|537124496|FG005|Overall Study|Protocol Deviation|1|||
148901525|NCT00463567|537124497|FG006|Overall Study|Protocol Deviation|2|||
148901526|NCT00463567|537124491|FG000|Overall Study|Lost to Follow-up|12|||
148901527|NCT00463567|537124492|FG001|Overall Study|Lost to Follow-up|6|||
148901528|NCT00463567|537124493|FG002|Overall Study|Lost to Follow-up|13|||
148901529|NCT00463567|537124494|FG003|Overall Study|Lost to Follow-up|8|||
148901530|NCT00463567|537124495|FG004|Overall Study|Lost to Follow-up|1|||
148901531|NCT00463567|537124496|FG005|Overall Study|Lost to Follow-up|1|||
148901532|NCT00463567|537124497|FG006|Overall Study|Lost to Follow-up|1|||
148901533|NCT00463567|537124491|FG000|Overall Study|Administrative problems|5|||
148901534|NCT00463567|537124492|FG001|Overall Study|Administrative problems|3|||
148901535|NCT00463567|537124493|FG002|Overall Study|Administrative problems|6|||
148901536|NCT00463567|537124494|FG003|Overall Study|Administrative problems|9|||
148901537|NCT00463567|537124495|FG004|Overall Study|Administrative problems|3|||
148901538|NCT00463567|537124496|FG005|Overall Study|Administrative problems|2|||
148901539|NCT00463567|537124497|FG006|Overall Study|Administrative problems|2|||
148901540|NCT00463567|537124491|FG000|Overall Study|Lack of Efficacy|4|||
148901541|NCT00463567|537124492|FG001|Overall Study|Lack of Efficacy|9|||
148901542|NCT00463567|537124493|FG002|Overall Study|Lack of Efficacy|9|||
148901543|NCT00463567|537124494|FG003|Overall Study|Lack of Efficacy|17|||
148901544|NCT00463567|537124495|FG004|Overall Study|Lack of Efficacy|1|||
148901545|NCT00463567|537124496|FG005|Overall Study|Lack of Efficacy|0|||
148901546|NCT00463567|537124497|FG006|Overall Study|Lack of Efficacy|1|||
148901547|NCT00463567|537124491|FG000|Overall Study|Abnormal lab value(s)|1|||
148901548|NCT00463567|537124492|FG001|Overall Study|Abnormal lab value(s)|1|||
148901549|NCT00463567|537124493|FG002|Overall Study|Abnormal lab value(s)|2|||
148901550|NCT00463567|537124494|FG003|Overall Study|Abnormal lab value(s)|1|||
148901551|NCT00463567|537124495|FG004|Overall Study|Abnormal lab value(s)|1|||
148901552|NCT00463567|537124496|FG005|Overall Study|Abnormal lab value(s)|0|||
148901553|NCT00463567|537124497|FG006|Overall Study|Abnormal lab value(s)|0|||
148901554|NCT00463567|537124491|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148901555|NCT00463567|537124492|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148901556|NCT00463567|537124493|FG002|Overall Study|Abnormal test procedure result(s)|6|||
148901557|NCT00463567|537124494|FG003|Overall Study|Abnormal test procedure result(s)|2|||
148901558|NCT00463567|537124495|FG004|Overall Study|Abnormal test procedure result(s)|0|||
148901559|NCT00463567|537124496|FG005|Overall Study|Abnormal test procedure result(s)|2|||
148901560|NCT00463567|537124497|FG006|Overall Study|Abnormal test procedure result(s)|0|||
148901561|NCT00463567|537124491|FG000|Overall Study|Death|1|||
149137996|NCT00698932|537986886|FG001|Overall Study|Safety reasons|2|||
149137997|NCT00698932|537986885|FG000|Overall Study|Death|1|||
149137998|NCT00698932|537986886|FG001|Overall Study|Death|0|||
149137999|NCT01245387|537986887|FG000|Overall Study|Lost to Follow-up|106|||
149138000|NCT01245387|537986887|FG000|Overall Study|Lack of Efficacy|195|||
149138001|NCT01245387|537986887|FG000|Overall Study|Adverse Event|9|||
149138002|NCT01245387|537986887|FG000|Overall Study|Death|3|||
149138003|NCT01245387|537986887|FG000|Overall Study|Other|131|||
149138004|NCT01245387|537986887|FG000|Overall Study|Missing discontinuation status|369|||
149138005|NCT00757003|537986888|FG000|Overall Study|Death|33|||
149138006|NCT00757003|537986888|FG000|Overall Study|Lost to Follow-up|9|||
149138007|NCT00757003|537986888|FG000|Overall Study|Withdrawal by Subject|4|||
149138008|NCT00757003|537986888|FG000|Overall Study|Surgically explanted|2|||
149138009|NCT00757003|537986888|FG000|Overall Study|Not implanted|1|||
149138010|NCT00601705|537986889|FG000|Overall Study|Withdrawal by Subject|1|||
149138011|NCT02146599|537986893|FG000|Overall Study|Failed to meet inclusion criteria|5|||
149138012|NCT04246801|537986894|FG000|Overall Study|Adverse Event|1|||
149138013|NCT04246801|537986895|FG001|Overall Study|Adverse Event|1|||
149138014|NCT04246801|537986894|FG000|Overall Study|Protocol Violation|1|||
149138015|NCT04246801|537986895|FG001|Overall Study|Protocol Violation|1|||
149138016|NCT04246801|537986894|FG000|Overall Study|Lack of Efficacy|0|||
149138017|NCT04246801|537986895|FG001|Overall Study|Lack of Efficacy|2|||
149138018|NCT04246801|537986894|FG000|Overall Study|Lost to Follow-up|1|||
149138019|NCT04246801|537986895|FG001|Overall Study|Lost to Follow-up|1|||
149138020|NCT04246801|537986894|FG000|Overall Study|Withdrawal by Subject|2|||
149138021|NCT04246801|537986895|FG001|Overall Study|Withdrawal by Subject|1|||
149138022|NCT02101021|537986899|FG000|Overall Study|Death|4|||
149138023|NCT02101021|537986900|FG001|Overall Study|Death|3|||
149138024|NCT02101021|537986901|FG002|Overall Study|Death|6|||
149138025|NCT02101021|537986902|FG003|Overall Study|Death|0|||
149138026|NCT02101021|537986903|FG004|Overall Study|Death|3|||
149138027|NCT02101021|537986899|FG000|Overall Study|Withdrew Consent from study|1|||
149138028|NCT02101021|537986900|FG001|Overall Study|Withdrew Consent from study|1|||
149138029|NCT02101021|537986901|FG002|Overall Study|Withdrew Consent from study|0|||
149138030|NCT02101021|537986902|FG003|Overall Study|Withdrew Consent from study|2|||
149138031|NCT02101021|537986903|FG004|Overall Study|Withdrew Consent from study|0|||
149138032|NCT02101021|537986899|FG000|Overall Study|Lost to Follow-up|1|||
149138033|NCT02101021|537986900|FG001|Overall Study|Lost to Follow-up|0|||
149138034|NCT02101021|537986901|FG002|Overall Study|Lost to Follow-up|0|||
149138035|NCT02101021|537986902|FG003|Overall Study|Lost to Follow-up|0|||
149138036|NCT02101021|537986903|FG004|Overall Study|Lost to Follow-up|0|||
149138037|NCT02101021|537986899|FG000|Overall Study|Study Terminated by Sponsor|1|||
149138038|NCT02101021|537986900|FG001|Overall Study|Study Terminated by Sponsor|0|||
149138039|NCT02101021|537986901|FG002|Overall Study|Study Terminated by Sponsor|1|||
149138040|NCT02101021|537986902|FG003|Overall Study|Study Terminated by Sponsor|1|||
149138041|NCT02101021|537986903|FG004|Overall Study|Study Terminated by Sponsor|1|||
149138042|NCT01621542|537986904|FG000|Overall Study|Adverse Event|0|||
149138043|NCT01621542|537986905|FG001|Overall Study|Adverse Event|0|||
149138044|NCT01621542|537986906|FG002|Overall Study|Adverse Event|1|||
149138045|NCT01621542|537986907|FG003|Overall Study|Adverse Event|3|||
149138046|NCT01621542|537986908|FG004|Overall Study|Adverse Event|0|||
149138047|NCT01621542|537986909|FG005|Overall Study|Adverse Event|0|||
149138048|NCT01621542|537986904|FG000|Overall Study|Death|0|||
149138049|NCT01621542|537986905|FG001|Overall Study|Death|1|||
149138050|NCT01621542|537986906|FG002|Overall Study|Death|0|||
149138051|NCT01621542|537986907|FG003|Overall Study|Death|0|||
149138052|NCT01621542|537986908|FG004|Overall Study|Death|0|||
149138053|NCT01621542|537986909|FG005|Overall Study|Death|0|||
149138054|NCT01621542|537986904|FG000|Overall Study|Physician Decision|1|||
149138055|NCT01621542|537986905|FG001|Overall Study|Physician Decision|0|||
149138056|NCT01621542|537986906|FG002|Overall Study|Physician Decision|1|||
149138057|NCT01621542|537986907|FG003|Overall Study|Physician Decision|13|||
149138058|NCT01621542|537986908|FG004|Overall Study|Physician Decision|3|||
149138059|NCT01621542|537986909|FG005|Overall Study|Physician Decision|1|||
148901562|NCT00463567|537124492|FG001|Overall Study|Death|0|||
148800611|NCT03327324|536749573|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
148800612|NCT03327324|536749574|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
148800613|NCT03327324|536749575|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
148800614|NCT03327324|536749576|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
148800615|NCT03327324|536749577|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
148800616|NCT03327324|536749572|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
148800617|NCT03327324|536749573|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
148800618|NCT03327324|536749574|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
148800619|NCT03327324|536749575|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
148800620|NCT03327324|536749576|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
148800621|NCT03327324|536749577|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
148800622|NCT03327324|536749572|FG000|Intervention (Month 3-Month 6)|Death|1|||
148800623|NCT03327324|536749573|FG001|Intervention (Month 3-Month 6)|Death|0|||
148800624|NCT03327324|536749574|FG002|Intervention (Month 3-Month 6)|Death|1|||
148800625|NCT03327324|536749575|FG003|Intervention (Month 3-Month 6)|Death|1|||
148800626|NCT03327324|536749576|FG004|Intervention (Month 3-Month 6)|Death|1|||
148800627|NCT03327324|536749577|FG005|Intervention (Month 3-Month 6)|Death|0|||
148800628|NCT03327324|536749572|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800629|NCT03327324|536749573|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800630|NCT03327324|536749574|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800631|NCT03327324|536749575|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800632|NCT03327324|536749576|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800633|NCT03327324|536749577|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
148800634|NCT03327324|536749572|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
148800635|NCT03327324|536749573|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800636|NCT03327324|536749574|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800637|NCT03327324|536749575|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800638|NCT03327324|536749576|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800639|NCT03327324|536749577|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
148800640|NCT03327324|536749572|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
148901563|NCT00463567|537124493|FG002|Overall Study|Death|2|||
148901564|NCT00463567|537124494|FG003|Overall Study|Death|0|||
148901565|NCT00463567|537124495|FG004|Overall Study|Death|0|||
148901566|NCT00463567|537124496|FG005|Overall Study|Death|0|||
148901567|NCT00463567|537124497|FG006|Overall Study|Death|0|||
148901568|NCT00641667|537124500|FG000|Overall Study|Withdrawal by Subject|1|||
148901569|NCT00641667|537124500|FG000|Overall Study|Adverse Event|1|||
148901570|NCT00641667|537124500|FG000|Overall Study|Physician Decision|1|||
148901571|NCT00641667|537124500|FG000|Overall Study|Worsening of underlying disease|3|||
148901572|NCT01472289|537124504|FG000|Overall Study|Death|2|||
148901573|NCT02435992|537124505|FG000|Overall Study|non compliance with protocol|2|||
148901574|NCT02435992|537124506|FG001|Overall Study|non compliance with protocol|0|||
148901575|NCT02435992|537124507|FG002|Overall Study|non compliance with protocol|1|||
148901576|NCT02435992|537124508|FG003|Overall Study|non compliance with protocol|0|||
148901577|NCT02435992|537124509|FG004|Overall Study|non compliance with protocol|0|||
148901578|NCT02435992|537124505|FG000|Overall Study|Adverse Event|11|||
148901579|NCT02435992|537124506|FG001|Overall Study|Adverse Event|6|||
148901580|NCT02435992|537124507|FG002|Overall Study|Adverse Event|12|||
148901581|NCT02435992|537124508|FG003|Overall Study|Adverse Event|0|||
148901582|NCT02435992|537124509|FG004|Overall Study|Adverse Event|0|||
148901583|NCT02435992|537124505|FG000|Overall Study|Lack of Efficacy|4|||
148901584|NCT02435992|537124506|FG001|Overall Study|Lack of Efficacy|10|||
148901585|NCT02435992|537124507|FG002|Overall Study|Lack of Efficacy|9|||
148901586|NCT02435992|537124508|FG003|Overall Study|Lack of Efficacy|0|||
148901587|NCT02435992|537124509|FG004|Overall Study|Lack of Efficacy|0|||
148901588|NCT02435992|537124505|FG000|Overall Study|Withdrawal by Subject|10|||
148901589|NCT02435992|537124506|FG001|Overall Study|Withdrawal by Subject|8|||
148901590|NCT02435992|537124507|FG002|Overall Study|Withdrawal by Subject|20|||
148901591|NCT02435992|537124508|FG003|Overall Study|Withdrawal by Subject|0|||
148901592|NCT02435992|537124509|FG004|Overall Study|Withdrawal by Subject|0|||
148901593|NCT02435992|537124505|FG000|Overall Study|Other Reason|1|||
148901594|NCT02435992|537124506|FG001|Overall Study|Other Reason|0|||
148901595|NCT02435992|537124507|FG002|Overall Study|Other Reason|0|||
148901596|NCT02435992|537124508|FG003|Overall Study|Other Reason|0|||
148901597|NCT02435992|537124509|FG004|Overall Study|Other Reason|0|||
148901598|NCT02435992|537124505|FG000|Overall Study|Physician Decision|0|||
148901599|NCT02435992|537124506|FG001|Overall Study|Physician Decision|0|||
148901600|NCT02435992|537124507|FG002|Overall Study|Physician Decision|1|||
148901601|NCT02435992|537124508|FG003|Overall Study|Physician Decision|0|||
148901602|NCT02435992|537124509|FG004|Overall Study|Physician Decision|0|||
148901603|NCT04004988|537124510|FG000|Period 1|Physician Decision|2|||
148901604|NCT04004988|537124511|FG001|Period 1|Physician Decision|0|||
148901605|NCT04004988|537124510|FG000|Period 1|Withdrawal by Subject|0|||
148901606|NCT04004988|537124511|FG001|Period 1|Withdrawal by Subject|1|||
148901607|NCT04004988|537124510|FG000|Period 1|Adverse Event|1|||
148901608|NCT04004988|537124511|FG001|Period 1|Adverse Event|2|||
148901609|NCT03873116|537124512|FG000|Part 1|Study drug discontinuation due to rash|0|||
148901610|NCT03873116|537124513|FG001|Part 1|Study drug discontinuation due to rash|0|||
148901611|NCT03873116|537124514|FG002|Part 1|Study drug discontinuation due to rash|0|||
148901612|NCT03873116|537124515|FG003|Part 1|Study drug discontinuation due to rash|0|||
148901613|NCT03873116|537124516|FG004|Part 1|Study drug discontinuation due to rash|0|||
148901614|NCT03873116|537124517|FG005|Part 1|Study drug discontinuation due to rash|1|||
148901615|NCT03873116|537124512|FG000|Part 2|Withdrawal by Subject|0|||
148901616|NCT03873116|537124513|FG001|Part 2|Withdrawal by Subject|0|||
148901617|NCT03873116|537124514|FG002|Part 2|Withdrawal by Subject|1|||
148901618|NCT03873116|537124515|FG003|Part 2|Withdrawal by Subject|0|||
148901619|NCT03873116|537124516|FG004|Part 2|Withdrawal by Subject|0|||
148901620|NCT03873116|537124517|FG005|Part 2|Withdrawal by Subject|0|||
148901621|NCT03873116|537124512|FG000|Part 2|Lab abnormality or AE|0|||
148901622|NCT03873116|537124513|FG001|Part 2|Lab abnormality or AE|0|||
148901623|NCT03873116|537124514|FG002|Part 2|Lab abnormality or AE|0|||
148901624|NCT03873116|537124515|FG003|Part 2|Lab abnormality or AE|0|||
148901625|NCT03873116|537124516|FG004|Part 2|Lab abnormality or AE|1|||
148901626|NCT03873116|537124517|FG005|Part 2|Lab abnormality or AE|0|||
148901627|NCT03873116|537124512|FG000|Part 3|Withdrawal by Subject|0|||
148901628|NCT03873116|537124513|FG001|Part 3|Withdrawal by Subject|0|||
148901629|NCT03873116|537124514|FG002|Part 3|Withdrawal by Subject|0|||
148901630|NCT03873116|537124515|FG003|Part 3|Withdrawal by Subject|0|||
148901631|NCT03873116|537124516|FG004|Part 3|Withdrawal by Subject|1|||
148901632|NCT03873116|537124517|FG005|Part 3|Withdrawal by Subject|0|||
148901633|NCT00912808|537124518|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
148901634|NCT00912808|537124519|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
148901635|NCT00912808|537124518|FG000|Washout|Withdrawal by Subject|0|||
148901636|NCT00912808|537124519|FG001|Washout|Withdrawal by Subject|1|||
148901637|NCT00912808|537124518|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
148901638|NCT00912808|537124519|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
148901639|NCT00912808|537124518|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
148901640|NCT00912808|537124519|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
148901641|NCT02531802|537124522|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
148901642|NCT02531802|537124523|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
148901643|NCT02531802|537124524|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
148901644|NCT02531802|537124525|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
148901645|NCT02531802|537124526|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
148901646|NCT02531802|537124527|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
148901647|NCT02531802|537124528|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
148901648|NCT02531802|537124529|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
148901649|NCT02531802|537124530|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
148901650|NCT02531802|537124531|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
148901651|NCT02531802|537124532|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
148901652|NCT02531802|537124533|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
148901653|NCT02531802|537124534|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
148901654|NCT02531802|537124535|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
148901655|NCT02531802|537124536|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
148901656|NCT02531802|537124537|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
148901657|NCT02531802|537124538|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
148901658|NCT02531802|537124539|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
148901659|NCT02531802|537124540|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
148901660|NCT02531802|537124541|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
148901661|NCT02531802|537124542|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
148901662|NCT02531802|537124522|FG000|Received Vaccination 2|Physician Decision|0|||
148901663|NCT02531802|537124523|FG001|Received Vaccination 2|Physician Decision|0|||
148901664|NCT02531802|537124524|FG002|Received Vaccination 2|Physician Decision|0|||
148901665|NCT02531802|537124525|FG003|Received Vaccination 2|Physician Decision|0|||
148901666|NCT02531802|537124526|FG004|Received Vaccination 2|Physician Decision|0|||
148901667|NCT02531802|537124527|FG005|Received Vaccination 2|Physician Decision|1|||
148901668|NCT02531802|537124528|FG006|Received Vaccination 2|Physician Decision|0|||
148901669|NCT02531802|537124529|FG007|Received Vaccination 2|Physician Decision|0|||
148901670|NCT02531802|537124530|FG008|Received Vaccination 2|Physician Decision|0|||
148901671|NCT02531802|537124531|FG009|Received Vaccination 2|Physician Decision|2|||
148901672|NCT02531802|537124532|FG010|Received Vaccination 2|Physician Decision|0|||
148901673|NCT02531802|537124533|FG011|Received Vaccination 2|Physician Decision|0|||
148901674|NCT02531802|537124534|FG012|Received Vaccination 2|Physician Decision|0|||
148901675|NCT02531802|537124535|FG013|Received Vaccination 2|Physician Decision|1|||
148901676|NCT02531802|537124536|FG014|Received Vaccination 2|Physician Decision|0|||
148901677|NCT02531802|537124537|FG015|Received Vaccination 2|Physician Decision|0|||
148901678|NCT02531802|537124538|FG016|Received Vaccination 2|Physician Decision|0|||
148901679|NCT02531802|537124539|FG017|Received Vaccination 2|Physician Decision|1|||
148901680|NCT02531802|537124540|FG018|Received Vaccination 2|Physician Decision|0|||
148901681|NCT02531802|537124541|FG019|Received Vaccination 2|Physician Decision|0|||
148901682|NCT02531802|537124542|FG020|Received Vaccination 2|Physician Decision|0|||
148901683|NCT02531802|537124522|FG000|Received Vaccination 2|Adverse Event|0|||
148901684|NCT02531802|537124523|FG001|Received Vaccination 2|Adverse Event|0|||
148901685|NCT02531802|537124524|FG002|Received Vaccination 2|Adverse Event|0|||
148901686|NCT02531802|537124525|FG003|Received Vaccination 2|Adverse Event|0|||
148901687|NCT02531802|537124526|FG004|Received Vaccination 2|Adverse Event|0|||
148901688|NCT02531802|537124527|FG005|Received Vaccination 2|Adverse Event|2|||
148901689|NCT02531802|537124528|FG006|Received Vaccination 2|Adverse Event|0|||
148901690|NCT02531802|537124529|FG007|Received Vaccination 2|Adverse Event|0|||
148901691|NCT02531802|537124530|FG008|Received Vaccination 2|Adverse Event|0|||
148901692|NCT02531802|537124531|FG009|Received Vaccination 2|Adverse Event|0|||
148901693|NCT02531802|537124532|FG010|Received Vaccination 2|Adverse Event|0|||
149138060|NCT01621542|537986904|FG000|Overall Study|Withdrawal by Subject|2|||
149138061|NCT01621542|537986905|FG001|Overall Study|Withdrawal by Subject|0|||
149138062|NCT01621542|537986906|FG002|Overall Study|Withdrawal by Subject|1|||
149138063|NCT01621542|537986907|FG003|Overall Study|Withdrawal by Subject|3|||
149138064|NCT01621542|537986908|FG004|Overall Study|Withdrawal by Subject|3|||
149138065|NCT01621542|537986909|FG005|Overall Study|Withdrawal by Subject|3|||
149138066|NCT01621542|537986904|FG000|Overall Study|progression/treatment failure|2|||
149138067|NCT01621542|537986905|FG001|Overall Study|progression/treatment failure|4|||
149138068|NCT01621542|537986906|FG002|Overall Study|progression/treatment failure|3|||
149138069|NCT01621542|537986907|FG003|Overall Study|progression/treatment failure|7|||
149138070|NCT01621542|537986908|FG004|Overall Study|progression/treatment failure|3|||
149138071|NCT01621542|537986909|FG005|Overall Study|progression/treatment failure|5|||
149138072|NCT01621542|537986904|FG000|Overall Study|Protocol Violation|0|||
149138073|NCT01621542|537986905|FG001|Overall Study|Protocol Violation|0|||
149138074|NCT01621542|537986906|FG002|Overall Study|Protocol Violation|0|||
149138075|NCT01621542|537986907|FG003|Overall Study|Protocol Violation|1|||
149138076|NCT01621542|537986908|FG004|Overall Study|Protocol Violation|0|||
149138077|NCT01621542|537986909|FG005|Overall Study|Protocol Violation|0|||
149138078|NCT01621542|537986904|FG000|Overall Study|study stopped by sponsor|0|||
149138079|NCT01621542|537986905|FG001|Overall Study|study stopped by sponsor|0|||
149138080|NCT01621542|537986906|FG002|Overall Study|study stopped by sponsor|0|||
149138081|NCT01621542|537986907|FG003|Overall Study|study stopped by sponsor|1|||
149138082|NCT01621542|537986908|FG004|Overall Study|study stopped by sponsor|0|||
149138083|NCT01621542|537986909|FG005|Overall Study|study stopped by sponsor|0|||
149138084|NCT02632721|537986913|FG000|Overall Study|Adverse Event|0|||
149138085|NCT02632721|537986914|FG001|Overall Study|Adverse Event|0|||
149138086|NCT02632721|537986915|FG002|Overall Study|Adverse Event|2|||
149138087|NCT02632721|537986916|FG003|Overall Study|Adverse Event|5|||
149138088|NCT02632721|537986917|FG004|Overall Study|Adverse Event|3|||
149138089|NCT02632721|537986913|FG000|Overall Study|Dose limiting toxicity|0|||
149138090|NCT02632721|537986914|FG001|Overall Study|Dose limiting toxicity|0|||
149138091|NCT02632721|537986915|FG002|Overall Study|Dose limiting toxicity|0|||
148800641|NCT03327324|536749573|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
148800642|NCT03327324|536749574|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
148800643|NCT03327324|536749575|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
148800644|NCT03327324|536749576|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
148800645|NCT03327324|536749577|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
148800646|NCT03327324|536749572|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
148800647|NCT03327324|536749573|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
148800648|NCT03327324|536749574|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
148800649|NCT03327324|536749575|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
148800650|NCT03327324|536749576|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
148800651|NCT03327324|536749577|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
148800652|NCT03327324|536749572|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800653|NCT03327324|536749573|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800654|NCT03327324|536749574|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800655|NCT03327324|536749575|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
148800656|NCT03327324|536749576|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
148800657|NCT03327324|536749577|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
148800658|NCT03327324|536749572|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
148800659|NCT03327324|536749573|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
148800660|NCT03327324|536749574|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
148800661|NCT03327324|536749575|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
148800662|NCT03327324|536749576|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
148901694|NCT02531802|537124533|FG011|Received Vaccination 2|Adverse Event|0|||
148901695|NCT02531802|537124534|FG012|Received Vaccination 2|Adverse Event|0|||
148901696|NCT02531802|537124535|FG013|Received Vaccination 2|Adverse Event|0|||
148901697|NCT02531802|537124536|FG014|Received Vaccination 2|Adverse Event|0|||
148901698|NCT02531802|537124537|FG015|Received Vaccination 2|Adverse Event|0|||
148901699|NCT02531802|537124538|FG016|Received Vaccination 2|Adverse Event|0|||
148901700|NCT02531802|537124539|FG017|Received Vaccination 2|Adverse Event|2|||
148901701|NCT02531802|537124540|FG018|Received Vaccination 2|Adverse Event|1|||
148901702|NCT02531802|537124541|FG019|Received Vaccination 2|Adverse Event|0|||
148901703|NCT02531802|537124542|FG020|Received Vaccination 2|Adverse Event|1|||
148901704|NCT02531802|537124522|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
148901705|NCT02531802|537124523|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
148901706|NCT02531802|537124524|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
148901707|NCT02531802|537124525|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
148800663|NCT03327324|536749577|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
148800664|NCT03327324|536749572|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
148800665|NCT03327324|536749573|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
148800666|NCT03327324|536749574|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
148800667|NCT03327324|536749575|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
148800668|NCT03327324|536749576|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
148800669|NCT03327324|536749577|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
148800670|NCT01103323|536749578|FG000|Without/Before Drug Switch|Adverse Event|50|||
148800671|NCT01103323|536749579|FG001|Without/Before Drug Switch|Adverse Event|7|||
148800672|NCT01103323|536749578|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
148800673|NCT01103323|536749579|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
148800674|NCT01103323|536749578|FG000|Without/Before Drug Switch|Protocol Violation|2|||
148901708|NCT02531802|537124526|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
148901709|NCT02531802|537124527|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
148901710|NCT02531802|537124528|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
148901711|NCT02531802|537124529|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
148901712|NCT02531802|537124530|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
148901713|NCT02531802|537124531|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
148901714|NCT02531802|537124532|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
148901715|NCT02531802|537124533|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
148901716|NCT02531802|537124534|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
148901717|NCT02531802|537124535|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
148901718|NCT02531802|537124536|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
148901719|NCT02531802|537124537|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
148901720|NCT02531802|537124538|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
148901721|NCT02531802|537124539|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
148901722|NCT02531802|537124540|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
148901723|NCT02531802|537124541|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
148901724|NCT02531802|537124542|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
148901725|NCT00538902|537124552|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
148901726|NCT00538902|537124553|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
148901727|NCT00538902|537124554|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
148901728|NCT00538902|537124552|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
148901729|NCT00538902|537124553|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
148901730|NCT00538902|537124554|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
148901731|NCT00538902|537124552|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
149011499|NCT02487095|537521491|FG003|Dose Expansion|Unable to scan/restage participant|0|||
148800675|NCT01103323|536749579|FG001|Without/Before Drug Switch|Protocol Violation|0|||
148800676|NCT01103323|536749578|FG000|Without/Before Drug Switch|Physician Decision|2|||
148800677|NCT01103323|536749579|FG001|Without/Before Drug Switch|Physician Decision|0|||
148800678|NCT01103323|536749578|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
148800679|NCT01103323|536749579|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
148800680|NCT01103323|536749578|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
148800681|NCT01103323|536749579|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
148800682|NCT01103323|536749578|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
148800683|NCT01103323|536749579|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
148800684|NCT00372424|536749580|FG000|Overall Study|Adverse Event|2|||
148800685|NCT00372424|536749580|FG000|Overall Study|Withdrawal by Subject|1|||
148800686|NCT00372424|536749580|FG000|Overall Study|Death|1|||
148800687|NCT00372424|536749580|FG000|Overall Study|Objective Progression or Relapse|14|||
148800688|NCT00372424|536749580|FG000|Overall Study|Other|7|||
148800689|NCT00372424|536749580|FG000|Overall Study|Enrolled, Not Treated|1|||
148800690|NCT05214118|536749590|FG000|Overall Study|Lost to Follow-up|0|||
148800691|NCT05214118|536749591|FG001|Overall Study|Lost to Follow-up|2|||
148800692|NCT05214118|536749590|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
148800693|NCT05214118|536749591|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
148800694|NCT05214118|536749590|FG000|Overall Study|moved|1|||
148800695|NCT05214118|536749591|FG001|Overall Study|moved|0|||
148800696|NCT03797898|536749592|FG000|Overall Study|Lost to Follow-up|60|||
148800697|NCT03797898|536749593|FG001|Overall Study|Lost to Follow-up|69|||
148800698|NCT03797898|536749592|FG000|Overall Study|Withdrawal by Subject|9|||
148800699|NCT03797898|536749593|FG001|Overall Study|Withdrawal by Subject|7|||
148800700|NCT03797898|536749592|FG000|Overall Study|Became ineligible|5|||
148800701|NCT03797898|536749593|FG001|Overall Study|Became ineligible|2|||
148800702|NCT02314728|536749594|FG000|Overall Study|Protocol Violation|1|||
148800703|NCT02314728|536749595|FG001|Overall Study|Protocol Violation|0|||
148800704|NCT02314728|536749594|FG000|Overall Study|Lost to Follow-up|0|||
148800705|NCT02314728|536749595|FG001|Overall Study|Lost to Follow-up|1|||
148800706|NCT01614470|536749596|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
148800707|NCT01614470|536749597|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
148800708|NCT01614470|536749598|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
148800709|NCT01614470|536749596|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
148800710|NCT01614470|536749597|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
148800711|NCT01614470|536749598|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
148800712|NCT02848664|536749611|FG000|Overall Study|Withdrawal by Subject|2|||
148800713|NCT02848664|536749611|FG000|Overall Study|Adverse Event|1|||
148800714|NCT02848664|536749611|FG000|Overall Study|no assistance for device training|1|||
148800715|NCT00732069|536749612|FG000|Washout After First Study Drug|Adverse Event|1|||
148800716|NCT00732069|536749613|FG001|Washout After First Study Drug|Adverse Event|0|||
148800717|NCT00732069|536749614|FG002|Washout After First Study Drug|Adverse Event|0|||
148800718|NCT00732069|536749615|FG003|Washout After First Study Drug|Adverse Event|0|||
148800719|NCT00732069|536749616|FG004|Washout After First Study Drug|Adverse Event|0|||
148800720|NCT00732069|536749617|FG005|Washout After First Study Drug|Adverse Event|0|||
148800721|NCT01405898|536749618|FG000|Overall Study|Withdrawal by Subject|2|||
148800722|NCT01405898|536749619|FG001|Overall Study|Withdrawal by Subject|2|||
148800723|NCT01204671|536749623|FG000|Overall Study|Adverse Event|4|||
148800724|NCT01204671|536749624|FG001|Overall Study|Adverse Event|3|||
148800725|NCT01204671|536749625|FG002|Overall Study|Adverse Event|3|||
148800726|NCT01204671|536749626|FG003|Overall Study|Adverse Event|3|||
148800727|NCT01204671|536749627|FG004|Overall Study|Adverse Event|1|||
148800728|NCT01204671|536749623|FG000|Overall Study|Withdrawal by Subject|2|||
148800729|NCT01204671|536749624|FG001|Overall Study|Withdrawal by Subject|3|||
148800730|NCT01204671|536749625|FG002|Overall Study|Withdrawal by Subject|4|||
148800731|NCT01204671|536749626|FG003|Overall Study|Withdrawal by Subject|5|||
148800732|NCT01204671|536749627|FG004|Overall Study|Withdrawal by Subject|3|||
148800733|NCT01204671|536749623|FG000|Overall Study|Lost to Follow-up|7|||
148800734|NCT01204671|536749624|FG001|Overall Study|Lost to Follow-up|8|||
148800735|NCT01204671|536749625|FG002|Overall Study|Lost to Follow-up|6|||
148800736|NCT01204671|536749626|FG003|Overall Study|Lost to Follow-up|4|||
148800737|NCT01204671|536749627|FG004|Overall Study|Lost to Follow-up|0|||
148800738|NCT01204671|536749623|FG000|Overall Study|Unknown Completion Status|1|||
148800739|NCT01204671|536749624|FG001|Overall Study|Unknown Completion Status|1|||
148800740|NCT01204671|536749625|FG002|Overall Study|Unknown Completion Status|0|||
148800741|NCT01204671|536749626|FG003|Overall Study|Unknown Completion Status|0|||
148800742|NCT01204671|536749627|FG004|Overall Study|Unknown Completion Status|0|||
148800743|NCT01204671|536749623|FG000|Overall Study|Physician Decision|0|||
148800744|NCT01204671|536749624|FG001|Overall Study|Physician Decision|0|||
148800745|NCT01204671|536749625|FG002|Overall Study|Physician Decision|0|||
148800746|NCT01204671|536749626|FG003|Overall Study|Physician Decision|1|||
148800747|NCT01204671|536749627|FG004|Overall Study|Physician Decision|0|||
148800748|NCT03106077|536749630|FG000|Overall Study|Screen Failure|94|||
148800749|NCT03106077|536749631|FG001|Overall Study|Screen Failure|0|||
148800750|NCT03669588|536749632|FG000|Overall Study|Adverse Event|1|||
148800751|NCT03669588|536749633|FG001|Overall Study|Adverse Event|0|||
148800752|NCT03669588|536749632|FG000|Overall Study|Physician Decision|0|||
148800753|NCT03669588|536749633|FG001|Overall Study|Physician Decision|1|||
148800754|NCT03669588|536749632|FG000|Overall Study|Protocol Violation|1|||
148800755|NCT03669588|536749633|FG001|Overall Study|Protocol Violation|0|||
148800756|NCT03669588|536749632|FG000|Overall Study|Sponsor Decision|1|||
148800757|NCT03669588|536749633|FG001|Overall Study|Sponsor Decision|1|||
148800758|NCT03669588|536749632|FG000|Overall Study|Withdrawal by Subject|1|||
148800759|NCT03669588|536749633|FG001|Overall Study|Withdrawal by Subject|4|||
148800760|NCT03669588|536749632|FG000|Overall Study|Rescue Therapy Needed|0|||
148800761|NCT03669588|536749633|FG001|Overall Study|Rescue Therapy Needed|1|||
148800762|NCT04386902|536749634|FG000|Overall Study|Withdrawal by Subject|5|||
148800763|NCT04386902|536749634|FG000|Overall Study|Technical problems in the recording|5|||
148800764|NCT00721799|536749637|FG000|Overall Study|Withdrawal by Subject|7|||
148800765|NCT00721799|536749637|FG000|Overall Study|withdraw by subject after scan 1|1|||
148800766|NCT02337764|536751292|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
148800767|NCT02337764|536751292|FG000|Overall Study|Voluntary Withdrawal|12|||
148800768|NCT02337764|536751292|FG000|Overall Study|Lack of Efficacy|2|||
148800769|NCT02990000|536751293|FG000|Overall Study|Failed to provide data beyond baseline|36|||
148901732|NCT00538902|537124553|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
148901733|NCT00538902|537124554|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
148901734|NCT00538902|537124552|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
148901735|NCT00538902|537124553|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
148901736|NCT00538902|537124554|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
148901737|NCT00538902|537124552|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
148901738|NCT00538902|537124553|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
148901739|NCT00538902|537124554|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
148901740|NCT00538902|537124552|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
148901741|NCT00538902|537124553|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
148901742|NCT00538902|537124554|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
148901743|NCT00538902|537124552|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
148800770|NCT02990000|536751294|FG001|Overall Study|Failed to provide data beyond baseline|34|||
148800771|NCT02579629|536751318|FG000|Overall Study|Withdrawal by Subject|0|||
148800772|NCT02579629|536751319|FG001|Overall Study|Withdrawal by Subject|1|||
148800773|NCT02579629|536751320|FG002|Overall Study|Withdrawal by Subject|0|||
148800774|NCT02579629|536751318|FG000|Overall Study|Screen Failure|2|||
148800775|NCT02579629|536751319|FG001|Overall Study|Screen Failure|0|||
148800776|NCT02579629|536751320|FG002|Overall Study|Screen Failure|2|||
148800777|NCT01930539|536751321|FG000|Overall Study|Withdrawal by Subject|2|||
148901744|NCT00538902|537124553|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
148901745|NCT00538902|537124554|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
148901746|NCT00538902|537124552|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
148901747|NCT00538902|537124553|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
148901748|NCT00538902|537124554|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
148901749|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
148901750|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
148901751|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
148800778|NCT01930539|536751322|FG001|Overall Study|Withdrawal by Subject|2|||
148800779|NCT01190891|536751323|FG000|Overall Study|Protocol Violation|1|||
148800780|NCT01190891|536751324|FG001|Overall Study|Protocol Violation|0|||
148800781|NCT01190891|536751323|FG000|Overall Study|Withdrawal by Subject|5|||
148901752|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
148901753|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
148800782|NCT01190891|536751324|FG001|Overall Study|Withdrawal by Subject|0|||
148800783|NCT01926028|536751325|FG000|Overall Study|Lost to Follow-up|7|||
148800784|NCT01926028|536751326|FG001|Overall Study|Lost to Follow-up|6|||
148901754|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
148901755|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
148901756|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
148901757|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
148901758|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
148901759|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
148901760|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
148901761|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
148901762|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
148901763|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
148901764|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
148901765|NCT03773978|537124557|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
148901766|NCT03773978|537124558|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
148901767|NCT03773978|537124557|FG000|DBW Period|Adverse Event|2|||
148901768|NCT03773978|537124558|FG001|DBW Period|Adverse Event|2|||
148901769|NCT03773978|537124557|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
148901770|NCT03773978|537124558|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
148901771|NCT03773978|537124557|FG000|DBW Period|Withdrawal by Subject|2|||
148901772|NCT03773978|537124558|FG001|DBW Period|Withdrawal by Subject|1|||
148800785|NCT01926028|536751327|FG002|Overall Study|Lost to Follow-up|0|||
148800786|NCT01926028|536751325|FG000|Overall Study|Physician Decision|1|||
148800787|NCT01926028|536751326|FG001|Overall Study|Physician Decision|5|||
148800788|NCT01926028|536751327|FG002|Overall Study|Physician Decision|0|||
148901773|NCT03773978|537124557|FG000|DBW Period|Due to epidemic or pandemic|5|||
148901774|NCT03773978|537124558|FG001|DBW Period|Due to epidemic or pandemic|6|||
148901775|NCT03773978|537124557|FG000|DBW Period|Study team decision|1|||
148901776|NCT03773978|537124558|FG001|DBW Period|Study team decision|0|||
148901777|NCT00870740|537124559|FG000|Overall Study|Adverse Event|2|||
148901778|NCT00870740|537124560|FG001|Overall Study|Adverse Event|1|||
148901779|NCT00870740|537124561|FG002|Overall Study|Adverse Event|3|||
148901780|NCT00870740|537124562|FG003|Overall Study|Adverse Event|2|||
148901781|NCT00870740|537124563|FG004|Overall Study|Adverse Event|1|||
148901782|NCT00870740|537124564|FG005|Overall Study|Adverse Event|6|||
148901783|NCT00870740|537124559|FG000|Overall Study|Consent Withdrawn|6|||
148901784|NCT00870740|537124560|FG001|Overall Study|Consent Withdrawn|3|||
148901785|NCT00870740|537124561|FG002|Overall Study|Consent Withdrawn|4|||
148901786|NCT00870740|537124562|FG003|Overall Study|Consent Withdrawn|6|||
148901787|NCT00870740|537124563|FG004|Overall Study|Consent Withdrawn|6|||
148901788|NCT00870740|537124564|FG005|Overall Study|Consent Withdrawn|5|||
148901789|NCT00870740|537124559|FG000|Overall Study|Investigator Decision|2|||
148901790|NCT00870740|537124560|FG001|Overall Study|Investigator Decision|0|||
148901791|NCT00870740|537124561|FG002|Overall Study|Investigator Decision|1|||
148901792|NCT00870740|537124562|FG003|Overall Study|Investigator Decision|0|||
148901793|NCT00870740|537124563|FG004|Overall Study|Investigator Decision|0|||
148901794|NCT00870740|537124564|FG005|Overall Study|Investigator Decision|0|||
148901795|NCT00870740|537124559|FG000|Overall Study|Subject Non-compliance|0|||
148901796|NCT00870740|537124560|FG001|Overall Study|Subject Non-compliance|0|||
148901797|NCT00870740|537124561|FG002|Overall Study|Subject Non-compliance|0|||
148901798|NCT00870740|537124562|FG003|Overall Study|Subject Non-compliance|0|||
148901799|NCT00870740|537124563|FG004|Overall Study|Subject Non-compliance|0|||
148901800|NCT00870740|537124564|FG005|Overall Study|Subject Non-compliance|1|||
148901801|NCT00870740|537124559|FG000|Overall Study|Death|0|||
148901802|NCT00870740|537124560|FG001|Overall Study|Death|0|||
148901803|NCT00870740|537124561|FG002|Overall Study|Death|0|||
148800789|NCT01926028|536751325|FG000|Overall Study|Withdrawal by Subject|9|||
148800790|NCT01926028|536751326|FG001|Overall Study|Withdrawal by Subject|9|||
148800791|NCT01926028|536751327|FG002|Overall Study|Withdrawal by Subject|2|||
148800792|NCT01926028|536751325|FG000|Overall Study|Non compliance or other reasons|4|||
148800793|NCT01926028|536751326|FG001|Overall Study|Non compliance or other reasons|2|||
148800794|NCT01926028|536751327|FG002|Overall Study|Non compliance or other reasons|0|||
148800795|NCT00737048|536751328|FG000|Overall Study|Physician Decision|0|||
148800796|NCT00737048|536751329|FG001|Overall Study|Physician Decision|0|||
148800797|NCT00737048|536751330|FG002|Overall Study|Physician Decision|1|||
148800798|NCT00737048|536751328|FG000|Overall Study|Adverse Event|0|||
148800799|NCT00737048|536751329|FG001|Overall Study|Adverse Event|1|||
148800800|NCT00737048|536751330|FG002|Overall Study|Adverse Event|0|||
148800801|NCT00737048|536751328|FG000|Overall Study|Worsening of the symptoms|3|||
148800802|NCT00737048|536751329|FG001|Overall Study|Worsening of the symptoms|5|||
148800803|NCT00737048|536751330|FG002|Overall Study|Worsening of the symptoms|3|||
148800804|NCT04635839|536751331|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
148800805|NCT04635839|536751332|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
148800806|NCT02737358|536751333|FG000|Overall Study|Withdrawal by Subject|7|||
148800807|NCT02737358|536751334|FG001|Overall Study|Withdrawal by Subject|12|||
148800808|NCT02737358|536751333|FG000|Overall Study|Lost to Follow-up|2|||
148800809|NCT02737358|536751334|FG001|Overall Study|Lost to Follow-up|3|||
148800810|NCT00744939|536751336|FG000|Overall Study|Withdrawal by Subject|9|||
148800811|NCT00744939|536751336|FG000|Overall Study|Protocol Violation|13|||
148800812|NCT00744939|536751336|FG000|Overall Study|Death|24|||
148800813|NCT00744939|536751336|FG000|Overall Study|distance|4|||
148800814|NCT00744939|536751336|FG000|Overall Study|Lost to Follow-up|12|||
148800815|NCT00744939|536751336|FG000|Overall Study|Medical history exclusionary|1|||
148800816|NCT00744939|536751336|FG000|Overall Study|Did not receive Magnevist|7|||
148800817|NCT00744939|536751336|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
148800818|NCT00744939|536751336|FG000|Overall Study|coma|1|||
148800819|NCT00744939|536751336|FG000|Overall Study|incorrect race|1|||
148800820|NCT01739335|536751337|FG000|Overall Study|Lost to Follow-up|7|||
148800821|NCT01739335|536751338|FG001|Overall Study|Lost to Follow-up|4|||
148800822|NCT01739335|536751337|FG000|Overall Study|Ineligible patient randomized|0|||
148800823|NCT01739335|536751338|FG001|Overall Study|Ineligible patient randomized|1|||
148800824|NCT00288912|536751339|FG000|Overall Study|Developed exclusion criterion|4|||
148800825|NCT00288912|536751340|FG001|Overall Study|Developed exclusion criterion|6|||
148800826|NCT00288912|536751341|FG002|Overall Study|Developed exclusion criterion|7|||
148800827|NCT00288912|536751339|FG000|Overall Study|Lost to Follow-up|9|||
149138092|NCT02632721|537986916|FG003|Overall Study|Dose limiting toxicity|1|||
149138093|NCT02632721|537986917|FG004|Overall Study|Dose limiting toxicity|0|||
149138094|NCT02632721|537986913|FG000|Overall Study|Progressive disease|3|||
149138095|NCT02632721|537986914|FG001|Overall Study|Progressive disease|0|||
149138096|NCT02632721|537986915|FG002|Overall Study|Progressive disease|4|||
149138097|NCT02632721|537986916|FG003|Overall Study|Progressive disease|6|||
149138098|NCT02632721|537986917|FG004|Overall Study|Progressive disease|5|||
149138099|NCT02632721|537986913|FG000|Overall Study|Refused to continue taking trial medication|0|||
149138100|NCT02632721|537986914|FG001|Overall Study|Refused to continue taking trial medication|1|||
149138101|NCT02632721|537986915|FG002|Overall Study|Refused to continue taking trial medication|1|||
149138102|NCT02632721|537986916|FG003|Overall Study|Refused to continue taking trial medication|1|||
149138103|NCT02632721|537986917|FG004|Overall Study|Refused to continue taking trial medication|2|||
149138104|NCT02632721|537986913|FG000|Overall Study|Inadequate clinical condition|0|||
149138105|NCT02632721|537986914|FG001|Overall Study|Inadequate clinical condition|0|||
149138106|NCT02632721|537986915|FG002|Overall Study|Inadequate clinical condition|0|||
149138107|NCT02632721|537986916|FG003|Overall Study|Inadequate clinical condition|0|||
149138108|NCT02632721|537986917|FG004|Overall Study|Inadequate clinical condition|1|||
149138109|NCT02632721|537986913|FG000|Overall Study|No meet eligibility|0|||
149138110|NCT02632721|537986914|FG001|Overall Study|No meet eligibility|0|||
149138111|NCT02632721|537986915|FG002|Overall Study|No meet eligibility|0|||
149138112|NCT02632721|537986916|FG003|Overall Study|No meet eligibility|0|||
149138113|NCT02632721|537986917|FG004|Overall Study|No meet eligibility|1|||
149138114|NCT02632721|537986913|FG000|Overall Study|Allergic reaction|0|||
149138115|NCT02632721|537986914|FG001|Overall Study|Allergic reaction|0|||
149138116|NCT02632721|537986915|FG002|Overall Study|Allergic reaction|0|||
149138117|NCT02632721|537986916|FG003|Overall Study|Allergic reaction|1|||
149138118|NCT02632721|537986917|FG004|Overall Study|Allergic reaction|0|||
149138119|NCT02632721|537986913|FG000|Overall Study|Receiving Decitabine locally|0|||
149138120|NCT02632721|537986914|FG001|Overall Study|Receiving Decitabine locally|0|||
149138121|NCT02632721|537986915|FG002|Overall Study|Receiving Decitabine locally|1|||
149138122|NCT02632721|537986916|FG003|Overall Study|Receiving Decitabine locally|0|||
149138123|NCT02632721|537986917|FG004|Overall Study|Receiving Decitabine locally|0|||
149138124|NCT02632721|537986913|FG000|Overall Study|No benefit from study treatment|1|||
149138125|NCT02632721|537986914|FG001|Overall Study|No benefit from study treatment|1|||
149138126|NCT02632721|537986915|FG002|Overall Study|No benefit from study treatment|0|||
149138127|NCT02632721|537986916|FG003|Overall Study|No benefit from study treatment|0|||
149138128|NCT02632721|537986917|FG004|Overall Study|No benefit from study treatment|1|||
149138129|NCT02632721|537986913|FG000|Overall Study|Patient wish for other treatment|0|||
149138130|NCT02632721|537986914|FG001|Overall Study|Patient wish for other treatment|1|||
149138131|NCT02632721|537986915|FG002|Overall Study|Patient wish for other treatment|0|||
149138132|NCT02632721|537986916|FG003|Overall Study|Patient wish for other treatment|0|||
149138133|NCT02632721|537986917|FG004|Overall Study|Patient wish for other treatment|0|||
149138134|NCT02632721|537986913|FG000|Overall Study|Relapsed Pneumonia|0|||
149138135|NCT02632721|537986914|FG001|Overall Study|Relapsed Pneumonia|0|||
149138136|NCT02632721|537986915|FG002|Overall Study|Relapsed Pneumonia|0|||
149138137|NCT02632721|537986916|FG003|Overall Study|Relapsed Pneumonia|0|||
149138138|NCT02632721|537986917|FG004|Overall Study|Relapsed Pneumonia|1|||
149138139|NCT02632721|537986913|FG000|Overall Study|Therapy refractory AML|0|||
149138140|NCT02632721|537986914|FG001|Overall Study|Therapy refractory AML|0|||
149138141|NCT02632721|537986915|FG002|Overall Study|Therapy refractory AML|0|||
149138142|NCT02632721|537986916|FG003|Overall Study|Therapy refractory AML|0|||
149138143|NCT02632721|537986917|FG004|Overall Study|Therapy refractory AML|1|||
149138144|NCT02632721|537986913|FG000|Overall Study|Increase of white blood cell count|0|||
149138145|NCT02632721|537986914|FG001|Overall Study|Increase of white blood cell count|0|||
149138146|NCT02632721|537986915|FG002|Overall Study|Increase of white blood cell count|0|||
149138147|NCT02632721|537986916|FG003|Overall Study|Increase of white blood cell count|0|||
148800828|NCT00288912|536751340|FG001|Overall Study|Lost to Follow-up|6|||
148800829|NCT00288912|536751341|FG002|Overall Study|Lost to Follow-up|9|||
148800830|NCT00288912|536751339|FG000|Overall Study|Withdrawal by Subject|4|||
148800831|NCT00288912|536751340|FG001|Overall Study|Withdrawal by Subject|5|||
148800832|NCT00288912|536751341|FG002|Overall Study|Withdrawal by Subject|12|||
148800833|NCT01218308|536751346|FG000|Overall Study|Adverse Event|1|||
148800834|NCT01218308|536751347|FG001|Overall Study|Adverse Event|2|||
148800835|NCT01218308|536751346|FG000|Overall Study|Protocol Violation|0|||
148800836|NCT01218308|536751347|FG001|Overall Study|Protocol Violation|2|||
148800837|NCT01218308|536751346|FG000|Overall Study|Withdrawal by Subject|61|||
148800838|NCT01218308|536751347|FG001|Overall Study|Withdrawal by Subject|64|||
148800839|NCT01218308|536751346|FG000|Overall Study|Lost to Follow-up|27|||
148800840|NCT01218308|536751347|FG001|Overall Study|Lost to Follow-up|31|||
148800841|NCT01218308|536751346|FG000|Overall Study|Other|14|||
148800842|NCT01218308|536751347|FG001|Overall Study|Other|21|||
148800843|NCT02062437|536751348|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
148800844|NCT02062437|536751348|FG000|Overall Study|Patient not available for the 2y visit|18|||
148800845|NCT02062437|536751348|FG000|Overall Study|Death|2|||
148800846|NCT02062437|536751348|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
148800847|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
148901804|NCT00870740|537124562|FG003|Overall Study|Death|0|||
148901805|NCT00870740|537124563|FG004|Overall Study|Death|1|||
148800848|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
148800849|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
148800850|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
148800851|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
148800852|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
148800853|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
148800854|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
148800855|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
148800856|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
148800857|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
148800858|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
148800859|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
148800860|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
148800861|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
148800862|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
148800863|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
148901806|NCT00870740|537124564|FG005|Overall Study|Death|0|||
148901807|NCT00870740|537124559|FG000|Overall Study|Other|2|||
148901808|NCT00870740|537124560|FG001|Overall Study|Other|5|||
148901809|NCT00870740|537124561|FG002|Overall Study|Other|2|||
148901810|NCT00870740|537124562|FG003|Overall Study|Other|4|||
148901811|NCT00870740|537124563|FG004|Overall Study|Other|3|||
148901812|NCT00870740|537124564|FG005|Overall Study|Other|5|||
148901813|NCT03592186|537124565|FG000|Overall Study|Withdrawal by Subject|1|||
148901814|NCT03592186|537124566|FG001|Overall Study|Withdrawal by Subject|0|||
148901815|NCT03592186|537124565|FG000|Overall Study|Lost to Follow-up|16|||
148901816|NCT03592186|537124566|FG001|Overall Study|Lost to Follow-up|11|||
148901817|NCT01498068|537124567|FG000|Overall Study|Withdrawal by Subject|1|||
148901818|NCT01498068|537124568|FG001|Overall Study|Withdrawal by Subject|1|||
148901819|NCT00307801|537124569|FG000|Overall Study|Adverse Event|12|||
148901820|NCT00307801|537124570|FG001|Overall Study|Adverse Event|4|||
148901821|NCT00307801|537124569|FG000|Overall Study|Withdrawal by Subject|9|||
148901822|NCT00307801|537124570|FG001|Overall Study|Withdrawal by Subject|4|||
148901823|NCT00307801|537124569|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
148901824|NCT00307801|537124570|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
148901825|NCT00307801|537124569|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
148901826|NCT00307801|537124570|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
148901827|NCT00307801|537124569|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
148901828|NCT00307801|537124570|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
148901829|NCT00307801|537124569|FG000|Overall Study|Wrong Randomization|1|||
148901830|NCT00307801|537124570|FG001|Overall Study|Wrong Randomization|0|||
148901831|NCT00307801|537124569|FG000|Overall Study|Lack of Efficacy|0|||
148901832|NCT00307801|537124570|FG001|Overall Study|Lack of Efficacy|2|||
148901833|NCT00307801|537124569|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
148901834|NCT00307801|537124570|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
148901835|NCT00307801|537124569|FG000|Overall Study|Frustration with e-diary|1|||
148901836|NCT00307801|537124570|FG001|Overall Study|Frustration with e-diary|0|||
148901837|NCT00307801|537124569|FG000|Overall Study|Protocol Violation|3|||
148901838|NCT00307801|537124570|FG001|Overall Study|Protocol Violation|2|||
148901839|NCT00307801|537124569|FG000|Overall Study|No reason specified|2|||
148901840|NCT00307801|537124570|FG001|Overall Study|No reason specified|0|||
149138148|NCT02632721|537986917|FG004|Overall Study|Increase of white blood cell count|1|||
148901841|NCT00307801|537124569|FG000|Overall Study|Pregnancy|0|||
149138149|NCT02632721|537986913|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
149138150|NCT02632721|537986914|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
149138151|NCT02632721|537986915|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
149138152|NCT02632721|537986916|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
149138153|NCT02632721|537986917|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
149138154|NCT00544648|537986921|FG000|Overall Study|Withdrawal by Subject|1|||
149138155|NCT00544648|537986922|FG001|Overall Study|Withdrawal by Subject|0|||
149138156|NCT00544648|537986921|FG000|Overall Study|Adverse Event|1|||
149138157|NCT00544648|537986922|FG001|Overall Study|Adverse Event|1|||
149138158|NCT00544648|537986921|FG000|Overall Study|progression of disease|1|||
149138159|NCT00544648|537986922|FG001|Overall Study|progression of disease|0|||
149138160|NCT04166383|537986923|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
149138161|NCT04166383|537986923|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
149138162|NCT04166383|537986923|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
149138163|NCT03346057|537986924|FG000|Overall Study|Death|1|||
149138164|NCT03346057|537986925|FG001|Overall Study|Death|2|||
149138165|NCT03346057|537986926|FG002|Overall Study|Death|0|||
149138166|NCT03346057|537986927|FG003|Overall Study|Death|0|||
149138167|NCT03346057|537986924|FG000|Overall Study|Lost to Follow-up|0|||
149138168|NCT03346057|537986925|FG001|Overall Study|Lost to Follow-up|2|||
149138169|NCT03346057|537986926|FG002|Overall Study|Lost to Follow-up|1|||
149138170|NCT03346057|537986927|FG003|Overall Study|Lost to Follow-up|0|||
149138171|NCT03346057|537986924|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
149138172|NCT03346057|537986925|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
149138173|NCT03346057|537986926|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
149138174|NCT03346057|537986927|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
149138175|NCT03346057|537986924|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
149138176|NCT03346057|537986925|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
149138177|NCT03346057|537986926|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
149138178|NCT03346057|537986927|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
149138179|NCT03346057|537986924|FG000|Overall Study|Physician Decision|3|||
149138180|NCT03346057|537986925|FG001|Overall Study|Physician Decision|2|||
149138181|NCT03346057|537986926|FG002|Overall Study|Physician Decision|0|||
149138182|NCT03346057|537986927|FG003|Overall Study|Physician Decision|2|||
149138183|NCT03346057|537986924|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
149138184|NCT03346057|537986925|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
149138185|NCT03346057|537986926|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
149138186|NCT03346057|537986927|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
149138187|NCT03346057|537986924|FG000|Overall Study|Withdrawal by Subject|1|||
149138188|NCT03346057|537986925|FG001|Overall Study|Withdrawal by Subject|0|||
149138189|NCT03346057|537986926|FG002|Overall Study|Withdrawal by Subject|0|||
149138190|NCT03346057|537986927|FG003|Overall Study|Withdrawal by Subject|0|||
149138191|NCT04399122|537986928|FG000|Overall Study|Lost to Follow-up|2|||
149138192|NCT04399122|537986929|FG001|Overall Study|Lost to Follow-up|0|||
149138193|NCT04399122|537986928|FG000|Overall Study|Withdrawal by Subject|1|||
149138194|NCT04399122|537986929|FG001|Overall Study|Withdrawal by Subject|0|||
149138195|NCT01174238|537986933|FG000|Overall Study|Lost to Follow-up|2|||
149138196|NCT02322229|537986934|FG000|Overall Study|Physician Decision|2|||
149138197|NCT01102803|537986935|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
149138198|NCT01102803|537986936|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
149138199|NCT01102803|537986935|FG000|Post to Follow-Up|Lost to Follow-up|1|||
149138200|NCT01102803|537986936|FG001|Post to Follow-Up|Lost to Follow-up|3|||
149138201|NCT00705432|537986937|FG000|Treatment Period|Adverse Event|45|||
149138202|NCT00705432|537986938|FG001|Treatment Period|Adverse Event|37|||
149138203|NCT00705432|537986939|FG002|Treatment Period|Adverse Event|51|||
149138204|NCT00705432|537986940|FG003|Treatment Period|Adverse Event|12|||
149138205|NCT00705432|537986941|FG004|Treatment Period|Adverse Event|8|||
149138206|NCT00705432|537986942|FG005|Treatment Period|Adverse Event|9|||
149138207|NCT00705432|537986937|FG000|Treatment Period|Treatment failure|92|||
149138208|NCT00705432|537986938|FG001|Treatment Period|Treatment failure|42|||
149138209|NCT00705432|537986939|FG002|Treatment Period|Treatment failure|33|||
149138210|NCT00705432|537986940|FG003|Treatment Period|Treatment failure|25|||
149138211|NCT00705432|537986941|FG004|Treatment Period|Treatment failure|13|||
149138212|NCT00705432|537986942|FG005|Treatment Period|Treatment failure|14|||
149138213|NCT00705432|537986937|FG000|Treatment Period|Non medical reason|26|||
149138214|NCT00705432|537986938|FG001|Treatment Period|Non medical reason|32|||
149138215|NCT00705432|537986939|FG002|Treatment Period|Non medical reason|37|||
149138216|NCT00705432|537986940|FG003|Treatment Period|Non medical reason|4|||
149138217|NCT00705432|537986941|FG004|Treatment Period|Non medical reason|7|||
149138218|NCT00705432|537986942|FG005|Treatment Period|Non medical reason|7|||
149138219|NCT00705432|537986937|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
149138220|NCT00705432|537986938|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
149138221|NCT00705432|537986939|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
149138222|NCT00705432|537986940|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
149138223|NCT00705432|537986941|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
149138224|NCT00705432|537986942|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
149138225|NCT00705432|537986937|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
149138226|NCT00705432|537986938|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
149138227|NCT00705432|537986939|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
149138228|NCT00705432|537986940|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
149138229|NCT00705432|537986941|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
149138230|NCT00705432|537986942|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
149138231|NCT00521053|537986943|FG000|Observation Phase|Disease Progression|55|||
149138232|NCT00521053|537986943|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
149138233|NCT00521053|537986943|FG000|Observation Phase|Death|2|||
149138234|NCT00521053|537986943|FG000|Observation Phase|Adverse Event|1|||
149138235|NCT00521053|537986943|FG000|Observation Phase|Other non-study melanoma treatment|1|||
149138236|NCT00521053|537986943|FG000|Observation Phase|Physician Decision|1|||
149138237|NCT02281357|537986946|FG000|Overall Study|Adverse Event|2|||
149138238|NCT02281357|537986947|FG001|Overall Study|Adverse Event|1|||
149138239|NCT02281357|537986946|FG000|Overall Study|Lost to Follow-up|1|||
149138240|NCT02281357|537986947|FG001|Overall Study|Lost to Follow-up|0|||
149138241|NCT02281357|537986946|FG000|Overall Study|Withdrawal by Subject|4|||
149138242|NCT02281357|537986947|FG001|Overall Study|Withdrawal by Subject|3|||
149138243|NCT02684279|537986948|FG000|Overall Study|Adverse Event|87|||
149138244|NCT02684279|537986948|FG000|Overall Study|Lack of Efficacy|4|||
149138245|NCT02684279|537986948|FG000|Overall Study|Lost to Follow-up|61|||
149138246|NCT02684279|537986948|FG000|Overall Study|Protocol Violation|6|||
149138247|NCT02684279|537986948|FG000|Overall Study|Pregnancy|8|||
149138248|NCT02684279|537986948|FG000|Overall Study|Withdrawal by Subject|92|||
149138249|NCT02684279|537986948|FG000|Overall Study|non-compliance with study drug|9|||
149138250|NCT02684279|537986948|FG000|Overall Study|non compliance with study visits|2|||
149138251|NCT02684279|537986948|FG000|Overall Study|subject to have surgery|1|||
149138252|NCT02684279|537986948|FG000|Overall Study|family emergency|1|||
149138253|NCT02684279|537986948|FG000|Overall Study|Site closures|7|||
149138254|NCT02684279|537986948|FG000|Overall Study|Physician Decision|1|||
149138255|NCT01162239|537986949|FG000|Treatment Phase|Withdrawal by Subject|1|||
149138256|NCT01162239|537986950|FG001|Treatment Phase|Withdrawal by Subject|3|||
149138257|NCT01162239|537986951|FG002|Treatment Phase|Withdrawal by Subject|2|||
149138258|NCT01162239|537986952|FG003|Treatment Phase|Withdrawal by Subject|3|||
149138259|NCT01162239|537986949|FG000|Treatment Phase|Death|0|||
149138260|NCT01162239|537986950|FG001|Treatment Phase|Death|0|||
149138261|NCT01162239|537986951|FG002|Treatment Phase|Death|0|||
149138262|NCT01162239|537986952|FG003|Treatment Phase|Death|1|||
149138263|NCT01162239|537986949|FG000|Treatment Phase|Lost to Follow-up|5|||
149138264|NCT01162239|537986950|FG001|Treatment Phase|Lost to Follow-up|4|||
149138265|NCT01162239|537986951|FG002|Treatment Phase|Lost to Follow-up|2|||
149138266|NCT01162239|537986952|FG003|Treatment Phase|Lost to Follow-up|1|||
149138267|NCT01162239|537986949|FG000|Extended Follow-up|Lost to Follow-up|8|||
149138268|NCT01162239|537986950|FG001|Extended Follow-up|Lost to Follow-up|13|||
149138269|NCT01162239|537986951|FG002|Extended Follow-up|Lost to Follow-up|8|||
149138270|NCT01162239|537986952|FG003|Extended Follow-up|Lost to Follow-up|6|||
149138271|NCT00228566|537986953|FG000|Overall Study|Adverse Event|31|||
148800864|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
148800865|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
148800866|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
148800867|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
148800868|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
148901842|NCT00307801|537124570|FG001|Overall Study|Pregnancy|1|||
148901843|NCT03058146|537124572|FG000|Overall Study|Withdrawal by Subject|4|||
148800869|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
148800870|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
148800871|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
148800872|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
148901844|NCT03058146|537124573|FG001|Overall Study|Withdrawal by Subject|1|||
148901845|NCT03058146|537124572|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
148901846|NCT03058146|537124573|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
148901847|NCT00632229|537124574|FG000|Overall Study|Adverse Event|6|||
148901848|NCT00632229|537124575|FG001|Overall Study|Adverse Event|0|||
148901849|NCT00632229|537124574|FG000|Overall Study|Lost to Follow-up|0|||
148901850|NCT00632229|537124575|FG001|Overall Study|Lost to Follow-up|3|||
148901851|NCT00632229|537124574|FG000|Overall Study|Lack of Efficacy|0|||
148901852|NCT00632229|537124575|FG001|Overall Study|Lack of Efficacy|2|||
148800873|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
148800874|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
148800875|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
148800876|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
148800877|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
148800878|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
148800879|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
148800880|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
148800881|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
148800882|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
148800883|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
148800884|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
148800885|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
148800886|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
148800887|NCT02709746|536751349|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
148800888|NCT02709746|536751350|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
148800889|NCT02709746|536751351|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
148800890|NCT02709746|536751352|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
148800891|NCT02709746|536751353|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
148800892|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
148800893|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
148800894|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
148800895|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
148800896|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
148800897|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
148800898|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
148800899|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
148800900|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
148800901|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
148800902|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
148800903|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
148800904|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
148800905|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
148800906|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
148800907|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
148901853|NCT00632229|537124574|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
148800908|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
148800909|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
148800910|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
148800911|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
148800912|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
148800913|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
148800914|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
148800915|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
148800916|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
148800917|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
148800918|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
148800919|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
148800920|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
148800921|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
148800922|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
148800923|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
148800924|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
148800925|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
148800926|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
148800927|NCT02709746|536751349|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
148800928|NCT02709746|536751350|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
148800929|NCT02709746|536751351|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
148800930|NCT02709746|536751352|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
148800931|NCT02709746|536751353|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
148800932|NCT02900352|536751354|FG000|Overall Study|Lost to Follow-up|28|||
148800933|NCT02900352|536751355|FG001|Overall Study|Lost to Follow-up|17|||
148800934|NCT00752089|536751356|FG000|Overall Study|Adverse Event|1|||
148800935|NCT00752089|536751356|FG000|Overall Study|Protocol Deviation|2|||
148800936|NCT00752089|536751356|FG000|Overall Study|Could not attend visit 9|1|||
148800937|NCT00752089|536751356|FG000|Overall Study|Not capable of wearing partial denture|1|||
148800938|NCT00752089|536751356|FG000|Overall Study|Cannot continue the study|1|||
148901854|NCT00632229|537124575|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
148800939|NCT00975416|536751357|FG000|Overall Study|early discharge from tx|3|||
148800940|NCT00975416|536751358|FG001|Overall Study|early discharge from tx|5|||
148800941|NCT00106002|536751360|FG000|Overall Study|Did not take any study drug|1|||
148800942|NCT00106002|536751360|FG000|Overall Study|Ineligible after Registration|1|||
148800943|NCT00630916|536751366|FG000|Overall Study|Death|110|||
148800944|NCT00630916|536751366|FG000|Overall Study|Explant|8|||
148800945|NCT00630916|536751366|FG000|Overall Study|Lost to Follow-up|5|||
148800946|NCT00630916|536751366|FG000|Overall Study|Withdrawal by Subject|30|||
148800947|NCT00630916|536751366|FG000|Overall Study|Protocol Violation|7|||
148800948|NCT00630916|536751366|FG000|Overall Study|Physician Decision|47|||
148800949|NCT00630916|536751366|FG000|Overall Study|Lack of Efficacy|3|||
148800950|NCT02295644|536751368|FG000|Overall Study|Did not meet inclusion criterion|0|||
148800951|NCT02295644|536751369|FG001|Overall Study|Did not meet inclusion criterion|0|||
148800952|NCT02295644|536751370|FG002|Overall Study|Did not meet inclusion criterion|1|||
148800953|NCT02295644|536751371|FG003|Overall Study|Did not meet inclusion criterion|2|||
148800954|NCT02147626|536751372|FG000|Overall Study|Lost to Follow-up|4|||
148800955|NCT02147626|536751373|FG001|Overall Study|Lost to Follow-up|4|||
148800956|NCT02147626|536751372|FG000|Overall Study|Pregnancy|1|||
148800957|NCT02147626|536751373|FG001|Overall Study|Pregnancy|2|||
148800958|NCT02147626|536751372|FG000|Overall Study|Withdrawal by Subject|0|||
148800959|NCT02147626|536751373|FG001|Overall Study|Withdrawal by Subject|1|||
148800960|NCT03504917|536751374|FG000|Blinded Treatment Period|Protocol Violation|1|||
148800961|NCT03504917|536751375|FG001|Blinded Treatment Period|Protocol Violation|0|||
148800962|NCT03504917|536751374|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
148800963|NCT03504917|536751375|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
148800964|NCT03504917|536751374|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
149138272|NCT00228566|537986953|FG000|Overall Study|Lack of Efficacy|14|||
149138273|NCT00228566|537986953|FG000|Overall Study|Lost to Follow-up|16|||
149138274|NCT00228566|537986953|FG000|Overall Study|Physician Decision|5|||
149138275|NCT00228566|537986953|FG000|Overall Study|Withdrawal by Subject|4|||
149138276|NCT00228566|537986953|FG000|Overall Study|Miscellaneous|1|||
149138277|NCT04448756|537986956|FG000|Overall Study|Adverse Event|0|||
149138278|NCT04448756|537986957|FG001|Overall Study|Adverse Event|1|||
149138279|NCT04448756|537986958|FG002|Overall Study|Adverse Event|0|||
149138280|NCT04448756|537986956|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
149138281|NCT04448756|537986957|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
149138282|NCT04448756|537986958|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
149138283|NCT04448756|537986956|FG000|Overall Study|Withdrawal by Subject|0|||
149138284|NCT04448756|537986957|FG001|Overall Study|Withdrawal by Subject|3|||
149138285|NCT04448756|537986958|FG002|Overall Study|Withdrawal by Subject|1|||
149138286|NCT04448756|537986956|FG000|Overall Study|Death|2|||
149138287|NCT04448756|537986957|FG001|Overall Study|Death|1|||
149138288|NCT04448756|537986958|FG002|Overall Study|Death|0|||
149138289|NCT02733185|537986959|FG000|Overall Study|Withdrawal by Subject|12|||
149138290|NCT02733185|537986960|FG001|Overall Study|Withdrawal by Subject|10|||
149138291|NCT02733185|537986961|FG002|Overall Study|Withdrawal by Subject|17|||
149138292|NCT02733185|537986962|FG003|Overall Study|Withdrawal by Subject|21|||
149138293|NCT02733185|537986959|FG000|Overall Study|Death|46|||
149138294|NCT02733185|537986960|FG001|Overall Study|Death|34|||
149138295|NCT02733185|537986961|FG002|Overall Study|Death|35|||
149138296|NCT02733185|537986962|FG003|Overall Study|Death|43|||
149138297|NCT02733185|537986959|FG000|Overall Study|Lost to Follow-up|17|||
149138298|NCT02733185|537986960|FG001|Overall Study|Lost to Follow-up|18|||
149138299|NCT02733185|537986961|FG002|Overall Study|Lost to Follow-up|16|||
149138300|NCT02733185|537986962|FG003|Overall Study|Lost to Follow-up|11|||
148901855|NCT03224819|537124577|FG000|Overall Study|Withdrawal by Subject|0|||
149138301|NCT01624259|537986963|FG000|Overall Study|Adverse Event|18|||
149138302|NCT01624259|537986964|FG001|Overall Study|Adverse Event|18|||
149138303|NCT01624259|537986963|FG000|Overall Study|Protocol Violation|1|||
149138304|NCT01624259|537986964|FG001|Overall Study|Protocol Violation|2|||
149138305|NCT01624259|537986963|FG000|Overall Study|Withdrawal by Subject|5|||
149138306|NCT01624259|537986964|FG001|Overall Study|Withdrawal by Subject|7|||
149138307|NCT01624259|537986963|FG000|Overall Study|Physician Decision|1|||
149138308|NCT01624259|537986964|FG001|Overall Study|Physician Decision|1|||
149138309|NCT01624259|537986963|FG000|Overall Study|Lost to Follow-up|2|||
149138310|NCT01624259|537986964|FG001|Overall Study|Lost to Follow-up|3|||
149138311|NCT01624259|537986963|FG000|Overall Study|Abnormal laboratory measure|3|||
149138312|NCT01624259|537986964|FG001|Overall Study|Abnormal laboratory measure|0|||
149138313|NCT02877927|537986970|FG000|Overall Study|Adverse Event|1|||
149138314|NCT02877927|537986971|FG001|Overall Study|Adverse Event|0|||
149138315|NCT02877927|537986970|FG000|Overall Study|Lost to Follow-up|37|||
149138316|NCT02877927|537986971|FG001|Overall Study|Lost to Follow-up|38|||
149138317|NCT02877927|537986970|FG000|Overall Study|Withdrawal by Subject|11|||
149138318|NCT02877927|537986971|FG001|Overall Study|Withdrawal by Subject|12|||
149138319|NCT02877927|537986970|FG000|Overall Study|Physician Decision|0|||
149138320|NCT02877927|537986971|FG001|Overall Study|Physician Decision|1|||
149138321|NCT02877927|537986970|FG000|Overall Study|Missed EOT/PTE Visit|5|||
149138322|NCT02877927|537986971|FG001|Overall Study|Missed EOT/PTE Visit|6|||
149138323|NCT00601250|537986972|FG000|Overall Study|Adverse Event|3|||
149138324|NCT00601250|537986973|FG001|Overall Study|Adverse Event|9|||
149138325|NCT00601250|537986972|FG000|Overall Study|Protocol Violation|3|||
149138326|NCT00601250|537986973|FG001|Overall Study|Protocol Violation|2|||
149138327|NCT00601250|537986972|FG000|Overall Study|Lost to Follow-up|2|||
149138328|NCT00601250|537986973|FG001|Overall Study|Lost to Follow-up|6|||
149138329|NCT00601250|537986972|FG000|Overall Study|Withdrawal by Subject|4|||
149138330|NCT00601250|537986973|FG001|Overall Study|Withdrawal by Subject|13|||
149138331|NCT00601250|537986972|FG000|Overall Study|Other incl. lack of efficacy|2|||
149138332|NCT00601250|537986973|FG001|Overall Study|Other incl. lack of efficacy|9|||
149138333|NCT01810016|537986974|FG000|Overall Study|Progressive disease|1|||
149138334|NCT01810016|537986975|FG001|Overall Study|Progressive disease|1|||
149138335|NCT01810016|537986976|FG002|Overall Study|Progressive disease|0|||
149138336|NCT01810016|537986974|FG000|Overall Study|Death|0|||
149138337|NCT01810016|537986975|FG001|Overall Study|Death|0|||
149138338|NCT01810016|537986976|FG002|Overall Study|Death|1|||
149138339|NCT02246582|537988840|FG000|Overall Study|Withdrawal by Subject|3|||
149138340|NCT02246582|537988841|FG001|Overall Study|Withdrawal by Subject|4|||
149138341|NCT02229539|537988842|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
149138342|NCT02229539|537988843|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
149138343|NCT02229539|537988844|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
149138344|NCT02229539|537988842|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
149138345|NCT02229539|537988843|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
149138346|NCT02229539|537988844|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
149138347|NCT02229539|537988842|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
149138348|NCT02229539|537988843|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
149138349|NCT02229539|537988844|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
149138350|NCT02229539|537988842|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
149138351|NCT02229539|537988843|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
149138352|NCT02229539|537988844|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
149138353|NCT02229539|537988842|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
149138354|NCT02229539|537988843|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
149138355|NCT02229539|537988844|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
149138356|NCT02229539|537988842|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
149138357|NCT02229539|537988843|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
149138358|NCT02229539|537988844|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
149138359|NCT02060383|537988846|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
149138360|NCT02060383|537988847|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
149138361|NCT02060383|537988848|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
149138362|NCT02060383|537988849|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
149138363|NCT02060383|537988850|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
149138364|NCT02060383|537988846|FG000|Core Phase|Adverse Event|2|||
149138365|NCT02060383|537988847|FG001|Core Phase|Adverse Event|0|||
149138366|NCT02060383|537988848|FG002|Core Phase|Adverse Event|0|||
149138367|NCT02060383|537988849|FG003|Core Phase|Adverse Event|2|||
149138368|NCT02060383|537988850|FG004|Core Phase|Adverse Event|6|||
149138369|NCT02060383|537988846|FG000|Core Phase|Administrative problems|0|||
149138370|NCT02060383|537988847|FG001|Core Phase|Administrative problems|1|||
149138371|NCT02060383|537988848|FG002|Core Phase|Administrative problems|0|||
149138372|NCT02060383|537988849|FG003|Core Phase|Administrative problems|0|||
148901856|NCT03224819|537124578|FG001|Overall Study|Withdrawal by Subject|0|||
148901857|NCT03224819|537124579|FG002|Overall Study|Withdrawal by Subject|0|||
148901858|NCT03224819|537124580|FG003|Overall Study|Withdrawal by Subject|0|||
148901859|NCT03224819|537124581|FG004|Overall Study|Withdrawal by Subject|0|||
148901860|NCT03224819|537124582|FG005|Overall Study|Withdrawal by Subject|0|||
148901861|NCT03224819|537124583|FG006|Overall Study|Withdrawal by Subject|0|||
148901862|NCT03224819|537124584|FG007|Overall Study|Withdrawal by Subject|0|||
148901863|NCT03224819|537124585|FG008|Overall Study|Withdrawal by Subject|0|||
148901864|NCT03224819|537124586|FG009|Overall Study|Withdrawal by Subject|0|||
148901865|NCT03224819|537124587|FG010|Overall Study|Withdrawal by Subject|0|||
148901866|NCT03224819|537124588|FG011|Overall Study|Withdrawal by Subject|0|||
148901867|NCT03224819|537124589|FG012|Overall Study|Withdrawal by Subject|1|||
148901868|NCT03224819|537124590|FG013|Overall Study|Withdrawal by Subject|0|||
148800965|NCT03504917|536751375|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
148800966|NCT03504917|536751374|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
148800967|NCT03504917|536751375|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
148800968|NCT03504917|536751374|FG000|Blinded Treatment Period|Adverse Event|4|||
148800969|NCT03504917|536751375|FG001|Blinded Treatment Period|Adverse Event|4|||
148800970|NCT03504917|536751374|FG000|Blinded Treatment Period|Physician Decision|1|||
148800971|NCT03504917|536751375|FG001|Blinded Treatment Period|Physician Decision|0|||
148800972|NCT03504917|536751374|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
148800973|NCT03504917|536751375|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
148800974|NCT03504917|536751374|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
148800975|NCT03504917|536751375|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
148800976|NCT03504917|536751374|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
148800977|NCT03504917|536751375|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
148800978|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
148800979|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
148800980|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
148800981|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
148800982|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
148800983|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
148800984|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
148800985|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
148800986|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
148800987|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
148800988|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
148800989|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
148800990|NCT03504917|536751374|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
148800991|NCT03504917|536751375|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
148800992|NCT01299584|536751376|FG000|Overall Study|Protocol Violation|9|||
148800993|NCT00572832|536751377|FG000|Overall Study|Lost to Follow-up|0|||
148800994|NCT00572832|536751378|FG001|Overall Study|Lost to Follow-up|11|||
148800995|NCT00572832|536751377|FG000|Overall Study|Pregnancy|0|||
148800996|NCT00572832|536751378|FG001|Overall Study|Pregnancy|1|||
148800997|NCT00324155|536751379|FG000|Enrolled and Randomized|No longer met study criteria|3|||
148800998|NCT00324155|536751380|FG001|Enrolled and Randomized|No longer met study criteria|0|||
148800999|NCT00324155|536751379|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
148801000|NCT00324155|536751380|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
148801001|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
148801002|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
148801003|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
148801004|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
148801005|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Death|8|||
148901869|NCT03224819|537124577|FG000|Overall Study|Sponsor Decision|0|||
148801006|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Death|15|||
148801007|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
148801008|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
148801009|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
148801010|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
148801011|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
148801012|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
148801013|NCT00324155|536751379|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
148801014|NCT00324155|536751380|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
148801015|NCT00324155|536751379|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
148801016|NCT00324155|536751380|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
148801017|NCT00324155|536751379|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
148801018|NCT00324155|536751380|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
148801019|NCT00324155|536751379|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
148901870|NCT03224819|537124578|FG001|Overall Study|Sponsor Decision|0|||
148901871|NCT03224819|537124579|FG002|Overall Study|Sponsor Decision|0|||
148901872|NCT03224819|537124580|FG003|Overall Study|Sponsor Decision|1|||
148901873|NCT03224819|537124581|FG004|Overall Study|Sponsor Decision|1|||
148901874|NCT03224819|537124582|FG005|Overall Study|Sponsor Decision|2|||
148901875|NCT03224819|537124583|FG006|Overall Study|Sponsor Decision|1|||
148901876|NCT03224819|537124584|FG007|Overall Study|Sponsor Decision|1|||
148901877|NCT03224819|537124585|FG008|Overall Study|Sponsor Decision|1|||
148901878|NCT03224819|537124586|FG009|Overall Study|Sponsor Decision|2|||
148901879|NCT03224819|537124587|FG010|Overall Study|Sponsor Decision|1|||
148901880|NCT03224819|537124588|FG011|Overall Study|Sponsor Decision|1|||
148901881|NCT03224819|537124589|FG012|Overall Study|Sponsor Decision|1|||
148901882|NCT03224819|537124590|FG013|Overall Study|Sponsor Decision|0|||
148901883|NCT03224819|537124577|FG000|Overall Study|Lost to Follow-up|0|||
148901884|NCT03224819|537124578|FG001|Overall Study|Lost to Follow-up|0|||
148901885|NCT03224819|537124579|FG002|Overall Study|Lost to Follow-up|0|||
148901886|NCT03224819|537124580|FG003|Overall Study|Lost to Follow-up|0|||
148901887|NCT03224819|537124581|FG004|Overall Study|Lost to Follow-up|0|||
148901888|NCT03224819|537124582|FG005|Overall Study|Lost to Follow-up|0|||
148901889|NCT03224819|537124583|FG006|Overall Study|Lost to Follow-up|0|||
148901890|NCT03224819|537124584|FG007|Overall Study|Lost to Follow-up|0|||
148901891|NCT03224819|537124585|FG008|Overall Study|Lost to Follow-up|1|||
148901892|NCT03224819|537124586|FG009|Overall Study|Lost to Follow-up|0|||
148901893|NCT03224819|537124587|FG010|Overall Study|Lost to Follow-up|0|||
148901894|NCT03224819|537124588|FG011|Overall Study|Lost to Follow-up|0|||
148901895|NCT03224819|537124589|FG012|Overall Study|Lost to Follow-up|0|||
148901896|NCT03224819|537124590|FG013|Overall Study|Lost to Follow-up|0|||
148901897|NCT03224819|537124577|FG000|Overall Study|Death|0|||
148901898|NCT03224819|537124578|FG001|Overall Study|Death|1|||
148801020|NCT00324155|536751380|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
148801021|NCT00324155|536751379|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
148801022|NCT00324155|536751380|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
148801023|NCT00324155|536751379|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
148801024|NCT00324155|536751380|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
148801025|NCT00324155|536751379|FG000|Follow-up Phase|On-going participants still on drug|11|||
148801026|NCT00324155|536751380|FG001|Follow-up Phase|On-going participants still on drug|6|||
148801027|NCT00390689|536751381|FG000|Overall Study|Adverse Event|2|||
148801028|NCT00390689|536751382|FG001|Overall Study|Adverse Event|5|||
148801029|NCT00390689|536751383|FG002|Overall Study|Adverse Event|2|||
148801030|NCT00390689|536751381|FG000|Overall Study|Lack of Efficacy|0|||
148801031|NCT00390689|536751382|FG001|Overall Study|Lack of Efficacy|0|||
148801032|NCT00390689|536751383|FG002|Overall Study|Lack of Efficacy|1|||
148801033|NCT00390689|536751381|FG000|Overall Study|Protocol Violation|1|||
148801034|NCT00390689|536751382|FG001|Overall Study|Protocol Violation|0|||
148801035|NCT00390689|536751383|FG002|Overall Study|Protocol Violation|0|||
148801036|NCT00390689|536751381|FG000|Overall Study|Investigator's judgement|2|||
148801037|NCT00390689|536751382|FG001|Overall Study|Investigator's judgement|0|||
148801038|NCT00390689|536751383|FG002|Overall Study|Investigator's judgement|0|||
148801039|NCT01253161|536751384|FG000|Overall Study|Adverse Event|1|||
148801040|NCT03101020|536751386|FG000|Overall Study|Lack of time to participate|1|||
148801041|NCT03101020|536751387|FG001|Overall Study|Lack of time to participate|0|||
148801042|NCT03101020|536751386|FG000|Overall Study|Ran over by a car|0|||
148801043|NCT03101020|536751387|FG001|Overall Study|Ran over by a car|1|||
148801044|NCT03101020|536751386|FG000|Overall Study|Withdrawal by Subject|0|||
148801045|NCT03101020|536751387|FG001|Overall Study|Withdrawal by Subject|2|||
148801046|NCT01924533|536751388|FG000|Overall Study|Death|181|||
148801047|NCT01924533|536751389|FG001|Overall Study|Death|200|||
148801048|NCT01924533|536751388|FG000|Overall Study|Lost to Follow-up|0|||
148801049|NCT01924533|536751389|FG001|Overall Study|Lost to Follow-up|1|||
148801050|NCT01924533|536751388|FG000|Overall Study|Withdrawal by Subject|7|||
148801051|NCT01924533|536751389|FG001|Overall Study|Withdrawal by Subject|3|||
148801052|NCT01924533|536751388|FG000|Overall Study|Other Eligibility criteria|1|||
148801053|NCT01924533|536751389|FG001|Overall Study|Other Eligibility criteria|1|||
148901899|NCT03224819|537124579|FG002|Overall Study|Death|0|||
148801054|NCT04233879|536751390|FG000|Overall Study|Death|2|||
148801055|NCT04233879|536751391|FG001|Overall Study|Death|0|||
148801056|NCT04233879|536751390|FG000|Overall Study|Lost to Follow-up|3|||
148801057|NCT04233879|536751391|FG001|Overall Study|Lost to Follow-up|8|||
149138373|NCT02060383|537988850|FG004|Core Phase|Administrative problems|0|||
149138374|NCT02060383|537988846|FG000|Core Phase|Protocol Violation|0|||
148801058|NCT04233879|536751390|FG000|Overall Study|Physician Decision|4|||
149138375|NCT02060383|537988847|FG001|Core Phase|Protocol Violation|0|||
149138376|NCT02060383|537988848|FG002|Core Phase|Protocol Violation|0|||
149138377|NCT02060383|537988849|FG003|Core Phase|Protocol Violation|1|||
149138378|NCT02060383|537988850|FG004|Core Phase|Protocol Violation|0|||
149138379|NCT02060383|537988846|FG000|Core Phase|Withdrawal by Subject|0|||
149138380|NCT02060383|537988847|FG001|Core Phase|Withdrawal by Subject|0|||
149138381|NCT02060383|537988848|FG002|Core Phase|Withdrawal by Subject|0|||
149138382|NCT02060383|537988849|FG003|Core Phase|Withdrawal by Subject|4|||
149138383|NCT02060383|537988850|FG004|Core Phase|Withdrawal by Subject|2|||
149138384|NCT02060383|537988846|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
149138385|NCT02060383|537988847|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
149138386|NCT02060383|537988848|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
149138387|NCT02060383|537988849|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
149138388|NCT02060383|537988850|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
149138389|NCT02060383|537988846|FG000|Extension Phase|Adverse Event|1|||
149138390|NCT02060383|537988847|FG001|Extension Phase|Adverse Event|1|||
149138391|NCT02060383|537988848|FG002|Extension Phase|Adverse Event|2|||
149138392|NCT02060383|537988849|FG003|Extension Phase|Adverse Event|0|||
149138393|NCT02060383|537988850|FG004|Extension Phase|Adverse Event|1|||
149138394|NCT02060383|537988846|FG000|Extension Phase|Withdrawal by Subject|0|||
148801059|NCT04233879|536751391|FG001|Overall Study|Physician Decision|4|||
148801060|NCT04233879|536751390|FG000|Overall Study|Withdrawal by Subject|7|||
148801061|NCT04233879|536751391|FG001|Overall Study|Withdrawal by Subject|10|||
148801062|NCT04233879|536751390|FG000|Overall Study|Other|281|||
148801063|NCT04233879|536751391|FG001|Overall Study|Other|279|||
148801064|NCT03810183|536751392|FG000|Overall Study|Study terminated by Sponsor|2|||
148801065|NCT03810183|536751393|FG001|Overall Study|Study terminated by Sponsor|1|||
148801066|NCT04275336|536751394|FG000|Overall Study|First venipuncture failed|4|||
148801067|NCT04275336|536751395|FG001|Overall Study|First venipuncture failed|6|||
148801068|NCT04275336|536751396|FG002|Overall Study|First venipuncture failed|5|||
148801069|NCT04275336|536751394|FG000|Overall Study|Unscheduled venipuncture|9|||
148801070|NCT04275336|536751395|FG001|Overall Study|Unscheduled venipuncture|13|||
148801071|NCT04275336|536751396|FG002|Overall Study|Unscheduled venipuncture|7|||
148801072|NCT04275336|536751394|FG000|Overall Study|Failed specimen of saliva|4|||
148801073|NCT04275336|536751395|FG001|Overall Study|Failed specimen of saliva|3|||
148801074|NCT04275336|536751396|FG002|Overall Study|Failed specimen of saliva|4|||
148801075|NCT03167242|536751397|FG000|Overall Study|Patient/Guardian Decision|0|||
148801076|NCT03167242|536751398|FG001|Overall Study|Patient/Guardian Decision|1|||
148801077|NCT03167242|536751399|FG002|Overall Study|Patient/Guardian Decision|2|||
148801078|NCT03167242|536751400|FG003|Overall Study|Patient/Guardian Decision|1|||
148801079|NCT03167242|536751401|FG004|Overall Study|Patient/Guardian Decision|1|||
148801080|NCT03167242|536751402|FG005|Overall Study|Patient/Guardian Decision|1|||
148801081|NCT03167242|536751403|FG006|Overall Study|Patient/Guardian Decision|0|||
148801082|NCT03167242|536751404|FG007|Overall Study|Patient/Guardian Decision|0|||
148801083|NCT03167242|536751405|FG008|Overall Study|Patient/Guardian Decision|0|||
148801084|NCT03167242|536751406|FG009|Overall Study|Patient/Guardian Decision|0|||
148801085|NCT03167242|536751407|FG010|Overall Study|Patient/Guardian Decision|1|||
148801086|NCT03167242|536751408|FG011|Overall Study|Patient/Guardian Decision|0|||
148801087|NCT03167242|536751397|FG000|Overall Study|Lost to Follow-up|0|||
148801088|NCT03167242|536751398|FG001|Overall Study|Lost to Follow-up|0|||
148801089|NCT03167242|536751399|FG002|Overall Study|Lost to Follow-up|1|||
148801090|NCT03167242|536751400|FG003|Overall Study|Lost to Follow-up|0|||
148801091|NCT03167242|536751401|FG004|Overall Study|Lost to Follow-up|0|||
148801092|NCT03167242|536751402|FG005|Overall Study|Lost to Follow-up|1|||
148801093|NCT03167242|536751403|FG006|Overall Study|Lost to Follow-up|2|||
148801094|NCT03167242|536751404|FG007|Overall Study|Lost to Follow-up|1|||
148801095|NCT03167242|536751405|FG008|Overall Study|Lost to Follow-up|0|||
148801096|NCT03167242|536751406|FG009|Overall Study|Lost to Follow-up|0|||
148801097|NCT03167242|536751407|FG010|Overall Study|Lost to Follow-up|1|||
148801098|NCT03167242|536751408|FG011|Overall Study|Lost to Follow-up|1|||
148801099|NCT03167242|536751397|FG000|Overall Study|Reason not provided|0|||
148801100|NCT03167242|536751398|FG001|Overall Study|Reason not provided|0|||
148801101|NCT03167242|536751399|FG002|Overall Study|Reason not provided|0|||
148801102|NCT03167242|536751400|FG003|Overall Study|Reason not provided|0|||
148801103|NCT03167242|536751401|FG004|Overall Study|Reason not provided|0|||
148801104|NCT03167242|536751402|FG005|Overall Study|Reason not provided|0|||
148801105|NCT03167242|536751403|FG006|Overall Study|Reason not provided|0|||
148801106|NCT03167242|536751404|FG007|Overall Study|Reason not provided|0|||
148801107|NCT03167242|536751405|FG008|Overall Study|Reason not provided|1|||
148801108|NCT03167242|536751406|FG009|Overall Study|Reason not provided|0|||
148801109|NCT03167242|536751407|FG010|Overall Study|Reason not provided|0|||
148801110|NCT03167242|536751408|FG011|Overall Study|Reason not provided|0|||
148801111|NCT00069264|536751413|FG000|Overall Study|Adverse Event|3|||
148801112|NCT00069264|536751413|FG000|Overall Study|Progressive Disease|23|||
148801113|NCT00069264|536751413|FG000|Overall Study|Withdrawal by Subject|3|||
148801114|NCT00069264|536751413|FG000|Overall Study|Discon Therapy|3|||
148801115|NCT03177148|536751414|FG000|Overall Study|Lost to Follow-up|50|||
148801116|NCT03177148|536751415|FG001|Overall Study|Lost to Follow-up|1|||
148801117|NCT03177148|536751414|FG000|Overall Study|Death|1|||
148801118|NCT03177148|536751415|FG001|Overall Study|Death|0|||
148801119|NCT00577317|536751416|FG000|Overall Study|Study Terminated|0|||
148801120|NCT00577317|536751417|FG001|Overall Study|Study Terminated|2|||
148801121|NCT00846586|536751425|FG000|Overall Study|Adverse Event|20|||
148801122|NCT00846586|536751426|FG001|Overall Study|Adverse Event|10|||
148801123|NCT00846586|536751425|FG000|Overall Study|Subject withdrew consent|8|||
148801124|NCT00846586|536751426|FG001|Overall Study|Subject withdrew consent|10|||
148801125|NCT00846586|536751425|FG000|Overall Study|Administrative problems|5|||
148801126|NCT00846586|536751426|FG001|Overall Study|Administrative problems|4|||
148801127|NCT00846586|536751425|FG000|Overall Study|Death|2|||
148801128|NCT00846586|536751426|FG001|Overall Study|Death|0|||
148901900|NCT03224819|537124580|FG003|Overall Study|Death|0|||
148901901|NCT03224819|537124581|FG004|Overall Study|Death|0|||
148901902|NCT03224819|537124582|FG005|Overall Study|Death|0|||
148901903|NCT03224819|537124583|FG006|Overall Study|Death|0|||
148901904|NCT03224819|537124584|FG007|Overall Study|Death|1|||
148901905|NCT03224819|537124585|FG008|Overall Study|Death|0|||
148901906|NCT03224819|537124586|FG009|Overall Study|Death|0|||
148901907|NCT03224819|537124587|FG010|Overall Study|Death|0|||
148901908|NCT03224819|537124588|FG011|Overall Study|Death|1|||
148901909|NCT03224819|537124589|FG012|Overall Study|Death|0|||
148901910|NCT03224819|537124590|FG013|Overall Study|Death|0|||
148901911|NCT00737672|537124597|FG000|Overall Study|Graft Abandonment|48|||
148901912|NCT00737672|537124598|FG001|Overall Study|Graft Abandonment|56|||
148901913|NCT00737672|537124597|FG000|Overall Study|Death|23|||
148901914|NCT00737672|537124598|FG001|Overall Study|Death|22|||
148901915|NCT00737672|537124597|FG000|Overall Study|Withdrawal by Subject|1|||
148901916|NCT00737672|537124598|FG001|Overall Study|Withdrawal by Subject|2|||
148901917|NCT00737672|537124597|FG000|Overall Study|Lost to Follow-up|1|||
148901918|NCT00737672|537124598|FG001|Overall Study|Lost to Follow-up|0|||
148901919|NCT00737672|537124597|FG000|Overall Study|Miscellaneous|7|||
148901920|NCT00737672|537124598|FG001|Overall Study|Miscellaneous|1|||
148901921|NCT00737672|537124597|FG000|Overall Study|Physician Decision|0|||
148901922|NCT00737672|537124598|FG001|Overall Study|Physician Decision|2|||
148901923|NCT02002598|537124602|FG000|Dose Level 1|Withdrawal by Subject|1|||
148901924|NCT02002598|537124603|FG001|Dose Level 1|Withdrawal by Subject|0|||
148901925|NCT02002598|537124604|FG002|Dose Level 1|Withdrawal by Subject|0|||
148901926|NCT02002598|537124605|FG003|Dose Level 1|Withdrawal by Subject|0|||
148901927|NCT02002598|537124606|FG004|Dose Level 1|Withdrawal by Subject|0|||
148901928|NCT04672239|537124607|FG000|Week 2 Survey|Failed survey check items|1|||
148901929|NCT04672239|537124608|FG001|Week 2 Survey|Failed survey check items|2|||
148901930|NCT04672239|537124609|FG002|Week 2 Survey|Failed survey check items|3|||
148901931|NCT04672239|537124607|FG000|Week 2 Survey|Partially completed survey|7|||
148901932|NCT04672239|537124608|FG001|Week 2 Survey|Partially completed survey|1|||
148901933|NCT04672239|537124609|FG002|Week 2 Survey|Partially completed survey|4|||
148901934|NCT04672239|537124607|FG000|Week 2 Survey|Withdrawal by Subject|0|||
148901935|NCT04672239|537124608|FG001|Week 2 Survey|Withdrawal by Subject|1|||
148901936|NCT04672239|537124609|FG002|Week 2 Survey|Withdrawal by Subject|0|||
148901937|NCT04672239|537124607|FG000|Week 2 Survey|Lost to Follow-up|3|||
148901938|NCT04672239|537124608|FG001|Week 2 Survey|Lost to Follow-up|2|||
148901939|NCT04672239|537124609|FG002|Week 2 Survey|Lost to Follow-up|5|||
148901940|NCT04672239|537124607|FG000|Week 6 Survey|Failed survey check items|2|||
148901941|NCT04672239|537124608|FG001|Week 6 Survey|Failed survey check items|2|||
148901942|NCT04672239|537124609|FG002|Week 6 Survey|Failed survey check items|2|||
148901943|NCT04672239|537124607|FG000|Week 6 Survey|Partially completed survey|3|||
148901944|NCT04672239|537124608|FG001|Week 6 Survey|Partially completed survey|3|||
148901945|NCT04672239|537124609|FG002|Week 6 Survey|Partially completed survey|2|||
148901946|NCT04672239|537124607|FG000|Week 6 Survey|Withdrawal by Subject|1|||
148901947|NCT04672239|537124608|FG001|Week 6 Survey|Withdrawal by Subject|1|||
148901948|NCT04672239|537124609|FG002|Week 6 Survey|Withdrawal by Subject|1|||
148901949|NCT04672239|537124607|FG000|Week 6 Survey|Withdrawn by PI|0|||
148901950|NCT04672239|537124608|FG001|Week 6 Survey|Withdrawn by PI|1|||
148901951|NCT04672239|537124609|FG002|Week 6 Survey|Withdrawn by PI|0|||
148901952|NCT04672239|537124607|FG000|Week 6 Survey|Lost to Follow-up|12|||
148901953|NCT04672239|537124608|FG001|Week 6 Survey|Lost to Follow-up|2|||
148901954|NCT04672239|537124609|FG002|Week 6 Survey|Lost to Follow-up|5|||
148901955|NCT04672239|537124607|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
148901956|NCT04672239|537124608|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
148901957|NCT04672239|537124609|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
148901958|NCT04672239|537124607|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
148901959|NCT04672239|537124608|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
148901960|NCT04672239|537124609|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
148901961|NCT04672239|537124607|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
148901962|NCT04672239|537124608|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
148901963|NCT04672239|537124609|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
148901964|NCT04672239|537124607|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
148901965|NCT04672239|537124608|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
148901966|NCT04672239|537124609|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
148901967|NCT04672239|537124607|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
148901968|NCT04672239|537124608|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
148901969|NCT04672239|537124609|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
148901970|NCT04672239|537124607|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
148901971|NCT04672239|537124608|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
148901972|NCT04672239|537124609|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
148901973|NCT04672239|537124607|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
148901974|NCT04672239|537124608|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
148901975|NCT04672239|537124609|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
148901976|NCT04606134|537124612|FG000|Overall Study|Adverse Event|0|||
148901977|NCT04606134|537124613|FG001|Overall Study|Adverse Event|1|||
148901978|NCT01099267|537124614|FG000|MDS-003 Study|Adverse Event|37|||
148901979|NCT01099267|537124614|FG000|MDS-003 Study|Lack of Efficacy|52|||
148901980|NCT01099267|537124614|FG000|MDS-003 Study|Withdrawal by Subject|8|||
148901981|NCT01099267|537124614|FG000|MDS-003 Study|Lost to Follow-up|1|||
148901982|NCT01099267|537124614|FG000|MDS-003 Study|Death|11|||
148901983|NCT01099267|537124614|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
148901984|NCT01099267|537124614|FG000|MDS-003 Study|Disease Progression|7|||
148901985|NCT01099267|537124614|FG000|MDS-003 Study|Investigator Decision|2|||
148901986|NCT01099267|537124614|FG000|MDS-003 Study|Non-Compliance|2|||
148901987|NCT01099267|537124614|FG000|MDS-003 Study|Loss of Response|1|||
148901988|NCT01099267|537124614|FG000|MDS-003 Study|Secondary Malign Disease|1|||
148901989|NCT04123470|537124617|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
148901990|NCT04123470|537124618|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
148901991|NCT04123470|537124617|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
148901992|NCT04123470|537124618|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
148901993|NCT04123470|537124617|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
148901994|NCT04123470|537124618|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
148901995|NCT04123470|537124617|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
148901996|NCT04123470|537124618|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
148901997|NCT05972993|537124624|FG000|Overall Study|Lost to Follow-up|2|||
148901998|NCT05972993|537124625|FG001|Overall Study|Lost to Follow-up|0|||
148901999|NCT05972993|537124626|FG002|Overall Study|Lost to Follow-up|1|||
148902000|NCT05972993|537124627|FG003|Overall Study|Lost to Follow-up|0|||
148902001|NCT05972993|537124628|FG004|Overall Study|Lost to Follow-up|0|||
148902002|NCT05972993|537124629|FG005|Overall Study|Lost to Follow-up|0|||
148902003|NCT05972993|537124630|FG006|Overall Study|Lost to Follow-up|0|||
148902004|NCT05972993|537124631|FG007|Overall Study|Lost to Follow-up|2|||
148902005|NCT05972993|537124632|FG008|Overall Study|Lost to Follow-up|0|||
148902006|NCT03866577|537124635|FG000|Overall Study|Protocol Violation|0|||
148902007|NCT03866577|537124636|FG001|Overall Study|Protocol Violation|0|||
148902008|NCT03866577|537124637|FG002|Overall Study|Protocol Violation|0|||
148902009|NCT03866577|537124638|FG003|Overall Study|Protocol Violation|0|||
148902010|NCT03866577|537124639|FG004|Overall Study|Protocol Violation|0|||
148902011|NCT03866577|537124640|FG005|Overall Study|Protocol Violation|0|||
148902012|NCT03866577|537124641|FG006|Overall Study|Protocol Violation|0|||
148902013|NCT03866577|537124642|FG007|Overall Study|Protocol Violation|0|||
148902014|NCT03866577|537124643|FG008|Overall Study|Protocol Violation|0|||
148902015|NCT03866577|537124644|FG009|Overall Study|Protocol Violation|0|||
148902016|NCT03866577|537124645|FG010|Overall Study|Protocol Violation|0|||
148902017|NCT03866577|537124646|FG011|Overall Study|Protocol Violation|1|||
148902018|NCT03866577|537124647|FG012|Overall Study|Protocol Violation|0|||
148902019|NCT03866577|537124635|FG000|Overall Study|Withdrawal by Subject|0|||
148902020|NCT03866577|537124636|FG001|Overall Study|Withdrawal by Subject|0|||
148902021|NCT03866577|537124637|FG002|Overall Study|Withdrawal by Subject|0|||
148902022|NCT03866577|537124638|FG003|Overall Study|Withdrawal by Subject|0|||
148902023|NCT03866577|537124639|FG004|Overall Study|Withdrawal by Subject|0|||
148902024|NCT03866577|537124640|FG005|Overall Study|Withdrawal by Subject|0|||
148902025|NCT03866577|537124641|FG006|Overall Study|Withdrawal by Subject|0|||
148902026|NCT03866577|537124642|FG007|Overall Study|Withdrawal by Subject|0|||
148902027|NCT03866577|537124643|FG008|Overall Study|Withdrawal by Subject|1|||
148902028|NCT03866577|537124644|FG009|Overall Study|Withdrawal by Subject|1|||
148902029|NCT03866577|537124645|FG010|Overall Study|Withdrawal by Subject|0|||
148902030|NCT03866577|537124646|FG011|Overall Study|Withdrawal by Subject|0|||
148902031|NCT03866577|537124647|FG012|Overall Study|Withdrawal by Subject|0|||
148902032|NCT03866577|537124635|FG000|Overall Study|Not qualified for IVIg infusion|0|||
148902033|NCT03866577|537124636|FG001|Overall Study|Not qualified for IVIg infusion|0|||
148902034|NCT03866577|537124637|FG002|Overall Study|Not qualified for IVIg infusion|0|||
148902035|NCT03866577|537124638|FG003|Overall Study|Not qualified for IVIg infusion|0|||
148902036|NCT03866577|537124639|FG004|Overall Study|Not qualified for IVIg infusion|0|||
148902037|NCT03866577|537124640|FG005|Overall Study|Not qualified for IVIg infusion|0|||
148902038|NCT03866577|537124641|FG006|Overall Study|Not qualified for IVIg infusion|0|||
148902039|NCT03866577|537124642|FG007|Overall Study|Not qualified for IVIg infusion|0|||
148902040|NCT03866577|537124643|FG008|Overall Study|Not qualified for IVIg infusion|0|||
148902041|NCT03866577|537124644|FG009|Overall Study|Not qualified for IVIg infusion|1|||
148902042|NCT03866577|537124645|FG010|Overall Study|Not qualified for IVIg infusion|0|||
148902043|NCT03866577|537124646|FG011|Overall Study|Not qualified for IVIg infusion|0|||
148902044|NCT03866577|537124647|FG012|Overall Study|Not qualified for IVIg infusion|0|||
148902045|NCT04825678|537124648|FG000|Overall Study|Decision by Sponsor|2|||
148902046|NCT04825678|537124649|FG001|Overall Study|Decision by Sponsor|3|||
148902047|NCT04825678|537124648|FG000|Overall Study|Withdrawal of Consent From Study|7|||
148902048|NCT04825678|537124649|FG001|Overall Study|Withdrawal of Consent From Study|9|||
148902049|NCT04825678|537124648|FG000|Overall Study|Lost to Follow-up|3|||
148902050|NCT04825678|537124649|FG001|Overall Study|Lost to Follow-up|4|||
148902051|NCT04825678|537124648|FG000|Overall Study|Never Received Investigational Product|1|||
148902052|NCT04825678|537124649|FG001|Overall Study|Never Received Investigational Product|1|||
148902053|NCT05530252|537124650|FG000|Overall Study|Lost to Follow-up|1|||
148902054|NCT05530252|537124651|FG001|Overall Study|Lost to Follow-up|1|||
148902055|NCT05530252|537124652|FG002|Overall Study|Lost to Follow-up|1|||
148902056|NCT00651742|537124657|FG000|Overall Study|Objective Disease Progression|22|||
148902057|NCT00651742|537124657|FG000|Overall Study|Toxicity|3|||
148902058|NCT00651742|537124657|FG000|Overall Study|Investigator Judgment|1|||
148902059|NCT00651742|537124657|FG000|Overall Study|Withdrawal of Consent|1|||
148902060|NCT00651742|537124657|FG000|Overall Study|Enrolled but not treated|1|||
148902061|NCT01535040|537124658|FG000|Overall Study|Physician Decision|0|||
148902062|NCT01535040|537124659|FG001|Overall Study|Physician Decision|1|||
148902063|NCT01535040|537124658|FG000|Overall Study|Withdrawal by Subject|13|||
148902064|NCT01535040|537124659|FG001|Overall Study|Withdrawal by Subject|10|||
148902065|NCT01535040|537124658|FG000|Overall Study|Never Started|9|||
148902066|NCT01535040|537124659|FG001|Overall Study|Never Started|4|||
148902067|NCT01535040|537124658|FG000|Overall Study|Toxicity|7|||
148902068|NCT01535040|537124659|FG001|Overall Study|Toxicity|5|||
148902069|NCT01535040|537124658|FG000|Overall Study|Multiple Reasons|1|||
148902070|NCT01535040|537124659|FG001|Overall Study|Multiple Reasons|1|||
148902071|NCT00911170|537124660|FG000|Treatment Period|Randomized in error|1|||
148902072|NCT00911170|537124661|FG001|Treatment Period|Randomized in error|1|||
148902073|NCT00911170|537124660|FG000|Treatment Period|Ineligibility determined|1|||
148902074|NCT00911170|537124661|FG001|Treatment Period|Ineligibility determined|3|||
148902075|NCT00911170|537124660|FG000|Treatment Period|Protocol deviation|1|||
148902076|NCT00911170|537124661|FG001|Treatment Period|Protocol deviation|2|||
148902077|NCT00911170|537124660|FG000|Treatment Period|Adverse Event|9|||
148902078|NCT00911170|537124661|FG001|Treatment Period|Adverse Event|10|||
148902079|NCT00911170|537124660|FG000|Treatment Period|Withdrawal by Subject|4|||
148902080|NCT00911170|537124661|FG001|Treatment Period|Withdrawal by Subject|4|||
148902081|NCT00911170|537124660|FG000|Treatment Period|Disease progression|0|||
148902082|NCT00911170|537124661|FG001|Treatment Period|Disease progression|2|||
148902083|NCT00911170|537124660|FG000|Treatment Period|Physician Decision|5|||
148902084|NCT00911170|537124661|FG001|Treatment Period|Physician Decision|5|||
148801129|NCT00846586|536751425|FG000|Overall Study|Protocol deviation|2|||
148801130|NCT00846586|536751426|FG001|Overall Study|Protocol deviation|6|||
148801131|NCT00846586|536751425|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148801132|NCT00846586|536751426|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148801133|NCT00846586|536751425|FG000|Overall Study|Lost to Follow-up|1|||
148801134|NCT00846586|536751426|FG001|Overall Study|Lost to Follow-up|4|||
148801135|NCT00846586|536751425|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148801136|NCT00846586|536751426|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148801137|NCT00875810|536751427|FG000|Overall Study|Withdrawal by Subject|1|||
148801138|NCT00875810|536751427|FG000|Overall Study|Physician Decision|3|||
148801139|NCT00875810|536751427|FG000|Overall Study|Lost to Follow-up|39|||
148801140|NCT00875810|536751427|FG000|Overall Study|Patient enroled but not implanted|2|||
148801141|NCT00875810|536751427|FG000|Overall Study|Device explanted|1|||
148801142|NCT00780975|536751428|FG000|Overall Study|Progressive disease|3|||
148801143|NCT00780975|536751428|FG000|Overall Study|Toxicity|5|||
148801144|NCT01061606|536751429|FG000|Overall Study|Adverse Event|1|||
148801145|NCT01061606|536751429|FG000|Overall Study|Death|1|||
148801146|NCT01061606|536751429|FG000|Overall Study|Disease Progression|4|||
148801147|NCT01061606|536751429|FG000|Overall Study|alternative therapy|2|||
148801148|NCT01274533|536751430|FG000|Overall Study|Withdrawal by Subject|1|||
148801149|NCT01274533|536751430|FG000|Overall Study|Non-compliance|1|||
148801150|NCT01274533|536751430|FG000|Overall Study|Disease progression|2|||
148801151|NCT02008526|536751431|FG000|Overall Study|Death|0|||
148801152|NCT02008526|536751432|FG001|Overall Study|Death|2|||
148801153|NCT02008526|536751433|FG002|Overall Study|Death|1|||
148801154|NCT02008526|536751431|FG000|Overall Study|Withdrawal by Subject|3|||
148801155|NCT02008526|536751432|FG001|Overall Study|Withdrawal by Subject|3|||
148801156|NCT02008526|536751433|FG002|Overall Study|Withdrawal by Subject|2|||
148801157|NCT02008526|536751431|FG000|Overall Study|Lost to Follow-up|5|||
148801158|NCT02008526|536751432|FG001|Overall Study|Lost to Follow-up|9|||
148801159|NCT02008526|536751433|FG002|Overall Study|Lost to Follow-up|6|||
148801160|NCT00492726|536751435|FG000|Overall Study|Adverse Event|10|||
148801161|NCT00492726|536751436|FG001|Overall Study|Adverse Event|6|||
148801162|NCT00492726|536751435|FG000|Overall Study|Death|7|||
148801163|NCT00492726|536751436|FG001|Overall Study|Death|2|||
148801164|NCT00492726|536751435|FG000|Overall Study|Lack of Efficacy|0|||
148801165|NCT00492726|536751436|FG001|Overall Study|Lack of Efficacy|2|||
148801166|NCT00492726|536751435|FG000|Overall Study|Lost to Follow-up|27|||
148801167|NCT00492726|536751436|FG001|Overall Study|Lost to Follow-up|19|||
148801168|NCT00492726|536751435|FG000|Overall Study|Physician Decision|0|||
148801169|NCT00492726|536751436|FG001|Overall Study|Physician Decision|1|||
148801170|NCT00492726|536751435|FG000|Overall Study|Withdrawal by Subject|6|||
148801171|NCT00492726|536751436|FG001|Overall Study|Withdrawal by Subject|3|||
148801172|NCT00492726|536751435|FG000|Overall Study|Non compliant with study medication|0|||
148801173|NCT00492726|536751436|FG001|Overall Study|Non compliant with study medication|3|||
148801174|NCT01100502|536751437|FG000|Overall Study|Withdrawal by Subject|18|||
148801175|NCT01100502|536751438|FG001|Overall Study|Withdrawal by Subject|25|||
148801176|NCT01100502|536751437|FG000|Overall Study|Lost to Follow-up|13|||
148801177|NCT01100502|536751438|FG001|Overall Study|Lost to Follow-up|28|||
148801178|NCT01100502|536751437|FG000|Overall Study|Site request to end participation in study|0|||
148801179|NCT01100502|536751438|FG001|Overall Study|Site request to end participation in study|1|||
148801180|NCT01100502|536751437|FG000|Overall Study|Death|45|||
148801181|NCT01100502|536751438|FG001|Overall Study|Death|40|||
148801182|NCT05158140|536751439|FG000|Overall Study|Death|0|||
148801183|NCT05158140|536751440|FG001|Overall Study|Death|0|||
148801184|NCT05158140|536751441|FG002|Overall Study|Death|0|||
148801185|NCT05158140|536751442|FG003|Overall Study|Death|1|||
148801186|NCT05158140|536751439|FG000|Overall Study|Lost to Follow-up|3|||
148801187|NCT05158140|536751440|FG001|Overall Study|Lost to Follow-up|6|||
148801188|NCT05158140|536751441|FG002|Overall Study|Lost to Follow-up|4|||
148801189|NCT05158140|536751442|FG003|Overall Study|Lost to Follow-up|3|||
148801190|NCT05158140|536751439|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148801191|NCT05158140|536751440|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148801192|NCT05158140|536751441|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
148801193|NCT05158140|536751442|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148801194|NCT05158140|536751439|FG000|Overall Study|Withdrawal by Subject|3|||
148801195|NCT05158140|536751440|FG001|Overall Study|Withdrawal by Subject|7|||
148801196|NCT05158140|536751441|FG002|Overall Study|Withdrawal by Subject|3|||
148801197|NCT05158140|536751442|FG003|Overall Study|Withdrawal by Subject|7|||
148801198|NCT01587885|536753559|FG000|Treatment Period 1|Failure to Return|0|||
148801199|NCT01587885|536753560|FG001|Treatment Period 1|Failure to Return|1|||
148801200|NCT01587885|536753559|FG000|Treatment Period 1|Protocol Violation|0|||
148801201|NCT01587885|536753560|FG001|Treatment Period 1|Protocol Violation|2|||
148801202|NCT00386334|536753564|FG000|Double Blind Period|Adverse Event|9|||
148801203|NCT00386334|536753565|FG001|Double Blind Period|Adverse Event|14|||
148801204|NCT00386334|536753564|FG000|Double Blind Period|Protocol Violation|1|||
148801205|NCT00386334|536753565|FG001|Double Blind Period|Protocol Violation|1|||
148801206|NCT00386334|536753564|FG000|Double Blind Period|Withdrawal by Subject|9|||
148801207|NCT00386334|536753565|FG001|Double Blind Period|Withdrawal by Subject|13|||
148801208|NCT00386334|536753564|FG000|Double Blind Period|Lack of Efficacy|20|||
148801209|NCT00386334|536753565|FG001|Double Blind Period|Lack of Efficacy|11|||
148801210|NCT00386334|536753564|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
148801211|NCT00386334|536753565|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
148801212|NCT00386334|536753564|FG000|Double Blind Period|Other|3|||
148801213|NCT00386334|536753565|FG001|Double Blind Period|Other|3|||
148801214|NCT00386334|536753564|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
148902085|NCT00911170|537124660|FG000|Treatment Period|Lost to Follow-up|0|||
148902086|NCT00911170|537124661|FG001|Treatment Period|Lost to Follow-up|1|||
148902087|NCT00911170|537124660|FG000|Treatment Period|Death|6|||
148902088|NCT00911170|537124661|FG001|Treatment Period|Death|9|||
148902089|NCT00911170|537124660|FG000|Long Term Follow-Up|Continuing in study|274|||
148902090|NCT00911170|537124661|FG001|Long Term Follow-Up|Continuing in study|269|||
148902091|NCT00911170|537124660|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
148902092|NCT00911170|537124661|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
148902093|NCT00911170|537124660|FG000|Long Term Follow-Up|Physician Decision|5|||
148902094|NCT00911170|537124661|FG001|Long Term Follow-Up|Physician Decision|4|||
148902095|NCT00911170|537124660|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
148902096|NCT00911170|537124661|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
148902097|NCT00911170|537124660|FG000|Long Term Follow-Up|Death|116|||
148902098|NCT00911170|537124661|FG001|Long Term Follow-Up|Death|121|||
148902099|NCT01824836|537124662|FG000|Overall Study|Adverse Event|48|||
148902100|NCT01824836|537124662|FG000|Overall Study|Withdrawal by Subject|63|||
148902101|NCT01824836|537124662|FG000|Overall Study|Other complicating disease|116|||
148902102|NCT01824836|537124662|FG000|Overall Study|Disease progression|5|||
148902103|NCT01824836|537124662|FG000|Overall Study|Alternative therapy|2|||
148902104|NCT01824836|537124662|FG000|Overall Study|Depression|1|||
148902105|NCT01824836|537124662|FG000|Overall Study|Non-compliance|3|||
148902106|NCT01824836|537124662|FG000|Overall Study|Patient regained ovarian function|3|||
148902107|NCT01824836|537124662|FG000|Overall Study|Lost to Follow-up|8|||
148902108|NCT01824836|537124662|FG000|Overall Study|Physician Decision|2|||
148902109|NCT01824836|537124662|FG000|Overall Study|Research office was closed|3|||
148902110|NCT01824836|537124662|FG000|Overall Study|Relocation|3|||
148902111|NCT01824836|537124662|FG000|Overall Study|Insurance-related issue|1|||
149138395|NCT02060383|537988847|FG001|Extension Phase|Withdrawal by Subject|1|||
148902112|NCT01824836|537124662|FG000|Overall Study|Transportation issue|1|||
149138396|NCT02060383|537988848|FG002|Extension Phase|Withdrawal by Subject|0|||
149138397|NCT02060383|537988849|FG003|Extension Phase|Withdrawal by Subject|0|||
149138398|NCT02060383|537988850|FG004|Extension Phase|Withdrawal by Subject|2|||
149138399|NCT02060383|537988846|FG000|Extension Phase|Administrative problems|1|||
149138400|NCT02060383|537988847|FG001|Extension Phase|Administrative problems|0|||
149138401|NCT02060383|537988848|FG002|Extension Phase|Administrative problems|0|||
149138402|NCT02060383|537988849|FG003|Extension Phase|Administrative problems|0|||
149138403|NCT02060383|537988850|FG004|Extension Phase|Administrative problems|0|||
149138404|NCT02060383|537988846|FG000|Extension Phase|Death|0|||
149138405|NCT02060383|537988847|FG001|Extension Phase|Death|0|||
149138406|NCT02060383|537988848|FG002|Extension Phase|Death|1|||
149138407|NCT02060383|537988849|FG003|Extension Phase|Death|0|||
149138408|NCT02060383|537988850|FG004|Extension Phase|Death|1|||
149138409|NCT02060383|537988846|FG000|Extension Phase|Protocol Violation|0|||
149138410|NCT02060383|537988847|FG001|Extension Phase|Protocol Violation|0|||
149138411|NCT02060383|537988848|FG002|Extension Phase|Protocol Violation|0|||
149138412|NCT02060383|537988849|FG003|Extension Phase|Protocol Violation|0|||
149138413|NCT02060383|537988850|FG004|Extension Phase|Protocol Violation|1|||
149138414|NCT03441334|537988851|FG000|Overall Study|Withdrawal by Subject|1|||
149138415|NCT03441334|537988852|FG001|Overall Study|Withdrawal by Subject|0|||
149138416|NCT03426787|537988859|FG000|Overall Study|Withdrawal by Subject|6|||
149138417|NCT03426787|537988859|FG000|Overall Study|Lost to Follow-up|7|||
149138418|NCT03426787|537988859|FG000|Overall Study|Unrelated to intervention death|1|||
149138419|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
149138420|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
149138421|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
149138422|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
149138423|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
149138424|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
149138425|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
149138426|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
149138427|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
149138428|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
149138429|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
149138430|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
149138431|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
149138432|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
149138433|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
149138434|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
149138435|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
149138436|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
148902113|NCT01824836|537124662|FG000|Overall Study|Patient transferred care|1|||
148902114|NCT01824836|537124662|FG000|Overall Study|Unknown reasons|4|||
148902115|NCT01824836|537124662|FG000|Overall Study|Never started treatment|16|||
148902116|NCT05523089|537124663|FG000|Overall Study|Withdrawal by Subject|1|||
148902117|NCT05523089|537124664|FG001|Overall Study|Withdrawal by Subject|0|||
148902118|NCT05523089|537124665|FG002|Overall Study|Withdrawal by Subject|0|||
148902119|NCT05523089|537124663|FG000|Overall Study|Lost to Follow-up|1|||
148902120|NCT05523089|537124664|FG001|Overall Study|Lost to Follow-up|0|||
148902121|NCT05523089|537124665|FG002|Overall Study|Lost to Follow-up|0|||
148902122|NCT02514083|537124666|FG000|Overall Study|Adverse Event|1|||
148902123|NCT01899040|537124667|FG000|Overall Study|Randomized in error|0|||
148902124|NCT01899040|537124668|FG001|Overall Study|Randomized in error|1|||
148902125|NCT01899040|537124669|FG002|Overall Study|Randomized in error|1|||
148902126|NCT01899040|537124667|FG000|Overall Study|Adverse Event|3|||
148902127|NCT01899040|537124668|FG001|Overall Study|Adverse Event|1|||
148902128|NCT01899040|537124669|FG002|Overall Study|Adverse Event|2|||
148902129|NCT01899040|537124667|FG000|Overall Study|Unspecified reasons|4|||
148902130|NCT01899040|537124668|FG001|Overall Study|Unspecified reasons|4|||
148902131|NCT01899040|537124669|FG002|Overall Study|Unspecified reasons|0|||
148902132|NCT01899040|537124667|FG000|Overall Study|Compliance issues|1|||
148902133|NCT01899040|537124668|FG001|Overall Study|Compliance issues|2|||
148902134|NCT01899040|537124669|FG002|Overall Study|Compliance issues|0|||
148902135|NCT02638220|537124670|FG000|Overall Study|Lost to Follow-up|6|||
148902136|NCT02638220|537124670|FG000|Overall Study|Withdrawal by Subject|3|||
148902137|NCT02638220|537124670|FG000|Overall Study|Physician Decision|1|||
148902138|NCT02638220|537124670|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
148902139|NCT04323124|537124677|FG000|Overall Study|Adverse Event|0|||
148902140|NCT04323124|537124678|FG001|Overall Study|Adverse Event|0|||
148902141|NCT04323124|537124679|FG002|Overall Study|Adverse Event|0|||
148902142|NCT04323124|537124680|FG003|Overall Study|Adverse Event|0|||
148902143|NCT04323124|537124681|FG004|Overall Study|Adverse Event|0|||
148902144|NCT04323124|537124682|FG005|Overall Study|Adverse Event|1|||
148902145|NCT04323124|537124683|FG006|Overall Study|Adverse Event|0|||
148902146|NCT04323124|537124684|FG007|Overall Study|Adverse Event|1|||
148902147|NCT04323124|537124685|FG008|Overall Study|Adverse Event|1|||
148902148|NCT04323124|537124686|FG009|Overall Study|Adverse Event|0|||
148902149|NCT04323124|537124687|FG010|Overall Study|Adverse Event|0|||
148902150|NCT04323124|537124688|FG011|Overall Study|Adverse Event|0|||
148902151|NCT04323124|537124689|FG012|Overall Study|Adverse Event|0|||
148902152|NCT04323124|537124690|FG013|Overall Study|Adverse Event|0|||
148902153|NCT04323124|537124691|FG014|Overall Study|Adverse Event|0|||
148902154|NCT04323124|537124677|FG000|Overall Study|Other|0|||
148902155|NCT04323124|537124678|FG001|Overall Study|Other|0|||
148902156|NCT04323124|537124679|FG002|Overall Study|Other|0|||
148902157|NCT04323124|537124680|FG003|Overall Study|Other|0|||
148902158|NCT04323124|537124681|FG004|Overall Study|Other|1|||
148902159|NCT04323124|537124682|FG005|Overall Study|Other|0|||
148902160|NCT04323124|537124683|FG006|Overall Study|Other|0|||
148902161|NCT04323124|537124684|FG007|Overall Study|Other|0|||
148902162|NCT04323124|537124685|FG008|Overall Study|Other|1|||
148902163|NCT04323124|537124686|FG009|Overall Study|Other|0|||
148902164|NCT04323124|537124687|FG010|Overall Study|Other|0|||
148902165|NCT04323124|537124688|FG011|Overall Study|Other|0|||
148902166|NCT04323124|537124689|FG012|Overall Study|Other|0|||
148902167|NCT04323124|537124690|FG013|Overall Study|Other|0|||
148902168|NCT04323124|537124691|FG014|Overall Study|Other|0|||
148902169|NCT04323124|537124677|FG000|Overall Study|Coming from a red zone (COVID)|0|||
148902170|NCT04323124|537124678|FG001|Overall Study|Coming from a red zone (COVID)|0|||
148902171|NCT04323124|537124679|FG002|Overall Study|Coming from a red zone (COVID)|0|||
148902172|NCT04323124|537124680|FG003|Overall Study|Coming from a red zone (COVID)|0|||
148902173|NCT04323124|537124681|FG004|Overall Study|Coming from a red zone (COVID)|1|||
148801215|NCT00386334|536753565|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
148801216|NCT01245101|536753570|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
148801217|NCT01245101|536753571|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
148801218|NCT01245101|536753570|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
148801219|NCT01245101|536753571|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
148801220|NCT01245101|536753570|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
148801221|NCT01245101|536753571|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
148801222|NCT01122173|536753572|FG000|Overall Study|Lost to Follow-up|3|||
148801223|NCT01122173|536753572|FG000|Overall Study|Withdrawal by Subject|3|||
148801224|NCT01122173|536753572|FG000|Overall Study|Left study for other reasons|3|||
148801225|NCT02133508|536753575|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
148801226|NCT02133508|536753575|FG000|Overall Study|Death|12|||
148801227|NCT02133508|536753575|FG000|Overall Study|Lost to Follow-up|2|||
148801228|NCT01026493|536753582|FG000|Overall Study|Protocol Violation|0|||
148801229|NCT01026493|536753583|FG001|Overall Study|Protocol Violation|1|||
148801230|NCT01026493|536753584|FG002|Overall Study|Protocol Violation|0|||
148801231|NCT01026493|536753585|FG003|Overall Study|Protocol Violation|0|||
148801232|NCT01026493|536753586|FG004|Overall Study|Protocol Violation|2|||
148801233|NCT01026493|536753587|FG005|Overall Study|Protocol Violation|3|||
148801234|NCT01026493|536753588|FG006|Overall Study|Protocol Violation|4|||
148801235|NCT01026493|536753589|FG007|Overall Study|Protocol Violation|1|||
148801236|NCT03093181|536753595|FG000|Overall Study|Withdrawal by Subject|2|||
148801237|NCT03093181|536753596|FG001|Overall Study|Withdrawal by Subject|1|||
148801238|NCT03093181|536753597|FG002|Overall Study|Withdrawal by Subject|2|||
148801239|NCT03093181|536753595|FG000|Overall Study|Other (Not specified)|1|||
148801240|NCT03093181|536753596|FG001|Overall Study|Other (Not specified)|0|||
148801241|NCT03093181|536753597|FG002|Overall Study|Other (Not specified)|0|||
148801242|NCT03093181|536753595|FG000|Overall Study|Adverse Event|0|||
148801243|NCT03093181|536753596|FG001|Overall Study|Adverse Event|1|||
148801244|NCT03093181|536753597|FG002|Overall Study|Adverse Event|0|||
148801245|NCT03093181|536753595|FG000|Overall Study|Other (Protocol violation)|0|||
148801246|NCT03093181|536753596|FG001|Overall Study|Other (Protocol violation)|0|||
148801247|NCT03093181|536753597|FG002|Overall Study|Other (Protocol violation)|1|||
148801248|NCT03154086|536753598|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801249|NCT03154086|536753599|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801250|NCT03154086|536753600|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801251|NCT03154086|536753601|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
148801252|NCT03154086|536753602|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801253|NCT03154086|536753603|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801254|NCT03154086|536753604|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801255|NCT03154086|536753605|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801256|NCT03154086|536753606|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801257|NCT03154086|536753607|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801258|NCT03154086|536753608|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801259|NCT03154086|536753609|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801260|NCT03154086|536753610|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801261|NCT03154086|536753611|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801262|NCT03154086|536753612|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
148801263|NCT03154086|536753598|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801264|NCT03154086|536753599|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
148801265|NCT03154086|536753600|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801266|NCT03154086|536753601|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801267|NCT03154086|536753602|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801268|NCT03154086|536753603|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801269|NCT03154086|536753604|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801270|NCT03154086|536753605|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801271|NCT03154086|536753606|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801272|NCT03154086|536753607|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801273|NCT03154086|536753608|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801274|NCT03154086|536753609|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801275|NCT03154086|536753610|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801276|NCT03154086|536753611|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801277|NCT03154086|536753612|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
148801278|NCT03154086|536753598|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801279|NCT03154086|536753599|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801280|NCT03154086|536753600|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
148801281|NCT03154086|536753601|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801282|NCT03154086|536753602|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148902174|NCT04323124|537124682|FG005|Overall Study|Coming from a red zone (COVID)|1|||
148902175|NCT04323124|537124683|FG006|Overall Study|Coming from a red zone (COVID)|0|||
148902176|NCT04323124|537124684|FG007|Overall Study|Coming from a red zone (COVID)|0|||
148902177|NCT04323124|537124685|FG008|Overall Study|Coming from a red zone (COVID)|0|||
148902178|NCT04323124|537124686|FG009|Overall Study|Coming from a red zone (COVID)|0|||
148902179|NCT04323124|537124687|FG010|Overall Study|Coming from a red zone (COVID)|0|||
148801283|NCT03154086|536753603|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801284|NCT03154086|536753604|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801285|NCT03154086|536753605|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801286|NCT03154086|536753606|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801287|NCT03154086|536753607|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801288|NCT03154086|536753608|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801289|NCT03154086|536753609|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801290|NCT03154086|536753610|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801291|NCT03154086|536753611|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148801292|NCT03154086|536753612|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
148902180|NCT04323124|537124688|FG011|Overall Study|Coming from a red zone (COVID)|0|||
148902181|NCT04323124|537124689|FG012|Overall Study|Coming from a red zone (COVID)|0|||
148902182|NCT04323124|537124690|FG013|Overall Study|Coming from a red zone (COVID)|0|||
148902183|NCT04323124|537124691|FG014|Overall Study|Coming from a red zone (COVID)|0|||
148902184|NCT04323124|537124677|FG000|Overall Study|No longer meets eligibility criteria|0|||
148902185|NCT04323124|537124678|FG001|Overall Study|No longer meets eligibility criteria|0|||
148902186|NCT04323124|537124679|FG002|Overall Study|No longer meets eligibility criteria|0|||
148902187|NCT04323124|537124680|FG003|Overall Study|No longer meets eligibility criteria|0|||
148902188|NCT04323124|537124681|FG004|Overall Study|No longer meets eligibility criteria|0|||
148902189|NCT04323124|537124682|FG005|Overall Study|No longer meets eligibility criteria|0|||
148902190|NCT04323124|537124683|FG006|Overall Study|No longer meets eligibility criteria|0|||
148902191|NCT04323124|537124684|FG007|Overall Study|No longer meets eligibility criteria|1|||
148902192|NCT04323124|537124685|FG008|Overall Study|No longer meets eligibility criteria|0|||
148902193|NCT04323124|537124686|FG009|Overall Study|No longer meets eligibility criteria|0|||
148902194|NCT04323124|537124687|FG010|Overall Study|No longer meets eligibility criteria|0|||
148902195|NCT04323124|537124688|FG011|Overall Study|No longer meets eligibility criteria|0|||
148902196|NCT04323124|537124689|FG012|Overall Study|No longer meets eligibility criteria|0|||
148902197|NCT04323124|537124690|FG013|Overall Study|No longer meets eligibility criteria|1|||
148902198|NCT04323124|537124691|FG014|Overall Study|No longer meets eligibility criteria|1|||
148902199|NCT04323124|537124677|FG000|Overall Study|Study terminated by sponsor|0|||
148902200|NCT04323124|537124678|FG001|Overall Study|Study terminated by sponsor|0|||
148902201|NCT04323124|537124679|FG002|Overall Study|Study terminated by sponsor|0|||
148801293|NCT03154086|536753598|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
148801294|NCT03154086|536753599|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801295|NCT03154086|536753600|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801296|NCT03154086|536753601|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801297|NCT03154086|536753602|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801298|NCT03154086|536753603|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801299|NCT03154086|536753604|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801300|NCT03154086|536753605|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801301|NCT03154086|536753606|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801302|NCT03154086|536753607|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801303|NCT03154086|536753608|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801304|NCT03154086|536753609|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801305|NCT03154086|536753610|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801306|NCT03154086|536753611|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801307|NCT03154086|536753612|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
148801308|NCT03154086|536753598|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801309|NCT03154086|536753599|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801310|NCT03154086|536753600|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801311|NCT03154086|536753601|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801312|NCT03154086|536753602|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801313|NCT03154086|536753603|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801314|NCT03154086|536753604|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801315|NCT03154086|536753605|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801316|NCT03154086|536753606|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
148801317|NCT03154086|536753607|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801318|NCT03154086|536753608|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801319|NCT03154086|536753609|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801320|NCT03154086|536753610|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801321|NCT03154086|536753611|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148902202|NCT04323124|537124680|FG003|Overall Study|Study terminated by sponsor|0|||
148902203|NCT04323124|537124681|FG004|Overall Study|Study terminated by sponsor|0|||
148902204|NCT04323124|537124682|FG005|Overall Study|Study terminated by sponsor|0|||
148902205|NCT04323124|537124683|FG006|Overall Study|Study terminated by sponsor|0|||
148902206|NCT04323124|537124684|FG007|Overall Study|Study terminated by sponsor|0|||
148902207|NCT04323124|537124685|FG008|Overall Study|Study terminated by sponsor|0|||
148902208|NCT04323124|537124686|FG009|Overall Study|Study terminated by sponsor|0|||
148902209|NCT04323124|537124687|FG010|Overall Study|Study terminated by sponsor|0|||
148902210|NCT04323124|537124688|FG011|Overall Study|Study terminated by sponsor|2|||
148902211|NCT04323124|537124689|FG012|Overall Study|Study terminated by sponsor|1|||
148902212|NCT04323124|537124690|FG013|Overall Study|Study terminated by sponsor|0|||
148902213|NCT04323124|537124691|FG014|Overall Study|Study terminated by sponsor|0|||
148902214|NCT01710501|537126850|FG000|Overall Study|Lost to Follow-up|2|||
148902215|NCT01710501|537126851|FG001|Overall Study|Lost to Follow-up|0|||
148902216|NCT01710501|537126852|FG002|Overall Study|Lost to Follow-up|0|||
148902217|NCT02144610|537126853|FG000|Overall Study|Physician Decision|1|||
148902218|NCT02144610|537126854|FG001|Overall Study|Physician Decision|0|||
148902219|NCT02144610|537126853|FG000|Overall Study|Withdrawal by Subject|1|||
148902220|NCT02144610|537126854|FG001|Overall Study|Withdrawal by Subject|5|||
148801322|NCT03154086|536753612|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
148801323|NCT03154086|536753598|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801324|NCT03154086|536753599|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801325|NCT03154086|536753600|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801326|NCT03154086|536753601|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801327|NCT03154086|536753602|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801328|NCT03154086|536753603|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801329|NCT03154086|536753604|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801330|NCT03154086|536753605|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
148801331|NCT03154086|536753606|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801332|NCT03154086|536753607|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801333|NCT03154086|536753608|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801334|NCT03154086|536753609|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801335|NCT03154086|536753610|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801336|NCT03154086|536753611|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801337|NCT03154086|536753612|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
148801338|NCT03154086|536753598|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
148801339|NCT03154086|536753599|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
148801340|NCT03154086|536753600|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
148801341|NCT03154086|536753601|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
148801342|NCT03154086|536753602|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
148801343|NCT03154086|536753603|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
148801344|NCT03154086|536753604|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
148801345|NCT03154086|536753605|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
148801346|NCT03154086|536753606|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
148801347|NCT03154086|536753607|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
148801348|NCT03154086|536753608|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
148801349|NCT03154086|536753609|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
148801350|NCT03154086|536753610|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
148801351|NCT03154086|536753611|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
148801352|NCT03154086|536753612|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
148801353|NCT04076917|536753615|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
148801354|NCT04076917|536753615|FG000|Overall Study|Study closure|13|||
148801355|NCT04076917|536753615|FG000|Overall Study|Physician Decision|3|||
148801356|NCT04076917|536753615|FG000|Overall Study|Death|1|||
148801357|NCT04076917|536753615|FG000|Overall Study|Lost to Follow-up|1|||
148801358|NCT04076917|536753615|FG000|Overall Study|Withdrawal by Subject|1|||
148801359|NCT04076917|536753615|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
148801360|NCT01701245|536753618|FG000|Overall Study|Protocol Violation|1|||
148801361|NCT01701245|536753619|FG001|Overall Study|Protocol Violation|3|||
148801362|NCT01701245|536753618|FG000|Overall Study|Did not complete the open label period|11|||
148801363|NCT01701245|536753619|FG001|Overall Study|Did not complete the open label period|12|||
148801364|NCT01774591|536753621|FG000|Overall Study|Physician Decision|1|||
148801365|NCT01774591|536753622|FG001|Overall Study|Physician Decision|1|||
148801366|NCT01774591|536753621|FG000|Overall Study|Withdrawal by Subject|0|||
148801367|NCT01774591|536753622|FG001|Overall Study|Withdrawal by Subject|1|||
148801368|NCT01774591|536753621|FG000|Overall Study|Adverse Event|0|||
148801369|NCT01774591|536753622|FG001|Overall Study|Adverse Event|2|||
148801370|NCT01159574|536753623|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
148801371|NCT01159574|536753623|FG000|Treatment Phase|Adverse Event|3|||
148801372|NCT01159574|536753623|FG000|Treatment Phase|Death|6|||
148801373|NCT01159574|536753623|FG000|Treatment Phase|Physician Decision|2|||
148801374|NCT01159574|536753623|FG000|Treatment Phase|Withdrawal by Subject|7|||
148801375|NCT01159574|536753623|FG000|Treatment Phase|still on treatment|2|||
148801376|NCT01159574|536753623|FG000|Follow Up Phase|Lost to Follow-up|2|||
148801377|NCT01159574|536753623|FG000|Follow Up Phase|still being followed for overall surviva|18|||
148801378|NCT03555149|536753626|FG000|Overall Study|Death|18|||
148801379|NCT03555149|536753627|FG001|Overall Study|Death|15|||
148801380|NCT03555149|536753628|FG002|Overall Study|Death|15|||
148801381|NCT03555149|536753629|FG003|Overall Study|Death|4|||
148801382|NCT03555149|536753630|FG004|Overall Study|Death|4|||
148801383|NCT03555149|536753631|FG005|Overall Study|Death|11|||
148902221|NCT02144610|537126853|FG000|Overall Study|Death|2|||
148902222|NCT02144610|537126854|FG001|Overall Study|Death|2|||
148902223|NCT02144610|537126853|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
148902224|NCT02144610|537126854|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
148902225|NCT02144610|537126853|FG000|Overall Study|Other|0|||
148902226|NCT02144610|537126854|FG001|Overall Study|Other|1|||
148902227|NCT01421719|537126856|FG000|Overall Study|Withdrawal by Subject|4|||
148902228|NCT01124006|537126857|FG000|Overall Study|Withdrawal by Subject|2|||
148902229|NCT01124006|537126858|FG001|Overall Study|Withdrawal by Subject|2|||
148902230|NCT01124006|537126859|FG002|Overall Study|Withdrawal by Subject|0|||
148902231|NCT01124006|537126857|FG000|Overall Study|Lost to Follow-up|1|||
148902232|NCT01124006|537126858|FG001|Overall Study|Lost to Follow-up|0|||
148902233|NCT01124006|537126859|FG002|Overall Study|Lost to Follow-up|1|||
148902234|NCT01124006|537126857|FG000|Overall Study|Other|0|||
148902235|NCT01124006|537126858|FG001|Overall Study|Other|0|||
148902236|NCT01124006|537126859|FG002|Overall Study|Other|1|||
148902237|NCT01712399|537126863|FG000|Overall Study|Lost to Follow-up|1|||
148902238|NCT01712399|537126863|FG000|Overall Study|Withdrawal by Subject|39|||
148902239|NCT01712399|537126863|FG000|Overall Study|Death|1|||
148902240|NCT01712399|537126863|FG000|Overall Study|Adverse Event|11|||
148902241|NCT01712399|537126863|FG000|Overall Study|Study closure|345|||
148902242|NCT01357850|537126864|FG000|Overall Study|Lost to Follow-up|1|||
148902243|NCT01357850|537126865|FG001|Overall Study|Lost to Follow-up|0|||
148902244|NCT01357850|537126866|FG002|Overall Study|Lost to Follow-up|0|||
148902245|NCT01357850|537126867|FG003|Overall Study|Lost to Follow-up|0|||
148902246|NCT04610281|537126868|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
148902247|NCT04610281|537126869|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
148902248|NCT01198795|537126885|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
148902249|NCT01198795|537126885|FG000|Overall Study|Withdrawal by Subject|17|||
148902250|NCT01198795|537126885|FG000|Overall Study|Lost to Follow-up|15|||
148902251|NCT01198795|537126885|FG000|Overall Study|Adverse Event|9|||
148902252|NCT01198795|537126885|FG000|Overall Study|Lack of Efficacy|5|||
148902253|NCT01198795|537126885|FG000|Overall Study|Protocol Violation|2|||
148902254|NCT01198795|537126885|FG000|Overall Study|Other Reason|4|||
148902255|NCT03038100|537126886|FG000|Overall Study|Death|289|||
148902256|NCT03038100|537126887|FG001|Overall Study|Death|272|||
148902257|NCT03038100|537126886|FG000|Overall Study|Lost to Follow-up|9|||
148902258|NCT03038100|537126887|FG001|Overall Study|Lost to Follow-up|10|||
148902259|NCT03038100|537126886|FG000|Overall Study|Protocol Deviation|1|||
148902260|NCT03038100|537126887|FG001|Overall Study|Protocol Deviation|4|||
148902261|NCT03038100|537126886|FG000|Overall Study|Withdrawal by Subject|45|||
148902262|NCT03038100|537126887|FG001|Overall Study|Withdrawal by Subject|51|||
148902263|NCT03038100|537126886|FG000|Overall Study|Study Terminated By Sponsor|305|||
148902264|NCT03038100|537126887|FG001|Overall Study|Study Terminated By Sponsor|311|||
148902265|NCT03038100|537126886|FG000|Overall Study|Physician Decision|1|||
148902266|NCT03038100|537126887|FG001|Overall Study|Physician Decision|3|||
148902267|NCT03250273|537126920|FG000|Overall Study|Disease Progression|2|||
148902268|NCT03250273|537126921|FG001|Overall Study|Disease Progression|11|||
148902269|NCT03250273|537126920|FG000|Overall Study|Death|0|||
148902270|NCT03250273|537126921|FG001|Overall Study|Death|1|||
148902271|NCT04154904|537126922|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
148902272|NCT04154904|537126923|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
148902273|NCT04154904|537126924|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
148902274|NCT02392624|537126925|FG000|Overall Study|Withdrawal by Subject|15|||
148902275|NCT02392624|537126926|FG001|Overall Study|Withdrawal by Subject|12|||
148902276|NCT02392624|537126927|FG002|Overall Study|Withdrawal by Subject|9|||
148902277|NCT02392624|537126925|FG000|Overall Study|Adverse Event|4|||
148902278|NCT02392624|537126926|FG001|Overall Study|Adverse Event|1|||
148902279|NCT02392624|537126927|FG002|Overall Study|Adverse Event|2|||
148902280|NCT02392624|537126925|FG000|Overall Study|Pregnancy|1|||
148902281|NCT02392624|537126926|FG001|Overall Study|Pregnancy|0|||
148902282|NCT02392624|537126927|FG002|Overall Study|Pregnancy|0|||
148902283|NCT02392624|537126925|FG000|Overall Study|Protocol Violation|0|||
148902284|NCT02392624|537126926|FG001|Overall Study|Protocol Violation|0|||
148902285|NCT02392624|537126927|FG002|Overall Study|Protocol Violation|1|||
148902286|NCT02392624|537126925|FG000|Overall Study|Sponsor/Investigator Decision|2|||
148902287|NCT02392624|537126926|FG001|Overall Study|Sponsor/Investigator Decision|1|||
148902288|NCT02392624|537126927|FG002|Overall Study|Sponsor/Investigator Decision|0|||
148902289|NCT02392624|537126925|FG000|Overall Study|Other|49|||
148902290|NCT02392624|537126926|FG001|Overall Study|Other|1|||
148902291|NCT02392624|537126927|FG002|Overall Study|Other|1|||
148902292|NCT00936715|537126928|FG000|Overall Study|Investigators Discretion|1|||
148902293|NCT00936715|537126928|FG000|Overall Study|Protocol Violation|1|||
148902294|NCT00936715|537126928|FG000|Overall Study|Safety or Tolerability Reasons|4|||
148902295|NCT03819114|537126929|FG000|Overall Study|Protocol Violation|0|||
148902296|NCT03819114|537126930|FG001|Overall Study|Protocol Violation|1|||
148902297|NCT03819114|537126931|FG002|Overall Study|Protocol Violation|1|||
148902298|NCT03819114|537126932|FG003|Overall Study|Protocol Violation|0|||
148902299|NCT03819114|537126929|FG000|Overall Study|Lost to Follow-up|0|||
148902300|NCT03819114|537126930|FG001|Overall Study|Lost to Follow-up|0|||
148902301|NCT03819114|537126931|FG002|Overall Study|Lost to Follow-up|1|||
148902302|NCT03819114|537126932|FG003|Overall Study|Lost to Follow-up|0|||
148902303|NCT03841604|537126933|FG000|Overall Study|Withdrawal by Subject|3|||
148902304|NCT03841604|537126934|FG001|Overall Study|Withdrawal by Subject|1|||
148902305|NCT03841604|537126933|FG000|Overall Study|Adverse Event|4|||
148902306|NCT03841604|537126934|FG001|Overall Study|Adverse Event|2|||
148902307|NCT03841604|537126933|FG000|Overall Study|Physician Decision|1|||
148902308|NCT03841604|537126934|FG001|Overall Study|Physician Decision|0|||
148902309|NCT02492763|537126935|FG000|Overall Study|Withdrawal by Subject|0|||
148902310|NCT02492763|537126936|FG001|Overall Study|Withdrawal by Subject|2|||
148902311|NCT02492763|537126937|FG002|Overall Study|Withdrawal by Subject|1|||
148902312|NCT02492763|537126938|FG003|Overall Study|Withdrawal by Subject|0|||
148902313|NCT02492763|537126935|FG000|Overall Study|Adverse Event|3|||
148902314|NCT02492763|537126936|FG001|Overall Study|Adverse Event|1|||
148902315|NCT02492763|537126937|FG002|Overall Study|Adverse Event|1|||
148902316|NCT02492763|537126938|FG003|Overall Study|Adverse Event|2|||
148902317|NCT02492763|537126935|FG000|Overall Study|Death|0|||
148902318|NCT02492763|537126936|FG001|Overall Study|Death|0|||
148902319|NCT02492763|537126937|FG002|Overall Study|Death|1|||
148902320|NCT02492763|537126938|FG003|Overall Study|Death|0|||
148902321|NCT02492763|537126935|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
148902322|NCT02492763|537126936|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
148902323|NCT02492763|537126937|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
148902324|NCT02492763|537126938|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
148902325|NCT02492763|537126935|FG000|Overall Study|Lost to Follow-up|0|||
148902326|NCT02492763|537126936|FG001|Overall Study|Lost to Follow-up|0|||
148902327|NCT02492763|537126937|FG002|Overall Study|Lost to Follow-up|1|||
148902328|NCT02492763|537126938|FG003|Overall Study|Lost to Follow-up|0|||
148902329|NCT02492763|537126935|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148902330|NCT02492763|537126936|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148902331|NCT02492763|537126937|FG002|Overall Study|Non-Compliance With Study Drug|0|||
148902332|NCT02492763|537126938|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148902333|NCT02492763|537126935|FG000|Overall Study|Screen Failure|0|||
148902334|NCT02492763|537126936|FG001|Overall Study|Screen Failure|0|||
148902335|NCT02492763|537126937|FG002|Overall Study|Screen Failure|0|||
148902336|NCT02492763|537126938|FG003|Overall Study|Screen Failure|1|||
148902337|NCT02492763|537126935|FG000|Overall Study|Study Terminated by Sponsor|13|||
148902338|NCT02492763|537126936|FG001|Overall Study|Study Terminated by Sponsor|10|||
148902339|NCT02492763|537126937|FG002|Overall Study|Study Terminated by Sponsor|6|||
148902340|NCT02492763|537126938|FG003|Overall Study|Study Terminated by Sponsor|10|||
148902341|NCT03877510|537126939|FG000|Overall Study|Death|6|||
148902342|NCT03877510|537126939|FG000|Overall Study|Lost to Follow-up|2|||
148902343|NCT03877510|537126939|FG000|Overall Study|Non-compliance with study drug|2|||
148902344|NCT03877510|537126939|FG000|Overall Study|Lack of Efficacy|14|||
148902345|NCT03877510|537126939|FG000|Overall Study|Adverse Event|20|||
148902346|NCT03877510|537126939|FG000|Overall Study|Withdrawal by Subject|22|||
148902347|NCT03877510|537126939|FG000|Overall Study|Miscellaneous|1|||
148902348|NCT01337960|537126940|FG000|Overall Study|Lost to Follow-up|1|||
148902349|NCT01337960|537126941|FG001|Overall Study|Lost to Follow-up|0|||
148902350|NCT01337960|537126942|FG002|Overall Study|Lost to Follow-up|0|||
148902351|NCT01337960|537126940|FG000|Overall Study|Withdrawal by Subject|1|||
148902352|NCT01337960|537126941|FG001|Overall Study|Withdrawal by Subject|0|||
148902353|NCT01337960|537126942|FG002|Overall Study|Withdrawal by Subject|0|||
148902354|NCT01772316|537126943|FG000|Overall Study|Serious adverse event|1|||
148902355|NCT01772316|537126943|FG000|Overall Study|Inform consent withdrawn|1|||
148902356|NCT01772316|537126943|FG000|Overall Study|Withdrawn by sponsor decision|5|||
148902357|NCT02085161|537126945|FG000|Overall Study|Not Treated|1|||
148902358|NCT02085161|537126946|FG001|Overall Study|Not Treated|0|||
148902359|NCT02085161|537126947|FG002|Overall Study|Not Treated|0|||
149138437|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
149138438|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
149138439|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
148902360|NCT02085161|537126948|FG003|Overall Study|Not Treated|0|||
148902361|NCT02085161|537126945|FG000|Overall Study|Adverse Event|8|||
148902362|NCT02085161|537126946|FG001|Overall Study|Adverse Event|5|||
148902363|NCT02085161|537126947|FG002|Overall Study|Adverse Event|4|||
148902364|NCT02085161|537126948|FG003|Overall Study|Adverse Event|5|||
148902365|NCT02085161|537126945|FG000|Overall Study|Protocol Violation|0|||
148902366|NCT02085161|537126946|FG001|Overall Study|Protocol Violation|1|||
148902367|NCT02085161|537126947|FG002|Overall Study|Protocol Violation|0|||
148902368|NCT02085161|537126948|FG003|Overall Study|Protocol Violation|1|||
148902369|NCT02085161|537126945|FG000|Overall Study|Withdrawal by Subject|2|||
148902370|NCT02085161|537126946|FG001|Overall Study|Withdrawal by Subject|4|||
148902371|NCT02085161|537126947|FG002|Overall Study|Withdrawal by Subject|0|||
148902372|NCT02085161|537126948|FG003|Overall Study|Withdrawal by Subject|3|||
148902373|NCT02085161|537126945|FG000|Overall Study|Other Reason|1|||
148902374|NCT02085161|537126946|FG001|Overall Study|Other Reason|0|||
148902375|NCT02085161|537126947|FG002|Overall Study|Other Reason|1|||
148902376|NCT02085161|537126948|FG003|Overall Study|Other Reason|1|||
148902377|NCT01936870|537126954|FG000|Overall Study|No Visit After Treatment|176|||
148902378|NCT01936870|537126954|FG000|Overall Study|Protocol Violation|12|||
148902379|NCT01936870|537126954|FG000|Overall Study|No Drug Administration|1|||
148902380|NCT00628108|537126963|FG000|Overall Study|Adverse Event|0|||
148902381|NCT00628108|537126964|FG001|Overall Study|Adverse Event|3|||
148902382|NCT00628108|537126963|FG000|Overall Study|Withdrawal by Subject|1|||
148902383|NCT00628108|537126964|FG001|Overall Study|Withdrawal by Subject|0|||
148902384|NCT03848832|537126965|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
148902385|NCT03848832|537126966|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
148902386|NCT03848832|537126967|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
148902387|NCT03848832|537126965|FG000|Overall Study|Withdrawal by Subject|0|||
148902388|NCT03848832|537126966|FG001|Overall Study|Withdrawal by Subject|0|||
148902389|NCT03848832|537126967|FG002|Overall Study|Withdrawal by Subject|1|||
148902390|NCT03848832|537126965|FG000|Overall Study|Withdrawal (Covid-19)|0|||
148902391|NCT03848832|537126966|FG001|Overall Study|Withdrawal (Covid-19)|2|||
148902392|NCT03848832|537126967|FG002|Overall Study|Withdrawal (Covid-19)|0|||
148902393|NCT03848832|537126965|FG000|Overall Study|Physician Decision|2|||
148902394|NCT03848832|537126966|FG001|Overall Study|Physician Decision|1|||
148902395|NCT03848832|537126967|FG002|Overall Study|Physician Decision|3|||
148902396|NCT03848832|537126965|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
148902397|NCT03848832|537126966|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
148902398|NCT03848832|537126967|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
148902399|NCT03848832|537126965|FG000|Overall Study|Adverse Event|1|||
148801384|NCT03555149|536753632|FG006|Overall Study|Death|12|||
148801385|NCT03555149|536753633|FG007|Overall Study|Death|1|||
148801386|NCT03555149|536753626|FG000|Overall Study|Lost to Follow-up|1|||
148801387|NCT03555149|536753627|FG001|Overall Study|Lost to Follow-up|0|||
148801388|NCT03555149|536753628|FG002|Overall Study|Lost to Follow-up|0|||
148801389|NCT03555149|536753629|FG003|Overall Study|Lost to Follow-up|0|||
148801390|NCT03555149|536753630|FG004|Overall Study|Lost to Follow-up|0|||
148801391|NCT03555149|536753631|FG005|Overall Study|Lost to Follow-up|1|||
148801392|NCT03555149|536753632|FG006|Overall Study|Lost to Follow-up|0|||
148801393|NCT03555149|536753633|FG007|Overall Study|Lost to Follow-up|0|||
148801394|NCT03555149|536753626|FG000|Overall Study|Physician Decision|1|||
148801395|NCT03555149|536753627|FG001|Overall Study|Physician Decision|0|||
148801396|NCT03555149|536753628|FG002|Overall Study|Physician Decision|0|||
148801397|NCT03555149|536753629|FG003|Overall Study|Physician Decision|0|||
148801398|NCT03555149|536753630|FG004|Overall Study|Physician Decision|0|||
148801399|NCT03555149|536753631|FG005|Overall Study|Physician Decision|0|||
148801400|NCT03555149|536753632|FG006|Overall Study|Physician Decision|0|||
148801401|NCT03555149|536753633|FG007|Overall Study|Physician Decision|0|||
148801402|NCT03555149|536753626|FG000|Overall Study|Study Terminated By Sponsor|1|||
148801403|NCT03555149|536753627|FG001|Overall Study|Study Terminated By Sponsor|0|||
148801404|NCT03555149|536753628|FG002|Overall Study|Study Terminated By Sponsor|0|||
148801405|NCT03555149|536753629|FG003|Overall Study|Study Terminated By Sponsor|0|||
148801406|NCT03555149|536753630|FG004|Overall Study|Study Terminated By Sponsor|0|||
148801407|NCT03555149|536753631|FG005|Overall Study|Study Terminated By Sponsor|2|||
148801408|NCT03555149|536753632|FG006|Overall Study|Study Terminated By Sponsor|3|||
148801409|NCT03555149|536753633|FG007|Overall Study|Study Terminated By Sponsor|1|||
148801410|NCT03555149|536753626|FG000|Overall Study|Withdrawal by Subject|3|||
148801411|NCT03555149|536753627|FG001|Overall Study|Withdrawal by Subject|0|||
148801412|NCT03555149|536753628|FG002|Overall Study|Withdrawal by Subject|0|||
148902400|NCT03848832|537126966|FG001|Overall Study|Adverse Event|0|||
148902401|NCT03848832|537126967|FG002|Overall Study|Adverse Event|0|||
148902402|NCT00719472|537126969|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
148902403|NCT00719472|537126969|FG000|Enrolled in Study|Subject decision to withdraw|8|||
148902404|NCT00719472|537126969|FG000|Enrolled in Study|Various Reasons|17|||
148902405|NCT00719472|537126969|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
148801413|NCT03555149|536753629|FG003|Overall Study|Withdrawal by Subject|2|||
148801414|NCT03555149|536753630|FG004|Overall Study|Withdrawal by Subject|0|||
148801415|NCT03555149|536753631|FG005|Overall Study|Withdrawal by Subject|1|||
148801416|NCT03555149|536753632|FG006|Overall Study|Withdrawal by Subject|0|||
148801417|NCT03555149|536753633|FG007|Overall Study|Withdrawal by Subject|0|||
148801418|NCT02666222|536753634|FG000|Overall Study|Death|2|||
148801419|NCT03292016|536753638|FG000|Second Washout|Adverse Event|0|||
148801420|NCT03292016|536753639|FG001|Second Washout|Adverse Event|1|||
148801421|NCT03292016|536753640|FG002|Second Washout|Adverse Event|0|||
148801422|NCT03292016|536753641|FG003|Second Washout|Adverse Event|0|||
148801423|NCT03292016|536753642|FG004|Second Washout|Adverse Event|0|||
148801424|NCT03292016|536753643|FG005|Second Washout|Adverse Event|0|||
148801425|NCT01909804|536753648|FG000|Overall Study|Randomized but Never Treated|0|||
148801426|NCT01909804|536753649|FG001|Overall Study|Randomized but Never Treated|0|||
148801427|NCT01909804|536753650|FG002|Overall Study|Randomized but Never Treated|0|||
148801428|NCT01909804|536753651|FG003|Overall Study|Randomized but Never Treated|0|||
148801429|NCT01909804|536753652|FG004|Overall Study|Randomized but Never Treated|0|||
148801430|NCT01909804|536753653|FG005|Overall Study|Randomized but Never Treated|0|||
148801431|NCT01909804|536753654|FG006|Overall Study|Randomized but Never Treated|1|||
148801432|NCT01909804|536753655|FG007|Overall Study|Randomized but Never Treated|0|||
148801433|NCT01909804|536753656|FG008|Overall Study|Randomized but Never Treated|0|||
148801434|NCT01909804|536753657|FG009|Overall Study|Randomized but Never Treated|0|||
148801435|NCT01909804|536753658|FG010|Overall Study|Randomized but Never Treated|0|||
148801436|NCT01909804|536753659|FG011|Overall Study|Randomized but Never Treated|1|||
148801437|NCT01909804|536753648|FG000|Overall Study|Death|0|||
148801438|NCT01909804|536753649|FG001|Overall Study|Death|0|||
148801439|NCT01909804|536753650|FG002|Overall Study|Death|0|||
148801440|NCT01909804|536753651|FG003|Overall Study|Death|0|||
148801441|NCT01909804|536753652|FG004|Overall Study|Death|0|||
148801442|NCT01909804|536753653|FG005|Overall Study|Death|0|||
148801443|NCT01909804|536753654|FG006|Overall Study|Death|0|||
148801444|NCT01909804|536753655|FG007|Overall Study|Death|0|||
148801445|NCT01909804|536753656|FG008|Overall Study|Death|0|||
148801446|NCT01909804|536753657|FG009|Overall Study|Death|0|||
148801447|NCT01909804|536753658|FG010|Overall Study|Death|1|||
148801448|NCT01909804|536753659|FG011|Overall Study|Death|0|||
148801449|NCT01909804|536753648|FG000|Overall Study|Lack of Efficacy|4|||
148801450|NCT01909804|536753649|FG001|Overall Study|Lack of Efficacy|1|||
148801451|NCT01909804|536753650|FG002|Overall Study|Lack of Efficacy|0|||
148801452|NCT01909804|536753651|FG003|Overall Study|Lack of Efficacy|0|||
148801453|NCT01909804|536753652|FG004|Overall Study|Lack of Efficacy|7|||
148801454|NCT01909804|536753653|FG005|Overall Study|Lack of Efficacy|3|||
148801455|NCT01909804|536753654|FG006|Overall Study|Lack of Efficacy|1|||
148801456|NCT01909804|536753655|FG007|Overall Study|Lack of Efficacy|1|||
148801457|NCT01909804|536753656|FG008|Overall Study|Lack of Efficacy|0|||
148801458|NCT01909804|536753657|FG009|Overall Study|Lack of Efficacy|1|||
148801459|NCT01909804|536753658|FG010|Overall Study|Lack of Efficacy|0|||
148801460|NCT01909804|536753659|FG011|Overall Study|Lack of Efficacy|1|||
148801461|NCT01909804|536753648|FG000|Overall Study|Withdrew Consent|0|||
148801462|NCT01909804|536753649|FG001|Overall Study|Withdrew Consent|0|||
148801463|NCT01909804|536753650|FG002|Overall Study|Withdrew Consent|0|||
148801464|NCT01909804|536753651|FG003|Overall Study|Withdrew Consent|0|||
148801465|NCT01909804|536753652|FG004|Overall Study|Withdrew Consent|1|||
148801466|NCT01909804|536753653|FG005|Overall Study|Withdrew Consent|1|||
148801467|NCT01909804|536753654|FG006|Overall Study|Withdrew Consent|0|||
148801468|NCT01909804|536753655|FG007|Overall Study|Withdrew Consent|0|||
148801469|NCT01909804|536753656|FG008|Overall Study|Withdrew Consent|0|||
148801470|NCT01909804|536753657|FG009|Overall Study|Withdrew Consent|0|||
148801471|NCT01909804|536753658|FG010|Overall Study|Withdrew Consent|0|||
148902406|NCT00719472|537126969|FG000|Received Cycle 1 Treatment|Death|5|||
148902407|NCT00719472|537126969|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
148902408|NCT00719472|537126969|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
148902409|NCT00719472|537126969|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
148902410|NCT00719472|537126969|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
148902411|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
148902412|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Death|6|||
148902413|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Disease progression|3|||
148902414|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
148902415|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
148902416|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
148902417|NCT00719472|537126969|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
148902418|NCT00711191|537126972|FG000|Overall Study|Adverse Event|1|||
148902419|NCT00711191|537126973|FG001|Overall Study|Adverse Event|1|||
148902420|NCT00711191|537126974|FG002|Overall Study|Adverse Event|2|||
148902421|NCT00711191|537126972|FG000|Overall Study|Objective progression or relapse|2|||
148902422|NCT00711191|537126973|FG001|Overall Study|Objective progression or relapse|3|||
148902423|NCT00711191|537126974|FG002|Overall Study|Objective progression or relapse|7|||
148902424|NCT00711191|537126972|FG000|Overall Study|Withdrawal by Subject|0|||
148902425|NCT00711191|537126973|FG001|Overall Study|Withdrawal by Subject|1|||
148902426|NCT00711191|537126974|FG002|Overall Study|Withdrawal by Subject|3|||
148902427|NCT02633306|537126975|FG000|Overall Study|Withdrawal by Subject|3|||
148902428|NCT01744977|537126976|FG000|Overall Study|Withdrawal by Subject|1|||
148902429|NCT01744977|537126977|FG001|Overall Study|Withdrawal by Subject|2|||
148902430|NCT01744977|537126976|FG000|Overall Study|Death|2|||
148902431|NCT01744977|537126977|FG001|Overall Study|Death|3|||
148902432|NCT01744977|537126976|FG000|Overall Study|Lost to Follow-up|2|||
148902433|NCT01744977|537126977|FG001|Overall Study|Lost to Follow-up|0|||
148902434|NCT01744977|537126976|FG000|Overall Study|No longer meets inclusion|6|||
148902435|NCT01744977|537126977|FG001|Overall Study|No longer meets inclusion|0|||
148902436|NCT01213472|537126978|FG000|Overall Study|Recurrence/Progressive disease|25|||
148902437|NCT01213472|537126978|FG000|Overall Study|Withdrawal by Subject|1|||
148902438|NCT01213472|537126978|FG000|Overall Study|Physician Decision|1|||
148902439|NCT03774576|537126979|FG000|Period 2|Adverse Event|1|||
148902440|NCT00907335|537126982|FG000|Overall Study|Withdrawal by Subject|2|||
148902441|NCT00907335|537126983|FG001|Overall Study|Withdrawal by Subject|0|||
148801472|NCT01909804|536753659|FG011|Overall Study|Withdrew Consent|0|||
148801473|NCT01909804|536753648|FG000|Overall Study|Protocol Violation|0|||
148801474|NCT01909804|536753649|FG001|Overall Study|Protocol Violation|0|||
148801475|NCT01909804|536753650|FG002|Overall Study|Protocol Violation|0|||
148801476|NCT01909804|536753651|FG003|Overall Study|Protocol Violation|0|||
148801477|NCT01909804|536753652|FG004|Overall Study|Protocol Violation|0|||
148801478|NCT01909804|536753653|FG005|Overall Study|Protocol Violation|0|||
148801479|NCT01909804|536753654|FG006|Overall Study|Protocol Violation|0|||
148801480|NCT01909804|536753655|FG007|Overall Study|Protocol Violation|0|||
148801481|NCT01909804|536753656|FG008|Overall Study|Protocol Violation|0|||
148801482|NCT01909804|536753657|FG009|Overall Study|Protocol Violation|0|||
148801483|NCT01909804|536753658|FG010|Overall Study|Protocol Violation|0|||
148801484|NCT01909804|536753659|FG011|Overall Study|Protocol Violation|1|||
148801485|NCT01038687|536753660|FG000|Overall Study|Adverse Event|0|||
148801486|NCT01038687|536753661|FG001|Overall Study|Adverse Event|2|||
148801487|NCT01038687|536753662|FG002|Overall Study|Adverse Event|1|||
148801488|NCT05401565|536753663|FG000|Overall Study|Lost to Follow-up|1|||
148801489|NCT05401565|536753664|FG001|Overall Study|Lost to Follow-up|0|||
148801490|NCT05401565|536753663|FG000|Overall Study|Adverse Event|2|||
148801491|NCT05401565|536753664|FG001|Overall Study|Adverse Event|0|||
148801492|NCT03080935|536753665|FG000|Overall Study|Death|34|||
148801493|NCT03080935|536753666|FG001|Overall Study|Death|50|||
148801494|NCT03080935|536753665|FG000|Overall Study|Lost to Follow-up|5|||
148801495|NCT03080935|536753666|FG001|Overall Study|Lost to Follow-up|4|||
148801496|NCT03080935|536753665|FG000|Overall Study|Withdrawal by Subject|11|||
148801497|NCT03080935|536753666|FG001|Overall Study|Withdrawal by Subject|15|||
148801498|NCT04249427|536753669|FG000|Overall Study|Adverse Event|3|||
148902442|NCT00907335|537126982|FG000|Overall Study|Adverse Event|4|||
148902443|NCT00907335|537126983|FG001|Overall Study|Adverse Event|1|||
148902444|NCT00907335|537126982|FG000|Overall Study|Lost to Follow-up|2|||
148801499|NCT04249427|536753670|FG001|Overall Study|Adverse Event|1|||
148801500|NCT04249427|536753669|FG000|Overall Study|Lack of Efficacy|0|||
148801501|NCT04249427|536753670|FG001|Overall Study|Lack of Efficacy|1|||
148801502|NCT04249427|536753669|FG000|Overall Study|Withdrawal by Subject|1|||
148801503|NCT04249427|536753670|FG001|Overall Study|Withdrawal by Subject|2|||
148801504|NCT03886272|536753671|FG000|Period 1|Withdrawal by Subject|0|||
148801505|NCT03886272|536753672|FG001|Period 1|Withdrawal by Subject|0|||
148801506|NCT03886272|536753673|FG002|Period 1|Withdrawal by Subject|0|||
148801507|NCT03886272|536753674|FG003|Period 1|Withdrawal by Subject|0|||
148801508|NCT03886272|536753675|FG004|Period 1|Withdrawal by Subject|0|||
148801509|NCT03886272|536753676|FG005|Period 1|Withdrawal by Subject|1|||
148801510|NCT03886272|536753677|FG006|Period 1|Withdrawal by Subject|0|||
148801511|NCT02895347|536753680|FG000|Overall Study|Withdrawal by Subject|3|||
148801512|NCT02895347|536753681|FG001|Overall Study|Withdrawal by Subject|1|||
148801513|NCT01673178|536753685|FG000|Overall Study|Lost to Follow-up|0|||
148801514|NCT01673178|536753686|FG001|Overall Study|Lost to Follow-up|1|||
148801515|NCT01673178|536753687|FG002|Overall Study|Lost to Follow-up|0|||
148801516|NCT01673178|536753688|FG003|Overall Study|Lost to Follow-up|0|||
148801517|NCT01673178|536753689|FG004|Overall Study|Lost to Follow-up|0|||
148801518|NCT01673178|536753685|FG000|Overall Study|Withdrawal by Subject|0|||
148801519|NCT01673178|536753686|FG001|Overall Study|Withdrawal by Subject|0|||
148801520|NCT01673178|536753687|FG002|Overall Study|Withdrawal by Subject|1|||
148801521|NCT01673178|536753688|FG003|Overall Study|Withdrawal by Subject|4|||
148801522|NCT01673178|536753689|FG004|Overall Study|Withdrawal by Subject|2|||
148801523|NCT01673178|536753685|FG000|Overall Study|Protocol Violation|1|||
148801524|NCT01673178|536753686|FG001|Overall Study|Protocol Violation|1|||
148801525|NCT01673178|536753687|FG002|Overall Study|Protocol Violation|0|||
148801526|NCT01673178|536753688|FG003|Overall Study|Protocol Violation|1|||
148801527|NCT01673178|536753689|FG004|Overall Study|Protocol Violation|0|||
148801528|NCT01673178|536753685|FG000|Overall Study|Adverse Event|1|||
148801529|NCT01673178|536753686|FG001|Overall Study|Adverse Event|0|||
148801530|NCT01673178|536753687|FG002|Overall Study|Adverse Event|0|||
148801531|NCT01673178|536753688|FG003|Overall Study|Adverse Event|2|||
148801532|NCT01673178|536753689|FG004|Overall Study|Adverse Event|0|||
148801533|NCT01673178|536753685|FG000|Overall Study|Other|1|||
148801534|NCT01673178|536753686|FG001|Overall Study|Other|0|||
148801535|NCT01673178|536753687|FG002|Overall Study|Other|2|||
148801536|NCT01673178|536753688|FG003|Overall Study|Other|1|||
148801537|NCT01673178|536753689|FG004|Overall Study|Other|0|||
148801538|NCT00931632|536753690|FG000|Overall Study|Withdrawal by Subject|2|||
148801539|NCT00931632|536753691|FG001|Overall Study|Withdrawal by Subject|3|||
148801540|NCT00931632|536753690|FG000|Overall Study|Adverse Event|19|||
148801541|NCT00931632|536753691|FG001|Overall Study|Adverse Event|15|||
148801542|NCT01419314|536753692|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
148801543|NCT01419314|536753693|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
148801544|NCT01419314|536753692|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
148801545|NCT01419314|536753693|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
148801546|NCT01419314|536753692|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
148801547|NCT01419314|536753693|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
148801548|NCT00402727|536753697|FG000|Overall Study|Adverse Event|10|||
148801549|NCT00402727|536753698|FG001|Overall Study|Adverse Event|6|||
148801550|NCT00402727|536753697|FG000|Overall Study|Death|1|||
148801551|NCT00402727|536753698|FG001|Overall Study|Death|0|||
148902445|NCT00907335|537126983|FG001|Overall Study|Lost to Follow-up|0|||
148902446|NCT03879772|537126984|FG000|Overall Study|Adverse Event|2|||
148902447|NCT03879772|537126985|FG001|Overall Study|Adverse Event|2|||
148902448|NCT03879772|537126986|FG002|Overall Study|Adverse Event|3|||
148902449|NCT03879772|537126987|FG003|Overall Study|Adverse Event|4|||
148902450|NCT03879772|537126988|FG004|Overall Study|Adverse Event|3|||
148902451|NCT03879772|537126984|FG000|Overall Study|Treatment Failure|1|||
148902452|NCT03879772|537126985|FG001|Overall Study|Treatment Failure|0|||
148902453|NCT03879772|537126986|FG002|Overall Study|Treatment Failure|0|||
148902454|NCT03879772|537126987|FG003|Overall Study|Treatment Failure|2|||
148902455|NCT03879772|537126988|FG004|Overall Study|Treatment Failure|1|||
148902456|NCT03879772|537126984|FG000|Overall Study|Lost to Follow-up|0|||
148902457|NCT03879772|537126985|FG001|Overall Study|Lost to Follow-up|0|||
148902458|NCT03879772|537126986|FG002|Overall Study|Lost to Follow-up|0|||
148902459|NCT03879772|537126987|FG003|Overall Study|Lost to Follow-up|0|||
148902460|NCT03879772|537126988|FG004|Overall Study|Lost to Follow-up|1|||
148902461|NCT03879772|537126984|FG000|Overall Study|Withdrawal by Subject|0|||
148902462|NCT03879772|537126985|FG001|Overall Study|Withdrawal by Subject|1|||
148902463|NCT03879772|537126986|FG002|Overall Study|Withdrawal by Subject|3|||
148902464|NCT03879772|537126987|FG003|Overall Study|Withdrawal by Subject|1|||
148902465|NCT03879772|537126988|FG004|Overall Study|Withdrawal by Subject|1|||
148902466|NCT03879772|537126984|FG000|Overall Study|Protocol Violation|0|||
148902467|NCT03879772|537126985|FG001|Overall Study|Protocol Violation|0|||
148902468|NCT03879772|537126986|FG002|Overall Study|Protocol Violation|3|||
148902469|NCT03879772|537126987|FG003|Overall Study|Protocol Violation|1|||
148902470|NCT03879772|537126988|FG004|Overall Study|Protocol Violation|2|||
148902471|NCT03879772|537126984|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
148902472|NCT03879772|537126985|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
148902473|NCT03879772|537126986|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
148902474|NCT03879772|537126987|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
148902475|NCT03879772|537126988|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
148902476|NCT03345784|537126991|FG000|Overall Study|Withdrawal by Subject|2|||
148902477|NCT03345784|537126992|FG001|Overall Study|Withdrawal by Subject|1|||
148902478|NCT00482053|537126997|FG000|Inter-treatment Period|Disease progression|1|||
148902479|NCT00728689|537126998|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
148902480|NCT00728689|537126999|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
148902481|NCT00389610|537127002|FG000|Overall Study|Disease Progression|0|||
148902482|NCT00389610|537127003|FG001|Overall Study|Disease Progression|19|||
148902483|NCT00389610|537127002|FG000|Overall Study|Death|0|||
148902484|NCT00389610|537127003|FG001|Overall Study|Death|1|||
148902485|NCT00389610|537127002|FG000|Overall Study|Physician Decision|0|||
148902486|NCT00389610|537127003|FG001|Overall Study|Physician Decision|1|||
148902487|NCT00389610|537127002|FG000|Overall Study|Withdrawal by Subject|0|||
148902488|NCT00389610|537127003|FG001|Overall Study|Withdrawal by Subject|1|||
148902489|NCT00887809|537127004|FG000|Overall Study|Patient Not Treated|3|||
148902490|NCT00887809|537127005|FG001|Overall Study|Patient Not Treated|0|||
148902491|NCT00887809|537127004|FG000|Overall Study|Death|1|||
148902492|NCT00887809|537127005|FG001|Overall Study|Death|0|||
148902493|NCT04109547|537127008|FG000|Overall Study|Withdrawal by Subject|3|||
148902494|NCT04109547|537127009|FG001|Overall Study|Withdrawal by Subject|2|||
148902495|NCT04109547|537127010|FG002|Overall Study|Withdrawal by Subject|6|||
148902496|NCT04109547|537127011|FG003|Overall Study|Withdrawal by Subject|6|||
148902497|NCT04109547|537127008|FG000|Overall Study|Lost to Follow-up|0|||
148902498|NCT04109547|537127009|FG001|Overall Study|Lost to Follow-up|0|||
148902499|NCT04109547|537127010|FG002|Overall Study|Lost to Follow-up|0|||
148902500|NCT04109547|537127011|FG003|Overall Study|Lost to Follow-up|1|||
148902501|NCT04109547|537127008|FG000|Overall Study|Physician Decision|1|||
148902502|NCT04109547|537127009|FG001|Overall Study|Physician Decision|2|||
148902503|NCT04109547|537127010|FG002|Overall Study|Physician Decision|0|||
148902504|NCT04109547|537127011|FG003|Overall Study|Physician Decision|0|||
148902505|NCT01550003|537127012|FG000|Overall Study|Adverse Event|0|||
148902506|NCT01550003|537127013|FG001|Overall Study|Adverse Event|9|||
148902507|NCT01550003|537127014|FG002|Overall Study|Adverse Event|15|||
148902508|NCT01550003|537127012|FG000|Overall Study|Lack of Efficacy|4|||
149138440|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
148902509|NCT01550003|537127013|FG001|Overall Study|Lack of Efficacy|11|||
148902510|NCT01550003|537127014|FG002|Overall Study|Lack of Efficacy|15|||
148902511|NCT01550003|537127012|FG000|Overall Study|Protocol Violation|0|||
148902512|NCT01550003|537127013|FG001|Overall Study|Protocol Violation|3|||
148902513|NCT01550003|537127014|FG002|Overall Study|Protocol Violation|2|||
148902514|NCT01550003|537127012|FG000|Overall Study|Lost to Follow-up|1|||
148902515|NCT01550003|537127013|FG001|Overall Study|Lost to Follow-up|4|||
148902516|NCT01550003|537127014|FG002|Overall Study|Lost to Follow-up|8|||
148902517|NCT01550003|537127012|FG000|Overall Study|Consent withdrawn|2|||
148902518|NCT01550003|537127013|FG001|Overall Study|Consent withdrawn|11|||
148902519|NCT01550003|537127014|FG002|Overall Study|Consent withdrawn|23|||
148902520|NCT01550003|537127012|FG000|Overall Study|Missing|1|||
148902521|NCT01550003|537127013|FG001|Overall Study|Missing|0|||
148902522|NCT01550003|537127014|FG002|Overall Study|Missing|2|||
148902523|NCT01550003|537127012|FG000|Overall Study|Study closure as announced by sponsor|7|||
148902524|NCT01550003|537127013|FG001|Overall Study|Study closure as announced by sponsor|6|||
148902525|NCT01550003|537127014|FG002|Overall Study|Study closure as announced by sponsor|24|||
148902526|NCT01550003|537127012|FG000|Overall Study|Protocol Noncompliance|1|||
148902527|NCT01550003|537127013|FG001|Overall Study|Protocol Noncompliance|0|||
148902528|NCT01550003|537127014|FG002|Overall Study|Protocol Noncompliance|0|||
148902529|NCT01550003|537127012|FG000|Overall Study|Study closure|0|||
148902530|NCT01550003|537127013|FG001|Overall Study|Study closure|1|||
148902531|NCT01550003|537127014|FG002|Overall Study|Study closure|1|||
148902532|NCT01550003|537127012|FG000|Overall Study|Patient reached adulthood|0|||
148902533|NCT01550003|537127013|FG001|Overall Study|Patient reached adulthood|1|||
148902534|NCT01550003|537127014|FG002|Overall Study|Patient reached adulthood|0|||
148902535|NCT01550003|537127012|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
148902536|NCT01550003|537127013|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
148902537|NCT01550003|537127014|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
148902538|NCT01550003|537127012|FG000|Overall Study|Sponsor's order|0|||
148902539|NCT01550003|537127013|FG001|Overall Study|Sponsor's order|3|||
148902540|NCT01550003|537127014|FG002|Overall Study|Sponsor's order|3|||
148902541|NCT01550003|537127012|FG000|Overall Study|Sponsor's decision|1|||
148902542|NCT01550003|537127013|FG001|Overall Study|Sponsor's decision|5|||
148902543|NCT01550003|537127014|FG002|Overall Study|Sponsor's decision|4|||
148902544|NCT01550003|537127012|FG000|Overall Study|Subject mother passed away|0|||
148902545|NCT01550003|537127013|FG001|Overall Study|Subject mother passed away|1|||
148902546|NCT01550003|537127014|FG002|Overall Study|Subject mother passed away|0|||
148902547|NCT01550003|537127012|FG000|Overall Study|Discontinuation|0|||
148902548|NCT01550003|537127013|FG001|Overall Study|Discontinuation|1|||
148902549|NCT01550003|537127014|FG002|Overall Study|Discontinuation|0|||
148902550|NCT01550003|537127012|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
148902551|NCT01550003|537127013|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
148902552|NCT01550003|537127014|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
148902553|NCT01550003|537127012|FG000|Overall Study|Site closure|0|||
148902554|NCT01550003|537127013|FG001|Overall Study|Site closure|2|||
148902555|NCT01550003|537127014|FG002|Overall Study|Site closure|0|||
148902556|NCT01550003|537127012|FG000|Overall Study|Pregnancy|0|||
148902557|NCT01550003|537127013|FG001|Overall Study|Pregnancy|1|||
148902558|NCT01550003|537127014|FG002|Overall Study|Pregnancy|0|||
148902559|NCT01550003|537127012|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
148902560|NCT01550003|537127013|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
148902561|NCT01550003|537127014|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
148902562|NCT01550003|537127012|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
148902563|NCT01550003|537127013|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
148902564|NCT01550003|537127014|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
148902565|NCT01550003|537127012|FG000|Overall Study|Switching to adult rheumatologist|0|||
148902566|NCT01550003|537127013|FG001|Overall Study|Switching to adult rheumatologist|0|||
148902567|NCT01550003|537127014|FG002|Overall Study|Switching to adult rheumatologist|1|||
148902568|NCT01550003|537127012|FG000|Overall Study|Patient transition to adult care|0|||
148902569|NCT01550003|537127013|FG001|Overall Study|Patient transition to adult care|0|||
148902570|NCT01550003|537127014|FG002|Overall Study|Patient transition to adult care|1|||
148902571|NCT01550003|537127012|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
149138441|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
149138442|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
148902572|NCT01550003|537127013|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
148902573|NCT01550003|537127014|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
148902574|NCT01550003|537127012|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
148902575|NCT01550003|537127013|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
148902576|NCT01550003|537127014|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
148902577|NCT01550003|537127012|FG000|Overall Study|Per Sponsor request|1|||
148902578|NCT01550003|537127013|FG001|Overall Study|Per Sponsor request|0|||
148902579|NCT01550003|537127014|FG002|Overall Study|Per Sponsor request|1|||
148902580|NCT01550003|537127012|FG000|Overall Study|Patient not compliance|0|||
148902581|NCT01550003|537127013|FG001|Overall Study|Patient not compliance|0|||
148902582|NCT01550003|537127014|FG002|Overall Study|Patient not compliance|1|||
148902583|NCT01550003|537127012|FG000|Overall Study|Non-compliance|0|||
148902584|NCT01550003|537127013|FG001|Overall Study|Non-compliance|0|||
148902585|NCT01550003|537127014|FG002|Overall Study|Non-compliance|1|||
148902586|NCT01550003|537127012|FG000|Overall Study|Study closed|0|||
148902587|NCT01550003|537127013|FG001|Overall Study|Study closed|1|||
148902588|NCT01550003|537127014|FG002|Overall Study|Study closed|0|||
148902589|NCT01550003|537127012|FG000|Overall Study|Transitioned to adult rheumatology|0|||
148902590|NCT01550003|537127013|FG001|Overall Study|Transitioned to adult rheumatology|0|||
148902591|NCT01550003|537127014|FG002|Overall Study|Transitioned to adult rheumatology|1|||
148902592|NCT05567783|537127015|FG000|Overall Study|Death|2|||
148902593|NCT05567783|537127016|FG001|Overall Study|Death|3|||
148902594|NCT05567783|537127017|FG002|Overall Study|Death|0|||
148902595|NCT05567783|537127015|FG000|Overall Study|Lost to Follow-up|25|||
148902596|NCT05567783|537127016|FG001|Overall Study|Lost to Follow-up|19|||
148902597|NCT05567783|537127017|FG002|Overall Study|Lost to Follow-up|17|||
148902598|NCT05567783|537127015|FG000|Overall Study|Physician Decision|10|||
148902599|NCT05567783|537127016|FG001|Overall Study|Physician Decision|7|||
148902600|NCT05567783|537127017|FG002|Overall Study|Physician Decision|9|||
148902601|NCT05567783|537127015|FG000|Overall Study|Study Terminated by Sponsor|924|||
148902602|NCT05567783|537127016|FG001|Overall Study|Study Terminated by Sponsor|937|||
148902603|NCT05567783|537127017|FG002|Overall Study|Study Terminated by Sponsor|941|||
148902604|NCT05567783|537127015|FG000|Overall Study|Withdrawal by Subject|23|||
148902605|NCT05567783|537127016|FG001|Overall Study|Withdrawal by Subject|27|||
148902606|NCT05567783|537127017|FG002|Overall Study|Withdrawal by Subject|24|||
148902607|NCT05567783|537127015|FG000|Overall Study|Incarcerated|1|||
148902608|NCT05567783|537127016|FG001|Overall Study|Incarcerated|0|||
148902609|NCT05567783|537127017|FG002|Overall Study|Incarcerated|0|||
148902610|NCT05567783|537127015|FG000|Overall Study|Participant randomized in error|4|||
148902611|NCT05567783|537127016|FG001|Overall Study|Participant randomized in error|2|||
148902612|NCT05567783|537127017|FG002|Overall Study|Participant randomized in error|2|||
148902613|NCT03675126|537127020|FG000|Overall Study|Study Terminated by Sponsor|9|||
148902614|NCT03675126|537127020|FG000|Overall Study|Death|2|||
148902615|NCT03675126|537127020|FG000|Overall Study|Withdrawal by Subject|4|||
148902616|NCT00001959|537127021|FG000|Overall Study|newly diagnosed colon cancer|1|||
148902617|NCT00001959|537127021|FG000|Overall Study|disabling sedation|1|||
148902618|NCT00001959|537127021|FG000|Overall Study|non-compliance|1|||
148902619|NCT03113487|537127024|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
148902620|NCT03777982|537127025|FG000|Overall Study|Physician Decision|0|||
148902621|NCT03777982|537127026|FG001|Overall Study|Physician Decision|1|||
148902622|NCT03995368|537127029|FG000|Overall Study|Lost to Follow-up|1|||
148902623|NCT03995368|537127030|FG001|Overall Study|Lost to Follow-up|4|||
148902624|NCT03995368|537127031|FG002|Overall Study|Lost to Follow-up|1|||
148902625|NCT03995368|537127029|FG000|Overall Study|Did not meet inclusion criteria|1|||
148902626|NCT03995368|537127030|FG001|Overall Study|Did not meet inclusion criteria|6|||
148902627|NCT03995368|537127031|FG002|Overall Study|Did not meet inclusion criteria|3|||
148902628|NCT03995368|537127029|FG000|Overall Study|Withdrawal by Subject|0|||
148902629|NCT03995368|537127030|FG001|Overall Study|Withdrawal by Subject|1|||
148902630|NCT03995368|537127031|FG002|Overall Study|Withdrawal by Subject|1|||
148902631|NCT03755934|537127034|FG000|Overall Study|Adverse Event|4|||
148902632|NCT03755934|537127035|FG001|Overall Study|Adverse Event|1|||
148902633|NCT03755934|537127036|FG002|Overall Study|Adverse Event|1|||
148902634|NCT03755934|537127037|FG003|Overall Study|Adverse Event|3|||
148902635|NCT03755934|537127034|FG000|Overall Study|Physician Decision|2|||
148902636|NCT03755934|537127035|FG001|Overall Study|Physician Decision|0|||
148902637|NCT03755934|537127036|FG002|Overall Study|Physician Decision|0|||
148902638|NCT03755934|537127037|FG003|Overall Study|Physician Decision|1|||
148902639|NCT03755934|537127034|FG000|Overall Study|Withdrawal by Subject|5|||
148902640|NCT03755934|537127035|FG001|Overall Study|Withdrawal by Subject|0|||
148902641|NCT03755934|537127036|FG002|Overall Study|Withdrawal by Subject|0|||
148902642|NCT03755934|537127037|FG003|Overall Study|Withdrawal by Subject|1|||
148902643|NCT03755934|537127034|FG000|Overall Study|Other|3|||
148902644|NCT03755934|537127035|FG001|Overall Study|Other|1|||
148902645|NCT03755934|537127036|FG002|Overall Study|Other|3|||
148902646|NCT03755934|537127037|FG003|Overall Study|Other|1|||
148902647|NCT00361296|537127040|FG000|Overall Study|Physician Decision|1|||
148902648|NCT00361296|537127040|FG000|Overall Study|Lack of Efficacy|2|||
148902649|NCT02072668|537127044|FG000|Second Intervention|Lost to Follow-up|1|||
148902650|NCT02072668|537127045|FG001|Second Intervention|Lost to Follow-up|0|||
148902651|NCT01352793|537127052|FG000|Overall Study|Lost to Follow-up|289|||
148902652|NCT01352793|537127053|FG001|Overall Study|Lost to Follow-up|125|||
148902653|NCT01352793|537127052|FG000|Overall Study|Withdrawal by Subject|120|||
148902654|NCT01352793|537127053|FG001|Overall Study|Withdrawal by Subject|55|||
148902655|NCT01352793|537127052|FG000|Overall Study|Protocol Violation|44|||
148902656|NCT01352793|537127053|FG001|Overall Study|Protocol Violation|23|||
148902657|NCT01352793|537127052|FG000|Overall Study|Adverse Event|44|||
148902658|NCT01352793|537127053|FG001|Overall Study|Adverse Event|10|||
148902659|NCT01352793|537127052|FG000|Overall Study|Physician Decision|1|||
148902660|NCT01352793|537127053|FG001|Overall Study|Physician Decision|0|||
148902661|NCT01352793|537127052|FG000|Overall Study|Pregnancy|26|||
148902662|NCT01352793|537127053|FG001|Overall Study|Pregnancy|8|||
148902663|NCT01352793|537127052|FG000|Overall Study|Other|25|||
148902664|NCT01352793|537127053|FG001|Overall Study|Other|7|||
148902665|NCT01352793|537127052|FG000|Overall Study|Medication error|2|||
148902666|NCT01352793|537127053|FG001|Overall Study|Medication error|2|||
148902667|NCT01352793|537127052|FG000|Overall Study|Death|1|||
148902668|NCT01352793|537127053|FG001|Overall Study|Death|0|||
148902669|NCT01352793|537127052|FG000|Overall Study|Randomized but not vaccinated|8|||
148902670|NCT01352793|537127053|FG001|Overall Study|Randomized but not vaccinated|0|||
148902671|NCT01352793|537127052|FG000|Overall Study|No longer meets eligibility criteria|25|||
148902672|NCT01352793|537127053|FG001|Overall Study|No longer meets eligibility criteria|15|||
148902673|NCT04322526|537127056|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
148902674|NCT04322526|537127057|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
148902675|NCT04322526|537127056|FG000|Washout (1 Week)|Lost to Follow-up|1|||
148902676|NCT04322526|537127057|FG001|Washout (1 Week)|Lost to Follow-up|2|||
148902677|NCT02594124|537127063|FG000|Overall Study|Adverse Event|0|||
148902678|NCT02594124|537127064|FG001|Overall Study|Adverse Event|5|||
148902679|NCT02594124|537127065|FG002|Overall Study|Adverse Event|8|||
148902680|NCT02594124|537127066|FG003|Overall Study|Adverse Event|1|||
148902681|NCT02594124|537127067|FG004|Overall Study|Adverse Event|0|||
148902682|NCT02594124|537127068|FG005|Overall Study|Adverse Event|0|||
148902683|NCT02594124|537127069|FG006|Overall Study|Adverse Event|2|||
148902684|NCT02594124|537127070|FG007|Overall Study|Adverse Event|2|||
148902685|NCT02594124|537127071|FG008|Overall Study|Adverse Event|0|||
148902686|NCT02594124|537127063|FG000|Overall Study|Withdrawal by Subject|2|||
148902687|NCT02594124|537127064|FG001|Overall Study|Withdrawal by Subject|3|||
148902688|NCT02594124|537127065|FG002|Overall Study|Withdrawal by Subject|5|||
148902689|NCT02594124|537127066|FG003|Overall Study|Withdrawal by Subject|1|||
148902690|NCT02594124|537127067|FG004|Overall Study|Withdrawal by Subject|8|||
148902691|NCT02594124|537127068|FG005|Overall Study|Withdrawal by Subject|4|||
148902692|NCT02594124|537127069|FG006|Overall Study|Withdrawal by Subject|13|||
148902693|NCT02594124|537127070|FG007|Overall Study|Withdrawal by Subject|19|||
148902694|NCT02594124|537127071|FG008|Overall Study|Withdrawal by Subject|0|||
148902695|NCT02594124|537127063|FG000|Overall Study|Physician Decision|0|||
148902696|NCT02594124|537127064|FG001|Overall Study|Physician Decision|2|||
148902697|NCT02594124|537127065|FG002|Overall Study|Physician Decision|0|||
148902698|NCT02594124|537127066|FG003|Overall Study|Physician Decision|0|||
148902699|NCT02594124|537127067|FG004|Overall Study|Physician Decision|0|||
148902700|NCT02594124|537127068|FG005|Overall Study|Physician Decision|0|||
148902701|NCT02594124|537127069|FG006|Overall Study|Physician Decision|0|||
149138443|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
149138444|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
148902702|NCT02594124|537127070|FG007|Overall Study|Physician Decision|1|||
148902703|NCT02594124|537127071|FG008|Overall Study|Physician Decision|0|||
148902704|NCT02594124|537127063|FG000|Overall Study|Commercial drug|0|||
148902705|NCT02594124|537127064|FG001|Overall Study|Commercial drug|1|||
148902706|NCT02594124|537127065|FG002|Overall Study|Commercial drug|6|||
148902707|NCT02594124|537127066|FG003|Overall Study|Commercial drug|3|||
148902708|NCT02594124|537127067|FG004|Overall Study|Commercial drug|0|||
148902709|NCT02594124|537127068|FG005|Overall Study|Commercial drug|0|||
148902710|NCT02594124|537127069|FG006|Overall Study|Commercial drug|7|||
148902711|NCT02594124|537127070|FG007|Overall Study|Commercial drug|11|||
148902712|NCT02594124|537127071|FG008|Overall Study|Commercial drug|2|||
148902713|NCT02594124|537127063|FG000|Overall Study|Reason Not Specified|1|||
148902714|NCT02594124|537127064|FG001|Overall Study|Reason Not Specified|3|||
148902715|NCT02594124|537127065|FG002|Overall Study|Reason Not Specified|4|||
148902716|NCT02594124|537127066|FG003|Overall Study|Reason Not Specified|0|||
148902717|NCT02594124|537127067|FG004|Overall Study|Reason Not Specified|0|||
148902718|NCT02594124|537127068|FG005|Overall Study|Reason Not Specified|1|||
148902719|NCT02594124|537127069|FG006|Overall Study|Reason Not Specified|1|||
148902720|NCT02594124|537127070|FG007|Overall Study|Reason Not Specified|6|||
148902721|NCT02594124|537127071|FG008|Overall Study|Reason Not Specified|1|||
148902722|NCT02083354|537128841|FG000|Overall Study|Withdrawal by Subject|9|||
148902723|NCT02083354|537128841|FG000|Overall Study|Lost to Follow-up|1|||
148902724|NCT02083354|537128841|FG000|Overall Study|Adverse Event|3|||
148902725|NCT02083354|537128841|FG000|Overall Study|Disease progression|46|||
148801552|NCT00402727|536753697|FG000|Overall Study|Lack of Efficacy|1|||
148801553|NCT00402727|536753698|FG001|Overall Study|Lack of Efficacy|3|||
148801554|NCT00402727|536753697|FG000|Overall Study|Lost to Follow-up|24|||
148801555|NCT00402727|536753698|FG001|Overall Study|Lost to Follow-up|11|||
148801556|NCT00402727|536753697|FG000|Overall Study|Physician Decision|1|||
148801557|NCT00402727|536753698|FG001|Overall Study|Physician Decision|1|||
148801558|NCT00402727|536753697|FG000|Overall Study|Protocol Violation|0|||
148801559|NCT00402727|536753698|FG001|Overall Study|Protocol Violation|4|||
148801560|NCT00402727|536753697|FG000|Overall Study|Withdrawal by Subject|3|||
148801561|NCT00402727|536753698|FG001|Overall Study|Withdrawal by Subject|7|||
148801562|NCT00402727|536753697|FG000|Overall Study|supply problems|2|||
148801563|NCT00402727|536753698|FG001|Overall Study|supply problems|1|||
148801564|NCT00402727|536753697|FG000|Overall Study|non-compliance|0|||
148801565|NCT00402727|536753698|FG001|Overall Study|non-compliance|1|||
148801566|NCT03372798|536753699|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
148801567|NCT03372798|536753700|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
148801568|NCT03372798|536753699|FG000|Overall Study|Failure of imaging probe|0|||
148801569|NCT03372798|536753700|FG001|Overall Study|Failure of imaging probe|1|||
148801570|NCT03608826|536753701|FG000|Overall Study|Death|3|||
148801571|NCT03608826|536753701|FG000|Overall Study|Heart Transplant|3|||
148801572|NCT03608826|536753701|FG000|Overall Study|Physician Decision|4|||
148801573|NCT03139552|536753718|FG000|Overall Study|unable to attend tasting due to schedule|3|||
148801574|NCT00887484|536753735|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
148801575|NCT00887484|536753735|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
148801576|NCT00887484|536753735|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
148801577|NCT03044314|536753737|FG000|Overall Study|Physician Decision|2|||
148801578|NCT03044314|536753737|FG000|Overall Study|Withdrawal by Subject|1|||
148801579|NCT03044314|536753737|FG000|Overall Study|Connector tubing not available|1|||
148801580|NCT00264147|536753738|FG000|Treatment I Period|Adverse Event|3|||
148801581|NCT00264147|536753739|FG001|Treatment I Period|Adverse Event|6|||
148801582|NCT00264147|536753740|FG002|Treatment I Period|Adverse Event|3|||
148801583|NCT00264147|536753741|FG003|Treatment I Period|Adverse Event|5|||
148801584|NCT00264147|536753742|FG004|Treatment I Period|Adverse Event|7|||
148801585|NCT00264147|536753743|FG005|Treatment I Period|Adverse Event|0|||
148801586|NCT00264147|536753738|FG000|Treatment I Period|Laboratory Adverse Event|0|||
148801587|NCT00264147|536753739|FG001|Treatment I Period|Laboratory Adverse Event|0|||
148801588|NCT00264147|536753740|FG002|Treatment I Period|Laboratory Adverse Event|0|||
148801589|NCT00264147|536753741|FG003|Treatment I Period|Laboratory Adverse Event|1|||
148801590|NCT00264147|536753742|FG004|Treatment I Period|Laboratory Adverse Event|0|||
148801591|NCT00264147|536753743|FG005|Treatment I Period|Laboratory Adverse Event|0|||
148801592|NCT00264147|536753738|FG000|Treatment I Period|Lack of Efficacy|6|||
148801593|NCT00264147|536753739|FG001|Treatment I Period|Lack of Efficacy|2|||
148801594|NCT00264147|536753740|FG002|Treatment I Period|Lack of Efficacy|8|||
148801595|NCT00264147|536753741|FG003|Treatment I Period|Lack of Efficacy|0|||
148801596|NCT00264147|536753742|FG004|Treatment I Period|Lack of Efficacy|1|||
148801597|NCT00264147|536753743|FG005|Treatment I Period|Lack of Efficacy|0|||
148801598|NCT00264147|536753738|FG000|Treatment I Period|Lost to Follow-up|1|||
148801599|NCT00264147|536753739|FG001|Treatment I Period|Lost to Follow-up|0|||
148801600|NCT00264147|536753740|FG002|Treatment I Period|Lost to Follow-up|0|||
148801601|NCT00264147|536753741|FG003|Treatment I Period|Lost to Follow-up|1|||
148801602|NCT00264147|536753742|FG004|Treatment I Period|Lost to Follow-up|1|||
148801603|NCT00264147|536753743|FG005|Treatment I Period|Lost to Follow-up|0|||
148801604|NCT00264147|536753738|FG000|Treatment I Period|Protocol Violation|2|||
148801605|NCT00264147|536753739|FG001|Treatment I Period|Protocol Violation|2|||
148902726|NCT02083354|537128841|FG000|Overall Study|Study closed/terminated|5|||
148902727|NCT03312634|537128842|FG000|Overall Study|Adverse Event|11|||
148902728|NCT03312634|537128843|FG001|Overall Study|Adverse Event|0|||
148801606|NCT00264147|536753740|FG002|Treatment I Period|Protocol Violation|0|||
148801607|NCT00264147|536753741|FG003|Treatment I Period|Protocol Violation|0|||
148801608|NCT00264147|536753742|FG004|Treatment I Period|Protocol Violation|0|||
148801609|NCT00264147|536753743|FG005|Treatment I Period|Protocol Violation|0|||
148801610|NCT00264147|536753738|FG000|Treatment I Period|Withdrawal by Subject|2|||
148801611|NCT00264147|536753739|FG001|Treatment I Period|Withdrawal by Subject|0|||
148801612|NCT00264147|536753740|FG002|Treatment I Period|Withdrawal by Subject|0|||
148801613|NCT00264147|536753741|FG003|Treatment I Period|Withdrawal by Subject|2|||
148801614|NCT00264147|536753742|FG004|Treatment I Period|Withdrawal by Subject|2|||
148801615|NCT00264147|536753743|FG005|Treatment I Period|Withdrawal by Subject|0|||
148801616|NCT00264147|536753738|FG000|Treatment I Period|Patient out of town for an extended time|0|||
148801617|NCT00264147|536753739|FG001|Treatment I Period|Patient out of town for an extended time|1|||
148801618|NCT00264147|536753740|FG002|Treatment I Period|Patient out of town for an extended time|0|||
148801619|NCT00264147|536753741|FG003|Treatment I Period|Patient out of town for an extended time|0|||
148801620|NCT00264147|536753742|FG004|Treatment I Period|Patient out of town for an extended time|0|||
148801621|NCT00264147|536753743|FG005|Treatment I Period|Patient out of town for an extended time|0|||
148801622|NCT00264147|536753738|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
148801623|NCT00264147|536753739|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
148801624|NCT00264147|536753740|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
148801625|NCT00264147|536753741|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
148801626|NCT00264147|536753742|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
148801627|NCT00264147|536753743|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
148801628|NCT00264147|536753738|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
148801629|NCT00264147|536753739|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
148801630|NCT00264147|536753740|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
148801631|NCT00264147|536753741|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
148801632|NCT00264147|536753742|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
148801633|NCT00264147|536753743|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
148801634|NCT00264147|536753738|FG000|Treatment II Period|Adverse Event|0|||
148801635|NCT00264147|536753739|FG001|Treatment II Period|Adverse Event|0|||
148801636|NCT00264147|536753740|FG002|Treatment II Period|Adverse Event|0|||
148801637|NCT00264147|536753741|FG003|Treatment II Period|Adverse Event|0|||
148801638|NCT00264147|536753742|FG004|Treatment II Period|Adverse Event|9|||
148801639|NCT00264147|536753743|FG005|Treatment II Period|Adverse Event|9|||
148801640|NCT00264147|536753738|FG000|Treatment II Period|Laboratory Adverse Event|0|||
148801641|NCT00264147|536753739|FG001|Treatment II Period|Laboratory Adverse Event|0|||
148801642|NCT00264147|536753740|FG002|Treatment II Period|Laboratory Adverse Event|0|||
148801643|NCT00264147|536753741|FG003|Treatment II Period|Laboratory Adverse Event|0|||
148801644|NCT00264147|536753742|FG004|Treatment II Period|Laboratory Adverse Event|0|||
148801645|NCT00264147|536753743|FG005|Treatment II Period|Laboratory Adverse Event|1|||
148801646|NCT00264147|536753738|FG000|Treatment II Period|Lack of Efficacy|0|||
148801647|NCT00264147|536753739|FG001|Treatment II Period|Lack of Efficacy|0|||
148801648|NCT00264147|536753740|FG002|Treatment II Period|Lack of Efficacy|0|||
148801649|NCT00264147|536753741|FG003|Treatment II Period|Lack of Efficacy|0|||
148801650|NCT00264147|536753742|FG004|Treatment II Period|Lack of Efficacy|20|||
148801651|NCT00264147|536753743|FG005|Treatment II Period|Lack of Efficacy|19|||
148801652|NCT00264147|536753738|FG000|Treatment II Period|Lost to Follow-up|0|||
148801653|NCT00264147|536753739|FG001|Treatment II Period|Lost to Follow-up|0|||
148801654|NCT00264147|536753740|FG002|Treatment II Period|Lost to Follow-up|0|||
148902729|NCT03312634|537128842|FG000|Overall Study|Sponsor request|2|||
148902730|NCT03312634|537128843|FG001|Overall Study|Sponsor request|0|||
148902731|NCT03312634|537128842|FG000|Overall Study|Withdrawal by Subject|31|||
148902732|NCT03312634|537128843|FG001|Overall Study|Withdrawal by Subject|9|||
148902733|NCT03312634|537128842|FG000|Overall Study|Enrolled in an interventional study|0|||
148902734|NCT03312634|537128843|FG001|Overall Study|Enrolled in an interventional study|52|||
148902735|NCT03312634|537128842|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
148902736|NCT03312634|537128843|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
148902737|NCT03312634|537128842|FG000|Overall Study|Death|0|||
148902738|NCT03312634|537128843|FG001|Overall Study|Death|1|||
148902739|NCT03312634|537128842|FG000|Overall Study|Non-compliance|0|||
148902740|NCT03312634|537128843|FG001|Overall Study|Non-compliance|2|||
148902741|NCT03312634|537128842|FG000|Overall Study|Lost to Follow-up|0|||
148902742|NCT03312634|537128843|FG001|Overall Study|Lost to Follow-up|1|||
148902743|NCT03312634|537128842|FG000|Overall Study|Enrolled into non-interventional study|0|||
148902744|NCT03312634|537128843|FG001|Overall Study|Enrolled into non-interventional study|5|||
148902745|NCT03312634|537128842|FG000|Overall Study|Worsening clinical condition|0|||
148902746|NCT03312634|537128843|FG001|Overall Study|Worsening clinical condition|1|||
148902747|NCT03312634|537128842|FG000|Overall Study|Participant did not want to travel|0|||
148902748|NCT03312634|537128843|FG001|Overall Study|Participant did not want to travel|1|||
148902749|NCT03312634|537128842|FG000|Overall Study|Physician Decision|1|||
148902750|NCT03312634|537128843|FG001|Overall Study|Physician Decision|0|||
148902751|NCT03312634|537128842|FG000|Overall Study|Other|13|||
148902752|NCT03312634|537128843|FG001|Overall Study|Other|0|||
148902753|NCT01148979|537128852|FG000|Overall Study|Lost to Follow-up|0|||
148902754|NCT01148979|537128853|FG001|Overall Study|Lost to Follow-up|1|||
148902755|NCT00777153|537128854|FG000|Overall Study|Lost to Follow-up|1|||
148902756|NCT00777153|537128855|FG001|Overall Study|Lost to Follow-up|1|||
148902757|NCT00777153|537128856|FG002|Overall Study|Lost to Follow-up|0|||
148902758|NCT00777153|537128854|FG000|Overall Study|Death|85|||
148902759|NCT00777153|537128855|FG001|Overall Study|Death|73|||
148902760|NCT00777153|537128856|FG002|Overall Study|Death|33|||
148902761|NCT00777153|537128854|FG000|Overall Study|Withdrawal by Subject|3|||
148902762|NCT00777153|537128855|FG001|Overall Study|Withdrawal by Subject|4|||
148902763|NCT00777153|537128856|FG002|Overall Study|Withdrawal by Subject|3|||
148902764|NCT00777153|537128854|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
148902765|NCT00777153|537128855|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
148902766|NCT00777153|537128856|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
148902767|NCT00554216|537128857|FG000|Overall Study|Lost to Follow-up|92|||
148902768|NCT00554216|537128858|FG001|Overall Study|Lost to Follow-up|31|||
148902769|NCT00554216|537128859|FG002|Overall Study|Lost to Follow-up|63|||
148902770|NCT00554216|537128857|FG000|Overall Study|Adverse Event|16|||
148902771|NCT00554216|537128858|FG001|Overall Study|Adverse Event|16|||
148902772|NCT00554216|537128859|FG002|Overall Study|Adverse Event|36|||
148902773|NCT00554216|537128857|FG000|Overall Study|Withdrawal by Subject|92|||
148902774|NCT00554216|537128858|FG001|Overall Study|Withdrawal by Subject|31|||
148902775|NCT00554216|537128859|FG002|Overall Study|Withdrawal by Subject|43|||
148902776|NCT00554216|537128857|FG000|Overall Study|Non compliance|10|||
148902777|NCT00554216|537128858|FG001|Overall Study|Non compliance|4|||
148902778|NCT00554216|537128859|FG002|Overall Study|Non compliance|5|||
148902779|NCT00554216|537128857|FG000|Overall Study|Pregnancy|2|||
148902780|NCT00554216|537128858|FG001|Overall Study|Pregnancy|1|||
148902781|NCT00554216|537128859|FG002|Overall Study|Pregnancy|14|||
148902782|NCT00554216|537128857|FG000|Overall Study|Restricted med|3|||
148902783|NCT00554216|537128858|FG001|Overall Study|Restricted med|1|||
148902784|NCT00554216|537128859|FG002|Overall Study|Restricted med|1|||
148902785|NCT00554216|537128857|FG000|Overall Study|Other|12|||
148902786|NCT00554216|537128858|FG001|Overall Study|Other|7|||
148902787|NCT00554216|537128859|FG002|Overall Study|Other|10|||
148902788|NCT00554216|537128857|FG000|Overall Study|Lack of Efficacy|15|||
148902789|NCT00554216|537128858|FG001|Overall Study|Lack of Efficacy|3|||
148902790|NCT00554216|537128859|FG002|Overall Study|Lack of Efficacy|0|||
148902791|NCT02066181|537128874|FG000|Overall Study|Withdrawal by Subject|1|||
148902792|NCT02066181|537128875|FG001|Overall Study|Withdrawal by Subject|1|||
148902793|NCT02141295|537128881|FG000|Overall Study|Adverse Event|1|||
148902794|NCT02141295|537128882|FG001|Overall Study|Adverse Event|18|||
148902795|NCT02141295|537128883|FG002|Overall Study|Adverse Event|11|||
148902796|NCT02141295|537128881|FG000|Overall Study|Physician Decision|2|||
148902797|NCT02141295|537128882|FG001|Overall Study|Physician Decision|19|||
148902798|NCT02141295|537128883|FG002|Overall Study|Physician Decision|14|||
148902799|NCT02141295|537128881|FG000|Overall Study|Study terminated by sponsor|0|||
148902800|NCT02141295|537128882|FG001|Overall Study|Study terminated by sponsor|6|||
148902801|NCT02141295|537128883|FG002|Overall Study|Study terminated by sponsor|6|||
148902802|NCT02141295|537128881|FG000|Overall Study|Non-compliance|0|||
148902803|NCT02141295|537128882|FG001|Overall Study|Non-compliance|1|||
148902804|NCT02141295|537128883|FG002|Overall Study|Non-compliance|0|||
148902805|NCT02141295|537128881|FG000|Overall Study|Progressive disease|3|||
148902806|NCT02141295|537128882|FG001|Overall Study|Progressive disease|32|||
148902807|NCT02141295|537128883|FG002|Overall Study|Progressive disease|50|||
148902808|NCT02141295|537128881|FG000|Overall Study|Reason not specified|0|||
148902809|NCT02141295|537128882|FG001|Overall Study|Reason not specified|9|||
148902810|NCT02141295|537128883|FG002|Overall Study|Reason not specified|10|||
148902811|NCT02141295|537128881|FG000|Overall Study|Withdrawal by Subject|0|||
148902812|NCT02141295|537128882|FG001|Overall Study|Withdrawal by Subject|9|||
148902813|NCT02141295|537128883|FG002|Overall Study|Withdrawal by Subject|4|||
148902814|NCT01671319|537128886|FG000|Overall Study|Withdrawal by Subject|1|||
148902815|NCT01389596|537128887|FG000|Overall Study|Protocol Violation|3|||
148902816|NCT01389596|537128888|FG001|Overall Study|Protocol Violation|4|||
148902817|NCT01389596|537128889|FG002|Overall Study|Protocol Violation|3|||
148902818|NCT01389596|537128887|FG000|Overall Study|Withdrawal by Subject|1|||
148902819|NCT01389596|537128888|FG001|Overall Study|Withdrawal by Subject|2|||
148902820|NCT01389596|537128889|FG002|Overall Study|Withdrawal by Subject|2|||
148902821|NCT01389596|537128887|FG000|Overall Study|Insufficient Clinical Response|3|||
148902822|NCT01389596|537128888|FG001|Overall Study|Insufficient Clinical Response|4|||
148902823|NCT01389596|537128889|FG002|Overall Study|Insufficient Clinical Response|5|||
148902824|NCT01389596|537128887|FG000|Overall Study|Adverse Event|1|||
148902825|NCT01389596|537128888|FG001|Overall Study|Adverse Event|4|||
148902826|NCT01389596|537128889|FG002|Overall Study|Adverse Event|0|||
148902827|NCT01389596|537128887|FG000|Overall Study|Death|0|||
148902828|NCT01389596|537128888|FG001|Overall Study|Death|1|||
148902829|NCT01389596|537128889|FG002|Overall Study|Death|0|||
148902830|NCT01389596|537128887|FG000|Overall Study|Other Unspecified|2|||
148902831|NCT01389596|537128888|FG001|Overall Study|Other Unspecified|1|||
148902832|NCT01389596|537128889|FG002|Overall Study|Other Unspecified|0|||
148902833|NCT00214201|537128890|FG000|Overall Study|Withdrawal by Subject|2|||
148902834|NCT00214201|537128891|FG001|Overall Study|Withdrawal by Subject|0|||
148902835|NCT00214201|537128890|FG000|Overall Study|Death|0|||
148902836|NCT00214201|537128891|FG001|Overall Study|Death|2|||
148902837|NCT01432730|537128892|FG000|Period 1|Adverse Event|2|||
148902838|NCT01432730|537128893|FG001|Period 1|Adverse Event|0|||
148902839|NCT01432730|537128892|FG000|Period 2|Adverse Event|0|||
148902840|NCT01432730|537128893|FG001|Period 2|Adverse Event|4|||
148902841|NCT01235741|537128894|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
148902842|NCT01235741|537128895|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
148902843|NCT01235741|537128896|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
148902844|NCT01235741|537128894|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
148902845|NCT01235741|537128895|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
148902846|NCT01235741|537128896|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
148902847|NCT01235741|537128894|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
148902848|NCT01235741|537128895|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
148902849|NCT01235741|537128896|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
148902850|NCT01235741|537128894|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
148902851|NCT01235741|537128895|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
148902852|NCT01235741|537128896|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
148902853|NCT01235741|537128894|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
148902854|NCT01235741|537128895|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
148902855|NCT01235741|537128896|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
148902856|NCT01235741|537128894|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
148902857|NCT01235741|537128895|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
148902858|NCT01235741|537128896|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
148902859|NCT01235741|537128894|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
148902860|NCT01235741|537128895|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
148902861|NCT01235741|537128896|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
148902862|NCT01235741|537128894|FG000|Randomized to Treatment|Adverse Event|0|||
148902863|NCT01235741|537128895|FG001|Randomized to Treatment|Adverse Event|1|||
148902864|NCT01235741|537128896|FG002|Randomized to Treatment|Adverse Event|1|||
148902865|NCT01235741|537128894|FG000|Randomized to Treatment|Sponsor terminated study|0|||
148902866|NCT01235741|537128895|FG001|Randomized to Treatment|Sponsor terminated study|35|||
148801655|NCT00264147|536753741|FG003|Treatment II Period|Lost to Follow-up|0|||
148801656|NCT00264147|536753742|FG004|Treatment II Period|Lost to Follow-up|1|||
148801657|NCT00264147|536753743|FG005|Treatment II Period|Lost to Follow-up|1|||
148801658|NCT00264147|536753738|FG000|Treatment II Period|Withdrawal by Subject|0|||
148801659|NCT00264147|536753739|FG001|Treatment II Period|Withdrawal by Subject|0|||
148801660|NCT00264147|536753740|FG002|Treatment II Period|Withdrawal by Subject|0|||
148801661|NCT00264147|536753741|FG003|Treatment II Period|Withdrawal by Subject|0|||
148801662|NCT00264147|536753742|FG004|Treatment II Period|Withdrawal by Subject|3|||
148801663|NCT00264147|536753743|FG005|Treatment II Period|Withdrawal by Subject|2|||
148801664|NCT00264147|536753738|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
148801665|NCT00264147|536753739|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
148801666|NCT00264147|536753740|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
148801667|NCT00264147|536753741|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
148801668|NCT00264147|536753742|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
148801669|NCT00264147|536753743|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
148801670|NCT01316224|536753744|FG000|Overall Study|Protocol Violation|3|||
148801671|NCT01316224|536753744|FG000|Overall Study|Adverse Event|3|||
148801672|NCT01316224|536753744|FG000|Overall Study|Lack of Efficacy|1|||
148801673|NCT01316224|536753744|FG000|Overall Study|Withdrawal by Subject|1|||
148801674|NCT01316224|536753744|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
148801675|NCT01316224|536753744|FG000|Overall Study|Other|1|||
148801676|NCT00434252|536755352|FG000|Overall Study|Lack of Efficacy|50|||
148801677|NCT00434252|536755353|FG001|Overall Study|Lack of Efficacy|100|||
148801678|NCT00434252|536755352|FG000|Overall Study|Adverse Event|6|||
148801679|NCT00434252|536755353|FG001|Overall Study|Adverse Event|13|||
148801680|NCT00434252|536755352|FG000|Overall Study|Death|1|||
148801681|NCT00434252|536755353|FG001|Overall Study|Death|2|||
148801682|NCT00434252|536755352|FG000|Overall Study|Lost to Follow-up|0|||
148801683|NCT00434252|536755353|FG001|Overall Study|Lost to Follow-up|1|||
148801684|NCT00434252|536755352|FG000|Overall Study|Physician Decision|4|||
148801685|NCT00434252|536755353|FG001|Overall Study|Physician Decision|8|||
148801686|NCT00434252|536755352|FG000|Overall Study|Withdrawal by Subject|3|||
148801687|NCT00434252|536755353|FG001|Overall Study|Withdrawal by Subject|7|||
148801688|NCT04745351|536755360|FG000|Overall Study|Death|51|||
148801689|NCT04745351|536755361|FG001|Overall Study|Death|25|||
148801690|NCT04745351|536755360|FG000|Overall Study|Lost to Follow-up|9|||
148801691|NCT04745351|536755361|FG001|Overall Study|Lost to Follow-up|3|||
148801692|NCT04745351|536755360|FG000|Overall Study|Randomized but Never Treated|3|||
148801693|NCT04745351|536755361|FG001|Overall Study|Randomized but Never Treated|3|||
148801694|NCT04745351|536755360|FG000|Overall Study|Adverse Event|4|||
148801695|NCT04745351|536755361|FG001|Overall Study|Adverse Event|0|||
148801696|NCT04745351|536755360|FG000|Overall Study|Withdrew Consent|1|||
148801697|NCT04745351|536755361|FG001|Overall Study|Withdrew Consent|2|||
148801698|NCT04745351|536755360|FG000|Overall Study|Investigator's Discretion|2|||
148801699|NCT04745351|536755361|FG001|Overall Study|Investigator's Discretion|0|||
148801700|NCT04745351|536755360|FG000|Overall Study|Protocol Violation|1|||
148801701|NCT04745351|536755361|FG001|Overall Study|Protocol Violation|0|||
148801702|NCT01863771|536755362|FG000|Induction Phase|Adverse Event|9|||
148801703|NCT01863771|536755363|FG001|Induction Phase|Adverse Event|0|||
148801704|NCT01863771|536755364|FG002|Induction Phase|Adverse Event|0|||
148801705|NCT01863771|536755365|FG003|Induction Phase|Adverse Event|0|||
148801706|NCT01863771|536755362|FG000|Induction Phase|Lack of Efficacy|10|||
148801707|NCT01863771|536755363|FG001|Induction Phase|Lack of Efficacy|0|||
148801708|NCT01863771|536755364|FG002|Induction Phase|Lack of Efficacy|0|||
148801709|NCT01863771|536755365|FG003|Induction Phase|Lack of Efficacy|0|||
148801710|NCT01863771|536755362|FG000|Induction Phase|Withdrawal by Subject|2|||
148801711|NCT01863771|536755363|FG001|Induction Phase|Withdrawal by Subject|0|||
148801712|NCT01863771|536755364|FG002|Induction Phase|Withdrawal by Subject|0|||
148801713|NCT01863771|536755365|FG003|Induction Phase|Withdrawal by Subject|0|||
148801714|NCT01863771|536755362|FG000|Maintenance Phase|Adverse Event|0|||
148801715|NCT01863771|536755363|FG001|Maintenance Phase|Adverse Event|0|||
148801716|NCT01863771|536755364|FG002|Maintenance Phase|Adverse Event|1|||
148801717|NCT01863771|536755365|FG003|Maintenance Phase|Adverse Event|1|||
148902867|NCT01235741|537128896|FG002|Randomized to Treatment|Sponsor terminated study|34|||
148801718|NCT01863771|536755362|FG000|Maintenance Phase|Lack of Efficacy|0|||
148801719|NCT01863771|536755363|FG001|Maintenance Phase|Lack of Efficacy|3|||
148801720|NCT01863771|536755364|FG002|Maintenance Phase|Lack of Efficacy|7|||
148801721|NCT01863771|536755365|FG003|Maintenance Phase|Lack of Efficacy|38|||
148902868|NCT01235741|537128894|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
148902869|NCT01235741|537128895|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
148801722|NCT01863771|536755362|FG000|Maintenance Phase|Physician Decision|0|||
148801723|NCT01863771|536755363|FG001|Maintenance Phase|Physician Decision|0|||
148801724|NCT01863771|536755364|FG002|Maintenance Phase|Physician Decision|2|||
148801725|NCT01863771|536755365|FG003|Maintenance Phase|Physician Decision|1|||
148801726|NCT01863771|536755362|FG000|Maintenance Phase|Pregnancy|0|||
148801727|NCT01863771|536755363|FG001|Maintenance Phase|Pregnancy|1|||
148801728|NCT01863771|536755364|FG002|Maintenance Phase|Pregnancy|0|||
148801729|NCT01863771|536755365|FG003|Maintenance Phase|Pregnancy|0|||
148801730|NCT01863771|536755362|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148801731|NCT01863771|536755363|FG001|Maintenance Phase|Withdrawal by Subject|1|||
148801732|NCT01863771|536755364|FG002|Maintenance Phase|Withdrawal by Subject|2|||
148801733|NCT01863771|536755365|FG003|Maintenance Phase|Withdrawal by Subject|3|||
148801734|NCT03499795|536755366|FG000|Overall Study|Adverse Event|1|||
148801735|NCT03499795|536755366|FG000|Overall Study|Lost to Follow-up|1|||
148801736|NCT03636256|536755367|FG000|Overall Study|Lost to Follow-up|3|||
148801737|NCT03636256|536755368|FG001|Overall Study|Lost to Follow-up|0|||
148801738|NCT03636256|536755369|FG002|Overall Study|Lost to Follow-up|2|||
148801739|NCT03636256|536755370|FG003|Overall Study|Lost to Follow-up|1|||
148801740|NCT03636256|536755371|FG004|Overall Study|Lost to Follow-up|0|||
148801741|NCT03636256|536755372|FG005|Overall Study|Lost to Follow-up|4|||
148801742|NCT03636256|536755373|FG006|Overall Study|Lost to Follow-up|2|||
148801743|NCT03636256|536755374|FG007|Overall Study|Lost to Follow-up|0|||
148801744|NCT03636256|536755375|FG008|Overall Study|Lost to Follow-up|4|||
148801745|NCT03636256|536755367|FG000|Overall Study|Withdrawal by Subject|0|||
148801746|NCT03636256|536755368|FG001|Overall Study|Withdrawal by Subject|0|||
148801747|NCT03636256|536755369|FG002|Overall Study|Withdrawal by Subject|0|||
148801748|NCT03636256|536755370|FG003|Overall Study|Withdrawal by Subject|0|||
148801749|NCT03636256|536755371|FG004|Overall Study|Withdrawal by Subject|0|||
148801750|NCT03636256|536755372|FG005|Overall Study|Withdrawal by Subject|0|||
148801751|NCT03636256|536755373|FG006|Overall Study|Withdrawal by Subject|0|||
148801752|NCT03636256|536755374|FG007|Overall Study|Withdrawal by Subject|0|||
148801753|NCT03636256|536755375|FG008|Overall Study|Withdrawal by Subject|1|||
148801754|NCT02426684|536755376|FG000|Overall Study|Physician Decision|1|||
148801755|NCT04748718|536755379|FG000|Overall Study|Lost to Follow-up|50|||
148801756|NCT01450813|536755380|FG000|Overall Study|Physician Decision|1|||
148801757|NCT01450813|536755381|FG001|Overall Study|Physician Decision|1|||
148801758|NCT01450813|536755382|FG002|Overall Study|Physician Decision|0|||
148801759|NCT01450813|536755383|FG003|Overall Study|Physician Decision|3|||
148801760|NCT01118299|536755384|FG000|Overall Study|Death|7|||
148801761|NCT01118299|536755385|FG001|Overall Study|Death|5|||
148801762|NCT01118299|536755384|FG000|Overall Study|Withdrawal by Subject|8|||
148801763|NCT01118299|536755385|FG001|Overall Study|Withdrawal by Subject|8|||
148801764|NCT01118299|536755384|FG000|Overall Study|Lost to Follow-up|2|||
148801765|NCT01118299|536755385|FG001|Overall Study|Lost to Follow-up|1|||
148801766|NCT01118299|536755384|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
148801767|NCT01118299|536755385|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
148801768|NCT01935089|536755387|FG000|Overall Study|Adverse Event|2|||
148801769|NCT01935089|536755387|FG000|Overall Study|Withdrawal by Subject|1|||
148801770|NCT02932943|536755388|FG000|Overall Study|Lost to Follow-up|0|||
148801771|NCT02932943|536755389|FG001|Overall Study|Lost to Follow-up|2|||
148801772|NCT02932943|536755388|FG000|Overall Study|Adverse Event|2|||
148801773|NCT02932943|536755389|FG001|Overall Study|Adverse Event|2|||
148801774|NCT02932943|536755388|FG000|Overall Study|Withdrawal by Subject|3|||
148801775|NCT02932943|536755389|FG001|Overall Study|Withdrawal by Subject|3|||
148801776|NCT02337491|536755390|FG000|Overall Study|Death|1|||
148801777|NCT02337491|536755391|FG001|Overall Study|Death|1|||
148801778|NCT02337491|536755390|FG000|Overall Study|Adverse Event|0|||
148902870|NCT01235741|537128896|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
148902871|NCT01235741|537128894|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
148902872|NCT01235741|537128895|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
148902873|NCT01235741|537128896|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
148902874|NCT01235741|537128894|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
148902875|NCT01235741|537128895|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
148902876|NCT01235741|537128896|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
148902877|NCT03910244|537128897|FG000|Overall Study|Adverse Event|14|||
148902878|NCT03910244|537128898|FG001|Overall Study|Adverse Event|0|||
148902879|NCT03910244|537128897|FG000|Overall Study|Death|1|||
148902880|NCT03910244|537128898|FG001|Overall Study|Death|0|||
148902881|NCT03910244|537128897|FG000|Overall Study|Lost to Follow-up|0|||
148902882|NCT03910244|537128898|FG001|Overall Study|Lost to Follow-up|2|||
148902883|NCT03910244|537128897|FG000|Overall Study|Joint withdrawal decision|1|||
148801779|NCT02337491|536755391|FG001|Overall Study|Adverse Event|1|||
148801780|NCT02337491|536755390|FG000|Overall Study|Withdrawal by Subject|3|||
148801781|NCT02337491|536755391|FG001|Overall Study|Withdrawal by Subject|0|||
148801782|NCT02337491|536755390|FG000|Overall Study|Progressive Disease|44|||
148801783|NCT02337491|536755391|FG001|Overall Study|Progressive Disease|28|||
148801784|NCT02337491|536755390|FG000|Overall Study|On Treatment|2|||
148801785|NCT02337491|536755391|FG001|Overall Study|On Treatment|0|||
148801786|NCT01483118|536755392|FG000|Overall Study|Lost to Follow-up|12|||
148801787|NCT01483118|536755393|FG001|Overall Study|Lost to Follow-up|16|||
148801788|NCT00785356|536755394|FG000|Overall Study|Study prematurely terminated|8|||
148801789|NCT01079780|536755395|FG000|Overall Study|Disease progression|43|||
148801790|NCT01079780|536755396|FG001|Overall Study|Disease progression|7|||
148801791|NCT01079780|536755397|FG002|Overall Study|Disease progression|31|||
148801792|NCT01079780|536755395|FG000|Overall Study|Adverse Event|13|||
148801793|NCT01079780|536755396|FG001|Overall Study|Adverse Event|5|||
148801794|NCT01079780|536755397|FG002|Overall Study|Adverse Event|7|||
148801795|NCT01079780|536755395|FG000|Overall Study|Death|2|||
148801796|NCT01079780|536755396|FG001|Overall Study|Death|0|||
148801797|NCT01079780|536755397|FG002|Overall Study|Death|2|||
148801798|NCT01079780|536755395|FG000|Overall Study|Withdrawal by Subject|6|||
148801799|NCT01079780|536755396|FG001|Overall Study|Withdrawal by Subject|4|||
148801800|NCT01079780|536755397|FG002|Overall Study|Withdrawal by Subject|4|||
148801801|NCT01079780|536755395|FG000|Overall Study|Alternative therapy|2|||
148801802|NCT01079780|536755396|FG001|Overall Study|Alternative therapy|0|||
148801803|NCT01079780|536755397|FG002|Overall Study|Alternative therapy|2|||
148801804|NCT01079780|536755395|FG000|Overall Study|Physician Decision|1|||
148801805|NCT01079780|536755396|FG001|Overall Study|Physician Decision|0|||
148801806|NCT01079780|536755397|FG002|Overall Study|Physician Decision|1|||
148801807|NCT01079780|536755395|FG000|Overall Study|Error made in lesion measurement|1|||
148801808|NCT01079780|536755396|FG001|Overall Study|Error made in lesion measurement|0|||
148801809|NCT01079780|536755397|FG002|Overall Study|Error made in lesion measurement|0|||
148801810|NCT01079780|536755395|FG000|Overall Study|Patient had surgery|1|||
148801811|NCT01079780|536755396|FG001|Overall Study|Patient had surgery|0|||
148801812|NCT01079780|536755397|FG002|Overall Study|Patient had surgery|0|||
148801813|NCT01079780|536755395|FG000|Overall Study|Treatment cycle delay|0|||
148801814|NCT01079780|536755396|FG001|Overall Study|Treatment cycle delay|0|||
148801815|NCT01079780|536755397|FG002|Overall Study|Treatment cycle delay|1|||
148801816|NCT01079780|536755395|FG000|Overall Study|Never started treatment|1|||
148801817|NCT01079780|536755396|FG001|Overall Study|Never started treatment|0|||
148801818|NCT01079780|536755397|FG002|Overall Study|Never started treatment|2|||
148801819|NCT01178294|536755403|FG000|Overall Study|Adverse Event|4|||
148801820|NCT01178294|536755403|FG000|Overall Study|Lost to Follow-up|2|||
148801821|NCT01178294|536755403|FG000|Overall Study|Lack of Efficacy|1|||
148801822|NCT01178294|536755403|FG000|Overall Study|Death|1|||
148801823|NCT01178294|536755403|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
148801824|NCT01178294|536755403|FG000|Overall Study|Subject status is terminal|1|||
148801825|NCT01178294|536755403|FG000|Overall Study|Completion status could not be verified|1|||
148801826|NCT02783066|536755404|FG000|Overall Study|Withdrawal by Subject|13|||
148801827|NCT00551369|536755405|FG000|Overall Study|Protocol Violation|5|||
148801828|NCT00551369|536755405|FG000|Overall Study|Withdrawal by Subject|1|||
148801829|NCT00551369|536755405|FG000|Overall Study|Not treated per protocol and re|1|||
148801830|NCT02051296|536755406|FG000|Overall Study|Lost to Follow-up|1|||
148801831|NCT02051296|536755407|FG001|Overall Study|Lost to Follow-up|2|||
148801832|NCT02051296|536755406|FG000|Overall Study|withdraw prior to treatment|7|||
148801833|NCT02051296|536755407|FG001|Overall Study|withdraw prior to treatment|7|||
148801834|NCT05379920|536755408|FG000|Overall Study|Lost to Follow-up|0|||
148801835|NCT05379920|536755409|FG001|Overall Study|Lost to Follow-up|5|||
148801836|NCT05379920|536755410|FG002|Overall Study|Lost to Follow-up|0|||
148801837|NCT05379920|536755411|FG003|Overall Study|Lost to Follow-up|0|||
148801838|NCT03176771|536755414|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
148902884|NCT03910244|537128898|FG001|Overall Study|Joint withdrawal decision|0|||
148902885|NCT03910244|537128897|FG000|Overall Study|Study Terminated by Sponsor|7|||
148902886|NCT03910244|537128898|FG001|Overall Study|Study Terminated by Sponsor|4|||
148902887|NCT03910244|537128897|FG000|Overall Study|Physician Decision|1|||
148902888|NCT03910244|537128898|FG001|Overall Study|Physician Decision|0|||
148902889|NCT03910244|537128897|FG000|Overall Study|Protocol Violation|1|||
148902890|NCT03910244|537128898|FG001|Overall Study|Protocol Violation|0|||
148902891|NCT03910244|537128897|FG000|Overall Study|Withdrawal by Subject|7|||
148902892|NCT03910244|537128898|FG001|Overall Study|Withdrawal by Subject|2|||
148902893|NCT00930046|537128899|FG000|Overall Study|Wound catheter malfunctioned|1|||
148902894|NCT00930046|537128900|FG001|Overall Study|Wound catheter malfunctioned|2|||
148902895|NCT01598532|537128901|FG000|Overall Study|Lost to Follow-up|3|||
148902896|NCT01598532|537128901|FG000|Overall Study|Did not meet inclusion criteria|8|||
148902897|NCT00702221|537128902|FG000|Overall Study|Adverse Event|4|||
148902898|NCT00702221|537128903|FG001|Overall Study|Adverse Event|3|||
148902899|NCT04798196|537128907|FG000|Overall Study|Lost to Follow-up|3|||
148902900|NCT04798196|537128908|FG001|Overall Study|Lost to Follow-up|1|||
148902901|NCT04798196|537128909|FG002|Overall Study|Lost to Follow-up|3|||
148902902|NCT01249261|537128910|FG000|Overall Study|Withdrawal by Subject|1|||
148902903|NCT01249261|537128911|FG001|Overall Study|Withdrawal by Subject|0|||
148902904|NCT01055197|537128913|FG000|Overall Study|Protocol Violation|7|||
148902905|NCT01055197|537128914|FG001|Overall Study|Protocol Violation|2|||
148902906|NCT01055197|537128913|FG000|Overall Study|Withdrawal by Subject|2|||
148902907|NCT01055197|537128914|FG001|Overall Study|Withdrawal by Subject|0|||
148902908|NCT01967940|537128915|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
148902909|NCT01967940|537128916|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
148902910|NCT01967940|537128917|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
148902911|NCT01967940|537128918|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
148902912|NCT01967940|537128915|FG000|Part 2|Adverse Event|0|||
148902913|NCT01967940|537128916|FG001|Part 2|Adverse Event|0|||
148902914|NCT01967940|537128917|FG002|Part 2|Adverse Event|0|||
148902915|NCT01967940|537128918|FG003|Part 2|Adverse Event|1|||
148902916|NCT01967940|537128915|FG000|Part 2|Unknown Reason|0|||
148902917|NCT01967940|537128916|FG001|Part 2|Unknown Reason|0|||
148902918|NCT01967940|537128917|FG002|Part 2|Unknown Reason|0|||
148902919|NCT01967940|537128918|FG003|Part 2|Unknown Reason|1|||
148902920|NCT04189952|537128919|FG000|Follow-up Period|Death|1|||
148902921|NCT04189952|537128919|FG000|Follow-up Period|Withdrawal by Subject|1|||
148902922|NCT04298697|537128922|FG000|Overall Study|Lost to Follow-up|5|||
148902923|NCT04298697|537128923|FG001|Overall Study|Lost to Follow-up|5|||
148902924|NCT04298697|537128924|FG002|Overall Study|Lost to Follow-up|1|||
148902925|NCT04298697|537128925|FG003|Overall Study|Lost to Follow-up|0|||
148902926|NCT04298697|537128922|FG000|Overall Study|Withdrawal by Subject|0|||
148902927|NCT04298697|537128923|FG001|Overall Study|Withdrawal by Subject|3|||
148902928|NCT04298697|537128924|FG002|Overall Study|Withdrawal by Subject|2|||
148902929|NCT04298697|537128925|FG003|Overall Study|Withdrawal by Subject|3|||
148902930|NCT00904982|537128926|FG000|Overall Study|Withdrawal by Subject|2|||
148902931|NCT00904982|537128927|FG001|Overall Study|Withdrawal by Subject|0|||
148902932|NCT00904982|537128928|FG002|Overall Study|Withdrawal by Subject|0|||
148902933|NCT00904982|537128929|FG003|Overall Study|Withdrawal by Subject|0|||
148902934|NCT01929317|537128937|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
148902935|NCT01929317|537128938|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
148902936|NCT01929317|537128937|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
148902937|NCT01929317|537128938|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
148902938|NCT01929317|537128937|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
148902939|NCT01929317|537128938|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
148902940|NCT01929317|537128937|FG000|Long-term Phase|Adverse Event|5|||
148902941|NCT01929317|537128938|FG001|Long-term Phase|Adverse Event|1|||
148902942|NCT01929317|537128937|FG000|Long-term Phase|Physician Decision|3|||
148902943|NCT01929317|537128938|FG001|Long-term Phase|Physician Decision|0|||
148902944|NCT01929317|537128937|FG000|Long-term Phase|Withdrawal by Subject|4|||
148902945|NCT01929317|537128938|FG001|Long-term Phase|Withdrawal by Subject|0|||
148902946|NCT01929317|537128937|FG000|Long-term Phase|Protocol Violation|1|||
148902947|NCT01929317|537128938|FG001|Long-term Phase|Protocol Violation|0|||
148902948|NCT01929317|537128937|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
148902949|NCT01929317|537128938|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
148902950|NCT01929317|537128937|FG000|Long-term Phase|Study Closed/Terminated|5|||
148902951|NCT01929317|537128938|FG001|Long-term Phase|Study Closed/Terminated|3|||
148902952|NCT01716234|537128939|FG000|Overall Study|Protocol Violation|0|||
148902953|NCT01716234|537128940|FG001|Overall Study|Protocol Violation|0|||
148902954|NCT01716234|537128941|FG002|Overall Study|Protocol Violation|0|||
148902955|NCT01716234|537128942|FG003|Overall Study|Protocol Violation|1|||
148902956|NCT01716234|537128943|FG004|Overall Study|Protocol Violation|1|||
148902957|NCT01716234|537128944|FG005|Overall Study|Protocol Violation|1|||
148902958|NCT01716234|537128945|FG006|Overall Study|Protocol Violation|0|||
148902959|NCT01716234|537128939|FG000|Overall Study|Lack of Efficacy|0|||
148902960|NCT01716234|537128940|FG001|Overall Study|Lack of Efficacy|0|||
148902961|NCT01716234|537128941|FG002|Overall Study|Lack of Efficacy|0|||
148801839|NCT03176771|536755415|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
148801840|NCT03176771|536755416|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
148801841|NCT03176771|536755417|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
148801842|NCT03176771|536755418|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
148801843|NCT03176771|536755414|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
148801844|NCT03176771|536755415|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
148801845|NCT03176771|536755416|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
148801846|NCT03176771|536755417|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
148801847|NCT03176771|536755418|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
148801848|NCT03176771|536755414|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
148801849|NCT03176771|536755415|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
148801850|NCT03176771|536755416|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
148801851|NCT03176771|536755417|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
148801852|NCT03176771|536755418|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
148801853|NCT03176771|536755414|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
148801854|NCT03176771|536755415|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
148801855|NCT03176771|536755416|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
148801856|NCT03176771|536755417|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
148801857|NCT03176771|536755418|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
148801858|NCT03176771|536755414|FG000|Double-Blind Extension Period|Adverse Event|0|||
148801859|NCT03176771|536755415|FG001|Double-Blind Extension Period|Adverse Event|0|||
148801860|NCT03176771|536755416|FG002|Double-Blind Extension Period|Adverse Event|0|||
148801861|NCT03176771|536755417|FG003|Double-Blind Extension Period|Adverse Event|15|||
148801862|NCT03176771|536755418|FG004|Double-Blind Extension Period|Adverse Event|18|||
148801863|NCT03176771|536755414|FG000|Double-Blind Extension Period|Death|0|||
148801864|NCT03176771|536755415|FG001|Double-Blind Extension Period|Death|0|||
148801865|NCT03176771|536755416|FG002|Double-Blind Extension Period|Death|0|||
148801866|NCT03176771|536755417|FG003|Double-Blind Extension Period|Death|3|||
148801867|NCT03176771|536755418|FG004|Double-Blind Extension Period|Death|4|||
148801868|NCT03176771|536755414|FG000|Double-Blind Extension Period|Physician Decision|0|||
148801869|NCT03176771|536755415|FG001|Double-Blind Extension Period|Physician Decision|0|||
148801870|NCT03176771|536755416|FG002|Double-Blind Extension Period|Physician Decision|0|||
148801871|NCT03176771|536755417|FG003|Double-Blind Extension Period|Physician Decision|3|||
148801872|NCT03176771|536755418|FG004|Double-Blind Extension Period|Physician Decision|1|||
148801873|NCT03176771|536755414|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
148801874|NCT03176771|536755415|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
148801875|NCT03176771|536755416|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
148801876|NCT03176771|536755417|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
148801877|NCT03176771|536755418|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
148801878|NCT02251275|536755419|FG000|Overall Study|Adverse Event|23|||
148801879|NCT02251275|536755420|FG001|Overall Study|Adverse Event|60|||
148801880|NCT02251275|536755421|FG002|Overall Study|Adverse Event|28|||
148801881|NCT02251275|536755422|FG003|Overall Study|Adverse Event|0|||
148801882|NCT02251275|536755423|FG004|Overall Study|Adverse Event|0|||
148801883|NCT02251275|536755419|FG000|Overall Study|Lost to Follow-up|5|||
148801884|NCT02251275|536755420|FG001|Overall Study|Lost to Follow-up|6|||
148801885|NCT02251275|536755421|FG002|Overall Study|Lost to Follow-up|4|||
148801886|NCT02251275|536755422|FG003|Overall Study|Lost to Follow-up|0|||
148801887|NCT02251275|536755423|FG004|Overall Study|Lost to Follow-up|0|||
148801888|NCT02251275|536755419|FG000|Overall Study|Physician Decision|19|||
148801889|NCT02251275|536755420|FG001|Overall Study|Physician Decision|30|||
148801890|NCT02251275|536755421|FG002|Overall Study|Physician Decision|26|||
148801891|NCT02251275|536755422|FG003|Overall Study|Physician Decision|0|||
148801892|NCT02251275|536755423|FG004|Overall Study|Physician Decision|1|||
148801893|NCT02251275|536755419|FG000|Overall Study|Protocol Deviation|0|||
148801894|NCT02251275|536755420|FG001|Overall Study|Protocol Deviation|0|||
148801895|NCT02251275|536755421|FG002|Overall Study|Protocol Deviation|1|||
148801896|NCT02251275|536755422|FG003|Overall Study|Protocol Deviation|0|||
148801897|NCT02251275|536755423|FG004|Overall Study|Protocol Deviation|0|||
148801898|NCT02251275|536755419|FG000|Overall Study|Withdrawal by Subject|25|||
148801899|NCT02251275|536755420|FG001|Overall Study|Withdrawal by Subject|51|||
148801900|NCT02251275|536755421|FG002|Overall Study|Withdrawal by Subject|35|||
148801901|NCT02251275|536755422|FG003|Overall Study|Withdrawal by Subject|1|||
148902962|NCT01716234|537128942|FG003|Overall Study|Lack of Efficacy|1|||
148902963|NCT01716234|537128943|FG004|Overall Study|Lack of Efficacy|0|||
148902964|NCT01716234|537128944|FG005|Overall Study|Lack of Efficacy|0|||
148902965|NCT01716234|537128945|FG006|Overall Study|Lack of Efficacy|0|||
148902966|NCT01716234|537128939|FG000|Overall Study|Did not meet protocol eligibility|0|||
148902967|NCT01716234|537128940|FG001|Overall Study|Did not meet protocol eligibility|0|||
148902968|NCT01716234|537128941|FG002|Overall Study|Did not meet protocol eligibility|1|||
148902969|NCT01716234|537128942|FG003|Overall Study|Did not meet protocol eligibility|0|||
148902970|NCT01716234|537128943|FG004|Overall Study|Did not meet protocol eligibility|0|||
148902971|NCT01716234|537128944|FG005|Overall Study|Did not meet protocol eligibility|4|||
148902972|NCT01716234|537128945|FG006|Overall Study|Did not meet protocol eligibility|0|||
148902973|NCT01716234|537128939|FG000|Overall Study|Adverse Event|7|||
148902974|NCT01716234|537128940|FG001|Overall Study|Adverse Event|10|||
148902975|NCT01716234|537128941|FG002|Overall Study|Adverse Event|2|||
148902976|NCT01716234|537128942|FG003|Overall Study|Adverse Event|8|||
148902977|NCT01716234|537128943|FG004|Overall Study|Adverse Event|3|||
148902978|NCT01716234|537128944|FG005|Overall Study|Adverse Event|6|||
148902979|NCT01716234|537128945|FG006|Overall Study|Adverse Event|0|||
148902980|NCT01716234|537128939|FG000|Overall Study|Withdrawal by Subject|3|||
148902981|NCT01716234|537128940|FG001|Overall Study|Withdrawal by Subject|0|||
148902982|NCT01716234|537128941|FG002|Overall Study|Withdrawal by Subject|2|||
148902983|NCT01716234|537128942|FG003|Overall Study|Withdrawal by Subject|2|||
148902984|NCT01716234|537128943|FG004|Overall Study|Withdrawal by Subject|1|||
148902985|NCT01716234|537128944|FG005|Overall Study|Withdrawal by Subject|3|||
148902986|NCT01716234|537128945|FG006|Overall Study|Withdrawal by Subject|0|||
148902987|NCT02667119|537128946|FG000|Overall Study|Lost to Follow-up|3|||
148902988|NCT02667119|537128947|FG001|Overall Study|Lost to Follow-up|0|||
148902989|NCT01523756|537128948|FG000|Baseline Period|Adverse Event|0|||
148902990|NCT01523756|537128949|FG001|Baseline Period|Adverse Event|1|||
148902991|NCT01523756|537128948|FG000|Test Period 1|Adverse Event|1|||
148902992|NCT01523756|537128949|FG001|Test Period 1|Adverse Event|0|||
148902993|NCT01523756|537128948|FG000|Test Period 2|Withdrawal by Subject|0|||
148902994|NCT01523756|537128949|FG001|Test Period 2|Withdrawal by Subject|1|||
148902995|NCT00993967|537128950|FG000|Overall Study|Adverse Event|8|||
148902996|NCT00993967|537128950|FG000|Overall Study|Death|1|||
148902997|NCT00993967|537128950|FG000|Overall Study|Lost to Follow-up|14|||
148902998|NCT00993967|537128950|FG000|Overall Study|Withdrawal by Subject|36|||
148902999|NCT00993967|537128950|FG000|Overall Study|Protocol Violation|2|||
148903000|NCT03783078|537128953|FG000|Overall Study|Death|31|||
148903001|NCT03783078|537128953|FG000|Overall Study|Sponsor Decision|23|||
148903002|NCT03783078|537128953|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148903003|NCT00474812|537128957|FG000|Overall Study|Withdrawal by Subject|5|||
148903004|NCT00474812|537128957|FG000|Overall Study|No Initiation of treatment|2|||
148903005|NCT02059278|537128958|FG000|Overall Study|Adverse Event|1|||
148903006|NCT02059278|537128959|FG001|Overall Study|Adverse Event|1|||
148903007|NCT02059278|537128958|FG000|Overall Study|Lost to Follow-up|1|||
148903008|NCT02059278|537128959|FG001|Overall Study|Lost to Follow-up|0|||
148903009|NCT02059278|537128958|FG000|Overall Study|Withdrawal by Subject|0|||
148903010|NCT02059278|537128959|FG001|Overall Study|Withdrawal by Subject|3|||
148903011|NCT02059278|537128958|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
148903012|NCT02059278|537128959|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
148903013|NCT05408429|537128962|FG000|Overall Study|Lost to Follow-up|1|||
148903014|NCT05408429|537128963|FG001|Overall Study|Lost to Follow-up|1|||
148903015|NCT05408429|537128964|FG002|Overall Study|Lost to Follow-up|0|||
148903016|NCT05408429|537128962|FG000|Overall Study|Withdrawal by Subject|5|||
148903017|NCT05408429|537128963|FG001|Overall Study|Withdrawal by Subject|0|||
148903018|NCT05408429|537128964|FG002|Overall Study|Withdrawal by Subject|1|||
148903019|NCT03435211|537128965|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
148903020|NCT02195518|537128966|FG000|Overall Study|Adverse Event|1|||
148903021|NCT02195518|537128966|FG000|Overall Study|Protocol Violation|4|||
148903022|NCT02195518|537128966|FG000|Overall Study|Pregnancy|2|||
148903023|NCT02195518|537128966|FG000|Overall Study|Withdrawal by Subject|1|||
148903024|NCT02195518|537128966|FG000|Overall Study|Lost to Follow-up|1|||
148903025|NCT03818256|537128967|FG000|Overall Study|Withdrawal by Subject|2|||
148903026|NCT03818256|537128968|FG001|Overall Study|Withdrawal by Subject|2|||
148903027|NCT03818256|537128967|FG000|Overall Study|Adverse Event|3|||
148903028|NCT03818256|537128968|FG001|Overall Study|Adverse Event|1|||
148903029|NCT03818256|537128967|FG000|Overall Study|Lost to Follow-up|0|||
148903030|NCT03818256|537128968|FG001|Overall Study|Lost to Follow-up|5|||
148903031|NCT03818256|537128967|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
148903032|NCT03818256|537128968|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
148903033|NCT03818256|537128967|FG000|Overall Study|Not reporting for scheduled visits|1|||
148903034|NCT03818256|537128968|FG001|Overall Study|Not reporting for scheduled visits|0|||
148903035|NCT03818256|537128967|FG000|Overall Study|Non-compliant with investigational product|1|||
148903036|NCT03818256|537128968|FG001|Overall Study|Non-compliant with investigational product|0|||
148903037|NCT01342211|537128969|FG000|Overall Study|Lost to Follow-up|0|||
148903038|NCT01342211|537128970|FG001|Overall Study|Lost to Follow-up|0|||
148903039|NCT01342211|537128971|FG002|Overall Study|Lost to Follow-up|0|||
148903040|NCT01342211|537128972|FG003|Overall Study|Lost to Follow-up|1|||
148903041|NCT01342211|537128973|FG004|Overall Study|Lost to Follow-up|0|||
148903042|NCT01342211|537128969|FG000|Overall Study|Adverse Event|0|||
148903043|NCT01342211|537128970|FG001|Overall Study|Adverse Event|0|||
148903044|NCT01342211|537128971|FG002|Overall Study|Adverse Event|0|||
148903045|NCT01342211|537128972|FG003|Overall Study|Adverse Event|0|||
148903046|NCT01342211|537128973|FG004|Overall Study|Adverse Event|1|||
148903047|NCT01342211|537128969|FG000|Overall Study|Withdrawal by Subject|0|||
148903048|NCT01342211|537128970|FG001|Overall Study|Withdrawal by Subject|0|||
148903049|NCT01342211|537128971|FG002|Overall Study|Withdrawal by Subject|0|||
148903050|NCT01342211|537128972|FG003|Overall Study|Withdrawal by Subject|1|||
148903051|NCT01342211|537128973|FG004|Overall Study|Withdrawal by Subject|0|||
148903052|NCT01342211|537128969|FG000|Overall Study|Randomized, but not Treated|0|||
148903053|NCT01342211|537128970|FG001|Overall Study|Randomized, but not Treated|2|||
148903054|NCT01342211|537128971|FG002|Overall Study|Randomized, but not Treated|0|||
148903055|NCT01342211|537128972|FG003|Overall Study|Randomized, but not Treated|0|||
148903056|NCT01342211|537128973|FG004|Overall Study|Randomized, but not Treated|1|||
148903057|NCT01588522|537128978|FG000|Overall Study|Withdrawal by Subject|1|||
148903058|NCT01588522|537128979|FG001|Overall Study|Withdrawal by Subject|5|||
148903059|NCT01588522|537128980|FG002|Overall Study|Withdrawal by Subject|3|||
148801902|NCT02251275|536755423|FG004|Overall Study|Withdrawal by Subject|0|||
148801903|NCT02265510|536755425|FG000|Overall Study|Withdrawal by Subject|1|||
148801904|NCT02265510|536755426|FG001|Overall Study|Withdrawal by Subject|1|||
148801905|NCT02265510|536755427|FG002|Overall Study|Withdrawal by Subject|2|||
148801906|NCT02265510|536755428|FG003|Overall Study|Withdrawal by Subject|1|||
148801907|NCT02265510|536755429|FG004|Overall Study|Withdrawal by Subject|0|||
148801908|NCT02265510|536755430|FG005|Overall Study|Withdrawal by Subject|2|||
148801909|NCT02265510|536755431|FG006|Overall Study|Withdrawal by Subject|0|||
148801910|NCT02265510|536755432|FG007|Overall Study|Withdrawal by Subject|2|||
148801911|NCT02265510|536755433|FG008|Overall Study|Withdrawal by Subject|0|||
148801912|NCT02265510|536755434|FG009|Overall Study|Withdrawal by Subject|0|||
148801913|NCT02265510|536755435|FG010|Overall Study|Withdrawal by Subject|0|||
148801914|NCT02265510|536755436|FG011|Overall Study|Withdrawal by Subject|0|||
148801915|NCT02265510|536755437|FG012|Overall Study|Withdrawal by Subject|1|||
148801916|NCT02265510|536755438|FG013|Overall Study|Withdrawal by Subject|0|||
148801917|NCT02265510|536755425|FG000|Overall Study|Disease Progression|0|||
148801918|NCT02265510|536755426|FG001|Overall Study|Disease Progression|1|||
148801919|NCT02265510|536755427|FG002|Overall Study|Disease Progression|2|||
148801920|NCT02265510|536755428|FG003|Overall Study|Disease Progression|1|||
148801921|NCT02265510|536755429|FG004|Overall Study|Disease Progression|1|||
148801922|NCT02265510|536755430|FG005|Overall Study|Disease Progression|0|||
148801923|NCT02265510|536755431|FG006|Overall Study|Disease Progression|0|||
148801924|NCT02265510|536755432|FG007|Overall Study|Disease Progression|0|||
148801925|NCT02265510|536755433|FG008|Overall Study|Disease Progression|0|||
148801926|NCT02265510|536755434|FG009|Overall Study|Disease Progression|0|||
148801927|NCT02265510|536755435|FG010|Overall Study|Disease Progression|0|||
148801928|NCT02265510|536755436|FG011|Overall Study|Disease Progression|0|||
148801929|NCT02265510|536755437|FG012|Overall Study|Disease Progression|0|||
148801930|NCT02265510|536755438|FG013|Overall Study|Disease Progression|0|||
148801931|NCT02265510|536755425|FG000|Overall Study|Death|2|||
148801932|NCT02265510|536755426|FG001|Overall Study|Death|0|||
148801933|NCT02265510|536755427|FG002|Overall Study|Death|2|||
148801934|NCT02265510|536755428|FG003|Overall Study|Death|2|||
148801935|NCT02265510|536755429|FG004|Overall Study|Death|1|||
148801936|NCT02265510|536755430|FG005|Overall Study|Death|3|||
148801937|NCT02265510|536755431|FG006|Overall Study|Death|2|||
148801938|NCT02265510|536755432|FG007|Overall Study|Death|1|||
148801939|NCT02265510|536755433|FG008|Overall Study|Death|3|||
148801940|NCT02265510|536755434|FG009|Overall Study|Death|3|||
148801941|NCT02265510|536755435|FG010|Overall Study|Death|4|||
148801942|NCT02265510|536755436|FG011|Overall Study|Death|12|||
148801943|NCT02265510|536755437|FG012|Overall Study|Death|7|||
148801944|NCT02265510|536755438|FG013|Overall Study|Death|6|||
148801945|NCT02265510|536755425|FG000|Overall Study|Lost to Follow-up|0|||
148801946|NCT02265510|536755426|FG001|Overall Study|Lost to Follow-up|0|||
148801947|NCT02265510|536755427|FG002|Overall Study|Lost to Follow-up|0|||
148903060|NCT01588522|537128981|FG003|Overall Study|Withdrawal by Subject|1|||
148801948|NCT02265510|536755428|FG003|Overall Study|Lost to Follow-up|0|||
148801949|NCT02265510|536755429|FG004|Overall Study|Lost to Follow-up|1|||
148801950|NCT02265510|536755430|FG005|Overall Study|Lost to Follow-up|0|||
148801951|NCT02265510|536755431|FG006|Overall Study|Lost to Follow-up|0|||
148903061|NCT01588522|537128982|FG004|Overall Study|Withdrawal by Subject|2|||
148801952|NCT02265510|536755432|FG007|Overall Study|Lost to Follow-up|0|||
148801953|NCT02265510|536755433|FG008|Overall Study|Lost to Follow-up|0|||
148801954|NCT02265510|536755434|FG009|Overall Study|Lost to Follow-up|2|||
148801955|NCT02265510|536755435|FG010|Overall Study|Lost to Follow-up|0|||
148801956|NCT02265510|536755436|FG011|Overall Study|Lost to Follow-up|0|||
148801957|NCT02265510|536755437|FG012|Overall Study|Lost to Follow-up|0|||
148903062|NCT01588522|537128983|FG005|Overall Study|Withdrawal by Subject|0|||
148903063|NCT01588522|537128978|FG000|Overall Study|Lack of Efficacy|0|||
148903064|NCT01588522|537128979|FG001|Overall Study|Lack of Efficacy|0|||
148903065|NCT01588522|537128980|FG002|Overall Study|Lack of Efficacy|0|||
148903066|NCT01588522|537128981|FG003|Overall Study|Lack of Efficacy|0|||
148903067|NCT01588522|537128982|FG004|Overall Study|Lack of Efficacy|1|||
148903068|NCT01588522|537128983|FG005|Overall Study|Lack of Efficacy|0|||
148903069|NCT01588522|537128978|FG000|Overall Study|Adverse Event|0|||
148801958|NCT02265510|536755438|FG013|Overall Study|Lost to Follow-up|2|||
148801959|NCT02265510|536755425|FG000|Overall Study|Other|0|||
148801960|NCT02265510|536755426|FG001|Overall Study|Other|1|||
148801961|NCT02265510|536755427|FG002|Overall Study|Other|0|||
148801962|NCT02265510|536755428|FG003|Overall Study|Other|0|||
148801963|NCT02265510|536755429|FG004|Overall Study|Other|0|||
148801964|NCT02265510|536755430|FG005|Overall Study|Other|0|||
148801965|NCT02265510|536755431|FG006|Overall Study|Other|0|||
148801966|NCT02265510|536755432|FG007|Overall Study|Other|0|||
148801967|NCT02265510|536755433|FG008|Overall Study|Other|0|||
148801968|NCT02265510|536755434|FG009|Overall Study|Other|0|||
148801969|NCT02265510|536755435|FG010|Overall Study|Other|0|||
148801970|NCT02265510|536755436|FG011|Overall Study|Other|0|||
148801971|NCT02265510|536755437|FG012|Overall Study|Other|0|||
148801972|NCT02265510|536755438|FG013|Overall Study|Other|0|||
148801973|NCT02265510|536755425|FG000|Overall Study|Study Terminated by Sponsor|0|||
148801974|NCT02265510|536755426|FG001|Overall Study|Study Terminated by Sponsor|0|||
148801975|NCT02265510|536755427|FG002|Overall Study|Study Terminated by Sponsor|0|||
148801976|NCT02265510|536755428|FG003|Overall Study|Study Terminated by Sponsor|0|||
148801977|NCT02265510|536755429|FG004|Overall Study|Study Terminated by Sponsor|0|||
148801978|NCT02265510|536755430|FG005|Overall Study|Study Terminated by Sponsor|1|||
148801979|NCT02265510|536755431|FG006|Overall Study|Study Terminated by Sponsor|1|||
148801980|NCT02265510|536755432|FG007|Overall Study|Study Terminated by Sponsor|1|||
148801981|NCT02265510|536755433|FG008|Overall Study|Study Terminated by Sponsor|1|||
148801982|NCT02265510|536755434|FG009|Overall Study|Study Terminated by Sponsor|2|||
148801983|NCT02265510|536755435|FG010|Overall Study|Study Terminated by Sponsor|1|||
148801984|NCT02265510|536755436|FG011|Overall Study|Study Terminated by Sponsor|4|||
148801985|NCT02265510|536755437|FG012|Overall Study|Study Terminated by Sponsor|1|||
148801986|NCT02265510|536755438|FG013|Overall Study|Study Terminated by Sponsor|2|||
148801987|NCT01004614|536755439|FG000|Washout|Withdrawal by Subject|0|||
148801988|NCT01004614|536755440|FG001|Washout|Withdrawal by Subject|1|||
148801989|NCT01004614|536755441|FG002|Washout|Withdrawal by Subject|0|||
148801990|NCT01004614|536755442|FG003|Washout|Withdrawal by Subject|0|||
148801991|NCT02530385|536755443|FG000|Overall Study|Withdrawal by Subject|0|||
148801992|NCT02530385|536755444|FG001|Overall Study|Withdrawal by Subject|1|||
148801993|NCT01569022|536755446|FG000|First Intervention|Lost to Follow-up|2|||
148801994|NCT01569022|536755447|FG001|First Intervention|Lost to Follow-up|1|||
148801995|NCT01569022|536755446|FG000|Second Intervention|Lost to Follow-up|2|||
148801996|NCT01569022|536755447|FG001|Second Intervention|Lost to Follow-up|2|||
148801997|NCT02111083|536755452|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
148801998|NCT02111083|536755453|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
148801999|NCT00116142|536755454|FG000|Overall Study|Adverse Event|8|||
148802000|NCT00116142|536755455|FG001|Overall Study|Adverse Event|7|||
148802001|NCT00116142|536755454|FG000|Overall Study|Protocol Violation|2|||
148802002|NCT00116142|536755455|FG001|Overall Study|Protocol Violation|1|||
148802003|NCT00116142|536755454|FG000|Overall Study|Withdrawal by Subject|5|||
148802004|NCT00116142|536755455|FG001|Overall Study|Withdrawal by Subject|5|||
148802005|NCT00116142|536755454|FG000|Overall Study|Physician Decision|3|||
148802006|NCT00116142|536755455|FG001|Overall Study|Physician Decision|1|||
148802007|NCT00116142|536755454|FG000|Overall Study|Delayed Radiation Therapy|1|||
148802008|NCT00116142|536755455|FG001|Overall Study|Delayed Radiation Therapy|0|||
148802009|NCT00116142|536755454|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
148802010|NCT00116142|536755455|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
148802011|NCT00116142|536755454|FG000|Overall Study|Patient stopped due to depression|0|||
148802012|NCT00116142|536755455|FG001|Overall Study|Patient stopped due to depression|1|||
148802013|NCT00116142|536755454|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
148802014|NCT00116142|536755455|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
148802015|NCT00116142|536755454|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
148802016|NCT00116142|536755455|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
148802017|NCT00116142|536755454|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
148802018|NCT00116142|536755455|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
148903070|NCT01588522|537128979|FG001|Overall Study|Adverse Event|0|||
148903071|NCT01588522|537128980|FG002|Overall Study|Adverse Event|0|||
148802019|NCT00644059|536755456|FG000|Overall Study|Lost to Follow-up|37|||
148802020|NCT00644059|536755457|FG001|Overall Study|Lost to Follow-up|34|||
148802021|NCT00644059|536755458|FG002|Overall Study|Lost to Follow-up|16|||
148802022|NCT00644059|536755456|FG000|Overall Study|Withdrawal by Subject|52|||
148802023|NCT00644059|536755457|FG001|Overall Study|Withdrawal by Subject|60|||
148802024|NCT00644059|536755458|FG002|Overall Study|Withdrawal by Subject|30|||
148802025|NCT00644059|536755456|FG000|Overall Study|Adverse Event|8|||
148802026|NCT00644059|536755457|FG001|Overall Study|Adverse Event|5|||
148802027|NCT00644059|536755458|FG002|Overall Study|Adverse Event|1|||
148802028|NCT00644059|536755456|FG000|Overall Study|Inappropriate Enrollment|1|||
148802029|NCT00644059|536755457|FG001|Overall Study|Inappropriate Enrollment|3|||
148802030|NCT00644059|536755458|FG002|Overall Study|Inappropriate Enrollment|0|||
148802031|NCT00644059|536755456|FG000|Overall Study|Protocol Deviation/violation|20|||
148802032|NCT00644059|536755457|FG001|Overall Study|Protocol Deviation/violation|19|||
148802033|NCT00644059|536755458|FG002|Overall Study|Protocol Deviation/violation|15|||
148802034|NCT00644059|536755456|FG000|Overall Study|Unable to classify|6|||
148802035|NCT00644059|536755457|FG001|Overall Study|Unable to classify|2|||
148802036|NCT00644059|536755458|FG002|Overall Study|Unable to classify|3|||
148802037|NCT02152007|536755459|FG000|Overall Study|Withdrawal by Subject|1|||
148802038|NCT01302899|536755464|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
148802039|NCT01302899|536755465|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
148802040|NCT01302899|536755464|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
148802041|NCT01302899|536755465|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
148802042|NCT03118934|536755468|FG000|Overall Study|Adverse Event|0|||
148802043|NCT03118934|536755469|FG001|Overall Study|Adverse Event|0|||
148802044|NCT03118934|536755470|FG002|Overall Study|Adverse Event|0|||
148802045|NCT03118934|536755471|FG003|Overall Study|Adverse Event|0|||
148802046|NCT03118934|536755472|FG004|Overall Study|Adverse Event|0|||
148802047|NCT03118934|536755473|FG005|Overall Study|Adverse Event|1|||
148802048|NCT03118934|536755468|FG000|Overall Study|Physician Decision|0|||
148802049|NCT03118934|536755469|FG001|Overall Study|Physician Decision|0|||
148802050|NCT03118934|536755470|FG002|Overall Study|Physician Decision|0|||
148802051|NCT03118934|536755471|FG003|Overall Study|Physician Decision|0|||
148802052|NCT03118934|536755472|FG004|Overall Study|Physician Decision|0|||
148802053|NCT03118934|536755473|FG005|Overall Study|Physician Decision|1|||
148802054|NCT03118934|536755468|FG000|Overall Study|Discontinued prior to exposure|0|||
148802055|NCT03118934|536755469|FG001|Overall Study|Discontinued prior to exposure|1|||
148802056|NCT03118934|536755470|FG002|Overall Study|Discontinued prior to exposure|1|||
148802057|NCT03118934|536755471|FG003|Overall Study|Discontinued prior to exposure|1|||
148802058|NCT03118934|536755472|FG004|Overall Study|Discontinued prior to exposure|2|||
148802059|NCT03118934|536755473|FG005|Overall Study|Discontinued prior to exposure|0|||
148802060|NCT02557399|536755475|FG000|Overall Study|Adverse Event|6|||
148802061|NCT02557399|536755476|FG001|Overall Study|Adverse Event|5|||
148802062|NCT02557399|536755475|FG000|Overall Study|Protocol Violation|0|||
148802063|NCT02557399|536755476|FG001|Overall Study|Protocol Violation|1|||
148802064|NCT02557399|536755475|FG000|Overall Study|Protocol-defined stopping criteria|0|||
148802065|NCT02557399|536755476|FG001|Overall Study|Protocol-defined stopping criteria|1|||
148802066|NCT02557399|536755475|FG000|Overall Study|Withdrawal by Subject|1|||
148802067|NCT02557399|536755476|FG001|Overall Study|Withdrawal by Subject|1|||
148802068|NCT03122171|536755478|FG000|Overall Study|Withdrawal by Subject|1|||
148802069|NCT03234465|536755479|FG000|Overall Study|Adverse Event|4|||
148802070|NCT03234465|536755480|FG001|Overall Study|Adverse Event|2|||
148802071|NCT03234465|536755479|FG000|Overall Study|Death|0|||
148802072|NCT03234465|536755480|FG001|Overall Study|Death|1|||
148802073|NCT03234465|536755479|FG000|Overall Study|Lost to Follow-up|1|||
148903072|NCT01588522|537128981|FG003|Overall Study|Adverse Event|1|||
148903073|NCT01588522|537128982|FG004|Overall Study|Adverse Event|0|||
148903074|NCT01588522|537128983|FG005|Overall Study|Adverse Event|0|||
148903075|NCT01588522|537128978|FG000|Overall Study|Grade 2 alopecia|1|||
148903076|NCT01588522|537128979|FG001|Overall Study|Grade 2 alopecia|0|||
148903077|NCT01588522|537128980|FG002|Overall Study|Grade 2 alopecia|0|||
148903078|NCT01588522|537128981|FG003|Overall Study|Grade 2 alopecia|0|||
148903079|NCT01588522|537128982|FG004|Overall Study|Grade 2 alopecia|0|||
148903080|NCT01588522|537128983|FG005|Overall Study|Grade 2 alopecia|0|||
148903081|NCT01588522|537128978|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
148903082|NCT01588522|537128979|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
148903083|NCT01588522|537128980|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
148903084|NCT01588522|537128981|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
148903085|NCT01588522|537128982|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
148903086|NCT01588522|537128983|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
148903087|NCT01588522|537128978|FG000|Overall Study|Taken off taxane-based regimen|0|||
148903088|NCT01588522|537128979|FG001|Overall Study|Taken off taxane-based regimen|0|||
148903089|NCT01588522|537128980|FG002|Overall Study|Taken off taxane-based regimen|0|||
148903090|NCT01588522|537128981|FG003|Overall Study|Taken off taxane-based regimen|1|||
148903091|NCT01588522|537128982|FG004|Overall Study|Taken off taxane-based regimen|0|||
148903092|NCT01588522|537128983|FG005|Overall Study|Taken off taxane-based regimen|0|||
148903093|NCT01588522|537128978|FG000|Overall Study|Did not initiate chemotherapy|0|||
148903094|NCT01588522|537128979|FG001|Overall Study|Did not initiate chemotherapy|0|||
148903095|NCT01588522|537128980|FG002|Overall Study|Did not initiate chemotherapy|0|||
148903096|NCT01588522|537128981|FG003|Overall Study|Did not initiate chemotherapy|0|||
148903097|NCT01588522|537128982|FG004|Overall Study|Did not initiate chemotherapy|1|||
148903098|NCT01588522|537128983|FG005|Overall Study|Did not initiate chemotherapy|0|||
148903099|NCT03043794|537128984|FG000|Overall Study|Lost to Follow-up|1|||
148903100|NCT03205423|537128989|FG000|Overall Study|Personal|1|||
148903101|NCT03205423|537128990|FG001|Overall Study|Personal|1|||
148903102|NCT03205423|537128989|FG000|Overall Study|Physician Decision|0|||
148903103|NCT03205423|537128990|FG001|Overall Study|Physician Decision|2|||
148903104|NCT02749422|537128991|FG000|Overall Study|Lost to Follow-up|0|||
148903105|NCT02749422|537128992|FG001|Overall Study|Lost to Follow-up|2|||
148903106|NCT02749422|537128991|FG000|Overall Study|Ineligible|0|||
148903107|NCT02749422|537128992|FG001|Overall Study|Ineligible|1|||
148903108|NCT02855125|537128993|FG000|Overall Study|Withdrawal by Subject|2|||
148903109|NCT02855125|537128994|FG001|Overall Study|Withdrawal by Subject|2|||
148903110|NCT02855125|537128993|FG000|Overall Study|Clinical Disease Progression|5|||
148903111|NCT02855125|537128994|FG001|Overall Study|Clinical Disease Progression|4|||
148903112|NCT02855125|537128993|FG000|Overall Study|Radiologic Disease Progression|36|||
148903113|NCT02855125|537128994|FG001|Overall Study|Radiologic Disease Progression|39|||
148903114|NCT02855125|537128993|FG000|Overall Study|Adverse Event|11|||
148903115|NCT02855125|537128994|FG001|Overall Study|Adverse Event|7|||
148903116|NCT02855125|537128993|FG000|Overall Study|Physician Decision|1|||
148903117|NCT02855125|537128994|FG001|Overall Study|Physician Decision|0|||
148903118|NCT02855125|537128993|FG000|Overall Study|On Treatment|9|||
148903119|NCT02855125|537128994|FG001|Overall Study|On Treatment|11|||
148903120|NCT02855125|537128993|FG000|Overall Study|Randomized but not treated|0|||
148903121|NCT02855125|537128994|FG001|Overall Study|Randomized but not treated|1|||
148903122|NCT04467905|537128995|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
148903123|NCT04467905|537128996|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
148903124|NCT04467905|537128997|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
148903125|NCT04467905|537128995|FG000|Overall Study|Conversion to SR|0|||
148903126|NCT04467905|537128996|FG001|Overall Study|Conversion to SR|0|||
148903127|NCT04467905|537128997|FG002|Overall Study|Conversion to SR|3|||
148903128|NCT04467905|537128995|FG000|Overall Study|Technical issue with Holter ECG|0|||
148903129|NCT04467905|537128996|FG001|Overall Study|Technical issue with Holter ECG|0|||
148903130|NCT04467905|537128997|FG002|Overall Study|Technical issue with Holter ECG|3|||
148903131|NCT04467905|537128995|FG000|Overall Study|Hemodynamic instability|0|||
148903132|NCT04467905|537128996|FG001|Overall Study|Hemodynamic instability|0|||
148903133|NCT04467905|537128997|FG002|Overall Study|Hemodynamic instability|1|||
148903134|NCT04467905|537128995|FG000|Overall Study|Site misinterpretation of protocol|0|||
148903135|NCT04467905|537128996|FG001|Overall Study|Site misinterpretation of protocol|0|||
148903136|NCT04467905|537128997|FG002|Overall Study|Site misinterpretation of protocol|1|||
148903137|NCT04586205|537129008|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
148903138|NCT04586205|537129009|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
148903139|NCT05462756|537131181|FG000|Treatment Period|Adverse Event|3|||
148903140|NCT05462756|537131182|FG001|Treatment Period|Adverse Event|0|||
148903141|NCT05462756|537131181|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
148903142|NCT05462756|537131182|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
148903143|NCT05462756|537131181|FG000|Treatment Period|Death|0|||
148903144|NCT05462756|537131182|FG001|Treatment Period|Death|1|||
148903145|NCT05462756|537131181|FG000|Treatment Period|Lost to Follow-up|2|||
148903146|NCT05462756|537131182|FG001|Treatment Period|Lost to Follow-up|1|||
148903147|NCT05462756|537131181|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
148903148|NCT05462756|537131182|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
148903149|NCT05462756|537131181|FG000|Treatment Period|Physician Decision|2|||
148903150|NCT05462756|537131182|FG001|Treatment Period|Physician Decision|0|||
148903151|NCT05462756|537131181|FG000|Treatment Period|Protocol Violation|0|||
148903152|NCT05462756|537131182|FG001|Treatment Period|Protocol Violation|1|||
148903153|NCT05462756|537131181|FG000|Treatment Period|Withdrawal by Subject|5|||
148903154|NCT05462756|537131182|FG001|Treatment Period|Withdrawal by Subject|12|||
148903155|NCT05462756|537131181|FG000|Follow-Up Period|Adverse Event|1|||
148903156|NCT05462756|537131182|FG001|Follow-Up Period|Adverse Event|0|||
148903157|NCT05462756|537131181|FG000|Follow-Up Period|Death|1|||
148903158|NCT05462756|537131182|FG001|Follow-Up Period|Death|0|||
148903159|NCT05462756|537131181|FG000|Follow-Up Period|Lost to Follow-up|3|||
148903160|NCT05462756|537131182|FG001|Follow-Up Period|Lost to Follow-up|1|||
148903161|NCT05462756|537131181|FG000|Follow-Up Period|Withdrawal by Subject|0|||
148903162|NCT05462756|537131182|FG001|Follow-Up Period|Withdrawal by Subject|4|||
148903163|NCT02079246|537131183|FG000|OLEX|Withdrawal before treatment|1|||
148903164|NCT02079246|537131184|FG001|OLEX|Withdrawal before treatment|0|||
148903165|NCT02079246|537131183|FG000|OLEX|Death|11|||
148903166|NCT02079246|537131184|FG001|OLEX|Death|0|||
148903167|NCT02079246|537131183|FG000|OLEX|Adverse Event|66|||
148903168|NCT02079246|537131184|FG001|OLEX|Adverse Event|0|||
148903169|NCT02079246|537131183|FG000|OLEX|Withdrawal by Subject|60|||
148903170|NCT02079246|537131184|FG001|OLEX|Withdrawal by Subject|0|||
148903171|NCT02079246|537131183|FG000|OLEX|Lost to Follow-up|6|||
148903172|NCT02079246|537131184|FG001|OLEX|Lost to Follow-up|0|||
148903173|NCT02079246|537131183|FG000|OLEX|Protocol Violation|6|||
148903174|NCT02079246|537131184|FG001|OLEX|Protocol Violation|0|||
148903175|NCT02079246|537131183|FG000|OLEX|Lack of Efficacy|3|||
148903176|NCT02079246|537131184|FG001|OLEX|Lack of Efficacy|0|||
148903177|NCT02079246|537131183|FG000|OLEX|Results of the lead-in studies|58|||
148903178|NCT02079246|537131184|FG001|OLEX|Results of the lead-in studies|0|||
148903179|NCT02079246|537131183|FG000|OLEX|Other: Disallowed medication|8|||
148903180|NCT02079246|537131184|FG001|OLEX|Other: Disallowed medication|0|||
148903181|NCT02079246|537131183|FG000|OLEX|Other: Insufficient compliance|2|||
148903182|NCT02079246|537131184|FG001|OLEX|Other: Insufficient compliance|0|||
148903183|NCT02079246|537131183|FG000|OLEX|Other: Caregiver unavailable|3|||
148903184|NCT02079246|537131184|FG001|OLEX|Other: Caregiver unavailable|0|||
148903185|NCT02079246|537131183|FG000|OLEX|Other: Coordinator decision|1|||
148903186|NCT02079246|537131184|FG001|OLEX|Other: Coordinator decision|0|||
148903187|NCT02079246|537131183|FG000|OLEX|Other: Worsening of condition|1|||
148903188|NCT02079246|537131184|FG001|OLEX|Other: Worsening of condition|0|||
148903189|NCT02079246|537131183|FG000|OLEX|Other: Moved to nursing home|1|||
148903190|NCT02079246|537131184|FG001|OLEX|Other: Moved to nursing home|0|||
148903191|NCT02079246|537131183|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
148903192|NCT02079246|537131184|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
148903193|NCT02079246|537131183|FG000|OLEX-MEM|Adverse Event|0|||
148903194|NCT02079246|537131184|FG001|OLEX-MEM|Adverse Event|6|||
148903195|NCT02079246|537131183|FG000|OLEX-MEM|Withdrawal by Subject|0|||
148903196|NCT02079246|537131184|FG001|OLEX-MEM|Withdrawal by Subject|7|||
148903197|NCT02079246|537131183|FG000|OLEX-MEM|Protocol Violation|0|||
148903198|NCT02079246|537131184|FG001|OLEX-MEM|Protocol Violation|2|||
148903199|NCT02079246|537131183|FG000|OLEX-MEM|Lost to Follow-up|0|||
148903200|NCT02079246|537131184|FG001|OLEX-MEM|Lost to Follow-up|1|||
148903201|NCT02079246|537131183|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
148903202|NCT02079246|537131184|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
148903203|NCT04040933|537131189|FG000|Overall Study|Protocol Violation|1|||
148903204|NCT04040933|537131189|FG000|Overall Study|Withdrawal by Subject|2|||
148903205|NCT00775190|537131190|FG000|Overall Study|Lost to Follow-up|2|||
148903206|NCT00775190|537131191|FG001|Overall Study|Lost to Follow-up|3|||
148903207|NCT00775190|537131190|FG000|Overall Study|Withdrawal by Subject|1|||
148903208|NCT00775190|537131191|FG001|Overall Study|Withdrawal by Subject|2|||
148903209|NCT00775190|537131190|FG000|Overall Study|Protocol Violation|1|||
148903210|NCT00775190|537131191|FG001|Overall Study|Protocol Violation|0|||
148903211|NCT01709084|537131192|FG000|Overall Study|Lost to Follow-up|4|||
148903212|NCT01709084|537131193|FG001|Overall Study|Lost to Follow-up|7|||
148903213|NCT01709084|537131192|FG000|Overall Study|Withdrawal by Subject|2|||
148903214|NCT01709084|537131193|FG001|Overall Study|Withdrawal by Subject|2|||
148903215|NCT01709084|537131192|FG000|Overall Study|Adverse Event|5|||
148903216|NCT01709084|537131193|FG001|Overall Study|Adverse Event|0|||
148903217|NCT01709084|537131192|FG000|Overall Study|Other|5|||
148903218|NCT01709084|537131193|FG001|Overall Study|Other|3|||
148903219|NCT01709084|537131192|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
148903220|NCT01709084|537131193|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
148903221|NCT01709084|537131192|FG000|Overall Study|Not Treated|0|||
148903222|NCT01709084|537131193|FG001|Overall Study|Not Treated|2|||
148903223|NCT01803607|537131198|FG000|Overall Study|Adverse Event|5|||
148903224|NCT01803607|537131199|FG001|Overall Study|Adverse Event|3|||
148903225|NCT01803607|537131198|FG000|Overall Study|Lack of Efficacy|0|||
148903226|NCT01803607|537131199|FG001|Overall Study|Lack of Efficacy|1|||
148903227|NCT01803607|537131198|FG000|Overall Study|Protocol Violation|3|||
148903228|NCT01803607|537131199|FG001|Overall Study|Protocol Violation|2|||
148903229|NCT01803607|537131198|FG000|Overall Study|Study terminated by sponsor|54|||
148903230|NCT01803607|537131199|FG001|Overall Study|Study terminated by sponsor|56|||
148903231|NCT01803607|537131198|FG000|Overall Study|Withdrawal by Subject|6|||
148903232|NCT01803607|537131199|FG001|Overall Study|Withdrawal by Subject|5|||
148903233|NCT00706238|537131203|FG000|Overall Study|Disease progression|4|||
148903234|NCT00706238|537131203|FG000|Overall Study|Other|1|||
148903235|NCT00753506|537131204|FG000|Overall Study|Withdrawal by Subject|4|||
148903236|NCT00753506|537131205|FG001|Overall Study|Withdrawal by Subject|1|||
148903237|NCT00753506|537131204|FG000|Overall Study|Lost to Follow-up|2|||
148903238|NCT00753506|537131205|FG001|Overall Study|Lost to Follow-up|0|||
148903239|NCT00753506|537131204|FG000|Overall Study|Other reason|1|||
148903240|NCT00753506|537131205|FG001|Overall Study|Other reason|1|||
148903241|NCT03763877|537131209|FG000|Overall Study|Withdrawal by Subject|3|||
148903242|NCT03763877|537131210|FG001|Overall Study|Withdrawal by Subject|1|||
148903243|NCT03763877|537131211|FG002|Overall Study|Withdrawal by Subject|3|||
148903244|NCT03763877|537131212|FG003|Overall Study|Withdrawal by Subject|4|||
148903245|NCT03763877|537131209|FG000|Overall Study|Adverse Event|1|||
148903246|NCT03763877|537131210|FG001|Overall Study|Adverse Event|1|||
148903247|NCT03763877|537131211|FG002|Overall Study|Adverse Event|3|||
148903248|NCT03763877|537131212|FG003|Overall Study|Adverse Event|1|||
148903249|NCT03763877|537131209|FG000|Overall Study|Protocol Violation|1|||
148903250|NCT03763877|537131210|FG001|Overall Study|Protocol Violation|1|||
148903251|NCT03763877|537131211|FG002|Overall Study|Protocol Violation|0|||
148903252|NCT03763877|537131212|FG003|Overall Study|Protocol Violation|0|||
148903253|NCT03763877|537131209|FG000|Overall Study|Lost to Follow-up|0|||
148903254|NCT03763877|537131210|FG001|Overall Study|Lost to Follow-up|1|||
148903255|NCT03763877|537131211|FG002|Overall Study|Lost to Follow-up|1|||
148903256|NCT03763877|537131212|FG003|Overall Study|Lost to Follow-up|0|||
148903257|NCT01774721|537131215|FG000|Overall Study|Death|133|||
148903258|NCT01774721|537131216|FG001|Overall Study|Death|152|||
148903259|NCT01774721|537131215|FG000|Overall Study|Withdrawal by Subject|20|||
148903260|NCT01774721|537131216|FG001|Overall Study|Withdrawal by Subject|14|||
148903261|NCT01774721|537131215|FG000|Overall Study|Lost to Follow-up|6|||
148903262|NCT01774721|537131216|FG001|Overall Study|Lost to Follow-up|7|||
148903263|NCT01774721|537131215|FG000|Overall Study|Did not meet eligibility criteria|0|||
148903264|NCT01774721|537131216|FG001|Overall Study|Did not meet eligibility criteria|3|||
148903265|NCT01774721|537131215|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
148903266|NCT01774721|537131216|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
148903267|NCT01774721|537131215|FG000|Overall Study|Study terminated by sponsor|5|||
148903268|NCT01774721|537131216|FG001|Overall Study|Study terminated by sponsor|0|||
148903269|NCT01774721|537131215|FG000|Overall Study|Disease progression|5|||
148903270|NCT01774721|537131216|FG001|Overall Study|Disease progression|0|||
148903271|NCT01600716|537131218|FG000|Overall Study|Other Reasons|3|||
149138445|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
148903272|NCT01600716|537131219|FG001|Overall Study|Other Reasons|1|||
148903273|NCT01600716|537131218|FG000|Overall Study|Personal Reasons|0|||
148903274|NCT01600716|537131219|FG001|Overall Study|Personal Reasons|2|||
148903275|NCT01600716|537131218|FG000|Overall Study|Lost to Follow-up|0|||
148903276|NCT01600716|537131219|FG001|Overall Study|Lost to Follow-up|2|||
148903277|NCT01600716|537131218|FG000|Overall Study|Pregnancy|1|||
148903278|NCT01600716|537131219|FG001|Overall Study|Pregnancy|0|||
148903279|NCT01600716|537131218|FG000|Overall Study|Lack of Efficacy|2|||
148903280|NCT01600716|537131219|FG001|Overall Study|Lack of Efficacy|1|||
148903281|NCT01600716|537131218|FG000|Overall Study|Adverse Event|1|||
148903282|NCT01600716|537131219|FG001|Overall Study|Adverse Event|1|||
148903283|NCT00248040|537131220|FG000|Overall Study|transplantectomy|2|||
148903284|NCT00248040|537131221|FG001|Overall Study|transplantectomy|1|||
148903285|NCT00248040|537131222|FG002|Overall Study|transplantectomy|3|||
148903286|NCT00248040|537131220|FG000|Overall Study|transplant cancelled post treat start|1|||
148903287|NCT00248040|537131221|FG001|Overall Study|transplant cancelled post treat start|0|||
149138446|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
148903288|NCT00248040|537131222|FG002|Overall Study|transplant cancelled post treat start|0|||
148903289|NCT00248040|537131220|FG000|Overall Study|Death|0|||
148903290|NCT00248040|537131221|FG001|Overall Study|Death|0|||
148903291|NCT00248040|537131222|FG002|Overall Study|Death|1|||
148903292|NCT01759446|537131225|FG000|Overall Study|Protocol Violation|1|||
148903293|NCT01759446|537131226|FG001|Overall Study|Protocol Violation|0|||
148903294|NCT01759446|537131227|FG002|Overall Study|Protocol Violation|1|||
148903295|NCT01759446|537131228|FG003|Overall Study|Protocol Violation|0|||
148903296|NCT01759446|537131229|FG004|Overall Study|Protocol Violation|0|||
148903297|NCT01759446|537131225|FG000|Overall Study|Withdrawal by Subject|0|||
148903298|NCT01759446|537131226|FG001|Overall Study|Withdrawal by Subject|1|||
148903299|NCT01759446|537131227|FG002|Overall Study|Withdrawal by Subject|0|||
148903300|NCT01759446|537131228|FG003|Overall Study|Withdrawal by Subject|1|||
148903301|NCT01759446|537131229|FG004|Overall Study|Withdrawal by Subject|0|||
148903302|NCT01760733|537131230|FG000|Waiting List|Death|18|||
148903303|NCT01760733|537131230|FG000|Waiting List|Removed from waiting list|41|||
148903304|NCT01760733|537131230|FG000|Waiting List|Not received a transplant yet|13|||
148903305|NCT01760733|537131230|FG000|Transplanted|Not reached 10 years post transplant|184|||
148903306|NCT01760733|537131230|FG000|Transplanted|Death|26|||
148903307|NCT01760733|537131230|FG000|Transplanted|Graft loss|7|||
148903308|NCT00815659|537131231|FG000|Overall Study|Adverse Event|9|||
148903309|NCT00815659|537131231|FG000|Overall Study|Withdrawal by Subject|9|||
148903310|NCT00815659|537131231|FG000|Overall Study|Lost to Follow-up|4|||
148903311|NCT00815659|537131231|FG000|Overall Study|Protocol Violation|1|||
148903312|NCT03847896|537131232|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
148903313|NCT03847896|537131233|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
148903314|NCT03847896|537131234|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
148903315|NCT03847896|537131235|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
148903316|NCT03847896|537131236|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
148903317|NCT03847896|537131232|FG000|Overall Study|Withdrawal by Subject|2|||
148903318|NCT03847896|537131233|FG001|Overall Study|Withdrawal by Subject|10|||
148903319|NCT03847896|537131234|FG002|Overall Study|Withdrawal by Subject|5|||
148903320|NCT03847896|537131235|FG003|Overall Study|Withdrawal by Subject|9|||
148903321|NCT03847896|537131236|FG004|Overall Study|Withdrawal by Subject|8|||
148903322|NCT03847896|537131232|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148903323|NCT03847896|537131233|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148903324|NCT03847896|537131234|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148903325|NCT03847896|537131235|FG003|Overall Study|Withdrawal by parent/guardian|0|||
148903326|NCT03847896|537131236|FG004|Overall Study|Withdrawal by parent/guardian|0|||
148903327|NCT03847896|537131232|FG000|Overall Study|Adverse Event|2|||
148903328|NCT03847896|537131233|FG001|Overall Study|Adverse Event|1|||
148903329|NCT03847896|537131234|FG002|Overall Study|Adverse Event|3|||
148903330|NCT03847896|537131235|FG003|Overall Study|Adverse Event|2|||
148903331|NCT03847896|537131236|FG004|Overall Study|Adverse Event|4|||
148903332|NCT03847896|537131232|FG000|Overall Study|A severe exacerbation event|0|||
148903333|NCT03847896|537131233|FG001|Overall Study|A severe exacerbation event|0|||
148903334|NCT03847896|537131234|FG002|Overall Study|A severe exacerbation event|0|||
148903335|NCT03847896|537131235|FG003|Overall Study|A severe exacerbation event|0|||
148903336|NCT03847896|537131236|FG004|Overall Study|A severe exacerbation event|3|||
148903337|NCT03847896|537131232|FG000|Overall Study|Protocol Violation|0|||
148903338|NCT03847896|537131233|FG001|Overall Study|Protocol Violation|2|||
148903339|NCT03847896|537131234|FG002|Overall Study|Protocol Violation|1|||
148903340|NCT03847896|537131235|FG003|Overall Study|Protocol Violation|0|||
148903341|NCT03847896|537131236|FG004|Overall Study|Protocol Violation|2|||
148903342|NCT03847896|537131232|FG000|Overall Study|Lost to Follow-up|0|||
148903343|NCT03847896|537131233|FG001|Overall Study|Lost to Follow-up|0|||
148903344|NCT03847896|537131234|FG002|Overall Study|Lost to Follow-up|0|||
148903345|NCT03847896|537131235|FG003|Overall Study|Lost to Follow-up|1|||
148903346|NCT03847896|537131236|FG004|Overall Study|Lost to Follow-up|0|||
148903347|NCT03847896|537131232|FG000|Overall Study|Condition under investigation worsened|0|||
148903348|NCT03847896|537131233|FG001|Overall Study|Condition under investigation worsened|0|||
148903349|NCT03847896|537131234|FG002|Overall Study|Condition under investigation worsened|0|||
148903350|NCT03847896|537131235|FG003|Overall Study|Condition under investigation worsened|1|||
148903351|NCT03847896|537131236|FG004|Overall Study|Condition under investigation worsened|1|||
148903352|NCT03847896|537131232|FG000|Overall Study|Lack of Efficacy|0|||
148903353|NCT03847896|537131233|FG001|Overall Study|Lack of Efficacy|0|||
148802074|NCT03234465|536755480|FG001|Overall Study|Lost to Follow-up|1|||
148802075|NCT03234465|536755479|FG000|Overall Study|Withdrawal by Subject|12|||
148802076|NCT03234465|536755480|FG001|Overall Study|Withdrawal by Subject|27|||
148802077|NCT03234465|536755479|FG000|Overall Study|Symptomatic deterioration|0|||
148802078|NCT03234465|536755480|FG001|Overall Study|Symptomatic deterioration|1|||
148802079|NCT03234465|536755479|FG000|Overall Study|Non-compliance|2|||
148802080|NCT03234465|536755480|FG001|Overall Study|Non-compliance|0|||
148802081|NCT03234465|536755479|FG000|Overall Study|Other|14|||
148802082|NCT03234465|536755480|FG001|Overall Study|Other|8|||
148802083|NCT00449163|536755483|FG000|Overall Study|Physician Decision|3|||
148802084|NCT00606307|536755486|FG000|Overall Study|Adverse Event|2|||
148802085|NCT00606307|536755486|FG000|Overall Study|Withdrawal by Subject|2|||
148802086|NCT00606307|536755486|FG000|Overall Study|Disease progression|6|||
148802087|NCT00606307|536755486|FG000|Overall Study|QTc prolongation|1|||
148802088|NCT03368807|536755495|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
148802089|NCT03368807|536755495|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
148802090|NCT03368807|536755495|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
148802091|NCT03368807|536755495|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
148802092|NCT02563899|536755496|FG000|Overall Study|Protocol Violation|1|||
148802093|NCT02563899|536755497|FG001|Overall Study|Protocol Violation|0|||
148802094|NCT02563899|536755498|FG002|Overall Study|Protocol Violation|0|||
148802095|NCT02563899|536755499|FG003|Overall Study|Protocol Violation|0|||
148802096|NCT02563899|536755496|FG000|Overall Study|Withdrawal by Subject|0|||
148802097|NCT02563899|536755497|FG001|Overall Study|Withdrawal by Subject|0|||
148802098|NCT02563899|536755498|FG002|Overall Study|Withdrawal by Subject|1|||
148802099|NCT02563899|536755499|FG003|Overall Study|Withdrawal by Subject|0|||
148802100|NCT02949947|536755518|FG000|Overall Study|Non Compliance|0|||
148802101|NCT02949947|536755519|FG001|Overall Study|Non Compliance|1|||
148802102|NCT02949947|536755518|FG000|Overall Study|Insurance change|1|||
148802103|NCT02949947|536755519|FG001|Overall Study|Insurance change|0|||
148802104|NCT01677741|536755520|FG000|Overall Study|Death|0|||
148802105|NCT01677741|536755521|FG001|Overall Study|Death|0|||
148802106|NCT01677741|536755522|FG002|Overall Study|Death|0|||
148802107|NCT01677741|536755523|FG003|Overall Study|Death|1|||
148802108|NCT01677741|536755524|FG004|Overall Study|Death|0|||
148802109|NCT01677741|536755525|FG005|Overall Study|Death|1|||
148802110|NCT01677741|536755526|FG006|Overall Study|Death|0|||
148802111|NCT01677741|536755527|FG007|Overall Study|Death|0|||
148802112|NCT01677741|536755520|FG000|Overall Study|Withdrawal by Subject|2|||
148802113|NCT01677741|536755521|FG001|Overall Study|Withdrawal by Subject|7|||
148802114|NCT01677741|536755522|FG002|Overall Study|Withdrawal by Subject|5|||
148802115|NCT01677741|536755523|FG003|Overall Study|Withdrawal by Subject|4|||
148802116|NCT01677741|536755524|FG004|Overall Study|Withdrawal by Subject|11|||
148802117|NCT01677741|536755525|FG005|Overall Study|Withdrawal by Subject|20|||
148802118|NCT01677741|536755526|FG006|Overall Study|Withdrawal by Subject|4|||
148802119|NCT01677741|536755527|FG007|Overall Study|Withdrawal by Subject|2|||
148802120|NCT01677741|536755520|FG000|Overall Study|Enrolled in a rollover study|0|||
148802121|NCT01677741|536755521|FG001|Overall Study|Enrolled in a rollover study|3|||
148802122|NCT01677741|536755522|FG002|Overall Study|Enrolled in a rollover study|2|||
148802123|NCT01677741|536755523|FG003|Overall Study|Enrolled in a rollover study|1|||
148802124|NCT01677741|536755524|FG004|Overall Study|Enrolled in a rollover study|6|||
148802125|NCT01677741|536755525|FG005|Overall Study|Enrolled in a rollover study|6|||
148802126|NCT01677741|536755526|FG006|Overall Study|Enrolled in a rollover study|7|||
148802127|NCT01677741|536755527|FG007|Overall Study|Enrolled in a rollover study|0|||
148802128|NCT01677741|536755520|FG000|Overall Study|Progressive disease|1|||
148802129|NCT01677741|536755521|FG001|Overall Study|Progressive disease|0|||
148802130|NCT01677741|536755522|FG002|Overall Study|Progressive disease|1|||
148802131|NCT01677741|536755523|FG003|Overall Study|Progressive disease|0|||
148802132|NCT01677741|536755524|FG004|Overall Study|Progressive disease|0|||
148802133|NCT01677741|536755525|FG005|Overall Study|Progressive disease|1|||
148802134|NCT01677741|536755526|FG006|Overall Study|Progressive disease|0|||
148802135|NCT01677741|536755527|FG007|Overall Study|Progressive disease|0|||
148802136|NCT01973218|536755528|FG000|Overall Study|Adverse Event|1|||
148802137|NCT01973218|536755529|FG001|Overall Study|Adverse Event|0|||
148802138|NCT01973218|536755528|FG000|Overall Study|Withdrawal by Subject|1|||
148802139|NCT01973218|536755529|FG001|Overall Study|Withdrawal by Subject|0|||
148802140|NCT00720499|536755530|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
148802141|NCT00720499|536755531|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
148802142|NCT00720499|536755530|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
148802143|NCT00720499|536755531|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
148802144|NCT00720499|536755530|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
148802145|NCT00720499|536755531|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
148802146|NCT02247466|536755532|FG000|Overall Study|Procedure changed to open surgery|0|||
148802147|NCT02247466|536755533|FG001|Overall Study|Procedure changed to open surgery|3|||
148802148|NCT02230891|536755540|FG000|Baseline|Did not meet inclusion|0|||
148802149|NCT02230891|536755541|FG001|Baseline|Did not meet inclusion|1|||
148802150|NCT02230891|536755542|FG002|Baseline|Did not meet inclusion|1|||
148802151|NCT02230891|536755540|FG000|2 Week|Withdrawal by Subject|2|||
148802152|NCT02230891|536755541|FG001|2 Week|Withdrawal by Subject|2|||
148802153|NCT02230891|536755542|FG002|2 Week|Withdrawal by Subject|0|||
148802154|NCT02230891|536755540|FG000|2 Week|Consent withdrawn|1|||
148802155|NCT02230891|536755541|FG001|2 Week|Consent withdrawn|0|||
148802156|NCT02230891|536755542|FG002|2 Week|Consent withdrawn|0|||
148802157|NCT02230891|536755540|FG000|6 Month|Withdrawal by Subject|1|||
148802158|NCT02230891|536755541|FG001|6 Month|Withdrawal by Subject|1|||
148802159|NCT02230891|536755542|FG002|6 Month|Withdrawal by Subject|1|||
148802160|NCT02230891|536755540|FG000|6 Month|Physician Decision|0|||
148802161|NCT02230891|536755541|FG001|6 Month|Physician Decision|2|||
148802162|NCT02230891|536755542|FG002|6 Month|Physician Decision|0|||
148802163|NCT02230891|536755540|FG000|12 Month|Death|1|||
148802164|NCT02230891|536755541|FG001|12 Month|Death|0|||
148802165|NCT02230891|536755542|FG002|12 Month|Death|0|||
148802166|NCT02230891|536755540|FG000|12 Month|Lost to Follow-up|0|||
148802167|NCT02230891|536755541|FG001|12 Month|Lost to Follow-up|1|||
148802168|NCT02230891|536755542|FG002|12 Month|Lost to Follow-up|0|||
148802169|NCT02230891|536755540|FG000|12 Month|Withdrawal by Subject|0|||
148802170|NCT02230891|536755541|FG001|12 Month|Withdrawal by Subject|2|||
148802171|NCT02230891|536755542|FG002|12 Month|Withdrawal by Subject|0|||
148802172|NCT02230891|536755540|FG000|18 Month End of Study|Death|0|||
148802173|NCT02230891|536755541|FG001|18 Month End of Study|Death|0|||
148802174|NCT02230891|536755542|FG002|18 Month End of Study|Death|1|||
148802175|NCT02230891|536755540|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
148802176|NCT02230891|536755541|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
148802177|NCT02230891|536755542|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
148802178|NCT04356937|536755545|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
148802179|NCT04356937|536755546|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
148802180|NCT04158219|536755547|FG000|Overall Study|Lost to Follow-up|1|||
148802181|NCT01814007|536755549|FG000|Overall Study|Withdrawal by Subject|1|||
148802182|NCT01324947|536755550|FG000|Overall Study|Adverse Event|7|||
148802183|NCT01324947|536755550|FG000|Overall Study|Death|10|||
148802184|NCT01324947|536755550|FG000|Overall Study|Other|3|||
148802185|NCT01324947|536755550|FG000|Overall Study|Progressive Disease|50|||
148802186|NCT01324947|536755550|FG000|Overall Study|Withdrawal by Subject|3|||
148802187|NCT01324947|536755550|FG000|Overall Study|1 discontinued before starting drug|1|||
148802188|NCT04194814|536755553|FG000|Overall Study|Physician Decision|3|||
148802189|NCT04194814|536755554|FG001|Overall Study|Physician Decision|0|||
148802190|NCT04194814|536755553|FG000|Overall Study|Withdrawal by Subject|0|||
148802191|NCT04194814|536755554|FG001|Overall Study|Withdrawal by Subject|2|||
148802192|NCT01586195|536757603|FG000|Overall Study|Death|11|||
148802193|NCT01586195|536757603|FG000|Overall Study|Withdrawal of Consent|5|||
148802194|NCT01586195|536757603|FG000|Overall Study|Started new anti-melanoma therapy|1|||
148802195|NCT01586195|536757603|FG000|Overall Study|Reason not specified|9|||
148802196|NCT00997334|536757604|FG000|Overall Study|still on therapy|12|||
148802197|NCT00997334|536757604|FG000|Overall Study|Adverse Event|3|||
148802198|NCT00997334|536757604|FG000|Overall Study|Patient non-compliance|1|||
148802199|NCT00997334|536757604|FG000|Overall Study|Withdrawal by Subject|3|||
148802200|NCT00997334|536757604|FG000|Overall Study|Death|2|||
148802201|NCT00997334|536757604|FG000|Overall Study|Urgent Palliative Care|2|||
148802202|NCT00997334|536757604|FG000|Overall Study|No lesion amenable|1|||
148802203|NCT00997334|536757604|FG000|Overall Study|Ineligible|1|||
148802204|NCT01855958|536757605|FG000|Overall Study|Withdrawal by Subject|1|||
148802205|NCT01855958|536757606|FG001|Overall Study|Withdrawal by Subject|0|||
148802206|NCT00499122|536757610|FG000|Overall Study|Withdrawal by Subject|2|||
148802207|NCT03312738|536757611|FG000|Overall Study|Progressive disease|58|||
148802208|NCT03312738|536757612|FG001|Overall Study|Progressive disease|67|||
148802209|NCT03312738|536757611|FG000|Overall Study|Patient/guardian decision|13|||
148802210|NCT03312738|536757612|FG001|Overall Study|Patient/guardian decision|5|||
148802211|NCT03312738|536757611|FG000|Overall Study|Adverse Event|5|||
148802212|NCT03312738|536757612|FG001|Overall Study|Adverse Event|3|||
148802213|NCT03312738|536757611|FG000|Overall Study|Protocol deviation|2|||
148802214|NCT03312738|536757612|FG001|Overall Study|Protocol deviation|0|||
148802215|NCT03312738|536757611|FG000|Overall Study|Technical problems|0|||
148802216|NCT03312738|536757612|FG001|Overall Study|Technical problems|1|||
148802217|NCT03312738|536757611|FG000|Overall Study|Physician Decision|2|||
148802218|NCT03312738|536757612|FG001|Overall Study|Physician Decision|3|||
148802219|NCT04539275|536757616|FG000|Overall Study|Death|2|||
148802220|NCT04539275|536757617|FG001|Overall Study|Death|4|||
148802221|NCT04539275|536757616|FG000|Overall Study|Lost to Follow-up|1|||
148903354|NCT03847896|537131234|FG002|Overall Study|Lack of Efficacy|0|||
148903355|NCT03847896|537131235|FG003|Overall Study|Lack of Efficacy|2|||
148903356|NCT03847896|537131236|FG004|Overall Study|Lack of Efficacy|2|||
148903357|NCT03847896|537131232|FG000|Overall Study|Other reasons|3|||
148903358|NCT03847896|537131233|FG001|Overall Study|Other reasons|3|||
148903359|NCT03847896|537131234|FG002|Overall Study|Other reasons|1|||
148903360|NCT03847896|537131235|FG003|Overall Study|Other reasons|2|||
148903361|NCT03847896|537131236|FG004|Overall Study|Other reasons|1|||
148903362|NCT02395471|537131237|FG000|Overall Study|Lost to Follow-up|2|||
148903363|NCT02395471|537131238|FG001|Overall Study|Lost to Follow-up|0|||
148903364|NCT02395471|537131237|FG000|Overall Study|Withdrawal by Subject|2|||
148903365|NCT02395471|537131238|FG001|Overall Study|Withdrawal by Subject|1|||
148903366|NCT02395471|537131237|FG000|Overall Study|Physician Decision|1|||
148903367|NCT02395471|537131238|FG001|Overall Study|Physician Decision|0|||
148903368|NCT02395471|537131237|FG000|Overall Study|Protocol Violation|0|||
148903369|NCT02395471|537131238|FG001|Overall Study|Protocol Violation|1|||
148903370|NCT02395471|537131237|FG000|Overall Study|Failure to swollow sponge twice|1|||
148903371|NCT02395471|537131238|FG001|Overall Study|Failure to swollow sponge twice|0|||
148903372|NCT02395471|537131237|FG000|Overall Study|Patient did not return for procedure|0|||
148903373|NCT02395471|537131238|FG001|Overall Study|Patient did not return for procedure|1|||
148903374|NCT02395471|537131237|FG000|Overall Study|Subject not eligible|1|||
148903375|NCT02395471|537131238|FG001|Overall Study|Subject not eligible|0|||
148903376|NCT00118417|537131239|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
148903377|NCT00118417|537131240|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
148903378|NCT00118417|537131239|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
148903379|NCT00118417|537131240|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
148903380|NCT00118417|537131239|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
148903381|NCT00118417|537131240|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
148903382|NCT00118417|537131239|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
148903383|NCT00118417|537131240|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
148903384|NCT00118417|537131239|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
148903385|NCT00118417|537131240|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
148903386|NCT02978781|537131241|FG000|Part A|Adverse Event|1|||
148903387|NCT02978781|537131242|FG001|Part A|Adverse Event|1|||
148903388|NCT02978781|537131243|FG002|Part A|Adverse Event|0|||
148903389|NCT02978781|537131244|FG003|Part A|Adverse Event|0|||
148903390|NCT02978781|537131245|FG004|Part A|Adverse Event|0|||
148903391|NCT02978781|537131241|FG000|Part A|Withdrawal by Subject|0|||
148903392|NCT02978781|537131242|FG001|Part A|Withdrawal by Subject|1|||
148903393|NCT02978781|537131243|FG002|Part A|Withdrawal by Subject|0|||
148903394|NCT02978781|537131244|FG003|Part A|Withdrawal by Subject|0|||
148903395|NCT02978781|537131245|FG004|Part A|Withdrawal by Subject|0|||
148903396|NCT02978781|537131241|FG000|Part B|Withdrawal by Subject|0|||
148903397|NCT02978781|537131242|FG001|Part B|Withdrawal by Subject|0|||
148903398|NCT02978781|537131243|FG002|Part B|Withdrawal by Subject|0|||
148903399|NCT02978781|537131244|FG003|Part B|Withdrawal by Subject|1|||
148903400|NCT02978781|537131245|FG004|Part B|Withdrawal by Subject|0|||
148903401|NCT02978781|537131241|FG000|Part C|Adverse Event|0|||
148903402|NCT02978781|537131242|FG001|Part C|Adverse Event|0|||
148903403|NCT02978781|537131243|FG002|Part C|Adverse Event|0|||
148903404|NCT02978781|537131244|FG003|Part C|Adverse Event|0|||
148903405|NCT02978781|537131245|FG004|Part C|Adverse Event|2|||
148903406|NCT02978781|537131241|FG000|Part C|Withdrawal by Subject|0|||
148903407|NCT02978781|537131242|FG001|Part C|Withdrawal by Subject|0|||
148903408|NCT02978781|537131243|FG002|Part C|Withdrawal by Subject|0|||
148903409|NCT02978781|537131244|FG003|Part C|Withdrawal by Subject|0|||
148903410|NCT02978781|537131245|FG004|Part C|Withdrawal by Subject|1|||
148903411|NCT02978781|537131241|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
148903412|NCT02978781|537131242|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
148903413|NCT02978781|537131243|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
148903414|NCT02978781|537131244|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
148903415|NCT02978781|537131245|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
148903416|NCT02453321|537131246|FG000|Overall Study|Weakness|1|||
148903417|NCT02453321|537131247|FG001|Overall Study|Weakness|1|||
148903418|NCT02453321|537131248|FG002|Overall Study|Weakness|2|||
148903419|NCT02453321|537131246|FG000|Overall Study|Deep Venous Thrombosis|0|||
148903420|NCT02453321|537131247|FG001|Overall Study|Deep Venous Thrombosis|1|||
148903421|NCT02453321|537131248|FG002|Overall Study|Deep Venous Thrombosis|0|||
148903422|NCT01244893|537131249|FG000|Baseline|Protocol Violation|0|||
148903423|NCT01244893|537131250|FG001|Baseline|Protocol Violation|1|||
148903424|NCT01244893|537131249|FG000|1-Week Follow Up|Lost to Follow-up|1|||
148903425|NCT01244893|537131250|FG001|1-Week Follow Up|Lost to Follow-up|0|||
148903426|NCT00357552|537131251|FG000|Screening|Did not meet eligibility criteria|84|||
148903427|NCT00357552|537131251|FG000|Weeks 0 to 24|Death|1|||
148903428|NCT00357552|537131251|FG000|Weeks 24 to 104|Death|3|||
148903429|NCT00357552|537131251|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
148903430|NCT01528969|537131259|FG000|Overall Study|absent from the school at baseline|2|||
148903431|NCT01528969|537131260|FG001|Overall Study|absent from the school at baseline|0|||
148903432|NCT02282605|537131261|FG000|Overall Study|negative SA result on Day -1|3|||
148903433|NCT02282605|537131262|FG001|Overall Study|negative SA result on Day -1|0|||
148903434|NCT02282605|537131263|FG002|Overall Study|negative SA result on Day -1|0|||
148903435|NCT02035267|537131267|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
148903436|NCT02035267|537131268|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
148903437|NCT02035267|537131269|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
148903438|NCT02035267|537131270|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
148903439|NCT02035267|537131267|FG000|Overall Study|Adverse Event|0|||
148903440|NCT02035267|537131268|FG001|Overall Study|Adverse Event|0|||
148903441|NCT02035267|537131269|FG002|Overall Study|Adverse Event|1|||
148903442|NCT02035267|537131270|FG003|Overall Study|Adverse Event|0|||
148903443|NCT02035267|537131267|FG000|Overall Study|Lost to Follow-up|0|||
148903444|NCT02035267|537131268|FG001|Overall Study|Lost to Follow-up|0|||
148903445|NCT02035267|537131269|FG002|Overall Study|Lost to Follow-up|0|||
148903446|NCT02035267|537131270|FG003|Overall Study|Lost to Follow-up|1|||
148903447|NCT02035267|537131267|FG000|Overall Study|Other unspecified|0|||
148903448|NCT02035267|537131268|FG001|Overall Study|Other unspecified|1|||
148903449|NCT02035267|537131269|FG002|Overall Study|Other unspecified|0|||
148903450|NCT02035267|537131270|FG003|Overall Study|Other unspecified|0|||
148903451|NCT04646044|537131271|FG000|Overall Study|Lost to Follow-up|0|||
148903452|NCT04646044|537131272|FG001|Overall Study|Lost to Follow-up|0|||
148903453|NCT04646044|537131273|FG002|Overall Study|Lost to Follow-up|1|||
148903454|NCT04646044|537131274|FG003|Overall Study|Lost to Follow-up|0|||
148903455|NCT04646044|537131271|FG000|Overall Study|Withdrawal by Subject|0|||
148903456|NCT04646044|537131272|FG001|Overall Study|Withdrawal by Subject|1|||
148903457|NCT04646044|537131273|FG002|Overall Study|Withdrawal by Subject|0|||
148903458|NCT04646044|537131274|FG003|Overall Study|Withdrawal by Subject|0|||
148903459|NCT03038880|537131280|FG000|Overall Study|Death|1|||
148903460|NCT03038880|537131281|FG001|Overall Study|Death|2|||
148903461|NCT03038880|537131282|FG002|Overall Study|Death|0|||
148903462|NCT03038880|537131280|FG000|Overall Study|Physician Decision|2|||
148903463|NCT03038880|537131281|FG001|Overall Study|Physician Decision|1|||
148903464|NCT03038880|537131282|FG002|Overall Study|Physician Decision|0|||
148903465|NCT02803580|537131283|FG000|Overall Study|Death|13|||
148903466|NCT02803580|537131283|FG000|Overall Study|Lost to Follow-up|19|||
148903467|NCT02803580|537131283|FG000|Overall Study|Withdrawal by Subject|3|||
148903468|NCT02803580|537131283|FG000|Overall Study|Inclusion in clinical trial|1|||
148903469|NCT02054104|537131284|FG000|Overall Study|Did not want to continue due to college classes|1|||
148903470|NCT02054104|537131285|FG001|Overall Study|Did not want to continue due to college classes|0|||
148903471|NCT02054104|537131284|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
148903472|NCT02054104|537131285|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
148903473|NCT02054104|537131284|FG000|Overall Study|No evidence of immunologic response|2|||
148903474|NCT02054104|537131285|FG001|Overall Study|No evidence of immunologic response|2|||
148903475|NCT02054104|537131284|FG000|Overall Study|Disease Progression On Study|4|||
148903476|NCT02054104|537131285|FG001|Overall Study|Disease Progression On Study|5|||
148903477|NCT02054104|537131284|FG000|Overall Study|Diagnosis of lymphoma|0|||
148903478|NCT02054104|537131285|FG001|Overall Study|Diagnosis of lymphoma|1|||
148903479|NCT02054104|537131284|FG000|Overall Study|Inconclusive response|0|||
148903480|NCT02054104|537131285|FG001|Overall Study|Inconclusive response|1|||
148903481|NCT03926611|537131286|FG000|Overall Study|Adverse Event|0|||
148903482|NCT03926611|537131287|FG001|Overall Study|Adverse Event|0|||
148903483|NCT03926611|537131288|FG002|Overall Study|Adverse Event|0|||
148903484|NCT03926611|537131289|FG003|Overall Study|Adverse Event|3|||
148903485|NCT03926611|537131290|FG004|Overall Study|Adverse Event|1|||
148903486|NCT03926611|537131291|FG005|Overall Study|Adverse Event|3|||
148903487|NCT03926611|537131292|FG006|Overall Study|Adverse Event|0|||
148903488|NCT03926611|537131286|FG000|Overall Study|Lack of Efficacy|1|||
148903489|NCT03926611|537131287|FG001|Overall Study|Lack of Efficacy|2|||
148903490|NCT03926611|537131288|FG002|Overall Study|Lack of Efficacy|0|||
148903491|NCT03926611|537131289|FG003|Overall Study|Lack of Efficacy|0|||
148903492|NCT03926611|537131290|FG004|Overall Study|Lack of Efficacy|1|||
148903493|NCT03926611|537131291|FG005|Overall Study|Lack of Efficacy|0|||
148903494|NCT03926611|537131292|FG006|Overall Study|Lack of Efficacy|1|||
148903495|NCT03926611|537131286|FG000|Overall Study|Physician Decision|0|||
148903496|NCT03926611|537131287|FG001|Overall Study|Physician Decision|0|||
148903497|NCT03926611|537131288|FG002|Overall Study|Physician Decision|0|||
148903498|NCT03926611|537131289|FG003|Overall Study|Physician Decision|0|||
148903499|NCT03926611|537131290|FG004|Overall Study|Physician Decision|0|||
148903500|NCT03926611|537131291|FG005|Overall Study|Physician Decision|1|||
148903501|NCT03926611|537131292|FG006|Overall Study|Physician Decision|0|||
148903502|NCT03926611|537131286|FG000|Overall Study|Protocol Violation|1|||
148903503|NCT03926611|537131287|FG001|Overall Study|Protocol Violation|0|||
148903504|NCT03926611|537131288|FG002|Overall Study|Protocol Violation|0|||
148903505|NCT03926611|537131289|FG003|Overall Study|Protocol Violation|1|||
148903506|NCT03926611|537131290|FG004|Overall Study|Protocol Violation|1|||
148903507|NCT03926611|537131291|FG005|Overall Study|Protocol Violation|1|||
148903508|NCT03926611|537131292|FG006|Overall Study|Protocol Violation|1|||
148903509|NCT03926611|537131286|FG000|Overall Study|Technical problems|0|||
148903510|NCT03926611|537131287|FG001|Overall Study|Technical problems|0|||
148903511|NCT03926611|537131288|FG002|Overall Study|Technical problems|0|||
148903512|NCT03926611|537131289|FG003|Overall Study|Technical problems|0|||
148903513|NCT03926611|537131290|FG004|Overall Study|Technical problems|0|||
148903514|NCT03926611|537131291|FG005|Overall Study|Technical problems|1|||
148903515|NCT03926611|537131292|FG006|Overall Study|Technical problems|0|||
148903516|NCT03926611|537131286|FG000|Overall Study|Withdrawal by Subject|1|||
148903517|NCT03926611|537131287|FG001|Overall Study|Withdrawal by Subject|1|||
148903518|NCT03926611|537131288|FG002|Overall Study|Withdrawal by Subject|1|||
148903519|NCT03926611|537131289|FG003|Overall Study|Withdrawal by Subject|0|||
148903520|NCT03926611|537131290|FG004|Overall Study|Withdrawal by Subject|0|||
148903521|NCT03926611|537131291|FG005|Overall Study|Withdrawal by Subject|1|||
148903522|NCT03926611|537131292|FG006|Overall Study|Withdrawal by Subject|3|||
148903523|NCT03926611|537131286|FG000|Overall Study|Covid-19 pandemic|0|||
148903524|NCT03926611|537131287|FG001|Overall Study|Covid-19 pandemic|0|||
148903525|NCT03926611|537131288|FG002|Overall Study|Covid-19 pandemic|1|||
148903526|NCT03926611|537131289|FG003|Overall Study|Covid-19 pandemic|0|||
148903527|NCT03926611|537131290|FG004|Overall Study|Covid-19 pandemic|1|||
148903528|NCT03926611|537131291|FG005|Overall Study|Covid-19 pandemic|2|||
148903529|NCT03926611|537131292|FG006|Overall Study|Covid-19 pandemic|0|||
148903530|NCT00084136|537131295|FG000|PI Comparison|Death|10|||
148903531|NCT00084136|537131296|FG001|PI Comparison|Death|9|||
148903532|NCT00084136|537131297|FG002|PI Comparison|Death|0|||
148903533|NCT00084136|537131295|FG000|PI Comparison|Lost to Follow-up|11|||
148903534|NCT00084136|537131296|FG001|PI Comparison|Lost to Follow-up|8|||
148903535|NCT00084136|537131297|FG002|PI Comparison|Lost to Follow-up|0|||
148903536|NCT00084136|537131295|FG000|PI Comparison|Withdrawal by Subject|33|||
148903537|NCT00084136|537131296|FG001|PI Comparison|Withdrawal by Subject|30|||
148903538|NCT00084136|537131297|FG002|PI Comparison|Withdrawal by Subject|0|||
148903539|NCT00084136|537131295|FG000|PI Comparison|Clinic site closed|1|||
148903540|NCT00084136|537131296|FG001|PI Comparison|Clinic site closed|0|||
148903541|NCT00084136|537131297|FG002|PI Comparison|Clinic site closed|0|||
148903542|NCT00084136|537131295|FG000|NRTI Comparison|Death|20|||
148903543|NCT00084136|537131296|FG001|NRTI Comparison|Death|0|||
148903544|NCT00084136|537131297|FG002|NRTI Comparison|Death|18|||
148903545|NCT00084136|537131295|FG000|NRTI Comparison|Lost to Follow-up|14|||
148903546|NCT00084136|537131296|FG001|NRTI Comparison|Lost to Follow-up|0|||
148903547|NCT00084136|537131297|FG002|NRTI Comparison|Lost to Follow-up|12|||
148903548|NCT00084136|537131295|FG000|NRTI Comparison|Withdrawal by Subject|54|||
148903549|NCT00084136|537131296|FG001|NRTI Comparison|Withdrawal by Subject|0|||
148903550|NCT00084136|537131297|FG002|NRTI Comparison|Withdrawal by Subject|38|||
148903551|NCT00084136|537131295|FG000|NRTI Comparison|Clinic site closed|12|||
148903552|NCT00084136|537131296|FG001|NRTI Comparison|Clinic site closed|0|||
148903553|NCT00084136|537131297|FG002|NRTI Comparison|Clinic site closed|14|||
148903554|NCT00084136|537131295|FG000|NRTI Comparison|Not reason above|1|||
148903555|NCT00084136|537131296|FG001|NRTI Comparison|Not reason above|0|||
148903556|NCT00084136|537131297|FG002|NRTI Comparison|Not reason above|0|||
148903557|NCT02230670|537131298|FG000|Overall Study|Adverse Event|1|||
148903558|NCT02230670|537131299|FG001|Overall Study|Adverse Event|2|||
148903559|NCT02230670|537131298|FG000|Overall Study|Withdrawal by Subject|2|||
148903560|NCT02230670|537131299|FG001|Overall Study|Withdrawal by Subject|2|||
148903561|NCT02230670|537131298|FG000|Overall Study|Physician Decision|0|||
148903562|NCT02230670|537131299|FG001|Overall Study|Physician Decision|1|||
148903563|NCT02230670|537131298|FG000|Overall Study|Protocol Violation|0|||
148903564|NCT02230670|537131299|FG001|Overall Study|Protocol Violation|1|||
148903565|NCT02230670|537131298|FG000|Overall Study|Progression to Child-Pugh C|1|||
148903566|NCT02230670|537131299|FG001|Overall Study|Progression to Child-Pugh C|2|||
148903567|NCT01524796|537131302|FG000|Overall Study|Adverse Event|13|||
148903568|NCT01524796|537131302|FG000|Overall Study|Lack of Efficacy|3|||
148903569|NCT01524796|537131302|FG000|Overall Study|Lost to Follow-up|1|||
148903570|NCT01524796|537131302|FG000|Overall Study|The price|1|||
148903571|NCT01524796|537131302|FG000|Overall Study|Withdrawal by Subject|4|||
148903572|NCT01524796|537131302|FG000|Overall Study|Move|1|||
148903573|NCT01524796|537131302|FG000|Overall Study|Deterioration of pains|1|||
148903574|NCT01524796|537131302|FG000|Overall Study|Gall stone surgery|1|||
148903575|NCT01524796|537131302|FG000|Overall Study|Nervous about confidentiality|1|||
148903576|NCT01524796|537131302|FG000|Overall Study|Switch to carbamazapine|1|||
148903577|NCT01524796|537131302|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
148903578|NCT00836693|537131306|FG000|Overall Study|Adverse Event|4|||
148903579|NCT00836693|537131307|FG001|Overall Study|Adverse Event|1|||
148903580|NCT00836693|537131306|FG000|Overall Study|Sponsor Decision|0|||
148903581|NCT00836693|537131307|FG001|Overall Study|Sponsor Decision|1|||
148903582|NCT00836693|537131306|FG000|Overall Study|Physician Decision|2|||
148903583|NCT00836693|537131307|FG001|Overall Study|Physician Decision|0|||
148903584|NCT00836693|537131306|FG000|Overall Study|Withdrawal by Subject|9|||
148903585|NCT00836693|537131307|FG001|Overall Study|Withdrawal by Subject|4|||
148903586|NCT00836693|537131306|FG000|Overall Study|Protocol Violation|1|||
148903587|NCT00836693|537131307|FG001|Overall Study|Protocol Violation|0|||
148903588|NCT00836693|537131306|FG000|Overall Study|Lost to Follow-up|1|||
148903589|NCT00836693|537131307|FG001|Overall Study|Lost to Follow-up|0|||
148903590|NCT03938259|537131308|FG000|Overall Study|unable to establish baseline for ventilation|1|||
148903591|NCT03938259|537131309|FG001|Overall Study|unable to establish baseline for ventilation|1|||
148903592|NCT02612779|537131310|FG000|Overall Study|Administrative reason by sponsor|4|||
148903593|NCT02612779|537131311|FG001|Overall Study|Administrative reason by sponsor|1|||
148903594|NCT02612779|537131310|FG000|Overall Study|No longer meet study criteria|0|||
148903595|NCT02612779|537131311|FG001|Overall Study|No longer meet study criteria|1|||
148903596|NCT02612779|537131310|FG000|Overall Study|Disease progression|29|||
148903597|NCT02612779|537131311|FG001|Overall Study|Disease progression|2|||
148903598|NCT02612779|537131310|FG000|Overall Study|Study drug toxicity|10|||
148903599|NCT02612779|537131311|FG001|Overall Study|Study drug toxicity|1|||
148903600|NCT02612779|537131310|FG000|Overall Study|Death|1|||
148903601|NCT02612779|537131311|FG001|Overall Study|Death|0|||
148903602|NCT02612779|537131310|FG000|Overall Study|Adverse event unrelated to study drug|5|||
148903603|NCT02612779|537131311|FG001|Overall Study|Adverse event unrelated to study drug|0|||
148903604|NCT02612779|537131310|FG000|Overall Study|Participant withdrew consent|4|||
148903605|NCT02612779|537131311|FG001|Overall Study|Participant withdrew consent|0|||
148903606|NCT02612779|537131310|FG000|Overall Study|Lost to Follow-up|1|||
148903607|NCT02612779|537131311|FG001|Overall Study|Lost to Follow-up|0|||
148903608|NCT02612779|537131310|FG000|Overall Study|Maximum clinical benefit|10|||
148903609|NCT02612779|537131311|FG001|Overall Study|Maximum clinical benefit|1|||
148903610|NCT02612779|537131310|FG000|Overall Study|Other reasons|4|||
148903611|NCT02612779|537131311|FG001|Overall Study|Other reasons|0|||
148903612|NCT01746901|537131316|FG000|Naloxone Challenge Phase|Adverse Event|2|||
148903613|NCT01746901|537131317|FG001|Naloxone Challenge Phase|Adverse Event|0|||
148903614|NCT01746901|537131318|FG002|Naloxone Challenge Phase|Adverse Event|0|||
148903615|NCT01746901|537131319|FG003|Naloxone Challenge Phase|Adverse Event|0|||
148903616|NCT01746901|537131320|FG004|Naloxone Challenge Phase|Adverse Event|0|||
148903617|NCT01746901|537131321|FG005|Naloxone Challenge Phase|Adverse Event|0|||
148903618|NCT01746901|537131322|FG006|Naloxone Challenge Phase|Adverse Event|0|||
148903619|NCT01746901|537131323|FG007|Naloxone Challenge Phase|Adverse Event|0|||
148903620|NCT01746901|537131324|FG008|Naloxone Challenge Phase|Adverse Event|0|||
148903621|NCT01746901|537131316|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
148903622|NCT01746901|537131317|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903623|NCT01746901|537131318|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903624|NCT01746901|537131319|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903625|NCT01746901|537131320|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903626|NCT01746901|537131321|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903627|NCT01746901|537131322|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903628|NCT01746901|537131323|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903629|NCT01746901|537131324|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
148903630|NCT01746901|537131316|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903631|NCT01746901|537131317|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
148903632|NCT01746901|537131318|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903633|NCT01746901|537131319|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903634|NCT01746901|537131320|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903635|NCT01746901|537131321|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903636|NCT01746901|537131322|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903637|NCT01746901|537131323|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903638|NCT01746901|537131324|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148903639|NCT01746901|537131316|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903640|NCT01746901|537131317|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
148903641|NCT01746901|537131318|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
148903642|NCT01746901|537131319|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903643|NCT01746901|537131320|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903644|NCT01746901|537131321|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903645|NCT01746901|537131322|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903646|NCT01746901|537131323|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903647|NCT01746901|537131324|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
148903648|NCT01746901|537131316|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903649|NCT01746901|537131317|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
148903650|NCT01746901|537131318|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
148903651|NCT01746901|537131319|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903652|NCT01746901|537131320|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903653|NCT01746901|537131321|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903654|NCT01746901|537131322|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903655|NCT01746901|537131323|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903656|NCT01746901|537131324|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
148903657|NCT01746901|537131316|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903658|NCT01746901|537131317|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
148903659|NCT01746901|537131318|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
148903660|NCT01746901|537131319|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903661|NCT01746901|537131320|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903662|NCT01746901|537131321|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903663|NCT01746901|537131322|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903664|NCT01746901|537131323|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903665|NCT01746901|537131324|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148903666|NCT01746901|537131316|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
148903667|NCT01746901|537131317|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
148903668|NCT01746901|537131318|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
148903669|NCT01746901|537131319|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
148903670|NCT01746901|537131320|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
148903671|NCT01746901|537131321|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
148903672|NCT01746901|537131322|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
148903673|NCT01746901|537131323|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
148903674|NCT01746901|537131324|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
148903675|NCT01746901|537131316|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903676|NCT01746901|537131317|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903677|NCT01746901|537131318|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903678|NCT01746901|537131319|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903679|NCT01746901|537131320|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903680|NCT01746901|537131321|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903681|NCT01746901|537131322|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903682|NCT01746901|537131323|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
148903683|NCT01746901|537131324|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
148903684|NCT01746901|537131316|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903685|NCT01746901|537131317|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903686|NCT01746901|537131318|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903687|NCT01746901|537131319|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903688|NCT01746901|537131320|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903689|NCT01746901|537131321|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
148903690|NCT01746901|537131322|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
148903691|NCT01746901|537131323|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903692|NCT01746901|537131324|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
148903693|NCT01746901|537131316|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903694|NCT01746901|537131317|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903695|NCT01746901|537131318|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903696|NCT01746901|537131319|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
148903697|NCT01746901|537131320|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903698|NCT01746901|537131321|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903699|NCT01746901|537131322|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903700|NCT01746901|537131323|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903701|NCT01746901|537131324|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
148903702|NCT01746901|537131316|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903703|NCT01746901|537131317|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903704|NCT01746901|537131318|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903705|NCT01746901|537131319|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903706|NCT01746901|537131320|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903707|NCT01746901|537131321|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
148903708|NCT01746901|537131322|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903709|NCT01746901|537131323|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
148903710|NCT01746901|537131324|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
148903711|NCT01746901|537131316|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903712|NCT01746901|537131317|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903713|NCT01746901|537131318|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903714|NCT01746901|537131319|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903715|NCT01746901|537131320|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903716|NCT01746901|537131321|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903717|NCT01746901|537131322|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
148903718|NCT01746901|537131323|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
148903719|NCT01746901|537131324|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
148903720|NCT03594110|537131328|FG000|Interventional Part|Participant concerned about study treatment|23|||
148903721|NCT03594110|537131329|FG001|Interventional Part|Participant concerned about study treatment|28|||
148903722|NCT03594110|537131328|FG000|Interventional Part|Doctor advice|38|||
148802222|NCT04539275|536757617|FG001|Overall Study|Lost to Follow-up|1|||
148802223|NCT04539275|536757616|FG000|Overall Study|Withdrawal by Subject|3|||
148802224|NCT04539275|536757617|FG001|Overall Study|Withdrawal by Subject|0|||
148802225|NCT00607893|536757618|FG000|Overall Study|Lost to Follow-up|4|||
148802226|NCT00607893|536757619|FG001|Overall Study|Lost to Follow-up|0|||
148802227|NCT00607893|536757618|FG000|Overall Study|withdrew due to loss of interest|0|||
148802228|NCT00607893|536757619|FG001|Overall Study|withdrew due to loss of interest|1|||
148802229|NCT00607893|536757618|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
148802230|NCT00607893|536757619|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
148802231|NCT00607893|536757618|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
148802232|NCT00607893|536757619|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
148802233|NCT00607893|536757618|FG000|Overall Study|Declined to be treated|1|||
148802234|NCT00607893|536757619|FG001|Overall Study|Declined to be treated|0|||
148802235|NCT00607893|536757618|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
148802236|NCT00607893|536757619|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
148802237|NCT01799941|536757620|FG000|Overall Study|Adverse Event|34|||
148802238|NCT01799941|536757620|FG000|Overall Study|Withdrawal by Subject|21|||
148802239|NCT01799941|536757620|FG000|Overall Study|Death|2|||
148802240|NCT01799941|536757620|FG000|Overall Study|Investigator Decision|4|||
148802241|NCT01799941|536757620|FG000|Overall Study|Lack of Efficacy|3|||
148802242|NCT01799941|536757620|FG000|Overall Study|Lost to Follow-up|17|||
148802243|NCT01799941|536757620|FG000|Overall Study|Other|15|||
148802244|NCT00606008|536757621|FG000|Overall Study|Adverse Event|1|||
148802245|NCT00606008|536757621|FG000|Overall Study|Withdrawal by Subject|4|||
148802246|NCT03712280|536757624|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
148802247|NCT03712280|536757625|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
148802248|NCT03712280|536757626|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
148802249|NCT03712280|536757627|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
148802250|NCT03712280|536757624|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
148802251|NCT03712280|536757625|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
148802252|NCT03712280|536757626|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
148802253|NCT03712280|536757627|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
148802254|NCT03712280|536757624|FG000|Overall Study|Adverse Event|0|||
148802255|NCT03712280|536757625|FG001|Overall Study|Adverse Event|0|||
148802256|NCT03712280|536757626|FG002|Overall Study|Adverse Event|1|||
148802257|NCT03712280|536757627|FG003|Overall Study|Adverse Event|0|||
148802258|NCT02497469|536757628|FG000|Overall Study|Randomized but not Treated|0|||
148802259|NCT02497469|536757629|FG001|Overall Study|Randomized but not Treated|2|||
148802260|NCT02497469|536757628|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
148802261|NCT02497469|536757629|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
148802262|NCT02497469|536757628|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
148802263|NCT02497469|536757629|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
148802264|NCT02497469|536757628|FG000|Overall Study|Significant Protocol Deviation|4|||
148802265|NCT02497469|536757629|FG001|Overall Study|Significant Protocol Deviation|5|||
148802266|NCT02497469|536757628|FG000|Overall Study|Lost to Follow-up|14|||
148802267|NCT02497469|536757629|FG001|Overall Study|Lost to Follow-up|4|||
148802268|NCT02497469|536757628|FG000|Overall Study|Voluntary Withdrawal|39|||
148802269|NCT02497469|536757629|FG001|Overall Study|Voluntary Withdrawal|41|||
148802270|NCT02497469|536757628|FG000|Overall Study|Pregnancy|1|||
148802271|NCT02497469|536757629|FG001|Overall Study|Pregnancy|1|||
148802272|NCT02497469|536757628|FG000|Overall Study|Lack of Efficacy|86|||
148802273|NCT02497469|536757629|FG001|Overall Study|Lack of Efficacy|40|||
148802274|NCT02497469|536757628|FG000|Overall Study|Reason not Specified|6|||
148802275|NCT02497469|536757629|FG001|Overall Study|Reason not Specified|6|||
148802276|NCT03558516|536757630|FG000|Overall Study|Protocol Violation|2|||
148802277|NCT03558516|536757631|FG001|Overall Study|Protocol Violation|2|||
148802278|NCT00472420|536757632|FG000|Induction Treatment Period|Physician Decision|9|||
148802279|NCT00472420|536757632|FG000|Induction Treatment Period|Adverse Event|3|||
148802280|NCT00472420|536757632|FG000|Induction Treatment Period|Non-compliance|1|||
148802281|NCT00472420|536757632|FG000|Induction Treatment Period|Death|3|||
148802282|NCT00472420|536757632|FG000|Follow-up Period|Death|5|||
148802283|NCT00472420|536757632|FG000|Follow-up Period|Physician Decision|9|||
148802284|NCT00472420|536757632|FG000|Follow-up Period|Lost to Follow-up|2|||
148802285|NCT00472420|536757632|FG000|Follow-up Period|Protocol Violation|1|||
148802286|NCT01462942|536757637|FG000|Overall Study|Adverse Event|7|||
148802287|NCT01462942|536757638|FG001|Overall Study|Adverse Event|12|||
148802288|NCT01462942|536757639|FG002|Overall Study|Adverse Event|10|||
148802289|NCT01462942|536757640|FG003|Overall Study|Adverse Event|11|||
148802290|NCT01462942|536757641|FG004|Overall Study|Adverse Event|11|||
148802291|NCT01462942|536757637|FG000|Overall Study|Other, including COPD exacerbation|3|||
148802292|NCT01462942|536757638|FG001|Overall Study|Other, including COPD exacerbation|5|||
148802293|NCT01462942|536757639|FG002|Overall Study|Other, including COPD exacerbation|2|||
148802294|NCT01462942|536757640|FG003|Overall Study|Other, including COPD exacerbation|8|||
148802295|NCT01462942|536757641|FG004|Overall Study|Other, including COPD exacerbation|5|||
148903723|NCT03594110|537131329|FG001|Interventional Part|Doctor advice|40|||
148903724|NCT03594110|537131328|FG000|Interventional Part|Participants' wish|89|||
148903725|NCT03594110|537131329|FG001|Interventional Part|Participants' wish|68|||
148903726|NCT03594110|537131328|FG000|Interventional Part|Adverse event-non-fatal events|119|||
148903727|NCT03594110|537131329|FG001|Interventional Part|Adverse event-non-fatal events|116|||
148903728|NCT03594110|537131328|FG000|Interventional Part|Study drug stopped, reason missing|336|||
148903729|NCT03594110|537131329|FG001|Interventional Part|Study drug stopped, reason missing|294|||
148903730|NCT03594110|537131328|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
148903731|NCT03594110|537131329|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
148903732|NCT03594110|537131328|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
148903733|NCT03594110|537131329|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
148903734|NCT03594110|537131328|FG000|Interventional Part|Contraindicated drug started|32|||
148903735|NCT03594110|537131329|FG001|Interventional Part|Contraindicated drug started|18|||
148903736|NCT03594110|537131328|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
148903737|NCT03594110|537131329|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
148903738|NCT03594110|537131328|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
148903739|NCT03594110|537131329|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
148903740|NCT03594110|537131328|FG000|Non-interventional Part|Withdrawal by Subject|3|||
148903741|NCT03594110|537131329|FG001|Non-interventional Part|Withdrawal by Subject|4|||
148903742|NCT03594110|537131328|FG000|Non-interventional Part|Lost to Follow-up|45|||
148903743|NCT03594110|537131329|FG001|Non-interventional Part|Lost to Follow-up|41|||
148903744|NCT02085460|537131331|FG000|Overall Study|Adverse Event|2|||
148903745|NCT02085460|537131332|FG001|Overall Study|Adverse Event|2|||
148903746|NCT02085460|537131333|FG002|Overall Study|Adverse Event|1|||
148903747|NCT02085460|537131331|FG000|Overall Study|Physician Decision|1|||
148903748|NCT02085460|537131332|FG001|Overall Study|Physician Decision|1|||
148903749|NCT02085460|537131333|FG002|Overall Study|Physician Decision|2|||
148903750|NCT02085460|537131331|FG000|Overall Study|Withdrawal by Subject|11|||
148903751|NCT02085460|537131332|FG001|Overall Study|Withdrawal by Subject|5|||
148903752|NCT02085460|537131333|FG002|Overall Study|Withdrawal by Subject|7|||
148903753|NCT00763035|537131334|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
148903754|NCT00763035|537131335|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
148903755|NCT00763035|537131334|FG000|First Intervention|Adverse Event|0|||
148903756|NCT00763035|537131335|FG001|First Intervention|Adverse Event|1|||
148903757|NCT00763035|537131334|FG000|Second Intervention|Adverse Event|1|||
148903758|NCT00763035|537131335|FG001|Second Intervention|Adverse Event|0|||
148903759|NCT00763035|537131334|FG000|Second Intervention|Physician Decision|2|||
148903760|NCT00763035|537131335|FG001|Second Intervention|Physician Decision|0|||
148903761|NCT01658436|537131347|FG000|Overall Study|Adverse Event|6|||
148903762|NCT01658436|537131348|FG001|Overall Study|Adverse Event|5|||
148903763|NCT01658436|537131347|FG000|Overall Study|Physician Decision|1|||
148903764|NCT01658436|537131348|FG001|Overall Study|Physician Decision|0|||
148903765|NCT01658436|537131347|FG000|Overall Study|Progressive disease|12|||
148903766|NCT01658436|537131348|FG001|Overall Study|Progressive disease|4|||
148903767|NCT01658436|537131347|FG000|Overall Study|Study terminated by sponsor|0|||
148903768|NCT01658436|537131348|FG001|Overall Study|Study terminated by sponsor|1|||
148903769|NCT01658436|537131347|FG000|Overall Study|Subject/guardian decision|0|||
148903770|NCT01658436|537131348|FG001|Overall Study|Subject/guardian decision|1|||
148903771|NCT01658436|537131347|FG000|Overall Study|Death|1|||
148903772|NCT01658436|537131348|FG001|Overall Study|Death|0|||
148903773|NCT00686712|537131349|FG000|Overall Study|Protocol Violation|8|||
148903774|NCT00686712|537131350|FG001|Overall Study|Protocol Violation|8|||
148903775|NCT00686712|537131351|FG002|Overall Study|Protocol Violation|10|||
148903776|NCT00686712|537131349|FG000|Overall Study|Lost to Follow-up|1|||
148903777|NCT00686712|537131350|FG001|Overall Study|Lost to Follow-up|2|||
148903778|NCT00686712|537131351|FG002|Overall Study|Lost to Follow-up|3|||
148903779|NCT00686712|537131349|FG000|Overall Study|Adverse Event|1|||
148903780|NCT00686712|537131350|FG001|Overall Study|Adverse Event|1|||
148903781|NCT00686712|537131351|FG002|Overall Study|Adverse Event|0|||
148903782|NCT01318915|537131354|FG000|Overall Study|Lost to Follow-up|1|||
148903783|NCT00926237|537131355|FG000|Overall Study|Withdrawal by Subject|2|||
148903784|NCT00926237|537131356|FG001|Overall Study|Withdrawal by Subject|1|||
148903785|NCT04119414|537131357|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
148903786|NCT01942837|537132923|FG000|Overall Study|Death|1|||
148903787|NCT01942837|537132923|FG000|Overall Study|Symptomatic or radiographic progression|49|||
148903788|NCT01942837|537132923|FG000|Overall Study|Adverse Event|6|||
148903789|NCT01942837|537132923|FG000|Overall Study|Physician Decision|3|||
148903790|NCT01942837|537132923|FG000|Overall Study|Withdrawal by Subject|2|||
148903791|NCT01942837|537132923|FG000|Overall Study|Intercurrent Illness|1|||
148903792|NCT01942837|537132923|FG000|Overall Study|On treatment|3|||
148903793|NCT01942837|537132923|FG000|Overall Study|Never initiate the treatment|2|||
148903794|NCT01298648|537132924|FG000|Overall Study|Withdrawal by Subject|2|||
148903795|NCT01298648|537132924|FG000|Overall Study|Lost to Follow-up|21|||
148903796|NCT03077412|537132927|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
148903797|NCT03077412|537132928|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
148903798|NCT03077412|537132929|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
148903799|NCT03077412|537132927|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
148903800|NCT03077412|537132928|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
148903801|NCT03077412|537132929|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
148903802|NCT03077412|537132927|FG000|Overall Study|Adverse Event|1|||
148903803|NCT03077412|537132928|FG001|Overall Study|Adverse Event|2|||
148903804|NCT03077412|537132929|FG002|Overall Study|Adverse Event|2|||
148903805|NCT03077412|537132927|FG000|Overall Study|Investigator's Discretion|0|||
148903806|NCT03077412|537132928|FG001|Overall Study|Investigator's Discretion|1|||
148903807|NCT03077412|537132929|FG002|Overall Study|Investigator's Discretion|1|||
148903808|NCT03077412|537132927|FG000|Overall Study|Withdrew Consent|0|||
148903809|NCT03077412|537132928|FG001|Overall Study|Withdrew Consent|2|||
148903810|NCT03077412|537132929|FG002|Overall Study|Withdrew Consent|0|||
148903811|NCT02266888|537132931|FG000|Overall Study|Death|2|||
148903812|NCT02266888|537132932|FG001|Overall Study|Death|2|||
148903813|NCT02266888|537132933|FG002|Overall Study|Death|4|||
148903814|NCT02266888|537132934|FG003|Overall Study|Death|2|||
148903815|NCT02266888|537132931|FG000|Overall Study|Physician Decision|0|||
148903816|NCT02266888|537132932|FG001|Overall Study|Physician Decision|1|||
148903817|NCT02266888|537132933|FG002|Overall Study|Physician Decision|2|||
148903818|NCT02266888|537132934|FG003|Overall Study|Physician Decision|2|||
148903819|NCT02266888|537132931|FG000|Overall Study|Study Terminated|5|||
148903820|NCT02266888|537132932|FG001|Overall Study|Study Terminated|1|||
148903821|NCT02266888|537132933|FG002|Overall Study|Study Terminated|0|||
148903822|NCT02266888|537132934|FG003|Overall Study|Study Terminated|0|||
148903823|NCT02266888|537132931|FG000|Overall Study|No Longer Eligible|0|||
148903824|NCT02266888|537132932|FG001|Overall Study|No Longer Eligible|0|||
148903825|NCT02266888|537132933|FG002|Overall Study|No Longer Eligible|0|||
148903826|NCT02266888|537132934|FG003|Overall Study|No Longer Eligible|2|||
148903827|NCT02266888|537132931|FG000|Overall Study|Randomization Closed|0|||
148903828|NCT02266888|537132932|FG001|Overall Study|Randomization Closed|0|||
148903829|NCT02266888|537132933|FG002|Overall Study|Randomization Closed|4|||
148903830|NCT02266888|537132934|FG003|Overall Study|Randomization Closed|0|||
148903831|NCT02266888|537132931|FG000|Overall Study|Personnel unavailable at transplant|0|||
148903832|NCT02266888|537132932|FG001|Overall Study|Personnel unavailable at transplant|0|||
148903833|NCT02266888|537132933|FG002|Overall Study|Personnel unavailable at transplant|0|||
148903834|NCT02266888|537132934|FG003|Overall Study|Personnel unavailable at transplant|1|||
148903835|NCT02266888|537132931|FG000|Overall Study|Transfer of care|0|||
148903836|NCT02266888|537132932|FG001|Overall Study|Transfer of care|0|||
148903837|NCT02266888|537132933|FG002|Overall Study|Transfer of care|1|||
148903838|NCT02266888|537132934|FG003|Overall Study|Transfer of care|0|||
148903839|NCT02351856|537132935|FG000|Overall Study|Adverse Event|2|||
148903840|NCT02351856|537132935|FG000|Overall Study|Physician Decision|5|||
148903841|NCT02351856|537132935|FG000|Overall Study|Study terminated by sponsor|1|||
148903842|NCT01458392|537132938|FG000|Overall Study|Death|2|||
148903843|NCT01458392|537132939|FG001|Overall Study|Death|11|||
148903844|NCT01458392|537132940|FG002|Overall Study|Death|22|||
148903845|NCT01458392|537132938|FG000|Overall Study|At the discretion of the sponsor|0|||
148903846|NCT01458392|537132939|FG001|Overall Study|At the discretion of the sponsor|2|||
148903847|NCT01458392|537132940|FG002|Overall Study|At the discretion of the sponsor|7|||
148903848|NCT01458392|537132938|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
148903849|NCT01458392|537132939|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
148903850|NCT01458392|537132940|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
148903851|NCT01281124|537132943|FG000|Overall Study|Death|1|||
148903852|NCT00918255|537132944|FG000|Overall Study|Adverse Event|1|||
148903853|NCT00918255|537132945|FG001|Overall Study|Adverse Event|0|||
148903854|NCT00918255|537132946|FG002|Overall Study|Adverse Event|0|||
148903855|NCT00918255|537132944|FG000|Overall Study|Withdrawal by Subject|1|||
148903856|NCT00918255|537132945|FG001|Overall Study|Withdrawal by Subject|0|||
148903857|NCT00918255|537132946|FG002|Overall Study|Withdrawal by Subject|2|||
148903858|NCT00918255|537132944|FG000|Overall Study|Lack of Efficacy|1|||
148903859|NCT00918255|537132945|FG001|Overall Study|Lack of Efficacy|0|||
148903860|NCT00918255|537132946|FG002|Overall Study|Lack of Efficacy|0|||
148903861|NCT00918255|537132944|FG000|Overall Study|Lost to Follow-up|1|||
148903862|NCT00918255|537132945|FG001|Overall Study|Lost to Follow-up|0|||
148903863|NCT00918255|537132946|FG002|Overall Study|Lost to Follow-up|2|||
148903864|NCT00918255|537132944|FG000|Overall Study|Exceeded allowed number of interventions|0|||
148903865|NCT00918255|537132945|FG001|Overall Study|Exceeded allowed number of interventions|0|||
148903866|NCT00918255|537132946|FG002|Overall Study|Exceeded allowed number of interventions|1|||
148903867|NCT00918255|537132944|FG000|Overall Study|Non-compliance|1|||
148903868|NCT00918255|537132945|FG001|Overall Study|Non-compliance|0|||
148903869|NCT00918255|537132946|FG002|Overall Study|Non-compliance|0|||
148903870|NCT00918255|537132944|FG000|Overall Study|Investigator discretion|1|||
148903871|NCT00918255|537132945|FG001|Overall Study|Investigator discretion|0|||
148903872|NCT00918255|537132946|FG002|Overall Study|Investigator discretion|0|||
148903873|NCT02038933|537132947|FG000|Overall Study|Disease progression|104|||
148903874|NCT02038933|537132947|FG000|Overall Study|Study drug toxicity|6|||
148903875|NCT02038933|537132947|FG000|Overall Study|Adverse event unrelated to study drug|6|||
148903876|NCT02038933|537132947|FG000|Overall Study|Participant request to discontinue treatment|2|||
148903877|NCT02038933|537132947|FG000|Overall Study|Lost to Follow-up|1|||
148903878|NCT02038933|537132947|FG000|Overall Study|Other reasons|2|||
148903879|NCT04226742|537132948|FG000|Overall Study|Lost to Follow-up|16|||
148903880|NCT04226742|537132949|FG001|Overall Study|Lost to Follow-up|13|||
148903881|NCT04226742|537132948|FG000|Overall Study|Withdrawal by Subject|5|||
148903882|NCT04226742|537132949|FG001|Overall Study|Withdrawal by Subject|3|||
148903883|NCT01193244|537132952|FG000|Overall Study|Withdrawal by Subject|79|||
148903884|NCT01193244|537132953|FG001|Overall Study|Withdrawal by Subject|97|||
148903885|NCT01193244|537132952|FG000|Overall Study|Other|303|||
148903886|NCT01193244|537132953|FG001|Overall Study|Other|278|||
148903887|NCT01193244|537132952|FG000|Overall Study|Lost to Follow-up|6|||
148903888|NCT01193244|537132953|FG001|Overall Study|Lost to Follow-up|15|||
148903889|NCT01417377|537132954|FG000|Overall Study|Lost to Follow-up|12|||
148903890|NCT01417377|537132954|FG000|Overall Study|Enrolled, but not treated|1|||
148903891|NCT02113982|537132955|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
148903892|NCT02113982|537132956|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
148903893|NCT02113982|537132957|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
148903894|NCT02113982|537132958|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
148903895|NCT02113982|537132959|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
148903896|NCT02113982|537132960|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
148903897|NCT02113982|537132961|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
148903898|NCT02113982|537132962|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
148903899|NCT02113982|537132963|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
148903900|NCT02113982|537132964|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
148903901|NCT02113982|537132965|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
148903902|NCT02113982|537132966|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
148903903|NCT02113982|537132967|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
148903904|NCT02113982|537132968|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
148903905|NCT02113982|537132955|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
148903906|NCT02113982|537132956|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
148903907|NCT02113982|537132957|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
148903908|NCT02113982|537132958|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
148903909|NCT02113982|537132959|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
148903910|NCT02113982|537132960|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
148903911|NCT02113982|537132961|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
148903912|NCT02113982|537132962|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
148903913|NCT02113982|537132963|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
148903914|NCT02113982|537132964|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
148903915|NCT02113982|537132965|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
148903916|NCT02113982|537132966|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
148903917|NCT02113982|537132967|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
148903918|NCT02113982|537132968|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
148903919|NCT02113982|537132955|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903920|NCT02113982|537132956|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903921|NCT02113982|537132957|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903922|NCT02113982|537132958|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903923|NCT02113982|537132959|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903924|NCT02113982|537132960|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903925|NCT02113982|537132961|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
148903926|NCT02113982|537132962|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903927|NCT02113982|537132963|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903928|NCT02113982|537132964|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903929|NCT02113982|537132965|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903930|NCT02113982|537132966|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903931|NCT02113982|537132967|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903932|NCT02113982|537132968|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
148903933|NCT02113982|537132955|FG000|Stage 1: Dose Escalation|Transplant|0|||
148903934|NCT02113982|537132956|FG001|Stage 1: Dose Escalation|Transplant|1|||
148903935|NCT02113982|537132957|FG002|Stage 1: Dose Escalation|Transplant|0|||
148903936|NCT02113982|537132958|FG003|Stage 1: Dose Escalation|Transplant|0|||
148903937|NCT02113982|537132959|FG004|Stage 1: Dose Escalation|Transplant|0|||
148903938|NCT02113982|537132960|FG005|Stage 1: Dose Escalation|Transplant|1|||
148903939|NCT02113982|537132961|FG006|Stage 1: Dose Escalation|Transplant|0|||
148903940|NCT02113982|537132962|FG007|Stage 1: Dose Escalation|Transplant|0|||
148903941|NCT02113982|537132963|FG008|Stage 1: Dose Escalation|Transplant|0|||
148903942|NCT02113982|537132964|FG009|Stage 1: Dose Escalation|Transplant|0|||
148903943|NCT02113982|537132965|FG010|Stage 1: Dose Escalation|Transplant|0|||
148903944|NCT02113982|537132966|FG011|Stage 1: Dose Escalation|Transplant|0|||
148903945|NCT02113982|537132967|FG012|Stage 1: Dose Escalation|Transplant|0|||
148903946|NCT02113982|537132968|FG013|Stage 1: Dose Escalation|Transplant|0|||
148903947|NCT02113982|537132955|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
148903948|NCT02113982|537132956|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
148903949|NCT02113982|537132957|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
148903950|NCT02113982|537132958|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
148903951|NCT02113982|537132959|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
148903952|NCT02113982|537132960|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
148903953|NCT02113982|537132961|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
148903954|NCT02113982|537132962|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
148903955|NCT02113982|537132963|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
148903956|NCT02113982|537132964|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
148903957|NCT02113982|537132965|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
148903958|NCT02113982|537132966|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
148903959|NCT02113982|537132967|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
148903960|NCT02113982|537132968|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
148903961|NCT02113982|537132955|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
148903962|NCT02113982|537132956|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
148903963|NCT02113982|537132957|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
148903964|NCT02113982|537132958|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
148903965|NCT02113982|537132959|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
148903966|NCT02113982|537132960|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
148903967|NCT02113982|537132961|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
148903968|NCT02113982|537132962|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
148903969|NCT02113982|537132963|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
148903970|NCT02113982|537132964|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
148903971|NCT02113982|537132965|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
148903972|NCT02113982|537132966|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
148903973|NCT02113982|537132967|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
148903974|NCT02113982|537132968|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
148903975|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
148903976|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
148903977|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
148903978|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
148903979|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
148903980|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
148903981|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
148903982|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
148903983|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
148903984|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
148903985|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
148903986|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
148903987|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
148903988|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
148903989|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
148903990|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
148903991|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
148903992|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
148903993|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
148903994|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
148903995|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
148903996|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
148903997|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
148903998|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
148903999|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
148904000|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
148904001|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
148904002|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
148904003|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904004|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904005|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904006|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904007|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904008|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904009|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904010|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
148904011|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904012|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
148904013|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
148904014|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904015|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904016|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
148904017|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904018|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904019|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904020|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904021|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904022|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904023|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904024|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
148904025|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904026|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
148904027|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904028|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904029|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904030|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
148904031|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904032|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904033|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904034|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904035|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904036|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904037|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904038|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
148904039|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904040|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904041|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904042|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904043|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904044|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
148904045|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Transplant|0|||
148904046|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Transplant|0|||
148904047|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Transplant|0|||
148904048|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Transplant|0|||
148904049|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Transplant|0|||
148904050|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Transplant|0|||
148904051|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Transplant|0|||
148904052|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Transplant|0|||
148904053|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Transplant|0|||
148904054|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Transplant|4|||
148904055|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Transplant|2|||
148904056|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Transplant|0|||
148904057|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Transplant|0|||
148904058|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Transplant|0|||
148904059|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
148904060|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
148904061|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
148904062|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
148904063|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
148904064|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
148904065|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
148904066|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
148904067|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
148904068|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
148904069|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
148904070|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
148904071|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
148904072|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
148904073|NCT02113982|537132955|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
148904074|NCT02113982|537132956|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
148904075|NCT02113982|537132957|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
148904076|NCT02113982|537132958|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
148904077|NCT02113982|537132959|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
148904078|NCT02113982|537132960|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
148904079|NCT02113982|537132961|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
148904080|NCT02113982|537132962|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
148904081|NCT02113982|537132963|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
148904082|NCT02113982|537132964|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
148904083|NCT02113982|537132965|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
148904084|NCT02113982|537132966|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
148904085|NCT02113982|537132967|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
148904086|NCT02113982|537132968|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
148904087|NCT02113982|537132955|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904088|NCT02113982|537132956|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904089|NCT02113982|537132957|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904090|NCT02113982|537132958|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904091|NCT02113982|537132959|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904092|NCT02113982|537132960|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904093|NCT02113982|537132961|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904094|NCT02113982|537132962|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904095|NCT02113982|537132963|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904096|NCT02113982|537132964|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904097|NCT02113982|537132965|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904098|NCT02113982|537132966|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
148904099|NCT02113982|537132967|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904100|NCT02113982|537132968|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
148904101|NCT02113982|537132955|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904102|NCT02113982|537132956|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904103|NCT02113982|537132957|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904104|NCT02113982|537132958|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904105|NCT02113982|537132959|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904106|NCT02113982|537132960|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904107|NCT02113982|537132961|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904108|NCT02113982|537132962|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904109|NCT02113982|537132963|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
148802296|NCT01462942|536757637|FG000|Overall Study|Withdrawal by Subject|14|||
148802297|NCT01462942|536757638|FG001|Overall Study|Withdrawal by Subject|10|||
148802298|NCT01462942|536757639|FG002|Overall Study|Withdrawal by Subject|14|||
148802299|NCT01462942|536757640|FG003|Overall Study|Withdrawal by Subject|16|||
148802300|NCT01462942|536757641|FG004|Overall Study|Withdrawal by Subject|19|||
148802301|NCT01462942|536757637|FG000|Overall Study|Lack of Efficacy|6|||
148802302|NCT01462942|536757638|FG001|Overall Study|Lack of Efficacy|0|||
148802303|NCT01462942|536757639|FG002|Overall Study|Lack of Efficacy|4|||
148802304|NCT01462942|536757640|FG003|Overall Study|Lack of Efficacy|5|||
148802305|NCT01462942|536757641|FG004|Overall Study|Lack of Efficacy|3|||
148802306|NCT01462942|536757637|FG000|Overall Study|Lost to Follow-up|0|||
148802307|NCT01462942|536757638|FG001|Overall Study|Lost to Follow-up|1|||
148802308|NCT01462942|536757639|FG002|Overall Study|Lost to Follow-up|1|||
148802309|NCT01462942|536757640|FG003|Overall Study|Lost to Follow-up|1|||
148802310|NCT01462942|536757641|FG004|Overall Study|Lost to Follow-up|1|||
148802311|NCT01462942|536757637|FG000|Overall Study|Protocol Violation|4|||
148802312|NCT01462942|536757638|FG001|Overall Study|Protocol Violation|6|||
148802313|NCT01462942|536757639|FG002|Overall Study|Protocol Violation|9|||
148802314|NCT01462942|536757640|FG003|Overall Study|Protocol Violation|9|||
148802315|NCT01462942|536757641|FG004|Overall Study|Protocol Violation|6|||
148802316|NCT02737722|536757642|FG000|Overall Study|Physician Decision|0|||
148802317|NCT02737722|536757643|FG001|Overall Study|Physician Decision|0|||
148802318|NCT02737722|536757644|FG002|Overall Study|Physician Decision|1|||
148802319|NCT02737722|536757645|FG003|Overall Study|Physician Decision|0|||
148802320|NCT02662569|536757648|FG000|Overall Study|Withdrawal by Subject|6|||
148802321|NCT02662569|536757649|FG001|Overall Study|Withdrawal by Subject|1|||
148802322|NCT02662569|536757650|FG002|Overall Study|Withdrawal by Subject|6|||
148802323|NCT02662569|536757651|FG003|Overall Study|Withdrawal by Subject|4|||
148802324|NCT02662569|536757648|FG000|Overall Study|Lost to Follow-up|1|||
148802325|NCT02662569|536757649|FG001|Overall Study|Lost to Follow-up|0|||
148802326|NCT02662569|536757650|FG002|Overall Study|Lost to Follow-up|0|||
148802327|NCT02662569|536757651|FG003|Overall Study|Lost to Follow-up|0|||
148802328|NCT02785939|536757659|FG000|Overall Study|Progression|25|||
148802329|NCT02785939|536757660|FG001|Overall Study|Progression|8|||
148802330|NCT02785939|536757659|FG000|Overall Study|Adverse Event|3|||
148802331|NCT02785939|536757660|FG001|Overall Study|Adverse Event|1|||
148802332|NCT02785939|536757659|FG000|Overall Study|Death|1|||
148802333|NCT02785939|536757660|FG001|Overall Study|Death|0|||
148802334|NCT02785939|536757659|FG000|Overall Study|Refusal|1|||
148802335|NCT02785939|536757660|FG001|Overall Study|Refusal|0|||
148802336|NCT02785939|536757659|FG000|Overall Study|Deteriorating health|1|||
148802337|NCT02785939|536757660|FG001|Overall Study|Deteriorating health|0|||
148802338|NCT02785939|536757659|FG000|Overall Study|Not protocol specified|0|||
148802339|NCT02785939|536757660|FG001|Overall Study|Not protocol specified|1|||
148802340|NCT01787552|536757663|FG000|Overall Study|Withdrawal by Subject|2|||
148802341|NCT01787552|536757664|FG001|Overall Study|Withdrawal by Subject|0|||
148802342|NCT01787552|536757665|FG002|Overall Study|Withdrawal by Subject|0|||
148802343|NCT01787552|536757666|FG003|Overall Study|Withdrawal by Subject|4|||
148802344|NCT01787552|536757663|FG000|Overall Study|Physician Decision|2|||
148802345|NCT01787552|536757664|FG001|Overall Study|Physician Decision|2|||
148802346|NCT01787552|536757665|FG002|Overall Study|Physician Decision|1|||
148802347|NCT01787552|536757666|FG003|Overall Study|Physician Decision|2|||
148802348|NCT01787552|536757663|FG000|Overall Study|Death|0|||
148802349|NCT01787552|536757664|FG001|Overall Study|Death|0|||
148904110|NCT02113982|537132964|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904111|NCT02113982|537132965|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
148802350|NCT01787552|536757665|FG002|Overall Study|Death|0|||
148802351|NCT01787552|536757666|FG003|Overall Study|Death|1|||
148802352|NCT01787552|536757663|FG000|Overall Study|Adverse Event|2|||
148802353|NCT01787552|536757664|FG001|Overall Study|Adverse Event|5|||
148802354|NCT01787552|536757665|FG002|Overall Study|Adverse Event|2|||
148802355|NCT01787552|536757666|FG003|Overall Study|Adverse Event|16|||
148802356|NCT01787552|536757663|FG000|Overall Study|Study terminated by Sponsor|0|||
148802357|NCT01787552|536757664|FG001|Overall Study|Study terminated by Sponsor|0|||
148802358|NCT01787552|536757665|FG002|Overall Study|Study terminated by Sponsor|1|||
148802359|NCT01787552|536757666|FG003|Overall Study|Study terminated by Sponsor|3|||
148802360|NCT01787552|536757663|FG000|Overall Study|Progressive Disease|2|||
148802361|NCT01787552|536757664|FG001|Overall Study|Progressive Disease|2|||
148802362|NCT01787552|536757665|FG002|Overall Study|Progressive Disease|1|||
148802363|NCT01787552|536757666|FG003|Overall Study|Progressive Disease|1|||
148802364|NCT03786380|536757669|FG000|Overall Study|Adverse Event|1|||
148802365|NCT03786380|536757670|FG001|Overall Study|Adverse Event|0|||
148802366|NCT03786380|536757671|FG002|Overall Study|Adverse Event|0|||
148802367|NCT03786380|536757672|FG003|Overall Study|Adverse Event|3|||
148802368|NCT03786380|536757673|FG004|Overall Study|Adverse Event|1|||
148802369|NCT03786380|536757669|FG000|Overall Study|Lack of Efficacy|0|||
148802370|NCT03786380|536757670|FG001|Overall Study|Lack of Efficacy|0|||
148802371|NCT03786380|536757671|FG002|Overall Study|Lack of Efficacy|0|||
148802372|NCT03786380|536757672|FG003|Overall Study|Lack of Efficacy|0|||
148802373|NCT03786380|536757673|FG004|Overall Study|Lack of Efficacy|1|||
148802374|NCT03786380|536757669|FG000|Overall Study|Withdrawal by Subject|1|||
148802375|NCT03786380|536757670|FG001|Overall Study|Withdrawal by Subject|2|||
148802376|NCT03786380|536757671|FG002|Overall Study|Withdrawal by Subject|2|||
148802377|NCT03786380|536757672|FG003|Overall Study|Withdrawal by Subject|1|||
148802378|NCT03786380|536757673|FG004|Overall Study|Withdrawal by Subject|2|||
148802379|NCT03786380|536757669|FG000|Overall Study|Lost to Follow-up|3|||
148802380|NCT03786380|536757670|FG001|Overall Study|Lost to Follow-up|0|||
148802381|NCT03786380|536757671|FG002|Overall Study|Lost to Follow-up|1|||
148802382|NCT03786380|536757672|FG003|Overall Study|Lost to Follow-up|2|||
148802383|NCT03786380|536757673|FG004|Overall Study|Lost to Follow-up|0|||
148802384|NCT03786380|536757669|FG000|Overall Study|Physician Decision|0|||
148802385|NCT03786380|536757670|FG001|Overall Study|Physician Decision|0|||
148802386|NCT03786380|536757671|FG002|Overall Study|Physician Decision|1|||
148802387|NCT03786380|536757672|FG003|Overall Study|Physician Decision|0|||
148802388|NCT03786380|536757673|FG004|Overall Study|Physician Decision|0|||
148802389|NCT03786380|536757669|FG000|Overall Study|Study Terminated by the Sponsor|30|||
148802390|NCT03786380|536757670|FG001|Overall Study|Study Terminated by the Sponsor|20|||
148802391|NCT03786380|536757671|FG002|Overall Study|Study Terminated by the Sponsor|50|||
148802392|NCT03786380|536757672|FG003|Overall Study|Study Terminated by the Sponsor|57|||
148802393|NCT03786380|536757673|FG004|Overall Study|Study Terminated by the Sponsor|23|||
148802394|NCT03786380|536757669|FG000|Overall Study|Reason Not Specified|0|||
148802395|NCT03786380|536757670|FG001|Overall Study|Reason Not Specified|0|||
148802396|NCT03786380|536757671|FG002|Overall Study|Reason Not Specified|0|||
148802397|NCT03786380|536757672|FG003|Overall Study|Reason Not Specified|0|||
148802398|NCT03786380|536757673|FG004|Overall Study|Reason Not Specified|1|||
148802399|NCT00423046|536757678|FG000|Overall Study|Other|340|||
148802400|NCT00423046|536757679|FG001|Overall Study|Other|345|||
148802401|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
148802402|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
148802403|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
148802404|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
148802405|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
148802406|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
148802407|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
148904112|NCT02113982|537132966|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
148904113|NCT02113982|537132967|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904114|NCT02113982|537132968|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
148904115|NCT02113982|537132955|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904116|NCT02113982|537132956|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904117|NCT02113982|537132957|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904118|NCT02113982|537132958|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904119|NCT02113982|537132959|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904120|NCT02113982|537132960|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904121|NCT02113982|537132961|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148802408|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
148802409|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
148802410|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
148802411|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
148802412|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
148802413|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
148904122|NCT02113982|537132962|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904123|NCT02113982|537132963|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904124|NCT02113982|537132964|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904125|NCT02113982|537132965|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904126|NCT02113982|537132966|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
148904127|NCT02113982|537132967|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904128|NCT02113982|537132968|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
148904129|NCT02113982|537132955|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
148904130|NCT02113982|537132956|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
148904131|NCT02113982|537132957|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
148904132|NCT02113982|537132958|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
148904133|NCT02113982|537132959|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
148904134|NCT02113982|537132960|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
148904135|NCT02113982|537132961|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
148904136|NCT02113982|537132962|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
148904137|NCT02113982|537132963|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
148904138|NCT02113982|537132964|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
148904139|NCT02113982|537132965|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
148904140|NCT02113982|537132966|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
148904141|NCT02113982|537132967|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
148904142|NCT02113982|537132968|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
148904143|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904144|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904145|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904146|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904147|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904148|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904149|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904150|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904151|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904152|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904153|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904154|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904155|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
148904156|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
148904157|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904158|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904159|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904160|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904161|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904162|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904163|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904164|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904165|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904166|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904167|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904168|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
148904169|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
148904170|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
148904171|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904172|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904173|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904174|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904175|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904176|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904177|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904178|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904179|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904180|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904181|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904182|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
148904183|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
148904184|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
148904185|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904186|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904187|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904188|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904189|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904190|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148802414|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
148802415|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
148802416|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
148802417|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
148802418|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
148802419|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
148802420|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
148802421|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
148802422|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
148802423|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
148802424|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
148802425|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
148802426|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
148802427|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
148802428|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
148802429|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
148802430|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
148802431|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
148802432|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
148802433|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
148802434|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
148802435|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
148802436|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
148802437|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
148802438|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
148802439|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
148802440|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
148802441|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
148802442|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
148802443|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
148802444|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
148802445|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
148802446|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
148802447|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
148802448|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
148802449|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
148802450|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
148802451|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
148802452|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
148802453|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
148802454|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
148802455|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
148802456|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
148802457|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
148802458|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
148802459|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
148802460|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
148802461|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
148802462|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
148802463|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
148802464|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
148802465|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
148802466|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
148802467|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
148802468|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
148802469|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
148802470|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
148802471|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
148802472|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
148802473|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
148802474|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
148802475|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
148904191|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904192|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904193|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904194|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904195|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904196|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
148904197|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
148904198|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
148904199|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904200|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904201|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904202|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904203|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904204|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904205|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904206|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904207|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904208|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904209|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904210|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904211|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
148904212|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
148904213|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904214|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904215|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904216|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904217|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904218|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904219|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904220|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904221|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904222|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904223|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904224|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904225|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
148904226|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
148904227|NCT02113982|537132955|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904228|NCT02113982|537132956|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904229|NCT02113982|537132957|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904230|NCT02113982|537132958|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904231|NCT02113982|537132959|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904232|NCT02113982|537132960|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904233|NCT02113982|537132961|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904234|NCT02113982|537132962|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904235|NCT02113982|537132963|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904236|NCT02113982|537132964|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904237|NCT02113982|537132965|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904238|NCT02113982|537132966|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904239|NCT02113982|537132967|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
148904240|NCT02113982|537132968|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
148904241|NCT03040336|537132977|FG000|Overall Study|Death|1|||
148904242|NCT03040336|537132978|FG001|Overall Study|Death|0|||
148904243|NCT03040336|537132977|FG000|Overall Study|Withdrawal by Subject|2|||
148904244|NCT03040336|537132978|FG001|Overall Study|Withdrawal by Subject|3|||
148904245|NCT00068692|537132981|FG000|Step 1: Registration|Disese progression/relapse|5|||
148904246|NCT00068692|537132982|FG001|Step 1: Registration|Disese progression/relapse|0|||
148904247|NCT00068692|537132983|FG002|Step 1: Registration|Disese progression/relapse|0|||
148904248|NCT00068692|537132984|FG003|Step 1: Registration|Disese progression/relapse|0|||
148904249|NCT00068692|537132985|FG004|Step 1: Registration|Disese progression/relapse|0|||
148904250|NCT00068692|537132986|FG005|Step 1: Registration|Disese progression/relapse|0|||
149138447|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
148904251|NCT00068692|537132987|FG006|Step 1: Registration|Disese progression/relapse|0|||
148904252|NCT00068692|537132988|FG007|Step 1: Registration|Disese progression/relapse|0|||
148904253|NCT00068692|537132981|FG000|Step 1: Registration|Adverse Event|7|||
148904254|NCT00068692|537132982|FG001|Step 1: Registration|Adverse Event|0|||
148904255|NCT00068692|537132983|FG002|Step 1: Registration|Adverse Event|0|||
148904256|NCT00068692|537132984|FG003|Step 1: Registration|Adverse Event|0|||
148904257|NCT00068692|537132985|FG004|Step 1: Registration|Adverse Event|0|||
148904258|NCT00068692|537132986|FG005|Step 1: Registration|Adverse Event|0|||
148904259|NCT00068692|537132987|FG006|Step 1: Registration|Adverse Event|0|||
148904260|NCT00068692|537132988|FG007|Step 1: Registration|Adverse Event|0|||
148904261|NCT00068692|537132981|FG000|Step 1: Registration|Death|1|||
148904262|NCT00068692|537132982|FG001|Step 1: Registration|Death|0|||
148904263|NCT00068692|537132983|FG002|Step 1: Registration|Death|0|||
148904264|NCT00068692|537132984|FG003|Step 1: Registration|Death|0|||
148904265|NCT00068692|537132985|FG004|Step 1: Registration|Death|0|||
148904266|NCT00068692|537132986|FG005|Step 1: Registration|Death|0|||
148904267|NCT00068692|537132987|FG006|Step 1: Registration|Death|0|||
148904268|NCT00068692|537132988|FG007|Step 1: Registration|Death|0|||
148904269|NCT00068692|537132981|FG000|Step 1: Registration|Withdrawal by Subject|11|||
148904270|NCT00068692|537132982|FG001|Step 1: Registration|Withdrawal by Subject|0|||
148904271|NCT00068692|537132983|FG002|Step 1: Registration|Withdrawal by Subject|0|||
148904272|NCT00068692|537132984|FG003|Step 1: Registration|Withdrawal by Subject|0|||
148904273|NCT00068692|537132985|FG004|Step 1: Registration|Withdrawal by Subject|0|||
148904274|NCT00068692|537132986|FG005|Step 1: Registration|Withdrawal by Subject|0|||
148904275|NCT00068692|537132987|FG006|Step 1: Registration|Withdrawal by Subject|0|||
148904276|NCT00068692|537132988|FG007|Step 1: Registration|Withdrawal by Subject|0|||
148904277|NCT00068692|537132981|FG000|Step 1: Registration|Alternative therapy|2|||
148904278|NCT00068692|537132982|FG001|Step 1: Registration|Alternative therapy|0|||
148904279|NCT00068692|537132983|FG002|Step 1: Registration|Alternative therapy|0|||
148904280|NCT00068692|537132984|FG003|Step 1: Registration|Alternative therapy|0|||
148904281|NCT00068692|537132985|FG004|Step 1: Registration|Alternative therapy|0|||
148904282|NCT00068692|537132986|FG005|Step 1: Registration|Alternative therapy|0|||
148904283|NCT00068692|537132987|FG006|Step 1: Registration|Alternative therapy|0|||
148904284|NCT00068692|537132988|FG007|Step 1: Registration|Alternative therapy|0|||
148904285|NCT00068692|537132981|FG000|Step 1: Registration|Complicating disease|2|||
148904286|NCT00068692|537132982|FG001|Step 1: Registration|Complicating disease|0|||
148904287|NCT00068692|537132983|FG002|Step 1: Registration|Complicating disease|0|||
148904288|NCT00068692|537132984|FG003|Step 1: Registration|Complicating disease|0|||
148904289|NCT00068692|537132985|FG004|Step 1: Registration|Complicating disease|0|||
148904290|NCT00068692|537132986|FG005|Step 1: Registration|Complicating disease|0|||
148904291|NCT00068692|537132987|FG006|Step 1: Registration|Complicating disease|0|||
148904292|NCT00068692|537132988|FG007|Step 1: Registration|Complicating disease|0|||
148904293|NCT00068692|537132981|FG000|Step 1: Registration|Protocol Violation|1|||
148904294|NCT00068692|537132982|FG001|Step 1: Registration|Protocol Violation|0|||
148904295|NCT00068692|537132983|FG002|Step 1: Registration|Protocol Violation|0|||
148904296|NCT00068692|537132984|FG003|Step 1: Registration|Protocol Violation|0|||
148904297|NCT00068692|537132985|FG004|Step 1: Registration|Protocol Violation|0|||
148904298|NCT00068692|537132986|FG005|Step 1: Registration|Protocol Violation|0|||
148904299|NCT00068692|537132987|FG006|Step 1: Registration|Protocol Violation|0|||
148904300|NCT00068692|537132988|FG007|Step 1: Registration|Protocol Violation|0|||
148904301|NCT00068692|537132981|FG000|Step 1: Registration|Not eligible|6|||
148904302|NCT00068692|537132982|FG001|Step 1: Registration|Not eligible|0|||
148904303|NCT00068692|537132983|FG002|Step 1: Registration|Not eligible|0|||
148904304|NCT00068692|537132984|FG003|Step 1: Registration|Not eligible|0|||
148904305|NCT00068692|537132985|FG004|Step 1: Registration|Not eligible|0|||
148904306|NCT00068692|537132986|FG005|Step 1: Registration|Not eligible|0|||
148904307|NCT00068692|537132987|FG006|Step 1: Registration|Not eligible|0|||
148904308|NCT00068692|537132988|FG007|Step 1: Registration|Not eligible|0|||
148904309|NCT00068692|537132981|FG000|Step 1: Registration|Other|2|||
148904310|NCT00068692|537132982|FG001|Step 1: Registration|Other|0|||
148904311|NCT00068692|537132983|FG002|Step 1: Registration|Other|0|||
148904312|NCT00068692|537132984|FG003|Step 1: Registration|Other|0|||
148904313|NCT00068692|537132985|FG004|Step 1: Registration|Other|0|||
148904314|NCT00068692|537132986|FG005|Step 1: Registration|Other|0|||
148904315|NCT00068692|537132987|FG006|Step 1: Registration|Other|0|||
148904316|NCT00068692|537132988|FG007|Step 1: Registration|Other|0|||
148904317|NCT00068692|537132981|FG000|Step 1: Registration|Not start protocol therapy|3|||
148904318|NCT00068692|537132982|FG001|Step 1: Registration|Not start protocol therapy|0|||
148904319|NCT00068692|537132983|FG002|Step 1: Registration|Not start protocol therapy|0|||
148904320|NCT00068692|537132984|FG003|Step 1: Registration|Not start protocol therapy|0|||
148904321|NCT00068692|537132985|FG004|Step 1: Registration|Not start protocol therapy|0|||
148904322|NCT00068692|537132986|FG005|Step 1: Registration|Not start protocol therapy|0|||
148904323|NCT00068692|537132987|FG006|Step 1: Registration|Not start protocol therapy|0|||
148904324|NCT00068692|537132988|FG007|Step 1: Registration|Not start protocol therapy|0|||
148904325|NCT00068692|537132981|FG000|Step 1: Registration|Registered but not randomized|0|||
148904326|NCT00068692|537132982|FG001|Step 1: Registration|Registered but not randomized|1|||
148904327|NCT00068692|537132983|FG002|Step 1: Registration|Registered but not randomized|0|||
148904328|NCT00068692|537132984|FG003|Step 1: Registration|Registered but not randomized|0|||
148904329|NCT00068692|537132985|FG004|Step 1: Registration|Registered but not randomized|0|||
148904330|NCT00068692|537132986|FG005|Step 1: Registration|Registered but not randomized|0|||
148904331|NCT00068692|537132987|FG006|Step 1: Registration|Registered but not randomized|0|||
148904332|NCT00068692|537132988|FG007|Step 1: Registration|Registered but not randomized|0|||
148904333|NCT00068692|537132981|FG000|Step 2: Randomization|Disesae progression/replase|0|||
148904334|NCT00068692|537132982|FG001|Step 2: Randomization|Disesae progression/replase|0|||
148904335|NCT00068692|537132983|FG002|Step 2: Randomization|Disesae progression/replase|1|||
148904336|NCT00068692|537132984|FG003|Step 2: Randomization|Disesae progression/replase|1|||
148904337|NCT00068692|537132985|FG004|Step 2: Randomization|Disesae progression/replase|0|||
148904338|NCT00068692|537132986|FG005|Step 2: Randomization|Disesae progression/replase|0|||
148904339|NCT00068692|537132987|FG006|Step 2: Randomization|Disesae progression/replase|0|||
148904340|NCT00068692|537132988|FG007|Step 2: Randomization|Disesae progression/replase|0|||
148904341|NCT00068692|537132981|FG000|Step 2: Randomization|Adverse Event|0|||
148904342|NCT00068692|537132982|FG001|Step 2: Randomization|Adverse Event|0|||
148904343|NCT00068692|537132983|FG002|Step 2: Randomization|Adverse Event|4|||
148904344|NCT00068692|537132984|FG003|Step 2: Randomization|Adverse Event|2|||
148904345|NCT00068692|537132985|FG004|Step 2: Randomization|Adverse Event|2|||
148904346|NCT00068692|537132986|FG005|Step 2: Randomization|Adverse Event|3|||
148904347|NCT00068692|537132987|FG006|Step 2: Randomization|Adverse Event|4|||
148904348|NCT00068692|537132988|FG007|Step 2: Randomization|Adverse Event|4|||
148904349|NCT00068692|537132981|FG000|Step 2: Randomization|Death|0|||
148904350|NCT00068692|537132982|FG001|Step 2: Randomization|Death|0|||
148904351|NCT00068692|537132983|FG002|Step 2: Randomization|Death|0|||
148904352|NCT00068692|537132984|FG003|Step 2: Randomization|Death|0|||
148904353|NCT00068692|537132985|FG004|Step 2: Randomization|Death|1|||
148904354|NCT00068692|537132986|FG005|Step 2: Randomization|Death|0|||
148904355|NCT00068692|537132987|FG006|Step 2: Randomization|Death|0|||
148904356|NCT00068692|537132988|FG007|Step 2: Randomization|Death|1|||
148904357|NCT00068692|537132981|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
148802476|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
148802477|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
148802478|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
148802479|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
148802480|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
148802481|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
148802482|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
148802483|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
148802484|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
148802485|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
148802486|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
148802487|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
148802488|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
148802489|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
148802490|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
148802491|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
148802492|NCT01791595|536757680|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
148802493|NCT01791595|536757681|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
148802494|NCT01791595|536757682|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
148802495|NCT01791595|536757683|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
148802496|NCT01791595|536757684|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
148802497|NCT01791595|536757685|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
148802498|NCT01791595|536757686|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
148802499|NCT01791595|536757680|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
148802500|NCT01791595|536757681|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
148802501|NCT01791595|536757682|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
148802502|NCT01791595|536757683|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
148802503|NCT01791595|536757684|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
148802504|NCT01791595|536757685|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
148802505|NCT01791595|536757686|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
148802506|NCT01791595|536757680|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
148802507|NCT01791595|536757681|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
148802508|NCT01791595|536757682|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
148802509|NCT01791595|536757683|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
148802510|NCT01791595|536757684|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
148802511|NCT01791595|536757685|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
148802512|NCT01791595|536757686|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
148802513|NCT01791595|536757680|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
148904358|NCT00068692|537132982|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
148904359|NCT00068692|537132983|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
148904360|NCT00068692|537132984|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
148904361|NCT00068692|537132985|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
148904362|NCT00068692|537132986|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
148904363|NCT00068692|537132987|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
148904364|NCT00068692|537132988|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
148904365|NCT00068692|537132981|FG000|Step 2: Randomization|alternative therapy|0|||
148904366|NCT00068692|537132982|FG001|Step 2: Randomization|alternative therapy|0|||
148904367|NCT00068692|537132983|FG002|Step 2: Randomization|alternative therapy|0|||
148904368|NCT00068692|537132984|FG003|Step 2: Randomization|alternative therapy|1|||
148904369|NCT00068692|537132985|FG004|Step 2: Randomization|alternative therapy|1|||
148904370|NCT00068692|537132986|FG005|Step 2: Randomization|alternative therapy|0|||
148904371|NCT00068692|537132987|FG006|Step 2: Randomization|alternative therapy|0|||
148904372|NCT00068692|537132988|FG007|Step 2: Randomization|alternative therapy|0|||
148904373|NCT00068692|537132981|FG000|Step 2: Randomization|Physician Decision|0|||
148904374|NCT00068692|537132982|FG001|Step 2: Randomization|Physician Decision|0|||
148904375|NCT00068692|537132983|FG002|Step 2: Randomization|Physician Decision|0|||
148904376|NCT00068692|537132984|FG003|Step 2: Randomization|Physician Decision|1|||
148904377|NCT00068692|537132985|FG004|Step 2: Randomization|Physician Decision|1|||
148904378|NCT00068692|537132986|FG005|Step 2: Randomization|Physician Decision|0|||
148802514|NCT01791595|536757681|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
148802515|NCT01791595|536757682|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
148802516|NCT01791595|536757683|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
148802517|NCT01791595|536757684|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
148802518|NCT01791595|536757685|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
148802519|NCT01791595|536757686|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
148802520|NCT01791595|536757680|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
148802521|NCT01791595|536757681|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
148802522|NCT01791595|536757682|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
148802523|NCT01791595|536757683|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
148802524|NCT01791595|536757684|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
148802525|NCT01791595|536757685|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
148802526|NCT01791595|536757686|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
148802527|NCT02175121|536757687|FG000|Overall Study|Lack of Efficacy|1|||
148802528|NCT02175121|536757688|FG001|Overall Study|Lack of Efficacy|0|||
148802529|NCT02175121|536757689|FG002|Overall Study|Lack of Efficacy|0|||
148802530|NCT02175121|536757690|FG003|Overall Study|Lack of Efficacy|0|||
148802531|NCT02175121|536757691|FG004|Overall Study|Lack of Efficacy|0|||
148802532|NCT02175121|536757687|FG000|Overall Study|Lost to Follow-up|0|||
148802533|NCT02175121|536757688|FG001|Overall Study|Lost to Follow-up|1|||
148802534|NCT02175121|536757689|FG002|Overall Study|Lost to Follow-up|0|||
148904379|NCT00068692|537132987|FG006|Step 2: Randomization|Physician Decision|0|||
148904380|NCT00068692|537132988|FG007|Step 2: Randomization|Physician Decision|0|||
148904381|NCT00068692|537132981|FG000|Step 2: Randomization|Other|0|||
148904382|NCT00068692|537132982|FG001|Step 2: Randomization|Other|0|||
148904383|NCT00068692|537132983|FG002|Step 2: Randomization|Other|0|||
148904384|NCT00068692|537132984|FG003|Step 2: Randomization|Other|1|||
148904385|NCT00068692|537132985|FG004|Step 2: Randomization|Other|0|||
148904386|NCT00068692|537132986|FG005|Step 2: Randomization|Other|1|||
148904387|NCT00068692|537132987|FG006|Step 2: Randomization|Other|0|||
148904388|NCT00068692|537132988|FG007|Step 2: Randomization|Other|0|||
148904389|NCT00068692|537132981|FG000|Step 2: Randomization|never start protocol therapy|0|||
148904390|NCT00068692|537132982|FG001|Step 2: Randomization|never start protocol therapy|0|||
148904391|NCT00068692|537132983|FG002|Step 2: Randomization|never start protocol therapy|1|||
148904392|NCT00068692|537132984|FG003|Step 2: Randomization|never start protocol therapy|0|||
148904393|NCT00068692|537132985|FG004|Step 2: Randomization|never start protocol therapy|1|||
148904394|NCT00068692|537132986|FG005|Step 2: Randomization|never start protocol therapy|0|||
148904395|NCT00068692|537132987|FG006|Step 2: Randomization|never start protocol therapy|0|||
148904396|NCT00068692|537132988|FG007|Step 2: Randomization|never start protocol therapy|0|||
148904397|NCT03557034|537132991|FG000|Overall Study|Withdrawal by Subject|1|||
148904398|NCT03557034|537132992|FG001|Overall Study|Withdrawal by Subject|0|||
148904399|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
148904400|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
148904401|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Adverse Event|31|||
148904402|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Adverse Event|21|||
148904403|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
148904404|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
148904405|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
148802535|NCT02175121|536757690|FG003|Overall Study|Lost to Follow-up|1|||
148802536|NCT02175121|536757691|FG004|Overall Study|Lost to Follow-up|0|||
148904406|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
148904407|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
148904408|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
148904409|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
148904410|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
148904411|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Administrative problems|3|||
148802537|NCT02175121|536757687|FG000|Overall Study|Personal emergency|0|||
148802538|NCT02175121|536757688|FG001|Overall Study|Personal emergency|0|||
148904412|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Administrative problems|3|||
148904413|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Death|5|||
148904414|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Death|8|||
148904415|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Disease progression|139|||
148904416|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Disease progression|119|||
148904417|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
148904418|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
148904419|NCT00785785|537132995|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
148904420|NCT00785785|537132996|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
148904421|NCT00785785|537132995|FG000|Optional Extension Phase|Adverse Event|4|||
148904422|NCT00785785|537132996|FG001|Optional Extension Phase|Adverse Event|5|||
148904423|NCT00785785|537132995|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
148904424|NCT00785785|537132996|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
148904425|NCT00785785|537132995|FG000|Optional Extension Phase|Lost to Follow-up|1|||
148904426|NCT00785785|537132996|FG001|Optional Extension Phase|Lost to Follow-up|0|||
148904427|NCT00785785|537132995|FG000|Optional Extension Phase|Administrative problems|2|||
148904428|NCT00785785|537132996|FG001|Optional Extension Phase|Administrative problems|0|||
148904429|NCT00785785|537132995|FG000|Optional Extension Phase|Death|1|||
148904430|NCT00785785|537132996|FG001|Optional Extension Phase|Death|5|||
148904431|NCT00785785|537132995|FG000|Optional Extension Phase|Disease progression|22|||
148904432|NCT00785785|537132996|FG001|Optional Extension Phase|Disease progression|70|||
148904433|NCT00785785|537132995|FG000|Optional Extension Phase|Protocol deviation|0|||
148904434|NCT00785785|537132996|FG001|Optional Extension Phase|Protocol deviation|2|||
148904435|NCT00785785|537132995|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
148904436|NCT00785785|537132996|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
148904437|NCT00521404|537132997|FG000|Overall Study|Adverse Event|13|||
148904438|NCT00521404|537132997|FG000|Overall Study|Disease Progression|33|||
148904439|NCT00521404|537132997|FG000|Overall Study|Investigator decision|5|||
148904440|NCT00521404|537132997|FG000|Overall Study|Withdrawal of consent|3|||
148802539|NCT02175121|536757689|FG002|Overall Study|Personal emergency|0|||
148802540|NCT02175121|536757690|FG003|Overall Study|Personal emergency|0|||
148802541|NCT02175121|536757691|FG004|Overall Study|Personal emergency|1|||
148802542|NCT02175121|536757687|FG000|Overall Study|Schedule conflict|0|||
148802543|NCT02175121|536757688|FG001|Overall Study|Schedule conflict|0|||
148802544|NCT02175121|536757689|FG002|Overall Study|Schedule conflict|1|||
148802545|NCT02175121|536757690|FG003|Overall Study|Schedule conflict|0|||
148802546|NCT02175121|536757691|FG004|Overall Study|Schedule conflict|0|||
148802547|NCT02175121|536757687|FG000|Overall Study|Time issues|0|||
148802548|NCT02175121|536757688|FG001|Overall Study|Time issues|0|||
148802549|NCT02175121|536757689|FG002|Overall Study|Time issues|1|||
148802550|NCT02175121|536757690|FG003|Overall Study|Time issues|0|||
148802551|NCT02175121|536757691|FG004|Overall Study|Time issues|0|||
148802552|NCT03329885|536757692|FG000|Overall Study|Sponsor discontinued the study early|0|||
148802553|NCT03329885|536757693|FG001|Overall Study|Sponsor discontinued the study early|0|||
148802554|NCT03329885|536757694|FG002|Overall Study|Sponsor discontinued the study early|0|||
148802555|NCT03329885|536757695|FG003|Overall Study|Sponsor discontinued the study early|0|||
148802556|NCT03329885|536757696|FG004|Overall Study|Sponsor discontinued the study early|0|||
148802557|NCT03329885|536757697|FG005|Overall Study|Sponsor discontinued the study early|0|||
148802558|NCT03329885|536757698|FG006|Overall Study|Sponsor discontinued the study early|1|||
148802559|NCT03329885|536757699|FG007|Overall Study|Sponsor discontinued the study early|1|||
148802560|NCT03329885|536757700|FG008|Overall Study|Sponsor discontinued the study early|0|||
148802561|NCT02027025|536757705|FG000|Overall Study|Adverse Event|0|||
148802562|NCT02027025|536757706|FG001|Overall Study|Adverse Event|1|||
148802563|NCT02027025|536757707|FG002|Overall Study|Adverse Event|1|||
148802564|NCT02027025|536757705|FG000|Overall Study|Protocol Violation|1|||
148802565|NCT02027025|536757706|FG001|Overall Study|Protocol Violation|0|||
148802566|NCT02027025|536757707|FG002|Overall Study|Protocol Violation|0|||
148802567|NCT02027025|536757705|FG000|Overall Study|Lost to Follow-up|0|||
148802568|NCT02027025|536757706|FG001|Overall Study|Lost to Follow-up|2|||
148802569|NCT02027025|536757707|FG002|Overall Study|Lost to Follow-up|0|||
148802570|NCT02027025|536757705|FG000|Overall Study|Withdrawal by Subject|0|||
148802571|NCT02027025|536757706|FG001|Overall Study|Withdrawal by Subject|1|||
148802572|NCT02027025|536757707|FG002|Overall Study|Withdrawal by Subject|0|||
148802573|NCT02027025|536757705|FG000|Overall Study|Sponsor's decision|0|||
148802574|NCT02027025|536757706|FG001|Overall Study|Sponsor's decision|1|||
148802575|NCT02027025|536757707|FG002|Overall Study|Sponsor's decision|0|||
148802576|NCT01118052|536757710|FG000|Overall Study|Never treated|2|||
148802577|NCT00843492|536757713|FG000|Overall Study|Adverse Event|0|||
148802578|NCT00843492|536757714|FG001|Overall Study|Adverse Event|3|||
148904441|NCT00521404|537132997|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
148904442|NCT00521404|537132997|FG000|Overall Study|Other|7|||
148802579|NCT00843492|536757713|FG000|Overall Study|Lost to Follow-up|4|||
148802580|NCT00843492|536757714|FG001|Overall Study|Lost to Follow-up|4|||
148904443|NCT00882557|537132998|FG000|Overall Study|Withdrawal by Subject|1|||
148904444|NCT00882557|537132999|FG001|Overall Study|Withdrawal by Subject|0|||
148904445|NCT00882557|537132998|FG000|Overall Study|Trouble with Vein Access|1|||
148904446|NCT00882557|537132999|FG001|Overall Study|Trouble with Vein Access|0|||
148904447|NCT00882557|537132998|FG000|Overall Study|Randomized Not Treated|0|||
148904448|NCT00882557|537132999|FG001|Overall Study|Randomized Not Treated|1|||
148904449|NCT01383356|537133002|FG000|Period 1|Adverse Event|5|||
148904450|NCT01383356|537133003|FG001|Period 1|Adverse Event|3|||
148904451|NCT01383356|537133002|FG000|Period 1|Non-compliance|3|||
148904452|NCT01383356|537133003|FG001|Period 1|Non-compliance|0|||
148904453|NCT01383356|537133002|FG000|Period 1|Out of Range Mid-study-Test|0|||
148904454|NCT01383356|537133003|FG001|Period 1|Out of Range Mid-study-Test|1|||
148904455|NCT01383356|537133002|FG000|Period 1|Personal|0|||
148904456|NCT01383356|537133003|FG001|Period 1|Personal|2|||
148904457|NCT03584789|537133004|FG000|Overall Study|refused EHR permission|19|||
148904458|NCT03584789|537133005|FG001|Overall Study|refused EHR permission|28|||
148904459|NCT03584789|537133006|FG002|Overall Study|refused EHR permission|23|||
148904460|NCT03584789|537133004|FG000|Overall Study|patients tied to a provider who retired|0|||
148904461|NCT03584789|537133005|FG001|Overall Study|patients tied to a provider who retired|0|||
148904462|NCT03584789|537133006|FG002|Overall Study|patients tied to a provider who retired|3|||
148904463|NCT00602472|537133008|FG000|Overall Study|Adverse Event|5|||
148904464|NCT00602472|537133009|FG001|Overall Study|Adverse Event|23|||
148904465|NCT00602472|537133008|FG000|Overall Study|Protocol Violation|4|||
148904466|NCT00602472|537133009|FG001|Overall Study|Protocol Violation|19|||
148904467|NCT00602472|537133008|FG000|Overall Study|Withdrawal by Subject|8|||
148904468|NCT00602472|537133009|FG001|Overall Study|Withdrawal by Subject|14|||
148904469|NCT00602472|537133008|FG000|Overall Study|Other incl. lack of efficacy|4|||
148904470|NCT00602472|537133009|FG001|Overall Study|Other incl. lack of efficacy|2|||
148904471|NCT01908803|537133014|FG000|Overall Study|Adverse Event|1|||
148904472|NCT01908803|537133015|FG001|Overall Study|Adverse Event|0|||
148904473|NCT01908803|537133014|FG000|Overall Study|Physician Decision|0|||
148904474|NCT01908803|537133015|FG001|Overall Study|Physician Decision|1|||
148904475|NCT01908803|537133014|FG000|Overall Study|Withdrawal by Subject|1|||
148904476|NCT01908803|537133015|FG001|Overall Study|Withdrawal by Subject|0|||
148904477|NCT01908803|537133014|FG000|Overall Study|Randomization Error|1|||
148904478|NCT01908803|537133015|FG001|Overall Study|Randomization Error|0|||
148904479|NCT01908803|537133014|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
148904480|NCT01908803|537133015|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
148904481|NCT00823615|537133016|FG000|Period 2|Lost to Follow-up|2|||
148904482|NCT00823615|537133017|FG001|Period 2|Lost to Follow-up|0|||
148904483|NCT00823615|537133016|FG000|Period 2|Time/Job Conflict|1|||
148904484|NCT00823615|537133017|FG001|Period 2|Time/Job Conflict|2|||
148904485|NCT02404025|537133018|FG000|Overall Study|Adverse Event|1|||
148904486|NCT02404025|537133018|FG000|Overall Study|Lack of Efficacy|3|||
148802581|NCT00843492|536757713|FG000|Overall Study|Withdrawal by Subject|0|||
148802582|NCT00843492|536757714|FG001|Overall Study|Withdrawal by Subject|4|||
148802583|NCT00843492|536757713|FG000|Overall Study|Immobilization Stopped|1|||
148802584|NCT00843492|536757714|FG001|Overall Study|Immobilization Stopped|0|||
148802585|NCT00843492|536757713|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
148802586|NCT00843492|536757714|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
148802587|NCT00843492|536757713|FG000|Overall Study|Orthopedic Surgery|0|||
148802588|NCT00843492|536757714|FG001|Overall Study|Orthopedic Surgery|2|||
148802589|NCT00843492|536757713|FG000|Overall Study|Visit Not Performed|1|||
148802590|NCT00843492|536757714|FG001|Overall Study|Visit Not Performed|0|||
148802591|NCT00843492|536757713|FG000|Overall Study|Deep-vein Thrombosis|1|||
148802592|NCT00843492|536757714|FG001|Overall Study|Deep-vein Thrombosis|0|||
148802593|NCT00369343|536757715|FG000|Double-blind Phase|Adverse Event|19|||
148802594|NCT00369343|536757716|FG001|Double-blind Phase|Adverse Event|4|||
148802595|NCT00369343|536757715|FG000|Double-blind Phase|Failed to return|2|||
148802596|NCT00369343|536757716|FG001|Double-blind Phase|Failed to return|0|||
148802597|NCT00369343|536757715|FG000|Double-blind Phase|Lost to Follow-up|9|||
148802598|NCT00369343|536757716|FG001|Double-blind Phase|Lost to Follow-up|2|||
148802599|NCT00369343|536757715|FG000|Double-blind Phase|Protocol Violation|2|||
148802600|NCT00369343|536757716|FG001|Double-blind Phase|Protocol Violation|0|||
148802601|NCT00369343|536757715|FG000|Double-blind Phase|Withdrawal by Subject|8|||
148802602|NCT00369343|536757716|FG001|Double-blind Phase|Withdrawal by Subject|6|||
148802603|NCT00369343|536757715|FG000|Double-blind Phase|Lack of Efficacy|0|||
148904487|NCT00098813|537133019|FG000|Overall Study|Death|8|||
148904488|NCT00098813|537133019|FG000|Overall Study|Protocol Violation|1|||
148904489|NCT00098813|537133019|FG000|Overall Study|Withdrawal by Subject|7|||
148904490|NCT00098813|537133019|FG000|Overall Study|Progression of Disease|1|||
148904491|NCT00098813|537133019|FG000|Overall Study|Other complicating disease|1|||
148904492|NCT00098813|537133019|FG000|Overall Study|Reversal of RAI resistance|1|||
148904493|NCT00956007|537133021|FG000|Overall Study|Protocol Violation|27|||
148904494|NCT00956007|537133022|FG001|Overall Study|Protocol Violation|23|||
148904495|NCT01750229|537133023|FG000|Randomized Crossover Phase|Adverse Event|1|||
148904496|NCT01750229|537133023|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
148904497|NCT01750229|537133023|FG000|Long-term Follow-up Phase|Adverse Event|2|||
148904498|NCT01750229|537133023|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
148904499|NCT01285323|537133024|FG000|Overall Study|Adverse Event|9|||
148904500|NCT01285323|537133025|FG001|Overall Study|Adverse Event|8|||
148904501|NCT01285323|537133024|FG000|Overall Study|Lack of Efficacy|4|||
148904502|NCT01285323|537133025|FG001|Overall Study|Lack of Efficacy|2|||
148904503|NCT01285323|537133024|FG000|Overall Study|Withdrawal by Subject|15|||
148904504|NCT01285323|537133025|FG001|Overall Study|Withdrawal by Subject|11|||
148904505|NCT01285323|537133024|FG000|Overall Study|Protocol Violation|1|||
148904506|NCT01285323|537133025|FG001|Overall Study|Protocol Violation|2|||
148904507|NCT01285323|537133024|FG000|Overall Study|Non-compliance with study procedures|2|||
148904508|NCT01285323|537133025|FG001|Overall Study|Non-compliance with study procedures|3|||
148904509|NCT01285323|537133024|FG000|Overall Study|Lost to Follow-up|1|||
148904510|NCT01285323|537133025|FG001|Overall Study|Lost to Follow-up|1|||
148904511|NCT01285323|537133024|FG000|Overall Study|Other|1|||
148904512|NCT01285323|537133025|FG001|Overall Study|Other|3|||
148904513|NCT02158546|537133027|FG000|Overall Study|Physician Decision|0|||
148904514|NCT02158546|537133028|FG001|Overall Study|Physician Decision|1|||
148904515|NCT02158546|537133029|FG002|Overall Study|Physician Decision|0|||
148904516|NCT02158546|537133030|FG003|Overall Study|Physician Decision|0|||
148904517|NCT02158546|537133027|FG000|Overall Study|Non-compliance|0|||
148904518|NCT02158546|537133028|FG001|Overall Study|Non-compliance|1|||
148904519|NCT02158546|537133029|FG002|Overall Study|Non-compliance|0|||
148904520|NCT02158546|537133030|FG003|Overall Study|Non-compliance|1|||
148904521|NCT02158546|537133027|FG000|Overall Study|Failure to meet eligibility criteria|0|||
148904522|NCT02158546|537133028|FG001|Overall Study|Failure to meet eligibility criteria|1|||
148904523|NCT02158546|537133029|FG002|Overall Study|Failure to meet eligibility criteria|0|||
148904524|NCT02158546|537133030|FG003|Overall Study|Failure to meet eligibility criteria|0|||
148904525|NCT02158546|537133027|FG000|Overall Study|Lack of Efficacy|1|||
148904526|NCT02158546|537133028|FG001|Overall Study|Lack of Efficacy|1|||
148904527|NCT02158546|537133029|FG002|Overall Study|Lack of Efficacy|0|||
148904528|NCT02158546|537133030|FG003|Overall Study|Lack of Efficacy|0|||
148904529|NCT02158546|537133027|FG000|Overall Study|Adverse Event|2|||
148904530|NCT02158546|537133028|FG001|Overall Study|Adverse Event|2|||
148904531|NCT02158546|537133029|FG002|Overall Study|Adverse Event|0|||
148904532|NCT02158546|537133030|FG003|Overall Study|Adverse Event|0|||
148904533|NCT02158546|537133027|FG000|Overall Study|Withdrawal by Subject|6|||
148904534|NCT02158546|537133028|FG001|Overall Study|Withdrawal by Subject|2|||
148904535|NCT02158546|537133029|FG002|Overall Study|Withdrawal by Subject|1|||
148904536|NCT02158546|537133030|FG003|Overall Study|Withdrawal by Subject|0|||
148904537|NCT02158546|537133027|FG000|Overall Study|Lost to Follow-up|5|||
148904538|NCT02158546|537133028|FG001|Overall Study|Lost to Follow-up|4|||
148904539|NCT02158546|537133029|FG002|Overall Study|Lost to Follow-up|0|||
148904540|NCT02158546|537133030|FG003|Overall Study|Lost to Follow-up|1|||
148904541|NCT02158546|537133027|FG000|Overall Study|Site Excluded|5|||
148904542|NCT02158546|537133028|FG001|Overall Study|Site Excluded|5|||
148904543|NCT02158546|537133029|FG002|Overall Study|Site Excluded|3|||
148904544|NCT02158546|537133030|FG003|Overall Study|Site Excluded|4|||
148904545|NCT02351817|537133032|FG000|Period 1|Adverse Event|1|||
148904546|NCT02351817|537133033|FG001|Period 1|Adverse Event|2|||
148904547|NCT02351817|537133032|FG000|Period 1|Lack of Efficacy|0|||
148904548|NCT02351817|537133033|FG001|Period 1|Lack of Efficacy|1|||
148904549|NCT02351817|537133032|FG000|Period 2|Adverse Event|0|||
148904550|NCT02351817|537133033|FG001|Period 2|Adverse Event|2|||
148904551|NCT02351817|537133032|FG000|Period 2|Protocol Violation|1|||
148904552|NCT02351817|537133033|FG001|Period 2|Protocol Violation|0|||
148904553|NCT00803569|537133036|FG000|Overall Study|Progressive Disease|3|||
148904554|NCT00803569|537133036|FG000|Overall Study|Noncompliance|1|||
148904555|NCT02488915|537133037|FG000|Overall Study|Death|21|||
148904556|NCT02488915|537133037|FG000|Overall Study|Lost to Follow-up|4|||
148904557|NCT02488915|537133037|FG000|Overall Study|Withdrawal by Subject|1|||
148904558|NCT04041414|537133038|FG000|Overall Study|Lost to Follow-up|1|||
148904559|NCT04041414|537133039|FG001|Overall Study|Lost to Follow-up|2|||
148904560|NCT00665652|537133040|FG000|Overall Study|Adverse Event|4|||
148904561|NCT00665652|537133040|FG000|Overall Study|Death|1|||
148904562|NCT00665652|537133040|FG000|Overall Study|No longer met inclusion criteria.|1|||
148904563|NCT01663103|537133048|FG000|Overall Study|Withdrawal by Subject|1|||
148904564|NCT01663103|537133049|FG001|Overall Study|Withdrawal by Subject|2|||
148904565|NCT01663103|537133048|FG000|Overall Study|Adverse Event|1|||
148904566|NCT01663103|537133049|FG001|Overall Study|Adverse Event|0|||
148904567|NCT01663103|537133048|FG000|Overall Study|dog bite|1|||
148904568|NCT01663103|537133049|FG001|Overall Study|dog bite|0|||
148904569|NCT01656408|537133050|FG000|Overall Study|Adverse Event|0|||
148904570|NCT01656408|537133051|FG001|Overall Study|Adverse Event|0|||
148904571|NCT01656408|537133052|FG002|Overall Study|Adverse Event|1|||
148904572|NCT01656408|537133053|FG003|Overall Study|Adverse Event|0|||
148904573|NCT01656408|537133054|FG004|Overall Study|Adverse Event|0|||
148904574|NCT01656408|537133055|FG005|Overall Study|Adverse Event|1|||
148904575|NCT01656408|537133056|FG006|Overall Study|Adverse Event|1|||
148904576|NCT01656408|537133057|FG007|Overall Study|Adverse Event|0|||
148904577|NCT01656408|537133058|FG008|Overall Study|Adverse Event|1|||
148904578|NCT01656408|537133059|FG009|Overall Study|Adverse Event|0|||
148904579|NCT01656408|537133050|FG000|Overall Study|Physician Decision|1|||
148904580|NCT01656408|537133051|FG001|Overall Study|Physician Decision|0|||
148904581|NCT01656408|537133052|FG002|Overall Study|Physician Decision|1|||
148904582|NCT01656408|537133053|FG003|Overall Study|Physician Decision|0|||
148904583|NCT01656408|537133054|FG004|Overall Study|Physician Decision|1|||
148904584|NCT01656408|537133055|FG005|Overall Study|Physician Decision|1|||
148904585|NCT01656408|537133056|FG006|Overall Study|Physician Decision|0|||
148904586|NCT01656408|537133057|FG007|Overall Study|Physician Decision|1|||
148904587|NCT01656408|537133058|FG008|Overall Study|Physician Decision|1|||
148904588|NCT01656408|537133059|FG009|Overall Study|Physician Decision|3|||
148904589|NCT02420821|537133062|FG000|Overall Study|Lost to Follow-up|6|||
148904590|NCT02420821|537133063|FG001|Overall Study|Lost to Follow-up|6|||
148904591|NCT02420821|537133062|FG000|Overall Study|Non-compliance|0|||
148904592|NCT02420821|537133063|FG001|Overall Study|Non-compliance|2|||
148904593|NCT02420821|537133062|FG000|Overall Study|Physician Decision|6|||
148904594|NCT02420821|537133063|FG001|Overall Study|Physician Decision|2|||
148904595|NCT02420821|537133062|FG000|Overall Study|Withdrawal by Subject|32|||
148904596|NCT02420821|537133063|FG001|Overall Study|Withdrawal by Subject|25|||
148904597|NCT02420821|537133062|FG000|Overall Study|Death|270|||
148904598|NCT02420821|537133063|FG001|Overall Study|Death|263|||
148904599|NCT02420821|537133062|FG000|Overall Study|Study Terminated By Sponsor|145|||
148904600|NCT02420821|537133063|FG001|Overall Study|Study Terminated By Sponsor|149|||
148904601|NCT02420821|537133062|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
148904602|NCT02420821|537133063|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
148904603|NCT02420821|537133062|FG000|Overall Study|Adverse Event|0|||
148904604|NCT02420821|537133063|FG001|Overall Study|Adverse Event|1|||
148904605|NCT02420821|537133062|FG000|Overall Study|Protinuria|0|||
148904606|NCT02420821|537133063|FG001|Overall Study|Protinuria|1|||
148904607|NCT02420821|537133062|FG000|Overall Study|Progressive Disease|1|||
148904608|NCT02420821|537133063|FG001|Overall Study|Progressive Disease|1|||
148904609|NCT02420821|537133062|FG000|Overall Study|Disease Progression|0|||
148904610|NCT02420821|537133063|FG001|Overall Study|Disease Progression|1|||
148904611|NCT02420821|537133062|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
148904612|NCT02420821|537133063|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
148904613|NCT03815929|537133072|FG000|Overall Study|Lost to Follow-up|2|||
148904614|NCT03815929|537133073|FG001|Overall Study|Lost to Follow-up|1|||
148904615|NCT03815929|537133074|FG002|Overall Study|Lost to Follow-up|0|||
148904616|NCT03815929|537133072|FG000|Overall Study|Physician Decision|2|||
148904617|NCT03815929|537133073|FG001|Overall Study|Physician Decision|2|||
148904618|NCT03815929|537133074|FG002|Overall Study|Physician Decision|0|||
148904619|NCT03815929|537133072|FG000|Overall Study|Withdrawal by Subject|0|||
148904620|NCT03815929|537133073|FG001|Overall Study|Withdrawal by Subject|0|||
148904621|NCT03815929|537133074|FG002|Overall Study|Withdrawal by Subject|1|||
148904622|NCT03313037|537133075|FG000|Overall Study|Protocol Violation|4|||
148904623|NCT03313037|537133076|FG001|Overall Study|Protocol Violation|1|||
148904624|NCT03313037|537133075|FG000|Overall Study|Other|1|||
148904625|NCT03313037|537133076|FG001|Overall Study|Other|1|||
148904626|NCT03313037|537133075|FG000|Overall Study|Withdrawal by Subject|4|||
148904627|NCT03313037|537133076|FG001|Overall Study|Withdrawal by Subject|3|||
148904628|NCT03313037|537133075|FG000|Overall Study|No longer meets eligibility criteria|1|||
148904629|NCT03313037|537133076|FG001|Overall Study|No longer meets eligibility criteria|7|||
148904630|NCT03313037|537133075|FG000|Overall Study|Lost to Follow-up|9|||
148904631|NCT03313037|537133076|FG001|Overall Study|Lost to Follow-up|8|||
148904632|NCT03313037|537133075|FG000|Overall Study|Randomized but not treated|1|||
148904633|NCT03313037|537133076|FG001|Overall Study|Randomized but not treated|0|||
148904634|NCT02760498|537133077|FG000|Overall Study|Adverse Event|3|||
148904635|NCT02760498|537133078|FG001|Overall Study|Adverse Event|3|||
148904636|NCT02760498|537133079|FG002|Overall Study|Adverse Event|1|||
148904637|NCT02760498|537133080|FG003|Overall Study|Adverse Event|1|||
148904638|NCT02760498|537133081|FG004|Overall Study|Adverse Event|0|||
148904639|NCT02760498|537133082|FG005|Overall Study|Adverse Event|6|||
148904640|NCT02760498|537133077|FG000|Overall Study|Death|7|||
148904641|NCT02760498|537133078|FG001|Overall Study|Death|5|||
148904642|NCT02760498|537133079|FG002|Overall Study|Death|5|||
148904643|NCT02760498|537133080|FG003|Overall Study|Death|7|||
148904644|NCT02760498|537133081|FG004|Overall Study|Death|0|||
148904645|NCT02760498|537133082|FG005|Overall Study|Death|23|||
148904646|NCT02760498|537133077|FG000|Overall Study|Lost to Follow-up|0|||
148904647|NCT02760498|537133078|FG001|Overall Study|Lost to Follow-up|0|||
148904648|NCT02760498|537133079|FG002|Overall Study|Lost to Follow-up|0|||
148904649|NCT02760498|537133080|FG003|Overall Study|Lost to Follow-up|0|||
148904650|NCT02760498|537133081|FG004|Overall Study|Lost to Follow-up|0|||
148904651|NCT02760498|537133082|FG005|Overall Study|Lost to Follow-up|3|||
148904652|NCT02760498|537133077|FG000|Overall Study|Non-compliance with study drug|0|||
148904653|NCT02760498|537133078|FG001|Overall Study|Non-compliance with study drug|2|||
148904654|NCT02760498|537133079|FG002|Overall Study|Non-compliance with study drug|0|||
148904655|NCT02760498|537133080|FG003|Overall Study|Non-compliance with study drug|0|||
148904656|NCT02760498|537133081|FG004|Overall Study|Non-compliance with study drug|0|||
148904657|NCT02760498|537133082|FG005|Overall Study|Non-compliance with study drug|0|||
148904658|NCT02760498|537133077|FG000|Overall Study|Participant decision|1|||
148904659|NCT02760498|537133078|FG001|Overall Study|Participant decision|4|||
148904660|NCT02760498|537133079|FG002|Overall Study|Participant decision|2|||
148904661|NCT02760498|537133080|FG003|Overall Study|Participant decision|2|||
148904662|NCT02760498|537133081|FG004|Overall Study|Participant decision|1|||
148904663|NCT02760498|537133082|FG005|Overall Study|Participant decision|6|||
148904664|NCT02760498|537133077|FG000|Overall Study|Sponsor decision|0|||
148904665|NCT02760498|537133078|FG001|Overall Study|Sponsor decision|0|||
148904666|NCT02760498|537133079|FG002|Overall Study|Sponsor decision|0|||
148904667|NCT02760498|537133080|FG003|Overall Study|Sponsor decision|3|||
148904668|NCT02760498|537133081|FG004|Overall Study|Sponsor decision|0|||
148904669|NCT02760498|537133082|FG005|Overall Study|Sponsor decision|0|||
148904670|NCT02760498|537133077|FG000|Overall Study|Physician Decision|3|||
148904671|NCT02760498|537133078|FG001|Overall Study|Physician Decision|4|||
148904672|NCT02760498|537133079|FG002|Overall Study|Physician Decision|1|||
148904673|NCT02760498|537133080|FG003|Overall Study|Physician Decision|4|||
148904674|NCT02760498|537133081|FG004|Overall Study|Physician Decision|0|||
148904675|NCT02760498|537133082|FG005|Overall Study|Physician Decision|2|||
148904676|NCT02760498|537133077|FG000|Overall Study|Disease progression|21|||
148904677|NCT02760498|537133078|FG001|Overall Study|Disease progression|19|||
148904678|NCT02760498|537133079|FG002|Overall Study|Disease progression|20|||
148904679|NCT02760498|537133080|FG003|Overall Study|Disease progression|18|||
148904680|NCT02760498|537133081|FG004|Overall Study|Disease progression|4|||
148904681|NCT02760498|537133082|FG005|Overall Study|Disease progression|55|||
148904682|NCT02760498|537133077|FG000|Overall Study|Withdrawal by Subject|4|||
148904683|NCT02760498|537133078|FG001|Overall Study|Withdrawal by Subject|7|||
148904684|NCT02760498|537133079|FG002|Overall Study|Withdrawal by Subject|5|||
148904685|NCT02760498|537133080|FG003|Overall Study|Withdrawal by Subject|1|||
148904686|NCT02760498|537133081|FG004|Overall Study|Withdrawal by Subject|0|||
148904687|NCT02760498|537133082|FG005|Overall Study|Withdrawal by Subject|6|||
148904688|NCT02760498|537133077|FG000|Overall Study|Other than specified|1|||
148904689|NCT02760498|537133078|FG001|Overall Study|Other than specified|6|||
148904690|NCT02760498|537133079|FG002|Overall Study|Other than specified|0|||
148904691|NCT02760498|537133080|FG003|Overall Study|Other than specified|3|||
148904692|NCT02760498|537133081|FG004|Overall Study|Other than specified|1|||
148904693|NCT02760498|537133082|FG005|Overall Study|Other than specified|0|||
148904694|NCT02760498|537133077|FG000|Overall Study|Not treated|0|||
148904695|NCT02760498|537133078|FG001|Overall Study|Not treated|0|||
148904696|NCT02760498|537133079|FG002|Overall Study|Not treated|0|||
148904697|NCT02760498|537133080|FG003|Overall Study|Not treated|0|||
148904698|NCT02760498|537133081|FG004|Overall Study|Not treated|0|||
148904699|NCT02760498|537133082|FG005|Overall Study|Not treated|2|||
148904700|NCT02202759|537135001|FG000|Overall Study|Study Terminated by Sponsor|3|||
148904701|NCT02202759|537135002|FG001|Overall Study|Study Terminated by Sponsor|3|||
148904702|NCT02202759|537135003|FG002|Overall Study|Study Terminated by Sponsor|3|||
148904703|NCT02202759|537135001|FG000|Overall Study|Withdrawal by Subject|2|||
148904704|NCT02202759|537135002|FG001|Overall Study|Withdrawal by Subject|1|||
148904705|NCT02202759|537135003|FG002|Overall Study|Withdrawal by Subject|1|||
148904706|NCT02202759|537135001|FG000|Overall Study|Reason not Specified|4|||
148904707|NCT02202759|537135002|FG001|Overall Study|Reason not Specified|11|||
148904708|NCT02202759|537135003|FG002|Overall Study|Reason not Specified|10|||
148904709|NCT01646125|537135004|FG000|Overall Study|Untreated|2|||
148904710|NCT01646125|537135005|FG001|Overall Study|Untreated|5|||
148904711|NCT01646125|537135004|FG000|Overall Study|Adverse Event|2|||
148904712|NCT01646125|537135005|FG001|Overall Study|Adverse Event|1|||
148904713|NCT01646125|537135004|FG000|Overall Study|Death|1|||
148904714|NCT01646125|537135005|FG001|Overall Study|Death|1|||
148904715|NCT01646125|537135004|FG000|Overall Study|Physician Decision|1|||
148904716|NCT01646125|537135005|FG001|Overall Study|Physician Decision|3|||
148904717|NCT01646125|537135004|FG000|Overall Study|Progressive disease|22|||
148904718|NCT01646125|537135005|FG001|Overall Study|Progressive disease|16|||
148904719|NCT01646125|537135004|FG000|Overall Study|Study terminated by sponsor|2|||
148904720|NCT01646125|537135005|FG001|Overall Study|Study terminated by sponsor|1|||
148904721|NCT01646125|537135004|FG000|Overall Study|Subject/Guardian decision|1|||
148904722|NCT01646125|537135005|FG001|Overall Study|Subject/Guardian decision|1|||
148904723|NCT00904033|537135008|FG000|Overall Study|Withdrawal by Subject|1|||
148904724|NCT00904033|537135009|FG001|Overall Study|Withdrawal by Subject|1|||
148904725|NCT00904033|537135010|FG002|Overall Study|Withdrawal by Subject|0|||
148904726|NCT00904033|537135011|FG003|Overall Study|Withdrawal by Subject|0|||
148904727|NCT00904033|537135008|FG000|Overall Study|Physician Decision|0|||
148904728|NCT00904033|537135009|FG001|Overall Study|Physician Decision|0|||
148904729|NCT00904033|537135010|FG002|Overall Study|Physician Decision|1|||
148904730|NCT00904033|537135011|FG003|Overall Study|Physician Decision|0|||
148904731|NCT00904033|537135008|FG000|Overall Study|Unable to obtain final blood draw|0|||
148904732|NCT00904033|537135009|FG001|Overall Study|Unable to obtain final blood draw|0|||
148904733|NCT00904033|537135010|FG002|Overall Study|Unable to obtain final blood draw|0|||
148904734|NCT00904033|537135011|FG003|Overall Study|Unable to obtain final blood draw|2|||
148904735|NCT00865566|537135013|FG000|Overall Study|Death|1|||
148904736|NCT00865566|537135014|FG001|Overall Study|Death|11|||
148904737|NCT00865566|537135013|FG000|Overall Study|Lost to Follow-up|314|||
148904738|NCT00865566|537135014|FG001|Overall Study|Lost to Follow-up|315|||
148904739|NCT00865566|537135013|FG000|Overall Study|Withdrawal by Subject|45|||
148904740|NCT00865566|537135014|FG001|Overall Study|Withdrawal by Subject|65|||
148904741|NCT00865566|537135013|FG000|Overall Study|Physician Decision|0|||
148904742|NCT00865566|537135014|FG001|Overall Study|Physician Decision|1|||
148904743|NCT00865566|537135013|FG000|Overall Study|Participant relocated|78|||
148904744|NCT00865566|537135014|FG001|Overall Study|Participant relocated|107|||
148904745|NCT00865566|537135013|FG000|Overall Study|Participant unable to adhere|27|||
148904746|NCT00865566|537135014|FG001|Overall Study|Participant unable to adhere|42|||
148904747|NCT00865566|537135013|FG000|Overall Study|Other; N=245 due to early study closure|154|||
148904748|NCT00865566|537135014|FG001|Overall Study|Other; N=245 due to early study closure|139|||
148904749|NCT00865566|537135013|FG000|Overall Study|HIV infection|5|||
148904750|NCT00865566|537135014|FG001|Overall Study|HIV infection|7|||
148904751|NCT03252925|537135017|FG000|Overall Study|Withdrawal by Subject|1|||
148904752|NCT03252925|537135018|FG001|Overall Study|Withdrawal by Subject|0|||
148904753|NCT03252925|537135017|FG000|Overall Study|Protocol Violation|6|||
148904754|NCT03252925|537135018|FG001|Overall Study|Protocol Violation|0|||
148904755|NCT03252925|537135017|FG000|Overall Study|Adverse Event|1|||
148904756|NCT03252925|537135018|FG001|Overall Study|Adverse Event|0|||
148904757|NCT03252925|537135017|FG000|Overall Study|Lost to Follow-up|6|||
148904758|NCT03252925|537135018|FG001|Overall Study|Lost to Follow-up|6|||
148904759|NCT01002339|537135021|FG000|Overall Study|Withdrawal by Subject|0|||
148904760|NCT01002339|537135022|FG001|Overall Study|Withdrawal by Subject|1|||
148904761|NCT01002339|537135023|FG002|Overall Study|Withdrawal by Subject|0|||
148904762|NCT01002339|537135021|FG000|Overall Study|Incorrect treatment assignment|0|||
148904763|NCT01002339|537135022|FG001|Overall Study|Incorrect treatment assignment|0|||
148904764|NCT01002339|537135023|FG002|Overall Study|Incorrect treatment assignment|1|||
148904765|NCT01002339|537135021|FG000|Overall Study|Protocol Violation|0|||
148904766|NCT01002339|537135022|FG001|Overall Study|Protocol Violation|0|||
148904767|NCT01002339|537135023|FG002|Overall Study|Protocol Violation|2|||
148904768|NCT01002339|537135021|FG000|Overall Study|Lung cancer detected before transplant|0|||
148904769|NCT01002339|537135022|FG001|Overall Study|Lung cancer detected before transplant|0|||
148904770|NCT01002339|537135023|FG002|Overall Study|Lung cancer detected before transplant|1|||
148904771|NCT01002339|537135021|FG000|Overall Study|Randomized. Not transplanted|0|||
148904772|NCT01002339|537135022|FG001|Overall Study|Randomized. Not transplanted|0|||
148904773|NCT01002339|537135023|FG002|Overall Study|Randomized. Not transplanted|1|||
148904774|NCT01907854|537135024|FG000|Overall Study|Protocol Violation|1|||
148904775|NCT01907854|537135025|FG001|Overall Study|Protocol Violation|1|||
148904776|NCT01907854|537135024|FG000|Overall Study|Withdrawal by Subject|9|||
148904777|NCT01907854|537135025|FG001|Overall Study|Withdrawal by Subject|7|||
148904778|NCT01907854|537135024|FG000|Overall Study|Lost to Follow-up|2|||
148904779|NCT01907854|537135025|FG001|Overall Study|Lost to Follow-up|2|||
148904780|NCT01907854|537135024|FG000|Overall Study|Unclassified|4|||
148904781|NCT01907854|537135025|FG001|Overall Study|Unclassified|3|||
148904782|NCT02215252|537135026|FG000|Overall Study|Adverse Event|1|||
148904783|NCT02215252|537135027|FG001|Overall Study|Adverse Event|5|||
148904784|NCT02215252|537135028|FG002|Overall Study|Adverse Event|2|||
148904785|NCT02215252|537135026|FG000|Overall Study|Lost to Follow-up|0|||
148904786|NCT02215252|537135027|FG001|Overall Study|Lost to Follow-up|0|||
148904787|NCT02215252|537135028|FG002|Overall Study|Lost to Follow-up|1|||
148904788|NCT02215252|537135026|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
148904789|NCT02215252|537135027|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
148904790|NCT02215252|537135028|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
148904791|NCT02215252|537135026|FG000|Overall Study|Protocol Violation|0|||
148904792|NCT02215252|537135027|FG001|Overall Study|Protocol Violation|1|||
148904793|NCT02215252|537135028|FG002|Overall Study|Protocol Violation|0|||
148904794|NCT02215252|537135026|FG000|Overall Study|Withdrawal by Subject|1|||
148904795|NCT02215252|537135027|FG001|Overall Study|Withdrawal by Subject|0|||
148904796|NCT02215252|537135028|FG002|Overall Study|Withdrawal by Subject|0|||
148904797|NCT02215252|537135026|FG000|Overall Study|Other|0|||
148904798|NCT02215252|537135027|FG001|Overall Study|Other|1|||
148904799|NCT02215252|537135028|FG002|Overall Study|Other|1|||
148904800|NCT00892099|537135029|FG000|Overall Study|Death|1|||
148904801|NCT00892099|537135030|FG001|Overall Study|Death|0|||
148904802|NCT00892099|537135031|FG002|Overall Study|Death|1|||
148802604|NCT00369343|536757716|FG001|Double-blind Phase|Lack of Efficacy|4|||
148802605|NCT00369343|536757715|FG000|Double-blind Phase|Protocol deviation|4|||
148802606|NCT00369343|536757716|FG001|Double-blind Phase|Protocol deviation|0|||
148802607|NCT00369343|536757715|FG000|Open-label Phase|Adverse Event|19|||
148802608|NCT00369343|536757716|FG001|Open-label Phase|Adverse Event|7|||
148802609|NCT00369343|536757715|FG000|Open-label Phase|Failed to return|4|||
148802610|NCT00369343|536757716|FG001|Open-label Phase|Failed to return|0|||
148802611|NCT00369343|536757715|FG000|Open-label Phase|Physician Decision|2|||
148802612|NCT00369343|536757716|FG001|Open-label Phase|Physician Decision|0|||
148802613|NCT00369343|536757715|FG000|Open-label Phase|Lost to Follow-up|5|||
148802614|NCT00369343|536757716|FG001|Open-label Phase|Lost to Follow-up|3|||
148802615|NCT00369343|536757715|FG000|Open-label Phase|inadvertently reported study completers|3|||
148802616|NCT00369343|536757716|FG001|Open-label Phase|inadvertently reported study completers|2|||
148802617|NCT00369343|536757715|FG000|Open-label Phase|Protocol Violation|1|||
148802618|NCT00369343|536757716|FG001|Open-label Phase|Protocol Violation|3|||
148802619|NCT00369343|536757715|FG000|Open-label Phase|Withdrawal by Subject|15|||
148802620|NCT00369343|536757716|FG001|Open-label Phase|Withdrawal by Subject|6|||
148802621|NCT00369343|536757715|FG000|Open-label Phase|Lack of Efficacy|4|||
148802622|NCT00369343|536757716|FG001|Open-label Phase|Lack of Efficacy|3|||
148802623|NCT00369343|536757715|FG000|Open-label Phase|Lack of continuance tolerability|3|||
148802624|NCT00369343|536757716|FG001|Open-label Phase|Lack of continuance tolerability|4|||
148802625|NCT00369343|536757715|FG000|Open-label Phase|did not take study drug|1|||
148802626|NCT00369343|536757716|FG001|Open-label Phase|did not take study drug|2|||
148802627|NCT00794664|536757717|FG000|Treatment Period|Withdrawal by Subject|0|||
148802628|NCT00794664|536757718|FG001|Treatment Period|Withdrawal by Subject|2|||
148802629|NCT00794664|536757717|FG000|Treatment Period|Protocol non-compliance|0|||
148802630|NCT00794664|536757718|FG001|Treatment Period|Protocol non-compliance|1|||
148802631|NCT00794664|536757717|FG000|Treatment Period|Other|0|||
148802632|NCT00794664|536757718|FG001|Treatment Period|Other|1|||
148802633|NCT00794664|536757717|FG000|Treatment Period|Adverse Event|1|||
148802634|NCT00794664|536757718|FG001|Treatment Period|Adverse Event|8|||
148802635|NCT00794664|536757717|FG000|Follow-up Period|Other|1|||
148802636|NCT00794664|536757718|FG001|Follow-up Period|Other|2|||
148802637|NCT00794664|536757717|FG000|Follow-up Period|Withdrawal by Subject|0|||
148802638|NCT00794664|536757718|FG001|Follow-up Period|Withdrawal by Subject|2|||
148802639|NCT00794664|536757717|FG000|Follow-up Period|Protocol non-compliance|0|||
148802640|NCT00794664|536757718|FG001|Follow-up Period|Protocol non-compliance|1|||
148802641|NCT00828711|536757722|FG000|Overall Study|Lost to Follow-up|1|||
148802642|NCT00828711|536757723|FG001|Overall Study|Lost to Follow-up|0|||
148802643|NCT00828711|536757724|FG002|Overall Study|Lost to Follow-up|0|||
148802644|NCT01618968|536757725|FG000|Overall Study|Adverse Event|1|||
148802645|NCT01618968|536757726|FG001|Overall Study|Adverse Event|0|||
148802646|NCT01618968|536757727|FG002|Overall Study|Adverse Event|0|||
148802647|NCT01618968|536757728|FG003|Overall Study|Adverse Event|0|||
148802648|NCT01618968|536757725|FG000|Overall Study|Death|0|||
148802649|NCT01618968|536757726|FG001|Overall Study|Death|0|||
148802650|NCT01618968|536757727|FG002|Overall Study|Death|0|||
148802651|NCT01618968|536757728|FG003|Overall Study|Death|1|||
148802652|NCT03883386|536757729|FG000|First Assignment|Lost to Follow-up|1|||
148802653|NCT03883386|536757730|FG001|First Assignment|Lost to Follow-up|0|||
148802654|NCT03883386|536757729|FG000|First Assignment|Withdrawal by Subject|1|||
148802655|NCT03883386|536757730|FG001|First Assignment|Withdrawal by Subject|1|||
148802656|NCT01326871|536757731|FG000|Overall Study|Major surgery|0|||
148802657|NCT01326871|536757732|FG001|Overall Study|Major surgery|1|||
148802658|NCT01326871|536757733|FG002|Overall Study|Major surgery|0|||
148802659|NCT01326871|536757731|FG000|Overall Study|SAE and death|0|||
148802660|NCT01326871|536757732|FG001|Overall Study|SAE and death|2|||
148802661|NCT01326871|536757733|FG002|Overall Study|SAE and death|0|||
148802662|NCT01326871|536757731|FG000|Overall Study|Physician decision and decreased performance status|0|||
148802663|NCT01326871|536757732|FG001|Overall Study|Physician decision and decreased performance status|1|||
148802664|NCT01326871|536757733|FG002|Overall Study|Physician decision and decreased performance status|0|||
148802665|NCT01326871|536757731|FG000|Overall Study|Disease progression|0|||
148802666|NCT01326871|536757732|FG001|Overall Study|Disease progression|11|||
148802667|NCT01326871|536757733|FG002|Overall Study|Disease progression|5|||
148802668|NCT01326871|536757731|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
148802669|NCT01326871|536757732|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
148802670|NCT01326871|536757733|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
148802671|NCT01326871|536757731|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
148802672|NCT01326871|536757732|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
148802673|NCT01326871|536757733|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
148802674|NCT01326871|536757731|FG000|Overall Study|Withdrawal by Subject|0|||
148802675|NCT01326871|536757732|FG001|Overall Study|Withdrawal by Subject|1|||
148802676|NCT01326871|536757733|FG002|Overall Study|Withdrawal by Subject|0|||
148802677|NCT01326871|536757731|FG000|Overall Study|DLT|0|||
148802678|NCT01326871|536757732|FG001|Overall Study|DLT|2|||
148802679|NCT01326871|536757733|FG002|Overall Study|DLT|0|||
148904803|NCT00892099|537135029|FG000|Overall Study|Adverse Event|1|||
148904804|NCT00892099|537135030|FG001|Overall Study|Adverse Event|0|||
148904805|NCT00892099|537135031|FG002|Overall Study|Adverse Event|0|||
148904806|NCT00892099|537135029|FG000|Overall Study|replocated|1|||
148904807|NCT00892099|537135030|FG001|Overall Study|replocated|0|||
148904808|NCT00892099|537135031|FG002|Overall Study|replocated|2|||
148904809|NCT00892099|537135029|FG000|Overall Study|Prolonged hospitalization|1|||
148904810|NCT00892099|537135030|FG001|Overall Study|Prolonged hospitalization|0|||
148904811|NCT00892099|537135031|FG002|Overall Study|Prolonged hospitalization|1|||
148904812|NCT00892099|537135029|FG000|Overall Study|no further details|1|||
148904813|NCT00892099|537135030|FG001|Overall Study|no further details|0|||
148904814|NCT00892099|537135031|FG002|Overall Study|no further details|1|||
148904815|NCT00892099|537135029|FG000|Overall Study|kidney function recovered|0|||
148904816|NCT00892099|537135030|FG001|Overall Study|kidney function recovered|1|||
148904817|NCT00892099|537135031|FG002|Overall Study|kidney function recovered|0|||
148904818|NCT00892099|537135029|FG000|Overall Study|investigator decision|0|||
148904819|NCT00892099|537135030|FG001|Overall Study|investigator decision|0|||
148904820|NCT00892099|537135031|FG002|Overall Study|investigator decision|1|||
148904821|NCT00892099|537135029|FG000|Overall Study|Lost to Follow-up|0|||
148904822|NCT00892099|537135030|FG001|Overall Study|Lost to Follow-up|0|||
148904823|NCT00892099|537135031|FG002|Overall Study|Lost to Follow-up|1|||
148904824|NCT01657019|537135032|FG000|Overall Study|Withdrawal by Subject|65|||
148904825|NCT01657019|537135032|FG000|Overall Study|Adverse Event|55|||
148904826|NCT01657019|537135032|FG000|Overall Study|Lost to Follow-up|48|||
148904827|NCT01657019|537135032|FG000|Overall Study|Protocol Violation|6|||
148904828|NCT01657019|537135032|FG000|Overall Study|Lack of Efficacy|3|||
148904829|NCT01657019|537135032|FG000|Overall Study|Other|58|||
148904830|NCT02346721|537135033|FG000|Overall Study|Withdrew Consent|3|||
148904831|NCT02346721|537135033|FG000|Overall Study|Lack of Efficacy|1|||
148904832|NCT00790842|537135034|FG000|Dose Level 1|Adverse Event|1|||
148904833|NCT00790842|537135035|FG001|Dose Level 1|Adverse Event|0|||
148904834|NCT00790842|537135036|FG002|Dose Level 1|Adverse Event|0|||
148904835|NCT00790842|537135037|FG003|Dose Level 1|Adverse Event|2|||
148904836|NCT00790842|537135038|FG004|Dose Level 1|Adverse Event|0|||
148904837|NCT00790842|537135039|FG005|Dose Level 1|Adverse Event|0|||
148904838|NCT00790842|537135040|FG006|Dose Level 1|Adverse Event|0|||
148904839|NCT00790842|537135041|FG007|Dose Level 1|Adverse Event|1|||
148904840|NCT00790842|537135042|FG008|Dose Level 1|Adverse Event|0|||
148904841|NCT00790842|537135043|FG009|Dose Level 1|Adverse Event|0|||
148904842|NCT00790842|537135044|FG010|Dose Level 1|Adverse Event|0|||
148904843|NCT00790842|537135034|FG000|Dose Level 1|Physician Decision|1|||
148904844|NCT00790842|537135035|FG001|Dose Level 1|Physician Decision|0|||
148904845|NCT00790842|537135036|FG002|Dose Level 1|Physician Decision|0|||
148904846|NCT00790842|537135037|FG003|Dose Level 1|Physician Decision|0|||
148904847|NCT00790842|537135038|FG004|Dose Level 1|Physician Decision|0|||
148904848|NCT00790842|537135039|FG005|Dose Level 1|Physician Decision|0|||
148904849|NCT00790842|537135040|FG006|Dose Level 1|Physician Decision|0|||
148904850|NCT00790842|537135041|FG007|Dose Level 1|Physician Decision|1|||
148904851|NCT00790842|537135042|FG008|Dose Level 1|Physician Decision|0|||
148904852|NCT00790842|537135043|FG009|Dose Level 1|Physician Decision|0|||
148904853|NCT00790842|537135044|FG010|Dose Level 1|Physician Decision|0|||
148904854|NCT00790842|537135034|FG000|Dose Level 1|Withdrawal by Subject|1|||
148904855|NCT00790842|537135035|FG001|Dose Level 1|Withdrawal by Subject|0|||
148904856|NCT00790842|537135036|FG002|Dose Level 1|Withdrawal by Subject|0|||
148904857|NCT00790842|537135037|FG003|Dose Level 1|Withdrawal by Subject|0|||
148904858|NCT00790842|537135038|FG004|Dose Level 1|Withdrawal by Subject|0|||
148904859|NCT00790842|537135039|FG005|Dose Level 1|Withdrawal by Subject|0|||
148904860|NCT00790842|537135040|FG006|Dose Level 1|Withdrawal by Subject|0|||
148904861|NCT00790842|537135041|FG007|Dose Level 1|Withdrawal by Subject|0|||
148904862|NCT00790842|537135042|FG008|Dose Level 1|Withdrawal by Subject|0|||
148904863|NCT00790842|537135043|FG009|Dose Level 1|Withdrawal by Subject|0|||
148904864|NCT00790842|537135044|FG010|Dose Level 1|Withdrawal by Subject|0|||
148904865|NCT00790842|537135034|FG000|Dose Level 2|Death|0|||
148904866|NCT00790842|537135035|FG001|Dose Level 2|Death|1|||
148904867|NCT00790842|537135036|FG002|Dose Level 2|Death|0|||
148904868|NCT00790842|537135037|FG003|Dose Level 2|Death|0|||
148904869|NCT00790842|537135038|FG004|Dose Level 2|Death|1|||
148904870|NCT00790842|537135039|FG005|Dose Level 2|Death|0|||
148904871|NCT00790842|537135040|FG006|Dose Level 2|Death|0|||
148904872|NCT00790842|537135041|FG007|Dose Level 2|Death|0|||
148904873|NCT00790842|537135042|FG008|Dose Level 2|Death|0|||
148904874|NCT00790842|537135043|FG009|Dose Level 2|Death|0|||
148904875|NCT00790842|537135044|FG010|Dose Level 2|Death|0|||
148904876|NCT00790842|537135034|FG000|Dose Level 2|Physician Decision|0|||
148904877|NCT00790842|537135035|FG001|Dose Level 2|Physician Decision|1|||
148904878|NCT00790842|537135036|FG002|Dose Level 2|Physician Decision|0|||
148904879|NCT00790842|537135037|FG003|Dose Level 2|Physician Decision|0|||
148904880|NCT00790842|537135038|FG004|Dose Level 2|Physician Decision|0|||
148904881|NCT00790842|537135039|FG005|Dose Level 2|Physician Decision|0|||
148904882|NCT00790842|537135040|FG006|Dose Level 2|Physician Decision|0|||
148904883|NCT00790842|537135041|FG007|Dose Level 2|Physician Decision|0|||
148904884|NCT00790842|537135042|FG008|Dose Level 2|Physician Decision|0|||
148904885|NCT00790842|537135043|FG009|Dose Level 2|Physician Decision|0|||
148904886|NCT00790842|537135044|FG010|Dose Level 2|Physician Decision|0|||
148904887|NCT00790842|537135034|FG000|Dose Level 2|Withdrawal by Subject|0|||
148904888|NCT00790842|537135035|FG001|Dose Level 2|Withdrawal by Subject|1|||
148904889|NCT00790842|537135036|FG002|Dose Level 2|Withdrawal by Subject|0|||
148904890|NCT00790842|537135037|FG003|Dose Level 2|Withdrawal by Subject|0|||
148904891|NCT00790842|537135038|FG004|Dose Level 2|Withdrawal by Subject|0|||
148904892|NCT00790842|537135039|FG005|Dose Level 2|Withdrawal by Subject|0|||
148904893|NCT00790842|537135040|FG006|Dose Level 2|Withdrawal by Subject|0|||
148904894|NCT00790842|537135041|FG007|Dose Level 2|Withdrawal by Subject|0|||
148904895|NCT00790842|537135042|FG008|Dose Level 2|Withdrawal by Subject|0|||
148904896|NCT00790842|537135043|FG009|Dose Level 2|Withdrawal by Subject|0|||
148904897|NCT00790842|537135044|FG010|Dose Level 2|Withdrawal by Subject|0|||
148904898|NCT00790842|537135034|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904899|NCT00790842|537135035|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904900|NCT00790842|537135036|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904901|NCT00790842|537135037|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904902|NCT00790842|537135038|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904903|NCT00790842|537135039|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904904|NCT00790842|537135040|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904905|NCT00790842|537135041|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904906|NCT00790842|537135042|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
148904907|NCT00790842|537135043|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904908|NCT00790842|537135044|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
148904909|NCT00790842|537135034|FG000|Dose Level 3|Adverse Event|0|||
148904910|NCT00790842|537135035|FG001|Dose Level 3|Adverse Event|0|||
148904911|NCT00790842|537135036|FG002|Dose Level 3|Adverse Event|1|||
148904912|NCT00790842|537135037|FG003|Dose Level 3|Adverse Event|0|||
148904913|NCT00790842|537135038|FG004|Dose Level 3|Adverse Event|0|||
148904914|NCT00790842|537135039|FG005|Dose Level 3|Adverse Event|0|||
148904915|NCT00790842|537135040|FG006|Dose Level 3|Adverse Event|0|||
148904916|NCT00790842|537135041|FG007|Dose Level 3|Adverse Event|0|||
148904917|NCT00790842|537135042|FG008|Dose Level 3|Adverse Event|0|||
148904918|NCT00790842|537135043|FG009|Dose Level 3|Adverse Event|0|||
148904919|NCT00790842|537135044|FG010|Dose Level 3|Adverse Event|0|||
148904920|NCT00790842|537135034|FG000|Dose Level 3|Withdrawal by Subject|0|||
148904921|NCT00790842|537135035|FG001|Dose Level 3|Withdrawal by Subject|0|||
148904922|NCT00790842|537135036|FG002|Dose Level 3|Withdrawal by Subject|3|||
148904923|NCT00790842|537135037|FG003|Dose Level 3|Withdrawal by Subject|0|||
148904924|NCT00790842|537135038|FG004|Dose Level 3|Withdrawal by Subject|0|||
148904925|NCT00790842|537135039|FG005|Dose Level 3|Withdrawal by Subject|0|||
148904926|NCT00790842|537135040|FG006|Dose Level 3|Withdrawal by Subject|0|||
148904927|NCT00790842|537135041|FG007|Dose Level 3|Withdrawal by Subject|0|||
148904928|NCT00790842|537135042|FG008|Dose Level 3|Withdrawal by Subject|0|||
148904929|NCT00790842|537135043|FG009|Dose Level 3|Withdrawal by Subject|2|||
148904930|NCT00790842|537135044|FG010|Dose Level 3|Withdrawal by Subject|0|||
148904931|NCT00790842|537135034|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904932|NCT00790842|537135035|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904933|NCT00790842|537135036|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904934|NCT00790842|537135037|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904935|NCT00790842|537135038|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904936|NCT00790842|537135039|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
148904937|NCT00790842|537135040|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904938|NCT00790842|537135041|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904939|NCT00790842|537135042|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904940|NCT00790842|537135043|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904941|NCT00790842|537135044|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
148904942|NCT00790842|537135034|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904943|NCT00790842|537135035|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904944|NCT00790842|537135036|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
148904945|NCT00790842|537135037|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904946|NCT00790842|537135038|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904947|NCT00790842|537135039|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904948|NCT00790842|537135040|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904949|NCT00790842|537135041|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904950|NCT00790842|537135042|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904951|NCT00790842|537135043|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904952|NCT00790842|537135044|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
148904953|NCT00790842|537135034|FG000|Dose Level 4|Adverse Event|0|||
148904954|NCT00790842|537135035|FG001|Dose Level 4|Adverse Event|0|||
148904955|NCT00790842|537135036|FG002|Dose Level 4|Adverse Event|0|||
148904956|NCT00790842|537135037|FG003|Dose Level 4|Adverse Event|0|||
148904957|NCT00790842|537135038|FG004|Dose Level 4|Adverse Event|0|||
148904958|NCT00790842|537135039|FG005|Dose Level 4|Adverse Event|0|||
148904959|NCT00790842|537135040|FG006|Dose Level 4|Adverse Event|1|||
148904960|NCT00790842|537135041|FG007|Dose Level 4|Adverse Event|0|||
148904961|NCT00790842|537135042|FG008|Dose Level 4|Adverse Event|0|||
148904962|NCT00790842|537135043|FG009|Dose Level 4|Adverse Event|0|||
148904963|NCT00790842|537135044|FG010|Dose Level 4|Adverse Event|0|||
148904964|NCT00790842|537135034|FG000|Dose Level 4|Physician Decision|0|||
148904965|NCT00790842|537135035|FG001|Dose Level 4|Physician Decision|0|||
148904966|NCT00790842|537135036|FG002|Dose Level 4|Physician Decision|0|||
148904967|NCT00790842|537135037|FG003|Dose Level 4|Physician Decision|0|||
148904968|NCT00790842|537135038|FG004|Dose Level 4|Physician Decision|0|||
148904969|NCT00790842|537135039|FG005|Dose Level 4|Physician Decision|0|||
148904970|NCT00790842|537135040|FG006|Dose Level 4|Physician Decision|1|||
148904971|NCT00790842|537135041|FG007|Dose Level 4|Physician Decision|0|||
148904972|NCT00790842|537135042|FG008|Dose Level 4|Physician Decision|0|||
148904973|NCT00790842|537135043|FG009|Dose Level 4|Physician Decision|0|||
148904974|NCT00790842|537135044|FG010|Dose Level 4|Physician Decision|1|||
148904975|NCT00790842|537135034|FG000|Dose Level 4|Withdrawal by Subject|0|||
148904976|NCT00790842|537135035|FG001|Dose Level 4|Withdrawal by Subject|0|||
148904977|NCT00790842|537135036|FG002|Dose Level 4|Withdrawal by Subject|0|||
148904978|NCT00790842|537135037|FG003|Dose Level 4|Withdrawal by Subject|0|||
148904979|NCT00790842|537135038|FG004|Dose Level 4|Withdrawal by Subject|0|||
148904980|NCT00790842|537135039|FG005|Dose Level 4|Withdrawal by Subject|0|||
148904981|NCT00790842|537135040|FG006|Dose Level 4|Withdrawal by Subject|0|||
148904982|NCT00790842|537135041|FG007|Dose Level 4|Withdrawal by Subject|0|||
148904983|NCT00790842|537135042|FG008|Dose Level 4|Withdrawal by Subject|0|||
148904984|NCT00790842|537135043|FG009|Dose Level 4|Withdrawal by Subject|0|||
148904985|NCT00790842|537135044|FG010|Dose Level 4|Withdrawal by Subject|1|||
148904986|NCT00790842|537135034|FG000|Expansion Cohort|Adverse Event|0|||
148904987|NCT00790842|537135035|FG001|Expansion Cohort|Adverse Event|0|||
148904988|NCT00790842|537135036|FG002|Expansion Cohort|Adverse Event|0|||
148904989|NCT00790842|537135037|FG003|Expansion Cohort|Adverse Event|0|||
148904990|NCT00790842|537135038|FG004|Expansion Cohort|Adverse Event|0|||
148904991|NCT00790842|537135039|FG005|Expansion Cohort|Adverse Event|0|||
148904992|NCT00790842|537135040|FG006|Expansion Cohort|Adverse Event|1|||
148904993|NCT00790842|537135041|FG007|Expansion Cohort|Adverse Event|0|||
148904994|NCT00790842|537135042|FG008|Expansion Cohort|Adverse Event|0|||
148904995|NCT00790842|537135043|FG009|Expansion Cohort|Adverse Event|0|||
148904996|NCT00790842|537135044|FG010|Expansion Cohort|Adverse Event|0|||
148904997|NCT00790842|537135034|FG000|Expansion Cohort|Death|0|||
148904998|NCT00790842|537135035|FG001|Expansion Cohort|Death|0|||
148904999|NCT00790842|537135036|FG002|Expansion Cohort|Death|2|||
148905000|NCT00790842|537135037|FG003|Expansion Cohort|Death|0|||
148905001|NCT00790842|537135038|FG004|Expansion Cohort|Death|0|||
148905002|NCT00790842|537135039|FG005|Expansion Cohort|Death|0|||
148905003|NCT00790842|537135040|FG006|Expansion Cohort|Death|0|||
148905004|NCT00790842|537135041|FG007|Expansion Cohort|Death|0|||
148905005|NCT00790842|537135042|FG008|Expansion Cohort|Death|0|||
148905006|NCT00790842|537135043|FG009|Expansion Cohort|Death|0|||
148905007|NCT00790842|537135044|FG010|Expansion Cohort|Death|0|||
148905008|NCT00790842|537135034|FG000|Expansion Cohort|Physician Decision|0|||
148905009|NCT00790842|537135035|FG001|Expansion Cohort|Physician Decision|0|||
148905010|NCT00790842|537135036|FG002|Expansion Cohort|Physician Decision|1|||
148905011|NCT00790842|537135037|FG003|Expansion Cohort|Physician Decision|0|||
148905012|NCT00790842|537135038|FG004|Expansion Cohort|Physician Decision|0|||
148905013|NCT00790842|537135039|FG005|Expansion Cohort|Physician Decision|0|||
148905014|NCT00790842|537135040|FG006|Expansion Cohort|Physician Decision|0|||
148905015|NCT00790842|537135041|FG007|Expansion Cohort|Physician Decision|0|||
148905016|NCT00790842|537135042|FG008|Expansion Cohort|Physician Decision|0|||
148905017|NCT00790842|537135043|FG009|Expansion Cohort|Physician Decision|0|||
148905018|NCT00790842|537135044|FG010|Expansion Cohort|Physician Decision|0|||
148905019|NCT00790842|537135034|FG000|Expansion Cohort|Withdrawal by Subject|0|||
148905020|NCT00790842|537135035|FG001|Expansion Cohort|Withdrawal by Subject|0|||
148905021|NCT00790842|537135036|FG002|Expansion Cohort|Withdrawal by Subject|3|||
148905022|NCT00790842|537135037|FG003|Expansion Cohort|Withdrawal by Subject|0|||
148905023|NCT00790842|537135038|FG004|Expansion Cohort|Withdrawal by Subject|0|||
148905024|NCT00790842|537135039|FG005|Expansion Cohort|Withdrawal by Subject|0|||
148905025|NCT00790842|537135040|FG006|Expansion Cohort|Withdrawal by Subject|0|||
148905026|NCT00790842|537135041|FG007|Expansion Cohort|Withdrawal by Subject|0|||
148905027|NCT00790842|537135042|FG008|Expansion Cohort|Withdrawal by Subject|0|||
148905028|NCT00790842|537135043|FG009|Expansion Cohort|Withdrawal by Subject|0|||
148905029|NCT00790842|537135044|FG010|Expansion Cohort|Withdrawal by Subject|0|||
148905030|NCT00790842|537135034|FG000|Expansion Cohort|Study Closure|0|||
148905031|NCT00790842|537135035|FG001|Expansion Cohort|Study Closure|0|||
148905032|NCT00790842|537135036|FG002|Expansion Cohort|Study Closure|1|||
148905033|NCT00790842|537135037|FG003|Expansion Cohort|Study Closure|0|||
148905034|NCT00790842|537135038|FG004|Expansion Cohort|Study Closure|0|||
148905035|NCT00790842|537135039|FG005|Expansion Cohort|Study Closure|0|||
148905036|NCT00790842|537135040|FG006|Expansion Cohort|Study Closure|0|||
148905037|NCT00790842|537135041|FG007|Expansion Cohort|Study Closure|0|||
148905038|NCT00790842|537135042|FG008|Expansion Cohort|Study Closure|0|||
148905039|NCT00790842|537135043|FG009|Expansion Cohort|Study Closure|0|||
148905040|NCT00790842|537135044|FG010|Expansion Cohort|Study Closure|0|||
148905041|NCT02968004|537135045|FG000|Main Study Phase|Adverse Event|1|||
148905042|NCT02968004|537135046|FG001|Main Study Phase|Adverse Event|0|||
148905043|NCT02968004|537135045|FG000|Main Study Phase|Withdrawal by Subject|0|||
148905044|NCT02968004|537135046|FG001|Main Study Phase|Withdrawal by Subject|1|||
148905045|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
148905046|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
148905047|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
148905048|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
148905049|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
148905050|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
148905051|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
148905052|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
148905053|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
148905054|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
148905055|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
148905056|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
148905057|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
148905058|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
148905059|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
148905060|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
148905061|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
148905062|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
148905063|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
148905064|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
148905065|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
148905066|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
148905067|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
148905068|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
148905069|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
148905070|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
148905071|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
148905072|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
148905073|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
148905074|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
148905075|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
148905076|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
148905077|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
148905078|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
148905079|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
148905080|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
148905081|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
148905082|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
148905083|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
148905084|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
148905085|NCT02968004|537135045|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
148905086|NCT02968004|537135046|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
148905087|NCT05029362|537135047|FG000|Overall Study|Lost to Follow-up|9|||
148905088|NCT00419952|537135050|FG000|Overall Study|Adverse Event|8|||
148905089|NCT00419952|537135051|FG001|Overall Study|Adverse Event|10|||
148905090|NCT00419952|537135050|FG000|Overall Study|Withdrawal by Subject|44|||
148905091|NCT00419952|537135051|FG001|Overall Study|Withdrawal by Subject|43|||
148905092|NCT00419952|537135050|FG000|Overall Study|Lost to Follow-up|43|||
148905093|NCT00419952|537135051|FG001|Overall Study|Lost to Follow-up|34|||
148905094|NCT00419952|537135050|FG000|Overall Study|Protocol Violation|32|||
148905095|NCT00419952|537135051|FG001|Overall Study|Protocol Violation|24|||
148905096|NCT00419952|537135050|FG000|Overall Study|Pregnancy|4|||
148905097|NCT00419952|537135051|FG001|Overall Study|Pregnancy|2|||
148905098|NCT00419952|537135050|FG000|Overall Study|Physician Decision|1|||
148905099|NCT00419952|537135051|FG001|Overall Study|Physician Decision|3|||
148905100|NCT00419952|537135050|FG000|Overall Study|Incorrectly enrolled|10|||
148905101|NCT00419952|537135051|FG001|Overall Study|Incorrectly enrolled|3|||
148905102|NCT00419952|537135050|FG000|Overall Study|Intake of prohibited medication|2|||
148905103|NCT00419952|537135051|FG001|Overall Study|Intake of prohibited medication|2|||
148905104|NCT00419952|537135050|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
148905105|NCT00419952|537135051|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
148905106|NCT00419952|537135050|FG000|Overall Study|Diary or medication non-compliance|2|||
148905107|NCT00419952|537135051|FG001|Overall Study|Diary or medication non-compliance|4|||
148905108|NCT00419952|537135050|FG000|Overall Study|Abnormal ECG|1|||
148905109|NCT00419952|537135051|FG001|Overall Study|Abnormal ECG|0|||
148905110|NCT03126591|537135052|FG000|Overall Study|Death|6|||
148905111|NCT03126591|537135053|FG001|Overall Study|Death|3|||
148905112|NCT03126591|537135054|FG002|Overall Study|Death|17|||
148905113|NCT03126591|537135052|FG000|Overall Study|Progressive Disease|0|||
148905114|NCT03126591|537135053|FG001|Overall Study|Progressive Disease|1|||
148905115|NCT03126591|537135054|FG002|Overall Study|Progressive Disease|2|||
148905116|NCT03126591|537135052|FG000|Overall Study|Terminated by Sponsor|0|||
148905117|NCT03126591|537135053|FG001|Overall Study|Terminated by Sponsor|1|||
148905118|NCT03126591|537135054|FG002|Overall Study|Terminated by Sponsor|4|||
148905119|NCT03126591|537135052|FG000|Overall Study|Withdrawal by Subject|1|||
148905120|NCT03126591|537135053|FG001|Overall Study|Withdrawal by Subject|1|||
148905121|NCT03126591|537135054|FG002|Overall Study|Withdrawal by Subject|4|||
148905122|NCT02606643|537135055|FG000|Overall Study|did not meet inclusion criteria|1|||
148905123|NCT02606643|537135056|FG001|Overall Study|did not meet inclusion criteria|3|||
148905124|NCT00885170|537135067|FG000|Overall Study|Adverse Event|12|||
148905125|NCT00885170|537135068|FG001|Overall Study|Adverse Event|4|||
148905126|NCT00885170|537135067|FG000|Overall Study|Excessive bone loss|6|||
148905127|NCT00885170|537135068|FG001|Overall Study|Excessive bone loss|3|||
148905128|NCT00885170|537135067|FG000|Overall Study|Lost to Follow-up|2|||
148905129|NCT00885170|537135068|FG001|Overall Study|Lost to Follow-up|1|||
148905130|NCT00885170|537135067|FG000|Overall Study|Physician Decision|2|||
148905131|NCT00885170|537135068|FG001|Overall Study|Physician Decision|1|||
148905132|NCT00885170|537135067|FG000|Overall Study|Protocol Violation|3|||
148905133|NCT00885170|537135068|FG001|Overall Study|Protocol Violation|1|||
148905134|NCT00885170|537135067|FG000|Overall Study|Withdrawal by Subject|13|||
148905135|NCT00885170|537135068|FG001|Overall Study|Withdrawal by Subject|13|||
148905136|NCT03771664|537135069|FG000|Overall Study|Adverse Event|1|||
148905137|NCT03771664|537135070|FG001|Overall Study|Adverse Event|0|||
148905138|NCT03771664|537135069|FG000|Overall Study|Lost to Follow-up|1|||
148905139|NCT03771664|537135070|FG001|Overall Study|Lost to Follow-up|0|||
148905140|NCT03771664|537135069|FG000|Overall Study|Withdrawal by Participant|1|||
148905141|NCT03771664|537135070|FG001|Overall Study|Withdrawal by Participant|4|||
148905142|NCT03771664|537135069|FG000|Overall Study|Randomized but not Treated|0|||
148905143|NCT03771664|537135070|FG001|Overall Study|Randomized but not Treated|1|||
148905144|NCT01208207|537135073|FG000|Part I|Adverse Event|19|||
148905145|NCT01208207|537135074|FG001|Part I|Adverse Event|2|||
148905146|NCT01208207|537135075|FG002|Part I|Adverse Event|6|||
148905147|NCT01208207|537135076|FG003|Part I|Adverse Event|0|||
148905148|NCT01208207|537135077|FG004|Part I|Adverse Event|0|||
148905149|NCT01208207|537135078|FG005|Part I|Adverse Event|0|||
148905150|NCT01208207|537135079|FG006|Part I|Adverse Event|0|||
148905151|NCT01208207|537135073|FG000|Part I|Lack of Efficacy|21|||
148905152|NCT01208207|537135074|FG001|Part I|Lack of Efficacy|3|||
148905153|NCT01208207|537135075|FG002|Part I|Lack of Efficacy|2|||
148905154|NCT01208207|537135076|FG003|Part I|Lack of Efficacy|0|||
148905155|NCT01208207|537135077|FG004|Part I|Lack of Efficacy|0|||
148905156|NCT01208207|537135078|FG005|Part I|Lack of Efficacy|0|||
148905157|NCT01208207|537135079|FG006|Part I|Lack of Efficacy|0|||
148905158|NCT01208207|537135073|FG000|Part I|Lost to Follow-up|6|||
148905159|NCT01208207|537135074|FG001|Part I|Lost to Follow-up|1|||
148905160|NCT01208207|537135075|FG002|Part I|Lost to Follow-up|0|||
148905161|NCT01208207|537135076|FG003|Part I|Lost to Follow-up|0|||
148905162|NCT01208207|537135077|FG004|Part I|Lost to Follow-up|0|||
148905163|NCT01208207|537135078|FG005|Part I|Lost to Follow-up|0|||
148905164|NCT01208207|537135079|FG006|Part I|Lost to Follow-up|0|||
148905165|NCT01208207|537135073|FG000|Part I|Non-Compliance With Study Drug|1|||
148905166|NCT01208207|537135074|FG001|Part I|Non-Compliance With Study Drug|0|||
148905167|NCT01208207|537135075|FG002|Part I|Non-Compliance With Study Drug|1|||
148905168|NCT01208207|537135076|FG003|Part I|Non-Compliance With Study Drug|0|||
148905169|NCT01208207|537135077|FG004|Part I|Non-Compliance With Study Drug|0|||
148905170|NCT01208207|537135078|FG005|Part I|Non-Compliance With Study Drug|0|||
148905171|NCT01208207|537135079|FG006|Part I|Non-Compliance With Study Drug|0|||
148905172|NCT01208207|537135073|FG000|Part I|Physician Decision|0|||
148905173|NCT01208207|537135074|FG001|Part I|Physician Decision|1|||
148905174|NCT01208207|537135075|FG002|Part I|Physician Decision|0|||
148905175|NCT01208207|537135076|FG003|Part I|Physician Decision|0|||
148905176|NCT01208207|537135077|FG004|Part I|Physician Decision|0|||
148905177|NCT01208207|537135078|FG005|Part I|Physician Decision|0|||
148905178|NCT01208207|537135079|FG006|Part I|Physician Decision|0|||
148905179|NCT01208207|537135073|FG000|Part I|Progressive Disease|1|||
148905180|NCT01208207|537135074|FG001|Part I|Progressive Disease|0|||
148905181|NCT01208207|537135075|FG002|Part I|Progressive Disease|0|||
148905182|NCT01208207|537135076|FG003|Part I|Progressive Disease|0|||
148905183|NCT01208207|537135077|FG004|Part I|Progressive Disease|0|||
148905184|NCT01208207|537135078|FG005|Part I|Progressive Disease|0|||
148905185|NCT01208207|537135079|FG006|Part I|Progressive Disease|0|||
148905186|NCT01208207|537135073|FG000|Part I|Protocol Violation|8|||
148905187|NCT01208207|537135074|FG001|Part I|Protocol Violation|0|||
148905188|NCT01208207|537135075|FG002|Part I|Protocol Violation|2|||
148905189|NCT01208207|537135076|FG003|Part I|Protocol Violation|0|||
148905190|NCT01208207|537135077|FG004|Part I|Protocol Violation|0|||
148905191|NCT01208207|537135078|FG005|Part I|Protocol Violation|0|||
148905192|NCT01208207|537135079|FG006|Part I|Protocol Violation|0|||
148905193|NCT01208207|537135073|FG000|Part I|Withdrawal by Subject|14|||
148905194|NCT01208207|537135074|FG001|Part I|Withdrawal by Subject|4|||
148905195|NCT01208207|537135075|FG002|Part I|Withdrawal by Subject|4|||
148905196|NCT01208207|537135076|FG003|Part I|Withdrawal by Subject|0|||
148905197|NCT01208207|537135077|FG004|Part I|Withdrawal by Subject|0|||
148905198|NCT01208207|537135078|FG005|Part I|Withdrawal by Subject|0|||
148905199|NCT01208207|537135079|FG006|Part I|Withdrawal by Subject|0|||
148905200|NCT01208207|537135073|FG000|Part II|Withdrawal by Subject|0|||
148905201|NCT01208207|537135074|FG001|Part II|Withdrawal by Subject|0|||
148905202|NCT01208207|537135075|FG002|Part II|Withdrawal by Subject|0|||
148905203|NCT01208207|537135076|FG003|Part II|Withdrawal by Subject|10|||
148905204|NCT01208207|537135077|FG004|Part II|Withdrawal by Subject|9|||
148905205|NCT01208207|537135078|FG005|Part II|Withdrawal by Subject|3|||
148905206|NCT01208207|537135079|FG006|Part II|Withdrawal by Subject|5|||
148905207|NCT01208207|537135073|FG000|Part II|Adverse Event|0|||
148905208|NCT01208207|537135074|FG001|Part II|Adverse Event|0|||
148905209|NCT01208207|537135075|FG002|Part II|Adverse Event|0|||
148905210|NCT01208207|537135076|FG003|Part II|Adverse Event|5|||
148905211|NCT01208207|537135077|FG004|Part II|Adverse Event|9|||
148905212|NCT01208207|537135078|FG005|Part II|Adverse Event|4|||
148905213|NCT01208207|537135079|FG006|Part II|Adverse Event|2|||
148905214|NCT01208207|537135073|FG000|Part II|Lack of Efficacy|0|||
148905215|NCT01208207|537135074|FG001|Part II|Lack of Efficacy|0|||
148905216|NCT01208207|537135075|FG002|Part II|Lack of Efficacy|0|||
148905217|NCT01208207|537135076|FG003|Part II|Lack of Efficacy|6|||
148905218|NCT01208207|537135077|FG004|Part II|Lack of Efficacy|4|||
148905219|NCT01208207|537135078|FG005|Part II|Lack of Efficacy|3|||
148905220|NCT01208207|537135079|FG006|Part II|Lack of Efficacy|3|||
148905221|NCT01208207|537135073|FG000|Part II|Lost to Follow-up|0|||
148905222|NCT01208207|537135074|FG001|Part II|Lost to Follow-up|0|||
148905223|NCT01208207|537135075|FG002|Part II|Lost to Follow-up|0|||
148905224|NCT01208207|537135076|FG003|Part II|Lost to Follow-up|4|||
148905225|NCT01208207|537135077|FG004|Part II|Lost to Follow-up|0|||
148905226|NCT01208207|537135078|FG005|Part II|Lost to Follow-up|2|||
148905227|NCT01208207|537135079|FG006|Part II|Lost to Follow-up|1|||
148905228|NCT01208207|537135073|FG000|Part II|Non-Compliance With Study Drug|0|||
148905229|NCT01208207|537135074|FG001|Part II|Non-Compliance With Study Drug|0|||
148905230|NCT01208207|537135075|FG002|Part II|Non-Compliance With Study Drug|0|||
148905231|NCT01208207|537135076|FG003|Part II|Non-Compliance With Study Drug|4|||
148905232|NCT01208207|537135077|FG004|Part II|Non-Compliance With Study Drug|1|||
148905233|NCT01208207|537135078|FG005|Part II|Non-Compliance With Study Drug|1|||
148905234|NCT01208207|537135079|FG006|Part II|Non-Compliance With Study Drug|0|||
148905235|NCT01208207|537135073|FG000|Part II|Physician Decision|0|||
148905236|NCT01208207|537135074|FG001|Part II|Physician Decision|0|||
148905237|NCT01208207|537135075|FG002|Part II|Physician Decision|0|||
148905238|NCT01208207|537135076|FG003|Part II|Physician Decision|1|||
148905239|NCT01208207|537135077|FG004|Part II|Physician Decision|0|||
148905240|NCT01208207|537135078|FG005|Part II|Physician Decision|2|||
148905241|NCT01208207|537135079|FG006|Part II|Physician Decision|0|||
148905242|NCT01208207|537135073|FG000|Part II|Protocol Violation|0|||
148905243|NCT01208207|537135074|FG001|Part II|Protocol Violation|0|||
148905244|NCT01208207|537135075|FG002|Part II|Protocol Violation|0|||
148905245|NCT01208207|537135076|FG003|Part II|Protocol Violation|1|||
148905246|NCT01208207|537135077|FG004|Part II|Protocol Violation|0|||
148905247|NCT01208207|537135078|FG005|Part II|Protocol Violation|0|||
148905248|NCT01208207|537135079|FG006|Part II|Protocol Violation|0|||
148905249|NCT01208207|537135073|FG000|Part II|Technical Problems|0|||
148905250|NCT01208207|537135074|FG001|Part II|Technical Problems|0|||
148905251|NCT01208207|537135075|FG002|Part II|Technical Problems|0|||
148905252|NCT01208207|537135076|FG003|Part II|Technical Problems|1|||
148905253|NCT01208207|537135077|FG004|Part II|Technical Problems|0|||
148905254|NCT01208207|537135078|FG005|Part II|Technical Problems|1|||
148905255|NCT01208207|537135079|FG006|Part II|Technical Problems|0|||
148905256|NCT02161016|537135082|FG000|Overall Study|withdrawn by IRB|1|||
148905257|NCT02900378|537135086|FG000|Randomization (Visit 2)|Adverse Event|14|||
148905258|NCT02900378|537135087|FG001|Randomization (Visit 2)|Adverse Event|11|||
148905259|NCT02900378|537135086|FG000|Randomization (Visit 2)|Death|1|||
148905260|NCT02900378|537135087|FG001|Randomization (Visit 2)|Death|4|||
148905261|NCT02900378|537135086|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
148905262|NCT02900378|537135087|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
148905263|NCT02900378|537135086|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
148905264|NCT02900378|537135087|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
148905265|NCT02900378|537135086|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
148905266|NCT02900378|537135087|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
148905267|NCT02900378|537135086|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
148905268|NCT02900378|537135087|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
148905269|NCT02900378|537135086|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
148905270|NCT02900378|537135087|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
148905271|NCT03818321|537135088|FG000|Overall Study|Withdrawal by Subject|1|||
148905272|NCT03818321|537135089|FG001|Overall Study|Withdrawal by Subject|2|||
148905273|NCT01134055|537135090|FG000|Overall Study|Adverse Event|5|||
148905274|NCT01134055|537135091|FG001|Overall Study|Adverse Event|2|||
148905275|NCT01134055|537135092|FG002|Overall Study|Adverse Event|2|||
148905276|NCT01134055|537135093|FG003|Overall Study|Adverse Event|2|||
148905277|NCT01134055|537135094|FG004|Overall Study|Adverse Event|5|||
148905278|NCT01134055|537135095|FG005|Overall Study|Adverse Event|7|||
148905279|NCT01134055|537135096|FG006|Overall Study|Adverse Event|2|||
148905280|NCT01134055|537135090|FG000|Overall Study|Lost to Follow-up|0|||
148905281|NCT01134055|537135091|FG001|Overall Study|Lost to Follow-up|1|||
148905282|NCT01134055|537135092|FG002|Overall Study|Lost to Follow-up|0|||
148905283|NCT01134055|537135093|FG003|Overall Study|Lost to Follow-up|1|||
148905284|NCT01134055|537135094|FG004|Overall Study|Lost to Follow-up|0|||
148905285|NCT01134055|537135095|FG005|Overall Study|Lost to Follow-up|0|||
148905286|NCT01134055|537135096|FG006|Overall Study|Lost to Follow-up|0|||
148905287|NCT01134055|537135090|FG000|Overall Study|Withdrawal by Subject|3|||
148905288|NCT01134055|537135091|FG001|Overall Study|Withdrawal by Subject|3|||
148905289|NCT01134055|537135092|FG002|Overall Study|Withdrawal by Subject|1|||
148905290|NCT01134055|537135093|FG003|Overall Study|Withdrawal by Subject|2|||
148905291|NCT01134055|537135094|FG004|Overall Study|Withdrawal by Subject|0|||
148905292|NCT01134055|537135095|FG005|Overall Study|Withdrawal by Subject|0|||
148905293|NCT01134055|537135096|FG006|Overall Study|Withdrawal by Subject|8|||
148905294|NCT01134055|537135090|FG000|Overall Study|Protocol Violation|0|||
148905295|NCT01134055|537135091|FG001|Overall Study|Protocol Violation|0|||
148905296|NCT01134055|537135092|FG002|Overall Study|Protocol Violation|0|||
148905297|NCT01134055|537135093|FG003|Overall Study|Protocol Violation|1|||
148905298|NCT01134055|537135094|FG004|Overall Study|Protocol Violation|1|||
148905299|NCT01134055|537135095|FG005|Overall Study|Protocol Violation|0|||
148905300|NCT01134055|537135096|FG006|Overall Study|Protocol Violation|0|||
148905301|NCT01134055|537135090|FG000|Overall Study|Physician Decision|0|||
148905302|NCT01134055|537135091|FG001|Overall Study|Physician Decision|0|||
148905303|NCT01134055|537135092|FG002|Overall Study|Physician Decision|0|||
148905304|NCT01134055|537135093|FG003|Overall Study|Physician Decision|0|||
148905305|NCT01134055|537135094|FG004|Overall Study|Physician Decision|0|||
148905306|NCT01134055|537135095|FG005|Overall Study|Physician Decision|0|||
148905307|NCT01134055|537135096|FG006|Overall Study|Physician Decision|1|||
148905308|NCT00380367|537135108|FG000|Overall Study|Lost to Follow-up|1|||
148905309|NCT00380367|537135108|FG000|Overall Study|Withdrawal by Subject|1|||
148905310|NCT01605799|537135109|FG000|Overall Study|Withdrawal by Subject|2|||
148905311|NCT01605799|537135110|FG001|Overall Study|Withdrawal by Subject|1|||
148905312|NCT00734539|537135113|FG000|Main Study|Death|33|||
148905313|NCT00734539|537135114|FG001|Main Study|Death|32|||
148905314|NCT00734539|537135113|FG000|Main Study|Physician Decision|2|||
148905315|NCT00734539|537135114|FG001|Main Study|Physician Decision|0|||
148905316|NCT00734539|537135113|FG000|Main Study|Withdrawal by Subject|1|||
148905317|NCT00734539|537135114|FG001|Main Study|Withdrawal by Subject|3|||
148905318|NCT00734539|537135113|FG000|Main Study|Enrolled in error; ineligible|1|||
148905319|NCT00734539|537135114|FG001|Main Study|Enrolled in error; ineligible|0|||
148905320|NCT02504151|537135119|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
148905321|NCT02504151|537135120|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
148905322|NCT02504151|537135119|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
148905323|NCT02504151|537135120|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
148905324|NCT02504151|537135119|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
148905325|NCT02504151|537135120|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148905326|NCT02504151|537135119|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
148905327|NCT02504151|537135120|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
148905328|NCT05038982|537135121|FG000|Overall Study|Withdrawal by Subject|0|||
148905329|NCT05038982|537135122|FG001|Overall Study|Withdrawal by Subject|2|||
148905330|NCT01454102|537135126|FG000|Overall Study|Continuing in the treatment period|0|||
148905331|NCT01454102|537135127|FG001|Overall Study|Continuing in the treatment period|0|||
148905332|NCT01454102|537135128|FG002|Overall Study|Continuing in the treatment period|0|||
148905333|NCT01454102|537135129|FG003|Overall Study|Continuing in the treatment period|0|||
148905334|NCT01454102|537135130|FG004|Overall Study|Continuing in the treatment period|3|||
148905335|NCT01454102|537135131|FG005|Overall Study|Continuing in the treatment period|3|||
148905336|NCT01454102|537135132|FG006|Overall Study|Continuing in the treatment period|2|||
148905337|NCT01454102|537135133|FG007|Overall Study|Continuing in the treatment period|0|||
148905338|NCT01454102|537135134|FG008|Overall Study|Continuing in the treatment period|1|||
148905339|NCT01454102|537135135|FG009|Overall Study|Continuing in the treatment period|0|||
148905340|NCT01454102|537135136|FG010|Overall Study|Continuing in the treatment period|0|||
148905341|NCT01454102|537135137|FG011|Overall Study|Continuing in the treatment period|4|||
148905342|NCT01454102|537135138|FG012|Overall Study|Continuing in the treatment period|7|||
148905343|NCT01454102|537135139|FG013|Overall Study|Continuing in the treatment period|4|||
148905344|NCT01454102|537135140|FG014|Overall Study|Continuing in the treatment period|3|||
148905345|NCT01454102|537135141|FG015|Overall Study|Continuing in the treatment period|1|||
148905346|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
148905347|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
148905348|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
148905349|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
148905350|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
148905351|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
148905352|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
148905353|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
148905354|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
148905355|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
148905356|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
148905357|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
148905358|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
148905359|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
148905360|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
148802680|NCT01326871|536757731|FG000|Overall Study|SAE, disease progression and subject decision|0|||
148802681|NCT01326871|536757732|FG001|Overall Study|SAE, disease progression and subject decision|1|||
148802682|NCT01326871|536757733|FG002|Overall Study|SAE, disease progression and subject decision|0|||
148802683|NCT01326871|536757731|FG000|Overall Study|Death|0|||
148802684|NCT01326871|536757732|FG001|Overall Study|Death|1|||
148802685|NCT01326871|536757733|FG002|Overall Study|Death|0|||
148802686|NCT01326871|536757731|FG000|Overall Study|Other|0|||
148802687|NCT01326871|536757732|FG001|Overall Study|Other|3|||
148802688|NCT01326871|536757733|FG002|Overall Study|Other|0|||
148802689|NCT01326871|536757731|FG000|Overall Study|SAE and disease progression|0|||
148802690|NCT01326871|536757732|FG001|Overall Study|SAE and disease progression|0|||
148802691|NCT01326871|536757733|FG002|Overall Study|SAE and disease progression|1|||
148802692|NCT01326871|536757731|FG000|Overall Study|SAE and physician decision|0|||
148802693|NCT01326871|536757732|FG001|Overall Study|SAE and physician decision|0|||
148802694|NCT01326871|536757733|FG002|Overall Study|SAE and physician decision|1|||
148802695|NCT01326871|536757731|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
148802696|NCT01326871|536757732|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
148802697|NCT01326871|536757733|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
148802698|NCT01326871|536757731|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
148802699|NCT01326871|536757732|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
148802700|NCT01326871|536757733|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
148802701|NCT01326871|536757731|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
148802702|NCT01326871|536757732|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
148802703|NCT01326871|536757733|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
148802704|NCT01326871|536757731|FG000|Overall Study|Physician Decision|0|||
148802705|NCT01326871|536757732|FG001|Overall Study|Physician Decision|0|||
148802706|NCT01326871|536757733|FG002|Overall Study|Physician Decision|1|||
148802707|NCT01326871|536757731|FG000|Overall Study|SAE|0|||
148802708|NCT01326871|536757732|FG001|Overall Study|SAE|0|||
148802709|NCT01326871|536757733|FG002|Overall Study|SAE|1|||
148802710|NCT01326871|536757731|FG000|Overall Study|Disease progression and death|0|||
148802711|NCT01326871|536757732|FG001|Overall Study|Disease progression and death|0|||
148802712|NCT01326871|536757733|FG002|Overall Study|Disease progression and death|1|||
148802713|NCT01326871|536757731|FG000|Overall Study|Subject decision|0|||
148802714|NCT01326871|536757732|FG001|Overall Study|Subject decision|0|||
148802715|NCT01326871|536757733|FG002|Overall Study|Subject decision|1|||
148802716|NCT01387269|536757736|FG000|Overall Study|Death|38|||
148802717|NCT01387269|536757737|FG001|Overall Study|Death|20|||
148802718|NCT01387269|536757736|FG000|Overall Study|Other|8|||
148802719|NCT01387269|536757737|FG001|Overall Study|Other|7|||
148802720|NCT01387269|536757736|FG000|Overall Study|Unrelated AE|12|||
148802721|NCT01387269|536757737|FG001|Overall Study|Unrelated AE|3|||
148802722|NCT01387269|536757736|FG000|Overall Study|Withdrawal by patient|32|||
148802723|NCT01387269|536757737|FG001|Overall Study|Withdrawal by patient|10|||
148802724|NCT01387269|536757736|FG000|Overall Study|Study drug-related AE|1|||
148802725|NCT01387269|536757737|FG001|Overall Study|Study drug-related AE|0|||
148802726|NCT01387269|536757736|FG000|Overall Study|Lost to Follow-up|1|||
148802727|NCT01387269|536757737|FG001|Overall Study|Lost to Follow-up|0|||
148802728|NCT01200329|536757738|FG000|Overall Study|Lack of financial coverage|2|||
148802729|NCT01200329|536757738|FG000|Overall Study|Progressive disease|1|||
148802730|NCT03087058|536757742|FG000|Overall Study|Withdrawal by Subject|2|||
148802731|NCT03087058|536757743|FG001|Overall Study|Withdrawal by Subject|0|||
148802732|NCT03087058|536757744|FG002|Overall Study|Withdrawal by Subject|0|||
148802733|NCT02078817|536757747|FG000|Overall Study|Withdrawal by Subject|1|||
148802734|NCT01441973|536757753|FG000|Overall Study|Disease progression|8|||
148802735|NCT01441973|536757754|FG001|Overall Study|Disease progression|6|||
148802736|NCT01441973|536757753|FG000|Overall Study|Adverse event unrelated to study drug|3|||
148802737|NCT01441973|536757754|FG001|Overall Study|Adverse event unrelated to study drug|2|||
148905361|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
148905362|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
148905363|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
148905364|NCT03739203|537135146|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
148905365|NCT03739203|537135147|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
148905366|NCT03739203|537135148|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
148905367|NCT03739203|537135146|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
148905368|NCT03739203|537135147|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
148905369|NCT03739203|537135148|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
148905370|NCT03739203|537135146|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
148905371|NCT03739203|537135147|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
148905372|NCT03739203|537135148|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
148905373|NCT03739203|537135146|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
148905374|NCT03739203|537135147|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
148905375|NCT03739203|537135148|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
148905376|NCT03739203|537135146|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
148905377|NCT03739203|537135147|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
148905378|NCT03739203|537135148|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
148905379|NCT01782378|537135149|FG000|First Series|Lost to Follow-up|7|||
148905380|NCT01782378|537135150|FG001|First Series|Lost to Follow-up|8|||
148905381|NCT01782378|537135149|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
148905382|NCT01782378|537135150|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
148905383|NCT01782378|537135149|FG000|Second Series|Lost to Follow-up|8|||
148905384|NCT01782378|537135150|FG001|Second Series|Lost to Follow-up|7|||
148905385|NCT01782378|537135149|FG000|Second Series|Did not choose to complete S2 Optional|18|||
148905386|NCT01782378|537135150|FG001|Second Series|Did not choose to complete S2 Optional|0|||
148905387|NCT00830440|537135151|FG000|Overall Study|Protocol Violation|1|||
148905388|NCT00830440|537135152|FG001|Overall Study|Protocol Violation|0|||
148905389|NCT00830440|537135151|FG000|Overall Study|Withdrawal by Subject|1|||
148905390|NCT00830440|537135152|FG001|Overall Study|Withdrawal by Subject|0|||
148905391|NCT00830440|537135151|FG000|Overall Study|unsuccessful procedure|4|||
148905392|NCT00830440|537135152|FG001|Overall Study|unsuccessful procedure|0|||
148905393|NCT00830440|537135151|FG000|Overall Study|Adverse Event|2|||
148905394|NCT00830440|537135152|FG001|Overall Study|Adverse Event|0|||
148905395|NCT02592798|537135153|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
148905396|NCT02592798|537135154|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
148905397|NCT02592798|537135153|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
148905398|NCT02592798|537135154|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
148905399|NCT02592798|537135153|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
148905400|NCT02592798|537135154|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
148905401|NCT02592798|537135153|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
148905402|NCT02592798|537135154|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
148905403|NCT02592798|537135153|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
148905404|NCT02592798|537135154|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
148905405|NCT02592798|537135153|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
148905406|NCT02592798|537135154|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
148905407|NCT02592798|537135153|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
148905408|NCT02592798|537135154|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
148905409|NCT02592798|537135153|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
148905410|NCT02592798|537135154|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
148905411|NCT02592798|537135153|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
148905412|NCT02592798|537135154|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
148905413|NCT02592798|537135153|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
148905414|NCT02592798|537135154|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
148905415|NCT02592798|537135153|FG000|Transition From DB2 to OLE|Other reasons|1|||
148905416|NCT02592798|537135154|FG001|Transition From DB2 to OLE|Other reasons|0|||
148905417|NCT02592798|537135153|FG000|Open Label Period (OLE)|Other reasons|0|||
148802738|NCT01441973|536757753|FG000|Overall Study|Participant request to discontinue|1|||
148802739|NCT01441973|536757754|FG001|Overall Study|Participant request to discontinue|1|||
148802740|NCT01441973|536757753|FG000|Overall Study|Poor compliance/noncompliance|0|||
148802741|NCT01441973|536757754|FG001|Overall Study|Poor compliance/noncompliance|1|||
148802742|NCT01441973|536757753|FG000|Overall Study|Administrative reason by sponsor|3|||
148802743|NCT01441973|536757754|FG001|Overall Study|Administrative reason by sponsor|5|||
148802744|NCT01441973|536757753|FG000|Overall Study|Participant withdrew consent|0|||
148802745|NCT01441973|536757754|FG001|Overall Study|Participant withdrew consent|1|||
148802746|NCT01149655|536757755|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
148802747|NCT01149655|536757756|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
148802748|NCT01149655|536757757|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
148802749|NCT01149655|536757758|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
148802750|NCT01149655|536757755|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
148802751|NCT01149655|536757756|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
148802752|NCT01149655|536757757|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
148802753|NCT01149655|536757758|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
148802754|NCT01149655|536757755|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
148802755|NCT01149655|536757756|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
148802756|NCT01149655|536757757|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
148802757|NCT01149655|536757758|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
148802758|NCT01149655|536757755|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
148802759|NCT01149655|536757756|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
148802760|NCT01149655|536757757|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
148802761|NCT01149655|536757758|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
148802762|NCT01149655|536757755|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
148802763|NCT01149655|536757756|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
148802764|NCT01149655|536757757|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
148802765|NCT01149655|536757758|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
148802766|NCT01149655|536757755|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
148802767|NCT01149655|536757756|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
148802768|NCT01149655|536757757|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
148802769|NCT01149655|536757758|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
148802770|NCT01149655|536757755|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
148802771|NCT01149655|536757756|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
148802772|NCT01149655|536757757|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
148802773|NCT01149655|536757758|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
148802774|NCT01149655|536757755|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
148802775|NCT01149655|536757756|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
148802776|NCT01149655|536757757|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
148802777|NCT01149655|536757758|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
148905418|NCT02592798|537135154|FG001|Open Label Period (OLE)|Other reasons|2|||
148905419|NCT02592798|537135153|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
148905420|NCT02592798|537135154|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
148905421|NCT02592798|537135153|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
148905422|NCT02592798|537135154|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
148905423|NCT02592798|537135153|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
148905424|NCT02592798|537135154|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
148905425|NCT02592798|537135153|FG000|Open Label Period (OLE)|Adverse Event|0|||
148905426|NCT02592798|537135154|FG001|Open Label Period (OLE)|Adverse Event|1|||
148905427|NCT00705016|537135155|FG000|Overall Study|Adverse Event|6|||
148905428|NCT00705016|537135156|FG001|Overall Study|Adverse Event|11|||
148802778|NCT01149655|536757755|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
148802779|NCT01149655|536757756|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
148802780|NCT01149655|536757757|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
148802781|NCT01149655|536757758|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
148802782|NCT01149655|536757755|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
148802783|NCT01149655|536757756|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
148802784|NCT01149655|536757757|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
148802785|NCT01149655|536757758|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
148802786|NCT01149655|536757755|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
148802787|NCT01149655|536757756|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
148802788|NCT01149655|536757757|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
148802789|NCT01149655|536757758|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
148802790|NCT01149655|536757755|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
148802791|NCT01149655|536757756|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
148802792|NCT01149655|536757757|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
148802793|NCT01149655|536757758|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
148802794|NCT01149655|536757755|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
148802795|NCT01149655|536757756|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
148802796|NCT01149655|536757757|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
148802797|NCT01149655|536757758|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
148802798|NCT01149655|536757755|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
148802799|NCT01149655|536757756|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
148802800|NCT01149655|536757757|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
148802801|NCT01149655|536757758|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
148802802|NCT01149655|536757755|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
148802803|NCT01149655|536757756|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
148802804|NCT01149655|536757757|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
148802805|NCT01149655|536757758|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
148802806|NCT01149655|536757755|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
148802807|NCT01149655|536757756|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
148802808|NCT01149655|536757757|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
148802809|NCT01149655|536757758|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
148802810|NCT01265498|536757759|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
148802811|NCT01265498|536757760|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
148802812|NCT00617279|536757767|FG000|Overall Study|Study terminated by Sponsor|10|||
148802813|NCT00617279|536757768|FG001|Overall Study|Study terminated by Sponsor|15|||
148802814|NCT00617279|536757767|FG000|Overall Study|Graft abandonment|2|||
148802815|NCT00617279|536757768|FG001|Overall Study|Graft abandonment|0|||
148802816|NCT00617279|536757767|FG000|Overall Study|Lost to Follow-up|1|||
148802817|NCT00617279|536757768|FG001|Overall Study|Lost to Follow-up|0|||
148802818|NCT00617279|536757767|FG000|Overall Study|Death|1|||
148802819|NCT00617279|536757768|FG001|Overall Study|Death|2|||
148802820|NCT00921024|536757769|FG000|Overall Study|Lost to Follow-up|2|||
148802821|NCT00921024|536757770|FG001|Overall Study|Lost to Follow-up|0|||
148802822|NCT00921024|536757769|FG000|Overall Study|Received concomittant therapy|2|||
148802823|NCT00921024|536757770|FG001|Overall Study|Received concomittant therapy|0|||
148802824|NCT00921024|536757769|FG000|Overall Study|Withdrawal by Subject|0|||
148802825|NCT00921024|536757770|FG001|Overall Study|Withdrawal by Subject|3|||
148802826|NCT02873689|536759401|FG000|Overall Study|Lack of Efficacy|1|||
148802827|NCT02873689|536759402|FG001|Overall Study|Lack of Efficacy|0|||
148802828|NCT02873689|536759401|FG000|Overall Study|Withdrawal by Subject|2|||
148802829|NCT02873689|536759402|FG001|Overall Study|Withdrawal by Subject|2|||
148802830|NCT02873689|536759401|FG000|Overall Study|Protocol Violation|1|||
148802831|NCT02873689|536759402|FG001|Overall Study|Protocol Violation|0|||
148802832|NCT02873689|536759401|FG000|Overall Study|Adverse Event|2|||
148802833|NCT02873689|536759402|FG001|Overall Study|Adverse Event|2|||
148802834|NCT02873689|536759401|FG000|Overall Study|Randomized but not Treated|1|||
148802835|NCT02873689|536759402|FG001|Overall Study|Randomized but not Treated|1|||
148802836|NCT00350545|536759403|FG000|Overall Study|Withdrawal by Subject|2|||
148802837|NCT00720278|536759426|FG000|Overall Study|Adverse Event|5|||
148802838|NCT00720278|536759427|FG001|Overall Study|Adverse Event|3|||
148802839|NCT00720278|536759428|FG002|Overall Study|Adverse Event|4|||
148802840|NCT00720278|536759426|FG000|Overall Study|Withdrawal by Subject|0|||
148802841|NCT00720278|536759427|FG001|Overall Study|Withdrawal by Subject|1|||
148802842|NCT00720278|536759428|FG002|Overall Study|Withdrawal by Subject|0|||
148802843|NCT00720278|536759426|FG000|Overall Study|Lost to Follow-up|0|||
148905429|NCT00705016|537135157|FG002|Overall Study|Adverse Event|10|||
148905430|NCT00705016|537135155|FG000|Overall Study|Death|5|||
148905431|NCT00705016|537135156|FG001|Overall Study|Death|7|||
148905432|NCT00705016|537135157|FG002|Overall Study|Death|5|||
148905433|NCT00705016|537135155|FG000|Overall Study|Protocol Violation|0|||
148905434|NCT00705016|537135156|FG001|Overall Study|Protocol Violation|1|||
148905435|NCT00705016|537135157|FG002|Overall Study|Protocol Violation|1|||
148905436|NCT00705016|537135155|FG000|Overall Study|Withdrawal by Subject|4|||
148905437|NCT00705016|537135156|FG001|Overall Study|Withdrawal by Subject|3|||
148905438|NCT00705016|537135157|FG002|Overall Study|Withdrawal by Subject|2|||
148905439|NCT00705016|537135155|FG000|Overall Study|Progressive Disease|33|||
148905440|NCT00705016|537135156|FG001|Overall Study|Progressive Disease|29|||
148905441|NCT00705016|537135157|FG002|Overall Study|Progressive Disease|33|||
148905442|NCT00705016|537135155|FG000|Overall Study|Symptomatic Deterioration|3|||
148905443|NCT00705016|537135156|FG001|Overall Study|Symptomatic Deterioration|1|||
148905444|NCT00705016|537135157|FG002|Overall Study|Symptomatic Deterioration|1|||
148905445|NCT00705016|537135155|FG000|Overall Study|Other|9|||
148905446|NCT00705016|537135156|FG001|Overall Study|Other|6|||
148905447|NCT00705016|537135157|FG002|Overall Study|Other|6|||
148905448|NCT00942604|537135160|FG000|Overall Study|Protocol Violation|1|||
148905449|NCT00942604|537135161|FG001|Overall Study|Protocol Violation|1|||
148905450|NCT00942604|537135160|FG000|Overall Study|Adverse Event|0|||
148905451|NCT00942604|537135161|FG001|Overall Study|Adverse Event|1|||
148905452|NCT00942604|537135160|FG000|Overall Study|Withdrawal by Subject|0|||
148905453|NCT00942604|537135161|FG001|Overall Study|Withdrawal by Subject|1|||
148905454|NCT00942604|537135160|FG000|Overall Study|Patient relocation|1|||
148905455|NCT00942604|537135161|FG001|Overall Study|Patient relocation|1|||
148905456|NCT00363480|537135162|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
148905457|NCT00363480|537135162|FG000|Overall Study|Adverse Event|4|||
148905458|NCT00363480|537135162|FG000|Overall Study|Lost to Follow-up|5|||
148905459|NCT00363480|537135162|FG000|Overall Study|Withdrawal by Subject|5|||
148905460|NCT00363480|537135162|FG000|Overall Study|Non-compliance of subject|1|||
148905461|NCT00363480|537135162|FG000|Overall Study|Participant discontinued on its own|1|||
148905462|NCT00888940|537135169|FG000|Overall Study|Adverse Event|12|||
148905463|NCT00888940|537135170|FG001|Overall Study|Adverse Event|3|||
148905464|NCT00888940|537135169|FG000|Overall Study|Lost to Follow-up|5|||
148905465|NCT00888940|537135170|FG001|Overall Study|Lost to Follow-up|5|||
148905466|NCT00888940|537135169|FG000|Overall Study|Randomized Not Treated|11|||
148905467|NCT00888940|537135170|FG001|Overall Study|Randomized Not Treated|13|||
148905468|NCT02205736|537135171|FG000|Overall Study|Lost to Follow-up|106|||
148905469|NCT03326713|537135172|FG000|Overall Study|Death|2|||
148905470|NCT03326713|537135173|FG001|Overall Study|Death|1|||
148905471|NCT03326713|537135174|FG002|Overall Study|Death|0|||
148905472|NCT03326713|537135172|FG000|Overall Study|Lost to Follow-up|20|||
148905473|NCT03326713|537135173|FG001|Overall Study|Lost to Follow-up|21|||
148905474|NCT03326713|537135174|FG002|Overall Study|Lost to Follow-up|33|||
148905475|NCT03326713|537135172|FG000|Overall Study|Withdrawal by Subject|1|||
148905476|NCT03326713|537135173|FG001|Overall Study|Withdrawal by Subject|2|||
148905477|NCT03326713|537135174|FG002|Overall Study|Withdrawal by Subject|11|||
148905478|NCT03326713|537135172|FG000|Overall Study|Found Ineligible|11|||
148905479|NCT03326713|537135173|FG001|Overall Study|Found Ineligible|11|||
148905480|NCT03326713|537135174|FG002|Overall Study|Found Ineligible|8|||
148905481|NCT00771758|537135175|FG000|Overall Study|Adverse Event|2|||
148905482|NCT00771758|537135176|FG001|Overall Study|Adverse Event|8|||
148905483|NCT00771758|537135177|FG002|Overall Study|Adverse Event|1|||
148905484|NCT00771758|537135175|FG000|Overall Study|Lack of Efficacy|0|||
148905485|NCT00771758|537135176|FG001|Overall Study|Lack of Efficacy|2|||
148905486|NCT00771758|537135177|FG002|Overall Study|Lack of Efficacy|1|||
148905487|NCT00771758|537135175|FG000|Overall Study|Lost to Follow-up|1|||
148905488|NCT00771758|537135176|FG001|Overall Study|Lost to Follow-up|0|||
148905489|NCT00771758|537135177|FG002|Overall Study|Lost to Follow-up|0|||
148905490|NCT00771758|537135175|FG000|Overall Study|Protocol Violation|1|||
148905491|NCT00771758|537135176|FG001|Overall Study|Protocol Violation|0|||
148905492|NCT00771758|537135177|FG002|Overall Study|Protocol Violation|0|||
148905493|NCT00771758|537135175|FG000|Overall Study|Withdrawal by Subject|1|||
148905494|NCT00771758|537135176|FG001|Overall Study|Withdrawal by Subject|0|||
148905495|NCT00771758|537135177|FG002|Overall Study|Withdrawal by Subject|0|||
148905496|NCT00771758|537135175|FG000|Overall Study|Other|3|||
148905497|NCT00771758|537135176|FG001|Overall Study|Other|2|||
148905498|NCT00771758|537135177|FG002|Overall Study|Other|0|||
148905499|NCT03067077|537135178|FG000|Overall Study|Did not receive surgery|4|||
148905500|NCT03067077|537135179|FG001|Overall Study|Did not receive surgery|5|||
148905501|NCT03067077|537135178|FG000|Overall Study|Lost to Follow-up|3|||
148905502|NCT03067077|537135179|FG001|Overall Study|Lost to Follow-up|2|||
148905503|NCT00935584|537135182|FG000|Overall Study|Withdrawal by Subject|9|||
148802844|NCT00720278|536759427|FG001|Overall Study|Lost to Follow-up|0|||
148802845|NCT00720278|536759428|FG002|Overall Study|Lost to Follow-up|1|||
148802846|NCT00720278|536759426|FG000|Overall Study|Non-compliance|1|||
148802847|NCT00720278|536759427|FG001|Overall Study|Non-compliance|0|||
148802848|NCT00720278|536759428|FG002|Overall Study|Non-compliance|0|||
148802849|NCT00720278|536759426|FG000|Overall Study|eligibility criteria violation|1|||
148802850|NCT00720278|536759427|FG001|Overall Study|eligibility criteria violation|0|||
148802851|NCT00720278|536759428|FG002|Overall Study|eligibility criteria violation|1|||
148802852|NCT03630393|536759434|FG000|Overall Study|Death|1|||
148802853|NCT03630393|536759435|FG001|Overall Study|Death|0|||
148802854|NCT00408499|536759436|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
148802855|NCT00408499|536759437|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
148802856|NCT00408499|536759438|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
148802857|NCT00408499|536759439|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
148802858|NCT00408499|536759440|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
148802859|NCT00408499|536759436|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
148802860|NCT00408499|536759437|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
148802861|NCT00408499|536759438|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
148802862|NCT00408499|536759439|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
148802863|NCT00408499|536759440|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
148802864|NCT00408499|536759436|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
148802865|NCT00408499|536759437|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
148802866|NCT00408499|536759438|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
148802867|NCT00408499|536759439|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
148802868|NCT00408499|536759440|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
148802869|NCT00408499|536759436|FG000|Phase II- MTD Expansion|Adverse Event|0|||
148802870|NCT00408499|536759437|FG001|Phase II- MTD Expansion|Adverse Event|0|||
148802871|NCT00408499|536759438|FG002|Phase II- MTD Expansion|Adverse Event|0|||
148802872|NCT00408499|536759439|FG003|Phase II- MTD Expansion|Adverse Event|0|||
148802873|NCT00408499|536759440|FG004|Phase II- MTD Expansion|Adverse Event|9|||
148802874|NCT00408499|536759436|FG000|Phase II- MTD Expansion|Death|0|||
148802875|NCT00408499|536759437|FG001|Phase II- MTD Expansion|Death|0|||
148905504|NCT00935584|537135183|FG001|Overall Study|Withdrawal by Subject|0|||
148905505|NCT00935584|537135182|FG000|Overall Study|Death|3|||
148905506|NCT00935584|537135183|FG001|Overall Study|Death|0|||
148905507|NCT00935584|537135182|FG000|Overall Study|Lost to Follow-up|8|||
148905508|NCT00935584|537135183|FG001|Overall Study|Lost to Follow-up|0|||
148905509|NCT00935584|537135182|FG000|Overall Study|No show|9|||
148905510|NCT00935584|537135183|FG001|Overall Study|No show|0|||
148905511|NCT00935584|537135182|FG000|Overall Study|Relocated|3|||
148905512|NCT00935584|537135183|FG001|Overall Study|Relocated|0|||
148905513|NCT00935584|537135182|FG000|Overall Study|Patient changed provider|3|||
148905514|NCT00935584|537135183|FG001|Overall Study|Patient changed provider|0|||
148905515|NCT00935584|537135182|FG000|Overall Study|Provider dropped out of study|14|||
148905516|NCT00935584|537135183|FG001|Overall Study|Provider dropped out of study|4|||
148905517|NCT05786651|537135188|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
148905518|NCT02105662|537136761|FG000|Overall Study|Lost to Follow-up|5|||
148905519|NCT02105662|537136761|FG000|Overall Study|Withdrawal by Subject|1|||
148905520|NCT00990704|537136765|FG000|Overall Study|Adverse Event|1|||
148905521|NCT00990704|537136766|FG001|Overall Study|Adverse Event|1|||
148905522|NCT00990704|537136765|FG000|Overall Study|Physician Decision|0|||
148905523|NCT00990704|537136766|FG001|Overall Study|Physician Decision|1|||
148905524|NCT03722238|537136769|FG000|Overall Study|Protocol Violation|1|||
148905525|NCT03722238|537136770|FG001|Overall Study|Protocol Violation|0|||
148905526|NCT03722238|537136769|FG000|Overall Study|Physician Decision|1|||
148905527|NCT03722238|537136770|FG001|Overall Study|Physician Decision|0|||
148905528|NCT03722238|537136769|FG000|Overall Study|Death|1|||
148905529|NCT03722238|537136770|FG001|Overall Study|Death|0|||
148905530|NCT03722238|537136769|FG000|Overall Study|Lost to Follow-up|6|||
148905531|NCT03722238|537136770|FG001|Overall Study|Lost to Follow-up|0|||
148905532|NCT03722238|537136769|FG000|Overall Study|Partial missing data|44|||
148905533|NCT03722238|537136770|FG001|Overall Study|Partial missing data|1|||
148905534|NCT03722238|537136769|FG000|Overall Study|Withdrawal by Subject|2|||
148905535|NCT03722238|537136770|FG001|Overall Study|Withdrawal by Subject|0|||
148905536|NCT03722238|537136769|FG000|Overall Study|Other|4|||
148905537|NCT03722238|537136770|FG001|Overall Study|Other|0|||
148905538|NCT03722238|537136769|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
148905539|NCT03722238|537136770|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
148905540|NCT03722238|537136769|FG000|Overall Study|Did not meet risk classification group criteria|90|||
148905541|NCT03722238|537136770|FG001|Overall Study|Did not meet risk classification group criteria|0|||
148905542|NCT03722238|537136769|FG000|Overall Study|Did not sign consent|17|||
148905543|NCT03722238|537136770|FG001|Overall Study|Did not sign consent|0|||
148905544|NCT03722238|537136769|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
148905545|NCT03722238|537136770|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
148905546|NCT03722238|537136769|FG000|Overall Study|Not willing to purchase study medication|142|||
148905547|NCT03722238|537136770|FG001|Overall Study|Not willing to purchase study medication|0|||
148905548|NCT03722238|537136769|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
148905549|NCT03722238|537136770|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
148905550|NCT00561925|537136771|FG000|14 Day Lead-In Period|Adverse Event|38|||
148905551|NCT00561925|537136772|FG001|14 Day Lead-In Period|Adverse Event|0|||
148905552|NCT00561925|537136773|FG002|14 Day Lead-In Period|Adverse Event|0|||
148905553|NCT00561925|537136774|FG003|14 Day Lead-In Period|Adverse Event|0|||
148905554|NCT00561925|537136775|FG004|14 Day Lead-In Period|Adverse Event|0|||
148905555|NCT00561925|537136771|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
148905556|NCT00561925|537136772|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
148905557|NCT00561925|537136773|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
148905558|NCT00561925|537136774|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
148905559|NCT00561925|537136775|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
148905560|NCT00561925|537136771|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
148905561|NCT00561925|537136772|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
148905562|NCT00561925|537136773|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
148905563|NCT00561925|537136774|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
148905564|NCT00561925|537136775|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
148905565|NCT00561925|537136771|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
148905566|NCT00561925|537136772|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
148905567|NCT00561925|537136773|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
148905568|NCT00561925|537136774|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
148905569|NCT00561925|537136775|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
148905570|NCT00561925|537136771|FG000|14 Day Lead-In Period|Other|5|||
148905571|NCT00561925|537136772|FG001|14 Day Lead-In Period|Other|0|||
148905572|NCT00561925|537136773|FG002|14 Day Lead-In Period|Other|0|||
148905573|NCT00561925|537136774|FG003|14 Day Lead-In Period|Other|0|||
148905574|NCT00561925|537136775|FG004|14 Day Lead-In Period|Other|0|||
148905575|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
148905576|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
148905577|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
148905578|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
148905579|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
148905580|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
148905581|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
148905582|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
148905583|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
148905584|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
148905585|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
148905586|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
148905587|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
148905588|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
148905589|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
148905590|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
148905591|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
148905592|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
148905593|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
148905594|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
148905595|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
148905596|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
148905597|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
148905598|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
148905599|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
148905600|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
148905601|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
148905602|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
148905603|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
148905604|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
148905605|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Death|0|||
148905606|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Death|6|||
148905607|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Death|3|||
148905608|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Death|0|||
148905609|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Death|0|||
148905610|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
148905611|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
148905612|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
148905613|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
148905614|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
148905615|NCT00561925|537136771|FG000|144-week Double-blind, Double-dummy|Other|0|||
148905616|NCT00561925|537136772|FG001|144-week Double-blind, Double-dummy|Other|8|||
148905617|NCT00561925|537136773|FG002|144-week Double-blind, Double-dummy|Other|11|||
148905618|NCT00561925|537136774|FG003|144-week Double-blind, Double-dummy|Other|0|||
148905619|NCT00561925|537136775|FG004|144-week Double-blind, Double-dummy|Other|0|||
148905620|NCT00561925|537136771|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
148905621|NCT00561925|537136772|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
148905622|NCT00561925|537136773|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
148905623|NCT00561925|537136774|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
148905624|NCT00561925|537136775|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
148802876|NCT00408499|536759438|FG002|Phase II- MTD Expansion|Death|0|||
148802877|NCT00408499|536759439|FG003|Phase II- MTD Expansion|Death|0|||
148802878|NCT00408499|536759440|FG004|Phase II- MTD Expansion|Death|2|||
148802879|NCT00408499|536759436|FG000|Phase II- MTD Expansion|Physician Decision|0|||
148802880|NCT00408499|536759437|FG001|Phase II- MTD Expansion|Physician Decision|0|||
148802881|NCT00408499|536759438|FG002|Phase II- MTD Expansion|Physician Decision|0|||
148802882|NCT00408499|536759439|FG003|Phase II- MTD Expansion|Physician Decision|0|||
148802883|NCT00408499|536759440|FG004|Phase II- MTD Expansion|Physician Decision|1|||
148802884|NCT00408499|536759436|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
148802885|NCT00408499|536759437|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
148802886|NCT00408499|536759438|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
148802887|NCT00408499|536759439|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
148802888|NCT00408499|536759440|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
148802889|NCT00408499|536759436|FG000|Phase II- MTD Expansion|treatment delay|0|||
148802890|NCT00408499|536759437|FG001|Phase II- MTD Expansion|treatment delay|0|||
148802891|NCT00408499|536759438|FG002|Phase II- MTD Expansion|treatment delay|0|||
148802892|NCT00408499|536759439|FG003|Phase II- MTD Expansion|treatment delay|0|||
148802893|NCT00408499|536759440|FG004|Phase II- MTD Expansion|treatment delay|3|||
148802894|NCT00266708|536759444|FG000|Overall Study|No renal function|1|||
148802895|NCT00266708|536759445|FG001|Overall Study|No renal function|1|||
148802896|NCT00266708|536759444|FG000|Overall Study|Refused biopsy|3|||
148802897|NCT00266708|536759445|FG001|Overall Study|Refused biopsy|6|||
148802898|NCT00266708|536759444|FG000|Overall Study|Asthma|0|||
148802899|NCT00266708|536759445|FG001|Overall Study|Asthma|2|||
148802900|NCT02791269|536759446|FG000|Overall Study|Lost to Follow-up|0|||
148802901|NCT02791269|536759447|FG001|Overall Study|Lost to Follow-up|1|||
148802902|NCT02351934|536759448|FG000|Allocation|POD weight<pre-op weight|3|||
148802903|NCT02351934|536759449|FG001|Allocation|POD weight<pre-op weight|0|||
148802904|NCT02351934|536759448|FG000|Allocation|Hypotension preventing administration|2|||
148802905|NCT02351934|536759449|FG001|Allocation|Hypotension preventing administration|0|||
148802906|NCT02351934|536759448|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
148802907|NCT02351934|536759449|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
148802908|NCT02351934|536759448|FG000|Follow-Up|POD weight<pre-op weight|3|||
148802909|NCT02351934|536759449|FG001|Follow-Up|POD weight<pre-op weight|0|||
148802910|NCT02351934|536759448|FG000|Follow-Up|Acute Kidney Injury|1|||
148802911|NCT02351934|536759449|FG001|Follow-Up|Acute Kidney Injury|0|||
148802912|NCT02351934|536759448|FG000|Follow-Up|Early dismissal|3|||
148802913|NCT02351934|536759449|FG001|Follow-Up|Early dismissal|0|||
148802914|NCT02351934|536759448|FG000|Follow-Up|Hypotension|3|||
148802915|NCT02351934|536759449|FG001|Follow-Up|Hypotension|0|||
148802916|NCT02351934|536759448|FG000|Follow-Up|No documentation|2|||
148802917|NCT02351934|536759449|FG001|Follow-Up|No documentation|0|||
148802918|NCT02351934|536759448|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
148802919|NCT02351934|536759449|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
148802920|NCT02351934|536759448|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
148802921|NCT02351934|536759449|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
148802922|NCT02683109|536759450|FG000|Overall Study|Adverse Event|1|||
148802923|NCT02683109|536759451|FG001|Overall Study|Adverse Event|0|||
148802924|NCT00368251|536759452|FG000|Overall Study|SAE, non-fatal|1|||
148802925|NCT00368251|536759453|FG001|Overall Study|SAE, non-fatal|0|||
148802926|NCT00368251|536759454|FG002|Overall Study|SAE, non-fatal|0|||
148802927|NCT00368251|536759452|FG000|Overall Study|AE, non-serious non-fatal|0|||
148802928|NCT00368251|536759453|FG001|Overall Study|AE, non-serious non-fatal|0|||
148802929|NCT00368251|536759454|FG002|Overall Study|AE, non-serious non-fatal|1|||
148802930|NCT02466399|536759458|FG000|Overall Study|Adverse Event|1|||
148802931|NCT02466399|536759459|FG001|Overall Study|Adverse Event|0|||
148802932|NCT02466399|536759458|FG000|Overall Study|Early exit due to family emergency|1|||
148802933|NCT02466399|536759459|FG001|Overall Study|Early exit due to family emergency|0|||
148802934|NCT01373164|536759460|FG000|Overall Study|Lost to Follow-up|0|||
148802935|NCT01373164|536759461|FG001|Overall Study|Lost to Follow-up|0|||
148802936|NCT01373164|536759462|FG002|Overall Study|Lost to Follow-up|1|||
148802937|NCT01373164|536759463|FG003|Overall Study|Lost to Follow-up|2|||
148802938|NCT01373164|536759464|FG004|Overall Study|Lost to Follow-up|0|||
148802939|NCT01373164|536759460|FG000|Overall Study|Withdrawal by Subject|0|||
148905625|NCT00684021|537136778|FG000|Overall Study|MRI Contraindicated|1|||
148905626|NCT00684021|537136779|FG001|Overall Study|MRI Contraindicated|1|||
148905627|NCT00684021|537136780|FG002|Overall Study|MRI Contraindicated|1|||
148905628|NCT00684021|537136781|FG003|Overall Study|MRI Contraindicated|0|||
148905629|NCT00684021|537136778|FG000|Overall Study|MRI not performed|0|||
148905630|NCT00684021|537136779|FG001|Overall Study|MRI not performed|1|||
148905631|NCT00684021|537136780|FG002|Overall Study|MRI not performed|1|||
148905632|NCT00684021|537136781|FG003|Overall Study|MRI not performed|2|||
148905633|NCT00684021|537136778|FG000|Overall Study|Death|1|||
148905634|NCT00684021|537136779|FG001|Overall Study|Death|0|||
148905635|NCT00684021|537136780|FG002|Overall Study|Death|0|||
148905636|NCT00684021|537136781|FG003|Overall Study|Death|0|||
148905637|NCT00891904|537136782|FG000|Overall Study|Death|1|||
148905638|NCT00891904|537136782|FG000|Overall Study|Adverse Event|1|||
148905639|NCT01046396|537136783|FG000|Overall Study|Withdrawal by Subject|5|||
148905640|NCT02177032|537136784|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
148905641|NCT02177032|537136785|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
148905642|NCT02177032|537136786|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
148905643|NCT02177032|537136787|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
148905644|NCT02177032|537136784|FG000|Overall Study|Lost to Follow-up|0|||
148905645|NCT02177032|537136785|FG001|Overall Study|Lost to Follow-up|2|||
148905646|NCT02177032|537136786|FG002|Overall Study|Lost to Follow-up|0|||
148905647|NCT02177032|537136787|FG003|Overall Study|Lost to Follow-up|0|||
148905648|NCT02177032|537136784|FG000|Overall Study|OTHER|2|||
148905649|NCT02177032|537136785|FG001|Overall Study|OTHER|0|||
148905650|NCT02177032|537136786|FG002|Overall Study|OTHER|1|||
148905651|NCT02177032|537136787|FG003|Overall Study|OTHER|0|||
148905652|NCT02177032|537136784|FG000|Overall Study|Withdrawal by Subject|1|||
148905653|NCT02177032|537136785|FG001|Overall Study|Withdrawal by Subject|0|||
148905654|NCT02177032|537136786|FG002|Overall Study|Withdrawal by Subject|1|||
148905655|NCT02177032|537136787|FG003|Overall Study|Withdrawal by Subject|0|||
148905656|NCT02556177|537136788|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
148905657|NCT02556177|537136789|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
148905658|NCT01188343|537136790|FG000|Overall Study|Not vaccinated|0|||
148905659|NCT01188343|537136791|FG001|Overall Study|Not vaccinated|2|||
148905660|NCT01188343|537136792|FG002|Overall Study|Not vaccinated|1|||
148905661|NCT01188343|537136790|FG000|Overall Study|Withdrawal by Subject|1|||
148905662|NCT01188343|537136791|FG001|Overall Study|Withdrawal by Subject|24|||
148905663|NCT01188343|537136792|FG002|Overall Study|Withdrawal by Subject|0|||
148905664|NCT01143246|537136793|FG000|Overall Study|Adverse Event|24|||
148905665|NCT01143246|537136794|FG001|Overall Study|Adverse Event|28|||
148905666|NCT01143246|537136793|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
148905667|NCT01143246|537136794|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
148905668|NCT01143246|537136793|FG000|Overall Study|Lost to Follow-up|0|||
148905669|NCT01143246|537136794|FG001|Overall Study|Lost to Follow-up|1|||
148905670|NCT01143246|537136793|FG000|Overall Study|Death|16|||
148905671|NCT01143246|537136794|FG001|Overall Study|Death|15|||
148905672|NCT01143246|537136793|FG000|Overall Study|Reason not Specified|3|||
148905673|NCT01143246|537136794|FG001|Overall Study|Reason not Specified|5|||
148905674|NCT04634253|537136795|FG000|Overall Study|Adverse Event|1|||
148905675|NCT04634253|537136796|FG001|Overall Study|Adverse Event|1|||
148905676|NCT04634253|537136797|FG002|Overall Study|Adverse Event|0|||
148905677|NCT04634253|537136795|FG000|Overall Study|Physician Decision|0|||
148905678|NCT04634253|537136796|FG001|Overall Study|Physician Decision|1|||
148905679|NCT04634253|537136797|FG002|Overall Study|Physician Decision|0|||
148905680|NCT04634253|537136795|FG000|Overall Study|Withdrawal by Subject|1|||
148905681|NCT04634253|537136796|FG001|Overall Study|Withdrawal by Subject|0|||
148905682|NCT04634253|537136797|FG002|Overall Study|Withdrawal by Subject|3|||
148905683|NCT01499355|537136798|FG000|Run-In Period|Study Termination|15|||
148905684|NCT01499355|537136799|FG001|Run-In Period|Study Termination|0|||
148905685|NCT01499355|537136800|FG002|Run-In Period|Study Termination|0|||
148905686|NCT01499355|537136801|FG003|Run-In Period|Study Termination|0|||
148905687|NCT01499355|537136798|FG000|Run-In Period|Other|3|||
148905688|NCT01499355|537136799|FG001|Run-In Period|Other|0|||
148905689|NCT01499355|537136800|FG002|Run-In Period|Other|0|||
148905690|NCT01499355|537136801|FG003|Run-In Period|Other|0|||
148905691|NCT01499355|537136798|FG000|Run-In Period|Death|2|||
148905692|NCT01499355|537136799|FG001|Run-In Period|Death|0|||
148905693|NCT01499355|537136800|FG002|Run-In Period|Death|0|||
148905694|NCT01499355|537136801|FG003|Run-In Period|Death|0|||
148905695|NCT01499355|537136798|FG000|Run-In Period|Investigator Decision|2|||
148905696|NCT01499355|537136799|FG001|Run-In Period|Investigator Decision|0|||
148905697|NCT01499355|537136800|FG002|Run-In Period|Investigator Decision|0|||
148905698|NCT01499355|537136801|FG003|Run-In Period|Investigator Decision|0|||
148905699|NCT01499355|537136798|FG000|Run-In Period|Consent Withdrawn|1|||
148905700|NCT01499355|537136799|FG001|Run-In Period|Consent Withdrawn|0|||
148905701|NCT01499355|537136800|FG002|Run-In Period|Consent Withdrawn|0|||
148905702|NCT01499355|537136801|FG003|Run-In Period|Consent Withdrawn|0|||
148905703|NCT01499355|537136798|FG000|Run-In Period|Adverse Event|8|||
148905704|NCT01499355|537136799|FG001|Run-In Period|Adverse Event|0|||
148905705|NCT01499355|537136800|FG002|Run-In Period|Adverse Event|0|||
148905706|NCT01499355|537136801|FG003|Run-In Period|Adverse Event|0|||
148905707|NCT01499355|537136798|FG000|Double-Blind Period|Adverse Event|0|||
148905708|NCT01499355|537136799|FG001|Double-Blind Period|Adverse Event|2|||
148905709|NCT01499355|537136800|FG002|Double-Blind Period|Adverse Event|3|||
148905710|NCT01499355|537136801|FG003|Double-Blind Period|Adverse Event|2|||
148905711|NCT01499355|537136798|FG000|Double-Blind Period|Study Termination|0|||
148905712|NCT01499355|537136799|FG001|Double-Blind Period|Study Termination|18|||
148905713|NCT01499355|537136800|FG002|Double-Blind Period|Study Termination|16|||
148905714|NCT01499355|537136801|FG003|Double-Blind Period|Study Termination|14|||
148905715|NCT01499355|537136798|FG000|Double-Blind Period|Other|0|||
148905716|NCT01499355|537136799|FG001|Double-Blind Period|Other|1|||
148905717|NCT01499355|537136800|FG002|Double-Blind Period|Other|2|||
148905718|NCT01499355|537136801|FG003|Double-Blind Period|Other|2|||
148905719|NCT01499355|537136798|FG000|Double-Blind Period|Death|0|||
148905720|NCT01499355|537136799|FG001|Double-Blind Period|Death|1|||
148905721|NCT01499355|537136800|FG002|Double-Blind Period|Death|0|||
148905722|NCT01499355|537136801|FG003|Double-Blind Period|Death|0|||
148905723|NCT01499355|537136798|FG000|Double-Blind Period|Investigator Decision|0|||
148905724|NCT01499355|537136799|FG001|Double-Blind Period|Investigator Decision|0|||
148905725|NCT01499355|537136800|FG002|Double-Blind Period|Investigator Decision|3|||
148905726|NCT01499355|537136801|FG003|Double-Blind Period|Investigator Decision|3|||
148905727|NCT01499355|537136798|FG000|Double-Blind Period|Consent Withdrawn|0|||
148905728|NCT01499355|537136799|FG001|Double-Blind Period|Consent Withdrawn|0|||
148905729|NCT01499355|537136800|FG002|Double-Blind Period|Consent Withdrawn|1|||
148905730|NCT01499355|537136801|FG003|Double-Blind Period|Consent Withdrawn|2|||
148905731|NCT01499355|537136798|FG000|Double-Blind Period|Lost to Follow-up|0|||
148905732|NCT01499355|537136799|FG001|Double-Blind Period|Lost to Follow-up|1|||
148905733|NCT01499355|537136800|FG002|Double-Blind Period|Lost to Follow-up|0|||
148905734|NCT01499355|537136801|FG003|Double-Blind Period|Lost to Follow-up|0|||
148905735|NCT01457703|537136805|FG000|Overall Study|Screen Failure|5|||
148905736|NCT01457703|537136806|FG001|Overall Study|Screen Failure|7|||
148905737|NCT01457703|537136805|FG000|Overall Study|Withdrawal by Subject|1|||
148905738|NCT01457703|537136806|FG001|Overall Study|Withdrawal by Subject|4|||
148905739|NCT03987503|537136807|FG000|Overall Study|Lost to Follow-up|20|||
148905740|NCT03987503|537136807|FG000|Overall Study|Withdrawal by Subject|2|||
148905741|NCT03133793|537136813|FG000|Overall Study|Withdrawal by Subject|0|||
148905742|NCT03133793|537136814|FG001|Overall Study|Withdrawal by Subject|4|||
148905743|NCT03133793|537136815|FG002|Overall Study|Withdrawal by Subject|2|||
148905744|NCT03133793|537136816|FG003|Overall Study|Withdrawal by Subject|4|||
148905745|NCT03133793|537136813|FG000|Overall Study|Lost to Follow-up|1|||
148905746|NCT03133793|537136814|FG001|Overall Study|Lost to Follow-up|0|||
148905747|NCT03133793|537136815|FG002|Overall Study|Lost to Follow-up|2|||
148905748|NCT03133793|537136816|FG003|Overall Study|Lost to Follow-up|0|||
148905749|NCT03133793|537136813|FG000|Overall Study|Death|0|||
148905750|NCT03133793|537136814|FG001|Overall Study|Death|0|||
148905751|NCT03133793|537136815|FG002|Overall Study|Death|0|||
148905752|NCT03133793|537136816|FG003|Overall Study|Death|1|||
148905753|NCT03486834|537136817|FG000|Overall Study|Withdrawal by Subject|46|||
148905754|NCT03486834|537136818|FG001|Overall Study|Withdrawal by Subject|46|||
148905755|NCT03486834|537136819|FG002|Overall Study|Withdrawal by Subject|52|||
148905756|NCT03486834|537136817|FG000|Overall Study|Adverse Event|8|||
148905757|NCT03486834|537136818|FG001|Overall Study|Adverse Event|7|||
148905758|NCT03486834|537136819|FG002|Overall Study|Adverse Event|0|||
148905759|NCT03486834|537136817|FG000|Overall Study|Lost to Follow-up|41|||
148905760|NCT03486834|537136818|FG001|Overall Study|Lost to Follow-up|24|||
148905761|NCT03486834|537136819|FG002|Overall Study|Lost to Follow-up|39|||
148905762|NCT03486834|537136817|FG000|Overall Study|Non-compliance with Study Drug|2|||
148905763|NCT03486834|537136818|FG001|Overall Study|Non-compliance with Study Drug|2|||
148905764|NCT03486834|537136819|FG002|Overall Study|Non-compliance with Study Drug|0|||
148905765|NCT03486834|537136817|FG000|Overall Study|Physician Decision|5|||
148905766|NCT03486834|537136818|FG001|Overall Study|Physician Decision|2|||
148905767|NCT03486834|537136819|FG002|Overall Study|Physician Decision|3|||
148905768|NCT03486834|537136817|FG000|Overall Study|Pregnancy|10|||
148905769|NCT03486834|537136818|FG001|Overall Study|Pregnancy|12|||
148905770|NCT03486834|537136819|FG002|Overall Study|Pregnancy|12|||
148905771|NCT03486834|537136817|FG000|Overall Study|Protocol Deviation|2|||
148905772|NCT03486834|537136818|FG001|Overall Study|Protocol Deviation|3|||
148905773|NCT03486834|537136819|FG002|Overall Study|Protocol Deviation|3|||
148905774|NCT03486834|537136817|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148905775|NCT03486834|537136818|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
148905776|NCT03486834|537136819|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
148905777|NCT03486834|537136817|FG000|Overall Study|Randomized but not treated|4|||
148802940|NCT01373164|536759461|FG001|Overall Study|Withdrawal by Subject|1|||
148905778|NCT03486834|537136818|FG001|Overall Study|Randomized but not treated|4|||
148905779|NCT03486834|537136819|FG002|Overall Study|Randomized but not treated|1|||
148905780|NCT02745119|537136821|FG000|Overall Study|Adverse Event|1|||
148905781|NCT02745119|537136822|FG001|Overall Study|Adverse Event|0|||
148905782|NCT02745119|537136823|FG002|Overall Study|Adverse Event|1|||
148905783|NCT02745119|537136824|FG003|Overall Study|Adverse Event|3|||
148905784|NCT02745119|537136821|FG000|Overall Study|Death|3|||
148905785|NCT02745119|537136822|FG001|Overall Study|Death|3|||
148905786|NCT02745119|537136823|FG002|Overall Study|Death|0|||
148905787|NCT02745119|537136824|FG003|Overall Study|Death|4|||
148905788|NCT02745119|537136821|FG000|Overall Study|Lost to Follow-up|0|||
148905789|NCT02745119|537136822|FG001|Overall Study|Lost to Follow-up|0|||
148905790|NCT02745119|537136823|FG002|Overall Study|Lost to Follow-up|0|||
148905791|NCT02745119|537136824|FG003|Overall Study|Lost to Follow-up|1|||
148905792|NCT02745119|537136821|FG000|Overall Study|Protocol Deviation|0|||
148905793|NCT02745119|537136822|FG001|Overall Study|Protocol Deviation|0|||
148905794|NCT02745119|537136823|FG002|Overall Study|Protocol Deviation|0|||
148905795|NCT02745119|537136824|FG003|Overall Study|Protocol Deviation|1|||
148905796|NCT02745119|537136821|FG000|Overall Study|Withdrawal by Subject|7|||
148905797|NCT02745119|537136822|FG001|Overall Study|Withdrawal by Subject|15|||
148905798|NCT02745119|537136823|FG002|Overall Study|Withdrawal by Subject|8|||
148905799|NCT02745119|537136824|FG003|Overall Study|Withdrawal by Subject|14|||
148905800|NCT02745119|537136821|FG000|Overall Study|Study Terminated by Sponsor|134|||
148905801|NCT02745119|537136822|FG001|Overall Study|Study Terminated by Sponsor|252|||
148905802|NCT02745119|537136823|FG002|Overall Study|Study Terminated by Sponsor|135|||
148802941|NCT01373164|536759462|FG002|Overall Study|Withdrawal by Subject|0|||
148802942|NCT01373164|536759463|FG003|Overall Study|Withdrawal by Subject|10|||
148802943|NCT01373164|536759464|FG004|Overall Study|Withdrawal by Subject|2|||
148802944|NCT02669849|536759465|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
148802945|NCT02669849|536759466|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
148802946|NCT02669849|536759467|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
148802947|NCT02669849|536759465|FG000|Overall Study|Lost to Follow-up|1|||
148802948|NCT02669849|536759466|FG001|Overall Study|Lost to Follow-up|0|||
148802949|NCT02669849|536759467|FG002|Overall Study|Lost to Follow-up|3|||
148802950|NCT02669849|536759465|FG000|Overall Study|Death|1|||
148802951|NCT02669849|536759466|FG001|Overall Study|Death|1|||
148802952|NCT02669849|536759467|FG002|Overall Study|Death|2|||
148802953|NCT02669849|536759465|FG000|Overall Study|Study terminated by sponsor|16|||
148802954|NCT02669849|536759466|FG001|Overall Study|Study terminated by sponsor|1|||
148802955|NCT02669849|536759467|FG002|Overall Study|Study terminated by sponsor|14|||
148802956|NCT02669849|536759465|FG000|Overall Study|Other|0|||
148802957|NCT02669849|536759466|FG001|Overall Study|Other|0|||
148802958|NCT02669849|536759467|FG002|Overall Study|Other|2|||
148802959|NCT03408899|536759470|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
148802960|NCT02014272|536759483|FG000|Intervention Period 1|Withdrawal by Subject|1|||
148802961|NCT02014272|536759484|FG001|Intervention Period 1|Withdrawal by Subject|0|||
148802962|NCT02014272|536759483|FG000|Intervention Period 1|Adverse Event|0|||
148802963|NCT02014272|536759484|FG001|Intervention Period 1|Adverse Event|1|||
148802964|NCT00547339|536759485|FG000|Overall Study|Physician Decision|0|||
148802965|NCT00547339|536759486|FG001|Overall Study|Physician Decision|0|||
148802966|NCT00547339|536759487|FG002|Overall Study|Physician Decision|1|||
148802967|NCT00547339|536759488|FG003|Overall Study|Physician Decision|0|||
148802968|NCT01516216|536759489|FG000|Overall Study|Adverse Event|2|||
148802969|NCT01516216|536759490|FG001|Overall Study|Adverse Event|4|||
148802970|NCT01516216|536759489|FG000|Overall Study|Disease Progression|38|||
148802971|NCT01516216|536759490|FG001|Overall Study|Disease Progression|34|||
148802972|NCT01516216|536759489|FG000|Overall Study|Withdrawal by Subject|9|||
148802973|NCT01516216|536759490|FG001|Overall Study|Withdrawal by Subject|11|||
148802974|NCT01516216|536759489|FG000|Overall Study|Potentially Curative Resection|6|||
148802975|NCT01516216|536759490|FG001|Overall Study|Potentially Curative Resection|12|||
148802976|NCT01516216|536759489|FG000|Overall Study|Nonadherence|2|||
148802977|NCT01516216|536759490|FG001|Overall Study|Nonadherence|3|||
148905803|NCT02745119|537136824|FG003|Overall Study|Study Terminated by Sponsor|251|||
148802978|NCT01516216|536759489|FG000|Overall Study|Physician Decision|6|||
148802979|NCT01516216|536759490|FG001|Overall Study|Physician Decision|3|||
148802980|NCT01516216|536759489|FG000|Overall Study|Prolonged Treatment Delay|5|||
148802981|NCT01516216|536759490|FG001|Overall Study|Prolonged Treatment Delay|1|||
148905804|NCT02745119|537136821|FG000|Overall Study|Physician Decision|0|||
148905805|NCT02745119|537136822|FG001|Overall Study|Physician Decision|2|||
148905806|NCT02745119|537136823|FG002|Overall Study|Physician Decision|2|||
148905807|NCT02745119|537136824|FG003|Overall Study|Physician Decision|2|||
148905808|NCT02745119|537136821|FG000|Overall Study|Reason Not Specified|0|||
148905809|NCT02745119|537136822|FG001|Overall Study|Reason Not Specified|2|||
148905810|NCT02745119|537136823|FG002|Overall Study|Reason Not Specified|0|||
148905811|NCT02745119|537136824|FG003|Overall Study|Reason Not Specified|1|||
148905812|NCT00432172|537136825|FG000|Overall Study|Physician Decision|0|||
148905813|NCT00432172|537136826|FG001|Overall Study|Physician Decision|0|||
148905814|NCT00432172|537136827|FG002|Overall Study|Physician Decision|2|||
148905815|NCT00432172|537136828|FG003|Overall Study|Physician Decision|0|||
148905816|NCT00432172|537136825|FG000|Overall Study|Adverse Event|4|||
148905817|NCT00432172|537136826|FG001|Overall Study|Adverse Event|2|||
148905818|NCT00432172|537136827|FG002|Overall Study|Adverse Event|4|||
148905819|NCT00432172|537136828|FG003|Overall Study|Adverse Event|3|||
148905820|NCT00432172|537136825|FG000|Overall Study|Disease progression|0|||
148905821|NCT00432172|537136826|FG001|Overall Study|Disease progression|2|||
148905822|NCT00432172|537136827|FG002|Overall Study|Disease progression|5|||
148905823|NCT00432172|537136828|FG003|Overall Study|Disease progression|1|||
148905824|NCT00432172|537136825|FG000|Overall Study|Withdrawal by Subject|0|||
148905825|NCT00432172|537136826|FG001|Overall Study|Withdrawal by Subject|1|||
148905826|NCT00432172|537136827|FG002|Overall Study|Withdrawal by Subject|0|||
148905827|NCT00432172|537136828|FG003|Overall Study|Withdrawal by Subject|2|||
148905828|NCT00432172|537136825|FG000|Overall Study|No treatment received|2|||
148905829|NCT00432172|537136826|FG001|Overall Study|No treatment received|2|||
148905830|NCT00432172|537136827|FG002|Overall Study|No treatment received|0|||
148905831|NCT00432172|537136828|FG003|Overall Study|No treatment received|1|||
148905832|NCT02379091|537136833|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
148905833|NCT02379091|537136834|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
148905834|NCT02379091|537136835|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
148905835|NCT02379091|537136836|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
148905836|NCT02379091|537136833|FG000|Overall Study|Principal Investigator Discretion|0|||
148905837|NCT02379091|537136834|FG001|Overall Study|Principal Investigator Discretion|1|||
148905838|NCT02379091|537136835|FG002|Overall Study|Principal Investigator Discretion|0|||
148905839|NCT02379091|537136836|FG003|Overall Study|Principal Investigator Discretion|0|||
148905840|NCT02379091|537136833|FG000|Overall Study|Lost to Follow-up|0|||
148905841|NCT02379091|537136834|FG001|Overall Study|Lost to Follow-up|0|||
148802982|NCT01516216|536759489|FG000|Overall Study|Intercurrent Illness|1|||
148802983|NCT01516216|536759490|FG001|Overall Study|Intercurrent Illness|0|||
148802984|NCT01516216|536759489|FG000|Overall Study|Death|1|||
148802985|NCT01516216|536759490|FG001|Overall Study|Death|1|||
148802986|NCT03736967|536759491|FG000|Overall Study|Withdrawal by Subject|26|||
148802987|NCT03736967|536759492|FG001|Overall Study|Withdrawal by Subject|25|||
148802988|NCT03736967|536759493|FG002|Overall Study|Withdrawal by Subject|23|||
148802989|NCT03736967|536759494|FG003|Overall Study|Withdrawal by Subject|26|||
148802990|NCT03736967|536759491|FG000|Overall Study|Lost to Follow-up|3|||
148802991|NCT03736967|536759492|FG001|Overall Study|Lost to Follow-up|2|||
148802992|NCT03736967|536759493|FG002|Overall Study|Lost to Follow-up|1|||
148802993|NCT03736967|536759494|FG003|Overall Study|Lost to Follow-up|1|||
148802994|NCT03736967|536759491|FG000|Overall Study|Physician Decision|1|||
148905842|NCT02379091|537136835|FG002|Overall Study|Lost to Follow-up|0|||
148905843|NCT02379091|537136836|FG003|Overall Study|Lost to Follow-up|1|||
148905844|NCT02379091|537136833|FG000|Overall Study|Voluntary Withdrawal|2|||
148905845|NCT02379091|537136834|FG001|Overall Study|Voluntary Withdrawal|5|||
148905846|NCT02379091|537136835|FG002|Overall Study|Voluntary Withdrawal|2|||
148905847|NCT02379091|537136836|FG003|Overall Study|Voluntary Withdrawal|4|||
148905848|NCT02379091|537136833|FG000|Overall Study|Study Termination|7|||
148905849|NCT02379091|537136834|FG001|Overall Study|Study Termination|2|||
148905850|NCT02379091|537136835|FG002|Overall Study|Study Termination|5|||
148905851|NCT02379091|537136836|FG003|Overall Study|Study Termination|8|||
148905852|NCT02379091|537136833|FG000|Overall Study|Lack of Efficacy|3|||
148905853|NCT02379091|537136834|FG001|Overall Study|Lack of Efficacy|0|||
148905854|NCT02379091|537136835|FG002|Overall Study|Lack of Efficacy|0|||
148905855|NCT02379091|537136836|FG003|Overall Study|Lack of Efficacy|0|||
148905856|NCT01394016|537136842|FG000|Overall Study|Progressive Disease|2|||
148905857|NCT01394016|537136843|FG001|Overall Study|Progressive Disease|0|||
148905858|NCT01394016|537136844|FG002|Overall Study|Progressive Disease|0|||
148905859|NCT01394016|537136845|FG003|Overall Study|Progressive Disease|0|||
148905860|NCT01394016|537136846|FG004|Overall Study|Progressive Disease|0|||
148905861|NCT01394016|537136847|FG005|Overall Study|Progressive Disease|0|||
148905862|NCT01394016|537136848|FG006|Overall Study|Progressive Disease|0|||
148905863|NCT01394016|537136849|FG007|Overall Study|Progressive Disease|0|||
148905864|NCT01394016|537136850|FG008|Overall Study|Progressive Disease|0|||
148905865|NCT01394016|537136851|FG009|Overall Study|Progressive Disease|0|||
148905866|NCT01394016|537136852|FG010|Overall Study|Progressive Disease|0|||
148905867|NCT01394016|537136853|FG011|Overall Study|Progressive Disease|0|||
148905868|NCT01394016|537136854|FG012|Overall Study|Progressive Disease|0|||
148905869|NCT01394016|537136855|FG013|Overall Study|Progressive Disease|0|||
148905870|NCT01394016|537136856|FG014|Overall Study|Progressive Disease|0|||
148905871|NCT01394016|537136857|FG015|Overall Study|Progressive Disease|0|||
148905872|NCT01394016|537136858|FG016|Overall Study|Progressive Disease|0|||
148905873|NCT01394016|537136859|FG017|Overall Study|Progressive Disease|0|||
148905874|NCT01394016|537136860|FG018|Overall Study|Progressive Disease|0|||
148905875|NCT01394016|537136842|FG000|Overall Study|Withdrawal by Subject|0|||
148905876|NCT01394016|537136843|FG001|Overall Study|Withdrawal by Subject|0|||
148905877|NCT01394016|537136844|FG002|Overall Study|Withdrawal by Subject|0|||
148905878|NCT01394016|537136845|FG003|Overall Study|Withdrawal by Subject|0|||
148905879|NCT01394016|537136846|FG004|Overall Study|Withdrawal by Subject|0|||
148905880|NCT01394016|537136847|FG005|Overall Study|Withdrawal by Subject|0|||
148905881|NCT01394016|537136848|FG006|Overall Study|Withdrawal by Subject|0|||
148905882|NCT01394016|537136849|FG007|Overall Study|Withdrawal by Subject|1|||
148905883|NCT01394016|537136850|FG008|Overall Study|Withdrawal by Subject|1|||
148905884|NCT01394016|537136851|FG009|Overall Study|Withdrawal by Subject|1|||
148905885|NCT01394016|537136852|FG010|Overall Study|Withdrawal by Subject|4|||
148905886|NCT01394016|537136853|FG011|Overall Study|Withdrawal by Subject|0|||
148905887|NCT01394016|537136854|FG012|Overall Study|Withdrawal by Subject|0|||
148905888|NCT01394016|537136855|FG013|Overall Study|Withdrawal by Subject|3|||
148905889|NCT01394016|537136856|FG014|Overall Study|Withdrawal by Subject|1|||
148905890|NCT01394016|537136857|FG015|Overall Study|Withdrawal by Subject|3|||
148905891|NCT01394016|537136858|FG016|Overall Study|Withdrawal by Subject|1|||
148905892|NCT01394016|537136859|FG017|Overall Study|Withdrawal by Subject|1|||
148905893|NCT01394016|537136860|FG018|Overall Study|Withdrawal by Subject|2|||
148905894|NCT01394016|537136842|FG000|Overall Study|Adverse Event|0|||
148905895|NCT01394016|537136843|FG001|Overall Study|Adverse Event|0|||
148905896|NCT01394016|537136844|FG002|Overall Study|Adverse Event|0|||
148905897|NCT01394016|537136845|FG003|Overall Study|Adverse Event|0|||
148905898|NCT01394016|537136846|FG004|Overall Study|Adverse Event|0|||
148905899|NCT01394016|537136847|FG005|Overall Study|Adverse Event|0|||
148905900|NCT01394016|537136848|FG006|Overall Study|Adverse Event|0|||
148905901|NCT01394016|537136849|FG007|Overall Study|Adverse Event|0|||
148905902|NCT01394016|537136850|FG008|Overall Study|Adverse Event|0|||
148905903|NCT01394016|537136851|FG009|Overall Study|Adverse Event|1|||
148905904|NCT01394016|537136852|FG010|Overall Study|Adverse Event|0|||
148905905|NCT01394016|537136853|FG011|Overall Study|Adverse Event|0|||
148905906|NCT01394016|537136854|FG012|Overall Study|Adverse Event|0|||
148905907|NCT01394016|537136855|FG013|Overall Study|Adverse Event|0|||
148905908|NCT01394016|537136856|FG014|Overall Study|Adverse Event|0|||
148905909|NCT01394016|537136857|FG015|Overall Study|Adverse Event|0|||
148905910|NCT01394016|537136858|FG016|Overall Study|Adverse Event|1|||
148905911|NCT01394016|537136859|FG017|Overall Study|Adverse Event|1|||
148905912|NCT01394016|537136860|FG018|Overall Study|Adverse Event|0|||
148905913|NCT01394016|537136842|FG000|Overall Study|Sponsor Decision|0|||
148905914|NCT01394016|537136843|FG001|Overall Study|Sponsor Decision|0|||
148905915|NCT01394016|537136844|FG002|Overall Study|Sponsor Decision|0|||
148905916|NCT01394016|537136845|FG003|Overall Study|Sponsor Decision|0|||
148905917|NCT01394016|537136846|FG004|Overall Study|Sponsor Decision|0|||
148905918|NCT01394016|537136847|FG005|Overall Study|Sponsor Decision|0|||
148905919|NCT01394016|537136848|FG006|Overall Study|Sponsor Decision|0|||
148905920|NCT01394016|537136849|FG007|Overall Study|Sponsor Decision|0|||
148905921|NCT01394016|537136850|FG008|Overall Study|Sponsor Decision|0|||
148905922|NCT01394016|537136851|FG009|Overall Study|Sponsor Decision|0|||
148905923|NCT01394016|537136852|FG010|Overall Study|Sponsor Decision|0|||
148905924|NCT01394016|537136853|FG011|Overall Study|Sponsor Decision|0|||
148905925|NCT01394016|537136854|FG012|Overall Study|Sponsor Decision|1|||
148905926|NCT01394016|537136855|FG013|Overall Study|Sponsor Decision|0|||
148905927|NCT01394016|537136856|FG014|Overall Study|Sponsor Decision|0|||
148905928|NCT01394016|537136857|FG015|Overall Study|Sponsor Decision|0|||
148905929|NCT01394016|537136858|FG016|Overall Study|Sponsor Decision|0|||
148905930|NCT01394016|537136859|FG017|Overall Study|Sponsor Decision|0|||
148905931|NCT01394016|537136860|FG018|Overall Study|Sponsor Decision|0|||
148905932|NCT01394016|537136842|FG000|Overall Study|Lost to Follow-up|0|||
148905933|NCT01394016|537136843|FG001|Overall Study|Lost to Follow-up|0|||
148905934|NCT01394016|537136844|FG002|Overall Study|Lost to Follow-up|0|||
148905935|NCT01394016|537136845|FG003|Overall Study|Lost to Follow-up|0|||
148905936|NCT01394016|537136846|FG004|Overall Study|Lost to Follow-up|0|||
148905937|NCT01394016|537136847|FG005|Overall Study|Lost to Follow-up|0|||
148905938|NCT01394016|537136848|FG006|Overall Study|Lost to Follow-up|0|||
148905939|NCT01394016|537136849|FG007|Overall Study|Lost to Follow-up|0|||
148905940|NCT01394016|537136850|FG008|Overall Study|Lost to Follow-up|0|||
148905941|NCT01394016|537136851|FG009|Overall Study|Lost to Follow-up|0|||
148905942|NCT01394016|537136852|FG010|Overall Study|Lost to Follow-up|0|||
148905943|NCT01394016|537136853|FG011|Overall Study|Lost to Follow-up|0|||
148905944|NCT01394016|537136854|FG012|Overall Study|Lost to Follow-up|0|||
148905945|NCT01394016|537136855|FG013|Overall Study|Lost to Follow-up|0|||
148905946|NCT01394016|537136856|FG014|Overall Study|Lost to Follow-up|0|||
148905947|NCT01394016|537136857|FG015|Overall Study|Lost to Follow-up|0|||
148905948|NCT01394016|537136858|FG016|Overall Study|Lost to Follow-up|0|||
148905949|NCT01394016|537136859|FG017|Overall Study|Lost to Follow-up|0|||
148905950|NCT01394016|537136860|FG018|Overall Study|Lost to Follow-up|1|||
148905951|NCT00174187|537136864|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
148905952|NCT00174187|537136865|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
148905953|NCT00174187|537136866|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
148905954|NCT00174187|537136864|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
148905955|NCT00174187|537136865|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
148905956|NCT00174187|537136866|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
148905957|NCT00174187|537136864|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
148905958|NCT00174187|537136865|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
148905959|NCT00174187|537136866|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
148905960|NCT00174187|537136864|FG000|Period 1 (up to 3 Years)|Other|0|||
148905961|NCT00174187|537136865|FG001|Period 1 (up to 3 Years)|Other|1|||
148905962|NCT00174187|537136866|FG002|Period 1 (up to 3 Years)|Other|0|||
148905963|NCT00174187|537136864|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
148905964|NCT00174187|537136865|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
148905965|NCT00174187|537136866|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
148905966|NCT00174187|537136864|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
148905967|NCT00174187|537136865|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
148905968|NCT00174187|537136866|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
148905969|NCT00174187|537136864|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
148905970|NCT00174187|537136865|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
148905971|NCT00174187|537136866|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
148905972|NCT00174187|537136864|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
148905973|NCT00174187|537136865|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
148905974|NCT00174187|537136866|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
148905975|NCT00174187|537136864|FG000|Period 2 (After 3 Years)|Other|0|||
148905976|NCT00174187|537136865|FG001|Period 2 (After 3 Years)|Other|0|||
148905977|NCT00174187|537136866|FG002|Period 2 (After 3 Years)|Other|5|||
148905978|NCT01198977|537136868|FG000|Overall Study|Lost to Follow-up|1|||
148905979|NCT01198977|537136869|FG001|Overall Study|Lost to Follow-up|0|||
148905980|NCT01285557|537136870|FG000|Overall Study|Death|173|||
148905981|NCT01285557|537136871|FG001|Overall Study|Death|90|||
148905982|NCT01285557|537136870|FG000|Overall Study|Lost to Follow-up|6|||
148905983|NCT01285557|537136871|FG001|Overall Study|Lost to Follow-up|2|||
148905984|NCT01285557|537136870|FG000|Overall Study|Withdrew Consent|6|||
148905985|NCT01285557|537136871|FG001|Overall Study|Withdrew Consent|1|||
148905986|NCT01285557|537136870|FG000|Overall Study|Sponsor Study Termination|23|||
148905987|NCT01285557|537136871|FG001|Overall Study|Sponsor Study Termination|13|||
148905988|NCT01285557|537136870|FG000|Overall Study|Randomized but not treated|1|||
148905989|NCT01285557|537136871|FG001|Overall Study|Randomized but not treated|1|||
148905990|NCT01285557|537136870|FG000|Overall Study|Study follow-up ongoing|28|||
148905991|NCT01285557|537136871|FG001|Overall Study|Study follow-up ongoing|14|||
148905992|NCT01285557|537136870|FG000|Overall Study|Sponsor Decision|2|||
148905993|NCT01285557|537136871|FG001|Overall Study|Sponsor Decision|1|||
148905994|NCT01648751|537136882|FG000|Overall Study|Withdrawal by Subject|2|||
148905995|NCT01648751|537136883|FG001|Overall Study|Withdrawal by Subject|3|||
148905996|NCT02484391|537136888|FG000|Overall Study|Lack of Efficacy|15|||
148905997|NCT02484391|537136889|FG001|Overall Study|Lack of Efficacy|14|||
148905998|NCT02484391|537136890|FG002|Overall Study|Lack of Efficacy|3|||
148905999|NCT02484391|537136888|FG000|Overall Study|Lost to Follow-up|0|||
148906000|NCT02484391|537136889|FG001|Overall Study|Lost to Follow-up|0|||
148906001|NCT02484391|537136890|FG002|Overall Study|Lost to Follow-up|2|||
148906002|NCT02484391|537136888|FG000|Overall Study|Physician Decision|1|||
148906003|NCT02484391|537136889|FG001|Overall Study|Physician Decision|3|||
148906004|NCT02484391|537136890|FG002|Overall Study|Physician Decision|0|||
148906005|NCT02484391|537136888|FG000|Overall Study|Went to Transplant|5|||
148906006|NCT02484391|537136889|FG001|Overall Study|Went to Transplant|3|||
148906007|NCT02484391|537136890|FG002|Overall Study|Went to Transplant|2|||
148906008|NCT04922216|537136893|FG000|Overall Study|Withdrawal by Subject|0|||
148906009|NCT04922216|537136894|FG001|Overall Study|Withdrawal by Subject|1|||
148906010|NCT04922216|537136895|FG002|Overall Study|Withdrawal by Subject|0|||
148906011|NCT04922216|537136896|FG003|Overall Study|Withdrawal by Subject|0|||
148906012|NCT04922216|537136897|FG004|Overall Study|Withdrawal by Subject|0|||
148906013|NCT04922216|537136898|FG005|Overall Study|Withdrawal by Subject|0|||
148906014|NCT04922216|537136899|FG006|Overall Study|Withdrawal by Subject|0|||
148906015|NCT04922216|537136900|FG007|Overall Study|Withdrawal by Subject|2|||
148906016|NCT04922216|537136901|FG008|Overall Study|Withdrawal by Subject|0|||
148906017|NCT04922216|537136902|FG009|Overall Study|Withdrawal by Subject|0|||
148906018|NCT04922216|537136903|FG010|Overall Study|Withdrawal by Subject|0|||
148906019|NCT04922216|537136904|FG011|Overall Study|Withdrawal by Subject|0|||
148906020|NCT04922216|537136905|FG012|Overall Study|Withdrawal by Subject|1|||
148906021|NCT04922216|537136906|FG013|Overall Study|Withdrawal by Subject|1|||
148906022|NCT04922216|537136907|FG014|Overall Study|Withdrawal by Subject|1|||
148906023|NCT04922216|537136908|FG015|Overall Study|Withdrawal by Subject|0|||
148906024|NCT04922216|537136909|FG016|Overall Study|Withdrawal by Subject|0|||
148906025|NCT04922216|537136910|FG017|Overall Study|Withdrawal by Subject|1|||
148906026|NCT04922216|537136911|FG018|Overall Study|Withdrawal by Subject|1|||
148906027|NCT04922216|537136912|FG019|Overall Study|Withdrawal by Subject|1|||
148906028|NCT04922216|537136913|FG020|Overall Study|Withdrawal by Subject|1|||
148906029|NCT04922216|537136914|FG021|Overall Study|Withdrawal by Subject|0|||
148906030|NCT04922216|537136915|FG022|Overall Study|Withdrawal by Subject|0|||
148906031|NCT04922216|537136916|FG023|Overall Study|Withdrawal by Subject|2|||
148906032|NCT04922216|537136917|FG024|Overall Study|Withdrawal by Subject|0|||
148906033|NCT04922216|537136918|FG025|Overall Study|Withdrawal by Subject|0|||
148906034|NCT04922216|537136919|FG026|Overall Study|Withdrawal by Subject|1|||
148906035|NCT04922216|537136920|FG027|Overall Study|Withdrawal by Subject|0|||
148906036|NCT04922216|537136921|FG028|Overall Study|Withdrawal by Subject|0|||
148906037|NCT04922216|537136922|FG029|Overall Study|Withdrawal by Subject|0|||
148906038|NCT04922216|537136923|FG030|Overall Study|Withdrawal by Subject|1|||
148906039|NCT04922216|537136924|FG031|Overall Study|Withdrawal by Subject|0|||
148906040|NCT04922216|537136893|FG000|Overall Study|Lost to Follow-up|1|||
148906041|NCT04922216|537136894|FG001|Overall Study|Lost to Follow-up|0|||
148906042|NCT04922216|537136895|FG002|Overall Study|Lost to Follow-up|2|||
148906043|NCT04922216|537136896|FG003|Overall Study|Lost to Follow-up|0|||
148906044|NCT04922216|537136897|FG004|Overall Study|Lost to Follow-up|0|||
148906045|NCT04922216|537136898|FG005|Overall Study|Lost to Follow-up|2|||
148906046|NCT04922216|537136899|FG006|Overall Study|Lost to Follow-up|0|||
148906047|NCT04922216|537136900|FG007|Overall Study|Lost to Follow-up|1|||
148906048|NCT04922216|537136901|FG008|Overall Study|Lost to Follow-up|1|||
148906049|NCT04922216|537136902|FG009|Overall Study|Lost to Follow-up|2|||
148906050|NCT04922216|537136903|FG010|Overall Study|Lost to Follow-up|2|||
148906051|NCT04922216|537136904|FG011|Overall Study|Lost to Follow-up|1|||
148906052|NCT04922216|537136905|FG012|Overall Study|Lost to Follow-up|1|||
148906053|NCT04922216|537136906|FG013|Overall Study|Lost to Follow-up|0|||
148906054|NCT04922216|537136907|FG014|Overall Study|Lost to Follow-up|1|||
148906055|NCT04922216|537136908|FG015|Overall Study|Lost to Follow-up|0|||
148906056|NCT04922216|537136909|FG016|Overall Study|Lost to Follow-up|0|||
148906057|NCT04922216|537136910|FG017|Overall Study|Lost to Follow-up|2|||
148906058|NCT04922216|537136911|FG018|Overall Study|Lost to Follow-up|1|||
148906059|NCT04922216|537136912|FG019|Overall Study|Lost to Follow-up|0|||
148906060|NCT04922216|537136913|FG020|Overall Study|Lost to Follow-up|1|||
148906061|NCT04922216|537136914|FG021|Overall Study|Lost to Follow-up|0|||
148906062|NCT04922216|537136915|FG022|Overall Study|Lost to Follow-up|2|||
148906063|NCT04922216|537136916|FG023|Overall Study|Lost to Follow-up|1|||
148906064|NCT04922216|537136917|FG024|Overall Study|Lost to Follow-up|0|||
148906065|NCT04922216|537136918|FG025|Overall Study|Lost to Follow-up|2|||
148906066|NCT04922216|537136919|FG026|Overall Study|Lost to Follow-up|0|||
148906067|NCT04922216|537136920|FG027|Overall Study|Lost to Follow-up|0|||
148906068|NCT04922216|537136921|FG028|Overall Study|Lost to Follow-up|1|||
148906069|NCT04922216|537136922|FG029|Overall Study|Lost to Follow-up|0|||
148906070|NCT04922216|537136923|FG030|Overall Study|Lost to Follow-up|2|||
148906071|NCT04922216|537136924|FG031|Overall Study|Lost to Follow-up|1|||
148906072|NCT04949490|537136925|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
148906073|NCT04949490|537136926|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
148906074|NCT04949490|537136927|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
148906075|NCT04949490|537136928|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
148906076|NCT04949490|537136929|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
148906077|NCT04949490|537136930|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
148906078|NCT04949490|537136925|FG000|Group A and Group B|Withdrawal by Subject|0|||
148906079|NCT04949490|537136926|FG001|Group A and Group B|Withdrawal by Subject|0|||
148906080|NCT04949490|537136927|FG002|Group A and Group B|Withdrawal by Subject|1|||
148906081|NCT04949490|537136928|FG003|Group A and Group B|Withdrawal by Subject|0|||
148906082|NCT04949490|537136929|FG004|Group A and Group B|Withdrawal by Subject|0|||
148906083|NCT04949490|537136930|FG005|Group A and Group B|Withdrawal by Subject|0|||
148906084|NCT04949490|537136925|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
148906085|NCT04949490|537136926|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
148906086|NCT04949490|537136927|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
148906087|NCT04949490|537136928|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
148906088|NCT04949490|537136929|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
148906089|NCT04949490|537136930|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
148906090|NCT04949490|537136925|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
148906091|NCT04949490|537136926|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
148906092|NCT04949490|537136927|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
148906093|NCT04949490|537136928|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
148906094|NCT04949490|537136929|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
148906095|NCT04949490|537136930|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
148906096|NCT04721977|537136931|FG000|Overall Study|Death|15|||
148906097|NCT04721977|537136931|FG000|Overall Study|Ongoing|51|||
148906098|NCT03278249|537136932|FG000|Overall Study|Withdrawal by Subject|2|||
148906099|NCT03278249|537136932|FG000|Overall Study|Lost to Follow-up|1|||
148906100|NCT02017405|537136933|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
148906101|NCT02017405|537136934|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
148906102|NCT02017405|537136935|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
148906103|NCT02017405|537136936|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
148906104|NCT02017405|537136937|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
148906105|NCT02017405|537136938|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
148906106|NCT02017405|537136933|FG000|Open-label Phase|Adverse Event|1|||
148906107|NCT02017405|537136934|FG001|Open-label Phase|Adverse Event|1|||
148906108|NCT02017405|537136935|FG002|Open-label Phase|Adverse Event|0|||
148906109|NCT02017405|537136936|FG003|Open-label Phase|Adverse Event|0|||
148906110|NCT02017405|537136937|FG004|Open-label Phase|Adverse Event|0|||
148906111|NCT02017405|537136938|FG005|Open-label Phase|Adverse Event|0|||
148906112|NCT02864394|537136940|FG000|Overall Study|Death|184|||
148906113|NCT02864394|537136941|FG001|Overall Study|Death|189|||
148906114|NCT02864394|537136940|FG000|Overall Study|Lost to Follow-up|0|||
148906115|NCT02864394|537136941|FG001|Overall Study|Lost to Follow-up|2|||
149011500|NCT02487095|537521492|FG004|Dose Expansion|Unable to scan/restage participant|1|||
149011501|NCT03108157|537521493|FG000|Overall Study|Protocol Violation|15|||
149011502|NCT03108157|537521494|FG001|Overall Study|Protocol Violation|4|||
149011503|NCT01279343|537521497|FG000|Overall Study|Did not receive treatment|2|||
149011504|NCT01279343|537521498|FG001|Overall Study|Did not receive treatment|6|||
149011505|NCT04534114|537521499|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
149011506|NCT04534114|537521500|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
149011507|NCT04534114|537521501|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
149011508|NCT04534114|537521502|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
149011509|NCT04534114|537521499|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
149011510|NCT04534114|537521500|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
149011511|NCT04534114|537521501|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
149011512|NCT04534114|537521502|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
149011513|NCT04534114|537521499|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
149011514|NCT04534114|537521500|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
149011515|NCT04534114|537521501|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
149011516|NCT04534114|537521502|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
149011517|NCT04534114|537521499|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
149011518|NCT04534114|537521500|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
149011519|NCT04534114|537521501|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
149011520|NCT04534114|537521502|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
149011521|NCT04534114|537521499|FG000|Main Treatment Period|Physician Decision|0|||
149011522|NCT04534114|537521500|FG001|Main Treatment Period|Physician Decision|0|||
149011523|NCT04534114|537521501|FG002|Main Treatment Period|Physician Decision|0|||
149011524|NCT04534114|537521502|FG003|Main Treatment Period|Physician Decision|1|||
149011525|NCT04534114|537521499|FG000|Main Treatment Period|Death|1|||
149011526|NCT04534114|537521500|FG001|Main Treatment Period|Death|0|||
149011527|NCT04534114|537521501|FG002|Main Treatment Period|Death|0|||
149011528|NCT04534114|537521502|FG003|Main Treatment Period|Death|1|||
149011529|NCT04534114|537521499|FG000|Main Treatment Period|Other reason|1|||
149011530|NCT04534114|537521500|FG001|Main Treatment Period|Other reason|1|||
149011531|NCT04534114|537521501|FG002|Main Treatment Period|Other reason|0|||
149011532|NCT04534114|537521502|FG003|Main Treatment Period|Other reason|0|||
149011533|NCT04534114|537521499|FG000|Main Treatment Period|Participant decision|1|||
149011534|NCT04534114|537521500|FG001|Main Treatment Period|Participant decision|3|||
149011535|NCT04534114|537521501|FG002|Main Treatment Period|Participant decision|3|||
149011536|NCT04534114|537521502|FG003|Main Treatment Period|Participant decision|1|||
149011537|NCT04534114|537521499|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
149011538|NCT04534114|537521500|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
149011539|NCT04534114|537521501|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
149011540|NCT04534114|537521502|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
149011541|NCT04534114|537521499|FG000|Main Treatment Period|Adverse Event|4|||
149011542|NCT04534114|537521500|FG001|Main Treatment Period|Adverse Event|2|||
149011543|NCT04534114|537521501|FG002|Main Treatment Period|Adverse Event|1|||
149011544|NCT04534114|537521502|FG003|Main Treatment Period|Adverse Event|2|||
149011545|NCT04534114|537521499|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
149011546|NCT04534114|537521500|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
149011547|NCT04534114|537521501|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
149011548|NCT04534114|537521502|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
149011549|NCT04534114|537521499|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
149011550|NCT04534114|537521500|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
149011551|NCT04534114|537521501|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
149011552|NCT04534114|537521502|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
148802995|NCT03736967|536759492|FG001|Overall Study|Physician Decision|0|||
148802996|NCT03736967|536759493|FG002|Overall Study|Physician Decision|0|||
148802997|NCT03736967|536759494|FG003|Overall Study|Physician Decision|1|||
148802998|NCT03736967|536759491|FG000|Overall Study|Adverse Event|0|||
148802999|NCT03736967|536759492|FG001|Overall Study|Adverse Event|1|||
148803000|NCT03736967|536759493|FG002|Overall Study|Adverse Event|0|||
148803001|NCT03736967|536759494|FG003|Overall Study|Adverse Event|1|||
148803002|NCT03736967|536759491|FG000|Overall Study|Death|0|||
149011553|NCT04534114|537521499|FG000|Extension Treatment Period|Other reason|0|||
149011554|NCT04534114|537521500|FG001|Extension Treatment Period|Other reason|1|||
149011555|NCT04534114|537521501|FG002|Extension Treatment Period|Other reason|0|||
148803003|NCT03736967|536759492|FG001|Overall Study|Death|0|||
148803004|NCT03736967|536759493|FG002|Overall Study|Death|0|||
149011556|NCT04534114|537521502|FG003|Extension Treatment Period|Other reason|0|||
149011557|NCT04534114|537521499|FG000|Extension Treatment Period|Death|0|||
149011558|NCT04534114|537521500|FG001|Extension Treatment Period|Death|0|||
149011559|NCT04534114|537521501|FG002|Extension Treatment Period|Death|1|||
149011560|NCT04534114|537521502|FG003|Extension Treatment Period|Death|2|||
149011561|NCT04534114|537521499|FG000|Extension Treatment Period|Adverse Event|0|||
148906116|NCT02864394|537136940|FG000|Overall Study|Sponsor Decision|26|||
148906117|NCT02864394|537136941|FG001|Overall Study|Sponsor Decision|11|||
148906118|NCT02864394|537136940|FG000|Overall Study|Withdrawal by Subject|3|||
148906119|NCT02864394|537136941|FG001|Overall Study|Withdrawal by Subject|10|||
148906120|NCT02374450|537136942|FG000|Overall Study|Protocol Violation|0|||
148906121|NCT02374450|537136943|FG001|Overall Study|Protocol Violation|1|||
148906122|NCT02374450|537136944|FG002|Overall Study|Protocol Violation|0|||
148906123|NCT02374450|537136942|FG000|Overall Study|Withdrawal by Subject|91|||
148906124|NCT02374450|537136943|FG001|Overall Study|Withdrawal by Subject|110|||
148906125|NCT02374450|537136944|FG002|Overall Study|Withdrawal by Subject|4|||
149011562|NCT04534114|537521500|FG001|Extension Treatment Period|Adverse Event|1|||
149011563|NCT04534114|537521501|FG002|Extension Treatment Period|Adverse Event|0|||
149011564|NCT04534114|537521502|FG003|Extension Treatment Period|Adverse Event|1|||
149011565|NCT04534114|537521499|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
149011566|NCT04534114|537521500|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
149011567|NCT04534114|537521501|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
149011568|NCT04534114|537521502|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
149011569|NCT03287414|537521503|FG000|Treatment Epoch|Adverse Event|0|||
149011570|NCT03287414|537521504|FG001|Treatment Epoch|Adverse Event|1|||
149011571|NCT03287414|537521503|FG000|Treatment Epoch|Study terminated by sponsor|2|||
149011572|NCT03287414|537521504|FG001|Treatment Epoch|Study terminated by sponsor|2|||
149011573|NCT03287414|537521503|FG000|Treatment Epoch|Subject/Guardian decision|4|||
149011574|NCT03287414|537521504|FG001|Treatment Epoch|Subject/Guardian decision|0|||
149011575|NCT03287414|537521503|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
149011576|NCT03287414|537521504|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
149011577|NCT03287414|537521503|FG000|Treatment Epoch|Withdrawal by Subject|1|||
149011578|NCT03287414|537521504|FG001|Treatment Epoch|Withdrawal by Subject|0|||
149011579|NCT03287414|537521503|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
149011580|NCT03287414|537521504|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
149011581|NCT03287414|537521503|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
149011582|NCT03287414|537521504|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
149011583|NCT02223754|537521505|FG000|Period 1|Adverse Event|1|||
149011584|NCT02223754|537521506|FG001|Period 1|Adverse Event|0|||
149011585|NCT02223754|537521505|FG000|Period 1|Lost to Follow-up|0|||
149011586|NCT02223754|537521506|FG001|Period 1|Lost to Follow-up|1|||
149011587|NCT02223754|537521505|FG000|Period 1|Protocol Violation|2|||
149011588|NCT02223754|537521506|FG001|Period 1|Protocol Violation|4|||
149011589|NCT02223754|537521505|FG000|Period 1|Withdrawal by Subject|0|||
149011590|NCT02223754|537521506|FG001|Period 1|Withdrawal by Subject|4|||
149011591|NCT02223754|537521505|FG000|Period 1|Test Article No Longer Available|1|||
149011592|NCT02223754|537521506|FG001|Period 1|Test Article No Longer Available|5|||
149011593|NCT02223754|537521505|FG000|Period 1|Unsatisfactory Visual Response|0|||
149011594|NCT02223754|537521506|FG001|Period 1|Unsatisfactory Visual Response|1|||
149011595|NCT02223754|537521505|FG000|Period 2|Adverse Event|0|||
149011596|NCT02223754|537521506|FG001|Period 2|Adverse Event|1|||
149011597|NCT02223754|537521505|FG000|Period 2|Protocol Violation|1|||
149011598|NCT02223754|537521506|FG001|Period 2|Protocol Violation|0|||
149011599|NCT02223754|537521505|FG000|Period 2|Lens Discomfort|1|||
149011600|NCT02223754|537521506|FG001|Period 2|Lens Discomfort|1|||
149011601|NCT02223754|537521505|FG000|Period 2|Lost to Follow-up|1|||
149011602|NCT02223754|537521506|FG001|Period 2|Lost to Follow-up|0|||
149011603|NCT02223754|537521505|FG000|Period 2|Test Article No Longer Available|0|||
149011604|NCT02223754|537521506|FG001|Period 2|Test Article No Longer Available|1|||
149011605|NCT01122381|537521516|FG000|Overall Study|study terminated early|0|||
148906126|NCT02374450|537136942|FG000|Overall Study|Lost to Follow-up|168|||
148906127|NCT02374450|537136943|FG001|Overall Study|Lost to Follow-up|194|||
148906128|NCT02374450|537136944|FG002|Overall Study|Lost to Follow-up|138|||
149011606|NCT01122381|537521517|FG001|Overall Study|study terminated early|1|||
149011607|NCT00736489|537521518|FG000|Period 1|Lost to Follow-up|1|||
149011608|NCT00736489|537521519|FG001|Period 1|Lost to Follow-up|0|||
149011609|NCT00736489|537521520|FG002|Period 1|Lost to Follow-up|0|||
149011610|NCT00736489|537521521|FG003|Period 1|Lost to Follow-up|0|||
148906129|NCT02374450|537136942|FG000|Overall Study|Death|173|||
148906130|NCT02374450|537136943|FG001|Overall Study|Death|185|||
149011611|NCT00736489|537521522|FG004|Period 1|Lost to Follow-up|0|||
149011612|NCT00736489|537521523|FG005|Period 1|Lost to Follow-up|0|||
148906131|NCT02374450|537136944|FG002|Overall Study|Death|81|||
148906132|NCT02374450|537136942|FG000|Overall Study|Migrated from the study area|538|||
148906133|NCT02374450|537136943|FG001|Overall Study|Migrated from the study area|648|||
149011613|NCT00736489|537521518|FG000|Period 1|Withdrawal by Subject|0|||
149011614|NCT00736489|537521519|FG001|Period 1|Withdrawal by Subject|0|||
149011615|NCT00736489|537521520|FG002|Period 1|Withdrawal by Subject|0|||
149011616|NCT00736489|537521521|FG003|Period 1|Withdrawal by Subject|0|||
148803005|NCT03736967|536759494|FG003|Overall Study|Death|1|||
148803006|NCT03736967|536759491|FG000|Overall Study|Randomized but never treated|1|||
148803007|NCT03736967|536759492|FG001|Overall Study|Randomized but never treated|0|||
148803008|NCT03736967|536759493|FG002|Overall Study|Randomized but never treated|0|||
148803009|NCT03736967|536759494|FG003|Overall Study|Randomized but never treated|0|||
148803010|NCT02369653|536759495|FG000|Overall Study|Lost to Follow-up|0|||
148803011|NCT02369653|536759496|FG001|Overall Study|Lost to Follow-up|1|||
148803012|NCT02369653|536759495|FG000|Overall Study|Administrative reason by sponsor|0|||
148803013|NCT02369653|536759496|FG001|Overall Study|Administrative reason by sponsor|1|||
148803014|NCT02369653|536759495|FG000|Overall Study|Death|1|||
148803015|NCT02369653|536759496|FG001|Overall Study|Death|2|||
148803016|NCT02369653|536759495|FG000|Overall Study|Participant withdrew consent|13|||
148803017|NCT02369653|536759496|FG001|Overall Study|Participant withdrew consent|3|||
148803018|NCT03587636|536759497|FG000|Overall Study|Lost to Follow-up|2|||
148803019|NCT03587636|536759498|FG001|Overall Study|Lost to Follow-up|5|||
148803020|NCT01458587|536759499|FG000|Overall Study|Withdrawal by Subject|1|||
148803021|NCT01458587|536759500|FG001|Overall Study|Withdrawal by Subject|0|||
148803022|NCT01603602|536759501|FG000|Overall Study|Adverse Event|1|||
148803023|NCT01603602|536759502|FG001|Overall Study|Adverse Event|0|||
148803024|NCT01603602|536759503|FG002|Overall Study|Adverse Event|0|||
148803025|NCT01603602|536759501|FG000|Overall Study|Personal Reasons|1|||
148803026|NCT01603602|536759502|FG001|Overall Study|Personal Reasons|0|||
148803027|NCT01603602|536759503|FG002|Overall Study|Personal Reasons|1|||
148803028|NCT01006629|536759504|FG000|Overall Study|Adverse Event|1|||
148803029|NCT01006629|536759504|FG000|Overall Study|Parent refused to continue participation|1|||
148803030|NCT01006629|536759504|FG000|Overall Study|Parent unable to perform site visit|4|||
148803031|NCT00316004|536759505|FG000|Overall Study|Subject was not given study fluid.|14|||
148803032|NCT00316004|536759506|FG001|Overall Study|Subject was not given study fluid.|14|||
148803033|NCT00316004|536759507|FG002|Overall Study|Subject was not given study fluid.|21|||
148803034|NCT02665117|536759510|FG000|Overall Study|Physician Decision|1|||
148803035|NCT02665117|536759511|FG001|Overall Study|Physician Decision|0|||
148803036|NCT00977197|536759514|FG000|Overall Study|Withdrawal by Subject|3|||
148803037|NCT00977197|536759515|FG001|Overall Study|Withdrawal by Subject|4|||
148803038|NCT00977197|536759514|FG000|Overall Study|Adverse Event|3|||
148803039|NCT00977197|536759515|FG001|Overall Study|Adverse Event|1|||
148803040|NCT00977197|536759514|FG000|Overall Study|Lack of Efficacy|1|||
148803041|NCT00977197|536759515|FG001|Overall Study|Lack of Efficacy|0|||
148803042|NCT00977197|536759514|FG000|Overall Study|Lost to Follow-up|1|||
148803043|NCT00977197|536759515|FG001|Overall Study|Lost to Follow-up|3|||
148803044|NCT00977197|536759514|FG000|Overall Study|Nonadherence|1|||
148803045|NCT00977197|536759515|FG001|Overall Study|Nonadherence|1|||
148803046|NCT01432951|536759516|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
148803047|NCT00958074|536759517|FG000|Overall Study|Withdrawal by Subject|0|||
148803048|NCT00958074|536759518|FG001|Overall Study|Withdrawal by Subject|1|||
148803049|NCT00095979|536759521|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
148803050|NCT01829347|536759522|FG000|VTI-210|Death|5|||
148803051|NCT01829347|536759523|FG001|VTI-210|Death|3|||
148803052|NCT01829347|536759522|FG000|VTI-210|Withdrawal by Subject|1|||
148803053|NCT01829347|536759523|FG001|VTI-210|Withdrawal by Subject|0|||
148803054|NCT01829347|536759522|FG000|VTI-210E|Death|2|||
148803055|NCT01829347|536759523|FG001|VTI-210E|Death|1|||
148803056|NCT01829347|536759522|FG000|VTI-210E|Study terminated prematurely|1|||
148906134|NCT02374450|537136944|FG002|Overall Study|Migrated from the study area|181|||
148906135|NCT02374450|537136942|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
148906136|NCT02374450|537136943|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
148906137|NCT02374450|537136944|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
148906138|NCT02374450|537136942|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
148906139|NCT02374450|537136943|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
148906140|NCT02374450|537136944|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
148906141|NCT02374450|537136942|FG000|Overall Study|Other|0|||
148906142|NCT02374450|537136943|FG001|Overall Study|Other|21|||
148906143|NCT02374450|537136944|FG002|Overall Study|Other|79|||
148906144|NCT00905164|537136947|FG000|Period 1|Protocol Violation|0|||
148906145|NCT00905164|537136948|FG001|Period 1|Protocol Violation|1|||
148906146|NCT04730804|537136949|FG000|Overall Study|Physician Decision|0|||
148906147|NCT04730804|537136950|FG001|Overall Study|Physician Decision|0|||
148906148|NCT04730804|537136951|FG002|Overall Study|Physician Decision|0|||
148906149|NCT04730804|537136952|FG003|Overall Study|Physician Decision|0|||
148803057|NCT01829347|536759523|FG001|VTI-210E|Study terminated prematurely|5|||
148803058|NCT03530293|536759527|FG000|Pre-randomization|Adverse Event|12|||
148803059|NCT03530293|536759528|FG001|Pre-randomization|Adverse Event|0|||
148803060|NCT03530293|536759529|FG002|Pre-randomization|Adverse Event|0|||
148803061|NCT03530293|536759527|FG000|Pre-randomization|Protocol Violation|2|||
148803062|NCT03530293|536759528|FG001|Pre-randomization|Protocol Violation|0|||
148803063|NCT03530293|536759529|FG002|Pre-randomization|Protocol Violation|0|||
148803064|NCT03530293|536759527|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
148906150|NCT04730804|537136953|FG004|Overall Study|Physician Decision|0|||
148906151|NCT04730804|537136954|FG005|Overall Study|Physician Decision|1|||
148906152|NCT04730804|537136949|FG000|Overall Study|Withdrawal by Subject|0|||
148906153|NCT04730804|537136950|FG001|Overall Study|Withdrawal by Subject|0|||
148906154|NCT04730804|537136951|FG002|Overall Study|Withdrawal by Subject|0|||
148906155|NCT04730804|537136952|FG003|Overall Study|Withdrawal by Subject|0|||
148906156|NCT04730804|537136953|FG004|Overall Study|Withdrawal by Subject|1|||
148906157|NCT04730804|537136954|FG005|Overall Study|Withdrawal by Subject|2|||
148906158|NCT01987453|537138088|FG000|Overall Study|Death|0|||
148906159|NCT01987453|537138089|FG001|Overall Study|Death|0|||
148906160|NCT01987453|537138090|FG002|Overall Study|Death|1|||
148906161|NCT01987453|537138088|FG000|Overall Study|Lack of Efficacy|1|||
148906162|NCT01987453|537138089|FG001|Overall Study|Lack of Efficacy|12|||
148906163|NCT01987453|537138090|FG002|Overall Study|Lack of Efficacy|0|||
148906164|NCT01590888|537138091|FG000|Overall Study|Adverse Event|3|||
148906165|NCT01590888|537138092|FG001|Overall Study|Adverse Event|0|||
148906166|NCT01590888|537138093|FG002|Overall Study|Adverse Event|1|||
148906167|NCT01590888|537138091|FG000|Overall Study|Lost to Follow-up|1|||
148906168|NCT01590888|537138092|FG001|Overall Study|Lost to Follow-up|0|||
148906169|NCT01590888|537138093|FG002|Overall Study|Lost to Follow-up|0|||
148906170|NCT04953728|537138094|FG000|Overall Study|Withdrawal by Subject|3|||
148906171|NCT04953728|537138094|FG000|Overall Study|Physician Decision|1|||
148906172|NCT02331277|537138095|FG000|Overall Study|Withdrawal by Subject|1|||
148906173|NCT02331277|537138096|FG001|Overall Study|Withdrawal by Subject|0|||
148906174|NCT01399372|537138098|FG000|Overall Study|Protocol Violation|3|||
148906175|NCT01399372|537138099|FG001|Overall Study|Protocol Violation|1|||
148906176|NCT01376804|537138100|FG000|Treatment Period|Withdrawal by Subject|1|||
148906177|NCT01376804|537138100|FG000|Treatment Period|Adverse Event|6|||
148906178|NCT01376804|537138100|FG000|Treatment Period|Patient did not receive study drug|1|||
148906179|NCT01071798|537138101|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
148906180|NCT01071798|537138101|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
148906181|NCT01071798|537138101|FG000|Participants Who Received One Cycle|Patient requirement|20|||
148906182|NCT01071798|537138101|FG000|Participants Who Received One Cycle|Death|5|||
148906183|NCT01071798|537138101|FG000|Participants Who Received One Cycle|Change of therapy|6|||
148906184|NCT01071798|537138101|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
148906185|NCT01071798|537138101|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
148906186|NCT01071798|537138101|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
148906187|NCT01071798|537138101|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
148906188|NCT01071798|537138101|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
148906189|NCT01705509|537138109|FG000|Inclusion CPET|Screen Failure|5|||
148906190|NCT01705509|537138109|FG000|Inclusion CPET|Withdrawal by Subject|2|||
148906191|NCT01705509|537138109|FG000|CPET w/ Ranexa|Screen Failure|2|||
148906192|NCT02736890|537138110|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
148906193|NCT02736890|537138111|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
148906194|NCT02736890|537138110|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
148906195|NCT02736890|537138111|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
148906196|NCT02904954|537138112|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
148906197|NCT02904954|537138113|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
148906198|NCT02904954|537138112|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
148906199|NCT02904954|537138113|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
148906200|NCT02904954|537138112|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
148906201|NCT02904954|537138113|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
148906202|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Recurrence|2|||
148906203|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Recurrence|0|||
148906204|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Adverse Event|2|||
148906205|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Adverse Event|6|||
148906206|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Participant wishes|12|||
148906207|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Participant wishes|7|||
148906208|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Physician Decision|2|||
148906209|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Physician Decision|1|||
148906210|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
148906211|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
148906212|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Death|0|||
148906213|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Death|1|||
148906214|NCT02904954|537138112|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
148906215|NCT02904954|537138113|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
149138448|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
148906216|NCT05097963|537138114|FG000|Overall Study|Protocol Violation|13|||
148906217|NCT05097963|537138114|FG000|Overall Study|Withdrawal by Subject|21|||
148906218|NCT03349034|537138117|FG000|Overall Study|catheters dislodged during transport|2|||
148906219|NCT03349034|537138118|FG001|Overall Study|catheters dislodged during transport|0|||
148906220|NCT03349034|537138117|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
149138449|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
149011617|NCT00736489|537521522|FG004|Period 1|Withdrawal by Subject|0|||
149011618|NCT00736489|537521523|FG005|Period 1|Withdrawal by Subject|1|||
149011619|NCT02395133|537521528|FG000|Overall Study|Adverse Event|4|||
149011620|NCT02395133|537521529|FG001|Overall Study|Adverse Event|1|||
149011621|NCT02395133|537521530|FG002|Overall Study|Adverse Event|3|||
149011622|NCT02395133|537521531|FG003|Overall Study|Adverse Event|0|||
149011623|NCT02395133|537521528|FG000|Overall Study|Lack of Efficacy|1|||
149011624|NCT02395133|537521529|FG001|Overall Study|Lack of Efficacy|0|||
149011625|NCT02395133|537521530|FG002|Overall Study|Lack of Efficacy|1|||
149011626|NCT02395133|537521531|FG003|Overall Study|Lack of Efficacy|1|||
149011627|NCT02395133|537521528|FG000|Overall Study|Protocol Violation|1|||
149011628|NCT02395133|537521529|FG001|Overall Study|Protocol Violation|1|||
149011629|NCT02395133|537521530|FG002|Overall Study|Protocol Violation|0|||
149011630|NCT02395133|537521531|FG003|Overall Study|Protocol Violation|3|||
149011631|NCT02395133|537521528|FG000|Overall Study|Lost to Follow-up|0|||
149011632|NCT02395133|537521529|FG001|Overall Study|Lost to Follow-up|1|||
149011633|NCT02395133|537521530|FG002|Overall Study|Lost to Follow-up|1|||
148906221|NCT03349034|537138118|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
148906222|NCT03349034|537138117|FG000|Overall Study|soft tissue flap used|1|||
148906223|NCT03349034|537138118|FG001|Overall Study|soft tissue flap used|0|||
148906224|NCT03349034|537138117|FG000|Overall Study|Other|0|||
148906225|NCT03349034|537138118|FG001|Overall Study|Other|1|||
148906226|NCT01039376|537138119|FG000|Overall Study|Lost to Follow-up|5|||
148906227|NCT01039376|537138120|FG001|Overall Study|Lost to Follow-up|12|||
148906228|NCT01039376|537138119|FG000|Overall Study|Physician Decision|15|||
148906229|NCT01039376|537138120|FG001|Overall Study|Physician Decision|10|||
148906230|NCT01039376|537138119|FG000|Overall Study|Withdrawal by Subject|20|||
148906231|NCT01039376|537138120|FG001|Overall Study|Withdrawal by Subject|32|||
148906232|NCT01039376|537138119|FG000|Overall Study|Study terminated by Sponsor|90|||
148906233|NCT01039376|537138120|FG001|Overall Study|Study terminated by Sponsor|72|||
148906234|NCT00123422|537138121|FG000|Overall Study|Physician Decision|2|||
149011634|NCT02395133|537521531|FG003|Overall Study|Lost to Follow-up|0|||
149011635|NCT02395133|537521528|FG000|Overall Study|Pregnancy|0|||
149011636|NCT02395133|537521529|FG001|Overall Study|Pregnancy|0|||
149011637|NCT02395133|537521530|FG002|Overall Study|Pregnancy|3|||
148906235|NCT00123422|537138122|FG001|Overall Study|Physician Decision|2|||
149011638|NCT02395133|537521531|FG003|Overall Study|Pregnancy|0|||
149011639|NCT02395133|537521528|FG000|Overall Study|Consent withdrawn with no reason given|1|||
149011640|NCT02395133|537521529|FG001|Overall Study|Consent withdrawn with no reason given|3|||
149011641|NCT02395133|537521530|FG002|Overall Study|Consent withdrawn with no reason given|0|||
149011642|NCT02395133|537521531|FG003|Overall Study|Consent withdrawn with no reason given|2|||
149011643|NCT02395133|537521528|FG000|Overall Study|Consent withdrawn with personal reason|0|||
149011644|NCT02395133|537521529|FG001|Overall Study|Consent withdrawn with personal reason|1|||
149011645|NCT02395133|537521530|FG002|Overall Study|Consent withdrawn with personal reason|0|||
149011646|NCT02395133|537521531|FG003|Overall Study|Consent withdrawn with personal reason|3|||
149011647|NCT02395133|537521528|FG000|Overall Study|Sponsor decision|2|||
149011648|NCT02395133|537521529|FG001|Overall Study|Sponsor decision|0|||
149011649|NCT02395133|537521530|FG002|Overall Study|Sponsor decision|0|||
149011650|NCT02395133|537521531|FG003|Overall Study|Sponsor decision|1|||
149011651|NCT02395133|537521528|FG000|Overall Study|Other than specified above|5|||
149011652|NCT02395133|537521529|FG001|Overall Study|Other than specified above|2|||
149011653|NCT02395133|537521530|FG002|Overall Study|Other than specified above|2|||
149011654|NCT02395133|537521531|FG003|Overall Study|Other than specified above|4|||
149011655|NCT00962247|537521534|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
149011656|NCT00962247|537521534|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
148906236|NCT00123422|537138123|FG002|Overall Study|Physician Decision|6|||
148906237|NCT00123422|537138121|FG000|Overall Study|Withdrawal by Subject|1|||
149011657|NCT02234063|537521543|FG000|Overall Study|Lost to Follow-up|235|||
149011658|NCT02234063|537521544|FG001|Overall Study|Lost to Follow-up|42|||
149011659|NCT02234063|537521543|FG000|Overall Study|Withdrawal by Subject|20|||
149011660|NCT02234063|537521544|FG001|Overall Study|Withdrawal by Subject|1|||
149011661|NCT02946918|537521547|FG000|Overall Study|Patient unblinded himself|1|||
149011662|NCT02946918|537521548|FG001|Overall Study|Patient unblinded himself|0|||
148906238|NCT00123422|537138122|FG001|Overall Study|Withdrawal by Subject|2|||
148906239|NCT00123422|537138123|FG002|Overall Study|Withdrawal by Subject|2|||
148906240|NCT00123422|537138121|FG000|Overall Study|Lost to Follow-up|1|||
148906241|NCT00123422|537138122|FG001|Overall Study|Lost to Follow-up|2|||
148906242|NCT00123422|537138123|FG002|Overall Study|Lost to Follow-up|2|||
148906243|NCT04555616|537138124|FG000|Overall Study|Death|1|||
148906244|NCT04555616|537138125|FG001|Overall Study|Death|0|||
148906245|NCT04555616|537138126|FG002|Overall Study|Death|1|||
149011663|NCT02946918|537521547|FG000|Overall Study|Physician Decision|0|||
149011664|NCT02946918|537521548|FG001|Overall Study|Physician Decision|2|||
149011665|NCT02946918|537521547|FG000|Overall Study|Ran out of study medication|0|||
149011666|NCT02946918|537521548|FG001|Overall Study|Ran out of study medication|1|||
148906246|NCT04555616|537138124|FG000|Overall Study|Withdrawal by Subject|2|||
148906247|NCT04555616|537138125|FG001|Overall Study|Withdrawal by Subject|1|||
148906248|NCT04555616|537138126|FG002|Overall Study|Withdrawal by Subject|0|||
149011667|NCT01861522|537521549|FG000|Overall Study|Adverse Event|1|||
149011668|NCT01861522|537521550|FG001|Overall Study|Adverse Event|0|||
149011669|NCT01861522|537521549|FG000|Overall Study|Withdrawal by Subject|2|||
149011670|NCT01861522|537521550|FG001|Overall Study|Withdrawal by Subject|0|||
149011671|NCT00069784|537521551|FG000|Overall Study|Adverse Event|105|||
149011672|NCT00069784|537521552|FG001|Overall Study|Adverse Event|0|||
149011673|NCT00069784|537521551|FG000|Overall Study|Withdrawal by Subject|1090|||
149011674|NCT00069784|537521552|FG001|Overall Study|Withdrawal by Subject|0|||
149011675|NCT00069784|537521551|FG000|Overall Study|Other|17|||
149011676|NCT00069784|537521552|FG001|Overall Study|Other|0|||
149011677|NCT01555164|537521555|FG000|Overall Study|Adverse Event|5|||
149011678|NCT01555164|537521556|FG001|Overall Study|Adverse Event|7|||
149011679|NCT01555164|537521555|FG000|Overall Study|Hyperglycemia|0|||
149011680|NCT01555164|537521556|FG001|Overall Study|Hyperglycemia|1|||
149011681|NCT01555164|537521555|FG000|Overall Study|Investigator's Discretion|2|||
149011682|NCT01555164|537521556|FG001|Overall Study|Investigator's Discretion|2|||
149011683|NCT01555164|537521555|FG000|Overall Study|Lost to Follow-up|4|||
149011684|NCT01555164|537521556|FG001|Overall Study|Lost to Follow-up|3|||
149011685|NCT01555164|537521555|FG000|Overall Study|Protocol Violation|9|||
149011686|NCT01555164|537521556|FG001|Overall Study|Protocol Violation|5|||
149011687|NCT01555164|537521555|FG000|Overall Study|Subject Non-compliance|14|||
149011688|NCT01555164|537521556|FG001|Overall Study|Subject Non-compliance|6|||
149011689|NCT01555164|537521555|FG000|Overall Study|Subject Withdrew Consent|6|||
149011690|NCT01555164|537521556|FG001|Overall Study|Subject Withdrew Consent|11|||
149011691|NCT03443713|537521557|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
149011692|NCT03443713|537521558|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
149011693|NCT03443713|537521559|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
149011694|NCT01672853|537521562|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
149011695|NCT01672853|537521563|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
149011696|NCT01672853|537521564|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
149011697|NCT01672853|537521562|FG000|Overall Study|Pregnancy|0|||
149011698|NCT01672853|537521563|FG001|Overall Study|Pregnancy|1|||
149011699|NCT01672853|537521564|FG002|Overall Study|Pregnancy|0|||
149011700|NCT01672853|537521562|FG000|Overall Study|Investigator's Discretion|1|||
149011701|NCT01672853|537521563|FG001|Overall Study|Investigator's Discretion|0|||
149011702|NCT01672853|537521564|FG002|Overall Study|Investigator's Discretion|0|||
149011703|NCT01672853|537521562|FG000|Overall Study|Withdrew Consent|5|||
149011704|NCT01672853|537521563|FG001|Overall Study|Withdrew Consent|5|||
148803065|NCT03530293|536759528|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
148803066|NCT03530293|536759529|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
148803067|NCT03530293|536759527|FG000|Pre-randomization|Withdrawal by Subject|5|||
148803068|NCT03530293|536759528|FG001|Pre-randomization|Withdrawal by Subject|0|||
148803069|NCT03530293|536759529|FG002|Pre-randomization|Withdrawal by Subject|0|||
148803070|NCT03530293|536759527|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
148803071|NCT03530293|536759528|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
148803072|NCT03530293|536759529|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
148803073|NCT03530293|536759527|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
148803074|NCT03530293|536759528|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
148803075|NCT03530293|536759529|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
148803076|NCT03530293|536759527|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
148803077|NCT03530293|536759528|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
148803078|NCT03530293|536759529|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
148803079|NCT03530293|536759527|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
148803080|NCT03530293|536759528|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
148803081|NCT03530293|536759529|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
148803082|NCT03530293|536759527|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
148803083|NCT03530293|536759528|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
148803084|NCT03530293|536759529|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
148803085|NCT01663623|536759530|FG000|Overall Study|Adverse Event|3|||
148803086|NCT01663623|536759531|FG001|Overall Study|Adverse Event|7|||
148803087|NCT01663623|536759530|FG000|Overall Study|Lack of Efficacy|5|||
148803088|NCT01663623|536759531|FG001|Overall Study|Lack of Efficacy|6|||
148803089|NCT01663623|536759530|FG000|Overall Study|Protocol Violation|0|||
148803090|NCT01663623|536759531|FG001|Overall Study|Protocol Violation|1|||
148803091|NCT01663623|536759530|FG000|Overall Study|Other-Study closed/terminated|1|||
148803092|NCT01663623|536759531|FG001|Overall Study|Other-Study closed/terminated|1|||
148803093|NCT01663623|536759530|FG000|Overall Study|Physician Decision|1|||
148803094|NCT01663623|536759531|FG001|Overall Study|Physician Decision|4|||
148803095|NCT01663623|536759530|FG000|Overall Study|Withdrawal by Subject|2|||
148803096|NCT01663623|536759531|FG001|Overall Study|Withdrawal by Subject|1|||
148803097|NCT00686972|536759532|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
148803098|NCT04465422|536759545|FG000|Overall Study|Lost to Follow-up|0|||
148803099|NCT04465422|536759546|FG001|Overall Study|Lost to Follow-up|2|||
148803100|NCT05412134|536759551|FG000|Overall Study|Lost to Follow-up|2|||
148803101|NCT05412134|536759552|FG001|Overall Study|Lost to Follow-up|0|||
148803102|NCT00251758|536759555|FG000|Overall Study|Adverse Event|7|||
148803103|NCT00251758|536759556|FG001|Overall Study|Adverse Event|9|||
148803104|NCT00251758|536759557|FG002|Overall Study|Adverse Event|11|||
148803105|NCT00251758|536759555|FG000|Overall Study|Lost to Follow-up|4|||
148803106|NCT00251758|536759556|FG001|Overall Study|Lost to Follow-up|2|||
148803107|NCT00251758|536759557|FG002|Overall Study|Lost to Follow-up|5|||
148803108|NCT00251758|536759555|FG000|Overall Study|Withdrawal by Subject|13|||
148803109|NCT00251758|536759556|FG001|Overall Study|Withdrawal by Subject|7|||
148803110|NCT00251758|536759557|FG002|Overall Study|Withdrawal by Subject|3|||
148803111|NCT00251758|536759555|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
148803112|NCT00251758|536759556|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
148803113|NCT00251758|536759557|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
148803114|NCT00251758|536759555|FG000|Overall Study|Lack of Efficacy|3|||
148803115|NCT00251758|536759556|FG001|Overall Study|Lack of Efficacy|0|||
148803116|NCT00251758|536759557|FG002|Overall Study|Lack of Efficacy|0|||
148803117|NCT00251758|536759555|FG000|Overall Study|Noncompliant|0|||
148803118|NCT00251758|536759556|FG001|Overall Study|Noncompliant|2|||
148803119|NCT00251758|536759557|FG002|Overall Study|Noncompliant|2|||
148803120|NCT00251758|536759555|FG000|Overall Study|Pregnancy|0|||
148803121|NCT00251758|536759556|FG001|Overall Study|Pregnancy|1|||
148803122|NCT00251758|536759557|FG002|Overall Study|Pregnancy|0|||
148803123|NCT00251758|536759555|FG000|Overall Study|Per Subject Request|0|||
148803124|NCT00251758|536759556|FG001|Overall Study|Per Subject Request|0|||
148803125|NCT00251758|536759557|FG002|Overall Study|Per Subject Request|1|||
148906249|NCT01554241|537138127|FG000|Overall Study|Death|3|||
148906250|NCT01554241|537138128|FG001|Overall Study|Death|1|||
148906251|NCT01554241|537138129|FG002|Overall Study|Death|1|||
148906252|NCT01554241|537138130|FG003|Overall Study|Death|0|||
148906253|NCT01554241|537138127|FG000|Overall Study|protocol specified renal stone|0|||
148906254|NCT01554241|537138128|FG001|Overall Study|protocol specified renal stone|0|||
148906255|NCT01554241|537138129|FG002|Overall Study|protocol specified renal stone|0|||
148906256|NCT01554241|537138130|FG003|Overall Study|protocol specified renal stone|1|||
148906257|NCT01554241|537138127|FG000|Overall Study|protocol specified change in eGFR|0|||
148906258|NCT01554241|537138128|FG001|Overall Study|protocol specified change in eGFR|0|||
148906259|NCT01554241|537138129|FG002|Overall Study|protocol specified change in eGFR|1|||
148906260|NCT01554241|537138130|FG003|Overall Study|protocol specified change in eGFR|0|||
148906261|NCT01554241|537138127|FG000|Overall Study|Withdrawal by Subject|0|||
148906262|NCT01554241|537138128|FG001|Overall Study|Withdrawal by Subject|0|||
148906263|NCT01554241|537138129|FG002|Overall Study|Withdrawal by Subject|2|||
148906264|NCT01554241|537138130|FG003|Overall Study|Withdrawal by Subject|0|||
148906265|NCT02118961|537138131|FG000|Overall Study|Withdrawal by Subject|1|||
148906266|NCT02118961|537138132|FG001|Overall Study|Withdrawal by Subject|0|||
148906267|NCT00998296|537138136|FG000|Overall Study|Progressive disease|0|||
148906268|NCT00998296|537138137|FG001|Overall Study|Progressive disease|1|||
148906269|NCT00998296|537138138|FG002|Overall Study|Progressive disease|0|||
148906270|NCT00998296|537138139|FG003|Overall Study|Progressive disease|0|||
148906271|NCT00998296|537138140|FG004|Overall Study|Progressive disease|0|||
148906272|NCT00998296|537138141|FG005|Overall Study|Progressive disease|0|||
148906273|NCT00998296|537138142|FG006|Overall Study|Progressive disease|1|||
148906274|NCT00998296|537138143|FG007|Overall Study|Progressive disease|0|||
148906275|NCT00998296|537138144|FG008|Overall Study|Progressive disease|0|||
148906276|NCT00998296|537138145|FG009|Overall Study|Progressive disease|14|||
148906277|NCT00998296|537138146|FG010|Overall Study|Progressive disease|5|||
148906278|NCT00998296|537138136|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906279|NCT00998296|537138137|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906280|NCT00998296|537138138|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906281|NCT00998296|537138139|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906282|NCT00998296|537138140|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
148906283|NCT00998296|537138141|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906284|NCT00998296|537138142|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906285|NCT00998296|537138143|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
148906286|NCT00998296|537138144|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
148906287|NCT00998296|537138145|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906288|NCT00998296|537138146|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
148906289|NCT00998296|537138136|FG000|Overall Study|Other adverse event|0|||
148906290|NCT00998296|537138137|FG001|Overall Study|Other adverse event|0|||
148906291|NCT00998296|537138138|FG002|Overall Study|Other adverse event|0|||
148906292|NCT00998296|537138139|FG003|Overall Study|Other adverse event|0|||
148906293|NCT00998296|537138140|FG004|Overall Study|Other adverse event|1|||
148906294|NCT00998296|537138141|FG005|Overall Study|Other adverse event|0|||
148906295|NCT00998296|537138142|FG006|Overall Study|Other adverse event|0|||
148906296|NCT00998296|537138143|FG007|Overall Study|Other adverse event|0|||
148906297|NCT00998296|537138144|FG008|Overall Study|Other adverse event|0|||
148906298|NCT00998296|537138145|FG009|Overall Study|Other adverse event|1|||
148906299|NCT00998296|537138146|FG010|Overall Study|Other adverse event|2|||
148906300|NCT00998296|537138136|FG000|Overall Study|Refused to continue taking trial med.|0|||
148906301|NCT00998296|537138137|FG001|Overall Study|Refused to continue taking trial med.|0|||
148906302|NCT00998296|537138138|FG002|Overall Study|Refused to continue taking trial med.|0|||
148906303|NCT00998296|537138139|FG003|Overall Study|Refused to continue taking trial med.|0|||
148906304|NCT00998296|537138140|FG004|Overall Study|Refused to continue taking trial med.|0|||
148906305|NCT00998296|537138141|FG005|Overall Study|Refused to continue taking trial med.|0|||
148906306|NCT00998296|537138142|FG006|Overall Study|Refused to continue taking trial med.|0|||
148906307|NCT00998296|537138143|FG007|Overall Study|Refused to continue taking trial med.|0|||
148906308|NCT00998296|537138144|FG008|Overall Study|Refused to continue taking trial med.|0|||
148906309|NCT00998296|537138145|FG009|Overall Study|Refused to continue taking trial med.|2|||
148906310|NCT00998296|537138146|FG010|Overall Study|Refused to continue taking trial med.|0|||
148906311|NCT00998296|537138136|FG000|Overall Study|Reason other than those specified above|0|||
149138450|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
149138451|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
149138452|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
149138453|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
149138454|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
149138455|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
148906312|NCT00998296|537138137|FG001|Overall Study|Reason other than those specified above|0|||
149011705|NCT01672853|537521564|FG002|Overall Study|Withdrew Consent|5|||
148906313|NCT00998296|537138138|FG002|Overall Study|Reason other than those specified above|0|||
148906314|NCT00998296|537138139|FG003|Overall Study|Reason other than those specified above|0|||
148906315|NCT00998296|537138140|FG004|Overall Study|Reason other than those specified above|0|||
148906316|NCT00998296|537138141|FG005|Overall Study|Reason other than those specified above|0|||
148906317|NCT00998296|537138142|FG006|Overall Study|Reason other than those specified above|0|||
148906318|NCT00998296|537138143|FG007|Overall Study|Reason other than those specified above|0|||
149138456|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
149138457|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
149138458|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
149138459|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
149138460|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
148906319|NCT00998296|537138144|FG008|Overall Study|Reason other than those specified above|0|||
148906320|NCT00998296|537138145|FG009|Overall Study|Reason other than those specified above|1|||
148906321|NCT00998296|537138146|FG010|Overall Study|Reason other than those specified above|0|||
148906322|NCT04396639|537138147|FG000|Overall Study|Withdrawal by Subject|1|||
148906323|NCT04396639|537138147|FG000|Overall Study|Other|1|||
148906324|NCT01544335|537138148|FG000|Overall Study|Lost to Follow-up|27|||
148906325|NCT01544335|537138148|FG000|Overall Study|Death|4|||
148906326|NCT01544335|537138148|FG000|Overall Study|Disease progression|3|||
148906327|NCT01544335|537138148|FG000|Overall Study|Baseline Measurements not Available|19|||
148906328|NCT03219528|537138149|FG000|Overall Study|Lost to Follow-up|5|||
148906329|NCT03219528|537138150|FG001|Overall Study|Lost to Follow-up|4|||
148906330|NCT03219528|537138149|FG000|Overall Study|Withdrawal by Subject|4|||
148906331|NCT03219528|537138150|FG001|Overall Study|Withdrawal by Subject|4|||
148906332|NCT03809104|537138151|FG000|Overall Study|Withdrawal by Subject|3|||
148906333|NCT01532986|537138152|FG000|Overall Study|Death|9|||
148906334|NCT01532986|537138153|FG001|Overall Study|Death|9|||
148906335|NCT01532986|537138152|FG000|Overall Study|Withdrawal by Subject|7|||
148906336|NCT01532986|537138153|FG001|Overall Study|Withdrawal by Subject|10|||
148906337|NCT01532986|537138152|FG000|Overall Study|Physician Decision|7|||
148906338|NCT01532986|537138153|FG001|Overall Study|Physician Decision|5|||
148906339|NCT02120898|537138154|FG000|Overall Study|Withdrawal by Subject|4|||
148906340|NCT02120898|537138155|FG001|Overall Study|Withdrawal by Subject|2|||
148906341|NCT02120898|537138156|FG002|Overall Study|Withdrawal by Subject|2|||
148906342|NCT02120898|537138154|FG000|Overall Study|Non-compliance with study drug|3|||
148906343|NCT02120898|537138155|FG001|Overall Study|Non-compliance with study drug|0|||
148906344|NCT02120898|537138156|FG002|Overall Study|Non-compliance with study drug|0|||
148906345|NCT02120898|537138154|FG000|Overall Study|Adverse Event|1|||
148906346|NCT02120898|537138155|FG001|Overall Study|Adverse Event|2|||
148906347|NCT02120898|537138156|FG002|Overall Study|Adverse Event|1|||
148906348|NCT02120898|537138154|FG000|Overall Study|Protocol Violation|1|||
148906349|NCT02120898|537138155|FG001|Overall Study|Protocol Violation|2|||
148906350|NCT02120898|537138156|FG002|Overall Study|Protocol Violation|0|||
148906351|NCT02120898|537138154|FG000|Overall Study|Lost to Follow-up|0|||
148906352|NCT02120898|537138155|FG001|Overall Study|Lost to Follow-up|0|||
148906353|NCT02120898|537138156|FG002|Overall Study|Lost to Follow-up|1|||
148906354|NCT04313244|537138157|FG000|Overall Study|Withdrawal of Consent|3|||
148906355|NCT04313244|537138158|FG001|Overall Study|Withdrawal of Consent|3|||
148906356|NCT04313244|537138157|FG000|Overall Study|Met Exclusion Criteria|1|||
148906357|NCT04313244|537138158|FG001|Overall Study|Met Exclusion Criteria|0|||
148906358|NCT04313244|537138157|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
148906359|NCT04313244|537138158|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
148906360|NCT02536963|537138160|FG000|Overall Study|Withdrawal by Subject|18|||
148906361|NCT00687193|537138161|FG000|Overall Study|Adverse Event|0|||
148906362|NCT00687193|537138162|FG001|Overall Study|Adverse Event|1|||
148906363|NCT00687193|537138163|FG002|Overall Study|Adverse Event|2|||
148906364|NCT00687193|537138164|FG003|Overall Study|Adverse Event|3|||
148906365|NCT00687193|537138165|FG004|Overall Study|Adverse Event|0|||
148906366|NCT00687193|537138166|FG005|Overall Study|Adverse Event|2|||
148906367|NCT00687193|537138161|FG000|Overall Study|Lack of Efficacy|1|||
148906368|NCT00687193|537138162|FG001|Overall Study|Lack of Efficacy|1|||
148906369|NCT00687193|537138163|FG002|Overall Study|Lack of Efficacy|0|||
148906370|NCT00687193|537138164|FG003|Overall Study|Lack of Efficacy|0|||
148906371|NCT00687193|537138165|FG004|Overall Study|Lack of Efficacy|0|||
148906372|NCT00687193|537138166|FG005|Overall Study|Lack of Efficacy|2|||
148906373|NCT00687193|537138161|FG000|Overall Study|Protocol Violation|1|||
148906374|NCT00687193|537138162|FG001|Overall Study|Protocol Violation|2|||
149138461|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
149138462|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
149138463|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
149138464|NCT03627767|537988866|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
149138465|NCT03627767|537988867|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
149138466|NCT03627767|537988868|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
149138467|NCT03627767|537988869|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
148906375|NCT00687193|537138163|FG002|Overall Study|Protocol Violation|0|||
148906376|NCT00687193|537138164|FG003|Overall Study|Protocol Violation|1|||
148906377|NCT00687193|537138165|FG004|Overall Study|Protocol Violation|2|||
148906378|NCT00687193|537138166|FG005|Overall Study|Protocol Violation|0|||
148906379|NCT02129699|537138167|FG000|Overall Study|Did not start treatment|3|||
148906380|NCT02129699|537138168|FG001|Overall Study|Did not start treatment|2|||
148906381|NCT02447003|537138169|FG000|Overall Study|Other|0|||
148906382|NCT02447003|537138170|FG001|Overall Study|Other|4|||
148906383|NCT02447003|537138169|FG000|Overall Study|Site discontinued|0|||
148906384|NCT02447003|537138170|FG001|Overall Study|Site discontinued|2|||
148906385|NCT02447003|537138169|FG000|Overall Study|Physician Decision|0|||
148906386|NCT02447003|537138170|FG001|Overall Study|Physician Decision|1|||
148906387|NCT02447003|537138169|FG000|Overall Study|Withdrawal by Subject|4|||
149011706|NCT01672853|537521562|FG000|Overall Study|Adverse Event|4|||
149011707|NCT01672853|537521563|FG001|Overall Study|Adverse Event|6|||
149011708|NCT01672853|537521564|FG002|Overall Study|Adverse Event|8|||
149011709|NCT01672853|537521562|FG000|Overall Study|Lost to Follow-up|0|||
149011710|NCT01672853|537521563|FG001|Overall Study|Lost to Follow-up|1|||
149011711|NCT01672853|537521564|FG002|Overall Study|Lost to Follow-up|0|||
149011712|NCT01672853|537521562|FG000|Overall Study|Randomized but Never Treated|0|||
149011713|NCT01672853|537521563|FG001|Overall Study|Randomized but Never Treated|0|||
149011714|NCT01672853|537521564|FG002|Overall Study|Randomized but Never Treated|1|||
149011715|NCT02073097|537521567|FG000|Overall Study|Adverse Event|0|||
149011716|NCT02073097|537521568|FG001|Overall Study|Adverse Event|0|||
149011717|NCT02073097|537521569|FG002|Overall Study|Adverse Event|0|||
149011718|NCT02073097|537521570|FG003|Overall Study|Adverse Event|0|||
149011719|NCT02073097|537521571|FG004|Overall Study|Adverse Event|0|||
149011720|NCT02073097|537521572|FG005|Overall Study|Adverse Event|0|||
149011721|NCT02073097|537521573|FG006|Overall Study|Adverse Event|0|||
149011722|NCT02073097|537521574|FG007|Overall Study|Adverse Event|2|||
149011723|NCT02073097|537521567|FG000|Overall Study|Withdrawal by Subject|0|||
149011724|NCT02073097|537521568|FG001|Overall Study|Withdrawal by Subject|0|||
149011725|NCT02073097|537521569|FG002|Overall Study|Withdrawal by Subject|0|||
149011726|NCT02073097|537521570|FG003|Overall Study|Withdrawal by Subject|0|||
149011727|NCT02073097|537521571|FG004|Overall Study|Withdrawal by Subject|0|||
149011728|NCT02073097|537521572|FG005|Overall Study|Withdrawal by Subject|0|||
149011729|NCT02073097|537521573|FG006|Overall Study|Withdrawal by Subject|0|||
149011730|NCT02073097|537521574|FG007|Overall Study|Withdrawal by Subject|2|||
149011731|NCT02073097|537521567|FG000|Overall Study|Death|0|||
149011732|NCT02073097|537521568|FG001|Overall Study|Death|0|||
149011733|NCT02073097|537521569|FG002|Overall Study|Death|0|||
149011734|NCT02073097|537521570|FG003|Overall Study|Death|0|||
149011735|NCT02073097|537521571|FG004|Overall Study|Death|0|||
149011736|NCT02073097|537521572|FG005|Overall Study|Death|0|||
149011737|NCT02073097|537521573|FG006|Overall Study|Death|0|||
149011738|NCT02073097|537521574|FG007|Overall Study|Death|1|||
149011739|NCT02073097|537521567|FG000|Overall Study|Physician Decision|0|||
149011740|NCT02073097|537521568|FG001|Overall Study|Physician Decision|0|||
149011741|NCT02073097|537521569|FG002|Overall Study|Physician Decision|0|||
149011742|NCT02073097|537521570|FG003|Overall Study|Physician Decision|0|||
149011743|NCT02073097|537521571|FG004|Overall Study|Physician Decision|0|||
149011744|NCT02073097|537521572|FG005|Overall Study|Physician Decision|0|||
149011745|NCT02073097|537521573|FG006|Overall Study|Physician Decision|0|||
149011746|NCT02073097|537521574|FG007|Overall Study|Physician Decision|1|||
149011747|NCT01806740|537523337|FG000|Overall Study|Withdrawal by Subject|4|||
149011748|NCT01806740|537523337|FG000|Overall Study|Physician Decision|1|||
149011749|NCT01806740|537523337|FG000|Overall Study|Patient's refusal of treatment|1|||
149011750|NCT00474929|537523342|FG000|Overall Study|Withdrawal by Subject|0|||
149011751|NCT00474929|537523343|FG001|Overall Study|Withdrawal by Subject|1|||
148906388|NCT02447003|537138170|FG001|Overall Study|Withdrawal by Subject|3|||
148906389|NCT02447003|537138169|FG000|Overall Study|Sponsor Decision|6|||
148906390|NCT02447003|537138170|FG001|Overall Study|Sponsor Decision|11|||
149011752|NCT00474929|537523344|FG002|Overall Study|Withdrawal by Subject|0|||
149011753|NCT00474929|537523345|FG003|Overall Study|Withdrawal by Subject|0|||
149011754|NCT00474929|537523346|FG004|Overall Study|Withdrawal by Subject|0|||
149011755|NCT00474929|537523342|FG000|Overall Study|Unrelated medical condition|0|||
149011756|NCT00474929|537523343|FG001|Overall Study|Unrelated medical condition|0|||
149011757|NCT00474929|537523344|FG002|Overall Study|Unrelated medical condition|1|||
149011758|NCT00474929|537523345|FG003|Overall Study|Unrelated medical condition|0|||
149011759|NCT00474929|537523346|FG004|Overall Study|Unrelated medical condition|0|||
149011760|NCT00474929|537523342|FG000|Overall Study|Physician Decision|0|||
148906391|NCT02447003|537138169|FG000|Overall Study|Progressive Disease|1|||
148906392|NCT02447003|537138170|FG001|Overall Study|Progressive Disease|0|||
148906393|NCT02447003|537138169|FG000|Overall Study|Lost to Follow-up|5|||
148906394|NCT02447003|537138170|FG001|Overall Study|Lost to Follow-up|0|||
148906395|NCT02447003|537138169|FG000|Overall Study|Death|154|||
148906396|NCT02447003|537138170|FG001|Overall Study|Death|63|||
149011761|NCT00474929|537523343|FG001|Overall Study|Physician Decision|0|||
149011762|NCT00474929|537523344|FG002|Overall Study|Physician Decision|1|||
149011763|NCT00474929|537523345|FG003|Overall Study|Physician Decision|2|||
149011764|NCT00474929|537523346|FG004|Overall Study|Physician Decision|0|||
149011765|NCT03661996|537523349|FG000|Overall Study|Adverse Event|0|||
149011766|NCT03661996|537523350|FG001|Overall Study|Adverse Event|0|||
149011767|NCT03661996|537523351|FG002|Overall Study|Adverse Event|1|||
149011768|NCT03661996|537523352|FG003|Overall Study|Adverse Event|1|||
149011769|NCT03661996|537523353|FG004|Overall Study|Adverse Event|0|||
149011770|NCT03661996|537523349|FG000|Overall Study|Lost to Follow-up|5|||
149011771|NCT03661996|537523350|FG001|Overall Study|Lost to Follow-up|1|||
149011772|NCT03661996|537523351|FG002|Overall Study|Lost to Follow-up|2|||
149011773|NCT03661996|537523352|FG003|Overall Study|Lost to Follow-up|2|||
149011774|NCT03661996|537523353|FG004|Overall Study|Lost to Follow-up|6|||
149011775|NCT03661996|537523349|FG000|Overall Study|Physician Decision|1|||
149011776|NCT03661996|537523350|FG001|Overall Study|Physician Decision|1|||
149011777|NCT03661996|537523351|FG002|Overall Study|Physician Decision|1|||
149011778|NCT03661996|537523352|FG003|Overall Study|Physician Decision|2|||
149011779|NCT03661996|537523353|FG004|Overall Study|Physician Decision|0|||
149011780|NCT03661996|537523349|FG000|Overall Study|Protocol Violation|0|||
149011781|NCT03661996|537523350|FG001|Overall Study|Protocol Violation|0|||
149011782|NCT03661996|537523351|FG002|Overall Study|Protocol Violation|0|||
149011783|NCT03661996|537523352|FG003|Overall Study|Protocol Violation|0|||
149011784|NCT03661996|537523353|FG004|Overall Study|Protocol Violation|1|||
149011785|NCT03661996|537523349|FG000|Overall Study|Withdrawal by Subject|3|||
149011786|NCT03661996|537523350|FG001|Overall Study|Withdrawal by Subject|5|||
149011787|NCT03661996|537523351|FG002|Overall Study|Withdrawal by Subject|1|||
149011788|NCT03661996|537523352|FG003|Overall Study|Withdrawal by Subject|7|||
149011789|NCT03661996|537523353|FG004|Overall Study|Withdrawal by Subject|7|||
149011790|NCT03661996|537523349|FG000|Overall Study|Sponsors Decision|2|||
149011791|NCT03661996|537523350|FG001|Overall Study|Sponsors Decision|0|||
149011792|NCT03661996|537523351|FG002|Overall Study|Sponsors Decision|0|||
149011793|NCT03661996|537523352|FG003|Overall Study|Sponsors Decision|0|||
149011794|NCT03661996|537523353|FG004|Overall Study|Sponsors Decision|0|||
149011795|NCT03661996|537523349|FG000|Overall Study|Other|1|||
148803126|NCT00251758|536759555|FG000|Overall Study|Per Investigator Request|1|||
148803127|NCT00251758|536759556|FG001|Overall Study|Per Investigator Request|0|||
148803128|NCT00251758|536759557|FG002|Overall Study|Per Investigator Request|0|||
148803129|NCT02404545|536759560|FG000|Overall Study|Sponsor Termination|6|||
148803130|NCT02404545|536759561|FG001|Overall Study|Sponsor Termination|6|||
148803131|NCT03641508|536759562|FG000|First Injection|Lost to Follow-up|2|||
148803132|NCT03641508|536759563|FG001|First Injection|Lost to Follow-up|0|||
148803133|NCT02577029|536759564|FG000|Overall Study|Adverse Event|1|||
148803134|NCT02577029|536759565|FG001|Overall Study|Adverse Event|0|||
148803135|NCT02577029|536759566|FG002|Overall Study|Adverse Event|2|||
148803136|NCT02577029|536759567|FG003|Overall Study|Adverse Event|0|||
148803137|NCT02577029|536759568|FG004|Overall Study|Adverse Event|1|||
148803138|NCT02577029|536759569|FG005|Overall Study|Adverse Event|0|||
148803139|NCT02577029|536759570|FG006|Overall Study|Adverse Event|0|||
148803140|NCT02577029|536759571|FG007|Overall Study|Adverse Event|0|||
148803141|NCT02577029|536759564|FG000|Overall Study|Withdrawal by Subject|0|||
148803142|NCT02577029|536759565|FG001|Overall Study|Withdrawal by Subject|0|||
148803143|NCT02577029|536759566|FG002|Overall Study|Withdrawal by Subject|0|||
148803144|NCT02577029|536759567|FG003|Overall Study|Withdrawal by Subject|0|||
148803145|NCT02577029|536759568|FG004|Overall Study|Withdrawal by Subject|0|||
148803146|NCT02577029|536759569|FG005|Overall Study|Withdrawal by Subject|1|||
148803147|NCT02577029|536759570|FG006|Overall Study|Withdrawal by Subject|0|||
148803148|NCT02577029|536759571|FG007|Overall Study|Withdrawal by Subject|0|||
148803149|NCT02577029|536759564|FG000|Overall Study|Sponsor Termination of the Study|9|||
148803150|NCT02577029|536759565|FG001|Overall Study|Sponsor Termination of the Study|2|||
148803151|NCT02577029|536759566|FG002|Overall Study|Sponsor Termination of the Study|5|||
148803152|NCT02577029|536759567|FG003|Overall Study|Sponsor Termination of the Study|12|||
148803153|NCT02577029|536759568|FG004|Overall Study|Sponsor Termination of the Study|10|||
148803154|NCT02577029|536759569|FG005|Overall Study|Sponsor Termination of the Study|12|||
148803155|NCT02577029|536759570|FG006|Overall Study|Sponsor Termination of the Study|12|||
148803156|NCT02577029|536759571|FG007|Overall Study|Sponsor Termination of the Study|12|||
148803157|NCT00750269|536761002|FG000|Overall Study|Protocol Violation|0|||
148803158|NCT00750269|536761003|FG001|Overall Study|Protocol Violation|1|||
148803159|NCT00750269|536761004|FG002|Overall Study|Protocol Violation|1|||
148803160|NCT00750269|536761005|FG003|Overall Study|Protocol Violation|2|||
148803161|NCT00750269|536761006|FG004|Overall Study|Protocol Violation|4|||
148803162|NCT00750269|536761002|FG000|Overall Study|Withdrawal by Subject|0|||
148803163|NCT00750269|536761003|FG001|Overall Study|Withdrawal by Subject|0|||
148803164|NCT00750269|536761004|FG002|Overall Study|Withdrawal by Subject|2|||
148803165|NCT00750269|536761005|FG003|Overall Study|Withdrawal by Subject|2|||
148803166|NCT00750269|536761006|FG004|Overall Study|Withdrawal by Subject|2|||
149011796|NCT03661996|537523350|FG001|Overall Study|Other|1|||
149011797|NCT03661996|537523351|FG002|Overall Study|Other|1|||
149011798|NCT03661996|537523352|FG003|Overall Study|Other|1|||
149011799|NCT03661996|537523353|FG004|Overall Study|Other|0|||
148906397|NCT03534804|537138171|FG000|Overall Study|Withdrawal by Subject|1|||
148906398|NCT04161157|537138172|FG000|Overall Study|Lost to Follow-up|4|||
148906399|NCT04161157|537138172|FG000|Overall Study|Death|3|||
148906400|NCT04161157|537138172|FG000|Overall Study|Ineligible|2|||
148906401|NCT04161157|537138172|FG000|Overall Study|Withdrawal by Subject|4|||
148906402|NCT05673876|537138186|FG000|Overall Study|Death|3|||
148906403|NCT05673876|537138187|FG001|Overall Study|Death|1|||
148906404|NCT05673876|537138186|FG000|Overall Study|Study Terminated by Sponsor|0|||
148906405|NCT05673876|537138187|FG001|Overall Study|Study Terminated by Sponsor|1|||
149138468|NCT03627767|537988870|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
148906406|NCT05673876|537138186|FG000|Overall Study|Physician Decision|0|||
148906407|NCT05673876|537138187|FG001|Overall Study|Physician Decision|1|||
148906408|NCT03529422|537138188|FG000|Overall Study|Withdrawal by Subject|1|||
148906409|NCT03529422|537138188|FG000|Overall Study|Protocol Violation|1|||
148906410|NCT03529422|537138188|FG000|Overall Study|Disease progression|2|||
148906411|NCT02000115|537138189|FG000|Overall Study|Death|56|||
148906412|NCT02000115|537138190|FG001|Overall Study|Death|45|||
148906413|NCT02000115|537138191|FG002|Overall Study|Death|0|||
148906414|NCT02000115|537138192|FG003|Overall Study|Death|0|||
148906415|NCT02000115|537138189|FG000|Overall Study|Missed Visit|6|||
148906416|NCT02000115|537138190|FG001|Overall Study|Missed Visit|8|||
148906417|NCT02000115|537138191|FG002|Overall Study|Missed Visit|1|||
148906418|NCT02000115|537138192|FG003|Overall Study|Missed Visit|0|||
148906419|NCT02000115|537138189|FG000|Overall Study|Protocol Violation|2|||
148906420|NCT02000115|537138190|FG001|Overall Study|Protocol Violation|1|||
148906421|NCT02000115|537138191|FG002|Overall Study|Protocol Violation|0|||
148906422|NCT02000115|537138192|FG003|Overall Study|Protocol Violation|0|||
148906423|NCT02000115|537138189|FG000|Overall Study|Physician Decision|2|||
148906424|NCT02000115|537138190|FG001|Overall Study|Physician Decision|0|||
148906425|NCT02000115|537138191|FG002|Overall Study|Physician Decision|0|||
148906426|NCT02000115|537138192|FG003|Overall Study|Physician Decision|0|||
148906427|NCT02000115|537138189|FG000|Overall Study|Withdrawal by Subject|11|||
148906428|NCT02000115|537138190|FG001|Overall Study|Withdrawal by Subject|11|||
148906429|NCT02000115|537138191|FG002|Overall Study|Withdrawal by Subject|0|||
148906430|NCT02000115|537138192|FG003|Overall Study|Withdrawal by Subject|0|||
148906431|NCT02000115|537138189|FG000|Overall Study|Lost to Follow-up|0|||
148906432|NCT02000115|537138190|FG001|Overall Study|Lost to Follow-up|1|||
148906433|NCT02000115|537138191|FG002|Overall Study|Lost to Follow-up|0|||
148906434|NCT02000115|537138192|FG003|Overall Study|Lost to Follow-up|0|||
148906435|NCT02000115|537138189|FG000|Overall Study|Non-compliance|2|||
148906436|NCT02000115|537138190|FG001|Overall Study|Non-compliance|1|||
148906437|NCT02000115|537138191|FG002|Overall Study|Non-compliance|0|||
148906438|NCT02000115|537138192|FG003|Overall Study|Non-compliance|0|||
148906439|NCT02000115|537138189|FG000|Overall Study|Withdrawn on day of randomization|0|||
148906440|NCT02000115|537138190|FG001|Overall Study|Withdrawn on day of randomization|1|||
148906441|NCT02000115|537138191|FG002|Overall Study|Withdrawn on day of randomization|0|||
148906442|NCT02000115|537138192|FG003|Overall Study|Withdrawn on day of randomization|0|||
149138469|NCT03627767|537988866|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
149138470|NCT03627767|537988867|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
149138471|NCT03627767|537988868|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
149138472|NCT03627767|537988869|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
149138473|NCT03627767|537988870|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
149138474|NCT03627767|537988866|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
149138475|NCT03627767|537988867|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
149138476|NCT03627767|537988868|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
149138477|NCT03627767|537988869|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
149138478|NCT03627767|537988870|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
149138479|NCT03627767|537988866|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
149138480|NCT03627767|537988867|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
149138481|NCT03627767|537988868|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
149138482|NCT03627767|537988869|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
149138483|NCT03627767|537988870|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
149138484|NCT03627767|537988866|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
149138485|NCT03627767|537988867|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
149138486|NCT03627767|537988868|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
149138487|NCT03627767|537988869|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
149138488|NCT03627767|537988870|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
149138489|NCT03627767|537988866|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
149138490|NCT03627767|537988867|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
149138491|NCT03627767|537988868|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
149138492|NCT03627767|537988869|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
149138493|NCT03627767|537988870|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
148906443|NCT02000115|537138189|FG000|Overall Study|Still on Study|0|||
148906444|NCT02000115|537138190|FG001|Overall Study|Still on Study|0|||
148906445|NCT02000115|537138191|FG002|Overall Study|Still on Study|0|||
148906446|NCT02000115|537138192|FG003|Overall Study|Still on Study|53|||
148906447|NCT05006573|537138195|FG000|Double-blind Treatment Period|Physician Decision|2|||
148906448|NCT05006573|537138196|FG001|Double-blind Treatment Period|Physician Decision|0|||
148906449|NCT05006573|537138195|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
148906450|NCT05006573|537138196|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
148906451|NCT05006573|537138195|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
148906452|NCT05006573|537138196|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
148906453|NCT05006573|537138195|FG000|Double-blind Treatment Period|Protocol Violation|2|||
148906454|NCT05006573|537138196|FG001|Double-blind Treatment Period|Protocol Violation|0|||
148906455|NCT05006573|537138195|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
148906456|NCT05006573|537138196|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
148906457|NCT05006573|537138195|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
148906458|NCT05006573|537138196|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
148906459|NCT01177397|537139847|FG000|Overall Study|Protocol Violation|0|||
148906460|NCT01177397|537139848|FG001|Overall Study|Protocol Violation|0|||
148906461|NCT01177397|537139849|FG002|Overall Study|Protocol Violation|0|||
148906462|NCT01177397|537139850|FG003|Overall Study|Protocol Violation|0|||
148906463|NCT01177397|537139851|FG004|Overall Study|Protocol Violation|0|||
148906464|NCT01177397|537139852|FG005|Overall Study|Protocol Violation|1|||
148906465|NCT01177397|537139853|FG006|Overall Study|Protocol Violation|0|||
148906466|NCT01177397|537139854|FG007|Overall Study|Protocol Violation|0|||
148906467|NCT01177397|537139855|FG008|Overall Study|Protocol Violation|0|||
148906468|NCT01177397|537139856|FG009|Overall Study|Protocol Violation|0|||
148906469|NCT01177397|537139857|FG010|Overall Study|Protocol Violation|0|||
148906470|NCT01177397|537139858|FG011|Overall Study|Protocol Violation|0|||
148906471|NCT01177397|537139847|FG000|Overall Study|Lost to Follow-up|0|||
148906472|NCT01177397|537139848|FG001|Overall Study|Lost to Follow-up|0|||
149011800|NCT03321513|537523354|FG000|Overall Study|Death|11|||
148906473|NCT01177397|537139849|FG002|Overall Study|Lost to Follow-up|0|||
148906474|NCT01177397|537139850|FG003|Overall Study|Lost to Follow-up|0|||
148906475|NCT01177397|537139851|FG004|Overall Study|Lost to Follow-up|1|||
149138494|NCT03627767|537988866|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
149011801|NCT03321513|537523355|FG001|Overall Study|Death|5|||
149011802|NCT03321513|537523354|FG000|Overall Study|Withdrawal by Subject|5|||
149011803|NCT03321513|537523355|FG001|Overall Study|Withdrawal by Subject|10|||
149011804|NCT03321513|537523354|FG000|Overall Study|Lost to Follow-up|10|||
149011805|NCT03321513|537523355|FG001|Overall Study|Lost to Follow-up|11|||
149011806|NCT03029247|537523356|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
149011807|NCT03029247|537523357|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
149011808|NCT03029247|537523356|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
149011809|NCT03029247|537523357|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
149011810|NCT03029247|537523356|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
149011811|NCT03029247|537523357|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
149011812|NCT03029247|537523356|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
149011813|NCT03029247|537523357|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
149011814|NCT02593305|537523358|FG000|Post 1|Comparison only group. No intervention.|0|||
149011815|NCT02593305|537523359|FG001|Post 1|Comparison only group. No intervention.|0|||
149011816|NCT02593305|537523360|FG002|Post 1|Comparison only group. No intervention.|10|||
149011817|NCT01993017|537523361|FG000|Overall Study|Death|23|||
149011818|NCT01993017|537523362|FG001|Overall Study|Death|26|||
149011819|NCT01993017|537523363|FG002|Overall Study|Death|18|||
149011820|NCT01993017|537523361|FG000|Overall Study|Could not be contacted|43|||
149011821|NCT01993017|537523362|FG001|Overall Study|Could not be contacted|42|||
149011822|NCT01993017|537523363|FG002|Overall Study|Could not be contacted|38|||
149011823|NCT01993017|537523361|FG000|Overall Study|Dropped out|19|||
149011824|NCT01993017|537523362|FG001|Overall Study|Dropped out|6|||
149011825|NCT01993017|537523363|FG002|Overall Study|Dropped out|11|||
148906476|NCT01177397|537139852|FG005|Overall Study|Lost to Follow-up|0|||
148906477|NCT01177397|537139853|FG006|Overall Study|Lost to Follow-up|0|||
148906478|NCT01177397|537139854|FG007|Overall Study|Lost to Follow-up|2|||
148906479|NCT01177397|537139855|FG008|Overall Study|Lost to Follow-up|0|||
148906480|NCT01177397|537139856|FG009|Overall Study|Lost to Follow-up|0|||
148906481|NCT01177397|537139857|FG010|Overall Study|Lost to Follow-up|0|||
149011826|NCT01993017|537523361|FG000|Overall Study|Other reasons|17|||
149011827|NCT01993017|537523362|FG001|Overall Study|Other reasons|11|||
148906482|NCT01177397|537139858|FG011|Overall Study|Lost to Follow-up|0|||
149011828|NCT01993017|537523363|FG002|Overall Study|Other reasons|7|||
149011829|NCT01993017|537523361|FG000|Overall Study|Ineligible after randomization|4|||
148906483|NCT01177397|537139847|FG000|Overall Study|Death|0|||
149011830|NCT01993017|537523362|FG001|Overall Study|Ineligible after randomization|5|||
149011831|NCT01993017|537523363|FG002|Overall Study|Ineligible after randomization|5|||
149011832|NCT00068380|537523364|FG000|Overall Study|Withdrawal by Subject|3|||
149011833|NCT00068380|537523364|FG000|Overall Study|Adverse Event|2|||
149011834|NCT01976364|537523365|FG000|Main Study (36 Months)|Adverse Event|63|||
149011835|NCT01976364|537523366|FG001|Main Study (36 Months)|Adverse Event|0|||
149011836|NCT01976364|537523367|FG002|Main Study (36 Months)|Adverse Event|0|||
149011837|NCT01976364|537523365|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
149011838|NCT01976364|537523366|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
149011839|NCT01976364|537523367|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
149011840|NCT01976364|537523365|FG000|Main Study (36 Months)|Other|13|||
149011841|NCT01976364|537523366|FG001|Main Study (36 Months)|Other|0|||
149011842|NCT01976364|537523367|FG002|Main Study (36 Months)|Other|0|||
149011843|NCT01976364|537523365|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
149011844|NCT01976364|537523366|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
149011845|NCT01976364|537523367|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
149011846|NCT01976364|537523365|FG000|Main Study (36 Months)|Medication error|1|||
149011847|NCT01976364|537523366|FG001|Main Study (36 Months)|Medication error|0|||
149011848|NCT01976364|537523367|FG002|Main Study (36 Months)|Medication error|0|||
149011849|NCT01976364|537523365|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
149011850|NCT01976364|537523366|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
149011851|NCT01976364|537523367|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
149011852|NCT01976364|537523365|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
149011853|NCT01976364|537523366|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
149011854|NCT01976364|537523367|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
149011855|NCT01976364|537523365|FG000|Main Study (36 Months)|Protocol Violation|13|||
149011856|NCT01976364|537523366|FG001|Main Study (36 Months)|Protocol Violation|0|||
148906484|NCT01177397|537139848|FG001|Overall Study|Death|0|||
148906485|NCT01177397|537139849|FG002|Overall Study|Death|1|||
148906486|NCT01177397|537139850|FG003|Overall Study|Death|1|||
148906487|NCT01177397|537139851|FG004|Overall Study|Death|0|||
148906488|NCT01177397|537139852|FG005|Overall Study|Death|0|||
148906489|NCT01177397|537139853|FG006|Overall Study|Death|0|||
148906490|NCT01177397|537139854|FG007|Overall Study|Death|5|||
149011857|NCT01976364|537523367|FG002|Main Study (36 Months)|Protocol Violation|0|||
149011858|NCT01976364|537523365|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
149011859|NCT01976364|537523366|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
149011860|NCT01976364|537523367|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
149011861|NCT01976364|537523365|FG000|Main Study (36 Months)|Death|5|||
149011862|NCT01976364|537523366|FG001|Main Study (36 Months)|Death|0|||
149011863|NCT01976364|537523367|FG002|Main Study (36 Months)|Death|0|||
149011864|NCT01976364|537523365|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
149011865|NCT01976364|537523366|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
149011866|NCT01976364|537523367|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
149011867|NCT01976364|537523365|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
149011868|NCT01976364|537523366|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
149011869|NCT01976364|537523367|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
149011870|NCT01976364|537523365|FG000|Sub-study (12 Months)|Protocol Violation|0|||
149011871|NCT01976364|537523366|FG001|Sub-study (12 Months)|Protocol Violation|1|||
149011872|NCT01976364|537523367|FG002|Sub-study (12 Months)|Protocol Violation|1|||
149011873|NCT01976364|537523365|FG000|Sub-study (12 Months)|Adverse Event|0|||
149011874|NCT01976364|537523366|FG001|Sub-study (12 Months)|Adverse Event|4|||
149011875|NCT01976364|537523367|FG002|Sub-study (12 Months)|Adverse Event|3|||
149011876|NCT02757521|537523368|FG000|Overall Study|Adverse Event|1|||
149011877|NCT02757521|537523369|FG001|Overall Study|Adverse Event|0|||
149011878|NCT01190215|537523370|FG000|Up to Month 6|Lost to Follow-up|2|||
149011879|NCT01190215|537523371|FG001|Up to Month 6|Lost to Follow-up|0|||
149011880|NCT00003511|537523372|FG000|Overall Study|Not evaluable|4|||
149011881|NCT01683994|537523396|FG000|Overall Study|Withdrawal by Subject|1|||
149011882|NCT01683994|537523397|FG001|Overall Study|Withdrawal by Subject|0|||
148906491|NCT01177397|537139855|FG008|Overall Study|Death|2|||
149011883|NCT01683994|537523398|FG002|Overall Study|Withdrawal by Subject|0|||
149011884|NCT01683994|537523399|FG003|Overall Study|Withdrawal by Subject|1|||
149011885|NCT01683994|537523400|FG004|Overall Study|Withdrawal by Subject|0|||
149011886|NCT01683994|537523396|FG000|Overall Study|Intercurrent illness|0|||
149011887|NCT01683994|537523397|FG001|Overall Study|Intercurrent illness|0|||
149011888|NCT01683994|537523398|FG002|Overall Study|Intercurrent illness|0|||
149011889|NCT01683994|537523399|FG003|Overall Study|Intercurrent illness|2|||
148906492|NCT01177397|537139856|FG009|Overall Study|Death|1|||
148906493|NCT01177397|537139857|FG010|Overall Study|Death|0|||
148906494|NCT01177397|537139858|FG011|Overall Study|Death|0|||
148906495|NCT01177397|537139847|FG000|Overall Study|Withdrawal by Subject|0|||
148906496|NCT01177397|537139848|FG001|Overall Study|Withdrawal by Subject|0|||
148906497|NCT01177397|537139849|FG002|Overall Study|Withdrawal by Subject|1|||
148906498|NCT01177397|537139850|FG003|Overall Study|Withdrawal by Subject|1|||
148906499|NCT01177397|537139851|FG004|Overall Study|Withdrawal by Subject|1|||
148906500|NCT01177397|537139852|FG005|Overall Study|Withdrawal by Subject|2|||
148906501|NCT01177397|537139853|FG006|Overall Study|Withdrawal by Subject|0|||
148906502|NCT01177397|537139854|FG007|Overall Study|Withdrawal by Subject|5|||
148906503|NCT01177397|537139855|FG008|Overall Study|Withdrawal by Subject|9|||
148906504|NCT01177397|537139856|FG009|Overall Study|Withdrawal by Subject|1|||
148906505|NCT01177397|537139857|FG010|Overall Study|Withdrawal by Subject|1|||
148906506|NCT01177397|537139858|FG011|Overall Study|Withdrawal by Subject|0|||
148906507|NCT01177397|537139847|FG000|Overall Study|Adverse Event|0|||
148906508|NCT01177397|537139848|FG001|Overall Study|Adverse Event|0|||
148906509|NCT01177397|537139849|FG002|Overall Study|Adverse Event|1|||
148906510|NCT01177397|537139850|FG003|Overall Study|Adverse Event|2|||
148906511|NCT01177397|537139851|FG004|Overall Study|Adverse Event|0|||
148906512|NCT01177397|537139852|FG005|Overall Study|Adverse Event|12|||
148906513|NCT01177397|537139853|FG006|Overall Study|Adverse Event|1|||
148906514|NCT01177397|537139854|FG007|Overall Study|Adverse Event|14|||
148906515|NCT01177397|537139855|FG008|Overall Study|Adverse Event|8|||
148906516|NCT01177397|537139856|FG009|Overall Study|Adverse Event|6|||
148906517|NCT01177397|537139857|FG010|Overall Study|Adverse Event|3|||
148906518|NCT01177397|537139858|FG011|Overall Study|Adverse Event|7|||
148906519|NCT01177397|537139847|FG000|Overall Study|Disease progression|1|||
148906520|NCT01177397|537139848|FG001|Overall Study|Disease progression|2|||
148906521|NCT01177397|537139849|FG002|Overall Study|Disease progression|5|||
148906522|NCT01177397|537139850|FG003|Overall Study|Disease progression|5|||
148906523|NCT01177397|537139851|FG004|Overall Study|Disease progression|4|||
148906524|NCT01177397|537139852|FG005|Overall Study|Disease progression|10|||
148906525|NCT01177397|537139853|FG006|Overall Study|Disease progression|10|||
148906526|NCT01177397|537139854|FG007|Overall Study|Disease progression|21|||
148906527|NCT01177397|537139855|FG008|Overall Study|Disease progression|18|||
148906528|NCT01177397|537139856|FG009|Overall Study|Disease progression|12|||
148906529|NCT01177397|537139857|FG010|Overall Study|Disease progression|10|||
148906530|NCT01177397|537139858|FG011|Overall Study|Disease progression|8|||
148906531|NCT01177397|537139847|FG000|Overall Study|Other reasons|0|||
148906532|NCT01177397|537139848|FG001|Overall Study|Other reasons|0|||
148906533|NCT01177397|537139849|FG002|Overall Study|Other reasons|1|||
148906534|NCT01177397|537139850|FG003|Overall Study|Other reasons|0|||
148906535|NCT01177397|537139851|FG004|Overall Study|Other reasons|1|||
148906536|NCT01177397|537139852|FG005|Overall Study|Other reasons|1|||
148906537|NCT01177397|537139853|FG006|Overall Study|Other reasons|2|||
148906538|NCT01177397|537139854|FG007|Overall Study|Other reasons|6|||
148906539|NCT01177397|537139855|FG008|Overall Study|Other reasons|10|||
148906540|NCT01177397|537139856|FG009|Overall Study|Other reasons|8|||
148906541|NCT01177397|537139857|FG010|Overall Study|Other reasons|0|||
148906542|NCT01177397|537139858|FG011|Overall Study|Other reasons|2|||
148906543|NCT01938716|537139861|FG000|Overall Study|Physician Decision|2|||
148906544|NCT01938716|537139861|FG000|Overall Study|Withdrawal by Subject|2|||
148906545|NCT01358721|537139862|FG000|Overall Study|Withdrawal by Subject|0|||
148906546|NCT01358721|537139863|FG001|Overall Study|Withdrawal by Subject|0|||
148906547|NCT01358721|537139864|FG002|Overall Study|Withdrawal by Subject|0|||
148906548|NCT01358721|537139865|FG003|Overall Study|Withdrawal by Subject|1|||
148906549|NCT01358721|537139862|FG000|Overall Study|Death|0|||
148906550|NCT01358721|537139863|FG001|Overall Study|Death|2|||
148906551|NCT01358721|537139864|FG002|Overall Study|Death|0|||
148906552|NCT01358721|537139865|FG003|Overall Study|Death|0|||
148906553|NCT01358721|537139862|FG000|Overall Study|Study Drug Toxicity|1|||
148906554|NCT01358721|537139863|FG001|Overall Study|Study Drug Toxicity|3|||
148906555|NCT01358721|537139864|FG002|Overall Study|Study Drug Toxicity|4|||
148906556|NCT01358721|537139865|FG003|Overall Study|Study Drug Toxicity|5|||
148906557|NCT01358721|537139862|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
148906558|NCT01358721|537139863|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
148906559|NCT01358721|537139864|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
148906560|NCT01358721|537139865|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
148906561|NCT01358721|537139862|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
148906562|NCT01358721|537139863|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
148906563|NCT01358721|537139864|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
148906564|NCT01358721|537139865|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
148906565|NCT01358721|537139862|FG000|Overall Study|Adverse Event related to study drug|1|||
148906566|NCT01358721|537139863|FG001|Overall Study|Adverse Event related to study drug|0|||
148906567|NCT01358721|537139864|FG002|Overall Study|Adverse Event related to study drug|0|||
148906568|NCT01358721|537139865|FG003|Overall Study|Adverse Event related to study drug|1|||
148906569|NCT01358721|537139862|FG000|Overall Study|Disease Progression|19|||
148906570|NCT01358721|537139863|FG001|Overall Study|Disease Progression|15|||
148906571|NCT01358721|537139864|FG002|Overall Study|Disease Progression|17|||
148906572|NCT01358721|537139865|FG003|Overall Study|Disease Progression|15|||
148906573|NCT01358721|537139862|FG000|Overall Study|Out of State/Unmet Criteria|0|||
148906574|NCT01358721|537139863|FG001|Overall Study|Out of State/Unmet Criteria|0|||
148906575|NCT01358721|537139864|FG002|Overall Study|Out of State/Unmet Criteria|1|||
148803167|NCT00750269|536761002|FG000|Overall Study|Physician Decision|0|||
148803168|NCT00750269|536761003|FG001|Overall Study|Physician Decision|0|||
148803169|NCT00750269|536761004|FG002|Overall Study|Physician Decision|0|||
148803170|NCT00750269|536761005|FG003|Overall Study|Physician Decision|0|||
148803171|NCT00750269|536761006|FG004|Overall Study|Physician Decision|2|||
148803172|NCT00750269|536761002|FG000|Overall Study|Patient too large for positioning|0|||
148803173|NCT00750269|536761003|FG001|Overall Study|Patient too large for positioning|0|||
148803174|NCT00750269|536761004|FG002|Overall Study|Patient too large for positioning|1|||
148803175|NCT00750269|536761005|FG003|Overall Study|Patient too large for positioning|0|||
148803176|NCT00750269|536761006|FG004|Overall Study|Patient too large for positioning|0|||
148803177|NCT00750269|536761002|FG000|Overall Study|Site error|0|||
148803178|NCT00750269|536761003|FG001|Overall Study|Site error|0|||
148803179|NCT00750269|536761004|FG002|Overall Study|Site error|0|||
148803180|NCT00750269|536761005|FG003|Overall Study|Site error|1|||
148803181|NCT00750269|536761006|FG004|Overall Study|Site error|0|||
148803182|NCT00750269|536761002|FG000|Overall Study|SBRT plan could not be drawn|0|||
148803183|NCT00750269|536761003|FG001|Overall Study|SBRT plan could not be drawn|0|||
148803184|NCT00750269|536761004|FG002|Overall Study|SBRT plan could not be drawn|0|||
148803185|NCT00750269|536761005|FG003|Overall Study|SBRT plan could not be drawn|0|||
148803186|NCT00750269|536761006|FG004|Overall Study|SBRT plan could not be drawn|1|||
148803187|NCT00750269|536761002|FG000|Overall Study|Fiducials could not be placed|0|||
148803188|NCT00750269|536761003|FG001|Overall Study|Fiducials could not be placed|0|||
148803189|NCT00750269|536761004|FG002|Overall Study|Fiducials could not be placed|0|||
148803190|NCT00750269|536761005|FG003|Overall Study|Fiducials could not be placed|0|||
148803191|NCT00750269|536761006|FG004|Overall Study|Fiducials could not be placed|1|||
148803192|NCT01898078|536761008|FG000|Overall Study|Progressive Disease|1|||
148803193|NCT01898078|536761009|FG001|Overall Study|Progressive Disease|5|||
148803194|NCT01898078|536761008|FG000|Overall Study|Adverse Event|2|||
148803195|NCT01898078|536761009|FG001|Overall Study|Adverse Event|1|||
148803196|NCT01898078|536761008|FG000|Overall Study|Withdrawal by Subject|1|||
148906576|NCT01358721|537139865|FG003|Overall Study|Out of State/Unmet Criteria|0|||
148906577|NCT02446899|537139870|FG000|Overall Study|Adverse Event|4|||
148906578|NCT02446899|537139871|FG001|Overall Study|Adverse Event|7|||
148906579|NCT02446899|537139870|FG000|Overall Study|Condition Under Investigation Worsened|1|||
148906580|NCT02446899|537139871|FG001|Overall Study|Condition Under Investigation Worsened|4|||
148906581|NCT02446899|537139870|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
148906582|NCT02446899|537139871|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
148906583|NCT02446899|537139870|FG000|Overall Study|Lack of Efficacy|2|||
148906584|NCT02446899|537139871|FG001|Overall Study|Lack of Efficacy|8|||
148906585|NCT02446899|537139870|FG000|Overall Study|Lost to Follow-up|1|||
148906586|NCT02446899|537139871|FG001|Overall Study|Lost to Follow-up|3|||
148906587|NCT02446899|537139870|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
148906588|NCT02446899|537139871|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
148906589|NCT02446899|537139870|FG000|Overall Study|Withdrawal by Subject|11|||
148906590|NCT02446899|537139871|FG001|Overall Study|Withdrawal by Subject|19|||
148906591|NCT02446899|537139870|FG000|Overall Study|Miscellaneous|5|||
148906592|NCT02446899|537139871|FG001|Overall Study|Miscellaneous|4|||
148906593|NCT02446899|537139870|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
148906594|NCT02446899|537139871|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
148906595|NCT04455815|537139876|FG000|Randomisation Phase|Adverse Event|1|||
148906596|NCT04455815|537139877|FG001|Randomisation Phase|Adverse Event|0|||
148906597|NCT04455815|537139876|FG000|Treatment Phase|Adverse Event|0|||
148906598|NCT04455815|537139877|FG001|Treatment Phase|Adverse Event|1|||
148906599|NCT04455815|537139876|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
148906600|NCT04455815|537139877|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
148906601|NCT04455815|537139876|FG000|Treatment Phase|Withdrawal by Subject|1|||
148906602|NCT04455815|537139877|FG001|Treatment Phase|Withdrawal by Subject|1|||
148906603|NCT02106390|537139878|FG000|Overall Study|Withdrawal by Subject|15|||
148906604|NCT02106390|537139879|FG001|Overall Study|Withdrawal by Subject|16|||
148906605|NCT02106390|537139880|FG002|Overall Study|Withdrawal by Subject|15|||
148906606|NCT02106390|537139878|FG000|Overall Study|Lost to Follow-up|25|||
148906607|NCT02106390|537139879|FG001|Overall Study|Lost to Follow-up|20|||
148906608|NCT02106390|537139880|FG002|Overall Study|Lost to Follow-up|13|||
148803197|NCT01898078|536761009|FG001|Overall Study|Withdrawal by Subject|1|||
148803198|NCT01898078|536761008|FG000|Overall Study|Symptomatic Deterioration|2|||
148803199|NCT01898078|536761009|FG001|Overall Study|Symptomatic Deterioration|0|||
148803200|NCT01898078|536761008|FG000|Overall Study|Reason not Specified|0|||
148803201|NCT01898078|536761009|FG001|Overall Study|Reason not Specified|1|||
148906609|NCT02106390|537139878|FG000|Overall Study|Other: Administrative Reason|8|||
148906610|NCT02106390|537139879|FG001|Overall Study|Other: Administrative Reason|5|||
148906611|NCT02106390|537139880|FG002|Overall Study|Other: Administrative Reason|12|||
148906612|NCT02106390|537139878|FG000|Overall Study|Other: Unspecified|1|||
148906613|NCT02106390|537139879|FG001|Overall Study|Other: Unspecified|4|||
148906614|NCT02106390|537139880|FG002|Overall Study|Other: Unspecified|2|||
148906615|NCT02106390|537139878|FG000|Overall Study|Adverse Event|0|||
148906616|NCT02106390|537139879|FG001|Overall Study|Adverse Event|2|||
148906617|NCT02106390|537139880|FG002|Overall Study|Adverse Event|1|||
148906618|NCT02106390|537139878|FG000|Overall Study|Protocol Violation|0|||
148906619|NCT02106390|537139879|FG001|Overall Study|Protocol Violation|1|||
148906620|NCT02106390|537139880|FG002|Overall Study|Protocol Violation|0|||
148906621|NCT00927953|537139881|FG000|Overall Study|Death|2|||
148906622|NCT00927953|537139882|FG001|Overall Study|Death|1|||
148906623|NCT02976038|537139883|FG000|Overall Study|Physician Decision|22|||
148906624|NCT02976038|537139883|FG000|Overall Study|Withdrawal by Subject|3|||
148906625|NCT02976038|537139883|FG000|Overall Study|Lost to Follow-up|2|||
148906626|NCT02976038|537139883|FG000|Overall Study|Adverse Event|1|||
148906627|NCT00724698|537139884|FG000|Overall Study|Adverse Event|9|||
148906628|NCT00724698|537139884|FG000|Overall Study|Failure of Therapy|4|||
148906629|NCT00724698|537139884|FG000|Overall Study|Poor Compliance|16|||
148906630|NCT00724698|537139884|FG000|Overall Study|Lost to Follow-up|36|||
148906631|NCT00724698|537139884|FG000|Overall Study|No Info|25|||
148906632|NCT05021978|537139887|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
148906633|NCT05021978|537139888|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
148906634|NCT05021978|537139889|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
148906635|NCT05021978|537139890|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
148906636|NCT05021978|537139887|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
148906637|NCT05021978|537139888|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
148906638|NCT05021978|537139889|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
148906639|NCT05021978|537139890|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
148906640|NCT00196313|537139891|FG000|Overall Study|Protocol Violation|2|||
148906641|NCT00196313|537139892|FG001|Overall Study|Protocol Violation|3|||
148906642|NCT00196313|537139891|FG000|Overall Study|Withdrawal by Subject|3|||
148906643|NCT00196313|537139892|FG001|Overall Study|Withdrawal by Subject|1|||
148906644|NCT00196313|537139891|FG000|Overall Study|Adverse Event|3|||
148906645|NCT00196313|537139892|FG001|Overall Study|Adverse Event|1|||
148906646|NCT00196313|537139891|FG000|Overall Study|Subject Pregnant|1|||
148906647|NCT00196313|537139892|FG001|Overall Study|Subject Pregnant|1|||
148906648|NCT00196313|537139891|FG000|Overall Study|Lost to Follow-up|2|||
148906649|NCT00196313|537139892|FG001|Overall Study|Lost to Follow-up|2|||
148906650|NCT03096288|537139894|FG000|Overall Study|Withdrawal by Subject|0|||
148906651|NCT03096288|537139895|FG001|Overall Study|Withdrawal by Subject|1|||
148906652|NCT03096288|537139896|FG002|Overall Study|Withdrawal by Subject|0|||
148906653|NCT03096288|537139897|FG003|Overall Study|Withdrawal by Subject|1|||
148906654|NCT02004093|537139903|FG000|Overall Study|Death|2|||
148906655|NCT02004093|537139904|FG001|Overall Study|Death|1|||
148906656|NCT02004093|537139903|FG000|Overall Study|Lack of Efficacy|66|||
148906657|NCT02004093|537139904|FG001|Overall Study|Lack of Efficacy|62|||
149138495|NCT03627767|537988867|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
149138496|NCT03627767|537988868|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
149138497|NCT03627767|537988869|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
149138498|NCT03627767|537988870|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
149138499|NCT03627767|537988866|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
149138500|NCT03627767|537988867|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
149138501|NCT03627767|537988868|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
149138502|NCT03627767|537988869|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
149138503|NCT03627767|537988870|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
149138504|NCT03627767|537988866|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
149138505|NCT03627767|537988867|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
149138506|NCT03627767|537988868|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
149138507|NCT03627767|537988869|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
149138508|NCT03627767|537988870|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
149138509|NCT03627767|537988866|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
149138510|NCT03627767|537988867|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
149138511|NCT03627767|537988868|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
149138512|NCT03627767|537988869|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
149138513|NCT03627767|537988870|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
149138514|NCT03627767|537988866|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
149138515|NCT03627767|537988867|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
148906658|NCT02004093|537139903|FG000|Overall Study|Protocol Violation|0|||
148906659|NCT02004093|537139904|FG001|Overall Study|Protocol Violation|1|||
148906660|NCT02004093|537139903|FG000|Overall Study|Lost to Follow-up|0|||
148906661|NCT02004093|537139904|FG001|Overall Study|Lost to Follow-up|1|||
148906662|NCT02004093|537139903|FG000|Overall Study|Withdrawal by Subject|3|||
148906663|NCT02004093|537139904|FG001|Overall Study|Withdrawal by Subject|7|||
148906664|NCT02004093|537139903|FG000|Overall Study|Other|3|||
148906665|NCT02004093|537139904|FG001|Overall Study|Other|1|||
148906666|NCT01411891|537139905|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
149011890|NCT01683994|537523400|FG004|Overall Study|Intercurrent illness|1|||
149011891|NCT00999661|537523401|FG000|Overall Study|Lost to Follow-up|59|||
149011892|NCT00999661|537523401|FG000|Overall Study|Adverse Event|1|||
149011893|NCT00999661|537523401|FG000|Overall Study|Withdrawal by Subject|1|||
149011894|NCT00999661|537523401|FG000|Overall Study|Not meeting eligibility criteria|9|||
149011895|NCT00917267|537523402|FG000|Overall Study|Adverse Event|15|||
149011896|NCT00917267|537523403|FG001|Overall Study|Adverse Event|36|||
149011897|NCT00917267|537523402|FG000|Overall Study|Physician Decision|2|||
149011898|NCT00917267|537523403|FG001|Overall Study|Physician Decision|4|||
149011899|NCT00917267|537523402|FG000|Overall Study|Protocol Violation|9|||
149011900|NCT00917267|537523403|FG001|Overall Study|Protocol Violation|18|||
149011901|NCT00917267|537523402|FG000|Overall Study|Withdrawal by Subject|5|||
149011902|NCT00917267|537523403|FG001|Overall Study|Withdrawal by Subject|12|||
149011903|NCT00917267|537523402|FG000|Overall Study|Lost to follow up|0|||
149011904|NCT00917267|537523403|FG001|Overall Study|Lost to follow up|2|||
149011905|NCT00917267|537523402|FG000|Overall Study|Entry Criteria Not Met|1|||
149011906|NCT00917267|537523403|FG001|Overall Study|Entry Criteria Not Met|0|||
149011907|NCT00917267|537523402|FG000|Overall Study|Sponsor Decision|5|||
149011908|NCT00917267|537523403|FG001|Overall Study|Sponsor Decision|5|||
149011909|NCT00917267|537523402|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
149011910|NCT00917267|537523403|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
149011911|NCT02960763|537523405|FG000|Step 1|Withdrawal by Subject|10|||
149011912|NCT02960763|537523406|FG001|Step 1|Withdrawal by Subject|8|||
149011913|NCT02960763|537523407|FG002|Step 1|Withdrawal by Subject|13|||
149011914|NCT02960763|537523408|FG003|Step 1|Withdrawal by Subject|0|||
149011915|NCT02960763|537523409|FG004|Step 1|Withdrawal by Subject|0|||
149011916|NCT02960763|537523405|FG000|Step 1|Lost to Follow-up|7|||
149011917|NCT02960763|537523406|FG001|Step 1|Lost to Follow-up|9|||
149011918|NCT02960763|537523407|FG002|Step 1|Lost to Follow-up|12|||
149011919|NCT02960763|537523408|FG003|Step 1|Lost to Follow-up|0|||
149011920|NCT02960763|537523409|FG004|Step 1|Lost to Follow-up|0|||
149011921|NCT02960763|537523405|FG000|Step 1|Death|1|||
149011922|NCT02960763|537523406|FG001|Step 1|Death|1|||
149011923|NCT02960763|537523407|FG002|Step 1|Death|1|||
149011924|NCT02960763|537523408|FG003|Step 1|Death|0|||
149011925|NCT02960763|537523409|FG004|Step 1|Death|0|||
149011926|NCT02960763|537523405|FG000|Step 1|Investigator discretion|1|||
149011927|NCT02960763|537523406|FG001|Step 1|Investigator discretion|0|||
149011928|NCT02960763|537523407|FG002|Step 1|Investigator discretion|1|||
149011929|NCT02960763|537523408|FG003|Step 1|Investigator discretion|0|||
149011930|NCT02960763|537523409|FG004|Step 1|Investigator discretion|0|||
149011931|NCT02960763|537523405|FG000|Step 1|Other|0|||
149011932|NCT02960763|537523406|FG001|Step 1|Other|0|||
149011933|NCT02960763|537523407|FG002|Step 1|Other|1|||
149011934|NCT02960763|537523408|FG003|Step 1|Other|0|||
149011935|NCT02960763|537523409|FG004|Step 1|Other|0|||
149011936|NCT02960763|537523405|FG000|Step 2|Withdrawal by Subject|0|||
149011937|NCT02960763|537523406|FG001|Step 2|Withdrawal by Subject|0|||
149011938|NCT02960763|537523407|FG002|Step 2|Withdrawal by Subject|0|||
149011939|NCT02960763|537523408|FG003|Step 2|Withdrawal by Subject|7|||
149011940|NCT02960763|537523409|FG004|Step 2|Withdrawal by Subject|3|||
149011941|NCT02960763|537523405|FG000|Step 2|Lost to Follow-up|0|||
149011942|NCT02960763|537523406|FG001|Step 2|Lost to Follow-up|0|||
149011943|NCT02960763|537523407|FG002|Step 2|Lost to Follow-up|0|||
149011944|NCT02960763|537523408|FG003|Step 2|Lost to Follow-up|4|||
149011945|NCT02960763|537523409|FG004|Step 2|Lost to Follow-up|1|||
149011946|NCT02960763|537523405|FG000|Step 2|Investigator discretion|0|||
149011947|NCT02960763|537523406|FG001|Step 2|Investigator discretion|0|||
149011948|NCT02960763|537523407|FG002|Step 2|Investigator discretion|0|||
149011949|NCT02960763|537523408|FG003|Step 2|Investigator discretion|0|||
149011950|NCT02960763|537523409|FG004|Step 2|Investigator discretion|1|||
149011951|NCT00312858|537523411|FG000|Overall Study|Adverse Event|0|||
149011952|NCT00312858|537523412|FG001|Overall Study|Adverse Event|1|||
149011953|NCT00312858|537523411|FG000|Overall Study|Lost to Follow-up|25|||
149011954|NCT00312858|537523412|FG001|Overall Study|Lost to Follow-up|42|||
149011955|NCT00312858|537523411|FG000|Overall Study|Protocol Violation|3|||
149011956|NCT00312858|537523412|FG001|Overall Study|Protocol Violation|8|||
149011957|NCT00312858|537523411|FG000|Overall Study|Withdraw by Participant|20|||
149011958|NCT00312858|537523412|FG001|Overall Study|Withdraw by Participant|20|||
149011959|NCT00312858|537523411|FG000|Overall Study|Participant Moved|11|||
149011960|NCT00312858|537523412|FG001|Overall Study|Participant Moved|10|||
149011961|NCT00312858|537523411|FG000|Overall Study|Other|9|||
149011962|NCT00312858|537523412|FG001|Overall Study|Other|12|||
149011963|NCT03638635|537523413|FG000|Initial Hospitalization|Study terminated prematurely|0|||
149011964|NCT03638635|537523414|FG001|Initial Hospitalization|Study terminated prematurely|1|||
149011965|NCT03638635|537523413|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
149011966|NCT03638635|537523414|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
149011967|NCT03638635|537523413|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
149011968|NCT03638635|537523414|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
149011969|NCT02318719|537523417|FG000|Double-blind Phase|Adverse Event|7|||
149011970|NCT02318719|537523418|FG001|Double-blind Phase|Adverse Event|6|||
149011971|NCT02318719|537523419|FG002|Double-blind Phase|Adverse Event|12|||
148906667|NCT01411891|537139906|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
148906668|NCT04085289|537139907|FG000|Overall Study|Withdrawal by Subject|0|||
149011972|NCT02318719|537523420|FG003|Double-blind Phase|Adverse Event|4|||
149011973|NCT02318719|537523421|FG004|Double-blind Phase|Adverse Event|0|||
149011974|NCT02318719|537523417|FG000|Double-blind Phase|Lack of Efficacy|5|||
149011975|NCT02318719|537523418|FG001|Double-blind Phase|Lack of Efficacy|0|||
149011976|NCT02318719|537523419|FG002|Double-blind Phase|Lack of Efficacy|1|||
149011977|NCT02318719|537523420|FG003|Double-blind Phase|Lack of Efficacy|1|||
149011978|NCT02318719|537523421|FG004|Double-blind Phase|Lack of Efficacy|0|||
149011979|NCT02318719|537523417|FG000|Double-blind Phase|Protocol Violation|0|||
149011980|NCT02318719|537523418|FG001|Double-blind Phase|Protocol Violation|1|||
149011981|NCT02318719|537523419|FG002|Double-blind Phase|Protocol Violation|3|||
149011982|NCT02318719|537523420|FG003|Double-blind Phase|Protocol Violation|0|||
149011983|NCT02318719|537523421|FG004|Double-blind Phase|Protocol Violation|0|||
149011984|NCT02318719|537523417|FG000|Double-blind Phase|Withdrawal by Subject|25|||
149011985|NCT02318719|537523418|FG001|Double-blind Phase|Withdrawal by Subject|7|||
149011986|NCT02318719|537523419|FG002|Double-blind Phase|Withdrawal by Subject|9|||
149011987|NCT02318719|537523420|FG003|Double-blind Phase|Withdrawal by Subject|10|||
149011988|NCT02318719|537523421|FG004|Double-blind Phase|Withdrawal by Subject|0|||
149011989|NCT02318719|537523417|FG000|Double-blind Phase|Other|1|||
148906669|NCT04085289|537139908|FG001|Overall Study|Withdrawal by Subject|0|||
148906670|NCT04085289|537139909|FG002|Overall Study|Withdrawal by Subject|1|||
148906671|NCT00414596|537139911|FG000|Overall Study|Protocol Violation|2|||
148906672|NCT04614974|537139912|FG000|Overall Study|Lost to Follow-up|14|||
148906673|NCT04614974|537139913|FG001|Overall Study|Lost to Follow-up|11|||
148906674|NCT00658359|537139914|FG000|Overall Study|Death|3|||
148906675|NCT00658359|537139915|FG001|Overall Study|Death|1|||
148906676|NCT00658359|537139916|FG002|Overall Study|Death|2|||
148906677|NCT00658359|537139914|FG000|Overall Study|Adverse Event|13|||
149011990|NCT02318719|537523418|FG001|Double-blind Phase|Other|2|||
149011991|NCT02318719|537523419|FG002|Double-blind Phase|Other|0|||
148906678|NCT00658359|537139915|FG001|Overall Study|Adverse Event|6|||
148906679|NCT00658359|537139916|FG002|Overall Study|Adverse Event|9|||
148906680|NCT00658359|537139914|FG000|Overall Study|Protocol Violation|1|||
148906681|NCT00658359|537139915|FG001|Overall Study|Protocol Violation|0|||
149011992|NCT02318719|537523420|FG003|Double-blind Phase|Other|0|||
149011993|NCT02318719|537523421|FG004|Double-blind Phase|Other|0|||
149011994|NCT02318719|537523417|FG000|Open-label Extension Phase|Adverse Event|0|||
149011995|NCT02318719|537523418|FG001|Open-label Extension Phase|Adverse Event|0|||
148906682|NCT00658359|537139916|FG002|Overall Study|Protocol Violation|0|||
148906683|NCT00658359|537139914|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
148906684|NCT00658359|537139915|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
148906685|NCT00658359|537139916|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
148906686|NCT00658359|537139914|FG000|Overall Study|Withdrawal by Subject|7|||
148906687|NCT00658359|537139915|FG001|Overall Study|Withdrawal by Subject|4|||
148906688|NCT00658359|537139916|FG002|Overall Study|Withdrawal by Subject|2|||
148906689|NCT00658359|537139914|FG000|Overall Study|Lost to Follow-up|2|||
148906690|NCT00658359|537139915|FG001|Overall Study|Lost to Follow-up|2|||
148906691|NCT00658359|537139916|FG002|Overall Study|Lost to Follow-up|4|||
148906692|NCT00658359|537139914|FG000|Overall Study|Lack of Efficacy|0|||
148906693|NCT00658359|537139915|FG001|Overall Study|Lack of Efficacy|1|||
148906694|NCT00658359|537139916|FG002|Overall Study|Lack of Efficacy|0|||
148906695|NCT02558296|537139917|FG000|Completed the Study Through Week 24|Adverse Event|9|||
148906696|NCT02558296|537139918|FG001|Completed the Study Through Week 24|Adverse Event|3|||
148906697|NCT02558296|537139917|FG000|Completed the Study Through Week 24|Death|7|||
148906698|NCT02558296|537139918|FG001|Completed the Study Through Week 24|Death|7|||
148906699|NCT02558296|537139917|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
148906700|NCT02558296|537139918|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
148906701|NCT02558296|537139917|FG000|Completed the Study Through Week 24|Physician Decision|1|||
148906702|NCT02558296|537139918|FG001|Completed the Study Through Week 24|Physician Decision|0|||
148906703|NCT02558296|537139917|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
148906704|NCT02558296|537139918|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
148906705|NCT02558296|537139917|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
148906706|NCT02558296|537139918|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
149011996|NCT02318719|537523419|FG002|Open-label Extension Phase|Adverse Event|0|||
149011997|NCT02318719|537523420|FG003|Open-label Extension Phase|Adverse Event|0|||
149011998|NCT02318719|537523421|FG004|Open-label Extension Phase|Adverse Event|15|||
149138516|NCT03627767|537988868|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
149138517|NCT03627767|537988869|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
148906707|NCT02558296|537139917|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
148906708|NCT02558296|537139918|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
148906709|NCT02558296|537139917|FG000|Completed the Study|Adverse Event|14|||
148906710|NCT02558296|537139918|FG001|Completed the Study|Adverse Event|5|||
148906711|NCT02558296|537139917|FG000|Completed the Study|Death|39|||
148906712|NCT02558296|537139918|FG001|Completed the Study|Death|25|||
148906713|NCT02558296|537139917|FG000|Completed the Study|Lost to Follow-up|31|||
148906714|NCT02558296|537139918|FG001|Completed the Study|Lost to Follow-up|23|||
148906715|NCT02558296|537139917|FG000|Completed the Study|Physician Decision|6|||
148906716|NCT02558296|537139918|FG001|Completed the Study|Physician Decision|0|||
148906717|NCT02558296|537139917|FG000|Completed the Study|Protocol Violation|2|||
148906718|NCT02558296|537139918|FG001|Completed the Study|Protocol Violation|1|||
148906719|NCT02558296|537139917|FG000|Completed the Study|Withdrawal by Subject|53|||
148906720|NCT02558296|537139918|FG001|Completed the Study|Withdrawal by Subject|31|||
148906721|NCT02558296|537139917|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
148906722|NCT02558296|537139918|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
148906723|NCT02919995|537139921|FG000|Overall Study|Adverse Event|0|||
148906724|NCT02919995|537139922|FG001|Overall Study|Adverse Event|0|||
148906725|NCT02919995|537139923|FG002|Overall Study|Adverse Event|0|||
148906726|NCT02919995|537139924|FG003|Overall Study|Adverse Event|0|||
148906727|NCT02919995|537139925|FG004|Overall Study|Adverse Event|0|||
148906728|NCT02919995|537139926|FG005|Overall Study|Adverse Event|1|||
148906729|NCT03967444|537139928|FG000|Overall Study|Lost to Follow-up|1|||
148906730|NCT03967444|537139929|FG001|Overall Study|Lost to Follow-up|2|||
148906731|NCT01821118|537139935|FG000|Overall Study|Death|0|||
148906732|NCT01821118|537139936|FG001|Overall Study|Death|1|||
148906733|NCT00345358|537139937|FG000|Primary Vaccination Phase|Other|0|||
148906734|NCT00345358|537139938|FG001|Primary Vaccination Phase|Other|1|||
148906735|NCT00345358|537139939|FG002|Primary Vaccination Phase|Other|1|||
148906736|NCT00345358|537139940|FG003|Primary Vaccination Phase|Other|0|||
148906737|NCT00345358|537139937|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
148906738|NCT00345358|537139938|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
148906739|NCT00345358|537139939|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
148906740|NCT00345358|537139940|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
148906741|NCT00345358|537139937|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
148906742|NCT00345358|537139938|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
148906743|NCT00345358|537139939|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
148906744|NCT00345358|537139940|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
148906745|NCT00345358|537139937|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
148906746|NCT00345358|537139938|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
148906747|NCT00345358|537139939|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
148906748|NCT00345358|537139940|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
148906749|NCT00345358|537139937|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
148906750|NCT00345358|537139938|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
148906751|NCT00345358|537139939|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
148906752|NCT00345358|537139940|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
148906753|NCT00345358|537139937|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
148906754|NCT00345358|537139938|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
148906755|NCT00345358|537139939|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
148906756|NCT00345358|537139940|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
148906757|NCT00346697|537139942|FG000|Overall Study|Lost to Follow-up|0|||
148906758|NCT00346697|537139943|FG001|Overall Study|Lost to Follow-up|1|||
148906759|NCT00318643|537139946|FG000|Overall Study|Adverse Event|0|||
148906760|NCT00318643|537139947|FG001|Overall Study|Adverse Event|0|||
148906761|NCT00318643|537139948|FG002|Overall Study|Adverse Event|0|||
148906762|NCT00318643|537139949|FG003|Overall Study|Adverse Event|0|||
148906763|NCT00318643|537139950|FG004|Overall Study|Adverse Event|1|||
148906764|NCT00318643|537139946|FG000|Overall Study|Participant's Decision|0|||
148906765|NCT00318643|537139947|FG001|Overall Study|Participant's Decision|0|||
148906766|NCT00318643|537139948|FG002|Overall Study|Participant's Decision|0|||
148906767|NCT00318643|537139949|FG003|Overall Study|Participant's Decision|0|||
148906768|NCT00318643|537139950|FG004|Overall Study|Participant's Decision|1|||
148906769|NCT00318643|537139946|FG000|Overall Study|Investigator's Decision|0|||
148906770|NCT00318643|537139947|FG001|Overall Study|Investigator's Decision|0|||
148906771|NCT00318643|537139948|FG002|Overall Study|Investigator's Decision|0|||
148906772|NCT00318643|537139949|FG003|Overall Study|Investigator's Decision|0|||
148906773|NCT00318643|537139950|FG004|Overall Study|Investigator's Decision|1|||
148906774|NCT01812252|537139951|FG000|Overall Study|Persistent Disease|1|||
148803202|NCT03307174|536761010|FG000|Overall Study|Unplanned ICU Administrion|5|||
148803203|NCT03307174|536761011|FG001|Overall Study|Unplanned ICU Administrion|3|||
148803204|NCT03307174|536761010|FG000|Overall Study|Aborted Surgery|1|||
148803205|NCT03307174|536761011|FG001|Overall Study|Aborted Surgery|2|||
148803206|NCT03307174|536761010|FG000|Overall Study|Hypotension|6|||
148803207|NCT03307174|536761011|FG001|Overall Study|Hypotension|0|||
148803208|NCT03307174|536761010|FG000|Overall Study|Nonfunctional epidural|1|||
148803209|NCT03307174|536761011|FG001|Overall Study|Nonfunctional epidural|1|||
148906775|NCT01812252|537139952|FG001|Overall Study|Persistent Disease|0|||
148803210|NCT03307174|536761010|FG000|Overall Study|Planned epidural removal|1|||
148906776|NCT01812252|537139951|FG000|Overall Study|Not transplanted|11|||
148906777|NCT01812252|537139952|FG001|Overall Study|Not transplanted|11|||
148906778|NCT01812252|537139951|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
148906779|NCT01812252|537139952|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
148906780|NCT01812252|537139951|FG000|Overall Study|Withdrawal by Subject|1|||
148906781|NCT01812252|537139952|FG001|Overall Study|Withdrawal by Subject|1|||
148906782|NCT01812252|537139951|FG000|Overall Study|Screen Failure|1|||
148906783|NCT01812252|537139952|FG001|Overall Study|Screen Failure|0|||
148906784|NCT02557139|537139953|FG000|Overall Study|Significant liver elevation|1|||
148906785|NCT02557139|537139954|FG001|Overall Study|Significant liver elevation|0|||
148906786|NCT02557139|537139955|FG002|Overall Study|Significant liver elevation|1|||
148906787|NCT02557139|537139953|FG000|Overall Study|Withdrawal by Subject|1|||
148906788|NCT02557139|537139954|FG001|Overall Study|Withdrawal by Subject|0|||
148906789|NCT02557139|537139955|FG002|Overall Study|Withdrawal by Subject|0|||
148906790|NCT02557139|537139953|FG000|Overall Study|Illness of prohibited medication|0|||
148906791|NCT02557139|537139954|FG001|Overall Study|Illness of prohibited medication|0|||
148906792|NCT02557139|537139955|FG002|Overall Study|Illness of prohibited medication|1|||
148906793|NCT01519921|537139957|FG000|Overall Study|Adverse Event|10|||
148906794|NCT01519921|537139958|FG001|Overall Study|Adverse Event|9|||
148906795|NCT01519921|537139957|FG000|Overall Study|Lack of Efficacy|4|||
148906796|NCT01519921|537139958|FG001|Overall Study|Lack of Efficacy|3|||
148906797|NCT01519921|537139957|FG000|Overall Study|Withdrawal by Subject|3|||
148906798|NCT01519921|537139958|FG001|Overall Study|Withdrawal by Subject|0|||
148906799|NCT01519921|537139957|FG000|Overall Study|Lost to Follow-up|2|||
148906800|NCT01519921|537139958|FG001|Overall Study|Lost to Follow-up|1|||
148906801|NCT01519921|537139957|FG000|Overall Study|Treatment refusal|2|||
148906802|NCT01519921|537139958|FG001|Overall Study|Treatment refusal|1|||
148906803|NCT01519921|537139957|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
148906804|NCT01519921|537139958|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
148906805|NCT01216189|537139959|FG000|Overall Study|Lost to Follow-up|21|||
148906806|NCT01216189|537139960|FG001|Overall Study|Lost to Follow-up|3|||
148906807|NCT01216189|537139959|FG000|Overall Study|Death|4|||
148906808|NCT01216189|537139960|FG001|Overall Study|Death|2|||
148906809|NCT01146795|537139961|FG000|Overall Study|Withdrawal by Subject|4|||
148906810|NCT01146795|537139961|FG000|Overall Study|Adverse Event|6|||
148906811|NCT01146795|537139961|FG000|Overall Study|Still in treatment at study closure|10|||
148906812|NCT05375760|537139962|FG000|Overall Study|Adverse Event|1|||
148906813|NCT05375760|537139963|FG001|Overall Study|Adverse Event|0|||
148906814|NCT05375760|537139962|FG000|Overall Study|Death|0|||
148906815|NCT05375760|537139963|FG001|Overall Study|Death|1|||
148906816|NCT05375760|537139962|FG000|Overall Study|Lost to Follow-up|6|||
148906817|NCT05375760|537139963|FG001|Overall Study|Lost to Follow-up|6|||
148906818|NCT05375760|537139962|FG000|Overall Study|Withdrawal by Subject|17|||
148906819|NCT05375760|537139963|FG001|Overall Study|Withdrawal by Subject|19|||
148906820|NCT05375760|537139962|FG000|Overall Study|Dosing halted by FDA|96|||
148906821|NCT05375760|537139963|FG001|Overall Study|Dosing halted by FDA|100|||
148906822|NCT05375760|537139962|FG000|Overall Study|Not compliant with study visit|2|||
148906823|NCT05375760|537139963|FG001|Overall Study|Not compliant with study visit|0|||
148906824|NCT05375760|537139962|FG000|Overall Study|Physician Decision|1|||
148906825|NCT05375760|537139963|FG001|Overall Study|Physician Decision|0|||
148906826|NCT05375760|537139962|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
148906827|NCT05375760|537139963|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
148906828|NCT05375760|537139962|FG000|Overall Study|Participant moved|1|||
148906829|NCT05375760|537139963|FG001|Overall Study|Participant moved|0|||
148906830|NCT03853109|537139964|FG000|Overall Study|Withdrawal by Subject|0|||
148906831|NCT03853109|537139965|FG001|Overall Study|Withdrawal by Subject|0|||
148906832|NCT03853109|537139966|FG002|Overall Study|Withdrawal by Subject|1|||
148906833|NCT03853109|537139967|FG003|Overall Study|Withdrawal by Subject|2|||
148906834|NCT03853109|537139968|FG004|Overall Study|Withdrawal by Subject|1|||
148906835|NCT03853109|537139969|FG005|Overall Study|Withdrawal by Subject|4|||
148906836|NCT03853109|537139970|FG006|Overall Study|Withdrawal by Subject|5|||
148906837|NCT03853109|537139971|FG007|Overall Study|Withdrawal by Subject|3|||
148906838|NCT03853109|537139964|FG000|Overall Study|Decision by Sponsor|0|||
148906839|NCT03853109|537139965|FG001|Overall Study|Decision by Sponsor|0|||
148906840|NCT03853109|537139966|FG002|Overall Study|Decision by Sponsor|1|||
148906841|NCT03853109|537139967|FG003|Overall Study|Decision by Sponsor|0|||
148906842|NCT03853109|537139968|FG004|Overall Study|Decision by Sponsor|1|||
148906843|NCT03853109|537139969|FG005|Overall Study|Decision by Sponsor|1|||
148906844|NCT03853109|537139970|FG006|Overall Study|Decision by Sponsor|10|||
148906845|NCT03853109|537139971|FG007|Overall Study|Decision by Sponsor|2|||
148906846|NCT03853109|537139964|FG000|Overall Study|Lost to Follow-up|0|||
148906847|NCT03853109|537139965|FG001|Overall Study|Lost to Follow-up|0|||
148906848|NCT03853109|537139966|FG002|Overall Study|Lost to Follow-up|0|||
148906849|NCT03853109|537139967|FG003|Overall Study|Lost to Follow-up|0|||
148906850|NCT03853109|537139968|FG004|Overall Study|Lost to Follow-up|1|||
148906851|NCT03853109|537139969|FG005|Overall Study|Lost to Follow-up|3|||
148906852|NCT03853109|537139970|FG006|Overall Study|Lost to Follow-up|0|||
148906853|NCT03853109|537139971|FG007|Overall Study|Lost to Follow-up|0|||
148906854|NCT03853109|537139964|FG000|Overall Study|Death|2|||
148906855|NCT03853109|537139965|FG001|Overall Study|Death|5|||
148906856|NCT03853109|537139966|FG002|Overall Study|Death|8|||
148906857|NCT03853109|537139967|FG003|Overall Study|Death|10|||
148906858|NCT03853109|537139968|FG004|Overall Study|Death|3|||
148906859|NCT03853109|537139969|FG005|Overall Study|Death|20|||
148906860|NCT03853109|537139970|FG006|Overall Study|Death|10|||
148906861|NCT03853109|537139971|FG007|Overall Study|Death|5|||
148906862|NCT01721044|537139972|FG000|Treatment Period|Adverse Event|7|||
148906863|NCT01721044|537139973|FG001|Treatment Period|Adverse Event|7|||
148906864|NCT01721044|537139974|FG002|Treatment Period|Adverse Event|10|||
148906865|NCT01721044|537139972|FG000|Treatment Period|Death|0|||
148906866|NCT01721044|537139973|FG001|Treatment Period|Death|0|||
148906867|NCT01721044|537139974|FG002|Treatment Period|Death|1|||
148906868|NCT01721044|537139972|FG000|Treatment Period|Lack of Efficacy|16|||
148906869|NCT01721044|537139973|FG001|Treatment Period|Lack of Efficacy|4|||
148906870|NCT01721044|537139974|FG002|Treatment Period|Lack of Efficacy|4|||
148906871|NCT01721044|537139972|FG000|Treatment Period|Lost to Follow-up|0|||
148906872|NCT01721044|537139973|FG001|Treatment Period|Lost to Follow-up|0|||
148906873|NCT01721044|537139974|FG002|Treatment Period|Lost to Follow-up|1|||
148906874|NCT01721044|537139972|FG000|Treatment Period|Physician Decision|1|||
148803211|NCT03307174|536761011|FG001|Overall Study|Planned epidural removal|0|||
148803212|NCT03307174|536761010|FG000|Overall Study|Intrathecal catheter placement|0|||
148803213|NCT03307174|536761011|FG001|Overall Study|Intrathecal catheter placement|1|||
148803214|NCT01192815|536761012|FG000|Overall Study|Withdrawal by Subject|1|||
148803215|NCT01192815|536761012|FG000|Overall Study|Lack of Efficacy|1|||
148803216|NCT03444584|536761013|FG000|Overall Study|Withdrawal by Subject|0|||
148803217|NCT03444584|536761014|FG001|Overall Study|Withdrawal by Subject|1|||
148803218|NCT03444584|536761013|FG000|Overall Study|Other|0|||
148803219|NCT03444584|536761014|FG001|Overall Study|Other|1|||
148803220|NCT00863707|536761015|FG000|Overall Study|Randomized, but drug not received|4|||
148803221|NCT00863707|536761016|FG001|Overall Study|Randomized, but drug not received|3|||
148803222|NCT01142336|536761017|FG000|Overall Study|Adverse Event|1|||
148803223|NCT01142336|536761018|FG001|Overall Study|Adverse Event|1|||
148803224|NCT01142336|536761017|FG000|Overall Study|Lost to Follow-up|0|||
148803225|NCT01142336|536761018|FG001|Overall Study|Lost to Follow-up|1|||
148803226|NCT01704261|536761019|FG000|Overall Study|Withdrawal by Subject|12|||
148803227|NCT01704261|536761020|FG001|Overall Study|Withdrawal by Subject|15|||
148803228|NCT01704261|536761019|FG000|Overall Study|Lost to Follow-up|1|||
148803229|NCT01704261|536761020|FG001|Overall Study|Lost to Follow-up|0|||
148803230|NCT02722967|536761021|FG000|Overall Study|Adverse Event|1|||
148906875|NCT01721044|537139973|FG001|Treatment Period|Physician Decision|0|||
148906876|NCT01721044|537139974|FG002|Treatment Period|Physician Decision|2|||
148906877|NCT01721044|537139972|FG000|Treatment Period|Protocol Violation|1|||
148906878|NCT01721044|537139973|FG001|Treatment Period|Protocol Violation|0|||
148906879|NCT01721044|537139974|FG002|Treatment Period|Protocol Violation|0|||
148906880|NCT01721044|537139972|FG000|Treatment Period|Withdrawal by Subject|7|||
148906881|NCT01721044|537139973|FG001|Treatment Period|Withdrawal by Subject|6|||
148906882|NCT01721044|537139974|FG002|Treatment Period|Withdrawal by Subject|1|||
148906883|NCT04032093|537139977|FG000|Overall Study|Lost to Follow-up|7|||
148906884|NCT04032093|537139978|FG001|Overall Study|Lost to Follow-up|7|||
148906885|NCT04032093|537139979|FG002|Overall Study|Lost to Follow-up|6|||
148906886|NCT04032093|537139980|FG003|Overall Study|Lost to Follow-up|10|||
148906887|NCT04032093|537139981|FG004|Overall Study|Lost to Follow-up|13|||
148906888|NCT04032093|537139982|FG005|Overall Study|Lost to Follow-up|7|||
148906889|NCT04032093|537139983|FG006|Overall Study|Lost to Follow-up|7|||
148906890|NCT04032093|537139984|FG007|Overall Study|Lost to Follow-up|5|||
148906891|NCT04032093|537139985|FG008|Overall Study|Lost to Follow-up|9|||
148906892|NCT04032093|537139986|FG009|Overall Study|Lost to Follow-up|12|||
148906893|NCT04032093|537139977|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
148906894|NCT04032093|537139978|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148906895|NCT04032093|537139979|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
148906896|NCT04032093|537139980|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
148906897|NCT04032093|537139981|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
148906898|NCT04032093|537139982|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
148906899|NCT04032093|537139983|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
148906900|NCT04032093|537139984|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
148906901|NCT04032093|537139985|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
148906902|NCT04032093|537139986|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
148906903|NCT04032093|537139977|FG000|Overall Study|Other|1|||
148906904|NCT04032093|537139978|FG001|Overall Study|Other|0|||
148906905|NCT04032093|537139979|FG002|Overall Study|Other|0|||
148906906|NCT04032093|537139980|FG003|Overall Study|Other|1|||
148906907|NCT04032093|537139981|FG004|Overall Study|Other|1|||
148906908|NCT04032093|537139982|FG005|Overall Study|Other|0|||
148906909|NCT04032093|537139983|FG006|Overall Study|Other|0|||
148906910|NCT04032093|537139984|FG007|Overall Study|Other|0|||
148906911|NCT04032093|537139985|FG008|Overall Study|Other|0|||
148906912|NCT04032093|537139986|FG009|Overall Study|Other|1|||
148906913|NCT04032093|537139977|FG000|Overall Study|Withdrawal by Subject|1|||
148906914|NCT04032093|537139978|FG001|Overall Study|Withdrawal by Subject|3|||
148906915|NCT04032093|537139979|FG002|Overall Study|Withdrawal by Subject|2|||
148906916|NCT04032093|537139980|FG003|Overall Study|Withdrawal by Subject|2|||
148906917|NCT04032093|537139981|FG004|Overall Study|Withdrawal by Subject|3|||
148906918|NCT04032093|537139982|FG005|Overall Study|Withdrawal by Subject|0|||
148906919|NCT04032093|537139983|FG006|Overall Study|Withdrawal by Subject|0|||
148906920|NCT04032093|537139984|FG007|Overall Study|Withdrawal by Subject|0|||
148906921|NCT04032093|537139985|FG008|Overall Study|Withdrawal by Subject|0|||
148906922|NCT04032093|537139986|FG009|Overall Study|Withdrawal by Subject|0|||
148906923|NCT04032093|537139977|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148906924|NCT04032093|537139978|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148906925|NCT04032093|537139979|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
148906926|NCT04032093|537139980|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
148906927|NCT04032093|537139981|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
148906928|NCT04032093|537139982|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
148906929|NCT04032093|537139983|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
148906930|NCT04032093|537139984|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
148906931|NCT04032093|537139985|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
148906932|NCT04032093|537139986|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
148906933|NCT04032093|537139977|FG000|Overall Study|Adverse Event|0|||
148906934|NCT04032093|537139978|FG001|Overall Study|Adverse Event|0|||
148906935|NCT04032093|537139979|FG002|Overall Study|Adverse Event|0|||
148906936|NCT04032093|537139980|FG003|Overall Study|Adverse Event|0|||
148906937|NCT04032093|537139981|FG004|Overall Study|Adverse Event|0|||
148906938|NCT04032093|537139982|FG005|Overall Study|Adverse Event|0|||
148906939|NCT04032093|537139983|FG006|Overall Study|Adverse Event|0|||
148906940|NCT04032093|537139984|FG007|Overall Study|Adverse Event|0|||
148906941|NCT04032093|537139985|FG008|Overall Study|Adverse Event|0|||
148906942|NCT04032093|537139986|FG009|Overall Study|Adverse Event|1|||
148906943|NCT04032093|537139977|FG000|Overall Study|Physician Decision|0|||
148906944|NCT04032093|537139978|FG001|Overall Study|Physician Decision|0|||
148906945|NCT04032093|537139979|FG002|Overall Study|Physician Decision|0|||
148906946|NCT04032093|537139980|FG003|Overall Study|Physician Decision|0|||
148906947|NCT04032093|537139981|FG004|Overall Study|Physician Decision|0|||
148906948|NCT04032093|537139982|FG005|Overall Study|Physician Decision|1|||
148906949|NCT04032093|537139983|FG006|Overall Study|Physician Decision|0|||
148803231|NCT02722967|536761022|FG001|Overall Study|Adverse Event|0|||
148803232|NCT02722967|536761023|FG002|Overall Study|Adverse Event|0|||
148803233|NCT02722967|536761021|FG000|Overall Study|Lost to Follow-up|0|||
148803234|NCT02722967|536761022|FG001|Overall Study|Lost to Follow-up|1|||
148803235|NCT02722967|536761023|FG002|Overall Study|Lost to Follow-up|0|||
148803236|NCT02722967|536761021|FG000|Overall Study|Non-compliance with patch wearing|2|||
148803237|NCT02722967|536761022|FG001|Overall Study|Non-compliance with patch wearing|1|||
148803238|NCT02722967|536761023|FG002|Overall Study|Non-compliance with patch wearing|1|||
148906950|NCT04032093|537139984|FG007|Overall Study|Physician Decision|0|||
148906951|NCT04032093|537139985|FG008|Overall Study|Physician Decision|0|||
148906952|NCT04032093|537139986|FG009|Overall Study|Physician Decision|0|||
148906953|NCT00949702|537139988|FG000|Overall Study|Death|40|||
148906954|NCT00949702|537139988|FG000|Overall Study|Disease progression|7|||
148906955|NCT00949702|537139988|FG000|Overall Study|Withdrawal of consent|1|||
148906956|NCT01654302|537139989|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
148906957|NCT01654302|537139990|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
148906958|NCT00960999|537139997|FG000|Overall Study|Withdrawal by Subject|1|||
148906959|NCT00960999|537139998|FG001|Overall Study|Withdrawal by Subject|0|||
148906960|NCT00960999|537139997|FG000|Overall Study|Protocol Violation|5|||
148906961|NCT00960999|537139998|FG001|Overall Study|Protocol Violation|2|||
148906962|NCT00960999|537139997|FG000|Overall Study|RT dose constraints not met|2|||
148906963|NCT00960999|537139998|FG001|Overall Study|RT dose constraints not met|0|||
148906964|NCT02141204|537139999|FG000|Overall Study|Lost to Follow-up|2|||
148906965|NCT02141204|537140000|FG001|Overall Study|Lost to Follow-up|1|||
148906966|NCT02141204|537139999|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
148906967|NCT02141204|537140000|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
148906968|NCT02141204|537139999|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
148906969|NCT02141204|537140000|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
148906970|NCT02141204|537139999|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
148906971|NCT02141204|537140000|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
148906972|NCT00515619|537140003|FG000|Overall Study|Adverse Event|34|||
148906973|NCT00515619|537140003|FG000|Overall Study|Lack of Efficacy|92|||
148906974|NCT00515619|537140003|FG000|Overall Study|Withdrawal by Subject|66|||
148906975|NCT00515619|537140003|FG000|Overall Study|Protocol Violation|3|||
148906976|NCT00515619|537140003|FG000|Overall Study|Lost to Follow-up|4|||
148906977|NCT00515619|537140003|FG000|Overall Study|Unsatisfactory compliance|6|||
148906978|NCT00515619|537140003|FG000|Overall Study|Other: Site discontinuing trials|2|||
148906979|NCT00515619|537140003|FG000|Overall Study|Other: Subject cannot attend visits|2|||
148906980|NCT00515619|537140003|FG000|Overall Study|Other: Subject required surgery|1|||
148906981|NCT00515619|537140003|FG000|Overall Study|Other: Subject moved to another country|1|||
148906982|NCT00515619|537140003|FG000|Overall Study|Other: Investigator decision|1|||
148906983|NCT00515619|537140003|FG000|Overall Study|Other: Subject became pregnant|1|||
148906984|NCT00515619|537140003|FG000|Overall Study|Other: Request from sponsor|1|||
148906985|NCT00515619|537140003|FG000|Overall Study|Other: Drug available on license|1|||
148906986|NCT00515619|537140003|FG000|Overall Study|Other: Subject interested in other AED|1|||
148906987|NCT00670748|537140008|FG000|Overall Study|Death during treatment|1|||
148906988|NCT00670748|537140009|FG001|Overall Study|Death during treatment|1|||
148906989|NCT00670748|537140010|FG002|Overall Study|Death during treatment|1|||
148906990|NCT00670748|537140011|FG003|Overall Study|Death during treatment|0|||
148906991|NCT00670748|537140008|FG000|Overall Study|Not off study|2|||
148906992|NCT00670748|537140009|FG001|Overall Study|Not off study|1|||
148906993|NCT00670748|537140010|FG002|Overall Study|Not off study|1|||
148906994|NCT00670748|537140011|FG003|Overall Study|Not off study|1|||
148906995|NCT03863080|537140012|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
148906996|NCT03863080|537140013|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
148906997|NCT03863080|537140014|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
148906998|NCT03863080|537140015|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
148906999|NCT03863080|537140012|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
148907000|NCT03863080|537140013|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
148907001|NCT03863080|537140014|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
148907002|NCT03863080|537140015|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
148907003|NCT03863080|537140012|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
148907004|NCT03863080|537140013|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
148907005|NCT03863080|537140014|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
148907006|NCT03863080|537140015|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
148907007|NCT02991768|537140017|FG000|Overall Study|Physician Decision|4|||
148907008|NCT03467750|537140018|FG000|Overall Study|Surgery canceled|1|||
148907009|NCT03467750|537140019|FG001|Overall Study|Surgery canceled|0|||
148907010|NCT03467750|537140018|FG000|Overall Study|Protocol Violation|1|||
148907011|NCT03467750|537140019|FG001|Overall Study|Protocol Violation|1|||
148907012|NCT03467750|537140018|FG000|Overall Study|Withdrawal by Subject|0|||
148907013|NCT03467750|537140019|FG001|Overall Study|Withdrawal by Subject|1|||
148907014|NCT03207763|537142133|FG000|Overall Study|Lost to Follow-up|1|||
148907015|NCT03207763|537142134|FG001|Overall Study|Lost to Follow-up|0|||
148907016|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
148907017|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
148907018|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
148907019|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
148907020|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
148907021|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
148907022|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
148907023|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
148803239|NCT02722967|536761021|FG000|Overall Study|Withdrawal by Subject|1|||
148803240|NCT02722967|536761022|FG001|Overall Study|Withdrawal by Subject|0|||
148803241|NCT02722967|536761023|FG002|Overall Study|Withdrawal by Subject|1|||
148803242|NCT02722967|536761021|FG000|Overall Study|Physician Decision|1|||
148803243|NCT02722967|536761022|FG001|Overall Study|Physician Decision|0|||
148803244|NCT02722967|536761023|FG002|Overall Study|Physician Decision|0|||
148803245|NCT02722967|536761021|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
148803246|NCT02722967|536761022|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
148803247|NCT02722967|536761023|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
148803248|NCT02783911|536761030|FG000|Overall Study|Lost to Follow-up|3|||
148803249|NCT02783911|536761031|FG001|Overall Study|Lost to Follow-up|32|||
148803250|NCT00467519|536761034|FG000|Overall Study|Protocol Violation|8|||
148803251|NCT00467519|536761035|FG001|Overall Study|Protocol Violation|4|||
148803252|NCT00467519|536761034|FG000|Overall Study|Lost to Follow-up|2|||
148803253|NCT00467519|536761035|FG001|Overall Study|Lost to Follow-up|9|||
148803254|NCT00467519|536761034|FG000|Overall Study|Withdrawal by Subject|4|||
148803255|NCT00467519|536761035|FG001|Overall Study|Withdrawal by Subject|10|||
148803256|NCT01218802|536761039|FG000|Overall Study|Lost to Follow-up|5|||
148803257|NCT01218802|536761040|FG001|Overall Study|Lost to Follow-up|6|||
148803258|NCT01218802|536761039|FG000|Overall Study|Withdrawal by Subject|3|||
148803259|NCT01218802|536761040|FG001|Overall Study|Withdrawal by Subject|10|||
148803260|NCT01218802|536761039|FG000|Overall Study|Adverse Event|0|||
148803261|NCT01218802|536761040|FG001|Overall Study|Adverse Event|2|||
148803262|NCT01218802|536761039|FG000|Overall Study|Incarcerated|2|||
148803263|NCT01218802|536761040|FG001|Overall Study|Incarcerated|0|||
148803264|NCT01123655|536761043|FG000|Overall Study|Medication for RA had to be changed|1|||
148803265|NCT01123655|536761044|FG001|Overall Study|Medication for RA had to be changed|0|||
148803266|NCT01123655|536761045|FG002|Overall Study|Medication for RA had to be changed|0|||
148803267|NCT01123655|536761043|FG000|Overall Study|new illness|0|||
148803268|NCT01123655|536761044|FG001|Overall Study|new illness|1|||
148803269|NCT01123655|536761045|FG002|Overall Study|new illness|0|||
148803270|NCT01123655|536761043|FG000|Overall Study|began prohibitive drug|0|||
148803271|NCT01123655|536761044|FG001|Overall Study|began prohibitive drug|0|||
148803272|NCT01123655|536761045|FG002|Overall Study|began prohibitive drug|1|||
148803273|NCT00062166|536761046|FG000|Overall Study|Withdrawal by Subject|6|||
148803274|NCT01776554|536761052|FG000|Overall Study|Adverse Event|1|||
148803275|NCT01776554|536761053|FG001|Overall Study|Adverse Event|0|||
148803276|NCT01776554|536761052|FG000|Overall Study|Withdrawal by Subject|3|||
148803277|NCT01776554|536761053|FG001|Overall Study|Withdrawal by Subject|8|||
148803278|NCT01776554|536761052|FG000|Overall Study|Lost to Follow-up|6|||
148803279|NCT01776554|536761053|FG001|Overall Study|Lost to Follow-up|9|||
148803280|NCT01776554|536761052|FG000|Overall Study|Administrative Reason|2|||
148803281|NCT01776554|536761053|FG001|Overall Study|Administrative Reason|5|||
148803282|NCT01776554|536761052|FG000|Overall Study|Protocol Violation|1|||
148803283|NCT01776554|536761053|FG001|Overall Study|Protocol Violation|0|||
148803284|NCT01776554|536761052|FG000|Overall Study|Unclassified|4|||
148803285|NCT01776554|536761053|FG001|Overall Study|Unclassified|1|||
148803286|NCT01041859|536761054|FG000|Open-Label Titration|Adverse Event|69|||
148803287|NCT01041859|536761055|FG001|Open-Label Titration|Adverse Event|0|||
148803288|NCT01041859|536761056|FG002|Open-Label Titration|Adverse Event|0|||
148803289|NCT01041859|536761054|FG000|Open-Label Titration|Lack of Efficacy|3|||
148803290|NCT01041859|536761055|FG001|Open-Label Titration|Lack of Efficacy|0|||
148803291|NCT01041859|536761056|FG002|Open-Label Titration|Lack of Efficacy|0|||
148803292|NCT01041859|536761054|FG000|Open-Label Titration|Lost to Follow-up|1|||
148803293|NCT01041859|536761055|FG001|Open-Label Titration|Lost to Follow-up|0|||
148803294|NCT01041859|536761056|FG002|Open-Label Titration|Lost to Follow-up|0|||
148803295|NCT01041859|536761054|FG000|Open-Label Titration|Physician Decision|1|||
148803296|NCT01041859|536761055|FG001|Open-Label Titration|Physician Decision|0|||
148803297|NCT01041859|536761056|FG002|Open-Label Titration|Physician Decision|0|||
148803298|NCT01041859|536761054|FG000|Open-Label Titration|Protocol Violation|1|||
148803299|NCT01041859|536761055|FG001|Open-Label Titration|Protocol Violation|0|||
148803300|NCT01041859|536761056|FG002|Open-Label Titration|Protocol Violation|0|||
148803301|NCT01041859|536761054|FG000|Open-Label Titration|Other|7|||
148803302|NCT01041859|536761055|FG001|Open-Label Titration|Other|0|||
148803303|NCT01041859|536761056|FG002|Open-Label Titration|Other|0|||
148803304|NCT01041859|536761054|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
148803305|NCT01041859|536761055|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
148907024|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
148907025|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
148907026|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
148907027|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
148907028|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
148907029|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
148907030|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
148907031|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148907032|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
148907033|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148907034|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
148907035|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
148907036|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
148907037|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
148907038|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
148907039|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
148907040|NCT01106690|537142137|FG000|Core Period: Baseline to Week 26|Other|10|||
148907041|NCT01106690|537142138|FG001|Core Period: Baseline to Week 26|Other|2|||
148907042|NCT01106690|537142139|FG002|Core Period: Baseline to Week 26|Other|6|||
148907043|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
148907044|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
148907045|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
148907046|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
148907047|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
148907048|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
148907049|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148907050|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
148907051|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
148907052|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
148907053|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
148907054|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
148907055|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
148907056|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
148907057|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148907058|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Other|8|||
148907059|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Other|3|||
148907060|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Other|4|||
148907061|NCT01106690|537142137|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
148907062|NCT01106690|537142138|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148907063|NCT01106690|537142139|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148907064|NCT00241839|537142148|FG000|Overall Study|Withdrawal by Subject|18|||
148907065|NCT00241839|537142149|FG001|Overall Study|Withdrawal by Subject|17|||
148907066|NCT00241839|537142148|FG000|Overall Study|Adverse Event|1|||
148907067|NCT00241839|537142149|FG001|Overall Study|Adverse Event|1|||
148907068|NCT00043979|537142152|FG000|Period 1|recipient with progressive disease|7|||
148907069|NCT00043979|537142153|FG001|Period 1|recipient with progressive disease|4|||
148907070|NCT00043979|537142154|FG002|Period 1|recipient with progressive disease|3|||
148907071|NCT04639258|537142155|FG000|Overall Study|Screen failure|5|||
148907072|NCT04639258|537142155|FG000|Overall Study|Physician Decision|2|||
148907073|NCT04639258|537142155|FG000|Overall Study|Early study termination|3|||
148907074|NCT04639258|537142155|FG000|Overall Study|Withdrawal by Subject|1|||
148907075|NCT01635153|537142157|FG000|Overall Study|Lost to Follow-up|40|||
148907076|NCT01635153|537142158|FG001|Overall Study|Lost to Follow-up|43|||
148803306|NCT01041859|536761056|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
148803307|NCT01041859|536761054|FG000|Open-Label Titration|Withdrawal by Subject|11|||
148803308|NCT01041859|536761055|FG001|Open-Label Titration|Withdrawal by Subject|0|||
148803309|NCT01041859|536761056|FG002|Open-Label Titration|Withdrawal by Subject|0|||
148803310|NCT01041859|536761054|FG000|Double-Blind Maintenance|Adverse Event|0|||
148803311|NCT01041859|536761055|FG001|Double-Blind Maintenance|Adverse Event|23|||
148803312|NCT01041859|536761056|FG002|Double-Blind Maintenance|Adverse Event|13|||
148803313|NCT01041859|536761054|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
148803314|NCT01041859|536761055|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
148803315|NCT01041859|536761056|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
148803316|NCT01041859|536761054|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
148803317|NCT01041859|536761055|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
148803318|NCT01041859|536761056|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
148907077|NCT02754440|537142160|FG000|Overall Study|Protocol Violation|3|||
148907078|NCT02754440|537142161|FG001|Overall Study|Protocol Violation|2|||
148907079|NCT02754440|537142162|FG002|Overall Study|Protocol Violation|2|||
148907080|NCT02754440|537142163|FG003|Overall Study|Protocol Violation|6|||
148907081|NCT02754440|537142160|FG000|Overall Study|Adverse Event|3|||
148907082|NCT02754440|537142161|FG001|Overall Study|Adverse Event|1|||
148907083|NCT02754440|537142162|FG002|Overall Study|Adverse Event|0|||
148907084|NCT02754440|537142163|FG003|Overall Study|Adverse Event|9|||
148907085|NCT02754440|537142160|FG000|Overall Study|Withdrawal by Subject|0|||
148907086|NCT02754440|537142161|FG001|Overall Study|Withdrawal by Subject|0|||
148907087|NCT02754440|537142162|FG002|Overall Study|Withdrawal by Subject|0|||
148907088|NCT02754440|537142163|FG003|Overall Study|Withdrawal by Subject|1|||
148907089|NCT02754440|537142160|FG000|Overall Study|Equipment failure|0|||
148907090|NCT02754440|537142161|FG001|Overall Study|Equipment failure|5|||
148907091|NCT02754440|537142162|FG002|Overall Study|Equipment failure|5|||
148907092|NCT02754440|537142163|FG003|Overall Study|Equipment failure|7|||
148907093|NCT02754440|537142160|FG000|Overall Study|Subject issues not resulting in AE|0|||
148907094|NCT02754440|537142161|FG001|Overall Study|Subject issues not resulting in AE|0|||
148907095|NCT02754440|537142162|FG002|Overall Study|Subject issues not resulting in AE|0|||
148907096|NCT02754440|537142163|FG003|Overall Study|Subject issues not resulting in AE|12|||
148907097|NCT02560558|537142164|FG000|Overall Study|Adverse Event|1|||
148907098|NCT02560558|537142165|FG001|Overall Study|Adverse Event|0|||
148907099|NCT02560558|537142164|FG000|Overall Study|Death|0|||
148907100|NCT02560558|537142165|FG001|Overall Study|Death|2|||
148907101|NCT02560558|537142164|FG000|Overall Study|Lost to Follow-up|0|||
148907102|NCT02560558|537142165|FG001|Overall Study|Lost to Follow-up|4|||
148907103|NCT02560558|537142164|FG000|Overall Study|Protocol Violation|3|||
148907104|NCT02560558|537142165|FG001|Overall Study|Protocol Violation|0|||
148907105|NCT02560558|537142164|FG000|Overall Study|Withdrawal by Subject|3|||
148907106|NCT02560558|537142165|FG001|Overall Study|Withdrawal by Subject|0|||
148907107|NCT00297258|537142176|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
148907108|NCT00297258|537142176|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
148907109|NCT00297258|537142176|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
148907110|NCT00297258|537142176|FG000|Overall Study|Intercurrent Illness|3|||
148907111|NCT00297258|537142176|FG000|Overall Study|Intercurrent Death|2|||
148907112|NCT00297258|537142176|FG000|Overall Study|Deteriorization of General Condition|1|||
148907113|NCT00297258|537142176|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
148907114|NCT00297258|537142176|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
148907115|NCT00297258|537142176|FG000|Overall Study|Switch to Commercial Treatment|1|||
148907116|NCT00297258|537142176|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
148907117|NCT01263197|537142177|FG000|First Intervention (Period 1)|Adverse Event|0|||
148907118|NCT01263197|537142178|FG001|First Intervention (Period 1)|Adverse Event|0|||
148907119|NCT01263197|537142179|FG002|First Intervention (Period 1)|Adverse Event|0|||
148907120|NCT01263197|537142180|FG003|First Intervention (Period 1)|Adverse Event|0|||
148907121|NCT01263197|537142181|FG004|First Intervention (Period 1)|Adverse Event|0|||
148907122|NCT01263197|537142182|FG005|First Intervention (Period 1)|Adverse Event|1|||
148907123|NCT01263197|537142177|FG000|Washout Period 1|Protocol Violation|0|||
148907124|NCT01263197|537142178|FG001|Washout Period 1|Protocol Violation|0|||
148907125|NCT01263197|537142179|FG002|Washout Period 1|Protocol Violation|0|||
148907126|NCT01263197|537142180|FG003|Washout Period 1|Protocol Violation|0|||
148907127|NCT01263197|537142181|FG004|Washout Period 1|Protocol Violation|1|||
148907128|NCT01263197|537142182|FG005|Washout Period 1|Protocol Violation|0|||
148907129|NCT01263197|537142177|FG000|Washout Period 2|Physician Decision|0|||
148907130|NCT01263197|537142178|FG001|Washout Period 2|Physician Decision|0|||
148907131|NCT01263197|537142179|FG002|Washout Period 2|Physician Decision|0|||
148907132|NCT01263197|537142180|FG003|Washout Period 2|Physician Decision|0|||
148907133|NCT01263197|537142181|FG004|Washout Period 2|Physician Decision|0|||
148907134|NCT01263197|537142182|FG005|Washout Period 2|Physician Decision|1|||
148907135|NCT01263197|537142177|FG000|Washout Period 2|Protocol Violation|0|||
148907136|NCT01263197|537142178|FG001|Washout Period 2|Protocol Violation|0|||
148907137|NCT01263197|537142179|FG002|Washout Period 2|Protocol Violation|0|||
148907138|NCT01263197|537142180|FG003|Washout Period 2|Protocol Violation|1|||
148907139|NCT01263197|537142181|FG004|Washout Period 2|Protocol Violation|0|||
148907140|NCT01263197|537142182|FG005|Washout Period 2|Protocol Violation|0|||
148907141|NCT01263197|537142177|FG000|Third Intervention (Period 3)|Adverse Event|0|||
148907142|NCT01263197|537142178|FG001|Third Intervention (Period 3)|Adverse Event|1|||
148907143|NCT01263197|537142179|FG002|Third Intervention (Period 3)|Adverse Event|0|||
148907144|NCT01263197|537142180|FG003|Third Intervention (Period 3)|Adverse Event|0|||
148907145|NCT01263197|537142181|FG004|Third Intervention (Period 3)|Adverse Event|0|||
148907146|NCT01263197|537142182|FG005|Third Intervention (Period 3)|Adverse Event|0|||
148907147|NCT01189032|537142183|FG000|Overall Study|Adverse Event|1|||
148907148|NCT01189032|537142184|FG001|Overall Study|Adverse Event|3|||
148907149|NCT01189032|537142185|FG002|Overall Study|Adverse Event|4|||
148907150|NCT01189032|537142183|FG000|Overall Study|Lack of Efficacy|2|||
148907151|NCT01189032|537142184|FG001|Overall Study|Lack of Efficacy|3|||
149138518|NCT03627767|537988870|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
148907152|NCT01189032|537142185|FG002|Overall Study|Lack of Efficacy|0|||
148907153|NCT01189032|537142183|FG000|Overall Study|Withdrawal by Subject|1|||
148907154|NCT01189032|537142184|FG001|Overall Study|Withdrawal by Subject|0|||
148907155|NCT01189032|537142185|FG002|Overall Study|Withdrawal by Subject|1|||
148907156|NCT01189032|537142183|FG000|Overall Study|Protocol Violation|1|||
148907157|NCT01189032|537142184|FG001|Overall Study|Protocol Violation|1|||
148907158|NCT01189032|537142185|FG002|Overall Study|Protocol Violation|1|||
148907159|NCT01470326|537142186|FG000|Overall Study|Protocol Violation|32|||
148907160|NCT01470326|537142186|FG000|Overall Study|No Drug Administration Information|2|||
148907161|NCT01470326|537142186|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
148907162|NCT01166282|537142187|FG000|Open-label Period|Adverse Event|0|||
148907163|NCT01166282|537142188|FG001|Open-label Period|Adverse Event|0|||
148907164|NCT01166282|537142189|FG002|Open-label Period|Adverse Event|6|||
148907165|NCT01166282|537142187|FG000|Open-label Period|Withdrawal by Subject|0|||
148907166|NCT01166282|537142188|FG001|Open-label Period|Withdrawal by Subject|0|||
148907167|NCT01166282|537142189|FG002|Open-label Period|Withdrawal by Subject|4|||
148907168|NCT01166282|537142187|FG000|Open-label Period|Lack of Efficacy|0|||
148907169|NCT01166282|537142188|FG001|Open-label Period|Lack of Efficacy|0|||
148907170|NCT01166282|537142189|FG002|Open-label Period|Lack of Efficacy|2|||
148907171|NCT01166282|537142187|FG000|Open-label Period|Remission|0|||
148907172|NCT01166282|537142188|FG001|Open-label Period|Remission|0|||
148907173|NCT01166282|537142189|FG002|Open-label Period|Remission|4|||
148907174|NCT01166282|537142187|FG000|Open-label Period|Irregular Compliance|0|||
148907175|NCT01166282|537142188|FG001|Open-label Period|Irregular Compliance|0|||
148907176|NCT01166282|537142189|FG002|Open-label Period|Irregular Compliance|1|||
148907177|NCT02577718|537142190|FG000|Overall Study|Death|6|||
148907178|NCT02577718|537142190|FG000|Overall Study|Withdrawal by Subject|2|||
148907179|NCT01995838|537142191|FG000|Overall Study|Lost to Follow-up|0|||
148907180|NCT01995838|537142192|FG001|Overall Study|Lost to Follow-up|1|||
148907181|NCT01995838|537142193|FG002|Overall Study|Lost to Follow-up|0|||
148907182|NCT01995838|537142194|FG003|Overall Study|Lost to Follow-up|0|||
148907183|NCT01995838|537142195|FG004|Overall Study|Lost to Follow-up|0|||
148907184|NCT01995838|537142196|FG005|Overall Study|Lost to Follow-up|0|||
148907185|NCT01995838|537142197|FG006|Overall Study|Lost to Follow-up|1|||
148907186|NCT01995838|537142191|FG000|Overall Study|Participant choice|2|||
148907187|NCT01995838|537142192|FG001|Overall Study|Participant choice|0|||
148907188|NCT01995838|537142193|FG002|Overall Study|Participant choice|0|||
148907189|NCT01995838|537142194|FG003|Overall Study|Participant choice|0|||
148907190|NCT01995838|537142195|FG004|Overall Study|Participant choice|0|||
148907191|NCT01995838|537142196|FG005|Overall Study|Participant choice|1|||
148907192|NCT01995838|537142197|FG006|Overall Study|Participant choice|1|||
148907193|NCT01995838|537142191|FG000|Overall Study|Adverse Event|0|||
148907194|NCT01995838|537142192|FG001|Overall Study|Adverse Event|0|||
148907195|NCT01995838|537142193|FG002|Overall Study|Adverse Event|0|||
148907196|NCT01995838|537142194|FG003|Overall Study|Adverse Event|0|||
148907197|NCT01995838|537142195|FG004|Overall Study|Adverse Event|0|||
148907198|NCT01995838|537142196|FG005|Overall Study|Adverse Event|0|||
148907199|NCT01995838|537142197|FG006|Overall Study|Adverse Event|1|||
148907200|NCT01995838|537142191|FG000|Overall Study|Withdrawal by Subject|0|||
148907201|NCT01995838|537142192|FG001|Overall Study|Withdrawal by Subject|0|||
148907202|NCT01995838|537142193|FG002|Overall Study|Withdrawal by Subject|0|||
148907203|NCT01995838|537142194|FG003|Overall Study|Withdrawal by Subject|0|||
148907204|NCT01995838|537142195|FG004|Overall Study|Withdrawal by Subject|1|||
148907205|NCT01995838|537142196|FG005|Overall Study|Withdrawal by Subject|0|||
148907206|NCT01995838|537142197|FG006|Overall Study|Withdrawal by Subject|0|||
148907207|NCT01995838|537142191|FG000|Overall Study|Other|3|||
148907208|NCT01995838|537142192|FG001|Overall Study|Other|1|||
148907209|NCT01995838|537142193|FG002|Overall Study|Other|0|||
148907210|NCT01995838|537142194|FG003|Overall Study|Other|2|||
148907211|NCT01995838|537142195|FG004|Overall Study|Other|1|||
148907212|NCT01995838|537142196|FG005|Overall Study|Other|1|||
148907213|NCT01995838|537142197|FG006|Overall Study|Other|2|||
148907214|NCT00275509|537142202|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
148907215|NCT00275509|537142203|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
148907216|NCT01967576|537142204|FG000|Overall Study|Withdrawal by Subject|3|||
148907217|NCT01967576|537142204|FG000|Overall Study|Progressed/Removed from treatment|1|||
148907218|NCT01967576|537142204|FG000|Overall Study|Study closing at site|1|||
148907219|NCT01967576|537142204|FG000|Overall Study|Adverse Event|1|||
148907220|NCT01967576|537142204|FG000|Overall Study|Refused further treatment|1|||
148907221|NCT03196349|537142207|FG000|Overall Study|Did not receive study drug|0|||
148907222|NCT03196349|537142208|FG001|Overall Study|Did not receive study drug|1|||
148907223|NCT03196349|537142209|FG002|Overall Study|Did not receive study drug|2|||
148907224|NCT03196349|537142207|FG000|Overall Study|No data entered|2|||
148907225|NCT03196349|537142208|FG001|Overall Study|No data entered|4|||
148907226|NCT03196349|537142209|FG002|Overall Study|No data entered|0|||
148907227|NCT03196349|537142207|FG000|Overall Study|Study Terminated early|15|||
148907228|NCT03196349|537142208|FG001|Overall Study|Study Terminated early|9|||
148907229|NCT03196349|537142209|FG002|Overall Study|Study Terminated early|11|||
148907230|NCT02819804|537142210|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
148907231|NCT03388164|537142215|FG000|Overall Study|Withdrawal by Subject|3|||
148907232|NCT03388164|537142216|FG001|Overall Study|Withdrawal by Subject|1|||
148803319|NCT01041859|536761054|FG000|Double-Blind Maintenance|Physician Decision|0|||
148803320|NCT01041859|536761055|FG001|Double-Blind Maintenance|Physician Decision|2|||
148803321|NCT01041859|536761056|FG002|Double-Blind Maintenance|Physician Decision|1|||
148803322|NCT01041859|536761054|FG000|Double-Blind Maintenance|Protocol Violation|0|||
148803323|NCT01041859|536761055|FG001|Double-Blind Maintenance|Protocol Violation|1|||
148803324|NCT01041859|536761056|FG002|Double-Blind Maintenance|Protocol Violation|3|||
148803325|NCT01041859|536761054|FG000|Double-Blind Maintenance|Other|0|||
148803326|NCT01041859|536761055|FG001|Double-Blind Maintenance|Other|6|||
148803327|NCT01041859|536761056|FG002|Double-Blind Maintenance|Other|2|||
148803328|NCT01041859|536761054|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
148803329|NCT01041859|536761055|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
148803330|NCT01041859|536761056|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
148803331|NCT01041859|536761054|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
148803332|NCT01041859|536761055|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
148803333|NCT01041859|536761056|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
148803334|NCT02475369|536761057|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
148803335|NCT02475369|536761058|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
148803336|NCT01991795|536761063|FG000|Overall Study|Lost to Follow-up|6|||
148803337|NCT01991795|536761064|FG001|Overall Study|Lost to Follow-up|4|||
148803338|NCT01991795|536761063|FG000|Overall Study|Withdrawal by Subject|117|||
148803339|NCT01991795|536761064|FG001|Overall Study|Withdrawal by Subject|94|||
148803340|NCT01991795|536761063|FG000|Overall Study|Site prematurely closed by sponsor|26|||
148803341|NCT01991795|536761064|FG001|Overall Study|Site prematurely closed by sponsor|25|||
148803342|NCT00885118|536761068|FG000|Overall Study|Adverse Event|1|||
148803343|NCT00885118|536761069|FG001|Overall Study|Adverse Event|0|||
148803344|NCT00885118|536761070|FG002|Overall Study|Adverse Event|0|||
148803345|NCT00885118|536761071|FG003|Overall Study|Adverse Event|0|||
148803346|NCT00885118|536761072|FG004|Overall Study|Adverse Event|0|||
148803347|NCT00885118|536761068|FG000|Overall Study|Withdrawal by Subject|0|||
148803348|NCT00885118|536761069|FG001|Overall Study|Withdrawal by Subject|0|||
148803349|NCT00885118|536761070|FG002|Overall Study|Withdrawal by Subject|0|||
148803350|NCT00885118|536761071|FG003|Overall Study|Withdrawal by Subject|0|||
148803351|NCT00885118|536761072|FG004|Overall Study|Withdrawal by Subject|1|||
148803352|NCT00885118|536761068|FG000|Overall Study|Other reason not defined above|0|||
148803353|NCT00885118|536761069|FG001|Overall Study|Other reason not defined above|0|||
148803354|NCT00885118|536761070|FG002|Overall Study|Other reason not defined above|1|||
148803355|NCT00885118|536761071|FG003|Overall Study|Other reason not defined above|0|||
148803356|NCT00885118|536761072|FG004|Overall Study|Other reason not defined above|0|||
148803357|NCT03642990|536761073|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
148803358|NCT03642990|536761073|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
148803359|NCT00094445|536761074|FG000|Overall Study|Withdrawal by Subject|3|||
148803360|NCT00094445|536761074|FG000|Overall Study|Lost to Follow-up|1|||
148803361|NCT00094445|536761074|FG000|Overall Study|Progressive Disease|2|||
148803362|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
148803363|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
148803364|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
148907233|NCT02892448|537142218|FG000|Overall Study|Screening failure|2|||
148803365|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
148907234|NCT02892448|537142219|FG001|Overall Study|Screening failure|2|||
148803366|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
148803367|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
148803368|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
148803369|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
148907235|NCT02892448|537142220|FG002|Overall Study|Screening failure|1|||
149138519|NCT00907257|537988873|FG000|Overall Study|Adverse Event|0|||
149138520|NCT00907257|537988874|FG001|Overall Study|Adverse Event|4|||
149138521|NCT00907257|537988873|FG000|Overall Study|Protocol Violation|1|||
149138522|NCT00907257|537988874|FG001|Overall Study|Protocol Violation|2|||
149138523|NCT00907257|537988873|FG000|Overall Study|Lost to Follow-up|3|||
149138524|NCT00907257|537988874|FG001|Overall Study|Lost to Follow-up|3|||
149138525|NCT00907257|537988873|FG000|Overall Study|Withdrawal by Subject|1|||
149138526|NCT00907257|537988874|FG001|Overall Study|Withdrawal by Subject|2|||
149138527|NCT00907257|537988873|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
149138528|NCT00907257|537988874|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
149138529|NCT00907257|537988873|FG000|Overall Study|Moved|1|||
149138530|NCT00907257|537988874|FG001|Overall Study|Moved|0|||
149138531|NCT00907257|537988873|FG000|Overall Study|Personal Reasons|6|||
149138532|NCT00907257|537988874|FG001|Overall Study|Personal Reasons|1|||
149138533|NCT04163900|537988875|FG000|Overall Study|Radiological disease progression|112|||
149138534|NCT04163900|537988876|FG001|Overall Study|Radiological disease progression|127|||
149138535|NCT04163900|537988875|FG000|Overall Study|Study closure|98|||
149138536|NCT04163900|537988876|FG001|Overall Study|Study closure|133|||
149138537|NCT04163900|537988875|FG000|Overall Study|Adverse Event|78|||
149138538|NCT04163900|537988876|FG001|Overall Study|Adverse Event|32|||
149138539|NCT04163900|537988875|FG000|Overall Study|Withdrawal by Subject|37|||
149138540|NCT04163900|537988876|FG001|Overall Study|Withdrawal by Subject|34|||
149138541|NCT04163900|537988875|FG000|Overall Study|Death|29|||
149138542|NCT04163900|537988876|FG001|Overall Study|Death|16|||
149138543|NCT04163900|537988875|FG000|Overall Study|Physician Decision|17|||
149138544|NCT04163900|537988876|FG001|Overall Study|Physician Decision|25|||
149138545|NCT04163900|537988875|FG000|Overall Study|Clinical disease progression|14|||
149138546|NCT04163900|537988876|FG001|Overall Study|Clinical disease progression|13|||
149138547|NCT04163900|537988875|FG000|Overall Study|Protocol Violation|3|||
149138548|NCT04163900|537988876|FG001|Overall Study|Protocol Violation|4|||
149138549|NCT04163900|537988875|FG000|Overall Study|Lost to Follow-up|0|||
149138550|NCT04163900|537988876|FG001|Overall Study|Lost to Follow-up|1|||
149138551|NCT00283049|537988877|FG000|Overall Study|Adverse Event|6|||
149138552|NCT00283049|537988878|FG001|Overall Study|Adverse Event|1|||
149138553|NCT00283049|537988879|FG002|Overall Study|Adverse Event|4|||
149138554|NCT00283049|537988877|FG000|Overall Study|Protocol Violation|3|||
149138555|NCT00283049|537988878|FG001|Overall Study|Protocol Violation|0|||
149138556|NCT00283049|537988879|FG002|Overall Study|Protocol Violation|3|||
149138557|NCT00283049|537988877|FG000|Overall Study|Death|1|||
149138558|NCT00283049|537988878|FG001|Overall Study|Death|1|||
149138559|NCT00283049|537988879|FG002|Overall Study|Death|1|||
149138560|NCT00283049|537988877|FG000|Overall Study|Lack of Efficacy|0|||
149138561|NCT00283049|537988878|FG001|Overall Study|Lack of Efficacy|1|||
149138562|NCT00283049|537988879|FG002|Overall Study|Lack of Efficacy|1|||
149138563|NCT00283049|537988877|FG000|Overall Study|Lost to Follow-up|4|||
149138564|NCT00283049|537988878|FG001|Overall Study|Lost to Follow-up|2|||
149138565|NCT00283049|537988879|FG002|Overall Study|Lost to Follow-up|5|||
149138566|NCT00283049|537988877|FG000|Overall Study|Withdrawal by Subject|26|||
149138567|NCT00283049|537988878|FG001|Overall Study|Withdrawal by Subject|24|||
149138568|NCT00283049|537988879|FG002|Overall Study|Withdrawal by Subject|19|||
149138569|NCT00283049|537988877|FG000|Overall Study|Discontinuation of Study|18|||
149138570|NCT00283049|537988878|FG001|Overall Study|Discontinuation of Study|16|||
149138571|NCT00283049|537988879|FG002|Overall Study|Discontinuation of Study|20|||
149138572|NCT00283049|537988877|FG000|Overall Study|No longer requires study treatment|0|||
148907236|NCT00499083|537142221|FG000|Overall Study|Not evaluable|3|||
148907237|NCT01254422|537142222|FG000|Overall Study|Protocol Violation|1|||
148803370|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
148803371|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
148803372|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
148803373|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
148803374|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
148803375|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
148803376|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
148803377|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
148803378|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
148803379|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
148803380|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
148803381|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
148803382|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
148803383|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
148803384|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
148907238|NCT01254422|537142223|FG001|Overall Study|Protocol Violation|0|||
148907239|NCT01254422|537142222|FG000|Overall Study|Adverse Event|1|||
148907240|NCT01254422|537142223|FG001|Overall Study|Adverse Event|0|||
148907241|NCT01254422|537142222|FG000|Overall Study|Serious adverse event|0|||
148907242|NCT01254422|537142223|FG001|Overall Study|Serious adverse event|1|||
148907243|NCT01254422|537142222|FG000|Overall Study|Lost to Follow-up|1|||
148907244|NCT01254422|537142223|FG001|Overall Study|Lost to Follow-up|0|||
148907245|NCT00643162|537142224|FG000|Overall Study|Withdrawal by Subject|1|||
148907246|NCT00643162|537142225|FG001|Overall Study|Withdrawal by Subject|1|||
148907247|NCT02691507|537142229|FG000|Overall Study|Missed Visit 3|0|||
148907248|NCT02691507|537142230|FG001|Overall Study|Missed Visit 3|1|||
148907249|NCT00541385|537142232|FG000|Overall Study|Adverse Event|6|||
148907250|NCT00541385|537142233|FG001|Overall Study|Adverse Event|3|||
148907251|NCT00541385|537142232|FG000|Overall Study|Withdrawal by Subject|2|||
148907252|NCT00541385|537142233|FG001|Overall Study|Withdrawal by Subject|2|||
148907253|NCT00541385|537142232|FG000|Overall Study|Lost to Follow-up|6|||
148907254|NCT00541385|537142233|FG001|Overall Study|Lost to Follow-up|1|||
148907255|NCT00541385|537142232|FG000|Overall Study|Parasite reappearance/malaria|67|||
148907256|NCT00541385|537142233|FG001|Overall Study|Parasite reappearance/malaria|32|||
148907257|NCT01733680|537142234|FG000|Overall Study|Withdrawal by Subject|0|||
148907258|NCT01733680|537142235|FG001|Overall Study|Withdrawal by Subject|1|||
148907259|NCT01526733|537142236|FG000|Phase 1|Protocol Violation|1|||
148907260|NCT01526733|537142237|FG001|Phase 1|Protocol Violation|0|||
148907261|NCT01526733|537142236|FG000|Phase 1|Withdrawal by Subject|1|||
148907262|NCT01526733|537142237|FG001|Phase 1|Withdrawal by Subject|1|||
148907263|NCT02699749|537142242|FG000|Overall Study|Other|0|||
148907264|NCT02699749|537142243|FG001|Overall Study|Other|0|||
148907265|NCT02699749|537142244|FG002|Overall Study|Other|2|||
148907266|NCT02699749|537142245|FG003|Overall Study|Other|0|||
148907267|NCT02699749|537142246|FG004|Overall Study|Other|0|||
148907268|NCT02699749|537142247|FG005|Overall Study|Other|1|||
148907269|NCT02699749|537142248|FG006|Overall Study|Other|1|||
148907270|NCT02699749|537142249|FG007|Overall Study|Other|0|||
148907271|NCT02699749|537142250|FG008|Overall Study|Other|0|||
148907272|NCT02699749|537142251|FG009|Overall Study|Other|0|||
148907273|NCT02699749|537142252|FG010|Overall Study|Other|1|||
148907274|NCT02699749|537142253|FG011|Overall Study|Other|0|||
148907275|NCT02699749|537142254|FG012|Overall Study|Other|0|||
148907276|NCT02699749|537142255|FG013|Overall Study|Other|0|||
148907277|NCT02699749|537142242|FG000|Overall Study|Progressive Disease|3|||
148907278|NCT02699749|537142243|FG001|Overall Study|Progressive Disease|3|||
148907279|NCT02699749|537142244|FG002|Overall Study|Progressive Disease|14|||
148907280|NCT02699749|537142245|FG003|Overall Study|Progressive Disease|3|||
148907281|NCT02699749|537142246|FG004|Overall Study|Progressive Disease|3|||
148907282|NCT02699749|537142247|FG005|Overall Study|Progressive Disease|7|||
148907283|NCT02699749|537142248|FG006|Overall Study|Progressive Disease|5|||
148907284|NCT02699749|537142249|FG007|Overall Study|Progressive Disease|5|||
148907285|NCT02699749|537142250|FG008|Overall Study|Progressive Disease|6|||
148907286|NCT02699749|537142251|FG009|Overall Study|Progressive Disease|6|||
148907287|NCT02699749|537142252|FG010|Overall Study|Progressive Disease|5|||
148907288|NCT02699749|537142253|FG011|Overall Study|Progressive Disease|4|||
148907289|NCT02699749|537142254|FG012|Overall Study|Progressive Disease|3|||
148907290|NCT02699749|537142255|FG013|Overall Study|Progressive Disease|5|||
148907291|NCT02699749|537142242|FG000|Overall Study|Death|0|||
148907292|NCT02699749|537142243|FG001|Overall Study|Death|0|||
148907293|NCT02699749|537142244|FG002|Overall Study|Death|0|||
148907294|NCT02699749|537142245|FG003|Overall Study|Death|0|||
148907295|NCT02699749|537142246|FG004|Overall Study|Death|0|||
148907296|NCT02699749|537142247|FG005|Overall Study|Death|0|||
148907297|NCT02699749|537142248|FG006|Overall Study|Death|0|||
148907298|NCT02699749|537142249|FG007|Overall Study|Death|0|||
148907299|NCT02699749|537142250|FG008|Overall Study|Death|0|||
149138573|NCT00283049|537988878|FG001|Overall Study|No longer requires study treatment|0|||
149138574|NCT00283049|537988879|FG002|Overall Study|No longer requires study treatment|1|||
149138575|NCT01628107|537988880|FG000|Overall Study|Withdrawal by Subject|17|||
149138576|NCT01628107|537988880|FG000|Overall Study|Lost to Follow-up|4|||
149138577|NCT01628107|537988880|FG000|Overall Study|Adverse Event|33|||
149138578|NCT01628107|537988880|FG000|Overall Study|Physician Decision|2|||
149138579|NCT01628107|537988880|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
149138580|NCT01628107|537988880|FG000|Overall Study|Non-compliant with Study Procedures|10|||
149138581|NCT01628107|537988880|FG000|Overall Study|Not Treated|8|||
149138582|NCT01628107|537988880|FG000|Overall Study|Sponsor Decision|11|||
149138583|NCT01628107|537988880|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
149138584|NCT01628107|537988880|FG000|Overall Study|Relocated|8|||
149138585|NCT01628107|537988880|FG000|Overall Study|Kidney Transplant|9|||
149138586|NCT01628107|537988880|FG000|Overall Study|Use of Standard of Care|9|||
149138587|NCT00930722|537988881|FG000|Overall Study|Lost to Follow-up|16|||
149138588|NCT00930722|537988881|FG000|Overall Study|No longer willing to participate|9|||
149138589|NCT00930722|537988881|FG000|Overall Study|Study terminated by sponsor|2|||
149138590|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Adverse Event|2|||
149138591|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Adverse Event|2|||
148907300|NCT02699749|537142251|FG009|Overall Study|Death|0|||
148907301|NCT02699749|537142252|FG010|Overall Study|Death|0|||
148907302|NCT02699749|537142253|FG011|Overall Study|Death|0|||
148907303|NCT02699749|537142254|FG012|Overall Study|Death|0|||
148907304|NCT02699749|537142255|FG013|Overall Study|Death|1|||
148907305|NCT02699749|537142242|FG000|Overall Study|Lost to Follow-up|0|||
148907306|NCT02699749|537142243|FG001|Overall Study|Lost to Follow-up|0|||
148907307|NCT02699749|537142244|FG002|Overall Study|Lost to Follow-up|0|||
148907308|NCT02699749|537142245|FG003|Overall Study|Lost to Follow-up|0|||
148907309|NCT02699749|537142246|FG004|Overall Study|Lost to Follow-up|0|||
148907310|NCT02699749|537142247|FG005|Overall Study|Lost to Follow-up|1|||
148907311|NCT02699749|537142248|FG006|Overall Study|Lost to Follow-up|0|||
148907312|NCT02699749|537142249|FG007|Overall Study|Lost to Follow-up|1|||
148907313|NCT02699749|537142250|FG008|Overall Study|Lost to Follow-up|0|||
148803385|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
148803386|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
148803387|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
148803388|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
148803389|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
148803390|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
148803391|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
148803392|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
148803393|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
148803394|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
148803395|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
148803396|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
148803397|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
148907314|NCT02699749|537142251|FG009|Overall Study|Lost to Follow-up|0|||
148803398|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
148803399|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
148803400|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
148803401|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
148803402|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
148803403|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
148803404|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
148803405|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
148803406|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
148803407|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
148803408|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
148803409|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
148803410|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
148803411|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
148803412|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
148803413|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
148803414|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
148803415|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
148803416|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
148803417|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
148803418|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
148803419|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
148803420|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
148803421|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
148803422|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
148803423|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
148803424|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
148803425|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
148803426|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
148803427|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
148803428|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
148803429|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
148803430|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
148803431|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
148803432|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
148803433|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
148803434|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
148803435|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
148803436|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
148803437|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
148803438|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
148803439|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
148803440|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
148803441|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
148803442|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
148803443|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
148803444|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
148803445|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
148803446|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
148803447|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
148803448|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
148803449|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
148803450|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
148803451|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
148803452|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
148803453|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
148803454|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
148803455|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
148803456|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
148907315|NCT02699749|537142252|FG010|Overall Study|Lost to Follow-up|0|||
148907316|NCT02699749|537142253|FG011|Overall Study|Lost to Follow-up|0|||
148907317|NCT02699749|537142254|FG012|Overall Study|Lost to Follow-up|0|||
148907318|NCT02699749|537142255|FG013|Overall Study|Lost to Follow-up|0|||
148907319|NCT02377817|537142257|FG000|Overall Study|Transportation/childcare barriers.|2|||
148907320|NCT02377817|537142258|FG001|Overall Study|Transportation/childcare barriers.|0|||
148907321|NCT02377817|537142257|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
148907322|NCT02377817|537142258|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
148907323|NCT02839200|537142259|FG000|Overall Study|Withdrawal by Subject|2|||
148907324|NCT02839200|537142260|FG001|Overall Study|Withdrawal by Subject|0|||
148907325|NCT02839200|537142261|FG002|Overall Study|Withdrawal by Subject|1|||
148907326|NCT02839200|537142262|FG003|Overall Study|Withdrawal by Subject|0|||
148907327|NCT02839200|537142263|FG004|Overall Study|Withdrawal by Subject|0|||
148907328|NCT02839200|537142264|FG005|Overall Study|Withdrawal by Subject|1|||
148907329|NCT02839200|537142259|FG000|Overall Study|Lost to Follow-up|2|||
148907330|NCT02839200|537142260|FG001|Overall Study|Lost to Follow-up|0|||
148907331|NCT02839200|537142261|FG002|Overall Study|Lost to Follow-up|0|||
148907332|NCT02839200|537142262|FG003|Overall Study|Lost to Follow-up|0|||
148907333|NCT02839200|537142263|FG004|Overall Study|Lost to Follow-up|1|||
148907334|NCT02839200|537142264|FG005|Overall Study|Lost to Follow-up|0|||
148907335|NCT02839200|537142259|FG000|Overall Study|Adverse Event|0|||
148907336|NCT02839200|537142260|FG001|Overall Study|Adverse Event|0|||
148907337|NCT02839200|537142261|FG002|Overall Study|Adverse Event|0|||
148907338|NCT02839200|537142262|FG003|Overall Study|Adverse Event|0|||
148907339|NCT02839200|537142263|FG004|Overall Study|Adverse Event|1|||
148907340|NCT02839200|537142264|FG005|Overall Study|Adverse Event|0|||
148907341|NCT02839200|537142259|FG000|Overall Study|Randomized in error|0|||
148907342|NCT02839200|537142260|FG001|Overall Study|Randomized in error|1|||
148907343|NCT02839200|537142261|FG002|Overall Study|Randomized in error|0|||
148907344|NCT02839200|537142262|FG003|Overall Study|Randomized in error|0|||
148907345|NCT02839200|537142263|FG004|Overall Study|Randomized in error|0|||
148907346|NCT02839200|537142264|FG005|Overall Study|Randomized in error|0|||
148907347|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
148907348|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
148907349|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
148907350|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
148907351|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
148907352|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
148907353|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
148907354|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
148907355|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
148907356|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
148907357|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
148907358|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
148907359|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
148907360|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
148907361|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
148907362|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
148907363|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
148907364|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
148907365|NCT02952820|537142265|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
148907366|NCT02952820|537142266|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
148907367|NCT02952820|537142267|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
148907368|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
148907369|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
148907370|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
148907371|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
148907372|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
148907373|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
148907374|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
148907375|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
148907376|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
148907377|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
148907378|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
148907379|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
148907380|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
148907381|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
148907382|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
148907383|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
148907384|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
148907385|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
148907386|NCT02952820|537142265|FG000|Active Treatment Period (6 Months)|Not treated|0|||
148907387|NCT02952820|537142266|FG001|Active Treatment Period (6 Months)|Not treated|0|||
148907388|NCT02952820|537142267|FG002|Active Treatment Period (6 Months)|Not treated|1|||
148907389|NCT04139018|537142268|FG000|Overall Study|Screen fail|1|||
148907390|NCT04139018|537142269|FG001|Overall Study|Screen fail|0|||
148907391|NCT04139018|537142268|FG000|Overall Study|Withdrawal by Subject|2|||
148907392|NCT04139018|537142269|FG001|Overall Study|Withdrawal by Subject|0|||
148907393|NCT04139018|537142268|FG000|Overall Study|Lost to Follow-up|0|||
148907394|NCT04139018|537142269|FG001|Overall Study|Lost to Follow-up|1|||
148907395|NCT02565108|537142270|FG000|Overall Study|Adverse Event|1|||
148907396|NCT02565108|537142271|FG001|Overall Study|Adverse Event|0|||
148907397|NCT02565108|537142270|FG000|Overall Study|Withdrew Consent|1|||
148907398|NCT02565108|537142271|FG001|Overall Study|Withdrew Consent|0|||
148907399|NCT03614156|537142288|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
148907400|NCT03614156|537142289|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
148907401|NCT03614156|537142290|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
148907402|NCT03614156|537142291|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
148907403|NCT03614156|537142288|FG000|Open-Label Treatment Period|Adverse Event|7|||
148907404|NCT03614156|537142289|FG001|Open-Label Treatment Period|Adverse Event|0|||
148907405|NCT03614156|537142290|FG002|Open-Label Treatment Period|Adverse Event|0|||
148907406|NCT03614156|537142291|FG003|Open-Label Treatment Period|Adverse Event|0|||
148907407|NCT03614156|537142288|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
148907408|NCT03614156|537142289|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
148907409|NCT03614156|537142290|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
148907410|NCT03614156|537142291|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
148907411|NCT03614156|537142288|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
148907412|NCT03614156|537142289|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
148907413|NCT03614156|537142290|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
148907414|NCT03614156|537142291|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
148907415|NCT03614156|537142288|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
148907416|NCT03614156|537142289|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
148907417|NCT03614156|537142290|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
148907418|NCT03614156|537142291|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
148907419|NCT03614156|537142288|FG000|Open-Label Treatment Period|Protocol Violation|2|||
148907420|NCT03614156|537142289|FG001|Open-Label Treatment Period|Protocol Violation|0|||
148907421|NCT03614156|537142290|FG002|Open-Label Treatment Period|Protocol Violation|0|||
148907422|NCT03614156|537142291|FG003|Open-Label Treatment Period|Protocol Violation|0|||
148907423|NCT03614156|537142288|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
148907424|NCT03614156|537142289|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
148907425|NCT03614156|537142290|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
148907426|NCT03614156|537142291|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
148907427|NCT03614156|537142288|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
148907428|NCT03614156|537142289|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
148907429|NCT03614156|537142290|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
148907430|NCT03614156|537142291|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
148907431|NCT03614156|537142288|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
148907432|NCT03614156|537142289|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
148907433|NCT03614156|537142290|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
148907434|NCT03614156|537142291|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
148907435|NCT03614156|537142288|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
148907436|NCT03614156|537142289|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
148907437|NCT03614156|537142290|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
148907438|NCT03614156|537142291|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
148907439|NCT03614156|537142288|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148907440|NCT03614156|537142289|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
148907441|NCT03614156|537142290|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
148907442|NCT03614156|537142291|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
148907443|NCT03614156|537142288|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
148907444|NCT03614156|537142289|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
148907445|NCT03614156|537142290|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
148907446|NCT03614156|537142291|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
148907447|NCT03614156|537142288|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
148907448|NCT03614156|537142289|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
148907449|NCT03614156|537142290|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
148907450|NCT03614156|537142291|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
148907451|NCT03614156|537142288|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
148907452|NCT03614156|537142289|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
148907453|NCT03614156|537142290|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
148907454|NCT03614156|537142291|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
148907455|NCT03614156|537142288|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
148907456|NCT03614156|537142289|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
148907457|NCT03614156|537142290|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
148907458|NCT03614156|537142291|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
148907459|NCT03614156|537142288|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
148907460|NCT03614156|537142289|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
148907461|NCT03614156|537142290|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
148907462|NCT03614156|537142291|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
148907463|NCT03614156|537142288|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
148907464|NCT03614156|537142289|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
148907465|NCT03614156|537142290|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
148907466|NCT03614156|537142291|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
148907467|NCT01310075|537142292|FG000|Overall Study|Lost to Follow-up|1|||
148907468|NCT01310075|537142293|FG001|Overall Study|Lost to Follow-up|0|||
148907469|NCT01310075|537142292|FG000|Overall Study|Physician Decision|10|||
148907470|NCT01310075|537142293|FG001|Overall Study|Physician Decision|7|||
148907471|NCT01310075|537142292|FG000|Overall Study|Protocol Violation|2|||
148907472|NCT01310075|537142293|FG001|Overall Study|Protocol Violation|2|||
148907473|NCT01310075|537142292|FG000|Overall Study|Withdrawal by Subject|1|||
148907474|NCT01310075|537142293|FG001|Overall Study|Withdrawal by Subject|1|||
148907475|NCT01094119|537142295|FG000|Overall Study|Lack of Efficacy|2|||
148907476|NCT01094119|537142296|FG001|Overall Study|Lack of Efficacy|4|||
148907477|NCT01587924|537142297|FG000|Overall Study|Adverse Event|0|||
148907478|NCT01587924|537142298|FG001|Overall Study|Adverse Event|2|||
148907479|NCT01587924|537142299|FG002|Overall Study|Adverse Event|0|||
148907480|NCT01587924|537142300|FG003|Overall Study|Adverse Event|0|||
148907481|NCT01587924|537142297|FG000|Overall Study|Protocol Violation|2|||
148907482|NCT01587924|537142298|FG001|Overall Study|Protocol Violation|1|||
148907483|NCT01587924|537142299|FG002|Overall Study|Protocol Violation|2|||
148907484|NCT01587924|537142300|FG003|Overall Study|Protocol Violation|1|||
148907485|NCT01587924|537142297|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
148907486|NCT01587924|537142298|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
148907487|NCT01587924|537142299|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
148907488|NCT01587924|537142300|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
148907489|NCT01587924|537142297|FG000|Overall Study|Withdrawal by Subject|0|||
148907490|NCT01587924|537142298|FG001|Overall Study|Withdrawal by Subject|1|||
148907491|NCT01587924|537142299|FG002|Overall Study|Withdrawal by Subject|1|||
148907492|NCT01587924|537142300|FG003|Overall Study|Withdrawal by Subject|0|||
148907493|NCT01696188|537142301|FG000|Overall Study|Protocol Violation|1|||
148907494|NCT01696188|537142302|FG001|Overall Study|Protocol Violation|1|||
148907495|NCT02668393|537142303|FG000|Overall Study|Progressive disease|6|||
148907496|NCT02668393|537142304|FG001|Overall Study|Progressive disease|3|||
148907497|NCT02668393|537142303|FG000|Overall Study|Adverse Event|0|||
148907498|NCT02668393|537142304|FG001|Overall Study|Adverse Event|2|||
148907499|NCT02668393|537142303|FG000|Overall Study|Withdrawal from the trial|0|||
148907500|NCT02668393|537142304|FG001|Overall Study|Withdrawal from the trial|1|||
148907501|NCT02668393|537142303|FG000|Overall Study|Lack of benefit and side effects|1|||
148907502|NCT02668393|537142304|FG001|Overall Study|Lack of benefit and side effects|0|||
148907503|NCT00606593|537142305|FG000|Overall Study|Adverse Event|0|||
148907504|NCT00606593|537142306|FG001|Overall Study|Adverse Event|0|||
148907505|NCT00606593|537142307|FG002|Overall Study|Adverse Event|0|||
148907506|NCT00606593|537142308|FG003|Overall Study|Adverse Event|1|||
148907507|NCT00606593|537142309|FG004|Overall Study|Adverse Event|1|||
148907508|NCT00606593|537142310|FG005|Overall Study|Adverse Event|0|||
148907509|NCT00606593|537142311|FG006|Overall Study|Adverse Event|1|||
148907510|NCT00606593|537142312|FG007|Overall Study|Adverse Event|2|||
148907511|NCT00606593|537142313|FG008|Overall Study|Adverse Event|1|||
148907512|NCT00606593|537142314|FG009|Overall Study|Adverse Event|0|||
148907513|NCT00606593|537142305|FG000|Overall Study|Withdrawal of consent|1|||
148907514|NCT00606593|537142306|FG001|Overall Study|Withdrawal of consent|0|||
148803457|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
148803458|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
148803459|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
148803460|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
148803461|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
148803462|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
148803463|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
148803464|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
148803465|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
148907515|NCT00606593|537142307|FG002|Overall Study|Withdrawal of consent|1|||
148907516|NCT00606593|537142308|FG003|Overall Study|Withdrawal of consent|0|||
148907517|NCT00606593|537142309|FG004|Overall Study|Withdrawal of consent|0|||
148907518|NCT00606593|537142310|FG005|Overall Study|Withdrawal of consent|0|||
148907519|NCT00606593|537142311|FG006|Overall Study|Withdrawal of consent|0|||
148907520|NCT00606593|537142312|FG007|Overall Study|Withdrawal of consent|0|||
148907521|NCT00606593|537142313|FG008|Overall Study|Withdrawal of consent|0|||
148907522|NCT00606593|537142314|FG009|Overall Study|Withdrawal of consent|0|||
148907523|NCT00606593|537142305|FG000|Overall Study|Administrative/Other|0|||
148907524|NCT00606593|537142306|FG001|Overall Study|Administrative/Other|0|||
148907525|NCT00606593|537142307|FG002|Overall Study|Administrative/Other|1|||
148907526|NCT00606593|537142308|FG003|Overall Study|Administrative/Other|0|||
148907527|NCT00606593|537142309|FG004|Overall Study|Administrative/Other|0|||
148907528|NCT00606593|537142310|FG005|Overall Study|Administrative/Other|0|||
148907529|NCT00606593|537142311|FG006|Overall Study|Administrative/Other|0|||
148907530|NCT00606593|537142312|FG007|Overall Study|Administrative/Other|0|||
148907531|NCT00606593|537142313|FG008|Overall Study|Administrative/Other|0|||
148907532|NCT00606593|537142314|FG009|Overall Study|Administrative/Other|0|||
148907533|NCT03181529|537142315|FG000|Overall Study|Withdrawal by Subject|1|||
148907534|NCT03181529|537142316|FG001|Overall Study|Withdrawal by Subject|1|||
148907535|NCT03181529|537142315|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
148907536|NCT03181529|537142316|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
148907537|NCT03848728|537142317|FG000|Overall Study|Death|16|||
148907538|NCT03848728|537142318|FG001|Overall Study|Death|13|||
148907539|NCT03848728|537142317|FG000|Overall Study|Outmigrated to non-study community|98|||
148907540|NCT03848728|537142318|FG001|Overall Study|Outmigrated to non-study community|106|||
148907541|NCT03848728|537142317|FG000|Overall Study|Transfered to non-study clinic|32|||
148907542|NCT03848728|537142318|FG001|Overall Study|Transfered to non-study clinic|48|||
148907543|NCT03848728|537142317|FG000|Overall Study|Withdrawal by Subject|1|||
148907544|NCT03848728|537142318|FG001|Overall Study|Withdrawal by Subject|0|||
148907545|NCT00536744|537142321|FG000|Overall Study|Adverse Event|13|||
148907546|NCT00536744|537142322|FG001|Overall Study|Adverse Event|10|||
148907547|NCT00536744|537142321|FG000|Overall Study|Death|2|||
148907548|NCT00536744|537142322|FG001|Overall Study|Death|1|||
148907549|NCT00536744|537142321|FG000|Overall Study|Physician Decision|3|||
148907550|NCT00536744|537142322|FG001|Overall Study|Physician Decision|1|||
148907551|NCT00536744|537142321|FG000|Overall Study|Lost to Follow-up|3|||
148907552|NCT00536744|537142322|FG001|Overall Study|Lost to Follow-up|5|||
148907553|NCT00536744|537142321|FG000|Overall Study|Withdrawal by Subject|7|||
148907554|NCT00536744|537142322|FG001|Overall Study|Withdrawal by Subject|8|||
148907555|NCT00536744|537142321|FG000|Overall Study|PI tried alternative treatment|1|||
148907556|NCT00536744|537142322|FG001|Overall Study|PI tried alternative treatment|3|||
148907557|NCT02581410|537142323|FG000|Vaccination Phase|Adverse Event|2|||
148907558|NCT02581410|537142324|FG001|Vaccination Phase|Adverse Event|1|||
148907559|NCT02581410|537142323|FG000|Vaccination Phase|Withdrawal by Subject|0|||
148907560|NCT02581410|537142324|FG001|Vaccination Phase|Withdrawal by Subject|1|||
148907561|NCT02581410|537142323|FG000|Vaccination Phase|Migrated/moved from study area|0|||
148907562|NCT02581410|537142324|FG001|Vaccination Phase|Migrated/moved from study area|1|||
148907563|NCT02581410|537142323|FG000|End of Study Phase|Adverse Event|4|||
148907564|NCT02581410|537142324|FG001|End of Study Phase|Adverse Event|3|||
148907565|NCT02581410|537142323|FG000|End of Study Phase|Withdrawal by Subject|1|||
148907566|NCT02581410|537142324|FG001|End of Study Phase|Withdrawal by Subject|2|||
148907567|NCT02581410|537142323|FG000|End of Study Phase|Migrated/moved from study area|0|||
148907568|NCT02581410|537142324|FG001|End of Study Phase|Migrated/moved from study area|3|||
148907569|NCT02581410|537142323|FG000|End of Study Phase|Lost to Follow-up|0|||
148907570|NCT02581410|537142324|FG001|End of Study Phase|Lost to Follow-up|2|||
148907571|NCT02581410|537142323|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
148907572|NCT02581410|537142324|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
148907573|NCT02876601|537142325|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
148907574|NCT02876601|537142326|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
148907575|NCT02876601|537142327|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
148907576|NCT02876601|537142328|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
148907577|NCT04774094|537142329|FG000|Overall Study|Other|2|||
148907578|NCT04774094|537142329|FG000|Overall Study|Withdrawal by Subject|9|||
148907579|NCT04774094|537142329|FG000|Overall Study|Lost to Follow-up|7|||
148907580|NCT04774094|537142329|FG000|Overall Study|Lack of Efficacy|5|||
148907581|NCT04774094|537142329|FG000|Overall Study|Death|17|||
148907582|NCT04774094|537142329|FG000|Overall Study|Adverse Event|4|||
148907583|NCT05232682|537142332|FG000|Overall Study|Lost to Follow-up|2|||
148907584|NCT02605122|537143567|FG000|Overall Study|Withdrawal by Subject|4|||
149138592|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Adverse Event|4|||
149138593|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Adverse Event|0|||
149138594|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Adverse Event|0|||
149138595|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Progressive disease|0|||
148907585|NCT02605122|537143568|FG001|Overall Study|Withdrawal by Subject|1|||
148907586|NCT02605122|537143567|FG000|Overall Study|Lost to Follow-up|1|||
148907587|NCT02605122|537143568|FG001|Overall Study|Lost to Follow-up|1|||
148907588|NCT03751657|537143569|FG000|Overall Study|Physician Decision|0|||
148907589|NCT03751657|537143570|FG001|Overall Study|Physician Decision|1|||
148907590|NCT03751657|537143569|FG000|Overall Study|Withdrawal by Subject|1|||
148907591|NCT03751657|537143570|FG001|Overall Study|Withdrawal by Subject|1|||
148907592|NCT03751657|537143569|FG000|Overall Study|Lost to Follow-up|2|||
148907593|NCT03751657|537143570|FG001|Overall Study|Lost to Follow-up|1|||
148907594|NCT02139592|537143572|FG000|Overall Study|Case Report Forms Uncollected|8|||
148907595|NCT00742235|537143576|FG000|Overall Study|Lost to Follow-up|0|||
148907596|NCT00742235|537143577|FG001|Overall Study|Lost to Follow-up|31|||
148907597|NCT00433004|537143578|FG000|Overall Study|Lost to Follow-up|5|||
148907598|NCT00433004|537143579|FG001|Overall Study|Lost to Follow-up|7|||
148907599|NCT05661409|537143580|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
148907600|NCT05661409|537143581|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
148907601|NCT05661409|537143582|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
148907602|NCT05661409|537143583|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
148907603|NCT05661409|537143584|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
148907604|NCT05661409|537143585|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
148907605|NCT05661409|537143580|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
148907606|NCT05661409|537143581|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
148907607|NCT05661409|537143582|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
148907608|NCT05661409|537143583|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
148907609|NCT05661409|537143584|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
148907610|NCT05661409|537143585|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
148907611|NCT05661409|537143580|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
148907612|NCT05661409|537143581|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
148907613|NCT05661409|537143582|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
148907614|NCT05661409|537143583|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
148907615|NCT05661409|537143584|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
148907616|NCT05661409|537143585|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
148907617|NCT05661409|537143580|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
148907618|NCT05661409|537143581|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
148907619|NCT05661409|537143582|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
148907620|NCT05661409|537143583|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
148907621|NCT05661409|537143584|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
148907622|NCT05661409|537143585|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
148907623|NCT05661409|537143580|FG000|Overall Study|Miscommu-nication about administration|0|||
148907624|NCT05661409|537143581|FG001|Overall Study|Miscommu-nication about administration|0|||
148907625|NCT05661409|537143582|FG002|Overall Study|Miscommu-nication about administration|0|||
148907626|NCT05661409|537143583|FG003|Overall Study|Miscommu-nication about administration|0|||
148907627|NCT05661409|537143584|FG004|Overall Study|Miscommu-nication about administration|0|||
148907628|NCT05661409|537143585|FG005|Overall Study|Miscommu-nication about administration|1|||
148907629|NCT04730271|537143586|FG000|Overall Study|Adverse Event|0|||
148907630|NCT04730271|537143587|FG001|Overall Study|Adverse Event|2|||
148907631|NCT04730271|537143586|FG000|Overall Study|Withdrawal by Subject|1|||
148907632|NCT04730271|537143587|FG001|Overall Study|Withdrawal by Subject|1|||
148907633|NCT04730271|537143586|FG000|Overall Study|Protocol Violation|7|||
148907634|NCT04730271|537143587|FG001|Overall Study|Protocol Violation|13|||
148907635|NCT04730271|537143586|FG000|Overall Study|Lost to Follow-up|3|||
148907636|NCT04730271|537143587|FG001|Overall Study|Lost to Follow-up|3|||
148907637|NCT04730271|537143586|FG000|Overall Study|Death|1|||
148907638|NCT04730271|537143587|FG001|Overall Study|Death|0|||
148907639|NCT02223858|537143590|FG000|Overall Study|Death|1|||
148907640|NCT02223858|537143591|FG001|Overall Study|Death|1|||
148907641|NCT02223858|537143590|FG000|Overall Study|Lost to Follow-up|6|||
148907642|NCT02223858|537143591|FG001|Overall Study|Lost to Follow-up|11|||
148907643|NCT02223858|537143590|FG000|Overall Study|Withdrawal by Subject|8|||
148907644|NCT02223858|537143591|FG001|Overall Study|Withdrawal by Subject|5|||
148907645|NCT02223858|537143590|FG000|Overall Study|Refused|9|||
148907646|NCT02223858|537143591|FG001|Overall Study|Refused|9|||
148907647|NCT03198507|537143592|FG000|Overall Study|Withdrawal by Subject|1|||
148907648|NCT03198507|537143593|FG001|Overall Study|Withdrawal by Subject|0|||
148907649|NCT00831181|537143598|FG000|Overall Study|Adverse Event|12|||
148907650|NCT02863419|537143599|FG000|Overall Study|Lost to Follow-up|0|||
148907651|NCT02863419|537143600|FG001|Overall Study|Lost to Follow-up|1|||
148907652|NCT02863419|537143601|FG002|Overall Study|Lost to Follow-up|4|||
148907653|NCT02863419|537143599|FG000|Overall Study|Withdrawal by Subject|5|||
148907654|NCT02863419|537143600|FG001|Overall Study|Withdrawal by Subject|5|||
148907655|NCT02863419|537143601|FG002|Overall Study|Withdrawal by Subject|3|||
148907656|NCT02863419|537143599|FG000|Overall Study|Died|3|||
148907657|NCT02863419|537143600|FG001|Overall Study|Died|4|||
148907658|NCT02863419|537143601|FG002|Overall Study|Died|1|||
148803466|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
148803467|NCT02717195|536761075|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
148803468|NCT02717195|536761076|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
148803469|NCT02717195|536761077|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
148907659|NCT02362282|537143602|FG000|Overall Study|Withdrawal by Subject|1|||
148907660|NCT02362282|537143603|FG001|Overall Study|Withdrawal by Subject|0|||
148907661|NCT00473382|537143610|FG000|Core Study|Adverse Event|3|||
148907662|NCT00473382|537143611|FG001|Core Study|Adverse Event|1|||
148907663|NCT00473382|537143612|FG002|Core Study|Adverse Event|1|||
148907664|NCT00473382|537143610|FG000|Core Study|Death|3|||
148907665|NCT00473382|537143611|FG001|Core Study|Death|5|||
148907666|NCT00473382|537143612|FG002|Core Study|Death|10|||
148907667|NCT00473382|537143610|FG000|Core Study|Lost to Follow-up|3|||
148907668|NCT00473382|537143611|FG001|Core Study|Lost to Follow-up|3|||
148907669|NCT00473382|537143612|FG002|Core Study|Lost to Follow-up|3|||
148907670|NCT00473382|537143610|FG000|Core Study|Physician Decision|1|||
148907671|NCT00473382|537143611|FG001|Core Study|Physician Decision|2|||
148907672|NCT00473382|537143612|FG002|Core Study|Physician Decision|2|||
148907673|NCT00473382|537143610|FG000|Core Study|Subject non-compliance|5|||
148907674|NCT00473382|537143611|FG001|Core Study|Subject non-compliance|2|||
148907675|NCT00473382|537143612|FG002|Core Study|Subject non-compliance|1|||
148907676|NCT00473382|537143610|FG000|Core Study|Subject needed other treatment|1|||
148907677|NCT00473382|537143611|FG001|Core Study|Subject needed other treatment|3|||
148907678|NCT00473382|537143612|FG002|Core Study|Subject needed other treatment|2|||
148907679|NCT00473382|537143610|FG000|Core Study|Subject's decision|12|||
148907680|NCT00473382|537143611|FG001|Core Study|Subject's decision|11|||
148907681|NCT00473382|537143612|FG002|Core Study|Subject's decision|10|||
148907682|NCT00473382|537143610|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
148907683|NCT00473382|537143611|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
148907684|NCT00473382|537143612|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
148907685|NCT00473382|537143610|FG000|Open-label Extension Through Month 48|Death|1|||
148907686|NCT00473382|537143611|FG001|Open-label Extension Through Month 48|Death|3|||
148907687|NCT00473382|537143612|FG002|Open-label Extension Through Month 48|Death|3|||
148907688|NCT00473382|537143610|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
148907689|NCT00473382|537143611|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
148907690|NCT00473382|537143612|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
148907691|NCT00473382|537143610|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
148907692|NCT00473382|537143611|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
148907693|NCT00473382|537143612|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
148907694|NCT00473382|537143610|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
148907695|NCT00473382|537143611|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
148907696|NCT00473382|537143612|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
148907697|NCT00473382|537143610|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
148907698|NCT00473382|537143611|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
148907699|NCT00473382|537143612|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
148907700|NCT00473382|537143610|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
148907701|NCT00473382|537143611|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
148907702|NCT00473382|537143612|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
148907703|NCT00473382|537143610|FG000|Open-label Extension Through Month 60|Death|1|||
148907704|NCT00473382|537143611|FG001|Open-label Extension Through Month 60|Death|7|||
148907705|NCT00473382|537143612|FG002|Open-label Extension Through Month 60|Death|4|||
148907706|NCT00473382|537143610|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
148907707|NCT00473382|537143611|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
148907708|NCT00473382|537143612|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
148907709|NCT00473382|537143610|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
148907710|NCT00473382|537143611|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
148907711|NCT00473382|537143612|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
148907712|NCT00473382|537143610|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
148907713|NCT00473382|537143611|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
148907714|NCT00473382|537143612|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
148907715|NCT00473382|537143610|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
148907716|NCT00473382|537143611|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
148907717|NCT00473382|537143612|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
148907718|NCT00686686|537143613|FG000|Overall Study|Non-compliance|1|||
148907719|NCT00686686|537143613|FG000|Overall Study|Adverse Event|2|||
148907720|NCT00686686|537143613|FG000|Overall Study|Lost to Follow-up|3|||
148907721|NCT01012440|537143614|FG000|Overall Study|Withdrawal by Subject|2|||
148907722|NCT00131248|537143616|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
148907723|NCT00131248|537143617|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
148907724|NCT00477386|537143625|FG000|Overall Study|Adverse Event|4|||
148907725|NCT00477386|537143626|FG001|Overall Study|Adverse Event|8|||
148907726|NCT00477386|537143625|FG000|Overall Study|Disease progression, relapse|3|||
148907727|NCT00477386|537143626|FG001|Overall Study|Disease progression, relapse|4|||
148907728|NCT00477386|537143625|FG000|Overall Study|Disease progression, refractory|1|||
148803470|NCT02717195|536761078|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
148803471|NCT02717195|536761079|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
148803472|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
148803473|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
148803474|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
148803475|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
148803476|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
148907729|NCT00477386|537143626|FG001|Overall Study|Disease progression, refractory|3|||
148907730|NCT00477386|537143625|FG000|Overall Study|Other|1|||
148907731|NCT00477386|537143626|FG001|Overall Study|Other|2|||
148907732|NCT00477386|537143625|FG000|Overall Study|Physician Decision|1|||
148907733|NCT00477386|537143626|FG001|Overall Study|Physician Decision|0|||
148907734|NCT00477386|537143625|FG000|Overall Study|Withdrawal by Subject|1|||
148907735|NCT00477386|537143626|FG001|Overall Study|Withdrawal by Subject|0|||
148907736|NCT02207088|537143627|FG000|Overall Study|Adverse Event|2|||
148907737|NCT03023397|537143628|FG000|Run-In|Failed screening allergen challenge|1|||
148907738|NCT03023397|537143629|FG001|Run-In|Failed screening allergen challenge|0|||
148907739|NCT03023397|537143630|FG002|Run-In|Failed screening allergen challenge|0|||
148907740|NCT03023397|537143628|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
148907741|NCT03023397|537143629|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
148907742|NCT03023397|537143630|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
148907743|NCT02284243|537143636|FG000|Overall Study|Lack of Efficacy|3|||
148907744|NCT02284243|537143637|FG001|Overall Study|Lack of Efficacy|3|||
148907745|NCT02284243|537143636|FG000|Overall Study|Adverse Event|1|||
148907746|NCT02284243|537143637|FG001|Overall Study|Adverse Event|0|||
148907747|NCT01932437|537143640|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
148907748|NCT01932437|537143641|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
148907749|NCT01932437|537143642|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
148907750|NCT01932437|537143643|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
148907751|NCT01932437|537143644|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
148907752|NCT01932437|537143645|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
148907753|NCT00074490|537143646|FG000|Overall Study|Progressive malignancy|0|||
148907754|NCT00074490|537143647|FG001|Overall Study|Progressive malignancy|7|||
148907755|NCT00074490|537143648|FG002|Overall Study|Progressive malignancy|0|||
148907756|NCT00074490|537143649|FG003|Overall Study|Progressive malignancy|0|||
148907757|NCT00074490|537143650|FG004|Overall Study|Progressive malignancy|3|||
148907758|NCT00074490|537143651|FG005|Overall Study|Progressive malignancy|0|||
148907759|NCT04269889|537143655|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
148907760|NCT03155841|537143656|FG000|Overall Study|Protocol Violation|3|||
148907761|NCT03155841|537143657|FG001|Overall Study|Protocol Violation|4|||
148907762|NCT03070964|537143660|FG000|Overall Study|Progressive disease|8|||
148907763|NCT03070964|537143660|FG000|Overall Study|Treatment-unrelated adverse event|2|||
148907764|NCT03070964|537143660|FG000|Overall Study|Never treated|1|||
148907765|NCT03070964|537143660|FG000|Overall Study|Physician Decision|1|||
148907766|NCT03070964|537143660|FG000|Overall Study|Withdrawal by Subject|1|||
148907767|NCT03070964|537143660|FG000|Overall Study|Adverse Event|1|||
148907768|NCT00787644|537143661|FG000|Overall Study|Lost to Follow-up|1|||
148907769|NCT00787644|537143662|FG001|Overall Study|Lost to Follow-up|1|||
148907770|NCT00787644|537143661|FG000|Overall Study|Withdrawal by Subject|1|||
148907771|NCT00787644|537143662|FG001|Overall Study|Withdrawal by Subject|1|||
148907772|NCT01642589|537143666|FG000|Overall Study|Withdrawal by Subject|1|||
148907773|NCT01642589|537143667|FG001|Overall Study|Withdrawal by Subject|1|||
148907774|NCT01108185|537143672|FG000|Overall Study|Non-compliance|15|||
148907775|NCT01108185|537143672|FG000|Overall Study|Lost to Follow-up|12|||
148907776|NCT02908672|537143675|FG000|Run-in Period|Death|12|||
148907777|NCT02908672|537143676|FG001|Run-in Period|Death|10|||
148907778|NCT02908672|537143677|FG002|Run-in Period|Death|0|||
148907779|NCT02908672|537143678|FG003|Run-in Period|Death|0|||
148907780|NCT02908672|537143675|FG000|Run-in Period|Lost to Follow-up|1|||
148907781|NCT02908672|537143676|FG001|Run-in Period|Lost to Follow-up|1|||
148907782|NCT02908672|537143677|FG002|Run-in Period|Lost to Follow-up|0|||
148907783|NCT02908672|537143678|FG003|Run-in Period|Lost to Follow-up|0|||
148907784|NCT02908672|537143675|FG000|Run-in Period|Reason Not Specified|2|||
148907785|NCT02908672|537143676|FG001|Run-in Period|Reason Not Specified|0|||
148907786|NCT02908672|537143677|FG002|Run-in Period|Reason Not Specified|0|||
148907787|NCT02908672|537143678|FG003|Run-in Period|Reason Not Specified|0|||
148907788|NCT02908672|537143675|FG000|Run-in Period|Protocol Violation|1|||
148907789|NCT02908672|537143676|FG001|Run-in Period|Protocol Violation|1|||
148907790|NCT02908672|537143677|FG002|Run-in Period|Protocol Violation|0|||
148907791|NCT02908672|537143678|FG003|Run-in Period|Protocol Violation|0|||
148907792|NCT02908672|537143675|FG000|Run-in Period|Study Ended by Sponsor|5|||
148907793|NCT02908672|537143676|FG001|Run-in Period|Study Ended by Sponsor|1|||
148907794|NCT02908672|537143677|FG002|Run-in Period|Study Ended by Sponsor|0|||
148907795|NCT02908672|537143678|FG003|Run-in Period|Study Ended by Sponsor|0|||
148907796|NCT02908672|537143675|FG000|Run-in Period|Withdrawal by Subject|3|||
148907797|NCT02908672|537143676|FG001|Run-in Period|Withdrawal by Subject|9|||
148907798|NCT02908672|537143677|FG002|Run-in Period|Withdrawal by Subject|0|||
148907799|NCT02908672|537143678|FG003|Run-in Period|Withdrawal by Subject|0|||
148907800|NCT02908672|537143675|FG000|Triple Combination Period|Death|0|||
148907801|NCT02908672|537143676|FG001|Triple Combination Period|Death|0|||
148907802|NCT02908672|537143677|FG002|Triple Combination Period|Death|150|||
148907803|NCT02908672|537143678|FG003|Triple Combination Period|Death|127|||
148907804|NCT02908672|537143675|FG000|Triple Combination Period|Lost to Follow-up|0|||
148907805|NCT02908672|537143676|FG001|Triple Combination Period|Lost to Follow-up|0|||
148907806|NCT02908672|537143677|FG002|Triple Combination Period|Lost to Follow-up|6|||
148907807|NCT02908672|537143678|FG003|Triple Combination Period|Lost to Follow-up|8|||
148907808|NCT02908672|537143675|FG000|Triple Combination Period|Reason Not Specified|0|||
148907809|NCT02908672|537143676|FG001|Triple Combination Period|Reason Not Specified|0|||
148907810|NCT02908672|537143677|FG002|Triple Combination Period|Reason Not Specified|0|||
148907811|NCT02908672|537143678|FG003|Triple Combination Period|Reason Not Specified|1|||
148907812|NCT02908672|537143675|FG000|Triple Combination Period|Physician Decision|0|||
148907813|NCT02908672|537143676|FG001|Triple Combination Period|Physician Decision|0|||
148907814|NCT02908672|537143677|FG002|Triple Combination Period|Physician Decision|1|||
148803477|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
148803478|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
148803479|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
148803480|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
148803481|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
148803482|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
148803483|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
148803484|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
148803485|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
148803486|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
148803487|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
148803488|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
148803489|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
148803490|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
148803491|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
148803492|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
148803493|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
148803494|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
148803495|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
148803496|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
148803497|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
148803498|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
148803499|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
148803500|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
148907815|NCT02908672|537143678|FG003|Triple Combination Period|Physician Decision|1|||
148907816|NCT02908672|537143675|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
148907817|NCT02908672|537143676|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
148907818|NCT02908672|537143677|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
148907819|NCT02908672|537143678|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
148907820|NCT02908672|537143675|FG000|Triple Combination Period|Withdrawal by Subject|0|||
148907821|NCT02908672|537143676|FG001|Triple Combination Period|Withdrawal by Subject|0|||
148907822|NCT02908672|537143677|FG002|Triple Combination Period|Withdrawal by Subject|13|||
148907823|NCT02908672|537143678|FG003|Triple Combination Period|Withdrawal by Subject|16|||
148907824|NCT01185080|537143682|FG000|Overall Study|Adverse Event|1|||
148907825|NCT01185080|537143683|FG001|Overall Study|Adverse Event|1|||
148907826|NCT01185080|537143684|FG002|Overall Study|Adverse Event|0|||
148907827|NCT01185080|537143682|FG000|Overall Study|Personal reasons|0|||
148907828|NCT01185080|537143683|FG001|Overall Study|Personal reasons|0|||
148907829|NCT01185080|537143684|FG002|Overall Study|Personal reasons|1|||
148907830|NCT00759941|537143685|FG000|Overall Study|Use of medication|1|||
148907831|NCT00759941|537143686|FG001|Overall Study|Use of medication|0|||
148907832|NCT00759941|537143685|FG000|Overall Study|Adverse Event|1|||
148907833|NCT00759941|537143686|FG001|Overall Study|Adverse Event|0|||
148907834|NCT00759941|537143685|FG000|Overall Study|Exited in error by site|1|||
148907835|NCT00759941|537143686|FG001|Overall Study|Exited in error by site|1|||
148907836|NCT05615922|537143690|FG000|Overall Study|Lost to Follow-up|1|||
148907837|NCT06083506|537143691|FG000|Overall Study|Physician Decision|2|||
148907838|NCT06083506|537143691|FG000|Overall Study|Lack of Efficacy|1|||
148907839|NCT05307692|537143693|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
148907840|NCT05307692|537143694|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
148907841|NCT05307692|537143695|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
148907842|NCT05307692|537143696|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
148907843|NCT05307692|537143693|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
148907844|NCT05307692|537143694|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
148907845|NCT05307692|537143695|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
148907846|NCT05307692|537143696|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
148907847|NCT05307692|537143693|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
148907848|NCT05307692|537143694|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
148907849|NCT05307692|537143695|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
148907850|NCT05307692|537143696|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
148907851|NCT05307692|537143693|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
148907852|NCT05307692|537143694|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
148907853|NCT05307692|537143695|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
148907854|NCT05307692|537143696|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
148907855|NCT05307692|537143693|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
148907856|NCT05307692|537143694|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
148907857|NCT05307692|537143695|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
148907858|NCT05307692|537143696|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
148907859|NCT05307692|537143693|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
148907860|NCT05307692|537143694|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
148907861|NCT05307692|537143695|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
148907862|NCT05307692|537143696|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
148907863|NCT05307692|537143693|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
148907864|NCT05307692|537143694|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
148907865|NCT05307692|537143695|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
148907866|NCT05307692|537143696|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
148907867|NCT05307692|537143693|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
148907868|NCT05307692|537143694|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
148907869|NCT05307692|537143695|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
148907870|NCT05307692|537143696|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
148907871|NCT04500158|537143697|FG000|Overall Study|Physician Decision|17|||
148907872|NCT04500158|537143698|FG001|Overall Study|Physician Decision|11|||
148907873|NCT01967238|537143699|FG000|Overall Study|Adverse Event|1|||
148907874|NCT01967238|537143700|FG001|Overall Study|Adverse Event|1|||
148907875|NCT01967238|537143701|FG002|Overall Study|Adverse Event|0|||
148907876|NCT01967238|537143699|FG000|Overall Study|Lost to Follow-up|1|||
148907877|NCT01967238|537143700|FG001|Overall Study|Lost to Follow-up|0|||
148907878|NCT01967238|537143701|FG002|Overall Study|Lost to Follow-up|1|||
148907879|NCT01967238|537143699|FG000|Overall Study|Withdrawal by Subject|0|||
148907880|NCT01967238|537143700|FG001|Overall Study|Withdrawal by Subject|0|||
148907881|NCT01967238|537143701|FG002|Overall Study|Withdrawal by Subject|1|||
148907882|NCT01442103|537144880|FG000|Overall Study|Lost to Follow-up|2|||
148907883|NCT00807001|537144888|FG000|Overall Study|Non-compliance|0|||
148907884|NCT00807001|537144889|FG001|Overall Study|Non-compliance|1|||
148907885|NCT00807001|537144890|FG002|Overall Study|Non-compliance|0|||
148907886|NCT00807001|537144891|FG003|Overall Study|Non-compliance|0|||
148907887|NCT00807001|537144892|FG004|Overall Study|Non-compliance|0|||
148907888|NCT00001213|537144907|FG000|Overall Study|Death|18|||
148907889|NCT01499277|537144910|FG000|Overall Study|Adverse Event|3|||
148907890|NCT01499277|537144911|FG001|Overall Study|Adverse Event|6|||
148907891|NCT01499277|537144910|FG000|Overall Study|Death|3|||
148907892|NCT01499277|537144911|FG001|Overall Study|Death|2|||
148907893|NCT01499277|537144910|FG000|Overall Study|Lost to Follow-up|15|||
148907894|NCT01499277|537144911|FG001|Overall Study|Lost to Follow-up|8|||
148907895|NCT01499277|537144910|FG000|Overall Study|Protocol Violation|2|||
148907896|NCT01499277|537144911|FG001|Overall Study|Protocol Violation|3|||
148907897|NCT01499277|537144910|FG000|Overall Study|Withdrawal by Subject|16|||
148907898|NCT01499277|537144911|FG001|Overall Study|Withdrawal by Subject|6|||
148907899|NCT01499277|537144910|FG000|Overall Study|Lack of therapeutic response and other|8|||
148907900|NCT01499277|537144911|FG001|Overall Study|Lack of therapeutic response and other|7|||
148907901|NCT02015637|537144916|FG000|Overall Study|Lost to Follow-up|3|||
148907902|NCT02015637|537144917|FG001|Overall Study|Lost to Follow-up|5|||
148907903|NCT02015637|537144916|FG000|Overall Study|Adverse Event|3|||
148907904|NCT02015637|537144917|FG001|Overall Study|Adverse Event|0|||
148907905|NCT02015637|537144916|FG000|Overall Study|Did not take study drug|2|||
148907906|NCT02015637|537144917|FG001|Overall Study|Did not take study drug|0|||
148907907|NCT01869764|537144920|FG000|Overall Study|Withdrawal by Subject|0|||
148907908|NCT01869764|537144921|FG001|Overall Study|Withdrawal by Subject|2|||
148907909|NCT01286480|537144922|FG000|Overall Study|Withdrawal by Subject|5|||
148907910|NCT01286480|537144923|FG001|Overall Study|Withdrawal by Subject|3|||
148907911|NCT00834093|537144924|FG000|Overall Study|Progressive Disease|3|||
148907912|NCT00834093|537144924|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
148907913|NCT01626872|537144925|FG000|Overall Study|Physician Decision|13|||
148907914|NCT01626872|537144926|FG001|Overall Study|Physician Decision|9|||
148907915|NCT01626872|537144927|FG002|Overall Study|Physician Decision|6|||
148907916|NCT01626872|537144925|FG000|Overall Study|Withdrawal by Subject|19|||
148907917|NCT01626872|537144926|FG001|Overall Study|Withdrawal by Subject|27|||
148907918|NCT01626872|537144927|FG002|Overall Study|Withdrawal by Subject|8|||
148907919|NCT01626872|537144925|FG000|Overall Study|Adverse Event (including Death)|20|||
148907920|NCT01626872|537144926|FG001|Overall Study|Adverse Event (including Death)|28|||
148907921|NCT01626872|537144927|FG002|Overall Study|Adverse Event (including Death)|8|||
148907922|NCT01626872|537144925|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
148907923|NCT01626872|537144926|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
148907924|NCT01626872|537144927|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
148907925|NCT01578486|537144928|FG000|Overall Study|Physician Decision|3|||
148907926|NCT01578486|537144928|FG000|Overall Study|Withdrawal by Subject|2|||
148907927|NCT02425943|537144929|FG000|Overall Study|Adverse Event|3|||
148907928|NCT02425943|537144930|FG001|Overall Study|Adverse Event|1|||
148907929|NCT02425943|537144929|FG000|Overall Study|Lost to Follow-up|59|||
148907930|NCT02425943|537144930|FG001|Overall Study|Lost to Follow-up|37|||
148907931|NCT02425943|537144929|FG000|Overall Study|Protocol Violation|4|||
148907932|NCT02425943|537144930|FG001|Overall Study|Protocol Violation|1|||
148907933|NCT02425943|537144929|FG000|Overall Study|Withdrawal by Subject|64|||
148907934|NCT02425943|537144930|FG001|Overall Study|Withdrawal by Subject|31|||
148907935|NCT02425943|537144929|FG000|Overall Study|Other|6|||
148907936|NCT02425943|537144930|FG001|Overall Study|Other|0|||
148907937|NCT01106248|537144933|FG000|Overall Study|Adverse Event|1|||
148907938|NCT01106248|537144933|FG000|Overall Study|Administrative|2|||
148907939|NCT00357903|537144934|FG000|Overall Study|Adverse Event|87|||
148907940|NCT00357903|537144935|FG001|Overall Study|Adverse Event|4|||
148907941|NCT00357903|537144934|FG000|Overall Study|Death|33|||
148907942|NCT00357903|537144935|FG001|Overall Study|Death|0|||
148907943|NCT00357903|537144934|FG000|Overall Study|Lost to Follow-up|23|||
148907944|NCT00357903|537144935|FG001|Overall Study|Lost to Follow-up|4|||
148907945|NCT00357903|537144934|FG000|Overall Study|Physician Decision|39|||
148907946|NCT00357903|537144935|FG001|Overall Study|Physician Decision|5|||
148907947|NCT00357903|537144934|FG000|Overall Study|Withdrawal by Subject|57|||
148907948|NCT00357903|537144935|FG001|Overall Study|Withdrawal by Subject|7|||
148907949|NCT00357903|537144934|FG000|Overall Study|Completed month 12 only|0|||
148907950|NCT00357903|537144935|FG001|Overall Study|Completed month 12 only|1|||
148907951|NCT00357903|537144934|FG000|Overall Study|Protocol issues|14|||
148907952|NCT00357903|537144935|FG001|Overall Study|Protocol issues|3|||
148907953|NCT00357903|537144934|FG000|Overall Study|Response status|61|||
148907954|NCT00357903|537144935|FG001|Overall Study|Response status|9|||
148907955|NCT00357903|537144934|FG000|Overall Study|Other|49|||
148907956|NCT00357903|537144935|FG001|Overall Study|Other|10|||
148907957|NCT01209325|537144938|FG000|Overall Study|Lost to Follow-up|24|||
148907958|NCT01209325|537144938|FG000|Overall Study|Adverse Event|1|||
148907959|NCT01209325|537144938|FG000|Overall Study|Relocated|3|||
148907960|NCT01209325|537144938|FG000|Overall Study|Refusal after starting therapy|8|||
148907961|NCT01209325|537144938|FG000|Overall Study|Protocol Violation|4|||
148907962|NCT01209325|537144938|FG000|Overall Study|Refusal prior to therapy|1|||
148907963|NCT01209325|537144938|FG000|Overall Study|Incarceration|2|||
148907964|NCT00607373|537144939|FG000|Treatment Period|Adverse Event|0|||
148907965|NCT00607373|537144940|FG001|Treatment Period|Adverse Event|4|||
148907966|NCT00607373|537144939|FG000|Treatment Period|Physician Decision|0|||
148907967|NCT00607373|537144940|FG001|Treatment Period|Physician Decision|1|||
148907968|NCT00607373|537144939|FG000|Treatment Period|Withdrawal by Subject|0|||
148907969|NCT00607373|537144940|FG001|Treatment Period|Withdrawal by Subject|1|||
148907970|NCT00607373|537144939|FG000|Follow-up Period|Other|0|||
148907971|NCT00607373|537144940|FG001|Follow-up Period|Other|1|||
148907972|NCT00607373|537144939|FG000|Follow-up Period|Protocol Violation|0|||
148907973|NCT00607373|537144940|FG001|Follow-up Period|Protocol Violation|1|||
148907974|NCT00607373|537144939|FG000|Follow-up Period|Withdrawal by Subject|1|||
148907975|NCT00607373|537144940|FG001|Follow-up Period|Withdrawal by Subject|3|||
148907976|NCT01918306|537144941|FG000|Overall Study|progresive disease|4|||
148907977|NCT01918306|537144942|FG001|Overall Study|progresive disease|0|||
148907978|NCT01918306|537144943|FG002|Overall Study|progresive disease|1|||
148907979|NCT01918306|537144944|FG003|Overall Study|progresive disease|1|||
148907980|NCT01918306|537144941|FG000|Overall Study|Withdrawal by Subject|0|||
148907981|NCT01918306|537144942|FG001|Overall Study|Withdrawal by Subject|0|||
148907982|NCT01918306|537144943|FG002|Overall Study|Withdrawal by Subject|0|||
148907983|NCT01918306|537144944|FG003|Overall Study|Withdrawal by Subject|2|||
148907984|NCT01918306|537144941|FG000|Overall Study|neutropenia|1|||
148907985|NCT01918306|537144942|FG001|Overall Study|neutropenia|0|||
148907986|NCT01918306|537144943|FG002|Overall Study|neutropenia|0|||
148907987|NCT01918306|537144944|FG003|Overall Study|neutropenia|0|||
148907988|NCT01918306|537144941|FG000|Overall Study|Lack of Efficacy|1|||
148907989|NCT01918306|537144942|FG001|Overall Study|Lack of Efficacy|0|||
148907990|NCT01918306|537144943|FG002|Overall Study|Lack of Efficacy|0|||
148907991|NCT01918306|537144944|FG003|Overall Study|Lack of Efficacy|0|||
148907992|NCT01918306|537144941|FG000|Overall Study|progress disease, crossover|0|||
148907993|NCT01918306|537144942|FG001|Overall Study|progress disease, crossover|0|||
148907994|NCT01918306|537144943|FG002|Overall Study|progress disease, crossover|1|||
148907995|NCT01918306|537144944|FG003|Overall Study|progress disease, crossover|0|||
148907996|NCT01160822|537144949|FG000|Overall Study|Adverse Event|0|||
148907997|NCT01160822|537144950|FG001|Overall Study|Adverse Event|0|||
148907998|NCT01160822|537144951|FG002|Overall Study|Adverse Event|0|||
148907999|NCT01160822|537144952|FG003|Overall Study|Adverse Event|0|||
148908000|NCT01160822|537144953|FG004|Overall Study|Adverse Event|1|||
148908001|NCT01160822|537144954|FG005|Overall Study|Adverse Event|2|||
148908002|NCT01160822|537144955|FG006|Overall Study|Adverse Event|5|||
148908003|NCT01160822|537144949|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148908004|NCT01160822|537144950|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148908005|NCT01160822|537144951|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
148908006|NCT01160822|537144952|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
148908007|NCT01160822|537144953|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
148908008|NCT01160822|537144954|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
148908009|NCT01160822|537144955|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
148908010|NCT01160822|537144949|FG000|Overall Study|Withdrawal by Subject|0|||
148908011|NCT01160822|537144950|FG001|Overall Study|Withdrawal by Subject|0|||
148908012|NCT01160822|537144951|FG002|Overall Study|Withdrawal by Subject|0|||
148908013|NCT01160822|537144952|FG003|Overall Study|Withdrawal by Subject|0|||
148908014|NCT01160822|537144953|FG004|Overall Study|Withdrawal by Subject|0|||
148908015|NCT01160822|537144954|FG005|Overall Study|Withdrawal by Subject|0|||
148908016|NCT01160822|537144955|FG006|Overall Study|Withdrawal by Subject|1|||
148908017|NCT01160822|537144949|FG000|Overall Study|Lost to Follow-up|0|||
148908018|NCT01160822|537144950|FG001|Overall Study|Lost to Follow-up|0|||
148908019|NCT01160822|537144951|FG002|Overall Study|Lost to Follow-up|0|||
148908020|NCT01160822|537144952|FG003|Overall Study|Lost to Follow-up|0|||
148908021|NCT01160822|537144953|FG004|Overall Study|Lost to Follow-up|1|||
148908022|NCT01160822|537144954|FG005|Overall Study|Lost to Follow-up|0|||
148908023|NCT01160822|537144955|FG006|Overall Study|Lost to Follow-up|0|||
148908024|NCT01160822|537144949|FG000|Overall Study|Administrative problems|0|||
148908025|NCT01160822|537144950|FG001|Overall Study|Administrative problems|0|||
149011999|NCT02318719|537523417|FG000|Open-label Extension Phase|Death|0|||
148908026|NCT01160822|537144951|FG002|Overall Study|Administrative problems|0|||
148908027|NCT01160822|537144952|FG003|Overall Study|Administrative problems|0|||
148908028|NCT01160822|537144953|FG004|Overall Study|Administrative problems|1|||
148908029|NCT01160822|537144954|FG005|Overall Study|Administrative problems|0|||
148908030|NCT01160822|537144955|FG006|Overall Study|Administrative problems|0|||
148908031|NCT01160822|537144949|FG000|Overall Study|Protocol deviation|0|||
148908032|NCT01160822|537144950|FG001|Overall Study|Protocol deviation|0|||
148908033|NCT01160822|537144951|FG002|Overall Study|Protocol deviation|0|||
148908034|NCT01160822|537144952|FG003|Overall Study|Protocol deviation|0|||
148908035|NCT01160822|537144953|FG004|Overall Study|Protocol deviation|2|||
148908036|NCT01160822|537144954|FG005|Overall Study|Protocol deviation|0|||
148908037|NCT01160822|537144955|FG006|Overall Study|Protocol deviation|0|||
148908038|NCT02506244|537144956|FG000|Overall Study|Did not undergo active monitoring|458|||
148908039|NCT02506244|537144957|FG001|Overall Study|Did not undergo active monitoring|459|||
148908040|NCT02506244|537144958|FG002|Overall Study|Did not undergo active monitoring|0|||
148908041|NCT00314795|537144962|FG000|Overall Study|Adverse Event|8|||
148908042|NCT00314795|537144962|FG000|Overall Study|Death|4|||
148908043|NCT00314795|537144962|FG000|Overall Study|Reason not Specified|3|||
148908044|NCT00314795|537144962|FG000|Overall Study|Renal Transplant|3|||
148908045|NCT00314795|537144962|FG000|Overall Study|Participants Withdrew Consent|2|||
148908046|NCT04717336|537144963|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
148908047|NCT04717336|537144964|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
148908048|NCT04717336|537144963|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
148908049|NCT04717336|537144964|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
148908050|NCT02039843|537144969|FG000|Randomization and Observation Period|Adverse Event|2|||
148908051|NCT02039843|537144970|FG001|Randomization and Observation Period|Adverse Event|0|||
148908052|NCT02039843|537144969|FG000|Randomization and Observation Period|Death|1|||
148908053|NCT02039843|537144970|FG001|Randomization and Observation Period|Death|0|||
148908054|NCT02039843|537144969|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
148908055|NCT02039843|537144970|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
148908056|NCT02039843|537144969|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
148908057|NCT02039843|537144970|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
148908058|NCT02039843|537144969|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
148908059|NCT02039843|537144970|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
148908060|NCT02039843|537144969|FG000|Pairing With a Study Dog|Death|1|||
148908061|NCT02039843|537144970|FG001|Pairing With a Study Dog|Death|0|||
148908062|NCT02039843|537144969|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
148908063|NCT02039843|537144970|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
148908064|NCT02039843|537144969|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
148908065|NCT02039843|537144970|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
148908066|NCT02039843|537144969|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
148908067|NCT02039843|537144970|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
148908068|NCT02170077|537144971|FG000|Overall Study|Withdrawal by Subject|3|||
148908069|NCT02170077|537144972|FG001|Overall Study|Withdrawal by Subject|4|||
148908070|NCT02170077|537144973|FG002|Overall Study|Withdrawal by Subject|2|||
148908071|NCT02170077|537144971|FG000|Overall Study|Adverse Event|4|||
148908072|NCT02170077|537144972|FG001|Overall Study|Adverse Event|4|||
148908073|NCT02170077|537144973|FG002|Overall Study|Adverse Event|4|||
148908074|NCT02170077|537144971|FG000|Overall Study|Lost to Follow-up|0|||
148908075|NCT02170077|537144972|FG001|Overall Study|Lost to Follow-up|1|||
148908076|NCT02170077|537144973|FG002|Overall Study|Lost to Follow-up|0|||
148908077|NCT02170077|537144971|FG000|Overall Study|Exclusion criteria|2|||
148908078|NCT02170077|537144972|FG001|Overall Study|Exclusion criteria|2|||
148908079|NCT02170077|537144973|FG002|Overall Study|Exclusion criteria|5|||
148908080|NCT02170077|537144971|FG000|Overall Study|Exacerbation of seizures|0|||
148908081|NCT02170077|537144972|FG001|Overall Study|Exacerbation of seizures|2|||
148908082|NCT02170077|537144973|FG002|Overall Study|Exacerbation of seizures|1|||
148908083|NCT01958164|537144976|FG000|Overall Study|Adverse Event|0|||
148908084|NCT01958164|537144977|FG001|Overall Study|Adverse Event|2|||
148908085|NCT01958164|537144976|FG000|Overall Study|Lost to Follow-up|2|||
148908086|NCT01958164|537144977|FG001|Overall Study|Lost to Follow-up|3|||
148908087|NCT01780974|537144980|FG000|Overall Study|Death|1|||
148908088|NCT01780974|537144981|FG001|Overall Study|Death|0|||
148908089|NCT01780974|537144980|FG000|Overall Study|Adverse Event|1|||
148908090|NCT01780974|537144981|FG001|Overall Study|Adverse Event|3|||
148908091|NCT01724346|537144982|FG000|Overall Study|Death|42|||
148908092|NCT01724346|537144983|FG001|Overall Study|Death|42|||
148908093|NCT01724346|537144982|FG000|Overall Study|Lost to Follow-up|5|||
148908094|NCT01724346|537144983|FG001|Overall Study|Lost to Follow-up|1|||
148908095|NCT01724346|537144982|FG000|Overall Study|Withdrawal by Subject|27|||
148908096|NCT01724346|537144983|FG001|Overall Study|Withdrawal by Subject|19|||
148908097|NCT01724346|537144982|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
148908098|NCT01724346|537144983|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
148908099|NCT00525161|537144986|FG000|Overall Study|Adverse Event|1|||
148908100|NCT01076361|537144987|FG000|Overall Study|22 leads were excluded from analysis|21|||
148908101|NCT00750438|537144992|FG000|Overall Study|Protocol Violation|4|||
148908102|NCT00750438|537144993|FG001|Overall Study|Protocol Violation|1|||
148908103|NCT00750438|537144992|FG000|Overall Study|Physician Decision|2|||
148908104|NCT00750438|537144993|FG001|Overall Study|Physician Decision|2|||
148908105|NCT00750438|537144992|FG000|Overall Study|Withdrawal by Subject|1|||
148908106|NCT00750438|537144993|FG001|Overall Study|Withdrawal by Subject|1|||
148908107|NCT02736578|537144996|FG000|Overall Study|Adverse Event|1|||
148908108|NCT02736578|537144997|FG001|Overall Study|Adverse Event|0|||
148908109|NCT00354432|537144998|FG000|Overall Study|Adverse Event|3|||
148908110|NCT00354432|537144999|FG001|Overall Study|Adverse Event|1|||
148908111|NCT00354432|537145000|FG002|Overall Study|Adverse Event|5|||
148908112|NCT00354432|537145001|FG003|Overall Study|Adverse Event|5|||
148908113|NCT00354432|537144998|FG000|Overall Study|Off/Toxicity|3|||
148908114|NCT00354432|537144999|FG001|Overall Study|Off/Toxicity|7|||
148908115|NCT00354432|537145000|FG002|Overall Study|Off/Toxicity|5|||
148908116|NCT00354432|537145001|FG003|Overall Study|Off/Toxicity|5|||
148908117|NCT00802945|537145002|FG000|Overall Study|Death|27|||
148908118|NCT00802945|537145003|FG001|Overall Study|Death|23|||
148908119|NCT00802945|537145002|FG000|Overall Study|Terminated by sponsor|8|||
148908120|NCT00802945|537145003|FG001|Overall Study|Terminated by sponsor|12|||
148908121|NCT03493464|537145006|FG000|Overall Study|Surgery not performed|1|||
148908122|NCT02807402|537145007|FG000|Overall Study|Failure to Return|1|||
148908123|NCT02807402|537145007|FG000|Overall Study|Death|3|||
148908124|NCT02807402|537145007|FG000|Overall Study|Other|2|||
148908125|NCT03894813|537146498|FG000|Overall Study|Adverse Event|1|||
148908126|NCT03894813|537146499|FG001|Overall Study|Adverse Event|1|||
148908127|NCT03894813|537146498|FG000|Overall Study|Lack of Efficacy|3|||
148908128|NCT03894813|537146499|FG001|Overall Study|Lack of Efficacy|3|||
148908129|NCT03894813|537146498|FG000|Overall Study|Lost to Follow-up|1|||
148908130|NCT03894813|537146499|FG001|Overall Study|Lost to Follow-up|0|||
148908131|NCT03894813|537146498|FG000|Overall Study|Pregnancy|2|||
148908132|NCT03894813|537146499|FG001|Overall Study|Pregnancy|1|||
148908133|NCT03894813|537146498|FG000|Overall Study|Protocol Violation|3|||
148908134|NCT03894813|537146499|FG001|Overall Study|Protocol Violation|7|||
148908135|NCT03894813|537146498|FG000|Overall Study|Withdrawal by Subject|1|||
148908136|NCT03894813|537146499|FG001|Overall Study|Withdrawal by Subject|3|||
148908137|NCT03894813|537146498|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
148908138|NCT03894813|537146499|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
148908139|NCT02656693|537146500|FG000|Overall Study|Pregnancy|1|||
148908140|NCT02656693|537146501|FG001|Overall Study|Pregnancy|1|||
148908141|NCT02656693|537146502|FG002|Overall Study|Pregnancy|1|||
148908142|NCT02656693|537146500|FG000|Overall Study|Bariatric surgery|0|||
148908143|NCT02656693|537146501|FG001|Overall Study|Bariatric surgery|1|||
148908144|NCT02656693|537146502|FG002|Overall Study|Bariatric surgery|2|||
148908145|NCT02269267|537146503|FG000|Overall Study|Death|5|||
148908146|NCT03773796|537146504|FG000|Overall Study|Adverse Event|1|||
148908147|NCT03773796|537146504|FG000|Overall Study|Withdrawal by Subject|1|||
148908148|NCT03773796|537146504|FG000|Overall Study|Lack of Efficacy|1|||
148908149|NCT03805659|537146506|FG000|Overall Study|Withdrawal by Subject|0|||
148908150|NCT03805659|537146507|FG001|Overall Study|Withdrawal by Subject|1|||
148908151|NCT02273596|537146509|FG000|24-Week Treatment Period|Adverse Event|3|||
148908152|NCT02273596|537146509|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
148908153|NCT02273596|537146509|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
148908154|NCT02273596|537146509|FG000|24-Week Treatment Period|Physician Decision|1|||
148908155|NCT02273596|537146509|FG000|24-Week Treatment Period|Protocol Deviation|1|||
148908156|NCT02273596|537146509|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
148908157|NCT02273596|537146509|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
148908158|NCT02273596|537146509|FG000|Extension Period|Lost to Follow-up|1|||
148908159|NCT02273596|537146509|FG000|Extension Period|Protocol Deviation|1|||
148908160|NCT02604160|537146510|FG000|Overall Study|Protocol Violation|0|||
148908161|NCT02604160|537146511|FG001|Overall Study|Protocol Violation|1|||
148908162|NCT02604160|537146510|FG000|Overall Study|Physician Decision|0|||
148908163|NCT02604160|537146511|FG001|Overall Study|Physician Decision|1|||
148908164|NCT01069900|537146512|FG000|Overall Study|Technical problems|0|||
148908165|NCT01069900|537146513|FG001|Overall Study|Technical problems|1|||
148908166|NCT01069900|537146512|FG000|Overall Study|Lost to Follow-up|7|||
148908167|NCT01069900|537146513|FG001|Overall Study|Lost to Follow-up|1|||
148908168|NCT01069900|537146512|FG000|Overall Study|Withdrawal by Subject|6|||
148908169|NCT01069900|537146513|FG001|Overall Study|Withdrawal by Subject|1|||
148908170|NCT01069900|537146512|FG000|Overall Study|Protocol Violation|4|||
148908171|NCT01069900|537146513|FG001|Overall Study|Protocol Violation|1|||
148908172|NCT01069900|537146512|FG000|Overall Study|Insufficient Therapeutic effect|1|||
148908173|NCT01069900|537146513|FG001|Overall Study|Insufficient Therapeutic effect|0|||
148908174|NCT00145158|537146514|FG000|Overall Study|premature withdrawal|2|||
148908175|NCT00145158|537146515|FG001|Overall Study|premature withdrawal|3|||
148908176|NCT02873702|537146518|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
148908177|NCT02873702|537146519|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
148908178|NCT02873702|537146520|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
148908179|NCT02873702|537146521|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
148908180|NCT02873702|537146518|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
148908181|NCT02873702|537146519|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
148908182|NCT02873702|537146520|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
148908183|NCT02873702|537146521|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
148908184|NCT02873702|537146518|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
148908185|NCT02873702|537146519|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
148908186|NCT02873702|537146520|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
148908187|NCT02873702|537146521|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
148908188|NCT02873702|537146518|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
148908189|NCT02873702|537146519|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
148908190|NCT02873702|537146520|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
148908191|NCT02873702|537146521|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
148908192|NCT02873702|537146518|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
148908193|NCT02873702|537146519|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
148908194|NCT02873702|537146520|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
148908195|NCT02873702|537146521|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
148908196|NCT01255436|537146531|FG000|Overall Study|Lost to Follow-up|178|||
148908197|NCT01255436|537146532|FG001|Overall Study|Lost to Follow-up|191|||
148908198|NCT01255436|537146531|FG000|Overall Study|Death, stroke, or MI|4|||
148908199|NCT01255436|537146532|FG001|Overall Study|Death, stroke, or MI|3|||
148908200|NCT04816669|537146533|FG000|Part 1|Adverse Event|1|||
148908201|NCT04816669|537146534|FG001|Part 1|Adverse Event|1|||
148908202|NCT04816669|537146535|FG002|Part 1|Adverse Event|0|||
148908203|NCT04816669|537146536|FG003|Part 1|Adverse Event|0|||
148908204|NCT04816669|537146533|FG000|Part 1|Lost to Follow-up|2|||
148908205|NCT04816669|537146534|FG001|Part 1|Lost to Follow-up|2|||
148908206|NCT04816669|537146535|FG002|Part 1|Lost to Follow-up|0|||
148908207|NCT04816669|537146536|FG003|Part 1|Lost to Follow-up|0|||
148908208|NCT04816669|537146533|FG000|Part 1|Protocol Violation|0|||
148908209|NCT04816669|537146534|FG001|Part 1|Protocol Violation|1|||
148908210|NCT04816669|537146535|FG002|Part 1|Protocol Violation|0|||
148908211|NCT04816669|537146536|FG003|Part 1|Protocol Violation|0|||
148908212|NCT04816669|537146533|FG000|Part 1|Withdrawal by Subject|1|||
148908213|NCT04816669|537146534|FG001|Part 1|Withdrawal by Subject|2|||
148908214|NCT04816669|537146535|FG002|Part 1|Withdrawal by Subject|0|||
148908215|NCT04816669|537146536|FG003|Part 1|Withdrawal by Subject|0|||
148908216|NCT04816669|537146533|FG000|Part 2|Other|0|||
148908217|NCT04816669|537146534|FG001|Part 2|Other|0|||
148908218|NCT04816669|537146535|FG002|Part 2|Other|1|||
148908219|NCT04816669|537146536|FG003|Part 2|Other|0|||
148908220|NCT04816669|537146533|FG000|Part 2|Withdrawal by Subject|0|||
148908221|NCT04816669|537146534|FG001|Part 2|Withdrawal by Subject|0|||
148908222|NCT04816669|537146535|FG002|Part 2|Withdrawal by Subject|0|||
148908223|NCT04816669|537146536|FG003|Part 2|Withdrawal by Subject|1|||
148908224|NCT04816669|537146533|FG000|Part 2|Lost to Follow-up|0|||
148908225|NCT04816669|537146534|FG001|Part 2|Lost to Follow-up|0|||
148908226|NCT04816669|537146535|FG002|Part 2|Lost to Follow-up|1|||
148908227|NCT04816669|537146536|FG003|Part 2|Lost to Follow-up|0|||
148908228|NCT01229267|537146537|FG000|Overall Study|Adverse Event|4|||
148908229|NCT01229267|537146538|FG001|Overall Study|Adverse Event|6|||
148908230|NCT01229267|537146539|FG002|Overall Study|Adverse Event|3|||
148908231|NCT01229267|537146540|FG003|Overall Study|Adverse Event|2|||
148908232|NCT01229267|537146541|FG004|Overall Study|Adverse Event|10|||
148908233|NCT01229267|537146537|FG000|Overall Study|Death|40|||
148908234|NCT01229267|537146538|FG001|Overall Study|Death|37|||
148908235|NCT01229267|537146539|FG002|Overall Study|Death|35|||
148908236|NCT01229267|537146540|FG003|Overall Study|Death|13|||
148908237|NCT01229267|537146541|FG004|Overall Study|Death|103|||
148908238|NCT01229267|537146537|FG000|Overall Study|Withdrawal by Subject|23|||
148908239|NCT01229267|537146538|FG001|Overall Study|Withdrawal by Subject|22|||
148908240|NCT01229267|537146539|FG002|Overall Study|Withdrawal by Subject|32|||
148908241|NCT01229267|537146540|FG003|Overall Study|Withdrawal by Subject|14|||
148908242|NCT01229267|537146541|FG004|Overall Study|Withdrawal by Subject|59|||
148908243|NCT01229267|537146537|FG000|Overall Study|Protocol Violation|0|||
148908244|NCT01229267|537146538|FG001|Overall Study|Protocol Violation|1|||
148908245|NCT01229267|537146539|FG002|Overall Study|Protocol Violation|0|||
148908246|NCT01229267|537146540|FG003|Overall Study|Protocol Violation|0|||
148908247|NCT01229267|537146541|FG004|Overall Study|Protocol Violation|0|||
148908248|NCT01229267|537146537|FG000|Overall Study|Progressive disease|0|||
148908249|NCT01229267|537146538|FG001|Overall Study|Progressive disease|0|||
148908250|NCT01229267|537146539|FG002|Overall Study|Progressive disease|0|||
148908251|NCT01229267|537146540|FG003|Overall Study|Progressive disease|0|||
148908252|NCT01229267|537146541|FG004|Overall Study|Progressive disease|1|||
148908253|NCT01229267|537146537|FG000|Overall Study|Physician Decision|8|||
148908254|NCT01229267|537146538|FG001|Overall Study|Physician Decision|11|||
148908255|NCT01229267|537146539|FG002|Overall Study|Physician Decision|8|||
148908256|NCT01229267|537146540|FG003|Overall Study|Physician Decision|3|||
148908257|NCT01229267|537146541|FG004|Overall Study|Physician Decision|25|||
148908258|NCT01229267|537146537|FG000|Overall Study|Lost to Follow-up|6|||
148908259|NCT01229267|537146538|FG001|Overall Study|Lost to Follow-up|5|||
148908260|NCT01229267|537146539|FG002|Overall Study|Lost to Follow-up|8|||
148908261|NCT01229267|537146540|FG003|Overall Study|Lost to Follow-up|3|||
148908262|NCT01229267|537146541|FG004|Overall Study|Lost to Follow-up|22|||
148908263|NCT03085797|537146547|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
148908264|NCT03085797|537146548|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
148908265|NCT03085797|537146547|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
148908266|NCT03085797|537146548|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
148908267|NCT03085797|537146547|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
148908268|NCT03085797|537146548|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
148908269|NCT00867815|537146549|FG000|Overall Study|Lost to Follow-up|1|||
148908270|NCT04050202|537146550|FG000|Overall Study|Lost to Follow-up|2|||
148908271|NCT00372593|537146553|FG000|Overall Study|Adverse Event|43|||
148908272|NCT00372593|537146554|FG001|Overall Study|Adverse Event|45|||
148908273|NCT00372593|537146555|FG002|Overall Study|Adverse Event|0|||
148908274|NCT00372593|537146553|FG000|Overall Study|Death|16|||
148908275|NCT00372593|537146554|FG001|Overall Study|Death|20|||
148908276|NCT00372593|537146555|FG002|Overall Study|Death|1|||
148908277|NCT00372593|537146553|FG000|Overall Study|Lack of Efficacy|82|||
148908278|NCT00372593|537146554|FG001|Overall Study|Lack of Efficacy|71|||
148908279|NCT00372593|537146555|FG002|Overall Study|Lack of Efficacy|2|||
148908280|NCT00372593|537146553|FG000|Overall Study|Lost to Follow-up|1|||
148908281|NCT00372593|537146554|FG001|Overall Study|Lost to Follow-up|0|||
148908282|NCT00372593|537146555|FG002|Overall Study|Lost to Follow-up|0|||
148908283|NCT00372593|537146553|FG000|Overall Study|Physician Decision|42|||
148908284|NCT00372593|537146554|FG001|Overall Study|Physician Decision|41|||
148908285|NCT00372593|537146555|FG002|Overall Study|Physician Decision|0|||
148908286|NCT00372593|537146553|FG000|Overall Study|Ineligible|20|||
148908287|NCT00372593|537146554|FG001|Overall Study|Ineligible|21|||
148908288|NCT00372593|537146555|FG002|Overall Study|Ineligible|1|||
148908289|NCT02974543|537146556|FG000|Overall Study|Withdrawal by Subject|1|||
148908290|NCT02974543|537146557|FG001|Overall Study|Withdrawal by Subject|0|||
148908291|NCT03534180|537146558|FG000|Overall Study|Withdrawal by Subject|1|||
148908292|NCT00220636|537146559|FG000|Overall Study|Withdrawal by Subject|4|||
148908293|NCT01237899|537146562|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
148908294|NCT01237899|537146563|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
148908295|NCT01237899|537146564|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
149012000|NCT02318719|537523418|FG001|Open-label Extension Phase|Death|0|||
148908296|NCT01237899|537146565|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
148908297|NCT01237899|537146566|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
148908298|NCT01237899|537146567|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
148908299|NCT01237899|537146568|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
148908300|NCT01237899|537146569|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
148908301|NCT01237899|537146570|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
148908302|NCT01237899|537146571|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
148908303|NCT01237899|537146572|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
148908304|NCT00790088|537146573|FG000|Overall Study|Protocol Violation|11|||
148908305|NCT00790088|537146573|FG000|Overall Study|Withdrawal by Subject|17|||
148908306|NCT00790088|537146573|FG000|Overall Study|Lost to Follow-up|7|||
148908307|NCT00790088|537146573|FG000|Overall Study|Physician Decision|4|||
148908308|NCT00859456|537146574|FG000|Overall Study|Adverse Event|3|||
148908309|NCT00859456|537146574|FG000|Overall Study|Progressive disease|2|||
148908310|NCT00859456|537146574|FG000|Overall Study|Non-compliance|3|||
148908311|NCT02636595|537146575|FG000|Overall Study|Lost to Follow-up|1|||
148908312|NCT02636595|537146575|FG000|Overall Study|Other|1|||
148908313|NCT05782179|537146577|FG000|Overall Study|Adverse Event|0|||
148908314|NCT05782179|537146578|FG001|Overall Study|Adverse Event|0|||
148908315|NCT05782179|537146579|FG002|Overall Study|Adverse Event|2|||
148908316|NCT05782179|537146580|FG003|Overall Study|Adverse Event|0|||
148908317|NCT05782179|537146581|FG004|Overall Study|Adverse Event|0|||
148908318|NCT05782179|537146582|FG005|Overall Study|Adverse Event|0|||
148908319|NCT06170242|537146583|FG000|Overall Study|Lost to Follow-up|0|||
148908320|NCT06170242|537146584|FG001|Overall Study|Lost to Follow-up|0|||
148908321|NCT06170242|537146585|FG002|Overall Study|Lost to Follow-up|1|||
148908322|NCT06170242|537146586|FG003|Overall Study|Lost to Follow-up|1|||
148908323|NCT04896073|537146587|FG000|Overall Study|Screen failure|0|||
148908324|NCT04896073|537146588|FG001|Overall Study|Screen failure|2|||
148908325|NCT04896073|537146587|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
148908326|NCT04896073|537146588|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
148908327|NCT02454517|537146589|FG000|Overall Study|Withdrawal by Subject|3|||
148908328|NCT02454517|537146590|FG001|Overall Study|Withdrawal by Subject|0|||
148908329|NCT02454517|537146589|FG000|Overall Study|Lost to Follow-up|4|||
148908330|NCT02454517|537146590|FG001|Overall Study|Lost to Follow-up|7|||
148908331|NCT02454517|537146589|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
148908332|NCT02454517|537146590|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
148908333|NCT03565497|537146591|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
148908334|NCT03565497|537146592|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
148908335|NCT03565497|537146593|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
148908336|NCT03565497|537146591|FG000|Overall Study|Lost to Follow-up|1|||
148908337|NCT03565497|537146592|FG001|Overall Study|Lost to Follow-up|1|||
148908338|NCT03565497|537146593|FG002|Overall Study|Lost to Follow-up|2|||
148908339|NCT03565497|537146591|FG000|Overall Study|Withdrawal by Subject|1|||
148908340|NCT03565497|537146592|FG001|Overall Study|Withdrawal by Subject|1|||
148908341|NCT03565497|537146593|FG002|Overall Study|Withdrawal by Subject|1|||
148908342|NCT02999672|537146594|FG000|Overall Study|Death|0|||
148908343|NCT02999672|537146595|FG001|Overall Study|Death|1|||
148908344|NCT02999672|537146594|FG000|Overall Study|Study Terminated by Sponsor|0|||
148908345|NCT02999672|537146595|FG001|Overall Study|Study Terminated by Sponsor|1|||
148908346|NCT02999672|537146594|FG000|Overall Study|Progressive Disease|9|||
148908347|NCT02999672|537146595|FG001|Overall Study|Progressive Disease|5|||
148908348|NCT02999672|537146594|FG000|Overall Study|Adverse Event|4|||
148908349|NCT02999672|537146595|FG001|Overall Study|Adverse Event|0|||
148908350|NCT01075685|537146596|FG000|Overall Study|Protocol Violation|9|||
148908351|NCT01075685|537146597|FG001|Overall Study|Protocol Violation|1|||
148908352|NCT01075685|537146596|FG000|Overall Study|Withdrawal by Subject|20|||
148908353|NCT01075685|537146597|FG001|Overall Study|Withdrawal by Subject|5|||
148908354|NCT01075685|537146596|FG000|Overall Study|Lost to Follow-up|563|||
148908355|NCT01075685|537146597|FG001|Overall Study|Lost to Follow-up|220|||
148908356|NCT02858362|537146600|FG000|Overall Study|Protocol Violation|0|||
148908357|NCT02858362|537146601|FG001|Overall Study|Protocol Violation|1|||
148908358|NCT02858362|537146602|FG002|Overall Study|Protocol Violation|0|||
148908359|NCT02858362|537146600|FG000|Overall Study|Withdrawal by Subject|1|||
148908360|NCT02858362|537146601|FG001|Overall Study|Withdrawal by Subject|0|||
148908361|NCT02858362|537146602|FG002|Overall Study|Withdrawal by Subject|0|||
148908362|NCT02858362|537146600|FG000|Overall Study|Early Study Termination|0|||
148908363|NCT02858362|537146601|FG001|Overall Study|Early Study Termination|0|||
148908364|NCT02858362|537146602|FG002|Overall Study|Early Study Termination|3|||
148908365|NCT02858362|537146600|FG000|Overall Study|Lost to Follow-up|1|||
148908366|NCT02858362|537146601|FG001|Overall Study|Lost to Follow-up|0|||
148908367|NCT02858362|537146602|FG002|Overall Study|Lost to Follow-up|0|||
148908368|NCT02194985|537146604|FG000|Overall Study|Adverse Event|1|||
148908369|NCT02194985|537146604|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
148908370|NCT02194985|537146604|FG000|Overall Study|Physician Decision|4|||
148908371|NCT02194985|537146604|FG000|Overall Study|Lost to Follow-up|1|||
148908372|NCT02194985|537146604|FG000|Overall Study|Withdrawal by Subject|2|||
148908373|NCT02561832|537146607|FG000|Overall Study|Withdrawal by Subject|1|||
148908374|NCT02561832|537146608|FG001|Overall Study|Withdrawal by Subject|1|||
148908375|NCT02561832|537146607|FG000|Overall Study|Adverse Event|3|||
148908376|NCT02561832|537146608|FG001|Overall Study|Adverse Event|0|||
148908377|NCT02561832|537146607|FG000|Overall Study|Disease progression|3|||
148908378|NCT02561832|537146608|FG001|Overall Study|Disease progression|3|||
148908379|NCT02304367|537146615|FG000|Overall Study|Lack of Response to Bruosumab|1|||
148908380|NCT02304367|537146615|FG000|Overall Study|Sponsor Decision|3|||
148908381|NCT02304367|537146615|FG000|Overall Study|Death|2|||
148908382|NCT02304367|537146615|FG000|Overall Study|Physician Decision|1|||
148908383|NCT02304367|537146615|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
148908384|NCT00594815|537146616|FG000|Overall Study|Never Treated|3|||
148908385|NCT00594815|537146616|FG000|Overall Study|Withdrawal by Subject|2|||
148908386|NCT00594815|537146616|FG000|Overall Study|Toxicity|4|||
148908387|NCT03599089|537146617|FG000|Overall Study|Lost to Follow-up|1|||
148908388|NCT03599089|537146618|FG001|Overall Study|Lost to Follow-up|0|||
148908389|NCT03599089|537146619|FG002|Overall Study|Lost to Follow-up|0|||
148908390|NCT03599089|537146620|FG003|Overall Study|Lost to Follow-up|0|||
148908391|NCT03599089|537146617|FG000|Overall Study|Withdrawal by Subject|2|||
148908392|NCT03599089|537146618|FG001|Overall Study|Withdrawal by Subject|1|||
148908393|NCT03599089|537146619|FG002|Overall Study|Withdrawal by Subject|0|||
148908394|NCT03599089|537146620|FG003|Overall Study|Withdrawal by Subject|0|||
148908395|NCT03599089|537146617|FG000|Overall Study|Lack of Efficacy|0|||
148908396|NCT03599089|537146618|FG001|Overall Study|Lack of Efficacy|0|||
148908397|NCT03599089|537146619|FG002|Overall Study|Lack of Efficacy|1|||
148908398|NCT03599089|537146620|FG003|Overall Study|Lack of Efficacy|2|||
148908399|NCT03214666|537146621|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
148908400|NCT03214666|537146622|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
148908401|NCT03214666|537146623|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
148908402|NCT03214666|537146624|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
148908403|NCT03214666|537146625|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
148908404|NCT03214666|537146626|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
148908405|NCT04139798|537146629|FG000|Overall Study|Withdrawal by Subject|6|||
148908406|NCT04139798|537146630|FG001|Overall Study|Withdrawal by Subject|5|||
148908407|NCT04139798|537146629|FG000|Overall Study|Lost to Follow-up|2|||
148908408|NCT04139798|537146630|FG001|Overall Study|Lost to Follow-up|5|||
148908409|NCT04139798|537146629|FG000|Overall Study|Discontinued|4|||
148908410|NCT04139798|537146630|FG001|Overall Study|Discontinued|2|||
148908411|NCT04139798|537146629|FG000|Overall Study|Adverse Event|1|||
148908412|NCT04139798|537146630|FG001|Overall Study|Adverse Event|3|||
148908413|NCT04139798|537146629|FG000|Overall Study|Protocol Violation|1|||
148908414|NCT04139798|537146630|FG001|Overall Study|Protocol Violation|0|||
148908415|NCT04411667|537146633|FG000|Overall Study|Physician Decision|1|||
148908416|NCT04411667|537146634|FG001|Overall Study|Physician Decision|0|||
148908417|NCT00714870|537146635|FG000|Overall Study|Lost to Follow-up|22|||
148908418|NCT00714870|537146636|FG001|Overall Study|Lost to Follow-up|5|||
148908419|NCT00714870|537146635|FG000|Overall Study|patient unable to come b/c back pain|1|||
148908420|NCT00714870|537146636|FG001|Overall Study|patient unable to come b/c back pain|0|||
148908421|NCT00714870|537146635|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
148908422|NCT00714870|537146636|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
148908423|NCT03399552|537146637|FG000|Overall Study|No evidence of disease|1|||
148908424|NCT03399552|537146637|FG000|Overall Study|Unevaluable|1|||
148908425|NCT02357368|537146638|FG000|Overall Study|Lost to Follow-up|0|||
148908426|NCT02357368|537146639|FG001|Overall Study|Lost to Follow-up|0|||
148908427|NCT02357368|537146640|FG002|Overall Study|Lost to Follow-up|0|||
148908428|NCT02357368|537146641|FG003|Overall Study|Lost to Follow-up|1|||
148908429|NCT02357368|537146638|FG000|Overall Study|Pregnancy|3|||
148908430|NCT02357368|537146639|FG001|Overall Study|Pregnancy|2|||
148908431|NCT02357368|537146640|FG002|Overall Study|Pregnancy|0|||
148908432|NCT02357368|537146641|FG003|Overall Study|Pregnancy|0|||
148908433|NCT02357368|537146638|FG000|Overall Study|Withdrawal by Subject|3|||
148908434|NCT02357368|537146639|FG001|Overall Study|Withdrawal by Subject|1|||
148908435|NCT02357368|537146640|FG002|Overall Study|Withdrawal by Subject|1|||
148908436|NCT02357368|537146641|FG003|Overall Study|Withdrawal by Subject|2|||
148908437|NCT03895840|537146642|FG000|Overall Study|Withdrawal by Subject|21|||
148908438|NCT01931566|537146643|FG000|Overall Study|Randomized But Not Treated|6|||
148908439|NCT01931566|537146644|FG001|Overall Study|Randomized But Not Treated|9|||
148908440|NCT01931566|537146645|FG002|Overall Study|Randomized But Not Treated|14|||
148908441|NCT01931566|537146643|FG000|Overall Study|Adverse Event|37|||
148908442|NCT01931566|537146644|FG001|Overall Study|Adverse Event|167|||
148908443|NCT01931566|537146645|FG002|Overall Study|Adverse Event|132|||
148908444|NCT01931566|537146643|FG000|Overall Study|Major Protocol Deviation|5|||
148908445|NCT01931566|537146644|FG001|Overall Study|Major Protocol Deviation|14|||
148908446|NCT01931566|537146645|FG002|Overall Study|Major Protocol Deviation|21|||
148908447|NCT01931566|537146643|FG000|Overall Study|Lost to Follow-up|3|||
148908448|NCT01931566|537146644|FG001|Overall Study|Lost to Follow-up|26|||
148908449|NCT01931566|537146645|FG002|Overall Study|Lost to Follow-up|23|||
148908450|NCT01931566|537146643|FG000|Overall Study|Voluntary Withdrawal|78|||
148908451|NCT01931566|537146644|FG001|Overall Study|Voluntary Withdrawal|245|||
148908452|NCT01931566|537146645|FG002|Overall Study|Voluntary Withdrawal|225|||
148908453|NCT01931566|537146643|FG000|Overall Study|Study Termination|289|||
148908454|NCT01931566|537146644|FG001|Overall Study|Study Termination|968|||
148908455|NCT01931566|537146645|FG002|Overall Study|Study Termination|1037|||
148908456|NCT01931566|537146643|FG000|Overall Study|Reason Not Specified|11|||
148803501|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
148803502|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
148803503|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
148803504|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
148803505|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
148803506|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
148803507|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
148803508|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
148803509|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
148803510|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
148803511|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
148803512|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
148803513|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
148803514|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
148803515|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
148803516|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
148803517|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
148803518|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
148803519|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
148803520|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
148803521|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
148803522|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
148803523|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
148803524|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
149012001|NCT02318719|537523419|FG002|Open-label Extension Phase|Death|0|||
148908457|NCT01931566|537146644|FG001|Overall Study|Reason Not Specified|47|||
148803525|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
148803526|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
148803527|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
148803528|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
148803529|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
148803530|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
148803531|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
148803532|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
148803533|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
148803534|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
148803535|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
148803536|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
148803537|NCT02717195|536761075|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
148803538|NCT02717195|536761076|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
148803539|NCT02717195|536761077|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
148803540|NCT02717195|536761078|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
148803541|NCT02717195|536761079|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
148803542|NCT00855218|536761080|FG000|Overall Study|Adverse Event|43|||
148803543|NCT00855218|536761081|FG001|Overall Study|Adverse Event|27|||
148803544|NCT00855218|536761080|FG000|Overall Study|Withdrawal by Subject|10|||
148803545|NCT00855218|536761081|FG001|Overall Study|Withdrawal by Subject|6|||
148803546|NCT00855218|536761080|FG000|Overall Study|Physician Decision|18|||
148803547|NCT00855218|536761081|FG001|Overall Study|Physician Decision|11|||
148803548|NCT00855218|536761080|FG000|Overall Study|Lost to Follow-up|0|||
148803549|NCT00855218|536761081|FG001|Overall Study|Lost to Follow-up|1|||
148803550|NCT00855218|536761080|FG000|Overall Study|Protocol Violation|5|||
148803551|NCT00855218|536761081|FG001|Overall Study|Protocol Violation|9|||
148803552|NCT00855218|536761080|FG000|Overall Study|non-compliant with study drug|3|||
148803553|NCT00855218|536761081|FG001|Overall Study|non-compliant with study drug|1|||
148803554|NCT00855218|536761080|FG000|Overall Study|patient convenience|2|||
148803555|NCT00855218|536761081|FG001|Overall Study|patient convenience|0|||
148803556|NCT00855218|536761080|FG000|Overall Study|technical problems|2|||
148803557|NCT00855218|536761081|FG001|Overall Study|technical problems|1|||
148803558|NCT00855218|536761080|FG000|Overall Study|Still treated with study medication|0|||
148803559|NCT00855218|536761081|FG001|Overall Study|Still treated with study medication|1|||
148803560|NCT00855218|536761080|FG000|Overall Study|Untreatable disease progression|54|||
148803561|NCT00855218|536761081|FG001|Overall Study|Untreatable disease progression|67|||
148803562|NCT00855218|536761080|FG000|Overall Study|Second malignancy|0|||
148803563|NCT00855218|536761081|FG001|Overall Study|Second malignancy|1|||
148803564|NCT00855218|536761080|FG000|Overall Study|Progression measurement proven|7|||
148803565|NCT00855218|536761081|FG001|Overall Study|Progression measurement proven|15|||
148803566|NCT00855218|536761080|FG000|Overall Study|Clinical endpoint reached|10|||
148803567|NCT00855218|536761081|FG001|Overall Study|Clinical endpoint reached|13|||
148803568|NCT00769561|536761083|FG000|Overall Study|Withdrawal by Subject|2|||
148803569|NCT00769561|536761084|FG001|Overall Study|Withdrawal by Subject|2|||
148803570|NCT00769561|536761083|FG000|Overall Study|Lost to Follow-up|1|||
148803571|NCT00769561|536761084|FG001|Overall Study|Lost to Follow-up|3|||
148803572|NCT03824561|536761091|FG000|Overall Study|Protocol Violation|19|||
148803573|NCT03191552|536761092|FG000|Overall Study|Lost to Follow-up|1|||
148803574|NCT03191552|536761093|FG001|Overall Study|Lost to Follow-up|0|||
148803575|NCT03191552|536761094|FG002|Overall Study|Lost to Follow-up|0|||
148803576|NCT03191552|536761092|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
148803577|NCT03191552|536761093|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
148803578|NCT03191552|536761094|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
148803579|NCT02370511|536761097|FG000|Overall Study|Death|10|||
148803580|NCT02370511|536761098|FG001|Overall Study|Death|7|||
148803581|NCT02370511|536761099|FG002|Overall Study|Death|1|||
148803582|NCT02370511|536761097|FG000|Overall Study|Withdrawal by Subject|2|||
148803583|NCT02370511|536761098|FG001|Overall Study|Withdrawal by Subject|0|||
148803584|NCT02370511|536761099|FG002|Overall Study|Withdrawal by Subject|0|||
148803585|NCT02370511|536761097|FG000|Overall Study|Lost to Follow-up|0|||
148803586|NCT02370511|536761098|FG001|Overall Study|Lost to Follow-up|4|||
148803587|NCT02370511|536761099|FG002|Overall Study|Lost to Follow-up|0|||
148803588|NCT03092752|536761102|FG000|Overall Study|Aged <40 years|14209|||
148803589|NCT03092752|536761102|FG000|Overall Study|At least one claim with T2DM|61299|||
148803590|NCT03092752|536761102|FG000|Overall Study|Having no claim of study drugs|29282|||
148803591|NCT03092752|536761102|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
148803592|NCT03092752|536761102|FG000|Overall Study|<6 month history|245900|||
148803593|NCT03882918|536761103|FG000|Overall Study|Study terminated by sponsor|98|||
148803594|NCT03882918|536761103|FG000|Overall Study|Protocol Violation|1|||
148803595|NCT03882918|536761103|FG000|Overall Study|Other|9|||
148908458|NCT01931566|537146645|FG002|Overall Study|Reason Not Specified|53|||
148908459|NCT01931566|537146643|FG000|Overall Study|Missing|0|||
148908460|NCT01931566|537146644|FG001|Overall Study|Missing|0|||
148908461|NCT01931566|537146645|FG002|Overall Study|Missing|1|||
148908462|NCT01599637|537146646|FG000|Overall Study|administrative problems|0|||
148908463|NCT01599637|537146647|FG001|Overall Study|administrative problems|2|||
148908464|NCT01599637|537146648|FG002|Overall Study|administrative problems|0|||
148908465|NCT01599637|537146646|FG000|Overall Study|Adverse Event|1|||
148908466|NCT01599637|537146647|FG001|Overall Study|Adverse Event|0|||
148908467|NCT01599637|537146648|FG002|Overall Study|Adverse Event|0|||
148908468|NCT00760617|537146650|FG000|Overall Study|Adverse Event|5|||
148908469|NCT00760617|537146651|FG001|Overall Study|Adverse Event|2|||
148908470|NCT00760617|537146652|FG002|Overall Study|Adverse Event|0|||
148908471|NCT00760617|537146650|FG000|Overall Study|Lost to Follow-up|0|||
148908472|NCT00760617|537146651|FG001|Overall Study|Lost to Follow-up|0|||
148908473|NCT00760617|537146652|FG002|Overall Study|Lost to Follow-up|5|||
148908474|NCT04476797|537146653|FG000|Overall Study|Withdrawal by Subject|1|||
148908475|NCT04476797|537146654|FG001|Overall Study|Withdrawal by Subject|0|||
148908476|NCT04476797|537146655|FG002|Overall Study|Withdrawal by Subject|0|||
148908477|NCT04476797|537146653|FG000|Overall Study|Death|0|||
148908478|NCT04476797|537146654|FG001|Overall Study|Death|1|||
148908479|NCT04476797|537146655|FG002|Overall Study|Death|2|||
148908480|NCT04476797|537146653|FG000|Overall Study|Sponsor Terminated Study|0|||
148908481|NCT04476797|537146654|FG001|Overall Study|Sponsor Terminated Study|18|||
148908482|NCT04476797|537146655|FG002|Overall Study|Sponsor Terminated Study|17|||
148908483|NCT04625101|537146658|FG000|Overall Study|Withdrawal by Subject|0|||
148908484|NCT04625101|537146659|FG001|Overall Study|Withdrawal by Subject|1|||
148908485|NCT04625101|537146658|FG000|Overall Study|Protocol Deviation|1|||
148908486|NCT04625101|537146659|FG001|Overall Study|Protocol Deviation|0|||
148908487|NCT02991040|537146660|FG000|Overall Study|Withdrawal by Subject|2|||
148908488|NCT02991040|537146660|FG000|Overall Study|Lost to Follow-up|2|||
148908489|NCT04287517|537146662|FG000|Overall Study|Withdrawal by Subject|1|||
148908490|NCT04287517|537146663|FG001|Overall Study|Withdrawal by Subject|1|||
148908491|NCT03857867|537146664|FG000|Overall Study|Physician Decision|1|||
148908492|NCT02102204|537148381|FG000|Overall Study|Withdrawal by Subject|137|||
148908493|NCT02102204|537148381|FG000|Overall Study|Death|92|||
148908494|NCT02102204|537148381|FG000|Overall Study|Lost to Follow-up|65|||
148908495|NCT02102204|537148381|FG000|Overall Study|Sponsor Decision|5|||
148908496|NCT02102204|537148381|FG000|Overall Study|Ongoing|5|||
148908497|NCT01596062|537148384|FG000|Overall Study|Adverse Event|1|||
148908498|NCT01596062|537148385|FG001|Overall Study|Adverse Event|0|||
148908499|NCT01596062|537148386|FG002|Overall Study|Adverse Event|2|||
148908500|NCT01596062|537148384|FG000|Overall Study|Lack of Efficacy|0|||
148908501|NCT01596062|537148385|FG001|Overall Study|Lack of Efficacy|0|||
148908502|NCT01596062|537148386|FG002|Overall Study|Lack of Efficacy|1|||
148908503|NCT02255435|537148387|FG000|Overall Study|Patient's Limited Time Availability|0|||
148908504|NCT02255435|537148388|FG001|Overall Study|Patient's Limited Time Availability|0|||
148908505|NCT02255435|537148389|FG002|Overall Study|Patient's Limited Time Availability|0|||
148908506|NCT02255435|537148390|FG003|Overall Study|Patient's Limited Time Availability|0|||
148908507|NCT02255435|537148391|FG004|Overall Study|Patient's Limited Time Availability|0|||
148908508|NCT02255435|537148392|FG005|Overall Study|Patient's Limited Time Availability|0|||
148908509|NCT02255435|537148393|FG006|Overall Study|Patient's Limited Time Availability|0|||
148908510|NCT02255435|537148394|FG007|Overall Study|Patient's Limited Time Availability|1|||
148908511|NCT02255435|537148395|FG008|Overall Study|Patient's Limited Time Availability|0|||
148908512|NCT02255435|537148396|FG009|Overall Study|Patient's Limited Time Availability|0|||
148908513|NCT02255435|537148387|FG000|Overall Study|Withdrawal by Subject|0|||
148908514|NCT02255435|537148388|FG001|Overall Study|Withdrawal by Subject|0|||
148908515|NCT02255435|537148389|FG002|Overall Study|Withdrawal by Subject|0|||
148908516|NCT02255435|537148390|FG003|Overall Study|Withdrawal by Subject|0|||
148908517|NCT02255435|537148391|FG004|Overall Study|Withdrawal by Subject|0|||
148908518|NCT02255435|537148392|FG005|Overall Study|Withdrawal by Subject|0|||
148908519|NCT02255435|537148393|FG006|Overall Study|Withdrawal by Subject|0|||
148908520|NCT02255435|537148394|FG007|Overall Study|Withdrawal by Subject|0|||
148908521|NCT02255435|537148395|FG008|Overall Study|Withdrawal by Subject|1|||
148908522|NCT02255435|537148396|FG009|Overall Study|Withdrawal by Subject|4|||
148908523|NCT02255435|537148387|FG000|Overall Study|Administrative reasons|0|||
148908524|NCT02255435|537148388|FG001|Overall Study|Administrative reasons|0|||
148908525|NCT02255435|537148389|FG002|Overall Study|Administrative reasons|0|||
148908526|NCT02255435|537148390|FG003|Overall Study|Administrative reasons|0|||
148908527|NCT02255435|537148391|FG004|Overall Study|Administrative reasons|0|||
148908528|NCT02255435|537148392|FG005|Overall Study|Administrative reasons|0|||
148908529|NCT02255435|537148393|FG006|Overall Study|Administrative reasons|0|||
148908530|NCT02255435|537148394|FG007|Overall Study|Administrative reasons|0|||
148908531|NCT02255435|537148395|FG008|Overall Study|Administrative reasons|0|||
148908532|NCT02255435|537148396|FG009|Overall Study|Administrative reasons|2|||
148908533|NCT02741518|537148399|FG000|Overall Study|Withdrawal by Subject|1|||
148908534|NCT02741518|537148400|FG001|Overall Study|Withdrawal by Subject|1|||
148908535|NCT00476008|537148401|FG000|Overall Study|Adverse Event|4|||
148908536|NCT00476008|537148402|FG001|Overall Study|Adverse Event|4|||
148908537|NCT00476008|537148401|FG000|Overall Study|Placebo concerns|2|||
148908538|NCT00476008|537148402|FG001|Overall Study|Placebo concerns|2|||
148908539|NCT00476008|537148401|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
148908540|NCT00476008|537148402|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
148908541|NCT00476008|537148401|FG000|Overall Study|Withdrawal by Subject|0|||
148908542|NCT00476008|537148402|FG001|Overall Study|Withdrawal by Subject|1|||
148908543|NCT00476008|537148401|FG000|Overall Study|Death|1|||
148908544|NCT00476008|537148402|FG001|Overall Study|Death|0|||
148908545|NCT01227018|537148403|FG000|Overall Study|Disease progression|9|||
148908546|NCT01227018|537148403|FG000|Overall Study|Toxicity|2|||
148908547|NCT01227018|537148403|FG000|Overall Study|Withdrew after beginning treatment|4|||
148908548|NCT02948634|537148404|FG000|Overall Study|Lack of efficacy and study suspended|10|||
148908549|NCT02948634|537148405|FG001|Overall Study|Lack of efficacy and study suspended|2|||
148908550|NCT00499616|537148408|FG000|Overall Study|Death|1|||
148908551|NCT00499616|537148409|FG001|Overall Study|Death|5|||
148908552|NCT00499616|537148410|FG002|Overall Study|Death|3|||
148908553|NCT00499616|537148411|FG003|Overall Study|Death|1|||
148908554|NCT00499616|537148408|FG000|Overall Study|Lack of Efficacy|5|||
148908555|NCT00499616|537148409|FG001|Overall Study|Lack of Efficacy|0|||
148908556|NCT00499616|537148410|FG002|Overall Study|Lack of Efficacy|19|||
148908557|NCT00499616|537148411|FG003|Overall Study|Lack of Efficacy|0|||
148908558|NCT00499616|537148408|FG000|Overall Study|Lost to Follow-up|0|||
148908559|NCT00499616|537148409|FG001|Overall Study|Lost to Follow-up|0|||
148908560|NCT00499616|537148410|FG002|Overall Study|Lost to Follow-up|1|||
148908561|NCT00499616|537148411|FG003|Overall Study|Lost to Follow-up|0|||
148908562|NCT00499616|537148408|FG000|Overall Study|Physician Decision|6|||
148908563|NCT00499616|537148409|FG001|Overall Study|Physician Decision|16|||
148908564|NCT00499616|537148410|FG002|Overall Study|Physician Decision|9|||
148908565|NCT00499616|537148411|FG003|Overall Study|Physician Decision|0|||
148908566|NCT00499616|537148408|FG000|Overall Study|Withdrawal by Subject|1|||
148908567|NCT00499616|537148409|FG001|Overall Study|Withdrawal by Subject|0|||
148908568|NCT00499616|537148410|FG002|Overall Study|Withdrawal by Subject|1|||
148908569|NCT00499616|537148411|FG003|Overall Study|Withdrawal by Subject|0|||
148908570|NCT00499616|537148408|FG000|Overall Study|Ineligible|1|||
148908571|NCT00499616|537148409|FG001|Overall Study|Ineligible|2|||
148908572|NCT00499616|537148410|FG002|Overall Study|Ineligible|0|||
148908573|NCT00499616|537148411|FG003|Overall Study|Ineligible|15|||
148908574|NCT00499616|537148408|FG000|Overall Study|Not evaluable|0|||
148908575|NCT00499616|537148409|FG001|Overall Study|Not evaluable|0|||
148908576|NCT00499616|537148410|FG002|Overall Study|Not evaluable|0|||
148908577|NCT00499616|537148411|FG003|Overall Study|Not evaluable|41|||
148908578|NCT00499616|537148408|FG000|Overall Study|Patient/Parent Refusal|1|||
148908579|NCT00499616|537148409|FG001|Overall Study|Patient/Parent Refusal|5|||
148908580|NCT00499616|537148410|FG002|Overall Study|Patient/Parent Refusal|3|||
148908581|NCT00499616|537148411|FG003|Overall Study|Patient/Parent Refusal|0|||
148908582|NCT04269265|537148412|FG000|Overall Study|Physician Decision|1|||
148908583|NCT04269265|537148412|FG000|Overall Study|Withdrawal by Subject|1|||
148908584|NCT04269265|537148412|FG000|Overall Study|Overenrolled (sample size reached)|4|||
148908585|NCT04439136|537148413|FG000|Overall Study|Ineligible|1|||
148908586|NCT04439136|537148413|FG000|Overall Study|Never Started Treatment|2|||
148908587|NCT04439136|537148413|FG000|Overall Study|Adverse Event|4|||
148908588|NCT04439136|537148413|FG000|Overall Study|Death|3|||
148908589|NCT04439136|537148413|FG000|Overall Study|Disease Progression|27|||
148908590|NCT04439136|537148413|FG000|Overall Study|Alternative Therapy|1|||
148908591|NCT04439136|537148413|FG000|Overall Study|Increased Tumor Burden|1|||
148908592|NCT04439136|537148413|FG000|Overall Study|Symptomatic Detrioration|1|||
148908593|NCT02910986|537148414|FG000|Overall Study|non-Latina|14|||
148908594|NCT02910986|537148415|FG001|Overall Study|non-Latina|13|||
148908595|NCT02910986|537148416|FG002|Overall Study|non-Latina|12|||
148908596|NCT02910986|537148414|FG000|Overall Study|Failure to return T! survey|72|||
148908597|NCT02910986|537148415|FG001|Overall Study|Failure to return T! survey|84|||
148908598|NCT02910986|537148416|FG002|Overall Study|Failure to return T! survey|72|||
148908599|NCT02910986|537148414|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
148908600|NCT02910986|537148415|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
148908601|NCT02910986|537148416|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
148908602|NCT02910986|537148414|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
148908603|NCT02910986|537148415|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
148908604|NCT02910986|537148416|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
148908605|NCT03682770|537148432|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
148908606|NCT03682770|537148433|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
148908607|NCT03682770|537148434|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
148908608|NCT03682770|537148435|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
148908609|NCT03682770|537148436|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
148908610|NCT03682770|537148437|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
148908611|NCT03682770|537148438|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
148908612|NCT03682770|537148432|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
148908613|NCT03682770|537148433|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
148908614|NCT03682770|537148434|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
148908615|NCT03682770|537148435|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
149012002|NCT02318719|537523420|FG003|Open-label Extension Phase|Death|0|||
148908616|NCT03682770|537148436|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
148908617|NCT03682770|537148437|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
148908618|NCT03682770|537148438|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
148908619|NCT03682770|537148432|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
148908620|NCT03682770|537148433|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
148908621|NCT03682770|537148434|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
148908622|NCT03682770|537148435|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
148908623|NCT03682770|537148436|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
148908624|NCT03682770|537148437|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
148908625|NCT03682770|537148438|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
148908626|NCT03682770|537148432|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
148908627|NCT03682770|537148433|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
148908628|NCT03682770|537148434|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
148908629|NCT03682770|537148435|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
148908630|NCT03682770|537148436|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
148908631|NCT03682770|537148437|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
148908632|NCT03682770|537148438|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
148908633|NCT03682770|537148432|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
148908634|NCT03682770|537148433|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
148908635|NCT03682770|537148434|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
148908636|NCT03682770|537148435|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
148908637|NCT03682770|537148436|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
148803596|NCT03882918|536761103|FG000|Overall Study|Lack of Efficacy|14|||
148803597|NCT03882918|536761103|FG000|Overall Study|Adverse Event|13|||
148803598|NCT03882918|536761103|FG000|Overall Study|Withdrawal by Subject|5|||
148803599|NCT06996301|536761104|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
148803600|NCT06996301|536761105|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
148803601|NCT06996301|536761104|FG000|Overall Study|Patients with discordant diagnostic results|107|||
148803602|NCT06996301|536761105|FG001|Overall Study|Patients with discordant diagnostic results|90|||
148803603|NCT06996301|536761104|FG000|Overall Study|Lost to Follow-up|31|||
148803604|NCT06996301|536761105|FG001|Overall Study|Lost to Follow-up|56|||
148908638|NCT03682770|537148437|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
148908639|NCT03682770|537148438|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
148908640|NCT03682770|537148432|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
148908641|NCT03682770|537148433|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
148908642|NCT03682770|537148434|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
148908643|NCT03682770|537148435|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
148908644|NCT03682770|537148436|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
148908645|NCT03682770|537148437|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
148908646|NCT03682770|537148438|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
148908647|NCT03682770|537148432|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
148908648|NCT03682770|537148433|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
148908649|NCT03682770|537148434|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
148908650|NCT03682770|537148435|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
148908651|NCT03682770|537148436|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
148908652|NCT03682770|537148437|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
148908653|NCT03682770|537148438|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
148908654|NCT03682770|537148432|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
148908655|NCT03682770|537148433|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
148908656|NCT03682770|537148434|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
148908657|NCT03682770|537148435|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
148908658|NCT03682770|537148436|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
148908659|NCT03682770|537148437|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
148908660|NCT03682770|537148438|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
148908661|NCT03682770|537148432|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
148908662|NCT03682770|537148433|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
148908663|NCT03682770|537148434|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
148908664|NCT03682770|537148435|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
148908665|NCT03682770|537148436|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
148908666|NCT03682770|537148437|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
148908667|NCT03682770|537148438|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
148908668|NCT03682770|537148432|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
148908669|NCT03682770|537148433|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
148908670|NCT03682770|537148434|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
148908671|NCT03682770|537148435|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
148908672|NCT03682770|537148436|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
148908673|NCT03682770|537148437|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
148908674|NCT03682770|537148438|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
148908675|NCT03682770|537148432|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
148908676|NCT03682770|537148433|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
148908677|NCT03682770|537148434|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
148908678|NCT03682770|537148435|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
148908679|NCT03682770|537148436|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
148908680|NCT03682770|537148437|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
148908681|NCT03682770|537148438|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
148908682|NCT03682770|537148432|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
149138596|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Progressive disease|0|||
149138597|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Progressive disease|1|||
149138598|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Progressive disease|0|||
149138599|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Progressive disease|0|||
148908683|NCT03682770|537148433|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
148908684|NCT03682770|537148434|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
149138600|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
149138601|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
149138602|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
149138603|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
149138604|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
149138605|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
149138606|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
149138607|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
149138608|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
149138609|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
149138610|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
149138611|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
149138612|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
148908685|NCT03682770|537148435|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
148908686|NCT03682770|537148436|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
148908687|NCT03682770|537148437|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
149012003|NCT02318719|537523421|FG004|Open-label Extension Phase|Death|1|||
149138613|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
149138614|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
149138615|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
148908688|NCT03682770|537148438|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
148908689|NCT01491607|537148439|FG000|Overall Study|Lost to Follow-up|7|||
148908690|NCT01491607|537148439|FG000|Overall Study|Withdrawal by Subject|3|||
148908691|NCT01317277|537148440|FG000|Overall Study|Lost to Follow-up|3|||
148908692|NCT01317277|537148441|FG001|Overall Study|Lost to Follow-up|1|||
148908693|NCT01317277|537148440|FG000|Overall Study|Lost MEMS|1|||
148908694|NCT01317277|537148441|FG001|Overall Study|Lost MEMS|1|||
148908695|NCT01317277|537148440|FG000|Overall Study|Unable to comply with intervention|1|||
148908696|NCT01317277|537148441|FG001|Overall Study|Unable to comply with intervention|0|||
148908697|NCT01317277|537148440|FG000|Overall Study|Withdrawal by Subject|1|||
148908698|NCT01317277|537148441|FG001|Overall Study|Withdrawal by Subject|0|||
148908699|NCT01317277|537148440|FG000|Overall Study|Adverse Event|1|||
148908700|NCT01317277|537148441|FG001|Overall Study|Adverse Event|0|||
148908701|NCT00774566|537148442|FG000|Overall Study|Protocol Violation|18|||
148908702|NCT00774566|537148443|FG001|Overall Study|Protocol Violation|15|||
148908703|NCT00439517|537148452|FG000|Overall Study|Subject on treatment|1|||
148908704|NCT00439517|537148453|FG001|Overall Study|Subject on treatment|0|||
148908705|NCT00439517|537148452|FG000|Overall Study|Subject in survival follow-up|1|||
148908706|NCT00439517|537148453|FG001|Overall Study|Subject in survival follow-up|0|||
148908707|NCT03527732|537148456|FG000|Overall Study|Lost to Follow-up|21|||
148908708|NCT03527732|537148457|FG001|Overall Study|Lost to Follow-up|23|||
148908709|NCT03527732|537148458|FG002|Overall Study|Lost to Follow-up|80|||
148908710|NCT03527732|537148459|FG003|Overall Study|Lost to Follow-up|62|||
148908711|NCT03527732|537148460|FG004|Overall Study|Lost to Follow-up|12|||
148908712|NCT03527732|537148461|FG005|Overall Study|Lost to Follow-up|20|||
148908713|NCT01262989|537148462|FG000|Period 1|Lost to Follow-up|1|||
148908714|NCT01262989|537148463|FG001|Period 1|Lost to Follow-up|1|||
148908715|NCT01262989|537148462|FG000|Period 1|Intercurrent disease|0|||
148908716|NCT01262989|537148463|FG001|Period 1|Intercurrent disease|1|||
148908717|NCT01262989|537148462|FG000|Period 1|Positive answer for exclusion criteria|0|||
148908718|NCT01262989|537148463|FG001|Period 1|Positive answer for exclusion criteria|1|||
148908719|NCT01262989|537148462|FG000|Period 2|Intercurrent disease|0|||
148908720|NCT01262989|537148463|FG001|Period 2|Intercurrent disease|1|||
148908721|NCT00470275|537148464|FG000|Overall Study|Death|1|||
148908722|NCT00470275|537148464|FG000|Overall Study|Lack of Efficacy|7|||
148908723|NCT00470275|537148464|FG000|Overall Study|Withdrawal by Subject|2|||
148908724|NCT02500797|537148465|FG000|Overall Study|Cancel (rapid disease progression)|0|||
148908725|NCT02500797|537148466|FG001|Overall Study|Cancel (rapid disease progression)|0|||
148908726|NCT02500797|537148467|FG002|Overall Study|Cancel (rapid disease progression)|0|||
148908727|NCT02500797|537148468|FG003|Overall Study|Cancel (rapid disease progression)|0|||
148908728|NCT02500797|537148469|FG004|Overall Study|Cancel (rapid disease progression)|1|||
148908729|NCT02500797|537148470|FG005|Overall Study|Cancel (rapid disease progression)|1|||
148908730|NCT02500797|537148471|FG006|Overall Study|Cancel (rapid disease progression)|0|||
148908731|NCT02500797|537148472|FG007|Overall Study|Cancel (rapid disease progression)|0|||
148908732|NCT02500797|537148465|FG000|Overall Study|Withdrawal by Subject|1|||
148908733|NCT02500797|537148466|FG001|Overall Study|Withdrawal by Subject|0|||
148908734|NCT02500797|537148467|FG002|Overall Study|Withdrawal by Subject|0|||
148908735|NCT02500797|537148468|FG003|Overall Study|Withdrawal by Subject|0|||
148908736|NCT02500797|537148469|FG004|Overall Study|Withdrawal by Subject|0|||
148908737|NCT02500797|537148470|FG005|Overall Study|Withdrawal by Subject|0|||
148908738|NCT02500797|537148471|FG006|Overall Study|Withdrawal by Subject|0|||
148908739|NCT02500797|537148472|FG007|Overall Study|Withdrawal by Subject|0|||
148908740|NCT00060840|537148473|FG000|Overall Study|Change in surgical plan|2|||
148908741|NCT00060840|537148474|FG001|Overall Study|Change in surgical plan|6|||
148908742|NCT00060840|537148473|FG000|Overall Study|Death|0|||
148908743|NCT00060840|537148474|FG001|Overall Study|Death|1|||
148908744|NCT00060840|537148473|FG000|Overall Study|Withdrawal by Subject|0|||
148908745|NCT00060840|537148474|FG001|Overall Study|Withdrawal by Subject|1|||
149138616|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
148908746|NCT00060840|537148473|FG000|Overall Study|Subinvestigator unavailable|0|||
148908747|NCT00060840|537148474|FG001|Overall Study|Subinvestigator unavailable|1|||
148908748|NCT00060840|537148473|FG000|Overall Study|Physician Decision|1|||
148908749|NCT00060840|537148474|FG001|Overall Study|Physician Decision|0|||
148908750|NCT00060840|537148473|FG000|Overall Study|Other|1|||
148908751|NCT00060840|537148474|FG001|Overall Study|Other|0|||
148908752|NCT00357006|537148479|FG000|Overall Study|Lost to Follow-up|1|||
148908753|NCT00357006|537148480|FG001|Overall Study|Lost to Follow-up|2|||
148908754|NCT00357006|537148481|FG002|Overall Study|Lost to Follow-up|1|||
148908755|NCT00357006|537148479|FG000|Overall Study|Withdrawal by Subject|1|||
148908756|NCT00357006|537148480|FG001|Overall Study|Withdrawal by Subject|3|||
148908757|NCT00357006|537148481|FG002|Overall Study|Withdrawal by Subject|2|||
148908758|NCT00976560|537148482|FG000|Overall Study|Adverse Event|5|||
148908759|NCT00976560|537148483|FG001|Overall Study|Adverse Event|5|||
148908760|NCT00976560|537148482|FG000|Overall Study|Lack of Efficacy|3|||
148908761|NCT00976560|537148483|FG001|Overall Study|Lack of Efficacy|5|||
148908762|NCT00976560|537148482|FG000|Overall Study|Protocol Violation|1|||
148908763|NCT00976560|537148483|FG001|Overall Study|Protocol Violation|0|||
148908764|NCT00976560|537148482|FG000|Overall Study|Lost to Follow-up|1|||
148908765|NCT00976560|537148483|FG001|Overall Study|Lost to Follow-up|0|||
148908766|NCT00976560|537148482|FG000|Overall Study|Physician Decision|2|||
148908767|NCT00976560|537148483|FG001|Overall Study|Physician Decision|0|||
148908768|NCT00976560|537148482|FG000|Overall Study|Withdrawal by Subject|2|||
148908769|NCT00976560|537148483|FG001|Overall Study|Withdrawal by Subject|3|||
148908770|NCT03710161|537148484|FG000|Overall Study|Study halted due to COVID pandemic|3|||
148908771|NCT03710161|537148485|FG001|Overall Study|Study halted due to COVID pandemic|2|||
148908772|NCT01469377|537148493|FG000|Overall Study|Protocol Deviation|7|||
148908773|NCT01469377|537148494|FG001|Overall Study|Protocol Deviation|10|||
148908774|NCT01469377|537148495|FG002|Overall Study|Protocol Deviation|10|||
148908775|NCT01469377|537148493|FG000|Overall Study|Lost to Follow-up|3|||
148908776|NCT01469377|537148494|FG001|Overall Study|Lost to Follow-up|2|||
148908777|NCT01469377|537148495|FG002|Overall Study|Lost to Follow-up|5|||
148908778|NCT01469377|537148493|FG000|Overall Study|Withdrawal of Consent|12|||
148908779|NCT01469377|537148494|FG001|Overall Study|Withdrawal of Consent|14|||
148908780|NCT01469377|537148495|FG002|Overall Study|Withdrawal of Consent|15|||
148908781|NCT01469377|537148493|FG000|Overall Study|Adverse Event|8|||
148908782|NCT01469377|537148494|FG001|Overall Study|Adverse Event|18|||
148908783|NCT01469377|537148495|FG002|Overall Study|Adverse Event|36|||
148908784|NCT01469377|537148493|FG000|Overall Study|Insufficient Therapeutic Response|3|||
148908785|NCT01469377|537148494|FG001|Overall Study|Insufficient Therapeutic Response|4|||
148908786|NCT01469377|537148495|FG002|Overall Study|Insufficient Therapeutic Response|0|||
148908787|NCT01469377|537148493|FG000|Overall Study|Other Miscellaneous Reasons|2|||
148908788|NCT01469377|537148494|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148908789|NCT01469377|537148495|FG002|Overall Study|Other Miscellaneous Reasons|0|||
148908790|NCT04939415|537148496|FG000|Overall Study|Withdrawal by Subject|1|||
148908791|NCT04939415|537148497|FG001|Overall Study|Withdrawal by Subject|3|||
148908792|NCT04939415|537148496|FG000|Overall Study|Lost to Follow-up|0|||
148908793|NCT04939415|537148497|FG001|Overall Study|Lost to Follow-up|2|||
148908794|NCT04308291|537148498|FG000|Run-In Phase|Withdrawal by Subject|4|||
148908795|NCT04308291|537148498|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
148908796|NCT04308291|537148498|FG000|Study Phase 6-M|Physician Decision|2|||
148908797|NCT04308291|537148498|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
148908798|NCT04308291|537148498|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
148908799|NCT04308291|537148498|FG000|Study Phase 12-M|Physician Decision|2|||
148908800|NCT04308291|537148498|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
148908801|NCT00611026|537148505|FG000|Randomized to Double-blind Treatment|Not treated|2|||
148908802|NCT00611026|537148506|FG001|Randomized to Double-blind Treatment|Not treated|1|||
148908803|NCT00611026|537148507|FG002|Randomized to Double-blind Treatment|Not treated|3|||
148908804|NCT00611026|537148505|FG000|Double-blind Treatment Period|Death|1|||
148908805|NCT00611026|537148506|FG001|Double-blind Treatment Period|Death|0|||
148908806|NCT00611026|537148507|FG002|Double-blind Treatment Period|Death|0|||
148908807|NCT00611026|537148505|FG000|Double-blind Treatment Period|Adverse Event|9|||
148908808|NCT00611026|537148506|FG001|Double-blind Treatment Period|Adverse Event|28|||
148908809|NCT00611026|537148507|FG002|Double-blind Treatment Period|Adverse Event|46|||
148908810|NCT00611026|537148505|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
148908811|NCT00611026|537148506|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
148908812|NCT00611026|537148507|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
148908813|NCT00611026|537148505|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
148908814|NCT00611026|537148506|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
148908815|NCT00611026|537148507|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
148908816|NCT00611026|537148505|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
148908817|NCT00611026|537148506|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
148908818|NCT00611026|537148507|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
148908819|NCT00611026|537148505|FG000|Double-blind Treatment Period|Other|13|||
148908820|NCT00611026|537148506|FG001|Double-blind Treatment Period|Other|20|||
148908821|NCT00611026|537148507|FG002|Double-blind Treatment Period|Other|18|||
148908822|NCT02395081|537148508|FG000|Overall Study|Withdrawal by Subject|1|||
148908823|NCT02395081|537148509|FG001|Overall Study|Withdrawal by Subject|1|||
148908824|NCT02395081|537148510|FG002|Overall Study|Withdrawal by Subject|0|||
148908825|NCT02395081|537148508|FG000|Overall Study|Moved where blood couldn't be collected|4|||
148908826|NCT02395081|537148509|FG001|Overall Study|Moved where blood couldn't be collected|1|||
148908827|NCT02395081|537148510|FG002|Overall Study|Moved where blood couldn't be collected|3|||
148908828|NCT02395081|537148508|FG000|Overall Study|Fetal Loss|2|||
148908829|NCT02395081|537148509|FG001|Overall Study|Fetal Loss|3|||
148908830|NCT02395081|537148510|FG002|Overall Study|Fetal Loss|1|||
148908831|NCT01147874|537148511|FG000|Overall Study|Adverse Event|5|||
148908832|NCT01147874|537148511|FG000|Overall Study|Investigator's Request|1|||
148908833|NCT01147874|537148511|FG000|Overall Study|Lost to Follow-up|25|||
148908834|NCT01147874|537148511|FG000|Overall Study|Other|5|||
148908835|NCT01147874|537148511|FG000|Overall Study|Protocol Violation|5|||
148908836|NCT01147874|537148511|FG000|Overall Study|Sponsor's Decision|2|||
148908837|NCT01147874|537148511|FG000|Overall Study|Withdrawal by Subject|24|||
148908838|NCT02721966|537148517|FG000|Overall Study|Protocol Violation|1|||
148908839|NCT02721966|537148518|FG001|Overall Study|Protocol Violation|0|||
148908840|NCT02721966|537148519|FG002|Overall Study|Protocol Violation|0|||
148908841|NCT02721966|537148520|FG003|Overall Study|Protocol Violation|0|||
148908842|NCT02721966|537148521|FG004|Overall Study|Protocol Violation|0|||
148908843|NCT02721966|537148517|FG000|Overall Study|Withdrawal by Subject|9|||
148908844|NCT02721966|537148518|FG001|Overall Study|Withdrawal by Subject|2|||
148908845|NCT02721966|537148519|FG002|Overall Study|Withdrawal by Subject|3|||
148908846|NCT02721966|537148520|FG003|Overall Study|Withdrawal by Subject|7|||
148908847|NCT02721966|537148521|FG004|Overall Study|Withdrawal by Subject|0|||
148908848|NCT02721966|537148517|FG000|Overall Study|Adverse Event|4|||
148908849|NCT02721966|537148518|FG001|Overall Study|Adverse Event|4|||
148908850|NCT02721966|537148519|FG002|Overall Study|Adverse Event|3|||
148908851|NCT02721966|537148520|FG003|Overall Study|Adverse Event|0|||
148908852|NCT02721966|537148521|FG004|Overall Study|Adverse Event|0|||
148908853|NCT02721966|537148517|FG000|Overall Study|Death|1|||
148908854|NCT02721966|537148518|FG001|Overall Study|Death|0|||
148908855|NCT02721966|537148519|FG002|Overall Study|Death|0|||
148908856|NCT02721966|537148520|FG003|Overall Study|Death|0|||
148908857|NCT02721966|537148521|FG004|Overall Study|Death|0|||
148908858|NCT02721966|537148517|FG000|Overall Study|Lack of Efficacy|7|||
148908859|NCT02721966|537148518|FG001|Overall Study|Lack of Efficacy|4|||
148908860|NCT02721966|537148519|FG002|Overall Study|Lack of Efficacy|0|||
148908861|NCT02721966|537148520|FG003|Overall Study|Lack of Efficacy|0|||
148908862|NCT02721966|537148521|FG004|Overall Study|Lack of Efficacy|0|||
148908863|NCT02721966|537148517|FG000|Overall Study|Lost to Follow-up|0|||
148908864|NCT02721966|537148518|FG001|Overall Study|Lost to Follow-up|0|||
148908865|NCT02721966|537148519|FG002|Overall Study|Lost to Follow-up|3|||
148908866|NCT02721966|537148520|FG003|Overall Study|Lost to Follow-up|0|||
148908867|NCT02721966|537148521|FG004|Overall Study|Lost to Follow-up|0|||
148908868|NCT02721966|537148517|FG000|Overall Study|Physician Decision|1|||
148908869|NCT02721966|537148518|FG001|Overall Study|Physician Decision|1|||
148908870|NCT02721966|537148519|FG002|Overall Study|Physician Decision|0|||
148908871|NCT02721966|537148520|FG003|Overall Study|Physician Decision|0|||
148908872|NCT02721966|537148521|FG004|Overall Study|Physician Decision|0|||
148908873|NCT02721966|537148517|FG000|Overall Study|Pregnancy|1|||
148908874|NCT02721966|537148518|FG001|Overall Study|Pregnancy|0|||
148908875|NCT02721966|537148519|FG002|Overall Study|Pregnancy|0|||
148908876|NCT02721966|537148520|FG003|Overall Study|Pregnancy|0|||
148908877|NCT02721966|537148521|FG004|Overall Study|Pregnancy|0|||
148908878|NCT02721966|537148517|FG000|Overall Study|Did not continue to period 2|5|||
148908879|NCT02721966|537148518|FG001|Overall Study|Did not continue to period 2|12|||
148908880|NCT02721966|537148519|FG002|Overall Study|Did not continue to period 2|0|||
148908881|NCT02721966|537148520|FG003|Overall Study|Did not continue to period 2|0|||
148908882|NCT02721966|537148521|FG004|Overall Study|Did not continue to period 2|5|||
148908883|NCT02175030|537148525|FG000|Overall Study|Failed screen after consent|7|||
148908884|NCT02175030|537148526|FG001|Overall Study|Failed screen after consent|6|||
148908885|NCT02175030|537148525|FG000|Overall Study|Failed IUD Insertion|20|||
148908886|NCT02175030|537148526|FG001|Overall Study|Failed IUD Insertion|21|||
148908887|NCT02175030|537148525|FG000|Overall Study|Physician Decision|1|||
148908888|NCT02175030|537148526|FG001|Overall Study|Physician Decision|1|||
148908889|NCT02175030|537148525|FG000|Overall Study|Lost to Follow-up|6|||
148908890|NCT02175030|537148526|FG001|Overall Study|Lost to Follow-up|6|||
148908891|NCT02175030|537148525|FG000|Overall Study|Withdrawal by Subject|1|||
148908892|NCT02175030|537148526|FG001|Overall Study|Withdrawal by Subject|4|||
148908893|NCT02533453|537148527|FG000|Overall Study|Adverse Event|6|||
148908894|NCT02533453|537148527|FG000|Overall Study|Protocol Violation|1|||
148908895|NCT02533453|537148527|FG000|Overall Study|Withdrawal by Subject|2|||
148908896|NCT05340478|537148529|FG000|Overall Study|Scheduling Issues|10|||
148908897|NCT05340478|537148530|FG001|Overall Study|Scheduling Issues|4|||
148908898|NCT05340478|537148529|FG000|Overall Study|Neither member of dyad started treatment|2|||
148908899|NCT05340478|537148530|FG001|Overall Study|Neither member of dyad started treatment|2|||
148908900|NCT05340478|537148529|FG000|Overall Study|Withdrawn from study|2|||
148908901|NCT05340478|537148530|FG001|Overall Study|Withdrawn from study|2|||
148908902|NCT05340478|537148529|FG000|Overall Study|Lost to Follow-up|1|||
148908903|NCT05340478|537148530|FG001|Overall Study|Lost to Follow-up|4|||
148908904|NCT00092443|537148533|FG000|Overall Study|Adverse Event|9|||
148908905|NCT00092443|537148534|FG001|Overall Study|Adverse Event|13|||
148908906|NCT00092443|537148533|FG000|Overall Study|Lost to Follow-up|7|||
148908907|NCT00092443|537148534|FG001|Overall Study|Lost to Follow-up|3|||
148908908|NCT00092443|537148533|FG000|Overall Study|Protocol Violation|11|||
148908909|NCT00092443|537148534|FG001|Overall Study|Protocol Violation|9|||
148908910|NCT00092443|537148533|FG000|Overall Study|Withdrawal by Subject|9|||
148908911|NCT00092443|537148534|FG001|Overall Study|Withdrawal by Subject|11|||
148908912|NCT00092443|537148533|FG000|Overall Study|Moved|5|||
148908913|NCT00092443|537148534|FG001|Overall Study|Moved|5|||
148908914|NCT00092443|537148533|FG000|Overall Study|Other|17|||
148908915|NCT00092443|537148534|FG001|Overall Study|Other|13|||
148908916|NCT02963506|537148535|FG000|Double-Blind Period|Adverse Event|0|||
148908917|NCT02963506|537148536|FG001|Double-Blind Period|Adverse Event|0|||
148908918|NCT02963506|537148537|FG002|Double-Blind Period|Adverse Event|1|||
148908919|NCT02963506|537148538|FG003|Double-Blind Period|Adverse Event|0|||
148908920|NCT02963506|537148539|FG004|Double-Blind Period|Adverse Event|0|||
148908921|NCT02963506|537148540|FG005|Double-Blind Period|Adverse Event|0|||
148908922|NCT02963506|537148541|FG006|Double-Blind Period|Adverse Event|0|||
148908923|NCT02963506|537148542|FG007|Double-Blind Period|Adverse Event|0|||
148908924|NCT02963506|537148543|FG008|Double-Blind Period|Adverse Event|0|||
148908925|NCT02963506|537148544|FG009|Double-Blind Period|Adverse Event|0|||
148908926|NCT02963506|537148545|FG010|Double-Blind Period|Adverse Event|0|||
148908927|NCT02963506|537148546|FG011|Double-Blind Period|Adverse Event|0|||
148908928|NCT02963506|537148547|FG012|Double-Blind Period|Adverse Event|0|||
148908929|NCT02963506|537148535|FG000|Double-Blind Period|Death|0|||
148908930|NCT02963506|537148536|FG001|Double-Blind Period|Death|0|||
148908931|NCT02963506|537148537|FG002|Double-Blind Period|Death|0|||
148908932|NCT02963506|537148538|FG003|Double-Blind Period|Death|1|||
148908933|NCT02963506|537148539|FG004|Double-Blind Period|Death|0|||
148908934|NCT02963506|537148540|FG005|Double-Blind Period|Death|0|||
148908935|NCT02963506|537148541|FG006|Double-Blind Period|Death|0|||
148908936|NCT02963506|537148542|FG007|Double-Blind Period|Death|0|||
148908937|NCT02963506|537148543|FG008|Double-Blind Period|Death|0|||
148908938|NCT02963506|537148544|FG009|Double-Blind Period|Death|0|||
148908939|NCT02963506|537148545|FG010|Double-Blind Period|Death|0|||
148908940|NCT02963506|537148546|FG011|Double-Blind Period|Death|0|||
148908941|NCT02963506|537148547|FG012|Double-Blind Period|Death|0|||
148908942|NCT02963506|537148535|FG000|Double-Blind Period|Lost to Follow-up|0|||
148908943|NCT02963506|537148536|FG001|Double-Blind Period|Lost to Follow-up|1|||
148908944|NCT02963506|537148537|FG002|Double-Blind Period|Lost to Follow-up|0|||
148908945|NCT02963506|537148538|FG003|Double-Blind Period|Lost to Follow-up|0|||
148908946|NCT02963506|537148539|FG004|Double-Blind Period|Lost to Follow-up|0|||
148908947|NCT02963506|537148540|FG005|Double-Blind Period|Lost to Follow-up|0|||
148908948|NCT02963506|537148541|FG006|Double-Blind Period|Lost to Follow-up|0|||
148908949|NCT02963506|537148542|FG007|Double-Blind Period|Lost to Follow-up|0|||
148908950|NCT02963506|537148543|FG008|Double-Blind Period|Lost to Follow-up|0|||
148908951|NCT02963506|537148544|FG009|Double-Blind Period|Lost to Follow-up|0|||
148908952|NCT02963506|537148545|FG010|Double-Blind Period|Lost to Follow-up|0|||
148908953|NCT02963506|537148546|FG011|Double-Blind Period|Lost to Follow-up|0|||
148908954|NCT02963506|537148547|FG012|Double-Blind Period|Lost to Follow-up|0|||
148908955|NCT02963506|537148535|FG000|Double-Blind Period|Withdrawal by Subject|0|||
148908956|NCT02963506|537148536|FG001|Double-Blind Period|Withdrawal by Subject|0|||
148908957|NCT02963506|537148537|FG002|Double-Blind Period|Withdrawal by Subject|1|||
148908958|NCT02963506|537148538|FG003|Double-Blind Period|Withdrawal by Subject|1|||
148908959|NCT02963506|537148539|FG004|Double-Blind Period|Withdrawal by Subject|0|||
148908960|NCT02963506|537148540|FG005|Double-Blind Period|Withdrawal by Subject|0|||
148908961|NCT02963506|537148541|FG006|Double-Blind Period|Withdrawal by Subject|0|||
149138617|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
148908962|NCT02963506|537148542|FG007|Double-Blind Period|Withdrawal by Subject|0|||
148908963|NCT02963506|537148543|FG008|Double-Blind Period|Withdrawal by Subject|0|||
148908964|NCT02963506|537148544|FG009|Double-Blind Period|Withdrawal by Subject|0|||
148908965|NCT02963506|537148545|FG010|Double-Blind Period|Withdrawal by Subject|0|||
148908966|NCT02963506|537148546|FG011|Double-Blind Period|Withdrawal by Subject|0|||
148908967|NCT02963506|537148547|FG012|Double-Blind Period|Withdrawal by Subject|0|||
148908968|NCT02963506|537148535|FG000|Double-Blind Period|No compliance|0|||
148908969|NCT02963506|537148536|FG001|Double-Blind Period|No compliance|1|||
148908970|NCT02963506|537148537|FG002|Double-Blind Period|No compliance|0|||
148908971|NCT02963506|537148538|FG003|Double-Blind Period|No compliance|0|||
148908972|NCT02963506|537148539|FG004|Double-Blind Period|No compliance|0|||
148908973|NCT02963506|537148540|FG005|Double-Blind Period|No compliance|0|||
148908974|NCT02963506|537148541|FG006|Double-Blind Period|No compliance|0|||
148908975|NCT02963506|537148542|FG007|Double-Blind Period|No compliance|0|||
148908976|NCT02963506|537148543|FG008|Double-Blind Period|No compliance|0|||
148908977|NCT02963506|537148544|FG009|Double-Blind Period|No compliance|0|||
148908978|NCT02963506|537148545|FG010|Double-Blind Period|No compliance|0|||
148908979|NCT02963506|537148546|FG011|Double-Blind Period|No compliance|0|||
148908980|NCT02963506|537148547|FG012|Double-Blind Period|No compliance|0|||
148908981|NCT02963506|537148535|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908982|NCT02963506|537148536|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
148908983|NCT02963506|537148537|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908984|NCT02963506|537148538|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908985|NCT02963506|537148539|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908986|NCT02963506|537148540|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908987|NCT02963506|537148541|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908988|NCT02963506|537148542|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908989|NCT02963506|537148543|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908990|NCT02963506|537148544|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908991|NCT02963506|537148545|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908992|NCT02963506|537148546|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908993|NCT02963506|537148547|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
148908994|NCT02963506|537148535|FG000|Dose-Blind Period|Adverse Event|0|||
148908995|NCT02963506|537148536|FG001|Dose-Blind Period|Adverse Event|0|||
148908996|NCT02963506|537148537|FG002|Dose-Blind Period|Adverse Event|0|||
148908997|NCT02963506|537148538|FG003|Dose-Blind Period|Adverse Event|0|||
148908998|NCT02963506|537148539|FG004|Dose-Blind Period|Adverse Event|0|||
148908999|NCT02963506|537148540|FG005|Dose-Blind Period|Adverse Event|1|||
148909000|NCT02963506|537148541|FG006|Dose-Blind Period|Adverse Event|3|||
148909001|NCT02963506|537148542|FG007|Dose-Blind Period|Adverse Event|2|||
148909002|NCT02963506|537148543|FG008|Dose-Blind Period|Adverse Event|2|||
148909003|NCT02963506|537148544|FG009|Dose-Blind Period|Adverse Event|2|||
148909004|NCT02963506|537148545|FG010|Dose-Blind Period|Adverse Event|1|||
148909005|NCT02963506|537148546|FG011|Dose-Blind Period|Adverse Event|1|||
148909006|NCT02963506|537148547|FG012|Dose-Blind Period|Adverse Event|6|||
148909007|NCT02963506|537148535|FG000|Dose-Blind Period|Lack of Efficacy|0|||
148909008|NCT02963506|537148536|FG001|Dose-Blind Period|Lack of Efficacy|0|||
148909009|NCT02963506|537148537|FG002|Dose-Blind Period|Lack of Efficacy|0|||
148909010|NCT02963506|537148538|FG003|Dose-Blind Period|Lack of Efficacy|0|||
148909011|NCT02963506|537148539|FG004|Dose-Blind Period|Lack of Efficacy|0|||
148909012|NCT02963506|537148540|FG005|Dose-Blind Period|Lack of Efficacy|0|||
148909013|NCT02963506|537148541|FG006|Dose-Blind Period|Lack of Efficacy|0|||
148909014|NCT02963506|537148542|FG007|Dose-Blind Period|Lack of Efficacy|1|||
148909015|NCT02963506|537148543|FG008|Dose-Blind Period|Lack of Efficacy|0|||
148909016|NCT02963506|537148544|FG009|Dose-Blind Period|Lack of Efficacy|1|||
148909017|NCT02963506|537148545|FG010|Dose-Blind Period|Lack of Efficacy|0|||
148909018|NCT02963506|537148546|FG011|Dose-Blind Period|Lack of Efficacy|0|||
148909019|NCT02963506|537148547|FG012|Dose-Blind Period|Lack of Efficacy|0|||
148909020|NCT02963506|537148535|FG000|Dose-Blind Period|Lost to Follow-up|0|||
148909021|NCT02963506|537148536|FG001|Dose-Blind Period|Lost to Follow-up|0|||
148909022|NCT02963506|537148537|FG002|Dose-Blind Period|Lost to Follow-up|0|||
148909023|NCT02963506|537148538|FG003|Dose-Blind Period|Lost to Follow-up|0|||
148909024|NCT02963506|537148539|FG004|Dose-Blind Period|Lost to Follow-up|0|||
148909025|NCT02963506|537148540|FG005|Dose-Blind Period|Lost to Follow-up|1|||
148909026|NCT02963506|537148541|FG006|Dose-Blind Period|Lost to Follow-up|0|||
148909027|NCT02963506|537148542|FG007|Dose-Blind Period|Lost to Follow-up|0|||
148909028|NCT02963506|537148543|FG008|Dose-Blind Period|Lost to Follow-up|1|||
148909029|NCT02963506|537148544|FG009|Dose-Blind Period|Lost to Follow-up|0|||
148909030|NCT02963506|537148545|FG010|Dose-Blind Period|Lost to Follow-up|0|||
148909031|NCT02963506|537148546|FG011|Dose-Blind Period|Lost to Follow-up|1|||
148909032|NCT02963506|537148547|FG012|Dose-Blind Period|Lost to Follow-up|0|||
148909033|NCT02963506|537148535|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
148909034|NCT02963506|537148536|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
148909035|NCT02963506|537148537|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
148909036|NCT02963506|537148538|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
148909037|NCT02963506|537148539|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
148909038|NCT02963506|537148540|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
148909039|NCT02963506|537148541|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
148909040|NCT02963506|537148542|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
148909041|NCT02963506|537148543|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
148909042|NCT02963506|537148544|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
148909043|NCT02963506|537148545|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
148909044|NCT02963506|537148546|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
148909045|NCT02963506|537148547|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
148909046|NCT02963506|537148535|FG000|Dose-Blind Period|Sponsor decision|0|||
148909047|NCT02963506|537148536|FG001|Dose-Blind Period|Sponsor decision|0|||
148909048|NCT02963506|537148537|FG002|Dose-Blind Period|Sponsor decision|0|||
148909049|NCT02963506|537148538|FG003|Dose-Blind Period|Sponsor decision|0|||
148909050|NCT02963506|537148539|FG004|Dose-Blind Period|Sponsor decision|0|||
148909051|NCT02963506|537148540|FG005|Dose-Blind Period|Sponsor decision|1|||
148909052|NCT02963506|537148541|FG006|Dose-Blind Period|Sponsor decision|0|||
148909053|NCT02963506|537148542|FG007|Dose-Blind Period|Sponsor decision|0|||
148909054|NCT02963506|537148543|FG008|Dose-Blind Period|Sponsor decision|0|||
148909055|NCT02963506|537148544|FG009|Dose-Blind Period|Sponsor decision|0|||
148909056|NCT02963506|537148545|FG010|Dose-Blind Period|Sponsor decision|0|||
148909057|NCT02963506|537148546|FG011|Dose-Blind Period|Sponsor decision|0|||
148909058|NCT02963506|537148547|FG012|Dose-Blind Period|Sponsor decision|0|||
148909059|NCT02963506|537148535|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909060|NCT02963506|537148536|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909061|NCT02963506|537148537|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909062|NCT02963506|537148538|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909063|NCT02963506|537148539|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909064|NCT02963506|537148540|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909065|NCT02963506|537148541|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909066|NCT02963506|537148542|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909067|NCT02963506|537148543|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909068|NCT02963506|537148544|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909069|NCT02963506|537148545|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909070|NCT02963506|537148546|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
148909071|NCT02963506|537148547|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
148909072|NCT00630838|537148550|FG000|Overall Study|Death|0|||
148909073|NCT00630838|537148551|FG001|Overall Study|Death|1|||
148909074|NCT00630838|537148550|FG000|Overall Study|Lost to Follow-up|0|||
148909075|NCT00630838|537148551|FG001|Overall Study|Lost to Follow-up|1|||
148909076|NCT00928408|537148552|FG000|Overall Study|Other|2|||
148909077|NCT00928408|537148552|FG000|Overall Study|Withdrawal by Subject|4|||
148909078|NCT00928408|537148552|FG000|Overall Study|Death|5|||
148909079|NCT00928408|537148552|FG000|Overall Study|Lost to Follow-up|12|||
148909080|NCT00256997|537148553|FG000|Overall Study|Protocol Violation|1|||
148909081|NCT00256997|537148554|FG001|Overall Study|Protocol Violation|4|||
148909082|NCT00256997|537148553|FG000|Overall Study|Lack of Efficacy|1|||
149138618|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
149138619|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
149138620|NCT03523728|537988882|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
149138621|NCT03523728|537988883|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
148909083|NCT00256997|537148554|FG001|Overall Study|Lack of Efficacy|4|||
148909084|NCT00256997|537148553|FG000|Overall Study|Death|2|||
148909085|NCT00256997|537148554|FG001|Overall Study|Death|0|||
148909086|NCT00256997|537148553|FG000|Overall Study|Adverse Event|4|||
148909087|NCT00256997|537148554|FG001|Overall Study|Adverse Event|0|||
149138622|NCT03523728|537988884|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
148909088|NCT00256997|537148553|FG000|Overall Study|Lost to Follow-up|3|||
148909089|NCT00256997|537148554|FG001|Overall Study|Lost to Follow-up|5|||
148909090|NCT00256997|537148553|FG000|Overall Study|Withdrawal by Subject|13|||
149138623|NCT03523728|537988885|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
149138624|NCT03523728|537988886|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
148909091|NCT00256997|537148554|FG001|Overall Study|Withdrawal by Subject|3|||
148909092|NCT00256997|537148553|FG000|Overall Study|Started but not treated|2|||
148909093|NCT00256997|537148554|FG001|Overall Study|Started but not treated|0|||
148909094|NCT00256997|537148553|FG000|Overall Study|Other|5|||
148909095|NCT00256997|537148554|FG001|Overall Study|Other|8|||
148909096|NCT00256997|537148553|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
148909097|NCT00256997|537148554|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
148909098|NCT00256997|537148553|FG000|Overall Study|Participant Non-compliant|3|||
148909099|NCT00256997|537148554|FG001|Overall Study|Participant Non-compliant|6|||
148909100|NCT00256997|537148553|FG000|Overall Study|Investigator Withdrew Participant|2|||
148909101|NCT00256997|537148554|FG001|Overall Study|Investigator Withdrew Participant|1|||
148909102|NCT03843541|537148555|FG000|Overall Study|Adverse Event|4|||
148909103|NCT03843541|537148556|FG001|Overall Study|Adverse Event|2|||
148909104|NCT03843541|537148557|FG002|Overall Study|Adverse Event|3|||
148909105|NCT03843541|537148555|FG000|Overall Study|Death|1|||
148909106|NCT03843541|537148556|FG001|Overall Study|Death|0|||
148909107|NCT03843541|537148557|FG002|Overall Study|Death|0|||
148909108|NCT03843541|537148555|FG000|Overall Study|Lack of adherence to study medication|0|||
148909109|NCT03843541|537148556|FG001|Overall Study|Lack of adherence to study medication|0|||
148909110|NCT03843541|537148557|FG002|Overall Study|Lack of adherence to study medication|1|||
148909111|NCT03843541|537148555|FG000|Overall Study|Physician Decision|1|||
148909112|NCT03843541|537148556|FG001|Overall Study|Physician Decision|2|||
148909113|NCT03843541|537148557|FG002|Overall Study|Physician Decision|2|||
148909114|NCT03843541|537148555|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
148909115|NCT03843541|537148556|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
148909116|NCT03843541|537148557|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
148909117|NCT03843541|537148555|FG000|Overall Study|Withdrawal by Subject|6|||
148909118|NCT03843541|537148556|FG001|Overall Study|Withdrawal by Subject|9|||
148909119|NCT03843541|537148557|FG002|Overall Study|Withdrawal by Subject|7|||
148909120|NCT03843541|537148555|FG000|Overall Study|Administration of rescue mucolytic|0|||
148909121|NCT03843541|537148556|FG001|Overall Study|Administration of rescue mucolytic|0|||
148909122|NCT03843541|537148557|FG002|Overall Study|Administration of rescue mucolytic|1|||
148909123|NCT03843541|537148555|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
148909124|NCT03843541|537148556|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
148909125|NCT03843541|537148557|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
148909126|NCT04163016|537148559|FG000|Enrollment|Adverse Event|1|||
148909127|NCT04163016|537148560|FG001|Enrollment|Adverse Event|0|||
148909128|NCT04163016|537148561|FG002|Enrollment|Adverse Event|0|||
148909129|NCT04163016|537148562|FG003|Enrollment|Adverse Event|0|||
148909130|NCT04163016|537148559|FG000|Treatment|Adverse Event|0|||
148909131|NCT04163016|537148560|FG001|Treatment|Adverse Event|1|||
148909132|NCT04163016|537148561|FG002|Treatment|Adverse Event|0|||
148909133|NCT04163016|537148562|FG003|Treatment|Adverse Event|0|||
148909134|NCT04163016|537148559|FG000|Treatment|Withdrawal by Subject|0|||
148909135|NCT04163016|537148560|FG001|Treatment|Withdrawal by Subject|2|||
148909136|NCT04163016|537148561|FG002|Treatment|Withdrawal by Subject|0|||
148909137|NCT04163016|537148562|FG003|Treatment|Withdrawal by Subject|0|||
148909138|NCT04163016|537148559|FG000|Treatment|Indeterminate TB-test|0|||
148909139|NCT04163016|537148560|FG001|Treatment|Indeterminate TB-test|0|||
148909140|NCT04163016|537148561|FG002|Treatment|Indeterminate TB-test|0|||
148909141|NCT04163016|537148562|FG003|Treatment|Indeterminate TB-test|1|||
148909142|NCT04163016|537148559|FG000|Treatment|Participant did not want to continue in study|0|||
148909143|NCT04163016|537148560|FG001|Treatment|Participant did not want to continue in study|0|||
148909144|NCT04163016|537148561|FG002|Treatment|Participant did not want to continue in study|0|||
148909145|NCT04163016|537148562|FG003|Treatment|Participant did not want to continue in study|1|||
148909146|NCT02930018|537148566|FG000|Overall Study|Lost to Follow-up|1|||
148909147|NCT02930018|537148567|FG001|Overall Study|Lost to Follow-up|1|||
148909148|NCT02930018|537148566|FG000|Overall Study|Withdrawal by Subject|5|||
148909149|NCT02930018|537148567|FG001|Overall Study|Withdrawal by Subject|2|||
148909150|NCT01104311|537148568|FG000|Overall Study|Withdrawal by Subject|6|||
148909151|NCT01104311|537148569|FG001|Overall Study|Withdrawal by Subject|6|||
148909152|NCT01104311|537148568|FG000|Overall Study|Protocol Violation|0|||
148909153|NCT01104311|537148569|FG001|Overall Study|Protocol Violation|1|||
148909154|NCT01104311|537148568|FG000|Overall Study|Physician Decision|2|||
148909155|NCT01104311|537148569|FG001|Overall Study|Physician Decision|2|||
148909156|NCT01104311|537148568|FG000|Overall Study|low compliance|1|||
148909157|NCT01104311|537148569|FG001|Overall Study|low compliance|1|||
148909158|NCT01104311|537148568|FG000|Overall Study|Adverse Event|1|||
148909159|NCT01104311|537148569|FG001|Overall Study|Adverse Event|2|||
148909160|NCT01788358|537150085|FG000|Overall Study|Other|11|||
148909161|NCT01788358|537150085|FG000|Overall Study|Logistical difficulties|1|||
148909162|NCT01788358|537150085|FG000|Overall Study|Lost to Follow-up|5|||
148909163|NCT01788358|537150085|FG000|Overall Study|Protocol Violation|3|||
148909164|NCT01788358|537150085|FG000|Overall Study|Withdrawal by Subject|26|||
148909165|NCT01788358|537150085|FG000|Overall Study|Lack of Efficacy|1|||
148909166|NCT01788358|537150085|FG000|Overall Study|Adverse Event|51|||
148909167|NCT01168219|537150086|FG000|Overall Study|off study before starting treatment|2|||
148909168|NCT01168219|537150086|FG000|Overall Study|withdrew before transplant|1|||
148909169|NCT01168219|537150086|FG000|Overall Study|ineligible due to CML|2|||
148909170|NCT01413204|537150087|FG000|Overall Study|Adverse Event|1|||
148909171|NCT01413204|537150088|FG001|Overall Study|Adverse Event|2|||
148909172|NCT01413204|537150089|FG002|Overall Study|Adverse Event|2|||
148909173|NCT01413204|537150087|FG000|Overall Study|Physician Decision|3|||
148909174|NCT01413204|537150088|FG001|Overall Study|Physician Decision|0|||
148909175|NCT01413204|537150089|FG002|Overall Study|Physician Decision|2|||
148909176|NCT01413204|537150087|FG000|Overall Study|Withdrawal by Subject|1|||
148909177|NCT01413204|537150088|FG001|Overall Study|Withdrawal by Subject|4|||
148909178|NCT01413204|537150089|FG002|Overall Study|Withdrawal by Subject|4|||
148909179|NCT01413204|537150087|FG000|Overall Study|Clearly not eligible for the study|0|||
148909180|NCT01413204|537150088|FG001|Overall Study|Clearly not eligible for the study|0|||
148909181|NCT01413204|537150089|FG002|Overall Study|Clearly not eligible for the study|1|||
148909182|NCT01413204|537150087|FG000|Overall Study|Fasting plasma glucose level increased|1|||
148909183|NCT01413204|537150088|FG001|Overall Study|Fasting plasma glucose level increased|0|||
148909184|NCT01413204|537150089|FG002|Overall Study|Fasting plasma glucose level increased|10|||
148909185|NCT00753649|537150090|FG000|Overall Study|Migrated/moved from study area|1|||
148909186|NCT00753649|537150091|FG001|Overall Study|Migrated/moved from study area|0|||
148909187|NCT00753649|537150090|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
148909188|NCT00753649|537150091|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
148909189|NCT00753649|537150090|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
148909190|NCT00753649|537150091|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
148909191|NCT00753649|537150090|FG000|Overall Study|Protocol Violation|2|||
148909192|NCT00753649|537150091|FG001|Overall Study|Protocol Violation|0|||
148909193|NCT01837823|537150093|FG000|Overall Study|Lost to Follow-up|6|||
148909194|NCT01864603|537150094|FG000|Stage 2|DSMB design modification|86056|||
148909195|NCT01864603|537150095|FG001|Stage 2|DSMB design modification|92558|||
148909196|NCT03830892|537150099|FG000|Overall Study|Physician Decision|2|||
148909197|NCT03830892|537150100|FG001|Overall Study|Physician Decision|3|||
148909198|NCT03830892|537150099|FG000|Overall Study|Study terminated due to COVID|4|||
148909199|NCT03830892|537150100|FG001|Overall Study|Study terminated due to COVID|0|||
148909200|NCT03830892|537150099|FG000|Overall Study|Protocol Violation|0|||
148909201|NCT03830892|537150100|FG001|Overall Study|Protocol Violation|1|||
148909202|NCT03830892|537150099|FG000|Overall Study|Withdrawal by Subject|0|||
148909203|NCT03830892|537150100|FG001|Overall Study|Withdrawal by Subject|2|||
148909204|NCT00330967|537150101|FG000|Overall Study|Withdrawal by Subject|0|||
148909205|NCT00330967|537150102|FG001|Overall Study|Withdrawal by Subject|5|||
148909206|NCT00330967|537150101|FG000|Overall Study|Physician Decision|0|||
148909207|NCT00330967|537150102|FG001|Overall Study|Physician Decision|9|||
148909208|NCT02578706|537150103|FG000|Overall Study|Withdrawal by Subject|1|||
148909209|NCT02578706|537150104|FG001|Overall Study|Withdrawal by Subject|0|||
148909210|NCT02578706|537150105|FG002|Overall Study|Withdrawal by Subject|0|||
148909211|NCT02578706|537150103|FG000|Overall Study|Lost to Follow-up|0|||
148909212|NCT02578706|537150104|FG001|Overall Study|Lost to Follow-up|4|||
148909213|NCT02578706|537150105|FG002|Overall Study|Lost to Follow-up|0|||
148909214|NCT02578706|537150103|FG000|Overall Study|Physician Decision|0|||
148909215|NCT02578706|537150104|FG001|Overall Study|Physician Decision|1|||
148909216|NCT02578706|537150105|FG002|Overall Study|Physician Decision|0|||
148909217|NCT04849559|537150106|FG000|Overall Study|Withdrawal by Subject|2|||
148909218|NCT04849559|537150107|FG001|Overall Study|Withdrawal by Subject|1|||
148909219|NCT01662102|537150108|FG000|Overall Study|Sponsor's decision|1|||
148909220|NCT01662102|537150109|FG001|Overall Study|Sponsor's decision|0|||
148909221|NCT02586207|537150110|FG000|Overall Study|Physician Decision|1|||
148909222|NCT02586207|537150110|FG000|Overall Study|Withdrawal by Subject|1|||
148909223|NCT00392769|537150111|FG000|Overall Study|Clinical Deterioration|9|||
148909224|NCT00392769|537150111|FG000|Overall Study|Adverse Event|1|||
148909225|NCT03048578|537150112|FG000|Overall Study|Withdrawal by Subject|5|||
148909226|NCT03048578|537150113|FG001|Overall Study|Withdrawal by Subject|6|||
148909227|NCT03048578|537150112|FG000|Overall Study|Lost to Follow-up|22|||
148909228|NCT03048578|537150113|FG001|Overall Study|Lost to Follow-up|10|||
148909229|NCT03048578|537150112|FG000|Overall Study|Adverse Event|1|||
148909230|NCT03048578|537150113|FG001|Overall Study|Adverse Event|2|||
148909231|NCT03048578|537150112|FG000|Overall Study|Terminated|3|||
148909232|NCT03048578|537150113|FG001|Overall Study|Terminated|2|||
148909233|NCT00526071|537150114|FG000|Overall Study|Adverse Event|1|||
148909234|NCT00526071|537150114|FG000|Overall Study|Withdrawal by Subject|1|||
148909235|NCT00526071|537150114|FG000|Overall Study|Lack of Response to Study Drug|4|||
148909236|NCT03306173|537150115|FG000|Overall Study|Lost to Follow-up|16|||
148909237|NCT03306173|537150116|FG001|Overall Study|Lost to Follow-up|23|||
148909238|NCT03306173|537150115|FG000|Overall Study|Withdrawal by Subject|4|||
148909239|NCT03306173|537150116|FG001|Overall Study|Withdrawal by Subject|3|||
148909240|NCT03306173|537150115|FG000|Overall Study|Discontinued|4|||
148909241|NCT03306173|537150116|FG001|Overall Study|Discontinued|4|||
148909242|NCT00573144|537150117|FG000|Overall Study|Withdrawal by Subject|2|||
148909243|NCT00573144|537150118|FG001|Overall Study|Withdrawal by Subject|3|||
148909244|NCT00125164|537150121|FG000|Overall Study|Adverse Event|0|||
148909245|NCT00125164|537150122|FG001|Overall Study|Adverse Event|0|||
148909246|NCT00125164|537150123|FG002|Overall Study|Adverse Event|2|||
148909247|NCT00125164|537150124|FG003|Overall Study|Adverse Event|4|||
148909248|NCT00125164|537150121|FG000|Overall Study|Lost to Follow-up|0|||
148909249|NCT00125164|537150122|FG001|Overall Study|Lost to Follow-up|0|||
148909250|NCT00125164|537150123|FG002|Overall Study|Lost to Follow-up|1|||
148909251|NCT00125164|537150124|FG003|Overall Study|Lost to Follow-up|1|||
148909252|NCT00125164|537150121|FG000|Overall Study|Withdrawal by Subject|2|||
148909253|NCT00125164|537150122|FG001|Overall Study|Withdrawal by Subject|0|||
148909254|NCT00125164|537150123|FG002|Overall Study|Withdrawal by Subject|1|||
148909255|NCT00125164|537150124|FG003|Overall Study|Withdrawal by Subject|1|||
148909256|NCT01339052|537150125|FG000|Overall Study|Disease progression|13|||
148909257|NCT01339052|537150126|FG001|Overall Study|Disease progression|46|||
148909258|NCT01339052|537150125|FG000|Overall Study|Adverse Event|1|||
148909259|NCT01339052|537150126|FG001|Overall Study|Adverse Event|1|||
148909260|NCT01339052|537150125|FG000|Overall Study|Withdrawal by Subject|0|||
148909261|NCT01339052|537150126|FG001|Overall Study|Withdrawal by Subject|3|||
148909262|NCT01339052|537150125|FG000|Overall Study|Physician Decision|1|||
148909263|NCT01339052|537150126|FG001|Overall Study|Physician Decision|0|||
148909264|NCT02637037|537150127|FG000|Overall Study|Positive drug screen at admission|1|||
148909265|NCT02637037|537150128|FG001|Overall Study|Positive drug screen at admission|0|||
148909266|NCT02637037|537150127|FG000|Overall Study|Withdrawal by Subject|2|||
148909267|NCT02637037|537150128|FG001|Overall Study|Withdrawal by Subject|1|||
148909268|NCT02637037|537150127|FG000|Overall Study|Adverse Event|1|||
148909269|NCT02637037|537150128|FG001|Overall Study|Adverse Event|0|||
148909270|NCT02023697|537150129|FG000|Treatment Period|Radiological progression|13|||
148909271|NCT02023697|537150130|FG001|Treatment Period|Radiological progression|17|||
148909272|NCT02023697|537150131|FG002|Treatment Period|Radiological progression|26|||
148909273|NCT02023697|537150129|FG000|Treatment Period|Never Treated|5|||
148909274|NCT02023697|537150130|FG001|Treatment Period|Never Treated|6|||
148909275|NCT02023697|537150131|FG002|Treatment Period|Never Treated|10|||
148909276|NCT02023697|537150129|FG000|Treatment Period|Adverse Event|13|||
148909277|NCT02023697|537150130|FG001|Treatment Period|Adverse Event|25|||
148909278|NCT02023697|537150131|FG002|Treatment Period|Adverse Event|23|||
148909279|NCT02023697|537150129|FG000|Treatment Period|Logistical difficulties|1|||
148909280|NCT02023697|537150130|FG001|Treatment Period|Logistical difficulties|1|||
148909281|NCT02023697|537150131|FG002|Treatment Period|Logistical difficulties|1|||
148909282|NCT02023697|537150129|FG000|Treatment Period|Clinical progression|10|||
148909283|NCT02023697|537150130|FG001|Treatment Period|Clinical progression|8|||
148909284|NCT02023697|537150131|FG002|Treatment Period|Clinical progression|28|||
148909285|NCT02023697|537150129|FG000|Treatment Period|Withdrawal by Subject|4|||
148909286|NCT02023697|537150130|FG001|Treatment Period|Withdrawal by Subject|5|||
148909287|NCT02023697|537150131|FG002|Treatment Period|Withdrawal by Subject|13|||
148909288|NCT02023697|537150129|FG000|Treatment Period|Safety outcome reached|0|||
148909289|NCT02023697|537150130|FG001|Treatment Period|Safety outcome reached|1|||
148909290|NCT02023697|537150131|FG002|Treatment Period|Safety outcome reached|0|||
148909291|NCT02023697|537150129|FG000|Treatment Period|Physician Decision|0|||
148909292|NCT02023697|537150130|FG001|Treatment Period|Physician Decision|0|||
148909293|NCT02023697|537150131|FG002|Treatment Period|Physician Decision|1|||
148909294|NCT02023697|537150129|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
148909295|NCT02023697|537150130|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
148909296|NCT02023697|537150131|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
148909297|NCT02023697|537150129|FG000|Active Follow-up Period|Lost to Follow-up|1|||
148909298|NCT02023697|537150130|FG001|Active Follow-up Period|Lost to Follow-up|1|||
148909299|NCT02023697|537150131|FG002|Active Follow-up Period|Lost to Follow-up|1|||
148909300|NCT02023697|537150129|FG000|Active Follow-up Period|Deterioration of general condition|1|||
148909301|NCT02023697|537150130|FG001|Active Follow-up Period|Deterioration of general condition|1|||
148909302|NCT02023697|537150131|FG002|Active Follow-up Period|Deterioration of general condition|1|||
148909303|NCT02023697|537150129|FG000|Active Follow-up Period|Other unspecified|2|||
148909304|NCT02023697|537150130|FG001|Active Follow-up Period|Other unspecified|0|||
148909305|NCT02023697|537150131|FG002|Active Follow-up Period|Other unspecified|1|||
148909306|NCT02023697|537150129|FG000|Active Follow-up Period|Clinical progression|0|||
148909307|NCT02023697|537150130|FG001|Active Follow-up Period|Clinical progression|2|||
148909308|NCT02023697|537150131|FG002|Active Follow-up Period|Clinical progression|1|||
148909309|NCT02023697|537150129|FG000|Active Follow-up Period|Radiological progression|0|||
148909310|NCT02023697|537150130|FG001|Active Follow-up Period|Radiological progression|0|||
148909311|NCT02023697|537150131|FG002|Active Follow-up Period|Radiological progression|1|||
148909312|NCT02023697|537150129|FG000|Active Follow-up Period|Death|83|||
148909313|NCT02023697|537150130|FG001|Active Follow-up Period|Death|82|||
148909314|NCT02023697|537150131|FG002|Active Follow-up Period|Death|87|||
148909315|NCT02023697|537150129|FG000|Long-term Follow-up Period|Death|9|||
148909316|NCT02023697|537150130|FG001|Long-term Follow-up Period|Death|6|||
148909317|NCT02023697|537150131|FG002|Long-term Follow-up Period|Death|4|||
148909318|NCT02023697|537150129|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
148909319|NCT02023697|537150130|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
148909320|NCT02023697|537150131|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
148909321|NCT02023697|537150129|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
148909322|NCT02023697|537150130|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
148909323|NCT02023697|537150131|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
148909324|NCT02023697|537150129|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
148909325|NCT02023697|537150130|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
148909326|NCT02023697|537150131|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
148909327|NCT02023697|537150129|FG000|Long-term Follow-up Period|Technical problems|0|||
148909328|NCT02023697|537150130|FG001|Long-term Follow-up Period|Technical problems|0|||
148909329|NCT02023697|537150131|FG002|Long-term Follow-up Period|Technical problems|1|||
148909330|NCT02023697|537150129|FG000|Long-term Follow-up Period|Other unspecified|6|||
148909331|NCT02023697|537150130|FG001|Long-term Follow-up Period|Other unspecified|3|||
148909332|NCT02023697|537150131|FG002|Long-term Follow-up Period|Other unspecified|5|||
148909333|NCT03610269|537150132|FG000|Overall Study|Physician Decision|10|||
148909334|NCT03610269|537150132|FG000|Overall Study|Protocol Violation|1|||
148909335|NCT03610269|537150132|FG000|Overall Study|Unable to draw blood|1|||
148909336|NCT03610269|537150132|FG000|Overall Study|Screen fail|4|||
148909337|NCT02453711|537150133|FG000|Overall Study|Withdrawal by Subject|5|||
148909338|NCT02453711|537150134|FG001|Overall Study|Withdrawal by Subject|4|||
148909339|NCT02453711|537150135|FG002|Overall Study|Withdrawal by Subject|6|||
148909340|NCT02453711|537150136|FG003|Overall Study|Withdrawal by Subject|4|||
148909341|NCT02453711|537150137|FG004|Overall Study|Withdrawal by Subject|1|||
148909342|NCT02453711|537150138|FG005|Overall Study|Withdrawal by Subject|1|||
148909343|NCT02453711|537150139|FG006|Overall Study|Withdrawal by Subject|0|||
148909344|NCT02453711|537150140|FG007|Overall Study|Withdrawal by Subject|1|||
148909345|NCT02453711|537150141|FG008|Overall Study|Withdrawal by Subject|7|||
148909346|NCT02453711|537150133|FG000|Overall Study|Lost to Follow-up|5|||
148909347|NCT02453711|537150134|FG001|Overall Study|Lost to Follow-up|3|||
148909348|NCT02453711|537150135|FG002|Overall Study|Lost to Follow-up|2|||
148909349|NCT02453711|537150136|FG003|Overall Study|Lost to Follow-up|3|||
148909350|NCT02453711|537150137|FG004|Overall Study|Lost to Follow-up|1|||
148909351|NCT02453711|537150138|FG005|Overall Study|Lost to Follow-up|5|||
148909352|NCT02453711|537150139|FG006|Overall Study|Lost to Follow-up|2|||
148909353|NCT02453711|537150140|FG007|Overall Study|Lost to Follow-up|6|||
148909354|NCT02453711|537150141|FG008|Overall Study|Lost to Follow-up|6|||
148909355|NCT02453711|537150133|FG000|Overall Study|Death|0|||
148909356|NCT02453711|537150134|FG001|Overall Study|Death|0|||
148909357|NCT02453711|537150135|FG002|Overall Study|Death|0|||
148909358|NCT02453711|537150136|FG003|Overall Study|Death|0|||
148909359|NCT02453711|537150137|FG004|Overall Study|Death|0|||
148909360|NCT02453711|537150138|FG005|Overall Study|Death|0|||
148909361|NCT02453711|537150139|FG006|Overall Study|Death|1|||
148909362|NCT02453711|537150140|FG007|Overall Study|Death|0|||
148909363|NCT02453711|537150141|FG008|Overall Study|Death|0|||
148909364|NCT02453711|537150133|FG000|Overall Study|Unclassified|1|||
148909365|NCT02453711|537150134|FG001|Overall Study|Unclassified|0|||
148909366|NCT02453711|537150135|FG002|Overall Study|Unclassified|1|||
148909367|NCT02453711|537150136|FG003|Overall Study|Unclassified|0|||
148909368|NCT02453711|537150137|FG004|Overall Study|Unclassified|0|||
148909369|NCT02453711|537150138|FG005|Overall Study|Unclassified|0|||
148909370|NCT02453711|537150139|FG006|Overall Study|Unclassified|0|||
148909371|NCT02453711|537150140|FG007|Overall Study|Unclassified|0|||
148909372|NCT02453711|537150141|FG008|Overall Study|Unclassified|0|||
148909373|NCT03695367|537150144|FG000|Overall Study|Missed the Day 28 visit.|1|||
148909374|NCT03695367|537150145|FG001|Overall Study|Missed the Day 28 visit.|0|||
148909375|NCT03695367|537150144|FG000|Overall Study|Lost to Follow-up|0|||
148909376|NCT03695367|537150145|FG001|Overall Study|Lost to Follow-up|1|||
148909377|NCT03695367|537150144|FG000|Overall Study|Withdrawal by Subject|0|||
148909378|NCT03695367|537150145|FG001|Overall Study|Withdrawal by Subject|1|||
148909379|NCT03695367|537150144|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
148909380|NCT03695367|537150145|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
148909381|NCT00068419|537150148|FG000|Overall Study|Adverse Event|3|||
148909382|NCT00068419|537150148|FG000|Overall Study|Lack of Efficacy|24|||
148909383|NCT00068419|537150148|FG000|Overall Study|Lost to Follow-up|1|||
148909384|NCT00068419|537150148|FG000|Overall Study|Physician Decision|7|||
148909385|NCT00068419|537150148|FG000|Overall Study|Withdrawal by Subject|14|||
148909386|NCT00068419|537150148|FG000|Overall Study|Ineligible|11|||
148909387|NCT00396253|537150157|FG000|Overall Study|Protocol Violation|1|||
148909388|NCT00396253|537150157|FG000|Overall Study|Withdrawal by Subject|7|||
148909389|NCT00396253|537150157|FG000|Overall Study|Death|3|||
148909390|NCT00396253|537150157|FG000|Overall Study|Physician Decision|1|||
148909391|NCT00396253|537150157|FG000|Overall Study|Change in eligibility status|1|||
148909392|NCT01032889|537150158|FG000|Overall Study|Adverse Event|2|||
148909393|NCT01032889|537150159|FG001|Overall Study|Adverse Event|2|||
148909394|NCT01032889|537150160|FG002|Overall Study|Adverse Event|0|||
148909395|NCT01032889|537150158|FG000|Overall Study|Withdrawal of Consent|1|||
148909396|NCT01032889|537150159|FG001|Overall Study|Withdrawal of Consent|2|||
148909397|NCT01032889|537150160|FG002|Overall Study|Withdrawal of Consent|1|||
149138625|NCT03523728|537988882|FG000|Stage 2 (24 Months)|Adverse Event|0|||
149138626|NCT03523728|537988883|FG001|Stage 2 (24 Months)|Adverse Event|0|||
149138627|NCT03523728|537988884|FG002|Stage 2 (24 Months)|Adverse Event|0|||
149138628|NCT03523728|537988885|FG003|Stage 2 (24 Months)|Adverse Event|1|||
149138629|NCT03523728|537988886|FG004|Stage 2 (24 Months)|Adverse Event|2|||
149138630|NCT03523728|537988882|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
149138631|NCT03523728|537988883|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
149138632|NCT03523728|537988884|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
149138633|NCT03523728|537988885|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
149138634|NCT03523728|537988886|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
148909398|NCT01032889|537150158|FG000|Overall Study|Patient Request|0|||
148909399|NCT01032889|537150159|FG001|Overall Study|Patient Request|1|||
148909400|NCT01032889|537150160|FG002|Overall Study|Patient Request|0|||
148909401|NCT01032889|537150158|FG000|Overall Study|Lost to Follow-up|1|||
148909402|NCT01032889|537150159|FG001|Overall Study|Lost to Follow-up|1|||
148909403|NCT01032889|537150160|FG002|Overall Study|Lost to Follow-up|0|||
148909404|NCT01032889|537150158|FG000|Overall Study|Lack of Submental Fat|2|||
148909405|NCT01032889|537150159|FG001|Overall Study|Lack of Submental Fat|8|||
149138635|NCT03523728|537988882|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
149138636|NCT03523728|537988883|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
148909406|NCT01032889|537150160|FG002|Overall Study|Lack of Submental Fat|1|||
148909407|NCT01032889|537150158|FG000|Overall Study|Miscellaneous Reasons|2|||
148909408|NCT01032889|537150159|FG001|Overall Study|Miscellaneous Reasons|1|||
148909409|NCT01032889|537150160|FG002|Overall Study|Miscellaneous Reasons|1|||
148909410|NCT01500720|537150168|FG000|Overall Study|Randomized But Not Treated|1|||
148909411|NCT01500720|537150169|FG001|Overall Study|Randomized But Not Treated|1|||
148909412|NCT01500720|537150168|FG000|Overall Study|Other|4|||
148909413|NCT01500720|537150169|FG001|Overall Study|Other|8|||
148909414|NCT00740857|537150171|FG000|Overall Study|Withdrawal by Subject|1|||
148909415|NCT00740857|537150172|FG001|Overall Study|Withdrawal by Subject|0|||
148909416|NCT00740857|537150173|FG002|Overall Study|Withdrawal by Subject|0|||
148909417|NCT04672655|537150181|FG000|Overall Study|Lost to Follow-up|12|||
148909418|NCT04672655|537150182|FG001|Overall Study|Lost to Follow-up|17|||
148909419|NCT04672655|537150181|FG000|Overall Study|Withdrawal by Subject|1|||
148909420|NCT04672655|537150182|FG001|Overall Study|Withdrawal by Subject|0|||
148909421|NCT04672655|537150181|FG000|Overall Study|Withdrawal by Study|1|||
149138637|NCT03523728|537988884|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
148909422|NCT04672655|537150182|FG001|Overall Study|Withdrawal by Study|0|||
148909423|NCT03892967|537150185|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
148909424|NCT03892967|537150186|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
148909425|NCT03892967|537150187|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
148956468|NCT00723892|537324428|FG000|Overall Study|Intercurrent infection|2|||
149138638|NCT03523728|537988885|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
149138639|NCT03523728|537988886|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
148909426|NCT03892967|537150188|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
148909427|NCT03892967|537150189|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
148909428|NCT03892967|537150185|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
148909429|NCT03892967|537150186|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
148909430|NCT03892967|537150187|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
148909431|NCT03892967|537150188|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
148909432|NCT03892967|537150189|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
148909433|NCT03892967|537150185|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
148909434|NCT03892967|537150186|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
148909435|NCT03892967|537150187|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
148909436|NCT03892967|537150188|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
148909437|NCT03892967|537150189|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
148909438|NCT03892967|537150185|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
148909439|NCT03892967|537150186|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
148909440|NCT03892967|537150187|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
148909441|NCT03892967|537150188|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
148909442|NCT03892967|537150189|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
148909443|NCT03892967|537150185|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
148909444|NCT03892967|537150186|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
148909445|NCT03892967|537150187|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
148909446|NCT03892967|537150188|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
148909447|NCT03892967|537150189|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
148909448|NCT03892967|537150185|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
148909449|NCT03892967|537150186|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
148909450|NCT03892967|537150187|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
148909451|NCT03892967|537150188|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
148909452|NCT03892967|537150189|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
148909453|NCT04434937|537150190|FG000|Overall Study|Death|4|||
148909454|NCT04434937|537150190|FG000|Overall Study|Withdrawal by Subject|1|||
148909455|NCT04434937|537150190|FG000|Overall Study|Transitioned to Rollover Study|19|||
148909456|NCT04434937|537150190|FG000|Overall Study|Progressive Disease|18|||
148909457|NCT03387085|537150195|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
148909458|NCT04193189|537150196|FG000|Overall Study|Lost to Follow-up|9|||
148909459|NCT04193189|537150197|FG001|Overall Study|Lost to Follow-up|7|||
148909460|NCT04193189|537150198|FG002|Overall Study|Lost to Follow-up|9|||
148909461|NCT04193189|537150199|FG003|Overall Study|Lost to Follow-up|0|||
148909462|NCT04193189|537150196|FG000|Overall Study|Withdrawal by Subject|1|||
148909463|NCT04193189|537150197|FG001|Overall Study|Withdrawal by Subject|2|||
148909464|NCT04193189|537150198|FG002|Overall Study|Withdrawal by Subject|2|||
148909465|NCT04193189|537150199|FG003|Overall Study|Withdrawal by Subject|0|||
148909466|NCT04193189|537150196|FG000|Overall Study|Death|1|||
148909467|NCT04193189|537150197|FG001|Overall Study|Death|1|||
148909468|NCT04193189|537150198|FG002|Overall Study|Death|0|||
148909469|NCT04193189|537150199|FG003|Overall Study|Death|0|||
148909470|NCT04193189|537150196|FG000|Overall Study|Protocol Violation|0|||
148909471|NCT04193189|537150197|FG001|Overall Study|Protocol Violation|0|||
148909472|NCT04193189|537150198|FG002|Overall Study|Protocol Violation|0|||
148909473|NCT04193189|537150199|FG003|Overall Study|Protocol Violation|1|||
148909474|NCT00684060|537151809|FG000|Overall Study|Lost to Follow-up|1|||
148909475|NCT00684060|537151810|FG001|Overall Study|Lost to Follow-up|0|||
148909476|NCT00684060|537151809|FG000|Overall Study|New stenosis identified|1|||
148909477|NCT00684060|537151810|FG001|Overall Study|New stenosis identified|0|||
148909478|NCT00684060|537151809|FG000|Overall Study|Unable to collect MRI|1|||
148909479|NCT00684060|537151810|FG001|Overall Study|Unable to collect MRI|2|||
148909480|NCT00684060|537151809|FG000|Overall Study|Death|0|||
148909481|NCT00684060|537151810|FG001|Overall Study|Death|1|||
148909482|NCT00702715|537151811|FG000|Overall Study|Lost to Follow-up|1|||
148909483|NCT00702715|537151812|FG001|Overall Study|Lost to Follow-up|0|||
148909484|NCT01677377|537151817|FG000|Overall Study|Protocol Violation|1|||
148909485|NCT01677377|537151818|FG001|Overall Study|Protocol Violation|0|||
148909486|NCT01677377|537151819|FG002|Overall Study|Protocol Violation|0|||
148909487|NCT01677377|537151817|FG000|Overall Study|Lost to Follow-up|0|||
148909488|NCT01677377|537151818|FG001|Overall Study|Lost to Follow-up|1|||
148909489|NCT01677377|537151819|FG002|Overall Study|Lost to Follow-up|1|||
148909490|NCT01677377|537151817|FG000|Overall Study|Withdrawal by Subject|0|||
148909491|NCT01677377|537151818|FG001|Overall Study|Withdrawal by Subject|0|||
148909492|NCT01677377|537151819|FG002|Overall Study|Withdrawal by Subject|3|||
148909493|NCT01677377|537151817|FG000|Overall Study|Lack of Efficacy|0|||
148909494|NCT01677377|537151818|FG001|Overall Study|Lack of Efficacy|0|||
148909495|NCT01677377|537151819|FG002|Overall Study|Lack of Efficacy|1|||
148909496|NCT01677377|537151817|FG000|Overall Study|Pregnancy|0|||
148909497|NCT01677377|537151818|FG001|Overall Study|Pregnancy|0|||
148909498|NCT01677377|537151819|FG002|Overall Study|Pregnancy|1|||
148909499|NCT00479687|537151820|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
148909500|NCT00479687|537151821|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
148909501|NCT00479687|537151822|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
148909502|NCT00479687|537151820|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
148909503|NCT00479687|537151821|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
148909504|NCT00479687|537151822|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
148909505|NCT00479687|537151820|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
148909506|NCT00479687|537151821|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
148909507|NCT00479687|537151822|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
148909508|NCT00479687|537151820|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
148909509|NCT00479687|537151821|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
148909510|NCT00479687|537151822|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
148909511|NCT00479687|537151820|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
148909512|NCT00479687|537151821|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
148909513|NCT00479687|537151822|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
148909514|NCT00479687|537151820|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
148909515|NCT00479687|537151821|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
148909516|NCT00479687|537151822|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
148909517|NCT00479687|537151820|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
148909518|NCT00479687|537151821|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
148909519|NCT00479687|537151822|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
148909520|NCT00479687|537151820|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
148909521|NCT00479687|537151821|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
148909522|NCT00479687|537151822|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
148909523|NCT00479687|537151820|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
148909524|NCT00479687|537151821|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
148909525|NCT00479687|537151822|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
148909526|NCT02260180|537151823|FG000|Overall Study|Adverse Event|2|||
148909527|NCT02260180|537151824|FG001|Overall Study|Adverse Event|0|||
148909528|NCT02260180|537151825|FG002|Overall Study|Adverse Event|1|||
148909529|NCT03180840|537151826|FG000|Overall Study|Withdrawal by Subject|1|||
148909530|NCT01193257|537151833|FG000|Overall Study|Death|202|||
148909531|NCT01193257|537151834|FG001|Overall Study|Death|391|||
148909532|NCT01193257|537151833|FG000|Overall Study|Study termination by sponsor|0|||
148909533|NCT01193257|537151834|FG001|Overall Study|Study termination by sponsor|3|||
148909534|NCT01193257|537151833|FG000|Overall Study|Withdrawal by Subject|26|||
148909535|NCT01193257|537151834|FG001|Overall Study|Withdrawal by Subject|86|||
148909536|NCT01193257|537151833|FG000|Overall Study|Lost to Follow-up|2|||
148909537|NCT01193257|537151834|FG001|Overall Study|Lost to Follow-up|3|||
148909538|NCT01193257|537151833|FG000|Overall Study|Unblinded due to futility|135|||
148909539|NCT01193257|537151834|FG001|Overall Study|Unblinded due to futility|251|||
148909540|NCT02563067|537151849|FG000|Overall Study|Subject/guardian decision|14|||
148909541|NCT02563067|537151850|FG001|Overall Study|Subject/guardian decision|20|||
148909542|NCT02563067|537151851|FG002|Overall Study|Subject/guardian decision|16|||
148909543|NCT02563067|537151849|FG000|Overall Study|Physician Decision|0|||
148909544|NCT02563067|537151850|FG001|Overall Study|Physician Decision|1|||
148909545|NCT02563067|537151851|FG002|Overall Study|Physician Decision|3|||
148909546|NCT02563067|537151849|FG000|Overall Study|Lost to Follow-up|1|||
148909547|NCT02563067|537151850|FG001|Overall Study|Lost to Follow-up|2|||
148909548|NCT02563067|537151851|FG002|Overall Study|Lost to Follow-up|0|||
148909549|NCT02563067|537151849|FG000|Overall Study|Technical problems|0|||
148909550|NCT02563067|537151850|FG001|Overall Study|Technical problems|1|||
148909551|NCT02563067|537151851|FG002|Overall Study|Technical problems|0|||
148909552|NCT02563067|537151849|FG000|Overall Study|Lack of Efficacy|1|||
148909553|NCT02563067|537151850|FG001|Overall Study|Lack of Efficacy|0|||
148803605|NCT06996301|536761104|FG000|Overall Study|Withdrawal by Subject|12|||
148803606|NCT06996301|536761105|FG001|Overall Study|Withdrawal by Subject|7|||
148909554|NCT02563067|537151851|FG002|Overall Study|Lack of Efficacy|0|||
148909555|NCT02563067|537151849|FG000|Overall Study|Death|0|||
148909556|NCT02563067|537151850|FG001|Overall Study|Death|1|||
148909557|NCT02563067|537151851|FG002|Overall Study|Death|1|||
148909558|NCT02563067|537151849|FG000|Overall Study|Adverse Event|2|||
148909559|NCT02563067|537151850|FG001|Overall Study|Adverse Event|1|||
148909560|NCT02563067|537151851|FG002|Overall Study|Adverse Event|0|||
148909561|NCT02563067|537151849|FG000|Overall Study|Death post Treatment/safety period|1|||
148909562|NCT02563067|537151850|FG001|Overall Study|Death post Treatment/safety period|0|||
148909563|NCT02563067|537151851|FG002|Overall Study|Death post Treatment/safety period|0|||
148909564|NCT03544333|537151852|FG000|Overall Study|Withdrawal by Subject|1|||
148909565|NCT03544333|537151853|FG001|Overall Study|Withdrawal by Subject|0|||
148909566|NCT01039519|537151861|FG000|Treatment|Progressive disease|20|||
148909567|NCT01039519|537151861|FG000|Treatment|Treatment failure|2|||
148909568|NCT01039519|537151861|FG000|Treatment|Adverse Event|3|||
148909569|NCT01039519|537151861|FG000|Treatment|Physician Decision|2|||
148909570|NCT01039519|537151861|FG000|Survival Follow-up|Death|23|||
148909571|NCT01039519|537151861|FG000|Survival Follow-up|Sponsor decision|4|||
148909572|NCT00808080|537151862|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
148909573|NCT00423917|537151865|FG000|Overall Study|Cancel|2|||
148909574|NCT00423917|537151865|FG000|Overall Study|Ineligible|1|||
148909575|NCT00243269|537151866|FG000|Overall Study|Protocol Violation|2|||
148803607|NCT04030598|536761106|FG000|Overall Study|Voluntary Withdrawal|0|||
148803608|NCT04030598|536761107|FG001|Overall Study|Voluntary Withdrawal|1|||
148803609|NCT04030598|536761108|FG002|Overall Study|Voluntary Withdrawal|0|||
148803610|NCT03141359|536761111|FG000|Overall Study|Death|32|||
148803611|NCT03141359|536761111|FG000|Overall Study|Still On Study (in follow up)|29|||
148803612|NCT02003144|536761112|FG000|Open Label Maintenance Phase|Other than specified|2|||
148803613|NCT02003144|536761113|FG001|Open Label Maintenance Phase|Other than specified|4|||
148803614|NCT02003144|536761112|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
148803615|NCT02003144|536761113|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
148803616|NCT02003144|536761112|FG000|Open Label Maintenance Phase|Pregnancy|0|||
148803617|NCT02003144|536761113|FG001|Open Label Maintenance Phase|Pregnancy|2|||
148803618|NCT02003144|536761112|FG000|Open Label Maintenance Phase|Physician Decision|1|||
148803619|NCT02003144|536761113|FG001|Open Label Maintenance Phase|Physician Decision|1|||
148803620|NCT02003144|536761112|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
148803621|NCT02003144|536761113|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
148803622|NCT02003144|536761112|FG000|Open Label Maintenance Phase|Adverse Event|2|||
148803623|NCT02003144|536761113|FG001|Open Label Maintenance Phase|Adverse Event|1|||
148803624|NCT01419535|536761115|FG000|Overall Study|could not maintain iv line|1|||
148803625|NCT01419535|536761116|FG001|Overall Study|could not maintain iv line|1|||
148803626|NCT01419535|536761115|FG000|Overall Study|Withdrawal by Subject|0|||
148909576|NCT00243269|537151867|FG001|Overall Study|Protocol Violation|1|||
148909577|NCT00243269|537151868|FG002|Overall Study|Protocol Violation|0|||
148909578|NCT00243269|537151869|FG003|Overall Study|Protocol Violation|1|||
148909579|NCT00243269|537151866|FG000|Overall Study|Lost to Follow-up|1|||
148909580|NCT00243269|537151867|FG001|Overall Study|Lost to Follow-up|0|||
148909581|NCT00243269|537151868|FG002|Overall Study|Lost to Follow-up|1|||
148909582|NCT00243269|537151869|FG003|Overall Study|Lost to Follow-up|3|||
148909583|NCT03052400|537151870|FG000|Overall Study|Lost to Follow-up|1|||
148909584|NCT03052400|537151871|FG001|Overall Study|Lost to Follow-up|0|||
148909585|NCT03052400|537151870|FG000|Overall Study|Withdrawal by Subject|0|||
148909586|NCT03052400|537151871|FG001|Overall Study|Withdrawal by Subject|1|||
148909587|NCT00555061|537151872|FG000|Overall Study|Adverse Event|3|||
148909588|NCT00555061|537151872|FG000|Overall Study|Protocol Violation|1|||
148909589|NCT00555061|537151872|FG000|Overall Study|Lost to Follow-up|2|||
148909590|NCT00555061|537151872|FG000|Overall Study|Withdrawal by Subject|2|||
148909591|NCT00555061|537151872|FG000|Overall Study|Participant enrolled, but never treated|1|||
148909592|NCT03656562|537151874|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
148909593|NCT03656562|537151875|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
148909594|NCT03656562|537151876|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
148909595|NCT03656562|537151877|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
148909596|NCT03656562|537151874|FG000|Overall Study|Physician Decision|1|||
148909597|NCT03656562|537151875|FG001|Overall Study|Physician Decision|2|||
148909598|NCT03656562|537151876|FG002|Overall Study|Physician Decision|0|||
148909599|NCT03656562|537151877|FG003|Overall Study|Physician Decision|0|||
148909600|NCT03656562|537151874|FG000|Overall Study|Subject Decision|3|||
148909601|NCT03656562|537151875|FG001|Overall Study|Subject Decision|5|||
148909602|NCT03656562|537151876|FG002|Overall Study|Subject Decision|0|||
148909603|NCT03656562|537151877|FG003|Overall Study|Subject Decision|2|||
148909604|NCT00337675|537151878|FG000|Overall Study|Adverse Event|10|||
148909605|NCT00337675|537151879|FG001|Overall Study|Adverse Event|9|||
148909606|NCT00337675|537151880|FG002|Overall Study|Adverse Event|19|||
148909607|NCT00337675|537151878|FG000|Overall Study|Lack of Efficacy|10|||
148909608|NCT00337675|537151879|FG001|Overall Study|Lack of Efficacy|7|||
148909609|NCT00337675|537151880|FG002|Overall Study|Lack of Efficacy|9|||
148909610|NCT00337675|537151878|FG000|Overall Study|Lost to Follow-up|22|||
148909611|NCT00337675|537151879|FG001|Overall Study|Lost to Follow-up|19|||
148909612|NCT00337675|537151880|FG002|Overall Study|Lost to Follow-up|17|||
148909613|NCT00337675|537151878|FG000|Overall Study|Physician Decision|9|||
148909614|NCT00337675|537151879|FG001|Overall Study|Physician Decision|17|||
148909615|NCT00337675|537151880|FG002|Overall Study|Physician Decision|14|||
148909616|NCT00337675|537151878|FG000|Overall Study|Protocol Violation|21|||
148909617|NCT00337675|537151879|FG001|Overall Study|Protocol Violation|24|||
148909618|NCT00337675|537151880|FG002|Overall Study|Protocol Violation|19|||
148909619|NCT00337675|537151878|FG000|Overall Study|Withdrawal by Subject|25|||
148909620|NCT00337675|537151879|FG001|Overall Study|Withdrawal by Subject|25|||
148909621|NCT00337675|537151880|FG002|Overall Study|Withdrawal by Subject|19|||
148909622|NCT00337675|537151878|FG000|Overall Study|Progressive Disease|0|||
148909623|NCT00337675|537151879|FG001|Overall Study|Progressive Disease|2|||
148909624|NCT00337675|537151880|FG002|Overall Study|Progressive Disease|0|||
149138640|NCT03523728|537988882|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
148909625|NCT00337675|537151878|FG000|Overall Study|Trial Terminated|0|||
149138641|NCT03523728|537988883|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
148909626|NCT00337675|537151879|FG001|Overall Study|Trial Terminated|0|||
148909627|NCT00337675|537151880|FG002|Overall Study|Trial Terminated|2|||
148909628|NCT02136069|537151881|FG000|Overall Study|UC flare-up|1|||
148909629|NCT02136069|537151882|FG001|Overall Study|UC flare-up|0|||
148909630|NCT02136069|537151881|FG000|Overall Study|Adverse Event|6|||
148909631|NCT02136069|537151882|FG001|Overall Study|Adverse Event|8|||
148909632|NCT02136069|537151881|FG000|Overall Study|Death|0|||
148909633|NCT02136069|537151882|FG001|Overall Study|Death|1|||
148909634|NCT02136069|537151881|FG000|Overall Study|Lack of Efficacy|10|||
148909635|NCT02136069|537151882|FG001|Overall Study|Lack of Efficacy|4|||
148909636|NCT02136069|537151881|FG000|Overall Study|Lost to Follow-up|1|||
148909637|NCT02136069|537151882|FG001|Overall Study|Lost to Follow-up|0|||
148909638|NCT02136069|537151881|FG000|Overall Study|Non-Compliance|1|||
148909639|NCT02136069|537151882|FG001|Overall Study|Non-Compliance|0|||
148909640|NCT02136069|537151881|FG000|Overall Study|Physician Decision|5|||
148909641|NCT02136069|537151882|FG001|Overall Study|Physician Decision|4|||
148909642|NCT02136069|537151881|FG000|Overall Study|Withdrawal by Subject|10|||
148909643|NCT02136069|537151882|FG001|Overall Study|Withdrawal by Subject|11|||
148909644|NCT04693234|537151883|FG000|Overall Study|Death|79|||
148909645|NCT04693234|537151884|FG001|Overall Study|Death|19|||
148909646|NCT04693234|537151883|FG000|Overall Study|Sponsor Ended Study|47|||
148909647|NCT04693234|537151884|FG001|Overall Study|Sponsor Ended Study|18|||
148909648|NCT04693234|537151883|FG000|Overall Study|Withdrawal by Subject|10|||
148909649|NCT04693234|537151884|FG001|Overall Study|Withdrawal by Subject|2|||
148909650|NCT04693234|537151883|FG000|Overall Study|Lost to Follow-up|2|||
148909651|NCT04693234|537151884|FG001|Overall Study|Lost to Follow-up|1|||
148909652|NCT00459186|537151891|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
148909653|NCT00459186|537151891|FG000|PET Imaging and Assessment|Adverse Event|3|||
148909654|NCT02920242|537151892|FG000|Overall Study|Withdrawal by Subject|1|||
148909655|NCT02920242|537151893|FG001|Overall Study|Withdrawal by Subject|0|||
148909656|NCT02920242|537151894|FG002|Overall Study|Withdrawal by Subject|1|||
148909657|NCT02920242|537151892|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
148909658|NCT02920242|537151893|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
148909659|NCT02920242|537151894|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
148909660|NCT04995419|537151897|FG000|Overall Study|Withdrawal by Subject|3|||
148909661|NCT04995419|537151897|FG000|Overall Study|Progressive Disease|19|||
148909662|NCT04995419|537151897|FG000|Overall Study|Adverse Event|2|||
148909663|NCT04995419|537151897|FG000|Overall Study|Ongoing|16|||
148909664|NCT01409811|537151898|FG000|Overall Study|Insurance denial|1|||
148909665|NCT00634101|537151899|FG000|Overall Study|Study Terminated|3|||
148909666|NCT00634101|537151900|FG001|Overall Study|Study Terminated|3|||
148909667|NCT00634101|537151899|FG000|Overall Study|Lost to Follow-up|2|||
148909668|NCT00634101|537151900|FG001|Overall Study|Lost to Follow-up|0|||
148909669|NCT00838513|537151902|FG000|Screening Period|Screen Failure|3|||
148909670|NCT00838513|537151902|FG000|Extension Treatment Period|Death|1|||
148909671|NCT00838513|537151902|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
148909672|NCT00441064|537151905|FG000|Overall Study|Adverse Event|1|||
148909673|NCT00441064|537151906|FG001|Overall Study|Adverse Event|0|||
148909674|NCT00441064|537151905|FG000|Overall Study|Abnormal laboratory values|0|||
148909675|NCT00441064|537151906|FG001|Overall Study|Abnormal laboratory values|2|||
148909676|NCT00441064|537151905|FG000|Overall Study|Abnormal test procedure results|0|||
148909677|NCT00441064|537151906|FG001|Overall Study|Abnormal test procedure results|1|||
148909678|NCT00441064|537151905|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148909679|NCT00441064|537151906|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148909680|NCT00441064|537151905|FG000|Overall Study|Protocol Deviation|3|||
148909681|NCT00441064|537151906|FG001|Overall Study|Protocol Deviation|2|||
148909682|NCT00441064|537151905|FG000|Overall Study|Patient withdrew consent|5|||
148909683|NCT00441064|537151906|FG001|Overall Study|Patient withdrew consent|2|||
148909684|NCT03051178|537151907|FG000|Overall Study|Withdrawal by Subject|5|||
148909685|NCT00953056|537151908|FG000|Overall Study|Withdrew Consent|0|||
148909686|NCT00953056|537151909|FG001|Overall Study|Withdrew Consent|0|||
148909687|NCT00953056|537151910|FG002|Overall Study|Withdrew Consent|0|||
148909688|NCT00953056|537151911|FG003|Overall Study|Withdrew Consent|0|||
148909689|NCT00953056|537151912|FG004|Overall Study|Withdrew Consent|2|||
148909690|NCT00953056|537151913|FG005|Overall Study|Withdrew Consent|3|||
148909691|NCT00953056|537151908|FG000|Overall Study|Serious Adverse Event|0|||
148909692|NCT00953056|537151909|FG001|Overall Study|Serious Adverse Event|0|||
148909693|NCT00953056|537151910|FG002|Overall Study|Serious Adverse Event|0|||
148909694|NCT00953056|537151911|FG003|Overall Study|Serious Adverse Event|0|||
148909695|NCT00953056|537151912|FG004|Overall Study|Serious Adverse Event|0|||
148909696|NCT00953056|537151913|FG005|Overall Study|Serious Adverse Event|1|||
148909697|NCT03962504|537151914|FG000|Overall Study|Other|11|||
148909698|NCT03962504|537151915|FG001|Overall Study|Other|32|||
148909699|NCT02813577|537151916|FG000|Overall Study|Study terminated|4|||
148909700|NCT01388335|537151917|FG000|Period 1|Progressive Disease|1|||
148909701|NCT01388335|537151917|FG000|Period 2|Progressive Disease|2|||
148909702|NCT01388335|537151917|FG000|Period 2|Sponsor Decision|1|||
148909703|NCT01388335|537151917|FG000|Safety Extension|Progressive Disease|7|||
148909704|NCT03339219|537151921|FG000|Overall Study|Death|12|||
148909705|NCT03339219|537151921|FG000|Overall Study|Site Terminated by Sponsor|22|||
148909706|NCT03339219|537151921|FG000|Overall Study|Withdrawal by Subject|1|||
148909707|NCT00067002|537151928|FG000|Overall Study|Early Death|1|||
148909708|NCT00067002|537151929|FG001|Overall Study|Early Death|2|||
148909709|NCT00067002|537151928|FG000|Overall Study|Delayed|1|||
148909710|NCT00067002|537151929|FG001|Overall Study|Delayed|1|||
148909711|NCT00067002|537151928|FG000|Overall Study|Graft Failure|5|||
148909712|NCT00067002|537151929|FG001|Overall Study|Graft Failure|6|||
148909713|NCT01354314|537151930|FG000|Overall Study|Lost to Follow-up|1|||
148909714|NCT01354314|537151931|FG001|Overall Study|Lost to Follow-up|0|||
148909715|NCT01354314|537151932|FG002|Overall Study|Lost to Follow-up|1|||
148909716|NCT01354314|537151933|FG003|Overall Study|Lost to Follow-up|1|||
148909717|NCT01354314|537151930|FG000|Overall Study|Withdrawal by Subject|0|||
148909718|NCT01354314|537151931|FG001|Overall Study|Withdrawal by Subject|0|||
148909719|NCT01354314|537151932|FG002|Overall Study|Withdrawal by Subject|1|||
148909720|NCT01354314|537151933|FG003|Overall Study|Withdrawal by Subject|0|||
148909721|NCT01354314|537151930|FG000|Overall Study|Adverse Event|0|||
148909722|NCT01354314|537151931|FG001|Overall Study|Adverse Event|0|||
148909723|NCT01354314|537151932|FG002|Overall Study|Adverse Event|0|||
148909724|NCT01354314|537151933|FG003|Overall Study|Adverse Event|1|||
148909725|NCT01354314|537151930|FG000|Overall Study|Protocol Violation|1|||
148909726|NCT01354314|537151931|FG001|Overall Study|Protocol Violation|1|||
148909727|NCT01354314|537151932|FG002|Overall Study|Protocol Violation|0|||
148909728|NCT01354314|537151933|FG003|Overall Study|Protocol Violation|0|||
148909729|NCT01354314|537151930|FG000|Overall Study|Less than 90% Adherence|4|||
148909730|NCT01354314|537151931|FG001|Overall Study|Less than 90% Adherence|2|||
148909731|NCT01354314|537151932|FG002|Overall Study|Less than 90% Adherence|6|||
148909732|NCT01354314|537151933|FG003|Overall Study|Less than 90% Adherence|4|||
148909733|NCT00478023|537151934|FG000|Overall Study|Adverse Event|11|||
148909734|NCT00478023|537151935|FG001|Overall Study|Adverse Event|7|||
148909735|NCT00478023|537151936|FG002|Overall Study|Adverse Event|8|||
148909736|NCT00478023|537151937|FG003|Overall Study|Adverse Event|14|||
148909737|NCT00478023|537151938|FG004|Overall Study|Adverse Event|6|||
148909738|NCT00478023|537151934|FG000|Overall Study|Death|1|||
148909739|NCT00478023|537151935|FG001|Overall Study|Death|0|||
148909740|NCT00478023|537151936|FG002|Overall Study|Death|0|||
148909741|NCT00478023|537151937|FG003|Overall Study|Death|0|||
148909742|NCT00478023|537151938|FG004|Overall Study|Death|0|||
148909743|NCT00478023|537151934|FG000|Overall Study|Lack of Efficacy|11|||
148909744|NCT00478023|537151935|FG001|Overall Study|Lack of Efficacy|10|||
148909745|NCT00478023|537151936|FG002|Overall Study|Lack of Efficacy|4|||
148909746|NCT00478023|537151937|FG003|Overall Study|Lack of Efficacy|5|||
148909747|NCT00478023|537151938|FG004|Overall Study|Lack of Efficacy|41|||
148909748|NCT00478023|537151934|FG000|Overall Study|Lost to Follow-up|3|||
148909749|NCT00478023|537151935|FG001|Overall Study|Lost to Follow-up|1|||
148909750|NCT00478023|537151936|FG002|Overall Study|Lost to Follow-up|1|||
148909751|NCT00478023|537151937|FG003|Overall Study|Lost to Follow-up|1|||
148909752|NCT00478023|537151938|FG004|Overall Study|Lost to Follow-up|0|||
148909753|NCT00478023|537151934|FG000|Overall Study|Withdrawal by Subject|2|||
148909754|NCT00478023|537151935|FG001|Overall Study|Withdrawal by Subject|3|||
148909755|NCT00478023|537151936|FG002|Overall Study|Withdrawal by Subject|2|||
148909756|NCT00478023|537151937|FG003|Overall Study|Withdrawal by Subject|4|||
148909757|NCT00478023|537151938|FG004|Overall Study|Withdrawal by Subject|5|||
148909758|NCT00478023|537151934|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
148909759|NCT00478023|537151935|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
148909760|NCT00478023|537151936|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
148909761|NCT00478023|537151937|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
148909762|NCT00478023|537151938|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
148909763|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
148909764|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
148909765|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
148909766|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
148909767|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
148909768|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
148909769|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
148909770|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
148909771|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
148909772|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909773|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
148909774|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909775|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909776|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909777|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
148909778|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
148909779|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
148909780|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
148909781|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
148909782|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
148909783|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
148909784|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
148909785|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
148909786|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
148909787|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
148909788|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
148909789|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
148909790|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
148909791|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
148909792|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
148909793|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
148909794|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
148909795|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
148909796|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
148909797|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
148909798|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
148909799|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909800|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909801|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909802|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909803|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909804|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909805|NCT05019521|537151943|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
148909806|NCT05019521|537151944|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909807|NCT05019521|537151945|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
148909808|NCT05019521|537151946|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
148909809|NCT05019521|537151947|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909810|NCT05019521|537151948|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909811|NCT05019521|537151949|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909812|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
148909813|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
148909814|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
148909815|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
148909816|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
148909817|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
148909818|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
148909819|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
148909820|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
148909821|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
148909822|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909823|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909824|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
148909825|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
148909826|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
148909827|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
148909828|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
148909829|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
148909830|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
148909831|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
148909832|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
148909833|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
148909834|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
148909835|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
148909836|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
148909837|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
148909838|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
148909839|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
148909840|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
148909841|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
148909842|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
149138642|NCT03523728|537988884|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
149138643|NCT03523728|537988885|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
149138644|NCT03523728|537988886|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
149138645|NCT03523728|537988882|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
149138646|NCT03523728|537988883|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
149138647|NCT03523728|537988884|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
149138648|NCT03523728|537988885|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
149138649|NCT03523728|537988886|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
149138650|NCT02230254|537988887|FG000|Overall Study|Lost to Follow-up|3|||
149138651|NCT00621751|537988888|FG000|Overall Study|Adverse Event|0|||
149138652|NCT00621751|537988889|FG001|Overall Study|Adverse Event|1|||
149138653|NCT00419120|537988893|FG000|Long Term Follow up Period|study ongoing|10|||
149138654|NCT01069120|537988896|FG000|Overall Study|Study prematurely terminated|27|||
149138655|NCT00710879|537988900|FG000|Overall Study|Lost to Follow-up|2|||
149138656|NCT00710879|537988901|FG001|Overall Study|Lost to Follow-up|1|||
149138657|NCT00710879|537988900|FG000|Overall Study|Protocol Violation|0|||
149138658|NCT00710879|537988901|FG001|Overall Study|Protocol Violation|3|||
149138659|NCT01809132|537988902|FG000|Overall Study|Withdrawal by Subject|0|||
149138660|NCT01809132|537988903|FG001|Overall Study|Withdrawal by Subject|0|||
149138661|NCT01809132|537988904|FG002|Overall Study|Withdrawal by Subject|1|||
149138662|NCT04854434|537988905|FG000|Overall Study|Death|1|||
149138663|NCT04854434|537988906|FG001|Overall Study|Death|3|||
149138664|NCT04854434|537988907|FG002|Overall Study|Death|4|||
149138665|NCT04854434|537988905|FG000|Overall Study|Study Terminated by Sponsor|2|||
149138666|NCT04854434|537988906|FG001|Overall Study|Study Terminated by Sponsor|0|||
149138667|NCT04854434|537988907|FG002|Overall Study|Study Terminated by Sponsor|0|||
149138668|NCT04854434|537988905|FG000|Overall Study|Other|1|||
149138669|NCT04854434|537988906|FG001|Overall Study|Other|1|||
149138670|NCT04854434|537988907|FG002|Overall Study|Other|0|||
148909843|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
148909844|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
148909845|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
149138671|NCT03349775|537988908|FG000|Overall Study|Side Effects|1|||
149138672|NCT03349775|537988909|FG001|Overall Study|Side Effects|2|||
149138673|NCT03349775|537988908|FG000|Overall Study|Withdrawal by Subject|1|||
149138674|NCT03349775|537988909|FG001|Overall Study|Withdrawal by Subject|1|||
149138675|NCT03349775|537988908|FG000|Overall Study|No primary outcome measurements|0|||
149138676|NCT03349775|537988909|FG001|Overall Study|No primary outcome measurements|1|||
149138677|NCT02667275|537988910|FG000|Overall Study|Protocol Violation|11|||
149138678|NCT02667275|537988911|FG001|Overall Study|Protocol Violation|7|||
149138679|NCT02667275|537988910|FG000|Overall Study|Lost to Follow-up|0|||
149138680|NCT02667275|537988911|FG001|Overall Study|Lost to Follow-up|2|||
149138681|NCT02667275|537988910|FG000|Overall Study|Withdrawal by Subject|0|||
149138682|NCT02667275|537988911|FG001|Overall Study|Withdrawal by Subject|5|||
149138683|NCT02667275|537988910|FG000|Overall Study|Discontinued early without completing|0|||
149138684|NCT02667275|537988911|FG001|Overall Study|Discontinued early without completing|1|||
149138685|NCT01756040|537988912|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
149138686|NCT01756040|537988912|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
149138687|NCT01756040|537988912|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
149138688|NCT01274715|537988913|FG000|Overall Study|Lost to Follow-up|1|||
149138689|NCT01274715|537988913|FG000|Overall Study|After consent, met exclusion criteria.|1|||
149138690|NCT01274715|537988913|FG000|Overall Study|After consent, met exclusion criteria.|1|||
149138691|NCT01274715|537988913|FG000|Overall Study|After consent, met exclusion criteria.|1|||
149138692|NCT03945591|537988918|FG000|Overall Study|Participant not transplanted|1|||
149138693|NCT03945591|537988918|FG000|Overall Study|Change in treatment plan|3|||
149138694|NCT03945591|537988918|FG000|Overall Study|Adverse Event|1|||
149138695|NCT00698204|537988921|FG000|Overall Study|Withdrawal by Subject|1|||
149138696|NCT00698204|537988922|FG001|Overall Study|Withdrawal by Subject|0|||
149138697|NCT01179672|537988923|FG000|Overall Study|Adverse Event|17|||
149138698|NCT01179672|537988924|FG001|Overall Study|Adverse Event|8|||
149138699|NCT01179672|537988923|FG000|Overall Study|Withdrawal by Subject|10|||
149138700|NCT01179672|537988924|FG001|Overall Study|Withdrawal by Subject|12|||
149138701|NCT01179672|537988923|FG000|Overall Study|Entry Criteria Not Met|0|||
149138702|NCT01179672|537988924|FG001|Overall Study|Entry Criteria Not Met|2|||
149138703|NCT01179672|537988923|FG000|Overall Study|Lost to Follow-up|0|||
149138704|NCT01179672|537988924|FG001|Overall Study|Lost to Follow-up|1|||
149138705|NCT01179672|537988923|FG000|Overall Study|Protocol Violation|2|||
149138706|NCT01179672|537988924|FG001|Overall Study|Protocol Violation|2|||
149138707|NCT01179672|537988923|FG000|Overall Study|Physician Decision|1|||
149138708|NCT01179672|537988924|FG001|Overall Study|Physician Decision|1|||
149138709|NCT01949155|537988925|FG000|Overall Study|Lost to Follow-up|1|||
149138710|NCT01949155|537988926|FG001|Overall Study|Lost to Follow-up|0|||
149138711|NCT01949155|537988925|FG000|Overall Study|Protocol Violation|1|||
149138712|NCT01949155|537988926|FG001|Overall Study|Protocol Violation|0|||
149138713|NCT00314249|537988927|FG000|Overall Study|Adverse Event|73|||
149138714|NCT00314249|537988928|FG001|Overall Study|Adverse Event|94|||
149138715|NCT00314249|537988927|FG000|Overall Study|Lack of Efficacy|33|||
149138716|NCT00314249|537988928|FG001|Overall Study|Lack of Efficacy|24|||
149138717|NCT00314249|537988927|FG000|Overall Study|Withdrawal by Subject|21|||
149138718|NCT00314249|537988928|FG001|Overall Study|Withdrawal by Subject|28|||
149138719|NCT00314249|537988927|FG000|Overall Study|Lost to Follow-up|15|||
149138720|NCT00314249|537988928|FG001|Overall Study|Lost to Follow-up|9|||
149138721|NCT00314249|537988927|FG000|Overall Study|Physician Decision|1|||
149138722|NCT00314249|537988928|FG001|Overall Study|Physician Decision|1|||
149138723|NCT00314249|537988927|FG000|Overall Study|Withdrawn for other reasons|4|||
149138724|NCT00314249|537988928|FG001|Overall Study|Withdrawn for other reasons|1|||
149138725|NCT00314249|537988927|FG000|Overall Study|Non-Compliant|5|||
149138726|NCT00314249|537988928|FG001|Overall Study|Non-Compliant|6|||
149138727|NCT04667377|537988929|FG000|Dose Escalation Period|Other not specified below|3|||
149138728|NCT04667377|537988930|FG001|Dose Escalation Period|Other not specified below|3|||
149138729|NCT04667377|537988931|FG002|Dose Escalation Period|Other not specified below|2|||
149138730|NCT04667377|537988932|FG003|Dose Escalation Period|Other not specified below|1|||
149138731|NCT04667377|537988933|FG004|Dose Escalation Period|Other not specified below|3|||
149138732|NCT04667377|537988929|FG000|Dose Escalation Period|Protocol Violation|2|||
149138733|NCT04667377|537988930|FG001|Dose Escalation Period|Protocol Violation|2|||
149138734|NCT04667377|537988931|FG002|Dose Escalation Period|Protocol Violation|0|||
149138735|NCT04667377|537988932|FG003|Dose Escalation Period|Protocol Violation|2|||
149138736|NCT04667377|537988933|FG004|Dose Escalation Period|Protocol Violation|1|||
149138737|NCT04667377|537988929|FG000|Dose Escalation Period|Burden of study procedures|2|||
149138738|NCT04667377|537988930|FG001|Dose Escalation Period|Burden of study procedures|1|||
149138739|NCT04667377|537988931|FG002|Dose Escalation Period|Burden of study procedures|1|||
149138740|NCT04667377|537988932|FG003|Dose Escalation Period|Burden of study procedures|1|||
149138741|NCT04667377|537988933|FG004|Dose Escalation Period|Burden of study procedures|5|||
149138742|NCT04667377|537988929|FG000|Dose Escalation Period|Change of residence|0|||
149138743|NCT04667377|537988930|FG001|Dose Escalation Period|Change of residence|0|||
149138744|NCT04667377|537988931|FG002|Dose Escalation Period|Change of residence|1|||
149138745|NCT04667377|537988932|FG003|Dose Escalation Period|Change of residence|0|||
149138746|NCT04667377|537988933|FG004|Dose Escalation Period|Change of residence|0|||
149138747|NCT04667377|537988929|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
149138748|NCT04667377|537988930|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
149138749|NCT04667377|537988931|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
149138750|NCT04667377|537988932|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
148909846|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
148956469|NCT00723892|537324429|FG001|Overall Study|Intercurrent infection|0|||
149138751|NCT04667377|537988933|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
149138752|NCT04667377|537988929|FG000|Dose Escalation Period|Adverse Event|9|||
149138753|NCT04667377|537988930|FG001|Dose Escalation Period|Adverse Event|10|||
149138754|NCT04667377|537988931|FG002|Dose Escalation Period|Adverse Event|12|||
149138755|NCT04667377|537988932|FG003|Dose Escalation Period|Adverse Event|17|||
149138756|NCT04667377|537988933|FG004|Dose Escalation Period|Adverse Event|3|||
149138757|NCT04667377|537988929|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
149138758|NCT04667377|537988930|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
148909847|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909848|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909849|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909850|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909851|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909852|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
148909853|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
148909854|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
148909855|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
148909856|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
148909857|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909858|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909859|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
148909860|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
148909861|NCT05019521|537151943|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
148909862|NCT05019521|537151944|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
148909863|NCT05019521|537151945|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
148909864|NCT05019521|537151946|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
148909865|NCT05019521|537151947|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
148909866|NCT05019521|537151948|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
148909867|NCT05019521|537151949|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
148909868|NCT00885534|537151950|FG000|Overall Study|Patient deemed ineligible|1|||
148909869|NCT01273519|537151951|FG000|Overall Study|Adverse Event|3|||
148909870|NCT01273519|537151952|FG001|Overall Study|Adverse Event|0|||
148909871|NCT01273519|537151953|FG002|Overall Study|Adverse Event|0|||
148909872|NCT01273519|537151951|FG000|Overall Study|Lost to Follow-up|2|||
148909873|NCT01273519|537151952|FG001|Overall Study|Lost to Follow-up|1|||
148909874|NCT01273519|537151953|FG002|Overall Study|Lost to Follow-up|3|||
148909875|NCT01273519|537151951|FG000|Overall Study|Lack of Efficacy|8|||
148909876|NCT01273519|537151952|FG001|Overall Study|Lack of Efficacy|3|||
148909877|NCT01273519|537151953|FG002|Overall Study|Lack of Efficacy|4|||
148909878|NCT01273519|537151951|FG000|Overall Study|Other|6|||
148909879|NCT01273519|537151952|FG001|Overall Study|Other|1|||
148909880|NCT01273519|537151953|FG002|Overall Study|Other|1|||
148909881|NCT04292899|537151954|FG000|Overall Study|Death|21|||
148909882|NCT04292899|537151955|FG001|Overall Study|Death|28|||
148909883|NCT04292899|537151956|FG002|Overall Study|Death|188|||
148909884|NCT04292899|537151957|FG003|Overall Study|Death|371|||
148909885|NCT04292899|537151954|FG000|Overall Study|Lost to Follow-up|8|||
148909886|NCT04292899|537151955|FG001|Overall Study|Lost to Follow-up|4|||
148909887|NCT04292899|537151956|FG002|Overall Study|Lost to Follow-up|22|||
148909888|NCT04292899|537151957|FG003|Overall Study|Lost to Follow-up|235|||
148909889|NCT04292899|537151954|FG000|Overall Study|Withdrew consent|1|||
148909890|NCT04292899|537151955|FG001|Overall Study|Withdrew consent|0|||
148909891|NCT04292899|537151956|FG002|Overall Study|Withdrew consent|11|||
148909892|NCT04292899|537151957|FG003|Overall Study|Withdrew consent|32|||
148909893|NCT04292899|537151954|FG000|Overall Study|Adverse Event|2|||
148909894|NCT04292899|537151955|FG001|Overall Study|Adverse Event|1|||
148909895|NCT04292899|537151956|FG002|Overall Study|Adverse Event|2|||
148909896|NCT04292899|537151957|FG003|Overall Study|Adverse Event|2|||
148909897|NCT04292899|537151954|FG000|Overall Study|Investigator's Discretion|0|||
148909898|NCT04292899|537151955|FG001|Overall Study|Investigator's Discretion|0|||
148909899|NCT04292899|537151956|FG002|Overall Study|Investigator's Discretion|0|||
148909900|NCT04292899|537151957|FG003|Overall Study|Investigator's Discretion|3|||
148909901|NCT04292899|537151954|FG000|Overall Study|Non-compliance With Study Drug|0|||
148909902|NCT04292899|537151955|FG001|Overall Study|Non-compliance With Study Drug|0|||
148909903|NCT04292899|537151956|FG002|Overall Study|Non-compliance With Study Drug|0|||
148909904|NCT04292899|537151957|FG003|Overall Study|Non-compliance With Study Drug|1|||
148909905|NCT04292899|537151954|FG000|Overall Study|Protocol Violation|0|||
148909906|NCT04292899|537151955|FG001|Overall Study|Protocol Violation|0|||
148909907|NCT04292899|537151956|FG002|Overall Study|Protocol Violation|0|||
148909908|NCT04292899|537151957|FG003|Overall Study|Protocol Violation|1|||
148909909|NCT01077050|537154011|FG000|Overall Study|Subjects signed ICF could not be located|1|||
148909910|NCT01077050|537154011|FG000|Overall Study|Screen failure|8|||
149138759|NCT04667377|537988931|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
149138760|NCT04667377|537988932|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
149138761|NCT04667377|537988933|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
149138762|NCT04667377|537988929|FG000|Dose Escalation Period|Not treated|1|||
149138763|NCT04667377|537988930|FG001|Dose Escalation Period|Not treated|0|||
149138764|NCT04667377|537988931|FG002|Dose Escalation Period|Not treated|0|||
148909911|NCT01006291|537154015|FG000|Overall Study|Adverse Event|2|||
148909912|NCT01006291|537154016|FG001|Overall Study|Adverse Event|1|||
148909913|NCT01006291|537154017|FG002|Overall Study|Adverse Event|2|||
148909914|NCT01006291|537154015|FG000|Overall Study|Lack of Efficacy|2|||
148909915|NCT01006291|537154016|FG001|Overall Study|Lack of Efficacy|2|||
148909916|NCT01006291|537154017|FG002|Overall Study|Lack of Efficacy|1|||
148909917|NCT01006291|537154015|FG000|Overall Study|Protocol Violation|3|||
148909918|NCT01006291|537154016|FG001|Overall Study|Protocol Violation|3|||
148909919|NCT01006291|537154017|FG002|Overall Study|Protocol Violation|3|||
148909920|NCT01006291|537154015|FG000|Overall Study|Withdrawal criteria|5|||
148909921|NCT01006291|537154016|FG001|Overall Study|Withdrawal criteria|4|||
148909922|NCT01006291|537154017|FG002|Overall Study|Withdrawal criteria|4|||
148909923|NCT01006291|537154015|FG000|Overall Study|Other|14|||
148909924|NCT01006291|537154016|FG001|Overall Study|Other|14|||
148909925|NCT01006291|537154017|FG002|Overall Study|Other|17|||
148909926|NCT01865552|537154018|FG000|Period 1|Adverse Event|1|||
148909927|NCT01865552|537154019|FG001|Period 1|Adverse Event|0|||
148909928|NCT01865552|537154020|FG002|Period 1|Adverse Event|0|||
148909929|NCT01865552|537154021|FG003|Period 1|Adverse Event|1|||
148909930|NCT01865552|537154022|FG004|Period 1|Adverse Event|1|||
148909931|NCT01865552|537154023|FG005|Period 1|Adverse Event|1|||
148909932|NCT01865552|537154018|FG000|Period 1|Pathological lab|0|||
148909933|NCT01865552|537154019|FG001|Period 1|Pathological lab|0|||
148909934|NCT01865552|537154020|FG002|Period 1|Pathological lab|0|||
148909935|NCT01865552|537154021|FG003|Period 1|Pathological lab|0|||
148909936|NCT01865552|537154022|FG004|Period 1|Pathological lab|1|||
148909937|NCT01865552|537154023|FG005|Period 1|Pathological lab|0|||
148909938|NCT01865552|537154018|FG000|Period 1|Other|0|||
148909939|NCT01865552|537154019|FG001|Period 1|Other|0|||
148909940|NCT01865552|537154020|FG002|Period 1|Other|0|||
148909941|NCT01865552|537154021|FG003|Period 1|Other|0|||
148909942|NCT01865552|537154022|FG004|Period 1|Other|1|||
148909943|NCT01865552|537154023|FG005|Period 1|Other|0|||
148909944|NCT03079102|537154026|FG000|Overall Study|Physician Decision|0|||
148909945|NCT03079102|537154027|FG001|Overall Study|Physician Decision|1|||
148909946|NCT02923921|537154028|FG000|Overall Study|Sponsor Decision|39|||
148909947|NCT02923921|537154029|FG001|Overall Study|Sponsor Decision|38|||
148909948|NCT02923921|537154028|FG000|Overall Study|Lost to Follow-up|1|||
148909949|NCT02923921|537154029|FG001|Overall Study|Lost to Follow-up|0|||
148909950|NCT02923921|537154028|FG000|Overall Study|Withdrawal by Subject|6|||
148909951|NCT02923921|537154029|FG001|Overall Study|Withdrawal by Subject|13|||
148909952|NCT02923921|537154028|FG000|Overall Study|Unknown, Not Collected|7|||
148909953|NCT02923921|537154029|FG001|Overall Study|Unknown, Not Collected|6|||
148909954|NCT03083873|537154030|FG000|Overall Study|Death|6|||
148909955|NCT03083873|537154031|FG001|Overall Study|Death|15|||
148909956|NCT03083873|537154032|FG002|Overall Study|Death|13|||
148909957|NCT03083873|537154033|FG003|Overall Study|Death|9|||
148909958|NCT03083873|537154034|FG004|Overall Study|Death|0|||
148909959|NCT03083873|537154030|FG000|Overall Study|Sponsor Terminated Study|0|||
148909960|NCT03083873|537154031|FG001|Overall Study|Sponsor Terminated Study|1|||
148909961|NCT03083873|537154032|FG002|Overall Study|Sponsor Terminated Study|2|||
148909962|NCT03083873|537154033|FG003|Overall Study|Sponsor Terminated Study|3|||
148909963|NCT03083873|537154034|FG004|Overall Study|Sponsor Terminated Study|0|||
148909964|NCT03083873|537154030|FG000|Overall Study|Lost to Follow-up|0|||
148909965|NCT03083873|537154031|FG001|Overall Study|Lost to Follow-up|1|||
148909966|NCT03083873|537154032|FG002|Overall Study|Lost to Follow-up|1|||
148909967|NCT03083873|537154033|FG003|Overall Study|Lost to Follow-up|0|||
148909968|NCT03083873|537154034|FG004|Overall Study|Lost to Follow-up|0|||
148909969|NCT03083873|537154030|FG000|Overall Study|Withdrawal by Subject|2|||
148909970|NCT03083873|537154031|FG001|Overall Study|Withdrawal by Subject|0|||
149138765|NCT04667377|537988932|FG003|Dose Escalation Period|Not treated|0|||
148909971|NCT03083873|537154032|FG002|Overall Study|Withdrawal by Subject|0|||
148909972|NCT03083873|537154033|FG003|Overall Study|Withdrawal by Subject|0|||
148909973|NCT03083873|537154034|FG004|Overall Study|Withdrawal by Subject|0|||
148909974|NCT03083873|537154030|FG000|Overall Study|Did Not Receive TIL|2|||
148909975|NCT03083873|537154031|FG001|Overall Study|Did Not Receive TIL|5|||
148909976|NCT03083873|537154032|FG002|Overall Study|Did Not Receive TIL|3|||
148909977|NCT03083873|537154033|FG003|Overall Study|Did Not Receive TIL|1|||
148909978|NCT03083873|537154034|FG004|Overall Study|Did Not Receive TIL|0|||
148909979|NCT00295880|537154035|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
148909980|NCT00295880|537154035|FG000|Overall Study|Unit randomization did not occur|1|||
148909981|NCT01474239|537154036|FG000|Overall Study|Disease Progression|37|||
148909982|NCT01474239|537154037|FG001|Overall Study|Disease Progression|25|||
148909983|NCT01474239|537154036|FG000|Overall Study|Adverse Event|12|||
148909984|NCT01474239|537154037|FG001|Overall Study|Adverse Event|3|||
148909985|NCT01474239|537154036|FG000|Overall Study|Withdrawal by Subject|1|||
148909986|NCT01474239|537154037|FG001|Overall Study|Withdrawal by Subject|2|||
148909987|NCT01474239|537154036|FG000|Overall Study|Death|1|||
148909988|NCT01474239|537154037|FG001|Overall Study|Death|1|||
148909989|NCT01474239|537154036|FG000|Overall Study|Clinical Disease Progression|7|||
148909990|NCT01474239|537154037|FG001|Overall Study|Clinical Disease Progression|1|||
148909991|NCT01474239|537154036|FG000|Overall Study|Withdrawal for Economic Reason|1|||
148909992|NCT01474239|537154037|FG001|Overall Study|Withdrawal for Economic Reason|0|||
148909993|NCT00854113|537154041|FG000|Overall Study|Adverse Event|0|||
148909994|NCT00854113|537154042|FG001|Overall Study|Adverse Event|0|||
148909995|NCT00854113|537154043|FG002|Overall Study|Adverse Event|0|||
148909996|NCT00854113|537154044|FG003|Overall Study|Adverse Event|0|||
148909997|NCT00854113|537154045|FG004|Overall Study|Adverse Event|0|||
148909998|NCT00854113|537154046|FG005|Overall Study|Adverse Event|0|||
148909999|NCT00854113|537154047|FG006|Overall Study|Adverse Event|0|||
148910000|NCT00854113|537154048|FG007|Overall Study|Adverse Event|2|||
148910001|NCT00854113|537154049|FG008|Overall Study|Adverse Event|0|||
148910002|NCT00854113|537154050|FG009|Overall Study|Adverse Event|0|||
148910003|NCT00854113|537154051|FG010|Overall Study|Adverse Event|0|||
148910004|NCT00854113|537154041|FG000|Overall Study|Withdrawal by Subject|0|||
148910005|NCT00854113|537154042|FG001|Overall Study|Withdrawal by Subject|0|||
148910006|NCT00854113|537154043|FG002|Overall Study|Withdrawal by Subject|0|||
148910007|NCT00854113|537154044|FG003|Overall Study|Withdrawal by Subject|0|||
148910008|NCT00854113|537154045|FG004|Overall Study|Withdrawal by Subject|0|||
148910009|NCT00854113|537154046|FG005|Overall Study|Withdrawal by Subject|0|||
148910010|NCT00854113|537154047|FG006|Overall Study|Withdrawal by Subject|0|||
148910011|NCT00854113|537154048|FG007|Overall Study|Withdrawal by Subject|1|||
148910012|NCT00854113|537154049|FG008|Overall Study|Withdrawal by Subject|1|||
148910013|NCT00854113|537154050|FG009|Overall Study|Withdrawal by Subject|0|||
148910014|NCT00854113|537154051|FG010|Overall Study|Withdrawal by Subject|0|||
148910015|NCT00796419|537154053|FG000|Overall Study|Death|0|||
148910016|NCT00796419|537154054|FG001|Overall Study|Death|1|||
148910017|NCT01250145|537154055|FG000|Overall Study|Adverse Event|2|||
148910018|NCT01250145|537154056|FG001|Overall Study|Adverse Event|1|||
148910019|NCT01250145|537154055|FG000|Overall Study|Withdrawal by Subject|0|||
148910020|NCT01250145|537154056|FG001|Overall Study|Withdrawal by Subject|4|||
148910021|NCT02840799|537154059|FG000|Phase 1|Physician Decision|1|||
148910022|NCT02840799|537154060|FG001|Phase 1|Physician Decision|3|||
148910023|NCT02840799|537154059|FG000|Phase 1|Withdrawal by Subject|4|||
148910024|NCT02840799|537154060|FG001|Phase 1|Withdrawal by Subject|0|||
148910025|NCT02840799|537154059|FG000|Phase 2 (Crossover)|Adverse Event|0|||
148910026|NCT02840799|537154060|FG001|Phase 2 (Crossover)|Adverse Event|1|||
148910027|NCT02840799|537154059|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
148910028|NCT02840799|537154060|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
148910029|NCT02565784|537154061|FG000|First Treatment|Adverse Event|1|||
148910030|NCT02565784|537154061|FG000|First Treatment|Withdrawal by Subject|1|||
148910031|NCT02565784|537154061|FG000|Second Treatment|Withdrawal by Subject|2|||
148910032|NCT02687191|537154063|FG000|Overall Study|Death|0|||
148910033|NCT02687191|537154064|FG001|Overall Study|Death|1|||
148910034|NCT02687191|537154065|FG002|Overall Study|Death|1|||
148910035|NCT02687191|537154066|FG003|Overall Study|Death|0|||
148910036|NCT02687191|537154067|FG004|Overall Study|Death|1|||
148910037|NCT02687191|537154068|FG005|Overall Study|Death|1|||
148910038|NCT02687191|537154063|FG000|Overall Study|Withdrawal by Subject|0|||
148803627|NCT01419535|536761116|FG001|Overall Study|Withdrawal by Subject|1|||
148803628|NCT05965752|536761123|FG000|Overall Study|Adverse Event|0|||
148803629|NCT05965752|536761124|FG001|Overall Study|Adverse Event|1|||
148803630|NCT05965752|536761125|FG002|Overall Study|Adverse Event|0|||
148803631|NCT05965752|536761126|FG003|Overall Study|Adverse Event|1|||
148803632|NCT05965752|536761127|FG004|Overall Study|Adverse Event|3|||
148803633|NCT05965752|536761123|FG000|Overall Study|Lost to Follow-up|2|||
148803634|NCT05965752|536761124|FG001|Overall Study|Lost to Follow-up|0|||
148803635|NCT05965752|536761125|FG002|Overall Study|Lost to Follow-up|1|||
148803636|NCT05965752|536761126|FG003|Overall Study|Lost to Follow-up|1|||
148803637|NCT05965752|536761127|FG004|Overall Study|Lost to Follow-up|1|||
148803638|NCT05965752|536761123|FG000|Overall Study|Withdrawal by Subject|2|||
148803639|NCT05965752|536761124|FG001|Overall Study|Withdrawal by Subject|2|||
148803640|NCT05965752|536761125|FG002|Overall Study|Withdrawal by Subject|1|||
148803641|NCT05965752|536761126|FG003|Overall Study|Withdrawal by Subject|5|||
148803642|NCT05965752|536761127|FG004|Overall Study|Withdrawal by Subject|0|||
148910039|NCT02687191|537154064|FG001|Overall Study|Withdrawal by Subject|0|||
148910040|NCT02687191|537154065|FG002|Overall Study|Withdrawal by Subject|0|||
148803643|NCT05965752|536761123|FG000|Overall Study|Disease Relapse|1|||
148803644|NCT05965752|536761124|FG001|Overall Study|Disease Relapse|0|||
148803645|NCT05965752|536761125|FG002|Overall Study|Disease Relapse|1|||
148910041|NCT02687191|537154066|FG003|Overall Study|Withdrawal by Subject|1|||
148910042|NCT02687191|537154067|FG004|Overall Study|Withdrawal by Subject|0|||
148910043|NCT02687191|537154068|FG005|Overall Study|Withdrawal by Subject|0|||
148910044|NCT00943072|537154071|FG000|Overall Study|Adverse Event|0|||
148910045|NCT00943072|537154072|FG001|Overall Study|Adverse Event|3|||
148910046|NCT00943072|537154071|FG000|Overall Study|Death|0|||
148910047|NCT00943072|537154072|FG001|Overall Study|Death|2|||
148910048|NCT00943072|537154071|FG000|Overall Study|Withdrawal by Subject|3|||
148910049|NCT00943072|537154072|FG001|Overall Study|Withdrawal by Subject|1|||
148910050|NCT00943072|537154071|FG000|Overall Study|Protocol Violation|0|||
148910051|NCT00943072|537154072|FG001|Overall Study|Protocol Violation|1|||
148910052|NCT00943072|537154071|FG000|Overall Study|Lost to Follow-up|1|||
148910053|NCT00943072|537154072|FG001|Overall Study|Lost to Follow-up|2|||
148910054|NCT00943072|537154071|FG000|Overall Study|Lack of Efficacy|0|||
148910055|NCT00943072|537154072|FG001|Overall Study|Lack of Efficacy|4|||
148910056|NCT00943072|537154071|FG000|Overall Study|Other|1|||
148910057|NCT00943072|537154072|FG001|Overall Study|Other|1|||
148910058|NCT01349049|537154073|FG000|Overall Study|Disease progression|3|||
148910059|NCT01349049|537154074|FG001|Overall Study|Disease progression|5|||
148910060|NCT01349049|537154075|FG002|Overall Study|Disease progression|3|||
148910061|NCT01349049|537154076|FG003|Overall Study|Disease progression|2|||
148910062|NCT01349049|537154077|FG004|Overall Study|Disease progression|2|||
148910063|NCT01349049|537154078|FG005|Overall Study|Disease progression|2|||
148910064|NCT01349049|537154079|FG006|Overall Study|Disease progression|3|||
148910065|NCT01349049|537154080|FG007|Overall Study|Disease progression|2|||
148910066|NCT01349049|537154081|FG008|Overall Study|Disease progression|33|||
148910067|NCT01349049|537154073|FG000|Overall Study|Adverse Event|0|||
148910068|NCT01349049|537154074|FG001|Overall Study|Adverse Event|1|||
148910069|NCT01349049|537154075|FG002|Overall Study|Adverse Event|0|||
148910070|NCT01349049|537154076|FG003|Overall Study|Adverse Event|0|||
148910071|NCT01349049|537154077|FG004|Overall Study|Adverse Event|0|||
148910072|NCT01349049|537154078|FG005|Overall Study|Adverse Event|3|||
148910073|NCT01349049|537154079|FG006|Overall Study|Adverse Event|1|||
148910074|NCT01349049|537154080|FG007|Overall Study|Adverse Event|0|||
148910075|NCT01349049|537154081|FG008|Overall Study|Adverse Event|4|||
148910076|NCT01349049|537154073|FG000|Overall Study|Physician Decision|0|||
148910077|NCT01349049|537154074|FG001|Overall Study|Physician Decision|1|||
148910078|NCT01349049|537154075|FG002|Overall Study|Physician Decision|0|||
148910079|NCT01349049|537154076|FG003|Overall Study|Physician Decision|0|||
148910080|NCT01349049|537154077|FG004|Overall Study|Physician Decision|0|||
148910081|NCT01349049|537154078|FG005|Overall Study|Physician Decision|0|||
148910082|NCT01349049|537154079|FG006|Overall Study|Physician Decision|0|||
148910083|NCT01349049|537154080|FG007|Overall Study|Physician Decision|0|||
148910084|NCT01349049|537154081|FG008|Overall Study|Physician Decision|2|||
148910085|NCT01349049|537154073|FG000|Overall Study|Protocol Violation|0|||
148910086|NCT01349049|537154074|FG001|Overall Study|Protocol Violation|0|||
148910087|NCT01349049|537154075|FG002|Overall Study|Protocol Violation|0|||
148910088|NCT01349049|537154076|FG003|Overall Study|Protocol Violation|0|||
148910089|NCT01349049|537154077|FG004|Overall Study|Protocol Violation|0|||
148910090|NCT01349049|537154078|FG005|Overall Study|Protocol Violation|0|||
148910091|NCT01349049|537154079|FG006|Overall Study|Protocol Violation|0|||
148910092|NCT01349049|537154080|FG007|Overall Study|Protocol Violation|0|||
148910093|NCT01349049|537154081|FG008|Overall Study|Protocol Violation|1|||
148910094|NCT01349049|537154073|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
148910095|NCT01349049|537154074|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
148910096|NCT01349049|537154075|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
148910097|NCT01349049|537154076|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
148910098|NCT01349049|537154077|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
148910099|NCT01349049|537154078|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
148910100|NCT01349049|537154079|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
148910101|NCT01349049|537154080|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
148910102|NCT01349049|537154081|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
148910103|NCT01349049|537154073|FG000|Overall Study|Other|0|||
148910104|NCT01349049|537154074|FG001|Overall Study|Other|0|||
148910105|NCT01349049|537154075|FG002|Overall Study|Other|0|||
148910106|NCT01349049|537154076|FG003|Overall Study|Other|0|||
148910107|NCT01349049|537154077|FG004|Overall Study|Other|0|||
149138766|NCT04667377|537988933|FG004|Dose Escalation Period|Not treated|0|||
149138767|NCT04667377|537988929|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
148910108|NCT01349049|537154078|FG005|Overall Study|Other|1|||
148910109|NCT01349049|537154079|FG006|Overall Study|Other|0|||
149138768|NCT04667377|537988930|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
148910110|NCT01349049|537154080|FG007|Overall Study|Other|0|||
148910111|NCT01349049|537154081|FG008|Overall Study|Other|4|||
148910112|NCT01349049|537154073|FG000|Overall Study|Death|0|||
148910113|NCT01349049|537154074|FG001|Overall Study|Death|0|||
148910114|NCT01349049|537154075|FG002|Overall Study|Death|0|||
148910115|NCT01349049|537154076|FG003|Overall Study|Death|0|||
148910116|NCT01349049|537154077|FG004|Overall Study|Death|0|||
148910117|NCT01349049|537154078|FG005|Overall Study|Death|0|||
148910118|NCT01349049|537154079|FG006|Overall Study|Death|0|||
148910119|NCT01349049|537154080|FG007|Overall Study|Death|1|||
148910120|NCT01349049|537154081|FG008|Overall Study|Death|5|||
148910121|NCT01349049|537154073|FG000|Overall Study|Non-compliance|0|||
148910122|NCT01349049|537154074|FG001|Overall Study|Non-compliance|0|||
149138769|NCT04667377|537988931|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
149138770|NCT04667377|537988932|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
149138771|NCT04667377|537988933|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
149138772|NCT04667377|537988929|FG000|Dose Escalation Period|Lost to Follow-up|0|||
149138773|NCT04667377|537988930|FG001|Dose Escalation Period|Lost to Follow-up|1|||
149138774|NCT04667377|537988931|FG002|Dose Escalation Period|Lost to Follow-up|0|||
149138775|NCT04667377|537988932|FG003|Dose Escalation Period|Lost to Follow-up|0|||
149138776|NCT04667377|537988933|FG004|Dose Escalation Period|Lost to Follow-up|0|||
149138777|NCT04667377|537988929|FG000|Maintenance Period|Perceived lack of efficacy|0|||
149138778|NCT04667377|537988930|FG001|Maintenance Period|Perceived lack of efficacy|2|||
149138779|NCT04667377|537988931|FG002|Maintenance Period|Perceived lack of efficacy|1|||
149138780|NCT04667377|537988932|FG003|Maintenance Period|Perceived lack of efficacy|0|||
149138781|NCT04667377|537988933|FG004|Maintenance Period|Perceived lack of efficacy|1|||
149138782|NCT04667377|537988929|FG000|Maintenance Period|Adverse Event|2|||
149138783|NCT04667377|537988930|FG001|Maintenance Period|Adverse Event|8|||
149138784|NCT04667377|537988931|FG002|Maintenance Period|Adverse Event|5|||
149138785|NCT04667377|537988932|FG003|Maintenance Period|Adverse Event|4|||
149138786|NCT04667377|537988933|FG004|Maintenance Period|Adverse Event|1|||
149138787|NCT04667377|537988929|FG000|Maintenance Period|Adverse event: COVID infection|0|||
149138788|NCT04667377|537988930|FG001|Maintenance Period|Adverse event: COVID infection|1|||
149138789|NCT04667377|537988931|FG002|Maintenance Period|Adverse event: COVID infection|0|||
149138790|NCT04667377|537988932|FG003|Maintenance Period|Adverse event: COVID infection|0|||
149138791|NCT04667377|537988933|FG004|Maintenance Period|Adverse event: COVID infection|0|||
149138792|NCT04667377|537988929|FG000|Maintenance Period|COVID-related|0|||
149138793|NCT04667377|537988930|FG001|Maintenance Period|COVID-related|0|||
149138794|NCT04667377|537988931|FG002|Maintenance Period|COVID-related|1|||
149138795|NCT04667377|537988932|FG003|Maintenance Period|COVID-related|1|||
149138796|NCT04667377|537988933|FG004|Maintenance Period|COVID-related|0|||
149138797|NCT04667377|537988929|FG000|Maintenance Period|Protocol Violation|1|||
149138798|NCT04667377|537988930|FG001|Maintenance Period|Protocol Violation|0|||
149138799|NCT04667377|537988931|FG002|Maintenance Period|Protocol Violation|0|||
149138800|NCT04667377|537988932|FG003|Maintenance Period|Protocol Violation|0|||
149138801|NCT04667377|537988933|FG004|Maintenance Period|Protocol Violation|1|||
149138802|NCT04667377|537988929|FG000|Maintenance Period|Burden of study procedures|1|||
149138803|NCT04667377|537988930|FG001|Maintenance Period|Burden of study procedures|2|||
149138804|NCT04667377|537988931|FG002|Maintenance Period|Burden of study procedures|0|||
149138805|NCT04667377|537988932|FG003|Maintenance Period|Burden of study procedures|1|||
149138806|NCT04667377|537988933|FG004|Maintenance Period|Burden of study procedures|0|||
149138807|NCT04667377|537988929|FG000|Maintenance Period|Change of residence|0|||
149138808|NCT04667377|537988930|FG001|Maintenance Period|Change of residence|1|||
149138809|NCT04667377|537988931|FG002|Maintenance Period|Change of residence|0|||
149138810|NCT04667377|537988932|FG003|Maintenance Period|Change of residence|0|||
149138811|NCT04667377|537988933|FG004|Maintenance Period|Change of residence|1|||
149138812|NCT04667377|537988929|FG000|Maintenance Period|Missing|1|||
149138813|NCT04667377|537988930|FG001|Maintenance Period|Missing|0|||
149138814|NCT04667377|537988931|FG002|Maintenance Period|Missing|0|||
149138815|NCT04667377|537988932|FG003|Maintenance Period|Missing|0|||
149138816|NCT04667377|537988933|FG004|Maintenance Period|Missing|0|||
149138817|NCT04667377|537988929|FG000|Maintenance Period|Other than listed above|2|||
149138818|NCT04667377|537988930|FG001|Maintenance Period|Other than listed above|0|||
149138819|NCT04667377|537988931|FG002|Maintenance Period|Other than listed above|3|||
148803646|NCT05965752|536761126|FG003|Overall Study|Disease Relapse|0|||
148803647|NCT05965752|536761127|FG004|Overall Study|Disease Relapse|0|||
148803648|NCT05965752|536761123|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
148803649|NCT05965752|536761124|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
148803650|NCT05965752|536761125|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
148803651|NCT05965752|536761126|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
148803652|NCT05965752|536761127|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
148803653|NCT05965752|536761123|FG000|Overall Study|Unable to Return for Study Visits|0|||
148803654|NCT05965752|536761124|FG001|Overall Study|Unable to Return for Study Visits|1|||
148803655|NCT05965752|536761125|FG002|Overall Study|Unable to Return for Study Visits|0|||
148803656|NCT05965752|536761126|FG003|Overall Study|Unable to Return for Study Visits|3|||
149138820|NCT04667377|537988932|FG003|Maintenance Period|Other than listed above|2|||
149138821|NCT04667377|537988933|FG004|Maintenance Period|Other than listed above|6|||
149138822|NCT04667377|537988929|FG000|Maintenance Period|Withdrawal by Subject|0|||
149138823|NCT04667377|537988930|FG001|Maintenance Period|Withdrawal by Subject|1|||
149138824|NCT04667377|537988931|FG002|Maintenance Period|Withdrawal by Subject|0|||
149138825|NCT04667377|537988932|FG003|Maintenance Period|Withdrawal by Subject|0|||
149138826|NCT04667377|537988933|FG004|Maintenance Period|Withdrawal by Subject|0|||
149138827|NCT04667377|537988929|FG000|Maintenance Period|Lost to Follow-up|1|||
148910123|NCT01349049|537154075|FG002|Overall Study|Non-compliance|0|||
148910124|NCT01349049|537154076|FG003|Overall Study|Non-compliance|1|||
148910125|NCT01349049|537154077|FG004|Overall Study|Non-compliance|0|||
148910126|NCT01349049|537154078|FG005|Overall Study|Non-compliance|0|||
148910127|NCT01349049|537154079|FG006|Overall Study|Non-compliance|0|||
148910128|NCT01349049|537154080|FG007|Overall Study|Non-compliance|0|||
148910129|NCT01349049|537154081|FG008|Overall Study|Non-compliance|0|||
148910130|NCT01349049|537154073|FG000|Overall Study|Withdrawal by Subject|0|||
148910131|NCT01349049|537154074|FG001|Overall Study|Withdrawal by Subject|0|||
148910132|NCT01349049|537154075|FG002|Overall Study|Withdrawal by Subject|0|||
148910133|NCT01349049|537154076|FG003|Overall Study|Withdrawal by Subject|0|||
148910134|NCT01349049|537154077|FG004|Overall Study|Withdrawal by Subject|0|||
148910135|NCT01349049|537154078|FG005|Overall Study|Withdrawal by Subject|0|||
148910136|NCT01349049|537154079|FG006|Overall Study|Withdrawal by Subject|0|||
148910137|NCT01349049|537154080|FG007|Overall Study|Withdrawal by Subject|0|||
148910138|NCT01349049|537154081|FG008|Overall Study|Withdrawal by Subject|6|||
148910139|NCT00552188|537154084|FG000|Overall Study|Adverse Event|0|||
148910140|NCT00552188|537154085|FG001|Overall Study|Adverse Event|2|||
148910141|NCT00552188|537154084|FG000|Overall Study|Lost to Follow-up|2|||
148910142|NCT00552188|537154085|FG001|Overall Study|Lost to Follow-up|1|||
148910143|NCT00552188|537154084|FG000|Overall Study|Withdrawal of consent|0|||
148910144|NCT00552188|537154085|FG001|Overall Study|Withdrawal of consent|1|||
148910145|NCT00552188|537154084|FG000|Overall Study|Subject returned to home country|0|||
148910146|NCT00552188|537154085|FG001|Overall Study|Subject returned to home country|1|||
148910147|NCT03887702|537154086|FG000|Overall Study|Study terminated|0|||
148910148|NCT03887702|537154087|FG001|Overall Study|Study terminated|0|||
148910149|NCT03887702|537154088|FG002|Overall Study|Study terminated|2|||
148910150|NCT03887702|537154089|FG003|Overall Study|Study terminated|2|||
148910151|NCT01675544|537154092|FG000|Overall Study|Withdrawal by Subject|2|||
148910152|NCT03126344|537154098|FG000|Overall Study|Lost to Follow-up|0|||
148910153|NCT03126344|537154099|FG001|Overall Study|Lost to Follow-up|0|||
148910154|NCT03126344|537154100|FG002|Overall Study|Lost to Follow-up|5|||
148910155|NCT01715857|537154101|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
148910156|NCT01027273|537154103|FG000|Overall Study|Lost to Follow-up|57|||
148910157|NCT01027273|537154104|FG001|Overall Study|Lost to Follow-up|31|||
148910158|NCT01027273|537154103|FG000|Overall Study|Death|2|||
148910159|NCT01027273|537154104|FG001|Overall Study|Death|2|||
148910160|NCT01330108|537154113|FG000|Overall Study|Withdrawal by Subject|4|||
148910161|NCT00485134|537154117|FG000|Overall Study|Lost to Follow-up|1|||
148910162|NCT00485134|537154118|FG001|Overall Study|Lost to Follow-up|0|||
148910163|NCT00485134|537154119|FG002|Overall Study|Lost to Follow-up|0|||
148910164|NCT00485134|537154120|FG003|Overall Study|Lost to Follow-up|0|||
148910165|NCT00485134|537154121|FG004|Overall Study|Lost to Follow-up|0|||
148910166|NCT00485134|537154122|FG005|Overall Study|Lost to Follow-up|0|||
148910167|NCT00485134|537154123|FG006|Overall Study|Lost to Follow-up|0|||
148910168|NCT00485134|537154124|FG007|Overall Study|Lost to Follow-up|0|||
148910169|NCT00485134|537154117|FG000|Overall Study|Withdrawal by Subject|0|||
148910170|NCT00485134|537154118|FG001|Overall Study|Withdrawal by Subject|1|||
148910171|NCT00485134|537154119|FG002|Overall Study|Withdrawal by Subject|0|||
148910172|NCT00485134|537154120|FG003|Overall Study|Withdrawal by Subject|0|||
148910173|NCT00485134|537154121|FG004|Overall Study|Withdrawal by Subject|0|||
148910174|NCT00485134|537154122|FG005|Overall Study|Withdrawal by Subject|0|||
148910175|NCT00485134|537154123|FG006|Overall Study|Withdrawal by Subject|0|||
148910176|NCT00485134|537154124|FG007|Overall Study|Withdrawal by Subject|0|||
148910177|NCT00485134|537154117|FG000|Overall Study|Change in health status|0|||
148910178|NCT00485134|537154118|FG001|Overall Study|Change in health status|1|||
148910179|NCT00485134|537154119|FG002|Overall Study|Change in health status|2|||
148910180|NCT00485134|537154120|FG003|Overall Study|Change in health status|1|||
148910181|NCT00485134|537154121|FG004|Overall Study|Change in health status|0|||
148910182|NCT00485134|537154122|FG005|Overall Study|Change in health status|1|||
148910183|NCT00485134|537154123|FG006|Overall Study|Change in health status|0|||
148910184|NCT00485134|537154124|FG007|Overall Study|Change in health status|0|||
148910185|NCT00485134|537154117|FG000|Overall Study|Withdrew for adverse event|0|||
148910186|NCT00485134|537154118|FG001|Overall Study|Withdrew for adverse event|0|||
148910187|NCT00485134|537154119|FG002|Overall Study|Withdrew for adverse event|1|||
148910188|NCT00485134|537154120|FG003|Overall Study|Withdrew for adverse event|0|||
148910189|NCT00485134|537154121|FG004|Overall Study|Withdrew for adverse event|0|||
148910190|NCT00485134|537154122|FG005|Overall Study|Withdrew for adverse event|0|||
148910191|NCT00485134|537154123|FG006|Overall Study|Withdrew for adverse event|0|||
148910192|NCT00485134|537154124|FG007|Overall Study|Withdrew for adverse event|0|||
148910193|NCT00485134|537154117|FG000|Overall Study|Positive drug test|0|||
148910194|NCT00485134|537154118|FG001|Overall Study|Positive drug test|0|||
148910195|NCT00485134|537154119|FG002|Overall Study|Positive drug test|0|||
148910196|NCT00485134|537154120|FG003|Overall Study|Positive drug test|0|||
148910197|NCT00485134|537154121|FG004|Overall Study|Positive drug test|2|||
148910198|NCT00485134|537154122|FG005|Overall Study|Positive drug test|1|||
148910199|NCT00485134|537154123|FG006|Overall Study|Positive drug test|0|||
148910200|NCT00485134|537154124|FG007|Overall Study|Positive drug test|0|||
148910201|NCT00485134|537154117|FG000|Overall Study|Non-compliance|0|||
148910202|NCT00485134|537154118|FG001|Overall Study|Non-compliance|0|||
148910203|NCT00485134|537154119|FG002|Overall Study|Non-compliance|0|||
148910204|NCT00485134|537154120|FG003|Overall Study|Non-compliance|0|||
148910205|NCT00485134|537154121|FG004|Overall Study|Non-compliance|1|||
148910206|NCT00485134|537154122|FG005|Overall Study|Non-compliance|2|||
148910207|NCT00485134|537154123|FG006|Overall Study|Non-compliance|2|||
148910208|NCT00485134|537154124|FG007|Overall Study|Non-compliance|0|||
148910209|NCT00485134|537154117|FG000|Overall Study|Unable to comply with study schedule|0|||
148910210|NCT00485134|537154118|FG001|Overall Study|Unable to comply with study schedule|0|||
148910211|NCT00485134|537154119|FG002|Overall Study|Unable to comply with study schedule|0|||
148910212|NCT00485134|537154120|FG003|Overall Study|Unable to comply with study schedule|0|||
148910213|NCT00485134|537154121|FG004|Overall Study|Unable to comply with study schedule|0|||
148910214|NCT00485134|537154122|FG005|Overall Study|Unable to comply with study schedule|0|||
148910215|NCT00485134|537154123|FG006|Overall Study|Unable to comply with study schedule|0|||
148910216|NCT00485134|537154124|FG007|Overall Study|Unable to comply with study schedule|1|||
148910217|NCT00485134|537154117|FG000|Overall Study|Pregnancy|0|||
148910218|NCT00485134|537154118|FG001|Overall Study|Pregnancy|0|||
149138828|NCT04667377|537988930|FG001|Maintenance Period|Lost to Follow-up|0|||
149138829|NCT04667377|537988931|FG002|Maintenance Period|Lost to Follow-up|1|||
149138830|NCT04667377|537988932|FG003|Maintenance Period|Lost to Follow-up|0|||
148910219|NCT00485134|537154119|FG002|Overall Study|Pregnancy|0|||
148910220|NCT00485134|537154120|FG003|Overall Study|Pregnancy|0|||
148910221|NCT00485134|537154121|FG004|Overall Study|Pregnancy|0|||
148910222|NCT00485134|537154122|FG005|Overall Study|Pregnancy|0|||
148910223|NCT00485134|537154123|FG006|Overall Study|Pregnancy|1|||
148910224|NCT00485134|537154124|FG007|Overall Study|Pregnancy|0|||
148910225|NCT00970684|537154125|FG000|Overall Study|Lack of Efficacy|5|||
148910226|NCT00970684|537154125|FG000|Overall Study|Adverse Event|4|||
148910227|NCT00970684|537154125|FG000|Overall Study|Withdrawal by Subject|1|||
148910228|NCT00475306|537154126|FG000|Overall Study|Protocol Violation|1|||
148910229|NCT00475306|537154127|FG001|Overall Study|Protocol Violation|1|||
148910230|NCT00475306|537154128|FG002|Overall Study|Protocol Violation|0|||
148910231|NCT00475306|537154129|FG003|Overall Study|Protocol Violation|1|||
148910232|NCT04294680|537154130|FG000|Overall Study|Withdrawal by Subject|2|||
148910233|NCT04294680|537154131|FG001|Overall Study|Withdrawal by Subject|1|||
148910234|NCT04294680|537154130|FG000|Overall Study|Follow-up visits completed outside of window|1|||
148910235|NCT04294680|537154131|FG001|Overall Study|Follow-up visits completed outside of window|0|||
148910236|NCT00905645|537154133|FG000|Overall Study|Death (not device related)|10|||
148910237|NCT00905645|537154134|FG001|Overall Study|Death (not device related)|4|||
148910238|NCT00905645|537154135|FG002|Overall Study|Death (not device related)|15|||
148910239|NCT00905645|537154136|FG003|Overall Study|Death (not device related)|8|||
148910240|NCT00905645|537154133|FG000|Overall Study|Explantation of study device(s)|78|||
148910241|NCT00905645|537154134|FG001|Overall Study|Explantation of study device(s)|47|||
148910242|NCT00905645|537154135|FG002|Overall Study|Explantation of study device(s)|28|||
148910243|NCT00905645|537154136|FG003|Overall Study|Explantation of study device(s)|21|||
148910244|NCT00905645|537154133|FG000|Overall Study|Subject Request|41|||
148910245|NCT00905645|537154134|FG001|Overall Study|Subject Request|17|||
148910246|NCT00905645|537154135|FG002|Overall Study|Subject Request|13|||
148910247|NCT00905645|537154136|FG003|Overall Study|Subject Request|11|||
148910248|NCT00905645|537154133|FG000|Overall Study|Lost to Follow-up|299|||
148910249|NCT00905645|537154134|FG001|Overall Study|Lost to Follow-up|103|||
148910250|NCT00905645|537154135|FG002|Overall Study|Lost to Follow-up|51|||
148910251|NCT00905645|537154136|FG003|Overall Study|Lost to Follow-up|12|||
148910252|NCT00578292|537154137|FG000|Overall Study|Death|1|||
149138831|NCT04667377|537988933|FG004|Maintenance Period|Lost to Follow-up|1|||
149138832|NCT02316340|537988934|FG000|First Progression|Clinical progression|2|||
148910253|NCT00578292|537154137|FG000|Overall Study|Graft failure|2|||
148910254|NCT01485172|537154138|FG000|Overall Study|Adverse Event|2|||
148910255|NCT01485172|537154139|FG001|Overall Study|Adverse Event|1|||
148910256|NCT01485172|537154140|FG002|Overall Study|Adverse Event|2|||
149138833|NCT02316340|537988935|FG001|First Progression|Clinical progression|1|||
149138834|NCT02316340|537988934|FG000|First Progression|Withdrawal by Subject|1|||
149138835|NCT02316340|537988935|FG001|First Progression|Withdrawal by Subject|0|||
149138836|NCT04004429|537988936|FG000|Overall Study|Protocol Violation|1|||
149138837|NCT04004429|537988937|FG001|Overall Study|Protocol Violation|0|||
149138838|NCT04004429|537988938|FG002|Overall Study|Protocol Violation|0|||
149138839|NCT04004429|537988936|FG000|Overall Study|Physician Decision|0|||
149138840|NCT04004429|537988937|FG001|Overall Study|Physician Decision|1|||
149138841|NCT04004429|537988938|FG002|Overall Study|Physician Decision|1|||
149138842|NCT04004429|537988936|FG000|Overall Study|Withdrawal by Subject|1|||
149138843|NCT04004429|537988937|FG001|Overall Study|Withdrawal by Subject|1|||
149138844|NCT04004429|537988938|FG002|Overall Study|Withdrawal by Subject|1|||
149138845|NCT02092350|537988940|FG000|Overall Study|Adverse Event|0|||
149138846|NCT02092350|537988941|FG001|Overall Study|Adverse Event|3|||
149138847|NCT02092350|537988940|FG000|Overall Study|Death|2|||
149138848|NCT02092350|537988941|FG001|Overall Study|Death|5|||
149138849|NCT02092350|537988940|FG000|Overall Study|Lost to Follow-up|3|||
149138850|NCT02092350|537988941|FG001|Overall Study|Lost to Follow-up|1|||
149138851|NCT02092350|537988940|FG000|Overall Study|Protocol Violation|1|||
148910257|NCT01485172|537154141|FG003|Overall Study|Adverse Event|2|||
148910258|NCT01485172|537154142|FG004|Overall Study|Adverse Event|1|||
148910259|NCT01485172|537154143|FG005|Overall Study|Adverse Event|2|||
148910260|NCT01485172|537154138|FG000|Overall Study|Lack of Efficacy|2|||
148910261|NCT01485172|537154139|FG001|Overall Study|Lack of Efficacy|0|||
148910262|NCT01485172|537154140|FG002|Overall Study|Lack of Efficacy|0|||
148910263|NCT01485172|537154141|FG003|Overall Study|Lack of Efficacy|0|||
148910264|NCT01485172|537154142|FG004|Overall Study|Lack of Efficacy|0|||
148910265|NCT01485172|537154143|FG005|Overall Study|Lack of Efficacy|0|||
148910266|NCT01485172|537154138|FG000|Overall Study|Protocol Violation|0|||
148910267|NCT01485172|537154139|FG001|Overall Study|Protocol Violation|0|||
148910268|NCT01485172|537154140|FG002|Overall Study|Protocol Violation|4|||
148910269|NCT01485172|537154141|FG003|Overall Study|Protocol Violation|5|||
148910270|NCT01485172|537154142|FG004|Overall Study|Protocol Violation|1|||
148910271|NCT01485172|537154143|FG005|Overall Study|Protocol Violation|0|||
148910272|NCT01485172|537154138|FG000|Overall Study|Protocol defined stopping criteria|1|||
148910273|NCT01485172|537154139|FG001|Overall Study|Protocol defined stopping criteria|0|||
148910274|NCT01485172|537154140|FG002|Overall Study|Protocol defined stopping criteria|0|||
148910275|NCT01485172|537154141|FG003|Overall Study|Protocol defined stopping criteria|0|||
148910276|NCT01485172|537154142|FG004|Overall Study|Protocol defined stopping criteria|1|||
148910277|NCT01485172|537154143|FG005|Overall Study|Protocol defined stopping criteria|0|||
148910278|NCT01485172|537154138|FG000|Overall Study|Lost to Follow-up|0|||
148910279|NCT01485172|537154139|FG001|Overall Study|Lost to Follow-up|0|||
148910280|NCT01485172|537154140|FG002|Overall Study|Lost to Follow-up|1|||
148910281|NCT01485172|537154141|FG003|Overall Study|Lost to Follow-up|0|||
148910282|NCT01485172|537154142|FG004|Overall Study|Lost to Follow-up|0|||
148910283|NCT01485172|537154143|FG005|Overall Study|Lost to Follow-up|1|||
148910284|NCT01485172|537154138|FG000|Overall Study|Physician Decision|0|||
148910285|NCT01485172|537154139|FG001|Overall Study|Physician Decision|0|||
148910286|NCT01485172|537154140|FG002|Overall Study|Physician Decision|0|||
148910287|NCT01485172|537154141|FG003|Overall Study|Physician Decision|0|||
148910288|NCT01485172|537154142|FG004|Overall Study|Physician Decision|1|||
148910289|NCT01485172|537154143|FG005|Overall Study|Physician Decision|0|||
148910290|NCT01485172|537154138|FG000|Overall Study|Withdrawal by Subject|2|||
148910291|NCT01485172|537154139|FG001|Overall Study|Withdrawal by Subject|0|||
148910292|NCT01485172|537154140|FG002|Overall Study|Withdrawal by Subject|0|||
148910293|NCT01485172|537154141|FG003|Overall Study|Withdrawal by Subject|1|||
148910294|NCT01485172|537154142|FG004|Overall Study|Withdrawal by Subject|1|||
148910295|NCT01485172|537154143|FG005|Overall Study|Withdrawal by Subject|1|||
148910296|NCT01587014|537154144|FG000|Overall Study|Death|2|||
148910297|NCT00139477|537154151|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
148910298|NCT00139477|537154152|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
148910299|NCT00139477|537154151|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
148910300|NCT00139477|537154152|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
148910301|NCT00139477|537154151|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
149138852|NCT02092350|537988941|FG001|Overall Study|Protocol Violation|0|||
149138853|NCT02092350|537988940|FG000|Overall Study|Physician Decision|1|||
149138854|NCT02092350|537988941|FG001|Overall Study|Physician Decision|1|||
149138855|NCT02092350|537988940|FG000|Overall Study|Screen Failure|1|||
149138856|NCT02092350|537988941|FG001|Overall Study|Screen Failure|0|||
149138857|NCT02092350|537988940|FG000|Overall Study|Withdrawal by Subject|2|||
149138858|NCT02092350|537988941|FG001|Overall Study|Withdrawal by Subject|2|||
149138859|NCT02448225|537988945|FG000|Overall Study|Withdrawal by Subject|1|||
149138860|NCT02448225|537988945|FG000|Overall Study|Did not get FSPG scan|18|||
149138861|NCT02448225|537988945|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
148910302|NCT00139477|537154152|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
148910303|NCT00139477|537154151|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
149138862|NCT00851682|537988946|FG000|Overall Study|screen failure|5|||
149138863|NCT00851682|537988947|FG001|Overall Study|screen failure|0|||
149138864|NCT00962390|537988958|FG000|Overall Study|Adverse Event|0|||
149138865|NCT00962390|537988959|FG001|Overall Study|Adverse Event|0|||
148910304|NCT00139477|537154152|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
148910305|NCT00139477|537154151|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
148910306|NCT00139477|537154152|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
148910307|NCT00139477|537154151|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
148910308|NCT00139477|537154152|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
148910309|NCT00139477|537154151|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
148910310|NCT00139477|537154152|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
148910311|NCT00975780|537154153|FG000|Follow Up|Death|88|||
149138866|NCT00962390|537988960|FG002|Overall Study|Adverse Event|3|||
149138867|NCT00962390|537988961|FG003|Overall Study|Adverse Event|1|||
149138868|NCT00962390|537988958|FG000|Overall Study|Lost to Follow-up|2|||
149138869|NCT00962390|537988959|FG001|Overall Study|Lost to Follow-up|2|||
149138870|NCT00962390|537988960|FG002|Overall Study|Lost to Follow-up|0|||
149138871|NCT00962390|537988961|FG003|Overall Study|Lost to Follow-up|0|||
149138872|NCT00962390|537988958|FG000|Overall Study|Protocol Violation|1|||
149138873|NCT00962390|537988959|FG001|Overall Study|Protocol Violation|0|||
149138874|NCT00962390|537988960|FG002|Overall Study|Protocol Violation|0|||
149138875|NCT00962390|537988961|FG003|Overall Study|Protocol Violation|0|||
149138876|NCT00962390|537988958|FG000|Overall Study|Withdrawal by Subject|1|||
148910312|NCT00975780|537154154|FG001|Follow Up|Death|122|||
148910313|NCT00975780|537154153|FG000|Follow Up|Facility Withdrawal|7|||
148910314|NCT00975780|537154154|FG001|Follow Up|Facility Withdrawal|23|||
148910315|NCT00975780|537154153|FG000|Follow Up|Discharged from Facility|7|||
148910316|NCT00975780|537154154|FG001|Follow Up|Discharged from Facility|12|||
148910317|NCT01077076|537154157|FG000|First Intervention|Withdrawal by Subject|1|||
148910318|NCT01077076|537154158|FG001|First Intervention|Withdrawal by Subject|0|||
148910319|NCT01077076|537154159|FG002|First Intervention|Withdrawal by Subject|0|||
148910320|NCT01077076|537154160|FG003|First Intervention|Withdrawal by Subject|0|||
148910321|NCT01077076|537154161|FG004|First Intervention|Withdrawal by Subject|0|||
148910322|NCT01077076|537154162|FG005|First Intervention|Withdrawal by Subject|0|||
148910323|NCT01077076|537154157|FG000|Third Intervention|Death in the participant's family|0|||
148910324|NCT01077076|537154158|FG001|Third Intervention|Death in the participant's family|0|||
149138877|NCT00962390|537988959|FG001|Overall Study|Withdrawal by Subject|1|||
149138878|NCT00962390|537988960|FG002|Overall Study|Withdrawal by Subject|1|||
149138879|NCT00962390|537988961|FG003|Overall Study|Withdrawal by Subject|0|||
149138880|NCT04422990|537988962|FG000|Overall Study|Withdrawal by Subject|0|||
149138881|NCT04422990|537988963|FG001|Overall Study|Withdrawal by Subject|1|||
149138882|NCT04422990|537988962|FG000|Overall Study|Travel|3|||
149138883|NCT04422990|537988963|FG001|Overall Study|Travel|0|||
149138884|NCT02486653|537988969|FG000|Overall Study|Withdrawal by Subject|1|||
149138885|NCT02486653|537988970|FG001|Overall Study|Withdrawal by Subject|3|||
149138886|NCT02486653|537988969|FG000|Overall Study|Protocol Violation|1|||
149138887|NCT02486653|537988970|FG001|Overall Study|Protocol Violation|0|||
149138888|NCT02486653|537988969|FG000|Overall Study|surgery cancelled|4|||
149138889|NCT02486653|537988970|FG001|Overall Study|surgery cancelled|1|||
149138890|NCT00800436|537988971|FG000|Overall Study|Withdrawal by Subject|0|||
149138891|NCT00800436|537988972|FG001|Overall Study|Withdrawal by Subject|0|||
149138892|NCT00800436|537988973|FG002|Overall Study|Withdrawal by Subject|1|||
149138893|NCT00800436|537988974|FG003|Overall Study|Withdrawal by Subject|1|||
149138894|NCT00800436|537988975|FG004|Overall Study|Withdrawal by Subject|0|||
149138895|NCT00800436|537988976|FG005|Overall Study|Withdrawal by Subject|0|||
148910325|NCT01077076|537154159|FG002|Third Intervention|Death in the participant's family|0|||
148910326|NCT01077076|537154160|FG003|Third Intervention|Death in the participant's family|0|||
148910327|NCT01077076|537154161|FG004|Third Intervention|Death in the participant's family|0|||
148910328|NCT01077076|537154162|FG005|Third Intervention|Death in the participant's family|1|||
148910329|NCT01415882|537154163|FG000|Overall Study|Ineligible|1|||
148910330|NCT01415882|537154164|FG001|Overall Study|Ineligible|0|||
148910331|NCT01415882|537154165|FG002|Overall Study|Ineligible|0|||
149138896|NCT00800436|537988977|FG006|Overall Study|Withdrawal by Subject|0|||
149138897|NCT00711529|537988984|FG000|Overall Study|Protocol Violation|2|||
149138898|NCT00711529|537988985|FG001|Overall Study|Protocol Violation|0|||
149138899|NCT00711529|537988984|FG000|Overall Study|Withdrawal by Subject|2|||
149138900|NCT00711529|537988985|FG001|Overall Study|Withdrawal by Subject|6|||
149138901|NCT03044886|537988994|FG000|Overall Study|Lost to Follow-up|15|||
149138902|NCT03044886|537988995|FG001|Overall Study|Lost to Follow-up|10|||
149138903|NCT03044886|537988996|FG002|Overall Study|Lost to Follow-up|12|||
149138904|NCT02921269|537988997|FG000|Overall Study|Did not complete DLT period|1|||
149138905|NCT03065023|537989007|FG000|Overall Study|Progressive Disease|0|||
149138906|NCT03065023|537989008|FG001|Overall Study|Progressive Disease|1|||
149138907|NCT03065023|537989009|FG002|Overall Study|Progressive Disease|0|||
149138908|NCT03065023|537989010|FG003|Overall Study|Progressive Disease|0|||
149138909|NCT03065023|537989011|FG004|Overall Study|Progressive Disease|0|||
149138910|NCT03065023|537989007|FG000|Overall Study|Death|2|||
149138911|NCT03065023|537989008|FG001|Overall Study|Death|0|||
149138912|NCT03065023|537989009|FG002|Overall Study|Death|1|||
149138913|NCT03065023|537989010|FG003|Overall Study|Death|1|||
149138914|NCT03065023|537989011|FG004|Overall Study|Death|0|||
149138915|NCT03065023|537989007|FG000|Overall Study|Lost to Follow-up|0|||
149138916|NCT03065023|537989008|FG001|Overall Study|Lost to Follow-up|1|||
149138917|NCT03065023|537989009|FG002|Overall Study|Lost to Follow-up|0|||
149138918|NCT03065023|537989010|FG003|Overall Study|Lost to Follow-up|0|||
149138919|NCT03065023|537989011|FG004|Overall Study|Lost to Follow-up|0|||
149138920|NCT03065023|537989007|FG000|Overall Study|Participant Decision|0|||
149138921|NCT03065023|537989008|FG001|Overall Study|Participant Decision|0|||
149138922|NCT03065023|537989009|FG002|Overall Study|Participant Decision|0|||
149138923|NCT03065023|537989010|FG003|Overall Study|Participant Decision|1|||
149138924|NCT03065023|537989011|FG004|Overall Study|Participant Decision|0|||
149138925|NCT03065023|537989007|FG000|Overall Study|Withdrawal by Subject|0|||
149138926|NCT03065023|537989008|FG001|Overall Study|Withdrawal by Subject|0|||
149138927|NCT03065023|537989009|FG002|Overall Study|Withdrawal by Subject|0|||
149138928|NCT03065023|537989010|FG003|Overall Study|Withdrawal by Subject|1|||
149138929|NCT03065023|537989011|FG004|Overall Study|Withdrawal by Subject|0|||
149138930|NCT05975840|537989012|FG000|Overall Study|Other|1|||
149138931|NCT05975840|537989013|FG001|Overall Study|Other|0|||
149138932|NCT05975840|537989014|FG002|Overall Study|Other|0|||
149138933|NCT05975840|537989015|FG003|Overall Study|Other|0|||
149138934|NCT05975840|537989016|FG004|Overall Study|Other|1|||
149138935|NCT05975840|537989017|FG005|Overall Study|Other|0|||
149138936|NCT05975840|537989018|FG006|Overall Study|Other|0|||
149138937|NCT05975840|537989019|FG007|Overall Study|Other|0|||
148910332|NCT01415882|537154166|FG003|Overall Study|Ineligible|3|||
148910333|NCT01415882|537154167|FG004|Overall Study|Ineligible|0|||
148910334|NCT01415882|537154163|FG000|Overall Study|Withdrawal by Subject|0|||
148910335|NCT01415882|537154164|FG001|Overall Study|Withdrawal by Subject|1|||
148910336|NCT01415882|537154165|FG002|Overall Study|Withdrawal by Subject|0|||
148910337|NCT01415882|537154166|FG003|Overall Study|Withdrawal by Subject|1|||
148910338|NCT01415882|537154167|FG004|Overall Study|Withdrawal by Subject|0|||
148910339|NCT00670306|537154168|FG000|Overall Study|Adverse Event|8|||
148910340|NCT00670306|537154168|FG000|Overall Study|Lack of Efficacy|10|||
148910341|NCT00670306|537154168|FG000|Overall Study|Withdrawal by Subject|9|||
148910342|NCT00670306|537154168|FG000|Overall Study|Physician Decision|1|||
148910343|NCT00670306|537154168|FG000|Overall Study|Lost to Follow-up|8|||
148910344|NCT00670306|537154168|FG000|Overall Study|incl/excl criterias did not meet|19|||
148910345|NCT02722499|537154169|FG000|Overall Study|Lost to Follow-up|2|||
148910346|NCT02722499|537154170|FG001|Overall Study|Lost to Follow-up|0|||
148910347|NCT02722499|537154171|FG002|Overall Study|Lost to Follow-up|1|||
148910348|NCT00369265|537154179|FG000|Overall Study|Study terminated|4|||
148910349|NCT00369265|537154180|FG001|Overall Study|Study terminated|7|||
148910350|NCT01192191|537154181|FG000|Overall Study|Adverse Event|7|||
148910351|NCT01192191|537154182|FG001|Overall Study|Adverse Event|12|||
148910352|NCT01192191|537154181|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
148910353|NCT01192191|537154182|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
148910354|NCT01192191|537154181|FG000|Overall Study|Lost to Follow-up|0|||
148910355|NCT01192191|537154182|FG001|Overall Study|Lost to Follow-up|1|||
148910356|NCT01192191|537154181|FG000|Overall Study|Withdrawal by Subject|1|||
148910357|NCT01192191|537154182|FG001|Overall Study|Withdrawal by Subject|6|||
148910358|NCT03532451|537154187|FG000|Overall Study|Withdrawal by Subject|0|||
148910359|NCT03532451|537154188|FG001|Overall Study|Withdrawal by Subject|1|||
148910360|NCT03532451|537154187|FG000|Overall Study|Did not undergo surgery|1|||
148910361|NCT03532451|537154188|FG001|Overall Study|Did not undergo surgery|1|||
148910362|NCT02527421|537154189|FG000|Overall Study|Withdrawal by Subject|1|||
148910363|NCT02527421|537154190|FG001|Overall Study|Withdrawal by Subject|0|||
148910364|NCT02541604|537154191|FG000|Overall Study|Death|6|||
148910365|NCT02541604|537154192|FG001|Overall Study|Death|5|||
148910366|NCT02541604|537154193|FG002|Overall Study|Death|7|||
148910367|NCT02541604|537154194|FG003|Overall Study|Death|2|||
148910368|NCT02541604|537154195|FG004|Overall Study|Death|9|||
148910369|NCT02541604|537154196|FG005|Overall Study|Death|8|||
148910370|NCT02541604|537154197|FG006|Overall Study|Death|9|||
148910371|NCT02541604|537154198|FG007|Overall Study|Death|9|||
148910372|NCT02541604|537154199|FG008|Overall Study|Death|3|||
148910373|NCT02541604|537154200|FG009|Overall Study|Death|4|||
148910374|NCT02541604|537154201|FG010|Overall Study|Death|2|||
148910375|NCT02541604|537154202|FG011|Overall Study|Death|3|||
149138938|NCT05975840|537989012|FG000|Overall Study|Lost to Follow-up|3|||
149138939|NCT05975840|537989013|FG001|Overall Study|Lost to Follow-up|6|||
149138940|NCT05975840|537989014|FG002|Overall Study|Lost to Follow-up|3|||
149138941|NCT05975840|537989015|FG003|Overall Study|Lost to Follow-up|1|||
148910376|NCT02541604|537154191|FG000|Overall Study|Lost to Follow-up|2|||
148910377|NCT02541604|537154192|FG001|Overall Study|Lost to Follow-up|0|||
148910378|NCT02541604|537154193|FG002|Overall Study|Lost to Follow-up|1|||
148910379|NCT02541604|537154194|FG003|Overall Study|Lost to Follow-up|0|||
148910380|NCT02541604|537154195|FG004|Overall Study|Lost to Follow-up|0|||
148910381|NCT02541604|537154196|FG005|Overall Study|Lost to Follow-up|1|||
148910382|NCT02541604|537154197|FG006|Overall Study|Lost to Follow-up|1|||
148910383|NCT02541604|537154198|FG007|Overall Study|Lost to Follow-up|0|||
148910384|NCT02541604|537154199|FG008|Overall Study|Lost to Follow-up|0|||
148910385|NCT02541604|537154200|FG009|Overall Study|Lost to Follow-up|0|||
148910386|NCT02541604|537154201|FG010|Overall Study|Lost to Follow-up|0|||
148910387|NCT02541604|537154202|FG011|Overall Study|Lost to Follow-up|0|||
148910388|NCT02541604|537154191|FG000|Overall Study|Withdrawal by Subject|2|||
148910389|NCT02541604|537154192|FG001|Overall Study|Withdrawal by Subject|0|||
148910390|NCT02541604|537154193|FG002|Overall Study|Withdrawal by Subject|1|||
148910391|NCT02541604|537154194|FG003|Overall Study|Withdrawal by Subject|0|||
148910392|NCT02541604|537154195|FG004|Overall Study|Withdrawal by Subject|1|||
148910393|NCT02541604|537154196|FG005|Overall Study|Withdrawal by Subject|1|||
148910394|NCT02541604|537154197|FG006|Overall Study|Withdrawal by Subject|0|||
148910395|NCT02541604|537154198|FG007|Overall Study|Withdrawal by Subject|0|||
148910396|NCT02541604|537154199|FG008|Overall Study|Withdrawal by Subject|1|||
148910397|NCT02541604|537154200|FG009|Overall Study|Withdrawal by Subject|0|||
148910398|NCT02541604|537154201|FG010|Overall Study|Withdrawal by Subject|0|||
148910399|NCT02541604|537154202|FG011|Overall Study|Withdrawal by Subject|0|||
148910400|NCT02541604|537154191|FG000|Overall Study|Study Terminated by Sponsor|1|||
148910401|NCT02541604|537154192|FG001|Overall Study|Study Terminated by Sponsor|4|||
148910402|NCT02541604|537154193|FG002|Overall Study|Study Terminated by Sponsor|2|||
148910403|NCT02541604|537154194|FG003|Overall Study|Study Terminated by Sponsor|1|||
148910404|NCT02541604|537154195|FG004|Overall Study|Study Terminated by Sponsor|0|||
148910405|NCT02541604|537154196|FG005|Overall Study|Study Terminated by Sponsor|0|||
148910406|NCT02541604|537154197|FG006|Overall Study|Study Terminated by Sponsor|0|||
148910407|NCT02541604|537154198|FG007|Overall Study|Study Terminated by Sponsor|0|||
148910408|NCT02541604|537154199|FG008|Overall Study|Study Terminated by Sponsor|0|||
148910409|NCT02541604|537154200|FG009|Overall Study|Study Terminated by Sponsor|0|||
148910410|NCT02541604|537154201|FG010|Overall Study|Study Terminated by Sponsor|0|||
148910411|NCT02541604|537154202|FG011|Overall Study|Study Terminated by Sponsor|0|||
148910412|NCT02541604|537154191|FG000|Overall Study|Medical condition may jeopardize safety|0|||
148910413|NCT02541604|537154192|FG001|Overall Study|Medical condition may jeopardize safety|0|||
148910414|NCT02541604|537154193|FG002|Overall Study|Medical condition may jeopardize safety|0|||
148910415|NCT02541604|537154194|FG003|Overall Study|Medical condition may jeopardize safety|0|||
148910416|NCT02541604|537154195|FG004|Overall Study|Medical condition may jeopardize safety|0|||
148910417|NCT02541604|537154196|FG005|Overall Study|Medical condition may jeopardize safety|0|||
148910418|NCT02541604|537154197|FG006|Overall Study|Medical condition may jeopardize safety|0|||
148910419|NCT02541604|537154198|FG007|Overall Study|Medical condition may jeopardize safety|1|||
148910420|NCT02541604|537154199|FG008|Overall Study|Medical condition may jeopardize safety|0|||
148910421|NCT02541604|537154200|FG009|Overall Study|Medical condition may jeopardize safety|0|||
148910422|NCT02541604|537154201|FG010|Overall Study|Medical condition may jeopardize safety|0|||
148910423|NCT02541604|537154202|FG011|Overall Study|Medical condition may jeopardize safety|0|||
148910424|NCT00828204|537154203|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
148910425|NCT00828204|537154204|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
148910426|NCT00828204|537154203|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
148910427|NCT00828204|537154204|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
148910428|NCT00828204|537154203|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
148910429|NCT00828204|537154204|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
148910430|NCT00828204|537154203|FG000|Main Study: After Study Restart|Adverse Event|0|||
148910431|NCT00828204|537154204|FG001|Main Study: After Study Restart|Adverse Event|2|||
148910432|NCT00828204|537154203|FG000|Main Study: After Study Restart|Noncompliance|0|||
148910433|NCT00828204|537154204|FG001|Main Study: After Study Restart|Noncompliance|1|||
148910434|NCT00828204|537154203|FG000|Extension Study|Lost to Follow-up|0|||
148910435|NCT00828204|537154204|FG001|Extension Study|Lost to Follow-up|1|||
148910436|NCT00828204|537154203|FG000|Extension Study|Physician Decision|0|||
148910437|NCT00828204|537154204|FG001|Extension Study|Physician Decision|2|||
148910438|NCT02840461|537154210|FG000|Overall Study|Adverse Event|1|||
148910439|NCT02840461|537154211|FG001|Overall Study|Adverse Event|5|||
148910440|NCT02840461|537154212|FG002|Overall Study|Adverse Event|3|||
148910441|NCT02840461|537154210|FG000|Overall Study|Lost to Follow-up|10|||
148910442|NCT02840461|537154211|FG001|Overall Study|Lost to Follow-up|7|||
148910443|NCT02840461|537154212|FG002|Overall Study|Lost to Follow-up|6|||
148910444|NCT02840461|537154210|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
148910445|NCT02840461|537154211|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
148910446|NCT02840461|537154212|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
148910447|NCT02840461|537154210|FG000|Overall Study|Protocol Violation|2|||
148910448|NCT02840461|537154211|FG001|Overall Study|Protocol Violation|3|||
148910449|NCT02840461|537154212|FG002|Overall Study|Protocol Violation|1|||
148910450|NCT02840461|537154210|FG000|Overall Study|Withdrawal by Subject|10|||
148910451|NCT02840461|537154211|FG001|Overall Study|Withdrawal by Subject|6|||
148910452|NCT02840461|537154212|FG002|Overall Study|Withdrawal by Subject|2|||
148910453|NCT02840461|537154210|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
149138942|NCT05975840|537989016|FG004|Overall Study|Lost to Follow-up|4|||
149138943|NCT05975840|537989017|FG005|Overall Study|Lost to Follow-up|1|||
149138944|NCT05975840|537989018|FG006|Overall Study|Lost to Follow-up|2|||
149138945|NCT05975840|537989019|FG007|Overall Study|Lost to Follow-up|4|||
149138946|NCT05975840|537989012|FG000|Overall Study|Migrated/moved from the study area|1|||
149138947|NCT05975840|537989013|FG001|Overall Study|Migrated/moved from the study area|0|||
149138948|NCT05975840|537989014|FG002|Overall Study|Migrated/moved from the study area|0|||
149138949|NCT05975840|537989015|FG003|Overall Study|Migrated/moved from the study area|0|||
149138950|NCT05975840|537989016|FG004|Overall Study|Migrated/moved from the study area|0|||
149138951|NCT05975840|537989017|FG005|Overall Study|Migrated/moved from the study area|0|||
149138952|NCT05975840|537989018|FG006|Overall Study|Migrated/moved from the study area|0|||
149138953|NCT05975840|537989019|FG007|Overall Study|Migrated/moved from the study area|0|||
149138954|NCT05975840|537989012|FG000|Overall Study|Withdrawal by Subject|0|||
149138955|NCT05975840|537989013|FG001|Overall Study|Withdrawal by Subject|5|||
149138956|NCT05975840|537989014|FG002|Overall Study|Withdrawal by Subject|2|||
149138957|NCT05975840|537989015|FG003|Overall Study|Withdrawal by Subject|2|||
149138958|NCT05975840|537989016|FG004|Overall Study|Withdrawal by Subject|0|||
149138959|NCT05975840|537989017|FG005|Overall Study|Withdrawal by Subject|2|||
149138960|NCT05975840|537989018|FG006|Overall Study|Withdrawal by Subject|2|||
149138961|NCT05975840|537989019|FG007|Overall Study|Withdrawal by Subject|1|||
149138962|NCT05975840|537989012|FG000|Overall Study|Protocol Violation|0|||
149138963|NCT05975840|537989013|FG001|Overall Study|Protocol Violation|1|||
149138964|NCT05975840|537989014|FG002|Overall Study|Protocol Violation|0|||
149138965|NCT05975840|537989015|FG003|Overall Study|Protocol Violation|0|||
149138966|NCT05975840|537989016|FG004|Overall Study|Protocol Violation|0|||
149138967|NCT05975840|537989017|FG005|Overall Study|Protocol Violation|0|||
148803657|NCT05965752|536761127|FG004|Overall Study|Unable to Return for Study Visits|1|||
148803658|NCT05965752|536761123|FG000|Overall Study|Early Termination|0|||
148803659|NCT05965752|536761124|FG001|Overall Study|Early Termination|0|||
148803660|NCT05965752|536761125|FG002|Overall Study|Early Termination|1|||
148803661|NCT05965752|536761126|FG003|Overall Study|Early Termination|0|||
148803662|NCT05965752|536761127|FG004|Overall Study|Early Termination|0|||
148803663|NCT05965752|536761123|FG000|Overall Study|Reported Unwanted Symptoms|0|||
148803664|NCT05965752|536761124|FG001|Overall Study|Reported Unwanted Symptoms|0|||
148803665|NCT05965752|536761125|FG002|Overall Study|Reported Unwanted Symptoms|0|||
148803666|NCT05965752|536761126|FG003|Overall Study|Reported Unwanted Symptoms|0|||
148803667|NCT05965752|536761127|FG004|Overall Study|Reported Unwanted Symptoms|1|||
148803668|NCT05965752|536761123|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
148803669|NCT05965752|536761124|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
148803670|NCT05965752|536761125|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
148803671|NCT05965752|536761126|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
148803672|NCT05965752|536761127|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
148803673|NCT01274351|536761128|FG000|Overall Study|Lost to Follow-up|1|||
148803674|NCT01274351|536761128|FG000|Overall Study|patient not compliant with the protocol|1|||
148803675|NCT01274351|536761128|FG000|Overall Study|Pregnancy|1|||
148803676|NCT01274351|536761128|FG000|Overall Study|Death|2|||
148803677|NCT01274351|536761128|FG000|Overall Study|Withdrawal by Subject|3|||
148803678|NCT01274351|536761128|FG000|Overall Study|Adverse Event|8|||
148803679|NCT01274351|536761128|FG000|Overall Study|progression of disease|3|||
148803680|NCT01274351|536761128|FG000|Overall Study|hospitalization|1|||
148803681|NCT01296412|536761131|FG000|Overall Study|Adverse Event|8|||
148803682|NCT01296412|536761132|FG001|Overall Study|Adverse Event|29|||
148803683|NCT01296412|536761131|FG000|Overall Study|Lack of Efficacy|1|||
148803684|NCT01296412|536761132|FG001|Overall Study|Lack of Efficacy|0|||
148803685|NCT01296412|536761131|FG000|Overall Study|Lost to Follow-up|10|||
148803686|NCT01296412|536761132|FG001|Overall Study|Lost to Follow-up|7|||
148803687|NCT01296412|536761131|FG000|Overall Study|Non-compliance with study drug|1|||
148803688|NCT01296412|536761132|FG001|Overall Study|Non-compliance with study drug|2|||
148803689|NCT01296412|536761131|FG000|Overall Study|Other reason not specified|20|||
148803690|NCT01296412|536761132|FG001|Overall Study|Other reason not specified|15|||
148803691|NCT01296412|536761131|FG000|Overall Study|Physician Decision|1|||
148803692|NCT01296412|536761132|FG001|Overall Study|Physician Decision|3|||
148803693|NCT01296412|536761131|FG000|Overall Study|Pregnancy|0|||
148803694|NCT01296412|536761132|FG001|Overall Study|Pregnancy|1|||
148803695|NCT01296412|536761131|FG000|Overall Study|Withdrawal by Subject|10|||
148803696|NCT01296412|536761132|FG001|Overall Study|Withdrawal by Subject|13|||
149138968|NCT05975840|537989018|FG006|Overall Study|Protocol Violation|0|||
149138969|NCT05975840|537989019|FG007|Overall Study|Protocol Violation|0|||
149138970|NCT05975840|537989012|FG000|Overall Study|Adverse Event|0|||
149138971|NCT05975840|537989013|FG001|Overall Study|Adverse Event|0|||
149138972|NCT05975840|537989014|FG002|Overall Study|Adverse Event|0|||
149138973|NCT05975840|537989015|FG003|Overall Study|Adverse Event|1|||
149138974|NCT05975840|537989016|FG004|Overall Study|Adverse Event|0|||
149138975|NCT05975840|537989017|FG005|Overall Study|Adverse Event|0|||
149138976|NCT05975840|537989018|FG006|Overall Study|Adverse Event|0|||
149138977|NCT05975840|537989019|FG007|Overall Study|Adverse Event|0|||
149138978|NCT05975840|537989012|FG000|Overall Study|Death|0|||
149138979|NCT05975840|537989013|FG001|Overall Study|Death|1|||
149138980|NCT05975840|537989014|FG002|Overall Study|Death|0|||
149138981|NCT05975840|537989015|FG003|Overall Study|Death|0|||
149138982|NCT05975840|537989016|FG004|Overall Study|Death|0|||
149138983|NCT05975840|537989017|FG005|Overall Study|Death|0|||
149138984|NCT05975840|537989018|FG006|Overall Study|Death|0|||
149138985|NCT05975840|537989019|FG007|Overall Study|Death|1|||
149138986|NCT00088907|537990306|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
149138987|NCT00088907|537990307|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
149138988|NCT00088907|537990306|FG000|Randomized Study (Step 1)|Adverse Event|14|||
149138989|NCT00088907|537990307|FG001|Randomized Study (Step 1)|Adverse Event|19|||
149138990|NCT00088907|537990306|FG000|Randomized Study (Step 1)|Death|11|||
149138991|NCT00088907|537990307|FG001|Randomized Study (Step 1)|Death|12|||
149138992|NCT00088907|537990306|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
149138993|NCT00088907|537990307|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
149138994|NCT00088907|537990306|FG000|Randomized Study (Step 1)|complicating disease|3|||
149138995|NCT00088907|537990307|FG001|Randomized Study (Step 1)|complicating disease|1|||
149138996|NCT00088907|537990306|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
149138997|NCT00088907|537990307|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
149138998|NCT00088907|537990306|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
149138999|NCT00088907|537990307|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
149139000|NCT00088907|537990306|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
149139001|NCT00088907|537990307|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
149139002|NCT00088907|537990306|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
149139003|NCT00088907|537990307|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
149139004|NCT00088907|537990306|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
149139005|NCT00088907|537990307|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
149139006|NCT00088907|537990306|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
149139007|NCT00088907|537990307|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
149139008|NCT00682448|537990308|FG000|Overall Study|Adverse Event|1|||
149139009|NCT00682448|537990309|FG001|Overall Study|Adverse Event|2|||
149139010|NCT00682448|537990308|FG000|Overall Study|Lack of Efficacy|1|||
149139011|NCT00682448|537990309|FG001|Overall Study|Lack of Efficacy|0|||
149139012|NCT00682448|537990308|FG000|Overall Study|Lost to Follow-up|1|||
149139013|NCT00682448|537990309|FG001|Overall Study|Lost to Follow-up|3|||
149139014|NCT00682448|537990308|FG000|Overall Study|Pregnancy|0|||
149139015|NCT00682448|537990309|FG001|Overall Study|Pregnancy|1|||
149139016|NCT00682448|537990308|FG000|Overall Study|Withdrawal by Subject|2|||
149139017|NCT00682448|537990309|FG001|Overall Study|Withdrawal by Subject|0|||
149139018|NCT04050670|537990312|FG000|Period 3|Physician Decision|0|||
149139019|NCT04050670|537990313|FG001|Period 3|Physician Decision|1|||
149139020|NCT04050670|537990314|FG002|Period 3|Physician Decision|0|||
149139021|NCT00761306|537990315|FG000|Overall Study|Adverse Event|5|||
149139022|NCT00761306|537990315|FG000|Overall Study|Lack of Efficacy|4|||
149139023|NCT00761306|537990315|FG000|Overall Study|Protocol Violation|2|||
149139024|NCT00761306|537990315|FG000|Overall Study|Withdrawal of Consent|3|||
149139025|NCT00761306|537990315|FG000|Overall Study|Lost to Follow-up|1|||
149139026|NCT00761306|537990315|FG000|Overall Study|Administrative or Other Reasons|5|||
148803697|NCT02160626|536761133|FG000|Overall Study|Adverse Event|1|||
149139027|NCT00268437|537990316|FG000|Overall Study|Ineligible|1|||
149139028|NCT00525044|537990317|FG000|Overall Study|Lost to Follow-up|0|||
149139029|NCT00525044|537990318|FG001|Overall Study|Lost to Follow-up|1|||
149139030|NCT02982239|537990322|FG000|Overall Study|Lost to Follow-up|3|||
149139031|NCT02982239|537990323|FG001|Overall Study|Lost to Follow-up|2|||
149139032|NCT00880555|537990324|FG000|Overall Study|Physician Decision|0|||
149139033|NCT00880555|537990325|FG001|Overall Study|Physician Decision|8|||
148803698|NCT02160626|536761134|FG001|Overall Study|Adverse Event|0|||
148803699|NCT02160626|536761135|FG002|Overall Study|Adverse Event|0|||
148803700|NCT02160626|536761133|FG000|Overall Study|Schedule not conducive to study visits|0|||
148803701|NCT02160626|536761134|FG001|Overall Study|Schedule not conducive to study visits|0|||
148803702|NCT02160626|536761135|FG002|Overall Study|Schedule not conducive to study visits|1|||
148803703|NCT02160626|536761133|FG000|Overall Study|Withdrawal by Subject|0|||
148803704|NCT02160626|536761134|FG001|Overall Study|Withdrawal by Subject|1|||
149139034|NCT00880555|537990326|FG002|Overall Study|Physician Decision|0|||
149139035|NCT00880555|537990327|FG003|Overall Study|Physician Decision|2|||
149139036|NCT00880555|537990328|FG004|Overall Study|Physician Decision|1|||
149139037|NCT00880555|537990329|FG005|Overall Study|Physician Decision|0|||
149139038|NCT00880555|537990324|FG000|Overall Study|Withdrawal by Subject|1|||
148910454|NCT02840461|537154211|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
148910455|NCT02840461|537154212|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
148910456|NCT01615029|537154213|FG000|Overall Study|Adverse Event|0|||
148910457|NCT01615029|537154214|FG001|Overall Study|Adverse Event|0|||
148910458|NCT01615029|537154215|FG002|Overall Study|Adverse Event|0|||
148910459|NCT01615029|537154216|FG003|Overall Study|Adverse Event|0|||
148910460|NCT01615029|537154217|FG004|Overall Study|Adverse Event|1|||
148910461|NCT01615029|537154213|FG000|Overall Study|Death|0|||
148910462|NCT01615029|537154214|FG001|Overall Study|Death|0|||
148910463|NCT01615029|537154215|FG002|Overall Study|Death|0|||
148910464|NCT01615029|537154216|FG003|Overall Study|Death|0|||
148910465|NCT01615029|537154217|FG004|Overall Study|Death|1|||
148910466|NCT01615029|537154213|FG000|Overall Study|Lost to Follow-up|0|||
148910467|NCT01615029|537154214|FG001|Overall Study|Lost to Follow-up|0|||
148910468|NCT01615029|537154215|FG002|Overall Study|Lost to Follow-up|0|||
148910469|NCT01615029|537154216|FG003|Overall Study|Lost to Follow-up|0|||
148910470|NCT01615029|537154217|FG004|Overall Study|Lost to Follow-up|1|||
148910471|NCT01615029|537154213|FG000|Overall Study|Progressive disease|2|||
148910472|NCT01615029|537154214|FG001|Overall Study|Progressive disease|1|||
148910473|NCT01615029|537154215|FG002|Overall Study|Progressive disease|1|||
148910474|NCT01615029|537154216|FG003|Overall Study|Progressive disease|1|||
148910475|NCT01615029|537154217|FG004|Overall Study|Progressive disease|5|||
148910476|NCT01615029|537154213|FG000|Overall Study|Physician Decision|0|||
148910477|NCT01615029|537154214|FG001|Overall Study|Physician Decision|0|||
148910478|NCT01615029|537154215|FG002|Overall Study|Physician Decision|0|||
148910479|NCT01615029|537154216|FG003|Overall Study|Physician Decision|0|||
148910480|NCT01615029|537154217|FG004|Overall Study|Physician Decision|1|||
148910481|NCT01615029|537154213|FG000|Overall Study|Ongoing|1|||
148910482|NCT01615029|537154214|FG001|Overall Study|Ongoing|2|||
148910483|NCT01615029|537154215|FG002|Overall Study|Ongoing|3|||
148910484|NCT01615029|537154216|FG003|Overall Study|Ongoing|2|||
148910485|NCT01615029|537154217|FG004|Overall Study|Ongoing|23|||
148910486|NCT05064358|537154218|FG000|Overall Study|Death|23|||
148910487|NCT05064358|537154219|FG001|Overall Study|Death|23|||
148910488|NCT05064358|537154220|FG002|Overall Study|Death|25|||
148910489|NCT05064358|537154221|FG003|Overall Study|Death|21|||
148910490|NCT05064358|537154222|FG004|Overall Study|Death|5|||
148910491|NCT05064358|537154218|FG000|Overall Study|Lost to Follow-up|1|||
148910492|NCT05064358|537154219|FG001|Overall Study|Lost to Follow-up|2|||
148910493|NCT05064358|537154220|FG002|Overall Study|Lost to Follow-up|0|||
148910494|NCT05064358|537154221|FG003|Overall Study|Lost to Follow-up|2|||
148910495|NCT05064358|537154222|FG004|Overall Study|Lost to Follow-up|0|||
148910496|NCT05064358|537154218|FG000|Overall Study|Physician Decision|1|||
148910497|NCT05064358|537154219|FG001|Overall Study|Physician Decision|1|||
148910498|NCT05064358|537154220|FG002|Overall Study|Physician Decision|2|||
148910499|NCT05064358|537154221|FG003|Overall Study|Physician Decision|0|||
148910500|NCT05064358|537154222|FG004|Overall Study|Physician Decision|0|||
148910501|NCT05064358|537154218|FG000|Overall Study|Withdrawal by Subject|4|||
149139039|NCT00880555|537990325|FG001|Overall Study|Withdrawal by Subject|1|||
149139040|NCT00880555|537990326|FG002|Overall Study|Withdrawal by Subject|0|||
149139041|NCT00880555|537990327|FG003|Overall Study|Withdrawal by Subject|0|||
148910502|NCT05064358|537154219|FG001|Overall Study|Withdrawal by Subject|5|||
148910503|NCT05064358|537154220|FG002|Overall Study|Withdrawal by Subject|3|||
148910504|NCT05064358|537154221|FG003|Overall Study|Withdrawal by Subject|6|||
148910505|NCT05064358|537154222|FG004|Overall Study|Withdrawal by Subject|3|||
148910506|NCT05064358|537154218|FG000|Overall Study|Ongoing at the time of analysis|1|||
148910507|NCT05064358|537154219|FG001|Overall Study|Ongoing at the time of analysis|2|||
148910508|NCT05064358|537154220|FG002|Overall Study|Ongoing at the time of analysis|2|||
148910509|NCT05064358|537154221|FG003|Overall Study|Ongoing at the time of analysis|2|||
148910510|NCT05064358|537154222|FG004|Overall Study|Ongoing at the time of analysis|2|||
148910511|NCT01287741|537154223|FG000|Overall Study|Withdrawal by Subject|35|||
148910512|NCT01287741|537154224|FG001|Overall Study|Withdrawal by Subject|38|||
148910513|NCT01287741|537154223|FG000|Overall Study|Protocol Violation|2|||
148910514|NCT01287741|537154224|FG001|Overall Study|Protocol Violation|0|||
148910515|NCT01287741|537154223|FG000|Overall Study|Physician Decision|15|||
148910516|NCT01287741|537154224|FG001|Overall Study|Physician Decision|23|||
149139042|NCT00880555|537990328|FG004|Overall Study|Withdrawal by Subject|0|||
148910517|NCT01287741|537154223|FG000|Overall Study|Non-compliance|8|||
148910518|NCT01287741|537154224|FG001|Overall Study|Non-compliance|6|||
148910519|NCT01287741|537154223|FG000|Overall Study|Lost to Follow-up|10|||
148910520|NCT01287741|537154224|FG001|Overall Study|Lost to Follow-up|8|||
148910521|NCT01287741|537154223|FG000|Overall Study|Death|32|||
148910522|NCT01287741|537154224|FG001|Overall Study|Death|44|||
148910523|NCT01287741|537154223|FG000|Overall Study|Adverse Event|4|||
148803705|NCT02160626|536761135|FG002|Overall Study|Withdrawal by Subject|0|||
148803706|NCT01075048|536762902|FG000|Overall Study|Death|4|||
148910524|NCT01287741|537154224|FG001|Overall Study|Adverse Event|6|||
148803707|NCT01075048|536762903|FG001|Overall Study|Death|17|||
148803708|NCT01075048|536762904|FG002|Overall Study|Death|12|||
148803709|NCT01075048|536762902|FG000|Overall Study|Start of other or new therapy|4|||
148803710|NCT01075048|536762903|FG001|Overall Study|Start of other or new therapy|36|||
148803711|NCT01075048|536762904|FG002|Overall Study|Start of other or new therapy|46|||
148803712|NCT01075048|536762902|FG000|Overall Study|Withdrawal by Subject|1|||
148803713|NCT01075048|536762903|FG001|Overall Study|Withdrawal by Subject|6|||
148803714|NCT01075048|536762904|FG002|Overall Study|Withdrawal by Subject|3|||
148803715|NCT01075048|536762902|FG000|Overall Study|Lost to Follow-up|0|||
148803716|NCT01075048|536762903|FG001|Overall Study|Lost to Follow-up|1|||
148803717|NCT01075048|536762904|FG002|Overall Study|Lost to Follow-up|1|||
148803718|NCT00761319|536762911|FG000|Overall Study|Protocol Violation|21|||
148803719|NCT00761319|536762912|FG001|Overall Study|Protocol Violation|14|||
148803720|NCT00761319|536762911|FG000|Overall Study|Adverse Event|11|||
148803721|NCT00761319|536762912|FG001|Overall Study|Adverse Event|7|||
148803722|NCT00761319|536762911|FG000|Overall Study|Withdrawal by Subject|8|||
148803723|NCT00761319|536762912|FG001|Overall Study|Withdrawal by Subject|7|||
148803724|NCT00761319|536762911|FG000|Overall Study|Noncompliance|4|||
148803725|NCT00761319|536762912|FG001|Overall Study|Noncompliance|3|||
148803726|NCT00761319|536762911|FG000|Overall Study|Lost to Follow-up|1|||
148803727|NCT00761319|536762912|FG001|Overall Study|Lost to Follow-up|1|||
148803728|NCT00761319|536762911|FG000|Overall Study|Nonspecified|2|||
148803729|NCT00761319|536762912|FG001|Overall Study|Nonspecified|2|||
148803730|NCT00761319|536762911|FG000|Overall Study|Missing|1|||
148803731|NCT00761319|536762912|FG001|Overall Study|Missing|0|||
148803732|NCT01715831|536762917|FG000|Overall Study|Adverse Event|1|||
148803733|NCT00900562|536762918|FG000|Overall Study|Progressive disease|9|||
148803734|NCT00900562|536762919|FG001|Overall Study|Progressive disease|5|||
148803735|NCT00900562|536762918|FG000|Overall Study|Toxicity|1|||
148803736|NCT00900562|536762919|FG001|Overall Study|Toxicity|0|||
148803737|NCT00900562|536762918|FG000|Overall Study|Death|1|||
148803738|NCT00900562|536762919|FG001|Overall Study|Death|1|||
148803739|NCT00900562|536762918|FG000|Overall Study|Withdrawal by Subject|0|||
148803740|NCT00900562|536762919|FG001|Overall Study|Withdrawal by Subject|1|||
148803741|NCT00900562|536762918|FG000|Overall Study|Unrelated adverse event|1|||
148803742|NCT00900562|536762919|FG001|Overall Study|Unrelated adverse event|0|||
148803743|NCT03098979|536762922|FG000|Overall Study|Adverse Event|1|||
148803744|NCT03098979|536762923|FG001|Overall Study|Adverse Event|0|||
148803745|NCT03098979|536762924|FG002|Overall Study|Adverse Event|1|||
148803746|NCT03098979|536762925|FG003|Overall Study|Adverse Event|4|||
148803747|NCT03098979|536762926|FG004|Overall Study|Adverse Event|6|||
148803748|NCT03098979|536762927|FG005|Overall Study|Adverse Event|1|||
148803749|NCT03098979|536762922|FG000|Overall Study|Withdrawal by Subject|2|||
148803750|NCT03098979|536762923|FG001|Overall Study|Withdrawal by Subject|1|||
148803751|NCT03098979|536762924|FG002|Overall Study|Withdrawal by Subject|1|||
148803752|NCT03098979|536762925|FG003|Overall Study|Withdrawal by Subject|1|||
148803753|NCT03098979|536762926|FG004|Overall Study|Withdrawal by Subject|2|||
148803754|NCT03098979|536762927|FG005|Overall Study|Withdrawal by Subject|1|||
148803755|NCT03098979|536762922|FG000|Overall Study|Death|1|||
148803756|NCT03098979|536762923|FG001|Overall Study|Death|0|||
148803757|NCT03098979|536762924|FG002|Overall Study|Death|2|||
148803758|NCT03098979|536762925|FG003|Overall Study|Death|0|||
148803759|NCT03098979|536762926|FG004|Overall Study|Death|1|||
148803760|NCT03098979|536762927|FG005|Overall Study|Death|0|||
148803761|NCT03098979|536762922|FG000|Overall Study|Physician Decision|2|||
148910525|NCT01287741|537154223|FG000|Overall Study|Study terminated by Sponsor|307|||
148803762|NCT03098979|536762923|FG001|Overall Study|Physician Decision|1|||
148803763|NCT03098979|536762924|FG002|Overall Study|Physician Decision|0|||
148803764|NCT03098979|536762925|FG003|Overall Study|Physician Decision|0|||
148803765|NCT03098979|536762926|FG004|Overall Study|Physician Decision|0|||
148803766|NCT03098979|536762927|FG005|Overall Study|Physician Decision|0|||
148803767|NCT03098979|536762922|FG000|Overall Study|Non-compliance|0|||
148803768|NCT03098979|536762923|FG001|Overall Study|Non-compliance|0|||
149139043|NCT00880555|537990329|FG005|Overall Study|Withdrawal by Subject|0|||
149139044|NCT00880555|537990324|FG000|Overall Study|Lack of resources (hired rater)|9|||
149139045|NCT00880555|537990325|FG001|Overall Study|Lack of resources (hired rater)|7|||
149139046|NCT00880555|537990326|FG002|Overall Study|Lack of resources (hired rater)|5|||
149139047|NCT00880555|537990327|FG003|Overall Study|Lack of resources (hired rater)|0|||
149139048|NCT00880555|537990328|FG004|Overall Study|Lack of resources (hired rater)|0|||
149139049|NCT00880555|537990329|FG005|Overall Study|Lack of resources (hired rater)|0|||
148910526|NCT01287741|537154224|FG001|Overall Study|Study terminated by Sponsor|315|||
148910527|NCT01287741|537154223|FG000|Overall Study|Progressive disease|190|||
148910528|NCT01287741|537154224|FG001|Overall Study|Progressive disease|166|||
148910529|NCT01287741|537154223|FG000|Overall Study|Reason not specified|23|||
148910530|NCT01287741|537154224|FG001|Overall Study|Reason not specified|9|||
148910531|NCT04421027|537154225|FG000|Treatment Period|Adverse Event|5|||
148910532|NCT04421027|537154226|FG001|Treatment Period|Adverse Event|3|||
148910533|NCT04421027|537154227|FG002|Treatment Period|Adverse Event|0|||
148910534|NCT04421027|537154228|FG003|Treatment Period|Adverse Event|0|||
148910535|NCT04421027|537154225|FG000|Treatment Period|Death|98|||
148910536|NCT04421027|537154226|FG001|Treatment Period|Death|61|||
148910537|NCT04421027|537154227|FG002|Treatment Period|Death|0|||
148910538|NCT04421027|537154228|FG003|Treatment Period|Death|0|||
148910539|NCT04421027|537154225|FG000|Treatment Period|Lost to Follow-up|22|||
148910540|NCT04421027|537154226|FG001|Treatment Period|Lost to Follow-up|20|||
149139050|NCT00880555|537990324|FG000|Overall Study|Death|0|||
149139051|NCT00880555|537990325|FG001|Overall Study|Death|0|||
149139052|NCT00880555|537990326|FG002|Overall Study|Death|0|||
149139053|NCT00880555|537990327|FG003|Overall Study|Death|0|||
149139054|NCT00880555|537990328|FG004|Overall Study|Death|0|||
149139055|NCT00880555|537990329|FG005|Overall Study|Death|1|||
149139056|NCT00880555|537990324|FG000|Overall Study|Lost to Follow-up|0|||
149139057|NCT00880555|537990325|FG001|Overall Study|Lost to Follow-up|1|||
149139058|NCT00880555|537990326|FG002|Overall Study|Lost to Follow-up|0|||
149139059|NCT00880555|537990327|FG003|Overall Study|Lost to Follow-up|0|||
149139060|NCT00880555|537990328|FG004|Overall Study|Lost to Follow-up|0|||
149139061|NCT00880555|537990329|FG005|Overall Study|Lost to Follow-up|0|||
149139062|NCT01873417|537990332|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
149139063|NCT01873417|537990332|FG000|Overall Study|Adverse Event|24|||
149139064|NCT01873417|537990332|FG000|Overall Study|Lost to Follow-up|2|||
149139065|NCT01873417|537990332|FG000|Overall Study|Withdrawal by Subject|2|||
149139066|NCT01873417|537990332|FG000|Overall Study|Physician Decision|3|||
149139067|NCT00785044|537990333|FG000|Overall Study|Dosed at non-participating sites|152|||
149139068|NCT00785044|537990333|FG000|Overall Study|Death|77|||
149139069|NCT00785044|537990333|FG000|Overall Study|Lost to Follow-up|266|||
149139070|NCT00785044|537990333|FG000|Overall Study|Withdrawal by Subject|1|||
149139071|NCT01086410|537990334|FG000|Overall Study|Adverse Event|1|||
149139072|NCT01086410|537990335|FG001|Overall Study|Adverse Event|0|||
148803769|NCT03098979|536762924|FG002|Overall Study|Non-compliance|0|||
148803770|NCT03098979|536762925|FG003|Overall Study|Non-compliance|0|||
148803771|NCT03098979|536762926|FG004|Overall Study|Non-compliance|0|||
148803772|NCT03098979|536762927|FG005|Overall Study|Non-compliance|1|||
148803773|NCT03098979|536762922|FG000|Overall Study|Protocol Violation|0|||
148803774|NCT03098979|536762923|FG001|Overall Study|Protocol Violation|0|||
148803775|NCT03098979|536762924|FG002|Overall Study|Protocol Violation|0|||
148803776|NCT03098979|536762925|FG003|Overall Study|Protocol Violation|0|||
148803777|NCT03098979|536762926|FG004|Overall Study|Protocol Violation|0|||
148803778|NCT03098979|536762927|FG005|Overall Study|Protocol Violation|1|||
148803779|NCT02419807|536762928|FG000|Overall Study|Withdrawal by Subject|4|||
148803780|NCT02419807|536762928|FG000|Overall Study|Physician Decision|1|||
148803781|NCT02419807|536762928|FG000|Overall Study|Protocol Violation|5|||
148803782|NCT01065818|536762929|FG000|Overall Study|Withdrawal by Subject|1|||
148803783|NCT01065818|536762929|FG000|Overall Study|Not a candidate for surgery|1|||
148803784|NCT04459338|536762932|FG000|Overall Study|Loss of IV during study|1|||
148803785|NCT04459338|536762933|FG001|Overall Study|Loss of IV during study|0|||
148803786|NCT03157089|536762934|FG000|Overall Study|Treated only with pembrolizumab|1|||
148803787|NCT03157089|536762935|FG001|Overall Study|Treated only with pembrolizumab|0|||
148803788|NCT03157089|536762934|FG000|Overall Study|Adverse Event|5|||
148803789|NCT03157089|536762935|FG001|Overall Study|Adverse Event|4|||
148803790|NCT03157089|536762934|FG000|Overall Study|Progressive disease|6|||
148803791|NCT03157089|536762935|FG001|Overall Study|Progressive disease|8|||
149139073|NCT01086410|537990336|FG002|Overall Study|Adverse Event|0|||
149139074|NCT01086410|537990337|FG003|Overall Study|Adverse Event|2|||
149139075|NCT01086410|537990334|FG000|Overall Study|Lack of Efficacy|1|||
148803792|NCT00784875|536762936|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
148803793|NCT00784875|536762937|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
148803794|NCT00784875|536762938|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
148910541|NCT04421027|537154227|FG002|Treatment Period|Lost to Follow-up|0|||
149139076|NCT01086410|537990335|FG001|Overall Study|Lack of Efficacy|1|||
149139077|NCT01086410|537990336|FG002|Overall Study|Lack of Efficacy|0|||
149139078|NCT01086410|537990337|FG003|Overall Study|Lack of Efficacy|0|||
149139079|NCT01086410|537990334|FG000|Overall Study|Protocol Violation|1|||
148910542|NCT04421027|537154228|FG003|Treatment Period|Lost to Follow-up|0|||
148910543|NCT04421027|537154225|FG000|Treatment Period|Other-Unknown|15|||
148910544|NCT04421027|537154226|FG001|Treatment Period|Other-Unknown|9|||
148910545|NCT04421027|537154227|FG002|Treatment Period|Other-Unknown|0|||
148910546|NCT04421027|537154228|FG003|Treatment Period|Other-Unknown|0|||
148910547|NCT04421027|537154225|FG000|Treatment Period|Physician Decision|1|||
148910548|NCT04421027|537154226|FG001|Treatment Period|Physician Decision|1|||
148910549|NCT04421027|537154227|FG002|Treatment Period|Physician Decision|0|||
148910550|NCT04421027|537154228|FG003|Treatment Period|Physician Decision|0|||
148910551|NCT04421027|537154225|FG000|Treatment Period|Withdrawal by Subject|7|||
148910552|NCT04421027|537154226|FG001|Treatment Period|Withdrawal by Subject|12|||
148910553|NCT04421027|537154227|FG002|Treatment Period|Withdrawal by Subject|0|||
148910554|NCT04421027|537154228|FG003|Treatment Period|Withdrawal by Subject|0|||
148910555|NCT04421027|537154225|FG000|Treatment Period|Randomized Not Dosed|9|||
148910556|NCT04421027|537154226|FG001|Treatment Period|Randomized Not Dosed|14|||
148910557|NCT04421027|537154227|FG002|Treatment Period|Randomized Not Dosed|0|||
148910558|NCT04421027|537154228|FG003|Treatment Period|Randomized Not Dosed|0|||
148910559|NCT04421027|537154225|FG000|Follow-Up Period|Adverse Event|0|||
148910560|NCT04421027|537154226|FG001|Follow-Up Period|Adverse Event|0|||
148910561|NCT04421027|537154227|FG002|Follow-Up Period|Adverse Event|0|||
148910562|NCT04421027|537154228|FG003|Follow-Up Period|Adverse Event|3|||
148910563|NCT04421027|537154225|FG000|Follow-Up Period|Death|0|||
148910564|NCT04421027|537154226|FG001|Follow-Up Period|Death|0|||
148910565|NCT04421027|537154227|FG002|Follow-Up Period|Death|16|||
148910566|NCT04421027|537154228|FG003|Follow-Up Period|Death|17|||
148910567|NCT04421027|537154225|FG000|Follow-Up Period|Lost to Follow-up|0|||
148910568|NCT04421027|537154226|FG001|Follow-Up Period|Lost to Follow-up|0|||
148910569|NCT04421027|537154227|FG002|Follow-Up Period|Lost to Follow-up|7|||
148910570|NCT04421027|537154228|FG003|Follow-Up Period|Lost to Follow-up|7|||
148910571|NCT04421027|537154225|FG000|Follow-Up Period|Protocol Deviation|0|||
148910572|NCT04421027|537154226|FG001|Follow-Up Period|Protocol Deviation|0|||
148910573|NCT04421027|537154227|FG002|Follow-Up Period|Protocol Deviation|1|||
148910574|NCT04421027|537154228|FG003|Follow-Up Period|Protocol Deviation|0|||
148910575|NCT04421027|537154225|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
148910576|NCT04421027|537154226|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
148910577|NCT04421027|537154227|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
148910578|NCT04421027|537154228|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
148910579|NCT04421027|537154225|FG000|Follow-Up Period|Left message, participant did not call back|0|||
148910580|NCT04421027|537154226|FG001|Follow-Up Period|Left message, participant did not call back|0|||
148910581|NCT04421027|537154227|FG002|Follow-Up Period|Left message, participant did not call back|0|||
148910582|NCT04421027|537154228|FG003|Follow-Up Period|Left message, participant did not call back|1|||
148910583|NCT04421027|537154225|FG000|Follow-Up Period|Participant died|0|||
148910584|NCT04421027|537154226|FG001|Follow-Up Period|Participant died|0|||
148910585|NCT04421027|537154227|FG002|Follow-Up Period|Participant died|0|||
148910586|NCT04421027|537154228|FG003|Follow-Up Period|Participant died|1|||
148910587|NCT04421027|537154225|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
148910588|NCT04421027|537154226|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
149139080|NCT01086410|537990335|FG001|Overall Study|Protocol Violation|1|||
149139081|NCT01086410|537990336|FG002|Overall Study|Protocol Violation|0|||
149139082|NCT01086410|537990337|FG003|Overall Study|Protocol Violation|0|||
149139083|NCT01086410|537990334|FG000|Overall Study|Lost to Follow-up|0|||
149139084|NCT01086410|537990335|FG001|Overall Study|Lost to Follow-up|0|||
149139085|NCT01086410|537990336|FG002|Overall Study|Lost to Follow-up|1|||
149139086|NCT01086410|537990337|FG003|Overall Study|Lost to Follow-up|0|||
149139087|NCT04196803|537990338|FG000|Overall Study|Withdrawal by Subject|1|||
149139088|NCT04196803|537990339|FG001|Overall Study|Withdrawal by Subject|3|||
149139089|NCT04196803|537990338|FG000|Overall Study|Adverse Event|4|||
149139090|NCT04196803|537990339|FG001|Overall Study|Adverse Event|2|||
149139091|NCT04196803|537990338|FG000|Overall Study|Lost to Follow-up|0|||
148910589|NCT04421027|537154227|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
148910590|NCT04421027|537154228|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
148910591|NCT00539864|537155703|FG000|Overall Study|Lost to Follow-up|0|||
148910592|NCT00539864|537155704|FG001|Overall Study|Lost to Follow-up|1|||
148910593|NCT00539864|537155703|FG000|Overall Study|Withdrawal by Subject|1|||
148910594|NCT00539864|537155704|FG001|Overall Study|Withdrawal by Subject|1|||
148910595|NCT02881567|537155705|FG000|Overall Study|Adverse Event|1|||
148910596|NCT02881567|537155705|FG000|Overall Study|Lost to Follow-up|3|||
148910597|NCT02881567|537155705|FG000|Overall Study|Consent withdrawn|1|||
149139092|NCT04196803|537990339|FG001|Overall Study|Lost to Follow-up|1|||
149139093|NCT01022996|537990340|FG000|Overall Study|Adverse Event|14|||
149139094|NCT01022996|537990340|FG000|Overall Study|Withdrawal by Subject|3|||
149139095|NCT01022996|537990340|FG000|Overall Study|Lost to Follow-up|1|||
149139096|NCT01022996|537990340|FG000|Overall Study|Administrative problems|6|||
149139097|NCT01022996|537990340|FG000|Overall Study|Disease Progression|32|||
149139098|NCT01022996|537990340|FG000|Overall Study|Protocol Violation|1|||
149139099|NCT02767323|537990341|FG000|Overall Study|Withdrawal by Subject|17|||
149139100|NCT02767323|537990342|FG001|Overall Study|Withdrawal by Subject|5|||
149139101|NCT02767323|537990343|FG002|Overall Study|Withdrawal by Subject|13|||
149139102|NCT02767323|537990344|FG003|Overall Study|Withdrawal by Subject|0|||
149139103|NCT02767323|537990341|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
149139104|NCT02767323|537990342|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
149139105|NCT02767323|537990343|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
149139106|NCT02767323|537990344|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
149139107|NCT04479436|537990349|FG000|Overall Study|Progressive disease|26|||
149139108|NCT04479436|537990350|FG001|Overall Study|Progressive disease|1|||
149139109|NCT04479436|537990349|FG000|Overall Study|Adverse Event|6|||
149139110|NCT04479436|537990350|FG001|Overall Study|Adverse Event|0|||
149139111|NCT04479436|537990349|FG000|Overall Study|Withdrawal by Subject|5|||
149139112|NCT04479436|537990350|FG001|Overall Study|Withdrawal by Subject|0|||
149139113|NCT04479436|537990349|FG000|Overall Study|Clinical progression|1|||
149139114|NCT04479436|537990350|FG001|Overall Study|Clinical progression|0|||
148910598|NCT02881567|537155705|FG000|Overall Study|Investigator decision|1|||
148910599|NCT02881567|537155705|FG000|Overall Study|Study terminated by sponsor|9|||
148910600|NCT02881567|537155705|FG000|Overall Study|Reason not Specified|3|||
148910601|NCT02405442|537155706|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
148910602|NCT02405442|537155707|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
148910603|NCT02405442|537155708|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
148910604|NCT02405442|537155709|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
148910605|NCT02405442|537155706|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
148910606|NCT02405442|537155707|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
148910607|NCT02405442|537155708|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
148910608|NCT02405442|537155709|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
148910609|NCT02405442|537155706|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
148910610|NCT02405442|537155707|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
148910611|NCT02405442|537155708|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
149139115|NCT04479436|537990349|FG000|Overall Study|Physician Decision|1|||
149139116|NCT04479436|537990350|FG001|Overall Study|Physician Decision|0|||
149139117|NCT02713542|537990354|FG000|Overall Study|Use of prohibited medication|14|||
149139118|NCT02713542|537990355|FG001|Overall Study|Use of prohibited medication|5|||
149139119|NCT02713542|537990354|FG000|Overall Study|Withdrawal by Subject|4|||
149139120|NCT02713542|537990355|FG001|Overall Study|Withdrawal by Subject|1|||
149139121|NCT02357134|537990356|FG000|Overall Study|Lost to Follow-up|1|||
149139122|NCT02357134|537990357|FG001|Overall Study|Lost to Follow-up|0|||
149139123|NCT02357134|537990358|FG002|Overall Study|Lost to Follow-up|0|||
149139124|NCT02357134|537990359|FG003|Overall Study|Lost to Follow-up|0|||
149139125|NCT03583450|537990360|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
149139126|NCT03583450|537990361|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
149139127|NCT05097716|537990362|FG000|Period 1|Adverse Event|1|||
149139128|NCT05097716|537990362|FG000|Period 1|Close contact with highly-transmissible infection|1|||
149139129|NCT00791258|537990363|FG000|Overall Study|Adverse Event|87|||
149139130|NCT00791258|537990363|FG000|Overall Study|Lost to Follow-up|18|||
149139131|NCT00791258|537990363|FG000|Overall Study|Protocol Violation|109|||
149139132|NCT00791258|537990363|FG000|Overall Study|Withdrawal by Subject|40|||
149139133|NCT00791258|537990363|FG000|Overall Study|Did not take medication for >3 days|1|||
148910612|NCT02405442|537155709|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
148910613|NCT02405442|537155706|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
148910614|NCT02405442|537155707|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
148910615|NCT02405442|537155708|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
148910616|NCT02405442|537155709|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
148910617|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
149139134|NCT00791258|537990363|FG000|Overall Study|subject left area|2|||
149139135|NCT00791258|537990363|FG000|Overall Study|non-compliance|3|||
148956470|NCT00723892|537324428|FG000|Overall Study|Drug addiction|1|||
149139136|NCT00791258|537990363|FG000|Overall Study|Subject incarcerated|1|||
149139137|NCT00791258|537990363|FG000|Overall Study|Subject required restricted medication|1|||
149139138|NCT00791258|537990363|FG000|Overall Study|Lack of Efficacy|1|||
149139139|NCT00210184|537990364|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
149139140|NCT01118325|537990369|FG000|Overall Study|Adverse Event|1|||
149139141|NCT01118325|537990370|FG001|Overall Study|Adverse Event|0|||
149139142|NCT01118325|537990371|FG002|Overall Study|Adverse Event|1|||
149139143|NCT03334409|537990372|FG000|Overall Study|Did not meet inclusion criteria|1|||
149139144|NCT03334409|537990373|FG001|Overall Study|Did not meet inclusion criteria|0|||
149139145|NCT00975715|537990374|FG000|Titration Period|Adverse Event|6|||
148910618|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
149139146|NCT00975715|537990375|FG001|Titration Period|Adverse Event|0|||
149139147|NCT00975715|537990374|FG000|Titration Period|Protocol Violation|1|||
149139148|NCT00975715|537990375|FG001|Titration Period|Protocol Violation|0|||
149139149|NCT00975715|537990374|FG000|Maintenance Period|Adverse Event|2|||
149139150|NCT00975715|537990375|FG001|Maintenance Period|Adverse Event|1|||
149139151|NCT05215262|537990385|FG000|Overall Study|Lost to Follow-up|12|||
149139152|NCT05215262|537990386|FG001|Overall Study|Lost to Follow-up|0|||
149139153|NCT00239226|537990391|FG000|Overall Study|permAF during stabilization period|0|||
149139154|NCT00239226|537990392|FG001|Overall Study|permAF during stabilization period|0|||
149139155|NCT00239226|537990393|FG002|Overall Study|permAF during stabilization period|0|||
149139156|NCT00239226|537990394|FG003|Overall Study|permAF during stabilization period|3|||
149139157|NCT00239226|537990391|FG000|Overall Study|Lost to Follow-up|1|||
149139158|NCT00239226|537990392|FG001|Overall Study|Lost to Follow-up|0|||
149139159|NCT00239226|537990393|FG002|Overall Study|Lost to Follow-up|1|||
149139160|NCT00239226|537990394|FG003|Overall Study|Lost to Follow-up|0|||
149139161|NCT00646906|537990395|FG000|Crossover Period 1|Withdrawal by Subject|1|||
149139162|NCT00646906|537990396|FG001|Crossover Period 1|Withdrawal by Subject|0|||
149139163|NCT00646906|537990397|FG002|Crossover Period 1|Withdrawal by Subject|0|||
149139164|NCT00646906|537990398|FG003|Crossover Period 1|Withdrawal by Subject|0|||
149139165|NCT00646906|537990399|FG004|Crossover Period 1|Withdrawal by Subject|0|||
149139166|NCT00646906|537990400|FG005|Crossover Period 1|Withdrawal by Subject|1|||
149139167|NCT00646906|537990401|FG006|Crossover Period 1|Withdrawal by Subject|0|||
149139168|NCT00646906|537990395|FG000|Crossover Period 2|Withdrawal by Subject|0|||
149139169|NCT00646906|537990396|FG001|Crossover Period 2|Withdrawal by Subject|1|||
149139170|NCT00646906|537990397|FG002|Crossover Period 2|Withdrawal by Subject|2|||
149139171|NCT00646906|537990398|FG003|Crossover Period 2|Withdrawal by Subject|1|||
149139172|NCT00646906|537990399|FG004|Crossover Period 2|Withdrawal by Subject|0|||
149139173|NCT00646906|537990400|FG005|Crossover Period 2|Withdrawal by Subject|0|||
149139174|NCT00646906|537990401|FG006|Crossover Period 2|Withdrawal by Subject|0|||
149139175|NCT00646906|537990395|FG000|Crossover Period 2|Physician Decision|0|||
149139176|NCT00646906|537990396|FG001|Crossover Period 2|Physician Decision|0|||
149139177|NCT00646906|537990397|FG002|Crossover Period 2|Physician Decision|0|||
149139178|NCT00646906|537990398|FG003|Crossover Period 2|Physician Decision|0|||
149139179|NCT00646906|537990399|FG004|Crossover Period 2|Physician Decision|0|||
149139180|NCT00646906|537990400|FG005|Crossover Period 2|Physician Decision|0|||
149139181|NCT00646906|537990401|FG006|Crossover Period 2|Physician Decision|1|||
149139182|NCT01303965|537990402|FG000|Overall Study|Adverse Event|1|||
149139183|NCT01303965|537990403|FG001|Overall Study|Adverse Event|1|||
149139184|NCT01303965|537990402|FG000|Overall Study|Death|0|||
149139185|NCT01303965|537990403|FG001|Overall Study|Death|3|||
149139186|NCT01303965|537990402|FG000|Overall Study|Withdrawal by Subject|1|||
149139187|NCT01303965|537990403|FG001|Overall Study|Withdrawal by Subject|0|||
148910619|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
148910620|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
148910621|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
148910622|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
148910623|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
148910624|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
148910625|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
148910626|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
148910627|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
149139188|NCT01303965|537990402|FG000|Overall Study|Disease Progression|1|||
149139189|NCT01303965|537990403|FG001|Overall Study|Disease Progression|6|||
149139190|NCT04060563|537990404|FG000|Overall Study|Lost to Follow-up|1|||
149139191|NCT04060563|537990405|FG001|Overall Study|Lost to Follow-up|1|||
149139192|NCT04060563|537990404|FG000|Overall Study|Physician Decision|0|||
149139193|NCT04060563|537990405|FG001|Overall Study|Physician Decision|1|||
149139194|NCT01379573|537990411|FG000|Overall Study|Lost to Follow-up|1|||
149139195|NCT01379573|537990411|FG000|Overall Study|Screen Failure|10|||
149139196|NCT02871778|537990412|FG000|Part A: Treatment Period 1|Adverse Event|1|||
149139197|NCT02871778|537990413|FG001|Part A: Treatment Period 1|Adverse Event|1|||
149139198|NCT02871778|537990414|FG002|Part A: Treatment Period 1|Adverse Event|1|||
149139199|NCT02871778|537990415|FG003|Part A: Treatment Period 1|Adverse Event|0|||
148910628|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
148910629|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
148910630|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
148910631|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
148910632|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
148910633|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
148910634|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
148910635|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
148910636|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
148910637|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
148910638|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
148910639|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
148910640|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
148910641|NCT02405442|537155706|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
148910642|NCT02405442|537155707|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
148910643|NCT02405442|537155708|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
148910644|NCT02405442|537155709|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
148910645|NCT02405442|537155706|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
148910646|NCT02405442|537155707|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
148910647|NCT02405442|537155708|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
148910648|NCT02405442|537155709|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
148910649|NCT02405442|537155706|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
148910650|NCT02405442|537155707|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
148910651|NCT02405442|537155708|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
148910652|NCT02405442|537155709|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
148910653|NCT02405442|537155706|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
148910654|NCT02405442|537155707|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
148910655|NCT02405442|537155708|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
148910656|NCT02405442|537155709|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
148910657|NCT00373113|537155710|FG000|Overall Study|Death|1|||
148910658|NCT00373113|537155711|FG001|Overall Study|Death|7|||
148910659|NCT00373113|537155710|FG000|Overall Study|Adverse Event|38|||
148910660|NCT00373113|537155711|FG001|Overall Study|Adverse Event|24|||
148910661|NCT00373113|537155710|FG000|Overall Study|Study terminated by sponsor|9|||
148910662|NCT00373113|537155711|FG001|Overall Study|Study terminated by sponsor|1|||
148910663|NCT00373113|537155710|FG000|Overall Study|Global deterioration of health status|10|||
148910664|NCT00373113|537155711|FG001|Overall Study|Global deterioration of health status|7|||
148910665|NCT00373113|537155710|FG000|Overall Study|Lost to Follow-up|1|||
148910666|NCT00373113|537155711|FG001|Overall Study|Lost to Follow-up|3|||
148910667|NCT00373113|537155710|FG000|Overall Study|Objective progression or relapse|150|||
148910668|NCT00373113|537155711|FG001|Overall Study|Objective progression or relapse|169|||
148910669|NCT00373113|537155710|FG000|Overall Study|Other|14|||
148910670|NCT00373113|537155711|FG001|Overall Study|Other|17|||
148910671|NCT00373113|537155710|FG000|Overall Study|Protocol Violation|5|||
148910672|NCT00373113|537155711|FG001|Overall Study|Protocol Violation|1|||
148910673|NCT00373113|537155710|FG000|Overall Study|Withdrawal by Subject|10|||
148910674|NCT00373113|537155711|FG001|Overall Study|Withdrawal by Subject|15|||
148910675|NCT02078960|537155712|FG000|Treatment Period|Other|0|||
148910676|NCT02078960|537155713|FG001|Treatment Period|Other|0|||
148910677|NCT02078960|537155714|FG002|Treatment Period|Other|1|||
148910678|NCT02078960|537155712|FG000|Treatment Period|Lack of Efficacy|0|||
148910679|NCT02078960|537155713|FG001|Treatment Period|Lack of Efficacy|1|||
148910680|NCT02078960|537155714|FG002|Treatment Period|Lack of Efficacy|0|||
148910681|NCT02078960|537155712|FG000|Treatment Period|Disease progression - accelerated phase|0|||
148910682|NCT02078960|537155713|FG001|Treatment Period|Disease progression - accelerated phase|1|||
148910683|NCT02078960|537155714|FG002|Treatment Period|Disease progression - accelerated phase|0|||
148910684|NCT02078960|537155712|FG000|Treatment Period|Disease progression - blast phase|1|||
148910685|NCT02078960|537155713|FG001|Treatment Period|Disease progression - blast phase|0|||
148910686|NCT02078960|537155714|FG002|Treatment Period|Disease progression - blast phase|0|||
148910687|NCT02078960|537155712|FG000|Treatment Period|Withdrawal by Subject|0|||
148910688|NCT02078960|537155713|FG001|Treatment Period|Withdrawal by Subject|1|||
148910689|NCT02078960|537155714|FG002|Treatment Period|Withdrawal by Subject|1|||
148910690|NCT02078960|537155712|FG000|Treatment Period|Adverse Event|1|||
148910691|NCT02078960|537155713|FG001|Treatment Period|Adverse Event|0|||
148910692|NCT02078960|537155714|FG002|Treatment Period|Adverse Event|0|||
148910693|NCT02078960|537155712|FG000|Treatment Period|Death|0|||
148910694|NCT02078960|537155713|FG001|Treatment Period|Death|0|||
148910695|NCT02078960|537155714|FG002|Treatment Period|Death|1|||
148910696|NCT02078960|537155712|FG000|Follow-up Period|Death|2|||
148910697|NCT02078960|537155713|FG001|Follow-up Period|Death|0|||
148910698|NCT02078960|537155714|FG002|Follow-up Period|Death|0|||
149139200|NCT02871778|537990416|FG004|Part A: Treatment Period 1|Adverse Event|0|||
149139201|NCT02871778|537990417|FG005|Part A: Treatment Period 1|Adverse Event|0|||
149139202|NCT02871778|537990418|FG006|Part A: Treatment Period 1|Adverse Event|0|||
149139203|NCT02871778|537990419|FG007|Part A: Treatment Period 1|Adverse Event|0|||
149139204|NCT02871778|537990412|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
149139205|NCT02871778|537990413|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
149139206|NCT02871778|537990414|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149139207|NCT02871778|537990415|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
149139208|NCT02871778|537990416|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149139209|NCT02871778|537990417|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149139210|NCT02871778|537990418|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149139211|NCT02871778|537990419|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
149139212|NCT02871778|537990412|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
149139213|NCT02871778|537990413|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
149139214|NCT02871778|537990414|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
149139215|NCT02871778|537990415|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
149139216|NCT02871778|537990416|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
149139217|NCT02871778|537990417|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
148803795|NCT00784875|536762939|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
148803796|NCT00784875|536762936|FG000|Period A - Baseline|Adverse Event|0|||
148803797|NCT00784875|536762937|FG001|Period A - Baseline|Adverse Event|0|||
148803798|NCT00784875|536762938|FG002|Period A - Baseline|Adverse Event|0|||
148803799|NCT00784875|536762939|FG003|Period A - Baseline|Adverse Event|8|||
148803800|NCT00784875|536762936|FG000|Period A - Baseline|Protocol Violation|0|||
148803801|NCT00784875|536762937|FG001|Period A - Baseline|Protocol Violation|0|||
148803802|NCT00784875|536762938|FG002|Period A - Baseline|Protocol Violation|0|||
148803803|NCT00784875|536762939|FG003|Period A - Baseline|Protocol Violation|25|||
148803804|NCT00784875|536762936|FG000|Period A - Baseline|Withdrawal by Subject|0|||
148803805|NCT00784875|536762937|FG001|Period A - Baseline|Withdrawal by Subject|0|||
148803806|NCT00784875|536762938|FG002|Period A - Baseline|Withdrawal by Subject|0|||
148803807|NCT00784875|536762939|FG003|Period A - Baseline|Withdrawal by Subject|27|||
148803808|NCT00784875|536762936|FG000|Period A - Baseline|Physician Decision|0|||
148803809|NCT00784875|536762937|FG001|Period A - Baseline|Physician Decision|0|||
148803810|NCT00784875|536762938|FG002|Period A - Baseline|Physician Decision|0|||
148803811|NCT00784875|536762939|FG003|Period A - Baseline|Physician Decision|2|||
148803812|NCT00784875|536762936|FG000|Period A - Baseline|Sponsor Decision|0|||
148803813|NCT00784875|536762937|FG001|Period A - Baseline|Sponsor Decision|0|||
148803814|NCT00784875|536762938|FG002|Period A - Baseline|Sponsor Decision|0|||
148803815|NCT00784875|536762939|FG003|Period A - Baseline|Sponsor Decision|113|||
148803816|NCT00784875|536762936|FG000|Period A - Baseline|Lost to Follow-up|0|||
148803817|NCT00784875|536762937|FG001|Period A - Baseline|Lost to Follow-up|0|||
148803818|NCT00784875|536762938|FG002|Period A - Baseline|Lost to Follow-up|0|||
148803819|NCT00784875|536762939|FG003|Period A - Baseline|Lost to Follow-up|2|||
148803820|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
148803821|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
148803822|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
148803823|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
148803824|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
148803825|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
148910699|NCT02078960|537155712|FG000|Follow-up Period|Lost to Follow-up|0|||
148910700|NCT02078960|537155713|FG001|Follow-up Period|Lost to Follow-up|1|||
148910701|NCT02078960|537155714|FG002|Follow-up Period|Lost to Follow-up|0|||
148910702|NCT03275350|537155715|FG000|Overall Study|Lost to Follow-up|4|||
148910703|NCT03275350|537155716|FG001|Overall Study|Lost to Follow-up|6|||
148910704|NCT03275350|537155715|FG000|Overall Study|Death|2|||
148910705|NCT03275350|537155716|FG001|Overall Study|Death|1|||
148910706|NCT03275350|537155715|FG000|Overall Study|Physician Decision|1|||
148910707|NCT03275350|537155716|FG001|Overall Study|Physician Decision|0|||
148910708|NCT03275350|537155715|FG000|Overall Study|Incarcerated|1|||
148910709|NCT03275350|537155716|FG001|Overall Study|Incarcerated|1|||
148910710|NCT04661579|537155719|FG000|Overall Study|Lost to Follow-up|19|||
148910711|NCT04661579|537155720|FG001|Overall Study|Lost to Follow-up|10|||
148910712|NCT04661579|537155721|FG002|Overall Study|Lost to Follow-up|2|||
148910713|NCT04661579|537155722|FG003|Overall Study|Lost to Follow-up|7|||
148910714|NCT04661579|537155723|FG004|Overall Study|Lost to Follow-up|11|||
148910715|NCT04661579|537155719|FG000|Overall Study|Physician Decision|2|||
148910716|NCT04661579|537155720|FG001|Overall Study|Physician Decision|0|||
148910717|NCT04661579|537155721|FG002|Overall Study|Physician Decision|0|||
148910718|NCT04661579|537155722|FG003|Overall Study|Physician Decision|1|||
148910719|NCT04661579|537155723|FG004|Overall Study|Physician Decision|0|||
148910720|NCT04661579|537155719|FG000|Overall Study|Withdrawal by Subject|1|||
148910721|NCT04661579|537155720|FG001|Overall Study|Withdrawal by Subject|4|||
148910722|NCT04661579|537155721|FG002|Overall Study|Withdrawal by Subject|0|||
148910723|NCT04661579|537155722|FG003|Overall Study|Withdrawal by Subject|2|||
148910724|NCT04661579|537155723|FG004|Overall Study|Withdrawal by Subject|0|||
148910725|NCT04661579|537155719|FG000|Overall Study|Death|1|||
148910726|NCT04661579|537155720|FG001|Overall Study|Death|0|||
148910727|NCT04661579|537155721|FG002|Overall Study|Death|0|||
148910728|NCT04661579|537155722|FG003|Overall Study|Death|0|||
148910729|NCT04661579|537155723|FG004|Overall Study|Death|0|||
148910730|NCT04661579|537155719|FG000|Overall Study|Other|1|||
148910731|NCT04661579|537155720|FG001|Overall Study|Other|2|||
148910732|NCT04661579|537155721|FG002|Overall Study|Other|1|||
148910733|NCT04661579|537155722|FG003|Overall Study|Other|1|||
148910734|NCT04661579|537155723|FG004|Overall Study|Other|1|||
148910735|NCT04661579|537155719|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
148910736|NCT04661579|537155720|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
148910737|NCT04661579|537155721|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
148910738|NCT04661579|537155722|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
148910739|NCT04661579|537155723|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
148910740|NCT01396447|537155724|FG000|Overall Study|Did Not Receive Treatment|3|||
148910741|NCT01396447|537155725|FG001|Overall Study|Did Not Receive Treatment|2|||
148910742|NCT01396447|537155726|FG002|Overall Study|Did Not Receive Treatment|1|||
148910743|NCT01396447|537155727|FG003|Overall Study|Did Not Receive Treatment|0|||
148910744|NCT01396447|537155724|FG000|Overall Study|Adverse Event|15|||
148910745|NCT01396447|537155725|FG001|Overall Study|Adverse Event|12|||
148910746|NCT01396447|537155726|FG002|Overall Study|Adverse Event|12|||
148910747|NCT01396447|537155727|FG003|Overall Study|Adverse Event|17|||
148910748|NCT01396447|537155724|FG000|Overall Study|Insufficient Therapeutic Response|5|||
149139218|NCT02871778|537990418|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
149139219|NCT02871778|537990419|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
149139220|NCT02871778|537990412|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
149139221|NCT02871778|537990413|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
149139222|NCT02871778|537990414|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
149139223|NCT02871778|537990415|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
149139224|NCT02871778|537990416|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
149139225|NCT02871778|537990417|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
148910749|NCT01396447|537155725|FG001|Overall Study|Insufficient Therapeutic Response|5|||
148910750|NCT01396447|537155726|FG002|Overall Study|Insufficient Therapeutic Response|2|||
148910751|NCT01396447|537155727|FG003|Overall Study|Insufficient Therapeutic Response|4|||
148910752|NCT01396447|537155724|FG000|Overall Study|Protocol Violation|5|||
148910753|NCT01396447|537155725|FG001|Overall Study|Protocol Violation|2|||
148910754|NCT01396447|537155726|FG002|Overall Study|Protocol Violation|3|||
148910755|NCT01396447|537155727|FG003|Overall Study|Protocol Violation|7|||
148910756|NCT01396447|537155724|FG000|Overall Study|Withdrawal of Consent|11|||
148910757|NCT01396447|537155725|FG001|Overall Study|Withdrawal of Consent|9|||
148910758|NCT01396447|537155726|FG002|Overall Study|Withdrawal of Consent|4|||
148910759|NCT01396447|537155727|FG003|Overall Study|Withdrawal of Consent|15|||
148910760|NCT01396447|537155724|FG000|Overall Study|Lost to Follow-up|4|||
148910761|NCT01396447|537155725|FG001|Overall Study|Lost to Follow-up|8|||
148910762|NCT01396447|537155726|FG002|Overall Study|Lost to Follow-up|7|||
148910763|NCT01396447|537155727|FG003|Overall Study|Lost to Follow-up|9|||
148910764|NCT01396447|537155724|FG000|Overall Study|Other Miscellaneous Reasons|0|||
148910765|NCT01396447|537155725|FG001|Overall Study|Other Miscellaneous Reasons|2|||
148910766|NCT01396447|537155726|FG002|Overall Study|Other Miscellaneous Reasons|1|||
149139226|NCT02871778|537990418|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
149139227|NCT02871778|537990419|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
149139228|NCT02871778|537990412|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139229|NCT02871778|537990413|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
149139230|NCT02871778|537990414|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139231|NCT02871778|537990415|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139232|NCT02871778|537990416|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139233|NCT02871778|537990417|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139234|NCT02871778|537990418|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139235|NCT02871778|537990419|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
149139236|NCT02871778|537990412|FG000|Part A: Treatment Period 2|Adverse Event|2|||
149139237|NCT02871778|537990413|FG001|Part A: Treatment Period 2|Adverse Event|2|||
149139238|NCT02871778|537990414|FG002|Part A: Treatment Period 2|Adverse Event|0|||
149139239|NCT02871778|537990415|FG003|Part A: Treatment Period 2|Adverse Event|0|||
149139240|NCT02871778|537990416|FG004|Part A: Treatment Period 2|Adverse Event|0|||
149139241|NCT02871778|537990417|FG005|Part A: Treatment Period 2|Adverse Event|0|||
149139242|NCT02871778|537990418|FG006|Part A: Treatment Period 2|Adverse Event|0|||
149139243|NCT02871778|537990419|FG007|Part A: Treatment Period 2|Adverse Event|0|||
149139244|NCT02871778|537990412|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139245|NCT02871778|537990413|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139246|NCT02871778|537990414|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139247|NCT02871778|537990415|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
149139248|NCT02871778|537990416|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139249|NCT02871778|537990417|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139250|NCT02871778|537990418|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139251|NCT02871778|537990419|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
149139252|NCT02871778|537990412|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
149139253|NCT02871778|537990413|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
149139254|NCT02871778|537990414|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
149139255|NCT02871778|537990415|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
149139256|NCT02871778|537990416|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
149139257|NCT02871778|537990417|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
149139258|NCT02871778|537990418|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
149139259|NCT02871778|537990419|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
149139260|NCT02871778|537990412|FG000|Part B: Treatment Period 3|Adverse Event|0|||
149139261|NCT02871778|537990413|FG001|Part B: Treatment Period 3|Adverse Event|0|||
149139262|NCT02871778|537990414|FG002|Part B: Treatment Period 3|Adverse Event|0|||
148803826|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
148803827|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
148910767|NCT01396447|537155727|FG003|Overall Study|Other Miscellaneous Reasons|0|||
148910768|NCT01402102|537155729|FG000|Overall Study|Protocol Violation|1|||
148910769|NCT01402102|537155730|FG001|Overall Study|Protocol Violation|0|||
148910770|NCT01402102|537155729|FG000|Overall Study|Insufficiency of compliance|1|||
148910771|NCT01402102|537155730|FG001|Overall Study|Insufficiency of compliance|1|||
148910772|NCT01402102|537155729|FG000|Overall Study|Withdrawal by Subject|0|||
148910773|NCT01402102|537155730|FG001|Overall Study|Withdrawal by Subject|2|||
148910774|NCT01386970|537155731|FG000|Overall Study|Withdrawal by Subject|0|||
148910775|NCT01386970|537155732|FG001|Overall Study|Withdrawal by Subject|1|||
149012004|NCT02318719|537523417|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
149139263|NCT02871778|537990415|FG003|Part B: Treatment Period 3|Adverse Event|0|||
148803828|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
148803829|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
148803830|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
148803831|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
148803832|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
148803833|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
148803834|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
148803835|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
148803836|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
148803837|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
148803838|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
148803839|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
148803840|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
149139264|NCT02871778|537990416|FG004|Part B: Treatment Period 3|Adverse Event|1|||
149139265|NCT02871778|537990417|FG005|Part B: Treatment Period 3|Adverse Event|1|||
148910776|NCT01386970|537155731|FG000|Overall Study|Adverse Event|4|||
148910777|NCT01386970|537155732|FG001|Overall Study|Adverse Event|1|||
148910778|NCT04881942|537155734|FG000|Overall Study|Adverse Event|0|||
148910779|NCT04881942|537155735|FG001|Overall Study|Adverse Event|0|||
148910780|NCT04881942|537155736|FG002|Overall Study|Adverse Event|0|||
148910781|NCT04881942|537155737|FG003|Overall Study|Adverse Event|0|||
148910782|NCT04881942|537155738|FG004|Overall Study|Adverse Event|1|||
148910783|NCT04881942|537155734|FG000|Overall Study|Alternates|0|||
148910784|NCT04881942|537155735|FG001|Overall Study|Alternates|0|||
148910785|NCT04881942|537155736|FG002|Overall Study|Alternates|0|||
148910786|NCT04881942|537155737|FG003|Overall Study|Alternates|0|||
148910787|NCT04881942|537155738|FG004|Overall Study|Alternates|2|||
148910788|NCT02423902|537155739|FG000|Overall Study|Disease progression|1|||
148910789|NCT02423902|537155740|FG001|Overall Study|Disease progression|4|||
148910790|NCT04329806|537155741|FG000|Overall Study|Physician Decision|3|||
148910791|NCT04329806|537155742|FG001|Overall Study|Physician Decision|4|||
148910792|NCT04838626|537155743|FG000|Overall Study|Adverse Event|2|||
148910793|NCT04838626|537155743|FG000|Overall Study|Physician Decision|6|||
148910794|NCT04838626|537155743|FG000|Overall Study|Protocol Violation|3|||
148910795|NCT04838626|537155743|FG000|Overall Study|Withdrawal by Subject|9|||
148910796|NCT04838626|537155743|FG000|Overall Study|Technical Problems|2|||
148910797|NCT02867384|537155744|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
148910798|NCT02867384|537155745|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
148910799|NCT02867384|537155746|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
148910800|NCT02867384|537155744|FG000|Overall Study|Progression/ Relapse|15|||
148910801|NCT02867384|537155745|FG001|Overall Study|Progression/ Relapse|19|||
148910802|NCT02867384|537155746|FG002|Overall Study|Progression/ Relapse|0|||
148910803|NCT02867384|537155744|FG000|Overall Study|Adverse Event|13|||
148910804|NCT02867384|537155745|FG001|Overall Study|Adverse Event|1|||
148910805|NCT02867384|537155746|FG002|Overall Study|Adverse Event|0|||
148910806|NCT02867384|537155744|FG000|Overall Study|Withdrawal by Subject|6|||
148910807|NCT02867384|537155745|FG001|Overall Study|Withdrawal by Subject|5|||
148910808|NCT02867384|537155746|FG002|Overall Study|Withdrawal by Subject|0|||
148910809|NCT02867384|537155744|FG000|Overall Study|Physician Decision|1|||
148910810|NCT02867384|537155745|FG001|Overall Study|Physician Decision|2|||
148910811|NCT02867384|537155746|FG002|Overall Study|Physician Decision|0|||
148910812|NCT02867384|537155744|FG000|Overall Study|Patient compliance|1|||
148910813|NCT02867384|537155745|FG001|Overall Study|Patient compliance|0|||
148910814|NCT02867384|537155746|FG002|Overall Study|Patient compliance|0|||
148910815|NCT02867384|537155744|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
148910816|NCT02867384|537155745|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
148910817|NCT02867384|537155746|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
148910818|NCT02867384|537155744|FG000|Overall Study|Never start treatment|3|||
148910819|NCT02867384|537155745|FG001|Overall Study|Never start treatment|0|||
148910820|NCT02867384|537155746|FG002|Overall Study|Never start treatment|0|||
148910821|NCT03901469|537155747|FG000|Overall Study|Radiographic Progression|4|||
148910822|NCT03901469|537155748|FG001|Overall Study|Radiographic Progression|6|||
148910823|NCT03901469|537155749|FG002|Overall Study|Radiographic Progression|3|||
148910824|NCT03901469|537155750|FG003|Overall Study|Radiographic Progression|30|||
148910825|NCT03901469|537155751|FG004|Overall Study|Radiographic Progression|7|||
148910826|NCT03901469|537155752|FG005|Overall Study|Radiographic Progression|2|||
148910827|NCT03901469|537155753|FG006|Overall Study|Radiographic Progression|11|||
148910828|NCT03901469|537155747|FG000|Overall Study|Clinical Progression|0|||
148910829|NCT03901469|537155748|FG001|Overall Study|Clinical Progression|2|||
148910830|NCT03901469|537155749|FG002|Overall Study|Clinical Progression|0|||
148910831|NCT03901469|537155750|FG003|Overall Study|Clinical Progression|7|||
148910832|NCT03901469|537155751|FG004|Overall Study|Clinical Progression|6|||
148910833|NCT03901469|537155752|FG005|Overall Study|Clinical Progression|0|||
148910834|NCT03901469|537155753|FG006|Overall Study|Clinical Progression|2|||
148910835|NCT03901469|537155747|FG000|Overall Study|Adverse Event|1|||
148910836|NCT03901469|537155748|FG001|Overall Study|Adverse Event|0|||
148910837|NCT03901469|537155749|FG002|Overall Study|Adverse Event|0|||
148910838|NCT03901469|537155750|FG003|Overall Study|Adverse Event|0|||
148910839|NCT03901469|537155751|FG004|Overall Study|Adverse Event|0|||
148910840|NCT03901469|537155752|FG005|Overall Study|Adverse Event|0|||
148910841|NCT03901469|537155753|FG006|Overall Study|Adverse Event|9|||
148910842|NCT03901469|537155747|FG000|Overall Study|Physician Decision|0|||
148910843|NCT03901469|537155748|FG001|Overall Study|Physician Decision|0|||
148910844|NCT03901469|537155749|FG002|Overall Study|Physician Decision|0|||
148910845|NCT03901469|537155750|FG003|Overall Study|Physician Decision|1|||
148910846|NCT03901469|537155751|FG004|Overall Study|Physician Decision|0|||
148910847|NCT03901469|537155752|FG005|Overall Study|Physician Decision|0|||
148910848|NCT03901469|537155753|FG006|Overall Study|Physician Decision|0|||
148910849|NCT03901469|537155747|FG000|Overall Study|Withdrawal by Subject|0|||
148910850|NCT03901469|537155748|FG001|Overall Study|Withdrawal by Subject|0|||
148910851|NCT03901469|537155749|FG002|Overall Study|Withdrawal by Subject|0|||
148910852|NCT03901469|537155750|FG003|Overall Study|Withdrawal by Subject|0|||
149139266|NCT02871778|537990418|FG006|Part B: Treatment Period 3|Adverse Event|1|||
149139267|NCT02871778|537990419|FG007|Part B: Treatment Period 3|Adverse Event|0|||
149139268|NCT02653300|537990421|FG000|Overall Study|Withdrawal by Subject|2|||
149139269|NCT01910116|537990430|FG000|Overall Study|Adverse Event|0|||
149139270|NCT01910116|537990431|FG001|Overall Study|Adverse Event|3|||
149139271|NCT01910116|537990430|FG000|Overall Study|Lack of Efficacy|3|||
149139272|NCT01910116|537990431|FG001|Overall Study|Lack of Efficacy|4|||
149139273|NCT01910116|537990430|FG000|Overall Study|Lost to Follow-up|1|||
149139274|NCT01910116|537990431|FG001|Overall Study|Lost to Follow-up|0|||
149139275|NCT01910116|537990430|FG000|Overall Study|Protocol Violation|1|||
149139276|NCT01910116|537990431|FG001|Overall Study|Protocol Violation|2|||
149139277|NCT01910116|537990430|FG000|Overall Study|Withdrawal by Subject|8|||
149139278|NCT01910116|537990431|FG001|Overall Study|Withdrawal by Subject|3|||
149139279|NCT01910116|537990430|FG000|Overall Study|uncertain allocation|1|||
149139280|NCT01910116|537990431|FG001|Overall Study|uncertain allocation|3|||
149139281|NCT01910116|537990430|FG000|Overall Study|incomplete data|0|||
149139282|NCT01910116|537990431|FG001|Overall Study|incomplete data|1|||
148803841|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
148803842|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
148803843|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
148803844|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
148803845|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
148803846|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
148803847|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
148803848|NCT00784875|536762936|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
148803849|NCT00784875|536762937|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
148803850|NCT00784875|536762938|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
148803851|NCT00784875|536762939|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
148803852|NCT00784875|536762936|FG000|Period C|Adverse Event|1|||
148803853|NCT00784875|536762937|FG001|Period C|Adverse Event|0|||
148803854|NCT00784875|536762938|FG002|Period C|Adverse Event|4|||
148803855|NCT00784875|536762939|FG003|Period C|Adverse Event|2|||
148803856|NCT00784875|536762936|FG000|Period C|Protocol Violation|0|||
148803857|NCT00784875|536762937|FG001|Period C|Protocol Violation|0|||
148803858|NCT00784875|536762938|FG002|Period C|Protocol Violation|1|||
148803859|NCT00784875|536762939|FG003|Period C|Protocol Violation|2|||
148803860|NCT00784875|536762936|FG000|Period C|Lack of Efficacy|0|||
148803861|NCT00784875|536762937|FG001|Period C|Lack of Efficacy|0|||
148803862|NCT00784875|536762938|FG002|Period C|Lack of Efficacy|1|||
148803863|NCT00784875|536762939|FG003|Period C|Lack of Efficacy|0|||
148803864|NCT00784875|536762936|FG000|Period C|Withdrawal by Subject|1|||
148803865|NCT00784875|536762937|FG001|Period C|Withdrawal by Subject|1|||
148803866|NCT00784875|536762938|FG002|Period C|Withdrawal by Subject|2|||
148803867|NCT00784875|536762939|FG003|Period C|Withdrawal by Subject|0|||
148803868|NCT00784875|536762936|FG000|Period C|Physician Decision|0|||
148803869|NCT00784875|536762937|FG001|Period C|Physician Decision|0|||
148803870|NCT00784875|536762938|FG002|Period C|Physician Decision|1|||
148803871|NCT00784875|536762939|FG003|Period C|Physician Decision|1|||
148803872|NCT00784875|536762936|FG000|Period C|Sponsor Decision|5|||
148803873|NCT00784875|536762937|FG001|Period C|Sponsor Decision|5|||
148803874|NCT00784875|536762938|FG002|Period C|Sponsor Decision|4|||
148803875|NCT00784875|536762939|FG003|Period C|Sponsor Decision|2|||
148803876|NCT00784875|536762936|FG000|Period D|Adverse Event|0|||
148803877|NCT00784875|536762937|FG001|Period D|Adverse Event|2|||
148803878|NCT00784875|536762938|FG002|Period D|Adverse Event|2|||
148803879|NCT00784875|536762939|FG003|Period D|Adverse Event|0|||
148803880|NCT00784875|536762936|FG000|Period D|Protocol Violation|1|||
148803881|NCT00784875|536762937|FG001|Period D|Protocol Violation|0|||
148803882|NCT00784875|536762938|FG002|Period D|Protocol Violation|0|||
148803883|NCT00784875|536762939|FG003|Period D|Protocol Violation|0|||
148803884|NCT00784875|536762936|FG000|Period D|Withdrawal by Subject|2|||
148803885|NCT00784875|536762937|FG001|Period D|Withdrawal by Subject|0|||
148803886|NCT00784875|536762938|FG002|Period D|Withdrawal by Subject|2|||
148803887|NCT00784875|536762939|FG003|Period D|Withdrawal by Subject|0|||
148803888|NCT00784875|536762936|FG000|Period D|Physician Decision|0|||
148803889|NCT00784875|536762937|FG001|Period D|Physician Decision|1|||
148803890|NCT00784875|536762938|FG002|Period D|Physician Decision|0|||
148803891|NCT00784875|536762939|FG003|Period D|Physician Decision|0|||
148803892|NCT00784875|536762936|FG000|Period D|Sponsor Decision|1|||
148803893|NCT00784875|536762937|FG001|Period D|Sponsor Decision|1|||
148803894|NCT00784875|536762938|FG002|Period D|Sponsor Decision|1|||
148803895|NCT00784875|536762939|FG003|Period D|Sponsor Decision|0|||
148803896|NCT00784875|536762936|FG000|Period D|Lost to Follow-up|1|||
148803897|NCT00784875|536762937|FG001|Period D|Lost to Follow-up|0|||
148803898|NCT00784875|536762938|FG002|Period D|Lost to Follow-up|1|||
148803899|NCT00784875|536762939|FG003|Period D|Lost to Follow-up|1|||
148803900|NCT00853385|536762940|FG000|Overall Study|Death|0|||
148803901|NCT00853385|536762941|FG001|Overall Study|Death|0|||
148803902|NCT00853385|536762942|FG002|Overall Study|Death|0|||
148803903|NCT00853385|536762943|FG003|Overall Study|Death|0|||
148803904|NCT00853385|536762944|FG004|Overall Study|Death|1|||
148803905|NCT00853385|536762940|FG000|Overall Study|Adverse Event|24|||
148803906|NCT00853385|536762941|FG001|Overall Study|Adverse Event|24|||
148803907|NCT00853385|536762942|FG002|Overall Study|Adverse Event|2|||
148803908|NCT00853385|536762943|FG003|Overall Study|Adverse Event|5|||
148803909|NCT00853385|536762944|FG004|Overall Study|Adverse Event|22|||
148803910|NCT00853385|536762940|FG000|Overall Study|Lack of Efficacy|6|||
148803911|NCT00853385|536762941|FG001|Overall Study|Lack of Efficacy|7|||
148803912|NCT00853385|536762942|FG002|Overall Study|Lack of Efficacy|3|||
148803913|NCT00853385|536762943|FG003|Overall Study|Lack of Efficacy|3|||
148803914|NCT00853385|536762944|FG004|Overall Study|Lack of Efficacy|6|||
148803915|NCT00853385|536762940|FG000|Overall Study|Lost to Follow-up|2|||
148803916|NCT00853385|536762941|FG001|Overall Study|Lost to Follow-up|1|||
148803917|NCT00853385|536762942|FG002|Overall Study|Lost to Follow-up|0|||
149139310|NCT02289352|537990435|FG000|Overall Study|Withdrawal by Subject|1|||
149139311|NCT02289352|537990436|FG001|Overall Study|Withdrawal by Subject|1|||
149139312|NCT02289352|537990437|FG002|Overall Study|Withdrawal by Subject|0|||
149139313|NCT01390272|537990438|FG000|Overall Study|Death|3|||
149139314|NCT01390272|537990439|FG001|Overall Study|Death|2|||
149139315|NCT01390272|537990438|FG000|Overall Study|Withdrawal by Subject|9|||
149139316|NCT01390272|537990439|FG001|Overall Study|Withdrawal by Subject|5|||
149139317|NCT01390272|537990438|FG000|Overall Study|Patient moved, no longer eligible|5|||
149139318|NCT01390272|537990439|FG001|Overall Study|Patient moved, no longer eligible|8|||
149139319|NCT01177384|537990440|FG000|Overall Study|Adverse Event|6|||
149139320|NCT01177384|537990441|FG001|Overall Study|Adverse Event|4|||
149139321|NCT01177384|537990440|FG000|Overall Study|Lack of Efficacy|0|||
149139322|NCT01177384|537990441|FG001|Overall Study|Lack of Efficacy|1|||
148910853|NCT03901469|537155751|FG004|Overall Study|Withdrawal by Subject|2|||
148910854|NCT03901469|537155752|FG005|Overall Study|Withdrawal by Subject|0|||
149139323|NCT01177384|537990440|FG000|Overall Study|Lost to Follow-up|3|||
149139324|NCT01177384|537990441|FG001|Overall Study|Lost to Follow-up|4|||
149139325|NCT01177384|537990440|FG000|Overall Study|Physician Decision|0|||
149139326|NCT01177384|537990441|FG001|Overall Study|Physician Decision|3|||
149139327|NCT01177384|537990440|FG000|Overall Study|Protocol Violation|0|||
149139328|NCT01177384|537990441|FG001|Overall Study|Protocol Violation|2|||
149139329|NCT01177384|537990440|FG000|Overall Study|Withdrawal by Subject|5|||
149139330|NCT01177384|537990441|FG001|Overall Study|Withdrawal by Subject|12|||
149139331|NCT01849497|537990442|FG000|Overall Study|Withdrawal by Subject|1|||
149139332|NCT01849497|537990443|FG001|Overall Study|Withdrawal by Subject|2|||
149139333|NCT01849497|537990442|FG000|Overall Study|Sponsor Decision|0|||
149139334|NCT01849497|537990443|FG001|Overall Study|Sponsor Decision|1|||
149139335|NCT01849497|537990442|FG000|Overall Study|Lost to Follow-up|0|||
149139336|NCT01849497|537990443|FG001|Overall Study|Lost to Follow-up|1|||
149139337|NCT00232141|537990444|FG000|Overall Study|Adverse Event|9|||
149139338|NCT00232141|537990445|FG001|Overall Study|Adverse Event|4|||
149139339|NCT00232141|537990444|FG000|Overall Study|Lack of Efficacy|0|||
149139340|NCT00232141|537990445|FG001|Overall Study|Lack of Efficacy|3|||
149139341|NCT00232141|537990444|FG000|Overall Study|Lost to Follow-up|9|||
149139342|NCT00232141|537990445|FG001|Overall Study|Lost to Follow-up|6|||
149139343|NCT00232141|537990444|FG000|Overall Study|Other|8|||
149139344|NCT00232141|537990445|FG001|Overall Study|Other|10|||
149139345|NCT00232141|537990444|FG000|Overall Study|Withdrawal by Subject|5|||
149139346|NCT00232141|537990445|FG001|Overall Study|Withdrawal by Subject|3|||
149139347|NCT04263896|537990446|FG000|Overall Study|Withdrawal by Subject|2|||
149139348|NCT04263896|537990447|FG001|Overall Study|Withdrawal by Subject|4|||
149139349|NCT04263896|537990446|FG000|Overall Study|converted to open procedure|0|||
149139350|NCT04263896|537990447|FG001|Overall Study|converted to open procedure|1|||
149139351|NCT04263896|537990446|FG000|Overall Study|Lost to Follow-up|9|||
149139352|NCT04263896|537990447|FG001|Overall Study|Lost to Follow-up|11|||
149139353|NCT04263896|537990446|FG000|Overall Study|surveys lost in mail|5|||
149139354|NCT04263896|537990447|FG001|Overall Study|surveys lost in mail|3|||
148910855|NCT03901469|537155753|FG006|Overall Study|Withdrawal by Subject|8|||
149139355|NCT04263896|537990446|FG000|Overall Study|excluded from analysis|1|||
149139356|NCT04263896|537990447|FG001|Overall Study|excluded from analysis|0|||
149139357|NCT01641237|537991824|FG000|Period II|Withdrawal by Subject|1|||
149139358|NCT01641237|537991825|FG001|Period II|Withdrawal by Subject|0|||
148910856|NCT03901469|537155747|FG000|Overall Study|Death|0|||
148910857|NCT03901469|537155748|FG001|Overall Study|Death|0|||
148910858|NCT03901469|537155749|FG002|Overall Study|Death|0|||
148910859|NCT03901469|537155750|FG003|Overall Study|Death|3|||
148910860|NCT03901469|537155751|FG004|Overall Study|Death|5|||
148910861|NCT03901469|537155752|FG005|Overall Study|Death|0|||
148910862|NCT03901469|537155753|FG006|Overall Study|Death|1|||
148910863|NCT03901469|537155747|FG000|Overall Study|Termination of study by sponsor|0|||
148910864|NCT03901469|537155748|FG001|Overall Study|Termination of study by sponsor|0|||
148910865|NCT03901469|537155749|FG002|Overall Study|Termination of study by sponsor|0|||
148910866|NCT03901469|537155750|FG003|Overall Study|Termination of study by sponsor|0|||
148910867|NCT03901469|537155751|FG004|Overall Study|Termination of study by sponsor|1|||
148910868|NCT03901469|537155752|FG005|Overall Study|Termination of study by sponsor|1|||
148910869|NCT03901469|537155753|FG006|Overall Study|Termination of study by sponsor|0|||
148910870|NCT03901469|537155747|FG000|Overall Study|Not Reported|1|||
148910871|NCT03901469|537155748|FG001|Overall Study|Not Reported|0|||
148910872|NCT03901469|537155749|FG002|Overall Study|Not Reported|0|||
148910873|NCT03901469|537155750|FG003|Overall Study|Not Reported|1|||
148910874|NCT03901469|537155751|FG004|Overall Study|Not Reported|0|||
148910875|NCT03901469|537155752|FG005|Overall Study|Not Reported|0|||
148910876|NCT03901469|537155753|FG006|Overall Study|Not Reported|1|||
148910877|NCT03710083|537155754|FG000|Overall Study|Withdrawal by Subject|2|||
148910878|NCT03710083|537155754|FG000|Overall Study|Unsuccessful Procedure|1|||
148910879|NCT01727024|537155755|FG000|Period 1|Lost to Follow-up|1|||
148910880|NCT01727024|537155756|FG001|Period 1|Lost to Follow-up|1|||
148910881|NCT01727024|537155755|FG000|Period 1|Withdrawal by Subject|2|||
148910882|NCT01727024|537155756|FG001|Period 1|Withdrawal by Subject|3|||
148910883|NCT02948088|537155757|FG000|Overall Study|Lost to Follow-up|8|||
148910884|NCT02948088|537155757|FG000|Overall Study|Death|1|||
148910885|NCT02948088|537155757|FG000|Overall Study|Withdrawal by Subject|4|||
148910886|NCT02948088|537155757|FG000|Overall Study|Other|2|||
148910887|NCT01976741|537155760|FG000|Overall Study|Withdrawal by Subject|1|||
148910888|NCT01976741|537155761|FG001|Overall Study|Withdrawal by Subject|0|||
148910889|NCT01976741|537155762|FG002|Overall Study|Withdrawal by Subject|1|||
148910890|NCT01976741|537155763|FG003|Overall Study|Withdrawal by Subject|1|||
148910891|NCT01976741|537155764|FG004|Overall Study|Withdrawal by Subject|0|||
148910892|NCT01976741|537155765|FG005|Overall Study|Withdrawal by Subject|0|||
148910893|NCT01976741|537155766|FG006|Overall Study|Withdrawal by Subject|1|||
148910894|NCT01976741|537155767|FG007|Overall Study|Withdrawal by Subject|4|||
148910895|NCT01976741|537155768|FG008|Overall Study|Withdrawal by Subject|0|||
148910896|NCT01976741|537155769|FG009|Overall Study|Withdrawal by Subject|0|||
148910897|NCT01976741|537155760|FG000|Overall Study|Adverse Event|0|||
148910898|NCT01976741|537155761|FG001|Overall Study|Adverse Event|0|||
148910899|NCT01976741|537155762|FG002|Overall Study|Adverse Event|2|||
148910900|NCT01976741|537155763|FG003|Overall Study|Adverse Event|0|||
148910901|NCT01976741|537155764|FG004|Overall Study|Adverse Event|0|||
148910902|NCT01976741|537155765|FG005|Overall Study|Adverse Event|0|||
148910903|NCT01976741|537155766|FG006|Overall Study|Adverse Event|3|||
148910904|NCT01976741|537155767|FG007|Overall Study|Adverse Event|8|||
148910905|NCT01976741|537155768|FG008|Overall Study|Adverse Event|1|||
148910906|NCT01976741|537155769|FG009|Overall Study|Adverse Event|4|||
148910907|NCT01301027|537155770|FG000|Overall Study|Physician Decision|2|||
148910908|NCT01301027|537155771|FG001|Overall Study|Physician Decision|0|||
148910909|NCT01301027|537155770|FG000|Overall Study|Withdrawal by Subject|2|||
148910910|NCT01301027|537155771|FG001|Overall Study|Withdrawal by Subject|3|||
148910911|NCT01301027|537155770|FG000|Overall Study|Adverse Event|0|||
148910912|NCT01301027|537155771|FG001|Overall Study|Adverse Event|2|||
148910913|NCT01301027|537155770|FG000|Overall Study|Fracture|1|||
148910914|NCT01301027|537155771|FG001|Overall Study|Fracture|3|||
148910915|NCT01301027|537155770|FG000|Overall Study|Transplant|0|||
148910916|NCT01301027|537155771|FG001|Overall Study|Transplant|2|||
148910917|NCT01301027|537155770|FG000|Overall Study|Volume Overload|3|||
148910918|NCT01301027|537155771|FG001|Overall Study|Volume Overload|0|||
148910919|NCT00845897|537155772|FG000|Overall Study|Lost to Follow-up|1|||
148910920|NCT00845897|537155773|FG001|Overall Study|Lost to Follow-up|1|||
148910921|NCT00845897|537155774|FG002|Overall Study|Lost to Follow-up|0|||
148910922|NCT00845897|537155772|FG000|Overall Study|Withdrawal by Subject|0|||
148910923|NCT00845897|537155773|FG001|Overall Study|Withdrawal by Subject|3|||
148910924|NCT00845897|537155774|FG002|Overall Study|Withdrawal by Subject|2|||
148910925|NCT00845897|537155772|FG000|Overall Study|Ulcer did not heal|1|||
148910926|NCT00845897|537155773|FG001|Overall Study|Ulcer did not heal|0|||
148910927|NCT00845897|537155774|FG002|Overall Study|Ulcer did not heal|1|||
148910928|NCT00845897|537155772|FG000|Overall Study|Too ill to participate|0|||
148910929|NCT00845897|537155773|FG001|Overall Study|Too ill to participate|1|||
148910930|NCT00845897|537155774|FG002|Overall Study|Too ill to participate|0|||
148910931|NCT03566485|537155777|FG000|Overall Study|Disease progression|5|||
148803918|NCT00853385|536762943|FG003|Overall Study|Lost to Follow-up|0|||
148803919|NCT00853385|536762944|FG004|Overall Study|Lost to Follow-up|0|||
148803920|NCT00853385|536762940|FG000|Overall Study|Withdrawal by Subject|4|||
148803921|NCT00853385|536762941|FG001|Overall Study|Withdrawal by Subject|2|||
148803922|NCT00853385|536762942|FG002|Overall Study|Withdrawal by Subject|0|||
148803923|NCT00853385|536762943|FG003|Overall Study|Withdrawal by Subject|1|||
148803924|NCT00853385|536762944|FG004|Overall Study|Withdrawal by Subject|1|||
148803925|NCT00853385|536762940|FG000|Overall Study|Other|18|||
148803926|NCT00853385|536762941|FG001|Overall Study|Other|9|||
148803927|NCT00853385|536762942|FG002|Overall Study|Other|4|||
148803928|NCT00853385|536762943|FG003|Overall Study|Other|4|||
148803929|NCT00853385|536762944|FG004|Overall Study|Other|12|||
148803930|NCT00941928|536762951|FG000|Overall Study|Withdrawal by Subject|1|||
148803931|NCT00941928|536762951|FG000|Overall Study|Disease Progression|1|||
148803932|NCT02300610|536762954|FG000|Overall Study|Withdrawal by Subject|1|||
148803933|NCT02300610|536762955|FG001|Overall Study|Withdrawal by Subject|0|||
148803934|NCT02300610|536762956|FG002|Overall Study|Withdrawal by Subject|1|||
148803935|NCT04018066|536762957|FG000|Overall Study|participants started taking medications during the study period|3|||
148803936|NCT04018066|536762957|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
148803937|NCT02765035|536762961|FG000|First Intervention (90 Days)|Adverse Event|1|||
148803938|NCT02765035|536762962|FG001|First Intervention (90 Days)|Adverse Event|1|||
148803939|NCT02765035|536762961|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
148803940|NCT02765035|536762962|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
148803941|NCT02515227|536762965|FG000|Overall Study|Adverse Event|0|||
148803942|NCT02515227|536762966|FG001|Overall Study|Adverse Event|2|||
148803943|NCT02515227|536762965|FG000|Overall Study|Progressive disease|2|||
148803944|NCT02515227|536762966|FG001|Overall Study|Progressive disease|9|||
148803945|NCT03451071|536762969|FG000|First Vaccine|Withdrawal by Subject|1|||
148803946|NCT03451071|536762969|FG000|Second Vaccine|Lost to Follow-up|19|||
148803947|NCT03451071|536762969|FG000|Third Vaccine|Lost to Follow-up|22|||
148803948|NCT03451071|536762969|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
148803949|NCT02834975|536762970|FG000|Overall Study|Physician Decision|2|||
148803950|NCT02834975|536762970|FG000|Overall Study|Adverse Event|1|||
148803951|NCT02834975|536762970|FG000|Overall Study|Withdrawal by Subject|1|||
148803952|NCT02834975|536762970|FG000|Overall Study|Lack of Efficacy|1|||
148803953|NCT03363906|536762971|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
148803954|NCT03363906|536762972|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
148803955|NCT03363906|536762971|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
148803956|NCT03363906|536762972|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
148803957|NCT03363906|536762971|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
148803958|NCT03363906|536762972|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
148803959|NCT03363906|536762971|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
148803960|NCT03363906|536762972|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
148803961|NCT00929669|536762974|FG000|Overall Study|elevated glucose levels|1|||
148803962|NCT02714153|536762975|FG000|Overall Study|Death|1|||
148803963|NCT01901185|536762976|FG000|Overall Study|Withdrawal by Subject|2|||
148803964|NCT00250588|536762977|FG000|Overall Study|Withdrawal by Subject|3|||
148803965|NCT00250588|536762978|FG001|Overall Study|Withdrawal by Subject|6|||
148803966|NCT00250588|536762979|FG002|Overall Study|Withdrawal by Subject|0|||
148803967|NCT00250588|536762977|FG000|Overall Study|Lost to Follow-up|6|||
148803968|NCT00250588|536762978|FG001|Overall Study|Lost to Follow-up|13|||
148803969|NCT00250588|536762979|FG002|Overall Study|Lost to Follow-up|13|||
148803970|NCT03502798|536762982|FG000|Overall Study|equipment failure|0|||
148803971|NCT03502798|536762983|FG001|Overall Study|equipment failure|7|||
148910932|NCT03566485|537155778|FG001|Overall Study|Disease progression|4|||
148910933|NCT03566485|537155777|FG000|Overall Study|Clinical progression|0|||
148910934|NCT03566485|537155778|FG001|Overall Study|Clinical progression|1|||
148803972|NCT00485303|536762985|FG000|Overall Study|Adverse Event|5|||
148803973|NCT00485303|536762985|FG000|Overall Study|Progressive Disease|44|||
148803974|NCT00485303|536762985|FG000|Overall Study|Other|3|||
148803975|NCT00485303|536762985|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
148910935|NCT03566485|537155777|FG000|Overall Study|Toxicity|0|||
148910936|NCT03566485|537155778|FG001|Overall Study|Toxicity|2|||
148910937|NCT01047553|537155779|FG000|Overall Study|Adverse Event|10|||
148910938|NCT01047553|537155780|FG001|Overall Study|Adverse Event|5|||
148910939|NCT01047553|537155779|FG000|Overall Study|Withdrawal by Subject|4|||
148910940|NCT01047553|537155780|FG001|Overall Study|Withdrawal by Subject|2|||
148910941|NCT01047553|537155779|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
148910942|NCT01047553|537155780|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
148910943|NCT01047553|537155779|FG000|Overall Study|Lost to Follow-up|1|||
148910944|NCT01047553|537155780|FG001|Overall Study|Lost to Follow-up|0|||
148910945|NCT01047553|537155779|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
148910946|NCT01047553|537155780|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
148910947|NCT01047553|537155779|FG000|Overall Study|PI's decision|0|||
148910948|NCT01047553|537155780|FG001|Overall Study|PI's decision|1|||
148910949|NCT02817464|537155781|FG000|Overall Study|Lost to Follow-up|1|||
148910950|NCT02817464|537155782|FG001|Overall Study|Lost to Follow-up|0|||
148910951|NCT02817464|537155781|FG000|Overall Study|Discontinued early due to personal decision|1|||
148910952|NCT02817464|537155782|FG001|Overall Study|Discontinued early due to personal decision|1|||
148910953|NCT00948441|537155783|FG000|Overall Study|no longer meet inclusion criteria|1|||
148910954|NCT00948441|537155784|FG001|Overall Study|no longer meet inclusion criteria|4|||
148910955|NCT00124306|537155800|FG000|Overall Study|Adverse Event|7|||
148910956|NCT00124306|537155801|FG001|Overall Study|Adverse Event|2|||
148910957|NCT00124306|537155800|FG000|Overall Study|Lost to Follow-up|10|||
148910958|NCT00124306|537155801|FG001|Overall Study|Lost to Follow-up|6|||
148910959|NCT00124306|537155800|FG000|Overall Study|Lack of Efficacy|3|||
148910960|NCT00124306|537155801|FG001|Overall Study|Lack of Efficacy|6|||
148910961|NCT00124306|537155800|FG000|Overall Study|Personal constraints|0|||
148910962|NCT00124306|537155801|FG001|Overall Study|Personal constraints|2|||
148910963|NCT00124306|537155800|FG000|Overall Study|Use of unacceptable medication|1|||
148910964|NCT00124306|537155801|FG001|Overall Study|Use of unacceptable medication|0|||
148910965|NCT00124306|537155800|FG000|Overall Study|Abnormal lab result|0|||
148910966|NCT00124306|537155801|FG001|Overall Study|Abnormal lab result|1|||
148910967|NCT00124306|537155800|FG000|Overall Study|Other|2|||
148910968|NCT00124306|537155801|FG001|Overall Study|Other|0|||
149139359|NCT01641237|537991826|FG002|Period II|Withdrawal by Subject|0|||
148910969|NCT05767749|537155805|FG000|Overall Study|Withdrawal by Subject|0|||
148910970|NCT05767749|537155806|FG001|Overall Study|Withdrawal by Subject|0|||
148910971|NCT05767749|537155807|FG002|Overall Study|Withdrawal by Subject|2|||
148910972|NCT05767749|537155808|FG003|Overall Study|Withdrawal by Subject|2|||
148910973|NCT05767749|537155809|FG004|Overall Study|Withdrawal by Subject|2|||
148910974|NCT05767749|537155810|FG005|Overall Study|Withdrawal by Subject|2|||
148910975|NCT04681352|537157004|FG000|Overall Study|Lost to Follow-up|2|||
149139360|NCT01641237|537991827|FG003|Period II|Withdrawal by Subject|0|||
149139361|NCT01641237|537991824|FG000|Period III|Lost to Follow-up|1|||
149139362|NCT01641237|537991825|FG001|Period III|Lost to Follow-up|0|||
149139363|NCT01641237|537991826|FG002|Period III|Lost to Follow-up|0|||
149139364|NCT01641237|537991827|FG003|Period III|Lost to Follow-up|0|||
149139365|NCT01301456|537991828|FG000|Stage 1|Withdrawal by Subject|0|||
149139366|NCT01301456|537991829|FG001|Stage 1|Withdrawal by Subject|0|||
149139367|NCT01301456|537991830|FG002|Stage 1|Withdrawal by Subject|1|||
149139368|NCT01301456|537991831|FG003|Stage 1|Withdrawal by Subject|0|||
149139369|NCT01301456|537991832|FG004|Stage 1|Withdrawal by Subject|1|||
149139370|NCT01301456|537991833|FG005|Stage 1|Withdrawal by Subject|0|||
149139371|NCT01301456|537991834|FG006|Stage 1|Withdrawal by Subject|0|||
149139372|NCT01301456|537991835|FG007|Stage 1|Withdrawal by Subject|0|||
149139373|NCT01301456|537991836|FG008|Stage 1|Withdrawal by Subject|0|||
149139374|NCT01301456|537991837|FG009|Stage 1|Withdrawal by Subject|0|||
149139375|NCT01301456|537991838|FG010|Stage 1|Withdrawal by Subject|0|||
149139376|NCT01301456|537991839|FG011|Stage 1|Withdrawal by Subject|0|||
149139377|NCT01301456|537991828|FG000|Stage 1|Randomized but not treated|0|||
149139378|NCT01301456|537991829|FG001|Stage 1|Randomized but not treated|0|||
149139379|NCT01301456|537991830|FG002|Stage 1|Randomized but not treated|0|||
149139380|NCT01301456|537991831|FG003|Stage 1|Randomized but not treated|0|||
148910976|NCT04681352|537157004|FG000|Overall Study|Withdrawal by Subject|22|||
149139381|NCT01301456|537991832|FG004|Stage 1|Randomized but not treated|0|||
148910977|NCT03860818|537157005|FG000|Overall Study|Death|144|||
148910978|NCT03860818|537157006|FG001|Overall Study|Death|195|||
148910979|NCT03860818|537157005|FG000|Overall Study|Graft Loss|32|||
148910980|NCT03860818|537157006|FG001|Overall Study|Graft Loss|45|||
148910981|NCT00792571|537157007|FG000|Overall Study|Death|1|||
148910982|NCT00792571|537157007|FG000|Overall Study|Adverse Event|4|||
148910983|NCT00792571|537157007|FG000|Overall Study|Withdrawal by Subject|1|||
148910984|NCT00792571|537157007|FG000|Overall Study|Other|4|||
148910985|NCT02600819|537157008|FG000|GEN Phase|Adverse Event|2|||
148910986|NCT02600819|537157009|FG001|GEN Phase|Adverse Event|0|||
148910987|NCT02600819|537157008|FG000|GEN Phase|Death|2|||
148910988|NCT02600819|537157009|FG001|GEN Phase|Death|0|||
148910989|NCT02600819|537157008|FG000|GEN Phase|Investigator's Discretion|4|||
148910990|NCT02600819|537157009|FG001|GEN Phase|Investigator's Discretion|0|||
148910991|NCT02600819|537157008|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
148910992|NCT02600819|537157009|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
148910993|NCT02600819|537157008|FG000|GEN Phase|Withdrew Consent|5|||
148910994|NCT02600819|537157009|FG001|GEN Phase|Withdrew Consent|0|||
148910995|NCT02600819|537157008|FG000|GEN Phase|Lost to Follow-up|2|||
148910996|NCT02600819|537157009|FG001|GEN Phase|Lost to Follow-up|0|||
148910997|NCT00505778|537157010|FG000|Overall Study|Adverse Event|2|||
148910998|NCT00505778|537157011|FG001|Overall Study|Adverse Event|7|||
148910999|NCT00505778|537157010|FG000|Overall Study|Physician Decision|8|||
148911000|NCT00505778|537157011|FG001|Overall Study|Physician Decision|14|||
148911001|NCT00505778|537157010|FG000|Overall Study|Lost to Follow-up|17|||
148911002|NCT00505778|537157011|FG001|Overall Study|Lost to Follow-up|23|||
148911003|NCT00505778|537157010|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
148911004|NCT00505778|537157011|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
148911005|NCT00505778|537157010|FG000|Overall Study|Protocol Violation|7|||
148911006|NCT00505778|537157011|FG001|Overall Study|Protocol Violation|9|||
148911007|NCT00505778|537157010|FG000|Overall Study|Withdrawal by Subject|29|||
148911008|NCT00505778|537157011|FG001|Overall Study|Withdrawal by Subject|14|||
148911009|NCT00505778|537157010|FG000|Overall Study|Relapse|65|||
148911010|NCT00505778|537157011|FG001|Overall Study|Relapse|65|||
148911011|NCT00505778|537157010|FG000|Overall Study|Took No Study Drug|2|||
148911012|NCT00505778|537157011|FG001|Overall Study|Took No Study Drug|2|||
148911013|NCT03790696|537157013|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
149139382|NCT01301456|537991833|FG005|Stage 1|Randomized but not treated|0|||
149139383|NCT01301456|537991834|FG006|Stage 1|Randomized but not treated|1|||
149139384|NCT01301456|537991835|FG007|Stage 1|Randomized but not treated|0|||
149139385|NCT01301456|537991836|FG008|Stage 1|Randomized but not treated|0|||
149139386|NCT01301456|537991837|FG009|Stage 1|Randomized but not treated|0|||
149139387|NCT01301456|537991838|FG010|Stage 1|Randomized but not treated|0|||
149139388|NCT01301456|537991839|FG011|Stage 1|Randomized but not treated|0|||
149139389|NCT01301456|537991828|FG000|Stage 2|Adverse Event|0|||
148911014|NCT03790696|537157014|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
148911015|NCT00481091|537157016|FG000|Overall Study|Withdrawal by Subject|0|||
148911016|NCT00481091|537157017|FG001|Overall Study|Withdrawal by Subject|1|||
148911017|NCT00481091|537157018|FG002|Overall Study|Withdrawal by Subject|1|||
148911018|NCT00481091|537157019|FG003|Overall Study|Withdrawal by Subject|0|||
148911019|NCT00481091|537157020|FG004|Overall Study|Withdrawal by Subject|0|||
148911020|NCT00481091|537157021|FG005|Overall Study|Withdrawal by Subject|0|||
148911021|NCT00481091|537157022|FG006|Overall Study|Withdrawal by Subject|0|||
148911022|NCT00481091|537157023|FG007|Overall Study|Withdrawal by Subject|0|||
148911023|NCT00481091|537157024|FG008|Overall Study|Withdrawal by Subject|1|||
149139390|NCT01301456|537991829|FG001|Stage 2|Adverse Event|0|||
149139391|NCT01301456|537991830|FG002|Stage 2|Adverse Event|0|||
149139392|NCT01301456|537991831|FG003|Stage 2|Adverse Event|0|||
149139393|NCT01301456|537991832|FG004|Stage 2|Adverse Event|0|||
149139394|NCT01301456|537991833|FG005|Stage 2|Adverse Event|0|||
149139395|NCT01301456|537991834|FG006|Stage 2|Adverse Event|0|||
149139396|NCT01301456|537991835|FG007|Stage 2|Adverse Event|0|||
149139397|NCT01301456|537991836|FG008|Stage 2|Adverse Event|0|||
149139398|NCT01301456|537991837|FG009|Stage 2|Adverse Event|0|||
149139399|NCT01301456|537991838|FG010|Stage 2|Adverse Event|1|||
149139400|NCT01301456|537991839|FG011|Stage 2|Adverse Event|0|||
149139401|NCT01383096|537991840|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
149139402|NCT01383096|537991841|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
149139403|NCT01383096|537991842|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
149139404|NCT01383096|537991840|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
149139405|NCT01383096|537991841|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
149139406|NCT01383096|537991842|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
149139407|NCT01383096|537991840|FG000|Third Intervention (8 Days)|Elevated AST|0|||
149139408|NCT01383096|537991841|FG001|Third Intervention (8 Days)|Elevated AST|1|||
149139409|NCT01383096|537991842|FG002|Third Intervention (8 Days)|Elevated AST|0|||
149139410|NCT01383096|537991840|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
149139411|NCT01383096|537991841|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
149139412|NCT01383096|537991842|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
149139413|NCT01383096|537991840|FG000|Third Intervention (8 Days)|Adverse Event|1|||
149139414|NCT01383096|537991841|FG001|Third Intervention (8 Days)|Adverse Event|0|||
149139415|NCT01383096|537991842|FG002|Third Intervention (8 Days)|Adverse Event|0|||
149139416|NCT01383096|537991840|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
149139417|NCT01383096|537991841|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
149139418|NCT01383096|537991842|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
149139419|NCT01383096|537991840|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
149139420|NCT01383096|537991841|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
148803976|NCT00485303|536762985|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
148803977|NCT00296335|536762988|FG000|Overall Study|Recurrence|3|||
148803978|NCT00296335|536762989|FG001|Overall Study|Recurrence|51|||
148803979|NCT00296335|536762988|FG000|Overall Study|Adverse Event|17|||
148803980|NCT00296335|536762989|FG001|Overall Study|Adverse Event|27|||
148803981|NCT00296335|536762988|FG000|Overall Study|Lost to Follow-up|7|||
148803982|NCT00296335|536762989|FG001|Overall Study|Lost to Follow-up|33|||
148803983|NCT00296335|536762988|FG000|Overall Study|Physician Decision|3|||
148803984|NCT00296335|536762989|FG001|Overall Study|Physician Decision|11|||
148803985|NCT01027845|536762990|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
148803986|NCT01027845|536762991|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
148803987|NCT01027845|536762992|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
148803988|NCT01027845|536762993|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
148803989|NCT01027845|536762990|FG000|Primary Vaccination Phase|Adverse Event|1|||
148803990|NCT01027845|536762991|FG001|Primary Vaccination Phase|Adverse Event|0|||
148803991|NCT01027845|536762992|FG002|Primary Vaccination Phase|Adverse Event|0|||
148803992|NCT01027845|536762993|FG003|Primary Vaccination Phase|Adverse Event|0|||
148803993|NCT01027845|536762990|FG000|Primary Vaccination Phase|Protocol Violation|1|||
148803994|NCT01027845|536762991|FG001|Primary Vaccination Phase|Protocol Violation|0|||
148803995|NCT01027845|536762992|FG002|Primary Vaccination Phase|Protocol Violation|0|||
148803996|NCT01027845|536762993|FG003|Primary Vaccination Phase|Protocol Violation|0|||
148803997|NCT01027845|536762990|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
148803998|NCT01027845|536762991|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
148803999|NCT01027845|536762992|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
148804000|NCT01027845|536762993|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
148804001|NCT01027845|536762990|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
148804002|NCT01027845|536762991|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
148804003|NCT01027845|536762992|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
148804004|NCT01027845|536762993|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
148804005|NCT01027845|536762990|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
148804006|NCT01027845|536762991|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
148804007|NCT01027845|536762992|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
148804008|NCT01027845|536762993|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
148804009|NCT01603277|536762997|FG000|Overall Study|Adverse Event|1|||
148804010|NCT01603277|536762998|FG001|Overall Study|Adverse Event|2|||
148804011|NCT01603277|536762997|FG000|Overall Study|Physician Decision|0|||
149139421|NCT01383096|537991842|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
148804012|NCT01603277|536762998|FG001|Overall Study|Physician Decision|1|||
148804013|NCT01603277|536762997|FG000|Overall Study|Protocol Violation|6|||
148804014|NCT01603277|536762998|FG001|Overall Study|Protocol Violation|10|||
148804015|NCT01603277|536762997|FG000|Overall Study|Withdrawal by Subject|5|||
148804016|NCT01603277|536762998|FG001|Overall Study|Withdrawal by Subject|4|||
148804017|NCT01603277|536762997|FG000|Overall Study|Non-Compliance|2|||
148804018|NCT01603277|536762998|FG001|Overall Study|Non-Compliance|1|||
148804019|NCT00087178|536762999|FG000|Overall Study|No follow up data|5|||
148804020|NCT00087178|536763000|FG001|Overall Study|No follow up data|15|||
148804021|NCT00087178|536762999|FG000|Overall Study|No clinical assessment|1|||
148804022|NCT00087178|536763000|FG001|Overall Study|No clinical assessment|2|||
148804023|NCT00087178|536762999|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
148804024|NCT00087178|536763000|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
148804025|NCT04494646|536763001|FG000|Overall Study|Adverse Event|0|||
148804026|NCT04494646|536763002|FG001|Overall Study|Adverse Event|1|||
148804027|NCT04494646|536763001|FG000|Overall Study|Withdrawal by Subject|0|||
148911024|NCT00481091|537157025|FG009|Overall Study|Withdrawal by Subject|6|||
148911025|NCT00481091|537157016|FG000|Overall Study|Other, Not Specified|0|||
148911026|NCT00481091|537157017|FG001|Overall Study|Other, Not Specified|1|||
148911027|NCT00481091|537157018|FG002|Overall Study|Other, Not Specified|1|||
148911028|NCT00481091|537157019|FG003|Overall Study|Other, Not Specified|0|||
148911029|NCT00481091|537157020|FG004|Overall Study|Other, Not Specified|0|||
148911030|NCT00481091|537157021|FG005|Overall Study|Other, Not Specified|1|||
148911031|NCT00481091|537157022|FG006|Overall Study|Other, Not Specified|0|||
148911032|NCT00481091|537157023|FG007|Overall Study|Other, Not Specified|0|||
148911033|NCT00481091|537157024|FG008|Overall Study|Other, Not Specified|0|||
148911034|NCT00481091|537157025|FG009|Overall Study|Other, Not Specified|4|||
148911035|NCT00481091|537157016|FG000|Overall Study|Adverse Event|1|||
148911036|NCT00481091|537157017|FG001|Overall Study|Adverse Event|2|||
148911037|NCT00481091|537157018|FG002|Overall Study|Adverse Event|0|||
148911038|NCT00481091|537157019|FG003|Overall Study|Adverse Event|1|||
148911039|NCT00481091|537157020|FG004|Overall Study|Adverse Event|1|||
148911040|NCT00481091|537157021|FG005|Overall Study|Adverse Event|1|||
148911041|NCT00481091|537157022|FG006|Overall Study|Adverse Event|2|||
148911042|NCT00481091|537157023|FG007|Overall Study|Adverse Event|1|||
148911043|NCT00481091|537157024|FG008|Overall Study|Adverse Event|1|||
148911044|NCT00481091|537157025|FG009|Overall Study|Adverse Event|6|||
148911045|NCT00481091|537157016|FG000|Overall Study|Progressive disease clinical|0|||
148911046|NCT00481091|537157017|FG001|Overall Study|Progressive disease clinical|0|||
148911047|NCT00481091|537157018|FG002|Overall Study|Progressive disease clinical|0|||
148911048|NCT00481091|537157019|FG003|Overall Study|Progressive disease clinical|0|||
148911049|NCT00481091|537157020|FG004|Overall Study|Progressive disease clinical|0|||
148911050|NCT00481091|537157021|FG005|Overall Study|Progressive disease clinical|0|||
148911051|NCT00481091|537157022|FG006|Overall Study|Progressive disease clinical|0|||
148911052|NCT00481091|537157023|FG007|Overall Study|Progressive disease clinical|0|||
148911053|NCT00481091|537157024|FG008|Overall Study|Progressive disease clinical|1|||
148911054|NCT00481091|537157025|FG009|Overall Study|Progressive disease clinical|7|||
148911055|NCT00481091|537157016|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
148911056|NCT00481091|537157017|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
148911057|NCT00481091|537157018|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911058|NCT00481091|537157019|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911059|NCT00481091|537157020|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911060|NCT00481091|537157021|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
148911061|NCT00481091|537157022|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911062|NCT00481091|537157023|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911063|NCT00481091|537157024|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911064|NCT00481091|537157025|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
148911065|NCT00481091|537157016|FG000|Overall Study|Progressive disease other|1|||
148911066|NCT00481091|537157017|FG001|Overall Study|Progressive disease other|1|||
148911067|NCT00481091|537157018|FG002|Overall Study|Progressive disease other|0|||
148911068|NCT00481091|537157019|FG003|Overall Study|Progressive disease other|1|||
148911069|NCT00481091|537157020|FG004|Overall Study|Progressive disease other|1|||
148911070|NCT00481091|537157021|FG005|Overall Study|Progressive disease other|1|||
148911071|NCT00481091|537157022|FG006|Overall Study|Progressive disease other|0|||
148911072|NCT00481091|537157023|FG007|Overall Study|Progressive disease other|2|||
148911073|NCT00481091|537157024|FG008|Overall Study|Progressive disease other|0|||
148911074|NCT00481091|537157025|FG009|Overall Study|Progressive disease other|0|||
148911075|NCT00481091|537157016|FG000|Overall Study|No reason given|0|||
148911076|NCT00481091|537157017|FG001|Overall Study|No reason given|0|||
148911077|NCT00481091|537157018|FG002|Overall Study|No reason given|1|||
148911078|NCT00481091|537157019|FG003|Overall Study|No reason given|1|||
148911079|NCT00481091|537157020|FG004|Overall Study|No reason given|1|||
148911080|NCT00481091|537157021|FG005|Overall Study|No reason given|0|||
148911081|NCT00481091|537157022|FG006|Overall Study|No reason given|1|||
148911082|NCT00481091|537157023|FG007|Overall Study|No reason given|1|||
148911083|NCT00481091|537157024|FG008|Overall Study|No reason given|1|||
148911084|NCT00481091|537157025|FG009|Overall Study|No reason given|4|||
148911085|NCT00975689|537157028|FG000|Overall Study|Adverse Event|0|||
148911086|NCT00975689|537157029|FG001|Overall Study|Adverse Event|3|||
148911087|NCT00975689|537157028|FG000|Overall Study|Withdrawal by Subject|1|||
148911088|NCT00975689|537157029|FG001|Overall Study|Withdrawal by Subject|0|||
148911089|NCT00975689|537157028|FG000|Overall Study|Physician Decision|1|||
148911090|NCT00975689|537157029|FG001|Overall Study|Physician Decision|0|||
148911091|NCT01349959|537157030|FG000|Overall Study|Adverse Event|7|||
148911092|NCT02675634|537157031|FG000|Test Period 1|Adverse Event|0|||
148911093|NCT02675634|537157032|FG001|Test Period 1|Adverse Event|1|||
148911094|NCT02675634|537157033|FG002|Test Period 1|Adverse Event|0|||
148911095|NCT02675634|537157034|FG003|Test Period 1|Adverse Event|1|||
148911096|NCT02675634|537157035|FG004|Test Period 1|Adverse Event|0|||
148911097|NCT02675634|537157036|FG005|Test Period 1|Adverse Event|0|||
148911098|NCT02675634|537157031|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
148911099|NCT02675634|537157032|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
148911100|NCT02675634|537157033|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
148911101|NCT02675634|537157034|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
148911102|NCT02675634|537157035|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
148911103|NCT02675634|537157036|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
148911104|NCT02675634|537157031|FG000|Test Period 2|Lack of Efficacy|1|||
148911105|NCT02675634|537157032|FG001|Test Period 2|Lack of Efficacy|0|||
148911106|NCT02675634|537157033|FG002|Test Period 2|Lack of Efficacy|0|||
148911107|NCT02675634|537157034|FG003|Test Period 2|Lack of Efficacy|0|||
148911108|NCT02675634|537157035|FG004|Test Period 2|Lack of Efficacy|0|||
148911109|NCT02675634|537157036|FG005|Test Period 2|Lack of Efficacy|0|||
148911110|NCT02675634|537157031|FG000|Test Period 2|Adverse Event|0|||
148911111|NCT02675634|537157032|FG001|Test Period 2|Adverse Event|0|||
148911112|NCT02675634|537157033|FG002|Test Period 2|Adverse Event|0|||
148911113|NCT02675634|537157034|FG003|Test Period 2|Adverse Event|0|||
148911114|NCT02675634|537157035|FG004|Test Period 2|Adverse Event|0|||
148911115|NCT02675634|537157036|FG005|Test Period 2|Adverse Event|1|||
148911116|NCT01652534|537157037|FG000|Overall Study|Lack of Efficacy|1|||
148911117|NCT01652534|537157038|FG001|Overall Study|Lack of Efficacy|0|||
148911118|NCT04758637|537157039|FG000|Overall Study|Lost to Follow-up|0|||
148911119|NCT04758637|537157040|FG001|Overall Study|Lost to Follow-up|1|||
148911120|NCT04758637|537157041|FG002|Overall Study|Lost to Follow-up|0|||
148911121|NCT04758637|537157042|FG003|Overall Study|Lost to Follow-up|0|||
148911122|NCT00467753|537157045|FG000|Overall Study|Lost to Follow-up|1|||
148911123|NCT00467753|537157046|FG001|Overall Study|Lost to Follow-up|2|||
148911124|NCT00467753|537157045|FG000|Overall Study|Adverse Event|2|||
148911125|NCT00467753|537157046|FG001|Overall Study|Adverse Event|0|||
148911126|NCT00104520|537157052|FG000|Overall Study|Unrelated adverse event|34|||
148911127|NCT00104520|537157053|FG001|Overall Study|Unrelated adverse event|47|||
148911128|NCT00104520|537157052|FG000|Overall Study|Study drug intolerance|0|||
148911129|NCT00104520|537157053|FG001|Overall Study|Study drug intolerance|1|||
148911130|NCT00104520|537157052|FG000|Overall Study|Related adverse event|13|||
148911131|NCT00104520|537157053|FG001|Overall Study|Related adverse event|15|||
148911132|NCT00104520|537157052|FG000|Overall Study|Lost to Follow-up|1|||
148911133|NCT00104520|537157053|FG001|Overall Study|Lost to Follow-up|0|||
148911134|NCT00104520|537157052|FG000|Overall Study|Noncompliance|0|||
148911135|NCT00104520|537157053|FG001|Overall Study|Noncompliance|2|||
148911136|NCT00104520|537157052|FG000|Overall Study|Personal/administrative|1|||
148911137|NCT00104520|537157053|FG001|Overall Study|Personal/administrative|1|||
148911138|NCT00104520|537157052|FG000|Overall Study|Other|1|||
148911139|NCT00104520|537157053|FG001|Overall Study|Other|5|||
148911140|NCT01026324|537157054|FG000|Follow up/Survival|Withdrawal by Subject|1|||
148911141|NCT01026324|537157055|FG001|Follow up/Survival|Withdrawal by Subject|0|||
148911142|NCT01026324|537157056|FG002|Follow up/Survival|Withdrawal by Subject|0|||
148911143|NCT02442804|537157057|FG000|Overall Study|Withdrawal by Subject|0|||
148911144|NCT02442804|537157058|FG001|Overall Study|Withdrawal by Subject|1|||
148911145|NCT02442804|537157057|FG000|Overall Study|Adverse Event|1|||
148911146|NCT02442804|537157058|FG001|Overall Study|Adverse Event|0|||
148911147|NCT02624986|537157062|FG000|Overall Study|Death|0|||
148911148|NCT02624986|537157063|FG001|Overall Study|Death|1|||
148911149|NCT02624986|537157064|FG002|Overall Study|Death|2|||
148911150|NCT02624986|537157065|FG003|Overall Study|Death|2|||
148911151|NCT02624986|537157066|FG004|Overall Study|Death|2|||
148911152|NCT02624986|537157067|FG005|Overall Study|Death|0|||
148911153|NCT02624986|537157068|FG006|Overall Study|Death|0|||
148911154|NCT02624986|537157069|FG007|Overall Study|Death|1|||
148911155|NCT02624986|537157062|FG000|Overall Study|Study Terminated by Sponsor|1|||
148911156|NCT02624986|537157063|FG001|Overall Study|Study Terminated by Sponsor|1|||
148911157|NCT02624986|537157064|FG002|Overall Study|Study Terminated by Sponsor|0|||
148911158|NCT02624986|537157065|FG003|Overall Study|Study Terminated by Sponsor|1|||
148911159|NCT02624986|537157066|FG004|Overall Study|Study Terminated by Sponsor|2|||
148911160|NCT02624986|537157067|FG005|Overall Study|Study Terminated by Sponsor|2|||
148911161|NCT02624986|537157068|FG006|Overall Study|Study Terminated by Sponsor|4|||
148911162|NCT02624986|537157069|FG007|Overall Study|Study Terminated by Sponsor|3|||
148911163|NCT02624986|537157062|FG000|Overall Study|Progressive Disease|0|||
148911164|NCT02624986|537157063|FG001|Overall Study|Progressive Disease|1|||
148911165|NCT02624986|537157064|FG002|Overall Study|Progressive Disease|0|||
148911166|NCT02624986|537157065|FG003|Overall Study|Progressive Disease|0|||
148911167|NCT02624986|537157066|FG004|Overall Study|Progressive Disease|0|||
148911168|NCT02624986|537157067|FG005|Overall Study|Progressive Disease|0|||
148911169|NCT02624986|537157068|FG006|Overall Study|Progressive Disease|0|||
148911170|NCT02624986|537157069|FG007|Overall Study|Progressive Disease|0|||
148911171|NCT02624986|537157062|FG000|Overall Study|Protocol Violation|1|||
148911172|NCT02624986|537157063|FG001|Overall Study|Protocol Violation|0|||
148911173|NCT02624986|537157064|FG002|Overall Study|Protocol Violation|0|||
149139422|NCT01383096|537991840|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
148804028|NCT04494646|536763002|FG001|Overall Study|Withdrawal by Subject|1|||
148804029|NCT01692119|536763003|FG000|Overall Study|Protocol Violation|3|||
148804030|NCT01692119|536763004|FG001|Overall Study|Protocol Violation|1|||
148804031|NCT01692119|536763003|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
148804032|NCT01692119|536763004|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
148804033|NCT00112957|536763011|FG000|Overall Study|Progressive disease|18|||
148804034|NCT00112957|536763011|FG000|Overall Study|Physician Decision|1|||
148804035|NCT03451045|536763016|FG000|Overall Study|Lack of Efficacy|3|||
148804036|NCT03451045|536763017|FG001|Overall Study|Lack of Efficacy|2|||
148804037|NCT03451045|536763018|FG002|Overall Study|Lack of Efficacy|2|||
148804038|NCT03451045|536763016|FG000|Overall Study|Physician Decision|1|||
148804039|NCT03451045|536763017|FG001|Overall Study|Physician Decision|1|||
148804040|NCT03451045|536763018|FG002|Overall Study|Physician Decision|1|||
148804041|NCT03451045|536763016|FG000|Overall Study|Withdrawal by Subject|4|||
148804042|NCT03451045|536763017|FG001|Overall Study|Withdrawal by Subject|0|||
148804043|NCT03451045|536763018|FG002|Overall Study|Withdrawal by Subject|5|||
148804044|NCT03451045|536763016|FG000|Overall Study|Pregnancy|0|||
148804045|NCT03451045|536763017|FG001|Overall Study|Pregnancy|0|||
148804046|NCT03451045|536763018|FG002|Overall Study|Pregnancy|2|||
148804047|NCT03451045|536763016|FG000|Overall Study|Adverse Event|7|||
148804048|NCT03451045|536763017|FG001|Overall Study|Adverse Event|1|||
148804049|NCT03451045|536763018|FG002|Overall Study|Adverse Event|3|||
148804050|NCT03451045|536763016|FG000|Overall Study|Non-compliance with study|2|||
148804051|NCT03451045|536763017|FG001|Overall Study|Non-compliance with study|0|||
148804052|NCT03451045|536763018|FG002|Overall Study|Non-compliance with study|1|||
148804053|NCT03451045|536763016|FG000|Overall Study|any other reason|10|||
148804054|NCT03451045|536763017|FG001|Overall Study|any other reason|2|||
148804055|NCT03451045|536763018|FG002|Overall Study|any other reason|13|||
148804056|NCT02391337|536763019|FG000|6 Months Follow-up|Death|5|||
148804057|NCT02391337|536763020|FG001|6 Months Follow-up|Death|4|||
148804058|NCT02391337|536763019|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
148804059|NCT02391337|536763020|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
148804060|NCT02391337|536763019|FG000|12 Months Follow-up|Death|2|||
148804061|NCT02391337|536763020|FG001|12 Months Follow-up|Death|0|||
148804062|NCT02391337|536763019|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
148804063|NCT02391337|536763020|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
148804064|NCT02391337|536763019|FG000|12 Months Follow-up|Lost to Follow-up|0|||
148804065|NCT02391337|536763020|FG001|12 Months Follow-up|Lost to Follow-up|2|||
148804066|NCT03704064|536763024|FG000|Overall Study|Lost to Follow-up|8|||
148804067|NCT03704064|536763025|FG001|Overall Study|Lost to Follow-up|4|||
148804068|NCT03704064|536763024|FG000|Overall Study|Withdrawal by Subject|1|||
148804069|NCT03704064|536763025|FG001|Overall Study|Withdrawal by Subject|1|||
148804070|NCT03704064|536763024|FG000|Overall Study|No longer available for study visits|0|||
148804071|NCT03704064|536763025|FG001|Overall Study|No longer available for study visits|1|||
148804072|NCT03704064|536763024|FG000|Overall Study|Censoring event|1|||
148804073|NCT03704064|536763025|FG001|Overall Study|Censoring event|0|||
148804074|NCT01286129|536763026|FG000|Overall Study|Withdrawal by Subject|4|||
148804075|NCT01286129|536763027|FG001|Overall Study|Withdrawal by Subject|1|||
148804076|NCT01286129|536763026|FG000|Overall Study|Could not comply with study requirements|4|||
148804077|NCT01286129|536763027|FG001|Overall Study|Could not comply with study requirements|4|||
148804078|NCT00830128|536763028|FG000|Overall Study|Adverse Event|5|||
148804079|NCT00830128|536763028|FG000|Overall Study|Lack of Efficacy|7|||
148804080|NCT00830128|536763028|FG000|Overall Study|Protocol Violation|1|||
148804081|NCT00830128|536763028|FG000|Overall Study|Withdrawal by Subject|2|||
148804082|NCT00830128|536763028|FG000|Overall Study|Family obligation|1|||
148804083|NCT00830128|536763028|FG000|Overall Study|Relocation|1|||
148804084|NCT00830128|536763028|FG000|Overall Study|Work obligation|1|||
148804085|NCT00830128|536763028|FG000|Overall Study|Operating a vehicle|1|||
148804086|NCT04142242|536763033|FG000|Stage I|Non-compliance with the protocol|1|||
148804087|NCT04142242|536763034|FG001|Stage I|Non-compliance with the protocol|0|||
148804088|NCT04142242|536763035|FG002|Stage I|Non-compliance with the protocol|0|||
148804089|NCT04142242|536763036|FG003|Stage I|Non-compliance with the protocol|0|||
148804090|NCT04142242|536763037|FG004|Stage I|Non-compliance with the protocol|0|||
148804091|NCT04142242|536763038|FG005|Stage I|Non-compliance with the protocol|1|||
148804092|NCT04142242|536763033|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
148911174|NCT02624986|537157065|FG003|Overall Study|Protocol Violation|0|||
148911175|NCT02624986|537157066|FG004|Overall Study|Protocol Violation|0|||
148911176|NCT02624986|537157067|FG005|Overall Study|Protocol Violation|0|||
148911177|NCT02624986|537157068|FG006|Overall Study|Protocol Violation|0|||
148911178|NCT02624986|537157069|FG007|Overall Study|Protocol Violation|0|||
148911179|NCT02624986|537157062|FG000|Overall Study|Withdrawal by Subject|0|||
148911180|NCT02624986|537157063|FG001|Overall Study|Withdrawal by Subject|0|||
148911181|NCT02624986|537157064|FG002|Overall Study|Withdrawal by Subject|0|||
148911182|NCT02624986|537157065|FG003|Overall Study|Withdrawal by Subject|0|||
148911183|NCT02624986|537157066|FG004|Overall Study|Withdrawal by Subject|0|||
148911184|NCT02624986|537157067|FG005|Overall Study|Withdrawal by Subject|0|||
148911185|NCT02624986|537157068|FG006|Overall Study|Withdrawal by Subject|0|||
148911186|NCT02624986|537157069|FG007|Overall Study|Withdrawal by Subject|1|||
148911187|NCT02116205|537157070|FG000|Overall Study|Withdrawal by Subject|2|||
148911188|NCT02116205|537157071|FG001|Overall Study|Withdrawal by Subject|4|||
148911189|NCT02116205|537157072|FG002|Overall Study|Withdrawal by Subject|1|||
148911190|NCT02116205|537157073|FG003|Overall Study|Withdrawal by Subject|3|||
148911191|NCT02116205|537157070|FG000|Overall Study|Lost to Follow-up|0|||
148911192|NCT02116205|537157071|FG001|Overall Study|Lost to Follow-up|2|||
148911193|NCT02116205|537157072|FG002|Overall Study|Lost to Follow-up|1|||
148911194|NCT02116205|537157073|FG003|Overall Study|Lost to Follow-up|2|||
148911195|NCT02116205|537157070|FG000|Overall Study|Physician Decision|0|||
148911196|NCT02116205|537157071|FG001|Overall Study|Physician Decision|1|||
148911197|NCT02116205|537157072|FG002|Overall Study|Physician Decision|1|||
148911198|NCT02116205|537157073|FG003|Overall Study|Physician Decision|1|||
148911199|NCT02116205|537157070|FG000|Overall Study|Exclusion criteria|0|||
148911200|NCT02116205|537157071|FG001|Overall Study|Exclusion criteria|0|||
148911201|NCT02116205|537157072|FG002|Overall Study|Exclusion criteria|1|||
148911202|NCT02116205|537157073|FG003|Overall Study|Exclusion criteria|0|||
148911203|NCT04200352|537157079|FG000|Overall Study|Death|1|||
148911204|NCT04200352|537157079|FG000|Overall Study|Adverse Event|6|||
148911205|NCT04200352|537157079|FG000|Overall Study|Withdrawal by parent/guardian|6|||
148911206|NCT04200352|537157079|FG000|Overall Study|Lack of Efficacy|1|||
148911207|NCT04200352|537157079|FG000|Overall Study|Other than specified|6|||
148911208|NCT00993148|537157080|FG000|Overall Study|Lost to Follow-up|2|||
148911209|NCT00993148|537157080|FG000|Overall Study|never initiated treatment|1|||
148911210|NCT00806819|537157081|FG000|Overall Study|progressive disease (modified RECIST )|217|||
148911211|NCT00806819|537157082|FG001|Overall Study|progressive disease (modified RECIST )|216|||
148911212|NCT00806819|537157081|FG000|Overall Study|Worsening or AE of underlying disease|18|||
148911213|NCT00806819|537157082|FG001|Overall Study|Worsening or AE of underlying disease|25|||
148911214|NCT00806819|537157081|FG000|Overall Study|Other AE|38|||
148911215|NCT00806819|537157082|FG001|Overall Study|Other AE|40|||
148911216|NCT00806819|537157081|FG000|Overall Study|Protocol Violation|9|||
148911217|NCT00806819|537157082|FG001|Overall Study|Protocol Violation|4|||
148911218|NCT00806819|537157081|FG000|Overall Study|Lost to Follow-up|1|||
148911219|NCT00806819|537157082|FG001|Overall Study|Lost to Follow-up|0|||
148911220|NCT00806819|537157081|FG000|Overall Study|Withdrawal by Subject|32|||
148911221|NCT00806819|537157082|FG001|Overall Study|Withdrawal by Subject|29|||
148911222|NCT00806819|537157081|FG000|Overall Study|Not treated|6|||
148911223|NCT00806819|537157082|FG001|Overall Study|Not treated|3|||
148911224|NCT00806819|537157081|FG000|Overall Study|Reasons other than stated above|25|||
148911225|NCT00806819|537157082|FG001|Overall Study|Reasons other than stated above|41|||
148911226|NCT02302339|537157085|FG000|Overall Study|Lost to Follow-up|1|||
148911227|NCT02302339|537157086|FG001|Overall Study|Lost to Follow-up|0|||
148911228|NCT02302339|537157087|FG002|Overall Study|Lost to Follow-up|0|||
148911229|NCT02302339|537157088|FG003|Overall Study|Lost to Follow-up|0|||
148911230|NCT02302339|537157085|FG000|Overall Study|Withdrawal by Subject|0|||
148911231|NCT02302339|537157086|FG001|Overall Study|Withdrawal by Subject|2|||
148911232|NCT02302339|537157087|FG002|Overall Study|Withdrawal by Subject|1|||
148911233|NCT02302339|537157088|FG003|Overall Study|Withdrawal by Subject|0|||
148911234|NCT02752165|537157092|FG000|Overall Study|Withdrawal by Subject|6|||
148911235|NCT02752165|537157093|FG001|Overall Study|Withdrawal by Subject|6|||
148911236|NCT02752165|537157092|FG000|Overall Study|Protocol Violation|6|||
148911237|NCT02752165|537157093|FG001|Overall Study|Protocol Violation|5|||
148911238|NCT02752165|537157092|FG000|Overall Study|Lost to Follow-up|33|||
148911239|NCT02752165|537157093|FG001|Overall Study|Lost to Follow-up|38|||
148911240|NCT01704599|537157096|FG000|Overall Study|Adverse Event|1|||
148911241|NCT01737502|537157097|FG000|Phase I|Disease progression|2|||
148911242|NCT01737502|537157098|FG001|Phase I|Disease progression|3|||
148911243|NCT01737502|537157097|FG000|Phase I|Complicating disease|1|||
148911244|NCT01737502|537157098|FG001|Phase I|Complicating disease|0|||
148911245|NCT01737502|537157097|FG000|Phase II|Adverse Event|0|||
148911246|NCT01737502|537157098|FG001|Phase II|Adverse Event|3|||
149139423|NCT01383096|537991841|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
148911247|NCT01737502|537157097|FG000|Phase II|Disease progression|0|||
148911248|NCT01737502|537157098|FG001|Phase II|Disease progression|18|||
148911249|NCT01737502|537157097|FG000|Phase II|Death|0|||
148911250|NCT01737502|537157098|FG001|Phase II|Death|1|||
148804093|NCT04142242|536763034|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
148804094|NCT04142242|536763035|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
148804095|NCT04142242|536763036|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
148804096|NCT04142242|536763037|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
148804097|NCT04142242|536763038|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
148804098|NCT04142242|536763033|FG000|Stage II|Non-compliance with the protocol|0|||
148804099|NCT04142242|536763034|FG001|Stage II|Non-compliance with the protocol|0|||
148804100|NCT04142242|536763035|FG002|Stage II|Non-compliance with the protocol|0|||
148804101|NCT04142242|536763036|FG003|Stage II|Non-compliance with the protocol|2|||
148804102|NCT04142242|536763037|FG004|Stage II|Non-compliance with the protocol|0|||
148804103|NCT04142242|536763038|FG005|Stage II|Non-compliance with the protocol|0|||
148804104|NCT04142242|536763033|FG000|Stage II|Lost to Follow-up|0|||
148804105|NCT04142242|536763034|FG001|Stage II|Lost to Follow-up|0|||
148804106|NCT04142242|536763035|FG002|Stage II|Lost to Follow-up|1|||
148804107|NCT04142242|536763036|FG003|Stage II|Lost to Follow-up|2|||
148911251|NCT01737502|537157097|FG000|Phase II|Transition to hospice care|0|||
148911252|NCT01737502|537157098|FG001|Phase II|Transition to hospice care|1|||
148911253|NCT00912197|537157101|FG000|Overall Study|Withdrawal by Subject|3|||
148911254|NCT00912197|537157102|FG001|Overall Study|Withdrawal by Subject|3|||
148911255|NCT01326104|537157108|FG000|Overall Study|progressed prior to vaccine|0|||
148911256|NCT01326104|537157109|FG001|Overall Study|progressed prior to vaccine|2|||
148911257|NCT01326104|537157108|FG000|Overall Study|unable to make vaccine|0|||
148911258|NCT01326104|537157109|FG001|Overall Study|unable to make vaccine|2|||
148911259|NCT00494676|537157112|FG000|Allocation|Withdrawal by Subject|2|||
148911260|NCT00494676|537157113|FG001|Allocation|Withdrawal by Subject|4|||
148911261|NCT00494676|537157112|FG000|First Intervention|Withdrawal by Subject|1|||
148911262|NCT00494676|537157113|FG001|First Intervention|Withdrawal by Subject|3|||
148911263|NCT00494676|537157112|FG000|Second Intervention|Withdrawal by Subject|1|||
148911264|NCT00494676|537157113|FG001|Second Intervention|Withdrawal by Subject|1|||
148911265|NCT04073225|537157115|FG000|Overall Study|Lost to Follow-up|4|||
148911266|NCT04073225|537157116|FG001|Overall Study|Lost to Follow-up|3|||
148911267|NCT00560352|537157119|FG000|Overall Study|Adverse event unrelated to study drug|2|||
148911268|NCT00560352|537157120|FG001|Overall Study|Adverse event unrelated to study drug|1|||
148911269|NCT00560352|537157121|FG002|Overall Study|Adverse event unrelated to study drug|1|||
148911270|NCT00560352|537157119|FG000|Overall Study|Study drug toxicity|3|||
148911271|NCT00560352|537157120|FG001|Overall Study|Study drug toxicity|0|||
148911272|NCT00560352|537157121|FG002|Overall Study|Study drug toxicity|1|||
148911273|NCT00560352|537157119|FG000|Overall Study|Disease progression|0|||
148911274|NCT00560352|537157120|FG001|Overall Study|Disease progression|1|||
148911275|NCT00560352|537157121|FG002|Overall Study|Disease progression|1|||
148911276|NCT00560352|537157119|FG000|Overall Study|Withdrawal by Subject|1|||
148911277|NCT00560352|537157120|FG001|Overall Study|Withdrawal by Subject|1|||
148911278|NCT00560352|537157121|FG002|Overall Study|Withdrawal by Subject|1|||
148911279|NCT00560352|537157119|FG000|Overall Study|Maximum clinical benefit|1|||
148911280|NCT00560352|537157120|FG001|Overall Study|Maximum clinical benefit|0|||
148911281|NCT00560352|537157121|FG002|Overall Study|Maximum clinical benefit|0|||
148911282|NCT00114517|537157122|FG000|Overall Study|Adverse Event|6|||
148911283|NCT00114517|537157123|FG001|Overall Study|Adverse Event|1|||
148911284|NCT00114517|537157124|FG002|Overall Study|Adverse Event|6|||
148911285|NCT00114517|537157125|FG003|Overall Study|Adverse Event|3|||
148911286|NCT00114517|537157122|FG000|Overall Study|Lost to Follow-up|2|||
148911287|NCT00114517|537157123|FG001|Overall Study|Lost to Follow-up|2|||
148911288|NCT00114517|537157124|FG002|Overall Study|Lost to Follow-up|2|||
148911289|NCT00114517|537157125|FG003|Overall Study|Lost to Follow-up|1|||
148911290|NCT00114517|537157122|FG000|Overall Study|Too busy|3|||
148911291|NCT00114517|537157123|FG001|Overall Study|Too busy|1|||
148911292|NCT00114517|537157124|FG002|Overall Study|Too busy|1|||
148911293|NCT00114517|537157125|FG003|Overall Study|Too busy|2|||
148911294|NCT00114517|537157122|FG000|Overall Study|Moved from area|0|||
148911295|NCT00114517|537157123|FG001|Overall Study|Moved from area|3|||
148911296|NCT00114517|537157124|FG002|Overall Study|Moved from area|2|||
148911297|NCT00114517|537157125|FG003|Overall Study|Moved from area|1|||
148911298|NCT00114517|537157122|FG000|Overall Study|Did not want estradiol|1|||
148911299|NCT00114517|537157123|FG001|Overall Study|Did not want estradiol|1|||
148911300|NCT00114517|537157124|FG002|Overall Study|Did not want estradiol|0|||
148911301|NCT00114517|537157125|FG003|Overall Study|Did not want estradiol|0|||
148911302|NCT00114517|537157122|FG000|Overall Study|Armed-services duty|0|||
148911303|NCT00114517|537157123|FG001|Overall Study|Armed-services duty|1|||
148911304|NCT00114517|537157124|FG002|Overall Study|Armed-services duty|0|||
148911305|NCT00114517|537157125|FG003|Overall Study|Armed-services duty|1|||
148911306|NCT00114517|537157122|FG000|Overall Study|Competing family issue|0|||
148911307|NCT00114517|537157123|FG001|Overall Study|Competing family issue|1|||
148911308|NCT00114517|537157124|FG002|Overall Study|Competing family issue|0|||
148911309|NCT00114517|537157125|FG003|Overall Study|Competing family issue|1|||
148911310|NCT00114517|537157122|FG000|Overall Study|Physician Decision|0|||
148911311|NCT00114517|537157123|FG001|Overall Study|Physician Decision|1|||
148911312|NCT00114517|537157124|FG002|Overall Study|Physician Decision|0|||
148911313|NCT00114517|537157125|FG003|Overall Study|Physician Decision|0|||
148911314|NCT00114517|537157122|FG000|Overall Study|Lost interest|0|||
148911315|NCT00114517|537157123|FG001|Overall Study|Lost interest|0|||
148911316|NCT00114517|537157124|FG002|Overall Study|Lost interest|1|||
148911317|NCT00114517|537157125|FG003|Overall Study|Lost interest|0|||
148911318|NCT00114517|537157122|FG000|Overall Study|Weight increase|0|||
148911319|NCT00114517|537157123|FG001|Overall Study|Weight increase|0|||
148911320|NCT00114517|537157124|FG002|Overall Study|Weight increase|1|||
148911321|NCT00114517|537157125|FG003|Overall Study|Weight increase|0|||
148911322|NCT00114517|537157122|FG000|Overall Study|Concern about blood clots|0|||
148911323|NCT00114517|537157123|FG001|Overall Study|Concern about blood clots|0|||
148911324|NCT00114517|537157124|FG002|Overall Study|Concern about blood clots|1|||
148911325|NCT00114517|537157125|FG003|Overall Study|Concern about blood clots|0|||
148911326|NCT00114517|537157122|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
148911327|NCT00114517|537157123|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
148956471|NCT00723892|537324429|FG001|Overall Study|Drug addiction|0|||
148911328|NCT00114517|537157124|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
148911329|NCT00114517|537157125|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
148911330|NCT03568461|537157126|FG000|Overall Study|Death|7|||
148911331|NCT03568461|537157126|FG000|Overall Study|Physician Decision|5|||
148911332|NCT03568461|537157126|FG000|Overall Study|Subject decision|5|||
148911333|NCT03568461|537157126|FG000|Overall Study|Lost to Follow-up|1|||
148911334|NCT04695977|537157127|FG000|Overall Study|Sponsor Decision|9|||
148911335|NCT04695977|537157128|FG001|Overall Study|Sponsor Decision|4|||
148911336|NCT04695977|537157127|FG000|Overall Study|Death|2|||
148911337|NCT04695977|537157128|FG001|Overall Study|Death|5|||
148911338|NCT04335136|537158619|FG000|Overall Study|Death|8|||
148911339|NCT04335136|537158620|FG001|Overall Study|Death|4|||
148911340|NCT04335136|537158619|FG000|Overall Study|Lost to Follow-up|2|||
148911341|NCT04335136|537158620|FG001|Overall Study|Lost to Follow-up|0|||
148911342|NCT04335136|537158619|FG000|Overall Study|Protocol Violation|1|||
148911343|NCT04335136|537158620|FG001|Overall Study|Protocol Violation|0|||
148911344|NCT04335136|537158619|FG000|Overall Study|Withdrawal by Subject|1|||
148911345|NCT04335136|537158620|FG001|Overall Study|Withdrawal by Subject|1|||
148911346|NCT04335136|537158619|FG000|Overall Study|Health-threatening condition|0|||
148911347|NCT04335136|537158620|FG001|Overall Study|Health-threatening condition|1|||
148911348|NCT04335136|537158619|FG000|Overall Study|Adverse Event|0|||
148911349|NCT04335136|537158620|FG001|Overall Study|Adverse Event|1|||
148911350|NCT04335136|537158619|FG000|Overall Study|Erroneously randomized|2|||
148911351|NCT04335136|537158620|FG001|Overall Study|Erroneously randomized|0|||
148911352|NCT01941186|537158621|FG000|Follow-up|Lost to Follow-up|1|||
148911353|NCT01941186|537158622|FG001|Follow-up|Lost to Follow-up|0|||
148911354|NCT03860259|537158623|FG000|Overall Study|Lost to Follow-up|5|||
148911355|NCT03860259|537158624|FG001|Overall Study|Lost to Follow-up|5|||
148911356|NCT03860259|537158623|FG000|Overall Study|Protocol Violation|1|||
148911357|NCT03860259|537158624|FG001|Overall Study|Protocol Violation|0|||
148911358|NCT00811018|537158625|FG000|Overall Study|Additional Chronic Treatment|31|||
148911359|NCT00811018|537158625|FG000|Overall Study|Adverse Event|79|||
148911360|NCT00811018|537158625|FG000|Overall Study|Death|147|||
148911361|NCT00811018|537158625|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
148911362|NCT00811018|537158625|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
148911363|NCT00811018|537158625|FG000|Overall Study|Investigator Decision|57|||
148911364|NCT00811018|537158625|FG000|Overall Study|Lost to Follow-up|19|||
148911365|NCT00811018|537158625|FG000|Overall Study|Pregnancy|6|||
148911366|NCT00811018|537158625|FG000|Overall Study|Sponsor Decision|450|||
148911367|NCT00811018|537158625|FG000|Overall Study|Withdrawal by Subject|70|||
148911368|NCT00811018|537158625|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
148911369|NCT00811018|537158625|FG000|Overall Study|Other|26|||
148911370|NCT02722304|537158629|FG000|Overall Study|Study Terminated by Sponsor|1|||
148911371|NCT02722304|537158630|FG001|Overall Study|Study Terminated by Sponsor|0|||
148911372|NCT02722304|537158631|FG002|Overall Study|Study Terminated by Sponsor|2|||
148911373|NCT02722304|537158632|FG003|Overall Study|Study Terminated by Sponsor|1|||
148911374|NCT02722304|537158633|FG004|Overall Study|Study Terminated by Sponsor|1|||
148911375|NCT02722304|537158629|FG000|Overall Study|Other|0|||
148911376|NCT02722304|537158630|FG001|Overall Study|Other|0|||
148911377|NCT02722304|537158631|FG002|Overall Study|Other|0|||
148911378|NCT02722304|537158632|FG003|Overall Study|Other|1|||
148911379|NCT02722304|537158633|FG004|Overall Study|Other|1|||
148911380|NCT00934362|537158634|FG000|Overall Study|Adverse Event|1|||
148911381|NCT00934362|537158635|FG001|Overall Study|Adverse Event|0|||
148911382|NCT01092117|537158638|FG000|Index Procedure to 1 Month|Death|1|||
148911383|NCT01092117|537158638|FG000|1 Month|Death|1|||
148911384|NCT01092117|537158638|FG000|1 Month|Withdrawal by Subject|1|||
148911385|NCT01092117|537158638|FG000|1 Month|Lost to Follow-up|1|||
148911386|NCT01092117|537158638|FG000|6 Months|Death|2|||
148911387|NCT01092117|537158638|FG000|6 Months|Withdrawal by Subject|3|||
148911388|NCT01092117|537158638|FG000|12 Month|Death|11|||
148911389|NCT01092117|537158638|FG000|12 Month|Withdrawal by Subject|2|||
148911390|NCT01092117|537158638|FG000|12 Month|Lost to Follow-up|1|||
148911391|NCT01092117|537158638|FG000|Year 2|Death|5|||
148911392|NCT01092117|537158638|FG000|Year 2|Withdrawal by Subject|4|||
148911393|NCT01092117|537158638|FG000|Year 2|Lost to Follow-up|1|||
148911394|NCT01092117|537158638|FG000|Year 3|Death|7|||
148911395|NCT01092117|537158638|FG000|Year 3|Withdrawal by Subject|9|||
148911396|NCT01092117|537158638|FG000|Year 3|Lost to Follow-up|3|||
148911397|NCT01092117|537158638|FG000|Year 4|Death|8|||
148911398|NCT01092117|537158638|FG000|Year 4|Withdrawal by Subject|4|||
148911399|NCT01092117|537158638|FG000|Year 4|Lost to Follow-up|4|||
148911400|NCT04380519|537158639|FG000|Overall Study|Withdrawal by Subject|4|||
148911401|NCT04380519|537158640|FG001|Overall Study|Withdrawal by Subject|0|||
148911402|NCT04380519|537158641|FG002|Overall Study|Withdrawal by Subject|1|||
148911403|NCT04380519|537158639|FG000|Overall Study|Death|14|||
148911404|NCT04380519|537158640|FG001|Overall Study|Death|9|||
148911405|NCT04380519|537158641|FG002|Overall Study|Death|6|||
148911406|NCT04380519|537158639|FG000|Overall Study|Adverse Event|0|||
148911407|NCT04380519|537158640|FG001|Overall Study|Adverse Event|1|||
148911408|NCT04380519|537158641|FG002|Overall Study|Adverse Event|0|||
148911409|NCT04380519|537158639|FG000|Overall Study|relatives' decision|0|||
148911410|NCT04380519|537158640|FG001|Overall Study|relatives' decision|1|||
148911411|NCT04380519|537158641|FG002|Overall Study|relatives' decision|0|||
148911412|NCT02147561|537158646|FG000|Overall Study|Lost to Follow-up|3|||
148911413|NCT02147561|537158646|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
148911414|NCT05300763|537158647|FG000|Overall Study|Adverse Event|0|||
148911415|NCT05300763|537158648|FG001|Overall Study|Adverse Event|1|||
148911416|NCT05300763|537158647|FG000|Overall Study|Major Protocol Deviation|1|||
148911417|NCT05300763|537158648|FG001|Overall Study|Major Protocol Deviation|0|||
148911418|NCT05300763|537158647|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
148911419|NCT05300763|537158648|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
148911420|NCT02283762|537158649|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
148911421|NCT02283762|537158650|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
148911422|NCT02283762|537158649|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
148911423|NCT02283762|537158650|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
148911424|NCT02283762|537158649|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
148911425|NCT02283762|537158650|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
148911426|NCT02283762|537158649|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
148911427|NCT02283762|537158650|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
148911428|NCT02283762|537158649|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
148911429|NCT02283762|537158650|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
148911430|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
148911431|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
148911432|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
148911433|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
148911434|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
148911435|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
148911436|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
148911437|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
148911438|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
148911439|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
148911440|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
148911441|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
148911442|NCT02283762|537158649|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
148911443|NCT02283762|537158650|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
148911444|NCT01598506|537158652|FG000|Overall Study|Withdrawal by Subject|2|||
148911445|NCT02367833|537158653|FG000|Overall Study|Withdrawal by Subject|1|||
148911446|NCT02367833|537158654|FG001|Overall Study|Withdrawal by Subject|1|||
148911447|NCT02367833|537158655|FG002|Overall Study|Withdrawal by Subject|0|||
148911448|NCT00889720|537158658|FG000|Overall Study|Withdrawal by Subject|4|||
148911449|NCT00889720|537158658|FG000|Overall Study|Other|4|||
148911450|NCT00775593|537158659|FG000|Overall Study|Unmet eligibility criteria|6|||
148911451|NCT00775593|537158659|FG000|Overall Study|Death|1|||
148911452|NCT02067676|537158660|FG000|Overall Study|Withdrawal by Subject|1|||
148911453|NCT02067676|537158661|FG001|Overall Study|Withdrawal by Subject|0|||
148911454|NCT02067676|537158662|FG002|Overall Study|Withdrawal by Subject|0|||
148911455|NCT02067676|537158663|FG003|Overall Study|Withdrawal by Subject|0|||
148911456|NCT02067676|537158664|FG004|Overall Study|Withdrawal by Subject|0|||
148911457|NCT02067676|537158665|FG005|Overall Study|Withdrawal by Subject|0|||
148911458|NCT00996333|537158666|FG000|Overall Study|Screen failure|1|||
148911459|NCT00996333|537158666|FG000|Overall Study|Withdrawal by Subject|1|||
148911460|NCT00996333|537158666|FG000|Overall Study|Death|4|||
148911461|NCT00996333|537158666|FG000|Overall Study|Adverse Event|1|||
148911462|NCT00996333|537158666|FG000|Overall Study|Physician Decision|1|||
148911463|NCT00996333|537158666|FG000|Overall Study|Other|5|||
148911464|NCT01327482|537158667|FG000|Overall Study|Adverse Event|1|||
148911465|NCT00476229|537158668|FG000|Overall Study|Progressive shortness of breath|1|||
148911466|NCT02164461|537158669|FG000|Overall Study|Adverse Event|0|||
148911467|NCT02164461|537158670|FG001|Overall Study|Adverse Event|0|||
148911468|NCT02164461|537158671|FG002|Overall Study|Adverse Event|1|||
148911469|NCT02164461|537158669|FG000|Overall Study|Disease Progression|1|||
148911470|NCT02164461|537158670|FG001|Overall Study|Disease Progression|3|||
148911471|NCT02164461|537158671|FG002|Overall Study|Disease Progression|4|||
148911472|NCT02164461|537158669|FG000|Overall Study|Withdrawal by Subject|0|||
148911473|NCT02164461|537158670|FG001|Overall Study|Withdrawal by Subject|3|||
148911474|NCT02164461|537158671|FG002|Overall Study|Withdrawal by Subject|0|||
148911475|NCT02100696|537158673|FG000|Induction Phase|Adverse Event|0|||
148911476|NCT02100696|537158674|FG001|Induction Phase|Adverse Event|0|||
148911477|NCT02100696|537158675|FG002|Induction Phase|Adverse Event|1|||
148911478|NCT02100696|537158676|FG003|Induction Phase|Adverse Event|0|||
148911479|NCT02100696|537158677|FG004|Induction Phase|Adverse Event|0|||
148911480|NCT02100696|537158678|FG005|Induction Phase|Adverse Event|0|||
148911481|NCT02100696|537158673|FG000|Induction Phase|Lost to Follow-up|1|||
148911482|NCT02100696|537158674|FG001|Induction Phase|Lost to Follow-up|0|||
148911483|NCT02100696|537158675|FG002|Induction Phase|Lost to Follow-up|1|||
148911484|NCT02100696|537158676|FG003|Induction Phase|Lost to Follow-up|0|||
148911485|NCT02100696|537158677|FG004|Induction Phase|Lost to Follow-up|0|||
148911486|NCT02100696|537158678|FG005|Induction Phase|Lost to Follow-up|0|||
148911487|NCT02100696|537158673|FG000|Induction Phase|Protocol Violation|0|||
148911488|NCT02100696|537158674|FG001|Induction Phase|Protocol Violation|1|||
148911489|NCT02100696|537158675|FG002|Induction Phase|Protocol Violation|1|||
148911490|NCT02100696|537158676|FG003|Induction Phase|Protocol Violation|0|||
148911491|NCT02100696|537158677|FG004|Induction Phase|Protocol Violation|0|||
148911492|NCT02100696|537158678|FG005|Induction Phase|Protocol Violation|0|||
148911493|NCT02100696|537158673|FG000|Induction Phase|Withdrawal by Subject|8|||
148911494|NCT02100696|537158674|FG001|Induction Phase|Withdrawal by Subject|2|||
148911495|NCT02100696|537158675|FG002|Induction Phase|Withdrawal by Subject|13|||
148911496|NCT02100696|537158676|FG003|Induction Phase|Withdrawal by Subject|0|||
148911497|NCT02100696|537158677|FG004|Induction Phase|Withdrawal by Subject|0|||
148911498|NCT02100696|537158678|FG005|Induction Phase|Withdrawal by Subject|0|||
148911499|NCT02100696|537158673|FG000|Induction Phase|Physician Decision|1|||
148911500|NCT02100696|537158674|FG001|Induction Phase|Physician Decision|0|||
148911501|NCT02100696|537158675|FG002|Induction Phase|Physician Decision|2|||
148911502|NCT02100696|537158676|FG003|Induction Phase|Physician Decision|0|||
148911503|NCT02100696|537158677|FG004|Induction Phase|Physician Decision|0|||
148911504|NCT02100696|537158678|FG005|Induction Phase|Physician Decision|0|||
148911505|NCT02100696|537158673|FG000|Induction Phase|Multiple Reasons|5|||
148911506|NCT02100696|537158674|FG001|Induction Phase|Multiple Reasons|2|||
148911507|NCT02100696|537158675|FG002|Induction Phase|Multiple Reasons|8|||
148911508|NCT02100696|537158676|FG003|Induction Phase|Multiple Reasons|0|||
148911509|NCT02100696|537158677|FG004|Induction Phase|Multiple Reasons|0|||
148911510|NCT02100696|537158678|FG005|Induction Phase|Multiple Reasons|0|||
148911511|NCT02100696|537158673|FG000|Maintenance Phase|Adverse Event|0|||
148911512|NCT02100696|537158674|FG001|Maintenance Phase|Adverse Event|0|||
148911513|NCT02100696|537158675|FG002|Maintenance Phase|Adverse Event|0|||
148911514|NCT02100696|537158676|FG003|Maintenance Phase|Adverse Event|0|||
148911515|NCT02100696|537158677|FG004|Maintenance Phase|Adverse Event|0|||
148911516|NCT02100696|537158678|FG005|Maintenance Phase|Adverse Event|2|||
148911517|NCT02100696|537158673|FG000|Maintenance Phase|Lost to Follow-up|0|||
148911518|NCT02100696|537158674|FG001|Maintenance Phase|Lost to Follow-up|0|||
148804108|NCT04142242|536763037|FG004|Stage II|Lost to Follow-up|0|||
148804109|NCT04142242|536763038|FG005|Stage II|Lost to Follow-up|0|||
148804110|NCT04142242|536763033|FG000|Stage II|Withdrawal by Subject|0|||
148804111|NCT04142242|536763034|FG001|Stage II|Withdrawal by Subject|0|||
148804112|NCT04142242|536763035|FG002|Stage II|Withdrawal by Subject|5|||
148804113|NCT04142242|536763036|FG003|Stage II|Withdrawal by Subject|9|||
148804114|NCT04142242|536763037|FG004|Stage II|Withdrawal by Subject|0|||
148804115|NCT04142242|536763038|FG005|Stage II|Withdrawal by Subject|0|||
148804116|NCT00846053|536763041|FG000|Overall Study|Physician Decision|3|||
148804117|NCT00846053|536763042|FG001|Overall Study|Physician Decision|0|||
148804118|NCT00111761|536763043|FG000|Part 1|Physician Decision|0|||
148804119|NCT00111761|536763044|FG001|Part 1|Physician Decision|1|||
148804120|NCT00111761|536763043|FG000|Part 1|Death|0|||
148804121|NCT00111761|536763044|FG001|Part 1|Death|2|||
148804122|NCT00111761|536763043|FG000|Part 1|Other|0|||
148804123|NCT00111761|536763044|FG001|Part 1|Other|1|||
148804124|NCT00111761|536763043|FG000|Part 1|Withdrawal by Subject|0|||
148804125|NCT00111761|536763044|FG001|Part 1|Withdrawal by Subject|1|||
148804126|NCT00111761|536763043|FG000|Part 2|Adverse Event|1|||
148804127|NCT00111761|536763044|FG001|Part 2|Adverse Event|0|||
148804128|NCT00111761|536763043|FG000|Part 2|Physician Decision|1|||
148804129|NCT00111761|536763044|FG001|Part 2|Physician Decision|0|||
148804130|NCT00111761|536763043|FG000|Part 2|Death|1|||
148804131|NCT00111761|536763044|FG001|Part 2|Death|0|||
148804132|NCT00111761|536763043|FG000|Part 2|Disease progression|3|||
148804133|NCT00111761|536763044|FG001|Part 2|Disease progression|0|||
148804134|NCT00111761|536763043|FG000|Part 2|Protocol-specified criteria|1|||
148804135|NCT00111761|536763044|FG001|Part 2|Protocol-specified criteria|0|||
148804136|NCT00111761|536763043|FG000|Part 2|Other|1|||
148804137|NCT00111761|536763044|FG001|Part 2|Other|0|||
148804138|NCT04798027|536763047|FG000|Overall Study|Protocol Violation|0|||
148804139|NCT04798027|536763048|FG001|Overall Study|Protocol Violation|0|||
148804140|NCT04798027|536763049|FG002|Overall Study|Protocol Violation|0|||
148804141|NCT04798027|536763050|FG003|Overall Study|Protocol Violation|0|||
148804142|NCT04798027|536763051|FG004|Overall Study|Protocol Violation|1|||
148804143|NCT04798027|536763052|FG005|Overall Study|Protocol Violation|0|||
148804144|NCT04798027|536763053|FG006|Overall Study|Protocol Violation|0|||
148804145|NCT04798027|536763054|FG007|Overall Study|Protocol Violation|1|||
148804146|NCT04798027|536763055|FG008|Overall Study|Protocol Violation|0|||
148804147|NCT04798027|536763047|FG000|Overall Study|Withdrawal by Subject|1|||
148804148|NCT04798027|536763048|FG001|Overall Study|Withdrawal by Subject|0|||
148911519|NCT02100696|537158675|FG002|Maintenance Phase|Lost to Follow-up|0|||
148911520|NCT02100696|537158676|FG003|Maintenance Phase|Lost to Follow-up|0|||
148911521|NCT02100696|537158677|FG004|Maintenance Phase|Lost to Follow-up|1|||
148911522|NCT02100696|537158678|FG005|Maintenance Phase|Lost to Follow-up|0|||
148911523|NCT02100696|537158673|FG000|Maintenance Phase|Protocol Violation|0|||
148911524|NCT02100696|537158674|FG001|Maintenance Phase|Protocol Violation|0|||
148911525|NCT02100696|537158675|FG002|Maintenance Phase|Protocol Violation|0|||
148911526|NCT02100696|537158676|FG003|Maintenance Phase|Protocol Violation|0|||
148911527|NCT02100696|537158677|FG004|Maintenance Phase|Protocol Violation|1|||
148911528|NCT02100696|537158678|FG005|Maintenance Phase|Protocol Violation|0|||
148911529|NCT02100696|537158673|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148911530|NCT02100696|537158674|FG001|Maintenance Phase|Withdrawal by Subject|0|||
148911531|NCT02100696|537158675|FG002|Maintenance Phase|Withdrawal by Subject|0|||
148911532|NCT02100696|537158676|FG003|Maintenance Phase|Withdrawal by Subject|1|||
148911533|NCT02100696|537158677|FG004|Maintenance Phase|Withdrawal by Subject|4|||
148911534|NCT02100696|537158678|FG005|Maintenance Phase|Withdrawal by Subject|2|||
148911535|NCT02100696|537158673|FG000|Maintenance Phase|Physician Decision|0|||
148911536|NCT02100696|537158674|FG001|Maintenance Phase|Physician Decision|0|||
148911537|NCT02100696|537158675|FG002|Maintenance Phase|Physician Decision|0|||
148911538|NCT02100696|537158676|FG003|Maintenance Phase|Physician Decision|0|||
148911539|NCT02100696|537158677|FG004|Maintenance Phase|Physician Decision|1|||
148911540|NCT02100696|537158678|FG005|Maintenance Phase|Physician Decision|0|||
148911541|NCT02100696|537158673|FG000|Maintenance Phase|Multiple Reasons|0|||
148911542|NCT02100696|537158674|FG001|Maintenance Phase|Multiple Reasons|0|||
148911543|NCT02100696|537158675|FG002|Maintenance Phase|Multiple Reasons|0|||
148911544|NCT02100696|537158676|FG003|Maintenance Phase|Multiple Reasons|0|||
148911545|NCT02100696|537158677|FG004|Maintenance Phase|Multiple Reasons|2|||
148911546|NCT02100696|537158678|FG005|Maintenance Phase|Multiple Reasons|1|||
148911547|NCT03865381|537158682|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
148911548|NCT03865381|537158682|FG000|Overall Study|Withdrawal by Subject|2|||
148911549|NCT04999852|537158683|FG000|Overall Study|Withdrawal by Subject|11|||
148911550|NCT04999852|537158684|FG001|Overall Study|Withdrawal by Subject|1|||
148911551|NCT04999852|537158683|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
148911552|NCT04999852|537158684|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
148911553|NCT05626322|537158685|FG000|Overall Study|Death|2|||
148911554|NCT05626322|537158686|FG001|Overall Study|Death|0|||
148911555|NCT05626322|537158687|FG002|Overall Study|Death|0|||
148911556|NCT05626322|537158685|FG000|Overall Study|Physician Decision|1|||
148911557|NCT05626322|537158686|FG001|Overall Study|Physician Decision|0|||
148911558|NCT05626322|537158687|FG002|Overall Study|Physician Decision|0|||
148911559|NCT05626322|537158685|FG000|Overall Study|Progressive Disease|0|||
148911560|NCT05626322|537158686|FG001|Overall Study|Progressive Disease|1|||
148911561|NCT05626322|537158687|FG002|Overall Study|Progressive Disease|1|||
148911562|NCT05626322|537158685|FG000|Overall Study|Study terminated by sponsor|0|||
148911563|NCT05626322|537158686|FG001|Overall Study|Study terminated by sponsor|1|||
148911564|NCT05626322|537158687|FG002|Overall Study|Study terminated by sponsor|0|||
148911565|NCT03776812|537158688|FG000|Overall Study|Death|53|||
148911566|NCT03776812|537158689|FG001|Overall Study|Death|49|||
148911567|NCT03776812|537158690|FG002|Overall Study|Death|56|||
148911568|NCT03776812|537158688|FG000|Overall Study|Withdrawal by Subject|1|||
148911569|NCT03776812|537158689|FG001|Overall Study|Withdrawal by Subject|7|||
148911570|NCT03776812|537158690|FG002|Overall Study|Withdrawal by Subject|2|||
148911571|NCT03776812|537158688|FG000|Overall Study|Lost to Follow-up|1|||
148911572|NCT03776812|537158689|FG001|Overall Study|Lost to Follow-up|1|||
148911573|NCT03776812|537158690|FG002|Overall Study|Lost to Follow-up|0|||
148911574|NCT03776812|537158688|FG000|Overall Study|Did not enter long-term follow-up|3|||
148911575|NCT03776812|537158689|FG001|Overall Study|Did not enter long-term follow-up|3|||
148911576|NCT03776812|537158690|FG002|Overall Study|Did not enter long-term follow-up|2|||
148911577|NCT03350672|537158698|FG000|Overall Study|Withdrawal by Subject|7|||
148911578|NCT03350672|537158699|FG001|Overall Study|Withdrawal by Subject|0|||
148911579|NCT03350672|537158700|FG002|Overall Study|Withdrawal by Subject|0|||
148911580|NCT00048074|537158701|FG000|Overall Study|Adverse Event|46|||
148911581|NCT00048074|537158702|FG001|Overall Study|Adverse Event|41|||
148911582|NCT00048074|537158703|FG002|Overall Study|Adverse Event|53|||
148911583|NCT00048074|537158701|FG000|Overall Study|Death|3|||
148911584|NCT00048074|537158702|FG001|Overall Study|Death|3|||
148911585|NCT00048074|537158703|FG002|Overall Study|Death|2|||
148911586|NCT00048074|537158701|FG000|Overall Study|Lost to Follow-up|2|||
148911587|NCT00048074|537158702|FG001|Overall Study|Lost to Follow-up|6|||
148911588|NCT00048074|537158703|FG002|Overall Study|Lost to Follow-up|6|||
148911589|NCT00048074|537158701|FG000|Overall Study|Withdrawal by Subject|28|||
148911590|NCT00048074|537158702|FG001|Overall Study|Withdrawal by Subject|30|||
148911591|NCT00048074|537158703|FG002|Overall Study|Withdrawal by Subject|35|||
148911592|NCT00048074|537158701|FG000|Overall Study|Protocol Violation|1|||
148911593|NCT00048074|537158702|FG001|Overall Study|Protocol Violation|3|||
148911594|NCT00048074|537158703|FG002|Overall Study|Protocol Violation|0|||
148911595|NCT00048074|537158701|FG000|Overall Study|Study participation was terminated|0|||
148911596|NCT00048074|537158702|FG001|Overall Study|Study participation was terminated|1|||
148911597|NCT00048074|537158703|FG002|Overall Study|Study participation was terminated|0|||
148804149|NCT04798027|536763049|FG002|Overall Study|Withdrawal by Subject|1|||
148804150|NCT04798027|536763050|FG003|Overall Study|Withdrawal by Subject|1|||
148804151|NCT04798027|536763051|FG004|Overall Study|Withdrawal by Subject|1|||
148804152|NCT04798027|536763052|FG005|Overall Study|Withdrawal by Subject|1|||
148804153|NCT04798027|536763053|FG006|Overall Study|Withdrawal by Subject|3|||
148804154|NCT04798027|536763054|FG007|Overall Study|Withdrawal by Subject|2|||
148804155|NCT04798027|536763055|FG008|Overall Study|Withdrawal by Subject|2|||
148804156|NCT04798027|536763047|FG000|Overall Study|Lost to Follow-up|1|||
148804157|NCT04798027|536763048|FG001|Overall Study|Lost to Follow-up|3|||
148804158|NCT04798027|536763049|FG002|Overall Study|Lost to Follow-up|0|||
148804159|NCT04798027|536763050|FG003|Overall Study|Lost to Follow-up|0|||
148804160|NCT04798027|536763051|FG004|Overall Study|Lost to Follow-up|0|||
148804161|NCT04798027|536763052|FG005|Overall Study|Lost to Follow-up|1|||
148804162|NCT04798027|536763053|FG006|Overall Study|Lost to Follow-up|0|||
148804163|NCT04798027|536763054|FG007|Overall Study|Lost to Follow-up|0|||
148911598|NCT00048074|537158701|FG000|Overall Study|Husband ill|0|||
149139424|NCT01383096|537991842|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
148804164|NCT04798027|536763055|FG008|Overall Study|Lost to Follow-up|1|||
148804165|NCT04798027|536763047|FG000|Overall Study|Withdrawal by Sponsor|8|||
148804166|NCT04798027|536763048|FG001|Overall Study|Withdrawal by Sponsor|22|||
148804167|NCT04798027|536763049|FG002|Overall Study|Withdrawal by Sponsor|9|||
148804168|NCT04798027|536763050|FG003|Overall Study|Withdrawal by Sponsor|26|||
148804169|NCT04798027|536763051|FG004|Overall Study|Withdrawal by Sponsor|24|||
148804170|NCT04798027|536763052|FG005|Overall Study|Withdrawal by Sponsor|11|||
148804171|NCT04798027|536763053|FG006|Overall Study|Withdrawal by Sponsor|25|||
148804172|NCT04798027|536763054|FG007|Overall Study|Withdrawal by Sponsor|26|||
148804173|NCT04798027|536763055|FG008|Overall Study|Withdrawal by Sponsor|11|||
148804174|NCT04609514|536763056|FG000|Overall Study|Lost to Follow-up|5|||
148804175|NCT04609514|536763057|FG001|Overall Study|Lost to Follow-up|4|||
148804176|NCT04609514|536763056|FG000|Overall Study|Withdrawal by PI|0|||
148804177|NCT04609514|536763057|FG001|Overall Study|Withdrawal by PI|2|||
148804178|NCT01981616|536763062|FG000|Overall Study|Adverse Event|0|||
148804179|NCT01981616|536763063|FG001|Overall Study|Adverse Event|1|||
148804180|NCT01981616|536763062|FG000|Overall Study|Protocol Violation|1|||
148804181|NCT01981616|536763063|FG001|Overall Study|Protocol Violation|0|||
148804182|NCT03225287|536763064|FG000|Overall Study|Adverse Event|0|||
148804183|NCT03225287|536763065|FG001|Overall Study|Adverse Event|0|||
148804184|NCT03225287|536763066|FG002|Overall Study|Adverse Event|1|||
148804185|NCT03225287|536763064|FG000|Overall Study|Protocol non-compliance|0|||
148804186|NCT03225287|536763065|FG001|Overall Study|Protocol non-compliance|0|||
148804187|NCT03225287|536763066|FG002|Overall Study|Protocol non-compliance|1|||
148804188|NCT03225287|536763064|FG000|Overall Study|Subject withdraws consent|3|||
148804189|NCT03225287|536763065|FG001|Overall Study|Subject withdraws consent|0|||
148804190|NCT03225287|536763066|FG002|Overall Study|Subject withdraws consent|0|||
148804191|NCT03225287|536763064|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
148804192|NCT03225287|536763065|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
148804193|NCT03225287|536763066|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
148804194|NCT03225287|536763064|FG000|Overall Study|Trial drug not effective|0|||
148804195|NCT03225287|536763065|FG001|Overall Study|Trial drug not effective|1|||
148804196|NCT03225287|536763066|FG002|Overall Study|Trial drug not effective|0|||
148804197|NCT03225287|536763064|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
148804198|NCT03225287|536763065|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
148804199|NCT03225287|536763066|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
148804200|NCT03225287|536763064|FG000|Overall Study|Stem cell transplantation|0|||
148804201|NCT03225287|536763065|FG001|Overall Study|Stem cell transplantation|1|||
148804202|NCT03225287|536763066|FG002|Overall Study|Stem cell transplantation|0|||
148804203|NCT02074514|536763068|FG000|Overall Study|Lack of Efficacy|3|||
148804204|NCT02074514|536763069|FG001|Overall Study|Lack of Efficacy|2|||
148804205|NCT02074514|536763068|FG000|Overall Study|Lost to Follow-up|0|||
148804206|NCT02074514|536763069|FG001|Overall Study|Lost to Follow-up|1|||
148804207|NCT02074514|536763068|FG000|Overall Study|Withdrew Consent|0|||
148804208|NCT02074514|536763069|FG001|Overall Study|Withdrew Consent|1|||
148804209|NCT05399680|536765031|FG000|Overall Study|Lost to Follow-up|1|||
148804210|NCT05399680|536765032|FG001|Overall Study|Lost to Follow-up|0|||
148804211|NCT05399680|536765031|FG000|Overall Study|Death|0|||
148804212|NCT05399680|536765032|FG001|Overall Study|Death|1|||
148804213|NCT03370172|536765033|FG000|Overall Study|Withdrawal by Subject|0|||
148804214|NCT03370172|536765034|FG001|Overall Study|Withdrawal by Subject|1|||
148804215|NCT01113749|536765036|FG000|Overall Study|Lost to Follow-up|1|||
148911599|NCT00048074|537158702|FG001|Overall Study|Husband ill|1|||
148911600|NCT00048074|537158703|FG002|Overall Study|Husband ill|0|||
148911601|NCT00048074|537158701|FG000|Overall Study|Poor compliance|0|||
148911602|NCT00048074|537158702|FG001|Overall Study|Poor compliance|1|||
148911603|NCT00048074|537158703|FG002|Overall Study|Poor compliance|0|||
148911604|NCT00048074|537158701|FG000|Overall Study|Out of station|0|||
148911605|NCT00048074|537158702|FG001|Overall Study|Out of station|1|||
148911606|NCT00048074|537158703|FG002|Overall Study|Out of station|1|||
148911607|NCT00048074|537158701|FG000|Overall Study|Social reasons|1|||
148911608|NCT00048074|537158702|FG001|Overall Study|Social reasons|0|||
148911609|NCT00048074|537158703|FG002|Overall Study|Social reasons|0|||
148911610|NCT02873377|537158704|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
148911611|NCT02873377|537158705|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
148911612|NCT02873377|537158704|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
148911613|NCT02873377|537158705|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
148911614|NCT01583296|537158708|FG000|Overall Study|Withdrawal by Subject|11|||
148911615|NCT01583296|537158709|FG001|Overall Study|Withdrawal by Subject|10|||
148911616|NCT01063283|537158710|FG000|Cycle 1|Adverse Event|2|||
148911617|NCT01063283|537158711|FG001|Cycle 1|Adverse Event|0|||
148911618|NCT01063283|537158712|FG002|Cycle 1|Adverse Event|0|||
148911619|NCT01063283|537158710|FG000|Cycle 1|Technical failure in data collection|1|||
148911620|NCT01063283|537158711|FG001|Cycle 1|Technical failure in data collection|0|||
148911621|NCT01063283|537158712|FG002|Cycle 1|Technical failure in data collection|0|||
148911622|NCT02504216|537158715|FG000|Overall Study|Lost to Follow-up|3|||
148911623|NCT02504216|537158716|FG001|Overall Study|Lost to Follow-up|3|||
148911624|NCT02504216|537158715|FG000|Overall Study|Withdrawal by Subject|8|||
148911625|NCT02504216|537158716|FG001|Overall Study|Withdrawal by Subject|12|||
148911626|NCT00223080|537158717|FG000|Overall Study|Withdrawal by Subject|253|||
148911627|NCT00223080|537158718|FG001|Overall Study|Withdrawal by Subject|232|||
148911628|NCT00223080|537158717|FG000|Overall Study|Required contraindicated med|0|||
148911629|NCT00223080|537158718|FG001|Overall Study|Required contraindicated med|1|||
148911630|NCT00223080|537158717|FG000|Overall Study|Non-compliant|7|||
148911631|NCT00223080|537158718|FG001|Overall Study|Non-compliant|7|||
149012005|NCT02318719|537523418|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
149139425|NCT01383096|537991840|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
148911632|NCT00223080|537158717|FG000|Overall Study|Moved from study area|37|||
148911633|NCT00223080|537158718|FG001|Overall Study|Moved from study area|47|||
148911634|NCT00223080|537158717|FG000|Overall Study|Lost to Follow-up|259|||
148911635|NCT00223080|537158718|FG001|Overall Study|Lost to Follow-up|284|||
148911636|NCT00223080|537158717|FG000|Overall Study|Death|85|||
148911637|NCT00223080|537158718|FG001|Overall Study|Death|74|||
148911638|NCT00223080|537158717|FG000|Overall Study|Other|14|||
148911639|NCT00223080|537158718|FG001|Overall Study|Other|11|||
148911640|NCT00223080|537158717|FG000|Overall Study|Reason not provided|141|||
148911641|NCT00223080|537158718|FG001|Overall Study|Reason not provided|140|||
148911642|NCT00223080|537158717|FG000|Overall Study|Adverse Event|0|||
148911643|NCT00223080|537158718|FG001|Overall Study|Adverse Event|1|||
148911644|NCT02598583|537158719|FG000|Extension Period|Withdrawal by Subject|1|||
148911645|NCT02598583|537158720|FG001|Extension Period|Withdrawal by Subject|0|||
148911646|NCT03237286|537158721|FG000|Overall Study|Withdrawal by Subject|1|||
148911647|NCT03237286|537158722|FG001|Overall Study|Withdrawal by Subject|0|||
148911648|NCT03237286|537158723|FG002|Overall Study|Withdrawal by Subject|2|||
148911649|NCT03237286|537158721|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
148911650|NCT03237286|537158722|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
148911651|NCT03237286|537158723|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
148911652|NCT02792829|537158731|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911653|NCT02792829|537158732|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
148911654|NCT02792829|537158733|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911655|NCT02792829|537158734|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911656|NCT02792829|537158735|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911657|NCT02792829|537158736|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911658|NCT02792829|537158737|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911659|NCT02792829|537158738|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
148911660|NCT02792829|537158731|FG000|Treatment Period 2|Adverse Event|0|||
148911661|NCT02792829|537158732|FG001|Treatment Period 2|Adverse Event|0|||
148911662|NCT02792829|537158733|FG002|Treatment Period 2|Adverse Event|0|||
148911663|NCT02792829|537158734|FG003|Treatment Period 2|Adverse Event|0|||
148911664|NCT02792829|537158735|FG004|Treatment Period 2|Adverse Event|1|||
148911665|NCT02792829|537158736|FG005|Treatment Period 2|Adverse Event|0|||
148911666|NCT02792829|537158737|FG006|Treatment Period 2|Adverse Event|1|||
148911667|NCT02792829|537158738|FG007|Treatment Period 2|Adverse Event|1|||
148911668|NCT02792829|537158731|FG000|Treatment Period 2|Use of proscribed medications|0|||
148911669|NCT02792829|537158732|FG001|Treatment Period 2|Use of proscribed medications|0|||
148911670|NCT02792829|537158733|FG002|Treatment Period 2|Use of proscribed medications|0|||
148911671|NCT02792829|537158734|FG003|Treatment Period 2|Use of proscribed medications|0|||
148911672|NCT02792829|537158735|FG004|Treatment Period 2|Use of proscribed medications|0|||
148911673|NCT02792829|537158736|FG005|Treatment Period 2|Use of proscribed medications|0|||
148911674|NCT02792829|537158737|FG006|Treatment Period 2|Use of proscribed medications|0|||
148911675|NCT02792829|537158738|FG007|Treatment Period 2|Use of proscribed medications|1|||
148911676|NCT01262820|537158741|FG000|Overall Study|Adverse Event|5|||
148911677|NCT01262820|537158741|FG000|Overall Study|Lack of Efficacy|9|||
148911678|NCT01262820|537158741|FG000|Overall Study|Drug held for 21+ days|1|||
148911679|NCT00452361|537158743|FG000|Overall Study|Adverse Event|8|||
148911680|NCT00452361|537158744|FG001|Overall Study|Adverse Event|0|||
148911681|NCT00452361|537158743|FG000|Overall Study|Withdrawal by Subject|0|||
148911682|NCT00452361|537158744|FG001|Overall Study|Withdrawal by Subject|1|||
148911683|NCT00452361|537158743|FG000|Overall Study|Premature termination|13|||
148911684|NCT00452361|537158744|FG001|Overall Study|Premature termination|9|||
148911685|NCT01010867|537158747|FG000|Overall Study|< 50% adherence to probiotic|1|||
148911686|NCT01668589|537158748|FG000|Overall Study|Lost to Follow-up|29|||
148911687|NCT01668589|537158749|FG001|Overall Study|Lost to Follow-up|37|||
148911688|NCT01668589|537158750|FG002|Overall Study|Lost to Follow-up|15|||
148911689|NCT01668589|537158751|FG003|Overall Study|Lost to Follow-up|5|||
148911690|NCT01668589|537158748|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
148911691|NCT01668589|537158749|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
148911692|NCT01668589|537158750|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
148911693|NCT01668589|537158751|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
148911694|NCT01668589|537158748|FG000|Overall Study|Death|12|||
148911695|NCT01668589|537158749|FG001|Overall Study|Death|3|||
148911696|NCT01668589|537158750|FG002|Overall Study|Death|2|||
148911697|NCT01668589|537158751|FG003|Overall Study|Death|11|||
148911698|NCT01668589|537158748|FG000|Overall Study|Other|44|||
148911699|NCT01668589|537158749|FG001|Overall Study|Other|10|||
148911700|NCT01668589|537158750|FG002|Overall Study|Other|7|||
148911701|NCT01668589|537158751|FG003|Overall Study|Other|15|||
148911702|NCT01120964|537158752|FG000|Overall Study|Did not receive full treatment|1|||
148911703|NCT01120964|537158753|FG001|Overall Study|Did not receive full treatment|0|||
148911704|NCT04198714|537158754|FG000|Overall Study|Physician Decision|0|||
148911705|NCT04198714|537158755|FG001|Overall Study|Physician Decision|1|||
148911706|NCT02175199|537160295|FG000|Overall Study|Withdrawal by Subject|1|||
148911707|NCT02175199|537160296|FG001|Overall Study|Withdrawal by Subject|5|||
148911708|NCT02175199|537160295|FG000|Overall Study|Randomized in Error|1|||
148911709|NCT02175199|537160296|FG001|Overall Study|Randomized in Error|0|||
149012006|NCT02318719|537523419|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
148804216|NCT01113749|536765037|FG001|Overall Study|Lost to Follow-up|2|||
148804217|NCT03427892|536765038|FG000|Overall Study|Lost to Follow-up|2|||
148804218|NCT03255187|536765039|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
148804219|NCT03255187|536765040|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
148804220|NCT03255187|536765039|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
148804221|NCT03255187|536765040|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
148804222|NCT02034006|536765041|FG000|Overall Study|Withdrawal by Subject|7|||
148804223|NCT02034006|536765041|FG000|Overall Study|Lost to Follow-up|5|||
148804224|NCT02034006|536765041|FG000|Overall Study|Death|1|||
148804225|NCT02034006|536765041|FG000|Overall Study|Pregnancy|1|||
148804226|NCT02934178|536765042|FG000|Received Vaccination 2|Death|0|||
148804227|NCT02934178|536765043|FG001|Received Vaccination 2|Death|1|||
148804228|NCT02934178|536765042|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
148804229|NCT02934178|536765043|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
148804230|NCT00296244|536765047|FG000|Overall Study|Underwent retransplant|0|||
148804231|NCT00296244|536765048|FG001|Overall Study|Underwent retransplant|1|||
148804232|NCT00703534|536765049|FG000|Overall Study|Adverse Event|14|||
148804233|NCT00703534|536765050|FG001|Overall Study|Adverse Event|3|||
148804234|NCT00703534|536765049|FG000|Overall Study|Withdrawal by Subject|8|||
148804235|NCT00703534|536765050|FG001|Overall Study|Withdrawal by Subject|7|||
148804236|NCT00703534|536765049|FG000|Overall Study|Incorrect Enrollment|6|||
148804237|NCT00703534|536765050|FG001|Overall Study|Incorrect Enrollment|6|||
148804238|NCT00703534|536765049|FG000|Overall Study|Lost to Follow-up|1|||
148804239|NCT00703534|536765050|FG001|Overall Study|Lost to Follow-up|4|||
148804240|NCT00703534|536765049|FG000|Overall Study|Severe Non Compliance|1|||
148804241|NCT00703534|536765050|FG001|Overall Study|Severe Non Compliance|5|||
148804242|NCT01125930|536765051|FG000|Overall Study|Adverse Event|0|||
148804243|NCT01125930|536765052|FG001|Overall Study|Adverse Event|1|||
148804244|NCT01125930|536765051|FG000|Overall Study|Withdrawal by Subject|1|||
148804245|NCT01125930|536765052|FG001|Overall Study|Withdrawal by Subject|6|||
148804246|NCT01125930|536765051|FG000|Overall Study|Protocol Violation|0|||
148804247|NCT01125930|536765052|FG001|Overall Study|Protocol Violation|1|||
148804248|NCT01125930|536765051|FG000|Overall Study|Lost to Follow-up|0|||
148804249|NCT01125930|536765052|FG001|Overall Study|Lost to Follow-up|2|||
148804250|NCT03617588|536765053|FG000|Overall Study|Withdrawal by Subject|1|||
148804251|NCT03617588|536765054|FG001|Overall Study|Withdrawal by Subject|0|||
148804252|NCT03261401|536765055|FG000|Overall Study|Withdrawal by Subject|0|||
148804253|NCT03261401|536765056|FG001|Overall Study|Withdrawal by Subject|0|||
148804254|NCT03261401|536765057|FG002|Overall Study|Withdrawal by Subject|0|||
148804255|NCT03261401|536765058|FG003|Overall Study|Withdrawal by Subject|0|||
148804256|NCT03261401|536765059|FG004|Overall Study|Withdrawal by Subject|0|||
148804257|NCT03261401|536765060|FG005|Overall Study|Withdrawal by Subject|1|||
148804258|NCT03261401|536765061|FG006|Overall Study|Withdrawal by Subject|0|||
148804259|NCT03261401|536765062|FG007|Overall Study|Withdrawal by Subject|0|||
148804260|NCT03261401|536765063|FG008|Overall Study|Withdrawal by Subject|0|||
148804261|NCT03261401|536765064|FG009|Overall Study|Withdrawal by Subject|0|||
148804262|NCT03261401|536765065|FG010|Overall Study|Withdrawal by Subject|0|||
148804263|NCT03261401|536765066|FG011|Overall Study|Withdrawal by Subject|0|||
148804264|NCT03261401|536765067|FG012|Overall Study|Withdrawal by Subject|0|||
148804265|NCT03261401|536765055|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
148911710|NCT02175199|537160295|FG000|Overall Study|Sponsor Decision|1|||
148911711|NCT02175199|537160296|FG001|Overall Study|Sponsor Decision|0|||
148911712|NCT01243242|537160297|FG000|Overall Study|Adverse Event|1|||
148911713|NCT01243242|537160298|FG001|Overall Study|Adverse Event|1|||
148911714|NCT01243242|537160297|FG000|Overall Study|Withdrawal by Subject|1|||
148911715|NCT01243242|537160298|FG001|Overall Study|Withdrawal by Subject|1|||
148911716|NCT01243242|537160297|FG000|Overall Study|Physician Decision|0|||
148911717|NCT01243242|537160298|FG001|Overall Study|Physician Decision|1|||
148911718|NCT01243242|537160297|FG000|Overall Study|sponsor decision|0|||
148911719|NCT01243242|537160298|FG001|Overall Study|sponsor decision|1|||
148911720|NCT01243242|537160297|FG000|Overall Study|non compliance|1|||
148911721|NCT01243242|537160298|FG001|Overall Study|non compliance|0|||
148911722|NCT03983317|537160303|FG000|Overall Study|Physician Decision|5|||
148804266|NCT03261401|536765056|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
148804267|NCT03261401|536765057|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
148804268|NCT03261401|536765058|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
148804269|NCT03261401|536765059|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
148804270|NCT03261401|536765060|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
148804271|NCT03261401|536765061|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
148804272|NCT03261401|536765062|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
148804273|NCT03261401|536765063|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
148804274|NCT03261401|536765064|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
148804275|NCT03261401|536765065|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
148804276|NCT03261401|536765066|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
148804277|NCT03261401|536765067|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
148804278|NCT01715298|536765068|FG000|Overall Study|Lost to Follow-up|0|||
148804279|NCT01715298|536765069|FG001|Overall Study|Lost to Follow-up|2|||
148804280|NCT01715298|536765068|FG000|Overall Study|Patient/guardian decision|7|||
148804281|NCT01715298|536765069|FG001|Overall Study|Patient/guardian decision|9|||
148804282|NCT03248037|536765073|FG000|Overall Study|Withdrawal by Subject|6|||
148804283|NCT03248037|536765074|FG001|Overall Study|Withdrawal by Subject|9|||
148804284|NCT03248037|536765073|FG000|Overall Study|Adverse Event|15|||
148804285|NCT03248037|536765074|FG001|Overall Study|Adverse Event|0|||
148804286|NCT02732639|536765081|FG000|Overall Study|Lost to Follow-up|1|||
148804287|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
148804288|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
148804289|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
148804290|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
148804291|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
148804292|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
148804293|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
148804294|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
148804295|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
148804296|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
148804297|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
148804298|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
148804299|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
148804300|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
148804301|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
148804302|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
148804303|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
148804304|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
148804305|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
148804306|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
148804307|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
148804308|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
148804309|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
148804310|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
148804311|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
148804312|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
148804313|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
148804314|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
148804315|NCT01668797|536765082|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
148804316|NCT01668797|536765083|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
148804317|NCT01668797|536765084|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
148804318|NCT01668797|536765085|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
148804319|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
148804320|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
148804321|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
148804322|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
148804323|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
148804324|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
148804325|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
148804326|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
148804327|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
148911723|NCT01761162|537160304|FG000|Overall Study|Withdrawal by Subject|3|||
148911724|NCT01256294|537160309|FG000|Overall Study|Adverse Event|1|||
148911725|NCT01256294|537160310|FG001|Overall Study|Adverse Event|0|||
148911726|NCT01256294|537160309|FG000|Overall Study|Withdrawal by Subject|1|||
148911727|NCT01256294|537160310|FG001|Overall Study|Withdrawal by Subject|1|||
148911728|NCT01256294|537160309|FG000|Overall Study|Protocol deviation|2|||
148911729|NCT01256294|537160310|FG001|Overall Study|Protocol deviation|1|||
148911730|NCT01643772|537160311|FG000|Overall Study|Protocol Violation|0|||
148911731|NCT01643772|537160312|FG001|Overall Study|Protocol Violation|0|||
148911732|NCT01643772|537160313|FG002|Overall Study|Protocol Violation|0|||
148911733|NCT01643772|537160314|FG003|Overall Study|Protocol Violation|1|||
148911734|NCT01643772|537160311|FG000|Overall Study|Adverse Event|0|||
148911735|NCT01643772|537160312|FG001|Overall Study|Adverse Event|0|||
148911736|NCT01643772|537160313|FG002|Overall Study|Adverse Event|0|||
148911737|NCT01643772|537160314|FG003|Overall Study|Adverse Event|1|||
148911738|NCT00724711|537160315|FG000|Overall Study|Adverse Event|7|||
148911739|NCT00724711|537160316|FG001|Overall Study|Adverse Event|3|||
148911740|NCT00724711|537160315|FG000|Overall Study|Pregnancy|0|||
148911741|NCT00724711|537160316|FG001|Overall Study|Pregnancy|1|||
148911742|NCT00724711|537160315|FG000|Overall Study|Lack of Efficacy|0|||
148911743|NCT00724711|537160316|FG001|Overall Study|Lack of Efficacy|1|||
148911744|NCT00724711|537160315|FG000|Overall Study|Physician Decision|0|||
148911745|NCT00724711|537160316|FG001|Overall Study|Physician Decision|3|||
148911746|NCT00724711|537160315|FG000|Overall Study|Withdrawal by Subject|5|||
148911747|NCT00724711|537160316|FG001|Overall Study|Withdrawal by Subject|4|||
148911748|NCT00724711|537160315|FG000|Overall Study|Lost to Follow-up|4|||
148911749|NCT00724711|537160316|FG001|Overall Study|Lost to Follow-up|5|||
148911750|NCT00724711|537160315|FG000|Overall Study|Protocol Violation|1|||
148911751|NCT00724711|537160316|FG001|Overall Study|Protocol Violation|0|||
148911752|NCT01139008|537160317|FG000|Overall Study|Withdrawal by Subject|5|||
148911753|NCT01139008|537160317|FG000|Overall Study|Non-compliant, lost product|1|||
148911754|NCT01088048|537160319|FG000|Overall Study|Adverse Event|7|||
148911755|NCT01088048|537160320|FG001|Overall Study|Adverse Event|9|||
148911756|NCT01088048|537160321|FG002|Overall Study|Adverse Event|7|||
148911757|NCT01088048|537160322|FG003|Overall Study|Adverse Event|5|||
148911758|NCT01088048|537160323|FG004|Overall Study|Adverse Event|6|||
148911759|NCT01088048|537160324|FG005|Overall Study|Adverse Event|3|||
148911760|NCT01088048|537160325|FG006|Overall Study|Adverse Event|3|||
148911761|NCT01088048|537160326|FG007|Overall Study|Adverse Event|0|||
148911762|NCT01088048|537160327|FG008|Overall Study|Adverse Event|2|||
148911763|NCT01088048|537160328|FG009|Overall Study|Adverse Event|2|||
148911764|NCT01088048|537160319|FG000|Overall Study|Withdrew Consent|1|||
148911765|NCT01088048|537160320|FG001|Overall Study|Withdrew Consent|1|||
148911766|NCT01088048|537160321|FG002|Overall Study|Withdrew Consent|1|||
148911767|NCT01088048|537160322|FG003|Overall Study|Withdrew Consent|1|||
148911768|NCT01088048|537160323|FG004|Overall Study|Withdrew Consent|2|||
148911769|NCT01088048|537160324|FG005|Overall Study|Withdrew Consent|1|||
148911770|NCT01088048|537160325|FG006|Overall Study|Withdrew Consent|0|||
148911771|NCT01088048|537160326|FG007|Overall Study|Withdrew Consent|2|||
148911772|NCT01088048|537160327|FG008|Overall Study|Withdrew Consent|2|||
148911773|NCT01088048|537160328|FG009|Overall Study|Withdrew Consent|1|||
148911774|NCT01088048|537160319|FG000|Overall Study|Concomitant Medication Prohibited|1|||
148911775|NCT01088048|537160320|FG001|Overall Study|Concomitant Medication Prohibited|0|||
148911776|NCT01088048|537160321|FG002|Overall Study|Concomitant Medication Prohibited|0|||
148911777|NCT01088048|537160322|FG003|Overall Study|Concomitant Medication Prohibited|0|||
148911778|NCT01088048|537160323|FG004|Overall Study|Concomitant Medication Prohibited|0|||
148911779|NCT01088048|537160324|FG005|Overall Study|Concomitant Medication Prohibited|0|||
148911780|NCT01088048|537160325|FG006|Overall Study|Concomitant Medication Prohibited|0|||
148911781|NCT01088048|537160326|FG007|Overall Study|Concomitant Medication Prohibited|0|||
148911782|NCT01088048|537160327|FG008|Overall Study|Concomitant Medication Prohibited|0|||
148911783|NCT01088048|537160328|FG009|Overall Study|Concomitant Medication Prohibited|0|||
148911784|NCT01088048|537160319|FG000|Overall Study|Investigator Request|2|||
148911785|NCT01088048|537160320|FG001|Overall Study|Investigator Request|2|||
148911786|NCT01088048|537160321|FG002|Overall Study|Investigator Request|0|||
148911787|NCT01088048|537160322|FG003|Overall Study|Investigator Request|0|||
148911788|NCT01088048|537160323|FG004|Overall Study|Investigator Request|3|||
148911789|NCT01088048|537160324|FG005|Overall Study|Investigator Request|1|||
148911790|NCT01088048|537160325|FG006|Overall Study|Investigator Request|1|||
148911791|NCT01088048|537160326|FG007|Overall Study|Investigator Request|0|||
148911792|NCT01088048|537160327|FG008|Overall Study|Investigator Request|0|||
148911793|NCT01088048|537160328|FG009|Overall Study|Investigator Request|0|||
148911794|NCT01088048|537160319|FG000|Overall Study|Patient Non-compliance|0|||
148911795|NCT01088048|537160320|FG001|Overall Study|Patient Non-compliance|1|||
148911796|NCT01088048|537160321|FG002|Overall Study|Patient Non-compliance|0|||
148911797|NCT01088048|537160322|FG003|Overall Study|Patient Non-compliance|0|||
148911798|NCT01088048|537160323|FG004|Overall Study|Patient Non-compliance|0|||
148911799|NCT01088048|537160324|FG005|Overall Study|Patient Non-compliance|0|||
148911800|NCT01088048|537160325|FG006|Overall Study|Patient Non-compliance|0|||
148911801|NCT01088048|537160326|FG007|Overall Study|Patient Non-compliance|0|||
148911802|NCT01088048|537160327|FG008|Overall Study|Patient Non-compliance|0|||
148911803|NCT01088048|537160328|FG009|Overall Study|Patient Non-compliance|0|||
148911804|NCT01088048|537160319|FG000|Overall Study|Disease Progression|7|||
148911805|NCT01088048|537160320|FG001|Overall Study|Disease Progression|4|||
148911806|NCT01088048|537160321|FG002|Overall Study|Disease Progression|3|||
148911807|NCT01088048|537160322|FG003|Overall Study|Disease Progression|5|||
148911808|NCT01088048|537160323|FG004|Overall Study|Disease Progression|3|||
148911809|NCT01088048|537160324|FG005|Overall Study|Disease Progression|3|||
148911810|NCT01088048|537160325|FG006|Overall Study|Disease Progression|2|||
148911811|NCT01088048|537160326|FG007|Overall Study|Disease Progression|1|||
148911812|NCT01088048|537160327|FG008|Overall Study|Disease Progression|0|||
148911813|NCT01088048|537160328|FG009|Overall Study|Disease Progression|0|||
148911814|NCT01088048|537160319|FG000|Overall Study|Death|1|||
148911815|NCT01088048|537160320|FG001|Overall Study|Death|5|||
148911816|NCT01088048|537160321|FG002|Overall Study|Death|3|||
148911817|NCT01088048|537160322|FG003|Overall Study|Death|3|||
148911818|NCT01088048|537160323|FG004|Overall Study|Death|1|||
148911819|NCT01088048|537160324|FG005|Overall Study|Death|3|||
148911820|NCT01088048|537160325|FG006|Overall Study|Death|0|||
148911821|NCT01088048|537160326|FG007|Overall Study|Death|0|||
148911822|NCT01088048|537160327|FG008|Overall Study|Death|3|||
148911823|NCT01088048|537160328|FG009|Overall Study|Death|1|||
148911824|NCT01088048|537160319|FG000|Overall Study|Other|3|||
148911825|NCT01088048|537160320|FG001|Overall Study|Other|5|||
148911826|NCT01088048|537160321|FG002|Overall Study|Other|0|||
148911827|NCT01088048|537160322|FG003|Overall Study|Other|0|||
148911828|NCT01088048|537160323|FG004|Overall Study|Other|2|||
148911829|NCT01088048|537160324|FG005|Overall Study|Other|0|||
148911830|NCT01088048|537160325|FG006|Overall Study|Other|0|||
148911831|NCT01088048|537160326|FG007|Overall Study|Other|2|||
148911832|NCT01088048|537160327|FG008|Overall Study|Other|0|||
148911833|NCT01088048|537160328|FG009|Overall Study|Other|0|||
148911834|NCT01621802|537160329|FG000|Overall Study|Protocol Violation|0|||
148911835|NCT01621802|537160330|FG001|Overall Study|Protocol Violation|0|||
148911836|NCT01621802|537160331|FG002|Overall Study|Protocol Violation|0|||
148911837|NCT01621802|537160332|FG003|Overall Study|Protocol Violation|0|||
148911838|NCT01621802|537160333|FG004|Overall Study|Protocol Violation|0|||
148911839|NCT01621802|537160334|FG005|Overall Study|Protocol Violation|1|||
148911840|NCT01621802|537160329|FG000|Overall Study|Withdrawal by Subject|8|||
148911841|NCT01621802|537160330|FG001|Overall Study|Withdrawal by Subject|4|||
148911842|NCT01621802|537160331|FG002|Overall Study|Withdrawal by Subject|4|||
148911843|NCT01621802|537160332|FG003|Overall Study|Withdrawal by Subject|2|||
148911844|NCT01621802|537160333|FG004|Overall Study|Withdrawal by Subject|2|||
148911845|NCT01621802|537160334|FG005|Overall Study|Withdrawal by Subject|0|||
148911846|NCT01621802|537160329|FG000|Overall Study|Migrated/moved from study area|0|||
148911847|NCT01621802|537160330|FG001|Overall Study|Migrated/moved from study area|0|||
148911848|NCT01621802|537160331|FG002|Overall Study|Migrated/moved from study area|2|||
148911849|NCT01621802|537160332|FG003|Overall Study|Migrated/moved from study area|0|||
148911850|NCT01621802|537160333|FG004|Overall Study|Migrated/moved from study area|1|||
148911851|NCT01621802|537160334|FG005|Overall Study|Migrated/moved from study area|0|||
148911852|NCT01621802|537160329|FG000|Overall Study|Others|3|||
148911853|NCT01621802|537160330|FG001|Overall Study|Others|3|||
148911854|NCT01621802|537160331|FG002|Overall Study|Others|3|||
148911855|NCT01621802|537160332|FG003|Overall Study|Others|2|||
148911856|NCT01621802|537160333|FG004|Overall Study|Others|1|||
148911857|NCT01621802|537160334|FG005|Overall Study|Others|0|||
148911858|NCT01621802|537160329|FG000|Overall Study|Lost to Follow-up|36|||
148911859|NCT01621802|537160330|FG001|Overall Study|Lost to Follow-up|16|||
148911860|NCT01621802|537160331|FG002|Overall Study|Lost to Follow-up|24|||
148911861|NCT01621802|537160332|FG003|Overall Study|Lost to Follow-up|7|||
148911862|NCT01621802|537160333|FG004|Overall Study|Lost to Follow-up|31|||
148911863|NCT01621802|537160334|FG005|Overall Study|Lost to Follow-up|11|||
148911864|NCT01149148|537160335|FG000|Overall Study|Lost to Follow-up|1|||
148911865|NCT01149148|537160336|FG001|Overall Study|Lost to Follow-up|2|||
148911866|NCT01149148|537160335|FG000|Overall Study|Death|1|||
148911867|NCT01149148|537160336|FG001|Overall Study|Death|0|||
148911868|NCT03436082|537160337|FG000|Overall Study|Did not undergo procedure|1|||
148911869|NCT03436082|537160338|FG001|Overall Study|Did not undergo procedure|0|||
148911870|NCT00950859|537160339|FG000|Overall Study|Adverse Event|3|||
148911871|NCT00950859|537160340|FG001|Overall Study|Adverse Event|3|||
148911872|NCT00950859|537160339|FG000|Overall Study|Insufficient Viral Load Response|12|||
148911873|NCT00950859|537160340|FG001|Overall Study|Insufficient Viral Load Response|3|||
148911874|NCT00950859|537160339|FG000|Overall Study|Protocol Violation|1|||
148911875|NCT00950859|537160340|FG001|Overall Study|Protocol Violation|1|||
149139426|NCT01383096|537991841|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
149139427|NCT01383096|537991842|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
149139428|NCT01383096|537991840|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
148911876|NCT00950859|537160339|FG000|Overall Study|Lost to Follow-up|0|||
148911877|NCT00950859|537160340|FG001|Overall Study|Lost to Follow-up|3|||
148911878|NCT04896086|537160341|FG000|Overall Study|Lost to Follow-up|0|||
149139429|NCT01383096|537991841|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
148911879|NCT04896086|537160342|FG001|Overall Study|Lost to Follow-up|2|||
148911880|NCT04896086|537160343|FG002|Overall Study|Lost to Follow-up|1|||
148911881|NCT04896086|537160344|FG003|Overall Study|Lost to Follow-up|0|||
148911882|NCT04896086|537160345|FG004|Overall Study|Lost to Follow-up|0|||
148911883|NCT04896086|537160341|FG000|Overall Study|Physician Decision|0|||
148911884|NCT04896086|537160342|FG001|Overall Study|Physician Decision|1|||
148911885|NCT04896086|537160343|FG002|Overall Study|Physician Decision|0|||
148911886|NCT04896086|537160344|FG003|Overall Study|Physician Decision|0|||
148911887|NCT04896086|537160345|FG004|Overall Study|Physician Decision|0|||
148911888|NCT04896086|537160341|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
148911889|NCT04896086|537160342|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
148911890|NCT04896086|537160343|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
148911891|NCT04896086|537160344|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
148911892|NCT04896086|537160345|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
148911893|NCT04896086|537160341|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
148911894|NCT04896086|537160342|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
148911895|NCT04896086|537160343|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
148911896|NCT04896086|537160344|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
148911897|NCT04896086|537160345|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
148911898|NCT02249832|537160348|FG000|Overall Study|Withdrawal by Subject|3|||
148911899|NCT02249832|537160348|FG000|Overall Study|Lost to Follow-up|10|||
148911900|NCT00545272|537160352|FG000|Overall Study|Protocol deviation|0|||
148911901|NCT00545272|537160353|FG001|Overall Study|Protocol deviation|1|||
148911902|NCT00545272|537160354|FG002|Overall Study|Protocol deviation|0|||
148911903|NCT00545272|537160355|FG003|Overall Study|Protocol deviation|1|||
148911904|NCT00545272|537160356|FG004|Overall Study|Protocol deviation|0|||
148911905|NCT00545272|537160357|FG005|Overall Study|Protocol deviation|1|||
148911906|NCT00545272|537160352|FG000|Overall Study|Adverse Event|0|||
148911907|NCT00545272|537160353|FG001|Overall Study|Adverse Event|0|||
148911908|NCT00545272|537160354|FG002|Overall Study|Adverse Event|1|||
148911909|NCT00545272|537160355|FG003|Overall Study|Adverse Event|0|||
148911910|NCT00545272|537160356|FG004|Overall Study|Adverse Event|0|||
148911911|NCT00545272|537160357|FG005|Overall Study|Adverse Event|1|||
148911912|NCT00545272|537160352|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148911913|NCT00545272|537160353|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148911914|NCT00545272|537160354|FG002|Overall Study|Abnormal laboratory value(s)|0|||
148911915|NCT00545272|537160355|FG003|Overall Study|Abnormal laboratory value(s)|0|||
148911916|NCT00545272|537160356|FG004|Overall Study|Abnormal laboratory value(s)|0|||
148911917|NCT00545272|537160357|FG005|Overall Study|Abnormal laboratory value(s)|1|||
148911918|NCT00545272|537160352|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148911919|NCT00545272|537160353|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148911920|NCT00545272|537160354|FG002|Overall Study|Abnormal test procedure result(s)|0|||
148911921|NCT00545272|537160355|FG003|Overall Study|Abnormal test procedure result(s)|0|||
148911922|NCT00545272|537160356|FG004|Overall Study|Abnormal test procedure result(s)|1|||
148911923|NCT00545272|537160357|FG005|Overall Study|Abnormal test procedure result(s)|0|||
148911924|NCT00545272|537160352|FG000|Overall Study|Lost to Follow-up|0|||
148911925|NCT00545272|537160353|FG001|Overall Study|Lost to Follow-up|0|||
148911926|NCT00545272|537160354|FG002|Overall Study|Lost to Follow-up|0|||
148911927|NCT00545272|537160355|FG003|Overall Study|Lost to Follow-up|0|||
148911928|NCT00545272|537160356|FG004|Overall Study|Lost to Follow-up|1|||
148911929|NCT00545272|537160357|FG005|Overall Study|Lost to Follow-up|0|||
148911930|NCT00724867|537160358|FG000|Overall Study|Adverse Event|25|||
148911931|NCT00724867|537160358|FG000|Overall Study|Lack of Efficacy|14|||
148911932|NCT00724867|537160358|FG000|Overall Study|Lost to Follow-up|12|||
148911933|NCT00724867|537160358|FG000|Overall Study|Non-compliance with study drug|6|||
148911934|NCT00724867|537160358|FG000|Overall Study|Physician Decision|17|||
148911935|NCT00724867|537160358|FG000|Overall Study|Protocol Violation|1|||
148911936|NCT00724867|537160358|FG000|Overall Study|Withdrawal by Subject|31|||
148911937|NCT00724867|537160358|FG000|Overall Study|Sponsor decision to end study|14|||
148911938|NCT00724867|537160358|FG000|Overall Study|Subject incarcerated|1|||
148911939|NCT00724867|537160358|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
148911940|NCT00724867|537160358|FG000|Overall Study|Subject moved out of state|1|||
148911941|NCT00724867|537160358|FG000|Overall Study|Elected to exit due to site closure|2|||
148911942|NCT00436345|537160359|FG000|Overall Study|ICU resident beyond follow-up period|3|||
148911943|NCT00436345|537160360|FG001|Overall Study|ICU resident beyond follow-up period|0|||
148911944|NCT01175083|537160361|FG000|Primary Epoch|Withdrawal by Subject|0|||
148911945|NCT01175083|537160362|FG001|Primary Epoch|Withdrawal by Subject|0|||
148911946|NCT01175083|537160363|FG002|Primary Epoch|Withdrawal by Subject|0|||
148911947|NCT01175083|537160364|FG003|Primary Epoch|Withdrawal by Subject|0|||
148911948|NCT01175083|537160365|FG004|Primary Epoch|Withdrawal by Subject|0|||
148911949|NCT01175083|537160366|FG005|Primary Epoch|Withdrawal by Subject|2|||
148911950|NCT01175083|537160361|FG000|Primary Epoch|Lost to Follow-up|0|||
148911951|NCT01175083|537160362|FG001|Primary Epoch|Lost to Follow-up|0|||
148911952|NCT01175083|537160363|FG002|Primary Epoch|Lost to Follow-up|0|||
148911953|NCT01175083|537160364|FG003|Primary Epoch|Lost to Follow-up|0|||
148911954|NCT01175083|537160365|FG004|Primary Epoch|Lost to Follow-up|0|||
148911955|NCT01175083|537160366|FG005|Primary Epoch|Lost to Follow-up|1|||
148911956|NCT01175083|537160361|FG000|Booster Epoch|Death|0|||
148911957|NCT01175083|537160362|FG001|Booster Epoch|Death|0|||
148911958|NCT01175083|537160363|FG002|Booster Epoch|Death|1|||
148911959|NCT01175083|537160364|FG003|Booster Epoch|Death|0|||
148911960|NCT01175083|537160365|FG004|Booster Epoch|Death|0|||
149139430|NCT01383096|537991842|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
148804328|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
148804329|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
148804330|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
148804331|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
148804332|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
148804333|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
148804334|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
148804335|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
148804336|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
148804337|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
148804338|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
148804339|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
148804340|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
148804341|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
148804342|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
148804343|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
148804344|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
148804345|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
148804346|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
148804347|NCT01668797|536765082|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
148804348|NCT01668797|536765083|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
148911961|NCT01175083|537160366|FG005|Booster Epoch|Death|0|||
148911962|NCT01175083|537160361|FG000|Booster Epoch|Withdrawal by Subject|0|||
148911963|NCT01175083|537160362|FG001|Booster Epoch|Withdrawal by Subject|0|||
148911964|NCT01175083|537160363|FG002|Booster Epoch|Withdrawal by Subject|0|||
148911965|NCT01175083|537160364|FG003|Booster Epoch|Withdrawal by Subject|1|||
148911966|NCT01175083|537160365|FG004|Booster Epoch|Withdrawal by Subject|0|||
148804349|NCT01668797|536765084|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
148911967|NCT01175083|537160366|FG005|Booster Epoch|Withdrawal by Subject|0|||
148911968|NCT01296672|537160367|FG000|Overall Study|Lost to Follow-up|73|||
148911969|NCT01296672|537160368|FG001|Overall Study|Lost to Follow-up|18|||
148911970|NCT01716052|537160369|FG000|Overall Study|Withdrawal of funding|1|||
148804350|NCT01668797|536765085|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
148804351|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
148804352|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
148804353|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
148804354|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
148804355|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
148804356|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
148804357|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
148804358|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
148804359|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
148804360|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
148804361|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
148804362|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
148804363|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
148804364|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
148804365|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
148804366|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
148911971|NCT01716052|537160370|FG001|Overall Study|Withdrawal of funding|1|||
148911972|NCT04027608|537160371|FG000|Overall Study|Withdrawal by Subject|13|||
148911973|NCT04027608|537160372|FG001|Overall Study|Withdrawal by Subject|2|||
148911974|NCT04027608|537160371|FG000|Overall Study|Protocol Violation|2|||
148911975|NCT04027608|537160372|FG001|Overall Study|Protocol Violation|1|||
148911976|NCT04027608|537160371|FG000|Overall Study|Physician Decision|1|||
148911977|NCT04027608|537160372|FG001|Overall Study|Physician Decision|0|||
148911978|NCT04027608|537160371|FG000|Overall Study|Lost to Follow-up|20|||
148911979|NCT04027608|537160372|FG001|Overall Study|Lost to Follow-up|4|||
148911980|NCT04248491|537160374|FG000|Overall Study|Lost to Follow-up|1|||
148911981|NCT04248491|537160375|FG001|Overall Study|Lost to Follow-up|0|||
148911982|NCT01311024|537160378|FG000|Overall Study|Protocol Violation|35|||
148911983|NCT01311024|537160379|FG001|Overall Study|Protocol Violation|22|||
148911984|NCT01652469|537160386|FG000|Overall Study|Withdrawal by Subject|1|||
148911985|NCT01652469|537160387|FG001|Overall Study|Withdrawal by Subject|4|||
148911986|NCT01652469|537160386|FG000|Overall Study|Lost to Follow-up|0|||
148911987|NCT01652469|537160387|FG001|Overall Study|Lost to Follow-up|2|||
148911988|NCT01305577|537160388|FG000|Overall Study|Adverse Event|2|||
148911989|NCT01305577|537160389|FG001|Overall Study|Adverse Event|2|||
148911990|NCT01305577|537160390|FG002|Overall Study|Adverse Event|1|||
148911991|NCT01305577|537160388|FG000|Overall Study|Withdrawal by Subject|7|||
148911992|NCT01305577|537160389|FG001|Overall Study|Withdrawal by Subject|5|||
148911993|NCT01305577|537160390|FG002|Overall Study|Withdrawal by Subject|6|||
148911994|NCT01305577|537160388|FG000|Overall Study|Lost to Follow-up|4|||
148911995|NCT01305577|537160389|FG001|Overall Study|Lost to Follow-up|3|||
148911996|NCT01305577|537160390|FG002|Overall Study|Lost to Follow-up|2|||
148911997|NCT01305577|537160388|FG000|Overall Study|Protocol Deviation|0|||
148911998|NCT01305577|537160389|FG001|Overall Study|Protocol Deviation|1|||
148911999|NCT01305577|537160390|FG002|Overall Study|Protocol Deviation|1|||
148912000|NCT00796978|537160391|FG000|Overall Study|Cardiac adverse event|5|||
148912001|NCT00796978|537160391|FG000|Overall Study|Adverse Event|4|||
148912002|NCT00796978|537160391|FG000|Overall Study|Withdrawal by Subject|3|||
148912003|NCT01092546|537160395|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
148912004|NCT00622440|537160408|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
148912005|NCT00622440|537160409|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
148912006|NCT00622440|537160408|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
148912007|NCT00622440|537160409|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
148912008|NCT00622440|537160408|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
148912009|NCT00622440|537160409|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
148912010|NCT00622440|537160408|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
148912011|NCT00622440|537160409|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
148912012|NCT00771953|537160412|FG000|Overall Study|Adverse Event|5|||
148912013|NCT00771953|537160413|FG001|Overall Study|Adverse Event|3|||
148912014|NCT00771953|537160412|FG000|Overall Study|Death|2|||
148912015|NCT00771953|537160413|FG001|Overall Study|Death|2|||
148912016|NCT00771953|537160412|FG000|Overall Study|Progression before active Tx|1|||
148912017|NCT00771953|537160413|FG001|Overall Study|Progression before active Tx|2|||
148912018|NCT00771953|537160412|FG000|Overall Study|Sponsor decision|1|||
148912019|NCT00771953|537160413|FG001|Overall Study|Sponsor decision|0|||
148912020|NCT00771953|537160412|FG000|Overall Study|Other complicating disease|1|||
148912021|NCT00771953|537160413|FG001|Overall Study|Other complicating disease|0|||
148912022|NCT00771953|537160412|FG000|Overall Study|Withdrawal by Subject|0|||
148912023|NCT00771953|537160413|FG001|Overall Study|Withdrawal by Subject|3|||
148912024|NCT00947193|537160416|FG000|Overall Study|Lost to Follow-up|1|||
148912025|NCT00947193|537160417|FG001|Overall Study|Lost to Follow-up|0|||
148912026|NCT00947193|537160416|FG000|Overall Study|Withdrawal by Subject|1|||
148912027|NCT00947193|537160417|FG001|Overall Study|Withdrawal by Subject|0|||
148912028|NCT00947193|537160416|FG000|Overall Study|Factor VIII >1%|1|||
148912029|NCT00947193|537160417|FG001|Overall Study|Factor VIII >1%|0|||
148912030|NCT04364984|537160418|FG000|Overall Study|Death|2|||
148912031|NCT04364984|537160419|FG001|Overall Study|Death|2|||
148912032|NCT04364984|537160420|FG002|Overall Study|Death|0|||
148912033|NCT02105961|537160421|FG000|Overall Study|Adverse Event|18|||
148912034|NCT02105961|537160422|FG001|Overall Study|Adverse Event|7|||
148912035|NCT02105961|537160423|FG002|Overall Study|Adverse Event|13|||
148912036|NCT02105961|537160421|FG000|Overall Study|Lack of Efficacy|3|||
148912037|NCT02105961|537160422|FG001|Overall Study|Lack of Efficacy|0|||
148912038|NCT02105961|537160423|FG002|Overall Study|Lack of Efficacy|3|||
148912039|NCT02105961|537160421|FG000|Overall Study|Lost to Follow-up|2|||
148912040|NCT02105961|537160422|FG001|Overall Study|Lost to Follow-up|0|||
148912041|NCT02105961|537160423|FG002|Overall Study|Lost to Follow-up|1|||
148912042|NCT02105961|537160421|FG000|Overall Study|Physician Decision|3|||
148912043|NCT02105961|537160422|FG001|Overall Study|Physician Decision|3|||
148912044|NCT02105961|537160423|FG002|Overall Study|Physician Decision|2|||
148912045|NCT02105961|537160421|FG000|Overall Study|Withdrawal by Subject|15|||
148912046|NCT02105961|537160422|FG001|Overall Study|Withdrawal by Subject|7|||
148912047|NCT02105961|537160423|FG002|Overall Study|Withdrawal by Subject|11|||
148912048|NCT04238819|537160424|FG000|Overall Study|Ongoing Treatment|0|||
148912049|NCT04238819|537160425|FG001|Overall Study|Ongoing Treatment|0|||
148912050|NCT04238819|537160426|FG002|Overall Study|Ongoing Treatment|0|||
148912051|NCT04238819|537160427|FG003|Overall Study|Ongoing Treatment|0|||
148912052|NCT04238819|537160428|FG004|Overall Study|Ongoing Treatment|1|||
148912053|NCT04238819|537160429|FG005|Overall Study|Ongoing Treatment|4|||
148912054|NCT04238819|537160430|FG006|Overall Study|Ongoing Treatment|0|||
148912055|NCT04238819|537160424|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
148912056|NCT04238819|537160425|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
148912057|NCT04238819|537160426|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
148912058|NCT04238819|537160427|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
148912059|NCT04238819|537160428|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
148912060|NCT04238819|537160429|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
148912061|NCT04238819|537160430|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
148912062|NCT02529553|537160431|FG000|Overall Study|Progressive Disease|1|||
148912063|NCT02529553|537160432|FG001|Overall Study|Progressive Disease|0|||
148912064|NCT02529553|537160433|FG002|Overall Study|Progressive Disease|1|||
148912065|NCT02529553|537160434|FG003|Overall Study|Progressive Disease|3|||
148912066|NCT02529553|537160435|FG004|Overall Study|Progressive Disease|2|||
148912067|NCT02529553|537160436|FG005|Overall Study|Progressive Disease|3|||
148912068|NCT02529553|537160437|FG006|Overall Study|Progressive Disease|3|||
148912069|NCT02529553|537160438|FG007|Overall Study|Progressive Disease|5|||
148912070|NCT02529553|537160439|FG008|Overall Study|Progressive Disease|3|||
148912071|NCT02529553|537160431|FG000|Overall Study|Physician Decision|0|||
148912072|NCT02529553|537160432|FG001|Overall Study|Physician Decision|1|||
148912073|NCT02529553|537160433|FG002|Overall Study|Physician Decision|0|||
148912074|NCT02529553|537160434|FG003|Overall Study|Physician Decision|0|||
148912075|NCT02529553|537160435|FG004|Overall Study|Physician Decision|1|||
148912076|NCT02529553|537160436|FG005|Overall Study|Physician Decision|0|||
148912077|NCT02529553|537160437|FG006|Overall Study|Physician Decision|0|||
148912078|NCT02529553|537160438|FG007|Overall Study|Physician Decision|0|||
148912079|NCT02529553|537160439|FG008|Overall Study|Physician Decision|0|||
148912080|NCT02529553|537160431|FG000|Overall Study|Withdrawal by Subject|0|||
148912081|NCT02529553|537160432|FG001|Overall Study|Withdrawal by Subject|0|||
148912082|NCT02529553|537160433|FG002|Overall Study|Withdrawal by Subject|0|||
148912083|NCT02529553|537160434|FG003|Overall Study|Withdrawal by Subject|0|||
148912084|NCT02529553|537160435|FG004|Overall Study|Withdrawal by Subject|0|||
148912085|NCT02529553|537160436|FG005|Overall Study|Withdrawal by Subject|1|||
148912086|NCT02529553|537160437|FG006|Overall Study|Withdrawal by Subject|0|||
148912087|NCT02529553|537160438|FG007|Overall Study|Withdrawal by Subject|1|||
148912088|NCT02529553|537160439|FG008|Overall Study|Withdrawal by Subject|0|||
148912089|NCT02355184|537160444|FG000|Overall Study|Lost to Follow-up|2|||
148912090|NCT02355184|537160444|FG000|Overall Study|Study Terminated|10|||
148912091|NCT04549545|537162075|FG000|Initial Period|Withdrawal by Subject|4|||
148912092|NCT04549545|537162076|FG001|Initial Period|Withdrawal by Subject|0|||
148912093|NCT04549545|537162075|FG000|Initial Period|Additional ENT Procedure|3|||
148912094|NCT04549545|537162076|FG001|Initial Period|Additional ENT Procedure|0|||
148912095|NCT04549545|537162075|FG000|Initial Period|Lost to Follow-up|3|||
148912096|NCT04549545|537162076|FG001|Initial Period|Lost to Follow-up|1|||
148912097|NCT04549545|537162075|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
148912098|NCT04549545|537162076|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
148912099|NCT04549545|537162075|FG000|Crossover Period|Additional ENT Procedure|0|||
148912100|NCT04549545|537162076|FG001|Crossover Period|Additional ENT Procedure|6|||
148912101|NCT04549545|537162075|FG000|Crossover Period|Lost to Follow-up|0|||
148912102|NCT04549545|537162076|FG001|Crossover Period|Lost to Follow-up|1|||
148912103|NCT04549545|537162075|FG000|Crossover Period|Withdrawal by Subject|0|||
148912104|NCT04549545|537162076|FG001|Crossover Period|Withdrawal by Subject|4|||
148912105|NCT01395524|537162081|FG000|Overall Study|Non-compliance with study schedule|1|||
148912106|NCT01395524|537162082|FG001|Overall Study|Non-compliance with study schedule|0|||
149139431|NCT01383096|537991840|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
149139432|NCT01383096|537991841|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
149139433|NCT01383096|537991842|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
149139434|NCT01509079|537991845|FG000|Overall Study|Lack of Efficacy|0|||
149139435|NCT01509079|537991846|FG001|Overall Study|Lack of Efficacy|2|||
149139436|NCT01509079|537991845|FG000|Overall Study|started an excluded medication|0|||
149139437|NCT01509079|537991846|FG001|Overall Study|started an excluded medication|1|||
149139438|NCT01338415|537991847|FG000|Core + Extension|Adverse Event|8|||
149139439|NCT01338415|537991848|FG001|Core + Extension|Adverse Event|6|||
149139440|NCT01338415|537991849|FG002|Core + Extension|Adverse Event|0|||
148804367|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
149139441|NCT01338415|537991847|FG000|Core + Extension|Withdrawal by Subject|1|||
149139442|NCT01338415|537991848|FG001|Core + Extension|Withdrawal by Subject|1|||
149139443|NCT01338415|537991849|FG002|Core + Extension|Withdrawal by Subject|0|||
149139444|NCT01338415|537991847|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
149139445|NCT01338415|537991848|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
149139446|NCT01338415|537991849|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
149139447|NCT01338415|537991847|FG000|Core + Extension|Other (administrative reason)|1|||
149139448|NCT01338415|537991848|FG001|Core + Extension|Other (administrative reason)|0|||
149139449|NCT01338415|537991849|FG002|Core + Extension|Other (administrative reason)|0|||
149139450|NCT01338415|537991847|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
149139451|NCT01338415|537991848|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
149139452|NCT01338415|537991849|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
149139453|NCT01338415|537991847|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
149139454|NCT01338415|537991848|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
149139455|NCT01338415|537991849|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
149139456|NCT01338415|537991847|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
149139457|NCT01338415|537991848|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
149139458|NCT01338415|537991849|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
149139459|NCT01338415|537991847|FG000|Exceptional Use Treatment Period|Death|0|||
149139460|NCT01338415|537991848|FG001|Exceptional Use Treatment Period|Death|0|||
149139461|NCT01338415|537991849|FG002|Exceptional Use Treatment Period|Death|1|||
149139462|NCT00233363|537991852|FG000|Overall Study|Adverse Event|1|||
149139463|NCT00233363|537991853|FG001|Overall Study|Adverse Event|2|||
149139464|NCT00233363|537991852|FG000|Overall Study|Lack of Efficacy|0|||
149139465|NCT00233363|537991853|FG001|Overall Study|Lack of Efficacy|2|||
149139466|NCT00233363|537991852|FG000|Overall Study|Withdrawal by Subject|1|||
149139467|NCT00233363|537991853|FG001|Overall Study|Withdrawal by Subject|1|||
149139468|NCT00233363|537991852|FG000|Overall Study|Aggravation of complication|1|||
149139469|NCT00233363|537991853|FG001|Overall Study|Aggravation of complication|0|||
149139470|NCT00874770|537991854|FG000|Overall Study|Lack of Efficacy|2|||
149139471|NCT00874770|537991855|FG001|Overall Study|Lack of Efficacy|0|||
149139472|NCT00874770|537991856|FG002|Overall Study|Lack of Efficacy|0|||
149139473|NCT00874770|537991857|FG003|Overall Study|Lack of Efficacy|2|||
149139474|NCT00874770|537991854|FG000|Overall Study|Adverse Event|1|||
149139475|NCT00874770|537991855|FG001|Overall Study|Adverse Event|1|||
149139476|NCT00874770|537991856|FG002|Overall Study|Adverse Event|4|||
149139477|NCT00874770|537991857|FG003|Overall Study|Adverse Event|2|||
149139478|NCT00874770|537991854|FG000|Overall Study|Lost to Follow-up|1|||
149139479|NCT00874770|537991855|FG001|Overall Study|Lost to Follow-up|0|||
149139480|NCT00874770|537991856|FG002|Overall Study|Lost to Follow-up|0|||
149139481|NCT00874770|537991857|FG003|Overall Study|Lost to Follow-up|1|||
149139482|NCT00874770|537991854|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
149139483|NCT00874770|537991855|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
149139484|NCT00874770|537991856|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
149139485|NCT00874770|537991857|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
149139486|NCT04880447|537991858|FG000|Overall Study|No vaccination information|1|||
149139487|NCT04880447|537991858|FG000|Overall Study|No adverse event information (missing information)|1|||
149139488|NCT04880447|537991858|FG000|Overall Study|Disease not covered in this study|35|||
148804368|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
148804369|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
148912107|NCT01395524|537162083|FG002|Overall Study|Non-compliance with study schedule|1|||
148804370|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
148912108|NCT01395524|537162081|FG000|Overall Study|Lost to Follow-up|3|||
149139489|NCT00718549|537991859|FG000|Induction Phase|Disease Progression|1|||
149139490|NCT00718549|537991860|FG001|Induction Phase|Disease Progression|0|||
149139491|NCT00718549|537991861|FG002|Induction Phase|Disease Progression|0|||
149139492|NCT00718549|537991859|FG000|Induction Phase|Eligibility Criteria Violation|2|||
149139493|NCT00718549|537991860|FG001|Induction Phase|Eligibility Criteria Violation|0|||
148804371|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
148804372|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
148804373|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
148912109|NCT01395524|537162082|FG001|Overall Study|Lost to Follow-up|1|||
148912110|NCT01395524|537162083|FG002|Overall Study|Lost to Follow-up|1|||
148912111|NCT01395524|537162081|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
149139494|NCT00718549|537991861|FG002|Induction Phase|Eligibility Criteria Violation|0|||
149139495|NCT00718549|537991859|FG000|Induction Phase|Early Termination - No Additional Info|59|||
149139496|NCT00718549|537991860|FG001|Induction Phase|Early Termination - No Additional Info|0|||
149139497|NCT00718549|537991861|FG002|Induction Phase|Early Termination - No Additional Info|0|||
149139498|NCT00718549|537991859|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
149139499|NCT00718549|537991860|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
149139500|NCT00718549|537991861|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
149139501|NCT00718549|537991859|FG000|Maintenance/ Observation Phase|Death|0|||
149139502|NCT00718549|537991860|FG001|Maintenance/ Observation Phase|Death|1|||
149139503|NCT00718549|537991861|FG002|Maintenance/ Observation Phase|Death|2|||
149139504|NCT00718549|537991859|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
149139505|NCT00718549|537991860|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
149139506|NCT00718549|537991861|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
149139507|NCT00718549|537991859|FG000|Maintenance/ Observation Phase|Progression|0|||
149139508|NCT00718549|537991860|FG001|Maintenance/ Observation Phase|Progression|5|||
148912112|NCT01395524|537162082|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
148912113|NCT01395524|537162083|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
148912114|NCT01395524|537162081|FG000|Overall Study|Severe noncompliance with protocol|1|||
148912115|NCT01395524|537162082|FG001|Overall Study|Severe noncompliance with protocol|0|||
148912116|NCT01395524|537162083|FG002|Overall Study|Severe noncompliance with protocol|0|||
148912117|NCT01395524|537162081|FG000|Overall Study|Adverse Event|4|||
149139509|NCT00718549|537991861|FG002|Maintenance/ Observation Phase|Progression|14|||
149139510|NCT00718549|537991859|FG000|Maintenance/ Observation Phase|Relapse|0|||
149139511|NCT00718549|537991860|FG001|Maintenance/ Observation Phase|Relapse|3|||
148912118|NCT01395524|537162082|FG001|Overall Study|Adverse Event|4|||
148912119|NCT01395524|537162083|FG002|Overall Study|Adverse Event|3|||
148912120|NCT01395524|537162081|FG000|Overall Study|Death|1|||
148912121|NCT01395524|537162082|FG001|Overall Study|Death|0|||
148912122|NCT01395524|537162083|FG002|Overall Study|Death|0|||
148912123|NCT01395524|537162081|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
148912124|NCT01395524|537162082|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
148912125|NCT01395524|537162083|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
148912126|NCT01395524|537162081|FG000|Overall Study|Withdrawal by Subject|4|||
148912127|NCT01395524|537162082|FG001|Overall Study|Withdrawal by Subject|8|||
148912128|NCT01395524|537162083|FG002|Overall Study|Withdrawal by Subject|8|||
148912129|NCT01395524|537162081|FG000|Overall Study|Did not receive treatment|1|||
148912130|NCT01395524|537162082|FG001|Overall Study|Did not receive treatment|1|||
148912131|NCT01395524|537162083|FG002|Overall Study|Did not receive treatment|3|||
148912132|NCT01395524|537162081|FG000|Overall Study|Subject had spinal surgery|0|||
148912133|NCT01395524|537162082|FG001|Overall Study|Subject had spinal surgery|0|||
148912134|NCT01395524|537162083|FG002|Overall Study|Subject had spinal surgery|1|||
148912135|NCT01657461|537162084|FG000|Overall Study|Death|9|||
148912136|NCT01657461|537162085|FG001|Overall Study|Death|12|||
148912137|NCT01657461|537162084|FG000|Overall Study|Lost to Follow-up|0|||
148912138|NCT01657461|537162085|FG001|Overall Study|Lost to Follow-up|3|||
148912139|NCT01657461|537162084|FG000|Overall Study|Physician Decision|0|||
148912140|NCT01657461|537162085|FG001|Overall Study|Physician Decision|2|||
148912141|NCT01657461|537162084|FG000|Overall Study|Withdrawal by Subject|1|||
148912142|NCT01657461|537162085|FG001|Overall Study|Withdrawal by Subject|3|||
148912143|NCT01868542|537162086|FG000|Overall Study|Protocol Violation|0|||
148912144|NCT01868542|537162087|FG001|Overall Study|Protocol Violation|1|||
148912145|NCT01868542|537162086|FG000|Overall Study|Unclassified|0|||
148912146|NCT01868542|537162087|FG001|Overall Study|Unclassified|1|||
148912147|NCT00130247|537162088|FG000|Overall Study|Pregnancy|1|||
148912148|NCT00130247|537162089|FG001|Overall Study|Pregnancy|0|||
148912149|NCT00130247|537162088|FG000|Overall Study|Post-randomization exclusion|1|||
148912150|NCT00130247|537162089|FG001|Overall Study|Post-randomization exclusion|2|||
148912151|NCT00130247|537162088|FG000|Overall Study|Not compliant with DOT|0|||
148912152|NCT00130247|537162089|FG001|Overall Study|Not compliant with DOT|2|||
148912153|NCT00843284|537162094|FG000|Overall Study|Adverse Event|39|||
148912154|NCT00843284|537162094|FG000|Overall Study|Lack of Efficacy|5|||
148912155|NCT00843284|537162094|FG000|Overall Study|Lost to Follow-up|11|||
148912156|NCT00843284|537162094|FG000|Overall Study|Other|10|||
148912157|NCT00843284|537162094|FG000|Overall Study|Withdrawal by Subject|4|||
148912158|NCT00843284|537162094|FG000|Overall Study|Death|3|||
148912159|NCT00122980|537162095|FG000|Overall Study|Death|0|||
148912160|NCT00122980|537162096|FG001|Overall Study|Death|1|||
148912161|NCT00122980|537162095|FG000|Overall Study|Physician Decision|2|||
148912162|NCT00122980|537162096|FG001|Overall Study|Physician Decision|0|||
148912163|NCT00122980|537162095|FG000|Overall Study|Protocol Violation|5|||
148912164|NCT00122980|537162096|FG001|Overall Study|Protocol Violation|1|||
148912165|NCT00122980|537162095|FG000|Overall Study|Withdrawal by Subject|2|||
148912166|NCT00122980|537162096|FG001|Overall Study|Withdrawal by Subject|3|||
148912167|NCT00122980|537162095|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
148912168|NCT00122980|537162096|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
148912169|NCT00122980|537162095|FG000|Overall Study|Study termination|27|||
148912170|NCT00122980|537162096|FG001|Overall Study|Study termination|35|||
148912171|NCT01124864|537162099|FG000|Overall Study|Follow up phase competed as per protocol|18|||
148912172|NCT01124864|537162100|FG001|Overall Study|Follow up phase competed as per protocol|22|||
148912173|NCT01124864|537162101|FG002|Overall Study|Follow up phase competed as per protocol|24|||
148912174|NCT01124864|537162102|FG003|Overall Study|Follow up phase competed as per protocol|18|||
148912175|NCT01124864|537162103|FG004|Overall Study|Follow up phase competed as per protocol|26|||
148912176|NCT01124864|537162104|FG005|Overall Study|Follow up phase competed as per protocol|2|||
148912177|NCT01124864|537162099|FG000|Overall Study|Death|6|||
148912178|NCT01124864|537162100|FG001|Overall Study|Death|9|||
148912179|NCT01124864|537162101|FG002|Overall Study|Death|6|||
148912180|NCT01124864|537162102|FG003|Overall Study|Death|2|||
148912181|NCT01124864|537162103|FG004|Overall Study|Death|1|||
148912182|NCT01124864|537162104|FG005|Overall Study|Death|0|||
148912183|NCT01124864|537162099|FG000|Overall Study|Withdrawal by Subject|2|||
148912184|NCT01124864|537162100|FG001|Overall Study|Withdrawal by Subject|3|||
148912185|NCT01124864|537162101|FG002|Overall Study|Withdrawal by Subject|4|||
148912186|NCT01124864|537162102|FG003|Overall Study|Withdrawal by Subject|0|||
148912187|NCT01124864|537162103|FG004|Overall Study|Withdrawal by Subject|2|||
148912188|NCT01124864|537162104|FG005|Overall Study|Withdrawal by Subject|1|||
148912189|NCT01124864|537162099|FG000|Overall Study|Lost to Follow-up|1|||
148912190|NCT01124864|537162100|FG001|Overall Study|Lost to Follow-up|1|||
148912191|NCT01124864|537162101|FG002|Overall Study|Lost to Follow-up|0|||
148912192|NCT01124864|537162102|FG003|Overall Study|Lost to Follow-up|1|||
148912193|NCT01124864|537162103|FG004|Overall Study|Lost to Follow-up|0|||
148912194|NCT01124864|537162104|FG005|Overall Study|Lost to Follow-up|0|||
148912195|NCT01124864|537162099|FG000|Overall Study|Protocol Violation|1|||
148912196|NCT01124864|537162100|FG001|Overall Study|Protocol Violation|0|||
148912197|NCT01124864|537162101|FG002|Overall Study|Protocol Violation|0|||
148912198|NCT01124864|537162102|FG003|Overall Study|Protocol Violation|0|||
148912199|NCT01124864|537162103|FG004|Overall Study|Protocol Violation|1|||
148912200|NCT01124864|537162104|FG005|Overall Study|Protocol Violation|0|||
148912201|NCT02834793|537162107|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
148912202|NCT02834793|537162108|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
148912203|NCT02834793|537162109|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
148912204|NCT02834793|537162110|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
148912205|NCT02834793|537162107|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
148912206|NCT02834793|537162108|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
148912207|NCT02834793|537162109|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
148912208|NCT02834793|537162110|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
148912209|NCT02834793|537162107|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
148912210|NCT02834793|537162108|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
148912211|NCT02834793|537162109|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
148912212|NCT02834793|537162110|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
148912213|NCT02834793|537162107|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
148912214|NCT02834793|537162108|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
148912215|NCT02834793|537162109|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
148912216|NCT02834793|537162110|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
148912217|NCT02834793|537162107|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
148912218|NCT02834793|537162108|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
148912219|NCT02834793|537162109|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
148912220|NCT02834793|537162110|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
148912221|NCT02834793|537162107|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
148912222|NCT02834793|537162108|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
148912223|NCT02834793|537162109|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
148912224|NCT02834793|537162110|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
148912225|NCT02834793|537162107|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
148912226|NCT02834793|537162108|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
148912227|NCT02834793|537162109|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
148912228|NCT02834793|537162110|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
148912229|NCT02834793|537162107|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
148912230|NCT02834793|537162108|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
148912231|NCT02834793|537162109|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
148912232|NCT02834793|537162110|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
148912233|NCT02834793|537162107|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
148912234|NCT02834793|537162108|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
148912235|NCT02834793|537162109|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
148912236|NCT02834793|537162110|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
148912237|NCT02834793|537162107|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
148912238|NCT02834793|537162108|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
148912239|NCT02834793|537162109|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
148912240|NCT02834793|537162110|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
148912241|NCT02834793|537162107|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
148912242|NCT02834793|537162108|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
148912243|NCT02834793|537162109|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
148912244|NCT02834793|537162110|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
148912245|NCT02834793|537162107|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
148912246|NCT02834793|537162108|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
148912247|NCT02834793|537162109|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
148912248|NCT02834793|537162110|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
148912249|NCT02834793|537162107|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
148912250|NCT02834793|537162108|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
148912251|NCT02834793|537162109|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
148912252|NCT02834793|537162110|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
148804374|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
148804375|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
148804376|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
148804377|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
148804378|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
148804379|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
148804380|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
148804381|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
148804382|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
148804383|NCT01668797|536765082|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
148804384|NCT01668797|536765083|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
148912253|NCT02834793|537162107|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
149139512|NCT00718549|537991861|FG002|Maintenance/ Observation Phase|Relapse|2|||
149139513|NCT01576172|537991862|FG000|Overall Study|Ineligible|2|||
149139514|NCT01576172|537991863|FG001|Overall Study|Ineligible|1|||
149139515|NCT01576172|537991862|FG000|Overall Study|Withdrawal by Subject|2|||
149139516|NCT01576172|537991863|FG001|Overall Study|Withdrawal by Subject|0|||
149139517|NCT01576172|537991862|FG000|Overall Study|Insurance issue|1|||
149139518|NCT01576172|537991863|FG001|Overall Study|Insurance issue|0|||
149139519|NCT02613884|537991865|FG000|Overall Study|Death|1|||
149139520|NCT02613884|537991865|FG000|Overall Study|Lost to Follow-up|1|||
149139521|NCT00433914|537991866|FG000|Overall Study|Withdrawal by Subject|0|||
149139522|NCT00433914|537991867|FG001|Overall Study|Withdrawal by Subject|2|||
149139523|NCT00433914|537991866|FG000|Overall Study|Lost to Follow-up|0|||
149139524|NCT00433914|537991867|FG001|Overall Study|Lost to Follow-up|1|||
149139525|NCT02844920|537991868|FG000|Overall Study|Lost to Follow-up|2|||
149139526|NCT04534491|537991869|FG000|Overall Study|Not completed end-of-study interview|24|||
149139527|NCT04534491|537991869|FG000|Overall Study|Non-users|70|||
149139528|NCT04534491|537991869|FG000|Overall Study|Non-verifiable users|58|||
149139529|NCT00766090|537991872|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139530|NCT00766090|537991873|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139531|NCT00766090|537991874|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139532|NCT00766090|537991875|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139533|NCT00766090|537991876|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139534|NCT00766090|537991877|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139535|NCT00766090|537991878|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139536|NCT00766090|537991879|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139537|NCT00766090|537991880|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
149139538|NCT00766090|537991881|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139539|NCT00766090|537991882|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139540|NCT00766090|537991883|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149139541|NCT00766090|537991872|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
149139542|NCT00766090|537991873|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139543|NCT00766090|537991874|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139544|NCT00766090|537991875|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139545|NCT00766090|537991876|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139546|NCT00766090|537991877|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139547|NCT00766090|537991878|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139548|NCT00766090|537991879|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139549|NCT00766090|537991880|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139550|NCT00766090|537991881|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139551|NCT00766090|537991882|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139552|NCT00766090|537991883|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
149139553|NCT00766090|537991872|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
149139554|NCT00766090|537991873|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139555|NCT00766090|537991874|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139556|NCT00766090|537991875|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
149139557|NCT00766090|537991876|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
148669507|NCT00643006|536261921|FG000|Overall Study|Lost to Follow-up|5|||
148669508|NCT00643006|536261922|FG001|Overall Study|Lost to Follow-up|4|||
148669509|NCT03772574|536261923|FG000|Overall Study|Protocol Violation|2|||
148669510|NCT03772574|536261924|FG001|Overall Study|Protocol Violation|0|||
148669511|NCT03772574|536261925|FG002|Overall Study|Protocol Violation|0|||
148669512|NCT03772574|536261923|FG000|Overall Study|Discomfort|0|||
148669513|NCT03772574|536261924|FG001|Overall Study|Discomfort|5|||
148669514|NCT03772574|536261925|FG002|Overall Study|Discomfort|4|||
148669515|NCT03586427|536261931|FG000|Overall Study|Lost to Follow-up|0|||
148669516|NCT03586427|536261932|FG001|Overall Study|Lost to Follow-up|3|||
148669517|NCT03586427|536261933|FG002|Overall Study|Lost to Follow-up|1|||
148669518|NCT03586427|536261934|FG003|Overall Study|Lost to Follow-up|3|||
148669519|NCT03586427|536261935|FG004|Overall Study|Lost to Follow-up|3|||
148669520|NCT03586427|536261931|FG000|Overall Study|Withdrawal by Subject|0|||
148669521|NCT03586427|536261932|FG001|Overall Study|Withdrawal by Subject|1|||
148669522|NCT03586427|536261933|FG002|Overall Study|Withdrawal by Subject|2|||
148669523|NCT03586427|536261934|FG003|Overall Study|Withdrawal by Subject|1|||
148669524|NCT03586427|536261935|FG004|Overall Study|Withdrawal by Subject|1|||
148669525|NCT03586427|536261931|FG000|Overall Study|Adverse Event|0|||
148669526|NCT03586427|536261932|FG001|Overall Study|Adverse Event|0|||
148669527|NCT03586427|536261933|FG002|Overall Study|Adverse Event|1|||
148669528|NCT03586427|536261934|FG003|Overall Study|Adverse Event|0|||
148669529|NCT03586427|536261935|FG004|Overall Study|Adverse Event|0|||
148669530|NCT03586427|536261931|FG000|Overall Study|Protocol Violation|0|||
148669531|NCT03586427|536261932|FG001|Overall Study|Protocol Violation|0|||
149139558|NCT00766090|537991877|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
148669532|NCT03586427|536261933|FG002|Overall Study|Protocol Violation|1|||
148669533|NCT03586427|536261934|FG003|Overall Study|Protocol Violation|0|||
148669534|NCT03586427|536261935|FG004|Overall Study|Protocol Violation|1|||
149139559|NCT00766090|537991878|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139560|NCT00766090|537991879|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139561|NCT00766090|537991880|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139562|NCT00766090|537991881|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139563|NCT00766090|537991882|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139564|NCT00766090|537991883|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149139565|NCT00766090|537991872|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139566|NCT00766090|537991873|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139567|NCT00766090|537991874|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
149139568|NCT00766090|537991875|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139569|NCT00766090|537991876|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139570|NCT00766090|537991877|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139571|NCT00766090|537991878|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139572|NCT00766090|537991879|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139573|NCT00766090|537991880|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139574|NCT00766090|537991881|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139575|NCT00766090|537991882|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139576|NCT00766090|537991883|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
149139577|NCT00766090|537991872|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149139578|NCT00766090|537991873|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148669535|NCT03586427|536261931|FG000|Overall Study|Noncompliance with study drug|0|||
148669536|NCT03586427|536261932|FG001|Overall Study|Noncompliance with study drug|0|||
149139579|NCT00766090|537991874|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148669537|NCT03586427|536261933|FG002|Overall Study|Noncompliance with study drug|1|||
148669538|NCT03586427|536261934|FG003|Overall Study|Noncompliance with study drug|0|||
148669539|NCT03586427|536261935|FG004|Overall Study|Noncompliance with study drug|0|||
148669540|NCT03193996|536261938|FG000|Overall Study|Withdrawal by Subject|4|||
148669541|NCT03193996|536261938|FG000|Overall Study|Lost to Follow-up|4|||
148669542|NCT03193996|536261938|FG000|Overall Study|Physician Decision|2|||
148669543|NCT03193996|536261938|FG000|Overall Study|Pregnancy|1|||
149139580|NCT00766090|537991875|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148669544|NCT03193996|536261938|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
148669545|NCT03193996|536261938|FG000|Overall Study|Complicating disease|1|||
148669546|NCT00593385|536261941|FG000|Overall Study|Death|14|||
148669547|NCT00593385|536261941|FG000|Overall Study|Lost to Follow-up|17|||
148669548|NCT00593385|536261941|FG000|Overall Study|Withdrawal by Subject|9|||
148912254|NCT02834793|537162108|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
148804385|NCT01668797|536765084|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
148804386|NCT01668797|536765085|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
148804387|NCT03482024|536765093|FG000|Overall Study|Physician Decision|1|||
148804388|NCT03482024|536765094|FG001|Overall Study|Physician Decision|0|||
148804389|NCT03482024|536765095|FG002|Overall Study|Physician Decision|0|||
148804390|NCT03482024|536765096|FG003|Overall Study|Physician Decision|0|||
148804391|NCT03482024|536765097|FG004|Overall Study|Physician Decision|0|||
148804392|NCT00676143|536765102|FG000|Overall Study|Adverse Event|34|||
148804393|NCT00676143|536765103|FG001|Overall Study|Adverse Event|60|||
148804394|NCT00676143|536765102|FG000|Overall Study|Death|4|||
149139581|NCT00766090|537991876|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
148804395|NCT00676143|536765103|FG001|Overall Study|Death|4|||
148804396|NCT00676143|536765102|FG000|Overall Study|Lack of Efficacy|0|||
148804397|NCT00676143|536765103|FG001|Overall Study|Lack of Efficacy|6|||
148804398|NCT00676143|536765102|FG000|Overall Study|Lost to Follow-up|0|||
148804399|NCT00676143|536765103|FG001|Overall Study|Lost to Follow-up|13|||
148804400|NCT00676143|536765102|FG000|Overall Study|Physician Decision|5|||
148804401|NCT00676143|536765103|FG001|Overall Study|Physician Decision|8|||
148804402|NCT00676143|536765102|FG000|Overall Study|Protocol Violation|4|||
148804403|NCT00676143|536765103|FG001|Overall Study|Protocol Violation|8|||
148804404|NCT00676143|536765102|FG000|Overall Study|Withdrawal by Subject|24|||
148804405|NCT00676143|536765103|FG001|Overall Study|Withdrawal by Subject|42|||
148804406|NCT00676143|536765102|FG000|Overall Study|Discontinuation of study by sponsor|65|||
148804407|NCT00676143|536765103|FG001|Overall Study|Discontinuation of study by sponsor|88|||
148804408|NCT00676143|536765102|FG000|Overall Study|Failed to return|2|||
148804409|NCT00676143|536765103|FG001|Overall Study|Failed to return|1|||
148804410|NCT00676143|536765102|FG000|Overall Study|Loss of caregiver|5|||
148804411|NCT00676143|536765103|FG001|Overall Study|Loss of caregiver|3|||
148804412|NCT00676143|536765102|FG000|Overall Study|Other|11|||
148804413|NCT00676143|536765103|FG001|Overall Study|Other|20|||
148804414|NCT00676143|536765102|FG000|Overall Study|Participant participation unknown|1|||
148804415|NCT00676143|536765103|FG001|Overall Study|Participant participation unknown|4|||
148804416|NCT00676143|536765102|FG000|Overall Study|Vasogenic edema recurrence|1|||
148804417|NCT00676143|536765103|FG001|Overall Study|Vasogenic edema recurrence|3|||
148804418|NCT03937778|536765104|FG000|Overall Study|Withdrawal by Subject|1|||
148804419|NCT03937778|536765104|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
148804420|NCT02065557|536765107|FG000|Induction Period|Withdrawal by Subject|2|||
148804421|NCT02065557|536765108|FG001|Induction Period|Withdrawal by Subject|1|||
148804422|NCT02065557|536765109|FG002|Induction Period|Withdrawal by Subject|0|||
148804423|NCT02065557|536765110|FG003|Induction Period|Withdrawal by Subject|0|||
148804424|NCT02065557|536765111|FG004|Induction Period|Withdrawal by Subject|0|||
148804425|NCT02065557|536765112|FG005|Induction Period|Withdrawal by Subject|0|||
148804426|NCT02065557|536765107|FG000|Induction Period|Lack of Efficacy|2|||
148804427|NCT02065557|536765108|FG001|Induction Period|Lack of Efficacy|1|||
148804428|NCT02065557|536765109|FG002|Induction Period|Lack of Efficacy|1|||
148804429|NCT02065557|536765110|FG003|Induction Period|Lack of Efficacy|0|||
148804430|NCT02065557|536765111|FG004|Induction Period|Lack of Efficacy|0|||
148804431|NCT02065557|536765112|FG005|Induction Period|Lack of Efficacy|0|||
148804432|NCT02065557|536765107|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
148804433|NCT02065557|536765108|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
148804434|NCT02065557|536765109|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
148804435|NCT02065557|536765110|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
148804436|NCT02065557|536765111|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
148804437|NCT02065557|536765112|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
148804438|NCT02065557|536765107|FG000|Induction Period|Non-Responder at Week 8|4|||
148804439|NCT02065557|536765108|FG001|Induction Period|Non-Responder at Week 8|4|||
148804440|NCT02065557|536765109|FG002|Induction Period|Non-Responder at Week 8|0|||
148912255|NCT02834793|537162109|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
149139582|NCT00766090|537991877|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148912256|NCT02834793|537162110|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
148912257|NCT02834793|537162107|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
148912258|NCT02834793|537162108|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
148912259|NCT02834793|537162109|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
148912260|NCT02834793|537162110|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
148669829|NCT01656850|536263272|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
148669830|NCT01656850|536263273|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
148669831|NCT02074982|536263274|FG000|Overall Study|Adverse Event|15|||
148669832|NCT02074982|536263275|FG001|Overall Study|Adverse Event|7|||
148669833|NCT02074982|536263274|FG000|Overall Study|Lack of Efficacy|6|||
148669834|NCT02074982|536263275|FG001|Overall Study|Lack of Efficacy|1|||
148669835|NCT02074982|536263274|FG000|Overall Study|Lost to Follow-up|9|||
148912261|NCT02364336|537162111|FG000|Overall Study|Adverse Event|0|||
148669836|NCT02074982|536263275|FG001|Overall Study|Lost to Follow-up|10|||
148669837|NCT02074982|536263274|FG000|Overall Study|Non-compliance with study treatment|0|||
148669838|NCT02074982|536263275|FG001|Overall Study|Non-compliance with study treatment|2|||
148804441|NCT02065557|536765110|FG003|Induction Period|Non-Responder at Week 8|0|||
148669839|NCT02074982|536263274|FG000|Overall Study|Physician Decision|1|||
148669840|NCT02074982|536263275|FG001|Overall Study|Physician Decision|1|||
148669841|NCT02074982|536263274|FG000|Overall Study|Pregnancy|1|||
148669842|NCT02074982|536263275|FG001|Overall Study|Pregnancy|2|||
148669843|NCT02074982|536263274|FG000|Overall Study|Protocol deviation|4|||
148669844|NCT02074982|536263275|FG001|Overall Study|Protocol deviation|3|||
148669845|NCT02074982|536263274|FG000|Overall Study|Technical problems|0|||
148669846|NCT02074982|536263275|FG001|Overall Study|Technical problems|2|||
148669847|NCT02074982|536263274|FG000|Overall Study|Subject/guardian decision|15|||
148669848|NCT02074982|536263275|FG001|Overall Study|Subject/guardian decision|24|||
148669849|NCT02074982|536263274|FG000|Overall Study|Death|0|||
148669850|NCT02074982|536263275|FG001|Overall Study|Death|2|||
148669851|NCT01817764|536263278|FG000|Overall Study|Adverse Event|7|||
148669852|NCT01817764|536263279|FG001|Overall Study|Adverse Event|10|||
148669853|NCT01817764|536263278|FG000|Overall Study|Lack of Efficacy|9|||
148669854|NCT01817764|536263279|FG001|Overall Study|Lack of Efficacy|7|||
148669855|NCT01817764|536263278|FG000|Overall Study|Protocol Violation|7|||
148669856|NCT01817764|536263279|FG001|Overall Study|Protocol Violation|5|||
148669857|NCT01817764|536263278|FG000|Overall Study|Lost to Follow-up|1|||
148669858|NCT01817764|536263279|FG001|Overall Study|Lost to Follow-up|4|||
148669859|NCT01817764|536263278|FG000|Overall Study|Withdrawal by Subject|10|||
148669860|NCT01817764|536263279|FG001|Overall Study|Withdrawal by Subject|12|||
148669861|NCT01432600|536263280|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
148669862|NCT01432600|536263281|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
148669863|NCT01432600|536263282|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
148669864|NCT02411110|536263285|FG000|Treatment Period 1|Adverse Event|4|||
148669865|NCT02411110|536263286|FG001|Treatment Period 1|Adverse Event|2|||
148669866|NCT02411110|536263285|FG000|Treatment Period 1|Lost to Follow-up|1|||
148669867|NCT02411110|536263286|FG001|Treatment Period 1|Lost to Follow-up|0|||
148669868|NCT02411110|536263285|FG000|Treatment Period 1|Personal Reasons|2|||
148669869|NCT02411110|536263286|FG001|Treatment Period 1|Personal Reasons|5|||
148669870|NCT02411110|536263285|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
148669871|NCT02411110|536263286|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
148669872|NCT02411110|536263285|FG000|Treatment Period 2|Adverse Event|1|||
148669873|NCT02411110|536263286|FG001|Treatment Period 2|Adverse Event|0|||
148669874|NCT02411110|536263285|FG000|Treatment Period 2|Lost to Follow-up|0|||
148669875|NCT02411110|536263286|FG001|Treatment Period 2|Lost to Follow-up|2|||
148669876|NCT02411110|536263285|FG000|Treatment Period 2|Personal Reasons|0|||
148669877|NCT02411110|536263286|FG001|Treatment Period 2|Personal Reasons|2|||
148669878|NCT02871921|536263290|FG000|Overall Study|Withdrawal by Subject|34|||
148669879|NCT02871921|536263291|FG001|Overall Study|Withdrawal by Subject|27|||
148669880|NCT02871921|536263292|FG002|Overall Study|Withdrawal by Subject|27|||
148669881|NCT02871921|536263293|FG003|Overall Study|Withdrawal by Subject|30|||
148669882|NCT00320801|536263294|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
148669883|NCT00320801|536263295|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
148669884|NCT00320801|536263296|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
148669885|NCT00320801|536263297|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
148669886|NCT00320801|536263294|FG000|Open-label Run-in Period|Adverse Event|33|||
148669887|NCT00320801|536263295|FG001|Open-label Run-in Period|Adverse Event|0|||
148669888|NCT00320801|536263296|FG002|Open-label Run-in Period|Adverse Event|0|||
148669889|NCT00320801|536263297|FG003|Open-label Run-in Period|Adverse Event|0|||
148669890|NCT00320801|536263294|FG000|Open-label Run-in Period|Administrative|10|||
148669891|NCT00320801|536263295|FG001|Open-label Run-in Period|Administrative|0|||
148669892|NCT00320801|536263296|FG002|Open-label Run-in Period|Administrative|0|||
148669893|NCT00320801|536263297|FG003|Open-label Run-in Period|Administrative|0|||
148669894|NCT00320801|536263294|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
148669895|NCT00320801|536263295|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
148669896|NCT00320801|536263296|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
148669897|NCT00320801|536263297|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
148669898|NCT00320801|536263294|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
148669899|NCT00320801|536263295|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
148669900|NCT00320801|536263296|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
148669901|NCT00320801|536263297|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
148669902|NCT00320801|536263294|FG000|Open-label Run-in Period|Did not qualify|1|||
148669903|NCT00320801|536263295|FG001|Open-label Run-in Period|Did not qualify|0|||
148669904|NCT00320801|536263296|FG002|Open-label Run-in Period|Did not qualify|0|||
148669905|NCT00320801|536263297|FG003|Open-label Run-in Period|Did not qualify|0|||
148669906|NCT00320801|536263294|FG000|Double-blind Phase|Withdrawal by Subject|0|||
148804442|NCT02065557|536765111|FG004|Induction Period|Non-Responder at Week 8|0|||
148669907|NCT00320801|536263295|FG001|Double-blind Phase|Withdrawal by Subject|0|||
148669908|NCT00320801|536263296|FG002|Double-blind Phase|Withdrawal by Subject|1|||
148669909|NCT00320801|536263297|FG003|Double-blind Phase|Withdrawal by Subject|0|||
148669910|NCT00320801|536263294|FG000|Double-blind Phase|Adverse Event|0|||
148669911|NCT00320801|536263295|FG001|Double-blind Phase|Adverse Event|2|||
148669912|NCT00320801|536263296|FG002|Double-blind Phase|Adverse Event|8|||
148669913|NCT00320801|536263297|FG003|Double-blind Phase|Adverse Event|0|||
148669914|NCT00320801|536263294|FG000|Double-blind Phase|Administrative|0|||
148669915|NCT00320801|536263295|FG001|Double-blind Phase|Administrative|0|||
148669916|NCT00320801|536263296|FG002|Double-blind Phase|Administrative|4|||
148669917|NCT00320801|536263297|FG003|Double-blind Phase|Administrative|0|||
148669918|NCT00320801|536263294|FG000|Double-blind Phase|Lack of Efficacy|0|||
148669919|NCT00320801|536263295|FG001|Double-blind Phase|Lack of Efficacy|9|||
148669920|NCT00320801|536263296|FG002|Double-blind Phase|Lack of Efficacy|1|||
148669921|NCT00320801|536263297|FG003|Double-blind Phase|Lack of Efficacy|0|||
148669922|NCT00320801|536263294|FG000|Extension Phase|Withdrawal by Subject|0|||
148669923|NCT00320801|536263295|FG001|Extension Phase|Withdrawal by Subject|0|||
148669924|NCT00320801|536263296|FG002|Extension Phase|Withdrawal by Subject|0|||
148669925|NCT00320801|536263297|FG003|Extension Phase|Withdrawal by Subject|6|||
148669926|NCT00320801|536263294|FG000|Extension Phase|Adverse Event|0|||
148669927|NCT00320801|536263295|FG001|Extension Phase|Adverse Event|0|||
148669928|NCT00320801|536263296|FG002|Extension Phase|Adverse Event|0|||
148669929|NCT00320801|536263297|FG003|Extension Phase|Adverse Event|8|||
148669930|NCT00320801|536263294|FG000|Extension Phase|Administrative|0|||
148669931|NCT00320801|536263295|FG001|Extension Phase|Administrative|0|||
148669932|NCT00320801|536263296|FG002|Extension Phase|Administrative|0|||
148669933|NCT00320801|536263297|FG003|Extension Phase|Administrative|29|||
148669934|NCT00320801|536263294|FG000|Extension Phase|Lack of Efficacy|0|||
148669935|NCT00320801|536263295|FG001|Extension Phase|Lack of Efficacy|0|||
148669936|NCT00320801|536263296|FG002|Extension Phase|Lack of Efficacy|0|||
148669937|NCT00320801|536263297|FG003|Extension Phase|Lack of Efficacy|2|||
148669938|NCT00320801|536263294|FG000|Extension Phase|Lost to Follow-up|0|||
148669939|NCT00320801|536263295|FG001|Extension Phase|Lost to Follow-up|0|||
148669940|NCT00320801|536263296|FG002|Extension Phase|Lost to Follow-up|0|||
148669941|NCT00320801|536263297|FG003|Extension Phase|Lost to Follow-up|3|||
148669942|NCT00491322|536263299|FG000|Overall Study|Protocol Violation|1|||
148669943|NCT00491322|536263300|FG001|Overall Study|Protocol Violation|0|||
148669944|NCT00491322|536263299|FG000|Overall Study|Pregnancy|0|||
148669945|NCT00491322|536263300|FG001|Overall Study|Pregnancy|1|||
148669946|NCT00807040|536263303|FG000|Overall Study|Death|24|||
148669947|NCT00807040|536263304|FG001|Overall Study|Death|29|||
148669948|NCT00807040|536263303|FG000|Overall Study|Withdrawal by Subject|8|||
148669949|NCT00807040|536263304|FG001|Overall Study|Withdrawal by Subject|6|||
148669950|NCT00807040|536263303|FG000|Overall Study|Lost to Follow-up|4|||
148669951|NCT00807040|536263304|FG001|Overall Study|Lost to Follow-up|6|||
148669952|NCT00890409|536263309|FG000|Overall Study|Lost to Follow-up|20|||
148669953|NCT00890409|536263310|FG001|Overall Study|Lost to Follow-up|21|||
148669954|NCT02353572|536263311|FG000|Overall Study|Withdrawal by Subject|1|||
148669955|NCT02353572|536263311|FG000|Overall Study|Study terminated|2|||
148669956|NCT01870921|536263313|FG000|Overall Study|Subject decision|80|||
148669957|NCT01870921|536263313|FG000|Overall Study|Severe non-compliance to protocol|7|||
148669958|NCT01870921|536263313|FG000|Overall Study|Subject Lost to Follow up|2|||
148669959|NCT01870921|536263313|FG000|Overall Study|Other|1|||
148669960|NCT02060188|536263314|FG000|Overall Study|Disease Progression|36|||
148669961|NCT02060188|536263315|FG001|Overall Study|Disease Progression|42|||
148669962|NCT02060188|536263316|FG002|Overall Study|Disease Progression|8|||
148669963|NCT02060188|536263317|FG003|Overall Study|Disease Progression|5|||
148669964|NCT02060188|536263318|FG004|Overall Study|Disease Progression|6|||
148669965|NCT02060188|536263319|FG005|Overall Study|Disease Progression|3|||
148669966|NCT02060188|536263320|FG006|Overall Study|Disease Progression|23|||
148669967|NCT02060188|536263321|FG007|Overall Study|Disease Progression|20|||
148669968|NCT02060188|536263322|FG008|Overall Study|Disease Progression|43|||
148669969|NCT02060188|536263314|FG000|Overall Study|Study Drug Toxicity|10|||
148669970|NCT02060188|536263315|FG001|Overall Study|Study Drug Toxicity|18|||
148669971|NCT02060188|536263316|FG002|Overall Study|Study Drug Toxicity|7|||
148669972|NCT02060188|536263317|FG003|Overall Study|Study Drug Toxicity|4|||
148669973|NCT02060188|536263318|FG004|Overall Study|Study Drug Toxicity|3|||
148669974|NCT02060188|536263319|FG005|Overall Study|Study Drug Toxicity|0|||
148669975|NCT02060188|536263320|FG006|Overall Study|Study Drug Toxicity|2|||
148669976|NCT02060188|536263321|FG007|Overall Study|Study Drug Toxicity|5|||
148912262|NCT02364336|537162112|FG001|Overall Study|Adverse Event|1|||
148912263|NCT01731938|537162113|FG000|Preliminary Part I|Withdrawal by Subject|2|||
148669977|NCT02060188|536263322|FG008|Overall Study|Study Drug Toxicity|0|||
148669978|NCT02060188|536263314|FG000|Overall Study|Adverse event unrelated to study drug|2|||
148669979|NCT02060188|536263315|FG001|Overall Study|Adverse event unrelated to study drug|5|||
148669980|NCT02060188|536263316|FG002|Overall Study|Adverse event unrelated to study drug|6|||
148669981|NCT02060188|536263317|FG003|Overall Study|Adverse event unrelated to study drug|0|||
148669982|NCT02060188|536263318|FG004|Overall Study|Adverse event unrelated to study drug|1|||
148669983|NCT02060188|536263319|FG005|Overall Study|Adverse event unrelated to study drug|0|||
148669984|NCT02060188|536263320|FG006|Overall Study|Adverse event unrelated to study drug|4|||
148669985|NCT02060188|536263321|FG007|Overall Study|Adverse event unrelated to study drug|4|||
148669986|NCT02060188|536263322|FG008|Overall Study|Adverse event unrelated to study drug|1|||
148669987|NCT02060188|536263314|FG000|Overall Study|Participant request to discontinue study treatment|7|||
148669988|NCT02060188|536263315|FG001|Overall Study|Participant request to discontinue study treatment|7|||
148669989|NCT02060188|536263316|FG002|Overall Study|Participant request to discontinue study treatment|4|||
148669990|NCT02060188|536263317|FG003|Overall Study|Participant request to discontinue study treatment|0|||
148669991|NCT02060188|536263318|FG004|Overall Study|Participant request to discontinue study treatment|0|||
148669992|NCT02060188|536263319|FG005|Overall Study|Participant request to discontinue study treatment|0|||
148669993|NCT02060188|536263320|FG006|Overall Study|Participant request to discontinue study treatment|1|||
148669994|NCT02060188|536263321|FG007|Overall Study|Participant request to discontinue study treatment|1|||
148669995|NCT02060188|536263322|FG008|Overall Study|Participant request to discontinue study treatment|0|||
148912264|NCT01731938|537162114|FG001|Preliminary Part I|Withdrawal by Subject|2|||
148669996|NCT02060188|536263314|FG000|Overall Study|Participant withdrew consent|3|||
148669997|NCT02060188|536263315|FG001|Overall Study|Participant withdrew consent|0|||
148669998|NCT02060188|536263316|FG002|Overall Study|Participant withdrew consent|0|||
148669999|NCT02060188|536263317|FG003|Overall Study|Participant withdrew consent|0|||
148670000|NCT02060188|536263318|FG004|Overall Study|Participant withdrew consent|0|||
148670001|NCT02060188|536263319|FG005|Overall Study|Participant withdrew consent|0|||
148670002|NCT02060188|536263320|FG006|Overall Study|Participant withdrew consent|0|||
148670003|NCT02060188|536263321|FG007|Overall Study|Participant withdrew consent|0|||
148670004|NCT02060188|536263322|FG008|Overall Study|Participant withdrew consent|0|||
148670005|NCT02060188|536263314|FG000|Overall Study|Maximum clinical benefit|13|||
148670006|NCT02060188|536263315|FG001|Overall Study|Maximum clinical benefit|38|||
148670007|NCT02060188|536263316|FG002|Overall Study|Maximum clinical benefit|19|||
148670008|NCT02060188|536263317|FG003|Overall Study|Maximum clinical benefit|0|||
148670009|NCT02060188|536263318|FG004|Overall Study|Maximum clinical benefit|0|||
148670010|NCT02060188|536263319|FG005|Overall Study|Maximum clinical benefit|0|||
148670011|NCT02060188|536263320|FG006|Overall Study|Maximum clinical benefit|0|||
148670012|NCT02060188|536263321|FG007|Overall Study|Maximum clinical benefit|10|||
148670013|NCT02060188|536263322|FG008|Overall Study|Maximum clinical benefit|0|||
148912265|NCT01731938|537162113|FG000|Preliminary Part I|Physician Decision|1|||
148912266|NCT01731938|537162114|FG001|Preliminary Part I|Physician Decision|0|||
148912267|NCT01731938|537162113|FG000|Preliminary Part I|Lost to Follow-up|0|||
148912268|NCT01731938|537162114|FG001|Preliminary Part I|Lost to Follow-up|3|||
148912269|NCT01731938|537162113|FG000|Preliminary Part I|Missed Week 6 visit|0|||
148912270|NCT01731938|537162114|FG001|Preliminary Part I|Missed Week 6 visit|3|||
148912271|NCT01731938|537162113|FG000|Primary Part II|Withdrawal by Subject|5|||
148670014|NCT02060188|536263314|FG000|Overall Study|Other reason|3|||
148670015|NCT02060188|536263315|FG001|Overall Study|Other reason|7|||
148670016|NCT02060188|536263316|FG002|Overall Study|Other reason|0|||
148670017|NCT02060188|536263317|FG003|Overall Study|Other reason|1|||
148670018|NCT02060188|536263318|FG004|Overall Study|Other reason|0|||
148912272|NCT01731938|537162114|FG001|Primary Part II|Withdrawal by Subject|4|||
148912273|NCT01731938|537162113|FG000|Primary Part II|Lost to Follow-up|4|||
148912274|NCT01731938|537162114|FG001|Primary Part II|Lost to Follow-up|5|||
148912275|NCT01731938|537162113|FG000|Primary Part II|Death|2|||
148912276|NCT01731938|537162114|FG001|Primary Part II|Death|1|||
148912277|NCT01731938|537162113|FG000|Primary Part II|Missed Week 6 visit|2|||
148912278|NCT01731938|537162114|FG001|Primary Part II|Missed Week 6 visit|3|||
148912279|NCT01049009|537162115|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
148912280|NCT01049009|537162116|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
148912281|NCT01049009|537162115|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148912282|NCT01049009|537162116|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
148670019|NCT02060188|536263319|FG005|Overall Study|Other reason|0|||
148670020|NCT02060188|536263320|FG006|Overall Study|Other reason|0|||
148670021|NCT02060188|536263321|FG007|Overall Study|Other reason|9|||
148670022|NCT02060188|536263322|FG008|Overall Study|Other reason|0|||
148670023|NCT02060188|536263314|FG000|Overall Study|Death|0|||
148912283|NCT01049009|537162115|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
148912284|NCT01049009|537162116|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
148912285|NCT01049009|537162115|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
148912286|NCT01049009|537162116|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
148670024|NCT02060188|536263315|FG001|Overall Study|Death|1|||
148670025|NCT02060188|536263316|FG002|Overall Study|Death|0|||
148670026|NCT02060188|536263317|FG003|Overall Study|Death|0|||
148670027|NCT02060188|536263318|FG004|Overall Study|Death|0|||
148670028|NCT02060188|536263319|FG005|Overall Study|Death|0|||
148670029|NCT02060188|536263320|FG006|Overall Study|Death|0|||
148670030|NCT02060188|536263321|FG007|Overall Study|Death|1|||
148670031|NCT02060188|536263322|FG008|Overall Study|Death|0|||
148670032|NCT02060188|536263314|FG000|Overall Study|Administrative reasons by sponsor|0|||
148670033|NCT02060188|536263315|FG001|Overall Study|Administrative reasons by sponsor|1|||
148670034|NCT02060188|536263316|FG002|Overall Study|Administrative reasons by sponsor|0|||
148670035|NCT02060188|536263317|FG003|Overall Study|Administrative reasons by sponsor|0|||
148670036|NCT02060188|536263318|FG004|Overall Study|Administrative reasons by sponsor|0|||
148670037|NCT02060188|536263319|FG005|Overall Study|Administrative reasons by sponsor|0|||
148670038|NCT02060188|536263320|FG006|Overall Study|Administrative reasons by sponsor|0|||
148670039|NCT02060188|536263321|FG007|Overall Study|Administrative reasons by sponsor|0|||
148670040|NCT02060188|536263322|FG008|Overall Study|Administrative reasons by sponsor|0|||
148670041|NCT02060188|536263314|FG000|Overall Study|Lost to Follow-up|0|||
148670042|NCT02060188|536263315|FG001|Overall Study|Lost to Follow-up|0|||
148670043|NCT02060188|536263316|FG002|Overall Study|Lost to Follow-up|1|||
148670044|NCT02060188|536263317|FG003|Overall Study|Lost to Follow-up|0|||
148670045|NCT02060188|536263318|FG004|Overall Study|Lost to Follow-up|0|||
148670046|NCT02060188|536263319|FG005|Overall Study|Lost to Follow-up|0|||
148670047|NCT02060188|536263320|FG006|Overall Study|Lost to Follow-up|0|||
148670048|NCT02060188|536263321|FG007|Overall Study|Lost to Follow-up|0|||
148670049|NCT02060188|536263322|FG008|Overall Study|Lost to Follow-up|0|||
148670050|NCT05455684|536263328|FG000|Overall Study|Withdrawal by Subject|7|||
148670051|NCT05455684|536263329|FG001|Overall Study|Withdrawal by Subject|4|||
148670052|NCT05455684|536263328|FG000|Overall Study|Lost to Follow-up|3|||
148670053|NCT05455684|536263329|FG001|Overall Study|Lost to Follow-up|3|||
148670054|NCT05455684|536263328|FG000|Overall Study|Adverse Event|2|||
148670055|NCT05455684|536263329|FG001|Overall Study|Adverse Event|3|||
148670056|NCT05455684|536263328|FG000|Overall Study|Protocol Violation|1|||
148670057|NCT05455684|536263329|FG001|Overall Study|Protocol Violation|1|||
148670058|NCT05455684|536263328|FG000|Overall Study|Non-Compliant with study drug|0|||
148670059|NCT05455684|536263329|FG001|Overall Study|Non-Compliant with study drug|1|||
148670060|NCT05455684|536263328|FG000|Overall Study|Other|1|||
148670061|NCT05455684|536263329|FG001|Overall Study|Other|2|||
148670062|NCT05455684|536263328|FG000|Overall Study|Randomized but not treated|1|||
148912287|NCT03179202|537162117|FG000|Overall Study|Screen Failure|67|||
148912288|NCT03179202|537162117|FG000|Overall Study|Subject Lost to Follow Up|12|||
148670063|NCT05455684|536263329|FG001|Overall Study|Randomized but not treated|0|||
148670064|NCT05204563|536263330|FG000|Overall Study|Other than Specified|2|||
148670065|NCT05204563|536263331|FG001|Overall Study|Other than Specified|1|||
148912289|NCT03179202|537162117|FG000|Overall Study|Withdrawal by Subject|7|||
148670066|NCT05204563|536263330|FG000|Overall Study|Death|18|||
148912290|NCT03179202|537162117|FG000|Overall Study|Adverse Event|3|||
148670067|NCT05204563|536263331|FG001|Overall Study|Death|4|||
148670068|NCT05204563|536263330|FG000|Overall Study|Lost to Follow-up|6|||
148670069|NCT05204563|536263331|FG001|Overall Study|Lost to Follow-up|3|||
148670070|NCT05204563|536263330|FG000|Overall Study|Withdrawal by Subject|12|||
148670071|NCT05204563|536263331|FG001|Overall Study|Withdrawal by Subject|3|||
148670072|NCT05204563|536263330|FG000|Overall Study|Enrolled, Not Treated|1|||
148670073|NCT05204563|536263331|FG001|Overall Study|Enrolled, Not Treated|0|||
148670074|NCT04411641|536263332|FG000|DB Period|Other|7|||
148670075|NCT04411641|536263333|FG001|DB Period|Other|27|||
148670076|NCT04411641|536263334|FG002|DB Period|Other|0|||
148670077|NCT04411641|536263335|FG003|DB Period|Other|0|||
148670078|NCT04411641|536263332|FG000|DB Period|Withdrawal by Subject|67|||
148670079|NCT04411641|536263333|FG001|DB Period|Withdrawal by Subject|122|||
148804443|NCT02065557|536765112|FG005|Induction Period|Non-Responder at Week 8|0|||
148670080|NCT04411641|536263334|FG002|DB Period|Withdrawal by Subject|0|||
148670081|NCT04411641|536263335|FG003|DB Period|Withdrawal by Subject|0|||
148670082|NCT04411641|536263332|FG000|DB Period|Progressive disease|76|||
148670083|NCT04411641|536263333|FG001|DB Period|Progressive disease|116|||
148670084|NCT04411641|536263334|FG002|DB Period|Progressive disease|0|||
148670085|NCT04411641|536263335|FG003|DB Period|Progressive disease|0|||
148670086|NCT04411641|536263332|FG000|DB Period|Poor compliance to protocol|1|||
148670087|NCT04411641|536263333|FG001|DB Period|Poor compliance to protocol|5|||
148670088|NCT04411641|536263334|FG002|DB Period|Poor compliance to protocol|0|||
148670089|NCT04411641|536263335|FG003|DB Period|Poor compliance to protocol|0|||
148670090|NCT04411641|536263332|FG000|DB Period|Lack of Efficacy|19|||
148670091|NCT04411641|536263333|FG001|DB Period|Lack of Efficacy|19|||
148670092|NCT04411641|536263334|FG002|DB Period|Lack of Efficacy|0|||
148670093|NCT04411641|536263335|FG003|DB Period|Lack of Efficacy|0|||
148670094|NCT04411641|536263332|FG000|DB Period|Adverse Event|13|||
148670095|NCT04411641|536263333|FG001|DB Period|Adverse Event|29|||
148670096|NCT04411641|536263334|FG002|DB Period|Adverse Event|0|||
148670097|NCT04411641|536263335|FG003|DB Period|Adverse Event|0|||
148670098|NCT04411641|536263332|FG000|DB Period|Randomized and not treated|2|||
148670099|NCT04411641|536263333|FG001|DB Period|Randomized and not treated|2|||
148670100|NCT04411641|536263334|FG002|DB Period|Randomized and not treated|0|||
148670101|NCT04411641|536263335|FG003|DB Period|Randomized and not treated|0|||
148670102|NCT04411641|536263332|FG000|OL|Withdrawal by Subject|0|||
148670103|NCT04411641|536263333|FG001|OL|Withdrawal by Subject|0|||
148670104|NCT04411641|536263334|FG002|OL|Withdrawal by Subject|6|||
148670105|NCT04411641|536263335|FG003|OL|Withdrawal by Subject|17|||
148670106|NCT04411641|536263332|FG000|OL|Progressive disease|0|||
148670107|NCT04411641|536263333|FG001|OL|Progressive disease|0|||
148670108|NCT04411641|536263334|FG002|OL|Progressive disease|1|||
148670109|NCT04411641|536263335|FG003|OL|Progressive disease|2|||
148670110|NCT04411641|536263332|FG000|OL|Poor compliance to protocol|0|||
148670111|NCT04411641|536263333|FG001|OL|Poor compliance to protocol|0|||
148670112|NCT04411641|536263334|FG002|OL|Poor compliance to protocol|1|||
148670113|NCT04411641|536263335|FG003|OL|Poor compliance to protocol|0|||
148670114|NCT04411641|536263332|FG000|OL|Adverse Event|0|||
148670115|NCT04411641|536263333|FG001|OL|Adverse Event|0|||
148670116|NCT04411641|536263334|FG002|OL|Adverse Event|1|||
148670117|NCT04411641|536263335|FG003|OL|Adverse Event|0|||
148670118|NCT04411641|536263332|FG000|OL|Other|0|||
148670119|NCT04411641|536263333|FG001|OL|Other|0|||
148670120|NCT04411641|536263334|FG002|OL|Other|0|||
148670121|NCT04411641|536263335|FG003|OL|Other|6|||
148670122|NCT04342390|536263341|FG000|Overall Study|Lost to Follow-up|3|||
148670123|NCT04342390|536263342|FG001|Overall Study|Lost to Follow-up|0|||
148670124|NCT01233284|536263360|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
148670125|NCT01233284|536263361|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
148670126|NCT01233284|536263362|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
148670127|NCT01233284|536263363|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
148670128|NCT01233284|536263364|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
148670129|NCT01233284|536263360|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
148670130|NCT01233284|536263361|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
148670131|NCT01233284|536263362|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
148670132|NCT01233284|536263363|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
148670133|NCT01233284|536263364|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
148670134|NCT01233284|536263360|FG000|Period 1 (4 Weeks)|Other|0|||
148670135|NCT01233284|536263361|FG001|Period 1 (4 Weeks)|Other|0|||
148670136|NCT01233284|536263362|FG002|Period 1 (4 Weeks)|Other|1|||
148670137|NCT01233284|536263363|FG003|Period 1 (4 Weeks)|Other|0|||
148670138|NCT01233284|536263364|FG004|Period 1 (4 Weeks)|Other|0|||
148670139|NCT01233284|536263360|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148670140|NCT01233284|536263361|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148670141|NCT01233284|536263362|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
148670142|NCT01233284|536263363|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
149012007|NCT02318719|537523420|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
148670143|NCT01233284|536263364|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148670144|NCT01233284|536263360|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148670145|NCT01233284|536263361|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148670146|NCT01233284|536263362|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
148804444|NCT02065557|536765107|FG000|Induction Period|Adverse Event|1|||
148804445|NCT02065557|536765108|FG001|Induction Period|Adverse Event|1|||
148804446|NCT02065557|536765109|FG002|Induction Period|Adverse Event|0|||
149139583|NCT00766090|537991878|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148670147|NCT01233284|536263363|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148670148|NCT01233284|536263364|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148670149|NCT01233284|536263360|FG000|Period 3 (4 Weeks)|Other|0|||
148670150|NCT01233284|536263361|FG001|Period 3 (4 Weeks)|Other|0|||
148670151|NCT01233284|536263362|FG002|Period 3 (4 Weeks)|Other|0|||
148670152|NCT01233284|536263363|FG003|Period 3 (4 Weeks)|Other|1|||
148670153|NCT01233284|536263364|FG004|Period 3 (4 Weeks)|Other|0|||
148670154|NCT01233284|536263360|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
148670155|NCT01233284|536263361|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
148670156|NCT01233284|536263362|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
148670157|NCT01233284|536263363|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
148670158|NCT01233284|536263364|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
148670159|NCT01233284|536263360|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
148670160|NCT01233284|536263361|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
148670161|NCT01233284|536263362|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
148670162|NCT01233284|536263363|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
148670163|NCT01233284|536263364|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
148670164|NCT05403502|536263365|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
148670165|NCT05403502|536263365|FG000|Humalog Lead-In Period|Physician Decision|2|||
148670166|NCT05403502|536263365|FG000|Humalog Lead-In Period|Protocol Violation|1|||
148670167|NCT05403502|536263365|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
148670168|NCT05403502|536263365|FG000|Lyumjev Treatment Period|Physician Decision|2|||
148670169|NCT01058707|536263367|FG000|Overall Study|Disease Progression|15|||
148670170|NCT01058707|536263368|FG001|Overall Study|Disease Progression|20|||
148670171|NCT01058707|536263369|FG002|Overall Study|Disease Progression|20|||
148670172|NCT01058707|536263370|FG003|Overall Study|Disease Progression|15|||
148670173|NCT01058707|536263371|FG004|Overall Study|Disease Progression|23|||
148670174|NCT01058707|536263372|FG005|Overall Study|Disease Progression|10|||
148670175|NCT01058707|536263373|FG006|Overall Study|Disease Progression|12|||
148670176|NCT01058707|536263367|FG000|Overall Study|Adverse Event|11|||
148670177|NCT01058707|536263368|FG001|Overall Study|Adverse Event|4|||
148670178|NCT01058707|536263369|FG002|Overall Study|Adverse Event|7|||
148670179|NCT01058707|536263370|FG003|Overall Study|Adverse Event|6|||
148670180|NCT01058707|536263371|FG004|Overall Study|Adverse Event|7|||
148670181|NCT01058707|536263372|FG005|Overall Study|Adverse Event|3|||
148670182|NCT01058707|536263373|FG006|Overall Study|Adverse Event|1|||
148670183|NCT01058707|536263367|FG000|Overall Study|Subject Decision|5|||
148670184|NCT01058707|536263368|FG001|Overall Study|Subject Decision|3|||
148670185|NCT01058707|536263369|FG002|Overall Study|Subject Decision|3|||
148670186|NCT01058707|536263370|FG003|Overall Study|Subject Decision|1|||
148670187|NCT01058707|536263371|FG004|Overall Study|Subject Decision|2|||
148670188|NCT01058707|536263372|FG005|Overall Study|Subject Decision|3|||
148670189|NCT01058707|536263373|FG006|Overall Study|Subject Decision|6|||
148670190|NCT01058707|536263367|FG000|Overall Study|Lost to Follow-up|0|||
148670191|NCT01058707|536263368|FG001|Overall Study|Lost to Follow-up|0|||
148670192|NCT01058707|536263369|FG002|Overall Study|Lost to Follow-up|1|||
148670193|NCT01058707|536263370|FG003|Overall Study|Lost to Follow-up|0|||
148670194|NCT01058707|536263371|FG004|Overall Study|Lost to Follow-up|0|||
148670195|NCT01058707|536263372|FG005|Overall Study|Lost to Follow-up|0|||
148670196|NCT01058707|536263373|FG006|Overall Study|Lost to Follow-up|0|||
148670197|NCT01058707|536263367|FG000|Overall Study|Reason Not Specified|0|||
148670198|NCT01058707|536263368|FG001|Overall Study|Reason Not Specified|3|||
148670199|NCT01058707|536263369|FG002|Overall Study|Reason Not Specified|2|||
148670200|NCT01058707|536263370|FG003|Overall Study|Reason Not Specified|0|||
148670201|NCT01058707|536263371|FG004|Overall Study|Reason Not Specified|7|||
148670202|NCT01058707|536263372|FG005|Overall Study|Reason Not Specified|1|||
148670203|NCT01058707|536263373|FG006|Overall Study|Reason Not Specified|7|||
148670204|NCT00167414|536263374|FG000|Overall Study|Death|10|||
148670205|NCT04814654|536263379|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
148670206|NCT04814654|536263380|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
148670207|NCT04814654|536263381|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
148670208|NCT01875731|536263382|FG000|Overall Study|Fail to obtain lab sample|1|||
148670209|NCT01875731|536263383|FG001|Overall Study|Fail to obtain lab sample|0|||
148670210|NCT03417102|536263384|FG000|Overall Study|Adverse Event|0|||
148670211|NCT03417102|536263385|FG001|Overall Study|Adverse Event|1|||
148670212|NCT03417102|536263384|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
148670213|NCT03417102|536263385|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
148670214|NCT03417102|536263384|FG000|Overall Study|Other|0|||
148670215|NCT03417102|536263385|FG001|Overall Study|Other|1|||
148670216|NCT03188991|536263386|FG000|Overall Study|Withdrawal by Subject|0|||
148670217|NCT03188991|536263387|FG001|Overall Study|Withdrawal by Subject|0|||
148670218|NCT03188991|536263388|FG002|Overall Study|Withdrawal by Subject|0|||
148670219|NCT03188991|536263389|FG003|Overall Study|Withdrawal by Subject|1|||
148804447|NCT02065557|536765110|FG003|Induction Period|Adverse Event|0|||
148670220|NCT00396318|536265120|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
148670221|NCT03255226|536265124|FG000|Overall Study|Adverse Event|2|||
148670222|NCT03255226|536265124|FG000|Overall Study|Physician Decision|3|||
148670223|NCT03255226|536265124|FG000|Overall Study|Withdrawal by Subject|1|||
148670224|NCT03255226|536265124|FG000|Overall Study|Serum or blood sodium increased|4|||
148670225|NCT03255226|536265124|FG000|Overall Study|Serum or blood potassium increased|4|||
148670226|NCT00602927|536265125|FG000|Period 1: 13 Days|Protocol Violation|2|||
148670227|NCT00602927|536265126|FG001|Period 1: 13 Days|Protocol Violation|4|||
148670228|NCT00602927|536265125|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
148670229|NCT00602927|536265126|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
148670230|NCT00602927|536265125|FG000|Period 1: 13 Days|Time|1|||
148670231|NCT00602927|536265126|FG001|Period 1: 13 Days|Time|0|||
148670232|NCT00602927|536265125|FG000|Period 1: 13 Days|Claustrophobia|0|||
148670233|NCT00602927|536265126|FG001|Period 1: 13 Days|Claustrophobia|1|||
148670234|NCT00602927|536265125|FG000|Period 2: 14 Days|Protocol Violation|0|||
148670235|NCT00602927|536265126|FG001|Period 2: 14 Days|Protocol Violation|2|||
148670236|NCT00602927|536265125|FG000|Period 3: 13 Days|Protocol Violation|0|||
148670237|NCT00602927|536265126|FG001|Period 3: 13 Days|Protocol Violation|1|||
148670238|NCT00602927|536265125|FG000|Period 3: 13 Days|MRI data quality|2|||
148670239|NCT00602927|536265126|FG001|Period 3: 13 Days|MRI data quality|2|||
148670240|NCT00685763|536265133|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
148670241|NCT00685763|536265133|FG000|Overall Study|Protocol Violation|1|||
148670242|NCT02525627|536265136|FG000|Overall Study|Revision|1|||
148670243|NCT02525627|536265137|FG001|Overall Study|Revision|1|||
148670244|NCT02525627|536265136|FG000|Overall Study|Withdrawal by Subject|1|||
148670245|NCT02525627|536265137|FG001|Overall Study|Withdrawal by Subject|2|||
148670246|NCT02525627|536265136|FG000|Overall Study|Death|1|||
148670247|NCT02525627|536265137|FG001|Overall Study|Death|0|||
148670248|NCT02525627|536265136|FG000|Overall Study|Site terminated|11|||
148670249|NCT02525627|536265137|FG001|Overall Study|Site terminated|10|||
148670250|NCT02875340|536265138|FG000|Overall Study|Death|2|||
148670251|NCT02875340|536265138|FG000|Overall Study|Withdrawal by Subject|2|||
148670252|NCT02875340|536265138|FG000|Overall Study|Physician Decision|3|||
148670253|NCT02875340|536265138|FG000|Overall Study|Adverse Event|1|||
148670254|NCT01160770|536265139|FG000|Overall Study|Adverse Event|10|||
148670255|NCT01160770|536265139|FG000|Overall Study|Protocol Violation|2|||
148670256|NCT01160770|536265139|FG000|Overall Study|Subject/parent/caregiver request|33|||
148670257|NCT01160770|536265139|FG000|Overall Study|Physician Decision|1|||
148670258|NCT01160770|536265139|FG000|Overall Study|Lost to Follow-up|7|||
148670259|NCT01160770|536265139|FG000|Overall Study|Study termination or sponsor request|1|||
148670260|NCT01160770|536265139|FG000|Overall Study|Death|9|||
148670261|NCT01160770|536265139|FG000|Overall Study|Lack of Efficacy|15|||
148670262|NCT01160770|536265139|FG000|Overall Study|Other Reasons|1|||
148670263|NCT00242567|536265140|FG000|Overall Study|Adverse Event|70|||
148670264|NCT00242567|536265141|FG001|Overall Study|Adverse Event|43|||
148670265|NCT00242567|536265140|FG000|Overall Study|Disease Progression|17|||
148670266|NCT00242567|536265141|FG001|Overall Study|Disease Progression|22|||
148670267|NCT00242567|536265140|FG000|Overall Study|Symptomatic deterioration|9|||
148670268|NCT00242567|536265141|FG001|Overall Study|Symptomatic deterioration|3|||
148670269|NCT00242567|536265140|FG000|Overall Study|Lack of Efficacy|2|||
148670270|NCT00242567|536265141|FG001|Overall Study|Lack of Efficacy|2|||
148670271|NCT00242567|536265140|FG000|Overall Study|Lost to Follow-up|9|||
148670272|NCT00242567|536265141|FG001|Overall Study|Lost to Follow-up|19|||
148670273|NCT00242567|536265140|FG000|Overall Study|Withdrawal by Subject|33|||
148670274|NCT00242567|536265141|FG001|Overall Study|Withdrawal by Subject|28|||
148670275|NCT00242567|536265140|FG000|Overall Study|Protocol Violation|12|||
148912291|NCT03179202|537162117|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
148912292|NCT03179202|537162117|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
148912293|NCT00859638|537162118|FG000|Overall Study|Lost to Follow-up|6|||
148912294|NCT00859638|537162119|FG001|Overall Study|Lost to Follow-up|1|||
148912295|NCT00859638|537162118|FG000|Overall Study|Withdrawal by Subject|3|||
148912296|NCT00859638|537162119|FG001|Overall Study|Withdrawal by Subject|2|||
148912297|NCT00859638|537162118|FG000|Overall Study|Ill health|1|||
148912298|NCT00859638|537162119|FG001|Overall Study|Ill health|1|||
148912299|NCT02969408|537162121|FG000|Overall Study|Adverse Event|2|||
148912300|NCT02969408|537162121|FG000|Overall Study|Withdrawal by Subject|8|||
148912301|NCT02969408|537162121|FG000|Overall Study|Lost to Follow-up|4|||
148912302|NCT02969408|537162121|FG000|Overall Study|Protocol Violation|1|||
148912303|NCT02969408|537162121|FG000|Overall Study|Other than specified|1|||
148912304|NCT04643158|537162122|FG000|Overall Study|Study terminated by sponsor|0|||
148912305|NCT04643158|537162123|FG001|Overall Study|Study terminated by sponsor|0|||
148912306|NCT04643158|537162124|FG002|Overall Study|Study terminated by sponsor|1|||
148912307|NCT04643158|537162125|FG003|Overall Study|Study terminated by sponsor|0|||
148912308|NCT04643158|537162126|FG004|Overall Study|Study terminated by sponsor|0|||
148912309|NCT04643158|537162127|FG005|Overall Study|Study terminated by sponsor|1|||
148912310|NCT04643158|537162128|FG006|Overall Study|Study terminated by sponsor|0|||
148912311|NCT04643158|537162122|FG000|Overall Study|Global/country situation|0|||
148670276|NCT00242567|536265141|FG001|Overall Study|Protocol Violation|12|||
148670277|NCT00242567|536265140|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
148670278|NCT00242567|536265141|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
148670279|NCT00242567|536265140|FG000|Overall Study|Other|14|||
148670280|NCT00242567|536265141|FG001|Overall Study|Other|9|||
148912312|NCT04643158|537162123|FG001|Overall Study|Global/country situation|0|||
148912313|NCT04643158|537162124|FG002|Overall Study|Global/country situation|1|||
149012008|NCT02318719|537523421|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
148912314|NCT04643158|537162125|FG003|Overall Study|Global/country situation|0|||
148912315|NCT04643158|537162126|FG004|Overall Study|Global/country situation|0|||
148670281|NCT01833897|536265147|FG000|Overall Study|Lack of Efficacy|1|||
148670282|NCT00669110|536265148|FG000|Overall Study|Adverse Event|4|||
148670283|NCT00669110|536265149|FG001|Overall Study|Adverse Event|3|||
148670284|NCT00669110|536265148|FG000|Overall Study|Caregiver request|3|||
148670285|NCT00669110|536265149|FG001|Overall Study|Caregiver request|2|||
148670286|NCT00669110|536265148|FG000|Overall Study|Physician Decision|0|||
148670287|NCT00669110|536265149|FG001|Overall Study|Physician Decision|1|||
148670288|NCT00669110|536265148|FG000|Overall Study|Lost to Follow-up|1|||
148670289|NCT00669110|536265149|FG001|Overall Study|Lost to Follow-up|0|||
148670290|NCT00669110|536265148|FG000|Overall Study|Protocol Violation|0|||
148670291|NCT00669110|536265149|FG001|Overall Study|Protocol Violation|5|||
148670292|NCT00669110|536265148|FG000|Overall Study|Withdrawal by Subject|0|||
148670293|NCT00669110|536265149|FG001|Overall Study|Withdrawal by Subject|2|||
148670294|NCT01244516|536265150|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
148670295|NCT01244516|536265151|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
148670296|NCT01244516|536265152|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
148670297|NCT01244516|536265150|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
148670298|NCT01244516|536265151|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
148670299|NCT01244516|536265152|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
148670300|NCT01244516|536265150|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
148670301|NCT01244516|536265151|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
148670302|NCT01244516|536265152|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
148670303|NCT01244516|536265150|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
148670304|NCT01244516|536265151|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
148670305|NCT01244516|536265152|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
148670306|NCT01244516|536265150|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
148670307|NCT01244516|536265151|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
148670308|NCT01244516|536265152|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
148670309|NCT01244516|536265150|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
148670310|NCT01244516|536265151|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
148670311|NCT01244516|536265152|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
148670312|NCT01244516|536265150|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
148670313|NCT01244516|536265151|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
148670314|NCT01244516|536265152|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
148670315|NCT03426995|536265156|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670316|NCT03426995|536265157|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670317|NCT03426995|536265158|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
148670318|NCT03426995|536265159|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670319|NCT03426995|536265160|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670320|NCT03426995|536265161|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670321|NCT03426995|536265162|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670322|NCT03426995|536265163|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670323|NCT03426995|536265164|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670324|NCT03426995|536265165|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670325|NCT03426995|536265166|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670326|NCT03426995|536265167|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670327|NCT03426995|536265168|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670328|NCT03426995|536265169|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670329|NCT03426995|536265170|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670330|NCT03426995|536265171|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670331|NCT03426995|536265172|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148804448|NCT02065557|536765111|FG004|Induction Period|Adverse Event|0|||
148804449|NCT02065557|536765112|FG005|Induction Period|Adverse Event|0|||
148670332|NCT03426995|536265173|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670333|NCT03426995|536265174|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
148670334|NCT03426995|536265156|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670335|NCT03426995|536265157|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670336|NCT03426995|536265158|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670337|NCT03426995|536265159|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670338|NCT03426995|536265160|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670339|NCT03426995|536265161|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
148670340|NCT03426995|536265162|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670341|NCT03426995|536265163|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670342|NCT03426995|536265164|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670343|NCT03426995|536265165|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670344|NCT03426995|536265166|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670345|NCT03426995|536265167|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670346|NCT03426995|536265168|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670347|NCT03426995|536265169|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670348|NCT03426995|536265170|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670349|NCT03426995|536265171|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670350|NCT03426995|536265172|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670351|NCT03426995|536265173|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
149012009|NCT02318719|537523417|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
149139584|NCT00766090|537991879|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149139585|NCT00766090|537991880|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149139586|NCT00766090|537991881|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149139587|NCT00766090|537991882|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148670352|NCT03426995|536265174|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
148670353|NCT03426995|536265156|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670354|NCT03426995|536265157|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670355|NCT03426995|536265158|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670356|NCT03426995|536265159|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670357|NCT03426995|536265160|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
148670358|NCT03426995|536265161|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
148670359|NCT03426995|536265162|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670360|NCT03426995|536265163|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670361|NCT03426995|536265164|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670362|NCT03426995|536265165|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670363|NCT03426995|536265166|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670364|NCT03426995|536265167|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670365|NCT03426995|536265168|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670366|NCT03426995|536265169|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670367|NCT03426995|536265170|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670368|NCT03426995|536265171|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670369|NCT03426995|536265172|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670370|NCT03426995|536265173|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670371|NCT03426995|536265174|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
148670372|NCT03426995|536265156|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670373|NCT03426995|536265157|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670374|NCT03426995|536265158|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670375|NCT03426995|536265159|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670376|NCT03426995|536265160|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670377|NCT03426995|536265161|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670378|NCT03426995|536265162|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670379|NCT03426995|536265163|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670380|NCT03426995|536265164|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670381|NCT03426995|536265165|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670382|NCT03426995|536265166|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
148670383|NCT03426995|536265167|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670384|NCT03426995|536265168|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670385|NCT03426995|536265169|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670386|NCT03426995|536265170|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670387|NCT03426995|536265171|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670388|NCT03426995|536265172|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670389|NCT03426995|536265173|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670390|NCT03426995|536265174|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
148670391|NCT03426995|536265156|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670392|NCT03426995|536265157|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670393|NCT03426995|536265158|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670394|NCT03426995|536265159|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670395|NCT03426995|536265160|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670396|NCT03426995|536265161|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670397|NCT03426995|536265162|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670398|NCT03426995|536265163|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
148670399|NCT03426995|536265164|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670400|NCT03426995|536265165|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670401|NCT03426995|536265166|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670402|NCT03426995|536265167|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670403|NCT03426995|536265168|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670404|NCT03426995|536265169|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670405|NCT03426995|536265170|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670406|NCT03426995|536265171|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670407|NCT03426995|536265172|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670408|NCT03426995|536265173|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670409|NCT03426995|536265174|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
148670410|NCT03426995|536265156|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670411|NCT03426995|536265157|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670412|NCT03426995|536265158|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670413|NCT03426995|536265159|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670414|NCT03426995|536265160|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670415|NCT03426995|536265161|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670416|NCT03426995|536265162|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670417|NCT03426995|536265163|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670418|NCT03426995|536265164|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670419|NCT03426995|536265165|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670420|NCT03426995|536265166|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670421|NCT03426995|536265167|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670422|NCT03426995|536265168|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670423|NCT03426995|536265169|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670424|NCT03426995|536265170|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
148670425|NCT03426995|536265171|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
148670426|NCT03426995|536265172|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670427|NCT03426995|536265173|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670428|NCT03426995|536265174|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
148670429|NCT03426995|536265156|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670430|NCT03426995|536265157|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670431|NCT03426995|536265158|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670432|NCT03426995|536265159|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670433|NCT03426995|536265160|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670434|NCT03426995|536265161|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670435|NCT03426995|536265162|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670436|NCT03426995|536265163|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670437|NCT03426995|536265164|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670438|NCT03426995|536265165|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670439|NCT03426995|536265166|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670440|NCT03426995|536265167|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670441|NCT03426995|536265168|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670442|NCT03426995|536265169|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670443|NCT03426995|536265170|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
148670444|NCT03426995|536265171|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
148670445|NCT03426995|536265172|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670446|NCT03426995|536265173|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670447|NCT03426995|536265174|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
148670448|NCT02335411|536265175|FG000|Overall Study|Death|223|||
148670449|NCT02335411|536265176|FG001|Overall Study|Death|22|||
148670450|NCT02335411|536265177|FG002|Overall Study|Death|26|||
148670451|NCT02335411|536265175|FG000|Overall Study|Physician Decision|3|||
148670452|NCT02335411|536265176|FG001|Overall Study|Physician Decision|0|||
148670453|NCT02335411|536265177|FG002|Overall Study|Physician Decision|0|||
148670454|NCT02335411|536265175|FG000|Overall Study|Protocol Violation|1|||
148670455|NCT02335411|536265176|FG001|Overall Study|Protocol Violation|0|||
148670456|NCT02335411|536265177|FG002|Overall Study|Protocol Violation|0|||
148670457|NCT02335411|536265175|FG000|Overall Study|Withdrawal by Subject|11|||
148670458|NCT02335411|536265176|FG001|Overall Study|Withdrawal by Subject|0|||
148670459|NCT02335411|536265177|FG002|Overall Study|Withdrawal by Subject|3|||
148670460|NCT02335411|536265175|FG000|Overall Study|Sponsor Decision|12|||
148670461|NCT02335411|536265176|FG001|Overall Study|Sponsor Decision|3|||
148670462|NCT02335411|536265177|FG002|Overall Study|Sponsor Decision|2|||
148670463|NCT02335411|536265175|FG000|Overall Study|Adverse Event|9|||
148670464|NCT02335411|536265176|FG001|Overall Study|Adverse Event|0|||
148670465|NCT02335411|536265177|FG002|Overall Study|Adverse Event|0|||
148670466|NCT04150107|536265180|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
148670467|NCT04150107|536265181|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
148670468|NCT04150107|536265180|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
148670469|NCT04150107|536265181|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
148670470|NCT03075826|536265183|FG000|Overall Study|Withdrawal by Subject|1|||
148670471|NCT03075826|536265183|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
148670472|NCT00650806|536265184|FG000|Overall Study|Adverse Event|0|||
148670473|NCT00650806|536265185|FG001|Overall Study|Adverse Event|5|||
148670474|NCT00650806|536265186|FG002|Overall Study|Adverse Event|3|||
148670475|NCT00650806|536265187|FG003|Overall Study|Adverse Event|4|||
148670476|NCT00650806|536265184|FG000|Overall Study|Lost to Follow-up|7|||
148670477|NCT00650806|536265185|FG001|Overall Study|Lost to Follow-up|6|||
148912316|NCT04643158|537162127|FG005|Overall Study|Global/country situation|0|||
148670478|NCT00650806|536265186|FG002|Overall Study|Lost to Follow-up|11|||
148670479|NCT00650806|536265187|FG003|Overall Study|Lost to Follow-up|10|||
148670480|NCT00650806|536265184|FG000|Overall Study|Protocol Violation|0|||
148670481|NCT00650806|536265185|FG001|Overall Study|Protocol Violation|0|||
148670482|NCT00650806|536265186|FG002|Overall Study|Protocol Violation|0|||
148670483|NCT00650806|536265187|FG003|Overall Study|Protocol Violation|1|||
148670484|NCT00650806|536265184|FG000|Overall Study|Pregnancy|0|||
148670485|NCT00650806|536265185|FG001|Overall Study|Pregnancy|0|||
148670486|NCT00650806|536265186|FG002|Overall Study|Pregnancy|0|||
148670487|NCT00650806|536265187|FG003|Overall Study|Pregnancy|1|||
148670488|NCT00650806|536265184|FG000|Overall Study|Withdrawal by Subject|7|||
148670489|NCT00650806|536265185|FG001|Overall Study|Withdrawal by Subject|5|||
148670490|NCT00650806|536265186|FG002|Overall Study|Withdrawal by Subject|8|||
148670491|NCT00650806|536265187|FG003|Overall Study|Withdrawal by Subject|6|||
148670492|NCT00650806|536265184|FG000|Overall Study|Noncompliance with study drug regimen|1|||
148670493|NCT00650806|536265185|FG001|Overall Study|Noncompliance with study drug regimen|1|||
148670494|NCT00650806|536265186|FG002|Overall Study|Noncompliance with study drug regimen|0|||
148670495|NCT00650806|536265187|FG003|Overall Study|Noncompliance with study drug regimen|0|||
148670496|NCT00650806|536265184|FG000|Overall Study|Study terminated by sponsor|2|||
148670497|NCT00650806|536265185|FG001|Overall Study|Study terminated by sponsor|3|||
148670498|NCT00650806|536265186|FG002|Overall Study|Study terminated by sponsor|5|||
148670499|NCT00650806|536265187|FG003|Overall Study|Study terminated by sponsor|4|||
148670500|NCT00650806|536265184|FG000|Overall Study|Other|1|||
148670501|NCT00650806|536265185|FG001|Overall Study|Other|1|||
148670502|NCT00650806|536265186|FG002|Overall Study|Other|2|||
148670503|NCT00650806|536265187|FG003|Overall Study|Other|0|||
148670504|NCT04456998|536265190|FG000|Overall Study|Adverse Event|0|||
148804450|NCT02065557|536765107|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
148670505|NCT04456998|536265191|FG001|Overall Study|Adverse Event|4|||
148670506|NCT04456998|536265190|FG000|Overall Study|Protocol Deviation|0|||
148670507|NCT04456998|536265191|FG001|Overall Study|Protocol Deviation|1|||
148670508|NCT04456998|536265190|FG000|Overall Study|Withdrawal by Subject|0|||
148670509|NCT04456998|536265191|FG001|Overall Study|Withdrawal by Subject|1|||
148804451|NCT02065557|536765108|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
148670510|NCT03707145|536265195|FG000|Overall Study|Lost to Follow-up|0|||
148670511|NCT03707145|536265196|FG001|Overall Study|Lost to Follow-up|1|||
148670512|NCT03707145|536265197|FG002|Overall Study|Lost to Follow-up|1|||
148670513|NCT03707145|536265198|FG003|Overall Study|Lost to Follow-up|0|||
148670514|NCT04221477|536265199|FG000|Overall Study|Adverse Event|1|||
148670515|NCT04221477|536265200|FG001|Overall Study|Adverse Event|1|||
148670516|NCT04221477|536265199|FG000|Overall Study|Death|5|||
148670517|NCT04221477|536265200|FG001|Overall Study|Death|4|||
148670518|NCT04221477|536265199|FG000|Overall Study|Lack of Efficacy|1|||
148670519|NCT04221477|536265200|FG001|Overall Study|Lack of Efficacy|2|||
148670520|NCT04221477|536265199|FG000|Overall Study|Lost to Follow-up|1|||
148670521|NCT04221477|536265200|FG001|Overall Study|Lost to Follow-up|2|||
148670522|NCT04221477|536265199|FG000|Overall Study|Non-compliance with Study Drug|1|||
148670523|NCT04221477|536265200|FG001|Overall Study|Non-compliance with Study Drug|0|||
148670524|NCT04221477|536265199|FG000|Overall Study|Reason not Specified|0|||
148670525|NCT04221477|536265200|FG001|Overall Study|Reason not Specified|5|||
148670526|NCT04221477|536265199|FG000|Overall Study|Physician Decision|0|||
148670527|NCT04221477|536265200|FG001|Overall Study|Physician Decision|6|||
148670528|NCT04221477|536265199|FG000|Overall Study|Withdrawal by Subject|10|||
148670529|NCT04221477|536265200|FG001|Overall Study|Withdrawal by Subject|14|||
148670530|NCT04221477|536265199|FG000|Overall Study|Ongoing in the Study|116|||
148670531|NCT04221477|536265200|FG001|Overall Study|Ongoing in the Study|102|||
148670532|NCT05012943|536265202|FG000|Overall Study|Adverse Event|2|||
148670533|NCT05012943|536265203|FG001|Overall Study|Adverse Event|1|||
148670534|NCT05012943|536265204|FG002|Overall Study|Adverse Event|0|||
148670535|NCT05012943|536265202|FG000|Overall Study|Withdrawal by Subject|1052|||
148670536|NCT05012943|536265203|FG001|Overall Study|Withdrawal by Subject|1006|||
148670537|NCT05012943|536265204|FG002|Overall Study|Withdrawal by Subject|20|||
148670538|NCT05012943|536265202|FG000|Overall Study|Death|25|||
148670539|NCT05012943|536265203|FG001|Overall Study|Death|17|||
148670540|NCT05012943|536265204|FG002|Overall Study|Death|4|||
148670541|NCT05012943|536265202|FG000|Overall Study|Lost to Follow-up|11|||
148670542|NCT05012943|536265203|FG001|Overall Study|Lost to Follow-up|24|||
149139588|NCT00766090|537991883|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
148670543|NCT05012943|536265204|FG002|Overall Study|Lost to Follow-up|3|||
148670544|NCT05012943|536265202|FG000|Overall Study|Physician Decision|1|||
148670545|NCT05012943|536265203|FG001|Overall Study|Physician Decision|1|||
148670546|NCT05012943|536265204|FG002|Overall Study|Physician Decision|0|||
148670547|NCT05012943|536265202|FG000|Overall Study|Other than Specified|2|||
149139589|NCT00766090|537991872|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
148670548|NCT05012943|536265203|FG001|Overall Study|Other than Specified|1|||
148670549|NCT05012943|536265204|FG002|Overall Study|Other than Specified|0|||
148670550|NCT04228107|536265205|FG000|Overall Study|Protocol Violation|1|||
148670551|NCT04228107|536265206|FG001|Overall Study|Protocol Violation|0|||
148670552|NCT04228107|536265205|FG000|Overall Study|Withdrawal by Subject|6|||
149139590|NCT00766090|537991873|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139591|NCT00766090|537991874|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
149139592|NCT00766090|537991875|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139593|NCT00766090|537991876|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139594|NCT00766090|537991877|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139595|NCT00766090|537991878|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139596|NCT00766090|537991879|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139597|NCT00766090|537991880|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139598|NCT00766090|537991881|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139599|NCT00766090|537991882|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139600|NCT00766090|537991883|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
149139601|NCT00766090|537991872|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
149139602|NCT00766090|537991873|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
149139603|NCT00766090|537991874|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
149139604|NCT00766090|537991875|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
149139605|NCT00766090|537991876|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
149139606|NCT00766090|537991877|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
149139607|NCT00766090|537991878|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
149139608|NCT00766090|537991879|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
149139609|NCT00766090|537991880|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
149139610|NCT00766090|537991881|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
149139611|NCT00766090|537991882|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
149139612|NCT00766090|537991883|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
149139613|NCT00766090|537991872|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139614|NCT00766090|537991873|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139615|NCT00766090|537991874|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139616|NCT00766090|537991875|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139617|NCT00766090|537991876|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139618|NCT00766090|537991877|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
149139619|NCT00766090|537991878|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139620|NCT00766090|537991879|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139621|NCT00766090|537991880|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139622|NCT00766090|537991881|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139623|NCT00766090|537991882|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139624|NCT00766090|537991883|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
149139625|NCT00766090|537991872|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139626|NCT00766090|537991873|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
149139627|NCT00766090|537991874|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139628|NCT00766090|537991875|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
149139629|NCT00766090|537991876|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139630|NCT00766090|537991877|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139631|NCT00766090|537991878|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139632|NCT00766090|537991879|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139633|NCT00766090|537991880|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139634|NCT00766090|537991881|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139635|NCT00766090|537991882|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
149139636|NCT00766090|537991883|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
149139637|NCT00766090|537991872|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139638|NCT00766090|537991873|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139639|NCT00766090|537991874|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139640|NCT00766090|537991875|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139641|NCT00766090|537991876|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
149139642|NCT00766090|537991877|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139643|NCT00766090|537991878|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139644|NCT00766090|537991879|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139645|NCT00766090|537991880|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139646|NCT00766090|537991881|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139647|NCT00766090|537991882|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139648|NCT00766090|537991883|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
149139649|NCT03024970|537991888|FG000|First Intervention|Adverse Event|1|||
149139650|NCT03024970|537991889|FG001|First Intervention|Adverse Event|0|||
149139651|NCT03024970|537991888|FG000|Second Intervention|Lost to Follow-up|1|||
149139652|NCT03024970|537991889|FG001|Second Intervention|Lost to Follow-up|0|||
149139653|NCT00131469|537991890|FG000|Overall Study|Withdrawal by Subject|3|||
149139654|NCT00131469|537991891|FG001|Overall Study|Withdrawal by Subject|4|||
149139655|NCT00131469|537991890|FG000|Overall Study|Protocol Violation|3|||
149139656|NCT00131469|537991891|FG001|Overall Study|Protocol Violation|1|||
149139657|NCT00131469|537991890|FG000|Overall Study|Death|0|||
149139658|NCT00131469|537991891|FG001|Overall Study|Death|1|||
149139659|NCT00131469|537991890|FG000|Overall Study|Lost to Follow-up|0|||
149139660|NCT00131469|537991891|FG001|Overall Study|Lost to Follow-up|1|||
149139661|NCT00131469|537991890|FG000|Overall Study|scan not analyzable|3|||
148670553|NCT04228107|536265206|FG001|Overall Study|Withdrawal by Subject|0|||
148670554|NCT04228107|536265205|FG000|Overall Study|Lost to Follow-up|18|||
148670555|NCT04228107|536265206|FG001|Overall Study|Lost to Follow-up|0|||
148670556|NCT04228107|536265205|FG000|Overall Study|No controller use data|1|||
148670557|NCT04228107|536265206|FG001|Overall Study|No controller use data|0|||
148670558|NCT04228107|536265205|FG000|Overall Study|No medication data collected|1|||
148670559|NCT04228107|536265206|FG001|Overall Study|No medication data collected|0|||
148670560|NCT00400985|536265207|FG000|Overall Study|Withdrawal by Subject|5|||
148670561|NCT00400985|536265207|FG000|Overall Study|system modification|8|||
148670562|NCT00400985|536265207|FG000|Overall Study|Death|30|||
148670563|NCT00400985|536265207|FG000|Overall Study|Lost to Follow-up|9|||
148670564|NCT00965562|536265208|FG000|Overall Study|Lost to Follow-up|1|||
148670565|NCT00965562|536265209|FG001|Overall Study|Lost to Follow-up|2|||
148670566|NCT00965562|536265210|FG002|Overall Study|Lost to Follow-up|3|||
148670567|NCT00965562|536265208|FG000|Overall Study|Withdrawal by Subject|2|||
148670568|NCT00965562|536265209|FG001|Overall Study|Withdrawal by Subject|2|||
148670569|NCT00965562|536265210|FG002|Overall Study|Withdrawal by Subject|0|||
148670570|NCT03792633|536265211|FG000|Overall Study|Alternative Treatment|17|||
148670571|NCT03792633|536265212|FG001|Overall Study|Alternative Treatment|19|||
148670572|NCT03792633|536265211|FG000|Overall Study|Death|2|||
148670573|NCT03792633|536265212|FG001|Overall Study|Death|0|||
148670574|NCT03792633|536265211|FG000|Overall Study|Disease progression|8|||
148670575|NCT03792633|536265212|FG001|Overall Study|Disease progression|9|||
148670576|NCT03792633|536265211|FG000|Overall Study|Lost to Follow-up|1|||
148670577|NCT03792633|536265212|FG001|Overall Study|Lost to Follow-up|1|||
148670578|NCT03792633|536265211|FG000|Overall Study|Screen fail|1|||
148670579|NCT03792633|536265212|FG001|Overall Study|Screen fail|0|||
148670580|NCT03792633|536265211|FG000|Overall Study|Second malignancy|0|||
148670581|NCT03792633|536265212|FG001|Overall Study|Second malignancy|1|||
148670582|NCT05048875|536265214|FG000|Overall Study|Withdrawal by Subject|1|||
148670583|NCT05048875|536265215|FG001|Overall Study|Withdrawal by Subject|0|||
148670584|NCT05048875|536265216|FG002|Overall Study|Withdrawal by Subject|0|||
148670585|NCT05048875|536265217|FG003|Overall Study|Withdrawal by Subject|0|||
148670586|NCT05048875|536265218|FG004|Overall Study|Withdrawal by Subject|0|||
148670587|NCT05048875|536265219|FG005|Overall Study|Withdrawal by Subject|0|||
148670588|NCT05048875|536265220|FG006|Overall Study|Withdrawal by Subject|0|||
148670589|NCT05048875|536265221|FG007|Overall Study|Withdrawal by Subject|0|||
148670590|NCT05048875|536265214|FG000|Overall Study|Adverse Event|0|||
148670591|NCT05048875|536265215|FG001|Overall Study|Adverse Event|0|||
148670592|NCT05048875|536265216|FG002|Overall Study|Adverse Event|0|||
148670593|NCT05048875|536265217|FG003|Overall Study|Adverse Event|1|||
148670594|NCT05048875|536265218|FG004|Overall Study|Adverse Event|0|||
148670595|NCT05048875|536265219|FG005|Overall Study|Adverse Event|0|||
148670596|NCT05048875|536265220|FG006|Overall Study|Adverse Event|0|||
148670597|NCT05048875|536265221|FG007|Overall Study|Adverse Event|0|||
148670598|NCT04755283|536265222|FG000|Overall Study|Withdrawal by Subject|14|||
148670599|NCT04755283|536265223|FG001|Overall Study|Withdrawal by Subject|3|||
148670600|NCT04755283|536265224|FG002|Overall Study|Withdrawal by Subject|6|||
148670601|NCT04755283|536265222|FG000|Overall Study|Lost to Follow-up|0|||
148670602|NCT04755283|536265223|FG001|Overall Study|Lost to Follow-up|0|||
148670603|NCT04755283|536265224|FG002|Overall Study|Lost to Follow-up|1|||
148670604|NCT04755283|536265222|FG000|Overall Study|Death|31|||
148670605|NCT04755283|536265223|FG001|Overall Study|Death|36|||
148670606|NCT04755283|536265224|FG002|Overall Study|Death|34|||
148670607|NCT04410978|536265238|FG000|Overall Study|Poor compliance to protocol|2|||
148670608|NCT04410978|536265239|FG001|Overall Study|Poor compliance to protocol|4|||
148670609|NCT04410978|536265238|FG000|Overall Study|Withdrawal by Subject|64|||
148670610|NCT04410978|536265239|FG001|Overall Study|Withdrawal by Subject|66|||
148670611|NCT04410978|536265238|FG000|Overall Study|Other|6|||
148670612|NCT04410978|536265239|FG001|Overall Study|Other|7|||
148670613|NCT04410978|536265238|FG000|Overall Study|Missing study status|1|||
148670614|NCT04410978|536265239|FG001|Overall Study|Missing study status|0|||
148670615|NCT02684162|536265242|FG000|Overall Study|Physician Decision|0|||
148670616|NCT02684162|536265243|FG001|Overall Study|Physician Decision|1|||
148670617|NCT02684162|536265244|FG002|Overall Study|Physician Decision|0|||
148670618|NCT05153629|536265245|FG000|Overall Study|Withdrawal by Subject|0|||
148670619|NCT05153629|536265246|FG001|Overall Study|Withdrawal by Subject|2|||
148670620|NCT04089566|536265251|FG000|Overall Study|Death|0|||
148670621|NCT04089566|536265252|FG001|Overall Study|Death|6|||
148670622|NCT04089566|536265253|FG002|Overall Study|Death|10|||
148670623|NCT04089566|536265254|FG003|Overall Study|Death|0|||
148670624|NCT04089566|536265255|FG004|Overall Study|Death|0|||
148670625|NCT04089566|536265256|FG005|Overall Study|Death|0|||
148670626|NCT04089566|536265251|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
148670627|NCT04089566|536265252|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
148670628|NCT04089566|536265253|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
148670629|NCT04089566|536265254|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
148670630|NCT04089566|536265255|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
148670631|NCT04089566|536265256|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
148670632|NCT04089566|536265251|FG000|Overall Study|Reason not Specified|0|||
148670633|NCT04089566|536265252|FG001|Overall Study|Reason not Specified|4|||
148670634|NCT04089566|536265253|FG002|Overall Study|Reason not Specified|4|||
148670635|NCT04089566|536265254|FG003|Overall Study|Reason not Specified|1|||
148670636|NCT04089566|536265255|FG004|Overall Study|Reason not Specified|0|||
148670637|NCT04089566|536265256|FG005|Overall Study|Reason not Specified|0|||
148670638|NCT01083121|536265257|FG000|Overall Study|Use of Humira outside the approved label|81|||
148670639|NCT03743571|536265263|FG000|Overall Study|Withdrawal by Subject|1|||
148670640|NCT03743571|536265264|FG001|Overall Study|Withdrawal by Subject|1|||
148670641|NCT03743571|536265263|FG000|Overall Study|Lost to Follow-up|1|||
148670642|NCT03743571|536265264|FG001|Overall Study|Lost to Follow-up|2|||
148670643|NCT04115488|536265265|FG000|Overall Study|Adverse Event|8|||
148670644|NCT04115488|536265266|FG001|Overall Study|Adverse Event|4|||
148670645|NCT04115488|536265265|FG000|Overall Study|Withdrawal by Subject|3|||
148670646|NCT04115488|536265266|FG001|Overall Study|Withdrawal by Subject|6|||
148670647|NCT04115488|536265265|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
148670648|NCT04115488|536265266|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
148670649|NCT04115488|536265265|FG000|Overall Study|Patient 's location change|1|||
148670650|NCT04115488|536265266|FG001|Overall Study|Patient 's location change|0|||
148670651|NCT04115488|536265265|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
148670652|NCT04115488|536265266|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
148670653|NCT00885677|536265267|FG000|Overall Study|Death|40|||
148670654|NCT00885677|536265268|FG001|Overall Study|Death|34|||
148670655|NCT00885677|536265267|FG000|Overall Study|Lost to Follow-up|15|||
148670656|NCT00885677|536265268|FG001|Overall Study|Lost to Follow-up|13|||
148670657|NCT00885677|536265267|FG000|Overall Study|Protocol Violation|54|||
148670658|NCT00885677|536265268|FG001|Overall Study|Protocol Violation|54|||
148670659|NCT00885677|536265267|FG000|Overall Study|premature study closure|41|||
148670660|NCT00885677|536265268|FG001|Overall Study|premature study closure|44|||
148670661|NCT00885677|536265267|FG000|Overall Study|device/lead revision or replacement|7|||
148670662|NCT00885677|536265268|FG001|Overall Study|device/lead revision or replacement|6|||
148670663|NCT00885677|536265267|FG000|Overall Study|Heart transplantation|1|||
148670664|NCT00885677|536265268|FG001|Overall Study|Heart transplantation|0|||
148670665|NCT00885677|536265267|FG000|Overall Study|Inclusion/exclusion not met|25|||
148670666|NCT00885677|536265268|FG001|Overall Study|Inclusion/exclusion not met|27|||
148670667|NCT00795886|536265271|FG000|Overall Study|Death|10|||
148670668|NCT00157820|536265274|FG000|Randomized|Physician Decision|4|||
148670669|NCT00157820|536265275|FG001|Randomized|Physician Decision|2|||
148670670|NCT00157820|536265276|FG002|Randomized|Physician Decision|3|||
148670671|NCT00157820|536265274|FG000|Randomized|Withdrawal by Subject|1|||
148670672|NCT00157820|536265275|FG001|Randomized|Withdrawal by Subject|2|||
148670673|NCT00157820|536265276|FG002|Randomized|Withdrawal by Subject|3|||
148670674|NCT00157820|536265274|FG000|Randomized|Protocol Violation|2|||
148670675|NCT00157820|536265275|FG001|Randomized|Protocol Violation|1|||
148670676|NCT00157820|536265276|FG002|Randomized|Protocol Violation|2|||
148670677|NCT00157820|536265274|FG000|1st 8 Month|Death|7|||
148670678|NCT00157820|536265275|FG001|1st 8 Month|Death|8|||
148670679|NCT00157820|536265276|FG002|1st 8 Month|Death|3|||
148670680|NCT00157820|536265274|FG000|1st 8 Month|Lost to Follow-up|1|||
148670681|NCT00157820|536265275|FG001|1st 8 Month|Lost to Follow-up|2|||
148670682|NCT00157820|536265276|FG002|1st 8 Month|Lost to Follow-up|1|||
148670683|NCT00157820|536265274|FG000|1st 8 Month|Premature cross-over|0|||
148670684|NCT00157820|536265275|FG001|1st 8 Month|Premature cross-over|2|||
148670685|NCT00157820|536265276|FG002|1st 8 Month|Premature cross-over|2|||
148670686|NCT00157820|536265274|FG000|2nd 8 Months|Death|3|||
148670687|NCT00157820|536265275|FG001|2nd 8 Months|Death|1|||
148670688|NCT00157820|536265276|FG002|2nd 8 Months|Death|3|||
148670689|NCT00157820|536265274|FG000|2nd 8 Months|Lost to Follow-up|1|||
148670690|NCT00157820|536265275|FG001|2nd 8 Months|Lost to Follow-up|5|||
148670691|NCT00157820|536265276|FG002|2nd 8 Months|Lost to Follow-up|2|||
148670692|NCT00157820|536265274|FG000|2nd 8 Months|Premature cross-over|1|||
148670693|NCT00157820|536265275|FG001|2nd 8 Months|Premature cross-over|7|||
148670694|NCT00157820|536265276|FG002|2nd 8 Months|Premature cross-over|9|||
148670695|NCT02674568|536266955|FG000|Overall Study|Withdrawal by Subject|5|||
148670696|NCT02674568|536266955|FG000|Overall Study|Death|303|||
148670697|NCT02674568|536266955|FG000|Overall Study|Physician Decision|2|||
148670698|NCT02674568|536266955|FG000|Overall Study|Lost to Follow-up|9|||
148670699|NCT02674568|536266955|FG000|Overall Study|Other, Not Specified|20|||
148670700|NCT03457727|536266964|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
148670701|NCT03457727|536266965|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
148670702|NCT03457727|536266966|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
148670703|NCT03457727|536266967|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
148670704|NCT00464308|536266968|FG000|Overall Study|Adverse Event|22|||
148670705|NCT00464308|536266969|FG001|Overall Study|Adverse Event|27|||
148670706|NCT00464308|536266970|FG002|Overall Study|Adverse Event|16|||
148670707|NCT00464308|536266968|FG000|Overall Study|Lost to Follow-up|29|||
148670708|NCT00464308|536266969|FG001|Overall Study|Lost to Follow-up|19|||
148670709|NCT00464308|536266970|FG002|Overall Study|Lost to Follow-up|20|||
149139662|NCT00131469|537991891|FG001|Overall Study|scan not analyzable|6|||
148670710|NCT00464308|536266968|FG000|Overall Study|Patient discontinued and other reasons|17|||
148670711|NCT00464308|536266969|FG001|Overall Study|Patient discontinued and other reasons|17|||
148670712|NCT00464308|536266970|FG002|Overall Study|Patient discontinued and other reasons|23|||
148670713|NCT00464308|536266968|FG000|Overall Study|Physician Decision|1|||
148670714|NCT00464308|536266969|FG001|Overall Study|Physician Decision|0|||
148670715|NCT00464308|536266970|FG002|Overall Study|Physician Decision|0|||
148670716|NCT01721200|536266971|FG000|Overall Study|Lost to Follow-up|3|||
148670717|NCT01721200|536266972|FG001|Overall Study|Lost to Follow-up|5|||
148670718|NCT00630994|536266973|FG000|Overall Study|Adverse Event|1|||
148670719|NCT00630994|536266973|FG000|Overall Study|Disease Progression|1|||
148670720|NCT00630994|536266973|FG000|Overall Study|Lack of Efficacy|1|||
148670721|NCT00630994|536266973|FG000|Overall Study|Other|1|||
148670722|NCT03722849|536266976|FG000|Overall Study|Withdrawal by Subject|1|||
148670723|NCT03722849|536266977|FG001|Overall Study|Withdrawal by Subject|1|||
148670724|NCT03533608|536266978|FG000|Overall Study|Withdrawal by Subject|3|||
148670725|NCT03533608|536266978|FG000|Overall Study|Physician Decision|2|||
148670726|NCT03286426|536266979|FG000|Overall Study|Physician Decision|3|||
148670727|NCT03514121|536266980|FG000|Overall Study|Withdrawal by Subject|0|||
148670728|NCT03514121|536266981|FG001|Overall Study|Withdrawal by Subject|0|||
148670729|NCT03514121|536266982|FG002|Overall Study|Withdrawal by Subject|0|||
148670730|NCT03514121|536266983|FG003|Overall Study|Withdrawal by Subject|0|||
148670731|NCT03514121|536266984|FG004|Overall Study|Withdrawal by Subject|1|||
148670732|NCT03514121|536266985|FG005|Overall Study|Withdrawal by Subject|2|||
148670733|NCT03514121|536266986|FG006|Overall Study|Withdrawal by Subject|1|||
148670734|NCT03514121|536266987|FG007|Overall Study|Withdrawal by Subject|1|||
148670735|NCT03514121|536266988|FG008|Overall Study|Withdrawal by Subject|7|||
148670736|NCT03514121|536266989|FG009|Overall Study|Withdrawal by Subject|2|||
148670737|NCT03514121|536266980|FG000|Overall Study|Death|0|||
148670738|NCT03514121|536266981|FG001|Overall Study|Death|0|||
148670739|NCT03514121|536266982|FG002|Overall Study|Death|0|||
148670740|NCT03514121|536266983|FG003|Overall Study|Death|0|||
148670741|NCT03514121|536266984|FG004|Overall Study|Death|0|||
148670742|NCT03514121|536266985|FG005|Overall Study|Death|3|||
148670743|NCT03514121|536266986|FG006|Overall Study|Death|2|||
148670744|NCT03514121|536266987|FG007|Overall Study|Death|1|||
148670745|NCT03514121|536266988|FG008|Overall Study|Death|26|||
148670746|NCT03514121|536266989|FG009|Overall Study|Death|3|||
148670747|NCT03514121|536266980|FG000|Overall Study|Lost to Follow-up|0|||
148670748|NCT03514121|536266981|FG001|Overall Study|Lost to Follow-up|0|||
148670749|NCT03514121|536266982|FG002|Overall Study|Lost to Follow-up|1|||
148670750|NCT03514121|536266983|FG003|Overall Study|Lost to Follow-up|0|||
148670751|NCT03514121|536266984|FG004|Overall Study|Lost to Follow-up|0|||
148670752|NCT03514121|536266985|FG005|Overall Study|Lost to Follow-up|0|||
148670753|NCT03514121|536266986|FG006|Overall Study|Lost to Follow-up|0|||
148670754|NCT03514121|536266987|FG007|Overall Study|Lost to Follow-up|0|||
148670755|NCT03514121|536266988|FG008|Overall Study|Lost to Follow-up|1|||
148670756|NCT03514121|536266989|FG009|Overall Study|Lost to Follow-up|0|||
148670757|NCT03514121|536266980|FG000|Overall Study|Adverse Event|0|||
148670758|NCT03514121|536266981|FG001|Overall Study|Adverse Event|0|||
148670759|NCT03514121|536266982|FG002|Overall Study|Adverse Event|0|||
148670760|NCT03514121|536266983|FG003|Overall Study|Adverse Event|0|||
148670761|NCT03514121|536266984|FG004|Overall Study|Adverse Event|0|||
148670762|NCT03514121|536266985|FG005|Overall Study|Adverse Event|0|||
148670763|NCT03514121|536266986|FG006|Overall Study|Adverse Event|1|||
148670764|NCT03514121|536266987|FG007|Overall Study|Adverse Event|0|||
148670765|NCT03514121|536266988|FG008|Overall Study|Adverse Event|0|||
148670766|NCT03514121|536266989|FG009|Overall Study|Adverse Event|0|||
148670767|NCT03514121|536266980|FG000|Overall Study|Other|0|||
148670768|NCT03514121|536266981|FG001|Overall Study|Other|1|||
148670769|NCT03514121|536266982|FG002|Overall Study|Other|1|||
148670770|NCT03514121|536266983|FG003|Overall Study|Other|0|||
148670771|NCT03514121|536266984|FG004|Overall Study|Other|1|||
148670772|NCT03514121|536266985|FG005|Overall Study|Other|2|||
148670773|NCT03514121|536266986|FG006|Overall Study|Other|3|||
148670774|NCT03514121|536266987|FG007|Overall Study|Other|2|||
148670775|NCT03514121|536266988|FG008|Overall Study|Other|7|||
148670776|NCT03514121|536266989|FG009|Overall Study|Other|3|||
148670777|NCT03514121|536266980|FG000|Overall Study|Study termination by Sponsor|0|||
148670778|NCT03514121|536266981|FG001|Overall Study|Study termination by Sponsor|0|||
148670779|NCT03514121|536266982|FG002|Overall Study|Study termination by Sponsor|0|||
148670780|NCT03514121|536266983|FG003|Overall Study|Study termination by Sponsor|0|||
148670781|NCT03514121|536266984|FG004|Overall Study|Study termination by Sponsor|0|||
148670782|NCT03514121|536266985|FG005|Overall Study|Study termination by Sponsor|0|||
148670783|NCT03514121|536266986|FG006|Overall Study|Study termination by Sponsor|0|||
148670784|NCT03514121|536266987|FG007|Overall Study|Study termination by Sponsor|0|||
148670785|NCT03514121|536266988|FG008|Overall Study|Study termination by Sponsor|11|||
148670786|NCT03514121|536266989|FG009|Overall Study|Study termination by Sponsor|3|||
148670787|NCT03514121|536266980|FG000|Overall Study|Investigator decision|0|||
148670788|NCT03514121|536266981|FG001|Overall Study|Investigator decision|0|||
148670789|NCT03514121|536266982|FG002|Overall Study|Investigator decision|0|||
148670790|NCT03514121|536266983|FG003|Overall Study|Investigator decision|0|||
148670791|NCT03514121|536266984|FG004|Overall Study|Investigator decision|0|||
148670792|NCT03514121|536266985|FG005|Overall Study|Investigator decision|0|||
148670793|NCT03514121|536266986|FG006|Overall Study|Investigator decision|0|||
148670794|NCT03514121|536266987|FG007|Overall Study|Investigator decision|0|||
148670795|NCT03514121|536266988|FG008|Overall Study|Investigator decision|1|||
148670796|NCT03514121|536266989|FG009|Overall Study|Investigator decision|0|||
148670797|NCT05553600|536266990|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
148670798|NCT05553600|536266991|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
148670799|NCT05553600|536266992|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
148670800|NCT05553600|536266993|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
148804452|NCT02065557|536765109|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
148670801|NCT05553600|536266990|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
148670802|NCT05553600|536266991|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
148670803|NCT05553600|536266992|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
148670804|NCT05553600|536266993|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
148670805|NCT05553600|536266990|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
148670806|NCT05553600|536266991|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
148670807|NCT05553600|536266992|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
148670808|NCT05553600|536266993|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
148670809|NCT05553600|536266990|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
148670810|NCT05553600|536266991|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
148670811|NCT05553600|536266992|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
148670812|NCT05553600|536266993|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
148670813|NCT05553600|536266990|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
148670814|NCT05553600|536266991|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
148670815|NCT05553600|536266992|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
148670816|NCT05553600|536266993|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
148670817|NCT05553600|536266990|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
148912317|NCT04643158|537162128|FG006|Overall Study|Global/country situation|0|||
148912318|NCT04643158|537162122|FG000|Overall Study|Withdrawal by Subject|0|||
148912319|NCT04643158|537162123|FG001|Overall Study|Withdrawal by Subject|0|||
148912320|NCT04643158|537162124|FG002|Overall Study|Withdrawal by Subject|0|||
148912321|NCT04643158|537162125|FG003|Overall Study|Withdrawal by Subject|0|||
148912322|NCT04643158|537162126|FG004|Overall Study|Withdrawal by Subject|0|||
149139663|NCT00736034|537991896|FG000|Overall Study|Adverse Event|2|||
148912323|NCT04643158|537162127|FG005|Overall Study|Withdrawal by Subject|1|||
148912324|NCT04643158|537162128|FG006|Overall Study|Withdrawal by Subject|0|||
148912325|NCT04154189|537162129|FG000|Overall Study|Withdrawal by Subject|4|||
148912326|NCT04154189|537162130|FG001|Overall Study|Withdrawal by Subject|6|||
148912327|NCT04154189|537162129|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
148912328|NCT04154189|537162130|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
148912329|NCT04154189|537162129|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
148912330|NCT04154189|537162130|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
148912331|NCT04154189|537162129|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
148912332|NCT04154189|537162130|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
148912333|NCT04154189|537162129|FG000|Overall Study|Death|25|||
148912334|NCT04154189|537162130|FG001|Overall Study|Death|25|||
148912335|NCT02280408|537162131|FG000|Overall Study|Lost to Follow-up|0|||
148912336|NCT02280408|537162132|FG001|Overall Study|Lost to Follow-up|2|||
148912337|NCT02280408|537162133|FG002|Overall Study|Lost to Follow-up|0|||
148912338|NCT02280408|537162134|FG003|Overall Study|Lost to Follow-up|0|||
148912339|NCT01068600|537162135|FG000|Overall Study|Withdrawal by Subject|5|||
148912340|NCT01068600|537162136|FG001|Overall Study|Withdrawal by Subject|6|||
148912341|NCT01068600|537162135|FG000|Overall Study|Adverse Event|3|||
148912342|NCT01068600|537162136|FG001|Overall Study|Adverse Event|3|||
148912343|NCT01068600|537162135|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148912344|NCT01068600|537162136|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148912345|NCT01068600|537162135|FG000|Overall Study|Lost to Follow-up|1|||
148912346|NCT01068600|537162136|FG001|Overall Study|Lost to Follow-up|2|||
148912347|NCT01068600|537162135|FG000|Overall Study|Protocol deviation|1|||
148912348|NCT01068600|537162136|FG001|Overall Study|Protocol deviation|1|||
148912349|NCT01068600|537162135|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148912350|NCT01068600|537162136|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
148912351|NCT01068600|537162135|FG000|Overall Study|Administrative problems|0|||
148912352|NCT01068600|537162136|FG001|Overall Study|Administrative problems|1|||
148912353|NCT02474069|537162137|FG000|Selection Phase (SP)|Adverse Event|8|||
148912354|NCT02474069|537162138|FG001|Selection Phase (SP)|Adverse Event|0|||
148912355|NCT02474069|537162139|FG002|Selection Phase (SP)|Adverse Event|0|||
148912356|NCT02474069|537162137|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
148912357|NCT02474069|537162138|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
148912358|NCT02474069|537162139|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
148912359|NCT02474069|537162137|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
148912360|NCT02474069|537162138|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
148912361|NCT02474069|537162139|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
148912362|NCT02474069|537162137|FG000|Selection Phase (SP)|Physician Decision|1|||
148912363|NCT02474069|537162138|FG001|Selection Phase (SP)|Physician Decision|0|||
148912364|NCT02474069|537162139|FG002|Selection Phase (SP)|Physician Decision|0|||
148912365|NCT02474069|537162137|FG000|Selection Phase (SP)|Protocol Violation|1|||
148912366|NCT02474069|537162138|FG001|Selection Phase (SP)|Protocol Violation|0|||
148912367|NCT02474069|537162139|FG002|Selection Phase (SP)|Protocol Violation|0|||
148912368|NCT02474069|537162137|FG000|Selection Phase (SP)|No longer requires treatment|1|||
148912369|NCT02474069|537162138|FG001|Selection Phase (SP)|No longer requires treatment|0|||
148912370|NCT02474069|537162139|FG002|Selection Phase (SP)|No longer requires treatment|0|||
148912371|NCT02474069|537162137|FG000|Selection Phase (SP)|Technical Problem|1|||
148912372|NCT02474069|537162138|FG001|Selection Phase (SP)|Technical Problem|0|||
148912373|NCT02474069|537162139|FG002|Selection Phase (SP)|Technical Problem|0|||
148912374|NCT02474069|537162137|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
148912375|NCT02474069|537162138|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
148912376|NCT02474069|537162139|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
148912377|NCT02474069|537162137|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
148912378|NCT02474069|537162138|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
148912379|NCT02474069|537162139|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
148912380|NCT02474069|537162137|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
148912381|NCT02474069|537162138|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
148912382|NCT02474069|537162139|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
148912383|NCT02474069|537162137|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
148912384|NCT02474069|537162138|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
148912385|NCT02474069|537162139|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
148912386|NCT02474069|537162137|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
148912387|NCT02474069|537162138|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
148912388|NCT02474069|537162139|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
148912389|NCT02474069|537162137|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
148912390|NCT02474069|537162138|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
148912391|NCT02474069|537162139|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
148912392|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
148912393|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
148912394|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
148912395|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
148912396|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
148912397|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
148912398|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
148670818|NCT05553600|536266991|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
148670819|NCT05553600|536266992|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
148912399|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
148912400|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
148912401|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
148912402|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
148912403|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
148912404|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
148912405|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
148912406|NCT04173494|537162140|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
148912407|NCT04173494|537162141|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
148912408|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
148912409|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
148912410|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
148912411|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
148912412|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
148912413|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
148912414|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
148912415|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
148912416|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
148912417|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
148912418|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
148912419|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
148912420|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
148912421|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
148912422|NCT04173494|537162140|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
148912423|NCT04173494|537162141|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
148912424|NCT01623050|537162142|FG000|Overall Study|Lost to Follow-up|9|||
148912425|NCT01191762|537162143|FG000|Overall Study|Adverse Event|1|||
148912426|NCT01191762|537162144|FG001|Overall Study|Adverse Event|0|||
148912427|NCT01519869|537162147|FG000|Overall Study|Lost to Follow-up|1|||
148912428|NCT03023813|537162148|FG000|Overall Study|Lost to Follow-up|1|||
148912429|NCT03023813|537162149|FG001|Overall Study|Lost to Follow-up|2|||
148912430|NCT03023813|537162150|FG002|Overall Study|Lost to Follow-up|0|||
148912431|NCT00393861|537162151|FG000|Overall Study|Adverse Event|2|||
148912432|NCT00393861|537162151|FG000|Overall Study|Disease Progression|24|||
148912433|NCT00202878|537162156|FG000|Overall Study|Death|964|||
148912434|NCT00202878|537162157|FG001|Overall Study|Death|968|||
148912435|NCT00202878|537162156|FG000|Overall Study|Only Vital Status Known|357|||
148912436|NCT00202878|537162157|FG001|Overall Study|Only Vital Status Known|356|||
148912437|NCT00202878|537162156|FG000|Overall Study|Lost to Follow-up|44|||
148912438|NCT00202878|537162157|FG001|Overall Study|Lost to Follow-up|49|||
148912439|NCT00202878|537162156|FG000|Overall Study|Site Closure|39|||
148912440|NCT00202878|537162157|FG001|Overall Study|Site Closure|36|||
148912441|NCT00202878|537162156|FG000|Overall Study|Withdrawal by Subject|795|||
148670820|NCT05553600|536266993|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
148912442|NCT00202878|537162157|FG001|Overall Study|Withdrawal by Subject|808|||
148912443|NCT02123472|537162158|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
148912444|NCT02123472|537162159|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
148912445|NCT01474018|537162161|FG000|Overall Study|Lost to Follow-up|0|||
148912446|NCT01474018|537162162|FG001|Overall Study|Lost to Follow-up|1|||
148912447|NCT01474018|537162161|FG000|Overall Study|Withdrawal by Subject|0|||
148912448|NCT01474018|537162162|FG001|Overall Study|Withdrawal by Subject|2|||
148912449|NCT02433080|537162163|FG000|Overall Study|Lost to Follow-up|1|||
148912450|NCT02433080|537162164|FG001|Overall Study|Lost to Follow-up|2|||
148912451|NCT02433080|537162163|FG000|Overall Study|Withdrawal by Subject|0|||
148912452|NCT02433080|537162164|FG001|Overall Study|Withdrawal by Subject|2|||
148912453|NCT03801031|537162166|FG000|Overall Study|Lost to Follow-up|1|||
148912454|NCT03801031|537162167|FG001|Overall Study|Lost to Follow-up|0|||
148912455|NCT03801031|537162166|FG000|Overall Study|Unable to comply|1|||
148912456|NCT03801031|537162167|FG001|Overall Study|Unable to comply|0|||
148912457|NCT03801031|537162166|FG000|Overall Study|Withdrawal by Subject|0|||
148912458|NCT03801031|537162167|FG001|Overall Study|Withdrawal by Subject|1|||
148912459|NCT00486291|537162171|FG000|Overall Study|Adverse Event|3|||
148912460|NCT00486291|537162172|FG001|Overall Study|Adverse Event|4|||
148912461|NCT00486291|537162171|FG000|Overall Study|Lost to Follow-up|3|||
148912462|NCT00486291|537162172|FG001|Overall Study|Lost to Follow-up|7|||
148912463|NCT00486291|537162171|FG000|Overall Study|protocol non-compliance|10|||
148912464|NCT00486291|537162172|FG001|Overall Study|protocol non-compliance|15|||
148912465|NCT00486291|537162171|FG000|Overall Study|requirement for restricted medication|0|||
148912466|NCT00486291|537162172|FG001|Overall Study|requirement for restricted medication|3|||
148912467|NCT00126490|537162178|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
148912468|NCT03462511|537162182|FG000|Overall Study|Withdrawal by Subject|2|||
148912469|NCT03462511|537162183|FG001|Overall Study|Withdrawal by Subject|3|||
148912470|NCT02925416|537162184|FG000|Overall Study|Adverse Event|2|||
148912471|NCT02925416|537162185|FG001|Overall Study|Adverse Event|0|||
148912472|NCT00200356|537162186|FG000|Overall Study|Lack of Efficacy|3|||
148912473|NCT00200356|537162187|FG001|Overall Study|Lack of Efficacy|3|||
148912474|NCT00200356|537162186|FG000|Overall Study|Protocol Violation|4|||
148912475|NCT00200356|537162187|FG001|Overall Study|Protocol Violation|4|||
148912476|NCT00200356|537162186|FG000|Overall Study|Nontreatment|1|||
148912477|NCT00200356|537162187|FG001|Overall Study|Nontreatment|0|||
148912478|NCT01703754|537162196|FG000|Overall Study|Clinically significant disease progression|2|||
148912479|NCT01703754|537162197|FG001|Overall Study|Clinically significant disease progression|2|||
148912480|NCT01703754|537162198|FG002|Overall Study|Clinically significant disease progression|1|||
148912481|NCT01703754|537162196|FG000|Overall Study|Adverse Event|1|||
148912482|NCT01703754|537162197|FG001|Overall Study|Adverse Event|1|||
148912483|NCT01703754|537162198|FG002|Overall Study|Adverse Event|0|||
148912484|NCT01703754|537162196|FG000|Overall Study|Withdrawal by Subject|2|||
148912485|NCT01703754|537162197|FG001|Overall Study|Withdrawal by Subject|0|||
148912486|NCT01703754|537162198|FG002|Overall Study|Withdrawal by Subject|0|||
148912487|NCT01459497|537162202|FG000|Overall Study|Inability to meet trial constraints.|1|||
148912488|NCT01459497|537162203|FG001|Overall Study|Inability to meet trial constraints.|0|||
148912489|NCT01459497|537162202|FG000|Overall Study|Physician Decision|1|||
148912490|NCT01459497|537162203|FG001|Overall Study|Physician Decision|1|||
148912491|NCT01459497|537162202|FG000|Overall Study|Hospitalization.|0|||
148912492|NCT01459497|537162203|FG001|Overall Study|Hospitalization.|3|||
148912493|NCT01459497|537162202|FG000|Overall Study|Disease progression.|0|||
148912494|NCT01459497|537162203|FG001|Overall Study|Disease progression.|1|||
148912495|NCT03530124|537162204|FG000|Overall Study|Withdrawal by Subject|0|||
148912496|NCT03530124|537162205|FG001|Overall Study|Withdrawal by Subject|1|||
148912497|NCT03530124|537162204|FG000|Overall Study|Protocol Violation|1|||
148912498|NCT03530124|537162205|FG001|Overall Study|Protocol Violation|0|||
148912499|NCT03530124|537162204|FG000|Overall Study|Discharged prior to study completion|1|||
148912500|NCT03530124|537162205|FG001|Overall Study|Discharged prior to study completion|0|||
148912501|NCT03179319|537162206|FG000|Overall Study|Lost to Follow-up|6|||
148912502|NCT03179319|537162207|FG001|Overall Study|Lost to Follow-up|0|||
148912503|NCT01120717|537162208|FG000|Overall Study|Withdrawal by Subject|11|||
148912504|NCT01120717|537162209|FG001|Overall Study|Withdrawal by Subject|6|||
148912505|NCT01120717|537162208|FG000|Overall Study|Adverse Event|10|||
148912506|NCT01120717|537162209|FG001|Overall Study|Adverse Event|6|||
148912507|NCT01120717|537162208|FG000|Overall Study|Protocol Deviation|2|||
148912508|NCT01120717|537162209|FG001|Overall Study|Protocol Deviation|5|||
148912509|NCT01120717|537162208|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148912510|NCT01120717|537162209|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148912511|NCT01120717|537162208|FG000|Overall Study|Lost to Follow-up|2|||
148912512|NCT01120717|537162209|FG001|Overall Study|Lost to Follow-up|3|||
148912513|NCT01120717|537162208|FG000|Overall Study|Death|3|||
148912514|NCT01120717|537162209|FG001|Overall Study|Death|1|||
148912515|NCT01120717|537162208|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
148912516|NCT01120717|537162209|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
148912517|NCT00947882|537162214|FG000|Overall Study|Adverse Event|0|||
148912518|NCT00947882|537162215|FG001|Overall Study|Adverse Event|1|||
149139664|NCT00911625|537991903|FG000|Overall Study|Lost to Follow-up|7|||
149139665|NCT00911625|537991904|FG001|Overall Study|Lost to Follow-up|0|||
149139666|NCT00590044|537991905|FG000|Overall Study|Withdrawal by Subject|2|||
149139667|NCT00590044|537991906|FG001|Overall Study|Withdrawal by Subject|2|||
149139668|NCT00590044|537991905|FG000|Overall Study|wrong insulin arm assigned|1|||
149139669|NCT00590044|537991906|FG001|Overall Study|wrong insulin arm assigned|0|||
149139670|NCT00590044|537991905|FG000|Overall Study|Protocol Violation|1|||
149139671|NCT00590044|537991906|FG001|Overall Study|Protocol Violation|0|||
149139672|NCT01514136|537991907|FG000|Test Period 1; Test A|Protocol Violation|1|||
149139673|NCT01514136|537991908|FG001|Test Period 1; Test A|Protocol Violation|0|||
149139674|NCT01514136|537991909|FG002|Test Period 1; Test A|Protocol Violation|0|||
149139675|NCT01514136|537991910|FG003|Test Period 1; Test A|Protocol Violation|0|||
149139676|NCT01514136|537991911|FG004|Test Period 1; Test A|Protocol Violation|0|||
149139677|NCT01514136|537991912|FG005|Test Period 1; Test A|Protocol Violation|0|||
149139678|NCT01514136|537991913|FG006|Test Period 1; Test A|Protocol Violation|0|||
149139679|NCT01514136|537991914|FG007|Test Period 1; Test A|Protocol Violation|0|||
149139680|NCT01514136|537991907|FG000|Test Period 1; Test A|Break from study holiday|2|||
148670821|NCT05553600|536266990|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
148670822|NCT05553600|536266991|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
148670823|NCT05553600|536266992|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
148912519|NCT00947882|537162216|FG002|Overall Study|Adverse Event|4|||
148912520|NCT00947882|537162217|FG003|Overall Study|Adverse Event|4|||
148912521|NCT00947882|537162214|FG000|Overall Study|Withdrawal by Subject|2|||
149139681|NCT01514136|537991908|FG001|Test Period 1; Test A|Break from study holiday|0|||
149139682|NCT01514136|537991909|FG002|Test Period 1; Test A|Break from study holiday|0|||
149139683|NCT01514136|537991910|FG003|Test Period 1; Test A|Break from study holiday|0|||
149139684|NCT01514136|537991911|FG004|Test Period 1; Test A|Break from study holiday|0|||
149139685|NCT01514136|537991912|FG005|Test Period 1; Test A|Break from study holiday|0|||
149139686|NCT01514136|537991913|FG006|Test Period 1; Test A|Break from study holiday|0|||
149012010|NCT02318719|537523418|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
149012011|NCT02318719|537523419|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
149012012|NCT02318719|537523420|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
149012013|NCT02318719|537523421|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
149012014|NCT02318719|537523417|FG000|Open-label Extension Phase|Other|0|||
149139687|NCT01514136|537991914|FG007|Test Period 1; Test A|Break from study holiday|0|||
149139688|NCT01514136|537991907|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
149139689|NCT01514136|537991908|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
149139690|NCT01514136|537991909|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
149012015|NCT02318719|537523418|FG001|Open-label Extension Phase|Other|0|||
149012016|NCT02318719|537523419|FG002|Open-label Extension Phase|Other|0|||
149012017|NCT02318719|537523420|FG003|Open-label Extension Phase|Other|0|||
149012018|NCT02318719|537523421|FG004|Open-label Extension Phase|Other|7|||
149012019|NCT00432835|537523425|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
149012020|NCT00432835|537523426|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
149012021|NCT00289770|537523427|FG000|Year 15|Withdrawal by Subject|1|||
149012022|NCT00423293|537523428|FG000|Overall Study|Ineligible / No protocol treatment|11|||
149012023|NCT05340751|537523435|FG000|Overall Study|Physician Decision|3|||
149012024|NCT01014975|537523436|FG000|Overall Study|Withdrawal by Subject|1|||
148804453|NCT02065557|536765110|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
148804454|NCT02065557|536765111|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
148804455|NCT02065557|536765112|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
148804456|NCT02065557|536765107|FG000|Maintenance Period|Withdrawal by Subject|0|||
148804457|NCT02065557|536765108|FG001|Maintenance Period|Withdrawal by Subject|0|||
148804458|NCT02065557|536765109|FG002|Maintenance Period|Withdrawal by Subject|0|||
148804459|NCT02065557|536765110|FG003|Maintenance Period|Withdrawal by Subject|0|||
148804460|NCT02065557|536765111|FG004|Maintenance Period|Withdrawal by Subject|2|||
148804461|NCT02065557|536765112|FG005|Maintenance Period|Withdrawal by Subject|1|||
148804462|NCT02065557|536765107|FG000|Maintenance Period|Lack of Efficacy|0|||
148804463|NCT02065557|536765108|FG001|Maintenance Period|Lack of Efficacy|0|||
148804464|NCT02065557|536765109|FG002|Maintenance Period|Lack of Efficacy|0|||
148804465|NCT02065557|536765110|FG003|Maintenance Period|Lack of Efficacy|0|||
148804466|NCT02065557|536765111|FG004|Maintenance Period|Lack of Efficacy|5|||
148804467|NCT02065557|536765112|FG005|Maintenance Period|Lack of Efficacy|2|||
148804468|NCT02065557|536765107|FG000|Maintenance Period|Subject Non-Compliance|0|||
148804469|NCT02065557|536765108|FG001|Maintenance Period|Subject Non-Compliance|0|||
148804470|NCT02065557|536765109|FG002|Maintenance Period|Subject Non-Compliance|0|||
148804471|NCT02065557|536765110|FG003|Maintenance Period|Subject Non-Compliance|0|||
148804472|NCT02065557|536765111|FG004|Maintenance Period|Subject Non-Compliance|0|||
148804473|NCT02065557|536765112|FG005|Maintenance Period|Subject Non-Compliance|1|||
148804474|NCT00706797|536765113|FG000|Overall Study|Lack of Efficacy|3|||
148804475|NCT00706797|536765114|FG001|Overall Study|Lack of Efficacy|0|||
148804476|NCT00706797|536765113|FG000|Overall Study|Adverse Event|0|||
148804477|NCT00706797|536765114|FG001|Overall Study|Adverse Event|3|||
148804478|NCT00706797|536765113|FG000|Overall Study|Withdrawal by Subject|8|||
148804479|NCT00706797|536765114|FG001|Overall Study|Withdrawal by Subject|1|||
148804480|NCT00706797|536765113|FG000|Overall Study|Death|1|||
148804481|NCT00706797|536765114|FG001|Overall Study|Death|0|||
148804482|NCT00706797|536765113|FG000|Overall Study|Discontinuation of study by sponsor|52|||
148804483|NCT00706797|536765114|FG001|Overall Study|Discontinuation of study by sponsor|63|||
148804484|NCT00706797|536765113|FG000|Overall Study|Protocol Violation|3|||
148804485|NCT00706797|536765114|FG001|Overall Study|Protocol Violation|2|||
148804486|NCT00706797|536765113|FG000|Overall Study|Lost to Follow-up|1|||
148804487|NCT00706797|536765114|FG001|Overall Study|Lost to Follow-up|2|||
148804488|NCT00706797|536765113|FG000|Overall Study|Other|1|||
148804489|NCT00706797|536765114|FG001|Overall Study|Other|0|||
148804490|NCT00368550|536765121|FG000|Overall Study|Adverse Event|7|||
148804491|NCT00368550|536765122|FG001|Overall Study|Adverse Event|4|||
148804492|NCT00368550|536765121|FG000|Overall Study|Lack of Efficacy|4|||
148804493|NCT00368550|536765122|FG001|Overall Study|Lack of Efficacy|9|||
148804494|NCT00368550|536765121|FG000|Overall Study|Withdrawal by Subject|17|||
148804495|NCT00368550|536765122|FG001|Overall Study|Withdrawal by Subject|10|||
148804496|NCT01670292|536765124|FG000|Overall Study|Lost to Follow-up|14|||
148804497|NCT02309359|536765127|FG000|Overall Study|Adverse Event|4|||
148804498|NCT02309359|536765128|FG001|Overall Study|Adverse Event|5|||
149012025|NCT01014975|537523437|FG001|Overall Study|Withdrawal by Subject|0|||
148804499|NCT02309359|536765129|FG002|Overall Study|Adverse Event|5|||
148804500|NCT02309359|536765130|FG003|Overall Study|Adverse Event|4|||
148804501|NCT02309359|536765131|FG004|Overall Study|Adverse Event|4|||
148804502|NCT02309359|536765127|FG000|Overall Study|Death|1|||
148804503|NCT02309359|536765128|FG001|Overall Study|Death|0|||
148804504|NCT02309359|536765129|FG002|Overall Study|Death|0|||
148804505|NCT02309359|536765130|FG003|Overall Study|Death|0|||
149012026|NCT01014975|537523438|FG002|Overall Study|Withdrawal by Subject|1|||
149012027|NCT01014975|537523436|FG000|Overall Study|Death|3|||
148804506|NCT02309359|536765131|FG004|Overall Study|Death|0|||
148804507|NCT02309359|536765127|FG000|Overall Study|Withdrawal by Subject|2|||
148804508|NCT02309359|536765128|FG001|Overall Study|Withdrawal by Subject|2|||
148804509|NCT02309359|536765129|FG002|Overall Study|Withdrawal by Subject|4|||
148804510|NCT02309359|536765130|FG003|Overall Study|Withdrawal by Subject|4|||
148804511|NCT02309359|536765131|FG004|Overall Study|Withdrawal by Subject|0|||
148804512|NCT02309359|536765127|FG000|Overall Study|Lack of Efficacy|3|||
148804513|NCT02309359|536765128|FG001|Overall Study|Lack of Efficacy|1|||
148804514|NCT02309359|536765129|FG002|Overall Study|Lack of Efficacy|0|||
148804515|NCT02309359|536765130|FG003|Overall Study|Lack of Efficacy|0|||
148804516|NCT02309359|536765131|FG004|Overall Study|Lack of Efficacy|3|||
148804517|NCT02309359|536765127|FG000|Overall Study|Lost to Follow-up|0|||
148804518|NCT02309359|536765128|FG001|Overall Study|Lost to Follow-up|0|||
148804519|NCT02309359|536765129|FG002|Overall Study|Lost to Follow-up|0|||
148804520|NCT02309359|536765130|FG003|Overall Study|Lost to Follow-up|1|||
148804521|NCT02309359|536765131|FG004|Overall Study|Lost to Follow-up|0|||
148804522|NCT02309359|536765127|FG000|Overall Study|Other|2|||
148804523|NCT02309359|536765128|FG001|Overall Study|Other|0|||
148804524|NCT02309359|536765129|FG002|Overall Study|Other|2|||
148804525|NCT02309359|536765130|FG003|Overall Study|Other|3|||
148804526|NCT02309359|536765131|FG004|Overall Study|Other|2|||
148804527|NCT01604785|536765133|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
148804528|NCT01604785|536765134|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
148804529|NCT03040726|536765135|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
148811244|NCT01995201|536787049|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
149139691|NCT01514136|537991910|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
149139692|NCT01514136|537991911|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
149139693|NCT01514136|537991912|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
149139694|NCT01514136|537991913|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
149139695|NCT01514136|537991914|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
149139696|NCT01514136|537991907|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139697|NCT01514136|537991908|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139698|NCT01514136|537991909|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139699|NCT01514136|537991910|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
149139700|NCT01514136|537991911|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139701|NCT01514136|537991912|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139702|NCT01514136|537991913|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139703|NCT01514136|537991914|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
149139704|NCT01514136|537991907|FG000|Test Period 2; Test A*|Adverse Event|0|||
149139705|NCT01514136|537991908|FG001|Test Period 2; Test A*|Adverse Event|0|||
149139706|NCT01514136|537991909|FG002|Test Period 2; Test A*|Adverse Event|0|||
149139707|NCT01514136|537991910|FG003|Test Period 2; Test A*|Adverse Event|0|||
149139708|NCT01514136|537991911|FG004|Test Period 2; Test A*|Adverse Event|1|||
149139709|NCT01514136|537991912|FG005|Test Period 2; Test A*|Adverse Event|0|||
149139710|NCT01514136|537991913|FG006|Test Period 2; Test A*|Adverse Event|0|||
149139711|NCT01514136|537991914|FG007|Test Period 2; Test A*|Adverse Event|0|||
149139712|NCT01514136|537991907|FG000|Test Period 2; Test A*|Holiday|0|||
149139713|NCT01514136|537991908|FG001|Test Period 2; Test A*|Holiday|0|||
149139714|NCT01514136|537991909|FG002|Test Period 2; Test A*|Holiday|0|||
149139715|NCT01514136|537991910|FG003|Test Period 2; Test A*|Holiday|0|||
149139716|NCT01514136|537991911|FG004|Test Period 2; Test A*|Holiday|1|||
149139717|NCT01514136|537991912|FG005|Test Period 2; Test A*|Holiday|0|||
149139718|NCT01514136|537991913|FG006|Test Period 2; Test A*|Holiday|0|||
149139719|NCT01514136|537991914|FG007|Test Period 2; Test A*|Holiday|0|||
149139720|NCT01514136|537991907|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139721|NCT01514136|537991908|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139722|NCT01514136|537991909|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139723|NCT01514136|537991910|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139724|NCT01514136|537991911|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139725|NCT01514136|537991912|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
149139726|NCT01514136|537991913|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139727|NCT01514136|537991914|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
149139728|NCT01514136|537991907|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
149139729|NCT01514136|537991908|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
149139730|NCT01514136|537991909|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
149139731|NCT01514136|537991910|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
149139732|NCT01514136|537991911|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
149139733|NCT01514136|537991912|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
149012028|NCT01014975|537523437|FG001|Overall Study|Death|3|||
149012029|NCT01014975|537523438|FG002|Overall Study|Death|4|||
148912522|NCT00947882|537162215|FG001|Overall Study|Withdrawal by Subject|0|||
148912523|NCT00947882|537162216|FG002|Overall Study|Withdrawal by Subject|8|||
148912524|NCT00947882|537162217|FG003|Overall Study|Withdrawal by Subject|2|||
148912525|NCT00947882|537162214|FG000|Overall Study|Protocol Violation|0|||
148912526|NCT00947882|537162215|FG001|Overall Study|Protocol Violation|0|||
148912527|NCT00947882|537162216|FG002|Overall Study|Protocol Violation|1|||
148912528|NCT00947882|537162217|FG003|Overall Study|Protocol Violation|0|||
148912529|NCT00947882|537162214|FG000|Overall Study|Lost to Follow-up|0|||
148912530|NCT00947882|537162215|FG001|Overall Study|Lost to Follow-up|2|||
148912531|NCT00947882|537162216|FG002|Overall Study|Lost to Follow-up|1|||
148912532|NCT00947882|537162217|FG003|Overall Study|Lost to Follow-up|0|||
148912533|NCT00947882|537162214|FG000|Overall Study|Other/Unknown|10|||
148912534|NCT00947882|537162215|FG001|Overall Study|Other/Unknown|13|||
148912535|NCT00947882|537162216|FG002|Overall Study|Other/Unknown|3|||
148912536|NCT00947882|537162217|FG003|Overall Study|Other/Unknown|6|||
149012030|NCT01014975|537523436|FG000|Overall Study|Lost to Follow-up|0|||
149139734|NCT01514136|537991913|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
149139735|NCT01514136|537991914|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
149139736|NCT01514136|537991907|FG000|Test Period 2; Test C*|holiday|0|||
148912537|NCT00947882|537162214|FG000|Overall Study|Trial Terminated by Sponsor|62|||
148912538|NCT00947882|537162215|FG001|Overall Study|Trial Terminated by Sponsor|61|||
148912539|NCT00947882|537162216|FG002|Overall Study|Trial Terminated by Sponsor|62|||
148912540|NCT00947882|537162217|FG003|Overall Study|Trial Terminated by Sponsor|70|||
148912541|NCT05188053|537162218|FG000|Overall Study|Lost to Follow-up|23|||
149012031|NCT01014975|537523437|FG001|Overall Study|Lost to Follow-up|0|||
149139737|NCT01514136|537991908|FG001|Test Period 2; Test C*|holiday|0|||
149139738|NCT01514136|537991909|FG002|Test Period 2; Test C*|holiday|0|||
149139739|NCT01514136|537991910|FG003|Test Period 2; Test C*|holiday|0|||
149139740|NCT01514136|537991911|FG004|Test Period 2; Test C*|holiday|0|||
149139741|NCT01514136|537991912|FG005|Test Period 2; Test C*|holiday|0|||
149139742|NCT01514136|537991913|FG006|Test Period 2; Test C*|holiday|1|||
149139743|NCT01514136|537991914|FG007|Test Period 2; Test C*|holiday|0|||
149139744|NCT01514136|537991907|FG000|Test Period 2; Test C*|Protocol Violation|0|||
149139745|NCT01514136|537991908|FG001|Test Period 2; Test C*|Protocol Violation|0|||
149139746|NCT01514136|537991909|FG002|Test Period 2; Test C*|Protocol Violation|0|||
149139747|NCT01514136|537991910|FG003|Test Period 2; Test C*|Protocol Violation|0|||
149139748|NCT01514136|537991911|FG004|Test Period 2; Test C*|Protocol Violation|0|||
149139749|NCT01514136|537991912|FG005|Test Period 2; Test C*|Protocol Violation|0|||
149139750|NCT01514136|537991913|FG006|Test Period 2; Test C*|Protocol Violation|1|||
149139751|NCT01514136|537991914|FG007|Test Period 2; Test C*|Protocol Violation|0|||
149139752|NCT02729740|537991919|FG000|Overall Study|Early Termination|130|||
149139753|NCT02729740|537991919|FG000|Overall Study|Other|1|||
149139754|NCT00888381|537991920|FG000|Overall Study|Lost to Follow-up|0|||
149139755|NCT00888381|537991921|FG001|Overall Study|Lost to Follow-up|1|||
149139756|NCT00175877|537991940|FG000|Overall Study|Adverse Event|136|||
149139757|NCT00175877|537991940|FG000|Overall Study|Withdrawal by Subject|141|||
149139758|NCT00175877|537991940|FG000|Overall Study|Lost to Follow-up|9|||
149139759|NCT00175877|537991940|FG000|Overall Study|Lack of Efficacy|26|||
149139760|NCT00175877|537991940|FG000|Overall Study|Protocol Violation|15|||
149139761|NCT00175877|537991940|FG000|Overall Study|Other Reason|20|||
149139762|NCT00175877|537991940|FG000|Overall Study|AE & Other|1|||
149139763|NCT00175877|537991940|FG000|Overall Study|Withdrawal by subject & Other|1|||
149139764|NCT03061175|537991943|FG000|Baseline|Participant was deemed ineligible|1|||
149139765|NCT03061175|537991944|FG001|Baseline|Participant was deemed ineligible|0|||
149139766|NCT03061175|537991943|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
149139767|NCT03061175|537991944|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
149139768|NCT03061175|537991943|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
149139769|NCT03061175|537991944|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
149139770|NCT03061175|537991943|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
149139771|NCT03061175|537991944|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
149139772|NCT03044249|537991945|FG000|Overall Study|Adverse Event|4|||
149139773|NCT03044249|537991946|FG001|Overall Study|Adverse Event|9|||
149139774|NCT03044249|537991945|FG000|Overall Study|Lost to Follow-up|1|||
149139775|NCT03044249|537991946|FG001|Overall Study|Lost to Follow-up|0|||
149139776|NCT03044249|537991945|FG000|Overall Study|Non-compliance with Study Drug|1|||
149139777|NCT03044249|537991946|FG001|Overall Study|Non-compliance with Study Drug|0|||
149139778|NCT03044249|537991945|FG000|Overall Study|Study Terminated by Sponsor|2|||
149139779|NCT03044249|537991946|FG001|Overall Study|Study Terminated by Sponsor|0|||
148912542|NCT05188053|537162219|FG001|Overall Study|Lost to Follow-up|30|||
148912543|NCT05188053|537162218|FG000|Overall Study|Protocol Violation|16|||
148912544|NCT05188053|537162219|FG001|Overall Study|Protocol Violation|16|||
148912545|NCT05188053|537162218|FG000|Overall Study|Physician Decision|3|||
148912546|NCT05188053|537162219|FG001|Overall Study|Physician Decision|0|||
148912547|NCT05188053|537162218|FG000|Overall Study|Withdrawal by Subject|0|||
148912548|NCT05188053|537162219|FG001|Overall Study|Withdrawal by Subject|1|||
148912549|NCT02379637|537162223|FG000|Overall Study|Protocol Violation|0|||
148912550|NCT02379637|537162224|FG001|Overall Study|Protocol Violation|1|||
148912551|NCT02379637|537162223|FG000|Overall Study|Adverse Event|1|||
148912552|NCT02379637|537162224|FG001|Overall Study|Adverse Event|0|||
148912553|NCT02379637|537162223|FG000|Overall Study|Withdrawal by Subject|1|||
148912554|NCT02379637|537162224|FG001|Overall Study|Withdrawal by Subject|0|||
148912555|NCT01309282|537162231|FG000|Overall Study|Lost to Follow-up|1|||
148912556|NCT02087423|537162232|FG000|Overall Study|Withdrawal by Subject|20|||
148912557|NCT02087423|537162233|FG001|Overall Study|Withdrawal by Subject|20|||
148912558|NCT02087423|537162234|FG002|Overall Study|Withdrawal by Subject|3|||
148912559|NCT02087423|537162232|FG000|Overall Study|Death|68|||
148912560|NCT02087423|537162233|FG001|Overall Study|Death|207|||
148912561|NCT02087423|537162234|FG002|Overall Study|Death|40|||
148912562|NCT02087423|537162232|FG000|Overall Study|Lost to Follow-up|0|||
148912563|NCT02087423|537162233|FG001|Overall Study|Lost to Follow-up|2|||
148912564|NCT02087423|537162234|FG002|Overall Study|Lost to Follow-up|0|||
148912565|NCT02087423|537162232|FG000|Overall Study|Terminated from study at final DCO|23|||
148912566|NCT02087423|537162233|FG001|Overall Study|Terminated from study at final DCO|36|||
148912567|NCT02087423|537162234|FG002|Overall Study|Terminated from study at final DCO|25|||
148912568|NCT02762370|537162237|FG000|Overall Study|Protocol Violation|1|||
149139780|NCT03044249|537991945|FG000|Overall Study|Withdrawal by Subject|2|||
149139781|NCT03044249|537991946|FG001|Overall Study|Withdrawal by Subject|5|||
149139782|NCT00955279|537991947|FG000|Overall Study|Other|0|||
149139783|NCT00955279|537991948|FG001|Overall Study|Other|0|||
148912569|NCT02762370|537162238|FG001|Overall Study|Protocol Violation|0|||
148912570|NCT02445794|537162240|FG000|Overall Study|Adverse Event|0|||
148912571|NCT02445794|537162241|FG001|Overall Study|Adverse Event|0|||
148912572|NCT02445794|537162242|FG002|Overall Study|Adverse Event|2|||
148912573|NCT02445794|537162243|FG003|Overall Study|Adverse Event|0|||
148912574|NCT03304249|537162247|FG000|Overall Study|Lost to Follow-up|8|||
148912575|NCT03304249|537162248|FG001|Overall Study|Lost to Follow-up|10|||
149012032|NCT01014975|537523438|FG002|Overall Study|Lost to Follow-up|1|||
149012033|NCT01336634|537523441|FG000|Overall Study|Study closed/terminated|5|||
149012034|NCT01336634|537523442|FG001|Overall Study|Study closed/terminated|6|||
149012035|NCT01336634|537523443|FG002|Overall Study|Study closed/terminated|6|||
149012036|NCT01336634|537523441|FG000|Overall Study|Lost to Follow-up|2|||
149012037|NCT01336634|537523442|FG001|Overall Study|Lost to Follow-up|1|||
149012038|NCT01336634|537523443|FG002|Overall Study|Lost to Follow-up|1|||
149012039|NCT01336634|537523441|FG000|Overall Study|Physician Decision|1|||
149012040|NCT01336634|537523442|FG001|Overall Study|Physician Decision|1|||
149012041|NCT01336634|537523443|FG002|Overall Study|Physician Decision|0|||
149012042|NCT01336634|537523441|FG000|Overall Study|Withdrawal by Subject|6|||
149012043|NCT01336634|537523442|FG001|Overall Study|Withdrawal by Subject|0|||
149012044|NCT01336634|537523443|FG002|Overall Study|Withdrawal by Subject|2|||
149012045|NCT02176421|537523444|FG000|Overall Study|Lost to Follow-up|4|||
149012046|NCT02176421|537523444|FG000|Overall Study|Adverse Event|1|||
149012047|NCT02632786|537523449|FG000|Overall Study|Adverse Event|2|||
149012048|NCT02632786|537523450|FG001|Overall Study|Adverse Event|1|||
149012049|NCT02632786|537523449|FG000|Overall Study|Death|3|||
148912576|NCT03304249|537162247|FG000|Overall Study|Withdrawal by Subject|12|||
148912577|NCT03304249|537162248|FG001|Overall Study|Withdrawal by Subject|2|||
148912578|NCT03304249|537162247|FG000|Overall Study|Moved Out of District|4|||
148912579|NCT03304249|537162248|FG001|Overall Study|Moved Out of District|2|||
148912580|NCT02621151|537162249|FG000|Overall Study|Not eligible for trial|6|||
148912581|NCT02160899|537164644|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
148912582|NCT02160899|537164645|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
148912583|NCT02160899|537164646|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
148912584|NCT02160899|537164647|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
148912585|NCT02160899|537164648|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
148912586|NCT02160899|537164649|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
148912587|NCT04129151|537164650|FG000|Overall Study|Adverse Event|1|||
148912588|NCT04129151|537164650|FG000|Overall Study|Disease Progression|7|||
148912589|NCT04129151|537164650|FG000|Overall Study|Study closure|1|||
148912590|NCT04838977|537164652|FG000|Overall Study|Lost to Follow-up|2|||
148912591|NCT04838977|537164653|FG001|Overall Study|Lost to Follow-up|3|||
148912592|NCT04838977|537164652|FG000|Overall Study|Withdrawal by Subject|1|||
148912593|NCT04838977|537164653|FG001|Overall Study|Withdrawal by Subject|1|||
148912594|NCT01463007|537164656|FG000|Overall Study|Physician Decision|1|||
148912595|NCT02314637|537164659|FG000|Overall Study|Adverse Event|4|||
148912596|NCT02314637|537164660|FG001|Overall Study|Adverse Event|8|||
148912597|NCT02314637|537164659|FG000|Overall Study|Lack of Efficacy|1|||
148912598|NCT02314637|537164660|FG001|Overall Study|Lack of Efficacy|0|||
148912599|NCT02314637|537164659|FG000|Overall Study|Physician Decision|5|||
148912600|NCT02314637|537164660|FG001|Overall Study|Physician Decision|2|||
148912601|NCT02314637|537164659|FG000|Overall Study|Withdrawal by Subject|5|||
148912602|NCT02314637|537164660|FG001|Overall Study|Withdrawal by Subject|4|||
148912603|NCT02314637|537164659|FG000|Overall Study|Other Reason|1|||
148912604|NCT02314637|537164660|FG001|Overall Study|Other Reason|0|||
148912605|NCT02934503|537164661|FG000|Overall Study|progression of disease|3|||
148912606|NCT02934503|537164661|FG000|Overall Study|Withdrawal by Subject|1|||
148912607|NCT02779556|537164668|FG000|Baseline|Partial baseline interview completed|1|||
148912608|NCT02779556|537164669|FG001|Baseline|Partial baseline interview completed|0|||
148912609|NCT02779556|537164668|FG000|3 Months|Lost to Follow-up|40|||
148912610|NCT02779556|537164669|FG001|3 Months|Lost to Follow-up|29|||
148912611|NCT02779556|537164668|FG000|3 Months|Missed 3 month clinic visit|27|||
148912612|NCT02779556|537164669|FG001|3 Months|Missed 3 month clinic visit|19|||
148912613|NCT02779556|537164668|FG000|6 Month|Lost to Follow-up|33|||
148912614|NCT02779556|537164669|FG001|6 Month|Lost to Follow-up|39|||
148912615|NCT02779556|537164668|FG000|6 Month HbA1c|No value collected during window|69|||
148912616|NCT02779556|537164669|FG001|6 Month HbA1c|No value collected during window|50|||
148912617|NCT02779556|537164668|FG000|12 Month HbA1c|No value collected during window|138|||
148912618|NCT02779556|537164669|FG001|12 Month HbA1c|No value collected during window|102|||
148912619|NCT03110770|537164670|FG000|Overall Study|Death|1|||
148912620|NCT03110770|537164671|FG001|Overall Study|Death|0|||
148912621|NCT03110770|537164672|FG002|Overall Study|Death|0|||
148912622|NCT03110770|537164673|FG003|Overall Study|Death|1|||
148912623|NCT03110770|537164674|FG004|Overall Study|Death|0|||
149012050|NCT02632786|537523450|FG001|Overall Study|Death|2|||
149012051|NCT02632786|537523449|FG000|Overall Study|Physician Decision|5|||
149012052|NCT02632786|537523450|FG001|Overall Study|Physician Decision|4|||
149012053|NCT02632786|537523449|FG000|Overall Study|Withdrawal by Subject|1|||
149012054|NCT02632786|537523450|FG001|Overall Study|Withdrawal by Subject|0|||
149012055|NCT04250337|537523451|FG000|Overall Study|Adverse Event|0|||
148912624|NCT03110770|537164670|FG000|Overall Study|Enrolled but did not receive product|0|||
148912625|NCT03110770|537164671|FG001|Overall Study|Enrolled but did not receive product|0|||
148912626|NCT03110770|537164672|FG002|Overall Study|Enrolled but did not receive product|0|||
148912627|NCT03110770|537164673|FG003|Overall Study|Enrolled but did not receive product|8|||
148912628|NCT03110770|537164674|FG004|Overall Study|Enrolled but did not receive product|7|||
148912629|NCT03110770|537164670|FG000|Overall Study|Lost to Follow-up|0|||
148912630|NCT03110770|537164671|FG001|Overall Study|Lost to Follow-up|0|||
148912631|NCT03110770|537164672|FG002|Overall Study|Lost to Follow-up|0|||
149139784|NCT00955279|537991949|FG002|Overall Study|Other|3|||
149139785|NCT00955279|537991947|FG000|Overall Study|Death|1|||
149139786|NCT00955279|537991948|FG001|Overall Study|Death|1|||
149139787|NCT00955279|537991949|FG002|Overall Study|Death|1|||
149139788|NCT00955279|537991947|FG000|Overall Study|Lost to Follow-up|0|||
149139789|NCT00955279|537991948|FG001|Overall Study|Lost to Follow-up|3|||
149139790|NCT00955279|537991949|FG002|Overall Study|Lost to Follow-up|1|||
149139791|NCT00955279|537991947|FG000|Overall Study|Withdrawal by Subject|2|||
148912632|NCT03110770|537164673|FG003|Overall Study|Lost to Follow-up|53|||
149139792|NCT00955279|537991948|FG001|Overall Study|Withdrawal by Subject|0|||
149139793|NCT00955279|537991949|FG002|Overall Study|Withdrawal by Subject|3|||
149139794|NCT00760669|537991950|FG000|Overall Study|Not assessed for overall improvement|18|||
149139795|NCT00760669|537991950|FG000|Overall Study|Participants missing efficacy assessment|6|||
149139796|NCT00760669|537991950|FG000|Overall Study|Participants with overlapping cases|1|||
149139797|NCT00760669|537991950|FG000|Overall Study|Took drug before entering in contract|5|||
149139798|NCT01235793|537991951|FG000|Overall Study|Death|6|||
149139799|NCT01159912|537991953|FG000|Overall Study|Adverse Event|2|||
149139800|NCT01159912|537991954|FG001|Overall Study|Adverse Event|2|||
149139801|NCT01159912|537991955|FG002|Overall Study|Adverse Event|3|||
149139802|NCT01159912|537991953|FG000|Overall Study|Lack of Efficacy|23|||
149139803|NCT01159912|537991954|FG001|Overall Study|Lack of Efficacy|15|||
149139804|NCT01159912|537991955|FG002|Overall Study|Lack of Efficacy|14|||
149139805|NCT01159912|537991953|FG000|Overall Study|Protocol Violation|1|||
149139806|NCT01159912|537991954|FG001|Overall Study|Protocol Violation|2|||
149139807|NCT01159912|537991955|FG002|Overall Study|Protocol Violation|3|||
149139808|NCT01159912|537991953|FG000|Overall Study|Lost to Follow-up|4|||
149139809|NCT01159912|537991954|FG001|Overall Study|Lost to Follow-up|0|||
149139810|NCT01159912|537991955|FG002|Overall Study|Lost to Follow-up|0|||
149139811|NCT01159912|537991953|FG000|Overall Study|Physician Decision|0|||
149139812|NCT01159912|537991954|FG001|Overall Study|Physician Decision|0|||
149139813|NCT01159912|537991955|FG002|Overall Study|Physician Decision|3|||
149139814|NCT01159912|537991953|FG000|Overall Study|Withdrawal by Subject|10|||
149139815|NCT01159912|537991954|FG001|Overall Study|Withdrawal by Subject|3|||
149139816|NCT01159912|537991955|FG002|Overall Study|Withdrawal by Subject|3|||
149139817|NCT02456662|537991958|FG000|Overall Study|Lost to Follow-up|2|||
149139818|NCT02456662|537991959|FG001|Overall Study|Lost to Follow-up|1|||
149139819|NCT02374021|537991962|FG000|Overall Study|Adverse Event|1|||
149139820|NCT02374021|537991963|FG001|Overall Study|Adverse Event|0|||
149139821|NCT02374021|537991962|FG000|Overall Study|Lost to Follow-up|3|||
149139822|NCT02374021|537991963|FG001|Overall Study|Lost to Follow-up|2|||
149139823|NCT02374021|537991962|FG000|Overall Study|Physician Decision|0|||
149139824|NCT02374021|537991963|FG001|Overall Study|Physician Decision|3|||
149139825|NCT02374021|537991962|FG000|Overall Study|Withdrawal by Subject|6|||
149139826|NCT02374021|537991963|FG001|Overall Study|Withdrawal by Subject|5|||
149139827|NCT02374021|537991962|FG000|Overall Study|Poor Adherence|0|||
149139828|NCT02374021|537991963|FG001|Overall Study|Poor Adherence|1|||
149139829|NCT02374021|537991962|FG000|Overall Study|Scan protocol not followed|0|||
149139830|NCT02374021|537991963|FG001|Overall Study|Scan protocol not followed|1|||
149139831|NCT02374021|537991962|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
149139832|NCT02374021|537991963|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
149139833|NCT00504153|537991968|FG000|Overall Study|Withdrawal by Subject|1|||
149139834|NCT00504153|537991968|FG000|Overall Study|Adverse Event|4|||
149139835|NCT00504153|537991968|FG000|Overall Study|Death|1|||
149139836|NCT00732251|537991971|FG000|Overall Study|Lost to Follow-up|3|||
149139837|NCT00732251|537991971|FG000|Overall Study|Withdrawal by Subject|3|||
149139838|NCT00732251|537991971|FG000|Overall Study|Early Term due to Site Closure|1|||
149139839|NCT00805025|537991972|FG000|Overall Study|Screened but not enrolled/treated|42|||
149139840|NCT00805025|537991972|FG000|Overall Study|Adverse Event|4|||
148912633|NCT03110770|537164674|FG004|Overall Study|Lost to Follow-up|45|||
149012056|NCT04250337|537523452|FG001|Overall Study|Adverse Event|3|||
149139841|NCT00805025|537991972|FG000|Overall Study|Withdrawal by Subject|2|||
149139842|NCT00805025|537991972|FG000|Overall Study|Physician Decision|1|||
149139843|NCT04029961|537991973|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
149139844|NCT04029961|537991974|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
149139845|NCT04029961|537991973|FG000|Overall Study|Change in Treatment Course|0|||
149139846|NCT04029961|537991974|FG001|Overall Study|Change in Treatment Course|1|||
149139847|NCT03007979|537991978|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
149139848|NCT02273726|537991979|FG000|Overall Study|Death|70|||
149139849|NCT02273726|537991980|FG001|Overall Study|Death|62|||
149139850|NCT02273726|537991979|FG000|Overall Study|Withdrawal by Subject|41|||
149139851|NCT02273726|537991980|FG001|Overall Study|Withdrawal by Subject|29|||
149139852|NCT02273726|537991979|FG000|Overall Study|Kidney transplant|31|||
148804530|NCT03040726|536765136|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
148804531|NCT03040726|536765135|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
148804532|NCT03040726|536765136|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
149139853|NCT02273726|537991980|FG001|Overall Study|Kidney transplant|39|||
148804533|NCT03040726|536765135|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
148804534|NCT03040726|536765136|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
148804535|NCT03040726|536765135|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
148804536|NCT03040726|536765136|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
148804537|NCT03040726|536765135|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
148804538|NCT03040726|536765136|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
148804539|NCT02908347|536765137|FG000|Overall Study|Adverse Event|0|||
148804540|NCT02908347|536765138|FG001|Overall Study|Adverse Event|1|||
148804541|NCT02908347|536765137|FG000|Overall Study|Lost to Follow-up|1|||
148804542|NCT02908347|536765138|FG001|Overall Study|Lost to Follow-up|0|||
148804543|NCT03104374|536765139|FG000|Period 1|Adverse Event|7|||
148804544|NCT03104374|536765140|FG001|Period 1|Adverse Event|7|||
148804545|NCT03104374|536765141|FG002|Period 1|Adverse Event|12|||
148804546|NCT03104374|536765142|FG003|Period 1|Adverse Event|14|||
148804547|NCT03104374|536765139|FG000|Period 1|Withdrawal by Subject|18|||
148804548|NCT03104374|536765140|FG001|Period 1|Withdrawal by Subject|9|||
148804549|NCT03104374|536765141|FG002|Period 1|Withdrawal by Subject|10|||
148804550|NCT03104374|536765142|FG003|Period 1|Withdrawal by Subject|17|||
148804551|NCT03104374|536765139|FG000|Period 1|Lost to Follow-up|4|||
148804552|NCT03104374|536765140|FG001|Period 1|Lost to Follow-up|4|||
148804553|NCT03104374|536765141|FG002|Period 1|Lost to Follow-up|6|||
148804554|NCT03104374|536765142|FG003|Period 1|Lost to Follow-up|8|||
148804555|NCT03104374|536765139|FG000|Period 1|Lack of Efficacy|6|||
148804556|NCT03104374|536765140|FG001|Period 1|Lack of Efficacy|7|||
148804557|NCT03104374|536765141|FG002|Period 1|Lack of Efficacy|12|||
148804558|NCT03104374|536765142|FG003|Period 1|Lack of Efficacy|6|||
148804559|NCT03104374|536765139|FG000|Period 1|Other|2|||
148804560|NCT03104374|536765140|FG001|Period 1|Other|2|||
148804561|NCT03104374|536765141|FG002|Period 1|Other|4|||
148804562|NCT03104374|536765142|FG003|Period 1|Other|7|||
148804563|NCT03104374|536765139|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
148804564|NCT03104374|536765140|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
148804565|NCT03104374|536765141|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
148804566|NCT03104374|536765142|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
148804567|NCT03104374|536765139|FG000|Period 2|Adverse Event|4|||
148804568|NCT03104374|536765140|FG001|Period 2|Adverse Event|7|||
148804569|NCT03104374|536765141|FG002|Period 2|Adverse Event|10|||
148804570|NCT03104374|536765142|FG003|Period 2|Adverse Event|10|||
148804571|NCT03104374|536765139|FG000|Period 2|Withdrawal by Subject|3|||
148804572|NCT03104374|536765140|FG001|Period 2|Withdrawal by Subject|7|||
148804573|NCT03104374|536765141|FG002|Period 2|Withdrawal by Subject|13|||
148804574|NCT03104374|536765142|FG003|Period 2|Withdrawal by Subject|16|||
148804575|NCT03104374|536765139|FG000|Period 2|Lost to Follow-up|2|||
148804576|NCT03104374|536765140|FG001|Period 2|Lost to Follow-up|2|||
148804577|NCT03104374|536765141|FG002|Period 2|Lost to Follow-up|3|||
148804578|NCT03104374|536765142|FG003|Period 2|Lost to Follow-up|5|||
148804579|NCT03104374|536765139|FG000|Period 2|Lack of Efficacy|2|||
148804580|NCT03104374|536765140|FG001|Period 2|Lack of Efficacy|4|||
148804581|NCT03104374|536765141|FG002|Period 2|Lack of Efficacy|7|||
148804582|NCT03104374|536765142|FG003|Period 2|Lack of Efficacy|4|||
148804583|NCT03104374|536765139|FG000|Period 2|COVID-19 Infection|0|||
148804584|NCT03104374|536765140|FG001|Period 2|COVID-19 Infection|0|||
148804585|NCT03104374|536765141|FG002|Period 2|COVID-19 Infection|1|||
148804586|NCT03104374|536765142|FG003|Period 2|COVID-19 Infection|0|||
148804587|NCT03104374|536765139|FG000|Period 2|Other|3|||
148804588|NCT03104374|536765140|FG001|Period 2|Other|2|||
148804589|NCT03104374|536765141|FG002|Period 2|Other|2|||
148804590|NCT03104374|536765142|FG003|Period 2|Other|4|||
148804591|NCT02121210|536765143|FG000|Overall Study|Adverse Event|5|||
149139854|NCT02273726|537991979|FG000|Overall Study|Physician Decision|30|||
149139855|NCT02273726|537991980|FG001|Overall Study|Physician Decision|15|||
149139856|NCT02273726|537991979|FG000|Overall Study|Adverse Event|27|||
149139857|NCT02273726|537991980|FG001|Overall Study|Adverse Event|9|||
149139858|NCT02273726|537991979|FG000|Overall Study|Lost to Follow-up|6|||
149139859|NCT02273726|537991980|FG001|Overall Study|Lost to Follow-up|3|||
149139860|NCT02273726|537991979|FG000|Overall Study|Lack of Efficacy|6|||
149139861|NCT02273726|537991980|FG001|Overall Study|Lack of Efficacy|1|||
149139862|NCT02273726|537991979|FG000|Overall Study|Protocol Violation|4|||
149139863|NCT02273726|537991980|FG001|Overall Study|Protocol Violation|0|||
149139864|NCT02273726|537991979|FG000|Overall Study|Other than specified|28|||
149139865|NCT02273726|537991980|FG001|Overall Study|Other than specified|30|||
149139866|NCT01479829|537991981|FG000|Overall Study|Withdrawal by Subject|8|||
149139867|NCT01479829|537991982|FG001|Overall Study|Withdrawal by Subject|10|||
149139868|NCT00257166|537994075|FG000|Overall Study|Adverse Event|18|||
149139869|NCT00257166|537994076|FG001|Overall Study|Adverse Event|13|||
148912634|NCT03110770|537164670|FG000|Overall Study|Investigator Decision|0|||
148912635|NCT03110770|537164671|FG001|Overall Study|Investigator Decision|0|||
148912636|NCT03110770|537164672|FG002|Overall Study|Investigator Decision|0|||
148912637|NCT03110770|537164673|FG003|Overall Study|Investigator Decision|5|||
148912638|NCT03110770|537164674|FG004|Overall Study|Investigator Decision|3|||
148912639|NCT03110770|537164670|FG000|Overall Study|Withdrawal by Subject|0|||
148912640|NCT03110770|537164671|FG001|Overall Study|Withdrawal by Subject|0|||
148912641|NCT03110770|537164672|FG002|Overall Study|Withdrawal by Subject|0|||
148912642|NCT03110770|537164673|FG003|Overall Study|Withdrawal by Subject|24|||
148912643|NCT03110770|537164674|FG004|Overall Study|Withdrawal by Subject|24|||
148912644|NCT03110770|537164670|FG000|Overall Study|Moved from area|5|||
148912645|NCT03110770|537164671|FG001|Overall Study|Moved from area|0|||
148912646|NCT03110770|537164672|FG002|Overall Study|Moved from area|2|||
148912647|NCT03110770|537164673|FG003|Overall Study|Moved from area|42|||
148912648|NCT03110770|537164674|FG004|Overall Study|Moved from area|43|||
148912649|NCT03110770|537164670|FG000|Overall Study|Illness/Injury unrelated to product|0|||
148912650|NCT03110770|537164671|FG001|Overall Study|Illness/Injury unrelated to product|0|||
148912651|NCT03110770|537164672|FG002|Overall Study|Illness/Injury unrelated to product|0|||
148912652|NCT03110770|537164673|FG003|Overall Study|Illness/Injury unrelated to product|0|||
148912653|NCT03110770|537164674|FG004|Overall Study|Illness/Injury unrelated to product|1|||
148912654|NCT01667419|537164675|FG000|Overall Study|Reason Not Specified|1|||
148912655|NCT01667419|537164676|FG001|Overall Study|Reason Not Specified|0|||
149139870|NCT00257166|537994075|FG000|Overall Study|Laboratory abnormality|1|||
149139871|NCT00257166|537994076|FG001|Overall Study|Laboratory abnormality|0|||
149139872|NCT00257166|537994075|FG000|Overall Study|Lost to Follow-up|8|||
149139873|NCT00257166|537994076|FG001|Overall Study|Lost to Follow-up|1|||
149139874|NCT00257166|537994075|FG000|Overall Study|Withdrawal by Subject|9|||
149139875|NCT00257166|537994076|FG001|Overall Study|Withdrawal by Subject|2|||
149139876|NCT00257166|537994075|FG000|Overall Study|Other|16|||
149139877|NCT00257166|537994076|FG001|Overall Study|Other|21|||
149139878|NCT00257166|537994075|FG000|Overall Study|Randomized, but not treated|1|||
149139879|NCT00257166|537994076|FG001|Overall Study|Randomized, but not treated|0|||
149139880|NCT02142738|537994077|FG000|Overall Study|Adverse Event|13|||
149139881|NCT02142738|537994078|FG001|Overall Study|Adverse Event|9|||
149139882|NCT02142738|537994077|FG000|Overall Study|Death|92|||
149139883|NCT02142738|537994078|FG001|Overall Study|Death|112|||
149139884|NCT02142738|537994077|FG000|Overall Study|Lost to Follow-up|0|||
149139885|NCT02142738|537994078|FG001|Overall Study|Lost to Follow-up|3|||
149139886|NCT02142738|537994077|FG000|Overall Study|Withdrawal by Subject|6|||
149139887|NCT02142738|537994078|FG001|Overall Study|Withdrawal by Subject|7|||
149139888|NCT02142738|537994077|FG000|Overall Study|Follow up ended by sponsor|43|||
149139889|NCT02142738|537994078|FG001|Overall Study|Follow up ended by sponsor|20|||
149012057|NCT04250337|537523451|FG000|Overall Study|Lack of Efficacy|1|||
149012058|NCT04250337|537523452|FG001|Overall Study|Lack of Efficacy|3|||
149012059|NCT04250337|537523451|FG000|Overall Study|Physician Decision|1|||
149012060|NCT04250337|537523452|FG001|Overall Study|Physician Decision|0|||
149012061|NCT04250337|537523451|FG000|Overall Study|Protocol Deviation|2|||
149012062|NCT04250337|537523452|FG001|Overall Study|Protocol Deviation|2|||
149139890|NCT03688880|537994079|FG000|Overall Study|Withdrawal by Subject|0|||
148912656|NCT01667419|537164677|FG002|Overall Study|Reason Not Specified|0|||
148912657|NCT01667419|537164678|FG003|Overall Study|Reason Not Specified|0|||
149012063|NCT04250337|537523451|FG000|Overall Study|Withdrawal by Subject|4|||
149139891|NCT03688880|537994080|FG001|Overall Study|Withdrawal by Subject|2|||
149139892|NCT03688880|537994079|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
149139893|NCT03688880|537994080|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
149139894|NCT03688880|537994079|FG000|Overall Study|Lost to Follow-up|4|||
149139895|NCT03688880|537994080|FG001|Overall Study|Lost to Follow-up|7|||
148912658|NCT01667419|537164675|FG000|Overall Study|Withdrawal by Subject|16|||
148912659|NCT01667419|537164676|FG001|Overall Study|Withdrawal by Subject|8|||
149012064|NCT04250337|537523452|FG001|Overall Study|Withdrawal by Subject|3|||
149139896|NCT03688880|537994079|FG000|Overall Study|Adverse Event|0|||
149139897|NCT03688880|537994080|FG001|Overall Study|Adverse Event|2|||
149139898|NCT03688880|537994079|FG000|Overall Study|Device deficiencies|0|||
148912660|NCT01667419|537164677|FG002|Overall Study|Withdrawal by Subject|9|||
148912661|NCT01667419|537164678|FG003|Overall Study|Withdrawal by Subject|8|||
148912662|NCT01667419|537164675|FG000|Overall Study|Non-compliance|0|||
148912663|NCT01667419|537164676|FG001|Overall Study|Non-compliance|0|||
148912664|NCT01667419|537164677|FG002|Overall Study|Non-compliance|0|||
148912665|NCT01667419|537164678|FG003|Overall Study|Non-compliance|1|||
148912666|NCT01667419|537164675|FG000|Overall Study|Protocol Violation|1|||
148912667|NCT01667419|537164676|FG001|Overall Study|Protocol Violation|0|||
148912668|NCT01667419|537164677|FG002|Overall Study|Protocol Violation|0|||
148912669|NCT01667419|537164678|FG003|Overall Study|Protocol Violation|0|||
148912670|NCT01667419|537164675|FG000|Overall Study|Lost to Follow-up|7|||
148912671|NCT01667419|537164676|FG001|Overall Study|Lost to Follow-up|6|||
148912672|NCT01667419|537164677|FG002|Overall Study|Lost to Follow-up|2|||
148912673|NCT01667419|537164678|FG003|Overall Study|Lost to Follow-up|4|||
148912674|NCT01667419|537164675|FG000|Overall Study|Death|18|||
148912675|NCT01667419|537164676|FG001|Overall Study|Death|33|||
148912676|NCT01667419|537164677|FG002|Overall Study|Death|25|||
148912677|NCT01667419|537164678|FG003|Overall Study|Death|26|||
148912678|NCT00856518|537164679|FG000|Overall Study|Lost to Follow-up|4|||
148912679|NCT00856518|537164680|FG001|Overall Study|Lost to Follow-up|2|||
148912680|NCT02082340|537164682|FG000|Overall Study|Lost to Follow-up|1|||
148912681|NCT02082340|537164683|FG001|Overall Study|Lost to Follow-up|1|||
148912682|NCT04195893|537164692|FG000|Second Intervention|Withdrawal by Subject|1|||
148912683|NCT04195893|537164693|FG001|Second Intervention|Withdrawal by Subject|0|||
148912684|NCT00918736|537164696|FG000|Overall Study|Withdrawal by Subject|4|||
148912685|NCT01942733|537164697|FG000|Overall Study|Lost to Follow-up|1|||
148912686|NCT01942733|537164697|FG000|Overall Study|Non-compliance with IMP|1|||
148912687|NCT01942733|537164697|FG000|Overall Study|Administrative|1|||
148912688|NCT02625909|537164698|FG000|Overall Study|Death|2|||
148912689|NCT02625909|537164699|FG001|Overall Study|Death|0|||
148912690|NCT02625909|537164698|FG000|Overall Study|Lost to Follow-up|3|||
148912691|NCT02625909|537164699|FG001|Overall Study|Lost to Follow-up|5|||
148912692|NCT02625909|537164698|FG000|Overall Study|Lack of Efficacy|9|||
149139899|NCT03688880|537994080|FG001|Overall Study|Device deficiencies|2|||
149139900|NCT03688880|537994079|FG000|Overall Study|Other|10|||
148804592|NCT02121210|536765144|FG001|Overall Study|Adverse Event|7|||
148804593|NCT02121210|536765143|FG000|Overall Study|Lack of Efficacy|2|||
148804594|NCT02121210|536765144|FG001|Overall Study|Lack of Efficacy|0|||
148804595|NCT02121210|536765143|FG000|Overall Study|Other than specified above|0|||
148804596|NCT02121210|536765144|FG001|Overall Study|Other than specified above|2|||
148804597|NCT00909870|536765145|FG000|Overall Study|Adverse Event|13|||
148804598|NCT00909870|536765146|FG001|Overall Study|Adverse Event|7|||
148804599|NCT00909870|536765145|FG000|Overall Study|Protocol Violation|1|||
148804600|NCT00909870|536765146|FG001|Overall Study|Protocol Violation|2|||
148804601|NCT00909870|536765145|FG000|Overall Study|Withdrawal by Subject|5|||
148804602|NCT00909870|536765146|FG001|Overall Study|Withdrawal by Subject|8|||
148804603|NCT00909870|536765145|FG000|Overall Study|Lost to Follow-up|3|||
148804604|NCT00909870|536765146|FG001|Overall Study|Lost to Follow-up|3|||
148804605|NCT00909870|536765145|FG000|Overall Study|Physician Decision|0|||
148804606|NCT00909870|536765146|FG001|Overall Study|Physician Decision|2|||
148804607|NCT00909870|536765145|FG000|Overall Study|Other|1|||
148804608|NCT00909870|536765146|FG001|Overall Study|Other|5|||
148804609|NCT01773928|536765150|FG000|Overall Study|Adverse Event|0|||
148804610|NCT01773928|536765151|FG001|Overall Study|Adverse Event|0|||
148804611|NCT01773928|536765152|FG002|Overall Study|Adverse Event|0|||
148804612|NCT01773928|536765153|FG003|Overall Study|Adverse Event|0|||
148804613|NCT01773928|536765154|FG004|Overall Study|Adverse Event|0|||
148804614|NCT01773928|536765155|FG005|Overall Study|Adverse Event|0|||
148804615|NCT01773928|536765156|FG006|Overall Study|Adverse Event|0|||
148804616|NCT01773928|536765157|FG007|Overall Study|Adverse Event|1|||
148804617|NCT01773928|536765158|FG008|Overall Study|Adverse Event|0|||
148804618|NCT01773928|536765150|FG000|Overall Study|Physician Decision|0|||
148804619|NCT01773928|536765151|FG001|Overall Study|Physician Decision|0|||
148804620|NCT01773928|536765152|FG002|Overall Study|Physician Decision|0|||
148804621|NCT01773928|536765153|FG003|Overall Study|Physician Decision|1|||
148804622|NCT01773928|536765154|FG004|Overall Study|Physician Decision|0|||
148804623|NCT01773928|536765155|FG005|Overall Study|Physician Decision|0|||
148804624|NCT01773928|536765156|FG006|Overall Study|Physician Decision|0|||
148804625|NCT01773928|536765157|FG007|Overall Study|Physician Decision|0|||
148804626|NCT01773928|536765158|FG008|Overall Study|Physician Decision|0|||
148804627|NCT01773928|536765150|FG000|Overall Study|Withdrawal by Subject|5|||
148912693|NCT02625909|537164699|FG001|Overall Study|Lack of Efficacy|2|||
148912694|NCT02625909|537164698|FG000|Overall Study|Reinfection|3|||
148804628|NCT01773928|536765151|FG001|Overall Study|Withdrawal by Subject|4|||
148804629|NCT01773928|536765152|FG002|Overall Study|Withdrawal by Subject|4|||
148804630|NCT01773928|536765153|FG003|Overall Study|Withdrawal by Subject|4|||
148804631|NCT01773928|536765154|FG004|Overall Study|Withdrawal by Subject|7|||
148912695|NCT02625909|537164699|FG001|Overall Study|Reinfection|2|||
148670824|NCT05553600|536266993|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
148670825|NCT05553600|536266990|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
148670826|NCT05553600|536266991|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
148670827|NCT05553600|536266992|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
148670828|NCT05553600|536266993|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
149139901|NCT03688880|537994080|FG001|Overall Study|Other|16|||
148670829|NCT05553600|536266990|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
148670830|NCT05553600|536266991|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
148670831|NCT05553600|536266992|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
148670832|NCT05553600|536266993|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
148670833|NCT05553600|536266990|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
148670834|NCT05553600|536266991|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
148670835|NCT05553600|536266992|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
148670836|NCT05553600|536266993|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
148670837|NCT05553600|536266990|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
148670838|NCT05553600|536266991|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
148804632|NCT01773928|536765155|FG005|Overall Study|Withdrawal by Subject|1|||
149139902|NCT01704287|537994081|FG000|Initial Treatment Period|Death|139|||
149139903|NCT01704287|537994082|FG001|Initial Treatment Period|Death|129|||
148804633|NCT01773928|536765156|FG006|Overall Study|Withdrawal by Subject|0|||
148804634|NCT01773928|536765157|FG007|Overall Study|Withdrawal by Subject|0|||
148804635|NCT01773928|536765158|FG008|Overall Study|Withdrawal by Subject|1|||
148804636|NCT01773928|536765150|FG000|Overall Study|Lost to Follow-up|0|||
148804637|NCT01773928|536765151|FG001|Overall Study|Lost to Follow-up|0|||
148804638|NCT01773928|536765152|FG002|Overall Study|Lost to Follow-up|0|||
148804639|NCT01773928|536765153|FG003|Overall Study|Lost to Follow-up|0|||
148804640|NCT01773928|536765154|FG004|Overall Study|Lost to Follow-up|0|||
148804641|NCT01773928|536765155|FG005|Overall Study|Lost to Follow-up|1|||
148804642|NCT01773928|536765156|FG006|Overall Study|Lost to Follow-up|0|||
148804643|NCT01773928|536765157|FG007|Overall Study|Lost to Follow-up|0|||
148804644|NCT01773928|536765158|FG008|Overall Study|Lost to Follow-up|0|||
148804645|NCT01773928|536765150|FG000|Overall Study|Subject misrepresented age|0|||
148804646|NCT01773928|536765151|FG001|Overall Study|Subject misrepresented age|1|||
148804647|NCT01773928|536765152|FG002|Overall Study|Subject misrepresented age|0|||
148804648|NCT01773928|536765153|FG003|Overall Study|Subject misrepresented age|0|||
148804649|NCT01773928|536765154|FG004|Overall Study|Subject misrepresented age|0|||
148804650|NCT01773928|536765155|FG005|Overall Study|Subject misrepresented age|0|||
148804651|NCT01773928|536765156|FG006|Overall Study|Subject misrepresented age|0|||
148804652|NCT01773928|536765157|FG007|Overall Study|Subject misrepresented age|0|||
148804653|NCT01773928|536765158|FG008|Overall Study|Subject misrepresented age|0|||
148804654|NCT01773928|536765150|FG000|Overall Study|Subject met exclusion criteria|0|||
148804655|NCT01773928|536765151|FG001|Overall Study|Subject met exclusion criteria|0|||
148804656|NCT01773928|536765152|FG002|Overall Study|Subject met exclusion criteria|0|||
148804657|NCT01773928|536765153|FG003|Overall Study|Subject met exclusion criteria|0|||
148804658|NCT01773928|536765154|FG004|Overall Study|Subject met exclusion criteria|0|||
148804659|NCT01773928|536765155|FG005|Overall Study|Subject met exclusion criteria|0|||
148804660|NCT01773928|536765156|FG006|Overall Study|Subject met exclusion criteria|0|||
148804661|NCT01773928|536765157|FG007|Overall Study|Subject met exclusion criteria|0|||
148804662|NCT01773928|536765158|FG008|Overall Study|Subject met exclusion criteria|1|||
148804663|NCT01773928|536765150|FG000|Overall Study|Randomized, had to leave, never returned|0|||
148804664|NCT01773928|536765151|FG001|Overall Study|Randomized, had to leave, never returned|0|||
148804665|NCT01773928|536765152|FG002|Overall Study|Randomized, had to leave, never returned|0|||
148804666|NCT01773928|536765153|FG003|Overall Study|Randomized, had to leave, never returned|1|||
148804667|NCT01773928|536765154|FG004|Overall Study|Randomized, had to leave, never returned|0|||
148804668|NCT01773928|536765155|FG005|Overall Study|Randomized, had to leave, never returned|0|||
148804669|NCT01773928|536765156|FG006|Overall Study|Randomized, had to leave, never returned|0|||
148804670|NCT01773928|536765157|FG007|Overall Study|Randomized, had to leave, never returned|0|||
148804671|NCT01773928|536765158|FG008|Overall Study|Randomized, had to leave, never returned|0|||
148804672|NCT01773928|536765150|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
148804673|NCT01773928|536765151|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
148804674|NCT01773928|536765152|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
148804675|NCT01773928|536765153|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
148804676|NCT01773928|536765154|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
148804677|NCT01773928|536765155|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
148804678|NCT01773928|536765156|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
148804679|NCT01773928|536765157|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
148804680|NCT01773928|536765158|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
148804681|NCT03054428|536765159|FG000|Overall Study|Physician Decision|0|||
148804682|NCT03054428|536765160|FG001|Overall Study|Physician Decision|1|||
148804683|NCT03054428|536765161|FG002|Overall Study|Physician Decision|1|||
149139904|NCT01704287|537994083|FG002|Initial Treatment Period|Death|71|||
149139905|NCT01704287|537994084|FG003|Initial Treatment Period|Death|0|||
149139906|NCT01704287|537994085|FG004|Initial Treatment Period|Death|0|||
149139907|NCT01704287|537994081|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
149139908|NCT01704287|537994082|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
149139909|NCT01704287|537994083|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
149139910|NCT01704287|537994084|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
149139911|NCT01704287|537994085|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
149139912|NCT01704287|537994081|FG000|Initial Treatment Period|Lost to Follow-up|5|||
149139913|NCT01704287|537994082|FG001|Initial Treatment Period|Lost to Follow-up|3|||
149139914|NCT01704287|537994083|FG002|Initial Treatment Period|Lost to Follow-up|0|||
149139915|NCT01704287|537994084|FG003|Initial Treatment Period|Lost to Follow-up|0|||
149139916|NCT01704287|537994085|FG004|Initial Treatment Period|Lost to Follow-up|0|||
149139917|NCT01704287|537994081|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
149139918|NCT01704287|537994082|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
149139919|NCT01704287|537994083|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
149139920|NCT01704287|537994084|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
149139921|NCT01704287|537994085|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
149139922|NCT01704287|537994081|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
149139923|NCT01704287|537994082|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
149139924|NCT01704287|537994083|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
149139925|NCT01704287|537994084|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
149139926|NCT01704287|537994085|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
149139927|NCT01704287|537994081|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
149139928|NCT01704287|537994082|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
149139929|NCT01704287|537994083|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
149139930|NCT01704287|537994084|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
149139931|NCT01704287|537994085|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
149139932|NCT01704287|537994081|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
149139933|NCT01704287|537994082|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
149139934|NCT01704287|537994083|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
149139935|NCT01704287|537994084|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
149139936|NCT01704287|537994085|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
149139937|NCT02615470|537994086|FG000|Overall Study|Lost to Follow-up|21|||
149139938|NCT02615470|537994087|FG001|Overall Study|Lost to Follow-up|32|||
149139939|NCT03713034|537994088|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
149139940|NCT03713034|537994089|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
149139941|NCT04024228|537994094|FG000|Overall Study|Adverse Event|1|||
149139942|NCT04024228|537994095|FG001|Overall Study|Adverse Event|0|||
149139943|NCT04024228|537994094|FG000|Overall Study|Protocol Deviation|0|||
149139944|NCT04024228|537994095|FG001|Overall Study|Protocol Deviation|2|||
149139945|NCT04024228|537994094|FG000|Overall Study|Withdrawal by Subject|3|||
149139946|NCT04024228|537994095|FG001|Overall Study|Withdrawal by Subject|4|||
149139947|NCT02982590|537994098|FG000|Overall Study|Lost to Follow-up|0|||
149139948|NCT02982590|537994099|FG001|Overall Study|Lost to Follow-up|1|||
149139949|NCT02982590|537994098|FG000|Overall Study|Death|4|||
149139950|NCT02982590|537994099|FG001|Overall Study|Death|0|||
149139951|NCT01168973|537994101|FG000|Overall Study|Progressive Disease|341|||
149139952|NCT01168973|537994102|FG001|Overall Study|Progressive Disease|429|||
149139953|NCT01168973|537994101|FG000|Overall Study|Adverse Event|94|||
149139954|NCT01168973|537994102|FG001|Overall Study|Adverse Event|55|||
149139955|NCT01168973|537994101|FG000|Overall Study|Withdrawal by Subject|90|||
149139956|NCT01168973|537994102|FG001|Overall Study|Withdrawal by Subject|53|||
149139957|NCT01168973|537994101|FG000|Overall Study|Death|42|||
149139958|NCT01168973|537994102|FG001|Overall Study|Death|45|||
149139959|NCT01168973|537994101|FG000|Overall Study|Physician Decision|37|||
149139960|NCT01168973|537994102|FG001|Overall Study|Physician Decision|19|||
148670839|NCT05553600|536266992|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
148670840|NCT05553600|536266993|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
149139961|NCT01168973|537994101|FG000|Overall Study|Sponsor Decision|2|||
149139962|NCT01168973|537994102|FG001|Overall Study|Sponsor Decision|1|||
149139963|NCT01168973|537994101|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
149139964|NCT01168973|537994102|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
149139965|NCT02716675|537994108|FG000|Overall Study|Death|2|||
149139966|NCT02716675|537994109|FG001|Overall Study|Death|3|||
149139967|NCT02716675|537994110|FG002|Overall Study|Death|0|||
149139968|NCT02716675|537994108|FG000|Overall Study|Physician Decision|2|||
149139969|NCT02716675|537994109|FG001|Overall Study|Physician Decision|1|||
148804684|NCT03054428|536765159|FG000|Overall Study|Lack of Efficacy|3|||
148804685|NCT03054428|536765160|FG001|Overall Study|Lack of Efficacy|1|||
148804686|NCT03054428|536765161|FG002|Overall Study|Lack of Efficacy|0|||
148804687|NCT03054428|536765159|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
149139970|NCT02716675|537994110|FG002|Overall Study|Physician Decision|1|||
149139971|NCT02716675|537994108|FG000|Overall Study|Lost to Follow-up|100|||
149139972|NCT02716675|537994109|FG001|Overall Study|Lost to Follow-up|87|||
149139973|NCT02716675|537994110|FG002|Overall Study|Lost to Follow-up|99|||
149139974|NCT02716675|537994108|FG000|Overall Study|Withdrawal by Subject|22|||
149139975|NCT02716675|537994109|FG001|Overall Study|Withdrawal by Subject|25|||
149139976|NCT02716675|537994110|FG002|Overall Study|Withdrawal by Subject|20|||
149139977|NCT02716675|537994108|FG000|Overall Study|Protocol Violation|0|||
149139978|NCT02716675|537994109|FG001|Overall Study|Protocol Violation|3|||
149139979|NCT02716675|537994110|FG002|Overall Study|Protocol Violation|1|||
149139980|NCT02716675|537994108|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
149139981|NCT02716675|537994109|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
149139982|NCT02716675|537994110|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
149139983|NCT02716675|537994108|FG000|Overall Study|Other|38|||
149139984|NCT02716675|537994109|FG001|Overall Study|Other|47|||
149139985|NCT02716675|537994110|FG002|Overall Study|Other|48|||
149139986|NCT00616434|537994113|FG000|Overall Study|Adverse Event|5|||
149139987|NCT00616434|537994114|FG001|Overall Study|Adverse Event|2|||
149139988|NCT00616434|537994113|FG000|Overall Study|Physician Decision|0|||
149139989|NCT00616434|537994114|FG001|Overall Study|Physician Decision|4|||
149139990|NCT00616434|537994113|FG000|Overall Study|Withdrawal by Subject|1|||
149139991|NCT00616434|537994114|FG001|Overall Study|Withdrawal by Subject|1|||
149139992|NCT00616434|537994113|FG000|Overall Study|Protocol deviation|0|||
149139993|NCT00616434|537994114|FG001|Overall Study|Protocol deviation|1|||
149139994|NCT00467779|537994115|FG000|Stage 1|Adverse Event|1|||
149139995|NCT00467779|537994116|FG001|Stage 1|Adverse Event|0|||
149139996|NCT00467779|537994117|FG002|Stage 1|Adverse Event|0|||
149139997|NCT00467779|537994118|FG003|Stage 1|Adverse Event|0|||
149139998|NCT00467779|537994119|FG004|Stage 1|Adverse Event|0|||
149139999|NCT00467779|537994120|FG005|Stage 1|Adverse Event|1|||
149140000|NCT00467779|537994121|FG006|Stage 1|Adverse Event|2|||
149140001|NCT00467779|537994122|FG007|Stage 1|Adverse Event|1|||
149140002|NCT00467779|537994123|FG008|Stage 1|Adverse Event|0|||
149140003|NCT00467779|537994124|FG009|Stage 1|Adverse Event|0|||
149140004|NCT00467779|537994125|FG010|Stage 1|Adverse Event|0|||
149140005|NCT00467779|537994126|FG011|Stage 1|Adverse Event|0|||
149140006|NCT00467779|537994127|FG012|Stage 1|Adverse Event|0|||
149140007|NCT00467779|537994128|FG013|Stage 1|Adverse Event|0|||
149140008|NCT00467779|537994129|FG014|Stage 1|Adverse Event|0|||
149140009|NCT00467779|537994115|FG000|Stage 1|Disease Progression|2|||
149140010|NCT00467779|537994116|FG001|Stage 1|Disease Progression|2|||
149140011|NCT00467779|537994117|FG002|Stage 1|Disease Progression|2|||
149140012|NCT00467779|537994118|FG003|Stage 1|Disease Progression|3|||
149140013|NCT00467779|537994119|FG004|Stage 1|Disease Progression|2|||
149140014|NCT00467779|537994120|FG005|Stage 1|Disease Progression|2|||
149140015|NCT00467779|537994121|FG006|Stage 1|Disease Progression|4|||
149140016|NCT00467779|537994122|FG007|Stage 1|Disease Progression|5|||
149140017|NCT00467779|537994123|FG008|Stage 1|Disease Progression|0|||
149140018|NCT00467779|537994124|FG009|Stage 1|Disease Progression|0|||
149140019|NCT00467779|537994125|FG010|Stage 1|Disease Progression|0|||
149140020|NCT00467779|537994126|FG011|Stage 1|Disease Progression|0|||
149140021|NCT00467779|537994127|FG012|Stage 1|Disease Progression|0|||
149140022|NCT00467779|537994128|FG013|Stage 1|Disease Progression|0|||
149140023|NCT00467779|537994129|FG014|Stage 1|Disease Progression|0|||
149140024|NCT00467779|537994115|FG000|Stage 1|Unspecified Reason|1|||
148912696|NCT00035932|537164707|FG000|Overall Study|Adverse Event|10|||
149140025|NCT00467779|537994116|FG001|Stage 1|Unspecified Reason|0|||
149140026|NCT00467779|537994117|FG002|Stage 1|Unspecified Reason|1|||
149140027|NCT00467779|537994118|FG003|Stage 1|Unspecified Reason|0|||
149140028|NCT00467779|537994119|FG004|Stage 1|Unspecified Reason|1|||
149140029|NCT00467779|537994120|FG005|Stage 1|Unspecified Reason|2|||
149140030|NCT00467779|537994121|FG006|Stage 1|Unspecified Reason|0|||
149140031|NCT00467779|537994122|FG007|Stage 1|Unspecified Reason|0|||
149140032|NCT00467779|537994123|FG008|Stage 1|Unspecified Reason|0|||
149140033|NCT00467779|537994124|FG009|Stage 1|Unspecified Reason|0|||
149140034|NCT00467779|537994125|FG010|Stage 1|Unspecified Reason|0|||
149140035|NCT00467779|537994126|FG011|Stage 1|Unspecified Reason|0|||
149140036|NCT00467779|537994127|FG012|Stage 1|Unspecified Reason|0|||
149140037|NCT00467779|537994128|FG013|Stage 1|Unspecified Reason|0|||
149140038|NCT00467779|537994129|FG014|Stage 1|Unspecified Reason|0|||
149140039|NCT00467779|537994115|FG000|Stage 1|Physician Decision|0|||
149140040|NCT00467779|537994116|FG001|Stage 1|Physician Decision|1|||
149140041|NCT00467779|537994117|FG002|Stage 1|Physician Decision|0|||
149140042|NCT00467779|537994118|FG003|Stage 1|Physician Decision|0|||
149140043|NCT00467779|537994119|FG004|Stage 1|Physician Decision|0|||
149140044|NCT00467779|537994120|FG005|Stage 1|Physician Decision|0|||
149140045|NCT00467779|537994121|FG006|Stage 1|Physician Decision|0|||
149140046|NCT00467779|537994122|FG007|Stage 1|Physician Decision|0|||
149140047|NCT00467779|537994123|FG008|Stage 1|Physician Decision|0|||
149140048|NCT00467779|537994124|FG009|Stage 1|Physician Decision|0|||
149140049|NCT00467779|537994125|FG010|Stage 1|Physician Decision|0|||
149140050|NCT00467779|537994126|FG011|Stage 1|Physician Decision|0|||
149140051|NCT00467779|537994127|FG012|Stage 1|Physician Decision|0|||
149140052|NCT00467779|537994128|FG013|Stage 1|Physician Decision|0|||
149140053|NCT00467779|537994129|FG014|Stage 1|Physician Decision|0|||
149140054|NCT00467779|537994115|FG000|Stage 1|Withdrawal by Subject|0|||
149140055|NCT00467779|537994116|FG001|Stage 1|Withdrawal by Subject|0|||
149140056|NCT00467779|537994117|FG002|Stage 1|Withdrawal by Subject|0|||
149140057|NCT00467779|537994118|FG003|Stage 1|Withdrawal by Subject|0|||
149140058|NCT00467779|537994119|FG004|Stage 1|Withdrawal by Subject|0|||
149140059|NCT00467779|537994120|FG005|Stage 1|Withdrawal by Subject|0|||
149140060|NCT00467779|537994121|FG006|Stage 1|Withdrawal by Subject|1|||
149140061|NCT00467779|537994122|FG007|Stage 1|Withdrawal by Subject|1|||
149140062|NCT00467779|537994123|FG008|Stage 1|Withdrawal by Subject|0|||
149140063|NCT00467779|537994124|FG009|Stage 1|Withdrawal by Subject|0|||
149140064|NCT00467779|537994125|FG010|Stage 1|Withdrawal by Subject|0|||
149140065|NCT00467779|537994126|FG011|Stage 1|Withdrawal by Subject|0|||
149140066|NCT00467779|537994127|FG012|Stage 1|Withdrawal by Subject|0|||
149140067|NCT00467779|537994128|FG013|Stage 1|Withdrawal by Subject|0|||
149140068|NCT00467779|537994129|FG014|Stage 1|Withdrawal by Subject|0|||
149140069|NCT00467779|537994115|FG000|Stage 1A|Adverse Event|0|||
149140070|NCT00467779|537994116|FG001|Stage 1A|Adverse Event|0|||
149140071|NCT00467779|537994117|FG002|Stage 1A|Adverse Event|0|||
149140072|NCT00467779|537994118|FG003|Stage 1A|Adverse Event|0|||
149140073|NCT00467779|537994119|FG004|Stage 1A|Adverse Event|0|||
149140074|NCT00467779|537994120|FG005|Stage 1A|Adverse Event|0|||
149140075|NCT00467779|537994121|FG006|Stage 1A|Adverse Event|0|||
149140076|NCT00467779|537994122|FG007|Stage 1A|Adverse Event|0|||
149140077|NCT00467779|537994123|FG008|Stage 1A|Adverse Event|0|||
149140078|NCT00467779|537994124|FG009|Stage 1A|Adverse Event|0|||
149140079|NCT00467779|537994125|FG010|Stage 1A|Adverse Event|0|||
149140080|NCT00467779|537994126|FG011|Stage 1A|Adverse Event|0|||
149140081|NCT00467779|537994127|FG012|Stage 1A|Adverse Event|1|||
149140082|NCT00467779|537994128|FG013|Stage 1A|Adverse Event|0|||
149140083|NCT00467779|537994129|FG014|Stage 1A|Adverse Event|0|||
149140084|NCT00467779|537994115|FG000|Stage 1A|Death|0|||
149140085|NCT00467779|537994116|FG001|Stage 1A|Death|0|||
149140086|NCT00467779|537994117|FG002|Stage 1A|Death|0|||
149140087|NCT00467779|537994118|FG003|Stage 1A|Death|0|||
149140088|NCT00467779|537994119|FG004|Stage 1A|Death|0|||
149140089|NCT00467779|537994120|FG005|Stage 1A|Death|0|||
149140090|NCT00467779|537994121|FG006|Stage 1A|Death|0|||
149140091|NCT00467779|537994122|FG007|Stage 1A|Death|0|||
149140092|NCT00467779|537994123|FG008|Stage 1A|Death|0|||
149140093|NCT00467779|537994124|FG009|Stage 1A|Death|0|||
149140094|NCT00467779|537994125|FG010|Stage 1A|Death|0|||
149140095|NCT00467779|537994126|FG011|Stage 1A|Death|1|||
149140096|NCT00467779|537994127|FG012|Stage 1A|Death|1|||
149140097|NCT00467779|537994128|FG013|Stage 1A|Death|0|||
148912697|NCT00035932|537164708|FG001|Overall Study|Adverse Event|9|||
148912698|NCT00035932|537164709|FG002|Overall Study|Adverse Event|9|||
148912699|NCT00035932|537164707|FG000|Overall Study|Death|0|||
148912700|NCT00035932|537164708|FG001|Overall Study|Death|0|||
148912701|NCT00035932|537164709|FG002|Overall Study|Death|1|||
148912702|NCT00035932|537164707|FG000|Overall Study|Disease Progression / Relapse|1|||
148912703|NCT00035932|537164708|FG001|Overall Study|Disease Progression / Relapse|1|||
148912704|NCT00035932|537164709|FG002|Overall Study|Disease Progression / Relapse|0|||
148912705|NCT00035932|537164707|FG000|Overall Study|Lost to Follow-up|4|||
148912706|NCT00035932|537164708|FG001|Overall Study|Lost to Follow-up|4|||
148912707|NCT00035932|537164709|FG002|Overall Study|Lost to Follow-up|3|||
148912708|NCT00035932|537164707|FG000|Overall Study|Noncompliance|6|||
149140098|NCT00467779|537994129|FG014|Stage 1A|Death|0|||
149140099|NCT00467779|537994115|FG000|Stage 1A|Disease Progression|0|||
149140100|NCT00467779|537994116|FG001|Stage 1A|Disease Progression|0|||
149140101|NCT00467779|537994117|FG002|Stage 1A|Disease Progression|0|||
149140102|NCT00467779|537994118|FG003|Stage 1A|Disease Progression|0|||
149140103|NCT00467779|537994119|FG004|Stage 1A|Disease Progression|0|||
148912709|NCT00035932|537164708|FG001|Overall Study|Noncompliance|7|||
148912710|NCT00035932|537164709|FG002|Overall Study|Noncompliance|6|||
149140104|NCT00467779|537994120|FG005|Stage 1A|Disease Progression|0|||
149140105|NCT00467779|537994121|FG006|Stage 1A|Disease Progression|0|||
149140106|NCT00467779|537994122|FG007|Stage 1A|Disease Progression|0|||
149140107|NCT00467779|537994123|FG008|Stage 1A|Disease Progression|0|||
149140108|NCT00467779|537994124|FG009|Stage 1A|Disease Progression|2|||
149140109|NCT00467779|537994125|FG010|Stage 1A|Disease Progression|2|||
149140110|NCT00467779|537994126|FG011|Stage 1A|Disease Progression|5|||
149140111|NCT00467779|537994127|FG012|Stage 1A|Disease Progression|2|||
149140112|NCT00467779|537994128|FG013|Stage 1A|Disease Progression|0|||
149140113|NCT00467779|537994129|FG014|Stage 1A|Disease Progression|0|||
149140114|NCT00467779|537994115|FG000|Stage 1A|Physician Decision|0|||
149140115|NCT00467779|537994116|FG001|Stage 1A|Physician Decision|0|||
149140116|NCT00467779|537994117|FG002|Stage 1A|Physician Decision|0|||
149140117|NCT00467779|537994118|FG003|Stage 1A|Physician Decision|0|||
149140118|NCT00467779|537994119|FG004|Stage 1A|Physician Decision|0|||
149140119|NCT00467779|537994120|FG005|Stage 1A|Physician Decision|0|||
149140120|NCT00467779|537994121|FG006|Stage 1A|Physician Decision|0|||
149140121|NCT00467779|537994122|FG007|Stage 1A|Physician Decision|0|||
149140122|NCT00467779|537994123|FG008|Stage 1A|Physician Decision|0|||
149140123|NCT00467779|537994124|FG009|Stage 1A|Physician Decision|1|||
149140124|NCT00467779|537994125|FG010|Stage 1A|Physician Decision|0|||
149140125|NCT00467779|537994126|FG011|Stage 1A|Physician Decision|0|||
149140126|NCT00467779|537994127|FG012|Stage 1A|Physician Decision|0|||
149140127|NCT00467779|537994128|FG013|Stage 1A|Physician Decision|0|||
149140128|NCT00467779|537994129|FG014|Stage 1A|Physician Decision|0|||
149140129|NCT00467779|537994115|FG000|Stage 1A|Withdrawal by Subject|0|||
149140130|NCT00467779|537994116|FG001|Stage 1A|Withdrawal by Subject|0|||
149140131|NCT00467779|537994117|FG002|Stage 1A|Withdrawal by Subject|0|||
149140132|NCT00467779|537994118|FG003|Stage 1A|Withdrawal by Subject|0|||
149140133|NCT00467779|537994119|FG004|Stage 1A|Withdrawal by Subject|0|||
149140134|NCT00467779|537994120|FG005|Stage 1A|Withdrawal by Subject|0|||
149140135|NCT00467779|537994121|FG006|Stage 1A|Withdrawal by Subject|0|||
149140136|NCT00467779|537994122|FG007|Stage 1A|Withdrawal by Subject|0|||
149140137|NCT00467779|537994123|FG008|Stage 1A|Withdrawal by Subject|0|||
149140138|NCT00467779|537994124|FG009|Stage 1A|Withdrawal by Subject|0|||
149140139|NCT00467779|537994125|FG010|Stage 1A|Withdrawal by Subject|1|||
149140140|NCT00467779|537994126|FG011|Stage 1A|Withdrawal by Subject|1|||
149140141|NCT00467779|537994127|FG012|Stage 1A|Withdrawal by Subject|1|||
149140142|NCT00467779|537994128|FG013|Stage 1A|Withdrawal by Subject|0|||
149140143|NCT00467779|537994129|FG014|Stage 1A|Withdrawal by Subject|0|||
149140144|NCT00467779|537994115|FG000|Stage 1A|Unspecified Reason|0|||
149140145|NCT00467779|537994116|FG001|Stage 1A|Unspecified Reason|0|||
149140146|NCT00467779|537994117|FG002|Stage 1A|Unspecified Reason|0|||
149140147|NCT00467779|537994118|FG003|Stage 1A|Unspecified Reason|0|||
149140148|NCT00467779|537994119|FG004|Stage 1A|Unspecified Reason|0|||
149140149|NCT00467779|537994120|FG005|Stage 1A|Unspecified Reason|0|||
149140150|NCT00467779|537994121|FG006|Stage 1A|Unspecified Reason|0|||
149140151|NCT00467779|537994122|FG007|Stage 1A|Unspecified Reason|0|||
149140152|NCT00467779|537994123|FG008|Stage 1A|Unspecified Reason|0|||
149140153|NCT00467779|537994124|FG009|Stage 1A|Unspecified Reason|0|||
149140154|NCT00467779|537994125|FG010|Stage 1A|Unspecified Reason|0|||
149140155|NCT00467779|537994126|FG011|Stage 1A|Unspecified Reason|1|||
149140156|NCT00467779|537994127|FG012|Stage 1A|Unspecified Reason|1|||
149140157|NCT00467779|537994128|FG013|Stage 1A|Unspecified Reason|0|||
149140158|NCT00467779|537994129|FG014|Stage 1A|Unspecified Reason|0|||
149140159|NCT00467779|537994115|FG000|Stage 2|Adverse Event|0|||
149140160|NCT00467779|537994116|FG001|Stage 2|Adverse Event|0|||
149140161|NCT00467779|537994117|FG002|Stage 2|Adverse Event|0|||
149140162|NCT00467779|537994118|FG003|Stage 2|Adverse Event|0|||
149140163|NCT00467779|537994119|FG004|Stage 2|Adverse Event|0|||
149140164|NCT00467779|537994120|FG005|Stage 2|Adverse Event|0|||
149140165|NCT00467779|537994121|FG006|Stage 2|Adverse Event|0|||
149140166|NCT00467779|537994122|FG007|Stage 2|Adverse Event|0|||
149140167|NCT00467779|537994123|FG008|Stage 2|Adverse Event|1|||
149140168|NCT00467779|537994124|FG009|Stage 2|Adverse Event|0|||
148804688|NCT03054428|536765160|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
148804689|NCT03054428|536765161|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
148804690|NCT03054428|536765159|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
148804691|NCT03054428|536765160|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
148804692|NCT03054428|536765161|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
148804693|NCT03054428|536765159|FG000|Overall Study|Transitioned to OLE study|76|||
148804694|NCT03054428|536765160|FG001|Overall Study|Transitioned to OLE study|76|||
148804695|NCT03054428|536765161|FG002|Overall Study|Transitioned to OLE study|73|||
148804696|NCT03054428|536765159|FG000|Overall Study|Withdrawal by Subject|3|||
148804697|NCT03054428|536765160|FG001|Overall Study|Withdrawal by Subject|2|||
148804698|NCT03054428|536765161|FG002|Overall Study|Withdrawal by Subject|3|||
148804699|NCT03054428|536765159|FG000|Overall Study|Lost to Follow-up|0|||
148804700|NCT03054428|536765160|FG001|Overall Study|Lost to Follow-up|0|||
149140169|NCT00467779|537994125|FG010|Stage 2|Adverse Event|0|||
149140170|NCT00467779|537994126|FG011|Stage 2|Adverse Event|0|||
149140171|NCT00467779|537994127|FG012|Stage 2|Adverse Event|0|||
149140172|NCT00467779|537994128|FG013|Stage 2|Adverse Event|0|||
149140173|NCT00467779|537994129|FG014|Stage 2|Adverse Event|0|||
149140174|NCT00467779|537994115|FG000|Stage 2|Death|0|||
149140175|NCT00467779|537994116|FG001|Stage 2|Death|0|||
149140176|NCT00467779|537994117|FG002|Stage 2|Death|0|||
149140177|NCT00467779|537994118|FG003|Stage 2|Death|0|||
149140178|NCT00467779|537994119|FG004|Stage 2|Death|0|||
149140179|NCT00467779|537994120|FG005|Stage 2|Death|0|||
149140180|NCT00467779|537994121|FG006|Stage 2|Death|0|||
149140181|NCT00467779|537994122|FG007|Stage 2|Death|0|||
149140182|NCT00467779|537994123|FG008|Stage 2|Death|1|||
149140183|NCT00467779|537994124|FG009|Stage 2|Death|0|||
149140184|NCT00467779|537994125|FG010|Stage 2|Death|0|||
149140185|NCT00467779|537994126|FG011|Stage 2|Death|0|||
149140186|NCT00467779|537994127|FG012|Stage 2|Death|0|||
149140187|NCT00467779|537994128|FG013|Stage 2|Death|0|||
149140188|NCT00467779|537994129|FG014|Stage 2|Death|0|||
149140189|NCT00467779|537994115|FG000|Stage 2|Disease Progression|0|||
149140190|NCT00467779|537994116|FG001|Stage 2|Disease Progression|0|||
149140191|NCT00467779|537994117|FG002|Stage 2|Disease Progression|0|||
149140192|NCT00467779|537994118|FG003|Stage 2|Disease Progression|0|||
149140193|NCT00467779|537994119|FG004|Stage 2|Disease Progression|0|||
149140194|NCT00467779|537994120|FG005|Stage 2|Disease Progression|0|||
149140195|NCT00467779|537994121|FG006|Stage 2|Disease Progression|0|||
149140196|NCT00467779|537994122|FG007|Stage 2|Disease Progression|0|||
149140197|NCT00467779|537994123|FG008|Stage 2|Disease Progression|16|||
149140198|NCT00467779|537994124|FG009|Stage 2|Disease Progression|0|||
149140199|NCT00467779|537994125|FG010|Stage 2|Disease Progression|0|||
149140200|NCT00467779|537994126|FG011|Stage 2|Disease Progression|0|||
149140201|NCT00467779|537994127|FG012|Stage 2|Disease Progression|0|||
149140202|NCT00467779|537994128|FG013|Stage 2|Disease Progression|0|||
149140203|NCT00467779|537994129|FG014|Stage 2|Disease Progression|0|||
149140204|NCT00467779|537994115|FG000|Stage 2|Unspecified Reason|0|||
149140205|NCT00467779|537994116|FG001|Stage 2|Unspecified Reason|0|||
149140206|NCT00467779|537994117|FG002|Stage 2|Unspecified Reason|0|||
149140207|NCT00467779|537994118|FG003|Stage 2|Unspecified Reason|0|||
149140208|NCT00467779|537994119|FG004|Stage 2|Unspecified Reason|0|||
149140209|NCT00467779|537994120|FG005|Stage 2|Unspecified Reason|0|||
149140210|NCT00467779|537994121|FG006|Stage 2|Unspecified Reason|0|||
149140211|NCT00467779|537994122|FG007|Stage 2|Unspecified Reason|0|||
149140212|NCT00467779|537994123|FG008|Stage 2|Unspecified Reason|3|||
149140213|NCT00467779|537994124|FG009|Stage 2|Unspecified Reason|0|||
149140214|NCT00467779|537994125|FG010|Stage 2|Unspecified Reason|0|||
149140215|NCT00467779|537994126|FG011|Stage 2|Unspecified Reason|0|||
149140216|NCT00467779|537994127|FG012|Stage 2|Unspecified Reason|0|||
149140217|NCT00467779|537994128|FG013|Stage 2|Unspecified Reason|0|||
149140218|NCT00467779|537994129|FG014|Stage 2|Unspecified Reason|0|||
149140219|NCT00467779|537994115|FG000|Stage 2A|Adverse Event|0|||
149140220|NCT00467779|537994116|FG001|Stage 2A|Adverse Event|0|||
149140221|NCT00467779|537994117|FG002|Stage 2A|Adverse Event|0|||
149140222|NCT00467779|537994118|FG003|Stage 2A|Adverse Event|0|||
149140223|NCT00467779|537994119|FG004|Stage 2A|Adverse Event|0|||
149140224|NCT00467779|537994120|FG005|Stage 2A|Adverse Event|0|||
149140225|NCT00467779|537994121|FG006|Stage 2A|Adverse Event|0|||
149140226|NCT00467779|537994122|FG007|Stage 2A|Adverse Event|0|||
149140227|NCT00467779|537994123|FG008|Stage 2A|Adverse Event|0|||
149140228|NCT00467779|537994124|FG009|Stage 2A|Adverse Event|0|||
149140229|NCT00467779|537994125|FG010|Stage 2A|Adverse Event|0|||
149140230|NCT00467779|537994126|FG011|Stage 2A|Adverse Event|0|||
149140231|NCT00467779|537994127|FG012|Stage 2A|Adverse Event|0|||
149140232|NCT00467779|537994128|FG013|Stage 2A|Adverse Event|2|||
149140233|NCT00467779|537994129|FG014|Stage 2A|Adverse Event|0|||
149140234|NCT00467779|537994115|FG000|Stage 2A|Death|0|||
149140235|NCT00467779|537994116|FG001|Stage 2A|Death|0|||
149140236|NCT00467779|537994117|FG002|Stage 2A|Death|0|||
149140237|NCT00467779|537994118|FG003|Stage 2A|Death|0|||
149140238|NCT00467779|537994119|FG004|Stage 2A|Death|0|||
149140239|NCT00467779|537994120|FG005|Stage 2A|Death|0|||
149140240|NCT00467779|537994121|FG006|Stage 2A|Death|0|||
149140241|NCT00467779|537994122|FG007|Stage 2A|Death|0|||
149140242|NCT00467779|537994123|FG008|Stage 2A|Death|0|||
149140243|NCT00467779|537994124|FG009|Stage 2A|Death|0|||
149140244|NCT00467779|537994125|FG010|Stage 2A|Death|0|||
149140245|NCT00467779|537994126|FG011|Stage 2A|Death|0|||
149140246|NCT00467779|537994127|FG012|Stage 2A|Death|0|||
149140247|NCT00467779|537994128|FG013|Stage 2A|Death|1|||
148804701|NCT03054428|536765161|FG002|Overall Study|Lost to Follow-up|1|||
149140248|NCT00467779|537994129|FG014|Stage 2A|Death|0|||
149140249|NCT00467779|537994115|FG000|Stage 2A|Disease Progression|0|||
149140250|NCT00467779|537994116|FG001|Stage 2A|Disease Progression|0|||
149140251|NCT00467779|537994117|FG002|Stage 2A|Disease Progression|0|||
149140252|NCT00467779|537994118|FG003|Stage 2A|Disease Progression|0|||
149140253|NCT00467779|537994119|FG004|Stage 2A|Disease Progression|0|||
149140254|NCT00467779|537994120|FG005|Stage 2A|Disease Progression|0|||
149140255|NCT00467779|537994121|FG006|Stage 2A|Disease Progression|0|||
149140256|NCT00467779|537994122|FG007|Stage 2A|Disease Progression|0|||
149140257|NCT00467779|537994123|FG008|Stage 2A|Disease Progression|0|||
149140258|NCT00467779|537994124|FG009|Stage 2A|Disease Progression|0|||
149140259|NCT00467779|537994125|FG010|Stage 2A|Disease Progression|0|||
149140260|NCT00467779|537994126|FG011|Stage 2A|Disease Progression|0|||
149140261|NCT00467779|537994127|FG012|Stage 2A|Disease Progression|0|||
149140262|NCT00467779|537994128|FG013|Stage 2A|Disease Progression|10|||
149140263|NCT00467779|537994129|FG014|Stage 2A|Disease Progression|0|||
149140264|NCT00467779|537994115|FG000|Stage 2A|Unspecified Reason|0|||
149140265|NCT00467779|537994116|FG001|Stage 2A|Unspecified Reason|0|||
149140266|NCT00467779|537994117|FG002|Stage 2A|Unspecified Reason|0|||
149140267|NCT00467779|537994118|FG003|Stage 2A|Unspecified Reason|0|||
149140268|NCT00467779|537994119|FG004|Stage 2A|Unspecified Reason|0|||
149140269|NCT00467779|537994120|FG005|Stage 2A|Unspecified Reason|0|||
149140270|NCT00467779|537994121|FG006|Stage 2A|Unspecified Reason|0|||
149140271|NCT00467779|537994122|FG007|Stage 2A|Unspecified Reason|0|||
149140272|NCT00467779|537994123|FG008|Stage 2A|Unspecified Reason|0|||
149140273|NCT00467779|537994124|FG009|Stage 2A|Unspecified Reason|0|||
149140274|NCT00467779|537994125|FG010|Stage 2A|Unspecified Reason|0|||
149140275|NCT00467779|537994126|FG011|Stage 2A|Unspecified Reason|0|||
149140276|NCT00467779|537994127|FG012|Stage 2A|Unspecified Reason|0|||
149140277|NCT00467779|537994128|FG013|Stage 2A|Unspecified Reason|7|||
149140278|NCT00467779|537994129|FG014|Stage 2A|Unspecified Reason|0|||
149140279|NCT00467779|537994115|FG000|Stage 2A|Withdrawal by Subject|0|||
149140280|NCT00467779|537994116|FG001|Stage 2A|Withdrawal by Subject|0|||
149140281|NCT00467779|537994117|FG002|Stage 2A|Withdrawal by Subject|0|||
149140282|NCT00467779|537994118|FG003|Stage 2A|Withdrawal by Subject|0|||
149140283|NCT00467779|537994119|FG004|Stage 2A|Withdrawal by Subject|0|||
149140284|NCT00467779|537994120|FG005|Stage 2A|Withdrawal by Subject|0|||
149140285|NCT00467779|537994121|FG006|Stage 2A|Withdrawal by Subject|0|||
149140286|NCT00467779|537994122|FG007|Stage 2A|Withdrawal by Subject|0|||
149140287|NCT00467779|537994123|FG008|Stage 2A|Withdrawal by Subject|0|||
149140288|NCT00467779|537994124|FG009|Stage 2A|Withdrawal by Subject|0|||
149140289|NCT00467779|537994125|FG010|Stage 2A|Withdrawal by Subject|0|||
149140290|NCT00467779|537994126|FG011|Stage 2A|Withdrawal by Subject|0|||
149140291|NCT00467779|537994127|FG012|Stage 2A|Withdrawal by Subject|0|||
149140292|NCT00467779|537994128|FG013|Stage 2A|Withdrawal by Subject|1|||
149140293|NCT00467779|537994129|FG014|Stage 2A|Withdrawal by Subject|0|||
149140294|NCT00467779|537994115|FG000|Stage 3|Adverse Event|0|||
149140295|NCT00467779|537994116|FG001|Stage 3|Adverse Event|0|||
149140296|NCT00467779|537994117|FG002|Stage 3|Adverse Event|0|||
149140297|NCT00467779|537994118|FG003|Stage 3|Adverse Event|0|||
149140298|NCT00467779|537994119|FG004|Stage 3|Adverse Event|0|||
149140299|NCT00467779|537994120|FG005|Stage 3|Adverse Event|0|||
149140300|NCT00467779|537994121|FG006|Stage 3|Adverse Event|0|||
149140301|NCT00467779|537994122|FG007|Stage 3|Adverse Event|0|||
149140302|NCT00467779|537994123|FG008|Stage 3|Adverse Event|0|||
149140303|NCT00467779|537994124|FG009|Stage 3|Adverse Event|0|||
149140304|NCT00467779|537994125|FG010|Stage 3|Adverse Event|0|||
149140305|NCT00467779|537994126|FG011|Stage 3|Adverse Event|0|||
149140306|NCT00467779|537994127|FG012|Stage 3|Adverse Event|0|||
149140307|NCT00467779|537994128|FG013|Stage 3|Adverse Event|0|||
149140308|NCT00467779|537994129|FG014|Stage 3|Adverse Event|2|||
149140309|NCT00467779|537994115|FG000|Stage 3|Death|0|||
149140310|NCT00467779|537994116|FG001|Stage 3|Death|0|||
149140311|NCT00467779|537994117|FG002|Stage 3|Death|0|||
149140312|NCT00467779|537994118|FG003|Stage 3|Death|0|||
149140313|NCT00467779|537994119|FG004|Stage 3|Death|0|||
149140314|NCT00467779|537994120|FG005|Stage 3|Death|0|||
149140315|NCT00467779|537994121|FG006|Stage 3|Death|0|||
149140316|NCT00467779|537994122|FG007|Stage 3|Death|0|||
149140317|NCT00467779|537994123|FG008|Stage 3|Death|0|||
149140318|NCT00467779|537994124|FG009|Stage 3|Death|0|||
149140319|NCT00467779|537994125|FG010|Stage 3|Death|0|||
149140320|NCT00467779|537994126|FG011|Stage 3|Death|0|||
149140321|NCT00467779|537994127|FG012|Stage 3|Death|0|||
149140322|NCT00467779|537994128|FG013|Stage 3|Death|0|||
149140323|NCT00467779|537994129|FG014|Stage 3|Death|1|||
149140324|NCT00467779|537994115|FG000|Stage 3|Disease Progression|0|||
149140325|NCT00467779|537994116|FG001|Stage 3|Disease Progression|0|||
149012065|NCT03101241|537523455|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
149012066|NCT03101241|537523456|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
149140326|NCT00467779|537994117|FG002|Stage 3|Disease Progression|0|||
149140327|NCT00467779|537994118|FG003|Stage 3|Disease Progression|0|||
149140328|NCT00467779|537994119|FG004|Stage 3|Disease Progression|0|||
149140329|NCT00467779|537994120|FG005|Stage 3|Disease Progression|0|||
149140330|NCT00467779|537994121|FG006|Stage 3|Disease Progression|0|||
149140331|NCT00467779|537994122|FG007|Stage 3|Disease Progression|0|||
149140332|NCT00467779|537994123|FG008|Stage 3|Disease Progression|0|||
149140333|NCT00467779|537994124|FG009|Stage 3|Disease Progression|0|||
149140334|NCT00467779|537994125|FG010|Stage 3|Disease Progression|0|||
149140335|NCT00467779|537994126|FG011|Stage 3|Disease Progression|0|||
149140336|NCT00467779|537994127|FG012|Stage 3|Disease Progression|0|||
149140337|NCT00467779|537994128|FG013|Stage 3|Disease Progression|0|||
149140338|NCT00467779|537994129|FG014|Stage 3|Disease Progression|9|||
149140339|NCT00467779|537994115|FG000|Stage 3|Unspecified Reason|0|||
149140340|NCT00467779|537994116|FG001|Stage 3|Unspecified Reason|0|||
149140341|NCT00467779|537994117|FG002|Stage 3|Unspecified Reason|0|||
149140342|NCT00467779|537994118|FG003|Stage 3|Unspecified Reason|0|||
149140343|NCT00467779|537994119|FG004|Stage 3|Unspecified Reason|0|||
149140344|NCT00467779|537994120|FG005|Stage 3|Unspecified Reason|0|||
149140345|NCT00467779|537994121|FG006|Stage 3|Unspecified Reason|0|||
149140346|NCT00467779|537994122|FG007|Stage 3|Unspecified Reason|0|||
149140347|NCT00467779|537994123|FG008|Stage 3|Unspecified Reason|0|||
149140348|NCT00467779|537994124|FG009|Stage 3|Unspecified Reason|0|||
149140349|NCT00467779|537994125|FG010|Stage 3|Unspecified Reason|0|||
149140350|NCT00467779|537994126|FG011|Stage 3|Unspecified Reason|0|||
149140351|NCT00467779|537994127|FG012|Stage 3|Unspecified Reason|0|||
149140352|NCT00467779|537994128|FG013|Stage 3|Unspecified Reason|0|||
149140353|NCT00467779|537994129|FG014|Stage 3|Unspecified Reason|5|||
149140354|NCT00436618|537994130|FG000|Overall Study|Withdrawal by Subject|5|||
149140355|NCT00436618|537994131|FG001|Overall Study|Withdrawal by Subject|8|||
149140356|NCT00436618|537994132|FG002|Overall Study|Withdrawal by Subject|11|||
149140357|NCT00436618|537994130|FG000|Overall Study|Adverse Event|8|||
149140358|NCT00436618|537994131|FG001|Overall Study|Adverse Event|8|||
149140359|NCT00436618|537994132|FG002|Overall Study|Adverse Event|9|||
149140360|NCT00436618|537994130|FG000|Overall Study|Alternate Treatment|3|||
149140361|NCT00436618|537994131|FG001|Overall Study|Alternate Treatment|4|||
149140362|NCT00436618|537994132|FG002|Overall Study|Alternate Treatment|12|||
149140363|NCT00436618|537994130|FG000|Overall Study|Other Medical Problems|3|||
149140364|NCT00436618|537994131|FG001|Overall Study|Other Medical Problems|1|||
149140365|NCT00436618|537994132|FG002|Overall Study|Other Medical Problems|7|||
149140366|NCT00436618|537994130|FG000|Overall Study|Death|4|||
149140367|NCT00436618|537994131|FG001|Overall Study|Death|2|||
149140368|NCT00436618|537994132|FG002|Overall Study|Death|3|||
149140369|NCT00436618|537994130|FG000|Overall Study|New Primary or Other Reasons|6|||
149140370|NCT00436618|537994131|FG001|Overall Study|New Primary or Other Reasons|2|||
149140371|NCT00436618|537994132|FG002|Overall Study|New Primary or Other Reasons|12|||
149140372|NCT00436618|537994130|FG000|Overall Study|Still on treatment|1|||
149140373|NCT00436618|537994131|FG001|Overall Study|Still on treatment|2|||
149140374|NCT00436618|537994132|FG002|Overall Study|Still on treatment|7|||
149140375|NCT01994382|537994133|FG000|Overall Study|Informed consent withdrawn|0|||
149140376|NCT01994382|537994134|FG001|Overall Study|Informed consent withdrawn|0|||
149140377|NCT01994382|537994135|FG002|Overall Study|Informed consent withdrawn|0|||
149140378|NCT01994382|537994136|FG003|Overall Study|Informed consent withdrawn|0|||
149140379|NCT01994382|537994137|FG004|Overall Study|Informed consent withdrawn|0|||
149140380|NCT01994382|537994138|FG005|Overall Study|Informed consent withdrawn|0|||
149140381|NCT01994382|537994139|FG006|Overall Study|Informed consent withdrawn|1|||
149140382|NCT01994382|537994140|FG007|Overall Study|Informed consent withdrawn|0|||
149140383|NCT01994382|537994141|FG008|Overall Study|Informed consent withdrawn|0|||
149140384|NCT01994382|537994142|FG009|Overall Study|Informed consent withdrawn|0|||
149140385|NCT01994382|537994143|FG010|Overall Study|Informed consent withdrawn|0|||
149140386|NCT01994382|537994144|FG011|Overall Study|Informed consent withdrawn|0|||
149140387|NCT01994382|537994145|FG012|Overall Study|Informed consent withdrawn|0|||
149140388|NCT01994382|537994146|FG013|Overall Study|Informed consent withdrawn|0|||
149140389|NCT01994382|537994147|FG014|Overall Study|Informed consent withdrawn|0|||
149140390|NCT01994382|537994148|FG015|Overall Study|Informed consent withdrawn|0|||
149140391|NCT01994382|537994149|FG016|Overall Study|Informed consent withdrawn|0|||
149140392|NCT01994382|537994133|FG000|Overall Study|Progressive disease|3|||
149140393|NCT01994382|537994134|FG001|Overall Study|Progressive disease|4|||
149140394|NCT01994382|537994135|FG002|Overall Study|Progressive disease|4|||
149140395|NCT01994382|537994136|FG003|Overall Study|Progressive disease|3|||
149140396|NCT01994382|537994137|FG004|Overall Study|Progressive disease|2|||
149140397|NCT01994382|537994138|FG005|Overall Study|Progressive disease|3|||
149140398|NCT01994382|537994139|FG006|Overall Study|Progressive disease|3|||
149140399|NCT01994382|537994140|FG007|Overall Study|Progressive disease|6|||
149140400|NCT01994382|537994141|FG008|Overall Study|Progressive disease|2|||
149140401|NCT01994382|537994142|FG009|Overall Study|Progressive disease|2|||
148804702|NCT01499810|536765162|FG000|Overall Study|Lost to Follow-up|10|||
149140402|NCT01994382|537994143|FG010|Overall Study|Progressive disease|13|||
149140403|NCT01994382|537994144|FG011|Overall Study|Progressive disease|8|||
149140404|NCT01994382|537994145|FG012|Overall Study|Progressive disease|7|||
149140405|NCT01994382|537994146|FG013|Overall Study|Progressive disease|3|||
149140406|NCT01994382|537994147|FG014|Overall Study|Progressive disease|6|||
149140407|NCT01994382|537994148|FG015|Overall Study|Progressive disease|44|||
149140408|NCT01994382|537994149|FG016|Overall Study|Progressive disease|28|||
148804703|NCT01499810|536765162|FG000|Overall Study|Protocol Violation|1|||
148804704|NCT01499810|536765162|FG000|Overall Study|Withdrawal by Subject|1|||
148804705|NCT05117060|536765163|FG000|Overall Study|Adverse Event|3|||
148804706|NCT05117060|536765164|FG001|Overall Study|Adverse Event|5|||
148804707|NCT05117060|536765165|FG002|Overall Study|Adverse Event|6|||
148804708|NCT05117060|536765166|FG003|Overall Study|Adverse Event|1|||
148804709|NCT05117060|536765163|FG000|Overall Study|Lost to Follow-up|0|||
148804710|NCT05117060|536765164|FG001|Overall Study|Lost to Follow-up|0|||
148804711|NCT05117060|536765165|FG002|Overall Study|Lost to Follow-up|0|||
148804712|NCT05117060|536765166|FG003|Overall Study|Lost to Follow-up|1|||
148804713|NCT05117060|536765163|FG000|Overall Study|Lack of Efficacy|4|||
148804714|NCT05117060|536765164|FG001|Overall Study|Lack of Efficacy|5|||
149140409|NCT01994382|537994133|FG000|Overall Study|Physician Decision|0|||
149140410|NCT01994382|537994134|FG001|Overall Study|Physician Decision|1|||
149140411|NCT01994382|537994135|FG002|Overall Study|Physician Decision|0|||
149140412|NCT01994382|537994136|FG003|Overall Study|Physician Decision|0|||
149140413|NCT01994382|537994137|FG004|Overall Study|Physician Decision|0|||
149140414|NCT01994382|537994138|FG005|Overall Study|Physician Decision|0|||
149140415|NCT01994382|537994139|FG006|Overall Study|Physician Decision|0|||
149140416|NCT01994382|537994140|FG007|Overall Study|Physician Decision|0|||
149140417|NCT01994382|537994141|FG008|Overall Study|Physician Decision|0|||
149140418|NCT01994382|537994142|FG009|Overall Study|Physician Decision|0|||
149140419|NCT01994382|537994143|FG010|Overall Study|Physician Decision|3|||
149140420|NCT01994382|537994144|FG011|Overall Study|Physician Decision|1|||
149140421|NCT01994382|537994145|FG012|Overall Study|Physician Decision|1|||
149140422|NCT01994382|537994146|FG013|Overall Study|Physician Decision|0|||
149140423|NCT01994382|537994147|FG014|Overall Study|Physician Decision|1|||
149140424|NCT01994382|537994148|FG015|Overall Study|Physician Decision|4|||
149140425|NCT01994382|537994149|FG016|Overall Study|Physician Decision|2|||
149140426|NCT01994382|537994133|FG000|Overall Study|Death|0|||
149140427|NCT01994382|537994134|FG001|Overall Study|Death|0|||
149140428|NCT01994382|537994135|FG002|Overall Study|Death|0|||
149140429|NCT01994382|537994136|FG003|Overall Study|Death|0|||
149140430|NCT01994382|537994137|FG004|Overall Study|Death|1|||
149140431|NCT01994382|537994138|FG005|Overall Study|Death|0|||
149140432|NCT01994382|537994139|FG006|Overall Study|Death|0|||
149140433|NCT01994382|537994140|FG007|Overall Study|Death|0|||
149140434|NCT01994382|537994141|FG008|Overall Study|Death|1|||
149140435|NCT01994382|537994142|FG009|Overall Study|Death|1|||
149140436|NCT01994382|537994143|FG010|Overall Study|Death|0|||
149140437|NCT01994382|537994144|FG011|Overall Study|Death|0|||
149140438|NCT01994382|537994145|FG012|Overall Study|Death|0|||
149140439|NCT01994382|537994146|FG013|Overall Study|Death|0|||
149140440|NCT01994382|537994147|FG014|Overall Study|Death|0|||
149140441|NCT01994382|537994148|FG015|Overall Study|Death|1|||
149140442|NCT01994382|537994149|FG016|Overall Study|Death|0|||
149140443|NCT01994382|537994133|FG000|Overall Study|Adverse Event|0|||
149140444|NCT01994382|537994134|FG001|Overall Study|Adverse Event|1|||
149140445|NCT01994382|537994135|FG002|Overall Study|Adverse Event|2|||
149140446|NCT01994382|537994136|FG003|Overall Study|Adverse Event|0|||
149140447|NCT01994382|537994137|FG004|Overall Study|Adverse Event|0|||
149140448|NCT01994382|537994138|FG005|Overall Study|Adverse Event|0|||
149140449|NCT01994382|537994139|FG006|Overall Study|Adverse Event|0|||
149140450|NCT01994382|537994140|FG007|Overall Study|Adverse Event|0|||
149140451|NCT01994382|537994141|FG008|Overall Study|Adverse Event|0|||
149140452|NCT01994382|537994142|FG009|Overall Study|Adverse Event|0|||
149140453|NCT01994382|537994143|FG010|Overall Study|Adverse Event|15|||
149140454|NCT01994382|537994144|FG011|Overall Study|Adverse Event|2|||
149140455|NCT01994382|537994145|FG012|Overall Study|Adverse Event|7|||
149012067|NCT03101241|537523455|FG000|Overall Study|Participant withdrew consent|3|||
149012068|NCT03101241|537523456|FG001|Overall Study|Participant withdrew consent|1|||
149012069|NCT03101241|537523455|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
149012070|NCT03101241|537523456|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
149012071|NCT03101241|537523455|FG000|Overall Study|Lost to Follow-up|2|||
149012072|NCT03101241|537523456|FG001|Overall Study|Lost to Follow-up|0|||
149012073|NCT03101241|537523455|FG000|Overall Study|Lack of Efficacy|0|||
149012074|NCT03101241|537523456|FG001|Overall Study|Lack of Efficacy|1|||
149012075|NCT03101241|537523455|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
149012076|NCT03101241|537523456|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
149012077|NCT01003184|537523457|FG000|Overall Study|Adverse Event|12|||
149012078|NCT01003184|537523458|FG001|Overall Study|Adverse Event|5|||
149012079|NCT01003184|537523457|FG000|Overall Study|Lost to Follow-up|1|||
149012080|NCT01003184|537523458|FG001|Overall Study|Lost to Follow-up|0|||
149012081|NCT01003184|537523457|FG000|Overall Study|Loss of glucose control|1|||
149012082|NCT01003184|537523458|FG001|Overall Study|Loss of glucose control|1|||
149012083|NCT01003184|537523457|FG000|Overall Study|Protocol Violation|3|||
149012084|NCT01003184|537523458|FG001|Overall Study|Protocol Violation|0|||
149140456|NCT01994382|537994146|FG013|Overall Study|Adverse Event|3|||
149140457|NCT01994382|537994147|FG014|Overall Study|Adverse Event|17|||
149140458|NCT01994382|537994148|FG015|Overall Study|Adverse Event|6|||
149140459|NCT01994382|537994149|FG016|Overall Study|Adverse Event|3|||
149140460|NCT01994382|537994133|FG000|Overall Study|Other than specified|0|||
149140461|NCT01994382|537994134|FG001|Overall Study|Other than specified|0|||
149140462|NCT01994382|537994135|FG002|Overall Study|Other than specified|0|||
149140463|NCT01994382|537994136|FG003|Overall Study|Other than specified|0|||
149140464|NCT01994382|537994137|FG004|Overall Study|Other than specified|0|||
149012085|NCT01003184|537523457|FG000|Overall Study|Withdrawal by Subject|1|||
149140465|NCT01994382|537994138|FG005|Overall Study|Other than specified|0|||
149140466|NCT01994382|537994139|FG006|Overall Study|Other than specified|0|||
149140467|NCT01994382|537994140|FG007|Overall Study|Other than specified|0|||
149140468|NCT01994382|537994141|FG008|Overall Study|Other than specified|0|||
149140469|NCT01994382|537994142|FG009|Overall Study|Other than specified|0|||
149140470|NCT01994382|537994143|FG010|Overall Study|Other than specified|2|||
149140471|NCT01994382|537994144|FG011|Overall Study|Other than specified|0|||
149140472|NCT01994382|537994145|FG012|Overall Study|Other than specified|2|||
149140473|NCT01994382|537994146|FG013|Overall Study|Other than specified|0|||
149140474|NCT01994382|537994147|FG014|Overall Study|Other than specified|0|||
149140475|NCT01994382|537994148|FG015|Overall Study|Other than specified|4|||
149140476|NCT01994382|537994149|FG016|Overall Study|Other than specified|4|||
149140477|NCT01994382|537994133|FG000|Overall Study|Withdrawal by Subject|0|||
149140478|NCT01994382|537994134|FG001|Overall Study|Withdrawal by Subject|0|||
149140479|NCT01994382|537994135|FG002|Overall Study|Withdrawal by Subject|0|||
149140480|NCT01994382|537994136|FG003|Overall Study|Withdrawal by Subject|0|||
149140481|NCT01994382|537994137|FG004|Overall Study|Withdrawal by Subject|0|||
149140482|NCT01994382|537994138|FG005|Overall Study|Withdrawal by Subject|0|||
149140483|NCT01994382|537994139|FG006|Overall Study|Withdrawal by Subject|0|||
149140484|NCT01994382|537994140|FG007|Overall Study|Withdrawal by Subject|0|||
149140485|NCT01994382|537994141|FG008|Overall Study|Withdrawal by Subject|0|||
149140486|NCT01994382|537994142|FG009|Overall Study|Withdrawal by Subject|0|||
149140487|NCT01994382|537994143|FG010|Overall Study|Withdrawal by Subject|6|||
149140488|NCT01994382|537994144|FG011|Overall Study|Withdrawal by Subject|0|||
149140489|NCT01994382|537994145|FG012|Overall Study|Withdrawal by Subject|2|||
149140490|NCT01994382|537994146|FG013|Overall Study|Withdrawal by Subject|0|||
149140491|NCT01994382|537994147|FG014|Overall Study|Withdrawal by Subject|4|||
149140492|NCT01994382|537994148|FG015|Overall Study|Withdrawal by Subject|3|||
149140493|NCT01994382|537994149|FG016|Overall Study|Withdrawal by Subject|0|||
149140494|NCT01994382|537994133|FG000|Overall Study|Lost to Follow-up|0|||
149140495|NCT01994382|537994134|FG001|Overall Study|Lost to Follow-up|0|||
149140496|NCT01994382|537994135|FG002|Overall Study|Lost to Follow-up|0|||
149140497|NCT01994382|537994136|FG003|Overall Study|Lost to Follow-up|0|||
149140498|NCT01994382|537994137|FG004|Overall Study|Lost to Follow-up|0|||
149140499|NCT01994382|537994138|FG005|Overall Study|Lost to Follow-up|0|||
149140500|NCT01994382|537994139|FG006|Overall Study|Lost to Follow-up|0|||
149140501|NCT01994382|537994140|FG007|Overall Study|Lost to Follow-up|0|||
149140502|NCT01994382|537994141|FG008|Overall Study|Lost to Follow-up|0|||
149140503|NCT01994382|537994142|FG009|Overall Study|Lost to Follow-up|0|||
149140504|NCT01994382|537994143|FG010|Overall Study|Lost to Follow-up|1|||
149140505|NCT01994382|537994144|FG011|Overall Study|Lost to Follow-up|0|||
149140506|NCT01994382|537994145|FG012|Overall Study|Lost to Follow-up|0|||
149140507|NCT01994382|537994146|FG013|Overall Study|Lost to Follow-up|0|||
149140508|NCT01994382|537994147|FG014|Overall Study|Lost to Follow-up|0|||
149140509|NCT01994382|537994148|FG015|Overall Study|Lost to Follow-up|0|||
149140510|NCT01994382|537994149|FG016|Overall Study|Lost to Follow-up|0|||
149140511|NCT01994382|537994133|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140512|NCT01994382|537994134|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140513|NCT01994382|537994135|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140514|NCT01994382|537994136|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140515|NCT01994382|537994137|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140516|NCT01994382|537994138|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140517|NCT01994382|537994139|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140518|NCT01994382|537994140|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140519|NCT01994382|537994141|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140520|NCT01994382|537994142|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140521|NCT01994382|537994143|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
149140522|NCT01994382|537994144|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140523|NCT01994382|537994145|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
149140524|NCT01994382|537994146|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
148912711|NCT00035932|537164707|FG000|Overall Study|Protocol Violation While on Study|0|||
148912712|NCT00035932|537164708|FG001|Overall Study|Protocol Violation While on Study|1|||
148912713|NCT00035932|537164709|FG002|Overall Study|Protocol Violation While on Study|2|||
148912714|NCT00035932|537164707|FG000|Overall Study|Withdrawal by Subject|1|||
148912715|NCT00035932|537164708|FG001|Overall Study|Withdrawal by Subject|5|||
148912716|NCT00035932|537164709|FG002|Overall Study|Withdrawal by Subject|0|||
149140525|NCT01994382|537994147|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
149140526|NCT01994382|537994148|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
149140527|NCT01994382|537994149|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
149140528|NCT01994382|537994133|FG000|Overall Study|Protocol violation/noncompliance|0|||
149140529|NCT01994382|537994134|FG001|Overall Study|Protocol violation/noncompliance|0|||
149140530|NCT01994382|537994135|FG002|Overall Study|Protocol violation/noncompliance|0|||
149140531|NCT01994382|537994136|FG003|Overall Study|Protocol violation/noncompliance|0|||
149140532|NCT01994382|537994137|FG004|Overall Study|Protocol violation/noncompliance|0|||
149140533|NCT01994382|537994138|FG005|Overall Study|Protocol violation/noncompliance|0|||
149140534|NCT01994382|537994139|FG006|Overall Study|Protocol violation/noncompliance|0|||
149140535|NCT01994382|537994140|FG007|Overall Study|Protocol violation/noncompliance|0|||
149140536|NCT01994382|537994141|FG008|Overall Study|Protocol violation/noncompliance|0|||
149140537|NCT01994382|537994142|FG009|Overall Study|Protocol violation/noncompliance|0|||
149140538|NCT01994382|537994143|FG010|Overall Study|Protocol violation/noncompliance|0|||
149140539|NCT01994382|537994144|FG011|Overall Study|Protocol violation/noncompliance|1|||
149140540|NCT01994382|537994145|FG012|Overall Study|Protocol violation/noncompliance|0|||
149140541|NCT01994382|537994146|FG013|Overall Study|Protocol violation/noncompliance|0|||
149012086|NCT01003184|537523458|FG001|Overall Study|Withdrawal by Subject|6|||
149012087|NCT01003184|537523457|FG000|Overall Study|Physician Decision|1|||
149012088|NCT01003184|537523458|FG001|Overall Study|Physician Decision|0|||
149012089|NCT04848662|537523459|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
149012090|NCT04848662|537523460|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
149012091|NCT02667886|537523461|FG000|Dose Escalation (Part A)|Adverse Event|1|||
149012092|NCT02667886|537523462|FG001|Dose Escalation (Part A)|Adverse Event|3|||
149012093|NCT02667886|537523463|FG002|Dose Escalation (Part A)|Adverse Event|1|||
149012094|NCT02667886|537523464|FG003|Dose Escalation (Part A)|Adverse Event|0|||
149012095|NCT02667886|537523465|FG004|Dose Escalation (Part A)|Adverse Event|0|||
149012096|NCT02667886|537523461|FG000|Dose Escalation (Part A)|Disease Progression|1|||
149012097|NCT02667886|537523462|FG001|Dose Escalation (Part A)|Disease Progression|4|||
149012098|NCT02667886|537523463|FG002|Dose Escalation (Part A)|Disease Progression|3|||
149012099|NCT02667886|537523464|FG003|Dose Escalation (Part A)|Disease Progression|0|||
149012100|NCT02667886|537523465|FG004|Dose Escalation (Part A)|Disease Progression|0|||
149012101|NCT02667886|537523461|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
149012102|NCT02667886|537523462|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
149012103|NCT02667886|537523463|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
149012104|NCT02667886|537523464|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
149012105|NCT02667886|537523465|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
149012106|NCT02667886|537523461|FG000|Dose Expansion (Part B)|Adverse Event|0|||
149012107|NCT02667886|537523462|FG001|Dose Expansion (Part B)|Adverse Event|0|||
149012108|NCT02667886|537523463|FG002|Dose Expansion (Part B)|Adverse Event|0|||
149012109|NCT02667886|537523464|FG003|Dose Expansion (Part B)|Adverse Event|9|||
149012110|NCT02667886|537523465|FG004|Dose Expansion (Part B)|Adverse Event|0|||
149012111|NCT02667886|537523461|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
149012112|NCT02667886|537523462|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
149012113|NCT02667886|537523463|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
149012114|NCT02667886|537523464|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
149012115|NCT02667886|537523465|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
149012116|NCT02667886|537523461|FG000|Dose Expansion (Part B)|Disease Progression|0|||
149012117|NCT02667886|537523462|FG001|Dose Expansion (Part B)|Disease Progression|0|||
149012118|NCT02667886|537523463|FG002|Dose Expansion (Part B)|Disease Progression|0|||
149012119|NCT02667886|537523464|FG003|Dose Expansion (Part B)|Disease Progression|38|||
149012120|NCT02667886|537523465|FG004|Dose Expansion (Part B)|Disease Progression|0|||
149012121|NCT02667886|537523461|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
149012122|NCT02667886|537523462|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
149012123|NCT02667886|537523463|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
149012124|NCT02667886|537523464|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
149012125|NCT02667886|537523465|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
149012126|NCT02667886|537523461|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
149012127|NCT02667886|537523462|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
149140542|NCT01994382|537994147|FG014|Overall Study|Protocol violation/noncompliance|0|||
149140543|NCT01994382|537994148|FG015|Overall Study|Protocol violation/noncompliance|0|||
149140544|NCT01994382|537994149|FG016|Overall Study|Protocol violation/noncompliance|2|||
149140545|NCT01994382|537994133|FG000|Overall Study|Rolled over to Phase 2a|0|||
149012128|NCT02667886|537523463|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
149012129|NCT02667886|537523464|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
149012130|NCT02667886|537523465|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
149012131|NCT02667886|537523461|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
149012132|NCT02667886|537523462|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
149012133|NCT02667886|537523463|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
149012134|NCT02667886|537523464|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
149012135|NCT02667886|537523465|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
149012136|NCT02759185|537523469|FG000|Stage 1|Adverse Event|0|||
149012137|NCT02759185|537523470|FG001|Stage 1|Adverse Event|1|||
149012138|NCT02759185|537523471|FG002|Stage 1|Adverse Event|3|||
149012139|NCT02759185|537523472|FG003|Stage 1|Adverse Event|0|||
149012140|NCT02759185|537523473|FG004|Stage 1|Adverse Event|0|||
149012141|NCT02759185|537523474|FG005|Stage 1|Adverse Event|0|||
149012142|NCT02759185|537523475|FG006|Stage 1|Adverse Event|0|||
148912717|NCT00035932|537164707|FG000|Overall Study|Study Termination by Sponsor|1|||
148912718|NCT00035932|537164708|FG001|Overall Study|Study Termination by Sponsor|0|||
148912719|NCT00035932|537164709|FG002|Overall Study|Study Termination by Sponsor|0|||
148912720|NCT00035932|537164707|FG000|Overall Study|Lack of Efficacy|33|||
148670841|NCT05553600|536266990|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
148670842|NCT05553600|536266991|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
148670843|NCT05553600|536266992|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
148670844|NCT05553600|536266993|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
148670845|NCT04930536|536266994|FG000|Overall Study|Adverse Event|1|||
148670846|NCT04930536|536266995|FG001|Overall Study|Adverse Event|0|||
148670847|NCT04930536|536266994|FG000|Overall Study|Disease Progression|2|||
148670848|NCT04930536|536266995|FG001|Overall Study|Disease Progression|0|||
148670849|NCT04930536|536266994|FG000|Overall Study|Patient Decision|4|||
148670850|NCT04930536|536266995|FG001|Overall Study|Patient Decision|2|||
148670851|NCT04930536|536266994|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
148670852|NCT04930536|536266995|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
148670853|NCT04292171|536266996|FG000|Overall Study|Pharmacy error|2|||
148670854|NCT04292171|536266997|FG001|Overall Study|Pharmacy error|0|||
148670855|NCT04292171|536266996|FG000|Overall Study|Delivered prior to procedure|0|||
148670856|NCT04292171|536266997|FG001|Overall Study|Delivered prior to procedure|1|||
148670857|NCT00848965|536266999|FG000|Overall Study|Adverse Event|1|||
148670858|NCT00848965|536266999|FG000|Overall Study|Withdrawal by Subject|1|||
148670859|NCT01605370|536267002|FG000|Overall Study|Adverse Event|1|||
148670860|NCT01605370|536267003|FG001|Overall Study|Adverse Event|0|||
148670861|NCT01976104|536267004|FG000|Overall Study|Adverse Event|0|||
148670862|NCT01976104|536267005|FG001|Overall Study|Adverse Event|0|||
148670863|NCT01976104|536267006|FG002|Overall Study|Adverse Event|1|||
148670864|NCT01976104|536267007|FG003|Overall Study|Adverse Event|0|||
148670865|NCT01976104|536267004|FG000|Overall Study|Lost to Follow-up|3|||
148670866|NCT01976104|536267005|FG001|Overall Study|Lost to Follow-up|0|||
148670867|NCT01976104|536267006|FG002|Overall Study|Lost to Follow-up|1|||
148670868|NCT01976104|536267007|FG003|Overall Study|Lost to Follow-up|1|||
148670869|NCT01976104|536267004|FG000|Overall Study|Subject Choice|0|||
148670870|NCT01976104|536267005|FG001|Overall Study|Subject Choice|1|||
148670871|NCT01976104|536267006|FG002|Overall Study|Subject Choice|0|||
148670872|NCT01976104|536267007|FG003|Overall Study|Subject Choice|1|||
148670873|NCT01976104|536267004|FG000|Overall Study|Withdrawal by Subject|3|||
148670874|NCT01976104|536267005|FG001|Overall Study|Withdrawal by Subject|0|||
148670875|NCT01976104|536267006|FG002|Overall Study|Withdrawal by Subject|0|||
148670876|NCT01976104|536267007|FG003|Overall Study|Withdrawal by Subject|1|||
148670877|NCT01976104|536267004|FG000|Overall Study|Other|0|||
148912721|NCT00035932|537164708|FG001|Overall Study|Lack of Efficacy|33|||
148912722|NCT00035932|537164709|FG002|Overall Study|Lack of Efficacy|28|||
148912723|NCT01297491|537164710|FG000|Overall Study|Adverse Event|11|||
148670878|NCT01976104|536267005|FG001|Overall Study|Other|1|||
148912724|NCT01297491|537164711|FG001|Overall Study|Adverse Event|6|||
148912725|NCT01297491|537164710|FG000|Overall Study|Physician Decision|3|||
148912726|NCT01297491|537164711|FG001|Overall Study|Physician Decision|2|||
148912727|NCT01297491|537164710|FG000|Overall Study|Progressive disease|11|||
148670879|NCT01976104|536267006|FG002|Overall Study|Other|0|||
148670880|NCT01976104|536267007|FG003|Overall Study|Other|0|||
148670881|NCT01301625|536267009|FG000|Overall Study|Death|5|||
148670882|NCT01301625|536267009|FG000|Overall Study|Not Due|21|||
148670883|NCT01301625|536267009|FG000|Overall Study|Expected|8|||
148670884|NCT01301625|536267009|FG000|Overall Study|Lost to Follow-up|1|||
148670885|NCT02181673|536267014|FG000|Up to Week 24|Adverse Event|2|||
148670886|NCT02181673|536267015|FG001|Up to Week 24|Adverse Event|0|||
148912728|NCT01297491|537164711|FG001|Overall Study|Progressive disease|20|||
148912729|NCT01297491|537164710|FG000|Overall Study|Patient/Guardian decision|3|||
148912730|NCT01297491|537164711|FG001|Overall Study|Patient/Guardian decision|4|||
148912731|NCT01297491|537164710|FG000|Overall Study|Death|2|||
148912732|NCT01297491|537164711|FG001|Overall Study|Death|1|||
148912733|NCT04413617|537164712|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
148912734|NCT04413617|537164713|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
148912735|NCT04413617|537164714|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
148912736|NCT04413617|537164715|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
148912737|NCT04413617|537164716|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
148912738|NCT04413617|537164712|FG000|Overall Study|Protocol Violation|0|||
148912739|NCT04413617|537164713|FG001|Overall Study|Protocol Violation|1|||
148912740|NCT04413617|537164714|FG002|Overall Study|Protocol Violation|0|||
148912741|NCT04413617|537164715|FG003|Overall Study|Protocol Violation|0|||
148912742|NCT04413617|537164716|FG004|Overall Study|Protocol Violation|1|||
148912743|NCT04413617|537164712|FG000|Overall Study|Lack of Efficacy|2|||
148912744|NCT04413617|537164713|FG001|Overall Study|Lack of Efficacy|0|||
148912745|NCT04413617|537164714|FG002|Overall Study|Lack of Efficacy|2|||
148912746|NCT04413617|537164715|FG003|Overall Study|Lack of Efficacy|1|||
148912747|NCT04413617|537164716|FG004|Overall Study|Lack of Efficacy|0|||
148912748|NCT04413617|537164712|FG000|Overall Study|Withdrawal by Subject|3|||
148912749|NCT04413617|537164713|FG001|Overall Study|Withdrawal by Subject|4|||
148912750|NCT04413617|537164714|FG002|Overall Study|Withdrawal by Subject|2|||
148912751|NCT04413617|537164715|FG003|Overall Study|Withdrawal by Subject|5|||
148912752|NCT04413617|537164716|FG004|Overall Study|Withdrawal by Subject|3|||
148912753|NCT04413617|537164712|FG000|Overall Study|Death|1|||
148912754|NCT04413617|537164713|FG001|Overall Study|Death|0|||
148912755|NCT04413617|537164714|FG002|Overall Study|Death|0|||
148912756|NCT04413617|537164715|FG003|Overall Study|Death|0|||
148912757|NCT04413617|537164716|FG004|Overall Study|Death|0|||
148912758|NCT04413617|537164712|FG000|Overall Study|Adverse Event|1|||
148912759|NCT04413617|537164713|FG001|Overall Study|Adverse Event|0|||
149012143|NCT02759185|537523469|FG000|Stage 1|Withdrawal by Subject|1|||
148912760|NCT04413617|537164714|FG002|Overall Study|Adverse Event|0|||
148912761|NCT04413617|537164715|FG003|Overall Study|Adverse Event|1|||
148912762|NCT04413617|537164716|FG004|Overall Study|Adverse Event|1|||
149012144|NCT02759185|537523470|FG001|Stage 1|Withdrawal by Subject|0|||
149012145|NCT02759185|537523471|FG002|Stage 1|Withdrawal by Subject|0|||
149012146|NCT02759185|537523472|FG003|Stage 1|Withdrawal by Subject|0|||
149012147|NCT02759185|537523473|FG004|Stage 1|Withdrawal by Subject|0|||
149012148|NCT02759185|537523474|FG005|Stage 1|Withdrawal by Subject|0|||
149012149|NCT02759185|537523475|FG006|Stage 1|Withdrawal by Subject|0|||
149012150|NCT02759185|537523469|FG000|Stage 2|Adverse Event|0|||
149012151|NCT02759185|537523470|FG001|Stage 2|Adverse Event|0|||
149012152|NCT02759185|537523471|FG002|Stage 2|Adverse Event|0|||
148912763|NCT04413617|537164712|FG000|Overall Study|COVID-19|0|||
148912764|NCT04413617|537164713|FG001|Overall Study|COVID-19|1|||
149012153|NCT02759185|537523472|FG003|Stage 2|Adverse Event|0|||
149012154|NCT02759185|537523473|FG004|Stage 2|Adverse Event|1|||
148912765|NCT04413617|537164714|FG002|Overall Study|COVID-19|0|||
148912766|NCT04413617|537164715|FG003|Overall Study|COVID-19|0|||
149012155|NCT02759185|537523474|FG005|Stage 2|Adverse Event|2|||
149012156|NCT02759185|537523475|FG006|Stage 2|Adverse Event|0|||
149140546|NCT01994382|537994134|FG001|Overall Study|Rolled over to Phase 2a|0|||
149140547|NCT01994382|537994135|FG002|Overall Study|Rolled over to Phase 2a|1|||
149140548|NCT01994382|537994136|FG003|Overall Study|Rolled over to Phase 2a|0|||
149140549|NCT01994382|537994137|FG004|Overall Study|Rolled over to Phase 2a|0|||
149140550|NCT01994382|537994138|FG005|Overall Study|Rolled over to Phase 2a|0|||
149140551|NCT01994382|537994139|FG006|Overall Study|Rolled over to Phase 2a|0|||
149140552|NCT01994382|537994140|FG007|Overall Study|Rolled over to Phase 2a|0|||
149140553|NCT01994382|537994141|FG008|Overall Study|Rolled over to Phase 2a|0|||
149140554|NCT01994382|537994142|FG009|Overall Study|Rolled over to Phase 2a|2|||
149140555|NCT01994382|537994143|FG010|Overall Study|Rolled over to Phase 2a|0|||
149140556|NCT01994382|537994144|FG011|Overall Study|Rolled over to Phase 2a|0|||
148670887|NCT02181673|536267016|FG002|Up to Week 24|Adverse Event|3|||
149140557|NCT01994382|537994145|FG012|Overall Study|Rolled over to Phase 2a|0|||
149140558|NCT01994382|537994146|FG013|Overall Study|Rolled over to Phase 2a|0|||
149140559|NCT01994382|537994147|FG014|Overall Study|Rolled over to Phase 2a|0|||
149140560|NCT01994382|537994148|FG015|Overall Study|Rolled over to Phase 2a|0|||
149140561|NCT01994382|537994149|FG016|Overall Study|Rolled over to Phase 2a|0|||
149140562|NCT02428855|537994150|FG000|Overall Study|Withdrawal by Subject|2|||
149140563|NCT02066311|537994151|FG000|Overall Study|Adverse Event|4|||
149140564|NCT02066311|537994151|FG000|Overall Study|Withdrawal by Subject|1|||
149140565|NCT04353596|537994152|FG000|Overall Study|Protocol Violation|4|||
149140566|NCT04353596|537994153|FG001|Overall Study|Protocol Violation|4|||
149140567|NCT04353596|537994152|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
149140568|NCT04353596|537994153|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
149140569|NCT05418673|537994154|FG000|Overall Study|Study Terminated by Sponsor|2|||
149140570|NCT05418673|537994155|FG001|Overall Study|Study Terminated by Sponsor|4|||
149140571|NCT05418673|537994154|FG000|Overall Study|Lost to Follow-up|1|||
149140572|NCT05418673|537994155|FG001|Overall Study|Lost to Follow-up|0|||
149140573|NCT01526551|537994159|FG000|Overall Study|Lack of returned parental consent form|424|||
149140574|NCT01353508|537994161|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
149140575|NCT01353508|537994162|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
149140576|NCT01353508|537994163|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
149140577|NCT01353508|537994164|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
149140578|NCT01353508|537994161|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
149140579|NCT01353508|537994162|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
149140580|NCT01353508|537994163|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
149140581|NCT01353508|537994164|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
149140582|NCT02170779|537994165|FG000|Overall Study|Withdrawal by Subject|1|||
149140583|NCT02170779|537994166|FG001|Overall Study|Withdrawal by Subject|0|||
149140584|NCT02170779|537994165|FG000|Overall Study|Lost to Follow-up|0|||
149140585|NCT02170779|537994166|FG001|Overall Study|Lost to Follow-up|1|||
149140586|NCT00935272|537994167|FG000|Overall Study|Lost to Follow-up|10|||
149140587|NCT00935272|537994168|FG001|Overall Study|Lost to Follow-up|3|||
149140588|NCT00935272|537994167|FG000|Overall Study|Withdrawal by Subject|8|||
149140589|NCT00935272|537994168|FG001|Overall Study|Withdrawal by Subject|2|||
149140590|NCT00935272|537994167|FG000|Overall Study|Physician Decision|1|||
149140591|NCT00935272|537994168|FG001|Overall Study|Physician Decision|0|||
149140592|NCT00935272|537994167|FG000|Overall Study|Protocol Violation|0|||
149140593|NCT00935272|537994168|FG001|Overall Study|Protocol Violation|1|||
149140594|NCT03492554|537994172|FG000|Overall Study|Protocol Violation|0|||
149140595|NCT03492554|537994173|FG001|Overall Study|Protocol Violation|14|||
149140596|NCT01478360|537994174|FG000|Overall Study|Lost to Follow-up|1|||
149140597|NCT01478360|537994175|FG001|Overall Study|Lost to Follow-up|0|||
149140598|NCT01478360|537994174|FG000|Overall Study|Adverse Event|0|||
149140599|NCT01478360|537994175|FG001|Overall Study|Adverse Event|1|||
149140600|NCT01478360|537994174|FG000|Overall Study|Administrative problems|1|||
149140601|NCT01478360|537994175|FG001|Overall Study|Administrative problems|2|||
149140602|NCT01289821|537994199|FG000|Treatment Period|Withdrawal by Subject|1|||
149140603|NCT01289821|537994199|FG000|Treatment Period|Physician Decision|3|||
149140604|NCT01289821|537994199|FG000|Treatment Period|Adverse Event|4|||
149140605|NCT01289821|537994199|FG000|Treatment Period|Radiological Progression|43|||
149140606|NCT01289821|537994199|FG000|Treatment Period|Clinical Progression|2|||
149140607|NCT01289821|537994199|FG000|Treatment Period|Therapeutic procedure required|1|||
149140608|NCT01289821|537994199|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
149140609|NCT01289821|537994199|FG000|Safety Follow-up Period|Protocol Violation|3|||
149140610|NCT01289821|537994199|FG000|Safety Follow-up Period|Unspecified reason|1|||
149140611|NCT01289821|537994199|FG000|Survival Follow-up Period|Protocol Violation|1|||
149140612|NCT01289821|537994199|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
149140613|NCT01289821|537994199|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
149140614|NCT01010633|537994206|FG000|Overall Study|Adverse Event|1|||
149140615|NCT01010633|537994207|FG001|Overall Study|Adverse Event|1|||
148670888|NCT02181673|536267014|FG000|Up to Week 24|Death|1|||
148670889|NCT02181673|536267015|FG001|Up to Week 24|Death|0|||
148670890|NCT02181673|536267016|FG002|Up to Week 24|Death|0|||
148670891|NCT02181673|536267014|FG000|Up to Week 24|Lack of Efficacy|1|||
149140616|NCT01010633|537994206|FG000|Overall Study|Protocol Violation|1|||
149140617|NCT01010633|537994207|FG001|Overall Study|Protocol Violation|2|||
149140618|NCT01010633|537994206|FG000|Overall Study|Withdrawal by Subject|2|||
149140619|NCT01010633|537994207|FG001|Overall Study|Withdrawal by Subject|1|||
149140620|NCT01010633|537994206|FG000|Overall Study|Investigator decision|0|||
149140621|NCT01010633|537994207|FG001|Overall Study|Investigator decision|1|||
149140622|NCT04411628|537994216|FG000|Overall Study|Withdrawal by Subject|1|||
149140623|NCT04411628|537994217|FG001|Overall Study|Withdrawal by Subject|1|||
149140624|NCT04411628|537994218|FG002|Overall Study|Withdrawal by Subject|2|||
149140625|NCT04411628|537994219|FG003|Overall Study|Withdrawal by Subject|0|||
149140626|NCT04411628|537994216|FG000|Overall Study|Lost to Follow-up|0|||
149140627|NCT04411628|537994217|FG001|Overall Study|Lost to Follow-up|1|||
149140628|NCT04411628|537994218|FG002|Overall Study|Lost to Follow-up|0|||
149140629|NCT04411628|537994219|FG003|Overall Study|Lost to Follow-up|0|||
149140630|NCT03734016|537994220|FG000|Overall Study|Sponsor Ended Study|225|||
149140631|NCT03734016|537994221|FG001|Overall Study|Sponsor Ended Study|200|||
149140632|NCT03734016|537994220|FG000|Overall Study|Death|69|||
149140633|NCT03734016|537994221|FG001|Overall Study|Death|83|||
149140634|NCT03734016|537994220|FG000|Overall Study|Withdrawal by Subject|21|||
149140635|NCT03734016|537994221|FG001|Overall Study|Withdrawal by Subject|27|||
149140636|NCT03734016|537994220|FG000|Overall Study|Physician Decision|1|||
149140637|NCT03734016|537994221|FG001|Overall Study|Physician Decision|12|||
149140638|NCT03734016|537994220|FG000|Overall Study|Lost to Follow-up|6|||
149140639|NCT03734016|537994221|FG001|Overall Study|Lost to Follow-up|2|||
149140640|NCT03734016|537994220|FG000|Overall Study|Miscellaneous|5|||
149140641|NCT03734016|537994221|FG001|Overall Study|Miscellaneous|1|||
149140642|NCT01979835|537994222|FG000|Primary Outcome SA Measurment|failed insertion|18|||
149140643|NCT01979835|537994222|FG000|Follow-up|Lost to Follow-up|32|||
149140644|NCT01428661|537994225|FG000|Double-Masked Phase|Protocol Violation|9|||
149140645|NCT01428661|537994226|FG001|Double-Masked Phase|Protocol Violation|4|||
148670892|NCT02181673|536267015|FG001|Up to Week 24|Lack of Efficacy|0|||
148670893|NCT02181673|536267016|FG002|Up to Week 24|Lack of Efficacy|0|||
148670894|NCT02181673|536267014|FG000|Up to Week 24|Lost to Follow-up|1|||
148670895|NCT02181673|536267015|FG001|Up to Week 24|Lost to Follow-up|0|||
148670896|NCT02181673|536267016|FG002|Up to Week 24|Lost to Follow-up|0|||
148670897|NCT02181673|536267014|FG000|Up to Week 24|Physician Decision|0|||
149140646|NCT01428661|537994227|FG002|Double-Masked Phase|Protocol Violation|0|||
149140647|NCT01428661|537994225|FG000|Double-Masked Phase|Adverse Event|13|||
149140648|NCT01428661|537994226|FG001|Double-Masked Phase|Adverse Event|4|||
149140649|NCT01428661|537994227|FG002|Double-Masked Phase|Adverse Event|0|||
149140650|NCT01428661|537994225|FG000|Double-Masked Phase|Lost to Follow-up|14|||
149140651|NCT01428661|537994226|FG001|Double-Masked Phase|Lost to Follow-up|14|||
149140652|NCT01428661|537994227|FG002|Double-Masked Phase|Lost to Follow-up|0|||
149140653|NCT01428661|537994225|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
149140654|NCT01428661|537994226|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
149140655|NCT01428661|537994227|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
149140656|NCT01428661|537994225|FG000|Double-Masked Phase|Lack of Efficacy|2|||
149140657|NCT01428661|537994226|FG001|Double-Masked Phase|Lack of Efficacy|1|||
149140658|NCT01428661|537994227|FG002|Double-Masked Phase|Lack of Efficacy|0|||
149140659|NCT01428661|537994225|FG000|Double-Masked Phase|*Various|1|||
149140660|NCT01428661|537994226|FG001|Double-Masked Phase|*Various|6|||
149140661|NCT01428661|537994227|FG002|Double-Masked Phase|*Various|0|||
149140662|NCT01428661|537994225|FG000|Open Label Extension|Protocol Violation|0|||
149140663|NCT01428661|537994226|FG001|Open Label Extension|Protocol Violation|0|||
149140664|NCT01428661|537994227|FG002|Open Label Extension|Protocol Violation|9|||
149140665|NCT01428661|537994225|FG000|Open Label Extension|Adverse Event|0|||
149140666|NCT01428661|537994226|FG001|Open Label Extension|Adverse Event|0|||
149140667|NCT01428661|537994227|FG002|Open Label Extension|Adverse Event|15|||
149140668|NCT01428661|537994225|FG000|Open Label Extension|Lost to Follow-up|0|||
149140669|NCT01428661|537994226|FG001|Open Label Extension|Lost to Follow-up|0|||
149140670|NCT01428661|537994227|FG002|Open Label Extension|Lost to Follow-up|38|||
149140671|NCT01428661|537994225|FG000|Open Label Extension|Withdrawal by Subject|0|||
149140672|NCT01428661|537994226|FG001|Open Label Extension|Withdrawal by Subject|0|||
149140673|NCT01428661|537994227|FG002|Open Label Extension|Withdrawal by Subject|49|||
149140674|NCT01428661|537994225|FG000|Open Label Extension|Lack of Efficacy|0|||
149140675|NCT01428661|537994226|FG001|Open Label Extension|Lack of Efficacy|0|||
149140676|NCT01428661|537994227|FG002|Open Label Extension|Lack of Efficacy|24|||
149140677|NCT01428661|537994225|FG000|Open Label Extension|**Various|0|||
149140678|NCT01428661|537994226|FG001|Open Label Extension|**Various|0|||
149140679|NCT01428661|537994227|FG002|Open Label Extension|**Various|185|||
149140680|NCT03828292|537994228|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
149140681|NCT03828292|537994229|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
149140682|NCT03828292|537994230|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
149140683|NCT03828292|537994231|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
149140684|NCT03828292|537994232|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
149140685|NCT03828292|537994233|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
149140686|NCT03828292|537994228|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
149140687|NCT03828292|537994229|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
149140688|NCT03828292|537994230|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
149140689|NCT03828292|537994231|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
149140690|NCT03828292|537994232|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
149140691|NCT03828292|537994233|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
149140692|NCT03828292|537994228|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
149140693|NCT03828292|537994229|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
149140694|NCT03828292|537994230|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
149140695|NCT03828292|537994231|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
149140696|NCT03828292|537994232|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
149140697|NCT03828292|537994233|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
149140698|NCT03828292|537994228|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
149140699|NCT03828292|537994229|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
148804715|NCT05117060|536765165|FG002|Overall Study|Lack of Efficacy|2|||
148804716|NCT05117060|536765166|FG003|Overall Study|Lack of Efficacy|6|||
148804717|NCT05117060|536765163|FG000|Overall Study|Withdrawal by Subject|8|||
148804718|NCT05117060|536765164|FG001|Overall Study|Withdrawal by Subject|5|||
148804719|NCT05117060|536765165|FG002|Overall Study|Withdrawal by Subject|5|||
148804720|NCT05117060|536765166|FG003|Overall Study|Withdrawal by Subject|6|||
148804721|NCT05117060|536765163|FG000|Overall Study|Other|2|||
148804722|NCT05117060|536765164|FG001|Overall Study|Other|1|||
148804723|NCT05117060|536765165|FG002|Overall Study|Other|3|||
148804724|NCT05117060|536765166|FG003|Overall Study|Other|1|||
148804725|NCT05079321|536765167|FG000|Overall Study|Withdrawal by Subject|2|||
148804726|NCT05079321|536765168|FG001|Overall Study|Withdrawal by Subject|2|||
148804727|NCT05079321|536765167|FG000|Overall Study|Lost to Follow-up|0|||
148804728|NCT05079321|536765168|FG001|Overall Study|Lost to Follow-up|1|||
148804729|NCT04239924|536765172|FG000|Overall Study|Lost to Follow-up|2|||
148804730|NCT00666237|536765173|FG000|Overall Study|Death|5|||
148804731|NCT00666237|536765174|FG001|Overall Study|Death|5|||
148804732|NCT00666237|536765173|FG000|Overall Study|Lost to Follow-up|29|||
148804733|NCT00666237|536765174|FG001|Overall Study|Lost to Follow-up|25|||
148804734|NCT03759379|536766540|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
148804735|NCT03759379|536766541|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
148804736|NCT03759379|536766540|FG000|Treatment Period|Death|2|||
148804737|NCT03759379|536766541|FG001|Treatment Period|Death|3|||
148804738|NCT03759379|536766540|FG000|Treatment Period|Lost to Follow-up|1|||
148804739|NCT03759379|536766541|FG001|Treatment Period|Lost to Follow-up|0|||
149140700|NCT03828292|537994230|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
149140701|NCT03828292|537994231|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
149140702|NCT03828292|537994232|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
149140703|NCT03828292|537994233|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
149140704|NCT03828292|537994228|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
149140705|NCT03828292|537994229|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
149140706|NCT03828292|537994230|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
149140707|NCT03828292|537994231|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
149140708|NCT03828292|537994232|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
149140709|NCT03828292|537994233|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
149140710|NCT01444456|537994234|FG000|Overall Study|Withdrawal by Subject|21|||
149140711|NCT01444456|537994234|FG000|Overall Study|Physician Decision|9|||
149140712|NCT01444456|537994234|FG000|Overall Study|Lost to Follow-up|37|||
149140713|NCT01444456|537994234|FG000|Overall Study|Death|73|||
149140714|NCT01444456|537994234|FG000|Overall Study|Ineligibility determined|23|||
149140715|NCT01444456|537994234|FG000|Overall Study|Other|18|||
149140716|NCT01444456|537994234|FG000|Overall Study|Not treated|104|||
149140717|NCT00382720|537995459|FG000|Overall Study|Adverse Event|21|||
149140718|NCT00382720|537995460|FG001|Overall Study|Adverse Event|23|||
149140719|NCT00382720|537995461|FG002|Overall Study|Adverse Event|15|||
149140720|NCT00382720|537995459|FG000|Overall Study|Protocol Violation|2|||
149140721|NCT00382720|537995460|FG001|Overall Study|Protocol Violation|5|||
149140722|NCT00382720|537995461|FG002|Overall Study|Protocol Violation|1|||
149140723|NCT00382720|537995459|FG000|Overall Study|Death|0|||
149140724|NCT00382720|537995460|FG001|Overall Study|Death|1|||
149140725|NCT00382720|537995461|FG002|Overall Study|Death|2|||
149140726|NCT00382720|537995459|FG000|Overall Study|Progressive disease|37|||
149140727|NCT00382720|537995460|FG001|Overall Study|Progressive disease|28|||
149140728|NCT00382720|537995461|FG002|Overall Study|Progressive disease|38|||
149140729|NCT00382720|537995459|FG000|Overall Study|Withdrew consent|1|||
149140730|NCT00382720|537995460|FG001|Overall Study|Withdrew consent|1|||
149140731|NCT00382720|537995461|FG002|Overall Study|Withdrew consent|2|||
149140732|NCT00382720|537995459|FG000|Overall Study|Withdrawal by Subject|11|||
149140733|NCT00382720|537995460|FG001|Overall Study|Withdrawal by Subject|20|||
149140734|NCT00382720|537995461|FG002|Overall Study|Withdrawal by Subject|12|||
149140735|NCT00382720|537995459|FG000|Overall Study|Surgery|1|||
149140736|NCT00382720|537995460|FG001|Overall Study|Surgery|1|||
149140737|NCT00382720|537995461|FG002|Overall Study|Surgery|4|||
149140738|NCT00382720|537995459|FG000|Overall Study|Patient did not receive study medication|1|||
149140739|NCT00382720|537995460|FG001|Overall Study|Patient did not receive study medication|1|||
149140740|NCT00382720|537995461|FG002|Overall Study|Patient did not receive study medication|4|||
149140741|NCT00382720|537995459|FG000|Overall Study|Clinically progressive disease|0|||
149140742|NCT00382720|537995460|FG001|Overall Study|Clinically progressive disease|1|||
149140743|NCT00382720|537995461|FG002|Overall Study|Clinically progressive disease|0|||
149140744|NCT00382720|537995459|FG000|Overall Study|Good prognosis|0|||
149140745|NCT00382720|537995460|FG001|Overall Study|Good prognosis|1|||
149140746|NCT00382720|537995461|FG002|Overall Study|Good prognosis|0|||
149140747|NCT00382720|537995459|FG000|Overall Study|Investigator/Clinical decision|5|||
149140748|NCT00382720|537995460|FG001|Overall Study|Investigator/Clinical decision|6|||
149140749|NCT00382720|537995461|FG002|Overall Study|Investigator/Clinical decision|6|||
149140750|NCT00382720|537995459|FG000|Overall Study|Discontinued at end of study|0|||
149140751|NCT00382720|537995460|FG001|Overall Study|Discontinued at end of study|1|||
149140752|NCT00382720|537995461|FG002|Overall Study|Discontinued at end of study|2|||
149140753|NCT02737852|537995464|FG000|Overall Study|Withdrawal by Subject|2|||
149140754|NCT04042740|537995466|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
149140755|NCT04042740|537995466|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
149140756|NCT01717287|537995467|FG000|Overall Study|Lost to Follow-up|0|||
149140757|NCT01717287|537995468|FG001|Overall Study|Lost to Follow-up|2|||
149140758|NCT01717287|537995467|FG000|Overall Study|Protocol Violation|0|||
149140759|NCT01717287|537995468|FG001|Overall Study|Protocol Violation|1|||
149140760|NCT04490395|537995469|FG000|Overall Study|Lost to Follow-up|0|||
149140761|NCT04490395|537995470|FG001|Overall Study|Lost to Follow-up|1|||
149140762|NCT00388505|537995472|FG000|Overall Study|Adverse Event or Death|43|||
149140763|NCT00388505|537995473|FG001|Overall Study|Adverse Event or Death|17|||
149140764|NCT00388505|537995472|FG000|Overall Study|Withdrawal by Subject|24|||
148912767|NCT04413617|537164716|FG004|Overall Study|COVID-19|0|||
149140765|NCT00388505|537995473|FG001|Overall Study|Withdrawal by Subject|9|||
149140766|NCT00388505|537995472|FG000|Overall Study|Lost to Follow-up|5|||
149140767|NCT00388505|537995473|FG001|Overall Study|Lost to Follow-up|3|||
149140768|NCT00388505|537995472|FG000|Overall Study|Inappropriate Enrollment|0|||
149140769|NCT00388505|537995473|FG001|Overall Study|Inappropriate Enrollment|1|||
149140770|NCT00388505|537995472|FG000|Overall Study|Administrative Reason|1|||
149140771|NCT00388505|537995473|FG001|Overall Study|Administrative Reason|0|||
149140772|NCT00388505|537995472|FG000|Overall Study|Protocol Violation|6|||
149140773|NCT00388505|537995473|FG001|Overall Study|Protocol Violation|5|||
149140774|NCT00388505|537995472|FG000|Overall Study|Unable to classify|4|||
149140775|NCT00388505|537995473|FG001|Overall Study|Unable to classify|3|||
149140776|NCT02163187|537995478|FG000|Overall Study|Device removed|1|||
149140777|NCT02163187|537995479|FG001|Overall Study|Device removed|0|||
149140778|NCT02163187|537995478|FG000|Overall Study|Progressive disease|1|||
149140779|NCT02163187|537995479|FG001|Overall Study|Progressive disease|0|||
149140780|NCT03281668|537995480|FG000|Overall Study|Physician Decision|1|||
149140781|NCT03281668|537995480|FG000|Overall Study|scheduling conflict, family circumstance|2|||
149140782|NCT03281668|537995480|FG000|Overall Study|Withdrawal by Subject|4|||
149140783|NCT03281668|537995480|FG000|Overall Study|Lost to Follow-up|1|||
149140784|NCT00709111|537995491|FG000|Overall Study|Withdrawal by Subject|1|||
149140785|NCT00709111|537995491|FG000|Overall Study|Unable to attend clinic visits|1|||
149140786|NCT00290290|537995498|FG000|Overall Study|Death|3|||
149140787|NCT00290290|537995499|FG001|Overall Study|Death|4|||
149140788|NCT00290290|537995498|FG000|Overall Study|Withdrawal by Subject|2|||
149140789|NCT00290290|537995499|FG001|Overall Study|Withdrawal by Subject|2|||
149140790|NCT00290290|537995498|FG000|Overall Study|Underwent clean surgical procedure|13|||
149140791|NCT00290290|537995499|FG001|Overall Study|Underwent clean surgical procedure|12|||
149140792|NCT00915772|537995500|FG000|Overall Study|Adverse Event|12|||
149140793|NCT00915772|537995501|FG001|Overall Study|Adverse Event|13|||
149140794|NCT00915772|537995502|FG002|Overall Study|Adverse Event|11|||
149140795|NCT00915772|537995500|FG000|Overall Study|Protocol Violation|4|||
149140796|NCT00915772|537995501|FG001|Overall Study|Protocol Violation|1|||
149140797|NCT00915772|537995502|FG002|Overall Study|Protocol Violation|2|||
149140798|NCT00915772|537995500|FG000|Overall Study|Lost to Follow-up|1|||
149140799|NCT00915772|537995501|FG001|Overall Study|Lost to Follow-up|2|||
149140800|NCT00915772|537995502|FG002|Overall Study|Lost to Follow-up|2|||
149140801|NCT00915772|537995500|FG000|Overall Study|Lack of Efficacy|9|||
149140802|NCT00915772|537995501|FG001|Overall Study|Lack of Efficacy|15|||
149012157|NCT02759185|537523469|FG000|Stage 2|Withdrawal by Subject|0|||
149012158|NCT02759185|537523470|FG001|Stage 2|Withdrawal by Subject|0|||
149012159|NCT02759185|537523471|FG002|Stage 2|Withdrawal by Subject|0|||
149012160|NCT02759185|537523472|FG003|Stage 2|Withdrawal by Subject|0|||
149012161|NCT02759185|537523473|FG004|Stage 2|Withdrawal by Subject|1|||
149012162|NCT02759185|537523474|FG005|Stage 2|Withdrawal by Subject|1|||
149012163|NCT02759185|537523475|FG006|Stage 2|Withdrawal by Subject|1|||
149012164|NCT01807650|537523481|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
149012165|NCT01807650|537523481|FG000|Overall Study|Adverse Event|5|||
149012166|NCT01807650|537523481|FG000|Overall Study|Other|2|||
149012167|NCT02716038|537523482|FG000|Overall Study|Not evaluable|1|||
149012168|NCT02716038|537523482|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
149012169|NCT02716038|537523482|FG000|Overall Study|Unresectable|3|||
149012170|NCT02669095|537523488|FG000|Overall Study|Adverse Event|1|||
149012171|NCT02669095|537523489|FG001|Overall Study|Adverse Event|0|||
149012172|NCT02669095|537523488|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
149012173|NCT02669095|537523489|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
149012174|NCT02669095|537523488|FG000|Overall Study|Torn Lens|0|||
149012175|NCT02669095|537523489|FG001|Overall Study|Torn Lens|1|||
149012176|NCT02669095|537523488|FG000|Overall Study|Visit 5 assessments not completed|0|||
149012177|NCT02669095|537523489|FG001|Overall Study|Visit 5 assessments not completed|1|||
149012178|NCT00886639|537523493|FG000|Overall Study|acute exacerbation|14|||
149012179|NCT00886639|537523493|FG000|Overall Study|non-compliance|2|||
149012180|NCT00926003|537523494|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
149012181|NCT00926003|537523495|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
149012182|NCT00926003|537523496|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
149012183|NCT00926003|537523494|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
149012184|NCT00926003|537523495|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
149140803|NCT00915772|537995502|FG002|Overall Study|Lack of Efficacy|3|||
149140804|NCT00915772|537995500|FG000|Overall Study|Refused to continue trial medication|6|||
149140805|NCT00915772|537995501|FG001|Overall Study|Refused to continue trial medication|8|||
149140806|NCT00915772|537995502|FG002|Overall Study|Refused to continue trial medication|4|||
149140807|NCT00915772|537995500|FG000|Overall Study|Any other reason|4|||
149140808|NCT00915772|537995501|FG001|Overall Study|Any other reason|7|||
149140809|NCT00915772|537995502|FG002|Overall Study|Any other reason|7|||
148670898|NCT02181673|536267015|FG001|Up to Week 24|Physician Decision|0|||
148670899|NCT02181673|536267016|FG002|Up to Week 24|Physician Decision|3|||
148670900|NCT02181673|536267014|FG000|Up to Week 24|Withdrawal by Subject|10|||
149012185|NCT00926003|537523496|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
149012186|NCT01871558|537523497|FG000|Overall Study|Other reason|0|||
149012187|NCT01871558|537523498|FG001|Overall Study|Other reason|1|||
149012188|NCT01871558|537523497|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
149012189|NCT01871558|537523498|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
149012190|NCT01871558|537523497|FG000|Overall Study|Withdrawal by Subject|2|||
149012191|NCT01871558|537523498|FG001|Overall Study|Withdrawal by Subject|0|||
149012192|NCT03203694|537523501|FG000|Overall Study|Withdrawal by Subject|2|||
149012193|NCT03203694|537523502|FG001|Overall Study|Withdrawal by Subject|0|||
149012194|NCT03203694|537523503|FG002|Overall Study|Withdrawal by Subject|0|||
149140810|NCT03374995|537995503|FG000|Overall Study|Withdrawal by Subject|0|||
149140811|NCT03374995|537995504|FG001|Overall Study|Withdrawal by Subject|1|||
149140812|NCT05111041|537995517|FG000|Overall Study|Lost to Follow-up|6|||
149140813|NCT05111041|537995518|FG001|Overall Study|Lost to Follow-up|7|||
149140814|NCT05111041|537995517|FG000|Overall Study|Withdrawal by Subject|1|||
149140815|NCT05111041|537995518|FG001|Overall Study|Withdrawal by Subject|0|||
149140816|NCT00041080|537995519|FG000|Overall Study|Adverse Event|21|||
149140817|NCT00041080|537995520|FG001|Overall Study|Adverse Event|1|||
149140818|NCT00041080|537995519|FG000|Overall Study|Withdrawal by Subject|6|||
149140819|NCT00041080|537995520|FG001|Overall Study|Withdrawal by Subject|6|||
149140820|NCT00041080|537995519|FG000|Overall Study|Concommitant Illness/Other|1|||
149140821|NCT00041080|537995520|FG001|Overall Study|Concommitant Illness/Other|2|||
149140822|NCT00041080|537995519|FG000|Overall Study|Did not start therapy|1|||
149140823|NCT00041080|537995520|FG001|Overall Study|Did not start therapy|1|||
149140824|NCT00041080|537995519|FG000|Overall Study|Ineligible|1|||
149140825|NCT00041080|537995520|FG001|Overall Study|Ineligible|0|||
149140826|NCT01011439|537995521|FG000|Overall Study|Death|37|||
149140827|NCT01011439|537995521|FG000|Overall Study|Lost to Follow-up|4|||
149140828|NCT01011439|537995521|FG000|Overall Study|Withdrawal by Subject|1|||
149140829|NCT01011439|537995521|FG000|Overall Study|Sponsor's decision|15|||
149140830|NCT00058552|537995522|FG000|Overall Study|Died prior to receiving treatment|4|||
149140831|NCT00058552|537995523|FG001|Overall Study|Died prior to receiving treatment|2|||
149140832|NCT00058552|537995522|FG000|Overall Study|Disease progression|52|||
149140833|NCT00058552|537995523|FG001|Overall Study|Disease progression|44|||
149140834|NCT00058552|537995522|FG000|Overall Study|Adverse Event|4|||
149140835|NCT00058552|537995523|FG001|Overall Study|Adverse Event|2|||
149140836|NCT00058552|537995522|FG000|Overall Study|Withdrawal by Subject|3|||
149140837|NCT00058552|537995523|FG001|Overall Study|Withdrawal by Subject|5|||
149140838|NCT00058552|537995522|FG000|Overall Study|Physician Decision|2|||
149140839|NCT00058552|537995523|FG001|Overall Study|Physician Decision|5|||
149140840|NCT00058552|537995522|FG000|Overall Study|Clinical disease progression|0|||
149140841|NCT00058552|537995523|FG001|Overall Study|Clinical disease progression|4|||
149140842|NCT03861936|537995524|FG000|Overall Study|Withdrawal by Subject|4|||
149140843|NCT03861936|537995525|FG001|Overall Study|Withdrawal by Subject|1|||
149140844|NCT03861936|537995526|FG002|Overall Study|Withdrawal by Subject|3|||
149140845|NCT03861936|537995524|FG000|Overall Study|Lost to Follow-up|5|||
149140846|NCT03861936|537995525|FG001|Overall Study|Lost to Follow-up|3|||
149140847|NCT03861936|537995526|FG002|Overall Study|Lost to Follow-up|3|||
149140848|NCT03861936|537995524|FG000|Overall Study|Physician Decision|0|||
149140849|NCT03861936|537995525|FG001|Overall Study|Physician Decision|1|||
149140850|NCT03861936|537995526|FG002|Overall Study|Physician Decision|0|||
149140851|NCT03861936|537995524|FG000|Overall Study|Protocol Deviation|0|||
149140852|NCT03861936|537995525|FG001|Overall Study|Protocol Deviation|0|||
149140853|NCT03861936|537995526|FG002|Overall Study|Protocol Deviation|1|||
149140854|NCT03861936|537995524|FG000|Overall Study|Reason not Specified|5|||
149140855|NCT03861936|537995525|FG001|Overall Study|Reason not Specified|5|||
149140856|NCT03861936|537995526|FG002|Overall Study|Reason not Specified|3|||
149140857|NCT00359021|537995527|FG000|Overall Study|Adverse Event|26|||
149140858|NCT00359021|537995528|FG001|Overall Study|Adverse Event|8|||
149140859|NCT00359021|537995527|FG000|Overall Study|Subject Non-Compliant|1|||
149140860|NCT00359021|537995528|FG001|Overall Study|Subject Non-Compliant|2|||
149140861|NCT00359021|537995527|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
149140862|NCT00359021|537995528|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
149140863|NCT00359021|537995527|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
149140864|NCT00359021|537995528|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
148804740|NCT03759379|536766540|FG000|Treatment Period|Physician Decision|0|||
149140865|NCT00359021|537995527|FG000|Overall Study|Withdrawal by Subject|2|||
149140866|NCT00359021|537995528|FG001|Overall Study|Withdrawal by Subject|9|||
149140867|NCT00359021|537995527|FG000|Overall Study|Lost to Follow-up|1|||
148804741|NCT03759379|536766541|FG001|Treatment Period|Physician Decision|1|||
148804742|NCT02659865|536766542|FG000|Period 1|Withdrawal by Subject|1|||
148804743|NCT02659865|536766543|FG001|Period 1|Withdrawal by Subject|0|||
148804744|NCT02659865|536766544|FG002|Period 1|Withdrawal by Subject|0|||
148804745|NCT02659865|536766545|FG003|Period 1|Withdrawal by Subject|0|||
148804746|NCT02659865|536766546|FG004|Period 1|Withdrawal by Subject|0|||
148804747|NCT02659865|536766542|FG000|Period 1|Adverse Event|0|||
148804748|NCT02659865|536766543|FG001|Period 1|Adverse Event|0|||
148804749|NCT02659865|536766544|FG002|Period 1|Adverse Event|0|||
148804750|NCT02659865|536766545|FG003|Period 1|Adverse Event|0|||
148804751|NCT02659865|536766546|FG004|Period 1|Adverse Event|1|||
148804752|NCT02325414|536766547|FG000|Overall Study|Withdrawal by Subject|3|||
148804753|NCT02325414|536766548|FG001|Overall Study|Withdrawal by Subject|1|||
148804754|NCT02325414|536766547|FG000|Overall Study|Lost to Follow-up|5|||
148804755|NCT02325414|536766548|FG001|Overall Study|Lost to Follow-up|5|||
149140868|NCT00359021|537995528|FG001|Overall Study|Lost to Follow-up|0|||
149140869|NCT00359021|537995527|FG000|Overall Study|Other|4|||
149140870|NCT00359021|537995528|FG001|Overall Study|Other|1|||
149140871|NCT00359021|537995527|FG000|Overall Study|Pregnancy|1|||
148804756|NCT05722522|536766549|FG000|Overall Study|Adverse Event|0|||
149140872|NCT00359021|537995528|FG001|Overall Study|Pregnancy|0|||
149140873|NCT03198520|537995535|FG000|Overall Study|Physician Decision|2|||
149140874|NCT03198520|537995535|FG000|Overall Study|Protocol Violation|2|||
148912768|NCT00312195|537164717|FG000|Overall Study|Adverse Event|4|||
148912769|NCT00312195|537164718|FG001|Overall Study|Adverse Event|6|||
148912770|NCT00312195|537164717|FG000|Overall Study|Lost to Follow-up|1|||
148912771|NCT00312195|537164718|FG001|Overall Study|Lost to Follow-up|0|||
148912772|NCT00312195|537164717|FG000|Overall Study|Protocol Violation|1|||
148912773|NCT00312195|537164718|FG001|Overall Study|Protocol Violation|0|||
148912774|NCT02511106|537164719|FG000|Overall Study|Lost to Follow-up|6|||
148912775|NCT02511106|537164720|FG001|Overall Study|Lost to Follow-up|4|||
148912776|NCT02511106|537164719|FG000|Overall Study|Withdrawal by Subject|24|||
148912777|NCT02511106|537164720|FG001|Overall Study|Withdrawal by Subject|21|||
148912778|NCT02511106|537164719|FG000|Overall Study|Death|42|||
148912779|NCT02511106|537164720|FG001|Overall Study|Death|82|||
148912780|NCT02511106|537164719|FG000|Overall Study|Ongoing study at data cut-off|3|||
148912781|NCT02511106|537164720|FG001|Overall Study|Ongoing study at data cut-off|2|||
148912782|NCT02511106|537164719|FG000|Overall Study|Without specified reason|3|||
148912783|NCT02511106|537164720|FG001|Overall Study|Without specified reason|0|||
148912784|NCT01015638|537164721|FG000|Overall Study|Withdrawal by Subject|1|||
148912785|NCT01015638|537164722|FG001|Overall Study|Withdrawal by Subject|0|||
148912786|NCT00984620|537164723|FG000|Overall Study|Adverse Event|5|||
148912787|NCT00984620|537164724|FG001|Overall Study|Adverse Event|5|||
148912788|NCT00984620|537164723|FG000|Overall Study|Lost to Follow-up|1|||
148912789|NCT00984620|537164724|FG001|Overall Study|Lost to Follow-up|1|||
148912790|NCT00984620|537164723|FG000|Overall Study|Withdrawal by Subject|0|||
148912791|NCT00984620|537164724|FG001|Overall Study|Withdrawal by Subject|2|||
148912792|NCT00984620|537164723|FG000|Overall Study|reason other than listed above|0|||
148912793|NCT00984620|537164724|FG001|Overall Study|reason other than listed above|4|||
148912794|NCT01561313|537164729|FG000|Overall Study|Withdrawal by Subject|1|||
148912795|NCT01561313|537164730|FG001|Overall Study|Withdrawal by Subject|0|||
148912796|NCT01561313|537164729|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
149012195|NCT03203694|537523504|FG003|Overall Study|Withdrawal by Subject|0|||
149012196|NCT03203694|537523505|FG004|Overall Study|Withdrawal by Subject|0|||
149012197|NCT03203694|537523506|FG005|Overall Study|Withdrawal by Subject|0|||
149012198|NCT01709305|537523507|FG000|Phase 1|Clinical Adverse Event|80|||
149012199|NCT01709305|537523508|FG001|Phase 1|Clinical Adverse Event|0|||
149012200|NCT01709305|537523509|FG002|Phase 1|Clinical Adverse Event|0|||
149012201|NCT01709305|537523510|FG003|Phase 1|Clinical Adverse Event|0|||
149012202|NCT01709305|537523511|FG004|Phase 1|Clinical Adverse Event|0|||
149012203|NCT01709305|537523507|FG000|Phase 1|Death|2|||
149012204|NCT01709305|537523508|FG001|Phase 1|Death|0|||
149012205|NCT01709305|537523509|FG002|Phase 1|Death|0|||
149012206|NCT01709305|537523510|FG003|Phase 1|Death|0|||
149012207|NCT01709305|537523511|FG004|Phase 1|Death|0|||
149012208|NCT01709305|537523507|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
149012209|NCT01709305|537523508|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
149012210|NCT01709305|537523509|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
149012211|NCT01709305|537523510|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
149012212|NCT01709305|537523511|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
149012213|NCT01709305|537523507|FG000|Phase 1|Laboratory Adverse Event|16|||
149012214|NCT01709305|537523508|FG001|Phase 1|Laboratory Adverse Event|0|||
149012215|NCT01709305|537523509|FG002|Phase 1|Laboratory Adverse Event|0|||
149012216|NCT01709305|537523510|FG003|Phase 1|Laboratory Adverse Event|0|||
149012217|NCT01709305|537523511|FG004|Phase 1|Laboratory Adverse Event|0|||
149012218|NCT01709305|537523507|FG000|Phase 1|Lost to Follow-up|147|||
149012219|NCT01709305|537523508|FG001|Phase 1|Lost to Follow-up|0|||
149012220|NCT01709305|537523509|FG002|Phase 1|Lost to Follow-up|0|||
149012221|NCT01709305|537523510|FG003|Phase 1|Lost to Follow-up|0|||
149012222|NCT01709305|537523511|FG004|Phase 1|Lost to Follow-up|0|||
149012223|NCT01709305|537523507|FG000|Phase 1|Travel, moving, etc.|30|||
149012224|NCT01709305|537523508|FG001|Phase 1|Travel, moving, etc.|0|||
149012225|NCT01709305|537523509|FG002|Phase 1|Travel, moving, etc.|0|||
149012226|NCT01709305|537523510|FG003|Phase 1|Travel, moving, etc.|0|||
149012227|NCT01709305|537523511|FG004|Phase 1|Travel, moving, etc.|0|||
149012228|NCT01709305|537523507|FG000|Phase 1|Physician Decision|13|||
149012229|NCT01709305|537523508|FG001|Phase 1|Physician Decision|0|||
149012230|NCT01709305|537523509|FG002|Phase 1|Physician Decision|0|||
149012231|NCT01709305|537523510|FG003|Phase 1|Physician Decision|0|||
149012232|NCT01709305|537523511|FG004|Phase 1|Physician Decision|0|||
149012233|NCT01709305|537523507|FG000|Phase 1|Protocol Violation|118|||
148912797|NCT01561313|537164730|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
149012234|NCT01709305|537523508|FG001|Phase 1|Protocol Violation|0|||
149012235|NCT01709305|537523509|FG002|Phase 1|Protocol Violation|0|||
149012236|NCT01709305|537523510|FG003|Phase 1|Protocol Violation|0|||
149012237|NCT01709305|537523511|FG004|Phase 1|Protocol Violation|0|||
149012238|NCT01709305|537523507|FG000|Phase 1|Withdrawal by Subject|218|||
148670901|NCT02181673|536267015|FG001|Up to Week 24|Withdrawal by Subject|0|||
148670902|NCT02181673|536267016|FG002|Up to Week 24|Withdrawal by Subject|1|||
148670903|NCT02181673|536267014|FG000|Up to Week 24|Other|2|||
148670904|NCT02181673|536267015|FG001|Up to Week 24|Other|0|||
148670905|NCT02181673|536267016|FG002|Up to Week 24|Other|3|||
148670906|NCT02181673|536267014|FG000|Up to Week 24|Randomized not Treated|0|||
148670907|NCT02181673|536267015|FG001|Up to Week 24|Randomized not Treated|0|||
148670908|NCT02181673|536267016|FG002|Up to Week 24|Randomized not Treated|1|||
148912798|NCT04535453|537164731|FG000|Overall Study|Death|0|||
148912799|NCT04535453|537164732|FG001|Overall Study|Death|1|||
148912800|NCT04535453|537164733|FG002|Overall Study|Death|0|||
148912801|NCT04535453|537164734|FG003|Overall Study|Death|0|||
148912802|NCT04535453|537164735|FG004|Overall Study|Death|0|||
148912803|NCT04535453|537164736|FG005|Overall Study|Death|0|||
148912804|NCT04535453|537164737|FG006|Overall Study|Death|0|||
148912805|NCT04535453|537164738|FG007|Overall Study|Death|0|||
149140875|NCT03198520|537995535|FG000|Overall Study|Withdrawal by Subject|1|||
149140876|NCT03198520|537995535|FG000|Overall Study|Study Ended|1|||
149140877|NCT01670539|537995536|FG000|Overall Study|Death|3|||
149140878|NCT01670539|537995537|FG001|Overall Study|Death|5|||
149140879|NCT01670539|537995536|FG000|Overall Study|Withdrawal by Subject|3|||
149140880|NCT01670539|537995537|FG001|Overall Study|Withdrawal by Subject|0|||
149140881|NCT01986920|537995540|FG000|A- 101 25%|Withdrawal by Subject|1|||
149140882|NCT01986920|537995541|FG001|A- 101 25%|Withdrawal by Subject|0|||
149140883|NCT01986920|537995542|FG002|A- 101 25%|Withdrawal by Subject|0|||
149140884|NCT01986920|537995543|FG003|A- 101 25%|Withdrawal by Subject|0|||
149140885|NCT01986920|537995540|FG000|A-101 32.5%|Withdrawal by Subject|0|||
149140886|NCT01986920|537995541|FG001|A-101 32.5%|Withdrawal by Subject|1|||
149140887|NCT01986920|537995542|FG002|A-101 32.5%|Withdrawal by Subject|0|||
149140888|NCT01986920|537995543|FG003|A-101 32.5%|Withdrawal by Subject|0|||
149140889|NCT01986920|537995540|FG000|A-101 40%|Withdrawal by Subject|0|||
149140890|NCT01986920|537995541|FG001|A-101 40%|Withdrawal by Subject|0|||
149140891|NCT01986920|537995542|FG002|A-101 40%|Withdrawal by Subject|1|||
149140892|NCT01986920|537995543|FG003|A-101 40%|Withdrawal by Subject|0|||
149140893|NCT01986920|537995540|FG000|Placebo|Withdrawal by Subject|0|||
149140894|NCT01986920|537995541|FG001|Placebo|Withdrawal by Subject|0|||
149140895|NCT01986920|537995542|FG002|Placebo|Withdrawal by Subject|0|||
149140896|NCT01986920|537995543|FG003|Placebo|Withdrawal by Subject|1|||
149140897|NCT03023059|537995544|FG000|Overall Study|Withdrawal by Subject|5|||
149140898|NCT03781323|537995545|FG000|Overall Study|Withdrawal by Subject|1|||
149140899|NCT00496730|537995564|FG000|Overall Study|Lost to Follow-up|4|||
149140900|NCT00496730|537995565|FG001|Overall Study|Lost to Follow-up|3|||
149140901|NCT00496730|537995564|FG000|Overall Study|Withdrawal by Subject|2|||
149140902|NCT00496730|537995565|FG001|Overall Study|Withdrawal by Subject|2|||
149140903|NCT00113074|537995569|FG000|Overall Study|Lost to Follow-up|10|||
149140904|NCT00113074|537995570|FG001|Overall Study|Lost to Follow-up|10|||
149140905|NCT00113074|537995571|FG002|Overall Study|Lost to Follow-up|14|||
149140906|NCT01106027|537995574|FG000|Overall Study|Lost graft early, discontinued|1|||
149140907|NCT00369785|537995575|FG000|Overall Study|Physician Decision|3|||
149140908|NCT00369785|537995576|FG001|Overall Study|Physician Decision|2|||
149140909|NCT00369785|537995575|FG000|Overall Study|Death|1|||
149140910|NCT00369785|537995576|FG001|Overall Study|Death|2|||
149140911|NCT00369785|537995575|FG000|Overall Study|Withdrawal by Subject|7|||
149140912|NCT00369785|537995576|FG001|Overall Study|Withdrawal by Subject|6|||
149140913|NCT00369785|537995575|FG000|Overall Study|Toxicity|6|||
149140914|NCT00369785|537995576|FG001|Overall Study|Toxicity|4|||
149140915|NCT00369785|537995575|FG000|Overall Study|Never started|0|||
149140916|NCT00369785|537995576|FG001|Overall Study|Never started|2|||
149140917|NCT00369785|537995575|FG000|Overall Study|Progression|4|||
149140918|NCT00369785|537995576|FG001|Overall Study|Progression|4|||
149140919|NCT00369785|537995575|FG000|Overall Study|Multiple reasons|6|||
149140920|NCT00369785|537995576|FG001|Overall Study|Multiple reasons|5|||
149140921|NCT00800683|537995577|FG000|Overall Study|Adverse Event|11|||
149140922|NCT00800683|537995578|FG001|Overall Study|Adverse Event|8|||
149140923|NCT00800683|537995577|FG000|Overall Study|Lost to Follow-up|3|||
149140924|NCT00800683|537995578|FG001|Overall Study|Lost to Follow-up|1|||
149140925|NCT00800683|537995577|FG000|Overall Study|Withdrawal by Subject|1|||
148670909|NCT02181673|536267014|FG000|Week 24-Week 60|Adverse Event|0|||
148670910|NCT02181673|536267015|FG001|Week 24-Week 60|Adverse Event|4|||
148670911|NCT02181673|536267016|FG002|Week 24-Week 60|Adverse Event|10|||
148670912|NCT02181673|536267014|FG000|Week 24-Week 60|Other|0|||
149140926|NCT00800683|537995578|FG001|Overall Study|Withdrawal by Subject|7|||
149140927|NCT00800683|537995577|FG000|Overall Study|Lack of Efficacy|1|||
149140928|NCT00800683|537995578|FG001|Overall Study|Lack of Efficacy|1|||
149140929|NCT00800683|537995577|FG000|Overall Study|Other|1|||
148670913|NCT02181673|536267015|FG001|Week 24-Week 60|Other|2|||
148912806|NCT04535453|537164739|FG008|Overall Study|Death|0|||
149140930|NCT00800683|537995578|FG001|Overall Study|Other|2|||
149140931|NCT00356889|537995580|FG000|Overall Study|Protocol Violation|2|||
149140932|NCT00356889|537995580|FG000|Overall Study|Adverse Event|1|||
149140933|NCT02678416|537995581|FG000|Part 1|Withdrawal by Subject|1|||
149140934|NCT02678416|537995581|FG000|Part 2|Adverse Event|2|||
149140935|NCT02678416|537995581|FG000|Part 2|Withdrawal by Subject|1|||
149140936|NCT01848353|537995582|FG000|Phase 1|Withdrawal by Subject|3|||
149140937|NCT01848353|537995583|FG001|Phase 1|Withdrawal by Subject|1|||
149140938|NCT01848353|537995584|FG002|Phase 1|Withdrawal by Subject|0|||
149140939|NCT01848353|537995585|FG003|Phase 1|Withdrawal by Subject|0|||
149140940|NCT01848353|537995582|FG000|Phase 2|Withdrawal by Subject|3|||
149140941|NCT01848353|537995583|FG001|Phase 2|Withdrawal by Subject|2|||
149140942|NCT01848353|537995584|FG002|Phase 2|Withdrawal by Subject|0|||
149140943|NCT01848353|537995585|FG003|Phase 2|Withdrawal by Subject|0|||
149140944|NCT01848353|537995582|FG000|Phase 3|Withdrawal by Subject|1|||
149140945|NCT01848353|537995583|FG001|Phase 3|Withdrawal by Subject|1|||
149140946|NCT01848353|537995584|FG002|Phase 3|Withdrawal by Subject|0|||
149140947|NCT01848353|537995585|FG003|Phase 3|Withdrawal by Subject|0|||
149140948|NCT04376827|537995588|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
149140949|NCT04376827|537995589|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
149140950|NCT04376827|537995588|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
149140951|NCT04376827|537995589|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
149140952|NCT04376827|537995588|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
149140953|NCT04376827|537995589|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
149140954|NCT04376827|537995588|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
149140955|NCT04376827|537995589|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
149140956|NCT04376827|537995588|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
149140957|NCT04376827|537995589|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
149140958|NCT05092919|537997348|FG000|Overall Study|Lost to Follow-up|7|||
149140959|NCT05092919|537997348|FG000|Overall Study|Withdrawal by Subject|2|||
149140960|NCT03785925|537997353|FG000|Overall Study|Withdrawal by Subject|15|||
149140961|NCT03785925|537997353|FG000|Overall Study|Lost to Follow-up|1|||
149140962|NCT00677820|537997355|FG000|Overall Study|Lost to Follow-up|1|||
149140963|NCT00677820|537997356|FG001|Overall Study|Lost to Follow-up|0|||
149140964|NCT03593850|537997359|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
149140965|NCT03593850|537997360|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
149140966|NCT02490475|537997361|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
149140967|NCT02490475|537997362|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
149140968|NCT02490475|537997363|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
149140969|NCT02490475|537997364|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
149012239|NCT01709305|537523508|FG001|Phase 1|Withdrawal by Subject|0|||
149012240|NCT01709305|537523509|FG002|Phase 1|Withdrawal by Subject|0|||
149012241|NCT01709305|537523510|FG003|Phase 1|Withdrawal by Subject|0|||
149012242|NCT01709305|537523511|FG004|Phase 1|Withdrawal by Subject|0|||
149012243|NCT01709305|537523507|FG000|Phase 2|Clinical Adverse Event|0|||
149012244|NCT01709305|537523508|FG001|Phase 2|Clinical Adverse Event|10|||
149012245|NCT01709305|537523509|FG002|Phase 2|Clinical Adverse Event|10|||
149012246|NCT01709305|537523510|FG003|Phase 2|Clinical Adverse Event|6|||
149012247|NCT01709305|537523511|FG004|Phase 2|Clinical Adverse Event|11|||
149012248|NCT01709305|537523507|FG000|Phase 2|Death|0|||
149012249|NCT01709305|537523508|FG001|Phase 2|Death|0|||
149012250|NCT01709305|537523509|FG002|Phase 2|Death|1|||
149012251|NCT01709305|537523510|FG003|Phase 2|Death|0|||
149012252|NCT01709305|537523511|FG004|Phase 2|Death|0|||
149012253|NCT01709305|537523507|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
149012254|NCT01709305|537523508|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
149012255|NCT01709305|537523509|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
149012256|NCT01709305|537523510|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
149012257|NCT01709305|537523511|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
149012258|NCT01709305|537523507|FG000|Phase 2|Laboratory Adverse Event|0|||
149012259|NCT01709305|537523508|FG001|Phase 2|Laboratory Adverse Event|1|||
149012260|NCT01709305|537523509|FG002|Phase 2|Laboratory Adverse Event|0|||
149012261|NCT01709305|537523510|FG003|Phase 2|Laboratory Adverse Event|1|||
149012262|NCT01709305|537523511|FG004|Phase 2|Laboratory Adverse Event|1|||
149012263|NCT01709305|537523507|FG000|Phase 2|Lost to Follow-up|0|||
149012264|NCT01709305|537523508|FG001|Phase 2|Lost to Follow-up|10|||
149012265|NCT01709305|537523509|FG002|Phase 2|Lost to Follow-up|6|||
149012266|NCT01709305|537523510|FG003|Phase 2|Lost to Follow-up|9|||
149012267|NCT01709305|537523511|FG004|Phase 2|Lost to Follow-up|5|||
149012268|NCT01709305|537523507|FG000|Phase 2|Travel, moving, etc.|0|||
149012269|NCT01709305|537523508|FG001|Phase 2|Travel, moving, etc.|2|||
149012270|NCT01709305|537523509|FG002|Phase 2|Travel, moving, etc.|3|||
149012271|NCT01709305|537523510|FG003|Phase 2|Travel, moving, etc.|3|||
149012272|NCT01709305|537523511|FG004|Phase 2|Travel, moving, etc.|5|||
149012273|NCT01709305|537523507|FG000|Phase 2|Physician Decision|0|||
149012274|NCT01709305|537523508|FG001|Phase 2|Physician Decision|2|||
149012275|NCT01709305|537523509|FG002|Phase 2|Physician Decision|0|||
149012276|NCT01709305|537523510|FG003|Phase 2|Physician Decision|1|||
149012277|NCT01709305|537523511|FG004|Phase 2|Physician Decision|2|||
149012278|NCT01709305|537523507|FG000|Phase 2|Protocol Violation|0|||
149012279|NCT01709305|537523508|FG001|Phase 2|Protocol Violation|19|||
149140970|NCT02490475|537997361|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
149140971|NCT02490475|537997362|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
149140972|NCT02490475|537997363|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
149140973|NCT02490475|537997364|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
149140974|NCT02490475|537997361|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
149140975|NCT02490475|537997362|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
149140976|NCT02490475|537997363|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
149140977|NCT02490475|537997364|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
149140978|NCT02490475|537997361|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
149140979|NCT02490475|537997362|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
149140980|NCT02490475|537997363|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
149140981|NCT02490475|537997364|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
149140982|NCT02490475|537997361|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
149140983|NCT02490475|537997362|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
149140984|NCT02490475|537997363|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
149140985|NCT02490475|537997364|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
149140986|NCT02490475|537997361|FG000|Period 2: Extension Phase|Refused Treatment|0|||
149140987|NCT02490475|537997362|FG001|Period 2: Extension Phase|Refused Treatment|0|||
149140988|NCT02490475|537997363|FG002|Period 2: Extension Phase|Refused Treatment|0|||
149140989|NCT02490475|537997364|FG003|Period 2: Extension Phase|Refused Treatment|1|||
149140990|NCT02490475|537997361|FG000|Period 2: Extension Phase|Adverse Event|0|||
149140991|NCT02490475|537997362|FG001|Period 2: Extension Phase|Adverse Event|0|||
149140992|NCT02490475|537997363|FG002|Period 2: Extension Phase|Adverse Event|1|||
149140993|NCT02490475|537997364|FG003|Period 2: Extension Phase|Adverse Event|0|||
149140994|NCT01195090|537997366|FG000|Overall Study|Adverse Event|1|||
149140995|NCT01195090|537997367|FG001|Overall Study|Adverse Event|2|||
149140996|NCT01195090|537997366|FG000|Overall Study|Lost to Follow-up|2|||
149140997|NCT01195090|537997367|FG001|Overall Study|Lost to Follow-up|2|||
149140998|NCT01195090|537997366|FG000|Overall Study|Protocol Violation|3|||
149140999|NCT01195090|537997367|FG001|Overall Study|Protocol Violation|4|||
149141000|NCT04912245|537997370|FG000|Overall Study|Withdrawal by Subject|21|||
149141001|NCT04912245|537997371|FG001|Overall Study|Withdrawal by Subject|4|||
149141002|NCT04912245|537997370|FG000|Overall Study|Lost to Follow-up|5|||
149141003|NCT04912245|537997371|FG001|Overall Study|Lost to Follow-up|11|||
149141004|NCT01205230|537997372|FG000|Overall Study|Adverse Event|4|||
149141005|NCT01205230|537997373|FG001|Overall Study|Adverse Event|0|||
149141006|NCT01205230|537997372|FG000|Overall Study|Physician Decision|1|||
149141007|NCT01205230|537997373|FG001|Overall Study|Physician Decision|0|||
149141008|NCT02319668|537997374|FG000|Overall Study|Other (Not specified)|0|||
149141009|NCT02319668|537997375|FG001|Overall Study|Other (Not specified)|2|||
149141010|NCT01372150|537997376|FG000|Overall Study|Lack of Efficacy|3|||
149141011|NCT01372150|537997377|FG001|Overall Study|Lack of Efficacy|0|||
149141012|NCT01372150|537997378|FG002|Overall Study|Lack of Efficacy|1|||
149141013|NCT01372150|537997376|FG000|Overall Study|Lost to Follow-up|4|||
149141014|NCT01372150|537997377|FG001|Overall Study|Lost to Follow-up|5|||
149141015|NCT01372150|537997378|FG002|Overall Study|Lost to Follow-up|6|||
149141016|NCT01372150|537997376|FG000|Overall Study|Protocol Violation|1|||
149141017|NCT01372150|537997377|FG001|Overall Study|Protocol Violation|0|||
148670914|NCT02181673|536267016|FG002|Week 24-Week 60|Other|1|||
148804757|NCT05722522|536766550|FG001|Overall Study|Adverse Event|1|||
148804758|NCT03834961|536766553|FG000|Overall Study|Lack of Efficacy|1|||
148804759|NCT03834961|536766554|FG001|Overall Study|Lack of Efficacy|1|||
148804760|NCT03834961|536766555|FG002|Overall Study|Lack of Efficacy|0|||
148804761|NCT03834961|536766553|FG000|Overall Study|Physician Decision|0|||
148804762|NCT03834961|536766554|FG001|Overall Study|Physician Decision|1|||
148804763|NCT03834961|536766555|FG002|Overall Study|Physician Decision|0|||
148804764|NCT04736199|536766558|FG000|Overall Study|Adverse Event|28|||
148804765|NCT04736199|536766559|FG001|Overall Study|Adverse Event|22|||
148804766|NCT04736199|536766558|FG000|Overall Study|Death|9|||
148804767|NCT04736199|536766559|FG001|Overall Study|Death|3|||
148804768|NCT04736199|536766558|FG000|Overall Study|Lost to Follow-up|4|||
148804769|NCT04736199|536766559|FG001|Overall Study|Lost to Follow-up|1|||
148804770|NCT04736199|536766558|FG000|Overall Study|Physician Decision|5|||
148912807|NCT04535453|537164740|FG009|Overall Study|Death|0|||
148804771|NCT04736199|536766559|FG001|Overall Study|Physician Decision|9|||
148804772|NCT04736199|536766558|FG000|Overall Study|Withdrawal by Subject|21|||
148804773|NCT04736199|536766559|FG001|Overall Study|Withdrawal by Subject|9|||
148804774|NCT04736199|536766558|FG000|Overall Study|Progressive disease|120|||
148804775|NCT04736199|536766559|FG001|Overall Study|Progressive disease|101|||
148804776|NCT04736199|536766558|FG000|Overall Study|Subject decision|13|||
148804777|NCT04736199|536766559|FG001|Overall Study|Subject decision|13|||
148804778|NCT04736199|536766558|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
148804779|NCT04736199|536766559|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
148804780|NCT04736199|536766558|FG000|Overall Study|Additional primary malignancy|1|||
149141018|NCT01372150|537997378|FG002|Overall Study|Protocol Violation|3|||
149012280|NCT01709305|537523509|FG002|Phase 2|Protocol Violation|19|||
149012281|NCT01709305|537523510|FG003|Phase 2|Protocol Violation|13|||
149012282|NCT01709305|537523511|FG004|Phase 2|Protocol Violation|9|||
149012283|NCT01709305|537523507|FG000|Phase 2|Withdrawal by Subject|0|||
149012284|NCT01709305|537523508|FG001|Phase 2|Withdrawal by Subject|8|||
149012285|NCT01709305|537523509|FG002|Phase 2|Withdrawal by Subject|6|||
149012286|NCT01709305|537523510|FG003|Phase 2|Withdrawal by Subject|15|||
149012287|NCT01709305|537523511|FG004|Phase 2|Withdrawal by Subject|12|||
149012288|NCT00118898|537523512|FG000|Overall Study|Death|6|||
149012289|NCT00118898|537523513|FG001|Overall Study|Death|11|||
149012290|NCT00118898|537523514|FG002|Overall Study|Death|6|||
149012291|NCT00118898|537523515|FG003|Overall Study|Death|8|||
149012292|NCT00118898|537523512|FG000|Overall Study|Lost to Follow-up|26|||
149012293|NCT00118898|537523513|FG001|Overall Study|Lost to Follow-up|34|||
149012294|NCT00118898|537523514|FG002|Overall Study|Lost to Follow-up|33|||
149012295|NCT00118898|537523515|FG003|Overall Study|Lost to Follow-up|33|||
149012296|NCT00118898|537523512|FG000|Overall Study|Withdrawal by Subject|10|||
149012297|NCT00118898|537523513|FG001|Overall Study|Withdrawal by Subject|5|||
149012298|NCT00118898|537523514|FG002|Overall Study|Withdrawal by Subject|8|||
149012299|NCT00118898|537523515|FG003|Overall Study|Withdrawal by Subject|8|||
149012300|NCT00118898|537523512|FG000|Overall Study|Site Closure|33|||
149012301|NCT00118898|537523513|FG001|Overall Study|Site Closure|31|||
149012302|NCT00118898|537523514|FG002|Overall Study|Site Closure|28|||
149012303|NCT00118898|537523515|FG003|Overall Study|Site Closure|37|||
149012304|NCT00118898|537523512|FG000|Overall Study|Severe debilitation|1|||
149012305|NCT00118898|537523513|FG001|Overall Study|Severe debilitation|4|||
149012306|NCT00118898|537523514|FG002|Overall Study|Severe debilitation|6|||
149012307|NCT00118898|537523515|FG003|Overall Study|Severe debilitation|4|||
149012308|NCT00118898|537523512|FG000|Overall Study|Not compliant with requirements|11|||
149012309|NCT00118898|537523513|FG001|Overall Study|Not compliant with requirements|13|||
149012310|NCT00118898|537523514|FG002|Overall Study|Not compliant with requirements|11|||
149012311|NCT00118898|537523515|FG003|Overall Study|Not compliant with requirements|11|||
149012312|NCT00118898|537523512|FG000|Overall Study|Not able to get to clinic|34|||
149012313|NCT00118898|537523513|FG001|Overall Study|Not able to get to clinic|43|||
149012314|NCT00118898|537523514|FG002|Overall Study|Not able to get to clinic|31|||
149012315|NCT00118898|537523515|FG003|Overall Study|Not able to get to clinic|40|||
149012316|NCT03813147|537523516|FG000|Overall Study|Lack of Efficacy|4|||
149012317|NCT03813147|537523517|FG001|Overall Study|Lack of Efficacy|4|||
149012318|NCT03813147|537523516|FG000|Overall Study|Physician Decision|2|||
149012319|NCT03813147|537523517|FG001|Overall Study|Physician Decision|1|||
149012320|NCT01693692|537523518|FG000|Overall Study|Withdrawal by Subject|12|||
149012321|NCT01693692|537523519|FG001|Overall Study|Withdrawal by Subject|10|||
149012322|NCT01693692|537523520|FG002|Overall Study|Withdrawal by Subject|11|||
149012323|NCT01693692|537523518|FG000|Overall Study|Adverse Event|7|||
149012324|NCT01693692|537523519|FG001|Overall Study|Adverse Event|14|||
149012325|NCT01693692|537523520|FG002|Overall Study|Adverse Event|9|||
149012326|NCT01693692|537523518|FG000|Overall Study|Physician Decision|0|||
149012327|NCT01693692|537523519|FG001|Overall Study|Physician Decision|0|||
149012328|NCT01693692|537523520|FG002|Overall Study|Physician Decision|1|||
149012329|NCT01693692|537523518|FG000|Overall Study|Protocol Violation|5|||
149012330|NCT01693692|537523519|FG001|Overall Study|Protocol Violation|4|||
149012331|NCT01693692|537523520|FG002|Overall Study|Protocol Violation|6|||
149012332|NCT01693692|537523518|FG000|Overall Study|Lost to Follow-up|2|||
149012333|NCT01693692|537523519|FG001|Overall Study|Lost to Follow-up|2|||
149012334|NCT01693692|537523520|FG002|Overall Study|Lost to Follow-up|3|||
149012335|NCT01693692|537523518|FG000|Overall Study|Other|4|||
149012336|NCT01693692|537523519|FG001|Overall Study|Other|4|||
149012337|NCT01693692|537523520|FG002|Overall Study|Other|6|||
149012338|NCT01167179|537525670|FG000|Overall Study|disease recurrence|4|||
149012339|NCT01167179|537525671|FG001|Overall Study|disease recurrence|4|||
149012340|NCT01167179|537525670|FG000|Overall Study|Death|4|||
149012341|NCT01167179|537525671|FG001|Overall Study|Death|10|||
149012342|NCT01167179|537525670|FG000|Overall Study|Withdrawal by Subject|1|||
149012343|NCT01167179|537525671|FG001|Overall Study|Withdrawal by Subject|2|||
149012344|NCT01167179|537525670|FG000|Overall Study|diverse|6|||
149012345|NCT01167179|537525671|FG001|Overall Study|diverse|5|||
149012346|NCT00663117|537525672|FG000|Overall Study|Lack of Efficacy|1|||
149012347|NCT00663117|537525673|FG001|Overall Study|Lack of Efficacy|0|||
149012348|NCT01158378|537525674|FG000|Overall Study|Death|4|||
149141019|NCT01372150|537997376|FG000|Overall Study|Withdrawal by Subject|2|||
149141020|NCT01372150|537997377|FG001|Overall Study|Withdrawal by Subject|7|||
149141021|NCT01372150|537997378|FG002|Overall Study|Withdrawal by Subject|2|||
149141022|NCT01372150|537997376|FG000|Overall Study|Other|1|||
149141023|NCT01372150|537997377|FG001|Overall Study|Other|0|||
149141024|NCT01372150|537997378|FG002|Overall Study|Other|2|||
149141025|NCT01372150|537997376|FG000|Overall Study|Adverse Event|2|||
149141026|NCT01372150|537997377|FG001|Overall Study|Adverse Event|1|||
149141027|NCT01372150|537997378|FG002|Overall Study|Adverse Event|2|||
149141028|NCT01372150|537997376|FG000|Overall Study|Randomized but not treated|0|||
149141029|NCT01372150|537997377|FG001|Overall Study|Randomized but not treated|1|||
149141030|NCT01372150|537997378|FG002|Overall Study|Randomized but not treated|0|||
148912808|NCT04535453|537164741|FG010|Overall Study|Death|0|||
148912809|NCT04535453|537164742|FG011|Overall Study|Death|0|||
148912810|NCT04535453|537164731|FG000|Overall Study|Lost to Follow-up|1|||
148912811|NCT04535453|537164732|FG001|Overall Study|Lost to Follow-up|1|||
148912812|NCT04535453|537164733|FG002|Overall Study|Lost to Follow-up|1|||
148912813|NCT04535453|537164734|FG003|Overall Study|Lost to Follow-up|0|||
148912814|NCT04535453|537164735|FG004|Overall Study|Lost to Follow-up|3|||
148912815|NCT04535453|537164736|FG005|Overall Study|Lost to Follow-up|1|||
148912816|NCT04535453|537164737|FG006|Overall Study|Lost to Follow-up|0|||
148912817|NCT04535453|537164738|FG007|Overall Study|Lost to Follow-up|0|||
148912818|NCT04535453|537164739|FG008|Overall Study|Lost to Follow-up|1|||
148912819|NCT04535453|537164740|FG009|Overall Study|Lost to Follow-up|1|||
148912820|NCT04535453|537164741|FG010|Overall Study|Lost to Follow-up|0|||
148912821|NCT04535453|537164742|FG011|Overall Study|Lost to Follow-up|0|||
148912822|NCT04535453|537164731|FG000|Overall Study|Physician Decision|0|||
148912823|NCT04535453|537164732|FG001|Overall Study|Physician Decision|0|||
148912824|NCT04535453|537164733|FG002|Overall Study|Physician Decision|0|||
148912825|NCT04535453|537164734|FG003|Overall Study|Physician Decision|1|||
148912826|NCT04535453|537164735|FG004|Overall Study|Physician Decision|0|||
148912827|NCT04535453|537164736|FG005|Overall Study|Physician Decision|0|||
148912828|NCT04535453|537164737|FG006|Overall Study|Physician Decision|0|||
148912829|NCT04535453|537164738|FG007|Overall Study|Physician Decision|0|||
148912830|NCT04535453|537164739|FG008|Overall Study|Physician Decision|0|||
148912831|NCT04535453|537164740|FG009|Overall Study|Physician Decision|0|||
148912832|NCT04535453|537164741|FG010|Overall Study|Physician Decision|0|||
148912833|NCT04535453|537164742|FG011|Overall Study|Physician Decision|0|||
148912834|NCT04535453|537164731|FG000|Overall Study|Withdrawal by Subject|3|||
148912835|NCT04535453|537164732|FG001|Overall Study|Withdrawal by Subject|6|||
148912836|NCT04535453|537164733|FG002|Overall Study|Withdrawal by Subject|3|||
148912837|NCT04535453|537164734|FG003|Overall Study|Withdrawal by Subject|3|||
148912838|NCT04535453|537164735|FG004|Overall Study|Withdrawal by Subject|2|||
148912839|NCT04535453|537164736|FG005|Overall Study|Withdrawal by Subject|1|||
148912840|NCT04535453|537164737|FG006|Overall Study|Withdrawal by Subject|1|||
148912841|NCT04535453|537164738|FG007|Overall Study|Withdrawal by Subject|1|||
148912842|NCT04535453|537164739|FG008|Overall Study|Withdrawal by Subject|1|||
148912843|NCT04535453|537164740|FG009|Overall Study|Withdrawal by Subject|1|||
148912844|NCT04535453|537164741|FG010|Overall Study|Withdrawal by Subject|0|||
148912845|NCT04535453|537164742|FG011|Overall Study|Withdrawal by Subject|1|||
148912846|NCT04535453|537164731|FG000|Overall Study|Other|0|||
148912847|NCT04535453|537164732|FG001|Overall Study|Other|0|||
148912848|NCT04535453|537164733|FG002|Overall Study|Other|1|||
148912849|NCT04535453|537164734|FG003|Overall Study|Other|0|||
148912850|NCT04535453|537164735|FG004|Overall Study|Other|1|||
148912851|NCT04535453|537164736|FG005|Overall Study|Other|0|||
148912852|NCT04535453|537164737|FG006|Overall Study|Other|1|||
148912853|NCT04535453|537164738|FG007|Overall Study|Other|1|||
148912854|NCT04535453|537164739|FG008|Overall Study|Other|1|||
148912855|NCT04535453|537164740|FG009|Overall Study|Other|0|||
148912856|NCT04535453|537164741|FG010|Overall Study|Other|0|||
148912857|NCT04535453|537164742|FG011|Overall Study|Other|0|||
148912858|NCT02695420|537164743|FG000|Overall Study|Death|0|||
148912859|NCT02695420|537164744|FG001|Overall Study|Death|1|||
148912860|NCT02695420|537164745|FG002|Overall Study|Death|0|||
148912861|NCT02695420|537164746|FG003|Overall Study|Death|0|||
148912862|NCT02929407|537164749|FG000|Overall Study|Adverse Event|1|||
148912863|NCT01742286|537164750|FG000|Escalation Phase|Administrative problems|1|||
149141031|NCT01236573|537997379|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
148912864|NCT01742286|537164751|FG001|Escalation Phase|Administrative problems|1|||
148912865|NCT01742286|537164752|FG002|Escalation Phase|Administrative problems|0|||
148912866|NCT01742286|537164753|FG003|Escalation Phase|Administrative problems|0|||
148912867|NCT01742286|537164754|FG004|Escalation Phase|Administrative problems|0|||
149141032|NCT01236573|537997380|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149141033|NCT01236573|537997381|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
148912868|NCT01742286|537164755|FG005|Escalation Phase|Administrative problems|0|||
148912869|NCT01742286|537164756|FG006|Escalation Phase|Administrative problems|2|||
148912870|NCT01742286|537164750|FG000|Escalation Phase|Adverse Event|0|||
148912871|NCT01742286|537164751|FG001|Escalation Phase|Adverse Event|1|||
148912872|NCT01742286|537164752|FG002|Escalation Phase|Adverse Event|2|||
149141034|NCT01236573|537997382|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149141035|NCT01236573|537997383|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149141036|NCT01236573|537997384|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149141037|NCT01236573|537997385|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
149141038|NCT01236573|537997386|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149141039|NCT01236573|537997387|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
149141040|NCT01236573|537997388|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
149141041|NCT01236573|537997389|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
149141042|NCT01236573|537997379|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141043|NCT01236573|537997380|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141044|NCT01236573|537997381|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141045|NCT01236573|537997382|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141046|NCT01236573|537997383|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141047|NCT01236573|537997384|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141048|NCT01236573|537997385|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141049|NCT01236573|537997386|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141050|NCT01236573|537997387|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
149141051|NCT01236573|537997388|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141052|NCT01236573|537997389|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
149141053|NCT01236573|537997379|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141054|NCT01236573|537997380|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141055|NCT01236573|537997381|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141056|NCT01236573|537997382|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141057|NCT01236573|537997383|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141058|NCT01236573|537997384|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141059|NCT01236573|537997385|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141060|NCT01236573|537997386|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141061|NCT01236573|537997387|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141062|NCT01236573|537997388|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
149141063|NCT01236573|537997389|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
149141064|NCT02665052|537997390|FG000|Overall Study|Lost to Follow-up|1|||
149141065|NCT02665052|537997391|FG001|Overall Study|Lost to Follow-up|0|||
149141066|NCT02665052|537997392|FG002|Overall Study|Lost to Follow-up|0|||
149141067|NCT02665052|537997393|FG003|Overall Study|Lost to Follow-up|0|||
149141068|NCT02665052|537997390|FG000|Overall Study|Withdrawal by Subject|1|||
149141069|NCT02665052|537997391|FG001|Overall Study|Withdrawal by Subject|1|||
149141070|NCT02665052|537997392|FG002|Overall Study|Withdrawal by Subject|0|||
149141071|NCT02665052|537997393|FG003|Overall Study|Withdrawal by Subject|5|||
149141072|NCT02665052|537997390|FG000|Overall Study|Adverse Event|1|||
149141073|NCT02665052|537997391|FG001|Overall Study|Adverse Event|1|||
149141074|NCT02665052|537997392|FG002|Overall Study|Adverse Event|0|||
149141075|NCT02665052|537997393|FG003|Overall Study|Adverse Event|0|||
149141076|NCT00823823|537997394|FG000|Overall Study|Lost to Follow-up|3|||
149141077|NCT00823823|537997395|FG001|Overall Study|Lost to Follow-up|1|||
149141078|NCT00823823|537997394|FG000|Overall Study|Protocol Violation|5|||
149141079|NCT00823823|537997395|FG001|Overall Study|Protocol Violation|5|||
149141080|NCT02234284|537997396|FG000|Overall Study|Death|4|||
149141081|NCT02234284|537997397|FG001|Overall Study|Death|2|||
149141082|NCT02234284|537997396|FG000|Overall Study|Withdrawal by Subject|1|||
149141083|NCT02234284|537997397|FG001|Overall Study|Withdrawal by Subject|0|||
149141084|NCT02234284|537997396|FG000|Overall Study|Lost to Follow-up|20|||
149141085|NCT02234284|537997397|FG001|Overall Study|Lost to Follow-up|7|||
149141086|NCT00536809|537997398|FG000|Phase II|Adverse Event|1|||
149141087|NCT00536809|537997398|FG000|Phase II|Referred for surgical resection|1|||
149141088|NCT04569032|537997399|FG000|Overall Study|Death|10|||
149141089|NCT04569032|537997400|FG001|Overall Study|Death|13|||
149141090|NCT04569032|537997399|FG000|Overall Study|Withdrawal by Subject|2|||
149141091|NCT04569032|537997400|FG001|Overall Study|Withdrawal by Subject|0|||
148804781|NCT04736199|536766559|FG001|Overall Study|Additional primary malignancy|0|||
149012349|NCT01158378|537525675|FG001|Overall Study|Death|5|||
149141092|NCT04569032|537997399|FG000|Overall Study|Lost to Follow-up|0|||
149141093|NCT04569032|537997400|FG001|Overall Study|Lost to Follow-up|1|||
149141094|NCT04569032|537997399|FG000|Overall Study|In long term follow up|22|||
149141095|NCT04569032|537997400|FG001|Overall Study|In long term follow up|34|||
149141096|NCT00873366|537997401|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
149141097|NCT00873366|537997401|FG000|Overall Study|Off tamoxifen due to side effects|2|||
149141098|NCT00873366|537997401|FG000|Overall Study|Refused to continue DM-BT testing|3|||
149141099|NCT02247960|537997409|FG000|Patient Consent and Randomization|Physician Decision|2|||
149141100|NCT02247960|537997410|FG001|Patient Consent and Randomization|Physician Decision|2|||
149141101|NCT02247960|537997409|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
148804782|NCT04736199|536766558|FG000|Overall Study|Non-compliance with study drug|0|||
149141102|NCT02247960|537997410|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
149141103|NCT02247960|537997409|FG000|Catheter Removed|Lost to Follow-up|7|||
149141104|NCT02247960|537997410|FG001|Catheter Removed|Lost to Follow-up|10|||
149141105|NCT03123250|537997416|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
149141106|NCT02361944|537997417|FG000|Overall Study|surgery cancellation|0|||
149141107|NCT02361944|537997418|FG001|Overall Study|surgery cancellation|1|||
149141108|NCT04340557|537997419|FG000|Overall Study|Transferred to ICU and/or death|1|||
149141109|NCT04340557|537997420|FG001|Overall Study|Transferred to ICU and/or death|2|||
149141110|NCT01221727|537997421|FG000|Overall Study|Physician Decision|2|||
149141111|NCT01221727|537997422|FG001|Overall Study|Physician Decision|0|||
149141112|NCT01221727|537997421|FG000|Overall Study|Withdrawal by Subject|1|||
149141113|NCT01221727|537997422|FG001|Overall Study|Withdrawal by Subject|1|||
149141114|NCT00773136|537997423|FG000|Overall Study|Physician Decision|2|||
149141115|NCT02463071|537997427|FG000|Overall Study|Adverse Event|3|||
149141116|NCT02463071|537997428|FG001|Overall Study|Adverse Event|5|||
149141117|NCT02463071|537997429|FG002|Overall Study|Adverse Event|1|||
149012350|NCT01158378|537525674|FG000|Overall Study|Lost to Follow-up|2|||
149012351|NCT01158378|537525675|FG001|Overall Study|Lost to Follow-up|4|||
149012352|NCT01158378|537525674|FG000|Overall Study|Withdrawal by Subject|4|||
149012353|NCT01158378|537525675|FG001|Overall Study|Withdrawal by Subject|0|||
149012354|NCT02769065|537525676|FG000|Overall Study|Voluntary Withdrawal|1|||
149012355|NCT02769065|537525677|FG001|Overall Study|Voluntary Withdrawal|0|||
149012356|NCT02769065|537525678|FG002|Overall Study|Voluntary Withdrawal|0|||
149012357|NCT02769065|537525679|FG003|Overall Study|Voluntary Withdrawal|0|||
149012358|NCT02769065|537525680|FG004|Overall Study|Voluntary Withdrawal|0|||
149012359|NCT02769065|537525681|FG005|Overall Study|Voluntary Withdrawal|0|||
149012360|NCT02769065|537525682|FG006|Overall Study|Voluntary Withdrawal|0|||
149012361|NCT02769065|537525683|FG007|Overall Study|Voluntary Withdrawal|0|||
149012362|NCT02769065|537525684|FG008|Overall Study|Voluntary Withdrawal|0|||
149012363|NCT02769065|537525685|FG009|Overall Study|Voluntary Withdrawal|0|||
149012364|NCT02769065|537525686|FG010|Overall Study|Voluntary Withdrawal|0|||
149012365|NCT02769065|537525687|FG011|Overall Study|Voluntary Withdrawal|0|||
149012366|NCT02769065|537525688|FG012|Overall Study|Voluntary Withdrawal|0|||
149012367|NCT02769065|537525689|FG013|Overall Study|Voluntary Withdrawal|0|||
149012368|NCT02769065|537525690|FG014|Overall Study|Voluntary Withdrawal|0|||
149012369|NCT02769065|537525691|FG015|Overall Study|Voluntary Withdrawal|0|||
149012370|NCT02769065|537525692|FG016|Overall Study|Voluntary Withdrawal|0|||
149012371|NCT02769065|537525693|FG017|Overall Study|Voluntary Withdrawal|0|||
149012372|NCT02769065|537525694|FG018|Overall Study|Voluntary Withdrawal|0|||
149012373|NCT02769065|537525695|FG019|Overall Study|Voluntary Withdrawal|0|||
149012374|NCT02769065|537525696|FG020|Overall Study|Voluntary Withdrawal|0|||
149012375|NCT02769065|537525697|FG021|Overall Study|Voluntary Withdrawal|0|||
149012376|NCT02769065|537525698|FG022|Overall Study|Voluntary Withdrawal|0|||
149012377|NCT02769065|537525699|FG023|Overall Study|Voluntary Withdrawal|0|||
149012378|NCT02769065|537525700|FG024|Overall Study|Voluntary Withdrawal|0|||
149012379|NCT02769065|537525701|FG025|Overall Study|Voluntary Withdrawal|0|||
149012380|NCT02769065|537525702|FG026|Overall Study|Voluntary Withdrawal|0|||
149012381|NCT02769065|537525703|FG027|Overall Study|Voluntary Withdrawal|0|||
149012382|NCT02769065|537525704|FG028|Overall Study|Voluntary Withdrawal|0|||
149012383|NCT02769065|537525705|FG029|Overall Study|Voluntary Withdrawal|0|||
149012384|NCT02769065|537525676|FG000|Overall Study|Reason Not Specified|0|||
149012385|NCT02769065|537525677|FG001|Overall Study|Reason Not Specified|0|||
149012386|NCT02769065|537525678|FG002|Overall Study|Reason Not Specified|0|||
149012387|NCT02769065|537525679|FG003|Overall Study|Reason Not Specified|0|||
149012388|NCT02769065|537525680|FG004|Overall Study|Reason Not Specified|0|||
149012389|NCT02769065|537525681|FG005|Overall Study|Reason Not Specified|0|||
149012390|NCT02769065|537525682|FG006|Overall Study|Reason Not Specified|1|||
149141118|NCT02463071|537997427|FG000|Overall Study|Death|1|||
149012391|NCT02769065|537525683|FG007|Overall Study|Reason Not Specified|0|||
149012392|NCT02769065|537525684|FG008|Overall Study|Reason Not Specified|0|||
149012393|NCT02769065|537525685|FG009|Overall Study|Reason Not Specified|0|||
149012394|NCT02769065|537525686|FG010|Overall Study|Reason Not Specified|0|||
149141119|NCT02463071|537997428|FG001|Overall Study|Death|0|||
149141120|NCT02463071|537997429|FG002|Overall Study|Death|0|||
148804783|NCT04736199|536766559|FG001|Overall Study|Non-compliance with study drug|1|||
148804784|NCT04736199|536766558|FG000|Overall Study|Other reason|0|||
148804785|NCT04736199|536766559|FG001|Overall Study|Other reason|1|||
148804786|NCT04736199|536766558|FG000|Overall Study|Ongoing with study drug|240|||
148804787|NCT04736199|536766559|FG001|Overall Study|Ongoing with study drug|63|||
148804788|NCT04736199|536766558|FG000|Overall Study|Study drug never administered|3|||
149141121|NCT02463071|537997427|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
149141122|NCT02463071|537997428|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149141123|NCT02463071|537997429|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
149141124|NCT02463071|537997427|FG000|Overall Study|Reason not specified|7|||
149141125|NCT02463071|537997428|FG001|Overall Study|Reason not specified|9|||
149141126|NCT02463071|537997429|FG002|Overall Study|Reason not specified|4|||
149141127|NCT02463071|537997427|FG000|Overall Study|Protocol Violation|0|||
149141128|NCT02463071|537997428|FG001|Overall Study|Protocol Violation|2|||
149141129|NCT02463071|537997429|FG002|Overall Study|Protocol Violation|0|||
148804789|NCT04736199|536766559|FG001|Overall Study|Study drug never administered|0|||
148804790|NCT02775851|536766560|FG000|Overall Study|Adverse Event|1|||
148804791|NCT02775851|536766561|FG001|Overall Study|Adverse Event|10|||
149141130|NCT02463071|537997427|FG000|Overall Study|Lost to Follow-up|0|||
149141131|NCT02463071|537997428|FG001|Overall Study|Lost to Follow-up|0|||
149141132|NCT02463071|537997429|FG002|Overall Study|Lost to Follow-up|1|||
149141133|NCT03086057|537997430|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
149141134|NCT03086057|537997431|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
149141135|NCT03086057|537997432|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
149141136|NCT03086057|537997433|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
149141137|NCT03086057|537997430|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
149141138|NCT03086057|537997431|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
149141139|NCT03086057|537997432|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
149141140|NCT03086057|537997433|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
149141141|NCT03086057|537997430|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
149141142|NCT03086057|537997431|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
149141143|NCT03086057|537997432|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
149141144|NCT03086057|537997433|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
149141145|NCT03086057|537997430|FG000|Stage 1: PrEP Uptake|Death|1|||
149141146|NCT03086057|537997431|FG001|Stage 1: PrEP Uptake|Death|0|||
149141147|NCT03086057|537997432|FG002|Stage 1: PrEP Uptake|Death|0|||
149141148|NCT03086057|537997433|FG003|Stage 1: PrEP Uptake|Death|0|||
149141149|NCT03086057|537997430|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
149141150|NCT03086057|537997431|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
149141151|NCT03086057|537997432|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
149141152|NCT03086057|537997433|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
149141153|NCT03086057|537997430|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
149141154|NCT03086057|537997431|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
149141155|NCT03086057|537997432|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
149141156|NCT03086057|537997433|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
149141157|NCT03086057|537997430|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
149141158|NCT03086057|537997431|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
149141159|NCT03086057|537997432|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
149141160|NCT03086057|537997433|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
149141161|NCT02941926|537997434|FG000|Core Phase|Progressive disease|1109|||
149141162|NCT02941926|537997434|FG000|Core Phase|Adverse Event|504|||
149141163|NCT02941926|537997434|FG000|Core Phase|Subject/guardian decision|127|||
149141164|NCT02941926|537997434|FG000|Core Phase|Physician Decision|112|||
149141165|NCT02941926|537997434|FG000|Core Phase|Death|46|||
149141166|NCT02941926|537997434|FG000|Core Phase|Protocol deviation|34|||
149141167|NCT02941926|537997434|FG000|Core Phase|Lost to Follow-up|8|||
149141168|NCT02941926|537997434|FG000|Core Phase|Technical problems|5|||
149141169|NCT02941926|537997434|FG000|Extension Phase|Physician Decision|155|||
149141170|NCT02941926|537997434|FG000|Extension Phase|Progressive disease|115|||
149141171|NCT02941926|537997434|FG000|Extension Phase|Adverse Event|13|||
149141172|NCT02941926|537997434|FG000|Extension Phase|Subject/Guardian decision|12|||
149141173|NCT02941926|537997434|FG000|Extension Phase|Death|6|||
149141174|NCT00097773|537997435|FG000|Overall Study|Lost to Follow-up|2|||
149141175|NCT00097773|537997436|FG001|Overall Study|Lost to Follow-up|2|||
149141176|NCT00097773|537997437|FG002|Overall Study|Lost to Follow-up|0|||
149141177|NCT00097773|537997438|FG003|Overall Study|Lost to Follow-up|1|||
149141178|NCT00097773|537997435|FG000|Overall Study|Physician Decision|2|||
149141179|NCT00097773|537997436|FG001|Overall Study|Physician Decision|2|||
149141180|NCT00097773|537997437|FG002|Overall Study|Physician Decision|3|||
149141181|NCT00097773|537997438|FG003|Overall Study|Physician Decision|1|||
149141182|NCT00097773|537997435|FG000|Overall Study|Withdrawal by Subject|3|||
149141183|NCT00097773|537997436|FG001|Overall Study|Withdrawal by Subject|3|||
149141184|NCT00097773|537997437|FG002|Overall Study|Withdrawal by Subject|3|||
149012395|NCT02769065|537525687|FG011|Overall Study|Reason Not Specified|0|||
149012396|NCT02769065|537525688|FG012|Overall Study|Reason Not Specified|0|||
149012397|NCT02769065|537525689|FG013|Overall Study|Reason Not Specified|0|||
149141185|NCT00097773|537997438|FG003|Overall Study|Withdrawal by Subject|1|||
149141186|NCT00097773|537997435|FG000|Overall Study|Adverse Event|0|||
149141187|NCT00097773|537997436|FG001|Overall Study|Adverse Event|1|||
149141188|NCT00097773|537997437|FG002|Overall Study|Adverse Event|0|||
149141189|NCT00097773|537997438|FG003|Overall Study|Adverse Event|0|||
149141190|NCT00097773|537997435|FG000|Overall Study|Other|1|||
149141191|NCT00097773|537997436|FG001|Overall Study|Other|0|||
149141192|NCT00097773|537997437|FG002|Overall Study|Other|2|||
149141193|NCT00097773|537997438|FG003|Overall Study|Other|0|||
149141194|NCT01009034|537997439|FG000|Overall Study|Lost to Follow-up|2|||
149141195|NCT01009034|537997439|FG000|Overall Study|Withdrawal by Subject|2|||
149141196|NCT04305275|537997440|FG000|Overall Study|Adverse Event|4|||
149141197|NCT04305275|537997441|FG001|Overall Study|Adverse Event|0|||
149141198|NCT04305275|537997440|FG000|Overall Study|Lost to Follow-up|1|||
149141199|NCT04305275|537997441|FG001|Overall Study|Lost to Follow-up|1|||
149141200|NCT04305275|537997440|FG000|Overall Study|Withdrawal by Participant|8|||
149141201|NCT04305275|537997441|FG001|Overall Study|Withdrawal by Participant|1|||
149141202|NCT00199836|537997443|FG000|Overall Study|Progressive Disease|5|||
149141203|NCT00199836|537997443|FG000|Overall Study|Death|1|||
149141204|NCT02243865|537997444|FG000|Overall Study|Protocol Violation|1|||
149141205|NCT02243865|537997445|FG001|Overall Study|Protocol Violation|3|||
149141206|NCT02243865|537997444|FG000|Overall Study|Lost to Follow-up|1|||
149141207|NCT02243865|537997445|FG001|Overall Study|Lost to Follow-up|1|||
149141208|NCT02243865|537997444|FG000|Overall Study|Withdrawal by Subject|1|||
149141209|NCT02243865|537997445|FG001|Overall Study|Withdrawal by Subject|0|||
149141210|NCT02243865|537997444|FG000|Overall Study|Adverse Event|1|||
149141211|NCT02243865|537997445|FG001|Overall Study|Adverse Event|1|||
149141212|NCT03098836|537997449|FG000|Overall Study|Adverse Event|1|||
149141213|NCT03098836|537997450|FG001|Overall Study|Adverse Event|3|||
149141214|NCT03098836|537997449|FG000|Overall Study|Lack of Efficacy|30|||
149141215|NCT03098836|537997450|FG001|Overall Study|Lack of Efficacy|15|||
149141216|NCT03098836|537997449|FG000|Overall Study|Physician Decision|2|||
149141217|NCT03098836|537997450|FG001|Overall Study|Physician Decision|1|||
149141218|NCT03098836|537997449|FG000|Overall Study|Withdrawal by Subject|3|||
149141219|NCT03098836|537997450|FG001|Overall Study|Withdrawal by Subject|2|||
149141220|NCT03986866|537997451|FG000|Overall Study|Withdrawal by Subject|0|||
149141221|NCT03986866|537997452|FG001|Overall Study|Withdrawal by Subject|3|||
149141222|NCT03986866|537997451|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
149141223|NCT03986866|537997452|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
149141224|NCT02003014|537997455|FG000|Overall Study|Case report forms uncollected|9|||
149141225|NCT02003014|537997455|FG000|Overall Study|Treatment started after contract period|1|||
149141226|NCT02003014|537997455|FG000|Overall Study|Patient did not visit the study site|5|||
149141227|NCT02003014|537997455|FG000|Overall Study|Investigator's transfer|4|||
149141228|NCT01660451|537997456|FG000|Overall Study|Protocol Violation|0|||
149141229|NCT01660451|537997457|FG001|Overall Study|Protocol Violation|1|||
149141230|NCT01660451|537997458|FG002|Overall Study|Protocol Violation|1|||
149141231|NCT01660451|537997456|FG000|Overall Study|AE not associated with clinical disease progression|13|||
149141232|NCT01660451|537997457|FG001|Overall Study|AE not associated with clinical disease progression|10|||
149141233|NCT01660451|537997458|FG002|Overall Study|AE not associated with clinical disease progression|40|||
149141234|NCT01660451|537997456|FG000|Overall Study|AE associated with clinical disease progression|1|||
149141235|NCT01660451|537997457|FG001|Overall Study|AE associated with clinical disease progression|3|||
149141236|NCT01660451|537997458|FG002|Overall Study|AE associated with clinical disease progression|11|||
149141237|NCT01660451|537997456|FG000|Overall Study|Sponsor Decision|0|||
149141238|NCT01660451|537997457|FG001|Overall Study|Sponsor Decision|0|||
149141239|NCT01660451|537997458|FG002|Overall Study|Sponsor Decision|1|||
149141240|NCT01660451|537997456|FG000|Overall Study|Protocol Deviation|0|||
149141241|NCT01660451|537997457|FG001|Overall Study|Protocol Deviation|0|||
149141242|NCT01660451|537997458|FG002|Overall Study|Protocol Deviation|1|||
149141243|NCT01660451|537997456|FG000|Overall Study|Physician Decision|1|||
149141244|NCT01660451|537997457|FG001|Overall Study|Physician Decision|2|||
149141245|NCT01660451|537997458|FG002|Overall Study|Physician Decision|5|||
149141246|NCT01660451|537997456|FG000|Overall Study|Withdrawal by Subject|1|||
149141247|NCT01660451|537997457|FG001|Overall Study|Withdrawal by Subject|1|||
149141248|NCT01660451|537997458|FG002|Overall Study|Withdrawal by Subject|20|||
149141249|NCT01660451|537997456|FG000|Overall Study|Trial closure.|0|||
149141250|NCT01660451|537997457|FG001|Overall Study|Trial closure.|0|||
149141251|NCT01660451|537997458|FG002|Overall Study|Trial closure.|1|||
149141252|NCT01660451|537997456|FG000|Overall Study|Switching to other therapy|0|||
149141253|NCT01660451|537997457|FG001|Overall Study|Switching to other therapy|1|||
149141254|NCT01660451|537997458|FG002|Overall Study|Switching to other therapy|1|||
149141255|NCT01660451|537997456|FG000|Overall Study|Progressive disease - clinical progression|4|||
149141256|NCT01660451|537997457|FG001|Overall Study|Progressive disease - clinical progression|10|||
149141257|NCT01660451|537997458|FG002|Overall Study|Progressive disease - clinical progression|9|||
149141258|NCT01660451|537997456|FG000|Overall Study|Progressive disease - radiological progression|12|||
149141259|NCT01660451|537997457|FG001|Overall Study|Progressive disease - radiological progression|23|||
149141260|NCT01660451|537997458|FG002|Overall Study|Progressive disease - radiological progression|50|||
149141261|NCT01660451|537997456|FG000|Overall Study|Death|1|||
149141262|NCT01660451|537997457|FG001|Overall Study|Death|0|||
149141263|NCT01660451|537997458|FG002|Overall Study|Death|1|||
148912873|NCT01742286|537164753|FG003|Escalation Phase|Adverse Event|0|||
149141264|NCT01660451|537997456|FG000|Overall Study|Other|0|||
149141265|NCT01660451|537997457|FG001|Overall Study|Other|0|||
149141266|NCT01660451|537997458|FG002|Overall Study|Other|1|||
149141267|NCT05093322|537997459|FG000|Overall Study|Death|6|||
149141268|NCT05093322|537997460|FG001|Overall Study|Death|2|||
148912874|NCT01742286|537164754|FG004|Escalation Phase|Adverse Event|0|||
148912875|NCT01742286|537164755|FG005|Escalation Phase|Adverse Event|1|||
148912876|NCT01742286|537164756|FG006|Escalation Phase|Adverse Event|0|||
148912877|NCT01742286|537164750|FG000|Escalation Phase|Disease progression|3|||
149141269|NCT05093322|537997459|FG000|Overall Study|Other|4|||
149141270|NCT05093322|537997460|FG001|Overall Study|Other|1|||
149141271|NCT00898443|537997461|FG000|Overall Study|Withdrawal by Subject|1|||
149141272|NCT00898443|537997462|FG001|Overall Study|Withdrawal by Subject|0|||
149141273|NCT00074581|537997466|FG000|Overall Study|Death|15|||
149141274|NCT00074581|537997467|FG001|Overall Study|Death|16|||
149141275|NCT00074581|537997466|FG000|Overall Study|Withdrawal by Subject|50|||
149141276|NCT00074581|537997467|FG001|Overall Study|Withdrawal by Subject|49|||
149141277|NCT00074581|537997466|FG000|Overall Study|Unable to adhere to visit schedule|13|||
149141278|NCT00074581|537997467|FG001|Overall Study|Unable to adhere to visit schedule|14|||
149141279|NCT00074581|537997466|FG000|Overall Study|Relocated|14|||
149141280|NCT00074581|537997467|FG001|Overall Study|Relocated|9|||
149141281|NCT00074581|537997466|FG000|Overall Study|Were withdrawn by investigator|5|||
149141282|NCT00074581|537997467|FG001|Overall Study|Were withdrawn by investigator|2|||
149141283|NCT00074581|537997466|FG000|Overall Study|Lost to Follow-up|16|||
149141284|NCT00074581|537997467|FG001|Overall Study|Lost to Follow-up|11|||
149141285|NCT00074581|537997466|FG000|Overall Study|Ended relationship w. index participant|117|||
149141286|NCT00074581|537997467|FG001|Overall Study|Ended relationship w. index participant|106|||
149141287|NCT00074581|537997466|FG000|Overall Study|Other|14|||
149141288|NCT00074581|537997467|FG001|Overall Study|Other|19|||
149141289|NCT03250832|537997469|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
149141290|NCT03250832|537997470|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
149141291|NCT03250832|537997471|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
149141292|NCT03250832|537997472|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
149141293|NCT03250832|537997473|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
149141294|NCT03250832|537997474|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
149141295|NCT03250832|537997475|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
149141296|NCT03250832|537997476|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
149141297|NCT03250832|537997477|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
149141298|NCT03250832|537997478|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
149141299|NCT03250832|537997479|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
149141300|NCT03250832|537997480|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
149141301|NCT03250832|537997469|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
149141302|NCT03250832|537997470|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
149141303|NCT03250832|537997471|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
149141304|NCT03250832|537997472|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
149141305|NCT03250832|537997473|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
149141306|NCT03250832|537997474|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
149141307|NCT03250832|537997475|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
149141308|NCT03250832|537997476|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
149141309|NCT03250832|537997477|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
149141310|NCT03250832|537997478|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
149141311|NCT03250832|537997479|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
149141312|NCT03250832|537997480|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
149141313|NCT03250832|537997469|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141314|NCT03250832|537997470|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141315|NCT03250832|537997471|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
149141316|NCT03250832|537997472|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141317|NCT03250832|537997473|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141318|NCT03250832|537997474|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141319|NCT03250832|537997475|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141320|NCT03250832|537997476|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141321|NCT03250832|537997477|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141322|NCT03250832|537997478|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
148804792|NCT02775851|536766560|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
148804793|NCT02775851|536766561|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
148804794|NCT02775851|536766560|FG000|Overall Study|Progression/Relapse|0|||
149141323|NCT03250832|537997479|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
149141324|NCT03250832|537997480|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
148804795|NCT02775851|536766561|FG001|Overall Study|Progression/Relapse|4|||
148804796|NCT02775851|536766560|FG000|Overall Study|Other - Not Protocol Specified|0|||
148804797|NCT02775851|536766561|FG001|Overall Study|Other - Not Protocol Specified|7|||
148804798|NCT02775851|536766560|FG000|Overall Study|Withdrawal by Subject|1|||
148804799|NCT02775851|536766561|FG001|Overall Study|Withdrawal by Subject|0|||
148804800|NCT05918055|536766562|FG000|Phase I - Dose Level 1|Ineligible|0|||
148804801|NCT05918055|536766563|FG001|Phase I - Dose Level 1|Ineligible|0|||
148804802|NCT05918055|536766564|FG002|Phase I - Dose Level 1|Ineligible|1|||
148804803|NCT05918055|536766562|FG000|Phase I - Dose Level -1|Physician Decision|1|||
148912878|NCT01742286|537164751|FG001|Escalation Phase|Disease progression|7|||
149141325|NCT03250832|537997469|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141326|NCT03250832|537997470|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141327|NCT03250832|537997471|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141328|NCT03250832|537997472|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141329|NCT03250832|537997473|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141330|NCT03250832|537997474|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141331|NCT03250832|537997475|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141332|NCT03250832|537997476|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
149141333|NCT03250832|537997477|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141334|NCT03250832|537997478|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141335|NCT03250832|537997479|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141336|NCT03250832|537997480|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
149141337|NCT03250832|537997469|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141338|NCT03250832|537997470|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141339|NCT03250832|537997471|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141340|NCT03250832|537997472|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141341|NCT03250832|537997473|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141342|NCT03250832|537997474|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141343|NCT03250832|537997475|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141344|NCT03250832|537997476|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
149141345|NCT03250832|537997477|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141346|NCT03250832|537997478|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141347|NCT03250832|537997479|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141348|NCT03250832|537997480|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
149141349|NCT03250832|537997469|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141350|NCT03250832|537997470|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141351|NCT03250832|537997471|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141352|NCT03250832|537997472|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141353|NCT03250832|537997473|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141354|NCT03250832|537997474|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141355|NCT03250832|537997475|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141356|NCT03250832|537997476|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
149141357|NCT03250832|537997477|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141358|NCT03250832|537997478|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141359|NCT03250832|537997479|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141360|NCT03250832|537997480|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
149141361|NCT03250832|537997469|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141362|NCT03250832|537997470|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141363|NCT03250832|537997471|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141364|NCT03250832|537997472|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141365|NCT03250832|537997473|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141366|NCT03250832|537997474|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141367|NCT03250832|537997475|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141368|NCT03250832|537997476|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
149141369|NCT03250832|537997477|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141370|NCT03250832|537997478|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141371|NCT03250832|537997479|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141372|NCT03250832|537997480|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
149141373|NCT03250832|537997469|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141374|NCT03250832|537997470|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141375|NCT03250832|537997471|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141376|NCT03250832|537997472|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141377|NCT03250832|537997473|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141378|NCT03250832|537997474|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141379|NCT03250832|537997475|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141380|NCT03250832|537997476|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
149141381|NCT03250832|537997477|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141382|NCT03250832|537997478|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141383|NCT03250832|537997479|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141384|NCT03250832|537997480|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
149141385|NCT03250832|537997469|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141386|NCT03250832|537997470|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141387|NCT03250832|537997471|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141388|NCT03250832|537997472|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141389|NCT03250832|537997473|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141390|NCT03250832|537997474|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141391|NCT03250832|537997475|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
148912879|NCT01742286|537164752|FG002|Escalation Phase|Disease progression|4|||
148912880|NCT01742286|537164753|FG003|Escalation Phase|Disease progression|1|||
148912881|NCT01742286|537164754|FG004|Escalation Phase|Disease progression|4|||
148912882|NCT01742286|537164755|FG005|Escalation Phase|Disease progression|3|||
148912883|NCT01742286|537164756|FG006|Escalation Phase|Disease progression|2|||
148912884|NCT01742286|537164750|FG000|Escalation Phase|Death|0|||
148912885|NCT01742286|537164751|FG001|Escalation Phase|Death|0|||
148912886|NCT01742286|537164752|FG002|Escalation Phase|Death|0|||
148912887|NCT01742286|537164753|FG003|Escalation Phase|Death|0|||
148912888|NCT01742286|537164754|FG004|Escalation Phase|Death|0|||
148912889|NCT01742286|537164755|FG005|Escalation Phase|Death|1|||
149012398|NCT02769065|537525690|FG014|Overall Study|Reason Not Specified|0|||
149012399|NCT02769065|537525691|FG015|Overall Study|Reason Not Specified|0|||
149012400|NCT02769065|537525692|FG016|Overall Study|Reason Not Specified|0|||
149012401|NCT02769065|537525693|FG017|Overall Study|Reason Not Specified|0|||
149012402|NCT02769065|537525694|FG018|Overall Study|Reason Not Specified|0|||
149012403|NCT02769065|537525695|FG019|Overall Study|Reason Not Specified|0|||
149012404|NCT02769065|537525696|FG020|Overall Study|Reason Not Specified|0|||
149012405|NCT02769065|537525697|FG021|Overall Study|Reason Not Specified|0|||
149012406|NCT02769065|537525698|FG022|Overall Study|Reason Not Specified|0|||
149012407|NCT02769065|537525699|FG023|Overall Study|Reason Not Specified|0|||
149012408|NCT02769065|537525700|FG024|Overall Study|Reason Not Specified|0|||
149012409|NCT02769065|537525701|FG025|Overall Study|Reason Not Specified|0|||
149012410|NCT02769065|537525702|FG026|Overall Study|Reason Not Specified|0|||
149012411|NCT02769065|537525703|FG027|Overall Study|Reason Not Specified|0|||
149012412|NCT02769065|537525704|FG028|Overall Study|Reason Not Specified|0|||
149012413|NCT02769065|537525705|FG029|Overall Study|Reason Not Specified|0|||
149012414|NCT02769065|537525676|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012415|NCT02769065|537525677|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012416|NCT02769065|537525678|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012417|NCT02769065|537525679|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012418|NCT02769065|537525680|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012419|NCT02769065|537525681|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012420|NCT02769065|537525682|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012421|NCT02769065|537525683|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012422|NCT02769065|537525684|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012423|NCT02769065|537525685|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012424|NCT02769065|537525686|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
149012425|NCT02769065|537525687|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012426|NCT02769065|537525688|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012427|NCT02769065|537525689|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012428|NCT02769065|537525690|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012429|NCT02769065|537525691|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012430|NCT02769065|537525692|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
148912890|NCT01742286|537164756|FG006|Escalation Phase|Death|0|||
148912891|NCT01742286|537164750|FG000|Escalation Phase|Physician Decision|0|||
148912892|NCT01742286|537164751|FG001|Escalation Phase|Physician Decision|3|||
149012431|NCT02769065|537525693|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012432|NCT02769065|537525694|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012433|NCT02769065|537525695|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012434|NCT02769065|537525696|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012435|NCT02769065|537525697|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
148912893|NCT01742286|537164752|FG002|Escalation Phase|Physician Decision|0|||
148912894|NCT01742286|537164753|FG003|Escalation Phase|Physician Decision|1|||
148912895|NCT01742286|537164754|FG004|Escalation Phase|Physician Decision|0|||
148912896|NCT01742286|537164755|FG005|Escalation Phase|Physician Decision|0|||
148912897|NCT01742286|537164756|FG006|Escalation Phase|Physician Decision|2|||
148912898|NCT01742286|537164750|FG000|Escalation Phase|Subject/guardian decision|1|||
148912899|NCT01742286|537164751|FG001|Escalation Phase|Subject/guardian decision|0|||
148912900|NCT01742286|537164752|FG002|Escalation Phase|Subject/guardian decision|0|||
148912901|NCT01742286|537164753|FG003|Escalation Phase|Subject/guardian decision|0|||
148912902|NCT01742286|537164754|FG004|Escalation Phase|Subject/guardian decision|0|||
148912903|NCT01742286|537164755|FG005|Escalation Phase|Subject/guardian decision|0|||
148912904|NCT01742286|537164756|FG006|Escalation Phase|Subject/guardian decision|0|||
148912905|NCT01742286|537164750|FG000|Expansion Phase|Administrative problems|0|||
148912906|NCT01742286|537164751|FG001|Expansion Phase|Administrative problems|0|||
148912907|NCT01742286|537164752|FG002|Expansion Phase|Administrative problems|0|||
148912908|NCT01742286|537164753|FG003|Expansion Phase|Administrative problems|0|||
148912909|NCT01742286|537164754|FG004|Expansion Phase|Administrative problems|0|||
148912910|NCT01742286|537164755|FG005|Expansion Phase|Administrative problems|0|||
148912911|NCT01742286|537164756|FG006|Expansion Phase|Administrative problems|5|||
148912912|NCT01742286|537164750|FG000|Expansion Phase|Physician Decision|0|||
148912913|NCT01742286|537164751|FG001|Expansion Phase|Physician Decision|0|||
148912914|NCT01742286|537164752|FG002|Expansion Phase|Physician Decision|4|||
148912915|NCT01742286|537164753|FG003|Expansion Phase|Physician Decision|0|||
148912916|NCT01742286|537164754|FG004|Expansion Phase|Physician Decision|0|||
148912917|NCT01742286|537164755|FG005|Expansion Phase|Physician Decision|0|||
148912918|NCT01742286|537164756|FG006|Expansion Phase|Physician Decision|9|||
148912919|NCT01742286|537164750|FG000|Expansion Phase|Adverse Event|0|||
148912920|NCT01742286|537164751|FG001|Expansion Phase|Adverse Event|0|||
148912921|NCT01742286|537164752|FG002|Expansion Phase|Adverse Event|0|||
148912922|NCT01742286|537164753|FG003|Expansion Phase|Adverse Event|0|||
148912923|NCT01742286|537164754|FG004|Expansion Phase|Adverse Event|0|||
148912924|NCT01742286|537164755|FG005|Expansion Phase|Adverse Event|0|||
148912925|NCT01742286|537164756|FG006|Expansion Phase|Adverse Event|6|||
148912926|NCT01742286|537164750|FG000|Expansion Phase|Disease progression|0|||
148912927|NCT01742286|537164751|FG001|Expansion Phase|Disease progression|0|||
148912928|NCT01742286|537164752|FG002|Expansion Phase|Disease progression|3|||
148912929|NCT01742286|537164753|FG003|Expansion Phase|Disease progression|0|||
148912930|NCT01742286|537164754|FG004|Expansion Phase|Disease progression|0|||
148912931|NCT01742286|537164755|FG005|Expansion Phase|Disease progression|0|||
148912932|NCT01742286|537164756|FG006|Expansion Phase|Disease progression|15|||
148912933|NCT01742286|537164750|FG000|Expansion Phase|Withdrawal by Subject|0|||
148912934|NCT01742286|537164751|FG001|Expansion Phase|Withdrawal by Subject|0|||
148912935|NCT01742286|537164752|FG002|Expansion Phase|Withdrawal by Subject|0|||
148912936|NCT01742286|537164753|FG003|Expansion Phase|Withdrawal by Subject|0|||
148912937|NCT01742286|537164754|FG004|Expansion Phase|Withdrawal by Subject|0|||
148912938|NCT01742286|537164755|FG005|Expansion Phase|Withdrawal by Subject|0|||
148912939|NCT01742286|537164756|FG006|Expansion Phase|Withdrawal by Subject|1|||
148912940|NCT04530136|537164757|FG000|Overall Study|Lost to Follow-up|2|||
148912941|NCT04530136|537164758|FG001|Overall Study|Lost to Follow-up|3|||
148912942|NCT04530136|537164757|FG000|Overall Study|Withdrawal by Subject|1|||
148912943|NCT04530136|537164758|FG001|Overall Study|Withdrawal by Subject|0|||
148912944|NCT04530136|537164757|FG000|Overall Study|Death|0|||
148912945|NCT04530136|537164758|FG001|Overall Study|Death|1|||
148912946|NCT02878798|537164759|FG000|Overall Study|Withdrawal by Subject|5|||
148912947|NCT02878798|537164760|FG001|Overall Study|Withdrawal by Subject|4|||
148912948|NCT02878798|537164759|FG000|Overall Study|Lost to Follow-up|2|||
148912949|NCT02878798|537164760|FG001|Overall Study|Lost to Follow-up|2|||
148912950|NCT02878798|537164759|FG000|Overall Study|Protocol Violation|0|||
148912951|NCT02878798|537164760|FG001|Overall Study|Protocol Violation|1|||
148912952|NCT01387542|537164761|FG000|Overall Study|Adverse Event|3|||
148912953|NCT01387542|537164761|FG000|Overall Study|Withdrawal by Subject|1|||
148912954|NCT01387542|537164761|FG000|Overall Study|Changed diagnosis|1|||
148912955|NCT01387542|537164761|FG000|Overall Study|Insufficient response|1|||
148912956|NCT01387542|537164761|FG000|Overall Study|Non-compliant|1|||
148912957|NCT01387542|537164761|FG000|Overall Study|Lost to Follow-up|1|||
148912958|NCT01761240|537164762|FG000|Overall Study|Progressive disease:radiology assessment|3|||
148912959|NCT01761240|537164763|FG001|Overall Study|Progressive disease:radiology assessment|3|||
148912960|NCT01761240|537164764|FG002|Overall Study|Progressive disease:radiology assessment|0|||
148912961|NCT01761240|537164765|FG003|Overall Study|Progressive disease:radiology assessment|0|||
148912962|NCT01761240|537164766|FG004|Overall Study|Progressive disease:radiology assessment|0|||
148912963|NCT01761240|537164762|FG000|Overall Study|Progressive disease:clinical assessment|0|||
149141392|NCT03250832|537997476|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141393|NCT03250832|537997477|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
149141394|NCT03250832|537997478|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
149141395|NCT03250832|537997479|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141396|NCT03250832|537997480|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
149141397|NCT03250832|537997469|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141398|NCT03250832|537997470|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141399|NCT03250832|537997471|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141400|NCT03250832|537997472|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141401|NCT03250832|537997473|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141402|NCT03250832|537997474|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141403|NCT03250832|537997475|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141404|NCT03250832|537997476|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141405|NCT03250832|537997477|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
149141406|NCT03250832|537997478|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
149141407|NCT03250832|537997479|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141408|NCT03250832|537997480|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
149141409|NCT03250832|537997469|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141410|NCT03250832|537997470|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141411|NCT03250832|537997471|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141412|NCT03250832|537997472|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141413|NCT03250832|537997473|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141414|NCT03250832|537997474|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141415|NCT03250832|537997475|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141416|NCT03250832|537997476|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141417|NCT03250832|537997477|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
149141418|NCT03250832|537997478|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
149141419|NCT03250832|537997479|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141420|NCT03250832|537997480|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
149141421|NCT03250832|537997469|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141422|NCT03250832|537997470|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141423|NCT03250832|537997471|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141424|NCT03250832|537997472|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141425|NCT03250832|537997473|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141426|NCT03250832|537997474|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141427|NCT03250832|537997475|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141428|NCT03250832|537997476|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141429|NCT03250832|537997477|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141430|NCT03250832|537997478|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141431|NCT03250832|537997479|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
149141432|NCT03250832|537997480|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
149141433|NCT01708291|537997481|FG000|Overall Study|fighting|2|||
149141434|NCT01708291|537997482|FG001|Overall Study|fighting|1|||
149141435|NCT00617604|537997483|FG000|Overall Study|Death|2|||
149141436|NCT00617604|537997484|FG001|Overall Study|Death|1|||
149141437|NCT00617604|537997483|FG000|Overall Study|Lost to Follow-up|1|||
149141438|NCT00617604|537997484|FG001|Overall Study|Lost to Follow-up|0|||
149141439|NCT00617604|537997483|FG000|Overall Study|Miscellaneous Reasons|8|||
149141440|NCT00617604|537997484|FG001|Overall Study|Miscellaneous Reasons|10|||
149141441|NCT00617604|537997483|FG000|Overall Study|Withdrawal by Subject|4|||
149141442|NCT00617604|537997484|FG001|Overall Study|Withdrawal by Subject|6|||
149141443|NCT00617604|537997483|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
149141444|NCT00617604|537997484|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
149141445|NCT02303704|537997485|FG000|Overall Study|Protocol Violation|5|||
149141446|NCT02303704|537997486|FG001|Overall Study|Protocol Violation|9|||
149141447|NCT01034540|537997487|FG000|Overall Study|Adverse Event|0|||
149141448|NCT01034540|537997488|FG001|Overall Study|Adverse Event|1|||
148912964|NCT01761240|537164763|FG001|Overall Study|Progressive disease:clinical assessment|0|||
149141449|NCT05293743|537997498|FG000|Overall Study|Withdrawal by Subject|1|||
149141450|NCT05293743|537997499|FG001|Overall Study|Withdrawal by Subject|0|||
149141451|NCT02064920|537997500|FG000|Overall Study|Adverse Event|0|||
149141452|NCT02064920|537997501|FG001|Overall Study|Adverse Event|4|||
149141453|NCT02064920|537997500|FG000|Overall Study|Physician Decision|0|||
148912965|NCT01761240|537164764|FG002|Overall Study|Progressive disease:clinical assessment|3|||
148912966|NCT01761240|537164765|FG003|Overall Study|Progressive disease:clinical assessment|1|||
148912967|NCT01761240|537164766|FG004|Overall Study|Progressive disease:clinical assessment|0|||
148912968|NCT01761240|537164762|FG000|Overall Study|Withdrawal by Subject|0|||
148912969|NCT01761240|537164763|FG001|Overall Study|Withdrawal by Subject|0|||
149141454|NCT02064920|537997501|FG001|Overall Study|Physician Decision|1|||
149141455|NCT02064920|537997500|FG000|Overall Study|Technical Problems|0|||
149141456|NCT02064920|537997501|FG001|Overall Study|Technical Problems|1|||
149141457|NCT02064920|537997500|FG000|Overall Study|Withdrawal by Subject|1|||
149141458|NCT02064920|537997501|FG001|Overall Study|Withdrawal by Subject|3|||
149141459|NCT00916279|537997502|FG000|Overall Study|Death|2|||
149141460|NCT00916279|537997502|FG000|Overall Study|Lost to Follow-up|2|||
149141461|NCT00310804|537997503|FG000|Overall Study|Lost to Follow-up|2|||
149141462|NCT00310804|537997504|FG001|Overall Study|Lost to Follow-up|0|||
149141463|NCT00310804|537997503|FG000|Overall Study|Withdrawal by Subject|3|||
149141464|NCT00310804|537997504|FG001|Overall Study|Withdrawal by Subject|0|||
149141465|NCT00688155|537997509|FG000|Overall Study|Withdrawal by Subject|2|||
149141466|NCT00688155|537997510|FG001|Overall Study|Withdrawal by Subject|2|||
149141467|NCT00688155|537997511|FG002|Overall Study|Withdrawal by Subject|1|||
149141468|NCT00688155|537997512|FG003|Overall Study|Withdrawal by Subject|1|||
149141469|NCT02717754|537997518|FG000|Overall Study|Incorrect Infusion Duration|0|||
149141470|NCT02717754|537997519|FG001|Overall Study|Incorrect Infusion Duration|0|||
149141471|NCT02717754|537997520|FG002|Overall Study|Incorrect Infusion Duration|0|||
149141472|NCT02717754|537997521|FG003|Overall Study|Incorrect Infusion Duration|10|||
149141473|NCT02717754|537997522|FG004|Overall Study|Incorrect Infusion Duration|20|||
149141474|NCT02717754|537997523|FG005|Overall Study|Incorrect Infusion Duration|20|||
149141475|NCT01200238|537997524|FG000|Overall Study|Adverse Event|2|||
149141476|NCT01200238|537997525|FG001|Overall Study|Adverse Event|1|||
149141477|NCT01200238|537997524|FG000|Overall Study|Progressive Disease|5|||
149141478|NCT01200238|537997525|FG001|Overall Study|Progressive Disease|8|||
149141479|NCT01200238|537997524|FG000|Overall Study|Withdrawal by Subject|0|||
149141480|NCT01200238|537997525|FG001|Overall Study|Withdrawal by Subject|1|||
149141481|NCT00482703|537997526|FG000|Overall Study|Poor compliance|1|||
149141482|NCT00482703|537997527|FG001|Overall Study|Poor compliance|0|||
149141483|NCT00667823|537997529|FG000|Overall Study|Lost to Follow-up|5|||
149141484|NCT00667823|537997529|FG000|Overall Study|Adverse Event|7|||
149141485|NCT00667823|537997529|FG000|Overall Study|Death|182|||
149141486|NCT00667823|537997529|FG000|Overall Study|Withdrawal by Subject|12|||
149141487|NCT00667823|537997529|FG000|Overall Study|Other|8|||
149141488|NCT00667823|537997529|FG000|Overall Study|Missing (completion page missing)|2|||
149141489|NCT03697720|537999182|FG000|Overall Study|Lost to Follow-up|7|||
149141490|NCT01183143|537999183|FG000|Overall Study|Protocol Violation|115|||
149141491|NCT01183143|537999183|FG000|Overall Study|Withdrawal by Subject|19|||
149141492|NCT01183143|537999183|FG000|Overall Study|Subject Questionnaires not returned|5|||
149141493|NCT01183143|537999183|FG000|Overall Study|Subjects enrolled, but not treated|11|||
149141494|NCT04096274|537999184|FG000|Phase I|Lost to Follow-up|5|||
149141495|NCT04096274|537999185|FG001|Phase I|Lost to Follow-up|5|||
149141496|NCT04096274|537999184|FG000|Phase II|Lost to Follow-up|11|||
149141497|NCT04096274|537999185|FG001|Phase II|Lost to Follow-up|11|||
149141498|NCT01942148|537999186|FG000|Overall Study|Adverse Event|4|||
149141499|NCT01942148|537999186|FG000|Overall Study|Lack of Efficacy|2|||
149141500|NCT01942148|537999186|FG000|Overall Study|Physician Decision|11|||
149141501|NCT01942148|537999186|FG000|Overall Study|Protocol Violation|1|||
149141502|NCT01942148|537999186|FG000|Overall Study|Withdrawal by Subject|8|||
149141503|NCT01942148|537999186|FG000|Overall Study|Use of the prohibition medicine|1|||
149141504|NCT02248259|537999187|FG000|Treatment Period 1|Adverse Event|0|||
149141505|NCT02248259|537999188|FG001|Treatment Period 1|Adverse Event|0|||
149141506|NCT02248259|537999189|FG002|Treatment Period 1|Adverse Event|1|||
149141507|NCT02248259|537999190|FG003|Treatment Period 1|Adverse Event|0|||
149141508|NCT02807480|537999191|FG000|Overall Study|Withdrawal by Subject|14|||
149141509|NCT02807480|537999192|FG001|Overall Study|Withdrawal by Subject|10|||
149141510|NCT02369848|537999193|FG000|Overall Study|Death|1|||
149141511|NCT02369848|537999193|FG000|Overall Study|Withdrawal by Subject|2|||
149141512|NCT02369848|537999193|FG000|Overall Study|Lost to Follow-up|1|||
149141513|NCT00096785|537999197|FG000|Overall Study|Lost to Follow-up|1|||
149141514|NCT00096785|537999198|FG001|Overall Study|Lost to Follow-up|0|||
148804804|NCT05918055|536766563|FG001|Phase I - Dose Level -1|Physician Decision|0|||
148804805|NCT05918055|536766564|FG002|Phase I - Dose Level -1|Physician Decision|0|||
149141515|NCT00096785|537999197|FG000|Overall Study|Withdrawal by Subject|0|||
149141516|NCT00096785|537999198|FG001|Overall Study|Withdrawal by Subject|1|||
149141517|NCT00096785|537999197|FG000|Overall Study|Relocated|1|||
149141518|NCT00096785|537999198|FG001|Overall Study|Relocated|0|||
149141519|NCT02573870|537999199|FG000|Overall Study|Adverse Event|0|||
149141520|NCT02573870|537999200|FG001|Overall Study|Adverse Event|2|||
149141521|NCT02573870|537999199|FG000|Overall Study|Lack of Efficacy|0|||
149141522|NCT02573870|537999200|FG001|Overall Study|Lack of Efficacy|1|||
149141523|NCT02573870|537999199|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
149141524|NCT02573870|537999200|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
149141525|NCT02573870|537999199|FG000|Overall Study|Lost to Follow-up|0|||
149141526|NCT02573870|537999200|FG001|Overall Study|Lost to Follow-up|1|||
149141527|NCT02573870|537999199|FG000|Overall Study|Other: Fail to Meet Visit|0|||
149141528|NCT02573870|537999200|FG001|Overall Study|Other: Fail to Meet Visit|2|||
149141529|NCT00257725|537999201|FG000|Overall Study|Adverse Event|3|||
149141530|NCT01858532|537999202|FG000|Overall Study|Adverse Event|58|||
149141531|NCT01858532|537999203|FG001|Overall Study|Adverse Event|50|||
149141532|NCT01858532|537999204|FG002|Overall Study|Adverse Event|23|||
149141533|NCT01858532|537999205|FG003|Overall Study|Adverse Event|28|||
149141534|NCT01858532|537999202|FG000|Overall Study|Withdrew consent|71|||
149141535|NCT01858532|537999203|FG001|Overall Study|Withdrew consent|93|||
149141536|NCT01858532|537999204|FG002|Overall Study|Withdrew consent|46|||
149141537|NCT01858532|537999205|FG003|Overall Study|Withdrew consent|27|||
149141538|NCT01858532|537999202|FG000|Overall Study|Lost to Follow-up|17|||
149141539|NCT01858532|537999203|FG001|Overall Study|Lost to Follow-up|26|||
149141540|NCT01858532|537999204|FG002|Overall Study|Lost to Follow-up|11|||
149141541|NCT01858532|537999205|FG003|Overall Study|Lost to Follow-up|14|||
149141542|NCT01858532|537999202|FG000|Overall Study|Deterioration of medical status|3|||
149141543|NCT01858532|537999203|FG001|Overall Study|Deterioration of medical status|4|||
149141544|NCT01858532|537999204|FG002|Overall Study|Deterioration of medical status|3|||
149141545|NCT01858532|537999205|FG003|Overall Study|Deterioration of medical status|7|||
149141546|NCT01858532|537999202|FG000|Overall Study|Investigator request|3|||
149141547|NCT01858532|537999203|FG001|Overall Study|Investigator request|4|||
149141548|NCT01858532|537999204|FG002|Overall Study|Investigator request|2|||
149141549|NCT01858532|537999205|FG003|Overall Study|Investigator request|6|||
149141550|NCT01858532|537999202|FG000|Overall Study|Other, not specified|29|||
149141551|NCT01858532|537999203|FG001|Overall Study|Other, not specified|15|||
149141552|NCT01858532|537999204|FG002|Overall Study|Other, not specified|13|||
149141553|NCT01858532|537999205|FG003|Overall Study|Other, not specified|11|||
149141554|NCT00514514|537999206|FG000|Pre-phase|Death|10|||
149141555|NCT00514514|537999207|FG001|Pre-phase|Death|0|||
149141556|NCT00514514|537999208|FG002|Pre-phase|Death|0|||
149141557|NCT00514514|537999206|FG000|Pre-phase|administrative problems|2|||
149141558|NCT00514514|537999207|FG001|Pre-phase|administrative problems|0|||
149141559|NCT00514514|537999208|FG002|Pre-phase|administrative problems|0|||
149141560|NCT00514514|537999206|FG000|Pre-phase|Protocol Violation|6|||
149141561|NCT00514514|537999207|FG001|Pre-phase|Protocol Violation|0|||
149141562|NCT00514514|537999208|FG002|Pre-phase|Protocol Violation|0|||
149141563|NCT00514514|537999206|FG000|Pre-phase|condition no longer requires study drug|7|||
149141564|NCT00514514|537999207|FG001|Pre-phase|condition no longer requires study drug|0|||
149141565|NCT00514514|537999208|FG002|Pre-phase|condition no longer requires study drug|0|||
149141566|NCT00514514|537999206|FG000|Pre-phase|abnormal test procedure results|15|||
149141567|NCT00514514|537999207|FG001|Pre-phase|abnormal test procedure results|0|||
149141568|NCT00514514|537999208|FG002|Pre-phase|abnormal test procedure results|0|||
149141569|NCT00514514|537999206|FG000|Pre-phase|Lost to Follow-up|2|||
149141570|NCT00514514|537999207|FG001|Pre-phase|Lost to Follow-up|0|||
149141571|NCT00514514|537999208|FG002|Pre-phase|Lost to Follow-up|0|||
149141572|NCT00514514|537999206|FG000|Pre-phase|abnormal lab values|23|||
149141573|NCT00514514|537999207|FG001|Pre-phase|abnormal lab values|0|||
149141574|NCT00514514|537999208|FG002|Pre-phase|abnormal lab values|0|||
149141575|NCT00514514|537999206|FG000|Pre-phase|Lack of Efficacy|35|||
149141576|NCT00514514|537999207|FG001|Pre-phase|Lack of Efficacy|0|||
149141577|NCT00514514|537999208|FG002|Pre-phase|Lack of Efficacy|0|||
149141578|NCT00514514|537999206|FG000|Pre-phase|Adverse Event|137|||
149141579|NCT00514514|537999207|FG001|Pre-phase|Adverse Event|0|||
149141580|NCT00514514|537999208|FG002|Pre-phase|Adverse Event|0|||
149141581|NCT00514514|537999206|FG000|Pre-phase|Withdrawal by Subject|66|||
149141582|NCT00514514|537999207|FG001|Pre-phase|Withdrawal by Subject|0|||
149141583|NCT00514514|537999208|FG002|Pre-phase|Withdrawal by Subject|0|||
149141584|NCT00514514|537999206|FG000|Randomized - 9 Month|Death|3|||
149012436|NCT02769065|537525698|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012437|NCT02769065|537525699|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012438|NCT02769065|537525700|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012439|NCT02769065|537525701|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
149141585|NCT00514514|537999207|FG001|Randomized - 9 Month|Death|2|||
149141586|NCT00514514|537999208|FG002|Randomized - 9 Month|Death|2|||
149141587|NCT00514514|537999206|FG000|Randomized - 9 Month|Administrative problems|1|||
149141588|NCT00514514|537999207|FG001|Randomized - 9 Month|Administrative problems|1|||
149141589|NCT00514514|537999208|FG002|Randomized - 9 Month|Administrative problems|2|||
149141590|NCT00514514|537999206|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
149141591|NCT00514514|537999207|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
149141592|NCT00514514|537999208|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
149141593|NCT00514514|537999206|FG000|Randomized - 9 Month|Protocol Violation|1|||
149141594|NCT00514514|537999207|FG001|Randomized - 9 Month|Protocol Violation|1|||
149141595|NCT00514514|537999208|FG002|Randomized - 9 Month|Protocol Violation|0|||
149141596|NCT00514514|537999206|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
149141597|NCT00514514|537999207|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
149141598|NCT00514514|537999208|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
149141599|NCT00514514|537999206|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
149141600|NCT00514514|537999207|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
149141601|NCT00514514|537999208|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
149141602|NCT00514514|537999206|FG000|Randomized - 9 Month|Adverse Event|25|||
149141603|NCT00514514|537999207|FG001|Randomized - 9 Month|Adverse Event|44|||
149141604|NCT00514514|537999208|FG002|Randomized - 9 Month|Adverse Event|27|||
149141605|NCT00514514|537999206|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
149141606|NCT00514514|537999207|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
149141607|NCT00514514|537999208|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
149141608|NCT00514514|537999206|FG000|Extension - 4 Years|Lost to Follow-up|12|||
149141609|NCT00514514|537999207|FG001|Extension - 4 Years|Lost to Follow-up|10|||
149141610|NCT00514514|537999208|FG002|Extension - 4 Years|Lost to Follow-up|9|||
149141611|NCT00514514|537999206|FG000|Extension - 4 Years|Administrative problems|3|||
149141612|NCT00514514|537999207|FG001|Extension - 4 Years|Administrative problems|1|||
149141613|NCT00514514|537999208|FG002|Extension - 4 Years|Administrative problems|1|||
149141614|NCT00514514|537999206|FG000|Extension - 4 Years|Death|8|||
149141615|NCT00514514|537999207|FG001|Extension - 4 Years|Death|3|||
149141616|NCT00514514|537999208|FG002|Extension - 4 Years|Death|6|||
149141617|NCT00514514|537999206|FG000|Extension - 4 Years|Adverse Event|9|||
149141618|NCT00514514|537999207|FG001|Extension - 4 Years|Adverse Event|6|||
149141619|NCT00514514|537999208|FG002|Extension - 4 Years|Adverse Event|3|||
149141620|NCT00957528|537999214|FG000|Overall Study|Protocol Violation|0|||
149141621|NCT00957528|537999215|FG001|Overall Study|Protocol Violation|1|||
149141622|NCT00957528|537999216|FG002|Overall Study|Protocol Violation|0|||
149141623|NCT00957528|537999214|FG000|Overall Study|Withdrawal by Subject|0|||
149141624|NCT00957528|537999215|FG001|Overall Study|Withdrawal by Subject|0|||
149141625|NCT00957528|537999216|FG002|Overall Study|Withdrawal by Subject|1|||
149141626|NCT02081534|537999221|FG000|Overall Study|Adverse Event|5|||
149141627|NCT02081534|537999222|FG001|Overall Study|Adverse Event|4|||
149141628|NCT02081534|537999223|FG002|Overall Study|Adverse Event|3|||
149141629|NCT02081534|537999224|FG003|Overall Study|Adverse Event|10|||
149141630|NCT02081534|537999225|FG004|Overall Study|Adverse Event|2|||
149141631|NCT02081534|537999226|FG005|Overall Study|Adverse Event|8|||
149141632|NCT02081534|537999227|FG006|Overall Study|Adverse Event|2|||
149141633|NCT02081534|537999221|FG000|Overall Study|Withdrawal by Subject|0|||
149141634|NCT02081534|537999222|FG001|Overall Study|Withdrawal by Subject|1|||
149141635|NCT02081534|537999223|FG002|Overall Study|Withdrawal by Subject|1|||
149141636|NCT02081534|537999224|FG003|Overall Study|Withdrawal by Subject|1|||
149141637|NCT02081534|537999225|FG004|Overall Study|Withdrawal by Subject|1|||
149141638|NCT02081534|537999226|FG005|Overall Study|Withdrawal by Subject|0|||
149141639|NCT02081534|537999227|FG006|Overall Study|Withdrawal by Subject|1|||
149141640|NCT02081534|537999221|FG000|Overall Study|Protocol Violation|0|||
149141641|NCT02081534|537999222|FG001|Overall Study|Protocol Violation|3|||
149141642|NCT02081534|537999223|FG002|Overall Study|Protocol Violation|0|||
149141643|NCT02081534|537999224|FG003|Overall Study|Protocol Violation|0|||
149141644|NCT02081534|537999225|FG004|Overall Study|Protocol Violation|0|||
149141645|NCT02081534|537999226|FG005|Overall Study|Protocol Violation|0|||
149141646|NCT02081534|537999227|FG006|Overall Study|Protocol Violation|1|||
149141647|NCT02081534|537999221|FG000|Overall Study|Lost to Follow-up|0|||
149141648|NCT02081534|537999222|FG001|Overall Study|Lost to Follow-up|0|||
149141649|NCT02081534|537999223|FG002|Overall Study|Lost to Follow-up|0|||
149141650|NCT02081534|537999224|FG003|Overall Study|Lost to Follow-up|2|||
149141651|NCT02081534|537999225|FG004|Overall Study|Lost to Follow-up|1|||
149141652|NCT02081534|537999226|FG005|Overall Study|Lost to Follow-up|1|||
149141653|NCT02081534|537999227|FG006|Overall Study|Lost to Follow-up|0|||
149141654|NCT00762892|537999228|FG000|Overall Study|Lost to Follow-up|2|||
149141655|NCT00762892|537999229|FG001|Overall Study|Lost to Follow-up|5|||
149012440|NCT02769065|537525702|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012441|NCT02769065|537525703|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012442|NCT02769065|537525704|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012443|NCT02769065|537525705|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
149012444|NCT03017235|537525706|FG000|Overall Study|Withdrawal by Subject|4|||
149012445|NCT03017235|537525707|FG001|Overall Study|Withdrawal by Subject|3|||
149012446|NCT03017235|537525706|FG000|Overall Study|Lost to Follow-up|2|||
149141656|NCT00762892|537999228|FG000|Overall Study|Withdrawal by Subject|0|||
149141657|NCT00762892|537999229|FG001|Overall Study|Withdrawal by Subject|1|||
149141658|NCT00762892|537999228|FG000|Overall Study|Death|1|||
149141659|NCT00762892|537999229|FG001|Overall Study|Death|0|||
149141660|NCT00762892|537999228|FG000|Overall Study|Pregnancy|1|||
149141661|NCT00762892|537999229|FG001|Overall Study|Pregnancy|0|||
149141662|NCT00762892|537999228|FG000|Overall Study|Incarceration|1|||
149141663|NCT00762892|537999229|FG001|Overall Study|Incarceration|0|||
149141664|NCT02234479|537999231|FG000|Overall Study|Withdrawal by Subject|1|||
149141665|NCT02234479|537999232|FG001|Overall Study|Withdrawal by Subject|3|||
149141666|NCT01841749|537999236|FG000|Overall Study|Protocol Violation|1|||
149141667|NCT02285920|537999237|FG000|Overall Study|Kidney transplantation|2|||
149141668|NCT02285920|537999238|FG001|Overall Study|Kidney transplantation|2|||
149141669|NCT02285920|537999239|FG002|Overall Study|Kidney transplantation|2|||
149141670|NCT02285920|537999240|FG003|Overall Study|Kidney transplantation|0|||
149141671|NCT02285920|537999237|FG000|Overall Study|Change to peritoneal dialysis|0|||
149141672|NCT02285920|537999238|FG001|Overall Study|Change to peritoneal dialysis|0|||
149141673|NCT02285920|537999239|FG002|Overall Study|Change to peritoneal dialysis|1|||
149141674|NCT02285920|537999240|FG003|Overall Study|Change to peritoneal dialysis|0|||
149141675|NCT02285920|537999237|FG000|Overall Study|Transfer to non-participating unit|0|||
149141676|NCT02285920|537999238|FG001|Overall Study|Transfer to non-participating unit|1|||
149141677|NCT02285920|537999239|FG002|Overall Study|Transfer to non-participating unit|0|||
149141678|NCT02285920|537999240|FG003|Overall Study|Transfer to non-participating unit|0|||
149141679|NCT02285920|537999237|FG000|Overall Study|Dialysis discontinuation|0|||
149141680|NCT02285920|537999238|FG001|Overall Study|Dialysis discontinuation|1|||
149141681|NCT02285920|537999239|FG002|Overall Study|Dialysis discontinuation|0|||
149141682|NCT02285920|537999240|FG003|Overall Study|Dialysis discontinuation|0|||
149141683|NCT02285920|537999237|FG000|Overall Study|Death|2|||
149141684|NCT02285920|537999238|FG001|Overall Study|Death|0|||
149141685|NCT02285920|537999239|FG002|Overall Study|Death|2|||
149141686|NCT02285920|537999240|FG003|Overall Study|Death|1|||
149141687|NCT01480284|537999244|FG000|Overall Study|Withdrawal by Subject|2|||
149141688|NCT01480284|537999245|FG001|Overall Study|Withdrawal by Subject|0|||
149141689|NCT01480284|537999244|FG000|Overall Study|Adverse Event|1|||
149141690|NCT01480284|537999245|FG001|Overall Study|Adverse Event|0|||
149141691|NCT01480284|537999244|FG000|Overall Study|Study closed/terminated|3|||
149141692|NCT01480284|537999245|FG001|Overall Study|Study closed/terminated|0|||
149141693|NCT01480284|537999244|FG000|Overall Study|Lost to Follow-up|1|||
149141694|NCT01480284|537999245|FG001|Overall Study|Lost to Follow-up|0|||
149141695|NCT01480284|537999244|FG000|Overall Study|Physician Decision|1|||
149141696|NCT01480284|537999245|FG001|Overall Study|Physician Decision|0|||
149141697|NCT00066742|537999246|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
149141698|NCT00066742|537999246|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
149141699|NCT00066742|537999246|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
149141700|NCT00066742|537999246|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
149141701|NCT00066742|537999246|FG000|Induction Chemoradiotherapy|Ineligible|3|||
149141702|NCT00066742|537999246|FG000|Consolidation Chemotherapy|not protocol specified|1|||
149141703|NCT00066742|537999246|FG000|Consolidation Chemotherapy|Ineligible|2|||
149141704|NCT01211535|537999249|FG000|Overall Study|Adverse Event|0|||
149141705|NCT01211535|537999250|FG001|Overall Study|Adverse Event|1|||
149141706|NCT00549939|537999253|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
149141707|NCT00549939|537999254|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
149141708|NCT00549939|537999255|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
149141709|NCT00549939|537999253|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
149141710|NCT00549939|537999254|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
149141711|NCT00549939|537999255|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
149141712|NCT00549939|537999253|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
149141713|NCT00549939|537999254|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
149141714|NCT00549939|537999255|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
149141715|NCT00549939|537999253|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
149141716|NCT00549939|537999254|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
149141717|NCT00549939|537999255|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
149141718|NCT00549939|537999253|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
149141719|NCT00549939|537999254|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
149141720|NCT00549939|537999255|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
149141721|NCT00549939|537999253|FG000|40-week Open Label Treatment Period|Other|0|||
149141722|NCT00549939|537999254|FG001|40-week Open Label Treatment Period|Other|1|||
149141723|NCT00549939|537999255|FG002|40-week Open Label Treatment Period|Other|4|||
149141724|NCT00003895|537999256|FG000|Overall Study|Adverse Event|4|||
149141725|NCT00003895|537999257|FG001|Overall Study|Adverse Event|0|||
149141726|NCT00003895|537999256|FG000|Overall Study|Lack of Efficacy|1|||
149141727|NCT00003895|537999257|FG001|Overall Study|Lack of Efficacy|1|||
149012447|NCT03017235|537525707|FG001|Overall Study|Lost to Follow-up|7|||
149141728|NCT00003895|537999256|FG000|Overall Study|Patient Vacation|2|||
149012448|NCT03017235|537525706|FG000|Overall Study|Adverse Event|0|||
149141729|NCT00003895|537999257|FG001|Overall Study|Patient Vacation|0|||
149141730|NCT00003895|537999256|FG000|Overall Study|Withdrawal by Subject|0|||
149141731|NCT00003895|537999257|FG001|Overall Study|Withdrawal by Subject|3|||
149141732|NCT01735279|537999260|FG000|Overall Study|Lost to Follow-up|11|||
149141733|NCT01735279|537999261|FG001|Overall Study|Lost to Follow-up|8|||
149141734|NCT01380730|537999262|FG000|Overall Study|Death|0|||
149141735|NCT01380730|537999263|FG001|Overall Study|Death|0|||
149141736|NCT01380730|537999264|FG002|Overall Study|Death|0|||
149141737|NCT01380730|537999265|FG003|Overall Study|Death|0|||
149141738|NCT01380730|537999266|FG004|Overall Study|Death|1|||
149141739|NCT01380730|537999267|FG005|Overall Study|Death|0|||
149141740|NCT01380730|537999268|FG006|Overall Study|Death|0|||
149141741|NCT01380730|537999269|FG007|Overall Study|Death|0|||
149141742|NCT00922480|537999272|FG000|Main Study|Protocol Violation|3|||
149141743|NCT00922480|537999273|FG001|Main Study|Protocol Violation|6|||
149141744|NCT00922480|537999272|FG000|Main Study|Adverse Event|6|||
149141745|NCT00922480|537999273|FG001|Main Study|Adverse Event|7|||
149141746|NCT00922480|537999272|FG000|Main Study|Lack of Efficacy|3|||
149141747|NCT00922480|537999273|FG001|Main Study|Lack of Efficacy|0|||
149141748|NCT00922480|537999272|FG000|Main Study|Withdrawal by Subject|20|||
149141749|NCT00922480|537999273|FG001|Main Study|Withdrawal by Subject|15|||
149141750|NCT00922480|537999272|FG000|Main Study|Lost to Follow-up|5|||
149141751|NCT00922480|537999273|FG001|Main Study|Lost to Follow-up|0|||
149141752|NCT00922480|537999272|FG000|Main Study|Physician Decision|0|||
149141753|NCT00922480|537999273|FG001|Main Study|Physician Decision|1|||
149141754|NCT00922480|537999272|FG000|Extension Study|Protocol Violation|3|||
149141755|NCT00922480|537999273|FG001|Extension Study|Protocol Violation|0|||
149141756|NCT00922480|537999272|FG000|Extension Study|Adverse Event|1|||
149141757|NCT00922480|537999273|FG001|Extension Study|Adverse Event|1|||
149141758|NCT00922480|537999272|FG000|Extension Study|Withdrawal by Subject|1|||
149141759|NCT00922480|537999273|FG001|Extension Study|Withdrawal by Subject|1|||
149141760|NCT00922480|537999272|FG000|Extension Study|Others|0|||
149141761|NCT00922480|537999273|FG001|Extension Study|Others|1|||
149141762|NCT04784897|537999274|FG000|Overall Study|Death|4|||
149141763|NCT04784897|537999275|FG001|Overall Study|Death|2|||
149141764|NCT04784897|537999276|FG002|Overall Study|Death|1|||
149141765|NCT04784897|537999274|FG000|Overall Study|Withdrawal by Subject|0|||
149141766|NCT04784897|537999275|FG001|Overall Study|Withdrawal by Subject|0|||
149141767|NCT04784897|537999276|FG002|Overall Study|Withdrawal by Subject|1|||
149141768|NCT04754802|537999282|FG000|Overall Study|Lost to Follow-up|0|||
149141769|NCT04754802|537999283|FG001|Overall Study|Lost to Follow-up|2|||
149141770|NCT04754802|537999282|FG000|Overall Study|Withdrawal by Subject|2|||
149141771|NCT04754802|537999283|FG001|Overall Study|Withdrawal by Subject|0|||
149141772|NCT00701090|537999284|FG000|Overall Study|Adverse Event|11|||
149141773|NCT00701090|537999285|FG001|Overall Study|Adverse Event|2|||
149141774|NCT00701090|537999284|FG000|Overall Study|Death|0|||
149141775|NCT00701090|537999285|FG001|Overall Study|Death|1|||
149141776|NCT00701090|537999284|FG000|Overall Study|Lack of Efficacy|5|||
149141777|NCT00701090|537999285|FG001|Overall Study|Lack of Efficacy|4|||
149141778|NCT00701090|537999284|FG000|Overall Study|Lost to Follow-up|9|||
149141779|NCT00701090|537999285|FG001|Overall Study|Lost to Follow-up|9|||
149141780|NCT00701090|537999284|FG000|Overall Study|Physician Decision|3|||
149141781|NCT00701090|537999285|FG001|Overall Study|Physician Decision|4|||
149141782|NCT00701090|537999284|FG000|Overall Study|Protocol Violation|2|||
149141783|NCT00701090|537999285|FG001|Overall Study|Protocol Violation|3|||
149141784|NCT00701090|537999284|FG000|Overall Study|Withdrawal by Subject|11|||
149141785|NCT00701090|537999285|FG001|Overall Study|Withdrawal by Subject|16|||
149141786|NCT00701090|537999284|FG000|Overall Study|Other|7|||
149141787|NCT00701090|537999285|FG001|Overall Study|Other|12|||
149141788|NCT01970488|537999286|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
149141789|NCT01970488|537999287|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
149141790|NCT01970488|537999288|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
149141791|NCT01970488|537999289|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
149141792|NCT01970488|537999290|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
148912970|NCT01761240|537164764|FG002|Overall Study|Withdrawal by Subject|0|||
148912971|NCT01761240|537164765|FG003|Overall Study|Withdrawal by Subject|3|||
148912972|NCT01761240|537164766|FG004|Overall Study|Withdrawal by Subject|1|||
149141793|NCT01970488|537999286|FG000|Part 1: Through Week 16|Protocol Violation|1|||
149141794|NCT01970488|537999287|FG001|Part 1: Through Week 16|Protocol Violation|2|||
149141795|NCT01970488|537999288|FG002|Part 1: Through Week 16|Protocol Violation|0|||
149141796|NCT01970488|537999289|FG003|Part 1: Through Week 16|Protocol Violation|0|||
149141797|NCT01970488|537999290|FG004|Part 1: Through Week 16|Protocol Violation|0|||
149141798|NCT01970488|537999286|FG000|Part 1: Through Week 16|Adverse Event|6|||
149141799|NCT01970488|537999287|FG001|Part 1: Through Week 16|Adverse Event|5|||
149141800|NCT01970488|537999288|FG002|Part 1: Through Week 16|Adverse Event|0|||
149141801|NCT01970488|537999289|FG003|Part 1: Through Week 16|Adverse Event|0|||
149141802|NCT01970488|537999290|FG004|Part 1: Through Week 16|Adverse Event|0|||
148912973|NCT01761240|537164762|FG000|Overall Study|Adverse Event|0|||
149141803|NCT01970488|537999286|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
149141804|NCT01970488|537999287|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
149141805|NCT01970488|537999288|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
149141806|NCT01970488|537999289|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
149141807|NCT01970488|537999290|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
149141808|NCT01970488|537999286|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
149141809|NCT01970488|537999287|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
149141810|NCT01970488|537999288|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
149141811|NCT01970488|537999289|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
149141812|NCT01970488|537999290|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
149141813|NCT01970488|537999286|FG000|Part 2: Post Week 16|Physician Decision|0|||
149141814|NCT01970488|537999287|FG001|Part 2: Post Week 16|Physician Decision|0|||
149141815|NCT01970488|537999288|FG002|Part 2: Post Week 16|Physician Decision|0|||
149141816|NCT01970488|537999289|FG003|Part 2: Post Week 16|Physician Decision|0|||
149141817|NCT01970488|537999290|FG004|Part 2: Post Week 16|Physician Decision|1|||
149141818|NCT01970488|537999286|FG000|Part 2: Post Week 16|Non-compliance|0|||
149141819|NCT01970488|537999287|FG001|Part 2: Post Week 16|Non-compliance|0|||
149141820|NCT01970488|537999288|FG002|Part 2: Post Week 16|Non-compliance|1|||
149141821|NCT01970488|537999289|FG003|Part 2: Post Week 16|Non-compliance|0|||
149141822|NCT01970488|537999290|FG004|Part 2: Post Week 16|Non-compliance|0|||
149141823|NCT01970488|537999286|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
149141824|NCT01970488|537999287|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
149141825|NCT01970488|537999288|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
149141826|NCT01970488|537999289|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
149141827|NCT01970488|537999290|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
149141828|NCT01970488|537999286|FG000|Part 2: Post Week 16|Adverse Event|0|||
149141829|NCT01970488|537999287|FG001|Part 2: Post Week 16|Adverse Event|0|||
149141830|NCT01970488|537999288|FG002|Part 2: Post Week 16|Adverse Event|5|||
149141831|NCT01970488|537999289|FG003|Part 2: Post Week 16|Adverse Event|1|||
149141832|NCT01970488|537999290|FG004|Part 2: Post Week 16|Adverse Event|1|||
149141833|NCT01970488|537999286|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
149141834|NCT01970488|537999287|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
149141835|NCT01970488|537999288|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
149141836|NCT01970488|537999289|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
149141837|NCT01970488|537999290|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
149141838|NCT01970488|537999286|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
149141839|NCT01970488|537999287|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
149141840|NCT01970488|537999288|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
149141841|NCT01970488|537999289|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
149141842|NCT01970488|537999290|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
148912974|NCT01761240|537164763|FG001|Overall Study|Adverse Event|0|||
148912975|NCT01761240|537164764|FG002|Overall Study|Adverse Event|0|||
148912976|NCT01761240|537164765|FG003|Overall Study|Adverse Event|1|||
148912977|NCT01761240|537164766|FG004|Overall Study|Adverse Event|6|||
148912978|NCT01761240|537164762|FG000|Overall Study|Death|0|||
148912979|NCT01761240|537164763|FG001|Overall Study|Death|1|||
148912980|NCT01761240|537164764|FG002|Overall Study|Death|1|||
148912981|NCT01761240|537164765|FG003|Overall Study|Death|2|||
148912982|NCT01761240|537164766|FG004|Overall Study|Death|1|||
149012449|NCT03017235|537525707|FG001|Overall Study|Adverse Event|1|||
149141843|NCT01490814|537999292|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
149141844|NCT01490814|537999293|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
149141845|NCT01490814|537999292|FG000|Overall Study|Physician Decision|1|||
149141846|NCT01490814|537999293|FG001|Overall Study|Physician Decision|0|||
149141847|NCT01490814|537999292|FG000|Overall Study|Withdrawal by Subject|0|||
149141848|NCT01490814|537999293|FG001|Overall Study|Withdrawal by Subject|5|||
149141849|NCT01537198|537999294|FG000|Overall Study|RSV infection|2|||
149141850|NCT01537198|537999294|FG000|Overall Study|Adverse Event|4|||
149141851|NCT01537198|537999294|FG000|Overall Study|No Further Visits to the Clinic|37|||
149141852|NCT01537198|537999294|FG000|Overall Study|Other|111|||
149141853|NCT01299376|537999295|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
149141854|NCT01299376|537999296|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
149141855|NCT01299376|537999295|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
149141856|NCT01299376|537999296|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
149141857|NCT01299376|537999295|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
149141858|NCT01299376|537999296|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
149141859|NCT01299376|537999295|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
149141860|NCT01299376|537999296|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
149141861|NCT01299376|537999295|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
149141862|NCT01299376|537999296|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
149141863|NCT01299376|537999295|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
149141864|NCT01299376|537999296|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
149141865|NCT01299376|537999295|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
149141866|NCT01299376|537999296|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
149141867|NCT01299376|537999295|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
149141868|NCT01299376|537999296|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
149141869|NCT01299376|537999295|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
149141870|NCT01299376|537999296|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
149141871|NCT01299376|537999295|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
149141872|NCT01299376|537999296|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
149141873|NCT01299376|537999295|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
149141874|NCT01299376|537999296|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
149141875|NCT03680911|537999297|FG000|At Home Treatment|Study Termination|3|||
149141876|NCT03680911|537999298|FG001|At Home Treatment|Study Termination|0|||
149141877|NCT03680911|537999297|FG000|At Home Treatment|Lost to Follow-up|0|||
149141878|NCT03680911|537999298|FG001|At Home Treatment|Lost to Follow-up|1|||
149141879|NCT03680911|537999297|FG000|At Home Treatment|Withdrawal by Subject|0|||
149141880|NCT03680911|537999298|FG001|At Home Treatment|Withdrawal by Subject|2|||
149141881|NCT03680911|537999297|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
149141882|NCT03680911|537999298|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
149141883|NCT03962738|537999299|FG000|Overall Study|Protocol Deviation|3|||
149141884|NCT03962738|537999300|FG001|Overall Study|Protocol Deviation|0|||
149141885|NCT03962738|537999301|FG002|Overall Study|Protocol Deviation|1|||
149141886|NCT03962738|537999302|FG003|Overall Study|Protocol Deviation|1|||
149141887|NCT03962738|537999299|FG000|Overall Study|Withdrawal by Subject|4|||
149141888|NCT03962738|537999300|FG001|Overall Study|Withdrawal by Subject|0|||
149141889|NCT03962738|537999301|FG002|Overall Study|Withdrawal by Subject|0|||
149141890|NCT03962738|537999302|FG003|Overall Study|Withdrawal by Subject|0|||
149141891|NCT03962738|537999299|FG000|Overall Study|Lost to Follow-up|0|||
149141892|NCT03962738|537999300|FG001|Overall Study|Lost to Follow-up|0|||
149141893|NCT03962738|537999301|FG002|Overall Study|Lost to Follow-up|1|||
149141894|NCT03962738|537999302|FG003|Overall Study|Lost to Follow-up|0|||
149141895|NCT00574288|537999303|FG000|Overall Study|Adverse Event|2|||
149141896|NCT00574288|537999304|FG001|Overall Study|Adverse Event|0|||
149141897|NCT00574288|537999305|FG002|Overall Study|Adverse Event|0|||
149141898|NCT00574288|537999306|FG003|Overall Study|Adverse Event|0|||
149141899|NCT00574288|537999307|FG004|Overall Study|Adverse Event|1|||
149141900|NCT00574288|537999308|FG005|Overall Study|Adverse Event|0|||
149141901|NCT00574288|537999309|FG006|Overall Study|Adverse Event|0|||
149141902|NCT00574288|537999303|FG000|Overall Study|Death|0|||
149141903|NCT00574288|537999304|FG001|Overall Study|Death|0|||
148804806|NCT00753519|536766565|FG000|Overall Study|Withdrawal by Subject|0|||
149141904|NCT00574288|537999305|FG002|Overall Study|Death|0|||
149141905|NCT00574288|537999306|FG003|Overall Study|Death|0|||
149141906|NCT00574288|537999307|FG004|Overall Study|Death|0|||
149141907|NCT00574288|537999308|FG005|Overall Study|Death|25|||
149141908|NCT00574288|537999309|FG006|Overall Study|Death|21|||
149141909|NCT00574288|537999303|FG000|Overall Study|Lost to Follow-up|0|||
149141910|NCT00574288|537999304|FG001|Overall Study|Lost to Follow-up|0|||
148804807|NCT00753519|536766566|FG001|Overall Study|Withdrawal by Subject|2|||
149141911|NCT00574288|537999305|FG002|Overall Study|Lost to Follow-up|0|||
149141912|NCT00574288|537999306|FG003|Overall Study|Lost to Follow-up|0|||
149141913|NCT00574288|537999307|FG004|Overall Study|Lost to Follow-up|0|||
149141914|NCT00574288|537999308|FG005|Overall Study|Lost to Follow-up|1|||
149141915|NCT00574288|537999309|FG006|Overall Study|Lost to Follow-up|2|||
149141916|NCT00574288|537999303|FG000|Overall Study|Study Terminated By Sponsor|0|||
149141917|NCT00574288|537999304|FG001|Overall Study|Study Terminated By Sponsor|0|||
149141918|NCT00574288|537999305|FG002|Overall Study|Study Terminated By Sponsor|0|||
149141919|NCT00574288|537999306|FG003|Overall Study|Study Terminated By Sponsor|0|||
149141920|NCT00574288|537999307|FG004|Overall Study|Study Terminated By Sponsor|0|||
149141921|NCT00574288|537999308|FG005|Overall Study|Study Terminated By Sponsor|0|||
149141922|NCT00574288|537999309|FG006|Overall Study|Study Terminated By Sponsor|5|||
149141923|NCT00574288|537999303|FG000|Overall Study|Progressive Disease|17|||
149141924|NCT00574288|537999304|FG001|Overall Study|Progressive Disease|2|||
149141925|NCT00574288|537999305|FG002|Overall Study|Progressive Disease|3|||
149141926|NCT00574288|537999306|FG003|Overall Study|Progressive Disease|2|||
149141927|NCT00574288|537999307|FG004|Overall Study|Progressive Disease|1|||
149141928|NCT00574288|537999308|FG005|Overall Study|Progressive Disease|0|||
149141929|NCT00574288|537999309|FG006|Overall Study|Progressive Disease|0|||
149141930|NCT00574288|537999303|FG000|Overall Study|Other|1|||
148804808|NCT00959751|536766567|FG000|Overall Study|Lost to Follow-up|2|||
149141931|NCT00574288|537999304|FG001|Overall Study|Other|1|||
149141932|NCT00574288|537999305|FG002|Overall Study|Other|0|||
149141933|NCT00574288|537999306|FG003|Overall Study|Other|0|||
149141934|NCT00574288|537999307|FG004|Overall Study|Other|0|||
148804809|NCT00959751|536766568|FG001|Overall Study|Lost to Follow-up|3|||
148804810|NCT00959751|536766567|FG000|Overall Study|Consent Withdrawn|0|||
148804811|NCT00959751|536766568|FG001|Overall Study|Consent Withdrawn|1|||
148804812|NCT00959751|536766567|FG000|Overall Study|Non-compliance to Study Procedures|0|||
148912983|NCT01761240|537164762|FG000|Overall Study|Non-compliance|0|||
149141935|NCT00574288|537999308|FG005|Overall Study|Other|0|||
149141936|NCT00574288|537999309|FG006|Overall Study|Other|0|||
149141937|NCT03716050|537999312|FG000|Overall Study|Lost to Follow-up|0|||
149141938|NCT03716050|537999313|FG001|Overall Study|Lost to Follow-up|0|||
149141939|NCT03716050|537999314|FG002|Overall Study|Lost to Follow-up|1|||
149141940|NCT03716050|537999315|FG003|Overall Study|Lost to Follow-up|0|||
149141941|NCT03716050|537999316|FG004|Overall Study|Lost to Follow-up|0|||
149141942|NCT03716050|537999317|FG005|Overall Study|Lost to Follow-up|0|||
149141943|NCT03716050|537999318|FG006|Overall Study|Lost to Follow-up|0|||
149141944|NCT03716050|537999319|FG007|Overall Study|Lost to Follow-up|0|||
149141945|NCT03716050|537999312|FG000|Overall Study|Physician Decision|0|||
149141946|NCT03716050|537999313|FG001|Overall Study|Physician Decision|0|||
149141947|NCT03716050|537999314|FG002|Overall Study|Physician Decision|0|||
149141948|NCT03716050|537999315|FG003|Overall Study|Physician Decision|1|||
149141949|NCT03716050|537999316|FG004|Overall Study|Physician Decision|0|||
149141950|NCT03716050|537999317|FG005|Overall Study|Physician Decision|0|||
149141951|NCT03716050|537999318|FG006|Overall Study|Physician Decision|0|||
149141952|NCT03716050|537999319|FG007|Overall Study|Physician Decision|0|||
149141953|NCT03716050|537999312|FG000|Overall Study|Protocol Violation|0|||
149141954|NCT03716050|537999313|FG001|Overall Study|Protocol Violation|0|||
149141955|NCT03716050|537999314|FG002|Overall Study|Protocol Violation|0|||
149141956|NCT03716050|537999315|FG003|Overall Study|Protocol Violation|1|||
149141957|NCT03716050|537999316|FG004|Overall Study|Protocol Violation|0|||
149141958|NCT03716050|537999317|FG005|Overall Study|Protocol Violation|0|||
149141959|NCT03716050|537999318|FG006|Overall Study|Protocol Violation|0|||
149141960|NCT03716050|537999319|FG007|Overall Study|Protocol Violation|2|||
149141961|NCT00529451|537999320|FG000|Overall Study|Subject withdrew consent|16|||
149141962|NCT00529451|537999321|FG001|Overall Study|Subject withdrew consent|21|||
149141963|NCT00529451|537999322|FG002|Overall Study|Subject withdrew consent|13|||
149141964|NCT00529451|537999323|FG003|Overall Study|Subject withdrew consent|12|||
149141965|NCT00529451|537999320|FG000|Overall Study|Adverse Event|9|||
149141966|NCT00529451|537999321|FG001|Overall Study|Adverse Event|16|||
149141967|NCT00529451|537999322|FG002|Overall Study|Adverse Event|14|||
149141968|NCT00529451|537999323|FG003|Overall Study|Adverse Event|8|||
149141969|NCT00529451|537999320|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
149141970|NCT00529451|537999321|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
149141971|NCT00529451|537999322|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
149141972|NCT00529451|537999323|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
149141973|NCT00529451|537999320|FG000|Overall Study|Lost to Follow-up|4|||
149141974|NCT00529451|537999321|FG001|Overall Study|Lost to Follow-up|7|||
149141975|NCT00529451|537999322|FG002|Overall Study|Lost to Follow-up|4|||
149141976|NCT00529451|537999323|FG003|Overall Study|Lost to Follow-up|4|||
149141977|NCT00529451|537999320|FG000|Overall Study|Protocol deviation|1|||
149141978|NCT00529451|537999321|FG001|Overall Study|Protocol deviation|1|||
149141979|NCT00529451|537999322|FG002|Overall Study|Protocol deviation|4|||
149141980|NCT00529451|537999323|FG003|Overall Study|Protocol deviation|1|||
148804813|NCT00959751|536766568|FG001|Overall Study|Non-compliance to Study Procedures|1|||
148804814|NCT00959751|536766567|FG000|Overall Study|No migraine headache without aura|7|||
148912984|NCT01761240|537164763|FG001|Overall Study|Non-compliance|0|||
149141981|NCT00529451|537999320|FG000|Overall Study|Administrative problems|1|||
149141982|NCT00529451|537999321|FG001|Overall Study|Administrative problems|1|||
149141983|NCT00529451|537999322|FG002|Overall Study|Administrative problems|0|||
149141984|NCT00529451|537999323|FG003|Overall Study|Administrative problems|2|||
149141985|NCT02566577|537999324|FG000|Overall Study|Withdrawal by Subject|1|||
149141986|NCT02566577|537999325|FG001|Overall Study|Withdrawal by Subject|1|||
149141987|NCT02566577|537999324|FG000|Overall Study|Equipment failure|1|||
149141988|NCT02566577|537999325|FG001|Overall Study|Equipment failure|1|||
149141989|NCT02566577|537999324|FG000|Overall Study|Physical limitation|1|||
149141990|NCT02566577|537999325|FG001|Overall Study|Physical limitation|0|||
149141991|NCT01494350|537999326|FG000|Overall Study|Worsening of lesion|1|||
149141992|NCT01786603|537999327|FG000|Overall Study|Death|5|||
149141993|NCT01786603|537999328|FG001|Overall Study|Death|1|||
149141994|NCT01786603|537999327|FG000|Overall Study|Adverse Event|6|||
149141995|NCT01786603|537999328|FG001|Overall Study|Adverse Event|2|||
149141996|NCT01786603|537999327|FG000|Overall Study|Physician decision to withdraw|6|||
149141997|NCT01786603|537999328|FG001|Overall Study|Physician decision to withdraw|7|||
149141998|NCT01786603|537999327|FG000|Overall Study|Lost to Follow-up|1|||
149141999|NCT01786603|537999328|FG001|Overall Study|Lost to Follow-up|2|||
149142000|NCT03700320|537999329|FG000|Overall Study|Adverse Event|5|||
149142001|NCT03700320|537999330|FG001|Overall Study|Adverse Event|31|||
149142002|NCT03700320|537999329|FG000|Overall Study|Lack of Efficacy|2|||
149142003|NCT03700320|537999330|FG001|Overall Study|Lack of Efficacy|5|||
149142004|NCT03700320|537999329|FG000|Overall Study|Withdrawal by Subject|29|||
149142005|NCT03700320|537999330|FG001|Overall Study|Withdrawal by Subject|75|||
149142006|NCT03700320|537999329|FG000|Overall Study|Lost to Follow-up|16|||
149142007|NCT03700320|537999330|FG001|Overall Study|Lost to Follow-up|23|||
149142008|NCT03700320|537999329|FG000|Overall Study|Pregnancy|2|||
149142009|NCT03700320|537999330|FG001|Overall Study|Pregnancy|4|||
149142010|NCT03700320|537999329|FG000|Overall Study|Protocol Deviation|7|||
149142011|NCT03700320|537999330|FG001|Overall Study|Protocol Deviation|31|||
149142012|NCT03700320|537999329|FG000|Overall Study|Non-compliance with Study Drug|1|||
149142013|NCT03700320|537999330|FG001|Overall Study|Non-compliance with Study Drug|3|||
149142014|NCT03700320|537999329|FG000|Overall Study|Reason not Specified|0|||
149142015|NCT03700320|537999330|FG001|Overall Study|Reason not Specified|1|||
149142016|NCT03654976|537999331|FG000|Overall Study|Withdrawal by Subject|12|||
149142017|NCT03654976|537999332|FG001|Overall Study|Withdrawal by Subject|11|||
149142018|NCT03654976|537999331|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
149142019|NCT03654976|537999332|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
149142020|NCT03654976|537999331|FG000|Overall Study|Adverse Event|5|||
149142021|NCT03654976|537999332|FG001|Overall Study|Adverse Event|0|||
149142022|NCT03654976|537999331|FG000|Overall Study|Lost to Follow-up|2|||
149142023|NCT03654976|537999332|FG001|Overall Study|Lost to Follow-up|0|||
149142024|NCT03654976|537999331|FG000|Overall Study|Lack of Efficacy|0|||
149142025|NCT03654976|537999332|FG001|Overall Study|Lack of Efficacy|1|||
149142026|NCT02054325|537999340|FG000|Overall Study|Lost to Follow-up|8|||
149142027|NCT02054325|537999341|FG001|Overall Study|Lost to Follow-up|5|||
149142028|NCT04688775|537999342|FG000|Placebo-controlled Period|Randomized, not treated|1|||
149142029|NCT04688775|537999343|FG001|Placebo-controlled Period|Randomized, not treated|1|||
148912985|NCT01761240|537164764|FG002|Overall Study|Non-compliance|1|||
148912986|NCT01761240|537164765|FG003|Overall Study|Non-compliance|0|||
148912987|NCT01761240|537164766|FG004|Overall Study|Non-compliance|0|||
148912988|NCT01233232|537164767|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
148912989|NCT01233232|537164768|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
148912990|NCT01233232|537164769|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
148912991|NCT01708902|537164776|FG000|Overall Study|Adverse Event|3|||
148912992|NCT01708902|537164777|FG001|Overall Study|Adverse Event|4|||
148912993|NCT01708902|537164778|FG002|Overall Study|Adverse Event|9|||
148912994|NCT01708902|537164779|FG003|Overall Study|Adverse Event|2|||
148912995|NCT01708902|537164780|FG004|Overall Study|Adverse Event|7|||
148912996|NCT01708902|537164781|FG005|Overall Study|Adverse Event|3|||
148912997|NCT01708902|537164782|FG006|Overall Study|Adverse Event|5|||
148912998|NCT01708902|537164776|FG000|Overall Study|Lack of Efficacy|3|||
149142030|NCT04688775|537999344|FG002|Placebo-controlled Period|Randomized, not treated|0|||
149142031|NCT04688775|537999345|FG003|Placebo-controlled Period|Randomized, not treated|0|||
149142032|NCT04688775|537999342|FG000|Placebo-controlled Period|Adverse Event|2|||
149142033|NCT04688775|537999343|FG001|Placebo-controlled Period|Adverse Event|0|||
148912999|NCT01708902|537164777|FG001|Overall Study|Lack of Efficacy|1|||
148913000|NCT01708902|537164778|FG002|Overall Study|Lack of Efficacy|0|||
148913001|NCT01708902|537164779|FG003|Overall Study|Lack of Efficacy|0|||
149142034|NCT04688775|537999344|FG002|Placebo-controlled Period|Adverse Event|0|||
149142035|NCT04688775|537999345|FG003|Placebo-controlled Period|Adverse Event|0|||
149142036|NCT04688775|537999342|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
148913002|NCT01708902|537164780|FG004|Overall Study|Lack of Efficacy|0|||
149142037|NCT04688775|537999343|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
149142038|NCT04688775|537999344|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
149142039|NCT04688775|537999345|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
148913003|NCT01708902|537164781|FG005|Overall Study|Lack of Efficacy|1|||
148913004|NCT01708902|537164782|FG006|Overall Study|Lack of Efficacy|0|||
148913005|NCT01708902|537164776|FG000|Overall Study|Non compliance with protocol|0|||
148913006|NCT01708902|537164777|FG001|Overall Study|Non compliance with protocol|2|||
148913007|NCT01708902|537164778|FG002|Overall Study|Non compliance with protocol|1|||
148913008|NCT01708902|537164779|FG003|Overall Study|Non compliance with protocol|3|||
148670915|NCT02181673|536267014|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
148670916|NCT02181673|536267015|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
148670917|NCT02181673|536267016|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
148670918|NCT02181673|536267014|FG000|Week 24-Week 60|Pregnancy|0|||
148670919|NCT02181673|536267015|FG001|Week 24-Week 60|Pregnancy|0|||
148670920|NCT02181673|536267016|FG002|Week 24-Week 60|Pregnancy|1|||
148670921|NCT02181673|536267014|FG000|Week 24-Week 60|Lack of Efficacy|0|||
148670922|NCT02181673|536267015|FG001|Week 24-Week 60|Lack of Efficacy|0|||
148670923|NCT02181673|536267016|FG002|Week 24-Week 60|Lack of Efficacy|1|||
148670924|NCT02181673|536267014|FG000|Week 24-Week 60|Lost to Follow-up|0|||
148670925|NCT02181673|536267015|FG001|Week 24-Week 60|Lost to Follow-up|0|||
148670926|NCT02181673|536267016|FG002|Week 24-Week 60|Lost to Follow-up|1|||
148670927|NCT02181673|536267014|FG000|Week 24-Week 60|Physician Decision|0|||
148670928|NCT02181673|536267015|FG001|Week 24-Week 60|Physician Decision|0|||
148670929|NCT02181673|536267016|FG002|Week 24-Week 60|Physician Decision|1|||
148670930|NCT00337727|536267017|FG000|Overall Study|Adverse Event|5|||
148670931|NCT00337727|536267018|FG001|Overall Study|Adverse Event|3|||
148670932|NCT00337727|536267017|FG000|Overall Study|Lost to Follow-up|5|||
148670933|NCT00337727|536267018|FG001|Overall Study|Lost to Follow-up|4|||
148670934|NCT00337727|536267017|FG000|Overall Study|Physician Decision|1|||
148670935|NCT00337727|536267018|FG001|Overall Study|Physician Decision|0|||
148670936|NCT00337727|536267017|FG000|Overall Study|Protocol Violation|4|||
148670937|NCT00337727|536267018|FG001|Overall Study|Protocol Violation|0|||
148670938|NCT00337727|536267017|FG000|Overall Study|Withdrawal by Subject|3|||
148670939|NCT00337727|536267018|FG001|Overall Study|Withdrawal by Subject|5|||
148670940|NCT00326625|536267019|FG000|Overall Study|Adverse Event|20|||
148670941|NCT00326625|536267020|FG001|Overall Study|Adverse Event|9|||
148670942|NCT00326625|536267019|FG000|Overall Study|Withdrawal by Subject|15|||
148670943|NCT00326625|536267020|FG001|Overall Study|Withdrawal by Subject|12|||
148670944|NCT00326625|536267019|FG000|Overall Study|Death|18|||
148670945|NCT00326625|536267020|FG001|Overall Study|Death|16|||
148670946|NCT00326625|536267019|FG000|Overall Study|Lost to Follow-up|1|||
148670947|NCT00326625|536267020|FG001|Overall Study|Lost to Follow-up|0|||
148670948|NCT00326625|536267019|FG000|Overall Study|prescheduled medical intervention|0|||
148670949|NCT00326625|536267020|FG001|Overall Study|prescheduled medical intervention|1|||
148670950|NCT06067191|536267026|FG000|Overall Study|Withdrawal by Subject|0|||
148670951|NCT06067191|536267027|FG001|Overall Study|Withdrawal by Subject|1|||
148670952|NCT04764669|536267028|FG000|Overall Study|Adverse Event|1|||
148670953|NCT04764669|536267029|FG001|Overall Study|Adverse Event|0|||
148670954|NCT04764669|536267030|FG002|Overall Study|Adverse Event|1|||
148670955|NCT04764669|536267031|FG003|Overall Study|Adverse Event|0|||
148670956|NCT04764669|536267028|FG000|Overall Study|Subject Choice|0|||
148670957|NCT04764669|536267029|FG001|Overall Study|Subject Choice|0|||
148670958|NCT04764669|536267030|FG002|Overall Study|Subject Choice|1|||
148670959|NCT04764669|536267031|FG003|Overall Study|Subject Choice|0|||
148670960|NCT04764669|536267028|FG000|Overall Study|Withdrawal by Subject|2|||
148670961|NCT04764669|536267029|FG001|Overall Study|Withdrawal by Subject|0|||
148670962|NCT04764669|536267030|FG002|Overall Study|Withdrawal by Subject|0|||
148670963|NCT04764669|536267031|FG003|Overall Study|Withdrawal by Subject|0|||
148670964|NCT00625846|536267032|FG000|Overall Study|Withdrawal by Subject|2|||
148670965|NCT00625846|536267033|FG001|Overall Study|Withdrawal by Subject|0|||
148670966|NCT00625846|536267034|FG002|Overall Study|Withdrawal by Subject|1|||
148670967|NCT00625846|536267035|FG003|Overall Study|Withdrawal by Subject|2|||
148670968|NCT00557830|536267046|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
148670969|NCT00557830|536267047|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
148670970|NCT00557830|536267048|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
148670971|NCT00557830|536267046|FG000|Screening Treatment Phase|Adverse Event|2|||
148670972|NCT00557830|536267047|FG001|Screening Treatment Phase|Adverse Event|0|||
148670973|NCT00557830|536267048|FG002|Screening Treatment Phase|Adverse Event|0|||
148670974|NCT00557830|536267046|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
148670975|NCT00557830|536267047|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
148670976|NCT00557830|536267048|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
148670977|NCT03664024|536267054|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
148670978|NCT03664024|536267054|FG000|Overall Study|Lost to Follow-up|2|||
148670979|NCT03664024|536267054|FG000|Overall Study|Withdrawal by Subject|2|||
148670980|NCT03664024|536267054|FG000|Overall Study|Death|80|||
148670981|NCT01157065|536267055|FG000|Overall Study|Death|0|||
148670982|NCT01157065|536267056|FG001|Overall Study|Death|1|||
148670983|NCT05275673|536267059|FG000|Overall Study|Study Termination by Sponsor|2|||
148670984|NCT05275673|536267060|FG001|Overall Study|Study Termination by Sponsor|3|||
148670985|NCT05275673|536267059|FG000|Overall Study|Death|1|||
148670986|NCT05275673|536267060|FG001|Overall Study|Death|0|||
148670987|NCT05275673|536267059|FG000|Overall Study|Withdrawal by Subject|1|||
148670988|NCT05275673|536267060|FG001|Overall Study|Withdrawal by Subject|0|||
148670989|NCT02325739|536267061|FG000|Phase I Part|Adverse Event|1|||
148670990|NCT02325739|536267062|FG001|Phase I Part|Adverse Event|0|||
148670991|NCT02325739|536267063|FG002|Phase I Part|Adverse Event|1|||
148670992|NCT02325739|536267064|FG003|Phase I Part|Adverse Event|2|||
148804815|NCT00959751|536766568|FG001|Overall Study|No migraine headache without aura|7|||
149012450|NCT03017235|537525706|FG000|Overall Study|Protocol Violation|2|||
149012451|NCT03017235|537525707|FG001|Overall Study|Protocol Violation|1|||
149012452|NCT03017235|537525706|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
149012453|NCT03017235|537525707|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
149012454|NCT00437125|537525711|FG000|Overall Study|Adverse Event|12|||
149012455|NCT00437125|537525711|FG000|Overall Study|Death|1|||
149012456|NCT00437125|537525711|FG000|Overall Study|Clinical Relapse|1|||
149012457|NCT00437125|537525711|FG000|Overall Study|Lack of Efficacy|1|||
149012458|NCT00437125|537525711|FG000|Overall Study|Lost to Follow-up|1|||
149012459|NCT00437125|537525711|FG000|Overall Study|Withdrawal by Subject|13|||
149012460|NCT00437125|537525711|FG000|Overall Study|Withdrawal by Caregiver|2|||
149012461|NCT00437125|537525711|FG000|Overall Study|Physician Decision|1|||
149012462|NCT02248961|537525712|FG000|Overall Study|Adverse Event|1|||
149012463|NCT02248961|537525713|FG001|Overall Study|Adverse Event|0|||
149012464|NCT02248961|537525712|FG000|Overall Study|Withdrawal by Subject|1|||
149012465|NCT02248961|537525713|FG001|Overall Study|Withdrawal by Subject|2|||
149012466|NCT02248961|537525712|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
149012467|NCT02248961|537525713|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
149012468|NCT03518658|537525714|FG000|Overall Study|Other|51|||
149012469|NCT03518658|537525715|FG001|Overall Study|Other|0|||
149012470|NCT02531295|537525716|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
149012471|NCT02531295|537525717|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
149012472|NCT02531295|537525718|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
149012473|NCT02531295|537525719|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
148670993|NCT02325739|536267065|FG004|Phase I Part|Adverse Event|3|||
148670994|NCT02325739|536267066|FG005|Phase I Part|Adverse Event|1|||
148670995|NCT02325739|536267067|FG006|Phase I Part|Adverse Event|0|||
148670996|NCT02325739|536267068|FG007|Phase I Part|Adverse Event|2|||
148670997|NCT02325739|536267069|FG008|Phase I Part|Adverse Event|0|||
148670998|NCT02325739|536267070|FG009|Phase I Part|Adverse Event|0|||
148670999|NCT02325739|536267071|FG010|Phase I Part|Adverse Event|0|||
148671000|NCT02325739|536267061|FG000|Phase I Part|Progressive disease|9|||
148671001|NCT02325739|536267062|FG001|Phase I Part|Progressive disease|6|||
148671002|NCT02325739|536267063|FG002|Phase I Part|Progressive disease|3|||
148671003|NCT02325739|536267064|FG003|Phase I Part|Progressive disease|23|||
148671004|NCT02325739|536267065|FG004|Phase I Part|Progressive disease|14|||
148671005|NCT02325739|536267066|FG005|Phase I Part|Progressive disease|6|||
148671006|NCT02325739|536267067|FG006|Phase I Part|Progressive disease|6|||
148671007|NCT02325739|536267068|FG007|Phase I Part|Progressive disease|3|||
148671008|NCT02325739|536267069|FG008|Phase I Part|Progressive disease|0|||
148671009|NCT02325739|536267070|FG009|Phase I Part|Progressive disease|0|||
148671010|NCT02325739|536267071|FG010|Phase I Part|Progressive disease|0|||
148671011|NCT02325739|536267061|FG000|Phase I Part|Subject/guardian decision|1|||
148671012|NCT02325739|536267062|FG001|Phase I Part|Subject/guardian decision|0|||
148671013|NCT02325739|536267063|FG002|Phase I Part|Subject/guardian decision|1|||
148671014|NCT02325739|536267064|FG003|Phase I Part|Subject/guardian decision|1|||
148671015|NCT02325739|536267065|FG004|Phase I Part|Subject/guardian decision|0|||
148671016|NCT02325739|536267066|FG005|Phase I Part|Subject/guardian decision|0|||
148671017|NCT02325739|536267067|FG006|Phase I Part|Subject/guardian decision|0|||
148671018|NCT02325739|536267068|FG007|Phase I Part|Subject/guardian decision|1|||
148671019|NCT02325739|536267069|FG008|Phase I Part|Subject/guardian decision|0|||
148671020|NCT02325739|536267070|FG009|Phase I Part|Subject/guardian decision|0|||
148671021|NCT02325739|536267071|FG010|Phase I Part|Subject/guardian decision|0|||
148671022|NCT02325739|536267061|FG000|Phase I Part|Death|0|||
148671023|NCT02325739|536267062|FG001|Phase I Part|Death|0|||
148671024|NCT02325739|536267063|FG002|Phase I Part|Death|0|||
148671025|NCT02325739|536267064|FG003|Phase I Part|Death|0|||
148671026|NCT02325739|536267065|FG004|Phase I Part|Death|2|||
148671027|NCT02325739|536267066|FG005|Phase I Part|Death|0|||
148671028|NCT02325739|536267067|FG006|Phase I Part|Death|0|||
148671029|NCT02325739|536267068|FG007|Phase I Part|Death|0|||
148671030|NCT02325739|536267069|FG008|Phase I Part|Death|0|||
148671031|NCT02325739|536267070|FG009|Phase I Part|Death|0|||
148671032|NCT02325739|536267071|FG010|Phase I Part|Death|0|||
148671033|NCT02325739|536267061|FG000|Phase II Part|Adverse Event|0|||
148671034|NCT02325739|536267062|FG001|Phase II Part|Adverse Event|0|||
148671035|NCT02325739|536267063|FG002|Phase II Part|Adverse Event|0|||
148671036|NCT02325739|536267064|FG003|Phase II Part|Adverse Event|0|||
148671037|NCT02325739|536267065|FG004|Phase II Part|Adverse Event|0|||
148671038|NCT02325739|536267066|FG005|Phase II Part|Adverse Event|0|||
148671039|NCT02325739|536267067|FG006|Phase II Part|Adverse Event|0|||
148671040|NCT02325739|536267068|FG007|Phase II Part|Adverse Event|0|||
148671041|NCT02325739|536267069|FG008|Phase II Part|Adverse Event|4|||
148671042|NCT02325739|536267070|FG009|Phase II Part|Adverse Event|5|||
148671043|NCT02325739|536267071|FG010|Phase II Part|Adverse Event|1|||
148671044|NCT02325739|536267061|FG000|Phase II Part|Physician Decision|0|||
148671045|NCT02325739|536267062|FG001|Phase II Part|Physician Decision|0|||
148671046|NCT02325739|536267063|FG002|Phase II Part|Physician Decision|0|||
148671047|NCT02325739|536267064|FG003|Phase II Part|Physician Decision|0|||
148671048|NCT02325739|536267065|FG004|Phase II Part|Physician Decision|0|||
148671049|NCT02325739|536267066|FG005|Phase II Part|Physician Decision|0|||
148671050|NCT02325739|536267067|FG006|Phase II Part|Physician Decision|0|||
148671051|NCT02325739|536267068|FG007|Phase II Part|Physician Decision|0|||
148671052|NCT02325739|536267069|FG008|Phase II Part|Physician Decision|0|||
148671053|NCT02325739|536267070|FG009|Phase II Part|Physician Decision|1|||
148671054|NCT02325739|536267071|FG010|Phase II Part|Physician Decision|0|||
148671055|NCT02325739|536267061|FG000|Phase II Part|Progressive disease|0|||
148671056|NCT02325739|536267062|FG001|Phase II Part|Progressive disease|0|||
148671057|NCT02325739|536267063|FG002|Phase II Part|Progressive disease|0|||
148671058|NCT02325739|536267064|FG003|Phase II Part|Progressive disease|0|||
148671059|NCT02325739|536267065|FG004|Phase II Part|Progressive disease|0|||
148671060|NCT02325739|536267066|FG005|Phase II Part|Progressive disease|0|||
148671061|NCT02325739|536267067|FG006|Phase II Part|Progressive disease|0|||
148671062|NCT02325739|536267068|FG007|Phase II Part|Progressive disease|0|||
148671063|NCT02325739|536267069|FG008|Phase II Part|Progressive disease|22|||
148671064|NCT02325739|536267070|FG009|Phase II Part|Progressive disease|29|||
148671065|NCT02325739|536267071|FG010|Phase II Part|Progressive disease|18|||
148671066|NCT02325739|536267061|FG000|Phase II Part|Subject/guardian decision|0|||
148671067|NCT02325739|536267062|FG001|Phase II Part|Subject/guardian decision|0|||
148671068|NCT02325739|536267063|FG002|Phase II Part|Subject/guardian decision|0|||
148671069|NCT02325739|536267064|FG003|Phase II Part|Subject/guardian decision|0|||
148671070|NCT02325739|536267065|FG004|Phase II Part|Subject/guardian decision|0|||
148671071|NCT02325739|536267066|FG005|Phase II Part|Subject/guardian decision|0|||
148671072|NCT02325739|536267067|FG006|Phase II Part|Subject/guardian decision|0|||
148671073|NCT02325739|536267068|FG007|Phase II Part|Subject/guardian decision|0|||
148671074|NCT02325739|536267069|FG008|Phase II Part|Subject/guardian decision|4|||
148671075|NCT02325739|536267070|FG009|Phase II Part|Subject/guardian decision|1|||
148671076|NCT02325739|536267071|FG010|Phase II Part|Subject/guardian decision|1|||
148671077|NCT00605839|536267075|FG000|Overall Study|Protocol Violation|1|||
148671078|NCT00605839|536267076|FG001|Overall Study|Protocol Violation|0|||
148671079|NCT00605839|536267077|FG002|Overall Study|Protocol Violation|0|||
148671080|NCT03917654|536267078|FG000|Year 1|Withdrawal by Subject|1|||
148671081|NCT03917654|536267079|FG001|Year 1|Withdrawal by Subject|0|||
148671082|NCT03917654|536267080|FG002|Year 1|Withdrawal by Subject|0|||
149012474|NCT02531295|537525720|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
149012475|NCT02531295|537525721|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
149012476|NCT00649389|537525722|FG000|Overall Study|Adverse Event|22|||
149012477|NCT00649389|537525723|FG001|Overall Study|Adverse Event|46|||
149012478|NCT00649389|537525724|FG002|Overall Study|Adverse Event|38|||
149012479|NCT00649389|537525725|FG003|Overall Study|Adverse Event|48|||
149012480|NCT00649389|537525722|FG000|Overall Study|Lost to Follow-up|15|||
149012481|NCT00649389|537525723|FG001|Overall Study|Lost to Follow-up|17|||
149012482|NCT00649389|537525724|FG002|Overall Study|Lost to Follow-up|21|||
149012483|NCT00649389|537525725|FG003|Overall Study|Lost to Follow-up|26|||
149012484|NCT00649389|537525722|FG000|Overall Study|Protocol Violation|11|||
149012485|NCT00649389|537525723|FG001|Overall Study|Protocol Violation|13|||
149012486|NCT00649389|537525724|FG002|Overall Study|Protocol Violation|9|||
149012487|NCT00649389|537525725|FG003|Overall Study|Protocol Violation|8|||
148671083|NCT03917654|536267081|FG003|Year 1|Withdrawal by Subject|0|||
148671084|NCT03917654|536267082|FG004|Year 1|Withdrawal by Subject|0|||
148671085|NCT03917654|536267083|FG005|Year 1|Withdrawal by Subject|1|||
148671086|NCT03917654|536267084|FG006|Year 1|Withdrawal by Subject|6|||
148671087|NCT03917654|536267085|FG007|Year 1|Withdrawal by Subject|2|||
148671088|NCT03917654|536267086|FG008|Year 1|Withdrawal by Subject|5|||
148671089|NCT03917654|536267087|FG009|Year 1|Withdrawal by Subject|3|||
148671090|NCT03917654|536267088|FG010|Year 1|Withdrawal by Subject|1|||
148671091|NCT03917654|536267089|FG011|Year 1|Withdrawal by Subject|0|||
148671092|NCT03917654|536267078|FG000|Year 1|Travel|0|||
148671093|NCT03917654|536267079|FG001|Year 1|Travel|1|||
148671094|NCT03917654|536267080|FG002|Year 1|Travel|1|||
148671095|NCT03917654|536267081|FG003|Year 1|Travel|0|||
149012488|NCT00649389|537525722|FG000|Overall Study|Withdrawal by Subject|20|||
149012489|NCT00649389|537525723|FG001|Overall Study|Withdrawal by Subject|21|||
149012490|NCT00649389|537525724|FG002|Overall Study|Withdrawal by Subject|19|||
149012491|NCT00649389|537525725|FG003|Overall Study|Withdrawal by Subject|23|||
149012492|NCT00649389|537525722|FG000|Overall Study|Other|3|||
149012493|NCT00649389|537525723|FG001|Overall Study|Other|9|||
149012494|NCT00649389|537525724|FG002|Overall Study|Other|1|||
149012495|NCT00649389|537525725|FG003|Overall Study|Other|6|||
149012496|NCT00453310|537525728|FG000|Overall Study|Progression of Disease|10|||
149012497|NCT04666922|537525729|FG000|Overall Study|Withdrawal by Subject|1|||
149012498|NCT04666922|537525730|FG001|Overall Study|Withdrawal by Subject|0|||
149012499|NCT04666922|537525731|FG002|Overall Study|Withdrawal by Subject|0|||
149012500|NCT04666922|537525732|FG003|Overall Study|Withdrawal by Subject|0|||
149012501|NCT04666922|537525733|FG004|Overall Study|Withdrawal by Subject|0|||
149012502|NCT04666922|537525734|FG005|Overall Study|Withdrawal by Subject|0|||
149012503|NCT04666922|537525735|FG006|Overall Study|Withdrawal by Subject|0|||
149012504|NCT01382940|537525736|FG000|Overall Study|Adverse Event|19|||
149012505|NCT01382940|537525736|FG000|Overall Study|Lost to Follow-up|4|||
149012506|NCT01382940|537525736|FG000|Overall Study|Physician Decision|7|||
149012507|NCT01382940|537525736|FG000|Overall Study|Withdrawal by Subject|23|||
148671096|NCT03917654|536267082|FG004|Year 1|Travel|4|||
149012508|NCT01382940|537525736|FG000|Overall Study|Protocol Violation|20|||
149012509|NCT00244374|537525739|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
148671097|NCT03917654|536267083|FG005|Year 1|Travel|4|||
148671098|NCT03917654|536267084|FG006|Year 1|Travel|10|||
148671099|NCT03917654|536267085|FG007|Year 1|Travel|8|||
149012510|NCT00244374|537525740|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
149012511|NCT00244374|537525741|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
149012512|NCT00244374|537525742|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
149012513|NCT00244374|537525743|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
149012514|NCT00244374|537525739|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
149012515|NCT00244374|537525740|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
149012516|NCT00244374|537525741|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
149012517|NCT00244374|537525742|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
149012518|NCT00244374|537525743|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
149012519|NCT00244374|537525739|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
149012520|NCT00244374|537525740|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
149012521|NCT00244374|537525741|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
149012522|NCT00244374|537525742|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
149012523|NCT00244374|537525743|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
149012524|NCT00244374|537525739|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
149012525|NCT00244374|537525740|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
149012526|NCT00244374|537525741|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
149012527|NCT00244374|537525742|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
149012528|NCT00244374|537525743|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
149012529|NCT00244374|537525739|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
149012530|NCT00244374|537525740|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
148671100|NCT03917654|536267086|FG008|Year 1|Travel|2|||
148671101|NCT03917654|536267087|FG009|Year 1|Travel|5|||
148671102|NCT03917654|536267088|FG010|Year 1|Travel|3|||
148671103|NCT03917654|536267089|FG011|Year 1|Travel|3|||
148671104|NCT03917654|536267078|FG000|Year 1|Subject moved away from site|0|||
148671105|NCT03917654|536267079|FG001|Year 1|Subject moved away from site|1|||
149012531|NCT00244374|537525741|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
149012532|NCT00244374|537525742|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
149012533|NCT00244374|537525743|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
149012534|NCT00244374|537525739|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
149012535|NCT00244374|537525740|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
149012536|NCT00244374|537525741|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
149012537|NCT00244374|537525742|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
149012538|NCT00244374|537525743|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
149012539|NCT00244374|537525739|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
149012540|NCT00244374|537525740|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
149012541|NCT00244374|537525741|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
149012542|NCT00244374|537525742|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
149012543|NCT00244374|537525743|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
149012544|NCT00244374|537525739|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
149012545|NCT00244374|537525740|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
149012546|NCT00244374|537525741|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
149012547|NCT00244374|537525742|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
149012548|NCT00244374|537525743|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
149012549|NCT00244374|537525739|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
149012550|NCT00244374|537525740|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
149012551|NCT00244374|537525741|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
149012552|NCT00244374|537525742|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
149012553|NCT00244374|537525743|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
149012554|NCT02105636|537525744|FG000|Pre-Treatment|Disease Progression|1|||
149012555|NCT02105636|537525745|FG001|Pre-Treatment|Disease Progression|0|||
149012556|NCT02105636|537525744|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
149012557|NCT02105636|537525745|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
149012558|NCT02105636|537525744|FG000|Pre-Treatment|Participant withdrew consent|0|||
149012559|NCT02105636|537525745|FG001|Pre-Treatment|Participant withdrew consent|6|||
149012560|NCT02105636|537525744|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
149012561|NCT02105636|537525745|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
149012562|NCT02105636|537525744|FG000|Treatment|Study Drug Toxicity|14|||
149012563|NCT02105636|537525745|FG001|Treatment|Study Drug Toxicity|10|||
149012564|NCT02105636|537525744|FG000|Treatment|Adverse event unrelated to study drug|19|||
149012565|NCT02105636|537525745|FG001|Treatment|Adverse event unrelated to study drug|3|||
149012566|NCT02105636|537525744|FG000|Treatment|Participant request to discontinue study treatment|8|||
149012567|NCT02105636|537525745|FG001|Treatment|Participant request to discontinue study treatment|6|||
149012568|NCT02105636|537525744|FG000|Treatment|Participant withdrew consent|5|||
149012569|NCT02105636|537525745|FG001|Treatment|Participant withdrew consent|1|||
149012570|NCT02105636|537525744|FG000|Treatment|Lost to Follow-up|1|||
149012571|NCT02105636|537525745|FG001|Treatment|Lost to Follow-up|0|||
149012572|NCT02105636|537525744|FG000|Treatment|Maximum Clinical Benefit|1|||
149012573|NCT02105636|537525745|FG001|Treatment|Maximum Clinical Benefit|3|||
149012574|NCT02105636|537525744|FG000|Treatment|Poor/Non-compliance|0|||
149012575|NCT02105636|537525745|FG001|Treatment|Poor/Non-compliance|1|||
149012576|NCT02105636|537525744|FG000|Treatment|Participant no longer meets study criteria|1|||
149012577|NCT02105636|537525745|FG001|Treatment|Participant no longer meets study criteria|0|||
149012578|NCT02105636|537525744|FG000|Treatment|Other reasons|1|||
149012579|NCT02105636|537525745|FG001|Treatment|Other reasons|0|||
149012580|NCT02105636|537525744|FG000|Treatment|Disease Progression|185|||
149012581|NCT02105636|537525745|FG001|Treatment|Disease Progression|87|||
149012582|NCT01863043|537525749|FG000|Overall Study|Death|6|||
149012583|NCT01863043|537525750|FG001|Overall Study|Death|1|||
148804816|NCT01171534|536766571|FG000|Overall Study|Lost to Follow-up|0|||
149012584|NCT01863043|537525749|FG000|Overall Study|Withdrawal by Subject|0|||
149012585|NCT01863043|537525750|FG001|Overall Study|Withdrawal by Subject|2|||
149012586|NCT01863043|537525749|FG000|Overall Study|Adverse Event|7|||
149012587|NCT01863043|537525750|FG001|Overall Study|Adverse Event|8|||
149012588|NCT01863043|537525749|FG000|Overall Study|exclusion criteria found after enrollment|0|||
149012589|NCT01863043|537525750|FG001|Overall Study|exclusion criteria found after enrollment|1|||
149012590|NCT03377790|537525751|FG000|Overall Study|Withdrawal by Subject|1|||
149012591|NCT03377790|537525752|FG001|Overall Study|Withdrawal by Subject|0|||
149012592|NCT03377790|537525751|FG000|Overall Study|Adverse Event|1|||
149012593|NCT03377790|537525752|FG001|Overall Study|Adverse Event|0|||
148913009|NCT01708902|537164780|FG004|Overall Study|Non compliance with protocol|0|||
148913010|NCT01708902|537164781|FG005|Overall Study|Non compliance with protocol|0|||
148913011|NCT01708902|537164782|FG006|Overall Study|Non compliance with protocol|0|||
148913012|NCT01708902|537164776|FG000|Overall Study|Lost to Follow-up|2|||
148913013|NCT01708902|537164777|FG001|Overall Study|Lost to Follow-up|1|||
148913014|NCT01708902|537164778|FG002|Overall Study|Lost to Follow-up|2|||
148913015|NCT01708902|537164779|FG003|Overall Study|Lost to Follow-up|2|||
148913016|NCT01708902|537164780|FG004|Overall Study|Lost to Follow-up|0|||
148913017|NCT01708902|537164781|FG005|Overall Study|Lost to Follow-up|0|||
148913018|NCT01708902|537164782|FG006|Overall Study|Lost to Follow-up|1|||
148913019|NCT01708902|537164776|FG000|Overall Study|Refused to continue trial medication|8|||
148913020|NCT01708902|537164777|FG001|Overall Study|Refused to continue trial medication|0|||
148913021|NCT01708902|537164778|FG002|Overall Study|Refused to continue trial medication|4|||
148913022|NCT01708902|537164779|FG003|Overall Study|Refused to continue trial medication|2|||
148913023|NCT01708902|537164780|FG004|Overall Study|Refused to continue trial medication|8|||
148913024|NCT01708902|537164781|FG005|Overall Study|Refused to continue trial medication|1|||
148913025|NCT01708902|537164782|FG006|Overall Study|Refused to continue trial medication|1|||
148913026|NCT01708902|537164776|FG000|Overall Study|Other Reason|1|||
149012594|NCT03377790|537525751|FG000|Overall Study|Lost to Follow-up|0|||
149012595|NCT03377790|537525752|FG001|Overall Study|Lost to Follow-up|2|||
149012596|NCT03377790|537525751|FG000|Overall Study|Randomized but not treated|1|||
149012597|NCT03377790|537525752|FG001|Overall Study|Randomized but not treated|0|||
149012598|NCT03377790|537525751|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
149012599|NCT03377790|537525752|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
149012600|NCT01928225|537525753|FG000|Overall Study|Pregnancy|1|||
149012601|NCT01928225|537525754|FG001|Overall Study|Pregnancy|0|||
149012602|NCT01928225|537525753|FG000|Overall Study|basaloid cervical cancer|1|||
149012603|NCT01928225|537525754|FG001|Overall Study|basaloid cervical cancer|0|||
149012604|NCT01928225|537525753|FG000|Overall Study|Lost to Follow-up|1|||
149012605|NCT01928225|537525754|FG001|Overall Study|Lost to Follow-up|3|||
149012606|NCT02440594|537525758|FG000|Overall Study|Lost to Follow-up|34|||
149012607|NCT02440594|537525759|FG001|Overall Study|Lost to Follow-up|33|||
149012608|NCT02440594|537525760|FG002|Overall Study|Lost to Follow-up|54|||
149012609|NCT02440594|537525761|FG003|Overall Study|Lost to Follow-up|47|||
149012610|NCT02440594|537525762|FG004|Overall Study|Lost to Follow-up|5|||
149012611|NCT02440594|537525763|FG005|Overall Study|Lost to Follow-up|4|||
149012612|NCT02440594|537525764|FG006|Overall Study|Lost to Follow-up|28|||
149012613|NCT02440594|537525765|FG007|Overall Study|Lost to Follow-up|48|||
149012614|NCT02440594|537525758|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
149012615|NCT02440594|537525759|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
149012616|NCT02440594|537525760|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
149012617|NCT02440594|537525761|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
149012618|NCT02440594|537525762|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
149012619|NCT02440594|537525763|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
149012620|NCT02440594|537525764|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
149012621|NCT02440594|537525765|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
149012622|NCT02440594|537525758|FG000|Overall Study|Withdrawal by Subject|81|||
149012623|NCT02440594|537525759|FG001|Overall Study|Withdrawal by Subject|67|||
149012624|NCT02440594|537525760|FG002|Overall Study|Withdrawal by Subject|59|||
149012625|NCT02440594|537525761|FG003|Overall Study|Withdrawal by Subject|38|||
149012626|NCT02440594|537525762|FG004|Overall Study|Withdrawal by Subject|2|||
149012627|NCT02440594|537525763|FG005|Overall Study|Withdrawal by Subject|2|||
149012628|NCT02440594|537525764|FG006|Overall Study|Withdrawal by Subject|7|||
149012629|NCT02440594|537525765|FG007|Overall Study|Withdrawal by Subject|7|||
149012630|NCT02440594|537525758|FG000|Overall Study|Administratively w/drawn|3|||
149012631|NCT02440594|537525759|FG001|Overall Study|Administratively w/drawn|2|||
149012632|NCT02440594|537525760|FG002|Overall Study|Administratively w/drawn|0|||
149012633|NCT02440594|537525761|FG003|Overall Study|Administratively w/drawn|0|||
149012634|NCT02440594|537525762|FG004|Overall Study|Administratively w/drawn|0|||
149012635|NCT02440594|537525763|FG005|Overall Study|Administratively w/drawn|0|||
149012636|NCT02440594|537525764|FG006|Overall Study|Administratively w/drawn|2|||
149012637|NCT02440594|537525765|FG007|Overall Study|Administratively w/drawn|1|||
149012638|NCT00152763|537525766|FG000|Overall Study|Death|4|||
149012639|NCT00152763|537525767|FG001|Overall Study|Death|1|||
149012640|NCT00152763|537525768|FG002|Overall Study|Death|2|||
149012641|NCT00152763|537525769|FG003|Overall Study|Death|1|||
149012642|NCT00152763|537525766|FG000|Overall Study|Lost to Follow-up|6|||
149012643|NCT00152763|537525767|FG001|Overall Study|Lost to Follow-up|4|||
149012644|NCT00152763|537525768|FG002|Overall Study|Lost to Follow-up|2|||
148913027|NCT01708902|537164777|FG001|Overall Study|Other Reason|0|||
148913028|NCT01708902|537164778|FG002|Overall Study|Other Reason|1|||
148913029|NCT01708902|537164779|FG003|Overall Study|Other Reason|1|||
149012645|NCT00152763|537525769|FG003|Overall Study|Lost to Follow-up|13|||
149012646|NCT00474175|537525774|FG000|Overall Study|Lack of Efficacy|0|||
149012647|NCT00474175|537525775|FG001|Overall Study|Lack of Efficacy|0|||
149012648|NCT00474175|537525776|FG002|Overall Study|Lack of Efficacy|1|||
148671106|NCT03917654|536267080|FG002|Year 1|Subject moved away from site|0|||
148671107|NCT03917654|536267081|FG003|Year 1|Subject moved away from site|0|||
148671108|NCT03917654|536267082|FG004|Year 1|Subject moved away from site|0|||
148671109|NCT03917654|536267083|FG005|Year 1|Subject moved away from site|0|||
148671110|NCT03917654|536267084|FG006|Year 1|Subject moved away from site|1|||
148671111|NCT03917654|536267085|FG007|Year 1|Subject moved away from site|2|||
148671112|NCT03917654|536267086|FG008|Year 1|Subject moved away from site|1|||
148671113|NCT03917654|536267087|FG009|Year 1|Subject moved away from site|0|||
148671114|NCT03917654|536267088|FG010|Year 1|Subject moved away from site|0|||
148671115|NCT03917654|536267089|FG011|Year 1|Subject moved away from site|3|||
148671116|NCT03917654|536267078|FG000|Year 1|Spouse/Family member request|0|||
148671117|NCT03917654|536267079|FG001|Year 1|Spouse/Family member request|0|||
148671118|NCT03917654|536267080|FG002|Year 1|Spouse/Family member request|1|||
148671119|NCT03917654|536267081|FG003|Year 1|Spouse/Family member request|0|||
148671120|NCT03917654|536267082|FG004|Year 1|Spouse/Family member request|1|||
148671121|NCT03917654|536267083|FG005|Year 1|Spouse/Family member request|0|||
148671122|NCT03917654|536267084|FG006|Year 1|Spouse/Family member request|0|||
148671123|NCT03917654|536267085|FG007|Year 1|Spouse/Family member request|2|||
148671124|NCT03917654|536267086|FG008|Year 1|Spouse/Family member request|0|||
148671125|NCT03917654|536267087|FG009|Year 1|Spouse/Family member request|0|||
148671126|NCT03917654|536267088|FG010|Year 1|Spouse/Family member request|0|||
148671127|NCT03917654|536267089|FG011|Year 1|Spouse/Family member request|1|||
148671128|NCT03917654|536267078|FG000|Year 1|Death|0|||
148671129|NCT03917654|536267079|FG001|Year 1|Death|0|||
148671130|NCT03917654|536267080|FG002|Year 1|Death|0|||
148671131|NCT03917654|536267081|FG003|Year 1|Death|0|||
148671132|NCT03917654|536267082|FG004|Year 1|Death|0|||
148671133|NCT03917654|536267083|FG005|Year 1|Death|0|||
148671134|NCT03917654|536267084|FG006|Year 1|Death|0|||
148671135|NCT03917654|536267085|FG007|Year 1|Death|0|||
148671136|NCT03917654|536267086|FG008|Year 1|Death|1|||
148671137|NCT03917654|536267087|FG009|Year 1|Death|1|||
148671138|NCT03917654|536267088|FG010|Year 1|Death|0|||
148671139|NCT03917654|536267089|FG011|Year 1|Death|0|||
148671140|NCT03917654|536267078|FG000|Year 1|Lost to Follow-up|0|||
148671141|NCT03917654|536267079|FG001|Year 1|Lost to Follow-up|0|||
148671142|NCT03917654|536267080|FG002|Year 1|Lost to Follow-up|0|||
148671143|NCT03917654|536267081|FG003|Year 1|Lost to Follow-up|0|||
148671144|NCT03917654|536267082|FG004|Year 1|Lost to Follow-up|0|||
148671145|NCT03917654|536267083|FG005|Year 1|Lost to Follow-up|0|||
148671146|NCT03917654|536267084|FG006|Year 1|Lost to Follow-up|2|||
148671147|NCT03917654|536267085|FG007|Year 1|Lost to Follow-up|0|||
148671148|NCT03917654|536267086|FG008|Year 1|Lost to Follow-up|0|||
148671149|NCT03917654|536267087|FG009|Year 1|Lost to Follow-up|0|||
148671150|NCT03917654|536267088|FG010|Year 1|Lost to Follow-up|0|||
148671151|NCT03917654|536267089|FG011|Year 1|Lost to Follow-up|0|||
148671152|NCT03917654|536267078|FG000|Year 1|Missed visits|0|||
148671153|NCT03917654|536267079|FG001|Year 1|Missed visits|0|||
148671154|NCT03917654|536267080|FG002|Year 1|Missed visits|0|||
148671155|NCT03917654|536267081|FG003|Year 1|Missed visits|0|||
148671156|NCT03917654|536267082|FG004|Year 1|Missed visits|0|||
148671157|NCT03917654|536267083|FG005|Year 1|Missed visits|0|||
148671158|NCT03917654|536267084|FG006|Year 1|Missed visits|0|||
148671159|NCT03917654|536267085|FG007|Year 1|Missed visits|0|||
148671160|NCT03917654|536267086|FG008|Year 1|Missed visits|0|||
148671161|NCT03917654|536267087|FG009|Year 1|Missed visits|0|||
148671162|NCT03917654|536267088|FG010|Year 1|Missed visits|1|||
148671163|NCT03917654|536267089|FG011|Year 1|Missed visits|1|||
148671164|NCT03917654|536267078|FG000|Year 1|Pregnancy|0|||
148671165|NCT03917654|536267079|FG001|Year 1|Pregnancy|0|||
148671166|NCT03917654|536267080|FG002|Year 1|Pregnancy|0|||
148804817|NCT01171534|536766572|FG001|Overall Study|Lost to Follow-up|2|||
148671167|NCT03917654|536267081|FG003|Year 1|Pregnancy|0|||
148671168|NCT03917654|536267082|FG004|Year 1|Pregnancy|0|||
148671169|NCT03917654|536267083|FG005|Year 1|Pregnancy|0|||
148671170|NCT03917654|536267084|FG006|Year 1|Pregnancy|0|||
148671171|NCT03917654|536267085|FG007|Year 1|Pregnancy|1|||
148671172|NCT03917654|536267086|FG008|Year 1|Pregnancy|0|||
148671173|NCT03917654|536267087|FG009|Year 1|Pregnancy|1|||
148804818|NCT01171534|536766571|FG000|Overall Study|screen failure|0|||
148804819|NCT01171534|536766572|FG001|Overall Study|screen failure|1|||
148671174|NCT03917654|536267088|FG010|Year 1|Pregnancy|0|||
148671175|NCT03917654|536267089|FG011|Year 1|Pregnancy|0|||
148671176|NCT03917654|536267078|FG000|Year 2|Travel|1|||
148671177|NCT03917654|536267079|FG001|Year 2|Travel|0|||
148671178|NCT03917654|536267080|FG002|Year 2|Travel|0|||
148671179|NCT03917654|536267081|FG003|Year 2|Travel|0|||
148671180|NCT03917654|536267082|FG004|Year 2|Travel|1|||
148671181|NCT03917654|536267083|FG005|Year 2|Travel|1|||
148671182|NCT03917654|536267084|FG006|Year 2|Travel|2|||
148671183|NCT03917654|536267085|FG007|Year 2|Travel|1|||
148671184|NCT03917654|536267086|FG008|Year 2|Travel|0|||
148671185|NCT03917654|536267087|FG009|Year 2|Travel|1|||
148671186|NCT03917654|536267088|FG010|Year 2|Travel|0|||
148671187|NCT03917654|536267089|FG011|Year 2|Travel|1|||
148671188|NCT03917654|536267078|FG000|Year 2|Married|1|||
148804820|NCT03861039|536766573|FG000|Overall Study|Adverse Event|2|||
148671189|NCT03917654|536267079|FG001|Year 2|Married|0|||
148671190|NCT03917654|536267080|FG002|Year 2|Married|0|||
148913030|NCT01708902|537164780|FG004|Overall Study|Other Reason|1|||
148913031|NCT01708902|537164781|FG005|Overall Study|Other Reason|2|||
148913032|NCT01708902|537164782|FG006|Overall Study|Other Reason|0|||
148913033|NCT02633020|537164783|FG000|Overall Study|Adverse Event|1|||
148913034|NCT02633020|537164784|FG001|Overall Study|Adverse Event|0|||
148913035|NCT00934440|537164785|FG000|Overall Study|Lost to Follow-up|1|||
148913036|NCT05661851|537164786|FG000|Overall Study|Protocol Violation|1|||
148913037|NCT05661851|537164787|FG001|Overall Study|Protocol Violation|1|||
148913038|NCT05661851|537164786|FG000|Overall Study|Covid-19 Related|3|||
148913039|NCT05661851|537164787|FG001|Overall Study|Covid-19 Related|4|||
148913040|NCT05661851|537164786|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
148913041|NCT05661851|537164787|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
148913042|NCT05661851|537164786|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
148913043|NCT05661851|537164787|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
148913044|NCT00530816|537164788|FG000|Overall Study|Progressive Disease|16|||
148913045|NCT00530816|537164789|FG001|Overall Study|Progressive Disease|24|||
148913046|NCT00530816|537164790|FG002|Overall Study|Progressive Disease|24|||
148913047|NCT00530816|537164788|FG000|Overall Study|Adverse Event|6|||
148913048|NCT00530816|537164789|FG001|Overall Study|Adverse Event|13|||
148913049|NCT00530816|537164790|FG002|Overall Study|Adverse Event|7|||
148913050|NCT00530816|537164788|FG000|Overall Study|Other|3|||
148913051|NCT00530816|537164789|FG001|Overall Study|Other|3|||
148913052|NCT00530816|537164790|FG002|Overall Study|Other|4|||
148913053|NCT00530816|537164788|FG000|Overall Study|Withdrawal by Subject|1|||
148913054|NCT00530816|537164789|FG001|Overall Study|Withdrawal by Subject|2|||
148913055|NCT00530816|537164790|FG002|Overall Study|Withdrawal by Subject|6|||
148913056|NCT02152956|537164791|FG000|Overall Study|Adverse Event|0|||
148913057|NCT02152956|537164792|FG001|Overall Study|Adverse Event|0|||
148913058|NCT02152956|537164793|FG002|Overall Study|Adverse Event|0|||
148913059|NCT02152956|537164794|FG003|Overall Study|Adverse Event|0|||
148913060|NCT02152956|537164795|FG004|Overall Study|Adverse Event|0|||
148913061|NCT02152956|537164796|FG005|Overall Study|Adverse Event|0|||
148913062|NCT02152956|537164797|FG006|Overall Study|Adverse Event|0|||
148913063|NCT02152956|537164798|FG007|Overall Study|Adverse Event|0|||
148913064|NCT02152956|537164799|FG008|Overall Study|Adverse Event|0|||
148913065|NCT02152956|537164800|FG009|Overall Study|Adverse Event|0|||
148913066|NCT02152956|537164801|FG010|Overall Study|Adverse Event|0|||
148913067|NCT02152956|537164802|FG011|Overall Study|Adverse Event|4|||
148913068|NCT02152956|537164803|FG012|Overall Study|Adverse Event|0|||
148913069|NCT02152956|537164791|FG000|Overall Study|Death|0|||
148913070|NCT02152956|537164792|FG001|Overall Study|Death|3|||
148913071|NCT02152956|537164793|FG002|Overall Study|Death|3|||
148913072|NCT02152956|537164794|FG003|Overall Study|Death|4|||
148913073|NCT02152956|537164795|FG004|Overall Study|Death|1|||
148913074|NCT02152956|537164796|FG005|Overall Study|Death|2|||
148913075|NCT02152956|537164797|FG006|Overall Study|Death|6|||
148913076|NCT02152956|537164798|FG007|Overall Study|Death|6|||
148913077|NCT02152956|537164799|FG008|Overall Study|Death|4|||
148913078|NCT02152956|537164800|FG009|Overall Study|Death|5|||
148913079|NCT02152956|537164801|FG010|Overall Study|Death|3|||
148913080|NCT02152956|537164802|FG011|Overall Study|Death|143|||
148913081|NCT02152956|537164803|FG012|Overall Study|Death|12|||
148913082|NCT02152956|537164791|FG000|Overall Study|Lost to Follow-up|0|||
148913083|NCT02152956|537164792|FG001|Overall Study|Lost to Follow-up|1|||
148913084|NCT02152956|537164793|FG002|Overall Study|Lost to Follow-up|0|||
148913085|NCT02152956|537164794|FG003|Overall Study|Lost to Follow-up|0|||
148913086|NCT02152956|537164795|FG004|Overall Study|Lost to Follow-up|0|||
148913087|NCT02152956|537164796|FG005|Overall Study|Lost to Follow-up|0|||
148913088|NCT02152956|537164797|FG006|Overall Study|Lost to Follow-up|0|||
148913089|NCT02152956|537164798|FG007|Overall Study|Lost to Follow-up|0|||
148913090|NCT02152956|537164799|FG008|Overall Study|Lost to Follow-up|0|||
148913091|NCT02152956|537164800|FG009|Overall Study|Lost to Follow-up|0|||
148913092|NCT02152956|537164801|FG010|Overall Study|Lost to Follow-up|0|||
148913093|NCT02152956|537164802|FG011|Overall Study|Lost to Follow-up|3|||
148913094|NCT02152956|537164803|FG012|Overall Study|Lost to Follow-up|0|||
148913095|NCT02152956|537164791|FG000|Overall Study|Withdrawal by Subject|1|||
148913096|NCT02152956|537164792|FG001|Overall Study|Withdrawal by Subject|0|||
148913097|NCT02152956|537164793|FG002|Overall Study|Withdrawal by Subject|1|||
148913098|NCT02152956|537164794|FG003|Overall Study|Withdrawal by Subject|0|||
148913099|NCT02152956|537164795|FG004|Overall Study|Withdrawal by Subject|2|||
148913100|NCT02152956|537164796|FG005|Overall Study|Withdrawal by Subject|2|||
148913101|NCT02152956|537164797|FG006|Overall Study|Withdrawal by Subject|0|||
149012649|NCT00474175|537525774|FG000|Overall Study|Withdrawal by Subject|0|||
148913102|NCT02152956|537164798|FG007|Overall Study|Withdrawal by Subject|0|||
148913103|NCT02152956|537164799|FG008|Overall Study|Withdrawal by Subject|1|||
148913104|NCT02152956|537164800|FG009|Overall Study|Withdrawal by Subject|0|||
149012650|NCT00474175|537525775|FG001|Overall Study|Withdrawal by Subject|1|||
148671191|NCT03917654|536267081|FG003|Year 2|Married|0|||
148671192|NCT03917654|536267082|FG004|Year 2|Married|0|||
148671193|NCT03917654|536267083|FG005|Year 2|Married|0|||
148671194|NCT03917654|536267084|FG006|Year 2|Married|1|||
148671195|NCT03917654|536267085|FG007|Year 2|Married|1|||
148671196|NCT03917654|536267086|FG008|Year 2|Married|0|||
148671197|NCT03917654|536267087|FG009|Year 2|Married|0|||
148671198|NCT03917654|536267088|FG010|Year 2|Married|0|||
148671199|NCT03917654|536267089|FG011|Year 2|Married|0|||
148671200|NCT03917654|536267078|FG000|Year 2|Subject moved away from site|1|||
148671201|NCT03917654|536267079|FG001|Year 2|Subject moved away from site|0|||
148913105|NCT02152956|537164801|FG010|Overall Study|Withdrawal by Subject|0|||
148913106|NCT02152956|537164802|FG011|Overall Study|Withdrawal by Subject|4|||
148913107|NCT02152956|537164803|FG012|Overall Study|Withdrawal by Subject|0|||
148913108|NCT02152956|537164791|FG000|Overall Study|Physician Decision|0|||
148913109|NCT02152956|537164792|FG001|Overall Study|Physician Decision|0|||
148913110|NCT02152956|537164793|FG002|Overall Study|Physician Decision|0|||
148671202|NCT03917654|536267080|FG002|Year 2|Subject moved away from site|0|||
148671203|NCT03917654|536267081|FG003|Year 2|Subject moved away from site|0|||
148671204|NCT03917654|536267082|FG004|Year 2|Subject moved away from site|1|||
148671205|NCT03917654|536267083|FG005|Year 2|Subject moved away from site|0|||
148671206|NCT03917654|536267084|FG006|Year 2|Subject moved away from site|2|||
148671207|NCT03917654|536267085|FG007|Year 2|Subject moved away from site|3|||
148671208|NCT03917654|536267086|FG008|Year 2|Subject moved away from site|0|||
148671209|NCT03917654|536267087|FG009|Year 2|Subject moved away from site|2|||
148671210|NCT03917654|536267088|FG010|Year 2|Subject moved away from site|0|||
148671211|NCT03917654|536267089|FG011|Year 2|Subject moved away from site|1|||
148671212|NCT03917654|536267078|FG000|Year 2|Year 2 Screening failure|0|||
148671213|NCT03917654|536267079|FG001|Year 2|Year 2 Screening failure|1|||
148671214|NCT03917654|536267080|FG002|Year 2|Year 2 Screening failure|0|||
148671215|NCT03917654|536267081|FG003|Year 2|Year 2 Screening failure|0|||
148671216|NCT03917654|536267082|FG004|Year 2|Year 2 Screening failure|2|||
148671217|NCT03917654|536267083|FG005|Year 2|Year 2 Screening failure|0|||
148671218|NCT03917654|536267084|FG006|Year 2|Year 2 Screening failure|4|||
148671219|NCT03917654|536267085|FG007|Year 2|Year 2 Screening failure|3|||
148671220|NCT03917654|536267086|FG008|Year 2|Year 2 Screening failure|10|||
148671221|NCT03917654|536267087|FG009|Year 2|Year 2 Screening failure|2|||
148671222|NCT03917654|536267088|FG010|Year 2|Year 2 Screening failure|1|||
148671223|NCT03917654|536267089|FG011|Year 2|Year 2 Screening failure|1|||
148671224|NCT03917654|536267078|FG000|Year 2|Death|0|||
148671225|NCT03917654|536267079|FG001|Year 2|Death|0|||
148671226|NCT03917654|536267080|FG002|Year 2|Death|0|||
148671227|NCT03917654|536267081|FG003|Year 2|Death|0|||
148671228|NCT03917654|536267082|FG004|Year 2|Death|0|||
148671229|NCT03917654|536267083|FG005|Year 2|Death|1|||
148671230|NCT03917654|536267084|FG006|Year 2|Death|0|||
148671231|NCT03917654|536267085|FG007|Year 2|Death|0|||
148671232|NCT03917654|536267086|FG008|Year 2|Death|1|||
148671233|NCT03917654|536267087|FG009|Year 2|Death|1|||
148671234|NCT03917654|536267088|FG010|Year 2|Death|0|||
148671235|NCT03917654|536267089|FG011|Year 2|Death|0|||
148671236|NCT03917654|536267078|FG000|Year 2|Withdrawal by Subject|0|||
148671237|NCT03917654|536267079|FG001|Year 2|Withdrawal by Subject|0|||
148671238|NCT03917654|536267080|FG002|Year 2|Withdrawal by Subject|0|||
148671239|NCT03917654|536267081|FG003|Year 2|Withdrawal by Subject|0|||
148671240|NCT03917654|536267082|FG004|Year 2|Withdrawal by Subject|0|||
148671241|NCT03917654|536267083|FG005|Year 2|Withdrawal by Subject|0|||
148671242|NCT03917654|536267084|FG006|Year 2|Withdrawal by Subject|3|||
148671243|NCT03917654|536267085|FG007|Year 2|Withdrawal by Subject|0|||
148671244|NCT03917654|536267086|FG008|Year 2|Withdrawal by Subject|2|||
148671245|NCT03917654|536267087|FG009|Year 2|Withdrawal by Subject|5|||
148671246|NCT03917654|536267088|FG010|Year 2|Withdrawal by Subject|0|||
148913111|NCT02152956|537164794|FG003|Overall Study|Physician Decision|0|||
148913112|NCT02152956|537164795|FG004|Overall Study|Physician Decision|0|||
148913113|NCT02152956|537164796|FG005|Overall Study|Physician Decision|0|||
148913114|NCT02152956|537164797|FG006|Overall Study|Physician Decision|0|||
148671247|NCT03917654|536267089|FG011|Year 2|Withdrawal by Subject|0|||
148671248|NCT03917654|536267078|FG000|Year 2|Spouse/family member request|0|||
148671249|NCT03917654|536267079|FG001|Year 2|Spouse/family member request|0|||
148671250|NCT03917654|536267080|FG002|Year 2|Spouse/family member request|0|||
148671251|NCT03917654|536267081|FG003|Year 2|Spouse/family member request|0|||
148671252|NCT03917654|536267082|FG004|Year 2|Spouse/family member request|0|||
148671253|NCT03917654|536267083|FG005|Year 2|Spouse/family member request|0|||
148671254|NCT03917654|536267084|FG006|Year 2|Spouse/family member request|1|||
148913115|NCT02152956|537164798|FG007|Overall Study|Physician Decision|0|||
148671255|NCT03917654|536267085|FG007|Year 2|Spouse/family member request|0|||
148671256|NCT03917654|536267086|FG008|Year 2|Spouse/family member request|0|||
148671257|NCT03917654|536267087|FG009|Year 2|Spouse/family member request|0|||
148671258|NCT03917654|536267088|FG010|Year 2|Spouse/family member request|0|||
148671259|NCT03917654|536267089|FG011|Year 2|Spouse/family member request|0|||
148671260|NCT03917654|536267078|FG000|Year 2|Lost to Follow-up|0|||
148671261|NCT03917654|536267079|FG001|Year 2|Lost to Follow-up|0|||
148913116|NCT02152956|537164799|FG008|Overall Study|Physician Decision|0|||
148671262|NCT03917654|536267080|FG002|Year 2|Lost to Follow-up|0|||
148671263|NCT03917654|536267081|FG003|Year 2|Lost to Follow-up|0|||
148671264|NCT03917654|536267082|FG004|Year 2|Lost to Follow-up|0|||
148671265|NCT03917654|536267083|FG005|Year 2|Lost to Follow-up|0|||
148671266|NCT03917654|536267084|FG006|Year 2|Lost to Follow-up|1|||
148671267|NCT03917654|536267085|FG007|Year 2|Lost to Follow-up|0|||
148671268|NCT03917654|536267086|FG008|Year 2|Lost to Follow-up|1|||
148671269|NCT03917654|536267087|FG009|Year 2|Lost to Follow-up|0|||
148671270|NCT03917654|536267088|FG010|Year 2|Lost to Follow-up|0|||
148671271|NCT03917654|536267089|FG011|Year 2|Lost to Follow-up|1|||
148671272|NCT03917654|536267078|FG000|Year 2|Adverse Event|0|||
148671273|NCT03917654|536267079|FG001|Year 2|Adverse Event|0|||
148671274|NCT03917654|536267080|FG002|Year 2|Adverse Event|0|||
148671275|NCT03917654|536267081|FG003|Year 2|Adverse Event|0|||
148671276|NCT03917654|536267082|FG004|Year 2|Adverse Event|0|||
148671277|NCT03917654|536267083|FG005|Year 2|Adverse Event|0|||
148671278|NCT03917654|536267084|FG006|Year 2|Adverse Event|0|||
148671279|NCT03917654|536267085|FG007|Year 2|Adverse Event|0|||
148671280|NCT03917654|536267086|FG008|Year 2|Adverse Event|0|||
148671281|NCT03917654|536267087|FG009|Year 2|Adverse Event|1|||
148671282|NCT03917654|536267088|FG010|Year 2|Adverse Event|0|||
148671283|NCT03917654|536267089|FG011|Year 2|Adverse Event|0|||
148671284|NCT01489865|536267093|FG000|Overall Study|Progression of Disease|4|||
148671285|NCT01489865|536267094|FG001|Overall Study|Progression of Disease|2|||
148671286|NCT01489865|536267095|FG002|Overall Study|Progression of Disease|2|||
148671287|NCT01489865|536267096|FG003|Overall Study|Progression of Disease|3|||
148671288|NCT01489865|536267097|FG004|Overall Study|Progression of Disease|1|||
148671289|NCT01489865|536267098|FG005|Overall Study|Progression of Disease|6|||
148671290|NCT01489865|536267099|FG006|Overall Study|Progression of Disease|3|||
148671291|NCT01489865|536267100|FG007|Overall Study|Progression of Disease|0|||
148671292|NCT01489865|536267101|FG008|Overall Study|Progression of Disease|23|||
148671293|NCT01489865|536267093|FG000|Overall Study|Adverse Event|2|||
148671294|NCT01489865|536267094|FG001|Overall Study|Adverse Event|0|||
148671295|NCT01489865|536267095|FG002|Overall Study|Adverse Event|0|||
148671296|NCT01489865|536267096|FG003|Overall Study|Adverse Event|0|||
148671297|NCT01489865|536267097|FG004|Overall Study|Adverse Event|1|||
148671298|NCT01489865|536267098|FG005|Overall Study|Adverse Event|0|||
148671299|NCT01489865|536267099|FG006|Overall Study|Adverse Event|2|||
148671300|NCT01489865|536267100|FG007|Overall Study|Adverse Event|0|||
148671301|NCT01489865|536267101|FG008|Overall Study|Adverse Event|5|||
148671302|NCT01489865|536267093|FG000|Overall Study|Death|0|||
148671303|NCT01489865|536267094|FG001|Overall Study|Death|1|||
148671304|NCT01489865|536267095|FG002|Overall Study|Death|0|||
148671305|NCT01489865|536267096|FG003|Overall Study|Death|0|||
148671306|NCT01489865|536267097|FG004|Overall Study|Death|1|||
148671307|NCT01489865|536267098|FG005|Overall Study|Death|0|||
148671308|NCT01489865|536267099|FG006|Overall Study|Death|0|||
148671309|NCT01489865|536267100|FG007|Overall Study|Death|0|||
148671310|NCT01489865|536267101|FG008|Overall Study|Death|2|||
148671311|NCT01489865|536267093|FG000|Overall Study|Withdrawal by Subject|0|||
148671312|NCT01489865|536267094|FG001|Overall Study|Withdrawal by Subject|0|||
148671313|NCT01489865|536267095|FG002|Overall Study|Withdrawal by Subject|0|||
148671314|NCT01489865|536267096|FG003|Overall Study|Withdrawal by Subject|0|||
148671315|NCT01489865|536267097|FG004|Overall Study|Withdrawal by Subject|0|||
148671316|NCT01489865|536267098|FG005|Overall Study|Withdrawal by Subject|1|||
148671317|NCT01489865|536267099|FG006|Overall Study|Withdrawal by Subject|1|||
148671318|NCT01489865|536267100|FG007|Overall Study|Withdrawal by Subject|0|||
148671319|NCT01489865|536267101|FG008|Overall Study|Withdrawal by Subject|2|||
148671320|NCT01489865|536267093|FG000|Overall Study|Shifted|0|||
148671321|NCT01489865|536267094|FG001|Overall Study|Shifted|0|||
148671322|NCT01489865|536267095|FG002|Overall Study|Shifted|1|||
148671323|NCT01489865|536267096|FG003|Overall Study|Shifted|0|||
148671324|NCT01489865|536267097|FG004|Overall Study|Shifted|0|||
148671325|NCT01489865|536267098|FG005|Overall Study|Shifted|0|||
148671326|NCT01489865|536267099|FG006|Overall Study|Shifted|0|||
148671327|NCT01489865|536267100|FG007|Overall Study|Shifted|0|||
148671328|NCT01489865|536267101|FG008|Overall Study|Shifted|0|||
148671329|NCT00972309|536267102|FG000|Overall Study|Switched to alternative treatment|0|||
148671330|NCT00972309|536267103|FG001|Overall Study|Switched to alternative treatment|2|||
148671331|NCT00972309|536267102|FG000|Overall Study|Refused further treatment|0|||
148671332|NCT00972309|536267103|FG001|Overall Study|Refused further treatment|1|||
148671333|NCT00972309|536267102|FG000|Overall Study|Late determination of ineligibility|0|||
148671334|NCT00972309|536267103|FG001|Overall Study|Late determination of ineligibility|1|||
148671335|NCT00972309|536267102|FG000|Overall Study|Second malignancy|1|||
148671336|NCT00972309|536267103|FG001|Overall Study|Second malignancy|1|||
148671337|NCT00972309|536267102|FG000|Overall Study|Visa issues|0|||
148671338|NCT00972309|536267103|FG001|Overall Study|Visa issues|1|||
148671339|NCT00972309|536267102|FG000|Overall Study|Secondary cancer (SCC)|0|||
148804821|NCT03861039|536766574|FG001|Overall Study|Adverse Event|5|||
148804822|NCT03861039|536766575|FG002|Overall Study|Adverse Event|11|||
148804823|NCT03861039|536766573|FG000|Overall Study|Withdrawal by Subject|1|||
148804824|NCT03861039|536766574|FG001|Overall Study|Withdrawal by Subject|3|||
149012651|NCT00474175|537525776|FG002|Overall Study|Withdrawal by Subject|1|||
149012652|NCT00474175|537525774|FG000|Overall Study|Ineligible|1|||
149012653|NCT00474175|537525775|FG001|Overall Study|Ineligible|3|||
149012654|NCT00474175|537525776|FG002|Overall Study|Ineligible|1|||
149012655|NCT00474175|537525774|FG000|Overall Study|Protocol Violation|0|||
149012656|NCT00474175|537525775|FG001|Overall Study|Protocol Violation|2|||
149012657|NCT00474175|537525776|FG002|Overall Study|Protocol Violation|1|||
149012658|NCT00474175|537525774|FG000|Overall Study|Administrative|0|||
149012659|NCT00474175|537525775|FG001|Overall Study|Administrative|1|||
149012660|NCT00474175|537525776|FG002|Overall Study|Administrative|0|||
149012661|NCT01619787|537525777|FG000|Overall Study|Lost to Follow-up|5|||
149012662|NCT04741802|537525778|FG000|Overall Study|Death|1|||
149012663|NCT04741802|537525778|FG000|Overall Study|Lost to Follow-up|11|||
149012664|NCT04498247|537525779|FG000|Overall Study|Lost to Follow-up|0|||
149012665|NCT04498247|537525780|FG001|Overall Study|Lost to Follow-up|0|||
149012666|NCT04498247|537525781|FG002|Overall Study|Lost to Follow-up|0|||
149012667|NCT04498247|537525782|FG003|Overall Study|Lost to Follow-up|1|||
149012668|NCT04498247|537525783|FG004|Overall Study|Lost to Follow-up|0|||
149012669|NCT04498247|537525784|FG005|Overall Study|Lost to Follow-up|0|||
149012670|NCT04498247|537525785|FG006|Overall Study|Lost to Follow-up|0|||
149012671|NCT04498247|537525786|FG007|Overall Study|Lost to Follow-up|0|||
149012672|NCT04498247|537525779|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
149012673|NCT04498247|537525780|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012674|NCT04498247|537525781|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012675|NCT04498247|537525782|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012676|NCT04498247|537525783|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012677|NCT04498247|537525784|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012678|NCT04498247|537525785|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012679|NCT04498247|537525786|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
149012680|NCT04498247|537525779|FG000|Overall Study|Withdrawal by Subject|0|||
149012681|NCT04498247|537525780|FG001|Overall Study|Withdrawal by Subject|8|||
149012682|NCT04498247|537525781|FG002|Overall Study|Withdrawal by Subject|0|||
149012683|NCT04498247|537525782|FG003|Overall Study|Withdrawal by Subject|7|||
149012684|NCT04498247|537525783|FG004|Overall Study|Withdrawal by Subject|0|||
149012685|NCT04498247|537525784|FG005|Overall Study|Withdrawal by Subject|0|||
149012686|NCT04498247|537525785|FG006|Overall Study|Withdrawal by Subject|1|||
149012687|NCT04498247|537525786|FG007|Overall Study|Withdrawal by Subject|0|||
149012688|NCT04498247|537525779|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
149012689|NCT04498247|537525780|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
149012690|NCT04498247|537525781|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
149012691|NCT04498247|537525782|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
149012692|NCT04498247|537525783|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
149012693|NCT04498247|537525784|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
149012694|NCT04498247|537525785|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
149012695|NCT04498247|537525786|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
149012696|NCT00669903|537525787|FG000|Overall Study|Adverse Event|0|||
149012697|NCT00669903|537525788|FG001|Overall Study|Adverse Event|1|||
149012698|NCT00669903|537525789|FG002|Overall Study|Adverse Event|3|||
149012699|NCT00669903|537525790|FG003|Overall Study|Adverse Event|1|||
149012700|NCT00669903|537525787|FG000|Overall Study|Withdrawal by Subject|0|||
149012701|NCT00669903|537525788|FG001|Overall Study|Withdrawal by Subject|2|||
149012702|NCT00669903|537525789|FG002|Overall Study|Withdrawal by Subject|2|||
149012703|NCT00669903|537525790|FG003|Overall Study|Withdrawal by Subject|2|||
149012704|NCT00669903|537525787|FG000|Overall Study|Lost to Follow-up|1|||
149012705|NCT00669903|537525788|FG001|Overall Study|Lost to Follow-up|1|||
149012706|NCT00669903|537525789|FG002|Overall Study|Lost to Follow-up|0|||
149012707|NCT00669903|537525790|FG003|Overall Study|Lost to Follow-up|1|||
149012708|NCT00669903|537525787|FG000|Overall Study|Protocol Violation|0|||
149012709|NCT00669903|537525788|FG001|Overall Study|Protocol Violation|1|||
149012710|NCT00669903|537525789|FG002|Overall Study|Protocol Violation|0|||
149012711|NCT00669903|537525790|FG003|Overall Study|Protocol Violation|0|||
149012712|NCT01678820|537525791|FG000|Overall Study|Study Terminated by Sponsor|45|||
149012713|NCT01678820|537525792|FG001|Overall Study|Study Terminated by Sponsor|43|||
149012714|NCT01678820|537525793|FG002|Overall Study|Study Terminated by Sponsor|43|||
149012715|NCT01678820|537525791|FG000|Overall Study|Withdrawal by Subject|2|||
149012716|NCT01678820|537525792|FG001|Overall Study|Withdrawal by Subject|5|||
149012717|NCT01678820|537525793|FG002|Overall Study|Withdrawal by Subject|2|||
149012718|NCT01678820|537525791|FG000|Overall Study|Protocol Specified Criteria|2|||
148913117|NCT02152956|537164800|FG009|Overall Study|Physician Decision|0|||
149142040|NCT04688775|537999342|FG000|Placebo-controlled Period|Protocol Violation|0|||
148913118|NCT02152956|537164801|FG010|Overall Study|Physician Decision|0|||
148913119|NCT02152956|537164802|FG011|Overall Study|Physician Decision|1|||
148913120|NCT02152956|537164803|FG012|Overall Study|Physician Decision|0|||
148913121|NCT02152956|537164791|FG000|Overall Study|Study terminated by sponsor|0|||
148913122|NCT02152956|537164792|FG001|Overall Study|Study terminated by sponsor|0|||
148913123|NCT02152956|537164793|FG002|Overall Study|Study terminated by sponsor|0|||
148913124|NCT02152956|537164794|FG003|Overall Study|Study terminated by sponsor|0|||
148913125|NCT02152956|537164795|FG004|Overall Study|Study terminated by sponsor|0|||
148913126|NCT02152956|537164796|FG005|Overall Study|Study terminated by sponsor|0|||
148913127|NCT02152956|537164797|FG006|Overall Study|Study terminated by sponsor|0|||
148913128|NCT02152956|537164798|FG007|Overall Study|Study terminated by sponsor|0|||
148913129|NCT02152956|537164799|FG008|Overall Study|Study terminated by sponsor|0|||
148913130|NCT02152956|537164800|FG009|Overall Study|Study terminated by sponsor|0|||
148913131|NCT02152956|537164801|FG010|Overall Study|Study terminated by sponsor|0|||
148913132|NCT02152956|537164802|FG011|Overall Study|Study terminated by sponsor|29|||
148913133|NCT02152956|537164803|FG012|Overall Study|Study terminated by sponsor|0|||
148913134|NCT02152956|537164791|FG000|Overall Study|progressive disease|0|||
148913135|NCT02152956|537164792|FG001|Overall Study|progressive disease|0|||
149142041|NCT04688775|537999343|FG001|Placebo-controlled Period|Protocol Violation|1|||
149142042|NCT04688775|537999344|FG002|Placebo-controlled Period|Protocol Violation|0|||
149142043|NCT04688775|537999345|FG003|Placebo-controlled Period|Protocol Violation|0|||
149142044|NCT04688775|537999342|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
149142045|NCT04688775|537999343|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
149142046|NCT04688775|537999344|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
149142047|NCT04688775|537999345|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
149142048|NCT04688775|537999342|FG000|Placebo-controlled Period|Other reasons|0|||
149142049|NCT04688775|537999343|FG001|Placebo-controlled Period|Other reasons|1|||
149142050|NCT04688775|537999344|FG002|Placebo-controlled Period|Other reasons|0|||
149142051|NCT04688775|537999345|FG003|Placebo-controlled Period|Other reasons|0|||
149142052|NCT04688775|537999342|FG000|Delayed Start Period|Adverse Event|0|||
149142053|NCT04688775|537999343|FG001|Delayed Start Period|Adverse Event|0|||
149142054|NCT04688775|537999344|FG002|Delayed Start Period|Adverse Event|1|||
149142055|NCT04688775|537999345|FG003|Delayed Start Period|Adverse Event|0|||
149142056|NCT04688775|537999342|FG000|Delayed Start Period|Lack of Efficacy|0|||
149142057|NCT04688775|537999343|FG001|Delayed Start Period|Lack of Efficacy|0|||
149142058|NCT04688775|537999344|FG002|Delayed Start Period|Lack of Efficacy|0|||
149142059|NCT04688775|537999345|FG003|Delayed Start Period|Lack of Efficacy|3|||
149142060|NCT04688775|537999342|FG000|Delayed Start Period|Withdrawal by Subject|0|||
149142061|NCT04688775|537999343|FG001|Delayed Start Period|Withdrawal by Subject|0|||
149142062|NCT04688775|537999344|FG002|Delayed Start Period|Withdrawal by Subject|2|||
149142063|NCT04688775|537999345|FG003|Delayed Start Period|Withdrawal by Subject|4|||
149142064|NCT04688775|537999342|FG000|Delayed Start Period|Lost to Follow-up|0|||
149142065|NCT04688775|537999343|FG001|Delayed Start Period|Lost to Follow-up|0|||
149142066|NCT04688775|537999344|FG002|Delayed Start Period|Lost to Follow-up|2|||
149142067|NCT04688775|537999345|FG003|Delayed Start Period|Lost to Follow-up|1|||
149142068|NCT04688775|537999342|FG000|Delayed Start Period|other reasons|0|||
149142069|NCT04688775|537999343|FG001|Delayed Start Period|other reasons|0|||
149142070|NCT04688775|537999344|FG002|Delayed Start Period|other reasons|1|||
149142071|NCT04688775|537999345|FG003|Delayed Start Period|other reasons|0|||
149142072|NCT00932425|537999348|FG000|Overall Study|Lost to Follow-up|0|||
149142073|NCT00932425|537999349|FG001|Overall Study|Lost to Follow-up|1|||
149142074|NCT00932425|537999348|FG000|Overall Study|Withdrawal by Subject|0|||
149142075|NCT00932425|537999349|FG001|Overall Study|Withdrawal by Subject|1|||
149142076|NCT00430482|537999350|FG000|Completed Treatment|Insufficient Treatment|7|||
149142077|NCT00430482|537999351|FG001|Completed Treatment|Insufficient Treatment|11|||
149142078|NCT01721876|537999352|FG000|Overall Study|Not treated|1|||
149142079|NCT01721876|537999353|FG001|Overall Study|Not treated|4|||
149012719|NCT01678820|537525792|FG001|Overall Study|Protocol Specified Criteria|3|||
149012720|NCT01678820|537525793|FG002|Overall Study|Protocol Specified Criteria|1|||
148913136|NCT02152956|537164793|FG002|Overall Study|progressive disease|0|||
148913137|NCT02152956|537164794|FG003|Overall Study|progressive disease|0|||
148913138|NCT02152956|537164795|FG004|Overall Study|progressive disease|0|||
149012721|NCT01678820|537525791|FG000|Overall Study|Adverse Event|2|||
149142080|NCT01721876|537999352|FG000|Overall Study|Disease progression / relapse|123|||
149142081|NCT01721876|537999353|FG001|Overall Study|Disease progression / relapse|156|||
149142082|NCT01721876|537999352|FG000|Overall Study|Death|6|||
149142083|NCT01721876|537999353|FG001|Overall Study|Death|13|||
149142084|NCT01721876|537999352|FG000|Overall Study|Adverse Event|41|||
149142085|NCT01721876|537999353|FG001|Overall Study|Adverse Event|165|||
148913139|NCT02152956|537164796|FG005|Overall Study|progressive disease|0|||
148913140|NCT02152956|537164797|FG006|Overall Study|progressive disease|0|||
148913141|NCT02152956|537164798|FG007|Overall Study|progressive disease|0|||
148913142|NCT02152956|537164799|FG008|Overall Study|progressive disease|1|||
148913143|NCT02152956|537164800|FG009|Overall Study|progressive disease|0|||
148913144|NCT02152956|537164801|FG010|Overall Study|progressive disease|0|||
149142086|NCT01721876|537999352|FG000|Overall Study|Protocol Violation|2|||
149142087|NCT01721876|537999353|FG001|Overall Study|Protocol Violation|1|||
149142088|NCT01721876|537999352|FG000|Overall Study|Withdrawal by Subject|15|||
149142089|NCT01721876|537999353|FG001|Overall Study|Withdrawal by Subject|38|||
149142090|NCT01721876|537999352|FG000|Overall Study|Reason not listed|34|||
149142091|NCT01721876|537999353|FG001|Overall Study|Reason not listed|63|||
149142092|NCT01721876|537999352|FG000|Overall Study|Sponsor terminated trial|0|||
149142093|NCT01721876|537999353|FG001|Overall Study|Sponsor terminated trial|4|||
148913145|NCT02152956|537164802|FG011|Overall Study|progressive disease|1|||
148913146|NCT02152956|537164803|FG012|Overall Study|progressive disease|0|||
148913147|NCT01014910|537164804|FG000|Overall Study|Withdrawal by Subject|0|||
148913148|NCT01014910|537164805|FG001|Overall Study|Withdrawal by Subject|2|||
148913149|NCT01136785|537164806|FG000|Overall Study|Protocol Violation|2|||
148913150|NCT01136785|537164807|FG001|Overall Study|Protocol Violation|1|||
148913151|NCT01388985|537164808|FG000|Overall Study|Death|0|||
148913152|NCT01388985|537164809|FG001|Overall Study|Death|1|||
148913153|NCT01388985|537164808|FG000|Overall Study|Lost to Follow-up|30|||
148913154|NCT01388985|537164809|FG001|Overall Study|Lost to Follow-up|30|||
148913155|NCT01388985|537164808|FG000|Overall Study|Withdrawal by Subject|13|||
148913156|NCT01388985|537164809|FG001|Overall Study|Withdrawal by Subject|4|||
148913157|NCT01388985|537164808|FG000|Overall Study|Subject unavailable|1|||
148913158|NCT01388985|537164809|FG001|Overall Study|Subject unavailable|1|||
148913159|NCT01388985|537164808|FG000|Overall Study|Other (no reason)|0|||
148913160|NCT01388985|537164809|FG001|Overall Study|Other (no reason)|1|||
148913161|NCT01388985|537164808|FG000|Overall Study|Error of nurse|5|||
148913162|NCT01388985|537164809|FG001|Overall Study|Error of nurse|1|||
148913163|NCT02954172|537164812|FG000|Overall Study|Protocol Violation|3|||
148913164|NCT02954172|537164813|FG001|Overall Study|Protocol Violation|0|||
148913165|NCT02954172|537164812|FG000|Overall Study|allergic reaction|2|||
148913166|NCT02954172|537164813|FG001|Overall Study|allergic reaction|1|||
148913167|NCT02954172|537164812|FG000|Overall Study|non-measurable lesions at baseline|1|||
148913168|NCT02954172|537164813|FG001|Overall Study|non-measurable lesions at baseline|2|||
148913169|NCT01519167|537164814|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
148913170|NCT01519167|537164815|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
148913171|NCT01519167|537164814|FG000|Overall Study|Adverse Event|0|||
148913172|NCT01519167|537164815|FG001|Overall Study|Adverse Event|1|||
148913173|NCT01519167|537164814|FG000|Overall Study|Lack of Efficacy|0|||
148913174|NCT01519167|537164815|FG001|Overall Study|Lack of Efficacy|1|||
148913175|NCT01519167|537164814|FG000|Overall Study|Medical condition changes&deep sedation|0|||
148913176|NCT01519167|537164815|FG001|Overall Study|Medical condition changes&deep sedation|2|||
148913177|NCT01519167|537164814|FG000|Overall Study|Physician Decision|0|||
148913178|NCT01519167|537164815|FG001|Overall Study|Physician Decision|1|||
148913179|NCT00233064|537164819|FG000|Overall Study|Lost to Follow-up|7|||
148913180|NCT00233064|537164820|FG001|Overall Study|Lost to Follow-up|7|||
148913181|NCT00233064|537164819|FG000|Overall Study|Withdrawal by Subject|5|||
148913182|NCT00233064|537164820|FG001|Overall Study|Withdrawal by Subject|3|||
148913183|NCT00233064|537164819|FG000|Overall Study|Death|0|||
148913184|NCT00233064|537164820|FG001|Overall Study|Death|1|||
148913185|NCT00233064|537164819|FG000|Overall Study|Relocation|0|||
148913186|NCT00233064|537164820|FG001|Overall Study|Relocation|1|||
148913187|NCT00233064|537164819|FG000|Overall Study|Protocol Violation|1|||
148913188|NCT00233064|537164820|FG001|Overall Study|Protocol Violation|0|||
148913189|NCT00233064|537164819|FG000|Overall Study|Moved to Dom. Republic|1|||
148913190|NCT00233064|537164820|FG001|Overall Study|Moved to Dom. Republic|0|||
149012722|NCT01678820|537525792|FG001|Overall Study|Adverse Event|2|||
148913191|NCT04393454|537164821|FG000|Overall Study|Death|1|||
148913192|NCT04393454|537164821|FG000|Overall Study|Lost to Follow-up|1|||
148913193|NCT04976192|537164822|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913194|NCT04976192|537164823|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
148913195|NCT04976192|537164824|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
149012723|NCT01678820|537525793|FG002|Overall Study|Adverse Event|2|||
149012724|NCT01678820|537525791|FG000|Overall Study|Lost to Follow-up|7|||
149012725|NCT01678820|537525792|FG001|Overall Study|Lost to Follow-up|2|||
149012726|NCT01678820|537525793|FG002|Overall Study|Lost to Follow-up|2|||
149012727|NCT01678820|537525791|FG000|Overall Study|Non-compliance with study drug|0|||
149012728|NCT01678820|537525792|FG001|Overall Study|Non-compliance with study drug|1|||
149012729|NCT01678820|537525793|FG002|Overall Study|Non-compliance with study drug|0|||
149012730|NCT01678820|537525791|FG000|Overall Study|Physician Decision|0|||
149012731|NCT01678820|537525792|FG001|Overall Study|Physician Decision|0|||
149012732|NCT01678820|537525793|FG002|Overall Study|Physician Decision|1|||
149012733|NCT01678820|537525791|FG000|Overall Study|Protocol Violation|4|||
149012734|NCT01678820|537525792|FG001|Overall Study|Protocol Violation|5|||
149012735|NCT01678820|537525793|FG002|Overall Study|Protocol Violation|4|||
149012736|NCT01678820|537525791|FG000|Overall Study|Not treated with double-blind study drug|0|||
149012737|NCT01678820|537525792|FG001|Overall Study|Not treated with double-blind study drug|2|||
149012738|NCT01678820|537525793|FG002|Overall Study|Not treated with double-blind study drug|2|||
149012739|NCT01381874|537525794|FG000|Overall Study|Lost to Follow-up|1|||
149012740|NCT01381874|537525795|FG001|Overall Study|Lost to Follow-up|1|||
149012741|NCT01381874|537525796|FG002|Overall Study|Lost to Follow-up|0|||
149012742|NCT01381874|537525794|FG000|Overall Study|Withdrawal by Subject|9|||
149012743|NCT01381874|537525795|FG001|Overall Study|Withdrawal by Subject|10|||
149012744|NCT01381874|537525796|FG002|Overall Study|Withdrawal by Subject|9|||
149012745|NCT01381874|537525794|FG000|Overall Study|Other|67|||
149012746|NCT01381874|537525795|FG001|Overall Study|Other|52|||
148913196|NCT04976192|537164825|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913197|NCT04976192|537164826|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913198|NCT04976192|537164827|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913199|NCT04976192|537164828|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913200|NCT04976192|537164829|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913201|NCT04976192|537164830|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913202|NCT04976192|537164831|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
148913203|NCT04976192|537164822|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
148913204|NCT04976192|537164823|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
148913205|NCT04976192|537164824|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
148913206|NCT04976192|537164825|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
148913207|NCT04976192|537164826|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913208|NCT04976192|537164827|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913209|NCT04976192|537164828|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913210|NCT04976192|537164829|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913211|NCT04976192|537164830|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913212|NCT04976192|537164831|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913213|NCT04976192|537164822|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
148913214|NCT04976192|537164823|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913215|NCT04976192|537164824|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
148913216|NCT04976192|537164825|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913217|NCT04976192|537164826|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913218|NCT04976192|537164827|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913219|NCT04976192|537164828|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913220|NCT04976192|537164829|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913221|NCT04976192|537164830|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
149012747|NCT01381874|537525796|FG002|Overall Study|Other|67|||
149012748|NCT04488003|537525797|FG000|Assessed for Eligibility|Screen Failure|24|||
149012749|NCT04488003|537525798|FG001|Assessed for Eligibility|Screen Failure|0|||
149012750|NCT04488003|537525799|FG002|Assessed for Eligibility|Screen Failure|0|||
149012751|NCT04488003|537525797|FG000|Assessed for Eligibility|Adverse Event|1|||
149012752|NCT04488003|537525798|FG001|Assessed for Eligibility|Adverse Event|0|||
149012753|NCT04488003|537525799|FG002|Assessed for Eligibility|Adverse Event|0|||
149012754|NCT04488003|537525797|FG000|Assessed for Eligibility|Death|1|||
149012755|NCT04488003|537525798|FG001|Assessed for Eligibility|Death|0|||
149012756|NCT04488003|537525799|FG002|Assessed for Eligibility|Death|0|||
149012757|NCT04488003|537525797|FG000|Assessed for Eligibility|Physician Decision|1|||
149012758|NCT04488003|537525798|FG001|Assessed for Eligibility|Physician Decision|0|||
149012759|NCT04488003|537525799|FG002|Assessed for Eligibility|Physician Decision|0|||
149012760|NCT04488003|537525797|FG000|Allocated to Treatment|Progressive Disease|51|||
149012761|NCT04488003|537525798|FG001|Allocated to Treatment|Progressive Disease|0|||
149012762|NCT04488003|537525799|FG002|Allocated to Treatment|Progressive Disease|0|||
149012763|NCT04488003|537525797|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
149012764|NCT04488003|537525798|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
149012765|NCT04488003|537525799|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
149012766|NCT04488003|537525797|FG000|Allocated to Treatment|Adverse Event|6|||
149012767|NCT04488003|537525798|FG001|Allocated to Treatment|Adverse Event|0|||
149012768|NCT04488003|537525799|FG002|Allocated to Treatment|Adverse Event|0|||
149012769|NCT04488003|537525797|FG000|Allocated to Treatment|Other|5|||
149012770|NCT04488003|537525798|FG001|Allocated to Treatment|Other|0|||
149012771|NCT04488003|537525799|FG002|Allocated to Treatment|Other|0|||
149012772|NCT04488003|537525797|FG000|Allocated to Treatment|Physician Decision|4|||
149012773|NCT04488003|537525798|FG001|Allocated to Treatment|Physician Decision|0|||
149012774|NCT04488003|537525799|FG002|Allocated to Treatment|Physician Decision|0|||
149012775|NCT04488003|537525797|FG000|Allocated to Treatment|Death|4|||
149012776|NCT04488003|537525798|FG001|Allocated to Treatment|Death|0|||
149012777|NCT04488003|537525799|FG002|Allocated to Treatment|Death|0|||
149012778|NCT01248962|537525802|FG000|Overall Study|Withdrawal by Subject|1|||
149012779|NCT01248962|537525803|FG001|Overall Study|Withdrawal by Subject|1|||
149012780|NCT01248962|537525802|FG000|Overall Study|Adverse Event|2|||
149012781|NCT01248962|537525803|FG001|Overall Study|Adverse Event|1|||
149012782|NCT01248962|537525802|FG000|Overall Study|Complete Response after 4 Cycles|1|||
149012783|NCT01248962|537525803|FG001|Overall Study|Complete Response after 4 Cycles|0|||
149012784|NCT01248962|537525802|FG000|Overall Study|Complete Response after 3 Cycles|0|||
149012785|NCT01248962|537525803|FG001|Overall Study|Complete Response after 3 Cycles|1|||
149012786|NCT01248962|537525802|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
149012787|NCT01248962|537525803|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
149012788|NCT00245856|537525805|FG000|Period Two|Withdrawal by Subject|0|||
149012789|NCT00245856|537525806|FG001|Period Two|Withdrawal by Subject|1|||
149012790|NCT01539863|537525807|FG000|Overall Study|Lost to Follow-up|5|||
149012791|NCT01539863|537525808|FG001|Overall Study|Lost to Follow-up|4|||
149012792|NCT00557622|537525809|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
149012793|NCT00557622|537525810|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
149012794|NCT00557622|537525809|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
149012795|NCT00557622|537525810|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
149012796|NCT00557622|537525809|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
149012797|NCT00557622|537525810|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
149012798|NCT02693834|537525811|FG000|Baseline Measurement|Withdrawal by Subject|1|||
149012799|NCT02693834|537525812|FG001|Baseline Measurement|Withdrawal by Subject|0|||
149012800|NCT02693834|537525811|FG000|Baseline Measurement|Adverse Event|1|||
149012801|NCT02693834|537525812|FG001|Baseline Measurement|Adverse Event|0|||
149012802|NCT02693834|537525811|FG000|Week 2 Practice|Adverse Event|0|||
149012803|NCT02693834|537525812|FG001|Week 2 Practice|Adverse Event|1|||
149012804|NCT01468922|537525813|FG000|Overall Study|Screening failure|0|||
149012805|NCT01468922|537525814|FG001|Overall Study|Screening failure|0|||
149012806|NCT01468922|537525815|FG002|Overall Study|Screening failure|0|||
149012807|NCT01468922|537525816|FG003|Overall Study|Screening failure|0|||
149012808|NCT01468922|537525817|FG004|Overall Study|Screening failure|0|||
149012809|NCT01468922|537525818|FG005|Overall Study|Screening failure|0|||
149012810|NCT01468922|537525819|FG006|Overall Study|Screening failure|0|||
149012811|NCT01468922|537525820|FG007|Overall Study|Screening failure|0|||
149012812|NCT01468922|537525821|FG008|Overall Study|Screening failure|1|||
149012813|NCT01468922|537525813|FG000|Overall Study|Per patient choice|1|||
149012814|NCT01468922|537525814|FG001|Overall Study|Per patient choice|0|||
149012815|NCT01468922|537525815|FG002|Overall Study|Per patient choice|0|||
148671340|NCT00972309|536267103|FG001|Overall Study|Secondary cancer (SCC)|1|||
148804825|NCT03861039|536766575|FG002|Overall Study|Withdrawal by Subject|4|||
148804826|NCT02100631|536766576|FG000|Overall Study|Withdrawal by Subject|1|||
149012816|NCT01468922|537525816|FG003|Overall Study|Per patient choice|0|||
149012817|NCT01468922|537525817|FG004|Overall Study|Per patient choice|0|||
149012818|NCT01468922|537525818|FG005|Overall Study|Per patient choice|0|||
149012819|NCT01468922|537525819|FG006|Overall Study|Per patient choice|0|||
149012820|NCT01468922|537525820|FG007|Overall Study|Per patient choice|0|||
149012821|NCT01468922|537525821|FG008|Overall Study|Per patient choice|0|||
149012822|NCT01468922|537525813|FG000|Overall Study|Switched to alternative treatment|1|||
149012823|NCT01468922|537525814|FG001|Overall Study|Switched to alternative treatment|0|||
149012824|NCT01468922|537525815|FG002|Overall Study|Switched to alternative treatment|0|||
149012825|NCT01468922|537525816|FG003|Overall Study|Switched to alternative treatment|0|||
149012826|NCT01468922|537525817|FG004|Overall Study|Switched to alternative treatment|1|||
149012827|NCT01468922|537525818|FG005|Overall Study|Switched to alternative treatment|0|||
149012828|NCT01468922|537525819|FG006|Overall Study|Switched to alternative treatment|0|||
149012829|NCT01468922|537525820|FG007|Overall Study|Switched to alternative treatment|0|||
148913222|NCT04976192|537164831|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
148913223|NCT04976192|537164822|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913224|NCT04976192|537164823|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913225|NCT04976192|537164824|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913226|NCT04976192|537164825|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148913227|NCT04976192|537164826|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
148913228|NCT04976192|537164827|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
148913229|NCT04976192|537164828|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
148913230|NCT04976192|537164829|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
148913231|NCT04976192|537164830|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
148913232|NCT04976192|537164831|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
148913233|NCT04976192|537164822|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913234|NCT04976192|537164823|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913235|NCT04976192|537164824|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913236|NCT04976192|537164825|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913237|NCT04976192|537164826|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
148913238|NCT04976192|537164827|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913239|NCT04976192|537164828|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913240|NCT04976192|537164829|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913241|NCT04976192|537164830|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913242|NCT04976192|537164831|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
148913243|NCT04976192|537164822|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913244|NCT04976192|537164823|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913245|NCT04976192|537164824|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913246|NCT04976192|537164825|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913247|NCT04976192|537164826|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913248|NCT04976192|537164827|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
148913249|NCT04976192|537164828|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913250|NCT04976192|537164829|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913251|NCT04976192|537164830|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148913252|NCT04976192|537164831|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148671341|NCT00972309|536267102|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
148804827|NCT02100631|536766577|FG001|Overall Study|Withdrawal by Subject|0|||
149142094|NCT00493220|537999354|FG000|Third Intervention|Withdrawal by Subject|1|||
149142095|NCT00493220|537999355|FG001|Third Intervention|Withdrawal by Subject|0|||
149142096|NCT00493220|537999356|FG002|Third Intervention|Withdrawal by Subject|0|||
149142097|NCT00493220|537999357|FG003|Third Intervention|Withdrawal by Subject|0|||
149142098|NCT00493220|537999358|FG004|Third Intervention|Withdrawal by Subject|0|||
149142099|NCT00493220|537999359|FG005|Third Intervention|Withdrawal by Subject|0|||
149142100|NCT02109562|537999360|FG000|Overall Study|Insufficient clinical response|2|||
149142101|NCT02109562|537999361|FG001|Overall Study|Insufficient clinical response|0|||
149142102|NCT02109562|537999362|FG002|Overall Study|Insufficient clinical response|4|||
149142103|NCT02109562|537999360|FG000|Overall Study|Adverse Event|0|||
149142104|NCT02109562|537999361|FG001|Overall Study|Adverse Event|2|||
149142105|NCT02109562|537999362|FG002|Overall Study|Adverse Event|3|||
149142106|NCT02109562|537999360|FG000|Overall Study|Lost to Follow-up|1|||
149142107|NCT02109562|537999361|FG001|Overall Study|Lost to Follow-up|0|||
149142108|NCT02109562|537999362|FG002|Overall Study|Lost to Follow-up|1|||
149142109|NCT02109562|537999360|FG000|Overall Study|Protocol Violation|0|||
149142110|NCT02109562|537999361|FG001|Overall Study|Protocol Violation|3|||
149142111|NCT02109562|537999362|FG002|Overall Study|Protocol Violation|1|||
149142112|NCT02109562|537999360|FG000|Overall Study|Withdrawal by Subject|20|||
149142113|NCT02109562|537999361|FG001|Overall Study|Withdrawal by Subject|25|||
149142114|NCT02109562|537999362|FG002|Overall Study|Withdrawal by Subject|21|||
149142115|NCT02109562|537999360|FG000|Overall Study|Physician Decision|3|||
149142116|NCT02109562|537999361|FG001|Overall Study|Physician Decision|4|||
149142117|NCT02109562|537999362|FG002|Overall Study|Physician Decision|5|||
149142118|NCT02844816|537999365|FG000|Overall Study|No protocol treatment received|5|||
149142119|NCT02844816|537999366|FG001|Overall Study|No protocol treatment received|1|||
149142120|NCT02844816|537999365|FG000|Overall Study|Ineligible|22|||
149142121|NCT02844816|537999366|FG001|Overall Study|Ineligible|15|||
149142122|NCT02844816|537999365|FG000|Overall Study|Participant refusal|5|||
149142123|NCT02844816|537999366|FG001|Overall Study|Participant refusal|5|||
149142124|NCT02844816|537999365|FG000|Overall Study|Adverse Event|5|||
149142125|NCT02844816|537999366|FG001|Overall Study|Adverse Event|4|||
149142126|NCT02844816|537999365|FG000|Overall Study|Death|0|||
149142127|NCT02844816|537999366|FG001|Overall Study|Death|1|||
149142128|NCT02844816|537999365|FG000|Overall Study|Disease progression/recurrence|50|||
149142129|NCT02844816|537999366|FG001|Overall Study|Disease progression/recurrence|24|||
149142130|NCT02844816|537999365|FG000|Overall Study|Physician Decision|1|||
149142131|NCT02844816|537999366|FG001|Overall Study|Physician Decision|1|||
149142132|NCT03677596|538000760|FG000|Overall Study|Adverse Event|0|||
149142133|NCT03677596|538000761|FG001|Overall Study|Adverse Event|1|||
149142134|NCT03677596|538000760|FG000|Overall Study|Death|10|||
149142135|NCT03677596|538000761|FG001|Overall Study|Death|6|||
149142136|NCT03677596|538000760|FG000|Overall Study|Lost to Follow-up|0|||
149142137|NCT03677596|538000761|FG001|Overall Study|Lost to Follow-up|1|||
149142138|NCT03677596|538000760|FG000|Overall Study|Progressive Disease|8|||
149142139|NCT03677596|538000761|FG001|Overall Study|Progressive Disease|8|||
149142140|NCT03677596|538000760|FG000|Overall Study|Withdrawal by Subject|3|||
149142141|NCT03677596|538000761|FG001|Overall Study|Withdrawal by Subject|0|||
149142142|NCT03677596|538000760|FG000|Overall Study|Disease Relapse|2|||
149142143|NCT03677596|538000761|FG001|Overall Study|Disease Relapse|2|||
149142144|NCT03677596|538000760|FG000|Overall Study|Other|0|||
149142145|NCT03677596|538000761|FG001|Overall Study|Other|1|||
149142149|NCT00806195|538000763|FG000|Overall Study|Death|6|||
149142150|NCT00806195|538000764|FG001|Overall Study|Death|0|||
149142151|NCT00806195|538000765|FG002|Overall Study|Death|1|||
149142152|NCT00806195|538000766|FG003|Overall Study|Death|0|||
149142153|NCT00806195|538000763|FG000|Overall Study|Adverse Event|25|||
149142154|NCT00806195|538000764|FG001|Overall Study|Adverse Event|5|||
149142155|NCT00806195|538000765|FG002|Overall Study|Adverse Event|11|||
149142156|NCT00806195|538000766|FG003|Overall Study|Adverse Event|2|||
149142157|NCT00806195|538000763|FG000|Overall Study|Withdrawal by Subject|119|||
149142158|NCT00806195|538000764|FG001|Overall Study|Withdrawal by Subject|31|||
149142159|NCT00806195|538000765|FG002|Overall Study|Withdrawal by Subject|76|||
149142160|NCT00806195|538000766|FG003|Overall Study|Withdrawal by Subject|35|||
149142161|NCT00806195|538000763|FG000|Overall Study|Lost to Follow-up|217|||
149142162|NCT00806195|538000764|FG001|Overall Study|Lost to Follow-up|66|||
149142163|NCT00806195|538000765|FG002|Overall Study|Lost to Follow-up|90|||
149142164|NCT00806195|538000766|FG003|Overall Study|Lost to Follow-up|34|||
149142165|NCT00806195|538000763|FG000|Overall Study|Inappropriate Enrollment|0|||
149142166|NCT00806195|538000764|FG001|Overall Study|Inappropriate Enrollment|1|||
149142167|NCT00806195|538000765|FG002|Overall Study|Inappropriate Enrollment|0|||
149142168|NCT00806195|538000766|FG003|Overall Study|Inappropriate Enrollment|0|||
149142169|NCT00806195|538000763|FG000|Overall Study|Administrative Reason|113|||
149142170|NCT00806195|538000764|FG001|Overall Study|Administrative Reason|35|||
149142171|NCT00806195|538000765|FG002|Overall Study|Administrative Reason|66|||
149142172|NCT00806195|538000766|FG003|Overall Study|Administrative Reason|26|||
149142173|NCT00806195|538000763|FG000|Overall Study|Protocol Violation|34|||
149142174|NCT00806195|538000764|FG001|Overall Study|Protocol Violation|24|||
149142175|NCT00806195|538000765|FG002|Overall Study|Protocol Violation|26|||
149142176|NCT00806195|538000766|FG003|Overall Study|Protocol Violation|9|||
149142177|NCT02752035|538000770|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
149142178|NCT02752035|538000771|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
149142179|NCT02752035|538000772|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
149142180|NCT02752035|538000773|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
149142181|NCT02752035|538000770|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
149142182|NCT02752035|538000771|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
149142183|NCT02752035|538000772|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
149142184|NCT02752035|538000773|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
149142185|NCT02752035|538000770|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
149142186|NCT02752035|538000771|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
149142187|NCT02752035|538000772|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
149142188|NCT02752035|538000773|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
149142189|NCT02752035|538000770|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
149142190|NCT02752035|538000771|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
149142191|NCT02752035|538000772|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
149142192|NCT02752035|538000773|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
149142193|NCT02752035|538000770|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
149142194|NCT02752035|538000771|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
149142195|NCT02752035|538000772|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
149142196|NCT02752035|538000773|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
149142197|NCT02752035|538000770|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
149142198|NCT02752035|538000771|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
149142199|NCT02752035|538000772|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
149142200|NCT02752035|538000773|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
149142201|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
149142202|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
149142203|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
149142204|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
149142205|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
149142206|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
149142207|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
149142208|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
149142209|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
149142210|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
149142211|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
149142212|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
149142213|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
149142214|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
149142215|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
149142216|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
149142217|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
149142218|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
149142219|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
149142220|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
149142221|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Death|0|||
149142222|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Death|25|||
149142223|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Death|13|||
149142224|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Death|4|||
149142225|NCT02752035|538000770|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
149142226|NCT02752035|538000771|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
149142227|NCT02752035|538000772|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
149142228|NCT02752035|538000773|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
149142229|NCT02752035|538000770|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
149142230|NCT02752035|538000771|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
149142231|NCT02752035|538000772|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
149142232|NCT02752035|538000773|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
149142233|NCT02752035|538000770|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
149142234|NCT02752035|538000771|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
149142235|NCT02752035|538000772|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
149142236|NCT02752035|538000773|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
149142237|NCT02752035|538000770|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
149142238|NCT02752035|538000771|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
149142239|NCT02752035|538000772|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
149142240|NCT02752035|538000773|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
149142241|NCT02752035|538000770|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
149142242|NCT02752035|538000771|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
149142243|NCT02752035|538000772|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
149142244|NCT02752035|538000773|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
149142245|NCT01161043|538000774|FG000|Overall Study|Withdrawal by Subject|3|||
149142246|NCT01131676|538000779|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
149142247|NCT01131676|538000780|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
149142248|NCT01131676|538000781|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
149142249|NCT01131676|538000779|FG000|Discontinuation From Treatment|Not treated|4|||
149142250|NCT01131676|538000780|FG001|Discontinuation From Treatment|Not treated|2|||
149142251|NCT01131676|538000781|FG002|Discontinuation From Treatment|Not treated|2|||
149142252|NCT01131676|538000779|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
149142253|NCT01131676|538000780|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
149142254|NCT01131676|538000781|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
149142255|NCT01131676|538000779|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
149142256|NCT01131676|538000780|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
149142257|NCT01131676|538000781|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
149142258|NCT01131676|538000779|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
149142259|NCT01131676|538000780|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
148913253|NCT00924027|537164832|FG000|Overall Study|Lost to Further Follow-Up|4|||
148913254|NCT00924027|537164833|FG001|Overall Study|Lost to Further Follow-Up|0|||
148913255|NCT00924027|537164834|FG002|Overall Study|Lost to Further Follow-Up|0|||
148913256|NCT00924027|537164835|FG003|Overall Study|Lost to Further Follow-Up|0|||
149142260|NCT01131676|538000781|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
148913257|NCT00924027|537164832|FG000|Overall Study|Physician Decision|1|||
149142261|NCT01131676|538000779|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
149142262|NCT01131676|538000780|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
149142263|NCT01131676|538000781|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
149142264|NCT01131676|538000779|FG000|Discontinuation From Treatment|Other than those specified|162|||
149142265|NCT01131676|538000780|FG001|Discontinuation From Treatment|Other than those specified|142|||
149142266|NCT01131676|538000781|FG002|Discontinuation From Treatment|Other than those specified|125|||
149142267|NCT01131676|538000779|FG000|Discontinuation From Treatment|Adverse Event|303|||
149142268|NCT01131676|538000780|FG001|Discontinuation From Treatment|Adverse Event|267|||
149142269|NCT01131676|538000781|FG002|Discontinuation From Treatment|Adverse Event|273|||
149142270|NCT01131676|538000779|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
149142271|NCT01131676|538000780|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
149142272|NCT01131676|538000781|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
149142273|NCT01131676|538000779|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
149142274|NCT01131676|538000780|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
149142275|NCT01131676|538000781|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
149142276|NCT01131676|538000779|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
149142277|NCT01131676|538000780|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
149142278|NCT01131676|538000781|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
149142279|NCT01131676|538000779|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
149142280|NCT01131676|538000780|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
149142281|NCT01131676|538000781|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
149142282|NCT01131676|538000779|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
149142283|NCT01131676|538000780|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
149142284|NCT01131676|538000781|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
149142285|NCT01131676|538000779|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
149142286|NCT01131676|538000780|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
149142287|NCT01131676|538000781|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
149142288|NCT01231659|538000783|FG000|Overall Study|Adverse Event|9|||
149142289|NCT01231659|538000783|FG000|Overall Study|Disease Progression|48|||
149142290|NCT01231659|538000783|FG000|Overall Study|Death|2|||
149142291|NCT01231659|538000783|FG000|Overall Study|Patient refused to complete study visit|1|||
149142292|NCT01231659|538000783|FG000|Overall Study|Other protocol defined criteria|12|||
149142293|NCT00509067|538000784|FG000|Overall Study|Lost to Follow-up|1|||
149142294|NCT00509067|538000785|FG001|Overall Study|Lost to Follow-up|1|||
149142295|NCT00509067|538000784|FG000|Overall Study|Adverse Event|3|||
149142296|NCT00509067|538000785|FG001|Overall Study|Adverse Event|1|||
149142297|NCT00509067|538000784|FG000|Overall Study|Protocol Violation|0|||
149142298|NCT00509067|538000785|FG001|Overall Study|Protocol Violation|3|||
149142299|NCT00117598|538000795|FG000|Prior to Treatment Cross Over|Death|40|||
149142300|NCT00117598|538000796|FG001|Prior to Treatment Cross Over|Death|41|||
149142301|NCT00117598|538000797|FG002|Prior to Treatment Cross Over|Death|37|||
149142302|NCT00117598|538000798|FG003|Prior to Treatment Cross Over|Death|0|||
149142303|NCT00117598|538000799|FG004|Prior to Treatment Cross Over|Death|0|||
149142304|NCT00117598|538000795|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
149142305|NCT00117598|538000796|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
149142306|NCT00117598|538000797|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
149142307|NCT00117598|538000798|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
149142308|NCT00117598|538000799|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
149142309|NCT00117598|538000795|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
149142310|NCT00117598|538000796|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
149142311|NCT00117598|538000797|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
149142312|NCT00117598|538000798|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
149142313|NCT00117598|538000799|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
149142314|NCT00117598|538000795|FG000|Prior to Treatment Cross Over|Other|15|||
149142315|NCT00117598|538000796|FG001|Prior to Treatment Cross Over|Other|9|||
149142316|NCT00117598|538000797|FG002|Prior to Treatment Cross Over|Other|9|||
149142317|NCT00117598|538000798|FG003|Prior to Treatment Cross Over|Other|0|||
149142318|NCT00117598|538000799|FG004|Prior to Treatment Cross Over|Other|0|||
149142319|NCT00117598|538000795|FG000|After Treament Cross Over|Death|0|||
149142320|NCT00117598|538000796|FG001|After Treament Cross Over|Death|0|||
149142321|NCT00117598|538000797|FG002|After Treament Cross Over|Death|0|||
149142322|NCT00117598|538000798|FG003|After Treament Cross Over|Death|1|||
149142323|NCT00117598|538000799|FG004|After Treament Cross Over|Death|2|||
149142324|NCT00117598|538000795|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
149142325|NCT00117598|538000796|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
149142326|NCT00117598|538000797|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
149142327|NCT00117598|538000798|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
149142328|NCT00117598|538000799|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
149142329|NCT00117598|538000795|FG000|After Treament Cross Over|Other|0|||
148913258|NCT00924027|537164833|FG001|Overall Study|Physician Decision|0|||
148913259|NCT00924027|537164834|FG002|Overall Study|Physician Decision|0|||
149142330|NCT00117598|538000796|FG001|After Treament Cross Over|Other|0|||
149142331|NCT00117598|538000797|FG002|After Treament Cross Over|Other|0|||
149142332|NCT00117598|538000798|FG003|After Treament Cross Over|Other|1|||
149142333|NCT00117598|538000799|FG004|After Treament Cross Over|Other|2|||
149142334|NCT00545064|538000800|FG000|Overall Study|Lost to Follow-up|3|||
149142335|NCT00545064|538000800|FG000|Overall Study|Withdrawal by Subject|2|||
149142336|NCT00545064|538000800|FG000|Overall Study|did not complete course of treatment|1|||
149142337|NCT00545064|538000800|FG000|Overall Study|cancel all appointments, no rebooking|1|||
149142338|NCT00545064|538000800|FG000|Overall Study|inclement weather|1|||
149142339|NCT01770912|538000801|FG000|Overall Study|Lost to Follow-up|2|||
149142340|NCT01770912|538000802|FG001|Overall Study|Lost to Follow-up|0|||
149142341|NCT01536951|538000804|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142342|NCT01536951|538000805|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142343|NCT01536951|538000806|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
149142344|NCT01536951|538000807|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142345|NCT01536951|538000808|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142346|NCT01536951|538000809|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142347|NCT01536951|538000810|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142348|NCT01536951|538000811|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142349|NCT01536951|538000812|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
149142350|NCT01536951|538000804|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
149142351|NCT01536951|538000805|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
149142352|NCT01536951|538000806|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
149142353|NCT01536951|538000807|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
149142354|NCT01536951|538000808|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
149142355|NCT01536951|538000809|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
149142356|NCT01536951|538000810|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
149142357|NCT01536951|538000811|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
149142358|NCT01536951|538000812|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
149142359|NCT01843972|538000815|FG000|Overall Study|Withdrawal by Subject|0|||
149142360|NCT01843972|538000816|FG001|Overall Study|Withdrawal by Subject|0|||
149142361|NCT01843972|538000817|FG002|Overall Study|Withdrawal by Subject|0|||
149142362|NCT01843972|538000818|FG003|Overall Study|Withdrawal by Subject|0|||
149142363|NCT01843972|538000819|FG004|Overall Study|Withdrawal by Subject|1|||
149142364|NCT01843972|538000820|FG005|Overall Study|Withdrawal by Subject|0|||
149142365|NCT01843972|538000821|FG006|Overall Study|Withdrawal by Subject|0|||
149142366|NCT01843972|538000822|FG007|Overall Study|Withdrawal by Subject|0|||
149142367|NCT01843972|538000823|FG008|Overall Study|Withdrawal by Subject|0|||
149142368|NCT01843972|538000824|FG009|Overall Study|Withdrawal by Subject|0|||
149142369|NCT01854645|538000830|FG000|Overall Study|Protocol-Specified Criteria|13|||
149142370|NCT01854645|538000831|FG001|Overall Study|Protocol-Specified Criteria|10|||
149142371|NCT01854645|538000832|FG002|Overall Study|Protocol-Specified Criteria|8|||
149142372|NCT01854645|538000833|FG003|Overall Study|Protocol-Specified Criteria|5|||
149142373|NCT01854645|538000834|FG004|Overall Study|Protocol-Specified Criteria|7|||
149142374|NCT01854645|538000830|FG000|Overall Study|Administrative Reasons / Missing|0|||
149142375|NCT01854645|538000831|FG001|Overall Study|Administrative Reasons / Missing|0|||
149142376|NCT01854645|538000832|FG002|Overall Study|Administrative Reasons / Missing|0|||
149142377|NCT01854645|538000833|FG003|Overall Study|Administrative Reasons / Missing|1|||
149142378|NCT01854645|538000834|FG004|Overall Study|Administrative Reasons / Missing|1|||
149142379|NCT01854645|538000830|FG000|Overall Study|Protocol Violation|3|||
149142380|NCT01854645|538000831|FG001|Overall Study|Protocol Violation|0|||
149142381|NCT01854645|538000832|FG002|Overall Study|Protocol Violation|5|||
149142382|NCT01854645|538000833|FG003|Overall Study|Protocol Violation|4|||
149142383|NCT01854645|538000834|FG004|Overall Study|Protocol Violation|1|||
149142384|NCT01854645|538000830|FG000|Overall Study|Lost to Follow-up|10|||
149142385|NCT01854645|538000831|FG001|Overall Study|Lost to Follow-up|7|||
149142386|NCT01854645|538000832|FG002|Overall Study|Lost to Follow-up|8|||
149142387|NCT01854645|538000833|FG003|Overall Study|Lost to Follow-up|5|||
149142388|NCT01854645|538000834|FG004|Overall Study|Lost to Follow-up|0|||
149142389|NCT01854645|538000830|FG000|Overall Study|Physician Decision|1|||
149142390|NCT01854645|538000831|FG001|Overall Study|Physician Decision|5|||
149142391|NCT01854645|538000832|FG002|Overall Study|Physician Decision|3|||
149142392|NCT01854645|538000833|FG003|Overall Study|Physician Decision|3|||
149142393|NCT01854645|538000834|FG004|Overall Study|Physician Decision|7|||
149142394|NCT01854645|538000830|FG000|Overall Study|Withdrawal by Subject|31|||
149142395|NCT01854645|538000831|FG001|Overall Study|Withdrawal by Subject|41|||
149142396|NCT01854645|538000832|FG002|Overall Study|Withdrawal by Subject|30|||
149142397|NCT01854645|538000833|FG003|Overall Study|Withdrawal by Subject|21|||
149142398|NCT01854645|538000834|FG004|Overall Study|Withdrawal by Subject|24|||
149142399|NCT01854645|538000830|FG000|Overall Study|Lack of Efficacy|7|||
149142400|NCT01854645|538000831|FG001|Overall Study|Lack of Efficacy|12|||
149142401|NCT01854645|538000832|FG002|Overall Study|Lack of Efficacy|9|||
149142402|NCT01854645|538000833|FG003|Overall Study|Lack of Efficacy|3|||
149142403|NCT01854645|538000834|FG004|Overall Study|Lack of Efficacy|9|||
149142404|NCT01854645|538000830|FG000|Overall Study|Adverse Event|33|||
149142405|NCT01854645|538000831|FG001|Overall Study|Adverse Event|31|||
149142406|NCT01854645|538000832|FG002|Overall Study|Adverse Event|19|||
149142407|NCT01854645|538000833|FG003|Overall Study|Adverse Event|20|||
149142408|NCT01854645|538000834|FG004|Overall Study|Adverse Event|11|||
149142409|NCT00555477|538000837|FG000|Overall Study|Adverse Event|0|||
149142410|NCT00555477|538000838|FG001|Overall Study|Adverse Event|9|||
149142411|NCT00555477|538000837|FG000|Overall Study|Withdrawal by Subject|1|||
149142412|NCT00555477|538000838|FG001|Overall Study|Withdrawal by Subject|2|||
149142413|NCT00555477|538000837|FG000|Overall Study|Physician Decision|1|||
149142414|NCT00555477|538000838|FG001|Overall Study|Physician Decision|2|||
149142415|NCT00545402|538000839|FG000|Overall Study|Discontinuation of treatment|17|||
149142416|NCT00545402|538000840|FG001|Overall Study|Discontinuation of treatment|9|||
149142417|NCT00545402|538000839|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
149142418|NCT00545402|538000840|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
149142419|NCT00545402|538000839|FG000|Overall Study|Death|5|||
149142420|NCT00545402|538000840|FG001|Overall Study|Death|7|||
149142421|NCT00545402|538000839|FG000|Overall Study|Graft loss|2|||
149142422|NCT00545402|538000840|FG001|Overall Study|Graft loss|4|||
149142423|NCT00545402|538000839|FG000|Overall Study|Withdrawal by Subject|0|||
149142424|NCT00545402|538000840|FG001|Overall Study|Withdrawal by Subject|1|||
149142425|NCT00545402|538000839|FG000|Overall Study|Protocol Violation|1|||
149142426|NCT00545402|538000840|FG001|Overall Study|Protocol Violation|0|||
149142427|NCT00545402|538000839|FG000|Overall Study|Reason not specified|1|||
149142428|NCT00545402|538000840|FG001|Overall Study|Reason not specified|1|||
149142429|NCT01817751|538000841|FG000|Overall Study|Physician Decision|1|||
149142430|NCT00397033|538000842|FG000|Overall Study|Adverse Event|7|||
149142431|NCT00397033|538000843|FG001|Overall Study|Adverse Event|10|||
149142432|NCT00397033|538000844|FG002|Overall Study|Adverse Event|4|||
149142433|NCT00397033|538000842|FG000|Overall Study|Lack of Efficacy|22|||
149142434|NCT00397033|538000843|FG001|Overall Study|Lack of Efficacy|12|||
149142435|NCT00397033|538000844|FG002|Overall Study|Lack of Efficacy|9|||
149142436|NCT00397033|538000842|FG000|Overall Study|Lost to Follow-up|3|||
149142437|NCT00397033|538000843|FG001|Overall Study|Lost to Follow-up|3|||
149142438|NCT00397033|538000844|FG002|Overall Study|Lost to Follow-up|3|||
149142439|NCT00397033|538000842|FG000|Overall Study|Withdrawal by Subject|12|||
149142440|NCT00397033|538000843|FG001|Overall Study|Withdrawal by Subject|7|||
149142441|NCT00397033|538000844|FG002|Overall Study|Withdrawal by Subject|5|||
149142442|NCT00397033|538000842|FG000|Overall Study|Other|0|||
149142443|NCT00397033|538000843|FG001|Overall Study|Other|5|||
149142444|NCT00397033|538000844|FG002|Overall Study|Other|2|||
149142445|NCT03519867|538000845|FG000|Overall Study|Adverse Event|1|||
149142446|NCT03519867|538000846|FG001|Overall Study|Adverse Event|1|||
149142447|NCT03519867|538000847|FG002|Overall Study|Adverse Event|0|||
149142448|NCT03519867|538000848|FG003|Overall Study|Adverse Event|0|||
149142449|NCT03519867|538000849|FG004|Overall Study|Adverse Event|0|||
149142450|NCT03519867|538000850|FG005|Overall Study|Adverse Event|0|||
149142451|NCT03519867|538000851|FG006|Overall Study|Adverse Event|0|||
149142452|NCT03519867|538000852|FG007|Overall Study|Adverse Event|0|||
149142453|NCT03519867|538000853|FG008|Overall Study|Adverse Event|0|||
149142454|NCT03519867|538000854|FG009|Overall Study|Adverse Event|0|||
149142455|NCT03519867|538000845|FG000|Overall Study|Protocol Violation|0|||
149142456|NCT03519867|538000846|FG001|Overall Study|Protocol Violation|0|||
149142457|NCT03519867|538000847|FG002|Overall Study|Protocol Violation|0|||
149142458|NCT03519867|538000848|FG003|Overall Study|Protocol Violation|0|||
149142459|NCT03519867|538000849|FG004|Overall Study|Protocol Violation|0|||
149142460|NCT03519867|538000850|FG005|Overall Study|Protocol Violation|1|||
149142461|NCT03519867|538000851|FG006|Overall Study|Protocol Violation|0|||
149142462|NCT03519867|538000852|FG007|Overall Study|Protocol Violation|0|||
149142463|NCT03519867|538000853|FG008|Overall Study|Protocol Violation|0|||
149142464|NCT03519867|538000854|FG009|Overall Study|Protocol Violation|0|||
149142465|NCT03519867|538000845|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142466|NCT03519867|538000846|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142467|NCT03519867|538000847|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142468|NCT03519867|538000848|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142469|NCT03519867|538000849|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142470|NCT03519867|538000850|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142471|NCT03519867|538000851|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
149142472|NCT03519867|538000852|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142473|NCT03519867|538000853|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142474|NCT03519867|538000854|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
149142475|NCT03519867|538000845|FG000|Overall Study|Admin. of other reversal agent|1|||
149142476|NCT03519867|538000846|FG001|Overall Study|Admin. of other reversal agent|1|||
149142477|NCT03519867|538000847|FG002|Overall Study|Admin. of other reversal agent|0|||
149142478|NCT03519867|538000848|FG003|Overall Study|Admin. of other reversal agent|0|||
149142479|NCT03519867|538000849|FG004|Overall Study|Admin. of other reversal agent|0|||
149142480|NCT03519867|538000850|FG005|Overall Study|Admin. of other reversal agent|1|||
149142481|NCT03519867|538000851|FG006|Overall Study|Admin. of other reversal agent|0|||
149142482|NCT03519867|538000852|FG007|Overall Study|Admin. of other reversal agent|0|||
149142483|NCT03519867|538000853|FG008|Overall Study|Admin. of other reversal agent|0|||
149142484|NCT03519867|538000854|FG009|Overall Study|Admin. of other reversal agent|0|||
149142485|NCT03519867|538000845|FG000|Overall Study|Reason not provided|1|||
149142486|NCT03519867|538000846|FG001|Overall Study|Reason not provided|1|||
149142487|NCT03519867|538000847|FG002|Overall Study|Reason not provided|1|||
149142488|NCT03519867|538000848|FG003|Overall Study|Reason not provided|1|||
149142489|NCT03519867|538000849|FG004|Overall Study|Reason not provided|0|||
149142490|NCT03519867|538000850|FG005|Overall Study|Reason not provided|1|||
149142491|NCT03519867|538000851|FG006|Overall Study|Reason not provided|0|||
149142492|NCT03519867|538000852|FG007|Overall Study|Reason not provided|1|||
149142493|NCT03519867|538000853|FG008|Overall Study|Reason not provided|1|||
149142494|NCT03519867|538000854|FG009|Overall Study|Reason not provided|0|||
149142495|NCT00382018|538000855|FG000|Overall Study|Progression|0|||
149142496|NCT00382018|538000856|FG001|Overall Study|Progression|136|||
149142497|NCT00382018|538000857|FG002|Overall Study|Progression|51|||
149142498|NCT00382018|538000858|FG003|Overall Study|Progression|43|||
149142499|NCT00382018|538000855|FG000|Overall Study|Death|0|||
149142500|NCT00382018|538000856|FG001|Overall Study|Death|9|||
149142501|NCT00382018|538000857|FG002|Overall Study|Death|7|||
149142502|NCT00382018|538000858|FG003|Overall Study|Death|11|||
149142503|NCT00382018|538000855|FG000|Overall Study|Withdrawal by Subject|0|||
149142504|NCT00382018|538000856|FG001|Overall Study|Withdrawal by Subject|4|||
149142505|NCT00382018|538000857|FG002|Overall Study|Withdrawal by Subject|3|||
149142506|NCT00382018|538000858|FG003|Overall Study|Withdrawal by Subject|4|||
149142507|NCT00382018|538000855|FG000|Overall Study|Other, not protocol specified|0|||
149142508|NCT00382018|538000856|FG001|Overall Study|Other, not protocol specified|16|||
149142509|NCT00382018|538000857|FG002|Overall Study|Other, not protocol specified|3|||
149142510|NCT00382018|538000858|FG003|Overall Study|Other, not protocol specified|1|||
149142511|NCT01252810|538000859|FG000|Overall Study|Withdrawal by Subject|4|||
149142512|NCT01252810|538000860|FG001|Overall Study|Withdrawal by Subject|1|||
149142513|NCT01252810|538000859|FG000|Overall Study|Lost to Follow-up|0|||
149142514|NCT01252810|538000860|FG001|Overall Study|Lost to Follow-up|1|||
149142515|NCT01252810|538000859|FG000|Overall Study|Physician Decision|2|||
149142516|NCT01252810|538000860|FG001|Overall Study|Physician Decision|1|||
149142517|NCT01252810|538000859|FG000|Overall Study|Various reasons|8|||
149142518|NCT01252810|538000860|FG001|Overall Study|Various reasons|0|||
149142519|NCT01721057|538000861|FG000|Treatment Period|Withdrawal by Subject|11|||
149142520|NCT01721057|538000862|FG001|Treatment Period|Withdrawal by Subject|5|||
149142521|NCT01721057|538000863|FG002|Treatment Period|Withdrawal by Subject|8|||
149142522|NCT01721057|538000864|FG003|Treatment Period|Withdrawal by Subject|0|||
149142523|NCT01721057|538000865|FG004|Treatment Period|Withdrawal by Subject|0|||
149142524|NCT01721057|538000866|FG005|Treatment Period|Withdrawal by Subject|0|||
149142525|NCT01721057|538000867|FG006|Treatment Period|Withdrawal by Subject|0|||
149142526|NCT01721057|538000861|FG000|Treatment Period|Adverse Event|7|||
149142527|NCT01721057|538000862|FG001|Treatment Period|Adverse Event|10|||
149142528|NCT01721057|538000863|FG002|Treatment Period|Adverse Event|12|||
149142529|NCT01721057|538000864|FG003|Treatment Period|Adverse Event|0|||
149142530|NCT01721057|538000865|FG004|Treatment Period|Adverse Event|0|||
149142531|NCT01721057|538000866|FG005|Treatment Period|Adverse Event|0|||
149142532|NCT01721057|538000867|FG006|Treatment Period|Adverse Event|0|||
149142533|NCT01721057|538000861|FG000|Treatment Period|Lack of Efficacy|7|||
149142534|NCT01721057|538000862|FG001|Treatment Period|Lack of Efficacy|3|||
149142535|NCT01721057|538000863|FG002|Treatment Period|Lack of Efficacy|0|||
149142536|NCT01721057|538000864|FG003|Treatment Period|Lack of Efficacy|0|||
149142537|NCT01721057|538000865|FG004|Treatment Period|Lack of Efficacy|0|||
149142538|NCT01721057|538000866|FG005|Treatment Period|Lack of Efficacy|0|||
149142539|NCT01721057|538000867|FG006|Treatment Period|Lack of Efficacy|0|||
149142540|NCT01721057|538000861|FG000|Treatment Period|Lost to Follow-up|1|||
149142541|NCT01721057|538000862|FG001|Treatment Period|Lost to Follow-up|0|||
149142542|NCT01721057|538000863|FG002|Treatment Period|Lost to Follow-up|0|||
149142543|NCT01721057|538000864|FG003|Treatment Period|Lost to Follow-up|0|||
149142544|NCT01721057|538000865|FG004|Treatment Period|Lost to Follow-up|0|||
149142545|NCT01721057|538000866|FG005|Treatment Period|Lost to Follow-up|0|||
149142546|NCT01721057|538000867|FG006|Treatment Period|Lost to Follow-up|0|||
149142547|NCT01721057|538000861|FG000|Treatment Period|Physician Decision|0|||
149142548|NCT01721057|538000862|FG001|Treatment Period|Physician Decision|1|||
149142549|NCT01721057|538000863|FG002|Treatment Period|Physician Decision|3|||
149142550|NCT01721057|538000864|FG003|Treatment Period|Physician Decision|0|||
149142551|NCT01721057|538000865|FG004|Treatment Period|Physician Decision|0|||
149142552|NCT01721057|538000866|FG005|Treatment Period|Physician Decision|0|||
149142553|NCT01721057|538000867|FG006|Treatment Period|Physician Decision|0|||
149142554|NCT01721057|538000861|FG000|Treatment Period|Death|2|||
149142555|NCT01721057|538000862|FG001|Treatment Period|Death|0|||
149142556|NCT01721057|538000863|FG002|Treatment Period|Death|0|||
149142557|NCT01721057|538000864|FG003|Treatment Period|Death|0|||
149142558|NCT01721057|538000865|FG004|Treatment Period|Death|0|||
149142559|NCT01721057|538000866|FG005|Treatment Period|Death|0|||
149142560|NCT01721057|538000867|FG006|Treatment Period|Death|0|||
149142561|NCT01721057|538000861|FG000|Rescue Period|Adverse Event|0|||
149142562|NCT01721057|538000862|FG001|Rescue Period|Adverse Event|0|||
149142563|NCT01721057|538000863|FG002|Rescue Period|Adverse Event|0|||
149142564|NCT01721057|538000864|FG003|Rescue Period|Adverse Event|1|||
149142565|NCT01721057|538000865|FG004|Rescue Period|Adverse Event|0|||
149142566|NCT01721057|538000866|FG005|Rescue Period|Adverse Event|0|||
149142567|NCT01721057|538000867|FG006|Rescue Period|Adverse Event|0|||
149142568|NCT01721057|538000861|FG000|Rescue Period|Lack of Efficacy|0|||
149142569|NCT01721057|538000862|FG001|Rescue Period|Lack of Efficacy|0|||
149142570|NCT01721057|538000863|FG002|Rescue Period|Lack of Efficacy|0|||
149142571|NCT01721057|538000864|FG003|Rescue Period|Lack of Efficacy|2|||
149142572|NCT01721057|538000865|FG004|Rescue Period|Lack of Efficacy|0|||
149142573|NCT01721057|538000866|FG005|Rescue Period|Lack of Efficacy|0|||
149142574|NCT01721057|538000867|FG006|Rescue Period|Lack of Efficacy|0|||
149142575|NCT01202279|538000870|FG000|Overall Study|Adverse Event|8|||
149142576|NCT01202279|538000871|FG001|Overall Study|Adverse Event|6|||
149142577|NCT01202279|538000870|FG000|Overall Study|Withdrawal by Subject|13|||
149142578|NCT01202279|538000871|FG001|Overall Study|Withdrawal by Subject|10|||
149142579|NCT01202279|538000870|FG000|Overall Study|Physician Decision|0|||
149142580|NCT01202279|538000871|FG001|Overall Study|Physician Decision|1|||
149142581|NCT01202279|538000870|FG000|Overall Study|Lost to Follow-up|10|||
149142582|NCT01202279|538000871|FG001|Overall Study|Lost to Follow-up|7|||
149142583|NCT01202279|538000870|FG000|Overall Study|Protocol Violation|1|||
149142584|NCT01202279|538000871|FG001|Overall Study|Protocol Violation|1|||
149142585|NCT01202279|538000870|FG000|Overall Study|study compliance|5|||
149142586|NCT01202279|538000871|FG001|Overall Study|study compliance|2|||
149142587|NCT03805750|538000872|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
149142588|NCT03805750|538000873|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
149142589|NCT01984164|538000874|FG000|Overall Study|Withdrawal by Subject|4|||
149142590|NCT01984164|538000875|FG001|Overall Study|Withdrawal by Subject|3|||
149142591|NCT01984164|538000874|FG000|Overall Study|Adverse Event|5|||
149142592|NCT01984164|538000875|FG001|Overall Study|Adverse Event|19|||
149142593|NCT01984164|538000874|FG000|Overall Study|Lost to Follow-up|1|||
149142594|NCT01984164|538000875|FG001|Overall Study|Lost to Follow-up|3|||
149142595|NCT02811549|538000876|FG000|Overall Study|Lost to Follow-up|1|||
149142596|NCT02811549|538000876|FG000|Overall Study|Withdrawal by Subject|3|||
149142597|NCT02811549|538000876|FG000|Overall Study|Subject screen failed|4|||
149142598|NCT02811549|538000876|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
149142599|NCT03472924|538000877|FG000|Overall Study|Adverse Event|1|||
149142600|NCT03472924|538000878|FG001|Overall Study|Adverse Event|0|||
149142601|NCT00427349|538000881|FG000|Overall Study|Lack of Efficacy|23|||
149142602|NCT00427349|538000881|FG000|Overall Study|Adverse Event|14|||
149142603|NCT00427349|538000881|FG000|Overall Study|Death|1|||
149142604|NCT00427349|538000881|FG000|Overall Study|Withdrawal by Subject|3|||
149142605|NCT00427349|538000881|FG000|Overall Study|Alternative therapy|1|||
149142606|NCT00427349|538000881|FG000|Overall Study|Other|2|||
149142607|NCT00427349|538000881|FG000|Overall Study|Ineligible|1|||
149142608|NCT00427349|538000881|FG000|Overall Study|Never started therapy|1|||
149142609|NCT02546765|538000885|FG000|Overall Study|Withdrawal by Subject|0|||
149142610|NCT02546765|538000886|FG001|Overall Study|Withdrawal by Subject|1|||
149142611|NCT02546765|538000887|FG002|Overall Study|Withdrawal by Subject|0|||
149142612|NCT02546765|538000888|FG003|Overall Study|Withdrawal by Subject|0|||
149142613|NCT00475722|538000889|FG000|Overall Study|Withdrawal by Subject|12|||
149142614|NCT00475722|538000890|FG001|Overall Study|Withdrawal by Subject|12|||
149142615|NCT00475722|538000889|FG000|Overall Study|Protocol Violation|3|||
149142616|NCT00475722|538000890|FG001|Overall Study|Protocol Violation|0|||
149142617|NCT00698997|538000891|FG000|Overall Study|Lost to Follow-up|3|||
149142618|NCT00698997|538000892|FG001|Overall Study|Lost to Follow-up|0|||
149142619|NCT00698997|538000891|FG000|Overall Study|Withdrawal by Subject|7|||
149142620|NCT00698997|538000892|FG001|Overall Study|Withdrawal by Subject|27|||
149142621|NCT05082376|538000893|FG000|Overall Study|Lost to Follow-up|2|||
149142622|NCT00445224|538000894|FG000|Specific Exercises|Withdrawal by Subject|3|||
149142623|NCT00445224|538000895|FG001|Specific Exercises|Withdrawal by Subject|3|||
149142624|NCT00445224|538000894|FG000|Specific Exercises|Withdrawal by Subject|1|||
149142625|NCT00445224|538000895|FG001|Specific Exercises|Withdrawal by Subject|0|||
149142626|NCT01889238|538000898|FG000|Overall Study|Death|1|||
149142627|NCT01889238|538000898|FG000|Overall Study|Withdrawal by Subject|1|||
149142628|NCT01889238|538000898|FG000|Overall Study|Adverse Event|6|||
149142629|NCT01889238|538000898|FG000|Overall Study|Disease Progression|104|||
149142630|NCT01889238|538000898|FG000|Overall Study|Other|6|||
149142631|NCT04136184|538000899|FG000|Overall Study|Lost to Follow-up|0|||
149142632|NCT04136184|538000900|FG001|Overall Study|Lost to Follow-up|3|||
148804828|NCT02100631|536766578|FG002|Overall Study|Withdrawal by Subject|0|||
149142633|NCT04136184|538000899|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
149142634|NCT04136184|538000900|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
149142635|NCT03318978|538000904|FG000|Overall Study|Withdrawal by Subject|1|||
149142636|NCT02592018|538000906|FG000|Overall Study|Adverse Event|1|||
149142637|NCT02592018|538000906|FG000|Overall Study|Lost to Follow-up|1|||
149142638|NCT06156215|538000909|FG000|Overall Study|Withdrawal by Subject|2|||
149142639|NCT06156215|538000910|FG001|Overall Study|Withdrawal by Subject|4|||
149142640|NCT06156215|538000911|FG002|Overall Study|Withdrawal by Subject|4|||
149142641|NCT06156215|538000912|FG003|Overall Study|Withdrawal by Subject|0|||
149142642|NCT06156215|538000913|FG004|Overall Study|Withdrawal by Subject|2|||
149142643|NCT06156215|538000914|FG005|Overall Study|Withdrawal by Subject|2|||
149142644|NCT06156215|538000909|FG000|Overall Study|Left ED without completing study|9|||
149142645|NCT06156215|538000910|FG001|Overall Study|Left ED without completing study|3|||
149142646|NCT06156215|538000911|FG002|Overall Study|Left ED without completing study|9|||
149142647|NCT06156215|538000912|FG003|Overall Study|Left ED without completing study|0|||
149142648|NCT06156215|538000913|FG004|Overall Study|Left ED without completing study|8|||
149142649|NCT06156215|538000914|FG005|Overall Study|Left ED without completing study|16|||
149142650|NCT06156215|538000909|FG000|Overall Study|Physician Decision|1|||
149142651|NCT06156215|538000910|FG001|Overall Study|Physician Decision|0|||
149142652|NCT06156215|538000911|FG002|Overall Study|Physician Decision|0|||
149142653|NCT06156215|538000912|FG003|Overall Study|Physician Decision|0|||
149142654|NCT06156215|538000913|FG004|Overall Study|Physician Decision|0|||
149142655|NCT06156215|538000914|FG005|Overall Study|Physician Decision|0|||
149142656|NCT06156215|538000909|FG000|Overall Study|Became or found ineligible|2|||
149142657|NCT06156215|538000910|FG001|Overall Study|Became or found ineligible|0|||
149142658|NCT06156215|538000911|FG002|Overall Study|Became or found ineligible|2|||
149142659|NCT06156215|538000912|FG003|Overall Study|Became or found ineligible|0|||
149142660|NCT06156215|538000913|FG004|Overall Study|Became or found ineligible|1|||
149142661|NCT06156215|538000914|FG005|Overall Study|Became or found ineligible|2|||
149142662|NCT05050318|538002878|FG000|Overall Study|Protocol Deviation|1|||
149142663|NCT05050318|538002879|FG001|Overall Study|Protocol Deviation|0|||
149142664|NCT05050318|538002880|FG002|Overall Study|Protocol Deviation|0|||
149142665|NCT04360551|538002883|FG000|Overall Study|Withdrawal by Subject|1|||
149142666|NCT04360551|538002884|FG001|Overall Study|Withdrawal by Subject|0|||
149142667|NCT03496012|538002888|FG000|Overall Study|Withdrawal by Subject|2|||
149142668|NCT03496012|538002889|FG001|Overall Study|Withdrawal by Subject|0|||
149142669|NCT03496012|538002890|FG002|Overall Study|Withdrawal by Subject|2|||
149142670|NCT03496012|538002888|FG000|Overall Study|Adverse Event|0|||
149142671|NCT03496012|538002889|FG001|Overall Study|Adverse Event|0|||
149142672|NCT03496012|538002890|FG002|Overall Study|Adverse Event|1|||
149142673|NCT03496012|538002888|FG000|Overall Study|Reason Not Specified|2|||
149142674|NCT03496012|538002889|FG001|Overall Study|Reason Not Specified|0|||
149142675|NCT03496012|538002890|FG002|Overall Study|Reason Not Specified|1|||
149142676|NCT02322125|538002891|FG000|Overall Study|Withdrawal by Subject|2|||
149142677|NCT00766038|538002901|FG000|Overall Study|Lost to Follow-up|15|||
149142678|NCT00766038|538002902|FG001|Overall Study|Lost to Follow-up|14|||
149142679|NCT01251653|538002904|FG000|Overall Study|Progressive Disease|1|||
149142680|NCT01251653|538002905|FG001|Overall Study|Progressive Disease|7|||
149142681|NCT01251653|538002906|FG002|Overall Study|Progressive Disease|16|||
149142682|NCT01251653|538002907|FG003|Overall Study|Progressive Disease|4|||
149142683|NCT01251653|538002908|FG004|Overall Study|Progressive Disease|0|||
149142684|NCT01251653|538002909|FG005|Overall Study|Progressive Disease|17|||
149142685|NCT01251653|538002910|FG006|Overall Study|Progressive Disease|14|||
149142686|NCT01251653|538002911|FG007|Overall Study|Progressive Disease|7|||
149142687|NCT01251653|538002912|FG008|Overall Study|Progressive Disease|5|||
149142688|NCT01251653|538002904|FG000|Overall Study|Dose-limiting toxicity|0|||
149142689|NCT01251653|538002905|FG001|Overall Study|Dose-limiting toxicity|1|||
149142690|NCT01251653|538002906|FG002|Overall Study|Dose-limiting toxicity|1|||
149142691|NCT01251653|538002907|FG003|Overall Study|Dose-limiting toxicity|1|||
149142692|NCT01251653|538002908|FG004|Overall Study|Dose-limiting toxicity|0|||
149142693|NCT01251653|538002909|FG005|Overall Study|Dose-limiting toxicity|0|||
149142694|NCT01251653|538002910|FG006|Overall Study|Dose-limiting toxicity|2|||
149142695|NCT01251653|538002911|FG007|Overall Study|Dose-limiting toxicity|0|||
149142696|NCT01251653|538002912|FG008|Overall Study|Dose-limiting toxicity|0|||
149142697|NCT01251653|538002904|FG000|Overall Study|Adverse Event|1|||
149142698|NCT01251653|538002905|FG001|Overall Study|Adverse Event|0|||
149142699|NCT01251653|538002906|FG002|Overall Study|Adverse Event|2|||
149142700|NCT01251653|538002907|FG003|Overall Study|Adverse Event|1|||
149142701|NCT01251653|538002908|FG004|Overall Study|Adverse Event|1|||
149142702|NCT01251653|538002909|FG005|Overall Study|Adverse Event|0|||
149142703|NCT01251653|538002910|FG006|Overall Study|Adverse Event|2|||
149142704|NCT01251653|538002911|FG007|Overall Study|Adverse Event|2|||
149142705|NCT01251653|538002912|FG008|Overall Study|Adverse Event|1|||
149142706|NCT01251653|538002904|FG000|Overall Study|Withdrawal by Subject|1|||
149142707|NCT01251653|538002905|FG001|Overall Study|Withdrawal by Subject|0|||
149142708|NCT01251653|538002906|FG002|Overall Study|Withdrawal by Subject|1|||
149142709|NCT01251653|538002907|FG003|Overall Study|Withdrawal by Subject|0|||
149142710|NCT01251653|538002908|FG004|Overall Study|Withdrawal by Subject|1|||
149142711|NCT01251653|538002909|FG005|Overall Study|Withdrawal by Subject|1|||
149142712|NCT01251653|538002910|FG006|Overall Study|Withdrawal by Subject|0|||
149142713|NCT01251653|538002911|FG007|Overall Study|Withdrawal by Subject|1|||
149142714|NCT01251653|538002912|FG008|Overall Study|Withdrawal by Subject|0|||
149142715|NCT01251653|538002904|FG000|Overall Study|Other reason not mentioned above|0|||
149142716|NCT01251653|538002905|FG001|Overall Study|Other reason not mentioned above|0|||
149142717|NCT01251653|538002906|FG002|Overall Study|Other reason not mentioned above|0|||
149142718|NCT01251653|538002907|FG003|Overall Study|Other reason not mentioned above|0|||
149142719|NCT01251653|538002908|FG004|Overall Study|Other reason not mentioned above|0|||
149142720|NCT01251653|538002909|FG005|Overall Study|Other reason not mentioned above|0|||
149142721|NCT01251653|538002910|FG006|Overall Study|Other reason not mentioned above|0|||
149142722|NCT01251653|538002911|FG007|Overall Study|Other reason not mentioned above|2|||
149142723|NCT01251653|538002912|FG008|Overall Study|Other reason not mentioned above|0|||
149142724|NCT01524198|538002920|FG000|Overall Study|Protocol Violation|8|||
149142725|NCT01524198|538002921|FG001|Overall Study|Protocol Violation|6|||
149142726|NCT01524198|538002920|FG000|Overall Study|Withdrawal by Subject|15|||
149142727|NCT01524198|538002921|FG001|Overall Study|Withdrawal by Subject|10|||
149142728|NCT02232802|538002923|FG000|Period 1|Sponsor request|1|||
149142729|NCT02232802|538002924|FG001|Period 1|Sponsor request|0|||
149142730|NCT02232802|538002923|FG000|Period 1|Adverse Event|1|||
149142731|NCT02232802|538002924|FG001|Period 1|Adverse Event|1|||
149142732|NCT00885703|538002929|FG000|Overall Study|Death|9|||
149142733|NCT00885703|538002930|FG001|Overall Study|Death|7|||
149142734|NCT00885703|538002931|FG002|Overall Study|Death|8|||
149142735|NCT00885703|538002932|FG003|Overall Study|Death|7|||
149142736|NCT00885703|538002933|FG004|Overall Study|Death|7|||
149142737|NCT00885703|538002934|FG005|Overall Study|Death|8|||
149142738|NCT00885703|538002935|FG006|Overall Study|Death|4|||
149142739|NCT00885703|538002929|FG000|Overall Study|Lost to Follow-up|0|||
149142740|NCT00885703|538002930|FG001|Overall Study|Lost to Follow-up|0|||
149142741|NCT00885703|538002931|FG002|Overall Study|Lost to Follow-up|1|||
149142742|NCT00885703|538002932|FG003|Overall Study|Lost to Follow-up|0|||
149142743|NCT00885703|538002933|FG004|Overall Study|Lost to Follow-up|0|||
149142744|NCT00885703|538002934|FG005|Overall Study|Lost to Follow-up|1|||
149142745|NCT00885703|538002935|FG006|Overall Study|Lost to Follow-up|0|||
149142746|NCT00885703|538002929|FG000|Overall Study|Withdrawal by Subject|0|||
149142747|NCT00885703|538002930|FG001|Overall Study|Withdrawal by Subject|0|||
149142748|NCT00885703|538002931|FG002|Overall Study|Withdrawal by Subject|0|||
149142749|NCT00885703|538002932|FG003|Overall Study|Withdrawal by Subject|1|||
149142750|NCT00885703|538002933|FG004|Overall Study|Withdrawal by Subject|3|||
149142751|NCT00885703|538002934|FG005|Overall Study|Withdrawal by Subject|1|||
149142752|NCT00885703|538002935|FG006|Overall Study|Withdrawal by Subject|1|||
149142753|NCT00885703|538002929|FG000|Overall Study|Ineligible (no CM)|1|||
149142754|NCT00885703|538002930|FG001|Overall Study|Ineligible (no CM)|3|||
149142755|NCT00885703|538002931|FG002|Overall Study|Ineligible (no CM)|2|||
149142756|NCT00885703|538002932|FG003|Overall Study|Ineligible (no CM)|1|||
149142757|NCT00885703|538002933|FG004|Overall Study|Ineligible (no CM)|2|||
149142758|NCT00885703|538002934|FG005|Overall Study|Ineligible (no CM)|3|||
149142759|NCT00885703|538002935|FG006|Overall Study|Ineligible (no CM)|1|||
149142760|NCT01490450|538002939|FG000|Period 1|Lack of Efficacy|2|||
149142761|NCT01490450|538002940|FG001|Period 1|Lack of Efficacy|0|||
149142762|NCT01490450|538002941|FG002|Period 1|Lack of Efficacy|3|||
149142763|NCT01490450|538002942|FG003|Period 1|Lack of Efficacy|0|||
149142764|NCT01490450|538002939|FG000|Period 1|Adverse Event|0|||
149142765|NCT01490450|538002940|FG001|Period 1|Adverse Event|0|||
149142766|NCT01490450|538002941|FG002|Period 1|Adverse Event|0|||
149142767|NCT01490450|538002942|FG003|Period 1|Adverse Event|5|||
149142768|NCT01490450|538002939|FG000|Period 1|Request to discontinue treatment|1|||
149142769|NCT01490450|538002940|FG001|Period 1|Request to discontinue treatment|0|||
149142770|NCT01490450|538002941|FG002|Period 1|Request to discontinue treatment|0|||
149142771|NCT01490450|538002942|FG003|Period 1|Request to discontinue treatment|0|||
149142772|NCT01490450|538002939|FG000|Period 1|Withdrawal by Subject|0|||
149142773|NCT01490450|538002940|FG001|Period 1|Withdrawal by Subject|0|||
149142774|NCT01490450|538002941|FG002|Period 1|Withdrawal by Subject|0|||
149142775|NCT01490450|538002942|FG003|Period 1|Withdrawal by Subject|3|||
149142776|NCT01490450|538002939|FG000|Period 1|No longer met study criteria|0|||
149142777|NCT01490450|538002940|FG001|Period 1|No longer met study criteria|1|||
149142778|NCT01490450|538002941|FG002|Period 1|No longer met study criteria|1|||
149142779|NCT01490450|538002942|FG003|Period 1|No longer met study criteria|0|||
149142780|NCT01490450|538002939|FG000|Period 2|Lack of Efficacy|0|||
149142781|NCT01490450|538002940|FG001|Period 2|Lack of Efficacy|0|||
149142782|NCT01490450|538002941|FG002|Period 2|Lack of Efficacy|0|||
149142783|NCT01490450|538002942|FG003|Period 2|Lack of Efficacy|1|||
149142784|NCT01490450|538002939|FG000|Period 2|Adverse Event|1|||
149142785|NCT01490450|538002940|FG001|Period 2|Adverse Event|1|||
149142786|NCT01490450|538002941|FG002|Period 2|Adverse Event|0|||
149142787|NCT01490450|538002942|FG003|Period 2|Adverse Event|1|||
149142788|NCT01490450|538002939|FG000|Period 2|Withdrawal by Subject|1|||
149142789|NCT01490450|538002940|FG001|Period 2|Withdrawal by Subject|0|||
149142790|NCT01490450|538002941|FG002|Period 2|Withdrawal by Subject|0|||
149142791|NCT01490450|538002942|FG003|Period 2|Withdrawal by Subject|0|||
149142792|NCT01490450|538002939|FG000|Period 2|Lost to Follow-up|0|||
149142793|NCT01490450|538002940|FG001|Period 2|Lost to Follow-up|0|||
149142794|NCT01490450|538002941|FG002|Period 2|Lost to Follow-up|0|||
149142795|NCT01490450|538002942|FG003|Period 2|Lost to Follow-up|2|||
149142796|NCT00404820|538002943|FG000|Overall Study|Adverse Event|4|||
149142797|NCT00404820|538002944|FG001|Overall Study|Adverse Event|16|||
149142798|NCT00404820|538002943|FG000|Overall Study|Withdrawal by Subject|5|||
149142799|NCT00404820|538002944|FG001|Overall Study|Withdrawal by Subject|3|||
149142800|NCT00404820|538002943|FG000|Overall Study|Lost to Follow-up|7|||
149142801|NCT00404820|538002944|FG001|Overall Study|Lost to Follow-up|3|||
149142802|NCT00404820|538002943|FG000|Overall Study|Administrative problems|2|||
149142803|NCT00404820|538002944|FG001|Overall Study|Administrative problems|0|||
149142804|NCT00404820|538002943|FG000|Overall Study|Death|1|||
149142805|NCT00404820|538002944|FG001|Overall Study|Death|0|||
149142806|NCT00404820|538002943|FG000|Overall Study|Other|0|||
149142807|NCT00404820|538002944|FG001|Overall Study|Other|2|||
149142808|NCT00938717|538002945|FG000|Overall Study|Adverse Event|10|||
149142809|NCT00938717|538002946|FG001|Overall Study|Adverse Event|41|||
149142810|NCT00938717|538002945|FG000|Overall Study|Protocol Violation|11|||
149142811|NCT00938717|538002946|FG001|Overall Study|Protocol Violation|8|||
149142812|NCT00938717|538002945|FG000|Overall Study|Withdrawal by Subject|26|||
149142813|NCT00938717|538002946|FG001|Overall Study|Withdrawal by Subject|24|||
149142814|NCT00938717|538002945|FG000|Overall Study|Lost to Follow-up|13|||
149142815|NCT00938717|538002946|FG001|Overall Study|Lost to Follow-up|18|||
149142816|NCT00938717|538002945|FG000|Overall Study|Lack of Efficacy|33|||
149142817|NCT00938717|538002946|FG001|Overall Study|Lack of Efficacy|15|||
149142818|NCT00938717|538002945|FG000|Overall Study|Other reason|5|||
149142819|NCT00938717|538002946|FG001|Overall Study|Other reason|2|||
149142820|NCT01462435|538002948|FG000|Overall Study|Lack of Efficacy|1|||
149142821|NCT01462435|538002949|FG001|Overall Study|Lack of Efficacy|0|||
149142822|NCT01462435|538002950|FG002|Overall Study|Lack of Efficacy|0|||
149142823|NCT01462435|538002951|FG003|Overall Study|Lack of Efficacy|3|||
149142824|NCT01462435|538002948|FG000|Overall Study|Physician Decision|0|||
149142825|NCT01462435|538002949|FG001|Overall Study|Physician Decision|0|||
149142826|NCT01462435|538002950|FG002|Overall Study|Physician Decision|1|||
149142827|NCT01462435|538002951|FG003|Overall Study|Physician Decision|0|||
149142828|NCT01462435|538002948|FG000|Overall Study|Withdrawal by Subject|0|||
149142829|NCT01462435|538002949|FG001|Overall Study|Withdrawal by Subject|0|||
149142830|NCT01462435|538002950|FG002|Overall Study|Withdrawal by Subject|0|||
149142831|NCT01462435|538002951|FG003|Overall Study|Withdrawal by Subject|1|||
149142832|NCT01462435|538002948|FG000|Overall Study|Lost to Follow-up|0|||
149142833|NCT01462435|538002949|FG001|Overall Study|Lost to Follow-up|0|||
149142834|NCT01462435|538002950|FG002|Overall Study|Lost to Follow-up|0|||
149142835|NCT01462435|538002951|FG003|Overall Study|Lost to Follow-up|1|||
149142836|NCT01543152|538002958|FG000|Overall Study|Withdrawal by Subject|0|||
149142837|NCT01543152|538002959|FG001|Overall Study|Withdrawal by Subject|2|||
149142838|NCT01543152|538002960|FG002|Overall Study|Withdrawal by Subject|0|||
149142839|NCT01543152|538002961|FG003|Overall Study|Withdrawal by Subject|0|||
149142840|NCT01543152|538002962|FG004|Overall Study|Withdrawal by Subject|0|||
149142841|NCT02053168|538002965|FG000|Overall Study|Withdrawal by Subject|1|||
149142842|NCT02053168|538002965|FG000|Overall Study|Physician Decision|1|||
149142843|NCT02053168|538002965|FG000|Overall Study|Lost to Follow-up|1|||
149142844|NCT00636675|538002967|FG000|Overall Study|Lost to Follow-up|121|||
149142845|NCT00636675|538002968|FG001|Overall Study|Lost to Follow-up|31|||
149142846|NCT00636675|538002967|FG000|Overall Study|Withdrawal by Subject|19|||
149142847|NCT00636675|538002968|FG001|Overall Study|Withdrawal by Subject|10|||
149142848|NCT02687542|538002969|FG000|Overall Study|Medication error without associated AEs|0|||
149142849|NCT02687542|538002970|FG001|Overall Study|Medication error without associated AEs|0|||
149142850|NCT02687542|538002971|FG002|Overall Study|Medication error without associated AEs|0|||
149142851|NCT02687542|538002972|FG003|Overall Study|Medication error without associated AEs|0|||
149142852|NCT02687542|538002973|FG004|Overall Study|Medication error without associated AEs|1|||
149142853|NCT02687542|538002969|FG000|Overall Study|Lost to Follow-up|0|||
149142854|NCT02687542|538002970|FG001|Overall Study|Lost to Follow-up|0|||
149142855|NCT02687542|538002971|FG002|Overall Study|Lost to Follow-up|0|||
149142856|NCT02687542|538002972|FG003|Overall Study|Lost to Follow-up|0|||
149142857|NCT02687542|538002973|FG004|Overall Study|Lost to Follow-up|1|||
149142858|NCT02687542|538002969|FG000|Overall Study|Protocol Violation|0|||
149142859|NCT02687542|538002970|FG001|Overall Study|Protocol Violation|1|||
149142860|NCT02687542|538002971|FG002|Overall Study|Protocol Violation|0|||
149142861|NCT02687542|538002972|FG003|Overall Study|Protocol Violation|0|||
149142862|NCT02687542|538002973|FG004|Overall Study|Protocol Violation|0|||
149142863|NCT02687542|538002969|FG000|Overall Study|Other|5|||
149142864|NCT02687542|538002970|FG001|Overall Study|Other|9|||
149142865|NCT02687542|538002971|FG002|Overall Study|Other|10|||
148913260|NCT00924027|537164835|FG003|Overall Study|Physician Decision|1|||
148913261|NCT00924027|537164832|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
149142866|NCT02687542|538002972|FG003|Overall Study|Other|6|||
149142867|NCT02687542|538002973|FG004|Overall Study|Other|5|||
149142868|NCT02687542|538002969|FG000|Overall Study|Adverse Event|3|||
149142869|NCT02687542|538002970|FG001|Overall Study|Adverse Event|1|||
149142870|NCT02687542|538002971|FG002|Overall Study|Adverse Event|3|||
149142871|NCT02687542|538002972|FG003|Overall Study|Adverse Event|2|||
149142872|NCT02687542|538002973|FG004|Overall Study|Adverse Event|9|||
149142873|NCT02687542|538002969|FG000|Overall Study|Withdrawal by Subject|0|||
149142874|NCT02687542|538002970|FG001|Overall Study|Withdrawal by Subject|1|||
149142875|NCT02687542|538002971|FG002|Overall Study|Withdrawal by Subject|1|||
149142876|NCT02687542|538002972|FG003|Overall Study|Withdrawal by Subject|2|||
149142877|NCT02687542|538002973|FG004|Overall Study|Withdrawal by Subject|4|||
149142878|NCT01838616|538002974|FG000|Titration Period|Adverse Event|18|||
149142879|NCT01838616|538002975|FG001|Titration Period|Adverse Event|48|||
149142880|NCT01838616|538002974|FG000|Titration Period|Lack of Efficacy|5|||
149142881|NCT01838616|538002975|FG001|Titration Period|Lack of Efficacy|12|||
149142882|NCT01838616|538002974|FG000|Titration Period|Withdrawal by Subject|5|||
149142883|NCT01838616|538002975|FG001|Titration Period|Withdrawal by Subject|5|||
149142884|NCT01838616|538002974|FG000|Titration Period|Technical problems|1|||
149142885|NCT01838616|538002975|FG001|Titration Period|Technical problems|0|||
149142886|NCT01838616|538002974|FG000|Titration Period|Other|1|||
149142887|NCT01838616|538002975|FG001|Titration Period|Other|0|||
149142888|NCT01838616|538002974|FG000|Titration Period|Protocol Violation|0|||
149142889|NCT01838616|538002975|FG001|Titration Period|Protocol Violation|1|||
149142890|NCT01838616|538002974|FG000|Continuation Period|Lack of Efficacy|3|||
149142891|NCT01838616|538002975|FG001|Continuation Period|Lack of Efficacy|5|||
149142892|NCT01838616|538002974|FG000|Continuation Period|Adverse Event|8|||
149142893|NCT01838616|538002975|FG001|Continuation Period|Adverse Event|4|||
149142894|NCT01838616|538002974|FG000|Continuation Period|Protocol Violation|2|||
148913262|NCT00924027|537164833|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
149142895|NCT01838616|538002975|FG001|Continuation Period|Protocol Violation|0|||
149142896|NCT01838616|538002974|FG000|Continuation Period|Lost to Follow-up|1|||
149142897|NCT01838616|538002975|FG001|Continuation Period|Lost to Follow-up|0|||
149142898|NCT01838616|538002974|FG000|Continuation Period|Withdrawal by Subject|0|||
149142899|NCT01838616|538002975|FG001|Continuation Period|Withdrawal by Subject|4|||
149142900|NCT01838616|538002974|FG000|Continuation Period|Technical problems|0|||
149142901|NCT01838616|538002975|FG001|Continuation Period|Technical problems|1|||
149142902|NCT01838616|538002974|FG000|Pick-up Arm|Lack of Efficacy|4|||
149142903|NCT01838616|538002975|FG001|Pick-up Arm|Lack of Efficacy|0|||
149142904|NCT01838616|538002974|FG000|Pick-up Arm|Adverse Event|9|||
149142905|NCT01838616|538002975|FG001|Pick-up Arm|Adverse Event|0|||
149142906|NCT01838616|538002974|FG000|Pick-up Arm|Withdrawal by Subject|1|||
149142907|NCT01838616|538002975|FG001|Pick-up Arm|Withdrawal by Subject|0|||
149142908|NCT01838616|538002974|FG000|Pick-up Arm|Technical problems|1|||
149142909|NCT01838616|538002975|FG001|Pick-up Arm|Technical problems|0|||
149142910|NCT01848288|538002976|FG000|Overall Study|Death|1|||
149142911|NCT01848288|538002976|FG000|Overall Study|Protocol Violation|1|||
149142912|NCT01848288|538002976|FG000|Overall Study|Withdrawal by Subject|1|||
149142913|NCT01007032|538002977|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
149142914|NCT01007032|538002978|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
149142915|NCT01007032|538002979|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
149142916|NCT01007032|538002980|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
149142917|NCT01007032|538002977|FG000|Overall Study|Withdrawal by Subject|0|||
149142918|NCT01007032|538002978|FG001|Overall Study|Withdrawal by Subject|0|||
149142919|NCT01007032|538002979|FG002|Overall Study|Withdrawal by Subject|0|||
149142920|NCT01007032|538002980|FG003|Overall Study|Withdrawal by Subject|1|||
149142921|NCT01101438|538002981|FG000|Overall Study|Withdrawal by Subject|8|||
149142922|NCT01101438|538002982|FG001|Overall Study|Withdrawal by Subject|9|||
149142923|NCT02865018|538002991|FG000|Overall Study|Withdrawal by Subject|1|||
149142924|NCT00139776|538002993|FG000|Period I|Did not enter Period II|575|||
149142925|NCT00139776|538002994|FG001|Period I|Did not enter Period II|0|||
149142926|NCT00139776|538002995|FG002|Period I|Did not enter Period II|0|||
149142927|NCT00139776|538002996|FG003|Period I|Did not enter Period II|0|||
149142928|NCT00139776|538002993|FG000|Period II|Not Randomized into Period III|0|||
149142929|NCT00139776|538002994|FG001|Period II|Not Randomized into Period III|322|||
149142930|NCT00139776|538002995|FG002|Period II|Not Randomized into Period III|0|||
149142931|NCT00139776|538002996|FG003|Period II|Not Randomized into Period III|0|||
149142932|NCT00139776|538002993|FG000|Period III|Adverse Event|0|||
149142933|NCT00139776|538002994|FG001|Period III|Adverse Event|0|||
149142934|NCT00139776|538002995|FG002|Period III|Adverse Event|22|||
149142935|NCT00139776|538002996|FG003|Period III|Adverse Event|23|||
149142936|NCT00139776|538002993|FG000|Period III|Other|0|||
149142937|NCT00139776|538002994|FG001|Period III|Other|0|||
149142938|NCT00139776|538002995|FG002|Period III|Other|23|||
148804829|NCT02100631|536766576|FG000|Overall Study|Lost to Follow-up|3|||
148804830|NCT02100631|536766577|FG001|Overall Study|Lost to Follow-up|4|||
148804831|NCT02100631|536766578|FG002|Overall Study|Lost to Follow-up|0|||
148804832|NCT02100631|536766576|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
148804833|NCT02100631|536766577|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
148804834|NCT02100631|536766578|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
149142939|NCT00139776|538002996|FG003|Period III|Other|34|||
149142940|NCT00139776|538002993|FG000|Period III|Lack of Efficacy|0|||
148804835|NCT03944616|536766579|FG000|Overall Study|Lost to Follow-up|0|||
149142941|NCT00139776|538002994|FG001|Period III|Lack of Efficacy|0|||
149142942|NCT00139776|538002995|FG002|Period III|Lack of Efficacy|10|||
149142943|NCT00139776|538002996|FG003|Period III|Lack of Efficacy|24|||
149142944|NCT00139776|538002993|FG000|Period III|Lost to Follow-up|0|||
149142945|NCT00139776|538002994|FG001|Period III|Lost to Follow-up|0|||
149142946|NCT00139776|538002995|FG002|Period III|Lost to Follow-up|5|||
149142947|NCT00139776|538002996|FG003|Period III|Lost to Follow-up|4|||
149142948|NCT00139776|538002993|FG000|Period III|Withdrawal by Subject|0|||
149142949|NCT00139776|538002994|FG001|Period III|Withdrawal by Subject|0|||
149142950|NCT00139776|538002995|FG002|Period III|Withdrawal by Subject|16|||
149142951|NCT00139776|538002996|FG003|Period III|Withdrawal by Subject|21|||
149142952|NCT00914927|538003001|FG000|Overall Study|Adverse Event|0|||
149142953|NCT00914927|538003002|FG001|Overall Study|Adverse Event|0|||
149142954|NCT00914927|538003003|FG002|Overall Study|Adverse Event|0|||
149142955|NCT00914927|538003004|FG003|Overall Study|Adverse Event|0|||
149142956|NCT00914927|538003005|FG004|Overall Study|Adverse Event|1|||
149142957|NCT00914927|538003006|FG005|Overall Study|Adverse Event|0|||
149142958|NCT00914927|538003007|FG006|Overall Study|Adverse Event|0|||
149142959|NCT00914927|538003001|FG000|Overall Study|Withdrawal by Subject|0|||
149142960|NCT00914927|538003002|FG001|Overall Study|Withdrawal by Subject|1|||
149142961|NCT00914927|538003003|FG002|Overall Study|Withdrawal by Subject|0|||
149142962|NCT00914927|538003004|FG003|Overall Study|Withdrawal by Subject|1|||
149142963|NCT00914927|538003005|FG004|Overall Study|Withdrawal by Subject|0|||
149142964|NCT00914927|538003006|FG005|Overall Study|Withdrawal by Subject|0|||
149142965|NCT00914927|538003007|FG006|Overall Study|Withdrawal by Subject|0|||
149142966|NCT00914927|538003001|FG000|Overall Study|Lost to Follow-up|0|||
149142967|NCT00914927|538003002|FG001|Overall Study|Lost to Follow-up|0|||
149142968|NCT00914927|538003003|FG002|Overall Study|Lost to Follow-up|0|||
149142969|NCT00914927|538003004|FG003|Overall Study|Lost to Follow-up|1|||
149142970|NCT00914927|538003005|FG004|Overall Study|Lost to Follow-up|0|||
149142971|NCT00914927|538003006|FG005|Overall Study|Lost to Follow-up|0|||
149142972|NCT00914927|538003007|FG006|Overall Study|Lost to Follow-up|0|||
149142973|NCT00914927|538003001|FG000|Overall Study|Administrative/Other|2|||
149142974|NCT00914927|538003002|FG001|Overall Study|Administrative/Other|1|||
149142975|NCT00914927|538003003|FG002|Overall Study|Administrative/Other|0|||
148804836|NCT03944616|536766580|FG001|Overall Study|Lost to Follow-up|2|||
148804837|NCT01287936|536766581|FG000|Overall Study|Lost to Follow-up|0|||
148804838|NCT01287936|536766582|FG001|Overall Study|Lost to Follow-up|1|||
148804839|NCT01287936|536766583|FG002|Overall Study|Lost to Follow-up|1|||
148804840|NCT00427934|536766584|FG000|Overall Study|Adverse Event|1|||
148804841|NCT00427934|536766585|FG001|Overall Study|Adverse Event|0|||
148804842|NCT00427934|536766586|FG002|Overall Study|Adverse Event|5|||
148804843|NCT00427934|536766587|FG003|Overall Study|Adverse Event|4|||
149142976|NCT00914927|538003004|FG003|Overall Study|Administrative/Other|0|||
149142977|NCT00914927|538003005|FG004|Overall Study|Administrative/Other|1|||
149142978|NCT00914927|538003006|FG005|Overall Study|Administrative/Other|0|||
149142979|NCT00914927|538003007|FG006|Overall Study|Administrative/Other|0|||
149142980|NCT01519934|538003012|FG000|Overall Study|Lost to Follow-up|3|||
149142981|NCT02164929|538003019|FG000|Overall Study|Converted to open procedure|1|||
149142982|NCT02164929|538003020|FG001|Overall Study|Converted to open procedure|0|||
149142983|NCT02164929|538003021|FG002|Overall Study|Converted to open procedure|0|||
149142984|NCT02164929|538003022|FG003|Overall Study|Converted to open procedure|2|||
149142985|NCT02164929|538003019|FG000|Overall Study|Failed regional block|0|||
149142986|NCT02164929|538003020|FG001|Overall Study|Failed regional block|0|||
149142987|NCT02164929|538003021|FG002|Overall Study|Failed regional block|1|||
149142988|NCT02164929|538003022|FG003|Overall Study|Failed regional block|0|||
149142989|NCT00365456|538003028|FG000|Trial Period I (12 Months)|Adverse Event|84|||
149142990|NCT00365456|538003029|FG001|Trial Period I (12 Months)|Adverse Event|0|||
149142991|NCT00365456|538003028|FG000|Trial Period I (12 Months)|Non-compliance|3|||
149142992|NCT00365456|538003029|FG001|Trial Period I (12 Months)|Non-compliance|0|||
149142993|NCT00365456|538003028|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
149142994|NCT00365456|538003029|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
149142995|NCT00365456|538003028|FG000|Trial Period I (12 Months)|Other|11|||
149142996|NCT00365456|538003029|FG001|Trial Period I (12 Months)|Other|0|||
149142997|NCT00365456|538003028|FG000|Trial Period II (12 Months)|Adverse Event|0|||
149142998|NCT00365456|538003029|FG001|Trial Period II (12 Months)|Adverse Event|6|||
149142999|NCT00365456|538003028|FG000|Trial Period II (12 Months)|Non-compliance|0|||
149143000|NCT00365456|538003029|FG001|Trial Period II (12 Months)|Non-compliance|2|||
149143001|NCT00365456|538003028|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
149143002|NCT00365456|538003029|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
149143003|NCT00365456|538003028|FG000|Trial Period II (12 Months)|Other|0|||
149143004|NCT00365456|538003029|FG001|Trial Period II (12 Months)|Other|1|||
149143005|NCT00365456|538003028|FG000|Trial Period III (12 Months)|Adverse Event|13|||
149143006|NCT00365456|538003029|FG001|Trial Period III (12 Months)|Adverse Event|3|||
149143007|NCT00365456|538003028|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
149143008|NCT00365456|538003029|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
149143009|NCT00365456|538003028|FG000|Trial Period III (12 Months)|Other|1|||
149143010|NCT00365456|538003029|FG001|Trial Period III (12 Months)|Other|1|||
149143011|NCT02161575|538003031|FG000|Overall Study|Protocol Violation|8|||
149143012|NCT02161575|538003031|FG000|Overall Study|Lack of Efficacy|1|||
149143013|NCT02161575|538003031|FG000|Overall Study|Adverse Event|2|||
149143014|NCT00714285|538003032|FG000|Overall Study|Lost to Follow-up|0|||
149143015|NCT00714285|538003033|FG001|Overall Study|Lost to Follow-up|2|||
149143016|NCT00714285|538003034|FG002|Overall Study|Lost to Follow-up|0|||
149143017|NCT00714285|538003035|FG003|Overall Study|Lost to Follow-up|1|||
149143018|NCT00714285|538003032|FG000|Overall Study|Migrated/moved from study area|0|||
149143019|NCT00714285|538003033|FG001|Overall Study|Migrated/moved from study area|1|||
149143020|NCT00714285|538003034|FG002|Overall Study|Migrated/moved from study area|0|||
149143021|NCT00714285|538003035|FG003|Overall Study|Migrated/moved from study area|0|||
149143022|NCT02138617|538003036|FG000|Overall Study|Death|1|||
149143023|NCT02138617|538003037|FG001|Overall Study|Death|2|||
149143024|NCT02138617|538003038|FG002|Overall Study|Death|2|||
149143025|NCT02138617|538003036|FG000|Overall Study|Adverse Event|8|||
149143026|NCT02138617|538003037|FG001|Overall Study|Adverse Event|5|||
149143027|NCT02138617|538003038|FG002|Overall Study|Adverse Event|2|||
149143028|NCT02138617|538003036|FG000|Overall Study|Disease Progression|20|||
149143029|NCT02138617|538003037|FG001|Overall Study|Disease Progression|13|||
149143030|NCT02138617|538003038|FG002|Overall Study|Disease Progression|4|||
149143031|NCT02138617|538003036|FG000|Overall Study|Withdrawal by Subject|7|||
149143032|NCT02138617|538003037|FG001|Overall Study|Withdrawal by Subject|10|||
149143033|NCT02138617|538003038|FG002|Overall Study|Withdrawal by Subject|2|||
149143034|NCT02138617|538003036|FG000|Overall Study|other complicating disease|0|||
149143035|NCT02138617|538003037|FG001|Overall Study|other complicating disease|2|||
149143036|NCT02138617|538003038|FG002|Overall Study|other complicating disease|0|||
149143037|NCT02138617|538003036|FG000|Overall Study|Protocol Violation|1|||
149143038|NCT02138617|538003037|FG001|Overall Study|Protocol Violation|0|||
149143039|NCT02138617|538003038|FG002|Overall Study|Protocol Violation|0|||
148804844|NCT00427934|536766584|FG000|Overall Study|Lack of Efficacy|0|||
149143040|NCT02138617|538003036|FG000|Overall Study|Physician Decision|7|||
149143041|NCT02138617|538003037|FG001|Overall Study|Physician Decision|6|||
149143042|NCT02138617|538003038|FG002|Overall Study|Physician Decision|0|||
149143043|NCT02138617|538003036|FG000|Overall Study|financial reason|0|||
149143044|NCT02138617|538003037|FG001|Overall Study|financial reason|1|||
149143045|NCT02138617|538003038|FG002|Overall Study|financial reason|0|||
149143046|NCT02138617|538003036|FG000|Overall Study|other therapy|3|||
149143047|NCT02138617|538003037|FG001|Overall Study|other therapy|4|||
149143048|NCT02138617|538003038|FG002|Overall Study|other therapy|0|||
149143049|NCT00702325|538003053|FG000|Overall Study|Adverse Event|1|||
149143050|NCT00702325|538003054|FG001|Overall Study|Adverse Event|0|||
149143051|NCT00702325|538003053|FG000|Overall Study|Withdrawal by Subject|7|||
149143052|NCT00702325|538003054|FG001|Overall Study|Withdrawal by Subject|7|||
149143053|NCT00702325|538003053|FG000|Overall Study|Lost to Follow-up|3|||
149143054|NCT00702325|538003054|FG001|Overall Study|Lost to Follow-up|4|||
148804845|NCT00427934|536766585|FG001|Overall Study|Lack of Efficacy|0|||
148804846|NCT00427934|536766586|FG002|Overall Study|Lack of Efficacy|5|||
149143055|NCT00702325|538003053|FG000|Overall Study|Incorrect enrollment|5|||
149143056|NCT00702325|538003054|FG001|Overall Study|Incorrect enrollment|7|||
149143057|NCT00702325|538003053|FG000|Overall Study|Developed study discontinuation criteria|18|||
149143058|NCT00702325|538003054|FG001|Overall Study|Developed study discontinuation criteria|28|||
149143059|NCT00702325|538003053|FG000|Overall Study|Severe noncompliance to protocol|3|||
149143060|NCT00702325|538003054|FG001|Overall Study|Severe noncompliance to protocol|3|||
149143061|NCT00702325|538003053|FG000|Overall Study|Termination due to lab results|1|||
149143062|NCT00702325|538003054|FG001|Overall Study|Termination due to lab results|0|||
149143063|NCT00702325|538003053|FG000|Overall Study|Didn't follow study medication dosage|0|||
149143064|NCT00702325|538003054|FG001|Overall Study|Didn't follow study medication dosage|2|||
149143065|NCT00702325|538003053|FG000|Overall Study|Withdrew consent|0|||
149143066|NCT00702325|538003054|FG001|Overall Study|Withdrew consent|1|||
149143067|NCT00702325|538003053|FG000|Overall Study|Incorrectly Discontinued|0|||
149143068|NCT00702325|538003054|FG001|Overall Study|Incorrectly Discontinued|1|||
149143069|NCT04556136|538003058|FG000|Overall Study|Lost to Follow-up|6|||
149143070|NCT04556136|538003059|FG001|Overall Study|Lost to Follow-up|6|||
149143071|NCT04556136|538003058|FG000|Overall Study|Physician Decision|2|||
149143072|NCT04556136|538003059|FG001|Overall Study|Physician Decision|1|||
149143073|NCT04556136|538003058|FG000|Overall Study|Withdrawal by Subject|2|||
149143074|NCT04556136|538003059|FG001|Overall Study|Withdrawal by Subject|1|||
149143075|NCT01022502|538003062|FG000|Overall Study|Adverse Event|1|||
149143076|NCT01022502|538003062|FG000|Overall Study|employment related reasons|1|||
149143077|NCT01022502|538003062|FG000|Overall Study|Withdrawal by Subject|1|||
149143078|NCT00073528|538003070|FG000|Overall Study|Death|488|||
149143079|NCT00073528|538003071|FG001|Overall Study|Death|473|||
149143080|NCT00073528|538003070|FG000|Overall Study|Lost to Follow-up|52|||
149143081|NCT00073528|538003071|FG001|Overall Study|Lost to Follow-up|45|||
149143082|NCT00073528|538003070|FG000|Overall Study|Withdrawal by Subject|50|||
149143083|NCT00073528|538003071|FG001|Overall Study|Withdrawal by Subject|45|||
149143084|NCT00073528|538003070|FG000|Overall Study|Study terminated by Sponsor|10|||
149143085|NCT00073528|538003071|FG001|Overall Study|Study terminated by Sponsor|29|||
149143086|NCT00073528|538003070|FG000|Overall Study|Other|18|||
148691438|NCT01325207|536344176|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
148804847|NCT00427934|536766587|FG003|Overall Study|Lack of Efficacy|2|||
148804848|NCT00427934|536766584|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
149143087|NCT00073528|538003071|FG001|Overall Study|Other|19|||
149143088|NCT00073528|538003070|FG000|Overall Study|Other|9|||
149143089|NCT00073528|538003071|FG001|Overall Study|Other|12|||
149143090|NCT00073528|538003070|FG000|Overall Study|Protocol Violation|3|||
149143091|NCT00073528|538003071|FG001|Overall Study|Protocol Violation|5|||
149143092|NCT00003702|538003074|FG000|Overall Study|Ineligible cell types|2|||
149143093|NCT00003702|538003075|FG001|Overall Study|Ineligible cell types|2|||
149143094|NCT00003702|538003074|FG000|Overall Study|Did not meet criteria for persistence|8|||
149143095|NCT00003702|538003075|FG001|Overall Study|Did not meet criteria for persistence|5|||
149143096|NCT00003702|538003074|FG000|Overall Study|WHO score > 6|2|||
149143097|NCT00003702|538003075|FG001|Overall Study|WHO score > 6|1|||
149143098|NCT00003702|538003074|FG000|Overall Study|Inadequate documentation of disease|1|||
149143099|NCT00003702|538003075|FG001|Overall Study|Inadequate documentation of disease|3|||
149143100|NCT02790138|538003076|FG000|Overall Study|Adverse Event|5|||
149143101|NCT02790138|538003077|FG001|Overall Study|Adverse Event|2|||
149143102|NCT02790138|538003076|FG000|Overall Study|Significant Protocol Deviation|0|||
149143103|NCT02790138|538003077|FG001|Overall Study|Significant Protocol Deviation|1|||
149143104|NCT02790138|538003076|FG000|Overall Study|Lost to Follow-up|1|||
149143105|NCT02790138|538003077|FG001|Overall Study|Lost to Follow-up|0|||
149143106|NCT02790138|538003076|FG000|Overall Study|Voluntary Withdrawal|8|||
149143107|NCT02790138|538003077|FG001|Overall Study|Voluntary Withdrawal|9|||
149143108|NCT02790138|538003076|FG000|Overall Study|Lack of Efficacy|6|||
149143109|NCT02790138|538003077|FG001|Overall Study|Lack of Efficacy|7|||
149143110|NCT02790138|538003076|FG000|Overall Study|Reason not Specified|1|||
149143111|NCT02790138|538003077|FG001|Overall Study|Reason not Specified|0|||
149143112|NCT03199040|538003078|FG000|Overall Study|Lack of Efficacy|2|||
149143113|NCT03199040|538003079|FG001|Overall Study|Lack of Efficacy|0|||
149143114|NCT03199040|538003078|FG000|Overall Study|Withdrawal by Subject|2|||
149143115|NCT03199040|538003079|FG001|Overall Study|Withdrawal by Subject|0|||
149143116|NCT03199040|538003078|FG000|Overall Study|Adverse Event|0|||
149143117|NCT03199040|538003079|FG001|Overall Study|Adverse Event|1|||
149143118|NCT03199040|538003078|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
149143119|NCT03199040|538003079|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
149143120|NCT01226459|538003080|FG000|Overall Study|Adverse Event|2|||
148804849|NCT00427934|536766585|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
148804850|NCT00427934|536766586|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
149143121|NCT01226459|538003081|FG001|Overall Study|Adverse Event|8|||
149143122|NCT01226459|538003080|FG000|Overall Study|Protocol Violation|4|||
149143123|NCT01226459|538003081|FG001|Overall Study|Protocol Violation|3|||
149143124|NCT01226459|538003080|FG000|Overall Study|Withdrawal by Subject|10|||
149143125|NCT01226459|538003081|FG001|Overall Study|Withdrawal by Subject|13|||
149143126|NCT01226459|538003080|FG000|Overall Study|Lost to Follow-up|4|||
149143127|NCT01226459|538003081|FG001|Overall Study|Lost to Follow-up|8|||
149143128|NCT01226459|538003080|FG000|Overall Study|Pregnancy|1|||
149143129|NCT01226459|538003081|FG001|Overall Study|Pregnancy|0|||
149143130|NCT00474708|538003082|FG000|Overall Study|Lack of Efficacy|11|||
149143131|NCT00474708|538003083|FG001|Overall Study|Lack of Efficacy|5|||
149143132|NCT00474708|538003082|FG000|Overall Study|Suicide ideation/behavior|0|||
149143133|NCT00474708|538003083|FG001|Overall Study|Suicide ideation/behavior|1|||
149143134|NCT00474708|538003082|FG000|Overall Study|Withdrawal by Subject|7|||
149143135|NCT00474708|538003083|FG001|Overall Study|Withdrawal by Subject|0|||
149143136|NCT00474708|538003082|FG000|Overall Study|Lack of compliance|12|||
149143137|NCT00474708|538003083|FG001|Overall Study|Lack of compliance|4|||
149143138|NCT00474708|538003082|FG000|Overall Study|Lost to Follow-up|18|||
149143139|NCT00474708|538003083|FG001|Overall Study|Lost to Follow-up|9|||
149143140|NCT00474708|538003082|FG000|Overall Study|Physician Decision|9|||
149143141|NCT00474708|538003083|FG001|Overall Study|Physician Decision|6|||
149143142|NCT00574145|538004795|FG000|Overall Study|Withdrawal by Subject|2|||
149143143|NCT00574145|538004796|FG001|Overall Study|Withdrawal by Subject|1|||
149143144|NCT03227471|538004797|FG000|Overall Study|Withdrawal by Subject|0|||
149143145|NCT03227471|538004798|FG001|Overall Study|Withdrawal by Subject|0|||
149143146|NCT03227471|538004799|FG002|Overall Study|Withdrawal by Subject|0|||
149143147|NCT03227471|538004800|FG003|Overall Study|Withdrawal by Subject|0|||
149143148|NCT03227471|538004801|FG004|Overall Study|Withdrawal by Subject|1|||
149143149|NCT03227471|538004802|FG005|Overall Study|Withdrawal by Subject|0|||
149143150|NCT03227471|538004803|FG006|Overall Study|Withdrawal by Subject|0|||
149143151|NCT03227471|538004804|FG007|Overall Study|Withdrawal by Subject|0|||
149143152|NCT03227471|538004805|FG008|Overall Study|Withdrawal by Subject|0|||
149143153|NCT03227471|538004806|FG009|Overall Study|Withdrawal by Subject|0|||
149143154|NCT03227471|538004807|FG010|Overall Study|Withdrawal by Subject|0|||
149143155|NCT03227471|538004808|FG011|Overall Study|Withdrawal by Subject|0|||
149143156|NCT03227471|538004809|FG012|Overall Study|Withdrawal by Subject|1|||
149143157|NCT03227471|538004810|FG013|Overall Study|Withdrawal by Subject|0|||
149143158|NCT03227471|538004811|FG014|Overall Study|Withdrawal by Subject|0|||
149143159|NCT03227471|538004797|FG000|Overall Study|Randomized, Never Dosed|0|||
149143160|NCT03227471|538004798|FG001|Overall Study|Randomized, Never Dosed|0|||
149143161|NCT03227471|538004799|FG002|Overall Study|Randomized, Never Dosed|0|||
149143162|NCT03227471|538004800|FG003|Overall Study|Randomized, Never Dosed|0|||
149143163|NCT03227471|538004801|FG004|Overall Study|Randomized, Never Dosed|0|||
149143164|NCT03227471|538004802|FG005|Overall Study|Randomized, Never Dosed|0|||
149143165|NCT03227471|538004803|FG006|Overall Study|Randomized, Never Dosed|0|||
149143166|NCT03227471|538004804|FG007|Overall Study|Randomized, Never Dosed|0|||
149143167|NCT03227471|538004805|FG008|Overall Study|Randomized, Never Dosed|0|||
149143168|NCT03227471|538004806|FG009|Overall Study|Randomized, Never Dosed|0|||
149143169|NCT03227471|538004807|FG010|Overall Study|Randomized, Never Dosed|0|||
149143170|NCT03227471|538004808|FG011|Overall Study|Randomized, Never Dosed|0|||
149143171|NCT03227471|538004809|FG012|Overall Study|Randomized, Never Dosed|0|||
149143172|NCT03227471|538004810|FG013|Overall Study|Randomized, Never Dosed|0|||
149143173|NCT03227471|538004811|FG014|Overall Study|Randomized, Never Dosed|1|||
149143174|NCT00449670|538004812|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
149143175|NCT00449670|538004813|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
149143176|NCT00449670|538004812|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
149143177|NCT00449670|538004813|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
149143178|NCT00449670|538004812|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
149143179|NCT00449670|538004813|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
149143180|NCT00449670|538004812|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
149143181|NCT00449670|538004813|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
149143182|NCT00449670|538004812|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
149143183|NCT00449670|538004813|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
149143184|NCT00449670|538004812|FG000|Booster Phase (Study no.109873)|Other|0|||
149143185|NCT00449670|538004813|FG001|Booster Phase (Study no.109873)|Other|2|||
149143186|NCT04183790|538004814|FG000|Overall Study|Participants did not rollover to Part B|12|||
149143187|NCT04183790|538004815|FG001|Overall Study|Participants did not rollover to Part B|0|||
149143188|NCT04183790|538004814|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
149143189|NCT04183790|538004815|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
149143190|NCT04183790|538004814|FG000|Overall Study|Commercial drug is available for participant|6|||
149143191|NCT04183790|538004815|FG001|Overall Study|Commercial drug is available for participant|0|||
149143192|NCT04183790|538004814|FG000|Overall Study|Adverse Event|1|||
149143193|NCT04183790|538004815|FG001|Overall Study|Adverse Event|0|||
149143194|NCT04183790|538004814|FG000|Overall Study|Not enrolled in 107 study|0|||
149143195|NCT04183790|538004815|FG001|Overall Study|Not enrolled in 107 study|2|||
149143196|NCT03197493|538004816|FG000|Overall Study|Withdrawal by Subject|5|||
149143197|NCT00176605|538004818|FG000|Overall Study|Withdrawal by Subject|2|||
149143198|NCT01321710|538004819|FG000|Overall Study|Lost to Follow-up|4|||
149143199|NCT01321710|538004820|FG001|Overall Study|Lost to Follow-up|5|||
149143200|NCT01321710|538004821|FG002|Overall Study|Lost to Follow-up|0|||
149143201|NCT01566773|538004823|FG000|Overall Study|Protocol specified criteria|4|||
149143202|NCT01566773|538004823|FG000|Overall Study|Protocol Violation|4|||
149143203|NCT01566773|538004823|FG000|Overall Study|Withdrawal by Subject|9|||
149143204|NCT01566773|538004823|FG000|Overall Study|Administrative reason|1|||
149143205|NCT01566773|538004823|FG000|Overall Study|Adverse Event|10|||
149143206|NCT01566773|538004823|FG000|Overall Study|Physician Decision|2|||
149143207|NCT00833053|538004824|FG000|Overall Study|Adverse Event|4|||
149143208|NCT00833053|538004825|FG001|Overall Study|Adverse Event|0|||
149143209|NCT00833053|538004824|FG000|Overall Study|Treatment Failure|3|||
149143210|NCT00833053|538004825|FG001|Overall Study|Treatment Failure|1|||
149143211|NCT00833053|538004824|FG000|Overall Study|Withdrawal by Subject|0|||
149143212|NCT00833053|538004825|FG001|Overall Study|Withdrawal by Subject|1|||
149143213|NCT00833053|538004824|FG000|Overall Study|Protocol Violation|2|||
149143214|NCT00833053|538004825|FG001|Overall Study|Protocol Violation|1|||
149143215|NCT02318667|538004826|FG000|Overall Study|Adverse Event|1|||
149143216|NCT02318667|538004826|FG000|Overall Study|Lack of Efficacy|6|||
149143217|NCT02318667|538004826|FG000|Overall Study|Protocol Violation|2|||
149143218|NCT01033734|538004827|FG000|Overall Study|Withdrawal by Subject|1|||
149143219|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
149143220|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
149143221|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
149143222|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
149143223|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
149143224|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
149143225|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
149143226|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
149143227|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
149143228|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
149143229|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
149143230|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
149143231|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
149143232|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
149143233|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
149143234|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
149143235|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
149143236|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
149143237|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
149143238|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
149143239|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
149143240|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
149143241|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
149143242|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
149143243|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
149143244|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
149143245|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
149143246|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
149143247|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
149143248|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
149143249|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143250|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
149143251|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
149143252|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
149143253|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143254|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
149143255|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
149143256|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
149143257|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
149143258|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
149143259|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
149143260|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
149143261|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
149143262|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
149143263|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
149143264|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
149143265|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
149143266|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
149143267|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
149143268|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
149143269|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
149143270|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
149143271|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
149143272|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
149143273|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
149143274|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
149143275|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
149143276|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
149143277|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
149143278|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
148804851|NCT00427934|536766587|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
148804852|NCT00427934|536766584|FG000|Overall Study|Other|0|||
148804853|NCT00427934|536766585|FG001|Overall Study|Other|0|||
148804854|NCT00427934|536766586|FG002|Overall Study|Other|11|||
149143279|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
149143280|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
149143281|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
149143282|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
149143283|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
149143284|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
149143285|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
149143286|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
149143287|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
149143288|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
149143289|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
149143290|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
149143291|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
149143292|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
149143293|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
149143294|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
149143295|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
149143296|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
149143297|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
149143298|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
149143299|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
149143300|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
149143301|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
149143302|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
149143303|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
149143304|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
149143305|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
149143306|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
149143307|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
149143308|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
149143309|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
149143310|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
149143311|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
149143312|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
149143313|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
149143314|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
149143315|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
149143316|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
149143317|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
149143318|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
149143319|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
149143320|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
149143321|NCT00111800|538004831|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
149143322|NCT00111800|538004832|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
149143323|NCT00111800|538004833|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
149143324|NCT00111800|538004834|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
149143325|NCT00111800|538004835|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
149143326|NCT00111800|538004836|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
149143327|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
149143328|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
149143329|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
149143330|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
148804855|NCT00427934|536766587|FG003|Overall Study|Other|5|||
148804856|NCT00427934|536766584|FG000|Overall Study|Withdrawal by Subject|0|||
149143331|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
149143332|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
149143333|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
149143334|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
149143335|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
149143336|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
149143337|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
149143338|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
149143339|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
149143340|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
149143341|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
149143342|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
149143343|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
149143344|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
149143345|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
149143346|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
149143347|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
149143348|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
149143349|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
149143350|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
149143351|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143352|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143353|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
149143354|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143355|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143356|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
149143357|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
149143358|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
149143359|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
149143360|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
149143361|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
149143362|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
149143363|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
149143364|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
149143365|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
149143366|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
149143367|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
149143368|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
149143369|NCT00111800|538004831|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
149143370|NCT00111800|538004832|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
149143371|NCT00111800|538004833|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
149143372|NCT00111800|538004834|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
149143373|NCT00111800|538004835|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
149143374|NCT00111800|538004836|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
149143375|NCT00971178|538004837|FG000|Overall Study|Lost to Follow-up|2|||
149143376|NCT00971178|538004838|FG001|Overall Study|Lost to Follow-up|2|||
149143377|NCT00971178|538004839|FG002|Overall Study|Lost to Follow-up|2|||
149143378|NCT00326209|538004840|FG000|Overall Study|Adverse Event|28|||
149143379|NCT00326209|538004840|FG000|Overall Study|Withdrawal by Subject|22|||
149143380|NCT00326209|538004840|FG000|Overall Study|Lack of Efficacy|31|||
149143381|NCT00326209|538004840|FG000|Overall Study|Lost to Follow-up|18|||
149143382|NCT00326209|538004840|FG000|Overall Study|Participant non-compliant|6|||
149143383|NCT00326209|538004840|FG000|Overall Study|Sponsor closed study|173|||
149143384|NCT00326209|538004840|FG000|Overall Study|Prohibited medication use|1|||
149143385|NCT00326209|538004840|FG000|Overall Study|Violation of entry criteria|1|||
149143386|NCT00326209|538004840|FG000|Overall Study|Withdrawn in error|1|||
149143387|NCT00326209|538004840|FG000|Overall Study|Pregnancy|1|||
149143388|NCT04109222|538004841|FG000|Overall Study|Adverse Event|1|||
149143389|NCT04109222|538004842|FG001|Overall Study|Adverse Event|0|||
149143390|NCT04109222|538004843|FG002|Overall Study|Adverse Event|0|||
149143391|NCT02577406|538004844|FG000|Randomized Period|Death|1|||
149143392|NCT02577406|538004845|FG001|Randomized Period|Death|0|||
149143393|NCT02577406|538004844|FG000|Randomized Period|Other reasons|0|||
149143394|NCT02577406|538004845|FG001|Randomized Period|Other reasons|20|||
149143395|NCT02577406|538004844|FG000|Treatment Period|Death|38|||
149143396|NCT02577406|538004845|FG001|Treatment Period|Death|23|||
149143397|NCT02577406|538004844|FG000|Treatment Period|Adverse Event|17|||
149143398|NCT02577406|538004845|FG001|Treatment Period|Adverse Event|12|||
149143399|NCT02577406|538004844|FG000|Treatment Period|Progressive Disease|53|||
149143400|NCT02577406|538004845|FG001|Treatment Period|Progressive Disease|37|||
149143401|NCT02577406|538004844|FG000|Treatment Period|Withdrawal by Subject|10|||
149143402|NCT02577406|538004845|FG001|Treatment Period|Withdrawal by Subject|24|||
149143403|NCT02577406|538004844|FG000|Treatment Period|Lost to Follow-up|0|||
149143404|NCT02577406|538004845|FG001|Treatment Period|Lost to Follow-up|1|||
149143405|NCT02577406|538004844|FG000|Treatment Period|Transition to commercially available treatment|1|||
149143406|NCT02577406|538004845|FG001|Treatment Period|Transition to commercially available treatment|1|||
149143407|NCT02577406|538004844|FG000|Treatment Period|Physician Decision|1|||
149143408|NCT02577406|538004845|FG001|Treatment Period|Physician Decision|0|||
149143409|NCT02577406|538004844|FG000|Treatment Period|Disease Relapse|28|||
149143410|NCT02577406|538004845|FG001|Treatment Period|Disease Relapse|1|||
149143411|NCT02577406|538004844|FG000|Treatment Period|Protocol Violation|0|||
149143412|NCT02577406|538004845|FG001|Treatment Period|Protocol Violation|1|||
149143413|NCT02577406|538004844|FG000|Treatment Period|Other Reasons|3|||
149143414|NCT02577406|538004845|FG001|Treatment Period|Other Reasons|39|||
149143415|NCT02577406|538004844|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
149143416|NCT02577406|538004845|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
149143417|NCT01111851|538004851|FG000|Overall Study|All planned PET scans were not obtained.|2|||
149143418|NCT01111851|538004852|FG001|Overall Study|All planned PET scans were not obtained.|0|||
149143419|NCT05500274|538004853|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
149143420|NCT05500274|538004854|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
149143421|NCT05500274|538004853|FG000|Overall Study|Lost to Follow-up|76|||
149143422|NCT05500274|538004854|FG001|Overall Study|Lost to Follow-up|51|||
149143423|NCT05807464|538004857|FG000|Overall Study|Adverse Event|1|||
149143424|NCT01555151|538004859|FG000|Overall Study|Withdrawal by Subject|6|||
149143425|NCT01555151|538004860|FG001|Overall Study|Withdrawal by Subject|2|||
149143426|NCT01555151|538004861|FG002|Overall Study|Withdrawal by Subject|0|||
149143427|NCT01555151|538004862|FG003|Overall Study|Withdrawal by Subject|2|||
149143428|NCT01555151|538004859|FG000|Overall Study|Administrative|3|||
149143429|NCT01555151|538004860|FG001|Overall Study|Administrative|1|||
149143430|NCT01555151|538004861|FG002|Overall Study|Administrative|2|||
149143431|NCT01555151|538004862|FG003|Overall Study|Administrative|0|||
149143432|NCT01555151|538004859|FG000|Overall Study|Protocol Violation|3|||
149143433|NCT01555151|538004860|FG001|Overall Study|Protocol Violation|3|||
149143434|NCT01555151|538004861|FG002|Overall Study|Protocol Violation|3|||
149143435|NCT01555151|538004862|FG003|Overall Study|Protocol Violation|5|||
149143436|NCT01555151|538004859|FG000|Overall Study|Adverse Event|1|||
149143437|NCT01555151|538004860|FG001|Overall Study|Adverse Event|2|||
149143438|NCT01555151|538004861|FG002|Overall Study|Adverse Event|1|||
149143439|NCT01555151|538004862|FG003|Overall Study|Adverse Event|2|||
149143440|NCT01555151|538004859|FG000|Overall Study|Lost to Follow-up|0|||
149143441|NCT01555151|538004860|FG001|Overall Study|Lost to Follow-up|0|||
149143442|NCT01555151|538004861|FG002|Overall Study|Lost to Follow-up|0|||
149143443|NCT01555151|538004862|FG003|Overall Study|Lost to Follow-up|1|||
149143444|NCT03596866|538004863|FG000|Overall Study|Site terminated by Sponsor|64|||
149143445|NCT03596866|538004864|FG001|Overall Study|Site terminated by Sponsor|65|||
149143446|NCT03596866|538004863|FG000|Overall Study|Death|37|||
149143447|NCT03596866|538004864|FG001|Overall Study|Death|24|||
149143448|NCT03596866|538004863|FG000|Overall Study|Withdrawal by Subject|4|||
149143449|NCT03596866|538004864|FG001|Overall Study|Withdrawal by Subject|6|||
149143450|NCT03596866|538004863|FG000|Overall Study|Missing|0|||
149143451|NCT03596866|538004864|FG001|Overall Study|Missing|6|||
149143452|NCT03596866|538004863|FG000|Overall Study|Lost to Follow-up|2|||
149143453|NCT03596866|538004864|FG001|Overall Study|Lost to Follow-up|3|||
149143454|NCT03596866|538004863|FG000|Overall Study|Protocol Violation|1|||
149143455|NCT03596866|538004864|FG001|Overall Study|Protocol Violation|0|||
149143456|NCT03596866|538004863|FG000|Overall Study|Reason Not Specified|14|||
149143457|NCT03596866|538004864|FG001|Overall Study|Reason Not Specified|13|||
149143458|NCT01816061|538004865|FG000|Overall Study|Lost to Follow-up|13|||
149143459|NCT01816061|538004866|FG001|Overall Study|Lost to Follow-up|24|||
149143460|NCT01961349|538004867|FG000|Overall Study|Withdrawal by Subject|1|||
149143461|NCT01961349|538004868|FG001|Overall Study|Withdrawal by Subject|4|||
149143462|NCT01961349|538004869|FG002|Overall Study|Withdrawal by Subject|0|||
149143463|NCT01961349|538004867|FG000|Overall Study|Adverse Event|0|||
148913263|NCT00924027|537164834|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
148913264|NCT00924027|537164835|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
148913265|NCT00924027|537164832|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
148913266|NCT00924027|537164833|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
149143464|NCT01961349|538004868|FG001|Overall Study|Adverse Event|0|||
149143465|NCT01961349|538004869|FG002|Overall Study|Adverse Event|1|||
149143466|NCT01961349|538004867|FG000|Overall Study|registration error, personal reason etc|2|||
149143467|NCT01961349|538004868|FG001|Overall Study|registration error, personal reason etc|2|||
148913267|NCT00924027|537164834|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
148913268|NCT00924027|537164835|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
149143468|NCT01961349|538004869|FG002|Overall Study|registration error, personal reason etc|1|||
149143469|NCT05525689|538004871|FG000|Overall Study|Lost to Follow-up|1|||
149143470|NCT05525689|538004872|FG001|Overall Study|Lost to Follow-up|0|||
149143471|NCT01671111|538004875|FG000|Overall Study|Adverse Event|2|||
149143472|NCT01671111|538004875|FG000|Overall Study|Lack of Efficacy|1|||
149143473|NCT01671111|538004875|FG000|Overall Study|Withdrawal by Subject|2|||
149143474|NCT01671111|538004875|FG000|Overall Study|Physician Decision|1|||
149143475|NCT01671111|538004875|FG000|Overall Study|Other|24|||
149143476|NCT02343159|538004876|FG000|Overall Study|Early Study Termination|16|||
149143477|NCT02343159|538004877|FG001|Overall Study|Early Study Termination|19|||
149143478|NCT02343159|538004878|FG002|Overall Study|Early Study Termination|23|||
149143479|NCT02343159|538004876|FG000|Overall Study|Physician Decision|2|||
149143480|NCT02343159|538004877|FG001|Overall Study|Physician Decision|0|||
149143481|NCT02343159|538004878|FG002|Overall Study|Physician Decision|1|||
149143482|NCT02343159|538004876|FG000|Overall Study|Withdrawal by Subject|3|||
149143483|NCT02343159|538004877|FG001|Overall Study|Withdrawal by Subject|0|||
149143484|NCT02343159|538004878|FG002|Overall Study|Withdrawal by Subject|2|||
149143485|NCT02343159|538004876|FG000|Overall Study|Lost to Follow-up|0|||
149143486|NCT02343159|538004877|FG001|Overall Study|Lost to Follow-up|2|||
149143487|NCT02343159|538004878|FG002|Overall Study|Lost to Follow-up|2|||
149143488|NCT02343159|538004876|FG000|Overall Study|Adverse Event|4|||
149143489|NCT02343159|538004877|FG001|Overall Study|Adverse Event|4|||
149143490|NCT02343159|538004878|FG002|Overall Study|Adverse Event|2|||
149143491|NCT02343159|538004876|FG000|Overall Study|Sponsor Decision|0|||
149143492|NCT02343159|538004877|FG001|Overall Study|Sponsor Decision|1|||
149143493|NCT02343159|538004878|FG002|Overall Study|Sponsor Decision|0|||
149143494|NCT02343159|538004876|FG000|Overall Study|Enrollment Error|1|||
149143495|NCT02343159|538004877|FG001|Overall Study|Enrollment Error|0|||
149143496|NCT02343159|538004878|FG002|Overall Study|Enrollment Error|0|||
149143497|NCT01092143|538004881|FG000|Overall Study|Adverse Event|10|||
149143498|NCT01092143|538004882|FG001|Overall Study|Adverse Event|5|||
149143499|NCT01092143|538004883|FG002|Overall Study|Adverse Event|1|||
149143500|NCT01092143|538004884|FG003|Overall Study|Adverse Event|4|||
149143501|NCT01092143|538004885|FG004|Overall Study|Adverse Event|3|||
149143502|NCT01092143|538004881|FG000|Overall Study|Lost to Follow-up|1|||
149143503|NCT01092143|538004882|FG001|Overall Study|Lost to Follow-up|0|||
149143504|NCT01092143|538004883|FG002|Overall Study|Lost to Follow-up|1|||
149143505|NCT01092143|538004884|FG003|Overall Study|Lost to Follow-up|0|||
149143506|NCT01092143|538004885|FG004|Overall Study|Lost to Follow-up|0|||
149143507|NCT01092143|538004881|FG000|Overall Study|Consent withdrawn|2|||
149143508|NCT01092143|538004882|FG001|Overall Study|Consent withdrawn|1|||
149143509|NCT01092143|538004883|FG002|Overall Study|Consent withdrawn|0|||
149143510|NCT01092143|538004884|FG003|Overall Study|Consent withdrawn|1|||
149143511|NCT01092143|538004885|FG004|Overall Study|Consent withdrawn|3|||
149143512|NCT01092143|538004881|FG000|Overall Study|Not treated|0|||
149143513|NCT01092143|538004882|FG001|Overall Study|Not treated|0|||
149143514|NCT01092143|538004883|FG002|Overall Study|Not treated|1|||
149143515|NCT01092143|538004884|FG003|Overall Study|Not treated|0|||
149143516|NCT01092143|538004885|FG004|Overall Study|Not treated|0|||
149143517|NCT01092143|538004881|FG000|Overall Study|did not reversibility criteria|0|||
149143518|NCT01092143|538004882|FG001|Overall Study|did not reversibility criteria|0|||
149143519|NCT01092143|538004883|FG002|Overall Study|did not reversibility criteria|1|||
149143520|NCT01092143|538004884|FG003|Overall Study|did not reversibility criteria|0|||
149143521|NCT01092143|538004885|FG004|Overall Study|did not reversibility criteria|0|||
149143522|NCT01092143|538004881|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
149143523|NCT01092143|538004882|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
149143524|NCT01092143|538004883|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
149143525|NCT01092143|538004884|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
149143526|NCT01092143|538004885|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
149143527|NCT01092143|538004881|FG000|Overall Study|Ineligible patient|1|||
149143528|NCT01092143|538004882|FG001|Overall Study|Ineligible patient|0|||
149143529|NCT01092143|538004883|FG002|Overall Study|Ineligible patient|0|||
149143530|NCT01092143|538004884|FG003|Overall Study|Ineligible patient|0|||
149143531|NCT01092143|538004885|FG004|Overall Study|Ineligible patient|0|||
149143532|NCT01092143|538004881|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
149143533|NCT01092143|538004882|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
149143534|NCT01092143|538004883|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
149143535|NCT01092143|538004884|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
149143536|NCT01092143|538004885|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
149143537|NCT01092143|538004881|FG000|Overall Study|Patient travel|0|||
149143538|NCT01092143|538004882|FG001|Overall Study|Patient travel|0|||
149143539|NCT01092143|538004883|FG002|Overall Study|Patient travel|0|||
149143540|NCT01092143|538004884|FG003|Overall Study|Patient travel|0|||
149143541|NCT01092143|538004885|FG004|Overall Study|Patient travel|1|||
149143542|NCT01092143|538004881|FG000|Overall Study|Non compliance with study medication|0|||
149143543|NCT01092143|538004882|FG001|Overall Study|Non compliance with study medication|0|||
149143544|NCT01092143|538004883|FG002|Overall Study|Non compliance with study medication|0|||
149143545|NCT01092143|538004884|FG003|Overall Study|Non compliance with study medication|0|||
149143546|NCT01092143|538004885|FG004|Overall Study|Non compliance with study medication|1|||
149143547|NCT01092143|538004881|FG000|Overall Study|Randomized by mistake|0|||
149143548|NCT01092143|538004882|FG001|Overall Study|Randomized by mistake|0|||
149143549|NCT01092143|538004883|FG002|Overall Study|Randomized by mistake|0|||
149143550|NCT01092143|538004884|FG003|Overall Study|Randomized by mistake|1|||
149143551|NCT01092143|538004885|FG004|Overall Study|Randomized by mistake|0|||
149143552|NCT01092143|538004881|FG000|Overall Study|Pregnancy|0|||
149143553|NCT01092143|538004882|FG001|Overall Study|Pregnancy|0|||
149143554|NCT01092143|538004883|FG002|Overall Study|Pregnancy|0|||
149143555|NCT01092143|538004884|FG003|Overall Study|Pregnancy|1|||
149143556|NCT01092143|538004885|FG004|Overall Study|Pregnancy|0|||
149143557|NCT01506960|538004886|FG000|Overall Study|Did not meet angiographic criteria|47|||
149143558|NCT01846624|538004887|FG000|Overall Study|Died during induction, no midostaurin|1|||
149143559|NCT04702737|538004888|FG000|Overall Study|Decision by Sponsor|1|||
149143560|NCT04702737|538004888|FG000|Overall Study|Withdrawal of Consent from Study|3|||
149143561|NCT04702737|538004888|FG000|Overall Study|Lost to Follow-up|1|||
149143562|NCT04702737|538004888|FG000|Overall Study|Death|35|||
149143563|NCT03574753|538004889|FG000|Overall Study|Adverse Event|3|||
149143564|NCT03574753|538004889|FG000|Overall Study|Progression/relapse|19|||
149143565|NCT03574753|538004889|FG000|Overall Study|Death|1|||
149143566|NCT01177683|538004890|FG000|Study Treatment|Disease Progressions during treatment|2|||
149143567|NCT01177683|538004891|FG001|Study Treatment|Disease Progressions during treatment|0|||
149143568|NCT01177683|538004892|FG002|Study Treatment|Disease Progressions during treatment|3|||
149143569|NCT01177683|538004890|FG000|Study Treatment|Adverse Event|0|||
149143570|NCT01177683|538004891|FG001|Study Treatment|Adverse Event|1|||
149143571|NCT01177683|538004892|FG002|Study Treatment|Adverse Event|12|||
149143572|NCT01177683|538004890|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
149143573|NCT01177683|538004891|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
149143574|NCT01177683|538004892|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
148804857|NCT00427934|536766585|FG001|Overall Study|Withdrawal by Subject|0|||
148804858|NCT00427934|536766586|FG002|Overall Study|Withdrawal by Subject|1|||
148804859|NCT00427934|536766587|FG003|Overall Study|Withdrawal by Subject|3|||
148804860|NCT02058095|536766590|FG000|Overall Study|Adverse Event|1|||
149143575|NCT01177683|538004890|FG000|Study Treatment|Alternative therapy|0|||
149143576|NCT01177683|538004891|FG001|Study Treatment|Alternative therapy|0|||
149143577|NCT01177683|538004892|FG002|Study Treatment|Alternative therapy|4|||
149143578|NCT01177683|538004890|FG000|Study Treatment|Physician Decision|1|||
149143579|NCT01177683|538004891|FG001|Study Treatment|Physician Decision|0|||
149143580|NCT01177683|538004892|FG002|Study Treatment|Physician Decision|1|||
149143581|NCT01177683|538004890|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
149143582|NCT01177683|538004891|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
149143583|NCT01177683|538004892|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
149143584|NCT01177683|538004890|FG000|Study Treatment|Symptomatic Deterioration|0|||
148804861|NCT02058095|536766591|FG001|Overall Study|Adverse Event|0|||
148913269|NCT00924027|537164832|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
148913270|NCT00924027|537164833|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
148913271|NCT00924027|537164834|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
148913272|NCT00924027|537164835|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
148913273|NCT04236141|537166871|FG000|Overall Study|Death|18|||
148913274|NCT04236141|537166872|FG001|Overall Study|Death|10|||
148913275|NCT04236141|537166871|FG000|Overall Study|Withdrawal by Participant|1|||
148913276|NCT04236141|537166872|FG001|Overall Study|Withdrawal by Participant|0|||
148913277|NCT04236141|537166871|FG000|Overall Study|Reason not Specified|1|||
148913278|NCT04236141|537166872|FG001|Overall Study|Reason not Specified|0|||
148913279|NCT04236141|537166871|FG000|Overall Study|Study terminated by Sponsor|8|||
148913280|NCT04236141|537166872|FG001|Overall Study|Study terminated by Sponsor|4|||
148913281|NCT01925131|537166873|FG000|Overall Study|Death|0|||
148913282|NCT01925131|537166874|FG001|Overall Study|Death|0|||
148913283|NCT01925131|537166875|FG002|Overall Study|Death|1|||
148913284|NCT01925131|537166876|FG003|Overall Study|Death|0|||
149143585|NCT01177683|538004891|FG001|Study Treatment|Symptomatic Deterioration|0|||
149143586|NCT01177683|538004892|FG002|Study Treatment|Symptomatic Deterioration|1|||
149143587|NCT01177683|538004890|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
149143588|NCT01177683|538004891|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
149143589|NCT01177683|538004892|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
149143590|NCT01177683|538004890|FG000|Follow up|Patient lost to follow up|0|||
149143591|NCT01177683|538004891|FG001|Follow up|Patient lost to follow up|0|||
149143592|NCT01177683|538004892|FG002|Follow up|Patient lost to follow up|2|||
149143593|NCT01177683|538004890|FG000|Follow up|Death|2|||
149143594|NCT01177683|538004891|FG001|Follow up|Death|1|||
149143595|NCT01177683|538004892|FG002|Follow up|Death|7|||
149143596|NCT01177683|538004890|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
149143597|NCT01177683|538004891|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
149143598|NCT01177683|538004892|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
149143599|NCT01977820|538004897|FG000|Overall Study|Sponsor terminated the study|1|||
149143600|NCT01977820|538004898|FG001|Overall Study|Sponsor terminated the study|1|||
149143601|NCT02568475|538004901|FG000|Overall Study|Lost to Follow-up|40|||
149143602|NCT02568475|538004902|FG001|Overall Study|Lost to Follow-up|39|||
149143603|NCT02568475|538004901|FG000|Overall Study|Withdrawal by Subject|2|||
149143604|NCT02568475|538004902|FG001|Overall Study|Withdrawal by Subject|0|||
149143605|NCT02568475|538004901|FG000|Overall Study|Discharged home|4|||
149143606|NCT02568475|538004902|FG001|Overall Study|Discharged home|4|||
149143607|NCT02568475|538004901|FG000|Overall Study|Short-term: Discharge location unknown|4|||
149143608|NCT02568475|538004902|FG001|Overall Study|Short-term: Discharge location unknown|0|||
149143609|NCT02568475|538004901|FG000|Overall Study|Transferred to another facility|1|||
149143610|NCT02568475|538004902|FG001|Overall Study|Transferred to another facility|0|||
149143611|NCT02625233|538004903|FG000|Overall Study|Adverse Event|2|||
149143612|NCT02625233|538004904|FG001|Overall Study|Adverse Event|0|||
149143613|NCT04425720|538004914|FG000|Overall Study|Withdrawal by Subject|0|||
149143614|NCT04425720|538004915|FG001|Overall Study|Withdrawal by Subject|20|||
149143615|NCT00290186|538004916|FG000|Overall Study|Adverse Event|1|||
149143616|NCT00290186|538004917|FG001|Overall Study|Adverse Event|1|||
149143617|NCT00290186|538004916|FG000|Overall Study|Lost to Follow-up|3|||
149143618|NCT00290186|538004917|FG001|Overall Study|Lost to Follow-up|2|||
149143619|NCT00290186|538004916|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
149143620|NCT00290186|538004917|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
149143621|NCT00290186|538004916|FG000|Overall Study|Withdrawal by Subject|0|||
149143622|NCT00290186|538004917|FG001|Overall Study|Withdrawal by Subject|1|||
149143623|NCT03184077|538004920|FG000|Overall Study|Lost to Follow-up|21|||
149143624|NCT03184077|538004921|FG001|Overall Study|Lost to Follow-up|21|||
149143625|NCT00262522|538004924|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
149143626|NCT00262522|538004925|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
149143627|NCT00262522|538004926|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
149143628|NCT00262522|538004927|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
149143629|NCT00262522|538004924|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
149143630|NCT00262522|538004925|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
149143631|NCT00262522|538004926|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
149143632|NCT00262522|538004927|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
149143633|NCT00262522|538004924|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
149143634|NCT00262522|538004925|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
149143635|NCT00262522|538004926|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
149143636|NCT00262522|538004927|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
149143637|NCT00262522|538004924|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
149143638|NCT00262522|538004925|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
149143639|NCT00262522|538004926|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
148913285|NCT01925131|537166877|FG004|Overall Study|Death|0|||
148913286|NCT01925131|537166878|FG005|Overall Study|Death|0|||
149143640|NCT00262522|538004927|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
149143641|NCT00262522|538004924|FG000|Study Start Through 8 Weeks|Death|1|||
149143642|NCT00262522|538004925|FG001|Study Start Through 8 Weeks|Death|0|||
149143643|NCT00262522|538004926|FG002|Study Start Through 8 Weeks|Death|0|||
149143644|NCT00262522|538004927|FG003|Study Start Through 8 Weeks|Death|0|||
149143645|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
149143646|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
149143647|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
148913287|NCT01925131|537166873|FG000|Overall Study|Progression/Relapse|1|||
148913288|NCT01925131|537166874|FG001|Overall Study|Progression/Relapse|1|||
148913289|NCT01925131|537166875|FG002|Overall Study|Progression/Relapse|4|||
148913290|NCT01925131|537166876|FG003|Overall Study|Progression/Relapse|0|||
148913291|NCT01925131|537166877|FG004|Overall Study|Progression/Relapse|0|||
148913292|NCT01925131|537166878|FG005|Overall Study|Progression/Relapse|1|||
149143648|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
149143649|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
149143650|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
149143651|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
149143652|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
149143653|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
149143654|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
149143655|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
149143656|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
149143657|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
149143658|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
149143659|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
149143660|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
149143661|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Death|2|||
149143662|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Death|0|||
149143663|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Death|1|||
148671342|NCT00972309|536267103|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
148913293|NCT01925131|537166873|FG000|Overall Study|Patient Refusal|1|||
148913294|NCT01925131|537166874|FG001|Overall Study|Patient Refusal|0|||
148913295|NCT01925131|537166875|FG002|Overall Study|Patient Refusal|0|||
149143664|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Death|0|||
149143665|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
149143666|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
149143667|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
149143668|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
149143669|NCT00262522|538004924|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
149143670|NCT00262522|538004925|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
149143671|NCT00262522|538004926|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
149143672|NCT00262522|538004927|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
149143673|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
149143674|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
149143675|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
149143676|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
149143677|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
149143678|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
149143679|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
149143680|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
149143681|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
149143682|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
149143683|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
149143684|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
149143685|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
149143686|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
149143687|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
149143688|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
149143689|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Death|2|||
149143690|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Death|0|||
149143691|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Death|2|||
149143692|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Death|0|||
149143693|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
149143694|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
149143695|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
149143696|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
149143697|NCT00262522|538004924|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
149143698|NCT00262522|538004925|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
149143699|NCT00262522|538004926|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
149143700|NCT00262522|538004927|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
149143701|NCT02269787|538004933|FG000|Overall Study|Lost to Follow-up|20|||
149143702|NCT02269787|538004934|FG001|Overall Study|Lost to Follow-up|6|||
149143703|NCT02269787|538004933|FG000|Overall Study|Death|2|||
149143704|NCT02269787|538004934|FG001|Overall Study|Death|3|||
149143705|NCT02269787|538004933|FG000|Overall Study|Incapacitated|0|||
149143706|NCT02269787|538004934|FG001|Overall Study|Incapacitated|1|||
149143707|NCT00687440|538004935|FG000|Overall Study|Adverse Event|3|||
149143708|NCT00687440|538004935|FG000|Overall Study|Lost to Follow-up|3|||
149143709|NCT00687440|538004935|FG000|Overall Study|Lack of Efficacy|2|||
149143710|NCT00687440|538004935|FG000|Overall Study|Death|2|||
149143711|NCT00687440|538004935|FG000|Overall Study|Other|1|||
149143712|NCT00687440|538004935|FG000|Overall Study|Missing|1|||
149143713|NCT00583024|538004938|FG000|Overall Study|Lost to Follow-up|4|||
149143714|NCT03977974|538004941|FG000|Period 2|Adverse Event|0|||
149143715|NCT03977974|538004942|FG001|Period 2|Adverse Event|0|||
149143716|NCT03977974|538004943|FG002|Period 2|Adverse Event|0|||
149143717|NCT03977974|538004944|FG003|Period 2|Adverse Event|0|||
149143718|NCT03977974|538004945|FG004|Period 2|Adverse Event|1|||
149143719|NCT03977974|538004946|FG005|Period 2|Adverse Event|0|||
149143720|NCT03977974|538004947|FG006|Period 2|Adverse Event|0|||
149143721|NCT03977974|538004948|FG007|Period 2|Adverse Event|0|||
149143722|NCT03977974|538004949|FG008|Period 2|Adverse Event|0|||
149143723|NCT03977974|538004950|FG009|Period 2|Adverse Event|0|||
149143724|NCT03977974|538004951|FG010|Period 2|Adverse Event|0|||
149143725|NCT03977974|538004952|FG011|Period 2|Adverse Event|0|||
149143726|NCT03977974|538004953|FG012|Period 2|Adverse Event|0|||
149143727|NCT00736255|538006337|FG000|Overall Study|Adverse Event|1|||
149143728|NCT00736255|538006338|FG001|Overall Study|Adverse Event|0|||
149143729|NCT00736255|538006337|FG000|Overall Study|Physician Decision|1|||
149143730|NCT00736255|538006338|FG001|Overall Study|Physician Decision|0|||
149143731|NCT00736255|538006337|FG000|Overall Study|Non-compliance|1|||
149143732|NCT00736255|538006338|FG001|Overall Study|Non-compliance|1|||
149143733|NCT02833974|538006341|FG000|Overall Study|Lost to Follow-up|1|||
149143734|NCT02833974|538006342|FG001|Overall Study|Lost to Follow-up|0|||
149143735|NCT02833974|538006341|FG000|Overall Study|Adverse Event|0|||
149143736|NCT02833974|538006342|FG001|Overall Study|Adverse Event|3|||
149143737|NCT04419610|538006343|FG000|Overall Study|Withdrawal by Subject|3|||
149143738|NCT04419610|538006344|FG001|Overall Study|Withdrawal by Subject|1|||
149143739|NCT04419610|538006343|FG000|Overall Study|Adverse Event|1|||
149143740|NCT04419610|538006344|FG001|Overall Study|Adverse Event|0|||
149143741|NCT04419610|538006343|FG000|Overall Study|discharged early|1|||
149143742|NCT04419610|538006344|FG001|Overall Study|discharged early|1|||
149143743|NCT01439282|538006345|FG000|Overall Study|Adverse Event|5|||
149143744|NCT01439282|538006346|FG001|Overall Study|Adverse Event|0|||
149143745|NCT01439282|538006345|FG000|Overall Study|Withdrawal by Subject|2|||
149143746|NCT01439282|538006346|FG001|Overall Study|Withdrawal by Subject|0|||
149143747|NCT01439282|538006345|FG000|Overall Study|Other|1|||
149143748|NCT01439282|538006346|FG001|Overall Study|Other|1|||
149143749|NCT01502709|538006350|FG000|Overall Study|Lost to Follow-up|4|||
149143750|NCT01502709|538006351|FG001|Overall Study|Lost to Follow-up|0|||
149143751|NCT03703882|538006355|FG000|Overall Study|Adverse Event|1|||
149143752|NCT03703882|538006356|FG001|Overall Study|Adverse Event|0|||
149143753|NCT03703882|538006355|FG000|Overall Study|Lost to Follow-up|0|||
149143754|NCT03703882|538006356|FG001|Overall Study|Lost to Follow-up|2|||
149143755|NCT03703882|538006355|FG000|Overall Study|Non-compliance with study drug|0|||
149143756|NCT03703882|538006356|FG001|Overall Study|Non-compliance with study drug|1|||
149143757|NCT03703882|538006355|FG000|Overall Study|Physician Decision|0|||
149143758|NCT03703882|538006356|FG001|Overall Study|Physician Decision|1|||
149143759|NCT03703882|538006355|FG000|Overall Study|Progressive disease|1|||
149143760|NCT03703882|538006356|FG001|Overall Study|Progressive disease|0|||
149143761|NCT03703882|538006355|FG000|Overall Study|Withdrawal by parent/guardian|1|||
149143762|NCT03703882|538006356|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149143763|NCT03703882|538006355|FG000|Overall Study|Starting another treatment|0|||
149143764|NCT03703882|538006356|FG001|Overall Study|Starting another treatment|1|||
149143765|NCT03703882|538006355|FG000|Overall Study|noncompliance with study procedures|0|||
149143766|NCT03703882|538006356|FG001|Overall Study|noncompliance with study procedures|1|||
149143767|NCT00457015|538006362|FG000|Overall Study|Left study site against medical advice|0|||
149143768|NCT00457015|538006363|FG001|Overall Study|Left study site against medical advice|1|||
149143769|NCT03670953|538006364|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
149143770|NCT03670953|538006365|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
149143771|NCT03670953|538006366|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
149143772|NCT03670953|538006367|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
149143773|NCT03670953|538006364|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
149143774|NCT03670953|538006365|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
149143775|NCT03670953|538006366|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
149143776|NCT03670953|538006367|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
149143777|NCT03670953|538006364|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
149143778|NCT03670953|538006365|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
149143779|NCT03670953|538006366|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
149143780|NCT03670953|538006367|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
149143781|NCT03670953|538006364|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
149143782|NCT03670953|538006365|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
149143783|NCT03670953|538006366|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
149143784|NCT03670953|538006367|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
149143785|NCT03670953|538006364|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
149143786|NCT03670953|538006365|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
149143787|NCT03670953|538006366|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
149143788|NCT03670953|538006367|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
149143789|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
149143790|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
149143791|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
149143792|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
149143793|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
149143794|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
149143795|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
149143796|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
149143797|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
149143798|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
149143799|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
149143800|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
149143801|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
149143802|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
149143803|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
149143804|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
149143805|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
149143806|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
149143807|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
149143808|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
149143809|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
149143810|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
149143811|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
149143812|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
149143813|NCT03670953|538006364|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
149143814|NCT03670953|538006365|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
149143815|NCT03670953|538006366|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
149143816|NCT03670953|538006367|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
149143817|NCT03670953|538006364|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
149143818|NCT03670953|538006365|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
149143819|NCT03670953|538006366|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
149143820|NCT03670953|538006367|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
149143821|NCT03670953|538006364|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
149143822|NCT03670953|538006365|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
149143823|NCT03670953|538006366|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
149143824|NCT03670953|538006367|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
149143825|NCT03670953|538006364|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
149143826|NCT03670953|538006365|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
149143827|NCT03670953|538006366|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
149143828|NCT03670953|538006367|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
149143829|NCT03670953|538006364|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
149143830|NCT03670953|538006365|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
149143831|NCT03670953|538006366|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
149143832|NCT03670953|538006367|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
149143833|NCT03670953|538006364|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
149143834|NCT03670953|538006365|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
149143835|NCT03670953|538006366|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
149143836|NCT03670953|538006367|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
149143837|NCT03670953|538006364|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
149143838|NCT03670953|538006365|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
149143839|NCT03670953|538006366|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
149143840|NCT03670953|538006367|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
149143841|NCT04179734|538006368|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
149143842|NCT04179734|538006369|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
149143843|NCT04179734|538006368|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
149143844|NCT04179734|538006369|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
149143845|NCT00937937|538006371|FG000|Overall Study|Adverse Event|6|||
149143846|NCT00937937|538006371|FG000|Overall Study|Withdrawal by Subject|2|||
149143847|NCT00937937|538006371|FG000|Overall Study|Progression/relapse|61|||
149143848|NCT00937937|538006371|FG000|Overall Study|Death|1|||
149143849|NCT00937937|538006371|FG000|Overall Study|Other|2|||
149143850|NCT02966509|538006372|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
149143851|NCT02966509|538006373|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
149143852|NCT02966509|538006372|FG000|Baseline Satisfaction Survey|Death|0|||
149143853|NCT02966509|538006373|FG001|Baseline Satisfaction Survey|Death|1|||
149143854|NCT02966509|538006372|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
149143855|NCT02966509|538006373|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
149143856|NCT02966509|538006372|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
149143857|NCT02966509|538006373|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
149143858|NCT02966509|538006372|FG000|6 Month Satisfaction Decision Survey|Death|22|||
149143859|NCT02966509|538006373|FG001|6 Month Satisfaction Decision Survey|Death|25|||
149143860|NCT02966509|538006372|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
149143861|NCT02966509|538006373|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
149143862|NCT02966509|538006372|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
149143863|NCT02966509|538006373|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
149143864|NCT02966509|538006372|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
149143865|NCT02966509|538006373|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
149143866|NCT02966509|538006372|FG000|6 Month Satisfaction Survey|Death|36|||
149143867|NCT02966509|538006373|FG001|6 Month Satisfaction Survey|Death|33|||
149143868|NCT02966509|538006372|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
149143869|NCT02966509|538006373|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
149143870|NCT02966509|538006372|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
149143871|NCT02966509|538006373|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
149143872|NCT02966509|538006372|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
149143873|NCT02966509|538006373|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
149143874|NCT02966509|538006372|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
149143875|NCT02966509|538006373|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
149143876|NCT02966509|538006372|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
149143877|NCT02966509|538006373|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
149143878|NCT01227187|538006376|FG000|Overall Study|Physician Decision|0|||
149143879|NCT01227187|538006377|FG001|Overall Study|Physician Decision|0|||
149143880|NCT01227187|538006378|FG002|Overall Study|Physician Decision|0|||
149143881|NCT01227187|538006379|FG003|Overall Study|Physician Decision|1|||
149143882|NCT02187471|538006380|FG000|Overall Study|Protocol Violation|4|||
149143883|NCT02187471|538006381|FG001|Overall Study|Protocol Violation|5|||
149143884|NCT02187471|538006382|FG002|Overall Study|Protocol Violation|4|||
149143885|NCT02187471|538006383|FG003|Overall Study|Protocol Violation|4|||
149143886|NCT02187471|538006380|FG000|Overall Study|Missing|0|||
149143887|NCT02187471|538006381|FG001|Overall Study|Missing|0|||
149143888|NCT02187471|538006382|FG002|Overall Study|Missing|0|||
149143889|NCT02187471|538006383|FG003|Overall Study|Missing|1|||
149143890|NCT02187471|538006380|FG000|Overall Study|Lack of Efficacy|18|||
149143891|NCT02187471|538006381|FG001|Overall Study|Lack of Efficacy|9|||
149143892|NCT02187471|538006382|FG002|Overall Study|Lack of Efficacy|13|||
149143893|NCT02187471|538006383|FG003|Overall Study|Lack of Efficacy|11|||
149143894|NCT02187471|538006380|FG000|Overall Study|Adverse Event|24|||
149143895|NCT02187471|538006381|FG001|Overall Study|Adverse Event|34|||
149143896|NCT02187471|538006382|FG002|Overall Study|Adverse Event|44|||
149143897|NCT02187471|538006383|FG003|Overall Study|Adverse Event|36|||
149143898|NCT02187471|538006380|FG000|Overall Study|Withdrawal by Subject|23|||
149143899|NCT02187471|538006381|FG001|Overall Study|Withdrawal by Subject|29|||
149143900|NCT02187471|538006382|FG002|Overall Study|Withdrawal by Subject|22|||
149143901|NCT02187471|538006383|FG003|Overall Study|Withdrawal by Subject|24|||
149143902|NCT02187471|538006380|FG000|Overall Study|Other|7|||
149143903|NCT02187471|538006381|FG001|Overall Study|Other|5|||
149143904|NCT02187471|538006382|FG002|Overall Study|Other|3|||
149143905|NCT02187471|538006383|FG003|Overall Study|Other|4|||
149143906|NCT02236520|538006384|FG000|Overall Study|Physician Decision|0|||
149143907|NCT02236520|538006385|FG001|Overall Study|Physician Decision|5|||
149143908|NCT02236520|538006386|FG002|Overall Study|Physician Decision|0|||
149143909|NCT02236520|538006387|FG003|Overall Study|Physician Decision|0|||
149143910|NCT02236520|538006384|FG000|Overall Study|Withdrawal by Subject|1|||
149143911|NCT02236520|538006385|FG001|Overall Study|Withdrawal by Subject|0|||
149143912|NCT02236520|538006386|FG002|Overall Study|Withdrawal by Subject|0|||
149143913|NCT02236520|538006387|FG003|Overall Study|Withdrawal by Subject|1|||
149143914|NCT02236520|538006384|FG000|Overall Study|Pregnancy|1|||
149143915|NCT02236520|538006385|FG001|Overall Study|Pregnancy|0|||
149143916|NCT02236520|538006386|FG002|Overall Study|Pregnancy|0|||
149143917|NCT02236520|538006387|FG003|Overall Study|Pregnancy|0|||
149143918|NCT01785160|538006388|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
149143919|NCT01785160|538006388|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
149143920|NCT01365039|538006393|FG000|Overall Study|Study related symptoms and complaints|1|||
149143921|NCT01365039|538006394|FG001|Overall Study|Study related symptoms and complaints|0|||
148913296|NCT01925131|537166876|FG003|Overall Study|Patient Refusal|0|||
149143922|NCT03807349|538006397|FG000|Overall Study|Early Study Termination|9|||
149143923|NCT00294060|538006398|FG000|Overall Study|Death|225|||
149143924|NCT00294060|538006398|FG000|Overall Study|Other|59|||
149143925|NCT00294060|538006398|FG000|Overall Study|Lost to Follow-up|55|||
149143926|NCT00294060|538006398|FG000|Overall Study|Withdrawal by Subject|11|||
149143927|NCT00294060|538006398|FG000|Overall Study|Physician Decision|797|||
148671343|NCT00972309|536267102|FG000|Overall Study|Lost to Follow-up|1|||
149143928|NCT00294060|538006398|FG000|Overall Study|Medical condition|3|||
149143929|NCT00294060|538006398|FG000|Overall Study|Device explanted/not replaced|23|||
149143930|NCT00187096|538006399|FG000|Overall Study|unacceptable toxicity|0|||
149143931|NCT00187096|538006400|FG001|Overall Study|unacceptable toxicity|0|||
149143932|NCT00187096|538006401|FG002|Overall Study|unacceptable toxicity|1|||
149143933|NCT00424749|538006404|FG000|Overall Study|Withdrawal by Subject|1|||
149143934|NCT01263483|538006405|FG000|Overall Study|Adverse Event|4|||
149143935|NCT01263483|538006406|FG001|Overall Study|Adverse Event|0|||
149143936|NCT01263483|538006407|FG002|Overall Study|Adverse Event|3|||
149143937|NCT01263483|538006405|FG000|Overall Study|Withdrawal by Subject|1|||
149143938|NCT01263483|538006406|FG001|Overall Study|Withdrawal by Subject|0|||
149143939|NCT01263483|538006407|FG002|Overall Study|Withdrawal by Subject|0|||
149143940|NCT01263483|538006405|FG000|Overall Study|Lack of Efficacy|2|||
149143941|NCT01263483|538006406|FG001|Overall Study|Lack of Efficacy|0|||
149143942|NCT01263483|538006407|FG002|Overall Study|Lack of Efficacy|0|||
149143943|NCT01263483|538006405|FG000|Overall Study|Protocol Violation|0|||
149143944|NCT01263483|538006406|FG001|Overall Study|Protocol Violation|1|||
149143945|NCT01263483|538006407|FG002|Overall Study|Protocol Violation|1|||
149143946|NCT01263483|538006405|FG000|Overall Study|Participant Unavailability|0|||
149143947|NCT01263483|538006406|FG001|Overall Study|Participant Unavailability|1|||
149143948|NCT01263483|538006407|FG002|Overall Study|Participant Unavailability|1|||
149143949|NCT00596947|538006408|FG000|Overall Study|study halted due to low enrollment|5|||
149143950|NCT00596947|538006409|FG001|Overall Study|study halted due to low enrollment|3|||
149143951|NCT00596947|538006408|FG000|Overall Study|Lost to Follow-up|1|||
149143952|NCT00596947|538006409|FG001|Overall Study|Lost to Follow-up|0|||
149143953|NCT00829179|538006410|FG000|Overall Study|Withdrawal by Subject|1|||
149143954|NCT03000179|538006411|FG000|Overall Study|Lost to Follow-up|2|||
149143955|NCT02114268|538006414|FG000|Overall Study|Lost to Follow-up|4|||
149143956|NCT02114268|538006415|FG001|Overall Study|Lost to Follow-up|1|||
149143957|NCT02114268|538006416|FG002|Overall Study|Lost to Follow-up|1|||
149143958|NCT02114268|538006417|FG003|Overall Study|Lost to Follow-up|0|||
149143959|NCT02114268|538006418|FG004|Overall Study|Lost to Follow-up|0|||
149143960|NCT02114268|538006419|FG005|Overall Study|Lost to Follow-up|2|||
149143961|NCT02114268|538006414|FG000|Overall Study|Withdrawal by Subject|1|||
149143962|NCT02114268|538006415|FG001|Overall Study|Withdrawal by Subject|0|||
149143963|NCT02114268|538006416|FG002|Overall Study|Withdrawal by Subject|0|||
149143964|NCT02114268|538006417|FG003|Overall Study|Withdrawal by Subject|0|||
149143965|NCT02114268|538006418|FG004|Overall Study|Withdrawal by Subject|0|||
149143966|NCT02114268|538006419|FG005|Overall Study|Withdrawal by Subject|1|||
149143967|NCT02114268|538006414|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
149143968|NCT02114268|538006415|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
149143969|NCT02114268|538006416|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
149143970|NCT02114268|538006417|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
149143971|NCT02114268|538006418|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
149143972|NCT02114268|538006419|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
149143973|NCT01075412|538006424|FG000|Overall Study|Withdrawal by Subject|0|||
149143974|NCT01075412|538006425|FG001|Overall Study|Withdrawal by Subject|1|||
149143975|NCT00865904|538006429|FG000|Overall Study|Randomized but not Treated|2|||
149143976|NCT00865904|538006430|FG001|Overall Study|Randomized but not Treated|0|||
149143977|NCT00865904|538006431|FG002|Overall Study|Randomized but not Treated|0|||
149143978|NCT00865904|538006432|FG003|Overall Study|Randomized but not Treated|1|||
149143979|NCT00865904|538006433|FG004|Overall Study|Randomized but not Treated|1|||
149143980|NCT01378858|538006434|FG000|Overall Study|Withdrawal by Subject|4|||
149143981|NCT01378858|538006435|FG001|Overall Study|Withdrawal by Subject|4|||
149143982|NCT03073980|538006436|FG000|Overall Study|Lost to Follow-up|10|||
149143983|NCT03073980|538006437|FG001|Overall Study|Lost to Follow-up|2|||
149143984|NCT03073980|538006438|FG002|Overall Study|Lost to Follow-up|9|||
149143985|NCT03073980|538006436|FG000|Overall Study|No post-procedure data|0|||
149143986|NCT03073980|538006437|FG001|Overall Study|No post-procedure data|0|||
148913297|NCT01925131|537166877|FG004|Overall Study|Patient Refusal|0|||
149143987|NCT03073980|538006438|FG002|Overall Study|No post-procedure data|2|||
149143988|NCT02047253|538006441|FG000|Overall Study|Lost to Follow-up|8|||
149143989|NCT04085523|538006442|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
149143990|NCT04085523|538006443|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
149143991|NCT04085523|538006444|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
149143992|NCT04085523|538006445|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
148913298|NCT01925131|537166878|FG005|Overall Study|Patient Refusal|0|||
148913299|NCT01925131|537166873|FG000|Overall Study|Adverse Event|0|||
149143993|NCT04085523|538006446|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
149143994|NCT04085523|538006447|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
149143995|NCT05318937|538006448|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149143996|NCT05318937|538006449|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149143997|NCT05318937|538006448|FG000|Overall Study|Lost to Follow-up|0|||
149143998|NCT05318937|538006449|FG001|Overall Study|Lost to Follow-up|1|||
149143999|NCT05318937|538006448|FG000|Overall Study|Withdrawal by Subject|0|||
149144000|NCT05318937|538006449|FG001|Overall Study|Withdrawal by Subject|2|||
149144001|NCT05318937|538006448|FG000|Overall Study|Protocol Violation|0|||
149144002|NCT05318937|538006449|FG001|Overall Study|Protocol Violation|1|||
149144003|NCT04722042|538006450|FG000|Overall Study|Withdrawal by Subject|2|||
149144004|NCT04722042|538006451|FG001|Overall Study|Withdrawal by Subject|1|||
149144005|NCT04722042|538006452|FG002|Overall Study|Withdrawal by Subject|0|||
149144006|NCT01877915|538006460|FG000|Overall Study|Lost to Follow-up|10|||
149144007|NCT01877915|538006461|FG001|Overall Study|Lost to Follow-up|9|||
149144008|NCT01877915|538006460|FG000|Overall Study|Withdrawal by Subject|42|||
149144009|NCT01877915|538006461|FG001|Overall Study|Withdrawal by Subject|55|||
149144010|NCT01877915|538006460|FG000|Overall Study|Other|2|||
149144011|NCT01877915|538006461|FG001|Overall Study|Other|4|||
149144012|NCT01449461|538006462|FG000|Overall Study|Adverse Event|0|||
149144013|NCT01449461|538006463|FG001|Overall Study|Adverse Event|3|||
149144014|NCT01449461|538006464|FG002|Overall Study|Adverse Event|2|||
149144015|NCT01449461|538006465|FG003|Overall Study|Adverse Event|3|||
149144016|NCT01449461|538006466|FG004|Overall Study|Adverse Event|4|||
149144017|NCT01449461|538006467|FG005|Overall Study|Adverse Event|4|||
149144018|NCT01449461|538006462|FG000|Overall Study|Death|0|||
149144019|NCT01449461|538006463|FG001|Overall Study|Death|2|||
149144020|NCT01449461|538006464|FG002|Overall Study|Death|0|||
148913300|NCT01925131|537166874|FG001|Overall Study|Adverse Event|0|||
148913301|NCT01925131|537166875|FG002|Overall Study|Adverse Event|2|||
148913302|NCT01925131|537166876|FG003|Overall Study|Adverse Event|0|||
148913303|NCT01925131|537166877|FG004|Overall Study|Adverse Event|1|||
148913304|NCT01925131|537166878|FG005|Overall Study|Adverse Event|3|||
148913305|NCT01925131|537166873|FG000|Overall Study|Other - Not Protocol Specified|3|||
148913306|NCT01925131|537166874|FG001|Overall Study|Other - Not Protocol Specified|1|||
148913307|NCT01925131|537166875|FG002|Overall Study|Other - Not Protocol Specified|2|||
148913308|NCT01925131|537166876|FG003|Overall Study|Other - Not Protocol Specified|5|||
148913309|NCT01925131|537166877|FG004|Overall Study|Other - Not Protocol Specified|10|||
148913310|NCT01925131|537166878|FG005|Overall Study|Other - Not Protocol Specified|6|||
149144021|NCT01449461|538006465|FG003|Overall Study|Death|0|||
149144022|NCT01449461|538006466|FG004|Overall Study|Death|7|||
149144023|NCT01449461|538006467|FG005|Overall Study|Death|1|||
149144024|NCT01449461|538006462|FG000|Overall Study|Physician Decision|0|||
149144025|NCT01449461|538006463|FG001|Overall Study|Physician Decision|1|||
149144026|NCT01449461|538006464|FG002|Overall Study|Physician Decision|0|||
149144027|NCT01449461|538006465|FG003|Overall Study|Physician Decision|4|||
149144028|NCT01449461|538006466|FG004|Overall Study|Physician Decision|1|||
149144029|NCT01449461|538006467|FG005|Overall Study|Physician Decision|0|||
149144030|NCT01449461|538006462|FG000|Overall Study|Documented Progressive Disease|4|||
149144031|NCT01449461|538006463|FG001|Overall Study|Documented Progressive Disease|7|||
148913311|NCT01217307|537166882|FG000|Overall Study|Withdrawal by Subject|0|||
148913312|NCT01217307|537166883|FG001|Overall Study|Withdrawal by Subject|1|||
148913313|NCT01888432|537166888|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
148913314|NCT01888432|537166889|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
148913315|NCT01888432|537166888|FG000|12-month Analysis (FAS)|Physician Decision|1|||
148913316|NCT01888432|537166889|FG001|12-month Analysis (FAS)|Physician Decision|1|||
148913317|NCT01888432|537166888|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
148913318|NCT01888432|537166889|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
148913319|NCT01888432|537166888|FG000|12-month Analysis (FAS)|Death|4|||
148913320|NCT01888432|537166889|FG001|12-month Analysis (FAS)|Death|3|||
148913321|NCT01888432|537166888|FG000|24-month Analysis (FAS)|Graft loss|0|||
148913322|NCT01888432|537166889|FG001|24-month Analysis (FAS)|Graft loss|1|||
148913323|NCT01888432|537166888|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
148913324|NCT01888432|537166889|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
148913325|NCT01888432|537166888|FG000|24-month Analysis (FAS)|Physician Decision|2|||
148913326|NCT01888432|537166889|FG001|24-month Analysis (FAS)|Physician Decision|4|||
149144032|NCT01449461|538006464|FG002|Overall Study|Documented Progressive Disease|14|||
149144033|NCT01449461|538006465|FG003|Overall Study|Documented Progressive Disease|15|||
148671344|NCT00972309|536267103|FG001|Overall Study|Lost to Follow-up|1|||
148913327|NCT01888432|537166888|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
148913328|NCT01888432|537166889|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
148913329|NCT01888432|537166888|FG000|24-month Analysis (FAS)|Death|8|||
148913330|NCT01888432|537166889|FG001|24-month Analysis (FAS)|Death|4|||
148913331|NCT01888432|537166888|FG000|36-month Analysis (Extension)|Death|1|||
149144034|NCT01449461|538006466|FG004|Overall Study|Documented Progressive Disease|24|||
149144035|NCT01449461|538006467|FG005|Overall Study|Documented Progressive Disease|5|||
149144036|NCT01449461|538006462|FG000|Overall Study|Clinical Progressive Disease|2|||
149144037|NCT01449461|538006463|FG001|Overall Study|Clinical Progressive Disease|2|||
149144038|NCT01449461|538006464|FG002|Overall Study|Clinical Progressive Disease|0|||
149144039|NCT01449461|538006465|FG003|Overall Study|Clinical Progressive Disease|3|||
149144040|NCT01449461|538006466|FG004|Overall Study|Clinical Progressive Disease|4|||
149144041|NCT01449461|538006467|FG005|Overall Study|Clinical Progressive Disease|2|||
149144042|NCT01449461|538006462|FG000|Overall Study|Protocol Violation|0|||
149144043|NCT01449461|538006463|FG001|Overall Study|Protocol Violation|0|||
149144044|NCT01449461|538006464|FG002|Overall Study|Protocol Violation|0|||
149144045|NCT01449461|538006465|FG003|Overall Study|Protocol Violation|1|||
149144046|NCT01449461|538006466|FG004|Overall Study|Protocol Violation|0|||
149144047|NCT01449461|538006467|FG005|Overall Study|Protocol Violation|0|||
149144048|NCT01449461|538006462|FG000|Overall Study|Site Terminated by Sponsor|0|||
149144049|NCT01449461|538006463|FG001|Overall Study|Site Terminated by Sponsor|1|||
149144050|NCT01449461|538006464|FG002|Overall Study|Site Terminated by Sponsor|2|||
149144051|NCT01449461|538006465|FG003|Overall Study|Site Terminated by Sponsor|3|||
149144052|NCT01449461|538006466|FG004|Overall Study|Site Terminated by Sponsor|4|||
149144053|NCT01449461|538006467|FG005|Overall Study|Site Terminated by Sponsor|1|||
149144054|NCT01449461|538006462|FG000|Overall Study|Withdrawal by Subject|0|||
149144055|NCT01449461|538006463|FG001|Overall Study|Withdrawal by Subject|1|||
149144056|NCT01449461|538006464|FG002|Overall Study|Withdrawal by Subject|0|||
149144057|NCT01449461|538006465|FG003|Overall Study|Withdrawal by Subject|0|||
149144058|NCT01449461|538006466|FG004|Overall Study|Withdrawal by Subject|2|||
149144059|NCT01449461|538006467|FG005|Overall Study|Withdrawal by Subject|1|||
149144060|NCT01449461|538006462|FG000|Overall Study|Reason not Specified|0|||
149144061|NCT01449461|538006463|FG001|Overall Study|Reason not Specified|1|||
149144062|NCT01449461|538006464|FG002|Overall Study|Reason not Specified|0|||
149144063|NCT01449461|538006465|FG003|Overall Study|Reason not Specified|3|||
149144064|NCT01449461|538006466|FG004|Overall Study|Reason not Specified|2|||
149144065|NCT01449461|538006467|FG005|Overall Study|Reason not Specified|1|||
149144066|NCT05314517|538006469|FG000|Double-blind Period|Adverse Event|4|||
149144067|NCT05314517|538006470|FG001|Double-blind Period|Adverse Event|0|||
149144068|NCT05314517|538006471|FG002|Double-blind Period|Adverse Event|0|||
149144069|NCT05314517|538006472|FG003|Double-blind Period|Adverse Event|0|||
149144070|NCT05314517|538006469|FG000|Double-blind Period|Noncompliance|0|||
149144071|NCT05314517|538006470|FG001|Double-blind Period|Noncompliance|1|||
149144072|NCT05314517|538006471|FG002|Double-blind Period|Noncompliance|0|||
149144073|NCT05314517|538006472|FG003|Double-blind Period|Noncompliance|0|||
149144074|NCT05314517|538006469|FG000|Double-blind Period|Randomized, not treated|1|||
149144075|NCT05314517|538006470|FG001|Double-blind Period|Randomized, not treated|0|||
149144076|NCT05314517|538006471|FG002|Double-blind Period|Randomized, not treated|0|||
149144077|NCT05314517|538006472|FG003|Double-blind Period|Randomized, not treated|0|||
149144078|NCT05314517|538006469|FG000|Open-label Extension|Adverse Event|0|||
149144079|NCT05314517|538006470|FG001|Open-label Extension|Adverse Event|0|||
149144080|NCT05314517|538006471|FG002|Open-label Extension|Adverse Event|1|||
149144081|NCT05314517|538006472|FG003|Open-label Extension|Adverse Event|2|||
149144082|NCT05314517|538006469|FG000|Open-label Extension|Investigator decision|0|||
149144083|NCT05314517|538006470|FG001|Open-label Extension|Investigator decision|0|||
149144084|NCT05314517|538006471|FG002|Open-label Extension|Investigator decision|1|||
149144085|NCT05314517|538006472|FG003|Open-label Extension|Investigator decision|0|||
149144086|NCT05314517|538006469|FG000|Open-label Extension|Lost to Follow-up|0|||
149144087|NCT05314517|538006470|FG001|Open-label Extension|Lost to Follow-up|0|||
149144088|NCT05314517|538006471|FG002|Open-label Extension|Lost to Follow-up|0|||
149144089|NCT05314517|538006472|FG003|Open-label Extension|Lost to Follow-up|1|||
149144090|NCT05314517|538006469|FG000|Open-label Extension|Withdrawal by Subject|0|||
149144091|NCT05314517|538006470|FG001|Open-label Extension|Withdrawal by Subject|0|||
149144092|NCT05314517|538006471|FG002|Open-label Extension|Withdrawal by Subject|1|||
149144093|NCT05314517|538006472|FG003|Open-label Extension|Withdrawal by Subject|2|||
149144094|NCT05314517|538006469|FG000|Open-label Extension|Use of prohibited medication|0|||
149144095|NCT05314517|538006470|FG001|Open-label Extension|Use of prohibited medication|0|||
149144096|NCT05314517|538006471|FG002|Open-label Extension|Use of prohibited medication|1|||
149144097|NCT05314517|538006472|FG003|Open-label Extension|Use of prohibited medication|0|||
149144098|NCT05314517|538006469|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
149144099|NCT05314517|538006470|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
149144100|NCT05314517|538006471|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
149144101|NCT05314517|538006472|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
149144102|NCT02710136|538006474|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
149144103|NCT02710136|538006475|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
149144104|NCT00798135|538006478|FG000|Overall Study|Disease progression, relapse|11|||
149144105|NCT00798135|538006478|FG000|Overall Study|Disease progression, refractory|1|||
149144106|NCT00798135|538006478|FG000|Overall Study|Physician Decision|1|||
149144107|NCT02228720|538006479|FG000|Open Label - Day 30|Lost to Follow-up|1|||
149144108|NCT01401842|538006482|FG000|Overall Study|Withdrawal by Subject|3|||
149144109|NCT01401842|538006483|FG001|Overall Study|Withdrawal by Subject|2|||
149144110|NCT01401842|538006482|FG000|Overall Study|academic reason|4|||
149144111|NCT01401842|538006483|FG001|Overall Study|academic reason|1|||
149144112|NCT01401842|538006482|FG000|Overall Study|changed companies|20|||
149144113|NCT01401842|538006483|FG001|Overall Study|changed companies|34|||
149144114|NCT01401842|538006482|FG000|Overall Study|discharged from US Army|3|||
149144115|NCT01401842|538006483|FG001|Overall Study|discharged from US Army|4|||
149144116|NCT01401842|538006482|FG000|Overall Study|invalid follow-up strength data|1|||
149144117|NCT01401842|538006483|FG001|Overall Study|invalid follow-up strength data|4|||
149144118|NCT01401842|538006482|FG000|Overall Study|on profile|9|||
149144119|NCT01401842|538006483|FG001|Overall Study|on profile|5|||
149144120|NCT01401842|538006482|FG000|Overall Study|other/unknown|28|||
149144121|NCT01401842|538006483|FG001|Overall Study|other/unknown|17|||
149144122|NCT03337542|538006484|FG000|Overall Study|Withdrew Consent|17|||
149144123|NCT03337542|538006484|FG000|Overall Study|Allergic Adverse Event|1|||
149144124|NCT03337542|538006484|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
149144125|NCT03337542|538006484|FG000|Overall Study|Lost to Follow-up|1|||
149144126|NCT03337542|538006484|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
149144127|NCT00282295|538006485|FG000|Overall Study|Adverse Event|0|||
149144128|NCT00282295|538006486|FG001|Overall Study|Adverse Event|1|||
149144129|NCT00282295|538006487|FG002|Overall Study|Adverse Event|0|||
149144130|NCT00282295|538006485|FG000|Overall Study|Serious Adverse Events|0|||
149144131|NCT00282295|538006486|FG001|Overall Study|Serious Adverse Events|0|||
149144132|NCT00282295|538006487|FG002|Overall Study|Serious Adverse Events|1|||
149144133|NCT00282295|538006485|FG000|Overall Study|Protocol Violation|0|||
149144134|NCT00282295|538006486|FG001|Overall Study|Protocol Violation|2|||
149144135|NCT00282295|538006487|FG002|Overall Study|Protocol Violation|1|||
149144136|NCT00282295|538006485|FG000|Overall Study|Withdrawal by Subject|2|||
149144137|NCT00282295|538006486|FG001|Overall Study|Withdrawal by Subject|6|||
149144138|NCT00282295|538006487|FG002|Overall Study|Withdrawal by Subject|4|||
149144139|NCT00282295|538006485|FG000|Overall Study|Lost to Follow-up|1|||
149144140|NCT00282295|538006486|FG001|Overall Study|Lost to Follow-up|7|||
149144141|NCT00282295|538006487|FG002|Overall Study|Lost to Follow-up|2|||
149144142|NCT00282295|538006485|FG000|Overall Study|Other|0|||
149144143|NCT00282295|538006486|FG001|Overall Study|Other|1|||
149144144|NCT00282295|538006487|FG002|Overall Study|Other|0|||
149144145|NCT00847145|538007756|FG000|Overall Study|AE or Death|0|||
149144146|NCT00847145|538007757|FG001|Overall Study|AE or Death|1|||
149144147|NCT00847145|538007758|FG002|Overall Study|AE or Death|1|||
149144148|NCT00847145|538007759|FG003|Overall Study|AE or Death|0|||
149144149|NCT00847145|538007760|FG004|Overall Study|AE or Death|0|||
149144150|NCT00847145|538007761|FG005|Overall Study|AE or Death|0|||
149144151|NCT00847145|538007762|FG006|Overall Study|AE or Death|0|||
149144152|NCT00847145|538007763|FG007|Overall Study|AE or Death|0|||
149144153|NCT00847145|538007756|FG000|Overall Study|Withdrawal by Subject|3|||
149144154|NCT00847145|538007757|FG001|Overall Study|Withdrawal by Subject|4|||
149144155|NCT00847145|538007758|FG002|Overall Study|Withdrawal by Subject|6|||
149144156|NCT00847145|538007759|FG003|Overall Study|Withdrawal by Subject|1|||
149144157|NCT00847145|538007760|FG004|Overall Study|Withdrawal by Subject|0|||
149144158|NCT00847145|538007761|FG005|Overall Study|Withdrawal by Subject|0|||
149144159|NCT00847145|538007762|FG006|Overall Study|Withdrawal by Subject|1|||
149144160|NCT00847145|538007763|FG007|Overall Study|Withdrawal by Subject|1|||
149144161|NCT00847145|538007756|FG000|Overall Study|Lost to Follow-up|3|||
149144162|NCT00847145|538007757|FG001|Overall Study|Lost to Follow-up|1|||
149144163|NCT00847145|538007758|FG002|Overall Study|Lost to Follow-up|1|||
149144164|NCT00847145|538007759|FG003|Overall Study|Lost to Follow-up|0|||
149144165|NCT00847145|538007760|FG004|Overall Study|Lost to Follow-up|4|||
149144166|NCT00847145|538007761|FG005|Overall Study|Lost to Follow-up|4|||
149144167|NCT00847145|538007762|FG006|Overall Study|Lost to Follow-up|8|||
149144168|NCT00847145|538007763|FG007|Overall Study|Lost to Follow-up|2|||
149144169|NCT00847145|538007756|FG000|Overall Study|Inappropriate enrollment|0|||
149144170|NCT00847145|538007757|FG001|Overall Study|Inappropriate enrollment|0|||
149144171|NCT00847145|538007758|FG002|Overall Study|Inappropriate enrollment|0|||
149144172|NCT00847145|538007759|FG003|Overall Study|Inappropriate enrollment|0|||
149144173|NCT00847145|538007760|FG004|Overall Study|Inappropriate enrollment|1|||
149144174|NCT00847145|538007761|FG005|Overall Study|Inappropriate enrollment|0|||
149144175|NCT00847145|538007762|FG006|Overall Study|Inappropriate enrollment|0|||
149144176|NCT00847145|538007763|FG007|Overall Study|Inappropriate enrollment|0|||
149144177|NCT00847145|538007756|FG000|Overall Study|Protocol Violation|0|||
149144178|NCT00847145|538007757|FG001|Overall Study|Protocol Violation|0|||
149144179|NCT00847145|538007758|FG002|Overall Study|Protocol Violation|3|||
149144180|NCT00847145|538007759|FG003|Overall Study|Protocol Violation|0|||
149144181|NCT00847145|538007760|FG004|Overall Study|Protocol Violation|1|||
149144182|NCT00847145|538007761|FG005|Overall Study|Protocol Violation|0|||
149144183|NCT00847145|538007762|FG006|Overall Study|Protocol Violation|0|||
149144184|NCT00847145|538007763|FG007|Overall Study|Protocol Violation|1|||
149144185|NCT00307151|538007764|FG000|Overall Study|Death|4|||
149144186|NCT00307151|538007765|FG001|Overall Study|Death|3|||
149144187|NCT00307151|538007766|FG002|Overall Study|Death|10|||
149144188|NCT00307151|538007767|FG003|Overall Study|Death|3|||
149144189|NCT00307151|538007764|FG000|Overall Study|Severe debilitation, unable to continue|1|||
149144190|NCT00307151|538007765|FG001|Overall Study|Severe debilitation, unable to continue|0|||
149144191|NCT00307151|538007766|FG002|Overall Study|Severe debilitation, unable to continue|0|||
149144192|NCT00307151|538007767|FG003|Overall Study|Severe debilitation, unable to continue|0|||
149144193|NCT00307151|538007764|FG000|Overall Study|Subject unable to get to clinic|1|||
149144194|NCT00307151|538007765|FG001|Overall Study|Subject unable to get to clinic|0|||
149144195|NCT00307151|538007766|FG002|Overall Study|Subject unable to get to clinic|6|||
149144196|NCT00307151|538007767|FG003|Overall Study|Subject unable to get to clinic|2|||
149144197|NCT00307151|538007764|FG000|Overall Study|Withdrew consent|0|||
149144198|NCT00307151|538007765|FG001|Overall Study|Withdrew consent|1|||
149144199|NCT00307151|538007766|FG002|Overall Study|Withdrew consent|1|||
149144200|NCT00307151|538007767|FG003|Overall Study|Withdrew consent|3|||
149144201|NCT00307151|538007764|FG000|Overall Study|Not willing to adhere to study reqs|2|||
149144202|NCT00307151|538007765|FG001|Overall Study|Not willing to adhere to study reqs|0|||
149144203|NCT00307151|538007766|FG002|Overall Study|Not willing to adhere to study reqs|2|||
149144204|NCT00307151|538007767|FG003|Overall Study|Not willing to adhere to study reqs|2|||
149144205|NCT00307151|538007764|FG000|Overall Study|Clinic unable to contact subject|3|||
149144206|NCT00307151|538007765|FG001|Overall Study|Clinic unable to contact subject|3|||
149144207|NCT00307151|538007766|FG002|Overall Study|Clinic unable to contact subject|1|||
149144208|NCT00307151|538007767|FG003|Overall Study|Clinic unable to contact subject|1|||
148913332|NCT01888432|537166889|FG001|36-month Analysis (Extension)|Death|0|||
148913333|NCT03844945|537166892|FG000|Overall Study|Adverse Event|1|||
148913334|NCT03844945|537166893|FG001|Overall Study|Adverse Event|1|||
148913335|NCT03844945|537166894|FG002|Overall Study|Adverse Event|4|||
148913336|NCT03844945|537166895|FG003|Overall Study|Adverse Event|0|||
148913337|NCT03844945|537166892|FG000|Overall Study|Withdrawal by Subject|0|||
149144209|NCT00346073|538007768|FG000|Overall Study|Serious Adverse Event|2|||
149144210|NCT00346073|538007769|FG001|Overall Study|Serious Adverse Event|0|||
149144211|NCT00346073|538007768|FG000|Overall Study|Lost to Follow-up|39|||
149144212|NCT00346073|538007769|FG001|Overall Study|Lost to Follow-up|24|||
149144213|NCT00980200|538007774|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
149144214|NCT00980200|538007775|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
149144215|NCT00980200|538007776|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
149144216|NCT00980200|538007777|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
149144217|NCT00980200|538007778|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
149144218|NCT00980200|538007774|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
149144219|NCT00980200|538007775|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
149144220|NCT00980200|538007776|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
149144221|NCT00980200|538007777|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
149144222|NCT00980200|538007778|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
149144223|NCT01617460|538007779|FG000|Overall Study|Adverse Event|10|||
149144224|NCT01617460|538007779|FG000|Overall Study|Physician Decision|16|||
149144225|NCT01617460|538007779|FG000|Overall Study|Protocol Violation|5|||
149144226|NCT01617460|538007779|FG000|Overall Study|Withdrawal by Subject|9|||
149144227|NCT00054704|538007782|FG000|Overall Study|Lack of Efficacy|2|||
149144228|NCT00054704|538007783|FG001|Overall Study|Lack of Efficacy|3|||
149144229|NCT00054704|538007782|FG000|Overall Study|Adverse Event|3|||
149144230|NCT00054704|538007783|FG001|Overall Study|Adverse Event|1|||
149144231|NCT00054704|538007782|FG000|Overall Study|Lost to Follow-up|0|||
149144232|NCT00054704|538007783|FG001|Overall Study|Lost to Follow-up|1|||
149144233|NCT00362414|538007784|FG000|Overall Study|Death|2|||
149144234|NCT00362414|538007784|FG000|Overall Study|Adverse Event|1|||
149144235|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
149144236|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
149144237|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
149144238|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
149144239|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
149144240|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
149144241|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Death|2|||
149144242|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Death|0|||
148913338|NCT03844945|537166893|FG001|Overall Study|Withdrawal by Subject|0|||
149144243|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
149144244|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
149144245|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
149144246|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
149144247|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
149144248|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
149144249|NCT02603120|538007785|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
149144250|NCT02603120|538007786|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
149144251|NCT02603120|538007785|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
149144252|NCT02603120|538007786|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
149144253|NCT02603120|538007785|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
149144254|NCT02603120|538007786|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
149144255|NCT02603120|538007785|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
149144256|NCT02603120|538007786|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
148913339|NCT03844945|537166894|FG002|Overall Study|Withdrawal by Subject|1|||
148913340|NCT03844945|537166895|FG003|Overall Study|Withdrawal by Subject|0|||
148913341|NCT03844945|537166892|FG000|Overall Study|Lack of Efficacy|0|||
148913342|NCT03844945|537166893|FG001|Overall Study|Lack of Efficacy|0|||
148913343|NCT03844945|537166894|FG002|Overall Study|Lack of Efficacy|0|||
148913344|NCT03844945|537166895|FG003|Overall Study|Lack of Efficacy|1|||
148913345|NCT01696929|537166896|FG000|Overall Study|Physician Decision|1|||
148913346|NCT04473235|537166901|FG000|Overall Study|Lost to Follow-up|6|||
148913347|NCT04473235|537166902|FG001|Overall Study|Lost to Follow-up|5|||
148913348|NCT04473235|537166901|FG000|Overall Study|Declined continuation|2|||
148913349|NCT04473235|537166902|FG001|Overall Study|Declined continuation|0|||
148913350|NCT04473235|537166901|FG000|Overall Study|Physician Decision|1|||
148913351|NCT04473235|537166902|FG001|Overall Study|Physician Decision|1|||
148913352|NCT04473235|537166901|FG000|Overall Study|Protocol Violation|10|||
148913353|NCT04473235|537166902|FG001|Overall Study|Protocol Violation|6|||
148913354|NCT00798759|537166905|FG000|Overall Study|Adverse Event|3|||
148913355|NCT00798759|537166906|FG001|Overall Study|Adverse Event|3|||
148913356|NCT00798759|537166905|FG000|Overall Study|Lost to Follow-up|1|||
148913357|NCT00798759|537166906|FG001|Overall Study|Lost to Follow-up|1|||
148913358|NCT00798759|537166905|FG000|Overall Study|Protocol Violation|4|||
148913359|NCT00798759|537166906|FG001|Overall Study|Protocol Violation|8|||
148913360|NCT00798759|537166905|FG000|Overall Study|Other|0|||
148913361|NCT00798759|537166906|FG001|Overall Study|Other|1|||
148913362|NCT01954927|537166907|FG000|Overall Study|Withdrawal by Subject|3|||
148913363|NCT01954927|537166908|FG001|Overall Study|Withdrawal by Subject|1|||
148913364|NCT02156271|537166909|FG000|Overall Study|Physician Decision|4|||
148913365|NCT02156271|537166910|FG001|Overall Study|Physician Decision|3|||
148913366|NCT03320824|537166911|FG000|Overall Study|Withdrawal by Subject|8|||
148913367|NCT03320824|537166912|FG001|Overall Study|Withdrawal by Subject|1|||
148913368|NCT03320824|537166911|FG000|Overall Study|Lost to Follow-up|10|||
148913369|NCT03320824|537166912|FG001|Overall Study|Lost to Follow-up|1|||
148913370|NCT03320824|537166911|FG000|Overall Study|moved out of state|0|||
148913371|NCT03320824|537166912|FG001|Overall Study|moved out of state|1|||
148913372|NCT03320824|537166911|FG000|Overall Study|could not complete final visit|0|||
149144257|NCT02603120|538007785|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
149144258|NCT02603120|538007786|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
149144259|NCT02603120|538007785|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
149144260|NCT02603120|538007786|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
149144261|NCT02603120|538007785|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
149144262|NCT02603120|538007786|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
149144263|NCT01469182|538007789|FG000|Overall Study|Adverse Event|21|||
149144264|NCT01469182|538007790|FG001|Overall Study|Adverse Event|3|||
148913373|NCT03320824|537166912|FG001|Overall Study|could not complete final visit|1|||
148913374|NCT00955305|537166913|FG000|Overall Study|Disease progression|39|||
148913375|NCT00955305|537166914|FG001|Overall Study|Disease progression|41|||
148913376|NCT00955305|537166913|FG000|Overall Study|Adverse Event|22|||
149144265|NCT01469182|538007789|FG000|Overall Study|Lost to Follow-up|3|||
149144266|NCT01469182|538007790|FG001|Overall Study|Lost to Follow-up|0|||
149144267|NCT01469182|538007789|FG000|Overall Study|Withdrawal by Subject|4|||
149144268|NCT01469182|538007790|FG001|Overall Study|Withdrawal by Subject|1|||
149144269|NCT01469182|538007789|FG000|Overall Study|Protocol Violation|4|||
149144270|NCT01469182|538007790|FG001|Overall Study|Protocol Violation|2|||
148913377|NCT00955305|537166914|FG001|Overall Study|Adverse Event|22|||
148913378|NCT00955305|537166913|FG000|Overall Study|Death|2|||
148913379|NCT00955305|537166914|FG001|Overall Study|Death|1|||
148913380|NCT00955305|537166913|FG000|Overall Study|Withdrawal by Subject|5|||
148913381|NCT00955305|537166914|FG001|Overall Study|Withdrawal by Subject|4|||
148913382|NCT00955305|537166913|FG000|Overall Study|Alternative therapy|4|||
148913383|NCT00955305|537166914|FG001|Overall Study|Alternative therapy|0|||
148913384|NCT00955305|537166913|FG000|Overall Study|Other complicating disease|2|||
149144271|NCT01469182|538007789|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
149144272|NCT01469182|538007790|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
149144273|NCT01761292|538007792|FG000|Part 1|Adverse Event|1|||
149144274|NCT01761292|538007792|FG000|Part 1|not receiving treatment in Part 1|1|||
149144275|NCT01761292|538007792|FG000|Extension 1|Withdrawal by Subject|1|||
149144276|NCT00840086|538007793|FG000|Overall Study|Adverse Event|1|||
149144277|NCT00840086|538007793|FG000|Overall Study|Protocol Violation|2|||
149144278|NCT00840086|538007793|FG000|Overall Study|Lost to Follow-up|1|||
149144279|NCT03332498|538007794|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
149144280|NCT03332498|538007795|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
149144281|NCT03332498|538007796|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
149144282|NCT02554019|538007797|FG000|Overall Study|Withdrawal by Subject|1|||
149144283|NCT02554019|538007798|FG001|Overall Study|Withdrawal by Subject|0|||
149144284|NCT02554019|538007799|FG002|Overall Study|Withdrawal by Subject|2|||
149144285|NCT02554019|538007797|FG000|Overall Study|Adverse Event|1|||
149144286|NCT02554019|538007798|FG001|Overall Study|Adverse Event|0|||
149144287|NCT02554019|538007799|FG002|Overall Study|Adverse Event|0|||
149144288|NCT02463409|538007800|FG000|Overall Study|Withdrawal by Subject|1|||
149144289|NCT02463409|538007800|FG000|Overall Study|Screen failure|1|||
149144290|NCT00916357|538007801|FG000|Period 1|Withdrawal by Subject|1|||
149144291|NCT00916357|538007802|FG001|Period 1|Withdrawal by Subject|0|||
149144292|NCT00916357|538007803|FG002|Period 1|Withdrawal by Subject|0|||
149144293|NCT00916357|538007804|FG003|Period 1|Withdrawal by Subject|0|||
149144294|NCT00916357|538007805|FG004|Period 1|Withdrawal by Subject|0|||
149144295|NCT00916357|538007806|FG005|Period 1|Withdrawal by Subject|0|||
149144296|NCT00916357|538007801|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
149144297|NCT00916357|538007802|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
149144298|NCT00916357|538007803|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
149144299|NCT00916357|538007804|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
149144300|NCT00916357|538007805|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
149144301|NCT00916357|538007806|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
149144302|NCT03577730|538007807|FG000|Overall Study|Physician Decision|3|||
149144303|NCT03577730|538007808|FG001|Overall Study|Physician Decision|1|||
149144304|NCT03577730|538007807|FG000|Overall Study|Did not receive allocated intervention|1|||
149144305|NCT03577730|538007808|FG001|Overall Study|Did not receive allocated intervention|0|||
149144306|NCT02634151|538007810|FG000|Overall Study|Withdrawal by Subject|1|||
149144307|NCT02634151|538007811|FG001|Overall Study|Withdrawal by Subject|0|||
149144308|NCT02634151|538007810|FG000|Overall Study|Non-Compliance|0|||
149144309|NCT02634151|538007811|FG001|Overall Study|Non-Compliance|1|||
149144310|NCT02634151|538007810|FG000|Overall Study|Other|0|||
149144311|NCT02634151|538007811|FG001|Overall Study|Other|1|||
149144312|NCT00003535|538007812|FG000|Overall Study|Not evaluable|5|||
149144313|NCT02289742|538007813|FG000|First Wear Period|Adverse event prior to treatment|0|||
149144314|NCT02289742|538007814|FG001|First Wear Period|Adverse event prior to treatment|1|||
149144315|NCT02289742|538007815|FG002|First Wear Period|Adverse event prior to treatment|0|||
149144316|NCT02289742|538007816|FG003|First Wear Period|Adverse event prior to treatment|0|||
149144317|NCT02289742|538007813|FG000|First Wear Period|Adverse Event|0|||
149144318|NCT02289742|538007814|FG001|First Wear Period|Adverse Event|0|||
149144319|NCT02289742|538007815|FG002|First Wear Period|Adverse Event|1|||
149144320|NCT02289742|538007816|FG003|First Wear Period|Adverse Event|0|||
149144321|NCT02289742|538007813|FG000|First Wear Period|Other prior to treatment|0|||
149144322|NCT02289742|538007814|FG001|First Wear Period|Other prior to treatment|0|||
149144323|NCT02289742|538007815|FG002|First Wear Period|Other prior to treatment|0|||
149144324|NCT02289742|538007816|FG003|First Wear Period|Other prior to treatment|1|||
149144325|NCT02289742|538007813|FG000|Third Wear Period|Adverse Event|0|||
149144326|NCT02289742|538007814|FG001|Third Wear Period|Adverse Event|1|||
149144327|NCT02289742|538007815|FG002|Third Wear Period|Adverse Event|0|||
149144328|NCT02289742|538007816|FG003|Third Wear Period|Adverse Event|0|||
149144329|NCT02289742|538007813|FG000|Third Wear Period|Reason not given|0|||
149144330|NCT02289742|538007814|FG001|Third Wear Period|Reason not given|0|||
149144331|NCT02289742|538007815|FG002|Third Wear Period|Reason not given|0|||
149144332|NCT02289742|538007816|FG003|Third Wear Period|Reason not given|1|||
149144333|NCT01360554|538007817|FG000|Overall Study|Death|359|||
149144334|NCT01360554|538007818|FG001|Overall Study|Death|371|||
149144335|NCT01360554|538007817|FG000|Overall Study|Lost to Follow-up|4|||
149144336|NCT01360554|538007818|FG001|Overall Study|Lost to Follow-up|4|||
149144337|NCT01360554|538007817|FG000|Overall Study|Withdrawal by Subject|23|||
149144338|NCT01360554|538007818|FG001|Overall Study|Withdrawal by Subject|24|||
149144339|NCT01360554|538007817|FG000|Overall Study|Study terminated by sponsor|49|||
149144340|NCT01360554|538007818|FG001|Overall Study|Study terminated by sponsor|37|||
149144341|NCT01360554|538007817|FG000|Overall Study|Other, not specified|1|||
149144342|NCT01360554|538007818|FG001|Overall Study|Other, not specified|0|||
149144343|NCT01360554|538007817|FG000|Overall Study|Randomized but not treated.|3|||
149144344|NCT01360554|538007818|FG001|Overall Study|Randomized but not treated.|3|||
149144345|NCT01911442|538007819|FG000|Overall Study|Adverse Event|2|||
149144346|NCT01911442|538007820|FG001|Overall Study|Adverse Event|2|||
149144347|NCT01911442|538007821|FG002|Overall Study|Adverse Event|4|||
149144348|NCT01911442|538007819|FG000|Overall Study|Lack of Efficacy|1|||
149144349|NCT01911442|538007820|FG001|Overall Study|Lack of Efficacy|1|||
149144350|NCT01911442|538007821|FG002|Overall Study|Lack of Efficacy|1|||
149144351|NCT01911442|538007819|FG000|Overall Study|Lost to Follow-up|2|||
149144352|NCT01911442|538007820|FG001|Overall Study|Lost to Follow-up|0|||
149144353|NCT01911442|538007821|FG002|Overall Study|Lost to Follow-up|1|||
149144354|NCT01911442|538007819|FG000|Overall Study|Withdrawal by Subject|1|||
149144355|NCT01911442|538007820|FG001|Overall Study|Withdrawal by Subject|0|||
149144356|NCT01911442|538007821|FG002|Overall Study|Withdrawal by Subject|6|||
149144357|NCT01911442|538007819|FG000|Overall Study|Mother's Work Schedule|0|||
149144358|NCT01911442|538007820|FG001|Overall Study|Mother's Work Schedule|1|||
149144359|NCT01911442|538007821|FG002|Overall Study|Mother's Work Schedule|0|||
149144360|NCT03668600|538007828|FG000|Overall Study|Study Terminated by the Sponsor|157|||
149144361|NCT03668600|538007828|FG000|Overall Study|Protocol Violation|1|||
149144362|NCT03668600|538007828|FG000|Overall Study|Pregnancy|1|||
149144363|NCT03668600|538007828|FG000|Overall Study|Lost to Follow-up|7|||
149144364|NCT03668600|538007828|FG000|Overall Study|Withdrawal by Subject|56|||
149144365|NCT03668600|538007828|FG000|Overall Study|Lack of Efficacy|7|||
149144366|NCT03668600|538007828|FG000|Overall Study|Adverse Event|1|||
149144367|NCT04451161|538007830|FG000|Overall Study|Lost to Follow-up|28|||
149144368|NCT04451161|538007831|FG001|Overall Study|Lost to Follow-up|37|||
149144369|NCT04451161|538007832|FG002|Overall Study|Lost to Follow-up|22|||
149144370|NCT04451161|538007833|FG003|Overall Study|Lost to Follow-up|13|||
149144371|NCT04451161|538007834|FG004|Overall Study|Lost to Follow-up|11|||
149144372|NCT04451161|538007835|FG005|Overall Study|Lost to Follow-up|14|||
149144373|NCT04451161|538007830|FG000|Overall Study|Withdrawal by Subject|3|||
149144374|NCT04451161|538007831|FG001|Overall Study|Withdrawal by Subject|0|||
149144375|NCT04451161|538007832|FG002|Overall Study|Withdrawal by Subject|0|||
149144376|NCT04451161|538007833|FG003|Overall Study|Withdrawal by Subject|0|||
149144377|NCT04451161|538007834|FG004|Overall Study|Withdrawal by Subject|2|||
149144378|NCT04451161|538007835|FG005|Overall Study|Withdrawal by Subject|4|||
149144379|NCT00454857|538007836|FG000|Overall Study|Withdrawal by Subject|15|||
149144380|NCT00454857|538007836|FG000|Overall Study|Lost to Follow-up|16|||
149144381|NCT00454857|538007836|FG000|Overall Study|Noncompliance|6|||
149144382|NCT00454857|538007836|FG000|Overall Study|Death|5|||
149144383|NCT00454857|538007836|FG000|Overall Study|Other|11|||
149144384|NCT00454857|538007836|FG000|Overall Study|Reason unknown|1|||
149144385|NCT01431274|538007837|FG000|Overall Study|Adverse Event|51|||
149144386|NCT01431274|538007838|FG001|Overall Study|Adverse Event|37|||
149144387|NCT01431274|538007839|FG002|Overall Study|Adverse Event|43|||
149144388|NCT01431274|538007840|FG003|Overall Study|Adverse Event|30|||
149144389|NCT01431274|538007841|FG004|Overall Study|Adverse Event|37|||
149144390|NCT01431274|538007837|FG000|Overall Study|Consent withdrawn not due to AE|29|||
149144391|NCT01431274|538007838|FG001|Overall Study|Consent withdrawn not due to AE|20|||
149144392|NCT01431274|538007839|FG002|Overall Study|Consent withdrawn not due to AE|17|||
149144393|NCT01431274|538007840|FG003|Overall Study|Consent withdrawn not due to AE|20|||
149144394|NCT01431274|538007841|FG004|Overall Study|Consent withdrawn not due to AE|11|||
149144395|NCT01431274|538007837|FG000|Overall Study|Non compliant with protocol|5|||
148804862|NCT01499511|536766592|FG000|Overall Study|Death|1|||
149144396|NCT01431274|538007838|FG001|Overall Study|Non compliant with protocol|8|||
149144397|NCT01431274|538007839|FG002|Overall Study|Non compliant with protocol|4|||
148804863|NCT01499511|536766593|FG001|Overall Study|Death|0|||
149144398|NCT01431274|538007840|FG003|Overall Study|Non compliant with protocol|4|||
149144399|NCT01431274|538007841|FG004|Overall Study|Non compliant with protocol|4|||
149144400|NCT01431274|538007837|FG000|Overall Study|Lost to Follow-up|6|||
149144401|NCT01431274|538007838|FG001|Overall Study|Lost to Follow-up|7|||
149144402|NCT01431274|538007839|FG002|Overall Study|Lost to Follow-up|1|||
148804864|NCT00998946|536766594|FG000|Overall Study|Lost to Follow-up|1|||
149144403|NCT01431274|538007840|FG003|Overall Study|Lost to Follow-up|4|||
148804865|NCT00998946|536766594|FG000|Overall Study|Withdrawal by Subject|1|||
149144404|NCT01431274|538007841|FG004|Overall Study|Lost to Follow-up|0|||
149144405|NCT01431274|538007837|FG000|Overall Study|Other reason not stated above|6|||
149144406|NCT01431274|538007838|FG001|Overall Study|Other reason not stated above|5|||
149144407|NCT01431274|538007839|FG002|Overall Study|Other reason not stated above|7|||
149144408|NCT01431274|538007840|FG003|Overall Study|Other reason not stated above|2|||
149144409|NCT01431274|538007841|FG004|Overall Study|Other reason not stated above|4|||
149144410|NCT02664272|538007842|FG000|Overall Study|Fluoroscopic images not made available|2|||
149144411|NCT01358760|538007843|FG000|Overall Study|Adverse Event|3|||
149144412|NCT01358760|538007844|FG001|Overall Study|Adverse Event|4|||
149144413|NCT01358760|538007845|FG002|Overall Study|Adverse Event|3|||
149144414|NCT01358760|538007843|FG000|Overall Study|Lost to Follow-up|1|||
149144415|NCT01358760|538007844|FG001|Overall Study|Lost to Follow-up|1|||
149144416|NCT01358760|538007845|FG002|Overall Study|Lost to Follow-up|3|||
149144417|NCT01358760|538007843|FG000|Overall Study|Withdrawal by Subject|5|||
149144418|NCT01358760|538007844|FG001|Overall Study|Withdrawal by Subject|3|||
149144419|NCT01358760|538007845|FG002|Overall Study|Withdrawal by Subject|2|||
149144420|NCT01358760|538007843|FG000|Overall Study|Physician Decision|1|||
149144421|NCT01358760|538007844|FG001|Overall Study|Physician Decision|0|||
149144422|NCT01358760|538007845|FG002|Overall Study|Physician Decision|1|||
149144423|NCT01358760|538007843|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
149144424|NCT01358760|538007844|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
149144425|NCT01358760|538007845|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
149144426|NCT00789880|538007848|FG000|Overall Study|Adverse Event|0|||
149144427|NCT00789880|538007849|FG001|Overall Study|Adverse Event|0|||
149144428|NCT00789880|538007850|FG002|Overall Study|Adverse Event|0|||
149144429|NCT00789880|538007851|FG003|Overall Study|Adverse Event|0|||
149144430|NCT00789880|538007852|FG004|Overall Study|Adverse Event|1|||
149144431|NCT00789880|538007853|FG005|Overall Study|Adverse Event|0|||
149144432|NCT00789880|538007848|FG000|Overall Study|Protocol Violation|0|||
149144433|NCT00789880|538007849|FG001|Overall Study|Protocol Violation|1|||
149144434|NCT00789880|538007850|FG002|Overall Study|Protocol Violation|0|||
149144435|NCT00789880|538007851|FG003|Overall Study|Protocol Violation|1|||
149144436|NCT00789880|538007852|FG004|Overall Study|Protocol Violation|0|||
149144437|NCT00789880|538007853|FG005|Overall Study|Protocol Violation|0|||
149144438|NCT00789880|538007848|FG000|Overall Study|Withdrawal by Subject|1|||
149144439|NCT00789880|538007849|FG001|Overall Study|Withdrawal by Subject|0|||
149144440|NCT00789880|538007850|FG002|Overall Study|Withdrawal by Subject|0|||
149144441|NCT00789880|538007851|FG003|Overall Study|Withdrawal by Subject|0|||
149144442|NCT00789880|538007852|FG004|Overall Study|Withdrawal by Subject|2|||
149144443|NCT00789880|538007853|FG005|Overall Study|Withdrawal by Subject|0|||
149144444|NCT00609986|538007857|FG000|Overall Study|Did not receive transplant or treatment|8|||
149144445|NCT00609986|538007858|FG001|Overall Study|Did not receive transplant or treatment|3|||
149144446|NCT03159091|538007859|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
149144447|NCT03159091|538007860|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
149144448|NCT03159091|538007859|FG000|Overall Study|Patient has taken no dose of study drug|0|||
149144449|NCT03159091|538007860|FG001|Overall Study|Patient has taken no dose of study drug|1|||
149144450|NCT04814823|538007861|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
149144451|NCT02044133|538007862|FG000|Overall Study|Lost to Follow-up|1|||
149144452|NCT02044133|538007863|FG001|Overall Study|Lost to Follow-up|1|||
149144453|NCT02044133|538007862|FG000|Overall Study|Death|1|||
149144454|NCT02044133|538007863|FG001|Overall Study|Death|0|||
149144455|NCT02044133|538007862|FG000|Overall Study|Release|3|||
149144456|NCT02044133|538007863|FG001|Overall Study|Release|4|||
149144457|NCT02044133|538007862|FG000|Overall Study|Transfer|1|||
149144458|NCT02044133|538007863|FG001|Overall Study|Transfer|0|||
149144459|NCT02044133|538007862|FG000|Overall Study|refusal of blood sampling|0|||
149144460|NCT02044133|538007863|FG001|Overall Study|refusal of blood sampling|1|||
149144461|NCT05678257|538007868|FG000|Overall Study|Withdrawal by Subject|2|||
149144462|NCT05678257|538007869|FG001|Overall Study|Withdrawal by Subject|0|||
149144463|NCT05678257|538007870|FG002|Overall Study|Withdrawal by Subject|5|||
149144464|NCT05678257|538007868|FG000|Overall Study|Physician Decision|1|||
149144465|NCT05678257|538007869|FG001|Overall Study|Physician Decision|0|||
149144466|NCT05678257|538007870|FG002|Overall Study|Physician Decision|1|||
149144467|NCT05678257|538007868|FG000|Overall Study|Adverse Event|1|||
149144468|NCT05678257|538007869|FG001|Overall Study|Adverse Event|3|||
149144469|NCT05678257|538007870|FG002|Overall Study|Adverse Event|1|||
149144470|NCT05678257|538007868|FG000|Overall Study|Progressive disease|11|||
149144471|NCT05678257|538007869|FG001|Overall Study|Progressive disease|18|||
149144472|NCT05678257|538007870|FG002|Overall Study|Progressive disease|7|||
149144473|NCT05678257|538007868|FG000|Overall Study|No longer clinically benefitting|2|||
149144474|NCT05678257|538007869|FG001|Overall Study|No longer clinically benefitting|1|||
149144475|NCT05678257|538007870|FG002|Overall Study|No longer clinically benefitting|0|||
149144476|NCT05678257|538007868|FG000|Overall Study|Sponsor decision|5|||
149144477|NCT05678257|538007869|FG001|Overall Study|Sponsor decision|9|||
149144478|NCT05678257|538007870|FG002|Overall Study|Sponsor decision|8|||
149144479|NCT05678257|538007868|FG000|Overall Study|Protocol Violation|0|||
149144480|NCT05678257|538007869|FG001|Overall Study|Protocol Violation|0|||
149144481|NCT05678257|538007870|FG002|Overall Study|Protocol Violation|1|||
149144482|NCT05678257|538007868|FG000|Overall Study|Patient non-compliance|0|||
149144483|NCT05678257|538007869|FG001|Overall Study|Patient non-compliance|0|||
149144484|NCT05678257|538007870|FG002|Overall Study|Patient non-compliance|3|||
149144485|NCT02046096|538007871|FG000|Overall Study|Death|28|||
149144486|NCT02046096|538007872|FG001|Overall Study|Death|45|||
149144487|NCT02046096|538007871|FG000|Overall Study|Lost to Follow-up|9|||
149144488|NCT02046096|538007872|FG001|Overall Study|Lost to Follow-up|20|||
149144489|NCT02046096|538007871|FG000|Overall Study|Withdrawal by Subject|5|||
149144490|NCT02046096|538007872|FG001|Overall Study|Withdrawal by Subject|17|||
149144491|NCT02046096|538007871|FG000|Overall Study|Other endpoint|2|||
149144492|NCT02046096|538007872|FG001|Overall Study|Other endpoint|19|||
149144493|NCT03520959|538007873|FG000|Overall Study|Study terminated by Sponsor|0|||
149144494|NCT03520959|538007874|FG001|Overall Study|Study terminated by Sponsor|1|||
149144495|NCT04969276|538007875|FG000|Overall Study|Protocol Deviation|0|||
149144496|NCT04969276|538007876|FG001|Overall Study|Protocol Deviation|1|||
149144497|NCT04969276|538007877|FG002|Overall Study|Protocol Deviation|0|||
149144498|NCT04969276|538007875|FG000|Overall Study|Withdrawal by Subject|1|||
149144499|NCT04969276|538007876|FG001|Overall Study|Withdrawal by Subject|10|||
149144500|NCT04969276|538007877|FG002|Overall Study|Withdrawal by Subject|0|||
149144501|NCT04969276|538007875|FG000|Overall Study|Lost to Follow-up|0|||
149144502|NCT04969276|538007876|FG001|Overall Study|Lost to Follow-up|1|||
149144503|NCT04969276|538007877|FG002|Overall Study|Lost to Follow-up|0|||
149144504|NCT04490018|538007881|FG000|Overall Study|Protocol Violation|0|||
149144505|NCT04490018|538007882|FG001|Overall Study|Protocol Violation|2|||
149144506|NCT04490018|538007883|FG002|Overall Study|Protocol Violation|1|||
149144507|NCT04490018|538007881|FG000|Overall Study|Lost to Follow-up|2|||
149144508|NCT04490018|538007882|FG001|Overall Study|Lost to Follow-up|2|||
149144509|NCT04490018|538007883|FG002|Overall Study|Lost to Follow-up|0|||
149144510|NCT04490018|538007881|FG000|Overall Study|Withdrawal by Subject|2|||
149144511|NCT04490018|538007882|FG001|Overall Study|Withdrawal by Subject|1|||
149144512|NCT04490018|538007883|FG002|Overall Study|Withdrawal by Subject|0|||
149144513|NCT04490018|538007881|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149144514|NCT04490018|538007882|FG001|Overall Study|Withdrawal by parent/guardian|3|||
149144515|NCT04490018|538007883|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149144516|NCT00943579|538007885|FG000|Overall Study|Adverse Event|4|||
149144517|NCT00943579|538007886|FG001|Overall Study|Adverse Event|3|||
149144518|NCT00943579|538007885|FG000|Overall Study|Lack of Efficacy|2|||
149144519|NCT00943579|538007886|FG001|Overall Study|Lack of Efficacy|2|||
149144520|NCT00418665|538007889|FG000|Treatment Period|Ineligibility determined|1|||
149144521|NCT00418665|538007890|FG001|Treatment Period|Ineligibility determined|1|||
149144522|NCT00418665|538007891|FG002|Treatment Period|Ineligibility determined|0|||
149144523|NCT00418665|538007889|FG000|Treatment Period|Adverse Event|2|||
149144524|NCT00418665|538007890|FG001|Treatment Period|Adverse Event|2|||
149144525|NCT00418665|538007891|FG002|Treatment Period|Adverse Event|0|||
149144526|NCT00418665|538007889|FG000|Treatment Period|Withdrawal by Subject|0|||
149144527|NCT00418665|538007890|FG001|Treatment Period|Withdrawal by Subject|3|||
149144528|NCT00418665|538007891|FG002|Treatment Period|Withdrawal by Subject|1|||
149144529|NCT00418665|538007889|FG000|Treatment Period|Requirement for alternative therapy|1|||
149144530|NCT00418665|538007890|FG001|Treatment Period|Requirement for alternative therapy|0|||
149144531|NCT00418665|538007891|FG002|Treatment Period|Requirement for alternative therapy|0|||
148804866|NCT00998946|536766594|FG000|Overall Study|Death|2|||
148804867|NCT00998946|536766594|FG000|Overall Study|Reason Unspecified|3|||
149144532|NCT00418665|538007889|FG000|Treatment Period|Physician Decision|1|||
149144533|NCT00418665|538007890|FG001|Treatment Period|Physician Decision|0|||
149144534|NCT00418665|538007891|FG002|Treatment Period|Physician Decision|3|||
148804868|NCT00998946|536766594|FG000|Overall Study|Enrolled but not Dosed|2|||
148671345|NCT00972309|536267102|FG000|Overall Study|Disease progression on study|10|||
148804869|NCT00915525|536766600|FG000|Overall Study|Protocol Violation|9|||
149144535|NCT00418665|538007889|FG000|Treatment Extension|Adverse Event|1|||
149144536|NCT00418665|538007890|FG001|Treatment Extension|Adverse Event|0|||
149144537|NCT00418665|538007891|FG002|Treatment Extension|Adverse Event|0|||
149144538|NCT00418665|538007889|FG000|Treatment Extension|Withdrawal by Subject|1|||
149144539|NCT00418665|538007890|FG001|Treatment Extension|Withdrawal by Subject|0|||
149144540|NCT00418665|538007891|FG002|Treatment Extension|Withdrawal by Subject|0|||
149144541|NCT00418665|538007889|FG000|Treatment Extension|Requirement for alternative therapy|2|||
149144542|NCT00418665|538007890|FG001|Treatment Extension|Requirement for alternative therapy|2|||
149144543|NCT00418665|538007891|FG002|Treatment Extension|Requirement for alternative therapy|0|||
149144544|NCT00418665|538007889|FG000|Treatment Extension|Physician Decision|2|||
149144545|NCT00418665|538007890|FG001|Treatment Extension|Physician Decision|2|||
148913385|NCT00955305|537166914|FG001|Overall Study|Other complicating disease|4|||
148913386|NCT00955305|537166913|FG000|Overall Study|Physician Decision|1|||
148913387|NCT00955305|537166914|FG001|Overall Study|Physician Decision|0|||
148913388|NCT00955305|537166913|FG000|Overall Study|Continued presence of residual disease|0|||
149144546|NCT00418665|538007891|FG002|Treatment Extension|Physician Decision|1|||
149144547|NCT00418665|538007889|FG000|Treatment Extension|Death|0|||
149144548|NCT00418665|538007890|FG001|Treatment Extension|Death|0|||
149144549|NCT00418665|538007891|FG002|Treatment Extension|Death|1|||
149144550|NCT01484977|538007892|FG000|Overall Study|Adverse Event|8|||
149144551|NCT01484977|538007892|FG000|Overall Study|Lack of Efficacy|4|||
149144552|NCT01484977|538007892|FG000|Overall Study|Protocol Violation|6|||
149144553|NCT01484977|538007892|FG000|Overall Study|Lost to Follow-up|1|||
149144554|NCT01484977|538007892|FG000|Overall Study|Withdrawal by Subject|4|||
149144555|NCT01484977|538007892|FG000|Overall Study|Subject Protocol Non-compliant|1|||
149144556|NCT01484977|538007892|FG000|Overall Study|Moving Overseas|1|||
149144557|NCT01484977|538007892|FG000|Overall Study|Low White Blood Cell Count|1|||
149144558|NCT01484977|538007892|FG000|Overall Study|Lack of Compliance|1|||
149144559|NCT02347098|538009405|FG000|Overall Study|Death|1|||
149144560|NCT02347098|538009406|FG001|Overall Study|Death|0|||
149144561|NCT02347098|538009405|FG000|Overall Study|Withdrawal by Subject|1|||
149144562|NCT02347098|538009406|FG001|Overall Study|Withdrawal by Subject|0|||
149144563|NCT02347098|538009405|FG000|Overall Study|Lost to Follow-up|2|||
148913389|NCT00955305|537166914|FG001|Overall Study|Continued presence of residual disease|1|||
148913390|NCT00955305|537166913|FG000|Overall Study|Functional decline|2|||
148913391|NCT00955305|537166914|FG001|Overall Study|Functional decline|0|||
148913392|NCT00955305|537166913|FG000|Overall Study|Maximum response achieved|0|||
148913393|NCT00955305|537166914|FG001|Overall Study|Maximum response achieved|1|||
148913394|NCT00955305|537166913|FG000|Overall Study|Lost to Follow-up|0|||
148913395|NCT00955305|537166914|FG001|Overall Study|Lost to Follow-up|1|||
148913396|NCT00955305|537166913|FG000|Overall Study|No off-treatment reason submitted|1|||
148913397|NCT00955305|537166914|FG001|Overall Study|No off-treatment reason submitted|0|||
148913398|NCT00955305|537166913|FG000|Overall Study|Never started protocol treatment|5|||
148913399|NCT00955305|537166914|FG001|Overall Study|Never started protocol treatment|5|||
148913400|NCT00955305|537166913|FG000|Overall Study|Ineligible|5|||
148913401|NCT00955305|537166914|FG001|Overall Study|Ineligible|7|||
148913402|NCT00109590|537166915|FG000|Overall Study|Lost to Follow-up|1|||
148913403|NCT00109590|537166916|FG001|Overall Study|Lost to Follow-up|0|||
148913404|NCT00109590|537166917|FG002|Overall Study|Lost to Follow-up|1|||
148913405|NCT00109590|537166915|FG000|Overall Study|Never Started Treatment|1|||
148913406|NCT00109590|537166916|FG001|Overall Study|Never Started Treatment|2|||
148913407|NCT00109590|537166917|FG002|Overall Study|Never Started Treatment|3|||
148913408|NCT01221285|537166918|FG000|Overall Study|Withdrawal by Subject|1|||
148913409|NCT02123251|537166919|FG000|Overall Study|Death|1|||
148913410|NCT02123251|537166920|FG001|Overall Study|Death|1|||
148913411|NCT02123251|537166919|FG000|Overall Study|Withdrawal by Subject|0|||
148913412|NCT02123251|537166920|FG001|Overall Study|Withdrawal by Subject|3|||
149144564|NCT02347098|538009406|FG001|Overall Study|Lost to Follow-up|2|||
149144565|NCT02347098|538009405|FG000|Overall Study|Refuse Follow-up Visit|1|||
149144566|NCT02347098|538009406|FG001|Overall Study|Refuse Follow-up Visit|5|||
149144567|NCT02347098|538009405|FG000|Overall Study|no visit due to illness|2|||
149144568|NCT02347098|538009406|FG001|Overall Study|no visit due to illness|1|||
149144569|NCT01444742|538009407|FG000|Overall Study|Death|1|||
149144570|NCT02187172|538009408|FG000|Overall Study|Lost to Follow-up|1|||
149144571|NCT02187172|538009409|FG001|Overall Study|Lost to Follow-up|2|||
148913413|NCT02123251|537166919|FG000|Overall Study|Lost Medicaid eligibility|29|||
148913414|NCT02123251|537166920|FG001|Overall Study|Lost Medicaid eligibility|22|||
148913415|NCT02123251|537166919|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
148913416|NCT02123251|537166920|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
148913417|NCT03387111|537166921|FG000|Overall Study|Progressive Disease|3|||
149144572|NCT02187172|538009408|FG000|Overall Study|Lack of Efficacy|1|||
149144573|NCT02187172|538009409|FG001|Overall Study|Lack of Efficacy|2|||
149144574|NCT02187172|538009408|FG000|Overall Study|Adverse Event|0|||
149144575|NCT02187172|538009409|FG001|Overall Study|Adverse Event|1|||
149144576|NCT02187172|538009408|FG000|Overall Study|Physician Decision|1|||
149144577|NCT02187172|538009409|FG001|Overall Study|Physician Decision|1|||
149144578|NCT02181816|538009410|FG000|Overall Study|Case Report Forms Uncollected|38|||
149144579|NCT02181816|538009410|FG000|Overall Study|Protocol Deviation|21|||
149144580|NCT02830880|538009411|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
149144581|NCT02830880|538009411|FG000|Overall Study|Death|1|||
149144582|NCT02830880|538009411|FG000|Overall Study|Physician Decision|1|||
149144583|NCT02349048|538009416|FG000|Overall Study|Withdrawal by Subject|4|||
149144584|NCT02349048|538009417|FG001|Overall Study|Withdrawal by Subject|0|||
149144585|NCT02349048|538009416|FG000|Overall Study|Lost to Follow-up|1|||
149144586|NCT02349048|538009417|FG001|Overall Study|Lost to Follow-up|0|||
149144587|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
149144588|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
149144589|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
149144590|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
149144591|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
149144592|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
149144593|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
149144594|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
149144595|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
149144596|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
149144597|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
149144598|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
149144599|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
149144600|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
149144601|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
149144602|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
149144603|NCT00094770|538009420|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
149144604|NCT00094770|538009421|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
149144605|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
149144606|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
149144607|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
149144608|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
149144609|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
149144610|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
149144611|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
149144612|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
149144613|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
149144614|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
149144615|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
149144616|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
149144617|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
149144618|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
149144619|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
149144620|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
149144621|NCT00094770|538009420|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
149144622|NCT00094770|538009421|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
149144623|NCT00253643|538009422|FG000|Overall Study|Withdrawal by Subject|0|||
149144624|NCT00253643|538009423|FG001|Overall Study|Withdrawal by Subject|0|||
149144625|NCT00253643|538009424|FG002|Overall Study|Withdrawal by Subject|1|||
149144626|NCT00253643|538009425|FG003|Overall Study|Withdrawal by Subject|1|||
149144627|NCT00253643|538009422|FG000|Overall Study|Non-Compliance|0|||
149144628|NCT00253643|538009423|FG001|Overall Study|Non-Compliance|0|||
149144629|NCT00253643|538009424|FG002|Overall Study|Non-Compliance|0|||
149144630|NCT00253643|538009425|FG003|Overall Study|Non-Compliance|2|||
149144631|NCT01368536|538009433|FG000|Overall Study|Adverse Event|5|||
149144632|NCT01368536|538009434|FG001|Overall Study|Adverse Event|6|||
149144633|NCT01368536|538009435|FG002|Overall Study|Adverse Event|8|||
149144634|NCT01368536|538009433|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149144635|NCT01368536|538009434|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149144636|NCT01368536|538009435|FG002|Overall Study|Abnormal laboratory value(s)|2|||
149144637|NCT01368536|538009433|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149144638|NCT01368536|538009434|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149144639|NCT01368536|538009435|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149144640|NCT01368536|538009433|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
149144641|NCT01368536|538009434|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149144642|NCT01368536|538009435|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
149144643|NCT01368536|538009433|FG000|Overall Study|No longer required study medication|0|||
149144644|NCT01368536|538009434|FG001|Overall Study|No longer required study medication|0|||
149144645|NCT01368536|538009435|FG002|Overall Study|No longer required study medication|1|||
149144646|NCT01368536|538009433|FG000|Overall Study|Withdrawal by Subject|2|||
149144647|NCT01368536|538009434|FG001|Overall Study|Withdrawal by Subject|5|||
149144648|NCT01368536|538009435|FG002|Overall Study|Withdrawal by Subject|4|||
149144649|NCT01368536|538009433|FG000|Overall Study|Lost to Follow-up|3|||
149144650|NCT01368536|538009434|FG001|Overall Study|Lost to Follow-up|3|||
149144651|NCT01368536|538009435|FG002|Overall Study|Lost to Follow-up|5|||
149144652|NCT01368536|538009433|FG000|Overall Study|Administrative problems|34|||
149144653|NCT01368536|538009434|FG001|Overall Study|Administrative problems|39|||
149144654|NCT01368536|538009435|FG002|Overall Study|Administrative problems|35|||
149144655|NCT01368536|538009433|FG000|Overall Study|Protocol deviation|0|||
149144656|NCT01368536|538009434|FG001|Overall Study|Protocol deviation|3|||
149144657|NCT01368536|538009435|FG002|Overall Study|Protocol deviation|1|||
149144658|NCT00383084|538009436|FG000|Overall Study|Withdrawal by Subject|12|||
149144659|NCT00383084|538009437|FG001|Overall Study|Withdrawal by Subject|10|||
149144660|NCT02113436|538009438|FG000|Period 1: 8 Weeks|Adverse Event|1|||
149144661|NCT02113436|538009439|FG001|Period 1: 8 Weeks|Adverse Event|0|||
149144662|NCT02113436|538009440|FG002|Period 1: 8 Weeks|Adverse Event|0|||
149144663|NCT02113436|538009441|FG003|Period 1: 8 Weeks|Adverse Event|0|||
149144664|NCT02113436|538009438|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
149144665|NCT02113436|538009439|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
149144666|NCT02113436|538009440|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
149144667|NCT02113436|538009441|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
149144668|NCT02113436|538009438|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
149144669|NCT02113436|538009439|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
149144670|NCT02113436|538009440|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
149144671|NCT02113436|538009441|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
149144672|NCT02113436|538009438|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
149144673|NCT02113436|538009439|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
149144674|NCT02113436|538009440|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
149144675|NCT02113436|538009441|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
149144676|NCT02113436|538009438|FG000|Period 2: 16 Weeks|Adverse Event|0|||
149144677|NCT02113436|538009439|FG001|Period 2: 16 Weeks|Adverse Event|0|||
149144678|NCT02113436|538009440|FG002|Period 2: 16 Weeks|Adverse Event|4|||
149144679|NCT02113436|538009441|FG003|Period 2: 16 Weeks|Adverse Event|5|||
149144680|NCT02113436|538009438|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
149144681|NCT02113436|538009439|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
149144682|NCT02113436|538009440|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
149144683|NCT02113436|538009441|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
149144684|NCT02113436|538009438|FG000|Period 2: 16 Weeks|Physician Decision|0|||
149144685|NCT02113436|538009439|FG001|Period 2: 16 Weeks|Physician Decision|0|||
149144686|NCT02113436|538009440|FG002|Period 2: 16 Weeks|Physician Decision|2|||
149144687|NCT02113436|538009441|FG003|Period 2: 16 Weeks|Physician Decision|0|||
149144688|NCT02113436|538009438|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
149144689|NCT02113436|538009439|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
149144690|NCT02113436|538009440|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
149144691|NCT02113436|538009441|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
149144692|NCT01648790|538009442|FG000|Treatment 3|Withdrawal by Subject|0|||
149144693|NCT01648790|538009443|FG001|Treatment 3|Withdrawal by Subject|0|||
149144694|NCT01648790|538009444|FG002|Treatment 3|Withdrawal by Subject|0|||
149144695|NCT01648790|538009445|FG003|Treatment 3|Withdrawal by Subject|1|||
149144696|NCT01648790|538009446|FG004|Treatment 3|Withdrawal by Subject|0|||
149144697|NCT01486927|538009447|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
149144698|NCT01486927|538009447|FG000|Overall Study|Physician Decision|1|||
149144699|NCT01486927|538009447|FG000|Overall Study|50 Exposure days not reached|2|||
149144700|NCT01486927|538009447|FG000|Overall Study|Withdrawal by Subject|8|||
149144701|NCT01486927|538009447|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
149144702|NCT02159729|538009451|FG000|Overall Study|Adverse Event|0|||
149144703|NCT02159729|538009452|FG001|Overall Study|Adverse Event|1|||
149144704|NCT02159729|538009451|FG000|Overall Study|Subject's Request|13|||
149144705|NCT02159729|538009452|FG001|Overall Study|Subject's Request|10|||
149144706|NCT02159729|538009451|FG000|Overall Study|Lost to Follow-up|24|||
149144707|NCT02159729|538009452|FG001|Overall Study|Lost to Follow-up|9|||
149144708|NCT02159729|538009451|FG000|Overall Study|Non compliance|2|||
149144709|NCT02159729|538009452|FG001|Overall Study|Non compliance|0|||
149144710|NCT02159729|538009451|FG000|Overall Study|Other Unspecified|3|||
149144711|NCT02159729|538009452|FG001|Overall Study|Other Unspecified|1|||
149144712|NCT02636582|538009453|FG000|Overall Study|Surgical Pathology|1|||
149144713|NCT02636582|538009454|FG001|Overall Study|Surgical Pathology|0|||
149144714|NCT00573430|538009455|FG000|Overall Study|Incorrect enrollment of randomization|0|||
149144715|NCT00573430|538009456|FG001|Overall Study|Incorrect enrollment of randomization|4|||
149144716|NCT00573430|538009457|FG002|Overall Study|Incorrect enrollment of randomization|3|||
149144717|NCT00573430|538009455|FG000|Overall Study|Adverse Event|0|||
149144718|NCT00573430|538009456|FG001|Overall Study|Adverse Event|0|||
149144719|NCT00573430|538009457|FG002|Overall Study|Adverse Event|2|||
149144720|NCT00573430|538009455|FG000|Overall Study|Withdrawal by Subject|1|||
149144721|NCT00573430|538009456|FG001|Overall Study|Withdrawal by Subject|0|||
149144722|NCT00573430|538009457|FG002|Overall Study|Withdrawal by Subject|1|||
149144723|NCT00573430|538009455|FG000|Overall Study|Protocol Violation|0|||
149144724|NCT00573430|538009456|FG001|Overall Study|Protocol Violation|1|||
149144725|NCT00573430|538009457|FG002|Overall Study|Protocol Violation|1|||
149144726|NCT00573430|538009455|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149144727|NCT00573430|538009456|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148804870|NCT00915525|536766601|FG001|Overall Study|Protocol Violation|4|||
149144728|NCT00573430|538009457|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
149144729|NCT01278745|538009458|FG000|Overall Study|Death|2|||
149144730|NCT01278745|538009459|FG001|Overall Study|Death|5|||
149144731|NCT01278745|538009460|FG002|Overall Study|Death|7|||
149144732|NCT01278745|538009461|FG003|Overall Study|Death|0|||
149144733|NCT01278745|538009458|FG000|Overall Study|Physician Decision|1|||
149144734|NCT01278745|538009459|FG001|Overall Study|Physician Decision|0|||
149144735|NCT01278745|538009460|FG002|Overall Study|Physician Decision|0|||
149144736|NCT01278745|538009461|FG003|Overall Study|Physician Decision|9|||
149144737|NCT01278745|538009458|FG000|Overall Study|Withdrawal by Subject|1|||
149144738|NCT01278745|538009459|FG001|Overall Study|Withdrawal by Subject|1|||
149144739|NCT01278745|538009460|FG002|Overall Study|Withdrawal by Subject|5|||
149144740|NCT01278745|538009461|FG003|Overall Study|Withdrawal by Subject|1|||
149144741|NCT01278745|538009458|FG000|Overall Study|Sponsor Decision|1|||
149144742|NCT01278745|538009459|FG001|Overall Study|Sponsor Decision|0|||
149144743|NCT01278745|538009460|FG002|Overall Study|Sponsor Decision|62|||
149144744|NCT01278745|538009461|FG003|Overall Study|Sponsor Decision|6|||
149144745|NCT01278745|538009458|FG000|Overall Study|Ineligible|0|||
149144746|NCT01278745|538009459|FG001|Overall Study|Ineligible|0|||
149144747|NCT01278745|538009460|FG002|Overall Study|Ineligible|42|||
149144748|NCT01278745|538009461|FG003|Overall Study|Ineligible|61|||
149144749|NCT01278745|538009458|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
149144750|NCT01278745|538009459|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
149144751|NCT01278745|538009460|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
149144752|NCT01278745|538009461|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
149144753|NCT01148537|538009462|FG000|Overall Study|Withdrawal by Subject|1|||
149144754|NCT01148537|538009463|FG001|Overall Study|Withdrawal by Subject|0|||
149144755|NCT01148537|538009464|FG002|Overall Study|Withdrawal by Subject|2|||
149144756|NCT01148537|538009462|FG000|Overall Study|Adverse Event|2|||
149144757|NCT01148537|538009463|FG001|Overall Study|Adverse Event|0|||
149144758|NCT01148537|538009464|FG002|Overall Study|Adverse Event|1|||
149144759|NCT01843842|538009467|FG000|Overall Study|Do not meet inclusion criteria|1|||
149144760|NCT01843842|538009468|FG001|Overall Study|Do not meet inclusion criteria|1|||
149144761|NCT02953340|538009469|FG000|Overall Study|Death|0|||
149144762|NCT02953340|538009470|FG001|Overall Study|Death|1|||
149144763|NCT02953340|538009469|FG000|Overall Study|Investigator Decision|3|||
149144764|NCT02953340|538009470|FG001|Overall Study|Investigator Decision|3|||
149144765|NCT02953340|538009469|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
149144766|NCT02953340|538009470|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
149144767|NCT02953340|538009469|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
149144768|NCT02953340|538009470|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
149144769|NCT02953340|538009469|FG000|Overall Study|Withdrawal by Subject|9|||
149144770|NCT02953340|538009470|FG001|Overall Study|Withdrawal by Subject|9|||
149144771|NCT02953340|538009469|FG000|Overall Study|Sponsor decision|0|||
149144772|NCT02953340|538009470|FG001|Overall Study|Sponsor decision|2|||
149144773|NCT02953340|538009469|FG000|Overall Study|Lost to Follow-up|3|||
149144774|NCT02953340|538009470|FG001|Overall Study|Lost to Follow-up|2|||
149144775|NCT02953340|538009469|FG000|Overall Study|Reason not specified|2|||
149144776|NCT02953340|538009470|FG001|Overall Study|Reason not specified|2|||
149144777|NCT01376778|538009471|FG000|Overall Study|Lost to Follow-up|3|||
149144778|NCT01376778|538009472|FG001|Overall Study|Lost to Follow-up|2|||
149144779|NCT01197521|538009473|FG000|Overall Study|Not reported|24|||
149144780|NCT01197521|538009474|FG001|Overall Study|Not reported|25|||
149144781|NCT01197521|538009475|FG002|Overall Study|Not reported|21|||
149144782|NCT01197521|538009473|FG000|Overall Study|Enrolment in long term extension|42|||
149144783|NCT01197521|538009474|FG001|Overall Study|Enrolment in long term extension|36|||
149144784|NCT01197521|538009475|FG002|Overall Study|Enrolment in long term extension|87|||
149144785|NCT01197521|538009473|FG000|Overall Study|Severe non-compliance to protocol|1|||
149144786|NCT01197521|538009474|FG001|Overall Study|Severe non-compliance to protocol|3|||
149144787|NCT01197521|538009475|FG002|Overall Study|Severe non-compliance to protocol|3|||
149144788|NCT01197521|538009473|FG000|Overall Study|Lack of therapeutic response|2|||
149144789|NCT01197521|538009474|FG001|Overall Study|Lack of therapeutic response|3|||
149144790|NCT01197521|538009475|FG002|Overall Study|Lack of therapeutic response|4|||
149144791|NCT01197521|538009473|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
149144792|NCT01197521|538009474|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
149144793|NCT01197521|538009475|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
149144794|NCT01197521|538009473|FG000|Overall Study|Lost to Follow-up|3|||
149144795|NCT01197521|538009474|FG001|Overall Study|Lost to Follow-up|2|||
149144796|NCT01197521|538009475|FG002|Overall Study|Lost to Follow-up|2|||
149144797|NCT01197521|538009473|FG000|Overall Study|Adverse Event|25|||
149144798|NCT01197521|538009474|FG001|Overall Study|Adverse Event|28|||
149144799|NCT01197521|538009475|FG002|Overall Study|Adverse Event|24|||
149144800|NCT01543828|538009476|FG000|Treatment 2|Lost to Follow-up|1|||
149144801|NCT01543828|538009477|FG001|Treatment 2|Lost to Follow-up|0|||
149144802|NCT01069172|538009478|FG000|Overall Study|Withdrawal by Subject|1|||
149144803|NCT01069172|538009479|FG001|Overall Study|Withdrawal by Subject|0|||
149144804|NCT00827606|538009482|FG000|Overall Study|Protocol Violation|4|||
149144805|NCT00827606|538009483|FG001|Overall Study|Protocol Violation|3|||
149144806|NCT00827606|538009482|FG000|Overall Study|Lost to Follow-up|3|||
149144807|NCT00827606|538009483|FG001|Overall Study|Lost to Follow-up|1|||
149144808|NCT00827606|538009482|FG000|Overall Study|Withdrawal by Subject|7|||
149144809|NCT00827606|538009483|FG001|Overall Study|Withdrawal by Subject|6|||
149144810|NCT00827606|538009482|FG000|Overall Study|Pregnancy|0|||
149144811|NCT00827606|538009483|FG001|Overall Study|Pregnancy|1|||
149144812|NCT00827606|538009482|FG000|Overall Study|Other|5|||
149144813|NCT00827606|538009483|FG001|Overall Study|Other|13|||
149144814|NCT00827606|538009482|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
149144815|NCT00827606|538009483|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
149144816|NCT00827606|538009482|FG000|Overall Study|Adverse Event|4|||
149144817|NCT00827606|538009483|FG001|Overall Study|Adverse Event|2|||
149144818|NCT00243386|538009486|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
149144819|NCT00243386|538009487|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
149144820|NCT00243386|538009488|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
149144821|NCT00243386|538009486|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
149144822|NCT00243386|538009487|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
149144823|NCT00243386|538009488|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
149144824|NCT00243386|538009486|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
149144825|NCT00243386|538009487|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
149144826|NCT00243386|538009488|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
149144827|NCT00243386|538009486|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
149144828|NCT00243386|538009487|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
149144829|NCT00243386|538009488|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
149144830|NCT00243386|538009486|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
149144831|NCT00243386|538009487|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
149144832|NCT00243386|538009488|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
149144833|NCT00243386|538009486|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
149144834|NCT00243386|538009487|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
149144835|NCT00243386|538009488|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
149144836|NCT00243386|538009486|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
149144837|NCT00243386|538009487|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
149144838|NCT00243386|538009488|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
149144839|NCT00243386|538009486|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
149144840|NCT00243386|538009487|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
149144841|NCT00243386|538009488|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
149144842|NCT04037748|538009489|FG000|Treatment Period 1|Withdrawal by Subject|3|||
149144843|NCT04037748|538009490|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149144844|NCT04037748|538009489|FG000|Treatment Period 1|Adverse Event|1|||
149144845|NCT04037748|538009490|FG001|Treatment Period 1|Adverse Event|1|||
149144846|NCT04037748|538009489|FG000|Treatment Period 1|Protocol Violation|4|||
149144847|NCT04037748|538009490|FG001|Treatment Period 1|Protocol Violation|5|||
149144848|NCT04037748|538009489|FG000|Treatment Period 2|Adverse Event|0|||
149144849|NCT04037748|538009490|FG001|Treatment Period 2|Adverse Event|1|||
149144850|NCT04037748|538009489|FG000|Treatment Period 2|Protocol Violation|2|||
149144851|NCT04037748|538009490|FG001|Treatment Period 2|Protocol Violation|0|||
149144852|NCT00133991|538009491|FG000|Overall Study|Death|4|||
149144853|NCT04995055|538009497|FG000|Period 1|COVID-19 Related|1|||
149144854|NCT04995055|538009498|FG001|Period 1|COVID-19 Related|0|||
149144855|NCT04995055|538009497|FG000|Period 1|Withdrawal by Subject|0|||
149144856|NCT04995055|538009498|FG001|Period 1|Withdrawal by Subject|1|||
149144857|NCT04995055|538009497|FG000|Period 1|Subject discontinued due to timing|4|||
149144858|NCT04995055|538009498|FG001|Period 1|Subject discontinued due to timing|4|||
149144859|NCT04695392|538009500|FG000|Overall Study|Withdrawn by parent/guardian|0|||
149144860|NCT04695392|538009501|FG001|Overall Study|Withdrawn by parent/guardian|1|||
149144861|NCT04695392|538009500|FG000|Overall Study|Withdrawn by physician|0|||
149144862|NCT04695392|538009501|FG001|Overall Study|Withdrawn by physician|1|||
149144863|NCT00450723|538009503|FG000|Overall Study|Physician Decision|5|||
149144864|NCT01987960|538009504|FG000|Period 1|Adverse Event|24|||
149144865|NCT01987960|538009505|FG001|Period 1|Adverse Event|0|||
149144866|NCT01987960|538009506|FG002|Period 1|Adverse Event|0|||
149144867|NCT01987960|538009507|FG003|Period 1|Adverse Event|0|||
149144868|NCT01987960|538009504|FG000|Period 1|Lack of Efficacy|4|||
149144869|NCT01987960|538009505|FG001|Period 1|Lack of Efficacy|0|||
149144870|NCT01987960|538009506|FG002|Period 1|Lack of Efficacy|0|||
149144871|NCT01987960|538009507|FG003|Period 1|Lack of Efficacy|0|||
149144872|NCT01987960|538009504|FG000|Period 1|Non-compliance with IMP|6|||
149144873|NCT01987960|538009505|FG001|Period 1|Non-compliance with IMP|0|||
149144874|NCT01987960|538009506|FG002|Period 1|Non-compliance with IMP|0|||
149144875|NCT01987960|538009507|FG003|Period 1|Non-compliance with IMP|0|||
149144876|NCT01987960|538009504|FG000|Period 1|Protocol Violation|12|||
149144877|NCT01987960|538009505|FG001|Period 1|Protocol Violation|0|||
149144878|NCT01987960|538009506|FG002|Period 1|Protocol Violation|0|||
149144879|NCT01987960|538009507|FG003|Period 1|Protocol Violation|0|||
149144880|NCT01987960|538009504|FG000|Period 1|Withdrawal by Subject|21|||
149144881|NCT01987960|538009505|FG001|Period 1|Withdrawal by Subject|0|||
149144882|NCT01987960|538009506|FG002|Period 1|Withdrawal by Subject|0|||
149144883|NCT01987960|538009507|FG003|Period 1|Withdrawal by Subject|0|||
149144884|NCT01987960|538009504|FG000|Period 1|Lost to Follow-up|40|||
149144885|NCT01987960|538009505|FG001|Period 1|Lost to Follow-up|0|||
149144886|NCT01987960|538009506|FG002|Period 1|Lost to Follow-up|0|||
149144887|NCT01987960|538009507|FG003|Period 1|Lost to Follow-up|0|||
149144888|NCT01987960|538009504|FG000|Period 1|administrative or other reason|75|||
149144889|NCT01987960|538009505|FG001|Period 1|administrative or other reason|0|||
149144890|NCT01987960|538009506|FG002|Period 1|administrative or other reason|0|||
149144891|NCT01987960|538009507|FG003|Period 1|administrative or other reason|0|||
149144892|NCT01987960|538009504|FG000|Period 1|Withdrawal of consent before treatment|4|||
149144893|NCT01987960|538009505|FG001|Period 1|Withdrawal of consent before treatment|0|||
149144894|NCT01987960|538009506|FG002|Period 1|Withdrawal of consent before treatment|0|||
149144895|NCT01987960|538009507|FG003|Period 1|Withdrawal of consent before treatment|0|||
149144896|NCT01987960|538009504|FG000|Period 2|Adverse Event|0|||
149144897|NCT01987960|538009505|FG001|Period 2|Adverse Event|0|||
149144898|NCT01987960|538009506|FG002|Period 2|Adverse Event|1|||
149144899|NCT01987960|538009507|FG003|Period 2|Adverse Event|0|||
149144900|NCT01987960|538009504|FG000|Period 2|Withdrawal by Subject|0|||
149144901|NCT01987960|538009505|FG001|Period 2|Withdrawal by Subject|0|||
149144902|NCT01987960|538009506|FG002|Period 2|Withdrawal by Subject|1|||
149144903|NCT01987960|538009507|FG003|Period 2|Withdrawal by Subject|0|||
149144904|NCT01987960|538009504|FG000|Period 2|Administrative or other reason|0|||
149144905|NCT01987960|538009505|FG001|Period 2|Administrative or other reason|5|||
149144906|NCT01987960|538009506|FG002|Period 2|Administrative or other reason|7|||
149144907|NCT01987960|538009507|FG003|Period 2|Administrative or other reason|0|||
149144908|NCT01987960|538009504|FG000|Period 3|Adverse Event|0|||
149144909|NCT01987960|538009505|FG001|Period 3|Adverse Event|0|||
149144910|NCT01987960|538009506|FG002|Period 3|Adverse Event|0|||
149144911|NCT01987960|538009507|FG003|Period 3|Adverse Event|7|||
149144912|NCT01987960|538009504|FG000|Period 3|Non-compliance with IMP|0|||
149144913|NCT01987960|538009505|FG001|Period 3|Non-compliance with IMP|0|||
149144914|NCT01987960|538009506|FG002|Period 3|Non-compliance with IMP|0|||
149144915|NCT01987960|538009507|FG003|Period 3|Non-compliance with IMP|1|||
149144916|NCT01987960|538009504|FG000|Period 3|Protocol Violation|0|||
149144917|NCT01987960|538009505|FG001|Period 3|Protocol Violation|0|||
149144918|NCT01987960|538009506|FG002|Period 3|Protocol Violation|0|||
149144919|NCT01987960|538009507|FG003|Period 3|Protocol Violation|6|||
149144920|NCT01987960|538009504|FG000|Period 3|Withdrawal by Subject|0|||
149144921|NCT01987960|538009505|FG001|Period 3|Withdrawal by Subject|0|||
149144922|NCT01987960|538009506|FG002|Period 3|Withdrawal by Subject|0|||
149144923|NCT01987960|538009507|FG003|Period 3|Withdrawal by Subject|9|||
149144924|NCT01987960|538009504|FG000|Period 3|Lost to Follow-up|0|||
149144925|NCT01987960|538009505|FG001|Period 3|Lost to Follow-up|0|||
149144926|NCT01987960|538009506|FG002|Period 3|Lost to Follow-up|0|||
149144927|NCT01987960|538009507|FG003|Period 3|Lost to Follow-up|5|||
149144928|NCT01987960|538009504|FG000|Period 3|Administrative or other reason|0|||
149144929|NCT01987960|538009505|FG001|Period 3|Administrative or other reason|0|||
149144930|NCT01987960|538009506|FG002|Period 3|Administrative or other reason|0|||
149144931|NCT01987960|538009507|FG003|Period 3|Administrative or other reason|43|||
149144932|NCT00807742|538009508|FG000|Overall Study|Death|9|||
149144933|NCT00807742|538009509|FG001|Overall Study|Death|2|||
149144934|NCT00807742|538009508|FG000|Overall Study|Withdrawal by Subject|2|||
148913418|NCT03387111|537166921|FG000|Overall Study|Other|1|||
148913419|NCT01945710|537166925|FG000|Overall Study|Progressive Disease|5|||
148913420|NCT01945710|537166926|FG001|Overall Study|Progressive Disease|4|||
148913421|NCT01945710|537166927|FG002|Overall Study|Progressive Disease|3|||
148913422|NCT01945710|537166928|FG003|Overall Study|Progressive Disease|2|||
148913423|NCT01945710|537166929|FG004|Overall Study|Progressive Disease|7|||
148913424|NCT01945710|537166930|FG005|Overall Study|Progressive Disease|3|||
148913425|NCT01945710|537166931|FG006|Overall Study|Progressive Disease|19|||
148913426|NCT01945710|537166925|FG000|Overall Study|Adverse Event|0|||
148913427|NCT01945710|537166926|FG001|Overall Study|Adverse Event|1|||
148913428|NCT01945710|537166927|FG002|Overall Study|Adverse Event|0|||
148913429|NCT01945710|537166928|FG003|Overall Study|Adverse Event|0|||
148913430|NCT01945710|537166929|FG004|Overall Study|Adverse Event|0|||
148913431|NCT01945710|537166930|FG005|Overall Study|Adverse Event|0|||
148913432|NCT01945710|537166931|FG006|Overall Study|Adverse Event|0|||
148913433|NCT01945710|537166925|FG000|Overall Study|Other|2|||
148913434|NCT01945710|537166926|FG001|Overall Study|Other|0|||
148913435|NCT01945710|537166927|FG002|Overall Study|Other|3|||
148913436|NCT01945710|537166928|FG003|Overall Study|Other|1|||
148913437|NCT01945710|537166929|FG004|Overall Study|Other|1|||
148913438|NCT01945710|537166930|FG005|Overall Study|Other|0|||
148913439|NCT01945710|537166931|FG006|Overall Study|Other|4|||
148913440|NCT01945710|537166925|FG000|Overall Study|Withdrawal by Subject|0|||
148913441|NCT01945710|537166926|FG001|Overall Study|Withdrawal by Subject|1|||
148913442|NCT01945710|537166927|FG002|Overall Study|Withdrawal by Subject|1|||
148913443|NCT01945710|537166928|FG003|Overall Study|Withdrawal by Subject|0|||
148913444|NCT01945710|537166929|FG004|Overall Study|Withdrawal by Subject|1|||
148913445|NCT01945710|537166930|FG005|Overall Study|Withdrawal by Subject|0|||
148913446|NCT01945710|537166931|FG006|Overall Study|Withdrawal by Subject|0|||
148913447|NCT02730195|537166932|FG000|Overall Study|Withdrawal by Subject|1|||
148913448|NCT00375609|537166935|FG000|Overall Study|Did not receive treatment|1|||
148913449|NCT00375609|537166936|FG001|Overall Study|Did not receive treatment|0|||
148913450|NCT00375609|537166937|FG002|Overall Study|Did not receive treatment|0|||
148913451|NCT00375609|537166935|FG000|Overall Study|Adverse Event|0|||
148913452|NCT00375609|537166936|FG001|Overall Study|Adverse Event|3|||
148913453|NCT00375609|537166937|FG002|Overall Study|Adverse Event|0|||
149144935|NCT00807742|538009509|FG001|Overall Study|Withdrawal by Subject|1|||
148913454|NCT00375609|537166935|FG000|Overall Study|Lost to Follow-up|1|||
148913455|NCT00375609|537166936|FG001|Overall Study|Lost to Follow-up|0|||
148913456|NCT00375609|537166937|FG002|Overall Study|Lost to Follow-up|0|||
148913457|NCT00375609|537166935|FG000|Overall Study|Physician Decision|0|||
149144936|NCT00807742|538009508|FG000|Overall Study|Lost to Follow-up|35|||
149144937|NCT00807742|538009509|FG001|Overall Study|Lost to Follow-up|51|||
149144938|NCT03834519|538009510|FG000|Overall Study|Lost to Follow-up|2|||
149144939|NCT03834519|538009511|FG001|Overall Study|Lost to Follow-up|1|||
149144940|NCT03834519|538009510|FG000|Overall Study|Withdrawal by Subject|5|||
149144941|NCT03834519|538009511|FG001|Overall Study|Withdrawal by Subject|8|||
149144942|NCT03834519|538009510|FG000|Overall Study|Death|368|||
149144943|NCT03834519|538009511|FG001|Overall Study|Death|174|||
149144944|NCT03834519|538009510|FG000|Overall Study|Physician Decision|5|||
149144945|NCT03834519|538009511|FG001|Overall Study|Physician Decision|1|||
149144946|NCT03834519|538009510|FG000|Overall Study|Sponsor decision|149|||
149144947|NCT03834519|538009511|FG001|Overall Study|Sponsor decision|80|||
149144948|NCT05248295|538009512|FG000|Overall Study|found ineligible|4|||
149144949|NCT05248295|538009513|FG001|Overall Study|found ineligible|1|||
149144950|NCT05248295|538009512|FG000|Overall Study|Withdrawal by Subject|0|||
149144951|NCT05248295|538009513|FG001|Overall Study|Withdrawal by Subject|1|||
149144952|NCT05248295|538009512|FG000|Overall Study|Data loss: audio recording error|1|||
149144953|NCT05248295|538009513|FG001|Overall Study|Data loss: audio recording error|1|||
149144954|NCT04655144|538009514|FG000|Overall Study|Consumed THC|1|||
149144955|NCT04655144|538009515|FG001|Overall Study|Consumed THC|0|||
149144956|NCT04655144|538009514|FG000|Overall Study|Unilateral embolization|0|||
149144957|NCT04655144|538009515|FG001|Overall Study|Unilateral embolization|1|||
148913458|NCT00375609|537166936|FG001|Overall Study|Physician Decision|0|||
148913459|NCT00375609|537166937|FG002|Overall Study|Physician Decision|1|||
148913460|NCT00375609|537166935|FG000|Overall Study|Withdrawal by Subject|1|||
148913461|NCT00375609|537166936|FG001|Overall Study|Withdrawal by Subject|4|||
148913462|NCT00375609|537166937|FG002|Overall Study|Withdrawal by Subject|0|||
148913463|NCT00375609|537166935|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
148913464|NCT00375609|537166936|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
148913465|NCT00375609|537166937|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
148913466|NCT01368562|537166938|FG000|Overall Study|Adverse Event|1|||
148913467|NCT01368562|537166938|FG000|Overall Study|Disease progression|1|||
148913468|NCT01368562|537166938|FG000|Overall Study|Lost to Follow-up|1|||
148913469|NCT01368562|537166938|FG000|Overall Study|Death|6|||
148913470|NCT01368562|537166938|FG000|Overall Study|Unresponsive to treatment|5|||
148913471|NCT01368562|537166938|FG000|Overall Study|Other|3|||
148913472|NCT01368562|537166938|FG000|Overall Study|Other than specified|2|||
148913473|NCT00727441|537166940|FG000|Overall Study|Disease Progression|11|||
148913474|NCT00727441|537166941|FG001|Overall Study|Disease Progression|14|||
148913475|NCT00727441|537166942|FG002|Overall Study|Disease Progression|17|||
148913476|NCT00727441|537166940|FG000|Overall Study|Eligibility|7|||
148913477|NCT00727441|537166941|FG001|Overall Study|Eligibility|5|||
148913478|NCT00727441|537166942|FG002|Overall Study|Eligibility|7|||
148913479|NCT00727441|537166940|FG000|Overall Study|Death|0|||
148913480|NCT00727441|537166941|FG001|Overall Study|Death|1|||
148913481|NCT00727441|537166942|FG002|Overall Study|Death|1|||
148913482|NCT00727441|537166940|FG000|Overall Study|Physician Decision|0|||
148913483|NCT00727441|537166941|FG001|Overall Study|Physician Decision|1|||
148913484|NCT00727441|537166942|FG002|Overall Study|Physician Decision|0|||
148913485|NCT00727441|537166940|FG000|Overall Study|Withdrawal by Subject|0|||
148913486|NCT00727441|537166941|FG001|Overall Study|Withdrawal by Subject|1|||
148913487|NCT00727441|537166942|FG002|Overall Study|Withdrawal by Subject|0|||
148913488|NCT01239992|537166943|FG000|Overall Study|Withdrawal by Subject|2|||
148913489|NCT00535288|537166944|FG000|Overall Study|Adverse Event|20|||
148913490|NCT00535288|537166945|FG001|Overall Study|Adverse Event|19|||
148913491|NCT00535288|537166946|FG002|Overall Study|Adverse Event|25|||
149144958|NCT00853749|538009516|FG000|Overall Study|Lost to Follow-up|0|||
149144959|NCT00853749|538009517|FG001|Overall Study|Lost to Follow-up|1|||
149144960|NCT01133379|538009518|FG000|Overall Study|Withdrawal by Subject|0|||
149144961|NCT01133379|538009519|FG001|Overall Study|Withdrawal by Subject|1|||
148913492|NCT00535288|537166947|FG003|Overall Study|Adverse Event|20|||
148913493|NCT00535288|537166948|FG004|Overall Study|Adverse Event|30|||
148913494|NCT00535288|537166944|FG000|Overall Study|Lost to Follow-up|0|||
148913495|NCT00535288|537166945|FG001|Overall Study|Lost to Follow-up|3|||
148913496|NCT00535288|537166946|FG002|Overall Study|Lost to Follow-up|0|||
148913497|NCT00535288|537166947|FG003|Overall Study|Lost to Follow-up|0|||
148913498|NCT00535288|537166948|FG004|Overall Study|Lost to Follow-up|0|||
148913499|NCT00535288|537166944|FG000|Overall Study|Lack of Efficacy|26|||
148913500|NCT00535288|537166945|FG001|Overall Study|Lack of Efficacy|3|||
148913501|NCT00535288|537166946|FG002|Overall Study|Lack of Efficacy|4|||
148913502|NCT00535288|537166947|FG003|Overall Study|Lack of Efficacy|4|||
148913503|NCT00535288|537166948|FG004|Overall Study|Lack of Efficacy|7|||
148913504|NCT00535288|537166944|FG000|Overall Study|Unwilling to cooperate|6|||
148913505|NCT00535288|537166945|FG001|Overall Study|Unwilling to cooperate|6|||
149144962|NCT01133379|538009520|FG002|Overall Study|Withdrawal by Subject|1|||
149144963|NCT01133379|538009518|FG000|Overall Study|Lost to Follow-up|1|||
149144964|NCT01133379|538009519|FG001|Overall Study|Lost to Follow-up|1|||
149144965|NCT01133379|538009520|FG002|Overall Study|Lost to Follow-up|1|||
149144966|NCT00591214|538009523|FG000|Overall Study|Physician Decision|7|||
149144967|NCT00591214|538009523|FG000|Overall Study|Withdrawal by Subject|1|||
149233847|NCT00948896|538324944|FG000|Randomization to 24 Months of Age|Death|1|||
149144968|NCT04857996|538009524|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
149144969|NCT04857996|538009525|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
149144970|NCT04857996|538009524|FG000|Overall Study|Lost to Follow-up|1|||
149144971|NCT04857996|538009525|FG001|Overall Study|Lost to Follow-up|3|||
149144972|NCT04857996|538009524|FG000|Overall Study|Site Closure|1|||
149144973|NCT04857996|538009525|FG001|Overall Study|Site Closure|0|||
149144974|NCT04857996|538009524|FG000|Overall Study|Withdrawal by Subject|1|||
149144975|NCT04857996|538009525|FG001|Overall Study|Withdrawal by Subject|0|||
149144976|NCT01129921|538009526|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
149144977|NCT01129921|538009527|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
149144978|NCT01129921|538009526|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
149144979|NCT01129921|538009527|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
149144980|NCT01129921|538009526|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
149144981|NCT01129921|538009527|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
149144982|NCT01129921|538009526|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
149144983|NCT01129921|538009527|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
149144984|NCT01392677|538009528|FG000|Overall Study|Adverse Event|3|||
149144985|NCT01392677|538009529|FG001|Overall Study|Adverse Event|1|||
149144986|NCT01392677|538009528|FG000|Overall Study|Withdrawal by Subject|0|||
149144987|NCT01392677|538009529|FG001|Overall Study|Withdrawal by Subject|2|||
149144988|NCT01392677|538009528|FG000|Overall Study|Incorrect enrollment|2|||
149144989|NCT01392677|538009529|FG001|Overall Study|Incorrect enrollment|3|||
148804871|NCT00915525|536766600|FG000|Overall Study|Withdrawal by Subject|59|||
148804872|NCT00915525|536766601|FG001|Overall Study|Withdrawal by Subject|21|||
148804873|NCT00915525|536766600|FG000|Overall Study|Lost to Follow-up|27|||
148804874|NCT00915525|536766601|FG001|Overall Study|Lost to Follow-up|16|||
148804875|NCT00915525|536766600|FG000|Overall Study|Pregnancy|2|||
148804876|NCT00915525|536766601|FG001|Overall Study|Pregnancy|0|||
148804877|NCT00915525|536766600|FG000|Overall Study|Lack of Efficacy|15|||
148804878|NCT00915525|536766601|FG001|Overall Study|Lack of Efficacy|32|||
148804879|NCT00915525|536766600|FG000|Overall Study|Adverse Event|29|||
148804880|NCT00915525|536766601|FG001|Overall Study|Adverse Event|13|||
148804881|NCT00915525|536766600|FG000|Overall Study|Missing|12|||
148804882|NCT00915525|536766601|FG001|Overall Study|Missing|1|||
148804883|NCT00915525|536766600|FG000|Overall Study|Other Reason|35|||
148804884|NCT00915525|536766601|FG001|Overall Study|Other Reason|12|||
148804885|NCT00915525|536766600|FG000|Overall Study|Site Closed|27|||
148804886|NCT00915525|536766601|FG001|Overall Study|Site Closed|9|||
148804887|NCT00915525|536766600|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
148804888|NCT00915525|536766601|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
148804889|NCT00915525|536766600|FG000|Overall Study|Study Burden|28|||
148804890|NCT00915525|536766601|FG001|Overall Study|Study Burden|12|||
148804891|NCT00915525|536766600|FG000|Overall Study|Non-Compliance|3|||
148804892|NCT00915525|536766601|FG001|Overall Study|Non-Compliance|1|||
148804893|NCT00915525|536766600|FG000|Overall Study|Patient Moved|15|||
148804894|NCT00915525|536766601|FG001|Overall Study|Patient Moved|9|||
148804895|NCT02842866|536766602|FG000|Overall Study|Serious Adverse Event|0|||
148804896|NCT02842866|536766603|FG001|Overall Study|Serious Adverse Event|1|||
148804897|NCT02842866|536766602|FG000|Overall Study|Protocol Violation|4|||
148913506|NCT00535288|537166946|FG002|Overall Study|Unwilling to cooperate|3|||
149144990|NCT01392677|538009528|FG000|Overall Study|Other reason|3|||
149144991|NCT01392677|538009529|FG001|Overall Study|Other reason|2|||
149144992|NCT00121108|538009532|FG000|Overall Study|Lost to Follow-up|10|||
149144993|NCT00121108|538009533|FG001|Overall Study|Lost to Follow-up|22|||
149144994|NCT00121108|538009532|FG000|Overall Study|Withdrawal by Subject|106|||
149144995|NCT00121108|538009533|FG001|Overall Study|Withdrawal by Subject|195|||
149144996|NCT00121108|538009532|FG000|Overall Study|Death|5|||
149144997|NCT00121108|538009533|FG001|Overall Study|Death|8|||
149144998|NCT01380379|538009536|FG000|Overall Study|Pregnancy|1|||
149144999|NCT01538628|538009539|FG000|Overall Study|Withdrawal by Subject|1|||
149145000|NCT01538628|538009540|FG001|Overall Study|Withdrawal by Subject|1|||
149145001|NCT01538628|538009539|FG000|Overall Study|Lost to Follow-up|0|||
149145002|NCT01538628|538009540|FG001|Overall Study|Lost to Follow-up|1|||
149145003|NCT01357577|538009541|FG000|Overall Study|Lost to Follow-up|20|||
149145004|NCT01357577|538009542|FG001|Overall Study|Lost to Follow-up|16|||
148913507|NCT00535288|537166947|FG003|Overall Study|Unwilling to cooperate|3|||
148913508|NCT00535288|537166948|FG004|Overall Study|Unwilling to cooperate|4|||
148913509|NCT00535288|537166944|FG000|Overall Study|Other|2|||
148913510|NCT00535288|537166945|FG001|Overall Study|Other|1|||
148913511|NCT00535288|537166946|FG002|Overall Study|Other|1|||
148913512|NCT00535288|537166947|FG003|Overall Study|Other|2|||
148913513|NCT00535288|537166948|FG004|Overall Study|Other|1|||
148913514|NCT02810444|537166949|FG000|Overall Study|Screen Failures|14|||
148913515|NCT02810444|537166949|FG000|Overall Study|Withdrawal by Subject|4|||
148913516|NCT02810444|537166949|FG000|Overall Study|Adverse Event|3|||
148913517|NCT00745849|537166950|FG000|First Intervention|Withdrawal by Subject|0|||
148913518|NCT00745849|537166951|FG001|First Intervention|Withdrawal by Subject|1|||
148913519|NCT00745849|537166950|FG000|First Intervention|Lost to Follow-up|1|||
148913520|NCT00745849|537166951|FG001|First Intervention|Lost to Follow-up|1|||
148913521|NCT00745849|537166950|FG000|Second Intervention|Lost to Follow-up|2|||
148913522|NCT00745849|537166951|FG001|Second Intervention|Lost to Follow-up|1|||
148913523|NCT01754727|537166954|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
148913524|NCT02785770|537166955|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
148913525|NCT02785770|537166956|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
148913526|NCT02785770|537166957|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
148913527|NCT02785770|537166958|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
148913528|NCT02785770|537166955|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
148913529|NCT02785770|537166956|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
148913530|NCT02785770|537166957|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
148913531|NCT02785770|537166958|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
148913532|NCT02785770|537166955|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
148913533|NCT02785770|537166956|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
148913534|NCT02785770|537166957|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
148913535|NCT02785770|537166958|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
148913536|NCT02597478|537166969|FG000|Overall Study|Withdrawal by Subject|2|||
148913537|NCT02597478|537166970|FG001|Overall Study|Withdrawal by Subject|0|||
148913538|NCT02597478|537166969|FG000|Overall Study|Change of opioid dose|1|||
148913539|NCT02597478|537166970|FG001|Overall Study|Change of opioid dose|0|||
148913540|NCT02597478|537166969|FG000|Overall Study|Insufficient exertional dyspnea|0|||
148913541|NCT02597478|537166970|FG001|Overall Study|Insufficient exertional dyspnea|1|||
148913542|NCT01256190|537166972|FG000|Overall Study|Lost to Follow-up|2|||
148913543|NCT01256190|537166973|FG001|Overall Study|Lost to Follow-up|0|||
148913544|NCT04931888|537166974|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
148913545|NCT04931888|537166975|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
148913546|NCT04931888|537166976|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
149145005|NCT01357577|538009541|FG000|Overall Study|Withdrawal by Subject|16|||
149145006|NCT01357577|538009542|FG001|Overall Study|Withdrawal by Subject|8|||
149145007|NCT01357577|538009541|FG000|Overall Study|look at data in database?|1|||
149145008|NCT01357577|538009542|FG001|Overall Study|look at data in database?|2|||
149145009|NCT03080883|538009543|FG000|Overall Study|Withdrawal by Subject|11|||
148671346|NCT00972309|536267103|FG001|Overall Study|Disease progression on study|4|||
148671347|NCT01593761|536267104|FG000|Overall Study|Lost to Follow-up|1|||
148913547|NCT04931888|537166977|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
148913548|NCT02350478|537166978|FG000|Overall Study|Lost to Follow-up|5|||
148913549|NCT02350478|537166979|FG001|Overall Study|Lost to Follow-up|1|||
148913550|NCT02644109|537166981|FG000|Overall Study|Adverse Event|0|||
148913551|NCT02644109|537166982|FG001|Overall Study|Adverse Event|4|||
148913552|NCT04080167|537166983|FG000|Overall Study|Lost to Follow-up-Patients|7|||
148913553|NCT04080167|537166984|FG001|Overall Study|Lost to Follow-up-Patients|14|||
148913554|NCT04080167|537166985|FG002|Overall Study|Lost to Follow-up-Patients|0|||
148913555|NCT04080167|537166983|FG000|Overall Study|Lost to Follow-up-Providers|2|||
148913556|NCT04080167|537166984|FG001|Overall Study|Lost to Follow-up-Providers|2|||
148913557|NCT04080167|537166985|FG002|Overall Study|Lost to Follow-up-Providers|0|||
148913558|NCT04080167|537166983|FG000|Overall Study|Withdrawal by Subject|1|||
148913559|NCT04080167|537166984|FG001|Overall Study|Withdrawal by Subject|2|||
149145010|NCT03080883|538009544|FG001|Overall Study|Withdrawal by Subject|15|||
149145011|NCT03080883|538009543|FG000|Overall Study|Adverse Event|22|||
149145012|NCT03080883|538009544|FG001|Overall Study|Adverse Event|22|||
149145013|NCT03080883|538009543|FG000|Overall Study|Alternative Therapy|0|||
149145014|NCT03080883|538009544|FG001|Overall Study|Alternative Therapy|3|||
149145015|NCT03080883|538009543|FG000|Overall Study|Other Complicating Disease|9|||
149145016|NCT03080883|538009544|FG001|Overall Study|Other Complicating Disease|5|||
149145017|NCT03080883|538009543|FG000|Overall Study|Death|21|||
149145018|NCT03080883|538009544|FG001|Overall Study|Death|16|||
149145019|NCT03080883|538009543|FG000|Overall Study|Physician Decision|2|||
149145020|NCT03080883|538009544|FG001|Overall Study|Physician Decision|2|||
149145021|NCT03080883|538009543|FG000|Overall Study|Disease Progression|2|||
149145022|NCT03080883|538009544|FG001|Overall Study|Disease Progression|8|||
149145023|NCT03080883|538009543|FG000|Overall Study|Lost to Follow-up|1|||
149145024|NCT03080883|538009544|FG001|Overall Study|Lost to Follow-up|1|||
149145025|NCT00909181|538010807|FG000|Overall Study|Lost to Follow-up|39|||
149145026|NCT00909181|538010808|FG001|Overall Study|Lost to Follow-up|18|||
149145027|NCT00909181|538010809|FG002|Overall Study|Lost to Follow-up|33|||
149145028|NCT00632099|538010811|FG000|Overall Study|Lost to Follow-up|3|||
149145029|NCT00632099|538010812|FG001|Overall Study|Lost to Follow-up|3|||
149145030|NCT02375724|538010815|FG000|Overall Study|Lack of Efficacy|1|||
149145031|NCT02375724|538010816|FG001|Overall Study|Lack of Efficacy|1|||
149145032|NCT02375724|538010815|FG000|Overall Study|Withdrawal by Subject|1|||
149145033|NCT02375724|538010816|FG001|Overall Study|Withdrawal by Subject|1|||
149145034|NCT02375724|538010815|FG000|Overall Study|Lost to Follow-up|1|||
149145035|NCT02375724|538010816|FG001|Overall Study|Lost to Follow-up|0|||
149145036|NCT02375724|538010815|FG000|Overall Study|Protocol Violation|1|||
149145037|NCT02375724|538010816|FG001|Overall Study|Protocol Violation|0|||
149145038|NCT02375724|538010815|FG000|Overall Study|Adverse Event|2|||
149145039|NCT02375724|538010816|FG001|Overall Study|Adverse Event|4|||
149145040|NCT04712110|538010817|FG000|Overall Study|Lost to Follow-up|0|||
149145041|NCT04712110|538010818|FG001|Overall Study|Lost to Follow-up|1|||
149145042|NCT04712110|538010817|FG000|Overall Study|Withdrawal by Subject|0|||
149145043|NCT04712110|538010818|FG001|Overall Study|Withdrawal by Subject|4|||
148913560|NCT04080167|537166985|FG002|Overall Study|Withdrawal by Subject|0|||
148913561|NCT04080167|537166983|FG000|Overall Study|Withdrawal by Provider|0|||
148913562|NCT04080167|537166984|FG001|Overall Study|Withdrawal by Provider|0|||
148913563|NCT04080167|537166985|FG002|Overall Study|Withdrawal by Provider|4|||
148913564|NCT04080167|537166983|FG000|Overall Study|Death-Patient|2|||
148913565|NCT04080167|537166984|FG001|Overall Study|Death-Patient|1|||
148913566|NCT04080167|537166985|FG002|Overall Study|Death-Patient|0|||
148913567|NCT04080167|537166983|FG000|Overall Study|Hydroxyurea New Starts|0|||
148913568|NCT04080167|537166984|FG001|Overall Study|Hydroxyurea New Starts|0|||
148913569|NCT04080167|537166985|FG002|Overall Study|Hydroxyurea New Starts|1|||
148913570|NCT04080167|537166983|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
148913571|NCT04080167|537166984|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
148913572|NCT04080167|537166985|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
148913573|NCT02167139|537166986|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
148913574|NCT02167139|537166987|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
148913575|NCT02167139|537166988|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
148913576|NCT02167139|537166989|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
149145044|NCT04712110|538010817|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
149145045|NCT04712110|538010818|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
149145046|NCT01517893|538010821|FG000|Overall Study|Withdrawal by Subject|3|||
149145047|NCT01517893|538010822|FG001|Overall Study|Withdrawal by Subject|0|||
149145048|NCT03462576|538010823|FG000|Overall Study|Protocol Violation|5|||
149145049|NCT03462576|538010824|FG001|Overall Study|Protocol Violation|11|||
149145050|NCT03462576|538010825|FG002|Overall Study|Protocol Violation|7|||
149145051|NCT03462576|538010823|FG000|Overall Study|Device Malfunction|0|||
148913577|NCT02167139|537166986|FG000|Randomised, Double-blind|Adverse Event|2|||
149145052|NCT03462576|538010824|FG001|Overall Study|Device Malfunction|0|||
149145053|NCT03462576|538010825|FG002|Overall Study|Device Malfunction|1|||
149145054|NCT00271596|538010831|FG000|Overall Study|Protocol Violation|1|||
149145055|NCT00271596|538010832|FG001|Overall Study|Protocol Violation|0|||
148913578|NCT02167139|537166987|FG001|Randomised, Double-blind|Adverse Event|9|||
148913579|NCT02167139|537166988|FG002|Randomised, Double-blind|Adverse Event|0|||
148913580|NCT02167139|537166989|FG003|Randomised, Double-blind|Adverse Event|0|||
148913581|NCT02167139|537166986|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
148913582|NCT02167139|537166987|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
149145056|NCT00271596|538010831|FG000|Overall Study|Withdrawal by Subject|0|||
149145057|NCT00271596|538010832|FG001|Overall Study|Withdrawal by Subject|1|||
149145058|NCT04707157|538010833|FG000|Overall Study|Adverse Event|12|||
149145059|NCT04707157|538010834|FG001|Overall Study|Adverse Event|3|||
149145060|NCT04707157|538010833|FG000|Overall Study|Lost to Follow-up|2|||
149145061|NCT04707157|538010834|FG001|Overall Study|Lost to Follow-up|0|||
149145062|NCT04707157|538010833|FG000|Overall Study|Sponsor's decision|1|||
149145063|NCT04707157|538010834|FG001|Overall Study|Sponsor's decision|0|||
149145064|NCT04707157|538010833|FG000|Overall Study|Physician Decision|8|||
149145065|NCT04707157|538010834|FG001|Overall Study|Physician Decision|5|||
149145066|NCT04707157|538010833|FG000|Overall Study|Protocol Deviation|1|||
149145067|NCT04707157|538010834|FG001|Overall Study|Protocol Deviation|0|||
149145068|NCT04707157|538010833|FG000|Overall Study|Withdrawal by Subject|1|||
149145069|NCT04707157|538010834|FG001|Overall Study|Withdrawal by Subject|1|||
149145070|NCT03625687|538010844|FG000|Overall Study|Death|1|||
149145071|NCT04206605|538010845|FG000|Overall Study|Adverse Event|0|||
149145072|NCT04206605|538010846|FG001|Overall Study|Adverse Event|1|||
149145073|NCT04206605|538010845|FG000|Overall Study|Withdrawal by Subject|1|||
149145074|NCT04206605|538010846|FG001|Overall Study|Withdrawal by Subject|0|||
149145075|NCT00711425|538010852|FG000|Overall Study|Protocol Violation|1|||
149145076|NCT00711425|538010852|FG000|Overall Study|Death|2|||
149145077|NCT00711425|538010852|FG000|Overall Study|Lost to Follow-up|1|||
149145078|NCT05879107|538010855|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
149145079|NCT05879107|538010856|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
149145080|NCT05879107|538010855|FG000|Overall Study|Migrated / moved from the study area|1|||
149145081|NCT05879107|538010856|FG001|Overall Study|Migrated / moved from the study area|1|||
149145082|NCT05879107|538010855|FG000|Overall Study|Lost to Follow-up|8|||
149145083|NCT05879107|538010856|FG001|Overall Study|Lost to Follow-up|13|||
149145084|NCT05879107|538010855|FG000|Overall Study|Death|0|||
149145085|NCT05879107|538010856|FG001|Overall Study|Death|2|||
149145086|NCT05879107|538010855|FG000|Overall Study|Other|0|||
149145087|NCT05879107|538010856|FG001|Overall Study|Other|3|||
149145088|NCT03901079|538010857|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
149145089|NCT00589420|538010860|FG000|Overall Study|screen failure|1|||
149145090|NCT00942175|538010861|FG000|Overall Study|Adverse Event|2|||
149145091|NCT00942175|538010862|FG001|Overall Study|Adverse Event|1|||
149145092|NCT00942175|538010863|FG002|Overall Study|Adverse Event|0|||
149145093|NCT00942175|538010864|FG003|Overall Study|Adverse Event|0|||
149145094|NCT00942175|538010861|FG000|Overall Study|Protocol Violation|0|||
149145095|NCT00942175|538010862|FG001|Overall Study|Protocol Violation|1|||
149145096|NCT00942175|538010863|FG002|Overall Study|Protocol Violation|2|||
149145097|NCT00942175|538010864|FG003|Overall Study|Protocol Violation|0|||
149145098|NCT00942175|538010861|FG000|Overall Study|Pregnancy|0|||
149145099|NCT00942175|538010862|FG001|Overall Study|Pregnancy|0|||
148804898|NCT02842866|536766603|FG001|Overall Study|Protocol Violation|2|||
149145100|NCT00942175|538010863|FG002|Overall Study|Pregnancy|0|||
149145101|NCT00942175|538010864|FG003|Overall Study|Pregnancy|1|||
149145102|NCT00942175|538010861|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
149145103|NCT00942175|538010862|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
149145104|NCT00942175|538010863|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
149145105|NCT00942175|538010864|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
149145106|NCT00942175|538010861|FG000|Overall Study|Low Platelet Count|0|||
149145107|NCT00942175|538010862|FG001|Overall Study|Low Platelet Count|2|||
149145108|NCT00942175|538010863|FG002|Overall Study|Low Platelet Count|0|||
149145109|NCT00942175|538010864|FG003|Overall Study|Low Platelet Count|0|||
149145110|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
149145111|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
149145112|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
149145113|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
149145114|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
149145115|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
149145116|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
149145117|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
149145118|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
149145119|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
149145120|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
149145121|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
149145122|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
149145123|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
149145124|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
149145125|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
149145126|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
149145127|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
149145128|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
149145129|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
149145130|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
149145131|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
149145132|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
149145133|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
149145134|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Death|2|||
149145135|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Death|1|||
149145136|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Death|0|||
149145137|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Death|0|||
149145138|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
149145139|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
149145140|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
149145141|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
149145142|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
149145143|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
149145144|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
149145145|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
149145146|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
149145147|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
149145148|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
149145149|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
149145150|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
149145151|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
149145152|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
149145153|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
149145154|NCT01940471|538010867|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
149145155|NCT01940471|538010868|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
149145156|NCT01940471|538010869|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
149145157|NCT01940471|538010870|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
149145158|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
149145159|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
149145160|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
149145161|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
149145162|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
149145163|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
149145164|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
149145165|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
149145166|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
149145167|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
149145168|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
149145169|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
149145170|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
149145171|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
149145172|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
149145173|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
149145174|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
149145175|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
149145176|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
149145177|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
149145178|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
149145179|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
149145180|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
149145181|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
149145182|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
149145183|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
149145184|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
149145185|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
149145186|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
149145187|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
148804899|NCT02842866|536766602|FG000|Overall Study|Lost to Follow-up|2|||
148804900|NCT02842866|536766603|FG001|Overall Study|Lost to Follow-up|0|||
148804901|NCT02842866|536766602|FG000|Overall Study|Withdrawal by Subject|1|||
148804902|NCT02842866|536766603|FG001|Overall Study|Withdrawal by Subject|0|||
148804903|NCT01432327|536766604|FG000|Posttest 3 Months|depression|3|||
148913583|NCT02167139|537166988|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
148913584|NCT02167139|537166989|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
148913585|NCT02167139|537166986|FG000|Randomised, Double-blind|Other|3|||
148913586|NCT02167139|537166987|FG001|Randomised, Double-blind|Other|0|||
148913587|NCT02167139|537166988|FG002|Randomised, Double-blind|Other|0|||
148913588|NCT02167139|537166989|FG003|Randomised, Double-blind|Other|0|||
148913589|NCT02167139|537166986|FG000|Transition-extension|Adverse Event|2|||
148913590|NCT02167139|537166987|FG001|Transition-extension|Adverse Event|0|||
148913591|NCT02167139|537166988|FG002|Transition-extension|Adverse Event|2|||
148913592|NCT02167139|537166989|FG003|Transition-extension|Adverse Event|3|||
148913593|NCT02167139|537166986|FG000|Transition-extension|Withdrawal by Subject|2|||
148913594|NCT02167139|537166987|FG001|Transition-extension|Withdrawal by Subject|0|||
148913595|NCT02167139|537166988|FG002|Transition-extension|Withdrawal by Subject|4|||
148913596|NCT02167139|537166989|FG003|Transition-extension|Withdrawal by Subject|1|||
148913597|NCT02167139|537166986|FG000|Transition-extension|Lack of Efficacy|0|||
148913598|NCT02167139|537166987|FG001|Transition-extension|Lack of Efficacy|0|||
148913599|NCT02167139|537166988|FG002|Transition-extension|Lack of Efficacy|1|||
148913600|NCT02167139|537166989|FG003|Transition-extension|Lack of Efficacy|1|||
148913601|NCT02167139|537166986|FG000|Transition-extension|Other|1|||
148913602|NCT02167139|537166987|FG001|Transition-extension|Other|0|||
148913603|NCT02167139|537166988|FG002|Transition-extension|Other|1|||
148913604|NCT02167139|537166989|FG003|Transition-extension|Other|0|||
148913605|NCT02167139|537166986|FG000|Transition-extension|Lost to Follow-up|1|||
148913606|NCT02167139|537166987|FG001|Transition-extension|Lost to Follow-up|0|||
148913607|NCT02167139|537166988|FG002|Transition-extension|Lost to Follow-up|0|||
148913608|NCT02167139|537166989|FG003|Transition-extension|Lost to Follow-up|0|||
148913609|NCT00324961|537166992|FG000|Overall Study|Adverse Event|5|||
148913610|NCT00324961|537166992|FG000|Overall Study|Consent Withdrawn|11|||
148913611|NCT00324961|537166992|FG000|Overall Study|Lost to Follow-up|22|||
148913612|NCT00324961|537166992|FG000|Overall Study|Protocol Violation|3|||
148913613|NCT00324961|537166992|FG000|Overall Study|Other|2|||
148913614|NCT00344487|537166993|FG000|Overall Study|immunologic failure|1|||
148913615|NCT02791763|537166997|FG000|Overall Study|Protocol Violation|0|||
148913616|NCT02791763|537166998|FG001|Overall Study|Protocol Violation|0|||
148913617|NCT02791763|537166999|FG002|Overall Study|Protocol Violation|1|||
148913618|NCT02791763|537166997|FG000|Overall Study|Withdrawal by Subject|5|||
148913619|NCT02791763|537166998|FG001|Overall Study|Withdrawal by Subject|1|||
148913620|NCT02791763|537166999|FG002|Overall Study|Withdrawal by Subject|0|||
148913621|NCT02791763|537166997|FG000|Overall Study|Physician Decision|0|||
148913622|NCT02791763|537166998|FG001|Overall Study|Physician Decision|1|||
148913623|NCT02791763|537166999|FG002|Overall Study|Physician Decision|0|||
148913624|NCT02791763|537166997|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
148913625|NCT02791763|537166998|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
148913626|NCT02791763|537166999|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
148804904|NCT01432327|536766605|FG001|Posttest 3 Months|depression|0|||
148804905|NCT01432327|536766606|FG002|Posttest 3 Months|depression|0|||
148804906|NCT01432327|536766607|FG003|Posttest 3 Months|depression|0|||
148804907|NCT01432327|536766604|FG000|Posttest 3 Months|Lost to Follow-up|1|||
148804908|NCT01432327|536766605|FG001|Posttest 3 Months|Lost to Follow-up|0|||
148804909|NCT01432327|536766606|FG002|Posttest 3 Months|Lost to Follow-up|2|||
148913627|NCT02791763|537166997|FG000|Overall Study|Cancer event|1|||
148913628|NCT02791763|537166998|FG001|Overall Study|Cancer event|3|||
148913629|NCT02791763|537166999|FG002|Overall Study|Cancer event|0|||
148913630|NCT02791763|537166997|FG000|Overall Study|Participant had renal transplant|3|||
148913631|NCT02791763|537166998|FG001|Overall Study|Participant had renal transplant|0|||
148913632|NCT02791763|537166999|FG002|Overall Study|Participant had renal transplant|0|||
148913633|NCT02791763|537166997|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
148913634|NCT02791763|537166998|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
148913635|NCT02791763|537166999|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
148913636|NCT02791763|537166997|FG000|Overall Study|Adverse Event|12|||
148913637|NCT02791763|537166998|FG001|Overall Study|Adverse Event|13|||
148913638|NCT02791763|537166999|FG002|Overall Study|Adverse Event|7|||
148913639|NCT01456897|537167002|FG000|Overall Study|Adverse Event|19|||
148913640|NCT01456897|537167003|FG001|Overall Study|Adverse Event|22|||
148913641|NCT01456897|537167002|FG000|Overall Study|Protocol Violation|3|||
148913642|NCT01456897|537167003|FG001|Overall Study|Protocol Violation|4|||
148804910|NCT01432327|536766607|FG003|Posttest 3 Months|Lost to Follow-up|1|||
148913643|NCT01456897|537167002|FG000|Overall Study|Physician Decision|5|||
148913644|NCT01456897|537167003|FG001|Overall Study|Physician Decision|3|||
148913645|NCT01456897|537167002|FG000|Overall Study|Withdrawal by Subject|44|||
148913646|NCT01456897|537167003|FG001|Overall Study|Withdrawal by Subject|17|||
148913647|NCT01456897|537167002|FG000|Overall Study|Lack of Efficacy|4|||
148913648|NCT01456897|537167003|FG001|Overall Study|Lack of Efficacy|11|||
148913649|NCT01396070|537167005|FG000|Overall Study|Withdrawal by Subject|2|||
148913650|NCT01396070|537167005|FG000|Overall Study|Death|2|||
148913651|NCT01396070|537167005|FG000|Overall Study|Adverse Event|8|||
148913652|NCT01396070|537167005|FG000|Overall Study|Physician Decision|3|||
148913653|NCT01396070|537167005|FG000|Overall Study|Lack of Efficacy|4|||
148913654|NCT04254913|537167006|FG000|Overall Study|Adverse Event|1|||
148913655|NCT01396057|537167007|FG000|Overall Study|Adverse Event|2|||
148913656|NCT01396057|537167008|FG001|Overall Study|Adverse Event|6|||
148913657|NCT01396057|537167007|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148913658|NCT01396057|537167008|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
148913659|NCT01396057|537167007|FG000|Overall Study|Protocol deviation|4|||
149145188|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
149145189|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
149145190|NCT01940471|538010867|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
149145191|NCT01940471|538010868|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
149145192|NCT01940471|538010869|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
149145193|NCT01940471|538010870|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
149145194|NCT02973087|538010871|FG000|Overall Study|Withdrawal by Subject|2|||
149145195|NCT02973087|538010872|FG001|Overall Study|Withdrawal by Subject|1|||
149145196|NCT02973087|538010871|FG000|Overall Study|Adverse Event|1|||
149145197|NCT02973087|538010872|FG001|Overall Study|Adverse Event|0|||
149145198|NCT02973087|538010871|FG000|Overall Study|other|1|||
149145199|NCT02973087|538010872|FG001|Overall Study|other|1|||
149145200|NCT03710486|538010875|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
149145201|NCT03710486|538010876|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
149145202|NCT03710486|538010875|FG000|Overall Study|Missing|0|||
149145203|NCT03710486|538010876|FG001|Overall Study|Missing|2|||
149145204|NCT01279850|538010881|FG000|Overall Study|Protocol Violation|50|||
149145205|NCT01279850|538010881|FG000|Overall Study|No Drug Administration Information|7|||
149145206|NCT01279850|538010881|FG000|Overall Study|No Visit After Treatment|34|||
149145207|NCT01131520|538010882|FG000|Overall Study|Computer problem|1|||
149145208|NCT01131520|538010883|FG001|Overall Study|Computer problem|0|||
149145209|NCT01131520|538010882|FG000|Overall Study|Counselor not available|0|||
149145210|NCT01131520|538010883|FG001|Overall Study|Counselor not available|3|||
149145211|NCT01131520|538010882|FG000|Overall Study|Subject changed history after enrollment|0|||
149145212|NCT01131520|538010883|FG001|Overall Study|Subject changed history after enrollment|1|||
149145213|NCT01147744|538010884|FG000|Overall Study|Protocol Violation|1|||
149145214|NCT01147744|538010885|FG001|Overall Study|Protocol Violation|0|||
149145215|NCT01147744|538010886|FG002|Overall Study|Protocol Violation|1|||
149145216|NCT01147744|538010887|FG003|Overall Study|Protocol Violation|0|||
149145217|NCT01147744|538010888|FG004|Overall Study|Protocol Violation|1|||
149145218|NCT01147744|538010889|FG005|Overall Study|Protocol Violation|3|||
149145219|NCT01147744|538010890|FG006|Overall Study|Protocol Violation|1|||
149145220|NCT01147744|538010884|FG000|Overall Study|Physician Decision|0|||
149145221|NCT01147744|538010885|FG001|Overall Study|Physician Decision|1|||
149145222|NCT01147744|538010886|FG002|Overall Study|Physician Decision|1|||
149145223|NCT01147744|538010887|FG003|Overall Study|Physician Decision|0|||
149145224|NCT01147744|538010888|FG004|Overall Study|Physician Decision|0|||
149145225|NCT01147744|538010889|FG005|Overall Study|Physician Decision|0|||
149145226|NCT01147744|538010890|FG006|Overall Study|Physician Decision|1|||
149145227|NCT01147744|538010884|FG000|Overall Study|Lack of Efficacy|11|||
149145228|NCT01147744|538010885|FG001|Overall Study|Lack of Efficacy|11|||
149145229|NCT01147744|538010886|FG002|Overall Study|Lack of Efficacy|9|||
149145230|NCT01147744|538010887|FG003|Overall Study|Lack of Efficacy|11|||
149145231|NCT01147744|538010888|FG004|Overall Study|Lack of Efficacy|13|||
149145232|NCT01147744|538010889|FG005|Overall Study|Lack of Efficacy|8|||
149145233|NCT01147744|538010890|FG006|Overall Study|Lack of Efficacy|7|||
149145234|NCT01147744|538010884|FG000|Overall Study|Adverse Event|1|||
149145235|NCT01147744|538010885|FG001|Overall Study|Adverse Event|2|||
149145236|NCT01147744|538010886|FG002|Overall Study|Adverse Event|3|||
149145237|NCT01147744|538010887|FG003|Overall Study|Adverse Event|0|||
148913660|NCT01396057|537167008|FG001|Overall Study|Protocol deviation|4|||
148913661|NCT01396057|537167007|FG000|Overall Study|Consent withdrawn|3|||
148913662|NCT01396057|537167008|FG001|Overall Study|Consent withdrawn|2|||
149145238|NCT01147744|538010888|FG004|Overall Study|Adverse Event|2|||
149145239|NCT01147744|538010889|FG005|Overall Study|Adverse Event|1|||
149145240|NCT01147744|538010890|FG006|Overall Study|Adverse Event|2|||
148913663|NCT01057589|537167011|FG000|Overall Study|Disease Progression|35|||
148913664|NCT01057589|537167011|FG000|Overall Study|Adverse Event|10|||
149012830|NCT01468922|537525821|FG008|Overall Study|Switched to alternative treatment|0|||
148913665|NCT01057589|537167011|FG000|Overall Study|Physician Decision|8|||
149012831|NCT01468922|537525813|FG000|Overall Study|Enrolled on new protocol|0|||
149145241|NCT01147744|538010884|FG000|Overall Study|Withdrawal by Subject|8|||
149145242|NCT01147744|538010885|FG001|Overall Study|Withdrawal by Subject|4|||
148804911|NCT01432327|536766604|FG000|Posttest 3 Months|Allergic reaction|0|||
148804912|NCT01432327|536766605|FG001|Posttest 3 Months|Allergic reaction|2|||
148804913|NCT01432327|536766606|FG002|Posttest 3 Months|Allergic reaction|0|||
148804914|NCT01432327|536766607|FG003|Posttest 3 Months|Allergic reaction|0|||
148804915|NCT01432327|536766604|FG000|Posttest 6 Months|Lost to Follow-up|0|||
148804916|NCT01432327|536766605|FG001|Posttest 6 Months|Lost to Follow-up|0|||
148804917|NCT01432327|536766606|FG002|Posttest 6 Months|Lost to Follow-up|3|||
148804918|NCT01432327|536766607|FG003|Posttest 6 Months|Lost to Follow-up|2|||
148913666|NCT01057589|537167011|FG000|Overall Study|Withdrawal by Subject|3|||
149145243|NCT01147744|538010886|FG002|Overall Study|Withdrawal by Subject|2|||
149145244|NCT01147744|538010887|FG003|Overall Study|Withdrawal by Subject|2|||
149145245|NCT01147744|538010888|FG004|Overall Study|Withdrawal by Subject|2|||
149145246|NCT01147744|538010889|FG005|Overall Study|Withdrawal by Subject|5|||
149145247|NCT01147744|538010890|FG006|Overall Study|Withdrawal by Subject|2|||
149145248|NCT01147744|538010884|FG000|Overall Study|Lost to Follow-up|0|||
149145249|NCT01147744|538010885|FG001|Overall Study|Lost to Follow-up|1|||
149145250|NCT01147744|538010886|FG002|Overall Study|Lost to Follow-up|0|||
149145251|NCT01147744|538010887|FG003|Overall Study|Lost to Follow-up|0|||
149145252|NCT01147744|538010888|FG004|Overall Study|Lost to Follow-up|0|||
149145253|NCT01147744|538010889|FG005|Overall Study|Lost to Follow-up|0|||
148913667|NCT01057589|537167011|FG000|Overall Study|Sponsor Decision|1|||
148913668|NCT01057589|537167011|FG000|Overall Study|Death|8|||
148913669|NCT01057589|537167011|FG000|Overall Study|Lost to Follow-up|1|||
148913670|NCT01215097|537167012|FG000|Overall Study|Adverse Event|1|||
148913671|NCT01215097|537167013|FG001|Overall Study|Adverse Event|3|||
148913672|NCT01215097|537167012|FG000|Overall Study|Protocol Violation|0|||
148913673|NCT01215097|537167013|FG001|Overall Study|Protocol Violation|2|||
148913674|NCT01215097|537167012|FG000|Overall Study|Lost to Follow-up|2|||
148913675|NCT01215097|537167013|FG001|Overall Study|Lost to Follow-up|0|||
148913676|NCT01215097|537167012|FG000|Overall Study|Withdrawal by Subject|6|||
148913677|NCT01215097|537167013|FG001|Overall Study|Withdrawal by Subject|3|||
148913678|NCT01215097|537167012|FG000|Overall Study|Lack of Efficacy|0|||
148913679|NCT01215097|537167013|FG001|Overall Study|Lack of Efficacy|3|||
148913680|NCT01215097|537167012|FG000|Overall Study|patient's refusal to come|2|||
148913681|NCT01215097|537167013|FG001|Overall Study|patient's refusal to come|2|||
148913682|NCT01215097|537167012|FG000|Overall Study|patient's private reason|1|||
148913683|NCT01215097|537167013|FG001|Overall Study|patient's private reason|1|||
148913684|NCT02252939|537167014|FG000|Overall Study|Lost to Follow-up|3|||
148913685|NCT01516034|537167015|FG000|Overall Study|Physician Decision|1|||
148913686|NCT01516034|537167015|FG000|Overall Study|Lack of Efficacy|7|||
148913687|NCT01033448|537167016|FG000|Overall Study|Withdrawal by Subject|4|||
148913688|NCT01033448|537167016|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
149145254|NCT01147744|538010890|FG006|Overall Study|Lost to Follow-up|0|||
148804919|NCT01432327|536766604|FG000|Posttest 6 Months|Allergic reaction|0|||
148913689|NCT01033448|537167016|FG000|Overall Study|Lost to Follow-up|3|||
148913690|NCT01033448|537167016|FG000|Overall Study|Withdrew due to other reasons|3|||
148913691|NCT01033448|537167016|FG000|Overall Study|Unknown disposition|1|||
149145255|NCT01147744|538010884|FG000|Overall Study|Sponsor decision to amend protocol|7|||
148913692|NCT00870584|537167017|FG000|Overall Study|Adverse Event|3|||
148913693|NCT00870584|537167018|FG001|Overall Study|Adverse Event|3|||
149145256|NCT01147744|538010885|FG001|Overall Study|Sponsor decision to amend protocol|4|||
149145257|NCT01147744|538010886|FG002|Overall Study|Sponsor decision to amend protocol|2|||
148804920|NCT01432327|536766605|FG001|Posttest 6 Months|Allergic reaction|0|||
148913694|NCT00870584|537167017|FG000|Overall Study|Withdrawal by Subject|6|||
149145258|NCT01147744|538010887|FG003|Overall Study|Sponsor decision to amend protocol|5|||
149145259|NCT01147744|538010888|FG004|Overall Study|Sponsor decision to amend protocol|7|||
149145260|NCT01147744|538010889|FG005|Overall Study|Sponsor decision to amend protocol|2|||
149145261|NCT01147744|538010890|FG006|Overall Study|Sponsor decision to amend protocol|6|||
149145262|NCT01147744|538010884|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149145263|NCT01147744|538010885|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149145264|NCT01147744|538010886|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149145265|NCT01147744|538010887|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149145266|NCT01147744|538010888|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149145267|NCT01147744|538010889|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149145268|NCT01147744|538010890|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149145269|NCT01436084|538010898|FG000|Overall Study|Disease Progression|2|||
149145270|NCT01436084|538010898|FG000|Overall Study|Withdrawal by Subject|1|||
149145271|NCT01436084|538010898|FG000|Overall Study|Early Closure of Study|1|||
149145272|NCT01744665|538010900|FG000|Monitoring Phase|Adverse Event|4|||
149145273|NCT01744665|538010900|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
149145274|NCT01744665|538010900|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
149145275|NCT01744665|538010900|FG000|Monitoring Phase|Withdrawal by Subject|5|||
149145276|NCT01744665|538010900|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
149145277|NCT01744665|538010900|FG000|Consolidation Phase|Adverse Event|2|||
149145278|NCT01744665|538010900|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
149145279|NCT01744665|538010900|FG000|Consolidation Phase|Withdrawal by Subject|4|||
149145280|NCT01744665|538010900|FG000|Consolidation Phase|Administrative problems|9|||
149145281|NCT01744665|538010900|FG000|Re-initiation Phase|Administrative problems|10|||
149145282|NCT01744665|538010900|FG000|Re-initiation Phase|Adverse Event|1|||
149145283|NCT01744665|538010900|FG000|Re-initiation Phase|No longer required treatment|1|||
149145284|NCT01744665|538010900|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
149145285|NCT03803059|538010901|FG000|Overall Study|Protocol Violation|2|||
149145286|NCT03803059|538010901|FG000|Overall Study|Lost to Follow-up|1|||
149145287|NCT01045798|538010906|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
149145288|NCT01045798|538010907|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
149145289|NCT01045798|538010906|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
149145290|NCT01045798|538010907|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
149145291|NCT01045798|538010906|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
149145292|NCT01045798|538010907|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
149145293|NCT01045798|538010906|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
149145294|NCT01045798|538010907|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
149145295|NCT02090413|538010908|FG000|Overall Study|Adverse Event|11|||
149145296|NCT02090413|538010909|FG001|Overall Study|Adverse Event|15|||
149145297|NCT02090413|538010910|FG002|Overall Study|Adverse Event|20|||
149145298|NCT02090413|538010908|FG000|Overall Study|Flushing event|2|||
149145299|NCT02090413|538010909|FG001|Overall Study|Flushing event|0|||
149145300|NCT02090413|538010910|FG002|Overall Study|Flushing event|1|||
149145301|NCT02090413|538010908|FG000|Overall Study|Withdrawal by Subject|2|||
149145302|NCT02090413|538010909|FG001|Overall Study|Withdrawal by Subject|2|||
149145303|NCT02090413|538010910|FG002|Overall Study|Withdrawal by Subject|2|||
149145304|NCT02090413|538010908|FG000|Overall Study|Investigator Decision|1|||
149145305|NCT02090413|538010909|FG001|Overall Study|Investigator Decision|1|||
149145306|NCT02090413|538010910|FG002|Overall Study|Investigator Decision|0|||
149145307|NCT02090413|538010908|FG000|Overall Study|Other|2|||
149145308|NCT02090413|538010909|FG001|Overall Study|Other|1|||
149145309|NCT02090413|538010910|FG002|Overall Study|Other|0|||
149145310|NCT02090413|538010908|FG000|Overall Study|Lost to Follow-up|1|||
149145311|NCT02090413|538010909|FG001|Overall Study|Lost to Follow-up|1|||
149145312|NCT02090413|538010910|FG002|Overall Study|Lost to Follow-up|0|||
149145313|NCT05419128|538010911|FG000|Overall Study|Withdrawal by Subject|1|||
149145314|NCT05419128|538010912|FG001|Overall Study|Withdrawal by Subject|1|||
149145315|NCT05419128|538010913|FG002|Overall Study|Withdrawal by Subject|0|||
149145316|NCT05419128|538010914|FG003|Overall Study|Withdrawal by Subject|1|||
149145317|NCT05419128|538010915|FG004|Overall Study|Withdrawal by Subject|1|||
149145318|NCT05419128|538010916|FG005|Overall Study|Withdrawal by Subject|0|||
149145319|NCT05419128|538010911|FG000|Overall Study|Lost to Follow-up|0|||
149145320|NCT05419128|538010912|FG001|Overall Study|Lost to Follow-up|0|||
149145321|NCT05419128|538010913|FG002|Overall Study|Lost to Follow-up|1|||
149145322|NCT05419128|538010914|FG003|Overall Study|Lost to Follow-up|0|||
149145323|NCT05419128|538010915|FG004|Overall Study|Lost to Follow-up|0|||
149145324|NCT05419128|538010916|FG005|Overall Study|Lost to Follow-up|1|||
149145325|NCT04066491|538010917|FG000|Overall Study|Randomized, not treated|0|||
149145326|NCT04066491|538010918|FG001|Overall Study|Randomized, not treated|0|||
149145327|NCT04066491|538010919|FG002|Overall Study|Randomized, not treated|2|||
149145328|NCT04506086|538010920|FG000|Overall Study|Withdrawal by Subject|2|||
149145329|NCT02321930|538010926|FG000|Overall Study|Lost to Follow-up|1|||
149145330|NCT01293968|538010927|FG000|Overall Study|non-cooperation|3|||
149145331|NCT01293968|538010928|FG001|Overall Study|non-cooperation|3|||
149145332|NCT03996876|538010931|FG000|Overall Study|Incomplete Data|2|||
149145333|NCT03996876|538010932|FG001|Overall Study|Incomplete Data|4|||
149145334|NCT00388973|538012392|FG000|Overall Study|Adverse Event|16|||
149145335|NCT00388973|538012393|FG001|Overall Study|Adverse Event|6|||
149145336|NCT00388973|538012392|FG000|Overall Study|Lack of Efficacy|1|||
149145337|NCT00388973|538012393|FG001|Overall Study|Lack of Efficacy|12|||
149145338|NCT00388973|538012392|FG000|Overall Study|Protocol Violation|3|||
149145339|NCT00388973|538012393|FG001|Overall Study|Protocol Violation|0|||
149145340|NCT00388973|538012392|FG000|Overall Study|Withdrawal by Subject|14|||
149145341|NCT00388973|538012393|FG001|Overall Study|Withdrawal by Subject|17|||
149145342|NCT00388973|538012392|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
149145343|NCT00388973|538012393|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
149145344|NCT00388973|538012392|FG000|Overall Study|Did not complete 61 days of treatment|5|||
149145345|NCT00388973|538012393|FG001|Overall Study|Did not complete 61 days of treatment|4|||
149145346|NCT00388973|538012392|FG000|Overall Study|Left region|0|||
149145347|NCT00388973|538012393|FG001|Overall Study|Left region|1|||
149145348|NCT00388973|538012392|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
149145349|NCT00388973|538012393|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
149145350|NCT01652885|538012406|FG000|Overall Study|Adverse Event|1|||
149145351|NCT00075400|538012407|FG000|Overall Study|Ineligible: wrong primary|1|||
149145352|NCT00075400|538012407|FG000|Overall Study|Never treated|2|||
149145353|NCT03723707|538012409|FG000|Overall Study|Death|32|||
149145354|NCT03723707|538012410|FG001|Overall Study|Death|32|||
149145355|NCT03723707|538012409|FG000|Overall Study|Admitted to long term care|12|||
149145356|NCT03723707|538012410|FG001|Overall Study|Admitted to long term care|12|||
149145357|NCT03723707|538012409|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
149145358|NCT03723707|538012410|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
149145359|NCT03723707|538012409|FG000|Overall Study|Lost to Follow-up|40|||
149145360|NCT03723707|538012410|FG001|Overall Study|Lost to Follow-up|22|||
149145361|NCT03723707|538012409|FG000|Overall Study|Discontinued after study closure|24|||
149145362|NCT03723707|538012410|FG001|Overall Study|Discontinued after study closure|12|||
149145363|NCT00075023|538012411|FG000|Pilot Study|Physician Decision|1|||
149145364|NCT00075023|538012412|FG001|Pilot Study|Physician Decision|2|||
149145365|NCT00075023|538012411|FG000|Pilot Study|Withdrawal by Subject|1|||
149145366|NCT00075023|538012412|FG001|Pilot Study|Withdrawal by Subject|0|||
149145367|NCT04342871|538012413|FG000|Overall Study|Death|4|||
149145368|NCT04342871|538012413|FG000|Overall Study|Clinical deterioration/illness progression|2|||
149145369|NCT04342871|538012413|FG000|Overall Study|Did not complete baseline assessments|5|||
149145370|NCT04342871|538012413|FG000|Overall Study|Lost to Follow-up|13|||
149145371|NCT00666458|538012415|FG000|Overall Study|Adverse Event|8|||
149145372|NCT00666458|538012416|FG001|Overall Study|Adverse Event|7|||
149145373|NCT00666458|538012415|FG000|Overall Study|Withdrawal by Subject|5|||
149145374|NCT00666458|538012416|FG001|Overall Study|Withdrawal by Subject|4|||
149145375|NCT00666458|538012415|FG000|Overall Study|Lost to Follow-up|0|||
149145376|NCT00666458|538012416|FG001|Overall Study|Lost to Follow-up|3|||
149145377|NCT00666458|538012415|FG000|Overall Study|Administrative reason by sponsor|1|||
149145378|NCT00666458|538012416|FG001|Overall Study|Administrative reason by sponsor|1|||
149145379|NCT00666458|538012415|FG000|Overall Study|Incorrect enrollment|7|||
149145380|NCT00666458|538012416|FG001|Overall Study|Incorrect enrollment|1|||
149145381|NCT00666458|538012415|FG000|Overall Study|Study specific discontinuation criteria|14|||
149145382|NCT00666458|538012416|FG001|Overall Study|Study specific discontinuation criteria|7|||
149145383|NCT00666458|538012415|FG000|Overall Study|Severe non-compliance to the protocol|1|||
149145384|NCT00666458|538012416|FG001|Overall Study|Severe non-compliance to the protocol|1|||
149145385|NCT00666458|538012415|FG000|Overall Study|Safety reasons|1|||
149145386|NCT00666458|538012416|FG001|Overall Study|Safety reasons|0|||
149145387|NCT00666458|538012415|FG000|Overall Study|Medical history of anemia|1|||
149145388|NCT00666458|538012416|FG001|Overall Study|Medical history of anemia|0|||
149145389|NCT02222207|538012417|FG000|Overall Study|Death|1|||
149145390|NCT02222207|538012417|FG000|Overall Study|Other reasons|2|||
149145391|NCT02222207|538012417|FG000|Overall Study|Adverse Event|1|||
149145392|NCT04682405|538012419|FG000|Overall Study|Adverse Event|0|||
149145393|NCT04682405|538012420|FG001|Overall Study|Adverse Event|1|||
149145394|NCT02982954|538012421|FG000|Overall Study|Death|55|||
149145395|NCT02982954|538012422|FG001|Overall Study|Death|29|||
149145396|NCT02982954|538012423|FG002|Overall Study|Death|15|||
149145397|NCT02982954|538012424|FG003|Overall Study|Death|20|||
149145398|NCT02982954|538012421|FG000|Overall Study|Lost to Follow-up|2|||
149145399|NCT02982954|538012422|FG001|Overall Study|Lost to Follow-up|1|||
149145400|NCT02982954|538012423|FG002|Overall Study|Lost to Follow-up|0|||
149145401|NCT02982954|538012424|FG003|Overall Study|Lost to Follow-up|0|||
149145402|NCT02982954|538012421|FG000|Overall Study|Participant withdrew consent|7|||
149145403|NCT02982954|538012422|FG001|Overall Study|Participant withdrew consent|5|||
149145404|NCT02982954|538012423|FG002|Overall Study|Participant withdrew consent|1|||
149145405|NCT02982954|538012424|FG003|Overall Study|Participant withdrew consent|1|||
149145406|NCT02982954|538012421|FG000|Overall Study|Other reasons|42|||
148913695|NCT00870584|537167018|FG001|Overall Study|Withdrawal by Subject|7|||
148913696|NCT00870584|537167017|FG000|Overall Study|Lost to Follow-up|5|||
148913697|NCT00870584|537167018|FG001|Overall Study|Lost to Follow-up|1|||
148913698|NCT00870584|537167017|FG000|Overall Study|Protocol Deviation|2|||
148913699|NCT00870584|537167018|FG001|Overall Study|Protocol Deviation|2|||
148913700|NCT01497366|537167019|FG000|Overall Study|Virologic failure|2|||
148913701|NCT01497366|537167020|FG001|Overall Study|Virologic failure|50|||
148913702|NCT01497366|537167019|FG000|Overall Study|Lost to Follow-up|11|||
148913703|NCT01497366|537167020|FG001|Overall Study|Lost to Follow-up|10|||
148913704|NCT01497366|537167019|FG000|Overall Study|Withdrawal by Subject|6|||
148913705|NCT01497366|537167020|FG001|Overall Study|Withdrawal by Subject|6|||
148913706|NCT01497366|537167019|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
148913707|NCT01497366|537167020|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
148913708|NCT01497366|537167019|FG000|Overall Study|Other|5|||
148913709|NCT01497366|537167020|FG001|Overall Study|Other|0|||
148913710|NCT01497366|537167019|FG000|Overall Study|Death|1|||
149145407|NCT02982954|538012422|FG001|Overall Study|Other reasons|17|||
149145408|NCT02982954|538012423|FG002|Overall Study|Other reasons|12|||
149145409|NCT02982954|538012424|FG003|Overall Study|Other reasons|3|||
149145410|NCT02982954|538012421|FG000|Overall Study|Premature site closure|0|||
149145411|NCT02982954|538012422|FG001|Overall Study|Premature site closure|0|||
149145412|NCT02982954|538012423|FG002|Overall Study|Premature site closure|0|||
149145413|NCT02982954|538012424|FG003|Overall Study|Premature site closure|1|||
149145414|NCT01429584|538012428|FG000|Overall Study|Withdrawal by Subject|1|||
149145415|NCT01429584|538012429|FG001|Overall Study|Withdrawal by Subject|0|||
149145416|NCT01429584|538012428|FG000|Overall Study|Protocol Violation|0|||
149145417|NCT01429584|538012429|FG001|Overall Study|Protocol Violation|1|||
149145418|NCT00747643|538012430|FG000|Overall Study|Withdrawal by Subject|36|||
149145419|NCT00747643|538012431|FG001|Overall Study|Withdrawal by Subject|27|||
149145420|NCT00750698|538012432|FG000|Overall Study|Withdrawal by Subject|1|||
149145421|NCT00750698|538012433|FG001|Overall Study|Withdrawal by Subject|0|||
149145422|NCT00750698|538012432|FG000|Overall Study|Progressive disease|5|||
149145423|NCT00750698|538012433|FG001|Overall Study|Progressive disease|2|||
149145424|NCT00516048|538012434|FG000|Overall Study|Death|0|||
149145425|NCT00516048|538012435|FG001|Overall Study|Death|0|||
149145426|NCT00516048|538012436|FG002|Overall Study|Death|1|||
148913711|NCT01497366|537167020|FG001|Overall Study|Death|1|||
149145427|NCT00516048|538012434|FG000|Overall Study|Subject Decision|0|||
149145428|NCT00516048|538012435|FG001|Overall Study|Subject Decision|2|||
149145429|NCT00516048|538012436|FG002|Overall Study|Subject Decision|0|||
149145430|NCT02263079|538012437|FG000|Overall Study|Physician Decision|1|||
149145431|NCT02263079|538012438|FG001|Overall Study|Physician Decision|0|||
148913712|NCT01497366|537167019|FG000|Overall Study|Randomized but not treated|7|||
148913713|NCT01497366|537167020|FG001|Overall Study|Randomized but not treated|21|||
148913714|NCT00472030|537167034|FG000|Overall Study|Physician Decision|1|||
148913715|NCT00472030|537167035|FG001|Overall Study|Physician Decision|0|||
149012832|NCT01468922|537525814|FG001|Overall Study|Enrolled on new protocol|0|||
149145432|NCT02263079|538012439|FG002|Overall Study|Physician Decision|0|||
149145433|NCT02263079|538012437|FG000|Overall Study|Withdrawal by Subject|2|||
149145434|NCT02263079|538012438|FG001|Overall Study|Withdrawal by Subject|8|||
149145435|NCT02263079|538012439|FG002|Overall Study|Withdrawal by Subject|0|||
148913716|NCT00829504|537167036|FG000|First Intervention|Adverse Event|1|||
148913717|NCT00829504|537167037|FG001|First Intervention|Adverse Event|0|||
149145436|NCT03557281|538012440|FG000|Overall Study|Investigator discretion|0|||
149145437|NCT03557281|538012441|FG001|Overall Study|Investigator discretion|0|||
148913718|NCT00829504|537167036|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
148913719|NCT00829504|537167037|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
148913720|NCT00829504|537167036|FG000|Second Intervention|Physician Decision|1|||
149145438|NCT03557281|538012442|FG002|Overall Study|Investigator discretion|1|||
149145439|NCT03557281|538012443|FG003|Overall Study|Investigator discretion|0|||
149145440|NCT03557281|538012444|FG004|Overall Study|Investigator discretion|0|||
149145441|NCT03557281|538012440|FG000|Overall Study|Withdrawal by Subject|0|||
149145442|NCT03557281|538012441|FG001|Overall Study|Withdrawal by Subject|1|||
149145443|NCT03557281|538012442|FG002|Overall Study|Withdrawal by Subject|1|||
149145444|NCT03557281|538012443|FG003|Overall Study|Withdrawal by Subject|1|||
149145445|NCT03557281|538012444|FG004|Overall Study|Withdrawal by Subject|2|||
149145446|NCT03557281|538012440|FG000|Overall Study|Randomized, but did not receive treatment|0|||
149145447|NCT03557281|538012441|FG001|Overall Study|Randomized, but did not receive treatment|0|||
149145448|NCT03557281|538012442|FG002|Overall Study|Randomized, but did not receive treatment|0|||
149145449|NCT03557281|538012443|FG003|Overall Study|Randomized, but did not receive treatment|0|||
149145450|NCT03557281|538012444|FG004|Overall Study|Randomized, but did not receive treatment|1|||
149145451|NCT00402649|538012445|FG000|Overall Study|Lost to Follow-up|1|||
149145452|NCT00402649|538012445|FG000|Overall Study|Withdrawal by Subject|1|||
149145453|NCT01999465|538012446|FG000|Overall Study|Lost to Follow-up|0|||
149145454|NCT01999465|538012447|FG001|Overall Study|Lost to Follow-up|2|||
149145455|NCT01999465|538012446|FG000|Overall Study|Protocol Violation|0|||
149145456|NCT01999465|538012447|FG001|Overall Study|Protocol Violation|1|||
148913721|NCT00829504|537167037|FG001|Second Intervention|Physician Decision|0|||
148913722|NCT04189224|537167038|FG000|Period 2|Adverse Event|0|||
148913723|NCT04189224|537167039|FG001|Period 2|Adverse Event|1|||
148913724|NCT01794338|537169792|FG000|Overall Study|Death|2|||
148913725|NCT01794338|537169793|FG001|Overall Study|Death|0|||
148913726|NCT01794338|537169792|FG000|Overall Study|Lost to Follow-up|6|||
148913727|NCT01794338|537169793|FG001|Overall Study|Lost to Follow-up|9|||
148913728|NCT01754402|537169794|FG000|Overall Study|Death|0|||
148913729|NCT01754402|537169795|FG001|Overall Study|Death|0|||
148913730|NCT01754402|537169796|FG002|Overall Study|Death|1|||
148913731|NCT01754402|537169794|FG000|Overall Study|Adverse Event|2|||
148913732|NCT01754402|537169795|FG001|Overall Study|Adverse Event|2|||
148913733|NCT01754402|537169796|FG002|Overall Study|Adverse Event|1|||
148913734|NCT01754402|537169794|FG000|Overall Study|Withdrawal by Subject|0|||
148913735|NCT01754402|537169795|FG001|Overall Study|Withdrawal by Subject|0|||
148913736|NCT01754402|537169796|FG002|Overall Study|Withdrawal by Subject|1|||
148913737|NCT01754402|537169794|FG000|Overall Study|Lack of Efficacy|0|||
148913738|NCT01754402|537169795|FG001|Overall Study|Lack of Efficacy|0|||
148913739|NCT01754402|537169796|FG002|Overall Study|Lack of Efficacy|1|||
148913740|NCT01282463|537169797|FG000|Overall Study|Lost to Follow-up|1|||
148913741|NCT01282463|537169798|FG001|Overall Study|Lost to Follow-up|0|||
148913742|NCT01282463|537169799|FG002|Overall Study|Lost to Follow-up|0|||
148913743|NCT01282463|537169797|FG000|Overall Study|Withdrawal by Subject|6|||
148913744|NCT01282463|537169798|FG001|Overall Study|Withdrawal by Subject|2|||
148913745|NCT01282463|537169799|FG002|Overall Study|Withdrawal by Subject|3|||
148913746|NCT01282463|537169797|FG000|Overall Study|"Never Treated Death"|0|||
148913747|NCT01282463|537169798|FG001|Overall Study|"Never Treated Death"|1|||
148913748|NCT01282463|537169799|FG002|Overall Study|"Never Treated Death"|0|||
148913749|NCT01282463|537169797|FG000|Overall Study|"Never Treated PD"|0|||
148913750|NCT01282463|537169798|FG001|Overall Study|"Never Treated PD"|1|||
148913751|NCT01282463|537169799|FG002|Overall Study|"Never Treated PD"|0|||
148913752|NCT01282463|537169797|FG000|Overall Study|Protocol Violation|0|||
148913753|NCT01282463|537169798|FG001|Overall Study|Protocol Violation|0|||
148913754|NCT01282463|537169799|FG002|Overall Study|Protocol Violation|1|||
149145457|NCT02969187|538012461|FG000|Overall Study|Physician Decision|12|||
149145458|NCT02969187|538012462|FG001|Overall Study|Physician Decision|13|||
148913755|NCT01282463|537169797|FG000|Overall Study|Physician Decision|1|||
148913756|NCT01282463|537169798|FG001|Overall Study|Physician Decision|0|||
148913757|NCT01282463|537169799|FG002|Overall Study|Physician Decision|0|||
148913758|NCT01129583|537169802|FG000|Overall Study|Death|1|||
148913759|NCT01129583|537169803|FG001|Overall Study|Death|0|||
148913760|NCT01129583|537169802|FG000|Overall Study|Lost to Follow-up|1|||
148913761|NCT01129583|537169803|FG001|Overall Study|Lost to Follow-up|1|||
148913762|NCT01129583|537169802|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
149145459|NCT04329702|538012463|FG000|Overall Study|illness|3|||
149145460|NCT04329702|538012464|FG001|Overall Study|illness|4|||
148913763|NCT01129583|537169803|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
148913764|NCT02338882|537169804|FG000|Overall Study|Death|1|||
148913765|NCT02338882|537169805|FG001|Overall Study|Death|0|||
148913766|NCT02338882|537169804|FG000|Overall Study|Lost to Follow-up|6|||
148913767|NCT02338882|537169805|FG001|Overall Study|Lost to Follow-up|3|||
148913768|NCT01904773|537169813|FG000|Screen|Screen failure|3|||
149145461|NCT04329702|538012465|FG002|Overall Study|illness|0|||
148671348|NCT01593761|536267104|FG000|Overall Study|culture negative for MRSA at baseline|5|||
148913769|NCT01904773|537169814|FG001|Screen|Screen failure|0|||
148913770|NCT01904773|537169815|FG002|Screen|Screen failure|0|||
148913771|NCT01904773|537169816|FG003|Screen|Screen failure|0|||
148913772|NCT01904773|537169817|FG004|Screen|Screen failure|0|||
148913773|NCT01904773|537169818|FG005|Screen|Screen failure|0|||
148913774|NCT01904773|537169819|FG006|Screen|Screen failure|0|||
148913775|NCT01904773|537169820|FG007|Screen|Screen failure|0|||
148913776|NCT01904773|537169821|FG008|Screen|Screen failure|0|||
148913777|NCT01904773|537169813|FG000|Screen|Withdrawal by Subject|1|||
148913778|NCT01904773|537169814|FG001|Screen|Withdrawal by Subject|0|||
148913779|NCT01904773|537169815|FG002|Screen|Withdrawal by Subject|0|||
149145462|NCT04329702|538012463|FG000|Overall Study|Lost to Follow-up|0|||
149145463|NCT04329702|538012464|FG001|Overall Study|Lost to Follow-up|0|||
149145464|NCT04329702|538012465|FG002|Overall Study|Lost to Follow-up|2|||
149145465|NCT04329702|538012463|FG000|Overall Study|Death|0|||
149145466|NCT04329702|538012464|FG001|Overall Study|Death|2|||
149145467|NCT04329702|538012465|FG002|Overall Study|Death|0|||
149145468|NCT01438489|538012466|FG000|Overall Study|Lost to Follow-up|4|||
149145469|NCT01438489|538012467|FG001|Overall Study|Lost to Follow-up|2|||
149145470|NCT01438489|538012468|FG002|Overall Study|Lost to Follow-up|2|||
149145471|NCT01438489|538012466|FG000|Overall Study|Withdrawal by Subject|11|||
149145472|NCT01438489|538012467|FG001|Overall Study|Withdrawal by Subject|3|||
149145473|NCT01438489|538012468|FG002|Overall Study|Withdrawal by Subject|8|||
149145474|NCT01438489|538012466|FG000|Overall Study|Death|0|||
149145475|NCT01438489|538012467|FG001|Overall Study|Death|0|||
149145476|NCT01438489|538012468|FG002|Overall Study|Death|1|||
149145477|NCT01438489|538012466|FG000|Overall Study|Sponsor decision|4|||
149145478|NCT01438489|538012467|FG001|Overall Study|Sponsor decision|1|||
149145479|NCT01438489|538012468|FG002|Overall Study|Sponsor decision|4|||
149145480|NCT01438489|538012466|FG000|Overall Study|Subject choice/Subject moved|2|||
149145481|NCT01438489|538012467|FG001|Overall Study|Subject choice/Subject moved|1|||
149145482|NCT01438489|538012468|FG002|Overall Study|Subject choice/Subject moved|1|||
149145483|NCT01438489|538012466|FG000|Overall Study|Investigator decision|0|||
149145484|NCT01438489|538012467|FG001|Overall Study|Investigator decision|1|||
149145485|NCT01438489|538012468|FG002|Overall Study|Investigator decision|0|||
149145486|NCT01438489|538012466|FG000|Overall Study|AE/SAEs|2|||
149145487|NCT01438489|538012467|FG001|Overall Study|AE/SAEs|1|||
149145488|NCT01438489|538012468|FG002|Overall Study|AE/SAEs|1|||
149145489|NCT01438489|538012466|FG000|Overall Study|Received prohibited medication|1|||
149145490|NCT01438489|538012467|FG001|Overall Study|Received prohibited medication|0|||
149145491|NCT01438489|538012468|FG002|Overall Study|Received prohibited medication|0|||
149145492|NCT01438489|538012466|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
149145493|NCT01438489|538012467|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
149145494|NCT01438489|538012468|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
149145495|NCT01438489|538012466|FG000|Overall Study|Inadequate venous access|0|||
149145496|NCT01438489|538012467|FG001|Overall Study|Inadequate venous access|2|||
149145497|NCT01438489|538012468|FG002|Overall Study|Inadequate venous access|0|||
149145498|NCT00766532|538012469|FG000|Overall Study|Protocol Violation|2|||
149145499|NCT03719690|538012475|FG000|Overall Study|Withdrawal by Subject|5|||
149145500|NCT03719690|538012476|FG001|Overall Study|Withdrawal by Subject|10|||
149145501|NCT03719690|538012475|FG000|Overall Study|Death|40|||
149145502|NCT03719690|538012476|FG001|Overall Study|Death|149|||
149145503|NCT03719690|538012475|FG000|Overall Study|Miscellaneous|12|||
149145504|NCT03719690|538012476|FG001|Overall Study|Miscellaneous|56|||
149145505|NCT03719690|538012475|FG000|Overall Study|Lost to Follow-up|2|||
149145506|NCT03719690|538012476|FG001|Overall Study|Lost to Follow-up|18|||
149145507|NCT03719690|538012475|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
149145508|NCT03719690|538012476|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
149145509|NCT01471015|538012477|FG000|Overall Study|Death|0|||
149145510|NCT01471015|538012478|FG001|Overall Study|Death|1|||
149145511|NCT01471015|538012479|FG002|Overall Study|Death|1|||
149145512|NCT00928889|538012484|FG000|Overall Study|Lost to Follow-up|3|||
149145513|NCT00928889|538012485|FG001|Overall Study|Lost to Follow-up|1|||
149145514|NCT00928889|538012484|FG000|Overall Study|Protocol Violation|0|||
149145515|NCT00928889|538012485|FG001|Overall Study|Protocol Violation|1|||
149145516|NCT00928889|538012484|FG000|Overall Study|Adverse Event|1|||
149145517|NCT00928889|538012485|FG001|Overall Study|Adverse Event|0|||
149145518|NCT00928889|538012484|FG000|Overall Study|Other|1|||
149145519|NCT00928889|538012485|FG001|Overall Study|Other|0|||
149145520|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
149145521|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
149145522|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Death|0|||
149145523|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Death|1|||
149145524|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
148671349|NCT01593761|536267104|FG000|Overall Study|positive for hepatitis C virus|1|||
148671350|NCT01593761|536267104|FG000|Overall Study|secondary cellulitis|1|||
148913780|NCT01904773|537169816|FG003|Screen|Withdrawal by Subject|0|||
148913781|NCT01904773|537169817|FG004|Screen|Withdrawal by Subject|0|||
149145525|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
149145526|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
149145527|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
149145528|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
149145529|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
149145530|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
149145531|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
149145532|NCT00843518|538012496|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
149145533|NCT00843518|538012497|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
149145534|NCT01342484|538012501|FG000|Overall Study|Other Reasons|1|||
149145535|NCT01342484|538012502|FG001|Overall Study|Other Reasons|0|||
149145536|NCT01342484|538012503|FG002|Overall Study|Other Reasons|0|||
149145537|NCT01342484|538012501|FG000|Overall Study|Protocol Violation|0|||
149145538|NCT01342484|538012502|FG001|Overall Study|Protocol Violation|0|||
149145539|NCT01342484|538012503|FG002|Overall Study|Protocol Violation|1|||
149145540|NCT01342484|538012501|FG000|Overall Study|Withdrawal by Subject|1|||
149145541|NCT01342484|538012502|FG001|Overall Study|Withdrawal by Subject|0|||
149145542|NCT01342484|538012503|FG002|Overall Study|Withdrawal by Subject|0|||
149145543|NCT01840579|538012504|FG000|Overall Study|Status not recorded|0|||
149145544|NCT01840579|538012505|FG001|Overall Study|Status not recorded|0|||
149145545|NCT01840579|538012506|FG002|Overall Study|Status not recorded|2|||
149145546|NCT01840579|538012507|FG003|Overall Study|Status not recorded|3|||
149145547|NCT01840579|538012508|FG004|Overall Study|Status not recorded|4|||
149145548|NCT01840579|538012509|FG005|Overall Study|Status not recorded|3|||
149145549|NCT01840579|538012510|FG006|Overall Study|Status not recorded|0|||
149145550|NCT01840579|538012511|FG007|Overall Study|Status not recorded|3|||
149145551|NCT01840579|538012512|FG008|Overall Study|Status not recorded|3|||
149145552|NCT01840579|538012513|FG009|Overall Study|Status not recorded|3|||
149145553|NCT01840579|538012504|FG000|Overall Study|Progressive disease|3|||
149145554|NCT01840579|538012505|FG001|Overall Study|Progressive disease|5|||
149145555|NCT01840579|538012506|FG002|Overall Study|Progressive disease|0|||
149145556|NCT01840579|538012507|FG003|Overall Study|Progressive disease|0|||
149145557|NCT01840579|538012508|FG004|Overall Study|Progressive disease|0|||
149145558|NCT01840579|538012509|FG005|Overall Study|Progressive disease|0|||
149145559|NCT01840579|538012510|FG006|Overall Study|Progressive disease|0|||
149145560|NCT01840579|538012511|FG007|Overall Study|Progressive disease|0|||
149145561|NCT01840579|538012512|FG008|Overall Study|Progressive disease|0|||
149145562|NCT01840579|538012513|FG009|Overall Study|Progressive disease|0|||
149145563|NCT01840579|538012504|FG000|Overall Study|Ongoing in study|0|||
149145564|NCT01840579|538012505|FG001|Overall Study|Ongoing in study|1|||
149145565|NCT01840579|538012506|FG002|Overall Study|Ongoing in study|0|||
149145566|NCT01840579|538012507|FG003|Overall Study|Ongoing in study|0|||
149145567|NCT01840579|538012508|FG004|Overall Study|Ongoing in study|0|||
149145568|NCT01840579|538012509|FG005|Overall Study|Ongoing in study|0|||
149145569|NCT01840579|538012510|FG006|Overall Study|Ongoing in study|0|||
149145570|NCT01840579|538012511|FG007|Overall Study|Ongoing in study|0|||
149145571|NCT01840579|538012512|FG008|Overall Study|Ongoing in study|0|||
149145572|NCT01840579|538012513|FG009|Overall Study|Ongoing in study|0|||
149145573|NCT01840579|538012504|FG000|Overall Study|Death|0|||
149145574|NCT01840579|538012505|FG001|Overall Study|Death|0|||
149145575|NCT01840579|538012506|FG002|Overall Study|Death|0|||
149145576|NCT01840579|538012507|FG003|Overall Study|Death|0|||
149145577|NCT01840579|538012508|FG004|Overall Study|Death|0|||
149145578|NCT01840579|538012509|FG005|Overall Study|Death|1|||
149145579|NCT01840579|538012510|FG006|Overall Study|Death|0|||
149145580|NCT01840579|538012511|FG007|Overall Study|Death|0|||
149145581|NCT01840579|538012512|FG008|Overall Study|Death|0|||
149145582|NCT01840579|538012513|FG009|Overall Study|Death|0|||
149012833|NCT01468922|537525815|FG002|Overall Study|Enrolled on new protocol|0|||
149145583|NCT01840579|538012504|FG000|Overall Study|Adverse Event|0|||
149145584|NCT01840579|538012505|FG001|Overall Study|Adverse Event|1|||
149145585|NCT01840579|538012506|FG002|Overall Study|Adverse Event|0|||
149145586|NCT01840579|538012507|FG003|Overall Study|Adverse Event|0|||
149145587|NCT01840579|538012508|FG004|Overall Study|Adverse Event|0|||
149145588|NCT01840579|538012509|FG005|Overall Study|Adverse Event|0|||
149145589|NCT01840579|538012510|FG006|Overall Study|Adverse Event|0|||
149145590|NCT01840579|538012511|FG007|Overall Study|Adverse Event|0|||
149145591|NCT01840579|538012512|FG008|Overall Study|Adverse Event|0|||
149145592|NCT01840579|538012513|FG009|Overall Study|Adverse Event|0|||
149145593|NCT01840579|538012504|FG000|Overall Study|Follow-up ended by Sponsor|0|||
149145594|NCT01840579|538012505|FG001|Overall Study|Follow-up ended by Sponsor|0|||
149145595|NCT01840579|538012506|FG002|Overall Study|Follow-up ended by Sponsor|0|||
149145596|NCT01840579|538012507|FG003|Overall Study|Follow-up ended by Sponsor|0|||
149145597|NCT01840579|538012508|FG004|Overall Study|Follow-up ended by Sponsor|0|||
149145598|NCT01840579|538012509|FG005|Overall Study|Follow-up ended by Sponsor|0|||
149145599|NCT01840579|538012510|FG006|Overall Study|Follow-up ended by Sponsor|2|||
149145600|NCT01840579|538012511|FG007|Overall Study|Follow-up ended by Sponsor|0|||
149145601|NCT01840579|538012512|FG008|Overall Study|Follow-up ended by Sponsor|0|||
149145602|NCT01840579|538012513|FG009|Overall Study|Follow-up ended by Sponsor|0|||
149145603|NCT03302975|538012515|FG000|Overall Study|Lost to Follow-up|4|||
149145604|NCT00597753|538012518|FG000|Overall Study|Adverse Event|6|||
149145605|NCT00597753|538012519|FG001|Overall Study|Adverse Event|2|||
149145606|NCT00597753|538012518|FG000|Overall Study|Death|55|||
149145607|NCT00597753|538012519|FG001|Overall Study|Death|29|||
149145608|NCT00597753|538012518|FG000|Overall Study|Lack of Efficacy|2|||
149145609|NCT00597753|538012519|FG001|Overall Study|Lack of Efficacy|0|||
149145610|NCT00597753|538012518|FG000|Overall Study|Lost to Follow-up|10|||
149145611|NCT00597753|538012519|FG001|Overall Study|Lost to Follow-up|3|||
149145612|NCT00597753|538012518|FG000|Overall Study|Physician Decision|5|||
149145613|NCT00597753|538012519|FG001|Overall Study|Physician Decision|1|||
149145614|NCT00597753|538012518|FG000|Overall Study|Pregnancy|1|||
149145615|NCT00597753|538012519|FG001|Overall Study|Pregnancy|0|||
149145616|NCT00597753|538012518|FG000|Overall Study|Withdrawal by Subject|35|||
149145617|NCT00597753|538012519|FG001|Overall Study|Withdrawal by Subject|12|||
149145618|NCT00597753|538012518|FG000|Overall Study|Discontinued Dialysis|0|||
149145619|NCT00597753|538012519|FG001|Overall Study|Discontinued Dialysis|1|||
149145620|NCT00597753|538012518|FG000|Overall Study|Never dosed|2|||
149145621|NCT00597753|538012519|FG001|Overall Study|Never dosed|0|||
149145622|NCT00597753|538012518|FG000|Overall Study|Noncompliance|2|||
149145623|NCT00597753|538012519|FG001|Overall Study|Noncompliance|1|||
149145624|NCT00597753|538012518|FG000|Overall Study|Relocation|17|||
149145625|NCT00597753|538012519|FG001|Overall Study|Relocation|6|||
149145626|NCT00597753|538012518|FG000|Overall Study|Renal transplant|10|||
149145627|NCT00597753|538012519|FG001|Overall Study|Renal transplant|3|||
149145628|NCT00597753|538012518|FG000|Overall Study|Site closed by sponsor|19|||
149145629|NCT00597753|538012519|FG001|Overall Study|Site closed by sponsor|7|||
149145630|NCT00597753|538012518|FG000|Overall Study|Site elected to close|2|||
149145631|NCT00597753|538012519|FG001|Overall Study|Site elected to close|4|||
149145632|NCT01199042|538014559|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
149145633|NCT01199042|538014559|FG000|At Home (3 Months)|Lost to Follow-up|1|||
149145634|NCT01308008|538014560|FG000|4 Weeks|Illness, disinterest, time|9|||
149145635|NCT01308008|538014561|FG001|4 Weeks|Illness, disinterest, time|2|||
149145636|NCT01239342|538014562|FG000|Overall Study|Adverse Event|1|||
149145637|NCT01239342|538014563|FG001|Overall Study|Adverse Event|0|||
149145638|NCT01239342|538014562|FG000|Overall Study|Withdrawal by Subject|1|||
149145639|NCT01239342|538014563|FG001|Overall Study|Withdrawal by Subject|5|||
149145640|NCT01239342|538014562|FG000|Overall Study|Reason Unknown|1|||
149145641|NCT01239342|538014563|FG001|Overall Study|Reason Unknown|1|||
149145642|NCT02325219|538014564|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
149145643|NCT02325219|538014565|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
149145644|NCT02325219|538014566|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
149145645|NCT02325219|538014567|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
149145646|NCT02325219|538014568|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
149145647|NCT02325219|538014564|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
149145648|NCT02325219|538014565|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
149145649|NCT02325219|538014566|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149145650|NCT02325219|538014567|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149145651|NCT02325219|538014568|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149145652|NCT02325219|538014564|FG000|Controlled Period (Week 0 - 16)|Other|0|||
149145653|NCT02325219|538014565|FG001|Controlled Period (Week 0 - 16)|Other|0|||
149145654|NCT02325219|538014566|FG002|Controlled Period (Week 0 - 16)|Other|1|||
149145655|NCT02325219|538014567|FG003|Controlled Period (Week 0 - 16)|Other|0|||
149145656|NCT02325219|538014568|FG004|Controlled Period (Week 0 - 16)|Other|0|||
149145657|NCT02325219|538014564|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
149145658|NCT02325219|538014565|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
149145659|NCT02325219|538014566|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
149145660|NCT02325219|538014567|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
149145661|NCT02325219|538014568|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
149145662|NCT02325219|538014564|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
149145663|NCT02325219|538014565|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
149145664|NCT02325219|538014566|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
149145665|NCT02325219|538014567|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
149145666|NCT02325219|538014568|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
149145667|NCT02325219|538014564|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149145668|NCT02325219|538014565|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
149145669|NCT02325219|538014566|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149145670|NCT02325219|538014567|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149145671|NCT02325219|538014568|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149145672|NCT04036708|538014569|FG000|Overall Study|Lost to Follow-up|14|||
149145673|NCT04036708|538014570|FG001|Overall Study|Lost to Follow-up|4|||
149145674|NCT04036708|538014571|FG002|Overall Study|Lost to Follow-up|14|||
149145675|NCT04036708|538014572|FG003|Overall Study|Lost to Follow-up|4|||
149145676|NCT02918864|538014573|FG000|Overall Study|Withdrawal by Subject|1|||
149145677|NCT02918864|538014574|FG001|Overall Study|Withdrawal by Subject|1|||
149145678|NCT02918864|538014573|FG000|Overall Study|Lost to Follow-up|3|||
149145679|NCT02918864|538014574|FG001|Overall Study|Lost to Follow-up|2|||
149145680|NCT02257372|538014578|FG000|Overall Study|Adverse Event|3|||
149145681|NCT02257372|538014579|FG001|Overall Study|Adverse Event|7|||
149145682|NCT02257372|538014578|FG000|Overall Study|Lack of Efficacy|2|||
149145683|NCT02257372|538014579|FG001|Overall Study|Lack of Efficacy|1|||
149145684|NCT02257372|538014578|FG000|Overall Study|Protocol Violation|1|||
149145685|NCT02257372|538014579|FG001|Overall Study|Protocol Violation|1|||
149145686|NCT02257372|538014578|FG000|Overall Study|Lost to Follow-up|0|||
149145687|NCT02257372|538014579|FG001|Overall Study|Lost to Follow-up|1|||
149145688|NCT02257372|538014578|FG000|Overall Study|Withdrew consent|1|||
149145689|NCT02257372|538014579|FG001|Overall Study|Withdrew consent|0|||
149145690|NCT01849874|538014581|FG000|Overall Study|Death|89|||
149145691|NCT01849874|538014582|FG001|Overall Study|Death|42|||
149145692|NCT01849874|538014581|FG000|Overall Study|Withdrawal by Subject|17|||
149145693|NCT01849874|538014582|FG001|Overall Study|Withdrawal by Subject|16|||
149145694|NCT01849874|538014581|FG000|Overall Study|Lost to Follow-up|3|||
149145695|NCT01849874|538014582|FG001|Overall Study|Lost to Follow-up|2|||
149145696|NCT01849874|538014581|FG000|Overall Study|Study Termination By Sponsor|93|||
149145697|NCT01849874|538014582|FG001|Overall Study|Study Termination By Sponsor|48|||
149145698|NCT01849874|538014581|FG000|Overall Study|Completed as per protocol amendment 6|3|||
149145699|NCT01849874|538014582|FG001|Overall Study|Completed as per protocol amendment 6|0|||
149145700|NCT01849874|538014581|FG000|Overall Study|Physician Decision|7|||
149145701|NCT01849874|538014582|FG001|Overall Study|Physician Decision|1|||
149145702|NCT01849874|538014581|FG000|Overall Study|Other|16|||
149145703|NCT01849874|538014582|FG001|Overall Study|Other|4|||
149145704|NCT02104583|538014583|FG000|Overall Study|New ICD or CRT-D implanted|2|||
149145705|NCT02104583|538014584|FG001|Overall Study|New ICD or CRT-D implanted|0|||
149145706|NCT02104583|538014585|FG002|Overall Study|New ICD or CRT-D implanted|1|||
149145707|NCT02104583|538014586|FG003|Overall Study|New ICD or CRT-D implanted|0|||
149145708|NCT02104583|538014587|FG004|Overall Study|New ICD or CRT-D implanted|0|||
149145709|NCT02104583|538014583|FG000|Overall Study|Death|2|||
149145710|NCT02104583|538014584|FG001|Overall Study|Death|1|||
149145711|NCT02104583|538014585|FG002|Overall Study|Death|3|||
149145712|NCT02104583|538014586|FG003|Overall Study|Death|3|||
149145713|NCT02104583|538014587|FG004|Overall Study|Death|5|||
149145714|NCT02104583|538014583|FG000|Overall Study|Subject required cardiac ablation|6|||
149145715|NCT02104583|538014584|FG001|Overall Study|Subject required cardiac ablation|4|||
149145716|NCT02104583|538014585|FG002|Overall Study|Subject required cardiac ablation|4|||
149145717|NCT02104583|538014586|FG003|Overall Study|Subject required cardiac ablation|5|||
149145718|NCT02104583|538014587|FG004|Overall Study|Subject required cardiac ablation|4|||
149145719|NCT02104583|538014583|FG000|Overall Study|Subject required prohibited medication|0|||
149145720|NCT02104583|538014584|FG001|Overall Study|Subject required prohibited medication|1|||
149145721|NCT02104583|538014585|FG002|Overall Study|Subject required prohibited medication|1|||
149145722|NCT02104583|538014586|FG003|Overall Study|Subject required prohibited medication|0|||
149145723|NCT02104583|538014587|FG004|Overall Study|Subject required prohibited medication|1|||
149145724|NCT02104583|538014583|FG000|Overall Study|Withdrew Consent|3|||
149145725|NCT02104583|538014584|FG001|Overall Study|Withdrew Consent|2|||
149145726|NCT02104583|538014585|FG002|Overall Study|Withdrew Consent|0|||
149145727|NCT02104583|538014586|FG003|Overall Study|Withdrew Consent|2|||
149145728|NCT02104583|538014587|FG004|Overall Study|Withdrew Consent|1|||
149145729|NCT02104583|538014583|FG000|Overall Study|Investigator's Discretion|1|||
149145730|NCT02104583|538014584|FG001|Overall Study|Investigator's Discretion|0|||
149145731|NCT02104583|538014585|FG002|Overall Study|Investigator's Discretion|0|||
149145732|NCT02104583|538014586|FG003|Overall Study|Investigator's Discretion|0|||
149145733|NCT02104583|538014587|FG004|Overall Study|Investigator's Discretion|0|||
149145734|NCT02104583|538014583|FG000|Overall Study|Protocol Violation|0|||
149145735|NCT02104583|538014584|FG001|Overall Study|Protocol Violation|0|||
149145736|NCT02104583|538014585|FG002|Overall Study|Protocol Violation|1|||
149145737|NCT02104583|538014586|FG003|Overall Study|Protocol Violation|0|||
149145738|NCT02104583|538014587|FG004|Overall Study|Protocol Violation|0|||
149145739|NCT02104583|538014583|FG000|Overall Study|Adverse Event|3|||
149145740|NCT02104583|538014584|FG001|Overall Study|Adverse Event|3|||
149145741|NCT02104583|538014585|FG002|Overall Study|Adverse Event|6|||
149145742|NCT02104583|538014586|FG003|Overall Study|Adverse Event|6|||
149145743|NCT02104583|538014587|FG004|Overall Study|Adverse Event|1|||
149145744|NCT02104583|538014583|FG000|Overall Study|Lost to Follow-up|1|||
149145745|NCT02104583|538014584|FG001|Overall Study|Lost to Follow-up|0|||
149145746|NCT02104583|538014585|FG002|Overall Study|Lost to Follow-up|0|||
149145747|NCT02104583|538014586|FG003|Overall Study|Lost to Follow-up|0|||
149145748|NCT02104583|538014587|FG004|Overall Study|Lost to Follow-up|0|||
149145749|NCT02104583|538014583|FG000|Overall Study|Randomized but Never Treated|0|||
149145750|NCT02104583|538014584|FG001|Overall Study|Randomized but Never Treated|0|||
149145751|NCT02104583|538014585|FG002|Overall Study|Randomized but Never Treated|0|||
149145752|NCT02104583|538014586|FG003|Overall Study|Randomized but Never Treated|1|||
149145753|NCT02104583|538014587|FG004|Overall Study|Randomized but Never Treated|0|||
149145754|NCT04640272|538014588|FG000|Overall Study|Subject moved out of area|1|||
149145755|NCT00880399|538014592|FG000|Overall Study|Adverse Event|4|||
149145756|NCT00880399|538014593|FG001|Overall Study|Adverse Event|6|||
149145757|NCT00880399|538014594|FG002|Overall Study|Adverse Event|5|||
149145758|NCT00880399|538014592|FG000|Overall Study|Lack of Efficacy|1|||
149145759|NCT00880399|538014593|FG001|Overall Study|Lack of Efficacy|4|||
149145760|NCT00880399|538014594|FG002|Overall Study|Lack of Efficacy|2|||
149145761|NCT00880399|538014592|FG000|Overall Study|Protocol Violation|4|||
149145762|NCT00880399|538014593|FG001|Overall Study|Protocol Violation|4|||
149145763|NCT00880399|538014594|FG002|Overall Study|Protocol Violation|6|||
149145764|NCT00880399|538014592|FG000|Overall Study|Study closed/terminated|3|||
149145765|NCT00880399|538014593|FG001|Overall Study|Study closed/terminated|7|||
149145766|NCT00880399|538014594|FG002|Overall Study|Study closed/terminated|4|||
149145767|NCT00880399|538014592|FG000|Overall Study|Lost to Follow-up|8|||
149145768|NCT00880399|538014593|FG001|Overall Study|Lost to Follow-up|5|||
149145769|NCT00880399|538014594|FG002|Overall Study|Lost to Follow-up|3|||
149145770|NCT00880399|538014592|FG000|Overall Study|Physician Decision|5|||
149145771|NCT00880399|538014593|FG001|Overall Study|Physician Decision|0|||
149145772|NCT00880399|538014594|FG002|Overall Study|Physician Decision|3|||
149145773|NCT00880399|538014592|FG000|Overall Study|Withdrawal by Subject|6|||
149145774|NCT00880399|538014593|FG001|Overall Study|Withdrawal by Subject|3|||
149145775|NCT00880399|538014594|FG002|Overall Study|Withdrawal by Subject|3|||
149145776|NCT02535715|538014595|FG000|Overall Study|Withdrawal by Subject|0|||
149145777|NCT02535715|538014596|FG001|Overall Study|Withdrawal by Subject|0|||
149145778|NCT02535715|538014597|FG002|Overall Study|Withdrawal by Subject|1|||
149145779|NCT04353284|538014598|FG000|Overall Study|Adverse Event|1|||
149145780|NCT04353284|538014599|FG001|Overall Study|Adverse Event|1|||
149145781|NCT04353284|538014598|FG000|Overall Study|Lost to Follow-up|1|||
149145782|NCT04353284|538014599|FG001|Overall Study|Lost to Follow-up|0|||
149145783|NCT03709654|538014605|FG000|Overall Study|Lost to Follow-up|1|||
149145784|NCT03709654|538014606|FG001|Overall Study|Lost to Follow-up|1|||
149145785|NCT03709654|538014605|FG000|Overall Study|Withdrawal by Subject|1|||
149145786|NCT03709654|538014606|FG001|Overall Study|Withdrawal by Subject|1|||
149145787|NCT03709654|538014605|FG000|Overall Study|Adverse Event|1|||
149145788|NCT03709654|538014606|FG001|Overall Study|Adverse Event|0|||
149145789|NCT01902966|538014607|FG000|Overall Study|Death|1|||
149145790|NCT01902966|538014607|FG000|Overall Study|Physician Decision|1|||
149145791|NCT01902966|538014607|FG000|Overall Study|Withdrawal by Subject|1|||
149145792|NCT01549275|538014608|FG000|Overall Study|Lost to Follow-up|1|||
149145793|NCT01549275|538014609|FG001|Overall Study|Lost to Follow-up|0|||
149145794|NCT01040351|538014610|FG000|Overall Study|poor ovarian response|1|||
148913782|NCT01904773|537169818|FG005|Screen|Withdrawal by Subject|0|||
148913783|NCT01904773|537169819|FG006|Screen|Withdrawal by Subject|0|||
148913784|NCT01904773|537169820|FG007|Screen|Withdrawal by Subject|0|||
148913785|NCT01904773|537169821|FG008|Screen|Withdrawal by Subject|0|||
148913786|NCT01904773|537169813|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
148913787|NCT01904773|537169814|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
149145795|NCT01040351|538014611|FG001|Overall Study|poor ovarian response|2|||
149145796|NCT01230307|538014612|FG000|Overall Study|LVAD Placement|0|||
149145797|NCT01230307|538014613|FG001|Overall Study|LVAD Placement|2|||
149145798|NCT04773106|538014616|FG000|Overall Study|Withdrawal by Subject|3|||
149145799|NCT04773106|538014616|FG000|Overall Study|Death|1|||
149145800|NCT00122681|538014624|FG000|Overall Study|Adverse Event|20|||
149145801|NCT00122681|538014625|FG001|Overall Study|Adverse Event|16|||
149145802|NCT00122681|538014624|FG000|Overall Study|Lost to Follow-up|1080|||
149145803|NCT00122681|538014625|FG001|Overall Study|Lost to Follow-up|1097|||
149145804|NCT00122681|538014624|FG000|Overall Study|Protocol Violation|7|||
149145805|NCT00122681|538014625|FG001|Overall Study|Protocol Violation|10|||
149145806|NCT00122681|538014624|FG000|Overall Study|Withdrawal by Subject|257|||
149145807|NCT00122681|538014625|FG001|Overall Study|Withdrawal by Subject|251|||
149145808|NCT00122681|538014624|FG000|Overall Study|Personal reasons|150|||
149145809|NCT00122681|538014625|FG001|Overall Study|Personal reasons|147|||
149145810|NCT02819635|538014630|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
149145811|NCT02819635|538014631|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
148913788|NCT01904773|537169815|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913789|NCT01904773|537169816|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913790|NCT01904773|537169817|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913791|NCT01904773|537169818|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913792|NCT01904773|537169819|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913793|NCT01904773|537169820|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913794|NCT01904773|537169821|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
148913795|NCT01904773|537169813|FG000|First Intervention|Adverse Event|0|||
148913796|NCT01904773|537169814|FG001|First Intervention|Adverse Event|0|||
148913797|NCT01904773|537169815|FG002|First Intervention|Adverse Event|0|||
148913798|NCT01904773|537169816|FG003|First Intervention|Adverse Event|0|||
148913799|NCT01904773|537169817|FG004|First Intervention|Adverse Event|0|||
148913800|NCT01904773|537169818|FG005|First Intervention|Adverse Event|0|||
148913801|NCT01904773|537169819|FG006|First Intervention|Adverse Event|1|||
148913802|NCT01904773|537169820|FG007|First Intervention|Adverse Event|0|||
148671351|NCT05554471|536267105|FG000|Overall Study|Physician Decision|2|||
148913803|NCT01904773|537169821|FG008|First Intervention|Adverse Event|0|||
148913804|NCT01904773|537169813|FG000|Placebo Washout First Intervention|Condition worsened|0|||
149145812|NCT02819635|538014632|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
149145813|NCT02819635|538014633|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
149145814|NCT02819635|538014634|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
149145815|NCT02819635|538014635|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
149145816|NCT02819635|538014636|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
149145817|NCT02819635|538014637|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
149145818|NCT02819635|538014638|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
149145819|NCT02819635|538014639|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
149145820|NCT02819635|538014640|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
149145821|NCT02819635|538014641|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
149145822|NCT02819635|538014630|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145823|NCT02819635|538014631|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145824|NCT02819635|538014632|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145825|NCT02819635|538014633|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145826|NCT02819635|538014634|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
149145827|NCT02819635|538014635|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
149145828|NCT02819635|538014636|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
149145829|NCT02819635|538014637|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145830|NCT02819635|538014638|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145831|NCT02819635|538014639|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145832|NCT02819635|538014640|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145833|NCT02819635|538014641|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
149145834|NCT02819635|538014630|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145835|NCT02819635|538014631|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145836|NCT02819635|538014632|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145837|NCT02819635|538014633|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145838|NCT02819635|538014634|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145839|NCT02819635|538014635|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
149145840|NCT02819635|538014636|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
149145841|NCT02819635|538014637|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145842|NCT02819635|538014638|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145843|NCT02819635|538014639|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145844|NCT02819635|538014640|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145845|NCT02819635|538014641|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
149145846|NCT02819635|538014630|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145847|NCT02819635|538014631|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145848|NCT02819635|538014632|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145849|NCT02819635|538014633|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145850|NCT02819635|538014634|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145851|NCT02819635|538014635|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145852|NCT02819635|538014636|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
149145853|NCT02819635|538014637|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145854|NCT02819635|538014638|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145855|NCT02819635|538014639|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145856|NCT02819635|538014640|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145857|NCT02819635|538014641|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
149145858|NCT02819635|538014630|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
149145859|NCT02819635|538014631|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
149145860|NCT02819635|538014632|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
149145861|NCT02819635|538014633|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
149145862|NCT02819635|538014634|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
149145863|NCT02819635|538014635|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
149145864|NCT02819635|538014636|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
149145865|NCT02819635|538014637|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
149145866|NCT02819635|538014638|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
149145867|NCT02819635|538014639|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
149145868|NCT02819635|538014640|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
149145869|NCT02819635|538014641|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
149145870|NCT02819635|538014630|FG000|Substudy 2, Part 2|Adverse Event|0|||
149145871|NCT02819635|538014631|FG001|Substudy 2, Part 2|Adverse Event|0|||
149145872|NCT02819635|538014632|FG002|Substudy 2, Part 2|Adverse Event|0|||
149145873|NCT02819635|538014633|FG003|Substudy 2, Part 2|Adverse Event|0|||
149145874|NCT02819635|538014634|FG004|Substudy 2, Part 2|Adverse Event|0|||
149145875|NCT02819635|538014635|FG005|Substudy 2, Part 2|Adverse Event|4|||
149145876|NCT02819635|538014636|FG006|Substudy 2, Part 2|Adverse Event|0|||
149145877|NCT02819635|538014637|FG007|Substudy 2, Part 2|Adverse Event|0|||
149145878|NCT02819635|538014638|FG008|Substudy 2, Part 2|Adverse Event|0|||
149145879|NCT02819635|538014639|FG009|Substudy 2, Part 2|Adverse Event|0|||
149145880|NCT02819635|538014640|FG010|Substudy 2, Part 2|Adverse Event|0|||
149145881|NCT02819635|538014641|FG011|Substudy 2, Part 2|Adverse Event|0|||
149145882|NCT02819635|538014630|FG000|Substudy 2, Part 2|Withdrew consent|0|||
149145883|NCT02819635|538014631|FG001|Substudy 2, Part 2|Withdrew consent|0|||
149145884|NCT02819635|538014632|FG002|Substudy 2, Part 2|Withdrew consent|0|||
149145885|NCT02819635|538014633|FG003|Substudy 2, Part 2|Withdrew consent|0|||
149145886|NCT02819635|538014634|FG004|Substudy 2, Part 2|Withdrew consent|0|||
149145887|NCT02819635|538014635|FG005|Substudy 2, Part 2|Withdrew consent|3|||
149145888|NCT02819635|538014636|FG006|Substudy 2, Part 2|Withdrew consent|1|||
149145889|NCT02819635|538014637|FG007|Substudy 2, Part 2|Withdrew consent|0|||
149145890|NCT02819635|538014638|FG008|Substudy 2, Part 2|Withdrew consent|0|||
149145891|NCT02819635|538014639|FG009|Substudy 2, Part 2|Withdrew consent|0|||
149145892|NCT02819635|538014640|FG010|Substudy 2, Part 2|Withdrew consent|0|||
149145893|NCT02819635|538014641|FG011|Substudy 2, Part 2|Withdrew consent|0|||
149145894|NCT02819635|538014630|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
149145895|NCT02819635|538014631|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
149145896|NCT02819635|538014632|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
149145897|NCT02819635|538014633|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
149145898|NCT02819635|538014634|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
149145899|NCT02819635|538014635|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
149145900|NCT02819635|538014636|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
149145901|NCT02819635|538014637|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
149145902|NCT02819635|538014638|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
149145903|NCT02819635|538014639|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
149145904|NCT02819635|538014640|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
149145905|NCT02819635|538014641|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
149145906|NCT02819635|538014630|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145907|NCT02819635|538014631|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145908|NCT02819635|538014632|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145909|NCT02819635|538014633|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145910|NCT02819635|538014634|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145911|NCT02819635|538014635|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145912|NCT02819635|538014636|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
149145913|NCT02819635|538014637|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145914|NCT02819635|538014638|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145915|NCT02819635|538014639|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145916|NCT02819635|538014640|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145917|NCT02819635|538014641|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
149145918|NCT02819635|538014630|FG000|Substudy 2, Part 2|Other, not specified|0|||
149145919|NCT02819635|538014631|FG001|Substudy 2, Part 2|Other, not specified|0|||
149145920|NCT02819635|538014632|FG002|Substudy 2, Part 2|Other, not specified|0|||
149145921|NCT02819635|538014633|FG003|Substudy 2, Part 2|Other, not specified|0|||
149145922|NCT02819635|538014634|FG004|Substudy 2, Part 2|Other, not specified|0|||
149145923|NCT02819635|538014635|FG005|Substudy 2, Part 2|Other, not specified|4|||
149145924|NCT02819635|538014636|FG006|Substudy 2, Part 2|Other, not specified|8|||
149145925|NCT02819635|538014637|FG007|Substudy 2, Part 2|Other, not specified|0|||
149145926|NCT02819635|538014638|FG008|Substudy 2, Part 2|Other, not specified|0|||
149145927|NCT02819635|538014639|FG009|Substudy 2, Part 2|Other, not specified|0|||
149145928|NCT02819635|538014640|FG010|Substudy 2, Part 2|Other, not specified|0|||
149145929|NCT02819635|538014641|FG011|Substudy 2, Part 2|Other, not specified|0|||
149145930|NCT02819635|538014630|FG000|Substudy 3|Adverse Event|0|||
149145931|NCT02819635|538014631|FG001|Substudy 3|Adverse Event|0|||
149145932|NCT02819635|538014632|FG002|Substudy 3|Adverse Event|0|||
149145933|NCT02819635|538014633|FG003|Substudy 3|Adverse Event|0|||
149145934|NCT02819635|538014634|FG004|Substudy 3|Adverse Event|0|||
149145935|NCT02819635|538014635|FG005|Substudy 3|Adverse Event|0|||
149145936|NCT02819635|538014636|FG006|Substudy 3|Adverse Event|0|||
148913805|NCT01904773|537169814|FG001|Placebo Washout First Intervention|Condition worsened|1|||
149145937|NCT02819635|538014637|FG007|Substudy 3|Adverse Event|0|||
149145938|NCT02819635|538014638|FG008|Substudy 3|Adverse Event|32|||
149145939|NCT02819635|538014639|FG009|Substudy 3|Adverse Event|3|||
149145940|NCT02819635|538014640|FG010|Substudy 3|Adverse Event|12|||
149145941|NCT02819635|538014641|FG011|Substudy 3|Adverse Event|18|||
149145942|NCT02819635|538014630|FG000|Substudy 3|Withdrew consent|0|||
149145943|NCT02819635|538014631|FG001|Substudy 3|Withdrew consent|0|||
149145944|NCT02819635|538014632|FG002|Substudy 3|Withdrew consent|0|||
149145945|NCT02819635|538014633|FG003|Substudy 3|Withdrew consent|0|||
149145946|NCT02819635|538014634|FG004|Substudy 3|Withdrew consent|0|||
149145947|NCT02819635|538014635|FG005|Substudy 3|Withdrew consent|0|||
149145948|NCT02819635|538014636|FG006|Substudy 3|Withdrew consent|0|||
149145949|NCT02819635|538014637|FG007|Substudy 3|Withdrew consent|0|||
149145950|NCT02819635|538014638|FG008|Substudy 3|Withdrew consent|11|||
148913806|NCT01904773|537169815|FG002|Placebo Washout First Intervention|Condition worsened|0|||
148913807|NCT01904773|537169816|FG003|Placebo Washout First Intervention|Condition worsened|0|||
148913808|NCT01904773|537169817|FG004|Placebo Washout First Intervention|Condition worsened|0|||
148913809|NCT01904773|537169818|FG005|Placebo Washout First Intervention|Condition worsened|0|||
148913810|NCT01904773|537169819|FG006|Placebo Washout First Intervention|Condition worsened|0|||
148913811|NCT01904773|537169820|FG007|Placebo Washout First Intervention|Condition worsened|0|||
149145951|NCT02819635|538014639|FG009|Substudy 3|Withdrew consent|1|||
149145952|NCT02819635|538014640|FG010|Substudy 3|Withdrew consent|4|||
149145953|NCT02819635|538014641|FG011|Substudy 3|Withdrew consent|9|||
149145954|NCT02819635|538014630|FG000|Substudy 3|Lost to Follow-up|0|||
149145955|NCT02819635|538014631|FG001|Substudy 3|Lost to Follow-up|0|||
149145956|NCT02819635|538014632|FG002|Substudy 3|Lost to Follow-up|0|||
149145957|NCT02819635|538014633|FG003|Substudy 3|Lost to Follow-up|0|||
149145958|NCT02819635|538014634|FG004|Substudy 3|Lost to Follow-up|0|||
149145959|NCT02819635|538014635|FG005|Substudy 3|Lost to Follow-up|0|||
149145960|NCT02819635|538014636|FG006|Substudy 3|Lost to Follow-up|0|||
149145961|NCT02819635|538014637|FG007|Substudy 3|Lost to Follow-up|0|||
149145962|NCT02819635|538014638|FG008|Substudy 3|Lost to Follow-up|1|||
149145963|NCT02819635|538014639|FG009|Substudy 3|Lost to Follow-up|0|||
149145964|NCT02819635|538014640|FG010|Substudy 3|Lost to Follow-up|1|||
149145965|NCT02819635|538014641|FG011|Substudy 3|Lost to Follow-up|1|||
149145966|NCT02819635|538014630|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145967|NCT02819635|538014631|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145968|NCT02819635|538014632|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145969|NCT02819635|538014633|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145970|NCT02819635|538014634|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145971|NCT02819635|538014635|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145972|NCT02819635|538014636|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145973|NCT02819635|538014637|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145974|NCT02819635|538014638|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145975|NCT02819635|538014639|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145976|NCT02819635|538014640|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
149145977|NCT02819635|538014641|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
149145978|NCT02819635|538014630|FG000|Substudy 3|Other, not specified|0|||
149145979|NCT02819635|538014631|FG001|Substudy 3|Other, not specified|0|||
149145980|NCT02819635|538014632|FG002|Substudy 3|Other, not specified|0|||
149145981|NCT02819635|538014633|FG003|Substudy 3|Other, not specified|0|||
149145982|NCT02819635|538014634|FG004|Substudy 3|Other, not specified|0|||
149145983|NCT02819635|538014635|FG005|Substudy 3|Other, not specified|0|||
149145984|NCT02819635|538014636|FG006|Substudy 3|Other, not specified|0|||
149145985|NCT02819635|538014637|FG007|Substudy 3|Other, not specified|0|||
149145986|NCT02819635|538014638|FG008|Substudy 3|Other, not specified|202|||
149145987|NCT02819635|538014639|FG009|Substudy 3|Other, not specified|5|||
149145988|NCT02819635|538014640|FG010|Substudy 3|Other, not specified|89|||
149145989|NCT02819635|538014641|FG011|Substudy 3|Other, not specified|39|||
149145990|NCT03179891|538014643|FG000|First Intervention|Withdrawal by Subject|1|||
149145991|NCT03179891|538014644|FG001|First Intervention|Withdrawal by Subject|1|||
149145992|NCT03179891|538014643|FG000|First Intervention|Unspecified reason|1|||
149145993|NCT03179891|538014644|FG001|First Intervention|Unspecified reason|0|||
149145994|NCT03179891|538014643|FG000|First Intervention|Protocol Violation|0|||
149145995|NCT03179891|538014644|FG001|First Intervention|Protocol Violation|1|||
149145996|NCT00530894|538014646|FG000|Overall Study|Death|84|||
149145997|NCT00530894|538014647|FG001|Overall Study|Death|89|||
149145998|NCT00530894|538014648|FG002|Overall Study|Death|55|||
149145999|NCT00530894|538014649|FG003|Overall Study|Death|89|||
149146000|NCT00530894|538014646|FG000|Overall Study|Lost to Follow-up|1|||
149146001|NCT00530894|538014647|FG001|Overall Study|Lost to Follow-up|3|||
149146002|NCT00530894|538014648|FG002|Overall Study|Lost to Follow-up|0|||
149146003|NCT00530894|538014649|FG003|Overall Study|Lost to Follow-up|0|||
149146004|NCT00530894|538014646|FG000|Overall Study|Withdrawal by Subject|1|||
149146005|NCT00530894|538014647|FG001|Overall Study|Withdrawal by Subject|23|||
149146006|NCT00530894|538014648|FG002|Overall Study|Withdrawal by Subject|0|||
149146007|NCT00530894|538014649|FG003|Overall Study|Withdrawal by Subject|5|||
149146008|NCT00530894|538014646|FG000|Overall Study|Alive and censored prior to 1 year|2|||
149146009|NCT00530894|538014647|FG001|Overall Study|Alive and censored prior to 1 year|0|||
149146010|NCT00530894|538014648|FG002|Overall Study|Alive and censored prior to 1 year|0|||
149146011|NCT00530894|538014649|FG003|Overall Study|Alive and censored prior to 1 year|0|||
149146012|NCT01349465|538014650|FG000|Overall Study|Adverse Event|1|||
149146013|NCT01349465|538014651|FG001|Overall Study|Adverse Event|0|||
149146014|NCT01349465|538014650|FG000|Overall Study|Death|3|||
149146015|NCT01349465|538014651|FG001|Overall Study|Death|0|||
149146016|NCT01349465|538014650|FG000|Overall Study|Lost to Follow-up|10|||
149146017|NCT01349465|538014651|FG001|Overall Study|Lost to Follow-up|1|||
149146018|NCT01349465|538014650|FG000|Overall Study|Withdrawal by Subject|4|||
149146019|NCT01349465|538014651|FG001|Overall Study|Withdrawal by Subject|2|||
148913812|NCT01904773|537169821|FG008|Placebo Washout First Intervention|Condition worsened|0|||
149012834|NCT01468922|537525816|FG003|Overall Study|Enrolled on new protocol|0|||
149146020|NCT01349465|538014650|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
149146021|NCT01349465|538014651|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
149146022|NCT01476475|538014654|FG000|Overall Study|Adverse Event|6|||
149146023|NCT01476475|538014655|FG001|Overall Study|Adverse Event|0|||
149146024|NCT01476475|538014654|FG000|Overall Study|Poor compliance to protocol|1|||
149146025|NCT01476475|538014655|FG001|Overall Study|Poor compliance to protocol|1|||
149146026|NCT01476475|538014654|FG000|Overall Study|Other reasons|4|||
149146027|NCT01476475|538014655|FG001|Overall Study|Other reasons|2|||
149146028|NCT00751400|538014659|FG000|Overall Study|Lost to Follow-up|10|||
149146029|NCT01372384|538014660|FG000|Overall Study|Progression of disease|3|||
149146030|NCT02576444|538014664|FG000|Overall Study|Death|1|||
149146031|NCT02576444|538014665|FG001|Overall Study|Death|1|||
149146032|NCT02576444|538014666|FG002|Overall Study|Death|0|||
149146033|NCT02576444|538014667|FG003|Overall Study|Death|0|||
149146034|NCT02576444|538014664|FG000|Overall Study|Withdrawal by Subject|0|||
149146035|NCT02576444|538014665|FG001|Overall Study|Withdrawal by Subject|0|||
149146036|NCT02576444|538014666|FG002|Overall Study|Withdrawal by Subject|2|||
149146037|NCT02576444|538014667|FG003|Overall Study|Withdrawal by Subject|0|||
149146038|NCT02576444|538014664|FG000|Overall Study|Adverse Event|0|||
149146039|NCT02576444|538014665|FG001|Overall Study|Adverse Event|0|||
149146040|NCT02576444|538014666|FG002|Overall Study|Adverse Event|1|||
149146041|NCT02576444|538014667|FG003|Overall Study|Adverse Event|0|||
149146042|NCT02576444|538014664|FG000|Overall Study|Physician Decision|0|||
149146043|NCT02576444|538014665|FG001|Overall Study|Physician Decision|0|||
149146044|NCT02576444|538014666|FG002|Overall Study|Physician Decision|1|||
149146045|NCT02576444|538014667|FG003|Overall Study|Physician Decision|0|||
149146046|NCT03370120|538014671|FG000|Overall Study|Adverse event, non-fatal|24|||
149146047|NCT03370120|538014671|FG000|Overall Study|Withdrawal by Subject|6|||
149146048|NCT03370120|538014671|FG000|Overall Study|Lost to Follow-up|1|||
149146049|NCT03370120|538014671|FG000|Overall Study|Lack of Efficacy|37|||
149146050|NCT03370120|538014671|FG000|Overall Study|Per sponsor's instructions|1|||
149146051|NCT03370120|538014671|FG000|Overall Study|Study was terminated by parent company UCB|2|||
149146052|NCT03370120|538014671|FG000|Overall Study|The study was ended by the promoter|3|||
149146053|NCT03370120|538014671|FG000|Overall Study|Discontinuation of drug development|3|||
149146054|NCT03370120|538014671|FG000|Overall Study|End of project|2|||
149146055|NCT03370120|538014671|FG000|Overall Study|Premature study closure|2|||
149146056|NCT03370120|538014671|FG000|Overall Study|Premature program termination|1|||
149146057|NCT03370120|538014671|FG000|Overall Study|Premature study termination|7|||
149146058|NCT03370120|538014671|FG000|Overall Study|Trial terminated by sponsor|2|||
149146059|NCT03370120|538014671|FG000|Overall Study|Trial discontinued by sponsor|2|||
149146060|NCT03370120|538014671|FG000|Overall Study|Study ended|15|||
149146061|NCT03370120|538014671|FG000|Overall Study|Clinical trial has been cancelled|1|||
149146062|NCT03370120|538014671|FG000|Overall Study|End of study per sponsor decision|2|||
149146063|NCT03370120|538014671|FG000|Overall Study|Promoter's decision|2|||
149146064|NCT03370120|538014671|FG000|Overall Study|The trial has been suspended|3|||
149146065|NCT03370120|538014671|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
149146066|NCT03370120|538014671|FG000|Overall Study|Early termination by order of sponsor|2|||
149146067|NCT03370120|538014671|FG000|Overall Study|Discontinuation of the study|5|||
149146068|NCT03370120|538014671|FG000|Overall Study|End of clinical trial discontinuation|1|||
149146069|NCT03370120|538014671|FG000|Overall Study|Because the clinical trial ended halfway|4|||
149146070|NCT03370120|538014671|FG000|Overall Study|Development discontinued|5|||
149146071|NCT03370120|538014671|FG000|Overall Study|Padsenovil program closed|3|||
149146072|NCT03370120|538014671|FG000|Overall Study|End of project|2|||
149146073|NCT03370120|538014671|FG000|Overall Study|Termination of project|1|||
149146074|NCT03370120|538014671|FG000|Overall Study|The study was interrupted by sponsor|4|||
149146075|NCT03370120|538014671|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
149146076|NCT03370120|538014671|FG000|Overall Study|End of sponsor decision|1|||
149146077|NCT03370120|538014671|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
148913813|NCT01904773|537169813|FG000|Fifth Intervention|Adverse Event|0|||
149146078|NCT03370120|538014671|FG000|Overall Study|Early termination of studies|5|||
149146079|NCT03370120|538014671|FG000|Overall Study|This study is ended early|1|||
149146080|NCT03370120|538014671|FG000|Overall Study|End of padsevonil program|2|||
149146081|NCT03370120|538014671|FG000|Overall Study|Decision of sponsor|6|||
149146082|NCT03370120|538014671|FG000|Overall Study|Asked by the sponsor|3|||
149146083|NCT03370120|538014671|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
149146084|NCT03370120|538014671|FG000|Overall Study|PI decision poor compliance from participant|1|||
149146085|NCT03370120|538014671|FG000|Overall Study|Promoter ended the study|3|||
149146086|NCT03370120|538014671|FG000|Overall Study|Premature study close by sponsor's decision|4|||
149146087|NCT03370120|538014671|FG000|Overall Study|Study terminated by sponsor|33|||
149146088|NCT03370120|538014671|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
149146089|NCT03370120|538014671|FG000|Overall Study|Sponsor decision to terminate study|63|||
149146090|NCT03370120|538014671|FG000|Overall Study|Program closure|3|||
149146091|NCT03370120|538014671|FG000|Overall Study|Study ended prematurely|1|||
148913814|NCT01904773|537169814|FG001|Fifth Intervention|Adverse Event|0|||
148913815|NCT01904773|537169815|FG002|Fifth Intervention|Adverse Event|0|||
149146092|NCT03370120|538014671|FG000|Overall Study|Study stopped by sponsor|2|||
149146093|NCT03370120|538014671|FG000|Overall Study|Program termination|55|||
149146094|NCT03370120|538014671|FG000|Overall Study|Sponsor decision|62|||
149146095|NCT03370120|538014671|FG000|Overall Study|Sponsor study closure|10|||
149146096|NCT04206020|538014672|FG000|Overall Study|Adverse Event|1|||
149146097|NCT04206020|538014673|FG001|Overall Study|Adverse Event|4|||
149146098|NCT04206020|538014672|FG000|Overall Study|Protocol Violation|2|||
149146099|NCT04206020|538014673|FG001|Overall Study|Protocol Violation|0|||
149146100|NCT04206020|538014672|FG000|Overall Study|Withdrawal by Subject|2|||
149146101|NCT04206020|538014673|FG001|Overall Study|Withdrawal by Subject|0|||
149146102|NCT04206020|538014672|FG000|Overall Study|Lost to Follow-up|2|||
149146103|NCT04206020|538014673|FG001|Overall Study|Lost to Follow-up|0|||
149146104|NCT04206020|538014672|FG000|Overall Study|Pregnancy|0|||
149146105|NCT04206020|538014673|FG001|Overall Study|Pregnancy|1|||
149146106|NCT04206020|538014672|FG000|Overall Study|Unable to attend visits|1|||
149146107|NCT04206020|538014673|FG001|Overall Study|Unable to attend visits|2|||
149146108|NCT04962022|538014676|FG000|Period 1|Withdrawal by Subject|1|||
149146109|NCT04962022|538014677|FG001|Period 1|Withdrawal by Subject|0|||
149146110|NCT04416555|538014678|FG000|Overall Study|Withdrawal by Subject|0|||
149146111|NCT04416555|538014679|FG001|Overall Study|Withdrawal by Subject|3|||
149146112|NCT03374189|538014680|FG000|Overall Study|Lost to Follow-up|1|||
149146113|NCT03374189|538014681|FG001|Overall Study|Lost to Follow-up|0|||
149146114|NCT03962101|538014682|FG000|Overall Study|Adverse Event|1|||
149146115|NCT03962101|538014682|FG000|Overall Study|Physician Decision|2|||
149146116|NCT03962101|538014682|FG000|Overall Study|Not related to medical events|1|||
149146117|NCT03972969|538014683|FG000|3-month Follow-up|Death|1|||
149146118|NCT03972969|538014684|FG001|3-month Follow-up|Death|1|||
149146119|NCT03972969|538014685|FG002|3-month Follow-up|Death|0|||
149146120|NCT03972969|538014683|FG000|6-month Follow-up|Death|1|||
149146121|NCT03972969|538014684|FG001|6-month Follow-up|Death|1|||
149146122|NCT03972969|538014685|FG002|6-month Follow-up|Death|1|||
149146123|NCT03972969|538014683|FG000|6-month Follow-up|Lost to Follow-up|2|||
148913816|NCT01904773|537169816|FG003|Fifth Intervention|Adverse Event|0|||
149146124|NCT03972969|538014684|FG001|6-month Follow-up|Lost to Follow-up|2|||
149146125|NCT03972969|538014685|FG002|6-month Follow-up|Lost to Follow-up|2|||
149146126|NCT04607148|538014688|FG000|Overall Study|Withdrawal by Subject|0|||
149146127|NCT04607148|538014689|FG001|Overall Study|Withdrawal by Subject|4|||
149146128|NCT04607148|538014690|FG002|Overall Study|Withdrawal by Subject|2|||
149146129|NCT04607148|538014691|FG003|Overall Study|Withdrawal by Subject|8|||
149146130|NCT04607148|538014688|FG000|Overall Study|Study Terminated by Sponsor|14|||
149146131|NCT04607148|538014689|FG001|Overall Study|Study Terminated by Sponsor|59|||
149146132|NCT04607148|538014690|FG002|Overall Study|Study Terminated by Sponsor|9|||
149146133|NCT04607148|538014691|FG003|Overall Study|Study Terminated by Sponsor|39|||
149146134|NCT04607148|538014688|FG000|Overall Study|Sponsor Decision|0|||
149146135|NCT04607148|538014689|FG001|Overall Study|Sponsor Decision|0|||
149146136|NCT04607148|538014690|FG002|Overall Study|Sponsor Decision|1|||
149146137|NCT04607148|538014691|FG003|Overall Study|Sponsor Decision|0|||
149146138|NCT04607148|538014688|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149146139|NCT04607148|538014689|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149146140|NCT04607148|538014690|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149146141|NCT04607148|538014691|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149146142|NCT04607148|538014688|FG000|Overall Study|Lost to Follow-up|0|||
149146143|NCT04607148|538014689|FG001|Overall Study|Lost to Follow-up|2|||
149146144|NCT04607148|538014690|FG002|Overall Study|Lost to Follow-up|0|||
149146145|NCT04607148|538014691|FG003|Overall Study|Lost to Follow-up|0|||
149146146|NCT04607148|538014688|FG000|Overall Study|Death|0|||
149146147|NCT04607148|538014689|FG001|Overall Study|Death|3|||
149146148|NCT04607148|538014690|FG002|Overall Study|Death|0|||
149146149|NCT04607148|538014691|FG003|Overall Study|Death|1|||
149146150|NCT04607148|538014688|FG000|Overall Study|Adverse Event|0|||
149146151|NCT04607148|538014689|FG001|Overall Study|Adverse Event|1|||
149146152|NCT04607148|538014690|FG002|Overall Study|Adverse Event|0|||
149146153|NCT04607148|538014691|FG003|Overall Study|Adverse Event|0|||
149146154|NCT04251910|538014692|FG000|Overall Study|Covid 19 lockdown|0|||
149146155|NCT04251910|538014693|FG001|Overall Study|Covid 19 lockdown|5|||
149146156|NCT04251910|538014694|FG002|Overall Study|Covid 19 lockdown|0|||
149146157|NCT04251910|538014695|FG003|Overall Study|Covid 19 lockdown|4|||
149146158|NCT04251910|538014696|FG004|Overall Study|Covid 19 lockdown|0|||
149146159|NCT04251910|538014697|FG005|Overall Study|Covid 19 lockdown|0|||
149146160|NCT04251910|538014692|FG000|Overall Study|Assisted living facility was closed|0|||
149146161|NCT04251910|538014693|FG001|Overall Study|Assisted living facility was closed|0|||
148804921|NCT01432327|536766606|FG002|Posttest 6 Months|Allergic reaction|1|||
148804922|NCT01432327|536766607|FG003|Posttest 6 Months|Allergic reaction|0|||
148804923|NCT01432327|536766604|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
148804924|NCT01432327|536766605|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
148804925|NCT01432327|536766606|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
148804926|NCT01432327|536766607|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
148804927|NCT01432327|536766604|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
148804928|NCT01432327|536766605|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
148804929|NCT01432327|536766606|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
148804930|NCT01432327|536766607|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
148804931|NCT01432327|536766604|FG000|Posttest 1 Year|Lost to Follow-up|0|||
148804932|NCT01432327|536766605|FG001|Posttest 1 Year|Lost to Follow-up|0|||
148804933|NCT01432327|536766606|FG002|Posttest 1 Year|Lost to Follow-up|4|||
148804934|NCT01432327|536766607|FG003|Posttest 1 Year|Lost to Follow-up|2|||
148804935|NCT01432327|536766604|FG000|Posttest 1 Year|Allergic reaction|0|||
148804936|NCT01432327|536766605|FG001|Posttest 1 Year|Allergic reaction|0|||
148804937|NCT01432327|536766606|FG002|Posttest 1 Year|Allergic reaction|1|||
148804938|NCT01432327|536766607|FG003|Posttest 1 Year|Allergic reaction|1|||
148804939|NCT00577408|536766608|FG000|Overall Study|Stopped attending study visits|9|||
148804940|NCT00577408|536766609|FG001|Overall Study|Stopped attending study visits|11|||
148804941|NCT00577408|536766608|FG000|Overall Study|Continued opioid use|3|||
148804942|NCT00577408|536766609|FG001|Overall Study|Continued opioid use|2|||
148804943|NCT00577408|536766608|FG000|Overall Study|Non-compliance with study meds|0|||
148804944|NCT00577408|536766609|FG001|Overall Study|Non-compliance with study meds|3|||
148804945|NCT00577408|536766608|FG000|Overall Study|Refused Oral Naltrexone|0|||
148804946|NCT00577408|536766609|FG001|Overall Study|Refused Oral Naltrexone|1|||
148804947|NCT00577408|536766608|FG000|Overall Study|Moved out of state|0|||
148804948|NCT00577408|536766609|FG001|Overall Study|Moved out of state|1|||
148804949|NCT00577408|536766608|FG000|Overall Study|Scheduling Issues|0|||
148804950|NCT00577408|536766609|FG001|Overall Study|Scheduling Issues|3|||
148804951|NCT00577408|536766608|FG000|Overall Study|Death|0|||
148804952|NCT00577408|536766609|FG001|Overall Study|Death|1|||
148804953|NCT00577408|536766608|FG000|Overall Study|Psychiatric hospitalization|0|||
148804954|NCT00577408|536766609|FG001|Overall Study|Psychiatric hospitalization|1|||
148804955|NCT02897349|536766610|FG000|Overall Study|Lost to Follow-up|2|||
148804956|NCT02897349|536766611|FG001|Overall Study|Lost to Follow-up|2|||
148804957|NCT02897349|536766610|FG000|Overall Study|Adverse Event|3|||
148804958|NCT02897349|536766611|FG001|Overall Study|Adverse Event|3|||
148804959|NCT02897349|536766610|FG000|Overall Study|Other than listed above|0|||
148804960|NCT02897349|536766611|FG001|Overall Study|Other than listed above|1|||
148804961|NCT03055013|536766614|FG000|Overall Study|Adverse Event|78|||
148804962|NCT03055013|536766615|FG001|Overall Study|Adverse Event|0|||
148804963|NCT03055013|536766614|FG000|Overall Study|Death|6|||
148804964|NCT03055013|536766615|FG001|Overall Study|Death|0|||
149146162|NCT04251910|538014694|FG002|Overall Study|Assisted living facility was closed|0|||
149146163|NCT04251910|538014695|FG003|Overall Study|Assisted living facility was closed|0|||
149146164|NCT04251910|538014696|FG004|Overall Study|Assisted living facility was closed|1|||
149146165|NCT04251910|538014697|FG005|Overall Study|Assisted living facility was closed|0|||
149146166|NCT00804570|538014698|FG000|Overall Study|Adverse Event|14|||
149146167|NCT00804570|538014699|FG001|Overall Study|Adverse Event|7|||
149146168|NCT00804570|538014698|FG000|Overall Study|Lack of Efficacy|0|||
149146169|NCT00804570|538014699|FG001|Overall Study|Lack of Efficacy|1|||
149146170|NCT00804570|538014698|FG000|Overall Study|Lost to Follow-up|18|||
149146171|NCT00804570|538014699|FG001|Overall Study|Lost to Follow-up|21|||
149146172|NCT00804570|538014698|FG000|Overall Study|Entry criteria not met|5|||
149146173|NCT00804570|538014699|FG001|Overall Study|Entry criteria not met|5|||
149146174|NCT00804570|538014698|FG000|Overall Study|Protocol Violation|12|||
149146175|NCT00804570|538014699|FG001|Overall Study|Protocol Violation|16|||
149146176|NCT00804570|538014698|FG000|Overall Study|Physician Decision|1|||
149146177|NCT00804570|538014699|FG001|Overall Study|Physician Decision|2|||
149146178|NCT00804570|538014698|FG000|Overall Study|Sponsor decision|1|||
149146179|NCT00804570|538014699|FG001|Overall Study|Sponsor decision|4|||
149146180|NCT00804570|538014698|FG000|Overall Study|Withdrawal by Subject|21|||
149146181|NCT00804570|538014699|FG001|Overall Study|Withdrawal by Subject|38|||
149146182|NCT00290342|538014700|FG000|Overall Study|Other|0|||
149146183|NCT00290342|538014701|FG001|Overall Study|Other|1|||
149146184|NCT00290342|538014700|FG000|Overall Study|Withdrawal by Subject|6|||
149146185|NCT00290342|538014701|FG001|Overall Study|Withdrawal by Subject|4|||
149146186|NCT00290342|538014700|FG000|Overall Study|Lost to Follow-up|1|||
149146187|NCT00290342|538014701|FG001|Overall Study|Lost to Follow-up|0|||
149146188|NCT00916149|538014702|FG000|Overall Study|Lost to Follow-up|3|||
149146189|NCT00916149|538014703|FG001|Overall Study|Lost to Follow-up|2|||
149146190|NCT00916149|538014704|FG002|Overall Study|Lost to Follow-up|0|||
149146191|NCT00916149|538014702|FG000|Overall Study|Unable to place scalp EEG leads|1|||
149146192|NCT00916149|538014703|FG001|Overall Study|Unable to place scalp EEG leads|0|||
149146193|NCT00916149|538014704|FG002|Overall Study|Unable to place scalp EEG leads|0|||
149146194|NCT01056510|538014705|FG000|Overall Study|Dropout Before Start of Treatment|1|||
149146195|NCT01056510|538014706|FG001|Overall Study|Dropout Before Start of Treatment|1|||
149146196|NCT01056510|538014705|FG000|Overall Study|Withdrawal by Subject|4|||
149146197|NCT01056510|538014706|FG001|Overall Study|Withdrawal by Subject|2|||
149146198|NCT01056510|538014705|FG000|Overall Study|Death|29|||
149146199|NCT01056510|538014706|FG001|Overall Study|Death|34|||
149146200|NCT01056510|538014705|FG000|Overall Study|Noncompliance|1|||
149146201|NCT01056510|538014706|FG001|Overall Study|Noncompliance|3|||
148913817|NCT01904773|537169817|FG004|Fifth Intervention|Adverse Event|0|||
149146202|NCT01056510|538014705|FG000|Overall Study|Physician Decision|4|||
149146203|NCT01056510|538014706|FG001|Overall Study|Physician Decision|5|||
149146204|NCT01056510|538014705|FG000|Overall Study|Lost to Follow-up|5|||
149146205|NCT01056510|538014706|FG001|Overall Study|Lost to Follow-up|6|||
149146206|NCT01056510|538014705|FG000|Overall Study|Other|10|||
149146207|NCT01056510|538014706|FG001|Overall Study|Other|12|||
148913818|NCT01904773|537169818|FG005|Fifth Intervention|Adverse Event|0|||
149146208|NCT01056510|538014705|FG000|Overall Study|Missing|0|||
149146209|NCT01056510|538014706|FG001|Overall Study|Missing|1|||
149146210|NCT00912028|538014709|FG000|Overall Study|Lost to Follow-up|2|||
149146211|NCT00912028|538014710|FG001|Overall Study|Lost to Follow-up|3|||
149146212|NCT00912028|538014711|FG002|Overall Study|Lost to Follow-up|0|||
149146213|NCT00912028|538014712|FG003|Overall Study|Lost to Follow-up|1|||
149146214|NCT00912028|538014713|FG004|Overall Study|Lost to Follow-up|3|||
149146215|NCT00912028|538014709|FG000|Overall Study|Withdrawal by Subject|3|||
149146216|NCT00912028|538014710|FG001|Overall Study|Withdrawal by Subject|0|||
149146217|NCT00912028|538014711|FG002|Overall Study|Withdrawal by Subject|0|||
149146218|NCT00912028|538014712|FG003|Overall Study|Withdrawal by Subject|0|||
149146219|NCT00912028|538014713|FG004|Overall Study|Withdrawal by Subject|0|||
149146220|NCT00841568|538014714|FG000|Overall Study|Adverse Event|1|||
149146221|NCT00841568|538014714|FG000|Overall Study|Death|1|||
149146222|NCT00841568|538014714|FG000|Overall Study|Withdrawal by Subject|2|||
149146223|NCT00841568|538014714|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
149146224|NCT03002155|538014715|FG000|Overall Study|Lost to Follow-up|1|||
149146225|NCT03002155|538014716|FG001|Overall Study|Lost to Follow-up|2|||
149146226|NCT03002155|538014715|FG000|Overall Study|Withdrawal by Subject|1|||
149146227|NCT03002155|538014716|FG001|Overall Study|Withdrawal by Subject|0|||
149146228|NCT03002155|538014715|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
149146229|NCT03002155|538014716|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
149146230|NCT00978029|538014717|FG000|Overall Study|Adverse Event|1|||
149146231|NCT00978029|538014718|FG001|Overall Study|Adverse Event|2|||
149146232|NCT00978029|538014719|FG002|Overall Study|Adverse Event|5|||
149146233|NCT00978029|538014717|FG000|Overall Study|Withdrawal by Subject|0|||
149146234|NCT00978029|538014718|FG001|Overall Study|Withdrawal by Subject|0|||
148913819|NCT01904773|537169819|FG006|Fifth Intervention|Adverse Event|0|||
148913820|NCT01904773|537169820|FG007|Fifth Intervention|Adverse Event|1|||
149146235|NCT00978029|538014719|FG002|Overall Study|Withdrawal by Subject|1|||
149146236|NCT00978029|538014717|FG000|Overall Study|Protocol Violation|0|||
149146237|NCT00978029|538014718|FG001|Overall Study|Protocol Violation|1|||
149146238|NCT00978029|538014719|FG002|Overall Study|Protocol Violation|0|||
149146239|NCT02830776|538014720|FG000|Overall Study|Lost to Follow-up|1|||
149146240|NCT01820364|538014721|FG000|Part I: LGX818|Death|1|||
149146241|NCT01820364|538014722|FG001|Part I: LGX818|Death|0|||
149146242|NCT01820364|538014721|FG000|Part I: LGX818|Administrative Problems|3|||
149146243|NCT01820364|538014722|FG001|Part I: LGX818|Administrative Problems|0|||
149146244|NCT01820364|538014721|FG000|Part I: LGX818|Adverse Event|6|||
149146245|NCT01820364|538014722|FG001|Part I: LGX818|Adverse Event|0|||
149146246|NCT01820364|538014721|FG000|Part I: LGX818|Disease Progression|4|||
149146247|NCT01820364|538014722|FG001|Part I: LGX818|Disease Progression|0|||
149146248|NCT01820364|538014721|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
149146249|NCT01820364|538014722|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
149146250|NCT01793142|538014723|FG000|Overall Study|Randomized not treated|7|||
149146251|NCT03451084|538014726|FG000|Overall Study|Withdrawal by Subject|2|||
149146252|NCT03451084|538014727|FG001|Overall Study|Withdrawal by Subject|1|||
149146253|NCT03451084|538014728|FG002|Overall Study|Withdrawal by Subject|2|||
149146254|NCT03451084|538014729|FG003|Overall Study|Withdrawal by Subject|1|||
149146255|NCT03451084|538014726|FG000|Overall Study|Disease recurrence|0|||
149146256|NCT03451084|538014727|FG001|Overall Study|Disease recurrence|2|||
149146257|NCT03451084|538014728|FG002|Overall Study|Disease recurrence|0|||
149146258|NCT03451084|538014729|FG003|Overall Study|Disease recurrence|0|||
149146259|NCT03451084|538014726|FG000|Overall Study|Lack of Efficacy|0|||
149146260|NCT03451084|538014727|FG001|Overall Study|Lack of Efficacy|3|||
149146261|NCT03451084|538014728|FG002|Overall Study|Lack of Efficacy|0|||
149146262|NCT03451084|538014729|FG003|Overall Study|Lack of Efficacy|1|||
149146263|NCT03451084|538014726|FG000|Overall Study|Death|1|||
149146264|NCT03451084|538014727|FG001|Overall Study|Death|0|||
149146265|NCT03451084|538014728|FG002|Overall Study|Death|2|||
149146266|NCT03451084|538014729|FG003|Overall Study|Death|0|||
149146267|NCT03451084|538014726|FG000|Overall Study|Physician Decision|0|||
149146268|NCT03451084|538014727|FG001|Overall Study|Physician Decision|0|||
149146269|NCT03451084|538014728|FG002|Overall Study|Physician Decision|2|||
149146270|NCT03451084|538014729|FG003|Overall Study|Physician Decision|2|||
149146271|NCT03451084|538014726|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
149146272|NCT03451084|538014727|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
149146273|NCT03451084|538014728|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
149146274|NCT03451084|538014729|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
149146275|NCT01087775|538014730|FG000|Overall Study|failed inclusion criteria|2|||
149146276|NCT03418129|538014731|FG000|Overall Study|Lost to Follow-up|11|||
148913821|NCT01904773|537169821|FG008|Fifth Intervention|Adverse Event|0|||
149146277|NCT03418129|538014732|FG001|Overall Study|Lost to Follow-up|20|||
149146278|NCT03418129|538014733|FG002|Overall Study|Lost to Follow-up|15|||
149146279|NCT03418129|538014731|FG000|Overall Study|Withdrawal by Subject|3|||
149146280|NCT03418129|538014732|FG001|Overall Study|Withdrawal by Subject|6|||
149146281|NCT03418129|538014733|FG002|Overall Study|Withdrawal by Subject|4|||
149146282|NCT01066585|538014736|FG000|Overall Study|Protocol Violation|1|||
149146283|NCT01066585|538014737|FG001|Overall Study|Protocol Violation|0|||
149146284|NCT01066585|538014736|FG000|Overall Study|Withdrawal by Subject|0|||
149146285|NCT01066585|538014737|FG001|Overall Study|Withdrawal by Subject|3|||
149146286|NCT00884273|538014738|FG000|Overall Study|Adverse Event|0|||
149146287|NCT00884273|538014739|FG001|Overall Study|Adverse Event|2|||
149146288|NCT00884273|538014738|FG000|Overall Study|Protocol Violation|1|||
149146289|NCT00884273|538014739|FG001|Overall Study|Protocol Violation|3|||
149146290|NCT00884273|538014738|FG000|Overall Study|Practical reasons|1|||
149146291|NCT00884273|538014739|FG001|Overall Study|Practical reasons|0|||
149146292|NCT00258674|538014740|FG000|Overall Study|Death|32|||
149146293|NCT00258674|538014741|FG001|Overall Study|Death|53|||
149146294|NCT00258674|538014742|FG002|Overall Study|Death|34|||
149146295|NCT03715153|538014743|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
149146296|NCT03715153|538014744|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
149146297|NCT03715153|538014743|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
149146298|NCT03715153|538014744|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
149146299|NCT03715153|538014743|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
149146300|NCT03715153|538014744|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
149146301|NCT03715153|538014743|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
149146302|NCT03715153|538014744|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
149146303|NCT03715153|538014743|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
149146304|NCT03715153|538014744|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
149146305|NCT03715153|538014743|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
149146306|NCT03715153|538014744|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
149146307|NCT00432042|538014748|FG000|Overall Study|Protocol Violation|2|||
149146308|NCT00432042|538014749|FG001|Overall Study|Protocol Violation|0|||
149146309|NCT00432042|538014750|FG002|Overall Study|Protocol Violation|0|||
148913822|NCT01904773|537169813|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913823|NCT01904773|537169814|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
148913824|NCT01904773|537169815|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913825|NCT01904773|537169816|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913826|NCT01904773|537169817|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913827|NCT01904773|537169818|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913828|NCT01904773|537169819|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913829|NCT01904773|537169820|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913830|NCT01904773|537169821|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
148913831|NCT04518995|537169822|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
148913832|NCT04518995|537169823|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
148913833|NCT04518995|537169824|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
148913834|NCT04518995|537169822|FG000|Overall Study|Lack of Efficacy|2|||
148913835|NCT04518995|537169823|FG001|Overall Study|Lack of Efficacy|1|||
148913836|NCT04518995|537169824|FG002|Overall Study|Lack of Efficacy|0|||
148913837|NCT04518995|537169822|FG000|Overall Study|Non-compliance With Study Drug|0|||
148913838|NCT04518995|537169823|FG001|Overall Study|Non-compliance With Study Drug|3|||
148913839|NCT04518995|537169824|FG002|Overall Study|Non-compliance With Study Drug|2|||
148913840|NCT04518995|537169822|FG000|Overall Study|Pregnancy|0|||
148913841|NCT04518995|537169823|FG001|Overall Study|Pregnancy|0|||
148913842|NCT04518995|537169824|FG002|Overall Study|Pregnancy|1|||
149146310|NCT00432042|538014748|FG000|Overall Study|Withdrawal by Subject|0|||
149146311|NCT00432042|538014749|FG001|Overall Study|Withdrawal by Subject|0|||
149146312|NCT00432042|538014750|FG002|Overall Study|Withdrawal by Subject|2|||
148913843|NCT04518995|537169822|FG000|Overall Study|Protocol Violation|2|||
148913844|NCT04518995|537169823|FG001|Overall Study|Protocol Violation|0|||
148913845|NCT04518995|537169824|FG002|Overall Study|Protocol Violation|1|||
148913846|NCT04518995|537169822|FG000|Overall Study|Reason not Specified|4|||
148913847|NCT04518995|537169823|FG001|Overall Study|Reason not Specified|11|||
148913848|NCT04518995|537169824|FG002|Overall Study|Reason not Specified|2|||
149146313|NCT00432042|538014748|FG000|Overall Study|Lost to Follow-up|5|||
149146314|NCT00432042|538014749|FG001|Overall Study|Lost to Follow-up|1|||
149146315|NCT00432042|538014750|FG002|Overall Study|Lost to Follow-up|0|||
149146316|NCT00492752|538014751|FG000|Double Blind Treatment|Death|13|||
149146317|NCT00492752|538014752|FG001|Double Blind Treatment|Death|0|||
149146318|NCT00492752|538014753|FG002|Double Blind Treatment|Death|2|||
149146319|NCT00492752|538014754|FG003|Double Blind Treatment|Death|0|||
149146320|NCT00492752|538014751|FG000|Double Blind Treatment|Adverse Event|1|||
149146321|NCT00492752|538014752|FG001|Double Blind Treatment|Adverse Event|0|||
149146322|NCT00492752|538014753|FG002|Double Blind Treatment|Adverse Event|0|||
149146323|NCT00492752|538014754|FG003|Double Blind Treatment|Adverse Event|0|||
148913849|NCT04518995|537169822|FG000|Overall Study|Lost to Follow-up|1|||
148913850|NCT04518995|537169823|FG001|Overall Study|Lost to Follow-up|10|||
148913851|NCT04518995|537169824|FG002|Overall Study|Lost to Follow-up|6|||
148913852|NCT02248675|537169825|FG000|Overall Study|Lost to Follow-up|3|||
149146324|NCT00492752|538014751|FG000|Double Blind Treatment|Protocol Violation|0|||
149146325|NCT00492752|538014752|FG001|Double Blind Treatment|Protocol Violation|0|||
149146326|NCT00492752|538014753|FG002|Double Blind Treatment|Protocol Violation|1|||
149146327|NCT00492752|538014754|FG003|Double Blind Treatment|Protocol Violation|0|||
149146328|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
149146329|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
149146330|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
149146331|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
149146332|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
149146333|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
149146334|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
149146335|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
149146336|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
149146337|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
149146338|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
149146339|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
149146340|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
149146341|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
149146342|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
149146343|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
149146344|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
148913853|NCT02248675|537169826|FG001|Overall Study|Lost to Follow-up|1|||
148913854|NCT03390101|537169829|FG000|Weeks 0-12|Withdrawal by Subject|0|||
148913855|NCT03390101|537169830|FG001|Weeks 0-12|Withdrawal by Subject|1|||
148913856|NCT03390101|537169831|FG002|Weeks 0-12|Withdrawal by Subject|1|||
148913857|NCT03390101|537169829|FG000|Weeks 0-12|Lost to Follow-up|0|||
148913858|NCT03390101|537169830|FG001|Weeks 0-12|Lost to Follow-up|1|||
148913859|NCT03390101|537169831|FG002|Weeks 0-12|Lost to Follow-up|0|||
148913860|NCT03390101|537169829|FG000|Weeks 12-54|Withdrawal by Subject|0|||
148913861|NCT03390101|537169830|FG001|Weeks 12-54|Withdrawal by Subject|3|||
148913862|NCT03390101|537169831|FG002|Weeks 12-54|Withdrawal by Subject|1|||
148913863|NCT03390101|537169829|FG000|Weeks 12-54|Pregnancy|1|||
148913864|NCT03390101|537169830|FG001|Weeks 12-54|Pregnancy|0|||
148913865|NCT03390101|537169831|FG002|Weeks 12-54|Pregnancy|0|||
148913866|NCT03390101|537169829|FG000|Weeks 12-54|Adverse Event|2|||
148913867|NCT03390101|537169830|FG001|Weeks 12-54|Adverse Event|1|||
148913868|NCT03390101|537169831|FG002|Weeks 12-54|Adverse Event|1|||
148913869|NCT01511055|537169832|FG000|Overall Study|Withdrawal by Subject|6|||
148913870|NCT00830869|537169833|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
148913871|NCT00830869|537169834|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
148913872|NCT00830869|537169835|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
148913873|NCT00830869|537169836|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
148913874|NCT00830869|537169837|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
148913875|NCT00830869|537169838|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
148913876|NCT00830869|537169839|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
148913877|NCT00830869|537169840|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
148913878|NCT00830869|537169841|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
148913879|NCT00830869|537169842|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
148913880|NCT00830869|537169843|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
148913881|NCT00830869|537169844|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
148913882|NCT00830869|537169833|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
148913883|NCT00830869|537169834|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
148913884|NCT00830869|537169835|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
148913885|NCT00830869|537169836|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
148913886|NCT00830869|537169837|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
148913887|NCT00830869|537169838|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
148913888|NCT00830869|537169839|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
148913889|NCT00830869|537169840|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
149146345|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
148913890|NCT00830869|537169841|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
148913891|NCT00830869|537169842|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
148913892|NCT00830869|537169843|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
148913893|NCT00830869|537169844|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
148913894|NCT00830869|537169833|FG000|Period 1: Part 1|Adverse Event|0|||
148913895|NCT00830869|537169834|FG001|Period 1: Part 1|Adverse Event|0|||
148913896|NCT00830869|537169835|FG002|Period 1: Part 1|Adverse Event|0|||
148913897|NCT00830869|537169836|FG003|Period 1: Part 1|Adverse Event|0|||
148913898|NCT00830869|537169837|FG004|Period 1: Part 1|Adverse Event|0|||
148913899|NCT00830869|537169838|FG005|Period 1: Part 1|Adverse Event|1|||
148913900|NCT00830869|537169839|FG006|Period 1: Part 1|Adverse Event|1|||
148913901|NCT00830869|537169840|FG007|Period 1: Part 1|Adverse Event|0|||
148913902|NCT00830869|537169841|FG008|Period 1: Part 1|Adverse Event|0|||
148913903|NCT00830869|537169842|FG009|Period 1: Part 1|Adverse Event|0|||
148913904|NCT00830869|537169843|FG010|Period 1: Part 1|Adverse Event|0|||
148913905|NCT00830869|537169844|FG011|Period 1: Part 1|Adverse Event|0|||
148913906|NCT00830869|537169833|FG000|Period 1: Part 1|Progressive disease|1|||
148913907|NCT00830869|537169834|FG001|Period 1: Part 1|Progressive disease|0|||
148913908|NCT00830869|537169835|FG002|Period 1: Part 1|Progressive disease|1|||
148913909|NCT00830869|537169836|FG003|Period 1: Part 1|Progressive disease|6|||
148913910|NCT00830869|537169837|FG004|Period 1: Part 1|Progressive disease|4|||
148913911|NCT00830869|537169838|FG005|Period 1: Part 1|Progressive disease|4|||
148913912|NCT00830869|537169839|FG006|Period 1: Part 1|Progressive disease|1|||
148913913|NCT00830869|537169840|FG007|Period 1: Part 1|Progressive disease|0|||
148913914|NCT00830869|537169841|FG008|Period 1: Part 1|Progressive disease|0|||
148913915|NCT00830869|537169842|FG009|Period 1: Part 1|Progressive disease|0|||
148913916|NCT00830869|537169843|FG010|Period 1: Part 1|Progressive disease|0|||
148913917|NCT00830869|537169844|FG011|Period 1: Part 1|Progressive disease|0|||
148913918|NCT00830869|537169833|FG000|Period 2: Part 2|Protocol Violation|0|||
148913919|NCT00830869|537169834|FG001|Period 2: Part 2|Protocol Violation|0|||
148913920|NCT00830869|537169835|FG002|Period 2: Part 2|Protocol Violation|0|||
148913921|NCT00830869|537169836|FG003|Period 2: Part 2|Protocol Violation|0|||
148913922|NCT00830869|537169837|FG004|Period 2: Part 2|Protocol Violation|0|||
148913923|NCT00830869|537169838|FG005|Period 2: Part 2|Protocol Violation|0|||
148913924|NCT00830869|537169839|FG006|Period 2: Part 2|Protocol Violation|0|||
148913925|NCT00830869|537169840|FG007|Period 2: Part 2|Protocol Violation|1|||
148913926|NCT00830869|537169841|FG008|Period 2: Part 2|Protocol Violation|0|||
148913927|NCT00830869|537169842|FG009|Period 2: Part 2|Protocol Violation|1|||
148913928|NCT00830869|537169843|FG010|Period 2: Part 2|Protocol Violation|0|||
148913929|NCT00830869|537169844|FG011|Period 2: Part 2|Protocol Violation|0|||
148913930|NCT00830869|537169833|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
148913931|NCT00830869|537169834|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
148913932|NCT00830869|537169835|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
148913933|NCT00830869|537169836|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
148913934|NCT00830869|537169837|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
148913935|NCT00830869|537169838|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
148913936|NCT00830869|537169839|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
148913937|NCT00830869|537169840|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
148913938|NCT00830869|537169841|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
148913939|NCT00830869|537169842|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
148913940|NCT00830869|537169843|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
148913941|NCT00830869|537169844|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
148913942|NCT00830869|537169833|FG000|Period 2: Part 2|Adverse Event|0|||
148913943|NCT00830869|537169834|FG001|Period 2: Part 2|Adverse Event|0|||
148913944|NCT00830869|537169835|FG002|Period 2: Part 2|Adverse Event|0|||
148913945|NCT00830869|537169836|FG003|Period 2: Part 2|Adverse Event|0|||
148913946|NCT00830869|537169837|FG004|Period 2: Part 2|Adverse Event|0|||
148913947|NCT00830869|537169838|FG005|Period 2: Part 2|Adverse Event|0|||
148913948|NCT00830869|537169839|FG006|Period 2: Part 2|Adverse Event|0|||
148913949|NCT00830869|537169840|FG007|Period 2: Part 2|Adverse Event|4|||
148913950|NCT00830869|537169841|FG008|Period 2: Part 2|Adverse Event|3|||
148913951|NCT00830869|537169842|FG009|Period 2: Part 2|Adverse Event|2|||
148913952|NCT00830869|537169843|FG010|Period 2: Part 2|Adverse Event|2|||
148913953|NCT00830869|537169844|FG011|Period 2: Part 2|Adverse Event|0|||
148913954|NCT00830869|537169833|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
148913955|NCT00830869|537169834|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
148913956|NCT00830869|537169835|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
148913957|NCT00830869|537169836|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
148913958|NCT00830869|537169837|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
148913959|NCT00830869|537169838|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
148913960|NCT00830869|537169839|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
148913961|NCT00830869|537169840|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
148913962|NCT00830869|537169841|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
148913963|NCT00830869|537169842|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
148913964|NCT00830869|537169843|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
148913965|NCT00830869|537169844|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
148913966|NCT00830869|537169833|FG000|Period 2: Part 2|Progressive disease|0|||
148913967|NCT00830869|537169834|FG001|Period 2: Part 2|Progressive disease|0|||
148913968|NCT00830869|537169835|FG002|Period 2: Part 2|Progressive disease|0|||
148913969|NCT00830869|537169836|FG003|Period 2: Part 2|Progressive disease|0|||
148913970|NCT00830869|537169837|FG004|Period 2: Part 2|Progressive disease|0|||
148913971|NCT00830869|537169838|FG005|Period 2: Part 2|Progressive disease|0|||
149146346|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
149146347|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
149146348|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
149146349|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
149146350|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
149146351|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
149146352|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
149146353|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
149146354|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
149146355|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
149146356|NCT00492752|538014751|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
149146357|NCT00492752|538014752|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
149146358|NCT00492752|538014753|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
149146359|NCT00492752|538014754|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
149146360|NCT01357655|538014755|FG000|Overall Study|Administrative Reason by Sponsor|45|||
149146361|NCT01357655|538014756|FG001|Overall Study|Administrative Reason by Sponsor|0|||
149146362|NCT01357655|538014755|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
149146363|NCT01357655|538014756|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149146364|NCT01357655|538014755|FG000|Overall Study|Disease Progression|1|||
149146365|NCT01357655|538014756|FG001|Overall Study|Disease Progression|0|||
149146366|NCT01357655|538014755|FG000|Overall Study|Lost to Follow-up|2|||
149146367|NCT01357655|538014756|FG001|Overall Study|Lost to Follow-up|0|||
149146368|NCT01357655|538014755|FG000|Overall Study|Maximum Clinical Benefit|2|||
149146369|NCT01357655|538014756|FG001|Overall Study|Maximum Clinical Benefit|0|||
149146370|NCT01357655|538014755|FG000|Overall Study|Reason Unspecified|1|||
149146371|NCT01357655|538014756|FG001|Overall Study|Reason Unspecified|0|||
149146372|NCT01357655|538014755|FG000|Overall Study|Study Drug Toxicity|11|||
149146373|NCT01357655|538014756|FG001|Overall Study|Study Drug Toxicity|0|||
149146374|NCT01357655|538014755|FG000|Overall Study|Subject Withdrew Consent|1|||
149146375|NCT01357655|538014756|FG001|Overall Study|Subject Withdrew Consent|0|||
148913972|NCT00830869|537169839|FG006|Period 2: Part 2|Progressive disease|0|||
149146376|NCT05003622|538014757|FG000|Overall Study|Progressive disease|2|||
149146377|NCT05003622|538014757|FG000|Overall Study|Withdrawal by Subject|1|||
149146378|NCT00390546|538016102|FG000|Overall Study|Renal impairment|1|||
148671352|NCT05554471|536267106|FG001|Overall Study|Physician Decision|1|||
148913973|NCT00830869|537169840|FG007|Period 2: Part 2|Progressive disease|14|||
148913974|NCT00830869|537169841|FG008|Period 2: Part 2|Progressive disease|11|||
148913975|NCT00830869|537169842|FG009|Period 2: Part 2|Progressive disease|12|||
149146379|NCT00390546|538016103|FG001|Overall Study|Renal impairment|0|||
149146380|NCT00390546|538016102|FG000|Overall Study|Physician Decision|5|||
149146381|NCT00390546|538016103|FG001|Overall Study|Physician Decision|5|||
149146382|NCT01417195|538016104|FG000|Overall Study|Stimulation failure|1|||
149146383|NCT01417195|538016105|FG001|Overall Study|Stimulation failure|0|||
149146384|NCT01417195|538016104|FG000|Overall Study|No embryos for transfer|0|||
149146385|NCT01417195|538016105|FG001|Overall Study|No embryos for transfer|1|||
149146386|NCT01417195|538016104|FG000|Overall Study|No transfer due to risk of OHSS|1|||
149146387|NCT01417195|538016105|FG001|Overall Study|No transfer due to risk of OHSS|0|||
149146388|NCT01417195|538016104|FG000|Overall Study|No transfer due to elevated progesterone|1|||
149146389|NCT01417195|538016105|FG001|Overall Study|No transfer due to elevated progesterone|0|||
149146390|NCT03357731|538016106|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
149146391|NCT03357731|538016107|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
149146392|NCT03357731|538016108|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
149146393|NCT03357731|538016109|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
149146394|NCT03357731|538016110|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
149146395|NCT03357731|538016111|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
149146396|NCT03357731|538016106|FG000|Overall Study|Acute bradycardia and hypotension|0|||
149146397|NCT03357731|538016107|FG001|Overall Study|Acute bradycardia and hypotension|0|||
149146398|NCT03357731|538016108|FG002|Overall Study|Acute bradycardia and hypotension|0|||
149146399|NCT03357731|538016109|FG003|Overall Study|Acute bradycardia and hypotension|1|||
149146400|NCT03357731|538016110|FG004|Overall Study|Acute bradycardia and hypotension|0|||
149146401|NCT03357731|538016111|FG005|Overall Study|Acute bradycardia and hypotension|0|||
149146402|NCT03357731|538016106|FG000|Overall Study|Adverse Event|0|||
149146403|NCT03357731|538016107|FG001|Overall Study|Adverse Event|0|||
149146404|NCT03357731|538016108|FG002|Overall Study|Adverse Event|0|||
149146405|NCT03357731|538016109|FG003|Overall Study|Adverse Event|0|||
149146406|NCT03357731|538016110|FG004|Overall Study|Adverse Event|0|||
149146407|NCT03357731|538016111|FG005|Overall Study|Adverse Event|1|||
149146408|NCT03357731|538016106|FG000|Overall Study|Hypotension|0|||
149146409|NCT03357731|538016107|FG001|Overall Study|Hypotension|0|||
149146410|NCT03357731|538016108|FG002|Overall Study|Hypotension|1|||
149146411|NCT03357731|538016109|FG003|Overall Study|Hypotension|1|||
149146412|NCT03357731|538016110|FG004|Overall Study|Hypotension|0|||
149146413|NCT03357731|538016111|FG005|Overall Study|Hypotension|0|||
149146414|NCT03357731|538016106|FG000|Overall Study|Lost to Follow-up|0|||
149146415|NCT03357731|538016107|FG001|Overall Study|Lost to Follow-up|0|||
149146416|NCT03357731|538016108|FG002|Overall Study|Lost to Follow-up|0|||
149146417|NCT03357731|538016109|FG003|Overall Study|Lost to Follow-up|1|||
149146418|NCT03357731|538016110|FG004|Overall Study|Lost to Follow-up|0|||
149146419|NCT03357731|538016111|FG005|Overall Study|Lost to Follow-up|0|||
149146420|NCT01773109|538016112|FG000|Overall Study|Symptomatic Progression|2|||
149146421|NCT01773109|538016112|FG000|Overall Study|Death|1|||
149146422|NCT04766021|538016115|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
149146423|NCT04766021|538016115|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
149146424|NCT01230242|538016119|FG000|Overall Study|Physician Decision|2|||
149146425|NCT01230242|538016119|FG000|Overall Study|Withdrawal by Subject|1|||
149146426|NCT02256540|538016120|FG000|Overall Study|Withdrawal by Subject|0|||
149146427|NCT02256540|538016121|FG001|Overall Study|Withdrawal by Subject|1|||
149146428|NCT02256540|538016122|FG002|Overall Study|Withdrawal by Subject|1|||
149146429|NCT02256540|538016120|FG000|Overall Study|Back pain preventing exercise|0|||
149146430|NCT02256540|538016121|FG001|Overall Study|Back pain preventing exercise|0|||
149146431|NCT02256540|538016122|FG002|Overall Study|Back pain preventing exercise|1|||
149146432|NCT03923426|538016123|FG000|Overall Study|Other|19|||
149146433|NCT03923426|538016123|FG000|Overall Study|Lost to Follow-up|16|||
149146434|NCT03923426|538016123|FG000|Overall Study|Death|107|||
149146435|NCT03923426|538016123|FG000|Overall Study|Incomplete response to question|13|||
149146436|NCT01918007|538016124|FG000|Overall Study|Baseline oximetry not acceptable|11|||
149146437|NCT01918007|538016125|FG001|Overall Study|Baseline oximetry not acceptable|7|||
149146438|NCT01918007|538016124|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
149146439|NCT01918007|538016125|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
149146440|NCT01918007|538016124|FG000|Overall Study|Lost to Follow-up|4|||
149146441|NCT01918007|538016125|FG001|Overall Study|Lost to Follow-up|7|||
149146442|NCT00441974|538016127|FG000|Overall Study|Adverse Event|6|||
149146443|NCT00441974|538016127|FG000|Overall Study|Consent Withdrawn|35|||
149146444|NCT00441974|538016127|FG000|Overall Study|Lost to Follow-up|80|||
149146445|NCT00441974|538016127|FG000|Overall Study|Protocol Violation|7|||
149146446|NCT02700412|538016130|FG000|Overall Study|Adverse Event|6|||
149146447|NCT02700412|538016130|FG000|Overall Study|Death|1|||
149146448|NCT02700412|538016130|FG000|Overall Study|Lack of Efficacy|19|||
149146449|NCT02700412|538016130|FG000|Overall Study|Protocol Violation|5|||
149146450|NCT02700412|538016130|FG000|Overall Study|Withdrawal by Subject|2|||
149146451|NCT00530270|538016132|FG000|Overall Study|Protocol Violation|1|||
149146452|NCT00530270|538016133|FG001|Overall Study|Protocol Violation|0|||
149146453|NCT01923285|538016136|FG000|Overall Study|Withdrawal by Subject|7|||
149146454|NCT01923285|538016137|FG001|Overall Study|Withdrawal by Subject|6|||
149146455|NCT01356407|538016141|FG000|Overall Study|Lost to Follow-up|2|||
149146456|NCT01356407|538016142|FG001|Overall Study|Lost to Follow-up|0|||
149146457|NCT01356407|538016141|FG000|Overall Study|Patient Withdrew Consent|2|||
149146458|NCT01356407|538016142|FG001|Overall Study|Patient Withdrew Consent|1|||
149146459|NCT01356407|538016141|FG000|Overall Study|Could not afford IMP administration|0|||
149146460|NCT01356407|538016142|FG001|Overall Study|Could not afford IMP administration|1|||
149146461|NCT01356407|538016141|FG000|Overall Study|Not complete Endoscopy|2|||
149146462|NCT01356407|538016142|FG001|Overall Study|Not complete Endoscopy|2|||
149146463|NCT01309659|538016145|FG000|Overall Study|Protocol Violation|0|||
149146464|NCT01309659|538016146|FG001|Overall Study|Protocol Violation|1|||
149146465|NCT02018822|538016147|FG000|Overall Study|filling replaced by crown|0|||
149146466|NCT02018822|538016148|FG001|Overall Study|filling replaced by crown|1|||
149146467|NCT02018822|538016149|FG002|Overall Study|filling replaced by crown|0|||
149146468|NCT02018822|538016147|FG000|Overall Study|Physician Decision|0|||
149146469|NCT02018822|538016148|FG001|Overall Study|Physician Decision|1|||
149146470|NCT02018822|538016149|FG002|Overall Study|Physician Decision|1|||
149146471|NCT02018822|538016147|FG000|Overall Study|Lost to Follow-up|6|||
149146472|NCT02018822|538016148|FG001|Overall Study|Lost to Follow-up|6|||
149146473|NCT02018822|538016149|FG002|Overall Study|Lost to Follow-up|5|||
149146474|NCT02285777|538016150|FG000|Overall Study|Withdrawal by Subject|1|||
149146475|NCT02285777|538016151|FG001|Overall Study|Withdrawal by Subject|1|||
149146476|NCT02285777|538016150|FG000|Overall Study|Lost to Follow-up|4|||
149146477|NCT02285777|538016151|FG001|Overall Study|Lost to Follow-up|2|||
149146478|NCT03201458|538016152|FG000|Overall Study|No longer eligible|2|||
149146479|NCT03201458|538016153|FG001|Overall Study|No longer eligible|5|||
149146480|NCT03201458|538016152|FG000|Overall Study|Health event before starting|1|||
149146481|NCT03201458|538016153|FG001|Overall Study|Health event before starting|0|||
149146482|NCT03201458|538016152|FG000|Overall Study|Physician Decision|1|||
149146483|NCT03201458|538016153|FG001|Overall Study|Physician Decision|0|||
149146484|NCT00715026|538016156|FG000|Overall Study|Withdrawal by Subject|5|||
149146485|NCT00715026|538016156|FG000|Overall Study|Lost to Follow-up|3|||
149146486|NCT00715026|538016156|FG000|Overall Study|Protocol Violation|1|||
149146487|NCT00715026|538016156|FG000|Overall Study|Surgery done on non-study consented hip|1|||
149146488|NCT00552175|538016157|FG000|Overall Study|Lack of Efficacy|2|||
149146489|NCT00552175|538016158|FG001|Overall Study|Lack of Efficacy|0|||
149146490|NCT00552175|538016159|FG002|Overall Study|Lack of Efficacy|1|||
149146491|NCT00552175|538016157|FG000|Overall Study|Adverse Event|9|||
149146492|NCT00552175|538016158|FG001|Overall Study|Adverse Event|9|||
149146493|NCT00552175|538016159|FG002|Overall Study|Adverse Event|10|||
149146494|NCT00552175|538016157|FG000|Overall Study|Withdrawal by Subject|2|||
149146495|NCT00552175|538016158|FG001|Overall Study|Withdrawal by Subject|2|||
149146496|NCT00552175|538016159|FG002|Overall Study|Withdrawal by Subject|1|||
149146497|NCT00552175|538016157|FG000|Overall Study|Lost to Follow-up|0|||
149146498|NCT00552175|538016158|FG001|Overall Study|Lost to Follow-up|0|||
149146499|NCT00552175|538016159|FG002|Overall Study|Lost to Follow-up|1|||
149146500|NCT00552175|538016157|FG000|Overall Study|Entry Criteria Not Met|1|||
149146501|NCT00552175|538016158|FG001|Overall Study|Entry Criteria Not Met|1|||
149146502|NCT00552175|538016159|FG002|Overall Study|Entry Criteria Not Met|0|||
149146503|NCT00552175|538016157|FG000|Overall Study|Reason Not Specified|3|||
149146504|NCT00552175|538016158|FG001|Overall Study|Reason Not Specified|1|||
149146505|NCT00552175|538016159|FG002|Overall Study|Reason Not Specified|1|||
149146506|NCT00750737|538016160|FG000|Overall Study|Withdrawal by Subject|3|||
149146507|NCT00750737|538016161|FG001|Overall Study|Withdrawal by Subject|3|||
149146508|NCT02614859|538016162|FG000|Overall Study|Physician Decision|0|||
149146509|NCT02614859|538016163|FG001|Overall Study|Physician Decision|1|||
149146510|NCT03699007|538016165|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
149146511|NCT03699007|538016166|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
149146512|NCT03699007|538016165|FG000|6-month Follow Up|Lost to Follow-up|2|||
149146513|NCT03699007|538016166|FG001|6-month Follow Up|Lost to Follow-up|3|||
149146514|NCT01389752|538016167|FG000|Study Period 1|Sponsor decision|0|||
149146515|NCT01389752|538016168|FG001|Study Period 1|Sponsor decision|2|||
149146516|NCT01389752|538016167|FG000|Study Period 2|Sponsor decision|1|||
149146517|NCT01389752|538016168|FG001|Study Period 2|Sponsor decision|0|||
149146518|NCT03259074|538016169|FG000|Overall Study|Adverse Event|9|||
149146519|NCT03259074|538016170|FG001|Overall Study|Adverse Event|12|||
149146520|NCT03259074|538016171|FG002|Overall Study|Adverse Event|8|||
149146521|NCT03259074|538016169|FG000|Overall Study|Death|1|||
149146522|NCT03259074|538016170|FG001|Overall Study|Death|1|||
149146523|NCT03259074|538016171|FG002|Overall Study|Death|3|||
149146524|NCT03259074|538016169|FG000|Overall Study|Lost to Follow-up|2|||
149146525|NCT03259074|538016170|FG001|Overall Study|Lost to Follow-up|4|||
149146526|NCT03259074|538016171|FG002|Overall Study|Lost to Follow-up|3|||
149146527|NCT03259074|538016169|FG000|Overall Study|New Therapy For Study Indication|1|||
149146528|NCT03259074|538016170|FG001|Overall Study|New Therapy For Study Indication|2|||
149146529|NCT03259074|538016171|FG002|Overall Study|New Therapy For Study Indication|2|||
148913976|NCT00830869|537169843|FG010|Period 2: Part 2|Progressive disease|8|||
148913977|NCT00830869|537169844|FG011|Period 2: Part 2|Progressive disease|15|||
148913978|NCT00830869|537169833|FG000|Period 2: Part 2|Other|0|||
149146530|NCT03259074|538016169|FG000|Overall Study|Physician Decision|4|||
149146531|NCT03259074|538016170|FG001|Overall Study|Physician Decision|12|||
149146532|NCT03259074|538016171|FG002|Overall Study|Physician Decision|10|||
149146533|NCT03259074|538016169|FG000|Overall Study|Pregnancy|1|||
149146534|NCT03259074|538016170|FG001|Overall Study|Pregnancy|1|||
149146535|NCT03259074|538016171|FG002|Overall Study|Pregnancy|0|||
149146536|NCT03259074|538016169|FG000|Overall Study|Progressive Disease|1|||
149146537|NCT03259074|538016170|FG001|Overall Study|Progressive Disease|0|||
149146538|NCT03259074|538016171|FG002|Overall Study|Progressive Disease|0|||
149146539|NCT03259074|538016169|FG000|Overall Study|Protocol Deviation|1|||
149146540|NCT03259074|538016170|FG001|Overall Study|Protocol Deviation|1|||
149146541|NCT03259074|538016171|FG002|Overall Study|Protocol Deviation|3|||
149146542|NCT03259074|538016169|FG000|Overall Study|Subject/Guardian Decision|13|||
149146543|NCT03259074|538016170|FG001|Overall Study|Subject/Guardian Decision|16|||
149146544|NCT03259074|538016171|FG002|Overall Study|Subject/Guardian Decision|14|||
149146545|NCT00053417|538016182|FG000|Overall Study|Adverse Event|1|||
149146546|NCT00053417|538016183|FG001|Overall Study|Adverse Event|0|||
149146547|NCT00053417|538016184|FG002|Overall Study|Adverse Event|1|||
149146548|NCT00053417|538016185|FG003|Overall Study|Adverse Event|5|||
149146549|NCT00053417|538016182|FG000|Overall Study|Non-Compliance|0|||
149146550|NCT00053417|538016183|FG001|Overall Study|Non-Compliance|0|||
149146551|NCT00053417|538016184|FG002|Overall Study|Non-Compliance|0|||
149146552|NCT00053417|538016185|FG003|Overall Study|Non-Compliance|1|||
149146553|NCT00053417|538016182|FG000|Overall Study|Withdrawal by Subject|0|||
149146554|NCT00053417|538016183|FG001|Overall Study|Withdrawal by Subject|1|||
149146555|NCT00053417|538016184|FG002|Overall Study|Withdrawal by Subject|0|||
149146556|NCT00053417|538016185|FG003|Overall Study|Withdrawal by Subject|0|||
149146557|NCT00053417|538016182|FG000|Overall Study|Lost to Follow-up|1|||
149146558|NCT00053417|538016183|FG001|Overall Study|Lost to Follow-up|1|||
149146559|NCT00053417|538016184|FG002|Overall Study|Lost to Follow-up|0|||
149146560|NCT00053417|538016185|FG003|Overall Study|Lost to Follow-up|0|||
149146561|NCT00705783|538016186|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
149146562|NCT00705783|538016187|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
149146563|NCT00705783|538016188|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
149146564|NCT00705783|538016186|FG000|Conversion Phase|Lost to Follow-up|13|||
149146565|NCT00705783|538016187|FG001|Conversion Phase|Lost to Follow-up|0|||
149146566|NCT00705783|538016188|FG002|Conversion Phase|Lost to Follow-up|0|||
149146567|NCT00705783|538016186|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
149146568|NCT00705783|538016187|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
149146569|NCT00705783|538016188|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
149146570|NCT00705783|538016186|FG000|Conversion Phase|Withdrawn by Investigator|4|||
149146571|NCT00705783|538016187|FG001|Conversion Phase|Withdrawn by Investigator|0|||
149146572|NCT00705783|538016188|FG002|Conversion Phase|Withdrawn by Investigator|0|||
149146573|NCT00705783|538016186|FG000|Conversion Phase|Withdrew Consent|24|||
149146574|NCT00705783|538016187|FG001|Conversion Phase|Withdrew Consent|0|||
149146575|NCT00705783|538016188|FG002|Conversion Phase|Withdrew Consent|0|||
149146576|NCT00705783|538016186|FG000|Conversion Phase|Protocol Deviation|2|||
149146577|NCT00705783|538016187|FG001|Conversion Phase|Protocol Deviation|0|||
149146578|NCT00705783|538016188|FG002|Conversion Phase|Protocol Deviation|0|||
149146579|NCT00705783|538016186|FG000|Conversion Phase|Adverse Event|11|||
149146580|NCT00705783|538016187|FG001|Conversion Phase|Adverse Event|0|||
149146581|NCT00705783|538016188|FG002|Conversion Phase|Adverse Event|0|||
149146582|NCT00705783|538016186|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
149146583|NCT00705783|538016187|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
149146584|NCT00705783|538016188|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
149146585|NCT00705783|538016186|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
149146586|NCT00705783|538016187|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
149146587|NCT00705783|538016188|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
149146588|NCT00705783|538016186|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
149146589|NCT00705783|538016187|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
149146590|NCT00705783|538016188|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
149146591|NCT00705783|538016186|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
148913979|NCT00830869|537169834|FG001|Period 2: Part 2|Other|0|||
149146592|NCT00705783|538016187|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
149146593|NCT00705783|538016188|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
149146594|NCT00705783|538016186|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
149146595|NCT00705783|538016187|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
149146596|NCT00705783|538016188|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
149146597|NCT00705783|538016186|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
149146598|NCT00705783|538016187|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
148913980|NCT00830869|537169835|FG002|Period 2: Part 2|Other|0|||
149146599|NCT00705783|538016188|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
149146600|NCT00705783|538016186|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
149146601|NCT00705783|538016187|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
149146602|NCT00705783|538016188|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
149146603|NCT00705783|538016186|FG000|Oral Stabilization Phase|Adverse Event|14|||
149146604|NCT00705783|538016187|FG001|Oral Stabilization Phase|Adverse Event|0|||
149146605|NCT00705783|538016188|FG002|Oral Stabilization Phase|Adverse Event|0|||
149146606|NCT00705783|538016186|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
149146607|NCT00705783|538016187|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149146608|NCT00705783|538016188|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149146609|NCT00705783|538016186|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
149146610|NCT00705783|538016187|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149146611|NCT00705783|538016188|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149146612|NCT00705783|538016186|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
149146613|NCT00705783|538016187|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
149146614|NCT00705783|538016188|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
149146615|NCT00705783|538016186|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
149146616|NCT00705783|538016187|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
149146617|NCT00705783|538016188|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
149146618|NCT00705783|538016186|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
149146619|NCT00705783|538016187|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
149146620|NCT00705783|538016188|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
149146621|NCT00705783|538016186|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
149146622|NCT00705783|538016187|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
149146623|NCT00705783|538016188|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
149146624|NCT00705783|538016186|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
149146625|NCT00705783|538016187|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
149146626|NCT00705783|538016188|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
149146627|NCT00705783|538016186|FG000|Depot Stabilization Phase|Adverse Event|17|||
149146628|NCT00705783|538016187|FG001|Depot Stabilization Phase|Adverse Event|0|||
149146629|NCT00705783|538016188|FG002|Depot Stabilization Phase|Adverse Event|0|||
149146630|NCT00705783|538016186|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
149146631|NCT00705783|538016187|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149146632|NCT00705783|538016188|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149146633|NCT00705783|538016186|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
149146634|NCT00705783|538016187|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149146635|NCT00705783|538016188|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149146636|NCT00705783|538016186|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
149146637|NCT00705783|538016187|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
149146638|NCT00705783|538016188|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
149146639|NCT00705783|538016186|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
149146640|NCT00705783|538016187|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
149146641|NCT00705783|538016188|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
149146642|NCT00705783|538016186|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
149146643|NCT00705783|538016187|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
149146644|NCT00705783|538016188|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
149146645|NCT00705783|538016186|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
149146646|NCT00705783|538016187|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
148913981|NCT00830869|537169836|FG003|Period 2: Part 2|Other|0|||
148913982|NCT00830869|537169837|FG004|Period 2: Part 2|Other|0|||
148913983|NCT00830869|537169838|FG005|Period 2: Part 2|Other|0|||
148913984|NCT00830869|537169839|FG006|Period 2: Part 2|Other|0|||
149146647|NCT00705783|538016188|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
149146648|NCT00705783|538016186|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
149146649|NCT00705783|538016187|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
149146650|NCT00705783|538016188|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
149146651|NCT00705783|538016186|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
149146652|NCT00705783|538016187|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
149146653|NCT00705783|538016188|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
149146654|NCT00705783|538016186|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
149146655|NCT00705783|538016187|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
149146656|NCT00705783|538016188|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
149146657|NCT00705783|538016186|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
149146658|NCT00705783|538016187|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
149146659|NCT00705783|538016188|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
149146660|NCT00705783|538016186|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
149146661|NCT00705783|538016187|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
149146662|NCT00705783|538016188|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
149146663|NCT02184195|538016189|FG000|Overall Study|Patient decision|5|||
149146664|NCT02184195|538016190|FG001|Overall Study|Patient decision|2|||
149146665|NCT02184195|538016189|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149146666|NCT02184195|538016190|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149146667|NCT02184195|538016189|FG000|Overall Study|Death|67|||
149146668|NCT02184195|538016190|FG001|Overall Study|Death|44|||
149146669|NCT02184195|538016189|FG000|Overall Study|Lost to Follow-up|1|||
149146670|NCT02184195|538016190|FG001|Overall Study|Lost to Follow-up|5|||
149146671|NCT02184195|538016189|FG000|Overall Study|Other|0|||
149146672|NCT02184195|538016190|FG001|Overall Study|Other|3|||
149146673|NCT02285998|538016193|FG000|Overall Study|Adverse Event|9|||
149146674|NCT02285998|538016194|FG001|Overall Study|Adverse Event|8|||
149146675|NCT02285998|538016193|FG000|Overall Study|Physician Decision|1|||
149146676|NCT02285998|538016194|FG001|Overall Study|Physician Decision|2|||
149146677|NCT02285998|538016193|FG000|Overall Study|Lost to Follow-up|176|||
149146678|NCT02285998|538016194|FG001|Overall Study|Lost to Follow-up|172|||
149146679|NCT02285998|538016193|FG000|Overall Study|Withdrawal by Subject|53|||
149146680|NCT02285998|538016194|FG001|Overall Study|Withdrawal by Subject|61|||
149146681|NCT02285998|538016193|FG000|Overall Study|Other Reasons|7|||
149146682|NCT02285998|538016194|FG001|Overall Study|Other Reasons|10|||
148913985|NCT00830869|537169840|FG007|Period 2: Part 2|Other|0|||
148913986|NCT00830869|537169841|FG008|Period 2: Part 2|Other|0|||
149146683|NCT00545298|538016195|FG000|Overall Study|Issues with Standard of Care|2|||
148913987|NCT00830869|537169842|FG009|Period 2: Part 2|Other|1|||
148913988|NCT00830869|537169843|FG010|Period 2: Part 2|Other|0|||
148913989|NCT00830869|537169844|FG011|Period 2: Part 2|Other|0|||
148913990|NCT00281658|537169852|FG000|Randomized Phase|Adverse Event|0|||
148913991|NCT00281658|537169853|FG001|Randomized Phase|Adverse Event|2|||
148913992|NCT00281658|537169854|FG002|Randomized Phase|Adverse Event|0|||
148913993|NCT00281658|537169855|FG003|Randomized Phase|Adverse Event|0|||
148913994|NCT00281658|537169852|FG000|Randomized Phase|Lost to Follow-up|34|||
148913995|NCT00281658|537169853|FG001|Randomized Phase|Lost to Follow-up|27|||
148913996|NCT00281658|537169854|FG002|Randomized Phase|Lost to Follow-up|0|||
148913997|NCT00281658|537169855|FG003|Randomized Phase|Lost to Follow-up|0|||
148913998|NCT00281658|537169852|FG000|Randomized Phase|Withdrawal by Subject|8|||
148913999|NCT00281658|537169853|FG001|Randomized Phase|Withdrawal by Subject|7|||
148914000|NCT00281658|537169854|FG002|Randomized Phase|Withdrawal by Subject|0|||
148914001|NCT00281658|537169855|FG003|Randomized Phase|Withdrawal by Subject|0|||
148914002|NCT00281658|537169852|FG000|Randomized Phase|Study closed/terminated|1|||
148914003|NCT00281658|537169853|FG001|Randomized Phase|Study closed/terminated|1|||
148914004|NCT00281658|537169854|FG002|Randomized Phase|Study closed/terminated|0|||
148914005|NCT00281658|537169855|FG003|Randomized Phase|Study closed/terminated|0|||
148914006|NCT00281658|537169852|FG000|Randomized Phase|Disease progression|36|||
148914007|NCT00281658|537169853|FG001|Randomized Phase|Disease progression|27|||
149146684|NCT00545298|538016196|FG001|Overall Study|Issues with Standard of Care|0|||
148914008|NCT00281658|537169854|FG002|Randomized Phase|Disease progression|0|||
149146685|NCT00545298|538016197|FG002|Overall Study|Issues with Standard of Care|1|||
149146686|NCT03029143|538016203|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
148914009|NCT00281658|537169855|FG003|Randomized Phase|Disease progression|0|||
148914010|NCT00281658|537169852|FG000|Randomized Phase|Physician Decision|1|||
148914011|NCT00281658|537169853|FG001|Randomized Phase|Physician Decision|1|||
148914012|NCT00281658|537169854|FG002|Randomized Phase|Physician Decision|0|||
148914013|NCT00281658|537169855|FG003|Randomized Phase|Physician Decision|0|||
149146687|NCT03029143|538016204|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
149146688|NCT03029143|538016205|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
149146689|NCT03029143|538016203|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
149146690|NCT03029143|538016204|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
149146691|NCT03029143|538016205|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
149146692|NCT03029143|538016203|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
149146693|NCT03029143|538016204|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
149146694|NCT03029143|538016205|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
149146695|NCT03029143|538016203|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
149146696|NCT03029143|538016204|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
149146697|NCT03029143|538016205|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
149146698|NCT03029143|538016203|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
149146699|NCT03029143|538016204|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
149146700|NCT03029143|538016205|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
149146701|NCT03029143|538016203|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
149146702|NCT03029143|538016204|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
149146703|NCT03029143|538016205|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
149146704|NCT03029143|538016203|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
149146705|NCT03029143|538016204|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
149146706|NCT03029143|538016205|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
149146707|NCT03029143|538016203|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149146708|NCT03029143|538016204|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149146709|NCT03029143|538016205|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
149146710|NCT03029143|538016203|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
149146711|NCT03029143|538016204|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
149146712|NCT03029143|538016205|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
149146713|NCT03029143|538016203|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149146714|NCT03029143|538016204|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
149146715|NCT03029143|538016205|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
149146716|NCT03029143|538016203|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
149146717|NCT03029143|538016204|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
149146718|NCT03029143|538016205|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
149146719|NCT00974675|538016208|FG000|Overall Study|Adverse Event|2|||
149146720|NCT00974675|538016209|FG001|Overall Study|Adverse Event|1|||
149146721|NCT00974675|538016210|FG002|Overall Study|Adverse Event|1|||
149146722|NCT00974675|538016211|FG003|Overall Study|Adverse Event|1|||
149146723|NCT00974675|538016208|FG000|Overall Study|Physician Decision|0|||
149146724|NCT00974675|538016209|FG001|Overall Study|Physician Decision|0|||
149146725|NCT00974675|538016210|FG002|Overall Study|Physician Decision|1|||
149146726|NCT00974675|538016211|FG003|Overall Study|Physician Decision|0|||
149146727|NCT00974675|538016208|FG000|Overall Study|Participant on holiday; unable to attend|0|||
149146728|NCT00974675|538016209|FG001|Overall Study|Participant on holiday; unable to attend|0|||
149146729|NCT00974675|538016210|FG002|Overall Study|Participant on holiday; unable to attend|0|||
149146730|NCT00974675|538016211|FG003|Overall Study|Participant on holiday; unable to attend|1|||
149146731|NCT04744207|538016212|FG000|Treatment|Withdrawal by Subject|2|||
149146732|NCT04744207|538016213|FG001|Treatment|Withdrawal by Subject|0|||
149146733|NCT04744207|538016212|FG000|Treatment|Adverse Event|1|||
149146734|NCT04744207|538016213|FG001|Treatment|Adverse Event|2|||
149146735|NCT01394627|538016214|FG000|First Intervention (1 Day)|poor intravenous access|0|||
149146736|NCT01394627|538016215|FG001|First Intervention (1 Day)|poor intravenous access|1|||
149146737|NCT01394627|538016214|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
149146738|NCT01394627|538016215|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
149146739|NCT01617070|538016216|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
149146740|NCT04544475|538016222|FG000|Overall Study|Withdrawal by Subject|1|||
149146741|NCT04544475|538016223|FG001|Overall Study|Withdrawal by Subject|3|||
149146742|NCT00777101|538016224|FG000|Overall Study|Death|48|||
149146743|NCT00777101|538016225|FG001|Overall Study|Death|43|||
149146744|NCT00777101|538016224|FG000|Overall Study|Withdrawal by Subject|11|||
148804965|NCT03055013|536766614|FG000|Overall Study|Disease relapse|33|||
149146745|NCT00777101|538016225|FG001|Overall Study|Withdrawal by Subject|6|||
149146746|NCT00777101|538016224|FG000|Overall Study|Lost to Follow-up|2|||
149146747|NCT00777101|538016225|FG001|Overall Study|Lost to Follow-up|1|||
149146748|NCT00777101|538016224|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
149146749|NCT00777101|538016225|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
149146750|NCT00777101|538016224|FG000|Overall Study|Failed to Return|0|||
149146751|NCT00777101|538016225|FG001|Overall Study|Failed to Return|1|||
149146752|NCT00808236|538016226|FG000|Overall Study|Was not resuscitated|50|||
149146753|NCT00808236|538016227|FG001|Overall Study|Was not resuscitated|56|||
149146754|NCT00808236|538016226|FG000|Overall Study|Pre-defined exclusion|13|||
149146755|NCT00808236|538016227|FG001|Overall Study|Pre-defined exclusion|3|||
149146756|NCT00808236|538016226|FG000|Overall Study|Lost to Follow-up|1|||
149146757|NCT00808236|538016227|FG001|Overall Study|Lost to Follow-up|1|||
149146758|NCT00808236|538016226|FG000|Overall Study|Physician Decision|0|||
149146759|NCT00808236|538016227|FG001|Overall Study|Physician Decision|1|||
149146760|NCT00808236|538016226|FG000|Overall Study|Death|18|||
149146761|NCT00808236|538016227|FG001|Overall Study|Death|30|||
149146762|NCT00961220|538016228|FG000|Overall Study|Adverse Event|3|||
149146763|NCT00961220|538016228|FG000|Overall Study|Lack of Efficacy|1|||
149146764|NCT00961220|538016228|FG000|Overall Study|No IV access for O6BG|1|||
149146765|NCT00961220|538016228|FG000|Overall Study|O6BG no longer supplied|1|||
149146766|NCT00961220|538016228|FG000|Overall Study|Complete Response prior to 12 courses|1|||
149146767|NCT05376215|538016229|FG000|Overall Study|Withdrawal by Subject|2|||
149146768|NCT05376215|538016230|FG001|Overall Study|Withdrawal by Subject|1|||
149146769|NCT05376215|538016229|FG000|Overall Study|Lost to Follow-up|0|||
149146770|NCT05376215|538016230|FG001|Overall Study|Lost to Follow-up|1|||
149146771|NCT00282334|538016234|FG000|Overall Study|Withdrawal by Subject|8|||
149146772|NCT00282334|538016235|FG001|Overall Study|Withdrawal by Subject|5|||
149146773|NCT01301950|538016239|FG000|Overall Study|Surgery was cancelled by patient|0|||
149146774|NCT01301950|538016240|FG001|Overall Study|Surgery was cancelled by patient|1|||
149146775|NCT04041284|538016241|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
149146776|NCT04041284|538016242|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
149146777|NCT04041284|538016241|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
149146778|NCT04041284|538016242|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
149146779|NCT04041284|538016241|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
149146780|NCT04041284|538016242|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
149146781|NCT04041284|538016241|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
149146782|NCT04041284|538016242|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
149146783|NCT04041284|538016241|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
149146784|NCT04041284|538016242|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
149146785|NCT04041284|538016241|FG000|DB Phase (12 Weeks)|Other than specified|1|||
149146786|NCT04041284|538016242|FG001|DB Phase (12 Weeks)|Other than specified|0|||
149146787|NCT04041284|538016241|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
149146788|NCT04041284|538016242|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
149146789|NCT04041284|538016241|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
149146790|NCT04041284|538016242|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
149146791|NCT04041284|538016241|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
149146792|NCT04041284|538016242|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
149146793|NCT04041284|538016241|FG000|OL Phase (12 Weeks)|Other than specified|6|||
148804966|NCT03055013|536766615|FG001|Overall Study|Disease relapse|0|||
148804967|NCT03055013|536766614|FG000|Overall Study|Withdrawal by Subject|28|||
149146794|NCT04041284|538016242|FG001|OL Phase (12 Weeks)|Other than specified|2|||
149146795|NCT00825162|538016243|FG000|Overall Study|Withdrawal by Subject|11|||
149146796|NCT00825162|538016244|FG001|Overall Study|Withdrawal by Subject|13|||
149146797|NCT00825162|538016245|FG002|Overall Study|Withdrawal by Subject|3|||
149146798|NCT00825162|538016243|FG000|Overall Study|Lost to Follow-up|9|||
149146799|NCT00825162|538016244|FG001|Overall Study|Lost to Follow-up|6|||
149146800|NCT00825162|538016245|FG002|Overall Study|Lost to Follow-up|3|||
149146801|NCT00825162|538016243|FG000|Overall Study|Physician Decision|2|||
149146802|NCT00825162|538016244|FG001|Overall Study|Physician Decision|0|||
149146803|NCT00825162|538016245|FG002|Overall Study|Physician Decision|0|||
149146804|NCT00825162|538016243|FG000|Overall Study|Move away from the study area|1|||
149146805|NCT00825162|538016244|FG001|Overall Study|Move away from the study area|0|||
149146806|NCT00825162|538016245|FG002|Overall Study|Move away from the study area|0|||
149146807|NCT00825162|538016243|FG000|Overall Study|Unable to attend the study visit|5|||
148804968|NCT03055013|536766615|FG001|Overall Study|Withdrawal by Subject|0|||
148804969|NCT03055013|536766614|FG000|Overall Study|Other complicating disease|5|||
148804970|NCT03055013|536766615|FG001|Overall Study|Other complicating disease|0|||
148804971|NCT03055013|536766614|FG000|Overall Study|Physician Decision|1|||
148804972|NCT03055013|536766615|FG001|Overall Study|Physician Decision|0|||
148804973|NCT03055013|536766614|FG000|Overall Study|Benign mass/non-RCC|4|||
148804974|NCT03055013|536766615|FG001|Overall Study|Benign mass/non-RCC|0|||
148804975|NCT03055013|536766614|FG000|Overall Study|Enrolled in another trial|1|||
148804976|NCT03055013|536766615|FG001|Overall Study|Enrolled in another trial|0|||
149146808|NCT00825162|538016244|FG001|Overall Study|Unable to attend the study visit|2|||
149146809|NCT00825162|538016245|FG002|Overall Study|Unable to attend the study visit|0|||
149146810|NCT02037295|538017639|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
149146811|NCT02037295|538017640|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
149146812|NCT02037295|538017641|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
149146813|NCT02037295|538017642|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
149146814|NCT01140451|538017643|FG000|Overall Study|Withdrawal by Subject|26|||
149146815|NCT01140451|538017644|FG001|Overall Study|Withdrawal by Subject|33|||
149146816|NCT01140451|538017643|FG000|Overall Study|Adverse Event|2|||
149146817|NCT01140451|538017644|FG001|Overall Study|Adverse Event|6|||
149146818|NCT01140451|538017643|FG000|Overall Study|Physician Decision|5|||
149146819|NCT01140451|538017644|FG001|Overall Study|Physician Decision|3|||
149146820|NCT01140451|538017643|FG000|Overall Study|Lost to Follow-up|2|||
149146821|NCT01140451|538017644|FG001|Overall Study|Lost to Follow-up|0|||
149146822|NCT01140451|538017643|FG000|Overall Study|Participants Planning Pregnancy|3|||
148671353|NCT05554471|536267105|FG000|Overall Study|Lost to Follow-up|2|||
148671354|NCT05554471|536267106|FG001|Overall Study|Lost to Follow-up|1|||
148804977|NCT03055013|536766614|FG000|Overall Study|Non-protocol therapy|1|||
148804978|NCT03055013|536766615|FG001|Overall Study|Non-protocol therapy|0|||
148804979|NCT03055013|536766614|FG000|Overall Study|Incompliance|1|||
148804980|NCT03055013|536766615|FG001|Overall Study|Incompliance|0|||
148804981|NCT03055013|536766614|FG000|Overall Study|Insurance issues|1|||
148804982|NCT03055013|536766615|FG001|Overall Study|Insurance issues|0|||
148804983|NCT03055013|536766614|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
148804984|NCT03055013|536766615|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
148804985|NCT03055013|536766614|FG000|Overall Study|Did not receive nivolumab|10|||
148804986|NCT03055013|536766615|FG001|Overall Study|Did not receive nivolumab|0|||
148804987|NCT03055013|536766614|FG000|Overall Study|Did not receive surgery|0|||
148804988|NCT03055013|536766615|FG001|Overall Study|Did not receive surgery|28|||
148804989|NCT03435055|536766616|FG000|Screening|Physician Decision|2|||
148804990|NCT03435055|536766616|FG000|Received Intervention|Did not complete nitrous administration|3|||
148804991|NCT03817528|536766623|FG000|Overall Study|Withdrawal by Subject|1|||
148804992|NCT03817528|536766623|FG000|Overall Study|Adverse Event|2|||
148804993|NCT01027949|536766629|FG000|Overall Study|Death|174|||
148804994|NCT01027949|536766629|FG000|Overall Study|Progressive Disease|163|||
148804995|NCT01027949|536766629|FG000|Overall Study|Adverse Event|172|||
148804996|NCT01027949|536766629|FG000|Overall Study|Withdrawal by Subject|113|||
148804997|NCT01027949|536766629|FG000|Overall Study|Lost to Follow-up|17|||
148804998|NCT01027949|536766629|FG000|Overall Study|Protocol Violation|13|||
148804999|NCT01027949|536766629|FG000|Overall Study|PI Decision|8|||
148805000|NCT01027949|536766629|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
148805001|NCT01027949|536766629|FG000|Overall Study|Non-compliance with Study Procedures|7|||
148805002|NCT01027949|536766629|FG000|Overall Study|Lung Transplant|5|||
148805003|NCT01027949|536766629|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
148805004|NCT01027949|536766629|FG000|Overall Study|Use of Excluded Medication|2|||
148805005|NCT01027949|536766629|FG000|Overall Study|Patient Self-discontinuation|1|||
148805006|NCT01027949|536766629|FG000|Overall Study|Pregnancy|1|||
148805007|NCT01027949|536766629|FG000|Overall Study|Surgery|1|||
148805008|NCT01712178|536766634|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
148805009|NCT01712178|536766635|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
148805010|NCT01712178|536766634|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
148805011|NCT01712178|536766635|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
148805012|NCT01712178|536766634|FG000|Overall Study|Lost to Follow-up|0|||
148805013|NCT01712178|536766635|FG001|Overall Study|Lost to Follow-up|1|||
148805014|NCT00856180|536766636|FG000|Overall Study|Adverse Event|4|||
148805015|NCT00856180|536766636|FG000|Overall Study|Progressive Disease|16|||
148805016|NCT00671749|536766637|FG000|Overall Study|Adverse Event|2|||
148805017|NCT00671749|536766637|FG000|Overall Study|Withdrawal by Subject|4|||
148805018|NCT00671749|536766637|FG000|Overall Study|Protocol Violation|1|||
148805019|NCT00671749|536766637|FG000|Overall Study|Lost to Follow-up|1|||
148805020|NCT00827567|536766638|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
148805021|NCT01259245|536766644|FG000|Overall Study|Withdrawal by Subject|27|||
148805022|NCT01259245|536766645|FG001|Overall Study|Withdrawal by Subject|24|||
148805023|NCT01259245|536766644|FG000|Overall Study|Death|1|||
148805024|NCT01259245|536766645|FG001|Overall Study|Death|2|||
148805025|NCT01200355|536766648|FG000|Overall Study|Death|7|||
148805026|NCT01200355|536766649|FG001|Overall Study|Death|2|||
148805027|NCT03466346|536766650|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
148805028|NCT03466346|536766651|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
148805029|NCT03466346|536766652|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
148805030|NCT03466346|536766653|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
148805031|NCT03466346|536766654|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
148805032|NCT03466346|536766650|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
148805033|NCT03466346|536766651|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
148805034|NCT03466346|536766652|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
148805035|NCT03466346|536766653|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
149146823|NCT01140451|538017644|FG001|Overall Study|Participants Planning Pregnancy|0|||
149146824|NCT00661531|538017650|FG000|Overall Study|Withdrawal by Subject|3|||
149146825|NCT03134599|538017651|FG000|Week 1|Lost to Follow-up|0|||
149146826|NCT03134599|538017652|FG001|Week 1|Lost to Follow-up|0|||
149146827|NCT03134599|538017653|FG002|Week 1|Lost to Follow-up|0|||
149146828|NCT03134599|538017654|FG003|Week 1|Lost to Follow-up|0|||
149146829|NCT03134599|538017655|FG004|Week 1|Lost to Follow-up|1|||
149146830|NCT03134599|538017656|FG005|Week 1|Lost to Follow-up|0|||
149146831|NCT03134599|538017651|FG000|Week 2|Lost to Follow-up|1|||
149146832|NCT03134599|538017652|FG001|Week 2|Lost to Follow-up|0|||
149146833|NCT03134599|538017653|FG002|Week 2|Lost to Follow-up|0|||
149146834|NCT03134599|538017654|FG003|Week 2|Lost to Follow-up|1|||
149146835|NCT03134599|538017655|FG004|Week 2|Lost to Follow-up|1|||
149146836|NCT03134599|538017656|FG005|Week 2|Lost to Follow-up|0|||
149146837|NCT03134599|538017651|FG000|Week 3|Lost to Follow-up|0|||
149146838|NCT03134599|538017652|FG001|Week 3|Lost to Follow-up|0|||
149146839|NCT03134599|538017653|FG002|Week 3|Lost to Follow-up|0|||
149146840|NCT03134599|538017654|FG003|Week 3|Lost to Follow-up|1|||
149146841|NCT03134599|538017655|FG004|Week 3|Lost to Follow-up|0|||
149146842|NCT03134599|538017656|FG005|Week 3|Lost to Follow-up|1|||
149146843|NCT01265615|538017657|FG000|Overall Study|Protocol Violation|2|||
149146844|NCT01265615|538017658|FG001|Overall Study|Protocol Violation|2|||
149146845|NCT01265615|538017659|FG002|Overall Study|Protocol Violation|4|||
149146846|NCT01265615|538017660|FG003|Overall Study|Protocol Violation|3|||
149146847|NCT00732303|538017672|FG000|Overall Study|Study Terminated|2|||
149146848|NCT01399788|538017681|FG000|First Intervention Period|Adverse Event|1|||
149146849|NCT01399788|538017682|FG001|First Intervention Period|Adverse Event|0|||
149146850|NCT02919436|538017684|FG000|Overall Study|Did not undergo surgery|16|||
149146851|NCT02919436|538017685|FG001|Overall Study|Did not undergo surgery|20|||
149146852|NCT02919436|538017684|FG000|Overall Study|Enrolled before trial registration|44|||
149146853|NCT02919436|538017685|FG001|Overall Study|Enrolled before trial registration|33|||
149146854|NCT00283595|538017686|FG000|Overall Study|Withdrawal by Subject|1|||
149146855|NCT00283595|538017687|FG001|Overall Study|Withdrawal by Subject|2|||
149146856|NCT04718974|538017691|FG000|Overall Study|Death|0|||
149146857|NCT04718974|538017692|FG001|Overall Study|Death|2|||
149146858|NCT04718974|538017691|FG000|Overall Study|Lost to Follow-up|10|||
149146859|NCT04718974|538017692|FG001|Overall Study|Lost to Follow-up|20|||
149146860|NCT04718974|538017691|FG000|Overall Study|Transferred out|2|||
149146861|NCT04718974|538017692|FG001|Overall Study|Transferred out|4|||
149146862|NCT02409290|538017693|FG000|Overall Study|Protocol Violation|3|||
149146863|NCT02409290|538017694|FG001|Overall Study|Protocol Violation|6|||
149146864|NCT02409290|538017695|FG002|Overall Study|Protocol Violation|9|||
149146865|NCT02409290|538017696|FG003|Overall Study|Protocol Violation|4|||
149146866|NCT02409290|538017693|FG000|Overall Study|No positive culture/no baseline sample|3|||
149146867|NCT02409290|538017694|FG001|Overall Study|No positive culture/no baseline sample|9|||
149146868|NCT02409290|538017695|FG002|Overall Study|No positive culture/no baseline sample|6|||
149146869|NCT02409290|538017696|FG003|Overall Study|No positive culture/no baseline sample|5|||
149146870|NCT02409290|538017693|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
149146871|NCT02409290|538017694|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
149146872|NCT02409290|538017695|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
149146873|NCT02409290|538017696|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
149146874|NCT02121262|538017702|FG000|Overall Study|Adverse Event|6|||
149146875|NCT02121262|538017703|FG001|Overall Study|Adverse Event|3|||
149146876|NCT02121262|538017702|FG000|Overall Study|Lack of Efficacy|3|||
149146877|NCT02121262|538017703|FG001|Overall Study|Lack of Efficacy|0|||
149146878|NCT02121262|538017702|FG000|Overall Study|Personal Reasons|19|||
149146879|NCT02121262|538017703|FG001|Overall Study|Personal Reasons|5|||
149146880|NCT02121262|538017702|FG000|Overall Study|Protocol Violation|1|||
149146881|NCT02121262|538017703|FG001|Overall Study|Protocol Violation|1|||
149146882|NCT02121262|538017702|FG000|Overall Study|Participant Dropped-out|0|||
149146883|NCT02121262|538017703|FG001|Overall Study|Participant Dropped-out|1|||
149146884|NCT02121262|538017702|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
149146885|NCT02121262|538017703|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
149146886|NCT02121262|538017702|FG000|Overall Study|Consent Withdrawn|1|||
148914014|NCT00281658|537169852|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
148914015|NCT00281658|537169853|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
148914016|NCT00281658|537169854|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
148914017|NCT00281658|537169855|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
148914018|NCT00281658|537169852|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
148914019|NCT00281658|537169853|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
148914020|NCT00281658|537169854|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
148914021|NCT00281658|537169855|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
148914022|NCT00281658|537169852|FG000|Randomized Phase|Treatment ongoing|1|||
148914023|NCT00281658|537169853|FG001|Randomized Phase|Treatment ongoing|0|||
148914024|NCT00281658|537169854|FG002|Randomized Phase|Treatment ongoing|0|||
148914025|NCT00281658|537169855|FG003|Randomized Phase|Treatment ongoing|0|||
148914026|NCT00281658|537169852|FG000|Open Label Phase|Adverse Event|0|||
148914027|NCT00281658|537169853|FG001|Open Label Phase|Adverse Event|0|||
148914028|NCT00281658|537169854|FG002|Open Label Phase|Adverse Event|1|||
148914029|NCT00281658|537169855|FG003|Open Label Phase|Adverse Event|0|||
148914030|NCT00281658|537169852|FG000|Open Label Phase|Lost to Follow-up|0|||
148914031|NCT00281658|537169853|FG001|Open Label Phase|Lost to Follow-up|0|||
148914032|NCT00281658|537169854|FG002|Open Label Phase|Lost to Follow-up|16|||
148914033|NCT00281658|537169855|FG003|Open Label Phase|Lost to Follow-up|2|||
148914034|NCT00281658|537169852|FG000|Open Label Phase|Withdrawal by Subject|0|||
148914035|NCT00281658|537169853|FG001|Open Label Phase|Withdrawal by Subject|0|||
148914036|NCT00281658|537169854|FG002|Open Label Phase|Withdrawal by Subject|3|||
148914037|NCT00281658|537169855|FG003|Open Label Phase|Withdrawal by Subject|2|||
148914038|NCT00281658|537169852|FG000|Open Label Phase|Disease progression|0|||
148914039|NCT00281658|537169853|FG001|Open Label Phase|Disease progression|0|||
148914040|NCT00281658|537169854|FG002|Open Label Phase|Disease progression|18|||
148914041|NCT00281658|537169855|FG003|Open Label Phase|Disease progression|0|||
148914042|NCT00281658|537169852|FG000|Open Label Phase|Physician Decision|0|||
148914043|NCT00281658|537169853|FG001|Open Label Phase|Physician Decision|0|||
148914044|NCT00281658|537169854|FG002|Open Label Phase|Physician Decision|1|||
148914045|NCT00281658|537169855|FG003|Open Label Phase|Physician Decision|0|||
148914046|NCT00281658|537169852|FG000|Open Label Phase|Relocation of patient|0|||
148914047|NCT00281658|537169853|FG001|Open Label Phase|Relocation of patient|0|||
148914048|NCT00281658|537169854|FG002|Open Label Phase|Relocation of patient|1|||
148914049|NCT00281658|537169855|FG003|Open Label Phase|Relocation of patient|0|||
148914050|NCT00281658|537169852|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
148914051|NCT00281658|537169853|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
148914052|NCT00281658|537169854|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
148914053|NCT00281658|537169855|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
148914054|NCT00669409|537169856|FG000|Part 2|Withdrawal by Subject|0|||
148914055|NCT00669409|537169857|FG001|Part 2|Withdrawal by Subject|0|||
148914056|NCT00669409|537169858|FG002|Part 2|Withdrawal by Subject|0|||
148914057|NCT00669409|537169859|FG003|Part 2|Withdrawal by Subject|0|||
148914058|NCT00669409|537169860|FG004|Part 2|Withdrawal by Subject|0|||
148914059|NCT00669409|537169861|FG005|Part 2|Withdrawal by Subject|0|||
148914060|NCT00669409|537169862|FG006|Part 2|Withdrawal by Subject|0|||
148914061|NCT00669409|537169863|FG007|Part 2|Withdrawal by Subject|0|||
148914062|NCT00669409|537169864|FG008|Part 2|Withdrawal by Subject|0|||
148914063|NCT00669409|537169865|FG009|Part 2|Withdrawal by Subject|1|||
148914064|NCT00669409|537169866|FG010|Part 2|Withdrawal by Subject|0|||
148914065|NCT04590248|537169867|FG000|Overall Study|Lost to Follow-up|1|||
148914066|NCT04590248|537169867|FG000|Overall Study|Withdrawal by Subject|16|||
148914067|NCT04590248|537169867|FG000|Overall Study|Other|2|||
148914068|NCT02052414|537169870|FG000|Overall Study|Adverse Event|12|||
148914069|NCT02052414|537169870|FG000|Overall Study|Lack of Efficacy|2|||
148914070|NCT02052414|537169870|FG000|Overall Study|Withdrawal by Subject|3|||
148914071|NCT00813943|537169876|FG000|Overall Study|Ongoing at cut-off date|5|||
148914072|NCT00813943|537169877|FG001|Overall Study|Ongoing at cut-off date|5|||
148914073|NCT00813943|537169878|FG002|Overall Study|Ongoing at cut-off date|3|||
148914074|NCT05367492|537169879|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
148914075|NCT05367492|537169880|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
148914076|NCT05367492|537169881|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
148914077|NCT05367492|537169879|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
148914078|NCT05367492|537169880|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
149146887|NCT02121262|538017703|FG001|Overall Study|Consent Withdrawn|0|||
149146888|NCT01553188|538017706|FG000|Overall Study|Patient choice|1|||
149146889|NCT01553188|538017707|FG001|Overall Study|Patient choice|0|||
149146890|NCT01553188|538017708|FG002|Overall Study|Patient choice|0|||
149146891|NCT01553188|538017709|FG003|Overall Study|Patient choice|0|||
149146892|NCT01553188|538017706|FG000|Overall Study|Intercurrent illness and adverse event|0|||
149146893|NCT01553188|538017707|FG001|Overall Study|Intercurrent illness and adverse event|1|||
149146894|NCT01553188|538017708|FG002|Overall Study|Intercurrent illness and adverse event|2|||
149146895|NCT01553188|538017709|FG003|Overall Study|Intercurrent illness and adverse event|0|||
149146896|NCT02829138|538017711|FG000|Overall Study|Withdrawal by Subject|1|||
149146897|NCT02829138|538017712|FG001|Overall Study|Withdrawal by Subject|0|||
149146898|NCT05289570|538017714|FG000|Overall Study|Physician Decision|1|||
149146899|NCT03223428|538017720|FG000|Overall Study|No longer taking Xermelo|27|||
149146900|NCT03223428|538017720|FG000|Overall Study|Declined Consent|1|||
149146901|NCT03223428|538017720|FG000|Overall Study|Non-responders|56|||
149146902|NCT03223428|538017720|FG000|Overall Study|Withdrawal by Subject|14|||
149146903|NCT02230384|538017722|FG000|Phase 1|Lost to Follow-up|1|||
149146904|NCT02230384|538017723|FG001|Phase 1|Lost to Follow-up|0|||
149146905|NCT02230384|538017722|FG000|Phase 1|Physician Decision|0|||
149146906|NCT02230384|538017723|FG001|Phase 1|Physician Decision|1|||
149146907|NCT02230384|538017722|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
149146908|NCT02230384|538017723|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
149146909|NCT02230384|538017722|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
149146910|NCT02230384|538017723|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
149146911|NCT02230384|538017722|FG000|Phase 2 - Switch|Adverse Event|2|||
149146912|NCT02230384|538017723|FG001|Phase 2 - Switch|Adverse Event|0|||
149146913|NCT00964743|538017731|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
149146914|NCT03317795|538017732|FG000|Overall Study|IUD Expulsion|1|||
149146915|NCT03317795|538017733|FG001|Overall Study|IUD Expulsion|0|||
149146916|NCT03317795|538017732|FG000|Overall Study|Lost to Follow-up|1|||
149146917|NCT03317795|538017733|FG001|Overall Study|Lost to Follow-up|3|||
149146918|NCT03317795|538017732|FG000|Overall Study|Treatment change|0|||
149146919|NCT03317795|538017733|FG001|Overall Study|Treatment change|3|||
149146920|NCT03317795|538017732|FG000|Overall Study|Intolerance of medication|0|||
149146921|NCT03317795|538017733|FG001|Overall Study|Intolerance of medication|1|||
149146922|NCT00939783|538017734|FG000|Overall Study|Death|6|||
149146923|NCT00939783|538017734|FG000|Overall Study|Adverse Event|39|||
149146924|NCT00939783|538017734|FG000|Overall Study|Study Terminated by Sponsor|498|||
149146925|NCT00939783|538017734|FG000|Overall Study|Withdrawal by Subject|78|||
149146926|NCT00939783|538017734|FG000|Overall Study|Other|16|||
149146927|NCT00939783|538017734|FG000|Overall Study|Lost to Follow-up|8|||
149146928|NCT00939783|538017734|FG000|Overall Study|Protocol Violation|3|||
149146929|NCT00939783|538017734|FG000|Overall Study|Enrolled but not treated|1|||
149146930|NCT01549002|538017738|FG000|Overall Study|Excessive pain|0|||
149146931|NCT01549002|538017739|FG001|Overall Study|Excessive pain|2|||
149146932|NCT01549002|538017738|FG000|Overall Study|Moderate sedation required|0|||
149146933|NCT01549002|538017739|FG001|Overall Study|Moderate sedation required|2|||
149146934|NCT03631732|538017744|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
149146935|NCT03631732|538017745|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
149146936|NCT03631732|538017744|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
149146937|NCT03631732|538017745|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
149146938|NCT03631732|538017744|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
149146939|NCT03631732|538017745|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
149146940|NCT03631732|538017744|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
149146941|NCT03631732|538017745|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
149146942|NCT03631732|538017744|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
149146943|NCT03631732|538017745|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
149146944|NCT03631732|538017744|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
149146945|NCT03631732|538017745|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
149146946|NCT03631732|538017744|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
149146947|NCT03631732|538017745|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
149146948|NCT03631732|538017744|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
149146949|NCT03631732|538017745|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
149146950|NCT03631732|538017744|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
149146951|NCT03631732|538017745|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
149146952|NCT03631732|538017744|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
149146953|NCT03631732|538017745|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
149146954|NCT00501007|538017746|FG000|Overall Study|Inclusion criteria not met.|29|||
149146955|NCT00501007|538017747|FG001|Overall Study|Inclusion criteria not met.|25|||
149146956|NCT03917823|538017748|FG000|Overall Study|Lost to Follow-up|1|||
149146957|NCT03917823|538017749|FG001|Overall Study|Lost to Follow-up|1|||
149146958|NCT03917823|538017748|FG000|Overall Study|Withdrawal by Subject|0|||
149146959|NCT03917823|538017749|FG001|Overall Study|Withdrawal by Subject|1|||
149146960|NCT00135668|538017750|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
149146961|NCT00135668|538017751|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
149146962|NCT00135668|538017752|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
149146963|NCT00135668|538017753|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
149146964|NCT02424253|538017754|FG000|Overall Study|Other, unspecified|1|||
149146965|NCT02424253|538017755|FG001|Overall Study|Other, unspecified|0|||
149146966|NCT02424253|538017754|FG000|Overall Study|Compliance problems|1|||
149146967|NCT02424253|538017755|FG001|Overall Study|Compliance problems|0|||
149146968|NCT02424253|538017754|FG000|Overall Study|Physician Decision|2|||
149146969|NCT02424253|538017755|FG001|Overall Study|Physician Decision|0|||
149146970|NCT02424253|538017754|FG000|Overall Study|Lack of Efficacy|0|||
149146971|NCT02424253|538017755|FG001|Overall Study|Lack of Efficacy|7|||
149146972|NCT02424253|538017754|FG000|Overall Study|Adverse Event|2|||
149146973|NCT02424253|538017755|FG001|Overall Study|Adverse Event|0|||
149146974|NCT02424253|538017754|FG000|Overall Study|Consent withdrawn by subject|4|||
149146975|NCT02424253|538017755|FG001|Overall Study|Consent withdrawn by subject|1|||
149146976|NCT02424253|538017754|FG000|Overall Study|Lost to Follow-up|1|||
149146977|NCT02424253|538017755|FG001|Overall Study|Lost to Follow-up|1|||
149146978|NCT02370615|538017758|FG000|Overall Study|Adverse Event|1|||
149146979|NCT02370615|538017759|FG001|Overall Study|Adverse Event|0|||
149146980|NCT01378104|538017762|FG000|Overall Study|Adverse Event|8|||
149146981|NCT01378104|538017763|FG001|Overall Study|Adverse Event|8|||
149146982|NCT01378104|538017762|FG000|Overall Study|Lack of Efficacy|7|||
149146983|NCT01378104|538017763|FG001|Overall Study|Lack of Efficacy|5|||
149146984|NCT01378104|538017762|FG000|Overall Study|Withdrawal by Subject|12|||
149146985|NCT01378104|538017763|FG001|Overall Study|Withdrawal by Subject|13|||
149146986|NCT00455013|538017764|FG000|Short Term Period|Adverse Event|2|||
149146987|NCT00455013|538017765|FG001|Short Term Period|Adverse Event|5|||
149146988|NCT00455013|538017766|FG002|Short Term Period|Adverse Event|0|||
149146989|NCT00455013|538017764|FG000|Short Term Period|Withdrawal by Subject|0|||
149146990|NCT00455013|538017765|FG001|Short Term Period|Withdrawal by Subject|0|||
149146991|NCT00455013|538017766|FG002|Short Term Period|Withdrawal by Subject|1|||
149146992|NCT00455013|538017764|FG000|Short Term Period|Lack of Efficacy|4|||
149146993|NCT00455013|538017765|FG001|Short Term Period|Lack of Efficacy|0|||
149146994|NCT00455013|538017766|FG002|Short Term Period|Lack of Efficacy|0|||
149146995|NCT00455013|538017764|FG000|Short Term Period|Other|0|||
149146996|NCT00455013|538017765|FG001|Short Term Period|Other|0|||
149146997|NCT00455013|538017766|FG002|Short Term Period|Other|1|||
149146998|NCT00455013|538017764|FG000|Long Term Extension (LTE)|Adverse Event|0|||
149146999|NCT00455013|538017765|FG001|Long Term Extension (LTE)|Adverse Event|1|||
149147000|NCT00455013|538017766|FG002|Long Term Extension (LTE)|Adverse Event|1|||
149147001|NCT00455013|538017764|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
149147002|NCT00455013|538017765|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
149147003|NCT00455013|538017766|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
149147004|NCT00455013|538017764|FG000|Long Term Extension (LTE)|Death|1|||
149147005|NCT00455013|538017765|FG001|Long Term Extension (LTE)|Death|1|||
149147006|NCT00455013|538017766|FG002|Long Term Extension (LTE)|Death|0|||
149147007|NCT00455013|538017764|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
149147008|NCT00455013|538017765|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
149147009|NCT00455013|538017766|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
149147010|NCT00455013|538017764|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
149147011|NCT00455013|538017765|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
149147012|NCT00455013|538017766|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
149147013|NCT00455013|538017764|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
149147014|NCT00455013|538017765|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
149147015|NCT00455013|538017766|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
149147016|NCT00455013|538017764|FG000|Long Term Extension (LTE)|non-specified|0|||
149147017|NCT00455013|538017765|FG001|Long Term Extension (LTE)|non-specified|0|||
149147018|NCT00455013|538017766|FG002|Long Term Extension (LTE)|non-specified|1|||
149147019|NCT01445951|538017767|FG000|Overall Study|Adverse Event|16|||
149147020|NCT01445951|538017768|FG001|Overall Study|Adverse Event|9|||
149147021|NCT01445951|538017769|FG002|Overall Study|Adverse Event|0|||
148671355|NCT05554471|536267105|FG000|Overall Study|Death|0|||
148671356|NCT05554471|536267106|FG001|Overall Study|Death|1|||
148671357|NCT02576951|536267108|FG000|Overall Study|Lost to Follow-up|0|||
148671358|NCT02576951|536267109|FG001|Overall Study|Lost to Follow-up|0|||
148671359|NCT02576951|536267110|FG002|Overall Study|Lost to Follow-up|2|||
148671360|NCT02576951|536267111|FG003|Overall Study|Lost to Follow-up|2|||
148671361|NCT02576951|536267108|FG000|Overall Study|Withdrawal by Subject|1|||
148671362|NCT02576951|536267109|FG001|Overall Study|Withdrawal by Subject|0|||
148671363|NCT02576951|536267110|FG002|Overall Study|Withdrawal by Subject|0|||
148671364|NCT02576951|536267111|FG003|Overall Study|Withdrawal by Subject|2|||
148671365|NCT02576951|536267108|FG000|Overall Study|Protocol Violation|0|||
148671366|NCT02576951|536267109|FG001|Overall Study|Protocol Violation|0|||
148671367|NCT02576951|536267110|FG002|Overall Study|Protocol Violation|0|||
148671368|NCT02576951|536267111|FG003|Overall Study|Protocol Violation|1|||
148671369|NCT00223990|536267115|FG000|Overall Study|Moved from area|2|||
148671370|NCT00223990|536267116|FG001|Overall Study|Moved from area|1|||
148671371|NCT00223990|536267115|FG000|Overall Study|Withdrawal by Subject|4|||
148671372|NCT00223990|536267116|FG001|Overall Study|Withdrawal by Subject|8|||
148671373|NCT00223990|536267115|FG000|Overall Study|Lost to Follow-up|1|||
148671374|NCT00223990|536267116|FG001|Overall Study|Lost to Follow-up|0|||
148914079|NCT05367492|537169881|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
148914080|NCT05367492|537169879|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
148671375|NCT01319994|536268724|FG000|Overall Study|Protocol Violation|7|||
148671376|NCT01319994|536268725|FG001|Overall Study|Protocol Violation|6|||
148671377|NCT01340794|536268726|FG000|Overall Study|Withdrawal by Subject|0|||
148671378|NCT01340794|536268727|FG001|Overall Study|Withdrawal by Subject|1|||
148671379|NCT01808508|536268733|FG000|Overall Study|Lost to Follow-up|1|||
148914081|NCT05367492|537169880|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
149147022|NCT01445951|538017767|FG000|Overall Study|Protocol Violation|2|||
149147023|NCT01445951|538017768|FG001|Overall Study|Protocol Violation|2|||
149147024|NCT01445951|538017769|FG002|Overall Study|Protocol Violation|2|||
149147025|NCT01445951|538017767|FG000|Overall Study|Withdrawal by Subject|21|||
149147026|NCT01445951|538017768|FG001|Overall Study|Withdrawal by Subject|16|||
149147027|NCT01445951|538017769|FG002|Overall Study|Withdrawal by Subject|8|||
149147028|NCT01445951|538017767|FG000|Overall Study|Physician Decision|3|||
149147029|NCT01445951|538017768|FG001|Overall Study|Physician Decision|1|||
149147030|NCT01445951|538017769|FG002|Overall Study|Physician Decision|0|||
149147031|NCT01445951|538017767|FG000|Overall Study|Lost to Follow-up|1|||
149147032|NCT01445951|538017768|FG001|Overall Study|Lost to Follow-up|2|||
148671380|NCT01808508|536268734|FG001|Overall Study|Lost to Follow-up|0|||
148671381|NCT01808508|536268735|FG002|Overall Study|Lost to Follow-up|0|||
148671382|NCT01118949|536268736|FG000|Overall Study|Adverse Event|5|||
148671383|NCT01118949|536268736|FG000|Overall Study|Withdrawal by Subject|4|||
149147033|NCT01445951|538017769|FG002|Overall Study|Lost to Follow-up|4|||
149147034|NCT01445951|538017767|FG000|Overall Study|Pregnancy|0|||
149147035|NCT01445951|538017768|FG001|Overall Study|Pregnancy|1|||
149147036|NCT01445951|538017769|FG002|Overall Study|Pregnancy|4|||
149147037|NCT01445951|538017767|FG000|Overall Study|Death|0|||
149147038|NCT01445951|538017768|FG001|Overall Study|Death|0|||
149147039|NCT01445951|538017769|FG002|Overall Study|Death|1|||
149147040|NCT01445951|538017767|FG000|Overall Study|Non-compliance with study drug|1|||
149147041|NCT01445951|538017768|FG001|Overall Study|Non-compliance with study drug|2|||
149147042|NCT01445951|538017769|FG002|Overall Study|Non-compliance with study drug|0|||
149147043|NCT01445951|538017767|FG000|Overall Study|Non-compliance with protocol|0|||
149147044|NCT01445951|538017768|FG001|Overall Study|Non-compliance with protocol|1|||
149147045|NCT01445951|538017769|FG002|Overall Study|Non-compliance with protocol|0|||
149147046|NCT01445951|538017767|FG000|Overall Study|Sponsor decision - subject travel|0|||
149147047|NCT01445951|538017768|FG001|Overall Study|Sponsor decision - subject travel|1|||
149147048|NCT01445951|538017769|FG002|Overall Study|Sponsor decision - subject travel|0|||
149147049|NCT01445951|538017767|FG000|Overall Study|Cough|0|||
149147050|NCT01445951|538017768|FG001|Overall Study|Cough|1|||
149147051|NCT01445951|538017769|FG002|Overall Study|Cough|0|||
149147052|NCT04126083|538017770|FG000|Overall Study|Withdrawal by Subject|1|||
149147053|NCT00578136|538017774|FG000|Overall Study|Not given intervention|1|||
149147054|NCT00578136|538017775|FG001|Overall Study|Not given intervention|1|||
149147055|NCT00754793|538017776|FG000|Overall Study|voluntary withdrawn from study|0|||
149147056|NCT00754793|538017777|FG001|Overall Study|voluntary withdrawn from study|1|||
149147057|NCT00645593|538017779|FG000|Overall Study|Later found to be ineligible|1|||
149147058|NCT00645593|538017780|FG001|Overall Study|Later found to be ineligible|0|||
149147059|NCT01585272|538017781|FG000|Overall Study|Adverse Event|22|||
149147060|NCT01585272|538017781|FG000|Overall Study|Protocol Violation|7|||
149147061|NCT01585272|538017781|FG000|Overall Study|Withdrawal by Subject|10|||
149147062|NCT00781911|538017782|FG000|Overall Study|Adverse Event|4|||
149147063|NCT00781911|538017783|FG001|Overall Study|Adverse Event|4|||
149147064|NCT00781911|538017782|FG000|Overall Study|Withdrawal by Subject|1|||
149147065|NCT00781911|538017783|FG001|Overall Study|Withdrawal by Subject|2|||
149147066|NCT00781911|538017782|FG000|Overall Study|Physician Decision|0|||
149147067|NCT00781911|538017783|FG001|Overall Study|Physician Decision|2|||
149147068|NCT00781911|538017782|FG000|Overall Study|Sponsor Decision|1|||
149147069|NCT00781911|538017783|FG001|Overall Study|Sponsor Decision|0|||
149147070|NCT00361270|538017787|FG000|Overall Study|Death|0|||
149147071|NCT00361270|538017788|FG001|Overall Study|Death|0|||
149147072|NCT00361270|538017789|FG002|Overall Study|Death|0|||
149147073|NCT00361270|538017790|FG003|Overall Study|Death|2|||
149147074|NCT00361270|538017787|FG000|Overall Study|Lost to Follow-up|4|||
149147075|NCT00361270|538017788|FG001|Overall Study|Lost to Follow-up|1|||
149147076|NCT00361270|538017789|FG002|Overall Study|Lost to Follow-up|0|||
149147077|NCT00361270|538017790|FG003|Overall Study|Lost to Follow-up|0|||
149147078|NCT00361270|538017787|FG000|Overall Study|Physician Decision|0|||
149147079|NCT00361270|538017788|FG001|Overall Study|Physician Decision|0|||
149147080|NCT00361270|538017789|FG002|Overall Study|Physician Decision|1|||
148914082|NCT05367492|537169881|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
148914083|NCT05367492|537169879|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
148914084|NCT05367492|537169880|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
148914085|NCT05367492|537169881|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
148914086|NCT01343693|537169890|FG000|Overall Study|Lost to Follow-up|9|||
148914087|NCT02891070|537169891|FG000|Overall Study|Adverse Event|1|||
148914088|NCT02891070|537169892|FG001|Overall Study|Adverse Event|0|||
148914089|NCT02891070|537169891|FG000|Overall Study|Physician Decision|0|||
148914090|NCT02891070|537169892|FG001|Overall Study|Physician Decision|1|||
148914091|NCT02891070|537169891|FG000|Overall Study|Lost to Follow-up|4|||
148914092|NCT02891070|537169892|FG001|Overall Study|Lost to Follow-up|4|||
148914093|NCT02891070|537169891|FG000|Overall Study|Other|1|||
148914094|NCT02891070|537169892|FG001|Overall Study|Other|0|||
148914095|NCT02891070|537169891|FG000|Overall Study|Protocol Violation|0|||
148914096|NCT02891070|537169892|FG001|Overall Study|Protocol Violation|1|||
148914097|NCT02891070|537169891|FG000|Overall Study|Withdrawal by Subject|1|||
148914098|NCT02891070|537169892|FG001|Overall Study|Withdrawal by Subject|2|||
149147081|NCT00361270|538017790|FG003|Overall Study|Physician Decision|0|||
149147082|NCT00361270|538017787|FG000|Overall Study|Protocol Violation|9|||
149147083|NCT00361270|538017788|FG001|Overall Study|Protocol Violation|4|||
149147084|NCT00361270|538017789|FG002|Overall Study|Protocol Violation|5|||
149147085|NCT00361270|538017790|FG003|Overall Study|Protocol Violation|4|||
149147086|NCT00361270|538017787|FG000|Overall Study|Withdrawal by Subject|6|||
149147087|NCT00361270|538017788|FG001|Overall Study|Withdrawal by Subject|6|||
149147088|NCT00361270|538017789|FG002|Overall Study|Withdrawal by Subject|3|||
149147089|NCT00361270|538017790|FG003|Overall Study|Withdrawal by Subject|7|||
149147090|NCT00361270|538017787|FG000|Overall Study|Afraid of Hypnosis|1|||
149147091|NCT00361270|538017788|FG001|Overall Study|Afraid of Hypnosis|2|||
149147092|NCT00361270|538017789|FG002|Overall Study|Afraid of Hypnosis|0|||
149147093|NCT00361270|538017790|FG003|Overall Study|Afraid of Hypnosis|0|||
149147094|NCT00361270|538017787|FG000|Overall Study|Problems with Transportation|4|||
149147095|NCT00361270|538017788|FG001|Overall Study|Problems with Transportation|0|||
149147096|NCT00361270|538017789|FG002|Overall Study|Problems with Transportation|0|||
149147097|NCT00361270|538017790|FG003|Overall Study|Problems with Transportation|0|||
149147098|NCT00361270|538017787|FG000|Overall Study|Adverse Event|0|||
149147099|NCT00361270|538017788|FG001|Overall Study|Adverse Event|1|||
149147100|NCT00361270|538017789|FG002|Overall Study|Adverse Event|1|||
149147101|NCT00361270|538017790|FG003|Overall Study|Adverse Event|0|||
149147102|NCT00495820|538017793|FG000|Overall Study|Adverse Event|1|||
149147103|NCT00495820|538017794|FG001|Overall Study|Adverse Event|1|||
149147104|NCT00820950|538017795|FG000|Overall Study|Scheduling Conflict|0|||
149147105|NCT00820950|538017796|FG001|Overall Study|Scheduling Conflict|0|||
149147106|NCT00820950|538017797|FG002|Overall Study|Scheduling Conflict|0|||
149147107|NCT00820950|538017798|FG003|Overall Study|Scheduling Conflict|0|||
149147108|NCT00820950|538017799|FG004|Overall Study|Scheduling Conflict|0|||
149147109|NCT00820950|538017800|FG005|Overall Study|Scheduling Conflict|0|||
149147110|NCT00820950|538017801|FG006|Overall Study|Scheduling Conflict|1|||
149147111|NCT00820950|538017802|FG007|Overall Study|Scheduling Conflict|1|||
149147112|NCT00820950|538017803|FG008|Overall Study|Scheduling Conflict|0|||
149147113|NCT00820950|538017804|FG009|Overall Study|Scheduling Conflict|0|||
149147114|NCT00820950|538017795|FG000|Overall Study|Protocol Violation|1|||
149147115|NCT00820950|538017796|FG001|Overall Study|Protocol Violation|1|||
149147116|NCT00820950|538017797|FG002|Overall Study|Protocol Violation|0|||
149147117|NCT00820950|538017798|FG003|Overall Study|Protocol Violation|0|||
149147118|NCT00820950|538017799|FG004|Overall Study|Protocol Violation|0|||
149147119|NCT00820950|538017800|FG005|Overall Study|Protocol Violation|0|||
149147120|NCT00820950|538017801|FG006|Overall Study|Protocol Violation|0|||
148914099|NCT02891070|537169891|FG000|Overall Study|Death|3|||
148914100|NCT02891070|537169892|FG001|Overall Study|Death|0|||
148914101|NCT02704143|537169893|FG000|Overall Study|disease progression|10|||
149147121|NCT00820950|538017802|FG007|Overall Study|Protocol Violation|0|||
149147122|NCT00820950|538017803|FG008|Overall Study|Protocol Violation|0|||
149147123|NCT00820950|538017804|FG009|Overall Study|Protocol Violation|0|||
149147124|NCT00528021|538017805|FG000|Overall Study|Lack of Efficacy|17|||
149147125|NCT00528021|538017806|FG001|Overall Study|Lack of Efficacy|13|||
149147126|NCT00528021|538017807|FG002|Overall Study|Lack of Efficacy|7|||
149147127|NCT00528021|538017808|FG003|Overall Study|Lack of Efficacy|9|||
149147128|NCT02581202|538017811|FG000|Overall Study|Lack of Efficacy|2|||
149147129|NCT02581202|538017811|FG000|Overall Study|Withdrawal by Subject|4|||
149147130|NCT02581202|538017811|FG000|Overall Study|Lost to Follow-up|5|||
149147131|NCT02581202|538017811|FG000|Overall Study|Pregnancy|3|||
149147132|NCT04050982|538017812|FG000|Overall Study|Did not meet eligibility criteria|0|||
149147133|NCT04050982|538017813|FG001|Overall Study|Did not meet eligibility criteria|1|||
149147134|NCT04050982|538017814|FG002|Overall Study|Did not meet eligibility criteria|0|||
149147135|NCT04050982|538017812|FG000|Overall Study|Withdrawal by Subject|1|||
149147136|NCT04050982|538017813|FG001|Overall Study|Withdrawal by Subject|0|||
149147137|NCT04050982|538017814|FG002|Overall Study|Withdrawal by Subject|0|||
149147138|NCT04050982|538017812|FG000|Overall Study|Unable to enroll on platform|1|||
149147139|NCT04050982|538017813|FG001|Overall Study|Unable to enroll on platform|0|||
149147140|NCT04050982|538017814|FG002|Overall Study|Unable to enroll on platform|0|||
149147141|NCT05264740|538017815|FG000|Baseline|Withdrawal by Subject|0|||
148914102|NCT01235598|537169894|FG000|Overall Study|Adverse Event|0|||
148914103|NCT01235598|537169895|FG001|Overall Study|Adverse Event|3|||
148914104|NCT01235598|537169894|FG000|Overall Study|Lack of Efficacy|0|||
148914105|NCT01235598|537169895|FG001|Overall Study|Lack of Efficacy|1|||
148914106|NCT01235598|537169894|FG000|Overall Study|Withdrawal by Subject|1|||
148914107|NCT01235598|537169895|FG001|Overall Study|Withdrawal by Subject|0|||
148914108|NCT02151773|537169896|FG000|Overall Study|Protocol Deviation|64|||
148914109|NCT02551991|537169897|FG000|Overall Study|Death|5|||
148914110|NCT02551991|537169898|FG001|Overall Study|Death|7|||
148914111|NCT02551991|537169899|FG002|Overall Study|Death|8|||
148914112|NCT02551991|537169900|FG003|Overall Study|Death|7|||
148914113|NCT02551991|537169901|FG004|Overall Study|Death|17|||
148914114|NCT02551991|537169897|FG000|Overall Study|Withdrawal by Subject|1|||
148914115|NCT02551991|537169898|FG001|Overall Study|Withdrawal by Subject|0|||
148671384|NCT01035229|536268737|FG000|Overall Study|Adverse Event|61|||
148914116|NCT02551991|537169899|FG002|Overall Study|Withdrawal by Subject|0|||
148914117|NCT02551991|537169900|FG003|Overall Study|Withdrawal by Subject|0|||
148914118|NCT02551991|537169901|FG004|Overall Study|Withdrawal by Subject|2|||
148914119|NCT02551991|537169897|FG000|Overall Study|Lost to Follow-up|0|||
149147142|NCT05264740|538017816|FG001|Baseline|Withdrawal by Subject|1|||
149147143|NCT05264740|538017815|FG000|Follow Up 1|Lost to Follow-up|1|||
149147144|NCT05264740|538017816|FG001|Follow Up 1|Lost to Follow-up|1|||
149147145|NCT05264740|538017815|FG000|Follow Up 1|Withdrawal by Subject|0|||
149147146|NCT05264740|538017816|FG001|Follow Up 1|Withdrawal by Subject|1|||
149147147|NCT05264740|538017815|FG000|Follow Up 2|Lost to Follow-up|1|||
149147148|NCT05264740|538017816|FG001|Follow Up 2|Lost to Follow-up|4|||
149147149|NCT05264740|538017815|FG000|Follow Up 3|Lost to Follow-up|7|||
149147150|NCT05264740|538017816|FG001|Follow Up 3|Lost to Follow-up|4|||
149147151|NCT05885737|538017817|FG000|DB Period|Adverse Event|4|||
149147152|NCT05885737|538017818|FG001|DB Period|Adverse Event|4|||
149147153|NCT05885737|538017817|FG000|DB Period|Lost to Follow-up|0|||
149147154|NCT05885737|538017818|FG001|DB Period|Lost to Follow-up|1|||
149147155|NCT05885737|538017817|FG000|DB Period|Physician Decision|2|||
149147156|NCT05885737|538017818|FG001|DB Period|Physician Decision|0|||
149147157|NCT05885737|538017817|FG000|DB Period|Withdrawal by Subject|12|||
149147158|NCT05885737|538017818|FG001|DB Period|Withdrawal by Subject|6|||
149147159|NCT05885737|538017817|FG000|DB Period|Other: Unspecified|2|||
149147160|NCT05885737|538017818|FG001|DB Period|Other: Unspecified|2|||
149147161|NCT05885737|538017817|FG000|OLE Period|Adverse Event|3|||
149147162|NCT05885737|538017818|FG001|OLE Period|Adverse Event|2|||
149147163|NCT05885737|538017817|FG000|OLE Period|Physician Decision|1|||
149147164|NCT05885737|538017818|FG001|OLE Period|Physician Decision|0|||
149147165|NCT05885737|538017817|FG000|OLE Period|Withdrawal by Subject|5|||
149147166|NCT05885737|538017818|FG001|OLE Period|Withdrawal by Subject|5|||
149147167|NCT05885737|538017817|FG000|OLE Period|Other: Unspecified|2|||
149147168|NCT05885737|538017818|FG001|OLE Period|Other: Unspecified|1|||
149147169|NCT00609791|538019430|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
149147170|NCT04218201|538019431|FG000|Overall Study|Death|0|||
149147171|NCT04218201|538019432|FG001|Overall Study|Death|0|||
149147172|NCT04218201|538019433|FG002|Overall Study|Death|2|||
149147173|NCT04218201|538019434|FG003|Overall Study|Death|0|||
149147174|NCT04218201|538019431|FG000|Overall Study|Unable to contact participant|4|||
149147175|NCT04218201|538019432|FG001|Overall Study|Unable to contact participant|0|||
149147176|NCT04218201|538019433|FG002|Overall Study|Unable to contact participant|3|||
149147177|NCT04218201|538019434|FG003|Overall Study|Unable to contact participant|0|||
149147178|NCT04218201|538019431|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
149147179|NCT04218201|538019432|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
149147180|NCT04218201|538019433|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
149147181|NCT04218201|538019434|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
149147182|NCT04218201|538019431|FG000|Overall Study|Withdrawal by Subject|2|||
149147183|NCT04218201|538019432|FG001|Overall Study|Withdrawal by Subject|0|||
149147184|NCT04218201|538019433|FG002|Overall Study|Withdrawal by Subject|0|||
149147185|NCT04218201|538019434|FG003|Overall Study|Withdrawal by Subject|0|||
149147186|NCT04218201|538019431|FG000|Overall Study|PCP plans to leave practice|0|||
149147187|NCT04218201|538019432|FG001|Overall Study|PCP plans to leave practice|8|||
149147188|NCT04218201|538019433|FG002|Overall Study|PCP plans to leave practice|0|||
149147189|NCT04218201|538019434|FG003|Overall Study|PCP plans to leave practice|5|||
149147190|NCT04218201|538019431|FG000|Overall Study|Reduced panel|0|||
149147191|NCT04218201|538019432|FG001|Overall Study|Reduced panel|0|||
149147192|NCT04218201|538019433|FG002|Overall Study|Reduced panel|0|||
149147193|NCT04218201|538019434|FG003|Overall Study|Reduced panel|1|||
149147194|NCT04218201|538019431|FG000|Overall Study|No longer interested in participating|0|||
149147195|NCT04218201|538019432|FG001|Overall Study|No longer interested in participating|1|||
149147196|NCT04218201|538019433|FG002|Overall Study|No longer interested in participating|0|||
149147197|NCT04218201|538019434|FG003|Overall Study|No longer interested in participating|0|||
149147198|NCT02004262|538019437|FG000|Overall Study|Death|67|||
149147199|NCT02004262|538019438|FG001|Overall Study|Death|64|||
149147200|NCT02004262|538019439|FG002|Overall Study|Death|66|||
149147201|NCT02004262|538019440|FG003|Overall Study|Death|28|||
149147202|NCT02004262|538019441|FG004|Overall Study|Death|29|||
149147203|NCT02004262|538019442|FG005|Overall Study|Death|22|||
149147204|NCT02004262|538019437|FG000|Overall Study|Withdrawal by Subject|1|||
149147205|NCT02004262|538019438|FG001|Overall Study|Withdrawal by Subject|0|||
149147206|NCT02004262|538019439|FG002|Overall Study|Withdrawal by Subject|4|||
149147207|NCT02004262|538019440|FG003|Overall Study|Withdrawal by Subject|0|||
149147208|NCT02004262|538019441|FG004|Overall Study|Withdrawal by Subject|1|||
149147209|NCT02004262|538019442|FG005|Overall Study|Withdrawal by Subject|3|||
149147210|NCT02004262|538019437|FG000|Overall Study|Lost to Follow-up|1|||
149147211|NCT02004262|538019438|FG001|Overall Study|Lost to Follow-up|1|||
149147212|NCT02004262|538019439|FG002|Overall Study|Lost to Follow-up|0|||
149147213|NCT02004262|538019440|FG003|Overall Study|Lost to Follow-up|0|||
149147214|NCT02004262|538019441|FG004|Overall Study|Lost to Follow-up|0|||
149147215|NCT02004262|538019442|FG005|Overall Study|Lost to Follow-up|0|||
149147216|NCT02004262|538019437|FG000|Overall Study|Study Terminated by Sponsor|4|||
149147217|NCT02004262|538019438|FG001|Overall Study|Study Terminated by Sponsor|3|||
149147218|NCT02004262|538019439|FG002|Overall Study|Study Terminated by Sponsor|2|||
149147219|NCT02004262|538019440|FG003|Overall Study|Study Terminated by Sponsor|1|||
149147220|NCT02004262|538019441|FG004|Overall Study|Study Terminated by Sponsor|1|||
149147221|NCT02004262|538019442|FG005|Overall Study|Study Terminated by Sponsor|5|||
149147222|NCT01146873|538019443|FG000|Overall Study|Transfer out|0|||
149147223|NCT01146873|538019444|FG001|Overall Study|Transfer out|6|||
149147224|NCT03200366|538019447|FG000|Patient Navigation Intervention Given|Death|0|||
149147225|NCT03200366|538019448|FG001|Patient Navigation Intervention Given|Death|2|||
149147226|NCT03200366|538019449|FG002|Patient Navigation Intervention Given|Death|0|||
149147227|NCT03200366|538019447|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
149147228|NCT03200366|538019448|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
149147229|NCT03200366|538019449|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
149147230|NCT03200366|538019447|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
149147231|NCT03200366|538019448|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
149147232|NCT03200366|538019449|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
149147233|NCT03200366|538019447|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
149147234|NCT03200366|538019448|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
149147235|NCT03200366|538019449|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
149147236|NCT03200366|538019447|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
149147237|NCT03200366|538019448|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
149147238|NCT03200366|538019449|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
149147239|NCT03200366|538019447|FG000|6 Month Post-Baseline Interview|Death|1|||
148914120|NCT02551991|537169898|FG001|Overall Study|Lost to Follow-up|0|||
148914121|NCT02551991|537169899|FG002|Overall Study|Lost to Follow-up|1|||
149147240|NCT03200366|538019448|FG001|6 Month Post-Baseline Interview|Death|1|||
149147241|NCT03200366|538019449|FG002|6 Month Post-Baseline Interview|Death|1|||
149147242|NCT03200366|538019447|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
149147243|NCT03200366|538019448|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
149147244|NCT03200366|538019449|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
149147245|NCT03200366|538019447|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
149147246|NCT03200366|538019448|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
149147247|NCT03200366|538019449|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
149147248|NCT03200366|538019447|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
149147249|NCT03200366|538019448|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
149147250|NCT03200366|538019449|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
149147251|NCT03200366|538019447|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
149147252|NCT03200366|538019448|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
149147253|NCT03200366|538019449|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
149147254|NCT03200366|538019447|FG000|9 Month Post-Baseline Interview|Death|1|||
149147255|NCT03200366|538019448|FG001|9 Month Post-Baseline Interview|Death|1|||
149147256|NCT03200366|538019449|FG002|9 Month Post-Baseline Interview|Death|1|||
149147257|NCT03200366|538019447|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
149147258|NCT03200366|538019448|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
149147259|NCT03200366|538019449|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
149147260|NCT03200366|538019447|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
149147261|NCT03200366|538019448|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
149147262|NCT03200366|538019449|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
149147263|NCT03200366|538019447|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
149147264|NCT03200366|538019448|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
149147265|NCT03200366|538019449|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
148671385|NCT01035229|536268738|FG001|Overall Study|Adverse Event|14|||
149147266|NCT00930761|538019450|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
149147267|NCT00930761|538019451|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
149147268|NCT00930761|538019450|FG000|Overall Study|less than 3 music therapy sessions|0|||
148671386|NCT01035229|536268737|FG000|Overall Study|Withdrawal by Subject|20|||
149147269|NCT00930761|538019451|FG001|Overall Study|less than 3 music therapy sessions|3|||
149147270|NCT03548935|538019452|FG000|Overall Study|Withdrawal by Subject|26|||
149147271|NCT03548935|538019453|FG001|Overall Study|Withdrawal by Subject|17|||
149147272|NCT03548935|538019452|FG000|Overall Study|Lost to Follow-up|39|||
149147273|NCT03548935|538019453|FG001|Overall Study|Lost to Follow-up|28|||
149147274|NCT03548935|538019452|FG000|Overall Study|Death|1|||
149147275|NCT03548935|538019453|FG001|Overall Study|Death|1|||
149147276|NCT04677959|538019454|FG000|Overall Study|Adverse Event|1|||
149147277|NCT04677959|538019455|FG001|Overall Study|Adverse Event|9|||
149147278|NCT04677959|538019454|FG000|Overall Study|Withdrawal by Subject|2|||
149147279|NCT04677959|538019455|FG001|Overall Study|Withdrawal by Subject|15|||
149147280|NCT04677959|538019454|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149147281|NCT04677959|538019455|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149147282|NCT04677959|538019454|FG000|Overall Study|Non-compliance with study drug|0|||
149147283|NCT04677959|538019455|FG001|Overall Study|Non-compliance with study drug|2|||
149147284|NCT04677959|538019454|FG000|Overall Study|Protocol deviation|0|||
149147285|NCT04677959|538019455|FG001|Overall Study|Protocol deviation|11|||
149147286|NCT04677959|538019454|FG000|Overall Study|Lost to Follow-up|9|||
149147287|NCT04677959|538019455|FG001|Overall Study|Lost to Follow-up|13|||
149147288|NCT04677959|538019454|FG000|Overall Study|Other than specified|0|||
149147289|NCT04677959|538019455|FG001|Overall Study|Other than specified|8|||
149147290|NCT01074190|538019456|FG000|Overall Study|Emergency Cesarean Delivery|1|||
149147291|NCT01074190|538019457|FG001|Overall Study|Emergency Cesarean Delivery|2|||
149147292|NCT01074190|538019458|FG002|Overall Study|Emergency Cesarean Delivery|1|||
149147293|NCT01074190|538019456|FG000|Overall Study|Protocol Violation|2|||
149147294|NCT01074190|538019457|FG001|Overall Study|Protocol Violation|1|||
149147295|NCT01074190|538019458|FG002|Overall Study|Protocol Violation|0|||
149147296|NCT01074190|538019456|FG000|Overall Study|Delivered in under 90 minutes|0|||
149147297|NCT01074190|538019457|FG001|Overall Study|Delivered in under 90 minutes|2|||
149147298|NCT01074190|538019458|FG002|Overall Study|Delivered in under 90 minutes|1|||
149147299|NCT01074190|538019456|FG000|Overall Study|Subject withdrew consent|1|||
149147300|NCT01074190|538019457|FG001|Overall Study|Subject withdrew consent|1|||
149147301|NCT01074190|538019458|FG002|Overall Study|Subject withdrew consent|1|||
149147302|NCT00264875|538019459|FG000|Overall Study|Adverse Event|6|||
149147303|NCT00264875|538019459|FG000|Overall Study|Lost to Follow-up|6|||
149147304|NCT00264875|538019459|FG000|Overall Study|Protocol Violation|11|||
149147305|NCT00264875|538019459|FG000|Overall Study|Withdrawal by Subject|7|||
149147306|NCT01500278|538019461|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
149147307|NCT01500278|538019462|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
149147308|NCT01500278|538019461|FG000|Week 0 - Week 12|Protocol Violation|10|||
148914122|NCT02551991|537169900|FG003|Overall Study|Lost to Follow-up|0|||
148805036|NCT03466346|536766654|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
148805037|NCT03466346|536766650|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
148805038|NCT03466346|536766651|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
148805039|NCT03466346|536766652|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
148805040|NCT03466346|536766653|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
148805041|NCT03466346|536766654|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
148805042|NCT03466346|536766650|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
148805043|NCT03466346|536766651|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
148805044|NCT03466346|536766652|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
148805045|NCT03466346|536766653|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
148805046|NCT03466346|536766654|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
148805047|NCT03466346|536766650|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
148805048|NCT03466346|536766651|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
148914123|NCT02551991|537169901|FG004|Overall Study|Lost to Follow-up|0|||
148914124|NCT02551991|537169897|FG000|Overall Study|Sponsor Decision|1|||
148914125|NCT02551991|537169898|FG001|Overall Study|Sponsor Decision|0|||
148914126|NCT02551991|537169899|FG002|Overall Study|Sponsor Decision|1|||
148914127|NCT02551991|537169900|FG003|Overall Study|Sponsor Decision|0|||
148914128|NCT02551991|537169901|FG004|Overall Study|Sponsor Decision|5|||
148914129|NCT02551991|537169897|FG000|Overall Study|Other|0|||
148914130|NCT02551991|537169898|FG001|Overall Study|Other|0|||
148914131|NCT02551991|537169899|FG002|Overall Study|Other|0|||
148914132|NCT02551991|537169900|FG003|Overall Study|Other|0|||
148914133|NCT02551991|537169901|FG004|Overall Study|Other|1|||
148914134|NCT00395343|537169902|FG000|Overall Study|Adverse Event|13|||
148914135|NCT00395343|537169903|FG001|Overall Study|Adverse Event|5|||
148914136|NCT00395343|537169902|FG000|Overall Study|Lack of Efficacy|0|||
148914137|NCT00395343|537169903|FG001|Overall Study|Lack of Efficacy|1|||
148914138|NCT00395343|537169902|FG000|Overall Study|Lost to Follow-up|4|||
148914139|NCT00395343|537169903|FG001|Overall Study|Lost to Follow-up|4|||
148914140|NCT00395343|537169902|FG000|Overall Study|Physician Decision|2|||
148914141|NCT00395343|537169903|FG001|Overall Study|Physician Decision|4|||
148914142|NCT00395343|537169902|FG000|Overall Study|Protocol Violation|6|||
148914143|NCT00395343|537169903|FG001|Overall Study|Protocol Violation|8|||
148914144|NCT00395343|537169902|FG000|Overall Study|Withdrawal by Subject|11|||
148914145|NCT00395343|537169903|FG001|Overall Study|Withdrawal by Subject|12|||
148914146|NCT00395343|537169902|FG000|Overall Study|Other|5|||
148914147|NCT00395343|537169903|FG001|Overall Study|Other|2|||
148914148|NCT00265148|537169904|FG000|Overall Study|Adverse Event|2|||
148914149|NCT00265148|537169905|FG001|Overall Study|Adverse Event|2|||
148914150|NCT00265148|537169904|FG000|Overall Study|Lack of Efficacy|0|||
148914151|NCT00265148|537169905|FG001|Overall Study|Lack of Efficacy|2|||
148914152|NCT00265148|537169904|FG000|Overall Study|Protocol Violation|3|||
148914153|NCT00265148|537169905|FG001|Overall Study|Protocol Violation|2|||
148914154|NCT00265148|537169904|FG000|Overall Study|Lost to Follow-up|0|||
148914155|NCT00265148|537169905|FG001|Overall Study|Lost to Follow-up|1|||
148914156|NCT00265148|537169904|FG000|Overall Study|Withdrawal by Subject|2|||
148914157|NCT00265148|537169905|FG001|Overall Study|Withdrawal by Subject|1|||
148914158|NCT00265148|537169904|FG000|Overall Study|Physician Decision|1|||
148914159|NCT00265148|537169905|FG001|Overall Study|Physician Decision|0|||
148914160|NCT00265148|537169904|FG000|Overall Study|Increasing frailty|0|||
148914161|NCT00265148|537169905|FG001|Overall Study|Increasing frailty|1|||
148914162|NCT00265148|537169904|FG000|Overall Study|Subject chose to change of the dose|1|||
148914163|NCT00265148|537169905|FG001|Overall Study|Subject chose to change of the dose|0|||
148914164|NCT00942994|537169911|FG000|Overall Study|Adverse Event|7|||
148914165|NCT00942994|537169912|FG001|Overall Study|Adverse Event|4|||
148914166|NCT00942994|537169911|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148914167|NCT00942994|537169912|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148914168|NCT00942994|537169911|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148914169|NCT00942994|537169912|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148914170|NCT00942994|537169911|FG000|Overall Study|Patient withdrew consent|5|||
148914171|NCT00942994|537169912|FG001|Overall Study|Patient withdrew consent|8|||
148914172|NCT00942994|537169911|FG000|Overall Study|Lost to Follow-up|1|||
148914173|NCT00942994|537169912|FG001|Overall Study|Lost to Follow-up|4|||
148914174|NCT00942994|537169911|FG000|Overall Study|Protocol deviation|1|||
148914175|NCT00942994|537169912|FG001|Overall Study|Protocol deviation|2|||
148914176|NCT03583385|537169913|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148914177|NCT03583385|537169914|FG001|Treatment Period 1|Withdrawal by Subject|1|||
148914178|NCT03583385|537169913|FG000|Treatment Period 2|Adverse Event|1|||
148914179|NCT03583385|537169914|FG001|Treatment Period 2|Adverse Event|0|||
148914180|NCT00095940|537169917|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
148914181|NCT00095940|537169918|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
148914182|NCT00095940|537169919|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
148914183|NCT00095940|537169920|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
148914184|NCT00095940|537169921|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
149147309|NCT01500278|538019462|FG001|Week 0 - Week 12|Protocol Violation|16|||
149147310|NCT01500278|538019461|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
149147311|NCT01500278|538019462|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
149147312|NCT01500278|538019461|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
149147313|NCT01500278|538019462|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
149147314|NCT01500278|538019461|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
149147315|NCT01500278|538019462|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
149147316|NCT01500278|538019461|FG000|Week 0 - Week 12|Patient decision|1|||
149147317|NCT01500278|538019462|FG001|Week 0 - Week 12|Patient decision|0|||
149147318|NCT01500278|538019461|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
149147319|NCT01500278|538019462|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
149147320|NCT01500278|538019461|FG000|Week 0 - Week 12|Investigator decision|1|||
149147321|NCT01500278|538019462|FG001|Week 0 - Week 12|Investigator decision|0|||
149147322|NCT01500278|538019461|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
149147323|NCT01500278|538019462|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
149147324|NCT01500278|538019461|FG000|Week 0 - Week 12|Sponsor decision|1|||
149147325|NCT01500278|538019462|FG001|Week 0 - Week 12|Sponsor decision|0|||
149147326|NCT01500278|538019461|FG000|Week 0 - Week 12|Personal reason|0|||
149147327|NCT01500278|538019462|FG001|Week 0 - Week 12|Personal reason|1|||
149147328|NCT01500278|538019461|FG000|Week 0 - Week 12|Other serious disease|0|||
149147329|NCT01500278|538019462|FG001|Week 0 - Week 12|Other serious disease|1|||
149147330|NCT01500278|538019461|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
149147331|NCT01500278|538019462|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
149147332|NCT01500278|538019461|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
149147333|NCT01500278|538019462|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
149147334|NCT01500278|538019461|FG000|Week 13 - Week 104|Protocol Violation|6|||
149147335|NCT01500278|538019462|FG001|Week 13 - Week 104|Protocol Violation|6|||
149147336|NCT01500278|538019461|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
149147337|NCT01500278|538019462|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
149147338|NCT01500278|538019461|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
149147339|NCT01500278|538019462|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
149147340|NCT01500278|538019461|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
149147341|NCT01500278|538019462|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
149147342|NCT01500278|538019461|FG000|Week 13 - Week 104|Non/bad compliance|7|||
149147343|NCT01500278|538019462|FG001|Week 13 - Week 104|Non/bad compliance|5|||
149147344|NCT01500278|538019461|FG000|Week 13 - Week 104|Recurrent infections|1|||
149147345|NCT01500278|538019462|FG001|Week 13 - Week 104|Recurrent infections|0|||
149147346|NCT01500278|538019461|FG000|Week 13 - Week 104|False positive test|1|||
149147347|NCT01500278|538019462|FG001|Week 13 - Week 104|False positive test|2|||
149147348|NCT01500278|538019461|FG000|Week 13 - Week 104|Sponsor request|4|||
149147349|NCT01500278|538019462|FG001|Week 13 - Week 104|Sponsor request|0|||
149147350|NCT01500278|538019461|FG000|Week 13 - Week 104|Withdrawn in error|1|||
149147351|NCT01500278|538019462|FG001|Week 13 - Week 104|Withdrawn in error|0|||
149147352|NCT01500278|538019461|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
149147353|NCT01500278|538019462|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
149147354|NCT01500278|538019461|FG000|Week 13 - Week 104|Protocol deviation|1|||
149147355|NCT01500278|538019462|FG001|Week 13 - Week 104|Protocol deviation|0|||
149147356|NCT01500278|538019461|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
149147357|NCT01500278|538019462|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
149147358|NCT01500278|538019461|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
149147359|NCT01500278|538019462|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
149147360|NCT01500278|538019461|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
149147361|NCT01500278|538019462|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
149147362|NCT01500278|538019461|FG000|Week 13 - Week 104|Relocation|0|||
149147363|NCT01500278|538019462|FG001|Week 13 - Week 104|Relocation|1|||
149147364|NCT01500278|538019461|FG000|Week 13 - Week 104|Sponsor decision|0|||
149147365|NCT01500278|538019462|FG001|Week 13 - Week 104|Sponsor decision|2|||
149147366|NCT01500278|538019461|FG000|Week 13 - Week 104|Medical monitor decision|0|||
149147367|NCT01500278|538019462|FG001|Week 13 - Week 104|Medical monitor decision|2|||
149147368|NCT01500278|538019461|FG000|Week 13 - Week 104|Personal reason|0|||
149147369|NCT01500278|538019462|FG001|Week 13 - Week 104|Personal reason|1|||
149147370|NCT01500278|538019461|FG000|Week 13 - Week 104|Not completed|0|||
149147371|NCT01500278|538019462|FG001|Week 13 - Week 104|Not completed|1|||
149147372|NCT01500278|538019461|FG000|Week 13 - Week 104|Death|2|||
149147373|NCT01500278|538019462|FG001|Week 13 - Week 104|Death|4|||
149147374|NCT01500278|538019461|FG000|Week 13 - Week 104|Adverse Event|54|||
149147375|NCT01500278|538019462|FG001|Week 13 - Week 104|Adverse Event|54|||
149147376|NCT00845728|538019465|FG000|Overall Study|Abnormal laboratory value (s)|2|||
149147377|NCT00845728|538019466|FG001|Overall Study|Abnormal laboratory value (s)|2|||
149147378|NCT00845728|538019465|FG000|Overall Study|Patient's inability to use the device|4|||
149147379|NCT00845728|538019466|FG001|Overall Study|Patient's inability to use the device|6|||
149147380|NCT00845728|538019465|FG000|Overall Study|Abnormal test procedure result (s)|7|||
148805049|NCT03466346|536766652|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
148914185|NCT00095940|537169922|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
148914186|NCT00095940|537169923|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
148914187|NCT00095940|537169924|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
148914188|NCT00095940|537169925|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
149147381|NCT00845728|538019466|FG001|Overall Study|Abnormal test procedure result (s)|2|||
149147382|NCT00845728|538019465|FG000|Overall Study|Lost to Follow-up|22|||
149147383|NCT00845728|538019466|FG001|Overall Study|Lost to Follow-up|13|||
149147384|NCT00845728|538019465|FG000|Overall Study|Death|24|||
149147385|NCT00845728|538019466|FG001|Overall Study|Death|26|||
149147386|NCT00845728|538019465|FG000|Overall Study|Administrative Problems|34|||
149147387|NCT00845728|538019466|FG001|Overall Study|Administrative Problems|26|||
148914189|NCT00095940|537169917|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
149147388|NCT00845728|538019465|FG000|Overall Study|Protocol Violation|36|||
149147389|NCT00845728|538019466|FG001|Overall Study|Protocol Violation|24|||
148671387|NCT01035229|536268738|FG001|Overall Study|Withdrawal by Subject|7|||
148671388|NCT01035229|536268737|FG000|Overall Study|Lost to Follow-up|1|||
148671389|NCT01035229|536268738|FG001|Overall Study|Lost to Follow-up|0|||
148671390|NCT01035229|536268737|FG000|Overall Study|Administrative problems|1|||
148671391|NCT01035229|536268738|FG001|Overall Study|Administrative problems|1|||
148914190|NCT00095940|537169918|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
148914191|NCT00095940|537169919|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
148914192|NCT00095940|537169920|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
148914193|NCT00095940|537169921|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
148914194|NCT00095940|537169922|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
148914195|NCT00095940|537169923|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
148914196|NCT00095940|537169924|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
148805050|NCT03466346|536766653|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
149147390|NCT00845728|538019465|FG000|Overall Study|Lack of Efficacy|51|||
149147391|NCT00845728|538019466|FG001|Overall Study|Lack of Efficacy|39|||
149147392|NCT00845728|538019465|FG000|Overall Study|Adverse Event|101|||
149147393|NCT00845728|538019466|FG001|Overall Study|Adverse Event|96|||
149147394|NCT00845728|538019465|FG000|Overall Study|Withdrawal by Subject|105|||
149147395|NCT00845728|538019466|FG001|Overall Study|Withdrawal by Subject|108|||
149147396|NCT01709435|538019467|FG000|Overall Study|Adverse Event|1|||
149147397|NCT01709435|538019468|FG001|Overall Study|Adverse Event|1|||
149147398|NCT01709435|538019469|FG002|Overall Study|Adverse Event|1|||
149147399|NCT01709435|538019470|FG003|Overall Study|Adverse Event|0|||
149147400|NCT01709435|538019471|FG004|Overall Study|Adverse Event|0|||
149147401|NCT01709435|538019472|FG005|Overall Study|Adverse Event|1|||
149147402|NCT01709435|538019467|FG000|Overall Study|Lack of Efficacy|5|||
149147403|NCT01709435|538019468|FG001|Overall Study|Lack of Efficacy|7|||
149147404|NCT01709435|538019469|FG002|Overall Study|Lack of Efficacy|2|||
149147405|NCT01709435|538019470|FG003|Overall Study|Lack of Efficacy|2|||
149147406|NCT01709435|538019471|FG004|Overall Study|Lack of Efficacy|6|||
149147407|NCT01709435|538019472|FG005|Overall Study|Lack of Efficacy|3|||
149147408|NCT01709435|538019467|FG000|Overall Study|Physician Decision|0|||
149147409|NCT01709435|538019468|FG001|Overall Study|Physician Decision|1|||
149147410|NCT01709435|538019469|FG002|Overall Study|Physician Decision|0|||
149147411|NCT01709435|538019470|FG003|Overall Study|Physician Decision|1|||
149147412|NCT01709435|538019471|FG004|Overall Study|Physician Decision|2|||
149147413|NCT01709435|538019472|FG005|Overall Study|Physician Decision|0|||
149147414|NCT01709435|538019467|FG000|Overall Study|Withdrawal by Subject|0|||
149147415|NCT01709435|538019468|FG001|Overall Study|Withdrawal by Subject|0|||
149147416|NCT01709435|538019469|FG002|Overall Study|Withdrawal by Subject|3|||
149147417|NCT01709435|538019470|FG003|Overall Study|Withdrawal by Subject|0|||
149147418|NCT01709435|538019471|FG004|Overall Study|Withdrawal by Subject|2|||
149147419|NCT01709435|538019472|FG005|Overall Study|Withdrawal by Subject|2|||
149147420|NCT02716987|538019475|FG000|Overall Study|Ligand synthesis failure|0|||
149147421|NCT02716987|538019476|FG001|Overall Study|Ligand synthesis failure|0|||
149147422|NCT02716987|538019477|FG002|Overall Study|Ligand synthesis failure|1|||
149147423|NCT02716987|538019478|FG003|Overall Study|Ligand synthesis failure|0|||
149147424|NCT02716987|538019479|FG004|Overall Study|Ligand synthesis failure|0|||
149147425|NCT02716987|538019480|FG005|Overall Study|Ligand synthesis failure|0|||
149147426|NCT02716987|538019475|FG000|Overall Study|Withdrawal by Subject|0|||
149147427|NCT02716987|538019476|FG001|Overall Study|Withdrawal by Subject|0|||
149147428|NCT02716987|538019477|FG002|Overall Study|Withdrawal by Subject|0|||
149147429|NCT02716987|538019478|FG003|Overall Study|Withdrawal by Subject|0|||
149147430|NCT02716987|538019479|FG004|Overall Study|Withdrawal by Subject|1|||
149147431|NCT02716987|538019480|FG005|Overall Study|Withdrawal by Subject|1|||
149147432|NCT01765920|538019481|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
149147433|NCT01765920|538019482|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
149147434|NCT01765920|538019481|FG000|Overall Study|Patient code disclosure|0|||
149147435|NCT01765920|538019482|FG001|Overall Study|Patient code disclosure|1|||
149147436|NCT00886600|538019492|FG000|Double-blind Monotherapy|Adverse Event|1|||
149147437|NCT00886600|538019493|FG001|Double-blind Monotherapy|Adverse Event|1|||
149147438|NCT00886600|538019494|FG002|Double-blind Monotherapy|Adverse Event|1|||
148914197|NCT00095940|537169925|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
149147439|NCT00886600|538019495|FG003|Double-blind Monotherapy|Adverse Event|1|||
149147440|NCT00886600|538019492|FG000|Double-blind Monotherapy|Protocol Violation|0|||
149147441|NCT00886600|538019493|FG001|Double-blind Monotherapy|Protocol Violation|0|||
149147442|NCT00886600|538019494|FG002|Double-blind Monotherapy|Protocol Violation|0|||
148914198|NCT00095940|537169917|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914199|NCT00095940|537169918|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914200|NCT00095940|537169919|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914201|NCT00095940|537169920|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914202|NCT00095940|537169921|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914203|NCT00095940|537169922|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914204|NCT00095940|537169923|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914205|NCT00095940|537169924|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
148914206|NCT00095940|537169925|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
148914207|NCT00387790|537169926|FG000|Overall Study|Adverse Event|5|||
148914208|NCT00387790|537169926|FG000|Overall Study|Lack of Efficacy|2|||
148914209|NCT00387790|537169926|FG000|Overall Study|Physician Decision|2|||
148914210|NCT00387790|537169926|FG000|Overall Study|Withdrawal by Subject|3|||
148914211|NCT00387790|537169926|FG000|Overall Study|Ineligible for study|2|||
148914212|NCT04491604|537169927|FG000|Overall Study|Withdrawal by Subject|3|||
148914213|NCT01874340|537169930|FG000|Overall Study|Study terminated by Sponsor|6|||
148914214|NCT01874340|537169931|FG001|Overall Study|Study terminated by Sponsor|8|||
149147443|NCT00886600|538019495|FG003|Double-blind Monotherapy|Protocol Violation|1|||
149147444|NCT00886600|538019492|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
149147445|NCT00886600|538019493|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
149147446|NCT00886600|538019494|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
149147447|NCT00886600|538019495|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
149147448|NCT00886600|538019492|FG000|Combination Therapy Period|Adverse Event|0|||
149147449|NCT00886600|538019493|FG001|Combination Therapy Period|Adverse Event|0|||
149147450|NCT00886600|538019494|FG002|Combination Therapy Period|Adverse Event|1|||
149147451|NCT00886600|538019495|FG003|Combination Therapy Period|Adverse Event|0|||
149147452|NCT00886600|538019492|FG000|Combination Therapy Period|Protocol Violation|0|||
149147453|NCT00886600|538019493|FG001|Combination Therapy Period|Protocol Violation|0|||
149147454|NCT00886600|538019494|FG002|Combination Therapy Period|Protocol Violation|1|||
149147455|NCT00886600|538019495|FG003|Combination Therapy Period|Protocol Violation|0|||
149147456|NCT02255409|538019496|FG000|Overall Study|Administrative Reason|3|||
149147457|NCT02255409|538019497|FG001|Overall Study|Administrative Reason|7|||
149147458|NCT02255409|538019496|FG000|Overall Study|Withdrawal by Subject|1|||
149147459|NCT02255409|538019497|FG001|Overall Study|Withdrawal by Subject|5|||
149147460|NCT02255409|538019496|FG000|Overall Study|Lost to Follow-up|10|||
149147461|NCT02255409|538019497|FG001|Overall Study|Lost to Follow-up|19|||
149147462|NCT01251367|538019498|FG000|Overall Study|Protocol Violation|1|||
149147463|NCT01251367|538019498|FG000|Overall Study|Lack of Efficacy|2|||
149147464|NCT01251367|538019498|FG000|Overall Study|Adverse Event|19|||
149147465|NCT01251367|538019498|FG000|Overall Study|Withdrawal by Subject|36|||
149147466|NCT01251367|538019498|FG000|Overall Study|Lost to Follow-up|5|||
149147467|NCT01251367|538019498|FG000|Overall Study|Subject Required Alternative Treatment|7|||
149147468|NCT01251367|538019498|FG000|Overall Study|No Study Drug Available|1|||
149147469|NCT01251367|538019498|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
149147470|NCT01251367|538019498|FG000|Overall Study|End of Study Visit Performed in Error|1|||
149147471|NCT02290873|538019502|FG000|Overall Study|Withdrawal by Subject|0|||
149147472|NCT02290873|538019503|FG001|Overall Study|Withdrawal by Subject|1|||
149147473|NCT02290873|538019504|FG002|Overall Study|Withdrawal by Subject|1|||
149147474|NCT02290873|538019502|FG000|Overall Study|Nellcor device error|1|||
149147475|NCT02290873|538019503|FG001|Overall Study|Nellcor device error|0|||
149147476|NCT02290873|538019504|FG002|Overall Study|Nellcor device error|0|||
149147477|NCT02290873|538019502|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
149147478|NCT02290873|538019503|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
149147479|NCT02290873|538019504|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
149147480|NCT02290873|538019502|FG000|Overall Study|Protocol Violation|0|||
149147481|NCT02290873|538019503|FG001|Overall Study|Protocol Violation|0|||
149147482|NCT02290873|538019504|FG002|Overall Study|Protocol Violation|1|||
149147483|NCT00506883|538019505|FG000|Overall Study|Lost to Follow-up|1|||
149147484|NCT00506883|538019506|FG001|Overall Study|Lost to Follow-up|1|||
149147485|NCT00506883|538019507|FG002|Overall Study|Lost to Follow-up|1|||
149147486|NCT00506883|538019505|FG000|Overall Study|Withdrawal by Subject|1|||
149147487|NCT00506883|538019506|FG001|Overall Study|Withdrawal by Subject|0|||
149147488|NCT00506883|538019507|FG002|Overall Study|Withdrawal by Subject|1|||
149147489|NCT00506883|538019505|FG000|Overall Study|Lack of Efficacy|0|||
149147490|NCT00506883|538019506|FG001|Overall Study|Lack of Efficacy|1|||
149147491|NCT00506883|538019507|FG002|Overall Study|Lack of Efficacy|1|||
149147492|NCT00506883|538019505|FG000|Overall Study|Other|5|||
149147493|NCT00506883|538019506|FG001|Overall Study|Other|1|||
149147494|NCT00506883|538019507|FG002|Overall Study|Other|1|||
149147495|NCT00078325|538019511|FG000|Overall Study|Adverse Event|15|||
149147496|NCT00078325|538019512|FG001|Overall Study|Adverse Event|10|||
149147497|NCT00078325|538019513|FG002|Overall Study|Adverse Event|5|||
149147498|NCT00078325|538019511|FG000|Overall Study|Protocol Violation|2|||
149147499|NCT00078325|538019512|FG001|Overall Study|Protocol Violation|2|||
149147500|NCT00078325|538019513|FG002|Overall Study|Protocol Violation|0|||
149147501|NCT00078325|538019511|FG000|Overall Study|Withdrawal by Subject|1|||
149147502|NCT00078325|538019512|FG001|Overall Study|Withdrawal by Subject|5|||
149147503|NCT00078325|538019513|FG002|Overall Study|Withdrawal by Subject|3|||
149147504|NCT00078325|538019511|FG000|Overall Study|Lost to Follow-up|0|||
149147505|NCT00078325|538019512|FG001|Overall Study|Lost to Follow-up|1|||
149147506|NCT00078325|538019513|FG002|Overall Study|Lost to Follow-up|1|||
149147507|NCT00078325|538019511|FG000|Overall Study|Physician Decision|2|||
149147508|NCT00078325|538019512|FG001|Overall Study|Physician Decision|0|||
149147509|NCT00078325|538019513|FG002|Overall Study|Physician Decision|1|||
149147510|NCT00078325|538019511|FG000|Overall Study|Miscellaneous|1|||
149147511|NCT00078325|538019512|FG001|Overall Study|Miscellaneous|1|||
149147512|NCT00078325|538019513|FG002|Overall Study|Miscellaneous|1|||
149147513|NCT01473563|538019514|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
149147514|NCT01519765|538019515|FG000|Overall Study|Adverse Event|0|||
149147515|NCT01519765|538019516|FG001|Overall Study|Adverse Event|1|||
148914215|NCT01874340|537169932|FG002|Overall Study|Study terminated by Sponsor|8|||
148914216|NCT01874340|537169933|FG003|Overall Study|Study terminated by Sponsor|4|||
148914217|NCT01874340|537169930|FG000|Overall Study|Withdrawal by Subject|0|||
148914218|NCT01874340|537169931|FG001|Overall Study|Withdrawal by Subject|0|||
148914219|NCT01874340|537169932|FG002|Overall Study|Withdrawal by Subject|0|||
148914220|NCT01874340|537169933|FG003|Overall Study|Withdrawal by Subject|1|||
148914221|NCT03539549|537169935|FG000|Overall Study|Adverse Event|12|||
148914222|NCT03539549|537169935|FG000|Overall Study|Lost to Follow-up|1|||
148914223|NCT03539549|537169935|FG000|Overall Study|Death|2|||
148914224|NCT03539549|537169935|FG000|Overall Study|Progressive Disease|1|||
148914225|NCT03539549|537169935|FG000|Overall Study|Reason not Specified|1|||
148914226|NCT02864862|537169940|FG000|Overall Study|Lost to Follow-up|1|||
148914227|NCT02864862|537169941|FG001|Overall Study|Lost to Follow-up|0|||
148914228|NCT02864862|537169942|FG002|Overall Study|Lost to Follow-up|1|||
148914229|NCT02864862|537169940|FG000|Overall Study|Protocol Violation|0|||
148914230|NCT02864862|537169941|FG001|Overall Study|Protocol Violation|0|||
148914231|NCT02864862|537169942|FG002|Overall Study|Protocol Violation|1|||
148914232|NCT04605991|537169943|FG000|Overall Study|Adverse Event|5|||
148914233|NCT04605991|537169943|FG000|Overall Study|Lack of Efficacy|1|||
148914234|NCT04605991|537169943|FG000|Overall Study|Lost to Follow-up|8|||
148914235|NCT04605991|537169943|FG000|Overall Study|Physician Decision|4|||
148914236|NCT04605991|537169943|FG000|Overall Study|Withdrawal by Subject|14|||
148914237|NCT04605991|537169943|FG000|Overall Study|Non-compliance with study|1|||
148914238|NCT01523275|537169947|FG000|Overall Study|Lost to Follow-up|1|||
148914239|NCT01523275|537169948|FG001|Overall Study|Lost to Follow-up|2|||
148914240|NCT01523275|537169947|FG000|Overall Study|Withdrawal by Subject|1|||
148914241|NCT01523275|537169948|FG001|Overall Study|Withdrawal by Subject|0|||
148914242|NCT03263702|537169949|FG000|Overall Study|Lost to Follow-up|2|||
148914243|NCT03263702|537169950|FG001|Overall Study|Lost to Follow-up|2|||
148914244|NCT03263702|537169949|FG000|Overall Study|Withdrawal by Subject|1|||
148914245|NCT03263702|537169950|FG001|Overall Study|Withdrawal by Subject|2|||
148914246|NCT03598114|537169951|FG000|Overall Study|Staff turnover/left the program|3|||
148914247|NCT03598114|537169952|FG001|Overall Study|Staff turnover/left the program|39|||
148914248|NCT02527200|537169953|FG000|Overall Study|Withdrawal by Subject|3|||
148914249|NCT02527200|537169954|FG001|Overall Study|Withdrawal by Subject|2|||
148914250|NCT02527200|537169955|FG002|Overall Study|Withdrawal by Subject|1|||
148914251|NCT02527200|537169956|FG003|Overall Study|Withdrawal by Subject|0|||
148914252|NCT02527200|537169953|FG000|Overall Study|Unclassified|0|||
148914253|NCT02527200|537169954|FG001|Overall Study|Unclassified|1|||
148914254|NCT02527200|537169955|FG002|Overall Study|Unclassified|0|||
148914255|NCT02527200|537169956|FG003|Overall Study|Unclassified|0|||
148671392|NCT01035229|536268737|FG000|Overall Study|Death|13|||
148914256|NCT02527200|537169953|FG000|Overall Study|Lost to Follow-up|0|||
148914257|NCT02527200|537169954|FG001|Overall Study|Lost to Follow-up|0|||
148914258|NCT02527200|537169955|FG002|Overall Study|Lost to Follow-up|1|||
148914259|NCT02527200|537169956|FG003|Overall Study|Lost to Follow-up|0|||
148914260|NCT00689117|537169957|FG000|Overall Study|Adverse Event|6|||
148914261|NCT00689117|537169958|FG001|Overall Study|Adverse Event|0|||
148914262|NCT00689117|537169959|FG002|Overall Study|Adverse Event|5|||
148914263|NCT00689117|537169960|FG003|Overall Study|Adverse Event|0|||
148914264|NCT00689117|537169957|FG000|Overall Study|Lost to Follow-up|26|||
148914265|NCT00689117|537169958|FG001|Overall Study|Lost to Follow-up|19|||
148914266|NCT00689117|537169959|FG002|Overall Study|Lost to Follow-up|17|||
148914267|NCT00689117|537169960|FG003|Overall Study|Lost to Follow-up|11|||
149147516|NCT01519765|538019515|FG000|Overall Study|Lack of Efficacy|2|||
149147517|NCT01519765|538019516|FG001|Overall Study|Lack of Efficacy|0|||
149147518|NCT01519765|538019515|FG000|Overall Study|Protocol Violation|1|||
149147519|NCT01519765|538019516|FG001|Overall Study|Protocol Violation|0|||
149147520|NCT01519765|538019515|FG000|Overall Study|Withdrawal by Subject|0|||
149147521|NCT01519765|538019516|FG001|Overall Study|Withdrawal by Subject|1|||
149147522|NCT02739620|538019517|FG000|Overall Study|Lost to Follow-up|3|||
149147523|NCT02739620|538019518|FG001|Overall Study|Lost to Follow-up|1|||
149147524|NCT02739620|538019517|FG000|Overall Study|Adverse Event|0|||
149147525|NCT02739620|538019518|FG001|Overall Study|Adverse Event|1|||
149147526|NCT02354222|538019519|FG000|Overall Study|Adverse Event|0|||
149147527|NCT02354222|538019520|FG001|Overall Study|Adverse Event|3|||
149147528|NCT02354222|538019519|FG000|Overall Study|Physician Decision|1|||
149147529|NCT02354222|538019520|FG001|Overall Study|Physician Decision|1|||
149147530|NCT02354222|538019519|FG000|Overall Study|Pregnancy|1|||
149147531|NCT02354222|538019520|FG001|Overall Study|Pregnancy|0|||
149147532|NCT02354222|538019519|FG000|Overall Study|Withdrawal by Subject|2|||
149147533|NCT02354222|538019520|FG001|Overall Study|Withdrawal by Subject|3|||
149147534|NCT02354222|538019519|FG000|Overall Study|Conflict with the stopping criteria|0|||
149147535|NCT02354222|538019520|FG001|Overall Study|Conflict with the stopping criteria|4|||
149147536|NCT02437864|538019532|FG000|Overall Study|Protocol Violation|4|||
149147537|NCT02437864|538019533|FG001|Overall Study|Protocol Violation|0|||
149147538|NCT01892163|538019534|FG000|Overall Study|Death|1|||
149147539|NCT01892163|538019535|FG001|Overall Study|Death|1|||
149147540|NCT01892163|538019534|FG000|Overall Study|Lost to Follow-up|1|||
149147541|NCT01892163|538019535|FG001|Overall Study|Lost to Follow-up|0|||
149147542|NCT01924182|538019536|FG000|Overall Study|Withdrawal by Subject|1|||
149147543|NCT01924182|538019537|FG001|Overall Study|Withdrawal by Subject|0|||
149147544|NCT00993265|538019543|FG000|Overall Study|Adverse Event|1|||
149147545|NCT00993265|538019544|FG001|Overall Study|Adverse Event|0|||
149147546|NCT00993265|538019543|FG000|Overall Study|Changed dose of concomitant drug|2|||
149147547|NCT00993265|538019544|FG001|Overall Study|Changed dose of concomitant drug|0|||
149147548|NCT00993265|538019543|FG000|Overall Study|Non-compliant with study medication|1|||
149147549|NCT00993265|538019544|FG001|Overall Study|Non-compliant with study medication|0|||
149147550|NCT02577146|538019545|FG000|Overall Study|Lost to Follow-up|8|||
149147551|NCT02577146|538019545|FG000|Overall Study|Physician Decision|3|||
149147552|NCT02577146|538019545|FG000|Overall Study|Screen Failure|17|||
149147553|NCT00219284|538019546|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
149147554|NCT00219284|538019547|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
149147555|NCT00219284|538019546|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
149147556|NCT00219284|538019547|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
149147557|NCT00219284|538019546|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
149147558|NCT00219284|538019547|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
149147559|NCT00219284|538019546|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
149147560|NCT00219284|538019547|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
149147561|NCT00219284|538019546|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
149147562|NCT00219284|538019547|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
149147563|NCT00219284|538019546|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
149147564|NCT00219284|538019547|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
149147565|NCT00219284|538019546|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
149147566|NCT00219284|538019547|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
149147567|NCT00219284|538019546|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
149147568|NCT00219284|538019547|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
149147569|NCT00219284|538019546|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
149147570|NCT00219284|538019547|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
149147571|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
149147572|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
149147573|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
149233848|NCT00948896|538324945|FG001|Randomization to 24 Months of Age|Death|0|||
149233849|NCT00948896|538324946|FG002|Randomization to 24 Months of Age|Death|0|||
149233850|NCT00948896|538324947|FG003|Randomization to 24 Months of Age|Death|0|||
149233851|NCT00948896|538324948|FG004|Randomization to 24 Months of Age|Death|2|||
149233852|NCT00948896|538324949|FG005|Randomization to 24 Months of Age|Death|1|||
149233853|NCT00948896|538324950|FG006|Randomization to 24 Months of Age|Death|2|||
149233854|NCT00948896|538324951|FG007|Randomization to 24 Months of Age|Death|1|||
149233855|NCT00948896|538324944|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
149233856|NCT00948896|538324945|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
149233857|NCT00948896|538324946|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
149233858|NCT00948896|538324947|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
149233859|NCT00948896|538324948|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
149233860|NCT00948896|538324949|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
149233861|NCT00948896|538324950|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
149147574|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
149147575|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
149147576|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
149147577|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
149147578|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
149147579|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to death|4|||
149147580|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to death|3|||
149147581|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
149147582|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
149147583|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
149147584|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
149147585|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
149147586|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
149147587|NCT02258451|538019551|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
149147588|NCT02258451|538019552|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
149147589|NCT02258451|538019551|FG000|Overall Study|Other reason|1|||
149147590|NCT02258451|538019552|FG001|Overall Study|Other reason|1|||
149147591|NCT02258451|538019551|FG000|Overall Study|Never treated|2|||
149147592|NCT02258451|538019552|FG001|Overall Study|Never treated|3|||
149147593|NCT00517751|538019562|FG000|Overall Study|Death|3|||
149147594|NCT00517751|538019562|FG000|Overall Study|Withdrawal by Subject|37|||
149147595|NCT00517751|538019562|FG000|Overall Study|Lost to Follow-up|4|||
149147596|NCT00517751|538019562|FG000|Overall Study|patient not over due|6|||
149147597|NCT00517751|538019562|FG000|Overall Study|Patient not due for visit|76|||
149147598|NCT00517751|538019562|FG000|Overall Study|Missing|3|||
149147599|NCT03021499|538019563|FG000|Overall Study|Adverse Event|1|||
149147600|NCT03021499|538019564|FG001|Overall Study|Adverse Event|0|||
149147601|NCT03021499|538019563|FG000|Overall Study|Death|1|||
149147602|NCT03021499|538019564|FG001|Overall Study|Death|5|||
149147603|NCT03021499|538019563|FG000|Overall Study|Lack of Efficacy|0|||
149147604|NCT03021499|538019564|FG001|Overall Study|Lack of Efficacy|1|||
149147605|NCT03021499|538019563|FG000|Overall Study|Lost to Follow-up|1|||
149147606|NCT03021499|538019564|FG001|Overall Study|Lost to Follow-up|3|||
149147607|NCT03021499|538019563|FG000|Overall Study|Physician Decision|2|||
149147608|NCT03021499|538019564|FG001|Overall Study|Physician Decision|3|||
149147609|NCT03021499|538019563|FG000|Overall Study|Pregnancy|1|||
149147610|NCT03021499|538019564|FG001|Overall Study|Pregnancy|0|||
149147611|NCT03021499|538019563|FG000|Overall Study|Withdrawal by Subject|7|||
149147612|NCT03021499|538019564|FG001|Overall Study|Withdrawal by Subject|14|||
149147613|NCT03021499|538019563|FG000|Overall Study|Prohibited medication required|1|||
149147614|NCT03021499|538019564|FG001|Overall Study|Prohibited medication required|0|||
149147615|NCT03021499|538019563|FG000|Overall Study|Protocol non-compliance|1|||
149147616|NCT03021499|538019564|FG001|Overall Study|Protocol non-compliance|1|||
149147617|NCT03021499|538019563|FG000|Overall Study|None of the above|0|||
149147618|NCT03021499|538019564|FG001|Overall Study|None of the above|4|||
149147619|NCT03021499|538019563|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
149147620|NCT03021499|538019564|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
149147621|NCT01210690|538019565|FG000|Overall Study|Adverse Event|7|||
149147622|NCT01210690|538019565|FG000|Overall Study|Lack of Efficacy|12|||
149147623|NCT01210690|538019565|FG000|Overall Study|Lost to Follow-up|3|||
149147624|NCT01210690|538019565|FG000|Overall Study|Disease Remission|1|||
149147625|NCT01210690|538019565|FG000|Overall Study|Withdrawal by Subject|1|||
149147626|NCT01210690|538019565|FG000|Overall Study|Patient refused to swallow|1|||
148805051|NCT03466346|536766654|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
149147627|NCT01210690|538019565|FG000|Overall Study|Patient could not take glucose|1|||
149147628|NCT00470054|538019566|FG000|Overall Study|Ineligible|1|||
149147629|NCT01246583|538019569|FG000|Overall Study|Lost to Follow-up|0|||
149147630|NCT01246583|538019570|FG001|Overall Study|Lost to Follow-up|0|||
149147631|NCT01246583|538019571|FG002|Overall Study|Lost to Follow-up|0|||
149147632|NCT01246583|538019572|FG003|Overall Study|Lost to Follow-up|1|||
149147633|NCT01246583|538019569|FG000|Overall Study|Protocol Violation|0|||
149147634|NCT01246583|538019570|FG001|Overall Study|Protocol Violation|0|||
149147635|NCT01246583|538019571|FG002|Overall Study|Protocol Violation|1|||
149147636|NCT01246583|538019572|FG003|Overall Study|Protocol Violation|0|||
149147637|NCT01246583|538019569|FG000|Overall Study|Withdrawal by Subject|1|||
149147638|NCT01246583|538019570|FG001|Overall Study|Withdrawal by Subject|0|||
149147639|NCT01246583|538019571|FG002|Overall Study|Withdrawal by Subject|0|||
149147640|NCT01246583|538019572|FG003|Overall Study|Withdrawal by Subject|0|||
149147641|NCT01423851|538019573|FG000|Whole Study|Disease progression|2|||
149147642|NCT01423851|538019574|FG001|Whole Study|Disease progression|1|||
149147643|NCT01423851|538019575|FG002|Whole Study|Disease progression|1|||
149147644|NCT01423851|538019576|FG003|Whole Study|Disease progression|4|||
149147645|NCT01423851|538019577|FG004|Whole Study|Disease progression|1|||
149147646|NCT01423851|538019578|FG005|Whole Study|Disease progression|3|||
149147647|NCT01423851|538019579|FG006|Whole Study|Disease progression|1|||
149147648|NCT01423851|538019580|FG007|Whole Study|Disease progression|4|||
149147649|NCT01423851|538019581|FG008|Whole Study|Disease progression|0|||
149147650|NCT01423851|538019582|FG009|Whole Study|Disease progression|2|||
149147651|NCT01423851|538019583|FG010|Whole Study|Disease progression|10|||
149147652|NCT01423851|538019573|FG000|Whole Study|Physician Decision|0|||
149147653|NCT01423851|538019574|FG001|Whole Study|Physician Decision|1|||
149147654|NCT01423851|538019575|FG002|Whole Study|Physician Decision|2|||
149147655|NCT01423851|538019576|FG003|Whole Study|Physician Decision|0|||
149147656|NCT01423851|538019577|FG004|Whole Study|Physician Decision|2|||
149147657|NCT01423851|538019578|FG005|Whole Study|Physician Decision|0|||
149147658|NCT01423851|538019579|FG006|Whole Study|Physician Decision|2|||
149147659|NCT01423851|538019580|FG007|Whole Study|Physician Decision|1|||
149147660|NCT01423851|538019581|FG008|Whole Study|Physician Decision|3|||
149147661|NCT01423851|538019582|FG009|Whole Study|Physician Decision|4|||
149147662|NCT01423851|538019583|FG010|Whole Study|Physician Decision|12|||
149147663|NCT01423851|538019573|FG000|Whole Study|Withdrawal by Subject|1|||
149147664|NCT01423851|538019574|FG001|Whole Study|Withdrawal by Subject|1|||
149147665|NCT01423851|538019575|FG002|Whole Study|Withdrawal by Subject|0|||
149147666|NCT01423851|538019576|FG003|Whole Study|Withdrawal by Subject|0|||
149147667|NCT01423851|538019577|FG004|Whole Study|Withdrawal by Subject|0|||
149147668|NCT01423851|538019578|FG005|Whole Study|Withdrawal by Subject|0|||
149147669|NCT01423851|538019579|FG006|Whole Study|Withdrawal by Subject|0|||
149147670|NCT01423851|538019580|FG007|Whole Study|Withdrawal by Subject|0|||
149147671|NCT01423851|538019581|FG008|Whole Study|Withdrawal by Subject|2|||
148671393|NCT01035229|536268738|FG001|Overall Study|Death|5|||
149147672|NCT01423851|538019582|FG009|Whole Study|Withdrawal by Subject|0|||
149147673|NCT01423851|538019583|FG010|Whole Study|Withdrawal by Subject|4|||
149147674|NCT01423851|538019573|FG000|Whole Study|Adverse Event|0|||
149147675|NCT01423851|538019574|FG001|Whole Study|Adverse Event|0|||
149147676|NCT01423851|538019575|FG002|Whole Study|Adverse Event|0|||
149147677|NCT01423851|538019576|FG003|Whole Study|Adverse Event|2|||
148671394|NCT01035229|536268737|FG000|Overall Study|New cancer therapy|2|||
149147678|NCT01423851|538019577|FG004|Whole Study|Adverse Event|0|||
149147679|NCT01423851|538019578|FG005|Whole Study|Adverse Event|0|||
149147680|NCT01423851|538019579|FG006|Whole Study|Adverse Event|0|||
149147681|NCT01423851|538019580|FG007|Whole Study|Adverse Event|3|||
149147682|NCT01423851|538019581|FG008|Whole Study|Adverse Event|3|||
148671395|NCT01035229|536268738|FG001|Overall Study|New cancer therapy|0|||
149147683|NCT01423851|538019582|FG009|Whole Study|Adverse Event|2|||
149147684|NCT01423851|538019583|FG010|Whole Study|Adverse Event|3|||
149147685|NCT00129766|538020655|FG000|Overall Study|Death|3|||
149147686|NCT00129766|538020656|FG001|Overall Study|Death|8|||
149147687|NCT00129766|538020655|FG000|Overall Study|Withdrawal of consent|31|||
149147688|NCT00129766|538020656|FG001|Overall Study|Withdrawal of consent|30|||
149147689|NCT00129766|538020655|FG000|Overall Study|Lost to Follow-up|26|||
149147690|NCT00129766|538020656|FG001|Overall Study|Lost to Follow-up|21|||
149147691|NCT01081912|538020657|FG000|Conversion/Titration|Adverse Event|47|||
149147692|NCT01081912|538020658|FG001|Conversion/Titration|Adverse Event|0|||
149147693|NCT01081912|538020659|FG002|Conversion/Titration|Adverse Event|0|||
149147694|NCT01081912|538020657|FG000|Conversion/Titration|Lack of Efficacy|17|||
149147695|NCT01081912|538020658|FG001|Conversion/Titration|Lack of Efficacy|0|||
149147696|NCT01081912|538020659|FG002|Conversion/Titration|Lack of Efficacy|0|||
149147697|NCT01081912|538020657|FG000|Conversion/Titration|Lost to Follow-up|5|||
149147698|NCT01081912|538020658|FG001|Conversion/Titration|Lost to Follow-up|0|||
149147699|NCT01081912|538020659|FG002|Conversion/Titration|Lost to Follow-up|0|||
149147700|NCT01081912|538020657|FG000|Conversion/Titration|Physician Decision|2|||
149147701|NCT01081912|538020658|FG001|Conversion/Titration|Physician Decision|0|||
149147702|NCT01081912|538020659|FG002|Conversion/Titration|Physician Decision|0|||
149147703|NCT01081912|538020657|FG000|Conversion/Titration|Protocol Violation|67|||
149147704|NCT01081912|538020658|FG001|Conversion/Titration|Protocol Violation|0|||
149147705|NCT01081912|538020659|FG002|Conversion/Titration|Protocol Violation|0|||
149147706|NCT01081912|538020657|FG000|Conversion/Titration|Withdrawal by Subject|23|||
149147707|NCT01081912|538020658|FG001|Conversion/Titration|Withdrawal by Subject|0|||
149147708|NCT01081912|538020659|FG002|Conversion/Titration|Withdrawal by Subject|0|||
149147709|NCT01081912|538020657|FG000|Conversion/Titration|Non-Compliance|47|||
149147710|NCT01081912|538020658|FG001|Conversion/Titration|Non-Compliance|0|||
149147711|NCT01081912|538020659|FG002|Conversion/Titration|Non-Compliance|0|||
149147712|NCT01081912|538020657|FG000|Maintenance Treatment|Adverse Event|0|||
149147713|NCT01081912|538020658|FG001|Maintenance Treatment|Adverse Event|2|||
149147714|NCT01081912|538020659|FG002|Maintenance Treatment|Adverse Event|12|||
149147715|NCT01081912|538020657|FG000|Maintenance Treatment|Lack of Efficacy|0|||
149147716|NCT01081912|538020658|FG001|Maintenance Treatment|Lack of Efficacy|14|||
149147717|NCT01081912|538020659|FG002|Maintenance Treatment|Lack of Efficacy|64|||
149147718|NCT01081912|538020657|FG000|Maintenance Treatment|Lost to Follow-up|0|||
149147719|NCT01081912|538020658|FG001|Maintenance Treatment|Lost to Follow-up|1|||
149147720|NCT01081912|538020659|FG002|Maintenance Treatment|Lost to Follow-up|0|||
149147721|NCT01081912|538020657|FG000|Maintenance Treatment|Physician Decision|0|||
149147722|NCT01081912|538020658|FG001|Maintenance Treatment|Physician Decision|0|||
149147723|NCT01081912|538020659|FG002|Maintenance Treatment|Physician Decision|1|||
149147724|NCT01081912|538020657|FG000|Maintenance Treatment|Protocol Violation|0|||
149147725|NCT01081912|538020658|FG001|Maintenance Treatment|Protocol Violation|1|||
149147726|NCT01081912|538020659|FG002|Maintenance Treatment|Protocol Violation|2|||
149147727|NCT01081912|538020657|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
149147728|NCT01081912|538020658|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
149147729|NCT01081912|538020659|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
149147730|NCT01081912|538020657|FG000|Maintenance Treatment|Non-Compliance|0|||
149147731|NCT01081912|538020658|FG001|Maintenance Treatment|Non-Compliance|4|||
149147732|NCT01081912|538020659|FG002|Maintenance Treatment|Non-Compliance|7|||
149147733|NCT01081912|538020657|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
149147734|NCT01081912|538020658|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
149147735|NCT01081912|538020659|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
149147736|NCT00405067|538020670|FG000|Overall Study|Adverse Event|4|||
149147737|NCT00405067|538020671|FG001|Overall Study|Adverse Event|9|||
149147738|NCT00405067|538020672|FG002|Overall Study|Adverse Event|4|||
149147739|NCT00405067|538020670|FG000|Overall Study|Lost to Follow-up|0|||
149147740|NCT00405067|538020671|FG001|Overall Study|Lost to Follow-up|0|||
149147741|NCT00405067|538020672|FG002|Overall Study|Lost to Follow-up|1|||
149147742|NCT02055820|538020673|FG000|Phase I: Dose-Finding|Death|1|||
149147743|NCT02055820|538020674|FG001|Phase I: Dose-Finding|Death|0|||
149147744|NCT02055820|538020675|FG002|Phase I: Dose-Finding|Death|1|||
149147745|NCT02055820|538020676|FG003|Phase I: Dose-Finding|Death|2|||
149147746|NCT02055820|538020677|FG004|Phase I: Dose-Finding|Death|0|||
149147747|NCT02055820|538020678|FG005|Phase I: Dose-Finding|Death|1|||
149147748|NCT02055820|538020679|FG006|Phase I: Dose-Finding|Death|1|||
149147749|NCT02055820|538020680|FG007|Phase I: Dose-Finding|Death|0|||
149147750|NCT02055820|538020681|FG008|Phase I: Dose-Finding|Death|0|||
149147751|NCT02055820|538020682|FG009|Phase I: Dose-Finding|Death|0|||
149147752|NCT02055820|538020673|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147753|NCT02055820|538020674|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147754|NCT02055820|538020675|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147755|NCT02055820|538020676|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147756|NCT02055820|538020677|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147757|NCT02055820|538020678|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
149147758|NCT02055820|538020679|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147759|NCT02055820|538020680|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147760|NCT02055820|538020681|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147761|NCT02055820|538020682|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
149147762|NCT02055820|538020673|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147763|NCT02055820|538020674|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147764|NCT02055820|538020675|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147765|NCT02055820|538020676|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
149147766|NCT02055820|538020677|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147767|NCT02055820|538020678|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147768|NCT02055820|538020679|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
149147769|NCT02055820|538020680|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147770|NCT02055820|538020681|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147771|NCT02055820|538020682|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
149147772|NCT02055820|538020673|FG000|Phase II: Expansion|Death|0|||
149147773|NCT02055820|538020674|FG001|Phase II: Expansion|Death|0|||
149147774|NCT02055820|538020675|FG002|Phase II: Expansion|Death|0|||
149147775|NCT02055820|538020676|FG003|Phase II: Expansion|Death|0|||
149147776|NCT02055820|538020677|FG004|Phase II: Expansion|Death|33|||
149147777|NCT02055820|538020678|FG005|Phase II: Expansion|Death|0|||
149147778|NCT02055820|538020679|FG006|Phase II: Expansion|Death|0|||
149147779|NCT02055820|538020680|FG007|Phase II: Expansion|Death|0|||
149147780|NCT02055820|538020681|FG008|Phase II: Expansion|Death|0|||
149147781|NCT02055820|538020682|FG009|Phase II: Expansion|Death|0|||
149147782|NCT02055820|538020673|FG000|Phase II: Expansion|Lost to Follow-up|0|||
149147783|NCT02055820|538020674|FG001|Phase II: Expansion|Lost to Follow-up|0|||
149147784|NCT02055820|538020675|FG002|Phase II: Expansion|Lost to Follow-up|0|||
149147785|NCT02055820|538020676|FG003|Phase II: Expansion|Lost to Follow-up|0|||
149147786|NCT02055820|538020677|FG004|Phase II: Expansion|Lost to Follow-up|4|||
149147787|NCT02055820|538020678|FG005|Phase II: Expansion|Lost to Follow-up|0|||
149147788|NCT02055820|538020679|FG006|Phase II: Expansion|Lost to Follow-up|0|||
149147789|NCT02055820|538020680|FG007|Phase II: Expansion|Lost to Follow-up|0|||
149147790|NCT02055820|538020681|FG008|Phase II: Expansion|Lost to Follow-up|0|||
148805052|NCT03466346|536766650|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
148805053|NCT03466346|536766651|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
148805054|NCT03466346|536766652|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
148805055|NCT03466346|536766653|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
148805056|NCT03466346|536766654|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
148805057|NCT03466346|536766650|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
148805058|NCT03466346|536766651|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
148805059|NCT03466346|536766652|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
149147791|NCT02055820|538020682|FG009|Phase II: Expansion|Lost to Follow-up|0|||
149147792|NCT02055820|538020673|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
149147793|NCT02055820|538020674|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
149147794|NCT02055820|538020675|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
149147795|NCT02055820|538020676|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
149147796|NCT02055820|538020677|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
149147797|NCT02055820|538020678|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
149147798|NCT02055820|538020679|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
149147799|NCT02055820|538020680|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
149147800|NCT02055820|538020681|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
149147801|NCT02055820|538020682|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
149147802|NCT00631020|538020686|FG000|Overall Study|Lost to Follow-up|7|||
149147803|NCT00631020|538020686|FG000|Overall Study|Incarcerated|1|||
149147804|NCT03571646|538020688|FG000|Overall Study|Adverse Event|1|||
149147805|NCT03571646|538020689|FG001|Overall Study|Adverse Event|0|||
149147806|NCT03571646|538020688|FG000|Overall Study|Withdrawal by Subject|1|||
149147807|NCT03571646|538020689|FG001|Overall Study|Withdrawal by Subject|1|||
149147808|NCT01970995|538020690|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
149147809|NCT01970995|538020691|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
149147810|NCT01970995|538020692|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
149147811|NCT01970995|538020690|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
149147812|NCT01970995|538020691|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
149147813|NCT01970995|538020692|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
149147814|NCT01157364|538020693|FG000|Overall Study|Other Reasons|1|||
149147815|NCT01157364|538020694|FG001|Overall Study|Other Reasons|1|||
149147816|NCT01157364|538020695|FG002|Overall Study|Other Reasons|2|||
149147817|NCT01157364|538020696|FG003|Overall Study|Other Reasons|1|||
149147818|NCT01157364|538020697|FG004|Overall Study|Other Reasons|0|||
149147819|NCT01157364|538020698|FG005|Overall Study|Other Reasons|0|||
149147820|NCT01157364|538020693|FG000|Overall Study|Personal Reasons|0|||
149147821|NCT01157364|538020694|FG001|Overall Study|Personal Reasons|2|||
149147822|NCT01157364|538020695|FG002|Overall Study|Personal Reasons|0|||
149147823|NCT01157364|538020696|FG003|Overall Study|Personal Reasons|0|||
149147824|NCT01157364|538020697|FG004|Overall Study|Personal Reasons|1|||
149147825|NCT01157364|538020698|FG005|Overall Study|Personal Reasons|1|||
149147826|NCT01157364|538020693|FG000|Overall Study|Lost to Follow-up|1|||
149147827|NCT01157364|538020694|FG001|Overall Study|Lost to Follow-up|0|||
149147828|NCT01157364|538020695|FG002|Overall Study|Lost to Follow-up|1|||
149147829|NCT01157364|538020696|FG003|Overall Study|Lost to Follow-up|0|||
149147830|NCT01157364|538020697|FG004|Overall Study|Lost to Follow-up|0|||
149147831|NCT01157364|538020698|FG005|Overall Study|Lost to Follow-up|0|||
149147832|NCT01157364|538020693|FG000|Overall Study|Lack of Efficacy|0|||
149147833|NCT01157364|538020694|FG001|Overall Study|Lack of Efficacy|0|||
149147834|NCT01157364|538020695|FG002|Overall Study|Lack of Efficacy|0|||
149147835|NCT01157364|538020696|FG003|Overall Study|Lack of Efficacy|1|||
149147836|NCT01157364|538020697|FG004|Overall Study|Lack of Efficacy|0|||
149147837|NCT01157364|538020698|FG005|Overall Study|Lack of Efficacy|0|||
148805060|NCT03466346|536766653|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
148805061|NCT03466346|536766654|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
148805062|NCT05282823|536766655|FG000|Overall Study|Withdrawal by Subject|9|||
148805063|NCT05282823|536766655|FG000|Overall Study|Adverse Event|1|||
148805064|NCT05282823|536766655|FG000|Overall Study|did not meet protocol criteria|2|||
148805065|NCT05282823|536766655|FG000|Overall Study|Withdrawal by Subject|7|||
148805066|NCT05569174|536766656|FG000|Overall Study|Adverse Event|0|||
148805067|NCT05569174|536766657|FG001|Overall Study|Adverse Event|1|||
148805068|NCT05569174|536766656|FG000|Overall Study|Lack of compliance|0|||
148805069|NCT05569174|536766657|FG001|Overall Study|Lack of compliance|1|||
148805070|NCT05569174|536766656|FG000|Overall Study|Withdrawal of consent|0|||
148805071|NCT05569174|536766657|FG001|Overall Study|Withdrawal of consent|1|||
148805072|NCT05569174|536766656|FG000|Overall Study|Participant wish|0|||
148805073|NCT05569174|536766657|FG001|Overall Study|Participant wish|1|||
148805074|NCT05569174|536766656|FG000|Overall Study|Lost to Follow-up|0|||
148805075|NCT05569174|536766657|FG001|Overall Study|Lost to Follow-up|1|||
148805076|NCT03895086|536766661|FG000|Overall Study|Early termination study|1|||
148805077|NCT03895086|536766662|FG001|Overall Study|Early termination study|0|||
148805078|NCT06129149|536766664|FG000|Overall Study|Death|1|||
148805079|NCT04649359|536766665|FG000|Overall Study|Withdrawal by Subject|7|||
148805080|NCT04649359|536766666|FG001|Overall Study|Withdrawal by Subject|7|||
148671396|NCT01035229|536268737|FG000|Overall Study|Protocol Violation|0|||
149147838|NCT01157364|538020693|FG000|Overall Study|Adverse Event|0|||
149147839|NCT01157364|538020694|FG001|Overall Study|Adverse Event|1|||
149147840|NCT01157364|538020695|FG002|Overall Study|Adverse Event|1|||
148805081|NCT04649359|536766665|FG000|Overall Study|Death|41|||
148805082|NCT04649359|536766666|FG001|Overall Study|Death|26|||
149147841|NCT01157364|538020696|FG003|Overall Study|Adverse Event|0|||
149147842|NCT01157364|538020697|FG004|Overall Study|Adverse Event|1|||
149147843|NCT01157364|538020698|FG005|Overall Study|Adverse Event|0|||
149147844|NCT01263639|538020699|FG000|Overall Study|Lost to Follow-up|66|||
148914268|NCT00689117|537169957|FG000|Overall Study|Lack of Efficacy|1|||
148914269|NCT00689117|537169958|FG001|Overall Study|Lack of Efficacy|2|||
148914270|NCT00689117|537169959|FG002|Overall Study|Lack of Efficacy|2|||
148914271|NCT00689117|537169960|FG003|Overall Study|Lack of Efficacy|2|||
148914272|NCT00689117|537169957|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
148914273|NCT00689117|537169958|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
148914274|NCT00689117|537169959|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
148914275|NCT00689117|537169960|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
148914276|NCT00689117|537169957|FG000|Overall Study|Withdrawal by Subject|19|||
148914277|NCT00689117|537169958|FG001|Overall Study|Withdrawal by Subject|18|||
148914278|NCT00689117|537169959|FG002|Overall Study|Withdrawal by Subject|26|||
148914279|NCT00689117|537169960|FG003|Overall Study|Withdrawal by Subject|13|||
148914280|NCT00689117|537169957|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
148914281|NCT00689117|537169958|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
148914282|NCT00689117|537169959|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
148914283|NCT00689117|537169960|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
148914284|NCT00689117|537169957|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
148914285|NCT00689117|537169958|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
148914286|NCT00689117|537169959|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
148914287|NCT00689117|537169960|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
148914288|NCT00689117|537169957|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
148914289|NCT00689117|537169958|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
149147845|NCT01263639|538020700|FG001|Overall Study|Lost to Follow-up|70|||
149147846|NCT01263639|538020699|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
149147847|NCT01263639|538020700|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
149147848|NCT01780662|538020701|FG000|Overall Study|Adverse Event|1|||
149147849|NCT01780662|538020702|FG001|Overall Study|Adverse Event|0|||
149147850|NCT01780662|538020703|FG002|Overall Study|Adverse Event|2|||
148914290|NCT00689117|537169959|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
148914291|NCT00689117|537169960|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
148914292|NCT00689117|537169957|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
149147851|NCT01780662|538020701|FG000|Overall Study|Physician Decision|0|||
149147852|NCT01780662|538020702|FG001|Overall Study|Physician Decision|5|||
149147853|NCT01780662|538020703|FG002|Overall Study|Physician Decision|7|||
149147854|NCT01780662|538020701|FG000|Overall Study|Protocol Violation|0|||
149147855|NCT01780662|538020702|FG001|Overall Study|Protocol Violation|1|||
149147856|NCT01780662|538020703|FG002|Overall Study|Protocol Violation|0|||
149147857|NCT01780662|538020701|FG000|Overall Study|Ineligible|0|||
149147858|NCT01780662|538020702|FG001|Overall Study|Ineligible|0|||
149147859|NCT01780662|538020703|FG002|Overall Study|Ineligible|1|||
149147860|NCT01576549|538020704|FG000|Overall Study|Sponsor Decision|2|||
149147861|NCT04081363|538020707|FG000|Overall Study|Withdrawal by Subject|1|||
149147862|NCT04081363|538020708|FG001|Overall Study|Withdrawal by Subject|0|||
149147863|NCT00586495|538020709|FG000|Treatment Period|Adverse Event|11|||
149147864|NCT00586495|538020709|FG000|Treatment Period|Death|1|||
149147865|NCT00586495|538020709|FG000|Treatment Period|Protocol Violation|1|||
149147866|NCT00586495|538020709|FG000|Treatment Period|Withdrawal by Subject|1|||
149147867|NCT00586495|538020709|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
149147868|NCT00586495|538020709|FG000|Treatment Period|Switch to commercial drug|10|||
149147869|NCT00586495|538020709|FG000|Follow-up|Death|40|||
149147870|NCT00586495|538020709|FG000|Follow-up|Lost to Follow-up|1|||
149147871|NCT00586495|538020709|FG000|Follow-up|Withdrawal by Subject|4|||
149147872|NCT00586495|538020709|FG000|Follow-up|Protocol driven decision point|37|||
149147873|NCT00586495|538020709|FG000|Follow-up|Switch to commercial drug|10|||
149147874|NCT01081249|538020712|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
149147875|NCT01081249|538020713|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
149147876|NCT02025907|538020714|FG000|Overall Study|Lack of Efficacy|1|||
149147877|NCT02025907|538020715|FG001|Overall Study|Lack of Efficacy|0|||
149147878|NCT02025907|538020714|FG000|Overall Study|Withdrawal by Subject|15|||
149147879|NCT02025907|538020715|FG001|Overall Study|Withdrawal by Subject|8|||
149147880|NCT02025907|538020714|FG000|Overall Study|Protocol Violation|2|||
149147881|NCT02025907|538020715|FG001|Overall Study|Protocol Violation|0|||
149147882|NCT02025907|538020714|FG000|Overall Study|Physician Decision|2|||
149147883|NCT02025907|538020715|FG001|Overall Study|Physician Decision|0|||
149147884|NCT02025907|538020714|FG000|Overall Study|Lost to Follow-up|2|||
149147885|NCT02025907|538020715|FG001|Overall Study|Lost to Follow-up|2|||
149147886|NCT02025907|538020714|FG000|Overall Study|Adverse Event|3|||
149147887|NCT02025907|538020715|FG001|Overall Study|Adverse Event|1|||
149147888|NCT02025907|538020714|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
149147889|NCT02025907|538020715|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
149147890|NCT02411539|538020719|FG000|Overall Study|Lost to Follow-up|2|||
148914293|NCT00689117|537169958|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
148914294|NCT00689117|537169959|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
149147891|NCT02411539|538020720|FG001|Overall Study|Lost to Follow-up|0|||
149147892|NCT02411539|538020719|FG000|Overall Study|Confounding medical condition|0|||
149147893|NCT02411539|538020720|FG001|Overall Study|Confounding medical condition|1|||
149147894|NCT03775421|538020723|FG000|Overall Study|Lost to Follow-up|2|||
149147895|NCT03775421|538020723|FG000|Overall Study|Withdrawal by Subject|10|||
149147896|NCT03775421|538020723|FG000|Overall Study|Physician Decision|3|||
149147897|NCT03775421|538020723|FG000|Overall Study|Death|1|||
149147898|NCT03775421|538020723|FG000|Overall Study|Study Terminated by Sponsor|94|||
149147899|NCT02016820|538020724|FG000|Overall Study|Lost to Follow-up|2|||
149147900|NCT02016820|538020725|FG001|Overall Study|Lost to Follow-up|4|||
149147901|NCT00473343|538020726|FG000|Overall Study|Adverse Event|9|||
149147902|NCT00473343|538020726|FG000|Overall Study|Lost to Follow-up|8|||
149147903|NCT00473343|538020726|FG000|Overall Study|Treatment failure|27|||
149147904|NCT00473343|538020726|FG000|Overall Study|Withdrew consent|3|||
149147905|NCT00473343|538020726|FG000|Overall Study|Other un-specified reason|3|||
149147906|NCT02287623|538020732|FG000|Overall Study|Protocol Violation|0|||
149147907|NCT02287623|538020733|FG001|Overall Study|Protocol Violation|1|||
149147908|NCT02700997|538020734|FG000|Overall Study|Did not undergo CT imaging|1|||
149147909|NCT02700997|538020734|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
149147910|NCT03610724|538020739|FG000|Overall Study|Death|17|||
149147911|NCT03610724|538020739|FG000|Overall Study|Lost to Follow-up|1|||
149147912|NCT03610724|538020739|FG000|Overall Study|Physician Decision|1|||
149147913|NCT03610724|538020739|FG000|Overall Study|Died prior to infusion|1|||
149147914|NCT00786565|538020740|FG000|Enrollment Prior to Surgery|Site Closed|3|||
149147915|NCT00786565|538020740|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
149147916|NCT00786565|538020740|FG000|Post Surgery|Abnormal macular pucker|1|||
149147917|NCT00786565|538020740|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
149147918|NCT02943564|538020743|FG000|Overall Study|Miscellaneous Reasons|0|||
149147919|NCT02943564|538020744|FG001|Overall Study|Miscellaneous Reasons|0|||
149147920|NCT02943564|538020745|FG002|Overall Study|Miscellaneous Reasons|3|||
149147921|NCT02943564|538020743|FG000|Overall Study|Site terminated by sponsor|0|||
149147922|NCT02943564|538020744|FG001|Overall Study|Site terminated by sponsor|1|||
149147923|NCT02943564|538020745|FG002|Overall Study|Site terminated by sponsor|0|||
149147924|NCT02943564|538020743|FG000|Overall Study|Non-compliance with study drug|0|||
149147925|NCT02943564|538020744|FG001|Overall Study|Non-compliance with study drug|1|||
149147926|NCT02943564|538020745|FG002|Overall Study|Non-compliance with study drug|0|||
149147927|NCT02943564|538020743|FG000|Overall Study|Pregnancy|0|||
149147928|NCT02943564|538020744|FG001|Overall Study|Pregnancy|1|||
149147929|NCT02943564|538020745|FG002|Overall Study|Pregnancy|1|||
149147930|NCT02943564|538020743|FG000|Overall Study|Protocol Violation|2|||
149147931|NCT02943564|538020744|FG001|Overall Study|Protocol Violation|2|||
149147932|NCT02943564|538020745|FG002|Overall Study|Protocol Violation|2|||
149147933|NCT02943564|538020743|FG000|Overall Study|Lost to Follow-up|1|||
149147934|NCT02943564|538020744|FG001|Overall Study|Lost to Follow-up|0|||
149147935|NCT02943564|538020745|FG002|Overall Study|Lost to Follow-up|0|||
149147936|NCT02943564|538020743|FG000|Overall Study|Withdrawal by Subject|6|||
149147937|NCT02943564|538020744|FG001|Overall Study|Withdrawal by Subject|5|||
149147938|NCT02943564|538020745|FG002|Overall Study|Withdrawal by Subject|2|||
149147939|NCT02943564|538020743|FG000|Overall Study|Adverse Event|1|||
149147940|NCT02943564|538020744|FG001|Overall Study|Adverse Event|2|||
149147941|NCT02943564|538020745|FG002|Overall Study|Adverse Event|1|||
149147942|NCT02943564|538020743|FG000|Overall Study|Lack of Efficacy|0|||
149147943|NCT02943564|538020744|FG001|Overall Study|Lack of Efficacy|1|||
149147944|NCT02943564|538020745|FG002|Overall Study|Lack of Efficacy|0|||
149147945|NCT00932360|538020746|FG000|Washout (One Week)|Withdrawal by Subject|0|||
149147946|NCT00932360|538020747|FG001|Washout (One Week)|Withdrawal by Subject|0|||
149147947|NCT00932360|538020748|FG002|Washout (One Week)|Withdrawal by Subject|0|||
149147948|NCT00932360|538020749|FG003|Washout (One Week)|Withdrawal by Subject|0|||
149147949|NCT00932360|538020750|FG004|Washout (One Week)|Withdrawal by Subject|2|||
149147950|NCT00932360|538020751|FG005|Washout (One Week)|Withdrawal by Subject|0|||
149147951|NCT02536313|538020752|FG000|Overall Study|Lack of Efficacy|0|||
149147952|NCT02536313|538020753|FG001|Overall Study|Lack of Efficacy|1|||
149147953|NCT04143009|538020754|FG000|Pilot Trial|Lost to Follow-up|0|||
148805083|NCT04649359|536766665|FG000|Overall Study|Ongoing in the study|75|||
148805084|NCT04649359|536766666|FG001|Overall Study|Ongoing in the study|31|||
148805085|NCT04656652|536766667|FG000|Overall Study|Lost to Follow-up|2|||
148805086|NCT04656652|536766668|FG001|Overall Study|Lost to Follow-up|2|||
148805087|NCT04656652|536766667|FG000|Overall Study|Death|213|||
148805088|NCT04656652|536766668|FG001|Overall Study|Death|212|||
148805089|NCT04656652|536766667|FG000|Overall Study|Other|1|||
149147954|NCT04143009|538020755|FG001|Pilot Trial|Lost to Follow-up|1|||
149147955|NCT04143009|538020756|FG002|Pilot Trial|Lost to Follow-up|1|||
149147956|NCT04013529|538020760|FG000|Overall Study|Withdrawal by Subject|1|||
149147957|NCT04013529|538020761|FG001|Overall Study|Withdrawal by Subject|1|||
148805090|NCT04656652|536766668|FG001|Overall Study|Other|0|||
149147958|NCT02116777|538020769|FG000|Overall Study|Adverse Event|0|||
149147959|NCT02116777|538020770|FG001|Overall Study|Adverse Event|0|||
149147960|NCT02116777|538020771|FG002|Overall Study|Adverse Event|0|||
149147961|NCT02116777|538020772|FG003|Overall Study|Adverse Event|0|||
149147962|NCT02116777|538020773|FG004|Overall Study|Adverse Event|2|||
149147963|NCT02116777|538020774|FG005|Overall Study|Adverse Event|2|||
149147964|NCT02116777|538020775|FG006|Overall Study|Adverse Event|0|||
149147965|NCT02116777|538020769|FG000|Overall Study|Death|0|||
149147966|NCT02116777|538020770|FG001|Overall Study|Death|0|||
149147967|NCT02116777|538020771|FG002|Overall Study|Death|0|||
149147968|NCT02116777|538020772|FG003|Overall Study|Death|1|||
149147969|NCT02116777|538020773|FG004|Overall Study|Death|0|||
149147970|NCT02116777|538020774|FG005|Overall Study|Death|0|||
149147971|NCT02116777|538020775|FG006|Overall Study|Death|0|||
149147972|NCT02116777|538020769|FG000|Overall Study|Lack of Efficacy|3|||
149147973|NCT02116777|538020770|FG001|Overall Study|Lack of Efficacy|3|||
149147974|NCT02116777|538020771|FG002|Overall Study|Lack of Efficacy|3|||
149147975|NCT02116777|538020772|FG003|Overall Study|Lack of Efficacy|8|||
149147976|NCT02116777|538020773|FG004|Overall Study|Lack of Efficacy|4|||
149147977|NCT02116777|538020774|FG005|Overall Study|Lack of Efficacy|1|||
149147978|NCT02116777|538020775|FG006|Overall Study|Lack of Efficacy|9|||
149147979|NCT02116777|538020769|FG000|Overall Study|Physician Decision|0|||
149147980|NCT02116777|538020770|FG001|Overall Study|Physician Decision|0|||
149147981|NCT02116777|538020771|FG002|Overall Study|Physician Decision|0|||
149147982|NCT02116777|538020772|FG003|Overall Study|Physician Decision|2|||
149147983|NCT02116777|538020773|FG004|Overall Study|Physician Decision|0|||
149147984|NCT02116777|538020774|FG005|Overall Study|Physician Decision|0|||
149147985|NCT02116777|538020775|FG006|Overall Study|Physician Decision|0|||
149147986|NCT02116777|538020769|FG000|Overall Study|Protocol Violation|0|||
149147987|NCT02116777|538020770|FG001|Overall Study|Protocol Violation|0|||
149147988|NCT02116777|538020771|FG002|Overall Study|Protocol Violation|0|||
149147989|NCT02116777|538020772|FG003|Overall Study|Protocol Violation|1|||
149147990|NCT02116777|538020773|FG004|Overall Study|Protocol Violation|0|||
149147991|NCT02116777|538020774|FG005|Overall Study|Protocol Violation|0|||
149147992|NCT02116777|538020775|FG006|Overall Study|Protocol Violation|0|||
149147993|NCT02116777|538020769|FG000|Overall Study|Withdrawal by Subject|0|||
149147994|NCT02116777|538020770|FG001|Overall Study|Withdrawal by Subject|0|||
149147995|NCT02116777|538020771|FG002|Overall Study|Withdrawal by Subject|0|||
149147996|NCT02116777|538020772|FG003|Overall Study|Withdrawal by Subject|1|||
149147997|NCT02116777|538020773|FG004|Overall Study|Withdrawal by Subject|0|||
149147998|NCT02116777|538020774|FG005|Overall Study|Withdrawal by Subject|0|||
149147999|NCT02116777|538020775|FG006|Overall Study|Withdrawal by Subject|0|||
149148000|NCT00733954|538020777|FG000|Overall Study|Lost to Follow-up|5|||
149148001|NCT00733954|538020778|FG001|Overall Study|Lost to Follow-up|2|||
149148002|NCT00733954|538020777|FG000|Overall Study|Protocol Violation|1|||
149148003|NCT00733954|538020778|FG001|Overall Study|Protocol Violation|0|||
149148004|NCT00733954|538020777|FG000|Overall Study|Withdrawal by Subject|2|||
149148005|NCT00733954|538020778|FG001|Overall Study|Withdrawal by Subject|0|||
149148006|NCT02663453|538020779|FG000|Overall Study|Death|4|||
149148007|NCT02663453|538020780|FG001|Overall Study|Death|4|||
149148008|NCT02663453|538020779|FG000|Overall Study|Withdrawal by Subject|1|||
149148009|NCT02663453|538020780|FG001|Overall Study|Withdrawal by Subject|0|||
149148010|NCT03416153|538020781|FG000|Overall Study|Physician Decision|1|||
149148011|NCT03416153|538020782|FG001|Overall Study|Physician Decision|1|||
149148012|NCT03416153|538020781|FG000|Overall Study|Withdrawal by Subject|1|||
149148013|NCT03416153|538020782|FG001|Overall Study|Withdrawal by Subject|0|||
149148014|NCT04649255|538021962|FG000|Overall Study|Death|9|||
149148015|NCT04649255|538021962|FG000|Overall Study|Withdrawal by Subject|1|||
149148016|NCT02484911|538021963|FG000|Overall Study|Withdrawal by Subject|2|||
149148017|NCT02484911|538021964|FG001|Overall Study|Withdrawal by Subject|1|||
149148018|NCT02484911|538021963|FG000|Overall Study|Protocol Violation|2|||
149148019|NCT02484911|538021964|FG001|Overall Study|Protocol Violation|1|||
149148020|NCT04129528|538021965|FG000|Overall Study|Adverse Event|1|||
149148021|NCT04129528|538021966|FG001|Overall Study|Adverse Event|0|||
149148022|NCT04129528|538021965|FG000|Overall Study|Physician Decision|1|||
149148023|NCT04129528|538021966|FG001|Overall Study|Physician Decision|1|||
149148024|NCT04129528|538021965|FG000|Overall Study|Withdrawal by Subject|1|||
149148025|NCT04129528|538021966|FG001|Overall Study|Withdrawal by Subject|1|||
149148026|NCT00490568|538021975|FG000|Overall Study|Adverse Event|116|||
149148027|NCT00490568|538021975|FG000|Overall Study|Lost to Follow-up|13|||
149148028|NCT00490568|538021975|FG000|Overall Study|Protocol Violation|45|||
149148029|NCT00490568|538021975|FG000|Overall Study|Withdrawal by Subject|135|||
149148030|NCT00490568|538021975|FG000|Overall Study|Still in the study at termination|974|||
149148031|NCT00490568|538021975|FG000|Overall Study|Other|1|||
149148032|NCT00490568|538021975|FG000|Overall Study|Exclusion criteria met|1|||
149148033|NCT00490568|538021975|FG000|Overall Study|Caregiver related|20|||
149148034|NCT00490568|538021975|FG000|Overall Study|Abnormal ECG|25|||
149148035|NCT00490568|538021975|FG000|Overall Study|Participant refused follow-up|9|||
149148036|NCT00490568|538021975|FG000|Overall Study|Legal representative withdrew consent|1|||
149148037|NCT00490568|538021975|FG000|Overall Study|Disease progression|4|||
149148038|NCT00490568|538021975|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
149148039|NCT00490568|538021975|FG000|Overall Study|Investigator decision|3|||
149148040|NCT00490568|538021975|FG000|Overall Study|Non-Compliance|7|||
149148041|NCT00490568|538021975|FG000|Overall Study|Efficacy related|3|||
149148042|NCT00490568|538021975|FG000|Overall Study|Participant died|1|||
149148043|NCT00490568|538021975|FG000|Overall Study|Participant withdrawal due to surgery|1|||
149148044|NCT01395394|538021976|FG000|Baseline Study Visit|Protocol Violation|1|||
149148045|NCT01395394|538021977|FG001|Baseline Study Visit|Protocol Violation|0|||
149148046|NCT01395394|538021978|FG002|Baseline Study Visit|Protocol Violation|0|||
149148047|NCT01157078|538021981|FG000|Overall Study|Withdrawal by Subject|12|||
149148048|NCT01157078|538021982|FG001|Overall Study|Withdrawal by Subject|14|||
149148049|NCT01157078|538021981|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
149148050|NCT01157078|538021982|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149148051|NCT01157078|538021981|FG000|Overall Study|Adverse Event|6|||
149148052|NCT01157078|538021982|FG001|Overall Study|Adverse Event|6|||
149148053|NCT01157078|538021981|FG000|Overall Study|Severe non-compliance to protocol|2|||
149148054|NCT01157078|538021982|FG001|Overall Study|Severe non-compliance to protocol|4|||
149148055|NCT01157078|538021981|FG000|Overall Study|Condition under investigation worsened|0|||
149148056|NCT01157078|538021982|FG001|Overall Study|Condition under investigation worsened|1|||
149148057|NCT01157078|538021981|FG000|Overall Study|Lack of Efficacy|2|||
149148058|NCT01157078|538021982|FG001|Overall Study|Lack of Efficacy|0|||
149148059|NCT01157078|538021981|FG000|Overall Study|Study-specific withdrawal criteria|2|||
148805091|NCT04656652|536766667|FG000|Overall Study|Withdrawal by Subject|15|||
148805092|NCT04656652|536766668|FG001|Overall Study|Withdrawal by Subject|29|||
149148060|NCT01157078|538021982|FG001|Overall Study|Study-specific withdrawal criteria|2|||
149148061|NCT01157078|538021981|FG000|Overall Study|Lost to Follow-up|7|||
149148062|NCT01157078|538021982|FG001|Overall Study|Lost to Follow-up|5|||
148805093|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
148805094|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
148805095|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
148805096|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149148063|NCT01157078|538021981|FG000|Overall Study|Other|2|||
148671397|NCT01035229|536268738|FG001|Overall Study|Protocol Violation|2|||
148671398|NCT01035229|536268737|FG000|Overall Study|Sponsor's decision to end study|3|||
148671399|NCT01035229|536268738|FG001|Overall Study|Sponsor's decision to end study|3|||
148671400|NCT01035229|536268737|FG000|Overall Study|Disease Progression|261|||
148671401|NCT01035229|536268738|FG001|Overall Study|Disease Progression|152|||
148671402|NCT03387423|536268744|FG000|Overall Study|Lost to Follow-up|16|||
148671403|NCT03387423|536268745|FG001|Overall Study|Lost to Follow-up|12|||
148671404|NCT03387423|536268746|FG002|Overall Study|Lost to Follow-up|1|||
148914295|NCT00689117|537169960|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
148914296|NCT00689117|537169957|FG000|Overall Study|Use of Prohibitive Medication|2|||
148671405|NCT03387423|536268747|FG003|Overall Study|Lost to Follow-up|0|||
148671406|NCT03387423|536268744|FG000|Overall Study|Other|0|||
148671407|NCT03387423|536268745|FG001|Overall Study|Other|3|||
148671408|NCT03387423|536268746|FG002|Overall Study|Other|0|||
148671409|NCT03387423|536268747|FG003|Overall Study|Other|0|||
148671410|NCT03387423|536268744|FG000|Overall Study|Administrative Reason|166|||
148671411|NCT03387423|536268745|FG001|Overall Study|Administrative Reason|89|||
148671412|NCT03387423|536268746|FG002|Overall Study|Administrative Reason|17|||
148671413|NCT03387423|536268747|FG003|Overall Study|Administrative Reason|19|||
148671414|NCT03387423|536268744|FG000|Overall Study|Revocation Consent|76|||
148671415|NCT03387423|536268745|FG001|Overall Study|Revocation Consent|32|||
148671416|NCT03387423|536268746|FG002|Overall Study|Revocation Consent|3|||
148671417|NCT03387423|536268747|FG003|Overall Study|Revocation Consent|5|||
148671418|NCT03862807|536268748|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
148671419|NCT00798707|536268751|FG000|Overall Study|Adverse Event|6|||
148671420|NCT00798707|536268752|FG001|Overall Study|Adverse Event|8|||
148671421|NCT00798707|536268753|FG002|Overall Study|Adverse Event|8|||
148671422|NCT00798707|536268751|FG000|Overall Study|Failed to return|2|||
148671423|NCT00798707|536268752|FG001|Overall Study|Failed to return|2|||
148671424|NCT00798707|536268753|FG002|Overall Study|Failed to return|0|||
148671425|NCT00798707|536268751|FG000|Overall Study|Investigator|0|||
148671426|NCT00798707|536268752|FG001|Overall Study|Investigator|1|||
148671427|NCT00798707|536268753|FG002|Overall Study|Investigator|2|||
148671428|NCT00798707|536268751|FG000|Overall Study|Lack of Efficacy|2|||
148671429|NCT00798707|536268752|FG001|Overall Study|Lack of Efficacy|2|||
148671430|NCT00798707|536268753|FG002|Overall Study|Lack of Efficacy|1|||
148671431|NCT00798707|536268751|FG000|Overall Study|Lost to Follow-up|5|||
148671432|NCT00798707|536268752|FG001|Overall Study|Lost to Follow-up|6|||
148671433|NCT00798707|536268753|FG002|Overall Study|Lost to Follow-up|6|||
148671434|NCT00798707|536268751|FG000|Overall Study|Other|0|||
148671435|NCT00798707|536268752|FG001|Overall Study|Other|1|||
148671436|NCT00798707|536268753|FG002|Overall Study|Other|0|||
148671437|NCT00798707|536268751|FG000|Overall Study|Protocol Violation|4|||
148671438|NCT00798707|536268752|FG001|Overall Study|Protocol Violation|0|||
148671439|NCT00798707|536268753|FG002|Overall Study|Protocol Violation|2|||
148671440|NCT00798707|536268751|FG000|Overall Study|Withdrawal by Subject|3|||
148671441|NCT00798707|536268752|FG001|Overall Study|Withdrawal by Subject|8|||
148671442|NCT00798707|536268753|FG002|Overall Study|Withdrawal by Subject|2|||
148671443|NCT00798707|536268751|FG000|Overall Study|Randomized not treated|4|||
148671444|NCT00798707|536268752|FG001|Overall Study|Randomized not treated|5|||
148671445|NCT00798707|536268753|FG002|Overall Study|Randomized not treated|1|||
148671446|NCT01473589|536268756|FG000|Overall Study|Adverse Event|1|||
148671447|NCT01473589|536268757|FG001|Overall Study|Adverse Event|1|||
148671448|NCT01473589|536268756|FG000|Overall Study|Death|2|||
148671449|NCT01473589|536268757|FG001|Overall Study|Death|0|||
148671450|NCT01473589|536268756|FG000|Overall Study|Lost to Follow-up|2|||
148671451|NCT01473589|536268757|FG001|Overall Study|Lost to Follow-up|2|||
148671452|NCT01473589|536268756|FG000|Overall Study|Protocol Violation|1|||
148671453|NCT01473589|536268757|FG001|Overall Study|Protocol Violation|0|||
148671454|NCT01473589|536268756|FG000|Overall Study|Withdrawal by Subject|5|||
148671455|NCT01473589|536268757|FG001|Overall Study|Withdrawal by Subject|11|||
148671456|NCT01473589|536268756|FG000|Overall Study|Physician Decision|0|||
148671457|NCT01473589|536268757|FG001|Overall Study|Physician Decision|1|||
148671458|NCT01473589|536268756|FG000|Overall Study|Entry criteria not met|0|||
148671459|NCT01473589|536268757|FG001|Overall Study|Entry criteria not met|1|||
148671460|NCT00929201|536268758|FG000|Period 1|Withdrawal by Subject|0|||
148671461|NCT00929201|536268759|FG001|Period 1|Withdrawal by Subject|1|||
148671462|NCT01513759|536268763|FG000|Overall Study|Protocol Violation|4|||
148671463|NCT01513759|536268763|FG000|Overall Study|Death during catheter placement|1|||
148671464|NCT03606109|536268764|FG000|Overall Study|Lost to Follow-up|2|||
148671465|NCT03606109|536268765|FG001|Overall Study|Lost to Follow-up|1|||
148671466|NCT03079869|536268773|FG000|Overall Study|Adverse Event|6|||
148671467|NCT03079869|536268774|FG001|Overall Study|Adverse Event|8|||
148671468|NCT03079869|536268773|FG000|Overall Study|Withdrawal by Subject|4|||
148671469|NCT03079869|536268774|FG001|Overall Study|Withdrawal by Subject|1|||
148671470|NCT03079869|536268773|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
148671471|NCT03079869|536268774|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
148671472|NCT04633434|536268775|FG000|Overall Study|Lost to Follow-up|32|||
148671473|NCT04633434|536268776|FG001|Overall Study|Lost to Follow-up|32|||
149148064|NCT01157078|538021982|FG001|Overall Study|Other|4|||
149148065|NCT00789529|538021985|FG000|Overall Study|Withdrawal by Subject|0|||
149148066|NCT00789529|538021986|FG001|Overall Study|Withdrawal by Subject|1|||
149148067|NCT00789529|538021985|FG000|Overall Study|Other Reason|1|||
149148068|NCT00789529|538021986|FG001|Overall Study|Other Reason|0|||
149148069|NCT01135498|538021987|FG000|Overall Study|Adverse Event|20|||
149148070|NCT01135498|538021987|FG000|Overall Study|Progressive disease|38|||
149148071|NCT01135498|538021987|FG000|Overall Study|Investigator judgement|25|||
149148072|NCT01135498|538021987|FG000|Overall Study|Withdrawal by Subject|4|||
149148073|NCT01135498|538021987|FG000|Overall Study|Death|1|||
149148074|NCT01135498|538021987|FG000|Overall Study|Ongoing at time of analysis|2|||
149148075|NCT02770547|538021989|FG000|Overall Study|Patient non-compliant|1|||
149148076|NCT02770547|538021990|FG001|Overall Study|Patient non-compliant|0|||
149148077|NCT02770547|538021989|FG000|Overall Study|Adverse Event|0|||
149148078|NCT02770547|538021990|FG001|Overall Study|Adverse Event|1|||
149148079|NCT01324232|538021991|FG000|Overall Study|Protocol Violation|0|||
149148080|NCT01324232|538021992|FG001|Overall Study|Protocol Violation|0|||
149148081|NCT01324232|538021993|FG002|Overall Study|Protocol Violation|0|||
149148082|NCT01324232|538021994|FG003|Overall Study|Protocol Violation|2|||
149148083|NCT01324232|538021991|FG000|Overall Study|Missing|0|||
149148084|NCT01324232|538021992|FG001|Overall Study|Missing|0|||
149148085|NCT01324232|538021993|FG002|Overall Study|Missing|1|||
149148086|NCT01324232|538021994|FG003|Overall Study|Missing|0|||
149148087|NCT01324232|538021991|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
149148088|NCT01324232|538021992|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
149148089|NCT01324232|538021993|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
149148090|NCT01324232|538021994|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
149148091|NCT01324232|538021991|FG000|Overall Study|Lack of Efficacy|2|||
149148092|NCT01324232|538021992|FG001|Overall Study|Lack of Efficacy|1|||
149148093|NCT01324232|538021993|FG002|Overall Study|Lack of Efficacy|2|||
149148094|NCT01324232|538021994|FG003|Overall Study|Lack of Efficacy|2|||
149148095|NCT01324232|538021991|FG000|Overall Study|Participant Refused Medication|0|||
149148096|NCT01324232|538021992|FG001|Overall Study|Participant Refused Medication|1|||
149148097|NCT01324232|538021993|FG002|Overall Study|Participant Refused Medication|0|||
149148098|NCT01324232|538021994|FG003|Overall Study|Participant Refused Medication|0|||
149148099|NCT01324232|538021991|FG000|Overall Study|Intercurrent illness|0|||
149148100|NCT01324232|538021992|FG001|Overall Study|Intercurrent illness|0|||
149148101|NCT01324232|538021993|FG002|Overall Study|Intercurrent illness|0|||
149148102|NCT01324232|538021994|FG003|Overall Study|Intercurrent illness|1|||
149148103|NCT01324232|538021991|FG000|Overall Study|Adverse Event|2|||
149148104|NCT01324232|538021992|FG001|Overall Study|Adverse Event|5|||
149148105|NCT01324232|538021993|FG002|Overall Study|Adverse Event|6|||
149148106|NCT01324232|538021994|FG003|Overall Study|Adverse Event|6|||
149148107|NCT01324232|538021991|FG000|Overall Study|Withdrawal by Subject|0|||
149148108|NCT01324232|538021992|FG001|Overall Study|Withdrawal by Subject|3|||
149148109|NCT01324232|538021993|FG002|Overall Study|Withdrawal by Subject|4|||
149148110|NCT01324232|538021994|FG003|Overall Study|Withdrawal by Subject|0|||
149148111|NCT01324232|538021991|FG000|Overall Study|Lost to Follow-up|1|||
149148112|NCT01324232|538021992|FG001|Overall Study|Lost to Follow-up|0|||
149148113|NCT01324232|538021993|FG002|Overall Study|Lost to Follow-up|0|||
149148114|NCT01324232|538021994|FG003|Overall Study|Lost to Follow-up|0|||
149148115|NCT05440539|538021995|FG000|Overall Study|Lost to Follow-up|4|||
149148116|NCT05440539|538021996|FG001|Overall Study|Lost to Follow-up|4|||
149148117|NCT05440539|538021995|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
149148118|NCT05440539|538021996|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
149148119|NCT00393887|538021997|FG000|Overall Study|Physician Decision|5|||
149148120|NCT00393887|538021998|FG001|Overall Study|Physician Decision|0|||
149148121|NCT00393887|538021997|FG000|Overall Study|Lost to Follow-up|11|||
149148122|NCT00393887|538021998|FG001|Overall Study|Lost to Follow-up|9|||
149148123|NCT01732796|538021999|FG000|Overall Study|Adverse Event|16|||
149148124|NCT01732796|538022000|FG001|Overall Study|Adverse Event|16|||
149148125|NCT01732796|538022001|FG002|Overall Study|Adverse Event|4|||
149148126|NCT01732796|538021999|FG000|Overall Study|Lack of Efficacy|21|||
149148127|NCT01732796|538022000|FG001|Overall Study|Lack of Efficacy|18|||
149148128|NCT01732796|538022001|FG002|Overall Study|Lack of Efficacy|5|||
149148129|NCT01732796|538021999|FG000|Overall Study|Lost to Follow-up|2|||
149148130|NCT01732796|538022000|FG001|Overall Study|Lost to Follow-up|0|||
149148131|NCT01732796|538022001|FG002|Overall Study|Lost to Follow-up|0|||
149148132|NCT01732796|538021999|FG000|Overall Study|Withdrawal by Subject|6|||
149148133|NCT01732796|538022000|FG001|Overall Study|Withdrawal by Subject|8|||
149148134|NCT01732796|538022001|FG002|Overall Study|Withdrawal by Subject|2|||
149148135|NCT01732796|538021999|FG000|Overall Study|Other reason not defined above|1|||
149148136|NCT01732796|538022000|FG001|Overall Study|Other reason not defined above|0|||
149148137|NCT01732796|538022001|FG002|Overall Study|Other reason not defined above|2|||
149148138|NCT00876187|538022007|FG000|Overall Study|Adverse Event|14|||
149148139|NCT00876187|538022008|FG001|Overall Study|Adverse Event|12|||
149148140|NCT00876187|538022009|FG002|Overall Study|Adverse Event|19|||
149148141|NCT00876187|538022010|FG003|Overall Study|Adverse Event|29|||
149148142|NCT00876187|538022011|FG004|Overall Study|Adverse Event|10|||
149148143|NCT00876187|538022007|FG000|Overall Study|Lack of Efficacy|59|||
149148144|NCT00876187|538022008|FG001|Overall Study|Lack of Efficacy|34|||
149148145|NCT00876187|538022009|FG002|Overall Study|Lack of Efficacy|45|||
149148146|NCT00876187|538022010|FG003|Overall Study|Lack of Efficacy|34|||
149148147|NCT00876187|538022011|FG004|Overall Study|Lack of Efficacy|59|||
149148148|NCT00876187|538022007|FG000|Overall Study|Lost to Follow-up|9|||
148914297|NCT00689117|537169958|FG001|Overall Study|Use of Prohibitive Medication|1|||
149148149|NCT00876187|538022008|FG001|Overall Study|Lost to Follow-up|10|||
149148150|NCT00876187|538022009|FG002|Overall Study|Lost to Follow-up|8|||
149148151|NCT00876187|538022010|FG003|Overall Study|Lost to Follow-up|8|||
149148152|NCT00876187|538022011|FG004|Overall Study|Lost to Follow-up|11|||
149148153|NCT00876187|538022007|FG000|Overall Study|Protocol Violation|6|||
149148154|NCT00876187|538022008|FG001|Overall Study|Protocol Violation|7|||
149148155|NCT00876187|538022009|FG002|Overall Study|Protocol Violation|7|||
149148156|NCT00876187|538022010|FG003|Overall Study|Protocol Violation|6|||
149148157|NCT00876187|538022011|FG004|Overall Study|Protocol Violation|3|||
149148158|NCT00876187|538022007|FG000|Overall Study|Withdrawal by Subject|16|||
149148159|NCT00876187|538022008|FG001|Overall Study|Withdrawal by Subject|26|||
149148160|NCT00876187|538022009|FG002|Overall Study|Withdrawal by Subject|32|||
149148161|NCT00876187|538022010|FG003|Overall Study|Withdrawal by Subject|38|||
149148162|NCT00876187|538022011|FG004|Overall Study|Withdrawal by Subject|37|||
149148163|NCT00876187|538022007|FG000|Overall Study|Entered extension study|101|||
149148164|NCT00876187|538022008|FG001|Overall Study|Entered extension study|120|||
149148165|NCT00876187|538022009|FG002|Overall Study|Entered extension study|156|||
149148166|NCT00876187|538022010|FG003|Overall Study|Entered extension study|151|||
149148167|NCT00876187|538022011|FG004|Overall Study|Entered extension study|144|||
149148168|NCT00876187|538022007|FG000|Overall Study|Randomized but not treated|3|||
149148169|NCT00876187|538022008|FG001|Overall Study|Randomized but not treated|1|||
149148170|NCT00876187|538022009|FG002|Overall Study|Randomized but not treated|3|||
149148171|NCT00876187|538022010|FG003|Overall Study|Randomized but not treated|2|||
149148172|NCT00876187|538022011|FG004|Overall Study|Randomized but not treated|3|||
149148173|NCT00876187|538022007|FG000|Overall Study|Other|2|||
149148174|NCT00876187|538022008|FG001|Overall Study|Other|5|||
149148175|NCT00876187|538022009|FG002|Overall Study|Other|9|||
149148176|NCT00876187|538022010|FG003|Overall Study|Other|7|||
149148177|NCT00876187|538022011|FG004|Overall Study|Other|4|||
149148178|NCT01967628|538022012|FG000|Overall Study|Withdrawal by Subject|2|||
149148179|NCT01967628|538022013|FG001|Overall Study|Withdrawal by Subject|0|||
149148180|NCT01967628|538022012|FG000|Overall Study|Unable to complete bronchoscopy|4|||
149148181|NCT01967628|538022013|FG001|Overall Study|Unable to complete bronchoscopy|6|||
149148182|NCT01967628|538022012|FG000|Overall Study|Lost to Follow-up|1|||
149148183|NCT01967628|538022013|FG001|Overall Study|Lost to Follow-up|0|||
149148184|NCT01967628|538022012|FG000|Overall Study|Low protein concentration in sample|20|||
149148185|NCT01967628|538022013|FG001|Overall Study|Low protein concentration in sample|25|||
149148186|NCT00838331|538022014|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
149148187|NCT01379274|538022015|FG000|Overall Study|funding withdrawn|1|||
149148188|NCT03287219|538022016|FG000|Overall Study|Protocol Violation|0|||
149148189|NCT03287219|538022017|FG001|Overall Study|Protocol Violation|2|||
149148190|NCT02182687|538022021|FG000|Overall Study|Withdrawal by Subject|4|||
149148191|NCT02182687|538022022|FG001|Overall Study|Withdrawal by Subject|0|||
149148192|NCT02182687|538022021|FG000|Overall Study|Adverse Event|1|||
149148193|NCT02182687|538022022|FG001|Overall Study|Adverse Event|0|||
149148194|NCT02182687|538022021|FG000|Overall Study|Lost to Follow-up|0|||
149148195|NCT02182687|538022022|FG001|Overall Study|Lost to Follow-up|1|||
149148196|NCT00794677|538022023|FG000|First Intervention|Withdrawal by Subject|2|||
149148197|NCT00794677|538022024|FG001|First Intervention|Withdrawal by Subject|0|||
149148198|NCT05513625|538022037|FG000|Overall Study|Withdrawal by Subject|1|||
149148199|NCT01073267|538022038|FG000|Overall Study|Disease Progression|3|||
149148200|NCT02039375|538022043|FG000|Overall Study|Lost to Follow-up|2|||
149148201|NCT03891264|538022044|FG000|Overall Study|Adverse Event|1|||
149148202|NCT03891264|538022044|FG000|Overall Study|Withdrawal by Subject|2|||
149148203|NCT03891264|538022044|FG000|Overall Study|Physician Decision|2|||
149148204|NCT03765138|538022045|FG000|Overall Study|Lost to Follow-up|1|||
148805097|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
148805098|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
149148205|NCT01624662|538022048|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
149148206|NCT01624662|538022049|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
149148207|NCT01624662|538022050|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
149148208|NCT01624662|538022051|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
149148209|NCT01624662|538022048|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
149148210|NCT01624662|538022049|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
149148211|NCT01624662|538022050|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
149148212|NCT01624662|538022051|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
149148213|NCT01624662|538022048|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149148214|NCT01624662|538022049|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
149148215|NCT01624662|538022050|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149148216|NCT01624662|538022051|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149148217|NCT01624662|538022048|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
149148218|NCT01624662|538022049|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
149148219|NCT01624662|538022050|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
149148220|NCT01624662|538022051|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
149148221|NCT01624662|538022048|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
149148222|NCT01624662|538022049|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
149148223|NCT01624662|538022050|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
149148224|NCT01624662|538022051|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
149148225|NCT01624662|538022048|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149148226|NCT01624662|538022049|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
149148227|NCT01624662|538022050|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149148228|NCT01624662|538022051|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
148805099|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
148805100|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
148805101|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
148805102|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
148671474|NCT00297882|536268780|FG000|Day 14|Lack of Efficacy|12|||
148671475|NCT00297882|536268781|FG001|Day 14|Lack of Efficacy|49|||
148671476|NCT00297882|536268780|FG000|Day 28|Lost to Follow-up|13|||
148671477|NCT00297882|536268781|FG001|Day 28|Lost to Follow-up|23|||
148671478|NCT00297882|536268780|FG000|Day 28|Lack of Efficacy|3|||
148671479|NCT00297882|536268781|FG001|Day 28|Lack of Efficacy|0|||
148671480|NCT04242264|536268782|FG000|Overall Study|Lost to Follow-up|2|||
148671481|NCT04242264|536268783|FG001|Overall Study|Lost to Follow-up|2|||
148671482|NCT04242264|536268784|FG002|Overall Study|Lost to Follow-up|1|||
148671483|NCT04242264|536268785|FG003|Overall Study|Lost to Follow-up|1|||
148671484|NCT04242264|536268782|FG000|Overall Study|Withdrawal by Subject|1|||
148671485|NCT04242264|536268783|FG001|Overall Study|Withdrawal by Subject|0|||
148671486|NCT04242264|536268784|FG002|Overall Study|Withdrawal by Subject|0|||
148671487|NCT04242264|536268785|FG003|Overall Study|Withdrawal by Subject|0|||
148671488|NCT02116309|536268787|FG000|Overall Study|Lost to Follow-up|0|||
148671489|NCT02116309|536268788|FG001|Overall Study|Lost to Follow-up|1|||
148671490|NCT00471237|536268789|FG000|Overall Study|Adverse Event|6|||
148671491|NCT00471237|536268790|FG001|Overall Study|Adverse Event|5|||
148671492|NCT00471237|536268791|FG002|Overall Study|Adverse Event|4|||
148671493|NCT00471237|536268792|FG003|Overall Study|Adverse Event|8|||
149148229|NCT01624662|538022048|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
149148230|NCT01624662|538022049|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
149148231|NCT01624662|538022050|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
149148232|NCT01624662|538022051|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
149148233|NCT01714687|538022054|FG000|Overall Study|Withdrawal by Subject|1|||
149148234|NCT01714687|538022055|FG001|Overall Study|Withdrawal by Subject|0|||
149148235|NCT01714687|538022054|FG000|Overall Study|Lost to Follow-up|2|||
149148236|NCT01714687|538022055|FG001|Overall Study|Lost to Follow-up|4|||
149148237|NCT03116698|538022056|FG000|Overall Study|Adverse Event|1|||
149148238|NCT03116698|538022057|FG001|Overall Study|Adverse Event|1|||
149148239|NCT03116698|538022058|FG002|Overall Study|Adverse Event|1|||
148671494|NCT00471237|536268793|FG004|Overall Study|Adverse Event|7|||
148671495|NCT00471237|536268794|FG005|Overall Study|Adverse Event|5|||
148671496|NCT00471237|536268795|FG006|Overall Study|Adverse Event|0|||
148671497|NCT00471237|536268789|FG000|Overall Study|Lost to Follow-up|1|||
148671498|NCT00471237|536268790|FG001|Overall Study|Lost to Follow-up|1|||
148671499|NCT00471237|536268791|FG002|Overall Study|Lost to Follow-up|0|||
148671500|NCT00471237|536268792|FG003|Overall Study|Lost to Follow-up|2|||
148671501|NCT00471237|536268793|FG004|Overall Study|Lost to Follow-up|3|||
148671502|NCT00471237|536268794|FG005|Overall Study|Lost to Follow-up|0|||
148671503|NCT00471237|536268795|FG006|Overall Study|Lost to Follow-up|0|||
148671504|NCT00471237|536268789|FG000|Overall Study|Protocol Violation|3|||
148671505|NCT00471237|536268790|FG001|Overall Study|Protocol Violation|6|||
148671506|NCT00471237|536268791|FG002|Overall Study|Protocol Violation|3|||
148671507|NCT00471237|536268792|FG003|Overall Study|Protocol Violation|2|||
148671508|NCT00471237|536268793|FG004|Overall Study|Protocol Violation|2|||
148671509|NCT00471237|536268794|FG005|Overall Study|Protocol Violation|4|||
148671510|NCT00471237|536268795|FG006|Overall Study|Protocol Violation|1|||
148671511|NCT00471237|536268789|FG000|Overall Study|Withdrawal by Subject|8|||
148671512|NCT00471237|536268790|FG001|Overall Study|Withdrawal by Subject|6|||
148671513|NCT00471237|536268791|FG002|Overall Study|Withdrawal by Subject|5|||
149148240|NCT03116698|538022059|FG003|Overall Study|Adverse Event|0|||
148671514|NCT00471237|536268792|FG003|Overall Study|Withdrawal by Subject|8|||
148671515|NCT00471237|536268793|FG004|Overall Study|Withdrawal by Subject|7|||
148671516|NCT00471237|536268794|FG005|Overall Study|Withdrawal by Subject|4|||
149148241|NCT03116698|538022056|FG000|Overall Study|Withdrawal by Subject|1|||
148671517|NCT00471237|536268795|FG006|Overall Study|Withdrawal by Subject|2|||
148671518|NCT00471237|536268789|FG000|Overall Study|Sponsor terminated study|20|||
148671519|NCT00471237|536268790|FG001|Overall Study|Sponsor terminated study|23|||
148671520|NCT00471237|536268791|FG002|Overall Study|Sponsor terminated study|19|||
148671521|NCT00471237|536268792|FG003|Overall Study|Sponsor terminated study|22|||
148671522|NCT00471237|536268793|FG004|Overall Study|Sponsor terminated study|18|||
148671523|NCT00471237|536268794|FG005|Overall Study|Sponsor terminated study|24|||
148671524|NCT00471237|536268795|FG006|Overall Study|Sponsor terminated study|0|||
149148242|NCT03116698|538022057|FG001|Overall Study|Withdrawal by Subject|4|||
149148243|NCT03116698|538022058|FG002|Overall Study|Withdrawal by Subject|5|||
149148244|NCT03116698|538022059|FG003|Overall Study|Withdrawal by Subject|2|||
149148245|NCT03116698|538022056|FG000|Overall Study|Lost to Follow-up|2|||
149148246|NCT03116698|538022057|FG001|Overall Study|Lost to Follow-up|0|||
149148247|NCT03116698|538022058|FG002|Overall Study|Lost to Follow-up|0|||
149148248|NCT03116698|538022059|FG003|Overall Study|Lost to Follow-up|0|||
149148249|NCT03116698|538022056|FG000|Overall Study|Physician Decision|1|||
149148250|NCT03116698|538022057|FG001|Overall Study|Physician Decision|1|||
149148251|NCT03116698|538022058|FG002|Overall Study|Physician Decision|0|||
149148252|NCT03116698|538022059|FG003|Overall Study|Physician Decision|0|||
149148253|NCT03116698|538022056|FG000|Overall Study|Protocol Violation|1|||
149148254|NCT03116698|538022057|FG001|Overall Study|Protocol Violation|0|||
149148255|NCT03116698|538022058|FG002|Overall Study|Protocol Violation|0|||
149148256|NCT03116698|538022059|FG003|Overall Study|Protocol Violation|0|||
149148257|NCT03116698|538022056|FG000|Overall Study|Death|0|||
149148258|NCT03116698|538022057|FG001|Overall Study|Death|0|||
148671525|NCT00471237|536268789|FG000|Overall Study|Non-compliance|0|||
149148259|NCT03116698|538022058|FG002|Overall Study|Death|2|||
148671526|NCT00471237|536268790|FG001|Overall Study|Non-compliance|1|||
148914298|NCT00689117|537169959|FG002|Overall Study|Use of Prohibitive Medication|3|||
148914299|NCT00689117|537169960|FG003|Overall Study|Use of Prohibitive Medication|0|||
148914300|NCT00689117|537169957|FG000|Overall Study|Pregnancy|0|||
148914301|NCT00689117|537169958|FG001|Overall Study|Pregnancy|2|||
148914302|NCT00689117|537169959|FG002|Overall Study|Pregnancy|0|||
148914303|NCT00689117|537169960|FG003|Overall Study|Pregnancy|2|||
148914304|NCT00689117|537169957|FG000|Overall Study|Incarceration|2|||
148914305|NCT00689117|537169958|FG001|Overall Study|Incarceration|0|||
148914306|NCT00689117|537169959|FG002|Overall Study|Incarceration|0|||
148914307|NCT00689117|537169960|FG003|Overall Study|Incarceration|0|||
148914308|NCT00689117|537169957|FG000|Overall Study|Fear of Birth Defects|0|||
148914309|NCT00689117|537169958|FG001|Overall Study|Fear of Birth Defects|0|||
148914310|NCT00689117|537169959|FG002|Overall Study|Fear of Birth Defects|1|||
148914311|NCT00689117|537169960|FG003|Overall Study|Fear of Birth Defects|0|||
148914312|NCT00689117|537169957|FG000|Overall Study|Transportation|1|||
148914313|NCT00689117|537169958|FG001|Overall Study|Transportation|0|||
148914314|NCT00689117|537169959|FG002|Overall Study|Transportation|0|||
148914315|NCT00689117|537169960|FG003|Overall Study|Transportation|0|||
148914316|NCT00689117|537169957|FG000|Overall Study|Patient Withdrew from Study|0|||
148914317|NCT00689117|537169958|FG001|Overall Study|Patient Withdrew from Study|0|||
148914318|NCT00689117|537169959|FG002|Overall Study|Patient Withdrew from Study|0|||
148914319|NCT00689117|537169960|FG003|Overall Study|Patient Withdrew from Study|1|||
148914320|NCT00689117|537169957|FG000|Overall Study|Personal Reason|0|||
148914321|NCT00689117|537169958|FG001|Overall Study|Personal Reason|1|||
148914322|NCT00689117|537169959|FG002|Overall Study|Personal Reason|0|||
148914323|NCT00689117|537169960|FG003|Overall Study|Personal Reason|0|||
148914324|NCT00689117|537169957|FG000|Overall Study|Dispensing Error|0|||
148914325|NCT00689117|537169958|FG001|Overall Study|Dispensing Error|1|||
148914326|NCT00689117|537169959|FG002|Overall Study|Dispensing Error|0|||
148914327|NCT00689117|537169960|FG003|Overall Study|Dispensing Error|0|||
148914328|NCT01206322|537169961|FG000|Overall Study|Adverse Event|0|||
148914329|NCT01206322|537169962|FG001|Overall Study|Adverse Event|0|||
148914330|NCT01206322|537169963|FG002|Overall Study|Adverse Event|0|||
148914331|NCT01206322|537169964|FG003|Overall Study|Adverse Event|1|||
148914332|NCT00444678|537169965|FG000|Overall Study|Toxicity|11|||
148914333|NCT00444678|537169965|FG000|Overall Study|Disease Progression|12|||
148914334|NCT00444678|537169965|FG000|Overall Study|Death|3|||
148914335|NCT00444678|537169965|FG000|Overall Study|Physician Decision|3|||
148914336|NCT00444678|537169965|FG000|Overall Study|Withdrawal by Subject|2|||
148914337|NCT02888119|537169973|FG000|Overall Study|Lost to Follow-up|5|||
148914338|NCT02888119|537169974|FG001|Overall Study|Lost to Follow-up|4|||
148914339|NCT02888119|537169975|FG002|Overall Study|Lost to Follow-up|0|||
148914340|NCT01767142|537169976|FG000|Overall Study|Lost to Follow-up|3|||
148914341|NCT00926029|537169982|FG000|Overall Study|Lost to Follow-up|2|||
149148260|NCT03116698|538022059|FG003|Overall Study|Death|0|||
149148261|NCT00788372|538022060|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
149148262|NCT00788372|538022060|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
149148263|NCT00788372|538022060|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
149148264|NCT00788372|538022060|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
149148265|NCT00788372|538022060|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
149148266|NCT00788372|538022060|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
149148267|NCT00788372|538022060|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
149148268|NCT03099187|538022065|FG000|Double-blind Treatment|Adverse Event|19|||
149148269|NCT03099187|538022066|FG001|Double-blind Treatment|Adverse Event|1|||
149148270|NCT03099187|538022067|FG002|Double-blind Treatment|Adverse Event|0|||
149148271|NCT03099187|538022068|FG003|Double-blind Treatment|Adverse Event|0|||
149148272|NCT03099187|538022065|FG000|Double-blind Treatment|Death|1|||
148805103|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
148805104|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
149148273|NCT03099187|538022066|FG001|Double-blind Treatment|Death|3|||
149148274|NCT03099187|538022067|FG002|Double-blind Treatment|Death|0|||
149148275|NCT03099187|538022068|FG003|Double-blind Treatment|Death|0|||
148671527|NCT00471237|536268791|FG002|Overall Study|Non-compliance|0|||
148671528|NCT00471237|536268792|FG003|Overall Study|Non-compliance|1|||
148671529|NCT00471237|536268793|FG004|Overall Study|Non-compliance|0|||
148671530|NCT00471237|536268794|FG005|Overall Study|Non-compliance|0|||
148671531|NCT00471237|536268795|FG006|Overall Study|Non-compliance|0|||
148671532|NCT00471237|536268789|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
148671533|NCT00471237|536268790|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
148671534|NCT00471237|536268791|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
148671535|NCT00471237|536268792|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
148671536|NCT00471237|536268793|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
148671537|NCT00471237|536268794|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
148671538|NCT00471237|536268795|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
148671539|NCT00471237|536268789|FG000|Overall Study|Early stopping due to non-efficacy|1|||
148671540|NCT00471237|536268790|FG001|Overall Study|Early stopping due to non-efficacy|0|||
148671541|NCT00471237|536268791|FG002|Overall Study|Early stopping due to non-efficacy|0|||
148671542|NCT00471237|536268792|FG003|Overall Study|Early stopping due to non-efficacy|0|||
148671543|NCT00471237|536268793|FG004|Overall Study|Early stopping due to non-efficacy|1|||
148671544|NCT00471237|536268794|FG005|Overall Study|Early stopping due to non-efficacy|0|||
148671545|NCT00471237|536268795|FG006|Overall Study|Early stopping due to non-efficacy|0|||
148671546|NCT00471237|536268789|FG000|Overall Study|Participant planned to travel to abraod|1|||
148671547|NCT00471237|536268790|FG001|Overall Study|Participant planned to travel to abraod|0|||
148671548|NCT00471237|536268791|FG002|Overall Study|Participant planned to travel to abraod|0|||
148671549|NCT00471237|536268792|FG003|Overall Study|Participant planned to travel to abraod|0|||
148671550|NCT00471237|536268793|FG004|Overall Study|Participant planned to travel to abraod|0|||
148671551|NCT00471237|536268794|FG005|Overall Study|Participant planned to travel to abraod|1|||
148671552|NCT00471237|536268795|FG006|Overall Study|Participant planned to travel to abraod|0|||
148671553|NCT00471237|536268789|FG000|Overall Study|High parathyroid hormone|0|||
148671554|NCT00471237|536268790|FG001|Overall Study|High parathyroid hormone|0|||
148671555|NCT00471237|536268791|FG002|Overall Study|High parathyroid hormone|1|||
148671556|NCT00471237|536268792|FG003|Overall Study|High parathyroid hormone|0|||
148671557|NCT00471237|536268793|FG004|Overall Study|High parathyroid hormone|0|||
148671558|NCT00471237|536268794|FG005|Overall Study|High parathyroid hormone|0|||
148671559|NCT00471237|536268795|FG006|Overall Study|High parathyroid hormone|0|||
148671560|NCT00471237|536268789|FG000|Overall Study|Participant lost medication|0|||
148671561|NCT00471237|536268790|FG001|Overall Study|Participant lost medication|0|||
148671562|NCT00471237|536268791|FG002|Overall Study|Participant lost medication|0|||
148671563|NCT00471237|536268792|FG003|Overall Study|Participant lost medication|0|||
148671564|NCT00471237|536268793|FG004|Overall Study|Participant lost medication|1|||
148671565|NCT00471237|536268794|FG005|Overall Study|Participant lost medication|0|||
148671566|NCT00471237|536268795|FG006|Overall Study|Participant lost medication|0|||
148671567|NCT00471237|536268789|FG000|Overall Study|Administration of prohibited medicine|0|||
148671568|NCT00471237|536268790|FG001|Overall Study|Administration of prohibited medicine|0|||
148671569|NCT00471237|536268791|FG002|Overall Study|Administration of prohibited medicine|0|||
148671570|NCT00471237|536268792|FG003|Overall Study|Administration of prohibited medicine|0|||
148671571|NCT00471237|536268793|FG004|Overall Study|Administration of prohibited medicine|1|||
148671572|NCT00471237|536268794|FG005|Overall Study|Administration of prohibited medicine|0|||
148914342|NCT00926029|537169983|FG001|Overall Study|Lost to Follow-up|1|||
148914343|NCT00926029|537169984|FG002|Overall Study|Lost to Follow-up|1|||
148914344|NCT02471612|537169985|FG000|Overall Study|Lost to Follow-up|2|||
148914345|NCT05573386|537169986|FG000|Overall Study|Withdrawal by Subject|3|||
148914346|NCT05573386|537169987|FG001|Overall Study|Withdrawal by Subject|2|||
148914347|NCT05246514|537169988|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
148914348|NCT05246514|537169988|FG000|Overall Study|Withdrawal by Subject|1|||
148914349|NCT05246514|537169988|FG000|Overall Study|Death|13|||
148914350|NCT03646123|537169989|FG000|Overall Study|Withdrawal by Subject|2|||
148914351|NCT03646123|537169990|FG001|Overall Study|Withdrawal by Subject|2|||
148914352|NCT03646123|537169991|FG002|Overall Study|Withdrawal by Subject|3|||
148914353|NCT03646123|537169989|FG000|Overall Study|Study termination by sponsor|0|||
148914354|NCT03646123|537169990|FG001|Overall Study|Study termination by sponsor|45|||
148914355|NCT03646123|537169991|FG002|Overall Study|Study termination by sponsor|139|||
149148276|NCT03099187|538022065|FG000|Double-blind Treatment|Lack of Efficacy|1|||
149148277|NCT03099187|538022066|FG001|Double-blind Treatment|Lack of Efficacy|0|||
149148278|NCT03099187|538022067|FG002|Double-blind Treatment|Lack of Efficacy|0|||
148914356|NCT03646123|537169989|FG000|Overall Study|Lost to Follow-up|4|||
148914357|NCT03646123|537169990|FG001|Overall Study|Lost to Follow-up|10|||
148914358|NCT03646123|537169991|FG002|Overall Study|Lost to Follow-up|10|||
148914359|NCT03646123|537169989|FG000|Overall Study|Death|2|||
148914360|NCT03646123|537169990|FG001|Overall Study|Death|1|||
148671573|NCT00471237|536268795|FG006|Overall Study|Administration of prohibited medicine|0|||
148671574|NCT00471237|536268789|FG000|Overall Study|Participant shifted residence|0|||
148671575|NCT00471237|536268790|FG001|Overall Study|Participant shifted residence|0|||
148671576|NCT00471237|536268791|FG002|Overall Study|Participant shifted residence|0|||
148671577|NCT00471237|536268792|FG003|Overall Study|Participant shifted residence|0|||
149148279|NCT03099187|538022068|FG003|Double-blind Treatment|Lack of Efficacy|0|||
149148280|NCT03099187|538022065|FG000|Double-blind Treatment|Physician Decision|2|||
149148281|NCT03099187|538022066|FG001|Double-blind Treatment|Physician Decision|1|||
149148282|NCT03099187|538022067|FG002|Double-blind Treatment|Physician Decision|0|||
149148283|NCT03099187|538022068|FG003|Double-blind Treatment|Physician Decision|0|||
149148284|NCT03099187|538022065|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
148671578|NCT00471237|536268793|FG004|Overall Study|Participant shifted residence|1|||
148671579|NCT00471237|536268794|FG005|Overall Study|Participant shifted residence|0|||
148914361|NCT03646123|537169991|FG002|Overall Study|Death|1|||
148914362|NCT03646123|537169989|FG000|Overall Study|Other|2|||
148914363|NCT03646123|537169990|FG001|Overall Study|Other|0|||
149148285|NCT03099187|538022066|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
149148286|NCT03099187|538022067|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
148914364|NCT03646123|537169991|FG002|Overall Study|Other|2|||
149148287|NCT03099187|538022068|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
149148288|NCT03099187|538022065|FG000|Double-blind Treatment|Lung transplantation|0|||
149148289|NCT03099187|538022066|FG001|Double-blind Treatment|Lung transplantation|1|||
149148290|NCT03099187|538022067|FG002|Double-blind Treatment|Lung transplantation|0|||
149148291|NCT03099187|538022068|FG003|Double-blind Treatment|Lung transplantation|0|||
149148292|NCT03099187|538022065|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
149148293|NCT03099187|538022066|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
149148294|NCT03099187|538022067|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
149148295|NCT03099187|538022068|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
149148296|NCT03099187|538022065|FG000|Double-blind Treatment|Disease progression|0|||
149148297|NCT03099187|538022066|FG001|Double-blind Treatment|Disease progression|1|||
149148298|NCT03099187|538022067|FG002|Double-blind Treatment|Disease progression|0|||
149148299|NCT03099187|538022068|FG003|Double-blind Treatment|Disease progression|0|||
149148300|NCT03099187|538022065|FG000|Double-blind Treatment|Randomization error|0|||
149148301|NCT03099187|538022066|FG001|Double-blind Treatment|Randomization error|2|||
149148302|NCT03099187|538022067|FG002|Double-blind Treatment|Randomization error|0|||
149148303|NCT03099187|538022068|FG003|Double-blind Treatment|Randomization error|0|||
149148304|NCT03099187|538022065|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
149148305|NCT03099187|538022066|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
149148306|NCT03099187|538022067|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
149148307|NCT03099187|538022068|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
149148308|NCT03099187|538022065|FG000|12-month Safety Follow-up|Adverse Event|0|||
149148309|NCT03099187|538022066|FG001|12-month Safety Follow-up|Adverse Event|0|||
149148310|NCT03099187|538022067|FG002|12-month Safety Follow-up|Adverse Event|5|||
149148311|NCT03099187|538022068|FG003|12-month Safety Follow-up|Adverse Event|12|||
149148312|NCT03099187|538022065|FG000|12-month Safety Follow-up|Death|0|||
148671580|NCT00471237|536268795|FG006|Overall Study|Participant shifted residence|0|||
149148313|NCT03099187|538022066|FG001|12-month Safety Follow-up|Death|0|||
148805105|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149148314|NCT03099187|538022067|FG002|12-month Safety Follow-up|Death|7|||
148914365|NCT01802073|537169994|FG000|Overall Study|Lost to Follow-up|0|||
148914366|NCT01802073|537169995|FG001|Overall Study|Lost to Follow-up|1|||
148914367|NCT01802073|537169994|FG000|Overall Study|Non-compliant|4|||
148914368|NCT01802073|537169995|FG001|Overall Study|Non-compliant|2|||
148914369|NCT01802073|537169994|FG000|Overall Study|Withdrawal by Subject|1|||
148914370|NCT01802073|537169995|FG001|Overall Study|Withdrawal by Subject|1|||
149148315|NCT03099187|538022068|FG003|12-month Safety Follow-up|Death|9|||
149148316|NCT03099187|538022065|FG000|12-month Safety Follow-up|Lung transplantation|0|||
149148317|NCT03099187|538022066|FG001|12-month Safety Follow-up|Lung transplantation|0|||
149148318|NCT03099187|538022067|FG002|12-month Safety Follow-up|Lung transplantation|2|||
149148319|NCT03099187|538022068|FG003|12-month Safety Follow-up|Lung transplantation|1|||
149148320|NCT03099187|538022065|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
149148321|NCT03099187|538022066|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
149148322|NCT03099187|538022067|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
149148323|NCT03099187|538022068|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
149148324|NCT03099187|538022065|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
149148325|NCT03099187|538022066|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
149148326|NCT03099187|538022067|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
149148327|NCT03099187|538022068|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
149148328|NCT03099187|538022065|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
149148329|NCT03099187|538022066|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
149148330|NCT03099187|538022067|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
149148331|NCT03099187|538022068|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
149148332|NCT03099187|538022065|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
149148333|NCT03099187|538022066|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
149148334|NCT03099187|538022067|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
149148335|NCT03099187|538022068|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
149148336|NCT01439555|538022069|FG000|Overall Study|Protocol Violation|1|||
149148337|NCT04869345|538022075|FG000|Overall Study|Lost to Follow-up|8|||
149148338|NCT04869345|538022076|FG001|Overall Study|Lost to Follow-up|3|||
149148339|NCT03921424|538022086|FG000|Overall Study|Lost to Follow-up|0|||
149148340|NCT03921424|538022087|FG001|Overall Study|Lost to Follow-up|1|||
149148341|NCT03921424|538022086|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
149148342|NCT03921424|538022087|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
149148343|NCT05121480|538023754|FG000|Overall Study|Lack of Efficacy|2|||
149148344|NCT05121480|538023755|FG001|Overall Study|Lack of Efficacy|2|||
149148345|NCT05121480|538023756|FG002|Overall Study|Lack of Efficacy|1|||
149148346|NCT05121480|538023757|FG003|Overall Study|Lack of Efficacy|4|||
149148347|NCT05121480|538023758|FG004|Overall Study|Lack of Efficacy|0|||
149148348|NCT05121480|538023759|FG005|Overall Study|Lack of Efficacy|1|||
149148349|NCT05121480|538023760|FG006|Overall Study|Lack of Efficacy|0|||
149148350|NCT05121480|538023761|FG007|Overall Study|Lack of Efficacy|2|||
149148351|NCT05121480|538023754|FG000|Overall Study|Treatment Failure|0|||
149148352|NCT05121480|538023755|FG001|Overall Study|Treatment Failure|2|||
149148353|NCT05121480|538023756|FG002|Overall Study|Treatment Failure|0|||
149148354|NCT05121480|538023757|FG003|Overall Study|Treatment Failure|1|||
149148355|NCT05121480|538023758|FG004|Overall Study|Treatment Failure|0|||
149148356|NCT05121480|538023759|FG005|Overall Study|Treatment Failure|0|||
149148357|NCT05121480|538023760|FG006|Overall Study|Treatment Failure|0|||
149148358|NCT05121480|538023761|FG007|Overall Study|Treatment Failure|0|||
149148359|NCT05121480|538023754|FG000|Overall Study|Adverse Event|0|||
149148360|NCT05121480|538023755|FG001|Overall Study|Adverse Event|1|||
149148361|NCT05121480|538023756|FG002|Overall Study|Adverse Event|0|||
149148362|NCT05121480|538023757|FG003|Overall Study|Adverse Event|5|||
149148363|NCT05121480|538023758|FG004|Overall Study|Adverse Event|3|||
149148364|NCT05121480|538023759|FG005|Overall Study|Adverse Event|2|||
149148365|NCT05121480|538023760|FG006|Overall Study|Adverse Event|0|||
149148366|NCT05121480|538023761|FG007|Overall Study|Adverse Event|4|||
149148367|NCT05121480|538023754|FG000|Overall Study|Withdrawal by Subject|4|||
149148368|NCT05121480|538023755|FG001|Overall Study|Withdrawal by Subject|9|||
149148369|NCT05121480|538023756|FG002|Overall Study|Withdrawal by Subject|1|||
149148370|NCT05121480|538023757|FG003|Overall Study|Withdrawal by Subject|8|||
149148371|NCT05121480|538023758|FG004|Overall Study|Withdrawal by Subject|0|||
149148372|NCT05121480|538023759|FG005|Overall Study|Withdrawal by Subject|9|||
149148373|NCT05121480|538023760|FG006|Overall Study|Withdrawal by Subject|0|||
149148374|NCT05121480|538023761|FG007|Overall Study|Withdrawal by Subject|4|||
149148375|NCT05121480|538023754|FG000|Overall Study|Non-compliance with the protocol|0|||
149148376|NCT05121480|538023755|FG001|Overall Study|Non-compliance with the protocol|0|||
149148377|NCT05121480|538023756|FG002|Overall Study|Non-compliance with the protocol|0|||
148914371|NCT01802073|537169994|FG000|Overall Study|Physician Decision|0|||
149148378|NCT05121480|538023757|FG003|Overall Study|Non-compliance with the protocol|0|||
149148379|NCT05121480|538023758|FG004|Overall Study|Non-compliance with the protocol|1|||
149148380|NCT05121480|538023759|FG005|Overall Study|Non-compliance with the protocol|6|||
149148381|NCT05121480|538023760|FG006|Overall Study|Non-compliance with the protocol|0|||
149148382|NCT05121480|538023761|FG007|Overall Study|Non-compliance with the protocol|1|||
148671581|NCT00471237|536268789|FG000|Overall Study|Participant's decision|0|||
148671582|NCT00471237|536268790|FG001|Overall Study|Participant's decision|0|||
148671583|NCT00471237|536268791|FG002|Overall Study|Participant's decision|0|||
148671584|NCT00471237|536268792|FG003|Overall Study|Participant's decision|0|||
148671585|NCT00471237|536268793|FG004|Overall Study|Participant's decision|0|||
148671586|NCT00471237|536268794|FG005|Overall Study|Participant's decision|1|||
148671587|NCT00471237|536268795|FG006|Overall Study|Participant's decision|0|||
148671588|NCT00348348|536268796|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
148671589|NCT00348348|536268797|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
148671590|NCT00348348|536268796|FG000|Overall Study|Lack of Efficacy|1|||
148671591|NCT00348348|536268797|FG001|Overall Study|Lack of Efficacy|1|||
148671592|NCT00348348|536268796|FG000|Overall Study|Lost to Follow-up|8|||
148671593|NCT00348348|536268797|FG001|Overall Study|Lost to Follow-up|10|||
148671594|NCT00348348|536268796|FG000|Overall Study|Withdrawal by Subject|4|||
148671595|NCT00348348|536268797|FG001|Overall Study|Withdrawal by Subject|1|||
148671596|NCT00348348|536268796|FG000|Overall Study|Other|7|||
148671597|NCT00348348|536268797|FG001|Overall Study|Other|4|||
148671598|NCT00348348|536268796|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
148671599|NCT00348348|536268797|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
148671600|NCT00348348|536268796|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
148671601|NCT00348348|536268797|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
148671602|NCT00348348|536268796|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
148671603|NCT00348348|536268797|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
148671604|NCT00348348|536268796|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
148671605|NCT00348348|536268797|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
148671606|NCT00348348|536268796|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
148671607|NCT00348348|536268797|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
148671608|NCT00348348|536268796|FG000|Overall Study|Adverse event probably related to study|1|||
148671609|NCT00348348|536268797|FG001|Overall Study|Adverse event probably related to study|0|||
148671610|NCT03710824|536268798|FG000|Overall Study|Withdrawal by Subject|1|||
148671611|NCT03710824|536268798|FG000|Overall Study|Lost to Follow-up|3|||
148671612|NCT03710824|536268798|FG000|Overall Study|Adverse Event|25|||
148671613|NCT03710824|536268798|FG000|Overall Study|Treatment discontinuation|2|||
148671614|NCT02329834|536268799|FG000|Overall Study|Physician Decision|1|||
148671615|NCT02329834|536268800|FG001|Overall Study|Physician Decision|0|||
148671616|NCT00578448|536268801|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
148671617|NCT00578448|536268801|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
148671618|NCT00578448|536268801|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
148671619|NCT00578448|536268801|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
148671620|NCT01317199|536268802|FG000|Dose-escalation Phase 1|Physician Decision|5|||
148671621|NCT01317199|536268803|FG001|Dose-escalation Phase 1|Physician Decision|0|||
148671622|NCT01317199|536268804|FG002|Dose-escalation Phase 1|Physician Decision|0|||
148671623|NCT01317199|536268805|FG003|Dose-escalation Phase 1|Physician Decision|0|||
148671624|NCT01317199|536268802|FG000|Dose-escalation Phase 1|Disease progression|1|||
148671625|NCT01317199|536268803|FG001|Dose-escalation Phase 1|Disease progression|0|||
149148383|NCT05121480|538023754|FG000|Overall Study|Lost to Follow-up|0|||
149148384|NCT05121480|538023755|FG001|Overall Study|Lost to Follow-up|4|||
149148385|NCT05121480|538023756|FG002|Overall Study|Lost to Follow-up|1|||
149148386|NCT05121480|538023757|FG003|Overall Study|Lost to Follow-up|3|||
149148387|NCT05121480|538023758|FG004|Overall Study|Lost to Follow-up|1|||
149148388|NCT05121480|538023759|FG005|Overall Study|Lost to Follow-up|1|||
149148389|NCT05121480|538023760|FG006|Overall Study|Lost to Follow-up|1|||
148671626|NCT01317199|536268804|FG002|Dose-escalation Phase 1|Disease progression|0|||
148671627|NCT01317199|536268805|FG003|Dose-escalation Phase 1|Disease progression|0|||
148671628|NCT01317199|536268802|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
148671629|NCT01317199|536268803|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
148671630|NCT01317199|536268804|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
148671631|NCT01317199|536268805|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
148671632|NCT01317199|536268802|FG000|Randomized Phase 2|Disease progression|0|||
148805106|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
149148390|NCT05121480|538023761|FG007|Overall Study|Lost to Follow-up|4|||
149148391|NCT05121480|538023754|FG000|Overall Study|Physician Decision|0|||
149148392|NCT05121480|538023755|FG001|Overall Study|Physician Decision|0|||
149148393|NCT05121480|538023756|FG002|Overall Study|Physician Decision|0|||
149148394|NCT05121480|538023757|FG003|Overall Study|Physician Decision|0|||
149148395|NCT05121480|538023758|FG004|Overall Study|Physician Decision|0|||
148671633|NCT01317199|536268803|FG001|Randomized Phase 2|Disease progression|3|||
148671634|NCT01317199|536268804|FG002|Randomized Phase 2|Disease progression|7|||
148671635|NCT01317199|536268805|FG003|Randomized Phase 2|Disease progression|5|||
148671636|NCT01317199|536268802|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
148671637|NCT01317199|536268803|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
149148396|NCT05121480|538023759|FG005|Overall Study|Physician Decision|1|||
149148397|NCT05121480|538023760|FG006|Overall Study|Physician Decision|0|||
149148398|NCT05121480|538023761|FG007|Overall Study|Physician Decision|1|||
149148399|NCT05121480|538023754|FG000|Overall Study|Other Reason|0|||
149148400|NCT05121480|538023755|FG001|Overall Study|Other Reason|0|||
149148401|NCT05121480|538023756|FG002|Overall Study|Other Reason|0|||
149148402|NCT05121480|538023757|FG003|Overall Study|Other Reason|0|||
149148403|NCT05121480|538023758|FG004|Overall Study|Other Reason|0|||
149148404|NCT05121480|538023759|FG005|Overall Study|Other Reason|1|||
149148405|NCT05121480|538023760|FG006|Overall Study|Other Reason|1|||
149148406|NCT05121480|538023761|FG007|Overall Study|Other Reason|1|||
149148407|NCT02356562|538023762|FG000|Overall Study|Withdrawal by Subject|0|||
149148408|NCT02356562|538023763|FG001|Overall Study|Withdrawal by Subject|1|||
149148409|NCT02356562|538023762|FG000|Overall Study|Re-entered treatment in a previous study|1|||
149148410|NCT02356562|538023763|FG001|Overall Study|Re-entered treatment in a previous study|0|||
149148411|NCT02356562|538023762|FG000|Overall Study|site closure|1|||
149148412|NCT02356562|538023763|FG001|Overall Study|site closure|0|||
149148413|NCT00412750|538023764|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149148414|NCT00412750|538023765|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149148415|NCT00412750|538023766|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149148416|NCT00412750|538023764|FG000|Overall Study|Administrative problems|21|||
149148417|NCT00412750|538023765|FG001|Overall Study|Administrative problems|17|||
149148418|NCT00412750|538023766|FG002|Overall Study|Administrative problems|14|||
148671638|NCT01317199|536268804|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
148671639|NCT01317199|536268805|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
148671640|NCT01317199|536268802|FG000|Randomized Phase 2|Adverse Event|0|||
148671641|NCT01317199|536268803|FG001|Randomized Phase 2|Adverse Event|0|||
148671642|NCT01317199|536268804|FG002|Randomized Phase 2|Adverse Event|0|||
148671643|NCT01317199|536268805|FG003|Randomized Phase 2|Adverse Event|1|||
148671644|NCT01317199|536268802|FG000|Randomized Phase 2|Comorbidities|0|||
148671645|NCT01317199|536268803|FG001|Randomized Phase 2|Comorbidities|2|||
148671646|NCT01317199|536268804|FG002|Randomized Phase 2|Comorbidities|2|||
148671647|NCT01317199|536268805|FG003|Randomized Phase 2|Comorbidities|2|||
148671648|NCT01317199|536268802|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
148671649|NCT01317199|536268803|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
148671650|NCT01317199|536268804|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
148671651|NCT01317199|536268805|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
148671652|NCT01317199|536268802|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
148671653|NCT01317199|536268803|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
148671654|NCT01317199|536268804|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
148671655|NCT01317199|536268805|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
148671656|NCT01317199|536268802|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
148671657|NCT01317199|536268803|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
148671658|NCT01317199|536268804|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
148671659|NCT01317199|536268805|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
148671660|NCT01317199|536268802|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
148671661|NCT01317199|536268803|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
148671662|NCT01317199|536268804|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
148671663|NCT01317199|536268805|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
148671664|NCT01353209|536268806|FG000|Overall Study|Adverse Event|1|||
148671665|NCT01353209|536268807|FG001|Overall Study|Adverse Event|1|||
148671666|NCT03237325|536268815|FG000|Overall Study|Lost to Follow-up|3|||
148671667|NCT03237325|536268816|FG001|Overall Study|Lost to Follow-up|5|||
148671668|NCT03237325|536268815|FG000|Overall Study|Physician Decision|2|||
148671669|NCT03237325|536268816|FG001|Overall Study|Physician Decision|4|||
148671670|NCT03237325|536268815|FG000|Overall Study|Withdrawal by Subject|9|||
148671671|NCT03237325|536268816|FG001|Overall Study|Withdrawal by Subject|12|||
148671672|NCT03237325|536268815|FG000|Overall Study|Noncompliance with Study Procedures|1|||
148671673|NCT03237325|536268816|FG001|Overall Study|Noncompliance with Study Procedures|1|||
148671674|NCT03237325|536268815|FG000|Overall Study|Termination by Sponsor|0|||
148671675|NCT03237325|536268816|FG001|Overall Study|Termination by Sponsor|1|||
148671676|NCT03237325|536268815|FG000|Overall Study|Reason other than described|0|||
148671677|NCT03237325|536268816|FG001|Overall Study|Reason other than described|2|||
148671678|NCT02684370|536268817|FG000|Part A|Adverse Event|2|||
148671679|NCT02684370|536268818|FG001|Part A|Adverse Event|0|||
148671680|NCT02684370|536268819|FG002|Part A|Adverse Event|1|||
148671681|NCT02684370|536268820|FG003|Part A|Adverse Event|0|||
148671682|NCT02684370|536268821|FG004|Part A|Adverse Event|0|||
148671683|NCT02684370|536268822|FG005|Part A|Adverse Event|0|||
148671684|NCT02684370|536268817|FG000|Part A|Lost to Follow-up|1|||
148671685|NCT02684370|536268818|FG001|Part A|Lost to Follow-up|1|||
148671686|NCT02684370|536268819|FG002|Part A|Lost to Follow-up|0|||
148671687|NCT02684370|536268820|FG003|Part A|Lost to Follow-up|0|||
148671688|NCT02684370|536268821|FG004|Part A|Lost to Follow-up|0|||
148671689|NCT02684370|536268822|FG005|Part A|Lost to Follow-up|0|||
148671690|NCT02684370|536268817|FG000|Part A|Subject Withdrawal|1|||
148671691|NCT02684370|536268818|FG001|Part A|Subject Withdrawal|0|||
148671692|NCT02684370|536268819|FG002|Part A|Subject Withdrawal|3|||
148671693|NCT02684370|536268820|FG003|Part A|Subject Withdrawal|0|||
148671694|NCT02684370|536268821|FG004|Part A|Subject Withdrawal|0|||
148671695|NCT02684370|536268822|FG005|Part A|Subject Withdrawal|0|||
148671696|NCT02684370|536268817|FG000|Part A|Other|0|||
148671697|NCT02684370|536268818|FG001|Part A|Other|0|||
148671698|NCT02684370|536268819|FG002|Part A|Other|1|||
148671699|NCT02684370|536268820|FG003|Part A|Other|0|||
148671700|NCT02684370|536268821|FG004|Part A|Other|0|||
148671701|NCT02684370|536268822|FG005|Part A|Other|0|||
148671702|NCT02684370|536268817|FG000|Part B|Adverse Event|0|||
148671703|NCT02684370|536268818|FG001|Part B|Adverse Event|0|||
148671704|NCT02684370|536268819|FG002|Part B|Adverse Event|0|||
148671705|NCT02684370|536268820|FG003|Part B|Adverse Event|0|||
148671706|NCT02684370|536268821|FG004|Part B|Adverse Event|2|||
148671707|NCT02684370|536268822|FG005|Part B|Adverse Event|1|||
148671708|NCT02684370|536268817|FG000|Part B|Lost to Follow-up|0|||
148671709|NCT02684370|536268818|FG001|Part B|Lost to Follow-up|0|||
148671710|NCT02684370|536268819|FG002|Part B|Lost to Follow-up|0|||
148671711|NCT02684370|536268820|FG003|Part B|Lost to Follow-up|1|||
148671712|NCT02684370|536268821|FG004|Part B|Lost to Follow-up|2|||
148805107|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148671713|NCT02684370|536268822|FG005|Part B|Lost to Follow-up|5|||
148671714|NCT02684370|536268817|FG000|Part B|Subject Withdrawal|0|||
148671715|NCT02684370|536268818|FG001|Part B|Subject Withdrawal|0|||
148671716|NCT02684370|536268819|FG002|Part B|Subject Withdrawal|0|||
148671717|NCT02684370|536268820|FG003|Part B|Subject Withdrawal|1|||
148671718|NCT02684370|536268821|FG004|Part B|Subject Withdrawal|1|||
148671719|NCT02684370|536268822|FG005|Part B|Subject Withdrawal|2|||
148671720|NCT00627094|536268824|FG000|Overall Study|Adverse Event|8|||
148671721|NCT00627094|536268825|FG001|Overall Study|Adverse Event|7|||
148671722|NCT00627094|536268824|FG000|Overall Study|Lost to Follow-up|1|||
148671723|NCT00627094|536268825|FG001|Overall Study|Lost to Follow-up|0|||
148671724|NCT00627094|536268824|FG000|Overall Study|Withdrawal by Subject|1|||
148671725|NCT00627094|536268825|FG001|Overall Study|Withdrawal by Subject|1|||
148671726|NCT00627094|536268824|FG000|Overall Study|ulcer healed|1|||
148671727|NCT00627094|536268825|FG001|Overall Study|ulcer healed|7|||
148671728|NCT00627094|536268824|FG000|Overall Study|Other reason|1|||
148671729|NCT00627094|536268825|FG001|Overall Study|Other reason|0|||
148671730|NCT01165424|536268831|FG000|Overall Study|Clinical adverse experiences|1|||
148671731|NCT01165424|536268831|FG000|Overall Study|Laboratory adverse experiences|1|||
148671732|NCT01165424|536268831|FG000|Overall Study|Did not meet entry criteria|1|||
148671733|NCT01165424|536268831|FG000|Overall Study|Participant moved (relocated)|1|||
148671734|NCT04139642|536268832|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
148671735|NCT04139642|536268833|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
148671736|NCT00433771|536268836|FG000|Overall Study|screen fail|14|||
148671737|NCT00433771|536268836|FG000|Overall Study|Treated and later found to be ineligible|2|||
148671738|NCT00433771|536268836|FG000|Overall Study|Death|2|||
148671739|NCT00433771|536268836|FG000|Overall Study|Failure to deploy stent|1|||
148671740|NCT03733301|536268837|FG000|Overall Study|Screen Fail|1|||
148671741|NCT03733301|536268838|FG001|Overall Study|Screen Fail|0|||
148671742|NCT03733301|536268839|FG002|Overall Study|Screen Fail|0|||
148671743|NCT03733301|536268837|FG000|Overall Study|Non-compliance|1|||
148671744|NCT03733301|536268838|FG001|Overall Study|Non-compliance|0|||
148671745|NCT03733301|536268839|FG002|Overall Study|Non-compliance|0|||
149148419|NCT00412750|538023764|FG000|Overall Study|Adverse Event|8|||
149148420|NCT00412750|538023765|FG001|Overall Study|Adverse Event|3|||
149148421|NCT00412750|538023766|FG002|Overall Study|Adverse Event|3|||
149148422|NCT00412750|538023764|FG000|Overall Study|Lost to Follow-up|1|||
148671746|NCT03733301|536268837|FG000|Overall Study|Lack of Efficacy|2|||
148671747|NCT03733301|536268838|FG001|Overall Study|Lack of Efficacy|3|||
148671748|NCT03733301|536268839|FG002|Overall Study|Lack of Efficacy|0|||
148671749|NCT03733301|536268837|FG000|Overall Study|Adverse Event|0|||
148671750|NCT03733301|536268838|FG001|Overall Study|Adverse Event|1|||
148914372|NCT01802073|537169995|FG001|Overall Study|Physician Decision|7|||
148914373|NCT02657408|537169998|FG000|Overall Study|Adverse Event|3|||
148914374|NCT02657408|537169999|FG001|Overall Study|Adverse Event|7|||
148914375|NCT05343624|537170000|FG000|Overall Study|Chart review not completed|1|||
148914376|NCT02447302|537170001|FG000|Overall Study|Physician Decision|1|||
148914377|NCT02447302|537170002|FG001|Overall Study|Physician Decision|0|||
148914378|NCT02447302|537170003|FG002|Overall Study|Physician Decision|0|||
148914379|NCT02447302|537170001|FG000|Overall Study|Adverse Event|4|||
148914380|NCT02447302|537170002|FG001|Overall Study|Adverse Event|3|||
148914381|NCT02447302|537170003|FG002|Overall Study|Adverse Event|0|||
148914382|NCT02447302|537170001|FG000|Overall Study|Withdrawal by Subject|0|||
148914383|NCT02447302|537170002|FG001|Overall Study|Withdrawal by Subject|1|||
148914384|NCT02447302|537170003|FG002|Overall Study|Withdrawal by Subject|5|||
148914385|NCT02447302|537170001|FG000|Overall Study|Sponsor Decision|0|||
148914386|NCT02447302|537170002|FG001|Overall Study|Sponsor Decision|0|||
148914387|NCT02447302|537170003|FG002|Overall Study|Sponsor Decision|1|||
148914388|NCT05334212|537170006|FG000|Overall Study|Study terminated prematurely|7|||
149148423|NCT00412750|538023765|FG001|Overall Study|Lost to Follow-up|0|||
149148424|NCT00412750|538023766|FG002|Overall Study|Lost to Follow-up|1|||
149148425|NCT00412750|538023764|FG000|Overall Study|Withdrawal by Subject|0|||
149148426|NCT00412750|538023765|FG001|Overall Study|Withdrawal by Subject|1|||
149148427|NCT00412750|538023766|FG002|Overall Study|Withdrawal by Subject|2|||
149148428|NCT00412750|538023764|FG000|Overall Study|Lack of Efficacy|0|||
149148429|NCT00412750|538023765|FG001|Overall Study|Lack of Efficacy|0|||
148671751|NCT03733301|536268839|FG002|Overall Study|Adverse Event|3|||
148671752|NCT03733301|536268837|FG000|Overall Study|Withdrawal by Subject|3|||
148671753|NCT03733301|536268838|FG001|Overall Study|Withdrawal by Subject|5|||
148671754|NCT03733301|536268839|FG002|Overall Study|Withdrawal by Subject|1|||
148671755|NCT01965431|536268842|FG000|Overall Study|Adverse Event|0|||
148671756|NCT01965431|536268843|FG001|Overall Study|Adverse Event|1|||
148671757|NCT01965431|536268844|FG002|Overall Study|Adverse Event|0|||
148671758|NCT01965431|536268845|FG003|Overall Study|Adverse Event|0|||
148671759|NCT01965431|536268846|FG004|Overall Study|Adverse Event|0|||
148671760|NCT01965431|536268847|FG005|Overall Study|Adverse Event|0|||
148914389|NCT00910299|537170007|FG000|Overall Study|Withdrawal by Subject|16|||
148914390|NCT00910299|537170008|FG001|Overall Study|Withdrawal by Subject|13|||
148914391|NCT00910299|537170007|FG000|Overall Study|Sponsor Decision|58|||
148914392|NCT00910299|537170008|FG001|Overall Study|Sponsor Decision|60|||
149148430|NCT00412750|538023766|FG002|Overall Study|Lack of Efficacy|3|||
149148431|NCT00105443|538023773|FG000|Double-Blind Treatment|Adverse Event|1|||
148671761|NCT01965431|536268842|FG000|Overall Study|Other than stated above|6|||
148671762|NCT01965431|536268843|FG001|Overall Study|Other than stated above|5|||
148671763|NCT01965431|536268844|FG002|Overall Study|Other than stated above|6|||
148671764|NCT01965431|536268845|FG003|Overall Study|Other than stated above|6|||
148671765|NCT01965431|536268846|FG004|Overall Study|Other than stated above|6|||
148671766|NCT01965431|536268847|FG005|Overall Study|Other than stated above|6|||
148671767|NCT00577031|536268848|FG000|Overall Study|Adverse Event|52|||
148671768|NCT00577031|536268848|FG000|Overall Study|Progression of disease|93|||
148671769|NCT00577031|536268848|FG000|Overall Study|Protocol Violation|5|||
148671770|NCT00577031|536268848|FG000|Overall Study|Participant withdrew consent|13|||
148671771|NCT00577031|536268848|FG000|Overall Study|Participant non-compliance|5|||
148671772|NCT00577031|536268848|FG000|Overall Study|Need for surgery|17|||
148671773|NCT00577031|536268848|FG000|Overall Study|Medical decision|14|||
148671774|NCT00577031|536268848|FG000|Overall Study|Death|6|||
148671775|NCT04635631|536268849|FG000|Overall Study|Adverse Event|1|||
148671776|NCT04635631|536268849|FG000|Overall Study|Progressive disease|13|||
148671777|NCT04635631|536268849|FG000|Overall Study|Withdrawal by Subject|1|||
148671778|NCT00943826|536268850|FG000|Concurrent Phase|Adverse Event|50|||
148671779|NCT00943826|536268851|FG001|Concurrent Phase|Adverse Event|27|||
148671780|NCT00943826|536268850|FG000|Concurrent Phase|Withdrew consent|3|||
148671781|NCT00943826|536268851|FG001|Concurrent Phase|Withdrew consent|7|||
148671782|NCT00943826|536268850|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
148671783|NCT00943826|536268851|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
148671784|NCT00943826|536268850|FG000|Concurrent Phase|Administrative reasons|2|||
148671785|NCT00943826|536268851|FG001|Concurrent Phase|Administrative reasons|1|||
148671786|NCT00943826|536268850|FG000|Concurrent Phase|Protocol Violation|1|||
148671787|NCT00943826|536268851|FG001|Concurrent Phase|Protocol Violation|0|||
148671788|NCT00943826|536268850|FG000|Maintenance Phase|Adverse Event|31|||
148671789|NCT00943826|536268851|FG001|Maintenance Phase|Adverse Event|30|||
148671790|NCT00943826|536268850|FG000|Maintenance Phase|Withdrew consent|2|||
148671791|NCT00943826|536268851|FG001|Maintenance Phase|Withdrew consent|4|||
148671792|NCT00943826|536268850|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
148671793|NCT00943826|536268851|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
148671794|NCT00943826|536268850|FG000|Maintenance Phase|Administrative reasons|4|||
148671795|NCT00943826|536268851|FG001|Maintenance Phase|Administrative reasons|1|||
148671796|NCT00943826|536268850|FG000|Maintenance Phase|Failure to return|0|||
148671797|NCT00943826|536268851|FG001|Maintenance Phase|Failure to return|1|||
148671798|NCT00943826|536268850|FG000|Monotherapy Phase|Adverse Event|42|||
148671799|NCT00943826|536268851|FG001|Monotherapy Phase|Adverse Event|5|||
148671800|NCT00943826|536268850|FG000|Monotherapy Phase|Administrative reasons|11|||
148671801|NCT00943826|536268851|FG001|Monotherapy Phase|Administrative reasons|5|||
148671802|NCT00943826|536268850|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
148671803|NCT00943826|536268851|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
148671804|NCT00943826|536268850|FG000|Monotherapy Phase|Withdrew Consent|2|||
148671805|NCT00943826|536268851|FG001|Monotherapy Phase|Withdrew Consent|3|||
148671806|NCT00943826|536268850|FG000|Monotherapy Phase|Failure to return|2|||
148671807|NCT00943826|536268851|FG001|Monotherapy Phase|Failure to return|1|||
148671808|NCT00943826|536268850|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
148671809|NCT00943826|536268851|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
148671810|NCT00943826|536268850|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
148671811|NCT00943826|536268851|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
148671812|NCT00943826|536268850|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
148671813|NCT00943826|536268851|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
148671814|NCT00943826|536268850|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
148671815|NCT00943826|536268851|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
148671816|NCT00127192|536268853|FG000|Overall Study|Adverse Event|0|||
148671817|NCT00127192|536268854|FG001|Overall Study|Adverse Event|1|||
148914393|NCT00910299|537170007|FG000|Overall Study|Didn't receive any study drug|2|||
148914394|NCT00910299|537170008|FG001|Overall Study|Didn't receive any study drug|1|||
148914395|NCT00916929|537170009|FG000|Overall Study|Lost to Follow-up|1|||
148914396|NCT00916929|537170010|FG001|Overall Study|Lost to Follow-up|3|||
148914397|NCT00916929|537170009|FG000|Overall Study|Death|5|||
148671818|NCT00127192|536268855|FG002|Overall Study|Adverse Event|1|||
148671819|NCT00127192|536268856|FG003|Overall Study|Adverse Event|1|||
148671820|NCT00127192|536268857|FG004|Overall Study|Adverse Event|0|||
148914398|NCT00916929|537170010|FG001|Overall Study|Death|10|||
148914399|NCT00916929|537170009|FG000|Overall Study|Withdrawal by Subject|1|||
148914400|NCT00916929|537170010|FG001|Overall Study|Withdrawal by Subject|5|||
148914401|NCT00916929|537170009|FG000|Overall Study|Left ventricular epicardial lead|1|||
148914402|NCT00916929|537170010|FG001|Overall Study|Left ventricular epicardial lead|2|||
148914403|NCT00916929|537170009|FG000|Overall Study|Transferred to hospice care|1|||
148914404|NCT00916929|537170010|FG001|Overall Study|Transferred to hospice care|1|||
148914405|NCT00916929|537170009|FG000|Overall Study|System explant|1|||
148914406|NCT00916929|537170010|FG001|Overall Study|System explant|0|||
148914407|NCT00916929|537170009|FG000|Overall Study|Moved to another state|0|||
148914408|NCT00916929|537170010|FG001|Overall Study|Moved to another state|1|||
148914409|NCT00916929|537170009|FG000|Overall Study|Device unable to process impedance data|0|||
148914410|NCT00916929|537170010|FG001|Overall Study|Device unable to process impedance data|7|||
148914411|NCT02281383|537170015|FG000|Overall Study|Progressive Disease|1|||
148914412|NCT02281383|537170015|FG000|Overall Study|Withdrawal by Subject|6|||
148914413|NCT02281383|537170015|FG000|Overall Study|Protocol Violation|2|||
148914414|NCT02281383|537170015|FG000|Overall Study|Death|1|||
148914415|NCT02281383|537170015|FG000|Overall Study|Adverse Event|2|||
148914416|NCT02051933|537171578|FG000|Overall Study|Physician Decision|0|||
148914417|NCT02051933|537171579|FG001|Overall Study|Physician Decision|1|||
148914418|NCT03254459|537171580|FG000|Overall Study|Adverse Event|7|||
148914419|NCT03254459|537171581|FG001|Overall Study|Adverse Event|20|||
148914420|NCT03254459|537171580|FG000|Overall Study|Withdrawal by Subject Consent|3|||
148914421|NCT03254459|537171581|FG001|Overall Study|Withdrawal by Subject Consent|1|||
148914422|NCT03254459|537171580|FG000|Overall Study|Lost to Follow-up|0|||
148914423|NCT03254459|537171581|FG001|Overall Study|Lost to Follow-up|1|||
148914424|NCT03254459|537171580|FG000|Overall Study|Miscellaneous|0|||
148914425|NCT03254459|537171581|FG001|Overall Study|Miscellaneous|1|||
148914426|NCT03206788|537171585|FG000|Overall Study|Withdrawal by Subject|0|||
148914427|NCT03206788|537171586|FG001|Overall Study|Withdrawal by Subject|1|||
148914428|NCT03206788|537171585|FG000|Overall Study|Adverse Event|0|||
148914429|NCT03206788|537171586|FG001|Overall Study|Adverse Event|1|||
148914430|NCT03206788|537171585|FG000|Overall Study|Physician Decision|0|||
148914431|NCT03206788|537171586|FG001|Overall Study|Physician Decision|1|||
148914432|NCT00833417|537171587|FG000|Overall Study|Adverse Event|5|||
148914433|NCT00833417|537171588|FG001|Overall Study|Adverse Event|16|||
148914434|NCT00833417|537171587|FG000|Overall Study|Death|1|||
148914435|NCT00833417|537171588|FG001|Overall Study|Death|3|||
148914436|NCT00833417|537171587|FG000|Overall Study|Lost to Follow-up|1|||
148914437|NCT00833417|537171588|FG001|Overall Study|Lost to Follow-up|2|||
148914438|NCT00833417|537171587|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
148914439|NCT00833417|537171588|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
148914440|NCT00833417|537171587|FG000|Overall Study|Patient Decision to Withdraw|4|||
148914441|NCT00833417|537171588|FG001|Overall Study|Patient Decision to Withdraw|23|||
148914442|NCT00833417|537171587|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
148914443|NCT00833417|537171588|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
148914444|NCT00833417|537171587|FG000|Overall Study|Disease Progression|18|||
148914445|NCT00833417|537171588|FG001|Overall Study|Disease Progression|17|||
148914446|NCT00833417|537171587|FG000|Overall Study|Reason Not Specified|0|||
148914447|NCT00833417|537171588|FG001|Overall Study|Reason Not Specified|1|||
149148432|NCT00105443|538023774|FG001|Double-Blind Treatment|Adverse Event|0|||
149148433|NCT00105443|538023775|FG002|Double-Blind Treatment|Adverse Event|0|||
149148434|NCT00105443|538023776|FG003|Double-Blind Treatment|Adverse Event|0|||
149148435|NCT00105443|538023773|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
149148436|NCT00105443|538023774|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
149148437|NCT00105443|538023775|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
149148438|NCT00105443|538023776|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
149148439|NCT00105443|538023773|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
149148440|NCT00105443|538023774|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
149148441|NCT00105443|538023775|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
149148442|NCT00105443|538023776|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
149148443|NCT00105443|538023773|FG000|Double-Blind Treatment|Physician Decision|1|||
149148444|NCT00105443|538023774|FG001|Double-Blind Treatment|Physician Decision|0|||
149148445|NCT00105443|538023775|FG002|Double-Blind Treatment|Physician Decision|2|||
149148446|NCT00105443|538023776|FG003|Double-Blind Treatment|Physician Decision|0|||
149148447|NCT00105443|538023773|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
149148448|NCT00105443|538023774|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
149148449|NCT00105443|538023775|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
149148450|NCT00105443|538023776|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
149148451|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
149148452|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
149148453|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
149148454|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
149148455|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
149148456|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
149148457|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
148914448|NCT03330002|537171589|FG000|Overall Study|Lost to Follow-up|15|||
149148458|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
149148459|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
149148460|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
149148461|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
149148462|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
149148463|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
149148464|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
149148465|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
149148466|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
149148467|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
149148468|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
149148469|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
149148470|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
149148471|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
149148472|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
149148473|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
149148474|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
149148475|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
149148476|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
149148477|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
148914449|NCT03330002|537171589|FG000|Overall Study|Death|7|||
148914450|NCT01625260|537171590|FG000|Overall Study|Adverse Event|3|||
148914451|NCT01625260|537171591|FG001|Overall Study|Adverse Event|0|||
148914452|NCT01625260|537171590|FG000|Overall Study|Study Terminated by Investigator|2|||
148914453|NCT01625260|537171591|FG001|Overall Study|Study Terminated by Investigator|0|||
148914454|NCT01625260|537171590|FG000|Overall Study|Disease Progression|2|||
148914455|NCT01625260|537171591|FG001|Overall Study|Disease Progression|0|||
148914456|NCT01625260|537171590|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
148914457|NCT01625260|537171591|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
148914458|NCT03899805|537171592|FG000|Overall Study|Physician Decision|3|||
148914459|NCT03899805|537171593|FG001|Overall Study|Physician Decision|0|||
148914460|NCT03899805|537171594|FG002|Overall Study|Physician Decision|2|||
149148478|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
149148479|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
149148480|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
149148481|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
149148482|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
149148483|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
149148484|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
149148485|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
149148486|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
148914461|NCT03899805|537171592|FG000|Overall Study|Withdrawal by Subject|1|||
148914462|NCT03899805|537171593|FG001|Overall Study|Withdrawal by Subject|0|||
148914463|NCT03899805|537171594|FG002|Overall Study|Withdrawal by Subject|2|||
148914464|NCT03899805|537171592|FG000|Overall Study|Progressive Disease|10|||
148914465|NCT03899805|537171593|FG001|Overall Study|Progressive Disease|18|||
148914466|NCT03899805|537171594|FG002|Overall Study|Progressive Disease|12|||
148914467|NCT03899805|537171592|FG000|Overall Study|Adverse Event|3|||
148914468|NCT03899805|537171593|FG001|Overall Study|Adverse Event|1|||
148914469|NCT03899805|537171594|FG002|Overall Study|Adverse Event|0|||
148914470|NCT03899805|537171592|FG000|Overall Study|Death|2|||
148914471|NCT03899805|537171593|FG001|Overall Study|Death|0|||
148914472|NCT03899805|537171594|FG002|Overall Study|Death|0|||
148914473|NCT03899805|537171592|FG000|Overall Study|Came off for surgery|0|||
148914474|NCT03899805|537171593|FG001|Overall Study|Came off for surgery|0|||
148914475|NCT03899805|537171594|FG002|Overall Study|Came off for surgery|1|||
148914476|NCT01776307|537171597|FG000|Overall Study|Not dosed|0|||
148914477|NCT01776307|537171598|FG001|Overall Study|Not dosed|0|||
148914478|NCT01776307|537171599|FG002|Overall Study|Not dosed|1|||
148914479|NCT02745145|537171602|FG000|Overall Study|Adverse Event|1|||
148914480|NCT02745145|537171603|FG001|Overall Study|Adverse Event|0|||
148671821|NCT00127192|536268853|FG000|Overall Study|Lack of Efficacy|2|||
148914481|NCT02745145|537171604|FG002|Overall Study|Adverse Event|0|||
148914482|NCT02745145|537171602|FG000|Overall Study|Death|0|||
148914483|NCT02745145|537171603|FG001|Overall Study|Death|1|||
148914484|NCT02745145|537171604|FG002|Overall Study|Death|0|||
148914485|NCT02745145|537171602|FG000|Overall Study|Progressive disease|0|||
148914486|NCT02745145|537171603|FG001|Overall Study|Progressive disease|0|||
148914487|NCT02745145|537171604|FG002|Overall Study|Progressive disease|1|||
148914488|NCT02745145|537171602|FG000|Overall Study|Withdrew consent|1|||
148914489|NCT02745145|537171603|FG001|Overall Study|Withdrew consent|1|||
148671822|NCT00127192|536268854|FG001|Overall Study|Lack of Efficacy|0|||
148914490|NCT02745145|537171604|FG002|Overall Study|Withdrew consent|1|||
148914491|NCT02745145|537171602|FG000|Overall Study|Study Termination|8|||
148914492|NCT02745145|537171603|FG001|Overall Study|Study Termination|3|||
148914493|NCT02745145|537171604|FG002|Overall Study|Study Termination|7|||
148914494|NCT03083990|537171605|FG000|Overall Study|Adverse Event|1|||
148914495|NCT03083990|537171606|FG001|Overall Study|Adverse Event|0|||
148914496|NCT01018810|537171607|FG000|Overall Study|Withdrawal by Subject|0|||
148914497|NCT01018810|537171608|FG001|Overall Study|Withdrawal by Subject|1|||
148914498|NCT01018810|537171609|FG002|Overall Study|Withdrawal by Subject|0|||
148914499|NCT01018810|537171610|FG003|Overall Study|Withdrawal by Subject|0|||
148914500|NCT01018810|537171611|FG004|Overall Study|Withdrawal by Subject|0|||
148914501|NCT01018810|537171607|FG000|Overall Study|Sponsor Decision|2|||
148914502|NCT01018810|537171608|FG001|Overall Study|Sponsor Decision|0|||
148914503|NCT01018810|537171609|FG002|Overall Study|Sponsor Decision|1|||
148914504|NCT01018810|537171610|FG003|Overall Study|Sponsor Decision|1|||
148914505|NCT01018810|537171611|FG004|Overall Study|Sponsor Decision|1|||
148914506|NCT02424578|537171612|FG000|Overall Study|Withdrawal by Subject|0|||
148914507|NCT02424578|537171613|FG001|Overall Study|Withdrawal by Subject|1|||
148914508|NCT02872935|537171618|FG000|Overall Study|Other|0|||
148914509|NCT02872935|537171619|FG001|Overall Study|Other|1|||
148914510|NCT02640508|537171620|FG000|Overall Study|Death|19|||
148914511|NCT02640508|537171620|FG000|Overall Study|Withdrawal by Subject|8|||
148914512|NCT02640508|537171620|FG000|Overall Study|Physician Decision|1|||
148914513|NCT02640508|537171620|FG000|Overall Study|Lost to Follow-up|1|||
148914514|NCT00862082|537171621|FG000|Overall Study|Sponsor decision to terminate the study|5|||
148914515|NCT00862082|537171622|FG001|Overall Study|Sponsor decision to terminate the study|0|||
148914516|NCT00862082|537171621|FG000|Overall Study|Withdrawal by Subject|0|||
148914517|NCT00862082|537171622|FG001|Overall Study|Withdrawal by Subject|1|||
148914518|NCT00329797|537171623|FG000|Overall Study|Protocol Violation|1|||
148914519|NCT00329797|537171624|FG001|Overall Study|Protocol Violation|0|||
148914520|NCT00329797|537171623|FG000|Overall Study|Withdrawal by Subject|6|||
148914521|NCT00329797|537171624|FG001|Overall Study|Withdrawal by Subject|6|||
148914522|NCT05405257|537171625|FG000|Overall Study|Withdrawal by Subject|1|||
149148487|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
149148488|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
149148489|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
149148490|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
149148491|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
149148492|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
149148493|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
149148494|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
149148495|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
149148496|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
149148497|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
149148498|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
149148499|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
149148500|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
149148501|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
149148502|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
149148503|NCT00105443|538023773|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
149148504|NCT00105443|538023774|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
149148505|NCT00105443|538023775|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
149148506|NCT00105443|538023776|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
149148507|NCT02135692|538023777|FG000|Overall Study|Adverse Event|3|||
149148508|NCT02135692|538023777|FG000|Overall Study|Lack of Efficacy|2|||
149148509|NCT02135692|538023777|FG000|Overall Study|Protocol Violation|2|||
149148510|NCT02135692|538023777|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
149148511|NCT02135692|538023777|FG000|Overall Study|Product commercially available|159|||
149148512|NCT02135692|538023777|FG000|Overall Study|Study closed/terminated|153|||
149148513|NCT02135692|538023777|FG000|Overall Study|Lost to Follow-up|4|||
149148514|NCT02135692|538023777|FG000|Overall Study|Withdrawal by Subject|15|||
149148515|NCT01623271|538023780|FG000|Overall Study|Withdrawal by Subject|2|||
149148516|NCT01611974|538023781|FG000|Overall Study|Death|10|||
149148517|NCT01611974|538023782|FG001|Overall Study|Death|12|||
149148518|NCT01611974|538023783|FG002|Overall Study|Death|10|||
149148519|NCT01611974|538023781|FG000|Overall Study|Lost to Follow-up|0|||
149148520|NCT01611974|538023782|FG001|Overall Study|Lost to Follow-up|1|||
149148521|NCT01611974|538023783|FG002|Overall Study|Lost to Follow-up|0|||
149148522|NCT01611974|538023781|FG000|Overall Study|Physician Decision|5|||
149148523|NCT01611974|538023782|FG001|Overall Study|Physician Decision|1|||
149148524|NCT01611974|538023783|FG002|Overall Study|Physician Decision|2|||
149148525|NCT01611974|538023781|FG000|Overall Study|Withdrawal by Subject|0|||
149148526|NCT01611974|538023782|FG001|Overall Study|Withdrawal by Subject|1|||
149148527|NCT01611974|538023783|FG002|Overall Study|Withdrawal by Subject|4|||
149148528|NCT01097746|538023784|FG000|Overall Study|Adverse Event|4|||
149148529|NCT01097746|538023784|FG000|Overall Study|taken off study before any treatment given|1|||
149148530|NCT00522431|538023785|FG000|Overall Study|Adverse Event|5|||
149148531|NCT00522431|538023785|FG000|Overall Study|Protocol Violation|2|||
149148532|NCT00522431|538023785|FG000|Overall Study|Withdrawal by Subject|2|||
149148533|NCT00522431|538023785|FG000|Overall Study|Subject non-compliance|1|||
149148534|NCT00522431|538023785|FG000|Overall Study|Other/unknown|1|||
149148535|NCT00772954|538023786|FG000|Overall Study|Adverse Event|0|||
148671823|NCT00127192|536268855|FG002|Overall Study|Lack of Efficacy|0|||
148671824|NCT00127192|536268856|FG003|Overall Study|Lack of Efficacy|0|||
148671825|NCT00127192|536268857|FG004|Overall Study|Lack of Efficacy|2|||
148671826|NCT00127192|536268853|FG000|Overall Study|Withdrawal by Subject|0|||
148914523|NCT00862641|537171637|FG000|Overall Study|Randomized, but drug not received|1|||
148914524|NCT00862641|537171638|FG001|Overall Study|Randomized, but drug not received|4|||
148914525|NCT00862641|537171639|FG002|Overall Study|Randomized, but drug not received|1|||
149148536|NCT00772954|538023787|FG001|Overall Study|Adverse Event|0|||
149148537|NCT00772954|538023788|FG002|Overall Study|Adverse Event|1|||
149148538|NCT02495844|538023792|FG000|Overall Study|Lack of Efficacy|1|||
149148539|NCT02495844|538023793|FG001|Overall Study|Lack of Efficacy|2|||
148914526|NCT00862641|537171640|FG003|Overall Study|Randomized, but drug not received|4|||
148671827|NCT00127192|536268854|FG001|Overall Study|Withdrawal by Subject|0|||
149148540|NCT02495844|538023792|FG000|Overall Study|AE, non-fatal|0|||
149148541|NCT02495844|538023793|FG001|Overall Study|AE, non-fatal|1|||
149148542|NCT02495844|538023792|FG000|Overall Study|Hepatitis Positivity|0|||
149148543|NCT02495844|538023793|FG001|Overall Study|Hepatitis Positivity|1|||
149148544|NCT03927105|538023794|FG000|Overall Study|Death|1|||
149148545|NCT03927105|538023794|FG000|Overall Study|In observation for potential re-treatment|2|||
149148546|NCT03927105|538023794|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
149148547|NCT02513329|538023795|FG000|Overall Study|Lost to Follow-up|5|||
149148548|NCT02513329|538023796|FG001|Overall Study|Lost to Follow-up|2|||
149148549|NCT02083380|538023799|FG000|Overall Study|Lack of Efficacy|68|||
149148550|NCT02083380|538023800|FG001|Overall Study|Lack of Efficacy|79|||
149148551|NCT02083380|538023801|FG002|Overall Study|Lack of Efficacy|64|||
149148552|NCT02083380|538023799|FG000|Overall Study|Withdrawal by Subject|9|||
149148553|NCT02083380|538023800|FG001|Overall Study|Withdrawal by Subject|3|||
149148554|NCT02083380|538023801|FG002|Overall Study|Withdrawal by Subject|7|||
149148555|NCT02083380|538023799|FG000|Overall Study|Physician Decision|1|||
149148556|NCT02083380|538023800|FG001|Overall Study|Physician Decision|6|||
149148557|NCT02083380|538023801|FG002|Overall Study|Physician Decision|3|||
149148558|NCT02083380|538023799|FG000|Overall Study|Adverse Event|0|||
149148559|NCT02083380|538023800|FG001|Overall Study|Adverse Event|0|||
149148560|NCT02083380|538023801|FG002|Overall Study|Adverse Event|1|||
149148561|NCT02083380|538023799|FG000|Overall Study|Lost to Follow-up|5|||
149148562|NCT02083380|538023800|FG001|Overall Study|Lost to Follow-up|3|||
149148563|NCT02083380|538023801|FG002|Overall Study|Lost to Follow-up|3|||
149148564|NCT02083380|538023799|FG000|Overall Study|Other|8|||
149148565|NCT02083380|538023800|FG001|Overall Study|Other|4|||
149148566|NCT02083380|538023801|FG002|Overall Study|Other|6|||
149148567|NCT04091087|538023802|FG000|Overall Study|Not treated|1|||
149148568|NCT04091087|538023803|FG001|Overall Study|Not treated|0|||
149148569|NCT04091087|538023802|FG000|Overall Study|Adverse Event|4|||
149148570|NCT04091087|538023803|FG001|Overall Study|Adverse Event|4|||
149148571|NCT04091087|538023802|FG000|Overall Study|Protocol Violation|0|||
149148572|NCT04091087|538023803|FG001|Overall Study|Protocol Violation|1|||
149148573|NCT04091087|538023802|FG000|Overall Study|Withdrawal by Subject|5|||
149148574|NCT04091087|538023803|FG001|Overall Study|Withdrawal by Subject|2|||
149148575|NCT03703102|538023804|FG000|Overall Study|Adverse Event|4|||
149148576|NCT03703102|538023805|FG001|Overall Study|Adverse Event|3|||
149148577|NCT03703102|538023806|FG002|Overall Study|Adverse Event|7|||
149148578|NCT03703102|538023807|FG003|Overall Study|Adverse Event|3|||
149148579|NCT03703102|538023808|FG004|Overall Study|Adverse Event|13|||
149148580|NCT03703102|538023804|FG000|Overall Study|Lack of Efficacy|4|||
149148581|NCT03703102|538023805|FG001|Overall Study|Lack of Efficacy|0|||
149148582|NCT03703102|538023806|FG002|Overall Study|Lack of Efficacy|1|||
149148583|NCT03703102|538023807|FG003|Overall Study|Lack of Efficacy|4|||
149148584|NCT03703102|538023808|FG004|Overall Study|Lack of Efficacy|1|||
149148585|NCT03703102|538023804|FG000|Overall Study|Lost to Follow-up|0|||
149148586|NCT03703102|538023805|FG001|Overall Study|Lost to Follow-up|0|||
149148587|NCT03703102|538023806|FG002|Overall Study|Lost to Follow-up|1|||
149148588|NCT03703102|538023807|FG003|Overall Study|Lost to Follow-up|2|||
149148589|NCT03703102|538023808|FG004|Overall Study|Lost to Follow-up|2|||
149148590|NCT03703102|538023804|FG000|Overall Study|Physician Decision|2|||
149148591|NCT03703102|538023805|FG001|Overall Study|Physician Decision|2|||
149148592|NCT03703102|538023806|FG002|Overall Study|Physician Decision|2|||
149148593|NCT03703102|538023807|FG003|Overall Study|Physician Decision|2|||
149148594|NCT03703102|538023808|FG004|Overall Study|Physician Decision|4|||
149148595|NCT03703102|538023804|FG000|Overall Study|Withdrawal by Subject|7|||
149148596|NCT03703102|538023805|FG001|Overall Study|Withdrawal by Subject|5|||
148914527|NCT03179605|537171641|FG000|Overall Study|Withdrawal by Subject|1|||
148914528|NCT00635999|537171642|FG000|Overall Study|Withdrawal by Subject|4|||
148914529|NCT00635999|537171643|FG001|Overall Study|Withdrawal by Subject|2|||
148914530|NCT00635999|537171644|FG002|Overall Study|Withdrawal by Subject|1|||
148914531|NCT00711477|537171645|FG000|Overall Study|Adverse Event|3|||
148914532|NCT00711477|537171646|FG001|Overall Study|Adverse Event|1|||
149148597|NCT03703102|538023806|FG002|Overall Study|Withdrawal by Subject|5|||
149148598|NCT03703102|538023807|FG003|Overall Study|Withdrawal by Subject|5|||
149148599|NCT03703102|538023808|FG004|Overall Study|Withdrawal by Subject|9|||
149148600|NCT03703102|538023804|FG000|Overall Study|Ineligibility|0|||
149148601|NCT03703102|538023805|FG001|Overall Study|Ineligibility|0|||
149148602|NCT03703102|538023806|FG002|Overall Study|Ineligibility|1|||
149148603|NCT03703102|538023807|FG003|Overall Study|Ineligibility|0|||
149148604|NCT03703102|538023808|FG004|Overall Study|Ineligibility|0|||
149148605|NCT03703102|538023804|FG000|Overall Study|Protocol Deviation|4|||
149148606|NCT03703102|538023805|FG001|Overall Study|Protocol Deviation|4|||
149148607|NCT03703102|538023806|FG002|Overall Study|Protocol Deviation|3|||
149148608|NCT03703102|538023807|FG003|Overall Study|Protocol Deviation|0|||
149148609|NCT03703102|538023808|FG004|Overall Study|Protocol Deviation|0|||
149148610|NCT03703102|538023804|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149148611|NCT03703102|538023805|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149148612|NCT03703102|538023806|FG002|Overall Study|Non-Compliance with Study Drug|2|||
149148613|NCT03703102|538023807|FG003|Overall Study|Non-Compliance with Study Drug|1|||
149148614|NCT03703102|538023808|FG004|Overall Study|Non-Compliance with Study Drug|4|||
149148615|NCT00957008|538023809|FG000|Overall Study|Withdrawal by Subject|13|||
149148616|NCT00957008|538023810|FG001|Overall Study|Withdrawal by Subject|10|||
149148617|NCT00957008|538023811|FG002|Overall Study|Withdrawal by Subject|12|||
149148618|NCT00957008|538023812|FG003|Overall Study|Withdrawal by Subject|16|||
149148619|NCT00957008|538023809|FG000|Overall Study|Lost to Follow-up|3|||
149148620|NCT00957008|538023810|FG001|Overall Study|Lost to Follow-up|1|||
149148621|NCT00957008|538023811|FG002|Overall Study|Lost to Follow-up|3|||
149148622|NCT00957008|538023812|FG003|Overall Study|Lost to Follow-up|4|||
149148623|NCT00957008|538023809|FG000|Overall Study|Physician Decision|1|||
149148624|NCT00957008|538023810|FG001|Overall Study|Physician Decision|0|||
149148625|NCT00957008|538023811|FG002|Overall Study|Physician Decision|1|||
149148626|NCT00957008|538023812|FG003|Overall Study|Physician Decision|1|||
149148627|NCT00957008|538023809|FG000|Overall Study|Relocated; Family conflict|4|||
149148628|NCT00957008|538023810|FG001|Overall Study|Relocated; Family conflict|1|||
149148629|NCT00957008|538023811|FG002|Overall Study|Relocated; Family conflict|1|||
149148630|NCT00957008|538023812|FG003|Overall Study|Relocated; Family conflict|3|||
149148631|NCT01118351|538023813|FG000|Overall Study|Adverse Event|3|||
149148632|NCT01118351|538023813|FG000|Overall Study|Withdrawal by Subject|1|||
149148633|NCT02797808|538023814|FG000|Overall Study|Withdrawal by Subject|1|||
149148634|NCT02797808|538023815|FG001|Overall Study|Withdrawal by Subject|1|||
149148635|NCT02797808|538023814|FG000|Overall Study|Physician Decision|6|||
149148636|NCT02797808|538023815|FG001|Overall Study|Physician Decision|2|||
149148637|NCT02192827|538023822|FG000|Overall Study|Lost to Follow-up|25|||
149148638|NCT02192827|538023823|FG001|Overall Study|Lost to Follow-up|27|||
149148639|NCT02192827|538023822|FG000|Overall Study|Given additional steroids with admission|13|||
149148640|NCT02192827|538023823|FG001|Overall Study|Given additional steroids with admission|11|||
149148641|NCT00414453|538023824|FG000|Overall Study|Abnormal lab work|16|||
149148642|NCT00708500|538023829|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
149148643|NCT00708500|538023830|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
149148644|NCT00708500|538023831|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
149148645|NCT00708500|538023829|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
149148646|NCT00708500|538023830|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
149148647|NCT00708500|538023831|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
149148648|NCT00708500|538023829|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
149148649|NCT00708500|538023830|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
149148650|NCT00708500|538023831|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
149148651|NCT00708500|538023829|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
149148652|NCT00708500|538023830|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
149148653|NCT00708500|538023831|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
149148654|NCT00708500|538023829|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
149148655|NCT00708500|538023830|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
149148656|NCT00708500|538023831|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
149148657|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
149148658|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
149148659|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
149148660|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
149148661|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
149148662|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
149148663|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
149148664|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
149148665|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
149148666|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
149148667|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
149148668|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
149148669|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
149148670|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
149148671|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
149148672|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
149148673|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
149148674|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
149148675|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
149148676|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
149148677|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
149148678|NCT00708500|538023829|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
149148679|NCT00708500|538023830|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
149148680|NCT00708500|538023831|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
149148681|NCT00708500|538023829|FG000|FOLLOWUP|Adverse Event|0|||
149148682|NCT00708500|538023830|FG001|FOLLOWUP|Adverse Event|1|||
149148683|NCT00708500|538023831|FG002|FOLLOWUP|Adverse Event|0|||
149148684|NCT00708500|538023829|FG000|FOLLOWUP|Lost to Follow-up|1|||
149148685|NCT00708500|538023830|FG001|FOLLOWUP|Lost to Follow-up|6|||
149148686|NCT00708500|538023831|FG002|FOLLOWUP|Lost to Follow-up|4|||
149148687|NCT00708500|538023829|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
149148688|NCT00708500|538023830|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
149148689|NCT00708500|538023831|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
149148690|NCT00708500|538023829|FG000|FOLLOWUP|Subject withdrew consent|31|||
149148691|NCT00708500|538023830|FG001|FOLLOWUP|Subject withdrew consent|4|||
149148692|NCT00708500|538023831|FG002|FOLLOWUP|Subject withdrew consent|5|||
149148693|NCT00708500|538023829|FG000|FOLLOWUP|Non-compliance with protocol|5|||
149148694|NCT00708500|538023830|FG001|FOLLOWUP|Non-compliance with protocol|0|||
149148695|NCT00708500|538023831|FG002|FOLLOWUP|Non-compliance with protocol|1|||
149148696|NCT03975920|538023832|FG000|Overall Study|Lost to Follow-up|1|||
149148697|NCT03975920|538023833|FG001|Overall Study|Lost to Follow-up|2|||
149148698|NCT03975920|538023832|FG000|Overall Study|Protocol Violation|1|||
149148699|NCT03975920|538023833|FG001|Overall Study|Protocol Violation|1|||
149148700|NCT03975920|538023832|FG000|Overall Study|Did not complete survey|2|||
149148701|NCT03975920|538023833|FG001|Overall Study|Did not complete survey|1|||
149148702|NCT03882970|538023844|FG000|Overall Study|Adverse Event|5|||
149148703|NCT03882970|538023845|FG001|Overall Study|Adverse Event|7|||
149148704|NCT03882970|538023846|FG002|Overall Study|Adverse Event|3|||
149148705|NCT03882970|538023847|FG003|Overall Study|Adverse Event|1|||
149148706|NCT03882970|538023844|FG000|Overall Study|Death|1|||
149148707|NCT03882970|538023845|FG001|Overall Study|Death|2|||
149148708|NCT03882970|538023846|FG002|Overall Study|Death|1|||
149148709|NCT03882970|538023847|FG003|Overall Study|Death|1|||
149148710|NCT03882970|538023844|FG000|Overall Study|Lost to Follow-up|8|||
149148711|NCT03882970|538023845|FG001|Overall Study|Lost to Follow-up|9|||
149148712|NCT03882970|538023846|FG002|Overall Study|Lost to Follow-up|5|||
149148713|NCT03882970|538023847|FG003|Overall Study|Lost to Follow-up|5|||
149148714|NCT03882970|538023844|FG000|Overall Study|Physician Decision|0|||
149148715|NCT03882970|538023845|FG001|Overall Study|Physician Decision|2|||
149148716|NCT03882970|538023846|FG002|Overall Study|Physician Decision|2|||
149148717|NCT03882970|538023847|FG003|Overall Study|Physician Decision|2|||
149148718|NCT03882970|538023844|FG000|Overall Study|Protocol Violation|2|||
149148719|NCT03882970|538023845|FG001|Overall Study|Protocol Violation|0|||
149148720|NCT03882970|538023846|FG002|Overall Study|Protocol Violation|0|||
149148721|NCT03882970|538023847|FG003|Overall Study|Protocol Violation|0|||
149148722|NCT03882970|538023844|FG000|Overall Study|Withdrawal by Subject|8|||
149148723|NCT03882970|538023845|FG001|Overall Study|Withdrawal by Subject|17|||
149148724|NCT03882970|538023846|FG002|Overall Study|Withdrawal by Subject|7|||
149148725|NCT03882970|538023847|FG003|Overall Study|Withdrawal by Subject|22|||
149148726|NCT03882970|538023844|FG000|Overall Study|Personal Reason|2|||
149148727|NCT03882970|538023845|FG001|Overall Study|Personal Reason|3|||
149148728|NCT03882970|538023846|FG002|Overall Study|Personal Reason|1|||
149148729|NCT03882970|538023847|FG003|Overall Study|Personal Reason|3|||
149148730|NCT02863809|538023849|FG000|Overall Study|Adverse Event|8|||
149148731|NCT02863809|538023850|FG001|Overall Study|Adverse Event|8|||
149148732|NCT02863809|538023849|FG000|Overall Study|Withdrawal by Subject|0|||
149148733|NCT02863809|538023850|FG001|Overall Study|Withdrawal by Subject|1|||
149148734|NCT02863809|538023849|FG000|Overall Study|Lost to Follow-up|1|||
149148735|NCT02863809|538023850|FG001|Overall Study|Lost to Follow-up|1|||
149148736|NCT02863809|538023849|FG000|Overall Study|Death|1|||
149148737|NCT02863809|538023850|FG001|Overall Study|Death|0|||
149148738|NCT01439204|538023851|FG000|Overall Study|Withdrawal by Subject|0|||
149148739|NCT01439204|538023852|FG001|Overall Study|Withdrawal by Subject|1|||
149148740|NCT01439204|538023851|FG000|Overall Study|Lost to Follow-up|0|||
149148741|NCT01439204|538023852|FG001|Overall Study|Lost to Follow-up|2|||
149148742|NCT01439204|538023851|FG000|Overall Study|No longer meets study criteria|1|||
149148743|NCT01439204|538023852|FG001|Overall Study|No longer meets study criteria|0|||
149148744|NCT01439204|538023851|FG000|Overall Study|poor/non-compliance|3|||
149148745|NCT01439204|538023852|FG001|Overall Study|poor/non-compliance|0|||
149148746|NCT01227044|538023856|FG000|Overall Study|Lost to Follow-up|5|||
149148747|NCT01227044|538023857|FG001|Overall Study|Lost to Follow-up|7|||
149148748|NCT01227044|538023856|FG000|Overall Study|Discontinued Intervention|1|||
149148749|NCT01227044|538023857|FG001|Overall Study|Discontinued Intervention|2|||
149148750|NCT04247061|538023858|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
149148751|NCT04247061|538023858|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
149148752|NCT04247061|538023858|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
149148753|NCT00205855|538023869|FG000|Overall Study|Only received temporary implants|16|||
149148754|NCT00205855|538023869|FG000|Overall Study|Withdrawal by Subject|5|||
149148755|NCT00917150|538023873|FG000|Overall Study|Adverse Event|12|||
149148756|NCT00917150|538023874|FG001|Overall Study|Adverse Event|7|||
149148757|NCT00917150|538023875|FG002|Overall Study|Adverse Event|12|||
149148758|NCT00917150|538023876|FG003|Overall Study|Adverse Event|11|||
149148759|NCT00917150|538023873|FG000|Overall Study|Death|1|||
149148760|NCT00917150|538023874|FG001|Overall Study|Death|4|||
149148761|NCT00917150|538023875|FG002|Overall Study|Death|3|||
149148762|NCT00917150|538023876|FG003|Overall Study|Death|2|||
149148763|NCT00917150|538023873|FG000|Overall Study|Lost to Follow-up|1|||
149148764|NCT00917150|538023874|FG001|Overall Study|Lost to Follow-up|0|||
149148765|NCT00917150|538023875|FG002|Overall Study|Lost to Follow-up|4|||
149148766|NCT00917150|538023876|FG003|Overall Study|Lost to Follow-up|2|||
149148767|NCT00917150|538023873|FG000|Overall Study|Physician Decision|0|||
149148768|NCT00917150|538023874|FG001|Overall Study|Physician Decision|2|||
149148769|NCT00917150|538023875|FG002|Overall Study|Physician Decision|0|||
149148770|NCT00917150|538023876|FG003|Overall Study|Physician Decision|1|||
149148771|NCT00917150|538023873|FG000|Overall Study|Protocol Violation|5|||
149148772|NCT00917150|538023874|FG001|Overall Study|Protocol Violation|5|||
149148773|NCT00917150|538023875|FG002|Overall Study|Protocol Violation|3|||
149148774|NCT00917150|538023876|FG003|Overall Study|Protocol Violation|5|||
149148775|NCT00917150|538023873|FG000|Overall Study|Withdrawal by Subject|15|||
149148776|NCT00917150|538023874|FG001|Overall Study|Withdrawal by Subject|16|||
149148777|NCT00917150|538023875|FG002|Overall Study|Withdrawal by Subject|18|||
149148778|NCT00917150|538023876|FG003|Overall Study|Withdrawal by Subject|11|||
149148779|NCT00917150|538023873|FG000|Overall Study|Other than specified|3|||
149148780|NCT00917150|538023874|FG001|Overall Study|Other than specified|3|||
149148781|NCT00917150|538023875|FG002|Overall Study|Other than specified|2|||
149148782|NCT00917150|538023876|FG003|Overall Study|Other than specified|2|||
149148783|NCT01505634|538023877|FG000|Overall Study|Withdrawal by Subject|2|||
149148784|NCT01505634|538023878|FG001|Overall Study|Withdrawal by Subject|5|||
149148785|NCT01505634|538023879|FG002|Overall Study|Withdrawal by Subject|1|||
149148786|NCT01505634|538023877|FG000|Overall Study|Physician Decision|1|||
149148787|NCT01505634|538023878|FG001|Overall Study|Physician Decision|1|||
149148788|NCT01505634|538023879|FG002|Overall Study|Physician Decision|0|||
149148789|NCT01505634|538023877|FG000|Overall Study|Adverse Event|1|||
149148790|NCT01505634|538023878|FG001|Overall Study|Adverse Event|0|||
149148791|NCT01505634|538023879|FG002|Overall Study|Adverse Event|0|||
149148792|NCT01505634|538023877|FG000|Overall Study|Insufficient supply of drug at site|1|||
149148793|NCT01505634|538023878|FG001|Overall Study|Insufficient supply of drug at site|0|||
149148794|NCT01505634|538023879|FG002|Overall Study|Insufficient supply of drug at site|0|||
149148795|NCT01505634|538023877|FG000|Overall Study|Protocol Violation|2|||
149148796|NCT01505634|538023878|FG001|Overall Study|Protocol Violation|0|||
149148797|NCT01505634|538023879|FG002|Overall Study|Protocol Violation|0|||
149148798|NCT01505634|538023877|FG000|Overall Study|Lost to Follow-up|1|||
148671828|NCT00127192|536268855|FG002|Overall Study|Withdrawal by Subject|1|||
148671829|NCT00127192|536268856|FG003|Overall Study|Withdrawal by Subject|0|||
148671830|NCT00127192|536268857|FG004|Overall Study|Withdrawal by Subject|3|||
148671831|NCT00127192|536268853|FG000|Overall Study|Adverse event in pre-treatment period|1|||
149148799|NCT01505634|538023878|FG001|Overall Study|Lost to Follow-up|4|||
149148800|NCT01505634|538023879|FG002|Overall Study|Lost to Follow-up|4|||
149148801|NCT01505634|538023877|FG000|Overall Study|Death|1|||
149148802|NCT01505634|538023878|FG001|Overall Study|Death|0|||
149148803|NCT01505634|538023879|FG002|Overall Study|Death|0|||
149148804|NCT01505634|538023877|FG000|Overall Study|In a conflict zone|0|||
149148805|NCT01505634|538023878|FG001|Overall Study|In a conflict zone|0|||
149148806|NCT01505634|538023879|FG002|Overall Study|In a conflict zone|1|||
149148807|NCT02821715|538023881|FG000|Overall Study|Protocol Violation|1|||
149148808|NCT02821715|538023882|FG001|Overall Study|Protocol Violation|0|||
149148809|NCT02821715|538023883|FG002|Overall Study|Protocol Violation|0|||
149148810|NCT02821715|538023884|FG003|Overall Study|Protocol Violation|0|||
149148811|NCT02821715|538023885|FG004|Overall Study|Protocol Violation|0|||
148671832|NCT00127192|536268854|FG001|Overall Study|Adverse event in pre-treatment period|0|||
148671833|NCT00127192|536268855|FG002|Overall Study|Adverse event in pre-treatment period|0|||
148671834|NCT00127192|536268856|FG003|Overall Study|Adverse event in pre-treatment period|0|||
148671835|NCT00127192|536268857|FG004|Overall Study|Adverse event in pre-treatment period|0|||
148671836|NCT00806416|536268858|FG000|Period 1 - Part I|Adverse Event|0|||
148671837|NCT00806416|536268859|FG001|Period 1 - Part I|Adverse Event|1|||
149148812|NCT02821715|538023886|FG005|Overall Study|Protocol Violation|0|||
149148813|NCT02374099|538023887|FG000|Overall Study|Adverse Event|1|||
149148814|NCT02374099|538023888|FG001|Overall Study|Adverse Event|0|||
149148815|NCT02374099|538023887|FG000|Overall Study|Progressive Disease|35|||
149148816|NCT02374099|538023888|FG001|Overall Study|Progressive Disease|40|||
149148817|NCT02374099|538023887|FG000|Overall Study|Withdrawal by Subject|5|||
148671838|NCT00806416|536268860|FG002|Period 1 - Part I|Adverse Event|0|||
149148818|NCT02374099|538023888|FG001|Overall Study|Withdrawal by Subject|1|||
149148819|NCT02374099|538023887|FG000|Overall Study|Miscellaneous|2|||
149148820|NCT02374099|538023888|FG001|Overall Study|Miscellaneous|3|||
149148821|NCT02374099|538023887|FG000|Overall Study|Randomized, but not treated|2|||
149148822|NCT02374099|538023888|FG001|Overall Study|Randomized, but not treated|1|||
149148823|NCT02374099|538023887|FG000|Overall Study|Study Terminated by Sponsor|3|||
149148824|NCT02374099|538023888|FG001|Overall Study|Study Terminated by Sponsor|4|||
149148825|NCT04294719|538023889|FG000|Overall Study|Withdrawal by Subject|1|||
149148826|NCT04194528|538023891|FG000|Overall Study|Adverse Event|1|||
149148827|NCT05054114|538023901|FG000|Overall Study|Protocol Violation|13|||
149148828|NCT05054114|538023902|FG001|Overall Study|Protocol Violation|1|||
149148829|NCT05054114|538023901|FG000|Overall Study|Pregnancy|0|||
149148830|NCT05054114|538023902|FG001|Overall Study|Pregnancy|1|||
149148831|NCT01806779|538023903|FG000|Overall Study|Physician Decision|2|||
149148832|NCT01806779|538023904|FG001|Overall Study|Physician Decision|0|||
149148833|NCT01806779|538023905|FG002|Overall Study|Physician Decision|1|||
149148834|NCT01806779|538023903|FG000|Overall Study|Lack of Efficacy|1|||
149148835|NCT01806779|538023904|FG001|Overall Study|Lack of Efficacy|1|||
149148836|NCT01806779|538023905|FG002|Overall Study|Lack of Efficacy|0|||
149148837|NCT01806779|538023903|FG000|Overall Study|Lost to Follow-up|19|||
149148838|NCT01806779|538023904|FG001|Overall Study|Lost to Follow-up|20|||
149148839|NCT01806779|538023905|FG002|Overall Study|Lost to Follow-up|0|||
149148840|NCT01806779|538023903|FG000|Overall Study|Withdrawal by Subject|20|||
149148841|NCT01806779|538023904|FG001|Overall Study|Withdrawal by Subject|23|||
149148842|NCT01806779|538023905|FG002|Overall Study|Withdrawal by Subject|22|||
149148843|NCT02595450|538023908|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
149148844|NCT02595450|538023908|FG000|Overall Study|Enrolled, but not treated|8|||
149148845|NCT04294901|538023910|FG000|Overall Study|Death|86|||
149148846|NCT04294901|538023911|FG001|Overall Study|Death|110|||
149148847|NCT04294901|538023910|FG000|Overall Study|Provider did not have historical control patients|581|||
149148848|NCT04294901|538023911|FG001|Overall Study|Provider did not have historical control patients|0|||
149148849|NCT04294901|538023910|FG000|Overall Study|Provider did not have intervention patients|0|||
149148850|NCT04294901|538023911|FG001|Overall Study|Provider did not have intervention patients|98|||
149148851|NCT01934556|538023913|FG000|Overall Study|Withdrawal by Subject|0|||
149148852|NCT01934556|538023914|FG001|Overall Study|Withdrawal by Subject|1|||
149148853|NCT01934556|538023915|FG002|Overall Study|Withdrawal by Subject|1|||
149148854|NCT01934556|538023913|FG000|Overall Study|Lost to Follow-up|4|||
149148855|NCT01934556|538023914|FG001|Overall Study|Lost to Follow-up|10|||
149148856|NCT01934556|538023915|FG002|Overall Study|Lost to Follow-up|7|||
149148857|NCT01934556|538023913|FG000|Overall Study|Death|1|||
149148858|NCT01934556|538023914|FG001|Overall Study|Death|5|||
149148859|NCT01934556|538023915|FG002|Overall Study|Death|2|||
149148860|NCT00102960|538023918|FG000|Overall Study|Death|23|||
149148861|NCT00102960|538023919|FG001|Overall Study|Death|11|||
149148862|NCT00102960|538023920|FG002|Overall Study|Death|11|||
149148863|NCT00102960|538023918|FG000|Overall Study|Lost to Follow-up|6|||
149148864|NCT00102960|538023919|FG001|Overall Study|Lost to Follow-up|12|||
149148865|NCT00102960|538023920|FG002|Overall Study|Lost to Follow-up|16|||
149148866|NCT00102960|538023918|FG000|Overall Study|Withdrawal by Subject|1|||
149148867|NCT00102960|538023919|FG001|Overall Study|Withdrawal by Subject|0|||
149148868|NCT00102960|538023920|FG002|Overall Study|Withdrawal by Subject|1|||
149148869|NCT05038020|538023921|FG000|Overall Study|Early Termination|3|||
148671839|NCT00806416|536268861|FG003|Period 1 - Part I|Adverse Event|0|||
148671840|NCT00806416|536268858|FG000|Period 1 - Part I|Lost to Follow-up|0|||
148671841|NCT00806416|536268859|FG001|Period 1 - Part I|Lost to Follow-up|2|||
148671842|NCT00806416|536268860|FG002|Period 1 - Part I|Lost to Follow-up|0|||
148671843|NCT00806416|536268861|FG003|Period 1 - Part I|Lost to Follow-up|0|||
148671844|NCT00806416|536268858|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
148671845|NCT00806416|536268859|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
148671846|NCT00806416|536268860|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
148671847|NCT00806416|536268861|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
148671848|NCT00806416|536268858|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
148671849|NCT00806416|536268859|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
149148870|NCT05038020|538023922|FG001|Overall Study|Early Termination|0|||
149148871|NCT03770260|538026231|FG000|Overall Study|Disease progression|0|||
149148872|NCT03770260|538026232|FG001|Overall Study|Disease progression|1|||
149148873|NCT03770260|538026233|FG002|Overall Study|Disease progression|0|||
149148874|NCT03770260|538026234|FG003|Overall Study|Disease progression|0|||
149148875|NCT01908101|538026241|FG000|Overall Study|Physician Decision|1|||
149148876|NCT01908101|538026241|FG000|Overall Study|Withdrawal by Subject|1|||
149148877|NCT01908101|538026241|FG000|Overall Study|Incorrect Diagnosis|2|||
149148878|NCT01908101|538026241|FG000|Overall Study|Incorrect Starting Dose|1|||
149148879|NCT01908101|538026241|FG000|Overall Study|Did not complete the first cycle|4|||
149148880|NCT01394939|538026242|FG000|Overall Study|Adverse Event|1|||
148671850|NCT00806416|536268860|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
148671851|NCT00806416|536268861|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
148671852|NCT04935931|536268867|FG000|Overall Study|Withdrawal by Subject|1|||
149148881|NCT01394939|538026243|FG001|Overall Study|Adverse Event|3|||
149148882|NCT01394939|538026244|FG002|Overall Study|Adverse Event|0|||
149148883|NCT01394939|538026245|FG003|Overall Study|Adverse Event|2|||
149148884|NCT01394939|538026242|FG000|Overall Study|Death|0|||
148914533|NCT00711477|537171645|FG000|Overall Study|Lost to Follow-up|0|||
148914534|NCT00711477|537171646|FG001|Overall Study|Lost to Follow-up|1|||
148914535|NCT00711477|537171645|FG000|Overall Study|Noncompliance|0|||
148914536|NCT00711477|537171646|FG001|Overall Study|Noncompliance|1|||
148914537|NCT03037580|537171647|FG000|Overall Study|Withdrawal by Subject|3|||
148914538|NCT03037580|537171648|FG001|Overall Study|Withdrawal by Subject|0|||
148914539|NCT03037580|537171647|FG000|Overall Study|Adverse Event|1|||
148914540|NCT03037580|537171648|FG001|Overall Study|Adverse Event|0|||
148914541|NCT03037580|537171647|FG000|Overall Study|Study Terminated by Sponsor|12|||
148914542|NCT03037580|537171648|FG001|Overall Study|Study Terminated by Sponsor|15|||
148914543|NCT03037580|537171647|FG000|Overall Study|Death|0|||
148914544|NCT03037580|537171648|FG001|Overall Study|Death|1|||
148914545|NCT03500224|537171649|FG000|Overall Study|Withdrawal by Subject|2|||
148914546|NCT01324401|537171650|FG000|Overall Study|Withdrawn before any treatment|0|||
148914547|NCT01324401|537171651|FG001|Overall Study|Withdrawn before any treatment|3|||
148914548|NCT01324401|537171650|FG000|Overall Study|Adverse Event|1|||
148914549|NCT01324401|537171651|FG001|Overall Study|Adverse Event|3|||
148914550|NCT00499590|537171652|FG000|Overall Study|Study Terminated|112|||
148914551|NCT00499590|537171653|FG001|Overall Study|Study Terminated|112|||
148914552|NCT00499590|537171654|FG002|Overall Study|Study Terminated|112|||
148914553|NCT00499590|537171652|FG000|Overall Study|Not treated|1|||
148914554|NCT00499590|537171653|FG001|Overall Study|Not treated|0|||
148914555|NCT00499590|537171654|FG002|Overall Study|Not treated|1|||
148914556|NCT02873429|537171657|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
148914557|NCT02873429|537171658|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
148914558|NCT02873429|537171657|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
148914559|NCT02873429|537171658|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
148914560|NCT02873429|537171657|FG000|16 Weeks|Lost to Follow-up|3|||
148914561|NCT02873429|537171658|FG001|16 Weeks|Lost to Follow-up|0|||
148914562|NCT00853567|537171660|FG000|Overall Study|Study prematurely terminated|71|||
148914563|NCT00782834|537171666|FG000|Treatment Phase|fibrous tumor not GIST|1|||
148914564|NCT02055118|537171667|FG000|Overall Study|Withdrawal by Subject|0|||
148914565|NCT02055118|537171668|FG001|Overall Study|Withdrawal by Subject|2|||
148914566|NCT02055118|537171669|FG002|Overall Study|Withdrawal by Subject|0|||
148914567|NCT02259088|537171671|FG000|Overall Study|Adverse Event|6|||
148914568|NCT02259088|537171672|FG001|Overall Study|Adverse Event|4|||
148914569|NCT02259088|537171671|FG000|Overall Study|Lost to Follow-up|2|||
148914570|NCT02259088|537171672|FG001|Overall Study|Lost to Follow-up|0|||
148914571|NCT02259088|537171671|FG000|Overall Study|Death|2|||
148914572|NCT02259088|537171672|FG001|Overall Study|Death|0|||
148914573|NCT02259088|537171671|FG000|Overall Study|Physician Decision|5|||
148914574|NCT02259088|537171672|FG001|Overall Study|Physician Decision|2|||
148914575|NCT02259088|537171671|FG000|Overall Study|Protocol deviation|5|||
148914576|NCT02259088|537171672|FG001|Overall Study|Protocol deviation|0|||
148914577|NCT02259088|537171671|FG000|Overall Study|Subject/guardian decision|8|||
148914578|NCT02259088|537171672|FG001|Overall Study|Subject/guardian decision|8|||
148914579|NCT01818752|537171674|FG000|Overall Study|Adverse Event|64|||
148914580|NCT01818752|537171675|FG001|Overall Study|Adverse Event|74|||
148914581|NCT01818752|537171674|FG000|Overall Study|Death|14|||
148914582|NCT01818752|537171675|FG001|Overall Study|Death|18|||
148914583|NCT01818752|537171674|FG000|Overall Study|Non-compliance|16|||
148914584|NCT01818752|537171675|FG001|Overall Study|Non-compliance|20|||
148914585|NCT01818752|537171674|FG000|Overall Study|Withdrawal by Subject|15|||
148914586|NCT01818752|537171675|FG001|Overall Study|Withdrawal by Subject|14|||
148914587|NCT01818752|537171674|FG000|Overall Study|Physician Decision|9|||
148914588|NCT01818752|537171675|FG001|Overall Study|Physician Decision|8|||
148914589|NCT01818752|537171674|FG000|Overall Study|Disease Progression|54|||
148914590|NCT01818752|537171675|FG001|Overall Study|Disease Progression|48|||
148914591|NCT01818752|537171674|FG000|Overall Study|Other|7|||
148914592|NCT01818752|537171675|FG001|Overall Study|Other|8|||
148914593|NCT01818752|537171674|FG000|Overall Study|Continuing Treatment|1|||
148914594|NCT01818752|537171675|FG001|Overall Study|Continuing Treatment|4|||
148914595|NCT01818752|537171674|FG000|Overall Study|Randomized but not Dosed|7|||
148914596|NCT01818752|537171675|FG001|Overall Study|Randomized but not Dosed|4|||
148914597|NCT04270370|537171676|FG000|Overall Study|Lost to Follow-up|1|||
148914598|NCT04270370|537171677|FG001|Overall Study|Lost to Follow-up|0|||
148914599|NCT04270370|537171678|FG002|Overall Study|Lost to Follow-up|0|||
148914600|NCT04270370|537171679|FG003|Overall Study|Lost to Follow-up|0|||
148914601|NCT04270370|537171680|FG004|Overall Study|Lost to Follow-up|0|||
148914602|NCT04270370|537171681|FG005|Overall Study|Lost to Follow-up|0|||
148914603|NCT04270370|537171682|FG006|Overall Study|Lost to Follow-up|0|||
148914604|NCT04270370|537171683|FG007|Overall Study|Lost to Follow-up|0|||
148914605|NCT04270370|537171684|FG008|Overall Study|Lost to Follow-up|1|||
148914606|NCT04270370|537171685|FG009|Overall Study|Lost to Follow-up|0|||
148914607|NCT04270370|537171686|FG010|Overall Study|Lost to Follow-up|0|||
148914608|NCT04270370|537171687|FG011|Overall Study|Lost to Follow-up|0|||
148914609|NCT01324141|537171688|FG000|Overall Study|Declined to participate before treatment started|1|||
148914610|NCT01324141|537171688|FG000|Overall Study|Disease progression on study|1|||
148914611|NCT02560025|537171694|FG000|Overall Study|Ineligible after consent/ registration|3|||
149148885|NCT01394939|538026243|FG001|Overall Study|Death|2|||
149148886|NCT01394939|538026244|FG002|Overall Study|Death|0|||
149148887|NCT01394939|538026245|FG003|Overall Study|Death|0|||
149148888|NCT01394939|538026242|FG000|Overall Study|Physician Decision|0|||
149148889|NCT01394939|538026243|FG001|Overall Study|Physician Decision|1|||
149148890|NCT01394939|538026244|FG002|Overall Study|Physician Decision|0|||
149148891|NCT01394939|538026245|FG003|Overall Study|Physician Decision|0|||
149148892|NCT01394939|538026242|FG000|Overall Study|Withdrawal by Subject|0|||
149148893|NCT01394939|538026243|FG001|Overall Study|Withdrawal by Subject|2|||
149148894|NCT01394939|538026244|FG002|Overall Study|Withdrawal by Subject|0|||
149148895|NCT01394939|538026245|FG003|Overall Study|Withdrawal by Subject|2|||
149148896|NCT01394939|538026242|FG000|Overall Study|Others|0|||
149148897|NCT01394939|538026243|FG001|Overall Study|Others|2|||
149148898|NCT01394939|538026244|FG002|Overall Study|Others|0|||
149148899|NCT01394939|538026245|FG003|Overall Study|Others|3|||
149148900|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
149148901|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
149148902|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
149148903|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
149148904|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
149148905|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
149148906|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
149148907|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
149148908|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
149148909|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
149148910|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
149148911|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
149148912|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
149148913|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
149148914|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
149148915|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
149148916|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
149148917|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
149148918|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
149148919|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
149148920|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
149148921|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
149148922|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
149148923|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
149148924|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
149148925|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
149148926|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
149148927|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
149148928|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
149148929|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
149148930|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
149148931|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
149148932|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
149148933|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
149148934|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
149148935|NCT02831673|538026249|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
149148936|NCT02831673|538026250|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
149148937|NCT02831673|538026251|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
149148938|NCT02831673|538026252|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
149148939|NCT02831673|538026253|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
149148940|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
149148941|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
149148942|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
149148943|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
149148944|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
149148945|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
149148946|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
149148947|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
149148948|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
149148949|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
149148950|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
149148951|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
149148952|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
149148953|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
149148954|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
149148955|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
149148956|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
149148957|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
149148958|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
149148959|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
149148960|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
149148961|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
149148962|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
149148963|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
149148964|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
149148965|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
149148966|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
149148967|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
149148968|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
149148969|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
149148970|NCT02831673|538026249|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
149148971|NCT02831673|538026250|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
149148972|NCT02831673|538026251|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
149148973|NCT02831673|538026252|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
149148974|NCT02831673|538026253|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
149148975|NCT02831673|538026249|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
149148976|NCT02831673|538026250|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
149148977|NCT02831673|538026251|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
149148978|NCT02831673|538026252|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
149148979|NCT02831673|538026253|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
149148980|NCT02831673|538026249|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
149148981|NCT02831673|538026250|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
149148982|NCT02831673|538026251|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
149148983|NCT02831673|538026252|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
149148984|NCT02831673|538026253|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
149148985|NCT02831673|538026249|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
149148986|NCT02831673|538026250|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
149148987|NCT02831673|538026251|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
149148988|NCT02831673|538026252|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
149148989|NCT02831673|538026253|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
149148990|NCT02831673|538026249|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
149148991|NCT02831673|538026250|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
149148992|NCT02831673|538026251|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
149148993|NCT02831673|538026252|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
149148994|NCT02831673|538026253|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
149148995|NCT02831673|538026249|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
149148996|NCT02831673|538026250|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
149148997|NCT02831673|538026251|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
148805108|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148805109|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148805110|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148805111|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148805112|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
148805113|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
148805114|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
149148998|NCT02831673|538026252|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
149148999|NCT02831673|538026253|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
149149000|NCT00150592|538026254|FG000|Overall Study|Adverse Event|4|||
149149001|NCT00150592|538026255|FG001|Overall Study|Adverse Event|1|||
149149002|NCT00150592|538026254|FG000|Overall Study|Protocol Violation|1|||
149149003|NCT00150592|538026255|FG001|Overall Study|Protocol Violation|0|||
149149004|NCT00150592|538026254|FG000|Overall Study|Withdrawal by Subject|1|||
149149005|NCT00150592|538026255|FG001|Overall Study|Withdrawal by Subject|2|||
149149006|NCT00150592|538026254|FG000|Overall Study|Non-compliance|1|||
149149007|NCT00150592|538026255|FG001|Overall Study|Non-compliance|0|||
149149008|NCT00874120|538026260|FG000|First Intervention|Adverse Event|0|||
149149009|NCT00874120|538026261|FG001|First Intervention|Adverse Event|1|||
149149010|NCT00874120|538026260|FG000|First Intervention|Withdrawal by Subject|2|||
149149011|NCT00874120|538026261|FG001|First Intervention|Withdrawal by Subject|0|||
149149012|NCT00874120|538026260|FG000|First Intervention|Lost to Follow-up|0|||
149149013|NCT00874120|538026261|FG001|First Intervention|Lost to Follow-up|1|||
149149014|NCT00874120|538026260|FG000|First Intervention|Protocol Violation|3|||
149149015|NCT00874120|538026261|FG001|First Intervention|Protocol Violation|0|||
149149016|NCT00874120|538026260|FG000|First Intervention|positive drug test|1|||
149149017|NCT00874120|538026261|FG001|First Intervention|positive drug test|0|||
149149018|NCT00874120|538026260|FG000|Second Intervention|Withdrawal by Subject|1|||
149149019|NCT00874120|538026261|FG001|Second Intervention|Withdrawal by Subject|0|||
149149020|NCT00874120|538026260|FG000|Second Intervention|Protocol Violation|1|||
149149021|NCT00874120|538026261|FG001|Second Intervention|Protocol Violation|0|||
149149022|NCT00477165|538026262|FG000|Overall Study|Adverse Event|7|||
149149023|NCT00477165|538026263|FG001|Overall Study|Adverse Event|2|||
149149024|NCT01823679|538026264|FG000|Overall Study|Death|1|||
149149025|NCT01659320|538026270|FG000|Overall Study|Withdrawal by Subject|2|||
149149026|NCT01659320|538026270|FG000|Overall Study|Physician Decision|1|||
149149027|NCT01870401|538026271|FG000|Overall Study|Death|48|||
149149028|NCT01870401|538026272|FG001|Overall Study|Death|24|||
149149029|NCT01870401|538026271|FG000|Overall Study|Withdrawal by Subject|39|||
149149030|NCT01870401|538026272|FG001|Overall Study|Withdrawal by Subject|26|||
149149031|NCT01870401|538026271|FG000|Overall Study|Lost to Follow-up|19|||
149149032|NCT01870401|538026272|FG001|Overall Study|Lost to Follow-up|14|||
149149033|NCT01870401|538026271|FG000|Overall Study|Other|9|||
149149034|NCT01870401|538026272|FG001|Overall Study|Other|7|||
149149035|NCT01870401|538026271|FG000|Overall Study|On-going in the Study|35|||
149149036|NCT01870401|538026272|FG001|Overall Study|On-going in the Study|25|||
149149037|NCT05634577|538026275|FG000|Overall Study|Lost to Follow-up|1|||
149149038|NCT05634577|538026275|FG000|Overall Study|Withdrawal by Subject|1|||
149149039|NCT01192022|538026276|FG000|Overall Study|Withdrawal of Consent|3|||
149149040|NCT01192022|538026277|FG001|Overall Study|Withdrawal of Consent|1|||
149149041|NCT01192022|538026278|FG002|Overall Study|Withdrawal of Consent|0|||
149149042|NCT01192022|538026279|FG003|Overall Study|Withdrawal of Consent|0|||
149149043|NCT01192022|538026280|FG004|Overall Study|Withdrawal of Consent|0|||
149149044|NCT01192022|538026276|FG000|Overall Study|Lost to Follow-up|4|||
149149045|NCT01192022|538026277|FG001|Overall Study|Lost to Follow-up|2|||
149149046|NCT01192022|538026278|FG002|Overall Study|Lost to Follow-up|1|||
149149047|NCT01192022|538026279|FG003|Overall Study|Lost to Follow-up|1|||
149149048|NCT01192022|538026280|FG004|Overall Study|Lost to Follow-up|0|||
149149049|NCT01192022|538026276|FG000|Overall Study|Adverse Event|1|||
149149050|NCT01192022|538026277|FG001|Overall Study|Adverse Event|0|||
149149051|NCT01192022|538026278|FG002|Overall Study|Adverse Event|0|||
149149052|NCT01192022|538026279|FG003|Overall Study|Adverse Event|0|||
149149053|NCT01192022|538026280|FG004|Overall Study|Adverse Event|0|||
148914612|NCT02703337|537171695|FG000|Period One (Part A)|Withdrawal by Subject|0|||
148914613|NCT02703337|537171696|FG001|Period One (Part A)|Withdrawal by Subject|0|||
149149054|NCT01192022|538026276|FG000|Overall Study|Fatal Adverse Event|4|||
149149055|NCT01192022|538026277|FG001|Overall Study|Fatal Adverse Event|6|||
148914614|NCT02703337|537171697|FG002|Period One (Part A)|Withdrawal by Subject|0|||
149149056|NCT01192022|538026278|FG002|Overall Study|Fatal Adverse Event|0|||
149149057|NCT01192022|538026279|FG003|Overall Study|Fatal Adverse Event|0|||
149149058|NCT01192022|538026280|FG004|Overall Study|Fatal Adverse Event|1|||
149149059|NCT01192022|538026276|FG000|Overall Study|Physician withdrew-patient hardship|1|||
149149060|NCT01192022|538026277|FG001|Overall Study|Physician withdrew-patient hardship|0|||
149149061|NCT01192022|538026278|FG002|Overall Study|Physician withdrew-patient hardship|0|||
149149062|NCT01192022|538026279|FG003|Overall Study|Physician withdrew-patient hardship|0|||
149149063|NCT01192022|538026280|FG004|Overall Study|Physician withdrew-patient hardship|0|||
149149064|NCT01192022|538026276|FG000|Overall Study|Patient too sick from chemotherapy|0|||
148914615|NCT02703337|537171698|FG003|Period One (Part A)|Withdrawal by Subject|0|||
148914616|NCT02703337|537171699|FG004|Period One (Part A)|Withdrawal by Subject|1|||
148914617|NCT02703337|537171700|FG005|Period One (Part A)|Withdrawal by Subject|0|||
148914618|NCT02703337|537171701|FG006|Period One (Part A)|Withdrawal by Subject|0|||
148914619|NCT02703337|537171702|FG007|Period One (Part A)|Withdrawal by Subject|0|||
148914620|NCT02745080|537171709|FG000|Overall Study|Adverse Event|13|||
148914621|NCT02745080|537171710|FG001|Overall Study|Adverse Event|21|||
148914622|NCT02745080|537171709|FG000|Overall Study|Lack of Efficacy|11|||
148914623|NCT02745080|537171710|FG001|Overall Study|Lack of Efficacy|23|||
148914624|NCT02745080|537171709|FG000|Overall Study|Lost to Follow-up|3|||
148914625|NCT02745080|537171710|FG001|Overall Study|Lost to Follow-up|3|||
148914626|NCT02745080|537171709|FG000|Overall Study|Physician Decision|3|||
148914627|NCT02745080|537171710|FG001|Overall Study|Physician Decision|0|||
148914628|NCT02745080|537171709|FG000|Overall Study|Protocol Violation|3|||
148914629|NCT02745080|537171710|FG001|Overall Study|Protocol Violation|1|||
149149065|NCT01192022|538026277|FG001|Overall Study|Patient too sick from chemotherapy|1|||
148914630|NCT02745080|537171709|FG000|Overall Study|Withdrawal by Subject|22|||
148914631|NCT02745080|537171710|FG001|Overall Study|Withdrawal by Subject|41|||
148914632|NCT00282308|537171711|FG000|Treatment Period|Lost to Follow-up|1|||
148914633|NCT00282308|537171712|FG001|Treatment Period|Lost to Follow-up|0|||
148914634|NCT00282308|537171713|FG002|Treatment Period|Lost to Follow-up|0|||
148914635|NCT00282308|537171711|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
148914636|NCT00282308|537171712|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
148914637|NCT00282308|537171713|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
148914638|NCT00282308|537171711|FG000|Treatment Period|Adverse Event|0|||
148914639|NCT00282308|537171712|FG001|Treatment Period|Adverse Event|2|||
148914640|NCT00282308|537171713|FG002|Treatment Period|Adverse Event|0|||
148914641|NCT00282308|537171711|FG000|Treatment Period|Not Treated with Study Drug|1|||
148914642|NCT00282308|537171712|FG001|Treatment Period|Not Treated with Study Drug|0|||
148914643|NCT00282308|537171713|FG002|Treatment Period|Not Treated with Study Drug|0|||
148914644|NCT00282308|537171711|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
148914645|NCT00282308|537171712|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
148914646|NCT00282308|537171713|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
148914647|NCT00282308|537171711|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
148914648|NCT00282308|537171712|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
148914649|NCT00282308|537171713|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
148914650|NCT00282308|537171711|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
148914651|NCT00282308|537171712|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
148914652|NCT00282308|537171713|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
148914653|NCT00282308|537171711|FG000|Safety Follow-up Period|Adverse Event|0|||
148914654|NCT00282308|537171712|FG001|Safety Follow-up Period|Adverse Event|0|||
148914655|NCT00282308|537171713|FG002|Safety Follow-up Period|Adverse Event|1|||
148914656|NCT00282308|537171711|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
148914657|NCT00282308|537171712|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
148914658|NCT00282308|537171713|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
148914659|NCT00282308|537171711|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
148914660|NCT00282308|537171712|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
148914661|NCT00282308|537171713|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
148914662|NCT00282308|537171711|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
148914663|NCT00282308|537171712|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
148914664|NCT00282308|537171713|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
148914665|NCT01001325|537171716|FG000|Overall Study|Lost to Follow-up|16|||
148914666|NCT01001325|537171717|FG001|Overall Study|Lost to Follow-up|10|||
148914667|NCT01001325|537171716|FG000|Overall Study|Protocol Violation|2|||
148914668|NCT01001325|537171717|FG001|Overall Study|Protocol Violation|0|||
149149066|NCT01192022|538026278|FG002|Overall Study|Patient too sick from chemotherapy|0|||
149149067|NCT01192022|538026279|FG003|Overall Study|Patient too sick from chemotherapy|0|||
148914669|NCT01584440|537171720|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
148914670|NCT01584440|537171721|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
148914671|NCT01584440|537171722|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
148914672|NCT01584440|537171723|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
148914673|NCT01584440|537171724|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
148914674|NCT01584440|537171720|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
148914675|NCT01584440|537171721|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
148914676|NCT01584440|537171722|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
148914677|NCT01584440|537171723|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
148914678|NCT01584440|537171724|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
148914679|NCT01584440|537171720|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
148914680|NCT01584440|537171721|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
148914681|NCT01584440|537171722|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
148914682|NCT01584440|537171723|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
148914683|NCT01584440|537171724|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
148914684|NCT01584440|537171720|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
148914685|NCT01584440|537171721|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
148914686|NCT01584440|537171722|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
148914687|NCT01584440|537171723|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
148914688|NCT01584440|537171724|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
148914689|NCT01584440|537171720|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
148914690|NCT01584440|537171721|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
148914691|NCT01584440|537171722|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
148914692|NCT01584440|537171723|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
148914693|NCT01584440|537171724|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
148914694|NCT01584440|537171720|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
148914695|NCT01584440|537171721|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
148914696|NCT01584440|537171722|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
148914697|NCT01584440|537171723|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
148914698|NCT01584440|537171724|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
148914699|NCT01584440|537171720|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
148914700|NCT01584440|537171721|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
148914701|NCT01584440|537171722|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
148914702|NCT01584440|537171723|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
148914703|NCT01584440|537171724|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
148914704|NCT01584440|537171720|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
148914705|NCT01584440|537171721|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
148914706|NCT01584440|537171722|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
148914707|NCT01584440|537171723|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
148914708|NCT01584440|537171724|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
148914709|NCT01584440|537171720|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
148914710|NCT01584440|537171721|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
148914711|NCT01584440|537171722|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
148914712|NCT01584440|537171723|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
148914713|NCT01584440|537171724|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
148914714|NCT04237116|537171725|FG000|Overall Study|Adverse Event|0|||
148914715|NCT04237116|537171726|FG001|Overall Study|Adverse Event|1|||
148914716|NCT04237116|537171725|FG000|Overall Study|Study terminated by Sponsor|4|||
148914717|NCT04237116|537171726|FG001|Overall Study|Study terminated by Sponsor|1|||
148914718|NCT03212144|537171727|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
148914719|NCT03212144|537171728|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
148914720|NCT03212144|537171727|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
148914721|NCT03212144|537171728|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
148914722|NCT00899431|537171729|FG000|Overall Study|Physician Decision|1|||
148914723|NCT00899431|537171730|FG001|Overall Study|Physician Decision|0|||
148914724|NCT00899431|537171731|FG002|Overall Study|Physician Decision|0|||
148914725|NCT00661427|537171732|FG000|Overall Study|Adverse Event|5|||
148914726|NCT00661427|537171733|FG001|Overall Study|Adverse Event|5|||
148914727|NCT00661427|537171732|FG000|Overall Study|Patient not treated|0|||
148914728|NCT00661427|537171733|FG001|Overall Study|Patient not treated|2|||
148914729|NCT00599339|537171734|FG000|Overall Study|Adverse Event|79|||
148914730|NCT00599339|537171734|FG000|Overall Study|Withdrawal by Subject|137|||
148914731|NCT00599339|537171734|FG000|Overall Study|Other Reason|179|||
148914732|NCT00599339|537171734|FG000|Overall Study|Lost to Follow-up|221|||
148914733|NCT00599339|537171734|FG000|Overall Study|No valid data consent|36|||
148914734|NCT00599339|537171734|FG000|Overall Study|Study Termination Status Unknown|12|||
148914735|NCT05564052|537171735|FG000|Overall Study|Withdrawal by Subject|0|||
148914736|NCT05564052|537171736|FG001|Overall Study|Withdrawal by Subject|0|||
148914737|NCT05564052|537171737|FG002|Overall Study|Withdrawal by Subject|0|||
148914738|NCT05564052|537171738|FG003|Overall Study|Withdrawal by Subject|1|||
148914739|NCT01821560|537171739|FG000|Overall Study|Lost to Follow-up|5|||
148914740|NCT01821560|537171740|FG001|Overall Study|Lost to Follow-up|5|||
148914741|NCT01821560|537171739|FG000|Overall Study|Withdrawal by Subject|1|||
148914742|NCT01821560|537171740|FG001|Overall Study|Withdrawal by Subject|1|||
148914743|NCT01821560|537171739|FG000|Overall Study|Protocol Violation|0|||
148914744|NCT01821560|537171740|FG001|Overall Study|Protocol Violation|1|||
148914745|NCT01338298|537171741|FG000|Overall Study|Withdrawal by Subject|1|||
148914746|NCT01338298|537171742|FG001|Overall Study|Withdrawal by Subject|1|||
148914747|NCT01338298|537171741|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
148914748|NCT01338298|537171742|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
148914749|NCT01338298|537171741|FG000|Overall Study|Administrative error|0|||
148914750|NCT01338298|537171742|FG001|Overall Study|Administrative error|1|||
148914751|NCT01338298|537171741|FG000|Overall Study|Positive symptom worsening|1|||
148914752|NCT01338298|537171742|FG001|Overall Study|Positive symptom worsening|0|||
148914753|NCT01338298|537171741|FG000|Overall Study|Depressive symptoms and nausea|1|||
148914754|NCT01338298|537171742|FG001|Overall Study|Depressive symptoms and nausea|0|||
148914755|NCT01338298|537171741|FG000|Overall Study|Non-adherence|1|||
148914756|NCT01338298|537171742|FG001|Overall Study|Non-adherence|0|||
148914757|NCT02872285|537171743|FG000|Overall Study|Withdrawal by Subject|2|||
148914758|NCT02872285|537171744|FG001|Overall Study|Withdrawal by Subject|0|||
148914759|NCT02872285|537171743|FG000|Overall Study|Lost to Follow-up|2|||
148914760|NCT02872285|537171744|FG001|Overall Study|Lost to Follow-up|2|||
148914761|NCT02872285|537171743|FG000|Overall Study|Discontinued due to back surgery|1|||
148914762|NCT02872285|537171744|FG001|Overall Study|Discontinued due to back surgery|0|||
148914763|NCT00531427|537171745|FG000|Overall Study|Withdrawal by Subject|7|||
148914764|NCT00531427|537171746|FG001|Overall Study|Withdrawal by Subject|13|||
148914765|NCT00531427|537171745|FG000|Overall Study|Adverse Event|44|||
148914766|NCT00531427|537171746|FG001|Overall Study|Adverse Event|30|||
148914767|NCT00531427|537171745|FG000|Overall Study|Lost to Follow-up|4|||
148914768|NCT00531427|537171746|FG001|Overall Study|Lost to Follow-up|3|||
148914769|NCT00531427|537171745|FG000|Overall Study|Lack of Efficacy|14|||
148914770|NCT00531427|537171746|FG001|Overall Study|Lack of Efficacy|39|||
148914771|NCT00531427|537171745|FG000|Overall Study|Administrative|4|||
148914772|NCT00531427|537171746|FG001|Overall Study|Administrative|9|||
148914773|NCT06457204|537171747|FG000|Washout|Adverse Event|0|||
148914774|NCT06457204|537171748|FG001|Washout|Adverse Event|2|||
148914775|NCT00588861|537173392|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
148914776|NCT00588861|537173393|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
148914777|NCT00588861|537173392|FG000|6 Months|Patients did not return for follow-up|98|||
148914778|NCT00588861|537173393|FG001|6 Months|Patients did not return for follow-up|73|||
148914779|NCT00588861|537173392|FG000|1 Year|Patients did not return for follow-up|89|||
148914780|NCT00588861|537173393|FG001|1 Year|Patients did not return for follow-up|82|||
148914781|NCT00588861|537173392|FG000|2 Years|Patients did not return for follow-up|92|||
148914782|NCT00588861|537173393|FG001|2 Years|Patients did not return for follow-up|87|||
148914783|NCT00588861|537173392|FG000|4 Years|Patients did not return for follow-up|91|||
148914784|NCT00588861|537173393|FG001|4 Years|Patients did not return for follow-up|103|||
148914785|NCT00588861|537173392|FG000|6 Years|Patients did not return for follow-up|104|||
148914786|NCT00588861|537173393|FG001|6 Years|Patients did not return for follow-up|109|||
148914787|NCT00588861|537173392|FG000|8 Years|Patients did not return for follow-up|105|||
148914788|NCT00588861|537173393|FG001|8 Years|Patients did not return for follow-up|114|||
148914789|NCT00588861|537173392|FG000|10 Years|Incomplete due to study termination|107|||
148914790|NCT00588861|537173393|FG001|10 Years|Incomplete due to study termination|114|||
148914791|NCT02848729|537173401|FG000|Overall Study|Withdrawal by Subject|1|||
148914792|NCT02848729|537173402|FG001|Overall Study|Withdrawal by Subject|0|||
148914793|NCT02848729|537173401|FG000|Overall Study|Emesis|15|||
148914794|NCT02848729|537173402|FG001|Overall Study|Emesis|11|||
148914795|NCT02617485|537173406|FG000|Treatment and Observation Period|Adverse Event|9|||
148914796|NCT02617485|537173407|FG001|Treatment and Observation Period|Adverse Event|1|||
148914797|NCT02617485|537173406|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
148914798|NCT02617485|537173407|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
148914799|NCT02617485|537173406|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
148914800|NCT02617485|537173407|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
148914801|NCT02617485|537173406|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
148914802|NCT02617485|537173407|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
148914803|NCT02617485|537173406|FG000|Treatment and Observation Period|Physician Decision|0|||
148914804|NCT02617485|537173407|FG001|Treatment and Observation Period|Physician Decision|1|||
149149068|NCT01192022|538026280|FG004|Overall Study|Patient too sick from chemotherapy|0|||
149149069|NCT01192022|538026276|FG000|Overall Study|Patient needed surgery|0|||
149149070|NCT01192022|538026277|FG001|Overall Study|Patient needed surgery|1|||
149149071|NCT01192022|538026278|FG002|Overall Study|Patient needed surgery|0|||
149149072|NCT01192022|538026279|FG003|Overall Study|Patient needed surgery|0|||
148805115|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805116|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805117|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805118|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805119|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805120|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805121|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805122|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
148805123|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
148805124|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
148805125|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805126|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805127|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805128|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805129|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805130|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805131|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805132|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
148805133|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
148805134|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
148805135|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805136|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805137|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805138|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805139|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805140|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805141|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805142|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
148805143|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
148805144|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
148805145|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805146|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805147|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805148|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805149|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805150|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805151|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805152|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
148805153|NCT01232283|536766673|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
148805154|NCT01232283|536766674|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
148805155|NCT01232283|536766675|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805156|NCT01232283|536766676|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805157|NCT01232283|536766677|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805158|NCT01232283|536766678|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805159|NCT01232283|536766679|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805160|NCT01232283|536766680|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805161|NCT01232283|536766681|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805162|NCT01232283|536766682|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
148805163|NCT01232283|536766673|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805164|NCT01232283|536766674|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805165|NCT01232283|536766675|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
148805166|NCT01232283|536766676|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
148805167|NCT01232283|536766677|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805168|NCT01232283|536766678|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805169|NCT01232283|536766679|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805170|NCT01232283|536766680|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805171|NCT01232283|536766681|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805172|NCT01232283|536766682|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
148805173|NCT01232283|536766673|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805174|NCT01232283|536766674|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
149149073|NCT01192022|538026280|FG004|Overall Study|Patient needed surgery|0|||
148805175|NCT01232283|536766675|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
148805176|NCT01232283|536766676|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
148805177|NCT01232283|536766677|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805178|NCT01232283|536766678|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805179|NCT01232283|536766679|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805180|NCT01232283|536766680|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805181|NCT01232283|536766681|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805182|NCT01232283|536766682|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
148805183|NCT01232283|536766673|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805184|NCT01232283|536766674|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805185|NCT01232283|536766675|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
148805186|NCT01232283|536766676|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805187|NCT01232283|536766677|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805188|NCT01232283|536766678|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805189|NCT01232283|536766679|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805190|NCT01232283|536766680|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805191|NCT01232283|536766681|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805192|NCT01232283|536766682|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
148805193|NCT01232283|536766673|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805194|NCT01232283|536766674|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805195|NCT01232283|536766675|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
148805196|NCT01232283|536766676|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
148805197|NCT01232283|536766677|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805198|NCT01232283|536766678|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805199|NCT01232283|536766679|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805200|NCT01232283|536766680|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805201|NCT01232283|536766681|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805202|NCT01232283|536766682|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
148805203|NCT01232283|536766673|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805204|NCT01232283|536766674|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805205|NCT01232283|536766675|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
148805206|NCT01232283|536766676|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
148805207|NCT01232283|536766677|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805208|NCT01232283|536766678|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805209|NCT01232283|536766679|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805210|NCT01232283|536766680|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805211|NCT01232283|536766681|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805212|NCT01232283|536766682|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
148805213|NCT01232283|536766673|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
148805214|NCT01232283|536766674|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
148805215|NCT01232283|536766675|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
148805216|NCT01232283|536766676|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
148805217|NCT01232283|536766677|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
148805218|NCT01232283|536766678|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
148805219|NCT01232283|536766679|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
148805220|NCT01232283|536766680|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
148805221|NCT01232283|536766681|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
148805222|NCT01232283|536766682|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
148805223|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148805224|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148805225|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148805226|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148805227|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
148805228|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
148805229|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148805230|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
148805231|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148805232|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
148914805|NCT02617485|537173406|FG000|Follow-up Period|Adverse Event|1|||
148914806|NCT02617485|537173407|FG001|Follow-up Period|Adverse Event|0|||
148914807|NCT02617485|537173406|FG000|Follow-up Period|Withdrawal by Subject|1|||
148805233|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148805234|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148805235|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148914808|NCT02617485|537173407|FG001|Follow-up Period|Withdrawal by Subject|0|||
148914809|NCT02617485|537173406|FG000|Follow-up Period|Disease progression|2|||
148914810|NCT02617485|537173407|FG001|Follow-up Period|Disease progression|1|||
148914811|NCT02617485|537173406|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
148914812|NCT02617485|537173407|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
148914813|NCT02617485|537173406|FG000|Follow-up Period|Patient needed radiotherapy|9|||
148914814|NCT02617485|537173407|FG001|Follow-up Period|Patient needed radiotherapy|5|||
148914815|NCT02617485|537173406|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
148914816|NCT02617485|537173407|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
148914817|NCT00220779|537173408|FG000|Overall Study|Adverse Event|1|||
148914818|NCT00220779|537173409|FG001|Overall Study|Adverse Event|0|||
148914819|NCT00220779|537173410|FG002|Overall Study|Adverse Event|0|||
148914820|NCT00220779|537173408|FG000|Overall Study|Withdrawal by Subject|1|||
148914821|NCT00220779|537173409|FG001|Overall Study|Withdrawal by Subject|4|||
148914822|NCT00220779|537173410|FG002|Overall Study|Withdrawal by Subject|1|||
148914823|NCT00220779|537173408|FG000|Overall Study|Non-compliance|1|||
148914824|NCT00220779|537173409|FG001|Overall Study|Non-compliance|0|||
148914825|NCT00220779|537173410|FG002|Overall Study|Non-compliance|0|||
148914826|NCT00220779|537173408|FG000|Overall Study|Too time consuming|1|||
148914827|NCT00220779|537173409|FG001|Overall Study|Too time consuming|0|||
148914828|NCT00220779|537173410|FG002|Overall Study|Too time consuming|0|||
148914829|NCT00220779|537173408|FG000|Overall Study|Pregnancy|0|||
148914830|NCT00220779|537173409|FG001|Overall Study|Pregnancy|0|||
148914831|NCT00220779|537173410|FG002|Overall Study|Pregnancy|2|||
148914832|NCT00220779|537173408|FG000|Overall Study|Lack of Efficacy|3|||
148914833|NCT00220779|537173409|FG001|Overall Study|Lack of Efficacy|0|||
148914834|NCT00220779|537173410|FG002|Overall Study|Lack of Efficacy|1|||
148914835|NCT00791076|537173411|FG000|Overall Study|Study was terminated,PI left institution|8|||
148914836|NCT03745820|537173419|FG000|Overall Study|Adverse Event|0|||
148914837|NCT03745820|537173420|FG001|Overall Study|Adverse Event|3|||
148914838|NCT03745820|537173421|FG002|Overall Study|Adverse Event|2|||
148914839|NCT03745820|537173419|FG000|Overall Study|Non-Compliance with Study Drug|4|||
148914840|NCT03745820|537173420|FG001|Overall Study|Non-Compliance with Study Drug|3|||
148914841|NCT03745820|537173421|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148914842|NCT03745820|537173419|FG000|Overall Study|Withdrawal by Subject|4|||
148914843|NCT03745820|537173420|FG001|Overall Study|Withdrawal by Subject|4|||
148914844|NCT03745820|537173421|FG002|Overall Study|Withdrawal by Subject|4|||
148914845|NCT03745820|537173419|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
148914846|NCT03745820|537173420|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
148914847|NCT03745820|537173421|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
148914848|NCT03745820|537173419|FG000|Overall Study|Lost to Follow-up|2|||
148914849|NCT03745820|537173420|FG001|Overall Study|Lost to Follow-up|0|||
148914850|NCT03745820|537173421|FG002|Overall Study|Lost to Follow-up|3|||
148914851|NCT03745820|537173419|FG000|Overall Study|Reason not Specified|2|||
148914852|NCT03745820|537173420|FG001|Overall Study|Reason not Specified|4|||
148914853|NCT03745820|537173421|FG002|Overall Study|Reason not Specified|1|||
148914854|NCT00507728|537173422|FG000|Randomization to Month 3|Lost to Follow-up|15|||
148914855|NCT00507728|537173423|FG001|Randomization to Month 3|Lost to Follow-up|14|||
148914856|NCT00507728|537173424|FG002|Randomization to Month 3|Lost to Follow-up|20|||
148914857|NCT00507728|537173422|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
148914858|NCT00507728|537173423|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
148914859|NCT00507728|537173424|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
148914860|NCT00966875|537173427|FG000|Part A|Adverse Event|2|||
148914861|NCT00966875|537173428|FG001|Part A|Adverse Event|1|||
148914862|NCT00966875|537173429|FG002|Part A|Adverse Event|0|||
148914863|NCT00966875|537173430|FG003|Part A|Adverse Event|1|||
148914864|NCT00966875|537173431|FG004|Part A|Adverse Event|0|||
148914865|NCT00966875|537173432|FG005|Part A|Adverse Event|1|||
148914866|NCT00966875|537173433|FG006|Part A|Adverse Event|0|||
148914867|NCT00966875|537173434|FG007|Part A|Adverse Event|3|||
148914868|NCT00966875|537173435|FG008|Part A|Adverse Event|3|||
148914869|NCT00966875|537173427|FG000|Part A|Entry Criteria|0|||
148914870|NCT00966875|537173428|FG001|Part A|Entry Criteria|0|||
148914871|NCT00966875|537173429|FG002|Part A|Entry Criteria|0|||
148914872|NCT00966875|537173430|FG003|Part A|Entry Criteria|0|||
148914873|NCT00966875|537173431|FG004|Part A|Entry Criteria|0|||
148914874|NCT00966875|537173432|FG005|Part A|Entry Criteria|2|||
148914875|NCT00966875|537173433|FG006|Part A|Entry Criteria|0|||
148914876|NCT00966875|537173434|FG007|Part A|Entry Criteria|0|||
148914877|NCT00966875|537173435|FG008|Part A|Entry Criteria|0|||
148914878|NCT00966875|537173427|FG000|Part A|Lack of Efficacy|0|||
148914879|NCT00966875|537173428|FG001|Part A|Lack of Efficacy|1|||
148914880|NCT00966875|537173429|FG002|Part A|Lack of Efficacy|0|||
148914881|NCT00966875|537173430|FG003|Part A|Lack of Efficacy|0|||
148914882|NCT00966875|537173431|FG004|Part A|Lack of Efficacy|0|||
148914883|NCT00966875|537173432|FG005|Part A|Lack of Efficacy|0|||
148914884|NCT00966875|537173433|FG006|Part A|Lack of Efficacy|4|||
148914885|NCT00966875|537173434|FG007|Part A|Lack of Efficacy|0|||
148914886|NCT00966875|537173435|FG008|Part A|Lack of Efficacy|0|||
148914887|NCT00966875|537173427|FG000|Part A|Lost to Follow-up|2|||
148914888|NCT00966875|537173428|FG001|Part A|Lost to Follow-up|0|||
148914889|NCT00966875|537173429|FG002|Part A|Lost to Follow-up|0|||
148914890|NCT00966875|537173430|FG003|Part A|Lost to Follow-up|0|||
148914891|NCT00966875|537173431|FG004|Part A|Lost to Follow-up|0|||
148914892|NCT00966875|537173432|FG005|Part A|Lost to Follow-up|1|||
148914893|NCT00966875|537173433|FG006|Part A|Lost to Follow-up|0|||
148914894|NCT00966875|537173434|FG007|Part A|Lost to Follow-up|0|||
148914895|NCT00966875|537173435|FG008|Part A|Lost to Follow-up|0|||
148914896|NCT00966875|537173427|FG000|Part A|Parent/Caregiver Decision|0|||
148914897|NCT00966875|537173428|FG001|Part A|Parent/Caregiver Decision|0|||
148914898|NCT00966875|537173429|FG002|Part A|Parent/Caregiver Decision|0|||
148914899|NCT00966875|537173430|FG003|Part A|Parent/Caregiver Decision|1|||
148914900|NCT00966875|537173431|FG004|Part A|Parent/Caregiver Decision|0|||
148914901|NCT00966875|537173432|FG005|Part A|Parent/Caregiver Decision|0|||
148914902|NCT00966875|537173433|FG006|Part A|Parent/Caregiver Decision|0|||
148914903|NCT00966875|537173434|FG007|Part A|Parent/Caregiver Decision|0|||
148914904|NCT00966875|537173435|FG008|Part A|Parent/Caregiver Decision|0|||
148914905|NCT00966875|537173427|FG000|Part A|Physician Decision|0|||
148914906|NCT00966875|537173428|FG001|Part A|Physician Decision|0|||
148914907|NCT00966875|537173429|FG002|Part A|Physician Decision|0|||
148914908|NCT00966875|537173430|FG003|Part A|Physician Decision|0|||
148914909|NCT00966875|537173431|FG004|Part A|Physician Decision|1|||
148914910|NCT00966875|537173432|FG005|Part A|Physician Decision|0|||
148914911|NCT00966875|537173433|FG006|Part A|Physician Decision|1|||
148914912|NCT00966875|537173434|FG007|Part A|Physician Decision|0|||
148914913|NCT00966875|537173435|FG008|Part A|Physician Decision|2|||
148914914|NCT00966875|537173427|FG000|Part A|Sponsor Decision|0|||
148914915|NCT00966875|537173428|FG001|Part A|Sponsor Decision|0|||
148914916|NCT00966875|537173429|FG002|Part A|Sponsor Decision|1|||
148914917|NCT00966875|537173430|FG003|Part A|Sponsor Decision|0|||
148914918|NCT00966875|537173431|FG004|Part A|Sponsor Decision|1|||
148914919|NCT00966875|537173432|FG005|Part A|Sponsor Decision|0|||
148914920|NCT00966875|537173433|FG006|Part A|Sponsor Decision|0|||
148914921|NCT00966875|537173434|FG007|Part A|Sponsor Decision|2|||
148914922|NCT00966875|537173435|FG008|Part A|Sponsor Decision|1|||
148914923|NCT00966875|537173427|FG000|Part A|Withdrawal by Subject|2|||
148914924|NCT00966875|537173428|FG001|Part A|Withdrawal by Subject|2|||
148914925|NCT00966875|537173429|FG002|Part A|Withdrawal by Subject|1|||
148914926|NCT00966875|537173430|FG003|Part A|Withdrawal by Subject|1|||
148914927|NCT00966875|537173431|FG004|Part A|Withdrawal by Subject|3|||
148914928|NCT00966875|537173432|FG005|Part A|Withdrawal by Subject|0|||
148914929|NCT00966875|537173433|FG006|Part A|Withdrawal by Subject|5|||
148914930|NCT00966875|537173434|FG007|Part A|Withdrawal by Subject|1|||
148914931|NCT00966875|537173435|FG008|Part A|Withdrawal by Subject|1|||
149149074|NCT01192022|538026276|FG000|Overall Study|Parents did not allow all follow up|0|||
149149075|NCT01192022|538026277|FG001|Overall Study|Parents did not allow all follow up|0|||
148914932|NCT00966875|537173427|FG000|Part A|Protocol Violation|0|||
148914933|NCT00966875|537173428|FG001|Part A|Protocol Violation|0|||
148914934|NCT00966875|537173429|FG002|Part A|Protocol Violation|0|||
148914935|NCT00966875|537173430|FG003|Part A|Protocol Violation|0|||
148914936|NCT00966875|537173431|FG004|Part A|Protocol Violation|0|||
148914937|NCT00966875|537173432|FG005|Part A|Protocol Violation|0|||
148914938|NCT00966875|537173433|FG006|Part A|Protocol Violation|2|||
148914939|NCT00966875|537173434|FG007|Part A|Protocol Violation|1|||
148914940|NCT00966875|537173435|FG008|Part A|Protocol Violation|1|||
148914941|NCT00966875|537173427|FG000|Part B|Adverse Event|0|||
148914942|NCT00966875|537173428|FG001|Part B|Adverse Event|1|||
148914943|NCT00966875|537173429|FG002|Part B|Adverse Event|1|||
148914944|NCT00966875|537173430|FG003|Part B|Adverse Event|0|||
148914945|NCT00966875|537173431|FG004|Part B|Adverse Event|1|||
148914946|NCT00966875|537173432|FG005|Part B|Adverse Event|0|||
148914947|NCT00966875|537173433|FG006|Part B|Adverse Event|5|||
148914948|NCT00966875|537173434|FG007|Part B|Adverse Event|2|||
148914949|NCT00966875|537173435|FG008|Part B|Adverse Event|2|||
149149076|NCT01192022|538026278|FG002|Overall Study|Parents did not allow all follow up|0|||
148914950|NCT00966875|537173427|FG000|Part B|Death|0|||
148914951|NCT00966875|537173428|FG001|Part B|Death|0|||
148914952|NCT00966875|537173429|FG002|Part B|Death|1|||
148914953|NCT00966875|537173430|FG003|Part B|Death|0|||
148914954|NCT00966875|537173431|FG004|Part B|Death|0|||
148914955|NCT00966875|537173432|FG005|Part B|Death|0|||
148914956|NCT00966875|537173433|FG006|Part B|Death|0|||
148914957|NCT00966875|537173434|FG007|Part B|Death|1|||
148914958|NCT00966875|537173435|FG008|Part B|Death|0|||
148914959|NCT00966875|537173427|FG000|Part B|Lack of Efficacy|2|||
148914960|NCT00966875|537173428|FG001|Part B|Lack of Efficacy|1|||
148914961|NCT00966875|537173429|FG002|Part B|Lack of Efficacy|1|||
148914962|NCT00966875|537173430|FG003|Part B|Lack of Efficacy|1|||
148914963|NCT00966875|537173431|FG004|Part B|Lack of Efficacy|2|||
148914964|NCT00966875|537173432|FG005|Part B|Lack of Efficacy|3|||
148914965|NCT00966875|537173433|FG006|Part B|Lack of Efficacy|12|||
148914966|NCT00966875|537173434|FG007|Part B|Lack of Efficacy|9|||
148914967|NCT00966875|537173435|FG008|Part B|Lack of Efficacy|6|||
148914968|NCT00966875|537173427|FG000|Part B|Lost to Follow-up|0|||
148914969|NCT00966875|537173428|FG001|Part B|Lost to Follow-up|0|||
148914970|NCT00966875|537173429|FG002|Part B|Lost to Follow-up|0|||
148914971|NCT00966875|537173430|FG003|Part B|Lost to Follow-up|1|||
148914972|NCT00966875|537173431|FG004|Part B|Lost to Follow-up|0|||
148914973|NCT00966875|537173432|FG005|Part B|Lost to Follow-up|0|||
148914974|NCT00966875|537173433|FG006|Part B|Lost to Follow-up|0|||
148914975|NCT00966875|537173434|FG007|Part B|Lost to Follow-up|0|||
148914976|NCT00966875|537173435|FG008|Part B|Lost to Follow-up|1|||
148914977|NCT00966875|537173427|FG000|Part B|Physician Decision|0|||
148914978|NCT00966875|537173428|FG001|Part B|Physician Decision|0|||
148914979|NCT00966875|537173429|FG002|Part B|Physician Decision|1|||
148914980|NCT00966875|537173430|FG003|Part B|Physician Decision|0|||
148914981|NCT00966875|537173431|FG004|Part B|Physician Decision|2|||
148914982|NCT00966875|537173432|FG005|Part B|Physician Decision|1|||
148914983|NCT00966875|537173433|FG006|Part B|Physician Decision|0|||
148914984|NCT00966875|537173434|FG007|Part B|Physician Decision|0|||
148914985|NCT00966875|537173435|FG008|Part B|Physician Decision|2|||
148914986|NCT00966875|537173427|FG000|Part B|Sponsor Decision|1|||
148914987|NCT00966875|537173428|FG001|Part B|Sponsor Decision|0|||
148914988|NCT00966875|537173429|FG002|Part B|Sponsor Decision|0|||
148914989|NCT00966875|537173430|FG003|Part B|Sponsor Decision|0|||
148914990|NCT00966875|537173431|FG004|Part B|Sponsor Decision|0|||
148914991|NCT00966875|537173432|FG005|Part B|Sponsor Decision|1|||
148914992|NCT00966875|537173433|FG006|Part B|Sponsor Decision|0|||
148914993|NCT00966875|537173434|FG007|Part B|Sponsor Decision|2|||
148914994|NCT00966875|537173435|FG008|Part B|Sponsor Decision|1|||
148914995|NCT00966875|537173427|FG000|Part B|Withdrawal by Subject|2|||
148914996|NCT00966875|537173428|FG001|Part B|Withdrawal by Subject|1|||
148914997|NCT00966875|537173429|FG002|Part B|Withdrawal by Subject|2|||
148914998|NCT00966875|537173430|FG003|Part B|Withdrawal by Subject|1|||
148914999|NCT00966875|537173431|FG004|Part B|Withdrawal by Subject|2|||
148915000|NCT00966875|537173432|FG005|Part B|Withdrawal by Subject|1|||
148915001|NCT00966875|537173433|FG006|Part B|Withdrawal by Subject|4|||
148915002|NCT00966875|537173434|FG007|Part B|Withdrawal by Subject|5|||
149149077|NCT01192022|538026279|FG003|Overall Study|Parents did not allow all follow up|1|||
149149078|NCT01192022|538026280|FG004|Overall Study|Parents did not allow all follow up|0|||
149149079|NCT01351389|538026281|FG000|Overall Study|Withdrawal by Subject|7|||
149149080|NCT01351389|538026282|FG001|Overall Study|Withdrawal by Subject|0|||
148805236|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148805237|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
148805238|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148805239|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
148805240|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
148805241|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148805242|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
148805243|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
148805244|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
148805245|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
148805246|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
148805247|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
148805248|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
148805249|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
148915003|NCT00966875|537173435|FG008|Part B|Withdrawal by Subject|5|||
148915004|NCT00966875|537173427|FG000|Part B|Entry Criteria|0|||
148915005|NCT00966875|537173428|FG001|Part B|Entry Criteria|0|||
148915006|NCT00966875|537173429|FG002|Part B|Entry Criteria|0|||
148915007|NCT00966875|537173430|FG003|Part B|Entry Criteria|0|||
148915008|NCT00966875|537173431|FG004|Part B|Entry Criteria|0|||
148915009|NCT00966875|537173432|FG005|Part B|Entry Criteria|0|||
149149081|NCT01351389|538026281|FG000|Overall Study|did not complete intervention|23|||
148915010|NCT00966875|537173433|FG006|Part B|Entry Criteria|1|||
148915011|NCT00966875|537173434|FG007|Part B|Entry Criteria|0|||
148915012|NCT00966875|537173435|FG008|Part B|Entry Criteria|1|||
148915013|NCT01589653|537173438|FG000|Overall Study|Protocol Violation|3|||
148915014|NCT01589653|537173439|FG001|Overall Study|Protocol Violation|1|||
148915015|NCT01589653|537173438|FG000|Overall Study|Withdrawal criteria|4|||
149149082|NCT01351389|538026282|FG001|Overall Study|did not complete intervention|15|||
149149083|NCT04839978|538026283|FG000|Overall Study|Lost to Follow-up|135|||
149149084|NCT04839978|538026284|FG001|Overall Study|Lost to Follow-up|147|||
149149085|NCT00623480|538026286|FG000|Overall Study|Lost to Follow-up|0|||
149149086|NCT00623480|538026287|FG001|Overall Study|Lost to Follow-up|1|||
149149087|NCT00623480|538026286|FG000|Overall Study|Withdrawal by Subject|2|||
149149088|NCT00623480|538026287|FG001|Overall Study|Withdrawal by Subject|4|||
149149089|NCT00623480|538026286|FG000|Overall Study|Lack of Efficacy|1|||
148805250|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
148805251|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
148805252|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
148805253|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805254|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805255|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805256|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805257|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
148805258|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805259|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805260|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805261|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805262|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
148805263|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805264|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805265|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805266|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805267|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
148805268|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805269|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
148805270|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
148805271|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805272|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
148805273|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805274|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805275|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805276|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805277|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805278|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805279|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805280|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
148805281|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805282|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
148805283|NCT01232283|536766673|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805284|NCT01232283|536766674|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805285|NCT01232283|536766675|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805286|NCT01232283|536766676|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805287|NCT01232283|536766677|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805288|NCT01232283|536766678|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
148805289|NCT01232283|536766679|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805290|NCT01232283|536766680|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805291|NCT01232283|536766681|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805292|NCT01232283|536766682|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
148805293|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805294|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805295|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805296|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805297|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805298|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805299|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805300|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
148805301|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
148805302|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
148805303|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148805304|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148805305|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148805306|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148805307|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
149149090|NCT00623480|538026287|FG001|Overall Study|Lack of Efficacy|0|||
148671853|NCT00227591|536268868|FG000|Overall Study|Withdrawal by Subject|1|||
148671854|NCT00077766|536268869|FG000|Overall Study|Adverse Event|1|||
148671855|NCT00077766|536268870|FG001|Overall Study|Adverse Event|1|||
148671856|NCT00077766|536268869|FG000|Overall Study|Withdrawal by Subject|4|||
148671857|NCT00077766|536268870|FG001|Overall Study|Withdrawal by Subject|3|||
148671858|NCT00077766|536268869|FG000|Overall Study|Death|12|||
148671859|NCT00077766|536268870|FG001|Overall Study|Death|10|||
148671860|NCT00077766|536268869|FG000|Overall Study|Lost to Follow-up|2|||
148671861|NCT00077766|536268870|FG001|Overall Study|Lost to Follow-up|0|||
148671862|NCT00077766|536268869|FG000|Overall Study|Protocol Violation|1|||
148671863|NCT00077766|536268870|FG001|Overall Study|Protocol Violation|0|||
148671864|NCT00077766|536268869|FG000|Overall Study|Kidney Transplantation|9|||
148671865|NCT00077766|536268870|FG001|Overall Study|Kidney Transplantation|5|||
148671866|NCT00077766|536268869|FG000|Overall Study|Transplantation|5|||
148671867|NCT00077766|536268870|FG001|Overall Study|Transplantation|1|||
148671868|NCT00077766|536268869|FG000|Overall Study|Investigators Discretion|1|||
148671869|NCT00077766|536268870|FG001|Overall Study|Investigators Discretion|0|||
148671870|NCT00077766|536268869|FG000|Overall Study|Participant's decision|1|||
148671871|NCT00077766|536268870|FG001|Overall Study|Participant's decision|0|||
148671872|NCT00077766|536268869|FG000|Overall Study|Dialysis Discontinued|1|||
148671873|NCT00077766|536268870|FG001|Overall Study|Dialysis Discontinued|0|||
148671874|NCT00077766|536268869|FG000|Overall Study|Dialysis|0|||
148671875|NCT00077766|536268870|FG001|Overall Study|Dialysis|1|||
148671876|NCT00077766|536268869|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
148671877|NCT00077766|536268870|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
148671878|NCT00077766|536268869|FG000|Overall Study|Started Nocturnal Dialysis|0|||
148671879|NCT00077766|536268870|FG001|Overall Study|Started Nocturnal Dialysis|1|||
148671880|NCT00077766|536268869|FG000|Overall Study|Stop Dialysis|0|||
148671881|NCT00077766|536268870|FG001|Overall Study|Stop Dialysis|1|||
148671882|NCT00077766|536268869|FG000|Overall Study|Participants Vacation|2|||
148671883|NCT00077766|536268870|FG001|Overall Study|Participants Vacation|1|||
148671884|NCT01886105|536268871|FG000|Overall Study|Lack of Efficacy|3|||
148671885|NCT02057549|536268873|FG000|Overall Study|Lost to Follow-up|1|||
148671886|NCT02057549|536268874|FG001|Overall Study|Lost to Follow-up|0|||
148671887|NCT02057549|536268873|FG000|Overall Study|Physician Decision|1|||
148671888|NCT02057549|536268874|FG001|Overall Study|Physician Decision|0|||
148671889|NCT02057549|536268873|FG000|Overall Study|Withdrawal by Subject|1|||
148671890|NCT02057549|536268874|FG001|Overall Study|Withdrawal by Subject|0|||
148915016|NCT01589653|537173439|FG001|Overall Study|Withdrawal criteria|7|||
149149091|NCT00623480|538026286|FG000|Overall Study|Non-compliant with study medication|4|||
149149092|NCT00623480|538026287|FG001|Overall Study|Non-compliant with study medication|0|||
149149093|NCT00623480|538026286|FG000|Overall Study|Protocol Violation|0|||
148671891|NCT01360021|536268877|FG000|Overall Study|Eligibility criteria + other|2|||
148671892|NCT01360021|536268878|FG001|Overall Study|Eligibility criteria + other|1|||
148671893|NCT01360021|536268879|FG002|Overall Study|Eligibility criteria + other|1|||
148671894|NCT01360021|536268877|FG000|Overall Study|Protocol Violation|0|||
148671895|NCT01360021|536268878|FG001|Overall Study|Protocol Violation|0|||
148915017|NCT01589653|537173438|FG000|Overall Study|Unclassified|0|||
148915018|NCT01589653|537173439|FG001|Overall Study|Unclassified|3|||
148915019|NCT01536067|537173440|FG000|Overall Study|Disease Progression|1|||
148915020|NCT04657666|537173443|FG000|Period 1|Withdrawal of participant consent|2|||
148915021|NCT04657666|537173444|FG001|Period 1|Withdrawal of participant consent|1|||
148915022|NCT04657666|537173443|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
148915023|NCT04657666|537173444|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
148915024|NCT04657666|537173443|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
148915025|NCT04657666|537173444|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
148915026|NCT04657666|537173443|FG000|Period 2|Other|2|||
148915027|NCT04657666|537173444|FG001|Period 2|Other|0|||
148915028|NCT04657666|537173443|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
148915029|NCT04657666|537173444|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
148915030|NCT02386189|537173445|FG000|Overall Study|Lost to Follow-up|2|||
148915031|NCT02386189|537173446|FG001|Overall Study|Lost to Follow-up|3|||
148915032|NCT02386189|537173445|FG000|Overall Study|Withdrawal by Subject|1|||
148915033|NCT02386189|537173446|FG001|Overall Study|Withdrawal by Subject|0|||
148915034|NCT02386189|537173445|FG000|Overall Study|Death|1|||
148915035|NCT02386189|537173446|FG001|Overall Study|Death|0|||
148915036|NCT00606905|537173447|FG000|Overall Study|No Pregnancy|9|||
148915037|NCT00606905|537173448|FG001|Overall Study|No Pregnancy|6|||
149149094|NCT00623480|538026287|FG001|Overall Study|Protocol Violation|1|||
148671896|NCT01360021|536268879|FG002|Overall Study|Protocol Violation|1|||
148671897|NCT01360021|536268877|FG000|Overall Study|Withdrawal by Subject|4|||
148671898|NCT01360021|536268878|FG001|Overall Study|Withdrawal by Subject|0|||
148915038|NCT00606905|537173447|FG000|Overall Study|Non-Index Pregnancy|1|||
148915039|NCT00606905|537173448|FG001|Overall Study|Non-Index Pregnancy|4|||
148915040|NCT00606905|537173447|FG000|Overall Study|Withdrew|5|||
148671899|NCT01360021|536268879|FG002|Overall Study|Withdrawal by Subject|2|||
148915041|NCT00606905|537173448|FG001|Overall Study|Withdrew|5|||
148915042|NCT03120351|537173449|FG000|Overall Study|Physician Decision|1|||
148915043|NCT03120351|537173450|FG001|Overall Study|Physician Decision|1|||
148915044|NCT04250077|537173459|FG000|Overall Study|Withdrawal by Subject|0|||
148915045|NCT04250077|537173460|FG001|Overall Study|Withdrawal by Subject|1|||
148915046|NCT04250077|537173461|FG002|Overall Study|Withdrawal by Subject|0|||
148915047|NCT04250077|537173459|FG000|Overall Study|Lost to Follow-up|2|||
148915048|NCT04250077|537173460|FG001|Overall Study|Lost to Follow-up|3|||
148915049|NCT04250077|537173461|FG002|Overall Study|Lost to Follow-up|0|||
148915050|NCT01022398|537173462|FG000|Overall Study|Study terminated|2|||
148915051|NCT01022398|537173463|FG001|Overall Study|Study terminated|2|||
148915052|NCT03319745|537173465|FG000|Overall Study|Death|1|||
148915053|NCT03319745|537173465|FG000|Overall Study|Toxicity Precluding Surgery|1|||
148915054|NCT01317550|537173466|FG000|Overall Study|Withdrawal by Subject|1|||
148915055|NCT01317550|537173467|FG001|Overall Study|Withdrawal by Subject|0|||
148915056|NCT01317550|537173468|FG002|Overall Study|Withdrawal by Subject|0|||
148915057|NCT01317550|537173469|FG003|Overall Study|Withdrawal by Subject|0|||
148915058|NCT01317550|537173466|FG000|Overall Study|Lack of compliance study med|1|||
148915059|NCT01317550|537173467|FG001|Overall Study|Lack of compliance study med|0|||
148915060|NCT01317550|537173468|FG002|Overall Study|Lack of compliance study med|0|||
148915061|NCT01317550|537173469|FG003|Overall Study|Lack of compliance study med|0|||
148915062|NCT00870103|537173470|FG000|Overall Study|Physician Decision|2|||
148915063|NCT00870103|537173470|FG000|Overall Study|Lost to Follow-up|2|||
148915064|NCT03255629|537173471|FG000|Overall Study|Adverse Event|1|||
148915065|NCT03255629|537173472|FG001|Overall Study|Adverse Event|0|||
148915066|NCT03255629|537173471|FG000|Overall Study|did not experience hypoglycemia|2|||
148915067|NCT03255629|537173472|FG001|Overall Study|did not experience hypoglycemia|1|||
148915068|NCT04540198|537173473|FG000|Overall Study|Lost to Follow-up|25|||
148915069|NCT04540198|537173474|FG001|Overall Study|Lost to Follow-up|23|||
148915070|NCT04540198|537173473|FG000|Overall Study|Withdrawal by Subject|15|||
148915071|NCT04540198|537173474|FG001|Overall Study|Withdrawal by Subject|9|||
148915072|NCT04540198|537173473|FG000|Overall Study|Discontinued|1|||
148915073|NCT04540198|537173474|FG001|Overall Study|Discontinued|0|||
148915074|NCT01086358|537173475|FG000|First Intervention|Lost to Follow-up|9|||
148915075|NCT01086358|537173476|FG001|First Intervention|Lost to Follow-up|4|||
148915076|NCT01086358|537173475|FG000|First Intervention|Withdrawal by Subject|0|||
148915077|NCT01086358|537173476|FG001|First Intervention|Withdrawal by Subject|1|||
148915078|NCT01086358|537173475|FG000|Second Intervention|Lost to Follow-up|4|||
148915079|NCT01086358|537173476|FG001|Second Intervention|Lost to Follow-up|4|||
148915080|NCT03317405|537173477|FG000|Overall Study|Withdrawal by Subject|1|||
148915081|NCT03317405|537173478|FG001|Overall Study|Withdrawal by Subject|0|||
148915082|NCT03317405|537173479|FG002|Overall Study|Withdrawal by Subject|0|||
148915083|NCT03317405|537173477|FG000|Overall Study|Physician Decision|0|||
148915084|NCT03317405|537173478|FG001|Overall Study|Physician Decision|0|||
148915085|NCT03317405|537173479|FG002|Overall Study|Physician Decision|1|||
148915086|NCT03317405|537173477|FG000|Overall Study|Surgery Rescheduled|0|||
148915087|NCT03317405|537173478|FG001|Overall Study|Surgery Rescheduled|1|||
148915088|NCT03317405|537173479|FG002|Overall Study|Surgery Rescheduled|0|||
148915089|NCT04075734|537173482|FG000|Overall Study|Lost to Follow-up|1|||
148915090|NCT04075734|537173483|FG001|Overall Study|Lost to Follow-up|1|||
148671900|NCT01360021|536268877|FG000|Overall Study|Adverse Event|2|||
148671901|NCT01360021|536268878|FG001|Overall Study|Adverse Event|3|||
148671902|NCT01360021|536268879|FG002|Overall Study|Adverse Event|3|||
148671903|NCT02255422|536268882|FG000|Overall Study|Withdrawal by Subject|0|||
148671904|NCT02255422|536268883|FG001|Overall Study|Withdrawal by Subject|0|||
148671905|NCT02255422|536268884|FG002|Overall Study|Withdrawal by Subject|0|||
148671906|NCT02255422|536268885|FG003|Overall Study|Withdrawal by Subject|0|||
148671907|NCT02255422|536268886|FG004|Overall Study|Withdrawal by Subject|0|||
148805308|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148805309|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148915091|NCT04075734|537173484|FG002|Overall Study|Lost to Follow-up|0|||
148915092|NCT04075734|537173482|FG000|Overall Study|Withdrawal by Subject|3|||
148915093|NCT04075734|537173483|FG001|Overall Study|Withdrawal by Subject|0|||
148915094|NCT04075734|537173484|FG002|Overall Study|Withdrawal by Subject|0|||
148915095|NCT01137604|537173485|FG000|Overall Study|Adverse Event|3|||
148915096|NCT01137604|537173486|FG001|Overall Study|Adverse Event|6|||
148805310|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
148805311|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
148805312|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
148805313|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805314|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805315|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805316|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805317|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805318|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
149149095|NCT00623480|538026286|FG000|Overall Study|Site closed by sponsor|0|||
148915097|NCT01137604|537173487|FG002|Overall Study|Adverse Event|9|||
148915098|NCT01137604|537173488|FG003|Overall Study|Adverse Event|9|||
148915099|NCT01137604|537173485|FG000|Overall Study|Participant Choice|0|||
148915100|NCT01137604|537173486|FG001|Overall Study|Participant Choice|2|||
148915101|NCT01137604|537173487|FG002|Overall Study|Participant Choice|2|||
148915102|NCT01137604|537173488|FG003|Overall Study|Participant Choice|0|||
148915103|NCT01137604|537173485|FG000|Overall Study|Withdrawal of consent|0|||
148915104|NCT01137604|537173486|FG001|Overall Study|Withdrawal of consent|0|||
148915105|NCT01137604|537173487|FG002|Overall Study|Withdrawal of consent|0|||
148915106|NCT01137604|537173488|FG003|Overall Study|Withdrawal of consent|2|||
148915107|NCT01137604|537173485|FG000|Overall Study|Clinical progression/deterioration|1|||
148915108|NCT01137604|537173486|FG001|Overall Study|Clinical progression/deterioration|2|||
148915109|NCT01137604|537173487|FG002|Overall Study|Clinical progression/deterioration|2|||
148915110|NCT01137604|537173488|FG003|Overall Study|Clinical progression/deterioration|0|||
148915111|NCT00591318|537173489|FG000|Overall Study|Lack of Efficacy|2|||
148915112|NCT00591318|537173490|FG001|Overall Study|Lack of Efficacy|0|||
148915113|NCT00591318|537173489|FG000|Overall Study|Adverse Event|2|||
148915114|NCT00591318|537173490|FG001|Overall Study|Adverse Event|0|||
148915115|NCT01024309|537173496|FG000|Overall Study|Physician Decision|4|||
148915116|NCT01024309|537173497|FG001|Overall Study|Physician Decision|0|||
148915117|NCT01024309|537173496|FG000|Overall Study|Withdrawal by Subject|4|||
148915118|NCT01024309|537173497|FG001|Overall Study|Withdrawal by Subject|4|||
148915119|NCT00335764|537173498|FG000|Overall Study|wrong histology|1|||
148915120|NCT00335764|537173499|FG001|Overall Study|wrong histology|0|||
148915121|NCT00335764|537173500|FG002|Overall Study|wrong histology|0|||
149149096|NCT00623480|538026287|FG001|Overall Study|Site closed by sponsor|1|||
149149097|NCT03551509|538026288|FG000|Overall Study|Lost to Follow-up|0|||
149149098|NCT03551509|538026289|FG001|Overall Study|Lost to Follow-up|1|||
149149099|NCT03551509|538026290|FG002|Overall Study|Lost to Follow-up|0|||
148805319|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805320|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
148805321|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
148805322|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
148805323|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148805324|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148915122|NCT00335764|537173501|FG003|Overall Study|wrong histology|0|||
148915123|NCT00335764|537173502|FG004|Overall Study|wrong histology|1|||
149149100|NCT01594853|538026291|FG000|Overall Study|Withdrawal by Subject|1|||
148805325|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148915124|NCT00612807|537173503|FG000|Overall Study|Withdrawal by Subject|2|||
148915125|NCT00612807|537173504|FG001|Overall Study|Withdrawal by Subject|0|||
149149101|NCT01594853|538026292|FG001|Overall Study|Withdrawal by Subject|1|||
149149102|NCT01594853|538026291|FG000|Overall Study|Lost to Follow-up|1|||
148915126|NCT00744042|537173505|FG000|Overall Study|Withdrawal by Subject|1|||
148915127|NCT02660983|537173509|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
148915128|NCT02660983|537173510|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
148915129|NCT02660983|537173509|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
148915130|NCT02660983|537173510|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
148915131|NCT02660983|537173509|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
148915132|NCT02660983|537173510|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
148915133|NCT02660983|537173509|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
148915134|NCT02660983|537173510|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
148915135|NCT02660983|537173509|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
148915136|NCT02660983|537173510|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
148915137|NCT02660983|537173509|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
148915138|NCT02660983|537173510|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
148915139|NCT02660983|537173509|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
148915140|NCT02660983|537173510|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
148915141|NCT01253577|537173514|FG000|Overall Study|Lost to Follow-up|3|||
148915142|NCT00721968|537173515|FG000|Overall Study|Lost to Follow-up|2|||
148915143|NCT00721968|537173516|FG001|Overall Study|Lost to Follow-up|0|||
148915144|NCT05601544|537173517|FG000|Phase 2 Period 1|Adverse Event|0|||
148915145|NCT05601544|537173518|FG001|Phase 2 Period 1|Adverse Event|1|||
148915146|NCT05601544|537173519|FG002|Phase 2 Period 1|Adverse Event|0|||
148915147|NCT05601544|537173520|FG003|Phase 2 Period 1|Adverse Event|0|||
148915148|NCT05601544|537173521|FG004|Phase 2 Period 1|Adverse Event|0|||
148915149|NCT05601544|537173522|FG005|Phase 2 Period 1|Adverse Event|0|||
148915150|NCT01064947|537173523|FG000|Overall Study|negative culture|41|||
148915151|NCT01065454|537173526|FG000|Treatment|Adverse Event|7|||
148915152|NCT01065454|537173527|FG001|Treatment|Adverse Event|4|||
148915153|NCT01065454|537173528|FG002|Treatment|Adverse Event|3|||
148915154|NCT01065454|537173529|FG003|Treatment|Adverse Event|6|||
148915155|NCT01065454|537173526|FG000|Treatment|Death|1|||
148915156|NCT01065454|537173527|FG001|Treatment|Death|0|||
148915157|NCT01065454|537173528|FG002|Treatment|Death|0|||
148915158|NCT01065454|537173529|FG003|Treatment|Death|0|||
148915159|NCT01065454|537173526|FG000|Treatment|Non-compliance|1|||
148915160|NCT01065454|537173527|FG001|Treatment|Non-compliance|0|||
148915161|NCT01065454|537173528|FG002|Treatment|Non-compliance|0|||
148915162|NCT01065454|537173529|FG003|Treatment|Non-compliance|1|||
148915163|NCT01065454|537173526|FG000|Treatment|Protocol Decision|0|||
148915164|NCT01065454|537173527|FG001|Treatment|Protocol Decision|0|||
148915165|NCT01065454|537173528|FG002|Treatment|Protocol Decision|3|||
148671908|NCT02255422|536268887|FG005|Overall Study|Withdrawal by Subject|0|||
148671909|NCT02255422|536268888|FG006|Overall Study|Withdrawal by Subject|2|||
148671910|NCT02255422|536268882|FG000|Overall Study|Lost to Follow-up|0|||
148671911|NCT02255422|536268883|FG001|Overall Study|Lost to Follow-up|0|||
148915166|NCT01065454|537173529|FG003|Treatment|Protocol Decision|2|||
148915167|NCT01065454|537173526|FG000|Treatment|Protocol Violation|1|||
148915168|NCT01065454|537173527|FG001|Treatment|Protocol Violation|0|||
148915169|NCT01065454|537173528|FG002|Treatment|Protocol Violation|1|||
148671912|NCT02255422|536268884|FG002|Overall Study|Lost to Follow-up|1|||
148671913|NCT02255422|536268885|FG003|Overall Study|Lost to Follow-up|0|||
148671914|NCT02255422|536268886|FG004|Overall Study|Lost to Follow-up|0|||
148671915|NCT02255422|536268887|FG005|Overall Study|Lost to Follow-up|0|||
148671916|NCT02255422|536268888|FG006|Overall Study|Lost to Follow-up|0|||
148671917|NCT02062385|536268889|FG000|Overall Study|Adverse Event|19|||
148671918|NCT02062385|536268890|FG001|Overall Study|Adverse Event|13|||
148671919|NCT02062385|536268891|FG002|Overall Study|Adverse Event|1|||
148671920|NCT02062385|536268892|FG003|Overall Study|Adverse Event|0|||
148671921|NCT02062385|536268889|FG000|Overall Study|Protocol Violation|1|||
148671922|NCT02062385|536268890|FG001|Overall Study|Protocol Violation|0|||
148915170|NCT01065454|537173529|FG003|Treatment|Protocol Violation|0|||
148915171|NCT01065454|537173526|FG000|Treatment|Withdrawal by Subject|3|||
148915172|NCT01065454|537173527|FG001|Treatment|Withdrawal by Subject|1|||
148915173|NCT01065454|537173528|FG002|Treatment|Withdrawal by Subject|2|||
148915174|NCT01065454|537173529|FG003|Treatment|Withdrawal by Subject|3|||
148915175|NCT01065454|537173526|FG000|Follow up|Adverse Event|1|||
148915176|NCT01065454|537173527|FG001|Follow up|Adverse Event|0|||
148915177|NCT01065454|537173528|FG002|Follow up|Adverse Event|0|||
148915178|NCT01065454|537173529|FG003|Follow up|Adverse Event|1|||
148671923|NCT02062385|536268891|FG002|Overall Study|Protocol Violation|0|||
148671924|NCT02062385|536268892|FG003|Overall Study|Protocol Violation|0|||
148915179|NCT01065454|537173526|FG000|Follow up|Death|0|||
148915180|NCT01065454|537173527|FG001|Follow up|Death|1|||
148915181|NCT01065454|537173528|FG002|Follow up|Death|1|||
148671925|NCT02062385|536268889|FG000|Overall Study|Incomplete EPI by database lock|2|||
148671926|NCT02062385|536268890|FG001|Overall Study|Incomplete EPI by database lock|0|||
148915182|NCT01065454|537173529|FG003|Follow up|Death|0|||
148671927|NCT02062385|536268891|FG002|Overall Study|Incomplete EPI by database lock|0|||
148671928|NCT02062385|536268892|FG003|Overall Study|Incomplete EPI by database lock|0|||
148915183|NCT01065454|537173526|FG000|Follow up|Lost to Follow-up|0|||
148915184|NCT01065454|537173527|FG001|Follow up|Lost to Follow-up|0|||
148915185|NCT01065454|537173528|FG002|Follow up|Lost to Follow-up|0|||
148915186|NCT01065454|537173529|FG003|Follow up|Lost to Follow-up|1|||
148915187|NCT01065454|537173526|FG000|Follow up|Progressive disease|0|||
148915188|NCT01065454|537173527|FG001|Follow up|Progressive disease|0|||
148915189|NCT01065454|537173528|FG002|Follow up|Progressive disease|0|||
148915190|NCT01065454|537173529|FG003|Follow up|Progressive disease|1|||
148915191|NCT01065454|537173526|FG000|Follow up|Withdrawal by Subject|1|||
148915192|NCT01065454|537173527|FG001|Follow up|Withdrawal by Subject|1|||
148915193|NCT01065454|537173528|FG002|Follow up|Withdrawal by Subject|1|||
148915194|NCT01065454|537173529|FG003|Follow up|Withdrawal by Subject|0|||
148915195|NCT01065454|537173526|FG000|Follow up|study ongoing|37|||
148915196|NCT01065454|537173527|FG001|Follow up|study ongoing|22|||
148915197|NCT01065454|537173528|FG002|Follow up|study ongoing|15|||
148915198|NCT01065454|537173529|FG003|Follow up|study ongoing|41|||
148915199|NCT01601652|537173531|FG000|Overall Study|Death|1|||
148915200|NCT00488683|537173538|FG000|Overall Study|Withdrawal by Subject|1|||
148915201|NCT00488683|537173539|FG001|Overall Study|Withdrawal by Subject|2|||
148915202|NCT00488683|537173540|FG002|Overall Study|Withdrawal by Subject|2|||
148915203|NCT00488683|537173538|FG000|Overall Study|Lost to Follow-up|5|||
148915204|NCT00488683|537173539|FG001|Overall Study|Lost to Follow-up|3|||
148915205|NCT00488683|537173540|FG002|Overall Study|Lost to Follow-up|0|||
148915206|NCT00488683|537173538|FG000|Overall Study|Protocol Violation|5|||
148915207|NCT00488683|537173539|FG001|Overall Study|Protocol Violation|1|||
148915208|NCT00488683|537173540|FG002|Overall Study|Protocol Violation|0|||
148915209|NCT00488683|537173538|FG000|Overall Study|Unable to Classify|1|||
148915210|NCT00488683|537173539|FG001|Overall Study|Unable to Classify|0|||
148915211|NCT00488683|537173540|FG002|Overall Study|Unable to Classify|0|||
148915212|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
148915213|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
148915214|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
148915215|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
148915216|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
148915217|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
148915218|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
148915219|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
148915220|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
148915221|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
148915222|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
148915223|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
148915224|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
148915225|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
148915226|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
148915227|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
148671929|NCT02062385|536268889|FG000|Overall Study|Moved|10|||
148671930|NCT02062385|536268890|FG001|Overall Study|Moved|11|||
148671931|NCT02062385|536268891|FG002|Overall Study|Moved|1|||
148915228|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
148915229|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
148915230|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
148915231|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
148915232|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
148915233|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
148915234|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
148915235|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
148915236|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
148915237|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
148915238|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
148915239|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
148671932|NCT02062385|536268892|FG003|Overall Study|Moved|0|||
148671933|NCT02062385|536268889|FG000|Overall Study|Withdrawn by parent/guardian|46|||
148915240|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
148915241|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
149149103|NCT01594853|538026292|FG001|Overall Study|Lost to Follow-up|1|||
148915242|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
148915243|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
148915244|NCT03818035|537173542|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
148915245|NCT03818035|537173543|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
148915246|NCT03818035|537173544|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
148915247|NCT03818035|537173545|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
148915248|NCT03818035|537173542|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
148915249|NCT03818035|537173543|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
148915250|NCT03818035|537173544|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
148915251|NCT03818035|537173545|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
148915252|NCT03818035|537173542|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
148915253|NCT03818035|537173543|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
148915254|NCT03818035|537173544|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
148915255|NCT03818035|537173545|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
148915256|NCT03818035|537173542|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
148915257|NCT03818035|537173543|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
148915258|NCT03818035|537173544|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
148915259|NCT03818035|537173545|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
148915260|NCT03818035|537173542|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
148915261|NCT03818035|537173543|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
148915262|NCT03818035|537173544|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
148915263|NCT03818035|537173545|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
149149104|NCT01594853|538026291|FG000|Overall Study|noncompliance with exercise|0|||
148915264|NCT03818035|537173542|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
148915265|NCT03818035|537173543|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
148915266|NCT03818035|537173544|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
148915267|NCT03818035|537173545|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
148915268|NCT03818035|537173542|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
148915269|NCT03818035|537173543|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
148915270|NCT03818035|537173544|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
148915271|NCT03818035|537173545|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
148915272|NCT03374202|537173548|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
148915273|NCT03374202|537173549|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
148915274|NCT03374202|537173550|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
148915275|NCT03374202|537173548|FG000|Five Year Long Term Follow Up|Death|0|||
148915276|NCT03374202|537173549|FG001|Five Year Long Term Follow Up|Death|1|||
148915277|NCT03374202|537173550|FG002|Five Year Long Term Follow Up|Death|0|||
148915278|NCT01031836|537175166|FG000|Stage I|Adverse Event|1|||
148915279|NCT01031836|537175167|FG001|Stage I|Adverse Event|1|||
148915280|NCT01031836|537175168|FG002|Stage I|Adverse Event|0|||
148915281|NCT01031836|537175169|FG003|Stage I|Adverse Event|0|||
148915282|NCT01031836|537175170|FG004|Stage I|Adverse Event|0|||
148915283|NCT01031836|537175171|FG005|Stage I|Adverse Event|0|||
148915284|NCT01031836|537175166|FG000|Stage I|Other|0|||
148915285|NCT01031836|537175167|FG001|Stage I|Other|1|||
148915286|NCT01031836|537175168|FG002|Stage I|Other|0|||
148915287|NCT01031836|537175169|FG003|Stage I|Other|0|||
148915288|NCT01031836|537175170|FG004|Stage I|Other|0|||
148915289|NCT01031836|537175171|FG005|Stage I|Other|1|||
148915290|NCT01031836|537175166|FG000|Stage II|Adverse Event|0|||
148915291|NCT01031836|537175167|FG001|Stage II|Adverse Event|0|||
148915292|NCT01031836|537175168|FG002|Stage II|Adverse Event|2|||
148915293|NCT01031836|537175169|FG003|Stage II|Adverse Event|2|||
148915294|NCT01031836|537175170|FG004|Stage II|Adverse Event|1|||
148915295|NCT01031836|537175171|FG005|Stage II|Adverse Event|1|||
148915296|NCT01031836|537175166|FG000|Stage II|Other|2|||
148915297|NCT01031836|537175167|FG001|Stage II|Other|0|||
148915298|NCT01031836|537175168|FG002|Stage II|Other|0|||
148915299|NCT01031836|537175169|FG003|Stage II|Other|1|||
148915300|NCT01031836|537175170|FG004|Stage II|Other|1|||
148915301|NCT01031836|537175171|FG005|Stage II|Other|0|||
148915302|NCT00490529|537175172|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
148915303|NCT00490529|537175172|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
148915304|NCT00490529|537175172|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
148915305|NCT00490529|537175172|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
148915306|NCT00490529|537175172|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
148915307|NCT00490529|537175172|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
148915308|NCT00617669|537175179|FG000|Overall Study|Withdrawal by Subject|71|||
148915309|NCT00617669|537175180|FG001|Overall Study|Withdrawal by Subject|77|||
148915310|NCT00617669|537175179|FG000|Overall Study|Lost to Follow-up|3|||
148915311|NCT00617669|537175180|FG001|Overall Study|Lost to Follow-up|2|||
148915312|NCT00617669|537175179|FG000|Overall Study|Adverse Event|87|||
148915313|NCT00617669|537175180|FG001|Overall Study|Adverse Event|76|||
148915314|NCT00617669|537175179|FG000|Overall Study|Protocol Violation|2|||
148915315|NCT00617669|537175180|FG001|Overall Study|Protocol Violation|3|||
148915316|NCT00617669|537175179|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
148915317|NCT00617669|537175180|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
148915318|NCT00617669|537175179|FG000|Overall Study|Patients randomized but not treated|2|||
148915319|NCT00617669|537175180|FG001|Overall Study|Patients randomized but not treated|3|||
148915320|NCT03680742|537175181|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
148915321|NCT02894502|537175184|FG000|Baseline|Withdrawal by Subject|24|||
148915322|NCT02894502|537175185|FG001|Baseline|Withdrawal by Subject|31|||
148915323|NCT02894502|537175186|FG002|Baseline|Withdrawal by Subject|36|||
148915324|NCT02894502|537175184|FG000|Baseline|Death|3|||
148915325|NCT02894502|537175185|FG001|Baseline|Death|1|||
148915326|NCT02894502|537175186|FG002|Baseline|Death|9|||
148915327|NCT02894502|537175184|FG000|First Follow up|Withdrawal by Subject|32|||
148915328|NCT02894502|537175185|FG001|First Follow up|Withdrawal by Subject|29|||
148915329|NCT02894502|537175186|FG002|First Follow up|Withdrawal by Subject|37|||
148915330|NCT02894502|537175184|FG000|First Follow up|Death|2|||
148915331|NCT02894502|537175185|FG001|First Follow up|Death|2|||
148915332|NCT02894502|537175186|FG002|First Follow up|Death|3|||
148915333|NCT02894502|537175184|FG000|Second Follow up|Withdrawal by Subject|13|||
148915334|NCT02894502|537175185|FG001|Second Follow up|Withdrawal by Subject|15|||
148915335|NCT02894502|537175186|FG002|Second Follow up|Withdrawal by Subject|13|||
148915336|NCT02894502|537175184|FG000|Second Follow up|Death|2|||
148915337|NCT02894502|537175185|FG001|Second Follow up|Death|3|||
148915338|NCT02894502|537175186|FG002|Second Follow up|Death|1|||
148915339|NCT02894502|537175184|FG000|Third Follow up|Withdrawal by Subject|5|||
148915340|NCT02894502|537175185|FG001|Third Follow up|Withdrawal by Subject|6|||
148915341|NCT02894502|537175186|FG002|Third Follow up|Withdrawal by Subject|3|||
148915342|NCT02894502|537175184|FG000|Third Follow up|Death|1|||
148915343|NCT02894502|537175185|FG001|Third Follow up|Death|1|||
148915344|NCT02894502|537175186|FG002|Third Follow up|Death|0|||
148915345|NCT01410357|537175187|FG000|Overall Study|Death|2|||
148915346|NCT01410357|537175188|FG001|Overall Study|Death|1|||
148915347|NCT01410357|537175187|FG000|Overall Study|Withdrawal by Subject|1|||
148915348|NCT01410357|537175188|FG001|Overall Study|Withdrawal by Subject|2|||
148915349|NCT01410357|537175187|FG000|Overall Study|Lost to Follow-up|23|||
148915350|NCT01410357|537175188|FG001|Overall Study|Lost to Follow-up|21|||
148915351|NCT00615901|537175189|FG000|Overall Study|Withdrawal by Subject|2|||
148915352|NCT00615901|537175189|FG000|Overall Study|Adverse Event|7|||
148915353|NCT03467152|537175196|FG000|Overall Study|Adverse Event|4|||
148915354|NCT03467152|537175197|FG001|Overall Study|Adverse Event|5|||
148915355|NCT03467152|537175198|FG002|Overall Study|Adverse Event|0|||
148915356|NCT03467152|537175196|FG000|Overall Study|Subject Choice|1|||
148915357|NCT03467152|537175197|FG001|Overall Study|Subject Choice|3|||
148915358|NCT03467152|537175198|FG002|Overall Study|Subject Choice|0|||
148915359|NCT03467152|537175196|FG000|Overall Study|Lost to Follow-up|1|||
148915360|NCT03467152|537175197|FG001|Overall Study|Lost to Follow-up|0|||
148915361|NCT03467152|537175198|FG002|Overall Study|Lost to Follow-up|0|||
148915362|NCT03467152|537175196|FG000|Overall Study|Withdrawal by Subject|4|||
148915363|NCT03467152|537175197|FG001|Overall Study|Withdrawal by Subject|2|||
148915364|NCT03467152|537175198|FG002|Overall Study|Withdrawal by Subject|0|||
148915365|NCT03467152|537175196|FG000|Overall Study|Others|3|||
148915366|NCT03467152|537175197|FG001|Overall Study|Others|0|||
148915367|NCT03467152|537175198|FG002|Overall Study|Others|0|||
148915368|NCT03467152|537175196|FG000|Overall Study|Not treated|3|||
148915369|NCT03467152|537175197|FG001|Overall Study|Not treated|1|||
148915370|NCT03467152|537175198|FG002|Overall Study|Not treated|6|||
148915371|NCT00945906|537175200|FG000|Overall Study|Withdrawal by Subject|1|||
148915372|NCT00945906|537175200|FG000|Overall Study|Did not want to return for last visit|2|||
148915373|NCT00945906|537175200|FG000|Overall Study|Unable to return for last visit|2|||
148915374|NCT00945906|537175200|FG000|Overall Study|Moved to another country|2|||
148915375|NCT00796445|537175203|FG000|Overall Study|Protocol Violation|5|||
148915376|NCT00796445|537175204|FG001|Overall Study|Protocol Violation|3|||
148915377|NCT00796445|537175203|FG000|Overall Study|Adverse event, serious fatal|10|||
148915378|NCT00796445|537175204|FG001|Overall Study|Adverse event, serious fatal|5|||
148915379|NCT00796445|537175203|FG000|Overall Study|Adverse event, non-fatal|4|||
148915380|NCT00796445|537175204|FG001|Overall Study|Adverse event, non-fatal|0|||
148915381|NCT00796445|537175203|FG000|Overall Study|Disease progression/recurrence|537|||
148915382|NCT00796445|537175204|FG001|Overall Study|Disease progression/recurrence|268|||
148915383|NCT00796445|537175203|FG000|Overall Study|Other|10|||
148915384|NCT00796445|537175204|FG001|Overall Study|Other|7|||
148915385|NCT00796445|537175203|FG000|Overall Study|Withdrawal by Subject|18|||
148915386|NCT00796445|537175204|FG001|Overall Study|Withdrawal by Subject|9|||
148915387|NCT00796445|537175203|FG000|Overall Study|Invalid Informed Consent Form|1|||
148915388|NCT00796445|537175204|FG001|Overall Study|Invalid Informed Consent Form|0|||
148915389|NCT00388583|537175205|FG000|Overall Study|Protocol Violation|1|||
148915390|NCT00388583|537175206|FG001|Overall Study|Protocol Violation|0|||
148915391|NCT00388583|537175205|FG000|Overall Study|Withdrawal by Subject|3|||
148915392|NCT00388583|537175206|FG001|Overall Study|Withdrawal by Subject|3|||
148915393|NCT00388583|537175205|FG000|Overall Study|Serious Adverse Event|2|||
148915394|NCT00388583|537175206|FG001|Overall Study|Serious Adverse Event|0|||
148915395|NCT00388583|537175205|FG000|Overall Study|Did not receive vaccine|0|||
148915396|NCT00388583|537175206|FG001|Overall Study|Did not receive vaccine|1|||
148915397|NCT05194579|537175209|FG000|Overall Study|Lost to Follow-up|2|||
148915398|NCT05194579|537175210|FG001|Overall Study|Lost to Follow-up|3|||
148915399|NCT05194579|537175209|FG000|Overall Study|Withdrawal by Subject|3|||
148915400|NCT05194579|537175210|FG001|Overall Study|Withdrawal by Subject|4|||
148915401|NCT05194579|537175209|FG000|Overall Study|Refused further study procedures|0|||
148915402|NCT05194579|537175210|FG001|Overall Study|Refused further study procedures|1|||
148915403|NCT05194579|537175209|FG000|Overall Study|Protocol deviation|1|||
148915404|NCT05194579|537175210|FG001|Overall Study|Protocol deviation|0|||
148915405|NCT03595228|537175215|FG000|Overall Study|Death|2|||
148915406|NCT03595228|537175215|FG000|Overall Study|Lack of Efficacy|13|||
148915407|NCT03595228|537175215|FG000|Overall Study|Withdrawal by Subject|3|||
148915408|NCT03595228|537175215|FG000|Overall Study|Withdrawal by Sponsor|1|||
148915409|NCT03232333|537175216|FG000|Overall Study|Infection or Osteomyelitis|9|||
148915410|NCT03232333|537175216|FG000|Overall Study|Lost to Follow-up|4|||
148915411|NCT03232333|537175216|FG000|Overall Study|Withdrawal by Subject|2|||
148915412|NCT01253811|537175217|FG000|Overall Study|Withdrawal criteria|1|||
148915413|NCT01087736|537175218|FG000|Overall Study|Lost to Follow-up|1|||
148915414|NCT01087736|537175219|FG001|Overall Study|Lost to Follow-up|0|||
148915415|NCT01087736|537175218|FG000|Overall Study|Death|0|||
148915416|NCT01087736|537175219|FG001|Overall Study|Death|1|||
148915417|NCT01087736|537175218|FG000|Overall Study|Withdrawal by Subject|0|||
148915418|NCT01087736|537175219|FG001|Overall Study|Withdrawal by Subject|1|||
148915419|NCT00435045|537175221|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
148671934|NCT02062385|536268890|FG001|Overall Study|Withdrawn by parent/guardian|41|||
148671935|NCT02062385|536268891|FG002|Overall Study|Withdrawn by parent/guardian|9|||
148671936|NCT02062385|536268892|FG003|Overall Study|Withdrawn by parent/guardian|8|||
148671937|NCT02062385|536268889|FG000|Overall Study|Death|0|||
148671938|NCT02062385|536268890|FG001|Overall Study|Death|0|||
148671939|NCT02062385|536268891|FG002|Overall Study|Death|0|||
148671940|NCT02062385|536268892|FG003|Overall Study|Death|1|||
148671941|NCT02062385|536268889|FG000|Overall Study|Lost to Follow-up|0|||
148671942|NCT02062385|536268890|FG001|Overall Study|Lost to Follow-up|0|||
148671943|NCT02062385|536268891|FG002|Overall Study|Lost to Follow-up|1|||
148671944|NCT02062385|536268892|FG003|Overall Study|Lost to Follow-up|0|||
148671945|NCT03222856|536268895|FG000|Overall Study|Adverse Event|6|||
148671946|NCT03222856|536268895|FG000|Overall Study|Death|1|||
148671947|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
148671948|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
148671949|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
148671950|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
148671951|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
148671952|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
148671953|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
148671954|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
148671955|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
148671956|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
148671957|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
148671958|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
148671959|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
148671960|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
148671961|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
148671962|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
148671963|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
148671964|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
148671965|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
148671966|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
148671967|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
148671968|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
148671969|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
148671970|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
148671971|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
148671972|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
148671973|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
148671974|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
148671975|NCT01299272|536270671|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
148671976|NCT01299272|536270672|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
148671977|NCT01299272|536270673|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
148671978|NCT01299272|536270674|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
148671979|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
148671980|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
148671981|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
148671982|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
148671983|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
148671984|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
148671985|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
148671986|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
148671987|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
148671988|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
148671989|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
148671990|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
148671991|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
148671992|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
148671993|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
148671994|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
148671995|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
148671996|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
148671997|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
148671998|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
148671999|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
148672000|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
148672001|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
148672002|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
148672003|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
148672004|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
148672005|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
148672006|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
148672007|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
148672008|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
148672009|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
148672010|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
148672011|NCT01299272|536270671|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
148672012|NCT01299272|536270672|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
148672013|NCT01299272|536270673|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
148672014|NCT01299272|536270674|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
148672015|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
148672016|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
148672017|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
148672018|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
148672019|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
148672020|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
148672021|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
148672022|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
148805326|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148805327|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148805328|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148805329|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148805330|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
148805331|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
148805332|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
148805333|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805334|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805335|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805336|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805337|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805338|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805339|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805340|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
148805341|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
148805342|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
148805343|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805344|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805345|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805346|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805347|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805348|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805349|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805350|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805351|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
148805352|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
148805353|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805354|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805355|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805356|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805357|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805358|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805359|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805360|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805361|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
148805362|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
148805363|NCT01232283|536766673|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805364|NCT01232283|536766674|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805365|NCT01232283|536766675|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805366|NCT01232283|536766676|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805367|NCT01232283|536766677|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805368|NCT01232283|536766678|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148915420|NCT00435045|537175222|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
148915421|NCT00435045|537175221|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
148915422|NCT00435045|537175222|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
148915423|NCT00435045|537175221|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
148915424|NCT00435045|537175222|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
148915425|NCT00435045|537175221|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
148915426|NCT00435045|537175222|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
148915427|NCT00435045|537175221|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
148915428|NCT00435045|537175222|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
148915429|NCT00435045|537175221|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
148915430|NCT00435045|537175222|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
148915431|NCT00435045|537175221|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
148915432|NCT00435045|537175222|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
148915433|NCT00435045|537175221|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
148915434|NCT00435045|537175222|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
148915435|NCT00435045|537175221|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
148915436|NCT00435045|537175222|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
148915437|NCT00435045|537175221|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
148915438|NCT00435045|537175222|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
148915439|NCT00435045|537175221|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
148915440|NCT00435045|537175222|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
148915441|NCT00567255|537175223|FG000|Overall Study|Adverse Event|241|||
148915442|NCT00567255|537175224|FG001|Overall Study|Adverse Event|68|||
148915443|NCT00567255|537175223|FG000|Overall Study|Lost to Follow-up|77|||
148915444|NCT00567255|537175224|FG001|Overall Study|Lost to Follow-up|48|||
148915445|NCT00567255|537175223|FG000|Overall Study|Withdrawal by Subject|75|||
148915446|NCT00567255|537175224|FG001|Overall Study|Withdrawal by Subject|56|||
148915447|NCT00567255|537175223|FG000|Overall Study|Lack of Efficacy|19|||
148915448|NCT00567255|537175224|FG001|Overall Study|Lack of Efficacy|33|||
148915449|NCT00567255|537175223|FG000|Overall Study|Protocol Violation|20|||
148915450|NCT00567255|537175224|FG001|Overall Study|Protocol Violation|8|||
148915451|NCT00567255|537175223|FG000|Overall Study|Pregnancy|6|||
148915452|NCT00567255|537175224|FG001|Overall Study|Pregnancy|0|||
148915453|NCT00567255|537175223|FG000|Overall Study|Drug noncompliance,moved,other|25|||
148915454|NCT00567255|537175224|FG001|Overall Study|Drug noncompliance,moved,other|15|||
148915455|NCT01743001|537175227|FG000|Overall Study|Physician Decision|1|||
148915456|NCT01743001|537175228|FG001|Overall Study|Physician Decision|0|||
148915457|NCT01743001|537175227|FG000|Overall Study|Pregnancy|1|||
148915458|NCT01743001|537175228|FG001|Overall Study|Pregnancy|0|||
148915459|NCT01743001|537175227|FG000|Overall Study|Death|1|||
148915460|NCT01743001|537175228|FG001|Overall Study|Death|0|||
148915461|NCT03052426|537175231|FG000|Overall Study|Withdrawal by Subject|0|||
148915462|NCT03052426|537175232|FG001|Overall Study|Withdrawal by Subject|1|||
148915463|NCT03052426|537175233|FG002|Overall Study|Withdrawal by Subject|0|||
148915464|NCT03052426|537175231|FG000|Overall Study|Lost to Follow-up|2|||
148915465|NCT03052426|537175232|FG001|Overall Study|Lost to Follow-up|0|||
148915466|NCT03052426|537175233|FG002|Overall Study|Lost to Follow-up|1|||
148915467|NCT03679754|537175237|FG000|Overall Study|Investigator request|1|||
148915468|NCT00964171|537175238|FG000|Overall Study|Death|5|||
148915469|NCT00080899|537175239|FG000|Overall Study|Adverse Event|1|||
148915470|NCT00776919|537175241|FG000|Overall Study|Withdrawal by Subject|16|||
148915471|NCT00776919|537175242|FG001|Overall Study|Withdrawal by Subject|14|||
148915472|NCT00776919|537175243|FG002|Overall Study|Withdrawal by Subject|15|||
148915473|NCT00776919|537175244|FG003|Overall Study|Withdrawal by Subject|26|||
148915474|NCT00776919|537175241|FG000|Overall Study|Lost to Follow-up|8|||
148915475|NCT00776919|537175242|FG001|Overall Study|Lost to Follow-up|12|||
148915476|NCT00776919|537175243|FG002|Overall Study|Lost to Follow-up|11|||
148915477|NCT00776919|537175244|FG003|Overall Study|Lost to Follow-up|8|||
148915478|NCT00776919|537175241|FG000|Overall Study|Adverse Event|1|||
148915479|NCT00776919|537175242|FG001|Overall Study|Adverse Event|0|||
148915480|NCT00776919|537175243|FG002|Overall Study|Adverse Event|2|||
148915481|NCT00776919|537175244|FG003|Overall Study|Adverse Event|2|||
148915482|NCT00776919|537175241|FG000|Overall Study|Protocol Violation|1|||
148915483|NCT00776919|537175242|FG001|Overall Study|Protocol Violation|2|||
148915484|NCT00776919|537175243|FG002|Overall Study|Protocol Violation|0|||
148915485|NCT00776919|537175244|FG003|Overall Study|Protocol Violation|1|||
148915486|NCT00776919|537175241|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
148915487|NCT00776919|537175242|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
148915488|NCT00776919|537175243|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
148915489|NCT00776919|537175244|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
148915490|NCT03116152|537175245|FG000|Overall Study|Disease Progression|49|||
148915491|NCT03116152|537175246|FG001|Overall Study|Disease Progression|47|||
148915492|NCT03116152|537175245|FG000|Overall Study|Death|5|||
148915493|NCT03116152|537175246|FG001|Overall Study|Death|2|||
148915494|NCT03116152|537175245|FG000|Overall Study|Adverse Event|21|||
148915495|NCT03116152|537175246|FG001|Overall Study|Adverse Event|7|||
148915496|NCT03116152|537175245|FG000|Overall Study|Protocol Violation|2|||
148915497|NCT03116152|537175246|FG001|Overall Study|Protocol Violation|2|||
148915498|NCT03116152|537175245|FG000|Overall Study|Withdrawal by Subject|0|||
148915499|NCT03116152|537175246|FG001|Overall Study|Withdrawal by Subject|1|||
148915500|NCT03116152|537175245|FG000|Overall Study|Physician Decision|3|||
148915501|NCT03116152|537175246|FG001|Overall Study|Physician Decision|2|||
148915502|NCT03116152|537175245|FG000|Overall Study|other|11|||
148915503|NCT03116152|537175246|FG001|Overall Study|other|34|||
148915504|NCT02636361|537175248|FG000|Period 4|Physician Decision|0|||
148915505|NCT02636361|537175249|FG001|Period 4|Physician Decision|0|||
148915506|NCT02636361|537175250|FG002|Period 4|Physician Decision|0|||
148915507|NCT02636361|537175251|FG003|Period 4|Physician Decision|1|||
148915508|NCT02636361|537175252|FG004|Period 4|Physician Decision|0|||
148915509|NCT02410343|537175258|FG000|Core Period (24 Weeks)|Adverse Event|1|||
148915510|NCT02410343|537175259|FG001|Core Period (24 Weeks)|Adverse Event|0|||
148915511|NCT02410343|537175258|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
148915512|NCT02410343|537175259|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
148915513|NCT02410343|537175258|FG000|Extension Period (12 Months)|Adverse Event|1|||
148915514|NCT02410343|537175259|FG001|Extension Period (12 Months)|Adverse Event|0|||
148915515|NCT02410343|537175258|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
148915516|NCT02410343|537175259|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
148915517|NCT02036853|537175260|FG000|Overall Study|Adverse Event|0|||
148915518|NCT02036853|537175261|FG001|Overall Study|Adverse Event|2|||
148915519|NCT02036853|537175260|FG000|Overall Study|Lack of Efficacy|0|||
148915520|NCT02036853|537175261|FG001|Overall Study|Lack of Efficacy|2|||
148915521|NCT02036853|537175260|FG000|Overall Study|Physician Decision|0|||
148915522|NCT02036853|537175261|FG001|Overall Study|Physician Decision|1|||
148915523|NCT02036853|537175260|FG000|Overall Study|Withdrawal by Subject|0|||
148915524|NCT02036853|537175261|FG001|Overall Study|Withdrawal by Subject|1|||
148915525|NCT00228553|537175264|FG000|Overall Study|Adverse Event|112|||
148915526|NCT00228553|537175264|FG000|Overall Study|Lack of Efficacy|34|||
148915527|NCT00228553|537175264|FG000|Overall Study|Lost to Follow-up|67|||
148915528|NCT00228553|537175264|FG000|Overall Study|Physician Decision|48|||
148915529|NCT00228553|537175264|FG000|Overall Study|Protocol Violation|6|||
148915530|NCT00228553|537175264|FG000|Overall Study|Withdrawal by Subject|115|||
148915531|NCT00228553|537175264|FG000|Overall Study|Pregnancy|2|||
148915532|NCT00228553|537175264|FG000|Overall Study|Miscellaneous|46|||
148915533|NCT04556383|537175265|FG000|PCP|Lack of Efficacy|28|||
148915534|NCT04556383|537175266|FG001|PCP|Lack of Efficacy|23|||
148915535|NCT04556383|537175267|FG002|PCP|Lack of Efficacy|23|||
148915536|NCT04556383|537175268|FG003|PCP|Lack of Efficacy|0|||
148915537|NCT04556383|537175265|FG000|PCP|Study terminated by sponsor|15|||
148915538|NCT04556383|537175266|FG001|PCP|Study terminated by sponsor|13|||
148915539|NCT04556383|537175267|FG002|PCP|Study terminated by sponsor|16|||
148915540|NCT04556383|537175268|FG003|PCP|Study terminated by sponsor|0|||
148915541|NCT04556383|537175265|FG000|PCP|Withdrawal by Subject|8|||
148915542|NCT04556383|537175266|FG001|PCP|Withdrawal by Subject|6|||
148915543|NCT04556383|537175267|FG002|PCP|Withdrawal by Subject|6|||
148915544|NCT04556383|537175268|FG003|PCP|Withdrawal by Subject|0|||
148915545|NCT04556383|537175265|FG000|PCP|Adverse Event|1|||
148915546|NCT04556383|537175266|FG001|PCP|Adverse Event|7|||
148915547|NCT04556383|537175267|FG002|PCP|Adverse Event|7|||
148915548|NCT04556383|537175268|FG003|PCP|Adverse Event|0|||
148915549|NCT04556383|537175265|FG000|PCP|Other, Not Specified|1|||
148915550|NCT04556383|537175266|FG001|PCP|Other, Not Specified|2|||
148915551|NCT04556383|537175267|FG002|PCP|Other, Not Specified|1|||
148915552|NCT04556383|537175268|FG003|PCP|Other, Not Specified|0|||
148915553|NCT04556383|537175265|FG000|PCP|Protocol Violation|1|||
148915554|NCT04556383|537175266|FG001|PCP|Protocol Violation|0|||
148915555|NCT04556383|537175267|FG002|PCP|Protocol Violation|1|||
148915556|NCT04556383|537175268|FG003|PCP|Protocol Violation|0|||
148915557|NCT04556383|537175265|FG000|PCP|Lost to Follow-up|1|||
148915558|NCT04556383|537175266|FG001|PCP|Lost to Follow-up|0|||
148915559|NCT04556383|537175267|FG002|PCP|Lost to Follow-up|0|||
148915560|NCT04556383|537175268|FG003|PCP|Lost to Follow-up|0|||
148915561|NCT04556383|537175265|FG000|PCP|Physician Decision|0|||
148915562|NCT04556383|537175266|FG001|PCP|Physician Decision|1|||
148915563|NCT04556383|537175267|FG002|PCP|Physician Decision|0|||
148915564|NCT04556383|537175268|FG003|PCP|Physician Decision|0|||
148915565|NCT04556383|537175265|FG000|PCP|Site terminated by sponsor|0|||
148915566|NCT04556383|537175266|FG001|PCP|Site terminated by sponsor|1|||
148915567|NCT04556383|537175267|FG002|PCP|Site terminated by sponsor|0|||
148915568|NCT04556383|537175268|FG003|PCP|Site terminated by sponsor|0|||
148915569|NCT04556383|537175265|FG000|OLE|Study terminated by sponsor|0|||
148915570|NCT04556383|537175266|FG001|OLE|Study terminated by sponsor|0|||
148915571|NCT04556383|537175267|FG002|OLE|Study terminated by sponsor|0|||
148915572|NCT04556383|537175268|FG003|OLE|Study terminated by sponsor|68|||
148915573|NCT04556383|537175265|FG000|OLE|Withdrawal by Subject|0|||
148915574|NCT04556383|537175266|FG001|OLE|Withdrawal by Subject|0|||
148915575|NCT04556383|537175267|FG002|OLE|Withdrawal by Subject|0|||
148915576|NCT04556383|537175268|FG003|OLE|Withdrawal by Subject|10|||
148915577|NCT04556383|537175265|FG000|OLE|Lack of Efficacy|0|||
148915578|NCT04556383|537175266|FG001|OLE|Lack of Efficacy|0|||
148915579|NCT04556383|537175267|FG002|OLE|Lack of Efficacy|0|||
148915580|NCT04556383|537175268|FG003|OLE|Lack of Efficacy|7|||
148915581|NCT04556383|537175265|FG000|OLE|Adverse Event|0|||
148915582|NCT04556383|537175266|FG001|OLE|Adverse Event|0|||
148915583|NCT04556383|537175267|FG002|OLE|Adverse Event|0|||
148915584|NCT04556383|537175268|FG003|OLE|Adverse Event|2|||
148915585|NCT04556383|537175265|FG000|OLE|Other, Not Specified|0|||
148915586|NCT04556383|537175266|FG001|OLE|Other, Not Specified|0|||
148915587|NCT04556383|537175267|FG002|OLE|Other, Not Specified|0|||
148915588|NCT04556383|537175268|FG003|OLE|Other, Not Specified|2|||
148915589|NCT04556383|537175265|FG000|OLE|Death|0|||
148915590|NCT04556383|537175266|FG001|OLE|Death|0|||
148915591|NCT04556383|537175267|FG002|OLE|Death|0|||
148915592|NCT04556383|537175268|FG003|OLE|Death|1|||
148915593|NCT04556383|537175265|FG000|OLE|Lost to Follow-up|0|||
148915594|NCT04556383|537175266|FG001|OLE|Lost to Follow-up|0|||
148915595|NCT04556383|537175267|FG002|OLE|Lost to Follow-up|0|||
148915596|NCT04556383|537175268|FG003|OLE|Lost to Follow-up|1|||
148915597|NCT00884741|537175276|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
148915598|NCT00884741|537175277|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
148915599|NCT00884741|537175278|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
148915600|NCT00884741|537175279|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
148915601|NCT00884741|537175276|FG000|Step 1 Registration: Tissue Screening|Death|3|||
148915602|NCT00884741|537175277|FG001|Step 1 Registration: Tissue Screening|Death|0|||
148915603|NCT00884741|537175278|FG002|Step 1 Registration: Tissue Screening|Death|0|||
148915604|NCT00884741|537175279|FG003|Step 1 Registration: Tissue Screening|Death|0|||
148915605|NCT00884741|537175276|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
148915606|NCT00884741|537175277|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
148915607|NCT00884741|537175278|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
148915608|NCT00884741|537175279|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
148915609|NCT00884741|537175276|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
148915610|NCT00884741|537175277|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
148915611|NCT00884741|537175278|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
148915612|NCT00884741|537175279|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
148915613|NCT00884741|537175276|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
148915614|NCT00884741|537175277|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
148915615|NCT00884741|537175278|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
148915616|NCT00884741|537175279|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
148915617|NCT00884741|537175276|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
148915618|NCT00884741|537175277|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
148915619|NCT00884741|537175278|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
148915620|NCT00884741|537175279|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
148915621|NCT00884741|537175276|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
148915622|NCT00884741|537175277|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
148915623|NCT00884741|537175278|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
148915624|NCT00884741|537175279|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
148915625|NCT00884741|537175276|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
148915626|NCT00884741|537175277|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
148915627|NCT00884741|537175278|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
148915628|NCT00884741|537175279|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
148915629|NCT00884741|537175276|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
148915630|NCT00884741|537175277|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
148915631|NCT00884741|537175278|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
148915632|NCT00884741|537175279|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
148915633|NCT00884741|537175276|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
149149105|NCT01594853|538026292|FG001|Overall Study|noncompliance with exercise|1|||
149149106|NCT02631200|538026295|FG000|First Period|Death|1|||
149149107|NCT02631200|538026296|FG001|First Period|Death|2|||
148915634|NCT00884741|537175277|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
148915635|NCT00884741|537175278|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
148915636|NCT00884741|537175279|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
148915637|NCT00884741|537175276|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
148915638|NCT00884741|537175277|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
148915639|NCT00884741|537175278|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
148915640|NCT00884741|537175279|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
148915641|NCT00884741|537175276|FG000|Randomization|Protocol Violation|0|||
148915642|NCT00884741|537175277|FG001|Randomization|Protocol Violation|0|||
148915643|NCT00884741|537175278|FG002|Randomization|Protocol Violation|8|||
148915644|NCT00884741|537175279|FG003|Randomization|Protocol Violation|8|||
148915645|NCT04303195|537175282|FG000|Overall Study|Adverse Event|1|||
148915646|NCT04303195|537175283|FG001|Overall Study|Adverse Event|3|||
148915647|NCT04303195|537175284|FG002|Overall Study|Adverse Event|7|||
148915648|NCT04303195|537175285|FG003|Overall Study|Adverse Event|0|||
148672023|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
148672024|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
148672025|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
148672026|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
148672027|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
148672028|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
148915649|NCT04303195|537175282|FG000|Overall Study|Lost to Follow-up|1|||
148915650|NCT04303195|537175283|FG001|Overall Study|Lost to Follow-up|0|||
148915651|NCT04303195|537175284|FG002|Overall Study|Lost to Follow-up|1|||
148915652|NCT04303195|537175285|FG003|Overall Study|Lost to Follow-up|4|||
148915653|NCT04303195|537175282|FG000|Overall Study|Withdrawal by Subject|3|||
148915654|NCT04303195|537175283|FG001|Overall Study|Withdrawal by Subject|1|||
148915655|NCT04303195|537175284|FG002|Overall Study|Withdrawal by Subject|1|||
148915656|NCT04303195|537175285|FG003|Overall Study|Withdrawal by Subject|1|||
148915657|NCT04303195|537175282|FG000|Overall Study|No study drug administered or protocol deviation|0|||
148915658|NCT04303195|537175283|FG001|Overall Study|No study drug administered or protocol deviation|2|||
148915659|NCT04303195|537175284|FG002|Overall Study|No study drug administered or protocol deviation|0|||
148915660|NCT04303195|537175285|FG003|Overall Study|No study drug administered or protocol deviation|2|||
148915661|NCT02970942|537175286|FG000|Overall Study|Death|0|||
148915662|NCT02970942|537175287|FG001|Overall Study|Death|1|||
148915663|NCT02970942|537175288|FG002|Overall Study|Death|0|||
148915664|NCT02970942|537175289|FG003|Overall Study|Death|0|||
148915665|NCT02970942|537175286|FG000|Overall Study|Lost to Follow-up|1|||
148915666|NCT02970942|537175287|FG001|Overall Study|Lost to Follow-up|0|||
148915667|NCT02970942|537175288|FG002|Overall Study|Lost to Follow-up|2|||
148915668|NCT02970942|537175289|FG003|Overall Study|Lost to Follow-up|1|||
148915669|NCT02970942|537175286|FG000|Overall Study|Withdrawal by Subject|3|||
148672029|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
148672030|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
148672031|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
148672032|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
148672033|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
148672034|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
148672035|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
148672036|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
148672037|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
148672038|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
148672039|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
148672040|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
148672041|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
148672042|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
148672043|NCT01299272|536270671|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
148672044|NCT01299272|536270672|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
148672045|NCT01299272|536270673|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
148672046|NCT01299272|536270674|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
148672047|NCT03926728|536270675|FG000|Overall Study|Withdrawal by Subject|0|||
148672048|NCT03926728|536270676|FG001|Overall Study|Withdrawal by Subject|1|||
148672049|NCT03926728|536270677|FG002|Overall Study|Withdrawal by Subject|1|||
148672050|NCT03926728|536270678|FG003|Overall Study|Withdrawal by Subject|0|||
148672051|NCT03926728|536270679|FG004|Overall Study|Withdrawal by Subject|0|||
148915670|NCT02970942|537175287|FG001|Overall Study|Withdrawal by Subject|5|||
148915671|NCT02970942|537175288|FG002|Overall Study|Withdrawal by Subject|3|||
148915672|NCT02970942|537175289|FG003|Overall Study|Withdrawal by Subject|2|||
148915673|NCT05688670|537175290|FG000|Overall Study|Change in surgery plan|1|||
148672052|NCT03926728|536270680|FG005|Overall Study|Withdrawal by Subject|1|||
148672053|NCT03926728|536270681|FG006|Overall Study|Withdrawal by Subject|1|||
148672054|NCT03926728|536270682|FG007|Overall Study|Withdrawal by Subject|0|||
148915674|NCT05688670|537175291|FG001|Overall Study|Change in surgery plan|4|||
148915675|NCT05688670|537175290|FG000|Overall Study|Inability to extubate|1|||
148915676|NCT05688670|537175291|FG001|Overall Study|Inability to extubate|2|||
148915677|NCT05688670|537175290|FG000|Overall Study|Day of surgery cancellation|0|||
148915678|NCT05688670|537175291|FG001|Overall Study|Day of surgery cancellation|1|||
148672055|NCT03926728|536270683|FG008|Overall Study|Withdrawal by Subject|0|||
148672056|NCT03926728|536270684|FG009|Overall Study|Withdrawal by Subject|1|||
148672057|NCT03926728|536270685|FG010|Overall Study|Withdrawal by Subject|0|||
148915679|NCT05688670|537175290|FG000|Overall Study|Reintubated on PCICU arrival|0|||
149149108|NCT02631200|538026295|FG000|First Period|Patient ill-health|2|||
148672058|NCT03926728|536270686|FG011|Overall Study|Withdrawal by Subject|0|||
148672059|NCT03669640|536270687|FG000|Overall Study|Study Terminated by Sponsor|0|||
148672060|NCT03669640|536270688|FG001|Overall Study|Study Terminated by Sponsor|0|||
148672061|NCT03669640|536270689|FG002|Overall Study|Study Terminated by Sponsor|0|||
148672062|NCT03669640|536270690|FG003|Overall Study|Study Terminated by Sponsor|0|||
148672063|NCT03669640|536270691|FG004|Overall Study|Study Terminated by Sponsor|1|||
148672064|NCT03669640|536270692|FG005|Overall Study|Study Terminated by Sponsor|0|||
148672065|NCT03669640|536270687|FG000|Overall Study|Lost to Follow-up|0|||
148672066|NCT03669640|536270688|FG001|Overall Study|Lost to Follow-up|0|||
148672067|NCT03669640|536270689|FG002|Overall Study|Lost to Follow-up|2|||
148672068|NCT03669640|536270690|FG003|Overall Study|Lost to Follow-up|0|||
148672069|NCT03669640|536270691|FG004|Overall Study|Lost to Follow-up|0|||
148672070|NCT03669640|536270692|FG005|Overall Study|Lost to Follow-up|0|||
148672071|NCT03669640|536270687|FG000|Overall Study|Death|0|||
148672072|NCT03669640|536270688|FG001|Overall Study|Death|0|||
148672073|NCT03669640|536270689|FG002|Overall Study|Death|1|||
148672074|NCT03669640|536270690|FG003|Overall Study|Death|0|||
148672075|NCT03669640|536270691|FG004|Overall Study|Death|0|||
148672076|NCT03669640|536270692|FG005|Overall Study|Death|0|||
148672077|NCT03669640|536270687|FG000|Overall Study|Withdrawal by Subject|1|||
148672078|NCT03669640|536270688|FG001|Overall Study|Withdrawal by Subject|2|||
148672079|NCT03669640|536270689|FG002|Overall Study|Withdrawal by Subject|1|||
148672080|NCT03669640|536270690|FG003|Overall Study|Withdrawal by Subject|0|||
148672081|NCT03669640|536270691|FG004|Overall Study|Withdrawal by Subject|1|||
148672082|NCT03669640|536270692|FG005|Overall Study|Withdrawal by Subject|3|||
148672083|NCT03669640|536270687|FG000|Overall Study|Protocol Violation|1|||
148672084|NCT03669640|536270688|FG001|Overall Study|Protocol Violation|0|||
148672085|NCT03669640|536270689|FG002|Overall Study|Protocol Violation|0|||
148672086|NCT03669640|536270690|FG003|Overall Study|Protocol Violation|0|||
148672087|NCT03669640|536270691|FG004|Overall Study|Protocol Violation|0|||
148672088|NCT03669640|536270692|FG005|Overall Study|Protocol Violation|0|||
148672089|NCT03669640|536270687|FG000|Overall Study|Physician Decision|0|||
148672090|NCT03669640|536270688|FG001|Overall Study|Physician Decision|2|||
148672091|NCT03669640|536270689|FG002|Overall Study|Physician Decision|0|||
148672092|NCT03669640|536270690|FG003|Overall Study|Physician Decision|0|||
148672093|NCT03669640|536270691|FG004|Overall Study|Physician Decision|0|||
148672094|NCT03669640|536270692|FG005|Overall Study|Physician Decision|0|||
148672095|NCT03669640|536270687|FG000|Overall Study|Disease Relapse|1|||
148915680|NCT05688670|537175291|FG001|Overall Study|Reintubated on PCICU arrival|1|||
148915681|NCT03700684|537177151|FG000|Overall Study|COVID-19|0|||
148915682|NCT03700684|537177152|FG001|Overall Study|COVID-19|0|||
148915683|NCT03700684|537177153|FG002|Overall Study|COVID-19|2|||
148915684|NCT01120782|537177154|FG000|Overall Study|Test article shipping error|11|||
148915685|NCT04140227|537177155|FG000|Overall Study|Withdrawal by Subject|26|||
149149109|NCT02631200|538026296|FG001|First Period|Patient ill-health|4|||
149149110|NCT02631200|538026295|FG000|First Period|Withdrawal by Subject|4|||
148672096|NCT03669640|536270688|FG001|Overall Study|Disease Relapse|0|||
148672097|NCT03669640|536270689|FG002|Overall Study|Disease Relapse|0|||
148672098|NCT03669640|536270690|FG003|Overall Study|Disease Relapse|0|||
148672099|NCT03669640|536270691|FG004|Overall Study|Disease Relapse|0|||
148672100|NCT03669640|536270692|FG005|Overall Study|Disease Relapse|0|||
148672101|NCT03669640|536270687|FG000|Overall Study|Adverse Event|2|||
148672102|NCT03669640|536270688|FG001|Overall Study|Adverse Event|1|||
148672103|NCT03669640|536270689|FG002|Overall Study|Adverse Event|0|||
148672104|NCT03669640|536270690|FG003|Overall Study|Adverse Event|0|||
148672105|NCT03669640|536270691|FG004|Overall Study|Adverse Event|1|||
148915686|NCT04140227|537177155|FG000|Overall Study|Lost to Follow-up|8|||
148915687|NCT04140227|537177155|FG000|Overall Study|Adverse Event|8|||
148915688|NCT04140227|537177155|FG000|Overall Study|Death|1|||
148915689|NCT04140227|537177155|FG000|Overall Study|Other|3|||
149149111|NCT02631200|538026296|FG001|First Period|Withdrawal by Subject|1|||
148672106|NCT03669640|536270692|FG005|Overall Study|Adverse Event|0|||
148672107|NCT03993288|536270693|FG000|Overall Study|Lost to Follow-up|2|||
148672108|NCT03993288|536270694|FG001|Overall Study|Lost to Follow-up|1|||
149149112|NCT02631200|538026295|FG000|Deferred Period|Death|0|||
149149113|NCT02631200|538026296|FG001|Deferred Period|Death|1|||
148672109|NCT03993288|536270693|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
148672110|NCT03993288|536270694|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
148672111|NCT03993288|536270693|FG000|Overall Study|wrong randomization|0|||
148672112|NCT03993288|536270694|FG001|Overall Study|wrong randomization|1|||
148672113|NCT03993288|536270693|FG000|Overall Study|improper enrollment|0|||
148672114|NCT03993288|536270694|FG001|Overall Study|improper enrollment|1|||
148672115|NCT03993288|536270693|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
148672116|NCT03993288|536270694|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
148672117|NCT03993288|536270693|FG000|Overall Study|developed SAE|2|||
148672118|NCT03993288|536270694|FG001|Overall Study|developed SAE|0|||
148672119|NCT03993288|536270693|FG000|Overall Study|consent withdrawal|1|||
148915690|NCT04140227|537177155|FG000|Overall Study|Protocol Violation|2|||
148915691|NCT00635219|537177156|FG000|Overall Study|Adverse Event|12|||
148915692|NCT00635219|537177157|FG001|Overall Study|Adverse Event|10|||
148915693|NCT00635219|537177158|FG002|Overall Study|Adverse Event|18|||
148915694|NCT00635219|537177159|FG003|Overall Study|Adverse Event|15|||
148915695|NCT00635219|537177160|FG004|Overall Study|Adverse Event|19|||
148915696|NCT00635219|537177156|FG000|Overall Study|Lack of Efficacy|5|||
148915697|NCT00635219|537177157|FG001|Overall Study|Lack of Efficacy|6|||
148915698|NCT00635219|537177158|FG002|Overall Study|Lack of Efficacy|3|||
148915699|NCT00635219|537177159|FG003|Overall Study|Lack of Efficacy|4|||
148915700|NCT00635219|537177160|FG004|Overall Study|Lack of Efficacy|6|||
148915701|NCT00635219|537177156|FG000|Overall Study|Non-compliance With Study Product|0|||
148915702|NCT00635219|537177157|FG001|Overall Study|Non-compliance With Study Product|0|||
148915703|NCT00635219|537177158|FG002|Overall Study|Non-compliance With Study Product|0|||
148915704|NCT00635219|537177159|FG003|Overall Study|Non-compliance With Study Product|2|||
149149114|NCT02631200|538026295|FG000|Deferred Period|Received kidney transplant|0|||
149149115|NCT02631200|538026296|FG001|Deferred Period|Received kidney transplant|1|||
149149116|NCT02631200|538026295|FG000|Deferred Period|Withdrawal by Subject|0|||
149149117|NCT02631200|538026296|FG001|Deferred Period|Withdrawal by Subject|2|||
148915705|NCT00635219|537177160|FG004|Overall Study|Non-compliance With Study Product|1|||
148915706|NCT00635219|537177156|FG000|Overall Study|Protocol Violation|0|||
148915707|NCT00635219|537177157|FG001|Overall Study|Protocol Violation|2|||
148915708|NCT00635219|537177158|FG002|Overall Study|Protocol Violation|3|||
148915709|NCT00635219|537177159|FG003|Overall Study|Protocol Violation|2|||
148915710|NCT00635219|537177160|FG004|Overall Study|Protocol Violation|4|||
148915711|NCT00635219|537177156|FG000|Overall Study|Withdrawal of Consent|8|||
148915712|NCT00635219|537177157|FG001|Overall Study|Withdrawal of Consent|6|||
148915713|NCT00635219|537177158|FG002|Overall Study|Withdrawal of Consent|8|||
148915714|NCT00635219|537177159|FG003|Overall Study|Withdrawal of Consent|11|||
148915715|NCT00635219|537177160|FG004|Overall Study|Withdrawal of Consent|8|||
148915716|NCT00635219|537177156|FG000|Overall Study|Lost to Follow-up|0|||
148915717|NCT00635219|537177157|FG001|Overall Study|Lost to Follow-up|0|||
148915718|NCT00635219|537177158|FG002|Overall Study|Lost to Follow-up|2|||
148915719|NCT00635219|537177159|FG003|Overall Study|Lost to Follow-up|0|||
148915720|NCT00635219|537177160|FG004|Overall Study|Lost to Follow-up|3|||
148915721|NCT00635219|537177156|FG000|Overall Study|Administrative or Other Reasons|0|||
148915722|NCT00635219|537177157|FG001|Overall Study|Administrative or Other Reasons|1|||
148915723|NCT00635219|537177158|FG002|Overall Study|Administrative or Other Reasons|1|||
148915724|NCT00635219|537177159|FG003|Overall Study|Administrative or Other Reasons|0|||
148915725|NCT00635219|537177160|FG004|Overall Study|Administrative or Other Reasons|1|||
148915726|NCT01639729|537177161|FG000|Overall Study|Withdrawal by Subject|1|||
148915727|NCT01639729|537177162|FG001|Overall Study|Withdrawal by Subject|0|||
148915728|NCT01639729|537177163|FG002|Overall Study|Withdrawal by Subject|1|||
148915729|NCT01639729|537177164|FG003|Overall Study|Withdrawal by Subject|1|||
148915730|NCT01639729|537177165|FG004|Overall Study|Withdrawal by Subject|0|||
148915731|NCT01639729|537177166|FG005|Overall Study|Withdrawal by Subject|0|||
148915732|NCT00759564|537177167|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
148915733|NCT00759564|537177168|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
148915734|NCT00759564|537177169|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
148915735|NCT00759564|537177170|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
148915736|NCT00759564|537177171|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
148915737|NCT01565343|537177174|FG000|Overall Study|Administrative decision/technical issues|1|||
148915738|NCT01565343|537177175|FG001|Overall Study|Administrative decision/technical issues|0|||
148915739|NCT01565343|537177176|FG002|Overall Study|Administrative decision/technical issues|0|||
148915740|NCT01853839|537177182|FG000|Overall Study|Violated inclusion criteria|2|||
148915741|NCT01853839|537177182|FG000|Overall Study|Not meet ITT population definition|58|||
148915742|NCT01853839|537177182|FG000|Overall Study|End of treatment visit too early|33|||
148915743|NCT01853839|537177182|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
148915744|NCT04145219|537177183|FG000|Overall Study|Adverse Event|18|||
148915745|NCT04145219|537177184|FG001|Overall Study|Adverse Event|6|||
148915746|NCT04145219|537177183|FG000|Overall Study|Lost to Follow-up|2|||
148915747|NCT04145219|537177184|FG001|Overall Study|Lost to Follow-up|3|||
148915748|NCT04145219|537177183|FG000|Overall Study|Physician Decision|0|||
149149118|NCT02631200|538026295|FG000|Deferred Period|Lost to Follow-up|0|||
148915749|NCT04145219|537177184|FG001|Overall Study|Physician Decision|2|||
148915750|NCT04145219|537177183|FG000|Overall Study|Withdrawal by Subject|12|||
148915751|NCT04145219|537177184|FG001|Overall Study|Withdrawal by Subject|8|||
148915752|NCT04145219|537177183|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
148915753|NCT04145219|537177184|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
148915754|NCT01640314|537177185|FG000|Overall Study|Protocol Violation|0|||
148915755|NCT01640314|537177186|FG001|Overall Study|Protocol Violation|1|||
149149119|NCT02631200|538026296|FG001|Deferred Period|Lost to Follow-up|1|||
149149120|NCT01877187|538026297|FG000|Overall Study|Death|2|||
148915756|NCT03672097|537177187|FG000|Period 1|Withdrawal by Subject|2|||
148915757|NCT03672097|537177187|FG000|Period 1|Adverse Event|1|||
148915758|NCT03672097|537177187|FG000|Period 1|Did not receive treatment|1|||
148915759|NCT03672097|537177187|FG000|Period 2|Withdrawal by Subject|3|||
148915760|NCT03672097|537177187|FG000|Period 2|Other|1|||
148915761|NCT01290796|537177188|FG000|Overall Study|Lost to Follow-up|21|||
148915762|NCT01290796|537177188|FG000|Overall Study|Withdrawal by Subject|4|||
148915763|NCT01290796|537177188|FG000|Overall Study|Physician Decision|2|||
148915764|NCT01290796|537177188|FG000|Overall Study|Secondary Surgical Intervention|2|||
148915765|NCT01290796|537177188|FG000|Overall Study|Withdrawal by Sponsor|1|||
148915766|NCT02709538|537177190|FG000|Overall Study|Adverse Event|13|||
148915767|NCT02709538|537177191|FG001|Overall Study|Adverse Event|2|||
148915768|NCT02709538|537177192|FG002|Overall Study|Adverse Event|3|||
148915769|NCT02709538|537177190|FG000|Overall Study|Lack of Efficacy|1|||
148915770|NCT02709538|537177191|FG001|Overall Study|Lack of Efficacy|0|||
148915771|NCT02709538|537177192|FG002|Overall Study|Lack of Efficacy|0|||
148915772|NCT02709538|537177190|FG000|Overall Study|Lost to Follow-up|24|||
148915773|NCT02709538|537177191|FG001|Overall Study|Lost to Follow-up|8|||
148915774|NCT02709538|537177192|FG002|Overall Study|Lost to Follow-up|4|||
148915775|NCT02709538|537177190|FG000|Overall Study|Physician Decision|1|||
148915776|NCT02709538|537177191|FG001|Overall Study|Physician Decision|0|||
148915777|NCT02709538|537177192|FG002|Overall Study|Physician Decision|0|||
148915778|NCT02709538|537177190|FG000|Overall Study|Withdrawal by Subject|40|||
148915779|NCT02709538|537177191|FG001|Overall Study|Withdrawal by Subject|7|||
148915780|NCT02709538|537177192|FG002|Overall Study|Withdrawal by Subject|4|||
148915781|NCT02709538|537177190|FG000|Overall Study|Non-compliance with study procedures|5|||
148915782|NCT02709538|537177191|FG001|Overall Study|Non-compliance with study procedures|0|||
148915783|NCT02709538|537177192|FG002|Overall Study|Non-compliance with study procedures|0|||
148915784|NCT02709538|537177190|FG000|Overall Study|Non-compliance with study drug|2|||
148915785|NCT02709538|537177191|FG001|Overall Study|Non-compliance with study drug|0|||
148915786|NCT02709538|537177192|FG002|Overall Study|Non-compliance with study drug|0|||
148915787|NCT02709538|537177190|FG000|Overall Study|Protocol deviation|10|||
148915788|NCT02709538|537177191|FG001|Overall Study|Protocol deviation|4|||
148915789|NCT02709538|537177192|FG002|Overall Study|Protocol deviation|4|||
148915790|NCT02709538|537177190|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
148915791|NCT02709538|537177191|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
148915792|NCT02709538|537177192|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
148915793|NCT02709538|537177190|FG000|Overall Study|Other|16|||
148915794|NCT02709538|537177191|FG001|Overall Study|Other|7|||
148915795|NCT02709538|537177192|FG002|Overall Study|Other|5|||
148915796|NCT00835211|537177194|FG000|First Intervention|Withdrawal by Subject|0|||
148915797|NCT00835211|537177195|FG001|First Intervention|Withdrawal by Subject|1|||
148915798|NCT00835211|537177194|FG000|Washout: 7 Days|Adverse Event|2|||
148915799|NCT00835211|537177195|FG001|Washout: 7 Days|Adverse Event|1|||
148915800|NCT00835211|537177194|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
148915801|NCT00835211|537177195|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
148915802|NCT03087617|537177196|FG000|Overall Study|Lost to Follow-up|32|||
148915803|NCT03087617|537177197|FG001|Overall Study|Lost to Follow-up|30|||
148915804|NCT03087617|537177198|FG002|Overall Study|Lost to Follow-up|30|||
148915805|NCT03087617|537177199|FG003|Overall Study|Lost to Follow-up|39|||
148915806|NCT02343549|537177201|FG000|Overall Study|Death|11|||
148915807|NCT02343549|537177201|FG000|Overall Study|Withdrawal by Subject|2|||
148915808|NCT02160041|537177203|FG000|Overall Study|Adverse Event|11|||
148915809|NCT02160041|537177203|FG000|Overall Study|Death|2|||
148915810|NCT02160041|537177203|FG000|Overall Study|disease progression|57|||
148915811|NCT02160041|537177203|FG000|Overall Study|Protocol Violation|1|||
148915812|NCT02160041|537177203|FG000|Overall Study|non-compliance with study|1|||
148915813|NCT02160041|537177203|FG000|Overall Study|Physician Decision|3|||
148915814|NCT02160041|537177203|FG000|Overall Study|Withdrawal by Subject|8|||
148915815|NCT02160041|537177203|FG000|Overall Study|study terminated by by sponsor|1|||
148915816|NCT01403948|537177204|FG000|Overall Study|Progressive disease|0|||
148915817|NCT01403948|537177205|FG001|Overall Study|Progressive disease|2|||
148915818|NCT01403948|537177206|FG002|Overall Study|Progressive disease|2|||
148915819|NCT01403948|537177207|FG003|Overall Study|Progressive disease|4|||
148915820|NCT01403948|537177208|FG004|Overall Study|Progressive disease|2|||
148915821|NCT01403948|537177209|FG005|Overall Study|Progressive disease|6|||
148915822|NCT01403948|537177210|FG006|Overall Study|Progressive disease|2|||
148915823|NCT01403948|537177211|FG007|Overall Study|Progressive disease|4|||
148915824|NCT01403948|537177212|FG008|Overall Study|Progressive disease|5|||
148672120|NCT03993288|536270694|FG001|Overall Study|consent withdrawal|0|||
148915825|NCT01403948|537177213|FG009|Overall Study|Progressive disease|5|||
148915826|NCT01403948|537177204|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
148915827|NCT01403948|537177205|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
148915828|NCT01403948|537177206|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
148915829|NCT01403948|537177207|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
148915830|NCT01403948|537177208|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
148915831|NCT01403948|537177209|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
148915832|NCT01403948|537177210|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
148915833|NCT01403948|537177211|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
148805369|NCT01232283|536766679|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805370|NCT01232283|536766680|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
148805371|NCT01232283|536766681|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
148805372|NCT01232283|536766682|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
148805373|NCT01652690|536766683|FG000|Overall Study|Withdrawal by Subject|16|||
148805374|NCT01652690|536766684|FG001|Overall Study|Withdrawal by Subject|4|||
148805375|NCT01652690|536766683|FG000|Overall Study|Other|8|||
148805376|NCT01652690|536766684|FG001|Overall Study|Other|9|||
148805377|NCT01652690|536766683|FG000|Overall Study|Lost to Follow-up|6|||
148805378|NCT01652690|536766684|FG001|Overall Study|Lost to Follow-up|6|||
148805379|NCT01652690|536766683|FG000|Overall Study|Death|5|||
148805380|NCT01652690|536766684|FG001|Overall Study|Death|2|||
148805381|NCT01884597|536766685|FG000|Overall Study|Adverse Event|0|||
148805382|NCT01884597|536766686|FG001|Overall Study|Adverse Event|0|||
148805383|NCT01884597|536766687|FG002|Overall Study|Adverse Event|1|||
148805384|NCT01884597|536766685|FG000|Overall Study|Lack of Efficacy|1|||
148805385|NCT01884597|536766686|FG001|Overall Study|Lack of Efficacy|0|||
148805386|NCT01884597|536766687|FG002|Overall Study|Lack of Efficacy|0|||
148805387|NCT01884597|536766685|FG000|Overall Study|Death|0|||
148805388|NCT01884597|536766686|FG001|Overall Study|Death|1|||
148805389|NCT01884597|536766687|FG002|Overall Study|Death|0|||
148805390|NCT02097823|536766688|FG000|Overall Study|Withdrawal by Subject|1|||
148805391|NCT02097823|536766689|FG001|Overall Study|Withdrawal by Subject|1|||
148805392|NCT01081626|536766690|FG000|Overall Study|Dosing error|1|||
148805393|NCT01081626|536766691|FG001|Overall Study|Dosing error|1|||
148805394|NCT01081626|536766690|FG000|Overall Study|Missing Estradiol|25|||
148805395|NCT01081626|536766691|FG001|Overall Study|Missing Estradiol|28|||
148805396|NCT01081626|536766690|FG000|Overall Study|Low antral follicle count|1|||
148805397|NCT01081626|536766691|FG001|Overall Study|Low antral follicle count|0|||
148805398|NCT01081626|536766690|FG000|Overall Study|Overstimulation|0|||
148805399|NCT01081626|536766691|FG001|Overall Study|Overstimulation|1|||
148805400|NCT01081626|536766690|FG000|Overall Study|Lost to Follow-up|0|||
148805401|NCT01081626|536766691|FG001|Overall Study|Lost to Follow-up|1|||
148805402|NCT01081626|536766690|FG000|Overall Study|Other|33|||
148805403|NCT01081626|536766691|FG001|Overall Study|Other|30|||
148805404|NCT05610605|536767958|FG000|6-month Assessment|Death|1|||
148805405|NCT05610605|536767959|FG001|6-month Assessment|Death|1|||
148805406|NCT05610605|536767958|FG000|6-month Assessment|Lost to Follow-up|20|||
148805407|NCT05610605|536767959|FG001|6-month Assessment|Lost to Follow-up|0|||
148805408|NCT05610605|536767958|FG000|6-month Assessment|Institutionalized|1|||
148805409|NCT05610605|536767959|FG001|6-month Assessment|Institutionalized|2|||
148805410|NCT05610605|536767958|FG000|12-month Assessment|Death|2|||
148805411|NCT05610605|536767959|FG001|12-month Assessment|Death|1|||
148805412|NCT05610605|536767958|FG000|12-month Assessment|Lost to Follow-up|1|||
148805413|NCT05610605|536767959|FG001|12-month Assessment|Lost to Follow-up|4|||
149149121|NCT01877187|538026297|FG000|Overall Study|Withdrawal by Subject|4|||
149149122|NCT01877187|538026297|FG000|Overall Study|Lost to Follow-up|3|||
148915834|NCT01403948|537177212|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
148915835|NCT01403948|537177213|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
148915836|NCT01403948|537177204|FG000|Overall Study|Lost to Follow-up|0|||
148915837|NCT01403948|537177205|FG001|Overall Study|Lost to Follow-up|0|||
148915838|NCT01403948|537177206|FG002|Overall Study|Lost to Follow-up|0|||
148915839|NCT01403948|537177207|FG003|Overall Study|Lost to Follow-up|0|||
148915840|NCT01403948|537177208|FG004|Overall Study|Lost to Follow-up|0|||
148915841|NCT01403948|537177209|FG005|Overall Study|Lost to Follow-up|0|||
148915842|NCT01403948|537177210|FG006|Overall Study|Lost to Follow-up|0|||
148915843|NCT01403948|537177211|FG007|Overall Study|Lost to Follow-up|0|||
148915844|NCT01403948|537177212|FG008|Overall Study|Lost to Follow-up|0|||
148915845|NCT01403948|537177213|FG009|Overall Study|Lost to Follow-up|1|||
148915846|NCT01403948|537177204|FG000|Overall Study|Refused cont. medication|0|||
148915847|NCT01403948|537177205|FG001|Overall Study|Refused cont. medication|0|||
148915848|NCT01403948|537177206|FG002|Overall Study|Refused cont. medication|0|||
148915849|NCT01403948|537177207|FG003|Overall Study|Refused cont. medication|0|||
148915850|NCT01403948|537177208|FG004|Overall Study|Refused cont. medication|1|||
148915851|NCT01403948|537177209|FG005|Overall Study|Refused cont. medication|0|||
148915852|NCT01403948|537177210|FG006|Overall Study|Refused cont. medication|0|||
148915853|NCT01403948|537177211|FG007|Overall Study|Refused cont. medication|0|||
148915854|NCT01403948|537177212|FG008|Overall Study|Refused cont. medication|0|||
148915855|NCT01403948|537177213|FG009|Overall Study|Refused cont. medication|1|||
148915856|NCT01403948|537177204|FG000|Overall Study|other than above|1|||
148915857|NCT01403948|537177205|FG001|Overall Study|other than above|2|||
148915858|NCT01403948|537177206|FG002|Overall Study|other than above|1|||
148915859|NCT01403948|537177207|FG003|Overall Study|other than above|0|||
148915860|NCT01403948|537177208|FG004|Overall Study|other than above|1|||
148915861|NCT01403948|537177209|FG005|Overall Study|other than above|1|||
148915862|NCT01403948|537177210|FG006|Overall Study|other than above|2|||
148915863|NCT01403948|537177211|FG007|Overall Study|other than above|0|||
148915864|NCT01403948|537177212|FG008|Overall Study|other than above|0|||
148915865|NCT01403948|537177213|FG009|Overall Study|other than above|0|||
148915866|NCT04450381|537177214|FG000|Overall Study|Protocol Violation|4|||
148915867|NCT04450381|537177214|FG000|Overall Study|Wrong device setting|2|||
148915868|NCT01090323|537177215|FG000|Overall Study|Adverse Event|12|||
148915869|NCT01090323|537177216|FG001|Overall Study|Adverse Event|2|||
148915870|NCT01090323|537177215|FG000|Overall Study|Abnormal Lab Values|3|||
148915871|NCT01090323|537177216|FG001|Overall Study|Abnormal Lab Values|1|||
148915872|NCT01090323|537177215|FG000|Overall Study|Abnormal Test Procedure Results|2|||
148915873|NCT01090323|537177216|FG001|Overall Study|Abnormal Test Procedure Results|0|||
148915874|NCT01090323|537177215|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
148915875|NCT01090323|537177216|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148915876|NCT01090323|537177215|FG000|Overall Study|Condition no longer requires drug|5|||
148915877|NCT01090323|537177216|FG001|Overall Study|Condition no longer requires drug|4|||
148915878|NCT01090323|537177215|FG000|Overall Study|Protocol Violation|2|||
148915879|NCT01090323|537177216|FG001|Overall Study|Protocol Violation|1|||
148915880|NCT01090323|537177215|FG000|Overall Study|Withdrew consent|33|||
148915881|NCT01090323|537177216|FG001|Overall Study|Withdrew consent|11|||
148915882|NCT01090323|537177215|FG000|Overall Study|Lost to Follow-up|11|||
148915883|NCT01090323|537177216|FG001|Overall Study|Lost to Follow-up|6|||
148915884|NCT01090323|537177215|FG000|Overall Study|Administrative problems|6|||
148915885|NCT01090323|537177216|FG001|Overall Study|Administrative problems|4|||
148915886|NCT01090323|537177215|FG000|Overall Study|Death|1|||
148915887|NCT01090323|537177216|FG001|Overall Study|Death|2|||
148915888|NCT01090323|537177215|FG000|Overall Study|Stopped end of core|7|||
148915889|NCT01090323|537177216|FG001|Overall Study|Stopped end of core|0|||
148915890|NCT01090323|537177215|FG000|Overall Study|Stopped end of extension 1#|3|||
148915891|NCT01090323|537177216|FG001|Overall Study|Stopped end of extension 1#|1|||
148915892|NCT05498701|537177217|FG000|Period 3|Adverse Event|1|||
148915893|NCT05498701|537177218|FG001|Period 3|Adverse Event|0|||
149149123|NCT01877187|538026297|FG000|Overall Study|Declining clinical status|11|||
149149124|NCT01877187|538026297|FG000|Overall Study|Liver transplant|2|||
148915894|NCT01864005|537177219|FG000|Overall Study|Protocol Violation|0|||
148915895|NCT01864005|537177220|FG001|Overall Study|Protocol Violation|1|||
148915896|NCT01864005|537177219|FG000|Overall Study|Withdrawal by Subject|0|||
148915897|NCT01864005|537177220|FG001|Overall Study|Withdrawal by Subject|1|||
148915898|NCT01864005|537177219|FG000|Overall Study|Incorrect enrolment|1|||
148915899|NCT01864005|537177220|FG001|Overall Study|Incorrect enrolment|0|||
148915900|NCT01864005|537177219|FG000|Overall Study|Disease need|1|||
148915901|NCT01864005|537177220|FG001|Overall Study|Disease need|1|||
148672121|NCT03993288|536270693|FG000|Overall Study|did not follow the treatment schedule|1|||
148672122|NCT03993288|536270694|FG001|Overall Study|did not follow the treatment schedule|0|||
148672123|NCT03993288|536270693|FG000|Overall Study|did not follow the treatment regimen|1|||
148672124|NCT03993288|536270694|FG001|Overall Study|did not follow the treatment regimen|0|||
148672125|NCT03993288|536270693|FG000|Overall Study|Adverse Event|1|||
148672126|NCT03993288|536270694|FG001|Overall Study|Adverse Event|0|||
148672127|NCT03993288|536270693|FG000|Overall Study|Withdrawal by Subject|1|||
148672128|NCT03993288|536270694|FG001|Overall Study|Withdrawal by Subject|1|||
148672129|NCT00366678|536270695|FG000|Infant Series|Withdrawal by Subject|8|||
148672130|NCT00366678|536270696|FG001|Infant Series|Withdrawal by Subject|6|||
148672131|NCT00366678|536270697|FG002|Infant Series|Withdrawal by Subject|0|||
148672132|NCT00366678|536270695|FG000|Infant Series|Protocol Violation|4|||
149149125|NCT00769002|538026299|FG000|Overall Study|Study was not completed, no data|9|||
149149126|NCT00769002|538026300|FG001|Overall Study|Study was not completed, no data|9|||
149149127|NCT03776175|538026303|FG000|Treatment Period (42 Days)|Adverse Event|0|||
149149128|NCT03776175|538026304|FG001|Treatment Period (42 Days)|Adverse Event|1|||
148672133|NCT00366678|536270696|FG001|Infant Series|Protocol Violation|3|||
148672134|NCT00366678|536270697|FG002|Infant Series|Protocol Violation|0|||
148672135|NCT00366678|536270695|FG000|Infant Series|Failed to return|1|||
148805414|NCT05610605|536767958|FG000|12-month Assessment|Institutionalized|2|||
148805415|NCT05610605|536767959|FG001|12-month Assessment|Institutionalized|1|||
148805416|NCT00042289|536767960|FG000|Overall Study|Lost to Follow-up|3|||
148805417|NCT00042289|536767961|FG001|Overall Study|Lost to Follow-up|0|||
148805418|NCT00042289|536767962|FG002|Overall Study|Lost to Follow-up|0|||
148805419|NCT00042289|536767963|FG003|Overall Study|Lost to Follow-up|1|||
148805420|NCT00042289|536767964|FG004|Overall Study|Lost to Follow-up|3|||
148805421|NCT00042289|536767965|FG005|Overall Study|Lost to Follow-up|3|||
148805422|NCT00042289|536767966|FG006|Overall Study|Lost to Follow-up|6|||
148805423|NCT00042289|536767967|FG007|Overall Study|Lost to Follow-up|1|||
148805424|NCT00042289|536767968|FG008|Overall Study|Lost to Follow-up|1|||
148805425|NCT00042289|536767969|FG009|Overall Study|Lost to Follow-up|0|||
148805426|NCT00042289|536767970|FG010|Overall Study|Lost to Follow-up|0|||
148805427|NCT00042289|536767971|FG011|Overall Study|Lost to Follow-up|0|||
148805428|NCT00042289|536767972|FG012|Overall Study|Lost to Follow-up|0|||
148805429|NCT00042289|536767973|FG013|Overall Study|Lost to Follow-up|0|||
148805430|NCT00042289|536767974|FG014|Overall Study|Lost to Follow-up|0|||
148805431|NCT00042289|536767975|FG015|Overall Study|Lost to Follow-up|1|||
148805432|NCT00042289|536767976|FG016|Overall Study|Lost to Follow-up|1|||
148805433|NCT00042289|536767977|FG017|Overall Study|Lost to Follow-up|0|||
148805434|NCT00042289|536767978|FG018|Overall Study|Lost to Follow-up|3|||
148805435|NCT00042289|536767979|FG019|Overall Study|Lost to Follow-up|2|||
148805436|NCT00042289|536767980|FG020|Overall Study|Lost to Follow-up|0|||
148805437|NCT00042289|536767981|FG021|Overall Study|Lost to Follow-up|0|||
148805438|NCT00042289|536767982|FG022|Overall Study|Lost to Follow-up|0|||
148805439|NCT00042289|536767983|FG023|Overall Study|Lost to Follow-up|0|||
148805440|NCT00042289|536767984|FG024|Overall Study|Lost to Follow-up|0|||
148805441|NCT00042289|536767985|FG025|Overall Study|Lost to Follow-up|0|||
148805442|NCT00042289|536767986|FG026|Overall Study|Lost to Follow-up|2|||
148805443|NCT00042289|536767987|FG027|Overall Study|Lost to Follow-up|2|||
148805444|NCT00042289|536767988|FG028|Overall Study|Lost to Follow-up|2|||
148805445|NCT00042289|536767989|FG029|Overall Study|Lost to Follow-up|0|||
148805446|NCT00042289|536767990|FG030|Overall Study|Lost to Follow-up|0|||
148805447|NCT00042289|536767991|FG031|Overall Study|Lost to Follow-up|2|||
148805448|NCT00042289|536767992|FG032|Overall Study|Lost to Follow-up|1|||
148805449|NCT00042289|536767993|FG033|Overall Study|Lost to Follow-up|1|||
148805450|NCT00042289|536767994|FG034|Overall Study|Lost to Follow-up|1|||
148805451|NCT00042289|536767995|FG035|Overall Study|Lost to Follow-up|2|||
148805452|NCT00042289|536767996|FG036|Overall Study|Lost to Follow-up|1|||
148805453|NCT00042289|536767997|FG037|Overall Study|Lost to Follow-up|1|||
148805454|NCT00042289|536767998|FG038|Overall Study|Lost to Follow-up|0|||
148805455|NCT00042289|536767999|FG039|Overall Study|Lost to Follow-up|5|||
148805456|NCT00042289|536768000|FG040|Overall Study|Lost to Follow-up|0|||
148805457|NCT00042289|536768001|FG041|Overall Study|Lost to Follow-up|2|||
148805458|NCT00042289|536768002|FG042|Overall Study|Lost to Follow-up|2|||
148805459|NCT00042289|536768003|FG043|Overall Study|Lost to Follow-up|0|||
148805460|NCT00042289|536768004|FG044|Overall Study|Lost to Follow-up|0|||
148805461|NCT00042289|536768005|FG045|Overall Study|Lost to Follow-up|1|||
148805462|NCT00042289|536768006|FG046|Overall Study|Lost to Follow-up|0|||
148805463|NCT00042289|536767960|FG000|Overall Study|Other reason|0|||
148805464|NCT00042289|536767961|FG001|Overall Study|Other reason|0|||
148672136|NCT00366678|536270696|FG001|Infant Series|Failed to return|1|||
148805465|NCT00042289|536767962|FG002|Overall Study|Other reason|0|||
148805466|NCT00042289|536767963|FG003|Overall Study|Other reason|2|||
148805467|NCT00042289|536767964|FG004|Overall Study|Other reason|0|||
148805468|NCT00042289|536767965|FG005|Overall Study|Other reason|0|||
148805469|NCT00042289|536767966|FG006|Overall Study|Other reason|0|||
148805470|NCT00042289|536767967|FG007|Overall Study|Other reason|0|||
148805471|NCT00042289|536767968|FG008|Overall Study|Other reason|0|||
148805472|NCT00042289|536767969|FG009|Overall Study|Other reason|0|||
148915902|NCT01864005|537177219|FG000|Overall Study|Need GP IIb/IIIa|1|||
148915903|NCT01864005|537177220|FG001|Overall Study|Need GP IIb/IIIa|3|||
148915904|NCT00763698|537177226|FG000|Overall Study|Unsuccessful Implant|5|||
148915905|NCT00763698|537177226|FG000|Overall Study|Death|4|||
148915906|NCT00763698|537177226|FG000|Overall Study|Withdrawal by Subject|1|||
148915907|NCT02184572|537177227|FG000|Overall Study|Lost to Follow-up|29|||
148915908|NCT02184572|537177228|FG001|Overall Study|Lost to Follow-up|21|||
148915909|NCT02184572|537177227|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
148915910|NCT02184572|537177228|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
149149129|NCT03776175|538026305|FG002|Treatment Period (42 Days)|Adverse Event|1|||
149149130|NCT03776175|538026306|FG003|Treatment Period (42 Days)|Adverse Event|0|||
149149131|NCT03776175|538026303|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
149149132|NCT03776175|538026304|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
149149133|NCT03776175|538026305|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
149149134|NCT03776175|538026306|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
149149135|NCT03776175|538026303|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
149149136|NCT03776175|538026304|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
148915911|NCT02184572|537177227|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
148915912|NCT02184572|537177228|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
148915913|NCT02184572|537177227|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
148915914|NCT02184572|537177228|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
148915915|NCT02184572|537177227|FG000|Overall Study|Traveling Outside The Country|1|||
148915916|NCT02184572|537177228|FG001|Overall Study|Traveling Outside The Country|0|||
148915917|NCT02184572|537177227|FG000|Overall Study|Withdrawal by Subject|14|||
148915918|NCT02184572|537177228|FG001|Overall Study|Withdrawal by Subject|9|||
148915919|NCT00638183|537177232|FG000|Overall Study|Adverse Event|23|||
148915920|NCT00638183|537177232|FG000|Overall Study|Lack of Efficacy|14|||
148915921|NCT00638183|537177232|FG000|Overall Study|Physician Decision|9|||
148915922|NCT00638183|537177232|FG000|Overall Study|Lost to Follow-up|46|||
148915923|NCT00638183|537177232|FG000|Overall Study|Other reason not defined above|27|||
148915924|NCT00006409|537177233|FG000|Baseline|Protocol Violation|48|||
148915925|NCT00006409|537177234|FG001|Baseline|Protocol Violation|70|||
148915926|NCT00006409|537177235|FG002|Baseline|Protocol Violation|0|||
148915927|NCT00006409|537177236|FG003|Baseline|Protocol Violation|0|||
148915928|NCT00006409|537177237|FG004|Baseline|Protocol Violation|0|||
148915929|NCT00006409|537177238|FG005|Baseline|Protocol Violation|0|||
148915930|NCT00006409|537177233|FG000|Post-2 Year Intervention|Protocol Violation|0|||
148915931|NCT00006409|537177234|FG001|Post-2 Year Intervention|Protocol Violation|0|||
148915932|NCT00006409|537177235|FG002|Post-2 Year Intervention|Protocol Violation|251|||
148915933|NCT00006409|537177236|FG003|Post-2 Year Intervention|Protocol Violation|168|||
148915934|NCT00006409|537177237|FG004|Post-2 Year Intervention|Protocol Violation|0|||
148915935|NCT00006409|537177238|FG005|Post-2 Year Intervention|Protocol Violation|0|||
148915936|NCT00006409|537177233|FG000|Post-3 Year Intervention|Protocol Violation|0|||
148915937|NCT00006409|537177234|FG001|Post-3 Year Intervention|Protocol Violation|0|||
148915938|NCT00006409|537177235|FG002|Post-3 Year Intervention|Protocol Violation|0|||
148915939|NCT00006409|537177236|FG003|Post-3 Year Intervention|Protocol Violation|0|||
148915940|NCT00006409|537177237|FG004|Post-3 Year Intervention|Protocol Violation|62|||
148915941|NCT00006409|537177238|FG005|Post-3 Year Intervention|Protocol Violation|62|||
148915942|NCT02059291|537177239|FG000|Epoch 2|Lack of Efficacy|0|||
148915943|NCT02059291|537177240|FG001|Epoch 2|Lack of Efficacy|0|||
148915944|NCT02059291|537177241|FG002|Epoch 2|Lack of Efficacy|0|||
148915945|NCT02059291|537177242|FG003|Epoch 2|Lack of Efficacy|1|||
148915946|NCT02059291|537177243|FG004|Epoch 2|Lack of Efficacy|0|||
148915947|NCT02059291|537177244|FG005|Epoch 2|Lack of Efficacy|1|||
148915948|NCT02059291|537177245|FG006|Epoch 2|Lack of Efficacy|0|||
148915949|NCT02059291|537177246|FG007|Epoch 2|Lack of Efficacy|0|||
148915950|NCT02059291|537177247|FG008|Epoch 2|Lack of Efficacy|0|||
148915951|NCT02059291|537177248|FG009|Epoch 2|Lack of Efficacy|0|||
148915952|NCT02059291|537177249|FG010|Epoch 2|Lack of Efficacy|0|||
148915953|NCT02059291|537177250|FG011|Epoch 2|Lack of Efficacy|0|||
148915954|NCT02059291|537177251|FG012|Epoch 2|Lack of Efficacy|0|||
149149137|NCT03776175|538026305|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
149149138|NCT03776175|538026306|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
148915955|NCT02059291|537177252|FG013|Epoch 2|Lack of Efficacy|0|||
148915956|NCT02059291|537177253|FG014|Epoch 2|Lack of Efficacy|0|||
148915957|NCT02059291|537177254|FG015|Epoch 2|Lack of Efficacy|0|||
149149139|NCT03776175|538026303|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
149149140|NCT03776175|538026304|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
148915958|NCT02059291|537177255|FG016|Epoch 2|Lack of Efficacy|0|||
148915959|NCT02059291|537177256|FG017|Epoch 2|Lack of Efficacy|0|||
148915960|NCT02059291|537177257|FG018|Epoch 2|Lack of Efficacy|0|||
148915961|NCT02059291|537177258|FG019|Epoch 2|Lack of Efficacy|0|||
148915962|NCT02059291|537177259|FG020|Epoch 2|Lack of Efficacy|0|||
148915963|NCT02059291|537177260|FG021|Epoch 2|Lack of Efficacy|0|||
148672137|NCT00366678|536270697|FG002|Infant Series|Failed to return|0|||
148672138|NCT00366678|536270695|FG000|Infant Series|Adverse Event|1|||
148672139|NCT00366678|536270696|FG001|Infant Series|Adverse Event|0|||
148672140|NCT00366678|536270697|FG002|Infant Series|Adverse Event|0|||
148672141|NCT00366678|536270695|FG000|After Infant|Withdrawal by Subject|8|||
148672142|NCT00366678|536270696|FG001|After Infant|Withdrawal by Subject|4|||
148672143|NCT00366678|536270697|FG002|After Infant|Withdrawal by Subject|0|||
148672144|NCT00366678|536270695|FG000|After Infant|Lost to Follow-up|2|||
148672145|NCT00366678|536270696|FG001|After Infant|Lost to Follow-up|1|||
148672146|NCT00366678|536270697|FG002|After Infant|Lost to Follow-up|0|||
148672147|NCT00366678|536270695|FG000|After Infant|Failed to return|5|||
148672148|NCT00366678|536270696|FG001|After Infant|Failed to return|5|||
148672149|NCT00366678|536270697|FG002|After Infant|Failed to return|0|||
148672150|NCT00366678|536270695|FG000|After Infant|Adverse Event|1|||
148672151|NCT00366678|536270696|FG001|After Infant|Adverse Event|0|||
148672152|NCT00366678|536270697|FG002|After Infant|Adverse Event|0|||
148672153|NCT00366678|536270695|FG000|After Infant|Protocol Violation|1|||
148672154|NCT00366678|536270696|FG001|After Infant|Protocol Violation|0|||
148672155|NCT00366678|536270697|FG002|After Infant|Protocol Violation|0|||
148672156|NCT00366678|536270695|FG000|Toddler Dose|Protocol Violation|2|||
148672157|NCT00366678|536270696|FG001|Toddler Dose|Protocol Violation|1|||
148672158|NCT00366678|536270697|FG002|Toddler Dose|Protocol Violation|0|||
148672159|NCT00366678|536270695|FG000|Toddler Dose|Failed to return|1|||
148672160|NCT00366678|536270696|FG001|Toddler Dose|Failed to return|0|||
148672161|NCT00366678|536270697|FG002|Toddler Dose|Failed to return|0|||
148672162|NCT00366678|536270695|FG000|Toddler Dose|Withdrawal by Subject|1|||
148672163|NCT00366678|536270696|FG001|Toddler Dose|Withdrawal by Subject|0|||
148672164|NCT00366678|536270697|FG002|Toddler Dose|Withdrawal by Subject|0|||
148672165|NCT00366678|536270695|FG000|Toddler Dose|protocol deviation|1|||
148672166|NCT00366678|536270696|FG001|Toddler Dose|protocol deviation|0|||
148672167|NCT00366678|536270697|FG002|Toddler Dose|protocol deviation|0|||
148672168|NCT00388674|536270707|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
148672169|NCT00388674|536270708|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
148672170|NCT00388674|536270707|FG000|Initial Treatment|Adverse Event|22|||
148672171|NCT00388674|536270708|FG001|Initial Treatment|Adverse Event|87|||
148672172|NCT00388674|536270707|FG000|Initial Treatment|Death|215|||
148672173|NCT00388674|536270708|FG001|Initial Treatment|Death|216|||
148672174|NCT00388674|536270707|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
148672175|NCT00388674|536270708|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
148672176|NCT00388674|536270707|FG000|Initial Treatment|HCC|12|||
148672177|NCT00388674|536270708|FG001|Initial Treatment|HCC|20|||
148672178|NCT00388674|536270707|FG000|Initial Treatment|Lost to Follow-up|526|||
148672179|NCT00388674|536270708|FG001|Initial Treatment|Lost to Follow-up|624|||
148672180|NCT00388674|536270707|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
148672181|NCT00388674|536270708|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
148672182|NCT00388674|536270707|FG000|Initial Treatment|Never Treated with Study Medication|1|||
148672183|NCT00388674|536270708|FG001|Initial Treatment|Never Treated with Study Medication|7|||
148672184|NCT00388674|536270707|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
148672185|NCT00388674|536270708|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
148672186|NCT00388674|536270707|FG000|Initial Treatment|Not Defined|125|||
148672187|NCT00388674|536270708|FG001|Initial Treatment|Not Defined|172|||
148672188|NCT00388674|536270707|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
148672189|NCT00388674|536270708|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
148672190|NCT00388674|536270707|FG000|Initial Treatment|Pregnancy|26|||
148672191|NCT00388674|536270708|FG001|Initial Treatment|Pregnancy|16|||
148672192|NCT00388674|536270707|FG000|Initial Treatment|Study Drug Toxicity|5|||
148672193|NCT00388674|536270708|FG001|Initial Treatment|Study Drug Toxicity|92|||
148672194|NCT00388674|536270707|FG000|Initial Treatment|Participant Request|501|||
148672195|NCT00388674|536270708|FG001|Initial Treatment|Participant Request|673|||
148805473|NCT00042289|536767970|FG010|Overall Study|Other reason|0|||
148805474|NCT00042289|536767971|FG011|Overall Study|Other reason|0|||
148805475|NCT00042289|536767972|FG012|Overall Study|Other reason|0|||
148805476|NCT00042289|536767973|FG013|Overall Study|Other reason|0|||
148805477|NCT00042289|536767974|FG014|Overall Study|Other reason|0|||
148805478|NCT00042289|536767975|FG015|Overall Study|Other reason|0|||
148805479|NCT00042289|536767976|FG016|Overall Study|Other reason|0|||
148805480|NCT00042289|536767977|FG017|Overall Study|Other reason|0|||
148805481|NCT00042289|536767978|FG018|Overall Study|Other reason|1|||
148805482|NCT00042289|536767979|FG019|Overall Study|Other reason|0|||
148915964|NCT02059291|537177261|FG022|Epoch 2|Lack of Efficacy|0|||
148672196|NCT00388674|536270707|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
148672197|NCT00388674|536270708|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
148672198|NCT00388674|536270707|FG000|Initial Treatment|Not Reported|10|||
148672199|NCT00388674|536270708|FG001|Initial Treatment|Not Reported|12|||
148672200|NCT00388674|536270707|FG000|End of Study|Administrative Reason By Sponsor|299|||
148672201|NCT00388674|536270708|FG001|End of Study|Administrative Reason By Sponsor|253|||
148805483|NCT00042289|536767980|FG020|Overall Study|Other reason|0|||
148805484|NCT00042289|536767981|FG021|Overall Study|Other reason|0|||
148915965|NCT02059291|537177262|FG023|Epoch 2|Lack of Efficacy|0|||
148915966|NCT02059291|537177263|FG024|Epoch 2|Lack of Efficacy|0|||
148915967|NCT02059291|537177239|FG000|Epoch 2|Adverse Event|0|||
148915968|NCT02059291|537177240|FG001|Epoch 2|Adverse Event|0|||
148915969|NCT02059291|537177241|FG002|Epoch 2|Adverse Event|1|||
148915970|NCT02059291|537177242|FG003|Epoch 2|Adverse Event|1|||
148915971|NCT02059291|537177243|FG004|Epoch 2|Adverse Event|0|||
148915972|NCT02059291|537177244|FG005|Epoch 2|Adverse Event|0|||
148915973|NCT02059291|537177245|FG006|Epoch 2|Adverse Event|0|||
148915974|NCT02059291|537177246|FG007|Epoch 2|Adverse Event|1|||
148915975|NCT02059291|537177247|FG008|Epoch 2|Adverse Event|1|||
148915976|NCT02059291|537177248|FG009|Epoch 2|Adverse Event|0|||
148915977|NCT02059291|537177249|FG010|Epoch 2|Adverse Event|0|||
148915978|NCT02059291|537177250|FG011|Epoch 2|Adverse Event|0|||
148915979|NCT02059291|537177251|FG012|Epoch 2|Adverse Event|0|||
148915980|NCT02059291|537177252|FG013|Epoch 2|Adverse Event|0|||
148915981|NCT02059291|537177253|FG014|Epoch 2|Adverse Event|0|||
148915982|NCT02059291|537177254|FG015|Epoch 2|Adverse Event|0|||
148915983|NCT02059291|537177255|FG016|Epoch 2|Adverse Event|0|||
148915984|NCT02059291|537177256|FG017|Epoch 2|Adverse Event|0|||
148915985|NCT02059291|537177257|FG018|Epoch 2|Adverse Event|0|||
148915986|NCT02059291|537177258|FG019|Epoch 2|Adverse Event|0|||
148915987|NCT02059291|537177259|FG020|Epoch 2|Adverse Event|0|||
148915988|NCT02059291|537177260|FG021|Epoch 2|Adverse Event|0|||
148915989|NCT02059291|537177261|FG022|Epoch 2|Adverse Event|0|||
148915990|NCT02059291|537177262|FG023|Epoch 2|Adverse Event|0|||
148915991|NCT02059291|537177263|FG024|Epoch 2|Adverse Event|0|||
148915992|NCT02059291|537177239|FG000|Epoch 2|Withdrawal by Subject|0|||
148915993|NCT02059291|537177240|FG001|Epoch 2|Withdrawal by Subject|1|||
148915994|NCT02059291|537177241|FG002|Epoch 2|Withdrawal by Subject|0|||
148915995|NCT02059291|537177242|FG003|Epoch 2|Withdrawal by Subject|0|||
148915996|NCT02059291|537177243|FG004|Epoch 2|Withdrawal by Subject|0|||
148915997|NCT02059291|537177244|FG005|Epoch 2|Withdrawal by Subject|1|||
148915998|NCT02059291|537177245|FG006|Epoch 2|Withdrawal by Subject|0|||
148915999|NCT02059291|537177246|FG007|Epoch 2|Withdrawal by Subject|0|||
148916000|NCT02059291|537177247|FG008|Epoch 2|Withdrawal by Subject|1|||
148916001|NCT02059291|537177248|FG009|Epoch 2|Withdrawal by Subject|0|||
148916002|NCT02059291|537177249|FG010|Epoch 2|Withdrawal by Subject|0|||
148916003|NCT02059291|537177250|FG011|Epoch 2|Withdrawal by Subject|0|||
148916004|NCT02059291|537177251|FG012|Epoch 2|Withdrawal by Subject|0|||
148916005|NCT02059291|537177252|FG013|Epoch 2|Withdrawal by Subject|0|||
148916006|NCT02059291|537177253|FG014|Epoch 2|Withdrawal by Subject|0|||
148916007|NCT02059291|537177254|FG015|Epoch 2|Withdrawal by Subject|0|||
148916008|NCT02059291|537177255|FG016|Epoch 2|Withdrawal by Subject|0|||
148916009|NCT02059291|537177256|FG017|Epoch 2|Withdrawal by Subject|0|||
148916010|NCT02059291|537177257|FG018|Epoch 2|Withdrawal by Subject|0|||
148916011|NCT02059291|537177258|FG019|Epoch 2|Withdrawal by Subject|0|||
148916012|NCT02059291|537177259|FG020|Epoch 2|Withdrawal by Subject|0|||
149149141|NCT03776175|538026305|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
148916013|NCT02059291|537177260|FG021|Epoch 2|Withdrawal by Subject|0|||
148916014|NCT02059291|537177261|FG022|Epoch 2|Withdrawal by Subject|0|||
148916015|NCT02059291|537177262|FG023|Epoch 2|Withdrawal by Subject|0|||
148916016|NCT02059291|537177263|FG024|Epoch 2|Withdrawal by Subject|0|||
148916017|NCT02059291|537177239|FG000|Epoch 3|Physician Decision|0|||
148916018|NCT02059291|537177240|FG001|Epoch 3|Physician Decision|0|||
148916019|NCT02059291|537177241|FG002|Epoch 3|Physician Decision|0|||
148916020|NCT02059291|537177242|FG003|Epoch 3|Physician Decision|0|||
148916021|NCT02059291|537177243|FG004|Epoch 3|Physician Decision|0|||
148916022|NCT02059291|537177244|FG005|Epoch 3|Physician Decision|0|||
148916023|NCT02059291|537177245|FG006|Epoch 3|Physician Decision|0|||
148916024|NCT02059291|537177246|FG007|Epoch 3|Physician Decision|0|||
148916025|NCT02059291|537177247|FG008|Epoch 3|Physician Decision|0|||
148916026|NCT02059291|537177248|FG009|Epoch 3|Physician Decision|0|||
148916027|NCT02059291|537177249|FG010|Epoch 3|Physician Decision|0|||
148916028|NCT02059291|537177250|FG011|Epoch 3|Physician Decision|0|||
148916029|NCT02059291|537177251|FG012|Epoch 3|Physician Decision|0|||
148916030|NCT02059291|537177252|FG013|Epoch 3|Physician Decision|1|||
148916031|NCT02059291|537177253|FG014|Epoch 3|Physician Decision|0|||
148916032|NCT02059291|537177254|FG015|Epoch 3|Physician Decision|1|||
148916033|NCT02059291|537177255|FG016|Epoch 3|Physician Decision|0|||
148916034|NCT02059291|537177256|FG017|Epoch 3|Physician Decision|0|||
148916035|NCT02059291|537177257|FG018|Epoch 3|Physician Decision|0|||
148916036|NCT02059291|537177258|FG019|Epoch 3|Physician Decision|0|||
148916037|NCT02059291|537177259|FG020|Epoch 3|Physician Decision|0|||
148916038|NCT02059291|537177260|FG021|Epoch 3|Physician Decision|0|||
148916039|NCT02059291|537177261|FG022|Epoch 3|Physician Decision|0|||
148916040|NCT02059291|537177262|FG023|Epoch 3|Physician Decision|0|||
148916041|NCT02059291|537177263|FG024|Epoch 3|Physician Decision|0|||
148916042|NCT02059291|537177239|FG000|Epoch 3|Adverse Event|0|||
148916043|NCT02059291|537177240|FG001|Epoch 3|Adverse Event|0|||
148916044|NCT02059291|537177241|FG002|Epoch 3|Adverse Event|0|||
148916045|NCT02059291|537177242|FG003|Epoch 3|Adverse Event|0|||
148916046|NCT02059291|537177243|FG004|Epoch 3|Adverse Event|0|||
148916047|NCT02059291|537177244|FG005|Epoch 3|Adverse Event|0|||
148916048|NCT02059291|537177245|FG006|Epoch 3|Adverse Event|0|||
148916049|NCT02059291|537177246|FG007|Epoch 3|Adverse Event|0|||
148916050|NCT02059291|537177247|FG008|Epoch 3|Adverse Event|0|||
148916051|NCT02059291|537177248|FG009|Epoch 3|Adverse Event|0|||
148916052|NCT02059291|537177249|FG010|Epoch 3|Adverse Event|0|||
148916053|NCT02059291|537177250|FG011|Epoch 3|Adverse Event|0|||
148916054|NCT02059291|537177251|FG012|Epoch 3|Adverse Event|0|||
148916055|NCT02059291|537177252|FG013|Epoch 3|Adverse Event|0|||
148916056|NCT02059291|537177253|FG014|Epoch 3|Adverse Event|0|||
148916057|NCT02059291|537177254|FG015|Epoch 3|Adverse Event|1|||
148916058|NCT02059291|537177255|FG016|Epoch 3|Adverse Event|0|||
148916059|NCT02059291|537177256|FG017|Epoch 3|Adverse Event|0|||
148916060|NCT02059291|537177257|FG018|Epoch 3|Adverse Event|0|||
148916061|NCT02059291|537177258|FG019|Epoch 3|Adverse Event|0|||
148916062|NCT02059291|537177259|FG020|Epoch 3|Adverse Event|0|||
148916063|NCT02059291|537177260|FG021|Epoch 3|Adverse Event|0|||
148916064|NCT02059291|537177261|FG022|Epoch 3|Adverse Event|0|||
148916065|NCT02059291|537177262|FG023|Epoch 3|Adverse Event|0|||
148916066|NCT02059291|537177263|FG024|Epoch 3|Adverse Event|0|||
148916067|NCT02059291|537177239|FG000|Epoch 3|Lack of Efficacy|0|||
148916068|NCT02059291|537177240|FG001|Epoch 3|Lack of Efficacy|0|||
148916069|NCT02059291|537177241|FG002|Epoch 3|Lack of Efficacy|0|||
148916070|NCT02059291|537177242|FG003|Epoch 3|Lack of Efficacy|0|||
148916071|NCT02059291|537177243|FG004|Epoch 3|Lack of Efficacy|0|||
148916072|NCT02059291|537177244|FG005|Epoch 3|Lack of Efficacy|0|||
148916073|NCT02059291|537177245|FG006|Epoch 3|Lack of Efficacy|0|||
148916074|NCT02059291|537177246|FG007|Epoch 3|Lack of Efficacy|0|||
148916075|NCT02059291|537177247|FG008|Epoch 3|Lack of Efficacy|0|||
148916076|NCT02059291|537177248|FG009|Epoch 3|Lack of Efficacy|0|||
148916077|NCT02059291|537177249|FG010|Epoch 3|Lack of Efficacy|0|||
148916078|NCT02059291|537177250|FG011|Epoch 3|Lack of Efficacy|0|||
148916079|NCT02059291|537177251|FG012|Epoch 3|Lack of Efficacy|0|||
148916080|NCT02059291|537177252|FG013|Epoch 3|Lack of Efficacy|0|||
148916081|NCT02059291|537177253|FG014|Epoch 3|Lack of Efficacy|0|||
148916082|NCT02059291|537177254|FG015|Epoch 3|Lack of Efficacy|3|||
148916083|NCT02059291|537177255|FG016|Epoch 3|Lack of Efficacy|0|||
148916084|NCT02059291|537177256|FG017|Epoch 3|Lack of Efficacy|0|||
148916085|NCT02059291|537177257|FG018|Epoch 3|Lack of Efficacy|0|||
148916086|NCT02059291|537177258|FG019|Epoch 3|Lack of Efficacy|0|||
148916087|NCT02059291|537177259|FG020|Epoch 3|Lack of Efficacy|0|||
148916088|NCT02059291|537177260|FG021|Epoch 3|Lack of Efficacy|0|||
148916089|NCT02059291|537177261|FG022|Epoch 3|Lack of Efficacy|0|||
148916090|NCT02059291|537177262|FG023|Epoch 3|Lack of Efficacy|0|||
148916091|NCT02059291|537177263|FG024|Epoch 3|Lack of Efficacy|0|||
148916092|NCT02059291|537177239|FG000|Epoch 3|Withdrawal by Subject|0|||
148916093|NCT02059291|537177240|FG001|Epoch 3|Withdrawal by Subject|0|||
148916094|NCT02059291|537177241|FG002|Epoch 3|Withdrawal by Subject|0|||
148916095|NCT02059291|537177242|FG003|Epoch 3|Withdrawal by Subject|0|||
148916096|NCT02059291|537177243|FG004|Epoch 3|Withdrawal by Subject|0|||
148916097|NCT02059291|537177244|FG005|Epoch 3|Withdrawal by Subject|0|||
148916098|NCT02059291|537177245|FG006|Epoch 3|Withdrawal by Subject|0|||
148916099|NCT02059291|537177246|FG007|Epoch 3|Withdrawal by Subject|0|||
148916100|NCT02059291|537177247|FG008|Epoch 3|Withdrawal by Subject|0|||
148916101|NCT02059291|537177248|FG009|Epoch 3|Withdrawal by Subject|0|||
148916102|NCT02059291|537177249|FG010|Epoch 3|Withdrawal by Subject|0|||
148916103|NCT02059291|537177250|FG011|Epoch 3|Withdrawal by Subject|0|||
148916104|NCT02059291|537177251|FG012|Epoch 3|Withdrawal by Subject|0|||
148916105|NCT02059291|537177252|FG013|Epoch 3|Withdrawal by Subject|0|||
148916106|NCT02059291|537177253|FG014|Epoch 3|Withdrawal by Subject|0|||
148916107|NCT02059291|537177254|FG015|Epoch 3|Withdrawal by Subject|1|||
148916108|NCT02059291|537177255|FG016|Epoch 3|Withdrawal by Subject|0|||
148916109|NCT02059291|537177256|FG017|Epoch 3|Withdrawal by Subject|0|||
148916110|NCT02059291|537177257|FG018|Epoch 3|Withdrawal by Subject|0|||
148916111|NCT02059291|537177258|FG019|Epoch 3|Withdrawal by Subject|0|||
148916112|NCT02059291|537177259|FG020|Epoch 3|Withdrawal by Subject|0|||
148916113|NCT02059291|537177260|FG021|Epoch 3|Withdrawal by Subject|0|||
148916114|NCT02059291|537177261|FG022|Epoch 3|Withdrawal by Subject|0|||
148916115|NCT02059291|537177262|FG023|Epoch 3|Withdrawal by Subject|0|||
148916116|NCT02059291|537177263|FG024|Epoch 3|Withdrawal by Subject|0|||
148916117|NCT02059291|537177239|FG000|Epoch 4|Adverse Event|0|||
148916118|NCT02059291|537177240|FG001|Epoch 4|Adverse Event|0|||
148916119|NCT02059291|537177241|FG002|Epoch 4|Adverse Event|0|||
148916120|NCT02059291|537177242|FG003|Epoch 4|Adverse Event|0|||
148916121|NCT02059291|537177243|FG004|Epoch 4|Adverse Event|0|||
148916122|NCT02059291|537177244|FG005|Epoch 4|Adverse Event|0|||
148916123|NCT02059291|537177245|FG006|Epoch 4|Adverse Event|0|||
148916124|NCT02059291|537177246|FG007|Epoch 4|Adverse Event|0|||
148916125|NCT02059291|537177247|FG008|Epoch 4|Adverse Event|0|||
148916126|NCT02059291|537177248|FG009|Epoch 4|Adverse Event|0|||
148916127|NCT02059291|537177249|FG010|Epoch 4|Adverse Event|0|||
148916128|NCT02059291|537177250|FG011|Epoch 4|Adverse Event|0|||
148916129|NCT02059291|537177251|FG012|Epoch 4|Adverse Event|0|||
148916130|NCT02059291|537177252|FG013|Epoch 4|Adverse Event|0|||
148916131|NCT02059291|537177253|FG014|Epoch 4|Adverse Event|0|||
148916132|NCT02059291|537177254|FG015|Epoch 4|Adverse Event|0|||
148916133|NCT02059291|537177255|FG016|Epoch 4|Adverse Event|1|||
148916134|NCT02059291|537177256|FG017|Epoch 4|Adverse Event|0|||
148916135|NCT02059291|537177257|FG018|Epoch 4|Adverse Event|0|||
148916136|NCT02059291|537177258|FG019|Epoch 4|Adverse Event|0|||
148916137|NCT02059291|537177259|FG020|Epoch 4|Adverse Event|0|||
148916138|NCT02059291|537177260|FG021|Epoch 4|Adverse Event|0|||
148916139|NCT02059291|537177261|FG022|Epoch 4|Adverse Event|1|||
148916140|NCT02059291|537177262|FG023|Epoch 4|Adverse Event|0|||
148916141|NCT02059291|537177263|FG024|Epoch 4|Adverse Event|0|||
148916142|NCT02059291|537177239|FG000|Epoch 4|Pregnancy|0|||
148916143|NCT02059291|537177240|FG001|Epoch 4|Pregnancy|0|||
148916144|NCT02059291|537177241|FG002|Epoch 4|Pregnancy|0|||
148916145|NCT02059291|537177242|FG003|Epoch 4|Pregnancy|0|||
148916146|NCT02059291|537177243|FG004|Epoch 4|Pregnancy|0|||
148916147|NCT02059291|537177244|FG005|Epoch 4|Pregnancy|0|||
148916148|NCT02059291|537177245|FG006|Epoch 4|Pregnancy|0|||
148916149|NCT02059291|537177246|FG007|Epoch 4|Pregnancy|0|||
148916150|NCT02059291|537177247|FG008|Epoch 4|Pregnancy|0|||
148916151|NCT02059291|537177248|FG009|Epoch 4|Pregnancy|0|||
148916152|NCT02059291|537177249|FG010|Epoch 4|Pregnancy|0|||
148916153|NCT02059291|537177250|FG011|Epoch 4|Pregnancy|0|||
148916154|NCT02059291|537177251|FG012|Epoch 4|Pregnancy|0|||
148916155|NCT02059291|537177252|FG013|Epoch 4|Pregnancy|0|||
148916156|NCT02059291|537177253|FG014|Epoch 4|Pregnancy|0|||
148916157|NCT02059291|537177254|FG015|Epoch 4|Pregnancy|0|||
148916158|NCT02059291|537177255|FG016|Epoch 4|Pregnancy|1|||
148916159|NCT02059291|537177256|FG017|Epoch 4|Pregnancy|0|||
148916160|NCT02059291|537177257|FG018|Epoch 4|Pregnancy|0|||
148916161|NCT02059291|537177258|FG019|Epoch 4|Pregnancy|0|||
148916162|NCT02059291|537177259|FG020|Epoch 4|Pregnancy|0|||
148916163|NCT02059291|537177260|FG021|Epoch 4|Pregnancy|0|||
148916164|NCT02059291|537177261|FG022|Epoch 4|Pregnancy|0|||
148916165|NCT02059291|537177262|FG023|Epoch 4|Pregnancy|0|||
148916166|NCT02059291|537177263|FG024|Epoch 4|Pregnancy|0|||
148916167|NCT02059291|537177239|FG000|Epoch 4|Withdrawal by Subject|0|||
148916168|NCT02059291|537177240|FG001|Epoch 4|Withdrawal by Subject|0|||
148916169|NCT02059291|537177241|FG002|Epoch 4|Withdrawal by Subject|0|||
148916170|NCT02059291|537177242|FG003|Epoch 4|Withdrawal by Subject|0|||
148916171|NCT02059291|537177243|FG004|Epoch 4|Withdrawal by Subject|0|||
148916172|NCT02059291|537177244|FG005|Epoch 4|Withdrawal by Subject|0|||
148916173|NCT02059291|537177245|FG006|Epoch 4|Withdrawal by Subject|0|||
148916174|NCT02059291|537177246|FG007|Epoch 4|Withdrawal by Subject|0|||
148916175|NCT02059291|537177247|FG008|Epoch 4|Withdrawal by Subject|0|||
148916176|NCT02059291|537177248|FG009|Epoch 4|Withdrawal by Subject|0|||
148916177|NCT02059291|537177249|FG010|Epoch 4|Withdrawal by Subject|0|||
148916178|NCT02059291|537177250|FG011|Epoch 4|Withdrawal by Subject|0|||
148916179|NCT02059291|537177251|FG012|Epoch 4|Withdrawal by Subject|0|||
148916180|NCT02059291|537177252|FG013|Epoch 4|Withdrawal by Subject|0|||
148916181|NCT02059291|537177253|FG014|Epoch 4|Withdrawal by Subject|0|||
148916182|NCT02059291|537177254|FG015|Epoch 4|Withdrawal by Subject|0|||
148916183|NCT02059291|537177255|FG016|Epoch 4|Withdrawal by Subject|0|||
148916184|NCT02059291|537177256|FG017|Epoch 4|Withdrawal by Subject|0|||
148916185|NCT02059291|537177257|FG018|Epoch 4|Withdrawal by Subject|0|||
148916186|NCT02059291|537177258|FG019|Epoch 4|Withdrawal by Subject|0|||
148916187|NCT02059291|537177259|FG020|Epoch 4|Withdrawal by Subject|1|||
148916188|NCT02059291|537177260|FG021|Epoch 4|Withdrawal by Subject|0|||
148916189|NCT02059291|537177261|FG022|Epoch 4|Withdrawal by Subject|0|||
148916190|NCT02059291|537177262|FG023|Epoch 4|Withdrawal by Subject|0|||
148916191|NCT02059291|537177263|FG024|Epoch 4|Withdrawal by Subject|0|||
148916192|NCT02059291|537177239|FG000|Epoch 4|Lack of Efficacy|0|||
148916193|NCT02059291|537177240|FG001|Epoch 4|Lack of Efficacy|0|||
148916194|NCT02059291|537177241|FG002|Epoch 4|Lack of Efficacy|0|||
148916195|NCT02059291|537177242|FG003|Epoch 4|Lack of Efficacy|0|||
148916196|NCT02059291|537177243|FG004|Epoch 4|Lack of Efficacy|0|||
148916197|NCT02059291|537177244|FG005|Epoch 4|Lack of Efficacy|0|||
148916198|NCT02059291|537177245|FG006|Epoch 4|Lack of Efficacy|0|||
148916199|NCT02059291|537177246|FG007|Epoch 4|Lack of Efficacy|0|||
148916200|NCT02059291|537177247|FG008|Epoch 4|Lack of Efficacy|0|||
148916201|NCT02059291|537177248|FG009|Epoch 4|Lack of Efficacy|0|||
148916202|NCT02059291|537177249|FG010|Epoch 4|Lack of Efficacy|0|||
148916203|NCT02059291|537177250|FG011|Epoch 4|Lack of Efficacy|0|||
148916204|NCT02059291|537177251|FG012|Epoch 4|Lack of Efficacy|0|||
148916205|NCT02059291|537177252|FG013|Epoch 4|Lack of Efficacy|0|||
148916206|NCT02059291|537177253|FG014|Epoch 4|Lack of Efficacy|0|||
148916207|NCT02059291|537177254|FG015|Epoch 4|Lack of Efficacy|0|||
148916208|NCT02059291|537177255|FG016|Epoch 4|Lack of Efficacy|0|||
148916209|NCT02059291|537177256|FG017|Epoch 4|Lack of Efficacy|0|||
148916210|NCT02059291|537177257|FG018|Epoch 4|Lack of Efficacy|0|||
148916211|NCT02059291|537177258|FG019|Epoch 4|Lack of Efficacy|0|||
148916212|NCT02059291|537177259|FG020|Epoch 4|Lack of Efficacy|0|||
148916213|NCT02059291|537177260|FG021|Epoch 4|Lack of Efficacy|0|||
148916214|NCT02059291|537177261|FG022|Epoch 4|Lack of Efficacy|0|||
148916215|NCT02059291|537177262|FG023|Epoch 4|Lack of Efficacy|1|||
148916216|NCT02059291|537177263|FG024|Epoch 4|Lack of Efficacy|0|||
148916217|NCT01433289|537177264|FG000|Overall Study|Pregnancy|0|||
148916218|NCT01433289|537177265|FG001|Overall Study|Pregnancy|1|||
148916219|NCT01433289|537177266|FG002|Overall Study|Pregnancy|0|||
148916220|NCT01433289|537177267|FG003|Overall Study|Pregnancy|0|||
148916221|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
148916222|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
148916223|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Adverse Event|7|||
148916224|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Adverse Event|6|||
148916225|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
148916226|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
148916227|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Physician Decision|4|||
148916228|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Physician Decision|4|||
148916229|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
148916230|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
148916231|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
148916232|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
148916233|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
148916234|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
148916235|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Non-compliance|1|||
148916236|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Non-compliance|0|||
148916237|NCT00470834|537177268|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
148916238|NCT00470834|537177269|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
148916239|NCT00470834|537177268|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
148916240|NCT00470834|537177269|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
148916241|NCT00470834|537177268|FG000|Extension Period (24 Months)|Adverse Event|3|||
148916242|NCT00470834|537177269|FG001|Extension Period (24 Months)|Adverse Event|4|||
148916243|NCT00470834|537177268|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
148916244|NCT00470834|537177269|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
148916245|NCT00470834|537177268|FG000|Extension Period (24 Months)|Physician Decision|4|||
148916246|NCT00470834|537177269|FG001|Extension Period (24 Months)|Physician Decision|3|||
148916247|NCT00470834|537177268|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
148916248|NCT00470834|537177269|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
148916249|NCT00470834|537177268|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
148916250|NCT00470834|537177269|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
148916251|NCT00470834|537177268|FG000|Extension Period (24 Months)|Non-compliance|0|||
148916252|NCT00470834|537177269|FG001|Extension Period (24 Months)|Non-compliance|1|||
148916253|NCT00470834|537177268|FG000|Extension Period (24 Months)|Disease Progression|0|||
148916254|NCT00470834|537177269|FG001|Extension Period (24 Months)|Disease Progression|1|||
148916255|NCT01989208|537177272|FG000|200 mg (7 Days)|Protocol Violation|0|||
148916256|NCT01989208|537177273|FG001|200 mg (7 Days)|Protocol Violation|1|||
148916257|NCT01276054|537177278|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
148916258|NCT01276054|537177279|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
148916259|NCT00787267|537177280|FG000|Overall Study|Screen failure/Ineligible|10|||
148916260|NCT00787267|537177280|FG000|Overall Study|No Reason Provided|1|||
148916261|NCT00787267|537177280|FG000|Overall Study|Withdrawal by Subject|1|||
148916262|NCT04343235|537177281|FG000|Overall Study|Lost to Follow-up|3|||
148916263|NCT04343235|537177282|FG001|Overall Study|Lost to Follow-up|2|||
148916264|NCT01763996|537177283|FG000|Treatment Period 2|Adverse Event|0|||
148916265|NCT01763996|537177284|FG001|Treatment Period 2|Adverse Event|1|||
148916266|NCT00865280|537177285|FG000|Overall Study|Withdrawal by Subject|4|||
148916267|NCT00865280|537177286|FG001|Overall Study|Withdrawal by Subject|1|||
148916268|NCT00865280|537177285|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
148916269|NCT00865280|537177286|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
148916270|NCT00865280|537177285|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
148916271|NCT00865280|537177286|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
148916272|NCT00865280|537177285|FG000|Overall Study|Exclusion Condition|1|||
148916273|NCT00865280|537177286|FG001|Overall Study|Exclusion Condition|0|||
148916274|NCT00865280|537177285|FG000|Overall Study|Adverse Event|0|||
148916275|NCT00865280|537177286|FG001|Overall Study|Adverse Event|1|||
148916276|NCT01419197|537177287|FG000|Overall Study|Death|247|||
148916277|NCT01419197|537177288|FG001|Overall Study|Death|122|||
148916278|NCT01419197|537177287|FG000|Overall Study|Physician Decision|4|||
148916279|NCT01419197|537177288|FG001|Overall Study|Physician Decision|4|||
148916280|NCT01419197|537177287|FG000|Overall Study|Non-compliance|3|||
148916281|NCT01419197|537177288|FG001|Overall Study|Non-compliance|1|||
148916282|NCT01419197|537177287|FG000|Overall Study|Withdrawal by Subject|33|||
148916283|NCT01419197|537177288|FG001|Overall Study|Withdrawal by Subject|32|||
148916284|NCT01419197|537177287|FG000|Overall Study|Study Completed by Sponsor|103|||
148916285|NCT01419197|537177288|FG001|Overall Study|Study Completed by Sponsor|34|||
148916286|NCT01419197|537177287|FG000|Overall Study|Reason Not Specified|0|||
148916287|NCT01419197|537177288|FG001|Overall Study|Reason Not Specified|1|||
148916288|NCT01419197|537177287|FG000|Overall Study|Lost to Follow-up|14|||
148916289|NCT01419197|537177288|FG001|Overall Study|Lost to Follow-up|4|||
148916290|NCT01798849|537177289|FG000|Overall Study|Physician Decision|0|||
148916291|NCT01798849|537177290|FG001|Overall Study|Physician Decision|0|||
148916292|NCT01798849|537177291|FG002|Overall Study|Physician Decision|1|||
148916293|NCT00743106|537177292|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
148916294|NCT00743106|537177293|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
148916295|NCT00145977|537177295|FG000|Overall Study|Lack of Efficacy|0|||
148916296|NCT00145977|537177296|FG001|Overall Study|Lack of Efficacy|4|||
148916297|NCT00145977|537177295|FG000|Overall Study|Lost to Follow-up|1|||
148916298|NCT00145977|537177296|FG001|Overall Study|Lost to Follow-up|0|||
148916299|NCT00145977|537177295|FG000|Overall Study|Withdrawal by Subject|1|||
148916300|NCT00145977|537177296|FG001|Overall Study|Withdrawal by Subject|0|||
148916301|NCT03060551|537177297|FG000|Overall Study|Withdrawal by Subject|1|||
148916302|NCT03060551|537177297|FG000|Overall Study|Adverse Event|1|||
148916303|NCT04629066|537177298|FG000|Overall Study|Lost to Follow-up|3|||
148916304|NCT04629066|537177299|FG001|Overall Study|Lost to Follow-up|2|||
148916305|NCT05477108|537177305|FG000|Overall Study|Participants randomized, not treated|1|||
148916306|NCT05477108|537177306|FG001|Overall Study|Participants randomized, not treated|1|||
148916307|NCT05477108|537177307|FG002|Overall Study|Participants randomized, not treated|1|||
148916308|NCT05477108|537177305|FG000|Overall Study|Physician Decision|0|||
148916309|NCT05477108|537177306|FG001|Overall Study|Physician Decision|0|||
148916310|NCT05477108|537177307|FG002|Overall Study|Physician Decision|1|||
148916311|NCT05477108|537177305|FG000|Overall Study|withdrawn from study|0|||
148916312|NCT05477108|537177306|FG001|Overall Study|withdrawn from study|0|||
148916313|NCT05477108|537177307|FG002|Overall Study|withdrawn from study|1|||
148916314|NCT00334113|537177309|FG000|Overall Study|Lost to Follow-up|2|||
148916315|NCT00334113|537177310|FG001|Overall Study|Lost to Follow-up|2|||
148916316|NCT00334113|537177309|FG000|Overall Study|Withdrawal by Subject|0|||
148916317|NCT00334113|537177310|FG001|Overall Study|Withdrawal by Subject|1|||
148916318|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
148916319|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
148916320|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
148916321|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
148916322|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Other|2|||
148916323|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
148916324|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
148916325|NCT02509026|537177318|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
148916326|NCT02509026|537177318|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
148916327|NCT02509026|537177318|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
148916328|NCT02509026|537177318|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
148916329|NCT02509026|537177318|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
148916330|NCT02509026|537177318|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
148916331|NCT00243841|537177322|FG000|Overall Study|Physician Decision|0|||
148916332|NCT00243841|537177323|FG001|Overall Study|Physician Decision|0|||
148916333|NCT00243841|537177324|FG002|Overall Study|Physician Decision|1|||
148916334|NCT00243841|537177325|FG003|Overall Study|Physician Decision|0|||
148916335|NCT00243841|537177326|FG004|Overall Study|Physician Decision|0|||
148916336|NCT00243841|537177327|FG005|Overall Study|Physician Decision|2|||
148916337|NCT02537015|537177328|FG000|Overall Study|Adverse Event|3|||
148916338|NCT02537015|537177328|FG000|Overall Study|Withdrawal by Subject|2|||
148916339|NCT02537015|537177328|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148916340|NCT01808092|537177329|FG000|Overall Study|Death|39|||
148916341|NCT01808092|537177330|FG001|Overall Study|Death|29|||
148916342|NCT01808092|537177329|FG000|Overall Study|Lost to Follow-up|3|||
148916343|NCT01808092|537177330|FG001|Overall Study|Lost to Follow-up|7|||
148916344|NCT01808092|537177329|FG000|Overall Study|Withdrawal by Subject|9|||
148916345|NCT01808092|537177330|FG001|Overall Study|Withdrawal by Subject|4|||
148916346|NCT01808092|537177329|FG000|Overall Study|Other Eligibility criteria|3|||
148916347|NCT01808092|537177330|FG001|Overall Study|Other Eligibility criteria|5|||
148916348|NCT01097005|537177336|FG000|Overall Study|Case Report Form not collected|18|||
148916349|NCT01097005|537177336|FG000|Overall Study|Subjects cannot visit the hospital|1|||
148916350|NCT01097005|537177336|FG000|Overall Study|Poor medication compliance|1|||
148916351|NCT01097005|537177336|FG000|Overall Study|No examination data available|244|||
148916352|NCT01097005|537177336|FG000|Overall Study|Deviation from exclusion criteria|37|||
148916353|NCT01097005|537177336|FG000|Overall Study|Adverse Event|14|||
148916354|NCT01097005|537177336|FG000|Overall Study|Discontinuance by complication|50|||
148916355|NCT04627285|537177337|FG000|Overall Study|Adverse Event|0|||
148916356|NCT04627285|537177338|FG001|Overall Study|Adverse Event|2|||
148916357|NCT04627285|537177337|FG000|Overall Study|Lost to Follow-up|1|||
148916358|NCT04627285|537177338|FG001|Overall Study|Lost to Follow-up|0|||
148916359|NCT04627285|537177337|FG000|Overall Study|Withdrawal by Subject|1|||
148916360|NCT04627285|537177338|FG001|Overall Study|Withdrawal by Subject|1|||
148916361|NCT04627285|537177337|FG000|Overall Study|Sponsor decision|5|||
148916362|NCT04627285|537177338|FG001|Overall Study|Sponsor decision|0|||
148916363|NCT04627285|537177337|FG000|Overall Study|Participant left country; aunt informed the site|0|||
148916364|NCT04627285|537177338|FG001|Overall Study|Participant left country; aunt informed the site|1|||
148916365|NCT01948193|537178800|FG000|Overall Study|Serious event|2|||
148916366|NCT01948193|537178800|FG000|Overall Study|Lost to Follow-up|7|||
148916367|NCT03338959|537178801|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
148916368|NCT03338959|537178801|FG000|Overall Study|Physician Decision|1|||
148916369|NCT00409331|537178802|FG000|Overall Study|Physician Decision|1|||
148916370|NCT02184455|537178803|FG000|Overall Study|Lost to Follow-up|1|||
148916371|NCT01964755|537178805|FG000|Overall Study|Death|2|||
148916372|NCT01425463|537178811|FG000|Overall Study|Adverse Event|5|||
148916373|NCT01425463|537178812|FG001|Overall Study|Adverse Event|7|||
148916374|NCT01425463|537178811|FG000|Overall Study|Lack of Efficacy|1|||
148916375|NCT01425463|537178812|FG001|Overall Study|Lack of Efficacy|1|||
148916376|NCT01425463|537178811|FG000|Overall Study|Protocol Violation|2|||
148916377|NCT01425463|537178812|FG001|Overall Study|Protocol Violation|2|||
148916378|NCT01425463|537178811|FG000|Overall Study|Lost to Follow-up|5|||
148916379|NCT01425463|537178812|FG001|Overall Study|Lost to Follow-up|2|||
148916380|NCT01425463|537178811|FG000|Overall Study|Withdrawal by Subject|7|||
148916381|NCT01425463|537178812|FG001|Overall Study|Withdrawal by Subject|5|||
148916382|NCT01425463|537178811|FG000|Overall Study|Unknown Reason|4|||
148916383|NCT01425463|537178812|FG001|Overall Study|Unknown Reason|7|||
148916384|NCT01332799|537178813|FG000|Overall Study|Insufficient funding|10|||
148916385|NCT01332799|537178814|FG001|Overall Study|Insufficient funding|10|||
148916386|NCT00668733|537178815|FG000|Overall Study|Lost to Follow-up|2|||
148916387|NCT00668733|537178816|FG001|Overall Study|Lost to Follow-up|3|||
148916388|NCT00668733|537178815|FG000|Overall Study|Withdrawal by Subject|0|||
148916389|NCT00668733|537178816|FG001|Overall Study|Withdrawal by Subject|4|||
148916390|NCT00538785|537178817|FG000|Overall Study|Death|9|||
148916391|NCT00538785|537178818|FG001|Overall Study|Death|10|||
148916392|NCT00538785|537178817|FG000|Overall Study|Withdrawal of consent|9|||
148916393|NCT00538785|537178818|FG001|Overall Study|Withdrawal of consent|7|||
148916394|NCT00538785|537178817|FG000|Overall Study|Lost to Follow-up|1|||
148916395|NCT00538785|537178818|FG001|Overall Study|Lost to Follow-up|0|||
148916396|NCT00361634|537178829|FG000|Overall Study|Lost to Follow-up|1|||
148916397|NCT00361634|537178829|FG000|Overall Study|Withdrawal by Subject|1|||
148916398|NCT05315908|537178830|FG000|Overall Study|Lost to Follow-up|4477|||
148916399|NCT05315908|537178831|FG001|Overall Study|Lost to Follow-up|4606|||
148916400|NCT00294762|537178832|FG000|Overall Study|Did not receive study treatment|3|||
148916401|NCT00294762|537178833|FG001|Overall Study|Did not receive study treatment|3|||
148916402|NCT02937584|537178834|FG000|Period 1|Adverse Event|1|||
148916403|NCT02937584|537178835|FG001|Period 1|Adverse Event|2|||
148916404|NCT02937584|537178834|FG000|Washout|Adverse Event|0|||
148916405|NCT02937584|537178835|FG001|Washout|Adverse Event|1|||
148916406|NCT02238080|537178844|FG000|Overall Study|Death|13|||
148916407|NCT02238080|537178844|FG000|Overall Study|Treatment interrupted|6|||
148916408|NCT02238080|537178844|FG000|Overall Study|Withdrawal by Subject|2|||
148916409|NCT02238080|537178844|FG000|Overall Study|Other|4|||
148916410|NCT01738646|537178845|FG000|Overall Study|Still Receiving Treatment|2|||
148916411|NCT01598129|537178846|FG000|Overall Study|Disease progression|6|||
148916412|NCT01598129|537178846|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
148916413|NCT01598129|537178846|FG000|Overall Study|Withdrawal by Subject|1|||
148916414|NCT00505076|537178847|FG000|Overall Study|Adverse Event|1|||
148916415|NCT00505076|537178848|FG001|Overall Study|Adverse Event|0|||
148916416|NCT00505076|537178849|FG002|Overall Study|Adverse Event|1|||
148916417|NCT00505076|537178847|FG000|Overall Study|Protocol Violation|2|||
148916418|NCT00505076|537178848|FG001|Overall Study|Protocol Violation|1|||
148916419|NCT00505076|537178849|FG002|Overall Study|Protocol Violation|2|||
148916420|NCT00505076|537178847|FG000|Overall Study|Withdrawal by Subject|0|||
148916421|NCT00505076|537178848|FG001|Overall Study|Withdrawal by Subject|1|||
148916422|NCT00505076|537178849|FG002|Overall Study|Withdrawal by Subject|2|||
148916423|NCT04093024|537178852|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
148916424|NCT04093024|537178853|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
148916425|NCT04093024|537178852|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
148916426|NCT04093024|537178853|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
148916427|NCT04093024|537178852|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
148916428|NCT04093024|537178853|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
148916429|NCT04093024|537178852|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
148916430|NCT04093024|537178853|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
148916431|NCT00647270|537178858|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
148805485|NCT00042289|536767982|FG022|Overall Study|Other reason|0|||
148805486|NCT00042289|536767983|FG023|Overall Study|Other reason|1|||
148805487|NCT00042289|536767984|FG024|Overall Study|Other reason|0|||
148805488|NCT00042289|536767985|FG025|Overall Study|Other reason|0|||
148805489|NCT00042289|536767986|FG026|Overall Study|Other reason|1|||
148805490|NCT00042289|536767987|FG027|Overall Study|Other reason|0|||
148805491|NCT00042289|536767988|FG028|Overall Study|Other reason|3|||
148805492|NCT00042289|536767989|FG029|Overall Study|Other reason|0|||
148805493|NCT00042289|536767990|FG030|Overall Study|Other reason|0|||
148805494|NCT00042289|536767991|FG031|Overall Study|Other reason|1|||
148916432|NCT00647270|537178859|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
148916433|NCT00647270|537178860|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
148916434|NCT00647270|537178858|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
148916435|NCT00647270|537178859|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
148916436|NCT00647270|537178860|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
148916437|NCT00647270|537178858|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
148916438|NCT00647270|537178859|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
148916439|NCT00647270|537178860|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
148916440|NCT00647270|537178858|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
148916441|NCT00647270|537178859|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
148916442|NCT00647270|537178860|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
148916443|NCT00647270|537178858|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
148916444|NCT00647270|537178859|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
148916445|NCT00647270|537178860|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
148916446|NCT00647270|537178858|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
148916447|NCT00647270|537178859|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
148916448|NCT00647270|537178860|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
148916449|NCT00647270|537178858|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
148916450|NCT00647270|537178859|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
148916451|NCT00647270|537178860|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
148916452|NCT03180619|537178861|FG000|Overall Study|Withdrew Consent|5|||
148916453|NCT03180619|537178862|FG001|Overall Study|Withdrew Consent|0|||
148916454|NCT03180619|537178863|FG002|Overall Study|Withdrew Consent|2|||
148916455|NCT03180619|537178861|FG000|Overall Study|Death|2|||
148805495|NCT00042289|536767992|FG032|Overall Study|Other reason|0|||
148805496|NCT00042289|536767993|FG033|Overall Study|Other reason|1|||
148805497|NCT00042289|536767994|FG034|Overall Study|Other reason|0|||
148805498|NCT00042289|536767995|FG035|Overall Study|Other reason|2|||
148805499|NCT00042289|536767996|FG036|Overall Study|Other reason|0|||
148805500|NCT00042289|536767997|FG037|Overall Study|Other reason|0|||
148805501|NCT00042289|536767998|FG038|Overall Study|Other reason|0|||
148805502|NCT00042289|536767999|FG039|Overall Study|Other reason|0|||
148805503|NCT00042289|536768000|FG040|Overall Study|Other reason|0|||
148805504|NCT00042289|536768001|FG041|Overall Study|Other reason|0|||
148805505|NCT00042289|536768002|FG042|Overall Study|Other reason|0|||
148805506|NCT00042289|536768003|FG043|Overall Study|Other reason|1|||
148805507|NCT00042289|536768004|FG044|Overall Study|Other reason|0|||
148805508|NCT00042289|536768005|FG045|Overall Study|Other reason|0|||
148805509|NCT00042289|536768006|FG046|Overall Study|Other reason|0|||
148805510|NCT00042289|536767960|FG000|Overall Study|Severe debilitation, unable to continue|0|||
148805511|NCT00042289|536767961|FG001|Overall Study|Severe debilitation, unable to continue|0|||
148805512|NCT00042289|536767962|FG002|Overall Study|Severe debilitation, unable to continue|0|||
148805513|NCT00042289|536767963|FG003|Overall Study|Severe debilitation, unable to continue|0|||
148805514|NCT00042289|536767964|FG004|Overall Study|Severe debilitation, unable to continue|0|||
148805515|NCT00042289|536767965|FG005|Overall Study|Severe debilitation, unable to continue|0|||
148805516|NCT00042289|536767966|FG006|Overall Study|Severe debilitation, unable to continue|0|||
148805517|NCT00042289|536767967|FG007|Overall Study|Severe debilitation, unable to continue|0|||
148805518|NCT00042289|536767968|FG008|Overall Study|Severe debilitation, unable to continue|0|||
148805519|NCT00042289|536767969|FG009|Overall Study|Severe debilitation, unable to continue|0|||
148805520|NCT00042289|536767970|FG010|Overall Study|Severe debilitation, unable to continue|0|||
148805521|NCT00042289|536767971|FG011|Overall Study|Severe debilitation, unable to continue|0|||
148805522|NCT00042289|536767972|FG012|Overall Study|Severe debilitation, unable to continue|0|||
148805523|NCT00042289|536767973|FG013|Overall Study|Severe debilitation, unable to continue|0|||
148916456|NCT03180619|537178862|FG001|Overall Study|Death|1|||
148916457|NCT03180619|537178863|FG002|Overall Study|Death|2|||
148916458|NCT03180619|537178861|FG000|Overall Study|Adverse Event|2|||
148916459|NCT03180619|537178862|FG001|Overall Study|Adverse Event|0|||
148916460|NCT03180619|537178863|FG002|Overall Study|Adverse Event|1|||
148916461|NCT03180619|537178861|FG000|Overall Study|Investigator's discretion|2|||
148916462|NCT03180619|537178862|FG001|Overall Study|Investigator's discretion|0|||
148916463|NCT03180619|537178863|FG002|Overall Study|Investigator's discretion|1|||
148916464|NCT00729469|537178864|FG000|Overall Study|Adverse Event|14|||
148916465|NCT00729469|537178865|FG001|Overall Study|Adverse Event|25|||
148916466|NCT00729469|537178864|FG000|Overall Study|Lost to Follow-up|9|||
148916467|NCT00729469|537178865|FG001|Overall Study|Lost to Follow-up|9|||
148916468|NCT00729469|537178864|FG000|Overall Study|Protocol Violation|2|||
148916469|NCT00729469|537178865|FG001|Overall Study|Protocol Violation|1|||
148916470|NCT00729469|537178864|FG000|Overall Study|Withdrawal by Subject|19|||
148916471|NCT00729469|537178865|FG001|Overall Study|Withdrawal by Subject|8|||
148916472|NCT00729469|537178864|FG000|Overall Study|Other-Not mentioned|9|||
148916473|NCT00729469|537178865|FG001|Overall Study|Other-Not mentioned|4|||
148916474|NCT04975438|537178871|FG000|Overall Study|Lost to Follow-up|1|||
148916475|NCT04975438|537178872|FG001|Overall Study|Lost to Follow-up|0|||
148916476|NCT04975438|537178873|FG002|Overall Study|Lost to Follow-up|1|||
148916477|NCT04975438|537178874|FG003|Overall Study|Lost to Follow-up|0|||
148916478|NCT04975438|537178871|FG000|Overall Study|Withdrawal by Subject|1|||
148916479|NCT04975438|537178872|FG001|Overall Study|Withdrawal by Subject|0|||
148916480|NCT04975438|537178873|FG002|Overall Study|Withdrawal by Subject|0|||
148916481|NCT04975438|537178874|FG003|Overall Study|Withdrawal by Subject|0|||
148916482|NCT04973436|537178875|FG000|Overall Study|Lost to Follow-up|3|||
148916483|NCT04973436|537178875|FG000|Overall Study|Withdrawal by Subject|1|||
148916484|NCT04973436|537178875|FG000|Overall Study|Death|2|||
148916485|NCT01788215|537178882|FG000|Overall Study|Withdrawal by Subject|0|||
148916486|NCT01788215|537178883|FG001|Overall Study|Withdrawal by Subject|1|||
148916487|NCT01788215|537178882|FG000|Overall Study|Lost to Follow-up|2|||
148916488|NCT01788215|537178883|FG001|Overall Study|Lost to Follow-up|0|||
148916489|NCT03091348|537178890|FG000|Overall Study|Lost to Follow-up|2|||
148916490|NCT03091348|537178891|FG001|Overall Study|Lost to Follow-up|1|||
148916491|NCT04534686|537178892|FG000|Baseline Measurement|Lost to Follow-up|4|||
148916492|NCT04534686|537178893|FG001|Baseline Measurement|Lost to Follow-up|6|||
148916493|NCT04534686|537178892|FG000|Baseline Measurement|Withdrawal by Subject|3|||
148916494|NCT04534686|537178893|FG001|Baseline Measurement|Withdrawal by Subject|1|||
148916495|NCT04534686|537178892|FG000|Intervention|Withdrawal by Subject|2|||
148916496|NCT04534686|537178893|FG001|Intervention|Withdrawal by Subject|2|||
148916497|NCT00146848|537178894|FG000|Pre-randomization|Death|19|||
148916498|NCT00146848|537178895|FG001|Pre-randomization|Death|0|||
148916499|NCT00146848|537178896|FG002|Pre-randomization|Death|0|||
148916500|NCT00146848|537178894|FG000|Pre-randomization|Lost to Follow-up|70|||
148916501|NCT00146848|537178895|FG001|Pre-randomization|Lost to Follow-up|0|||
148916502|NCT00146848|537178896|FG002|Pre-randomization|Lost to Follow-up|0|||
148916503|NCT00146848|537178894|FG000|Pre-randomization|Physician Decision|8|||
148916504|NCT00146848|537178895|FG001|Pre-randomization|Physician Decision|0|||
148916505|NCT00146848|537178896|FG002|Pre-randomization|Physician Decision|0|||
148916506|NCT00146848|537178894|FG000|Pre-randomization|Protocol Violation|172|||
148916507|NCT00146848|537178895|FG001|Pre-randomization|Protocol Violation|0|||
148916508|NCT00146848|537178896|FG002|Pre-randomization|Protocol Violation|0|||
148916509|NCT00146848|537178894|FG000|Pre-randomization|Withdrawal by Subject|40|||
148916510|NCT00146848|537178895|FG001|Pre-randomization|Withdrawal by Subject|0|||
148916511|NCT00146848|537178896|FG002|Pre-randomization|Withdrawal by Subject|0|||
148916512|NCT00146848|537178894|FG000|Post-randomization|Lost to Follow-up|12|||
148916513|NCT00146848|537178895|FG001|Post-randomization|Lost to Follow-up|15|||
148916514|NCT00146848|537178896|FG002|Post-randomization|Lost to Follow-up|12|||
148916515|NCT00146848|537178894|FG000|Post-randomization|Withdrawn|26|||
148916516|NCT00146848|537178895|FG001|Post-randomization|Withdrawn|32|||
148916517|NCT00146848|537178896|FG002|Post-randomization|Withdrawn|27|||
148916518|NCT03704636|537178899|FG000|Overall Study|Inadequate Venous Flow|3|||
148916519|NCT00509145|537178900|FG000|Overall Study|Death|0|||
148916520|NCT00509145|537178901|FG001|Overall Study|Death|2|||
148916521|NCT00509145|537178900|FG000|Overall Study|Adverse Event|42|||
148916522|NCT00509145|537178901|FG001|Overall Study|Adverse Event|28|||
148916523|NCT00509145|537178900|FG000|Overall Study|Withdrawal by Subject|32|||
148916524|NCT00509145|537178901|FG001|Overall Study|Withdrawal by Subject|38|||
148916525|NCT00509145|537178900|FG000|Overall Study|Physician Decision|11|||
148916526|NCT00509145|537178901|FG001|Overall Study|Physician Decision|14|||
148916527|NCT00509145|537178900|FG000|Overall Study|Protocol Violation|1|||
148916528|NCT00509145|537178901|FG001|Overall Study|Protocol Violation|6|||
148916529|NCT00509145|537178900|FG000|Overall Study|Pregnancy|3|||
148916530|NCT00509145|537178901|FG001|Overall Study|Pregnancy|8|||
148916531|NCT00509145|537178900|FG000|Overall Study|Lost to Follow-up|6|||
148916532|NCT00509145|537178901|FG001|Overall Study|Lost to Follow-up|5|||
148916533|NCT00509145|537178900|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
148916534|NCT00509145|537178901|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
148916535|NCT00509145|537178900|FG000|Overall Study|Other|6|||
148916536|NCT00509145|537178901|FG001|Overall Study|Other|6|||
148916537|NCT00246740|537178902|FG000|Initial Enrollment|Death|1|||
148916538|NCT00246740|537178903|FG001|Initial Enrollment|Death|0|||
148916539|NCT00246740|537178902|FG000|Initial Enrollment|Additional surgery scheduled|0|||
148916540|NCT00246740|537178903|FG001|Initial Enrollment|Additional surgery scheduled|2|||
148916541|NCT00246740|537178902|FG000|Initial Enrollment|Surgery schedule change|4|||
148916542|NCT00246740|537178903|FG001|Initial Enrollment|Surgery schedule change|4|||
148916543|NCT00246740|537178902|FG000|Initial Enrollment|Other|1|||
148916544|NCT00246740|537178903|FG001|Initial Enrollment|Other|2|||
148916545|NCT00101452|537178906|FG000|Overall Study|Adverse Event|2|||
148916546|NCT00101452|537178907|FG001|Overall Study|Adverse Event|0|||
148916547|NCT00101452|537178908|FG002|Overall Study|Adverse Event|1|||
148916548|NCT00101452|537178906|FG000|Overall Study|Lost to Follow-up|13|||
148916549|NCT00101452|537178907|FG001|Overall Study|Lost to Follow-up|8|||
148916550|NCT00101452|537178908|FG002|Overall Study|Lost to Follow-up|14|||
148916551|NCT00101452|537178906|FG000|Overall Study|Withdrawal by Subject|10|||
148916552|NCT00101452|537178907|FG001|Overall Study|Withdrawal by Subject|14|||
148916553|NCT00101452|537178908|FG002|Overall Study|Withdrawal by Subject|9|||
148916554|NCT00101452|537178906|FG000|Overall Study|Baseline Fail|2|||
148916555|NCT00101452|537178907|FG001|Overall Study|Baseline Fail|1|||
148916556|NCT00101452|537178908|FG002|Overall Study|Baseline Fail|2|||
148916557|NCT00101452|537178906|FG000|Overall Study|Physician Decision|0|||
148916558|NCT00101452|537178907|FG001|Overall Study|Physician Decision|3|||
148916559|NCT00101452|537178908|FG002|Overall Study|Physician Decision|2|||
148916560|NCT00101452|537178906|FG000|Overall Study|Protocol Violation|2|||
148916561|NCT00101452|537178907|FG001|Overall Study|Protocol Violation|1|||
148916562|NCT00101452|537178908|FG002|Overall Study|Protocol Violation|3|||
148916563|NCT00101452|537178906|FG000|Overall Study|Other|15|||
148916564|NCT00101452|537178907|FG001|Overall Study|Other|16|||
148916565|NCT00101452|537178908|FG002|Overall Study|Other|12|||
148916566|NCT01994889|537178909|FG000|Overall Study|Adverse Event|5|||
148916567|NCT01994889|537178910|FG001|Overall Study|Adverse Event|12|||
148916568|NCT01994889|537178911|FG002|Overall Study|Adverse Event|11|||
148916569|NCT01994889|537178909|FG000|Overall Study|Cardiac Device Implantation|0|||
148916570|NCT01994889|537178910|FG001|Overall Study|Cardiac Device Implantation|2|||
148916571|NCT01994889|537178911|FG002|Overall Study|Cardiac Device Implantation|0|||
148916572|NCT01994889|537178909|FG000|Overall Study|Organ Transplantation|1|||
148916573|NCT01994889|537178910|FG001|Overall Study|Organ Transplantation|5|||
148916574|NCT01994889|537178911|FG002|Overall Study|Organ Transplantation|5|||
148916575|NCT01994889|537178909|FG000|Overall Study|No longer willing to participate|8|||
148916576|NCT01994889|537178910|FG001|Overall Study|No longer willing to participate|17|||
148916577|NCT01994889|537178911|FG002|Overall Study|No longer willing to participate|37|||
148916578|NCT01994889|537178909|FG000|Overall Study|Lost to Follow-up|0|||
148916579|NCT01994889|537178910|FG001|Overall Study|Lost to Follow-up|1|||
148916580|NCT01994889|537178911|FG002|Overall Study|Lost to Follow-up|0|||
148916581|NCT01994889|537178909|FG000|Overall Study|Protocol Violation|0|||
148916582|NCT01994889|537178910|FG001|Overall Study|Protocol Violation|1|||
148916583|NCT01994889|537178911|FG002|Overall Study|Protocol Violation|1|||
148916584|NCT01994889|537178909|FG000|Overall Study|Death|14|||
148916585|NCT01994889|537178910|FG001|Overall Study|Death|25|||
148916586|NCT01994889|537178911|FG002|Overall Study|Death|38|||
148916587|NCT02969655|537178912|FG000|Overall Study|Withdrawal by Subject|3|||
148916588|NCT02969655|537178913|FG001|Overall Study|Withdrawal by Subject|2|||
148916589|NCT02969655|537178912|FG000|Overall Study|Physician Decision|4|||
148916590|NCT02969655|537178913|FG001|Overall Study|Physician Decision|3|||
148916591|NCT02969655|537178912|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
148916592|NCT02969655|537178913|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
148916593|NCT02969655|537178912|FG000|Overall Study|Adverse Event|10|||
148916594|NCT02969655|537178913|FG001|Overall Study|Adverse Event|8|||
148916595|NCT02674204|537178914|FG000|Overall Study|Adverse Event|1|||
148916596|NCT02674204|537178915|FG001|Overall Study|Adverse Event|0|||
148916597|NCT02466659|537178918|FG000|Overall Study|Lost to Follow-up|5|||
148916598|NCT02466659|537178919|FG001|Overall Study|Lost to Follow-up|2|||
148916599|NCT01536392|537178920|FG000|Overall Study|Adverse Event|2|||
148916600|NCT01536392|537178921|FG001|Overall Study|Adverse Event|2|||
148916601|NCT01536392|537178920|FG000|Overall Study|Physician Decision|2|||
148672202|NCT00388674|536270707|FG000|End of Study|Death|239|||
148916602|NCT01536392|537178921|FG001|Overall Study|Physician Decision|3|||
148916603|NCT01536392|537178920|FG000|Overall Study|Withdrawal by Subject|3|||
148916604|NCT01536392|537178921|FG001|Overall Study|Withdrawal by Subject|6|||
148916605|NCT01536392|537178920|FG000|Overall Study|Non Compliance|3|||
148916606|NCT01536392|537178921|FG001|Overall Study|Non Compliance|4|||
148916607|NCT01536392|537178920|FG000|Overall Study|Completed therapy early|3|||
148916608|NCT01536392|537178921|FG001|Overall Study|Completed therapy early|0|||
148916609|NCT03753789|537178922|FG000|Overall Study|Withdrawal by Subject|2|||
148916610|NCT01030666|537178927|FG000|Overall Study|Lost to Follow-up|3|||
148916611|NCT01030666|537178928|FG001|Overall Study|Lost to Follow-up|2|||
148916612|NCT04002908|537178931|FG000|Overall Study|Death|41|||
148916613|NCT04002908|537178932|FG001|Overall Study|Death|0|||
148916614|NCT04002908|537178933|FG002|Overall Study|Death|0|||
148916615|NCT04002908|537178934|FG003|Overall Study|Death|0|||
148916616|NCT04002908|537178931|FG000|Overall Study|Withdrawal by Subject|112|||
148916617|NCT04002908|537178932|FG001|Overall Study|Withdrawal by Subject|0|||
148916618|NCT04002908|537178933|FG002|Overall Study|Withdrawal by Subject|0|||
148916619|NCT04002908|537178934|FG003|Overall Study|Withdrawal by Subject|0|||
148916620|NCT04002908|537178931|FG000|Overall Study|Lost to Follow-up|72|||
149149142|NCT03776175|538026306|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
149149143|NCT03776175|538026303|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
148916621|NCT04002908|537178932|FG001|Overall Study|Lost to Follow-up|0|||
148916622|NCT04002908|537178933|FG002|Overall Study|Lost to Follow-up|0|||
148916623|NCT04002908|537178934|FG003|Overall Study|Lost to Follow-up|0|||
148916624|NCT04002908|537178931|FG000|Overall Study|Infant died, so mother withdrawn|34|||
148916625|NCT04002908|537178932|FG001|Overall Study|Infant died, so mother withdrawn|0|||
148916626|NCT04002908|537178933|FG002|Overall Study|Infant died, so mother withdrawn|0|||
148916627|NCT04002908|537178934|FG003|Overall Study|Infant died, so mother withdrawn|0|||
148916628|NCT04359901|537178937|FG000|Overall Study|Withdrawal by Subject|0|||
148916629|NCT04359901|537178938|FG001|Overall Study|Withdrawal by Subject|1|||
148916630|NCT04359901|537178937|FG000|Overall Study|Death|6|||
148916631|NCT04359901|537178938|FG001|Overall Study|Death|2|||
148916632|NCT03425253|537178941|FG000|Overall Study|Adverse Event|2|||
148916633|NCT03425253|537178941|FG000|Overall Study|Lost to Follow-up|3|||
148916634|NCT03425253|537178941|FG000|Overall Study|Withdrew Consent|6|||
148916635|NCT03425253|537178941|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
148916636|NCT04614324|537178942|FG000|Overall Study|Lost to Follow-up|3|||
148916637|NCT04614324|537178942|FG000|Overall Study|Physician Decision|1|||
148916638|NCT04614324|537178942|FG000|Overall Study|Withdrawal by Subject|2|||
148916639|NCT04614324|537178942|FG000|Overall Study|Remaining in Follow up|123|||
148916640|NCT02870933|537180912|FG000|Overall Study|Death|2|||
148916641|NCT02870933|537180913|FG001|Overall Study|Death|1|||
148916642|NCT02870933|537180912|FG000|Overall Study|Withdrawal by Subject|0|||
148916643|NCT02870933|537180913|FG001|Overall Study|Withdrawal by Subject|1|||
148916644|NCT01250496|537180916|FG000|Overall Study|Study terminated|124|||
148916645|NCT01250496|537180917|FG001|Overall Study|Study terminated|124|||
148916646|NCT00003590|537180918|FG000|Overall Study|Ineligible Patient|1|||
148916647|NCT00003590|537180918|FG000|Overall Study|Adverse Event|7|||
148916648|NCT00003590|537180918|FG000|Overall Study|Withdrawal by Subject|1|||
148916649|NCT00003590|537180918|FG000|Overall Study|Lack of Efficacy|11|||
148916650|NCT00003590|537180918|FG000|Overall Study|Death|1|||
148916651|NCT00003590|537180918|FG000|Overall Study|Physician Decision|1|||
148916652|NCT01236547|537180921|FG000|Overall Study|Protocol Violation|0|||
148916653|NCT01236547|537180922|FG001|Overall Study|Protocol Violation|1|||
148916654|NCT01236547|537180923|FG002|Overall Study|Protocol Violation|1|||
148916655|NCT01236547|537180924|FG003|Overall Study|Protocol Violation|6|||
148916656|NCT01236547|537180925|FG004|Overall Study|Protocol Violation|12|||
148916657|NCT03615040|537180929|FG000|Overall Study|Withdrawal by Subject|2|||
148916658|NCT03615040|537180930|FG001|Overall Study|Withdrawal by Subject|1|||
148916659|NCT03615040|537180929|FG000|Overall Study|Physician Decision|2|||
148916660|NCT03615040|537180930|FG001|Overall Study|Physician Decision|2|||
148916661|NCT03615040|537180929|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
148916662|NCT03615040|537180930|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
148916663|NCT03615040|537180929|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
148916664|NCT03615040|537180930|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
148916665|NCT03615040|537180929|FG000|Overall Study|Death|0|||
148916666|NCT03615040|537180930|FG001|Overall Study|Death|2|||
148916667|NCT01541397|537180935|FG000|Overall Study|Study ended prior to data collection|4|||
148916668|NCT01541397|537180936|FG001|Overall Study|Study ended prior to data collection|2|||
148916669|NCT02365480|537180941|FG000|Overall Study|Withdrawal by Subject|2|||
148916670|NCT02365480|537180942|FG001|Overall Study|Withdrawal by Subject|0|||
148916671|NCT00706342|537180943|FG000|Overall Study|Adverse Event|3|||
148916672|NCT00706342|537180943|FG000|Overall Study|Not responding to treatment|2|||
149149144|NCT03776175|538026304|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
148916673|NCT00706342|537180943|FG000|Overall Study|Withdrawn due to failure to respond|1|||
148916674|NCT00706342|537180943|FG000|Overall Study|Death|1|||
148916675|NCT00706342|537180943|FG000|Overall Study|Withdrew from the study on his own.|1|||
148916676|NCT00706342|537180943|FG000|Overall Study|Investigator discretion|2|||
148916677|NCT00706342|537180943|FG000|Overall Study|Non-responder Week 12|1|||
148916678|NCT00706342|537180943|FG000|Overall Study|Ongoing|6|||
148916679|NCT00706342|537180943|FG000|Overall Study|WIthdrawal of consent|1|||
148916680|NCT01781299|537180948|FG000|Overall Study|Withdrawal by Subject|0|||
148916681|NCT01781299|537180949|FG001|Overall Study|Withdrawal by Subject|1|||
148916682|NCT02032238|537180954|FG000|Overall Study|Lost to Follow-up|2|||
148916683|NCT02032238|537180955|FG001|Overall Study|Lost to Follow-up|0|||
148916684|NCT00653939|537180956|FG000|Overall Study|Adverse Event|1|||
148916685|NCT00653939|537180957|FG001|Overall Study|Adverse Event|3|||
148916686|NCT00653939|537180956|FG000|Overall Study|Withdrawal by Subject|3|||
148916687|NCT00653939|537180957|FG001|Overall Study|Withdrawal by Subject|3|||
148916688|NCT00653939|537180956|FG000|Overall Study|Physician Decision|4|||
148916689|NCT00653939|537180957|FG001|Overall Study|Physician Decision|0|||
148916690|NCT00653939|537180956|FG000|Overall Study|Disease Progression|2|||
148916691|NCT00653939|537180957|FG001|Overall Study|Disease Progression|3|||
148916692|NCT00653939|537180956|FG000|Overall Study|Other|2|||
148916693|NCT00653939|537180957|FG001|Overall Study|Other|6|||
148916694|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
148916695|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
148916696|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
148916697|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
148916698|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
148916699|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
148916700|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
149149145|NCT03776175|538026305|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
149149146|NCT03776175|538026306|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
148916701|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
148916702|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
148916703|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
148916704|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
148916705|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
148916706|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
148916707|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
148916708|NCT00612105|537180958|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
148916709|NCT00612105|537180959|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
148916710|NCT00612105|537180958|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
148916711|NCT00612105|537180959|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
148916712|NCT00612105|537180958|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
148916713|NCT00612105|537180959|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
148916714|NCT00612105|537180958|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
148916715|NCT00612105|537180959|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
148916716|NCT00612105|537180958|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
148916717|NCT00612105|537180959|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
148916718|NCT00717236|537180960|FG000|Double-Blind Period|Adverse Event|33|||
148916719|NCT00717236|537180961|FG001|Double-Blind Period|Adverse Event|6|||
148916720|NCT00717236|537180960|FG000|Double-Blind Period|Lack of Efficacy|6|||
148916721|NCT00717236|537180961|FG001|Double-Blind Period|Lack of Efficacy|6|||
148916722|NCT00717236|537180960|FG000|Double-Blind Period|Lost to Follow-up|3|||
148916723|NCT00717236|537180961|FG001|Double-Blind Period|Lost to Follow-up|5|||
148916724|NCT00717236|537180960|FG000|Double-Blind Period|Withdrawal by Subject|10|||
148916725|NCT00717236|537180961|FG001|Double-Blind Period|Withdrawal by Subject|2|||
148916726|NCT00717236|537180960|FG000|Double-Blind Period|Loss of efficacy|3|||
148916727|NCT00717236|537180961|FG001|Double-Blind Period|Loss of efficacy|0|||
148916728|NCT00717236|537180960|FG000|Double-Blind Period|Other: Death|1|||
148916729|NCT00717236|537180961|FG001|Double-Blind Period|Other: Death|0|||
148916730|NCT00717236|537180960|FG000|Double-Blind Period|Other: Pregnancy|1|||
148916731|NCT00717236|537180961|FG001|Double-Blind Period|Other: Pregnancy|0|||
148916732|NCT00717236|537180960|FG000|Double-Blind Period|Other: Protocol Violation|2|||
148916733|NCT00717236|537180961|FG001|Double-Blind Period|Other: Protocol Violation|0|||
148916734|NCT00717236|537180960|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
148916735|NCT00717236|537180961|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
148916736|NCT00717236|537180960|FG000|Double-Blind Period|Other: Site withdrew|2|||
148916737|NCT00717236|537180961|FG001|Double-Blind Period|Other: Site withdrew|0|||
148916738|NCT00717236|537180960|FG000|Double-Blind Period|Other: Screening failure|1|||
148916739|NCT00717236|537180961|FG001|Double-Blind Period|Other: Screening failure|0|||
148916740|NCT00717236|537180960|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
148916741|NCT00717236|537180961|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
148916742|NCT00717236|537180960|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
148916743|NCT00717236|537180961|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
148916744|NCT00717236|537180960|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
148916745|NCT00717236|537180961|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
148916746|NCT00717236|537180960|FG000|Double-Blind Period|Other: History of cancer|1|||
148916747|NCT00717236|537180961|FG001|Double-Blind Period|Other: History of cancer|0|||
148916748|NCT00717236|537180960|FG000|Double-Blind Period|Other: Sponsor request|1|||
148916749|NCT00717236|537180961|FG001|Double-Blind Period|Other: Sponsor request|0|||
148916750|NCT00717236|537180960|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
148916751|NCT00717236|537180961|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
148916752|NCT00717236|537180960|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
148916753|NCT00717236|537180961|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
148916754|NCT00717236|537180960|FG000|Double-Blind Period|Other: Subject moved|1|||
148916755|NCT00717236|537180961|FG001|Double-Blind Period|Other: Subject moved|1|||
148916756|NCT00717236|537180960|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
148916757|NCT00717236|537180961|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
148916758|NCT00717236|537180960|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
148916759|NCT00717236|537180961|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
148916760|NCT00717236|537180960|FG000|Double-Blind Period|Other: Transportation problems|0|||
148916761|NCT00717236|537180961|FG001|Double-Blind Period|Other: Transportation problems|1|||
148916762|NCT00717236|537180960|FG000|Double-Blind Period|Other: Investigator Decision|0|||
148916763|NCT00717236|537180961|FG001|Double-Blind Period|Other: Investigator Decision|1|||
148916764|NCT00717236|537180960|FG000|Open-Label Period|Adverse Event|29|||
148916765|NCT00717236|537180961|FG001|Open-Label Period|Adverse Event|4|||
148916766|NCT00717236|537180960|FG000|Open-Label Period|Lack of Efficacy|30|||
148916767|NCT00717236|537180961|FG001|Open-Label Period|Lack of Efficacy|8|||
148916768|NCT00717236|537180960|FG000|Open-Label Period|Lost to Follow-up|28|||
148916769|NCT00717236|537180961|FG001|Open-Label Period|Lost to Follow-up|4|||
148916770|NCT00717236|537180960|FG000|Open-Label Period|Withdrawal by Subject|20|||
148916771|NCT00717236|537180961|FG001|Open-Label Period|Withdrawal by Subject|2|||
148916772|NCT00717236|537180960|FG000|Open-Label Period|Loss of Efficacy|6|||
148916773|NCT00717236|537180961|FG001|Open-Label Period|Loss of Efficacy|1|||
148916774|NCT00717236|537180960|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
148916775|NCT00717236|537180961|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
148916776|NCT00717236|537180960|FG000|Open-Label Period|Other: Lack of Compliance|1|||
148916777|NCT00717236|537180961|FG001|Open-Label Period|Other: Lack of Compliance|1|||
148916778|NCT00717236|537180960|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
148916779|NCT00717236|537180961|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
148916780|NCT00717236|537180960|FG000|Open-Label Period|Other: Moved|1|||
148916781|NCT00717236|537180961|FG001|Open-Label Period|Other: Moved|0|||
148916782|NCT00717236|537180960|FG000|Open-Label Period|Other: Investigator Decision|1|||
148916783|NCT00717236|537180961|FG001|Open-Label Period|Other: Investigator Decision|0|||
148916784|NCT00717236|537180960|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
148916785|NCT00717236|537180961|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
148916786|NCT00717236|537180960|FG000|Open-Label Period|Other: Sponsor Request|3|||
148916787|NCT00717236|537180961|FG001|Open-Label Period|Other: Sponsor Request|0|||
148916788|NCT00717236|537180960|FG000|Open-Label Period|Other: Cataract Surgery|1|||
148916789|NCT00717236|537180961|FG001|Open-Label Period|Other: Cataract Surgery|0|||
148916790|NCT00717236|537180960|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
148916791|NCT00717236|537180961|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
148916792|NCT00717236|537180960|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
148916793|NCT00717236|537180961|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
148916794|NCT00717236|537180960|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
148916795|NCT00717236|537180961|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
148916796|NCT00475982|537180962|FG000|Overall Study|surgery rescheduled|7|||
148916797|NCT00475982|537180963|FG001|Overall Study|surgery rescheduled|3|||
148916798|NCT01105767|537180964|FG000|Overall Study|Lost to Follow-up|1160|||
148916799|NCT01105767|537180965|FG001|Overall Study|Lost to Follow-up|1614|||
148916800|NCT01105767|537180966|FG002|Overall Study|Lost to Follow-up|1184|||
148916801|NCT00783198|537180975|FG000|Overall Study|Adverse Event|15|||
148916802|NCT00783198|537180976|FG001|Overall Study|Adverse Event|19|||
148916803|NCT00783198|537180977|FG002|Overall Study|Adverse Event|3|||
148916804|NCT00783198|537180975|FG000|Overall Study|Lost to Follow-up|11|||
148916805|NCT00783198|537180976|FG001|Overall Study|Lost to Follow-up|1|||
148916806|NCT00783198|537180977|FG002|Overall Study|Lost to Follow-up|7|||
148916807|NCT00783198|537180975|FG000|Overall Study|Withdrawal by Subject|22|||
148916808|NCT00783198|537180976|FG001|Overall Study|Withdrawal by Subject|14|||
148916809|NCT00783198|537180977|FG002|Overall Study|Withdrawal by Subject|20|||
148916810|NCT00783198|537180975|FG000|Overall Study|Noncompliance with protocol|7|||
148916811|NCT00783198|537180976|FG001|Overall Study|Noncompliance with protocol|7|||
148916812|NCT00783198|537180977|FG002|Overall Study|Noncompliance with protocol|10|||
148916813|NCT00783198|537180975|FG000|Overall Study|Did not meet protocol eligibility|0|||
148916814|NCT00783198|537180976|FG001|Overall Study|Did not meet protocol eligibility|1|||
148916815|NCT00783198|537180977|FG002|Overall Study|Did not meet protocol eligibility|0|||
148916816|NCT00783198|537180975|FG000|Overall Study|Administrative|2|||
148916817|NCT00783198|537180976|FG001|Overall Study|Administrative|1|||
148916818|NCT00783198|537180977|FG002|Overall Study|Administrative|2|||
148916819|NCT00271505|537180978|FG000|Overall Study|Screen Failure|3|||
148916820|NCT00271505|537180978|FG000|Overall Study|Adverse Event|1|||
148916821|NCT00271505|537180978|FG000|Overall Study|Death|1|||
148916822|NCT00119678|537180979|FG000|Double-blind Treatment Period|Death|1|||
148916823|NCT00119678|537180980|FG001|Double-blind Treatment Period|Death|0|||
148916824|NCT00119678|537180979|FG000|Double-blind Treatment Period|Adverse Event|7|||
148916825|NCT00119678|537180980|FG001|Double-blind Treatment Period|Adverse Event|1|||
148916826|NCT00119678|537180979|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
148916827|NCT00119678|537180980|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
148916828|NCT00119678|537180979|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
148916829|NCT00119678|537180980|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
148805524|NCT00042289|536767974|FG014|Overall Study|Severe debilitation, unable to continue|0|||
148805525|NCT00042289|536767975|FG015|Overall Study|Severe debilitation, unable to continue|0|||
148805526|NCT00042289|536767976|FG016|Overall Study|Severe debilitation, unable to continue|0|||
148805527|NCT00042289|536767977|FG017|Overall Study|Severe debilitation, unable to continue|0|||
148805528|NCT00042289|536767978|FG018|Overall Study|Severe debilitation, unable to continue|0|||
148805529|NCT00042289|536767979|FG019|Overall Study|Severe debilitation, unable to continue|0|||
148805530|NCT00042289|536767980|FG020|Overall Study|Severe debilitation, unable to continue|0|||
148805531|NCT00042289|536767981|FG021|Overall Study|Severe debilitation, unable to continue|1|||
148916830|NCT00119678|537180979|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
148916831|NCT00119678|537180980|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
148916832|NCT00119678|537180979|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
148916833|NCT00119678|537180980|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
148916834|NCT00119678|537180979|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
148916835|NCT00119678|537180980|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
148916836|NCT00119678|537180979|FG000|Double-blind Treatment Period|Pregnancy|0|||
148916837|NCT00119678|537180980|FG001|Double-blind Treatment Period|Pregnancy|2|||
148916838|NCT00119678|537180979|FG000|Double-blind Treatment Period|Not treated|1|||
148916839|NCT00119678|537180980|FG001|Double-blind Treatment Period|Not treated|2|||
148916840|NCT00119678|537180979|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
148916841|NCT00119678|537180980|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
148916842|NCT00119678|537180979|FG000|Open-label Treatment Period|Death|1|||
148916843|NCT00119678|537180980|FG001|Open-label Treatment Period|Death|0|||
148916844|NCT00119678|537180979|FG000|Open-label Treatment Period|Adverse Event|3|||
148916845|NCT00119678|537180980|FG001|Open-label Treatment Period|Adverse Event|0|||
148916846|NCT00119678|537180979|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
148916847|NCT00119678|537180980|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
148916848|NCT00119678|537180979|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
148916849|NCT00119678|537180980|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
148916850|NCT00119678|537180979|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
148916851|NCT00119678|537180980|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
148916852|NCT00119678|537180979|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
148916853|NCT00119678|537180980|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
148916854|NCT00119678|537180979|FG000|Open-label Treatment Period|Pregnancy|1|||
148916855|NCT00119678|537180980|FG001|Open-label Treatment Period|Pregnancy|0|||
148916856|NCT00119678|537180979|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
148916857|NCT00119678|537180980|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
148916858|NCT02720042|537180981|FG000|Overall Study|Death|3|||
148916859|NCT02720042|537180981|FG000|Overall Study|Lost to Follow-up|4|||
148916860|NCT02720042|537180981|FG000|Overall Study|Withdrawal by Subject|1|||
148916861|NCT02720042|537180981|FG000|Overall Study|Physician Decision|3|||
148916862|NCT02720042|537180981|FG000|Overall Study|Phasix Mesh explanted|1|||
148916863|NCT02720042|537180981|FG000|Overall Study|unable due to non-study-related illness|3|||
148916864|NCT01134705|537180986|FG000|Overall Study|Adverse Event|1|||
148916865|NCT01134705|537180987|FG001|Overall Study|Adverse Event|7|||
148916866|NCT01134705|537180986|FG000|Overall Study|Withdrawal by Subject|6|||
148916867|NCT01134705|537180987|FG001|Overall Study|Withdrawal by Subject|6|||
148916868|NCT01134705|537180986|FG000|Overall Study|Pregnancy|1|||
148916869|NCT01134705|537180987|FG001|Overall Study|Pregnancy|0|||
148916870|NCT01134705|537180986|FG000|Overall Study|Lost to Follow-up|5|||
148916871|NCT01134705|537180987|FG001|Overall Study|Lost to Follow-up|2|||
148916872|NCT01134705|537180986|FG000|Overall Study|Protocol Violation|1|||
148916873|NCT01134705|537180987|FG001|Overall Study|Protocol Violation|1|||
148916874|NCT01134705|537180986|FG000|Overall Study|Other|1|||
148916875|NCT01134705|537180987|FG001|Overall Study|Other|6|||
148916876|NCT01510769|537180988|FG000|Overall Study|Adverse Event|7|||
148916877|NCT01510769|537180989|FG001|Overall Study|Adverse Event|6|||
148916878|NCT01510769|537180990|FG002|Overall Study|Adverse Event|4|||
148916879|NCT01510769|537180988|FG000|Overall Study|Gout Flare|0|||
148916880|NCT01510769|537180989|FG001|Overall Study|Gout Flare|3|||
148916881|NCT01510769|537180990|FG002|Overall Study|Gout Flare|1|||
148916882|NCT01510769|537180988|FG000|Overall Study|Protocol Violation|11|||
148916883|NCT01510769|537180989|FG001|Overall Study|Protocol Violation|10|||
148916884|NCT01510769|537180990|FG002|Overall Study|Protocol Violation|9|||
148916885|NCT01510769|537180988|FG000|Overall Study|Lost to Follow-up|5|||
148916886|NCT01510769|537180989|FG001|Overall Study|Lost to Follow-up|1|||
148916887|NCT01510769|537180990|FG002|Overall Study|Lost to Follow-up|5|||
148916888|NCT01510769|537180988|FG000|Overall Study|Withdrawal by Subject|3|||
148916889|NCT01510769|537180989|FG001|Overall Study|Withdrawal by Subject|4|||
148916890|NCT01510769|537180990|FG002|Overall Study|Withdrawal by Subject|3|||
148916891|NCT01510769|537180988|FG000|Overall Study|Death|1|||
148916892|NCT01510769|537180989|FG001|Overall Study|Death|1|||
148916893|NCT01510769|537180990|FG002|Overall Study|Death|0|||
148916894|NCT00929643|537180991|FG000|Overall Study|Protocol Violation|2|||
148916895|NCT02874144|537180992|FG000|Overall Study|Lost to Follow-up|3|||
148916896|NCT02874144|537180993|FG001|Overall Study|Lost to Follow-up|5|||
148916897|NCT00486811|537180996|FG000|Overall Study|Adverse Event|28|||
148916898|NCT00486811|537180997|FG001|Overall Study|Adverse Event|60|||
148916899|NCT00486811|537180998|FG002|Overall Study|Adverse Event|135|||
148916900|NCT00486811|537180996|FG000|Overall Study|Lack of Efficacy|34|||
148916901|NCT00486811|537180997|FG001|Overall Study|Lack of Efficacy|14|||
148916902|NCT00486811|537180998|FG002|Overall Study|Lack of Efficacy|7|||
148916903|NCT00486811|537180996|FG000|Overall Study|Lost to Follow-up|4|||
148916904|NCT00486811|537180997|FG001|Overall Study|Lost to Follow-up|6|||
148916905|NCT00486811|537180998|FG002|Overall Study|Lost to Follow-up|4|||
148916906|NCT00486811|537180996|FG000|Overall Study|Withdrawal by Subject|33|||
148916907|NCT00486811|537180997|FG001|Overall Study|Withdrawal by Subject|44|||
148916908|NCT00486811|537180998|FG002|Overall Study|Withdrawal by Subject|58|||
148916909|NCT00486811|537180996|FG000|Overall Study|Study drug non-compliant|5|||
148916910|NCT00486811|537180997|FG001|Overall Study|Study drug non-compliant|6|||
148916911|NCT00486811|537180998|FG002|Overall Study|Study drug non-compliant|3|||
148916912|NCT00486811|537180996|FG000|Overall Study|All other|18|||
148916913|NCT00486811|537180997|FG001|Overall Study|All other|11|||
148916914|NCT00486811|537180998|FG002|Overall Study|All other|7|||
148916915|NCT01578850|537181005|FG000|Period 1|Insufficient Clinical Response|1|||
148916916|NCT01578850|537181006|FG001|Period 1|Insufficient Clinical Response|0|||
148916917|NCT01578850|537181007|FG002|Period 1|Insufficient Clinical Response|0|||
148916918|NCT01578850|537181005|FG000|Period 1|Adverse Event|11|||
148916919|NCT01578850|537181006|FG001|Period 1|Adverse Event|0|||
148916920|NCT01578850|537181007|FG002|Period 1|Adverse Event|0|||
148916921|NCT01578850|537181005|FG000|Period 1|Death|1|||
148916922|NCT01578850|537181006|FG001|Period 1|Death|0|||
148916923|NCT01578850|537181007|FG002|Period 1|Death|0|||
148916924|NCT01578850|537181005|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
148916925|NCT01578850|537181006|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
148916926|NCT01578850|537181007|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
148916927|NCT01578850|537181005|FG000|Period 1|Withdrawal by Subject|9|||
148916928|NCT01578850|537181006|FG001|Period 1|Withdrawal by Subject|0|||
148916929|NCT01578850|537181007|FG002|Period 1|Withdrawal by Subject|0|||
148916930|NCT01578850|537181005|FG000|Period 1|Study Terminated by Sponsor|3|||
148916931|NCT01578850|537181006|FG001|Period 1|Study Terminated by Sponsor|0|||
148916932|NCT01578850|537181007|FG002|Period 1|Study Terminated by Sponsor|0|||
148916933|NCT01578850|537181005|FG000|Period 2|Insufficient Clinical Response|0|||
148916934|NCT01578850|537181006|FG001|Period 2|Insufficient Clinical Response|1|||
148916935|NCT01578850|537181007|FG002|Period 2|Insufficient Clinical Response|0|||
148916936|NCT01578850|537181005|FG000|Period 2|Adverse Event|0|||
148916937|NCT01578850|537181006|FG001|Period 2|Adverse Event|3|||
148916938|NCT01578850|537181007|FG002|Period 2|Adverse Event|6|||
148916939|NCT01578850|537181005|FG000|Period 2|Lost to Follow-up|0|||
148916940|NCT01578850|537181006|FG001|Period 2|Lost to Follow-up|1|||
148916941|NCT01578850|537181007|FG002|Period 2|Lost to Follow-up|2|||
148916942|NCT01578850|537181005|FG000|Period 2|Withdrawal by Subject|0|||
148916943|NCT01578850|537181006|FG001|Period 2|Withdrawal by Subject|2|||
148916944|NCT01578850|537181007|FG002|Period 2|Withdrawal by Subject|2|||
148916945|NCT01578850|537181005|FG000|Period 2|Study Terminated by Sponsor|0|||
148916946|NCT01578850|537181006|FG001|Period 2|Study Terminated by Sponsor|5|||
148916947|NCT01578850|537181007|FG002|Period 2|Study Terminated by Sponsor|4|||
148916948|NCT01578850|537181005|FG000|Period 2|Unspecified Reasons|0|||
148916949|NCT01578850|537181006|FG001|Period 2|Unspecified Reasons|1|||
148916950|NCT01578850|537181007|FG002|Period 2|Unspecified Reasons|0|||
148916951|NCT03158285|537181008|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
148916952|NCT03158285|537181009|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
148916953|NCT03158285|537181010|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
148916954|NCT03158285|537181008|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
148916955|NCT03158285|537181009|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
148916956|NCT03158285|537181010|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
148916957|NCT03158285|537181008|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
148916958|NCT03158285|537181009|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
148916959|NCT03158285|537181010|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
148916960|NCT03158285|537181008|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
148916961|NCT03158285|537181009|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
148916962|NCT03158285|537181010|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
148916963|NCT03158285|537181008|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
148916964|NCT03158285|537181009|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
148916965|NCT03158285|537181010|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
148916966|NCT03158285|537181008|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
148916967|NCT03158285|537181009|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
148916968|NCT03158285|537181010|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
148916969|NCT03158285|537181008|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
148916970|NCT03158285|537181009|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
148916971|NCT03158285|537181010|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
148916972|NCT03158285|537181008|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
148916973|NCT03158285|537181009|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
148916974|NCT03158285|537181010|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
148916975|NCT03158285|537181008|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
148916976|NCT03158285|537181009|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
148916977|NCT03158285|537181010|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
148916978|NCT03158285|537181008|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
148916979|NCT03158285|537181009|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
148916980|NCT03158285|537181010|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
148916981|NCT03158285|537181008|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
148916982|NCT03158285|537181009|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
148916983|NCT03158285|537181010|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
148916984|NCT03158285|537181008|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
148916985|NCT03158285|537181009|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
148916986|NCT03158285|537181010|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
148916987|NCT03158285|537181008|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
148916988|NCT03158285|537181009|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
148916989|NCT03158285|537181010|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
148916990|NCT03158285|537181008|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
148916991|NCT03158285|537181009|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
148916992|NCT03158285|537181010|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
148916993|NCT03158285|537181008|FG000|Active Treatment Period: Week 52-100|Death|1|||
148916994|NCT03158285|537181009|FG001|Active Treatment Period: Week 52-100|Death|0|||
148916995|NCT03158285|537181010|FG002|Active Treatment Period: Week 52-100|Death|0|||
148916996|NCT03158285|537181008|FG000|Active Treatment Period: Week 52-100|Other|4|||
148916997|NCT03158285|537181009|FG001|Active Treatment Period: Week 52-100|Other|1|||
148916998|NCT03158285|537181010|FG002|Active Treatment Period: Week 52-100|Other|0|||
148916999|NCT01711216|537181011|FG000|Overall Study|Adverse Event|4|||
148917000|NCT01711216|537181011|FG000|Overall Study|Pregnancy|56|||
148917001|NCT01711216|537181011|FG000|Overall Study|Withdrawal by Subject|6|||
148917002|NCT01711216|537181011|FG000|Overall Study|Lost to Follow-up|46|||
148917003|NCT01711216|537181011|FG000|Overall Study|variety of other minor reasons|83|||
148917004|NCT01711216|537181011|FG000|Overall Study|no reason specified|22|||
148917005|NCT02228980|537181012|FG000|Overall Study|Adverse Event|14|||
148917006|NCT02228980|537181013|FG001|Overall Study|Adverse Event|0|||
148917007|NCT02228980|537181014|FG002|Overall Study|Adverse Event|0|||
148917008|NCT02228980|537181015|FG003|Overall Study|Adverse Event|0|||
148917009|NCT02228980|537181012|FG000|Overall Study|Protocol Violation|7|||
148917010|NCT02228980|537181013|FG001|Overall Study|Protocol Violation|0|||
148917011|NCT02228980|537181014|FG002|Overall Study|Protocol Violation|0|||
148917012|NCT02228980|537181015|FG003|Overall Study|Protocol Violation|0|||
148917013|NCT02228980|537181012|FG000|Overall Study|Withdrawal by Subject|3|||
148917014|NCT02228980|537181013|FG001|Overall Study|Withdrawal by Subject|3|||
148917015|NCT02228980|537181014|FG002|Overall Study|Withdrawal by Subject|2|||
148917016|NCT02228980|537181015|FG003|Overall Study|Withdrawal by Subject|3|||
148917017|NCT02929498|537181016|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
148917018|NCT02929498|537181017|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
148917019|NCT02929498|537181018|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
148917020|NCT02929498|537181016|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
148917021|NCT02929498|537181017|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
148917022|NCT02929498|537181018|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
148917023|NCT00750152|537181021|FG000|Overall Study|Adverse Event|2|||
148917024|NCT00750152|537181022|FG001|Overall Study|Adverse Event|1|||
148917025|NCT00750152|537181021|FG000|Overall Study|Lost to Follow-up|8|||
148917026|NCT00750152|537181022|FG001|Overall Study|Lost to Follow-up|13|||
148917027|NCT00750152|537181021|FG000|Overall Study|Withdrawal by Subject|3|||
148917028|NCT00750152|537181022|FG001|Overall Study|Withdrawal by Subject|3|||
148917029|NCT00750152|537181021|FG000|Overall Study|Physician Decision|1|||
148917030|NCT00750152|537181022|FG001|Overall Study|Physician Decision|1|||
148917031|NCT00750152|537181021|FG000|Overall Study|Non-compliance|0|||
148917032|NCT00750152|537181022|FG001|Overall Study|Non-compliance|1|||
148917033|NCT00750152|537181021|FG000|Overall Study|Termination by sponsor|1|||
148917034|NCT00750152|537181022|FG001|Overall Study|Termination by sponsor|0|||
148917035|NCT00750152|537181021|FG000|Overall Study|Other|7|||
148917036|NCT00750152|537181022|FG001|Overall Study|Other|8|||
148917037|NCT01028300|537181023|FG000|Overall Study|Study Terminated|4|||
148917038|NCT00715910|537181024|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
148917039|NCT00715910|537181025|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
148917040|NCT00715910|537181026|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
148917041|NCT00715910|537181027|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
148917042|NCT00715910|537181028|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
148917043|NCT00715910|537181029|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
148917044|NCT00715910|537181024|FG000|Booster and ESFU Phase|Other|0|||
148917045|NCT00715910|537181025|FG001|Booster and ESFU Phase|Other|0|||
148917046|NCT00715910|537181026|FG002|Booster and ESFU Phase|Other|0|||
148917047|NCT00715910|537181027|FG003|Booster and ESFU Phase|Other|5|||
148917048|NCT00715910|537181028|FG004|Booster and ESFU Phase|Other|1|||
148917049|NCT00715910|537181029|FG005|Booster and ESFU Phase|Other|0|||
148917050|NCT03698591|537181030|FG000|Overall Study|Withdrawal by Subject|2|||
148917051|NCT03698591|537181031|FG001|Overall Study|Withdrawal by Subject|2|||
148917052|NCT03698591|537181030|FG000|Overall Study|Failed drug screen|1|||
148917053|NCT03698591|537181031|FG001|Overall Study|Failed drug screen|1|||
148917054|NCT03698591|537181030|FG000|Overall Study|Failed health screen|0|||
148917055|NCT03698591|537181031|FG001|Overall Study|Failed health screen|1|||
148917056|NCT03698591|537181030|FG000|Overall Study|Ineligible for financial compensation|1|||
148917057|NCT03698591|537181031|FG001|Overall Study|Ineligible for financial compensation|0|||
148917058|NCT03698591|537181030|FG000|Overall Study|Equipment Error|1|||
148917059|NCT03698591|537181031|FG001|Overall Study|Equipment Error|0|||
148917060|NCT03698591|537181030|FG000|Overall Study|Could not establish TMS dosage|0|||
148917061|NCT03698591|537181031|FG001|Overall Study|Could not establish TMS dosage|1|||
148917062|NCT01165216|537181032|FG000|Overall Study|Adverse Event|6|||
148917063|NCT01165216|537181033|FG001|Overall Study|Adverse Event|3|||
148917064|NCT01165216|537181032|FG000|Overall Study|Withdrawal by Subject|1|||
148917065|NCT01165216|537181033|FG001|Overall Study|Withdrawal by Subject|1|||
148917066|NCT01165216|537181032|FG000|Overall Study|Disease progression|1|||
148917067|NCT01165216|537181033|FG001|Overall Study|Disease progression|3|||
148917068|NCT01379508|537181036|FG000|Treatment to Week 104|Adverse Event|2|||
148917069|NCT01379508|537181037|FG001|Treatment to Week 104|Adverse Event|0|||
148917070|NCT01379508|537181038|FG002|Treatment to Week 104|Adverse Event|5|||
148917071|NCT01379508|537181039|FG003|Treatment to Week 104|Adverse Event|0|||
148917072|NCT01379508|537181036|FG000|Treatment to Week 104|Abnormal lab value|1|||
148917073|NCT01379508|537181037|FG001|Treatment to Week 104|Abnormal lab value|0|||
148917074|NCT01379508|537181038|FG002|Treatment to Week 104|Abnormal lab value|0|||
148917075|NCT01379508|537181039|FG003|Treatment to Week 104|Abnormal lab value|0|||
148917076|NCT01379508|537181036|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
148917077|NCT01379508|537181037|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
148917078|NCT01379508|537181038|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
148917079|NCT01379508|537181039|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
148917080|NCT01379508|537181036|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
148917081|NCT01379508|537181037|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
148917082|NCT01379508|537181038|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
148917083|NCT01379508|537181039|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
148917084|NCT01379508|537181036|FG000|Treatment to Week 104|Lost to Follow-up|5|||
148917085|NCT01379508|537181037|FG001|Treatment to Week 104|Lost to Follow-up|0|||
148917086|NCT01379508|537181038|FG002|Treatment to Week 104|Lost to Follow-up|3|||
148917087|NCT01379508|537181039|FG003|Treatment to Week 104|Lost to Follow-up|0|||
148917088|NCT01379508|537181036|FG000|Treatment to Week 104|Administrative problems|3|||
148917089|NCT01379508|537181037|FG001|Treatment to Week 104|Administrative problems|1|||
148917090|NCT01379508|537181038|FG002|Treatment to Week 104|Administrative problems|0|||
148917091|NCT01379508|537181039|FG003|Treatment to Week 104|Administrative problems|0|||
148917092|NCT01379508|537181036|FG000|Treatment to Week 104|Protocol Violation|1|||
149149147|NCT03776175|538026303|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
148917093|NCT01379508|537181037|FG001|Treatment to Week 104|Protocol Violation|1|||
148917094|NCT01379508|537181038|FG002|Treatment to Week 104|Protocol Violation|1|||
148917095|NCT01379508|537181039|FG003|Treatment to Week 104|Protocol Violation|0|||
148917096|NCT01379508|537181036|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
148917097|NCT01379508|537181037|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
148917098|NCT01379508|537181038|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
148917099|NCT01379508|537181039|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
148917100|NCT01379508|537181036|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
148917101|NCT01379508|537181037|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
148917102|NCT01379508|537181038|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
148917103|NCT01379508|537181039|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
148917104|NCT01379508|537181036|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
149149148|NCT03776175|538026304|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
149149149|NCT03776175|538026305|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
148672203|NCT00388674|536270708|FG001|End of Study|Death|262|||
148672204|NCT00388674|536270707|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
148672205|NCT00388674|536270708|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
148672206|NCT00388674|536270707|FG000|End of Study|HCC|8|||
148672207|NCT00388674|536270708|FG001|End of Study|HCC|7|||
148672208|NCT00388674|536270707|FG000|End of Study|Lost to Follow-up|587|||
148672209|NCT00388674|536270708|FG001|End of Study|Lost to Follow-up|715|||
148672210|NCT00388674|536270707|FG000|End of Study|Malignancy (Non-HCC)|1|||
148672211|NCT00388674|536270708|FG001|End of Study|Malignancy (Non-HCC)|1|||
148672212|NCT00388674|536270707|FG000|End of Study|Non-Study Related Comorbidities|3|||
148672213|NCT00388674|536270708|FG001|End of Study|Non-Study Related Comorbidities|4|||
148672214|NCT00388674|536270707|FG000|End of Study|Not Defined|135|||
148672215|NCT00388674|536270708|FG001|End of Study|Not Defined|214|||
148672216|NCT00388674|536270707|FG000|End of Study|Participant Withdrew Consent|437|||
148672217|NCT00388674|536270708|FG001|End of Study|Participant Withdrew Consent|673|||
148672218|NCT00388674|536270707|FG000|End of Study|No Off-Treatment Status Data|22|||
148672219|NCT00388674|536270708|FG001|End of Study|No Off-Treatment Status Data|30|||
148672220|NCT00388674|536270707|FG000|End of Study|Not Reported|0|||
148672221|NCT00388674|536270708|FG001|End of Study|Not Reported|1|||
148672222|NCT00996632|536270713|FG000|Overall Study|Physician Decision|0|||
148672223|NCT00996632|536270714|FG001|Overall Study|Physician Decision|0|||
148672224|NCT04484805|536270725|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
148672225|NCT04484805|536270726|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
148672226|NCT04484805|536270725|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
148805532|NCT00042289|536767982|FG022|Overall Study|Severe debilitation, unable to continue|0|||
148805533|NCT00042289|536767983|FG023|Overall Study|Severe debilitation, unable to continue|1|||
148805534|NCT00042289|536767984|FG024|Overall Study|Severe debilitation, unable to continue|0|||
148805535|NCT00042289|536767985|FG025|Overall Study|Severe debilitation, unable to continue|0|||
148805536|NCT00042289|536767986|FG026|Overall Study|Severe debilitation, unable to continue|0|||
148805537|NCT00042289|536767987|FG027|Overall Study|Severe debilitation, unable to continue|1|||
148805538|NCT00042289|536767988|FG028|Overall Study|Severe debilitation, unable to continue|0|||
148805539|NCT00042289|536767989|FG029|Overall Study|Severe debilitation, unable to continue|0|||
148805540|NCT00042289|536767990|FG030|Overall Study|Severe debilitation, unable to continue|0|||
148805541|NCT00042289|536767991|FG031|Overall Study|Severe debilitation, unable to continue|1|||
148805542|NCT00042289|536767992|FG032|Overall Study|Severe debilitation, unable to continue|1|||
148805543|NCT00042289|536767993|FG033|Overall Study|Severe debilitation, unable to continue|0|||
148805544|NCT00042289|536767994|FG034|Overall Study|Severe debilitation, unable to continue|0|||
148805545|NCT00042289|536767995|FG035|Overall Study|Severe debilitation, unable to continue|0|||
148805546|NCT00042289|536767996|FG036|Overall Study|Severe debilitation, unable to continue|0|||
148805547|NCT00042289|536767997|FG037|Overall Study|Severe debilitation, unable to continue|0|||
148805548|NCT00042289|536767998|FG038|Overall Study|Severe debilitation, unable to continue|0|||
148805549|NCT00042289|536767999|FG039|Overall Study|Severe debilitation, unable to continue|0|||
148805550|NCT00042289|536768000|FG040|Overall Study|Severe debilitation, unable to continue|0|||
148805551|NCT00042289|536768001|FG041|Overall Study|Severe debilitation, unable to continue|0|||
148805552|NCT00042289|536768002|FG042|Overall Study|Severe debilitation, unable to continue|0|||
148805553|NCT00042289|536768003|FG043|Overall Study|Severe debilitation, unable to continue|0|||
148805554|NCT00042289|536768004|FG044|Overall Study|Severe debilitation, unable to continue|0|||
148805555|NCT00042289|536768005|FG045|Overall Study|Severe debilitation, unable to continue|0|||
148805556|NCT00042289|536768006|FG046|Overall Study|Severe debilitation, unable to continue|0|||
148805557|NCT00042289|536767960|FG000|Overall Study|Site closed|0|||
148805558|NCT00042289|536767961|FG001|Overall Study|Site closed|0|||
148805559|NCT00042289|536767962|FG002|Overall Study|Site closed|0|||
148805560|NCT00042289|536767963|FG003|Overall Study|Site closed|0|||
148805561|NCT00042289|536767964|FG004|Overall Study|Site closed|0|||
148805562|NCT00042289|536767965|FG005|Overall Study|Site closed|0|||
148805563|NCT00042289|536767966|FG006|Overall Study|Site closed|0|||
148805564|NCT00042289|536767967|FG007|Overall Study|Site closed|0|||
148805565|NCT00042289|536767968|FG008|Overall Study|Site closed|0|||
148805566|NCT00042289|536767969|FG009|Overall Study|Site closed|0|||
148805567|NCT00042289|536767970|FG010|Overall Study|Site closed|0|||
148805568|NCT00042289|536767971|FG011|Overall Study|Site closed|0|||
148805569|NCT00042289|536767972|FG012|Overall Study|Site closed|0|||
148805570|NCT00042289|536767973|FG013|Overall Study|Site closed|0|||
148805571|NCT00042289|536767974|FG014|Overall Study|Site closed|0|||
148805572|NCT00042289|536767975|FG015|Overall Study|Site closed|0|||
148805573|NCT00042289|536767976|FG016|Overall Study|Site closed|0|||
148805574|NCT00042289|536767977|FG017|Overall Study|Site closed|0|||
148805575|NCT00042289|536767978|FG018|Overall Study|Site closed|0|||
148805576|NCT00042289|536767979|FG019|Overall Study|Site closed|0|||
148805577|NCT00042289|536767980|FG020|Overall Study|Site closed|0|||
148805578|NCT00042289|536767981|FG021|Overall Study|Site closed|0|||
148805579|NCT00042289|536767982|FG022|Overall Study|Site closed|0|||
148805580|NCT00042289|536767983|FG023|Overall Study|Site closed|0|||
148805581|NCT00042289|536767984|FG024|Overall Study|Site closed|0|||
148805582|NCT00042289|536767985|FG025|Overall Study|Site closed|0|||
148917105|NCT01379508|537181037|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
148917106|NCT01379508|537181038|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
148917107|NCT01379508|537181039|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
148917108|NCT01379508|537181036|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
148917109|NCT01379508|537181037|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
148917110|NCT01379508|537181038|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
148917111|NCT01379508|537181039|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
148917112|NCT02626624|537181042|FG000|Overall Study|Adverse Event|1|||
148917113|NCT02626624|537181042|FG000|Overall Study|Lost to Follow-up|3|||
148917114|NCT02626624|537181042|FG000|Overall Study|Protocol Violation|4|||
148917115|NCT02626624|537181042|FG000|Overall Study|Death|2|||
148917116|NCT03865316|537182455|FG000|Overall Study|Procedure Cancelled|4|||
148917117|NCT03865316|537182455|FG000|Overall Study|Equipment failure|4|||
148917118|NCT03137069|537182461|FG000|Overall Study|Withdrawal by Subject|1|||
148917119|NCT03137069|537182462|FG001|Overall Study|Withdrawal by Subject|2|||
148917120|NCT03137069|537182463|FG002|Overall Study|Withdrawal by Subject|2|||
148917121|NCT03137069|537182464|FG003|Overall Study|Withdrawal by Subject|2|||
148917122|NCT03137069|537182465|FG004|Overall Study|Withdrawal by Subject|0|||
148917123|NCT03137069|537182466|FG005|Overall Study|Withdrawal by Subject|0|||
148917124|NCT03137069|537182461|FG000|Overall Study|Adverse Event|0|||
148917125|NCT03137069|537182462|FG001|Overall Study|Adverse Event|3|||
148917126|NCT03137069|537182463|FG002|Overall Study|Adverse Event|1|||
148917127|NCT03137069|537182464|FG003|Overall Study|Adverse Event|1|||
148917128|NCT03137069|537182465|FG004|Overall Study|Adverse Event|0|||
148917129|NCT03137069|537182466|FG005|Overall Study|Adverse Event|1|||
148917130|NCT03137069|537182461|FG000|Overall Study|Protocol Violation|0|||
148917131|NCT03137069|537182462|FG001|Overall Study|Protocol Violation|1|||
148917132|NCT03137069|537182463|FG002|Overall Study|Protocol Violation|0|||
148917133|NCT03137069|537182464|FG003|Overall Study|Protocol Violation|1|||
148917134|NCT03137069|537182465|FG004|Overall Study|Protocol Violation|1|||
148917135|NCT03137069|537182466|FG005|Overall Study|Protocol Violation|1|||
148917136|NCT03137069|537182461|FG000|Overall Study|Physician Decision|0|||
148917137|NCT03137069|537182462|FG001|Overall Study|Physician Decision|0|||
148917138|NCT03137069|537182463|FG002|Overall Study|Physician Decision|0|||
148917139|NCT03137069|537182464|FG003|Overall Study|Physician Decision|1|||
148917140|NCT03137069|537182465|FG004|Overall Study|Physician Decision|0|||
148917141|NCT03137069|537182466|FG005|Overall Study|Physician Decision|0|||
148917142|NCT03137069|537182461|FG000|Overall Study|Study Terminated by Sponsor|0|||
148917143|NCT03137069|537182462|FG001|Overall Study|Study Terminated by Sponsor|0|||
148917144|NCT03137069|537182463|FG002|Overall Study|Study Terminated by Sponsor|0|||
148917145|NCT03137069|537182464|FG003|Overall Study|Study Terminated by Sponsor|0|||
148917146|NCT03137069|537182465|FG004|Overall Study|Study Terminated by Sponsor|1|||
148917147|NCT03137069|537182466|FG005|Overall Study|Study Terminated by Sponsor|0|||
148917148|NCT03137069|537182461|FG000|Overall Study|Data Entry Error|0|||
148917149|NCT03137069|537182462|FG001|Overall Study|Data Entry Error|0|||
148917150|NCT03137069|537182463|FG002|Overall Study|Data Entry Error|0|||
148917151|NCT03137069|537182464|FG003|Overall Study|Data Entry Error|1|||
148917152|NCT03137069|537182465|FG004|Overall Study|Data Entry Error|0|||
148917153|NCT03137069|537182466|FG005|Overall Study|Data Entry Error|0|||
148917154|NCT00336856|537182467|FG000|Overall Study|Withdrawal by Subject|3|||
148917155|NCT00336856|537182467|FG000|Overall Study|Found ineligible at time of analysis|1|||
148917156|NCT02522624|537182469|FG000|Overall Study|Technical failure|1|||
148917157|NCT02522624|537182470|FG001|Overall Study|Technical failure|0|||
148917158|NCT01325337|537182471|FG000|Overall Study|Adverse Event|0|||
148917159|NCT01325337|537182472|FG001|Overall Study|Adverse Event|2|||
148917160|NCT01325337|537182473|FG002|Overall Study|Adverse Event|2|||
148917161|NCT01325337|537182474|FG003|Overall Study|Adverse Event|1|||
148917162|NCT01325337|537182475|FG004|Overall Study|Adverse Event|2|||
148917163|NCT01325337|537182471|FG000|Overall Study|Lost to Follow-up|2|||
148917164|NCT01325337|537182472|FG001|Overall Study|Lost to Follow-up|2|||
148917165|NCT01325337|537182473|FG002|Overall Study|Lost to Follow-up|2|||
148917166|NCT01325337|537182474|FG003|Overall Study|Lost to Follow-up|1|||
148917167|NCT01325337|537182475|FG004|Overall Study|Lost to Follow-up|2|||
148917168|NCT01325337|537182471|FG000|Overall Study|Personal Reasons|2|||
148917169|NCT01325337|537182472|FG001|Overall Study|Personal Reasons|5|||
149149150|NCT03776175|538026306|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
148917170|NCT01325337|537182473|FG002|Overall Study|Personal Reasons|4|||
148917171|NCT01325337|537182474|FG003|Overall Study|Personal Reasons|8|||
148917172|NCT01325337|537182475|FG004|Overall Study|Personal Reasons|3|||
148917173|NCT01325337|537182471|FG000|Overall Study|Withdrawal by Subject|1|||
148917174|NCT01325337|537182472|FG001|Overall Study|Withdrawal by Subject|0|||
148917175|NCT01325337|537182473|FG002|Overall Study|Withdrawal by Subject|1|||
148917176|NCT01325337|537182474|FG003|Overall Study|Withdrawal by Subject|0|||
148917177|NCT01325337|537182475|FG004|Overall Study|Withdrawal by Subject|1|||
148917178|NCT00843778|537182488|FG000|Overall Study|Adverse Event|15|||
148917179|NCT00843778|537182488|FG000|Overall Study|Lack of Efficacy|14|||
148917180|NCT00843778|537182488|FG000|Overall Study|Loss of efficacy|2|||
148917181|NCT00843778|537182488|FG000|Overall Study|Withdrawal by Subject|4|||
148672227|NCT04484805|536270726|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
148672228|NCT02118896|536270727|FG000|Overall Study|Death|4|||
148672229|NCT02118896|536270728|FG001|Overall Study|Death|0|||
148672230|NCT02118896|536270729|FG002|Overall Study|Death|4|||
148672231|NCT02118896|536270730|FG003|Overall Study|Death|6|||
148672232|NCT02118896|536270731|FG004|Overall Study|Death|3|||
148672233|NCT02118896|536270732|FG005|Overall Study|Death|1|||
148672234|NCT02118896|536270733|FG006|Overall Study|Death|0|||
148672235|NCT02118896|536270734|FG007|Overall Study|Death|0|||
148672236|NCT02118896|536270735|FG008|Overall Study|Death|0|||
148672237|NCT02118896|536270736|FG009|Overall Study|Death|0|||
148672238|NCT02118896|536270727|FG000|Overall Study|Adverse Event|5|||
148672239|NCT02118896|536270728|FG001|Overall Study|Adverse Event|4|||
148672240|NCT02118896|536270729|FG002|Overall Study|Adverse Event|4|||
148672241|NCT02118896|536270730|FG003|Overall Study|Adverse Event|5|||
148672242|NCT02118896|536270731|FG004|Overall Study|Adverse Event|5|||
148672243|NCT02118896|536270732|FG005|Overall Study|Adverse Event|9|||
148672244|NCT02118896|536270733|FG006|Overall Study|Adverse Event|1|||
148672245|NCT02118896|536270734|FG007|Overall Study|Adverse Event|1|||
148672246|NCT02118896|536270735|FG008|Overall Study|Adverse Event|4|||
148672247|NCT02118896|536270736|FG009|Overall Study|Adverse Event|0|||
148672248|NCT02118896|536270727|FG000|Overall Study|Consent withdrawn|2|||
148672249|NCT02118896|536270728|FG001|Overall Study|Consent withdrawn|0|||
148672250|NCT02118896|536270729|FG002|Overall Study|Consent withdrawn|3|||
148672251|NCT02118896|536270730|FG003|Overall Study|Consent withdrawn|4|||
148672252|NCT02118896|536270731|FG004|Overall Study|Consent withdrawn|1|||
148672253|NCT02118896|536270732|FG005|Overall Study|Consent withdrawn|4|||
148672254|NCT02118896|536270733|FG006|Overall Study|Consent withdrawn|0|||
148672255|NCT02118896|536270734|FG007|Overall Study|Consent withdrawn|0|||
148672256|NCT02118896|536270735|FG008|Overall Study|Consent withdrawn|0|||
148672257|NCT02118896|536270736|FG009|Overall Study|Consent withdrawn|0|||
148672258|NCT02118896|536270727|FG000|Overall Study|Non-compliance|2|||
148672259|NCT02118896|536270728|FG001|Overall Study|Non-compliance|1|||
148672260|NCT02118896|536270729|FG002|Overall Study|Non-compliance|1|||
148672261|NCT02118896|536270730|FG003|Overall Study|Non-compliance|5|||
148672262|NCT02118896|536270731|FG004|Overall Study|Non-compliance|0|||
148672263|NCT02118896|536270732|FG005|Overall Study|Non-compliance|1|||
148672264|NCT02118896|536270733|FG006|Overall Study|Non-compliance|0|||
148672265|NCT02118896|536270734|FG007|Overall Study|Non-compliance|1|||
148672266|NCT02118896|536270735|FG008|Overall Study|Non-compliance|0|||
148672267|NCT02118896|536270736|FG009|Overall Study|Non-compliance|0|||
148672268|NCT02118896|536270727|FG000|Overall Study|Pregnancy|1|||
148672269|NCT02118896|536270728|FG001|Overall Study|Pregnancy|1|||
148672270|NCT02118896|536270729|FG002|Overall Study|Pregnancy|0|||
148672271|NCT02118896|536270730|FG003|Overall Study|Pregnancy|0|||
148672272|NCT02118896|536270731|FG004|Overall Study|Pregnancy|1|||
148672273|NCT02118896|536270732|FG005|Overall Study|Pregnancy|3|||
148672274|NCT02118896|536270733|FG006|Overall Study|Pregnancy|1|||
148672275|NCT02118896|536270734|FG007|Overall Study|Pregnancy|0|||
148672276|NCT02118896|536270735|FG008|Overall Study|Pregnancy|0|||
148672277|NCT02118896|536270736|FG009|Overall Study|Pregnancy|0|||
148917182|NCT00730028|537182495|FG000|Overall Study|Adverse Event|23|||
148917183|NCT00730028|537182496|FG001|Overall Study|Adverse Event|26|||
148917184|NCT00730028|537182497|FG002|Overall Study|Adverse Event|16|||
148917185|NCT00730028|537182498|FG003|Overall Study|Adverse Event|20|||
148917186|NCT00730028|537182499|FG004|Overall Study|Adverse Event|43|||
148917187|NCT00730028|537182495|FG000|Overall Study|Lost to Follow-up|13|||
148672278|NCT02118896|536270727|FG000|Overall Study|Lost to Follow-up|1|||
148672279|NCT02118896|536270728|FG001|Overall Study|Lost to Follow-up|2|||
148672280|NCT02118896|536270729|FG002|Overall Study|Lost to Follow-up|1|||
148672281|NCT02118896|536270730|FG003|Overall Study|Lost to Follow-up|0|||
148672282|NCT02118896|536270731|FG004|Overall Study|Lost to Follow-up|2|||
148672283|NCT02118896|536270732|FG005|Overall Study|Lost to Follow-up|1|||
148672284|NCT02118896|536270733|FG006|Overall Study|Lost to Follow-up|0|||
148672285|NCT02118896|536270734|FG007|Overall Study|Lost to Follow-up|0|||
148672286|NCT02118896|536270735|FG008|Overall Study|Lost to Follow-up|0|||
148672287|NCT02118896|536270736|FG009|Overall Study|Lost to Follow-up|0|||
148672288|NCT02118896|536270727|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
148672289|NCT02118896|536270728|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
148672290|NCT02118896|536270729|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
148672291|NCT02118896|536270730|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
148672292|NCT02118896|536270731|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
148672293|NCT02118896|536270732|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
148672294|NCT02118896|536270733|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
148672295|NCT02118896|536270734|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
148672296|NCT02118896|536270735|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
148672297|NCT02118896|536270736|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
148672298|NCT02118896|536270727|FG000|Overall Study|Prohibited medication|0|||
148917188|NCT00730028|537182496|FG001|Overall Study|Lost to Follow-up|26|||
148672299|NCT02118896|536270728|FG001|Overall Study|Prohibited medication|0|||
148917189|NCT00730028|537182497|FG002|Overall Study|Lost to Follow-up|22|||
148917190|NCT00730028|537182498|FG003|Overall Study|Lost to Follow-up|26|||
148917191|NCT00730028|537182499|FG004|Overall Study|Lost to Follow-up|25|||
148917192|NCT00730028|537182495|FG000|Overall Study|Protocol Violation|6|||
148917193|NCT00730028|537182496|FG001|Overall Study|Protocol Violation|1|||
148917194|NCT00730028|537182497|FG002|Overall Study|Protocol Violation|1|||
148917195|NCT00730028|537182498|FG003|Overall Study|Protocol Violation|2|||
148917196|NCT00730028|537182499|FG004|Overall Study|Protocol Violation|0|||
148917197|NCT00730028|537182495|FG000|Overall Study|Withdrawal by Subject|9|||
148917198|NCT00730028|537182496|FG001|Overall Study|Withdrawal by Subject|5|||
148917199|NCT00730028|537182497|FG002|Overall Study|Withdrawal by Subject|4|||
148917200|NCT00730028|537182498|FG003|Overall Study|Withdrawal by Subject|5|||
148917201|NCT00730028|537182499|FG004|Overall Study|Withdrawal by Subject|9|||
148917202|NCT00730028|537182495|FG000|Overall Study|Physician Decision|3|||
148917203|NCT00730028|537182496|FG001|Overall Study|Physician Decision|3|||
148917204|NCT00730028|537182497|FG002|Overall Study|Physician Decision|2|||
148917205|NCT00730028|537182498|FG003|Overall Study|Physician Decision|3|||
148917206|NCT00730028|537182499|FG004|Overall Study|Physician Decision|2|||
148917207|NCT00730028|537182495|FG000|Overall Study|Treatment Failure|5|||
148917208|NCT00730028|537182496|FG001|Overall Study|Treatment Failure|5|||
148917209|NCT00730028|537182497|FG002|Overall Study|Treatment Failure|0|||
148917210|NCT00730028|537182498|FG003|Overall Study|Treatment Failure|0|||
148917211|NCT00730028|537182499|FG004|Overall Study|Treatment Failure|1|||
148917212|NCT00730028|537182495|FG000|Overall Study|Randomization Error|1|||
148917213|NCT00730028|537182496|FG001|Overall Study|Randomization Error|0|||
148917214|NCT00730028|537182497|FG002|Overall Study|Randomization Error|0|||
148917215|NCT00730028|537182498|FG003|Overall Study|Randomization Error|0|||
148917216|NCT00730028|537182499|FG004|Overall Study|Randomization Error|2|||
148917217|NCT04022733|537182500|FG000|Overall Study|conversion to open surgery|3|||
148917218|NCT04022733|537182501|FG001|Overall Study|conversion to open surgery|2|||
148917219|NCT04022733|537182500|FG000|Overall Study|bradycardia|0|||
148917220|NCT04022733|537182501|FG001|Overall Study|bradycardia|1|||
148917221|NCT01128621|537182502|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
148917222|NCT01128621|537182503|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
148917223|NCT00233454|537182507|FG000|Overall Study|Death|6|||
148917224|NCT04224688|537182508|FG000|Overall Study|Withdrawal by Subject|1|||
148917225|NCT04224688|537182509|FG001|Overall Study|Withdrawal by Subject|3|||
148917226|NCT04224688|537182508|FG000|Overall Study|Lack of Efficacy|1|||
148917227|NCT04224688|537182509|FG001|Overall Study|Lack of Efficacy|1|||
148917228|NCT04224688|537182508|FG000|Overall Study|Adverse event, not fatal|0|||
148917229|NCT04224688|537182509|FG001|Overall Study|Adverse event, not fatal|2|||
148917230|NCT04224688|537182508|FG000|Overall Study|COVID-19|0|||
148917231|NCT04224688|537182509|FG001|Overall Study|COVID-19|1|||
148917232|NCT04074161|537182510|FG000|Overall Study|Withdrawal by Subject|2|||
148917233|NCT04074161|537182511|FG001|Overall Study|Withdrawal by Subject|4|||
148917234|NCT04074161|537182512|FG002|Overall Study|Withdrawal by Subject|1|||
148917235|NCT04074161|537182510|FG000|Overall Study|Lost to Follow-up|4|||
148917236|NCT04074161|537182511|FG001|Overall Study|Lost to Follow-up|5|||
148917237|NCT04074161|537182512|FG002|Overall Study|Lost to Follow-up|3|||
148917238|NCT00864916|537182513|FG000|Overall Study|Lost to Follow-up|4|||
148917239|NCT00864916|537182514|FG001|Overall Study|Lost to Follow-up|4|||
148917240|NCT00864916|537182513|FG000|Overall Study|Protocol Violation|1|||
148917241|NCT00864916|537182514|FG001|Overall Study|Protocol Violation|0|||
148917242|NCT00864916|537182513|FG000|Overall Study|Withdrawal by Subject|1|||
148917243|NCT00864916|537182514|FG001|Overall Study|Withdrawal by Subject|0|||
148917244|NCT00329849|537182518|FG000|Overall Study|Withdrawal by Subject|6|||
148917245|NCT00329849|537182519|FG001|Overall Study|Withdrawal by Subject|4|||
148917246|NCT00322621|537182520|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
148917247|NCT00322621|537182521|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
148917248|NCT00322621|537182522|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
148917249|NCT00322621|537182520|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
148917250|NCT00322621|537182521|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
148917251|NCT00322621|537182522|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
148917252|NCT00322621|537182520|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
148917253|NCT00322621|537182521|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
148917254|NCT00322621|537182522|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
148917255|NCT00322621|537182520|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
148917256|NCT00322621|537182521|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
148917257|NCT00322621|537182522|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
148917258|NCT00322621|537182520|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
148917259|NCT00322621|537182521|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
148917260|NCT00322621|537182522|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
148917261|NCT00322621|537182520|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
148917262|NCT00322621|537182521|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
148917263|NCT00322621|537182522|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
149149151|NCT00960661|538026307|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
149149152|NCT00960661|538026308|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
148917264|NCT00322621|537182520|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
148917265|NCT00322621|537182521|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
148917266|NCT00322621|537182522|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
148917267|NCT00322621|537182520|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
148917268|NCT00322621|537182521|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
148917269|NCT00322621|537182522|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
148917270|NCT00322621|537182520|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
148917271|NCT00322621|537182521|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
148917272|NCT00322621|537182522|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
148917273|NCT00322621|537182520|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
148917274|NCT00322621|537182521|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
148917275|NCT00322621|537182522|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
148917276|NCT00322621|537182520|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
148917277|NCT00322621|537182521|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
148917278|NCT00322621|537182522|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
148917279|NCT01038869|537182525|FG000|Overall Study|Withdrawal by Subject|1|||
148917280|NCT01038869|537182525|FG000|Overall Study|Lost to Follow-up|6|||
148917281|NCT02238067|537182526|FG000|Overall Study|Not completed survey at Month 6|45|||
148917282|NCT03726996|537182530|FG000|Overall Study|Parent's decision|2|||
148917283|NCT03726996|537182530|FG000|Overall Study|Study early termination|2|||
148917284|NCT01328444|537182531|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
148917285|NCT01328444|537182532|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
148917286|NCT01328444|537182533|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
148917287|NCT01328444|537182534|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
148917288|NCT01328444|537182535|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
148917289|NCT01328444|537182536|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
148917290|NCT01328444|537182531|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
148917291|NCT01328444|537182532|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
148917292|NCT01328444|537182533|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
148917293|NCT01328444|537182534|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
148917294|NCT01328444|537182535|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
148917295|NCT01328444|537182536|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
148917296|NCT01328444|537182531|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
148917297|NCT01328444|537182532|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
148917298|NCT01328444|537182533|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
148917299|NCT01328444|537182534|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
148917300|NCT01328444|537182535|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
148917301|NCT01328444|537182536|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
148917302|NCT01328444|537182531|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
148917303|NCT01328444|537182532|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
148917304|NCT01328444|537182533|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
148917305|NCT01328444|537182534|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
148917306|NCT01328444|537182535|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
148917307|NCT01328444|537182536|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
148917308|NCT01328444|537182531|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
148917309|NCT01328444|537182532|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148917310|NCT01328444|537182533|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148917311|NCT01328444|537182534|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
148917312|NCT01328444|537182535|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148917313|NCT01328444|537182536|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
148917314|NCT01328444|537182531|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
148917315|NCT01328444|537182532|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
148917316|NCT01328444|537182533|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
148917317|NCT01328444|537182534|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
148917318|NCT01328444|537182535|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
148917319|NCT01328444|537182536|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
148805583|NCT00042289|536767986|FG026|Overall Study|Site closed|0|||
148805584|NCT00042289|536767987|FG027|Overall Study|Site closed|0|||
148805585|NCT00042289|536767988|FG028|Overall Study|Site closed|0|||
148805586|NCT00042289|536767989|FG029|Overall Study|Site closed|0|||
148805587|NCT00042289|536767990|FG030|Overall Study|Site closed|0|||
148805588|NCT00042289|536767991|FG031|Overall Study|Site closed|3|||
148805589|NCT00042289|536767992|FG032|Overall Study|Site closed|0|||
148805590|NCT00042289|536767993|FG033|Overall Study|Site closed|0|||
148805591|NCT00042289|536767994|FG034|Overall Study|Site closed|0|||
149149153|NCT00960661|538026309|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
149149154|NCT00960661|538026307|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
149149155|NCT00960661|538026308|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
149149156|NCT00960661|538026309|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
149149157|NCT00960661|538026307|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
149149158|NCT00960661|538026308|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
149149159|NCT00960661|538026309|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
149149160|NCT00960661|538026307|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
149149161|NCT00960661|538026308|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
149149162|NCT00960661|538026309|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
149149163|NCT00960661|538026307|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
149149164|NCT00960661|538026308|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
149149165|NCT00960661|538026309|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
149149166|NCT00960661|538026307|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
149149167|NCT00960661|538026308|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
149149168|NCT00960661|538026309|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
149149169|NCT00960661|538026307|FG000|Interventional Phase|Adverse Event|0|||
149149170|NCT00960661|538026308|FG001|Interventional Phase|Adverse Event|17|||
149149171|NCT00960661|538026309|FG002|Interventional Phase|Adverse Event|8|||
149149172|NCT00960661|538026307|FG000|Interventional Phase|Death|0|||
149149173|NCT00960661|538026308|FG001|Interventional Phase|Death|1|||
149149174|NCT00960661|538026309|FG002|Interventional Phase|Death|0|||
149149175|NCT00960661|538026307|FG000|Interventional Phase|Lost to Follow-up|0|||
149149176|NCT00960661|538026308|FG001|Interventional Phase|Lost to Follow-up|0|||
149149177|NCT00960661|538026309|FG002|Interventional Phase|Lost to Follow-up|2|||
149149178|NCT00960661|538026307|FG000|Interventional Phase|entry criteria not met|0|||
148917320|NCT01328444|537182531|FG000|Washout Period (14 Days)|Adverse Event|1|||
148917321|NCT01328444|537182532|FG001|Washout Period (14 Days)|Adverse Event|1|||
148917322|NCT01328444|537182533|FG002|Washout Period (14 Days)|Adverse Event|0|||
148917323|NCT01328444|537182534|FG003|Washout Period (14 Days)|Adverse Event|1|||
148917324|NCT01328444|537182535|FG004|Washout Period (14 Days)|Adverse Event|1|||
149149179|NCT00960661|538026308|FG001|Interventional Phase|entry criteria not met|3|||
149149180|NCT00960661|538026309|FG002|Interventional Phase|entry criteria not met|0|||
149149181|NCT00960661|538026307|FG000|Interventional Phase|Protocol Violation|0|||
149149182|NCT00960661|538026308|FG001|Interventional Phase|Protocol Violation|7|||
149149183|NCT00960661|538026309|FG002|Interventional Phase|Protocol Violation|2|||
149149184|NCT00960661|538026307|FG000|Interventional Phase|Withdrawal by Subject|0|||
149149185|NCT00960661|538026308|FG001|Interventional Phase|Withdrawal by Subject|18|||
149149186|NCT00960661|538026309|FG002|Interventional Phase|Withdrawal by Subject|29|||
149149187|NCT00960661|538026307|FG000|Interventional Phase|Physician Decision|0|||
149149188|NCT00960661|538026308|FG001|Interventional Phase|Physician Decision|3|||
149149189|NCT00960661|538026309|FG002|Interventional Phase|Physician Decision|5|||
148917325|NCT01328444|537182536|FG005|Washout Period (14 Days)|Adverse Event|2|||
148917326|NCT01328444|537182531|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
148917327|NCT01328444|537182532|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
148917328|NCT01328444|537182533|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
148917329|NCT01328444|537182534|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
148917330|NCT01328444|537182535|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
148917331|NCT01328444|537182536|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
148917332|NCT01328444|537182531|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
148917333|NCT01328444|537182532|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
148917334|NCT01328444|537182533|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
148917335|NCT01328444|537182534|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
148917336|NCT01328444|537182535|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
148917337|NCT01328444|537182536|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
148917338|NCT01328444|537182531|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
148917339|NCT01328444|537182532|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
148917340|NCT01328444|537182533|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
148917341|NCT01328444|537182534|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
148917342|NCT01328444|537182535|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
148917343|NCT01328444|537182536|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
148917344|NCT01328444|537182531|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
149149190|NCT00960661|538026307|FG000|Interventional Phase|sponsor decision|0|||
149149191|NCT00960661|538026308|FG001|Interventional Phase|sponsor decision|1|||
149149192|NCT00960661|538026309|FG002|Interventional Phase|sponsor decision|0|||
149149193|NCT00960661|538026307|FG000|Interventional Phase|Lack of Efficacy|0|||
149149194|NCT00960661|538026308|FG001|Interventional Phase|Lack of Efficacy|2|||
149149195|NCT00960661|538026309|FG002|Interventional Phase|Lack of Efficacy|0|||
149149196|NCT02699892|538026310|FG000|Overall Study|Other|36|||
148917345|NCT01328444|537182532|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
148917346|NCT01328444|537182533|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
149149197|NCT04677712|538026312|FG000|Overall Study|Lost to Follow-up|0|||
149149198|NCT04677712|538026313|FG001|Overall Study|Lost to Follow-up|1|||
149149199|NCT04677712|538026314|FG002|Overall Study|Lost to Follow-up|0|||
149149200|NCT04677712|538026315|FG003|Overall Study|Lost to Follow-up|0|||
149149201|NCT04677712|538026316|FG004|Overall Study|Lost to Follow-up|0|||
149149202|NCT04677712|538026317|FG005|Overall Study|Lost to Follow-up|0|||
149149203|NCT00711100|538026318|FG000|Overall Study|Lack of Efficacy|5|||
149149204|NCT00711100|538026318|FG000|Overall Study|Withdrawal by Subject|8|||
149149205|NCT00847912|538026319|FG000|Overall Study|Protocol Violation|6|||
149149206|NCT00847912|538026320|FG001|Overall Study|Protocol Violation|7|||
149149207|NCT00847912|538026319|FG000|Overall Study|Withdrawal by Subject|3|||
149149208|NCT00847912|538026320|FG001|Overall Study|Withdrawal by Subject|6|||
149149209|NCT00783094|538026321|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
149149210|NCT00783094|538026322|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
149149211|NCT00783094|538026323|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
149149212|NCT00783094|538026321|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
149149213|NCT00783094|538026322|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
149149214|NCT00783094|538026323|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
149149215|NCT00783094|538026321|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
149149216|NCT00783094|538026322|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
149149217|NCT00783094|538026323|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
149149218|NCT00783094|538026321|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
149149219|NCT00783094|538026322|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
149149220|NCT00783094|538026323|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
149149221|NCT00783094|538026321|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
149149222|NCT00783094|538026322|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
149149223|NCT00783094|538026323|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
149149224|NCT00783094|538026321|FG000|Open-Label Extension Period|Adverse Event|12|||
149149225|NCT00783094|538026322|FG001|Open-Label Extension Period|Adverse Event|7|||
149149226|NCT00783094|538026323|FG002|Open-Label Extension Period|Adverse Event|16|||
149149227|NCT00783094|538026321|FG000|Open-Label Extension Period|Death|0|||
149149228|NCT00783094|538026322|FG001|Open-Label Extension Period|Death|0|||
149149229|NCT00783094|538026323|FG002|Open-Label Extension Period|Death|1|||
149149230|NCT00783094|538026321|FG000|Open-Label Extension Period|Protocol Violation|4|||
149149231|NCT00783094|538026322|FG001|Open-Label Extension Period|Protocol Violation|5|||
148917347|NCT01328444|537182534|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
149149232|NCT00783094|538026323|FG002|Open-Label Extension Period|Protocol Violation|7|||
149149233|NCT00783094|538026321|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
149149234|NCT00783094|538026322|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
148917348|NCT01328444|537182535|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
148917349|NCT01328444|537182536|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
148917350|NCT01328444|537182531|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
148917351|NCT01328444|537182532|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
148917352|NCT01328444|537182533|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
148917353|NCT01328444|537182534|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
148917354|NCT01328444|537182535|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
148917355|NCT01328444|537182536|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
148917356|NCT01328444|537182531|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
148917357|NCT01328444|537182532|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
148917358|NCT01328444|537182533|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
148917359|NCT01328444|537182534|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
148917360|NCT01328444|537182535|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
148917361|NCT01328444|537182536|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
148917362|NCT01328444|537182531|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
148917363|NCT01328444|537182532|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
148917364|NCT01328444|537182533|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
148917365|NCT01328444|537182534|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
148917366|NCT01328444|537182535|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
148917367|NCT01328444|537182536|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
148917368|NCT01328444|537182531|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148917369|NCT01328444|537182532|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149149235|NCT00783094|538026323|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
149149236|NCT00783094|538026321|FG000|Open-Label Extension Period|Physician Decision|4|||
149149237|NCT00783094|538026322|FG001|Open-Label Extension Period|Physician Decision|2|||
149149238|NCT00783094|538026323|FG002|Open-Label Extension Period|Physician Decision|3|||
149149239|NCT00783094|538026321|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
149149240|NCT00783094|538026322|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
149149241|NCT00783094|538026323|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
149149242|NCT01294670|538026324|FG000|Overall Study|Not treated|1|||
149149243|NCT01294670|538026325|FG001|Overall Study|Not treated|0|||
149149244|NCT01294670|538026326|FG002|Overall Study|Not treated|0|||
149149245|NCT01294670|538026327|FG003|Overall Study|Not treated|0|||
149149246|NCT01294670|538026328|FG004|Overall Study|Not treated|0|||
149149247|NCT03808077|538026329|FG000|Overall Study|Physician Decision|2|||
149149248|NCT03808077|538026330|FG001|Overall Study|Physician Decision|3|||
149149249|NCT03808077|538026329|FG000|Overall Study|Withdrawal by Subject|1|||
149149250|NCT03808077|538026330|FG001|Overall Study|Withdrawal by Subject|0|||
149149251|NCT03808077|538026329|FG000|Overall Study|Equipment Issues|2|||
149149252|NCT03808077|538026330|FG001|Overall Study|Equipment Issues|1|||
149149253|NCT04152161|538026331|FG000|Overall Study|Death|0|||
149149254|NCT04152161|538026332|FG001|Overall Study|Death|1|||
149149255|NCT04152161|538026331|FG000|Overall Study|Physician Decision|0|||
149149256|NCT04152161|538026332|FG001|Overall Study|Physician Decision|1|||
149149257|NCT04152161|538026331|FG000|Overall Study|Lost to Follow-up|9|||
149149258|NCT04152161|538026332|FG001|Overall Study|Lost to Follow-up|3|||
149149259|NCT04152161|538026331|FG000|Overall Study|Protocol Violation|1|||
149149260|NCT04152161|538026332|FG001|Overall Study|Protocol Violation|0|||
149149261|NCT04152161|538026331|FG000|Overall Study|Withdrawal by Subject|29|||
149149262|NCT04152161|538026332|FG001|Overall Study|Withdrawal by Subject|28|||
149149263|NCT04152161|538026331|FG000|Overall Study|Sponsor termination of study|750|||
149149264|NCT04152161|538026332|FG001|Overall Study|Sponsor termination of study|755|||
149149265|NCT04152161|538026331|FG000|Overall Study|Other|20|||
149149266|NCT04152161|538026332|FG001|Overall Study|Other|18|||
149149267|NCT02412787|538026333|FG000|Overall Study|Withdrawal by Subject|9|||
149149268|NCT02412787|538026333|FG000|Overall Study|Participation Terminated by Investigator|1|||
149149269|NCT02412787|538026333|FG000|Overall Study|Site Terminated by Sponsor|21|||
149149270|NCT02412787|538026333|FG000|Overall Study|Technical Problems|1|||
149149271|NCT02412787|538026333|FG000|Overall Study|Reason Not Specified|1|||
149149272|NCT00001379|538026334|FG000|Initial Treatment|Disease progression|21|||
149149273|NCT00001379|538026335|FG001|Initial Treatment|Disease progression|3|||
149149274|NCT00001379|538026336|FG002|Initial Treatment|Disease progression|0|||
149149275|NCT00001379|538026337|FG003|Initial Treatment|Disease progression|0|||
149149276|NCT00001379|538026334|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
148805592|NCT00042289|536767995|FG035|Overall Study|Site closed|0|||
148805593|NCT00042289|536767996|FG036|Overall Study|Site closed|1|||
148805594|NCT00042289|536767997|FG037|Overall Study|Site closed|0|||
148805595|NCT00042289|536767998|FG038|Overall Study|Site closed|0|||
148805596|NCT00042289|536767999|FG039|Overall Study|Site closed|0|||
148805597|NCT00042289|536768000|FG040|Overall Study|Site closed|0|||
148805598|NCT00042289|536768001|FG041|Overall Study|Site closed|0|||
148805599|NCT00042289|536768002|FG042|Overall Study|Site closed|1|||
148805600|NCT00042289|536768003|FG043|Overall Study|Site closed|0|||
148805601|NCT00042289|536768004|FG044|Overall Study|Site closed|0|||
148805602|NCT00042289|536768005|FG045|Overall Study|Site closed|0|||
148805603|NCT00042289|536768006|FG046|Overall Study|Site closed|0|||
148805604|NCT00042289|536767960|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
148805605|NCT00042289|536767961|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
148805606|NCT00042289|536767962|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
148805607|NCT00042289|536767963|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
149149277|NCT00001379|538026335|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
149149278|NCT00001379|538026336|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
149149279|NCT00001379|538026337|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
149149280|NCT00001379|538026334|FG000|Initial Treatment|Received alternative treatment|2|||
149149281|NCT00001379|538026335|FG001|Initial Treatment|Received alternative treatment|1|||
149149282|NCT00001379|538026336|FG002|Initial Treatment|Received alternative treatment|0|||
149149283|NCT00001379|538026337|FG003|Initial Treatment|Received alternative treatment|0|||
149149284|NCT00001379|538026334|FG000|Initial Treatment|Refused further treatment|2|||
149149285|NCT00001379|538026335|FG001|Initial Treatment|Refused further treatment|0|||
149149286|NCT00001379|538026336|FG002|Initial Treatment|Refused further treatment|0|||
149149287|NCT00001379|538026337|FG003|Initial Treatment|Refused further treatment|0|||
149149288|NCT00001379|538026334|FG000|Initial Treatment|Did not receive protocol treatment|0|||
149149289|NCT00001379|538026335|FG001|Initial Treatment|Did not receive protocol treatment|0|||
149149290|NCT00001379|538026336|FG002|Initial Treatment|Did not receive protocol treatment|5|||
149149291|NCT00001379|538026337|FG003|Initial Treatment|Did not receive protocol treatment|0|||
149149292|NCT00001379|538026334|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
149149293|NCT00001379|538026335|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
149149294|NCT00001379|538026336|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
149149295|NCT00001379|538026337|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
149149296|NCT00001379|538026334|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
149149297|NCT00001379|538026335|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
149149298|NCT00001379|538026336|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
149149299|NCT00001379|538026337|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
149149300|NCT00001379|538026334|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
149149301|NCT00001379|538026335|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
149149302|NCT00001379|538026336|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
149149303|NCT00001379|538026337|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
149149304|NCT00001379|538026334|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
149149305|NCT00001379|538026335|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
149149306|NCT00001379|538026336|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
149149307|NCT00001379|538026337|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
149149308|NCT00001379|538026334|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
149149309|NCT00001379|538026335|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
149149310|NCT00001379|538026336|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
149149311|NCT00001379|538026337|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
149149312|NCT03246958|538026338|FG000|Overall Study|Withdrawal by Subject|0|||
148917370|NCT01328444|537182533|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148917371|NCT01328444|537182534|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148917372|NCT01328444|537182535|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
148917373|NCT01328444|537182536|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
148917374|NCT03531632|537182537|FG000|Overall Study|Adverse Event|0|||
148917375|NCT03531632|537182538|FG001|Overall Study|Adverse Event|0|||
148917376|NCT03531632|537182539|FG002|Overall Study|Adverse Event|1|||
148917377|NCT03531632|537182537|FG000|Overall Study|Death|4|||
148917378|NCT03531632|537182538|FG001|Overall Study|Death|0|||
148917379|NCT03531632|537182539|FG002|Overall Study|Death|14|||
148917380|NCT03531632|537182537|FG000|Overall Study|Study Terminated|1|||
148917381|NCT03531632|537182538|FG001|Overall Study|Study Terminated|3|||
148917382|NCT03531632|537182539|FG002|Overall Study|Study Terminated|11|||
148917383|NCT02743611|537182540|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
148917384|NCT02743611|537182541|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
148917385|NCT02743611|537182542|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
148917386|NCT02743611|537182543|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
148917387|NCT00600119|537182544|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
148917388|NCT00600119|537182545|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
148917389|NCT00600119|537182546|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
148917390|NCT00600119|537182547|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
148917391|NCT00600119|537182548|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
148917392|NCT00600119|537182549|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
148917393|NCT00600119|537182544|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
149149313|NCT03246958|538026339|FG001|Overall Study|Withdrawal by Subject|1|||
149149314|NCT03246958|538026340|FG002|Overall Study|Withdrawal by Subject|0|||
149149315|NCT03246958|538026341|FG003|Overall Study|Withdrawal by Subject|0|||
148917394|NCT00600119|537182545|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
148917395|NCT00600119|537182546|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
148917396|NCT00600119|537182547|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148917397|NCT00600119|537182548|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148917398|NCT00600119|537182549|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148917399|NCT00600119|537182544|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
148917400|NCT00600119|537182545|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
148917401|NCT00600119|537182546|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
148917402|NCT00600119|537182547|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
148917403|NCT00600119|537182548|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
148917404|NCT00600119|537182549|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
148917405|NCT00600119|537182544|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
148917406|NCT00600119|537182545|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
148917407|NCT00600119|537182546|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
148917408|NCT00600119|537182547|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
148917409|NCT00600119|537182548|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
148917410|NCT00600119|537182549|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
148917411|NCT00600119|537182544|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
148917412|NCT00600119|537182545|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
148917413|NCT00600119|537182546|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
148917414|NCT00600119|537182547|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
148917415|NCT00600119|537182548|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
148917416|NCT00600119|537182549|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
148917417|NCT00600119|537182544|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
148917418|NCT00600119|537182545|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
148917419|NCT00600119|537182546|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
148917420|NCT00600119|537182547|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
148917421|NCT00600119|537182548|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
148917422|NCT00600119|537182549|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
148917423|NCT00600119|537182544|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
148917424|NCT00600119|537182545|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
148917425|NCT00600119|537182546|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
148917426|NCT00600119|537182547|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
148917427|NCT00600119|537182548|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
148917428|NCT00600119|537182549|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
148917429|NCT00600119|537182544|FG000|Double-blind Treatment Period|Other|0|||
148917430|NCT00600119|537182545|FG001|Double-blind Treatment Period|Other|0|||
148917431|NCT00600119|537182546|FG002|Double-blind Treatment Period|Other|0|||
148917432|NCT00600119|537182547|FG003|Double-blind Treatment Period|Other|0|||
148917433|NCT00600119|537182548|FG004|Double-blind Treatment Period|Other|2|||
148917434|NCT00600119|537182549|FG005|Double-blind Treatment Period|Other|1|||
148917435|NCT00600119|537182544|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
148917436|NCT00600119|537182545|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
148917437|NCT00600119|537182546|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
148917438|NCT00600119|537182547|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
148917439|NCT00600119|537182548|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
148917440|NCT00600119|537182549|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
148917441|NCT00600119|537182544|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
148917442|NCT00600119|537182545|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
148917443|NCT00600119|537182546|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
148917444|NCT00600119|537182547|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
148917445|NCT00600119|537182548|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
148917446|NCT00600119|537182549|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
148917447|NCT00600119|537182544|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
148917448|NCT00600119|537182545|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
148917449|NCT00600119|537182546|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
148917450|NCT00600119|537182547|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
148917451|NCT00600119|537182548|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
148917452|NCT00600119|537182549|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
148917453|NCT00600119|537182544|FG000|Double-blind Treatment Period|Physician Decision|2|||
148917454|NCT00600119|537182545|FG001|Double-blind Treatment Period|Physician Decision|0|||
148917455|NCT00600119|537182546|FG002|Double-blind Treatment Period|Physician Decision|0|||
148917456|NCT00600119|537182547|FG003|Double-blind Treatment Period|Physician Decision|0|||
149149316|NCT03246958|538026342|FG004|Overall Study|Withdrawal by Subject|0|||
149149317|NCT03246958|538026343|FG005|Overall Study|Withdrawal by Subject|1|||
149149318|NCT03246958|538026344|FG006|Overall Study|Withdrawal by Subject|0|||
149149319|NCT03246958|538026338|FG000|Overall Study|Progression|13|||
149149320|NCT03246958|538026339|FG001|Overall Study|Progression|9|||
149149321|NCT03246958|538026340|FG002|Overall Study|Progression|3|||
149149322|NCT03246958|538026341|FG003|Overall Study|Progression|2|||
149149323|NCT03246958|538026342|FG004|Overall Study|Progression|1|||
149149324|NCT03246958|538026343|FG005|Overall Study|Progression|2|||
149149325|NCT03246958|538026344|FG006|Overall Study|Progression|1|||
149149326|NCT03246958|538026338|FG000|Overall Study|Adverse Event|2|||
149149327|NCT03246958|538026339|FG001|Overall Study|Adverse Event|2|||
149149328|NCT03246958|538026340|FG002|Overall Study|Adverse Event|0|||
149149329|NCT03246958|538026341|FG003|Overall Study|Adverse Event|1|||
148917457|NCT00600119|537182548|FG004|Double-blind Treatment Period|Physician Decision|0|||
148917458|NCT00600119|537182549|FG005|Double-blind Treatment Period|Physician Decision|0|||
148917459|NCT00600119|537182544|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
148917460|NCT00600119|537182545|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
148917461|NCT00600119|537182546|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
148917462|NCT00600119|537182547|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
148917463|NCT00600119|537182548|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
148917464|NCT00600119|537182549|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
148917465|NCT00600119|537182544|FG000|Double-blind Treatment Period|Adverse Event|1|||
148917466|NCT00600119|537182545|FG001|Double-blind Treatment Period|Adverse Event|1|||
148917467|NCT00600119|537182546|FG002|Double-blind Treatment Period|Adverse Event|0|||
148917468|NCT00600119|537182547|FG003|Double-blind Treatment Period|Adverse Event|1|||
148917469|NCT00600119|537182548|FG004|Double-blind Treatment Period|Adverse Event|2|||
148917470|NCT00600119|537182549|FG005|Double-blind Treatment Period|Adverse Event|10|||
148917471|NCT00600119|537182544|FG000|Follow-up Period|Adverse Event|0|||
148917472|NCT00600119|537182545|FG001|Follow-up Period|Adverse Event|0|||
148917473|NCT00600119|537182546|FG002|Follow-up Period|Adverse Event|0|||
148917474|NCT00600119|537182547|FG003|Follow-up Period|Adverse Event|0|||
148917475|NCT00600119|537182548|FG004|Follow-up Period|Adverse Event|0|||
148917476|NCT00600119|537182549|FG005|Follow-up Period|Adverse Event|1|||
148917477|NCT00600119|537182544|FG000|Follow-up Period|Other|1|||
148917478|NCT00600119|537182545|FG001|Follow-up Period|Other|0|||
148917479|NCT00600119|537182546|FG002|Follow-up Period|Other|0|||
148917480|NCT00600119|537182547|FG003|Follow-up Period|Other|0|||
148917481|NCT00600119|537182548|FG004|Follow-up Period|Other|0|||
148917482|NCT00600119|537182549|FG005|Follow-up Period|Other|0|||
148917483|NCT00561977|537182550|FG000|Overall Study|Withdrawal by Subject|0|||
148917484|NCT00561977|537182551|FG001|Overall Study|Withdrawal by Subject|2|||
148917485|NCT00561977|537182552|FG002|Overall Study|Withdrawal by Subject|1|||
148917486|NCT00561977|537182550|FG000|Overall Study|Pregnancy|0|||
148917487|NCT00561977|537182551|FG001|Overall Study|Pregnancy|1|||
148917488|NCT00561977|537182552|FG002|Overall Study|Pregnancy|1|||
148917489|NCT00977080|537182553|FG000|Overall Study|Adverse Event|2|||
148917490|NCT00977080|537182554|FG001|Overall Study|Adverse Event|7|||
148917491|NCT00977080|537182555|FG002|Overall Study|Adverse Event|7|||
148917492|NCT00977080|537182556|FG003|Overall Study|Adverse Event|7|||
148917493|NCT00977080|537182553|FG000|Overall Study|Withdrawal by Subject|1|||
148917494|NCT00977080|537182554|FG001|Overall Study|Withdrawal by Subject|5|||
148917495|NCT00977080|537182555|FG002|Overall Study|Withdrawal by Subject|1|||
148917496|NCT00977080|537182556|FG003|Overall Study|Withdrawal by Subject|5|||
148917497|NCT00977080|537182553|FG000|Overall Study|Protocol Violation|7|||
148917498|NCT00977080|537182554|FG001|Overall Study|Protocol Violation|3|||
148917499|NCT00977080|537182555|FG002|Overall Study|Protocol Violation|4|||
148917500|NCT00977080|537182556|FG003|Overall Study|Protocol Violation|3|||
148917501|NCT00977080|537182553|FG000|Overall Study|Noncompliance|0|||
148917502|NCT00977080|537182554|FG001|Overall Study|Noncompliance|2|||
148917503|NCT00977080|537182555|FG002|Overall Study|Noncompliance|1|||
148917504|NCT00977080|537182556|FG003|Overall Study|Noncompliance|0|||
148917505|NCT00977080|537182553|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
149149330|NCT03246958|538026342|FG004|Overall Study|Adverse Event|1|||
149149331|NCT03246958|538026343|FG005|Overall Study|Adverse Event|0|||
148917506|NCT00977080|537182554|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
148917507|NCT00977080|537182555|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
148917508|NCT00977080|537182556|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
148917509|NCT00977080|537182553|FG000|Overall Study|Required kidney transplantation|1|||
148917510|NCT00977080|537182554|FG001|Overall Study|Required kidney transplantation|3|||
149149332|NCT03246958|538026344|FG006|Overall Study|Adverse Event|2|||
149149333|NCT03246958|538026338|FG000|Overall Study|Death|0|||
149149334|NCT03246958|538026339|FG001|Overall Study|Death|1|||
149149335|NCT03246958|538026340|FG002|Overall Study|Death|0|||
149149336|NCT03246958|538026341|FG003|Overall Study|Death|0|||
148917511|NCT00977080|537182555|FG002|Overall Study|Required kidney transplantation|3|||
148917512|NCT00977080|537182556|FG003|Overall Study|Required kidney transplantation|1|||
149149337|NCT03246958|538026342|FG004|Overall Study|Death|0|||
149149338|NCT03246958|538026343|FG005|Overall Study|Death|0|||
149149339|NCT03246958|538026344|FG006|Overall Study|Death|0|||
149149340|NCT03246958|538026338|FG000|Overall Study|Physician Decision|0|||
149149341|NCT03246958|538026339|FG001|Overall Study|Physician Decision|0|||
149149342|NCT03246958|538026340|FG002|Overall Study|Physician Decision|0|||
149149343|NCT03246958|538026341|FG003|Overall Study|Physician Decision|1|||
149149344|NCT03246958|538026342|FG004|Overall Study|Physician Decision|0|||
149149345|NCT03246958|538026343|FG005|Overall Study|Physician Decision|0|||
149149346|NCT03246958|538026344|FG006|Overall Study|Physician Decision|0|||
149149347|NCT03246958|538026338|FG000|Overall Study|Never start treatment|1|||
149149348|NCT03246958|538026339|FG001|Overall Study|Never start treatment|0|||
149149349|NCT03246958|538026340|FG002|Overall Study|Never start treatment|0|||
149149350|NCT03246958|538026341|FG003|Overall Study|Never start treatment|0|||
149149351|NCT03246958|538026342|FG004|Overall Study|Never start treatment|0|||
149149352|NCT03246958|538026343|FG005|Overall Study|Never start treatment|0|||
149149353|NCT03246958|538026344|FG006|Overall Study|Never start treatment|0|||
149149354|NCT03246958|538026338|FG000|Overall Study|Over enrollment|0|||
149149355|NCT03246958|538026339|FG001|Overall Study|Over enrollment|2|||
149149356|NCT03246958|538026340|FG002|Overall Study|Over enrollment|0|||
149149357|NCT03246958|538026341|FG003|Overall Study|Over enrollment|0|||
149149358|NCT03246958|538026342|FG004|Overall Study|Over enrollment|0|||
149149359|NCT03246958|538026343|FG005|Overall Study|Over enrollment|0|||
149149360|NCT03246958|538026344|FG006|Overall Study|Over enrollment|0|||
149149361|NCT02311153|538026350|FG000|Overall Study|Lost to Follow-up|5|||
149149362|NCT02311153|538026351|FG001|Overall Study|Lost to Follow-up|7|||
149149363|NCT01650636|538026356|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
149149364|NCT01650636|538026357|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
149149365|NCT01650636|538026356|FG000|Washout up to 5 Months|Physician Decision|2|||
149149366|NCT01650636|538026357|FG001|Washout up to 5 Months|Physician Decision|2|||
149149367|NCT01650636|538026356|FG000|Washout up to 5 Months|Death|1|||
149149368|NCT01650636|538026357|FG001|Washout up to 5 Months|Death|0|||
149149369|NCT01650636|538026356|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
149149370|NCT01650636|538026357|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
149149371|NCT01650636|538026356|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
148672300|NCT02118896|536270729|FG002|Overall Study|Prohibited medication|0|||
148672301|NCT02118896|536270730|FG003|Overall Study|Prohibited medication|0|||
148672302|NCT02118896|536270731|FG004|Overall Study|Prohibited medication|1|||
148672303|NCT02118896|536270732|FG005|Overall Study|Prohibited medication|3|||
148672304|NCT02118896|536270733|FG006|Overall Study|Prohibited medication|0|||
148672305|NCT02118896|536270734|FG007|Overall Study|Prohibited medication|0|||
148672306|NCT02118896|536270735|FG008|Overall Study|Prohibited medication|0|||
148672307|NCT02118896|536270736|FG009|Overall Study|Prohibited medication|0|||
148672308|NCT02118896|536270727|FG000|Overall Study|Miscellaneous|1|||
148672309|NCT02118896|536270728|FG001|Overall Study|Miscellaneous|2|||
148672310|NCT02118896|536270729|FG002|Overall Study|Miscellaneous|0|||
148672311|NCT02118896|536270730|FG003|Overall Study|Miscellaneous|2|||
148672312|NCT02118896|536270731|FG004|Overall Study|Miscellaneous|0|||
148672313|NCT02118896|536270732|FG005|Overall Study|Miscellaneous|4|||
148672314|NCT02118896|536270733|FG006|Overall Study|Miscellaneous|0|||
148672315|NCT02118896|536270734|FG007|Overall Study|Miscellaneous|0|||
148672316|NCT02118896|536270735|FG008|Overall Study|Miscellaneous|0|||
148672317|NCT02118896|536270736|FG009|Overall Study|Miscellaneous|0|||
148672318|NCT03292731|536270737|FG000|Overall Study|Protocol Violation|4|||
148672319|NCT03292731|536270738|FG001|Overall Study|Protocol Violation|11|||
148672320|NCT03292731|536270739|FG002|Overall Study|Protocol Violation|1|||
148672321|NCT04221373|536270740|FG000|Overall Study|Physician Decision|4|||
148672322|NCT04221373|536270741|FG001|Overall Study|Physician Decision|0|||
148672323|NCT00138658|536270748|FG000|Overall Study|Adverse Event|23|||
148672324|NCT00138658|536270748|FG000|Overall Study|Death|1|||
148672325|NCT00138658|536270748|FG000|Overall Study|Disease Progression|21|||
148672326|NCT00138658|536270748|FG000|Overall Study|Physician Decision|11|||
148672327|NCT00138658|536270748|FG000|Overall Study|Withdrawal by Subject|5|||
149149372|NCT01650636|538026357|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
149149373|NCT01650636|538026356|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
149149374|NCT01650636|538026357|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
149149375|NCT01560780|538026358|FG000|Overall Study|Death|2|||
148672328|NCT02050373|536270749|FG000|Overall Study|Adverse Event|4|||
148672329|NCT02050373|536270750|FG001|Overall Study|Adverse Event|7|||
148672330|NCT02050373|536270749|FG000|Overall Study|Death|3|||
148672331|NCT02050373|536270750|FG001|Overall Study|Death|3|||
148672332|NCT01067339|536270751|FG000|Overall Study|Withdrawal by Subject|6|||
148672333|NCT01067339|536270752|FG001|Overall Study|Withdrawal by Subject|5|||
148672334|NCT01179191|536270753|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
149149376|NCT01560780|538026359|FG001|Overall Study|Death|1|||
149149377|NCT01560780|538026358|FG000|Overall Study|Patient Preference|11|||
149149378|NCT01560780|538026359|FG001|Overall Study|Patient Preference|11|||
149149379|NCT01577186|538026360|FG000|Overall Study|Adverse Event|23|||
149149380|NCT01577186|538026360|FG000|Overall Study|Death|1|||
149149381|NCT01577186|538026360|FG000|Overall Study|Lost to Follow-up|28|||
149149382|NCT01577186|538026360|FG000|Overall Study|Withdrawal by Subject|35|||
149149383|NCT01577186|538026360|FG000|Overall Study|Insufficient Response|18|||
149149384|NCT01577186|538026360|FG000|Overall Study|Ineligible to Continue|15|||
149149385|NCT01577186|538026360|FG000|Overall Study|Non-Compliant|8|||
149149386|NCT01577186|538026360|FG000|Overall Study|Other|2|||
148917513|NCT00977080|537182553|FG000|Overall Study|Travel for family reasons|1|||
149149387|NCT00811135|538026361|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
149149388|NCT00811135|538026361|FG000|Overall Study|Death|3|||
149149389|NCT00811135|538026361|FG000|Overall Study|Protocol Violation|2|||
149149390|NCT00811135|538026361|FG000|Overall Study|Violation of Selection Criteria|1|||
149149391|NCT00811135|538026361|FG000|Overall Study|Refused Treatment|1|||
149149392|NCT00811135|538026361|FG000|Overall Study|Withdrawal by Subject|3|||
149149393|NCT00811135|538026361|FG000|Overall Study|Administrative/Other Unspecified|11|||
149149394|NCT00811135|538026361|FG000|Overall Study|Ongoing|59|||
149149395|NCT01780831|538026365|FG000|Overall Study|Withdrawal by Subject|0|||
149149396|NCT01780831|538026366|FG001|Overall Study|Withdrawal by Subject|0|||
149149397|NCT01780831|538026367|FG002|Overall Study|Withdrawal by Subject|4|||
149149398|NCT01780831|538026368|FG003|Overall Study|Withdrawal by Subject|0|||
149149399|NCT01780831|538026365|FG000|Overall Study|Lost to Follow-up|0|||
149149400|NCT01780831|538026366|FG001|Overall Study|Lost to Follow-up|0|||
149149401|NCT01780831|538026367|FG002|Overall Study|Lost to Follow-up|0|||
149149402|NCT01780831|538026368|FG003|Overall Study|Lost to Follow-up|1|||
149149403|NCT00183274|538026369|FG000|Phase 1: Open-Label|Adverse Event|31|||
149149404|NCT00183274|538026370|FG001|Phase 1: Open-Label|Adverse Event|0|||
149149405|NCT00183274|538026371|FG002|Phase 1: Open-Label|Adverse Event|0|||
149149406|NCT00183274|538026372|FG003|Phase 1: Open-Label|Adverse Event|0|||
149149407|NCT00183274|538026373|FG004|Phase 1: Open-Label|Adverse Event|0|||
149149408|NCT00183274|538026374|FG005|Phase 1: Open-Label|Adverse Event|0|||
149149409|NCT00183274|538026369|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
149149410|NCT00183274|538026370|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
149149411|NCT00183274|538026371|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
149149412|NCT00183274|538026372|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
149149413|NCT00183274|538026373|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
149149414|NCT00183274|538026374|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
148917514|NCT00977080|537182554|FG001|Overall Study|Travel for family reasons|0|||
148917515|NCT00977080|537182555|FG002|Overall Study|Travel for family reasons|0|||
148917516|NCT00977080|537182556|FG003|Overall Study|Travel for family reasons|0|||
148917517|NCT00566696|537182557|FG000|Overall Study|Met Exclusion Criteria|2|||
148917518|NCT00566696|537182557|FG000|Overall Study|Muromonab not available|1|||
148917519|NCT00566696|537182557|FG000|Overall Study|Health Status Change|1|||
148917520|NCT00566696|537182557|FG000|Overall Study|Physician Decision|1|||
148917521|NCT00566696|537182557|FG000|Overall Study|Non-Patient Donors|37|||
148917522|NCT01616693|537182560|FG000|Evaluated for Safety|Physician Decision|1|||
148917523|NCT01616693|537182561|FG001|Evaluated for Safety|Physician Decision|0|||
148917524|NCT01616693|537182562|FG002|Evaluated for Safety|Physician Decision|1|||
148917525|NCT01616693|537182563|FG003|Evaluated for Safety|Physician Decision|0|||
148917526|NCT01616693|537182560|FG000|Received Both Vaccines|Adverse Event|2|||
148917527|NCT01616693|537182561|FG001|Received Both Vaccines|Adverse Event|0|||
148917528|NCT01616693|537182562|FG002|Received Both Vaccines|Adverse Event|0|||
148917529|NCT01616693|537182563|FG003|Received Both Vaccines|Adverse Event|0|||
148917530|NCT01616693|537182560|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
148917531|NCT01616693|537182561|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
148917532|NCT01616693|537182562|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
148917533|NCT01616693|537182563|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
148917534|NCT01616693|537182560|FG000|Received Both Vaccines|Lost to Follow-up|4|||
148917535|NCT01616693|537182561|FG001|Received Both Vaccines|Lost to Follow-up|3|||
148917536|NCT01616693|537182562|FG002|Received Both Vaccines|Lost to Follow-up|4|||
148917537|NCT01616693|537182563|FG003|Received Both Vaccines|Lost to Follow-up|4|||
148917538|NCT01616693|537182560|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
148917539|NCT01616693|537182561|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
148917540|NCT01616693|537182562|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
148917541|NCT01616693|537182563|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
148917542|NCT01950013|537182564|FG000|Overall Study|Withdrawal by Subject|0|||
148917543|NCT01950013|537182565|FG001|Overall Study|Withdrawal by Subject|2|||
148917544|NCT01950013|537182566|FG002|Overall Study|Withdrawal by Subject|0|||
148917545|NCT00275340|537182567|FG000|Overall Study|Lost to Follow-up|2|||
148917546|NCT00275340|537182568|FG001|Overall Study|Lost to Follow-up|4|||
148917547|NCT00539188|537182569|FG000|Overall Study|Withdrawal by Subject|1|||
148917548|NCT00539188|537182570|FG001|Overall Study|Withdrawal by Subject|0|||
149149415|NCT00183274|538026369|FG000|Phase 1: Open-Label|Protocol Violation|11|||
149149416|NCT00183274|538026370|FG001|Phase 1: Open-Label|Protocol Violation|0|||
149149417|NCT00183274|538026371|FG002|Phase 1: Open-Label|Protocol Violation|0|||
149149418|NCT00183274|538026372|FG003|Phase 1: Open-Label|Protocol Violation|0|||
149149419|NCT00183274|538026373|FG004|Phase 1: Open-Label|Protocol Violation|0|||
149149420|NCT00183274|538026374|FG005|Phase 1: Open-Label|Protocol Violation|0|||
148672335|NCT01179191|536270753|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
148672336|NCT01179191|536270753|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
148672337|NCT01179191|536270753|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
148672338|NCT01179191|536270753|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
148672339|NCT01179191|536270753|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
148672340|NCT01179191|536270753|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
148672341|NCT01179191|536270753|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
148672342|NCT01179191|536270753|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
148672343|NCT01179191|536270753|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
148672344|NCT01179191|536270753|FG000|Maintenance Phase (8 Weeks)|Other|66|||
148672345|NCT00572910|536270754|FG000|Overall Study|Adverse Event|1|||
148672346|NCT00572910|536270755|FG001|Overall Study|Adverse Event|2|||
148672347|NCT00572910|536270756|FG002|Overall Study|Adverse Event|0|||
148672348|NCT00572910|536270757|FG003|Overall Study|Adverse Event|2|||
148672349|NCT00572910|536270758|FG004|Overall Study|Adverse Event|0|||
148917549|NCT00539188|537182569|FG000|Overall Study|Lost to Follow-up|2|||
148917550|NCT00539188|537182570|FG001|Overall Study|Lost to Follow-up|1|||
148917551|NCT04784442|537182571|FG000|Overall Study|Adverse Event|1|||
148917552|NCT04784442|537182572|FG001|Overall Study|Adverse Event|0|||
148917553|NCT04784442|537182573|FG002|Overall Study|Adverse Event|2|||
148917554|NCT04784442|537182574|FG003|Overall Study|Adverse Event|1|||
148917555|NCT04784442|537182571|FG000|Overall Study|Protocol Violation|1|||
148917556|NCT04784442|537182572|FG001|Overall Study|Protocol Violation|0|||
148917557|NCT04784442|537182573|FG002|Overall Study|Protocol Violation|0|||
148917558|NCT04784442|537182574|FG003|Overall Study|Protocol Violation|0|||
148917559|NCT04784442|537182571|FG000|Overall Study|Non-compliance with study drug|1|||
148917560|NCT04784442|537182572|FG001|Overall Study|Non-compliance with study drug|0|||
148917561|NCT04784442|537182573|FG002|Overall Study|Non-compliance with study drug|0|||
148917562|NCT04784442|537182574|FG003|Overall Study|Non-compliance with study drug|0|||
148917563|NCT00852371|537182575|FG000|Overall Study|Lost to Follow-up|2|||
148917564|NCT00852371|537182576|FG001|Overall Study|Lost to Follow-up|3|||
148917565|NCT00852371|537182577|FG002|Overall Study|Lost to Follow-up|4|||
148917566|NCT00852371|537182578|FG003|Overall Study|Lost to Follow-up|2|||
148917567|NCT02756806|537182579|FG000|Overall Study|Study terminated early|5|||
148917568|NCT01642615|537182582|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
148917569|NCT01642615|537182583|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
148917570|NCT01642615|537182584|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
148917571|NCT01642615|537182582|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
148917572|NCT01642615|537182583|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
148917573|NCT01642615|537182584|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
148917574|NCT01642615|537182582|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
148917575|NCT01642615|537182583|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
148917576|NCT01642615|537182584|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
148917577|NCT01642615|537182582|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
148917578|NCT01642615|537182583|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
148917579|NCT01642615|537182584|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
148917580|NCT01642615|537182582|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
148917581|NCT01642615|537182583|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
148917582|NCT01642615|537182584|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
148917583|NCT01642615|537182582|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
148917584|NCT01642615|537182583|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
148917585|NCT01642615|537182584|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
148917586|NCT01642615|537182582|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
148917587|NCT01642615|537182583|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
148917588|NCT01642615|537182584|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
148917589|NCT01642615|537182582|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
148917590|NCT01642615|537182583|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
148917591|NCT01642615|537182584|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
148917592|NCT01642615|537182582|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
148917593|NCT01642615|537182583|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
148917594|NCT01642615|537182584|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
148917595|NCT02744040|537182585|FG000|Overall Study|Withdrawal by Subject|3|||
148917596|NCT02744040|537182586|FG001|Overall Study|Withdrawal by Subject|2|||
148917597|NCT02744040|537182587|FG002|Overall Study|Withdrawal by Subject|2|||
148917598|NCT02744040|537182585|FG000|Overall Study|Physician Decision|0|||
148917599|NCT02744040|537182586|FG001|Overall Study|Physician Decision|8|||
148917600|NCT02744040|537182587|FG002|Overall Study|Physician Decision|13|||
148917601|NCT02744040|537182585|FG000|Overall Study|Lost to Follow-up|3|||
148917602|NCT02744040|537182586|FG001|Overall Study|Lost to Follow-up|1|||
148672350|NCT00572910|536270759|FG005|Overall Study|Adverse Event|0|||
148672351|NCT00572910|536270760|FG006|Overall Study|Adverse Event|4|||
148672352|NCT00572910|536270761|FG007|Overall Study|Adverse Event|2|||
149149421|NCT00183274|538026369|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
149149422|NCT00183274|538026370|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
149149423|NCT00183274|538026371|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
149149424|NCT00183274|538026372|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
149149425|NCT00183274|538026373|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
149149426|NCT00183274|538026374|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
149149427|NCT00183274|538026369|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
149149428|NCT00183274|538026370|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
149149429|NCT00183274|538026371|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
149149430|NCT00183274|538026372|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
149149431|NCT00183274|538026373|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
149149432|NCT00183274|538026374|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
149149433|NCT00183274|538026369|FG000|Phase 1: Open-Label|Other|9|||
148917603|NCT02744040|537182587|FG002|Overall Study|Lost to Follow-up|7|||
149149434|NCT00183274|538026370|FG001|Phase 1: Open-Label|Other|0|||
149149435|NCT00183274|538026371|FG002|Phase 1: Open-Label|Other|0|||
149149436|NCT00183274|538026372|FG003|Phase 1: Open-Label|Other|0|||
149149437|NCT00183274|538026373|FG004|Phase 1: Open-Label|Other|0|||
149149438|NCT00183274|538026374|FG005|Phase 1: Open-Label|Other|0|||
148917604|NCT01008423|537182588|FG000|Overall Study|Adverse Event|13|||
148917605|NCT01008423|537182589|FG001|Overall Study|Adverse Event|6|||
148917606|NCT01008423|537182588|FG000|Overall Study|Withdrawal by Subject|4|||
148917607|NCT01008423|537182589|FG001|Overall Study|Withdrawal by Subject|7|||
148917608|NCT01008423|537182588|FG000|Overall Study|Lost to Follow-up|0|||
148917609|NCT01008423|537182589|FG001|Overall Study|Lost to Follow-up|2|||
148917610|NCT01008423|537182588|FG000|Overall Study|Low Cortisol|0|||
148917611|NCT01008423|537182589|FG001|Overall Study|Low Cortisol|1|||
148917612|NCT01008423|537182588|FG000|Overall Study|Lack of Efficacy|0|||
148917613|NCT01008423|537182589|FG001|Overall Study|Lack of Efficacy|5|||
148917614|NCT01008423|537182588|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
148917615|NCT01008423|537182589|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
148917616|NCT01008423|537182588|FG000|Overall Study|Personal Conflict|1|||
148917617|NCT01008423|537182589|FG001|Overall Study|Personal Conflict|0|||
148917618|NCT01008423|537182588|FG000|Overall Study|Other|0|||
148917619|NCT01008423|537182589|FG001|Overall Study|Other|1|||
149149439|NCT00183274|538026369|FG000|Phase 2: Double-Blind|Relapsed|0|||
149149440|NCT00183274|538026370|FG001|Phase 2: Double-Blind|Relapsed|8|||
149149441|NCT00183274|538026371|FG002|Phase 2: Double-Blind|Relapsed|29|||
149149442|NCT00183274|538026372|FG003|Phase 2: Double-Blind|Relapsed|0|||
149149443|NCT00183274|538026373|FG004|Phase 2: Double-Blind|Relapsed|0|||
148917620|NCT00946153|537182600|FG000|Phase 2|Adverse Event|0|||
148917621|NCT00946153|537182601|FG001|Phase 2|Adverse Event|0|||
148917622|NCT00946153|537182602|FG002|Phase 2|Adverse Event|0|||
148917623|NCT00946153|537182603|FG003|Phase 2|Adverse Event|0|||
148917624|NCT00946153|537182604|FG004|Phase 2|Adverse Event|6|||
149149444|NCT00183274|538026374|FG005|Phase 2: Double-Blind|Relapsed|0|||
149149445|NCT00183274|538026369|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
149149446|NCT00183274|538026370|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
149149447|NCT00183274|538026371|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
149149448|NCT00183274|538026372|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
149149449|NCT00183274|538026373|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
149149450|NCT00183274|538026374|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
149149451|NCT00183274|538026369|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
149149452|NCT00183274|538026370|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
149149453|NCT00183274|538026371|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
149149454|NCT00183274|538026372|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
149149455|NCT00183274|538026373|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
149149456|NCT00183274|538026374|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
149149457|NCT00183274|538026369|FG000|Phase 3: Double-Blind|Relapsed|0|||
149149458|NCT00183274|538026370|FG001|Phase 3: Double-Blind|Relapsed|0|||
149149459|NCT00183274|538026371|FG002|Phase 3: Double-Blind|Relapsed|0|||
149149460|NCT00183274|538026372|FG003|Phase 3: Double-Blind|Relapsed|1|||
149149461|NCT00183274|538026373|FG004|Phase 3: Double-Blind|Relapsed|11|||
149149462|NCT00183274|538026374|FG005|Phase 3: Double-Blind|Relapsed|2|||
149149463|NCT00607386|538026379|FG000|Overall Study|Physician Decision|1|||
149149464|NCT01422915|538026386|FG000|Overall Study|Adverse Event|1|||
149149465|NCT01265797|538026387|FG000|Run-in Month|Withdrawal by Subject|0|||
149149466|NCT01265797|538026388|FG001|Run-in Month|Withdrawal by Subject|4|||
149149467|NCT01265797|538026387|FG000|Run-in Month|1st seizure during run-in month|0|||
149149468|NCT01265797|538026388|FG001|Run-in Month|1st seizure during run-in month|1|||
149149469|NCT01265797|538026387|FG000|Blinded Month|Lack of Efficacy|5|||
149149470|NCT01265797|538026388|FG001|Blinded Month|Lack of Efficacy|0|||
148805608|NCT00042289|536767964|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
148805609|NCT00042289|536767965|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
148805610|NCT00042289|536767966|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
148805611|NCT00042289|536767967|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
148805612|NCT00042289|536767968|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
148805613|NCT00042289|536767969|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
148805614|NCT00042289|536767970|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
148805615|NCT00042289|536767971|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
148805616|NCT00042289|536767972|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
148805617|NCT00042289|536767973|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
148917625|NCT00946153|537182600|FG000|Phase 2|Need more reduction of dose|0|||
148917626|NCT00946153|537182601|FG001|Phase 2|Need more reduction of dose|0|||
148917627|NCT00946153|537182602|FG002|Phase 2|Need more reduction of dose|0|||
148917628|NCT00946153|537182603|FG003|Phase 2|Need more reduction of dose|0|||
148917629|NCT00946153|537182604|FG004|Phase 2|Need more reduction of dose|2|||
148917630|NCT00946153|537182600|FG000|Phase 2|Physician Decision|0|||
148917631|NCT00946153|537182601|FG001|Phase 2|Physician Decision|0|||
148917632|NCT00946153|537182602|FG002|Phase 2|Physician Decision|0|||
148917633|NCT00946153|537182603|FG003|Phase 2|Physician Decision|0|||
148917634|NCT00946153|537182604|FG004|Phase 2|Physician Decision|1|||
148917635|NCT00946153|537182600|FG000|Phase 2|14 days washout for recovery due to AE|0|||
148917636|NCT00946153|537182601|FG001|Phase 2|14 days washout for recovery due to AE|0|||
148917637|NCT00946153|537182602|FG002|Phase 2|14 days washout for recovery due to AE|0|||
148917638|NCT00946153|537182603|FG003|Phase 2|14 days washout for recovery due to AE|0|||
148917639|NCT00946153|537182604|FG004|Phase 2|14 days washout for recovery due to AE|4|||
148917640|NCT01675167|537182613|FG000|Open-label Titration Phase|Adverse Event|81|||
148917641|NCT01675167|537182614|FG001|Open-label Titration Phase|Adverse Event|0|||
148917642|NCT01675167|537182615|FG002|Open-label Titration Phase|Adverse Event|0|||
148917643|NCT01675167|537182613|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
148917644|NCT01675167|537182614|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
148917645|NCT01675167|537182615|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
148917646|NCT01675167|537182613|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
148917647|NCT01675167|537182614|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
148917648|NCT01675167|537182615|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
148917649|NCT01675167|537182613|FG000|Open-label Titration Phase|Protocol Violation|43|||
148917650|NCT01675167|537182614|FG001|Open-label Titration Phase|Protocol Violation|0|||
148917651|NCT01675167|537182615|FG002|Open-label Titration Phase|Protocol Violation|0|||
148917652|NCT01675167|537182613|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
148917653|NCT01675167|537182614|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
148917654|NCT01675167|537182615|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
148917655|NCT01675167|537182613|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
148917656|NCT01675167|537182614|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
148917657|NCT01675167|537182615|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
148917658|NCT01675167|537182613|FG000|Open-label Titration Phase|Other|55|||
148917659|NCT01675167|537182614|FG001|Open-label Titration Phase|Other|0|||
148917660|NCT01675167|537182615|FG002|Open-label Titration Phase|Other|0|||
148917661|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
148917662|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
148917663|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
148917664|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148917665|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
148917666|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
148917667|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Adverse Event|0|||
148917668|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Adverse Event|5|||
148917669|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Adverse Event|13|||
148917670|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
148917671|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
148917672|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
148917673|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
148917674|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
148917675|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
148917676|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
148917677|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
148917678|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
148917679|NCT01675167|537182613|FG000|Double-blind Treatment Phase|Other|0|||
148917680|NCT01675167|537182614|FG001|Double-blind Treatment Phase|Other|7|||
148672353|NCT00572910|536270762|FG008|Overall Study|Adverse Event|1|||
148917681|NCT01675167|537182615|FG002|Double-blind Treatment Phase|Other|5|||
149149471|NCT01265797|538026387|FG000|Blinded Month|Lost to Follow-up|1|||
148672354|NCT00572910|536270763|FG009|Overall Study|Adverse Event|3|||
149149472|NCT01265797|538026388|FG001|Blinded Month|Lost to Follow-up|0|||
149149473|NCT01265797|538026387|FG000|Blinded Month|Protocol Violation|2|||
149149474|NCT01265797|538026388|FG001|Blinded Month|Protocol Violation|1|||
149149475|NCT01265797|538026387|FG000|Blinded Month|Adverse Event|2|||
149149476|NCT01265797|538026388|FG001|Blinded Month|Adverse Event|0|||
149149477|NCT01265797|538026387|FG000|Blinded Month|Diary data incomplete|0|||
149149478|NCT01265797|538026388|FG001|Blinded Month|Diary data incomplete|1|||
149149479|NCT01265797|538026387|FG000|Open Label Month|Lost to Follow-up|0|||
149149480|NCT01265797|538026388|FG001|Open Label Month|Lost to Follow-up|1|||
149149481|NCT02980224|538026389|FG000|Overall Study|Adverse Event|4|||
149149482|NCT02980224|538026390|FG001|Overall Study|Adverse Event|1|||
149149483|NCT02980224|538026389|FG000|Overall Study|Withdrawal by Subject|0|||
149149484|NCT02980224|538026390|FG001|Overall Study|Withdrawal by Subject|2|||
149149485|NCT00583362|538026391|FG000|Overall Study|Adverse Event|44|||
149149486|NCT00583362|538026391|FG000|Overall Study|Lack of Efficacy|22|||
149149487|NCT00583362|538026391|FG000|Overall Study|Lost to Follow-up|4|||
149149488|NCT00583362|538026391|FG000|Overall Study|Non-compliance with study drug|28|||
149149489|NCT00583362|538026391|FG000|Overall Study|Pregnancy|7|||
149149490|NCT00583362|538026391|FG000|Overall Study|Miscommunication of visit window|5|||
149149491|NCT00583362|538026391|FG000|Overall Study|Current site closed|7|||
149149492|NCT00583362|538026391|FG000|Overall Study|Subject not dosed in LBSL99|1|||
149149493|NCT00583362|538026391|FG000|Overall Study|Subject moved out of the country/state|2|||
149149494|NCT00583362|538026391|FG000|Overall Study|Missed visits due to staff changes|1|||
149149495|NCT00583362|538026391|FG000|Overall Study|Misunderstanding of protocol|1|||
149149496|NCT00583362|538026391|FG000|Overall Study|Behavioral problems and non-compliance|1|||
149149497|NCT00583362|538026391|FG000|Overall Study|Sponsor request due to missed doses|1|||
149149498|NCT00583362|538026391|FG000|Overall Study|Physician Decision|19|||
149149499|NCT00583362|538026391|FG000|Overall Study|Protocol Violation|2|||
149149500|NCT00583362|538026391|FG000|Overall Study|Withdrawal by Subject|57|||
149149501|NCT00577642|538026392|FG000|Overall Study|Clinical Disease Progression|1|||
149149502|NCT04770389|538026393|FG000|Overall Study|Adverse Event|1|||
149149503|NCT04770389|538026394|FG001|Overall Study|Adverse Event|2|||
149149504|NCT04770389|538026395|FG002|Overall Study|Adverse Event|0|||
149149505|NCT04770389|538026396|FG003|Overall Study|Adverse Event|1|||
149149506|NCT04770389|538026393|FG000|Overall Study|Withdrawal by Subject|0|||
149149507|NCT04770389|538026394|FG001|Overall Study|Withdrawal by Subject|2|||
149149508|NCT04770389|538026395|FG002|Overall Study|Withdrawal by Subject|1|||
149149509|NCT04770389|538026396|FG003|Overall Study|Withdrawal by Subject|0|||
149149510|NCT04770389|538026393|FG000|Overall Study|Failed attempt to draw blood|1|||
149149511|NCT04770389|538026394|FG001|Overall Study|Failed attempt to draw blood|0|||
149149512|NCT04770389|538026395|FG002|Overall Study|Failed attempt to draw blood|0|||
149149513|NCT04770389|538026396|FG003|Overall Study|Failed attempt to draw blood|0|||
149149514|NCT04770389|538026393|FG000|Overall Study|Left the country|0|||
149149515|NCT04770389|538026394|FG001|Overall Study|Left the country|0|||
149149516|NCT04770389|538026395|FG002|Overall Study|Left the country|1|||
149149517|NCT04770389|538026396|FG003|Overall Study|Left the country|2|||
149149518|NCT04770389|538026393|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
149149519|NCT04770389|538026394|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
149149520|NCT04770389|538026395|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
149149521|NCT04770389|538026396|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
149149522|NCT04770389|538026393|FG000|Overall Study|Lost to Follow-up|0|||
149149523|NCT04770389|538026394|FG001|Overall Study|Lost to Follow-up|0|||
149149524|NCT04770389|538026395|FG002|Overall Study|Lost to Follow-up|0|||
149149525|NCT04770389|538026396|FG003|Overall Study|Lost to Follow-up|1|||
149149526|NCT04770389|538026393|FG000|Overall Study|Moved away from study site|0|||
149149527|NCT04770389|538026394|FG001|Overall Study|Moved away from study site|1|||
149149528|NCT04770389|538026395|FG002|Overall Study|Moved away from study site|0|||
149149529|NCT04770389|538026396|FG003|Overall Study|Moved away from study site|0|||
149149530|NCT00794157|538026397|FG000|Overall Study|Adverse Event|4|||
149149531|NCT00794157|538026398|FG001|Overall Study|Adverse Event|1|||
149149532|NCT00794157|538026399|FG002|Overall Study|Adverse Event|8|||
149149533|NCT00794157|538026397|FG000|Overall Study|Subject withdrew consent|2|||
149149534|NCT00794157|538026398|FG001|Overall Study|Subject withdrew consent|0|||
148805618|NCT00042289|536767974|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
149149535|NCT00794157|538026399|FG002|Overall Study|Subject withdrew consent|3|||
149149536|NCT00794157|538026397|FG000|Overall Study|Lost to Follow-up|2|||
149149537|NCT00794157|538026398|FG001|Overall Study|Lost to Follow-up|0|||
149149538|NCT00794157|538026399|FG002|Overall Study|Lost to Follow-up|1|||
149149539|NCT00794157|538026397|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149149540|NCT00794157|538026398|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149149541|NCT00794157|538026399|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
149149542|NCT00794157|538026397|FG000|Overall Study|Administrative problems|1|||
149149543|NCT00794157|538026398|FG001|Overall Study|Administrative problems|7|||
149149544|NCT00794157|538026399|FG002|Overall Study|Administrative problems|4|||
149149545|NCT00794157|538026397|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148917682|NCT03952039|537182616|FG000|Overall Study|Adverse Event|22|||
148917683|NCT03952039|537182617|FG001|Overall Study|Adverse Event|8|||
148917684|NCT03952039|537182616|FG000|Overall Study|Withdrawal by Participant|17|||
148917685|NCT03952039|537182617|FG001|Overall Study|Withdrawal by Participant|12|||
148917686|NCT03952039|537182616|FG000|Overall Study|Death|13|||
148917687|NCT03952039|537182617|FG001|Overall Study|Death|6|||
148917688|NCT03952039|537182616|FG000|Overall Study|Lack of Efficacy|12|||
148917689|NCT03952039|537182617|FG001|Overall Study|Lack of Efficacy|2|||
148917690|NCT03952039|537182616|FG000|Overall Study|Physician Decision|9|||
148917691|NCT03952039|537182617|FG001|Overall Study|Physician Decision|3|||
148917692|NCT03952039|537182616|FG000|Overall Study|Progressive Disease|6|||
148917693|NCT03952039|537182617|FG001|Overall Study|Progressive Disease|4|||
148917694|NCT03952039|537182616|FG000|Overall Study|Other Reasons|12|||
148917695|NCT03952039|537182617|FG001|Overall Study|Other Reasons|4|||
148917696|NCT04174365|537182618|FG000|Overall Study|Lost to Follow-up|1|||
148917697|NCT04174365|537182619|FG001|Overall Study|Lost to Follow-up|2|||
148917698|NCT04174365|537182618|FG000|Overall Study|Adverse Event|2|||
148917699|NCT04174365|537182619|FG001|Overall Study|Adverse Event|1|||
148917700|NCT04174365|537182618|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
148917701|NCT04174365|537182619|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
148917702|NCT04174365|537182618|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
148917703|NCT04174365|537182619|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
148917704|NCT04174365|537182618|FG000|Overall Study|Protocol Deviation|1|||
148917705|NCT04174365|537182619|FG001|Overall Study|Protocol Deviation|0|||
148917706|NCT04174365|537182618|FG000|Overall Study|Lack of Efficacy|0|||
148917707|NCT04174365|537182619|FG001|Overall Study|Lack of Efficacy|2|||
148917708|NCT04174365|537182618|FG000|Overall Study|Disease Relapse|1|||
148917709|NCT04174365|537182619|FG001|Overall Study|Disease Relapse|0|||
148917710|NCT04174365|537182618|FG000|Overall Study|Reason Not Specified|0|||
148917711|NCT04174365|537182619|FG001|Overall Study|Reason Not Specified|1|||
148917712|NCT03472547|537182620|FG000|Overall Study|Withdrawal by Subject|30|||
148917713|NCT05141448|537182621|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
148917714|NCT05141448|537182622|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
148917715|NCT05141448|537182623|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
148917716|NCT05141448|537182624|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
148917717|NCT05141448|537182625|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
148917718|NCT05141448|537182626|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
148917719|NCT05141448|537182621|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
148917720|NCT05141448|537182622|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
148917721|NCT05141448|537182623|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
148917722|NCT05141448|537182624|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
148917723|NCT05141448|537182625|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
148917724|NCT05141448|537182626|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
148917725|NCT05141448|537182621|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148917726|NCT05141448|537182622|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
148917727|NCT05141448|537182623|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148917728|NCT05141448|537182624|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148917729|NCT05141448|537182625|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148917730|NCT05141448|537182626|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148917731|NCT05141448|537182621|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
148917732|NCT05141448|537182622|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
148917733|NCT05141448|537182623|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
148917734|NCT05141448|537182624|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
148917735|NCT05141448|537182625|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
148917736|NCT05141448|537182626|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
148917737|NCT05141448|537182621|FG000|Period 2|COVID-19 Related|0|||
148917738|NCT05141448|537182622|FG001|Period 2|COVID-19 Related|0|||
148917739|NCT05141448|537182623|FG002|Period 2|COVID-19 Related|0|||
148917740|NCT05141448|537182624|FG003|Period 2|COVID-19 Related|1|||
148917741|NCT05141448|537182625|FG004|Period 2|COVID-19 Related|0|||
148917742|NCT05141448|537182626|FG005|Period 2|COVID-19 Related|1|||
148917743|NCT05141448|537182621|FG000|3|Covid-19 related|2|||
148917744|NCT05141448|537182622|FG001|3|Covid-19 related|0|||
148917745|NCT05141448|537182623|FG002|3|Covid-19 related|0|||
148917746|NCT05141448|537182624|FG003|3|Covid-19 related|0|||
148917747|NCT05141448|537182625|FG004|3|Covid-19 related|0|||
148917748|NCT05141448|537182626|FG005|3|Covid-19 related|1|||
149149546|NCT00794157|538026398|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148917749|NCT05141448|537182621|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
148917750|NCT05141448|537182622|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
148917751|NCT05141448|537182623|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
149149547|NCT00794157|538026399|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149149548|NCT00794157|538026397|FG000|Overall Study|Protocol deviation|0|||
149149549|NCT00794157|538026398|FG001|Overall Study|Protocol deviation|1|||
149149550|NCT00794157|538026399|FG002|Overall Study|Protocol deviation|1|||
149149551|NCT01692275|538026400|FG000|Overall Study|Lost to Follow-up|57|||
149149552|NCT01692275|538026401|FG001|Overall Study|Lost to Follow-up|48|||
149149553|NCT01692275|538026400|FG000|Overall Study|Withdrawal by Subject|9|||
149149554|NCT01692275|538026401|FG001|Overall Study|Withdrawal by Subject|11|||
149149555|NCT00401375|538026404|FG000|Overall Study|Protocol Violation|2|||
149149556|NCT00401375|538026405|FG001|Overall Study|Protocol Violation|2|||
149149557|NCT00401375|538026406|FG002|Overall Study|Protocol Violation|1|||
149149558|NCT00401375|538026404|FG000|Overall Study|Adverse Event|6|||
149149559|NCT00401375|538026405|FG001|Overall Study|Adverse Event|11|||
149149560|NCT00401375|538026406|FG002|Overall Study|Adverse Event|10|||
149149561|NCT00401375|538026404|FG000|Overall Study|Withdrawal by Subject|9|||
149149562|NCT00401375|538026405|FG001|Overall Study|Withdrawal by Subject|7|||
149149563|NCT00401375|538026406|FG002|Overall Study|Withdrawal by Subject|7|||
149149564|NCT00401375|538026404|FG000|Overall Study|Lost to Follow-up|0|||
149149565|NCT00401375|538026405|FG001|Overall Study|Lost to Follow-up|1|||
149149566|NCT00401375|538026406|FG002|Overall Study|Lost to Follow-up|1|||
149149567|NCT00401375|538026404|FG000|Overall Study|Other than specified|2|||
149149568|NCT00401375|538026405|FG001|Overall Study|Other than specified|1|||
149149569|NCT00401375|538026406|FG002|Overall Study|Other than specified|3|||
149149570|NCT00401375|538026404|FG000|Overall Study|Randomized but not treated|3|||
149149571|NCT00401375|538026405|FG001|Overall Study|Randomized but not treated|3|||
149149572|NCT00401375|538026406|FG002|Overall Study|Randomized but not treated|3|||
149149573|NCT00677014|538026407|FG000|Overall Study|Lost to Follow-up|20|||
149149574|NCT00677014|538026408|FG001|Overall Study|Lost to Follow-up|12|||
149149575|NCT00677014|538026409|FG002|Overall Study|Lost to Follow-up|24|||
149149576|NCT00677014|538026407|FG000|Overall Study|Death|6|||
149149577|NCT00677014|538026408|FG001|Overall Study|Death|15|||
149149578|NCT00677014|538026409|FG002|Overall Study|Death|7|||
149149579|NCT00677014|538026407|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
149149580|NCT00677014|538026408|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
149149581|NCT00677014|538026409|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
149149582|NCT00640328|538026410|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
149149583|NCT00640328|538026411|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
149149584|NCT00640328|538026412|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
149149585|NCT00640328|538026413|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
149149586|NCT00640328|538026414|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
149149587|NCT00640328|538026415|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
149149588|NCT00640328|538026410|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
149149589|NCT00640328|538026411|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
149149590|NCT00640328|538026412|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
149149591|NCT00640328|538026413|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
149149592|NCT00640328|538026414|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
149149593|NCT00640328|538026415|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
149149594|NCT00640328|538026410|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
149149595|NCT00640328|538026411|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
149149596|NCT00640328|538026412|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
149149597|NCT00640328|538026413|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
149149598|NCT00640328|538026414|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
149149599|NCT00640328|538026415|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
149149600|NCT00640328|538026410|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
149149601|NCT00640328|538026411|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
149149602|NCT00640328|538026412|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
149149603|NCT00640328|538026413|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
149149604|NCT00640328|538026414|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
149149605|NCT00640328|538026415|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
148917752|NCT05141448|537182624|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
148917753|NCT05141448|537182625|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
148917754|NCT05141448|537182626|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
148672355|NCT00572910|536270764|FG010|Overall Study|Adverse Event|2|||
148672356|NCT00572910|536270754|FG000|Overall Study|Lost to Follow-up|0|||
148917755|NCT02600871|537184413|FG000|Overall Study|Lost to Follow-up|13|||
148917756|NCT02600871|537184414|FG001|Overall Study|Lost to Follow-up|10|||
148917757|NCT01604278|537184415|FG000|Overall Study|Lack of Efficacy|0|||
149149606|NCT01033825|538026416|FG000|Overall Study|Withdrawal by Subject|2|||
148917758|NCT01604278|537184416|FG001|Overall Study|Lack of Efficacy|1|||
149149607|NCT01033825|538026417|FG001|Overall Study|Withdrawal by Subject|3|||
148917759|NCT01604278|537184415|FG000|Overall Study|Lost to Follow-up|1|||
149149608|NCT01033825|538026418|FG002|Overall Study|Withdrawal by Subject|2|||
149149609|NCT01033825|538026419|FG003|Overall Study|Withdrawal by Subject|1|||
149149610|NCT01033825|538026420|FG004|Overall Study|Withdrawal by Subject|1|||
149149611|NCT01033825|538026421|FG005|Overall Study|Withdrawal by Subject|0|||
149149612|NCT01033825|538026422|FG006|Overall Study|Withdrawal by Subject|0|||
149149613|NCT01033825|538026416|FG000|Overall Study|Adverse Event|0|||
149149614|NCT01033825|538026417|FG001|Overall Study|Adverse Event|0|||
149149615|NCT01033825|538026418|FG002|Overall Study|Adverse Event|0|||
149149616|NCT01033825|538026419|FG003|Overall Study|Adverse Event|1|||
149149617|NCT01033825|538026420|FG004|Overall Study|Adverse Event|0|||
149149618|NCT01033825|538026421|FG005|Overall Study|Adverse Event|0|||
149149619|NCT01033825|538026422|FG006|Overall Study|Adverse Event|0|||
149149620|NCT01033825|538026416|FG000|Overall Study|Protocol Violation|1|||
149149621|NCT01033825|538026417|FG001|Overall Study|Protocol Violation|0|||
149149622|NCT01033825|538026418|FG002|Overall Study|Protocol Violation|0|||
149149623|NCT01033825|538026419|FG003|Overall Study|Protocol Violation|0|||
149149624|NCT01033825|538026420|FG004|Overall Study|Protocol Violation|0|||
149149625|NCT01033825|538026421|FG005|Overall Study|Protocol Violation|0|||
149149626|NCT01033825|538026422|FG006|Overall Study|Protocol Violation|0|||
149149627|NCT01033825|538026416|FG000|Overall Study|Other|0|||
149149628|NCT01033825|538026417|FG001|Overall Study|Other|0|||
149149629|NCT01033825|538026418|FG002|Overall Study|Other|0|||
149149630|NCT01033825|538026419|FG003|Overall Study|Other|0|||
149149631|NCT01033825|538026420|FG004|Overall Study|Other|1|||
149149632|NCT01033825|538026421|FG005|Overall Study|Other|0|||
148917760|NCT01604278|537184416|FG001|Overall Study|Lost to Follow-up|0|||
148917761|NCT01604278|537184415|FG000|Overall Study|Administrative problems|2|||
148917762|NCT01604278|537184416|FG001|Overall Study|Administrative problems|1|||
148917763|NCT01604278|537184415|FG000|Overall Study|Withdrawal by Subject|3|||
148917764|NCT01604278|537184416|FG001|Overall Study|Withdrawal by Subject|3|||
148917765|NCT01604278|537184415|FG000|Overall Study|Adverse Event|3|||
148917766|NCT01604278|537184416|FG001|Overall Study|Adverse Event|5|||
148917767|NCT01604278|537184415|FG000|Overall Study|Protocol Deviation|5|||
148917768|NCT01604278|537184416|FG001|Overall Study|Protocol Deviation|3|||
148917769|NCT00874939|537184419|FG000|Overall Study|Study terminated|4|||
148917770|NCT02267317|537184425|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
148917771|NCT02267317|537184426|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
148917772|NCT02267317|537184427|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
148917773|NCT02267317|537184428|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
148917774|NCT02267317|537184429|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
148917775|NCT02267317|537184430|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
148917776|NCT02267317|537184425|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
148917777|NCT02267317|537184426|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
148917778|NCT02267317|537184427|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
148917779|NCT02267317|537184428|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
148917780|NCT02267317|537184429|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
148917781|NCT02267317|537184430|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
148917782|NCT02208063|537184433|FG000|Overall Study|Death|3|||
148917783|NCT02208063|537184434|FG001|Overall Study|Death|5|||
148917784|NCT02208063|537184433|FG000|Overall Study|Not Specified in report|3|||
148917785|NCT02208063|537184434|FG001|Overall Study|Not Specified in report|4|||
148917786|NCT02208063|537184433|FG000|Overall Study|Withdrawal by Subject|5|||
148917787|NCT02208063|537184434|FG001|Overall Study|Withdrawal by Subject|2|||
148917788|NCT02208063|537184433|FG000|Overall Study|Lost to Follow-up|1|||
149149633|NCT01033825|538026422|FG006|Overall Study|Other|0|||
149149634|NCT03885089|538026423|FG000|Overall Study|No informed consent for publication of study results|2|||
149149635|NCT03349099|538026426|FG000|Overall Study|Physician Decision|3|||
148917789|NCT02208063|537184434|FG001|Overall Study|Lost to Follow-up|0|||
148917790|NCT00913458|537184435|FG000|Phase 1|Non-Responder|54|||
148917791|NCT00913458|537184436|FG001|Phase 1|Non-Responder|0|||
148917792|NCT00913458|537184437|FG002|Phase 1|Non-Responder|0|||
148917793|NCT00913458|537184438|FG003|Phase 1|Non-Responder|0|||
148917794|NCT00913458|537184439|FG004|Phase 1|Non-Responder|0|||
148917795|NCT00913458|537184440|FG005|Phase 1|Non-Responder|0|||
148917796|NCT00913458|537184441|FG006|Phase 1|Non-Responder|0|||
149149636|NCT03349099|538026427|FG001|Overall Study|Physician Decision|4|||
149149637|NCT03349099|538026426|FG000|Overall Study|Stone migrated from the kidney|1|||
149149638|NCT03349099|538026427|FG001|Overall Study|Stone migrated from the kidney|0|||
149149639|NCT00278993|538026428|FG000|Overall Study|Adverse Event|24|||
149149640|NCT00278993|538026428|FG000|Overall Study|Withdrawal by Subject|5|||
149149641|NCT00278993|538026428|FG000|Overall Study|Progressive Disease|65|||
149149642|NCT00278993|538026428|FG000|Overall Study|Physician Decision|9|||
149149643|NCT00278993|538026428|FG000|Overall Study|Not Otherwise Specified|4|||
149149644|NCT01979536|538026432|FG000|Overall Study|Physician Decision|2|||
149149645|NCT01979536|538026433|FG001|Overall Study|Physician Decision|3|||
149149646|NCT01979536|538026432|FG000|Overall Study|Withdrawal by Subject|0|||
149149647|NCT01979536|538026433|FG001|Overall Study|Withdrawal by Subject|1|||
149149648|NCT01979536|538026432|FG000|Overall Study|Refusal|0|||
149149649|NCT01979536|538026433|FG001|Overall Study|Refusal|1|||
149149650|NCT01979536|538026432|FG000|Overall Study|Relapse|0|||
149149651|NCT01979536|538026433|FG001|Overall Study|Relapse|1|||
149149652|NCT01979536|538026432|FG000|Overall Study|Study terminated by Sponsor|0|||
149149653|NCT01979536|538026433|FG001|Overall Study|Study terminated by Sponsor|1|||
149149654|NCT01979536|538026432|FG000|Overall Study|Did not start treatment|0|||
149149655|NCT01979536|538026433|FG001|Overall Study|Did not start treatment|1|||
149149656|NCT03077685|538026434|FG000|Overall Study|Lost to Follow-up|0|||
148917797|NCT00913458|537184435|FG000|Phase 1|Subject Request|17|||
148917798|NCT00913458|537184436|FG001|Phase 1|Subject Request|0|||
148917799|NCT00913458|537184437|FG002|Phase 1|Subject Request|0|||
148917800|NCT00913458|537184438|FG003|Phase 1|Subject Request|0|||
148917801|NCT00913458|537184439|FG004|Phase 1|Subject Request|0|||
148917802|NCT00913458|537184440|FG005|Phase 1|Subject Request|0|||
148917803|NCT00913458|537184441|FG006|Phase 1|Subject Request|0|||
148917804|NCT00913458|537184435|FG000|Phase 1|Adverse Event|20|||
148917805|NCT00913458|537184436|FG001|Phase 1|Adverse Event|0|||
148917806|NCT00913458|537184437|FG002|Phase 1|Adverse Event|0|||
148917807|NCT00913458|537184438|FG003|Phase 1|Adverse Event|0|||
148917808|NCT00913458|537184439|FG004|Phase 1|Adverse Event|0|||
148917809|NCT00913458|537184440|FG005|Phase 1|Adverse Event|0|||
148917810|NCT00913458|537184441|FG006|Phase 1|Adverse Event|0|||
148917811|NCT00913458|537184435|FG000|Phase 1|Lost to Follow-up|2|||
148917812|NCT00913458|537184436|FG001|Phase 1|Lost to Follow-up|0|||
148917813|NCT00913458|537184437|FG002|Phase 1|Lost to Follow-up|0|||
148917814|NCT00913458|537184438|FG003|Phase 1|Lost to Follow-up|0|||
148917815|NCT00913458|537184439|FG004|Phase 1|Lost to Follow-up|0|||
148917816|NCT00913458|537184440|FG005|Phase 1|Lost to Follow-up|0|||
148917817|NCT00913458|537184441|FG006|Phase 1|Lost to Follow-up|0|||
148917818|NCT00913458|537184435|FG000|Phase 1|Protocol Violation|10|||
148917819|NCT00913458|537184436|FG001|Phase 1|Protocol Violation|0|||
148917820|NCT00913458|537184437|FG002|Phase 1|Protocol Violation|0|||
148917821|NCT00913458|537184438|FG003|Phase 1|Protocol Violation|0|||
148917822|NCT00913458|537184439|FG004|Phase 1|Protocol Violation|0|||
148917823|NCT00913458|537184440|FG005|Phase 1|Protocol Violation|0|||
148917824|NCT00913458|537184441|FG006|Phase 1|Protocol Violation|0|||
148917825|NCT00913458|537184435|FG000|Phase 1|Sponsor|2|||
148917826|NCT00913458|537184436|FG001|Phase 1|Sponsor|0|||
148917827|NCT00913458|537184437|FG002|Phase 1|Sponsor|0|||
148917828|NCT00913458|537184438|FG003|Phase 1|Sponsor|0|||
148917829|NCT00913458|537184439|FG004|Phase 1|Sponsor|0|||
148917830|NCT00913458|537184440|FG005|Phase 1|Sponsor|0|||
148917831|NCT00913458|537184441|FG006|Phase 1|Sponsor|0|||
148917832|NCT00913458|537184435|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
148917833|NCT00913458|537184436|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
148917834|NCT00913458|537184437|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
148917835|NCT00913458|537184438|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
148917836|NCT00913458|537184439|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
148917837|NCT00913458|537184440|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
148917838|NCT00913458|537184441|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
148917839|NCT00913458|537184435|FG000|Phase 2|Non-Responder|0|||
148917840|NCT00913458|537184436|FG001|Phase 2|Non-Responder|5|||
148917841|NCT00913458|537184437|FG002|Phase 2|Non-Responder|7|||
148917842|NCT00913458|537184438|FG003|Phase 2|Non-Responder|12|||
148917843|NCT00913458|537184439|FG004|Phase 2|Non-Responder|0|||
148917844|NCT00913458|537184440|FG005|Phase 2|Non-Responder|0|||
148917845|NCT00913458|537184441|FG006|Phase 2|Non-Responder|0|||
148917846|NCT00913458|537184435|FG000|Phase 2|Subject Request|0|||
148917847|NCT00913458|537184436|FG001|Phase 2|Subject Request|0|||
149149657|NCT03077685|538026435|FG001|Overall Study|Lost to Follow-up|0|||
148917848|NCT00913458|537184437|FG002|Phase 2|Subject Request|1|||
148917849|NCT00913458|537184438|FG003|Phase 2|Subject Request|2|||
148917850|NCT00913458|537184439|FG004|Phase 2|Subject Request|0|||
148917851|NCT00913458|537184440|FG005|Phase 2|Subject Request|0|||
148917852|NCT00913458|537184441|FG006|Phase 2|Subject Request|0|||
148917853|NCT00913458|537184435|FG000|Phase 2|Adverse Event|0|||
148917854|NCT00913458|537184436|FG001|Phase 2|Adverse Event|3|||
148917855|NCT00913458|537184437|FG002|Phase 2|Adverse Event|0|||
148917856|NCT00913458|537184438|FG003|Phase 2|Adverse Event|1|||
149149658|NCT03077685|538026436|FG002|Overall Study|Lost to Follow-up|0|||
149149659|NCT03077685|538026437|FG003|Overall Study|Lost to Follow-up|0|||
149149660|NCT03077685|538026438|FG004|Overall Study|Lost to Follow-up|1|||
148917857|NCT00913458|537184439|FG004|Phase 2|Adverse Event|0|||
148917858|NCT00913458|537184440|FG005|Phase 2|Adverse Event|0|||
148917859|NCT00913458|537184441|FG006|Phase 2|Adverse Event|0|||
148917860|NCT00913458|537184435|FG000|Phase 2|Lost to Follow-up|0|||
148917861|NCT00913458|537184436|FG001|Phase 2|Lost to Follow-up|0|||
148917862|NCT00913458|537184437|FG002|Phase 2|Lost to Follow-up|0|||
148917863|NCT00913458|537184438|FG003|Phase 2|Lost to Follow-up|1|||
148917864|NCT00913458|537184439|FG004|Phase 2|Lost to Follow-up|0|||
149149661|NCT03077685|538026434|FG000|Overall Study|Death|0|||
149149662|NCT03077685|538026435|FG001|Overall Study|Death|0|||
149149663|NCT03077685|538026436|FG002|Overall Study|Death|1|||
149149664|NCT03077685|538026437|FG003|Overall Study|Death|1|||
149149665|NCT03077685|538026438|FG004|Overall Study|Death|3|||
149149666|NCT03077685|538026434|FG000|Overall Study|Withdrawal by Subject|0|||
149149667|NCT03077685|538026435|FG001|Overall Study|Withdrawal by Subject|0|||
149149668|NCT03077685|538026436|FG002|Overall Study|Withdrawal by Subject|0|||
149149669|NCT03077685|538026437|FG003|Overall Study|Withdrawal by Subject|2|||
149149670|NCT03077685|538026438|FG004|Overall Study|Withdrawal by Subject|1|||
149149671|NCT03077685|538026434|FG000|Overall Study|Physician Decision|0|||
149149672|NCT03077685|538026435|FG001|Overall Study|Physician Decision|0|||
149149673|NCT03077685|538026436|FG002|Overall Study|Physician Decision|1|||
149149674|NCT03077685|538026437|FG003|Overall Study|Physician Decision|0|||
149149675|NCT03077685|538026438|FG004|Overall Study|Physician Decision|3|||
149149676|NCT03077685|538026434|FG000|Overall Study|Disease Progression|1|||
149149677|NCT03077685|538026435|FG001|Overall Study|Disease Progression|0|||
149149678|NCT03077685|538026436|FG002|Overall Study|Disease Progression|0|||
149149679|NCT03077685|538026437|FG003|Overall Study|Disease Progression|2|||
149149680|NCT03077685|538026438|FG004|Overall Study|Disease Progression|1|||
149149681|NCT03077685|538026434|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
149149682|NCT03077685|538026435|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
149149683|NCT03077685|538026436|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
149149684|NCT03077685|538026437|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
149149685|NCT03077685|538026438|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
149149686|NCT03077685|538026434|FG000|Overall Study|Subject entered hospice care|0|||
149149687|NCT03077685|538026435|FG001|Overall Study|Subject entered hospice care|0|||
149149688|NCT03077685|538026436|FG002|Overall Study|Subject entered hospice care|0|||
149149689|NCT03077685|538026437|FG003|Overall Study|Subject entered hospice care|0|||
149149690|NCT03077685|538026438|FG004|Overall Study|Subject entered hospice care|1|||
149233862|NCT00948896|538324951|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
149233863|NCT00948896|538324944|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
149233864|NCT00948896|538324945|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
149233865|NCT00948896|538324946|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
149233866|NCT00948896|538324947|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
149233867|NCT00948896|538324948|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
149233868|NCT00948896|538324949|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
149233869|NCT00948896|538324950|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
149233870|NCT00948896|538324951|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
149233871|NCT00948896|538324944|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
149233872|NCT00948896|538324945|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
148672357|NCT00572910|536270755|FG001|Overall Study|Lost to Follow-up|1|||
148672358|NCT00572910|536270756|FG002|Overall Study|Lost to Follow-up|1|||
148672359|NCT00572910|536270757|FG003|Overall Study|Lost to Follow-up|2|||
148672360|NCT00572910|536270758|FG004|Overall Study|Lost to Follow-up|1|||
148672361|NCT00572910|536270759|FG005|Overall Study|Lost to Follow-up|0|||
148672362|NCT00572910|536270760|FG006|Overall Study|Lost to Follow-up|0|||
148672363|NCT00572910|536270761|FG007|Overall Study|Lost to Follow-up|0|||
148672364|NCT00572910|536270762|FG008|Overall Study|Lost to Follow-up|0|||
148672365|NCT00572910|536270763|FG009|Overall Study|Lost to Follow-up|1|||
148672366|NCT00572910|536270764|FG010|Overall Study|Lost to Follow-up|0|||
148672367|NCT00572910|536270754|FG000|Overall Study|Withdrawal by Subject|3|||
148672368|NCT00572910|536270755|FG001|Overall Study|Withdrawal by Subject|0|||
148672369|NCT00572910|536270756|FG002|Overall Study|Withdrawal by Subject|1|||
148672370|NCT00572910|536270757|FG003|Overall Study|Withdrawal by Subject|0|||
148917865|NCT00913458|537184440|FG005|Phase 2|Lost to Follow-up|0|||
148917866|NCT00913458|537184441|FG006|Phase 2|Lost to Follow-up|0|||
148917867|NCT00913458|537184435|FG000|Phase 2|Protocol Violation|0|||
148917868|NCT00913458|537184436|FG001|Phase 2|Protocol Violation|2|||
148917869|NCT00913458|537184437|FG002|Phase 2|Protocol Violation|0|||
148917870|NCT00913458|537184438|FG003|Phase 2|Protocol Violation|0|||
148917871|NCT00913458|537184439|FG004|Phase 2|Protocol Violation|0|||
148917872|NCT00913458|537184440|FG005|Phase 2|Protocol Violation|0|||
148917873|NCT00913458|537184441|FG006|Phase 2|Protocol Violation|0|||
148917874|NCT00913458|537184435|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
149233873|NCT00948896|538324946|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
149233874|NCT00948896|538324947|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
149233875|NCT00948896|538324948|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
149233876|NCT00948896|538324949|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
149233877|NCT00948896|538324950|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
149233878|NCT00948896|538324951|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
149233879|NCT00948896|538324944|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
148672371|NCT00572910|536270758|FG004|Overall Study|Withdrawal by Subject|1|||
148672372|NCT00572910|536270759|FG005|Overall Study|Withdrawal by Subject|3|||
148917875|NCT00913458|537184436|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
148917876|NCT00913458|537184437|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
148917877|NCT00913458|537184438|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
148917878|NCT00913458|537184439|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
148917879|NCT00913458|537184440|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
148917880|NCT00913458|537184441|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
148917881|NCT00913458|537184435|FG000|Phase 3|Adverse Event|0|||
148917882|NCT00913458|537184436|FG001|Phase 3|Adverse Event|0|||
148917883|NCT00913458|537184437|FG002|Phase 3|Adverse Event|0|||
148917884|NCT00913458|537184438|FG003|Phase 3|Adverse Event|0|||
148917885|NCT00913458|537184439|FG004|Phase 3|Adverse Event|5|||
148917886|NCT00913458|537184440|FG005|Phase 3|Adverse Event|4|||
148917887|NCT00913458|537184441|FG006|Phase 3|Adverse Event|1|||
148917888|NCT00913458|537184435|FG000|Phase 3|Lost to Follow-up|0|||
148917889|NCT00913458|537184436|FG001|Phase 3|Lost to Follow-up|0|||
148917890|NCT00913458|537184437|FG002|Phase 3|Lost to Follow-up|0|||
148917891|NCT00913458|537184438|FG003|Phase 3|Lost to Follow-up|0|||
148917892|NCT00913458|537184439|FG004|Phase 3|Lost to Follow-up|2|||
148917893|NCT00913458|537184440|FG005|Phase 3|Lost to Follow-up|0|||
148917894|NCT00913458|537184441|FG006|Phase 3|Lost to Follow-up|0|||
148917895|NCT00913458|537184435|FG000|Phase 3|Non-Responder|0|||
148917896|NCT00913458|537184436|FG001|Phase 3|Non-Responder|0|||
148917897|NCT00913458|537184437|FG002|Phase 3|Non-Responder|0|||
148917898|NCT00913458|537184438|FG003|Phase 3|Non-Responder|0|||
148917899|NCT00913458|537184439|FG004|Phase 3|Non-Responder|0|||
148917900|NCT00913458|537184440|FG005|Phase 3|Non-Responder|1|||
148917901|NCT00913458|537184441|FG006|Phase 3|Non-Responder|3|||
148917902|NCT00913458|537184435|FG000|Phase 3|Withdrawal by Subject|0|||
148917903|NCT00913458|537184436|FG001|Phase 3|Withdrawal by Subject|0|||
148917904|NCT00913458|537184437|FG002|Phase 3|Withdrawal by Subject|0|||
148917905|NCT00913458|537184438|FG003|Phase 3|Withdrawal by Subject|0|||
148917906|NCT00913458|537184439|FG004|Phase 3|Withdrawal by Subject|1|||
148917907|NCT00913458|537184440|FG005|Phase 3|Withdrawal by Subject|2|||
148917908|NCT00913458|537184441|FG006|Phase 3|Withdrawal by Subject|0|||
148917909|NCT00913458|537184435|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
148917910|NCT00913458|537184436|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
148917911|NCT00913458|537184437|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
148917912|NCT00913458|537184438|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
148917913|NCT00913458|537184439|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
148917914|NCT00913458|537184440|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
148917915|NCT00913458|537184441|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
148917916|NCT03595618|537184442|FG000|Overall Study|Adverse Event|16|||
148917917|NCT03595618|537184443|FG001|Overall Study|Adverse Event|17|||
148917918|NCT03595618|537184444|FG002|Overall Study|Adverse Event|20|||
148917919|NCT03595618|537184445|FG003|Overall Study|Adverse Event|8|||
148917920|NCT03595618|537184442|FG000|Overall Study|Withdrawal by Subject|12|||
148917921|NCT03595618|537184443|FG001|Overall Study|Withdrawal by Subject|14|||
148917922|NCT03595618|537184444|FG002|Overall Study|Withdrawal by Subject|14|||
148917923|NCT03595618|537184445|FG003|Overall Study|Withdrawal by Subject|10|||
148917924|NCT03595618|537184442|FG000|Overall Study|Lost to Follow-up|6|||
148917925|NCT03595618|537184443|FG001|Overall Study|Lost to Follow-up|4|||
148917926|NCT03595618|537184444|FG002|Overall Study|Lost to Follow-up|5|||
148917927|NCT03595618|537184445|FG003|Overall Study|Lost to Follow-up|6|||
148917928|NCT03595618|537184442|FG000|Overall Study|Protocol Violation|2|||
148917929|NCT03595618|537184443|FG001|Overall Study|Protocol Violation|0|||
148917930|NCT03595618|537184444|FG002|Overall Study|Protocol Violation|6|||
148917931|NCT03595618|537184445|FG003|Overall Study|Protocol Violation|2|||
148917932|NCT03595618|537184442|FG000|Overall Study|Physician Decision|0|||
148917933|NCT03595618|537184443|FG001|Overall Study|Physician Decision|0|||
148917934|NCT03595618|537184444|FG002|Overall Study|Physician Decision|1|||
148917935|NCT03595618|537184445|FG003|Overall Study|Physician Decision|2|||
148917936|NCT03595618|537184442|FG000|Overall Study|Miscellaneous|7|||
148917937|NCT03595618|537184443|FG001|Overall Study|Miscellaneous|5|||
148917938|NCT03595618|537184444|FG002|Overall Study|Miscellaneous|10|||
148917939|NCT03595618|537184445|FG003|Overall Study|Miscellaneous|6|||
148917940|NCT02279407|537184446|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
148672373|NCT00572910|536270760|FG006|Overall Study|Withdrawal by Subject|0|||
148672374|NCT00572910|536270761|FG007|Overall Study|Withdrawal by Subject|2|||
148672375|NCT00572910|536270762|FG008|Overall Study|Withdrawal by Subject|2|||
148917941|NCT02279407|537184447|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
148917942|NCT02279407|537184448|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
148917943|NCT02279407|537184449|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
148917944|NCT02279407|537184446|FG000|Overall Study|Withdrawal by Subject|1|||
148917945|NCT02279407|537184447|FG001|Overall Study|Withdrawal by Subject|0|||
148917946|NCT02279407|537184448|FG002|Overall Study|Withdrawal by Subject|1|||
148917947|NCT02279407|537184449|FG003|Overall Study|Withdrawal by Subject|1|||
148917948|NCT02279407|537184446|FG000|Overall Study|Adverse Event|1|||
148917949|NCT02279407|537184447|FG001|Overall Study|Adverse Event|1|||
148917950|NCT02279407|537184448|FG002|Overall Study|Adverse Event|2|||
148917951|NCT02279407|537184449|FG003|Overall Study|Adverse Event|0|||
148917952|NCT02500056|537184450|FG000|Overall Study|Lost to Follow-up|3|||
148917953|NCT02500056|537184451|FG001|Overall Study|Lost to Follow-up|7|||
149149691|NCT01964352|538027883|FG000|Overall Study|Adverse Event|13|||
149149692|NCT01964352|538027884|FG001|Overall Study|Adverse Event|3|||
149149693|NCT01964352|538027885|FG002|Overall Study|Adverse Event|4|||
149149694|NCT01964352|538027886|FG003|Overall Study|Adverse Event|3|||
149149695|NCT01964352|538027883|FG000|Overall Study|Lack of Efficacy|6|||
149149696|NCT01964352|538027884|FG001|Overall Study|Lack of Efficacy|0|||
149149697|NCT01964352|538027885|FG002|Overall Study|Lack of Efficacy|0|||
149149698|NCT01964352|538027886|FG003|Overall Study|Lack of Efficacy|0|||
149149699|NCT01964352|538027883|FG000|Overall Study|Protocol Violation|2|||
149149700|NCT01964352|538027884|FG001|Overall Study|Protocol Violation|4|||
149149701|NCT01964352|538027885|FG002|Overall Study|Protocol Violation|0|||
149149702|NCT01964352|538027886|FG003|Overall Study|Protocol Violation|2|||
149149703|NCT01964352|538027883|FG000|Overall Study|Lost to Follow-up|1|||
149149704|NCT01964352|538027884|FG001|Overall Study|Lost to Follow-up|0|||
149149705|NCT01964352|538027885|FG002|Overall Study|Lost to Follow-up|0|||
149149706|NCT01964352|538027886|FG003|Overall Study|Lost to Follow-up|1|||
149149707|NCT01964352|538027883|FG000|Overall Study|Withdrawal by Subject|4|||
149149708|NCT01964352|538027884|FG001|Overall Study|Withdrawal by Subject|2|||
149149709|NCT01964352|538027885|FG002|Overall Study|Withdrawal by Subject|1|||
149149710|NCT01964352|538027886|FG003|Overall Study|Withdrawal by Subject|0|||
149149711|NCT01964352|538027883|FG000|Overall Study|Other than stated above|0|||
149149712|NCT01964352|538027884|FG001|Overall Study|Other than stated above|2|||
149149713|NCT01964352|538027885|FG002|Overall Study|Other than stated above|1|||
149149714|NCT01964352|538027886|FG003|Overall Study|Other than stated above|2|||
149149715|NCT00631371|538027892|FG000|Overall Study|Lost to Follow-up|24|||
149149716|NCT00631371|538027893|FG001|Overall Study|Lost to Follow-up|19|||
149149717|NCT00631371|538027892|FG000|Overall Study|Other reason|5|||
149149718|NCT00631371|538027893|FG001|Overall Study|Other reason|12|||
149149719|NCT00631371|538027892|FG000|Overall Study|subject request|38|||
149149720|NCT00631371|538027893|FG001|Overall Study|subject request|45|||
149149721|NCT00631371|538027892|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
149149722|NCT00631371|538027893|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
149149723|NCT00631371|538027892|FG000|Overall Study|Death|263|||
149149724|NCT00631371|538027893|FG001|Overall Study|Death|239|||
149149725|NCT00590590|538027896|FG000|Overall Study|Lack of Efficacy|1|||
149149726|NCT00590590|538027897|FG001|Overall Study|Lack of Efficacy|2|||
149149727|NCT00590590|538027898|FG002|Overall Study|Lack of Efficacy|0|||
149149728|NCT00590590|538027896|FG000|Overall Study|Adverse Event|1|||
149149729|NCT00590590|538027897|FG001|Overall Study|Adverse Event|0|||
149149730|NCT00590590|538027898|FG002|Overall Study|Adverse Event|0|||
149149731|NCT00590590|538027896|FG000|Overall Study|Protocol Violation|0|||
149149732|NCT00590590|538027897|FG001|Overall Study|Protocol Violation|0|||
149149733|NCT00590590|538027898|FG002|Overall Study|Protocol Violation|2|||
149149734|NCT00590590|538027896|FG000|Overall Study|Lost to Follow-up|4|||
149149735|NCT00590590|538027897|FG001|Overall Study|Lost to Follow-up|1|||
149149736|NCT00590590|538027898|FG002|Overall Study|Lost to Follow-up|2|||
149149737|NCT00590590|538027896|FG000|Overall Study|Withdrawal by Subject|0|||
149149738|NCT00590590|538027897|FG001|Overall Study|Withdrawal by Subject|1|||
149149739|NCT00590590|538027898|FG002|Overall Study|Withdrawal by Subject|1|||
149149740|NCT00590590|538027896|FG000|Overall Study|Did not complete due to study closure|1|||
149149741|NCT00590590|538027897|FG001|Overall Study|Did not complete due to study closure|1|||
149149742|NCT00590590|538027898|FG002|Overall Study|Did not complete due to study closure|1|||
149149743|NCT00590590|538027896|FG000|Overall Study|Did not complete study|0|||
148917954|NCT02500056|537184450|FG000|Overall Study|Recurrence|1|||
149149744|NCT00590590|538027897|FG001|Overall Study|Did not complete study|1|||
149149745|NCT00590590|538027898|FG002|Overall Study|Did not complete study|0|||
149149746|NCT02145741|538027899|FG000|Overall Study|Progressive disease|3|||
149149747|NCT02145741|538027900|FG001|Overall Study|Progressive disease|6|||
149149748|NCT02145741|538027901|FG002|Overall Study|Progressive disease|6|||
149149749|NCT02145741|538027899|FG000|Overall Study|quality issue with the administered drug|3|||
149149750|NCT02145741|538027900|FG001|Overall Study|quality issue with the administered drug|0|||
149149751|NCT02145741|538027901|FG002|Overall Study|quality issue with the administered drug|0|||
149149752|NCT03865706|538027902|FG000|Overall Study|Death|0|||
149149753|NCT03865706|538027903|FG001|Overall Study|Death|3|||
149149754|NCT03865706|538027904|FG002|Overall Study|Death|1|||
149149755|NCT02095535|538027905|FG000|Recruitment|Protocol Violation|2|||
148917955|NCT02500056|537184451|FG001|Overall Study|Recurrence|0|||
149149756|NCT02646982|538027906|FG000|Overall Study|Adverse Event|1|||
149149757|NCT02646982|538027907|FG001|Overall Study|Adverse Event|1|||
149149758|NCT02646982|538027906|FG000|Overall Study|Withdrawal by Subject|2|||
149149759|NCT02646982|538027907|FG001|Overall Study|Withdrawal by Subject|1|||
149149760|NCT00713700|538027908|FG000|Overall Study|Lost to Follow-up|3|||
149149761|NCT00713700|538027908|FG000|Overall Study|Withdrawal by Subject|1|||
149149762|NCT00781456|538027909|FG000|Overall Study|Adverse Event|3|||
149149763|NCT00781456|538027910|FG001|Overall Study|Adverse Event|3|||
149149764|NCT00781456|538027909|FG000|Overall Study|Withdrawal by Subject|3|||
149149765|NCT00781456|538027910|FG001|Overall Study|Withdrawal by Subject|5|||
149149766|NCT00781456|538027909|FG000|Overall Study|Protocol Violation|4|||
149149767|NCT00781456|538027910|FG001|Overall Study|Protocol Violation|1|||
149149768|NCT00781456|538027909|FG000|Overall Study|Noncompliance With Protocol|1|||
149149769|NCT00781456|538027910|FG001|Overall Study|Noncompliance With Protocol|1|||
149149770|NCT00781456|538027909|FG000|Overall Study|Lost to Follow-up|10|||
149149771|NCT00781456|538027910|FG001|Overall Study|Lost to Follow-up|5|||
149149772|NCT00781456|538027909|FG000|Overall Study|Other Reason, Unknown|0|||
149149773|NCT00781456|538027910|FG001|Overall Study|Other Reason, Unknown|1|||
149149774|NCT03273166|538027912|FG000|Overall Study|Withdrawn prior to Completion|31|||
149149775|NCT03363321|538027913|FG000|Overall Study|Withdrawal by Subject|0|||
149149776|NCT03363321|538027914|FG001|Overall Study|Withdrawal by Subject|1|||
149149777|NCT03363321|538027915|FG002|Overall Study|Withdrawal by Subject|0|||
149149778|NCT03363321|538027916|FG003|Overall Study|Withdrawal by Subject|1|||
149149779|NCT03363321|538027917|FG004|Overall Study|Withdrawal by Subject|0|||
149149780|NCT01032915|538027918|FG000|Overall Study|Adverse Event|2|||
149149781|NCT01032915|538027919|FG001|Overall Study|Adverse Event|2|||
149149782|NCT01032915|538027920|FG002|Overall Study|Adverse Event|1|||
149149783|NCT01032915|538027921|FG003|Overall Study|Adverse Event|1|||
149149784|NCT01032915|538027918|FG000|Overall Study|Abnormal test procedure result|0|||
149149785|NCT01032915|538027919|FG001|Overall Study|Abnormal test procedure result|0|||
149149786|NCT01032915|538027920|FG002|Overall Study|Abnormal test procedure result|1|||
149149787|NCT01032915|538027921|FG003|Overall Study|Abnormal test procedure result|0|||
149149788|NCT01032915|538027918|FG000|Overall Study|Withdrawal by Subject|0|||
149149789|NCT01032915|538027919|FG001|Overall Study|Withdrawal by Subject|3|||
149149790|NCT01032915|538027920|FG002|Overall Study|Withdrawal by Subject|1|||
149149791|NCT01032915|538027921|FG003|Overall Study|Withdrawal by Subject|1|||
149149792|NCT01032915|538027918|FG000|Overall Study|Administrative reasons|5|||
149149793|NCT01032915|538027919|FG001|Overall Study|Administrative reasons|6|||
149149794|NCT01032915|538027920|FG002|Overall Study|Administrative reasons|4|||
149149795|NCT01032915|538027921|FG003|Overall Study|Administrative reasons|4|||
149149796|NCT01032915|538027918|FG000|Overall Study|Protocol Violation|1|||
149149797|NCT01032915|538027919|FG001|Overall Study|Protocol Violation|0|||
149149798|NCT01032915|538027920|FG002|Overall Study|Protocol Violation|0|||
149149799|NCT01032915|538027921|FG003|Overall Study|Protocol Violation|1|||
149149800|NCT02915523|538027923|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
149149801|NCT02915523|538027924|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
149149802|NCT02915523|538027925|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
149149803|NCT02915523|538027926|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
149149804|NCT02915523|538027923|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
149149805|NCT02915523|538027924|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
149149806|NCT02915523|538027925|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
149149807|NCT02915523|538027926|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
149149808|NCT02915523|538027923|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
149149809|NCT02915523|538027924|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
149149810|NCT02915523|538027925|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
148672376|NCT00572910|536270763|FG009|Overall Study|Withdrawal by Subject|2|||
148917956|NCT02500056|537184450|FG000|Overall Study|Death|3|||
148917957|NCT02500056|537184451|FG001|Overall Study|Death|1|||
148917958|NCT03890666|537184452|FG000|Overall Study|Withdrawal by Subject|0|||
148917959|NCT03890666|537184453|FG001|Overall Study|Withdrawal by Subject|1|||
148917960|NCT03890666|537184452|FG000|Overall Study|Protocol deviation|1|||
148917961|NCT03890666|537184453|FG001|Overall Study|Protocol deviation|4|||
148917962|NCT03890666|537184452|FG000|Overall Study|Lost to Follow-up|2|||
148917963|NCT03890666|537184453|FG001|Overall Study|Lost to Follow-up|5|||
148672377|NCT00572910|536270764|FG010|Overall Study|Withdrawal by Subject|1|||
148672378|NCT01803464|536270765|FG000|Overall Study|Incomplete data|0|||
148672379|NCT01803464|536270766|FG001|Overall Study|Incomplete data|0|||
149149811|NCT02915523|538027926|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
149149812|NCT02915523|538027923|FG000|Expansion Phase (Phase 2)|Death|0|||
149149813|NCT02915523|538027924|FG001|Expansion Phase (Phase 2)|Death|0|||
149149814|NCT02915523|538027925|FG002|Expansion Phase (Phase 2)|Death|26|||
149149815|NCT02915523|538027926|FG003|Expansion Phase (Phase 2)|Death|53|||
149149816|NCT02915523|538027923|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
149149817|NCT02915523|538027924|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
149149818|NCT02915523|538027925|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
148917964|NCT03890666|537184452|FG000|Overall Study|Other than specified|1|||
149149819|NCT02915523|538027926|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
149149820|NCT02915523|538027923|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
149149821|NCT02915523|538027924|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
149149822|NCT02915523|538027925|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
149149823|NCT02915523|538027926|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
149149824|NCT02915523|538027923|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
149149825|NCT02915523|538027924|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
149149826|NCT02915523|538027925|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
149149827|NCT02915523|538027926|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
149149828|NCT00382993|538027929|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
149149829|NCT00382993|538027930|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
149149830|NCT00382993|538027929|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
149149831|NCT00382993|538027930|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
149149832|NCT00382993|538027929|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
149149833|NCT00382993|538027930|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
149149834|NCT00382993|538027929|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
149149835|NCT00382993|538027930|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
149149836|NCT00382993|538027929|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
149149837|NCT00382993|538027930|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
149149838|NCT00382993|538027929|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
149149839|NCT00382993|538027930|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
149149840|NCT00382993|538027929|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
149149841|NCT00382993|538027930|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
149149842|NCT00382993|538027929|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
149149843|NCT00382993|538027930|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
149149844|NCT00382993|538027929|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
149149845|NCT00382993|538027930|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
148917965|NCT03890666|537184453|FG001|Overall Study|Other than specified|8|||
148917966|NCT01155011|537184456|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
148917967|NCT01155011|537184457|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
148917968|NCT01155011|537184456|FG000|Baseline to 6 Months|investigator decision, moved|4|||
148917969|NCT01155011|537184457|FG001|Baseline to 6 Months|investigator decision, moved|5|||
148917970|NCT01155011|537184456|FG000|Baseline to 6 Months|Death|0|||
148917971|NCT01155011|537184457|FG001|Baseline to 6 Months|Death|1|||
148917972|NCT01155011|537184456|FG000|6 to 12 Months|Withdrawal by Subject|8|||
148917973|NCT01155011|537184457|FG001|6 to 12 Months|Withdrawal by Subject|5|||
148917974|NCT01155011|537184456|FG000|6 to 12 Months|Death|1|||
148917975|NCT01155011|537184457|FG001|6 to 12 Months|Death|5|||
148917976|NCT02122783|537184463|FG000|Overall Study|Adverse Event|0|||
148917977|NCT02122783|537184464|FG001|Overall Study|Adverse Event|1|||
148917978|NCT00653432|537184469|FG000|Overall Study|Adverse Event|4|||
148917979|NCT00653432|537184470|FG001|Overall Study|Adverse Event|1|||
148917980|NCT00653432|537184469|FG000|Overall Study|Withdrawal by Subject|4|||
148917981|NCT00653432|537184470|FG001|Overall Study|Withdrawal by Subject|5|||
148917982|NCT00653432|537184469|FG000|Overall Study|Lost to Follow-up|7|||
148917983|NCT00653432|537184470|FG001|Overall Study|Lost to Follow-up|6|||
148917984|NCT00653432|537184469|FG000|Overall Study|Use/Need of Con Therapy|2|||
148917985|NCT00653432|537184470|FG001|Overall Study|Use/Need of Con Therapy|1|||
148917986|NCT00653432|537184469|FG000|Overall Study|Other - Reason Not Provided|5|||
148917987|NCT00653432|537184470|FG001|Overall Study|Other - Reason Not Provided|3|||
148917988|NCT05277337|537184471|FG000|Overall Study|Lost to Follow-up|2|||
148917989|NCT05277337|537184472|FG001|Overall Study|Lost to Follow-up|0|||
149149846|NCT00382993|538027929|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
149149847|NCT00382993|538027930|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
148917990|NCT05277337|537184471|FG000|Overall Study|Withdrawal by Subject|1|||
148917991|NCT05277337|537184472|FG001|Overall Study|Withdrawal by Subject|0|||
148917992|NCT00357760|537184475|FG000|Overall Study|Disease progression|44|||
148917993|NCT00357760|537184476|FG001|Overall Study|Disease progression|17|||
148917994|NCT00357760|537184475|FG000|Overall Study|Adverse Event|10|||
148917995|NCT00357760|537184476|FG001|Overall Study|Adverse Event|7|||
148917996|NCT00357760|537184475|FG000|Overall Study|Death|0|||
148917997|NCT00357760|537184476|FG001|Overall Study|Death|3|||
148917998|NCT00357760|537184475|FG000|Overall Study|Alternative therapy|1|||
148917999|NCT00357760|537184476|FG001|Overall Study|Alternative therapy|0|||
148918000|NCT00357760|537184475|FG000|Overall Study|Withdrawal by Subject|0|||
148918001|NCT00357760|537184476|FG001|Overall Study|Withdrawal by Subject|2|||
148918002|NCT00357760|537184475|FG000|Overall Study|Never started treatment|2|||
148918003|NCT00357760|537184476|FG001|Overall Study|Never started treatment|1|||
148918004|NCT00357760|537184475|FG000|Overall Study|Ineligible|0|||
148918005|NCT00357760|537184476|FG001|Overall Study|Ineligible|2|||
148918006|NCT00357760|537184475|FG000|Overall Study|Physician Decision|2|||
148918007|NCT00357760|537184476|FG001|Overall Study|Physician Decision|1|||
149149848|NCT02941627|538027951|FG000|Overall Study|Death|1|||
149149849|NCT02941627|538027951|FG000|Overall Study|Surgical failure|1|||
149149850|NCT02941627|538027951|FG000|Overall Study|cholesteatoma prevented implantation|1|||
149149851|NCT00606320|538027952|FG000|Overall Study|Adverse Event|3|||
149149852|NCT00606320|538027952|FG000|Overall Study|Lack of Efficacy|5|||
149149853|NCT00606320|538027952|FG000|Overall Study|Physician Decision|7|||
149149854|NCT00606320|538027952|FG000|Overall Study|Protocol Violation|8|||
149149855|NCT00606320|538027952|FG000|Overall Study|Withdrawal by Subject|10|||
149149856|NCT00606320|538027952|FG000|Overall Study|Progression to depressive phase|4|||
149149857|NCT00563186|538027953|FG000|Overall Study|LOS<48 hours|97|||
149149858|NCT00563186|538027954|FG001|Overall Study|LOS<48 hours|74|||
149149859|NCT00563186|538027953|FG000|Overall Study|Incomplete data|1|||
149149860|NCT00563186|538027954|FG001|Overall Study|Incomplete data|1|||
149149861|NCT04839380|538027955|FG000|Overall Study|Withdrawal by Subject|2|||
149149862|NCT04839380|538027955|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
149149863|NCT00879645|538027956|FG000|Overall Study|Adverse Event|1|||
149149864|NCT00879645|538027957|FG001|Overall Study|Adverse Event|0|||
149149865|NCT00879645|538027958|FG002|Overall Study|Adverse Event|0|||
149149866|NCT00879645|538027959|FG003|Overall Study|Adverse Event|0|||
149149867|NCT00513500|538027960|FG000|Overall Study|Lost to Follow-up|35|||
149149868|NCT00513500|538027961|FG001|Overall Study|Lost to Follow-up|39|||
149149869|NCT00513500|538027960|FG000|Overall Study|Death|2|||
149149870|NCT00513500|538027961|FG001|Overall Study|Death|1|||
149149871|NCT00513500|538027960|FG000|Overall Study|Hospitalized|4|||
149149872|NCT00513500|538027961|FG001|Overall Study|Hospitalized|14|||
149149873|NCT00749996|538027962|FG000|Overall Study|Lost to Follow-up|7|||
149149874|NCT00749996|538027963|FG001|Overall Study|Lost to Follow-up|4|||
149149875|NCT00749996|538027962|FG000|Overall Study|Withdrawal by Subject|5|||
149149876|NCT00749996|538027963|FG001|Overall Study|Withdrawal by Subject|4|||
149149877|NCT00749996|538027962|FG000|Overall Study|Protocol Violation|2|||
149149878|NCT00749996|538027963|FG001|Overall Study|Protocol Violation|3|||
149149879|NCT00749996|538027962|FG000|Overall Study|Physician Decision|2|||
149149880|NCT00749996|538027963|FG001|Overall Study|Physician Decision|0|||
149149881|NCT00749996|538027962|FG000|Overall Study|Pregnancy|0|||
149149882|NCT00749996|538027963|FG001|Overall Study|Pregnancy|2|||
149149883|NCT00749996|538027962|FG000|Overall Study|Adverse Event|1|||
149149884|NCT00749996|538027963|FG001|Overall Study|Adverse Event|0|||
149149885|NCT00749996|538027962|FG000|Overall Study|Death|1|||
149149886|NCT00749996|538027963|FG001|Overall Study|Death|0|||
149149887|NCT01225731|538027970|FG000|Part 1|Did not meet eligibility criteria|1|||
149149888|NCT01225731|538027971|FG001|Part 1|Did not meet eligibility criteria|0|||
149149889|NCT01225731|538027972|FG002|Part 1|Did not meet eligibility criteria|0|||
149149890|NCT01225731|538027973|FG003|Part 1|Did not meet eligibility criteria|0|||
149149891|NCT01225731|538027974|FG004|Part 1|Did not meet eligibility criteria|1|||
149149892|NCT01225731|538027975|FG005|Part 1|Did not meet eligibility criteria|0|||
149149893|NCT01225731|538027976|FG006|Part 1|Did not meet eligibility criteria|0|||
149149894|NCT01225731|538027977|FG007|Part 1|Did not meet eligibility criteria|0|||
149149895|NCT01225731|538027978|FG008|Part 1|Did not meet eligibility criteria|0|||
149149896|NCT01225731|538027979|FG009|Part 1|Did not meet eligibility criteria|0|||
149149897|NCT01225731|538027980|FG010|Part 1|Did not meet eligibility criteria|0|||
149149898|NCT01225731|538027981|FG011|Part 1|Did not meet eligibility criteria|0|||
149149899|NCT01225731|538027982|FG012|Part 1|Did not meet eligibility criteria|0|||
149149900|NCT01225731|538027970|FG000|Part 1|Adverse Event|1|||
149149901|NCT01225731|538027971|FG001|Part 1|Adverse Event|2|||
149149902|NCT01225731|538027972|FG002|Part 1|Adverse Event|1|||
149149903|NCT01225731|538027973|FG003|Part 1|Adverse Event|1|||
149149904|NCT01225731|538027974|FG004|Part 1|Adverse Event|1|||
149149905|NCT01225731|538027975|FG005|Part 1|Adverse Event|0|||
149149906|NCT01225731|538027976|FG006|Part 1|Adverse Event|0|||
149149907|NCT01225731|538027977|FG007|Part 1|Adverse Event|0|||
149149908|NCT01225731|538027978|FG008|Part 1|Adverse Event|0|||
149149909|NCT01225731|538027979|FG009|Part 1|Adverse Event|0|||
149149910|NCT01225731|538027980|FG010|Part 1|Adverse Event|0|||
149149911|NCT01225731|538027981|FG011|Part 1|Adverse Event|0|||
149149912|NCT01225731|538027982|FG012|Part 1|Adverse Event|0|||
149149913|NCT01225731|538027970|FG000|Part 1|Withdrawal by Subject|0|||
149149914|NCT01225731|538027971|FG001|Part 1|Withdrawal by Subject|3|||
149149915|NCT01225731|538027972|FG002|Part 1|Withdrawal by Subject|0|||
149149916|NCT01225731|538027973|FG003|Part 1|Withdrawal by Subject|0|||
149149917|NCT01225731|538027974|FG004|Part 1|Withdrawal by Subject|4|||
149149918|NCT01225731|538027975|FG005|Part 1|Withdrawal by Subject|0|||
149149919|NCT01225731|538027976|FG006|Part 1|Withdrawal by Subject|0|||
149149920|NCT01225731|538027977|FG007|Part 1|Withdrawal by Subject|0|||
149149921|NCT01225731|538027978|FG008|Part 1|Withdrawal by Subject|0|||
149149922|NCT01225731|538027979|FG009|Part 1|Withdrawal by Subject|0|||
149149923|NCT01225731|538027980|FG010|Part 1|Withdrawal by Subject|0|||
149149924|NCT01225731|538027981|FG011|Part 1|Withdrawal by Subject|0|||
149149925|NCT01225731|538027982|FG012|Part 1|Withdrawal by Subject|0|||
149149926|NCT01225731|538027970|FG000|Part 1|Protocol Violation|0|||
149149927|NCT01225731|538027971|FG001|Part 1|Protocol Violation|0|||
149149928|NCT01225731|538027972|FG002|Part 1|Protocol Violation|0|||
149149929|NCT01225731|538027973|FG003|Part 1|Protocol Violation|1|||
149149930|NCT01225731|538027974|FG004|Part 1|Protocol Violation|0|||
149149931|NCT01225731|538027975|FG005|Part 1|Protocol Violation|0|||
149149932|NCT01225731|538027976|FG006|Part 1|Protocol Violation|0|||
149149933|NCT01225731|538027977|FG007|Part 1|Protocol Violation|0|||
149149934|NCT01225731|538027978|FG008|Part 1|Protocol Violation|0|||
149149935|NCT01225731|538027979|FG009|Part 1|Protocol Violation|0|||
149149936|NCT01225731|538027980|FG010|Part 1|Protocol Violation|0|||
149149937|NCT01225731|538027981|FG011|Part 1|Protocol Violation|0|||
149149938|NCT01225731|538027982|FG012|Part 1|Protocol Violation|0|||
149149939|NCT01225731|538027970|FG000|Part 2|Protocol Violation|0|||
149149940|NCT01225731|538027971|FG001|Part 2|Protocol Violation|0|||
149149941|NCT01225731|538027972|FG002|Part 2|Protocol Violation|0|||
149149942|NCT01225731|538027973|FG003|Part 2|Protocol Violation|0|||
149149943|NCT01225731|538027974|FG004|Part 2|Protocol Violation|0|||
149149944|NCT01225731|538027975|FG005|Part 2|Protocol Violation|1|||
149149945|NCT01225731|538027976|FG006|Part 2|Protocol Violation|0|||
149149946|NCT01225731|538027977|FG007|Part 2|Protocol Violation|0|||
149149947|NCT01225731|538027978|FG008|Part 2|Protocol Violation|1|||
149149948|NCT01225731|538027979|FG009|Part 2|Protocol Violation|0|||
149149949|NCT01225731|538027980|FG010|Part 2|Protocol Violation|0|||
149149950|NCT01225731|538027981|FG011|Part 2|Protocol Violation|0|||
149149951|NCT01225731|538027982|FG012|Part 2|Protocol Violation|0|||
149149952|NCT01225731|538027970|FG000|Part 2|Adverse Event|0|||
149149953|NCT01225731|538027971|FG001|Part 2|Adverse Event|0|||
149149954|NCT01225731|538027972|FG002|Part 2|Adverse Event|0|||
149149955|NCT01225731|538027973|FG003|Part 2|Adverse Event|0|||
149149956|NCT01225731|538027974|FG004|Part 2|Adverse Event|0|||
149149957|NCT01225731|538027975|FG005|Part 2|Adverse Event|0|||
149149958|NCT01225731|538027976|FG006|Part 2|Adverse Event|4|||
149149959|NCT01225731|538027977|FG007|Part 2|Adverse Event|4|||
149149960|NCT01225731|538027978|FG008|Part 2|Adverse Event|2|||
149149961|NCT01225731|538027979|FG009|Part 2|Adverse Event|0|||
149149962|NCT01225731|538027980|FG010|Part 2|Adverse Event|0|||
149149963|NCT01225731|538027981|FG011|Part 2|Adverse Event|0|||
149149964|NCT01225731|538027982|FG012|Part 2|Adverse Event|0|||
149149965|NCT01225731|538027970|FG000|Part 2|Lack of Efficacy|0|||
149149966|NCT01225731|538027971|FG001|Part 2|Lack of Efficacy|0|||
149149967|NCT01225731|538027972|FG002|Part 2|Lack of Efficacy|0|||
149149968|NCT01225731|538027973|FG003|Part 2|Lack of Efficacy|0|||
149149969|NCT01225731|538027974|FG004|Part 2|Lack of Efficacy|0|||
149149970|NCT01225731|538027975|FG005|Part 2|Lack of Efficacy|1|||
149149971|NCT01225731|538027976|FG006|Part 2|Lack of Efficacy|0|||
149149972|NCT01225731|538027977|FG007|Part 2|Lack of Efficacy|12|||
149149973|NCT01225731|538027978|FG008|Part 2|Lack of Efficacy|3|||
149149974|NCT01225731|538027979|FG009|Part 2|Lack of Efficacy|0|||
149149975|NCT01225731|538027980|FG010|Part 2|Lack of Efficacy|0|||
149149976|NCT01225731|538027981|FG011|Part 2|Lack of Efficacy|0|||
149149977|NCT01225731|538027982|FG012|Part 2|Lack of Efficacy|0|||
149149978|NCT01225731|538027970|FG000|Part 2|Pregnancy|0|||
149149979|NCT01225731|538027971|FG001|Part 2|Pregnancy|0|||
149149980|NCT01225731|538027972|FG002|Part 2|Pregnancy|0|||
149149981|NCT01225731|538027973|FG003|Part 2|Pregnancy|0|||
149149982|NCT01225731|538027974|FG004|Part 2|Pregnancy|0|||
149149983|NCT01225731|538027975|FG005|Part 2|Pregnancy|0|||
148918008|NCT00357760|537184475|FG000|Overall Study|Protocol Violation|0|||
148918009|NCT00357760|537184476|FG001|Overall Study|Protocol Violation|1|||
148918010|NCT00357760|537184475|FG000|Overall Study|To receive hospice care|0|||
148918011|NCT00357760|537184476|FG001|Overall Study|To receive hospice care|1|||
148918012|NCT02213133|537184477|FG000|Overall Study|Participant discontinued study therapy|2|||
149149984|NCT01225731|538027976|FG006|Part 2|Pregnancy|1|||
149149985|NCT01225731|538027977|FG007|Part 2|Pregnancy|0|||
149149986|NCT01225731|538027978|FG008|Part 2|Pregnancy|1|||
149149987|NCT01225731|538027979|FG009|Part 2|Pregnancy|0|||
149149988|NCT01225731|538027980|FG010|Part 2|Pregnancy|0|||
149149989|NCT01225731|538027981|FG011|Part 2|Pregnancy|0|||
149149990|NCT01225731|538027982|FG012|Part 2|Pregnancy|0|||
149149991|NCT01225731|538027970|FG000|Part 2|Lost to Follow-up|0|||
148918013|NCT02213133|537184478|FG001|Overall Study|Participant discontinued study therapy|0|||
149149992|NCT01225731|538027971|FG001|Part 2|Lost to Follow-up|0|||
149149993|NCT01225731|538027972|FG002|Part 2|Lost to Follow-up|0|||
149149994|NCT01225731|538027973|FG003|Part 2|Lost to Follow-up|0|||
149149995|NCT01225731|538027974|FG004|Part 2|Lost to Follow-up|0|||
149149996|NCT01225731|538027975|FG005|Part 2|Lost to Follow-up|0|||
149149997|NCT01225731|538027976|FG006|Part 2|Lost to Follow-up|0|||
149149998|NCT01225731|538027977|FG007|Part 2|Lost to Follow-up|3|||
149149999|NCT01225731|538027978|FG008|Part 2|Lost to Follow-up|1|||
149150000|NCT01225731|538027979|FG009|Part 2|Lost to Follow-up|0|||
149150001|NCT01225731|538027980|FG010|Part 2|Lost to Follow-up|0|||
149150002|NCT01225731|538027981|FG011|Part 2|Lost to Follow-up|0|||
149150003|NCT01225731|538027982|FG012|Part 2|Lost to Follow-up|0|||
149150004|NCT01225731|538027970|FG000|Part 2|Physician Decision|0|||
149150005|NCT01225731|538027971|FG001|Part 2|Physician Decision|0|||
149150006|NCT01225731|538027972|FG002|Part 2|Physician Decision|0|||
149150007|NCT01225731|538027973|FG003|Part 2|Physician Decision|0|||
149150008|NCT01225731|538027974|FG004|Part 2|Physician Decision|0|||
149150009|NCT01225731|538027975|FG005|Part 2|Physician Decision|0|||
149150010|NCT01225731|538027976|FG006|Part 2|Physician Decision|0|||
149150011|NCT01225731|538027977|FG007|Part 2|Physician Decision|2|||
149150012|NCT01225731|538027978|FG008|Part 2|Physician Decision|2|||
149150013|NCT01225731|538027979|FG009|Part 2|Physician Decision|0|||
149150014|NCT01225731|538027980|FG010|Part 2|Physician Decision|0|||
149150015|NCT01225731|538027981|FG011|Part 2|Physician Decision|0|||
149150016|NCT01225731|538027982|FG012|Part 2|Physician Decision|0|||
149150017|NCT01225731|538027970|FG000|Part 2|Withdrawal by Subject|0|||
149150018|NCT01225731|538027971|FG001|Part 2|Withdrawal by Subject|0|||
149150019|NCT01225731|538027972|FG002|Part 2|Withdrawal by Subject|0|||
149150020|NCT01225731|538027973|FG003|Part 2|Withdrawal by Subject|0|||
149150021|NCT01225731|538027974|FG004|Part 2|Withdrawal by Subject|0|||
149150022|NCT01225731|538027975|FG005|Part 2|Withdrawal by Subject|1|||
149150023|NCT01225731|538027976|FG006|Part 2|Withdrawal by Subject|3|||
149150024|NCT01225731|538027977|FG007|Part 2|Withdrawal by Subject|4|||
149150025|NCT01225731|538027978|FG008|Part 2|Withdrawal by Subject|1|||
149150026|NCT01225731|538027979|FG009|Part 2|Withdrawal by Subject|0|||
149150027|NCT01225731|538027980|FG010|Part 2|Withdrawal by Subject|0|||
149150028|NCT01225731|538027981|FG011|Part 2|Withdrawal by Subject|0|||
149150029|NCT01225731|538027982|FG012|Part 2|Withdrawal by Subject|0|||
149150030|NCT01225731|538027970|FG000|Part 3|Adverse Event|0|||
149150031|NCT01225731|538027971|FG001|Part 3|Adverse Event|0|||
149150032|NCT01225731|538027972|FG002|Part 3|Adverse Event|0|||
149150033|NCT01225731|538027973|FG003|Part 3|Adverse Event|0|||
149150034|NCT01225731|538027974|FG004|Part 3|Adverse Event|0|||
149150035|NCT01225731|538027975|FG005|Part 3|Adverse Event|0|||
149150036|NCT01225731|538027976|FG006|Part 3|Adverse Event|0|||
149150037|NCT01225731|538027977|FG007|Part 3|Adverse Event|0|||
149150038|NCT01225731|538027978|FG008|Part 3|Adverse Event|0|||
149150039|NCT01225731|538027979|FG009|Part 3|Adverse Event|0|||
149150040|NCT01225731|538027980|FG010|Part 3|Adverse Event|1|||
149150041|NCT01225731|538027981|FG011|Part 3|Adverse Event|1|||
149150042|NCT01225731|538027982|FG012|Part 3|Adverse Event|0|||
149150043|NCT01225731|538027970|FG000|Part 3|Lost to Follow-up|0|||
149150044|NCT01225731|538027971|FG001|Part 3|Lost to Follow-up|0|||
149150045|NCT01225731|538027972|FG002|Part 3|Lost to Follow-up|0|||
149150046|NCT01225731|538027973|FG003|Part 3|Lost to Follow-up|0|||
149150047|NCT01225731|538027974|FG004|Part 3|Lost to Follow-up|0|||
149150048|NCT01225731|538027975|FG005|Part 3|Lost to Follow-up|0|||
149150049|NCT01225731|538027976|FG006|Part 3|Lost to Follow-up|0|||
149150050|NCT01225731|538027977|FG007|Part 3|Lost to Follow-up|0|||
149150051|NCT01225731|538027978|FG008|Part 3|Lost to Follow-up|0|||
149150052|NCT01225731|538027979|FG009|Part 3|Lost to Follow-up|0|||
149150053|NCT01225731|538027980|FG010|Part 3|Lost to Follow-up|1|||
149150054|NCT01225731|538027981|FG011|Part 3|Lost to Follow-up|2|||
149150055|NCT01225731|538027982|FG012|Part 3|Lost to Follow-up|1|||
149150056|NCT01225731|538027970|FG000|Part 3|Physician Decision|0|||
149150057|NCT01225731|538027971|FG001|Part 3|Physician Decision|0|||
148672380|NCT01803464|536270767|FG002|Overall Study|Incomplete data|4|||
148672381|NCT01803464|536270768|FG003|Overall Study|Incomplete data|0|||
148672382|NCT01803464|536270765|FG000|Overall Study|Withdrawal by Subject|1|||
148672383|NCT01803464|536270766|FG001|Overall Study|Withdrawal by Subject|0|||
148672384|NCT01803464|536270767|FG002|Overall Study|Withdrawal by Subject|0|||
148672385|NCT01803464|536270768|FG003|Overall Study|Withdrawal by Subject|0|||
148672386|NCT02860039|536270771|FG000|Overall Study|Death|4|||
148672387|NCT02860039|536270772|FG001|Overall Study|Death|0|||
148672388|NCT02860039|536270771|FG000|Overall Study|Lost to Follow-up|2|||
148672389|NCT02860039|536270772|FG001|Overall Study|Lost to Follow-up|2|||
148672390|NCT02860039|536270771|FG000|Overall Study|Protocol Violation|3|||
148805619|NCT00042289|536767975|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
149150058|NCT01225731|538027972|FG002|Part 3|Physician Decision|0|||
149150059|NCT01225731|538027973|FG003|Part 3|Physician Decision|0|||
149150060|NCT01225731|538027974|FG004|Part 3|Physician Decision|0|||
149150061|NCT01225731|538027975|FG005|Part 3|Physician Decision|0|||
148672391|NCT02860039|536270772|FG001|Overall Study|Protocol Violation|1|||
148805620|NCT00042289|536767976|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
148805621|NCT00042289|536767977|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
149150062|NCT01225731|538027976|FG006|Part 3|Physician Decision|0|||
149150063|NCT01225731|538027977|FG007|Part 3|Physician Decision|0|||
148805622|NCT00042289|536767978|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
149150064|NCT01225731|538027978|FG008|Part 3|Physician Decision|0|||
149150065|NCT01225731|538027979|FG009|Part 3|Physician Decision|0|||
149150066|NCT01225731|538027980|FG010|Part 3|Physician Decision|0|||
149150067|NCT01225731|538027981|FG011|Part 3|Physician Decision|1|||
149150068|NCT01225731|538027982|FG012|Part 3|Physician Decision|2|||
149150069|NCT01225731|538027970|FG000|Part 3|Withdrawal by Subject|0|||
149150070|NCT01225731|538027971|FG001|Part 3|Withdrawal by Subject|0|||
149150071|NCT01225731|538027972|FG002|Part 3|Withdrawal by Subject|0|||
149150072|NCT01225731|538027973|FG003|Part 3|Withdrawal by Subject|0|||
149150073|NCT01225731|538027974|FG004|Part 3|Withdrawal by Subject|0|||
149150074|NCT01225731|538027975|FG005|Part 3|Withdrawal by Subject|0|||
149150075|NCT01225731|538027976|FG006|Part 3|Withdrawal by Subject|0|||
149150076|NCT01225731|538027977|FG007|Part 3|Withdrawal by Subject|0|||
149150077|NCT01225731|538027978|FG008|Part 3|Withdrawal by Subject|0|||
149150078|NCT01225731|538027979|FG009|Part 3|Withdrawal by Subject|0|||
149150079|NCT01225731|538027980|FG010|Part 3|Withdrawal by Subject|4|||
149150080|NCT01225731|538027981|FG011|Part 3|Withdrawal by Subject|6|||
149150081|NCT01225731|538027982|FG012|Part 3|Withdrawal by Subject|4|||
149150082|NCT03873714|538027993|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
149150083|NCT01970501|538027994|FG000|Overall Study|Discontinuation of study by sponsor|16|||
149150084|NCT01970501|538027995|FG001|Overall Study|Discontinuation of study by sponsor|14|||
149150085|NCT01970501|538027994|FG000|Overall Study|Withdrawal by Subject|6|||
149150086|NCT01970501|538027995|FG001|Overall Study|Withdrawal by Subject|7|||
149150087|NCT01970501|538027994|FG000|Overall Study|Adverse Event|2|||
149150088|NCT01970501|538027995|FG001|Overall Study|Adverse Event|4|||
149150089|NCT01970501|538027994|FG000|Overall Study|Death|1|||
149150090|NCT01970501|538027995|FG001|Overall Study|Death|3|||
149150091|NCT01970501|538027994|FG000|Overall Study|Physician Decision|2|||
149150092|NCT01970501|538027995|FG001|Overall Study|Physician Decision|0|||
149150093|NCT00708123|538027996|FG000|Period 1|Protocol Violation|0|||
149150094|NCT00708123|538027997|FG001|Period 1|Protocol Violation|1|||
149150095|NCT00708123|538027998|FG002|Period 1|Protocol Violation|0|||
149150096|NCT00708123|538027999|FG003|Period 1|Protocol Violation|1|||
149150097|NCT00708123|538028000|FG004|Period 1|Protocol Violation|0|||
149150098|NCT00708123|538027996|FG000|Period 1|Adverse Event|0|||
149150099|NCT00708123|538027997|FG001|Period 1|Adverse Event|0|||
149150100|NCT00708123|538027998|FG002|Period 1|Adverse Event|1|||
149150101|NCT00708123|538027999|FG003|Period 1|Adverse Event|0|||
149150102|NCT00708123|538028000|FG004|Period 1|Adverse Event|0|||
149150103|NCT00708123|538027996|FG000|Period 2|Protocol Violation|0|||
149150104|NCT00708123|538027997|FG001|Period 2|Protocol Violation|0|||
149150105|NCT00708123|538027998|FG002|Period 2|Protocol Violation|0|||
149150106|NCT00708123|538027999|FG003|Period 2|Protocol Violation|1|||
149150107|NCT00708123|538028000|FG004|Period 2|Protocol Violation|0|||
149150108|NCT00708123|538027996|FG000|Period 2|Other Reason|1|||
149150109|NCT00708123|538027997|FG001|Period 2|Other Reason|0|||
149150110|NCT00708123|538027998|FG002|Period 2|Other Reason|0|||
149150111|NCT00708123|538027999|FG003|Period 2|Other Reason|0|||
149150112|NCT00708123|538028000|FG004|Period 2|Other Reason|0|||
149150113|NCT00708123|538027996|FG000|Period 3|Lost to Follow-up|0|||
149150114|NCT00708123|538027997|FG001|Period 3|Lost to Follow-up|0|||
149150115|NCT00708123|538027998|FG002|Period 3|Lost to Follow-up|1|||
149150116|NCT00708123|538027999|FG003|Period 3|Lost to Follow-up|1|||
149150117|NCT00708123|538028000|FG004|Period 3|Lost to Follow-up|0|||
149150118|NCT00708123|538027996|FG000|Period 4|Protocol Violation|0|||
149150119|NCT00708123|538027997|FG001|Period 4|Protocol Violation|1|||
149150120|NCT00708123|538027998|FG002|Period 4|Protocol Violation|0|||
149150121|NCT00708123|538027999|FG003|Period 4|Protocol Violation|0|||
149150122|NCT00708123|538028000|FG004|Period 4|Protocol Violation|0|||
149150123|NCT02970292|538028001|FG000|Overall Study|Physician Decision|1|||
149150124|NCT02970292|538028002|FG001|Overall Study|Physician Decision|1|||
149150125|NCT02970292|538028001|FG000|Overall Study|Withdrawal by Subject|11|||
149150126|NCT02970292|538028002|FG001|Overall Study|Withdrawal by Subject|5|||
149150127|NCT02970292|538028001|FG000|Overall Study|Noncompliance with study drug|2|||
149150128|NCT02970292|538028002|FG001|Overall Study|Noncompliance with study drug|2|||
149150129|NCT02970292|538028001|FG000|Overall Study|Adverse Event|5|||
149150130|NCT02970292|538028002|FG001|Overall Study|Adverse Event|0|||
149150131|NCT02970292|538028001|FG000|Overall Study|Lack of Efficacy|1|||
149150132|NCT02970292|538028002|FG001|Overall Study|Lack of Efficacy|0|||
149150133|NCT02970292|538028001|FG000|Overall Study|Lost to Follow-up|1|||
149150134|NCT02970292|538028002|FG001|Overall Study|Lost to Follow-up|0|||
149150135|NCT02970292|538028001|FG000|Overall Study|Protocol Violation|2|||
149150136|NCT02970292|538028002|FG001|Overall Study|Protocol Violation|0|||
149150137|NCT02970292|538028001|FG000|Overall Study|Other|1|||
149150138|NCT02970292|538028002|FG001|Overall Study|Other|0|||
149150139|NCT00814892|538028003|FG000|Overall Study|Disease Progression|1|||
149150140|NCT00814892|538028003|FG000|Overall Study|Study Termination|1|||
149150141|NCT00845650|538028004|FG000|Overall Study|Withdrawal by Subject|0|||
149150142|NCT00845650|538028005|FG001|Overall Study|Withdrawal by Subject|0|||
149150143|NCT00845650|538028006|FG002|Overall Study|Withdrawal by Subject|0|||
149150144|NCT00845650|538028007|FG003|Overall Study|Withdrawal by Subject|0|||
149150145|NCT00845650|538028008|FG004|Overall Study|Withdrawal by Subject|2|||
149150146|NCT00845650|538028009|FG005|Overall Study|Withdrawal by Subject|0|||
149150147|NCT00845650|538028004|FG000|Overall Study|Lost to Follow-up|0|||
149150148|NCT00845650|538028005|FG001|Overall Study|Lost to Follow-up|0|||
149150149|NCT00845650|538028006|FG002|Overall Study|Lost to Follow-up|3|||
149150150|NCT00845650|538028007|FG003|Overall Study|Lost to Follow-up|1|||
149150151|NCT00845650|538028008|FG004|Overall Study|Lost to Follow-up|0|||
149150152|NCT00845650|538028009|FG005|Overall Study|Lost to Follow-up|1|||
149150153|NCT00845650|538028004|FG000|Overall Study|Sponsor hold on dosing|0|||
149150154|NCT00845650|538028005|FG001|Overall Study|Sponsor hold on dosing|0|||
149150155|NCT00845650|538028006|FG002|Overall Study|Sponsor hold on dosing|0|||
149150156|NCT00845650|538028007|FG003|Overall Study|Sponsor hold on dosing|0|||
149150157|NCT00845650|538028008|FG004|Overall Study|Sponsor hold on dosing|1|||
149150158|NCT00845650|538028009|FG005|Overall Study|Sponsor hold on dosing|1|||
149150159|NCT00845650|538028004|FG000|Overall Study|Unable to access IV line|1|||
149150160|NCT00845650|538028005|FG001|Overall Study|Unable to access IV line|0|||
149150161|NCT00845650|538028006|FG002|Overall Study|Unable to access IV line|0|||
149150162|NCT00845650|538028007|FG003|Overall Study|Unable to access IV line|0|||
149150163|NCT00845650|538028008|FG004|Overall Study|Unable to access IV line|0|||
149150164|NCT00845650|538028009|FG005|Overall Study|Unable to access IV line|0|||
149150165|NCT04486950|538028012|FG000|Overall Study|Lost to Follow-up|0|||
149150166|NCT04486950|538028013|FG001|Overall Study|Lost to Follow-up|0|||
149150167|NCT04486950|538028014|FG002|Overall Study|Lost to Follow-up|0|||
149150168|NCT04486950|538028015|FG003|Overall Study|Lost to Follow-up|0|||
149150169|NCT04486950|538028016|FG004|Overall Study|Lost to Follow-up|0|||
149150170|NCT04486950|538028017|FG005|Overall Study|Lost to Follow-up|1|||
149150171|NCT04486950|538028018|FG006|Overall Study|Lost to Follow-up|0|||
149150172|NCT00950664|538028019|FG000|First Intervention|Lost to Follow-up|1|||
149150173|NCT00950664|538028020|FG001|First Intervention|Lost to Follow-up|3|||
149150174|NCT00950664|538028019|FG000|First Intervention|Withdrawal by Subject|2|||
149150175|NCT00950664|538028020|FG001|First Intervention|Withdrawal by Subject|2|||
149150176|NCT01326546|538028023|FG000|Overall Study|Lost to Follow-up|8|||
149150177|NCT01326546|538028024|FG001|Overall Study|Lost to Follow-up|7|||
149150178|NCT01326546|538028023|FG000|Overall Study|Protocol Violation|3|||
149150179|NCT01326546|538028024|FG001|Overall Study|Protocol Violation|4|||
149150180|NCT01326546|538028023|FG000|Overall Study|Pregnancy|0|||
149150181|NCT01326546|538028024|FG001|Overall Study|Pregnancy|1|||
149150182|NCT01326546|538028023|FG000|Overall Study|Adverse Event|1|||
149150183|NCT01326546|538028024|FG001|Overall Study|Adverse Event|0|||
149150184|NCT01326546|538028023|FG000|Overall Study|Withdrawal by Subject|5|||
149150185|NCT01326546|538028024|FG001|Overall Study|Withdrawal by Subject|1|||
149150186|NCT03152019|538028025|FG000|Overall Study|Adverse Event|0|||
149150187|NCT03152019|538028026|FG001|Overall Study|Adverse Event|1|||
149150188|NCT00081159|538028030|FG000|Overall Study|Withdrawal by Subject|0|||
149150189|NCT00081159|538028031|FG001|Overall Study|Withdrawal by Subject|3|||
149150190|NCT00081159|538028030|FG000|Overall Study|Myelosuppression prior to treatment|0|||
149150191|NCT00081159|538028031|FG001|Overall Study|Myelosuppression prior to treatment|1|||
149150192|NCT00081159|538028030|FG000|Overall Study|Lost to Follow-up|2|||
149150193|NCT00081159|538028031|FG001|Overall Study|Lost to Follow-up|1|||
149150194|NCT00923130|538028034|FG000|Overall Study|Stopped treatment due to progression|17|||
149150195|NCT00923130|538028034|FG000|Overall Study|Death|1|||
149150196|NCT00923130|538028034|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
149150197|NCT00923130|538028034|FG000|Overall Study|Switched to alternative treatment|2|||
149150198|NCT00923130|538028034|FG000|Overall Study|Refused further treatment|2|||
149150199|NCT03693625|538028035|FG000|Overall Study|Adverse Event|2|||
149150200|NCT03693625|538028036|FG001|Overall Study|Adverse Event|0|||
149150201|NCT03693625|538028035|FG000|Overall Study|Study Terminated By Sponsor|20|||
149150202|NCT03693625|538028036|FG001|Overall Study|Study Terminated By Sponsor|7|||
149150203|NCT03693625|538028035|FG000|Overall Study|Withdrawal by Subject|1|||
149150204|NCT03693625|538028036|FG001|Overall Study|Withdrawal by Subject|1|||
149150205|NCT01187953|538028038|FG000|Overall Study|Death|11|||
148918014|NCT02213133|537184479|FG002|Overall Study|Participant discontinued study therapy|0|||
148918015|NCT02213133|537184477|FG000|Overall Study|Participant withdrew informed consent|2|||
148918016|NCT02213133|537184478|FG001|Overall Study|Participant withdrew informed consent|1|||
148918017|NCT02213133|537184479|FG002|Overall Study|Participant withdrew informed consent|2|||
148918018|NCT02213133|537184477|FG000|Overall Study|Disease progression|11|||
148918019|NCT02213133|537184478|FG001|Overall Study|Disease progression|2|||
148918020|NCT02213133|537184479|FG002|Overall Study|Disease progression|0|||
149150206|NCT01187953|538028039|FG001|Overall Study|Death|13|||
149150207|NCT01187953|538028038|FG000|Overall Study|Adverse Event|1|||
149150208|NCT01187953|538028039|FG001|Overall Study|Adverse Event|2|||
149150209|NCT01187953|538028038|FG000|Overall Study|Lost to Follow-up|0|||
149150210|NCT01187953|538028039|FG001|Overall Study|Lost to Follow-up|3|||
149150211|NCT01187953|538028038|FG000|Overall Study|Withdrawal by Subject|3|||
149150212|NCT01187953|538028039|FG001|Overall Study|Withdrawal by Subject|3|||
149150213|NCT01464307|538028040|FG000|Main Period|Death|0|||
149150214|NCT01464307|538028041|FG001|Main Period|Death|1|||
149150215|NCT01464307|538028040|FG000|Main Period|Adverse Event|6|||
149150216|NCT01464307|538028041|FG001|Main Period|Adverse Event|1|||
148918021|NCT02213133|537184477|FG000|Overall Study|Adverse Event (AE)|1|||
148918022|NCT02213133|537184478|FG001|Overall Study|Adverse Event (AE)|0|||
149150217|NCT01464307|538028040|FG000|Main Period|Lack of Efficacy|2|||
149150218|NCT01464307|538028041|FG001|Main Period|Lack of Efficacy|0|||
149150219|NCT01464307|538028040|FG000|Main Period|Withdrawal by Subject|5|||
149150220|NCT01464307|538028041|FG001|Main Period|Withdrawal by Subject|2|||
149150221|NCT01464307|538028040|FG000|Main Period|Predefined discontinuation criteria|2|||
149150222|NCT01464307|538028041|FG001|Main Period|Predefined discontinuation criteria|1|||
149150223|NCT01464307|538028040|FG000|Open-Label Extension Period|Adverse Event|15|||
149150224|NCT01464307|538028041|FG001|Open-Label Extension Period|Adverse Event|0|||
149150225|NCT01464307|538028040|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
149150226|NCT01464307|538028041|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
149150227|NCT01464307|538028040|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
149150228|NCT01464307|538028041|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
149150229|NCT01464307|538028040|FG000|Open-Label Extension Period|Death|1|||
149150230|NCT01464307|538028041|FG001|Open-Label Extension Period|Death|0|||
149150231|NCT01464307|538028040|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
149150232|NCT01464307|538028041|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
149150233|NCT01464307|538028040|FG000|Open-Label Extension Period|Non-compliance|9|||
149150234|NCT01464307|538028041|FG001|Open-Label Extension Period|Non-compliance|0|||
149150235|NCT01464307|538028040|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
149150236|NCT01464307|538028041|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
149150237|NCT02457637|538028046|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
149150238|NCT00159861|538028047|FG000|Core Study - 16 Weeks|Death|3|||
149150239|NCT00159861|538028048|FG001|Core Study - 16 Weeks|Death|0|||
149150240|NCT00159861|538028047|FG000|Core Study - 16 Weeks|Adverse Event|12|||
149150241|NCT00159861|538028048|FG001|Core Study - 16 Weeks|Adverse Event|6|||
149150242|NCT00159861|538028047|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
149150243|NCT00159861|538028048|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
149150244|NCT00159861|538028047|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
149150245|NCT00159861|538028048|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
149150246|NCT00159861|538028047|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
149150247|NCT00159861|538028048|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
149150248|NCT00159861|538028047|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
149150249|NCT00159861|538028048|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
149150250|NCT00159861|538028047|FG000|Extension Study - up to 3 Years|Death|24|||
149150251|NCT00159861|538028048|FG001|Extension Study - up to 3 Years|Death|28|||
149150252|NCT00159861|538028047|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
149150253|NCT00159861|538028048|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
149150254|NCT00159861|538028047|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
149150255|NCT00159861|538028048|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
149150256|NCT00159861|538028047|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
149150257|NCT00159861|538028048|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
149150258|NCT00159861|538028047|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
149150259|NCT00159861|538028048|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
149150260|NCT01553136|538028050|FG000|Overall Study|Adverse Event|3|||
149150261|NCT01553136|538028051|FG001|Overall Study|Adverse Event|2|||
149150262|NCT01553136|538028050|FG000|Overall Study|Withdrawal by Subject|2|||
149150263|NCT01553136|538028051|FG001|Overall Study|Withdrawal by Subject|3|||
149150264|NCT01553136|538028050|FG000|Overall Study|Lost to Follow-up|4|||
149150265|NCT01553136|538028051|FG001|Overall Study|Lost to Follow-up|10|||
149150266|NCT01553136|538028050|FG000|Overall Study|Physician Decision|2|||
149150267|NCT01553136|538028051|FG001|Overall Study|Physician Decision|3|||
149150268|NCT01553136|538028050|FG000|Overall Study|Scheduling Difficulties|5|||
149150269|NCT01553136|538028051|FG001|Overall Study|Scheduling Difficulties|4|||
149150270|NCT01014689|538028054|FG000|Overall Study|Lack of Efficacy|0|||
149150271|NCT01014689|538028055|FG001|Overall Study|Lack of Efficacy|1|||
148918023|NCT02213133|537184479|FG002|Overall Study|Adverse Event (AE)|0|||
148918024|NCT02213133|537184477|FG000|Overall Study|Death|16|||
148918025|NCT02213133|537184478|FG001|Overall Study|Death|2|||
148918026|NCT02213133|537184479|FG002|Overall Study|Death|1|||
148918027|NCT02213133|537184477|FG000|Overall Study|Other|5|||
148918028|NCT02213133|537184478|FG001|Overall Study|Other|0|||
149150272|NCT01014689|538028054|FG000|Overall Study|Adverse Event|3|||
149150273|NCT01014689|538028055|FG001|Overall Study|Adverse Event|0|||
149150274|NCT01014689|538028054|FG000|Overall Study|Withdrawal by Subject|5|||
149150275|NCT01014689|538028055|FG001|Overall Study|Withdrawal by Subject|4|||
149150276|NCT01014689|538028054|FG000|Overall Study|Protocol Violation|1|||
149150277|NCT01014689|538028055|FG001|Overall Study|Protocol Violation|1|||
149150278|NCT01014689|538028054|FG000|Overall Study|Lost to Follow-up|3|||
149150279|NCT01014689|538028055|FG001|Overall Study|Lost to Follow-up|7|||
149150280|NCT01014689|538028054|FG000|Overall Study|Pregnancy|1|||
149150281|NCT01014689|538028055|FG001|Overall Study|Pregnancy|0|||
149150282|NCT04311502|538029826|FG000|Overall Study|Death|1|||
148918029|NCT02213133|537184479|FG002|Overall Study|Other|0|||
149150283|NCT04311502|538029827|FG001|Overall Study|Death|1|||
149150284|NCT04311502|538029828|FG002|Overall Study|Death|1|||
149150285|NCT04311502|538029826|FG000|Overall Study|Lost to Follow-up|2|||
149150286|NCT04311502|538029827|FG001|Overall Study|Lost to Follow-up|3|||
149150287|NCT04311502|538029828|FG002|Overall Study|Lost to Follow-up|0|||
149150288|NCT04311502|538029826|FG000|Overall Study|Participant is in prison|1|||
149150289|NCT04311502|538029827|FG001|Overall Study|Participant is in prison|0|||
148918030|NCT02350764|537184480|FG000|Overall Study|Adverse Event|4|||
149150290|NCT04311502|538029828|FG002|Overall Study|Participant is in prison|0|||
149150291|NCT04311502|538029826|FG000|Overall Study|Participant moved out of country|1|||
149150292|NCT04311502|538029827|FG001|Overall Study|Participant moved out of country|0|||
149150293|NCT04311502|538029828|FG002|Overall Study|Participant moved out of country|0|||
149150294|NCT04311502|538029826|FG000|Overall Study|Withdrawal by Subject|2|||
148918031|NCT02350764|537184480|FG000|Overall Study|Death|3|||
148918032|NCT02350764|537184480|FG000|Overall Study|Physician Decision|2|||
148918033|NCT02350764|537184480|FG000|Overall Study|Withdrawal by Subject|2|||
148918034|NCT00441116|537184483|FG000|Overall Study|Adverse Event|1|||
148918035|NCT00441116|537184484|FG001|Overall Study|Adverse Event|1|||
148918036|NCT00441116|537184483|FG000|Overall Study|Withdrawal by Subject|1|||
148918037|NCT00441116|537184484|FG001|Overall Study|Withdrawal by Subject|0|||
148918038|NCT00441116|537184483|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
148918039|NCT00441116|537184484|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
148918040|NCT02925338|537184485|FG000|Overall Study|Death|0|||
148918041|NCT02925338|537184486|FG001|Overall Study|Death|2|||
149150295|NCT04311502|538029827|FG001|Overall Study|Withdrawal by Subject|0|||
149150296|NCT04311502|538029828|FG002|Overall Study|Withdrawal by Subject|0|||
149150297|NCT04311502|538029826|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
149150298|NCT04311502|538029827|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
149150299|NCT04311502|538029828|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
149150300|NCT01661140|538029839|FG000|Open-Label Period|Adverse Event|44|||
149150301|NCT01661140|538029840|FG001|Open-Label Period|Adverse Event|0|||
149150302|NCT01661140|538029841|FG002|Open-Label Period|Adverse Event|0|||
149150303|NCT01661140|538029839|FG000|Open-Label Period|Protocol Violation|3|||
149150304|NCT01661140|538029840|FG001|Open-Label Period|Protocol Violation|0|||
149150305|NCT01661140|538029841|FG002|Open-Label Period|Protocol Violation|0|||
149150306|NCT01661140|538029839|FG000|Open-Label Period|Withdrawal by Subject|5|||
149150307|NCT01661140|538029840|FG001|Open-Label Period|Withdrawal by Subject|0|||
149150308|NCT01661140|538029841|FG002|Open-Label Period|Withdrawal by Subject|0|||
149150309|NCT01661140|538029839|FG000|Open-Label Period|Investigator Decision|3|||
149150310|NCT01661140|538029840|FG001|Open-Label Period|Investigator Decision|0|||
149150311|NCT01661140|538029841|FG002|Open-Label Period|Investigator Decision|0|||
149150312|NCT01661140|538029839|FG000|Open-Label Period|Death|1|||
149150313|NCT01661140|538029840|FG001|Open-Label Period|Death|0|||
149150314|NCT01661140|538029841|FG002|Open-Label Period|Death|0|||
149150315|NCT01661140|538029839|FG000|Open-Label Period|Administrative/Other|1|||
149150316|NCT01661140|538029840|FG001|Open-Label Period|Administrative/Other|0|||
149150317|NCT01661140|538029841|FG002|Open-Label Period|Administrative/Other|0|||
149150318|NCT01661140|538029839|FG000|Open-Label Period|Sponsor termination|16|||
149150319|NCT01661140|538029840|FG001|Open-Label Period|Sponsor termination|0|||
149150320|NCT01661140|538029841|FG002|Open-Label Period|Sponsor termination|0|||
149150321|NCT01661140|538029839|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
149150322|NCT01661140|538029840|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
149150323|NCT01661140|538029841|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
149150324|NCT01661140|538029839|FG000|Open-Label Period|Lost to Follow-up|2|||
149150325|NCT01661140|538029840|FG001|Open-Label Period|Lost to Follow-up|0|||
149150326|NCT01661140|538029841|FG002|Open-Label Period|Lost to Follow-up|0|||
149150327|NCT01661140|538029839|FG000|Double-Blind Period|Refused Treatment|0|||
149150328|NCT01661140|538029840|FG001|Double-Blind Period|Refused Treatment|0|||
149150329|NCT01661140|538029841|FG002|Double-Blind Period|Refused Treatment|1|||
149150330|NCT01661140|538029839|FG000|Double-Blind Period|Adverse Event|0|||
149150331|NCT01661140|538029840|FG001|Double-Blind Period|Adverse Event|16|||
149150332|NCT01661140|538029841|FG002|Double-Blind Period|Adverse Event|18|||
149150333|NCT01661140|538029839|FG000|Double-Blind Period|Protocol Violation|0|||
149150334|NCT01661140|538029840|FG001|Double-Blind Period|Protocol Violation|2|||
149150335|NCT01661140|538029841|FG002|Double-Blind Period|Protocol Violation|3|||
148918042|NCT02925338|537184487|FG002|Overall Study|Death|1|||
148918043|NCT02925338|537184488|FG003|Overall Study|Death|0|||
149150336|NCT01661140|538029839|FG000|Double-Blind Period|Withdrawal by Subject|0|||
149150337|NCT01661140|538029840|FG001|Double-Blind Period|Withdrawal by Subject|1|||
148918044|NCT02925338|537184489|FG004|Overall Study|Death|0|||
149150338|NCT01661140|538029841|FG002|Double-Blind Period|Withdrawal by Subject|3|||
149150339|NCT01661140|538029839|FG000|Double-Blind Period|Investigator's Decision|0|||
149150340|NCT01661140|538029840|FG001|Double-Blind Period|Investigator's Decision|1|||
149150341|NCT01661140|538029841|FG002|Double-Blind Period|Investigator's Decision|2|||
149150342|NCT01661140|538029839|FG000|Double-Blind Period|Sponsor Termination|0|||
148918045|NCT02925338|537184485|FG000|Overall Study|Lost to Follow-up|30|||
148918046|NCT02925338|537184486|FG001|Overall Study|Lost to Follow-up|10|||
149150343|NCT01661140|538029840|FG001|Double-Blind Period|Sponsor Termination|14|||
149150344|NCT01661140|538029841|FG002|Double-Blind Period|Sponsor Termination|17|||
149150345|NCT01661140|538029839|FG000|Double-Blind Period|Administrative/Other|0|||
149150346|NCT01661140|538029840|FG001|Double-Blind Period|Administrative/Other|7|||
149150347|NCT01661140|538029841|FG002|Double-Blind Period|Administrative/Other|6|||
149150348|NCT00513409|538029842|FG000|Overall Study|Adverse Event|0|||
149150349|NCT00513409|538029843|FG001|Overall Study|Adverse Event|1|||
149150350|NCT00513409|538029842|FG000|Overall Study|Withdrawal by Subject|0|||
149150351|NCT00513409|538029843|FG001|Overall Study|Withdrawal by Subject|2|||
149150352|NCT00513409|538029842|FG000|Overall Study|Lost to Follow-up|0|||
149150353|NCT00513409|538029843|FG001|Overall Study|Lost to Follow-up|1|||
149150354|NCT00513409|538029842|FG000|Overall Study|Physician Decision|1|||
149150355|NCT00513409|538029843|FG001|Overall Study|Physician Decision|0|||
149150356|NCT00513409|538029842|FG000|Overall Study|Visit 3 not done|1|||
149150357|NCT00513409|538029843|FG001|Overall Study|Visit 3 not done|2|||
149150358|NCT01049035|538029844|FG000|Overall Study|Serious adverse event|0|||
149150359|NCT01049035|538029845|FG001|Overall Study|Serious adverse event|1|||
149150360|NCT01049035|538029846|FG002|Overall Study|Serious adverse event|1|||
149150361|NCT01049035|538029847|FG003|Overall Study|Serious adverse event|2|||
149150362|NCT01049035|538029848|FG004|Overall Study|Serious adverse event|0|||
149150363|NCT01049035|538029849|FG005|Overall Study|Serious adverse event|0|||
149150364|NCT01049035|538029850|FG006|Overall Study|Serious adverse event|0|||
149150365|NCT01049035|538029844|FG000|Overall Study|Other adverse event (AE)|0|||
149150366|NCT01049035|538029845|FG001|Overall Study|Other adverse event (AE)|0|||
149150367|NCT01049035|538029846|FG002|Overall Study|Other adverse event (AE)|0|||
149150368|NCT01049035|538029847|FG003|Overall Study|Other adverse event (AE)|1|||
149150369|NCT01049035|538029848|FG004|Overall Study|Other adverse event (AE)|0|||
149150370|NCT01049035|538029849|FG005|Overall Study|Other adverse event (AE)|0|||
149150371|NCT01049035|538029850|FG006|Overall Study|Other adverse event (AE)|0|||
149150372|NCT01049035|538029844|FG000|Overall Study|Non-compliance with the protocol|12|||
149150373|NCT01049035|538029845|FG001|Overall Study|Non-compliance with the protocol|6|||
149150374|NCT01049035|538029846|FG002|Overall Study|Non-compliance with the protocol|14|||
149150375|NCT01049035|538029847|FG003|Overall Study|Non-compliance with the protocol|5|||
149150376|NCT01049035|538029848|FG004|Overall Study|Non-compliance with the protocol|3|||
149150377|NCT01049035|538029849|FG005|Overall Study|Non-compliance with the protocol|4|||
149150378|NCT01049035|538029850|FG006|Overall Study|Non-compliance with the protocol|10|||
149150379|NCT01049035|538029844|FG000|Overall Study|Lost to Follow-up|5|||
149150380|NCT01049035|538029845|FG001|Overall Study|Lost to Follow-up|4|||
149150381|NCT01049035|538029846|FG002|Overall Study|Lost to Follow-up|4|||
149150382|NCT01049035|538029847|FG003|Overall Study|Lost to Follow-up|1|||
149150383|NCT01049035|538029848|FG004|Overall Study|Lost to Follow-up|0|||
149150384|NCT01049035|538029849|FG005|Overall Study|Lost to Follow-up|3|||
149150385|NCT01049035|538029850|FG006|Overall Study|Lost to Follow-up|3|||
149150386|NCT01049035|538029844|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
149150387|NCT01049035|538029845|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
149150388|NCT01049035|538029846|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
149150389|NCT01049035|538029847|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
149150390|NCT01049035|538029848|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
149150391|NCT01049035|538029849|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
149150392|NCT01049035|538029850|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
149150393|NCT02239939|538029851|FG000|Overall Study|Adverse Event|1|||
149150394|NCT02239939|538029852|FG001|Overall Study|Adverse Event|0|||
149150395|NCT02239939|538029851|FG000|Overall Study|Withdrawal by Subject|1|||
149150396|NCT02239939|538029852|FG001|Overall Study|Withdrawal by Subject|1|||
149150397|NCT02239939|538029851|FG000|Overall Study|Lost to Follow-up|0|||
149150398|NCT02239939|538029852|FG001|Overall Study|Lost to Follow-up|1|||
149150399|NCT00812214|538029856|FG000|Overall Study|Lost to Follow-up|3|||
149150400|NCT00812214|538029857|FG001|Overall Study|Lost to Follow-up|1|||
148918047|NCT02925338|537184487|FG002|Overall Study|Lost to Follow-up|1|||
148918048|NCT02925338|537184488|FG003|Overall Study|Lost to Follow-up|16|||
148918049|NCT02925338|537184489|FG004|Overall Study|Lost to Follow-up|3|||
148918050|NCT02925338|537184485|FG000|Overall Study|Withdrawal by Subject|3|||
148918051|NCT02925338|537184486|FG001|Overall Study|Withdrawal by Subject|0|||
148918052|NCT02925338|537184487|FG002|Overall Study|Withdrawal by Subject|3|||
149150401|NCT01514682|538029858|FG000|Overall Study|Withdrawal by Subject|2|||
149150402|NCT01514682|538029859|FG001|Overall Study|Withdrawal by Subject|3|||
149150403|NCT01514682|538029858|FG000|Overall Study|Physician Decision|4|||
149150404|NCT01514682|538029859|FG001|Overall Study|Physician Decision|3|||
149150405|NCT00132132|538029860|FG000|Overall Study|Lost to Follow-up|7|||
148918053|NCT02925338|537184488|FG003|Overall Study|Withdrawal by Subject|2|||
149150406|NCT00132132|538029861|FG001|Overall Study|Lost to Follow-up|2|||
149150407|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
149150408|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
149150409|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
149150410|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
148918054|NCT02925338|537184489|FG004|Overall Study|Withdrawal by Subject|2|||
149150411|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
148918055|NCT02925338|537184485|FG000|Overall Study|Missing|38|||
149150412|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
149150413|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
149150414|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
149150415|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
149150416|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
149150417|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
149150418|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
149150419|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
149150420|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
149150421|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
149150422|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
149150423|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
149150424|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
149150425|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
149150426|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
149150427|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
149150428|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
149150429|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
149150430|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
149150431|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
149150432|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
149150433|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
149150434|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
149150435|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
149150436|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
149150437|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
149150438|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
149150439|NCT03605680|538029863|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
149150440|NCT03605680|538029864|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
149150441|NCT03605680|538029865|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
149150442|NCT03605680|538029866|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
149150443|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
149150444|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
149150445|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
149150446|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
149150447|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
149150448|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
149150449|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
149150450|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
149150451|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149150452|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149150453|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149150454|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
149150455|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
149150456|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
149150457|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
149150458|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
149150459|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
149150460|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
149150461|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
149233880|NCT00948896|538324945|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
149233881|NCT00948896|538324946|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
149233882|NCT00948896|538324947|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
149233883|NCT00948896|538324948|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149233884|NCT00948896|538324949|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
148672392|NCT02860039|536270771|FG000|Overall Study|Withdrawal by Subject|1|||
148672393|NCT02860039|536270772|FG001|Overall Study|Withdrawal by Subject|0|||
148672394|NCT02860039|536270771|FG000|Overall Study|Not otherwise eligible|1|||
148672395|NCT02860039|536270772|FG001|Overall Study|Not otherwise eligible|1|||
149233885|NCT00948896|538324950|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149233886|NCT00948896|538324951|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
149233887|NCT00948896|538324944|FG000|24 Months of Age to 36 Months of Age|Death|0|||
149233888|NCT00948896|538324945|FG001|24 Months of Age to 36 Months of Age|Death|2|||
149150462|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
149150463|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
149150464|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
149150465|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
149150466|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
149150467|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
149150468|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
149150469|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
149150470|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
149150471|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
149150472|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
149150473|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
149150474|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
149150475|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
149150476|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
149150477|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
149150478|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
149150479|NCT03605680|538029863|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
149150480|NCT03605680|538029864|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
149150481|NCT03605680|538029865|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
149150482|NCT03605680|538029866|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
149150483|NCT03189446|538029867|FG000|Overall Study|Adverse Event|2|||
149150484|NCT03189446|538029867|FG000|Overall Study|Withdrawal by Subject|2|||
149150485|NCT03189446|538029867|FG000|Overall Study|Physician Decision|1|||
149150486|NCT00647556|538029868|FG000|Overall Study|Adverse Event|0|||
149150487|NCT00647556|538029869|FG001|Overall Study|Adverse Event|1|||
149150488|NCT00647556|538029868|FG000|Overall Study|Lost to Follow-up|1|||
149150489|NCT00647556|538029869|FG001|Overall Study|Lost to Follow-up|0|||
149150490|NCT00647556|538029868|FG000|Overall Study|Protocol Violation|0|||
149150491|NCT00647556|538029869|FG001|Overall Study|Protocol Violation|1|||
149150492|NCT00647556|538029868|FG000|Overall Study|Withdrawal by Subject|1|||
149150493|NCT00647556|538029869|FG001|Overall Study|Withdrawal by Subject|0|||
149150494|NCT00647556|538029868|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
149150495|NCT00647556|538029869|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
149150496|NCT05594173|538029870|FG000|Overall Study|Adverse Event|1|||
149150497|NCT05594173|538029870|FG000|Overall Study|COVID-19 Pandemic|2|||
149150498|NCT01496885|538029872|FG000|Overall Study|Lost to Follow-up|13|||
149150499|NCT01496885|538029872|FG000|Overall Study|Withdrawal by Subject|7|||
149150500|NCT01496885|538029872|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
149150501|NCT01496885|538029872|FG000|Overall Study|Death|1|||
149150502|NCT00915681|538029875|FG000|Overall Study|Screening failures|46|||
149150503|NCT03221751|538029878|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
149150504|NCT03221751|538029879|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
149150505|NCT00535132|538029885|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
149150506|NCT00535132|538029886|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
148918056|NCT02925338|537184486|FG001|Overall Study|Missing|27|||
148918057|NCT02925338|537184487|FG002|Overall Study|Missing|0|||
148918058|NCT02925338|537184488|FG003|Overall Study|Missing|3|||
148918059|NCT02925338|537184489|FG004|Overall Study|Missing|2|||
148918060|NCT02925338|537184485|FG000|Overall Study|Participant's Decision|11|||
148918061|NCT02925338|537184486|FG001|Overall Study|Participant's Decision|7|||
148918062|NCT02925338|537184487|FG002|Overall Study|Participant's Decision|3|||
148918063|NCT02925338|537184488|FG003|Overall Study|Participant's Decision|8|||
148918064|NCT02925338|537184489|FG004|Overall Study|Participant's Decision|1|||
148918065|NCT02925338|537184485|FG000|Overall Study|Treatment Discontinuation|144|||
148918066|NCT02925338|537184486|FG001|Overall Study|Treatment Discontinuation|65|||
148918067|NCT02925338|537184487|FG002|Overall Study|Treatment Discontinuation|56|||
148918068|NCT02925338|537184488|FG003|Overall Study|Treatment Discontinuation|131|||
148918069|NCT02925338|537184489|FG004|Overall Study|Treatment Discontinuation|22|||
148918070|NCT02395172|537184490|FG000|Overall Study|Participants randomized but not treated|3|||
148918071|NCT02395172|537184491|FG001|Overall Study|Participants randomized but not treated|31|||
148918072|NCT00029146|537184494|FG000|Overall Study|Lost to Follow-up|2|||
148918073|NCT00029146|537184495|FG001|Overall Study|Lost to Follow-up|1|||
148918074|NCT01765218|537184496|FG000|Overall Study|Protocol Violation|1|||
148918075|NCT01765218|537184497|FG001|Overall Study|Protocol Violation|2|||
148918076|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
149150507|NCT00535132|538029885|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
149150508|NCT00535132|538029886|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
149150509|NCT02590588|538029887|FG000|Overall Study|Adverse Event|1|||
149150510|NCT02559687|538029895|FG000|Overall Study|Death|112|||
149150511|NCT02559687|538029895|FG000|Overall Study|Sponsor Decision|5|||
149150512|NCT02559687|538029895|FG000|Overall Study|Withdrawal by Subject|4|||
149150513|NCT02706873|538029898|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
149150514|NCT02706873|538029899|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
149150515|NCT02706873|538029900|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
149150516|NCT02706873|538029901|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
149150517|NCT02706873|538029898|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
149150518|NCT02706873|538029899|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
149150519|NCT02706873|538029900|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
149150520|NCT02706873|538029901|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
149150521|NCT02706873|538029898|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
149150522|NCT02706873|538029899|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
149150523|NCT02706873|538029900|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
149150524|NCT02706873|538029901|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
149150525|NCT02706873|538029898|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
149150526|NCT02706873|538029899|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
149150527|NCT02706873|538029900|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
149150528|NCT02706873|538029901|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
149150529|NCT02706873|538029898|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
149150530|NCT02706873|538029899|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
149150531|NCT02706873|538029900|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
149150532|NCT02706873|538029901|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
149150533|NCT02706873|538029898|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
149150534|NCT02706873|538029899|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
149150535|NCT02706873|538029900|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
148672396|NCT01102972|536270776|FG000|Overall Study|Adverse Event|8|||
148672397|NCT01102972|536270777|FG001|Overall Study|Adverse Event|2|||
148672398|NCT01102972|536270776|FG000|Overall Study|Lack of Efficacy|2|||
148672399|NCT01102972|536270777|FG001|Overall Study|Lack of Efficacy|1|||
148672400|NCT01102972|536270776|FG000|Overall Study|Protocol Violation|1|||
148672401|NCT01102972|536270777|FG001|Overall Study|Protocol Violation|0|||
148672402|NCT01102972|536270776|FG000|Overall Study|Lost to Follow-up|10|||
148672403|NCT01102972|536270777|FG001|Overall Study|Lost to Follow-up|5|||
148672404|NCT01102972|536270776|FG000|Overall Study|Investigator Discretion|2|||
148672405|NCT01102972|536270777|FG001|Overall Study|Investigator Discretion|0|||
148672406|NCT01102972|536270776|FG000|Overall Study|Withdrawal by Subject|6|||
148672407|NCT01102972|536270777|FG001|Overall Study|Withdrawal by Subject|6|||
148672408|NCT01856257|536270778|FG000|Overall Study|Death|2|||
148672409|NCT01856257|536270779|FG001|Overall Study|Death|0|||
148672410|NCT01856257|536270780|FG002|Overall Study|Death|0|||
148672411|NCT01856257|536270781|FG003|Overall Study|Death|0|||
148672412|NCT01856257|536270778|FG000|Overall Study|Physician Decision|0|||
148672413|NCT01856257|536270779|FG001|Overall Study|Physician Decision|0|||
148672414|NCT01856257|536270780|FG002|Overall Study|Physician Decision|0|||
148672415|NCT01856257|536270781|FG003|Overall Study|Physician Decision|1|||
148672416|NCT01856257|536270778|FG000|Overall Study|Withdrawal by Subject|1|||
148672417|NCT01856257|536270779|FG001|Overall Study|Withdrawal by Subject|1|||
148672418|NCT01856257|536270780|FG002|Overall Study|Withdrawal by Subject|0|||
148672419|NCT01856257|536270781|FG003|Overall Study|Withdrawal by Subject|0|||
148672420|NCT01856257|536270778|FG000|Overall Study|Donor complication|0|||
148672421|NCT01856257|536270779|FG001|Overall Study|Donor complication|0|||
148672422|NCT01856257|536270780|FG002|Overall Study|Donor complication|0|||
148672423|NCT01856257|536270781|FG003|Overall Study|Donor complication|1|||
148672424|NCT03843775|536270782|FG000|Overall Study|Adverse Event|1|||
148672425|NCT03843775|536270783|FG001|Overall Study|Adverse Event|1|||
148672426|NCT03843775|536270782|FG000|Overall Study|Lack of Efficacy|2|||
148672427|NCT03843775|536270783|FG001|Overall Study|Lack of Efficacy|6|||
149150536|NCT02706873|538029901|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
149150537|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
149150538|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
148672428|NCT03843775|536270782|FG000|Overall Study|Withdrawal by Subject|0|||
148672429|NCT03843775|536270783|FG001|Overall Study|Withdrawal by Subject|1|||
148672430|NCT00530621|536270789|FG000|Overall Study|Adverse Event|11|||
148672431|NCT00530621|536270790|FG001|Overall Study|Adverse Event|8|||
148672432|NCT00530621|536270789|FG000|Overall Study|Physician Decision|2|||
148672433|NCT00530621|536270790|FG001|Overall Study|Physician Decision|4|||
148672434|NCT00530621|536270789|FG000|Overall Study|Progressive Disease (PD)|47|||
149150539|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
149150540|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
148672435|NCT00530621|536270790|FG001|Overall Study|Progressive Disease (PD)|40|||
148672436|NCT00530621|536270789|FG000|Overall Study|Sponsor Decision|12|||
148672437|NCT00530621|536270790|FG001|Overall Study|Sponsor Decision|15|||
148672438|NCT00530621|536270789|FG000|Overall Study|Subject Decision|4|||
148672439|NCT00530621|536270790|FG001|Overall Study|Subject Decision|7|||
149150541|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
149150542|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
149150543|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
149150544|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
149150545|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
149150546|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
149150547|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
149150548|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
149150549|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
149150550|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
149150551|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
149150552|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
149150553|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
149150554|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
149150555|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
149150556|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
149150557|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
149150558|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
149150559|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
149150560|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
149150561|NCT02706873|538029898|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
149150562|NCT02706873|538029899|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
149150563|NCT02706873|538029900|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
149150564|NCT02706873|538029901|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
149150565|NCT05098041|538029905|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
148918077|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
148918078|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
148918079|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
148918080|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
148918081|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
148918082|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
148918083|NCT00946985|537184498|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
148918084|NCT00946985|537184498|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
148918085|NCT00313781|537184499|FG000|Before Crossover|Death|22|||
148918086|NCT00313781|537184500|FG001|Before Crossover|Death|8|||
148918087|NCT00313781|537184501|FG002|Before Crossover|Death|0|||
148918088|NCT00313781|537184499|FG000|Before Crossover|Lost to Follow-up|0|||
148918089|NCT00313781|537184500|FG001|Before Crossover|Lost to Follow-up|3|||
148918090|NCT00313781|537184501|FG002|Before Crossover|Lost to Follow-up|0|||
148918091|NCT00313781|537184499|FG000|Before Crossover|Withdrawal by Subject|3|||
148918092|NCT00313781|537184500|FG001|Before Crossover|Withdrawal by Subject|1|||
148918093|NCT00313781|537184501|FG002|Before Crossover|Withdrawal by Subject|0|||
148918094|NCT00313781|537184499|FG000|Before Crossover|Other|45|||
148918095|NCT00313781|537184500|FG001|Before Crossover|Other|30|||
148918096|NCT00313781|537184501|FG002|Before Crossover|Other|0|||
148918097|NCT00313781|537184499|FG000|Before Crossover|Crossover|0|||
148918098|NCT00313781|537184500|FG001|Before Crossover|Crossover|37|||
148918099|NCT00313781|537184501|FG002|Before Crossover|Crossover|0|||
148918100|NCT00313781|537184499|FG000|Before Crossover|Randomized, not treated|5|||
148918101|NCT00313781|537184500|FG001|Before Crossover|Randomized, not treated|0|||
148918102|NCT00313781|537184501|FG002|Before Crossover|Randomized, not treated|0|||
148918103|NCT00313781|537184499|FG000|After Crossover|Death|0|||
148918104|NCT00313781|537184500|FG001|After Crossover|Death|0|||
148918105|NCT00313781|537184501|FG002|After Crossover|Death|6|||
148918106|NCT00313781|537184499|FG000|After Crossover|Withdrawal by Subject|0|||
148918107|NCT00313781|537184500|FG001|After Crossover|Withdrawal by Subject|0|||
148918108|NCT00313781|537184501|FG002|After Crossover|Withdrawal by Subject|3|||
148918109|NCT00313781|537184499|FG000|After Crossover|Other|0|||
148918110|NCT00313781|537184500|FG001|After Crossover|Other|0|||
148918111|NCT00313781|537184501|FG002|After Crossover|Other|18|||
148918112|NCT01546623|537184502|FG000|Overall Study|Adverse Event|2|||
148918113|NCT01546623|537184503|FG001|Overall Study|Adverse Event|3|||
148918114|NCT01546623|537184502|FG000|Overall Study|Major Protocol Deviation|1|||
148918115|NCT01546623|537184503|FG001|Overall Study|Major Protocol Deviation|1|||
148918116|NCT01546623|537184502|FG000|Overall Study|High Prostate specific antigen|2|||
148918117|NCT01546623|537184503|FG001|Overall Study|High Prostate specific antigen|1|||
148918118|NCT01546623|537184502|FG000|Overall Study|Did Not Receive Study Drug|1|||
148918119|NCT01546623|537184503|FG001|Overall Study|Did Not Receive Study Drug|1|||
149150566|NCT00618410|538029906|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
148672440|NCT00530621|536270789|FG000|Overall Study|Death|3|||
148918120|NCT03567343|537184504|FG000|Overall Study|Lost to Follow-up|2|||
148918121|NCT03567343|537184505|FG001|Overall Study|Lost to Follow-up|1|||
148918122|NCT03567343|537184504|FG000|Overall Study|No longer eligible|2|||
148918123|NCT03567343|537184505|FG001|Overall Study|No longer eligible|1|||
148918124|NCT03567343|537184504|FG000|Overall Study|Adverse Event|1|||
148918125|NCT03567343|537184505|FG001|Overall Study|Adverse Event|0|||
149150567|NCT00618410|538029907|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
148918126|NCT03567343|537184504|FG000|Overall Study|Protocol Violation|1|||
148918127|NCT03567343|537184505|FG001|Overall Study|Protocol Violation|1|||
148918128|NCT01590758|537184508|FG000|Overall Study|Withdrawal by Subject|0|||
148918129|NCT01590758|537184509|FG001|Overall Study|Withdrawal by Subject|3|||
148918130|NCT01590758|537184508|FG000|Overall Study|Physician Decision|1|||
148918131|NCT01590758|537184509|FG001|Overall Study|Physician Decision|2|||
148918132|NCT01590758|537184508|FG000|Overall Study|Lost to Follow-up|4|||
148918133|NCT01590758|537184509|FG001|Overall Study|Lost to Follow-up|2|||
148918134|NCT04525885|537184510|FG000|Overall Study|Screen Failure|1|||
148918135|NCT04525885|537184511|FG001|Overall Study|Screen Failure|0|||
148918136|NCT04525885|537184512|FG002|Overall Study|Screen Failure|0|||
148918137|NCT04525885|537184510|FG000|Overall Study|Withdrawal by Subject|14|||
148918138|NCT04525885|537184511|FG001|Overall Study|Withdrawal by Subject|6|||
148918139|NCT04525885|537184512|FG002|Overall Study|Withdrawal by Subject|20|||
148918140|NCT04525885|537184510|FG000|Overall Study|Physician Decision|1|||
148918141|NCT04525885|537184511|FG001|Overall Study|Physician Decision|0|||
148918142|NCT04525885|537184512|FG002|Overall Study|Physician Decision|1|||
148918143|NCT02717832|537184513|FG000|Overall Study|Inability to place IV|3|||
148918144|NCT00096356|537184516|FG000|Overall Study|Adverse Event|11|||
148918145|NCT00096356|537184517|FG001|Overall Study|Adverse Event|9|||
148918146|NCT00096356|537184516|FG000|Overall Study|Physician Decision|5|||
148918147|NCT00096356|537184517|FG001|Overall Study|Physician Decision|3|||
148918148|NCT00096356|537184516|FG000|Overall Study|Withdrawal by Subject|17|||
148918149|NCT00096356|537184517|FG001|Overall Study|Withdrawal by Subject|23|||
148918150|NCT00096356|537184516|FG000|Overall Study|Lack of Efficacy|1|||
148918151|NCT00096356|537184517|FG001|Overall Study|Lack of Efficacy|0|||
148918152|NCT00096356|537184516|FG000|Overall Study|multiple reasons|10|||
148918153|NCT00096356|537184517|FG001|Overall Study|multiple reasons|18|||
148918154|NCT00978757|537184519|FG000|Overall Study|Physician Decision|1|||
148918155|NCT00978757|537184520|FG001|Overall Study|Physician Decision|3|||
148918156|NCT03288142|537184521|FG000|Overall Study|Lost to Follow-up|22|||
148918157|NCT03288142|537184522|FG001|Overall Study|Lost to Follow-up|15|||
148918158|NCT00402740|537184525|FG000|Overall Study|Withdrawal by Subject|18|||
148918159|NCT00402740|537184525|FG000|Overall Study|Death|50|||
148918160|NCT00402740|537184525|FG000|Overall Study|Lost to Follow-up|6|||
148918161|NCT00402740|537184525|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
148918162|NCT00402740|537184525|FG000|Overall Study|Subject disposition unknown.|1|||
148918163|NCT01214395|537184526|FG000|Overall Study|All patients had infection|5|||
148918164|NCT01185353|537184527|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
148918165|NCT01185353|537184528|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
148918166|NCT01185353|537184529|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
148918167|NCT01185353|537184530|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
148918168|NCT01185353|537184531|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
148918169|NCT01185353|537184532|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
148918170|NCT01185353|537184533|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
148918171|NCT01185353|537184534|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
148918172|NCT01185353|537184535|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
148918173|NCT01185353|537184536|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
148918174|NCT01185353|537184527|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918175|NCT01185353|537184528|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918176|NCT01185353|537184529|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918177|NCT01185353|537184530|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918178|NCT01185353|537184531|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
148918179|NCT01185353|537184532|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918180|NCT01185353|537184533|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918181|NCT01185353|537184534|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918182|NCT01185353|537184535|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918183|NCT01185353|537184536|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
148918184|NCT01185353|537184527|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
148918185|NCT01185353|537184528|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918186|NCT01185353|537184529|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918187|NCT01185353|537184530|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918188|NCT01185353|537184531|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
148918189|NCT01185353|537184532|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918190|NCT01185353|537184533|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918191|NCT01185353|537184534|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918192|NCT01185353|537184535|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918193|NCT01185353|537184536|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
148918194|NCT01185353|537184527|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918195|NCT01185353|537184528|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918196|NCT01185353|537184529|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
148918197|NCT01185353|537184530|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918198|NCT01185353|537184531|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
148918199|NCT01185353|537184532|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
149150568|NCT01297270|538029912|FG000|Overall Study|Adverse Event|19|||
149150569|NCT01297270|538029913|FG001|Overall Study|Adverse Event|32|||
148805623|NCT00042289|536767979|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
148805624|NCT00042289|536767980|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
148805625|NCT00042289|536767981|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
148805626|NCT00042289|536767982|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
148805627|NCT00042289|536767983|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
148805628|NCT00042289|536767984|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
148805629|NCT00042289|536767985|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
148805630|NCT00042289|536767986|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
148805631|NCT00042289|536767987|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
148805632|NCT00042289|536767988|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
148805633|NCT00042289|536767989|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
148805634|NCT00042289|536767990|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
148805635|NCT00042289|536767991|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
148805636|NCT00042289|536767992|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
148805637|NCT00042289|536767993|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
148805638|NCT00042289|536767994|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
148805639|NCT00042289|536767995|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
148805640|NCT00042289|536767996|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
148805641|NCT00042289|536767997|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
148805642|NCT00042289|536767998|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
148805643|NCT00042289|536767999|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
148805644|NCT00042289|536768000|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
148805645|NCT00042289|536768001|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
148805646|NCT00042289|536768002|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
148805647|NCT00042289|536768003|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
148805648|NCT00042289|536768004|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
148805649|NCT00042289|536768005|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
148805650|NCT00042289|536768006|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
148805651|NCT00042289|536767960|FG000|Overall Study|Protocol Violation|0|||
148805652|NCT00042289|536767961|FG001|Overall Study|Protocol Violation|0|||
148805653|NCT00042289|536767962|FG002|Overall Study|Protocol Violation|0|||
148805654|NCT00042289|536767963|FG003|Overall Study|Protocol Violation|0|||
148805655|NCT00042289|536767964|FG004|Overall Study|Protocol Violation|0|||
148805656|NCT00042289|536767965|FG005|Overall Study|Protocol Violation|1|||
148805657|NCT00042289|536767966|FG006|Overall Study|Protocol Violation|0|||
148805658|NCT00042289|536767967|FG007|Overall Study|Protocol Violation|1|||
148805659|NCT00042289|536767968|FG008|Overall Study|Protocol Violation|0|||
148805660|NCT00042289|536767969|FG009|Overall Study|Protocol Violation|0|||
148805661|NCT00042289|536767970|FG010|Overall Study|Protocol Violation|0|||
148805662|NCT00042289|536767971|FG011|Overall Study|Protocol Violation|0|||
148805663|NCT00042289|536767972|FG012|Overall Study|Protocol Violation|0|||
148805664|NCT00042289|536767973|FG013|Overall Study|Protocol Violation|0|||
148805665|NCT00042289|536767974|FG014|Overall Study|Protocol Violation|0|||
148805666|NCT00042289|536767975|FG015|Overall Study|Protocol Violation|0|||
148805667|NCT00042289|536767976|FG016|Overall Study|Protocol Violation|0|||
148805668|NCT00042289|536767977|FG017|Overall Study|Protocol Violation|0|||
148805669|NCT00042289|536767978|FG018|Overall Study|Protocol Violation|0|||
148805670|NCT00042289|536767979|FG019|Overall Study|Protocol Violation|0|||
148805671|NCT00042289|536767980|FG020|Overall Study|Protocol Violation|0|||
148805672|NCT00042289|536767981|FG021|Overall Study|Protocol Violation|0|||
148805673|NCT00042289|536767982|FG022|Overall Study|Protocol Violation|0|||
148805674|NCT00042289|536767983|FG023|Overall Study|Protocol Violation|1|||
148805675|NCT00042289|536767984|FG024|Overall Study|Protocol Violation|1|||
148805676|NCT00042289|536767985|FG025|Overall Study|Protocol Violation|0|||
148805677|NCT00042289|536767986|FG026|Overall Study|Protocol Violation|2|||
148805678|NCT00042289|536767987|FG027|Overall Study|Protocol Violation|0|||
148805679|NCT00042289|536767988|FG028|Overall Study|Protocol Violation|0|||
148805680|NCT00042289|536767989|FG029|Overall Study|Protocol Violation|0|||
148805681|NCT00042289|536767990|FG030|Overall Study|Protocol Violation|1|||
148805682|NCT00042289|536767991|FG031|Overall Study|Protocol Violation|0|||
148805683|NCT00042289|536767992|FG032|Overall Study|Protocol Violation|0|||
148805684|NCT00042289|536767993|FG033|Overall Study|Protocol Violation|0|||
148805685|NCT00042289|536767994|FG034|Overall Study|Protocol Violation|0|||
148805686|NCT00042289|536767995|FG035|Overall Study|Protocol Violation|0|||
148805687|NCT00042289|536767996|FG036|Overall Study|Protocol Violation|0|||
148805688|NCT00042289|536767997|FG037|Overall Study|Protocol Violation|0|||
148805689|NCT00042289|536767998|FG038|Overall Study|Protocol Violation|0|||
148805690|NCT00042289|536767999|FG039|Overall Study|Protocol Violation|0|||
148918200|NCT01185353|537184533|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918201|NCT01185353|537184534|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918202|NCT01185353|537184535|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918203|NCT01185353|537184536|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
148918204|NCT01185353|537184527|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918205|NCT01185353|537184528|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918206|NCT01185353|537184529|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918207|NCT01185353|537184530|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918208|NCT01185353|537184531|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
148918209|NCT01185353|537184532|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918210|NCT01185353|537184533|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918211|NCT01185353|537184534|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918212|NCT01185353|537184535|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918213|NCT01185353|537184536|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
148918214|NCT01185353|537184527|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
148918215|NCT01185353|537184528|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918216|NCT01185353|537184529|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918217|NCT01185353|537184530|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918218|NCT01185353|537184531|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
148918219|NCT01185353|537184532|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918220|NCT01185353|537184533|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918221|NCT01185353|537184534|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918222|NCT01185353|537184535|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918223|NCT01185353|537184536|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
148918224|NCT01185353|537184527|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
148918225|NCT01185353|537184528|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
148918226|NCT01185353|537184529|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
148918227|NCT01185353|537184530|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
148918228|NCT01185353|537184531|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
148918229|NCT01185353|537184532|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
148918230|NCT01185353|537184533|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
148918231|NCT01185353|537184534|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
149150570|NCT01297270|538029914|FG002|Overall Study|Adverse Event|5|||
149150571|NCT01297270|538029912|FG000|Overall Study|Lack of Efficacy|15|||
149150572|NCT01297270|538029913|FG001|Overall Study|Lack of Efficacy|17|||
149150573|NCT01297270|538029914|FG002|Overall Study|Lack of Efficacy|15|||
149150574|NCT01297270|538029912|FG000|Overall Study|Lost to Follow-up|1|||
149150575|NCT01297270|538029913|FG001|Overall Study|Lost to Follow-up|2|||
149150576|NCT01297270|538029914|FG002|Overall Study|Lost to Follow-up|1|||
149150577|NCT01297270|538029912|FG000|Overall Study|Protocol Violation|0|||
149150578|NCT01297270|538029913|FG001|Overall Study|Protocol Violation|2|||
149150579|NCT01297270|538029914|FG002|Overall Study|Protocol Violation|0|||
149150580|NCT01297270|538029912|FG000|Overall Study|Withdrawal by Subject|7|||
149150581|NCT01297270|538029913|FG001|Overall Study|Withdrawal by Subject|15|||
149150582|NCT01297270|538029914|FG002|Overall Study|Withdrawal by Subject|7|||
149150583|NCT01297270|538029912|FG000|Overall Study|Other reason not defined above|3|||
149150584|NCT01297270|538029913|FG001|Overall Study|Other reason not defined above|3|||
149150585|NCT01297270|538029914|FG002|Overall Study|Other reason not defined above|1|||
149150586|NCT01297270|538029912|FG000|Overall Study|Not treated|0|||
149150587|NCT01297270|538029913|FG001|Overall Study|Not treated|1|||
149150588|NCT01297270|538029914|FG002|Overall Study|Not treated|0|||
149150589|NCT01965262|538029918|FG000|Second Intervention (7 Days)|Discontinued|0|||
149150590|NCT01965262|538029919|FG001|Second Intervention (7 Days)|Discontinued|1|||
149150591|NCT01965262|538029918|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
149150592|NCT01965262|538029919|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
149150593|NCT01965262|538029918|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
149150594|NCT01965262|538029919|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
149150595|NCT01029366|538029920|FG000|Overall Study|Withdrawal by Subject|1|||
149150596|NCT01029366|538029921|FG001|Overall Study|Withdrawal by Subject|0|||
149150597|NCT01029366|538029920|FG000|Overall Study|Death|1|||
149150598|NCT01029366|538029921|FG001|Overall Study|Death|1|||
149150599|NCT01029366|538029920|FG000|Overall Study|disease progression|2|||
149150600|NCT01029366|538029921|FG001|Overall Study|disease progression|0|||
149150601|NCT01029366|538029920|FG000|Overall Study|manufacturing failure|0|||
149150602|NCT01029366|538029921|FG001|Overall Study|manufacturing failure|1|||
149150603|NCT00906087|538029927|FG000|Initial Washout|Withdrawal by Subject|1|||
149150604|NCT00906087|538029927|FG000|Initial Washout|Physician Decision|1|||
149150605|NCT00440947|538029928|FG000|36-Week Induction Phase|Adverse Event|16|||
149150606|NCT00440947|538029929|FG001|36-Week Induction Phase|Adverse Event|0|||
149150607|NCT00440947|538029930|FG002|36-Week Induction Phase|Adverse Event|0|||
149150608|NCT00440947|538029931|FG003|36-Week Induction Phase|Adverse Event|0|||
149150609|NCT00440947|538029932|FG004|36-Week Induction Phase|Adverse Event|0|||
148918232|NCT01185353|537184535|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
148918233|NCT01185353|537184536|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
149150610|NCT00440947|538029928|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
149150611|NCT00440947|538029929|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
149150612|NCT00440947|538029930|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
149150613|NCT00440947|538029931|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
149150614|NCT00440947|538029932|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
149150615|NCT00440947|538029928|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
149150616|NCT00440947|538029929|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
149150617|NCT00440947|538029930|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
149150618|NCT00440947|538029931|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
149150619|NCT00440947|538029932|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
149150620|NCT00440947|538029928|FG000|36-Week Induction Phase|Non-compliance|10|||
149150621|NCT00440947|538029929|FG001|36-Week Induction Phase|Non-compliance|0|||
149150622|NCT00440947|538029930|FG002|36-Week Induction Phase|Non-compliance|0|||
149150623|NCT00440947|538029931|FG003|36-Week Induction Phase|Non-compliance|0|||
149150624|NCT00440947|538029932|FG004|36-Week Induction Phase|Non-compliance|0|||
149150625|NCT00440947|538029928|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
149150626|NCT00440947|538029929|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
149150627|NCT00440947|538029930|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
149150628|NCT00440947|538029931|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
149150629|NCT00440947|538029932|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
149150630|NCT00440947|538029928|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
149150631|NCT00440947|538029929|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
149150632|NCT00440947|538029930|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
149150633|NCT00440947|538029931|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
149150634|NCT00440947|538029932|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
149150635|NCT00440947|538029928|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
149150636|NCT00440947|538029929|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
149150637|NCT00440947|538029930|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
149150638|NCT00440947|538029931|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
149150639|NCT00440947|538029932|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
149150640|NCT00440947|538029928|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
149150641|NCT00440947|538029929|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
149150642|NCT00440947|538029930|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
149150643|NCT00440947|538029931|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
149150644|NCT00440947|538029932|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
149150645|NCT00440947|538029928|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
149150646|NCT00440947|538029929|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
149150647|NCT00440947|538029930|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
149150648|NCT00440947|538029931|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
149150649|NCT00440947|538029932|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
149150650|NCT00440947|538029928|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
149150651|NCT00440947|538029929|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
149150652|NCT00440947|538029930|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
149150653|NCT00440947|538029931|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
149150654|NCT00440947|538029932|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
149150655|NCT00440947|538029928|FG000|36-Week Induction Phase|Incarceration|3|||
149150656|NCT00440947|538029929|FG001|36-Week Induction Phase|Incarceration|0|||
149150657|NCT00440947|538029930|FG002|36-Week Induction Phase|Incarceration|0|||
149150658|NCT00440947|538029931|FG003|36-Week Induction Phase|Incarceration|0|||
149150659|NCT00440947|538029932|FG004|36-Week Induction Phase|Incarceration|0|||
149150660|NCT00440947|538029928|FG000|36-Week Induction Phase|Pregnancy|1|||
149150661|NCT00440947|538029929|FG001|36-Week Induction Phase|Pregnancy|0|||
149150662|NCT00440947|538029930|FG002|36-Week Induction Phase|Pregnancy|0|||
149150663|NCT00440947|538029931|FG003|36-Week Induction Phase|Pregnancy|0|||
149150664|NCT00440947|538029932|FG004|36-Week Induction Phase|Pregnancy|0|||
149150665|NCT00440947|538029928|FG000|48-Week Randomization Phase|Adverse Event|0|||
149150666|NCT00440947|538029929|FG001|48-Week Randomization Phase|Adverse Event|2|||
149150667|NCT00440947|538029930|FG002|48-Week Randomization Phase|Adverse Event|5|||
149150668|NCT00440947|538029931|FG003|48-Week Randomization Phase|Adverse Event|0|||
149150669|NCT00440947|538029932|FG004|48-Week Randomization Phase|Adverse Event|0|||
149150670|NCT00440947|538029928|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
149150671|NCT00440947|538029929|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
148805691|NCT00042289|536768000|FG040|Overall Study|Protocol Violation|0|||
149150672|NCT00440947|538029930|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
149150673|NCT00440947|538029931|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
149150674|NCT00440947|538029932|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
148805692|NCT00042289|536768001|FG041|Overall Study|Protocol Violation|1|||
148805693|NCT00042289|536768002|FG042|Overall Study|Protocol Violation|1|||
149150675|NCT00440947|538029928|FG000|48-Week Randomization Phase|Non-compliance|0|||
149150676|NCT00440947|538029929|FG001|48-Week Randomization Phase|Non-compliance|3|||
149150677|NCT00440947|538029930|FG002|48-Week Randomization Phase|Non-compliance|4|||
149150678|NCT00440947|538029931|FG003|48-Week Randomization Phase|Non-compliance|0|||
149150679|NCT00440947|538029932|FG004|48-Week Randomization Phase|Non-compliance|0|||
149150680|NCT00440947|538029928|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
149150681|NCT00440947|538029929|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
149150682|NCT00440947|538029930|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
149150683|NCT00440947|538029931|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
149150684|NCT00440947|538029932|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
149150685|NCT00440947|538029928|FG000|48-Week Randomization Phase|Protocol Violation|0|||
149150686|NCT00440947|538029929|FG001|48-Week Randomization Phase|Protocol Violation|0|||
149150687|NCT00440947|538029930|FG002|48-Week Randomization Phase|Protocol Violation|1|||
149150688|NCT00440947|538029931|FG003|48-Week Randomization Phase|Protocol Violation|0|||
149150689|NCT00440947|538029932|FG004|48-Week Randomization Phase|Protocol Violation|0|||
149150690|NCT00440947|538029928|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
149150691|NCT00440947|538029929|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
149150692|NCT00440947|538029930|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
149150693|NCT00440947|538029931|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
149150694|NCT00440947|538029932|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
149150695|NCT00440947|538029928|FG000|48-Week Randomization Phase|Pregnancy|0|||
149150696|NCT00440947|538029929|FG001|48-Week Randomization Phase|Pregnancy|0|||
149150697|NCT00440947|538029930|FG002|48-Week Randomization Phase|Pregnancy|1|||
149150698|NCT00440947|538029931|FG003|48-Week Randomization Phase|Pregnancy|0|||
149150699|NCT00440947|538029932|FG004|48-Week Randomization Phase|Pregnancy|0|||
149150700|NCT00440947|538029928|FG000|48-Week Randomization Phase|Incarceration|0|||
149150701|NCT00440947|538029929|FG001|48-Week Randomization Phase|Incarceration|3|||
149150702|NCT00440947|538029930|FG002|48-Week Randomization Phase|Incarceration|0|||
149150703|NCT00440947|538029931|FG003|48-Week Randomization Phase|Incarceration|0|||
149150704|NCT00440947|538029932|FG004|48-Week Randomization Phase|Incarceration|0|||
149150705|NCT00440947|538029928|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
149150706|NCT00440947|538029929|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
149150707|NCT00440947|538029930|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
149150708|NCT00440947|538029931|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
149150709|NCT00440947|538029932|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
149150710|NCT00440947|538029928|FG000|48-Week Randomization Phase|Physician Decision|0|||
149150711|NCT00440947|538029929|FG001|48-Week Randomization Phase|Physician Decision|2|||
149150712|NCT00440947|538029930|FG002|48-Week Randomization Phase|Physician Decision|0|||
149150713|NCT00440947|538029931|FG003|48-Week Randomization Phase|Physician Decision|0|||
149150714|NCT00440947|538029932|FG004|48-Week Randomization Phase|Physician Decision|0|||
149150715|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
149150716|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
149150717|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
149150718|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
149150719|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
149150720|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
149150721|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
149150722|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
149150723|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
149150724|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
149150725|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
149150726|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
148672441|NCT00530621|536270790|FG001|Overall Study|Death|6|||
148805694|NCT00042289|536768003|FG043|Overall Study|Protocol Violation|1|||
148805695|NCT00042289|536768004|FG044|Overall Study|Protocol Violation|0|||
148805696|NCT00042289|536768005|FG045|Overall Study|Protocol Violation|0|||
148805697|NCT00042289|536768006|FG046|Overall Study|Protocol Violation|0|||
148918234|NCT01185353|537184527|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918235|NCT01185353|537184528|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
148918236|NCT01185353|537184529|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918237|NCT01185353|537184530|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
148918238|NCT01185353|537184531|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918239|NCT01185353|537184532|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918240|NCT01185353|537184533|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918241|NCT01185353|537184534|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918242|NCT01185353|537184535|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918243|NCT01185353|537184536|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
148918244|NCT01185353|537184527|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918245|NCT01185353|537184528|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918246|NCT01185353|537184529|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918247|NCT01185353|537184530|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
148918248|NCT01185353|537184531|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918249|NCT01185353|537184532|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918250|NCT01185353|537184533|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
148918251|NCT01185353|537184534|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918252|NCT01185353|537184535|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918253|NCT01185353|537184536|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
148918254|NCT01185353|537184527|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
148918255|NCT01185353|537184528|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
148918256|NCT01185353|537184529|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
148918257|NCT01185353|537184530|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
148918258|NCT01185353|537184531|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
148918259|NCT01185353|537184532|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
148918260|NCT01185353|537184533|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
148918261|NCT01185353|537184534|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
148918262|NCT01185353|537184535|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
148918263|NCT01185353|537184536|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
148918264|NCT01185353|537184527|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918265|NCT01185353|537184528|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918266|NCT01185353|537184529|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918267|NCT01185353|537184530|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918268|NCT01185353|537184531|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918269|NCT01185353|537184532|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918270|NCT01185353|537184533|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
148918271|NCT01185353|537184534|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918272|NCT01185353|537184535|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918273|NCT01185353|537184536|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
148918274|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918275|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918276|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918277|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918278|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918279|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918280|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
148918281|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
148918282|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
148918283|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
148918284|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918285|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918286|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918287|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918288|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918289|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918290|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
148918291|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
148918292|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
148918293|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
148918294|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
148918295|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
149150727|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
148918296|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
148918297|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
148918298|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
148918299|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
149150728|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
149150729|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
149150730|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
149150731|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
149150732|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
149150733|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
149150734|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
149150735|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
149150736|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
149150737|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
149150738|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
149150739|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
149150740|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
149150741|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
149150742|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
149150743|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
149150744|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
149150745|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
149150746|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
149150747|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
149150748|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
149150749|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
149150750|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
149150751|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
149150752|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
149150753|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
149150754|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
149150755|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
149150756|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
149150757|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
149150758|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
149150759|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
149150760|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
149150761|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
149150762|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
149150763|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
149150764|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
149150765|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
149150766|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
149150767|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
148672442|NCT00530621|536270789|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
149150768|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
149150769|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
149150770|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Other|0|||
149150771|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Other|0|||
149150772|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Other|0|||
149150773|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Other|1|||
149150774|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Other|0|||
149150775|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
149150776|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
149150777|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
149150778|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
149150779|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
149150780|NCT00440947|538029928|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
148672443|NCT00530621|536270790|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
148672444|NCT02596009|536270791|FG000|Overall Study|Administrative problems|0|||
148672445|NCT02596009|536270792|FG001|Overall Study|Administrative problems|1|||
148672446|NCT02596009|536270793|FG002|Overall Study|Administrative problems|0|||
148672447|NCT02596009|536270794|FG003|Overall Study|Administrative problems|0|||
149150781|NCT00440947|538029929|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
149150782|NCT00440947|538029930|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
149150783|NCT00440947|538029931|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
149150784|NCT00440947|538029932|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
148672448|NCT02596009|536270795|FG004|Overall Study|Administrative problems|0|||
148672449|NCT02596009|536270796|FG005|Overall Study|Administrative problems|0|||
148918300|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
148918301|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
149150785|NCT01827670|538029933|FG000|Overall Study|Withdrawal of Consent|3|||
149150786|NCT01827670|538029934|FG001|Overall Study|Withdrawal of Consent|2|||
149150787|NCT01827670|538029933|FG000|Overall Study|Lost to Follow-up|0|||
149150788|NCT01827670|538029934|FG001|Overall Study|Lost to Follow-up|1|||
149150789|NCT02813694|538029942|FG000|Overall Study|Physician Decision|0|||
149150790|NCT02813694|538029943|FG001|Overall Study|Physician Decision|1|||
149150791|NCT02813694|538029942|FG000|Overall Study|Withdrawal by Subject|10|||
149150792|NCT02813694|538029943|FG001|Overall Study|Withdrawal by Subject|9|||
148672450|NCT04611152|536270799|FG000|Overall Study|Adverse Event|9|||
148672451|NCT04611152|536270800|FG001|Overall Study|Adverse Event|8|||
148672452|NCT04611152|536270799|FG000|Overall Study|Non-compliance with study schedule|1|||
148672453|NCT04611152|536270800|FG001|Overall Study|Non-compliance with study schedule|3|||
148672454|NCT04611152|536270799|FG000|Overall Study|Withdrawal by Subject|5|||
148672455|NCT04611152|536270800|FG001|Overall Study|Withdrawal by Subject|6|||
148672456|NCT04611152|536270799|FG000|Overall Study|Lost to Follow-up|11|||
148672457|NCT04611152|536270800|FG001|Overall Study|Lost to Follow-up|2|||
148672458|NCT00602667|536270801|FG000|Overall Study|Still on Therapy|0|||
148672459|NCT00602667|536270802|FG001|Overall Study|Still on Therapy|2|||
148672460|NCT00602667|536270803|FG002|Overall Study|Still on Therapy|2|||
148672461|NCT00602667|536270801|FG000|Overall Study|Death|0|||
148672462|NCT00602667|536270802|FG001|Overall Study|Death|1|||
148672463|NCT00602667|536270803|FG002|Overall Study|Death|1|||
148672464|NCT00602667|536270801|FG000|Overall Study|Family request|3|||
148672465|NCT00602667|536270802|FG001|Overall Study|Family request|25|||
148672466|NCT00602667|536270803|FG002|Overall Study|Family request|6|||
148672467|NCT00602667|536270801|FG000|Overall Study|Excessive toxicity|1|||
148672468|NCT00602667|536270802|FG001|Overall Study|Excessive toxicity|1|||
148672469|NCT00602667|536270803|FG002|Overall Study|Excessive toxicity|0|||
148672470|NCT00602667|536270801|FG000|Overall Study|Second malignancy|0|||
148672471|NCT00602667|536270802|FG001|Overall Study|Second malignancy|1|||
148672472|NCT00602667|536270803|FG002|Overall Study|Second malignancy|0|||
148672473|NCT00602667|536270801|FG000|Overall Study|Physician Decision|2|||
148672474|NCT00602667|536270802|FG001|Overall Study|Physician Decision|3|||
148672475|NCT00602667|536270803|FG002|Overall Study|Physician Decision|8|||
148672476|NCT00602667|536270801|FG000|Overall Study|Progressive disease|13|||
148672477|NCT00602667|536270802|FG001|Overall Study|Progressive disease|48|||
148672478|NCT00602667|536270803|FG002|Overall Study|Progressive disease|45|||
148672479|NCT00602667|536270801|FG000|Overall Study|Progressive disease prior to therapy|0|||
148672480|NCT00602667|536270802|FG001|Overall Study|Progressive disease prior to therapy|0|||
148672481|NCT00602667|536270803|FG002|Overall Study|Progressive disease prior to therapy|1|||
148672482|NCT03179462|536270809|FG000|Overall Study|screening failure|1|||
148672483|NCT03179462|536270810|FG001|Overall Study|screening failure|2|||
148672484|NCT03179462|536270811|FG002|Overall Study|screening failure|0|||
148672485|NCT04636437|536270815|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
148672486|NCT04636437|536270816|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
148672487|NCT04636437|536270817|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
148672488|NCT04636437|536270815|FG000|Overall Study|Started weight loss drug/program|2|||
148672489|NCT04636437|536270816|FG001|Overall Study|Started weight loss drug/program|1|||
149150793|NCT02813694|538029942|FG000|Overall Study|Lost to Follow-up|1|||
149150794|NCT02813694|538029943|FG001|Overall Study|Lost to Follow-up|1|||
148805698|NCT00042289|536767960|FG000|Overall Study|Withdrawal by Subject|4|||
148672490|NCT04636437|536270817|FG002|Overall Study|Started weight loss drug/program|1|||
148672491|NCT04636437|536270815|FG000|Overall Study|Lost to Follow-up|3|||
148672492|NCT04636437|536270816|FG001|Overall Study|Lost to Follow-up|1|||
148672493|NCT04636437|536270817|FG002|Overall Study|Lost to Follow-up|4|||
148672494|NCT04636437|536270815|FG000|Overall Study|Participant or physician decision|3|||
148805699|NCT00042289|536767961|FG001|Overall Study|Withdrawal by Subject|1|||
149150795|NCT02813694|538029942|FG000|Overall Study|Death|3|||
149150796|NCT02813694|538029943|FG001|Overall Study|Death|3|||
149150797|NCT02813694|538029942|FG000|Overall Study|Randomized- did not receive study drug|2|||
149150798|NCT02813694|538029943|FG001|Overall Study|Randomized- did not receive study drug|0|||
149150799|NCT02813694|538029942|FG000|Overall Study|Patient hospitalized|1|||
149150800|NCT02813694|538029943|FG001|Overall Study|Patient hospitalized|0|||
149150801|NCT01152021|538029951|FG000|Overall Study|Adverse Event|4|||
149150802|NCT01152021|538029952|FG001|Overall Study|Adverse Event|4|||
149150803|NCT01152021|538029951|FG000|Overall Study|Study drug had expired|1|||
149150804|NCT01152021|538029952|FG001|Overall Study|Study drug had expired|0|||
149150805|NCT01152021|538029951|FG000|Overall Study|Physician Decision|1|||
149150806|NCT01152021|538029952|FG001|Overall Study|Physician Decision|1|||
149150807|NCT01152021|538029951|FG000|Overall Study|No access to study drug in Pharmacy|0|||
149150808|NCT01152021|538029952|FG001|Overall Study|No access to study drug in Pharmacy|1|||
149150809|NCT02595723|538029953|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
149150810|NCT02595723|538029954|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
149150811|NCT02595723|538029955|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
149150812|NCT02595723|538029953|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
149150813|NCT02595723|538029954|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
149150814|NCT02595723|538029955|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
149150815|NCT04288154|538029956|FG000|Overall Study|Withdrawal by Subject|9|||
149150816|NCT04288154|538029957|FG001|Overall Study|Withdrawal by Subject|9|||
149150817|NCT00996944|538029959|FG000|Double-blind Treatment Period|Adverse Event|2|||
149150818|NCT00996944|538029960|FG001|Double-blind Treatment Period|Adverse Event|1|||
149150819|NCT00996944|538029959|FG000|Double-blind Treatment Period|Protocol Violation|1|||
149150820|NCT00996944|538029960|FG001|Double-blind Treatment Period|Protocol Violation|0|||
149150821|NCT00996944|538029959|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
149150822|NCT00996944|538029960|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
149150823|NCT00996944|538029959|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149150824|NCT00996944|538029960|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
149150825|NCT00996944|538029959|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
149150826|NCT00996944|538029960|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
149150827|NCT01902290|538029961|FG000|Overall Study|Withdrawal by Subject|19|||
149150828|NCT01902290|538029962|FG001|Overall Study|Withdrawal by Subject|27|||
149150829|NCT01902290|538029961|FG000|Overall Study|Lost to Follow-up|2|||
149150830|NCT01902290|538029962|FG001|Overall Study|Lost to Follow-up|2|||
149150831|NCT01902290|538029961|FG000|Overall Study|Death|1|||
149150832|NCT01902290|538029962|FG001|Overall Study|Death|0|||
149150833|NCT01902290|538029961|FG000|Overall Study|Sponsor Decision|26|||
149150834|NCT01902290|538029962|FG001|Overall Study|Sponsor Decision|24|||
149150835|NCT00769184|538029963|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
149150836|NCT00769184|538029964|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
149150837|NCT00769184|538029963|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
149150838|NCT00769184|538029964|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
149150839|NCT00769184|538029963|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
149150840|NCT00769184|538029964|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
149150841|NCT00385255|538029966|FG000|Overall Study|Serious Adverse Event|1|||
149150842|NCT00385255|538029967|FG001|Overall Study|Serious Adverse Event|2|||
149150843|NCT00385255|538029966|FG000|Overall Study|Protocol Violation|0|||
149150844|NCT00385255|538029967|FG001|Overall Study|Protocol Violation|4|||
149150845|NCT00385255|538029966|FG000|Overall Study|Withdrawal by Subject|0|||
149150846|NCT00385255|538029967|FG001|Overall Study|Withdrawal by Subject|8|||
149150847|NCT00385255|538029966|FG000|Overall Study|Migrated/moved from study area|0|||
149150848|NCT00385255|538029967|FG001|Overall Study|Migrated/moved from study area|1|||
149150849|NCT00385255|538029966|FG000|Overall Study|Lost to Follow-up|20|||
149150850|NCT00385255|538029967|FG001|Overall Study|Lost to Follow-up|58|||
149150851|NCT02250274|538029968|FG000|Overall Study|Insufficient blood draw amount|7|||
149150852|NCT02250274|538029969|FG001|Overall Study|Insufficient blood draw amount|6|||
149150853|NCT00446511|538029970|FG000|Overall Study|Adverse Event|7|||
149150854|NCT00446511|538029971|FG001|Overall Study|Adverse Event|2|||
149150855|NCT00446511|538029972|FG002|Overall Study|Adverse Event|3|||
149150856|NCT00446511|538029973|FG003|Overall Study|Adverse Event|1|||
149150857|NCT00446511|538029970|FG000|Overall Study|Protocol Violation|0|||
149150858|NCT00446511|538029971|FG001|Overall Study|Protocol Violation|0|||
149150859|NCT00446511|538029972|FG002|Overall Study|Protocol Violation|0|||
149150860|NCT00446511|538029973|FG003|Overall Study|Protocol Violation|1|||
149150861|NCT00446511|538029970|FG000|Overall Study|Withdrawal by Subject|0|||
149150862|NCT00446511|538029971|FG001|Overall Study|Withdrawal by Subject|0|||
149150863|NCT00446511|538029972|FG002|Overall Study|Withdrawal by Subject|0|||
149150864|NCT00446511|538029973|FG003|Overall Study|Withdrawal by Subject|3|||
149150865|NCT00446511|538029970|FG000|Overall Study|Administrative Problems|3|||
149150866|NCT00446511|538029971|FG001|Overall Study|Administrative Problems|0|||
149150867|NCT00446511|538029972|FG002|Overall Study|Administrative Problems|4|||
149150868|NCT00446511|538029973|FG003|Overall Study|Administrative Problems|1|||
149150869|NCT01136655|538029974|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
149150870|NCT01136655|538029974|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
149150871|NCT01136655|538029974|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
149150872|NCT01136655|538029974|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
149150873|NCT02873936|538029977|FG000|Overall Study|Withdrew Consent|4|||
149150874|NCT02873936|538029978|FG001|Overall Study|Withdrew Consent|11|||
149150875|NCT02873936|538029979|FG002|Overall Study|Withdrew Consent|20|||
149150876|NCT02873936|538029977|FG000|Overall Study|Investigator's Discretion|3|||
149150877|NCT02873936|538029978|FG001|Overall Study|Investigator's Discretion|5|||
149150878|NCT02873936|538029979|FG002|Overall Study|Investigator's Discretion|4|||
149150879|NCT02873936|538029977|FG000|Overall Study|Adverse Event|3|||
149150880|NCT02873936|538029978|FG001|Overall Study|Adverse Event|5|||
149150881|NCT02873936|538029979|FG002|Overall Study|Adverse Event|3|||
149150882|NCT02873936|538029977|FG000|Overall Study|Protocol Violation|0|||
149150883|NCT02873936|538029978|FG001|Overall Study|Protocol Violation|1|||
149150884|NCT02873936|538029979|FG002|Overall Study|Protocol Violation|3|||
149150885|NCT02873936|538029977|FG000|Overall Study|Lost to Follow-up|1|||
149150886|NCT02873936|538029978|FG001|Overall Study|Lost to Follow-up|1|||
149150887|NCT02873936|538029979|FG002|Overall Study|Lost to Follow-up|1|||
149150888|NCT02873936|538029977|FG000|Overall Study|Non-compliance With Study Drug|1|||
149150889|NCT02873936|538029978|FG001|Overall Study|Non-compliance With Study Drug|0|||
149150890|NCT02873936|538029979|FG002|Overall Study|Non-compliance With Study Drug|1|||
149150891|NCT02873936|538029977|FG000|Overall Study|Randomized but not Dosed|1|||
149150892|NCT02873936|538029978|FG001|Overall Study|Randomized but not Dosed|0|||
149150893|NCT02873936|538029979|FG002|Overall Study|Randomized but not Dosed|0|||
149150894|NCT01015768|538029980|FG000|Overall Study|Some subject data unuseable|4|||
149150895|NCT01015768|538029981|FG001|Overall Study|Some subject data unuseable|4|||
149150896|NCT01627860|538029982|FG000|Overall Study|Adverse Event|9|||
149150897|NCT01627860|538029983|FG001|Overall Study|Adverse Event|4|||
149150898|NCT01627860|538029982|FG000|Overall Study|Withdrawal by Subject|2|||
149150899|NCT01627860|538029983|FG001|Overall Study|Withdrawal by Subject|1|||
149150900|NCT01627860|538029982|FG000|Overall Study|Seizure frequency doubled|0|||
149150901|NCT01627860|538029983|FG001|Overall Study|Seizure frequency doubled|1|||
149150902|NCT01627860|538029982|FG000|Overall Study|Protocol Violation|1|||
149150903|NCT01627860|538029983|FG001|Overall Study|Protocol Violation|0|||
149150904|NCT00542269|538029985|FG000|Overall Study|Adverse Event|10|||
149150905|NCT00542269|538029986|FG001|Overall Study|Adverse Event|4|||
149150906|NCT00542269|538029987|FG002|Overall Study|Adverse Event|5|||
149150907|NCT00542269|538029985|FG000|Overall Study|Protocol Violation|1|||
149150908|NCT00542269|538029986|FG001|Overall Study|Protocol Violation|1|||
149150909|NCT00542269|538029987|FG002|Overall Study|Protocol Violation|0|||
149150910|NCT00542269|538029985|FG000|Overall Study|Withdrawal by Subject|1|||
149150911|NCT00542269|538029986|FG001|Overall Study|Withdrawal by Subject|0|||
149150912|NCT00542269|538029987|FG002|Overall Study|Withdrawal by Subject|0|||
149150913|NCT00542269|538029985|FG000|Overall Study|Administrative problems|1|||
149150914|NCT00542269|538029986|FG001|Overall Study|Administrative problems|1|||
149150915|NCT00542269|538029987|FG002|Overall Study|Administrative problems|1|||
149150916|NCT01883635|538029988|FG000|Overall Study|Withdrawal by Subject|4|||
149150917|NCT01883635|538029989|FG001|Overall Study|Withdrawal by Subject|0|||
149150918|NCT00761514|538029990|FG000|Overall Study|Adverse Event|1|||
149150919|NCT00761514|538029990|FG000|Overall Study|Withdrawal by Subject|2|||
149150920|NCT00761514|538029990|FG000|Overall Study|Lost to Follow-up|1|||
148918302|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
148918303|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
148918304|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918305|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918306|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918307|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918308|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918309|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918310|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
149150921|NCT00761514|538029990|FG000|Overall Study|Health insurance didn't cover study drug|1|||
149150922|NCT00761514|538029990|FG000|Overall Study|Problem complying with study visit|1|||
149150923|NCT00761514|538029990|FG000|Overall Study|Unable to pay for medications|1|||
149150924|NCT00894556|538029991|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
149150925|NCT00894556|538029992|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
149150926|NCT00894556|538029993|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
149150927|NCT00894556|538029994|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
149150928|NCT00894556|538029991|FG000|Treatment Phase|Lost to Follow-up|2|||
149150929|NCT00894556|538029992|FG001|Treatment Phase|Lost to Follow-up|3|||
148918311|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918312|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
149150930|NCT00894556|538029993|FG002|Treatment Phase|Lost to Follow-up|1|||
149150931|NCT00894556|538029994|FG003|Treatment Phase|Lost to Follow-up|0|||
149150932|NCT00894556|538029991|FG000|Treatment Phase|Lack of Qualifying Event|2|||
149150933|NCT00894556|538029992|FG001|Treatment Phase|Lack of Qualifying Event|1|||
149150934|NCT00894556|538029993|FG002|Treatment Phase|Lack of Qualifying Event|0|||
149150935|NCT00894556|538029994|FG003|Treatment Phase|Lack of Qualifying Event|0|||
149150936|NCT03040999|538031151|FG000|Overall Study|Lost to Follow-up|2|||
149150937|NCT03040999|538031152|FG001|Overall Study|Lost to Follow-up|2|||
149150938|NCT03040999|538031151|FG000|Overall Study|Withdrawal by Subject|12|||
149150939|NCT03040999|538031152|FG001|Overall Study|Withdrawal by Subject|13|||
149150940|NCT03040999|538031151|FG000|Overall Study|Death|155|||
149150941|NCT03040999|538031152|FG001|Overall Study|Death|171|||
149150942|NCT03040999|538031151|FG000|Overall Study|Physician Decision|0|||
149150943|NCT03040999|538031152|FG001|Overall Study|Physician Decision|3|||
149150944|NCT03451773|538031153|FG000|Overall Study|Death on study|1|||
149150945|NCT03451773|538031154|FG001|Overall Study|Death on study|5|||
149150946|NCT03451773|538031153|FG000|Overall Study|Death during follow-up period|0|||
149150947|NCT03451773|538031154|FG001|Overall Study|Death during follow-up period|1|||
149150948|NCT03468855|538031155|FG000|Overall Study|Adverse Event|2|||
149150949|NCT03468855|538031155|FG000|Overall Study|Lost to Follow-up|5|||
149150950|NCT03468855|538031155|FG000|Overall Study|Withdrawal by Subject|3|||
149150951|NCT03468855|538031155|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
149150952|NCT02068547|538031156|FG000|Overall Study|Lost to Follow-up|3|||
149150953|NCT02068547|538031157|FG001|Overall Study|Lost to Follow-up|3|||
149150954|NCT02068547|538031156|FG000|Overall Study|Physician Decision|1|||
149150955|NCT02068547|538031157|FG001|Overall Study|Physician Decision|0|||
149150956|NCT03657043|538031158|FG000|Overall Study|Withdrawal by Subject|1|||
149150957|NCT03657043|538031159|FG001|Overall Study|Withdrawal by Subject|1|||
149150958|NCT03657043|538031160|FG002|Overall Study|Withdrawal by Subject|0|||
149150959|NCT03657043|538031161|FG003|Overall Study|Withdrawal by Subject|0|||
149150960|NCT03657043|538031162|FG004|Overall Study|Withdrawal by Subject|4|||
148918313|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
148918314|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Death|0|||
148918315|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Death|0|||
148918316|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Death|0|||
148918317|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Death|0|||
148918318|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Death|0|||
148918319|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Death|0|||
148918320|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Death|0|||
148918321|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Death|0|||
148918322|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Death|0|||
148918323|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Death|1|||
148918324|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918325|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918326|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918327|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918328|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918329|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918330|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918331|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918332|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
148918333|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
148918334|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918335|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918336|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918337|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918338|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918339|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
149150961|NCT03657043|538031158|FG000|Overall Study|Study closure by Sponsor|0|||
149150962|NCT03657043|538031159|FG001|Overall Study|Study closure by Sponsor|2|||
149150963|NCT03657043|538031160|FG002|Overall Study|Study closure by Sponsor|0|||
149150964|NCT03657043|538031161|FG003|Overall Study|Study closure by Sponsor|0|||
149150965|NCT03657043|538031162|FG004|Overall Study|Study closure by Sponsor|17|||
149150966|NCT03657043|538031158|FG000|Overall Study|Lost to Follow-up|0|||
149150967|NCT03657043|538031159|FG001|Overall Study|Lost to Follow-up|0|||
149150968|NCT03657043|538031160|FG002|Overall Study|Lost to Follow-up|0|||
149150969|NCT03657043|538031161|FG003|Overall Study|Lost to Follow-up|0|||
149150970|NCT03657043|538031162|FG004|Overall Study|Lost to Follow-up|4|||
149150971|NCT03657043|538031158|FG000|Overall Study|Death|6|||
149150972|NCT03657043|538031159|FG001|Overall Study|Death|5|||
149150973|NCT03657043|538031160|FG002|Overall Study|Death|0|||
149150974|NCT03657043|538031161|FG003|Overall Study|Death|0|||
149150975|NCT03657043|538031162|FG004|Overall Study|Death|53|||
148918340|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918341|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
149150976|NCT03657043|538031158|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
149150977|NCT03657043|538031159|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
149150978|NCT03657043|538031160|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
149150979|NCT03657043|538031161|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
149150980|NCT03657043|538031162|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
149150981|NCT03657043|538031158|FG000|Overall Study|Adverse Event|0|||
149150982|NCT03657043|538031159|FG001|Overall Study|Adverse Event|0|||
149150983|NCT03657043|538031160|FG002|Overall Study|Adverse Event|0|||
149150984|NCT03657043|538031161|FG003|Overall Study|Adverse Event|0|||
149150985|NCT03657043|538031162|FG004|Overall Study|Adverse Event|2|||
149150986|NCT03657043|538031158|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
149150987|NCT03657043|538031159|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
149150988|NCT03657043|538031160|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
149150989|NCT03657043|538031161|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
149150990|NCT03657043|538031162|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
149150991|NCT03657043|538031158|FG000|Overall Study|Withdrawal - declined follow-up|0|||
149150992|NCT03657043|538031159|FG001|Overall Study|Withdrawal - declined follow-up|0|||
149150993|NCT03657043|538031160|FG002|Overall Study|Withdrawal - declined follow-up|0|||
149150994|NCT03657043|538031161|FG003|Overall Study|Withdrawal - declined follow-up|0|||
149150995|NCT03657043|538031162|FG004|Overall Study|Withdrawal - declined follow-up|1|||
149150996|NCT02627495|538031165|FG000|Overall Study|Withdrawal by Subject|4|||
149150997|NCT00880893|538031166|FG000|Overall Study|Protocol Violation|13|||
149150998|NCT00880893|538031167|FG001|Overall Study|Protocol Violation|1|||
149150999|NCT00880893|538031166|FG000|Overall Study|Withdrawal by Subject|15|||
149151000|NCT00880893|538031167|FG001|Overall Study|Withdrawal by Subject|11|||
149151001|NCT00880893|538031166|FG000|Overall Study|Lost to Follow-up|76|||
149151002|NCT00880893|538031167|FG001|Overall Study|Lost to Follow-up|33|||
149151003|NCT00880893|538031166|FG000|Overall Study|Serious adverse event|3|||
149151004|NCT00880893|538031167|FG001|Overall Study|Serious adverse event|0|||
149151005|NCT01979523|538031168|FG000|Overall Study|Withdrawal by Subject|1|||
149151006|NCT01979523|538031169|FG001|Overall Study|Withdrawal by Subject|0|||
149151007|NCT01982292|538031170|FG000|Overall Study|Adverse Event|2|||
149151008|NCT01982292|538031171|FG001|Overall Study|Adverse Event|0|||
149151009|NCT01982292|538031170|FG000|Overall Study|Death|1|||
149151010|NCT01982292|538031171|FG001|Overall Study|Death|0|||
149151011|NCT01982292|538031170|FG000|Overall Study|Lost to Follow-up|2|||
149151012|NCT01982292|538031171|FG001|Overall Study|Lost to Follow-up|0|||
149151013|NCT01982292|538031170|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
149151014|NCT01982292|538031171|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
149151015|NCT01982292|538031170|FG000|Overall Study|Protocol Deviation|1|||
149151016|NCT01982292|538031171|FG001|Overall Study|Protocol Deviation|0|||
149151017|NCT01982292|538031170|FG000|Overall Study|Patient/Guardian Decision|3|||
149151018|NCT01982292|538031171|FG001|Overall Study|Patient/Guardian Decision|1|||
149151019|NCT01982292|538031170|FG000|Overall Study|Technical Problems|2|||
149151020|NCT01982292|538031171|FG001|Overall Study|Technical Problems|0|||
149151021|NCT00879229|538031172|FG000|Overall Study|Study terminated by Sponsor|13|||
149151022|NCT00879229|538031173|FG001|Overall Study|Study terminated by Sponsor|12|||
149151023|NCT00879229|538031172|FG000|Overall Study|Death|4|||
149151024|NCT00879229|538031173|FG001|Overall Study|Death|2|||
149151025|NCT00879229|538031172|FG000|Overall Study|Adverse Event|2|||
149151026|NCT00879229|538031173|FG001|Overall Study|Adverse Event|0|||
149151027|NCT00879229|538031172|FG000|Overall Study|Withdrawal by Subject|1|||
149151028|NCT00879229|538031173|FG001|Overall Study|Withdrawal by Subject|0|||
149151029|NCT00879229|538031172|FG000|Overall Study|Clinical status did not improve|1|||
149151030|NCT00879229|538031173|FG001|Overall Study|Clinical status did not improve|0|||
148805700|NCT00042289|536767962|FG002|Overall Study|Withdrawal by Subject|0|||
148805701|NCT00042289|536767963|FG003|Overall Study|Withdrawal by Subject|2|||
148805702|NCT00042289|536767964|FG004|Overall Study|Withdrawal by Subject|0|||
148805703|NCT00042289|536767965|FG005|Overall Study|Withdrawal by Subject|2|||
148805704|NCT00042289|536767966|FG006|Overall Study|Withdrawal by Subject|0|||
148805705|NCT00042289|536767967|FG007|Overall Study|Withdrawal by Subject|0|||
148805706|NCT00042289|536767968|FG008|Overall Study|Withdrawal by Subject|0|||
148805707|NCT00042289|536767969|FG009|Overall Study|Withdrawal by Subject|1|||
148805708|NCT00042289|536767970|FG010|Overall Study|Withdrawal by Subject|0|||
148805709|NCT00042289|536767971|FG011|Overall Study|Withdrawal by Subject|0|||
148805710|NCT00042289|536767972|FG012|Overall Study|Withdrawal by Subject|2|||
148805711|NCT00042289|536767973|FG013|Overall Study|Withdrawal by Subject|0|||
148805712|NCT00042289|536767974|FG014|Overall Study|Withdrawal by Subject|0|||
148805713|NCT00042289|536767975|FG015|Overall Study|Withdrawal by Subject|0|||
148805714|NCT00042289|536767976|FG016|Overall Study|Withdrawal by Subject|0|||
148805715|NCT00042289|536767977|FG017|Overall Study|Withdrawal by Subject|0|||
148805716|NCT00042289|536767978|FG018|Overall Study|Withdrawal by Subject|0|||
148805717|NCT00042289|536767979|FG019|Overall Study|Withdrawal by Subject|0|||
148805718|NCT00042289|536767980|FG020|Overall Study|Withdrawal by Subject|0|||
148805719|NCT00042289|536767981|FG021|Overall Study|Withdrawal by Subject|1|||
148805720|NCT00042289|536767982|FG022|Overall Study|Withdrawal by Subject|1|||
149151031|NCT00879229|538031172|FG000|Overall Study|Other|1|||
149151032|NCT00879229|538031173|FG001|Overall Study|Other|0|||
149151033|NCT01339559|538031181|FG000|Overall Study|Adverse Event|92|||
149151034|NCT01339559|538031181|FG000|Overall Study|Death|5|||
149151035|NCT01339559|538031181|FG000|Overall Study|Lack of Efficacy|164|||
149151036|NCT01339559|538031181|FG000|Overall Study|Lost to Follow-up|22|||
149151037|NCT01339559|538031181|FG000|Overall Study|Subject choice|89|||
149151038|NCT01339559|538031181|FG000|Overall Study|Protocol Violation|15|||
149151039|NCT01339559|538031181|FG000|Overall Study|Study closure at site|1|||
149151040|NCT01339559|538031181|FG000|Overall Study|Incarcerated|2|||
149151041|NCT01339559|538031181|FG000|Overall Study|Epilepsy surgery|1|||
149151042|NCT01339559|538031181|FG000|Overall Study|Pregnancy planned|2|||
149151043|NCT01339559|538031181|FG000|Overall Study|Left the country|1|||
149151044|NCT01339559|538031181|FG000|Overall Study|Investigator decision|2|||
149151045|NCT01339559|538031181|FG000|Overall Study|Patient didn't wish to continue|1|||
149151046|NCT01339559|538031181|FG000|Overall Study|PI decision|1|||
149151047|NCT00971945|538031182|FG000|Overall Study|Progressive Disease|3|||
149151048|NCT00971945|538031182|FG000|Overall Study|Change in treatment policy|1|||
148918342|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
148918343|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
149151049|NCT00971945|538031182|FG000|Overall Study|Other reasons|2|||
149151050|NCT03354663|538031183|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
149151051|NCT03354663|538031183|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
149151052|NCT03354663|538031183|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
149151053|NCT03354663|538031183|FG000|Completed 30-day Visit|Missed Visit|1|||
149151054|NCT01137773|538031184|FG000|Overall Study|Death|3|||
149151055|NCT01137773|538031185|FG001|Overall Study|Death|3|||
149151056|NCT01137773|538031184|FG000|Overall Study|Lost to Follow-up|6|||
149151057|NCT01137773|538031185|FG001|Overall Study|Lost to Follow-up|0|||
149151058|NCT03548051|538031189|FG000|Overall Study|Death|1|||
149151059|NCT03548051|538031190|FG001|Overall Study|Death|1|||
149151060|NCT03548051|538031189|FG000|Overall Study|Withdrawal by Subject|1|||
149151061|NCT03548051|538031190|FG001|Overall Study|Withdrawal by Subject|0|||
149151062|NCT00817531|538031192|FG000|Overall Study|Adverse Event|1|||
149151063|NCT00817531|538031192|FG000|Overall Study|Lack of Efficacy|1|||
149151064|NCT03325673|538031193|FG000|Overall Study|Adverse Event|4|||
149151065|NCT03325673|538031194|FG001|Overall Study|Adverse Event|0|||
149151066|NCT01485627|538031198|FG000|Overall Study|Patient withdrew|6|||
149151067|NCT01485627|538031199|FG001|Overall Study|Patient withdrew|5|||
149151068|NCT01485627|538031198|FG000|Overall Study|Patient died|3|||
149151069|NCT01485627|538031199|FG001|Overall Study|Patient died|1|||
149151070|NCT01485627|538031198|FG000|Overall Study|Patient lost to followup|0|||
149151071|NCT01485627|538031199|FG001|Overall Study|Patient lost to followup|1|||
148918344|NCT01185353|537184527|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
148918345|NCT01185353|537184528|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
148918346|NCT01185353|537184529|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
149151072|NCT01485627|538031198|FG000|Overall Study|Caregiver withdrew|3|||
149151073|NCT01485627|538031199|FG001|Overall Study|Caregiver withdrew|3|||
149151074|NCT01485627|538031198|FG000|Overall Study|Caregiver lost to follow up|11|||
149151075|NCT01485627|538031199|FG001|Overall Study|Caregiver lost to follow up|12|||
149151076|NCT01485627|538031198|FG000|Overall Study|Caregiver died|1|||
149151077|NCT01485627|538031199|FG001|Overall Study|Caregiver died|0|||
149151078|NCT01485627|538031198|FG000|Overall Study|caregiver was not bereaved|42|||
149151079|NCT01485627|538031199|FG001|Overall Study|caregiver was not bereaved|35|||
149151080|NCT00763815|538031200|FG000|Overall Study|Adverse Event|14|||
149151081|NCT00763815|538031201|FG001|Overall Study|Adverse Event|29|||
149151082|NCT00763815|538031200|FG000|Overall Study|Lack of Efficacy|10|||
148805721|NCT00042289|536767983|FG023|Overall Study|Withdrawal by Subject|1|||
148805722|NCT00042289|536767984|FG024|Overall Study|Withdrawal by Subject|0|||
148805723|NCT00042289|536767985|FG025|Overall Study|Withdrawal by Subject|0|||
148805724|NCT00042289|536767986|FG026|Overall Study|Withdrawal by Subject|1|||
148805725|NCT00042289|536767987|FG027|Overall Study|Withdrawal by Subject|0|||
148805726|NCT00042289|536767988|FG028|Overall Study|Withdrawal by Subject|2|||
148805727|NCT00042289|536767989|FG029|Overall Study|Withdrawal by Subject|0|||
148805728|NCT00042289|536767990|FG030|Overall Study|Withdrawal by Subject|0|||
148805729|NCT00042289|536767991|FG031|Overall Study|Withdrawal by Subject|1|||
148805730|NCT00042289|536767992|FG032|Overall Study|Withdrawal by Subject|2|||
148805731|NCT00042289|536767993|FG033|Overall Study|Withdrawal by Subject|1|||
148805732|NCT00042289|536767994|FG034|Overall Study|Withdrawal by Subject|0|||
148805733|NCT00042289|536767995|FG035|Overall Study|Withdrawal by Subject|0|||
148805734|NCT00042289|536767996|FG036|Overall Study|Withdrawal by Subject|0|||
148805735|NCT00042289|536767997|FG037|Overall Study|Withdrawal by Subject|1|||
148805736|NCT00042289|536767998|FG038|Overall Study|Withdrawal by Subject|0|||
148805737|NCT00042289|536767999|FG039|Overall Study|Withdrawal by Subject|0|||
148805738|NCT00042289|536768000|FG040|Overall Study|Withdrawal by Subject|0|||
148805739|NCT00042289|536768001|FG041|Overall Study|Withdrawal by Subject|0|||
149151083|NCT00763815|538031201|FG001|Overall Study|Lack of Efficacy|11|||
149151084|NCT00763815|538031200|FG000|Overall Study|Poor Compliance to Protocol|6|||
149151085|NCT00763815|538031201|FG001|Overall Study|Poor Compliance to Protocol|6|||
149151086|NCT00763815|538031200|FG000|Overall Study|Lost to Follow-up|2|||
149151087|NCT00763815|538031201|FG001|Overall Study|Lost to Follow-up|4|||
149151088|NCT00763815|538031200|FG000|Overall Study|Early Termination|1|||
149151089|NCT00763815|538031201|FG001|Overall Study|Early Termination|0|||
149151090|NCT00763815|538031200|FG000|Overall Study|Familial and Personal Reasons|9|||
149151091|NCT00763815|538031201|FG001|Overall Study|Familial and Personal Reasons|16|||
149151092|NCT00763815|538031200|FG000|Overall Study|Physician Decision|1|||
149151093|NCT00763815|538031201|FG001|Overall Study|Physician Decision|0|||
149151094|NCT00763815|538031200|FG000|Overall Study|Withdrawal by Subject|7|||
149151095|NCT00763815|538031201|FG001|Overall Study|Withdrawal by Subject|12|||
149151096|NCT00763815|538031200|FG000|Overall Study|Protocol Violation|2|||
149151097|NCT00763815|538031201|FG001|Overall Study|Protocol Violation|5|||
149151098|NCT00763815|538031200|FG000|Overall Study|Sponsor's Decision|0|||
149151099|NCT00763815|538031201|FG001|Overall Study|Sponsor's Decision|1|||
149151100|NCT03245450|538031202|FG000|Overall Study|Radiological disease progression|3|||
149151101|NCT03245450|538031203|FG001|Overall Study|Radiological disease progression|3|||
149151102|NCT03245450|538031204|FG002|Overall Study|Radiological disease progression|2|||
149151103|NCT03245450|538031205|FG003|Overall Study|Radiological disease progression|2|||
149151104|NCT03245450|538031206|FG004|Overall Study|Radiological disease progression|7|||
149151105|NCT03245450|538031207|FG005|Overall Study|Radiological disease progression|6|||
149151106|NCT03245450|538031208|FG006|Overall Study|Radiological disease progression|6|||
149151107|NCT03245450|538031202|FG000|Overall Study|Clinical disease progression|0|||
149151108|NCT03245450|538031203|FG001|Overall Study|Clinical disease progression|0|||
149151109|NCT03245450|538031204|FG002|Overall Study|Clinical disease progression|1|||
149151110|NCT03245450|538031205|FG003|Overall Study|Clinical disease progression|0|||
149151111|NCT03245450|538031206|FG004|Overall Study|Clinical disease progression|0|||
149151112|NCT03245450|538031207|FG005|Overall Study|Clinical disease progression|2|||
149151113|NCT03245450|538031208|FG006|Overall Study|Clinical disease progression|0|||
149151114|NCT03245450|538031202|FG000|Overall Study|Other|0|||
149151115|NCT03245450|538031203|FG001|Overall Study|Other|0|||
149151116|NCT03245450|538031204|FG002|Overall Study|Other|0|||
149151117|NCT03245450|538031205|FG003|Overall Study|Other|1|||
149151118|NCT03245450|538031206|FG004|Overall Study|Other|1|||
149151119|NCT03245450|538031207|FG005|Overall Study|Other|1|||
149151120|NCT03245450|538031208|FG006|Overall Study|Other|1|||
149151121|NCT03245450|538031202|FG000|Overall Study|Withdrawal by Subject|0|||
149151122|NCT03245450|538031203|FG001|Overall Study|Withdrawal by Subject|1|||
149151123|NCT03245450|538031204|FG002|Overall Study|Withdrawal by Subject|0|||
149151124|NCT03245450|538031205|FG003|Overall Study|Withdrawal by Subject|0|||
149151125|NCT03245450|538031206|FG004|Overall Study|Withdrawal by Subject|0|||
149151126|NCT03245450|538031207|FG005|Overall Study|Withdrawal by Subject|0|||
149151127|NCT03245450|538031208|FG006|Overall Study|Withdrawal by Subject|0|||
149151128|NCT03245450|538031202|FG000|Overall Study|Adverse Event|0|||
149151129|NCT03245450|538031203|FG001|Overall Study|Adverse Event|0|||
149151130|NCT03245450|538031204|FG002|Overall Study|Adverse Event|0|||
149151131|NCT03245450|538031205|FG003|Overall Study|Adverse Event|0|||
149151132|NCT03245450|538031206|FG004|Overall Study|Adverse Event|1|||
149151133|NCT03245450|538031207|FG005|Overall Study|Adverse Event|0|||
149151134|NCT03245450|538031208|FG006|Overall Study|Adverse Event|2|||
149151135|NCT00267748|538031209|FG000|Non-randomized Period|Progressive disease|10|||
149151136|NCT00267748|538031210|FG001|Non-randomized Period|Progressive disease|0|||
149151137|NCT00267748|538031211|FG002|Non-randomized Period|Progressive disease|0|||
149151138|NCT00267748|538031209|FG000|Non-randomized Period|Adverse Event|8|||
149151139|NCT00267748|538031210|FG001|Non-randomized Period|Adverse Event|0|||
149151140|NCT00267748|538031211|FG002|Non-randomized Period|Adverse Event|0|||
149151141|NCT00267748|538031209|FG000|Non-randomized Period|Death|1|||
148918347|NCT01185353|537184530|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
148918348|NCT01185353|537184531|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
148918349|NCT01185353|537184532|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
148918350|NCT01185353|537184533|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
148918351|NCT01185353|537184534|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
149151142|NCT00267748|538031210|FG001|Non-randomized Period|Death|0|||
149151143|NCT00267748|538031211|FG002|Non-randomized Period|Death|0|||
149151144|NCT00267748|538031209|FG000|Non-randomized Period|Participant not willing to participate|1|||
148918352|NCT01185353|537184535|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
148918353|NCT01185353|537184536|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
149151145|NCT00267748|538031210|FG001|Non-randomized Period|Participant not willing to participate|0|||
149151146|NCT00267748|538031211|FG002|Non-randomized Period|Participant not willing to participate|0|||
149151147|NCT00267748|538031209|FG000|Non-randomized Period|Other|3|||
149151148|NCT00267748|538031210|FG001|Non-randomized Period|Other|0|||
149151149|NCT00267748|538031211|FG002|Non-randomized Period|Other|0|||
149151150|NCT00267748|538031209|FG000|Randomized Period|Death|0|||
149151151|NCT00267748|538031210|FG001|Randomized Period|Death|2|||
149151152|NCT00267748|538031211|FG002|Randomized Period|Death|3|||
149151153|NCT00267748|538031209|FG000|Randomized Period|Adverse Event|0|||
149151154|NCT00267748|538031210|FG001|Randomized Period|Adverse Event|23|||
149151155|NCT00267748|538031211|FG002|Randomized Period|Adverse Event|25|||
149151156|NCT00267748|538031209|FG000|Randomized Period|Global deterioration of health status|0|||
149151157|NCT00267748|538031210|FG001|Randomized Period|Global deterioration of health status|6|||
149151158|NCT00267748|538031211|FG002|Randomized Period|Global deterioration of health status|7|||
149151159|NCT00267748|538031209|FG000|Randomized Period|Lost to Follow-up|0|||
149151160|NCT00267748|538031210|FG001|Randomized Period|Lost to Follow-up|1|||
149151161|NCT00267748|538031211|FG002|Randomized Period|Lost to Follow-up|0|||
149151162|NCT00267748|538031209|FG000|Randomized Period|Objective progression or relapse|0|||
149151163|NCT00267748|538031210|FG001|Randomized Period|Objective progression or relapse|77|||
149151164|NCT00267748|538031211|FG002|Randomized Period|Objective progression or relapse|86|||
149151165|NCT00267748|538031209|FG000|Randomized Period|Withdrawal by Subject|0|||
149151166|NCT00267748|538031210|FG001|Randomized Period|Withdrawal by Subject|9|||
149151167|NCT00267748|538031211|FG002|Randomized Period|Withdrawal by Subject|2|||
149151168|NCT00267748|538031209|FG000|Randomized Period|Other|0|||
149151169|NCT00267748|538031210|FG001|Randomized Period|Other|9|||
149151170|NCT00267748|538031211|FG002|Randomized Period|Other|6|||
149151171|NCT00267748|538031209|FG000|Randomized Period|randomized but not treated|0|||
149151172|NCT00267748|538031210|FG001|Randomized Period|randomized but not treated|0|||
149151173|NCT00267748|538031211|FG002|Randomized Period|randomized but not treated|3|||
149151174|NCT01784861|538031212|FG000|Overall Study|Adverse Event|0|||
149151175|NCT01784861|538031213|FG001|Overall Study|Adverse Event|0|||
149151176|NCT01784861|538031214|FG002|Overall Study|Adverse Event|1|||
149151177|NCT01784861|538031215|FG003|Overall Study|Adverse Event|2|||
149151178|NCT01784861|538031216|FG004|Overall Study|Adverse Event|1|||
149151179|NCT01784861|538031217|FG005|Overall Study|Adverse Event|0|||
149151180|NCT01784861|538031212|FG000|Overall Study|Withdrawal by Subject|0|||
149151181|NCT01784861|538031213|FG001|Overall Study|Withdrawal by Subject|0|||
149151182|NCT01784861|538031214|FG002|Overall Study|Withdrawal by Subject|0|||
149151183|NCT01784861|538031215|FG003|Overall Study|Withdrawal by Subject|1|||
149151184|NCT01784861|538031216|FG004|Overall Study|Withdrawal by Subject|0|||
149151185|NCT01784861|538031217|FG005|Overall Study|Withdrawal by Subject|0|||
149151186|NCT01784861|538031212|FG000|Overall Study|Physician Decision|0|||
149151187|NCT01784861|538031213|FG001|Overall Study|Physician Decision|0|||
149151188|NCT01784861|538031214|FG002|Overall Study|Physician Decision|0|||
149151189|NCT01784861|538031215|FG003|Overall Study|Physician Decision|2|||
149151190|NCT01784861|538031216|FG004|Overall Study|Physician Decision|0|||
149151191|NCT01784861|538031217|FG005|Overall Study|Physician Decision|1|||
149151192|NCT03948178|538031218|FG000|Overall Study|Protocol Violation|1|||
149151193|NCT03948178|538031218|FG000|Overall Study|Lost to Follow-up|2|||
149151194|NCT03948178|538031218|FG000|Overall Study|Withdrawal by Subject|2|||
149151195|NCT03948178|538031218|FG000|Overall Study|Reason not known|2|||
149151196|NCT03948178|538031218|FG000|Overall Study|Personal reason|14|||
149151197|NCT03948178|538031218|FG000|Overall Study|Disease progression|30|||
149151198|NCT03948178|538031218|FG000|Overall Study|Adverse Event|12|||
149151199|NCT03948178|538031218|FG000|Overall Study|Sponsor terminated study|164|||
149151200|NCT00401752|538031219|FG000|Overall Study|Adverse Event|2|||
149151201|NCT00401752|538031220|FG001|Overall Study|Adverse Event|5|||
149151202|NCT00401752|538031219|FG000|Overall Study|Withdrawal by Subject|2|||
149151203|NCT00401752|538031220|FG001|Overall Study|Withdrawal by Subject|6|||
149151204|NCT00401752|538031219|FG000|Overall Study|Lost to Follow-up|1|||
149151205|NCT00401752|538031220|FG001|Overall Study|Lost to Follow-up|4|||
149151206|NCT00401752|538031219|FG000|Overall Study|Development of any exclusion criteria|4|||
149151207|NCT00401752|538031220|FG001|Overall Study|Development of any exclusion criteria|2|||
149151208|NCT00401752|538031219|FG000|Overall Study|Physician Decision|1|||
149151209|NCT00401752|538031220|FG001|Overall Study|Physician Decision|1|||
149151210|NCT02898259|538031223|FG000|Overall Study|Adverse Event|0|||
149151211|NCT02898259|538031224|FG001|Overall Study|Adverse Event|0|||
149151212|NCT02898259|538031225|FG002|Overall Study|Adverse Event|1|||
149151213|NCT02898259|538031226|FG003|Overall Study|Adverse Event|0|||
149151214|NCT02898259|538031227|FG004|Overall Study|Adverse Event|0|||
149151215|NCT02898259|538031223|FG000|Overall Study|Lack of Efficacy|1|||
148918354|NCT01185353|537184527|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918355|NCT01185353|537184528|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
149151216|NCT02898259|538031224|FG001|Overall Study|Lack of Efficacy|1|||
149151217|NCT02898259|538031225|FG002|Overall Study|Lack of Efficacy|3|||
149151218|NCT02898259|538031226|FG003|Overall Study|Lack of Efficacy|0|||
149151219|NCT02898259|538031227|FG004|Overall Study|Lack of Efficacy|0|||
149151220|NCT02898259|538031223|FG000|Overall Study|Lost to Follow-up|0|||
149151221|NCT02898259|538031224|FG001|Overall Study|Lost to Follow-up|0|||
149151222|NCT02898259|538031225|FG002|Overall Study|Lost to Follow-up|1|||
149151223|NCT02898259|538031226|FG003|Overall Study|Lost to Follow-up|0|||
149151224|NCT02898259|538031227|FG004|Overall Study|Lost to Follow-up|0|||
149151225|NCT02898259|538031223|FG000|Overall Study|Transformation before study began|0|||
148805740|NCT00042289|536768002|FG042|Overall Study|Withdrawal by Subject|1|||
148805741|NCT00042289|536768003|FG043|Overall Study|Withdrawal by Subject|0|||
148918356|NCT01185353|537184529|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918357|NCT01185353|537184530|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918358|NCT01185353|537184531|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918359|NCT01185353|537184532|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918360|NCT01185353|537184533|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918361|NCT01185353|537184534|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
148918362|NCT01185353|537184535|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
148918363|NCT01185353|537184536|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
148918364|NCT01185353|537184527|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918365|NCT01185353|537184528|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918366|NCT01185353|537184529|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918367|NCT01185353|537184530|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918368|NCT01185353|537184531|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918369|NCT01185353|537184532|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918370|NCT01185353|537184533|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
148918371|NCT01185353|537184534|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
148918372|NCT01185353|537184535|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
148918373|NCT01185353|537184536|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
148918374|NCT01185353|537184527|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918375|NCT01185353|537184528|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918376|NCT01185353|537184529|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918377|NCT01185353|537184530|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918378|NCT01185353|537184531|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918379|NCT01185353|537184532|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918380|NCT01185353|537184533|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918381|NCT01185353|537184534|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
148918382|NCT01185353|537184535|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
148918383|NCT01185353|537184536|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
148918384|NCT01699867|537184537|FG000|Overall Study|Screening Failure|3|||
148918385|NCT00530504|537184552|FG000|Overall Study|Death|54|||
148918386|NCT00530504|537184552|FG000|Overall Study|Lost to Follow-up|26|||
148918387|NCT00530504|537184552|FG000|Overall Study|Withdrawal by Subject|39|||
148918388|NCT00530504|537184552|FG000|Overall Study|Exited study due to other reasons|33|||
148918389|NCT00006289|537184553|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
148918390|NCT00006289|537184554|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
148918391|NCT00006289|537184553|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
148918392|NCT00006289|537184554|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
148918393|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
148918394|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
148918395|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
148918396|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
148918397|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
148918398|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
148918399|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
148918400|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
148918401|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
148918402|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
148918403|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918404|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
148918405|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918406|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918407|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918408|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918409|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918410|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
148918411|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
148918412|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
148805742|NCT00042289|536768004|FG044|Overall Study|Withdrawal by Subject|0|||
148918413|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
149151226|NCT02898259|538031224|FG001|Overall Study|Transformation before study began|0|||
149151227|NCT02898259|538031225|FG002|Overall Study|Transformation before study began|0|||
149151228|NCT02898259|538031226|FG003|Overall Study|Transformation before study began|1|||
149151229|NCT02898259|538031227|FG004|Overall Study|Transformation before study began|0|||
149151230|NCT01046877|538031231|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
149151231|NCT01046877|538031231|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
149151232|NCT03681119|538031232|FG000|Overall Study|No specific reason|4|||
149151233|NCT03681119|538031233|FG001|Overall Study|No specific reason|0|||
149151234|NCT03681119|538031232|FG000|Overall Study|Sickness|2|||
149151235|NCT03681119|538031233|FG001|Overall Study|Sickness|0|||
149151236|NCT01087905|538031235|FG000|Overall Study|Lost to Follow-up|24|||
149151237|NCT01087905|538031236|FG001|Overall Study|Lost to Follow-up|28|||
149151238|NCT01087905|538031237|FG002|Overall Study|Lost to Follow-up|18|||
149151239|NCT01087905|538031238|FG003|Overall Study|Lost to Follow-up|31|||
149151240|NCT01087905|538031239|FG004|Overall Study|Lost to Follow-up|27|||
149151241|NCT01087905|538031240|FG005|Overall Study|Lost to Follow-up|25|||
149151242|NCT01087905|538031241|FG006|Overall Study|Lost to Follow-up|20|||
149151243|NCT01087905|538031242|FG007|Overall Study|Lost to Follow-up|24|||
149151244|NCT01087905|538031235|FG000|Overall Study|Withdrawal by Subject|5|||
149151245|NCT01087905|538031236|FG001|Overall Study|Withdrawal by Subject|4|||
149151246|NCT01087905|538031237|FG002|Overall Study|Withdrawal by Subject|4|||
149151247|NCT01087905|538031238|FG003|Overall Study|Withdrawal by Subject|5|||
149151248|NCT01087905|538031239|FG004|Overall Study|Withdrawal by Subject|4|||
149151249|NCT01087905|538031240|FG005|Overall Study|Withdrawal by Subject|3|||
149151250|NCT01087905|538031241|FG006|Overall Study|Withdrawal by Subject|3|||
149151251|NCT01087905|538031242|FG007|Overall Study|Withdrawal by Subject|5|||
149151252|NCT00517829|538031249|FG000|Overall Study|Adverse Event|22|||
149151253|NCT00517829|538031250|FG001|Overall Study|Adverse Event|34|||
149151254|NCT00517829|538031249|FG000|Overall Study|Disease Progression|39|||
149151255|NCT00517829|538031250|FG001|Overall Study|Disease Progression|32|||
149151256|NCT00517829|538031249|FG000|Overall Study|Patient Request|6|||
149151257|NCT00517829|538031250|FG001|Overall Study|Patient Request|5|||
149151258|NCT00517829|538031249|FG000|Overall Study|Investigator Request|5|||
149151259|NCT00517829|538031250|FG001|Overall Study|Investigator Request|3|||
149151260|NCT00517829|538031249|FG000|Overall Study|Other|3|||
149151261|NCT00517829|538031250|FG001|Overall Study|Other|1|||
149151262|NCT01618214|538031257|FG000|Overall Study|Adverse Event|3|||
149151263|NCT01618214|538031258|FG001|Overall Study|Adverse Event|1|||
149151264|NCT01618214|538031257|FG000|Overall Study|Lack of Efficacy|1|||
149151265|NCT01618214|538031258|FG001|Overall Study|Lack of Efficacy|1|||
149151266|NCT01618214|538031257|FG000|Overall Study|Protocol Violation|1|||
149151267|NCT01618214|538031258|FG001|Overall Study|Protocol Violation|4|||
149151268|NCT01618214|538031257|FG000|Overall Study|Withdrawal Criteria|1|||
149151269|NCT01618214|538031258|FG001|Overall Study|Withdrawal Criteria|2|||
149151270|NCT01618214|538031257|FG000|Overall Study|Unclassified|4|||
149151271|NCT01618214|538031258|FG001|Overall Study|Unclassified|5|||
149151272|NCT00835237|538031259|FG000|Overall Study|Lost to Follow-up|4|||
149151273|NCT00835237|538031260|FG001|Overall Study|Lost to Follow-up|0|||
149151274|NCT00835237|538031259|FG000|Overall Study|Withdrawal by Subject|2|||
149151275|NCT00835237|538031260|FG001|Overall Study|Withdrawal by Subject|0|||
149151276|NCT01265550|538031263|FG000|Pre Randomization|Withdrawal by Subject|0|||
149151277|NCT01265550|538031264|FG001|Pre Randomization|Withdrawal by Subject|0|||
149151278|NCT01265550|538031265|FG002|Pre Randomization|Withdrawal by Subject|0|||
149151279|NCT01265550|538031266|FG003|Pre Randomization|Withdrawal by Subject|70|||
149151280|NCT01265550|538031263|FG000|Pre Randomization|Technical Exclusions|0|||
149151281|NCT01265550|538031264|FG001|Pre Randomization|Technical Exclusions|0|||
148672495|NCT04636437|536270816|FG001|Overall Study|Participant or physician decision|1|||
148672496|NCT04636437|536270817|FG002|Overall Study|Participant or physician decision|1|||
148672497|NCT00816166|536270818|FG000|Overall Study|Lost to Follow-up|6|||
148672498|NCT00816166|536270819|FG001|Overall Study|Lost to Follow-up|10|||
148805743|NCT00042289|536768005|FG045|Overall Study|Withdrawal by Subject|0|||
148805744|NCT00042289|536768006|FG046|Overall Study|Withdrawal by Subject|0|||
148918414|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
148918415|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
149151282|NCT01265550|538031265|FG002|Pre Randomization|Technical Exclusions|0|||
149151283|NCT01265550|538031266|FG003|Pre Randomization|Technical Exclusions|54|||
149151284|NCT01265550|538031263|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
149151285|NCT01265550|538031264|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
149151286|NCT01265550|538031265|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
149151287|NCT01265550|538031266|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
148672499|NCT00816166|536270818|FG000|Overall Study|Death|4|||
148672500|NCT00816166|536270819|FG001|Overall Study|Death|2|||
148918416|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
149151288|NCT01265550|538031263|FG000|Pre Randomization|Non-GERD organic disorders|0|||
149151289|NCT01265550|538031264|FG001|Pre Randomization|Non-GERD organic disorders|0|||
149151290|NCT01265550|538031265|FG002|Pre Randomization|Non-GERD organic disorders|0|||
149151291|NCT01265550|538031266|FG003|Pre Randomization|Non-GERD organic disorders|23|||
149151292|NCT01265550|538031263|FG000|Pre Randomization|Functional heartburn|0|||
149151293|NCT01265550|538031264|FG001|Pre Randomization|Functional heartburn|0|||
149151294|NCT01265550|538031265|FG002|Pre Randomization|Functional heartburn|0|||
149151295|NCT01265550|538031266|FG003|Pre Randomization|Functional heartburn|99|||
149151296|NCT01119248|538031270|FG000|Overall Study|Physician Decision|5|||
149151297|NCT01100437|538031271|FG000|Titration/Stabilization|Adverse Event|0|||
149151298|NCT01100437|538031272|FG001|Titration/Stabilization|Adverse Event|0|||
149151299|NCT01100437|538031273|FG002|Titration/Stabilization|Adverse Event|4|||
149151300|NCT01100437|538031271|FG000|Titration/Stabilization|Non-compliance|0|||
149151301|NCT01100437|538031272|FG001|Titration/Stabilization|Non-compliance|0|||
149151302|NCT01100437|538031273|FG002|Titration/Stabilization|Non-compliance|1|||
149151303|NCT01100437|538031271|FG000|Titration/Stabilization|Sponsor canceled study|0|||
149151304|NCT01100437|538031272|FG001|Titration/Stabilization|Sponsor canceled study|0|||
149151305|NCT01100437|538031273|FG002|Titration/Stabilization|Sponsor canceled study|1|||
149151306|NCT01100437|538031271|FG000|Maintenance|Withdrawal by Subject|0|||
149151307|NCT01100437|538031272|FG001|Maintenance|Withdrawal by Subject|0|||
149151308|NCT01100437|538031273|FG002|Maintenance|Withdrawal by Subject|1|||
149151309|NCT01100437|538031271|FG000|Maintenance|Sponsor termination of study|0|||
149151310|NCT01100437|538031272|FG001|Maintenance|Sponsor termination of study|0|||
149151311|NCT01100437|538031273|FG002|Maintenance|Sponsor termination of study|1|||
149151312|NCT00805480|538031280|FG000|Overall Study|Withdrawal by Subject|13|||
149151313|NCT00805480|538031281|FG001|Overall Study|Withdrawal by Subject|5|||
149151314|NCT00805480|538031282|FG002|Overall Study|Withdrawal by Subject|11|||
149151315|NCT00805480|538031283|FG003|Overall Study|Withdrawal by Subject|5|||
149151316|NCT00805480|538031280|FG000|Overall Study|Lost to Follow-up|1|||
149151317|NCT00805480|538031281|FG001|Overall Study|Lost to Follow-up|2|||
149151318|NCT00805480|538031282|FG002|Overall Study|Lost to Follow-up|0|||
149151319|NCT00805480|538031283|FG003|Overall Study|Lost to Follow-up|0|||
149151320|NCT00805480|538031280|FG000|Overall Study|Adverse Event|0|||
149151321|NCT00805480|538031281|FG001|Overall Study|Adverse Event|0|||
149151322|NCT00805480|538031282|FG002|Overall Study|Adverse Event|1|||
149151323|NCT00805480|538031283|FG003|Overall Study|Adverse Event|0|||
149151324|NCT05032157|538032920|FG000|Overall Study|Adverse Event|12|||
149151325|NCT05032157|538032921|FG001|Overall Study|Adverse Event|7|||
149151326|NCT05032157|538032920|FG000|Overall Study|Pregnancy|0|||
149151327|NCT05032157|538032921|FG001|Overall Study|Pregnancy|2|||
149151328|NCT05032157|538032920|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149151329|NCT05032157|538032921|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
149151330|NCT05032157|538032920|FG000|Overall Study|Protocol Deviation|8|||
149151331|NCT05032157|538032921|FG001|Overall Study|Protocol Deviation|4|||
149151332|NCT05032157|538032920|FG000|Overall Study|Lost to Follow-up|1|||
149151333|NCT05032157|538032921|FG001|Overall Study|Lost to Follow-up|3|||
149151334|NCT05032157|538032920|FG000|Overall Study|Physician Decision|7|||
149151335|NCT05032157|538032921|FG001|Overall Study|Physician Decision|2|||
149151336|NCT05032157|538032920|FG000|Overall Study|Patient Decision|38|||
149151337|NCT05032157|538032921|FG001|Overall Study|Patient Decision|19|||
149151338|NCT02404103|538032927|FG000|Overall Study|Adverse Event|1|||
149151339|NCT02404103|538032928|FG001|Overall Study|Adverse Event|0|||
149151340|NCT02404103|538032927|FG000|Overall Study|Lost to Follow-up|3|||
149151341|NCT02404103|538032928|FG001|Overall Study|Lost to Follow-up|3|||
149151342|NCT01995071|538032929|FG000|Overall Study|Adverse Event|0|||
149151343|NCT01995071|538032930|FG001|Overall Study|Adverse Event|0|||
149151344|NCT01995071|538032931|FG002|Overall Study|Adverse Event|0|||
149151345|NCT01995071|538032932|FG003|Overall Study|Adverse Event|0|||
149151346|NCT01995071|538032933|FG004|Overall Study|Adverse Event|0|||
149151347|NCT01995071|538032934|FG005|Overall Study|Adverse Event|0|||
149151348|NCT01995071|538032935|FG006|Overall Study|Adverse Event|1|||
149151349|NCT01995071|538032936|FG007|Overall Study|Adverse Event|0|||
149151350|NCT01995071|538032937|FG008|Overall Study|Adverse Event|0|||
149151351|NCT01995071|538032938|FG009|Overall Study|Adverse Event|0|||
149151352|NCT01995071|538032939|FG010|Overall Study|Adverse Event|0|||
149151353|NCT01995071|538032940|FG011|Overall Study|Adverse Event|0|||
149151354|NCT01995071|538032929|FG000|Overall Study|Moved|0|||
149151355|NCT01995071|538032930|FG001|Overall Study|Moved|0|||
149151356|NCT01995071|538032931|FG002|Overall Study|Moved|1|||
149151357|NCT01995071|538032932|FG003|Overall Study|Moved|0|||
149151358|NCT01995071|538032933|FG004|Overall Study|Moved|1|||
149151359|NCT01995071|538032934|FG005|Overall Study|Moved|0|||
149151360|NCT01995071|538032935|FG006|Overall Study|Moved|0|||
149151361|NCT01995071|538032936|FG007|Overall Study|Moved|0|||
149151362|NCT01995071|538032937|FG008|Overall Study|Moved|0|||
149151363|NCT01995071|538032938|FG009|Overall Study|Moved|0|||
149151364|NCT01995071|538032939|FG010|Overall Study|Moved|1|||
149151365|NCT01995071|538032940|FG011|Overall Study|Moved|0|||
149151366|NCT01995071|538032929|FG000|Overall Study|Lost to Follow-up|1|||
149151367|NCT01995071|538032930|FG001|Overall Study|Lost to Follow-up|0|||
149151368|NCT01995071|538032931|FG002|Overall Study|Lost to Follow-up|0|||
149151369|NCT01995071|538032932|FG003|Overall Study|Lost to Follow-up|0|||
149151370|NCT01995071|538032933|FG004|Overall Study|Lost to Follow-up|0|||
149151371|NCT01995071|538032934|FG005|Overall Study|Lost to Follow-up|0|||
149151372|NCT01995071|538032935|FG006|Overall Study|Lost to Follow-up|0|||
149151373|NCT01995071|538032936|FG007|Overall Study|Lost to Follow-up|1|||
149151374|NCT01995071|538032937|FG008|Overall Study|Lost to Follow-up|1|||
149151375|NCT01995071|538032938|FG009|Overall Study|Lost to Follow-up|0|||
149151376|NCT01995071|538032939|FG010|Overall Study|Lost to Follow-up|0|||
148918417|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
148918418|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
148918419|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
148918420|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|Other|0|||
148918421|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|Other|0|||
148918422|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|Other|1|||
148918423|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|Other|1|||
148918424|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|Other|0|||
148918425|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|Other|0|||
148918426|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|Other|0|||
148918427|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|Other|1|||
149151377|NCT01995071|538032940|FG011|Overall Study|Lost to Follow-up|0|||
149151378|NCT01995071|538032929|FG000|Overall Study|Incarcerated|0|||
149151379|NCT01995071|538032930|FG001|Overall Study|Incarcerated|0|||
149151380|NCT01995071|538032931|FG002|Overall Study|Incarcerated|0|||
149151381|NCT01995071|538032932|FG003|Overall Study|Incarcerated|0|||
149151382|NCT01995071|538032933|FG004|Overall Study|Incarcerated|0|||
149151383|NCT01995071|538032934|FG005|Overall Study|Incarcerated|0|||
149151384|NCT01995071|538032935|FG006|Overall Study|Incarcerated|0|||
149151385|NCT01995071|538032936|FG007|Overall Study|Incarcerated|1|||
148918428|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|Other|0|||
149151386|NCT01995071|538032937|FG008|Overall Study|Incarcerated|0|||
149151387|NCT01995071|538032938|FG009|Overall Study|Incarcerated|0|||
149151388|NCT01995071|538032939|FG010|Overall Study|Incarcerated|0|||
149151389|NCT01995071|538032940|FG011|Overall Study|Incarcerated|0|||
149151390|NCT02543528|538032941|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
149151391|NCT02543528|538032942|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
149151392|NCT02543528|538032943|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
149151393|NCT02543528|538032944|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
149151394|NCT02543528|538032945|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
149151395|NCT02543528|538032941|FG000|Adaptation Period|Lens Handling Difficultes|0|||
149151396|NCT02543528|538032942|FG001|Adaptation Period|Lens Handling Difficultes|0|||
149151397|NCT02543528|538032943|FG002|Adaptation Period|Lens Handling Difficultes|0|||
149151398|NCT02543528|538032944|FG003|Adaptation Period|Lens Handling Difficultes|0|||
149151399|NCT02543528|538032945|FG004|Adaptation Period|Lens Handling Difficultes|8|||
149151400|NCT02543528|538032941|FG000|Adaptation Period|Lost to Follow-up|0|||
149151401|NCT02543528|538032942|FG001|Adaptation Period|Lost to Follow-up|0|||
149151402|NCT02543528|538032943|FG002|Adaptation Period|Lost to Follow-up|0|||
149151403|NCT02543528|538032944|FG003|Adaptation Period|Lost to Follow-up|0|||
149151404|NCT02543528|538032945|FG004|Adaptation Period|Lost to Follow-up|14|||
149151405|NCT02543528|538032941|FG000|Adaptation Period|Adverse Event|0|||
149151406|NCT02543528|538032942|FG001|Adaptation Period|Adverse Event|0|||
149151407|NCT02543528|538032943|FG002|Adaptation Period|Adverse Event|0|||
149151408|NCT02543528|538032944|FG003|Adaptation Period|Adverse Event|0|||
149151409|NCT02543528|538032945|FG004|Adaptation Period|Adverse Event|2|||
149151410|NCT02543528|538032941|FG000|Extended Wear Period|Adverse Event|17|||
149151411|NCT02543528|538032942|FG001|Extended Wear Period|Adverse Event|11|||
149151412|NCT02543528|538032943|FG002|Extended Wear Period|Adverse Event|16|||
149151413|NCT02543528|538032944|FG003|Extended Wear Period|Adverse Event|3|||
149151414|NCT02543528|538032945|FG004|Extended Wear Period|Adverse Event|0|||
149151415|NCT02543528|538032941|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
149151416|NCT02543528|538032942|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
149151417|NCT02543528|538032943|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
149151418|NCT02543528|538032944|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
149151419|NCT02543528|538032945|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
149151420|NCT02543528|538032941|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
149151421|NCT02543528|538032942|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
149151422|NCT02543528|538032943|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
149151423|NCT02543528|538032944|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
149151424|NCT02543528|538032945|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
149151425|NCT02543528|538032941|FG000|Extended Wear Period|Lost to Follow-up|0|||
149151426|NCT02543528|538032942|FG001|Extended Wear Period|Lost to Follow-up|1|||
149151427|NCT02543528|538032943|FG002|Extended Wear Period|Lost to Follow-up|2|||
149151428|NCT02543528|538032944|FG003|Extended Wear Period|Lost to Follow-up|1|||
149151429|NCT02543528|538032945|FG004|Extended Wear Period|Lost to Follow-up|0|||
149151430|NCT02543528|538032941|FG000|Extended Wear Period|Withdrawal by Subject|10|||
149151431|NCT02543528|538032942|FG001|Extended Wear Period|Withdrawal by Subject|9|||
149151432|NCT02543528|538032943|FG002|Extended Wear Period|Withdrawal by Subject|4|||
149151433|NCT02543528|538032944|FG003|Extended Wear Period|Withdrawal by Subject|5|||
149151434|NCT02543528|538032945|FG004|Extended Wear Period|Withdrawal by Subject|0|||
149151435|NCT02669017|538032948|FG000|Overall Study|Death|1|||
149151436|NCT02669017|538032949|FG001|Overall Study|Death|2|||
149151437|NCT02669017|538032950|FG002|Overall Study|Death|2|||
149151438|NCT02669017|538032951|FG003|Overall Study|Death|3|||
149151439|NCT02669017|538032952|FG004|Overall Study|Death|8|||
149151440|NCT02669017|538032953|FG005|Overall Study|Death|18|||
149151441|NCT02669017|538032954|FG006|Overall Study|Death|10|||
149151442|NCT02669017|538032955|FG007|Overall Study|Death|47|||
149151443|NCT02669017|538032956|FG008|Overall Study|Death|20|||
149151444|NCT02669017|538032948|FG000|Overall Study|Withdrawal by Subject|0|||
149151445|NCT02669017|538032949|FG001|Overall Study|Withdrawal by Subject|0|||
149151446|NCT02669017|538032950|FG002|Overall Study|Withdrawal by Subject|0|||
149151447|NCT02669017|538032951|FG003|Overall Study|Withdrawal by Subject|1|||
149151448|NCT02669017|538032952|FG004|Overall Study|Withdrawal by Subject|2|||
148918429|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|Death|0|||
148918430|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|Death|0|||
148918431|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|Death|0|||
148918432|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|Death|0|||
149151449|NCT02669017|538032953|FG005|Overall Study|Withdrawal by Subject|0|||
149151450|NCT02669017|538032954|FG006|Overall Study|Withdrawal by Subject|0|||
149151451|NCT02669017|538032955|FG007|Overall Study|Withdrawal by Subject|2|||
149151452|NCT02669017|538032956|FG008|Overall Study|Withdrawal by Subject|2|||
149151453|NCT02669017|538032948|FG000|Overall Study|Lost to Follow-up|0|||
149151454|NCT02669017|538032949|FG001|Overall Study|Lost to Follow-up|0|||
149151455|NCT02669017|538032950|FG002|Overall Study|Lost to Follow-up|0|||
149151456|NCT02669017|538032951|FG003|Overall Study|Lost to Follow-up|0|||
149151457|NCT02669017|538032952|FG004|Overall Study|Lost to Follow-up|0|||
149151458|NCT02669017|538032953|FG005|Overall Study|Lost to Follow-up|0|||
148672501|NCT01071278|536270820|FG000|Overall Study|Premature Discontinuation|254|||
148918433|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|Death|0|||
148918434|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|Death|1|||
149151459|NCT02669017|538032954|FG006|Overall Study|Lost to Follow-up|0|||
149151460|NCT02669017|538032955|FG007|Overall Study|Lost to Follow-up|0|||
149151461|NCT02669017|538032956|FG008|Overall Study|Lost to Follow-up|1|||
149151462|NCT02669017|538032948|FG000|Overall Study|Miscellaneous|0|||
149151463|NCT02669017|538032949|FG001|Overall Study|Miscellaneous|0|||
149151464|NCT02669017|538032950|FG002|Overall Study|Miscellaneous|0|||
149151465|NCT02669017|538032951|FG003|Overall Study|Miscellaneous|0|||
149151466|NCT02669017|538032952|FG004|Overall Study|Miscellaneous|2|||
149151467|NCT02669017|538032953|FG005|Overall Study|Miscellaneous|1|||
149151468|NCT02669017|538032954|FG006|Overall Study|Miscellaneous|1|||
149151469|NCT02669017|538032955|FG007|Overall Study|Miscellaneous|13|||
149151470|NCT02669017|538032956|FG008|Overall Study|Miscellaneous|2|||
149151471|NCT03509350|538032958|FG000|Overall Study|Withdrawal by Subject|0|||
149151472|NCT03509350|538032959|FG001|Overall Study|Withdrawal by Subject|2|||
149151473|NCT04951037|538032960|FG000|Overall Study|Lost to Follow-up|16|||
149151474|NCT04951037|538032960|FG000|Overall Study|Withdrawal by Subject|5|||
149151475|NCT04951037|538032960|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
149151476|NCT05630937|538032963|FG000|Overall Study|Study terminated by sponsor|1|||
149151477|NCT05630937|538032964|FG001|Overall Study|Study terminated by sponsor|1|||
149151478|NCT05630937|538032965|FG002|Overall Study|Study terminated by sponsor|8|||
149151479|NCT05630937|538032966|FG003|Overall Study|Study terminated by sponsor|0|||
149151480|NCT05630937|538032963|FG000|Overall Study|Lost to Follow-up|0|||
149151481|NCT05630937|538032964|FG001|Overall Study|Lost to Follow-up|0|||
149151482|NCT05630937|538032965|FG002|Overall Study|Lost to Follow-up|1|||
149151483|NCT05630937|538032966|FG003|Overall Study|Lost to Follow-up|0|||
149151484|NCT05630937|538032963|FG000|Overall Study|Enrolled but not treated|0|||
149151485|NCT05630937|538032964|FG001|Overall Study|Enrolled but not treated|0|||
149151486|NCT05630937|538032965|FG002|Overall Study|Enrolled but not treated|0|||
149151487|NCT05630937|538032966|FG003|Overall Study|Enrolled but not treated|1|||
149151488|NCT02429414|538032969|FG000|Overall Study|Physician Decision|0|||
149151489|NCT02429414|538032970|FG001|Overall Study|Physician Decision|1|||
149151490|NCT00464334|538032979|FG000|Overall Study|Adverse Event|0|||
149151491|NCT00464334|538032980|FG001|Overall Study|Adverse Event|0|||
149151492|NCT00464334|538032981|FG002|Overall Study|Adverse Event|0|||
149151493|NCT00464334|538032982|FG003|Overall Study|Adverse Event|1|||
149151494|NCT00464334|538032983|FG004|Overall Study|Adverse Event|1|||
149151495|NCT00464334|538032984|FG005|Overall Study|Adverse Event|1|||
149151496|NCT00464334|538032985|FG006|Overall Study|Adverse Event|0|||
149151497|NCT00464334|538032986|FG007|Overall Study|Adverse Event|0|||
149151498|NCT00464334|538032987|FG008|Overall Study|Adverse Event|2|||
149151499|NCT00464334|538032988|FG009|Overall Study|Adverse Event|1|||
149151500|NCT00464334|538032989|FG010|Overall Study|Adverse Event|2|||
149151501|NCT00464334|538032979|FG000|Overall Study|Lack of Efficacy|0|||
149151502|NCT00464334|538032980|FG001|Overall Study|Lack of Efficacy|1|||
149151503|NCT00464334|538032981|FG002|Overall Study|Lack of Efficacy|0|||
149151504|NCT00464334|538032982|FG003|Overall Study|Lack of Efficacy|0|||
149151505|NCT00464334|538032983|FG004|Overall Study|Lack of Efficacy|0|||
149151506|NCT00464334|538032984|FG005|Overall Study|Lack of Efficacy|0|||
149151507|NCT00464334|538032985|FG006|Overall Study|Lack of Efficacy|0|||
149151508|NCT00464334|538032986|FG007|Overall Study|Lack of Efficacy|0|||
149151509|NCT00464334|538032987|FG008|Overall Study|Lack of Efficacy|0|||
149151510|NCT00464334|538032988|FG009|Overall Study|Lack of Efficacy|0|||
149151511|NCT00464334|538032989|FG010|Overall Study|Lack of Efficacy|0|||
149151512|NCT00464334|538032979|FG000|Overall Study|Lost to Follow-up|0|||
149151513|NCT00464334|538032980|FG001|Overall Study|Lost to Follow-up|0|||
149151514|NCT00464334|538032981|FG002|Overall Study|Lost to Follow-up|1|||
149151515|NCT00464334|538032982|FG003|Overall Study|Lost to Follow-up|0|||
149151516|NCT00464334|538032983|FG004|Overall Study|Lost to Follow-up|1|||
149151517|NCT00464334|538032984|FG005|Overall Study|Lost to Follow-up|0|||
149151518|NCT00464334|538032985|FG006|Overall Study|Lost to Follow-up|1|||
149151519|NCT00464334|538032986|FG007|Overall Study|Lost to Follow-up|0|||
149151520|NCT00464334|538032987|FG008|Overall Study|Lost to Follow-up|0|||
149151521|NCT00464334|538032988|FG009|Overall Study|Lost to Follow-up|0|||
148918435|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|Death|0|||
148918436|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|Death|0|||
149151522|NCT00464334|538032989|FG010|Overall Study|Lost to Follow-up|2|||
149151523|NCT00464334|538032979|FG000|Overall Study|Progressive Disease|0|||
149151524|NCT00464334|538032980|FG001|Overall Study|Progressive Disease|0|||
149151525|NCT00464334|538032981|FG002|Overall Study|Progressive Disease|0|||
149151526|NCT00464334|538032982|FG003|Overall Study|Progressive Disease|0|||
149151527|NCT00464334|538032983|FG004|Overall Study|Progressive Disease|0|||
149151528|NCT00464334|538032984|FG005|Overall Study|Progressive Disease|1|||
149151529|NCT00464334|538032985|FG006|Overall Study|Progressive Disease|0|||
149151530|NCT00464334|538032986|FG007|Overall Study|Progressive Disease|0|||
149151531|NCT00464334|538032987|FG008|Overall Study|Progressive Disease|1|||
149151532|NCT00464334|538032988|FG009|Overall Study|Progressive Disease|0|||
149151533|NCT00464334|538032989|FG010|Overall Study|Progressive Disease|0|||
149151534|NCT00464334|538032979|FG000|Overall Study|Study Terminated by Sponsor|0|||
149151535|NCT00464334|538032980|FG001|Overall Study|Study Terminated by Sponsor|0|||
149151536|NCT00464334|538032981|FG002|Overall Study|Study Terminated by Sponsor|0|||
149151537|NCT00464334|538032982|FG003|Overall Study|Study Terminated by Sponsor|1|||
149151538|NCT00464334|538032983|FG004|Overall Study|Study Terminated by Sponsor|0|||
149151539|NCT00464334|538032984|FG005|Overall Study|Study Terminated by Sponsor|0|||
149151540|NCT00464334|538032985|FG006|Overall Study|Study Terminated by Sponsor|0|||
149151541|NCT00464334|538032986|FG007|Overall Study|Study Terminated by Sponsor|0|||
149151542|NCT00464334|538032987|FG008|Overall Study|Study Terminated by Sponsor|0|||
149151543|NCT00464334|538032988|FG009|Overall Study|Study Terminated by Sponsor|0|||
149151544|NCT00464334|538032989|FG010|Overall Study|Study Terminated by Sponsor|0|||
149151545|NCT00464334|538032979|FG000|Overall Study|Withdrawal by Subject|1|||
149151546|NCT00464334|538032980|FG001|Overall Study|Withdrawal by Subject|7|||
149151547|NCT00464334|538032981|FG002|Overall Study|Withdrawal by Subject|4|||
149151548|NCT00464334|538032982|FG003|Overall Study|Withdrawal by Subject|2|||
149151549|NCT00464334|538032983|FG004|Overall Study|Withdrawal by Subject|2|||
149151550|NCT00464334|538032984|FG005|Overall Study|Withdrawal by Subject|2|||
149151551|NCT00464334|538032985|FG006|Overall Study|Withdrawal by Subject|2|||
149151552|NCT00464334|538032986|FG007|Overall Study|Withdrawal by Subject|1|||
149151553|NCT00464334|538032987|FG008|Overall Study|Withdrawal by Subject|3|||
149151554|NCT00464334|538032988|FG009|Overall Study|Withdrawal by Subject|0|||
149151555|NCT00464334|538032989|FG010|Overall Study|Withdrawal by Subject|0|||
149151556|NCT03016325|538032996|FG000|Treatment Period|Participant withdrew consent|0|||
149151557|NCT03016325|538032997|FG001|Treatment Period|Participant withdrew consent|1|||
149151558|NCT03016325|538032998|FG002|Treatment Period|Participant withdrew consent|0|||
149151559|NCT03016325|538032999|FG003|Treatment Period|Participant withdrew consent|0|||
149151560|NCT03016325|538033000|FG004|Treatment Period|Participant withdrew consent|0|||
148672502|NCT01071278|536270820|FG000|Overall Study|Completion Status Unknown|459|||
148672503|NCT02851069|536270821|FG000|Overall Study|Failure to Return|3|||
148672504|NCT02851069|536270821|FG000|Overall Study|Other|3|||
148672505|NCT00352664|536270822|FG000|Overall Study|Withdrawal by Subject|7|||
148672506|NCT00352664|536270823|FG001|Overall Study|Withdrawal by Subject|0|||
148672507|NCT02146365|536270824|FG000|Overall Study|Lost to Follow-up|2|||
148672508|NCT02146365|536270825|FG001|Overall Study|Lost to Follow-up|1|||
148672509|NCT02146365|536270826|FG002|Overall Study|Lost to Follow-up|3|||
148672510|NCT02146365|536270827|FG003|Overall Study|Lost to Follow-up|3|||
148672511|NCT02146365|536270828|FG004|Overall Study|Lost to Follow-up|1|||
148672512|NCT02146365|536270829|FG005|Overall Study|Lost to Follow-up|1|||
148672513|NCT02146365|536270830|FG006|Overall Study|Lost to Follow-up|0|||
148672514|NCT02146365|536270831|FG007|Overall Study|Lost to Follow-up|1|||
148672515|NCT02146365|536270824|FG000|Overall Study|Withdrawal by Subject|1|||
148672516|NCT02146365|536270825|FG001|Overall Study|Withdrawal by Subject|2|||
148672517|NCT02146365|536270826|FG002|Overall Study|Withdrawal by Subject|1|||
148672518|NCT02146365|536270827|FG003|Overall Study|Withdrawal by Subject|5|||
148672519|NCT02146365|536270828|FG004|Overall Study|Withdrawal by Subject|1|||
148672520|NCT02146365|536270829|FG005|Overall Study|Withdrawal by Subject|0|||
148672521|NCT02146365|536270830|FG006|Overall Study|Withdrawal by Subject|0|||
148672522|NCT02146365|536270831|FG007|Overall Study|Withdrawal by Subject|0|||
148672523|NCT02146365|536270824|FG000|Overall Study|Unable to Comply with Protocol|0|||
148672524|NCT02146365|536270825|FG001|Overall Study|Unable to Comply with Protocol|1|||
148672525|NCT02146365|536270826|FG002|Overall Study|Unable to Comply with Protocol|1|||
148672526|NCT02146365|536270827|FG003|Overall Study|Unable to Comply with Protocol|0|||
148672527|NCT02146365|536270828|FG004|Overall Study|Unable to Comply with Protocol|0|||
148672528|NCT02146365|536270829|FG005|Overall Study|Unable to Comply with Protocol|0|||
148672529|NCT02146365|536270830|FG006|Overall Study|Unable to Comply with Protocol|0|||
148672530|NCT02146365|536270831|FG007|Overall Study|Unable to Comply with Protocol|0|||
148672531|NCT02146365|536270824|FG000|Overall Study|Other|1|||
148672532|NCT02146365|536270825|FG001|Overall Study|Other|0|||
148672533|NCT02146365|536270826|FG002|Overall Study|Other|2|||
148918437|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|Death|0|||
148672534|NCT02146365|536270827|FG003|Overall Study|Other|1|||
148672535|NCT02146365|536270828|FG004|Overall Study|Other|0|||
148672536|NCT02146365|536270829|FG005|Overall Study|Other|0|||
148672537|NCT02146365|536270830|FG006|Overall Study|Other|0|||
148672538|NCT02146365|536270831|FG007|Overall Study|Other|0|||
148672539|NCT01525407|536270832|FG000|Overall Study|Change in recipient treatment plan|2|||
148672540|NCT01525407|536270833|FG001|Overall Study|Change in recipient treatment plan|2|||
148918438|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148918439|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148672541|NCT01525407|536270832|FG000|Overall Study|Withdrawal by Subject|0|||
148918440|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148672542|NCT01525407|536270833|FG001|Overall Study|Withdrawal by Subject|1|||
148672543|NCT01525407|536270832|FG000|Overall Study|Transplant was delayed|0|||
149151561|NCT03016325|538033001|FG005|Treatment Period|Participant withdrew consent|0|||
149151562|NCT03016325|538033002|FG006|Treatment Period|Participant withdrew consent|0|||
149151563|NCT03016325|538033003|FG007|Treatment Period|Participant withdrew consent|0|||
149151564|NCT03016325|538032996|FG000|Treatment Period|Death|0|||
149151565|NCT03016325|538032997|FG001|Treatment Period|Death|0|||
149151566|NCT03016325|538032998|FG002|Treatment Period|Death|0|||
149151567|NCT03016325|538032999|FG003|Treatment Period|Death|0|||
149151568|NCT03016325|538033000|FG004|Treatment Period|Death|2|||
149151569|NCT03016325|538033001|FG005|Treatment Period|Death|0|||
149151570|NCT03016325|538033002|FG006|Treatment Period|Death|0|||
149151571|NCT03016325|538033003|FG007|Treatment Period|Death|0|||
149151572|NCT03016325|538032996|FG000|Treatment Period|Participant refuses assessments|0|||
149151573|NCT03016325|538032997|FG001|Treatment Period|Participant refuses assessments|0|||
149151574|NCT03016325|538032998|FG002|Treatment Period|Participant refuses assessments|1|||
149151575|NCT03016325|538032999|FG003|Treatment Period|Participant refuses assessments|0|||
149151576|NCT03016325|538033000|FG004|Treatment Period|Participant refuses assessments|0|||
149151577|NCT03016325|538033001|FG005|Treatment Period|Participant refuses assessments|0|||
149151578|NCT03016325|538033002|FG006|Treatment Period|Participant refuses assessments|0|||
149151579|NCT03016325|538033003|FG007|Treatment Period|Participant refuses assessments|0|||
149151580|NCT03016325|538032996|FG000|32-Day Follow-Up Period|Death|2|||
149151581|NCT03016325|538032997|FG001|32-Day Follow-Up Period|Death|0|||
149151582|NCT03016325|538032998|FG002|32-Day Follow-Up Period|Death|5|||
149151583|NCT03016325|538032999|FG003|32-Day Follow-Up Period|Death|6|||
149151584|NCT03016325|538033000|FG004|32-Day Follow-Up Period|Death|3|||
149151585|NCT03016325|538033001|FG005|32-Day Follow-Up Period|Death|0|||
149151586|NCT03016325|538033002|FG006|32-Day Follow-Up Period|Death|0|||
149151587|NCT03016325|538033003|FG007|32-Day Follow-Up Period|Death|0|||
149151588|NCT03016325|538032996|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
149151589|NCT03016325|538032997|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
149151590|NCT03016325|538032998|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
149151591|NCT03016325|538032999|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
149151592|NCT03016325|538033000|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
149151593|NCT03016325|538033001|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
149151594|NCT03016325|538033002|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
149151595|NCT03016325|538033003|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
149151596|NCT03016325|538032996|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
149151597|NCT03016325|538032997|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
149151598|NCT03016325|538032998|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
149151599|NCT03016325|538032999|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
149151600|NCT03016325|538033000|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
149151601|NCT03016325|538033001|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
149151602|NCT03016325|538033002|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
149151603|NCT03016325|538033003|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
149151604|NCT03016325|538032996|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
149151605|NCT03016325|538032997|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
149151606|NCT03016325|538032998|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
149151607|NCT03016325|538032999|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
149151608|NCT03016325|538033000|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
149151609|NCT03016325|538033001|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
149151610|NCT03016325|538033002|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
149151611|NCT03016325|538033003|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
149151612|NCT03016325|538032996|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
149151613|NCT03016325|538032997|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
149151614|NCT03016325|538032998|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
149151615|NCT03016325|538032999|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
149151616|NCT03016325|538033000|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
149151617|NCT03016325|538033001|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
149151618|NCT03016325|538033002|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
149151619|NCT03016325|538033003|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
149151620|NCT03016325|538032996|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151621|NCT03016325|538032997|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151622|NCT03016325|538032998|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
149151623|NCT03016325|538032999|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151624|NCT03016325|538033000|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151625|NCT03016325|538033001|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151626|NCT03016325|538033002|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151627|NCT03016325|538033003|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
149151628|NCT03016325|538032996|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
149151629|NCT03016325|538032997|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
149151630|NCT03016325|538032998|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
148918441|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148918442|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148918443|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
148918444|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
148918445|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148918446|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
148918447|NCT00557856|537184556|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
148918448|NCT00557856|537184557|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918449|NCT00557856|537184558|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918450|NCT00557856|537184559|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918451|NCT00557856|537184560|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918452|NCT00557856|537184561|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918453|NCT00557856|537184562|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918454|NCT00557856|537184563|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918455|NCT00557856|537184564|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
148918456|NCT00557856|537184556|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918457|NCT00557856|537184557|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918458|NCT00557856|537184558|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918459|NCT00557856|537184559|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918460|NCT00557856|537184560|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918461|NCT00557856|537184561|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918462|NCT00557856|537184562|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918463|NCT00557856|537184563|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
148918464|NCT00557856|537184564|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
148918465|NCT00557856|537184556|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918466|NCT00557856|537184557|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918467|NCT00557856|537184558|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918468|NCT00557856|537184559|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918469|NCT00557856|537184560|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918470|NCT00557856|537184561|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918471|NCT00557856|537184562|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918472|NCT00557856|537184563|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
148918473|NCT00557856|537184564|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
148918474|NCT00557856|537184556|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
148918475|NCT00557856|537184557|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
148918476|NCT00557856|537184558|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
148918477|NCT00557856|537184559|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
148918478|NCT00557856|537184560|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
148918479|NCT00557856|537184561|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
148918480|NCT00557856|537184562|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
148918481|NCT00557856|537184563|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
148918482|NCT00557856|537184564|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
148918483|NCT00557856|537184556|FG000|Part 2: Exploratory Phase|Other|0|||
148918484|NCT00557856|537184557|FG001|Part 2: Exploratory Phase|Other|0|||
148918485|NCT00557856|537184558|FG002|Part 2: Exploratory Phase|Other|0|||
148918486|NCT00557856|537184559|FG003|Part 2: Exploratory Phase|Other|0|||
148918487|NCT00557856|537184560|FG004|Part 2: Exploratory Phase|Other|0|||
148918488|NCT00557856|537184561|FG005|Part 2: Exploratory Phase|Other|0|||
148918489|NCT00557856|537184562|FG006|Part 2: Exploratory Phase|Other|0|||
148918490|NCT00557856|537184563|FG007|Part 2: Exploratory Phase|Other|0|||
148918491|NCT00557856|537184564|FG008|Part 2: Exploratory Phase|Other|1|||
148918492|NCT00557856|537184556|FG000|Part 2: Exploratory Phase|Death|0|||
149151631|NCT03016325|538032999|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
149151632|NCT03016325|538033000|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
148918493|NCT00557856|537184557|FG001|Part 2: Exploratory Phase|Death|0|||
148918494|NCT00557856|537184558|FG002|Part 2: Exploratory Phase|Death|0|||
148918495|NCT00557856|537184559|FG003|Part 2: Exploratory Phase|Death|0|||
148918496|NCT00557856|537184560|FG004|Part 2: Exploratory Phase|Death|0|||
148918497|NCT00557856|537184561|FG005|Part 2: Exploratory Phase|Death|0|||
148918498|NCT00557856|537184562|FG006|Part 2: Exploratory Phase|Death|0|||
148918499|NCT00557856|537184563|FG007|Part 2: Exploratory Phase|Death|0|||
148918500|NCT00557856|537184564|FG008|Part 2: Exploratory Phase|Death|2|||
148918501|NCT00557856|537184556|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918502|NCT00557856|537184557|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918503|NCT00557856|537184558|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918504|NCT00557856|537184559|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918505|NCT00557856|537184560|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918506|NCT00557856|537184561|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
149151633|NCT03016325|538033001|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
149151634|NCT03016325|538033002|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
149151635|NCT03016325|538033003|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
149151636|NCT03016325|538032996|FG000|182-Day Follow-Up Period|Death|3|||
149151637|NCT03016325|538032997|FG001|182-Day Follow-Up Period|Death|3|||
149151638|NCT03016325|538032998|FG002|182-Day Follow-Up Period|Death|11|||
149151639|NCT03016325|538032999|FG003|182-Day Follow-Up Period|Death|12|||
149151640|NCT03016325|538033000|FG004|182-Day Follow-Up Period|Death|9|||
149151641|NCT03016325|538033001|FG005|182-Day Follow-Up Period|Death|0|||
149151642|NCT03016325|538033002|FG006|182-Day Follow-Up Period|Death|0|||
149151643|NCT03016325|538033003|FG007|182-Day Follow-Up Period|Death|1|||
149151644|NCT03016325|538032996|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
149151645|NCT03016325|538032997|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151646|NCT03016325|538032998|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151647|NCT03016325|538032999|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151648|NCT03016325|538033000|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151649|NCT03016325|538033001|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151650|NCT03016325|538033002|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151651|NCT03016325|538033003|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
149151652|NCT03016325|538032996|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
149151653|NCT03016325|538032997|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
149151654|NCT03016325|538032998|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
149151655|NCT03016325|538032999|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
149151656|NCT03016325|538033000|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
149151657|NCT03016325|538033001|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
149151658|NCT03016325|538033002|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
149151659|NCT03016325|538033003|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
149151660|NCT03016325|538032996|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151661|NCT03016325|538032997|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151662|NCT03016325|538032998|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151663|NCT03016325|538032999|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151664|NCT03016325|538033000|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
149151665|NCT03016325|538033001|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151666|NCT03016325|538033002|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151667|NCT03016325|538033003|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
149151668|NCT03016325|538032996|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151669|NCT03016325|538032997|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151670|NCT03016325|538032998|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151671|NCT03016325|538032999|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151672|NCT03016325|538033000|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
149151673|NCT03016325|538033001|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151674|NCT03016325|538033002|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151675|NCT03016325|538033003|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
149151676|NCT03016325|538032996|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151677|NCT03016325|538032997|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151678|NCT03016325|538032998|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151679|NCT03016325|538032999|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
149151680|NCT03016325|538033000|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151681|NCT03016325|538033001|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151682|NCT03016325|538033002|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151683|NCT03016325|538033003|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
149151684|NCT03016325|538032996|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
149151685|NCT03016325|538032997|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
149151686|NCT03016325|538032998|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
149151687|NCT03016325|538032999|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
148918507|NCT00557856|537184562|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918508|NCT00557856|537184563|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
148918509|NCT00557856|537184564|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
148918510|NCT03255083|537184565|FG000|Overall Study|Clinical progression|1|||
148918511|NCT03255083|537184566|FG001|Overall Study|Clinical progression|0|||
148918512|NCT03255083|537184567|FG002|Overall Study|Clinical progression|0|||
149151688|NCT03016325|538033000|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
148918513|NCT03255083|537184568|FG003|Overall Study|Clinical progression|0|||
149151689|NCT03016325|538033001|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
149151690|NCT03016325|538033002|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
149151691|NCT03016325|538033003|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
149151692|NCT03016325|538032996|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
149151693|NCT03016325|538032997|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
149151694|NCT03016325|538032998|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
149151695|NCT03016325|538032999|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
149151696|NCT03016325|538033000|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
149151697|NCT03016325|538033001|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
149151698|NCT03016325|538033002|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
149151699|NCT03016325|538033003|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
149151700|NCT01347554|538033004|FG000|Overall Study|Lack of Efficacy|7|||
149151701|NCT01347554|538033005|FG001|Overall Study|Lack of Efficacy|11|||
149151702|NCT00004259|538033006|FG000|Overall Study|Protocol Violation|1|||
149151703|NCT00004259|538033007|FG001|Overall Study|Protocol Violation|2|||
149151704|NCT00004259|538033008|FG002|Overall Study|Protocol Violation|0|||
149151705|NCT00004259|538033009|FG003|Overall Study|Protocol Violation|0|||
149151706|NCT00004259|538033006|FG000|Overall Study|Withdrawal by Subject|0|||
149151707|NCT00004259|538033007|FG001|Overall Study|Withdrawal by Subject|2|||
149151708|NCT00004259|538033008|FG002|Overall Study|Withdrawal by Subject|0|||
149151709|NCT00004259|538033009|FG003|Overall Study|Withdrawal by Subject|0|||
149151710|NCT00790907|538033010|FG000|Overall Study|Adverse Event|9|||
149151711|NCT00790907|538033011|FG001|Overall Study|Adverse Event|7|||
149151712|NCT00790907|538033012|FG002|Overall Study|Adverse Event|6|||
149151713|NCT00790907|538033010|FG000|Overall Study|Physician Decision|304|||
149151714|NCT00790907|538033011|FG001|Overall Study|Physician Decision|271|||
149151715|NCT00790907|538033012|FG002|Overall Study|Physician Decision|255|||
149151716|NCT00790907|538033010|FG000|Overall Study|Withdrawal by Subject|1|||
149151717|NCT00790907|538033011|FG001|Overall Study|Withdrawal by Subject|7|||
149151718|NCT00790907|538033012|FG002|Overall Study|Withdrawal by Subject|5|||
149151719|NCT00790907|538033010|FG000|Overall Study|Bleeding Event|11|||
149151720|NCT00790907|538033011|FG001|Overall Study|Bleeding Event|16|||
149151721|NCT00790907|538033012|FG002|Overall Study|Bleeding Event|21|||
149151722|NCT00790907|538033010|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
149151723|NCT00790907|538033011|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
149151724|NCT00790907|538033012|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
149151725|NCT00790907|538033010|FG000|Overall Study|Qualifying Condition Not Present|29|||
149151726|NCT00790907|538033011|FG001|Overall Study|Qualifying Condition Not Present|14|||
149151727|NCT00790907|538033012|FG002|Overall Study|Qualifying Condition Not Present|16|||
149151728|NCT00790907|538033010|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
149151729|NCT00790907|538033011|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
149151730|NCT00790907|538033012|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
149151731|NCT00790907|538033010|FG000|Overall Study|Did Not Receive Study Drug|10|||
149151732|NCT00790907|538033011|FG001|Overall Study|Did Not Receive Study Drug|0|||
149151733|NCT00790907|538033012|FG002|Overall Study|Did Not Receive Study Drug|0|||
149151734|NCT01888640|538033013|FG000|Overall Study|Lost to Follow-up|1|||
149151735|NCT01888640|538033014|FG001|Overall Study|Lost to Follow-up|2|||
149151736|NCT01888640|538033015|FG002|Overall Study|Lost to Follow-up|0|||
149151737|NCT01888640|538033013|FG000|Overall Study|Withdrawal by Subject|15|||
149151738|NCT01888640|538033014|FG001|Overall Study|Withdrawal by Subject|11|||
149151739|NCT01888640|538033015|FG002|Overall Study|Withdrawal by Subject|4|||
149151740|NCT01888640|538033013|FG000|Overall Study|Minimum dose not met|10|||
149151741|NCT01888640|538033014|FG001|Overall Study|Minimum dose not met|16|||
149151742|NCT01888640|538033015|FG002|Overall Study|Minimum dose not met|0|||
149151743|NCT01888640|538033013|FG000|Overall Study|Given wrong unit (placebo)|1|||
149151744|NCT01888640|538033014|FG001|Overall Study|Given wrong unit (placebo)|0|||
149151745|NCT01888640|538033015|FG002|Overall Study|Given wrong unit (placebo)|0|||
148672544|NCT01525407|536270833|FG001|Overall Study|Transplant was delayed|1|||
148672545|NCT01525407|536270832|FG000|Overall Study|Delay in Transplant|1|||
148672546|NCT01525407|536270833|FG001|Overall Study|Delay in Transplant|0|||
148918514|NCT03255083|537184565|FG000|Overall Study|Adverse Event|0|||
148918515|NCT03255083|537184566|FG001|Overall Study|Adverse Event|1|||
148918516|NCT03255083|537184567|FG002|Overall Study|Adverse Event|0|||
148672547|NCT01721369|536270834|FG000|Overall Study|Not initial etiological diagnosis|12|||
148672548|NCT00698009|536272396|FG000|Overall Study|Withdrawal by Subject|1|||
148672549|NCT00529802|536272402|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
149151746|NCT01888640|538033013|FG000|Overall Study|Excluded for prior TENS|0|||
149151747|NCT01888640|538033014|FG001|Overall Study|Excluded for prior TENS|1|||
149151748|NCT01888640|538033015|FG002|Overall Study|Excluded for prior TENS|0|||
148918517|NCT03255083|537184568|FG003|Overall Study|Adverse Event|0|||
149151749|NCT01888640|538033013|FG000|Overall Study|Researcher Termination of Participant|0|||
149151750|NCT01888640|538033014|FG001|Overall Study|Researcher Termination of Participant|1|||
149151751|NCT01888640|538033015|FG002|Overall Study|Researcher Termination of Participant|1|||
149151752|NCT00109707|538033021|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
149151753|NCT00109707|538033022|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
149151754|NCT00109707|538033023|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
149151755|NCT00109707|538033021|FG000|Overall Study|Abnormal laboratory values|1|||
149151756|NCT00109707|538033022|FG001|Overall Study|Abnormal laboratory values|0|||
149151757|NCT00109707|538033023|FG002|Overall Study|Abnormal laboratory values|0|||
149151758|NCT00109707|538033021|FG000|Overall Study|Administrative problems|2|||
149151759|NCT00109707|538033022|FG001|Overall Study|Administrative problems|0|||
149151760|NCT00109707|538033023|FG002|Overall Study|Administrative problems|1|||
149151761|NCT00109707|538033021|FG000|Overall Study|Adverse Event|10|||
149151762|NCT00109707|538033022|FG001|Overall Study|Adverse Event|2|||
149151763|NCT00109707|538033023|FG002|Overall Study|Adverse Event|3|||
149151764|NCT00109707|538033021|FG000|Overall Study|Death|4|||
149151765|NCT00109707|538033022|FG001|Overall Study|Death|0|||
149151766|NCT00109707|538033023|FG002|Overall Study|Death|0|||
149151767|NCT00109707|538033021|FG000|Overall Study|Disease progression|12|||
149151768|NCT00109707|538033022|FG001|Overall Study|Disease progression|4|||
149151769|NCT00109707|538033023|FG002|Overall Study|Disease progression|3|||
149151770|NCT00109707|538033021|FG000|Overall Study|Lost to Follow-up|3|||
149151771|NCT00109707|538033022|FG001|Overall Study|Lost to Follow-up|0|||
149151772|NCT00109707|538033023|FG002|Overall Study|Lost to Follow-up|0|||
149151773|NCT00109707|538033021|FG000|Overall Study|Protocol Violation|1|||
149151774|NCT00109707|538033022|FG001|Overall Study|Protocol Violation|0|||
149151775|NCT00109707|538033023|FG002|Overall Study|Protocol Violation|0|||
148918518|NCT03255083|537184565|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
148918519|NCT03255083|537184566|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
148918520|NCT03255083|537184567|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
148918521|NCT03255083|537184568|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
148918522|NCT03255083|537184565|FG000|Overall Study|Withdrawal by Subject|1|||
148918523|NCT03255083|537184566|FG001|Overall Study|Withdrawal by Subject|1|||
149151776|NCT00109707|538033021|FG000|Overall Study|Patient withdrew consent|6|||
149151777|NCT00109707|538033022|FG001|Overall Study|Patient withdrew consent|1|||
149151778|NCT00109707|538033023|FG002|Overall Study|Patient withdrew consent|0|||
149151779|NCT02443883|538033024|FG000|Overall Study|Adverse Event|0|||
149151780|NCT02443883|538033025|FG001|Overall Study|Adverse Event|1|||
149151781|NCT02443883|538033026|FG002|Overall Study|Adverse Event|0|||
149151782|NCT02443883|538033027|FG003|Overall Study|Adverse Event|0|||
149151783|NCT02443883|538033024|FG000|Overall Study|Lost to Follow-up|3|||
149151784|NCT02443883|538033025|FG001|Overall Study|Lost to Follow-up|2|||
149151785|NCT02443883|538033026|FG002|Overall Study|Lost to Follow-up|1|||
149151786|NCT02443883|538033027|FG003|Overall Study|Lost to Follow-up|0|||
149151787|NCT02443883|538033024|FG000|Overall Study|Physician Decision|1|||
149151788|NCT02443883|538033025|FG001|Overall Study|Physician Decision|1|||
149151789|NCT02443883|538033026|FG002|Overall Study|Physician Decision|0|||
149151790|NCT02443883|538033027|FG003|Overall Study|Physician Decision|3|||
149151791|NCT02443883|538033024|FG000|Overall Study|Withdrawal by Subject|1|||
149151792|NCT02443883|538033025|FG001|Overall Study|Withdrawal by Subject|0|||
149151793|NCT02443883|538033026|FG002|Overall Study|Withdrawal by Subject|0|||
149151794|NCT02443883|538033027|FG003|Overall Study|Withdrawal by Subject|2|||
149151795|NCT02443883|538033024|FG000|Overall Study|Randomized, but never treated|1|||
149151796|NCT02443883|538033025|FG001|Overall Study|Randomized, but never treated|0|||
149151797|NCT02443883|538033026|FG002|Overall Study|Randomized, but never treated|0|||
149151798|NCT02443883|538033027|FG003|Overall Study|Randomized, but never treated|0|||
149151799|NCT02199080|538033028|FG000|Overall Study|Protocol Violation|12|||
148918524|NCT03255083|537184567|FG002|Overall Study|Withdrawal by Subject|1|||
148918525|NCT03255083|537184568|FG003|Overall Study|Withdrawal by Subject|0|||
148918526|NCT00363545|537184569|FG000|Overall Study|Serious Adverse Event|0|||
149151800|NCT03436862|538033029|FG000|Overall Study|Adverse Event|4|||
149151801|NCT03436862|538033029|FG000|Overall Study|Progressive Disease|2|||
149151802|NCT02937818|538033030|FG000|Overall Study|Participants decision|2|||
149151803|NCT02937818|538033031|FG001|Overall Study|Participants decision|1|||
149151804|NCT02937818|538033032|FG002|Overall Study|Participants decision|1|||
148918527|NCT00363545|537184570|FG001|Overall Study|Serious Adverse Event|1|||
148918528|NCT00363545|537184569|FG000|Overall Study|Withdrawal by Subject|12|||
148918529|NCT00363545|537184570|FG001|Overall Study|Withdrawal by Subject|15|||
149151805|NCT02937818|538033033|FG003|Overall Study|Participants decision|1|||
149151806|NCT02937818|538033030|FG000|Overall Study|Adverse Event|2|||
149151807|NCT02937818|538033031|FG001|Overall Study|Adverse Event|4|||
149151808|NCT02937818|538033032|FG002|Overall Study|Adverse Event|1|||
149151809|NCT02937818|538033033|FG003|Overall Study|Adverse Event|1|||
149151810|NCT02937818|538033030|FG000|Overall Study|Disease progression|17|||
149151811|NCT02937818|538033031|FG001|Overall Study|Disease progression|15|||
149151812|NCT02937818|538033032|FG002|Overall Study|Disease progression|7|||
149151813|NCT02937818|538033033|FG003|Overall Study|Disease progression|19|||
149151814|NCT02937818|538033030|FG000|Overall Study|Condition under investigation worsened|0|||
149151815|NCT02937818|538033031|FG001|Overall Study|Condition under investigation worsened|0|||
149151816|NCT02937818|538033032|FG002|Overall Study|Condition under investigation worsened|1|||
149151817|NCT02937818|538033033|FG003|Overall Study|Condition under investigation worsened|0|||
149151818|NCT00606086|538033034|FG000|Overall Study|Adverse Event|1|||
149151819|NCT00606086|538033035|FG001|Overall Study|Adverse Event|1|||
149151820|NCT00606086|538033034|FG000|Overall Study|Lost to Follow-up|4|||
149151821|NCT00606086|538033035|FG001|Overall Study|Lost to Follow-up|8|||
149151822|NCT00606086|538033034|FG000|Overall Study|Protocol Violation|1|||
149151823|NCT00606086|538033035|FG001|Overall Study|Protocol Violation|0|||
149151824|NCT00606086|538033034|FG000|Overall Study|Withdrawal by Subject|5|||
149151825|NCT00606086|538033035|FG001|Overall Study|Withdrawal by Subject|3|||
149151826|NCT00606086|538033034|FG000|Overall Study|Non-compliance|0|||
149151827|NCT00606086|538033035|FG001|Overall Study|Non-compliance|1|||
149151828|NCT00606086|538033034|FG000|Overall Study|Randomized, not treated|1|||
149151829|NCT00606086|538033035|FG001|Overall Study|Randomized, not treated|2|||
149151830|NCT01929408|538033038|FG000|Overall Study|received HCT as initial treatment|8|||
149151831|NCT00391222|538033042|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
149151832|NCT00391222|538033043|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
149151833|NCT00391222|538033044|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
149151834|NCT00391222|538033045|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
149151835|NCT00391222|538033042|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
149151836|NCT00391222|538033043|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
149151837|NCT00391222|538033044|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
149151838|NCT00391222|538033045|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
149151839|NCT00391222|538033042|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
149151840|NCT00391222|538033043|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
149151841|NCT00391222|538033044|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
149151842|NCT00391222|538033045|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
149151843|NCT00391222|538033042|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
149151844|NCT00391222|538033043|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
149151845|NCT00391222|538033044|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
149151846|NCT00391222|538033045|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
149151847|NCT00391222|538033042|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
149151848|NCT00391222|538033043|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
149151849|NCT00391222|538033044|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
149151850|NCT00391222|538033045|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
149151851|NCT00391222|538033042|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
149151852|NCT00391222|538033043|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
149151853|NCT00391222|538033044|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
149151854|NCT00391222|538033045|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
149151855|NCT00391222|538033042|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
149151856|NCT00391222|538033043|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
149151857|NCT00391222|538033044|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
149151858|NCT00391222|538033045|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
149151859|NCT00391222|538033042|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
149151860|NCT00391222|538033043|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
149151861|NCT00391222|538033044|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
149151862|NCT00391222|538033045|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
149151863|NCT00391222|538033042|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
149151864|NCT00391222|538033043|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
149151865|NCT00391222|538033044|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
149151866|NCT00391222|538033045|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
148918530|NCT00363545|537184569|FG000|Overall Study|Migrated/moved from study area|3|||
148918531|NCT00363545|537184570|FG001|Overall Study|Migrated/moved from study area|6|||
148918532|NCT00363545|537184569|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
148918533|NCT00363545|537184570|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
148918534|NCT00363545|537184569|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
148918535|NCT00363545|537184570|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
148918536|NCT00363545|537184569|FG000|Overall Study|Others|1|||
148918537|NCT00363545|537184570|FG001|Overall Study|Others|0|||
149151867|NCT00391222|538033042|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
149151868|NCT00391222|538033043|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
148918538|NCT01457352|537184571|FG000|Period 1|Adverse Event|2|||
148918539|NCT01457352|537184572|FG001|Period 1|Adverse Event|0|||
148918540|NCT01457352|537184571|FG000|Period 1|Withdrawal by Subject|2|||
149151869|NCT00391222|538033044|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
149151870|NCT00391222|538033045|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
149151871|NCT00391222|538033042|FG000|Period III (Double-Blind Treatment)|Other|6|||
149151872|NCT00391222|538033043|FG001|Period III (Double-Blind Treatment)|Other|1|||
149151873|NCT00391222|538033044|FG002|Period III (Double-Blind Treatment)|Other|6|||
149151874|NCT00391222|538033045|FG003|Period III (Double-Blind Treatment)|Other|0|||
149151875|NCT00889265|538033046|FG000|Overall Study|Adverse Event|1|||
149151876|NCT00889265|538033046|FG000|Overall Study|Lost to Follow-up|5|||
149151877|NCT00889265|538033046|FG000|Overall Study|Protocol Violation|1|||
149151878|NCT02069899|538033047|FG000|Overall Study|Adverse Event|6|||
149151879|NCT02069899|538033048|FG001|Overall Study|Adverse Event|0|||
149151880|NCT02069899|538033049|FG002|Overall Study|Adverse Event|1|||
149151881|NCT02069899|538033047|FG000|Overall Study|Withdrawal by Participant|2|||
149151882|NCT02069899|538033048|FG001|Overall Study|Withdrawal by Participant|0|||
149151883|NCT02069899|538033049|FG002|Overall Study|Withdrawal by Participant|0|||
149151884|NCT02069899|538033047|FG000|Overall Study|Lost to Follow-up|1|||
149151885|NCT02069899|538033048|FG001|Overall Study|Lost to Follow-up|0|||
149151886|NCT02069899|538033049|FG002|Overall Study|Lost to Follow-up|1|||
149151887|NCT02069899|538033047|FG000|Overall Study|Other|4|||
149151888|NCT02069899|538033048|FG001|Overall Study|Other|0|||
149151889|NCT02069899|538033049|FG002|Overall Study|Other|0|||
149151890|NCT02069899|538033047|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
149151891|NCT02069899|538033048|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
149151892|NCT02069899|538033049|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
149151893|NCT02069899|538033047|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
149151894|NCT02069899|538033048|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
149151895|NCT02069899|538033049|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
149151896|NCT00531752|538033050|FG000|First Double-blind Intervention Period|Adverse Event|2|||
149151897|NCT00531752|538033051|FG001|First Double-blind Intervention Period|Adverse Event|0|||
149151898|NCT00531752|538033052|FG002|First Double-blind Intervention Period|Adverse Event|1|||
149151899|NCT00531752|538033053|FG003|First Double-blind Intervention Period|Adverse Event|1|||
149151900|NCT00531752|538033050|FG000|First Double-blind Intervention Period|Other|1|||
149151901|NCT00531752|538033051|FG001|First Double-blind Intervention Period|Other|4|||
149151902|NCT00531752|538033052|FG002|First Double-blind Intervention Period|Other|4|||
149151903|NCT00531752|538033053|FG003|First Double-blind Intervention Period|Other|0|||
149151904|NCT00531752|538033050|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
149151905|NCT00531752|538033051|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
149151906|NCT00531752|538033052|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
149151907|NCT00531752|538033053|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
149151908|NCT00531752|538033050|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
148918541|NCT01457352|537184572|FG001|Period 1|Withdrawal by Subject|0|||
148918542|NCT01457352|537184571|FG000|Period 1|Physician Decision|2|||
148918543|NCT01457352|537184572|FG001|Period 1|Physician Decision|0|||
148918544|NCT01457352|537184571|FG000|Period 1|MS related disease progression|1|||
148918545|NCT01457352|537184572|FG001|Period 1|MS related disease progression|0|||
148918546|NCT01457352|537184571|FG000|Period 1|Withdrawn|1|||
148918547|NCT01457352|537184572|FG001|Period 1|Withdrawn|0|||
148918548|NCT01457352|537184571|FG000|Period 1|withdrew per sponsor|1|||
148918549|NCT01457352|537184572|FG001|Period 1|withdrew per sponsor|0|||
148918550|NCT01457352|537184571|FG000|Period 1|Protocol Violation|4|||
148805745|NCT03973996|536768007|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148918551|NCT01457352|537184572|FG001|Period 1|Protocol Violation|0|||
148918552|NCT01457352|537184571|FG000|Period 1|Did not meet eligibility criteria|3|||
148918553|NCT01457352|537184572|FG001|Period 1|Did not meet eligibility criteria|0|||
148918554|NCT01457352|537184571|FG000|Period 2|Withdrawal by Subject|23|||
148918555|NCT01457352|537184572|FG001|Period 2|Withdrawal by Subject|0|||
148918556|NCT01457352|537184571|FG000|Period 2|Adverse Event|22|||
148918557|NCT01457352|537184572|FG001|Period 2|Adverse Event|0|||
148918558|NCT01457352|537184571|FG000|Period 2|no analysis|10|||
148918559|NCT01457352|537184572|FG001|Period 2|no analysis|0|||
148918560|NCT01457352|537184571|FG000|Period 2|Lack of Efficacy|8|||
148918561|NCT01457352|537184572|FG001|Period 2|Lack of Efficacy|0|||
149151909|NCT00531752|538033051|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
148805746|NCT03973996|536768008|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148918562|NCT01457352|537184571|FG000|Period 2|Protocol Violation|4|||
148918563|NCT01457352|537184572|FG001|Period 2|Protocol Violation|0|||
148918564|NCT01457352|537184571|FG000|Period 2|Sponsor's withdrawal|7|||
148918565|NCT01457352|537184572|FG001|Period 2|Sponsor's withdrawal|0|||
148918566|NCT01457352|537184571|FG000|Period 2|Lost to Follow-up|1|||
148918567|NCT01457352|537184572|FG001|Period 2|Lost to Follow-up|0|||
148918568|NCT01457352|537184571|FG000|Period 2|dose change|1|||
149151910|NCT00531752|538033052|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
149151911|NCT00531752|538033053|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
149151912|NCT00531752|538033050|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
149151913|NCT00531752|538033051|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
149151914|NCT00531752|538033052|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
149151915|NCT00531752|538033053|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
149151916|NCT00531752|538033050|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
149151917|NCT00531752|538033051|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
149151918|NCT00531752|538033052|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
149151919|NCT00531752|538033053|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
149151920|NCT00531752|538033050|FG000|Second Double-blind Intervention Period|Other|1|||
149151921|NCT00531752|538033051|FG001|Second Double-blind Intervention Period|Other|1|||
149151922|NCT00531752|538033052|FG002|Second Double-blind Intervention Period|Other|0|||
149151923|NCT00531752|538033053|FG003|Second Double-blind Intervention Period|Other|0|||
149151924|NCT00531752|538033050|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
149151925|NCT00531752|538033051|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
149151926|NCT00531752|538033052|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
149151927|NCT00531752|538033053|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
149151928|NCT00531752|538033050|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
149151929|NCT00531752|538033051|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
149151930|NCT00531752|538033052|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
149151931|NCT00531752|538033053|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
149151932|NCT00490451|538033054|FG000|Overall Study|Adverse Event|3|||
149151933|NCT00490451|538033055|FG001|Overall Study|Adverse Event|3|||
149151934|NCT00490451|538033054|FG000|Overall Study|Death|3|||
149151935|NCT00490451|538033055|FG001|Overall Study|Death|1|||
149151936|NCT00490451|538033054|FG000|Overall Study|Withdrawal by Subject|2|||
149151937|NCT00490451|538033055|FG001|Overall Study|Withdrawal by Subject|0|||
149151938|NCT00490451|538033054|FG000|Overall Study|Investigator Decision|1|||
149151939|NCT00490451|538033055|FG001|Overall Study|Investigator Decision|0|||
149151940|NCT00490451|538033054|FG000|Overall Study|Protocol Violation|1|||
149151941|NCT00490451|538033055|FG001|Overall Study|Protocol Violation|0|||
149151942|NCT00490451|538033054|FG000|Overall Study|Progressive Disease|53|||
149151943|NCT00490451|538033055|FG001|Overall Study|Progressive Disease|34|||
149151944|NCT01181011|538033056|FG000|Overall Study|Adverse Event|2|||
149151945|NCT01181011|538033056|FG000|Overall Study|Lost to Follow-up|1|||
149151946|NCT04703075|538033057|FG000|Overall Study|Adverse Event|11|||
149151947|NCT04703075|538033058|FG001|Overall Study|Adverse Event|7|||
149151948|NCT04703075|538033057|FG000|Overall Study|Lost to Follow-up|6|||
149151949|NCT04703075|538033058|FG001|Overall Study|Lost to Follow-up|12|||
149151950|NCT04703075|538033057|FG000|Overall Study|Physician Decision|3|||
149151951|NCT04703075|538033058|FG001|Overall Study|Physician Decision|0|||
149151952|NCT04703075|538033057|FG000|Overall Study|Moved|0|||
149151953|NCT04703075|538033058|FG001|Overall Study|Moved|2|||
149151954|NCT04703075|538033057|FG000|Overall Study|Index INH Resistant|0|||
149151955|NCT04703075|538033058|FG001|Overall Study|Index INH Resistant|1|||
149151956|NCT04703075|538033057|FG000|Overall Study|Lack of Efficacy|6|||
149151957|NCT04703075|538033058|FG001|Overall Study|Lack of Efficacy|18|||
149151958|NCT00254501|538033061|FG000|Overall Study|Lost to Follow-up|1|||
149151959|NCT00254501|538033062|FG001|Overall Study|Lost to Follow-up|1|||
149151960|NCT00550680|538033063|FG000|Overall Study|Administrative Reasons|1|||
149151961|NCT00550680|538033063|FG000|Overall Study|Adverse Event|5|||
148918569|NCT01457352|537184572|FG001|Period 2|dose change|0|||
148918570|NCT01457352|537184571|FG000|Period 2|Physician Decision|1|||
149151962|NCT00550680|538033063|FG000|Overall Study|Death|3|||
149151963|NCT00550680|538033063|FG000|Overall Study|Early Improvement|1|||
148918571|NCT01457352|537184572|FG001|Period 2|Physician Decision|0|||
149151964|NCT00550680|538033063|FG000|Overall Study|Lost to Follow-up|3|||
149151965|NCT00550680|538033063|FG000|Overall Study|Lack of Efficacy|1|||
149151966|NCT00550680|538033063|FG000|Overall Study|Other|10|||
149151967|NCT00550680|538033063|FG000|Overall Study|Protocol Violation|7|||
149151968|NCT00550680|538033063|FG000|Overall Study|Refused Treatment|19|||
149151969|NCT00550680|538033063|FG000|Overall Study|Screen Failure|6|||
149151970|NCT01967550|538033064|FG000|Overall Study|Withdrawal by Subject|1|||
149151971|NCT01967550|538033065|FG001|Overall Study|Withdrawal by Subject|0|||
149151972|NCT01967550|538033064|FG000|Overall Study|Adverse Event|2|||
149151973|NCT01967550|538033065|FG001|Overall Study|Adverse Event|0|||
149151974|NCT01967550|538033064|FG000|Overall Study|Protocol Violation|2|||
149151975|NCT01967550|538033065|FG001|Overall Study|Protocol Violation|1|||
149151976|NCT01967550|538033064|FG000|Overall Study|Non Compliance|0|||
149151977|NCT01967550|538033065|FG001|Overall Study|Non Compliance|1|||
148918572|NCT01457352|537184571|FG000|Period 2|Did not meet eligibility criteria|3|||
149151978|NCT00250835|538033070|FG000|Overall Study|Withdrawal by Subject|1|||
149151979|NCT01836783|538033074|FG000|Overall Study|Withdrawal by Subject|0|||
149151980|NCT01836783|538033075|FG001|Overall Study|Withdrawal by Subject|2|||
149151981|NCT01035905|538033077|FG000|Overall Study|Lack of Efficacy|1|||
149151982|NCT01035905|538033078|FG001|Overall Study|Lack of Efficacy|1|||
149151983|NCT01273883|538033079|FG000|First Intervention|Adverse Event|2|||
149151984|NCT01273883|538033080|FG001|First Intervention|Adverse Event|1|||
149151985|NCT01273883|538033079|FG000|Second Intervention|Lost to Follow-up|1|||
149151986|NCT01273883|538033080|FG001|Second Intervention|Lost to Follow-up|1|||
149151987|NCT01273883|538033079|FG000|Second Intervention|Lack of Efficacy|1|||
149151988|NCT01273883|538033080|FG001|Second Intervention|Lack of Efficacy|0|||
149151989|NCT04489888|538033083|FG000|Overall Study|Death|75|||
149151990|NCT04489888|538033083|FG000|Overall Study|Sponsor Decision|26|||
149151991|NCT00333359|538033089|FG000|Overall Study|Adverse Event|29|||
149151992|NCT00333359|538033090|FG001|Overall Study|Adverse Event|35|||
149151993|NCT00333359|538033089|FG000|Overall Study|Withdrawal by Subject|19|||
149151994|NCT00333359|538033090|FG001|Overall Study|Withdrawal by Subject|37|||
149151995|NCT00333359|538033089|FG000|Overall Study|Physician Decision|2|||
149151996|NCT00333359|538033090|FG001|Overall Study|Physician Decision|2|||
149151997|NCT00333359|538033089|FG000|Overall Study|Protocol Non-compliance|2|||
149151998|NCT00333359|538033090|FG001|Overall Study|Protocol Non-compliance|8|||
149151999|NCT00333359|538033089|FG000|Overall Study|Lost to Follow-up|15|||
149152000|NCT00333359|538033090|FG001|Overall Study|Lost to Follow-up|25|||
149152001|NCT00333359|538033089|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
149152002|NCT00333359|538033090|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
149152003|NCT00333359|538033089|FG000|Overall Study|Treatment Failure|3|||
149152004|NCT00333359|538033090|FG001|Overall Study|Treatment Failure|8|||
149152005|NCT00333359|538033089|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
149152006|NCT00333359|538033090|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
149152007|NCT01452152|538033091|FG000|Overall Study|Study termination by sponsor|5|||
149152008|NCT01452152|538033092|FG001|Overall Study|Study termination by sponsor|0|||
149152009|NCT01452152|538033093|FG002|Overall Study|Study termination by sponsor|4|||
149152010|NCT02867995|538033095|FG000|Overall Study|Withdrawal by Subject|0|||
149152011|NCT02867995|538033096|FG001|Overall Study|Withdrawal by Subject|1|||
149152012|NCT02867995|538033095|FG000|Overall Study|Lost to Follow-up|0|||
149152013|NCT02867995|538033096|FG001|Overall Study|Lost to Follow-up|2|||
149152014|NCT01534533|538033097|FG000|Overall Study|Lost to Follow-up|3|||
149152015|NCT01534533|538033098|FG001|Overall Study|Lost to Follow-up|0|||
148918573|NCT01457352|537184572|FG001|Period 2|Did not meet eligibility criteria|0|||
148918574|NCT01457352|537184571|FG000|Period 3|Adverse Event|1|||
148918575|NCT01457352|537184572|FG001|Period 3|Adverse Event|1|||
148918576|NCT01457352|537184571|FG000|Period 3|Withdrawal by Subject|0|||
148918577|NCT01457352|537184572|FG001|Period 3|Withdrawal by Subject|2|||
148918578|NCT01457352|537184571|FG000|Period 3|incorrect treatment|0|||
148918579|NCT01457352|537184572|FG001|Period 3|incorrect treatment|1|||
148918580|NCT01457352|537184571|FG000|Period 3|Sponsor's withdrawal|0|||
148918581|NCT01457352|537184572|FG001|Period 3|Sponsor's withdrawal|1|||
148918582|NCT00369629|537185930|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
148918583|NCT00369629|537185931|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
148918584|NCT00369629|537185932|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
148918585|NCT00369629|537185933|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
148918586|NCT00369629|537185930|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
148918587|NCT00369629|537185931|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
148918588|NCT00369629|537185932|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
148918589|NCT00369629|537185933|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
148918590|NCT00369629|537185930|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
148918591|NCT00369629|537185931|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
148918592|NCT00369629|537185932|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
148918593|NCT00369629|537185933|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
148918594|NCT00369629|537185930|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
148918595|NCT00369629|537185931|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
148918596|NCT00369629|537185932|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
149152016|NCT01534533|538033099|FG002|Overall Study|Lost to Follow-up|4|||
148918597|NCT00369629|537185933|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
149152017|NCT01534533|538033100|FG003|Overall Study|Lost to Follow-up|3|||
149152018|NCT01534533|538033097|FG000|Overall Study|Withdrawal by Subject|5|||
149152019|NCT01534533|538033098|FG001|Overall Study|Withdrawal by Subject|3|||
149152020|NCT01534533|538033099|FG002|Overall Study|Withdrawal by Subject|4|||
149152021|NCT01534533|538033100|FG003|Overall Study|Withdrawal by Subject|1|||
149152022|NCT04099251|538034716|FG000|Pre-Treatment|Other reasons|1|||
149152023|NCT04099251|538034717|FG001|Pre-Treatment|Other reasons|0|||
148918598|NCT00369629|537185930|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
148918599|NCT00369629|537185931|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
149152024|NCT04099251|538034716|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
149152025|NCT04099251|538034717|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
149152026|NCT04099251|538034716|FG000|Blinded Treatment Phase|Other reasons|16|||
149152027|NCT04099251|538034717|FG001|Blinded Treatment Phase|Other reasons|7|||
149152028|NCT04099251|538034716|FG000|Blinded Treatment Phase|Disease recurrence|26|||
149152029|NCT04099251|538034717|FG001|Blinded Treatment Phase|Disease recurrence|41|||
149152030|NCT04099251|538034716|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
149152031|NCT04099251|538034717|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
149152032|NCT04099251|538034716|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
149152033|NCT04099251|538034717|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
149152034|NCT04099251|538034716|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
149152035|NCT04099251|538034717|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
149152036|NCT04099251|538034716|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
149152037|NCT04099251|538034717|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
149152038|NCT04099251|538034716|FG000|Blinded Treatment Phase|Death|6|||
149152039|NCT04099251|538034717|FG001|Blinded Treatment Phase|Death|2|||
149152040|NCT04099251|538034716|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
149152041|NCT04099251|538034717|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
149152042|NCT04099251|538034716|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
149152043|NCT04099251|538034717|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
149152044|NCT04099251|538034716|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
149152045|NCT04099251|538034717|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
149152046|NCT04099251|538034716|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
149152047|NCT04099251|538034717|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
149152048|NCT04099251|538034716|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
149152049|NCT04099251|538034717|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
149152050|NCT04099251|538034716|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
149152051|NCT04099251|538034717|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
149152052|NCT04099251|538034716|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
149152053|NCT04099251|538034717|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
148805747|NCT03973996|536768009|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149152054|NCT04099251|538034716|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
149152055|NCT04099251|538034717|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
148805748|NCT03973996|536768010|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
148672550|NCT00529802|536272402|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
148672551|NCT00529802|536272402|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
148672552|NCT00529802|536272402|FG000|Evaluable for Primary Endpoint|Death|1|||
148672553|NCT00529802|536272402|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
148672554|NCT00529802|536272402|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
148672555|NCT00529802|536272402|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
148672556|NCT03286400|536272406|FG000|Overall Study|Death|10|||
148672557|NCT03286400|536272406|FG000|Overall Study|Lost to Follow-up|10|||
148672558|NCT03286400|536272406|FG000|Overall Study|Physician Decision|1|||
148672559|NCT03286400|536272406|FG000|Overall Study|Scheduling difficulty|4|||
148672560|NCT00826176|536272411|FG000|Overall Study|Lost to Follow-up|1|||
148672561|NCT00826176|536272412|FG001|Overall Study|Lost to Follow-up|0|||
148672562|NCT00826176|536272411|FG000|Overall Study|Subject Withdrew Consent|3|||
148672563|NCT00826176|536272412|FG001|Overall Study|Subject Withdrew Consent|0|||
148672564|NCT00826176|536272411|FG000|Overall Study|Administrative|9|||
148672565|NCT00826176|536272412|FG001|Overall Study|Administrative|0|||
148672566|NCT00740480|536272413|FG000|Overall Study|Adverse Event|1|||
148672567|NCT00740480|536272413|FG000|Overall Study|Physician Decision|1|||
149152056|NCT04099251|538034716|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
149152057|NCT04099251|538034717|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
149152058|NCT03368170|538034718|FG000|Overall Study|Adverse Event|2|||
149152059|NCT03368170|538034719|FG001|Overall Study|Adverse Event|1|||
149152060|NCT03047980|538034720|FG000|Overall Study|Adverse Event|1|||
149152061|NCT02164981|538034721|FG000|Started|Withdrawal by Subject|2|||
149152062|NCT02164981|538034722|FG001|Started|Withdrawal by Subject|1|||
149152063|NCT02164981|538034723|FG002|Started|Withdrawal by Subject|0|||
149152064|NCT02164981|538034721|FG000|Started|Protocol Violation|2|||
149152065|NCT02164981|538034722|FG001|Started|Protocol Violation|0|||
149152066|NCT02164981|538034723|FG002|Started|Protocol Violation|0|||
149152067|NCT02164981|538034721|FG000|Started|Adverse Event|1|||
149152068|NCT02164981|538034722|FG001|Started|Adverse Event|2|||
149152069|NCT02164981|538034723|FG002|Started|Adverse Event|0|||
149152070|NCT02164981|538034721|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
149152071|NCT02164981|538034722|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
149152072|NCT02164981|538034723|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
148672568|NCT01325701|536272419|FG000|Overall Study|Adverse Event|12|||
148672569|NCT01325701|536272420|FG001|Overall Study|Adverse Event|0|||
148672570|NCT01325701|536272419|FG000|Overall Study|Protocol Violation|1|||
148672571|NCT01325701|536272420|FG001|Overall Study|Protocol Violation|0|||
148672572|NCT01325701|536272419|FG000|Overall Study|Physician Decision|2|||
148672573|NCT01325701|536272420|FG001|Overall Study|Physician Decision|2|||
148672574|NCT01325701|536272419|FG000|Overall Study|Withdrawal by Subject|2|||
148672575|NCT01325701|536272420|FG001|Overall Study|Withdrawal by Subject|1|||
148672576|NCT01325701|536272419|FG000|Overall Study|Rollerover Extension Study|4|||
148672577|NCT01325701|536272420|FG001|Overall Study|Rollerover Extension Study|0|||
148672578|NCT00568776|536272422|FG000|Overall Study|Adverse Event|8|||
148672579|NCT00568776|536272423|FG001|Overall Study|Adverse Event|8|||
148672580|NCT00568776|536272424|FG002|Overall Study|Adverse Event|10|||
148672581|NCT00568776|536272425|FG003|Overall Study|Adverse Event|8|||
148672582|NCT00568776|536272422|FG000|Overall Study|Death|0|||
148672583|NCT00568776|536272423|FG001|Overall Study|Death|1|||
148672584|NCT00568776|536272424|FG002|Overall Study|Death|4|||
148672585|NCT00568776|536272425|FG003|Overall Study|Death|3|||
148672586|NCT00568776|536272422|FG000|Overall Study|Physician Decision|0|||
148672587|NCT00568776|536272423|FG001|Overall Study|Physician Decision|2|||
148672588|NCT00568776|536272424|FG002|Overall Study|Physician Decision|0|||
148672589|NCT00568776|536272425|FG003|Overall Study|Physician Decision|0|||
148672590|NCT00568776|536272422|FG000|Overall Study|Lack of Efficacy|2|||
148672591|NCT00568776|536272423|FG001|Overall Study|Lack of Efficacy|2|||
148918600|NCT00369629|537185932|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
148918601|NCT00369629|537185933|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
148672592|NCT00568776|536272424|FG002|Overall Study|Lack of Efficacy|2|||
148672593|NCT00568776|536272425|FG003|Overall Study|Lack of Efficacy|4|||
148918602|NCT00369629|537185930|FG000|Completed 4 More Cycles|Progressive disease|2|||
148672594|NCT00568776|536272422|FG000|Overall Study|Lost to Follow-up|1|||
149152073|NCT02164981|538034721|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
149152074|NCT02164981|538034722|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
149152075|NCT02164981|538034723|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
149152076|NCT02164981|538034721|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
149152077|NCT02164981|538034722|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
148805749|NCT02194465|536768013|FG000|Overall Study|Adverse Event|6|||
148805750|NCT02194465|536768014|FG001|Overall Study|Adverse Event|1|||
149152078|NCT02164981|538034723|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
149152079|NCT01736579|538034724|FG000|Overall Study|Termination of Study by Sponsor|2|||
148672595|NCT00568776|536272423|FG001|Overall Study|Lost to Follow-up|1|||
148672596|NCT00568776|536272424|FG002|Overall Study|Lost to Follow-up|1|||
148805751|NCT02194465|536768015|FG002|Overall Study|Adverse Event|4|||
149152080|NCT01736579|538034725|FG001|Overall Study|Termination of Study by Sponsor|2|||
149152081|NCT01783678|538034730|FG000|Overall Study|Randomized but Not Treated|0|||
149152082|NCT01783678|538034731|FG001|Overall Study|Randomized but Not Treated|0|||
149152083|NCT01783678|538034732|FG002|Overall Study|Randomized but Not Treated|0|||
149152084|NCT01783678|538034733|FG003|Overall Study|Randomized but Not Treated|1|||
149152085|NCT01783678|538034734|FG004|Overall Study|Randomized but Not Treated|0|||
149152086|NCT01783678|538034735|FG005|Overall Study|Randomized but Not Treated|0|||
149152087|NCT01783678|538034730|FG000|Overall Study|Lack of Efficacy|1|||
149152088|NCT01783678|538034731|FG001|Overall Study|Lack of Efficacy|13|||
149152089|NCT01783678|538034732|FG002|Overall Study|Lack of Efficacy|1|||
149152090|NCT01783678|538034733|FG003|Overall Study|Lack of Efficacy|3|||
149152091|NCT01783678|538034734|FG004|Overall Study|Lack of Efficacy|6|||
149152092|NCT01783678|538034735|FG005|Overall Study|Lack of Efficacy|5|||
149152093|NCT01783678|538034730|FG000|Overall Study|Lost to Follow-up|0|||
149152094|NCT01783678|538034731|FG001|Overall Study|Lost to Follow-up|4|||
149152095|NCT01783678|538034732|FG002|Overall Study|Lost to Follow-up|0|||
149152096|NCT01783678|538034733|FG003|Overall Study|Lost to Follow-up|2|||
149152097|NCT01783678|538034734|FG004|Overall Study|Lost to Follow-up|1|||
149152098|NCT01783678|538034735|FG005|Overall Study|Lost to Follow-up|0|||
149152099|NCT01783678|538034730|FG000|Overall Study|Withdrew Consent|1|||
149152100|NCT01783678|538034731|FG001|Overall Study|Withdrew Consent|1|||
149152101|NCT01783678|538034732|FG002|Overall Study|Withdrew Consent|0|||
149152102|NCT01783678|538034733|FG003|Overall Study|Withdrew Consent|2|||
149152103|NCT01783678|538034734|FG004|Overall Study|Withdrew Consent|0|||
149152104|NCT01783678|538034735|FG005|Overall Study|Withdrew Consent|0|||
149152105|NCT01408147|538034736|FG000|Overall Study|Withdrawal by Subject|0|||
149152106|NCT01408147|538034737|FG001|Overall Study|Withdrawal by Subject|1|||
149152107|NCT01761266|538034738|FG000|Overall Study|Death|415|||
149152108|NCT01761266|538034739|FG001|Overall Study|Death|402|||
149152109|NCT01761266|538034738|FG000|Overall Study|Lost to Follow-up|8|||
149152110|NCT01761266|538034739|FG001|Overall Study|Lost to Follow-up|12|||
149152111|NCT01761266|538034738|FG000|Overall Study|Withdrawal by Subject|14|||
149152112|NCT01761266|538034739|FG001|Overall Study|Withdrawal by Subject|10|||
149152113|NCT01761266|538034738|FG000|Overall Study|Sponsor Decision|41|||
149152114|NCT01761266|538034739|FG001|Overall Study|Sponsor Decision|52|||
149152115|NCT00112905|538034740|FG000|Overall Study|Adverse Event|4|||
149152116|NCT00112905|538034740|FG000|Overall Study|Death|1|||
149152117|NCT00112905|538034740|FG000|Overall Study|Ineligibility|5|||
149152118|NCT00112905|538034740|FG000|Overall Study|Alternative treatment|1|||
149152119|NCT00112905|538034740|FG000|Overall Study|performance status was deteiorating|1|||
149152120|NCT01042600|538034741|FG000|Overall Study|Ineligible|1|||
149152121|NCT01042600|538034742|FG001|Overall Study|Ineligible|0|||
149152122|NCT04541004|538034743|FG000|Overall Study|Adverse Event|2|||
149152123|NCT00621504|538034744|FG000|Overall Study|Adverse Event|1|||
149152124|NCT00621504|538034745|FG001|Overall Study|Adverse Event|3|||
149152125|NCT00621504|538034744|FG000|Overall Study|At the request of sponsor/investigator|1|||
149152126|NCT00621504|538034745|FG001|Overall Study|At the request of sponsor/investigator|0|||
149152127|NCT00621504|538034744|FG000|Overall Study|Withdrew consent|9|||
149152128|NCT00621504|538034745|FG001|Overall Study|Withdrew consent|6|||
149152129|NCT00621504|538034744|FG000|Overall Study|Lost to Follow-up|8|||
149152130|NCT00621504|538034745|FG001|Overall Study|Lost to Follow-up|10|||
149152131|NCT00621504|538034744|FG000|Overall Study|Other|1|||
149152132|NCT00621504|538034745|FG001|Overall Study|Other|0|||
149152133|NCT00621504|538034744|FG000|Overall Study|Death|6|||
149152134|NCT00621504|538034745|FG001|Overall Study|Death|6|||
149152135|NCT03257267|538034749|FG000|Overall Study|Adverse Event|17|||
149152136|NCT03257267|538034750|FG001|Overall Study|Adverse Event|7|||
149152137|NCT03257267|538034749|FG000|Overall Study|Death|96|||
149152138|NCT03257267|538034750|FG001|Overall Study|Death|98|||
148918603|NCT00369629|537185931|FG001|Completed 4 More Cycles|Progressive disease|1|||
149152139|NCT03257267|538034749|FG000|Overall Study|Lost to Follow-up|2|||
149152140|NCT03257267|538034750|FG001|Overall Study|Lost to Follow-up|2|||
149152141|NCT03257267|538034749|FG000|Overall Study|Non-compliance with Study Drug|0|||
149152142|NCT03257267|538034750|FG001|Overall Study|Non-compliance with Study Drug|2|||
149152143|NCT03257267|538034749|FG000|Overall Study|Participant Decision|35|||
149152144|NCT03257267|538034750|FG001|Overall Study|Participant Decision|43|||
149152145|NCT03257267|538034749|FG000|Overall Study|Sponsor Decision|1|||
149152146|NCT03257267|538034750|FG001|Overall Study|Sponsor Decision|0|||
149152147|NCT03257267|538034749|FG000|Overall Study|Physician Decision|1|||
149152148|NCT03257267|538034750|FG001|Overall Study|Physician Decision|3|||
149152149|NCT03257267|538034749|FG000|Overall Study|Disease Progression|109|||
149152150|NCT03257267|538034750|FG001|Overall Study|Disease Progression|121|||
149152151|NCT03257267|538034749|FG000|Overall Study|Withdrawal by Subject|8|||
149152152|NCT03257267|538034750|FG001|Overall Study|Withdrawal by Subject|26|||
149152153|NCT03257267|538034749|FG000|Overall Study|Other|0|||
149152154|NCT03257267|538034750|FG001|Overall Study|Other|2|||
149152155|NCT03445000|538034751|FG000|Overall Study|Disease progression|8|||
149152156|NCT03445000|538034751|FG000|Overall Study|Adverse Event|3|||
149152157|NCT03445000|538034751|FG000|Overall Study|Death|2|||
149152158|NCT03445000|538034751|FG000|Overall Study|Physician Decision|1|||
149152159|NCT03311711|538034752|FG000|Overall Study|Death|1|||
148918604|NCT00369629|537185932|FG002|Completed 4 More Cycles|Progressive disease|2|||
148918605|NCT00369629|537185933|FG003|Completed 4 More Cycles|Progressive disease|0|||
148918606|NCT00369629|537185930|FG000|Follow up for 1 Year|Death|2|||
148918607|NCT00369629|537185931|FG001|Follow up for 1 Year|Death|1|||
148918608|NCT00369629|537185932|FG002|Follow up for 1 Year|Death|1|||
148918609|NCT00369629|537185933|FG003|Follow up for 1 Year|Death|0|||
148918610|NCT00369629|537185930|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
148918611|NCT00369629|537185931|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
148918612|NCT00369629|537185932|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
148918613|NCT00369629|537185933|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
148918614|NCT00369629|537185930|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
148918615|NCT00369629|537185931|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
148918616|NCT00369629|537185932|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
148918617|NCT00369629|537185933|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
148918618|NCT01347580|537185934|FG000|Overall Study|Withdrawal by Subject|13|||
148918619|NCT01347580|537185935|FG001|Overall Study|Withdrawal by Subject|23|||
148918620|NCT01347580|537185934|FG000|Overall Study|Death|30|||
148918621|NCT01347580|537185935|FG001|Overall Study|Death|19|||
148918622|NCT01347580|537185934|FG000|Overall Study|Protocol Violation|10|||
148918623|NCT01347580|537185935|FG001|Overall Study|Protocol Violation|7|||
148918624|NCT01347580|537185934|FG000|Overall Study|Lost to Follow-up|3|||
148918625|NCT01347580|537185935|FG001|Overall Study|Lost to Follow-up|1|||
148918626|NCT01347580|537185934|FG000|Overall Study|Had other reason|9|||
148918627|NCT01347580|537185935|FG001|Overall Study|Had other reason|6|||
148918628|NCT01909791|537185936|FG000|Overall Study|Death|9|||
148918629|NCT01909791|537185937|FG001|Overall Study|Death|8|||
148918630|NCT01909791|537185938|FG002|Overall Study|Death|4|||
148918631|NCT01909791|537185936|FG000|Overall Study|Withdrawal by Subject|5|||
148918632|NCT01909791|537185937|FG001|Overall Study|Withdrawal by Subject|9|||
148918633|NCT01909791|537185938|FG002|Overall Study|Withdrawal by Subject|13|||
148918634|NCT01909791|537185936|FG000|Overall Study|Lost to Follow-up|5|||
148918635|NCT01909791|537185937|FG001|Overall Study|Lost to Follow-up|11|||
148918636|NCT01909791|537185938|FG002|Overall Study|Lost to Follow-up|10|||
148918637|NCT01909791|537185936|FG000|Overall Study|Missed Visit|2|||
148918638|NCT01909791|537185937|FG001|Overall Study|Missed Visit|0|||
148918639|NCT01909791|537185938|FG002|Overall Study|Missed Visit|1|||
148918640|NCT02168387|537185939|FG000|Overall Study|Planned exubation|6|||
148918641|NCT02168387|537185940|FG001|Overall Study|Planned exubation|3|||
148918642|NCT02168387|537185939|FG000|Overall Study|Death|1|||
148918643|NCT02168387|537185940|FG001|Overall Study|Death|0|||
148918644|NCT01659554|537185941|FG000|Overall Study|Study Termination|4|||
148918645|NCT00412373|537185947|FG000|Overall Study|Adverse Event|8|||
148918646|NCT00412373|537185948|FG001|Overall Study|Adverse Event|13|||
148918647|NCT00412373|537185947|FG000|Overall Study|Lack of Efficacy|16|||
148918648|NCT00412373|537185948|FG001|Overall Study|Lack of Efficacy|22|||
148918649|NCT00412373|537185947|FG000|Overall Study|Lost to Follow-up|7|||
148918650|NCT00412373|537185948|FG001|Overall Study|Lost to Follow-up|13|||
148918651|NCT00412373|537185947|FG000|Overall Study|Withdrawal by Subject|8|||
148918652|NCT00412373|537185948|FG001|Overall Study|Withdrawal by Subject|27|||
148918653|NCT00412373|537185947|FG000|Overall Study|Other|2|||
148918654|NCT00412373|537185948|FG001|Overall Study|Other|2|||
148918655|NCT01002820|537185949|FG000|Overall Study|Adverse Event|1|||
148918656|NCT01002820|537185949|FG000|Overall Study|Withdrawal by Subject|2|||
148918657|NCT01002820|537185949|FG000|Overall Study|Lack of Efficacy|1|||
148918658|NCT01673347|537185950|FG000|Overall Study|failure of allograft|7|||
148918659|NCT00895011|537185956|FG000|Overall Study|Withdrawal by Subject|14|||
148918660|NCT00895011|537185957|FG001|Overall Study|Withdrawal by Subject|7|||
148918661|NCT00895011|537185958|FG002|Overall Study|Withdrawal by Subject|2|||
148918662|NCT00895011|537185956|FG000|Overall Study|Lost to Follow-up|5|||
148918663|NCT00895011|537185957|FG001|Overall Study|Lost to Follow-up|4|||
148918664|NCT00895011|537185958|FG002|Overall Study|Lost to Follow-up|1|||
148918665|NCT00895011|537185956|FG000|Overall Study|Protocol Violation|3|||
149152160|NCT03311711|538034753|FG001|Overall Study|Death|0|||
149152161|NCT03311711|538034754|FG002|Overall Study|Death|0|||
149152162|NCT03311711|538034755|FG003|Overall Study|Death|0|||
149152163|NCT03311711|538034756|FG004|Overall Study|Death|0|||
149152164|NCT03311711|538034757|FG005|Overall Study|Death|0|||
149152165|NCT03311711|538034758|FG006|Overall Study|Death|1|||
149152166|NCT03311711|538034759|FG007|Overall Study|Death|0|||
149152167|NCT03311711|538034760|FG008|Overall Study|Death|1|||
149152168|NCT03311711|538034761|FG009|Overall Study|Death|0|||
149152169|NCT03311711|538034752|FG000|Overall Study|Death of dyad partner|0|||
148918666|NCT00895011|537185957|FG001|Overall Study|Protocol Violation|1|||
148918667|NCT00895011|537185958|FG002|Overall Study|Protocol Violation|3|||
148918668|NCT00895011|537185956|FG000|Overall Study|Adverse Event|1|||
148918669|NCT00895011|537185957|FG001|Overall Study|Adverse Event|2|||
148918670|NCT00895011|537185958|FG002|Overall Study|Adverse Event|2|||
148918671|NCT00895011|537185956|FG000|Overall Study|schedule conflict|1|||
149152170|NCT03311711|538034753|FG001|Overall Study|Death of dyad partner|1|||
149152171|NCT03311711|538034754|FG002|Overall Study|Death of dyad partner|0|||
149152172|NCT03311711|538034755|FG003|Overall Study|Death of dyad partner|0|||
149152173|NCT03311711|538034756|FG004|Overall Study|Death of dyad partner|0|||
149152174|NCT03311711|538034757|FG005|Overall Study|Death of dyad partner|0|||
149152175|NCT03311711|538034758|FG006|Overall Study|Death of dyad partner|0|||
149152176|NCT03311711|538034759|FG007|Overall Study|Death of dyad partner|1|||
149152177|NCT03311711|538034760|FG008|Overall Study|Death of dyad partner|0|||
149152178|NCT03311711|538034761|FG009|Overall Study|Death of dyad partner|1|||
149152179|NCT03311711|538034752|FG000|Overall Study|Lost to Follow-up|2|||
149152180|NCT03311711|538034753|FG001|Overall Study|Lost to Follow-up|2|||
149152181|NCT03311711|538034754|FG002|Overall Study|Lost to Follow-up|0|||
149152182|NCT03311711|538034755|FG003|Overall Study|Lost to Follow-up|0|||
149152183|NCT03311711|538034756|FG004|Overall Study|Lost to Follow-up|0|||
149152184|NCT03311711|538034757|FG005|Overall Study|Lost to Follow-up|0|||
149152185|NCT03311711|538034758|FG006|Overall Study|Lost to Follow-up|1|||
149152186|NCT03311711|538034759|FG007|Overall Study|Lost to Follow-up|1|||
149152187|NCT03311711|538034760|FG008|Overall Study|Lost to Follow-up|0|||
149152188|NCT03311711|538034761|FG009|Overall Study|Lost to Follow-up|0|||
149152189|NCT03311711|538034752|FG000|Overall Study|Withdrawal by Subject|1|||
149152190|NCT03311711|538034753|FG001|Overall Study|Withdrawal by Subject|1|||
149152191|NCT03311711|538034754|FG002|Overall Study|Withdrawal by Subject|0|||
149152192|NCT03311711|538034755|FG003|Overall Study|Withdrawal by Subject|0|||
149152193|NCT03311711|538034756|FG004|Overall Study|Withdrawal by Subject|0|||
149152194|NCT03311711|538034757|FG005|Overall Study|Withdrawal by Subject|0|||
149152195|NCT03311711|538034758|FG006|Overall Study|Withdrawal by Subject|3|||
149152196|NCT03311711|538034759|FG007|Overall Study|Withdrawal by Subject|3|||
149152197|NCT03311711|538034760|FG008|Overall Study|Withdrawal by Subject|0|||
149152198|NCT03311711|538034761|FG009|Overall Study|Withdrawal by Subject|0|||
149152199|NCT02229552|538034762|FG000|Baseline|Withdrawal by Subject|6|||
149152200|NCT02229552|538034762|FG000|1-year Follow up|Withdrawal by Subject|7|||
149152201|NCT02229552|538034762|FG000|1-year Follow up|Lost to Follow-up|18|||
149152202|NCT02229552|538034762|FG000|2-Year Follow up|Withdrawal by Subject|9|||
149152203|NCT02229552|538034762|FG000|2-Year Follow up|Lost to Follow-up|17|||
149152204|NCT02684981|538034763|FG000|Overall Study|Permanently discontinued the treatment|157|||
149152205|NCT02684981|538034764|FG001|Overall Study|Permanently discontinued the treatment|161|||
149152206|NCT02684981|538034765|FG002|Overall Study|Permanently discontinued the treatment|110|||
149152207|NCT02684981|538034763|FG000|Overall Study|Other|83|||
149152208|NCT02684981|538034764|FG001|Overall Study|Other|49|||
149152209|NCT02684981|538034765|FG002|Overall Study|Other|17|||
149152210|NCT00820898|538034768|FG000|Overall Study|Inelgible - wrong primary site|1|||
149152211|NCT02921971|538034771|FG000|Overall Study|Adverse Event|1|||
149152212|NCT02921971|538034772|FG001|Overall Study|Adverse Event|2|||
149152213|NCT02921971|538034771|FG000|Overall Study|Lack of Efficacy|3|||
149152214|NCT02921971|538034772|FG001|Overall Study|Lack of Efficacy|1|||
149152215|NCT02921971|538034771|FG000|Overall Study|Other than specified above|2|||
149152216|NCT02921971|538034772|FG001|Overall Study|Other than specified above|1|||
149152217|NCT00452699|538034773|FG000|Overall Study|Adverse Event|10|||
149152218|NCT00452699|538034774|FG001|Overall Study|Adverse Event|3|||
149152219|NCT00452699|538034773|FG000|Overall Study|Lack of Efficacy|6|||
149152220|NCT00452699|538034774|FG001|Overall Study|Lack of Efficacy|4|||
149152221|NCT00452699|538034773|FG000|Overall Study|Lost to Follow-up|6|||
149152222|NCT00452699|538034774|FG001|Overall Study|Lost to Follow-up|9|||
149152223|NCT00452699|538034773|FG000|Overall Study|Protocol Violation|21|||
149152224|NCT00452699|538034774|FG001|Overall Study|Protocol Violation|25|||
149152225|NCT00452699|538034773|FG000|Overall Study|Withdrawal by Subject|26|||
149152226|NCT00452699|538034774|FG001|Overall Study|Withdrawal by Subject|25|||
149152227|NCT00452699|538034773|FG000|Overall Study|Other|12|||
149152228|NCT00452699|538034774|FG001|Overall Study|Other|7|||
149152229|NCT00763139|538034779|FG000|Overall Study|Adverse Event|4|||
149152230|NCT00763139|538034780|FG001|Overall Study|Adverse Event|2|||
149152231|NCT00763139|538034779|FG000|Overall Study|Withdrawal by Subject|0|||
149152232|NCT00763139|538034780|FG001|Overall Study|Withdrawal by Subject|1|||
148805752|NCT02194465|536768016|FG003|Overall Study|Adverse Event|4|||
149152233|NCT00763139|538034779|FG000|Overall Study|med change not allowed by protocol|1|||
149152234|NCT00763139|538034780|FG001|Overall Study|med change not allowed by protocol|0|||
149152235|NCT01289015|538034781|FG000|Overall Study|Protocol Violation|12|||
149152236|NCT01289015|538034782|FG001|Overall Study|Protocol Violation|9|||
149152237|NCT01289015|538034781|FG000|Overall Study|Adverse Event|3|||
149152238|NCT01289015|538034782|FG001|Overall Study|Adverse Event|0|||
149152239|NCT01289015|538034781|FG000|Overall Study|Lost to Follow-up|33|||
149152240|NCT01289015|538034782|FG001|Overall Study|Lost to Follow-up|17|||
149152241|NCT01289015|538034781|FG000|Overall Study|Withdrawal by Subject|17|||
149152242|NCT01289015|538034782|FG001|Overall Study|Withdrawal by Subject|8|||
149152243|NCT01289015|538034781|FG000|Overall Study|Disease progression|1|||
149152244|NCT01289015|538034782|FG001|Overall Study|Disease progression|0|||
149152245|NCT01289015|538034781|FG000|Overall Study|Negative baseline culture and others|33|||
149152246|NCT01289015|538034782|FG001|Overall Study|Negative baseline culture and others|20|||
149152247|NCT01709149|538034783|FG000|Open-label Lead-in Phase|Adverse Event|109|||
149152248|NCT01709149|538034784|FG001|Open-label Lead-in Phase|Adverse Event|0|||
149152249|NCT01709149|538034785|FG002|Open-label Lead-in Phase|Adverse Event|0|||
149152250|NCT01709149|538034783|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
149152251|NCT01709149|538034784|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
149152252|NCT01709149|538034785|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
149152253|NCT01709149|538034783|FG000|Open-label Lead-in Phase|Death|1|||
149152254|NCT01709149|538034784|FG001|Open-label Lead-in Phase|Death|0|||
149152255|NCT01709149|538034785|FG002|Open-label Lead-in Phase|Death|0|||
149152256|NCT01709149|538034783|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
149152257|NCT01709149|538034784|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
149152258|NCT01709149|538034785|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
149152259|NCT01709149|538034783|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
149152260|NCT01709149|538034784|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
149152261|NCT01709149|538034785|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
149152262|NCT01709149|538034783|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149152263|NCT01709149|538034784|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
149152264|NCT01709149|538034785|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
149152265|NCT01709149|538034783|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149152266|NCT01709149|538034784|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
149152267|NCT01709149|538034785|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
149152268|NCT01709149|538034783|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
149152269|NCT01709149|538034784|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
149152270|NCT01709149|538034785|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
149152271|NCT01709149|538034783|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
149152272|NCT01709149|538034784|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
148918672|NCT00895011|537185957|FG001|Overall Study|schedule conflict|0|||
148918673|NCT00895011|537185958|FG002|Overall Study|schedule conflict|0|||
149152273|NCT01709149|538034785|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
149152274|NCT01709149|538034783|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149152275|NCT01709149|538034784|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
149152276|NCT01709149|538034785|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149152277|NCT01425203|538034786|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
149152278|NCT01425203|538034787|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
149152279|NCT01425203|538034788|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
149152280|NCT01425203|538034786|FG000|Treatment Phase|Failure at futility timepoint|8|||
149152281|NCT01425203|538034787|FG001|Treatment Phase|Failure at futility timepoint|27|||
149152282|NCT01425203|538034788|FG002|Treatment Phase|Failure at futility timepoint|0|||
149152283|NCT01425203|538034786|FG000|Treatment Phase|Other virologic failure criteria|5|||
149152284|NCT01425203|538034787|FG001|Treatment Phase|Other virologic failure criteria|3|||
149152285|NCT01425203|538034788|FG002|Treatment Phase|Other virologic failure criteria|0|||
149152286|NCT01425203|538034786|FG000|Treatment Phase|Unidentified reasons|11|||
149152287|NCT01425203|538034787|FG001|Treatment Phase|Unidentified reasons|5|||
149152288|NCT01425203|538034788|FG002|Treatment Phase|Unidentified reasons|0|||
149152289|NCT01425203|538034786|FG000|Treatment Phase|Did not receive treatment|0|||
149152290|NCT01425203|538034787|FG001|Treatment Phase|Did not receive treatment|1|||
149152291|NCT01425203|538034788|FG002|Treatment Phase|Did not receive treatment|0|||
149152292|NCT01425203|538034786|FG000|Crossover Phase|Failure at futility timepoint|0|||
149152293|NCT01425203|538034787|FG001|Crossover Phase|Failure at futility timepoint|0|||
149152294|NCT01425203|538034788|FG002|Crossover Phase|Failure at futility timepoint|3|||
149152295|NCT01425203|538034786|FG000|Crossover Phase|Other virologic failure criteria|0|||
149152296|NCT01425203|538034787|FG001|Crossover Phase|Other virologic failure criteria|0|||
149152297|NCT01425203|538034788|FG002|Crossover Phase|Other virologic failure criteria|3|||
149152298|NCT01098071|538034793|FG000|Overall Study|Surgery (adenoidectomy)|2|||
149152299|NCT01098071|538034793|FG000|Overall Study|Lost to Follow-up|13|||
149152300|NCT01604265|538034794|FG000|Overall Study|Adverse Event|1|||
149152301|NCT01604265|538034795|FG001|Overall Study|Adverse Event|0|||
149152302|NCT01604265|538034794|FG000|Overall Study|Withdrawal by Subject|1|||
149152303|NCT01604265|538034795|FG001|Overall Study|Withdrawal by Subject|0|||
149152304|NCT01903837|538034797|FG000|Part A|Withdrawal by Subject|4|||
149152305|NCT01903837|538034798|FG001|Part A|Withdrawal by Subject|9|||
149152306|NCT01903837|538034799|FG002|Part A|Withdrawal by Subject|8|||
149152307|NCT01903837|538034800|FG003|Part A|Withdrawal by Subject|5|||
148918674|NCT00640224|537185959|FG000|Overall Study|Lost to Follow-up|5|||
149152308|NCT01903837|538034797|FG000|Part A|Adverse Event|3|||
149152309|NCT01903837|538034798|FG001|Part A|Adverse Event|6|||
148918675|NCT00640224|537185960|FG001|Overall Study|Lost to Follow-up|2|||
148918676|NCT00640224|537185961|FG002|Overall Study|Lost to Follow-up|0|||
148918677|NCT00640224|537185962|FG003|Overall Study|Lost to Follow-up|0|||
149152310|NCT01903837|538034799|FG002|Part A|Adverse Event|9|||
149152311|NCT01903837|538034800|FG003|Part A|Adverse Event|6|||
149152312|NCT01903837|538034797|FG000|Part A|Lost to Follow-up|9|||
148918678|NCT00640224|537185959|FG000|Overall Study|Withdrawal by Subject|1|||
148918679|NCT00640224|537185960|FG001|Overall Study|Withdrawal by Subject|0|||
149152313|NCT01903837|538034798|FG001|Part A|Lost to Follow-up|7|||
149152314|NCT01903837|538034799|FG002|Part A|Lost to Follow-up|7|||
149152315|NCT01903837|538034800|FG003|Part A|Lost to Follow-up|2|||
149152316|NCT01903837|538034797|FG000|Part A|Non-compliance with study drug|1|||
149152317|NCT01903837|538034798|FG001|Part A|Non-compliance with study drug|4|||
149152318|NCT01903837|538034799|FG002|Part A|Non-compliance with study drug|4|||
149152319|NCT01903837|538034800|FG003|Part A|Non-compliance with study drug|0|||
149152320|NCT01903837|538034797|FG000|Part A|Physician Decision|1|||
149152321|NCT01903837|538034798|FG001|Part A|Physician Decision|1|||
149152322|NCT01903837|538034799|FG002|Part A|Physician Decision|0|||
149152323|NCT01903837|538034800|FG003|Part A|Physician Decision|0|||
149152324|NCT01903837|538034797|FG000|Part A|Protocol Violation|1|||
149152325|NCT01903837|538034798|FG001|Part A|Protocol Violation|1|||
149152326|NCT01903837|538034799|FG002|Part A|Protocol Violation|0|||
149152327|NCT01903837|538034800|FG003|Part A|Protocol Violation|0|||
149152328|NCT01903837|538034797|FG000|Part B|Lost to Follow-up|0|||
149152329|NCT01903837|538034798|FG001|Part B|Lost to Follow-up|3|||
149152330|NCT01903837|538034799|FG002|Part B|Lost to Follow-up|3|||
149152331|NCT01903837|538034800|FG003|Part B|Lost to Follow-up|4|||
149152332|NCT01903837|538034797|FG000|Part B|Withdrawal by Subject|1|||
149152333|NCT01903837|538034798|FG001|Part B|Withdrawal by Subject|2|||
149152334|NCT01903837|538034799|FG002|Part B|Withdrawal by Subject|0|||
149152335|NCT01903837|538034800|FG003|Part B|Withdrawal by Subject|3|||
149152336|NCT01903837|538034797|FG000|Part B|Adverse Event|3|||
149152337|NCT01903837|538034798|FG001|Part B|Adverse Event|0|||
149152338|NCT01903837|538034799|FG002|Part B|Adverse Event|2|||
149152339|NCT01903837|538034800|FG003|Part B|Adverse Event|0|||
149152340|NCT01903837|538034797|FG000|Part B|Non-compliance with study drug|2|||
149152341|NCT01903837|538034798|FG001|Part B|Non-compliance with study drug|0|||
149152342|NCT01903837|538034799|FG002|Part B|Non-compliance with study drug|0|||
149152343|NCT01903837|538034800|FG003|Part B|Non-compliance with study drug|1|||
149152344|NCT01903837|538034797|FG000|Part B|Incarceration|2|||
149152345|NCT01903837|538034798|FG001|Part B|Incarceration|0|||
149152346|NCT01903837|538034799|FG002|Part B|Incarceration|0|||
149152347|NCT01903837|538034800|FG003|Part B|Incarceration|1|||
149152348|NCT01903837|538034797|FG000|Part B|Physician Decision|1|||
149152349|NCT01903837|538034798|FG001|Part B|Physician Decision|0|||
149152350|NCT01903837|538034799|FG002|Part B|Physician Decision|0|||
149152351|NCT01903837|538034800|FG003|Part B|Physician Decision|2|||
149152352|NCT01903837|538034797|FG000|Part B|Lack of Efficacy|0|||
149152353|NCT01903837|538034798|FG001|Part B|Lack of Efficacy|1|||
149152354|NCT01903837|538034799|FG002|Part B|Lack of Efficacy|0|||
149152355|NCT01903837|538034800|FG003|Part B|Lack of Efficacy|0|||
149152356|NCT02599961|538034802|FG000|Overall Study|Withdrawal by Subject|1|||
149152357|NCT02599961|538034802|FG000|Overall Study|Subject Non-Compliance|2|||
149152358|NCT02599961|538034802|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
149152359|NCT02599961|538034802|FG000|Overall Study|Other, Not Specified|3|||
149152360|NCT02432235|538034803|FG000|Overall Study|Death|1|||
149152361|NCT02432235|538034804|FG001|Overall Study|Death|1|||
149152362|NCT02432235|538034805|FG002|Overall Study|Death|2|||
149152363|NCT02432235|538034806|FG003|Overall Study|Death|2|||
149152364|NCT02432235|538034807|FG004|Overall Study|Death|1|||
149152365|NCT02432235|538034808|FG005|Overall Study|Death|3|||
148672597|NCT00568776|536272425|FG003|Overall Study|Lost to Follow-up|1|||
148918680|NCT00640224|537185961|FG002|Overall Study|Withdrawal by Subject|0|||
148918681|NCT00640224|537185962|FG003|Overall Study|Withdrawal by Subject|0|||
148918682|NCT00640224|537185959|FG000|Overall Study|Headaches|0|||
148918683|NCT00640224|537185960|FG001|Overall Study|Headaches|1|||
148918684|NCT00640224|537185961|FG002|Overall Study|Headaches|0|||
148918685|NCT00640224|537185962|FG003|Overall Study|Headaches|0|||
148918686|NCT00422513|537185963|FG000|Overall Study|Lack of Efficacy|4|||
148918687|NCT00422513|537185964|FG001|Overall Study|Lack of Efficacy|5|||
148918688|NCT00422513|537185963|FG000|Overall Study|Protocol Violation|23|||
149152366|NCT02432235|538034809|FG006|Overall Study|Death|11|||
149152367|NCT02432235|538034810|FG007|Overall Study|Death|15|||
149152368|NCT02432235|538034811|FG008|Overall Study|Death|15|||
149152369|NCT02432235|538034812|FG009|Overall Study|Death|3|||
149152370|NCT02432235|538034813|FG010|Overall Study|Death|1|||
149152371|NCT02432235|538034814|FG011|Overall Study|Death|0|||
149152372|NCT02432235|538034803|FG000|Overall Study|Withdrawal by Subject|0|||
149152373|NCT02432235|538034804|FG001|Overall Study|Withdrawal by Subject|1|||
149152374|NCT02432235|538034805|FG002|Overall Study|Withdrawal by Subject|0|||
149152375|NCT02432235|538034806|FG003|Overall Study|Withdrawal by Subject|0|||
149152376|NCT02432235|538034807|FG004|Overall Study|Withdrawal by Subject|0|||
149152377|NCT02432235|538034808|FG005|Overall Study|Withdrawal by Subject|2|||
149152378|NCT02432235|538034809|FG006|Overall Study|Withdrawal by Subject|5|||
148918689|NCT00422513|537185964|FG001|Overall Study|Protocol Violation|7|||
149152379|NCT02432235|538034810|FG007|Overall Study|Withdrawal by Subject|3|||
149152380|NCT02432235|538034811|FG008|Overall Study|Withdrawal by Subject|1|||
149152381|NCT02432235|538034812|FG009|Overall Study|Withdrawal by Subject|0|||
149152382|NCT02432235|538034813|FG010|Overall Study|Withdrawal by Subject|0|||
149152383|NCT02432235|538034814|FG011|Overall Study|Withdrawal by Subject|0|||
149152384|NCT02432235|538034803|FG000|Overall Study|Lost to Follow-up|0|||
148672598|NCT00568776|536272422|FG000|Overall Study|Protocol Violation|1|||
148672599|NCT00568776|536272423|FG001|Overall Study|Protocol Violation|0|||
148672600|NCT00568776|536272424|FG002|Overall Study|Protocol Violation|1|||
148672601|NCT00568776|536272425|FG003|Overall Study|Protocol Violation|1|||
148672602|NCT00568776|536272422|FG000|Overall Study|Withdrawal by Subject|13|||
148672603|NCT00568776|536272423|FG001|Overall Study|Withdrawal by Subject|15|||
148672604|NCT00568776|536272424|FG002|Overall Study|Withdrawal by Subject|13|||
148672605|NCT00568776|536272425|FG003|Overall Study|Withdrawal by Subject|7|||
148672606|NCT00568776|536272422|FG000|Overall Study|Loss of Caregiver|0|||
148672607|NCT00568776|536272423|FG001|Overall Study|Loss of Caregiver|2|||
148672608|NCT00568776|536272424|FG002|Overall Study|Loss of Caregiver|1|||
148672609|NCT00568776|536272425|FG003|Overall Study|Loss of Caregiver|2|||
148672610|NCT00568776|536272422|FG000|Overall Study|Sponsor Decision|2|||
148672611|NCT00568776|536272423|FG001|Overall Study|Sponsor Decision|2|||
148672612|NCT00568776|536272424|FG002|Overall Study|Sponsor Decision|41|||
148672613|NCT00568776|536272425|FG003|Overall Study|Sponsor Decision|42|||
148672614|NCT00568776|536272422|FG000|Overall Study|Miscellaeneous|3|||
148672615|NCT00568776|536272423|FG001|Overall Study|Miscellaeneous|3|||
148672616|NCT00568776|536272424|FG002|Overall Study|Miscellaeneous|1|||
148672617|NCT00568776|536272425|FG003|Overall Study|Miscellaeneous|4|||
148672618|NCT01005680|536272426|FG000|Overall Study|Lost to Follow-up|4|||
148672619|NCT01005680|536272427|FG001|Overall Study|Lost to Follow-up|6|||
148672620|NCT01005680|536272426|FG000|Overall Study|Withdrawal by Subject|1|||
148672621|NCT01005680|536272427|FG001|Overall Study|Withdrawal by Subject|4|||
148672622|NCT01005680|536272426|FG000|Overall Study|Physician Decision|1|||
148672623|NCT01005680|536272427|FG001|Overall Study|Physician Decision|1|||
148672624|NCT03576131|536272428|FG000|Overall Study|Investigator decision|0|||
148672625|NCT03576131|536272429|FG001|Overall Study|Investigator decision|0|||
148672626|NCT03576131|536272430|FG002|Overall Study|Investigator decision|0|||
148672627|NCT03576131|536272431|FG003|Overall Study|Investigator decision|1|||
148672628|NCT03576131|536272432|FG004|Overall Study|Investigator decision|0|||
148672629|NCT03576131|536272433|FG005|Overall Study|Investigator decision|1|||
148672630|NCT03576131|536272434|FG006|Overall Study|Investigator decision|0|||
148672631|NCT03576131|536272435|FG007|Overall Study|Investigator decision|0|||
148672632|NCT03576131|536272428|FG000|Overall Study|Withdrawal by Subject|1|||
148672633|NCT03576131|536272429|FG001|Overall Study|Withdrawal by Subject|1|||
148672634|NCT03576131|536272430|FG002|Overall Study|Withdrawal by Subject|0|||
148672635|NCT03576131|536272431|FG003|Overall Study|Withdrawal by Subject|1|||
148672636|NCT03576131|536272432|FG004|Overall Study|Withdrawal by Subject|2|||
148672637|NCT03576131|536272433|FG005|Overall Study|Withdrawal by Subject|3|||
148672638|NCT03576131|536272434|FG006|Overall Study|Withdrawal by Subject|1|||
148672639|NCT03576131|536272435|FG007|Overall Study|Withdrawal by Subject|0|||
148672640|NCT03576131|536272428|FG000|Overall Study|Death|3|||
148672641|NCT03576131|536272429|FG001|Overall Study|Death|3|||
148672642|NCT03576131|536272430|FG002|Overall Study|Death|1|||
148672643|NCT03576131|536272431|FG003|Overall Study|Death|5|||
148672644|NCT03576131|536272432|FG004|Overall Study|Death|4|||
148672645|NCT03576131|536272433|FG005|Overall Study|Death|1|||
148672646|NCT03576131|536272434|FG006|Overall Study|Death|0|||
148672647|NCT03576131|536272435|FG007|Overall Study|Death|1|||
148672648|NCT03576131|536272428|FG000|Overall Study|New anti-cancer treatment|5|||
148672649|NCT03576131|536272429|FG001|Overall Study|New anti-cancer treatment|1|||
148672650|NCT03576131|536272430|FG002|Overall Study|New anti-cancer treatment|2|||
148672651|NCT03576131|536272431|FG003|Overall Study|New anti-cancer treatment|3|||
148672652|NCT03576131|536272432|FG004|Overall Study|New anti-cancer treatment|0|||
148672653|NCT03576131|536272433|FG005|Overall Study|New anti-cancer treatment|0|||
148672654|NCT03576131|536272434|FG006|Overall Study|New anti-cancer treatment|0|||
148672655|NCT03576131|536272435|FG007|Overall Study|New anti-cancer treatment|0|||
148672656|NCT03576131|536272428|FG000|Overall Study|Unspecified reason|0|||
148672657|NCT03576131|536272429|FG001|Overall Study|Unspecified reason|0|||
148672658|NCT03576131|536272430|FG002|Overall Study|Unspecified reason|1|||
148672659|NCT03576131|536272431|FG003|Overall Study|Unspecified reason|1|||
148672660|NCT03576131|536272432|FG004|Overall Study|Unspecified reason|1|||
148672661|NCT03576131|536272433|FG005|Overall Study|Unspecified reason|1|||
148672662|NCT03576131|536272434|FG006|Overall Study|Unspecified reason|0|||
148672663|NCT03576131|536272435|FG007|Overall Study|Unspecified reason|0|||
148672664|NCT03576131|536272428|FG000|Overall Study|Subject non-compliance|0|||
148672665|NCT03576131|536272429|FG001|Overall Study|Subject non-compliance|0|||
148672666|NCT03576131|536272430|FG002|Overall Study|Subject non-compliance|0|||
148672667|NCT03576131|536272431|FG003|Overall Study|Subject non-compliance|0|||
148672668|NCT03576131|536272432|FG004|Overall Study|Subject non-compliance|0|||
148672669|NCT03576131|536272433|FG005|Overall Study|Subject non-compliance|1|||
148672670|NCT03576131|536272434|FG006|Overall Study|Subject non-compliance|0|||
148672671|NCT03576131|536272435|FG007|Overall Study|Subject non-compliance|0|||
148672672|NCT00539006|536272453|FG000|Pre-treatment|Other|0|||
148672673|NCT00539006|536272454|FG001|Pre-treatment|Other|1|||
148672674|NCT00539006|536272455|FG002|Pre-treatment|Other|0|||
148672675|NCT00539006|536272456|FG003|Pre-treatment|Other|0|||
148672676|NCT00539006|536272453|FG000|Treatment Period 1|Lost to Follow-up|0|||
149152385|NCT02432235|538034804|FG001|Overall Study|Lost to Follow-up|0|||
149152386|NCT02432235|538034805|FG002|Overall Study|Lost to Follow-up|0|||
149152387|NCT02432235|538034806|FG003|Overall Study|Lost to Follow-up|0|||
149152388|NCT02432235|538034807|FG004|Overall Study|Lost to Follow-up|0|||
149152389|NCT02432235|538034808|FG005|Overall Study|Lost to Follow-up|1|||
149152390|NCT02432235|538034809|FG006|Overall Study|Lost to Follow-up|0|||
149152391|NCT02432235|538034810|FG007|Overall Study|Lost to Follow-up|0|||
149152392|NCT02432235|538034811|FG008|Overall Study|Lost to Follow-up|1|||
149152393|NCT02432235|538034812|FG009|Overall Study|Lost to Follow-up|0|||
149152394|NCT02432235|538034813|FG010|Overall Study|Lost to Follow-up|0|||
149152395|NCT02432235|538034814|FG011|Overall Study|Lost to Follow-up|0|||
149152396|NCT02432235|538034803|FG000|Overall Study|Miscellaneous|0|||
149152397|NCT02432235|538034804|FG001|Overall Study|Miscellaneous|0|||
149152398|NCT02432235|538034805|FG002|Overall Study|Miscellaneous|0|||
149152399|NCT02432235|538034806|FG003|Overall Study|Miscellaneous|0|||
149152400|NCT02432235|538034807|FG004|Overall Study|Miscellaneous|1|||
149152401|NCT02432235|538034808|FG005|Overall Study|Miscellaneous|6|||
149152402|NCT02432235|538034809|FG006|Overall Study|Miscellaneous|2|||
149152403|NCT02432235|538034810|FG007|Overall Study|Miscellaneous|2|||
149152404|NCT02432235|538034811|FG008|Overall Study|Miscellaneous|4|||
149152405|NCT02432235|538034812|FG009|Overall Study|Miscellaneous|0|||
149152406|NCT02432235|538034813|FG010|Overall Study|Miscellaneous|0|||
149152407|NCT02432235|538034814|FG011|Overall Study|Miscellaneous|1|||
149152408|NCT01895322|538034815|FG000|Overall Study|Adverse Event|1|||
149152409|NCT01895322|538034815|FG000|Overall Study|Withdrawal by Subject|2|||
149152410|NCT01895322|538034815|FG000|Overall Study|Protocol Violation|10|||
149152411|NCT00143312|538034823|FG000|Overall Study|Death|11|||
149152412|NCT00143312|538034823|FG000|Overall Study|Adverse Event|2|||
149152413|NCT00143312|538034823|FG000|Overall Study|Lost to Follow-up|1|||
149152414|NCT00143312|538034823|FG000|Overall Study|Other|1|||
149152415|NCT00143312|538034823|FG000|Overall Study|Withdrawal by Subject|1|||
149152416|NCT01834274|538034824|FG000|Overall Study|Study Termination|41|||
149152417|NCT01834274|538034825|FG001|Overall Study|Study Termination|38|||
149152418|NCT01834274|538034824|FG000|Overall Study|Withdrawal by Subject|1|||
149152419|NCT01834274|538034825|FG001|Overall Study|Withdrawal by Subject|1|||
149152420|NCT01834274|538034824|FG000|Overall Study|Lost to Follow-up|3|||
149152421|NCT01834274|538034825|FG001|Overall Study|Lost to Follow-up|1|||
149152422|NCT01834274|538034824|FG000|Overall Study|Other|2|||
149152423|NCT01834274|538034825|FG001|Overall Study|Other|1|||
149152424|NCT03603496|538034826|FG000|Overall Study|Death|19|||
149152425|NCT03603496|538034827|FG001|Overall Study|Death|24|||
149152426|NCT03603496|538034826|FG000|Overall Study|Lost to Follow-up|141|||
149152427|NCT03603496|538034827|FG001|Overall Study|Lost to Follow-up|141|||
149152428|NCT03603496|538034826|FG000|Overall Study|Withdrawal by Subject|26|||
149152429|NCT03603496|538034827|FG001|Overall Study|Withdrawal by Subject|20|||
149152430|NCT03594227|538034828|FG000|Overall Study|Adverse Event|2|||
149152431|NCT03594227|538034829|FG001|Overall Study|Adverse Event|1|||
149152432|NCT03594227|538034830|FG002|Overall Study|Adverse Event|0|||
149152433|NCT03594227|538034831|FG003|Overall Study|Adverse Event|2|||
149152434|NCT03594227|538034828|FG000|Overall Study|Lost to Follow-up|1|||
149152435|NCT03594227|538034829|FG001|Overall Study|Lost to Follow-up|1|||
149152436|NCT03594227|538034830|FG002|Overall Study|Lost to Follow-up|1|||
149152437|NCT03594227|538034831|FG003|Overall Study|Lost to Follow-up|0|||
149152438|NCT03594227|538034828|FG000|Overall Study|Withdrawal by Subject|1|||
149152439|NCT03594227|538034829|FG001|Overall Study|Withdrawal by Subject|1|||
149152440|NCT03594227|538034830|FG002|Overall Study|Withdrawal by Subject|1|||
149152441|NCT03594227|538034831|FG003|Overall Study|Withdrawal by Subject|1|||
149152442|NCT03594227|538034828|FG000|Overall Study|Pregnancy|0|||
149152443|NCT03594227|538034829|FG001|Overall Study|Pregnancy|1|||
149152444|NCT03594227|538034830|FG002|Overall Study|Pregnancy|0|||
149152445|NCT03594227|538034831|FG003|Overall Study|Pregnancy|0|||
149152446|NCT03594227|538034828|FG000|Overall Study|Sponsor Decision|0|||
149152447|NCT03594227|538034829|FG001|Overall Study|Sponsor Decision|0|||
149152448|NCT03594227|538034830|FG002|Overall Study|Sponsor Decision|0|||
149152449|NCT03594227|538034831|FG003|Overall Study|Sponsor Decision|1|||
149152450|NCT03594227|538034828|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
149152451|NCT03594227|538034829|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
149152452|NCT03594227|538034830|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
149152453|NCT03594227|538034831|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
149152454|NCT00774345|538034832|FG000|Pre-treatment|Other reasons|2|||
149152455|NCT00774345|538034833|FG001|Pre-treatment|Other reasons|0|||
149152456|NCT00774345|538034832|FG000|Treatment|Adverse Event|61|||
149152457|NCT00774345|538034833|FG001|Treatment|Adverse Event|15|||
149152458|NCT00774345|538034832|FG000|Treatment|Progressive Disease without histologic transformation|51|||
149152459|NCT00774345|538034833|FG001|Treatment|Progressive Disease without histologic transformation|111|||
149152460|NCT00774345|538034832|FG000|Treatment|Progressive Disease with histologic transformation|4|||
148918690|NCT00422513|537185963|FG000|Overall Study|Refused Treatment|4|||
148918691|NCT00422513|537185964|FG001|Overall Study|Refused Treatment|2|||
148918692|NCT00422513|537185963|FG000|Overall Study|Withdrawal by Subject|2|||
149152461|NCT00774345|538034833|FG001|Treatment|Progressive Disease with histologic transformation|2|||
149152462|NCT00774345|538034832|FG000|Treatment|Withdrawal by Subject|5|||
149152463|NCT00774345|538034833|FG001|Treatment|Withdrawal by Subject|2|||
148918693|NCT00422513|537185964|FG001|Overall Study|Withdrawal by Subject|1|||
148918694|NCT00422513|537185963|FG000|Overall Study|early termination of the study|67|||
148918695|NCT00422513|537185964|FG001|Overall Study|early termination of the study|80|||
148918696|NCT00422513|537185963|FG000|Overall Study|Adverse Event|4|||
148918697|NCT00422513|537185964|FG001|Overall Study|Adverse Event|4|||
148918698|NCT00422513|537185963|FG000|Overall Study|Death|3|||
148918699|NCT00422513|537185964|FG001|Overall Study|Death|7|||
148918700|NCT03135119|537185965|FG000|Overall Study|Lost to Follow-up|2|||
148918701|NCT03135119|537185966|FG001|Overall Study|Lost to Follow-up|0|||
148918702|NCT03135119|537185965|FG000|Overall Study|Physician Decision|1|||
148918703|NCT03135119|537185966|FG001|Overall Study|Physician Decision|1|||
148918704|NCT03135119|537185965|FG000|Overall Study|COVID-19 Shutdown|2|||
148918705|NCT03135119|537185966|FG001|Overall Study|COVID-19 Shutdown|2|||
148918706|NCT01478048|537185967|FG000|Overall Study|Disease Progression|52|||
148918707|NCT01478048|537185968|FG001|Overall Study|Disease Progression|35|||
148918708|NCT01478048|537185967|FG000|Overall Study|study drug toxicity|11|||
148918709|NCT01478048|537185968|FG001|Overall Study|study drug toxicity|14|||
148918710|NCT01478048|537185967|FG000|Overall Study|Adverse Event|2|||
148918711|NCT01478048|537185968|FG001|Overall Study|Adverse Event|11|||
148918712|NCT01478048|537185967|FG000|Overall Study|subject request to discontinue treatment|3|||
148918713|NCT01478048|537185968|FG001|Overall Study|subject request to discontinue treatment|5|||
148918714|NCT01478048|537185967|FG000|Overall Study|Withdrawal by Subject|2|||
148918715|NCT01478048|537185968|FG001|Overall Study|Withdrawal by Subject|5|||
148918716|NCT01478048|537185967|FG000|Overall Study|non-specified|6|||
148918717|NCT01478048|537185968|FG001|Overall Study|non-specified|4|||
148918718|NCT01478048|537185967|FG000|Overall Study|poor/non-compliance|0|||
148918719|NCT01478048|537185968|FG001|Overall Study|poor/non-compliance|1|||
148918720|NCT01478048|537185967|FG000|Overall Study|no longer meets study criteria|1|||
148918721|NCT01478048|537185968|FG001|Overall Study|no longer meets study criteria|0|||
148918722|NCT01252667|537185973|FG000|Overall Study|Transplant aborted post-conditioning|0|||
148918723|NCT01252667|537185974|FG001|Overall Study|Transplant aborted post-conditioning|0|||
148918724|NCT01252667|537185975|FG002|Overall Study|Transplant aborted post-conditioning|0|||
148918725|NCT01252667|537185976|FG003|Overall Study|Transplant aborted post-conditioning|0|||
148918726|NCT01252667|537185977|FG004|Overall Study|Transplant aborted post-conditioning|0|||
148918727|NCT01252667|537185978|FG005|Overall Study|Transplant aborted post-conditioning|1|||
148918728|NCT04644315|537185979|FG000|Overall Study|Subject withdrawal of consent|1|||
148918729|NCT03032380|537185980|FG000|Overall Study|Adverse Event|0|||
148918730|NCT03032380|537185981|FG001|Overall Study|Adverse Event|1|||
148918731|NCT03032380|537185980|FG000|Overall Study|Lack of Efficacy|1|||
148918732|NCT03032380|537185981|FG001|Overall Study|Lack of Efficacy|0|||
148918733|NCT03032380|537185980|FG000|Overall Study|Withdrawal by Subject|2|||
148918734|NCT03032380|537185981|FG001|Overall Study|Withdrawal by Subject|3|||
148918735|NCT03032380|537185980|FG000|Overall Study|Recovery|0|||
148918736|NCT03032380|537185981|FG001|Overall Study|Recovery|1|||
148918737|NCT03032380|537185980|FG000|Overall Study|Death|39|||
148918738|NCT03032380|537185981|FG001|Overall Study|Death|34|||
148918739|NCT03032380|537185980|FG000|Overall Study|Other - Miscellaneous|0|||
148918740|NCT03032380|537185981|FG001|Overall Study|Other - Miscellaneous|1|||
148918741|NCT01836276|537185982|FG000|Overall Study|Lost to Follow-up|28|||
148918742|NCT01836276|537185983|FG001|Overall Study|Lost to Follow-up|51|||
148918743|NCT01561898|537185984|FG000|Overall Study|Withdrawal by Subject|0|||
148918744|NCT01561898|537185985|FG001|Overall Study|Withdrawal by Subject|8|||
148918745|NCT01561898|537185986|FG002|Overall Study|Withdrawal by Subject|12|||
148918746|NCT01561898|537185987|FG003|Overall Study|Withdrawal by Subject|5|||
148918747|NCT01561898|537185984|FG000|Overall Study|Lack of Efficacy|0|||
148918748|NCT01561898|537185985|FG001|Overall Study|Lack of Efficacy|8|||
149152464|NCT00774345|538034832|FG000|Treatment|Lost to Follow-up|1|||
149152465|NCT00774345|538034833|FG001|Treatment|Lost to Follow-up|1|||
149152466|NCT00774345|538034832|FG000|Treatment|Death|4|||
148918749|NCT01561898|537185986|FG002|Overall Study|Lack of Efficacy|10|||
148918750|NCT01561898|537185987|FG003|Overall Study|Lack of Efficacy|5|||
148918751|NCT01561898|537185984|FG000|Overall Study|Worsening of complications|0|||
148918752|NCT01561898|537185985|FG001|Overall Study|Worsening of complications|1|||
148918753|NCT01561898|537185986|FG002|Overall Study|Worsening of complications|0|||
148918754|NCT01561898|537185987|FG003|Overall Study|Worsening of complications|0|||
148918755|NCT01561898|537185984|FG000|Overall Study|Lost to Follow-up|0|||
148918756|NCT01561898|537185985|FG001|Overall Study|Lost to Follow-up|0|||
148918757|NCT01561898|537185986|FG002|Overall Study|Lost to Follow-up|1|||
148918758|NCT01561898|537185987|FG003|Overall Study|Lost to Follow-up|0|||
148918759|NCT01561898|537185984|FG000|Overall Study|Adverse Event|1|||
149152467|NCT00774345|538034833|FG001|Treatment|Death|0|||
149152468|NCT00774345|538034832|FG000|Treatment|Other Reasons|32|||
149152469|NCT00774345|538034833|FG001|Treatment|Other Reasons|26|||
149152470|NCT00796315|538034836|FG000|Overall Study|Protocol Violation|0|||
149152471|NCT00796315|538034837|FG001|Overall Study|Protocol Violation|1|||
149152472|NCT00796315|538034838|FG002|Overall Study|Protocol Violation|0|||
149152473|NCT00689871|538034850|FG000|Overall Study|Lost to Follow-up|123|||
149152474|NCT00689871|538034851|FG001|Overall Study|Lost to Follow-up|13|||
149152475|NCT00689871|538034852|FG002|Overall Study|Lost to Follow-up|37|||
149152476|NCT00689871|538034853|FG003|Overall Study|Lost to Follow-up|1|||
149152477|NCT00689871|538034850|FG000|Overall Study|Explanted of All Study Devices|36|||
149152478|NCT00689871|538034851|FG001|Overall Study|Explanted of All Study Devices|25|||
149152479|NCT00689871|538034852|FG002|Overall Study|Explanted of All Study Devices|29|||
149152480|NCT00689871|538034853|FG003|Overall Study|Explanted of All Study Devices|3|||
149152481|NCT00689871|538034850|FG000|Overall Study|Withdrawal by Subject|13|||
149152482|NCT00689871|538034851|FG001|Overall Study|Withdrawal by Subject|3|||
149152483|NCT00689871|538034852|FG002|Overall Study|Withdrawal by Subject|4|||
149152484|NCT00689871|538034853|FG003|Overall Study|Withdrawal by Subject|1|||
149152485|NCT00689871|538034850|FG000|Overall Study|Death|1|||
149152486|NCT00689871|538034851|FG001|Overall Study|Death|10|||
149152487|NCT00689871|538034852|FG002|Overall Study|Death|2|||
149152488|NCT00689871|538034853|FG003|Overall Study|Death|2|||
149152489|NCT00689871|538034850|FG000|Overall Study|Physician Decision|2|||
149152490|NCT00689871|538034851|FG001|Overall Study|Physician Decision|1|||
149152491|NCT00689871|538034852|FG002|Overall Study|Physician Decision|1|||
149152492|NCT00689871|538034853|FG003|Overall Study|Physician Decision|0|||
149152493|NCT02054897|538034854|FG000|Overall Study|Withdrawal by Subject|2|||
149152494|NCT02054897|538034855|FG001|Overall Study|Withdrawal by Subject|0|||
149152495|NCT02054897|538034856|FG002|Overall Study|Withdrawal by Subject|2|||
149152496|NCT02054897|538034854|FG000|Overall Study|Missing follow-up information|3|||
149152497|NCT02054897|538034855|FG001|Overall Study|Missing follow-up information|5|||
149152498|NCT02054897|538034856|FG002|Overall Study|Missing follow-up information|3|||
149152499|NCT02054897|538034854|FG000|Overall Study|Lost to Follow-up|4|||
149152500|NCT02054897|538034855|FG001|Overall Study|Lost to Follow-up|2|||
149152501|NCT02054897|538034856|FG002|Overall Study|Lost to Follow-up|7|||
149152502|NCT02054897|538034854|FG000|Overall Study|Randomized but not exposed|1|||
149152503|NCT02054897|538034855|FG001|Overall Study|Randomized but not exposed|0|||
149152504|NCT02054897|538034856|FG002|Overall Study|Randomized but not exposed|0|||
149152505|NCT00960843|538034857|FG000|Overall Study|Lost to Follow-up|2|||
149152506|NCT00960843|538034858|FG001|Overall Study|Lost to Follow-up|0|||
149152507|NCT00960843|538034857|FG000|Overall Study|Protocol Violation|0|||
149152508|NCT00960843|538034858|FG001|Overall Study|Protocol Violation|4|||
149152509|NCT00960843|538034857|FG000|Overall Study|Repeated needle dislodgment|0|||
148918760|NCT01561898|537185985|FG001|Overall Study|Adverse Event|19|||
148918761|NCT01561898|537185986|FG002|Overall Study|Adverse Event|14|||
148918762|NCT01561898|537185987|FG003|Overall Study|Adverse Event|9|||
148918763|NCT01561898|537185984|FG000|Overall Study|Physician Decision|1|||
148918764|NCT01561898|537185985|FG001|Overall Study|Physician Decision|5|||
148918765|NCT01561898|537185986|FG002|Overall Study|Physician Decision|7|||
148918766|NCT01561898|537185987|FG003|Overall Study|Physician Decision|1|||
148918767|NCT00331552|537185990|FG000|Period 3: Phase II|Neurological Symptoms|1|||
148918768|NCT00331552|537185991|FG001|Period 3: Phase II|Neurological Symptoms|0|||
148918769|NCT00331552|537185990|FG000|Period 3: Phase II|Severe Nausea|1|||
148918770|NCT00331552|537185991|FG001|Period 3: Phase II|Severe Nausea|0|||
148918771|NCT01445548|537185992|FG000|Overall Study|Adverse Event|1|||
148918772|NCT01883453|537185993|FG000|Overall Study|No episode of common cold|25|||
148918773|NCT01883453|537185994|FG001|Overall Study|No episode of common cold|23|||
148918774|NCT03642132|537185996|FG000|Chemotherapy Period|Adverse Event|1|||
148918775|NCT03642132|537185997|FG001|Chemotherapy Period|Adverse Event|1|||
148918776|NCT03642132|537185998|FG002|Chemotherapy Period|Adverse Event|0|||
149152510|NCT00960843|538034858|FG001|Overall Study|Repeated needle dislodgment|1|||
149152511|NCT00652366|538034859|FG000|Overall Study|Adverse Event|8|||
149152512|NCT00652366|538034860|FG001|Overall Study|Adverse Event|4|||
149152513|NCT00652366|538034861|FG002|Overall Study|Adverse Event|7|||
149152514|NCT00652366|538034862|FG003|Overall Study|Adverse Event|17|||
149152515|NCT00652366|538034863|FG004|Overall Study|Adverse Event|13|||
149152516|NCT00652366|538034859|FG000|Overall Study|Death|5|||
149152517|NCT00652366|538034860|FG001|Overall Study|Death|4|||
149152518|NCT00652366|538034861|FG002|Overall Study|Death|1|||
149152519|NCT00652366|538034862|FG003|Overall Study|Death|8|||
149152520|NCT00652366|538034863|FG004|Overall Study|Death|5|||
148918777|NCT03642132|537185996|FG000|Chemotherapy Period|Physician's decision|4|||
148918778|NCT03642132|537185997|FG001|Chemotherapy Period|Physician's decision|1|||
148918779|NCT03642132|537185998|FG002|Chemotherapy Period|Physician's decision|0|||
148918780|NCT03642132|537185996|FG000|Chemotherapy Period|Progressive disease|0|||
149152521|NCT00652366|538034859|FG000|Overall Study|Lack of Efficacy|84|||
149152522|NCT00652366|538034860|FG001|Overall Study|Lack of Efficacy|58|||
148918781|NCT03642132|537185997|FG001|Chemotherapy Period|Progressive disease|0|||
149152523|NCT00652366|538034861|FG002|Overall Study|Lack of Efficacy|53|||
148918782|NCT03642132|537185998|FG002|Chemotherapy Period|Progressive disease|1|||
148918783|NCT03642132|537185996|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
148918784|NCT03642132|537185997|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
148918785|NCT03642132|537185998|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
148918786|NCT03642132|537185996|FG000|Chemotherapy Period|Other|1|||
148918787|NCT03642132|537185997|FG001|Chemotherapy Period|Other|0|||
148918788|NCT03642132|537185998|FG002|Chemotherapy Period|Other|2|||
148918789|NCT03642132|537185996|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
148918790|NCT03642132|537185997|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
148918791|NCT03642132|537185998|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
148918792|NCT03642132|537185996|FG000|Maintenance Period|Adverse Event|1|||
148918793|NCT03642132|537185997|FG001|Maintenance Period|Adverse Event|2|||
148918794|NCT03642132|537185998|FG002|Maintenance Period|Adverse Event|0|||
148918795|NCT03642132|537185996|FG000|Maintenance Period|Non-compliance with study drug|0|||
148918796|NCT03642132|537185997|FG001|Maintenance Period|Non-compliance with study drug|0|||
148918797|NCT03642132|537185998|FG002|Maintenance Period|Non-compliance with study drug|1|||
148918798|NCT03642132|537185996|FG000|Maintenance Period|Physician's decision|2|||
148918799|NCT03642132|537185997|FG001|Maintenance Period|Physician's decision|2|||
148918800|NCT03642132|537185998|FG002|Maintenance Period|Physician's decision|2|||
148918801|NCT03642132|537185996|FG000|Maintenance Period|Progressive disease|9|||
148918802|NCT03642132|537185997|FG001|Maintenance Period|Progressive disease|3|||
148918803|NCT03642132|537185998|FG002|Maintenance Period|Progressive disease|6|||
148918804|NCT03642132|537185996|FG000|Maintenance Period|Other|0|||
148918805|NCT03642132|537185997|FG001|Maintenance Period|Other|0|||
148918806|NCT03642132|537185998|FG002|Maintenance Period|Other|3|||
148918807|NCT03642132|537185996|FG000|Maintenance Period|Withdrawal by Subject|1|||
148918808|NCT03642132|537185997|FG001|Maintenance Period|Withdrawal by Subject|1|||
148918809|NCT03642132|537185998|FG002|Maintenance Period|Withdrawal by Subject|2|||
148918810|NCT03642132|537185996|FG000|Follow-up Period|Other|0|||
148918811|NCT03642132|537185997|FG001|Follow-up Period|Other|0|||
148918812|NCT03642132|537185998|FG002|Follow-up Period|Other|1|||
148918813|NCT03642132|537185996|FG000|Follow-up Period|Withdrawal by Subject|1|||
148918814|NCT03642132|537185997|FG001|Follow-up Period|Withdrawal by Subject|2|||
148918815|NCT03642132|537185998|FG002|Follow-up Period|Withdrawal by Subject|0|||
148918816|NCT03642132|537185996|FG000|Follow-up Period|Study terminated by sponsor|1|||
148918817|NCT03642132|537185997|FG001|Follow-up Period|Study terminated by sponsor|0|||
148918818|NCT03642132|537185998|FG002|Follow-up Period|Study terminated by sponsor|1|||
148918819|NCT03642132|537185996|FG000|Follow-up Period|Lack of Efficacy|1|||
148918820|NCT03642132|537185997|FG001|Follow-up Period|Lack of Efficacy|0|||
148918821|NCT03642132|537185998|FG002|Follow-up Period|Lack of Efficacy|0|||
148918822|NCT03642132|537185996|FG000|Follow-up Period|Death|1|||
148918823|NCT03642132|537185997|FG001|Follow-up Period|Death|0|||
148918824|NCT03642132|537185998|FG002|Follow-up Period|Death|2|||
148918825|NCT03642132|537185996|FG000|Follow-up Period|Adverse Event|1|||
148918826|NCT03642132|537185997|FG001|Follow-up Period|Adverse Event|0|||
148918827|NCT03642132|537185998|FG002|Follow-up Period|Adverse Event|0|||
148918828|NCT04493892|537185999|FG000|Overall Study|Withdrawal by Subject|15|||
148918829|NCT02577887|537186000|FG000|Overall Study|Death|93|||
148918830|NCT02577887|537186000|FG000|Overall Study|Protocol Violation|125|||
148918831|NCT02577887|537186000|FG000|Overall Study|Withdrawal by Subject|80|||
148918832|NCT02366091|537186001|FG000|Overall Study|Withdrawal by Subject|3|||
148918833|NCT02366091|537186002|FG001|Overall Study|Withdrawal by Subject|7|||
148918834|NCT02366091|537186003|FG002|Overall Study|Withdrawal by Subject|3|||
148918835|NCT02366091|537186004|FG003|Overall Study|Withdrawal by Subject|1|||
148918836|NCT02338232|537186005|FG000|Overall Study|Screen Failure|3|||
148918837|NCT02338232|537186005|FG000|Overall Study|Withdrawal by Subject|6|||
148918838|NCT02338232|537186005|FG000|Overall Study|Adverse Event|2|||
148918839|NCT01105065|537186006|FG000|Overall Study|Adverse Event|5|||
148918840|NCT01105065|537186006|FG000|Overall Study|Technical Problems|1|||
148918841|NCT00422084|537186007|FG000|Overall Study|Adverse Event|21|||
148918842|NCT00422084|537186008|FG001|Overall Study|Adverse Event|7|||
148918843|NCT00422084|537186007|FG000|Overall Study|Withdrawal by Subject|12|||
148918844|NCT00422084|537186008|FG001|Overall Study|Withdrawal by Subject|9|||
148918845|NCT00422084|537186007|FG000|Overall Study|Lost to Follow-up|14|||
148918846|NCT00422084|537186008|FG001|Overall Study|Lost to Follow-up|9|||
148918847|NCT00422084|537186007|FG000|Overall Study|Protocol Violation|4|||
148918848|NCT00422084|537186008|FG001|Overall Study|Protocol Violation|1|||
148918849|NCT00422084|537186007|FG000|Overall Study|Lack of Efficacy|40|||
148918850|NCT00422084|537186008|FG001|Overall Study|Lack of Efficacy|42|||
148918851|NCT00422084|537186007|FG000|Overall Study|P. vivax infection|3|||
148918852|NCT00422084|537186008|FG001|Overall Study|P. vivax infection|6|||
148918853|NCT00422084|537186007|FG000|Overall Study|Cyesis|1|||
148918854|NCT00422084|537186008|FG001|Overall Study|Cyesis|0|||
148918855|NCT00422084|537186007|FG000|Overall Study|Withdrawn from study accidentally|1|||
148918856|NCT00422084|537186008|FG001|Overall Study|Withdrawn from study accidentally|0|||
148918857|NCT00422084|537186007|FG000|Overall Study|Non-compliance|1|||
148918858|NCT00422084|537186008|FG001|Overall Study|Non-compliance|0|||
148918859|NCT00422084|537186007|FG000|Overall Study|Re-location|0|||
148918860|NCT00422084|537186008|FG001|Overall Study|Re-location|1|||
149152524|NCT00652366|538034862|FG003|Overall Study|Lack of Efficacy|133|||
149152525|NCT00652366|538034863|FG004|Overall Study|Lack of Efficacy|13|||
149152526|NCT00652366|538034859|FG000|Overall Study|Violation of Selection Criteria|0|||
149152527|NCT00652366|538034860|FG001|Overall Study|Violation of Selection Criteria|0|||
149152528|NCT00652366|538034861|FG002|Overall Study|Violation of Selection Criteria|1|||
149152529|NCT00652366|538034862|FG003|Overall Study|Violation of Selection Criteria|0|||
149152530|NCT00652366|538034863|FG004|Overall Study|Violation of Selection Criteria|0|||
149152531|NCT00652366|538034859|FG000|Overall Study|Protocol Violation|1|||
149152532|NCT00652366|538034860|FG001|Overall Study|Protocol Violation|0|||
149152533|NCT00652366|538034861|FG002|Overall Study|Protocol Violation|0|||
149152534|NCT00652366|538034862|FG003|Overall Study|Protocol Violation|0|||
149152535|NCT00652366|538034863|FG004|Overall Study|Protocol Violation|0|||
149152536|NCT00652366|538034859|FG000|Overall Study|Refused treatment|3|||
149152537|NCT00652366|538034860|FG001|Overall Study|Refused treatment|7|||
149152538|NCT00652366|538034861|FG002|Overall Study|Refused treatment|6|||
149152539|NCT00652366|538034862|FG003|Overall Study|Refused treatment|17|||
149152540|NCT00652366|538034863|FG004|Overall Study|Refused treatment|5|||
149152541|NCT00652366|538034859|FG000|Overall Study|Other|5|||
149152542|NCT00652366|538034860|FG001|Overall Study|Other|2|||
149152543|NCT00652366|538034861|FG002|Overall Study|Other|3|||
149152544|NCT00652366|538034862|FG003|Overall Study|Other|4|||
149152545|NCT00652366|538034863|FG004|Overall Study|Other|0|||
149152546|NCT01967537|538034866|FG000|Overall Study|Withdrawal by Subject|52|||
149152547|NCT01967537|538034866|FG000|Overall Study|Refuse treatment|2|||
149152548|NCT01967537|538034866|FG000|Overall Study|Lost to Follow-up|6|||
149152549|NCT04942925|538034870|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
148918861|NCT00422084|537186007|FG000|Overall Study|Not defined|1|||
148918862|NCT00422084|537186008|FG001|Overall Study|Not defined|1|||
148918863|NCT03996369|537186009|FG000|Overall Study|Protocol deviation|1|||
148918864|NCT03996369|537186010|FG001|Overall Study|Protocol deviation|1|||
148918865|NCT03996369|537186009|FG000|Overall Study|Physician Decision|4|||
148918866|NCT03996369|537186010|FG001|Overall Study|Physician Decision|2|||
148918867|NCT03996369|537186009|FG000|Overall Study|Participant decision|0|||
148918868|NCT03996369|537186010|FG001|Overall Study|Participant decision|1|||
148918869|NCT03996369|537186009|FG000|Overall Study|Lack of Efficacy|4|||
148918870|NCT03996369|537186010|FG001|Overall Study|Lack of Efficacy|0|||
148918871|NCT03996369|537186009|FG000|Overall Study|Adverse Event|9|||
148918872|NCT03996369|537186010|FG001|Overall Study|Adverse Event|0|||
148918873|NCT03996369|537186009|FG000|Overall Study|Withdrawal by Subject|6|||
148918874|NCT03996369|537186010|FG001|Overall Study|Withdrawal by Subject|8|||
148918875|NCT03996369|537186009|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
148918876|NCT03996369|537186010|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
148918877|NCT03996369|537186009|FG000|Overall Study|Lost to Follow-up|0|||
148918878|NCT03996369|537186010|FG001|Overall Study|Lost to Follow-up|1|||
148918879|NCT01782469|537186011|FG000|Overall Study|Lost to Follow-up|1|||
148918880|NCT04620798|537186016|FG000|Overall Study|Lost to Follow-up|126|||
148918881|NCT04620798|537186017|FG001|Overall Study|Lost to Follow-up|138|||
148918882|NCT01224782|537186018|FG000|Overall Study|Lost to Follow-up|177|||
148918883|NCT01224782|537186018|FG000|Overall Study|Withdrawal by Subject|16|||
148918884|NCT01224782|537186018|FG000|Overall Study|Death|14|||
148918885|NCT01224782|537186018|FG000|Overall Study|Improvement|13|||
148918886|NCT01224782|537186018|FG000|Overall Study|Adverse Event|12|||
148918887|NCT01224782|537186018|FG000|Overall Study|Adverse Reaction|11|||
148918888|NCT01224782|537186018|FG000|Overall Study|Noncompliance|10|||
148918889|NCT01224782|537186018|FG000|Overall Study|Other|4|||
148918890|NCT01224782|537186018|FG000|Overall Study|Start of Dialysis|3|||
148918891|NCT01224782|537186018|FG000|Overall Study|Change of Treatment|1|||
148918892|NCT01224782|537186018|FG000|Overall Study|Financial Reasons|1|||
149152550|NCT04942925|538034871|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
149152551|NCT04942925|538034870|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
149152552|NCT04942925|538034871|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
149152553|NCT02124564|538034872|FG000|Treatment Period|Adverse Event|2|||
149152554|NCT02124564|538034872|FG000|Treatment Period|Lack of Efficacy|3|||
149152555|NCT02124564|538034872|FG000|Treatment Period|Withdrawal by Subject|2|||
149152556|NCT02043548|538034875|FG000|Overall Study|Lack of Efficacy|1|||
148918893|NCT01224782|537186018|FG000|Overall Study|Deterioration|1|||
148918894|NCT01224782|537186018|FG000|Overall Study|Transplantation|1|||
148918895|NCT01960907|537186019|FG000|Overall Study|Death|4|||
148918896|NCT01960907|537186020|FG001|Overall Study|Death|3|||
149152557|NCT02043548|538034876|FG001|Overall Study|Lack of Efficacy|0|||
149152558|NCT02043548|538034875|FG000|Overall Study|Adverse Event|0|||
149152559|NCT02043548|538034876|FG001|Overall Study|Adverse Event|1|||
148918897|NCT01960907|537186019|FG000|Overall Study|Withdrawal by Subject|32|||
148918898|NCT01960907|537186020|FG001|Overall Study|Withdrawal by Subject|42|||
148672677|NCT00539006|536272454|FG001|Treatment Period 1|Lost to Follow-up|0|||
148672678|NCT00539006|536272455|FG002|Treatment Period 1|Lost to Follow-up|1|||
148672679|NCT00539006|536272456|FG003|Treatment Period 1|Lost to Follow-up|0|||
148672680|NCT00539006|536272453|FG000|Treatment Period 1|Protocol Violation|0|||
148672681|NCT00539006|536272454|FG001|Treatment Period 1|Protocol Violation|0|||
148672682|NCT00539006|536272455|FG002|Treatment Period 1|Protocol Violation|1|||
148672683|NCT00539006|536272456|FG003|Treatment Period 1|Protocol Violation|0|||
148672684|NCT00539006|536272453|FG000|Treatment Period 1|Lack of Efficacy|0|||
148672685|NCT00539006|536272454|FG001|Treatment Period 1|Lack of Efficacy|0|||
148672686|NCT00539006|536272455|FG002|Treatment Period 1|Lack of Efficacy|0|||
148672687|NCT00539006|536272456|FG003|Treatment Period 1|Lack of Efficacy|1|||
148672688|NCT00539006|536272453|FG000|Washout|Adverse Event|2|||
148672689|NCT00539006|536272454|FG001|Washout|Adverse Event|1|||
148672690|NCT00539006|536272455|FG002|Washout|Adverse Event|0|||
148672691|NCT00539006|536272456|FG003|Washout|Adverse Event|0|||
148672692|NCT00539006|536272453|FG000|Washout|Protocol Violation|1|||
148672693|NCT00539006|536272454|FG001|Washout|Protocol Violation|1|||
148672694|NCT00539006|536272455|FG002|Washout|Protocol Violation|0|||
148672695|NCT00539006|536272456|FG003|Washout|Protocol Violation|0|||
148672696|NCT00539006|536272453|FG000|Washout|Withdrawal by Subject|0|||
148672697|NCT00539006|536272454|FG001|Washout|Withdrawal by Subject|2|||
148672698|NCT00539006|536272455|FG002|Washout|Withdrawal by Subject|0|||
148672699|NCT00539006|536272456|FG003|Washout|Withdrawal by Subject|0|||
148672700|NCT00539006|536272453|FG000|Washout|Failed to meet continuation criteria|16|||
148672701|NCT00539006|536272454|FG001|Washout|Failed to meet continuation criteria|5|||
148672702|NCT00539006|536272455|FG002|Washout|Failed to meet continuation criteria|14|||
148672703|NCT00539006|536272456|FG003|Washout|Failed to meet continuation criteria|6|||
148672704|NCT00539006|536272453|FG000|Washout|Other|1|||
148672705|NCT00539006|536272454|FG001|Washout|Other|1|||
148672706|NCT00539006|536272455|FG002|Washout|Other|2|||
148672707|NCT00539006|536272456|FG003|Washout|Other|3|||
148672708|NCT00539006|536272453|FG000|Treatment Period 2|Protocol Violation|1|||
148672709|NCT00539006|536272454|FG001|Treatment Period 2|Protocol Violation|0|||
148672710|NCT00539006|536272455|FG002|Treatment Period 2|Protocol Violation|0|||
148672711|NCT00539006|536272456|FG003|Treatment Period 2|Protocol Violation|0|||
148672712|NCT00539006|536272453|FG000|Treatment Period 2|Other|0|||
148672713|NCT00539006|536272454|FG001|Treatment Period 2|Other|1|||
148672714|NCT00539006|536272455|FG002|Treatment Period 2|Other|0|||
148672715|NCT00539006|536272456|FG003|Treatment Period 2|Other|0|||
148672716|NCT00769132|536272459|FG000|Period 1|Adverse Event|1|||
148672717|NCT00769132|536272460|FG001|Period 1|Adverse Event|0|||
148672718|NCT00769132|536272461|FG002|Period 1|Adverse Event|0|||
148672719|NCT00769132|536272462|FG003|Period 1|Adverse Event|1|||
148672720|NCT00769132|536272459|FG000|Period 2|Withdrawal by Subject|0|||
148672721|NCT00769132|536272460|FG001|Period 2|Withdrawal by Subject|0|||
148672722|NCT00769132|536272461|FG002|Period 2|Withdrawal by Subject|0|||
148672723|NCT00769132|536272462|FG003|Period 2|Withdrawal by Subject|1|||
148672724|NCT00769132|536272459|FG000|Period 3|Withdrawal by Subject|1|||
148672725|NCT00769132|536272460|FG001|Period 3|Withdrawal by Subject|0|||
148672726|NCT00769132|536272461|FG002|Period 3|Withdrawal by Subject|0|||
148672727|NCT00769132|536272462|FG003|Period 3|Withdrawal by Subject|0|||
148672728|NCT00769132|536272459|FG000|Period 4|Withdrawal by Subject|0|||
148918899|NCT02270944|537186028|FG000|Overall Study|Lost to Follow-up|9|||
148918900|NCT02270944|537186029|FG001|Overall Study|Lost to Follow-up|4|||
148918901|NCT02270944|537186028|FG000|Overall Study|Withdrawal by Subject|2|||
148918902|NCT02270944|537186029|FG001|Overall Study|Withdrawal by Subject|1|||
148918903|NCT01181986|537186032|FG000|Phase 1|Lost to Follow-up|0|||
148918904|NCT01181986|537186033|FG001|Phase 1|Lost to Follow-up|1|||
148672729|NCT00769132|536272460|FG001|Period 4|Withdrawal by Subject|1|||
148672730|NCT00769132|536272461|FG002|Period 4|Withdrawal by Subject|0|||
148672731|NCT00769132|536272462|FG003|Period 4|Withdrawal by Subject|0|||
148672732|NCT02230332|536272463|FG000|Overall Study|Adverse Event|2|||
148672733|NCT02230332|536272464|FG001|Overall Study|Adverse Event|1|||
148672734|NCT02230332|536272463|FG000|Overall Study|Lost to Follow-up|1|||
148672735|NCT02230332|536272464|FG001|Overall Study|Lost to Follow-up|0|||
148672736|NCT02230332|536272463|FG000|Overall Study|Protocol Violation|1|||
148918905|NCT01181986|537186034|FG002|Phase 1|Lost to Follow-up|1|||
148672737|NCT02230332|536272464|FG001|Overall Study|Protocol Violation|0|||
148672738|NCT01260194|536272466|FG000|Overall Study|Withdrawal of Consent|1|||
148672739|NCT00877799|536272467|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
148672740|NCT00877799|536272468|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
148672741|NCT00877799|536272469|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
148672742|NCT00877799|536272470|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
148672743|NCT00877799|536272471|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
148672744|NCT00877799|536272467|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
148672745|NCT00877799|536272468|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
148672746|NCT00877799|536272469|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
148805753|NCT02194465|536768017|FG004|Overall Study|Adverse Event|4|||
148918906|NCT01181986|537186032|FG000|Phase 1|Adverse Event|0|||
148918907|NCT01181986|537186033|FG001|Phase 1|Adverse Event|0|||
148918908|NCT01181986|537186034|FG002|Phase 1|Adverse Event|1|||
148918909|NCT01181986|537186032|FG000|Phase 1|Protocol Violation|1|||
148918910|NCT01181986|537186033|FG001|Phase 1|Protocol Violation|0|||
148918911|NCT01181986|537186034|FG002|Phase 1|Protocol Violation|0|||
148918912|NCT01181986|537186032|FG000|Phase 2|Adverse Event|0|||
148918913|NCT01181986|537186033|FG001|Phase 2|Adverse Event|3|||
148918914|NCT01181986|537186034|FG002|Phase 2|Adverse Event|0|||
149152560|NCT03829657|538034880|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
149152561|NCT03829657|538034881|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
149152562|NCT03829657|538034882|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
149152563|NCT03829657|538034883|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
149152564|NCT03829657|538034884|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
149152565|NCT03829657|538034880|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
149152566|NCT03829657|538034881|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149152567|NCT03829657|538034882|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149152568|NCT03829657|538034883|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149152569|NCT03829657|538034884|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149152570|NCT03829657|538034880|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
149152571|NCT03829657|538034881|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
148918915|NCT01181986|537186032|FG000|Phase 2|Medical condition|0|||
148918916|NCT01181986|537186033|FG001|Phase 2|Medical condition|1|||
148918917|NCT01181986|537186034|FG002|Phase 2|Medical condition|0|||
148918918|NCT01011309|537186035|FG000|Overall Study|Adverse Event|2|||
148918919|NCT01011309|537186036|FG001|Overall Study|Adverse Event|1|||
148918920|NCT01011309|537186037|FG002|Overall Study|Adverse Event|2|||
148918921|NCT01011309|537186035|FG000|Overall Study|Lack of Efficacy|0|||
148918922|NCT01011309|537186036|FG001|Overall Study|Lack of Efficacy|1|||
148918923|NCT01011309|537186037|FG002|Overall Study|Lack of Efficacy|0|||
148918924|NCT01011309|537186035|FG000|Overall Study|Protocol Violation|0|||
148918925|NCT01011309|537186036|FG001|Overall Study|Protocol Violation|1|||
148918926|NCT01011309|537186037|FG002|Overall Study|Protocol Violation|3|||
148918927|NCT00831493|537186040|FG000|Overall Study|Intractable nausea and vomiting|1|||
148918928|NCT05092360|537186048|FG000|Overall Study|Withdrawal by Subject|21|||
148918929|NCT05092360|537186049|FG001|Overall Study|Withdrawal by Subject|4|||
148918930|NCT05092360|537186050|FG002|Overall Study|Withdrawal by Subject|9|||
148918931|NCT05092360|537186051|FG003|Overall Study|Withdrawal by Subject|26|||
148918932|NCT05092360|537186048|FG000|Overall Study|Death|97|||
148918933|NCT05092360|537186049|FG001|Overall Study|Death|14|||
148918934|NCT05092360|537186050|FG002|Overall Study|Death|31|||
148918935|NCT05092360|537186051|FG003|Overall Study|Death|101|||
148918936|NCT05092360|537186048|FG000|Overall Study|Lost to Follow-up|1|||
148918937|NCT05092360|537186049|FG001|Overall Study|Lost to Follow-up|2|||
148918938|NCT05092360|537186050|FG002|Overall Study|Lost to Follow-up|2|||
148918939|NCT05092360|537186051|FG003|Overall Study|Lost to Follow-up|2|||
148918940|NCT05092360|537186048|FG000|Overall Study|Study terminated by sponsor|65|||
148918941|NCT05092360|537186049|FG001|Overall Study|Study terminated by sponsor|7|||
148918942|NCT05092360|537186050|FG002|Overall Study|Study terminated by sponsor|13|||
148918943|NCT05092360|537186051|FG003|Overall Study|Study terminated by sponsor|61|||
148918944|NCT01525225|537186052|FG000|Enrollment|No longer met study criteria|1|||
148918945|NCT01525225|537186052|FG000|Enrollment|Other|1|||
148918946|NCT01182844|537186053|FG000|Overall Study|Withdrawal by Subject|0|||
148918947|NCT01182844|537186054|FG001|Overall Study|Withdrawal by Subject|2|||
148918948|NCT05009979|537186058|FG000|Overall Study|Withdrawal by Subject|1|||
148918949|NCT00576420|537187747|FG000|Overall Study|Death|0|||
148918950|NCT00576420|537187748|FG001|Overall Study|Death|0|||
148918951|NCT00576420|537187749|FG002|Overall Study|Death|1|||
148918952|NCT02043899|537187753|FG000|Overall Study|Adverse Event|3|||
148918953|NCT02043899|537187753|FG000|Overall Study|Physician Decision|1|||
148918954|NCT02043899|537187753|FG000|Overall Study|Withdrawal by Subject|2|||
148918955|NCT02043899|537187753|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
148918956|NCT02043899|537187753|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
148918957|NCT02043899|537187753|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
148918958|NCT02043899|537187753|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
148918959|NCT02043899|537187753|FG000|Overall Study|Treatment delayed|1|||
148918960|NCT03254108|537187754|FG000|Overall Study|Adverse Event|0|||
148918961|NCT03254108|537187755|FG001|Overall Study|Adverse Event|2|||
148918962|NCT03254108|537187756|FG002|Overall Study|Adverse Event|0|||
148918963|NCT03254108|537187757|FG003|Overall Study|Adverse Event|1|||
148918964|NCT03254108|537187758|FG004|Overall Study|Adverse Event|1|||
148918965|NCT03254108|537187754|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
148918966|NCT03254108|537187755|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
148918967|NCT03254108|537187756|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
148918968|NCT03254108|537187757|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
148918969|NCT03254108|537187758|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
148918970|NCT01771809|537187759|FG000|Overall Study|Adverse Event|4|||
148918971|NCT01771809|537187760|FG001|Overall Study|Adverse Event|12|||
148918972|NCT01771809|537187759|FG000|Overall Study|Protocol Violation|0|||
148918973|NCT01771809|537187760|FG001|Overall Study|Protocol Violation|1|||
148918974|NCT01771809|537187759|FG000|Overall Study|Withdrawal by Subject|34|||
148918975|NCT01771809|537187760|FG001|Overall Study|Withdrawal by Subject|42|||
148918976|NCT01771809|537187759|FG000|Overall Study|Lost to Follow-up|1|||
148918977|NCT01771809|537187760|FG001|Overall Study|Lost to Follow-up|3|||
148805754|NCT02194465|536768018|FG005|Overall Study|Adverse Event|2|||
148918978|NCT01771809|537187759|FG000|Overall Study|Other (Insufficient clinical response)|22|||
148918979|NCT01771809|537187760|FG001|Overall Study|Other (Insufficient clinical response)|20|||
148918980|NCT01771809|537187759|FG000|Overall Study|Death|1|||
148918981|NCT01771809|537187760|FG001|Overall Study|Death|0|||
148918982|NCT01771809|537187759|FG000|Overall Study|Other (other)|9|||
148918983|NCT01771809|537187760|FG001|Overall Study|Other (other)|5|||
148918984|NCT00362180|537187761|FG000|Treated Period|Withdrawal by Subject|1|||
148805755|NCT02194465|536768019|FG006|Overall Study|Adverse Event|0|||
148918985|NCT00362180|537187762|FG001|Treated Period|Withdrawal by Subject|0|||
148918986|NCT00362180|537187763|FG002|Treated Period|Withdrawal by Subject|0|||
148918987|NCT00362180|537187764|FG003|Treated Period|Withdrawal by Subject|0|||
148918988|NCT00362180|537187765|FG004|Treated Period|Withdrawal by Subject|0|||
148918989|NCT00362180|537187766|FG005|Treated Period|Withdrawal by Subject|0|||
148918990|NCT00362180|537187767|FG006|Treated Period|Withdrawal by Subject|0|||
148918991|NCT00362180|537187768|FG007|Treated Period|Withdrawal by Subject|0|||
148918992|NCT00362180|537187769|FG008|Treated Period|Withdrawal by Subject|0|||
148918993|NCT00362180|537187761|FG000|Treated Period|Adverse Event|0|||
148918994|NCT00362180|537187762|FG001|Treated Period|Adverse Event|0|||
148918995|NCT00362180|537187763|FG002|Treated Period|Adverse Event|0|||
148918996|NCT00362180|537187764|FG003|Treated Period|Adverse Event|0|||
148918997|NCT00362180|537187765|FG004|Treated Period|Adverse Event|0|||
148918998|NCT00362180|537187766|FG005|Treated Period|Adverse Event|1|||
148918999|NCT00362180|537187767|FG006|Treated Period|Adverse Event|0|||
148919000|NCT00362180|537187768|FG007|Treated Period|Adverse Event|1|||
148919001|NCT00362180|537187769|FG008|Treated Period|Adverse Event|0|||
148919002|NCT01106092|537187770|FG000|Overall Study|Withdrawal by Subject|0|||
148919003|NCT01106092|537187771|FG001|Overall Study|Withdrawal by Subject|0|||
148919004|NCT01106092|537187772|FG002|Overall Study|Withdrawal by Subject|0|||
148919005|NCT01106092|537187773|FG003|Overall Study|Withdrawal by Subject|1|||
148919006|NCT02434471|537187778|FG000|Overall Study|Physician Decision|9|||
148919007|NCT04839562|537187783|FG000|Overall Study|Withdrawal by Subject|0|||
148919008|NCT04839562|537187784|FG001|Overall Study|Withdrawal by Subject|1|||
148919009|NCT04839562|537187783|FG000|Overall Study|Physician Decision|0|||
148919010|NCT04839562|537187784|FG001|Overall Study|Physician Decision|1|||
148919011|NCT00003472|537187792|FG000|Overall Study|Not evaluable|3|||
148919012|NCT01012219|537187793|FG000|Period 1|Withdrawal by Subject|1|||
148919013|NCT01012219|537187793|FG000|Period 2|Withdrawal by Subject|1|||
148919014|NCT01350544|537187798|FG000|Overall Study|Administrative Withdrawal|0|||
148919015|NCT01350544|537187799|FG001|Overall Study|Administrative Withdrawal|1|||
148919016|NCT01350544|537187798|FG000|Overall Study|Death|1|||
148919017|NCT01350544|537187799|FG001|Overall Study|Death|2|||
148919018|NCT01350544|537187798|FG000|Overall Study|Moved out of LA County|2|||
148919019|NCT01350544|537187799|FG001|Overall Study|Moved out of LA County|2|||
148919020|NCT01350544|537187798|FG000|Overall Study|Medical Issues|1|||
148919021|NCT01350544|537187799|FG001|Overall Study|Medical Issues|1|||
148919022|NCT01350544|537187798|FG000|Overall Study|Withdrawal by Subject|0|||
148919023|NCT01350544|537187799|FG001|Overall Study|Withdrawal by Subject|1|||
148919024|NCT01350544|537187798|FG000|Overall Study|Incarceration|1|||
148919025|NCT01350544|537187799|FG001|Overall Study|Incarceration|0|||
148919026|NCT01350544|537187798|FG000|Overall Study|Lost to Follow-up|18|||
148919027|NCT01350544|537187799|FG001|Overall Study|Lost to Follow-up|15|||
148919028|NCT01444092|537187800|FG000|Overall Study|Adverse Event|8|||
148919029|NCT01444092|537187800|FG000|Overall Study|Protocol Violation|1|||
148919030|NCT01444092|537187800|FG000|Overall Study|Withdrawal by Subject|1|||
148919031|NCT01444092|537187800|FG000|Overall Study|Other Eligibility criteria|7|||
148919032|NCT01328366|537187803|FG000|Overall Study|Death|1|||
148919033|NCT01328366|537187803|FG000|Overall Study|Withdrawal by Subject|2|||
148919034|NCT01328366|537187803|FG000|Overall Study|Lost to Follow-up|7|||
148919035|NCT00910624|537187804|FG000|Treatment Phase|Adverse Event|2|||
148919036|NCT00910624|537187805|FG001|Treatment Phase|Adverse Event|6|||
148919037|NCT00910624|537187806|FG002|Treatment Phase|Adverse Event|6|||
148919038|NCT00910624|537187807|FG003|Treatment Phase|Adverse Event|0|||
148919039|NCT00910624|537187804|FG000|Treatment Phase|Treatment Failure|23|||
148919040|NCT00910624|537187805|FG001|Treatment Phase|Treatment Failure|10|||
148919041|NCT00910624|537187806|FG002|Treatment Phase|Treatment Failure|0|||
148919042|NCT00910624|537187807|FG003|Treatment Phase|Treatment Failure|0|||
148919043|NCT00910624|537187804|FG000|Treatment Phase|Lost to Follow-up|0|||
148919044|NCT00910624|537187805|FG001|Treatment Phase|Lost to Follow-up|0|||
148919045|NCT00910624|537187806|FG002|Treatment Phase|Lost to Follow-up|1|||
148672747|NCT00877799|536272470|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
148919046|NCT00910624|537187807|FG003|Treatment Phase|Lost to Follow-up|0|||
148919047|NCT00910624|537187804|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
148919048|NCT00910624|537187805|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
148919049|NCT00910624|537187806|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
148919050|NCT00910624|537187807|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
148919051|NCT00910624|537187804|FG000|Treatment Phase|Withdrawal by Subject|2|||
148919052|NCT00910624|537187805|FG001|Treatment Phase|Withdrawal by Subject|1|||
149152572|NCT03829657|538034882|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
149152573|NCT03829657|538034883|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
149152574|NCT03829657|538034884|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
149152575|NCT03829657|538034880|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
149152576|NCT03829657|538034881|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
149152577|NCT03829657|538034882|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
149152578|NCT03829657|538034883|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
149152579|NCT03829657|538034884|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
149152580|NCT03829657|538034880|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
149152581|NCT03829657|538034881|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
149152582|NCT03829657|538034882|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
149152583|NCT03829657|538034883|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
149152584|NCT03829657|538034884|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
149152585|NCT03829657|538034880|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
149152586|NCT03829657|538034881|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
149152587|NCT03829657|538034882|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
149152588|NCT03829657|538034883|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
149152589|NCT03829657|538034884|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
149152590|NCT03829657|538034880|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
149152591|NCT03829657|538034881|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
149152592|NCT03829657|538034882|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
149152593|NCT03829657|538034883|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
149152594|NCT03829657|538034884|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
149152595|NCT03829657|538034880|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
149152596|NCT03829657|538034881|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
149152597|NCT03829657|538034882|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
149152598|NCT03829657|538034883|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
149152599|NCT03829657|538034884|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
149152600|NCT03829657|538034880|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
149152601|NCT03829657|538034881|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
149152602|NCT03829657|538034882|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
149152603|NCT03829657|538034883|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
149152604|NCT03829657|538034884|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
149152605|NCT03829657|538034880|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
149152606|NCT03829657|538034881|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
149152607|NCT03829657|538034882|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
149152608|NCT03829657|538034883|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
149152609|NCT03829657|538034884|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
149152610|NCT04418076|538034885|FG000|Overall Study|Death|1|||
149152611|NCT04418076|538034886|FG001|Overall Study|Death|0|||
149152612|NCT04418076|538034887|FG002|Overall Study|Death|0|||
149152613|NCT04418076|538034888|FG003|Overall Study|Death|0|||
149152614|NCT04418076|538034885|FG000|Overall Study|Lost to Follow-up|2|||
149152615|NCT04418076|538034886|FG001|Overall Study|Lost to Follow-up|5|||
149152616|NCT04418076|538034887|FG002|Overall Study|Lost to Follow-up|1|||
149152617|NCT04418076|538034888|FG003|Overall Study|Lost to Follow-up|2|||
149152618|NCT04418076|538034885|FG000|Overall Study|Withdrawal by Subject|1|||
149152619|NCT04418076|538034886|FG001|Overall Study|Withdrawal by Subject|0|||
149152620|NCT04418076|538034887|FG002|Overall Study|Withdrawal by Subject|1|||
149152621|NCT04418076|538034888|FG003|Overall Study|Withdrawal by Subject|1|||
149152622|NCT04418076|538034885|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
149152623|NCT04418076|538034886|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
149152624|NCT04418076|538034887|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
149152625|NCT04418076|538034888|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
149152626|NCT03315871|538034892|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
149152627|NCT03315871|538034893|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
149152628|NCT03315871|538034894|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
149152629|NCT03315871|538034892|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
149152630|NCT03315871|538034893|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
149152631|NCT03315871|538034894|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
149152632|NCT03315871|538034892|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
149152633|NCT03315871|538034893|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
149152634|NCT03315871|538034894|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
149152635|NCT03315871|538034892|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
149152636|NCT03315871|538034893|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
149152637|NCT03315871|538034894|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
149152638|NCT03315871|538034892|FG000|PROSTVAC + CV301|Progressive disease|0|||
149152639|NCT03315871|538034893|FG001|PROSTVAC + CV301|Progressive disease|0|||
149152640|NCT03315871|538034894|FG002|PROSTVAC + CV301|Progressive disease|1|||
149152641|NCT03315871|538034892|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
149152642|NCT03315871|538034893|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
149152643|NCT03315871|538034894|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
149152644|NCT02600507|538036620|FG000|Overall Study|Adverse Event|3|||
149152645|NCT02600507|538036621|FG001|Overall Study|Adverse Event|15|||
149152646|NCT02600507|538036622|FG002|Overall Study|Adverse Event|5|||
149152647|NCT02600507|538036620|FG000|Overall Study|Lack of Efficacy|3|||
149152648|NCT02600507|538036621|FG001|Overall Study|Lack of Efficacy|8|||
149152649|NCT02600507|538036622|FG002|Overall Study|Lack of Efficacy|5|||
149152650|NCT02600507|538036620|FG000|Overall Study|Lost to Follow-up|3|||
149152651|NCT02600507|538036621|FG001|Overall Study|Lost to Follow-up|5|||
149152652|NCT02600507|538036622|FG002|Overall Study|Lost to Follow-up|2|||
149152653|NCT02600507|538036620|FG000|Overall Study|Protocol Violation|12|||
149152654|NCT02600507|538036621|FG001|Overall Study|Protocol Violation|4|||
149152655|NCT02600507|538036622|FG002|Overall Study|Protocol Violation|4|||
149152656|NCT02600507|538036620|FG000|Overall Study|Physician Decision|1|||
149152657|NCT02600507|538036621|FG001|Overall Study|Physician Decision|0|||
149152658|NCT02600507|538036622|FG002|Overall Study|Physician Decision|1|||
149152659|NCT02600507|538036620|FG000|Overall Study|Withdrawal by Subject|7|||
149152660|NCT02600507|538036621|FG001|Overall Study|Withdrawal by Subject|11|||
149152661|NCT02600507|538036622|FG002|Overall Study|Withdrawal by Subject|7|||
149152662|NCT02600507|538036620|FG000|Overall Study|Other|0|||
149152663|NCT02600507|538036621|FG001|Overall Study|Other|1|||
149152664|NCT02600507|538036622|FG002|Overall Study|Other|1|||
149152665|NCT05048719|538036627|FG000|Overall Study|Withdrawal by Subject|2|||
149152666|NCT05048719|538036628|FG001|Overall Study|Withdrawal by Subject|1|||
149152667|NCT05048719|538036629|FG002|Overall Study|Withdrawal by Subject|3|||
149152668|NCT05048719|538036630|FG003|Overall Study|Withdrawal by Subject|1|||
149152669|NCT05048719|538036631|FG004|Overall Study|Withdrawal by Subject|0|||
149152670|NCT05048719|538036632|FG005|Overall Study|Withdrawal by Subject|2|||
149152671|NCT05048719|538036633|FG006|Overall Study|Withdrawal by Subject|1|||
149152672|NCT05048719|538036634|FG007|Overall Study|Withdrawal by Subject|1|||
149152673|NCT05048719|538036635|FG008|Overall Study|Withdrawal by Subject|0|||
149152674|NCT05048719|538036627|FG000|Overall Study|Death|1|||
149152675|NCT05048719|538036628|FG001|Overall Study|Death|0|||
149152676|NCT05048719|538036629|FG002|Overall Study|Death|0|||
149152677|NCT05048719|538036630|FG003|Overall Study|Death|0|||
149152678|NCT05048719|538036631|FG004|Overall Study|Death|0|||
149152679|NCT05048719|538036632|FG005|Overall Study|Death|0|||
149152680|NCT05048719|538036633|FG006|Overall Study|Death|0|||
149152681|NCT05048719|538036634|FG007|Overall Study|Death|0|||
149152682|NCT05048719|538036635|FG008|Overall Study|Death|0|||
149152683|NCT05048719|538036627|FG000|Overall Study|Adverse Event|0|||
149152684|NCT05048719|538036628|FG001|Overall Study|Adverse Event|1|||
149152685|NCT05048719|538036629|FG002|Overall Study|Adverse Event|2|||
149152686|NCT05048719|538036630|FG003|Overall Study|Adverse Event|0|||
149152687|NCT05048719|538036631|FG004|Overall Study|Adverse Event|1|||
149152688|NCT05048719|538036632|FG005|Overall Study|Adverse Event|0|||
149152689|NCT05048719|538036633|FG006|Overall Study|Adverse Event|0|||
149152690|NCT05048719|538036634|FG007|Overall Study|Adverse Event|0|||
149152691|NCT05048719|538036635|FG008|Overall Study|Adverse Event|0|||
149152692|NCT05048719|538036627|FG000|Overall Study|Lost to Follow-up|0|||
149152693|NCT05048719|538036628|FG001|Overall Study|Lost to Follow-up|0|||
149152694|NCT05048719|538036629|FG002|Overall Study|Lost to Follow-up|1|||
149152695|NCT05048719|538036630|FG003|Overall Study|Lost to Follow-up|3|||
149152696|NCT05048719|538036631|FG004|Overall Study|Lost to Follow-up|1|||
149152697|NCT05048719|538036632|FG005|Overall Study|Lost to Follow-up|1|||
149152698|NCT05048719|538036633|FG006|Overall Study|Lost to Follow-up|1|||
149152699|NCT05048719|538036634|FG007|Overall Study|Lost to Follow-up|1|||
149152700|NCT05048719|538036635|FG008|Overall Study|Lost to Follow-up|0|||
149152701|NCT05048719|538036627|FG000|Overall Study|Physician Decision|0|||
149152702|NCT05048719|538036628|FG001|Overall Study|Physician Decision|0|||
149152703|NCT05048719|538036629|FG002|Overall Study|Physician Decision|0|||
149152704|NCT05048719|538036630|FG003|Overall Study|Physician Decision|0|||
149152705|NCT05048719|538036631|FG004|Overall Study|Physician Decision|0|||
149152706|NCT05048719|538036632|FG005|Overall Study|Physician Decision|0|||
149152707|NCT05048719|538036633|FG006|Overall Study|Physician Decision|0|||
149152708|NCT05048719|538036634|FG007|Overall Study|Physician Decision|1|||
149152709|NCT05048719|538036635|FG008|Overall Study|Physician Decision|1|||
149152710|NCT05048719|538036627|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
149152711|NCT05048719|538036628|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152712|NCT05048719|538036629|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152713|NCT05048719|538036630|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152714|NCT05048719|538036631|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152715|NCT05048719|538036632|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152716|NCT05048719|538036633|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152717|NCT05048719|538036634|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152718|NCT05048719|538036635|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
149152719|NCT05048719|538036627|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152720|NCT05048719|538036628|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
149152721|NCT05048719|538036629|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152722|NCT05048719|538036630|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152723|NCT05048719|538036631|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152724|NCT05048719|538036632|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152725|NCT05048719|538036633|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152726|NCT05048719|538036634|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152727|NCT05048719|538036635|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
149152728|NCT05048719|538036627|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152729|NCT05048719|538036628|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
149152730|NCT05048719|538036629|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152731|NCT05048719|538036630|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152732|NCT05048719|538036631|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152733|NCT05048719|538036632|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152734|NCT05048719|538036633|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152735|NCT05048719|538036634|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152736|NCT05048719|538036635|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
149152737|NCT05048719|538036627|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152738|NCT05048719|538036628|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152739|NCT05048719|538036629|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152740|NCT05048719|538036630|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
149152741|NCT05048719|538036631|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152742|NCT05048719|538036632|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152743|NCT05048719|538036633|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152744|NCT05048719|538036634|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
149152745|NCT05048719|538036635|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
148919053|NCT00910624|537187806|FG002|Treatment Phase|Withdrawal by Subject|0|||
148919054|NCT00910624|537187807|FG003|Treatment Phase|Withdrawal by Subject|0|||
148919055|NCT00910624|537187804|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
148919056|NCT00910624|537187805|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
148919057|NCT00910624|537187806|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
148919058|NCT00910624|537187807|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
148672748|NCT00877799|536272471|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
148919059|NCT00910624|537187804|FG000|Follow-Up Phase|Adverse Event|0|||
148919060|NCT00910624|537187805|FG001|Follow-Up Phase|Adverse Event|0|||
149152746|NCT05048719|538036627|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152747|NCT05048719|538036628|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152748|NCT05048719|538036629|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152749|NCT05048719|538036630|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152750|NCT05048719|538036631|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152751|NCT05048719|538036632|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
149152752|NCT05048719|538036633|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152753|NCT05048719|538036634|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152754|NCT05048719|538036635|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
149152755|NCT00605085|538036636|FG000|Overall Study|Withdrawal by Subject|8|||
149152756|NCT00605085|538036637|FG001|Overall Study|Withdrawal by Subject|5|||
149152757|NCT00605085|538036636|FG000|Overall Study|Adverse Event|9|||
149152758|NCT00605085|538036637|FG001|Overall Study|Adverse Event|5|||
149152759|NCT00605085|538036636|FG000|Overall Study|Pregnancy|2|||
149152760|NCT00605085|538036637|FG001|Overall Study|Pregnancy|0|||
149152761|NCT00605085|538036636|FG000|Overall Study|Protocol Violation|3|||
149152762|NCT00605085|538036637|FG001|Overall Study|Protocol Violation|2|||
149152763|NCT00605085|538036636|FG000|Overall Study|Lost to Follow-up|10|||
149152764|NCT00605085|538036637|FG001|Overall Study|Lost to Follow-up|5|||
149152765|NCT00605085|538036636|FG000|Overall Study|administrative reasons|18|||
149152766|NCT00605085|538036637|FG001|Overall Study|administrative reasons|8|||
149152767|NCT00706134|538036641|FG000|Overall Study|Adverse Event|8|||
149152768|NCT00706134|538036642|FG001|Overall Study|Adverse Event|7|||
149152769|NCT00706134|538036643|FG002|Overall Study|Adverse Event|2|||
149152770|NCT00706134|538036644|FG003|Overall Study|Adverse Event|3|||
149152771|NCT00706134|538036641|FG000|Overall Study|Lost to Follow-up|0|||
149152772|NCT00706134|538036642|FG001|Overall Study|Lost to Follow-up|1|||
149152773|NCT00706134|538036643|FG002|Overall Study|Lost to Follow-up|0|||
149152774|NCT00706134|538036644|FG003|Overall Study|Lost to Follow-up|0|||
149152775|NCT00706134|538036641|FG000|Overall Study|Protocol Violation|0|||
149152776|NCT00706134|538036642|FG001|Overall Study|Protocol Violation|6|||
149152777|NCT00706134|538036643|FG002|Overall Study|Protocol Violation|0|||
149152778|NCT00706134|538036644|FG003|Overall Study|Protocol Violation|3|||
149152779|NCT00706134|538036641|FG000|Overall Study|Withdrawal by Subject|1|||
149152780|NCT00706134|538036642|FG001|Overall Study|Withdrawal by Subject|2|||
149152781|NCT00706134|538036643|FG002|Overall Study|Withdrawal by Subject|1|||
149152782|NCT00706134|538036644|FG003|Overall Study|Withdrawal by Subject|0|||
149152783|NCT00706134|538036641|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
149152784|NCT00706134|538036642|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149152785|NCT00706134|538036643|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
149152786|NCT00706134|538036644|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
149152787|NCT00706134|538036641|FG000|Overall Study|Did not meet study criteria|2|||
149152788|NCT00706134|538036642|FG001|Overall Study|Did not meet study criteria|0|||
149152789|NCT00706134|538036643|FG002|Overall Study|Did not meet study criteria|0|||
149152790|NCT00706134|538036644|FG003|Overall Study|Did not meet study criteria|0|||
149152791|NCT00691483|538036648|FG000|Overall Study|Adverse Event|14|||
149152792|NCT00691483|538036649|FG001|Overall Study|Adverse Event|6|||
148919061|NCT00910624|537187806|FG002|Follow-Up Phase|Adverse Event|1|||
148919062|NCT00910624|537187807|FG003|Follow-Up Phase|Adverse Event|0|||
148919063|NCT00910624|537187804|FG000|Follow-Up Phase|Lost to Follow-up|3|||
148919064|NCT00910624|537187805|FG001|Follow-Up Phase|Lost to Follow-up|1|||
148919065|NCT00910624|537187806|FG002|Follow-Up Phase|Lost to Follow-up|2|||
148919066|NCT00910624|537187807|FG003|Follow-Up Phase|Lost to Follow-up|0|||
148919067|NCT00910624|537187804|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
148919068|NCT00910624|537187805|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
148919069|NCT00910624|537187806|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
148919070|NCT00910624|537187807|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
149152793|NCT00691483|538036648|FG000|Overall Study|Lost to Follow-up|17|||
149152794|NCT00691483|538036649|FG001|Overall Study|Lost to Follow-up|10|||
149152795|NCT00691483|538036648|FG000|Overall Study|Withdrawal by Subject|24|||
148919071|NCT00910624|537187804|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
148919072|NCT00910624|537187805|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
148919073|NCT00910624|537187806|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
149152796|NCT00691483|538036649|FG001|Overall Study|Withdrawal by Subject|7|||
149152797|NCT00691483|538036648|FG000|Overall Study|Other known cause|6|||
149152798|NCT00691483|538036649|FG001|Overall Study|Other known cause|1|||
149152799|NCT00691483|538036648|FG000|Overall Study|Randomized by not treated|7|||
149152800|NCT00691483|538036649|FG001|Overall Study|Randomized by not treated|1|||
149152801|NCT00746252|538036650|FG000|Overall Study|weight gain >7.5 %|1|||
149152802|NCT00746252|538036651|FG001|Overall Study|weight gain >7.5 %|2|||
149152803|NCT01391000|538036652|FG000|Overall Study|Lost to Follow-up|2|||
149152804|NCT01391000|538036653|FG001|Overall Study|Lost to Follow-up|0|||
149152805|NCT00082888|538036654|FG000|Overall Study|Ineligible|1|||
149152806|NCT00082888|538036655|FG001|Overall Study|Ineligible|0|||
148805756|NCT02194465|536768013|FG000|Overall Study|Lost to Follow-up|0|||
149152807|NCT00082888|538036656|FG002|Overall Study|Ineligible|0|||
149152808|NCT03860961|538036657|FG000|Overall Study|Withdrawal by Subject|6|||
149152809|NCT03860961|538036658|FG001|Overall Study|Withdrawal by Subject|11|||
149152810|NCT03860961|538036657|FG000|Overall Study|Death|10|||
149152811|NCT03860961|538036658|FG001|Overall Study|Death|6|||
149152812|NCT03860961|538036657|FG000|Overall Study|Incomplete two-year data|4|||
149152813|NCT03860961|538036658|FG001|Overall Study|Incomplete two-year data|0|||
149152814|NCT02105454|538036661|FG000|Overall Study|Withdrawal by Subject|1|||
149152815|NCT00493870|538036662|FG000|Overall Study|Lost to Follow-up|12|||
149152816|NCT00493870|538036663|FG001|Overall Study|Lost to Follow-up|15|||
149152817|NCT00272038|538036664|FG000|Overall Study|withdrew before they received 2 cycles|7|||
149152818|NCT00883337|538036665|FG000|Core Treatment Period|Adverse Event|9|||
149152819|NCT00883337|538036666|FG001|Core Treatment Period|Adverse Event|12|||
149152820|NCT00883337|538036667|FG002|Core Treatment Period|Adverse Event|22|||
149152821|NCT00883337|538036665|FG000|Core Treatment Period|Lack of Efficacy|7|||
149152822|NCT00883337|538036666|FG001|Core Treatment Period|Lack of Efficacy|4|||
149152823|NCT00883337|538036667|FG002|Core Treatment Period|Lack of Efficacy|2|||
149152824|NCT00883337|538036665|FG000|Core Treatment Period|Lost to Follow-up|1|||
149152825|NCT00883337|538036666|FG001|Core Treatment Period|Lost to Follow-up|1|||
149152826|NCT00883337|538036667|FG002|Core Treatment Period|Lost to Follow-up|0|||
149152827|NCT00883337|538036665|FG000|Core Treatment Period|Withdrawal by Subject|2|||
149152828|NCT00883337|538036666|FG001|Core Treatment Period|Withdrawal by Subject|2|||
149152829|NCT00883337|538036667|FG002|Core Treatment Period|Withdrawal by Subject|6|||
149152830|NCT00883337|538036665|FG000|Core Treatment Period|Wish to be pregnant|1|||
149152831|NCT00883337|538036666|FG001|Core Treatment Period|Wish to be pregnant|2|||
149152832|NCT00883337|538036667|FG002|Core Treatment Period|Wish to be pregnant|1|||
149152833|NCT00883337|538036665|FG000|Core Treatment Period|Poor compliance to protocol|0|||
149152834|NCT00883337|538036666|FG001|Core Treatment Period|Poor compliance to protocol|0|||
149152835|NCT00883337|538036667|FG002|Core Treatment Period|Poor compliance to protocol|1|||
149152836|NCT00883337|538036665|FG000|Core Treatment Period|Other than above|0|||
149152837|NCT00883337|538036666|FG001|Core Treatment Period|Other than above|1|||
149152838|NCT00883337|538036667|FG002|Core Treatment Period|Other than above|1|||
149152839|NCT00883337|538036665|FG000|Extension Treatment Period|Adverse Event|8|||
149152840|NCT00883337|538036666|FG001|Extension Treatment Period|Adverse Event|5|||
149152841|NCT00883337|538036667|FG002|Extension Treatment Period|Adverse Event|5|||
149152842|NCT00883337|538036665|FG000|Extension Treatment Period|Lack of Efficacy|8|||
149152843|NCT00883337|538036666|FG001|Extension Treatment Period|Lack of Efficacy|8|||
149152844|NCT00883337|538036667|FG002|Extension Treatment Period|Lack of Efficacy|8|||
149152845|NCT00883337|538036665|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
149152846|NCT00883337|538036666|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
149152847|NCT00883337|538036667|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
149152848|NCT00883337|538036665|FG000|Extension Treatment Period|Lost to Follow-up|1|||
149152849|NCT00883337|538036666|FG001|Extension Treatment Period|Lost to Follow-up|0|||
149152850|NCT00883337|538036667|FG002|Extension Treatment Period|Lost to Follow-up|0|||
149152851|NCT00883337|538036665|FG000|Extension Treatment Period|Other than above|10|||
149152852|NCT00883337|538036666|FG001|Extension Treatment Period|Other than above|9|||
149152853|NCT00883337|538036667|FG002|Extension Treatment Period|Other than above|5|||
149152854|NCT00527605|538036668|FG000|Overall Study|Adverse Event|3|||
149152855|NCT00527605|538036669|FG001|Overall Study|Adverse Event|0|||
149152856|NCT00527605|538036668|FG000|Overall Study|Withdrawal by Subject|3|||
149152857|NCT00527605|538036669|FG001|Overall Study|Withdrawal by Subject|7|||
148919074|NCT00910624|537187807|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
148919075|NCT00910624|537187804|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
148919076|NCT00910624|537187805|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
148919077|NCT00910624|537187806|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
148919078|NCT00910624|537187807|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
148919079|NCT00910624|537187804|FG000|Follow-Up Phase|Administrative|0|||
148919080|NCT00910624|537187805|FG001|Follow-Up Phase|Administrative|1|||
148919081|NCT00910624|537187806|FG002|Follow-Up Phase|Administrative|1|||
148919082|NCT00910624|537187807|FG003|Follow-Up Phase|Administrative|0|||
149152858|NCT00527605|538036668|FG000|Overall Study|Lost to Follow-up|6|||
149152859|NCT00527605|538036669|FG001|Overall Study|Lost to Follow-up|2|||
149152860|NCT00527605|538036668|FG000|Overall Study|Protocol Violation|1|||
149152861|NCT00527605|538036669|FG001|Overall Study|Protocol Violation|2|||
149152862|NCT04312009|538036673|FG000|Overall Study|Withdrawal by Subject|2|||
149152863|NCT04312009|538036674|FG001|Overall Study|Withdrawal by Subject|1|||
149152864|NCT02111564|538036675|FG000|Overall Study|Death|109|||
149152865|NCT02111564|538036676|FG001|Overall Study|Death|120|||
149152866|NCT02111564|538036675|FG000|Overall Study|Lost to Follow-up|2|||
149152867|NCT02111564|538036676|FG001|Overall Study|Lost to Follow-up|3|||
149152868|NCT02111564|538036675|FG000|Overall Study|Withdrawal by Subject|20|||
149152869|NCT02111564|538036676|FG001|Overall Study|Withdrawal by Subject|20|||
149152870|NCT03468309|538036677|FG000|Overall Study|Lost to Follow-up|4|||
148919083|NCT01122264|537187808|FG000|Overall Study|Adverse Event|6|||
149152871|NCT03468309|538036677|FG000|Overall Study|Withdrawal by Subject|2|||
149152872|NCT04986202|538036680|FG000|Overall Study|Death|10|||
149152873|NCT04986202|538036681|FG001|Overall Study|Death|3|||
149152874|NCT04986202|538036682|FG002|Overall Study|Death|10|||
149152875|NCT04986202|538036680|FG000|Overall Study|Physician Decision|3|||
149152876|NCT04986202|538036681|FG001|Overall Study|Physician Decision|1|||
149152877|NCT04986202|538036682|FG002|Overall Study|Physician Decision|2|||
149152878|NCT04986202|538036680|FG000|Overall Study|Withdrawal by Subject|4|||
149152879|NCT04986202|538036681|FG001|Overall Study|Withdrawal by Subject|2|||
149152880|NCT04986202|538036682|FG002|Overall Study|Withdrawal by Subject|4|||
149152881|NCT00488982|538036683|FG000|Course 1|Physician Decision|0|||
149152882|NCT00488982|538036684|FG001|Course 1|Physician Decision|2|||
149152883|NCT00488982|538036685|FG002|Course 1|Physician Decision|4|||
149152884|NCT00488982|538036683|FG000|Course 1|Withdrawal by Subject|0|||
149152885|NCT00488982|538036684|FG001|Course 1|Withdrawal by Subject|8|||
149152886|NCT00488982|538036685|FG002|Course 1|Withdrawal by Subject|2|||
149152887|NCT00488982|538036683|FG000|Course 1|nonprotocol therapy|0|||
149152888|NCT00488982|538036684|FG001|Course 1|nonprotocol therapy|2|||
149152889|NCT00488982|538036685|FG002|Course 1|nonprotocol therapy|2|||
149152890|NCT00488982|538036683|FG000|Course 1|Adverse Event|0|||
149152891|NCT00488982|538036684|FG001|Course 1|Adverse Event|0|||
149152892|NCT00488982|538036685|FG002|Course 1|Adverse Event|6|||
149152893|NCT03548558|538036688|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
149152894|NCT03548558|538036689|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
149152895|NCT03548558|538036690|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
149152896|NCT03548558|538036691|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
149152897|NCT03548558|538036692|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
149152898|NCT03548558|538036693|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
149152899|NCT03548558|538036694|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
149152900|NCT03548558|538036688|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
149152901|NCT03548558|538036689|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
149152902|NCT03548558|538036690|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
149152903|NCT03548558|538036691|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
149152904|NCT03548558|538036692|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
149152905|NCT03548558|538036693|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
149152906|NCT03548558|538036694|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
149152907|NCT03548558|538036688|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
149152908|NCT03548558|538036689|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
149152909|NCT03548558|538036690|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
149152910|NCT03548558|538036691|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
149152911|NCT03548558|538036692|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
149152912|NCT03548558|538036693|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
149152913|NCT03548558|538036694|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
149152914|NCT03548558|538036688|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
149152915|NCT03548558|538036689|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
149152916|NCT03548558|538036690|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
149152917|NCT03548558|538036691|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
149152918|NCT03548558|538036692|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
149152919|NCT03548558|538036693|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
149152920|NCT03548558|538036694|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
149152921|NCT03548558|538036688|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
149152922|NCT03548558|538036689|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
149152923|NCT03548558|538036690|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
149152924|NCT03548558|538036691|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
149152925|NCT03548558|538036692|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
149152926|NCT03548558|538036693|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
149152927|NCT03548558|538036694|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
149152928|NCT03548558|538036688|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
149152929|NCT03548558|538036689|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
149152930|NCT03548558|538036690|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
149152931|NCT03548558|538036691|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
149152932|NCT03548558|538036692|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
149152933|NCT03548558|538036693|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
149152934|NCT03548558|538036694|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
149152935|NCT00290433|538036697|FG000|Overall Study|Disease Progression|13|||
149152936|NCT00290433|538036697|FG000|Overall Study|Adverse Event|14|||
149152937|NCT00290433|538036697|FG000|Overall Study|Withdrawal by Subject|1|||
149152938|NCT00290433|538036697|FG000|Overall Study|Non-Compliance|1|||
149152939|NCT00290433|538036697|FG000|Overall Study|Congestive Heart Failure|1|||
149152940|NCT00290433|538036697|FG000|Overall Study|Transplant in CR|5|||
149152941|NCT00290433|538036697|FG000|Overall Study|Unrelated Infection/Death|1|||
149152942|NCT02264990|538036702|FG000|Overall Study|Death|255|||
149152943|NCT02264990|538036703|FG001|Overall Study|Death|250|||
149152944|NCT02264990|538036702|FG000|Overall Study|Withdrawal by Subject|4|||
149152945|NCT02264990|538036703|FG001|Overall Study|Withdrawal by Subject|5|||
149152946|NCT02264990|538036702|FG000|Overall Study|Lost to Follow-up|1|||
149152947|NCT02264990|538036703|FG001|Overall Study|Lost to Follow-up|3|||
149152948|NCT02264990|538036702|FG000|Overall Study|Other|0|||
149152949|NCT02264990|538036703|FG001|Overall Study|Other|1|||
149152950|NCT03031301|538036704|FG000|Overall Study|Protocol Violation|4|||
149152951|NCT03031301|538036705|FG001|Overall Study|Protocol Violation|8|||
149152952|NCT03031301|538036704|FG000|Overall Study|Withdrawal by Subject|7|||
149152953|NCT03031301|538036705|FG001|Overall Study|Withdrawal by Subject|4|||
148672749|NCT00877799|536272467|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
148919084|NCT01122264|537187809|FG001|Overall Study|Adverse Event|5|||
148919085|NCT01122264|537187810|FG002|Overall Study|Adverse Event|7|||
148919086|NCT01122264|537187808|FG000|Overall Study|Death|1|||
148919087|NCT01122264|537187809|FG001|Overall Study|Death|0|||
148919088|NCT01122264|537187810|FG002|Overall Study|Death|0|||
148919089|NCT01122264|537187808|FG000|Overall Study|Lost to Follow-up|5|||
148919090|NCT01122264|537187809|FG001|Overall Study|Lost to Follow-up|9|||
148919091|NCT01122264|537187810|FG002|Overall Study|Lost to Follow-up|13|||
148919092|NCT01122264|537187808|FG000|Overall Study|Entry Criteria Not Met|1|||
148919093|NCT01122264|537187809|FG001|Overall Study|Entry Criteria Not Met|0|||
148919094|NCT01122264|537187810|FG002|Overall Study|Entry Criteria Not Met|0|||
148919095|NCT01122264|537187808|FG000|Overall Study|Protocol Violation|7|||
148919096|NCT01122264|537187809|FG001|Overall Study|Protocol Violation|7|||
148919097|NCT01122264|537187810|FG002|Overall Study|Protocol Violation|9|||
148919098|NCT01122264|537187808|FG000|Overall Study|Withdrawal by Subject|6|||
148919099|NCT01122264|537187809|FG001|Overall Study|Withdrawal by Subject|6|||
148919100|NCT01122264|537187810|FG002|Overall Study|Withdrawal by Subject|16|||
148919101|NCT01122264|537187808|FG000|Overall Study|Physician Decision|3|||
148919102|NCT01122264|537187809|FG001|Overall Study|Physician Decision|1|||
148919103|NCT01122264|537187810|FG002|Overall Study|Physician Decision|1|||
148919104|NCT01122264|537187808|FG000|Overall Study|Lack of Efficacy|3|||
148919105|NCT01122264|537187809|FG001|Overall Study|Lack of Efficacy|1|||
148919106|NCT01122264|537187810|FG002|Overall Study|Lack of Efficacy|1|||
148919107|NCT04585009|537187811|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
148919108|NCT04585009|537187812|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919109|NCT04585009|537187813|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919110|NCT04585009|537187814|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919111|NCT04585009|537187815|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919112|NCT04585009|537187816|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919113|NCT04585009|537187817|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919114|NCT04585009|537187818|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919115|NCT04585009|537187819|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919116|NCT04585009|537187820|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919117|NCT04585009|537187821|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
148919118|NCT04585009|537187822|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
149152954|NCT03031301|538036704|FG000|Overall Study|Lost to Follow-up|4|||
148919119|NCT04585009|537187811|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
148919120|NCT04585009|537187812|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
149152955|NCT03031301|538036705|FG001|Overall Study|Lost to Follow-up|12|||
149152956|NCT03031301|538036704|FG000|Overall Study|Noncompliance|1|||
149152957|NCT03031301|538036705|FG001|Overall Study|Noncompliance|3|||
149152958|NCT03031301|538036704|FG000|Overall Study|Technical issue|1|||
149152959|NCT03031301|538036705|FG001|Overall Study|Technical issue|1|||
149152960|NCT03031301|538036704|FG000|Overall Study|Adverse Event|1|||
149152961|NCT03031301|538036705|FG001|Overall Study|Adverse Event|0|||
149152962|NCT00797732|538036709|FG000|Overall Study|Withdrawal by Subject|3|||
149152963|NCT00797732|538036710|FG001|Overall Study|Withdrawal by Subject|3|||
149152964|NCT00797732|538036711|FG002|Overall Study|Withdrawal by Subject|0|||
149152965|NCT00797732|538036709|FG000|Overall Study|Lost to Follow-up|1|||
149152966|NCT00797732|538036710|FG001|Overall Study|Lost to Follow-up|0|||
149152967|NCT00797732|538036711|FG002|Overall Study|Lost to Follow-up|0|||
149152968|NCT00797732|538036709|FG000|Overall Study|Death|1|||
149152969|NCT00797732|538036710|FG001|Overall Study|Death|0|||
149152970|NCT00797732|538036711|FG002|Overall Study|Death|0|||
149152971|NCT00797732|538036709|FG000|Overall Study|Not meet inclusion criteria|0|||
149152972|NCT00797732|538036710|FG001|Overall Study|Not meet inclusion criteria|0|||
149152973|NCT00797732|538036711|FG002|Overall Study|Not meet inclusion criteria|7|||
149152974|NCT00797732|538036709|FG000|Overall Study|Excluded due to time constraints|0|||
149152975|NCT00797732|538036710|FG001|Overall Study|Excluded due to time constraints|0|||
149152976|NCT00797732|538036711|FG002|Overall Study|Excluded due to time constraints|24|||
149152977|NCT00797732|538036709|FG000|Overall Study|Refused to Participate|0|||
149152978|NCT00797732|538036710|FG001|Overall Study|Refused to Participate|0|||
149152979|NCT00797732|538036711|FG002|Overall Study|Refused to Participate|123|||
149152980|NCT01857869|538036714|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
149152981|NCT01857869|538036715|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
149152982|NCT01857869|538036716|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
149152983|NCT01857869|538036717|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
149152984|NCT01857869|538036718|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
149152985|NCT01857869|538036719|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
149152986|NCT01857869|538036720|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
149152987|NCT01857869|538036721|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
149152988|NCT01857869|538036722|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
149152989|NCT01857869|538036723|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
149152990|NCT01857869|538036714|FG000|Primary/Challenge Phase|Pregnancy|1|||
149152991|NCT01857869|538036715|FG001|Primary/Challenge Phase|Pregnancy|0|||
149152992|NCT01857869|538036716|FG002|Primary/Challenge Phase|Pregnancy|0|||
149152993|NCT01857869|538036717|FG003|Primary/Challenge Phase|Pregnancy|0|||
149152994|NCT01857869|538036718|FG004|Primary/Challenge Phase|Pregnancy|0|||
149152995|NCT01857869|538036719|FG005|Primary/Challenge Phase|Pregnancy|0|||
149152996|NCT01857869|538036720|FG006|Primary/Challenge Phase|Pregnancy|0|||
149152997|NCT01857869|538036721|FG007|Primary/Challenge Phase|Pregnancy|0|||
149152998|NCT01857869|538036722|FG008|Primary/Challenge Phase|Pregnancy|0|||
149152999|NCT01857869|538036723|FG009|Primary/Challenge Phase|Pregnancy|0|||
149153000|NCT01857869|538036714|FG000|Primary/Challenge Phase|Protocol Violation|1|||
149153001|NCT01857869|538036715|FG001|Primary/Challenge Phase|Protocol Violation|0|||
149153002|NCT01857869|538036716|FG002|Primary/Challenge Phase|Protocol Violation|0|||
149153003|NCT01857869|538036717|FG003|Primary/Challenge Phase|Protocol Violation|0|||
149153004|NCT01857869|538036718|FG004|Primary/Challenge Phase|Protocol Violation|0|||
149153005|NCT01857869|538036719|FG005|Primary/Challenge Phase|Protocol Violation|0|||
149153006|NCT01857869|538036720|FG006|Primary/Challenge Phase|Protocol Violation|0|||
149153007|NCT01857869|538036721|FG007|Primary/Challenge Phase|Protocol Violation|0|||
149153008|NCT01857869|538036722|FG008|Primary/Challenge Phase|Protocol Violation|0|||
149153009|NCT01857869|538036723|FG009|Primary/Challenge Phase|Protocol Violation|0|||
149153010|NCT01857869|538036714|FG000|Primary/Challenge Phase|Other|1|||
149153011|NCT01857869|538036715|FG001|Primary/Challenge Phase|Other|1|||
149153012|NCT01857869|538036716|FG002|Primary/Challenge Phase|Other|0|||
149153013|NCT01857869|538036717|FG003|Primary/Challenge Phase|Other|0|||
149153014|NCT01857869|538036718|FG004|Primary/Challenge Phase|Other|0|||
149153015|NCT01857869|538036719|FG005|Primary/Challenge Phase|Other|0|||
149153016|NCT01857869|538036720|FG006|Primary/Challenge Phase|Other|0|||
149153017|NCT01857869|538036721|FG007|Primary/Challenge Phase|Other|0|||
149153018|NCT01857869|538036722|FG008|Primary/Challenge Phase|Other|0|||
149153019|NCT01857869|538036723|FG009|Primary/Challenge Phase|Other|0|||
149153020|NCT01857869|538036714|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153021|NCT01857869|538036715|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153022|NCT01857869|538036716|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153023|NCT01857869|538036717|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
149153024|NCT01857869|538036718|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153025|NCT01857869|538036719|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153026|NCT01857869|538036720|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153027|NCT01857869|538036721|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153028|NCT01857869|538036722|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153029|NCT01857869|538036723|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
149153030|NCT01857869|538036714|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153031|NCT01857869|538036715|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153032|NCT01857869|538036716|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153033|NCT01857869|538036717|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
149153034|NCT01857869|538036718|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153035|NCT01857869|538036719|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153036|NCT01857869|538036720|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153037|NCT01857869|538036721|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153038|NCT01857869|538036722|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153039|NCT01857869|538036723|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
149153040|NCT01277549|538036727|FG000|Overall Study|Failed to meet eligibility criteria|13|||
149153041|NCT01277549|538036728|FG001|Overall Study|Failed to meet eligibility criteria|9|||
149153042|NCT01277549|538036727|FG000|Overall Study|Withdrawal by Subject|1|||
149153043|NCT01277549|538036728|FG001|Overall Study|Withdrawal by Subject|3|||
149153044|NCT01277549|538036727|FG000|Overall Study|Protocol Violation|10|||
149153045|NCT01277549|538036728|FG001|Overall Study|Protocol Violation|1|||
149153046|NCT01277549|538036727|FG000|Overall Study|Physician Decision|2|||
149153047|NCT01277549|538036728|FG001|Overall Study|Physician Decision|1|||
149153048|NCT02228590|538036729|FG000|Overall Study|Withdrawal by Subject|1|||
149153049|NCT02109484|538036730|FG000|Overall Study|Lost to Follow-up|0|||
148805757|NCT02194465|536768014|FG001|Overall Study|Lost to Follow-up|0|||
149153050|NCT02109484|538036731|FG001|Overall Study|Lost to Follow-up|0|||
149153051|NCT02109484|538036732|FG002|Overall Study|Lost to Follow-up|0|||
149153052|NCT02109484|538036733|FG003|Overall Study|Lost to Follow-up|1|||
149153053|NCT02109484|538036734|FG004|Overall Study|Lost to Follow-up|1|||
149153054|NCT02109484|538036735|FG005|Overall Study|Lost to Follow-up|0|||
149153055|NCT02109484|538036736|FG006|Overall Study|Lost to Follow-up|1|||
149153056|NCT02109484|538036737|FG007|Overall Study|Lost to Follow-up|0|||
149153057|NCT02109484|538036730|FG000|Overall Study|Withdrawal by Subject|0|||
149153058|NCT02109484|538036731|FG001|Overall Study|Withdrawal by Subject|0|||
149153059|NCT02109484|538036732|FG002|Overall Study|Withdrawal by Subject|0|||
149153060|NCT02109484|538036733|FG003|Overall Study|Withdrawal by Subject|0|||
148805758|NCT02194465|536768015|FG002|Overall Study|Lost to Follow-up|0|||
149153061|NCT02109484|538036734|FG004|Overall Study|Withdrawal by Subject|1|||
149153062|NCT02109484|538036735|FG005|Overall Study|Withdrawal by Subject|1|||
149153063|NCT02109484|538036736|FG006|Overall Study|Withdrawal by Subject|1|||
149153064|NCT02109484|538036737|FG007|Overall Study|Withdrawal by Subject|0|||
149153065|NCT02109484|538036730|FG000|Overall Study|Physician Decision|0|||
149153066|NCT02109484|538036731|FG001|Overall Study|Physician Decision|0|||
149153067|NCT02109484|538036732|FG002|Overall Study|Physician Decision|0|||
149153068|NCT02109484|538036733|FG003|Overall Study|Physician Decision|0|||
149153069|NCT02109484|538036734|FG004|Overall Study|Physician Decision|2|||
149153070|NCT02109484|538036735|FG005|Overall Study|Physician Decision|0|||
149153071|NCT02109484|538036736|FG006|Overall Study|Physician Decision|0|||
149153072|NCT02109484|538036737|FG007|Overall Study|Physician Decision|0|||
149153073|NCT02109484|538036730|FG000|Overall Study|Death|0|||
149153074|NCT02109484|538036731|FG001|Overall Study|Death|0|||
149153075|NCT02109484|538036732|FG002|Overall Study|Death|0|||
149153076|NCT02109484|538036733|FG003|Overall Study|Death|0|||
149153077|NCT02109484|538036734|FG004|Overall Study|Death|0|||
149153078|NCT02109484|538036735|FG005|Overall Study|Death|0|||
149153079|NCT02109484|538036736|FG006|Overall Study|Death|0|||
149153080|NCT02109484|538036737|FG007|Overall Study|Death|2|||
149153081|NCT02109484|538036730|FG000|Overall Study|Moved away from study area|0|||
149153082|NCT02109484|538036731|FG001|Overall Study|Moved away from study area|0|||
149153083|NCT02109484|538036732|FG002|Overall Study|Moved away from study area|0|||
149153084|NCT02109484|538036733|FG003|Overall Study|Moved away from study area|0|||
149153085|NCT02109484|538036734|FG004|Overall Study|Moved away from study area|0|||
149153086|NCT02109484|538036735|FG005|Overall Study|Moved away from study area|0|||
149153087|NCT02109484|538036736|FG006|Overall Study|Moved away from study area|1|||
149153088|NCT02109484|538036737|FG007|Overall Study|Moved away from study area|1|||
149153089|NCT02111993|538036738|FG000|Overall Study|Physician Decision|5|||
149153090|NCT02111993|538036739|FG001|Overall Study|Physician Decision|4|||
149153091|NCT01097863|538036740|FG000|Overall Study|Discomfort|1|||
149153092|NCT01097863|538036741|FG001|Overall Study|Discomfort|0|||
149153093|NCT01097863|538036742|FG002|Overall Study|Discomfort|1|||
149153094|NCT01097863|538036740|FG000|Overall Study|Did not return for final visit|0|||
149153095|NCT01097863|538036741|FG001|Overall Study|Did not return for final visit|0|||
149153096|NCT01097863|538036742|FG002|Overall Study|Did not return for final visit|1|||
149153097|NCT01400451|538036743|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
149153098|NCT01400451|538036744|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
149153099|NCT01400451|538036745|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
149153100|NCT01400451|538036743|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
149153101|NCT01400451|538036744|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
149153102|NCT01400451|538036745|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
149153103|NCT01400451|538036743|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
149153104|NCT01400451|538036744|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
149153105|NCT01400451|538036745|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
149153106|NCT01400451|538036743|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
149153107|NCT01400451|538036744|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
149153108|NCT01400451|538036745|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
149153109|NCT01400451|538036743|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
149153110|NCT01400451|538036744|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
149153111|NCT01400451|538036745|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
149153112|NCT03028870|538036750|FG000|Overall Study|Adverse Event|7|||
149153113|NCT03028870|538036751|FG001|Overall Study|Adverse Event|4|||
148919121|NCT04585009|537187813|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
149153114|NCT03028870|538036752|FG002|Overall Study|Adverse Event|3|||
149153115|NCT03028870|538036753|FG003|Overall Study|Adverse Event|3|||
149153116|NCT03028870|538036750|FG000|Overall Study|Withdrawal by Subject|1|||
149153117|NCT03028870|538036751|FG001|Overall Study|Withdrawal by Subject|1|||
149153118|NCT03028870|538036752|FG002|Overall Study|Withdrawal by Subject|1|||
149153119|NCT03028870|538036753|FG003|Overall Study|Withdrawal by Subject|2|||
149153120|NCT03028870|538036750|FG000|Overall Study|Lost to Follow-up|1|||
149153121|NCT03028870|538036751|FG001|Overall Study|Lost to Follow-up|0|||
149153122|NCT03028870|538036752|FG002|Overall Study|Lost to Follow-up|0|||
149153123|NCT03028870|538036753|FG003|Overall Study|Lost to Follow-up|0|||
149153124|NCT03028870|538036750|FG000|Overall Study|Lack of Efficacy|3|||
149153125|NCT03028870|538036751|FG001|Overall Study|Lack of Efficacy|0|||
149153126|NCT03028870|538036752|FG002|Overall Study|Lack of Efficacy|0|||
149153127|NCT03028870|538036753|FG003|Overall Study|Lack of Efficacy|0|||
149153128|NCT03028870|538036750|FG000|Overall Study|Administrative|5|||
149153129|NCT03028870|538036751|FG001|Overall Study|Administrative|5|||
149153130|NCT03028870|538036752|FG002|Overall Study|Administrative|12|||
149153131|NCT03028870|538036753|FG003|Overall Study|Administrative|4|||
149153132|NCT00317109|538036754|FG000|Overall Study|Withdrawal by Subject|2|||
149153133|NCT00317109|538036755|FG001|Overall Study|Withdrawal by Subject|0|||
149153134|NCT00317109|538036754|FG000|Overall Study|Migated/moved from study area|1|||
149153135|NCT00317109|538036755|FG001|Overall Study|Migated/moved from study area|0|||
149153136|NCT01079182|538036756|FG000|Overall Study|Lost to Follow-up|1634|||
149153137|NCT01079182|538036756|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
149153138|NCT01079182|538036756|FG000|Overall Study|Lack of Efficacy|514|||
149153139|NCT01079182|538036756|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
149153140|NCT01079182|538036756|FG000|Overall Study|Reasons not Evaluated|271|||
149153141|NCT01026831|538036758|FG000|Overall Study|Adverse Event|4|||
149153142|NCT01026831|538036759|FG001|Overall Study|Adverse Event|3|||
149153143|NCT01026831|538036758|FG000|Overall Study|Lost to Follow-up|2|||
149153144|NCT01026831|538036759|FG001|Overall Study|Lost to Follow-up|0|||
149153145|NCT01026831|538036758|FG000|Overall Study|Physician Decision|1|||
149153146|NCT01026831|538036759|FG001|Overall Study|Physician Decision|1|||
149153147|NCT01026831|538036758|FG000|Overall Study|Protocol Violation|0|||
149153148|NCT01026831|538036759|FG001|Overall Study|Protocol Violation|2|||
149153149|NCT01026831|538036758|FG000|Overall Study|Withdrawal by Subject|7|||
149153150|NCT01026831|538036759|FG001|Overall Study|Withdrawal by Subject|5|||
149153151|NCT04417894|538036760|FG000|Overall Study|Lost to Follow-up|3|||
149153152|NCT04417894|538036761|FG001|Overall Study|Lost to Follow-up|0|||
149153153|NCT04417894|538036760|FG000|Overall Study|Withdrawal by Subject|7|||
149153154|NCT04417894|538036761|FG001|Overall Study|Withdrawal by Subject|6|||
149153155|NCT04417894|538036760|FG000|Overall Study|Lack of Efficacy|3|||
149153156|NCT04417894|538036761|FG001|Overall Study|Lack of Efficacy|1|||
149153157|NCT01508702|538036762|FG000|Overall Study|Adverse Event|7|||
149153158|NCT01508702|538036763|FG001|Overall Study|Adverse Event|3|||
149153159|NCT01508702|538036762|FG000|Overall Study|Gout flare|2|||
149153160|NCT01508702|538036763|FG001|Overall Study|Gout flare|0|||
149153161|NCT01508702|538036762|FG000|Overall Study|Protocol Violation|2|||
149153162|NCT01508702|538036763|FG001|Overall Study|Protocol Violation|1|||
149153163|NCT01508702|538036762|FG000|Overall Study|Lost to Follow-up|1|||
149153164|NCT01508702|538036763|FG001|Overall Study|Lost to Follow-up|2|||
149153165|NCT01508702|538036762|FG000|Overall Study|Withdrawal by Subject|11|||
148919122|NCT04585009|537187814|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919123|NCT04585009|537187815|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919124|NCT04585009|537187816|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919125|NCT04585009|537187817|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919126|NCT04585009|537187818|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919127|NCT04585009|537187819|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
149153166|NCT01508702|538036763|FG001|Overall Study|Withdrawal by Subject|7|||
149153167|NCT02425826|538036764|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
148919128|NCT04585009|537187820|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
149153168|NCT02425826|538036765|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
149153169|NCT02425826|538036766|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
149153170|NCT02425826|538036764|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
149153171|NCT02425826|538036765|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
149153172|NCT02425826|538036766|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
148919129|NCT04585009|537187821|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919130|NCT04585009|537187822|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
148919131|NCT04585009|537187811|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919132|NCT04585009|537187812|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919133|NCT04585009|537187813|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919134|NCT04585009|537187814|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919135|NCT04585009|537187815|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919136|NCT04585009|537187816|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919137|NCT04585009|537187817|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919138|NCT04585009|537187818|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
148919139|NCT04585009|537187819|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919140|NCT04585009|537187820|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919141|NCT04585009|537187821|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919142|NCT04585009|537187822|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
148919143|NCT04585009|537187811|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919144|NCT04585009|537187812|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919145|NCT04585009|537187813|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919146|NCT04585009|537187814|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919147|NCT04585009|537187815|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
148919148|NCT04585009|537187816|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919149|NCT04585009|537187817|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919150|NCT04585009|537187818|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919151|NCT04585009|537187819|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148805759|NCT02194465|536768016|FG003|Overall Study|Lost to Follow-up|1|||
148805760|NCT02194465|536768017|FG004|Overall Study|Lost to Follow-up|0|||
148805761|NCT02194465|536768018|FG005|Overall Study|Lost to Follow-up|1|||
148805762|NCT02194465|536768019|FG006|Overall Study|Lost to Follow-up|0|||
148919152|NCT04585009|537187820|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919153|NCT04585009|537187821|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919154|NCT04585009|537187822|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
148919155|NCT04585009|537187811|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919156|NCT04585009|537187812|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919157|NCT04585009|537187813|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919158|NCT04585009|537187814|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919159|NCT04585009|537187815|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919160|NCT04585009|537187816|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919161|NCT04585009|537187817|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919162|NCT04585009|537187818|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919163|NCT04585009|537187819|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919164|NCT04585009|537187820|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
148919165|NCT04585009|537187821|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919166|NCT04585009|537187822|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
148919167|NCT04585009|537187811|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919168|NCT04585009|537187812|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919169|NCT04585009|537187813|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919170|NCT04585009|537187814|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919171|NCT04585009|537187815|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919172|NCT04585009|537187816|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919173|NCT04585009|537187817|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919174|NCT04585009|537187818|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919175|NCT04585009|537187819|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919176|NCT04585009|537187820|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919177|NCT04585009|537187821|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
148919178|NCT04585009|537187822|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
148919179|NCT00097981|537187831|FG000|Overall Study|Adverse Event|31|||
148919180|NCT00097981|537187832|FG001|Overall Study|Adverse Event|44|||
148919181|NCT00097981|537187831|FG000|Overall Study|Withdrawal by Subject|10|||
149153173|NCT02425826|538036764|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
149153174|NCT02425826|538036765|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
149153175|NCT02425826|538036766|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
148919182|NCT00097981|537187832|FG001|Overall Study|Withdrawal by Subject|8|||
149153176|NCT02425826|538036764|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
148805763|NCT02194465|536768013|FG000|Overall Study|Physician Decision|1|||
148919183|NCT00097981|537187831|FG000|Overall Study|Protocol Violation|1|||
148919184|NCT00097981|537187832|FG001|Overall Study|Protocol Violation|1|||
148919185|NCT00097981|537187831|FG000|Overall Study|Death|2|||
148919186|NCT00097981|537187832|FG001|Overall Study|Death|4|||
148919187|NCT00097981|537187831|FG000|Overall Study|Physician Decision|7|||
148919188|NCT00097981|537187832|FG001|Overall Study|Physician Decision|1|||
148919189|NCT00097981|537187831|FG000|Overall Study|Disease Progression|8|||
148919190|NCT00097981|537187832|FG001|Overall Study|Disease Progression|2|||
148919191|NCT00097981|537187831|FG000|Overall Study|Transplant planned|28|||
148919192|NCT00097981|537187832|FG001|Overall Study|Transplant planned|27|||
148919193|NCT00097981|537187831|FG000|Overall Study|Other|19|||
148919194|NCT00097981|537187832|FG001|Overall Study|Other|13|||
148919195|NCT03774823|537187835|FG000|Overall Study|Withdrawal by Subject|1|||
148919196|NCT03774823|537187836|FG001|Overall Study|Withdrawal by Subject|1|||
148919197|NCT01579812|537187843|FG000|Overall Study|Ineligible after treatment start|40|||
148919198|NCT01579812|537187843|FG000|Overall Study|Patient choice|3|||
148805764|NCT02194465|536768014|FG001|Overall Study|Physician Decision|0|||
148805765|NCT02194465|536768015|FG002|Overall Study|Physician Decision|0|||
148805766|NCT02194465|536768016|FG003|Overall Study|Physician Decision|0|||
148805767|NCT02194465|536768017|FG004|Overall Study|Physician Decision|0|||
148805768|NCT02194465|536768018|FG005|Overall Study|Physician Decision|0|||
148805769|NCT02194465|536768019|FG006|Overall Study|Physician Decision|0|||
148805770|NCT02194465|536768013|FG000|Overall Study|Protocol Violation|1|||
148805771|NCT02194465|536768014|FG001|Overall Study|Protocol Violation|1|||
148805772|NCT02194465|536768015|FG002|Overall Study|Protocol Violation|2|||
148805773|NCT02194465|536768016|FG003|Overall Study|Protocol Violation|1|||
148805774|NCT02194465|536768017|FG004|Overall Study|Protocol Violation|1|||
148805775|NCT02194465|536768018|FG005|Overall Study|Protocol Violation|0|||
148805776|NCT02194465|536768019|FG006|Overall Study|Protocol Violation|0|||
148805777|NCT02194465|536768013|FG000|Overall Study|Withdrawal by Subject|1|||
148805778|NCT02194465|536768014|FG001|Overall Study|Withdrawal by Subject|3|||
148805779|NCT02194465|536768015|FG002|Overall Study|Withdrawal by Subject|1|||
148805780|NCT02194465|536768016|FG003|Overall Study|Withdrawal by Subject|2|||
148805781|NCT02194465|536768017|FG004|Overall Study|Withdrawal by Subject|2|||
148805782|NCT02194465|536768018|FG005|Overall Study|Withdrawal by Subject|1|||
148805783|NCT02194465|536768019|FG006|Overall Study|Withdrawal by Subject|2|||
148805784|NCT02194465|536768013|FG000|Overall Study|Discontinued follow-up period|0|||
148805785|NCT02194465|536768014|FG001|Overall Study|Discontinued follow-up period|2|||
148805786|NCT02194465|536768015|FG002|Overall Study|Discontinued follow-up period|1|||
148805787|NCT02194465|536768016|FG003|Overall Study|Discontinued follow-up period|0|||
148805788|NCT02194465|536768017|FG004|Overall Study|Discontinued follow-up period|2|||
148805789|NCT02194465|536768018|FG005|Overall Study|Discontinued follow-up period|0|||
148805790|NCT02194465|536768019|FG006|Overall Study|Discontinued follow-up period|0|||
148805791|NCT04810962|536768020|FG000|Overall Study|Adverse Event|0|||
148805792|NCT04810962|536768021|FG001|Overall Study|Adverse Event|1|||
148805793|NCT04810962|536768020|FG000|Overall Study|Lost to Follow-up|2|||
148805794|NCT04810962|536768021|FG001|Overall Study|Lost to Follow-up|1|||
148805795|NCT04810962|536768020|FG000|Overall Study|Physician Decision|1|||
148805796|NCT04810962|536768021|FG001|Overall Study|Physician Decision|0|||
148805797|NCT04810962|536768020|FG000|Overall Study|Withdrawal by Subject|1|||
148805798|NCT04810962|536768021|FG001|Overall Study|Withdrawal by Subject|3|||
148805799|NCT04810962|536768020|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
148805800|NCT04810962|536768021|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
148805801|NCT02412657|536768022|FG000|Overall Study|Lost to Follow-up|1|||
148805802|NCT02412657|536768023|FG001|Overall Study|Lost to Follow-up|0|||
148805803|NCT02412657|536768024|FG002|Overall Study|Lost to Follow-up|0|||
148919199|NCT01579812|537187843|FG000|Overall Study|Noncompliance|3|||
148919200|NCT01579812|537187843|FG000|Overall Study|Withdrawal by Subject|6|||
148919201|NCT01133990|537187846|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
148919202|NCT01133990|537187847|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148919203|NCT01133990|537187848|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148919204|NCT01133990|537187849|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148919205|NCT01133990|537187850|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148919206|NCT01133990|537187851|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148919207|NCT01133990|537187846|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
148919208|NCT01133990|537187847|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
149153177|NCT02425826|538036765|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
149153178|NCT02425826|538036766|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
149153179|NCT02425826|538036764|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
149153180|NCT02425826|538036765|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
149153181|NCT02425826|538036766|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
149153182|NCT02425826|538036764|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
149153183|NCT02425826|538036765|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
149153184|NCT02425826|538036766|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
149153185|NCT02425826|538036764|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
149153186|NCT02425826|538036765|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
149153187|NCT02425826|538036766|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
149153188|NCT02425826|538036764|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
149153189|NCT02425826|538036765|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
149153190|NCT02425826|538036766|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
149153191|NCT02425826|538036764|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
149153192|NCT02425826|538036765|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
149153193|NCT02425826|538036766|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
149153194|NCT02425826|538036764|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
149153195|NCT02425826|538036765|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
149153196|NCT02425826|538036766|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
149153197|NCT00879697|538036775|FG000|Overall Study|Physician Decision|2|||
149153198|NCT00879697|538036776|FG001|Overall Study|Physician Decision|2|||
149153199|NCT02500121|538036777|FG000|Overall Study|Lost to Follow-up|0|||
149153200|NCT02500121|538036778|FG001|Overall Study|Lost to Follow-up|1|||
149153201|NCT02500121|538036777|FG000|Overall Study|Withdrawal by Subject|1|||
148805804|NCT02412657|536768022|FG000|Overall Study|Protocol Violation|0|||
148805805|NCT02412657|536768023|FG001|Overall Study|Protocol Violation|2|||
149153202|NCT02500121|538036778|FG001|Overall Study|Withdrawal by Subject|1|||
149153203|NCT02500121|538036777|FG000|Overall Study|Death|26|||
149153204|NCT02500121|538036778|FG001|Overall Study|Death|24|||
149153205|NCT01430455|538036782|FG000|Overall Study|Withdrawal by Subject|1|||
149153206|NCT01430455|538036782|FG000|Overall Study|Switched to follow-up phase|1|||
149153207|NCT01425008|538036788|FG000|Dose Escalation Phase|Progressive Disease|2|||
149153208|NCT01425008|538036789|FG001|Dose Escalation Phase|Progressive Disease|3|||
149153209|NCT01425008|538036790|FG002|Dose Escalation Phase|Progressive Disease|2|||
149153210|NCT01425008|538036791|FG003|Dose Escalation Phase|Progressive Disease|3|||
149153211|NCT01425008|538036792|FG004|Dose Escalation Phase|Progressive Disease|5|||
149153212|NCT01425008|538036793|FG005|Dose Escalation Phase|Progressive Disease|4|||
149153213|NCT01425008|538036794|FG006|Dose Escalation Phase|Progressive Disease|0|||
149153214|NCT01425008|538036795|FG007|Dose Escalation Phase|Progressive Disease|2|||
149153215|NCT01425008|538036796|FG008|Dose Escalation Phase|Progressive Disease|6|||
149153216|NCT01425008|538036797|FG009|Dose Escalation Phase|Progressive Disease|2|||
149153217|NCT01425008|538036798|FG010|Dose Escalation Phase|Progressive Disease|0|||
149153218|NCT01425008|538036799|FG011|Dose Escalation Phase|Progressive Disease|0|||
149153219|NCT01425008|538036800|FG012|Dose Escalation Phase|Progressive Disease|0|||
149153220|NCT01425008|538036801|FG013|Dose Escalation Phase|Progressive Disease|0|||
149153221|NCT01425008|538036802|FG014|Dose Escalation Phase|Progressive Disease|0|||
149153222|NCT01425008|538036803|FG015|Dose Escalation Phase|Progressive Disease|0|||
149153223|NCT01425008|538036804|FG016|Dose Escalation Phase|Progressive Disease|0|||
149153224|NCT01425008|538036805|FG017|Dose Escalation Phase|Progressive Disease|0|||
149153225|NCT01425008|538036806|FG018|Dose Escalation Phase|Progressive Disease|0|||
149153226|NCT01425008|538036788|FG000|Dose Escalation Phase|Adverse Event|2|||
149153227|NCT01425008|538036789|FG001|Dose Escalation Phase|Adverse Event|0|||
149153228|NCT01425008|538036790|FG002|Dose Escalation Phase|Adverse Event|0|||
149153229|NCT01425008|538036791|FG003|Dose Escalation Phase|Adverse Event|0|||
149153230|NCT01425008|538036792|FG004|Dose Escalation Phase|Adverse Event|0|||
149153231|NCT01425008|538036793|FG005|Dose Escalation Phase|Adverse Event|2|||
149153232|NCT01425008|538036794|FG006|Dose Escalation Phase|Adverse Event|0|||
149153233|NCT01425008|538036795|FG007|Dose Escalation Phase|Adverse Event|0|||
149153234|NCT01425008|538036796|FG008|Dose Escalation Phase|Adverse Event|2|||
148805806|NCT02412657|536768024|FG002|Overall Study|Protocol Violation|3|||
148805807|NCT01281306|536768026|FG000|Overall Study|Lack of Efficacy|0|||
148805808|NCT01281306|536768027|FG001|Overall Study|Lack of Efficacy|1|||
148805809|NCT01281306|536768028|FG002|Overall Study|Lack of Efficacy|3|||
149153235|NCT01425008|538036797|FG009|Dose Escalation Phase|Adverse Event|0|||
149153236|NCT01425008|538036798|FG010|Dose Escalation Phase|Adverse Event|0|||
149153237|NCT01425008|538036799|FG011|Dose Escalation Phase|Adverse Event|0|||
148805810|NCT01281306|536768029|FG003|Overall Study|Lack of Efficacy|0|||
148805811|NCT01281306|536768030|FG004|Overall Study|Lack of Efficacy|2|||
149153238|NCT01425008|538036800|FG012|Dose Escalation Phase|Adverse Event|0|||
149153239|NCT01425008|538036801|FG013|Dose Escalation Phase|Adverse Event|0|||
148805812|NCT01281306|536768031|FG005|Overall Study|Lack of Efficacy|0|||
148805813|NCT01281306|536768032|FG006|Overall Study|Lack of Efficacy|1|||
148805814|NCT01281306|536768026|FG000|Overall Study|Withdrawal by Subject|1|||
148805815|NCT01281306|536768027|FG001|Overall Study|Withdrawal by Subject|0|||
148805816|NCT01281306|536768028|FG002|Overall Study|Withdrawal by Subject|2|||
148805817|NCT01281306|536768029|FG003|Overall Study|Withdrawal by Subject|4|||
148805818|NCT01281306|536768030|FG004|Overall Study|Withdrawal by Subject|1|||
148805819|NCT01281306|536768031|FG005|Overall Study|Withdrawal by Subject|3|||
148805820|NCT01281306|536768032|FG006|Overall Study|Withdrawal by Subject|1|||
148805821|NCT01281306|536768026|FG000|Overall Study|Protocol deviation|0|||
148805822|NCT01281306|536768027|FG001|Overall Study|Protocol deviation|1|||
148805823|NCT01281306|536768028|FG002|Overall Study|Protocol deviation|1|||
148805824|NCT01281306|536768029|FG003|Overall Study|Protocol deviation|1|||
148805825|NCT01281306|536768030|FG004|Overall Study|Protocol deviation|1|||
148805826|NCT01281306|536768031|FG005|Overall Study|Protocol deviation|0|||
148805827|NCT01281306|536768032|FG006|Overall Study|Protocol deviation|0|||
148805828|NCT01281306|536768026|FG000|Overall Study|Condition no longer requires study drug|1|||
148805829|NCT01281306|536768027|FG001|Overall Study|Condition no longer requires study drug|0|||
148805830|NCT01281306|536768028|FG002|Overall Study|Condition no longer requires study drug|0|||
148805831|NCT01281306|536768029|FG003|Overall Study|Condition no longer requires study drug|0|||
148805832|NCT01281306|536768030|FG004|Overall Study|Condition no longer requires study drug|0|||
148805833|NCT01281306|536768031|FG005|Overall Study|Condition no longer requires study drug|1|||
148805834|NCT01281306|536768032|FG006|Overall Study|Condition no longer requires study drug|1|||
148805835|NCT01281306|536768026|FG000|Overall Study|Lost to Follow-up|1|||
148805836|NCT01281306|536768027|FG001|Overall Study|Lost to Follow-up|0|||
148805837|NCT01281306|536768028|FG002|Overall Study|Lost to Follow-up|0|||
148805838|NCT01281306|536768029|FG003|Overall Study|Lost to Follow-up|2|||
148805839|NCT01281306|536768030|FG004|Overall Study|Lost to Follow-up|0|||
148805840|NCT01281306|536768031|FG005|Overall Study|Lost to Follow-up|0|||
148805841|NCT01281306|536768032|FG006|Overall Study|Lost to Follow-up|1|||
148805842|NCT01281306|536768026|FG000|Overall Study|Death|1|||
148805843|NCT01281306|536768027|FG001|Overall Study|Death|0|||
148805844|NCT01281306|536768028|FG002|Overall Study|Death|0|||
148805845|NCT01281306|536768029|FG003|Overall Study|Death|0|||
148805846|NCT01281306|536768030|FG004|Overall Study|Death|0|||
148805847|NCT01281306|536768031|FG005|Overall Study|Death|0|||
148805848|NCT01281306|536768032|FG006|Overall Study|Death|0|||
148805849|NCT01281306|536768026|FG000|Overall Study|Adverse Event|3|||
148805850|NCT01281306|536768027|FG001|Overall Study|Adverse Event|2|||
148805851|NCT01281306|536768028|FG002|Overall Study|Adverse Event|2|||
148805852|NCT01281306|536768029|FG003|Overall Study|Adverse Event|3|||
148805853|NCT01281306|536768030|FG004|Overall Study|Adverse Event|5|||
148805854|NCT01281306|536768031|FG005|Overall Study|Adverse Event|3|||
148805855|NCT01281306|536768032|FG006|Overall Study|Adverse Event|3|||
148805856|NCT01281306|536768026|FG000|Overall Study|Randomized in error|1|||
148805857|NCT01281306|536768027|FG001|Overall Study|Randomized in error|0|||
148805858|NCT01281306|536768028|FG002|Overall Study|Randomized in error|0|||
148805859|NCT01281306|536768029|FG003|Overall Study|Randomized in error|1|||
148805860|NCT01281306|536768030|FG004|Overall Study|Randomized in error|0|||
148805861|NCT01281306|536768031|FG005|Overall Study|Randomized in error|0|||
148805862|NCT01281306|536768032|FG006|Overall Study|Randomized in error|0|||
149153240|NCT01425008|538036802|FG014|Dose Escalation Phase|Adverse Event|0|||
149153241|NCT01425008|538036803|FG015|Dose Escalation Phase|Adverse Event|0|||
149153242|NCT01425008|538036804|FG016|Dose Escalation Phase|Adverse Event|0|||
149153243|NCT01425008|538036805|FG017|Dose Escalation Phase|Adverse Event|0|||
149153244|NCT01425008|538036806|FG018|Dose Escalation Phase|Adverse Event|0|||
149153245|NCT01425008|538036788|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153246|NCT01425008|538036789|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153247|NCT01425008|538036790|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153248|NCT01425008|538036791|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153249|NCT01425008|538036792|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
148805863|NCT01401322|536768033|FG000|Overall Study|Withdrawal by Subject|1|||
148805864|NCT01401322|536768033|FG000|Overall Study|Physician Decision|1|||
148805865|NCT00486044|536768034|FG000|Overall Study|Withdrawal by Subject|2|||
148805866|NCT00486044|536768035|FG001|Overall Study|Withdrawal by Subject|1|||
148805867|NCT00486044|536768034|FG000|Overall Study|Adverse Event|0|||
148805868|NCT00486044|536768035|FG001|Overall Study|Adverse Event|1|||
148805869|NCT00486044|536768034|FG000|Overall Study|Lost to Follow-up|0|||
148805870|NCT00486044|536768035|FG001|Overall Study|Lost to Follow-up|1|||
148805871|NCT02410629|536768036|FG000|Overall Study|Family cannot commit to the study|2|||
148805872|NCT02410629|536768037|FG001|Overall Study|Family cannot commit to the study|1|||
148805873|NCT02410629|536768036|FG000|Overall Study|Subject returned to work|1|||
148805874|NCT02410629|536768037|FG001|Overall Study|Subject returned to work|0|||
148805875|NCT02410629|536768036|FG000|Overall Study|Subject moved back to home country|0|||
148805876|NCT02410629|536768037|FG001|Overall Study|Subject moved back to home country|1|||
149153250|NCT01425008|538036793|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153251|NCT01425008|538036794|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
149153252|NCT01425008|538036795|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
149153253|NCT01425008|538036796|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
149153254|NCT01425008|538036797|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153255|NCT01425008|538036798|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153256|NCT01425008|538036799|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153257|NCT01425008|538036800|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153258|NCT01425008|538036801|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153259|NCT01425008|538036802|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153260|NCT01425008|538036803|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153261|NCT01425008|538036804|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153262|NCT01425008|538036805|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153263|NCT01425008|538036806|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149153264|NCT01425008|538036788|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
149153265|NCT01425008|538036789|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
149153266|NCT01425008|538036790|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
149153267|NCT01425008|538036791|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149153268|NCT01425008|538036792|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
149153269|NCT01425008|538036793|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
149153270|NCT01425008|538036794|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
149153271|NCT01425008|538036795|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
149153272|NCT01425008|538036796|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
149153273|NCT01425008|538036797|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
149153274|NCT01425008|538036798|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
149153275|NCT01425008|538036799|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
149153276|NCT01425008|538036800|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
149153277|NCT01425008|538036801|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
149153278|NCT01425008|538036802|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
149153279|NCT01425008|538036803|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
149153280|NCT01425008|538036804|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
149153281|NCT01425008|538036805|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
149153282|NCT01425008|538036806|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
149153283|NCT01425008|538036788|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153284|NCT01425008|538036789|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153285|NCT01425008|538036790|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
149153286|NCT01425008|538036791|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153287|NCT01425008|538036792|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153288|NCT01425008|538036793|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153289|NCT01425008|538036794|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153290|NCT01425008|538036795|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153291|NCT01425008|538036796|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
149153292|NCT01425008|538036797|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
149153293|NCT01425008|538036798|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153294|NCT01425008|538036799|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153295|NCT01425008|538036800|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153296|NCT01425008|538036801|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153297|NCT01425008|538036802|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153298|NCT01425008|538036803|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153299|NCT01425008|538036804|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153300|NCT01425008|538036805|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153301|NCT01425008|538036806|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
149153302|NCT01425008|538036788|FG000|Dose Escalation Phase|Other|0|||
149153303|NCT01425008|538036789|FG001|Dose Escalation Phase|Other|0|||
149153304|NCT01425008|538036790|FG002|Dose Escalation Phase|Other|0|||
149153305|NCT01425008|538036791|FG003|Dose Escalation Phase|Other|0|||
149153306|NCT01425008|538036792|FG004|Dose Escalation Phase|Other|0|||
149153307|NCT01425008|538036793|FG005|Dose Escalation Phase|Other|0|||
149153308|NCT01425008|538036794|FG006|Dose Escalation Phase|Other|0|||
149153309|NCT01425008|538036795|FG007|Dose Escalation Phase|Other|0|||
149153310|NCT01425008|538036796|FG008|Dose Escalation Phase|Other|1|||
149153311|NCT01425008|538036797|FG009|Dose Escalation Phase|Other|0|||
149153312|NCT01425008|538036798|FG010|Dose Escalation Phase|Other|0|||
149153313|NCT01425008|538036799|FG011|Dose Escalation Phase|Other|0|||
149153314|NCT01425008|538036800|FG012|Dose Escalation Phase|Other|0|||
149153315|NCT01425008|538036801|FG013|Dose Escalation Phase|Other|0|||
149153316|NCT01425008|538036802|FG014|Dose Escalation Phase|Other|0|||
149153317|NCT01425008|538036803|FG015|Dose Escalation Phase|Other|0|||
149153318|NCT01425008|538036804|FG016|Dose Escalation Phase|Other|0|||
149153319|NCT01425008|538036805|FG017|Dose Escalation Phase|Other|0|||
149153320|NCT01425008|538036806|FG018|Dose Escalation Phase|Other|0|||
149153321|NCT01425008|538036788|FG000|Dose Expansion Phase|Progressive Disease|0|||
149153322|NCT01425008|538036789|FG001|Dose Expansion Phase|Progressive Disease|0|||
149153323|NCT01425008|538036790|FG002|Dose Expansion Phase|Progressive Disease|0|||
149153324|NCT01425008|538036791|FG003|Dose Expansion Phase|Progressive Disease|0|||
149153325|NCT01425008|538036792|FG004|Dose Expansion Phase|Progressive Disease|0|||
149153326|NCT01425008|538036793|FG005|Dose Expansion Phase|Progressive Disease|0|||
149153327|NCT01425008|538036794|FG006|Dose Expansion Phase|Progressive Disease|0|||
149153328|NCT01425008|538036795|FG007|Dose Expansion Phase|Progressive Disease|0|||
149153329|NCT01425008|538036796|FG008|Dose Expansion Phase|Progressive Disease|0|||
149153330|NCT01425008|538036797|FG009|Dose Expansion Phase|Progressive Disease|0|||
149153331|NCT01425008|538036798|FG010|Dose Expansion Phase|Progressive Disease|10|||
149153332|NCT01425008|538036799|FG011|Dose Expansion Phase|Progressive Disease|4|||
149153333|NCT01425008|538036800|FG012|Dose Expansion Phase|Progressive Disease|12|||
149153334|NCT01425008|538036801|FG013|Dose Expansion Phase|Progressive Disease|1|||
149153335|NCT01425008|538036802|FG014|Dose Expansion Phase|Progressive Disease|5|||
149153336|NCT01425008|538036803|FG015|Dose Expansion Phase|Progressive Disease|8|||
149153337|NCT01425008|538036804|FG016|Dose Expansion Phase|Progressive Disease|9|||
149153338|NCT01425008|538036805|FG017|Dose Expansion Phase|Progressive Disease|2|||
149153339|NCT01425008|538036806|FG018|Dose Expansion Phase|Progressive Disease|10|||
149153340|NCT01425008|538036788|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
149153341|NCT01425008|538036789|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
149153342|NCT01425008|538036790|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
149153343|NCT01425008|538036791|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
149153344|NCT01425008|538036792|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
149153345|NCT01425008|538036793|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
149153346|NCT01425008|538036794|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
149153347|NCT01425008|538036795|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
149153348|NCT01425008|538036796|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
149153349|NCT01425008|538036797|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
149153350|NCT01425008|538036798|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
149153351|NCT01425008|538036799|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
149153352|NCT01425008|538036800|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
149153353|NCT01425008|538036801|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
149153354|NCT01425008|538036802|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
149153355|NCT01425008|538036803|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
149153356|NCT01425008|538036804|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
149153357|NCT01425008|538036805|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
149153358|NCT01425008|538036806|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
149153359|NCT01425008|538036788|FG000|Dose Expansion Phase|Other|0|||
149153360|NCT01425008|538036789|FG001|Dose Expansion Phase|Other|0|||
149153361|NCT01425008|538036790|FG002|Dose Expansion Phase|Other|0|||
149153362|NCT01425008|538036791|FG003|Dose Expansion Phase|Other|0|||
149153363|NCT01425008|538036792|FG004|Dose Expansion Phase|Other|0|||
149153364|NCT01425008|538036793|FG005|Dose Expansion Phase|Other|0|||
149153365|NCT01425008|538036794|FG006|Dose Expansion Phase|Other|0|||
149153366|NCT01425008|538036795|FG007|Dose Expansion Phase|Other|0|||
149153367|NCT01425008|538036796|FG008|Dose Expansion Phase|Other|0|||
149153368|NCT01425008|538036797|FG009|Dose Expansion Phase|Other|0|||
149153369|NCT01425008|538036798|FG010|Dose Expansion Phase|Other|0|||
149153370|NCT01425008|538036799|FG011|Dose Expansion Phase|Other|0|||
149153371|NCT01425008|538036800|FG012|Dose Expansion Phase|Other|1|||
149153372|NCT01425008|538036801|FG013|Dose Expansion Phase|Other|0|||
149153373|NCT01425008|538036802|FG014|Dose Expansion Phase|Other|0|||
149153374|NCT01425008|538036803|FG015|Dose Expansion Phase|Other|0|||
149153375|NCT01425008|538036804|FG016|Dose Expansion Phase|Other|2|||
149153376|NCT01425008|538036805|FG017|Dose Expansion Phase|Other|0|||
149153377|NCT01425008|538036806|FG018|Dose Expansion Phase|Other|4|||
149153378|NCT01425008|538036788|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153379|NCT01425008|538036789|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153380|NCT01425008|538036790|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153381|NCT01425008|538036791|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153382|NCT01425008|538036792|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153383|NCT01425008|538036793|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153384|NCT01425008|538036794|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153385|NCT01425008|538036795|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153386|NCT01425008|538036796|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153387|NCT01425008|538036797|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153388|NCT01425008|538036798|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
149153389|NCT01425008|538036799|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
149153390|NCT01425008|538036800|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153391|NCT01425008|538036801|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153392|NCT01425008|538036802|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153393|NCT01425008|538036803|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
149153394|NCT01425008|538036804|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
149153395|NCT01425008|538036805|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
149153396|NCT01425008|538036806|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
149153397|NCT01425008|538036788|FG000|Dose Expansion Phase|Adverse Event|0|||
149153398|NCT01425008|538036789|FG001|Dose Expansion Phase|Adverse Event|0|||
149153399|NCT01425008|538036790|FG002|Dose Expansion Phase|Adverse Event|0|||
149153400|NCT01425008|538036791|FG003|Dose Expansion Phase|Adverse Event|0|||
149153401|NCT01425008|538036792|FG004|Dose Expansion Phase|Adverse Event|0|||
149153402|NCT01425008|538036793|FG005|Dose Expansion Phase|Adverse Event|0|||
149153403|NCT01425008|538036794|FG006|Dose Expansion Phase|Adverse Event|0|||
149153404|NCT01425008|538036795|FG007|Dose Expansion Phase|Adverse Event|0|||
149153405|NCT01425008|538036796|FG008|Dose Expansion Phase|Adverse Event|0|||
149153406|NCT01425008|538036797|FG009|Dose Expansion Phase|Adverse Event|0|||
149153407|NCT01425008|538036798|FG010|Dose Expansion Phase|Adverse Event|2|||
149153408|NCT01425008|538036799|FG011|Dose Expansion Phase|Adverse Event|3|||
149153409|NCT01425008|538036800|FG012|Dose Expansion Phase|Adverse Event|3|||
149153410|NCT01425008|538036801|FG013|Dose Expansion Phase|Adverse Event|0|||
149153411|NCT01425008|538036802|FG014|Dose Expansion Phase|Adverse Event|1|||
149153412|NCT01425008|538036803|FG015|Dose Expansion Phase|Adverse Event|1|||
149153413|NCT01425008|538036804|FG016|Dose Expansion Phase|Adverse Event|5|||
149153414|NCT01425008|538036805|FG017|Dose Expansion Phase|Adverse Event|0|||
149153415|NCT01425008|538036806|FG018|Dose Expansion Phase|Adverse Event|3|||
149153416|NCT01425008|538036788|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
149153417|NCT01425008|538036789|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
149153418|NCT01425008|538036790|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
149153419|NCT01425008|538036791|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
149153420|NCT01425008|538036792|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
149153421|NCT01425008|538036793|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
149153422|NCT01425008|538036794|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
149153423|NCT01425008|538036795|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
149153424|NCT01425008|538036796|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
149153425|NCT01425008|538036797|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
149153426|NCT01425008|538036798|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
149153427|NCT01425008|538036799|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
149153428|NCT01425008|538036800|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
149153429|NCT01425008|538036801|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
149153430|NCT01425008|538036802|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
149153431|NCT01425008|538036803|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
149153432|NCT01425008|538036804|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
149153433|NCT01425008|538036805|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
149153434|NCT01425008|538036806|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
149153435|NCT01425008|538036788|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153436|NCT01425008|538036789|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153437|NCT01425008|538036790|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153438|NCT01425008|538036791|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153439|NCT01425008|538036792|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153440|NCT01425008|538036793|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153441|NCT01425008|538036794|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153442|NCT01425008|538036795|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153443|NCT01425008|538036796|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153444|NCT01425008|538036797|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153445|NCT01425008|538036798|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153446|NCT01425008|538036799|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153447|NCT01425008|538036800|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153448|NCT01425008|538036801|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153449|NCT01425008|538036802|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153450|NCT01425008|538036803|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153451|NCT01425008|538036804|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153452|NCT01425008|538036805|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149153453|NCT01425008|538036806|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
149153454|NCT00264238|538036807|FG000|Overall Study|Protocol Violation|1|||
149153455|NCT00562588|538036808|FG000|Overall Study|Adverse Event|40|||
149153456|NCT00562588|538036809|FG001|Overall Study|Adverse Event|58|||
149153457|NCT00562588|538036808|FG000|Overall Study|Protocol Violation|30|||
149153458|NCT00562588|538036809|FG001|Overall Study|Protocol Violation|26|||
149153459|NCT00562588|538036808|FG000|Overall Study|Lost to Follow-up|12|||
149153460|NCT00562588|538036809|FG001|Overall Study|Lost to Follow-up|4|||
149153461|NCT00562588|538036808|FG000|Overall Study|Withdrawal by Subject|10|||
149153462|NCT00562588|538036809|FG001|Overall Study|Withdrawal by Subject|9|||
149153463|NCT00562588|538036808|FG000|Overall Study|Other|0|||
149153464|NCT00562588|538036809|FG001|Overall Study|Other|2|||
149153465|NCT00328627|538039943|FG000|Overall Study|Hyperglycemic Rescue|41|||
149153466|NCT00328627|538039944|FG001|Overall Study|Hyperglycemic Rescue|18|||
149153467|NCT00328627|538039945|FG002|Overall Study|Hyperglycemic Rescue|16|||
149153468|NCT00328627|538039946|FG003|Overall Study|Hyperglycemic Rescue|13|||
149153469|NCT00328627|538039947|FG004|Overall Study|Hyperglycemic Rescue|6|||
149153470|NCT00328627|538039948|FG005|Overall Study|Hyperglycemic Rescue|5|||
149153471|NCT00328627|538039949|FG006|Overall Study|Hyperglycemic Rescue|19|||
149153472|NCT00328627|538039950|FG007|Overall Study|Hyperglycemic Rescue|6|||
149153473|NCT00328627|538039951|FG008|Overall Study|Hyperglycemic Rescue|6|||
149153474|NCT00328627|538039952|FG009|Overall Study|Hyperglycemic Rescue|11|||
149153475|NCT00328627|538039953|FG010|Overall Study|Hyperglycemic Rescue|3|||
149153476|NCT00328627|538039954|FG011|Overall Study|Hyperglycemic Rescue|2|||
149153477|NCT00328627|538039943|FG000|Overall Study|Adverse Event|3|||
149153478|NCT00328627|538039944|FG001|Overall Study|Adverse Event|1|||
149153479|NCT00328627|538039945|FG002|Overall Study|Adverse Event|2|||
149153480|NCT00328627|538039946|FG003|Overall Study|Adverse Event|3|||
149153481|NCT00328627|538039947|FG004|Overall Study|Adverse Event|1|||
149153482|NCT00328627|538039948|FG005|Overall Study|Adverse Event|2|||
149153483|NCT00328627|538039949|FG006|Overall Study|Adverse Event|1|||
149153484|NCT00328627|538039950|FG007|Overall Study|Adverse Event|2|||
149153485|NCT00328627|538039951|FG008|Overall Study|Adverse Event|0|||
149153486|NCT00328627|538039952|FG009|Overall Study|Adverse Event|7|||
149153487|NCT00328627|538039953|FG010|Overall Study|Adverse Event|5|||
149153488|NCT00328627|538039954|FG011|Overall Study|Adverse Event|4|||
149153489|NCT00328627|538039943|FG000|Overall Study|Protocol Violation|2|||
149153490|NCT00328627|538039944|FG001|Overall Study|Protocol Violation|2|||
149153491|NCT00328627|538039945|FG002|Overall Study|Protocol Violation|2|||
149153492|NCT00328627|538039946|FG003|Overall Study|Protocol Violation|8|||
149153493|NCT00328627|538039947|FG004|Overall Study|Protocol Violation|5|||
149153494|NCT00328627|538039948|FG005|Overall Study|Protocol Violation|5|||
149153495|NCT00328627|538039949|FG006|Overall Study|Protocol Violation|6|||
149153496|NCT00328627|538039950|FG007|Overall Study|Protocol Violation|2|||
149153497|NCT00328627|538039951|FG008|Overall Study|Protocol Violation|1|||
149153498|NCT00328627|538039952|FG009|Overall Study|Protocol Violation|4|||
149153499|NCT00328627|538039953|FG010|Overall Study|Protocol Violation|6|||
149153500|NCT00328627|538039954|FG011|Overall Study|Protocol Violation|2|||
149153501|NCT00328627|538039943|FG000|Overall Study|Lost to Follow-up|4|||
149153502|NCT00328627|538039944|FG001|Overall Study|Lost to Follow-up|2|||
149153503|NCT00328627|538039945|FG002|Overall Study|Lost to Follow-up|2|||
149153504|NCT00328627|538039946|FG003|Overall Study|Lost to Follow-up|4|||
149153505|NCT00328627|538039947|FG004|Overall Study|Lost to Follow-up|0|||
149153506|NCT00328627|538039948|FG005|Overall Study|Lost to Follow-up|2|||
149153507|NCT00328627|538039949|FG006|Overall Study|Lost to Follow-up|3|||
149153508|NCT00328627|538039950|FG007|Overall Study|Lost to Follow-up|0|||
149153509|NCT00328627|538039951|FG008|Overall Study|Lost to Follow-up|3|||
149153510|NCT00328627|538039952|FG009|Overall Study|Lost to Follow-up|2|||
149153511|NCT00328627|538039953|FG010|Overall Study|Lost to Follow-up|0|||
149153512|NCT00328627|538039954|FG011|Overall Study|Lost to Follow-up|1|||
149153513|NCT00328627|538039943|FG000|Overall Study|Withdrawal by Subject|5|||
149153514|NCT00328627|538039944|FG001|Overall Study|Withdrawal by Subject|4|||
149153515|NCT00328627|538039945|FG002|Overall Study|Withdrawal by Subject|5|||
149153516|NCT00328627|538039946|FG003|Overall Study|Withdrawal by Subject|6|||
149153517|NCT00328627|538039947|FG004|Overall Study|Withdrawal by Subject|2|||
149153518|NCT00328627|538039948|FG005|Overall Study|Withdrawal by Subject|5|||
149153519|NCT00328627|538039949|FG006|Overall Study|Withdrawal by Subject|4|||
149153520|NCT00328627|538039950|FG007|Overall Study|Withdrawal by Subject|4|||
149153521|NCT00328627|538039951|FG008|Overall Study|Withdrawal by Subject|4|||
149153522|NCT00328627|538039952|FG009|Overall Study|Withdrawal by Subject|5|||
149153523|NCT00328627|538039953|FG010|Overall Study|Withdrawal by Subject|2|||
149153524|NCT00328627|538039954|FG011|Overall Study|Withdrawal by Subject|7|||
149153525|NCT00328627|538039943|FG000|Overall Study|Pregnancy|0|||
149153526|NCT00328627|538039944|FG001|Overall Study|Pregnancy|1|||
149153527|NCT00328627|538039945|FG002|Overall Study|Pregnancy|0|||
149153528|NCT00328627|538039946|FG003|Overall Study|Pregnancy|0|||
149153529|NCT00328627|538039947|FG004|Overall Study|Pregnancy|0|||
149153530|NCT00328627|538039948|FG005|Overall Study|Pregnancy|0|||
149153531|NCT00328627|538039949|FG006|Overall Study|Pregnancy|0|||
149153532|NCT00328627|538039950|FG007|Overall Study|Pregnancy|0|||
149153533|NCT00328627|538039951|FG008|Overall Study|Pregnancy|0|||
149153534|NCT00328627|538039952|FG009|Overall Study|Pregnancy|0|||
149153535|NCT00328627|538039953|FG010|Overall Study|Pregnancy|0|||
149153536|NCT00328627|538039954|FG011|Overall Study|Pregnancy|0|||
149153537|NCT00328627|538039943|FG000|Overall Study|Physician Decision|4|||
149153538|NCT00328627|538039944|FG001|Overall Study|Physician Decision|3|||
149153539|NCT00328627|538039945|FG002|Overall Study|Physician Decision|1|||
149153540|NCT00328627|538039946|FG003|Overall Study|Physician Decision|2|||
149153541|NCT00328627|538039947|FG004|Overall Study|Physician Decision|1|||
149153542|NCT00328627|538039948|FG005|Overall Study|Physician Decision|1|||
149153543|NCT00328627|538039949|FG006|Overall Study|Physician Decision|1|||
149153544|NCT00328627|538039950|FG007|Overall Study|Physician Decision|0|||
149153545|NCT00328627|538039951|FG008|Overall Study|Physician Decision|3|||
149153546|NCT00328627|538039952|FG009|Overall Study|Physician Decision|2|||
149153547|NCT00328627|538039953|FG010|Overall Study|Physician Decision|1|||
149153548|NCT00328627|538039954|FG011|Overall Study|Physician Decision|0|||
149153549|NCT00328627|538039943|FG000|Overall Study|Other|0|||
149153550|NCT00328627|538039944|FG001|Overall Study|Other|0|||
149153551|NCT00328627|538039945|FG002|Overall Study|Other|0|||
149153552|NCT00328627|538039946|FG003|Overall Study|Other|1|||
149153553|NCT00328627|538039947|FG004|Overall Study|Other|0|||
149153554|NCT00328627|538039948|FG005|Overall Study|Other|0|||
149153555|NCT00328627|538039949|FG006|Overall Study|Other|1|||
149153556|NCT00328627|538039950|FG007|Overall Study|Other|0|||
149153557|NCT00328627|538039951|FG008|Overall Study|Other|0|||
149153558|NCT00328627|538039952|FG009|Overall Study|Other|1|||
149153559|NCT00328627|538039953|FG010|Overall Study|Other|1|||
149153560|NCT00328627|538039954|FG011|Overall Study|Other|0|||
149153561|NCT02049944|538039955|FG000|Overall Study|Protocol Violation|2|||
149153562|NCT01662440|538039956|FG000|Overall Study|Adverse Event|1|||
149153563|NCT01662440|538039957|FG001|Overall Study|Adverse Event|0|||
149153564|NCT01662440|538039958|FG002|Overall Study|Adverse Event|0|||
149153565|NCT01662440|538039959|FG003|Overall Study|Adverse Event|1|||
149153566|NCT01662440|538039956|FG000|Overall Study|Death|0|||
149153567|NCT01662440|538039957|FG001|Overall Study|Death|1|||
149153568|NCT01662440|538039958|FG002|Overall Study|Death|0|||
149153569|NCT01662440|538039959|FG003|Overall Study|Death|0|||
149153570|NCT01662440|538039956|FG000|Overall Study|Lost to Follow-up|2|||
149153571|NCT01662440|538039957|FG001|Overall Study|Lost to Follow-up|2|||
149153572|NCT01662440|538039958|FG002|Overall Study|Lost to Follow-up|4|||
149153573|NCT01662440|538039959|FG003|Overall Study|Lost to Follow-up|1|||
149153574|NCT01662440|538039956|FG000|Overall Study|Subject moved to another country.|0|||
149153575|NCT01662440|538039957|FG001|Overall Study|Subject moved to another country.|1|||
149153576|NCT01662440|538039958|FG002|Overall Study|Subject moved to another country.|0|||
149153577|NCT01662440|538039959|FG003|Overall Study|Subject moved to another country.|0|||
149153578|NCT01662440|538039956|FG000|Overall Study|Protocol Violation|1|||
149153579|NCT01662440|538039957|FG001|Overall Study|Protocol Violation|0|||
149153580|NCT01662440|538039958|FG002|Overall Study|Protocol Violation|0|||
149153581|NCT01662440|538039959|FG003|Overall Study|Protocol Violation|0|||
149153582|NCT01662440|538039956|FG000|Overall Study|Withdrawal by Subject|5|||
149153583|NCT01662440|538039957|FG001|Overall Study|Withdrawal by Subject|2|||
149153584|NCT01662440|538039958|FG002|Overall Study|Withdrawal by Subject|2|||
149153585|NCT01662440|538039959|FG003|Overall Study|Withdrawal by Subject|2|||
149153586|NCT04872101|538039960|FG000|Overall Study|Withdrawal by Subject|10|||
149153587|NCT04872101|538039961|FG001|Overall Study|Withdrawal by Subject|16|||
149153588|NCT04872101|538039960|FG000|Overall Study|Lack of Efficacy|6|||
149153589|NCT04872101|538039961|FG001|Overall Study|Lack of Efficacy|14|||
149153590|NCT04872101|538039960|FG000|Overall Study|Adverse Event|1|||
149153591|NCT04872101|538039961|FG001|Overall Study|Adverse Event|6|||
149153592|NCT04872101|538039960|FG000|Overall Study|Lost to Follow-up|2|||
149153593|NCT04872101|538039961|FG001|Overall Study|Lost to Follow-up|1|||
149153594|NCT04872101|538039960|FG000|Overall Study|Pregnancy|2|||
149153595|NCT04872101|538039961|FG001|Overall Study|Pregnancy|0|||
149153596|NCT04872101|538039960|FG000|Overall Study|Prohibited Medication|1|||
149153597|NCT04872101|538039961|FG001|Overall Study|Prohibited Medication|0|||
149153598|NCT04872101|538039960|FG000|Overall Study|Not dosed|1|||
149153599|NCT04872101|538039961|FG001|Overall Study|Not dosed|0|||
149153600|NCT00264004|538039962|FG000|Overall Study|Adverse Event|2|||
149153601|NCT00264004|538039963|FG001|Overall Study|Adverse Event|3|||
149153602|NCT00264004|538039964|FG002|Overall Study|Adverse Event|6|||
149153603|NCT00264004|538039965|FG003|Overall Study|Adverse Event|4|||
149153604|NCT00264004|538039962|FG000|Overall Study|Withdrawal by Subject|0|||
149153605|NCT00264004|538039963|FG001|Overall Study|Withdrawal by Subject|1|||
149153606|NCT00264004|538039964|FG002|Overall Study|Withdrawal by Subject|2|||
149153607|NCT00264004|538039965|FG003|Overall Study|Withdrawal by Subject|2|||
149153608|NCT00264004|538039962|FG000|Overall Study|Other|2|||
149153609|NCT00264004|538039963|FG001|Overall Study|Other|2|||
149153610|NCT00264004|538039964|FG002|Overall Study|Other|0|||
149153611|NCT00264004|538039965|FG003|Overall Study|Other|3|||
149153612|NCT00264004|538039962|FG000|Overall Study|Development study specific disc. crit.|1|||
149153613|NCT00264004|538039963|FG001|Overall Study|Development study specific disc. crit.|0|||
149153614|NCT00264004|538039964|FG002|Overall Study|Development study specific disc. crit.|1|||
149153615|NCT00264004|538039965|FG003|Overall Study|Development study specific disc. crit.|0|||
149153616|NCT00264004|538039962|FG000|Overall Study|Cond. under inv. worsened|9|||
149153617|NCT00264004|538039963|FG001|Overall Study|Cond. under inv. worsened|5|||
149153618|NCT00264004|538039964|FG002|Overall Study|Cond. under inv. worsened|3|||
149153619|NCT00264004|538039965|FG003|Overall Study|Cond. under inv. worsened|4|||
149153620|NCT00264004|538039962|FG000|Overall Study|Not treated|3|||
149153621|NCT00264004|538039963|FG001|Overall Study|Not treated|0|||
149153622|NCT00264004|538039964|FG002|Overall Study|Not treated|2|||
149153623|NCT00264004|538039965|FG003|Overall Study|Not treated|2|||
149153624|NCT03691974|538039966|FG000|Overall Study|Physician Decision|1|||
149153625|NCT03691974|538039967|FG001|Overall Study|Physician Decision|0|||
149153626|NCT03691974|538039966|FG000|Overall Study|Adverse Event|1|||
149153627|NCT03691974|538039967|FG001|Overall Study|Adverse Event|0|||
149153628|NCT03691974|538039966|FG000|Overall Study|Withdrawal by Subject|11|||
149153629|NCT03691974|538039967|FG001|Overall Study|Withdrawal by Subject|9|||
149153630|NCT03691974|538039966|FG000|Overall Study|Protocol Violation|1|||
149153631|NCT03691974|538039967|FG001|Overall Study|Protocol Violation|0|||
149153632|NCT03691974|538039966|FG000|Overall Study|Lost to Follow-up|8|||
149153633|NCT03691974|538039967|FG001|Overall Study|Lost to Follow-up|7|||
149153634|NCT04623242|538039969|FG000|Overall Study|Withdrawal by Subject|7|||
149153635|NCT04623242|538039970|FG001|Overall Study|Withdrawal by Subject|12|||
149153636|NCT04623242|538039971|FG002|Overall Study|Withdrawal by Subject|5|||
149153637|NCT04623242|538039972|FG003|Overall Study|Withdrawal by Subject|7|||
149153638|NCT04623242|538039973|FG004|Overall Study|Withdrawal by Subject|0|||
149153639|NCT04623242|538039969|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
149153640|NCT04623242|538039970|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
149153641|NCT04623242|538039971|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
149153642|NCT04623242|538039972|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
149153643|NCT04623242|538039973|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
149153644|NCT04623242|538039969|FG000|Overall Study|Subject unblinded to mutation status|0|||
149153645|NCT04623242|538039970|FG001|Overall Study|Subject unblinded to mutation status|0|||
149153646|NCT04623242|538039971|FG002|Overall Study|Subject unblinded to mutation status|0|||
149153647|NCT04623242|538039972|FG003|Overall Study|Subject unblinded to mutation status|13|||
149153648|NCT04623242|538039973|FG004|Overall Study|Subject unblinded to mutation status|0|||
149153649|NCT00326898|538039976|FG000|Overall Study|Disease progression|52|||
149153650|NCT00326898|538039977|FG001|Overall Study|Disease progression|54|||
149153651|NCT00326898|538039978|FG002|Overall Study|Disease progression|102|||
149153652|NCT00326898|538039976|FG000|Overall Study|Adverse Event|124|||
149153653|NCT00326898|538039977|FG001|Overall Study|Adverse Event|128|||
149153654|NCT00326898|538039978|FG002|Overall Study|Adverse Event|33|||
149153655|NCT00326898|538039976|FG000|Overall Study|Death|2|||
149153656|NCT00326898|538039977|FG001|Overall Study|Death|0|||
149153657|NCT00326898|538039978|FG002|Overall Study|Death|0|||
149153658|NCT00326898|538039976|FG000|Overall Study|Withdrawal by Subject|134|||
149153659|NCT00326898|538039977|FG001|Overall Study|Withdrawal by Subject|128|||
149153660|NCT00326898|538039978|FG002|Overall Study|Withdrawal by Subject|32|||
149153661|NCT00326898|538039976|FG000|Overall Study|Alternative therapy|1|||
149153662|NCT00326898|538039977|FG001|Overall Study|Alternative therapy|0|||
149153663|NCT00326898|538039978|FG002|Overall Study|Alternative therapy|0|||
149153664|NCT00326898|538039976|FG000|Overall Study|Other complicating disease|5|||
149153665|NCT00326898|538039977|FG001|Overall Study|Other complicating disease|5|||
149153666|NCT00326898|538039978|FG002|Overall Study|Other complicating disease|4|||
149153667|NCT00326898|538039976|FG000|Overall Study|Other/Missing/Unknown|33|||
149153668|NCT00326898|538039977|FG001|Overall Study|Other/Missing/Unknown|28|||
149153669|NCT00326898|538039978|FG002|Overall Study|Other/Missing/Unknown|32|||
149153670|NCT03847987|538039979|FG000|Overall Study|Lost to Follow-up|1|||
149153671|NCT03847987|538039980|FG001|Overall Study|Lost to Follow-up|0|||
149153672|NCT03847987|538039979|FG000|Overall Study|Adverse Event|2|||
149153673|NCT03847987|538039980|FG001|Overall Study|Adverse Event|0|||
149153674|NCT02721355|538039981|FG000|Overall Study|Lost to Follow-up|6|||
149153675|NCT02721355|538039982|FG001|Overall Study|Lost to Follow-up|1|||
149153676|NCT01652287|538039985|FG000|Overall Study|Withdrawal by Subject|2|||
149153677|NCT01652287|538039986|FG001|Overall Study|Withdrawal by Subject|0|||
149153678|NCT01592760|538039990|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
149153679|NCT01592760|538039991|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
149153680|NCT01592760|538039992|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
149153681|NCT02605642|538039995|FG000|Overall Study|Other|11|||
149153682|NCT02605642|538039996|FG001|Overall Study|Other|1|||
149153683|NCT02605642|538039995|FG000|Overall Study|Participant non-compliance|2|||
149153684|NCT02605642|538039996|FG001|Overall Study|Participant non-compliance|4|||
149153685|NCT02605642|538039995|FG000|Overall Study|Physician Decision|10|||
149153686|NCT02605642|538039996|FG001|Overall Study|Physician Decision|0|||
149153687|NCT02605642|538039995|FG000|Overall Study|Lost to Follow-up|12|||
149153688|NCT02605642|538039996|FG001|Overall Study|Lost to Follow-up|1|||
149153689|NCT02605642|538039995|FG000|Overall Study|Adverse Event|14|||
149153690|NCT02605642|538039996|FG001|Overall Study|Adverse Event|2|||
149153691|NCT02605642|538039995|FG000|Overall Study|Withdrawal by Subject|23|||
149153692|NCT02605642|538039996|FG001|Overall Study|Withdrawal by Subject|2|||
149153693|NCT02605642|538039995|FG000|Overall Study|Lack of response|24|||
149153694|NCT02605642|538039996|FG001|Overall Study|Lack of response|11|||
149153695|NCT00925015|538040003|FG000|Overall Study|Adverse Event|1|||
149153696|NCT00925015|538040004|FG001|Overall Study|Adverse Event|2|||
149153697|NCT00925015|538040005|FG002|Overall Study|Adverse Event|1|||
149153698|NCT00925015|538040003|FG000|Overall Study|Physician Decision|0|||
149153699|NCT00925015|538040004|FG001|Overall Study|Physician Decision|1|||
149153700|NCT00925015|538040005|FG002|Overall Study|Physician Decision|0|||
149153701|NCT00925015|538040003|FG000|Overall Study|Progressive Disease|7|||
149153702|NCT00925015|538040004|FG001|Overall Study|Progressive Disease|3|||
149153703|NCT00925015|538040005|FG002|Overall Study|Progressive Disease|4|||
149153704|NCT00925015|538040003|FG000|Overall Study|Withdrawal by Subject|0|||
149153705|NCT00925015|538040004|FG001|Overall Study|Withdrawal by Subject|0|||
149153706|NCT00925015|538040005|FG002|Overall Study|Withdrawal by Subject|1|||
149153707|NCT00179309|538040006|FG000|Treatment|Toxicity|2|||
149153708|NCT00179309|538040007|FG001|Treatment|Toxicity|3|||
149153709|NCT00179309|538040006|FG000|Treatment|Withdrawal by Subject|1|||
149153710|NCT00179309|538040007|FG001|Treatment|Withdrawal by Subject|2|||
149153711|NCT00179309|538040006|FG000|Treatment|Allergy|1|||
149153712|NCT00179309|538040007|FG001|Treatment|Allergy|0|||
149153713|NCT05882318|538040019|FG000|Overall Study|Withdrawal by Subject|1|||
149153714|NCT05882318|538040020|FG001|Overall Study|Withdrawal by Subject|0|||
149153715|NCT05882318|538040019|FG000|Overall Study|Protocol Violation|0|||
149153716|NCT05882318|538040020|FG001|Overall Study|Protocol Violation|1|||
149153717|NCT05030311|538040023|FG000|Overall Study|Technical problems|0|||
149153718|NCT05030311|538040024|FG001|Overall Study|Technical problems|1|||
149153719|NCT05030311|538040023|FG000|Overall Study|Withdrawal by Subject|31|||
149153720|NCT05030311|538040024|FG001|Overall Study|Withdrawal by Subject|17|||
149153721|NCT05030311|538040023|FG000|Overall Study|Adverse Event|13|||
149153722|NCT05030311|538040024|FG001|Overall Study|Adverse Event|5|||
149153723|NCT05030311|538040023|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149153724|NCT05030311|538040024|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149153725|NCT05030311|538040023|FG000|Overall Study|Physician Decision|5|||
149153726|NCT05030311|538040024|FG001|Overall Study|Physician Decision|2|||
149153727|NCT05030311|538040023|FG000|Overall Study|Lost to Follow-up|5|||
149153728|NCT05030311|538040024|FG001|Overall Study|Lost to Follow-up|1|||
149153729|NCT05030311|538040023|FG000|Overall Study|Protocol Violation|4|||
149153730|NCT05030311|538040024|FG001|Overall Study|Protocol Violation|4|||
149153731|NCT03557359|538040027|FG000|Dose 1: 240 mg|Adverse Event|1|||
149153732|NCT03557359|538040028|FG001|Dose 1: 240 mg|Adverse Event|0|||
149153733|NCT05980299|538040035|FG000|Overall Study|Death|28|||
149153734|NCT05980299|538040036|FG001|Overall Study|Death|0|||
149153735|NCT05980299|538040035|FG000|Overall Study|Discharged from Nursing Home|9|||
149153736|NCT05980299|538040036|FG001|Overall Study|Discharged from Nursing Home|0|||
149153737|NCT05980299|538040035|FG000|Overall Study|Lost to Follow-up|0|||
149153738|NCT05980299|538040036|FG001|Overall Study|Lost to Follow-up|10|||
149153739|NCT00705939|538040045|FG000|Overall Study|Protocol Violation|0|||
149153740|NCT00705939|538040046|FG001|Overall Study|Protocol Violation|0|||
149153741|NCT00705939|538040047|FG002|Overall Study|Protocol Violation|1|||
149153742|NCT00705939|538040045|FG000|Overall Study|Withdrawal by Subject|0|||
149153743|NCT00705939|538040046|FG001|Overall Study|Withdrawal by Subject|1|||
149153744|NCT00705939|538040047|FG002|Overall Study|Withdrawal by Subject|3|||
149153745|NCT00705939|538040045|FG000|Overall Study|Physician Decision|0|||
149153746|NCT00705939|538040046|FG001|Overall Study|Physician Decision|1|||
149153747|NCT00705939|538040047|FG002|Overall Study|Physician Decision|0|||
149153748|NCT01662895|538040048|FG000|Overall Study|Lost to Follow-up|0|||
149153749|NCT01662895|538040049|FG001|Overall Study|Lost to Follow-up|1|||
149153750|NCT05048342|538040050|FG000|Overall Study|Adverse Event|1|||
149153751|NCT05048342|538040050|FG000|Overall Study|Subject decision|2|||
149153752|NCT00493038|538040051|FG000|Treatment|Adverse Event|8|||
149153753|NCT00493038|538040052|FG001|Treatment|Adverse Event|4|||
149153754|NCT00493038|538040051|FG000|Treatment|Lost to Follow-up|5|||
149153755|NCT00493038|538040052|FG001|Treatment|Lost to Follow-up|3|||
149153756|NCT00493038|538040051|FG000|Treatment|Withdrawal by Subject|11|||
149153757|NCT00493038|538040052|FG001|Treatment|Withdrawal by Subject|12|||
149153758|NCT00493038|538040051|FG000|Treatment|Other|0|||
149153759|NCT00493038|538040052|FG001|Treatment|Other|1|||
149153760|NCT00493038|538040051|FG000|Follow-up|Lost to Follow-up|1|||
149153761|NCT00493038|538040052|FG001|Follow-up|Lost to Follow-up|0|||
149153762|NCT01441063|538040053|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
149153763|NCT01441063|538040053|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
149153764|NCT02275338|538040060|FG000|Overall Study|Adverse Event|15|||
149153765|NCT02275338|538040060|FG000|Overall Study|Lack of Efficacy|3|||
149153766|NCT02275338|538040060|FG000|Overall Study|Withdrawal by Subject|4|||
149153767|NCT02275338|538040060|FG000|Overall Study|Disease progression (death)|1|||
149153768|NCT02275338|538040060|FG000|Overall Study|Ineligible to start Phase 2|4|||
149153769|NCT02275338|538040060|FG000|Overall Study|Reason not specified|5|||
149153770|NCT02275338|538040060|FG000|Overall Study|Does not meet entry criteria|1|||
149153771|NCT04607733|538040061|FG000|Overall Study|Lost to Follow-up|1|||
149153772|NCT04607733|538040062|FG001|Overall Study|Lost to Follow-up|0|||
149153773|NCT04607733|538040063|FG002|Overall Study|Lost to Follow-up|0|||
149153774|NCT04607733|538040064|FG003|Overall Study|Lost to Follow-up|1|||
149153775|NCT04607733|538040065|FG004|Overall Study|Lost to Follow-up|1|||
149153776|NCT04607733|538040066|FG005|Overall Study|Lost to Follow-up|0|||
149153777|NCT04607733|538040061|FG000|Overall Study|Withdrawal by Subject|0|||
149153778|NCT04607733|538040062|FG001|Overall Study|Withdrawal by Subject|0|||
149153779|NCT04607733|538040063|FG002|Overall Study|Withdrawal by Subject|0|||
149153780|NCT04607733|538040064|FG003|Overall Study|Withdrawal by Subject|0|||
149153781|NCT04607733|538040065|FG004|Overall Study|Withdrawal by Subject|1|||
149153782|NCT04607733|538040066|FG005|Overall Study|Withdrawal by Subject|0|||
149153783|NCT01665807|538040067|FG000|Overall Study|Withdrawal by Subject|2|||
149153784|NCT01665807|538040068|FG001|Overall Study|Withdrawal by Subject|0|||
148805877|NCT02410629|536768036|FG000|Overall Study|Subject underwent heart surgery|0|||
148805878|NCT02410629|536768037|FG001|Overall Study|Subject underwent heart surgery|1|||
148805879|NCT01206764|536768038|FG000|Overall Study|Adverse Event|20|||
148805880|NCT01206764|536768038|FG000|Overall Study|Abnormal laboratory value|2|||
149153785|NCT01665807|538040069|FG002|Overall Study|Withdrawal by Subject|1|||
149153786|NCT02728830|538040074|FG000|Overall Study|Exclusionary Surgery|9|||
149153787|NCT02728830|538040074|FG000|Overall Study|Exclusionary Pathology|6|||
149153788|NCT02728830|538040074|FG000|Overall Study|Physician Decision|3|||
149153789|NCT02728830|538040074|FG000|Overall Study|Withdrawal by Subject|2|||
148805881|NCT01206764|536768038|FG000|Overall Study|Abnormal test procedure result|1|||
149153790|NCT02728830|538040074|FG000|Overall Study|Lost to Follow-up|1|||
149153791|NCT02728830|538040074|FG000|Overall Study|Exclusionary Lab Values|1|||
149153792|NCT02728830|538040074|FG000|Overall Study|Contraindicated Illness|1|||
149153793|NCT02728830|538040074|FG000|Overall Study|Language Barrier|1|||
149153794|NCT03504397|538040075|FG000|Overall Study|Progressive Disease|151|||
149153795|NCT03504397|538040076|FG001|Overall Study|Progressive Disease|199|||
149153796|NCT03504397|538040075|FG000|Overall Study|Withdrawal by Subject|29|||
149153797|NCT03504397|538040076|FG001|Overall Study|Withdrawal by Subject|17|||
149153798|NCT03504397|538040075|FG000|Overall Study|Lost to Follow-up|1|||
148805882|NCT01206764|536768038|FG000|Overall Study|Patient withdrew consent|5|||
149153799|NCT03504397|538040076|FG001|Overall Study|Lost to Follow-up|0|||
149153800|NCT03504397|538040075|FG000|Overall Study|Death|14|||
149153801|NCT03504397|538040076|FG001|Overall Study|Death|16|||
149153802|NCT03504397|538040075|FG000|Overall Study|Adverse Event|40|||
149153803|NCT03504397|538040076|FG001|Overall Study|Adverse Event|14|||
149153804|NCT03504397|538040075|FG000|Overall Study|miscellaneous|17|||
149153805|NCT03504397|538040076|FG001|Overall Study|miscellaneous|15|||
149153806|NCT03504397|538040075|FG000|Overall Study|Protocol deviation|1|||
149153807|NCT03504397|538040076|FG001|Overall Study|Protocol deviation|0|||
149153808|NCT03504397|538040075|FG000|Overall Study|Participants who did not take the study drug|4|||
149153809|NCT03504397|538040076|FG001|Overall Study|Participants who did not take the study drug|4|||
149153810|NCT00075504|538040077|FG000|Overall Study|Withdrawal by Subject|9|||
149153811|NCT00075504|538040078|FG001|Overall Study|Withdrawal by Subject|7|||
149153812|NCT03215771|538040085|FG000|Overall Study|Withdrawal by Subject|2|||
149153813|NCT03215771|538040085|FG000|Overall Study|Physician Decision|1|||
149153814|NCT00574275|538040090|FG000|Overall Study|Randomized but not treated|2|||
149153815|NCT00574275|538040091|FG001|Overall Study|Randomized but not treated|3|||
149153816|NCT00574275|538040090|FG000|Overall Study|Adverse Event|32|||
149153817|NCT00574275|538040091|FG001|Overall Study|Adverse Event|76|||
149153818|NCT00574275|538040090|FG000|Overall Study|Disease progression|160|||
149153819|NCT00574275|538040091|FG001|Overall Study|Disease progression|146|||
149153820|NCT00574275|538040090|FG000|Overall Study|Lost to Follow-up|2|||
149153821|NCT00574275|538040091|FG001|Overall Study|Lost to Follow-up|1|||
149153822|NCT00574275|538040090|FG000|Overall Study|Study stopped based on DMC decision|62|||
149153823|NCT00574275|538040091|FG001|Overall Study|Study stopped based on DMC decision|23|||
149153824|NCT00574275|538040090|FG000|Overall Study|Withdrawal by Subject|15|||
149153825|NCT00574275|538040091|FG001|Overall Study|Withdrawal by Subject|17|||
149153826|NCT00574275|538040090|FG000|Overall Study|Error calculating tumor measurement|1|||
149153827|NCT00574275|538040091|FG001|Overall Study|Error calculating tumor measurement|0|||
149153828|NCT00574275|538040090|FG000|Overall Study|Physician Decision|1|||
149153829|NCT00574275|538040091|FG001|Overall Study|Physician Decision|1|||
149153830|NCT00574275|538040090|FG000|Overall Study|Protocol Violation|0|||
149153831|NCT00574275|538040091|FG001|Overall Study|Protocol Violation|1|||
149153832|NCT00574275|538040090|FG000|Overall Study|Patient and Investigator decision|0|||
149153833|NCT00574275|538040091|FG001|Overall Study|Patient and Investigator decision|1|||
149153834|NCT00574275|538040090|FG000|Overall Study|Insurance change|0|||
149153835|NCT00574275|538040091|FG001|Overall Study|Insurance change|1|||
149153836|NCT00574275|538040090|FG000|Overall Study|Operation for curative intent|0|||
149153837|NCT00574275|538040091|FG001|Overall Study|Operation for curative intent|1|||
149153838|NCT02703311|538040092|FG000|Overall Study|Death|5|||
149153839|NCT02703311|538040092|FG000|Overall Study|Withdrawal by Subject|3|||
149153840|NCT00137111|538040097|FG000|Total Therapy|Death|35|||
149153841|NCT00137111|538040098|FG001|Total Therapy|Death|0|||
149153842|NCT00137111|538040099|FG002|Total Therapy|Death|0|||
149153843|NCT00137111|538040100|FG003|Total Therapy|Death|0|||
149153844|NCT00137111|538040097|FG000|Total Therapy|Non Compliance|5|||
149153845|NCT00137111|538040098|FG001|Total Therapy|Non Compliance|0|||
149153846|NCT00137111|538040099|FG002|Total Therapy|Non Compliance|0|||
149153847|NCT00137111|538040100|FG003|Total Therapy|Non Compliance|0|||
149153848|NCT02788747|538040101|FG000|Overall Study|Adverse Event|1|||
149153849|NCT02788747|538040102|FG001|Overall Study|Adverse Event|0|||
149153850|NCT02788747|538040103|FG002|Overall Study|Adverse Event|0|||
149153851|NCT03461757|538040104|FG000|Overall Study|Adverse Event|1|||
149153852|NCT03461757|538040105|FG001|Overall Study|Adverse Event|0|||
149153853|NCT03461757|538040104|FG000|Overall Study|Lost to Follow-up|13|||
149153854|NCT03461757|538040105|FG001|Overall Study|Lost to Follow-up|7|||
149153855|NCT03461757|538040104|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
149153856|NCT03461757|538040105|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
149153857|NCT03461757|538040104|FG000|Overall Study|Non-compliance with study treatment|0|||
149153858|NCT03461757|538040105|FG001|Overall Study|Non-compliance with study treatment|1|||
149153859|NCT03461757|538040104|FG000|Overall Study|Pregnancy|2|||
149153860|NCT03461757|538040105|FG001|Overall Study|Pregnancy|0|||
149153861|NCT03461757|538040104|FG000|Overall Study|Protocol Violation|1|||
149153862|NCT03461757|538040105|FG001|Overall Study|Protocol Violation|1|||
149153863|NCT03461757|538040104|FG000|Overall Study|Withdrawal by Subject|7|||
149153864|NCT03461757|538040105|FG001|Overall Study|Withdrawal by Subject|7|||
149153865|NCT03461757|538040104|FG000|Overall Study|Other Reasons|1|||
149153866|NCT03461757|538040105|FG001|Overall Study|Other Reasons|4|||
149153867|NCT03861559|538040106|FG000|Overall Study|Adverse Event|0|||
149153868|NCT03861559|538040107|FG001|Overall Study|Adverse Event|2|||
149153869|NCT03861559|538040106|FG000|Overall Study|Treatment failure|0|||
149153870|NCT03861559|538040107|FG001|Overall Study|Treatment failure|2|||
149153871|NCT03861559|538040106|FG000|Overall Study|Noncompliance|1|||
149153872|NCT03861559|538040107|FG001|Overall Study|Noncompliance|1|||
149153873|NCT03861559|538040106|FG000|Overall Study|Did not meet eligibility requirements|1|||
149153874|NCT03861559|538040107|FG001|Overall Study|Did not meet eligibility requirements|0|||
149153875|NCT00903175|538040108|FG000|Period 1 - First Line|Adverse Event|36|||
149153876|NCT00903175|538040109|FG001|Period 1 - First Line|Adverse Event|50|||
149153877|NCT00903175|538040108|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
149153878|NCT00903175|538040109|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
149153879|NCT00903175|538040108|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
149153880|NCT00903175|538040109|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
149153881|NCT00903175|538040108|FG000|Period 1 - First Line|Protocol Violation|3|||
149153882|NCT00903175|538040109|FG001|Period 1 - First Line|Protocol Violation|3|||
149153883|NCT00903175|538040108|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
149153884|NCT00903175|538040109|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
149153885|NCT00903175|538040108|FG000|Period 1 - First Line|Administrative problems|12|||
149153886|NCT00903175|538040109|FG001|Period 1 - First Line|Administrative problems|13|||
149153887|NCT00903175|538040108|FG000|Period 1 - First Line|Death|17|||
149153888|NCT00903175|538040109|FG001|Period 1 - First Line|Death|10|||
149153889|NCT00903175|538040108|FG000|Period 2 - Second Line|Missing|1|||
149153890|NCT00903175|538040109|FG001|Period 2 - Second Line|Missing|0|||
149153891|NCT00903175|538040108|FG000|Period 2 - Second Line|Adverse Event|16|||
149153892|NCT00903175|538040109|FG001|Period 2 - Second Line|Adverse Event|20|||
149153893|NCT00903175|538040108|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
149153894|NCT00903175|538040109|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
149153895|NCT00903175|538040108|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
149153896|NCT00903175|538040109|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
149153897|NCT00903175|538040108|FG000|Period 2 - Second Line|Administrative problems|19|||
149153898|NCT00903175|538040109|FG001|Period 2 - Second Line|Administrative problems|9|||
149153899|NCT00903175|538040108|FG000|Period 2 - Second Line|Death|5|||
149153900|NCT00903175|538040109|FG001|Period 2 - Second Line|Death|2|||
149153901|NCT01344876|538040111|FG000|Overall Study|Adverse Event|0|||
149153902|NCT01344876|538040112|FG001|Overall Study|Adverse Event|0|||
149153903|NCT01344876|538040113|FG002|Overall Study|Adverse Event|0|||
149153904|NCT01344876|538040114|FG003|Overall Study|Adverse Event|0|||
149153905|NCT01344876|538040115|FG004|Overall Study|Adverse Event|1|||
149153906|NCT01344876|538040111|FG000|Overall Study|Withdrawal by Subject|0|||
149153907|NCT01344876|538040112|FG001|Overall Study|Withdrawal by Subject|0|||
149153908|NCT01344876|538040113|FG002|Overall Study|Withdrawal by Subject|1|||
149153909|NCT01344876|538040114|FG003|Overall Study|Withdrawal by Subject|0|||
149153910|NCT01344876|538040115|FG004|Overall Study|Withdrawal by Subject|0|||
149153911|NCT01344876|538040111|FG000|Overall Study|Definite progression of primary disease|1|||
149153912|NCT01344876|538040112|FG001|Overall Study|Definite progression of primary disease|0|||
149153913|NCT01344876|538040113|FG002|Overall Study|Definite progression of primary disease|0|||
149153914|NCT01344876|538040114|FG003|Overall Study|Definite progression of primary disease|3|||
149153915|NCT01344876|538040115|FG004|Overall Study|Definite progression of primary disease|0|||
149153916|NCT05107765|538040116|FG000|Overall Study|Lost to Follow-up|4|||
149153917|NCT05107765|538040117|FG001|Overall Study|Lost to Follow-up|1|||
149153918|NCT05107765|538040116|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
149153919|NCT05107765|538040117|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
149153920|NCT05107765|538040116|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
149153921|NCT05107765|538040117|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
149153922|NCT01765673|538041729|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
149153923|NCT02475681|538041730|FG000|Overall Study|Death|16|||
149153924|NCT02475681|538041731|FG001|Overall Study|Death|6|||
149153925|NCT02475681|538041732|FG002|Overall Study|Death|9|||
149153926|NCT02475681|538041730|FG000|Overall Study|Physician Decision|0|||
149153927|NCT02475681|538041731|FG001|Overall Study|Physician Decision|3|||
149153928|NCT02475681|538041732|FG002|Overall Study|Physician Decision|1|||
149153929|NCT02475681|538041730|FG000|Overall Study|Withdrawal by Subject|12|||
149153930|NCT02475681|538041731|FG001|Overall Study|Withdrawal by Subject|6|||
149153931|NCT02475681|538041732|FG002|Overall Study|Withdrawal by Subject|9|||
149153932|NCT02475681|538041730|FG000|Overall Study|Lost to Follow-up|2|||
149153933|NCT02475681|538041731|FG001|Overall Study|Lost to Follow-up|1|||
149153934|NCT02475681|538041732|FG002|Overall Study|Lost to Follow-up|3|||
149153935|NCT02475681|538041730|FG000|Overall Study|Ongoing in Study|0|||
149153936|NCT02475681|538041731|FG001|Overall Study|Ongoing in Study|163|||
149153937|NCT02475681|538041732|FG002|Overall Study|Ongoing in Study|157|||
149153938|NCT02475681|538041730|FG000|Overall Study|Reasons other than above listed|2|||
149153939|NCT02475681|538041731|FG001|Overall Study|Reasons other than above listed|0|||
149153940|NCT02475681|538041732|FG002|Overall Study|Reasons other than above listed|0|||
149153941|NCT00356278|538041741|FG000|Overall Study|Withdrawal by Subject|25|||
149153942|NCT00356278|538041742|FG001|Overall Study|Withdrawal by Subject|15|||
149153943|NCT00356278|538041743|FG002|Overall Study|Withdrawal by Subject|19|||
149153944|NCT01363986|538041746|FG000|Overall Study|Disease progression|1|||
149153945|NCT01637142|538041747|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
149153946|NCT00687362|538041753|FG000|Overall Study|Protocol Violation|2|||
149153947|NCT00687362|538041753|FG000|Overall Study|Withdrawal by Subject|1|||
149153948|NCT02354703|538041754|FG000|Overall Study|Withdrawal by Subject|1|||
149153949|NCT02354703|538041755|FG001|Overall Study|Withdrawal by Subject|1|||
149153950|NCT02354703|538041756|FG002|Overall Study|Withdrawal by Subject|1|||
149153951|NCT02354703|538041757|FG003|Overall Study|Withdrawal by Subject|1|||
149153952|NCT02354703|538041754|FG000|Overall Study|Lost to Follow-up|2|||
149153953|NCT02354703|538041755|FG001|Overall Study|Lost to Follow-up|7|||
149153954|NCT02354703|538041756|FG002|Overall Study|Lost to Follow-up|9|||
149153955|NCT02354703|538041757|FG003|Overall Study|Lost to Follow-up|2|||
149153956|NCT02354703|538041754|FG000|Overall Study|Adverse Event|0|||
149153957|NCT02354703|538041755|FG001|Overall Study|Adverse Event|0|||
149153958|NCT02354703|538041756|FG002|Overall Study|Adverse Event|1|||
149153959|NCT02354703|538041757|FG003|Overall Study|Adverse Event|0|||
149153960|NCT01268293|538041762|FG000|Overall Study|Disease progression|7|||
149153961|NCT01268293|538041762|FG000|Overall Study|Adverse Event|1|||
149153962|NCT01268293|538041762|FG000|Overall Study|Subject choice|1|||
149153963|NCT02597855|538041763|FG000|Overall Study|Lost to Follow-up|2|||
149153964|NCT02597855|538041764|FG001|Overall Study|Lost to Follow-up|1|||
149153965|NCT04681170|538041767|FG000|Stratified Enrolment & run-in|Death|1|||
149153966|NCT04681170|538041768|FG001|Stratified Enrolment & run-in|Death|0|||
149153967|NCT04681170|538041767|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
149153968|NCT04681170|538041768|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
149153969|NCT04681170|538041767|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
149153970|NCT04681170|538041768|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
149153971|NCT04681170|538041767|FG000|Open Label Efficacy Phase|Adverse Event|0|||
149153972|NCT04681170|538041768|FG001|Open Label Efficacy Phase|Adverse Event|2|||
149153973|NCT04681170|538041767|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
149153974|NCT04681170|538041768|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
149153975|NCT04681170|538041767|FG000|Open Label Safety Phase|AEs and none compliance|0|||
149153976|NCT04681170|538041768|FG001|Open Label Safety Phase|AEs and none compliance|1|||
149153977|NCT01407926|538041773|FG000|Overall Study|Lost to Follow-up|55|||
149153978|NCT02814565|538041774|FG000|Overall Study|Lack of Efficacy|0|||
149153979|NCT02814565|538041775|FG001|Overall Study|Lack of Efficacy|1|||
149153980|NCT02814565|538041774|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
149153981|NCT02814565|538041775|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
149153982|NCT02468648|538041776|FG000|Overall Study|Death|1|||
149153983|NCT02118792|538041777|FG000|Overall Study|Withdrawal by Subject|6|||
149153984|NCT02118792|538041778|FG001|Overall Study|Withdrawal by Subject|3|||
149153985|NCT02118792|538041777|FG000|Overall Study|Lost to Follow-up|4|||
149153986|NCT02118792|538041778|FG001|Overall Study|Lost to Follow-up|4|||
149153987|NCT02118792|538041777|FG000|Overall Study|Adverse Event|5|||
149153988|NCT02118792|538041778|FG001|Overall Study|Adverse Event|4|||
149153989|NCT02118792|538041777|FG000|Overall Study|Withdrawal by parent/guardian|14|||
149153990|NCT02118792|538041778|FG001|Overall Study|Withdrawal by parent/guardian|20|||
149153991|NCT02118792|538041777|FG000|Overall Study|Other|1|||
149153992|NCT02118792|538041778|FG001|Overall Study|Other|6|||
149153993|NCT02118792|538041777|FG000|Overall Study|Randomised but not treated|1|||
149153994|NCT02118792|538041778|FG001|Overall Study|Randomised but not treated|0|||
149153995|NCT05131204|538041779|FG000|Overall Study|Sponsor request|2|||
149153996|NCT05131204|538041780|FG001|Overall Study|Sponsor request|1|||
149153997|NCT01777152|538041781|FG000|Overall Study|Withdrawal by Subject|22|||
149153998|NCT01777152|538041782|FG001|Overall Study|Withdrawal by Subject|16|||
149153999|NCT01777152|538041781|FG000|Overall Study|Lost to Follow-up|3|||
149154000|NCT01777152|538041782|FG001|Overall Study|Lost to Follow-up|5|||
149154001|NCT01777152|538041781|FG000|Overall Study|Death|68|||
149154002|NCT01777152|538041782|FG001|Overall Study|Death|89|||
149154003|NCT01777152|538041781|FG000|Overall Study|Not eligible, no study drug received|1|||
149154004|NCT01777152|538041782|FG001|Overall Study|Not eligible, no study drug received|0|||
149154005|NCT01777152|538041781|FG000|Overall Study|Change of diagnosis|1|||
149154006|NCT01777152|538041782|FG001|Overall Study|Change of diagnosis|0|||
149154007|NCT02363686|538041786|FG000|Overall Study|Withdrawal by Subject|22|||
149154008|NCT02363686|538041786|FG000|Overall Study|incomplete FEES examinations|13|||
149154009|NCT02469090|538041791|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
149154010|NCT02469090|538041792|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
148805883|NCT01206764|536768038|FG000|Overall Study|Lost to Follow-up|6|||
148805884|NCT01206764|536768038|FG000|Overall Study|Death|11|||
148805885|NCT01206764|536768038|FG000|Overall Study|New cancer therapy|2|||
148805886|NCT01206764|536768038|FG000|Overall Study|Disease progression|88|||
148805887|NCT01206764|536768038|FG000|Overall Study|Protocol deviation|3|||
148805888|NCT00997893|536768041|FG000|Overall Study|Adverse Event|1|||
148805889|NCT00997893|536768042|FG001|Overall Study|Adverse Event|0|||
148805890|NCT00997893|536768043|FG002|Overall Study|Adverse Event|0|||
148805891|NCT00997893|536768041|FG000|Overall Study|Unable to meet study timelines|1|||
148805892|NCT00997893|536768042|FG001|Overall Study|Unable to meet study timelines|0|||
148805893|NCT00997893|536768043|FG002|Overall Study|Unable to meet study timelines|0|||
148805894|NCT00997893|536768041|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
148805895|NCT00997893|536768042|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
148805896|NCT00997893|536768043|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
148805897|NCT05911841|536768044|FG000|Induction Period|Study Terminated by Sponsor|2|||
148805898|NCT05911841|536768045|FG001|Induction Period|Study Terminated by Sponsor|0|||
149154011|NCT02469090|538041793|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
149154012|NCT02469090|538041791|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
148805899|NCT05911841|536768046|FG002|Induction Period|Study Terminated by Sponsor|14|||
148805900|NCT05911841|536768047|FG003|Induction Period|Study Terminated by Sponsor|6|||
148805901|NCT05911841|536768048|FG004|Induction Period|Study Terminated by Sponsor|0|||
148805902|NCT05911841|536768049|FG005|Induction Period|Study Terminated by Sponsor|0|||
148805903|NCT05911841|536768050|FG006|Induction Period|Study Terminated by Sponsor|0|||
148919209|NCT01133990|537187848|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
148919210|NCT01133990|537187849|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
148919211|NCT01133990|537187850|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
148919212|NCT01133990|537187851|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
148919213|NCT01133990|537187846|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
149154013|NCT02469090|538041792|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
149154014|NCT02469090|538041793|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
149154015|NCT02469090|538041791|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
149154016|NCT02469090|538041792|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
149154017|NCT02469090|538041793|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
149154018|NCT02469090|538041791|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
148919214|NCT01133990|537187847|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
148919215|NCT01133990|537187848|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
149154019|NCT02469090|538041792|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
149154020|NCT02469090|538041793|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
149154021|NCT02469090|538041791|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
149154022|NCT02469090|538041792|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
149154023|NCT02469090|538041793|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
149154024|NCT02469090|538041791|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
148919216|NCT01133990|537187849|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
149154025|NCT02469090|538041792|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
149154026|NCT02469090|538041793|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
148919217|NCT01133990|537187850|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
148919218|NCT01133990|537187851|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
148919219|NCT01133990|537187846|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
149154027|NCT02469090|538041791|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
149154028|NCT02469090|538041792|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
149154029|NCT02469090|538041793|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
149154030|NCT02469090|538041791|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
149154031|NCT02469090|538041792|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
149154032|NCT02469090|538041793|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
149154033|NCT03446885|538041796|FG000|Overall Study|Lost to Follow-up|1|||
149154034|NCT03446885|538041797|FG001|Overall Study|Lost to Follow-up|0|||
148919220|NCT01133990|537187847|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
148919221|NCT01133990|537187848|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
148919222|NCT01133990|537187849|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
149154035|NCT03446885|538041796|FG000|Overall Study|Did not complete entire visit|1|||
149154036|NCT03446885|538041797|FG001|Overall Study|Did not complete entire visit|0|||
148805904|NCT05911841|536768051|FG007|Induction Period|Study Terminated by Sponsor|0|||
148805905|NCT05911841|536768052|FG008|Induction Period|Study Terminated by Sponsor|0|||
149154037|NCT03823391|538041800|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
149154038|NCT03823391|538041801|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
149154039|NCT03823391|538041800|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
149154040|NCT03823391|538041801|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
149154041|NCT03042468|538041806|FG000|Overall Study|Death|0|||
149154042|NCT03042468|538041807|FG001|Overall Study|Death|1|||
149154043|NCT03042468|538041808|FG002|Overall Study|Death|1|||
149154044|NCT03042468|538041809|FG003|Overall Study|Death|0|||
149154045|NCT03042468|538041810|FG004|Overall Study|Death|0|||
149154046|NCT03042468|538041811|FG005|Overall Study|Death|0|||
149154047|NCT03042468|538041806|FG000|Overall Study|Withdrawal by Subject|0|||
149154048|NCT03042468|538041807|FG001|Overall Study|Withdrawal by Subject|0|||
149154049|NCT03042468|538041808|FG002|Overall Study|Withdrawal by Subject|0|||
149154050|NCT03042468|538041809|FG003|Overall Study|Withdrawal by Subject|0|||
149154051|NCT03042468|538041810|FG004|Overall Study|Withdrawal by Subject|0|||
149154052|NCT03042468|538041811|FG005|Overall Study|Withdrawal by Subject|1|||
149154053|NCT03042468|538041806|FG000|Overall Study|Lost to Follow-up|0|||
149154054|NCT03042468|538041807|FG001|Overall Study|Lost to Follow-up|0|||
149154055|NCT03042468|538041808|FG002|Overall Study|Lost to Follow-up|0|||
149154056|NCT03042468|538041809|FG003|Overall Study|Lost to Follow-up|0|||
149154057|NCT03042468|538041810|FG004|Overall Study|Lost to Follow-up|1|||
149154058|NCT03042468|538041811|FG005|Overall Study|Lost to Follow-up|1|||
149154059|NCT03345472|538041812|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
149154060|NCT03345472|538041812|FG000|Implant to 3 Months|Physician Decision|1|||
149154061|NCT03345472|538041812|FG000|Implant to 3 Months|Adverse Event|1|||
149154062|NCT03345472|538041812|FG000|3 Months to 12 Months|Physician Decision|3|||
149154063|NCT03345472|538041812|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
149154064|NCT03345472|538041812|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
149154065|NCT03345472|538041812|FG000|3 Months to 12 Months|Adverse Event|1|||
149154066|NCT03345472|538041812|FG000|3 Months to 12 Months|Death|1|||
149154067|NCT01926782|538041813|FG000|Overall Study|Participant moved|2|||
149154068|NCT01926782|538041814|FG001|Overall Study|Participant moved|0|||
149154069|NCT01926782|538041815|FG002|Overall Study|Participant moved|1|||
149154070|NCT01926782|538041816|FG003|Overall Study|Participant moved|1|||
149154071|NCT01926782|538041817|FG004|Overall Study|Participant moved|0|||
149154072|NCT01926782|538041818|FG005|Overall Study|Participant moved|3|||
149154073|NCT01926782|538041813|FG000|Overall Study|Physician Decision|0|||
149154074|NCT01926782|538041814|FG001|Overall Study|Physician Decision|2|||
149154075|NCT01926782|538041815|FG002|Overall Study|Physician Decision|1|||
149154076|NCT01926782|538041816|FG003|Overall Study|Physician Decision|1|||
149154077|NCT01926782|538041817|FG004|Overall Study|Physician Decision|0|||
149154078|NCT01926782|538041818|FG005|Overall Study|Physician Decision|0|||
149154079|NCT01926782|538041813|FG000|Overall Study|Other than specified|2|||
149154080|NCT01926782|538041814|FG001|Overall Study|Other than specified|3|||
149154081|NCT01926782|538041815|FG002|Overall Study|Other than specified|5|||
149154082|NCT01926782|538041816|FG003|Overall Study|Other than specified|12|||
149154083|NCT01926782|538041817|FG004|Overall Study|Other than specified|4|||
149154084|NCT01926782|538041818|FG005|Overall Study|Other than specified|11|||
149154085|NCT01926782|538041813|FG000|Overall Study|Adverse Event|13|||
149154086|NCT01926782|538041814|FG001|Overall Study|Adverse Event|4|||
149154087|NCT01926782|538041815|FG002|Overall Study|Adverse Event|17|||
149154088|NCT01926782|538041816|FG003|Overall Study|Adverse Event|4|||
149154089|NCT01926782|538041817|FG004|Overall Study|Adverse Event|3|||
149154090|NCT01926782|538041818|FG005|Overall Study|Adverse Event|14|||
149154091|NCT01926782|538041813|FG000|Overall Study|Poor compliance to protocol|5|||
149154092|NCT01926782|538041814|FG001|Overall Study|Poor compliance to protocol|3|||
149154093|NCT01926782|538041815|FG002|Overall Study|Poor compliance to protocol|8|||
149154094|NCT01926782|538041816|FG003|Overall Study|Poor compliance to protocol|0|||
149154095|NCT01926782|538041817|FG004|Overall Study|Poor compliance to protocol|1|||
149154096|NCT01926782|538041818|FG005|Overall Study|Poor compliance to protocol|6|||
149154097|NCT01926782|538041813|FG000|Overall Study|Randomized and not treated|0|||
149154098|NCT01926782|538041814|FG001|Overall Study|Randomized and not treated|0|||
149154099|NCT01926782|538041815|FG002|Overall Study|Randomized and not treated|0|||
149154100|NCT01926782|538041816|FG003|Overall Study|Randomized and not treated|1|||
149154101|NCT01926782|538041817|FG004|Overall Study|Randomized and not treated|0|||
149154102|NCT01926782|538041818|FG005|Overall Study|Randomized and not treated|0|||
149154103|NCT01926782|538041813|FG000|Overall Study|Withdrawal by Subject|6|||
149154104|NCT01926782|538041814|FG001|Overall Study|Withdrawal by Subject|1|||
149154105|NCT01926782|538041815|FG002|Overall Study|Withdrawal by Subject|8|||
149154106|NCT01926782|538041816|FG003|Overall Study|Withdrawal by Subject|1|||
149154107|NCT01926782|538041817|FG004|Overall Study|Withdrawal by Subject|0|||
149154108|NCT01926782|538041818|FG005|Overall Study|Withdrawal by Subject|5|||
149154109|NCT01926782|538041813|FG000|Overall Study|Related to study drug administration|0|||
149154110|NCT01926782|538041814|FG001|Overall Study|Related to study drug administration|0|||
149154111|NCT01926782|538041815|FG002|Overall Study|Related to study drug administration|0|||
149154112|NCT01926782|538041816|FG003|Overall Study|Related to study drug administration|0|||
149154113|NCT01926782|538041817|FG004|Overall Study|Related to study drug administration|0|||
149154114|NCT01926782|538041818|FG005|Overall Study|Related to study drug administration|2|||
149154115|NCT00070941|538041845|FG000|Overall Study|Adverse Event|10|||
149154116|NCT00070941|538041846|FG001|Overall Study|Adverse Event|8|||
149154117|NCT00070941|538041847|FG002|Overall Study|Adverse Event|4|||
149154118|NCT00623428|538041852|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
149154119|NCT00623428|538041853|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
149154120|NCT00623428|538041852|FG000|Treatment Period|Death|0|||
149154121|NCT00623428|538041853|FG001|Treatment Period|Death|1|||
149154122|NCT00623428|538041852|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
149154123|NCT00623428|538041853|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
149154124|NCT00623428|538041852|FG000|Treatment Period|Insufficient therapeutic response|0|||
149154125|NCT00623428|538041853|FG001|Treatment Period|Insufficient therapeutic response|2|||
149154126|NCT00623428|538041852|FG000|Treatment Period|Other|0|||
149154127|NCT00623428|538041853|FG001|Treatment Period|Other|1|||
149154128|NCT00623428|538041852|FG000|Treatment Period|Withdrawal by Subject|0|||
149154129|NCT00623428|538041853|FG001|Treatment Period|Withdrawal by Subject|1|||
149154130|NCT00623428|538041852|FG000|Follow-up Period|Relapse post-treatment|11|||
149154131|NCT00623428|538041853|FG001|Follow-up Period|Relapse post-treatment|3|||
149154132|NCT00623428|538041852|FG000|Follow-up Period|Failure to return|10|||
149154133|NCT00623428|538041853|FG001|Follow-up Period|Failure to return|2|||
149154134|NCT00623428|538041852|FG000|Follow-up Period|Patient withdrew consent|5|||
149154135|NCT00623428|538041853|FG001|Follow-up Period|Patient withdrew consent|4|||
149154136|NCT00623428|538041852|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
149154137|NCT00623428|538041853|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
149154138|NCT00623428|538041852|FG000|Follow-up Period|Did not cooperate|0|||
149154139|NCT00623428|538041853|FG001|Follow-up Period|Did not cooperate|3|||
149154140|NCT00623428|538041852|FG000|Follow-up Period|Reason not specified|1|||
149154141|NCT00623428|538041853|FG001|Follow-up Period|Reason not specified|1|||
149154142|NCT00623428|538041852|FG000|Follow-up Period|Death|0|||
149154143|NCT00623428|538041853|FG001|Follow-up Period|Death|1|||
149154144|NCT01142726|538041854|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
149154145|NCT01142726|538041855|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
149154146|NCT01142726|538041856|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
149154147|NCT01142726|538041854|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
149154148|NCT01142726|538041855|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
149154149|NCT01142726|538041856|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
149154150|NCT01142726|538041854|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
149154151|NCT01142726|538041855|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
149154152|NCT01142726|538041856|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
149154153|NCT01142726|538041854|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
149154154|NCT01142726|538041855|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
149154155|NCT01142726|538041856|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
148919223|NCT01133990|537187850|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
149154156|NCT01142726|538041854|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
149154157|NCT01142726|538041855|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
149154158|NCT01142726|538041856|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
149154159|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
148919224|NCT01133990|537187851|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
149154160|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
149154161|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
149154162|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
149154163|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
149154164|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
149154165|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
149154166|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
149154167|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
149154168|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
149154169|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
149154170|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
149154171|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
149154172|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
149154173|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
149154174|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
149154175|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
149154176|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
149154177|NCT01142726|538041854|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
149154178|NCT01142726|538041855|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
149154179|NCT01142726|538041856|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
149154180|NCT01142726|538041854|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
149154181|NCT01142726|538041855|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
149154182|NCT01142726|538041856|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
149154183|NCT01142726|538041854|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
149154184|NCT01142726|538041855|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
149154185|NCT01142726|538041856|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
149154186|NCT01142726|538041854|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
149154187|NCT01142726|538041855|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
149154188|NCT01142726|538041856|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
149154189|NCT01142726|538041854|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
149154190|NCT01142726|538041855|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
149154191|NCT01142726|538041856|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
149154192|NCT00419380|538041857|FG000|Overall Study|Lack of Efficacy|1|||
149154193|NCT00419380|538041858|FG001|Overall Study|Lack of Efficacy|7|||
149154194|NCT00419380|538041857|FG000|Overall Study|Physician Decision|0|||
149154195|NCT00419380|538041858|FG001|Overall Study|Physician Decision|1|||
149154196|NCT00419380|538041857|FG000|Overall Study|Lost to Follow-up|0|||
149154197|NCT00419380|538041858|FG001|Overall Study|Lost to Follow-up|1|||
149154198|NCT00419380|538041857|FG000|Overall Study|Withdrawal by Subject|0|||
149154199|NCT00419380|538041858|FG001|Overall Study|Withdrawal by Subject|1|||
149154200|NCT03099707|538041859|FG000|Overall Study|Withdrawal by Subject|0|||
149154201|NCT03099707|538041860|FG001|Overall Study|Withdrawal by Subject|3|||
149154202|NCT03099707|538041859|FG000|Overall Study|Lost to Follow-up|0|||
149154203|NCT03099707|538041860|FG001|Overall Study|Lost to Follow-up|1|||
149154204|NCT03167073|538041861|FG000|Overall Study|Stillbirth|1|||
149154205|NCT03167073|538041862|FG001|Overall Study|Stillbirth|0|||
149154206|NCT01276236|538041863|FG000|Overall Study|Lack of Efficacy|2|||
149154207|NCT01276236|538041863|FG000|Overall Study|Withdrawal by Subject|4|||
149154208|NCT03127384|538041865|FG000|Overall Study|Lost to Follow-up|4|||
148805906|NCT05911841|536768053|FG009|Induction Period|Study Terminated by Sponsor|0|||
149154209|NCT03127384|538041865|FG000|Overall Study|Subject request|2|||
149154210|NCT00343889|538041873|FG000|Overall Study|Lost to Follow-up|2|||
149154211|NCT00343889|538041874|FG001|Overall Study|Lost to Follow-up|0|||
149154212|NCT00343889|538041873|FG000|Overall Study|Withdrawal by Subject|0|||
149154213|NCT00343889|538041874|FG001|Overall Study|Withdrawal by Subject|1|||
149154214|NCT00343889|538041873|FG000|Overall Study|Protocol Violation|1|||
149154215|NCT00343889|538041874|FG001|Overall Study|Protocol Violation|0|||
149154216|NCT01294579|538041877|FG000|Overall Study|Disease progression|12|||
149154217|NCT01294579|538041877|FG000|Overall Study|Adverse Event|11|||
149154218|NCT01294579|538041877|FG000|Overall Study|Study closed/terminated|3|||
149154219|NCT01294579|538041877|FG000|Overall Study|Lost to Follow-up|1|||
149154220|NCT01294579|538041877|FG000|Overall Study|Physician Decision|3|||
149154221|NCT01294579|538041877|FG000|Overall Study|Withdrawal by Subject|5|||
149154222|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
149154223|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
149154224|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
149154225|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
149154226|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
149154227|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
149154228|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
149154229|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
149154230|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
149154231|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
149154232|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
149154233|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
149154234|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
149154235|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
149154236|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
149154237|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
149154238|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
149154239|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
149154240|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
149154241|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
149154242|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
149154243|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
149154244|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
149154245|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
149154246|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
149154247|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
149154248|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
149154249|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
149154250|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
149154251|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
149154252|NCT00784654|538041878|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
149154253|NCT00784654|538041879|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
149154254|NCT00784654|538041880|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
149154255|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
149154256|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
149154257|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
149154258|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
149154259|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
149154260|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
149154261|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149154262|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
149154263|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
149154264|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
149154265|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
149154266|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
149154267|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Adverse Event|0|||
149154268|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Adverse Event|1|||
149154269|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Adverse Event|1|||
149154270|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
149154271|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
149154272|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
148805907|NCT05911841|536768044|FG000|Induction Period|Withdrawal by Subject|4|||
148805908|NCT05911841|536768045|FG001|Induction Period|Withdrawal by Subject|3|||
149154273|NCT00784654|538041878|FG000|Randomized Withdrawal Period|Family reasons|0|||
149154274|NCT00784654|538041879|FG001|Randomized Withdrawal Period|Family reasons|0|||
149154275|NCT00784654|538041880|FG002|Randomized Withdrawal Period|Family reasons|1|||
149154276|NCT00562354|538041881|FG000|Overall Study|Physician Decision|0|||
149154277|NCT00562354|538041882|FG001|Overall Study|Physician Decision|1|||
149154278|NCT00562354|538041881|FG000|Overall Study|Lost to Follow-up|0|||
149154279|NCT00562354|538041882|FG001|Overall Study|Lost to Follow-up|1|||
149154280|NCT00262873|538041883|FG000|Overall Study|Adverse Event|3|||
149154281|NCT00262873|538041883|FG000|Overall Study|Withdrawal by Subject|5|||
149154282|NCT05130463|538041884|FG000|Overall Study|Unspecified reasons|2|||
149154283|NCT05130463|538041884|FG000|Overall Study|off-label indication dose|435|||
149154284|NCT03440814|538041885|FG000|Overall Study|Adverse Event|2|||
149154285|NCT03440814|538041886|FG001|Overall Study|Adverse Event|1|||
149154286|NCT03440814|538041885|FG000|Overall Study|Lost to Follow-up|2|||
149154287|NCT03440814|538041886|FG001|Overall Study|Lost to Follow-up|0|||
149154288|NCT03440814|538041885|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
149154289|NCT03440814|538041886|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
149154290|NCT01437397|538041887|FG000|Overall Study|Lost to Follow-up|9|||
149154291|NCT01437397|538041888|FG001|Overall Study|Lost to Follow-up|4|||
149154292|NCT01437397|538041889|FG002|Overall Study|Lost to Follow-up|2|||
149154293|NCT01437397|538041890|FG003|Overall Study|Lost to Follow-up|4|||
149154294|NCT01437397|538041891|FG004|Overall Study|Lost to Follow-up|5|||
149154295|NCT01437397|538041887|FG000|Overall Study|Withdrawal by Subject|11|||
149154296|NCT01437397|538041888|FG001|Overall Study|Withdrawal by Subject|12|||
149154297|NCT01437397|538041889|FG002|Overall Study|Withdrawal by Subject|24|||
149154298|NCT01437397|538041890|FG003|Overall Study|Withdrawal by Subject|11|||
149154299|NCT01437397|538041891|FG004|Overall Study|Withdrawal by Subject|22|||
149154300|NCT01437397|538041887|FG000|Overall Study|Protocol Violation|10|||
149154301|NCT01437397|538041888|FG001|Overall Study|Protocol Violation|12|||
149154302|NCT01437397|538041889|FG002|Overall Study|Protocol Violation|13|||
149154303|NCT01437397|538041890|FG003|Overall Study|Protocol Violation|21|||
149154304|NCT01437397|538041891|FG004|Overall Study|Protocol Violation|19|||
149154305|NCT01437397|538041887|FG000|Overall Study|Lack of Efficacy|5|||
149154306|NCT01437397|538041888|FG001|Overall Study|Lack of Efficacy|4|||
149154307|NCT01437397|538041889|FG002|Overall Study|Lack of Efficacy|8|||
149154308|NCT01437397|538041890|FG003|Overall Study|Lack of Efficacy|10|||
149154309|NCT01437397|538041891|FG004|Overall Study|Lack of Efficacy|20|||
149154310|NCT01437397|538041887|FG000|Overall Study|Adverse Event|21|||
149154311|NCT01437397|538041888|FG001|Overall Study|Adverse Event|22|||
149154312|NCT01437397|538041889|FG002|Overall Study|Adverse Event|16|||
149154313|NCT01437397|538041890|FG003|Overall Study|Adverse Event|14|||
149154314|NCT01437397|538041891|FG004|Overall Study|Adverse Event|21|||
149154315|NCT01437397|538041887|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
149154316|NCT01437397|538041888|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
149154317|NCT01437397|538041889|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
149154318|NCT01437397|538041890|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
149154319|NCT01437397|538041891|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
149154320|NCT03074474|538041894|FG000|Overall Study|Lost to Follow-up|10|||
149154321|NCT03074474|538041894|FG000|Overall Study|Withdrawal by Subject|10|||
149154322|NCT03074474|538041894|FG000|Overall Study|Death|4|||
149154323|NCT03074474|538041894|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
149154324|NCT01358864|538041900|FG000|Overall Study|Adverse Event|0|||
148919225|NCT01185301|537187852|FG000|Overall Study|Adverse Event|3|||
149154325|NCT01358864|538041901|FG001|Overall Study|Adverse Event|6|||
149154326|NCT01358864|538041902|FG002|Overall Study|Adverse Event|9|||
149154327|NCT01358864|538041903|FG003|Overall Study|Adverse Event|0|||
149154328|NCT01358864|538041904|FG004|Overall Study|Adverse Event|4|||
149154329|NCT01358864|538041905|FG005|Overall Study|Adverse Event|8|||
149154330|NCT01358864|538041906|FG006|Overall Study|Adverse Event|12|||
149154331|NCT01358864|538041907|FG007|Overall Study|Adverse Event|7|||
148919226|NCT01185301|537187853|FG001|Overall Study|Adverse Event|0|||
148919227|NCT01185301|537187854|FG002|Overall Study|Adverse Event|2|||
148919228|NCT01185301|537187855|FG003|Overall Study|Adverse Event|3|||
149154332|NCT01358864|538041900|FG000|Overall Study|Lack of Efficacy|26|||
149154333|NCT01358864|538041901|FG001|Overall Study|Lack of Efficacy|3|||
149154334|NCT01358864|538041902|FG002|Overall Study|Lack of Efficacy|4|||
149154335|NCT01358864|538041903|FG003|Overall Study|Lack of Efficacy|19|||
149154336|NCT01358864|538041904|FG004|Overall Study|Lack of Efficacy|7|||
149154337|NCT01358864|538041905|FG005|Overall Study|Lack of Efficacy|4|||
149154338|NCT01358864|538041906|FG006|Overall Study|Lack of Efficacy|49|||
149154339|NCT01358864|538041907|FG007|Overall Study|Lack of Efficacy|44|||
149154340|NCT01358864|538041900|FG000|Overall Study|Lost to Follow-up|0|||
149154341|NCT01358864|538041901|FG001|Overall Study|Lost to Follow-up|0|||
149154342|NCT01358864|538041902|FG002|Overall Study|Lost to Follow-up|1|||
149154343|NCT01358864|538041903|FG003|Overall Study|Lost to Follow-up|0|||
149154344|NCT01358864|538041904|FG004|Overall Study|Lost to Follow-up|0|||
149154345|NCT01358864|538041905|FG005|Overall Study|Lost to Follow-up|0|||
149154346|NCT01358864|538041906|FG006|Overall Study|Lost to Follow-up|0|||
149154347|NCT01358864|538041907|FG007|Overall Study|Lost to Follow-up|1|||
149154348|NCT01358864|538041900|FG000|Overall Study|Withdrawal by Subject|3|||
149154349|NCT01358864|538041901|FG001|Overall Study|Withdrawal by Subject|4|||
149154350|NCT01358864|538041902|FG002|Overall Study|Withdrawal by Subject|2|||
149154351|NCT01358864|538041903|FG003|Overall Study|Withdrawal by Subject|0|||
149154352|NCT01358864|538041904|FG004|Overall Study|Withdrawal by Subject|0|||
149154353|NCT01358864|538041905|FG005|Overall Study|Withdrawal by Subject|1|||
149154354|NCT01358864|538041906|FG006|Overall Study|Withdrawal by Subject|1|||
149154355|NCT01358864|538041907|FG007|Overall Study|Withdrawal by Subject|3|||
149154356|NCT01358864|538041900|FG000|Overall Study|Other reason not defined above|2|||
149154357|NCT01358864|538041901|FG001|Overall Study|Other reason not defined above|0|||
149154358|NCT01358864|538041902|FG002|Overall Study|Other reason not defined above|0|||
149154359|NCT01358864|538041903|FG003|Overall Study|Other reason not defined above|0|||
149154360|NCT01358864|538041904|FG004|Overall Study|Other reason not defined above|0|||
149154361|NCT01358864|538041905|FG005|Overall Study|Other reason not defined above|0|||
149154362|NCT01358864|538041906|FG006|Overall Study|Other reason not defined above|2|||
149154363|NCT01358864|538041907|FG007|Overall Study|Other reason not defined above|0|||
149154364|NCT01358864|538041900|FG000|Overall Study|Not treated|0|||
149154365|NCT01358864|538041901|FG001|Overall Study|Not treated|0|||
149154366|NCT01358864|538041902|FG002|Overall Study|Not treated|0|||
149154367|NCT01358864|538041903|FG003|Overall Study|Not treated|0|||
149154368|NCT01358864|538041904|FG004|Overall Study|Not treated|0|||
149154369|NCT01358864|538041905|FG005|Overall Study|Not treated|0|||
149154370|NCT01358864|538041906|FG006|Overall Study|Not treated|1|||
149154371|NCT01358864|538041907|FG007|Overall Study|Not treated|0|||
149154372|NCT04209855|538041908|FG000|Overall Study|Death|161|||
149154373|NCT04209855|538041909|FG001|Overall Study|Death|177|||
149154374|NCT04209855|538041908|FG000|Overall Study|PI Discretion|1|||
149154375|NCT04209855|538041909|FG001|Overall Study|PI Discretion|1|||
149154376|NCT04209855|538041908|FG000|Overall Study|Lost to Follow-up|5|||
149154377|NCT04209855|538041909|FG001|Overall Study|Lost to Follow-up|2|||
149154378|NCT04209855|538041908|FG000|Overall Study|Withdrew consent|10|||
149154379|NCT04209855|538041909|FG001|Overall Study|Withdrew consent|24|||
149154380|NCT04209855|538041908|FG000|Overall Study|Sponsor decision|44|||
149154381|NCT04209855|538041909|FG001|Overall Study|Sponsor decision|18|||
149154382|NCT04209855|538041908|FG000|Overall Study|Other than specified|6|||
149154383|NCT04209855|538041909|FG001|Overall Study|Other than specified|4|||
149154384|NCT01284114|538043513|FG000|Overall Study|viral infection|1|||
149154385|NCT01284114|538043513|FG000|Overall Study|From the results of ALLTITUDE study|1|||
149154386|NCT01284114|538043513|FG000|Overall Study|Symptomatic hypotension|1|||
149154387|NCT01284114|538043513|FG000|Overall Study|dizziness|1|||
149154388|NCT03409744|538043514|FG000|Overall Study|Death|2|||
149154389|NCT03409744|538043514|FG000|Overall Study|Physician Decision|5|||
149154390|NCT03409744|538043514|FG000|Overall Study|Pregnancy|1|||
149154391|NCT03409744|538043514|FG000|Overall Study|Lost to Follow-up|1|||
149154392|NCT03409744|538043514|FG000|Overall Study|Protocol Violation|1|||
149154393|NCT01745146|538043517|FG000|Overall Study|Withdrawal by Subject|1|||
149154394|NCT01745146|538043518|FG001|Overall Study|Withdrawal by Subject|3|||
149154395|NCT01745146|538043517|FG000|Overall Study|Lost to Follow-up|2|||
149154396|NCT01745146|538043518|FG001|Overall Study|Lost to Follow-up|0|||
149154397|NCT04161131|538043519|FG000|Overall Study|Ineligible|2|||
149154398|NCT04161131|538043519|FG000|Overall Study|Lost to Follow-up|4|||
149154399|NCT00699348|538043523|FG000|Overall Study|Death|6|||
149154400|NCT00699348|538043523|FG000|Overall Study|Adverse Event|15|||
149154401|NCT00699348|538043523|FG000|Overall Study|Withdrawal by Subject|11|||
149154402|NCT00699348|538043523|FG000|Overall Study|Protocol Violation|10|||
149154403|NCT00699348|538043523|FG000|Overall Study|Lack of Efficacy|8|||
149154404|NCT00699348|538043523|FG000|Overall Study|Failure to return|1|||
149154405|NCT00699348|538043523|FG000|Overall Study|Blood transfusion|24|||
149154406|NCT00699348|538043523|FG000|Overall Study|Renal transplantation|10|||
149154407|NCT00699348|538043523|FG000|Overall Study|Other|5|||
149154408|NCT03704194|538043529|FG000|Overall Study|Withdrawal by Subject|0|||
149154409|NCT03704194|538043530|FG001|Overall Study|Withdrawal by Subject|1|||
149154410|NCT01368835|538043535|FG000|Overall Study|Inclusion criteria/photography quality|22|||
149154411|NCT01368835|538043535|FG000|Overall Study|Lost to Follow-up|11|||
149154412|NCT01678144|538043536|FG000|Stage 1: MAR Classic|Adverse Event|1|||
149154413|NCT02754726|538043537|FG000|Overall Study|Progressive Disease by RECIST|13|||
149154414|NCT02754726|538043537|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
149154415|NCT02754726|538043537|FG000|Overall Study|Clinical Disease Progression|5|||
149154416|NCT02754726|538043537|FG000|Overall Study|Adverse Event|3|||
149154417|NCT02754726|538043537|FG000|Overall Study|Withdrawal by Subject|1|||
149154418|NCT02754726|538043537|FG000|Overall Study|Tolerability|1|||
149154419|NCT01885000|538043538|FG000|Overall Study|Adverse Event|1|||
149154420|NCT01885000|538043539|FG001|Overall Study|Adverse Event|0|||
149154421|NCT01885000|538043538|FG000|Overall Study|Withdrawal by Subject|1|||
149154422|NCT01885000|538043539|FG001|Overall Study|Withdrawal by Subject|1|||
149154423|NCT01885000|538043538|FG000|Overall Study|Protocol Violation|0|||
149154424|NCT01885000|538043539|FG001|Overall Study|Protocol Violation|1|||
149154425|NCT02792842|538043542|FG000|Overall Study|Adverse Event|4|||
149154426|NCT02792842|538043543|FG001|Overall Study|Adverse Event|2|||
149154427|NCT02792842|538043544|FG002|Overall Study|Adverse Event|3|||
149154428|NCT02792842|538043542|FG000|Overall Study|Withdrawal by Subject|0|||
149154429|NCT02792842|538043543|FG001|Overall Study|Withdrawal by Subject|1|||
149154430|NCT02792842|538043544|FG002|Overall Study|Withdrawal by Subject|2|||
149154431|NCT02792842|538043542|FG000|Overall Study|Lost to Follow-up|0|||
149154432|NCT02792842|538043543|FG001|Overall Study|Lost to Follow-up|0|||
149154433|NCT02792842|538043544|FG002|Overall Study|Lost to Follow-up|1|||
149154434|NCT02792842|538043542|FG000|Overall Study|Schedule delay|0|||
149154435|NCT02792842|538043543|FG001|Overall Study|Schedule delay|1|||
149154436|NCT02792842|538043544|FG002|Overall Study|Schedule delay|1|||
149154437|NCT03806127|538043545|FG000|Overall Study|Withdrawal by Subject|4|||
149154438|NCT03806127|538043546|FG001|Overall Study|Withdrawal by Subject|5|||
149154439|NCT03806127|538043545|FG000|Overall Study|Protocol Violation|3|||
149154440|NCT03806127|538043546|FG001|Overall Study|Protocol Violation|1|||
149154441|NCT03806127|538043545|FG000|Overall Study|Adverse Event|3|||
149154442|NCT03806127|538043546|FG001|Overall Study|Adverse Event|0|||
149154443|NCT03806127|538043545|FG000|Overall Study|Unable to Complete Procedures|0|||
149154444|NCT03806127|538043546|FG001|Overall Study|Unable to Complete Procedures|1|||
149154445|NCT03806127|538043545|FG000|Overall Study|Pregnancy|0|||
149154446|NCT03806127|538043546|FG001|Overall Study|Pregnancy|1|||
149154447|NCT03806127|538043545|FG000|Overall Study|Lost to Follow-up|5|||
149154448|NCT03806127|538043546|FG001|Overall Study|Lost to Follow-up|1|||
149154449|NCT03806127|538043545|FG000|Overall Study|Physician Decision|1|||
149154450|NCT03806127|538043546|FG001|Overall Study|Physician Decision|1|||
149154451|NCT03806127|538043545|FG000|Overall Study|Could Not Come Due to Covid|1|||
149154452|NCT03806127|538043546|FG001|Overall Study|Could Not Come Due to Covid|0|||
149154453|NCT03806127|538043545|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
149154454|NCT03806127|538043546|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
149154455|NCT03806127|538043545|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
149154456|NCT03806127|538043546|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
149154457|NCT03806127|538043545|FG000|Overall Study|Covid 19 Restrictions|2|||
149154458|NCT03806127|538043546|FG001|Overall Study|Covid 19 Restrictions|0|||
149154459|NCT03806127|538043545|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
149154460|NCT03806127|538043546|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
149154461|NCT03806127|538043545|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
149154462|NCT03806127|538043546|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
149154463|NCT03092726|538043551|FG000|Overall Study|Adverse Event|3|||
149154464|NCT03092726|538043552|FG001|Overall Study|Adverse Event|10|||
149154465|NCT03092726|538043551|FG000|Overall Study|Lack of Efficacy|0|||
149154466|NCT03092726|538043552|FG001|Overall Study|Lack of Efficacy|1|||
149154467|NCT03092726|538043551|FG000|Overall Study|Lost to Follow-up|1|||
149154468|NCT03092726|538043552|FG001|Overall Study|Lost to Follow-up|0|||
149154469|NCT03092726|538043551|FG000|Overall Study|Withdrawal by Subject|5|||
149154470|NCT03092726|538043552|FG001|Overall Study|Withdrawal by Subject|3|||
149154471|NCT00252057|538043553|FG000|Overall Study|Withdrawal by Subject|2|||
149154472|NCT00252057|538043554|FG001|Overall Study|Withdrawal by Subject|5|||
149154473|NCT00252057|538043553|FG000|Overall Study|Death|1|||
149154474|NCT00252057|538043554|FG001|Overall Study|Death|2|||
149154475|NCT00252057|538043553|FG000|Overall Study|Participant previously enrolled|0|||
149154476|NCT00252057|538043554|FG001|Overall Study|Participant previously enrolled|1|||
149154477|NCT01294800|538043556|FG000|Overall Study|Adverse Event|7|||
149154478|NCT01294800|538043557|FG001|Overall Study|Adverse Event|6|||
149154479|NCT01294800|538043558|FG002|Overall Study|Adverse Event|12|||
149154480|NCT01294800|538043559|FG003|Overall Study|Adverse Event|5|||
149154481|NCT01294800|538043556|FG000|Overall Study|Subject Withdrew Consent|2|||
149154482|NCT01294800|538043557|FG001|Overall Study|Subject Withdrew Consent|2|||
149154483|NCT01294800|538043558|FG002|Overall Study|Subject Withdrew Consent|2|||
149154484|NCT01294800|538043559|FG003|Overall Study|Subject Withdrew Consent|11|||
149154485|NCT01294800|538043556|FG000|Overall Study|Lost to Follow-up|0|||
149154486|NCT01294800|538043557|FG001|Overall Study|Lost to Follow-up|0|||
148919229|NCT01185301|537187852|FG000|Overall Study|Withdrawal by Subject|7|||
148919230|NCT01185301|537187853|FG001|Overall Study|Withdrawal by Subject|5|||
148919231|NCT01185301|537187854|FG002|Overall Study|Withdrawal by Subject|2|||
148919232|NCT01185301|537187855|FG003|Overall Study|Withdrawal by Subject|3|||
148919233|NCT01185301|537187852|FG000|Overall Study|Lost to Follow-up|2|||
148919234|NCT01185301|537187853|FG001|Overall Study|Lost to Follow-up|0|||
148919235|NCT01185301|537187854|FG002|Overall Study|Lost to Follow-up|0|||
148919236|NCT01185301|537187855|FG003|Overall Study|Lost to Follow-up|1|||
148919237|NCT01185301|537187852|FG000|Overall Study|Other Reason|3|||
148919238|NCT01185301|537187853|FG001|Overall Study|Other Reason|2|||
148919239|NCT01185301|537187854|FG002|Overall Study|Other Reason|2|||
148919240|NCT01185301|537187855|FG003|Overall Study|Other Reason|2|||
148919241|NCT02683746|537187856|FG000|Overall Study|Adverse Event|3|||
148919242|NCT02683746|537187857|FG001|Overall Study|Adverse Event|2|||
148919243|NCT02683746|537187856|FG000|Overall Study|Lost to Follow-up|5|||
148919244|NCT02683746|537187857|FG001|Overall Study|Lost to Follow-up|6|||
148919245|NCT02683746|537187856|FG000|Overall Study|Withdrawal by Subject|6|||
148919246|NCT02683746|537187857|FG001|Overall Study|Withdrawal by Subject|5|||
148919247|NCT02683746|537187856|FG000|Overall Study|Physician Decision|2|||
148919248|NCT02683746|537187857|FG001|Overall Study|Physician Decision|1|||
148919249|NCT03241368|537187868|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
148919250|NCT03241368|537187868|FG000|Overall Study|Lost to Follow-up|1|||
148919251|NCT03241368|537187868|FG000|Overall Study|Physician Decision|6|||
148919252|NCT03241368|537187868|FG000|Overall Study|Withdrawal by Subject|6|||
148919253|NCT03241368|537187868|FG000|Overall Study|Protocol Violation|1|||
148919254|NCT04740905|537187869|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
148919255|NCT04740905|537187870|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
148919256|NCT04740905|537187869|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
148919257|NCT04740905|537187870|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
148919258|NCT04740905|537187869|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
148919259|NCT04740905|537187870|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
148919260|NCT04740905|537187869|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
148919261|NCT04740905|537187870|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
148919262|NCT04740905|537187869|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
148919263|NCT04740905|537187870|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
148919264|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
148919265|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
148919266|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
148919267|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
148919268|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
148919269|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
148919270|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
148919271|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
148919272|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
148919273|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
148919274|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
148919275|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
148919276|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
148919277|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
148919278|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
148919279|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
148919280|NCT04740905|537187869|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
148919281|NCT04740905|537187870|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
148919282|NCT03051620|537187871|FG000|Overall Study|Lost to Follow-up|6|||
148919283|NCT03051620|537187871|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
148919284|NCT00065429|537187877|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
148919285|NCT00065429|537187878|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
148919286|NCT00065429|537187879|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
148919287|NCT00065429|537187880|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
148919288|NCT00065429|537187881|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
148919289|NCT00065429|537187882|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
148919290|NCT00065429|537187883|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
148919291|NCT00065429|537187877|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
148919292|NCT00065429|537187878|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
148919293|NCT00065429|537187879|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
148919294|NCT00065429|537187880|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
148919295|NCT00065429|537187881|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
148919296|NCT00065429|537187882|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
148919297|NCT00065429|537187883|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
148919298|NCT00065429|537187877|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
149012835|NCT01468922|537525817|FG004|Overall Study|Enrolled on new protocol|1|||
149154487|NCT01294800|538043558|FG002|Overall Study|Lost to Follow-up|1|||
149154488|NCT01294800|538043559|FG003|Overall Study|Lost to Follow-up|0|||
149154489|NCT01294800|538043556|FG000|Overall Study|Non-compliance With Protocol|0|||
149154490|NCT01294800|538043557|FG001|Overall Study|Non-compliance With Protocol|1|||
149154491|NCT01294800|538043558|FG002|Overall Study|Non-compliance With Protocol|1|||
149154492|NCT01294800|538043559|FG003|Overall Study|Non-compliance With Protocol|0|||
149154493|NCT01294800|538043556|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
149154494|NCT01294800|538043557|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
149154495|NCT01294800|538043558|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
149154496|NCT01294800|538043559|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
149154497|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
149154498|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
149154499|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
149154500|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
149154501|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
149154502|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
149154503|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
149154504|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
149154505|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
149154506|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
149154507|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
149154508|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
149154509|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
149154510|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
149154511|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
149154512|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
149154513|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
149154514|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
149154515|NCT04418765|538043561|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
149154516|NCT04418765|538043562|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
149154517|NCT04418765|538043563|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
149154518|NCT04418765|538043561|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
149154519|NCT04418765|538043562|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
149154520|NCT04418765|538043563|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
149154521|NCT04418765|538043561|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
149154522|NCT04418765|538043562|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
149154523|NCT04418765|538043563|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
149154524|NCT04418765|538043561|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
149154525|NCT04418765|538043562|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
149154526|NCT04418765|538043563|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
149154527|NCT04418765|538043561|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
149154528|NCT04418765|538043562|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
149154529|NCT04418765|538043563|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
149154530|NCT04418765|538043561|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
149154531|NCT04418765|538043562|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
149154532|NCT04418765|538043563|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
149154533|NCT04418765|538043561|FG000|Extension Period (48 Weeks)|Other than specified|0|||
149154534|NCT04418765|538043562|FG001|Extension Period (48 Weeks)|Other than specified|5|||
149154535|NCT04418765|538043563|FG002|Extension Period (48 Weeks)|Other than specified|2|||
149154536|NCT02217566|538043568|FG000|Overall Study|Lost to Follow-up|2|||
149154537|NCT02217566|538043568|FG000|Overall Study|Death|3|||
149154538|NCT02217566|538043568|FG000|Overall Study|Early study termination|6|||
149154539|NCT02296242|538043569|FG000|Overall Study|Death|1|||
149154540|NCT02296242|538043570|FG001|Overall Study|Death|1|||
148919299|NCT00065429|537187878|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
148919300|NCT00065429|537187879|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
149154541|NCT02296242|538043571|FG002|Overall Study|Death|1|||
149154542|NCT02296242|538043572|FG003|Overall Study|Death|1|||
149154543|NCT02296242|538043573|FG004|Overall Study|Death|1|||
149154544|NCT02296242|538043569|FG000|Overall Study|Withdrawal by Subject|0|||
149154545|NCT02296242|538043570|FG001|Overall Study|Withdrawal by Subject|0|||
149154546|NCT02296242|538043571|FG002|Overall Study|Withdrawal by Subject|1|||
149154547|NCT02296242|538043572|FG003|Overall Study|Withdrawal by Subject|1|||
149154548|NCT02296242|538043573|FG004|Overall Study|Withdrawal by Subject|3|||
149154549|NCT02296242|538043569|FG000|Overall Study|Disease Progression|1|||
149154550|NCT02296242|538043570|FG001|Overall Study|Disease Progression|3|||
149154551|NCT02296242|538043571|FG002|Overall Study|Disease Progression|2|||
149154552|NCT02296242|538043572|FG003|Overall Study|Disease Progression|8|||
149154553|NCT02296242|538043573|FG004|Overall Study|Disease Progression|11|||
149154554|NCT02296242|538043569|FG000|Overall Study|Unacceptable Toxicity|0|||
149154555|NCT02296242|538043570|FG001|Overall Study|Unacceptable Toxicity|0|||
149154556|NCT02296242|538043571|FG002|Overall Study|Unacceptable Toxicity|0|||
149154557|NCT02296242|538043572|FG003|Overall Study|Unacceptable Toxicity|0|||
149154558|NCT02296242|538043573|FG004|Overall Study|Unacceptable Toxicity|1|||
149154559|NCT02296242|538043569|FG000|Overall Study|Patient Condition Changed|0|||
149154560|NCT02296242|538043570|FG001|Overall Study|Patient Condition Changed|0|||
149154561|NCT02296242|538043571|FG002|Overall Study|Patient Condition Changed|2|||
149154562|NCT02296242|538043572|FG003|Overall Study|Patient Condition Changed|0|||
149154563|NCT02296242|538043573|FG004|Overall Study|Patient Condition Changed|1|||
149154564|NCT02296242|538043569|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
149154565|NCT02296242|538043570|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
149154566|NCT02296242|538043571|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
149154567|NCT02296242|538043572|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
149154568|NCT02296242|538043573|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
149154569|NCT02296242|538043569|FG000|Overall Study|Lost to Follow-up|1|||
149154570|NCT02296242|538043570|FG001|Overall Study|Lost to Follow-up|0|||
149154571|NCT02296242|538043571|FG002|Overall Study|Lost to Follow-up|0|||
149154572|NCT02296242|538043572|FG003|Overall Study|Lost to Follow-up|0|||
149154573|NCT02296242|538043573|FG004|Overall Study|Lost to Follow-up|0|||
149154574|NCT02296242|538043569|FG000|Overall Study|Need for Hydroxyurea|2|||
149154575|NCT02296242|538043570|FG001|Overall Study|Need for Hydroxyurea|0|||
149154576|NCT02296242|538043571|FG002|Overall Study|Need for Hydroxyurea|0|||
149154577|NCT02296242|538043572|FG003|Overall Study|Need for Hydroxyurea|0|||
149154578|NCT02296242|538043573|FG004|Overall Study|Need for Hydroxyurea|0|||
149154579|NCT02296242|538043569|FG000|Overall Study|Screened for Other Protocol|0|||
149154580|NCT02296242|538043570|FG001|Overall Study|Screened for Other Protocol|1|||
149154581|NCT02296242|538043571|FG002|Overall Study|Screened for Other Protocol|0|||
149154582|NCT02296242|538043572|FG003|Overall Study|Screened for Other Protocol|0|||
149154583|NCT02296242|538043573|FG004|Overall Study|Screened for Other Protocol|0|||
149154584|NCT02296242|538043569|FG000|Overall Study|Physician Decision|0|||
149154585|NCT02296242|538043570|FG001|Overall Study|Physician Decision|1|||
149154586|NCT02296242|538043571|FG002|Overall Study|Physician Decision|0|||
149154587|NCT02296242|538043572|FG003|Overall Study|Physician Decision|1|||
149154588|NCT02296242|538043573|FG004|Overall Study|Physician Decision|0|||
149154589|NCT02296242|538043569|FG000|Overall Study|Alternative Treatment|0|||
149154590|NCT02296242|538043570|FG001|Overall Study|Alternative Treatment|0|||
149154591|NCT02296242|538043571|FG002|Overall Study|Alternative Treatment|0|||
149154592|NCT02296242|538043572|FG003|Overall Study|Alternative Treatment|1|||
149154593|NCT02296242|538043573|FG004|Overall Study|Alternative Treatment|0|||
149154594|NCT02296242|538043569|FG000|Overall Study|Adverse Event|0|||
149154595|NCT02296242|538043570|FG001|Overall Study|Adverse Event|0|||
149154596|NCT02296242|538043571|FG002|Overall Study|Adverse Event|0|||
149154597|NCT02296242|538043572|FG003|Overall Study|Adverse Event|1|||
149154598|NCT02296242|538043573|FG004|Overall Study|Adverse Event|0|||
149154599|NCT02296242|538043569|FG000|Overall Study|Lack of Efficacy|0|||
149154600|NCT02296242|538043570|FG001|Overall Study|Lack of Efficacy|0|||
149154601|NCT02296242|538043571|FG002|Overall Study|Lack of Efficacy|0|||
149154602|NCT02296242|538043572|FG003|Overall Study|Lack of Efficacy|0|||
149154603|NCT02296242|538043573|FG004|Overall Study|Lack of Efficacy|3|||
149154604|NCT02436876|538043577|FG000|Overall Study|Lost to Follow-up|0|||
149154605|NCT02436876|538043578|FG001|Overall Study|Lost to Follow-up|1|||
149154606|NCT02436876|538043579|FG002|Overall Study|Lost to Follow-up|1|||
149154607|NCT02436876|538043580|FG003|Overall Study|Lost to Follow-up|1|||
149154608|NCT02436876|538043577|FG000|Overall Study|Withdrawal by Subject|1|||
149154609|NCT02436876|538043578|FG001|Overall Study|Withdrawal by Subject|0|||
149154610|NCT02436876|538043579|FG002|Overall Study|Withdrawal by Subject|0|||
149154611|NCT02436876|538043580|FG003|Overall Study|Withdrawal by Subject|1|||
149154612|NCT02436876|538043577|FG000|Overall Study|Physician Decision|0|||
148672750|NCT00877799|536272468|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
148672751|NCT00877799|536272469|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
148672752|NCT00877799|536272470|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
148672753|NCT00877799|536272471|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
148672754|NCT00877799|536272467|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
148672755|NCT00877799|536272468|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
148672756|NCT00877799|536272469|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
148672757|NCT00877799|536272470|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
148672758|NCT00877799|536272471|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
148672759|NCT00877799|536272467|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
148672760|NCT00877799|536272468|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
148672761|NCT00877799|536272469|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
148805909|NCT05911841|536768046|FG002|Induction Period|Withdrawal by Subject|4|||
148805910|NCT05911841|536768047|FG003|Induction Period|Withdrawal by Subject|6|||
148919301|NCT00065429|537187880|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
148919302|NCT00065429|537187881|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
148919303|NCT00065429|537187882|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
148919304|NCT00065429|537187883|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
148919305|NCT00065429|537187877|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
148919306|NCT00065429|537187878|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
148919307|NCT00065429|537187879|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
148919308|NCT00065429|537187880|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
148919309|NCT00065429|537187881|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
148919310|NCT00065429|537187882|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
148919311|NCT00065429|537187883|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
148919312|NCT00065429|537187877|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
148919313|NCT00065429|537187878|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
148919314|NCT00065429|537187879|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
148919315|NCT00065429|537187880|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
148919316|NCT00065429|537187881|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
148919317|NCT00065429|537187882|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
148919318|NCT00065429|537187883|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
148919319|NCT00065429|537187877|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
148919320|NCT00065429|537187878|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
148919321|NCT00065429|537187879|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
148919322|NCT00065429|537187880|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
148919323|NCT00065429|537187881|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
148919324|NCT00065429|537187882|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
148919325|NCT00065429|537187883|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
148919326|NCT00065429|537187877|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
148919327|NCT00065429|537187878|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
148919328|NCT00065429|537187879|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
148919329|NCT00065429|537187880|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
148919330|NCT00065429|537187881|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
148919331|NCT00065429|537187882|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
148919332|NCT00065429|537187883|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
148919333|NCT00548184|537187887|FG000|Overall Study|Adverse Event|3|||
148919334|NCT00548184|537187887|FG000|Overall Study|took other drug|1|||
148919335|NCT00548184|537187887|FG000|Overall Study|Found Her2 negative|1|||
148919336|NCT00636363|537187888|FG000|Overall Study|Conjunctivitis|0|||
148919337|NCT00636363|537187889|FG001|Overall Study|Conjunctivitis|0|||
148919338|NCT00636363|537187890|FG002|Overall Study|Conjunctivitis|1|||
148919339|NCT00636363|537187888|FG000|Overall Study|Adverse Event|0|||
148919340|NCT00636363|537187889|FG001|Overall Study|Adverse Event|0|||
148919341|NCT00636363|537187890|FG002|Overall Study|Adverse Event|1|||
148919342|NCT00636363|537187888|FG000|Overall Study|Positive slit lamp finding|0|||
148919343|NCT00636363|537187889|FG001|Overall Study|Positive slit lamp finding|2|||
148919344|NCT00636363|537187890|FG002|Overall Study|Positive slit lamp finding|1|||
148919345|NCT00636363|537187888|FG000|Overall Study|Study related symptoms/complaints|8|||
148919346|NCT00636363|537187889|FG001|Overall Study|Study related symptoms/complaints|7|||
148919347|NCT00636363|537187890|FG002|Overall Study|Study related symptoms/complaints|4|||
148919348|NCT00636363|537187888|FG000|Overall Study|Met ineligibility criteria|0|||
148919349|NCT00636363|537187889|FG001|Overall Study|Met ineligibility criteria|0|||
148919350|NCT00636363|537187890|FG002|Overall Study|Met ineligibility criteria|3|||
148919351|NCT00636363|537187888|FG000|Overall Study|Missed > 1 visit|0|||
149154613|NCT02436876|538043578|FG001|Overall Study|Physician Decision|2|||
148919352|NCT00636363|537187889|FG001|Overall Study|Missed > 1 visit|1|||
148919353|NCT00636363|537187890|FG002|Overall Study|Missed > 1 visit|3|||
148919354|NCT00636363|537187888|FG000|Overall Study|Lack of motivation|1|||
148919355|NCT00636363|537187889|FG001|Overall Study|Lack of motivation|0|||
148919356|NCT00636363|537187890|FG002|Overall Study|Lack of motivation|1|||
148919357|NCT00636363|537187888|FG000|Overall Study|Protocol Violation|0|||
149154614|NCT02436876|538043579|FG002|Overall Study|Physician Decision|1|||
149154615|NCT02436876|538043580|FG003|Overall Study|Physician Decision|0|||
149154616|NCT02436876|538043577|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
149154617|NCT02436876|538043578|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
149154618|NCT02436876|538043579|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
149154619|NCT02436876|538043580|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
149154620|NCT00999908|538043583|FG000|Treatment Period 1|Subject withdrew consent|2|||
149154621|NCT00999908|538043584|FG001|Treatment Period 1|Subject withdrew consent|0|||
149154622|NCT00999908|538043585|FG002|Treatment Period 1|Subject withdrew consent|0|||
149154623|NCT00999908|538043583|FG000|Treatment Period 2|Protocol Violation|1|||
149154624|NCT00999908|538043584|FG001|Treatment Period 2|Protocol Violation|0|||
149154625|NCT00999908|538043585|FG002|Treatment Period 2|Protocol Violation|0|||
149154626|NCT01692301|538043588|FG000|Overall Study|Adverse Event|15|||
149154627|NCT01692301|538043589|FG001|Overall Study|Adverse Event|12|||
149154628|NCT01692301|538043588|FG000|Overall Study|Death|1|||
149154629|NCT01692301|538043589|FG001|Overall Study|Death|2|||
149154630|NCT01692301|538043588|FG000|Overall Study|Lack of Efficacy|0|||
149154631|NCT01692301|538043589|FG001|Overall Study|Lack of Efficacy|5|||
149154632|NCT01692301|538043588|FG000|Overall Study|Non-compliance with study treatment|1|||
149154633|NCT01692301|538043589|FG001|Overall Study|Non-compliance with study treatment|2|||
149154634|NCT01692301|538043588|FG000|Overall Study|Protocol deviation|9|||
149154635|NCT01692301|538043589|FG001|Overall Study|Protocol deviation|2|||
149154636|NCT01692301|538043588|FG000|Overall Study|Patient/guardian decision|16|||
149154637|NCT01692301|538043589|FG001|Overall Study|Patient/guardian decision|15|||
149154638|NCT01692301|538043588|FG000|Overall Study|Technical problems|0|||
149154639|NCT01692301|538043589|FG001|Overall Study|Technical problems|1|||
149154640|NCT01692301|538043588|FG000|Overall Study|Physician Decision|2|||
149154641|NCT01692301|538043589|FG001|Overall Study|Physician Decision|2|||
149154642|NCT01692301|538043588|FG000|Overall Study|Lost to Follow-up|1|||
149154643|NCT01692301|538043589|FG001|Overall Study|Lost to Follow-up|1|||
149154644|NCT01290692|538043590|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
149154645|NCT01568593|538043591|FG000|Overall Study|Lack of Efficacy|4|||
149154646|NCT01568593|538043592|FG001|Overall Study|Lack of Efficacy|1|||
149154647|NCT01568593|538043591|FG000|Overall Study|Adverse Event|3|||
149154648|NCT01568593|538043592|FG001|Overall Study|Adverse Event|2|||
149154649|NCT02780648|538043594|FG000|Overall Study|Disease Progression|1|||
149154650|NCT02780648|538043595|FG001|Overall Study|Disease Progression|0|||
149154651|NCT00293579|538043602|FG000|Overall Study|Withdrawal by Subject|1|||
149154652|NCT04472429|538043603|FG000|Randomized Period|Ongoing|90|||
149154653|NCT04472429|538043604|FG001|Randomized Period|Ongoing|40|||
149154654|NCT04472429|538043605|FG002|Randomized Period|Ongoing|0|||
149154655|NCT04472429|538043603|FG000|Randomized Period|Death|52|||
149154656|NCT04472429|538043604|FG001|Randomized Period|Death|37|||
149154657|NCT04472429|538043605|FG002|Randomized Period|Death|0|||
149154658|NCT04472429|538043603|FG000|Randomized Period|Lost to Follow-up|4|||
149154659|NCT04472429|538043604|FG001|Randomized Period|Lost to Follow-up|0|||
149154660|NCT04472429|538043605|FG002|Randomized Period|Lost to Follow-up|0|||
149154661|NCT04472429|538043603|FG000|Randomized Period|Physician Decision|1|||
149154662|NCT04472429|538043604|FG001|Randomized Period|Physician Decision|2|||
149154663|NCT04472429|538043605|FG002|Randomized Period|Physician Decision|0|||
149154664|NCT04472429|538043603|FG000|Randomized Period|Withdrawal by Subject|6|||
149154665|NCT04472429|538043604|FG001|Randomized Period|Withdrawal by Subject|5|||
149154666|NCT04472429|538043605|FG002|Randomized Period|Withdrawal by Subject|0|||
149154667|NCT04472429|538043603|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
149154668|NCT04472429|538043604|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
149154669|NCT04472429|538043605|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
149154670|NCT04472429|538043603|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
149154671|NCT04472429|538043604|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
149154672|NCT04472429|538043605|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
149154673|NCT04472429|538043603|FG000|Open-label Monotherapy Period|Ongoing|0|||
149154674|NCT04472429|538043604|FG001|Open-label Monotherapy Period|Ongoing|0|||
149154675|NCT04472429|538043605|FG002|Open-label Monotherapy Period|Ongoing|32|||
149154676|NCT04472429|538043603|FG000|Open-label Monotherapy Period|Death|0|||
149154677|NCT04472429|538043604|FG001|Open-label Monotherapy Period|Death|0|||
149154678|NCT04472429|538043605|FG002|Open-label Monotherapy Period|Death|35|||
149154679|NCT04472429|538043603|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
149154680|NCT04472429|538043604|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
149154681|NCT04472429|538043605|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
149154682|NCT01180660|538043606|FG000|Overall Study|Changed to open surgery|1|||
149154683|NCT01180660|538043607|FG001|Overall Study|Changed to open surgery|0|||
149154684|NCT00844753|538043608|FG000|Overall Study|Lack of Efficacy|1|||
149154685|NCT00844753|538043609|FG001|Overall Study|Lack of Efficacy|0|||
149154686|NCT00844753|538043610|FG002|Overall Study|Lack of Efficacy|2|||
149154687|NCT00844753|538043611|FG003|Overall Study|Lack of Efficacy|2|||
149154688|NCT00844753|538043608|FG000|Overall Study|Adverse Event|3|||
149154689|NCT00844753|538043609|FG001|Overall Study|Adverse Event|2|||
149154690|NCT00844753|538043610|FG002|Overall Study|Adverse Event|5|||
149154691|NCT00844753|538043611|FG003|Overall Study|Adverse Event|5|||
149154692|NCT00844753|538043608|FG000|Overall Study|Lost to Follow-up|1|||
149154693|NCT00844753|538043609|FG001|Overall Study|Lost to Follow-up|1|||
149154694|NCT00844753|538043610|FG002|Overall Study|Lost to Follow-up|0|||
149154695|NCT00844753|538043611|FG003|Overall Study|Lost to Follow-up|1|||
149154696|NCT00844753|538043608|FG000|Overall Study|could not swallow medication|2|||
149154697|NCT00844753|538043609|FG001|Overall Study|could not swallow medication|0|||
149154698|NCT00844753|538043610|FG002|Overall Study|could not swallow medication|0|||
149154699|NCT00844753|538043611|FG003|Overall Study|could not swallow medication|0|||
149154700|NCT00844753|538043608|FG000|Overall Study|Withdrawal by Subject|1|||
149154701|NCT00844753|538043609|FG001|Overall Study|Withdrawal by Subject|0|||
149154702|NCT00844753|538043610|FG002|Overall Study|Withdrawal by Subject|0|||
149154703|NCT00844753|538043611|FG003|Overall Study|Withdrawal by Subject|3|||
149154704|NCT00088374|538043614|FG000|Overall Study|patient did not receive any 17AAG|1|||
149154705|NCT00088374|538043614|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
149154706|NCT00371865|538043617|FG000|Overall Study|Lack of Efficacy|0|||
149154707|NCT00371865|538043618|FG001|Overall Study|Lack of Efficacy|2|||
149154708|NCT00371865|538043617|FG000|Overall Study|Protocol Violation|3|||
149154709|NCT00371865|538043618|FG001|Overall Study|Protocol Violation|2|||
149154710|NCT00371865|538043617|FG000|Overall Study|Withdrawal by Subject|12|||
149154711|NCT00371865|538043618|FG001|Overall Study|Withdrawal by Subject|10|||
149154712|NCT01632566|538043622|FG000|Overall Study|Withdrawal by Subject|0|||
149154713|NCT01632566|538043623|FG001|Overall Study|Withdrawal by Subject|1|||
149154714|NCT01632566|538043624|FG002|Overall Study|Withdrawal by Subject|0|||
149154715|NCT01632566|538043625|FG003|Overall Study|Withdrawal by Subject|0|||
149154716|NCT01632566|538043626|FG004|Overall Study|Withdrawal by Subject|0|||
149154717|NCT01632566|538043622|FG000|Overall Study|Sponsor Decision|0|||
149154718|NCT01632566|538043623|FG001|Overall Study|Sponsor Decision|2|||
149154719|NCT01632566|538043624|FG002|Overall Study|Sponsor Decision|9|||
149154720|NCT01632566|538043625|FG003|Overall Study|Sponsor Decision|2|||
149154721|NCT01632566|538043626|FG004|Overall Study|Sponsor Decision|2|||
149154722|NCT05073458|538043627|FG000|24-week Double-blind Period|Adverse Event|1|||
148672762|NCT00877799|536272470|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
148672763|NCT00877799|536272471|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
148672764|NCT04054011|536272472|FG000|Overall Study|COVID|3|||
148672765|NCT00592007|536272473|FG000|Overall Study|Withdrawal by Subject|1|||
148805911|NCT05911841|536768048|FG004|Induction Period|Withdrawal by Subject|0|||
148805912|NCT05911841|536768049|FG005|Induction Period|Withdrawal by Subject|0|||
148805913|NCT05911841|536768050|FG006|Induction Period|Withdrawal by Subject|0|||
148805914|NCT05911841|536768051|FG007|Induction Period|Withdrawal by Subject|0|||
148805915|NCT05911841|536768052|FG008|Induction Period|Withdrawal by Subject|0|||
148805916|NCT05911841|536768053|FG009|Induction Period|Withdrawal by Subject|0|||
149154723|NCT05073458|538043628|FG001|24-week Double-blind Period|Adverse Event|0|||
149154724|NCT05073458|538043627|FG000|24-week Double-blind Period|Physician Decision|1|||
149154725|NCT05073458|538043628|FG001|24-week Double-blind Period|Physician Decision|0|||
149154726|NCT05073458|538043627|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
148805917|NCT05911841|536768044|FG000|Induction Period|Lack of Efficacy|3|||
148805918|NCT05911841|536768045|FG001|Induction Period|Lack of Efficacy|0|||
148805919|NCT05911841|536768046|FG002|Induction Period|Lack of Efficacy|3|||
149154727|NCT05073458|538043628|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
149154728|NCT05073458|538043627|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
149154729|NCT05073458|538043628|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
149154730|NCT05073458|538043627|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
149154731|NCT05073458|538043628|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
149154732|NCT05073458|538043627|FG000|24-week Open-label Period|Adverse Event|1|||
149154733|NCT05073458|538043628|FG001|24-week Open-label Period|Adverse Event|2|||
149154734|NCT01328951|538043636|FG000|Overall Study|Disease Progression|17|||
149154735|NCT01328951|538043637|FG001|Overall Study|Disease Progression|14|||
149154736|NCT01328951|538043636|FG000|Overall Study|Adverse Event|2|||
149154737|NCT01328951|538043637|FG001|Overall Study|Adverse Event|0|||
149154738|NCT01328951|538043636|FG000|Overall Study|Death|243|||
149154739|NCT01328951|538043637|FG001|Overall Study|Death|258|||
149154740|NCT01328951|538043636|FG000|Overall Study|Lost to Follow-up|6|||
149154741|NCT01328951|538043637|FG001|Overall Study|Lost to Follow-up|7|||
149154742|NCT01328951|538043636|FG000|Overall Study|Withdrawal by Subject|6|||
149154743|NCT01328951|538043637|FG001|Overall Study|Withdrawal by Subject|6|||
149154744|NCT01328951|538043636|FG000|Overall Study|Study Closed by the Sponsor|36|||
149154745|NCT01328951|538043637|FG001|Overall Study|Study Closed by the Sponsor|31|||
149154746|NCT01328951|538043636|FG000|Overall Study|Other|11|||
149154747|NCT01328951|538043637|FG001|Overall Study|Other|6|||
149154748|NCT01627899|538043642|FG000|Overall Study|Study terminated early by sponsor.|5|||
149154749|NCT05103332|538043643|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154750|NCT05103332|538043644|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
149154751|NCT05103332|538043645|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
149154752|NCT05103332|538043646|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154753|NCT05103332|538043647|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154754|NCT05103332|538043648|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
149154755|NCT05103332|538043649|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154756|NCT05103332|538043650|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154757|NCT05103332|538043651|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154758|NCT05103332|538043652|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154759|NCT05103332|538043653|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154760|NCT05103332|538043654|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154761|NCT05103332|538043655|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154762|NCT05103332|538043656|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154763|NCT05103332|538043657|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154764|NCT05103332|538043658|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
148919358|NCT00636363|537187889|FG001|Overall Study|Protocol Violation|3|||
148919359|NCT00636363|537187890|FG002|Overall Study|Protocol Violation|0|||
148919360|NCT00636363|537187888|FG000|Overall Study|Lost to Follow-up|3|||
148919361|NCT00636363|537187889|FG001|Overall Study|Lost to Follow-up|4|||
148919362|NCT00636363|537187890|FG002|Overall Study|Lost to Follow-up|2|||
148919363|NCT00636363|537187888|FG000|Overall Study|Withdrawal by Subject|1|||
148919364|NCT00636363|537187889|FG001|Overall Study|Withdrawal by Subject|3|||
148919365|NCT00636363|537187890|FG002|Overall Study|Withdrawal by Subject|2|||
148919366|NCT00280748|537187894|FG000|Overall Study|Decline in performance|3|||
148919367|NCT00280748|537187894|FG000|Overall Study|Extra-cranial disease progression|1|||
148919368|NCT02034409|537187898|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
149154765|NCT05103332|538043659|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154766|NCT05103332|538043660|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154767|NCT05103332|538043643|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154768|NCT05103332|538043644|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
149154769|NCT05103332|538043645|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154770|NCT05103332|538043646|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
149154771|NCT05103332|538043647|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154772|NCT05103332|538043648|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154773|NCT05103332|538043649|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154774|NCT05103332|538043650|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154775|NCT05103332|538043651|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154776|NCT05103332|538043652|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154777|NCT05103332|538043653|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154778|NCT05103332|538043654|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154779|NCT05103332|538043655|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154780|NCT05103332|538043656|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154781|NCT05103332|538043657|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154782|NCT05103332|538043658|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154783|NCT05103332|538043659|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
149012836|NCT01468922|537525818|FG005|Overall Study|Enrolled on new protocol|0|||
149154784|NCT05103332|538043660|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
149154785|NCT05103332|538043643|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
149154786|NCT05103332|538043644|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
149154787|NCT05103332|538043645|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
149154788|NCT05103332|538043646|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
149154789|NCT05103332|538043647|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
149154790|NCT05103332|538043648|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
149154791|NCT05103332|538043649|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154792|NCT05103332|538043650|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154793|NCT05103332|538043651|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154794|NCT05103332|538043652|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154795|NCT05103332|538043653|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154796|NCT05103332|538043654|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154797|NCT05103332|538043655|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154798|NCT05103332|538043656|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154799|NCT05103332|538043657|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154800|NCT05103332|538043658|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154801|NCT05103332|538043659|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154802|NCT05103332|538043660|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154803|NCT05103332|538043643|FG000|DB Period (6 Months=168 Days)|Other|0|||
149154804|NCT05103332|538043644|FG001|DB Period (6 Months=168 Days)|Other|0|||
149154805|NCT05103332|538043645|FG002|DB Period (6 Months=168 Days)|Other|0|||
149154806|NCT05103332|538043646|FG003|DB Period (6 Months=168 Days)|Other|1|||
149154807|NCT05103332|538043647|FG004|DB Period (6 Months=168 Days)|Other|0|||
149154808|NCT05103332|538043648|FG005|DB Period (6 Months=168 Days)|Other|0|||
149154809|NCT05103332|538043649|FG006|DB Period (6 Months=168 Days)|Other|0|||
149154810|NCT05103332|538043650|FG007|DB Period (6 Months=168 Days)|Other|0|||
149154811|NCT05103332|538043651|FG008|DB Period (6 Months=168 Days)|Other|0|||
149154812|NCT05103332|538043652|FG009|DB Period (6 Months=168 Days)|Other|0|||
149154813|NCT05103332|538043653|FG010|DB Period (6 Months=168 Days)|Other|0|||
149154814|NCT05103332|538043654|FG011|DB Period (6 Months=168 Days)|Other|0|||
149154815|NCT05103332|538043655|FG012|DB Period (6 Months=168 Days)|Other|0|||
149154816|NCT05103332|538043656|FG013|DB Period (6 Months=168 Days)|Other|0|||
149154817|NCT05103332|538043657|FG014|DB Period (6 Months=168 Days)|Other|0|||
149154818|NCT05103332|538043658|FG015|DB Period (6 Months=168 Days)|Other|0|||
149154819|NCT05103332|538043659|FG016|DB Period (6 Months=168 Days)|Other|0|||
149154820|NCT05103332|538043660|FG017|DB Period (6 Months=168 Days)|Other|0|||
149154821|NCT05103332|538043643|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154822|NCT05103332|538043644|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154823|NCT05103332|538043645|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154824|NCT05103332|538043646|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154825|NCT05103332|538043647|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154826|NCT05103332|538043648|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154827|NCT05103332|538043649|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154828|NCT05103332|538043650|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154829|NCT05103332|538043651|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154830|NCT05103332|538043652|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154831|NCT05103332|538043653|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
149154832|NCT05103332|538043654|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154833|NCT05103332|538043655|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154834|NCT05103332|538043656|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154835|NCT05103332|538043657|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154836|NCT05103332|538043658|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154837|NCT05103332|538043659|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154838|NCT05103332|538043660|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
149154839|NCT05103332|538043643|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154840|NCT05103332|538043644|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154841|NCT05103332|538043645|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154842|NCT05103332|538043646|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154843|NCT05103332|538043647|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154844|NCT05103332|538043648|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154845|NCT05103332|538043649|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154846|NCT05103332|538043650|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154847|NCT05103332|538043651|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
149154848|NCT05103332|538043652|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154849|NCT05103332|538043653|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154850|NCT05103332|538043654|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154851|NCT05103332|538043655|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154852|NCT05103332|538043656|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154853|NCT05103332|538043657|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154854|NCT05103332|538043658|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154855|NCT05103332|538043659|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154856|NCT05103332|538043660|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
149154857|NCT05103332|538043643|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154858|NCT05103332|538043644|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154859|NCT05103332|538043645|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154860|NCT05103332|538043646|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154861|NCT05103332|538043647|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154862|NCT05103332|538043648|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154863|NCT05103332|538043649|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154864|NCT05103332|538043650|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154865|NCT05103332|538043651|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154866|NCT05103332|538043652|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154867|NCT05103332|538043653|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154868|NCT05103332|538043654|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
149154869|NCT05103332|538043655|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154870|NCT05103332|538043656|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154871|NCT05103332|538043657|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154872|NCT05103332|538043658|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154873|NCT05103332|538043659|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154874|NCT05103332|538043660|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
149154875|NCT05103332|538043643|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154876|NCT05103332|538043644|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154877|NCT05103332|538043645|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154878|NCT05103332|538043646|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154879|NCT05103332|538043647|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154880|NCT05103332|538043648|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154881|NCT05103332|538043649|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
149154882|NCT05103332|538043650|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
148919369|NCT02034409|537187899|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
148919370|NCT02034409|537187898|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
148919371|NCT02034409|537187899|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
148919372|NCT02034409|537187898|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
148919373|NCT02034409|537187899|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
148919374|NCT02034409|537187898|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
148919375|NCT02034409|537187899|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
148919376|NCT02034409|537187898|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
148919377|NCT02034409|537187899|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
148919378|NCT02034409|537187898|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
148805920|NCT05911841|536768047|FG003|Induction Period|Lack of Efficacy|3|||
148805921|NCT05911841|536768048|FG004|Induction Period|Lack of Efficacy|0|||
148805922|NCT05911841|536768049|FG005|Induction Period|Lack of Efficacy|0|||
148805923|NCT05911841|536768050|FG006|Induction Period|Lack of Efficacy|0|||
148805924|NCT05911841|536768051|FG007|Induction Period|Lack of Efficacy|0|||
148919379|NCT02034409|537187899|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
149154883|NCT05103332|538043651|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154884|NCT05103332|538043652|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
149154885|NCT05103332|538043653|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
149154886|NCT05103332|538043654|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
148919380|NCT00934843|537187900|FG000|Overall Study|Protocol Violation|0|||
148919381|NCT00934843|537187901|FG001|Overall Study|Protocol Violation|1|||
148919382|NCT01144299|537187902|FG000|Overall Study|Lost to Follow-up|1|||
148919383|NCT01144299|537187903|FG001|Overall Study|Lost to Follow-up|0|||
148919384|NCT01144299|537187902|FG000|Overall Study|Withdrawal by Subject|1|||
148919385|NCT01144299|537187903|FG001|Overall Study|Withdrawal by Subject|0|||
148919386|NCT02342418|537187906|FG000|Overall Study|Adverse Event|0|||
148919387|NCT02342418|537187907|FG001|Overall Study|Adverse Event|1|||
148919388|NCT04255394|537187908|FG000|Overall Study|Death|35|||
148919389|NCT04255394|537187909|FG001|Overall Study|Death|25|||
148919390|NCT04255394|537187908|FG000|Overall Study|Device removed|2|||
148919391|NCT04255394|537187909|FG001|Overall Study|Device removed|10|||
148919392|NCT04255394|537187908|FG000|Overall Study|Withdrawal by Subject|9|||
148919393|NCT04255394|537187909|FG001|Overall Study|Withdrawal by Subject|8|||
148919394|NCT04255394|537187908|FG000|Overall Study|Screen Failure/Not treated|12|||
149154887|NCT05103332|538043655|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154888|NCT05103332|538043656|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154889|NCT05103332|538043657|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154890|NCT05103332|538043658|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154891|NCT05103332|538043659|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
149154892|NCT05103332|538043660|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
148919395|NCT04255394|537187909|FG001|Overall Study|Screen Failure/Not treated|8|||
148919396|NCT04255394|537187908|FG000|Overall Study|Lost to Follow-up|123|||
148919397|NCT04255394|537187909|FG001|Overall Study|Lost to Follow-up|265|||
148919398|NCT04255394|537187908|FG000|Overall Study|Adverse Event|1|||
148919399|NCT04255394|537187909|FG001|Overall Study|Adverse Event|3|||
148919400|NCT03612856|537187917|FG000|Pre-dose Period|Physician Decision|0|||
148919401|NCT03612856|537187918|FG001|Pre-dose Period|Physician Decision|1|||
148919402|NCT03612856|537187919|FG002|Pre-dose Period|Physician Decision|1|||
148919403|NCT03612856|537187917|FG000|Pre-dose Period|Withdrawal by Subject|0|||
149154893|NCT05103332|538043643|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154894|NCT05103332|538043644|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
148919404|NCT03612856|537187918|FG001|Pre-dose Period|Withdrawal by Subject|1|||
148919405|NCT03612856|537187919|FG002|Pre-dose Period|Withdrawal by Subject|0|||
148919406|NCT01576159|537187920|FG000|Overall Study|Withdrawal by Subject|0|||
148919407|NCT01576159|537187921|FG001|Overall Study|Withdrawal by Subject|1|||
148919408|NCT01576159|537187922|FG002|Overall Study|Withdrawal by Subject|0|||
148919409|NCT01576159|537187923|FG003|Overall Study|Withdrawal by Subject|0|||
148919410|NCT01576159|537187920|FG000|Overall Study|Physician Decision|0|||
148919411|NCT01576159|537187921|FG001|Overall Study|Physician Decision|0|||
148919412|NCT01576159|537187922|FG002|Overall Study|Physician Decision|1|||
148919413|NCT01576159|537187923|FG003|Overall Study|Physician Decision|0|||
148919414|NCT01576159|537187920|FG000|Overall Study|Lost to Follow-up|0|||
148919415|NCT01576159|537187921|FG001|Overall Study|Lost to Follow-up|0|||
148919416|NCT01576159|537187922|FG002|Overall Study|Lost to Follow-up|0|||
148919417|NCT01576159|537187923|FG003|Overall Study|Lost to Follow-up|1|||
148919418|NCT01576159|537187920|FG000|Overall Study|Protocol Violation|1|||
148919419|NCT01576159|537187921|FG001|Overall Study|Protocol Violation|0|||
148919420|NCT01576159|537187922|FG002|Overall Study|Protocol Violation|0|||
148919421|NCT01576159|537187923|FG003|Overall Study|Protocol Violation|0|||
148919422|NCT01330017|537189842|FG000|Overall Study|Adverse Event|0|||
148919423|NCT01330017|537189843|FG001|Overall Study|Adverse Event|1|||
148919424|NCT01330017|537189844|FG002|Overall Study|Adverse Event|1|||
148919425|NCT01330017|537189845|FG003|Overall Study|Adverse Event|4|||
148919426|NCT01330017|537189846|FG004|Overall Study|Adverse Event|0|||
149154895|NCT05103332|538043645|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154896|NCT05103332|538043646|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
148919427|NCT01330017|537189842|FG000|Overall Study|Withdrawal by Subject|0|||
149154897|NCT05103332|538043647|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154898|NCT05103332|538043648|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154899|NCT05103332|538043649|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154900|NCT05103332|538043650|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154901|NCT05103332|538043651|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154902|NCT05103332|538043652|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154903|NCT05103332|538043653|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
149154904|NCT05103332|538043654|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
148919428|NCT01330017|537189843|FG001|Overall Study|Withdrawal by Subject|0|||
148919429|NCT01330017|537189844|FG002|Overall Study|Withdrawal by Subject|1|||
148919430|NCT01330017|537189845|FG003|Overall Study|Withdrawal by Subject|0|||
148919431|NCT01330017|537189846|FG004|Overall Study|Withdrawal by Subject|1|||
148919432|NCT01330017|537189842|FG000|Overall Study|Lost to Follow-up|0|||
148919433|NCT01330017|537189843|FG001|Overall Study|Lost to Follow-up|0|||
148919434|NCT01330017|537189844|FG002|Overall Study|Lost to Follow-up|1|||
148919435|NCT01330017|537189845|FG003|Overall Study|Lost to Follow-up|0|||
149154905|NCT05103332|538043655|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
149154906|NCT05103332|538043656|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
148919436|NCT01330017|537189846|FG004|Overall Study|Lost to Follow-up|0|||
148919437|NCT01330017|537189842|FG000|Overall Study|Protocol Violation|0|||
148919438|NCT01330017|537189843|FG001|Overall Study|Protocol Violation|0|||
148919439|NCT01330017|537189844|FG002|Overall Study|Protocol Violation|0|||
148919440|NCT01330017|537189845|FG003|Overall Study|Protocol Violation|1|||
148919441|NCT01330017|537189846|FG004|Overall Study|Protocol Violation|0|||
148919442|NCT01330017|537189842|FG000|Overall Study|Unknown Reason|5|||
148919443|NCT01330017|537189843|FG001|Overall Study|Unknown Reason|3|||
148919444|NCT01330017|537189844|FG002|Overall Study|Unknown Reason|5|||
148919445|NCT01330017|537189845|FG003|Overall Study|Unknown Reason|7|||
148919446|NCT01330017|537189846|FG004|Overall Study|Unknown Reason|2|||
148919447|NCT01221272|537189848|FG000|Period 1|Adverse Event|2|||
148919448|NCT01221272|537189849|FG001|Period 1|Adverse Event|0|||
148919449|NCT01221272|537189848|FG000|Period 1|Consent Withdrawal|0|||
148919450|NCT01221272|537189849|FG001|Period 1|Consent Withdrawal|1|||
148919451|NCT01221272|537189848|FG000|Period 1|Significant Dosing Noncompliance|0|||
148919452|NCT01221272|537189849|FG001|Period 1|Significant Dosing Noncompliance|1|||
148919453|NCT01221272|537189848|FG000|Period 2|Adverse Event|0|||
148919454|NCT01221272|537189849|FG001|Period 2|Adverse Event|2|||
148919455|NCT01340872|537189850|FG000|Double-blind Phase|Adverse Event|6|||
148919456|NCT01340872|537189851|FG001|Double-blind Phase|Adverse Event|4|||
148919457|NCT01340872|537189852|FG002|Double-blind Phase|Adverse Event|0|||
148919458|NCT01340872|537189853|FG003|Double-blind Phase|Adverse Event|0|||
148919459|NCT01340872|537189850|FG000|Double-blind Phase|Withdrawal by Subject|3|||
148919460|NCT01340872|537189851|FG001|Double-blind Phase|Withdrawal by Subject|5|||
149154907|NCT05103332|538043657|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
149154908|NCT05103332|538043658|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
148672766|NCT00592007|536272473|FG000|Overall Study|patient ineligible (out of lab range)|1|||
148672767|NCT00595127|536272474|FG000|Overall Study|Death|6|||
148672768|NCT00595127|536272474|FG000|Overall Study|Relapsed|3|||
148672769|NCT00595127|536272474|FG000|Overall Study|joined another trial|1|||
148672770|NCT00538473|536272475|FG000|Overall Study|Adverse Event|1|||
148672771|NCT00538473|536272476|FG001|Overall Study|Adverse Event|0|||
148672772|NCT01569074|536272477|FG000|Overall Study|Study stopped|6|||
148672773|NCT01569074|536272478|FG001|Overall Study|Study stopped|6|||
148672774|NCT01569074|536272479|FG002|Overall Study|Study stopped|8|||
148672775|NCT01569074|536272480|FG003|Overall Study|Study stopped|7|||
148672776|NCT01569074|536272481|FG004|Overall Study|Study stopped|7|||
149154909|NCT05103332|538043659|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
149154910|NCT05103332|538043660|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
149154911|NCT05103332|538043643|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154912|NCT05103332|538043644|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
148672777|NCT01569074|536272477|FG000|Overall Study|Study-specific discontinuation criteria|0|||
148919461|NCT01340872|537189852|FG002|Double-blind Phase|Withdrawal by Subject|0|||
148919462|NCT01340872|537189853|FG003|Double-blind Phase|Withdrawal by Subject|0|||
148919463|NCT01340872|537189850|FG000|Double-blind Phase|Lost to Follow-up|0|||
148919464|NCT01340872|537189851|FG001|Double-blind Phase|Lost to Follow-up|1|||
148919465|NCT01340872|537189852|FG002|Double-blind Phase|Lost to Follow-up|0|||
148919466|NCT01340872|537189853|FG003|Double-blind Phase|Lost to Follow-up|0|||
149154913|NCT05103332|538043645|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154914|NCT05103332|538043646|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
148672778|NCT01569074|536272478|FG001|Overall Study|Study-specific discontinuation criteria|1|||
148919467|NCT01340872|537189850|FG000|Double-blind Phase|Protocol Violation|0|||
149154915|NCT05103332|538043647|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154916|NCT05103332|538043648|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154917|NCT05103332|538043649|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154918|NCT05103332|538043650|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154919|NCT05103332|538043651|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154920|NCT05103332|538043652|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154921|NCT05103332|538043653|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154922|NCT05103332|538043654|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154923|NCT05103332|538043655|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154924|NCT05103332|538043656|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154925|NCT05103332|538043657|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154926|NCT05103332|538043658|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154927|NCT05103332|538043659|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
149154928|NCT05103332|538043660|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
149154929|NCT05103332|538043643|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154930|NCT05103332|538043644|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154931|NCT05103332|538043645|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154932|NCT05103332|538043646|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154933|NCT05103332|538043647|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154934|NCT05103332|538043648|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154935|NCT05103332|538043649|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154936|NCT05103332|538043650|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154937|NCT05103332|538043651|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154938|NCT05103332|538043652|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154939|NCT05103332|538043653|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
148919468|NCT01340872|537189851|FG001|Double-blind Phase|Protocol Violation|1|||
148672779|NCT01569074|536272479|FG002|Overall Study|Study-specific discontinuation criteria|0|||
148919469|NCT01340872|537189852|FG002|Double-blind Phase|Protocol Violation|0|||
148919470|NCT01340872|537189853|FG003|Double-blind Phase|Protocol Violation|0|||
148919471|NCT01340872|537189850|FG000|Open-label Phase|Physician Decision|0|||
148919472|NCT01340872|537189851|FG001|Open-label Phase|Physician Decision|0|||
148919473|NCT01340872|537189852|FG002|Open-label Phase|Physician Decision|2|||
148919474|NCT01340872|537189853|FG003|Open-label Phase|Physician Decision|1|||
148919475|NCT01340872|537189850|FG000|Open-label Phase|Pregnancy|0|||
148919476|NCT01340872|537189851|FG001|Open-label Phase|Pregnancy|0|||
148919477|NCT01340872|537189852|FG002|Open-label Phase|Pregnancy|1|||
148919478|NCT01340872|537189853|FG003|Open-label Phase|Pregnancy|0|||
148919479|NCT01340872|537189850|FG000|Open-label Phase|Adverse Event|0|||
148919480|NCT01340872|537189851|FG001|Open-label Phase|Adverse Event|0|||
148919481|NCT01340872|537189852|FG002|Open-label Phase|Adverse Event|8|||
148919482|NCT01340872|537189853|FG003|Open-label Phase|Adverse Event|4|||
148919483|NCT01340872|537189850|FG000|Open-label Phase|Withdrawal by Subject|0|||
148919484|NCT01340872|537189851|FG001|Open-label Phase|Withdrawal by Subject|0|||
148919485|NCT01340872|537189852|FG002|Open-label Phase|Withdrawal by Subject|1|||
148919486|NCT01340872|537189853|FG003|Open-label Phase|Withdrawal by Subject|6|||
148919487|NCT01340872|537189850|FG000|Open-label Phase|Worsening of IBD|0|||
148919488|NCT01340872|537189851|FG001|Open-label Phase|Worsening of IBD|0|||
149154940|NCT05103332|538043654|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
149154941|NCT05103332|538043655|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
149154942|NCT05103332|538043656|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
149154943|NCT05103332|538043657|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
149154944|NCT05103332|538043658|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
149154945|NCT05103332|538043659|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
149154946|NCT05103332|538043660|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
149154947|NCT05103332|538043643|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154948|NCT05103332|538043644|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154949|NCT05103332|538043645|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
148919489|NCT01340872|537189852|FG002|Open-label Phase|Worsening of IBD|1|||
148919490|NCT01340872|537189853|FG003|Open-label Phase|Worsening of IBD|0|||
148919491|NCT02656680|537189856|FG000|Overall Study|Lost to Follow-up|0|||
148919492|NCT02656680|537189857|FG001|Overall Study|Lost to Follow-up|1|||
148919493|NCT02656680|537189858|FG002|Overall Study|Lost to Follow-up|7|||
148919494|NCT01246466|537189861|FG000|Overall Study|Death|1|||
148919495|NCT01246466|537189861|FG000|Overall Study|Withdrawal by Subject|1|||
148919496|NCT00877773|537189862|FG000|Overall Study|Disease Progression|44|||
148919497|NCT00603590|537189863|FG000|Overall Study|Did not attend study clinic|39|||
148919498|NCT00603590|537189864|FG001|Overall Study|Did not attend study clinic|30|||
148919499|NCT00603590|537189863|FG000|Overall Study|Refused blood test|5|||
148919500|NCT00603590|537189864|FG001|Overall Study|Refused blood test|1|||
148919501|NCT00603590|537189863|FG000|Overall Study|Patient discontinued study drug|22|||
148919502|NCT00603590|537189864|FG001|Overall Study|Patient discontinued study drug|15|||
148919503|NCT00603590|537189863|FG000|Overall Study|Adverse Event|2|||
148919504|NCT00603590|537189864|FG001|Overall Study|Adverse Event|0|||
148919505|NCT00603590|537189863|FG000|Overall Study|Lost to Follow-up|8|||
148919506|NCT00603590|537189864|FG001|Overall Study|Lost to Follow-up|4|||
148919507|NCT00603590|537189863|FG000|Overall Study|Cardiovascular event|0|||
148919508|NCT00603590|537189864|FG001|Overall Study|Cardiovascular event|1|||
149154950|NCT05103332|538043646|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
148919509|NCT03005873|537189865|FG000|Overall Study|Prohibited medication use post radnomization|1|||
148919510|NCT03005873|537189866|FG001|Overall Study|Prohibited medication use post radnomization|1|||
149154951|NCT05103332|538043647|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154952|NCT05103332|538043648|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154953|NCT05103332|538043649|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154954|NCT05103332|538043650|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154955|NCT05103332|538043651|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154956|NCT05103332|538043652|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154957|NCT05103332|538043653|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154958|NCT05103332|538043654|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154959|NCT05103332|538043655|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154960|NCT05103332|538043656|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154961|NCT05103332|538043657|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
149154962|NCT05103332|538043658|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
149154963|NCT05103332|538043659|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
149154964|NCT05103332|538043660|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
149154965|NCT05103332|538043643|FG000|SFU Period (6 Months=168 Days)|Death|0|||
149154966|NCT05103332|538043644|FG001|SFU Period (6 Months=168 Days)|Death|0|||
149154967|NCT05103332|538043645|FG002|SFU Period (6 Months=168 Days)|Death|0|||
149154968|NCT05103332|538043646|FG003|SFU Period (6 Months=168 Days)|Death|0|||
149154969|NCT05103332|538043647|FG004|SFU Period (6 Months=168 Days)|Death|0|||
148919511|NCT03005873|537189867|FG002|Overall Study|Prohibited medication use post radnomization|1|||
148919512|NCT03005873|537189865|FG000|Overall Study|Withdrew consent|0|||
148919513|NCT03005873|537189866|FG001|Overall Study|Withdrew consent|1|||
148919514|NCT03005873|537189867|FG002|Overall Study|Withdrew consent|2|||
148919515|NCT03005873|537189865|FG000|Overall Study|Lost to Follow-up|0|||
149154970|NCT05103332|538043648|FG005|SFU Period (6 Months=168 Days)|Death|0|||
149154971|NCT05103332|538043649|FG006|SFU Period (6 Months=168 Days)|Death|0|||
149154972|NCT05103332|538043650|FG007|SFU Period (6 Months=168 Days)|Death|0|||
149154973|NCT05103332|538043651|FG008|SFU Period (6 Months=168 Days)|Death|0|||
149154974|NCT05103332|538043652|FG009|SFU Period (6 Months=168 Days)|Death|0|||
149154975|NCT05103332|538043653|FG010|SFU Period (6 Months=168 Days)|Death|0|||
148919516|NCT03005873|537189866|FG001|Overall Study|Lost to Follow-up|1|||
148919517|NCT03005873|537189867|FG002|Overall Study|Lost to Follow-up|0|||
148919518|NCT03005873|537189865|FG000|Overall Study|Ineligible post randomization|0|||
149012837|NCT01468922|537525819|FG006|Overall Study|Enrolled on new protocol|0|||
149154976|NCT05103332|538043654|FG011|SFU Period (6 Months=168 Days)|Death|0|||
149154977|NCT05103332|538043655|FG012|SFU Period (6 Months=168 Days)|Death|0|||
149154978|NCT05103332|538043656|FG013|SFU Period (6 Months=168 Days)|Death|0|||
149154979|NCT05103332|538043657|FG014|SFU Period (6 Months=168 Days)|Death|1|||
149154980|NCT05103332|538043658|FG015|SFU Period (6 Months=168 Days)|Death|0|||
149154981|NCT05103332|538043659|FG016|SFU Period (6 Months=168 Days)|Death|0|||
148919519|NCT03005873|537189866|FG001|Overall Study|Ineligible post randomization|0|||
148919520|NCT03005873|537189867|FG002|Overall Study|Ineligible post randomization|1|||
148919521|NCT01713933|537189868|FG000|Overall Study|Lost to Follow-up|2|||
148919522|NCT01713933|537189868|FG000|Overall Study|Withdrawal by Subject|3|||
148919523|NCT01713933|537189868|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
148919524|NCT02882152|537189869|FG000|Overall Study|Lost to Follow-up|1|||
148919525|NCT02882152|537189870|FG001|Overall Study|Lost to Follow-up|0|||
148919526|NCT01009840|537189873|FG000|Overall Study|Lost to Follow-up|1|||
148919527|NCT01009840|537189873|FG000|Overall Study|Adverse Event|4|||
149154982|NCT05103332|538043660|FG017|SFU Period (6 Months=168 Days)|Death|1|||
149154983|NCT00861744|538043670|FG000|Overall Study|Adverse Event|0|||
149154984|NCT00861744|538043671|FG001|Overall Study|Adverse Event|0|||
149154985|NCT00861744|538043672|FG002|Overall Study|Adverse Event|0|||
148672780|NCT01569074|536272480|FG003|Overall Study|Study-specific discontinuation criteria|0|||
148672781|NCT01569074|536272481|FG004|Overall Study|Study-specific discontinuation criteria|0|||
148672782|NCT01569074|536272477|FG000|Overall Study|Severe non-compliance to protocol|0|||
148672783|NCT01569074|536272478|FG001|Overall Study|Severe non-compliance to protocol|0|||
148672784|NCT01569074|536272479|FG002|Overall Study|Severe non-compliance to protocol|1|||
148672785|NCT01569074|536272480|FG003|Overall Study|Severe non-compliance to protocol|0|||
148672786|NCT01569074|536272481|FG004|Overall Study|Severe non-compliance to protocol|0|||
148672787|NCT01569074|536272477|FG000|Overall Study|eg change in circumstances|0|||
148672788|NCT01569074|536272478|FG001|Overall Study|eg change in circumstances|2|||
148672789|NCT01569074|536272479|FG002|Overall Study|eg change in circumstances|0|||
148672790|NCT01569074|536272480|FG003|Overall Study|eg change in circumstances|1|||
148672791|NCT01569074|536272481|FG004|Overall Study|eg change in circumstances|1|||
148672792|NCT01569074|536272477|FG000|Overall Study|Adverse Event|1|||
148919528|NCT01009840|537189873|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
148919529|NCT01009840|537189873|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
149154986|NCT00861744|538043673|FG003|Overall Study|Adverse Event|1|||
149154987|NCT00861744|538043670|FG000|Overall Study|Lost to Follow-up|7|||
148672793|NCT01569074|536272478|FG001|Overall Study|Adverse Event|0|||
148672794|NCT01569074|536272479|FG002|Overall Study|Adverse Event|3|||
148919530|NCT01009840|537189873|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
148919531|NCT01104376|537189878|FG000|Overall Study|Withdrawal by Subject|15|||
149154988|NCT00861744|538043671|FG001|Overall Study|Lost to Follow-up|19|||
148919532|NCT01104376|537189878|FG000|Overall Study|Consented but excluded after labs|13|||
148919533|NCT00797966|537189879|FG000|Phase A|Lost to Follow-up|0|||
148919534|NCT00797966|537189880|FG001|Phase A|Lost to Follow-up|0|||
148919535|NCT00797966|537189881|FG002|Phase A|Lost to Follow-up|0|||
148919536|NCT00797966|537189882|FG003|Phase A|Lost to Follow-up|0|||
148919537|NCT00797966|537189883|FG004|Phase A|Lost to Follow-up|33|||
148919538|NCT00797966|537189884|FG005|Phase A|Lost to Follow-up|0|||
148919539|NCT00797966|537189879|FG000|Phase A|Adverse Event|0|||
148919540|NCT00797966|537189880|FG001|Phase A|Adverse Event|0|||
148919541|NCT00797966|537189881|FG002|Phase A|Adverse Event|0|||
148919542|NCT00797966|537189882|FG003|Phase A|Adverse Event|0|||
148919543|NCT00797966|537189883|FG004|Phase A|Adverse Event|46|||
148919544|NCT00797966|537189884|FG005|Phase A|Adverse Event|0|||
148919545|NCT00797966|537189879|FG000|Phase A|Met withdrawal criteria|0|||
148919546|NCT00797966|537189880|FG001|Phase A|Met withdrawal criteria|0|||
148919547|NCT00797966|537189881|FG002|Phase A|Met withdrawal criteria|0|||
148919548|NCT00797966|537189882|FG003|Phase A|Met withdrawal criteria|0|||
148919549|NCT00797966|537189883|FG004|Phase A|Met withdrawal criteria|4|||
148919550|NCT00797966|537189884|FG005|Phase A|Met withdrawal criteria|0|||
148919551|NCT00797966|537189879|FG000|Phase A|Physician Decision|0|||
148919552|NCT00797966|537189880|FG001|Phase A|Physician Decision|0|||
148919553|NCT00797966|537189881|FG002|Phase A|Physician Decision|0|||
148919554|NCT00797966|537189882|FG003|Phase A|Physician Decision|0|||
148919555|NCT00797966|537189883|FG004|Phase A|Physician Decision|13|||
148919556|NCT00797966|537189884|FG005|Phase A|Physician Decision|0|||
148919557|NCT00797966|537189879|FG000|Phase A|Withdrawal by Subject|0|||
148919558|NCT00797966|537189880|FG001|Phase A|Withdrawal by Subject|0|||
148919559|NCT00797966|537189881|FG002|Phase A|Withdrawal by Subject|0|||
148919560|NCT00797966|537189882|FG003|Phase A|Withdrawal by Subject|0|||
148919561|NCT00797966|537189883|FG004|Phase A|Withdrawal by Subject|33|||
148919562|NCT00797966|537189884|FG005|Phase A|Withdrawal by Subject|0|||
148919563|NCT00797966|537189879|FG000|Phase A|Protocol deviation|0|||
148919564|NCT00797966|537189880|FG001|Phase A|Protocol deviation|0|||
148919565|NCT00797966|537189881|FG002|Phase A|Protocol deviation|0|||
148919566|NCT00797966|537189882|FG003|Phase A|Protocol deviation|0|||
148919567|NCT00797966|537189883|FG004|Phase A|Protocol deviation|56|||
148919568|NCT00797966|537189884|FG005|Phase A|Protocol deviation|0|||
148919569|NCT00797966|537189879|FG000|Phase B|Lost to Follow-up|0|||
148919570|NCT00797966|537189880|FG001|Phase B|Lost to Follow-up|1|||
148919571|NCT00797966|537189881|FG002|Phase B|Lost to Follow-up|3|||
148919572|NCT00797966|537189882|FG003|Phase B|Lost to Follow-up|0|||
148919573|NCT00797966|537189883|FG004|Phase B|Lost to Follow-up|0|||
148919574|NCT00797966|537189884|FG005|Phase B|Lost to Follow-up|0|||
149154989|NCT00861744|538043672|FG002|Overall Study|Lost to Follow-up|17|||
149154990|NCT00861744|538043673|FG003|Overall Study|Lost to Follow-up|12|||
149154991|NCT00861744|538043670|FG000|Overall Study|Withdrawal by Subject|10|||
149154992|NCT00861744|538043671|FG001|Overall Study|Withdrawal by Subject|6|||
149154993|NCT00861744|538043672|FG002|Overall Study|Withdrawal by Subject|6|||
149154994|NCT00861744|538043673|FG003|Overall Study|Withdrawal by Subject|19|||
149154995|NCT00861744|538043670|FG000|Overall Study|Protocol Violation|0|||
149154996|NCT00861744|538043671|FG001|Overall Study|Protocol Violation|1|||
149154997|NCT00861744|538043672|FG002|Overall Study|Protocol Violation|0|||
149154998|NCT00861744|538043673|FG003|Overall Study|Protocol Violation|0|||
149154999|NCT00861744|538043670|FG000|Overall Study|Migration from study area|0|||
149155000|NCT00861744|538043671|FG001|Overall Study|Migration from study area|3|||
149155001|NCT00861744|538043672|FG002|Overall Study|Migration from study area|1|||
149155002|NCT00861744|538043673|FG003|Overall Study|Migration from study area|0|||
149155003|NCT00861744|538043670|FG000|Overall Study|Blood draws|0|||
149155004|NCT00861744|538043671|FG001|Overall Study|Blood draws|0|||
149155005|NCT00861744|538043672|FG002|Overall Study|Blood draws|0|||
149155006|NCT00861744|538043673|FG003|Overall Study|Blood draws|1|||
148919575|NCT00797966|537189879|FG000|Phase B|Adverse Event|2|||
149155007|NCT04428424|538043674|FG000|Overall Study|Does not meet entrance criteria|132|||
149155008|NCT04428424|538043674|FG000|Overall Study|Lost to Follow-up|115|||
149155009|NCT03809611|538043675|FG000|Overall Study|Withdrawal by Subject|1|||
148919576|NCT00797966|537189880|FG001|Phase B|Adverse Event|1|||
148919577|NCT00797966|537189881|FG002|Phase B|Adverse Event|3|||
148919578|NCT00797966|537189882|FG003|Phase B|Adverse Event|1|||
148919579|NCT00797966|537189883|FG004|Phase B|Adverse Event|0|||
148919580|NCT00797966|537189884|FG005|Phase B|Adverse Event|0|||
148919581|NCT00797966|537189879|FG000|Phase B|Met Withdrawal Criteria|3|||
148919582|NCT00797966|537189880|FG001|Phase B|Met Withdrawal Criteria|3|||
149155010|NCT03809611|538043676|FG001|Overall Study|Withdrawal by Subject|1|||
149155011|NCT02193074|538043679|FG000|Overall Study|Withdrawal by Subject|1|||
148919583|NCT00797966|537189881|FG002|Phase B|Met Withdrawal Criteria|6|||
148919584|NCT00797966|537189882|FG003|Phase B|Met Withdrawal Criteria|1|||
149155012|NCT02193074|538043680|FG001|Overall Study|Withdrawal by Subject|2|||
149155013|NCT02193074|538043679|FG000|Overall Study|Adverse Event|16|||
149155014|NCT02193074|538043680|FG001|Overall Study|Adverse Event|13|||
148919585|NCT00797966|537189883|FG004|Phase B|Met Withdrawal Criteria|0|||
148919586|NCT00797966|537189884|FG005|Phase B|Met Withdrawal Criteria|0|||
148919587|NCT00797966|537189879|FG000|Phase B|Physician Decision|1|||
149155015|NCT04179175|538045656|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
148919588|NCT00797966|537189880|FG001|Phase B|Physician Decision|0|||
148919589|NCT00797966|537189881|FG002|Phase B|Physician Decision|3|||
148919590|NCT00797966|537189882|FG003|Phase B|Physician Decision|1|||
148919591|NCT00797966|537189883|FG004|Phase B|Physician Decision|0|||
148919592|NCT00797966|537189884|FG005|Phase B|Physician Decision|0|||
148919593|NCT00797966|537189879|FG000|Phase B|Withdrawal by Subject|1|||
148919594|NCT00797966|537189880|FG001|Phase B|Withdrawal by Subject|4|||
148919595|NCT00797966|537189881|FG002|Phase B|Withdrawal by Subject|3|||
148919596|NCT00797966|537189882|FG003|Phase B|Withdrawal by Subject|3|||
148919597|NCT00797966|537189883|FG004|Phase B|Withdrawal by Subject|0|||
148919598|NCT00797966|537189884|FG005|Phase B|Withdrawal by Subject|0|||
148919599|NCT00797966|537189879|FG000|Phase B|Protocol Deviation|4|||
148919600|NCT00797966|537189880|FG001|Phase B|Protocol Deviation|8|||
148919601|NCT00797966|537189881|FG002|Phase B|Protocol Deviation|2|||
148919602|NCT00797966|537189882|FG003|Phase B|Protocol Deviation|6|||
148919603|NCT00797966|537189883|FG004|Phase B|Protocol Deviation|0|||
148919604|NCT00797966|537189884|FG005|Phase B|Protocol Deviation|0|||
148919605|NCT00797966|537189879|FG000|Phase B|Lack of Efficacy|0|||
148919606|NCT00797966|537189880|FG001|Phase B|Lack of Efficacy|1|||
148919607|NCT00797966|537189881|FG002|Phase B|Lack of Efficacy|1|||
148919608|NCT00797966|537189882|FG003|Phase B|Lack of Efficacy|4|||
148919609|NCT00797966|537189883|FG004|Phase B|Lack of Efficacy|0|||
148919610|NCT00797966|537189884|FG005|Phase B|Lack of Efficacy|0|||
148919611|NCT00797966|537189879|FG000|Phase A+|Lost to Follow-up|0|||
149155016|NCT04179175|538045657|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
149155017|NCT04179175|538045658|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
149155018|NCT04179175|538045659|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
149155019|NCT04179175|538045660|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
149155020|NCT04179175|538045661|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
149155021|NCT04179175|538045656|FG000|Overall Study|Adverse Event|5|||
149155022|NCT04179175|538045657|FG001|Overall Study|Adverse Event|3|||
149155023|NCT04179175|538045658|FG002|Overall Study|Adverse Event|3|||
149155024|NCT04179175|538045659|FG003|Overall Study|Adverse Event|4|||
149155025|NCT04179175|538045660|FG004|Overall Study|Adverse Event|6|||
148919612|NCT00797966|537189880|FG001|Phase A+|Lost to Follow-up|0|||
148919613|NCT00797966|537189881|FG002|Phase A+|Lost to Follow-up|0|||
148919614|NCT00797966|537189882|FG003|Phase A+|Lost to Follow-up|0|||
148919615|NCT00797966|537189883|FG004|Phase A+|Lost to Follow-up|0|||
148919616|NCT00797966|537189884|FG005|Phase A+|Lost to Follow-up|9|||
148919617|NCT00797966|537189879|FG000|Phase A+|Met withdrawal criteria|0|||
148919618|NCT00797966|537189880|FG001|Phase A+|Met withdrawal criteria|0|||
149155026|NCT04179175|538045661|FG005|Overall Study|Adverse Event|6|||
149155027|NCT04179175|538045656|FG000|Overall Study|Lack of Efficacy|5|||
149155028|NCT04179175|538045657|FG001|Overall Study|Lack of Efficacy|1|||
149155029|NCT04179175|538045658|FG002|Overall Study|Lack of Efficacy|3|||
149155030|NCT04179175|538045659|FG003|Overall Study|Lack of Efficacy|2|||
148672795|NCT01569074|536272480|FG003|Overall Study|Adverse Event|0|||
148672796|NCT01569074|536272481|FG004|Overall Study|Adverse Event|0|||
148672797|NCT00203892|536272487|FG000|Overall Study|Physician Decision|1|||
148672798|NCT00203892|536272488|FG001|Overall Study|Physician Decision|2|||
148672799|NCT00203892|536272489|FG002|Overall Study|Physician Decision|0|||
148672800|NCT00203892|536272487|FG000|Overall Study|Death|1|||
148919619|NCT00797966|537189881|FG002|Phase A+|Met withdrawal criteria|0|||
148919620|NCT00797966|537189882|FG003|Phase A+|Met withdrawal criteria|0|||
148919621|NCT00797966|537189883|FG004|Phase A+|Met withdrawal criteria|0|||
148919622|NCT00797966|537189884|FG005|Phase A+|Met withdrawal criteria|5|||
148919623|NCT00797966|537189879|FG000|Phase A+|Withdrawal by Subject|0|||
148919624|NCT00797966|537189880|FG001|Phase A+|Withdrawal by Subject|0|||
148919625|NCT00797966|537189881|FG002|Phase A+|Withdrawal by Subject|0|||
148919626|NCT00797966|537189882|FG003|Phase A+|Withdrawal by Subject|0|||
148919627|NCT00797966|537189883|FG004|Phase A+|Withdrawal by Subject|0|||
148919628|NCT00797966|537189884|FG005|Phase A+|Withdrawal by Subject|6|||
148919629|NCT00797966|537189879|FG000|Phase A+|Adverse Event|0|||
149155031|NCT04179175|538045660|FG004|Overall Study|Lack of Efficacy|18|||
149155032|NCT04179175|538045661|FG005|Overall Study|Lack of Efficacy|7|||
148919630|NCT00797966|537189880|FG001|Phase A+|Adverse Event|0|||
148919631|NCT00797966|537189881|FG002|Phase A+|Adverse Event|0|||
148919632|NCT00797966|537189882|FG003|Phase A+|Adverse Event|0|||
148919633|NCT00797966|537189883|FG004|Phase A+|Adverse Event|0|||
148919634|NCT00797966|537189884|FG005|Phase A+|Adverse Event|4|||
149155033|NCT04179175|538045656|FG000|Overall Study|Lost to Follow-up|5|||
149155034|NCT04179175|538045657|FG001|Overall Study|Lost to Follow-up|3|||
148672801|NCT00203892|536272488|FG001|Overall Study|Death|0|||
148672802|NCT00203892|536272489|FG002|Overall Study|Death|0|||
148672803|NCT01036594|536272498|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
148919635|NCT00797966|537189879|FG000|Phase A+|Protocol deviation|0|||
148919636|NCT00797966|537189880|FG001|Phase A+|Protocol deviation|0|||
148919637|NCT00797966|537189881|FG002|Phase A+|Protocol deviation|0|||
148919638|NCT00797966|537189882|FG003|Phase A+|Protocol deviation|0|||
148919639|NCT00797966|537189883|FG004|Phase A+|Protocol deviation|0|||
148919640|NCT00797966|537189884|FG005|Phase A+|Protocol deviation|4|||
148919641|NCT01430754|537189892|FG000|Run-In Phase|Circadian Period Ineligible|24|||
148919642|NCT01430754|537189893|FG001|Run-In Phase|Circadian Period Ineligible|0|||
148919643|NCT01430754|537189892|FG000|Run-In Phase|Protocol Violation|6|||
148919644|NCT01430754|537189893|FG001|Run-In Phase|Protocol Violation|0|||
148919645|NCT01430754|537189892|FG000|Run-In Phase|Adverse Event|2|||
148919646|NCT01430754|537189893|FG001|Run-In Phase|Adverse Event|0|||
148919647|NCT01430754|537189892|FG000|Run-In Phase|Other|2|||
148919648|NCT01430754|537189893|FG001|Run-In Phase|Other|0|||
148919649|NCT01430754|537189892|FG000|Run-In Phase|Withdrawal by Subject|2|||
148919650|NCT01430754|537189893|FG001|Run-In Phase|Withdrawal by Subject|0|||
148919651|NCT01430754|537189892|FG000|Run-In Phase|Lost to Follow-up|1|||
148919652|NCT01430754|537189893|FG001|Run-In Phase|Lost to Follow-up|0|||
148919653|NCT02661178|537189901|FG000|Part 1|Protocol Violation|1|||
148919654|NCT02661178|537189902|FG001|Part 1|Protocol Violation|0|||
148919655|NCT02661178|537189903|FG002|Part 1|Protocol Violation|0|||
148919656|NCT02661178|537189904|FG003|Part 1|Protocol Violation|0|||
148919657|NCT02661178|537189905|FG004|Part 1|Protocol Violation|0|||
148919658|NCT02661178|537189906|FG005|Part 1|Protocol Violation|0|||
148919659|NCT02661178|537189907|FG006|Part 1|Protocol Violation|0|||
148919660|NCT02661178|537189908|FG007|Part 1|Protocol Violation|0|||
148919661|NCT02661178|537189909|FG008|Part 1|Protocol Violation|0|||
148919662|NCT02661178|537189910|FG009|Part 1|Protocol Violation|0|||
148919663|NCT02661178|537189911|FG010|Part 1|Protocol Violation|0|||
148919664|NCT02661178|537189912|FG011|Part 1|Protocol Violation|0|||
148919665|NCT02661178|537189913|FG012|Part 1|Protocol Violation|0|||
148919666|NCT02661178|537189914|FG013|Part 1|Protocol Violation|0|||
148919667|NCT02661178|537189915|FG014|Part 1|Protocol Violation|0|||
148919668|NCT03859973|537189918|FG000|Overall Study|Other reason than listed|3|||
148919669|NCT03859973|537189919|FG001|Overall Study|Other reason than listed|2|||
148919670|NCT03859973|537189918|FG000|Overall Study|COVID-19 related, not due to AE|3|||
148919671|NCT03859973|537189919|FG001|Overall Study|COVID-19 related, not due to AE|4|||
148919672|NCT03859973|537189918|FG000|Overall Study|Withdrawal by Subject|8|||
148919673|NCT03859973|537189919|FG001|Overall Study|Withdrawal by Subject|9|||
148919674|NCT03859973|537189918|FG000|Overall Study|Lost to Follow-up|2|||
148919675|NCT03859973|537189919|FG001|Overall Study|Lost to Follow-up|3|||
148919676|NCT03859973|537189918|FG000|Overall Study|Protocol Violation|1|||
148919677|NCT03859973|537189919|FG001|Overall Study|Protocol Violation|3|||
148919678|NCT03859973|537189918|FG000|Overall Study|Adverse Event|3|||
148919679|NCT03859973|537189919|FG001|Overall Study|Adverse Event|5|||
148919680|NCT02855541|537189920|FG000|Overall Study|Change in health status|2|||
148919681|NCT02855541|537189920|FG000|Overall Study|Withdrawal by Subject|2|||
148919682|NCT01242813|537189921|FG000|Overall Study|Lost to Follow-up|2|||
148919683|NCT01369329|537189924|FG000|Overall Study|Withdrawal by Subject|8|||
148919684|NCT01369329|537189925|FG001|Overall Study|Withdrawal by Subject|6|||
148919685|NCT01369329|537189926|FG002|Overall Study|Withdrawal by Subject|10|||
148919686|NCT01369329|537189924|FG000|Overall Study|Lost to Follow-up|2|||
148919687|NCT01369329|537189925|FG001|Overall Study|Lost to Follow-up|2|||
148919688|NCT01369329|537189926|FG002|Overall Study|Lost to Follow-up|2|||
148919689|NCT01369329|537189924|FG000|Overall Study|Other|2|||
148919690|NCT01369329|537189925|FG001|Overall Study|Other|3|||
148919691|NCT01369329|537189926|FG002|Overall Study|Other|2|||
148919692|NCT00701662|537189927|FG000|Overall Study|Lack of Efficacy|1|||
148919693|NCT03337490|537189933|FG000|Overall Study|Withdrawal by Subject|1|||
148919694|NCT03337490|537189934|FG001|Overall Study|Withdrawal by Subject|0|||
148919695|NCT03337490|537189935|FG002|Overall Study|Withdrawal by Subject|0|||
148919696|NCT03337490|537189933|FG000|Overall Study|Lack of Efficacy|10|||
148919697|NCT03337490|537189934|FG001|Overall Study|Lack of Efficacy|12|||
148919698|NCT03337490|537189935|FG002|Overall Study|Lack of Efficacy|35|||
148919699|NCT03337490|537189933|FG000|Overall Study|Physician Decision|0|||
148919700|NCT03337490|537189934|FG001|Overall Study|Physician Decision|1|||
148919701|NCT03337490|537189935|FG002|Overall Study|Physician Decision|0|||
148919702|NCT03337490|537189933|FG000|Overall Study|Lost to Follow-up|0|||
148919703|NCT03337490|537189934|FG001|Overall Study|Lost to Follow-up|1|||
148919704|NCT03337490|537189935|FG002|Overall Study|Lost to Follow-up|0|||
148919705|NCT03560518|537189936|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
148919706|NCT03560518|537189937|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
148919707|NCT03560518|537189938|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
148919708|NCT03560518|537189936|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
148919709|NCT03560518|537189937|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
148919710|NCT03560518|537189938|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
148919711|NCT03560518|537189936|FG000|Double Blind Treatment Period|Protocol Violation|1|||
148919712|NCT03560518|537189937|FG001|Double Blind Treatment Period|Protocol Violation|2|||
148919713|NCT03560518|537189938|FG002|Double Blind Treatment Period|Protocol Violation|0|||
148919714|NCT03560518|537189936|FG000|Double Blind Treatment Period|Pregnancy|0|||
148919715|NCT03560518|537189937|FG001|Double Blind Treatment Period|Pregnancy|2|||
148919716|NCT03560518|537189938|FG002|Double Blind Treatment Period|Pregnancy|0|||
148919717|NCT03560518|537189936|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
148919718|NCT03560518|537189937|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
148919719|NCT03560518|537189938|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
148919720|NCT03560518|537189936|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
148919721|NCT03560518|537189937|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
148919722|NCT03560518|537189938|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
148919723|NCT03560518|537189936|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
148919724|NCT03560518|537189937|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
148919725|NCT03560518|537189938|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
148919726|NCT03560518|537189936|FG000|Double Blind Treatment Period|Adverse Event|0|||
148919727|NCT03560518|537189937|FG001|Double Blind Treatment Period|Adverse Event|3|||
148919728|NCT03560518|537189938|FG002|Double Blind Treatment Period|Adverse Event|1|||
148919729|NCT00159822|537189939|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
148919730|NCT00159822|537189939|FG000|Voriconazole Treatment Period|Adverse Event|9|||
148919731|NCT00159822|537189939|FG000|Voriconazole Treatment Period|Death|4|||
148919732|NCT00159822|537189939|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
148919733|NCT00159822|537189939|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
148919734|NCT00159822|537189939|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
148919735|NCT00159822|537189939|FG000|Post-treatment Follow-up Period|Death|1|||
148919736|NCT00159822|537189939|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
148919737|NCT00159822|537189939|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
148919738|NCT01689532|537189940|FG000|Overall Study|Adverse Event|9|||
148919739|NCT01689532|537189941|FG001|Overall Study|Adverse Event|5|||
148919740|NCT01689532|537189940|FG000|Overall Study|Lack of Efficacy|2|||
148919741|NCT01689532|537189941|FG001|Overall Study|Lack of Efficacy|2|||
148919742|NCT01689532|537189940|FG000|Overall Study|Withdrawal by Subject|1|||
148919743|NCT01689532|537189941|FG001|Overall Study|Withdrawal by Subject|2|||
148919744|NCT01689532|537189940|FG000|Overall Study|Physician Decision|2|||
148919745|NCT01689532|537189941|FG001|Overall Study|Physician Decision|0|||
148919746|NCT01363349|537189942|FG000|Overall Study|Adverse Event|6|||
148919747|NCT01363349|537189943|FG001|Overall Study|Adverse Event|7|||
148919748|NCT01363349|537189942|FG000|Overall Study|Lack of Efficacy|3|||
148919749|NCT01363349|537189943|FG001|Overall Study|Lack of Efficacy|10|||
148919750|NCT01363349|537189942|FG000|Overall Study|Non compliance/Protocol deviations|2|||
148919751|NCT01363349|537189943|FG001|Overall Study|Non compliance/Protocol deviations|2|||
148919752|NCT01363349|537189942|FG000|Overall Study|Withdrawal by Subject|14|||
148919753|NCT01363349|537189943|FG001|Overall Study|Withdrawal by Subject|6|||
148919754|NCT01363349|537189942|FG000|Overall Study|Lost to Follow-up|5|||
148919755|NCT01363349|537189943|FG001|Overall Study|Lost to Follow-up|6|||
148919756|NCT01363349|537189942|FG000|Overall Study|Not reported|36|||
148919757|NCT01363349|537189943|FG001|Overall Study|Not reported|37|||
148919758|NCT01363349|537189942|FG000|Overall Study|missing|1|||
148919759|NCT01363349|537189943|FG001|Overall Study|missing|2|||
148919760|NCT01958489|537189944|FG000|Period 2|Adverse Event|0|||
148919761|NCT01958489|537189945|FG001|Period 2|Adverse Event|1|||
148919762|NCT00917644|537189946|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
148919763|NCT00917644|537189947|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
148919764|NCT00917644|537189946|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
148919765|NCT00917644|537189947|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
148919766|NCT00917644|537189946|FG000|Period 2: Second Intervention|family emergency|1|||
148919767|NCT00917644|537189947|FG001|Period 2: Second Intervention|family emergency|0|||
148919768|NCT00275821|537189951|FG000|Overall Study|Adverse Event|4|||
148919769|NCT00275821|537189952|FG001|Overall Study|Adverse Event|12|||
148919770|NCT00275821|537189953|FG002|Overall Study|Adverse Event|5|||
148919771|NCT00275821|537189951|FG000|Overall Study|Administrative problems|3|||
148919772|NCT00275821|537189952|FG001|Overall Study|Administrative problems|4|||
148919773|NCT00275821|537189953|FG002|Overall Study|Administrative problems|4|||
148919774|NCT00275821|537189951|FG000|Overall Study|Withdrawal by Subject|0|||
148919775|NCT00275821|537189952|FG001|Overall Study|Withdrawal by Subject|2|||
148919776|NCT00275821|537189953|FG002|Overall Study|Withdrawal by Subject|1|||
148919777|NCT00275821|537189951|FG000|Overall Study|Lost to Follow-up|0|||
148672804|NCT01036594|536272499|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
148919778|NCT00275821|537189952|FG001|Overall Study|Lost to Follow-up|1|||
148919779|NCT00275821|537189953|FG002|Overall Study|Lost to Follow-up|1|||
148919780|NCT00275821|537189951|FG000|Overall Study|Death|0|||
148919781|NCT00275821|537189952|FG001|Overall Study|Death|2|||
148919782|NCT00275821|537189953|FG002|Overall Study|Death|1|||
148919783|NCT00275821|537189951|FG000|Overall Study|Lack of Efficacy|2|||
148919784|NCT00275821|537189952|FG001|Overall Study|Lack of Efficacy|1|||
148919785|NCT00275821|537189953|FG002|Overall Study|Lack of Efficacy|0|||
148919786|NCT00275821|537189951|FG000|Overall Study|Protocol Violation|5|||
148919787|NCT00275821|537189952|FG001|Overall Study|Protocol Violation|1|||
149155035|NCT04179175|538045658|FG002|Overall Study|Lost to Follow-up|2|||
148919788|NCT00275821|537189953|FG002|Overall Study|Protocol Violation|0|||
148919789|NCT00958438|537189956|FG000|Overall Study|Protocol Violation|3|||
148805925|NCT05911841|536768052|FG008|Induction Period|Lack of Efficacy|0|||
148919790|NCT00958438|537189957|FG001|Overall Study|Protocol Violation|2|||
148919791|NCT00958438|537189958|FG002|Overall Study|Protocol Violation|2|||
148919792|NCT00958438|537189956|FG000|Overall Study|Withdrawal by Subject|4|||
148919793|NCT00958438|537189957|FG001|Overall Study|Withdrawal by Subject|2|||
148919794|NCT00958438|537189958|FG002|Overall Study|Withdrawal by Subject|1|||
148919795|NCT00958438|537189956|FG000|Overall Study|Adverse Event|0|||
148919796|NCT00958438|537189957|FG001|Overall Study|Adverse Event|3|||
148919797|NCT00958438|537189958|FG002|Overall Study|Adverse Event|0|||
148919798|NCT00958438|537189956|FG000|Overall Study|Physician Decision|1|||
148919799|NCT00958438|537189957|FG001|Overall Study|Physician Decision|0|||
148919800|NCT00958438|537189958|FG002|Overall Study|Physician Decision|1|||
148919801|NCT00958438|537189956|FG000|Overall Study|Other than specified above|2|||
148919802|NCT00958438|537189957|FG001|Overall Study|Other than specified above|3|||
148919803|NCT00958438|537189958|FG002|Overall Study|Other than specified above|2|||
148919804|NCT02788279|537189959|FG000|Overall Study|Death|62|||
148919805|NCT02788279|537189960|FG001|Overall Study|Death|136|||
148919806|NCT02788279|537189961|FG002|Overall Study|Death|72|||
148919807|NCT02788279|537189959|FG000|Overall Study|Withdrawal by Subject|10|||
148919808|NCT02788279|537189960|FG001|Overall Study|Withdrawal by Subject|15|||
148919809|NCT02788279|537189961|FG002|Overall Study|Withdrawal by Subject|5|||
148919810|NCT02788279|537189959|FG000|Overall Study|Lost to Follow-up|0|||
148919811|NCT02788279|537189960|FG001|Overall Study|Lost to Follow-up|3|||
148919812|NCT02788279|537189961|FG002|Overall Study|Lost to Follow-up|2|||
148919813|NCT02788279|537189959|FG000|Overall Study|Sponsor decision|18|||
148919814|NCT02788279|537189960|FG001|Overall Study|Sponsor decision|29|||
148919815|NCT02788279|537189961|FG002|Overall Study|Sponsor decision|11|||
148919816|NCT02282345|537189963|FG000|Overall Study|Progression|0|||
148919817|NCT02282345|537189964|FG001|Overall Study|Progression|1|||
148919818|NCT04987944|537189969|FG000|Overall Study|Adverse Event|0|||
148919819|NCT04987944|537189970|FG001|Overall Study|Adverse Event|1|||
148919820|NCT04987944|537189969|FG000|Overall Study|Withdrawal by Subject|0|||
148919821|NCT04987944|537189970|FG001|Overall Study|Withdrawal by Subject|1|||
148919822|NCT04136444|537189976|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
148919823|NCT04136444|537189977|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
148919824|NCT02095132|537189984|FG000|Overall Study|Adverse Event|0|||
148919825|NCT02095132|537189985|FG001|Overall Study|Adverse Event|0|||
148919826|NCT02095132|537189986|FG002|Overall Study|Adverse Event|0|||
148919827|NCT02095132|537189987|FG003|Overall Study|Adverse Event|0|||
148919828|NCT02095132|537189988|FG004|Overall Study|Adverse Event|1|||
148919829|NCT02095132|537189989|FG005|Overall Study|Adverse Event|0|||
148919830|NCT02095132|537189990|FG006|Overall Study|Adverse Event|1|||
148919831|NCT02095132|537189991|FG007|Overall Study|Adverse Event|0|||
148919832|NCT02095132|537189992|FG008|Overall Study|Adverse Event|0|||
148919833|NCT02095132|537189984|FG000|Overall Study|Death|0|||
148919834|NCT02095132|537189985|FG001|Overall Study|Death|0|||
148919835|NCT02095132|537189986|FG002|Overall Study|Death|0|||
148919836|NCT02095132|537189987|FG003|Overall Study|Death|0|||
148919837|NCT02095132|537189988|FG004|Overall Study|Death|0|||
148919838|NCT02095132|537189989|FG005|Overall Study|Death|0|||
148919839|NCT02095132|537189990|FG006|Overall Study|Death|1|||
148919840|NCT02095132|537189991|FG007|Overall Study|Death|0|||
148919841|NCT02095132|537189992|FG008|Overall Study|Death|0|||
148919842|NCT02095132|537189984|FG000|Overall Study|Lack of Efficacy|3|||
148919843|NCT02095132|537189985|FG001|Overall Study|Lack of Efficacy|5|||
148919844|NCT02095132|537189986|FG002|Overall Study|Lack of Efficacy|2|||
148919845|NCT02095132|537189987|FG003|Overall Study|Lack of Efficacy|8|||
148919846|NCT02095132|537189988|FG004|Overall Study|Lack of Efficacy|3|||
148919847|NCT02095132|537189989|FG005|Overall Study|Lack of Efficacy|6|||
148919848|NCT02095132|537189990|FG006|Overall Study|Lack of Efficacy|10|||
148919849|NCT02095132|537189991|FG007|Overall Study|Lack of Efficacy|9|||
148919850|NCT02095132|537189992|FG008|Overall Study|Lack of Efficacy|8|||
148919851|NCT02095132|537189984|FG000|Overall Study|Physician Decision|1|||
148919852|NCT02095132|537189985|FG001|Overall Study|Physician Decision|0|||
148919853|NCT02095132|537189986|FG002|Overall Study|Physician Decision|0|||
148919854|NCT02095132|537189987|FG003|Overall Study|Physician Decision|0|||
148919855|NCT02095132|537189988|FG004|Overall Study|Physician Decision|0|||
148919856|NCT02095132|537189989|FG005|Overall Study|Physician Decision|0|||
148919857|NCT02095132|537189990|FG006|Overall Study|Physician Decision|1|||
148919858|NCT02095132|537189991|FG007|Overall Study|Physician Decision|0|||
148919859|NCT02095132|537189992|FG008|Overall Study|Physician Decision|2|||
148919860|NCT02095132|537189984|FG000|Overall Study|Withdrawal by Subject|0|||
148919861|NCT02095132|537189985|FG001|Overall Study|Withdrawal by Subject|0|||
148919862|NCT02095132|537189986|FG002|Overall Study|Withdrawal by Subject|2|||
148919863|NCT02095132|537189987|FG003|Overall Study|Withdrawal by Subject|2|||
148919864|NCT02095132|537189988|FG004|Overall Study|Withdrawal by Subject|3|||
148919865|NCT02095132|537189989|FG005|Overall Study|Withdrawal by Subject|0|||
148919866|NCT02095132|537189990|FG006|Overall Study|Withdrawal by Subject|5|||
148919867|NCT02095132|537189991|FG007|Overall Study|Withdrawal by Subject|0|||
148919868|NCT02095132|537189992|FG008|Overall Study|Withdrawal by Subject|0|||
148919869|NCT04905498|537189993|FG000|Overall Study|Lost to Follow-up|0|||
148919870|NCT04905498|537189994|FG001|Overall Study|Lost to Follow-up|2|||
148919871|NCT04905498|537189993|FG000|Overall Study|COVID lockdown|1|||
148919872|NCT04905498|537189994|FG001|Overall Study|COVID lockdown|0|||
148919873|NCT00409175|537189995|FG000|Overall Study|Adverse Event|4|||
148919874|NCT00409175|537189996|FG001|Overall Study|Adverse Event|3|||
148919875|NCT00409175|537189995|FG000|Overall Study|Withdrawal by Subject|1|||
148919876|NCT00409175|537189996|FG001|Overall Study|Withdrawal by Subject|2|||
148919877|NCT00409175|537189995|FG000|Overall Study|Negative genotype|0|||
148919878|NCT00409175|537189996|FG001|Overall Study|Negative genotype|1|||
148919879|NCT00409175|537189995|FG000|Overall Study|Liver transplantation|13|||
148919880|NCT00409175|537189996|FG001|Overall Study|Liver transplantation|13|||
148919881|NCT02946931|537190001|FG000|Overall Study|Did not require collection of CRFs|588|||
148919882|NCT02946931|537190001|FG000|Overall Study|Other than listed|37|||
148919883|NCT02946931|537190001|FG000|Overall Study|Discharge from hospital|118|||
148919884|NCT02946931|537190001|FG000|Overall Study|Adverse Event|81|||
148919885|NCT02946931|537190001|FG000|Overall Study|CRFs not valid|1|||
148919886|NCT02946931|537190001|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
148919887|NCT03339297|537190002|FG000|Overall Study|Relapse of Hematologic Disease|1|||
148919888|NCT03339297|537190003|FG001|Overall Study|Relapse of Hematologic Disease|0|||
148919889|NCT03339297|537190002|FG000|Overall Study|Death|10|||
148919890|NCT03339297|537190003|FG001|Overall Study|Death|7|||
148919891|NCT03339297|537190002|FG000|Overall Study|Hepatic Candidosis|1|||
148919892|NCT03339297|537190003|FG001|Overall Study|Hepatic Candidosis|0|||
148919893|NCT03339297|537190002|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
148919894|NCT03339297|537190003|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
148919895|NCT03339297|537190002|FG000|Overall Study|Consent Withdrawn by Participant|3|||
148919896|NCT03339297|537190003|FG001|Overall Study|Consent Withdrawn by Participant|3|||
148919897|NCT03339297|537190002|FG000|Overall Study|Disease Relapse|2|||
148919898|NCT03339297|537190003|FG001|Overall Study|Disease Relapse|0|||
148919899|NCT03339297|537190002|FG000|Overall Study|Physician Decision|1|||
148919900|NCT03339297|537190003|FG001|Overall Study|Physician Decision|1|||
148919901|NCT03339297|537190002|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
148919902|NCT03339297|537190003|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
148919903|NCT03339297|537190002|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
148919904|NCT03339297|537190003|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
148919905|NCT03339297|537190002|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
148919906|NCT03339297|537190003|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
148919907|NCT03339297|537190002|FG000|Overall Study|Adverse Event, Non-fatal|1|||
148919908|NCT03339297|537190003|FG001|Overall Study|Adverse Event, Non-fatal|0|||
148919909|NCT03339297|537190002|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
148919910|NCT03339297|537190003|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
148919911|NCT03339297|537190002|FG000|Overall Study|Patient Was Not Eligible|1|||
148919912|NCT03339297|537190003|FG001|Overall Study|Patient Was Not Eligible|0|||
148919913|NCT03316911|537190007|FG000|Overall Study|Lost to Follow-up|33|||
148919914|NCT03316911|537190008|FG001|Overall Study|Lost to Follow-up|29|||
148919915|NCT01566214|537190013|FG000|Overall Study|Lost to Follow-up|3|||
148919916|NCT01566214|537190014|FG001|Overall Study|Lost to Follow-up|0|||
148919917|NCT04449029|537190015|FG000|Overall Study|Adverse Event|0|||
148919918|NCT04449029|537190016|FG001|Overall Study|Adverse Event|1|||
148919919|NCT04449029|537190017|FG002|Overall Study|Adverse Event|1|||
148919920|NCT04449029|537190018|FG003|Overall Study|Adverse Event|0|||
148919921|NCT04449029|537190019|FG004|Overall Study|Adverse Event|1|||
148919922|NCT04449029|537190020|FG005|Overall Study|Adverse Event|0|||
148919923|NCT04449029|537190021|FG006|Overall Study|Adverse Event|1|||
148919924|NCT04449029|537190022|FG007|Overall Study|Adverse Event|0|||
148919925|NCT04449029|537190015|FG000|Overall Study|Lost to Follow-up|0|||
148919926|NCT04449029|537190016|FG001|Overall Study|Lost to Follow-up|1|||
148919927|NCT04449029|537190017|FG002|Overall Study|Lost to Follow-up|0|||
148919928|NCT04449029|537190018|FG003|Overall Study|Lost to Follow-up|0|||
148919929|NCT04449029|537190019|FG004|Overall Study|Lost to Follow-up|0|||
148919930|NCT04449029|537190020|FG005|Overall Study|Lost to Follow-up|0|||
148919931|NCT04449029|537190021|FG006|Overall Study|Lost to Follow-up|0|||
148919932|NCT04449029|537190022|FG007|Overall Study|Lost to Follow-up|0|||
148919933|NCT04449029|537190015|FG000|Overall Study|Protocol Violation|0|||
148919934|NCT04449029|537190016|FG001|Overall Study|Protocol Violation|1|||
148919935|NCT04449029|537190017|FG002|Overall Study|Protocol Violation|0|||
148919936|NCT04449029|537190018|FG003|Overall Study|Protocol Violation|0|||
148919937|NCT04449029|537190019|FG004|Overall Study|Protocol Violation|0|||
148919938|NCT04449029|537190020|FG005|Overall Study|Protocol Violation|0|||
148919939|NCT04449029|537190021|FG006|Overall Study|Protocol Violation|0|||
148919940|NCT04449029|537190022|FG007|Overall Study|Protocol Violation|0|||
148919941|NCT04449029|537190015|FG000|Overall Study|Physician Decision|0|||
148919942|NCT04449029|537190016|FG001|Overall Study|Physician Decision|0|||
148919943|NCT04449029|537190017|FG002|Overall Study|Physician Decision|0|||
148919944|NCT04449029|537190018|FG003|Overall Study|Physician Decision|0|||
148919945|NCT04449029|537190019|FG004|Overall Study|Physician Decision|0|||
148919946|NCT04449029|537190020|FG005|Overall Study|Physician Decision|1|||
148919947|NCT04449029|537190021|FG006|Overall Study|Physician Decision|0|||
148919948|NCT04449029|537190022|FG007|Overall Study|Physician Decision|0|||
148919949|NCT04449029|537190015|FG000|Overall Study|Withdrawal by Subject|3|||
148919950|NCT04449029|537190016|FG001|Overall Study|Withdrawal by Subject|0|||
148919951|NCT04449029|537190017|FG002|Overall Study|Withdrawal by Subject|1|||
148919952|NCT04449029|537190018|FG003|Overall Study|Withdrawal by Subject|1|||
148919953|NCT04449029|537190019|FG004|Overall Study|Withdrawal by Subject|5|||
148919954|NCT04449029|537190020|FG005|Overall Study|Withdrawal by Subject|1|||
148919955|NCT04449029|537190021|FG006|Overall Study|Withdrawal by Subject|4|||
148919956|NCT04449029|537190022|FG007|Overall Study|Withdrawal by Subject|0|||
148919957|NCT01073462|537190028|FG000|Overall Study|Death|14|||
148919958|NCT01073462|537190028|FG000|Overall Study|Kidney transplant|10|||
148919959|NCT01073462|537190028|FG000|Overall Study|Low parathyroid hormone levels|8|||
148919960|NCT01073462|537190028|FG000|Overall Study|Serious adverse event|2|||
148919961|NCT01073462|537190028|FG000|Overall Study|Lost to Follow-up|7|||
148919962|NCT03554486|537190029|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
148919963|NCT03554486|537190030|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
148919964|NCT03554486|537190031|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
148919965|NCT03554486|537190029|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
148919966|NCT03554486|537190030|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
148919967|NCT03554486|537190031|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
148919968|NCT03554486|537190029|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
148919969|NCT03554486|537190030|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
148919970|NCT03554486|537190031|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
148919971|NCT02509117|537190034|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919972|NCT02509117|537190035|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
148919973|NCT02509117|537190036|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919974|NCT02509117|537190037|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919975|NCT02509117|537190038|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919976|NCT02509117|537190039|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919977|NCT02509117|537190040|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919978|NCT02509117|537190041|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919979|NCT02509117|537190042|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919980|NCT02509117|537190043|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
148919981|NCT02509117|537190034|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919982|NCT02509117|537190035|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919983|NCT02509117|537190036|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919984|NCT02509117|537190037|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919985|NCT02509117|537190038|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919986|NCT02509117|537190039|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919987|NCT02509117|537190040|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919988|NCT02509117|537190041|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919989|NCT02509117|537190042|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
148919990|NCT02509117|537190043|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
148919991|NCT02509117|537190034|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919992|NCT02509117|537190035|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919993|NCT02509117|537190036|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919994|NCT02509117|537190037|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919995|NCT02509117|537190038|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919996|NCT02509117|537190039|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919997|NCT02509117|537190040|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919998|NCT02509117|537190041|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
148919999|NCT02509117|537190042|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
149155036|NCT04179175|538045659|FG003|Overall Study|Lost to Follow-up|2|||
149155037|NCT04179175|538045660|FG004|Overall Study|Lost to Follow-up|4|||
149155038|NCT04179175|538045661|FG005|Overall Study|Lost to Follow-up|5|||
149155039|NCT04179175|538045656|FG000|Overall Study|Physician Decision|2|||
149155040|NCT04179175|538045657|FG001|Overall Study|Physician Decision|0|||
149155041|NCT04179175|538045658|FG002|Overall Study|Physician Decision|2|||
149155042|NCT04179175|538045659|FG003|Overall Study|Physician Decision|3|||
149155043|NCT04179175|538045660|FG004|Overall Study|Physician Decision|1|||
149155044|NCT04179175|538045661|FG005|Overall Study|Physician Decision|1|||
148920000|NCT02509117|537190043|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
148920001|NCT00832624|537190044|FG000|Overall Study|Study Terminated|10|||
148920002|NCT03658876|537192051|FG000|Overall Study|Protocol Violation|3|||
148920003|NCT03658876|537192052|FG001|Overall Study|Protocol Violation|2|||
148920004|NCT03658876|537192051|FG000|Overall Study|Withdrawal by Subject|2|||
148920005|NCT03658876|537192052|FG001|Overall Study|Withdrawal by Subject|0|||
148920006|NCT03658876|537192051|FG000|Overall Study|Death|0|||
148920007|NCT03658876|537192052|FG001|Overall Study|Death|1|||
148920008|NCT03658876|537192051|FG000|Overall Study|Intercurrent illness|6|||
148920009|NCT03658876|537192052|FG001|Overall Study|Intercurrent illness|4|||
148920010|NCT03658876|537192051|FG000|Overall Study|Transplantation/other operation|1|||
148920011|NCT03658876|537192052|FG001|Overall Study|Transplantation/other operation|5|||
148920012|NCT02616146|537192053|FG000|Overall Study|Adverse Event|64|||
148920013|NCT02616146|537192054|FG001|Overall Study|Adverse Event|24|||
148920014|NCT02616146|537192053|FG000|Overall Study|Lost to Follow-up|23|||
148920015|NCT02616146|537192054|FG001|Overall Study|Lost to Follow-up|13|||
148920016|NCT02616146|537192053|FG000|Overall Study|Non-compliance with study protocol|2|||
148920017|NCT02616146|537192054|FG001|Overall Study|Non-compliance with study protocol|0|||
148920018|NCT02616146|537192053|FG000|Overall Study|Non-compliance with study drug|4|||
148920019|NCT02616146|537192054|FG001|Overall Study|Non-compliance with study drug|2|||
148920020|NCT02616146|537192053|FG000|Overall Study|Pregnancy|2|||
148920021|NCT02616146|537192054|FG001|Overall Study|Pregnancy|2|||
149155045|NCT04179175|538045656|FG000|Overall Study|Pregnancy|3|||
149155046|NCT04179175|538045657|FG001|Overall Study|Pregnancy|0|||
148805926|NCT05911841|536768053|FG009|Induction Period|Lack of Efficacy|0|||
148920022|NCT02616146|537192053|FG000|Overall Study|Pregnancy wish|3|||
148920023|NCT02616146|537192054|FG001|Overall Study|Pregnancy wish|0|||
148920024|NCT02616146|537192053|FG000|Overall Study|Protocol Violation|6|||
148920025|NCT02616146|537192054|FG001|Overall Study|Protocol Violation|3|||
149155047|NCT04179175|538045658|FG002|Overall Study|Pregnancy|3|||
149155048|NCT04179175|538045659|FG003|Overall Study|Pregnancy|0|||
149155049|NCT04179175|538045660|FG004|Overall Study|Pregnancy|1|||
148805927|NCT05911841|536768044|FG000|Induction Period|Adverse Event|3|||
148920026|NCT02616146|537192053|FG000|Overall Study|Study terminated by sponsor|1372|||
148920027|NCT02616146|537192054|FG001|Overall Study|Study terminated by sponsor|432|||
148920028|NCT02616146|537192053|FG000|Overall Study|Participant moved|4|||
148920029|NCT02616146|537192054|FG001|Overall Study|Participant moved|3|||
148920030|NCT02616146|537192053|FG000|Overall Study|Withdrawal by Subject|30|||
149155050|NCT04179175|538045661|FG005|Overall Study|Pregnancy|2|||
148805928|NCT05911841|536768045|FG001|Induction Period|Adverse Event|1|||
149155051|NCT04179175|538045656|FG000|Overall Study|Withdrawal by Subject|22|||
149155052|NCT04179175|538045657|FG001|Overall Study|Withdrawal by Subject|10|||
149155053|NCT04179175|538045658|FG002|Overall Study|Withdrawal by Subject|12|||
149155054|NCT04179175|538045659|FG003|Overall Study|Withdrawal by Subject|8|||
149155055|NCT04179175|538045660|FG004|Overall Study|Withdrawal by Subject|23|||
149155056|NCT04179175|538045661|FG005|Overall Study|Withdrawal by Subject|31|||
149155057|NCT04179175|538045656|FG000|Overall Study|Technical problems|0|||
149155058|NCT04179175|538045657|FG001|Overall Study|Technical problems|0|||
149155059|NCT04179175|538045658|FG002|Overall Study|Technical problems|1|||
149155060|NCT04179175|538045659|FG003|Overall Study|Technical problems|1|||
149155061|NCT04179175|538045660|FG004|Overall Study|Technical problems|0|||
149155062|NCT04179175|538045661|FG005|Overall Study|Technical problems|0|||
149155063|NCT01262365|538045662|FG000|Overall Study|Lack of Efficacy|35|||
149155064|NCT01262365|538045663|FG001|Overall Study|Lack of Efficacy|30|||
149155065|NCT01262365|538045664|FG002|Overall Study|Lack of Efficacy|47|||
149155066|NCT01262365|538045662|FG000|Overall Study|Protocol Violation|3|||
149155067|NCT01262365|538045663|FG001|Overall Study|Protocol Violation|1|||
149155068|NCT01262365|538045664|FG002|Overall Study|Protocol Violation|1|||
149155069|NCT01262365|538045662|FG000|Overall Study|Lost to Follow-up|3|||
149155070|NCT01262365|538045663|FG001|Overall Study|Lost to Follow-up|7|||
149155071|NCT01262365|538045664|FG002|Overall Study|Lost to Follow-up|6|||
149155072|NCT01262365|538045662|FG000|Overall Study|Withdrawal by Subject|17|||
149155073|NCT01262365|538045663|FG001|Overall Study|Withdrawal by Subject|22|||
149155074|NCT01262365|538045664|FG002|Overall Study|Withdrawal by Subject|22|||
149155075|NCT01262365|538045662|FG000|Overall Study|Death|1|||
149155076|NCT01262365|538045663|FG001|Overall Study|Death|2|||
149155077|NCT01262365|538045664|FG002|Overall Study|Death|1|||
149155078|NCT01262365|538045662|FG000|Overall Study|Adverse Event|26|||
149155079|NCT01262365|538045663|FG001|Overall Study|Adverse Event|16|||
149155080|NCT01262365|538045664|FG002|Overall Study|Adverse Event|11|||
149155081|NCT01262365|538045662|FG000|Overall Study|sponsor decision|1|||
149155082|NCT01262365|538045663|FG001|Overall Study|sponsor decision|1|||
149155083|NCT01262365|538045664|FG002|Overall Study|sponsor decision|0|||
149155084|NCT01262365|538045662|FG000|Overall Study|Randomization error|1|||
149155085|NCT01262365|538045663|FG001|Overall Study|Randomization error|0|||
149155086|NCT01262365|538045664|FG002|Overall Study|Randomization error|2|||
149155087|NCT01262365|538045662|FG000|Overall Study|Non-compliance|1|||
149155088|NCT01262365|538045663|FG001|Overall Study|Non-compliance|0|||
148920031|NCT02616146|537192054|FG001|Overall Study|Withdrawal by Subject|24|||
148920032|NCT02616146|537192053|FG000|Overall Study|Physician Decision|2|||
148920033|NCT02616146|537192054|FG001|Overall Study|Physician Decision|1|||
148920034|NCT03039621|537192055|FG000|Overall Study|Violation of inclusion criteria|3|||
148920035|NCT03039621|537192056|FG001|Overall Study|Violation of inclusion criteria|2|||
148920036|NCT03039621|537192055|FG000|Overall Study|Non-compliance with protocol requirement|4|||
148920037|NCT03039621|537192056|FG001|Overall Study|Non-compliance with protocol requirement|5|||
148920038|NCT03039621|537192055|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
148920039|NCT03039621|537192056|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
148920040|NCT03039621|537192055|FG000|Overall Study|Violation of non-inclusion criteria|1|||
148920041|NCT03039621|537192056|FG001|Overall Study|Violation of non-inclusion criteria|2|||
148920042|NCT01142089|537192059|FG000|Overall Study|Physician Decision|1|||
148920043|NCT01142089|537192060|FG001|Overall Study|Physician Decision|0|||
148920044|NCT01142089|537192059|FG000|Overall Study|Withdrawal by Subject|1|||
148920045|NCT01142089|537192060|FG001|Overall Study|Withdrawal by Subject|2|||
148920046|NCT01142089|537192059|FG000|Overall Study|Use of prohibited medications|0|||
148920047|NCT01142089|537192060|FG001|Overall Study|Use of prohibited medications|1|||
148920048|NCT01142089|537192059|FG000|Overall Study|Noncompliance with study procedures|2|||
149155089|NCT01262365|538045664|FG002|Overall Study|Non-compliance|2|||
149155090|NCT01262365|538045662|FG000|Overall Study|Suspected pregnancy|1|||
149155091|NCT01262365|538045663|FG001|Overall Study|Suspected pregnancy|0|||
149155092|NCT01262365|538045664|FG002|Overall Study|Suspected pregnancy|0|||
149155093|NCT01262365|538045662|FG000|Overall Study|Patient pregnant|1|||
149155094|NCT01262365|538045663|FG001|Overall Study|Patient pregnant|0|||
149155095|NCT01262365|538045664|FG002|Overall Study|Patient pregnant|1|||
149155096|NCT01262365|538045662|FG000|Overall Study|Toxicity related to study drug|0|||
149155097|NCT01262365|538045663|FG001|Overall Study|Toxicity related to study drug|1|||
149155098|NCT01262365|538045664|FG002|Overall Study|Toxicity related to study drug|0|||
149155099|NCT01262365|538045662|FG000|Overall Study|Cannot tolerate the protocol|0|||
149155100|NCT01262365|538045663|FG001|Overall Study|Cannot tolerate the protocol|1|||
149155101|NCT01262365|538045664|FG002|Overall Study|Cannot tolerate the protocol|0|||
149155102|NCT01262365|538045662|FG000|Overall Study|Patient unavailable|0|||
149155103|NCT01262365|538045663|FG001|Overall Study|Patient unavailable|0|||
149155104|NCT01262365|538045664|FG002|Overall Study|Patient unavailable|1|||
149155105|NCT00494091|538045665|FG000|Overall Study|Death|5|||
148920049|NCT01142089|537192060|FG001|Overall Study|Noncompliance with study procedures|1|||
148920050|NCT01142089|537192059|FG000|Overall Study|Patient required rescue medication|8|||
148920051|NCT01142089|537192060|FG001|Overall Study|Patient required rescue medication|17|||
148920052|NCT01974765|537192065|FG000|Overall Study|Withdrawal by Subject|1|||
148920053|NCT01974765|537192065|FG000|Overall Study|Death|1|||
148920054|NCT01974765|537192065|FG000|Overall Study|Adverse Event|2|||
148920055|NCT05338671|537192069|FG000|Overall Study|Lost to Follow-up|2|||
148920056|NCT05338671|537192070|FG001|Overall Study|Lost to Follow-up|2|||
148920057|NCT05338671|537192069|FG000|Overall Study|Root canal completed in a single visit|1|||
148920058|NCT05338671|537192070|FG001|Overall Study|Root canal completed in a single visit|0|||
148920059|NCT03085914|537192073|FG000|Overall Study|Death|6|||
148920060|NCT03085914|537192074|FG001|Overall Study|Death|6|||
148920061|NCT03085914|537192075|FG002|Overall Study|Death|4|||
148920062|NCT03085914|537192076|FG003|Overall Study|Death|1|||
148920063|NCT03085914|537192077|FG004|Overall Study|Death|5|||
148920064|NCT03085914|537192078|FG005|Overall Study|Death|2|||
148920065|NCT03085914|537192079|FG006|Overall Study|Death|2|||
148920066|NCT03085914|537192073|FG000|Overall Study|Withdrawal by Subject|1|||
148920067|NCT03085914|537192074|FG001|Overall Study|Withdrawal by Subject|1|||
148920068|NCT03085914|537192075|FG002|Overall Study|Withdrawal by Subject|2|||
148920069|NCT03085914|537192076|FG003|Overall Study|Withdrawal by Subject|2|||
148920070|NCT03085914|537192077|FG004|Overall Study|Withdrawal by Subject|2|||
148920071|NCT03085914|537192078|FG005|Overall Study|Withdrawal by Subject|0|||
148920072|NCT03085914|537192079|FG006|Overall Study|Withdrawal by Subject|1|||
148920073|NCT03085914|537192073|FG000|Overall Study|Lost to Follow-up|0|||
148920074|NCT03085914|537192074|FG001|Overall Study|Lost to Follow-up|0|||
148920075|NCT03085914|537192075|FG002|Overall Study|Lost to Follow-up|1|||
149155106|NCT00494091|538045666|FG001|Overall Study|Death|54|||
148920076|NCT03085914|537192076|FG003|Overall Study|Lost to Follow-up|0|||
148920077|NCT03085914|537192077|FG004|Overall Study|Lost to Follow-up|0|||
149155107|NCT00494091|538045665|FG000|Overall Study|Lost to Follow-up|0|||
149155108|NCT00494091|538045666|FG001|Overall Study|Lost to Follow-up|4|||
149155109|NCT00494091|538045665|FG000|Overall Study|Other|1|||
148920078|NCT03085914|537192078|FG005|Overall Study|Lost to Follow-up|1|||
148920079|NCT03085914|537192079|FG006|Overall Study|Lost to Follow-up|1|||
148920080|NCT03085914|537192073|FG000|Overall Study|Reason was not specified,|2|||
148920081|NCT03085914|537192074|FG001|Overall Study|Reason was not specified,|2|||
148920082|NCT03085914|537192075|FG002|Overall Study|Reason was not specified,|2|||
148920083|NCT03085914|537192076|FG003|Overall Study|Reason was not specified,|3|||
148920084|NCT03085914|537192077|FG004|Overall Study|Reason was not specified,|3|||
149155110|NCT00494091|538045666|FG001|Overall Study|Other|11|||
148920085|NCT03085914|537192078|FG005|Overall Study|Reason was not specified,|3|||
148920086|NCT03085914|537192079|FG006|Overall Study|Reason was not specified,|6|||
148920087|NCT03085914|537192073|FG000|Overall Study|Progressive Disease|0|||
148920088|NCT03085914|537192074|FG001|Overall Study|Progressive Disease|0|||
148920089|NCT03085914|537192075|FG002|Overall Study|Progressive Disease|2|||
148920090|NCT03085914|537192076|FG003|Overall Study|Progressive Disease|2|||
148920091|NCT03085914|537192077|FG004|Overall Study|Progressive Disease|1|||
148920092|NCT03085914|537192078|FG005|Overall Study|Progressive Disease|1|||
148920093|NCT03085914|537192079|FG006|Overall Study|Progressive Disease|1|||
148920094|NCT03085914|537192073|FG000|Overall Study|Study Terminated by the Sponsor|0|||
148920095|NCT03085914|537192074|FG001|Overall Study|Study Terminated by the Sponsor|0|||
148920096|NCT03085914|537192075|FG002|Overall Study|Study Terminated by the Sponsor|0|||
148920097|NCT03085914|537192076|FG003|Overall Study|Study Terminated by the Sponsor|1|||
148920098|NCT03085914|537192077|FG004|Overall Study|Study Terminated by the Sponsor|2|||
148920099|NCT03085914|537192078|FG005|Overall Study|Study Terminated by the Sponsor|1|||
148920100|NCT03085914|537192079|FG006|Overall Study|Study Terminated by the Sponsor|0|||
148920101|NCT01215916|537192080|FG000|Overall Study|Progressive Disease|0|||
148920102|NCT01215916|537192081|FG001|Overall Study|Progressive Disease|2|||
148920103|NCT01215916|537192082|FG002|Overall Study|Progressive Disease|1|||
148920104|NCT01215916|537192083|FG003|Overall Study|Progressive Disease|2|||
148920105|NCT01215916|537192084|FG004|Overall Study|Progressive Disease|5|||
148920106|NCT01215916|537192085|FG005|Overall Study|Progressive Disease|4|||
148920107|NCT01215916|537192086|FG006|Overall Study|Progressive Disease|5|||
148920108|NCT01215916|537192087|FG007|Overall Study|Progressive Disease|3|||
148920109|NCT01215916|537192088|FG008|Overall Study|Progressive Disease|1|||
148920110|NCT01215916|537192080|FG000|Overall Study|Adverse Event|1|||
148920111|NCT01215916|537192081|FG001|Overall Study|Adverse Event|1|||
148920112|NCT01215916|537192082|FG002|Overall Study|Adverse Event|0|||
148920113|NCT01215916|537192083|FG003|Overall Study|Adverse Event|1|||
148920114|NCT01215916|537192084|FG004|Overall Study|Adverse Event|0|||
148920115|NCT01215916|537192085|FG005|Overall Study|Adverse Event|0|||
148920116|NCT01215916|537192086|FG006|Overall Study|Adverse Event|3|||
148920117|NCT01215916|537192087|FG007|Overall Study|Adverse Event|0|||
148920118|NCT01215916|537192088|FG008|Overall Study|Adverse Event|0|||
148920119|NCT01215916|537192080|FG000|Overall Study|Withdrawal by Subject|0|||
148920120|NCT01215916|537192081|FG001|Overall Study|Withdrawal by Subject|1|||
148920121|NCT01215916|537192082|FG002|Overall Study|Withdrawal by Subject|1|||
148920122|NCT01215916|537192083|FG003|Overall Study|Withdrawal by Subject|2|||
148920123|NCT01215916|537192084|FG004|Overall Study|Withdrawal by Subject|0|||
148920124|NCT01215916|537192085|FG005|Overall Study|Withdrawal by Subject|0|||
148920125|NCT01215916|537192086|FG006|Overall Study|Withdrawal by Subject|1|||
148920126|NCT01215916|537192087|FG007|Overall Study|Withdrawal by Subject|0|||
148920127|NCT01215916|537192088|FG008|Overall Study|Withdrawal by Subject|0|||
148920128|NCT01215916|537192080|FG000|Overall Study|Death|0|||
148920129|NCT01215916|537192081|FG001|Overall Study|Death|1|||
148920130|NCT01215916|537192082|FG002|Overall Study|Death|0|||
148920131|NCT01215916|537192083|FG003|Overall Study|Death|0|||
148920132|NCT01215916|537192084|FG004|Overall Study|Death|1|||
148920133|NCT01215916|537192085|FG005|Overall Study|Death|0|||
148920134|NCT01215916|537192086|FG006|Overall Study|Death|0|||
148920135|NCT01215916|537192087|FG007|Overall Study|Death|0|||
148920136|NCT01215916|537192088|FG008|Overall Study|Death|1|||
148920137|NCT01215916|537192080|FG000|Overall Study|Physician Decision|0|||
148920138|NCT01215916|537192081|FG001|Overall Study|Physician Decision|0|||
148920139|NCT01215916|537192082|FG002|Overall Study|Physician Decision|1|||
148920140|NCT01215916|537192083|FG003|Overall Study|Physician Decision|1|||
148920141|NCT01215916|537192084|FG004|Overall Study|Physician Decision|0|||
148920142|NCT01215916|537192085|FG005|Overall Study|Physician Decision|0|||
148920143|NCT01215916|537192086|FG006|Overall Study|Physician Decision|0|||
148920144|NCT01215916|537192087|FG007|Overall Study|Physician Decision|0|||
148920145|NCT01215916|537192088|FG008|Overall Study|Physician Decision|0|||
148920146|NCT02353143|537192089|FG000|Overall Study|Withdrawal by Subject|1|||
148920147|NCT02353143|537192090|FG001|Overall Study|Withdrawal by Subject|0|||
148920148|NCT02353143|537192091|FG002|Overall Study|Withdrawal by Subject|0|||
148920149|NCT02353143|537192092|FG003|Overall Study|Withdrawal by Subject|0|||
148920150|NCT02353143|537192093|FG004|Overall Study|Withdrawal by Subject|1|||
148920151|NCT02353143|537192094|FG005|Overall Study|Withdrawal by Subject|0|||
148920152|NCT02353143|537192095|FG006|Overall Study|Withdrawal by Subject|0|||
148920153|NCT02353143|537192096|FG007|Overall Study|Withdrawal by Subject|1|||
148920154|NCT02353143|537192097|FG008|Overall Study|Withdrawal by Subject|1|||
148920155|NCT02353143|537192089|FG000|Overall Study|Lack of Efficacy|2|||
148920156|NCT02353143|537192090|FG001|Overall Study|Lack of Efficacy|1|||
148920157|NCT02353143|537192091|FG002|Overall Study|Lack of Efficacy|2|||
148920158|NCT02353143|537192092|FG003|Overall Study|Lack of Efficacy|4|||
148920159|NCT02353143|537192093|FG004|Overall Study|Lack of Efficacy|13|||
148920160|NCT02353143|537192094|FG005|Overall Study|Lack of Efficacy|2|||
148920161|NCT02353143|537192095|FG006|Overall Study|Lack of Efficacy|2|||
148920162|NCT02353143|537192096|FG007|Overall Study|Lack of Efficacy|2|||
148920163|NCT02353143|537192097|FG008|Overall Study|Lack of Efficacy|1|||
148920164|NCT02353143|537192089|FG000|Overall Study|reason not specified|1|||
148920165|NCT02353143|537192090|FG001|Overall Study|reason not specified|2|||
148920166|NCT02353143|537192091|FG002|Overall Study|reason not specified|0|||
148920167|NCT02353143|537192092|FG003|Overall Study|reason not specified|0|||
148920168|NCT02353143|537192093|FG004|Overall Study|reason not specified|6|||
148920169|NCT02353143|537192094|FG005|Overall Study|reason not specified|1|||
148920170|NCT02353143|537192095|FG006|Overall Study|reason not specified|0|||
148920171|NCT02353143|537192096|FG007|Overall Study|reason not specified|3|||
148920172|NCT02353143|537192097|FG008|Overall Study|reason not specified|1|||
148920173|NCT02353143|537192089|FG000|Overall Study|Physician Decision|0|||
148920174|NCT02353143|537192090|FG001|Overall Study|Physician Decision|4|||
148920175|NCT02353143|537192091|FG002|Overall Study|Physician Decision|2|||
148920176|NCT02353143|537192092|FG003|Overall Study|Physician Decision|3|||
148920177|NCT02353143|537192093|FG004|Overall Study|Physician Decision|4|||
148920178|NCT02353143|537192094|FG005|Overall Study|Physician Decision|0|||
148920179|NCT02353143|537192095|FG006|Overall Study|Physician Decision|1|||
148920180|NCT02353143|537192096|FG007|Overall Study|Physician Decision|2|||
148920181|NCT02353143|537192097|FG008|Overall Study|Physician Decision|0|||
148920182|NCT02353143|537192089|FG000|Overall Study|Adverse Event|0|||
148920183|NCT02353143|537192090|FG001|Overall Study|Adverse Event|0|||
148920184|NCT02353143|537192091|FG002|Overall Study|Adverse Event|1|||
148920185|NCT02353143|537192092|FG003|Overall Study|Adverse Event|0|||
148920186|NCT02353143|537192093|FG004|Overall Study|Adverse Event|1|||
148920187|NCT02353143|537192094|FG005|Overall Study|Adverse Event|1|||
149155111|NCT00494091|538045665|FG000|Overall Study|Withdrawal by Subject|0|||
149155112|NCT00494091|538045666|FG001|Overall Study|Withdrawal by Subject|7|||
149155113|NCT00130832|538045667|FG000|Overall Study|Adverse Event|1|||
149155114|NCT00130832|538045668|FG001|Overall Study|Adverse Event|1|||
149155115|NCT00130832|538045667|FG000|Overall Study|Lost to Follow-up|1|||
149155116|NCT00130832|538045668|FG001|Overall Study|Lost to Follow-up|2|||
149155117|NCT00130832|538045667|FG000|Overall Study|Protocol Violation|6|||
149155118|NCT00130832|538045668|FG001|Overall Study|Protocol Violation|8|||
149155119|NCT00130832|538045667|FG000|Overall Study|Withdrawal by Subject|6|||
149155120|NCT00130832|538045668|FG001|Overall Study|Withdrawal by Subject|1|||
149155121|NCT00130832|538045667|FG000|Overall Study|Moved|2|||
149155122|NCT00130832|538045668|FG001|Overall Study|Moved|2|||
149155123|NCT00130832|538045667|FG000|Overall Study|Other|0|||
149155124|NCT00130832|538045668|FG001|Overall Study|Other|3|||
149155125|NCT00984204|538045670|FG000|Overall Study|Death|1|||
149155126|NCT00984204|538045670|FG000|Overall Study|Lost to Follow-up|4|||
149155127|NCT00984204|538045670|FG000|Overall Study|Lack of Efficacy|10|||
149155128|NCT00559507|538045671|FG000|Overall Study|Not treated, patient ineligible|3|||
149155129|NCT04232696|538045672|FG000|Overall Study|Implant attempted but not completed|5|||
149155130|NCT04232696|538045673|FG001|Overall Study|Implant attempted but not completed|2|||
149155131|NCT04232696|538045672|FG000|Overall Study|Not satisfied with therapy outcome|0|||
149155132|NCT04232696|538045673|FG001|Overall Study|Not satisfied with therapy outcome|8|||
149155133|NCT04232696|538045672|FG000|Overall Study|Adverse Event|0|||
149155134|NCT04232696|538045673|FG001|Overall Study|Adverse Event|3|||
149155135|NCT04232696|538045672|FG000|Overall Study|Withdrawal by Subject|0|||
149155136|NCT04232696|538045673|FG001|Overall Study|Withdrawal by Subject|3|||
149155137|NCT04232696|538045672|FG000|Overall Study|Missed Visit|0|||
149155138|NCT04232696|538045673|FG001|Overall Study|Missed Visit|2|||
149155139|NCT04232696|538045672|FG000|Overall Study|Other reason|0|||
148920188|NCT02353143|537192095|FG006|Overall Study|Adverse Event|0|||
148920189|NCT02353143|537192096|FG007|Overall Study|Adverse Event|0|||
148920190|NCT02353143|537192097|FG008|Overall Study|Adverse Event|0|||
148920191|NCT02353143|537192089|FG000|Overall Study|patient receiving other treatment for AML|0|||
148920192|NCT02353143|537192090|FG001|Overall Study|patient receiving other treatment for AML|0|||
148920193|NCT02353143|537192091|FG002|Overall Study|patient receiving other treatment for AML|1|||
148920194|NCT02353143|537192092|FG003|Overall Study|patient receiving other treatment for AML|0|||
149155140|NCT04232696|538045673|FG001|Overall Study|Other reason|1|||
149155141|NCT02787863|538045674|FG000|Overall Study|Death|1|||
148920195|NCT02353143|537192093|FG004|Overall Study|patient receiving other treatment for AML|0|||
148920196|NCT02353143|537192094|FG005|Overall Study|patient receiving other treatment for AML|0|||
148920197|NCT02353143|537192095|FG006|Overall Study|patient receiving other treatment for AML|0|||
149155142|NCT02787863|538045675|FG001|Overall Study|Death|0|||
149155143|NCT02787863|538045676|FG002|Overall Study|Death|1|||
149155144|NCT02787863|538045677|FG003|Overall Study|Death|0|||
149155145|NCT02787863|538045678|FG004|Overall Study|Death|0|||
148920198|NCT02353143|537192096|FG007|Overall Study|patient receiving other treatment for AML|0|||
148920199|NCT02353143|537192097|FG008|Overall Study|patient receiving other treatment for AML|0|||
149155146|NCT02787863|538045679|FG005|Overall Study|Death|0|||
148920200|NCT02353143|537192089|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
148920201|NCT02353143|537192090|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
148920202|NCT02353143|537192091|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
148920203|NCT02353143|537192092|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
148920204|NCT02353143|537192093|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
148920205|NCT02353143|537192094|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
148920206|NCT02353143|537192095|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
148920207|NCT02353143|537192096|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
148920208|NCT02353143|537192097|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
148920209|NCT01029405|537192098|FG000|Overall Study|Withdrawal by Subject|0|||
148920210|NCT01029405|537192099|FG001|Overall Study|Withdrawal by Subject|1|||
148920211|NCT01029405|537192100|FG002|Overall Study|Withdrawal by Subject|2|||
148920212|NCT01029405|537192101|FG003|Overall Study|Withdrawal by Subject|0|||
148920213|NCT01029405|537192098|FG000|Overall Study|Protocol Violation|0|||
148920214|NCT01029405|537192099|FG001|Overall Study|Protocol Violation|0|||
148920215|NCT01029405|537192100|FG002|Overall Study|Protocol Violation|0|||
148920216|NCT01029405|537192101|FG003|Overall Study|Protocol Violation|1|||
148920217|NCT01029405|537192098|FG000|Overall Study|Adverse Event|0|||
148920218|NCT01029405|537192099|FG001|Overall Study|Adverse Event|0|||
148920219|NCT01029405|537192100|FG002|Overall Study|Adverse Event|1|||
148920220|NCT01029405|537192101|FG003|Overall Study|Adverse Event|1|||
148920221|NCT01029405|537192098|FG000|Overall Study|Lost to Follow-up|2|||
148920222|NCT01029405|537192099|FG001|Overall Study|Lost to Follow-up|1|||
148920223|NCT01029405|537192100|FG002|Overall Study|Lost to Follow-up|1|||
148920224|NCT01029405|537192101|FG003|Overall Study|Lost to Follow-up|2|||
148920225|NCT01029405|537192098|FG000|Overall Study|Other|0|||
148920226|NCT01029405|537192099|FG001|Overall Study|Other|1|||
148920227|NCT01029405|537192100|FG002|Overall Study|Other|0|||
148920228|NCT01029405|537192101|FG003|Overall Study|Other|1|||
148920229|NCT02108262|537192104|FG000|Overall Study|Non-compliance|0|||
148920230|NCT02108262|537192105|FG001|Overall Study|Non-compliance|2|||
148920231|NCT02108262|537192106|FG002|Overall Study|Non-compliance|1|||
148920232|NCT02108262|537192107|FG003|Overall Study|Non-compliance|1|||
148920233|NCT02108262|537192104|FG000|Overall Study|Randomized by error/screen failure|0|||
148920234|NCT02108262|537192105|FG001|Overall Study|Randomized by error/screen failure|0|||
148920235|NCT02108262|537192106|FG002|Overall Study|Randomized by error/screen failure|1|||
148920236|NCT02108262|537192107|FG003|Overall Study|Randomized by error/screen failure|0|||
148920237|NCT02108262|537192104|FG000|Overall Study|Distance to center|0|||
148920238|NCT02108262|537192105|FG001|Overall Study|Distance to center|1|||
148920239|NCT02108262|537192106|FG002|Overall Study|Distance to center|1|||
148920240|NCT02108262|537192107|FG003|Overall Study|Distance to center|0|||
148920241|NCT02108262|537192104|FG000|Overall Study|Adverse Event|0|||
148920242|NCT02108262|537192105|FG001|Overall Study|Adverse Event|11|||
148920243|NCT02108262|537192106|FG002|Overall Study|Adverse Event|6|||
148920244|NCT02108262|537192107|FG003|Overall Study|Adverse Event|12|||
148920245|NCT02108262|537192104|FG000|Overall Study|Death|0|||
148920246|NCT02108262|537192105|FG001|Overall Study|Death|2|||
148920247|NCT02108262|537192106|FG002|Overall Study|Death|2|||
148920248|NCT02108262|537192107|FG003|Overall Study|Death|1|||
148920249|NCT02108262|537192104|FG000|Overall Study|Lost to Follow-up|0|||
148920250|NCT02108262|537192105|FG001|Overall Study|Lost to Follow-up|0|||
148920251|NCT02108262|537192106|FG002|Overall Study|Lost to Follow-up|1|||
148920252|NCT02108262|537192107|FG003|Overall Study|Lost to Follow-up|0|||
148920253|NCT02108262|537192104|FG000|Overall Study|Physician Decision|0|||
148920254|NCT02108262|537192105|FG001|Overall Study|Physician Decision|0|||
148920255|NCT02108262|537192106|FG002|Overall Study|Physician Decision|2|||
148920256|NCT02108262|537192107|FG003|Overall Study|Physician Decision|0|||
148920257|NCT02108262|537192104|FG000|Overall Study|Withdrawal by Subject|0|||
148672805|NCT01036594|536272498|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
148672806|NCT01036594|536272499|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
148920258|NCT02108262|537192105|FG001|Overall Study|Withdrawal by Subject|7|||
148920259|NCT02108262|537192106|FG002|Overall Study|Withdrawal by Subject|3|||
148920260|NCT02108262|537192107|FG003|Overall Study|Withdrawal by Subject|4|||
148920261|NCT02108262|537192104|FG000|Overall Study|Due to key hepatic values|0|||
148920262|NCT02108262|537192105|FG001|Overall Study|Due to key hepatic values|1|||
148920263|NCT02108262|537192106|FG002|Overall Study|Due to key hepatic values|0|||
148920264|NCT02108262|537192107|FG003|Overall Study|Due to key hepatic values|0|||
148920265|NCT02108262|537192104|FG000|Overall Study|Unable to contact patient|0|||
148920266|NCT02108262|537192105|FG001|Overall Study|Unable to contact patient|3|||
148920267|NCT02108262|537192106|FG002|Overall Study|Unable to contact patient|1|||
148920268|NCT02108262|537192107|FG003|Overall Study|Unable to contact patient|2|||
148920269|NCT02108262|537192104|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
148920270|NCT02108262|537192105|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
148920271|NCT02108262|537192106|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
148920272|NCT02108262|537192107|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
148920273|NCT02108262|537192104|FG000|Overall Study|Patient did not want another infusion|0|||
148672807|NCT01036594|536272498|FG000|Week 12 Evaluation|Adverse Event|5|||
149155147|NCT02787863|538045680|FG006|Overall Study|Death|0|||
149155148|NCT02787863|538045681|FG007|Overall Study|Death|0|||
148920274|NCT02108262|537192105|FG001|Overall Study|Patient did not want another infusion|3|||
148920275|NCT02108262|537192106|FG002|Overall Study|Patient did not want another infusion|3|||
149155149|NCT02787863|538045674|FG000|Overall Study|Withdrawal by Subject|0|||
149155150|NCT02787863|538045675|FG001|Overall Study|Withdrawal by Subject|1|||
149155151|NCT02787863|538045676|FG002|Overall Study|Withdrawal by Subject|1|||
148920276|NCT02108262|537192107|FG003|Overall Study|Patient did not want another infusion|2|||
148920277|NCT02108262|537192104|FG000|Overall Study|Vacation|0|||
148920278|NCT02108262|537192105|FG001|Overall Study|Vacation|1|||
148920279|NCT02108262|537192106|FG002|Overall Study|Vacation|0|||
148920280|NCT02108262|537192107|FG003|Overall Study|Vacation|0|||
148920281|NCT02108262|537192104|FG000|Overall Study|Patient decision|0|||
148920282|NCT02108262|537192105|FG001|Overall Study|Patient decision|7|||
148920283|NCT02108262|537192106|FG002|Overall Study|Patient decision|9|||
148920284|NCT02108262|537192107|FG003|Overall Study|Patient decision|14|||
148920285|NCT02108262|537192104|FG000|Overall Study|Missed IV due to pharmacy error|0|||
148920286|NCT02108262|537192105|FG001|Overall Study|Missed IV due to pharmacy error|0|||
148920287|NCT02108262|537192106|FG002|Overall Study|Missed IV due to pharmacy error|1|||
148920288|NCT02108262|537192107|FG003|Overall Study|Missed IV due to pharmacy error|0|||
148920289|NCT00869778|537192111|FG000|Overall Study|Adverse Event|2|||
148920290|NCT00869778|537192112|FG001|Overall Study|Adverse Event|0|||
148920291|NCT00869778|537192113|FG002|Overall Study|Adverse Event|0|||
148920292|NCT00869778|537192111|FG000|Overall Study|Withdrawal by Subject|3|||
148920293|NCT00869778|537192112|FG001|Overall Study|Withdrawal by Subject|4|||
148920294|NCT00869778|537192113|FG002|Overall Study|Withdrawal by Subject|5|||
148920295|NCT00869778|537192111|FG000|Overall Study|Pregnancy|1|||
148920296|NCT00869778|537192112|FG001|Overall Study|Pregnancy|0|||
148920297|NCT00869778|537192113|FG002|Overall Study|Pregnancy|0|||
148920298|NCT00869778|537192111|FG000|Overall Study|Protocol Violation|5|||
148920299|NCT00869778|537192112|FG001|Overall Study|Protocol Violation|3|||
148920300|NCT00869778|537192113|FG002|Overall Study|Protocol Violation|5|||
148920301|NCT00869778|537192111|FG000|Overall Study|Unblinding|1|||
148920302|NCT00869778|537192112|FG001|Overall Study|Unblinding|0|||
148920303|NCT00869778|537192113|FG002|Overall Study|Unblinding|0|||
148920304|NCT01119937|537192116|FG000|Overall Study|Adverse Event|11|||
148920305|NCT01119937|537192117|FG001|Overall Study|Adverse Event|5|||
148920306|NCT01119937|537192116|FG000|Overall Study|Protocol deviation|3|||
148920307|NCT01119937|537192117|FG001|Overall Study|Protocol deviation|1|||
148920308|NCT01119937|537192116|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
148920309|NCT01119937|537192117|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148920310|NCT01119937|537192116|FG000|Overall Study|Withdrawal by Subject|2|||
148920311|NCT01119937|537192117|FG001|Overall Study|Withdrawal by Subject|1|||
148920312|NCT01270802|537192118|FG000|Overall Study|Withdrawal by Subject|1|||
149155152|NCT02787863|538045677|FG003|Overall Study|Withdrawal by Subject|0|||
149155153|NCT02787863|538045678|FG004|Overall Study|Withdrawal by Subject|0|||
149155154|NCT02787863|538045679|FG005|Overall Study|Withdrawal by Subject|0|||
149155155|NCT02787863|538045680|FG006|Overall Study|Withdrawal by Subject|0|||
149155156|NCT02787863|538045681|FG007|Overall Study|Withdrawal by Subject|0|||
149155157|NCT03118297|538045682|FG000|Overall Study|Lost to Follow-up|0|||
149155158|NCT03118297|538045683|FG001|Overall Study|Lost to Follow-up|2|||
149155159|NCT04227899|538045684|FG000|Overall Study|Withdrawal by Subject|6|||
149155160|NCT04227899|538045685|FG001|Overall Study|Withdrawal by Subject|3|||
149155161|NCT04227899|538045684|FG000|Overall Study|Death|12|||
149155162|NCT04227899|538045685|FG001|Overall Study|Death|6|||
149155163|NCT04227899|538045684|FG000|Overall Study|Lost to Follow-up|2|||
149155164|NCT04227899|538045685|FG001|Overall Study|Lost to Follow-up|1|||
149155165|NCT02162732|538045687|FG000|Overall Study|Biopsy not performed.|18|||
149155166|NCT04735653|538045688|FG000|Overall Study|Lost to Follow-up|17|||
149155167|NCT04735653|538045689|FG001|Overall Study|Lost to Follow-up|7|||
149155168|NCT04735653|538045688|FG000|Overall Study|Withdrawal by Subject|8|||
149155169|NCT04735653|538045689|FG001|Overall Study|Withdrawal by Subject|2|||
149155170|NCT04735653|538045688|FG000|Overall Study|Death|0|||
149155171|NCT04735653|538045689|FG001|Overall Study|Death|2|||
148920313|NCT01270802|537192119|FG001|Overall Study|Withdrawal by Subject|0|||
148920314|NCT01270802|537192118|FG000|Overall Study|Adverse Event|1|||
148920315|NCT01270802|537192119|FG001|Overall Study|Adverse Event|0|||
148920316|NCT01270802|537192118|FG000|Overall Study|Lost to Follow-up|0|||
148920317|NCT01270802|537192119|FG001|Overall Study|Lost to Follow-up|1|||
148920318|NCT00393510|537192120|FG000|Overall Study|Physician Decision|3|||
148920319|NCT00393510|537192121|FG001|Overall Study|Physician Decision|9|||
148920320|NCT01534182|537192125|FG000|Overall Study|Administrative problems|1|||
148920321|NCT01534182|537192126|FG001|Overall Study|Administrative problems|0|||
148920322|NCT01534182|537192125|FG000|Overall Study|Withdrawal by Subject|4|||
148920323|NCT01534182|537192126|FG001|Overall Study|Withdrawal by Subject|7|||
148920324|NCT01534182|537192125|FG000|Overall Study|Adverse Event|7|||
148920325|NCT01534182|537192126|FG001|Overall Study|Adverse Event|3|||
148920326|NCT03077087|537192127|FG000|Overall Study|Physician Decision|2|||
148920327|NCT00770146|537192128|FG000|Treatment Period|Withdrawal by Subject|6|||
148920328|NCT00770146|537192129|FG001|Treatment Period|Withdrawal by Subject|13|||
148920329|NCT00770146|537192128|FG000|Treatment Period|Adverse Event|2|||
148920330|NCT00770146|537192129|FG001|Treatment Period|Adverse Event|26|||
148920331|NCT00770146|537192128|FG000|Treatment Period|Other|1|||
148920332|NCT00770146|537192129|FG001|Treatment Period|Other|5|||
148920333|NCT00770146|537192128|FG000|Treatment Period|Protocol non-compliance|0|||
148920334|NCT00770146|537192129|FG001|Treatment Period|Protocol non-compliance|1|||
148920335|NCT00770146|537192128|FG000|Follow-up Period|Withdrawal by Subject|7|||
148920336|NCT00770146|537192129|FG001|Follow-up Period|Withdrawal by Subject|13|||
148920337|NCT00770146|537192128|FG000|Follow-up Period|Adverse Event|0|||
148920338|NCT00770146|537192129|FG001|Follow-up Period|Adverse Event|2|||
148920339|NCT00770146|537192128|FG000|Follow-up Period|Other|4|||
148920340|NCT00770146|537192129|FG001|Follow-up Period|Other|5|||
148920341|NCT02412488|537192132|FG000|Overall Study|Lost to Follow-up|10|||
148920342|NCT02412488|537192132|FG000|Overall Study|Withdrawal by Subject|5|||
148920343|NCT02412488|537192132|FG000|Overall Study|Physician Decision|1|||
148920344|NCT02412488|537192132|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
148920345|NCT02412488|537192132|FG000|Overall Study|Reveal LINQ explant|1|||
148920346|NCT01989468|537192133|FG000|Overall Study|Adverse Event|10|||
148920347|NCT01989468|537192134|FG001|Overall Study|Adverse Event|15|||
148920348|NCT01989468|537192135|FG002|Overall Study|Adverse Event|4|||
148920349|NCT01989468|537192136|FG003|Overall Study|Adverse Event|5|||
148920350|NCT01989468|537192137|FG004|Overall Study|Adverse Event|4|||
148920351|NCT01989468|537192133|FG000|Overall Study|Lack of Efficacy|11|||
148920352|NCT01989468|537192134|FG001|Overall Study|Lack of Efficacy|11|||
148920353|NCT01989468|537192135|FG002|Overall Study|Lack of Efficacy|7|||
149155172|NCT04735653|538045688|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
149155173|NCT04735653|538045689|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
149155174|NCT01100944|538045692|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
149155175|NCT01100944|538045693|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
149155176|NCT01100944|538045694|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
149155177|NCT01100944|538045692|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
149155178|NCT01100944|538045693|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
149155179|NCT01100944|538045694|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
149155180|NCT01100944|538045692|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
149155181|NCT01100944|538045693|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
149155182|NCT01100944|538045694|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
149155183|NCT01100944|538045692|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
149155184|NCT01100944|538045693|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
149155185|NCT01100944|538045694|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
149155186|NCT01639833|538045695|FG000|Overall Study|Death|4|||
149155187|NCT01639833|538045696|FG001|Overall Study|Death|2|||
149155188|NCT01639833|538045695|FG000|Overall Study|Withdrawal by Subject|2|||
149155189|NCT01639833|538045696|FG001|Overall Study|Withdrawal by Subject|2|||
149155190|NCT02064387|538045697|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155191|NCT02064387|538045698|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155192|NCT02064387|538045699|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155193|NCT02064387|538045700|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155194|NCT02064387|538045701|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155195|NCT02064387|538045702|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155196|NCT02064387|538045703|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155197|NCT02064387|538045704|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
149155198|NCT02064387|538045705|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155199|NCT02064387|538045706|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
148920354|NCT01989468|537192136|FG003|Overall Study|Lack of Efficacy|4|||
148920355|NCT01989468|537192137|FG004|Overall Study|Lack of Efficacy|2|||
148920356|NCT01989468|537192133|FG000|Overall Study|Lost to Follow-up|5|||
148920357|NCT01989468|537192134|FG001|Overall Study|Lost to Follow-up|2|||
148805929|NCT05911841|536768046|FG002|Induction Period|Adverse Event|2|||
148920358|NCT01989468|537192135|FG002|Overall Study|Lost to Follow-up|0|||
148805930|NCT05911841|536768047|FG003|Induction Period|Adverse Event|0|||
148672808|NCT01036594|536272499|FG001|Week 12 Evaluation|Adverse Event|0|||
148672809|NCT01036594|536272498|FG000|Week 12 Evaluation|Physician Decision|1|||
148920359|NCT01989468|537192136|FG003|Overall Study|Lost to Follow-up|1|||
148920360|NCT01989468|537192137|FG004|Overall Study|Lost to Follow-up|1|||
148920361|NCT01989468|537192133|FG000|Overall Study|Physician Decision|4|||
148920362|NCT01989468|537192134|FG001|Overall Study|Physician Decision|1|||
148920363|NCT01989468|537192135|FG002|Overall Study|Physician Decision|0|||
148920364|NCT01989468|537192136|FG003|Overall Study|Physician Decision|1|||
148920365|NCT01989468|537192137|FG004|Overall Study|Physician Decision|0|||
149155200|NCT02064387|538045707|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155201|NCT02064387|538045708|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
149155202|NCT02064387|538045697|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155203|NCT02064387|538045698|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155204|NCT02064387|538045699|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155205|NCT02064387|538045700|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155206|NCT02064387|538045701|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155207|NCT02064387|538045702|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
148672810|NCT01036594|536272499|FG001|Week 12 Evaluation|Physician Decision|0|||
148672811|NCT01036594|536272498|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
148672812|NCT01036594|536272499|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
148672813|NCT01036594|536272498|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
148920366|NCT01989468|537192133|FG000|Overall Study|Pregnancy|0|||
148920367|NCT01989468|537192134|FG001|Overall Study|Pregnancy|1|||
148920368|NCT01989468|537192135|FG002|Overall Study|Pregnancy|0|||
148920369|NCT01989468|537192136|FG003|Overall Study|Pregnancy|0|||
148920370|NCT01989468|537192137|FG004|Overall Study|Pregnancy|0|||
148920371|NCT01989468|537192133|FG000|Overall Study|Technical Problems|3|||
148920372|NCT01989468|537192134|FG001|Overall Study|Technical Problems|1|||
148920373|NCT01989468|537192135|FG002|Overall Study|Technical Problems|3|||
148920374|NCT01989468|537192136|FG003|Overall Study|Technical Problems|1|||
148920375|NCT01989468|537192137|FG004|Overall Study|Technical Problems|0|||
148920376|NCT01989468|537192133|FG000|Overall Study|Subject Guardian Decision|11|||
148920377|NCT01989468|537192134|FG001|Overall Study|Subject Guardian Decision|6|||
148920378|NCT01989468|537192135|FG002|Overall Study|Subject Guardian Decision|4|||
148672814|NCT01036594|536272499|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
148805931|NCT05911841|536768048|FG004|Induction Period|Adverse Event|0|||
148920379|NCT01989468|537192136|FG003|Overall Study|Subject Guardian Decision|4|||
148920380|NCT01989468|537192137|FG004|Overall Study|Subject Guardian Decision|1|||
148920381|NCT01989468|537192133|FG000|Overall Study|Death|3|||
148920382|NCT01989468|537192134|FG001|Overall Study|Death|0|||
148920383|NCT01989468|537192135|FG002|Overall Study|Death|1|||
148920384|NCT01989468|537192136|FG003|Overall Study|Death|0|||
148920385|NCT01989468|537192137|FG004|Overall Study|Death|0|||
148920386|NCT00674154|537192141|FG000|Overall Study|Withdrawal by Subject|3|||
148920387|NCT00674154|537192142|FG001|Overall Study|Withdrawal by Subject|1|||
148920388|NCT00674154|537192141|FG000|Overall Study|Did not want parathyroidectomy|0|||
148920389|NCT00674154|537192142|FG001|Overall Study|Did not want parathyroidectomy|2|||
148920390|NCT03222492|537192143|FG000|Overall Study|Withdrawal by Subject|0|||
148920391|NCT03222492|537192144|FG001|Overall Study|Withdrawal by Subject|0|||
148920392|NCT03222492|537192145|FG002|Overall Study|Withdrawal by Subject|1|||
148920393|NCT03222492|537192146|FG003|Overall Study|Withdrawal by Subject|0|||
148672815|NCT01036594|536272498|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
148672816|NCT01036594|536272499|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
148920394|NCT03222492|537192143|FG000|Overall Study|COVID-19 related|0|||
148920395|NCT03222492|537192144|FG001|Overall Study|COVID-19 related|0|||
148920396|NCT03222492|537192145|FG002|Overall Study|COVID-19 related|1|||
148920397|NCT03222492|537192146|FG003|Overall Study|COVID-19 related|0|||
148920398|NCT00816023|537192147|FG000|Overall Study|Lost to Follow-up|1|||
148920399|NCT00816023|537192148|FG001|Overall Study|Lost to Follow-up|1|||
148920400|NCT00816023|537192149|FG002|Overall Study|Lost to Follow-up|0|||
148805932|NCT05911841|536768049|FG005|Induction Period|Adverse Event|0|||
148920401|NCT00816023|537192150|FG003|Overall Study|Lost to Follow-up|0|||
148920402|NCT00816023|537192147|FG000|Overall Study|Withdrawal by Subject|1|||
148920403|NCT00816023|537192148|FG001|Overall Study|Withdrawal by Subject|0|||
148920404|NCT00816023|537192149|FG002|Overall Study|Withdrawal by Subject|0|||
148920405|NCT00816023|537192150|FG003|Overall Study|Withdrawal by Subject|0|||
148920406|NCT00816023|537192147|FG000|Overall Study|Physician Decision|0|||
148920407|NCT00816023|537192148|FG001|Overall Study|Physician Decision|0|||
148920408|NCT00816023|537192149|FG002|Overall Study|Physician Decision|1|||
148920409|NCT00816023|537192150|FG003|Overall Study|Physician Decision|0|||
148920410|NCT00816023|537192147|FG000|Overall Study|assessments complete prior to window|1|||
148920411|NCT00816023|537192148|FG001|Overall Study|assessments complete prior to window|1|||
148920412|NCT00816023|537192149|FG002|Overall Study|assessments complete prior to window|2|||
148920413|NCT00816023|537192150|FG003|Overall Study|assessments complete prior to window|1|||
148920414|NCT00816023|537192147|FG000|Overall Study|Randomized Not Treated|6|||
148920415|NCT00816023|537192148|FG001|Overall Study|Randomized Not Treated|4|||
148920416|NCT00816023|537192149|FG002|Overall Study|Randomized Not Treated|6|||
148920417|NCT00816023|537192150|FG003|Overall Study|Randomized Not Treated|11|||
148920418|NCT01525901|537192151|FG000|Period 2: 12 Weeks|Adverse Event|0|||
148920419|NCT01525901|537192152|FG001|Period 2: 12 Weeks|Adverse Event|1|||
148920420|NCT01525901|537192153|FG002|Period 2: 12 Weeks|Adverse Event|0|||
148920421|NCT01525901|537192154|FG003|Period 2: 12 Weeks|Adverse Event|0|||
148920422|NCT02025556|537192160|FG000|Overall Study|Adverse Event|0|||
148920423|NCT02025556|537192161|FG001|Overall Study|Adverse Event|4|||
148920424|NCT02025556|537192162|FG002|Overall Study|Adverse Event|2|||
148920425|NCT02025556|537192160|FG000|Overall Study|Lack of Efficacy|2|||
148920426|NCT02025556|537192161|FG001|Overall Study|Lack of Efficacy|1|||
148920427|NCT02025556|537192162|FG002|Overall Study|Lack of Efficacy|0|||
148920428|NCT02025556|537192160|FG000|Overall Study|Protocol Violation|2|||
148920429|NCT02025556|537192161|FG001|Overall Study|Protocol Violation|1|||
148920430|NCT02025556|537192162|FG002|Overall Study|Protocol Violation|0|||
148920431|NCT02025556|537192160|FG000|Overall Study|Withdrawal by Subject|0|||
148920432|NCT02025556|537192161|FG001|Overall Study|Withdrawal by Subject|3|||
148920433|NCT02025556|537192162|FG002|Overall Study|Withdrawal by Subject|6|||
148920434|NCT02025556|537192160|FG000|Overall Study|Lost to Follow-up|2|||
148920435|NCT02025556|537192161|FG001|Overall Study|Lost to Follow-up|4|||
148920436|NCT02025556|537192162|FG002|Overall Study|Lost to Follow-up|0|||
148920437|NCT02025556|537192160|FG000|Overall Study|Reason not reported|0|||
148920438|NCT02025556|537192161|FG001|Overall Study|Reason not reported|0|||
148920439|NCT02025556|537192162|FG002|Overall Study|Reason not reported|1|||
148920440|NCT02112045|537192165|FG000|Overall Study|Withdrawal by Subject|1|||
148920441|NCT02112045|537192166|FG001|Overall Study|Withdrawal by Subject|0|||
148920442|NCT00627445|537192167|FG000|Overall Study|Adverse Event|3|||
148920443|NCT00627445|537192168|FG001|Overall Study|Adverse Event|3|||
148920444|NCT00627445|537192167|FG000|Overall Study|Lack of Efficacy|0|||
148920445|NCT00627445|537192168|FG001|Overall Study|Lack of Efficacy|1|||
148920446|NCT00627445|537192167|FG000|Overall Study|Other|6|||
148920447|NCT00627445|537192168|FG001|Overall Study|Other|8|||
148920448|NCT00247611|537192172|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
148920449|NCT00247611|537192173|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
148920450|NCT00247611|537192172|FG000|Baselined|Completed baseline only|9|||
148920451|NCT00247611|537192173|FG001|Baselined|Completed baseline only|8|||
148920452|NCT05395091|537192174|FG000|Baseline to Month 12|Adverse Event|7|||
148920453|NCT05395091|537192175|FG001|Baseline to Month 12|Adverse Event|2|||
148920454|NCT05395091|537192176|FG002|Baseline to Month 12|Adverse Event|0|||
148920455|NCT05395091|537192174|FG000|Baseline to Month 12|Death|3|||
148920456|NCT05395091|537192175|FG001|Baseline to Month 12|Death|1|||
148920457|NCT05395091|537192176|FG002|Baseline to Month 12|Death|0|||
148920458|NCT05395091|537192174|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
148920459|NCT05395091|537192175|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
148920460|NCT05395091|537192176|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
148920461|NCT05395091|537192174|FG000|Baseline to Month 12|Protocol Violation|2|||
148920462|NCT05395091|537192175|FG001|Baseline to Month 12|Protocol Violation|3|||
148920463|NCT05395091|537192176|FG002|Baseline to Month 12|Protocol Violation|0|||
148920464|NCT05395091|537192174|FG000|Baseline to Month 12|Physician Decision|1|||
148920465|NCT05395091|537192175|FG001|Baseline to Month 12|Physician Decision|0|||
148920466|NCT05395091|537192176|FG002|Baseline to Month 12|Physician Decision|0|||
148920467|NCT05395091|537192174|FG000|Month 12 to Month 18|Death|1|||
148920468|NCT05395091|537192175|FG001|Month 12 to Month 18|Death|0|||
148920469|NCT05395091|537192176|FG002|Month 12 to Month 18|Death|0|||
148920470|NCT05395091|537192174|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
148920471|NCT05395091|537192175|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
148920472|NCT05395091|537192176|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
148920473|NCT05395091|537192174|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
148920474|NCT05395091|537192175|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
148920475|NCT05395091|537192176|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
148920476|NCT05395091|537192174|FG000|Month 12 to Month 18|Other reasons|0|||
148920477|NCT05395091|537192175|FG001|Month 12 to Month 18|Other reasons|0|||
148920478|NCT05395091|537192176|FG002|Month 12 to Month 18|Other reasons|1|||
148920479|NCT01433250|537192180|FG000|Overall Study|Protocol Violation|0|||
148920480|NCT01433250|537192181|FG001|Overall Study|Protocol Violation|1|||
148920481|NCT01433250|537192180|FG000|Overall Study|Withdrawal by Subject|3|||
148920482|NCT01433250|537192181|FG001|Overall Study|Withdrawal by Subject|2|||
148920483|NCT03148691|537192182|FG000|Overall Study|Protocol Violation|1|||
148920484|NCT03148691|537192183|FG001|Overall Study|Protocol Violation|2|||
148920485|NCT03148691|537192184|FG002|Overall Study|Protocol Violation|7|||
148920486|NCT03148691|537192182|FG000|Overall Study|Lost to Follow-up|0|||
148920487|NCT03148691|537192183|FG001|Overall Study|Lost to Follow-up|0|||
148920488|NCT03148691|537192184|FG002|Overall Study|Lost to Follow-up|1|||
148920489|NCT03148691|537192182|FG000|Overall Study|Other|1|||
148920490|NCT03148691|537192183|FG001|Overall Study|Other|0|||
148920491|NCT03148691|537192184|FG002|Overall Study|Other|0|||
148920492|NCT03148691|537192182|FG000|Overall Study|Withdrawal by Subject|1|||
148920493|NCT03148691|537192183|FG001|Overall Study|Withdrawal by Subject|0|||
148920494|NCT03148691|537192184|FG002|Overall Study|Withdrawal by Subject|0|||
148920495|NCT04345367|537192185|FG000|Overall Study|Other|3|||
148920496|NCT04345367|537192186|FG001|Overall Study|Other|4|||
148920497|NCT04345367|537192185|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
148920498|NCT04345367|537192186|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
148920499|NCT04345367|537192185|FG000|Overall Study|Withdrawal by Subject|11|||
148920500|NCT04345367|537192186|FG001|Overall Study|Withdrawal by Subject|11|||
148920501|NCT04345367|537192185|FG000|Overall Study|Protocol Violation|4|||
148920502|NCT04345367|537192186|FG001|Overall Study|Protocol Violation|3|||
148920503|NCT04345367|537192185|FG000|Overall Study|Lost to Follow-up|2|||
148920504|NCT04345367|537192186|FG001|Overall Study|Lost to Follow-up|4|||
148920505|NCT04345367|537192185|FG000|Overall Study|Lack of Efficacy|2|||
148920506|NCT04345367|537192186|FG001|Overall Study|Lack of Efficacy|0|||
148920507|NCT04345367|537192185|FG000|Overall Study|Death|2|||
148920508|NCT04345367|537192186|FG001|Overall Study|Death|0|||
148920509|NCT04345367|537192185|FG000|Overall Study|Adverse Event|10|||
148920510|NCT04345367|537192186|FG001|Overall Study|Adverse Event|9|||
148920511|NCT02576145|537192192|FG000|Overall Study|Adverse Event|1|||
148920512|NCT02576145|537192193|FG001|Overall Study|Adverse Event|0|||
148920513|NCT02576145|537192192|FG000|Overall Study|Withdrawal by Subject|1|||
148920514|NCT02576145|537192193|FG001|Overall Study|Withdrawal by Subject|0|||
148920515|NCT02576145|537192192|FG000|Overall Study|Acute rejection|1|||
148920516|NCT02576145|537192193|FG001|Overall Study|Acute rejection|0|||
148920517|NCT02576145|537192192|FG000|Overall Study|Tetanus Titers Decreased|0|||
148920518|NCT02576145|537192193|FG001|Overall Study|Tetanus Titers Decreased|1|||
148920519|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
148920520|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
148920521|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
148920522|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
148920523|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
148920524|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
148920525|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
148920526|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
148920527|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
148920528|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
148920529|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
148920530|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
148920531|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
148920532|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
148920533|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
148920534|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
148920535|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
148920536|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
148920537|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
148920538|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
148920539|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
148920540|NCT01227824|537192194|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
148920541|NCT01227824|537192195|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
148920542|NCT01227824|537192196|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
148920543|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
148920544|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
148920545|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
148920546|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
148920547|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
148920548|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
148920549|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
148920550|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
148920551|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
148920552|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
148920553|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
148920554|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
148920555|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
148920556|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
148920557|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
148920558|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
148920559|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
148920560|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
148920561|NCT01227824|537192194|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
148920562|NCT01227824|537192195|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
148920563|NCT01227824|537192196|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
148920564|NCT00781885|537192197|FG000|Overall Study|Physician Decision|1|||
148920565|NCT01755026|537192198|FG000|Overall Study|Adverse Event|1|||
148920566|NCT01755026|537192199|FG001|Overall Study|Adverse Event|0|||
148920567|NCT01755026|537192198|FG000|Overall Study|Withdrawal by Subject|1|||
148920568|NCT01755026|537192199|FG001|Overall Study|Withdrawal by Subject|1|||
148920569|NCT01700387|537192202|FG000|Overall Study|Withdrawal by Subject|1|||
148920570|NCT01700387|537192203|FG001|Overall Study|Withdrawal by Subject|2|||
148920571|NCT01700387|537192202|FG000|Overall Study|Adverse Event|1|||
148920572|NCT01700387|537192203|FG001|Overall Study|Adverse Event|1|||
148920573|NCT01700387|537192202|FG000|Overall Study|Lost to Follow-up|2|||
148920574|NCT01700387|537192203|FG001|Overall Study|Lost to Follow-up|1|||
148920575|NCT02730793|537192211|FG000|Overall Study|Physician Decision|0|||
148920576|NCT02730793|537192212|FG001|Overall Study|Physician Decision|1|||
148920577|NCT02730793|537192211|FG000|Overall Study|Withdrawal by Subject|0|||
148920578|NCT02730793|537192212|FG001|Overall Study|Withdrawal by Subject|1|||
148920579|NCT02365233|537192213|FG000|Overall Study|IRB withheld the data|1|||
148920580|NCT02365233|537192214|FG001|Overall Study|IRB withheld the data|2|||
148920581|NCT02365233|537192215|FG002|Overall Study|IRB withheld the data|2|||
148920582|NCT00995566|537192216|FG000|Overall Study|Adverse Event|2|||
148920583|NCT00995566|537192216|FG000|Overall Study|Early study termination|52|||
148920584|NCT00545129|537192217|FG000|Overall Study|Lack of Efficacy|2|||
148920585|NCT00545129|537192218|FG001|Overall Study|Lack of Efficacy|5|||
148920586|NCT00545129|537192217|FG000|Overall Study|Death|2|||
148920587|NCT00545129|537192218|FG001|Overall Study|Death|1|||
148920588|NCT00545129|537192217|FG000|Overall Study|Adverse Event|1|||
148920589|NCT00545129|537192218|FG001|Overall Study|Adverse Event|1|||
148920590|NCT00545129|537192217|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
148920591|NCT00545129|537192218|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
148920592|NCT00545129|537192217|FG000|Overall Study|Other|3|||
148920593|NCT00545129|537192218|FG001|Overall Study|Other|3|||
148920594|NCT03678870|537192219|FG000|Overall Study|prescribed non- protocol medications|10|||
148920595|NCT03678870|537192220|FG001|Overall Study|prescribed non- protocol medications|6|||
148920596|NCT03678870|537192219|FG000|Overall Study|Lost to Follow-up|3|||
148920597|NCT03678870|537192220|FG001|Overall Study|Lost to Follow-up|2|||
148920598|NCT01454778|537192221|FG000|Overall Study|Lost to Follow-up|2|||
148920599|NCT01454778|537192221|FG000|Overall Study|Death|1|||
148920600|NCT00348881|537192222|FG000|Overall Study|Lost to Follow-up|12|||
148920601|NCT00348881|537192223|FG001|Overall Study|Lost to Follow-up|6|||
148920602|NCT00348881|537192222|FG000|Overall Study|Withdrawal by Subject|3|||
148920603|NCT00348881|537192223|FG001|Overall Study|Withdrawal by Subject|4|||
149155208|NCT02064387|538045703|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
148920604|NCT00348881|537192222|FG000|Overall Study|Adverse Event|2|||
149155209|NCT02064387|538045704|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
149155210|NCT02064387|538045705|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
148920605|NCT00348881|537192223|FG001|Overall Study|Adverse Event|0|||
148920606|NCT00348881|537192222|FG000|Overall Study|Serious Adverse Event|0|||
148920607|NCT00348881|537192223|FG001|Overall Study|Serious Adverse Event|2|||
148920608|NCT01981551|537192230|FG000|Overall Study|Refused further treatment|8|||
148920609|NCT01981551|537192230|FG000|Overall Study|Adverse Event|1|||
148920610|NCT02880956|537192231|FG000|Overall Study|Adverse Event|3|||
148920611|NCT02880956|537192232|FG001|Overall Study|Adverse Event|6|||
148920612|NCT02880956|537192233|FG002|Overall Study|Adverse Event|5|||
149155211|NCT02064387|538045706|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155212|NCT02064387|538045707|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155213|NCT02064387|538045708|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
149155214|NCT02064387|538045697|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
148920613|NCT02880956|537192234|FG003|Overall Study|Adverse Event|4|||
148920614|NCT02880956|537192231|FG000|Overall Study|Withdrawal by Subject|9|||
148920615|NCT02880956|537192232|FG001|Overall Study|Withdrawal by Subject|4|||
148920616|NCT02880956|537192233|FG002|Overall Study|Withdrawal by Subject|6|||
148920617|NCT02880956|537192234|FG003|Overall Study|Withdrawal by Subject|11|||
148920618|NCT02880956|537192231|FG000|Overall Study|Lost to Follow-up|0|||
148920619|NCT02880956|537192232|FG001|Overall Study|Lost to Follow-up|1|||
148920620|NCT02880956|537192233|FG002|Overall Study|Lost to Follow-up|0|||
148920621|NCT02880956|537192234|FG003|Overall Study|Lost to Follow-up|0|||
148672817|NCT01036594|536272498|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
148672818|NCT01036594|536272499|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
148805933|NCT05911841|536768050|FG006|Induction Period|Adverse Event|0|||
148920622|NCT02880956|537192231|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
148920623|NCT02880956|537192232|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
148920624|NCT02880956|537192233|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
148920625|NCT02880956|537192234|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
148920626|NCT02880956|537192231|FG000|Overall Study|Other, Not Specified|4|||
148920627|NCT02880956|537192232|FG001|Overall Study|Other, Not Specified|2|||
148920628|NCT02880956|537192233|FG002|Overall Study|Other, Not Specified|0|||
148920629|NCT02880956|537192234|FG003|Overall Study|Other, Not Specified|3|||
148920630|NCT02055365|537193945|FG000|Overall Study|Prematurely Withdrawn|1|||
148920631|NCT00002931|537193948|FG000|Overall Study|rapidly progressing disease during|2|||
148920632|NCT05027971|537193949|FG000|Overall Study|Physician Decision|7|||
148920633|NCT05027971|537193950|FG001|Overall Study|Physician Decision|3|||
148920634|NCT05027971|537193949|FG000|Overall Study|Lost to Follow-up|1|||
148920635|NCT05027971|537193950|FG001|Overall Study|Lost to Follow-up|1|||
148920636|NCT05027971|537193949|FG000|Overall Study|Withdrawal by Subject|0|||
148920637|NCT05027971|537193950|FG001|Overall Study|Withdrawal by Subject|2|||
148920638|NCT05027971|537193949|FG000|Overall Study|Non-study fiber used.|0|||
148920639|NCT05027971|537193950|FG001|Overall Study|Non-study fiber used.|1|||
148920640|NCT05027971|537193949|FG000|Overall Study|Protocol Violation|0|||
148920641|NCT05027971|537193950|FG001|Overall Study|Protocol Violation|2|||
148920642|NCT02486627|537193952|FG000|Overall Study|Death|1|||
148920643|NCT02486627|537193953|FG001|Overall Study|Death|0|||
148920644|NCT02486627|537193952|FG000|Overall Study|Other Unspecified|0|||
148920645|NCT02486627|537193953|FG001|Overall Study|Other Unspecified|2|||
148920646|NCT02486627|537193952|FG000|Overall Study|Consent Withdrawn by Participant|4|||
148920647|NCT02486627|537193953|FG001|Overall Study|Consent Withdrawn by Participant|3|||
148920648|NCT02486627|537193952|FG000|Overall Study|Significant Participant Noncompliance|1|||
148920649|NCT02486627|537193953|FG001|Overall Study|Significant Participant Noncompliance|1|||
148920650|NCT02486627|537193952|FG000|Overall Study|Lost to Follow-up|1|||
148920651|NCT02486627|537193953|FG001|Overall Study|Lost to Follow-up|3|||
148920652|NCT01238588|537193957|FG000|Overall Study|Withdrawal by Subject|1|||
148920653|NCT01238588|537193957|FG000|Overall Study|Physician Decision|2|||
148920654|NCT01509053|537193959|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
148920655|NCT01509053|537193959|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
148920656|NCT01509053|537193959|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
148920657|NCT01509053|537193959|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
148920658|NCT01509053|537193959|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
148672819|NCT01036594|536272498|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
148805934|NCT05911841|536768051|FG007|Induction Period|Adverse Event|0|||
148920659|NCT01509053|537193959|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
148920660|NCT01915303|537193962|FG000|Core Phase|Adverse Event|7|||
148920661|NCT01915303|537193962|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
148920662|NCT01915303|537193962|FG000|Core Phase|Death|2|||
148920663|NCT01915303|537193962|FG000|Core Phase|Protocol Violation|2|||
148920664|NCT01915303|537193962|FG000|Core Phase|Abnormal lab value|1|||
148920665|NCT01915303|537193962|FG000|Core Phase|Withdrawal by Subject|1|||
148920666|NCT01915303|537193962|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
148920667|NCT01915303|537193962|FG000|Extension Phase|Withdrawal by Subject|4|||
148920668|NCT01915303|537193962|FG000|Extension Phase|Adverse Event|3|||
148920669|NCT01915303|537193962|FG000|Extension Phase|Death|1|||
148920670|NCT01915303|537193962|FG000|Extension Phase|Protocol Violation|1|||
148920671|NCT00796991|537193968|FG000|Overall Study|Adverse Event|0|||
148920672|NCT00796991|537193969|FG001|Overall Study|Adverse Event|0|||
148920673|NCT00796991|537193970|FG002|Overall Study|Adverse Event|1|||
148920674|NCT00796991|537193968|FG000|Overall Study|Death|2|||
148920675|NCT00796991|537193969|FG001|Overall Study|Death|0|||
148920676|NCT00796991|537193970|FG002|Overall Study|Death|0|||
148920677|NCT00796991|537193968|FG000|Overall Study|Disease Progression|10|||
148920678|NCT00796991|537193969|FG001|Overall Study|Disease Progression|9|||
148920679|NCT00796991|537193970|FG002|Overall Study|Disease Progression|7|||
148920680|NCT00796991|537193968|FG000|Overall Study|Study Drug Toxicity|3|||
148920681|NCT00796991|537193969|FG001|Overall Study|Study Drug Toxicity|3|||
148920682|NCT00796991|537193970|FG002|Overall Study|Study Drug Toxicity|5|||
148920683|NCT00796991|537193968|FG000|Overall Study|Withdrawal by Subject|0|||
148920684|NCT00796991|537193969|FG001|Overall Study|Withdrawal by Subject|0|||
148920685|NCT00796991|537193970|FG002|Overall Study|Withdrawal by Subject|1|||
148920686|NCT00171834|537193971|FG000|Overall Study|Adverse Event|2|||
148920687|NCT00171834|537193972|FG001|Overall Study|Adverse Event|1|||
148920688|NCT00171834|537193973|FG002|Overall Study|Adverse Event|3|||
148920689|NCT00171834|537193974|FG003|Overall Study|Adverse Event|2|||
148920690|NCT00171834|537193975|FG004|Overall Study|Adverse Event|2|||
148920691|NCT00171834|537193976|FG005|Overall Study|Adverse Event|15|||
148920692|NCT00171834|537193977|FG006|Overall Study|Adverse Event|1|||
148920693|NCT00171834|537193971|FG000|Overall Study|Withdrawal by Subject|0|||
148920694|NCT00171834|537193972|FG001|Overall Study|Withdrawal by Subject|2|||
148920695|NCT00171834|537193973|FG002|Overall Study|Withdrawal by Subject|0|||
148920696|NCT00171834|537193974|FG003|Overall Study|Withdrawal by Subject|1|||
148920697|NCT00171834|537193975|FG004|Overall Study|Withdrawal by Subject|1|||
148920698|NCT00171834|537193976|FG005|Overall Study|Withdrawal by Subject|1|||
148920699|NCT00171834|537193977|FG006|Overall Study|Withdrawal by Subject|0|||
148920700|NCT00171834|537193971|FG000|Overall Study|Death from study indication|0|||
148920701|NCT00171834|537193972|FG001|Overall Study|Death from study indication|1|||
148920702|NCT00171834|537193973|FG002|Overall Study|Death from study indication|0|||
148920703|NCT00171834|537193974|FG003|Overall Study|Death from study indication|0|||
148920704|NCT00171834|537193975|FG004|Overall Study|Death from study indication|1|||
148920705|NCT00171834|537193976|FG005|Overall Study|Death from study indication|0|||
148920706|NCT00171834|537193977|FG006|Overall Study|Death from study indication|0|||
148920707|NCT00171834|537193971|FG000|Overall Study|Disease Progression|4|||
148920708|NCT00171834|537193972|FG001|Overall Study|Disease Progression|8|||
148920709|NCT00171834|537193973|FG002|Overall Study|Disease Progression|8|||
148920710|NCT00171834|537193974|FG003|Overall Study|Disease Progression|9|||
148920711|NCT00171834|537193975|FG004|Overall Study|Disease Progression|2|||
148920712|NCT00171834|537193976|FG005|Overall Study|Disease Progression|18|||
148920713|NCT00171834|537193977|FG006|Overall Study|Disease Progression|3|||
148920714|NCT00171834|537193971|FG000|Overall Study|Treatment Duration Completed|0|||
148920715|NCT00171834|537193972|FG001|Overall Study|Treatment Duration Completed|0|||
148920716|NCT00171834|537193973|FG002|Overall Study|Treatment Duration Completed|1|||
148920717|NCT00171834|537193974|FG003|Overall Study|Treatment Duration Completed|0|||
148920718|NCT00171834|537193975|FG004|Overall Study|Treatment Duration Completed|2|||
148920719|NCT00171834|537193976|FG005|Overall Study|Treatment Duration Completed|1|||
148920720|NCT00171834|537193977|FG006|Overall Study|Treatment Duration Completed|0|||
148920721|NCT00834080|537193978|FG000|Overall Study|Adverse Event|7|||
148920722|NCT00834080|537193978|FG000|Overall Study|Lost to Follow-up|7|||
148920723|NCT00834080|537193978|FG000|Overall Study|Withdrawal by Subject|5|||
148920724|NCT00834080|537193978|FG000|Overall Study|Other - Pregnancy|1|||
148920725|NCT00834080|537193978|FG000|Overall Study|Other - False positive tests of the UDS|1|||
148920726|NCT00834080|537193978|FG000|Overall Study|Physician Decision|1|||
148920727|NCT00834080|537193978|FG000|Overall Study|Subject Relocated|1|||
148920728|NCT00796523|537193982|FG000|Overall Study|Lost to Follow-up|9|||
148920729|NCT00796523|537193983|FG001|Overall Study|Lost to Follow-up|7|||
148920730|NCT02431260|537193985|FG000|Overall Study|Subject Decision|0|||
148920731|NCT02431260|537193986|FG001|Overall Study|Subject Decision|1|||
148920732|NCT02431260|537193987|FG002|Overall Study|Subject Decision|1|||
148920733|NCT02431260|537193988|FG003|Overall Study|Subject Decision|0|||
148920734|NCT02431260|537193989|FG004|Overall Study|Subject Decision|0|||
148920735|NCT02431260|537193990|FG005|Overall Study|Subject Decision|0|||
148920736|NCT02431260|537193991|FG006|Overall Study|Subject Decision|0|||
148920737|NCT02431260|537193992|FG007|Overall Study|Subject Decision|0|||
148920738|NCT02431260|537193993|FG008|Overall Study|Subject Decision|1|||
148920739|NCT02431260|537193994|FG009|Overall Study|Subject Decision|1|||
148920740|NCT02431260|537193995|FG010|Overall Study|Subject Decision|0|||
148920741|NCT02431260|537193996|FG011|Overall Study|Subject Decision|1|||
148920742|NCT02431260|537193997|FG012|Overall Study|Subject Decision|0|||
148920743|NCT02431260|537193998|FG013|Overall Study|Subject Decision|0|||
148920744|NCT02431260|537193985|FG000|Overall Study|Death|4|||
148920745|NCT02431260|537193986|FG001|Overall Study|Death|4|||
148920746|NCT02431260|537193987|FG002|Overall Study|Death|3|||
148920747|NCT02431260|537193988|FG003|Overall Study|Death|4|||
148920748|NCT02431260|537193989|FG004|Overall Study|Death|2|||
148920749|NCT02431260|537193990|FG005|Overall Study|Death|2|||
148920750|NCT02431260|537193991|FG006|Overall Study|Death|3|||
148920751|NCT02431260|537193992|FG007|Overall Study|Death|1|||
148920752|NCT02431260|537193993|FG008|Overall Study|Death|6|||
148920753|NCT02431260|537193994|FG009|Overall Study|Death|6|||
148920754|NCT02431260|537193995|FG010|Overall Study|Death|3|||
148920755|NCT02431260|537193996|FG011|Overall Study|Death|2|||
148920756|NCT02431260|537193997|FG012|Overall Study|Death|5|||
148920757|NCT02431260|537193998|FG013|Overall Study|Death|1|||
148920758|NCT02431260|537193985|FG000|Overall Study|Lost to Follow-up|0|||
148920759|NCT02431260|537193986|FG001|Overall Study|Lost to Follow-up|0|||
148920760|NCT02431260|537193987|FG002|Overall Study|Lost to Follow-up|0|||
148920761|NCT02431260|537193988|FG003|Overall Study|Lost to Follow-up|0|||
148920762|NCT02431260|537193989|FG004|Overall Study|Lost to Follow-up|0|||
148920763|NCT02431260|537193990|FG005|Overall Study|Lost to Follow-up|1|||
148920764|NCT02431260|537193991|FG006|Overall Study|Lost to Follow-up|0|||
148920765|NCT02431260|537193992|FG007|Overall Study|Lost to Follow-up|0|||
148920766|NCT02431260|537193993|FG008|Overall Study|Lost to Follow-up|0|||
148920767|NCT02431260|537193994|FG009|Overall Study|Lost to Follow-up|0|||
148920768|NCT02431260|537193995|FG010|Overall Study|Lost to Follow-up|0|||
148920769|NCT02431260|537193996|FG011|Overall Study|Lost to Follow-up|0|||
148920770|NCT02431260|537193997|FG012|Overall Study|Lost to Follow-up|0|||
148920771|NCT02431260|537193998|FG013|Overall Study|Lost to Follow-up|0|||
148920772|NCT02431260|537193985|FG000|Overall Study|Study Terminated by the Sponsor|0|||
148920773|NCT02431260|537193986|FG001|Overall Study|Study Terminated by the Sponsor|0|||
148920774|NCT02431260|537193987|FG002|Overall Study|Study Terminated by the Sponsor|2|||
148920775|NCT02431260|537193988|FG003|Overall Study|Study Terminated by the Sponsor|1|||
148920776|NCT02431260|537193989|FG004|Overall Study|Study Terminated by the Sponsor|1|||
148920777|NCT02431260|537193990|FG005|Overall Study|Study Terminated by the Sponsor|0|||
148920778|NCT02431260|537193991|FG006|Overall Study|Study Terminated by the Sponsor|1|||
148920779|NCT02431260|537193992|FG007|Overall Study|Study Terminated by the Sponsor|2|||
148920780|NCT02431260|537193993|FG008|Overall Study|Study Terminated by the Sponsor|1|||
148920781|NCT02431260|537193994|FG009|Overall Study|Study Terminated by the Sponsor|1|||
148920782|NCT02431260|537193995|FG010|Overall Study|Study Terminated by the Sponsor|1|||
148920783|NCT02431260|537193996|FG011|Overall Study|Study Terminated by the Sponsor|0|||
148920784|NCT02431260|537193997|FG012|Overall Study|Study Terminated by the Sponsor|4|||
148920785|NCT02431260|537193998|FG013|Overall Study|Study Terminated by the Sponsor|0|||
148920786|NCT02431260|537193985|FG000|Overall Study|Physician Decision|0|||
149155215|NCT02064387|538045698|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
148920787|NCT02431260|537193986|FG001|Overall Study|Physician Decision|0|||
148920788|NCT02431260|537193987|FG002|Overall Study|Physician Decision|0|||
148920789|NCT02431260|537193988|FG003|Overall Study|Physician Decision|0|||
148920790|NCT02431260|537193989|FG004|Overall Study|Physician Decision|0|||
148920791|NCT02431260|537193990|FG005|Overall Study|Physician Decision|1|||
148920792|NCT02431260|537193991|FG006|Overall Study|Physician Decision|0|||
148920793|NCT02431260|537193992|FG007|Overall Study|Physician Decision|0|||
148920794|NCT02431260|537193993|FG008|Overall Study|Physician Decision|0|||
148920795|NCT02431260|537193994|FG009|Overall Study|Physician Decision|0|||
148920796|NCT02431260|537193995|FG010|Overall Study|Physician Decision|0|||
148920797|NCT02431260|537193996|FG011|Overall Study|Physician Decision|0|||
148920798|NCT02431260|537193997|FG012|Overall Study|Physician Decision|0|||
148920799|NCT02431260|537193998|FG013|Overall Study|Physician Decision|0|||
149155216|NCT02064387|538045699|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155217|NCT02064387|538045700|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155218|NCT02064387|538045701|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155219|NCT02064387|538045702|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155220|NCT02064387|538045703|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
148920800|NCT02431260|537193985|FG000|Overall Study|Other Unspecified|0|||
148920801|NCT02431260|537193986|FG001|Overall Study|Other Unspecified|0|||
149155221|NCT02064387|538045704|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155222|NCT02064387|538045705|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
149155223|NCT02064387|538045706|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155224|NCT02064387|538045707|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
148920802|NCT02431260|537193987|FG002|Overall Study|Other Unspecified|0|||
148920803|NCT02431260|537193988|FG003|Overall Study|Other Unspecified|0|||
148920804|NCT02431260|537193989|FG004|Overall Study|Other Unspecified|0|||
148920805|NCT02431260|537193990|FG005|Overall Study|Other Unspecified|0|||
148920806|NCT02431260|537193991|FG006|Overall Study|Other Unspecified|0|||
148920807|NCT02431260|537193992|FG007|Overall Study|Other Unspecified|0|||
148920808|NCT02431260|537193993|FG008|Overall Study|Other Unspecified|0|||
148920809|NCT02431260|537193994|FG009|Overall Study|Other Unspecified|0|||
148920810|NCT02431260|537193995|FG010|Overall Study|Other Unspecified|0|||
148920811|NCT02431260|537193996|FG011|Overall Study|Other Unspecified|1|||
148920812|NCT02431260|537193997|FG012|Overall Study|Other Unspecified|1|||
148920813|NCT02431260|537193998|FG013|Overall Study|Other Unspecified|0|||
148920814|NCT00321646|537193999|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
148920815|NCT00321646|537193999|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
148920816|NCT00321646|537193999|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
148920817|NCT00392379|537194001|FG000|Overall Study|Withdrawal by Subject|17|||
148920818|NCT00392379|537194002|FG001|Overall Study|Withdrawal by Subject|28|||
148920819|NCT00392379|537194001|FG000|Overall Study|Lost to Follow-up|4|||
148920820|NCT00392379|537194002|FG001|Overall Study|Lost to Follow-up|9|||
148920821|NCT00392379|537194001|FG000|Overall Study|Adverse Event|1|||
148920822|NCT00392379|537194002|FG001|Overall Study|Adverse Event|1|||
148920823|NCT01978938|537194003|FG000|Overall Study|Lost to Follow-up|12|||
148920824|NCT01978938|537194004|FG001|Overall Study|Lost to Follow-up|6|||
148920825|NCT01978938|537194003|FG000|Overall Study|Withdrawal by Subject|8|||
148920826|NCT01978938|537194004|FG001|Overall Study|Withdrawal by Subject|4|||
148920827|NCT01978938|537194003|FG000|Overall Study|Adverse Event, non-fatal|2|||
148920828|NCT01978938|537194004|FG001|Overall Study|Adverse Event, non-fatal|1|||
148920829|NCT01978938|537194003|FG000|Overall Study|Participant noncompliance|1|||
148920830|NCT01978938|537194004|FG001|Overall Study|Participant noncompliance|1|||
148920831|NCT01978938|537194003|FG000|Overall Study|Did not meet inclusion criteria|0|||
148920832|NCT01978938|537194004|FG001|Overall Study|Did not meet inclusion criteria|1|||
148920833|NCT01978938|537194003|FG000|Overall Study|Previously scheduled procedure|0|||
148920834|NCT01978938|537194004|FG001|Overall Study|Previously scheduled procedure|1|||
148920835|NCT01806662|537194008|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
148920836|NCT01806662|537194009|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
148920837|NCT01806662|537194008|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
148920838|NCT01806662|537194009|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
148920839|NCT01806662|537194008|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
148920840|NCT01806662|537194009|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
148920841|NCT01806662|537194008|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
148920842|NCT01806662|537194009|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
148920843|NCT00043550|537194012|FG000|Overall Study|Withdrawal by Subject|22|||
148920844|NCT00043550|537194013|FG001|Overall Study|Withdrawal by Subject|12|||
148920845|NCT00043550|537194014|FG002|Overall Study|Withdrawal by Subject|20|||
148920846|NCT00510653|537194019|FG000|Overall Study|Withdrawal by Subject|8|||
148920847|NCT00510653|537194019|FG000|Overall Study|Monetary|3|||
148920848|NCT00483756|537194020|FG000|Overall Study|Death|2|||
148920849|NCT00483756|537194021|FG001|Overall Study|Death|0|||
148920850|NCT00483756|537194022|FG002|Overall Study|Death|1|||
148920851|NCT00483756|537194020|FG000|Overall Study|Adverse Event|19|||
148920852|NCT00483756|537194021|FG001|Overall Study|Adverse Event|38|||
148920853|NCT00483756|537194022|FG002|Overall Study|Adverse Event|40|||
148920854|NCT00483756|537194020|FG000|Overall Study|Lack of Efficacy|1|||
148920855|NCT00483756|537194021|FG001|Overall Study|Lack of Efficacy|0|||
148920856|NCT00483756|537194022|FG002|Overall Study|Lack of Efficacy|0|||
148920857|NCT00483756|537194020|FG000|Overall Study|Lost to Follow-up|3|||
148920858|NCT00483756|537194021|FG001|Overall Study|Lost to Follow-up|1|||
148920859|NCT00483756|537194022|FG002|Overall Study|Lost to Follow-up|0|||
148920860|NCT00483756|537194020|FG000|Overall Study|Withdrawal by Subject|5|||
148920861|NCT00483756|537194021|FG001|Overall Study|Withdrawal by Subject|3|||
148920862|NCT00483756|537194022|FG002|Overall Study|Withdrawal by Subject|4|||
148920863|NCT00483756|537194020|FG000|Overall Study|Other|2|||
148920864|NCT00483756|537194021|FG001|Overall Study|Other|4|||
148920865|NCT00483756|537194022|FG002|Overall Study|Other|3|||
148920866|NCT00483756|537194020|FG000|Overall Study|Randomized, Not Treated|1|||
148920867|NCT00483756|537194021|FG001|Overall Study|Randomized, Not Treated|4|||
148920868|NCT00483756|537194022|FG002|Overall Study|Randomized, Not Treated|4|||
148920869|NCT00710762|537194023|FG000|Overall Study|Progressive disease|27|||
148920870|NCT00710762|537194024|FG001|Overall Study|Progressive disease|30|||
148920871|NCT00710762|537194023|FG000|Overall Study|Adverse Event other disease worsening|2|||
148920872|NCT00710762|537194024|FG001|Overall Study|Adverse Event other disease worsening|1|||
148920873|NCT00710762|537194023|FG000|Overall Study|Other Adverse Event|7|||
148920874|NCT00710762|537194024|FG001|Overall Study|Other Adverse Event|7|||
148920875|NCT00710762|537194023|FG000|Overall Study|Lost to Follow-up|1|||
148920876|NCT00710762|537194024|FG001|Overall Study|Lost to Follow-up|0|||
148920877|NCT00710762|537194023|FG000|Overall Study|Reason other than listed above|2|||
148920878|NCT00710762|537194024|FG001|Overall Study|Reason other than listed above|2|||
148920879|NCT00436501|537194025|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
148920880|NCT00436501|537194026|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
148920881|NCT00436501|537194025|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
148920882|NCT00436501|537194026|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
148920883|NCT03011892|537194031|FG000|Double Blind (DB) Period|Adverse Event|0|||
148920884|NCT03011892|537194032|FG001|Double Blind (DB) Period|Adverse Event|1|||
148920885|NCT03011892|537194033|FG002|Double Blind (DB) Period|Adverse Event|1|||
148920886|NCT03011892|537194034|FG003|Double Blind (DB) Period|Adverse Event|0|||
148920887|NCT03011892|537194035|FG004|Double Blind (DB) Period|Adverse Event|0|||
148920888|NCT03011892|537194036|FG005|Double Blind (DB) Period|Adverse Event|0|||
148920889|NCT03011892|537194037|FG006|Double Blind (DB) Period|Adverse Event|0|||
148920890|NCT03011892|537194038|FG007|Double Blind (DB) Period|Adverse Event|0|||
148920891|NCT03011892|537194039|FG008|Double Blind (DB) Period|Adverse Event|0|||
148920892|NCT03011892|537194040|FG009|Double Blind (DB) Period|Adverse Event|0|||
149155225|NCT02064387|538045708|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
149155226|NCT02064387|538045697|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
149155227|NCT02064387|538045698|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
149155228|NCT02064387|538045699|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
149155229|NCT02064387|538045700|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
149155230|NCT02064387|538045701|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
149155231|NCT02064387|538045702|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
149155232|NCT02064387|538045703|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
149155233|NCT02064387|538045704|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
149155234|NCT02064387|538045705|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
149155235|NCT02064387|538045706|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
149155236|NCT02064387|538045707|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
149155237|NCT02064387|538045708|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
149155238|NCT02064387|538045697|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155239|NCT02064387|538045698|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155240|NCT02064387|538045699|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155241|NCT02064387|538045700|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155242|NCT02064387|538045701|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155243|NCT02064387|538045702|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155244|NCT02064387|538045703|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155245|NCT02064387|538045704|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155246|NCT02064387|538045705|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155247|NCT02064387|538045706|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155248|NCT02064387|538045707|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
148920893|NCT03011892|537194041|FG010|Double Blind (DB) Period|Adverse Event|0|||
148920894|NCT03011892|537194042|FG011|Double Blind (DB) Period|Adverse Event|0|||
148920895|NCT03011892|537194031|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
148920896|NCT03011892|537194032|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
148920897|NCT03011892|537194033|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
148920898|NCT03011892|537194034|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
148920899|NCT03011892|537194035|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
148920900|NCT03011892|537194036|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
148920901|NCT03011892|537194037|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
148920902|NCT03011892|537194038|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
148920903|NCT03011892|537194039|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
148920904|NCT03011892|537194040|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
148920905|NCT03011892|537194041|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
148920906|NCT03011892|537194042|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
148920907|NCT03011892|537194031|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
148920908|NCT03011892|537194032|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
148920909|NCT03011892|537194033|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
148920910|NCT03011892|537194034|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
148920911|NCT03011892|537194035|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
148920912|NCT03011892|537194036|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
148920913|NCT03011892|537194037|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
148920914|NCT03011892|537194038|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
148920915|NCT03011892|537194039|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
149155249|NCT02064387|538045708|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
149155250|NCT03728309|538045709|FG000|Overall Study|Randomized but not Treated|0|||
149155251|NCT03728309|538045710|FG001|Overall Study|Randomized but not Treated|1|||
149155252|NCT03728309|538045709|FG000|Overall Study|Adverse Event|0|||
149155253|NCT03728309|538045710|FG001|Overall Study|Adverse Event|1|||
148920916|NCT03011892|537194040|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
148920917|NCT03011892|537194041|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
148920918|NCT03011892|537194042|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
148920919|NCT03011892|537194031|FG000|Double Blind (DB) Period|Other|1|||
148920920|NCT03011892|537194032|FG001|Double Blind (DB) Period|Other|1|||
148920921|NCT03011892|537194033|FG002|Double Blind (DB) Period|Other|1|||
148920922|NCT03011892|537194034|FG003|Double Blind (DB) Period|Other|0|||
149155254|NCT03728309|538045709|FG000|Overall Study|Withdrawal by Subject|2|||
149155255|NCT03728309|538045710|FG001|Overall Study|Withdrawal by Subject|8|||
149155256|NCT03728309|538045709|FG000|Overall Study|Lost to Follow-up|9|||
149155257|NCT03728309|538045710|FG001|Overall Study|Lost to Follow-up|10|||
149155258|NCT03728309|538045709|FG000|Overall Study|Protocol Deviation|0|||
149155259|NCT03728309|538045710|FG001|Overall Study|Protocol Deviation|1|||
149155260|NCT03728309|538045709|FG000|Overall Study|Due to COVID|1|||
149155261|NCT03728309|538045710|FG001|Overall Study|Due to COVID|3|||
149155262|NCT00927095|538045711|FG000|Overall Study|Adverse Event|3|||
149155263|NCT00927095|538045712|FG001|Overall Study|Adverse Event|1|||
149155264|NCT00927095|538045713|FG002|Overall Study|Adverse Event|0|||
149155265|NCT00927095|538045711|FG000|Overall Study|Withdrawal by Subject|2|||
149155266|NCT00927095|538045712|FG001|Overall Study|Withdrawal by Subject|1|||
149155267|NCT00927095|538045713|FG002|Overall Study|Withdrawal by Subject|1|||
149155268|NCT00927095|538045711|FG000|Overall Study|Physician Decision|1|||
149155269|NCT00927095|538045712|FG001|Overall Study|Physician Decision|2|||
149155270|NCT00927095|538045713|FG002|Overall Study|Physician Decision|1|||
149155271|NCT00044512|538045720|FG000|Follow Up|Lost to Follow-up|2|||
149155272|NCT00866307|538045721|FG000|Induction|Adverse Event|5|||
149155273|NCT00866307|538045722|FG001|Induction|Adverse Event|0|||
149155274|NCT00866307|538045723|FG002|Induction|Adverse Event|0|||
149155275|NCT00866307|538045721|FG000|Induction|Death|2|||
149155276|NCT00866307|538045722|FG001|Induction|Death|0|||
149155277|NCT00866307|538045723|FG002|Induction|Death|0|||
149155278|NCT00866307|538045721|FG000|Induction|Physician Decision|5|||
149155279|NCT00866307|538045722|FG001|Induction|Physician Decision|0|||
149155280|NCT00866307|538045723|FG002|Induction|Physician Decision|0|||
149155281|NCT00866307|538045721|FG000|Induction|Progressive Disease|1|||
149155282|NCT00866307|538045722|FG001|Induction|Progressive Disease|0|||
149155283|NCT00866307|538045723|FG002|Induction|Progressive Disease|0|||
149155284|NCT00866307|538045721|FG000|Induction|Identification of Patients with Day 29 M|3|||
149155285|NCT00866307|538045722|FG001|Induction|Identification of Patients with Day 29 M|0|||
149155286|NCT00866307|538045723|FG002|Induction|Identification of Patients with Day 29 M|0|||
149155287|NCT00866307|538045721|FG000|Induction|Inadequate cytognetic samples th|1|||
149155288|NCT00866307|538045722|FG001|Induction|Inadequate cytognetic samples th|0|||
149155289|NCT00866307|538045723|FG002|Induction|Inadequate cytognetic samples th|0|||
149155290|NCT00866307|538045721|FG000|Induction|Improper post-induction consent|2|||
149155291|NCT00866307|538045722|FG001|Induction|Improper post-induction consent|0|||
149155292|NCT00866307|538045723|FG002|Induction|Improper post-induction consent|0|||
149155293|NCT00866307|538045721|FG000|Induction|Study was closed at the time|1|||
149155294|NCT00866307|538045722|FG001|Induction|Study was closed at the time|0|||
149155295|NCT00866307|538045723|FG002|Induction|Study was closed at the time|0|||
149155296|NCT00866307|538045721|FG000|Consolidation/Maintenance|Adverse Event|0|||
149155297|NCT00866307|538045722|FG001|Consolidation/Maintenance|Adverse Event|0|||
148672820|NCT01036594|536272499|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
148672821|NCT03466060|536272500|FG000|Period 1|Test Lens Damage|0|||
148672822|NCT03466060|536272501|FG001|Period 1|Test Lens Damage|2|||
148672823|NCT03466060|536272502|FG002|Period 1|Test Lens Damage|0|||
148672824|NCT03466060|536272503|FG003|Period 1|Test Lens Damage|0|||
148672825|NCT03466060|536272504|FG004|Period 1|Test Lens Damage|0|||
148672826|NCT03466060|536272505|FG005|Period 1|Test Lens Damage|0|||
148920923|NCT03011892|537194035|FG004|Double Blind (DB) Period|Other|1|||
148920924|NCT03011892|537194036|FG005|Double Blind (DB) Period|Other|0|||
148920925|NCT03011892|537194037|FG006|Double Blind (DB) Period|Other|0|||
148672827|NCT03466060|536272500|FG000|Period 1|Withdrawal by Subject|0|||
148672828|NCT03466060|536272501|FG001|Period 1|Withdrawal by Subject|0|||
148920926|NCT03011892|537194038|FG007|Double Blind (DB) Period|Other|0|||
148920927|NCT03011892|537194039|FG008|Double Blind (DB) Period|Other|0|||
148920928|NCT03011892|537194040|FG009|Double Blind (DB) Period|Other|0|||
148920929|NCT03011892|537194041|FG010|Double Blind (DB) Period|Other|0|||
149155298|NCT00866307|538045723|FG002|Consolidation/Maintenance|Adverse Event|8|||
149155299|NCT00866307|538045721|FG000|Consolidation/Maintenance|Death|0|||
149155300|NCT00866307|538045722|FG001|Consolidation/Maintenance|Death|0|||
149155301|NCT00866307|538045723|FG002|Consolidation/Maintenance|Death|1|||
149155302|NCT00866307|538045721|FG000|Consolidation/Maintenance|Physician Decision|0|||
149155303|NCT00866307|538045722|FG001|Consolidation/Maintenance|Physician Decision|3|||
149155304|NCT00866307|538045723|FG002|Consolidation/Maintenance|Physician Decision|2|||
148672829|NCT03466060|536272502|FG002|Period 1|Withdrawal by Subject|2|||
148672830|NCT03466060|536272503|FG003|Period 1|Withdrawal by Subject|0|||
149155305|NCT00866307|538045721|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
149155306|NCT00866307|538045722|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
149155307|NCT00866307|538045723|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
149155308|NCT00866307|538045721|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
149155309|NCT00866307|538045722|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
149155310|NCT00866307|538045723|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
149155311|NCT00866307|538045721|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
149155312|NCT00866307|538045722|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
149155313|NCT00866307|538045723|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
149155314|NCT00866307|538045721|FG000|Consolidation/Maintenance|Therapy error|0|||
149155315|NCT00866307|538045722|FG001|Consolidation/Maintenance|Therapy error|1|||
149155316|NCT00866307|538045723|FG002|Consolidation/Maintenance|Therapy error|0|||
149155317|NCT00866307|538045721|FG000|Consolidation/Maintenance|Non-compliance|0|||
149155318|NCT00866307|538045722|FG001|Consolidation/Maintenance|Non-compliance|0|||
149155319|NCT00866307|538045723|FG002|Consolidation/Maintenance|Non-compliance|1|||
149155320|NCT00866307|538045721|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
149155321|NCT00866307|538045722|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
149155322|NCT00866307|538045723|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
149155323|NCT02573155|538045724|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
149155324|NCT02573155|538045725|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
149155325|NCT02573155|538045724|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
149155326|NCT02573155|538045725|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
149155327|NCT02573155|538045724|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
149155328|NCT02573155|538045725|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
149155329|NCT02573155|538045724|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
149155330|NCT02573155|538045725|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
149155331|NCT02573155|538045724|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
149155332|NCT02573155|538045725|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
148920930|NCT03011892|537194042|FG011|Double Blind (DB) Period|Other|0|||
148920931|NCT03011892|537194031|FG000|Double Blind (DB) Period|Physician Decision|1|||
148920932|NCT03011892|537194032|FG001|Double Blind (DB) Period|Physician Decision|0|||
148920933|NCT03011892|537194033|FG002|Double Blind (DB) Period|Physician Decision|1|||
148920934|NCT03011892|537194034|FG003|Double Blind (DB) Period|Physician Decision|0|||
148920935|NCT03011892|537194035|FG004|Double Blind (DB) Period|Physician Decision|0|||
148920936|NCT03011892|537194036|FG005|Double Blind (DB) Period|Physician Decision|0|||
148920937|NCT03011892|537194037|FG006|Double Blind (DB) Period|Physician Decision|0|||
148920938|NCT03011892|537194038|FG007|Double Blind (DB) Period|Physician Decision|0|||
148920939|NCT03011892|537194039|FG008|Double Blind (DB) Period|Physician Decision|0|||
148920940|NCT03011892|537194040|FG009|Double Blind (DB) Period|Physician Decision|0|||
148920941|NCT03011892|537194041|FG010|Double Blind (DB) Period|Physician Decision|0|||
148920942|NCT03011892|537194042|FG011|Double Blind (DB) Period|Physician Decision|0|||
148920943|NCT03011892|537194031|FG000|Double Blind (DB) Period|Pregnancy|0|||
148920944|NCT03011892|537194032|FG001|Double Blind (DB) Period|Pregnancy|0|||
148920945|NCT03011892|537194033|FG002|Double Blind (DB) Period|Pregnancy|0|||
148920946|NCT03011892|537194034|FG003|Double Blind (DB) Period|Pregnancy|0|||
148920947|NCT03011892|537194035|FG004|Double Blind (DB) Period|Pregnancy|1|||
148920948|NCT03011892|537194036|FG005|Double Blind (DB) Period|Pregnancy|0|||
148920949|NCT03011892|537194037|FG006|Double Blind (DB) Period|Pregnancy|0|||
148920950|NCT03011892|537194038|FG007|Double Blind (DB) Period|Pregnancy|0|||
148920951|NCT03011892|537194039|FG008|Double Blind (DB) Period|Pregnancy|0|||
148920952|NCT03011892|537194040|FG009|Double Blind (DB) Period|Pregnancy|0|||
148920953|NCT03011892|537194041|FG010|Double Blind (DB) Period|Pregnancy|0|||
148920954|NCT03011892|537194042|FG011|Double Blind (DB) Period|Pregnancy|0|||
149155333|NCT02573155|538045724|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
149155334|NCT02573155|538045725|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
149155335|NCT02573155|538045724|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
149155336|NCT02573155|538045725|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
149155337|NCT02573155|538045724|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
149155338|NCT02573155|538045725|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
149155339|NCT02508194|538045728|FG000|Overall Study|Death|5|||
149155340|NCT02508194|538045729|FG001|Overall Study|Death|3|||
149155341|NCT02508194|538045728|FG000|Overall Study|Lost to Follow-up|25|||
149155342|NCT02508194|538045729|FG001|Overall Study|Lost to Follow-up|18|||
149155343|NCT02508194|538045728|FG000|Overall Study|Withdrawal by Subject|20|||
149155344|NCT02508194|538045729|FG001|Overall Study|Withdrawal by Subject|18|||
149155345|NCT02508194|538045728|FG000|Overall Study|Error in Randomization|1|||
149155346|NCT02508194|538045729|FG001|Overall Study|Error in Randomization|3|||
149155347|NCT02508194|538045728|FG000|Overall Study|Principal Investigator Decision|1|||
149155348|NCT02508194|538045729|FG001|Overall Study|Principal Investigator Decision|2|||
149155349|NCT00511355|538045733|FG000|Overall Study|Adverse Event|4|||
149155350|NCT00511355|538045734|FG001|Overall Study|Adverse Event|4|||
149155351|NCT00511355|538045733|FG000|Overall Study|Pregnancy Wish|1|||
149155352|NCT00511355|538045734|FG001|Overall Study|Pregnancy Wish|0|||
149155353|NCT00511355|538045733|FG000|Overall Study|Lost to Follow-up|2|||
149155354|NCT00511355|538045734|FG001|Overall Study|Lost to Follow-up|1|||
149155355|NCT00511355|538045733|FG000|Overall Study|Other Reason|0|||
149155356|NCT00511355|538045734|FG001|Overall Study|Other Reason|1|||
149155357|NCT00511355|538045733|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
149155358|NCT00511355|538045734|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
149155359|NCT00511355|538045733|FG000|Overall Study|Withdrawal of informed consent|0|||
149155360|NCT00511355|538045734|FG001|Overall Study|Withdrawal of informed consent|1|||
149155361|NCT00511355|538045733|FG000|Overall Study|Other reason pre-treatment|0|||
149155362|NCT00511355|538045734|FG001|Overall Study|Other reason pre-treatment|1|||
149155363|NCT00454805|538045736|FG000|Overall Study|Withdrawal by Subject|9|||
149155364|NCT00454805|538045737|FG001|Overall Study|Withdrawal by Subject|2|||
149155365|NCT00454805|538045736|FG000|Overall Study|Death|0|||
149155366|NCT00454805|538045737|FG001|Overall Study|Death|2|||
149155367|NCT00454805|538045736|FG000|Overall Study|Disease progression|16|||
149155368|NCT00454805|538045737|FG001|Overall Study|Disease progression|19|||
149155369|NCT00454805|538045736|FG000|Overall Study|In order to begin radiotherapy|1|||
149155370|NCT00454805|538045737|FG001|Overall Study|In order to begin radiotherapy|0|||
149155371|NCT00217087|538045738|FG000|Overall Study|decided to have esophagectomy|1|||
149155372|NCT00217087|538045739|FG001|Overall Study|decided to have esophagectomy|2|||
149155373|NCT00217087|538045738|FG000|Overall Study|completed less than 12 months return|10|||
149155374|NCT00217087|538045739|FG001|Overall Study|completed less than 12 months return|18|||
149155375|NCT04947800|538045742|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
149155376|NCT04947800|538045743|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
149155377|NCT04947800|538045744|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
149155378|NCT02158091|538045745|FG000|Overall Study|DLT|2|||
149155379|NCT02158091|538045746|FG001|Overall Study|DLT|1|||
149155380|NCT02158091|538045747|FG002|Overall Study|DLT|0|||
149155381|NCT03977467|538045748|FG000|Overall Study|Disease Progression|1|||
149155382|NCT03977467|538045749|FG001|Overall Study|Disease Progression|1|||
149155383|NCT03977467|538045750|FG002|Overall Study|Disease Progression|30|||
149155384|NCT03977467|538045751|FG003|Overall Study|Disease Progression|0|||
149155385|NCT03977467|538045748|FG000|Overall Study|Adverse Event|0|||
149155386|NCT03977467|538045749|FG001|Overall Study|Adverse Event|1|||
149155387|NCT03977467|538045750|FG002|Overall Study|Adverse Event|0|||
149155388|NCT03977467|538045751|FG003|Overall Study|Adverse Event|0|||
149155389|NCT03977467|538045748|FG000|Overall Study|Death|0|||
149155390|NCT03977467|538045749|FG001|Overall Study|Death|0|||
149155391|NCT03977467|538045750|FG002|Overall Study|Death|3|||
149155392|NCT03977467|538045751|FG003|Overall Study|Death|0|||
148672831|NCT03466060|536272504|FG004|Period 1|Withdrawal by Subject|0|||
148672832|NCT03466060|536272505|FG005|Period 1|Withdrawal by Subject|0|||
149155393|NCT03977467|538045748|FG000|Overall Study|Lack of Efficacy|0|||
149155394|NCT03977467|538045749|FG001|Overall Study|Lack of Efficacy|0|||
149155395|NCT03977467|538045750|FG002|Overall Study|Lack of Efficacy|1|||
149155396|NCT03977467|538045751|FG003|Overall Study|Lack of Efficacy|0|||
149155397|NCT03977467|538045748|FG000|Overall Study|Withdrawal by Subject|2|||
149155398|NCT03977467|538045749|FG001|Overall Study|Withdrawal by Subject|1|||
149155399|NCT03977467|538045750|FG002|Overall Study|Withdrawal by Subject|4|||
149155400|NCT03977467|538045751|FG003|Overall Study|Withdrawal by Subject|0|||
149155401|NCT03977467|538045748|FG000|Overall Study|Study Terminated|1|||
149155402|NCT03977467|538045749|FG001|Overall Study|Study Terminated|0|||
149155403|NCT03977467|538045750|FG002|Overall Study|Study Terminated|0|||
149155404|NCT03977467|538045751|FG003|Overall Study|Study Terminated|1|||
149155405|NCT05913232|538045752|FG000|Overall Study|Adverse Event|0|||
149155406|NCT05913232|538045753|FG001|Overall Study|Adverse Event|2|||
149155407|NCT05913232|538045754|FG002|Overall Study|Adverse Event|1|||
149155408|NCT05913232|538045755|FG003|Overall Study|Adverse Event|1|||
149155409|NCT04428476|538045756|FG000|Overall Study|Withdrawal by Subject|1|||
149155410|NCT04428476|538045756|FG000|Overall Study|Still on treatment|12|||
149155411|NCT04042103|538045765|FG000|Overall Study|Lost to Follow-up|1|||
149155412|NCT04042103|538045765|FG000|Overall Study|Withdrawal by Subject|1|||
149155413|NCT02289950|538045768|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
149155414|NCT02289950|538045769|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
149155415|NCT02289950|538045768|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
149155416|NCT02289950|538045769|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
149155417|NCT02289950|538045768|FG000|Overall Study|Lost to Follow-up|1|||
149155418|NCT02289950|538045769|FG001|Overall Study|Lost to Follow-up|0|||
149155419|NCT02289950|538045768|FG000|Overall Study|Physician Decision|9|||
149155420|NCT02289950|538045769|FG001|Overall Study|Physician Decision|3|||
149155421|NCT02289950|538045768|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
149155422|NCT02289950|538045769|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
149155423|NCT02289950|538045768|FG000|Overall Study|Withdrawal by Subject|1|||
149155424|NCT02289950|538045769|FG001|Overall Study|Withdrawal by Subject|3|||
149155425|NCT02289950|538045768|FG000|Overall Study|Test article held for greater than 28 days|0|||
149155426|NCT02289950|538045769|FG001|Overall Study|Test article held for greater than 28 days|1|||
149155427|NCT02289950|538045768|FG000|Overall Study|Adverse Event|11|||
149155428|NCT02289950|538045769|FG001|Overall Study|Adverse Event|3|||
149155429|NCT02289950|538045768|FG000|Overall Study|Death|1|||
149155430|NCT02289950|538045769|FG001|Overall Study|Death|1|||
149155431|NCT02289950|538045768|FG000|Overall Study|Other|5|||
149155432|NCT02289950|538045769|FG001|Overall Study|Other|2|||
149155433|NCT02289950|538045768|FG000|Overall Study|Not Treated|2|||
149155434|NCT02289950|538045769|FG001|Overall Study|Not Treated|1|||
149155435|NCT04518462|538045770|FG000|Overall Study|Withdrawal by Subject|0|||
149155436|NCT04518462|538045771|FG001|Overall Study|Withdrawal by Subject|0|||
149155437|NCT04518462|538045772|FG002|Overall Study|Withdrawal by Subject|1|||
149155438|NCT04518462|538045770|FG000|Overall Study|Physician Decision|1|||
149155439|NCT04518462|538045771|FG001|Overall Study|Physician Decision|1|||
149155440|NCT04518462|538045772|FG002|Overall Study|Physician Decision|0|||
149155441|NCT01003210|538045773|FG000|Overall Study|Lost to Follow-up|1|||
149155442|NCT01003210|538045774|FG001|Overall Study|Lost to Follow-up|3|||
149155443|NCT00271817|538045775|FG000|Part 1|Adverse Event|68|||
149155444|NCT00271817|538045776|FG001|Part 1|Adverse Event|25|||
149155445|NCT00271817|538045777|FG002|Part 1|Adverse Event|156|||
149155446|NCT00271817|538045775|FG000|Part 1|Lost to Follow-up|6|||
149155447|NCT00271817|538045776|FG001|Part 1|Lost to Follow-up|8|||
149155448|NCT00271817|538045777|FG002|Part 1|Lost to Follow-up|24|||
149155449|NCT00271817|538045775|FG000|Part 1|Protocol Violation|5|||
149155450|NCT00271817|538045776|FG001|Part 1|Protocol Violation|4|||
149155451|NCT00271817|538045777|FG002|Part 1|Protocol Violation|7|||
149155452|NCT00271817|538045775|FG000|Part 1|Patient Moved|3|||
149155453|NCT00271817|538045776|FG001|Part 1|Patient Moved|1|||
149155454|NCT00271817|538045777|FG002|Part 1|Patient Moved|5|||
149155455|NCT00271817|538045775|FG000|Part 1|Withdrawal by Subject|23|||
149155456|NCT00271817|538045776|FG001|Part 1|Withdrawal by Subject|17|||
149155457|NCT00271817|538045777|FG002|Part 1|Withdrawal by Subject|45|||
149155458|NCT00271817|538045775|FG000|Part 1|LDL < 50 mg/dL|1|||
149155459|NCT00271817|538045776|FG001|Part 1|LDL < 50 mg/dL|4|||
149155460|NCT00271817|538045777|FG002|Part 1|LDL < 50 mg/dL|48|||
149155461|NCT00271817|538045775|FG000|Part 2|Adverse Event|0|||
149155462|NCT00271817|538045776|FG001|Part 2|Adverse Event|17|||
148920955|NCT03011892|537194031|FG000|Double Blind (DB) Period|Protocol Violation|1|||
148920956|NCT03011892|537194032|FG001|Double Blind (DB) Period|Protocol Violation|0|||
149155463|NCT00271817|538045777|FG002|Part 2|Adverse Event|33|||
149155464|NCT00271817|538045775|FG000|Part 2|Lack of Efficacy|0|||
149155465|NCT00271817|538045776|FG001|Part 2|Lack of Efficacy|1|||
149155466|NCT00271817|538045777|FG002|Part 2|Lack of Efficacy|6|||
149155467|NCT00271817|538045775|FG000|Part 2|Lost to Follow-up|0|||
149155468|NCT00271817|538045776|FG001|Part 2|Lost to Follow-up|6|||
149155469|NCT00271817|538045777|FG002|Part 2|Lost to Follow-up|18|||
149155470|NCT00271817|538045775|FG000|Part 2|Protocol Violation|0|||
149155471|NCT00271817|538045776|FG001|Part 2|Protocol Violation|3|||
149155472|NCT00271817|538045777|FG002|Part 2|Protocol Violation|5|||
149155473|NCT00271817|538045775|FG000|Part 2|Patient Moved|0|||
149155474|NCT00271817|538045776|FG001|Part 2|Patient Moved|0|||
149155475|NCT00271817|538045777|FG002|Part 2|Patient Moved|5|||
149155476|NCT00271817|538045775|FG000|Part 2|Withdrawal by Subject|0|||
149155477|NCT00271817|538045776|FG001|Part 2|Withdrawal by Subject|2|||
149155478|NCT00271817|538045777|FG002|Part 2|Withdrawal by Subject|13|||
149155479|NCT00271817|538045775|FG000|Part 2|LDL < 50 mg/dL|0|||
149155480|NCT00271817|538045776|FG001|Part 2|LDL < 50 mg/dL|3|||
149155481|NCT00271817|538045777|FG002|Part 2|LDL < 50 mg/dL|4|||
149155482|NCT04153188|538045782|FG000|Overall Study|Lost to Follow-up|1|||
149155483|NCT04153188|538045783|FG001|Overall Study|Lost to Follow-up|1|||
149155484|NCT04153188|538045782|FG000|Overall Study|Withdrawal by Subject|2|||
149155485|NCT04153188|538045783|FG001|Overall Study|Withdrawal by Subject|0|||
149155486|NCT04153188|538045782|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
149155487|NCT04153188|538045783|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
149155488|NCT01471782|538045785|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
149155489|NCT01471782|538045786|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
149155490|NCT01471782|538045787|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
149155491|NCT01471782|538045788|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
149155492|NCT01471782|538045789|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
149155493|NCT01471782|538045790|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
149155494|NCT01471782|538045785|FG000|Overall Study|Lack of Efficacy|1|||
149155495|NCT01471782|538045786|FG001|Overall Study|Lack of Efficacy|2|||
149155496|NCT01471782|538045787|FG002|Overall Study|Lack of Efficacy|1|||
149155497|NCT01471782|538045788|FG003|Overall Study|Lack of Efficacy|1|||
149155498|NCT01471782|538045789|FG004|Overall Study|Lack of Efficacy|5|||
149155499|NCT01471782|538045790|FG005|Overall Study|Lack of Efficacy|18|||
149155500|NCT01471782|538045785|FG000|Overall Study|Adverse Event|1|||
149155501|NCT01471782|538045786|FG001|Overall Study|Adverse Event|1|||
149155502|NCT01471782|538045787|FG002|Overall Study|Adverse Event|2|||
149155503|NCT01471782|538045788|FG003|Overall Study|Adverse Event|2|||
149155504|NCT01471782|538045789|FG004|Overall Study|Adverse Event|3|||
149155505|NCT01471782|538045790|FG005|Overall Study|Adverse Event|1|||
149155506|NCT01471782|538045785|FG000|Overall Study|Other|0|||
149155507|NCT01471782|538045786|FG001|Overall Study|Other|0|||
149155508|NCT01471782|538045787|FG002|Overall Study|Other|1|||
149155509|NCT01471782|538045788|FG003|Overall Study|Other|1|||
149155510|NCT01471782|538045789|FG004|Overall Study|Other|6|||
149155511|NCT01471782|538045790|FG005|Overall Study|Other|5|||
149155512|NCT01471782|538045785|FG000|Overall Study|Change of Chemotherapy|1|||
149155513|NCT01471782|538045786|FG001|Overall Study|Change of Chemotherapy|1|||
149155514|NCT01471782|538045787|FG002|Overall Study|Change of Chemotherapy|0|||
149155515|NCT01471782|538045788|FG003|Overall Study|Change of Chemotherapy|0|||
149155516|NCT01471782|538045789|FG004|Overall Study|Change of Chemotherapy|1|||
149155517|NCT01471782|538045790|FG005|Overall Study|Change of Chemotherapy|4|||
149155518|NCT01471782|538045785|FG000|Overall Study|Disease Relapse|0|||
149155519|NCT01471782|538045786|FG001|Overall Study|Disease Relapse|0|||
149155520|NCT01471782|538045787|FG002|Overall Study|Disease Relapse|0|||
149155521|NCT01471782|538045788|FG003|Overall Study|Disease Relapse|1|||
148672833|NCT03466060|536272500|FG000|Period 1|Lost to Follow-up|0|||
148672834|NCT03466060|536272501|FG001|Period 1|Lost to Follow-up|0|||
148672835|NCT03466060|536272502|FG002|Period 1|Lost to Follow-up|0|||
148672836|NCT03466060|536272503|FG003|Period 1|Lost to Follow-up|1|||
149155522|NCT01471782|538045789|FG004|Overall Study|Disease Relapse|2|||
148672837|NCT03466060|536272504|FG004|Period 1|Lost to Follow-up|0|||
148672838|NCT03466060|536272505|FG005|Period 1|Lost to Follow-up|0|||
148672839|NCT03466060|536272500|FG000|Period 1|Grade 2 Conjunctivitis|0|||
148672840|NCT03466060|536272501|FG001|Period 1|Grade 2 Conjunctivitis|0|||
148672841|NCT03466060|536272502|FG002|Period 1|Grade 2 Conjunctivitis|1|||
148672842|NCT03466060|536272503|FG003|Period 1|Grade 2 Conjunctivitis|0|||
148672843|NCT03466060|536272504|FG004|Period 1|Grade 2 Conjunctivitis|0|||
148672844|NCT03466060|536272505|FG005|Period 1|Grade 2 Conjunctivitis|0|||
148805935|NCT05911841|536768052|FG008|Induction Period|Adverse Event|0|||
149155523|NCT01471782|538045790|FG005|Overall Study|Disease Relapse|1|||
149155524|NCT01471782|538045785|FG000|Overall Study|Physician Decision|0|||
149155525|NCT01471782|538045786|FG001|Overall Study|Physician Decision|0|||
149155526|NCT01471782|538045787|FG002|Overall Study|Physician Decision|0|||
149155527|NCT01471782|538045788|FG003|Overall Study|Physician Decision|0|||
149155528|NCT01471782|538045789|FG004|Overall Study|Physician Decision|3|||
149155529|NCT01471782|538045790|FG005|Overall Study|Physician Decision|8|||
149155530|NCT01471782|538045785|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148672845|NCT03466060|536272500|FG000|Period 2|Lens Handling Difficulties|0|||
148672846|NCT03466060|536272501|FG001|Period 2|Lens Handling Difficulties|0|||
148672847|NCT03466060|536272502|FG002|Period 2|Lens Handling Difficulties|1|||
148672848|NCT03466060|536272503|FG003|Period 2|Lens Handling Difficulties|0|||
148805936|NCT05911841|536768053|FG009|Induction Period|Adverse Event|0|||
149155531|NCT01471782|538045786|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149155532|NCT01471782|538045787|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149155533|NCT01471782|538045788|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149155534|NCT01471782|538045789|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
149155535|NCT01471782|538045790|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
149155536|NCT01471782|538045785|FG000|Overall Study|Death|0|||
149155537|NCT01471782|538045786|FG001|Overall Study|Death|0|||
149155538|NCT01471782|538045787|FG002|Overall Study|Death|0|||
149155539|NCT01471782|538045788|FG003|Overall Study|Death|0|||
149155540|NCT01471782|538045789|FG004|Overall Study|Death|0|||
149155541|NCT01471782|538045790|FG005|Overall Study|Death|1|||
149155542|NCT00936208|538045791|FG000|Overall Study|Protocol Violation|37|||
149155543|NCT00936208|538045792|FG001|Overall Study|Protocol Violation|22|||
149155544|NCT01411085|538045793|FG000|Overall Study|Physician Decision|1|||
149155545|NCT01411085|538045793|FG000|Overall Study|Protocol Violation|1|||
149155546|NCT01411085|538045793|FG000|Overall Study|Adverse Event|1|||
149155547|NCT04818593|538045794|FG000|Overall Study|Low Oocyte Yield|8|||
149155548|NCT04818593|538045795|FG001|Overall Study|Low Oocyte Yield|8|||
149155549|NCT04818593|538045794|FG000|Overall Study|Not ICSI Insemination|7|||
149155550|NCT04818593|538045795|FG001|Overall Study|Not ICSI Insemination|7|||
149155551|NCT04818593|538045794|FG000|Overall Study|Poor Sperm Quality|2|||
149155552|NCT04818593|538045795|FG001|Overall Study|Poor Sperm Quality|2|||
149155553|NCT04818593|538045794|FG000|Overall Study|Withdrawal by Subject|2|||
149155554|NCT04818593|538045795|FG001|Overall Study|Withdrawal by Subject|2|||
149155555|NCT04818593|538045794|FG000|Overall Study|Conversion to IUI due to low response|1|||
149155556|NCT04818593|538045795|FG001|Overall Study|Conversion to IUI due to low response|1|||
149155557|NCT01564862|538045796|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
149155558|NCT01564862|538045797|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
149155559|NCT01564862|538045798|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
149155560|NCT01564862|538045796|FG000|Overall Study|Major Protocol Deviation|3|||
149155561|NCT01564862|538045797|FG001|Overall Study|Major Protocol Deviation|3|||
149155562|NCT01564862|538045798|FG002|Overall Study|Major Protocol Deviation|4|||
149155563|NCT01564862|538045796|FG000|Overall Study|Lost to Follow-up|10|||
149155564|NCT01564862|538045797|FG001|Overall Study|Lost to Follow-up|8|||
149155565|NCT01564862|538045798|FG002|Overall Study|Lost to Follow-up|6|||
149155566|NCT01564862|538045796|FG000|Overall Study|Voluntary Withdrawal|9|||
149155567|NCT01564862|538045797|FG001|Overall Study|Voluntary Withdrawal|6|||
149155568|NCT01564862|538045798|FG002|Overall Study|Voluntary Withdrawal|8|||
149155569|NCT01564862|538045796|FG000|Overall Study|Lack of Efficacy|1|||
149155570|NCT01564862|538045797|FG001|Overall Study|Lack of Efficacy|5|||
149155571|NCT01564862|538045798|FG002|Overall Study|Lack of Efficacy|6|||
149155572|NCT01564862|538045796|FG000|Overall Study|Other reason(s)|1|||
149155573|NCT01564862|538045797|FG001|Overall Study|Other reason(s)|0|||
149155574|NCT01564862|538045798|FG002|Overall Study|Other reason(s)|0|||
149155575|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
149155576|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
149155577|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
149155578|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
149155579|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
149155580|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
149155581|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
149155582|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
149155583|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
149155584|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
149155585|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
149155586|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
149155587|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
149155588|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
149155589|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
148672849|NCT03466060|536272504|FG004|Period 2|Lens Handling Difficulties|0|||
148672850|NCT03466060|536272505|FG005|Period 2|Lens Handling Difficulties|0|||
148672851|NCT00244881|536272507|FG000|Overall Study|Withdrawal by Subject|3|||
148672852|NCT03345485|536272508|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
148672853|NCT03345485|536272509|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
149155590|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
149155591|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
149155592|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
149155593|NCT02600494|538045806|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
149155594|NCT02600494|538045807|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
149155595|NCT02600494|538045808|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
149155596|NCT02600494|538045806|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
149155597|NCT02600494|538045807|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
149155598|NCT02600494|538045808|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
149155599|NCT02600494|538045806|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
148672854|NCT03345485|536272510|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
148920957|NCT03011892|537194033|FG002|Double Blind (DB) Period|Protocol Violation|0|||
148920958|NCT03011892|537194034|FG003|Double Blind (DB) Period|Protocol Violation|0|||
148920959|NCT03011892|537194035|FG004|Double Blind (DB) Period|Protocol Violation|0|||
148920960|NCT03011892|537194036|FG005|Double Blind (DB) Period|Protocol Violation|0|||
149155600|NCT02600494|538045807|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
149155601|NCT02600494|538045808|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
149155602|NCT02600494|538045806|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
149155603|NCT02600494|538045807|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
149155604|NCT02600494|538045808|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
149155605|NCT02600494|538045806|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
149155606|NCT02600494|538045807|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
149155607|NCT02600494|538045808|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
149155608|NCT02600494|538045806|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
149155609|NCT02600494|538045807|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
149155610|NCT02600494|538045808|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
149155611|NCT02600494|538045806|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
149155612|NCT02600494|538045807|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
149155613|NCT02600494|538045808|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
149155614|NCT03124563|538045809|FG000|Overall Study|Lost to Follow-up|1|||
149155615|NCT03124563|538045810|FG001|Overall Study|Lost to Follow-up|1|||
149155616|NCT03124563|538045809|FG000|Overall Study|Withdrawal by Subject|1|||
149155617|NCT03124563|538045810|FG001|Overall Study|Withdrawal by Subject|1|||
149155618|NCT05061719|538045813|FG000|Overall Study|Adverse Event|60|||
149155619|NCT05061719|538045813|FG000|Overall Study|Death|1|||
149155620|NCT05061719|538045813|FG000|Overall Study|Lack of Efficacy|7|||
149155621|NCT05061719|538045813|FG000|Overall Study|Lost to Follow-up|5|||
149155622|NCT05061719|538045813|FG000|Overall Study|Pregnancy|1|||
149155623|NCT05061719|538045813|FG000|Overall Study|Protocol Violation|8|||
149155624|NCT05061719|538045813|FG000|Overall Study|Withdrawal by Subject|41|||
149155625|NCT05061719|538045813|FG000|Overall Study|Site Closure|2|||
149155626|NCT05593016|538047589|FG000|Overall Study|Death|1|||
149155627|NCT05593016|538047590|FG001|Overall Study|Death|1|||
149155628|NCT05593016|538047591|FG002|Overall Study|Death|1|||
149155629|NCT05593016|538047592|FG003|Overall Study|Death|0|||
149155630|NCT05593016|538047593|FG004|Overall Study|Death|0|||
149155631|NCT05593016|538047589|FG000|Overall Study|Lost to Follow-up|1|||
149155632|NCT05593016|538047590|FG001|Overall Study|Lost to Follow-up|1|||
149155633|NCT05593016|538047591|FG002|Overall Study|Lost to Follow-up|1|||
149155634|NCT05593016|538047592|FG003|Overall Study|Lost to Follow-up|2|||
149155635|NCT05593016|538047593|FG004|Overall Study|Lost to Follow-up|0|||
149155636|NCT00598975|538047597|FG000|Overall Study|Adverse Event|1|||
149155637|NCT00598975|538047598|FG001|Overall Study|Adverse Event|1|||
149155638|NCT00598975|538047597|FG000|Overall Study|Brain metastases|1|||
149155639|NCT00598975|538047598|FG001|Overall Study|Brain metastases|0|||
149155640|NCT00598975|538047597|FG000|Overall Study|Withdrawal by Subject|1|||
149155641|NCT00598975|538047598|FG001|Overall Study|Withdrawal by Subject|1|||
149155642|NCT00598975|538047597|FG000|Overall Study|Withdrawal of consent|0|||
149155643|NCT00598975|538047598|FG001|Overall Study|Withdrawal of consent|1|||
149155644|NCT00598975|538047597|FG000|Overall Study|Disease progression|8|||
149155645|NCT00598975|538047598|FG001|Overall Study|Disease progression|3|||
149155646|NCT00598975|538047597|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
149155647|NCT00598975|538047598|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
149155648|NCT01790503|538047601|FG000|Overall Study|Adverse Event|1|||
149155649|NCT01790503|538047602|FG001|Overall Study|Adverse Event|0|||
149155650|NCT01790503|538047603|FG002|Overall Study|Adverse Event|0|||
149155651|NCT01790503|538047604|FG003|Overall Study|Adverse Event|0|||
149155652|NCT01790503|538047605|FG004|Overall Study|Adverse Event|0|||
149155653|NCT01790503|538047606|FG005|Overall Study|Adverse Event|2|||
149155654|NCT01790503|538047607|FG006|Overall Study|Adverse Event|0|||
149155655|NCT01790503|538047608|FG007|Overall Study|Adverse Event|0|||
149155656|NCT01790503|538047609|FG008|Overall Study|Adverse Event|2|||
149155657|NCT01790503|538047610|FG009|Overall Study|Adverse Event|4|||
149155658|NCT01790503|538047611|FG010|Overall Study|Adverse Event|7|||
149155659|NCT01790503|538047601|FG000|Overall Study|Withdrawal by Subject|0|||
149155660|NCT01790503|538047602|FG001|Overall Study|Withdrawal by Subject|0|||
149155661|NCT01790503|538047603|FG002|Overall Study|Withdrawal by Subject|1|||
149155662|NCT01790503|538047604|FG003|Overall Study|Withdrawal by Subject|1|||
148672855|NCT03345485|536272511|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
148672856|NCT03345485|536272512|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
148805937|NCT05911841|536768044|FG000|Induction Period|Assigned Treatment by Mistake|0|||
149155663|NCT01790503|538047605|FG004|Overall Study|Withdrawal by Subject|1|||
149155664|NCT01790503|538047606|FG005|Overall Study|Withdrawal by Subject|2|||
149155665|NCT01790503|538047607|FG006|Overall Study|Withdrawal by Subject|1|||
149155666|NCT01790503|538047608|FG007|Overall Study|Withdrawal by Subject|0|||
149155667|NCT01790503|538047609|FG008|Overall Study|Withdrawal by Subject|0|||
149155668|NCT01790503|538047610|FG009|Overall Study|Withdrawal by Subject|0|||
149155669|NCT01790503|538047611|FG010|Overall Study|Withdrawal by Subject|1|||
148805938|NCT05911841|536768045|FG001|Induction Period|Assigned Treatment by Mistake|1|||
149155670|NCT01790503|538047601|FG000|Overall Study|Disease progression|2|||
149155671|NCT01790503|538047602|FG001|Overall Study|Disease progression|1|||
149155672|NCT01790503|538047603|FG002|Overall Study|Disease progression|0|||
148920961|NCT03011892|537194037|FG006|Double Blind (DB) Period|Protocol Violation|0|||
148920962|NCT03011892|537194038|FG007|Double Blind (DB) Period|Protocol Violation|0|||
148920963|NCT03011892|537194039|FG008|Double Blind (DB) Period|Protocol Violation|0|||
148920964|NCT03011892|537194040|FG009|Double Blind (DB) Period|Protocol Violation|0|||
148920965|NCT03011892|537194041|FG010|Double Blind (DB) Period|Protocol Violation|0|||
148920966|NCT03011892|537194042|FG011|Double Blind (DB) Period|Protocol Violation|0|||
148920967|NCT03011892|537194031|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
148920968|NCT03011892|537194032|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
148920969|NCT03011892|537194033|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
148920970|NCT03011892|537194034|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
148920971|NCT03011892|537194035|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
148920972|NCT03011892|537194036|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
148920973|NCT03011892|537194037|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
148920974|NCT03011892|537194038|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
148920975|NCT03011892|537194039|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
148920976|NCT03011892|537194040|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
148920977|NCT03011892|537194041|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
148920978|NCT03011892|537194042|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
148920979|NCT03011892|537194031|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
148920980|NCT03011892|537194032|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
148920981|NCT03011892|537194033|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
149155673|NCT01790503|538047604|FG003|Overall Study|Disease progression|1|||
149155674|NCT01790503|538047605|FG004|Overall Study|Disease progression|2|||
149155675|NCT01790503|538047606|FG005|Overall Study|Disease progression|1|||
149155676|NCT01790503|538047607|FG006|Overall Study|Disease progression|0|||
149155677|NCT01790503|538047608|FG007|Overall Study|Disease progression|1|||
149155678|NCT01790503|538047609|FG008|Overall Study|Disease progression|0|||
149155679|NCT01790503|538047610|FG009|Overall Study|Disease progression|17|||
149155680|NCT01790503|538047611|FG010|Overall Study|Disease progression|7|||
149155681|NCT01790503|538047601|FG000|Overall Study|Protocol Violation|0|||
149155682|NCT01790503|538047602|FG001|Overall Study|Protocol Violation|0|||
149155683|NCT01790503|538047603|FG002|Overall Study|Protocol Violation|0|||
149155684|NCT01790503|538047604|FG003|Overall Study|Protocol Violation|0|||
149155685|NCT01790503|538047605|FG004|Overall Study|Protocol Violation|0|||
149155686|NCT01790503|538047606|FG005|Overall Study|Protocol Violation|0|||
149155687|NCT01790503|538047607|FG006|Overall Study|Protocol Violation|0|||
149155688|NCT01790503|538047608|FG007|Overall Study|Protocol Violation|0|||
149155689|NCT01790503|538047609|FG008|Overall Study|Protocol Violation|0|||
149155690|NCT01790503|538047610|FG009|Overall Study|Protocol Violation|1|||
149155691|NCT01790503|538047611|FG010|Overall Study|Protocol Violation|0|||
149155692|NCT01790503|538047601|FG000|Overall Study|Physician Decision|0|||
149155693|NCT01790503|538047602|FG001|Overall Study|Physician Decision|0|||
149155694|NCT01790503|538047603|FG002|Overall Study|Physician Decision|0|||
149155695|NCT01790503|538047604|FG003|Overall Study|Physician Decision|0|||
149155696|NCT01790503|538047605|FG004|Overall Study|Physician Decision|0|||
149155697|NCT01790503|538047606|FG005|Overall Study|Physician Decision|0|||
149155698|NCT01790503|538047607|FG006|Overall Study|Physician Decision|0|||
149155699|NCT01790503|538047608|FG007|Overall Study|Physician Decision|0|||
149155700|NCT01790503|538047609|FG008|Overall Study|Physician Decision|0|||
149155701|NCT01790503|538047610|FG009|Overall Study|Physician Decision|1|||
149155702|NCT01790503|538047611|FG010|Overall Study|Physician Decision|1|||
149155703|NCT01790503|538047601|FG000|Overall Study|Death|0|||
149155704|NCT01790503|538047602|FG001|Overall Study|Death|0|||
149155705|NCT01790503|538047603|FG002|Overall Study|Death|0|||
149155706|NCT01790503|538047604|FG003|Overall Study|Death|0|||
149155707|NCT01790503|538047605|FG004|Overall Study|Death|0|||
149155708|NCT01790503|538047606|FG005|Overall Study|Death|0|||
149155709|NCT01790503|538047607|FG006|Overall Study|Death|0|||
149155710|NCT01790503|538047608|FG007|Overall Study|Death|0|||
149155711|NCT01790503|538047609|FG008|Overall Study|Death|0|||
149155712|NCT01790503|538047610|FG009|Overall Study|Death|1|||
149155713|NCT01790503|538047611|FG010|Overall Study|Death|0|||
149155714|NCT01790503|538047601|FG000|Overall Study|Non Compliance|0|||
149155715|NCT01790503|538047602|FG001|Overall Study|Non Compliance|0|||
149155716|NCT01790503|538047603|FG002|Overall Study|Non Compliance|0|||
149155717|NCT01790503|538047604|FG003|Overall Study|Non Compliance|0|||
149155718|NCT01790503|538047605|FG004|Overall Study|Non Compliance|1|||
149155719|NCT01790503|538047606|FG005|Overall Study|Non Compliance|0|||
149155720|NCT01790503|538047607|FG006|Overall Study|Non Compliance|0|||
149155721|NCT01790503|538047608|FG007|Overall Study|Non Compliance|0|||
149155722|NCT01790503|538047609|FG008|Overall Study|Non Compliance|0|||
149155723|NCT01790503|538047610|FG009|Overall Study|Non Compliance|0|||
149155724|NCT01790503|538047611|FG010|Overall Study|Non Compliance|0|||
149155725|NCT01790503|538047601|FG000|Overall Study|Other|0|||
149155726|NCT01790503|538047602|FG001|Overall Study|Other|0|||
149155727|NCT01790503|538047603|FG002|Overall Study|Other|0|||
149155728|NCT01790503|538047604|FG003|Overall Study|Other|0|||
149155729|NCT01790503|538047605|FG004|Overall Study|Other|1|||
149155730|NCT01790503|538047606|FG005|Overall Study|Other|0|||
149155731|NCT01790503|538047607|FG006|Overall Study|Other|0|||
149155732|NCT01790503|538047608|FG007|Overall Study|Other|0|||
149155733|NCT01790503|538047609|FG008|Overall Study|Other|1|||
149155734|NCT01790503|538047610|FG009|Overall Study|Other|2|||
149155735|NCT01790503|538047611|FG010|Overall Study|Other|0|||
149155736|NCT02322710|538047614|FG000|Overall Study|No efficacy assessment post-baseline|0|||
149155737|NCT02322710|538047615|FG001|Overall Study|No efficacy assessment post-baseline|1|||
149155738|NCT02322710|538047614|FG000|Overall Study|Protocol Violation|20|||
149155739|NCT02322710|538047615|FG001|Overall Study|Protocol Violation|25|||
149155740|NCT00122135|538047617|FG000|Overall Study|Withdrawal by Subject|3|||
149155741|NCT00122135|538047618|FG001|Overall Study|Withdrawal by Subject|0|||
149155742|NCT02770326|538047622|FG000|Overall Study|Death|3|||
149155743|NCT02770326|538047622|FG000|Overall Study|Lost to Follow-up|1|||
149155744|NCT02479802|538047628|FG000|Overall Study|Lost to Follow-up|1|||
149155745|NCT02479802|538047628|FG000|Overall Study|Adverse Event|1|||
149155746|NCT03124784|538047629|FG000|Overall Study|Adverse Event|1|||
149155747|NCT03124784|538047629|FG000|Overall Study|Computer/Equip Malfunction|1|||
148672857|NCT03345485|536272513|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
148672858|NCT03345485|536272514|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
149155748|NCT05702515|538047630|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
149155749|NCT03757988|538047631|FG000|Overall Study|Withdrawal by Subject|1|||
149155750|NCT01121393|538047634|FG000|Overall Study|Progressive disease|201|||
149155751|NCT01121393|538047635|FG001|Overall Study|Progressive disease|20|||
149155752|NCT01121393|538047634|FG000|Overall Study|Other Adverse events|24|||
149155753|NCT01121393|538047635|FG001|Overall Study|Other Adverse events|45|||
149155754|NCT01121393|538047634|FG000|Overall Study|Non-compliant with protocol|0|||
149155755|NCT01121393|538047635|FG001|Overall Study|Non-compliant with protocol|3|||
149155756|NCT01121393|538047634|FG000|Overall Study|Lost to Follow-up|1|||
149155757|NCT01121393|538047635|FG001|Overall Study|Lost to Follow-up|0|||
149155758|NCT01121393|538047634|FG000|Overall Study|Refused cont. medication|7|||
149155759|NCT01121393|538047635|FG001|Overall Study|Refused cont. medication|7|||
149155760|NCT01121393|538047634|FG000|Overall Study|Not treated|3|||
149155761|NCT01121393|538047635|FG001|Overall Study|Not treated|9|||
149155762|NCT01121393|538047634|FG000|Overall Study|Other than listed|6|||
149155763|NCT01121393|538047635|FG001|Overall Study|Other than listed|0|||
149155764|NCT04372927|538047636|FG000|Overall Study|Death|1|||
149155765|NCT00577993|538047637|FG000|Overall Study|Adverse Event|1|||
149155766|NCT00577993|538047638|FG001|Overall Study|Adverse Event|0|||
149155767|NCT00577993|538047639|FG002|Overall Study|Adverse Event|0|||
149155768|NCT00577993|538047637|FG000|Overall Study|Death|0|||
149155769|NCT00577993|538047638|FG001|Overall Study|Death|1|||
149155770|NCT00577993|538047639|FG002|Overall Study|Death|1|||
149155771|NCT00577993|538047637|FG000|Overall Study|Lack of Efficacy|0|||
149155772|NCT00577993|538047638|FG001|Overall Study|Lack of Efficacy|1|||
149155773|NCT00577993|538047639|FG002|Overall Study|Lack of Efficacy|0|||
149155774|NCT00577993|538047637|FG000|Overall Study|Protocol Violation|2|||
149155775|NCT00577993|538047638|FG001|Overall Study|Protocol Violation|3|||
149155776|NCT00577993|538047639|FG002|Overall Study|Protocol Violation|0|||
149155777|NCT00577993|538047637|FG000|Overall Study|Withdrawal by Subject|1|||
149155778|NCT00577993|538047638|FG001|Overall Study|Withdrawal by Subject|0|||
149155779|NCT00577993|538047639|FG002|Overall Study|Withdrawal by Subject|2|||
149155780|NCT00577993|538047637|FG000|Overall Study|Conversion|2|||
149155781|NCT00577993|538047638|FG001|Overall Study|Conversion|5|||
149155782|NCT00577993|538047639|FG002|Overall Study|Conversion|0|||
149155783|NCT00577993|538047637|FG000|Overall Study|Uninsured|1|||
149155784|NCT00577993|538047638|FG001|Overall Study|Uninsured|0|||
149155785|NCT00577993|538047639|FG002|Overall Study|Uninsured|0|||
149155786|NCT00608985|538047647|FG000|Overall Study|Adverse Event|2|||
149155787|NCT00608985|538047648|FG001|Overall Study|Adverse Event|7|||
149155788|NCT00608985|538047649|FG002|Overall Study|Adverse Event|4|||
149155789|NCT00608985|538047650|FG003|Overall Study|Adverse Event|6|||
149155790|NCT00608985|538047647|FG000|Overall Study|Administrative/Other|7|||
149155791|NCT00608985|538047648|FG001|Overall Study|Administrative/Other|4|||
149155792|NCT00608985|538047649|FG002|Overall Study|Administrative/Other|1|||
149155793|NCT00608985|538047650|FG003|Overall Study|Administrative/Other|2|||
149155794|NCT00608985|538047647|FG000|Overall Study|Withdrawal of Consent|5|||
149155795|NCT00608985|538047648|FG001|Overall Study|Withdrawal of Consent|1|||
149155796|NCT00608985|538047649|FG002|Overall Study|Withdrawal of Consent|1|||
149155797|NCT00608985|538047650|FG003|Overall Study|Withdrawal of Consent|1|||
149155798|NCT00608985|538047647|FG000|Overall Study|Lost to Follow-up|2|||
149155799|NCT00608985|538047648|FG001|Overall Study|Lost to Follow-up|1|||
149155800|NCT00608985|538047649|FG002|Overall Study|Lost to Follow-up|0|||
149155801|NCT00608985|538047650|FG003|Overall Study|Lost to Follow-up|0|||
149155802|NCT03033745|538047651|FG000|Overall Study|Protocol Violation|0|||
149155803|NCT03033745|538047652|FG001|Overall Study|Protocol Violation|0|||
149155804|NCT03033745|538047653|FG002|Overall Study|Protocol Violation|1|||
149155805|NCT03033745|538047651|FG000|Overall Study|Adverse Event|1|||
149155806|NCT03033745|538047652|FG001|Overall Study|Adverse Event|0|||
149155807|NCT03033745|538047653|FG002|Overall Study|Adverse Event|1|||
149155808|NCT03033745|538047651|FG000|Overall Study|Withdrawal by Subject|0|||
149155809|NCT03033745|538047652|FG001|Overall Study|Withdrawal by Subject|1|||
149155810|NCT03033745|538047653|FG002|Overall Study|Withdrawal by Subject|0|||
149155811|NCT02706730|538047654|FG000|Overall Study|Adverse Event|3|||
149155812|NCT02706730|538047654|FG000|Overall Study|Lack of Efficacy|5|||
149155813|NCT02706730|538047654|FG000|Overall Study|Withdrawal by Subject|11|||
149155814|NCT02706730|538047654|FG000|Overall Study|Study Terminated by Sponsor|11|||
149155815|NCT02706730|538047654|FG000|Overall Study|Subject chose not to receive injection|3|||
149155816|NCT02499029|538047655|FG000|Overall Study|Lost to Follow-up|2|||
149155817|NCT02499029|538047656|FG001|Overall Study|Lost to Follow-up|2|||
149155818|NCT02499029|538047655|FG000|Overall Study|Physician Decision|2|||
149155819|NCT02499029|538047656|FG001|Overall Study|Physician Decision|1|||
149155820|NCT02499029|538047655|FG000|Overall Study|Death|1|||
149155821|NCT02499029|538047656|FG001|Overall Study|Death|0|||
149155822|NCT01999582|538047657|FG000|Overall Study|Withdrawal by Subject|0|||
149155823|NCT01999582|538047658|FG001|Overall Study|Withdrawal by Subject|0|||
149155824|NCT01999582|538047659|FG002|Overall Study|Withdrawal by Subject|0|||
149155825|NCT01999582|538047660|FG003|Overall Study|Withdrawal by Subject|1|||
149155826|NCT01999582|538047661|FG004|Overall Study|Withdrawal by Subject|0|||
149155827|NCT01999582|538047662|FG005|Overall Study|Withdrawal by Subject|0|||
149155828|NCT01999582|538047657|FG000|Overall Study|Adverse Event|0|||
149155829|NCT01999582|538047658|FG001|Overall Study|Adverse Event|0|||
149155830|NCT01999582|538047659|FG002|Overall Study|Adverse Event|3|||
149155831|NCT01999582|538047660|FG003|Overall Study|Adverse Event|0|||
149155832|NCT01999582|538047661|FG004|Overall Study|Adverse Event|1|||
149155833|NCT01999582|538047662|FG005|Overall Study|Adverse Event|0|||
149155834|NCT01999582|538047657|FG000|Overall Study|Other Reasons|1|||
149155835|NCT01999582|538047658|FG001|Overall Study|Other Reasons|0|||
149155836|NCT01999582|538047659|FG002|Overall Study|Other Reasons|3|||
149155837|NCT01999582|538047660|FG003|Overall Study|Other Reasons|1|||
149155838|NCT01999582|538047661|FG004|Overall Study|Other Reasons|1|||
149155839|NCT01999582|538047662|FG005|Overall Study|Other Reasons|2|||
149155840|NCT01999582|538047657|FG000|Overall Study|Protocol Violation|1|||
149155841|NCT01999582|538047658|FG001|Overall Study|Protocol Violation|0|||
149155842|NCT01999582|538047659|FG002|Overall Study|Protocol Violation|0|||
149155843|NCT01999582|538047660|FG003|Overall Study|Protocol Violation|0|||
149155844|NCT01999582|538047661|FG004|Overall Study|Protocol Violation|0|||
149155845|NCT01999582|538047662|FG005|Overall Study|Protocol Violation|1|||
149155846|NCT01999582|538047657|FG000|Overall Study|Lack of Efficacy|1|||
149155847|NCT01999582|538047658|FG001|Overall Study|Lack of Efficacy|3|||
149155848|NCT01999582|538047659|FG002|Overall Study|Lack of Efficacy|0|||
149155849|NCT01999582|538047660|FG003|Overall Study|Lack of Efficacy|1|||
149155850|NCT01999582|538047661|FG004|Overall Study|Lack of Efficacy|0|||
149155851|NCT01999582|538047662|FG005|Overall Study|Lack of Efficacy|0|||
149155852|NCT01081795|538047665|FG000|Overall Study|Adverse Event|18|||
149155853|NCT01081795|538047666|FG001|Overall Study|Adverse Event|23|||
149155854|NCT01081795|538047667|FG002|Overall Study|Adverse Event|6|||
149155855|NCT01081795|538047665|FG000|Overall Study|Lack of Efficacy|7|||
149155856|NCT01081795|538047666|FG001|Overall Study|Lack of Efficacy|5|||
149155857|NCT01081795|538047667|FG002|Overall Study|Lack of Efficacy|19|||
149155858|NCT01081795|538047665|FG000|Overall Study|Subject's schedule|1|||
149155859|NCT01081795|538047666|FG001|Overall Study|Subject's schedule|1|||
149155860|NCT01081795|538047667|FG002|Overall Study|Subject's schedule|2|||
149155861|NCT01081795|538047665|FG000|Overall Study|Revocation of informed consent|2|||
149155862|NCT01081795|538047666|FG001|Overall Study|Revocation of informed consent|0|||
149155863|NCT01081795|538047667|FG002|Overall Study|Revocation of informed consent|0|||
149155864|NCT01081795|538047665|FG000|Overall Study|Ineligible for participation|1|||
149155865|NCT01081795|538047666|FG001|Overall Study|Ineligible for participation|0|||
149155866|NCT01081795|538047667|FG002|Overall Study|Ineligible for participation|0|||
149155867|NCT01081795|538047665|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
149155868|NCT01081795|538047666|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
149155869|NCT01081795|538047667|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
149155870|NCT01081795|538047665|FG000|Overall Study|Using drug with restricted days of use|2|||
149155871|NCT01081795|538047666|FG001|Overall Study|Using drug with restricted days of use|3|||
149155872|NCT01081795|538047667|FG002|Overall Study|Using drug with restricted days of use|2|||
149155873|NCT01081795|538047665|FG000|Overall Study|Other|1|||
149155874|NCT01081795|538047666|FG001|Overall Study|Other|2|||
149155875|NCT01081795|538047667|FG002|Overall Study|Other|0|||
149155876|NCT02462473|538047668|FG000|Overall Study|Death|1|||
149155877|NCT02462473|538047668|FG000|Overall Study|Other|3|||
149155878|NCT00661271|538047669|FG000|Overall Study|Lost to Follow-up|28|||
149155879|NCT00661271|538047670|FG001|Overall Study|Lost to Follow-up|25|||
149155880|NCT00953758|538047672|FG000|Overall Study|Death|2|||
149155881|NCT00953758|538047673|FG001|Overall Study|Death|0|||
149155882|NCT00953758|538047674|FG002|Overall Study|Death|1|||
149155883|NCT00953758|538047675|FG003|Overall Study|Death|1|||
149155884|NCT00953758|538047676|FG004|Overall Study|Death|1|||
149155885|NCT00953758|538047677|FG005|Overall Study|Death|1|||
149155886|NCT00953758|538047678|FG006|Overall Study|Death|1|||
149155887|NCT00953758|538047679|FG007|Overall Study|Death|3|||
149155888|NCT00953758|538047680|FG008|Overall Study|Death|1|||
149155889|NCT00953758|538047681|FG009|Overall Study|Death|0|||
149155890|NCT00953758|538047672|FG000|Overall Study|Participant refused further follow-up|0|||
149155891|NCT00953758|538047673|FG001|Overall Study|Participant refused further follow-up|0|||
149155892|NCT00953758|538047674|FG002|Overall Study|Participant refused further follow-up|1|||
149155893|NCT00953758|538047675|FG003|Overall Study|Participant refused further follow-up|0|||
149155894|NCT00953758|538047676|FG004|Overall Study|Participant refused further follow-up|3|||
149155895|NCT00953758|538047677|FG005|Overall Study|Participant refused further follow-up|0|||
149155896|NCT00953758|538047678|FG006|Overall Study|Participant refused further follow-up|0|||
149155897|NCT00953758|538047679|FG007|Overall Study|Participant refused further follow-up|0|||
149155898|NCT00953758|538047680|FG008|Overall Study|Participant refused further follow-up|1|||
148672859|NCT03345485|536272515|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
148672860|NCT03345485|536272516|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
148672861|NCT03345485|536272517|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
148672862|NCT03345485|536272518|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
149155899|NCT00953758|538047681|FG009|Overall Study|Participant refused further follow-up|0|||
149155900|NCT00953758|538047672|FG000|Overall Study|Lost to Follow-up|0|||
149155901|NCT00953758|538047673|FG001|Overall Study|Lost to Follow-up|0|||
149155902|NCT00953758|538047674|FG002|Overall Study|Lost to Follow-up|0|||
149155903|NCT00953758|538047675|FG003|Overall Study|Lost to Follow-up|1|||
149155904|NCT00953758|538047676|FG004|Overall Study|Lost to Follow-up|0|||
149155905|NCT00953758|538047677|FG005|Overall Study|Lost to Follow-up|0|||
149155906|NCT00953758|538047678|FG006|Overall Study|Lost to Follow-up|0|||
149155907|NCT00953758|538047679|FG007|Overall Study|Lost to Follow-up|1|||
148672863|NCT03345485|536272519|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
149155908|NCT00953758|538047680|FG008|Overall Study|Lost to Follow-up|0|||
149155909|NCT00953758|538047681|FG009|Overall Study|Lost to Follow-up|1|||
149155910|NCT00953758|538047672|FG000|Overall Study|Physician Decision|0|||
149155911|NCT00953758|538047673|FG001|Overall Study|Physician Decision|0|||
149155912|NCT00953758|538047674|FG002|Overall Study|Physician Decision|0|||
149155913|NCT00953758|538047675|FG003|Overall Study|Physician Decision|0|||
149155914|NCT00953758|538047676|FG004|Overall Study|Physician Decision|1|||
149155915|NCT00953758|538047677|FG005|Overall Study|Physician Decision|0|||
149155916|NCT00953758|538047678|FG006|Overall Study|Physician Decision|0|||
149155917|NCT00953758|538047679|FG007|Overall Study|Physician Decision|0|||
149155918|NCT00953758|538047680|FG008|Overall Study|Physician Decision|0|||
149155919|NCT00953758|538047681|FG009|Overall Study|Physician Decision|0|||
149155920|NCT00953758|538047672|FG000|Overall Study|Disease progression|0|||
149155921|NCT00953758|538047673|FG001|Overall Study|Disease progression|0|||
149155922|NCT00953758|538047674|FG002|Overall Study|Disease progression|0|||
149155923|NCT00953758|538047675|FG003|Overall Study|Disease progression|0|||
149155924|NCT00953758|538047676|FG004|Overall Study|Disease progression|1|||
149155925|NCT00953758|538047677|FG005|Overall Study|Disease progression|0|||
149155926|NCT00953758|538047678|FG006|Overall Study|Disease progression|0|||
149155927|NCT00953758|538047679|FG007|Overall Study|Disease progression|0|||
149155928|NCT00953758|538047680|FG008|Overall Study|Disease progression|0|||
149155929|NCT00953758|538047681|FG009|Overall Study|Disease progression|0|||
149155930|NCT00953758|538047672|FG000|Overall Study|Participant went for transplant|0|||
149155931|NCT00953758|538047673|FG001|Overall Study|Participant went for transplant|0|||
149155932|NCT00953758|538047674|FG002|Overall Study|Participant went for transplant|0|||
149155933|NCT00953758|538047675|FG003|Overall Study|Participant went for transplant|0|||
149155934|NCT00953758|538047676|FG004|Overall Study|Participant went for transplant|0|||
149155935|NCT00953758|538047677|FG005|Overall Study|Participant went for transplant|0|||
149155936|NCT00953758|538047678|FG006|Overall Study|Participant went for transplant|0|||
149155937|NCT00953758|538047679|FG007|Overall Study|Participant went for transplant|0|||
149155938|NCT00953758|538047680|FG008|Overall Study|Participant went for transplant|1|||
148672864|NCT03345485|536272520|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
148920982|NCT03011892|537194034|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
149155939|NCT00953758|538047681|FG009|Overall Study|Participant went for transplant|0|||
149155940|NCT01707693|538047683|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
149155941|NCT01707693|538047684|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
149155942|NCT01707693|538047683|FG000|Overall Study Allocation|Protocol Violation|4|||
149155943|NCT01707693|538047684|FG001|Overall Study Allocation|Protocol Violation|3|||
149155944|NCT01707693|538047683|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
149155945|NCT01707693|538047684|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
149155946|NCT01707693|538047683|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
149155947|NCT01707693|538047684|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
149155948|NCT03115151|538047686|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
149155949|NCT03115151|538047687|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
149155950|NCT03115151|538047686|FG000|Overall Study|Epidural catheter removal|1|||
149155951|NCT03115151|538047687|FG001|Overall Study|Epidural catheter removal|0|||
149155952|NCT03115151|538047686|FG000|Overall Study|Withdrawal by Subject|0|||
149155953|NCT03115151|538047687|FG001|Overall Study|Withdrawal by Subject|1|||
149155954|NCT03115151|538047686|FG000|Overall Study|Intervention not received according to the protocol.|1|||
149155955|NCT03115151|538047687|FG001|Overall Study|Intervention not received according to the protocol.|1|||
149155956|NCT03115151|538047686|FG000|Overall Study|Physician Decision|1|||
149155957|NCT03115151|538047687|FG001|Overall Study|Physician Decision|0|||
149155958|NCT03115151|538047686|FG000|Overall Study|Randomization not applied|1|||
149155959|NCT03115151|538047687|FG001|Overall Study|Randomization not applied|1|||
149155960|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
149155961|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
149155962|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
149155963|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
149155964|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149155965|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149155966|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
149155967|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149155968|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
149155969|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149155970|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149155971|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149155972|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
149155973|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
149155974|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
149155975|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
149155976|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
149155977|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
149155978|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
149155979|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
149155980|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149155981|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149155982|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149155983|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
149155984|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
149155985|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149155986|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149155987|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149155988|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149155989|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
149155990|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149155991|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
149155992|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149155993|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149155994|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
149155995|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
148805939|NCT05911841|536768046|FG002|Induction Period|Assigned Treatment by Mistake|0|||
148805940|NCT05911841|536768047|FG003|Induction Period|Assigned Treatment by Mistake|1|||
149155996|NCT03403205|538047688|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
149155997|NCT03403205|538047689|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
149155998|NCT03403205|538047690|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
149155999|NCT03403205|538047691|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
149156000|NCT03403205|538047692|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
149156001|NCT03403205|538047693|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
149156002|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
149156003|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
149156004|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
149156005|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
149156006|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
149156007|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
149156008|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
149156009|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
149156010|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
149156011|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
149156012|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
149156013|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
149156014|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Death|1|||
149156015|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Death|0|||
149156016|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Death|0|||
149156017|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Death|0|||
149156018|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Death|0|||
149156019|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Death|0|||
149156020|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
149156021|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149156022|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149156023|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149156024|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149156025|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
149156026|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
149156027|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
149156028|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
149156029|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
149156030|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
149156031|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
149156032|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
149156033|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149156034|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149156035|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149156036|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149156037|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
149156038|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
149156039|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
149156040|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
149156041|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
149156042|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
149156043|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
149156044|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
149156045|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
149156046|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
149156047|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
149156048|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
149156049|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
149156050|NCT03403205|538047688|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
149156051|NCT03403205|538047689|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
149156052|NCT03403205|538047690|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
149156053|NCT03403205|538047691|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
149156054|NCT03403205|538047692|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
148920983|NCT03011892|537194035|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
148920984|NCT03011892|537194036|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
148920985|NCT03011892|537194037|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
148920986|NCT03011892|537194038|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
149156055|NCT03403205|538047693|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
149156056|NCT00706030|538047694|FG000|Overall Study|Disease Progression|4|||
149156057|NCT00706030|538047695|FG001|Overall Study|Disease Progression|6|||
149156058|NCT00706030|538047696|FG002|Overall Study|Disease Progression|46|||
149156059|NCT00706030|538047697|FG003|Overall Study|Disease Progression|12|||
149156060|NCT00706030|538047694|FG000|Overall Study|Adverse Event|1|||
149156061|NCT00706030|538047695|FG001|Overall Study|Adverse Event|0|||
149156062|NCT00706030|538047696|FG002|Overall Study|Adverse Event|4|||
149156063|NCT00706030|538047697|FG003|Overall Study|Adverse Event|2|||
149156064|NCT00706030|538047694|FG000|Overall Study|Withdrawal by Subject|1|||
148920987|NCT03011892|537194039|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
148920988|NCT03011892|537194040|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
149156065|NCT00706030|538047695|FG001|Overall Study|Withdrawal by Subject|0|||
149156066|NCT00706030|538047696|FG002|Overall Study|Withdrawal by Subject|2|||
149156067|NCT00706030|538047697|FG003|Overall Study|Withdrawal by Subject|0|||
149156068|NCT00706030|538047694|FG000|Overall Study|Physician Decision|0|||
149156069|NCT00706030|538047695|FG001|Overall Study|Physician Decision|0|||
148920989|NCT03011892|537194041|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
148920990|NCT03011892|537194042|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
148920991|NCT03011892|537194031|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
148920992|NCT03011892|537194032|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
148920993|NCT03011892|537194033|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
148920994|NCT03011892|537194034|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
148920995|NCT03011892|537194035|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
149156070|NCT00706030|538047696|FG002|Overall Study|Physician Decision|2|||
148920996|NCT03011892|537194036|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
148920997|NCT03011892|537194037|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
148920998|NCT03011892|537194038|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
148920999|NCT03011892|537194039|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
148921000|NCT03011892|537194040|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
148921001|NCT03011892|537194041|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
148921002|NCT03011892|537194042|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
148921003|NCT03011892|537194031|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
148921004|NCT03011892|537194032|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
149156071|NCT00706030|538047697|FG003|Overall Study|Physician Decision|0|||
149156072|NCT00706030|538047694|FG000|Overall Study|Not recorded|0|||
149156073|NCT00706030|538047695|FG001|Overall Study|Not recorded|0|||
149156074|NCT00706030|538047696|FG002|Overall Study|Not recorded|2|||
149156075|NCT00706030|538047697|FG003|Overall Study|Not recorded|0|||
149156076|NCT00706030|538047694|FG000|Overall Study|Protocol Violation|0|||
149156077|NCT00706030|538047695|FG001|Overall Study|Protocol Violation|0|||
149156078|NCT00706030|538047696|FG002|Overall Study|Protocol Violation|1|||
149156079|NCT00706030|538047697|FG003|Overall Study|Protocol Violation|1|||
149156080|NCT00706030|538047694|FG000|Overall Study|Failed to return|0|||
149156081|NCT00706030|538047695|FG001|Overall Study|Failed to return|0|||
149156082|NCT00706030|538047696|FG002|Overall Study|Failed to return|1|||
149156083|NCT00706030|538047697|FG003|Overall Study|Failed to return|0|||
149156084|NCT00706030|538047694|FG000|Overall Study|Symptomatic Deterioration|0|||
149156085|NCT00706030|538047695|FG001|Overall Study|Symptomatic Deterioration|0|||
149156086|NCT00706030|538047696|FG002|Overall Study|Symptomatic Deterioration|1|||
149156087|NCT00706030|538047697|FG003|Overall Study|Symptomatic Deterioration|0|||
149156088|NCT00706030|538047694|FG000|Overall Study|No treatment received|0|||
149156089|NCT00706030|538047695|FG001|Overall Study|No treatment received|0|||
149156090|NCT00706030|538047696|FG002|Overall Study|No treatment received|0|||
149156091|NCT00706030|538047697|FG003|Overall Study|No treatment received|1|||
149156092|NCT00706030|538047694|FG000|Overall Study|Death|0|||
149156093|NCT00706030|538047695|FG001|Overall Study|Death|0|||
149156094|NCT00706030|538047696|FG002|Overall Study|Death|1|||
149156095|NCT00706030|538047697|FG003|Overall Study|Death|0|||
149156096|NCT05779072|538047698|FG000|Overall Study|Lost to Follow-up|0|||
149156097|NCT05779072|538047699|FG001|Overall Study|Lost to Follow-up|1|||
149156098|NCT05779072|538047698|FG000|Overall Study|Withdrawal by Subject|1|||
149156099|NCT05779072|538047699|FG001|Overall Study|Withdrawal by Subject|5|||
149156100|NCT02682901|538047700|FG000|Overall Study|Adverse Event|10|||
149156101|NCT02682901|538047701|FG001|Overall Study|Adverse Event|3|||
149156102|NCT02682901|538047700|FG000|Overall Study|Lack of Efficacy|0|||
149156103|NCT02682901|538047701|FG001|Overall Study|Lack of Efficacy|1|||
149156104|NCT03713944|538047702|FG000|Study Treatment|Patient non-compliance|1|||
149156105|NCT03713944|538047702|FG000|Study Treatment|Alternative Cancer Therapy|3|||
149156106|NCT03713944|538047702|FG000|Study Treatment|Disease Progression|18|||
149156107|NCT03713944|538047702|FG000|Study Treatment|AE/Side Effects/Complications|2|||
149156108|NCT03713944|538047702|FG000|Study Treatment|Death|2|||
149156109|NCT03713944|538047702|FG000|Study Treatment|Withdrawal by Subject|1|||
149156110|NCT03713944|538047702|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
149156111|NCT03713944|538047702|FG000|Study Treatment|Symptomatic Deterioration|2|||
149156112|NCT03713944|538047702|FG000|Follow up|Withdrawal by Subject|2|||
149156113|NCT03713944|538047702|FG000|Follow up|Death|11|||
149156114|NCT03713944|538047702|FG000|Follow up|Study Terminated|3|||
149156115|NCT03847610|538047703|FG000|Overall Study|Withdrawal by Subject|1|||
149156116|NCT03298022|538047704|FG000|Overall Study|Lack of Efficacy|4|||
149156117|NCT03298022|538047704|FG000|Overall Study|Withdrawal by Subject|7|||
149156118|NCT03298022|538047704|FG000|Overall Study|Adverse Event|1|||
149156119|NCT03298022|538047704|FG000|Overall Study|disease relapse|1|||
149156120|NCT01445769|538047705|FG000|Overall Study|Consent Withdrawn|2|||
149156121|NCT01445769|538047705|FG000|Overall Study|Disease Progression|1|||
148921005|NCT03011892|537194033|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
148921006|NCT03011892|537194034|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
148921007|NCT03011892|537194035|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
148921008|NCT03011892|537194036|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
148921009|NCT03011892|537194037|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
148921010|NCT03011892|537194038|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
148921011|NCT03011892|537194039|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
148921012|NCT03011892|537194040|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
148921013|NCT03011892|537194041|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
148921014|NCT03011892|537194042|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
148921015|NCT03011892|537194031|FG000|Open Label (OL) Period|Reason not specified|0|||
149156122|NCT01445769|538047705|FG000|Overall Study|Lost to Follow-up|5|||
149156123|NCT00487539|538047710|FG000|Overall Study|Adverse Event|3|||
149156124|NCT00487539|538047711|FG001|Overall Study|Adverse Event|2|||
149156125|NCT00487539|538047712|FG002|Overall Study|Adverse Event|1|||
149156126|NCT00487539|538047713|FG003|Overall Study|Adverse Event|1|||
149156127|NCT00487539|538047710|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149156128|NCT00487539|538047711|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149156129|NCT00487539|538047712|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149156130|NCT00487539|538047713|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
149156131|NCT00487539|538047710|FG000|Overall Study|Other|3|||
149156132|NCT00487539|538047711|FG001|Overall Study|Other|1|||
149156133|NCT00487539|538047712|FG002|Overall Study|Other|2|||
149156134|NCT00487539|538047713|FG003|Overall Study|Other|2|||
149156135|NCT02751502|538047714|FG000|Overall Study|Lack of funding|4|||
149156136|NCT02695628|538047715|FG000|Overall Study|Withdrawal by Subject|1|||
149156137|NCT02678390|538047716|FG000|AE (1 Day)|Withdrawal by Subject|0|||
149156138|NCT02678390|538047717|FG001|AE (1 Day)|Withdrawal by Subject|1|||
149156139|NCT00852995|538047718|FG000|Overall Study|Adverse Event|1|||
149156140|NCT00852995|538047719|FG001|Overall Study|Adverse Event|0|||
149156141|NCT00852995|538047720|FG002|Overall Study|Adverse Event|4|||
149156142|NCT00852995|538047721|FG003|Overall Study|Adverse Event|0|||
149156143|NCT00852995|538047722|FG004|Overall Study|Adverse Event|0|||
149156144|NCT00852995|538047718|FG000|Overall Study|Lost to Follow-up|0|||
149156145|NCT00852995|538047719|FG001|Overall Study|Lost to Follow-up|1|||
149156146|NCT00852995|538047720|FG002|Overall Study|Lost to Follow-up|1|||
149156147|NCT00852995|538047721|FG003|Overall Study|Lost to Follow-up|0|||
149156148|NCT00852995|538047722|FG004|Overall Study|Lost to Follow-up|0|||
149156149|NCT00852995|538047718|FG000|Overall Study|Withdrawal by Subject|4|||
149156150|NCT00852995|538047719|FG001|Overall Study|Withdrawal by Subject|0|||
149156151|NCT00852995|538047720|FG002|Overall Study|Withdrawal by Subject|0|||
149156152|NCT00852995|538047721|FG003|Overall Study|Withdrawal by Subject|1|||
149156153|NCT00852995|538047722|FG004|Overall Study|Withdrawal by Subject|2|||
149156154|NCT00852995|538047718|FG000|Overall Study|Non-Compliance|0|||
149156155|NCT00852995|538047719|FG001|Overall Study|Non-Compliance|0|||
149156156|NCT00852995|538047720|FG002|Overall Study|Non-Compliance|0|||
149156157|NCT00852995|538047721|FG003|Overall Study|Non-Compliance|2|||
149156158|NCT00852995|538047722|FG004|Overall Study|Non-Compliance|0|||
149156159|NCT00852995|538047718|FG000|Overall Study|Progressive Disease|1|||
149156160|NCT00852995|538047719|FG001|Overall Study|Progressive Disease|0|||
149156161|NCT00852995|538047720|FG002|Overall Study|Progressive Disease|0|||
149156162|NCT00852995|538047721|FG003|Overall Study|Progressive Disease|2|||
149156163|NCT00852995|538047722|FG004|Overall Study|Progressive Disease|1|||
149156164|NCT00852995|538047718|FG000|Overall Study|Physician Decision|1|||
149156165|NCT00852995|538047719|FG001|Overall Study|Physician Decision|0|||
149156166|NCT00852995|538047720|FG002|Overall Study|Physician Decision|0|||
149156167|NCT00852995|538047721|FG003|Overall Study|Physician Decision|0|||
149156168|NCT00852995|538047722|FG004|Overall Study|Physician Decision|0|||
149156169|NCT00852995|538047718|FG000|Overall Study|Protocol Violation|0|||
149156170|NCT00852995|538047719|FG001|Overall Study|Protocol Violation|0|||
149156171|NCT00852995|538047720|FG002|Overall Study|Protocol Violation|0|||
149156172|NCT00852995|538047721|FG003|Overall Study|Protocol Violation|0|||
149156173|NCT00852995|538047722|FG004|Overall Study|Protocol Violation|1|||
149156174|NCT00852995|538047718|FG000|Overall Study|Moved Out of Area|1|||
149156175|NCT00852995|538047719|FG001|Overall Study|Moved Out of Area|0|||
149156176|NCT00852995|538047720|FG002|Overall Study|Moved Out of Area|0|||
149156177|NCT00852995|538047721|FG003|Overall Study|Moved Out of Area|0|||
149156178|NCT00852995|538047722|FG004|Overall Study|Moved Out of Area|0|||
149156179|NCT00720109|538047723|FG000|Induction Period|Did not meet eligibility criteria|3|||
149156180|NCT00720109|538047724|FG001|Induction Period|Did not meet eligibility criteria|0|||
149156181|NCT00720109|538047725|FG002|Induction Period|Did not meet eligibility criteria|0|||
149156182|NCT00720109|538047723|FG000|Induction Period|Bone Marrow Transplant|2|||
149156183|NCT00720109|538047724|FG001|Induction Period|Bone Marrow Transplant|0|||
149156184|NCT00720109|538047725|FG002|Induction Period|Bone Marrow Transplant|0|||
149156185|NCT00720109|538047723|FG000|Induction Period|Physician Decision|1|||
149156186|NCT00720109|538047724|FG001|Induction Period|Physician Decision|0|||
149156187|NCT00720109|538047725|FG002|Induction Period|Physician Decision|0|||
149156188|NCT00720109|538047723|FG000|Risk Stratification Period|Adverse Event|0|||
149156189|NCT00720109|538047724|FG001|Risk Stratification Period|Adverse Event|1|||
149156190|NCT00720109|538047725|FG002|Risk Stratification Period|Adverse Event|0|||
149156191|NCT00720109|538047723|FG000|Risk Stratification Period|Physician Decision|0|||
149156192|NCT00720109|538047724|FG001|Risk Stratification Period|Physician Decision|2|||
149156193|NCT00720109|538047725|FG002|Risk Stratification Period|Physician Decision|1|||
149156194|NCT00720109|538047723|FG000|Risk Stratification Period|Bone marrow transplant|0|||
149156195|NCT00720109|538047724|FG001|Risk Stratification Period|Bone marrow transplant|9|||
149156196|NCT00720109|538047725|FG002|Risk Stratification Period|Bone marrow transplant|7|||
149156197|NCT00720109|538047723|FG000|Risk Stratification Period|Disease progression or relapse|0|||
149156198|NCT00720109|538047724|FG001|Risk Stratification Period|Disease progression or relapse|2|||
149156199|NCT00720109|538047725|FG002|Risk Stratification Period|Disease progression or relapse|0|||
149156200|NCT00720109|538047723|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
149156201|NCT00720109|538047724|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
149156202|NCT00720109|538047725|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
149156203|NCT03595553|538047726|FG000|Overall Study|Withdrawal by Subject|20|||
149156204|NCT03595553|538047727|FG001|Overall Study|Withdrawal by Subject|8|||
149156205|NCT03595553|538047726|FG000|Overall Study|Physician Decision|3|||
149156206|NCT03595553|538047727|FG001|Overall Study|Physician Decision|2|||
149156207|NCT03595553|538047726|FG000|Overall Study|Adverse Event|2|||
149156208|NCT03595553|538047727|FG001|Overall Study|Adverse Event|5|||
149156209|NCT03595553|538047726|FG000|Overall Study|Death|24|||
149156210|NCT03595553|538047727|FG001|Overall Study|Death|22|||
149156211|NCT03595553|538047726|FG000|Overall Study|Lost to Follow-up|6|||
149156212|NCT03595553|538047727|FG001|Overall Study|Lost to Follow-up|7|||
149156213|NCT03595553|538047726|FG000|Overall Study|Other as indicated in CSR|3|||
149156214|NCT03595553|538047727|FG001|Overall Study|Other as indicated in CSR|3|||
149156215|NCT03595553|538047726|FG000|Overall Study|Sponsor Decision|0|||
149156216|NCT03595553|538047727|FG001|Overall Study|Sponsor Decision|1|||
149156217|NCT03467958|538047729|FG000|Overall Study|Adverse Event|20|||
149156218|NCT03467958|538047730|FG001|Overall Study|Adverse Event|32|||
149156219|NCT03467958|538047731|FG002|Overall Study|Adverse Event|5|||
149156220|NCT03467958|538047732|FG003|Overall Study|Adverse Event|3|||
149156221|NCT03467958|538047733|FG004|Overall Study|Adverse Event|3|||
149156222|NCT03467958|538047734|FG005|Overall Study|Adverse Event|3|||
149156223|NCT03467958|538047735|FG006|Overall Study|Adverse Event|6|||
149156224|NCT03467958|538047736|FG007|Overall Study|Adverse Event|5|||
149156225|NCT03467958|538047737|FG008|Overall Study|Adverse Event|0|||
149156226|NCT03467958|538047729|FG000|Overall Study|Lack of Efficacy|59|||
149156227|NCT03467958|538047730|FG001|Overall Study|Lack of Efficacy|120|||
149156228|NCT03467958|538047731|FG002|Overall Study|Lack of Efficacy|6|||
149156229|NCT03467958|538047732|FG003|Overall Study|Lack of Efficacy|9|||
149156230|NCT03467958|538047733|FG004|Overall Study|Lack of Efficacy|8|||
149156231|NCT03467958|538047734|FG005|Overall Study|Lack of Efficacy|9|||
149156232|NCT03467958|538047735|FG006|Overall Study|Lack of Efficacy|11|||
149156233|NCT03467958|538047736|FG007|Overall Study|Lack of Efficacy|9|||
149156234|NCT03467958|538047737|FG008|Overall Study|Lack of Efficacy|3|||
149156235|NCT03467958|538047729|FG000|Overall Study|Lost to Follow-up|1|||
149156236|NCT03467958|538047730|FG001|Overall Study|Lost to Follow-up|2|||
149156237|NCT03467958|538047731|FG002|Overall Study|Lost to Follow-up|1|||
149156238|NCT03467958|538047732|FG003|Overall Study|Lost to Follow-up|0|||
149156239|NCT03467958|538047733|FG004|Overall Study|Lost to Follow-up|4|||
149156240|NCT03467958|538047734|FG005|Overall Study|Lost to Follow-up|0|||
149156241|NCT03467958|538047735|FG006|Overall Study|Lost to Follow-up|0|||
149156242|NCT03467958|538047736|FG007|Overall Study|Lost to Follow-up|0|||
149156243|NCT03467958|538047737|FG008|Overall Study|Lost to Follow-up|0|||
149156244|NCT03467958|538047729|FG000|Overall Study|Other reasons|8|||
149156245|NCT03467958|538047730|FG001|Overall Study|Other reasons|14|||
149156246|NCT03467958|538047731|FG002|Overall Study|Other reasons|2|||
149156247|NCT03467958|538047732|FG003|Overall Study|Other reasons|1|||
149156248|NCT03467958|538047733|FG004|Overall Study|Other reasons|4|||
149156249|NCT03467958|538047734|FG005|Overall Study|Other reasons|0|||
149156250|NCT03467958|538047735|FG006|Overall Study|Other reasons|1|||
149156251|NCT03467958|538047736|FG007|Overall Study|Other reasons|0|||
149156252|NCT03467958|538047737|FG008|Overall Study|Other reasons|1|||
149156253|NCT03467958|538047729|FG000|Overall Study|Pregnancy|1|||
149156254|NCT03467958|538047730|FG001|Overall Study|Pregnancy|0|||
149156255|NCT03467958|538047731|FG002|Overall Study|Pregnancy|0|||
149156256|NCT03467958|538047732|FG003|Overall Study|Pregnancy|0|||
149156257|NCT03467958|538047733|FG004|Overall Study|Pregnancy|0|||
149156258|NCT03467958|538047734|FG005|Overall Study|Pregnancy|1|||
149156259|NCT03467958|538047735|FG006|Overall Study|Pregnancy|0|||
149156260|NCT03467958|538047736|FG007|Overall Study|Pregnancy|0|||
149156261|NCT03467958|538047737|FG008|Overall Study|Pregnancy|0|||
149156262|NCT03467958|538047729|FG000|Overall Study|Study terminated by sponsor|65|||
149156263|NCT03467958|538047730|FG001|Overall Study|Study terminated by sponsor|117|||
149156264|NCT03467958|538047731|FG002|Overall Study|Study terminated by sponsor|45|||
149156265|NCT03467958|538047732|FG003|Overall Study|Study terminated by sponsor|64|||
149156266|NCT03467958|538047733|FG004|Overall Study|Study terminated by sponsor|66|||
149012838|NCT01468922|537525820|FG007|Overall Study|Enrolled on new protocol|0|||
149156267|NCT03467958|538047734|FG005|Overall Study|Study terminated by sponsor|17|||
149156268|NCT03467958|538047735|FG006|Overall Study|Study terminated by sponsor|11|||
149156269|NCT03467958|538047736|FG007|Overall Study|Study terminated by sponsor|5|||
149156270|NCT03467958|538047737|FG008|Overall Study|Study terminated by sponsor|5|||
149156271|NCT03467958|538047729|FG000|Overall Study|Withdrawal by Subject|25|||
149156272|NCT03467958|538047730|FG001|Overall Study|Withdrawal by Subject|44|||
149156273|NCT03467958|538047731|FG002|Overall Study|Withdrawal by Subject|7|||
149156274|NCT03467958|538047732|FG003|Overall Study|Withdrawal by Subject|8|||
149156275|NCT03467958|538047733|FG004|Overall Study|Withdrawal by Subject|6|||
149156276|NCT03467958|538047734|FG005|Overall Study|Withdrawal by Subject|8|||
149156277|NCT03467958|538047735|FG006|Overall Study|Withdrawal by Subject|4|||
149156278|NCT03467958|538047736|FG007|Overall Study|Withdrawal by Subject|1|||
149156279|NCT03467958|538047737|FG008|Overall Study|Withdrawal by Subject|4|||
149156280|NCT02925156|538047738|FG000|Overall Study|Lost to Follow-up|27|||
149156281|NCT02925156|538047739|FG001|Overall Study|Lost to Follow-up|53|||
149156282|NCT02925156|538047740|FG002|Overall Study|Lost to Follow-up|51|||
149156283|NCT02925156|538047741|FG003|Overall Study|Lost to Follow-up|59|||
149156284|NCT02925156|538047742|FG004|Overall Study|Lost to Follow-up|89|||
149156285|NCT02925156|538047743|FG005|Overall Study|Lost to Follow-up|107|||
149156286|NCT02925156|538047744|FG006|Overall Study|Lost to Follow-up|34|||
149156287|NCT02925156|538047745|FG007|Overall Study|Lost to Follow-up|36|||
149156288|NCT02925156|538047746|FG008|Overall Study|Lost to Follow-up|73|||
149156289|NCT02925156|538047747|FG009|Overall Study|Lost to Follow-up|34|||
149156290|NCT01844895|538047750|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
149156291|NCT01844895|538047750|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
149156292|NCT01844895|538047750|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
149156293|NCT01844895|538047750|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
149156294|NCT01844895|538047750|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
149156295|NCT01844895|538047750|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
149156296|NCT01844895|538047750|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
149156297|NCT03208231|538047753|FG000|Overall Study|Death|1|||
149156298|NCT03208231|538047754|FG001|Overall Study|Death|2|||
149156299|NCT03208231|538047753|FG000|Overall Study|Moved and unable to get to clinic|1|||
149156300|NCT03208231|538047754|FG001|Overall Study|Moved and unable to get to clinic|0|||
149156301|NCT03208231|538047753|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
149156302|NCT03208231|538047754|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
149156303|NCT01318109|538047760|FG000|Overall Study|Adverse Event|0|||
149156304|NCT01318109|538047761|FG001|Overall Study|Adverse Event|2|||
149156305|NCT01318109|538047762|FG002|Overall Study|Adverse Event|0|||
149156306|NCT01318109|538047760|FG000|Overall Study|Withdrawal by Subject|1|||
149156307|NCT01318109|538047761|FG001|Overall Study|Withdrawal by Subject|0|||
149156308|NCT01318109|538047762|FG002|Overall Study|Withdrawal by Subject|0|||
149156309|NCT01318109|538047760|FG000|Overall Study|Schedule Conflict|0|||
149156310|NCT01318109|538047761|FG001|Overall Study|Schedule Conflict|1|||
149156311|NCT01318109|538047762|FG002|Overall Study|Schedule Conflict|0|||
149156312|NCT04982250|538047770|FG000|Overall Study|Lost to Follow-up|0|||
149156313|NCT04982250|538047771|FG001|Overall Study|Lost to Follow-up|26|||
149156314|NCT04982250|538047772|FG002|Overall Study|Lost to Follow-up|0|||
149156315|NCT04982250|538047773|FG003|Overall Study|Lost to Follow-up|0|||
149156316|NCT04982250|538047774|FG004|Overall Study|Lost to Follow-up|72|||
149156317|NCT04982250|538047775|FG005|Overall Study|Lost to Follow-up|69|||
149156318|NCT04982250|538047770|FG000|Overall Study|Not Eligible to Enroll|0|||
149156319|NCT04982250|538047771|FG001|Overall Study|Not Eligible to Enroll|0|||
149156320|NCT04982250|538047772|FG002|Overall Study|Not Eligible to Enroll|0|||
149156321|NCT04982250|538047773|FG003|Overall Study|Not Eligible to Enroll|0|||
149156322|NCT04982250|538047774|FG004|Overall Study|Not Eligible to Enroll|10|||
149156323|NCT04982250|538047775|FG005|Overall Study|Not Eligible to Enroll|7|||
149156324|NCT01489527|538047776|FG000|Overall Study|Pregnancy|9|||
149156325|NCT01489527|538047777|FG001|Overall Study|Pregnancy|14|||
149156326|NCT01489527|538047776|FG000|Overall Study|Participant moved|6|||
149156327|NCT01489527|538047777|FG001|Overall Study|Participant moved|7|||
149156328|NCT01489527|538047776|FG000|Overall Study|Withdrawal by Subject|0|||
149156329|NCT01489527|538047777|FG001|Overall Study|Withdrawal by Subject|4|||
149156330|NCT01489527|538047776|FG000|Overall Study|Lost to Follow-up|5|||
149156331|NCT01489527|538047777|FG001|Overall Study|Lost to Follow-up|1|||
149156332|NCT01489527|538047776|FG000|Overall Study|Procedures|1|||
149156333|NCT01489527|538047777|FG001|Overall Study|Procedures|0|||
149156334|NCT01489527|538047776|FG000|Overall Study|Not compliant|1|||
149156335|NCT01489527|538047777|FG001|Overall Study|Not compliant|0|||
149156336|NCT00700271|538047778|FG000|Overall Study|Adverse Event|4|||
149156337|NCT00700271|538047779|FG001|Overall Study|Adverse Event|6|||
149156338|NCT00700271|538047778|FG000|Overall Study|Protocol Violation|1|||
149156339|NCT00700271|538047779|FG001|Overall Study|Protocol Violation|0|||
149156340|NCT00700271|538047778|FG000|Overall Study|Administrative Reasons|1|||
149156341|NCT00700271|538047779|FG001|Overall Study|Administrative Reasons|0|||
149156342|NCT00700271|538047778|FG000|Overall Study|Withdrawal by Subject|6|||
149156343|NCT00700271|538047779|FG001|Overall Study|Withdrawal by Subject|4|||
149156344|NCT00700271|538047778|FG000|Overall Study|Lost to Follow-up|2|||
149156345|NCT00700271|538047779|FG001|Overall Study|Lost to Follow-up|2|||
149156346|NCT04440592|538047780|FG000|Overall Study|Adverse Event|8|||
149156347|NCT04440592|538047781|FG001|Overall Study|Adverse Event|0|||
149156348|NCT04440592|538047780|FG000|Overall Study|Lost to Follow-up|1|||
149156349|NCT04440592|538047781|FG001|Overall Study|Lost to Follow-up|0|||
149156350|NCT04440592|538047780|FG000|Overall Study|Withdrawal by Subject|1|||
149156351|NCT04440592|538047781|FG001|Overall Study|Withdrawal by Subject|1|||
149156352|NCT04440592|538047780|FG000|Overall Study|Other therapy needed|0|||
149156353|NCT04440592|538047781|FG001|Overall Study|Other therapy needed|1|||
149156354|NCT02028455|538047784|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149156355|NCT02028455|538047785|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149156356|NCT02028455|538047786|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149156357|NCT02028455|538047787|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149156358|NCT02028455|538047788|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149156359|NCT02028455|538047789|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
149156360|NCT02028455|538047790|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
149156361|NCT02028455|538047791|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
149156362|NCT02028455|538047784|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
149156363|NCT02028455|538047785|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
149156364|NCT02028455|538047786|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
149156365|NCT02028455|538047787|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
149156366|NCT02028455|538047788|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
149156367|NCT02028455|538047789|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
149156368|NCT02028455|538047790|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
149156369|NCT02028455|538047791|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
149156370|NCT02028455|538047784|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149156371|NCT02028455|538047785|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149156372|NCT02028455|538047786|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149156373|NCT02028455|538047787|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149156374|NCT02028455|538047788|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149156375|NCT02028455|538047789|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
149156376|NCT02028455|538047790|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
149156377|NCT02028455|538047791|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
149156378|NCT02028455|538047784|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149156379|NCT02028455|538047785|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149156380|NCT02028455|538047786|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
149156381|NCT02028455|538047787|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
149156382|NCT02028455|538047788|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149156383|NCT02028455|538047789|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
149156384|NCT02028455|538047790|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
149156385|NCT02028455|538047791|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
149156386|NCT02396589|538047792|FG000|Intervention|Lost to Follow-up|1|||
149156387|NCT02396589|538047793|FG001|Intervention|Lost to Follow-up|0|||
149156388|NCT02396589|538047792|FG000|6 Month Follow-up|change in health status|0|||
149156389|NCT02396589|538047793|FG001|6 Month Follow-up|change in health status|1|||
149156390|NCT02396589|538047792|FG000|9 Month Follow-up|Death|0|||
149156391|NCT02396589|538047793|FG001|9 Month Follow-up|Death|1|||
149156392|NCT02396589|538047792|FG000|12 Month Follow up|Lost to Follow-up|0|||
149156393|NCT02396589|538047793|FG001|12 Month Follow up|Lost to Follow-up|2|||
149156394|NCT04705051|538050228|FG000|Overall Study|Enrolled but not treated|1|||
149156395|NCT04705051|538050228|FG000|Overall Study|Study terminated by sponsor|23|||
148805941|NCT05911841|536768048|FG004|Induction Period|Assigned Treatment by Mistake|0|||
148805942|NCT05911841|536768049|FG005|Induction Period|Assigned Treatment by Mistake|0|||
148921016|NCT03011892|537194032|FG001|Open Label (OL) Period|Reason not specified|0|||
148921017|NCT03011892|537194033|FG002|Open Label (OL) Period|Reason not specified|0|||
149156396|NCT01178138|538050229|FG000|Overall Study|Lost to Follow-up|8|||
149156397|NCT01178138|538050229|FG000|Overall Study|Withdrawal by Subject|7|||
149156398|NCT01178138|538050229|FG000|Overall Study|Physician Decision|8|||
149156399|NCT01241708|538050230|FG000|Overall Study|Withdrawal by Subject|6|||
149156400|NCT01241708|538050230|FG000|Overall Study|Screen Failure|6|||
149156401|NCT01241708|538050230|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
149156402|NCT01241708|538050230|FG000|Overall Study|Lost to Follow-up|5|||
149156403|NCT02968810|538050231|FG000|Overall Study|Lost to Follow-up|1|||
149156404|NCT02968810|538050232|FG001|Overall Study|Lost to Follow-up|0|||
149156405|NCT02968810|538050231|FG000|Overall Study|Physician Decision|1|||
149156406|NCT02968810|538050232|FG001|Overall Study|Physician Decision|0|||
149156407|NCT02968810|538050231|FG000|Overall Study|Withdrawal by Subject|1|||
149156408|NCT02968810|538050232|FG001|Overall Study|Withdrawal by Subject|3|||
149156409|NCT02968810|538050231|FG000|Overall Study|Disease Progression|0|||
149156410|NCT02968810|538050232|FG001|Overall Study|Disease Progression|1|||
148921018|NCT03011892|537194034|FG003|Open Label (OL) Period|Reason not specified|0|||
149156411|NCT04183335|538050235|FG000|Overall Study|Adverse Event|1|||
149156412|NCT04183335|538050236|FG001|Overall Study|Adverse Event|0|||
148921019|NCT03011892|537194035|FG004|Open Label (OL) Period|Reason not specified|0|||
148921020|NCT03011892|537194036|FG005|Open Label (OL) Period|Reason not specified|0|||
148921021|NCT03011892|537194037|FG006|Open Label (OL) Period|Reason not specified|0|||
148921022|NCT03011892|537194038|FG007|Open Label (OL) Period|Reason not specified|1|||
148921023|NCT03011892|537194039|FG008|Open Label (OL) Period|Reason not specified|0|||
149156413|NCT04183335|538050235|FG000|Overall Study|Withdrawal by Subject|12|||
149156414|NCT04183335|538050236|FG001|Overall Study|Withdrawal by Subject|3|||
149156415|NCT00049673|538050237|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
149156416|NCT00049673|538050238|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
149156417|NCT01535729|538050239|FG000|Overall Study|Withdrawal by Subject|2|||
149156418|NCT01535729|538050239|FG000|Overall Study|Disease progression|230|||
149156419|NCT01535729|538050239|FG000|Overall Study|Discontinued treatment|25|||
149156420|NCT01535729|538050239|FG000|Overall Study|Lost to Follow-up|8|||
149156421|NCT01535729|538050239|FG000|Overall Study|Death|52|||
149156422|NCT01535729|538050239|FG000|Overall Study|Other|19|||
149156423|NCT01535729|538050239|FG000|Overall Study|Did not sign informed consent|1|||
149156424|NCT01535729|538050239|FG000|Overall Study|No previous chemotherapy|33|||
149156425|NCT01535729|538050239|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
149156426|NCT01535729|538050239|FG000|Overall Study|Protocol Violation|11|||
149156427|NCT01535729|538050239|FG000|Overall Study|Screening failure|1|||
149156428|NCT01535729|538050239|FG000|Overall Study|Not treated|9|||
149156429|NCT01535729|538050239|FG000|Overall Study|No participant record available|5|||
148921024|NCT03011892|537194040|FG009|Open Label (OL) Period|Reason not specified|0|||
148921025|NCT03011892|537194041|FG010|Open Label (OL) Period|Reason not specified|0|||
149156430|NCT02787850|538050240|FG000|Overall Study|Withdrawal by Subject|0|||
148921026|NCT03011892|537194042|FG011|Open Label (OL) Period|Reason not specified|0|||
148921027|NCT01375075|537194048|FG000|Overall Study|Adverse Event|0|||
148921028|NCT01375075|537194049|FG001|Overall Study|Adverse Event|0|||
148921029|NCT01375075|537194050|FG002|Overall Study|Adverse Event|3|||
148921030|NCT01375075|537194051|FG003|Overall Study|Adverse Event|1|||
148921031|NCT01375075|537194052|FG004|Overall Study|Adverse Event|0|||
148921032|NCT01375075|537194053|FG005|Overall Study|Adverse Event|1|||
148921033|NCT01375075|537194048|FG000|Overall Study|Entry Criterion Not Met|1|||
149156431|NCT02787850|538050241|FG001|Overall Study|Withdrawal by Subject|1|||
149156432|NCT03733392|538050244|FG000|Overall Study|Withdrawal by Subject|11|||
149156433|NCT03733392|538050245|FG001|Overall Study|Withdrawal by Subject|1|||
149156434|NCT03733392|538050244|FG000|Overall Study|Death|1|||
149156435|NCT03733392|538050245|FG001|Overall Study|Death|0|||
149156436|NCT03733392|538050244|FG000|Overall Study|Lost to Follow-up|5|||
149156437|NCT03733392|538050245|FG001|Overall Study|Lost to Follow-up|0|||
149156438|NCT03733392|538050244|FG000|Overall Study|Protocol Violation|0|||
149156439|NCT03733392|538050245|FG001|Overall Study|Protocol Violation|1|||
149156440|NCT03733392|538050244|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
149156441|NCT03733392|538050245|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
149156442|NCT03733392|538050244|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
148921034|NCT01375075|537194049|FG001|Overall Study|Entry Criterion Not Met|0|||
148921035|NCT01375075|537194050|FG002|Overall Study|Entry Criterion Not Met|0|||
148921036|NCT01375075|537194051|FG003|Overall Study|Entry Criterion Not Met|0|||
148921037|NCT01375075|537194052|FG004|Overall Study|Entry Criterion Not Met|0|||
148921038|NCT01375075|537194053|FG005|Overall Study|Entry Criterion Not Met|1|||
148921039|NCT01375075|537194048|FG000|Overall Study|Withdrawal by Subject|0|||
148921040|NCT01375075|537194049|FG001|Overall Study|Withdrawal by Subject|1|||
149156443|NCT03733392|538050245|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
149156444|NCT03733392|538050244|FG000|Overall Study|Patient Non-Compliance|2|||
149156445|NCT03733392|538050245|FG001|Overall Study|Patient Non-Compliance|1|||
149156446|NCT03733392|538050244|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
149156447|NCT03733392|538050245|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
149156448|NCT03733392|538050244|FG000|Overall Study|Withdrawal prior to procedure|5|||
149156449|NCT03733392|538050245|FG001|Overall Study|Withdrawal prior to procedure|2|||
149156450|NCT00808444|538050253|FG000|Overall Study|Withdrawal by Subject|1|||
149156451|NCT00808444|538050254|FG001|Overall Study|Withdrawal by Subject|0|||
149156452|NCT00808444|538050253|FG000|Overall Study|Lost to Follow-up|0|||
149156453|NCT00808444|538050254|FG001|Overall Study|Lost to Follow-up|1|||
149156454|NCT00618748|538050255|FG000|Overall Study|Adverse Event|4|||
149156455|NCT00618748|538050256|FG001|Overall Study|Adverse Event|3|||
149156456|NCT00618748|538050257|FG002|Overall Study|Adverse Event|8|||
149156457|NCT00618748|538050255|FG000|Overall Study|Physician Decision|3|||
149156458|NCT00618748|538050256|FG001|Overall Study|Physician Decision|1|||
149156459|NCT00618748|538050257|FG002|Overall Study|Physician Decision|1|||
148921041|NCT01375075|537194050|FG002|Overall Study|Withdrawal by Subject|0|||
148921042|NCT01375075|537194051|FG003|Overall Study|Withdrawal by Subject|0|||
148921043|NCT01375075|537194052|FG004|Overall Study|Withdrawal by Subject|0|||
148921044|NCT01375075|537194053|FG005|Overall Study|Withdrawal by Subject|1|||
148921045|NCT00384111|537194056|FG000|Overall Study|Disease Progression|3|||
148921046|NCT00384111|537194056|FG000|Overall Study|Adverse Event|1|||
149156460|NCT00618748|538050255|FG000|Overall Study|Withdrawal by Subject|4|||
149156461|NCT00618748|538050256|FG001|Overall Study|Withdrawal by Subject|1|||
149156462|NCT00618748|538050257|FG002|Overall Study|Withdrawal by Subject|5|||
149156463|NCT03269344|538050258|FG000|Overall Study|Protocol Violation|4|||
149156464|NCT03269344|538050259|FG001|Overall Study|Protocol Violation|3|||
148921047|NCT00384111|537194056|FG000|Overall Study|Investigator Decision|3|||
148921048|NCT00384111|537194056|FG000|Overall Study|Study Terminated by the Sponsor|19|||
148921049|NCT00821509|537194057|FG000|Overall Study|Withdrawal by Subject|12|||
149156465|NCT04401267|538050260|FG000|Overall Study|Death|0|||
149156466|NCT04401267|538050261|FG001|Overall Study|Death|1|||
148921050|NCT00821509|537194058|FG001|Overall Study|Withdrawal by Subject|11|||
148921051|NCT00821509|537194059|FG002|Overall Study|Withdrawal by Subject|34|||
148921052|NCT03104816|537194061|FG000|Overall Study|Lack of Efficacy|0|||
148921053|NCT03104816|537194062|FG001|Overall Study|Lack of Efficacy|2|||
148921054|NCT03104816|537194063|FG002|Overall Study|Lack of Efficacy|0|||
148921055|NCT03104816|537194061|FG000|Overall Study|Protocol Violation|2|||
148921056|NCT03104816|537194062|FG001|Overall Study|Protocol Violation|0|||
148921057|NCT03104816|537194063|FG002|Overall Study|Protocol Violation|2|||
148921058|NCT01894568|537194064|FG000|Overall Study|Adverse Event|2|||
149156467|NCT04401267|538050260|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
149156468|NCT04401267|538050261|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
149156469|NCT04401267|538050260|FG000|Overall Study|Found to be Ineligible|1|||
149156470|NCT04401267|538050261|FG001|Overall Study|Found to be Ineligible|0|||
149156471|NCT01449708|538050267|FG000|Overall Study|Protocol Violation|0|||
149156472|NCT01449708|538050268|FG001|Overall Study|Protocol Violation|1|||
149156473|NCT01449708|538050267|FG000|Overall Study|surgical complication|1|||
149156474|NCT01449708|538050268|FG001|Overall Study|surgical complication|2|||
149156475|NCT01449708|538050267|FG000|Overall Study|respiratory failure|1|||
149156476|NCT01449708|538050268|FG001|Overall Study|respiratory failure|0|||
149156477|NCT02889796|538050273|FG000|Overall Study|Withdrew Consent|18|||
149156478|NCT02889796|538050274|FG001|Overall Study|Withdrew Consent|29|||
149156479|NCT02889796|538050275|FG002|Overall Study|Withdrew Consent|20|||
149156480|NCT02889796|538050276|FG003|Overall Study|Withdrew Consent|1|||
149156481|NCT02889796|538050277|FG004|Overall Study|Withdrew Consent|2|||
149156482|NCT02889796|538050278|FG005|Overall Study|Withdrew Consent|35|||
149156483|NCT02889796|538050273|FG000|Overall Study|Investigator's Discretion|10|||
149156484|NCT02889796|538050274|FG001|Overall Study|Investigator's Discretion|9|||
149156485|NCT02889796|538050275|FG002|Overall Study|Investigator's Discretion|10|||
149156486|NCT02889796|538050276|FG003|Overall Study|Investigator's Discretion|3|||
149156487|NCT02889796|538050277|FG004|Overall Study|Investigator's Discretion|0|||
149156488|NCT02889796|538050278|FG005|Overall Study|Investigator's Discretion|15|||
149156489|NCT02889796|538050273|FG000|Overall Study|Adverse Event|17|||
149156490|NCT02889796|538050274|FG001|Overall Study|Adverse Event|8|||
149156491|NCT02889796|538050275|FG002|Overall Study|Adverse Event|8|||
149156492|NCT02889796|538050276|FG003|Overall Study|Adverse Event|4|||
149156493|NCT02889796|538050277|FG004|Overall Study|Adverse Event|1|||
149156494|NCT02889796|538050278|FG005|Overall Study|Adverse Event|7|||
149156495|NCT02889796|538050273|FG000|Overall Study|Lost to Follow-up|5|||
149156496|NCT02889796|538050274|FG001|Overall Study|Lost to Follow-up|7|||
149156497|NCT02889796|538050275|FG002|Overall Study|Lost to Follow-up|2|||
149156498|NCT02889796|538050276|FG003|Overall Study|Lost to Follow-up|0|||
149156499|NCT02889796|538050277|FG004|Overall Study|Lost to Follow-up|2|||
149156500|NCT02889796|538050278|FG005|Overall Study|Lost to Follow-up|6|||
149156501|NCT02889796|538050273|FG000|Overall Study|Protocol Violation|0|||
149156502|NCT02889796|538050274|FG001|Overall Study|Protocol Violation|1|||
149156503|NCT02889796|538050275|FG002|Overall Study|Protocol Violation|3|||
149156504|NCT02889796|538050276|FG003|Overall Study|Protocol Violation|0|||
149156505|NCT02889796|538050277|FG004|Overall Study|Protocol Violation|0|||
149156506|NCT02889796|538050278|FG005|Overall Study|Protocol Violation|4|||
149156507|NCT02889796|538050273|FG000|Overall Study|Non-compliance With Study Drug|0|||
149156508|NCT02889796|538050274|FG001|Overall Study|Non-compliance With Study Drug|2|||
149156509|NCT02889796|538050275|FG002|Overall Study|Non-compliance With Study Drug|0|||
149156510|NCT02889796|538050276|FG003|Overall Study|Non-compliance With Study Drug|0|||
148921059|NCT01894568|537194065|FG001|Overall Study|Adverse Event|3|||
148921060|NCT01894568|537194064|FG000|Overall Study|Protocol required discontinuation|2|||
148921061|NCT01894568|537194065|FG001|Overall Study|Protocol required discontinuation|1|||
148921062|NCT01894568|537194064|FG000|Overall Study|Withdrawal by Subject|5|||
148921063|NCT01894568|537194065|FG001|Overall Study|Withdrawal by Subject|5|||
148921064|NCT01894568|537194064|FG000|Overall Study|Physician Decision|1|||
148921065|NCT01894568|537194065|FG001|Overall Study|Physician Decision|0|||
148921066|NCT01894568|537194064|FG000|Overall Study|Lost to Follow-up|0|||
149156511|NCT02889796|538050277|FG004|Overall Study|Non-compliance With Study Drug|1|||
149156512|NCT02889796|538050278|FG005|Overall Study|Non-compliance With Study Drug|2|||
149156513|NCT02889796|538050273|FG000|Overall Study|Death|1|||
149156514|NCT02889796|538050274|FG001|Overall Study|Death|1|||
149156515|NCT02889796|538050275|FG002|Overall Study|Death|0|||
149156516|NCT02889796|538050276|FG003|Overall Study|Death|1|||
149156517|NCT02889796|538050277|FG004|Overall Study|Death|0|||
149156518|NCT02889796|538050278|FG005|Overall Study|Death|1|||
149156519|NCT02889796|538050273|FG000|Overall Study|Pregnancy|0|||
149156520|NCT02889796|538050274|FG001|Overall Study|Pregnancy|1|||
149156521|NCT02889796|538050275|FG002|Overall Study|Pregnancy|1|||
149156522|NCT02889796|538050276|FG003|Overall Study|Pregnancy|0|||
149156523|NCT02889796|538050277|FG004|Overall Study|Pregnancy|0|||
149156524|NCT02889796|538050278|FG005|Overall Study|Pregnancy|0|||
149156525|NCT02889796|538050273|FG000|Overall Study|Randomized but not Dosed|2|||
149156526|NCT02889796|538050274|FG001|Overall Study|Randomized but not Dosed|0|||
149156527|NCT02889796|538050275|FG002|Overall Study|Randomized but not Dosed|0|||
148921067|NCT01894568|537194065|FG001|Overall Study|Lost to Follow-up|1|||
148921068|NCT00807573|537194066|FG000|Overall Study|Withdrawal by Subject|1|||
148921069|NCT00807573|537194066|FG000|Overall Study|Adverse Event|1|||
148921070|NCT01426789|537194067|FG000|Part 1|Protocol deviation|0|||
148921071|NCT01426789|537194068|FG001|Part 1|Protocol deviation|1|||
148921072|NCT01426789|537194069|FG002|Part 1|Protocol deviation|0|||
149156528|NCT02889796|538050276|FG003|Overall Study|Randomized but not Dosed|0|||
149156529|NCT02889796|538050277|FG004|Overall Study|Randomized but not Dosed|0|||
149156530|NCT02889796|538050278|FG005|Overall Study|Randomized but not Dosed|2|||
149156531|NCT04294459|538050279|FG000|Overall Study|Adverse Event|0|||
149156532|NCT04294459|538050280|FG001|Overall Study|Adverse Event|1|||
149156533|NCT04033367|538050281|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
149156534|NCT04033367|538050282|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
149156535|NCT04033367|538050281|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
149156536|NCT04033367|538050282|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
149156537|NCT04033367|538050281|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
149156538|NCT04033367|538050282|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
149156539|NCT04033367|538050281|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
149156540|NCT04033367|538050282|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
149156541|NCT01191697|538050283|FG000|Overall Study|Death|1|||
149156542|NCT01191697|538050283|FG000|Overall Study|Physician Decision|2|||
149156543|NCT01191697|538050283|FG000|Overall Study|Pursue chemoradiation|2|||
149156544|NCT01191697|538050283|FG000|Overall Study|Break from chemotherapy|2|||
149156545|NCT01191697|538050283|FG000|Overall Study|Withdrawal by Subject|1|||
149156546|NCT01191697|538050283|FG000|Overall Study|Surveillance|1|||
149156547|NCT01191697|538050283|FG000|Overall Study|Adverse Event|2|||
149156548|NCT01191697|538050283|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
149156549|NCT01191697|538050283|FG000|Overall Study|Not completed but analyzed|25|||
149156550|NCT02421887|538050284|FG000|Overall Study|Lost to Follow-up|5|||
149156551|NCT02421887|538050285|FG001|Overall Study|Lost to Follow-up|0|||
149156552|NCT02421887|538050284|FG000|Overall Study|Withdrawal by Subject|8|||
149156553|NCT02421887|538050285|FG001|Overall Study|Withdrawal by Subject|5|||
149156554|NCT02421887|538050284|FG000|Overall Study|Physician Decision|2|||
149156555|NCT02421887|538050285|FG001|Overall Study|Physician Decision|4|||
149156556|NCT02421887|538050284|FG000|Overall Study|Adverse Event|2|||
149156557|NCT02421887|538050285|FG001|Overall Study|Adverse Event|0|||
149156558|NCT01882907|538050286|FG000|Overall Study|Adverse Event|3|||
149156559|NCT01882907|538050287|FG001|Overall Study|Adverse Event|1|||
149156560|NCT01882907|538050286|FG000|Overall Study|Lack of Efficacy|0|||
149156561|NCT01882907|538050287|FG001|Overall Study|Lack of Efficacy|3|||
149156562|NCT01882907|538050286|FG000|Overall Study|Lost to Follow-up|1|||
149156563|NCT01882907|538050287|FG001|Overall Study|Lost to Follow-up|4|||
149156564|NCT01882907|538050286|FG000|Overall Study|Protocol Violation|10|||
149156565|NCT01882907|538050287|FG001|Overall Study|Protocol Violation|14|||
149156566|NCT01882907|538050286|FG000|Overall Study|Withdrawal by Subject|0|||
149156567|NCT01882907|538050287|FG001|Overall Study|Withdrawal by Subject|6|||
149156568|NCT01784965|538050288|FG000|Overall Study|Withdrawal by Subject|6|||
149156569|NCT01784965|538050289|FG001|Overall Study|Withdrawal by Subject|3|||
149156570|NCT01784965|538050288|FG000|Overall Study|Adverse Event|0|||
149156571|NCT01784965|538050289|FG001|Overall Study|Adverse Event|8|||
149156572|NCT01467492|538050292|FG000|Overall Study|Withdrawal by Subject|6|||
149156573|NCT01467492|538050293|FG001|Overall Study|Withdrawal by Subject|4|||
149156574|NCT01467492|538050292|FG000|Overall Study|Study Terminated by Sponsor|6|||
149156575|NCT01467492|538050293|FG001|Overall Study|Study Terminated by Sponsor|4|||
149156576|NCT01467492|538050292|FG000|Overall Study|Adverse Event|4|||
149156577|NCT01467492|538050293|FG001|Overall Study|Adverse Event|3|||
149156578|NCT01467492|538050292|FG000|Overall Study|Lost to Follow-up|3|||
149156579|NCT01467492|538050293|FG001|Overall Study|Lost to Follow-up|2|||
149156580|NCT01467492|538050292|FG000|Overall Study|Undefined|2|||
149156581|NCT01467492|538050293|FG001|Overall Study|Undefined|0|||
149156582|NCT01467492|538050292|FG000|Overall Study|Enrolled But Not Treated|1|||
149156583|NCT01467492|538050293|FG001|Overall Study|Enrolled But Not Treated|0|||
149156584|NCT02450487|538050294|FG000|Overall Study|Lost to Follow-up|3|||
148921073|NCT01426789|537194070|FG003|Part 1|Protocol deviation|0|||
149156585|NCT04269395|538050295|FG000|Overall Study|Lost to Follow-up|1|||
149156586|NCT04269395|538050296|FG001|Overall Study|Lost to Follow-up|0|||
149156587|NCT04269395|538050295|FG000|Overall Study|Study terminated by Sponsor|13|||
149156588|NCT04269395|538050296|FG001|Overall Study|Study terminated by Sponsor|10|||
149156589|NCT01491178|538050297|FG000|Overall Study|Adverse Event|1016|||
149156590|NCT01491178|538050297|FG000|Overall Study|Improvement of NVAF|210|||
149156591|NCT01491178|538050297|FG000|Overall Study|To conduct invasive treatment|59|||
149156592|NCT01491178|538050297|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
149156593|NCT01491178|538050297|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
149156594|NCT01491178|538050297|FG000|Overall Study|To take a contraindication|20|||
149156595|NCT01491178|538050297|FG000|Overall Study|Other than specified above|657|||
149156596|NCT03132636|538050298|FG000|Overall Study|Adverse Event|1|||
149156597|NCT03132636|538050299|FG001|Overall Study|Adverse Event|2|||
149156598|NCT03132636|538050298|FG000|Overall Study|Death|4|||
149156599|NCT03132636|538050299|FG001|Overall Study|Death|7|||
149156600|NCT03132636|538050298|FG000|Overall Study|Lost to Follow-up|3|||
149156601|NCT03132636|538050299|FG001|Overall Study|Lost to Follow-up|2|||
149156602|NCT03132636|538050298|FG000|Overall Study|Non compliance with protocol by participant|1|||
149156603|NCT03132636|538050299|FG001|Overall Study|Non compliance with protocol by participant|1|||
149156604|NCT03132636|538050298|FG000|Overall Study|Subject decision|1|||
149156605|NCT03132636|538050299|FG001|Overall Study|Subject decision|9|||
149156606|NCT03132636|538050298|FG000|Overall Study|Sponsor decision|0|||
149156607|NCT03132636|538050299|FG001|Overall Study|Sponsor decision|1|||
149156608|NCT03132636|538050298|FG000|Overall Study|Physician Decision|1|||
149156609|NCT03132636|538050299|FG001|Overall Study|Physician Decision|0|||
149156610|NCT03132636|538050298|FG000|Overall Study|Progressive disease|33|||
149156611|NCT03132636|538050299|FG001|Overall Study|Progressive disease|36|||
149156612|NCT03132636|538050298|FG000|Overall Study|Withdrawal of consent|2|||
149156613|NCT03132636|538050299|FG001|Overall Study|Withdrawal of consent|5|||
149156614|NCT03132636|538050298|FG000|Overall Study|Did not re-consent|1|||
149156615|NCT03132636|538050299|FG001|Overall Study|Did not re-consent|0|||
149156616|NCT03132636|538050298|FG000|Overall Study|Lost insurance coverage|1|||
149156617|NCT03132636|538050299|FG001|Overall Study|Lost insurance coverage|0|||
149156618|NCT03132636|538050298|FG000|Overall Study|Related to radiological outcomes|0|||
149156619|NCT03132636|538050299|FG001|Overall Study|Related to radiological outcomes|1|||
149156620|NCT03132636|538050298|FG000|Overall Study|Unable to come to site for continued visits|0|||
149156621|NCT03132636|538050299|FG001|Overall Study|Unable to come to site for continued visits|1|||
149156622|NCT01415752|538050300|FG000|Induction (Step 1)|Ineligible|4|||
149156623|NCT01415752|538050301|FG001|Induction (Step 1)|Ineligible|3|||
149156624|NCT01415752|538050302|FG002|Induction (Step 1)|Ineligible|4|||
149156625|NCT01415752|538050303|FG003|Induction (Step 1)|Ineligible|4|||
149156626|NCT01415752|538050300|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
149156627|NCT01415752|538050301|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
149156628|NCT01415752|538050302|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
149156629|NCT01415752|538050303|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
149156630|NCT01415752|538050300|FG000|Maintenance (Step 2)|Adverse Event|3|||
149156631|NCT01415752|538050301|FG001|Maintenance (Step 2)|Adverse Event|4|||
149156632|NCT01415752|538050302|FG002|Maintenance (Step 2)|Adverse Event|9|||
149156633|NCT01415752|538050303|FG003|Maintenance (Step 2)|Adverse Event|6|||
149156634|NCT01415752|538050300|FG000|Maintenance (Step 2)|Death|1|||
149156635|NCT01415752|538050301|FG001|Maintenance (Step 2)|Death|1|||
149156636|NCT01415752|538050302|FG002|Maintenance (Step 2)|Death|2|||
149156637|NCT01415752|538050303|FG003|Maintenance (Step 2)|Death|0|||
149156638|NCT01415752|538050300|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
149156639|NCT01415752|538050301|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
149156640|NCT01415752|538050302|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
149156641|NCT01415752|538050303|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
149156642|NCT01415752|538050300|FG000|Maintenance (Step 2)|Alternative therapy|0|||
149156643|NCT01415752|538050301|FG001|Maintenance (Step 2)|Alternative therapy|1|||
149156644|NCT01415752|538050302|FG002|Maintenance (Step 2)|Alternative therapy|0|||
149156645|NCT01415752|538050303|FG003|Maintenance (Step 2)|Alternative therapy|0|||
149156646|NCT01415752|538050300|FG000|Maintenance (Step 2)|Other reasons|3|||
149156647|NCT01415752|538050301|FG001|Maintenance (Step 2)|Other reasons|6|||
149156648|NCT01415752|538050302|FG002|Maintenance (Step 2)|Other reasons|4|||
149156649|NCT01415752|538050303|FG003|Maintenance (Step 2)|Other reasons|6|||
149156650|NCT01415752|538050300|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
149156651|NCT01415752|538050301|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
149156652|NCT01415752|538050302|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
149156653|NCT01415752|538050303|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
149156654|NCT01415752|538050300|FG000|Maintenance (Step 2)|ineligible|1|||
149156655|NCT01415752|538050301|FG001|Maintenance (Step 2)|ineligible|1|||
149156656|NCT01415752|538050302|FG002|Maintenance (Step 2)|ineligible|1|||
149156657|NCT01415752|538050303|FG003|Maintenance (Step 2)|ineligible|0|||
149156658|NCT01415752|538050300|FG000|Maintenance (Step 2)|Missing|4|||
149156659|NCT01415752|538050301|FG001|Maintenance (Step 2)|Missing|1|||
149156660|NCT01415752|538050302|FG002|Maintenance (Step 2)|Missing|4|||
149156661|NCT01415752|538050303|FG003|Maintenance (Step 2)|Missing|3|||
149156662|NCT03286842|538050304|FG000|Overall Study|Patients rolled over to another study|80|||
149156663|NCT01391507|538050305|FG000|Overall Study|Death|0|||
149156664|NCT01391507|538050306|FG001|Overall Study|Death|0|||
149156665|NCT01391507|538050307|FG002|Overall Study|Death|0|||
149156666|NCT01391507|538050308|FG003|Overall Study|Death|1|||
149156667|NCT01391507|538050305|FG000|Overall Study|Adverse Event|1|||
149156668|NCT01391507|538050306|FG001|Overall Study|Adverse Event|1|||
149156669|NCT01391507|538050307|FG002|Overall Study|Adverse Event|2|||
149156670|NCT01391507|538050308|FG003|Overall Study|Adverse Event|2|||
149156671|NCT01391507|538050305|FG000|Overall Study|Withdrawal by Subject|1|||
149156672|NCT01391507|538050306|FG001|Overall Study|Withdrawal by Subject|2|||
149156673|NCT01391507|538050307|FG002|Overall Study|Withdrawal by Subject|1|||
149156674|NCT01391507|538050308|FG003|Overall Study|Withdrawal by Subject|1|||
149156675|NCT01391507|538050305|FG000|Overall Study|Lack of Efficacy|0|||
149156676|NCT01391507|538050306|FG001|Overall Study|Lack of Efficacy|0|||
149156677|NCT01391507|538050307|FG002|Overall Study|Lack of Efficacy|0|||
149156678|NCT01391507|538050308|FG003|Overall Study|Lack of Efficacy|1|||
149156679|NCT01391507|538050305|FG000|Overall Study|Protocol Violation|2|||
149156680|NCT01391507|538050306|FG001|Overall Study|Protocol Violation|1|||
149156681|NCT01391507|538050307|FG002|Overall Study|Protocol Violation|1|||
149156682|NCT01391507|538050308|FG003|Overall Study|Protocol Violation|2|||
149156683|NCT01562548|538050313|FG000|Overall Study|Lost to Follow-up|0|||
149156684|NCT01562548|538050314|FG001|Overall Study|Lost to Follow-up|0|||
149156685|NCT01562548|538050315|FG002|Overall Study|Lost to Follow-up|1|||
149156686|NCT01562548|538050316|FG003|Overall Study|Lost to Follow-up|0|||
149156687|NCT01285908|538050317|FG000|Baseline Measurement|unable to insert catheter|1|||
149156688|NCT01285908|538050318|FG001|Baseline Measurement|unable to insert catheter|0|||
149156689|NCT01285908|538050319|FG002|Baseline Measurement|unable to insert catheter|0|||
149156690|NCT01285908|538050317|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
149156691|NCT01285908|538050318|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
149156692|NCT01285908|538050319|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
149156693|NCT01285908|538050317|FG000|Baseline Measurement|unable to tolerate procedure|1|||
149156694|NCT01285908|538050318|FG001|Baseline Measurement|unable to tolerate procedure|0|||
149156695|NCT01285908|538050319|FG002|Baseline Measurement|unable to tolerate procedure|0|||
149156696|NCT02926209|538050320|FG000|Study Cohort|Poor Bowel Preparation|1|||
149156697|NCT02926209|538050321|FG001|Study Cohort|Poor Bowel Preparation|0|||
149156698|NCT01239160|538050322|FG000|Overall Study|Lost to Follow-up|3|||
149156699|NCT01239160|538050323|FG001|Overall Study|Lost to Follow-up|5|||
149156700|NCT01239160|538050324|FG002|Overall Study|Lost to Follow-up|0|||
149156701|NCT01239160|538050322|FG000|Overall Study|Withdrawal by Subject|17|||
149156702|NCT01239160|538050323|FG001|Overall Study|Withdrawal by Subject|6|||
149156703|NCT01239160|538050324|FG002|Overall Study|Withdrawal by Subject|2|||
149156704|NCT01239160|538050322|FG000|Overall Study|Physician Decision|5|||
149156705|NCT01239160|538050323|FG001|Overall Study|Physician Decision|7|||
149156706|NCT01239160|538050324|FG002|Overall Study|Physician Decision|2|||
149156707|NCT01239160|538050322|FG000|Overall Study|Early Termination Due to Study Closure|0|||
149156708|NCT01239160|538050323|FG001|Overall Study|Early Termination Due to Study Closure|1|||
149156709|NCT01239160|538050324|FG002|Overall Study|Early Termination Due to Study Closure|6|||
149156710|NCT04781816|538050331|FG000|Overall Study|Adverse Event|0|||
149156711|NCT04781816|538050332|FG001|Overall Study|Adverse Event|1|||
149156712|NCT04781816|538050331|FG000|Overall Study|Withdrawal by Subject|1|||
149156713|NCT04781816|538050332|FG001|Overall Study|Withdrawal by Subject|1|||
149156714|NCT04781816|538050331|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
149156715|NCT04781816|538050332|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
149156716|NCT01789970|538050333|FG000|Open-label Titration Period|Adverse Event|68|||
149156717|NCT01789970|538050334|FG001|Open-label Titration Period|Adverse Event|0|||
149156718|NCT01789970|538050335|FG002|Open-label Titration Period|Adverse Event|0|||
149156719|NCT01789970|538050333|FG000|Open-label Titration Period|Lack of Efficacy|31|||
149156720|NCT01789970|538050334|FG001|Open-label Titration Period|Lack of Efficacy|0|||
149156721|NCT01789970|538050335|FG002|Open-label Titration Period|Lack of Efficacy|0|||
149156722|NCT01789970|538050333|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
149156723|NCT01789970|538050334|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
149156724|NCT01789970|538050335|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
149156725|NCT01789970|538050333|FG000|Open-label Titration Period|Protocol Violation|18|||
149156726|NCT01789970|538050334|FG001|Open-label Titration Period|Protocol Violation|0|||
149156727|NCT01789970|538050335|FG002|Open-label Titration Period|Protocol Violation|0|||
149156728|NCT01789970|538050333|FG000|Open-label Titration Period|Lost to Follow-up|5|||
149156729|NCT01789970|538050334|FG001|Open-label Titration Period|Lost to Follow-up|0|||
149156730|NCT01789970|538050335|FG002|Open-label Titration Period|Lost to Follow-up|0|||
149156731|NCT01789970|538050333|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
149156732|NCT01789970|538050334|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
149156733|NCT01789970|538050335|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
149156734|NCT01789970|538050333|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
149156735|NCT01789970|538050334|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
149156736|NCT01789970|538050335|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
149156737|NCT01789970|538050333|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
149156738|NCT01789970|538050334|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
149156739|NCT01789970|538050335|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
149156740|NCT01789970|538050333|FG000|Open-label Titration Period|Pregnancy|2|||
149156741|NCT01789970|538050334|FG001|Open-label Titration Period|Pregnancy|0|||
149156742|NCT01789970|538050335|FG002|Open-label Titration Period|Pregnancy|0|||
149156743|NCT01789970|538050333|FG000|Open-label Titration Period|Other|76|||
149156744|NCT01789970|538050334|FG001|Open-label Titration Period|Other|0|||
149156745|NCT01789970|538050335|FG002|Open-label Titration Period|Other|0|||
149156746|NCT01789970|538050333|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
149156747|NCT01789970|538050334|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
149156748|NCT01789970|538050335|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
149156749|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
149156750|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
149156751|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
149156752|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
149156753|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
149156754|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
149156755|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
149156756|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
148672865|NCT01610284|536272521|FG000|Randomization Phase|Adverse Event|1|||
148672866|NCT01610284|536272522|FG001|Randomization Phase|Adverse Event|0|||
148921074|NCT01426789|537194071|FG004|Part 1|Protocol deviation|0|||
149156757|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
148672867|NCT01610284|536272521|FG000|Randomization Phase|Physician Decision|1|||
148921075|NCT01426789|537194072|FG005|Part 1|Protocol deviation|0|||
148921076|NCT01426789|537194067|FG000|Part 1|Lost to Follow-up|1|||
149156758|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
149156759|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
149156760|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
149156761|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
149156762|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
149156763|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
149156764|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
149156765|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
149156766|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
149156767|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
149156768|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
149156769|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
149156770|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
149156771|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
149156772|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
149156773|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
149156774|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
149156775|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
149156776|NCT01789970|538050333|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
149156777|NCT01789970|538050334|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
149156778|NCT01789970|538050335|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
149156779|NCT01847885|538050342|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
149156780|NCT01847885|538050343|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
149156781|NCT01847885|538050344|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
149156782|NCT01847885|538050342|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
149156783|NCT01847885|538050343|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
149156784|NCT01847885|538050344|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
149156785|NCT01847885|538050342|FG000|Initial Enrollment (Consented)|Screen failure|39|||
149156786|NCT01847885|538050343|FG001|Initial Enrollment (Consented)|Screen failure|0|||
149156787|NCT01847885|538050344|FG002|Initial Enrollment (Consented)|Screen failure|0|||
149156788|NCT01847885|538050342|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
149156789|NCT01847885|538050343|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
149156790|NCT01847885|538050344|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
149156791|NCT01847885|538050342|FG000|Randomization|Protocol Violation|0|||
149156792|NCT01847885|538050343|FG001|Randomization|Protocol Violation|1|||
149156793|NCT01847885|538050344|FG002|Randomization|Protocol Violation|0|||
149156794|NCT01847885|538050342|FG000|Randomization|Withdrawal by Subject|0|||
149156795|NCT01847885|538050343|FG001|Randomization|Withdrawal by Subject|0|||
149156796|NCT01847885|538050344|FG002|Randomization|Withdrawal by Subject|2|||
149156797|NCT01847885|538050342|FG000|Randomization|Screen Failure|0|||
149156798|NCT01847885|538050343|FG001|Randomization|Screen Failure|3|||
149156799|NCT01847885|538050344|FG002|Randomization|Screen Failure|0|||
149156800|NCT02574637|538050345|FG000|Double-blind Period|Adverse Event|1|||
149156801|NCT02574637|538050346|FG001|Double-blind Period|Adverse Event|0|||
148921077|NCT01426789|537194068|FG001|Part 1|Lost to Follow-up|2|||
148921078|NCT01426789|537194069|FG002|Part 1|Lost to Follow-up|0|||
149156802|NCT02574637|538050347|FG002|Double-blind Period|Adverse Event|0|||
149156803|NCT02574637|538050348|FG003|Double-blind Period|Adverse Event|0|||
149156804|NCT02574637|538050349|FG004|Double-blind Period|Adverse Event|0|||
149156805|NCT02574637|538050350|FG005|Double-blind Period|Adverse Event|0|||
149156806|NCT02574637|538050351|FG006|Double-blind Period|Adverse Event|0|||
149156807|NCT02574637|538050352|FG007|Double-blind Period|Adverse Event|0|||
149156808|NCT02574637|538050353|FG008|Double-blind Period|Adverse Event|0|||
149156809|NCT02574637|538050354|FG009|Double-blind Period|Adverse Event|0|||
149156810|NCT02574637|538050345|FG000|Double-blind Period|Lack of Efficacy|0|||
149156811|NCT02574637|538050346|FG001|Double-blind Period|Lack of Efficacy|0|||
149156812|NCT02574637|538050347|FG002|Double-blind Period|Lack of Efficacy|2|||
149156813|NCT02574637|538050348|FG003|Double-blind Period|Lack of Efficacy|0|||
149156814|NCT02574637|538050349|FG004|Double-blind Period|Lack of Efficacy|0|||
148921079|NCT01426789|537194070|FG003|Part 1|Lost to Follow-up|0|||
148921080|NCT01426789|537194071|FG004|Part 1|Lost to Follow-up|0|||
148921081|NCT01426789|537194072|FG005|Part 1|Lost to Follow-up|0|||
148921082|NCT01426789|537194067|FG000|Part 1|Lack of Efficacy|2|||
148921083|NCT01426789|537194068|FG001|Part 1|Lack of Efficacy|1|||
149156815|NCT02574637|538050350|FG005|Double-blind Period|Lack of Efficacy|0|||
148921084|NCT01426789|537194069|FG002|Part 1|Lack of Efficacy|0|||
148921085|NCT01426789|537194070|FG003|Part 1|Lack of Efficacy|0|||
148921086|NCT01426789|537194071|FG004|Part 1|Lack of Efficacy|0|||
148921087|NCT01426789|537194072|FG005|Part 1|Lack of Efficacy|0|||
148921088|NCT01426789|537194067|FG000|Part 1|Adverse Event|3|||
149156816|NCT02574637|538050351|FG006|Double-blind Period|Lack of Efficacy|0|||
149156817|NCT02574637|538050352|FG007|Double-blind Period|Lack of Efficacy|0|||
149156818|NCT02574637|538050353|FG008|Double-blind Period|Lack of Efficacy|0|||
149156819|NCT02574637|538050354|FG009|Double-blind Period|Lack of Efficacy|0|||
149156820|NCT02574637|538050345|FG000|Double-blind Period|Protocol Deviation|1|||
149156821|NCT02574637|538050346|FG001|Double-blind Period|Protocol Deviation|0|||
149156822|NCT02574637|538050347|FG002|Double-blind Period|Protocol Deviation|0|||
149156823|NCT02574637|538050348|FG003|Double-blind Period|Protocol Deviation|0|||
149156824|NCT02574637|538050349|FG004|Double-blind Period|Protocol Deviation|0|||
149156825|NCT02574637|538050350|FG005|Double-blind Period|Protocol Deviation|0|||
149156826|NCT02574637|538050351|FG006|Double-blind Period|Protocol Deviation|0|||
149156827|NCT02574637|538050352|FG007|Double-blind Period|Protocol Deviation|0|||
149156828|NCT02574637|538050353|FG008|Double-blind Period|Protocol Deviation|0|||
149156829|NCT02574637|538050354|FG009|Double-blind Period|Protocol Deviation|0|||
149156830|NCT02574637|538050345|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
149156831|NCT02574637|538050346|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
149156832|NCT02574637|538050347|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
149156833|NCT02574637|538050348|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
149156834|NCT02574637|538050349|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
149156835|NCT02574637|538050350|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
149156836|NCT02574637|538050351|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
149156837|NCT02574637|538050352|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
149156838|NCT02574637|538050353|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
149156839|NCT02574637|538050354|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
149156840|NCT02574637|538050345|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
149156841|NCT02574637|538050346|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
149156842|NCT02574637|538050347|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
149156843|NCT02574637|538050348|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
149156844|NCT02574637|538050349|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
149156845|NCT02574637|538050350|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
149156846|NCT02574637|538050351|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
149156847|NCT02574637|538050352|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
149156848|NCT02574637|538050353|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
149156849|NCT02574637|538050354|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
149156850|NCT02574637|538050345|FG000|Double-blind Period|Reason Not Specified|0|||
149156851|NCT02574637|538050346|FG001|Double-blind Period|Reason Not Specified|0|||
149156852|NCT02574637|538050347|FG002|Double-blind Period|Reason Not Specified|0|||
149156853|NCT02574637|538050348|FG003|Double-blind Period|Reason Not Specified|1|||
149156854|NCT02574637|538050349|FG004|Double-blind Period|Reason Not Specified|0|||
149156855|NCT02574637|538050350|FG005|Double-blind Period|Reason Not Specified|0|||
149156856|NCT02574637|538050351|FG006|Double-blind Period|Reason Not Specified|0|||
149156857|NCT02574637|538050352|FG007|Double-blind Period|Reason Not Specified|0|||
149156858|NCT02574637|538050353|FG008|Double-blind Period|Reason Not Specified|0|||
149156859|NCT02574637|538050354|FG009|Double-blind Period|Reason Not Specified|0|||
149156860|NCT02574637|538050345|FG000|Open-label (OL) Period|Adverse Event|0|||
149156861|NCT02574637|538050346|FG001|Open-label (OL) Period|Adverse Event|0|||
149156862|NCT02574637|538050347|FG002|Open-label (OL) Period|Adverse Event|0|||
149156863|NCT02574637|538050348|FG003|Open-label (OL) Period|Adverse Event|0|||
149156864|NCT02574637|538050349|FG004|Open-label (OL) Period|Adverse Event|0|||
149156865|NCT02574637|538050350|FG005|Open-label (OL) Period|Adverse Event|0|||
149156866|NCT02574637|538050351|FG006|Open-label (OL) Period|Adverse Event|0|||
149156867|NCT02574637|538050352|FG007|Open-label (OL) Period|Adverse Event|0|||
149156868|NCT02574637|538050353|FG008|Open-label (OL) Period|Adverse Event|1|||
149156869|NCT02574637|538050354|FG009|Open-label (OL) Period|Adverse Event|0|||
149156870|NCT02574637|538050345|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
148921089|NCT01426789|537194068|FG001|Part 1|Adverse Event|0|||
148921090|NCT01426789|537194069|FG002|Part 1|Adverse Event|0|||
149156871|NCT02574637|538050346|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
149156872|NCT02574637|538050347|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
149156873|NCT02574637|538050348|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
149156874|NCT02574637|538050349|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
149156875|NCT02574637|538050350|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
149156876|NCT02574637|538050351|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
149156877|NCT02574637|538050352|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
149156878|NCT02574637|538050353|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
149156879|NCT02574637|538050354|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
149156880|NCT02574637|538050345|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149156881|NCT02574637|538050346|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149156882|NCT02574637|538050347|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149156883|NCT02574637|538050348|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149156884|NCT02574637|538050349|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149156885|NCT02574637|538050350|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
149156886|NCT02574637|538050351|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
149156887|NCT02574637|538050352|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
149156888|NCT02574637|538050353|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
149156889|NCT02574637|538050354|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
149156890|NCT01536860|538050356|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
149156891|NCT01536860|538050357|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
149156892|NCT01536860|538050358|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
149156893|NCT01164722|538050359|FG000|Overall Study|Adverse Event|0|||
149156894|NCT01164722|538050360|FG001|Overall Study|Adverse Event|1|||
149156895|NCT01164722|538050359|FG000|Overall Study|Withdrawal by Subject|3|||
149156896|NCT01164722|538050360|FG001|Overall Study|Withdrawal by Subject|4|||
149156897|NCT01164722|538050359|FG000|Overall Study|Lost to Follow-up|3|||
148672868|NCT01610284|536272522|FG001|Randomization Phase|Physician Decision|1|||
149156898|NCT01164722|538050360|FG001|Overall Study|Lost to Follow-up|6|||
149156899|NCT01164722|538050359|FG000|Overall Study|met protocol criteria for non-treatment|11|||
149156900|NCT01164722|538050360|FG001|Overall Study|met protocol criteria for non-treatment|1|||
149156901|NCT01164722|538050359|FG000|Overall Study|enrolled on other study, concomitant med|1|||
149156902|NCT01164722|538050360|FG001|Overall Study|enrolled on other study, concomitant med|3|||
149156903|NCT03870555|538050361|FG000|Period 3 (2 Days)|Adverse Event|1|||
149156904|NCT03870555|538050362|FG001|Period 3 (2 Days)|Adverse Event|0|||
149156905|NCT03870555|538050363|FG002|Period 3 (2 Days)|Adverse Event|0|||
149156906|NCT02902120|538050364|FG000|Overall Study|Lack of Efficacy|1|||
149156907|NCT03694925|538050368|FG000|Overall Study|Inadequate laboratory testing|0|||
149156908|NCT03694925|538050369|FG001|Overall Study|Inadequate laboratory testing|3|||
149156909|NCT03694925|538050370|FG002|Overall Study|Inadequate laboratory testing|0|||
149156910|NCT01422239|538050373|FG000|Overall Study|Lost to Follow-up|4|||
149156911|NCT01422239|538050374|FG001|Overall Study|Lost to Follow-up|3|||
149156912|NCT02799069|538050377|FG000|Overall Study|Adverse Event|0|||
149156913|NCT02799069|538050378|FG001|Overall Study|Adverse Event|2|||
149156914|NCT02799069|538050379|FG002|Overall Study|Adverse Event|2|||
149156915|NCT02799069|538050377|FG000|Overall Study|Lack of Efficacy|2|||
149156916|NCT02799069|538050378|FG001|Overall Study|Lack of Efficacy|0|||
149156917|NCT02799069|538050379|FG002|Overall Study|Lack of Efficacy|0|||
149156918|NCT02799069|538050377|FG000|Overall Study|Lost to Follow-up|1|||
149156919|NCT02799069|538050378|FG001|Overall Study|Lost to Follow-up|1|||
149156920|NCT02799069|538050379|FG002|Overall Study|Lost to Follow-up|0|||
149156921|NCT02799069|538050377|FG000|Overall Study|Withdrawal by Subject|4|||
149156922|NCT02799069|538050378|FG001|Overall Study|Withdrawal by Subject|4|||
149156923|NCT02799069|538050379|FG002|Overall Study|Withdrawal by Subject|3|||
149156924|NCT02799069|538050377|FG000|Overall Study|Protocol Violation|1|||
149156925|NCT02799069|538050378|FG001|Overall Study|Protocol Violation|0|||
149156926|NCT02799069|538050379|FG002|Overall Study|Protocol Violation|2|||
149156927|NCT03652662|538050387|FG000|Overall Study|Withdrawal by Subject|2|||
149156928|NCT03652662|538050388|FG001|Overall Study|Withdrawal by Subject|1|||
149156929|NCT03652662|538050387|FG000|Overall Study|Lost to Follow-up|1|||
149156930|NCT03652662|538050388|FG001|Overall Study|Lost to Follow-up|0|||
149156931|NCT03499028|538050389|FG000|Overall Study|Lost to Follow-up|12|||
149156932|NCT03499028|538050390|FG001|Overall Study|Lost to Follow-up|9|||
149156933|NCT03499028|538050389|FG000|Overall Study|Withdrawal by Subject|5|||
149156934|NCT03499028|538050390|FG001|Overall Study|Withdrawal by Subject|8|||
149156935|NCT03499028|538050389|FG000|Overall Study|Unplanned SNF discharge|5|||
149156936|NCT03499028|538050390|FG001|Overall Study|Unplanned SNF discharge|8|||
149156937|NCT01110200|538050391|FG000|Overall Study|Adverse Event|28|||
149156938|NCT01110200|538050392|FG001|Overall Study|Adverse Event|28|||
149156939|NCT01110200|538050391|FG000|Overall Study|Withdrawal by Subject|25|||
149156940|NCT01110200|538050392|FG001|Overall Study|Withdrawal by Subject|32|||
149156941|NCT01110200|538050391|FG000|Overall Study|Lack of Efficacy|16|||
149156942|NCT01110200|538050392|FG001|Overall Study|Lack of Efficacy|25|||
149156943|NCT01110200|538050391|FG000|Overall Study|Protocol Violation|14|||
149156944|NCT01110200|538050392|FG001|Overall Study|Protocol Violation|12|||
149156945|NCT01110200|538050391|FG000|Overall Study|Physician Decision|13|||
149156946|NCT01110200|538050392|FG001|Overall Study|Physician Decision|17|||
149156947|NCT01110200|538050391|FG000|Overall Study|Lost to Follow-up|10|||
149156948|NCT01110200|538050392|FG001|Overall Study|Lost to Follow-up|7|||
149156949|NCT01687712|538050393|FG000|Cycle 1|Not Biochemically Pregnant|386|||
149156950|NCT01687712|538050394|FG001|Cycle 1|Not Biochemically Pregnant|348|||
149156951|NCT01687712|538050393|FG000|Cycle 1|Early Pregnancy Loss|43|||
149156952|NCT01687712|538050394|FG001|Cycle 1|Early Pregnancy Loss|60|||
149156953|NCT01687712|538050393|FG000|Cycle 1|Ectopic Pregnancy|5|||
149156954|NCT01687712|538050394|FG001|Cycle 1|Ectopic Pregnancy|5|||
148921091|NCT01426789|537194070|FG003|Part 1|Adverse Event|0|||
149156955|NCT01687712|538050393|FG000|Cycle 1|Heterotropic Pregnancy|1|||
149156956|NCT01687712|538050394|FG001|Cycle 1|Heterotropic Pregnancy|0|||
149156957|NCT01687712|538050393|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
149156958|NCT01687712|538050394|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
149156959|NCT01687712|538050393|FG000|Cycle 1|Abortion|3|||
149156960|NCT01687712|538050394|FG001|Cycle 1|Abortion|0|||
149156961|NCT01687712|538050393|FG000|Cycle 1|Intrauterine Fetal Death|0|||
149156962|NCT01687712|538050394|FG001|Cycle 1|Intrauterine Fetal Death|1|||
149156963|NCT01687712|538050393|FG000|Cycle 1|Lost to Follow-up|1|||
149156964|NCT01687712|538050394|FG001|Cycle 1|Lost to Follow-up|1|||
149156965|NCT01687712|538050393|FG000|Cycle 2|Not Biochemically Pregnant|74|||
149156966|NCT01687712|538050394|FG001|Cycle 2|Not Biochemically Pregnant|77|||
149156967|NCT01687712|538050393|FG000|Cycle 2|Early Pregnancy Loss|18|||
149156968|NCT01687712|538050394|FG001|Cycle 2|Early Pregnancy Loss|16|||
149156969|NCT01687712|538050393|FG000|Cycle 2|Ectopic Pregnancy|0|||
149156970|NCT01687712|538050394|FG001|Cycle 2|Ectopic Pregnancy|1|||
149156971|NCT01687712|538050393|FG000|Cycle 2|Still Birth|1|||
148921092|NCT01426789|537194071|FG004|Part 1|Adverse Event|0|||
148921093|NCT01426789|537194072|FG005|Part 1|Adverse Event|0|||
148921094|NCT01426789|537194067|FG000|Part 2|Protocol deviation|0|||
148921095|NCT01426789|537194068|FG001|Part 2|Protocol deviation|0|||
148921096|NCT01426789|537194069|FG002|Part 2|Protocol deviation|1|||
148921097|NCT01426789|537194070|FG003|Part 2|Protocol deviation|0|||
148921098|NCT01426789|537194071|FG004|Part 2|Protocol deviation|0|||
148921099|NCT01426789|537194072|FG005|Part 2|Protocol deviation|0|||
148921100|NCT01426789|537194067|FG000|Part 2|Death|0|||
148921101|NCT01426789|537194068|FG001|Part 2|Death|0|||
148921102|NCT01426789|537194069|FG002|Part 2|Death|1|||
149156972|NCT01687712|538050394|FG001|Cycle 2|Still Birth|0|||
149156973|NCT01687712|538050393|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
149156974|NCT01687712|538050394|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
149156975|NCT01687712|538050393|FG000|Cycle 3|Not Biochemically Pregnant|21|||
148805943|NCT05911841|536768050|FG006|Induction Period|Assigned Treatment by Mistake|0|||
148805944|NCT05911841|536768051|FG007|Induction Period|Assigned Treatment by Mistake|0|||
149156976|NCT01687712|538050394|FG001|Cycle 3|Not Biochemically Pregnant|22|||
149156977|NCT01687712|538050393|FG000|Cycle 3|Early Pregnancy Loss|1|||
148805945|NCT05911841|536768052|FG008|Induction Period|Assigned Treatment by Mistake|0|||
148921103|NCT01426789|537194070|FG003|Part 2|Death|0|||
148921104|NCT01426789|537194071|FG004|Part 2|Death|1|||
149156978|NCT01687712|538050394|FG001|Cycle 3|Early Pregnancy Loss|2|||
148921105|NCT01426789|537194072|FG005|Part 2|Death|0|||
148921106|NCT01426789|537194067|FG000|Part 2|Administrative problems|0|||
148921107|NCT01426789|537194068|FG001|Part 2|Administrative problems|0|||
148921108|NCT01426789|537194069|FG002|Part 2|Administrative problems|2|||
148921109|NCT01426789|537194070|FG003|Part 2|Administrative problems|0|||
148921110|NCT01426789|537194071|FG004|Part 2|Administrative problems|1|||
148921111|NCT01426789|537194072|FG005|Part 2|Administrative problems|0|||
148921112|NCT01426789|537194067|FG000|Part 2|Lost to Follow-up|0|||
148921113|NCT01426789|537194068|FG001|Part 2|Lost to Follow-up|0|||
148921114|NCT01426789|537194069|FG002|Part 2|Lost to Follow-up|4|||
148921115|NCT01426789|537194070|FG003|Part 2|Lost to Follow-up|0|||
148921116|NCT01426789|537194071|FG004|Part 2|Lost to Follow-up|1|||
148921117|NCT01426789|537194072|FG005|Part 2|Lost to Follow-up|0|||
148921118|NCT01426789|537194067|FG000|Part 2|Withdrawal by Subject|0|||
148921119|NCT01426789|537194068|FG001|Part 2|Withdrawal by Subject|0|||
148921120|NCT01426789|537194069|FG002|Part 2|Withdrawal by Subject|0|||
148921121|NCT01426789|537194070|FG003|Part 2|Withdrawal by Subject|1|||
148921122|NCT01426789|537194071|FG004|Part 2|Withdrawal by Subject|2|||
148921123|NCT01426789|537194072|FG005|Part 2|Withdrawal by Subject|0|||
148921124|NCT01426789|537194067|FG000|Part 2|Lack of Efficacy|0|||
148921125|NCT01426789|537194068|FG001|Part 2|Lack of Efficacy|0|||
148921126|NCT01426789|537194069|FG002|Part 2|Lack of Efficacy|5|||
148921127|NCT01426789|537194070|FG003|Part 2|Lack of Efficacy|0|||
148921128|NCT01426789|537194071|FG004|Part 2|Lack of Efficacy|2|||
148921129|NCT01426789|537194072|FG005|Part 2|Lack of Efficacy|0|||
148921130|NCT01426789|537194067|FG000|Part 2|Adverse Event|0|||
149156979|NCT01687712|538050393|FG000|Cycle 3|Ectopic Pregnancy|1|||
149156980|NCT01687712|538050394|FG001|Cycle 3|Ectopic Pregnancy|0|||
149156981|NCT01687712|538050393|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
149156982|NCT01687712|538050394|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
149156983|NCT01681433|538050395|FG000|Overall Study|Lack of Efficacy|23|||
149156984|NCT01681433|538050396|FG001|Overall Study|Lack of Efficacy|23|||
149156985|NCT01681433|538050395|FG000|Overall Study|Withdrawal by Subject|5|||
148921131|NCT01426789|537194068|FG001|Part 2|Adverse Event|0|||
148921132|NCT01426789|537194069|FG002|Part 2|Adverse Event|2|||
149156986|NCT01681433|538050396|FG001|Overall Study|Withdrawal by Subject|5|||
149156987|NCT01681433|538050395|FG000|Overall Study|Protocol Violation|2|||
149156988|NCT01681433|538050396|FG001|Overall Study|Protocol Violation|0|||
148921133|NCT01426789|537194070|FG003|Part 2|Adverse Event|0|||
148921134|NCT01426789|537194071|FG004|Part 2|Adverse Event|1|||
148921135|NCT01426789|537194072|FG005|Part 2|Adverse Event|0|||
148921136|NCT04054947|537194073|FG000|Overall Study|Withdrawal by Subject|1|||
148921137|NCT04054947|537194074|FG001|Overall Study|Withdrawal by Subject|0|||
148921138|NCT04054947|537194073|FG000|Overall Study|Lost to Follow-up|2|||
148921139|NCT04054947|537194074|FG001|Overall Study|Lost to Follow-up|5|||
149156989|NCT01681433|538050395|FG000|Overall Study|Adverse Event|2|||
149156990|NCT01681433|538050396|FG001|Overall Study|Adverse Event|4|||
149156991|NCT01681433|538050395|FG000|Overall Study|Lost to Follow-up|0|||
149156992|NCT01681433|538050396|FG001|Overall Study|Lost to Follow-up|1|||
149156993|NCT00730639|538050397|FG000|Overall Study|Adverse Event|3|||
149156994|NCT00730639|538050398|FG001|Overall Study|Adverse Event|0|||
149156995|NCT00730639|538050399|FG002|Overall Study|Adverse Event|9|||
149156996|NCT00730639|538050400|FG003|Overall Study|Adverse Event|8|||
149156997|NCT00730639|538050401|FG004|Overall Study|Adverse Event|23|||
149156998|NCT00730639|538050397|FG000|Overall Study|Complete Response|0|||
149156999|NCT00730639|538050398|FG001|Overall Study|Complete Response|0|||
149157000|NCT00730639|538050399|FG002|Overall Study|Complete Response|2|||
148805946|NCT05911841|536768053|FG009|Induction Period|Assigned Treatment by Mistake|0|||
148805947|NCT05911841|536768044|FG000|Induction Period|Lost to Follow-up|0|||
148805948|NCT05911841|536768045|FG001|Induction Period|Lost to Follow-up|0|||
148805949|NCT05911841|536768046|FG002|Induction Period|Lost to Follow-up|1|||
149157001|NCT00730639|538050400|FG003|Overall Study|Complete Response|2|||
149157002|NCT00730639|538050401|FG004|Overall Study|Complete Response|1|||
149157003|NCT00730639|538050397|FG000|Overall Study|Completed Maximum Cycles|0|||
149157004|NCT00730639|538050398|FG001|Overall Study|Completed Maximum Cycles|0|||
149157005|NCT00730639|538050399|FG002|Overall Study|Completed Maximum Cycles|11|||
149157006|NCT00730639|538050400|FG003|Overall Study|Completed Maximum Cycles|3|||
149157007|NCT00730639|538050401|FG004|Overall Study|Completed Maximum Cycles|6|||
149157008|NCT00730639|538050397|FG000|Overall Study|Death|0|||
149157009|NCT00730639|538050398|FG001|Overall Study|Death|0|||
149157010|NCT00730639|538050399|FG002|Overall Study|Death|0|||
149157011|NCT00730639|538050400|FG003|Overall Study|Death|0|||
148921140|NCT00311584|537194075|FG000|Overall Study|Death|1|||
148921141|NCT00311584|537194076|FG001|Overall Study|Death|0|||
148921142|NCT00311584|537194075|FG000|Overall Study|Lack of Efficacy|12|||
148921143|NCT00311584|537194076|FG001|Overall Study|Lack of Efficacy|15|||
148921144|NCT00311584|537194075|FG000|Overall Study|Physician Decision|4|||
148921145|NCT00311584|537194076|FG001|Overall Study|Physician Decision|5|||
148921146|NCT00311584|537194075|FG000|Overall Study|Withdrawal by Subject|1|||
148921147|NCT00311584|537194076|FG001|Overall Study|Withdrawal by Subject|1|||
148921148|NCT00311584|537194075|FG000|Overall Study|ineligible|2|||
148921149|NCT00311584|537194076|FG001|Overall Study|ineligible|2|||
148921150|NCT03720652|537194077|FG000|Overall Study|Withdrawal by Subject|2|||
148921151|NCT03720652|537194078|FG001|Overall Study|Withdrawal by Subject|7|||
149157012|NCT00730639|538050401|FG004|Overall Study|Death|2|||
148921152|NCT03720652|537194077|FG000|Overall Study|Lost to Follow-up|0|||
148921153|NCT03720652|537194078|FG001|Overall Study|Lost to Follow-up|4|||
148921154|NCT03073733|537194085|FG000|Overall Study|Lost to Follow-up|1|||
148921155|NCT03073733|537194086|FG001|Overall Study|Lost to Follow-up|0|||
148921156|NCT03073733|537194087|FG002|Overall Study|Lost to Follow-up|0|||
148921157|NCT03073733|537194085|FG000|Overall Study|Physician Decision|0|||
148921158|NCT03073733|537194086|FG001|Overall Study|Physician Decision|1|||
148921159|NCT03073733|537194087|FG002|Overall Study|Physician Decision|0|||
148921160|NCT03073733|537194085|FG000|Overall Study|Withdrawal by Subject|0|||
148921161|NCT03073733|537194086|FG001|Overall Study|Withdrawal by Subject|0|||
148921162|NCT03073733|537194087|FG002|Overall Study|Withdrawal by Subject|1|||
148921163|NCT00835731|537194088|FG000|Overall Study|Withdrawal by Subject|1|||
148921164|NCT00835731|537194089|FG001|Overall Study|Withdrawal by Subject|0|||
148921165|NCT00835731|537194088|FG000|Overall Study|Physician Decision|1|||
148921166|NCT00835731|537194089|FG001|Overall Study|Physician Decision|1|||
148921167|NCT01227629|537194090|FG000|Overall Study|Adverse Event|2|||
148921168|NCT01227629|537194091|FG001|Overall Study|Adverse Event|2|||
148921169|NCT01227629|537194092|FG002|Overall Study|Adverse Event|1|||
148921170|NCT01227629|537194093|FG003|Overall Study|Adverse Event|6|||
149157013|NCT00730639|538050397|FG000|Overall Study|Disease Progression|12|||
149157014|NCT00730639|538050398|FG001|Overall Study|Disease Progression|13|||
149157015|NCT00730639|538050399|FG002|Overall Study|Disease Progression|48|||
149157016|NCT00730639|538050400|FG003|Overall Study|Disease Progression|32|||
149157017|NCT00730639|538050401|FG004|Overall Study|Disease Progression|88|||
149157018|NCT00730639|538050397|FG000|Overall Study|non-specified|0|||
149157019|NCT00730639|538050398|FG001|Overall Study|non-specified|0|||
149157020|NCT00730639|538050399|FG002|Overall Study|non-specified|4|||
149157021|NCT00730639|538050400|FG003|Overall Study|non-specified|2|||
149157022|NCT00730639|538050401|FG004|Overall Study|non-specified|3|||
149157023|NCT00730639|538050397|FG000|Overall Study|Protocol Violation|0|||
149157024|NCT00730639|538050398|FG001|Overall Study|Protocol Violation|0|||
149157025|NCT00730639|538050399|FG002|Overall Study|Protocol Violation|1|||
149157026|NCT00730639|538050400|FG003|Overall Study|Protocol Violation|0|||
149157027|NCT00730639|538050401|FG004|Overall Study|Protocol Violation|0|||
149157028|NCT00730639|538050397|FG000|Overall Study|Withdrawal by Subject|0|||
149157029|NCT00730639|538050398|FG001|Overall Study|Withdrawal by Subject|0|||
149157030|NCT00730639|538050399|FG002|Overall Study|Withdrawal by Subject|6|||
149157031|NCT00730639|538050400|FG003|Overall Study|Withdrawal by Subject|3|||
149157032|NCT00730639|538050401|FG004|Overall Study|Withdrawal by Subject|4|||
149157033|NCT00730639|538050397|FG000|Overall Study|Treatment on-going|2|||
149157034|NCT00730639|538050398|FG001|Overall Study|Treatment on-going|5|||
149157035|NCT00730639|538050399|FG002|Overall Study|Treatment on-going|5|||
149157036|NCT00730639|538050400|FG003|Overall Study|Treatment on-going|4|||
149157037|NCT00730639|538050401|FG004|Overall Study|Treatment on-going|4|||
149157038|NCT00903929|538050402|FG000|Overall Study|Withdrawal by Subject|0|||
149157039|NCT00903929|538050403|FG001|Overall Study|Withdrawal by Subject|0|||
149157040|NCT00903929|538050404|FG002|Overall Study|Withdrawal by Subject|1|||
149157041|NCT00903929|538050405|FG003|Overall Study|Withdrawal by Subject|2|||
149157042|NCT00903929|538050402|FG000|Overall Study|Adverse Event|0|||
149157043|NCT00903929|538050403|FG001|Overall Study|Adverse Event|0|||
149157044|NCT00903929|538050404|FG002|Overall Study|Adverse Event|0|||
149157045|NCT00903929|538050405|FG003|Overall Study|Adverse Event|1|||
149157046|NCT02665286|538050406|FG000|Overall Study|Lost to Follow-up|3|||
149157047|NCT02665286|538050407|FG001|Overall Study|Lost to Follow-up|2|||
149157048|NCT02665286|538050408|FG002|Overall Study|Lost to Follow-up|1|||
149157049|NCT01250379|538050415|FG000|Overall Study|Death|141|||
149157050|NCT01250379|538050416|FG001|Overall Study|Death|148|||
149157051|NCT01250379|538050415|FG000|Overall Study|Withdrawal by Subject|32|||
149157052|NCT01250379|538050416|FG001|Overall Study|Withdrawal by Subject|20|||
149157053|NCT01250379|538050415|FG000|Overall Study|Physician Decision|11|||
149157054|NCT01250379|538050416|FG001|Overall Study|Physician Decision|3|||
149157055|NCT01250379|538050415|FG000|Overall Study|Protocol Violation|2|||
149157056|NCT01250379|538050416|FG001|Overall Study|Protocol Violation|8|||
149157057|NCT01250379|538050415|FG000|Overall Study|Lost to Follow-up|9|||
149157058|NCT01250379|538050416|FG001|Overall Study|Lost to Follow-up|6|||
149157059|NCT01250379|538050415|FG000|Overall Study|Adverse Event|5|||
149157060|NCT01250379|538050416|FG001|Overall Study|Adverse Event|4|||
149157061|NCT01250379|538050415|FG000|Overall Study|Other|0|||
148672869|NCT01610284|536272521|FG000|Randomization Phase|Death|0|||
148672870|NCT01610284|536272522|FG001|Randomization Phase|Death|1|||
148672871|NCT01610284|536272521|FG000|Treatment Phase|Adverse Event|80|||
148672872|NCT01610284|536272522|FG001|Treatment Phase|Adverse Event|12|||
149157062|NCT01250379|538050416|FG001|Overall Study|Other|4|||
149157063|NCT01250379|538050415|FG000|Overall Study|Participant noncompliance|2|||
149157064|NCT01250379|538050416|FG001|Overall Study|Participant noncompliance|0|||
149157065|NCT04899232|538050417|FG000|Screening Period|Physician Decision|1|||
148672873|NCT01610284|536272521|FG000|Treatment Phase|Lost to Follow-up|1|||
148672874|NCT01610284|536272522|FG001|Treatment Phase|Lost to Follow-up|0|||
148672875|NCT01610284|536272521|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
148672876|NCT01610284|536272522|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
148672877|NCT01610284|536272521|FG000|Treatment Phase|Physician Decision|27|||
148672878|NCT01610284|536272522|FG001|Treatment Phase|Physician Decision|24|||
148672879|NCT01610284|536272521|FG000|Treatment Phase|Progressive Disease|377|||
148672880|NCT01610284|536272522|FG001|Treatment Phase|Progressive Disease|486|||
148672881|NCT01610284|536272521|FG000|Treatment Phase|Protocol Deviation|2|||
148672882|NCT01610284|536272522|FG001|Treatment Phase|Protocol Deviation|3|||
148672883|NCT01610284|536272521|FG000|Treatment Phase|Study terminated by Sponsor|18|||
148672884|NCT01610284|536272522|FG001|Treatment Phase|Study terminated by Sponsor|15|||
149157066|NCT04899232|538050418|FG001|Screening Period|Physician Decision|0|||
149157067|NCT04899232|538050419|FG002|Screening Period|Physician Decision|0|||
149157068|NCT04899232|538050417|FG000|Screening Period|Withdrawal by Subject|1|||
149157069|NCT04899232|538050418|FG001|Screening Period|Withdrawal by Subject|0|||
149157070|NCT04899232|538050419|FG002|Screening Period|Withdrawal by Subject|0|||
149157071|NCT04899232|538050417|FG000|Screening Period|Participant discharged before receiving intervention|3|||
149157072|NCT04899232|538050418|FG001|Screening Period|Participant discharged before receiving intervention|0|||
149157073|NCT04899232|538050419|FG002|Screening Period|Participant discharged before receiving intervention|0|||
149157074|NCT01314716|538050420|FG000|Double-Blind Phase|Randomized but not treated|1|||
149157075|NCT01314716|538050421|FG001|Double-Blind Phase|Randomized but not treated|1|||
149157076|NCT01314716|538050420|FG000|Double-Blind Phase|Adverse Event|10|||
149157077|NCT01314716|538050421|FG001|Double-Blind Phase|Adverse Event|4|||
149157078|NCT01314716|538050420|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
149157079|NCT01314716|538050421|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
149157080|NCT01314716|538050420|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149157081|NCT01314716|538050421|FG001|Double-Blind Phase|Lost to Follow-up|1|||
149157082|NCT01314716|538050420|FG000|Double-Blind Phase|Sponsor request|1|||
149157083|NCT01314716|538050421|FG001|Double-Blind Phase|Sponsor request|2|||
149157084|NCT01314716|538050420|FG000|Double-Blind Phase|Physician Decision|0|||
149157085|NCT01314716|538050421|FG001|Double-Blind Phase|Physician Decision|1|||
149157086|NCT01314716|538050420|FG000|Open-Label Phase|Adverse Event|4|||
149157087|NCT01314716|538050421|FG001|Open-Label Phase|Adverse Event|6|||
149157088|NCT01314716|538050420|FG000|Open-Label Phase|Withdrawal by Subject|1|||
149157089|NCT01314716|538050421|FG001|Open-Label Phase|Withdrawal by Subject|2|||
149157090|NCT01314716|538050420|FG000|Open-Label Phase|Physician Decision|5|||
149157091|NCT01314716|538050421|FG001|Open-Label Phase|Physician Decision|4|||
149157092|NCT02926950|538050425|FG000|Overall Study|Adverse Event|4|||
149157093|NCT02926950|538050426|FG001|Overall Study|Adverse Event|6|||
149157094|NCT02926950|538050425|FG000|Overall Study|At the participant's own request|21|||
149157095|NCT02926950|538050426|FG001|Overall Study|At the participant's own request|25|||
149157096|NCT02926950|538050425|FG000|Overall Study|Reason not Specified|17|||
149157097|NCT02926950|538050426|FG001|Overall Study|Reason not Specified|9|||
149157098|NCT02926950|538050425|FG000|Overall Study|Lost to Follow-up|7|||
149157099|NCT02926950|538050426|FG001|Overall Study|Lost to Follow-up|8|||
149157100|NCT05036083|538050427|FG000|Overall Study|Physician Decision|1|||
149157101|NCT05036083|538050427|FG000|Overall Study|Withdrawal by Subject|1|||
149157102|NCT05036083|538050427|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
149157103|NCT05036083|538050427|FG000|Overall Study|IV not sustainable|1|||
149157104|NCT03087955|538051743|FG000|Overall Study|Death|4|||
149157105|NCT03087955|538051744|FG001|Overall Study|Death|0|||
149157106|NCT03087955|538051743|FG000|Overall Study|Lack of Efficacy|2|||
149157107|NCT03087955|538051744|FG001|Overall Study|Lack of Efficacy|0|||
149157108|NCT03087955|538051743|FG000|Overall Study|Lost to Follow-up|1|||
149157109|NCT03087955|538051744|FG001|Overall Study|Lost to Follow-up|0|||
149157110|NCT02392429|538051745|FG000|Screening|Screen failure|15|||
149157111|NCT02392429|538051745|FG000|Enrolled Participants|Ineligible due to disease|3|||
149157112|NCT02392429|538051745|FG000|Enrolled Participants|Withdrawal by Subject|4|||
149157113|NCT02392429|538051745|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
149157114|NCT02392429|538051745|FG000|Evaluable|Death|5|||
149157115|NCT02392429|538051745|FG000|Evaluable|Withdrawal by Subject|1|||
149157116|NCT02392429|538051745|FG000|Evaluable|Adverse Event|1|||
149157117|NCT02392429|538051745|FG000|Evaluable|remission bone marrow biopsy|3|||
149157118|NCT00482014|538051746|FG000|Overall Study|Withdrawal by Subject|1|||
149157119|NCT00482014|538051747|FG001|Overall Study|Withdrawal by Subject|2|||
149157120|NCT00482014|538051748|FG002|Overall Study|Withdrawal by Subject|3|||
149157121|NCT00482014|538051749|FG003|Overall Study|Withdrawal by Subject|4|||
149157122|NCT00482014|538051746|FG000|Overall Study|Adverse Event|3|||
149157123|NCT00482014|538051747|FG001|Overall Study|Adverse Event|0|||
149157124|NCT00482014|538051748|FG002|Overall Study|Adverse Event|2|||
149157125|NCT00482014|538051749|FG003|Overall Study|Adverse Event|8|||
149157126|NCT00482014|538051746|FG000|Overall Study|Death|1|||
149157127|NCT00482014|538051747|FG001|Overall Study|Death|2|||
149157128|NCT00482014|538051748|FG002|Overall Study|Death|1|||
149157129|NCT00482014|538051749|FG003|Overall Study|Death|4|||
149157130|NCT00482014|538051746|FG000|Overall Study|Lack of Efficacy|1|||
149157131|NCT00482014|538051747|FG001|Overall Study|Lack of Efficacy|0|||
149157132|NCT00482014|538051748|FG002|Overall Study|Lack of Efficacy|4|||
149157133|NCT00482014|538051749|FG003|Overall Study|Lack of Efficacy|6|||
149157134|NCT00482014|538051746|FG000|Overall Study|Sponsor Decision|1|||
149157135|NCT00482014|538051747|FG001|Overall Study|Sponsor Decision|2|||
149157136|NCT00482014|538051748|FG002|Overall Study|Sponsor Decision|1|||
148921171|NCT01227629|537194094|FG004|Overall Study|Adverse Event|1|||
148921172|NCT01227629|537194095|FG005|Overall Study|Adverse Event|1|||
148921173|NCT01227629|537194096|FG006|Overall Study|Adverse Event|6|||
148921174|NCT01227629|537194097|FG007|Overall Study|Adverse Event|6|||
148921175|NCT01227629|537194098|FG008|Overall Study|Adverse Event|4|||
148921176|NCT01227629|537194099|FG009|Overall Study|Adverse Event|0|||
149157137|NCT00482014|538051749|FG003|Overall Study|Sponsor Decision|1|||
149157138|NCT03686397|538051750|FG000|Overall Study|Lack of Efficacy|3|||
149157139|NCT03686397|538051751|FG001|Overall Study|Lack of Efficacy|5|||
149157140|NCT03686397|538051750|FG000|Overall Study|Adverse Event|0|||
149157141|NCT03686397|538051751|FG001|Overall Study|Adverse Event|1|||
149157142|NCT03686397|538051750|FG000|Overall Study|Protocol Violation|0|||
149157143|NCT03686397|538051751|FG001|Overall Study|Protocol Violation|1|||
148672885|NCT01610284|536272521|FG000|Treatment Phase|Subject/Guardian Decision|55|||
148672886|NCT01610284|536272522|FG001|Treatment Phase|Subject/Guardian Decision|23|||
148672887|NCT01610284|536272521|FG000|Treatment Phase|Death|6|||
148672888|NCT01610284|536272522|FG001|Treatment Phase|Death|5|||
148921177|NCT01227629|537194090|FG000|Overall Study|Protocol Violation|0|||
148921178|NCT01227629|537194091|FG001|Overall Study|Protocol Violation|0|||
149157144|NCT03686397|538051750|FG000|Overall Study|Withdrawal by Subject|0|||
149157145|NCT03686397|538051751|FG001|Overall Study|Withdrawal by Subject|1|||
149157146|NCT03686397|538051750|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
149157147|NCT03686397|538051751|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
149157148|NCT00403260|538051754|FG000|Overall Study|Adverse Event|5|||
149157149|NCT00403260|538051755|FG001|Overall Study|Adverse Event|4|||
149157150|NCT00403260|538051754|FG000|Overall Study|Withdrawal by Subject|5|||
149157151|NCT00403260|538051755|FG001|Overall Study|Withdrawal by Subject|6|||
149157152|NCT00403260|538051754|FG000|Overall Study|Lost to Follow-up|49|||
149157153|NCT00403260|538051755|FG001|Overall Study|Lost to Follow-up|25|||
149157154|NCT00403260|538051754|FG000|Overall Study|Re-appearance of P. falciparum|34|||
149157155|NCT00403260|538051755|FG001|Overall Study|Re-appearance of P. falciparum|25|||
149157156|NCT00403260|538051754|FG000|Overall Study|P. vivax infection|26|||
149157157|NCT00403260|538051755|FG001|Overall Study|P. vivax infection|4|||
149157158|NCT00403260|538051754|FG000|Overall Study|Mixed infection with P. vivax|2|||
149157159|NCT00403260|538051755|FG001|Overall Study|Mixed infection with P. vivax|0|||
149157160|NCT00403260|538051754|FG000|Overall Study|Mixed infection with P. falciparum|1|||
149157161|NCT00403260|538051755|FG001|Overall Study|Mixed infection with P. falciparum|0|||
149157162|NCT00403260|538051754|FG000|Overall Study|P. vivax infection at screening|1|||
149157163|NCT00403260|538051755|FG001|Overall Study|P. vivax infection at screening|0|||
149157164|NCT00403260|538051754|FG000|Overall Study|P. ovale infection|1|||
149157165|NCT00403260|538051755|FG001|Overall Study|P. ovale infection|0|||
149157166|NCT00403260|538051754|FG000|Overall Study|Gametocyte re-appearance|1|||
149157167|NCT00403260|538051755|FG001|Overall Study|Gametocyte re-appearance|1|||
149157168|NCT00403260|538051754|FG000|Overall Study|Withdrawn from study accidentally|0|||
149157169|NCT00403260|538051755|FG001|Overall Study|Withdrawn from study accidentally|1|||
149157170|NCT04137887|538051758|FG000|Overall Study|Death|102|||
149157171|NCT04137887|538051759|FG001|Overall Study|Death|92|||
149157172|NCT04137887|538051758|FG000|Overall Study|Withdrawal by Subject|2|||
149157173|NCT04137887|538051759|FG001|Overall Study|Withdrawal by Subject|3|||
149157174|NCT04137887|538051758|FG000|Overall Study|Randomized but not treated|0|||
149157175|NCT04137887|538051759|FG001|Overall Study|Randomized but not treated|1|||
149157176|NCT05064059|538051762|FG000|Overall Study|Death|199|||
149157177|NCT05064059|538051763|FG001|Overall Study|Death|196|||
149157178|NCT05064059|538051762|FG000|Overall Study|Physician Decision|4|||
148921179|NCT01227629|537194092|FG002|Overall Study|Protocol Violation|0|||
149157179|NCT05064059|538051763|FG001|Overall Study|Physician Decision|2|||
149157180|NCT05064059|538051762|FG000|Overall Study|Sponsor Decision|14|||
149157181|NCT05064059|538051763|FG001|Overall Study|Sponsor Decision|11|||
149157182|NCT05064059|538051762|FG000|Overall Study|Withdrawal by Subject|4|||
149157183|NCT05064059|538051763|FG001|Overall Study|Withdrawal by Subject|11|||
149157184|NCT02740478|538051764|FG000|Overall Study|Withdrawal by Subject|1|||
149157185|NCT02615990|538051766|FG000|Overall Study|study terminated|1|||
149157186|NCT02615990|538051767|FG001|Overall Study|study terminated|1|||
149157187|NCT04316585|538051768|FG000|Overall Study|Adverse Event|2|||
149157188|NCT04316585|538051769|FG001|Overall Study|Adverse Event|1|||
148921180|NCT01227629|537194093|FG003|Overall Study|Protocol Violation|1|||
148921181|NCT01227629|537194094|FG004|Overall Study|Protocol Violation|0|||
148921182|NCT01227629|537194095|FG005|Overall Study|Protocol Violation|0|||
148921183|NCT01227629|537194096|FG006|Overall Study|Protocol Violation|0|||
148921184|NCT01227629|537194097|FG007|Overall Study|Protocol Violation|0|||
148921185|NCT01227629|537194098|FG008|Overall Study|Protocol Violation|0|||
148921186|NCT01227629|537194099|FG009|Overall Study|Protocol Violation|0|||
148921187|NCT01227629|537194090|FG000|Overall Study|Lost to Follow-up|0|||
148921188|NCT01227629|537194091|FG001|Overall Study|Lost to Follow-up|0|||
148921189|NCT01227629|537194092|FG002|Overall Study|Lost to Follow-up|0|||
148921190|NCT01227629|537194093|FG003|Overall Study|Lost to Follow-up|0|||
148921191|NCT01227629|537194094|FG004|Overall Study|Lost to Follow-up|1|||
148921192|NCT01227629|537194095|FG005|Overall Study|Lost to Follow-up|0|||
148921193|NCT01227629|537194096|FG006|Overall Study|Lost to Follow-up|0|||
148921194|NCT01227629|537194097|FG007|Overall Study|Lost to Follow-up|0|||
148921195|NCT01227629|537194098|FG008|Overall Study|Lost to Follow-up|0|||
148921196|NCT01227629|537194099|FG009|Overall Study|Lost to Follow-up|0|||
148921197|NCT01227629|537194090|FG000|Overall Study|Withdrawal by Subject|0|||
148921198|NCT01227629|537194091|FG001|Overall Study|Withdrawal by Subject|0|||
149157189|NCT04316585|538051768|FG000|Overall Study|Lost to Follow-up|1|||
149157190|NCT04316585|538051769|FG001|Overall Study|Lost to Follow-up|0|||
149157191|NCT04316585|538051768|FG000|Overall Study|Withdrawal by Subject|2|||
148921199|NCT01227629|537194092|FG002|Overall Study|Withdrawal by Subject|0|||
148921200|NCT01227629|537194093|FG003|Overall Study|Withdrawal by Subject|0|||
148921201|NCT01227629|537194094|FG004|Overall Study|Withdrawal by Subject|0|||
148921202|NCT01227629|537194095|FG005|Overall Study|Withdrawal by Subject|0|||
148921203|NCT01227629|537194096|FG006|Overall Study|Withdrawal by Subject|2|||
148921204|NCT01227629|537194097|FG007|Overall Study|Withdrawal by Subject|0|||
148921205|NCT01227629|537194098|FG008|Overall Study|Withdrawal by Subject|0|||
149157192|NCT04316585|538051769|FG001|Overall Study|Withdrawal by Subject|3|||
148672889|NCT01610284|536272521|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
149157193|NCT04316585|538051768|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
148921206|NCT01227629|537194099|FG009|Overall Study|Withdrawal by Subject|1|||
148921207|NCT01227629|537194090|FG000|Overall Study|Other|0|||
148921208|NCT01227629|537194091|FG001|Overall Study|Other|0|||
148672890|NCT01610284|536272522|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148672891|NCT01610284|536272521|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
148672892|NCT01610284|536272522|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
148672893|NCT01610284|536272521|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
148672894|NCT01610284|536272522|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
148672895|NCT01610284|536272521|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
148672896|NCT01610284|536272522|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
148672897|NCT01610284|536272521|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
148672898|NCT01610284|536272522|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
148672899|NCT01610284|536272521|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
148672900|NCT01610284|536272522|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
148672901|NCT01125358|536272526|FG000|Overall Study|Adverse Event|3|||
148672902|NCT01125358|536272527|FG001|Overall Study|Adverse Event|0|||
148672903|NCT01125358|536272528|FG002|Overall Study|Adverse Event|0|||
148672904|NCT01125358|536272529|FG003|Overall Study|Adverse Event|2|||
148672905|NCT01125358|536272526|FG000|Overall Study|Perceived Lack of Efficacy|6|||
149157194|NCT04316585|538051769|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
149157195|NCT04316585|538051768|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
149157196|NCT04316585|538051769|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
149157197|NCT03905863|538051770|FG000|Overall Study|Adverse Event|2|||
149157198|NCT03905863|538051771|FG001|Overall Study|Adverse Event|4|||
148672906|NCT01125358|536272527|FG001|Overall Study|Perceived Lack of Efficacy|3|||
148672907|NCT01125358|536272528|FG002|Overall Study|Perceived Lack of Efficacy|7|||
148672908|NCT01125358|536272529|FG003|Overall Study|Perceived Lack of Efficacy|4|||
148672909|NCT01125358|536272526|FG000|Overall Study|Protocol Violation|1|||
148672910|NCT01125358|536272527|FG001|Overall Study|Protocol Violation|0|||
148672911|NCT01125358|536272528|FG002|Overall Study|Protocol Violation|0|||
148672912|NCT01125358|536272529|FG003|Overall Study|Protocol Violation|0|||
148672913|NCT01125358|536272526|FG000|Overall Study|Sponsor Decision|0|||
148672914|NCT01125358|536272527|FG001|Overall Study|Sponsor Decision|0|||
148672915|NCT01125358|536272528|FG002|Overall Study|Sponsor Decision|1|||
148672916|NCT01125358|536272529|FG003|Overall Study|Sponsor Decision|1|||
148672917|NCT01125358|536272526|FG000|Overall Study|Withdrawal by Subject|2|||
148672918|NCT01125358|536272527|FG001|Overall Study|Withdrawal by Subject|1|||
148672919|NCT01125358|536272528|FG002|Overall Study|Withdrawal by Subject|1|||
148672920|NCT01125358|536272529|FG003|Overall Study|Withdrawal by Subject|1|||
148672921|NCT01060007|536272530|FG000|Overall Study|Withdrawal by Subject|1|||
148672922|NCT01060007|536272530|FG000|Overall Study|Inevaluable for response at surgery|3|||
148672923|NCT05168657|536272531|FG000|Overall Study|Adverse Event|0|||
148672924|NCT05168657|536272532|FG001|Overall Study|Adverse Event|0|||
148672925|NCT05168657|536272533|FG002|Overall Study|Adverse Event|1|||
148672926|NCT05168657|536272534|FG003|Overall Study|Adverse Event|0|||
148672927|NCT05168657|536272535|FG004|Overall Study|Adverse Event|0|||
148672928|NCT05168657|536272536|FG005|Overall Study|Adverse Event|0|||
148672929|NCT05168657|536272537|FG006|Overall Study|Adverse Event|0|||
149157199|NCT03905863|538051770|FG000|Overall Study|Withdrawal by Subject|2|||
149157200|NCT03905863|538051771|FG001|Overall Study|Withdrawal by Subject|2|||
149157201|NCT03905863|538051770|FG000|Overall Study|Physician Decision|0|||
149157202|NCT03905863|538051771|FG001|Overall Study|Physician Decision|3|||
149157203|NCT03905863|538051770|FG000|Overall Study|Lost to Follow-up|1|||
149157204|NCT03905863|538051771|FG001|Overall Study|Lost to Follow-up|0|||
149157205|NCT03905863|538051770|FG000|Overall Study|Protocol Violation|0|||
149157206|NCT03905863|538051771|FG001|Overall Study|Protocol Violation|2|||
149157207|NCT03905863|538051770|FG000|Overall Study|Death|0|||
149157208|NCT03905863|538051771|FG001|Overall Study|Death|1|||
149157209|NCT01072344|538051773|FG000|Overall Study|Relasped-reached end point|7|||
149157210|NCT01072344|538051774|FG001|Overall Study|Relasped-reached end point|12|||
149157211|NCT01072344|538051773|FG000|Overall Study|Protocol Violation|1|||
149157212|NCT01072344|538051774|FG001|Overall Study|Protocol Violation|2|||
149157213|NCT01072344|538051773|FG000|Overall Study|Lost to Follow-up|3|||
149157214|NCT01072344|538051774|FG001|Overall Study|Lost to Follow-up|4|||
149157215|NCT01934140|538051781|FG000|Persistence Phase (Year 6-10)|Other|24|||
149157216|NCT01934140|538051782|FG001|Persistence Phase (Year 6-10)|Other|6|||
149157217|NCT01934140|538051781|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
149157218|NCT01934140|538051782|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
149157219|NCT01934140|538051781|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
149157220|NCT01934140|538051782|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
149157221|NCT01934140|538051781|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
149157222|NCT01934140|538051782|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
149157223|NCT01934140|538051781|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
149157224|NCT01934140|538051782|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
148921209|NCT01227629|537194092|FG002|Overall Study|Other|0|||
149157225|NCT01934140|538051781|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
149157226|NCT01934140|538051782|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
149157227|NCT01934140|538051781|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
149157228|NCT01934140|538051782|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
149157229|NCT01934140|538051781|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
149157230|NCT01934140|538051782|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
149157231|NCT02944448|538051786|FG000|Overall Study|Adverse Event|37|||
149157232|NCT02944448|538051787|FG001|Overall Study|Adverse Event|6|||
149157233|NCT02944448|538051786|FG000|Overall Study|Lack of Efficacy|8|||
149157234|NCT02944448|538051787|FG001|Overall Study|Lack of Efficacy|5|||
149157235|NCT02944448|538051786|FG000|Overall Study|Lost to Follow-up|3|||
149157236|NCT02944448|538051787|FG001|Overall Study|Lost to Follow-up|1|||
149157237|NCT02944448|538051786|FG000|Overall Study|Protocol Violation|25|||
149157238|NCT02944448|538051787|FG001|Overall Study|Protocol Violation|7|||
149157239|NCT02944448|538051786|FG000|Overall Study|Withdrawal by Subject|14|||
149157240|NCT02944448|538051787|FG001|Overall Study|Withdrawal by Subject|4|||
149157241|NCT02944448|538051786|FG000|Overall Study|Sponsor did not supply drug in time|0|||
149157242|NCT02944448|538051787|FG001|Overall Study|Sponsor did not supply drug in time|1|||
149157243|NCT02944448|538051786|FG000|Overall Study|Noncompliant with dosing|1|||
149157244|NCT02944448|538051787|FG001|Overall Study|Noncompliant with dosing|0|||
149157245|NCT02944448|538051786|FG000|Overall Study|Abnormal laboratory values|1|||
149157246|NCT02944448|538051787|FG001|Overall Study|Abnormal laboratory values|0|||
149157247|NCT01461044|538051788|FG000|Overall Study|Death|58|||
149157248|NCT01461044|538051789|FG001|Overall Study|Death|35|||
149157249|NCT01461044|538051788|FG000|Overall Study|Lost to Follow-up|12|||
149157250|NCT01461044|538051789|FG001|Overall Study|Lost to Follow-up|5|||
149157251|NCT00716976|538051790|FG000|Overall Study|Adverse Event|2|||
148672930|NCT05168657|536272538|FG007|Overall Study|Adverse Event|0|||
148672931|NCT01984229|536272541|FG000|Safety Follow-up Period|Adverse Event|1|||
148672932|NCT01984229|536272542|FG001|Safety Follow-up Period|Adverse Event|1|||
148672933|NCT01984229|536272541|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
148672934|NCT01984229|536272542|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
148672935|NCT01418365|536272546|FG000|First Intervention|Withdrawal by Subject|0|||
148672936|NCT01418365|536272547|FG001|First Intervention|Withdrawal by Subject|1|||
148672937|NCT01418365|536272546|FG000|First Intervention|Non-compliance|1|||
148672938|NCT01418365|536272547|FG001|First Intervention|Non-compliance|0|||
148672939|NCT01418365|536272546|FG000|Second Intervention|Withdrawal by Subject|0|||
148672940|NCT01418365|536272547|FG001|Second Intervention|Withdrawal by Subject|1|||
148672941|NCT03539952|536272556|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
148672942|NCT03539952|536272557|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
148672943|NCT03539952|536272556|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
148672944|NCT03539952|536272557|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
148672945|NCT03539952|536272556|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
148672946|NCT03539952|536272557|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
148672947|NCT03539952|536272556|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
148672948|NCT03539952|536272557|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
148672949|NCT03539952|536272556|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
148672950|NCT03539952|536272557|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
148672951|NCT03539952|536272556|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
148672952|NCT03539952|536272557|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
148672953|NCT03539952|536272556|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
148672954|NCT03539952|536272557|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
148672955|NCT02184988|536272558|FG000|Overall Study|Pregnancy|2|||
148672956|NCT02184988|536272558|FG000|Overall Study|Adverse Event|2|||
148672957|NCT02184988|536272558|FG000|Overall Study|moving away/travelling/unable to complet|6|||
148672958|NCT02184988|536272558|FG000|Overall Study|work scheduling issues|4|||
148672959|NCT02184988|536272558|FG000|Overall Study|various other reasons|9|||
148672960|NCT02184988|536272558|FG000|Overall Study|Lost to Follow-up|32|||
148672961|NCT03075215|536272559|FG000|12-Month Primary Endpoint|Death|152|||
148672962|NCT03075215|536272559|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
148672963|NCT03075215|536272559|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
148672964|NCT03075215|536272559|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
148672965|NCT01821391|536272560|FG000|Overall Study|Adverse Event|1|||
148672966|NCT01821391|536272561|FG001|Overall Study|Adverse Event|0|||
148672967|NCT01843660|536272562|FG000|Overall Study|Other|30|||
148672968|NCT01977482|536272563|FG000|Overall Study|Adverse Event|0|||
148672969|NCT01977482|536272564|FG001|Overall Study|Adverse Event|1|||
148672970|NCT01977482|536272565|FG002|Overall Study|Adverse Event|1|||
148672971|NCT01977482|536272566|FG003|Overall Study|Adverse Event|0|||
148672972|NCT01977482|536272567|FG004|Overall Study|Adverse Event|2|||
148672973|NCT01977482|536272568|FG005|Overall Study|Adverse Event|0|||
148921210|NCT01227629|537194093|FG003|Overall Study|Other|1|||
148921211|NCT01227629|537194094|FG004|Overall Study|Other|0|||
148921212|NCT01227629|537194095|FG005|Overall Study|Other|0|||
148921213|NCT01227629|537194096|FG006|Overall Study|Other|0|||
148921214|NCT01227629|537194097|FG007|Overall Study|Other|0|||
148921215|NCT01227629|537194098|FG008|Overall Study|Other|2|||
148921216|NCT01227629|537194099|FG009|Overall Study|Other|1|||
148921217|NCT00881868|537194101|FG000|Overall Study|Adverse Event|0|||
148921218|NCT00881868|537194102|FG001|Overall Study|Adverse Event|1|||
149157252|NCT00716976|538051791|FG001|Overall Study|Adverse Event|0|||
148921219|NCT00881868|537194101|FG000|Overall Study|Lost to Follow-up|2|||
148921220|NCT00881868|537194102|FG001|Overall Study|Lost to Follow-up|1|||
149157253|NCT00716976|538051790|FG000|Overall Study|Death|1|||
149157254|NCT00716976|538051791|FG001|Overall Study|Death|0|||
149157255|NCT00716976|538051790|FG000|Overall Study|Physician Decision|2|||
149157256|NCT00716976|538051791|FG001|Overall Study|Physician Decision|2|||
149157257|NCT00716976|538051790|FG000|Overall Study|Withdrawal by Subject|5|||
149157258|NCT00716976|538051791|FG001|Overall Study|Withdrawal by Subject|1|||
149157259|NCT00716976|538051790|FG000|Overall Study|Premature discontinuation cisplatin|5|||
149157260|NCT00716976|538051791|FG001|Overall Study|Premature discontinuation cisplatin|4|||
149157261|NCT00716976|538051790|FG000|Overall Study|Radiation during protocol|1|||
149157262|NCT00716976|538051791|FG001|Overall Study|Radiation during protocol|0|||
149157263|NCT00716976|538051790|FG000|Overall Study|Ineligibles|4|||
149157264|NCT00716976|538051791|FG001|Overall Study|Ineligibles|2|||
149157265|NCT00200850|538051792|FG000|Overall Study|relocation|1|||
149157266|NCT00200850|538051793|FG001|Overall Study|relocation|0|||
149157267|NCT00200850|538051794|FG002|Overall Study|relocation|1|||
149157268|NCT00200850|538051792|FG000|Overall Study|too busy|1|||
148921221|NCT00881868|537194101|FG000|Overall Study|Physician Decision|4|||
148921222|NCT00881868|537194102|FG001|Overall Study|Physician Decision|0|||
148921223|NCT00881868|537194101|FG000|Overall Study|Protocol Violation|2|||
148921224|NCT00881868|537194102|FG001|Overall Study|Protocol Violation|0|||
148921225|NCT00336583|537196135|FG000|Overall Study|Lost to Follow-up|1|||
148921226|NCT00336583|537196135|FG000|Overall Study|Death|1|||
148921227|NCT01258998|537196138|FG000|Overall Study|Ineligible|1|||
148921228|NCT01143389|537196139|FG000|Overall Study|Lost to Follow-up|26|||
148921229|NCT01143389|537196140|FG001|Overall Study|Lost to Follow-up|25|||
148921230|NCT04966910|537196141|FG000|Baseline|Participant did not complete measure|0|||
149157269|NCT00200850|538051793|FG001|Overall Study|too busy|0|||
149157270|NCT00200850|538051794|FG002|Overall Study|too busy|0|||
149157271|NCT00200850|538051792|FG000|Overall Study|Pregnancy|0|||
149157272|NCT00200850|538051793|FG001|Overall Study|Pregnancy|0|||
148805950|NCT05911841|536768047|FG003|Induction Period|Lost to Follow-up|1|||
148921231|NCT04966910|537196142|FG001|Baseline|Participant did not complete measure|0|||
148921232|NCT04966910|537196143|FG002|Baseline|Participant did not complete measure|1|||
148921233|NCT04966910|537196144|FG003|Baseline|Participant did not complete measure|0|||
148921234|NCT04966910|537196141|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
148921235|NCT04966910|537196142|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
148921236|NCT04966910|537196143|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
148921237|NCT04966910|537196144|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
148921238|NCT04966910|537196141|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
148921239|NCT04966910|537196142|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
148921240|NCT04966910|537196143|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
148921241|NCT04966910|537196144|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
148921242|NCT04966910|537196141|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
148921243|NCT04966910|537196142|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
148921244|NCT04966910|537196143|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
148921245|NCT04966910|537196144|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
148921246|NCT02276027|537196147|FG000|Overall Study|Death|1|||
148921247|NCT02276027|537196148|FG001|Overall Study|Death|0|||
148921248|NCT02276027|537196149|FG002|Overall Study|Death|0|||
148921249|NCT02276027|537196150|FG003|Overall Study|Death|2|||
148921250|NCT02276027|537196147|FG000|Overall Study|Physician Decision|0|||
148921251|NCT02276027|537196148|FG001|Overall Study|Physician Decision|0|||
148921252|NCT02276027|537196149|FG002|Overall Study|Physician Decision|0|||
148921253|NCT02276027|537196150|FG003|Overall Study|Physician Decision|1|||
148921254|NCT02276027|537196147|FG000|Overall Study|Progressive disease|1|||
148921255|NCT02276027|537196148|FG001|Overall Study|Progressive disease|13|||
148921256|NCT02276027|537196149|FG002|Overall Study|Progressive disease|12|||
148921257|NCT02276027|537196150|FG003|Overall Study|Progressive disease|14|||
148921258|NCT02276027|537196147|FG000|Overall Study|Subject/guardian decision|0|||
148921259|NCT02276027|537196148|FG001|Overall Study|Subject/guardian decision|1|||
148921260|NCT02276027|537196149|FG002|Overall Study|Subject/guardian decision|0|||
148921261|NCT02276027|537196150|FG003|Overall Study|Subject/guardian decision|3|||
148921262|NCT02276027|537196147|FG000|Overall Study|Adverse Event|0|||
148921263|NCT02276027|537196148|FG001|Overall Study|Adverse Event|2|||
148921264|NCT02276027|537196149|FG002|Overall Study|Adverse Event|8|||
148921265|NCT02276027|537196150|FG003|Overall Study|Adverse Event|2|||
148921266|NCT03224598|537196151|FG000|Overall Study|Lost to Follow-up|0|||
148921267|NCT03224598|537196152|FG001|Overall Study|Lost to Follow-up|2|||
148921268|NCT03224598|537196153|FG002|Overall Study|Lost to Follow-up|0|||
148921269|NCT03224598|537196151|FG000|Overall Study|Other|0|||
148921270|NCT03224598|537196152|FG001|Overall Study|Other|1|||
148921271|NCT03224598|537196153|FG002|Overall Study|Other|0|||
148921272|NCT02446171|537196161|FG000|Overall Study|Withdrawal by Subject|0|||
148921273|NCT02446171|537196162|FG001|Overall Study|Withdrawal by Subject|0|||
148921274|NCT02446171|537196163|FG002|Overall Study|Withdrawal by Subject|2|||
148921275|NCT02446171|537196164|FG003|Overall Study|Withdrawal by Subject|0|||
148921276|NCT02907892|537196165|FG000|Overall Study|Lost to Follow-up|27|||
148921277|NCT02907892|537196166|FG001|Overall Study|Lost to Follow-up|40|||
148921278|NCT03328182|537196169|FG000|Overall Study|Withdrawal by Subject|1|||
148921279|NCT03328182|537196169|FG000|Overall Study|Protocol Violation|2|||
148672974|NCT01977482|536272563|FG000|Overall Study|Lost to Follow-up|1|||
148672975|NCT01977482|536272564|FG001|Overall Study|Lost to Follow-up|0|||
148672976|NCT01977482|536272565|FG002|Overall Study|Lost to Follow-up|0|||
148921280|NCT03328182|537196169|FG000|Overall Study|No Product Evaluated|1|||
148921281|NCT04531462|537196170|FG000|Overall Study|Withdrawal by Subject|3|||
148921282|NCT04531462|537196171|FG001|Overall Study|Withdrawal by Subject|1|||
148921283|NCT04531462|537196170|FG000|Overall Study|Adverse Event|3|||
148921284|NCT04531462|537196171|FG001|Overall Study|Adverse Event|3|||
148921285|NCT00504582|537196172|FG000|Overall Study|Lost to Follow-up|1|||
148921286|NCT00504582|537196173|FG001|Overall Study|Lost to Follow-up|0|||
148921287|NCT00504582|537196174|FG002|Overall Study|Lost to Follow-up|0|||
148921288|NCT00348933|537196177|FG000|Overall Study|Withdrawal by Subject|10|||
148672977|NCT01977482|536272566|FG003|Overall Study|Lost to Follow-up|0|||
148672978|NCT01977482|536272567|FG004|Overall Study|Lost to Follow-up|0|||
148672979|NCT01977482|536272568|FG005|Overall Study|Lost to Follow-up|0|||
148672980|NCT01977482|536272563|FG000|Overall Study|Physician Decision|0|||
148672981|NCT01977482|536272564|FG001|Overall Study|Physician Decision|1|||
148672982|NCT01977482|536272565|FG002|Overall Study|Physician Decision|0|||
148672983|NCT01977482|536272566|FG003|Overall Study|Physician Decision|0|||
148672984|NCT01977482|536272567|FG004|Overall Study|Physician Decision|0|||
148672985|NCT01977482|536272568|FG005|Overall Study|Physician Decision|0|||
148672986|NCT01977482|536272563|FG000|Overall Study|Protocol Violation|0|||
148672987|NCT01977482|536272564|FG001|Overall Study|Protocol Violation|0|||
148672988|NCT01977482|536272565|FG002|Overall Study|Protocol Violation|1|||
148672989|NCT01977482|536272566|FG003|Overall Study|Protocol Violation|0|||
148672990|NCT01977482|536272567|FG004|Overall Study|Protocol Violation|0|||
148672991|NCT01977482|536272568|FG005|Overall Study|Protocol Violation|0|||
148672992|NCT01977482|536272563|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
148672993|NCT01977482|536272564|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
148672994|NCT01977482|536272565|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
148672995|NCT01977482|536272566|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
148672996|NCT01977482|536272567|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
148672997|NCT01977482|536272568|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
148672998|NCT01977482|536272563|FG000|Overall Study|Withdrawal by Subject|2|||
148672999|NCT01977482|536272564|FG001|Overall Study|Withdrawal by Subject|4|||
148673000|NCT01977482|536272565|FG002|Overall Study|Withdrawal by Subject|1|||
148673001|NCT01977482|536272566|FG003|Overall Study|Withdrawal by Subject|3|||
148673002|NCT01977482|536272567|FG004|Overall Study|Withdrawal by Subject|1|||
148673003|NCT01977482|536272568|FG005|Overall Study|Withdrawal by Subject|5|||
148673004|NCT00209560|536272569|FG000|Overall Study|Lack of Efficacy|1|||
148805951|NCT05911841|536768048|FG004|Induction Period|Lost to Follow-up|0|||
148921289|NCT00348933|537196177|FG000|Overall Study|Lost to Follow-up|6|||
148921290|NCT00348933|537196177|FG000|Overall Study|Protocol Violation|2|||
148921291|NCT00348933|537196177|FG000|Overall Study|Adverse Event|7|||
148921292|NCT01264081|537196178|FG000|Participants Screened|Screening failures|30|||
148805952|NCT05911841|536768049|FG005|Induction Period|Lost to Follow-up|0|||
148921293|NCT01264081|537196178|FG000|Started Treatment|Withdrawal by Subject|1|||
148921294|NCT01264081|537196178|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
148921295|NCT01489111|537196179|FG000|Overall Study|Withdrawal criterion|1|||
148921296|NCT02716896|537196180|FG000|Overall Study|Physician Decision|0|||
148921297|NCT02716896|537196181|FG001|Overall Study|Physician Decision|1|||
148921298|NCT01727700|537196182|FG000|Overall Study|Adverse Event|0|||
148921299|NCT01727700|537196183|FG001|Overall Study|Adverse Event|7|||
148921300|NCT01727700|537196184|FG002|Overall Study|Adverse Event|1|||
148921301|NCT01727700|537196182|FG000|Overall Study|Particpant withdrew consent|0|||
148921302|NCT01727700|537196183|FG001|Overall Study|Particpant withdrew consent|3|||
148921303|NCT01727700|537196184|FG002|Overall Study|Particpant withdrew consent|1|||
148921304|NCT01727700|537196182|FG000|Overall Study|Protocol Violation|2|||
148921305|NCT01727700|537196183|FG001|Overall Study|Protocol Violation|0|||
148921306|NCT01727700|537196184|FG002|Overall Study|Protocol Violation|0|||
148673005|NCT00209560|536272570|FG001|Overall Study|Lack of Efficacy|0|||
148673006|NCT01608321|536272577|FG000|Overall Study|Withdrawal by Subject|1|||
148673007|NCT01608321|536272578|FG001|Overall Study|Withdrawal by Subject|0|||
148673008|NCT03505606|536273998|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
148673009|NCT03505606|536273999|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
148673010|NCT03505606|536274000|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
148805953|NCT05911841|536768050|FG006|Induction Period|Lost to Follow-up|0|||
148921307|NCT01757691|537196189|FG000|Overall Study|Administrative problems|2|||
148921308|NCT01757691|537196190|FG001|Overall Study|Administrative problems|0|||
148691439|NCT01325207|536344177|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
148673011|NCT03505606|536273998|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
148673012|NCT03505606|536273999|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
148673013|NCT03505606|536274000|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
148673014|NCT03505606|536273998|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
148673015|NCT03505606|536273999|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
148673016|NCT03505606|536274000|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
148673017|NCT03505606|536273998|FG000|Overall Study|Poor compliance with refractive correction|0|||
148673018|NCT03505606|536273999|FG001|Overall Study|Poor compliance with refractive correction|0|||
148673019|NCT03505606|536274000|FG002|Overall Study|Poor compliance with refractive correction|1|||
148673020|NCT03505606|536273998|FG000|Overall Study|Insufficient anisometropia|0|||
148673021|NCT03505606|536273999|FG001|Overall Study|Insufficient anisometropia|0|||
148673022|NCT03505606|536274000|FG002|Overall Study|Insufficient anisometropia|2|||
148673023|NCT03505606|536273998|FG000|Overall Study|Ectopia Lentis|0|||
148673024|NCT03505606|536273999|FG001|Overall Study|Ectopia Lentis|0|||
148673025|NCT03505606|536274000|FG002|Overall Study|Ectopia Lentis|1|||
148673026|NCT03505606|536273998|FG000|Overall Study|alternation of amblyopic eye|0|||
148673027|NCT03505606|536273999|FG001|Overall Study|alternation of amblyopic eye|1|||
148673028|NCT03505606|536274000|FG002|Overall Study|alternation of amblyopic eye|0|||
148673029|NCT02087865|536274002|FG000|Overall Study|Withdrawal by Subject|6|||
148673030|NCT02087865|536274003|FG001|Overall Study|Withdrawal by Subject|0|||
148673031|NCT02087865|536274004|FG002|Overall Study|Withdrawal by Subject|1|||
148673032|NCT02087865|536274002|FG000|Overall Study|Lost to Follow-up|0|||
148673033|NCT02087865|536274003|FG001|Overall Study|Lost to Follow-up|0|||
148673034|NCT02087865|536274004|FG002|Overall Study|Lost to Follow-up|1|||
148673035|NCT02087865|536274002|FG000|Overall Study|Drug Non-compliance|0|||
148673036|NCT02087865|536274003|FG001|Overall Study|Drug Non-compliance|2|||
148673037|NCT02087865|536274004|FG002|Overall Study|Drug Non-compliance|0|||
148673038|NCT02087865|536274002|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
148673039|NCT02087865|536274003|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
148673040|NCT02087865|536274004|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
148673041|NCT01392469|536274007|FG000|Overall Study|Adverse Event|2|||
148673042|NCT01392469|536274007|FG000|Overall Study|Withdrawal by Subject|1|||
148673043|NCT01392469|536274007|FG000|Overall Study|Protocol Violation|1|||
148673044|NCT01017731|536274009|FG000|Overall Study|Lost to Follow-up|2|||
148673045|NCT01017731|536274009|FG000|Overall Study|Withdrawal by Subject|3|||
148673046|NCT01017731|536274009|FG000|Overall Study|Physician Decision|2|||
148673047|NCT01017731|536274009|FG000|Overall Study|Adverse Event|1|||
148673048|NCT00648739|536274011|FG000|Overall Study|Adverse Event|1|||
148673049|NCT00648739|536274012|FG001|Overall Study|Adverse Event|0|||
148673050|NCT00648739|536274013|FG002|Overall Study|Adverse Event|1|||
148673051|NCT00648739|536274014|FG003|Overall Study|Adverse Event|2|||
148673052|NCT00648739|536274015|FG004|Overall Study|Adverse Event|1|||
148673053|NCT00648739|536274016|FG005|Overall Study|Adverse Event|0|||
148673054|NCT00648739|536274017|FG006|Overall Study|Adverse Event|0|||
148673055|NCT00648739|536274011|FG000|Overall Study|Withdrawal by Subject|1|||
148673056|NCT00648739|536274012|FG001|Overall Study|Withdrawal by Subject|0|||
148673057|NCT00648739|536274013|FG002|Overall Study|Withdrawal by Subject|1|||
148673058|NCT00648739|536274014|FG003|Overall Study|Withdrawal by Subject|0|||
148673059|NCT00648739|536274015|FG004|Overall Study|Withdrawal by Subject|0|||
148673060|NCT00648739|536274016|FG005|Overall Study|Withdrawal by Subject|2|||
148673061|NCT00648739|536274017|FG006|Overall Study|Withdrawal by Subject|0|||
148673062|NCT00648739|536274011|FG000|Overall Study|Lack of Efficacy|0|||
148673063|NCT00648739|536274012|FG001|Overall Study|Lack of Efficacy|0|||
148673064|NCT00648739|536274013|FG002|Overall Study|Lack of Efficacy|0|||
148673065|NCT00648739|536274014|FG003|Overall Study|Lack of Efficacy|0|||
148673066|NCT00648739|536274015|FG004|Overall Study|Lack of Efficacy|1|||
148673067|NCT00648739|536274016|FG005|Overall Study|Lack of Efficacy|2|||
148673068|NCT00648739|536274017|FG006|Overall Study|Lack of Efficacy|0|||
148673069|NCT00648739|536274011|FG000|Overall Study|Investigator Considered it Advisable|0|||
148673070|NCT00648739|536274012|FG001|Overall Study|Investigator Considered it Advisable|0|||
148673071|NCT00648739|536274013|FG002|Overall Study|Investigator Considered it Advisable|0|||
148673072|NCT00648739|536274014|FG003|Overall Study|Investigator Considered it Advisable|0|||
148673073|NCT00648739|536274015|FG004|Overall Study|Investigator Considered it Advisable|0|||
148673074|NCT00648739|536274016|FG005|Overall Study|Investigator Considered it Advisable|1|||
148673075|NCT00648739|536274017|FG006|Overall Study|Investigator Considered it Advisable|1|||
148673076|NCT00648739|536274011|FG000|Overall Study|Death|0|||
148673077|NCT00648739|536274012|FG001|Overall Study|Death|1|||
148673078|NCT00648739|536274013|FG002|Overall Study|Death|0|||
148673079|NCT00648739|536274014|FG003|Overall Study|Death|0|||
148673080|NCT00648739|536274015|FG004|Overall Study|Death|0|||
148673081|NCT00648739|536274016|FG005|Overall Study|Death|0|||
148673082|NCT00648739|536274017|FG006|Overall Study|Death|0|||
148673083|NCT00648739|536274011|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
148673084|NCT00648739|536274012|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
148673085|NCT00648739|536274013|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
148673086|NCT00648739|536274014|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
148673087|NCT00648739|536274015|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
148673088|NCT00648739|536274016|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
148673089|NCT00648739|536274017|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
148673090|NCT00648739|536274011|FG000|Overall Study|Follow-up Visits Not Completed|0|||
148673091|NCT00648739|536274012|FG001|Overall Study|Follow-up Visits Not Completed|1|||
148673092|NCT00648739|536274013|FG002|Overall Study|Follow-up Visits Not Completed|0|||
148673093|NCT00648739|536274014|FG003|Overall Study|Follow-up Visits Not Completed|0|||
148673094|NCT00648739|536274015|FG004|Overall Study|Follow-up Visits Not Completed|0|||
148673095|NCT00648739|536274016|FG005|Overall Study|Follow-up Visits Not Completed|0|||
148673096|NCT00648739|536274017|FG006|Overall Study|Follow-up Visits Not Completed|0|||
148673097|NCT00564486|536274020|FG000|Overall Study|Adverse Event|0|||
148673098|NCT00564486|536274021|FG001|Overall Study|Adverse Event|1|||
148673099|NCT00564486|536274022|FG002|Overall Study|Adverse Event|0|||
148673100|NCT00564486|536274023|FG003|Overall Study|Adverse Event|0|||
148673101|NCT00564486|536274020|FG000|Overall Study|Withdrawal by Subject|4|||
148673102|NCT00564486|536274021|FG001|Overall Study|Withdrawal by Subject|0|||
148673103|NCT00564486|536274022|FG002|Overall Study|Withdrawal by Subject|0|||
148673104|NCT00564486|536274023|FG003|Overall Study|Withdrawal by Subject|5|||
148673105|NCT00564486|536274020|FG000|Overall Study|Subject refused to have blood drawn|0|||
148673106|NCT00564486|536274021|FG001|Overall Study|Subject refused to have blood drawn|0|||
148673107|NCT00564486|536274022|FG002|Overall Study|Subject refused to have blood drawn|1|||
148673108|NCT00564486|536274023|FG003|Overall Study|Subject refused to have blood drawn|0|||
148673109|NCT00564486|536274020|FG000|Overall Study|Lost to Follow-up|3|||
148673110|NCT00564486|536274021|FG001|Overall Study|Lost to Follow-up|0|||
148673111|NCT00564486|536274022|FG002|Overall Study|Lost to Follow-up|2|||
148673112|NCT00564486|536274023|FG003|Overall Study|Lost to Follow-up|2|||
148673113|NCT04362761|536274028|FG000|Part A (48 Weeks)|Adverse Event|2|||
148673114|NCT04362761|536274028|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
148673115|NCT04362761|536274028|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
148673116|NCT04362761|536274028|FG000|Part A (48 Weeks)|Other|5|||
148673117|NCT04362761|536274028|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
148673118|NCT04362761|536274028|FG000|Part B (86 Weeks)|Other|4|||
148673119|NCT01819467|536274029|FG000|Overall Study|Physician Decision|20|||
148673120|NCT01819467|536274030|FG001|Overall Study|Physician Decision|9|||
148673121|NCT02729545|536274031|FG000|Overall Study|Pregnancy|1|||
148673122|NCT02729545|536274032|FG001|Overall Study|Pregnancy|1|||
148673123|NCT02729545|536274031|FG000|Overall Study|Lost to Follow-up|0|||
148673124|NCT02729545|536274032|FG001|Overall Study|Lost to Follow-up|1|||
148673125|NCT02729545|536274031|FG000|Overall Study|Withdrawal by Subject|2|||
148673126|NCT02729545|536274032|FG001|Overall Study|Withdrawal by Subject|3|||
148673127|NCT00915473|536274033|FG000|Screening|Withdrawal by Subject|1|||
148673128|NCT00915473|536274034|FG001|Screening|Withdrawal by Subject|0|||
148673129|NCT00915473|536274033|FG000|4-week Follow Up|Lost to Follow-up|1|||
148673130|NCT00915473|536274034|FG001|4-week Follow Up|Lost to Follow-up|5|||
148673131|NCT01389024|536274035|FG000|Overall Study|Withdrawal by Subject|0|||
148673132|NCT01389024|536274036|FG001|Overall Study|Withdrawal by Subject|1|||
148673133|NCT01389024|536274035|FG000|Overall Study|Lost to Follow-up|1|||
148673134|NCT01389024|536274036|FG001|Overall Study|Lost to Follow-up|0|||
148673135|NCT03443973|536274040|FG000|Double-blind Treatment Period|Adverse Event|5|||
148673136|NCT03443973|536274041|FG001|Double-blind Treatment Period|Adverse Event|19|||
148673137|NCT03443973|536274042|FG002|Double-blind Treatment Period|Adverse Event|0|||
148673138|NCT03443973|536274043|FG003|Double-blind Treatment Period|Adverse Event|0|||
148673139|NCT03443973|536274040|FG000|Double-blind Treatment Period|Death|5|||
148673140|NCT03443973|536274041|FG001|Double-blind Treatment Period|Death|7|||
148673141|NCT03443973|536274042|FG002|Double-blind Treatment Period|Death|0|||
148673142|NCT03443973|536274043|FG003|Double-blind Treatment Period|Death|0|||
148673143|NCT03443973|536274040|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
148673144|NCT03443973|536274041|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
148673145|NCT03443973|536274042|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
148673146|NCT03443973|536274043|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
148673147|NCT03443973|536274040|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
148673148|NCT03443973|536274041|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
148673149|NCT03443973|536274042|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
148673150|NCT03443973|536274043|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
148673151|NCT03443973|536274040|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
148673152|NCT03443973|536274041|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
148673153|NCT03443973|536274042|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
148673154|NCT03443973|536274043|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
148673155|NCT03443973|536274040|FG000|Double-blind Treatment Period|Physician Decision|5|||
148673156|NCT03443973|536274041|FG001|Double-blind Treatment Period|Physician Decision|6|||
148673157|NCT03443973|536274042|FG002|Double-blind Treatment Period|Physician Decision|0|||
148673158|NCT03443973|536274043|FG003|Double-blind Treatment Period|Physician Decision|0|||
148673159|NCT03443973|536274040|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
148673160|NCT03443973|536274041|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
148673161|NCT03443973|536274042|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
148673162|NCT03443973|536274043|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
148673163|NCT03443973|536274040|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
148673164|NCT03443973|536274041|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
148673165|NCT03443973|536274042|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
148673166|NCT03443973|536274043|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
148673167|NCT03443973|536274040|FG000|Open-label Extension Period|Reason Not Specified|0|||
148673168|NCT03443973|536274041|FG001|Open-label Extension Period|Reason Not Specified|0|||
148673169|NCT03443973|536274042|FG002|Open-label Extension Period|Reason Not Specified|3|||
148673170|NCT03443973|536274043|FG003|Open-label Extension Period|Reason Not Specified|0|||
148673171|NCT03443973|536274040|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
148673172|NCT03443973|536274041|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
148673173|NCT03443973|536274042|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
148673174|NCT03443973|536274043|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
148673175|NCT01956123|536274044|FG000|COS Cycle 2|Protocol Violation|8|||
148673176|NCT01956123|536274045|FG001|COS Cycle 2|Protocol Violation|3|||
148673177|NCT01956123|536274046|FG002|COS Cycle 2|Protocol Violation|0|||
148673178|NCT01956123|536274047|FG003|COS Cycle 2|Protocol Violation|0|||
148673179|NCT01956123|536274044|FG000|COS Cycle 2|Adverse Event|3|||
148805954|NCT05911841|536768051|FG007|Induction Period|Lost to Follow-up|0|||
148805955|NCT05911841|536768052|FG008|Induction Period|Lost to Follow-up|0|||
148805956|NCT05911841|536768053|FG009|Induction Period|Lost to Follow-up|0|||
148805957|NCT05911841|536768044|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
148805958|NCT05911841|536768045|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
148805959|NCT05911841|536768046|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
148805960|NCT05911841|536768047|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
148805961|NCT05911841|536768048|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
148805962|NCT05911841|536768049|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
148805963|NCT05911841|536768050|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
148805964|NCT05911841|536768051|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
148805965|NCT05911841|536768052|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
148805966|NCT05911841|536768053|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
148805967|NCT05911841|536768044|FG000|Maintenance Period|Lack of Efficacy|0|||
148805968|NCT05911841|536768045|FG001|Maintenance Period|Lack of Efficacy|0|||
148805969|NCT05911841|536768046|FG002|Maintenance Period|Lack of Efficacy|0|||
148805970|NCT05911841|536768047|FG003|Maintenance Period|Lack of Efficacy|0|||
148805971|NCT05911841|536768048|FG004|Maintenance Period|Lack of Efficacy|1|||
148805972|NCT05911841|536768049|FG005|Maintenance Period|Lack of Efficacy|0|||
148805973|NCT05911841|536768050|FG006|Maintenance Period|Lack of Efficacy|1|||
148805974|NCT05911841|536768051|FG007|Maintenance Period|Lack of Efficacy|0|||
148805975|NCT05911841|536768052|FG008|Maintenance Period|Lack of Efficacy|0|||
148805976|NCT05911841|536768053|FG009|Maintenance Period|Lack of Efficacy|0|||
148673180|NCT01956123|536274045|FG001|COS Cycle 2|Adverse Event|4|||
148673181|NCT01956123|536274046|FG002|COS Cycle 2|Adverse Event|0|||
148673182|NCT01956123|536274047|FG003|COS Cycle 2|Adverse Event|0|||
148673183|NCT01956123|536274044|FG000|COS Cycle 2|Personal Reasons|2|||
148673184|NCT01956123|536274045|FG001|COS Cycle 2|Personal Reasons|0|||
148673185|NCT01956123|536274046|FG002|COS Cycle 2|Personal Reasons|0|||
148673186|NCT01956123|536274047|FG003|COS Cycle 2|Personal Reasons|0|||
148673187|NCT01956123|536274044|FG000|COS Cycle 2|Withdrawal by Subject|1|||
148673188|NCT01956123|536274045|FG001|COS Cycle 2|Withdrawal by Subject|0|||
148673189|NCT01956123|536274046|FG002|COS Cycle 2|Withdrawal by Subject|0|||
148673190|NCT01956123|536274047|FG003|COS Cycle 2|Withdrawal by Subject|0|||
148673191|NCT01956123|536274044|FG000|COS Cycle 3|Protocol Violation|0|||
148673192|NCT01956123|536274045|FG001|COS Cycle 3|Protocol Violation|0|||
148673193|NCT01956123|536274046|FG002|COS Cycle 3|Protocol Violation|2|||
148673194|NCT01956123|536274047|FG003|COS Cycle 3|Protocol Violation|1|||
148673195|NCT01956123|536274044|FG000|COS Cycle 3|Adverse Event|0|||
148673196|NCT01956123|536274045|FG001|COS Cycle 3|Adverse Event|0|||
148673197|NCT01956123|536274046|FG002|COS Cycle 3|Adverse Event|3|||
148673198|NCT01956123|536274047|FG003|COS Cycle 3|Adverse Event|0|||
148673199|NCT01956123|536274044|FG000|COS Cycle 3|Personal Reasons|0|||
148921309|NCT02054481|537196194|FG000|Overall Study|Adverse Event|1|||
148921310|NCT02054481|537196195|FG001|Overall Study|Adverse Event|1|||
148921311|NCT02054481|537196196|FG002|Overall Study|Adverse Event|0|||
148921312|NCT02054481|537196197|FG003|Overall Study|Adverse Event|1|||
148921313|NCT02054481|537196194|FG000|Overall Study|Lost to Follow-up|1|||
148921314|NCT02054481|537196195|FG001|Overall Study|Lost to Follow-up|0|||
148921315|NCT02054481|537196196|FG002|Overall Study|Lost to Follow-up|0|||
148921316|NCT02054481|537196197|FG003|Overall Study|Lost to Follow-up|0|||
148673200|NCT01956123|536274045|FG001|COS Cycle 3|Personal Reasons|0|||
148921317|NCT02054481|537196194|FG000|Overall Study|Other reason|2|||
148921318|NCT02054481|537196195|FG001|Overall Study|Other reason|1|||
148921319|NCT02054481|537196196|FG002|Overall Study|Other reason|2|||
148921320|NCT02054481|537196197|FG003|Overall Study|Other reason|0|||
148921321|NCT02320903|537196198|FG000|Overall Study|Withdrawal by Subject|0|||
148921322|NCT02320903|537196199|FG001|Overall Study|Withdrawal by Subject|9|||
148921323|NCT02320903|537196200|FG002|Overall Study|Withdrawal by Subject|9|||
148921324|NCT02320903|537196198|FG000|Overall Study|Exited therapy; no longer eligible|8|||
148921325|NCT02320903|537196199|FG001|Overall Study|Exited therapy; no longer eligible|2|||
148921326|NCT02320903|537196200|FG002|Overall Study|Exited therapy; no longer eligible|2|||
148921327|NCT02320903|537196198|FG000|Overall Study|Lost to Follow-up|0|||
148921328|NCT02320903|537196199|FG001|Overall Study|Lost to Follow-up|5|||
148921329|NCT02320903|537196200|FG002|Overall Study|Lost to Follow-up|5|||
148921330|NCT01752036|537196202|FG000|Overall Study|Death|2|||
148921331|NCT01011478|537196203|FG000|Overall Study|No follow up data|12|||
148673201|NCT01956123|536274046|FG002|COS Cycle 3|Personal Reasons|1|||
148673202|NCT01956123|536274047|FG003|COS Cycle 3|Personal Reasons|0|||
148673203|NCT01956123|536274044|FG000|COS Cycle 3|Withdrawal by Subject|0|||
148921332|NCT01011478|537196204|FG001|Overall Study|No follow up data|7|||
148921333|NCT04618770|537196208|FG000|Overall Study|Censored from Analysis|12|||
148921334|NCT04618770|537196208|FG000|Overall Study|Early Termination|25|||
148921335|NCT04456673|537196209|FG000|Overall Study|Adverse Event|7|||
148921336|NCT04456673|537196210|FG001|Overall Study|Adverse Event|14|||
148921337|NCT04456673|537196209|FG000|Overall Study|Poor compliance to protocol|1|||
148921338|NCT04456673|537196210|FG001|Overall Study|Poor compliance to protocol|0|||
148921339|NCT04456673|537196209|FG000|Overall Study|Withdrawal by Subject|31|||
148921340|NCT04456673|537196210|FG001|Overall Study|Withdrawal by Subject|23|||
148921341|NCT04456673|537196209|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
148921342|NCT04456673|537196210|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
148921343|NCT03874429|537196211|FG000|Overall Study|Adverse Event|2|||
148921344|NCT03874429|537196212|FG001|Overall Study|Adverse Event|2|||
148921345|NCT03874429|537196211|FG000|Overall Study|Lack of Efficacy|0|||
148921346|NCT03874429|537196212|FG001|Overall Study|Lack of Efficacy|1|||
148921347|NCT03874429|537196211|FG000|Overall Study|Covid-19 pandemic|4|||
148921348|NCT03874429|537196212|FG001|Overall Study|Covid-19 pandemic|2|||
148921349|NCT01101308|537196214|FG000|Period 1|Adverse Event|2|||
148921350|NCT01101308|537196215|FG001|Period 1|Adverse Event|1|||
148921351|NCT01101308|537196214|FG000|Period 1|Positive for cotinine|1|||
148921352|NCT01101308|537196215|FG001|Period 1|Positive for cotinine|0|||
148921353|NCT00711516|537196216|FG000|Overall Study|Adverse Event|1|||
148921354|NCT00711516|537196217|FG001|Overall Study|Adverse Event|1|||
148921355|NCT00711516|537196216|FG000|Overall Study|Withdrawal by Subject|0|||
148921356|NCT00711516|537196217|FG001|Overall Study|Withdrawal by Subject|1|||
148921357|NCT00711516|537196216|FG000|Overall Study|Protocol Violation|0|||
148921358|NCT00711516|537196217|FG001|Overall Study|Protocol Violation|1|||
148921359|NCT04575597|537196218|FG000|Overall Study|Death|0|||
148921360|NCT04575597|537196219|FG001|Overall Study|Death|0|||
148921361|NCT04575597|537196220|FG002|Overall Study|Death|0|||
148921362|NCT04575597|537196221|FG003|Overall Study|Death|1|||
148921363|NCT04575597|537196222|FG004|Overall Study|Death|3|||
148921364|NCT04575597|537196223|FG005|Overall Study|Death|14|||
148921365|NCT04575597|537196218|FG000|Overall Study|Lost to Follow-up|2|||
148921366|NCT04575597|537196219|FG001|Overall Study|Lost to Follow-up|1|||
148921367|NCT04575597|537196220|FG002|Overall Study|Lost to Follow-up|1|||
148921368|NCT04575597|537196221|FG003|Overall Study|Lost to Follow-up|2|||
148921369|NCT04575597|537196222|FG004|Overall Study|Lost to Follow-up|10|||
148921370|NCT04575597|537196223|FG005|Overall Study|Lost to Follow-up|8|||
148921371|NCT04575597|537196218|FG000|Overall Study|Withdrawal by Subject|2|||
148921372|NCT04575597|537196219|FG001|Overall Study|Withdrawal by Subject|2|||
148921373|NCT04575597|537196220|FG002|Overall Study|Withdrawal by Subject|4|||
148921374|NCT04575597|537196221|FG003|Overall Study|Withdrawal by Subject|2|||
148921375|NCT04575597|537196222|FG004|Overall Study|Withdrawal by Subject|25|||
148921376|NCT04575597|537196223|FG005|Overall Study|Withdrawal by Subject|28|||
148921377|NCT04575597|537196218|FG000|Overall Study|Not Recorded|0|||
148921378|NCT04575597|537196219|FG001|Overall Study|Not Recorded|0|||
148921379|NCT04575597|537196220|FG002|Overall Study|Not Recorded|0|||
148921380|NCT04575597|537196221|FG003|Overall Study|Not Recorded|0|||
148921381|NCT04575597|537196222|FG004|Overall Study|Not Recorded|0|||
148921382|NCT04575597|537196223|FG005|Overall Study|Not Recorded|2|||
148921383|NCT04575597|537196218|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148921384|NCT04575597|537196219|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148921385|NCT04575597|537196220|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148921386|NCT04575597|537196221|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148921387|NCT04575597|537196222|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
148921388|NCT04575597|537196223|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
148921389|NCT00439738|537196225|FG000|Overall Study|Withdrawal by Subject|16|||
148921390|NCT00439738|537196226|FG001|Overall Study|Withdrawal by Subject|13|||
148921391|NCT00439738|537196225|FG000|Overall Study|Adverse Event|6|||
148921392|NCT00439738|537196226|FG001|Overall Study|Adverse Event|4|||
148921393|NCT00439738|537196225|FG000|Overall Study|Lost to Follow-up|5|||
148921394|NCT00439738|537196226|FG001|Overall Study|Lost to Follow-up|6|||
148921395|NCT00439738|537196225|FG000|Overall Study|Protocol Violation|6|||
148921396|NCT00439738|537196226|FG001|Overall Study|Protocol Violation|3|||
148921397|NCT00439738|537196225|FG000|Overall Study|Lack of Efficacy|2|||
148921398|NCT00439738|537196226|FG001|Overall Study|Lack of Efficacy|2|||
148921399|NCT00439738|537196225|FG000|Overall Study|Abnormal Lab Values|1|||
148921400|NCT00439738|537196226|FG001|Overall Study|Abnormal Lab Values|0|||
148921401|NCT01284491|537196228|FG000|Overall Study|Study termination|13|||
148921402|NCT02694757|537196229|FG000|Overall Study|Lack of Efficacy|3|||
148921403|NCT00095147|537196230|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
148921404|NCT00095147|537196231|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
148921405|NCT00095147|537196232|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
148921406|NCT00095147|537196233|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
148921407|NCT00095147|537196234|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
148921408|NCT00095147|537196230|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
148921409|NCT00095147|537196231|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
148921410|NCT00095147|537196232|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
148921411|NCT00095147|537196233|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
148921412|NCT00095147|537196234|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
148921413|NCT00095147|537196230|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
148921414|NCT00095147|537196231|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
148921415|NCT00095147|537196232|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
148921416|NCT00095147|537196233|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
148921417|NCT00095147|537196234|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
148921418|NCT00095147|537196230|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
148921419|NCT00095147|537196231|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
148921420|NCT00095147|537196232|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
148921421|NCT00095147|537196233|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
148921422|NCT00095147|537196234|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
148921423|NCT00095147|537196230|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
148921424|NCT00095147|537196231|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
148673204|NCT01956123|536274045|FG001|COS Cycle 3|Withdrawal by Subject|0|||
148673205|NCT01956123|536274046|FG002|COS Cycle 3|Withdrawal by Subject|0|||
148921425|NCT00095147|537196232|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
148921426|NCT00095147|537196233|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
148921427|NCT00095147|537196234|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
148921428|NCT00095147|537196230|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
148921429|NCT00095147|537196231|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
148921430|NCT00095147|537196232|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
148921431|NCT00095147|537196233|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
148921432|NCT00095147|537196234|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
148921433|NCT00095147|537196230|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
148921434|NCT00095147|537196231|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
148921435|NCT00095147|537196232|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
148921436|NCT00095147|537196233|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
148921437|NCT00095147|537196234|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
148921438|NCT00095147|537196230|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
148921439|NCT00095147|537196231|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
148921440|NCT00095147|537196232|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
148921441|NCT00095147|537196233|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
148921442|NCT00095147|537196234|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
148921443|NCT00095147|537196230|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
148921444|NCT00095147|537196231|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
148921445|NCT00095147|537196232|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
148921446|NCT00095147|537196233|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
148921447|NCT00095147|537196234|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
148921448|NCT00095147|537196230|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
148921449|NCT00095147|537196231|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
148921450|NCT00095147|537196232|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
148921451|NCT00095147|537196233|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
148921452|NCT00095147|537196234|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
148921453|NCT00095147|537196230|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
148921454|NCT00095147|537196231|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
148921455|NCT00095147|537196232|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
148921456|NCT00095147|537196233|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
148921457|NCT00095147|537196234|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
148673206|NCT01956123|536274047|FG003|COS Cycle 3|Withdrawal by Subject|1|||
148921458|NCT00095147|537196230|FG000|Long-term Extension Period|Death|0|||
148921459|NCT00095147|537196231|FG001|Long-term Extension Period|Death|0|||
148673207|NCT00398632|536274050|FG000|Overall Study|Withdrawal by Subject|1|||
148673208|NCT00398632|536274050|FG000|Overall Study|Lack of Efficacy|1|||
148921460|NCT00095147|537196232|FG002|Long-term Extension Period|Death|0|||
148921461|NCT00095147|537196233|FG003|Long-term Extension Period|Death|0|||
148921462|NCT00095147|537196234|FG004|Long-term Extension Period|Death|3|||
148921463|NCT00095147|537196230|FG000|Long-term Extension Period|Adverse Event|0|||
148921464|NCT00095147|537196231|FG001|Long-term Extension Period|Adverse Event|0|||
148921465|NCT00095147|537196232|FG002|Long-term Extension Period|Adverse Event|0|||
148921466|NCT00095147|537196233|FG003|Long-term Extension Period|Adverse Event|0|||
148921467|NCT00095147|537196234|FG004|Long-term Extension Period|Adverse Event|11|||
148921468|NCT00095147|537196230|FG000|Long-term Extension Period|Lack of Efficacy|0|||
148921469|NCT00095147|537196231|FG001|Long-term Extension Period|Lack of Efficacy|0|||
148921470|NCT00095147|537196232|FG002|Long-term Extension Period|Lack of Efficacy|0|||
148921471|NCT00095147|537196233|FG003|Long-term Extension Period|Lack of Efficacy|0|||
148921472|NCT00095147|537196234|FG004|Long-term Extension Period|Lack of Efficacy|9|||
148921473|NCT00095147|537196230|FG000|Long-term Extension Period|Lost to Follow-up|0|||
148921474|NCT00095147|537196231|FG001|Long-term Extension Period|Lost to Follow-up|0|||
148921475|NCT00095147|537196232|FG002|Long-term Extension Period|Lost to Follow-up|0|||
148921476|NCT00095147|537196233|FG003|Long-term Extension Period|Lost to Follow-up|0|||
148921477|NCT00095147|537196234|FG004|Long-term Extension Period|Lost to Follow-up|6|||
148921478|NCT00095147|537196230|FG000|Long-term Extension Period|Withdrawal of consent|0|||
148921479|NCT00095147|537196231|FG001|Long-term Extension Period|Withdrawal of consent|0|||
148921480|NCT00095147|537196232|FG002|Long-term Extension Period|Withdrawal of consent|0|||
148921481|NCT00095147|537196233|FG003|Long-term Extension Period|Withdrawal of consent|0|||
148921482|NCT00095147|537196234|FG004|Long-term Extension Period|Withdrawal of consent|12|||
148921483|NCT00095147|537196230|FG000|Long-term Extension Period|Pregnancy|0|||
148921484|NCT00095147|537196231|FG001|Long-term Extension Period|Pregnancy|0|||
148921485|NCT00095147|537196232|FG002|Long-term Extension Period|Pregnancy|0|||
148921486|NCT00095147|537196233|FG003|Long-term Extension Period|Pregnancy|0|||
148921487|NCT00095147|537196234|FG004|Long-term Extension Period|Pregnancy|1|||
148921488|NCT00095147|537196230|FG000|Long-term Extension Period|No longer meets study criteria|0|||
148921489|NCT00095147|537196231|FG001|Long-term Extension Period|No longer meets study criteria|0|||
148921490|NCT00095147|537196232|FG002|Long-term Extension Period|No longer meets study criteria|0|||
149157273|NCT00200850|538051794|FG002|Overall Study|Pregnancy|1|||
149157274|NCT00200850|538051792|FG000|Overall Study|Poor adherence|0|||
149157275|NCT00200850|538051793|FG001|Overall Study|Poor adherence|0|||
149157276|NCT00200850|538051794|FG002|Overall Study|Poor adherence|1|||
148921491|NCT00095147|537196233|FG003|Long-term Extension Period|No longer meets study criteria|0|||
149157277|NCT00200850|538051792|FG000|Overall Study|optic neuritis|0|||
149157278|NCT00200850|538051793|FG001|Overall Study|optic neuritis|0|||
149157279|NCT00200850|538051794|FG002|Overall Study|optic neuritis|1|||
149157280|NCT00200850|538051792|FG000|Overall Study|Adverse Event|1|||
149157281|NCT00200850|538051793|FG001|Overall Study|Adverse Event|1|||
148921492|NCT00095147|537196234|FG004|Long-term Extension Period|No longer meets study criteria|1|||
148921493|NCT00095147|537196230|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
148921494|NCT00095147|537196231|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
148921495|NCT00095147|537196232|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
148921496|NCT00095147|537196233|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
148921497|NCT00095147|537196234|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
148921498|NCT00095147|537196230|FG000|Long-term Extension Period|Leaving country|0|||
148921499|NCT00095147|537196231|FG001|Long-term Extension Period|Leaving country|0|||
148673209|NCT00267020|536274051|FG000|Overall Study|Adverse Event|22|||
148673210|NCT00267020|536274052|FG001|Overall Study|Adverse Event|5|||
148673211|NCT00267020|536274051|FG000|Overall Study|Death|2|||
148673212|NCT00267020|536274052|FG001|Overall Study|Death|1|||
148673213|NCT00267020|536274051|FG000|Overall Study|Withdrawal by Subject|17|||
148673214|NCT00267020|536274052|FG001|Overall Study|Withdrawal by Subject|7|||
148673215|NCT00267020|536274051|FG000|Overall Study|Physician Decision|3|||
148673216|NCT00267020|536274052|FG001|Overall Study|Physician Decision|2|||
148673217|NCT00267020|536274051|FG000|Overall Study|Disease Progression|39|||
148673218|NCT00267020|536274052|FG001|Overall Study|Disease Progression|25|||
148673219|NCT00267020|536274051|FG000|Overall Study|Unrelated Complication|1|||
148673220|NCT00267020|536274052|FG001|Overall Study|Unrelated Complication|1|||
148673221|NCT00267020|536274051|FG000|Overall Study|Sponsor Request|1|||
148673222|NCT00267020|536274052|FG001|Overall Study|Sponsor Request|0|||
148673223|NCT00267020|536274051|FG000|Overall Study|Other|1|||
148673224|NCT00267020|536274052|FG001|Overall Study|Other|2|||
148673225|NCT00640614|536274053|FG000|Overall Study|Lost to Follow-up|1|||
148673226|NCT00640614|536274054|FG001|Overall Study|Lost to Follow-up|0|||
148673227|NCT02209454|536274057|FG000|Second Period|Adverse Event|1|||
148673228|NCT02209454|536274058|FG001|Second Period|Adverse Event|0|||
148673229|NCT02545868|536274059|FG000|Overall Study|Lack of Efficacy|1|||
148673230|NCT02545868|536274060|FG001|Overall Study|Lack of Efficacy|1|||
148673231|NCT02545868|536274061|FG002|Overall Study|Lack of Efficacy|0|||
148673232|NCT02545868|536274059|FG000|Overall Study|Lost to Follow-up|1|||
148673233|NCT02545868|536274060|FG001|Overall Study|Lost to Follow-up|5|||
148673234|NCT02545868|536274061|FG002|Overall Study|Lost to Follow-up|1|||
148673235|NCT02545868|536274059|FG000|Overall Study|Non-compliance|1|||
148673236|NCT02545868|536274060|FG001|Overall Study|Non-compliance|1|||
148673237|NCT02545868|536274061|FG002|Overall Study|Non-compliance|1|||
148673238|NCT02545868|536274059|FG000|Overall Study|Treatment change|21|||
148673239|NCT02545868|536274060|FG001|Overall Study|Treatment change|19|||
148673240|NCT02545868|536274061|FG002|Overall Study|Treatment change|22|||
148673241|NCT02545868|536274059|FG000|Overall Study|Physician Decision|1|||
148673242|NCT02545868|536274060|FG001|Overall Study|Physician Decision|1|||
148673243|NCT02545868|536274061|FG002|Overall Study|Physician Decision|1|||
148673244|NCT02545868|536274059|FG000|Overall Study|Withdrawal by Subject|6|||
148673245|NCT02545868|536274060|FG001|Overall Study|Withdrawal by Subject|7|||
148673246|NCT02545868|536274061|FG002|Overall Study|Withdrawal by Subject|9|||
148673247|NCT01777191|536274062|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
148673248|NCT01777191|536274063|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
148673249|NCT01777191|536274062|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
148673250|NCT01777191|536274063|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
148673251|NCT01777191|536274062|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
148673252|NCT01777191|536274063|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
148673253|NCT01777191|536274062|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
148673254|NCT01777191|536274063|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
148673255|NCT01777191|536274062|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
148673256|NCT01777191|536274063|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
148673257|NCT01777191|536274062|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
148673258|NCT01777191|536274063|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
148673259|NCT01777191|536274062|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
148673260|NCT01777191|536274063|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
148673261|NCT01777191|536274062|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
148673262|NCT01777191|536274063|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
148673263|NCT01777191|536274062|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
148673264|NCT01777191|536274063|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
148673265|NCT01777191|536274062|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
148673266|NCT01777191|536274063|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
148673267|NCT01777191|536274062|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
148673268|NCT01777191|536274063|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
148673269|NCT04465916|536274068|FG000|Overall Study|Withdrawal by Subject|0|||
148673270|NCT04465916|536274069|FG001|Overall Study|Withdrawal by Subject|1|||
148673271|NCT01856686|536274070|FG000|Overall Study|Lost to Follow-up|5|||
148673272|NCT01856686|536274071|FG001|Overall Study|Lost to Follow-up|11|||
148673273|NCT00468312|536274072|FG000|Overall Study|Adverse Event|2|||
148673274|NCT00468312|536274073|FG001|Overall Study|Adverse Event|1|||
148673275|NCT00468312|536274072|FG000|Overall Study|Lack of Efficacy|0|||
148673276|NCT00468312|536274073|FG001|Overall Study|Lack of Efficacy|1|||
148673277|NCT00468312|536274072|FG000|Overall Study|Withdrawal by Subject|0|||
148673278|NCT00468312|536274073|FG001|Overall Study|Withdrawal by Subject|1|||
148673279|NCT00468312|536274072|FG000|Overall Study|Protocol Violation|2|||
148805977|NCT05911841|536768044|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
148805978|NCT05911841|536768045|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
148673280|NCT00468312|536274073|FG001|Overall Study|Protocol Violation|1|||
148673281|NCT00468312|536274072|FG000|Overall Study|Did not meet protocol eligibility|0|||
148673282|NCT00468312|536274073|FG001|Overall Study|Did not meet protocol eligibility|1|||
149157282|NCT00200850|538051794|FG002|Overall Study|Adverse Event|2|||
149157283|NCT01764633|538051797|FG000|Overall Study|Withdrawal by Subject|105|||
149157284|NCT01764633|538051798|FG001|Overall Study|Withdrawal by Subject|88|||
149157285|NCT01764633|538051797|FG000|Overall Study|Lost to Follow-up|13|||
149157286|NCT01764633|538051798|FG001|Overall Study|Lost to Follow-up|5|||
149157287|NCT02268058|538051799|FG000|Overall Study|Protocol Violation|1|||
149157288|NCT02268058|538051800|FG001|Overall Study|Protocol Violation|0|||
149157289|NCT02268058|538051801|FG002|Overall Study|Protocol Violation|0|||
149157290|NCT02268058|538051802|FG003|Overall Study|Protocol Violation|0|||
149157291|NCT04142983|538051803|FG000|Overall Study|Lost to Follow-up|73|||
149157292|NCT04142983|538051803|FG000|Overall Study|Withdrawal by Subject|10|||
149157293|NCT04142983|538051803|FG000|Overall Study|Physician Decision|1|||
149157294|NCT04142983|538051803|FG000|Overall Study|Adverse Event|1|||
149157295|NCT04142983|538051803|FG000|Overall Study|No longer eligible|4|||
149157296|NCT04142983|538051803|FG000|Overall Study|Screen Failure|10|||
149157297|NCT02062658|538051804|FG000|Overall Study|Withdrawal by Subject|1|||
149157298|NCT02062658|538051804|FG000|Overall Study|Lack of Efficacy|1|||
149157299|NCT00643994|538051805|FG000|Overall Study|Death|24|||
149157300|NCT00643994|538051805|FG000|Overall Study|Lost to Follow-up|72|||
149157301|NCT04016311|538051811|FG000|Overall Study|Withdrawal by Subject|1|||
149157302|NCT04016311|538051812|FG001|Overall Study|Withdrawal by Subject|0|||
149157303|NCT04029519|538051814|FG000|Overall Study|Protocol Violation|1|||
149157304|NCT04029519|538051814|FG000|Overall Study|Withdrawal by Subject|3|||
149157305|NCT04029519|538051814|FG000|Overall Study|Lost to Follow-up|1|||
149157306|NCT00094055|538051821|FG000|Overall Study|Adverse Event|11|||
149157307|NCT00094055|538051821|FG000|Overall Study|Death|4|||
149157308|NCT00094055|538051821|FG000|Overall Study|Lack of Efficacy|17|||
149157309|NCT00094055|538051821|FG000|Overall Study|Lost to Follow-up|2|||
149157310|NCT00094055|538051821|FG000|Overall Study|progressive disease|2|||
149157311|NCT00094055|538051821|FG000|Overall Study|clinical progression|1|||
149157312|NCT00094055|538051821|FG000|Overall Study|roll-over to another study|14|||
149157313|NCT00094055|538051821|FG000|Overall Study|Withdrawal by Subject|9|||
148673283|NCT02886494|536274082|FG000|Overall Study|Adverse Event|1|||
148673284|NCT02886494|536274083|FG001|Overall Study|Adverse Event|0|||
148673285|NCT02886494|536274082|FG000|Overall Study|Withdrawal by Subject|12|||
148673286|NCT02886494|536274083|FG001|Overall Study|Withdrawal by Subject|3|||
148673287|NCT02886494|536274082|FG000|Overall Study|Protocol Violation|4|||
148673288|NCT02886494|536274083|FG001|Overall Study|Protocol Violation|1|||
148673289|NCT00916617|536274086|FG000|Overall Study|Adverse Event|3|||
148673290|NCT00916617|536274087|FG001|Overall Study|Adverse Event|2|||
148673291|NCT00916617|536274088|FG002|Overall Study|Adverse Event|6|||
148673292|NCT00916617|536274089|FG003|Overall Study|Adverse Event|3|||
148673293|NCT00916617|536274086|FG000|Overall Study|Withdrawal by Subject|3|||
148673294|NCT00916617|536274087|FG001|Overall Study|Withdrawal by Subject|2|||
148673295|NCT00916617|536274088|FG002|Overall Study|Withdrawal by Subject|0|||
148673296|NCT00916617|536274089|FG003|Overall Study|Withdrawal by Subject|1|||
148673297|NCT00916617|536274086|FG000|Overall Study|Caregiver Request|3|||
148673298|NCT00916617|536274087|FG001|Overall Study|Caregiver Request|2|||
148673299|NCT00916617|536274088|FG002|Overall Study|Caregiver Request|1|||
148673300|NCT00916617|536274089|FG003|Overall Study|Caregiver Request|0|||
148673301|NCT00916617|536274086|FG000|Overall Study|Physician Decision|1|||
148673302|NCT00916617|536274087|FG001|Overall Study|Physician Decision|1|||
148673303|NCT00916617|536274088|FG002|Overall Study|Physician Decision|0|||
148673304|NCT00916617|536274089|FG003|Overall Study|Physician Decision|0|||
148673305|NCT00916617|536274086|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
148673306|NCT00916617|536274087|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
148673307|NCT00916617|536274088|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
148673308|NCT00916617|536274089|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
148673309|NCT00916617|536274086|FG000|Overall Study|Lost to Follow-up|2|||
148673310|NCT00916617|536274087|FG001|Overall Study|Lost to Follow-up|1|||
148673311|NCT00916617|536274088|FG002|Overall Study|Lost to Follow-up|0|||
148673312|NCT00916617|536274089|FG003|Overall Study|Lost to Follow-up|0|||
148673313|NCT00916617|536274086|FG000|Overall Study|Lack of Efficacy|1|||
148673314|NCT00916617|536274087|FG001|Overall Study|Lack of Efficacy|0|||
148673315|NCT00916617|536274088|FG002|Overall Study|Lack of Efficacy|0|||
148673316|NCT00916617|536274089|FG003|Overall Study|Lack of Efficacy|0|||
148673317|NCT00916617|536274086|FG000|Overall Study|Other|2|||
148673318|NCT00916617|536274087|FG001|Overall Study|Other|0|||
148673319|NCT00916617|536274088|FG002|Overall Study|Other|0|||
148673320|NCT00916617|536274089|FG003|Overall Study|Other|2|||
148673321|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
148673322|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
148673323|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
148673324|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
148673325|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
148673326|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
148673327|NCT00566631|536274091|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
148673328|NCT00566631|536274091|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
148673329|NCT00566631|536274091|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
148673330|NCT00566631|536274091|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
148673331|NCT00566631|536274091|FG000|Part 2: Extension Phase|Adverse Event|11|||
148673332|NCT00566631|536274091|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
148673333|NCT00566631|536274091|FG000|Part 2: Extension Phase|Death|1|||
148673334|NCT00566631|536274091|FG000|Part 2: Extension Phase|Other|5|||
148673335|NCT02723786|536274092|FG000|Overall Study|Lost to Follow-up|1|||
148673336|NCT03170271|536274095|FG000|Overall Study|Adverse Event|7|||
148673337|NCT03170271|536274096|FG001|Overall Study|Adverse Event|2|||
148673338|NCT03170271|536274095|FG000|Overall Study|Lost to Follow-up|0|||
148673339|NCT03170271|536274096|FG001|Overall Study|Lost to Follow-up|1|||
148673340|NCT03170271|536274095|FG000|Overall Study|Physician Decision|1|||
148673341|NCT03170271|536274096|FG001|Overall Study|Physician Decision|0|||
148673342|NCT03170271|536274095|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
148673343|NCT03170271|536274096|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
148673344|NCT03170271|536274095|FG000|Overall Study|Withdrawal by Subject|17|||
148805979|NCT05911841|536768046|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
148673345|NCT03170271|536274096|FG001|Overall Study|Withdrawal by Subject|5|||
148673346|NCT03170271|536274095|FG000|Overall Study|Other|2|||
148673347|NCT03170271|536274096|FG001|Overall Study|Other|2|||
148673348|NCT03170271|536274095|FG000|Overall Study|Randomized in error|4|||
148673349|NCT03170271|536274096|FG001|Overall Study|Randomized in error|0|||
148673350|NCT03319368|536274098|FG000|Overall Study|Discharge swabs not collected from resident|57|||
148805980|NCT05911841|536768047|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
148673351|NCT03319368|536274099|FG001|Overall Study|Discharge swabs not collected from resident|46|||
148673352|NCT00824993|536274104|FG000|Overall Study|Withdrawal by Subject|1|||
148673353|NCT00824993|536274105|FG001|Overall Study|Withdrawal by Subject|1|||
148673354|NCT00824993|536274104|FG000|Overall Study|Malignancy Relapse|9|||
148673355|NCT00824993|536274105|FG001|Overall Study|Malignancy Relapse|10|||
148673356|NCT00824993|536274104|FG000|Overall Study|Rapid Bone Loss|0|||
148673357|NCT00824993|536274105|FG001|Overall Study|Rapid Bone Loss|1|||
148673358|NCT00824993|536274104|FG000|Overall Study|Non-Compliant|2|||
148673359|NCT00824993|536274105|FG001|Overall Study|Non-Compliant|1|||
148673360|NCT00824993|536274104|FG000|Overall Study|Insurance Issue|2|||
148673361|NCT00824993|536274105|FG001|Overall Study|Insurance Issue|1|||
148673362|NCT00824993|536274104|FG000|Overall Study|Death|0|||
148673363|NCT00824993|536274105|FG001|Overall Study|Death|3|||
148673364|NCT00518011|536274106|FG000|Overall Study|Death|1|||
148673365|NCT00518011|536274107|FG001|Overall Study|Death|1|||
148673366|NCT00518011|536274106|FG000|Overall Study|Adverse Event|2|||
148673367|NCT00518011|536274107|FG001|Overall Study|Adverse Event|3|||
148673368|NCT00518011|536274106|FG000|Overall Study|Disease Progression|2|||
148673369|NCT00518011|536274107|FG001|Overall Study|Disease Progression|2|||
148673370|NCT00518011|536274106|FG000|Overall Study|Other Reasons|3|||
148673371|NCT00518011|536274107|FG001|Overall Study|Other Reasons|2|||
148673372|NCT00518011|536274106|FG000|Overall Study|Withdrawal by Subject|1|||
148673373|NCT00518011|536274107|FG001|Overall Study|Withdrawal by Subject|0|||
148673374|NCT03409328|536274108|FG000|Overall Study|Lost to Follow-up|6|||
148673375|NCT03409328|536274109|FG001|Overall Study|Lost to Follow-up|3|||
148673376|NCT02998645|536274110|FG000|Treatment Period 1|Adverse Event|6|||
148673377|NCT02998645|536274110|FG000|Treatment Period 1|Death|5|||
148673378|NCT02998645|536274110|FG000|Treatment Period 1|Technical Problems|4|||
148673379|NCT02998645|536274110|FG000|Treatment Period 1|Lack of Efficacy|2|||
148673380|NCT02998645|536274110|FG000|Treatment Period 1|Progressive disease|1|||
148673381|NCT02998645|536274110|FG000|Treatment Period 1|Subject/guardian decision|1|||
148673382|NCT02998645|536274110|FG000|Treatment Period 2|Lack of Efficacy|5|||
148673383|NCT02998645|536274110|FG000|Treatment Period 2|Adverse Event|2|||
148673384|NCT02998645|536274110|FG000|Treatment Period 2|Progressive disease|2|||
148673385|NCT02998645|536274110|FG000|Treatment Period 2|Physician Decision|1|||
148673386|NCT03701516|536274111|FG000|Period 1|Lost to Follow-up|0|||
148673387|NCT03701516|536274112|FG001|Period 1|Lost to Follow-up|1|||
148673388|NCT03701516|536274111|FG000|Period 1|Adverse Event|0|||
148673389|NCT03701516|536274112|FG001|Period 1|Adverse Event|2|||
148673390|NCT03701516|536274111|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
148673391|NCT03701516|536274112|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
148673392|NCT03701516|536274111|FG000|Period 1|Non Compliance to Protocol|2|||
148673393|NCT03701516|536274112|FG001|Period 1|Non Compliance to Protocol|1|||
148673394|NCT03701516|536274111|FG000|Period 1|Withdrawal by Subject|0|||
148673395|NCT03701516|536274112|FG001|Period 1|Withdrawal by Subject|1|||
148673396|NCT03701516|536274111|FG000|Period 2|failed to meet all eligibility creiteria|1|||
148673397|NCT03701516|536274112|FG001|Period 2|failed to meet all eligibility creiteria|0|||
148673398|NCT03701516|536274111|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
148673399|NCT03701516|536274112|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
148673400|NCT03930615|536274114|FG000|Overall Study|Death|9|||
148673401|NCT03930615|536274115|FG001|Overall Study|Death|3|||
148673402|NCT03930615|536274114|FG000|Overall Study|Lost to Follow-up|1|||
148673403|NCT03930615|536274115|FG001|Overall Study|Lost to Follow-up|2|||
148673404|NCT03930615|536274114|FG000|Overall Study|Physician Decision|3|||
148673405|NCT03930615|536274115|FG001|Overall Study|Physician Decision|4|||
149157314|NCT00756938|538051822|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
148673406|NCT03930615|536274114|FG000|Overall Study|Withdrawal by Subject|13|||
148673407|NCT03930615|536274115|FG001|Overall Study|Withdrawal by Subject|2|||
148673408|NCT03930615|536274114|FG000|Overall Study|Not treated|1|||
148673409|NCT03930615|536274115|FG001|Overall Study|Not treated|1|||
148673410|NCT03644927|536274116|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
148673411|NCT03644927|536274117|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
148673412|NCT00956813|536274118|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
148673413|NCT00956813|536274119|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
148673414|NCT00956813|536274118|FG000|Flaxseed and Placebo|Ineligible|3|||
148673415|NCT00956813|536274119|FG001|Flaxseed and Placebo|Ineligible|1|||
148673416|NCT02864953|536274120|FG000|Overall Study|Adverse Event|22|||
148673417|NCT02864953|536274121|FG001|Overall Study|Adverse Event|19|||
148673418|NCT02864953|536274120|FG000|Overall Study|Withdrawal by Subject|1|||
148673419|NCT02864953|536274121|FG001|Overall Study|Withdrawal by Subject|0|||
148673420|NCT02864953|536274120|FG000|Overall Study|Physician Decision|4|||
148673421|NCT02864953|536274121|FG001|Overall Study|Physician Decision|2|||
148673422|NCT02864953|536274120|FG000|Overall Study|Death|3|||
148673423|NCT02864953|536274121|FG001|Overall Study|Death|13|||
148673424|NCT02864953|536274120|FG000|Overall Study|Reason not specified|14|||
148673425|NCT02864953|536274121|FG001|Overall Study|Reason not specified|12|||
148673426|NCT02864953|536274120|FG000|Overall Study|Withdrew Prior to Dosing|9|||
148673427|NCT02864953|536274121|FG001|Overall Study|Withdrew Prior to Dosing|8|||
148673428|NCT00358670|536274122|FG000|Overall Study|Adverse Event|26|||
148673429|NCT00358670|536274123|FG001|Overall Study|Adverse Event|29|||
148673430|NCT00358670|536274122|FG000|Overall Study|Lack of Efficacy|20|||
148673431|NCT00358670|536274123|FG001|Overall Study|Lack of Efficacy|23|||
148673432|NCT00358670|536274122|FG000|Overall Study|Protocol Violation|6|||
148921500|NCT00095147|537196232|FG002|Long-term Extension Period|Leaving country|0|||
148673433|NCT00358670|536274123|FG001|Overall Study|Protocol Violation|9|||
148673434|NCT00358670|536274122|FG000|Overall Study|Lost to Follow-up|4|||
148673435|NCT00358670|536274123|FG001|Overall Study|Lost to Follow-up|5|||
148673436|NCT00358670|536274122|FG000|Overall Study|Withdrawal by Subject|13|||
148673437|NCT00358670|536274123|FG001|Overall Study|Withdrawal by Subject|24|||
148673438|NCT00358670|536274122|FG000|Overall Study|Protocol Defined Clinical Event|0|||
148673439|NCT00358670|536274123|FG001|Overall Study|Protocol Defined Clinical Event|1|||
148673440|NCT00358670|536274122|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
148673441|NCT00358670|536274123|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
148673442|NCT00358670|536274122|FG000|Overall Study|Administrative|153|||
148673443|NCT00358670|536274123|FG001|Overall Study|Administrative|125|||
148673444|NCT00981019|536274124|FG000|Overall Study|Did not respond|65|||
148673445|NCT00981019|536274124|FG000|Overall Study|Did not match target population|94|||
148673446|NCT00981019|536274124|FG000|Overall Study|Inadvertent exclusion|239|||
148673447|NCT00981019|536274124|FG000|Overall Study|Hit the survey after closure|79|||
148673448|NCT05083559|536274125|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
148673449|NCT05083559|536274126|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
148673450|NCT05083559|536274125|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
148673451|NCT05083559|536274126|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
148673452|NCT05083559|536274125|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
148673453|NCT05083559|536274126|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
148673454|NCT00905437|536274127|FG000|Overall Study|Adverse Event|3|||
148673455|NCT00905437|536274128|FG001|Overall Study|Adverse Event|2|||
148673456|NCT00905437|536274127|FG000|Overall Study|Lost to Follow-up|0|||
148673457|NCT00905437|536274128|FG001|Overall Study|Lost to Follow-up|1|||
148673458|NCT00905437|536274127|FG000|Overall Study|Withdrawal by Subject|0|||
148673459|NCT00905437|536274128|FG001|Overall Study|Withdrawal by Subject|1|||
148673460|NCT00905437|536274127|FG000|Overall Study|Other|5|||
148673461|NCT00905437|536274128|FG001|Overall Study|Other|6|||
148673462|NCT03252015|536274131|FG000|Overall Study|Withdrawal by Subject|0|||
148673463|NCT03252015|536274132|FG001|Overall Study|Withdrawal by Subject|1|||
148673464|NCT03252015|536274133|FG002|Overall Study|Withdrawal by Subject|1|||
148673465|NCT03252015|536274134|FG003|Overall Study|Withdrawal by Subject|0|||
148673466|NCT03252015|536274131|FG000|Overall Study|Adverse Event|1|||
148673467|NCT03252015|536274132|FG001|Overall Study|Adverse Event|0|||
148673468|NCT03252015|536274133|FG002|Overall Study|Adverse Event|0|||
148673469|NCT03252015|536274134|FG003|Overall Study|Adverse Event|1|||
148673470|NCT03128931|536274135|FG000|Overall Study|Physician Decision|1|||
148673471|NCT03128931|536274135|FG000|Overall Study|Equipment Issues|3|||
148673472|NCT04993339|536274136|FG000|Overall Study|Lost to Follow-up|0|||
148673473|NCT04993339|536274137|FG001|Overall Study|Lost to Follow-up|1|||
148673474|NCT04993339|536274136|FG000|Overall Study|no MRI scan|3|||
148673475|NCT04993339|536274137|FG001|Overall Study|no MRI scan|1|||
148673476|NCT00903409|536274138|FG000|Overall Study|Adverse Event|11|||
148673477|NCT00903409|536274139|FG001|Overall Study|Adverse Event|9|||
148673478|NCT00903409|536274138|FG000|Overall Study|Non-compliance with Protocol|1|||
148673479|NCT00903409|536274139|FG001|Overall Study|Non-compliance with Protocol|1|||
148673480|NCT00903409|536274138|FG000|Overall Study|Laboratory Abnormality|2|||
148673481|NCT00903409|536274139|FG001|Overall Study|Laboratory Abnormality|0|||
148673482|NCT00903409|536274138|FG000|Overall Study|Withdrawal by Subject|8|||
148673483|NCT00903409|536274139|FG001|Overall Study|Withdrawal by Subject|8|||
148673484|NCT00903409|536274138|FG000|Overall Study|Other|2|||
148673485|NCT00903409|536274139|FG001|Overall Study|Other|3|||
148673486|NCT00903409|536274138|FG000|Overall Study|Lost to Follow-up|2|||
148805981|NCT05911841|536768048|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
148921501|NCT00095147|537196233|FG003|Long-term Extension Period|Leaving country|0|||
148921502|NCT00095147|537196234|FG004|Long-term Extension Period|Leaving country|1|||
148921503|NCT02650921|537196235|FG000|Overall Study|Withdrawal by Subject|4|||
148921504|NCT02650921|537196235|FG000|Overall Study|Lost to Follow-up|2|||
148921505|NCT02650921|537196235|FG000|Overall Study|Adverse Event|1|||
148921506|NCT02650921|537196235|FG000|Overall Study|Due to Medical Condition|1|||
148921507|NCT02395302|537196236|FG000|Overall Study|Screen Failure|3|||
149157315|NCT00756938|538051823|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
148673487|NCT00903409|536274139|FG001|Overall Study|Lost to Follow-up|6|||
148673488|NCT03256526|536275727|FG000|Overall Study|Adverse Event|1|||
148673489|NCT03256526|536275728|FG001|Overall Study|Adverse Event|0|||
148673490|NCT03256526|536275729|FG002|Overall Study|Adverse Event|1|||
148673491|NCT03256526|536275727|FG000|Overall Study|Lost to Follow-up|1|||
148673492|NCT03256526|536275728|FG001|Overall Study|Lost to Follow-up|0|||
148673493|NCT03256526|536275729|FG002|Overall Study|Lost to Follow-up|2|||
148673494|NCT01607398|536275730|FG000|Overall Study|Adverse Event|0|||
148673495|NCT01607398|536275731|FG001|Overall Study|Adverse Event|2|||
148921508|NCT02395302|537196236|FG000|Overall Study|Run In Failure|7|||
148921509|NCT02395302|537196236|FG000|Overall Study|Withdrawal by Subject|2|||
148673496|NCT01607398|536275730|FG000|Overall Study|Severe COPD|2|||
148673497|NCT01607398|536275731|FG001|Overall Study|Severe COPD|0|||
148921510|NCT02395302|537196236|FG000|Overall Study|Physician Decision|2|||
148921511|NCT00783302|537196237|FG000|Overall Study|Lost to Follow-up|17|||
149157316|NCT00756938|538051824|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
149157317|NCT00756938|538051825|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
149157318|NCT00756938|538051822|FG000|12-week Base Study|Protocol Violation|0|||
149157319|NCT00756938|538051823|FG001|12-week Base Study|Protocol Violation|0|||
149157320|NCT00756938|538051824|FG002|12-week Base Study|Protocol Violation|1|||
149157321|NCT00756938|538051825|FG003|12-week Base Study|Protocol Violation|0|||
149157322|NCT00756938|538051822|FG000|12-week Base Study|Lost to Follow-up|1|||
149157323|NCT00756938|538051823|FG001|12-week Base Study|Lost to Follow-up|0|||
149157324|NCT00756938|538051824|FG002|12-week Base Study|Lost to Follow-up|0|||
149157325|NCT00756938|538051825|FG003|12-week Base Study|Lost to Follow-up|0|||
149157326|NCT00756938|538051822|FG000|Optional Extension|Lack of Efficacy|0|||
148921512|NCT00783302|537196237|FG000|Overall Study|Technical Problems|11|||
148921513|NCT00783302|537196237|FG000|Overall Study|Protocol Violation|3|||
149157327|NCT00756938|538051823|FG001|Optional Extension|Lack of Efficacy|0|||
148921514|NCT00783302|537196237|FG000|Overall Study|Physician Decision|1|||
148921515|NCT00783302|537196237|FG000|Overall Study|Withdrawal by Subject|3|||
148805982|NCT05911841|536768049|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
148805983|NCT05911841|536768050|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
148921516|NCT00160667|537196238|FG000|Overall Study|Adverse Event|3|||
149157328|NCT00756938|538051824|FG002|Optional Extension|Lack of Efficacy|0|||
149157329|NCT00756938|538051825|FG003|Optional Extension|Lack of Efficacy|1|||
148921517|NCT00160667|537196239|FG001|Overall Study|Adverse Event|1|||
149157330|NCT00756938|538051822|FG000|Optional Extension|End of Study|0|||
149157331|NCT00756938|538051823|FG001|Optional Extension|End of Study|0|||
148921518|NCT00160667|537196240|FG002|Overall Study|Adverse Event|4|||
148921519|NCT00160667|537196238|FG000|Overall Study|Withdrawal by Subject|2|||
148921520|NCT00160667|537196239|FG001|Overall Study|Withdrawal by Subject|0|||
148921521|NCT00160667|537196240|FG002|Overall Study|Withdrawal by Subject|1|||
148921522|NCT00160667|537196238|FG000|Overall Study|Lack of Efficacy|0|||
148921523|NCT00160667|537196239|FG001|Overall Study|Lack of Efficacy|1|||
148921524|NCT00160667|537196240|FG002|Overall Study|Lack of Efficacy|0|||
148921525|NCT00160667|537196238|FG000|Overall Study|Protocol Violation|0|||
148921526|NCT00160667|537196239|FG001|Overall Study|Protocol Violation|1|||
148921527|NCT00160667|537196240|FG002|Overall Study|Protocol Violation|0|||
148921528|NCT00160667|537196238|FG000|Overall Study|Patient decision|0|||
148921529|NCT00160667|537196239|FG001|Overall Study|Patient decision|0|||
148921530|NCT00160667|537196240|FG002|Overall Study|Patient decision|1|||
148921531|NCT01917656|537196244|FG000|Overall Study|Adverse Event|11|||
148921532|NCT01917656|537196245|FG001|Overall Study|Adverse Event|0|||
148921533|NCT01917656|537196244|FG000|Overall Study|Withdrawal criteria|8|||
148921534|NCT01917656|537196245|FG001|Overall Study|Withdrawal criteria|14|||
148921535|NCT01917656|537196244|FG000|Overall Study|Unclassified|0|||
148921536|NCT01917656|537196245|FG001|Overall Study|Unclassified|3|||
148921537|NCT01917656|537196244|FG000|Overall Study|Withdrawal by Subject|4|||
148921538|NCT01917656|537196245|FG001|Overall Study|Withdrawal by Subject|3|||
148921539|NCT01917656|537196244|FG000|Overall Study|Lost to Follow-up|3|||
148921540|NCT01917656|537196245|FG001|Overall Study|Lost to Follow-up|4|||
148921541|NCT02285062|537196246|FG000|Pre-Treatment Period|Protocol Violation|0|||
148921542|NCT02285062|537196247|FG001|Pre-Treatment Period|Protocol Violation|2|||
148921543|NCT02285062|537196246|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
148921544|NCT02285062|537196247|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
148921545|NCT02015221|537196248|FG000|Overall Study|Withdrawal by Subject|8|||
148921546|NCT02015221|537196249|FG001|Overall Study|Withdrawal by Subject|6|||
148921547|NCT02015221|537196248|FG000|Overall Study|Lost to Follow-up|1|||
148921548|NCT02015221|537196249|FG001|Overall Study|Lost to Follow-up|0|||
148921549|NCT01306929|537196250|FG000|Overall Study|Withdrawal by Subject|23|||
148921550|NCT01306929|537196250|FG000|Overall Study|Adverse Event|21|||
148921551|NCT01306929|537196250|FG000|Overall Study|Physician Decision|13|||
148921552|NCT01306929|537196250|FG000|Overall Study|Death|8|||
148921553|NCT01306929|537196250|FG000|Overall Study|Withdrawal by parent/guardian|5|||
148921554|NCT01306929|537196250|FG000|Overall Study|Protocol Violation|3|||
148921555|NCT01306929|537196250|FG000|Overall Study|Non-compliance with study drug|2|||
148921556|NCT01306929|537196250|FG000|Overall Study|Lost to Follow-up|2|||
148921557|NCT01306929|537196250|FG000|Overall Study|Various|17|||
148921558|NCT03709576|537196256|FG000|Overall Study|progression prior to enrollment|1|||
148921559|NCT03041129|537196260|FG000|Overall Study|Withdrawal by Subject|2|||
148921560|NCT03041129|537196261|FG001|Overall Study|Withdrawal by Subject|0|||
148921561|NCT03041129|537196262|FG002|Overall Study|Withdrawal by Subject|0|||
148921562|NCT03041129|537196263|FG003|Overall Study|Withdrawal by Subject|0|||
148921563|NCT00495040|537196268|FG000|Overall Study|Withdrawal by Subject|3|||
148921564|NCT02282293|537196269|FG000|Overall Study|Lost to Follow-up|2|||
148921565|NCT02282293|537196270|FG001|Overall Study|Lost to Follow-up|2|||
148921566|NCT02282293|537196269|FG000|Overall Study|Unable to comply with study procedures|1|||
148921567|NCT02282293|537196270|FG001|Overall Study|Unable to comply with study procedures|0|||
148921568|NCT02282293|537196269|FG000|Overall Study|Moved out of study area|0|||
148921569|NCT02282293|537196270|FG001|Overall Study|Moved out of study area|1|||
148921570|NCT00906971|537196276|FG000|Overall Study|Withdrawal by Subject|8|||
148921571|NCT00906971|537196277|FG001|Overall Study|Withdrawal by Subject|2|||
148921572|NCT00906971|537196276|FG000|Overall Study|Lost to Follow-up|0|||
148921573|NCT00906971|537196277|FG001|Overall Study|Lost to Follow-up|1|||
148921574|NCT01551420|537196278|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
148921575|NCT01551420|537196279|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
148921576|NCT01551420|537196278|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
148921577|NCT01551420|537196279|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
148921578|NCT01551420|537196278|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
148921579|NCT01551420|537196279|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
148921580|NCT01551420|537196278|FG000|Screened for Part B Eligibility|Declined participation|8|||
148921581|NCT01551420|537196279|FG001|Screened for Part B Eligibility|Declined participation|1|||
148921582|NCT01551420|537196278|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
148921583|NCT01551420|537196279|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
148921584|NCT01551420|537196278|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
148921585|NCT01551420|537196279|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
148921586|NCT01551420|537196278|FG000|Home Use (Part B)|Withdrawal by staff|0|||
148921587|NCT01551420|537196279|FG001|Home Use (Part B)|Withdrawal by staff|1|||
148921588|NCT00169442|537196280|FG000|Overall Study|Withdrawal by Subject|0|||
148921589|NCT00169442|537196281|FG001|Overall Study|Withdrawal by Subject|0|||
148921590|NCT00169442|537196282|FG002|Overall Study|Withdrawal by Subject|1|||
148921591|NCT00169442|537196283|FG003|Overall Study|Withdrawal by Subject|0|||
148921592|NCT00169442|537196284|FG004|Overall Study|Withdrawal by Subject|0|||
148921593|NCT00169442|537196285|FG005|Overall Study|Withdrawal by Subject|0|||
149157332|NCT00756938|538051824|FG002|Optional Extension|End of Study|0|||
149157333|NCT00756938|538051825|FG003|Optional Extension|End of Study|11|||
149157334|NCT00756938|538051822|FG000|Optional Extension|Protocol-specific criteria met|0|||
149157335|NCT00756938|538051823|FG001|Optional Extension|Protocol-specific criteria met|0|||
149157336|NCT00756938|538051824|FG002|Optional Extension|Protocol-specific criteria met|0|||
149157337|NCT00756938|538051825|FG003|Optional Extension|Protocol-specific criteria met|9|||
149157338|NCT00756938|538051822|FG000|Optional Extension|Physician Decision|0|||
149157339|NCT00756938|538051823|FG001|Optional Extension|Physician Decision|0|||
149157340|NCT00756938|538051824|FG002|Optional Extension|Physician Decision|0|||
149157341|NCT00756938|538051825|FG003|Optional Extension|Physician Decision|3|||
149157342|NCT00756938|538051822|FG000|Optional Extension|Lost to Follow-up|0|||
149157343|NCT00756938|538051823|FG001|Optional Extension|Lost to Follow-up|0|||
149157344|NCT00756938|538051824|FG002|Optional Extension|Lost to Follow-up|0|||
149157345|NCT00756938|538051825|FG003|Optional Extension|Lost to Follow-up|1|||
149157346|NCT00756938|538051822|FG000|Optional Extension|Protocol Violation|0|||
149157347|NCT00756938|538051823|FG001|Optional Extension|Protocol Violation|0|||
149157348|NCT00756938|538051824|FG002|Optional Extension|Protocol Violation|0|||
148673498|NCT00602979|536275732|FG000|Overall Study|Lost to Follow-up|3|||
148673499|NCT00602979|536275733|FG001|Overall Study|Lost to Follow-up|2|||
148673500|NCT00602979|536275734|FG002|Overall Study|Lost to Follow-up|3|||
148673501|NCT00602979|536275735|FG003|Overall Study|Lost to Follow-up|2|||
148673502|NCT00602979|536275736|FG004|Overall Study|Lost to Follow-up|3|||
148673503|NCT00602979|536275732|FG000|Overall Study|Failed Intubation|0|||
148673504|NCT00602979|536275733|FG001|Overall Study|Failed Intubation|1|||
148673505|NCT00602979|536275734|FG002|Overall Study|Failed Intubation|0|||
148673506|NCT00602979|536275735|FG003|Overall Study|Failed Intubation|1|||
148673507|NCT00602979|536275736|FG004|Overall Study|Failed Intubation|0|||
148673508|NCT01461369|536275739|FG000|Overall Study|Lack of Efficacy|2|||
148673509|NCT01461369|536275740|FG001|Overall Study|Lack of Efficacy|0|||
148673510|NCT01461369|536275741|FG002|Overall Study|Lack of Efficacy|6|||
148673511|NCT01461369|536275739|FG000|Overall Study|Lost to Follow-up|0|||
148673512|NCT01461369|536275740|FG001|Overall Study|Lost to Follow-up|0|||
148673513|NCT01461369|536275741|FG002|Overall Study|Lost to Follow-up|3|||
148673514|NCT01461369|536275739|FG000|Overall Study|Adverse Event|9|||
148673515|NCT01461369|536275740|FG001|Overall Study|Adverse Event|12|||
148673516|NCT01461369|536275741|FG002|Overall Study|Adverse Event|4|||
148673517|NCT01461369|536275739|FG000|Overall Study|Protocol Violation|1|||
148673518|NCT01461369|536275740|FG001|Overall Study|Protocol Violation|2|||
148673519|NCT01461369|536275741|FG002|Overall Study|Protocol Violation|2|||
148673520|NCT01461369|536275739|FG000|Overall Study|Withdrawal by Subject|1|||
148673521|NCT01461369|536275740|FG001|Overall Study|Withdrawal by Subject|3|||
148673522|NCT01461369|536275741|FG002|Overall Study|Withdrawal by Subject|2|||
148673523|NCT00734617|536275744|FG000|Overall Study|Adverse Event|4|||
148673524|NCT00734617|536275745|FG001|Overall Study|Adverse Event|7|||
148673525|NCT00734617|536275744|FG000|Overall Study|Withdrawal by Subject|103|||
148673526|NCT00734617|536275745|FG001|Overall Study|Withdrawal by Subject|95|||
148673527|NCT00499252|536275753|FG000|Overall Study|Adverse Event|3|||
148673528|NCT00499252|536275753|FG000|Overall Study|Refused further treatment|2|||
148673529|NCT00499252|536275753|FG000|Overall Study|Ineligible|4|||
148673530|NCT00499252|536275753|FG000|Overall Study|<no further label>|3|||
148673531|NCT00556166|536275771|FG000|Overall Study|Withdrawal by Subject|1|||
148673532|NCT01612780|536275772|FG000|Overall Study|Treatment not completed|1|||
148673533|NCT01612780|536275772|FG000|Overall Study|Withdrawal by Subject|5|||
148673534|NCT02985515|536275775|FG000|Olfaction Testing|Lost to Follow-up|0|||
148921594|NCT00169442|537196280|FG000|Overall Study|Migrated/moved from study area|0|||
148921595|NCT00169442|537196281|FG001|Overall Study|Migrated/moved from study area|0|||
148921596|NCT00169442|537196282|FG002|Overall Study|Migrated/moved from study area|0|||
148921597|NCT00169442|537196283|FG003|Overall Study|Migrated/moved from study area|0|||
149157349|NCT00756938|538051825|FG003|Optional Extension|Protocol Violation|1|||
149157350|NCT00756938|538051822|FG000|Optional Extension|Withdrawal by Subject|0|||
149157351|NCT00756938|538051823|FG001|Optional Extension|Withdrawal by Subject|0|||
149157352|NCT00756938|538051824|FG002|Optional Extension|Withdrawal by Subject|0|||
149157353|NCT00756938|538051825|FG003|Optional Extension|Withdrawal by Subject|10|||
149157354|NCT00756938|538051822|FG000|Optional Extension|Adverse Event|0|||
149157355|NCT00756938|538051823|FG001|Optional Extension|Adverse Event|0|||
148673535|NCT02985515|536275776|FG001|Olfaction Testing|Lost to Follow-up|5|||
148673536|NCT02985515|536275775|FG000|Olfaction Testing|Protocol Violation|0|||
148673537|NCT02985515|536275776|FG001|Olfaction Testing|Protocol Violation|3|||
148673538|NCT03359473|536275777|FG000|Overall Study|Adverse Event|0|||
148673539|NCT03359473|536275778|FG001|Overall Study|Adverse Event|2|||
148673540|NCT03359473|536275779|FG002|Overall Study|Adverse Event|5|||
148673541|NCT03359473|536275780|FG003|Overall Study|Adverse Event|3|||
148673542|NCT03359473|536275777|FG000|Overall Study|Lost to Follow-up|0|||
148673543|NCT03359473|536275778|FG001|Overall Study|Lost to Follow-up|1|||
149157356|NCT00756938|538051824|FG002|Optional Extension|Adverse Event|0|||
149157357|NCT00756938|538051825|FG003|Optional Extension|Adverse Event|1|||
148673544|NCT03359473|536275779|FG002|Overall Study|Lost to Follow-up|0|||
148673545|NCT03359473|536275780|FG003|Overall Study|Lost to Follow-up|0|||
149157358|NCT04823949|538051826|FG000|Overall Study|Withdrawal by Subject|0|||
149157359|NCT04823949|538051827|FG001|Overall Study|Withdrawal by Subject|4|||
149157360|NCT04823949|538051826|FG000|Overall Study|Physician Decision|0|||
149157361|NCT04823949|538051827|FG001|Overall Study|Physician Decision|1|||
149157362|NCT02347176|538051830|FG000|Overall Study|Lost to Follow-up|2|||
148921598|NCT00169442|537196284|FG004|Overall Study|Migrated/moved from study area|0|||
148921599|NCT00169442|537196285|FG005|Overall Study|Migrated/moved from study area|2|||
149157363|NCT02347176|538051831|FG001|Overall Study|Lost to Follow-up|3|||
149157364|NCT02347176|538051832|FG002|Overall Study|Lost to Follow-up|1|||
148921600|NCT00169442|537196280|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
148921601|NCT00169442|537196281|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
148921602|NCT00169442|537196282|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
148921603|NCT00169442|537196283|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
148921604|NCT00169442|537196284|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
148921605|NCT00169442|537196285|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
148921606|NCT00169442|537196280|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
148921607|NCT00169442|537196281|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
148921608|NCT00169442|537196282|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
148921609|NCT00169442|537196283|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
148921610|NCT00169442|537196284|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
148921611|NCT00169442|537196285|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
148921612|NCT04463069|537196288|FG000|Overall Study|Withdrawal by Subject|2|||
148921613|NCT04463069|537196289|FG001|Overall Study|Withdrawal by Subject|10|||
148921614|NCT04463069|537196288|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
148921615|NCT04463069|537196289|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
148921616|NCT03976648|537196290|FG000|Overall Study|Adverse Event|0|||
148921617|NCT03976648|537196291|FG001|Overall Study|Adverse Event|2|||
148921618|NCT03976648|537196290|FG000|Overall Study|Study terminated by sponsor|21|||
148921619|NCT03976648|537196291|FG001|Overall Study|Study terminated by sponsor|8|||
148921620|NCT01155167|537196292|FG000|Overall Study|Insufficient ultrasound data|2|||
148921621|NCT01155167|537196293|FG001|Overall Study|Insufficient ultrasound data|0|||
148921622|NCT01155167|537196292|FG000|Overall Study|Access site changed to femoral artery|1|||
148921623|NCT01155167|537196293|FG001|Overall Study|Access site changed to femoral artery|0|||
148921624|NCT00960570|537196294|FG000|21 Day Washout Period|Adverse Event|1|||
148921625|NCT00960570|537196294|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
148921626|NCT00960570|537196294|FG000|1 Day Period Between Dosing|Adverse Event|2|||
148921627|NCT00960570|537196294|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
148921628|NCT01451437|537196295|FG000|Overall Study|Adverse Event|0|||
148921629|NCT01451437|537196296|FG001|Overall Study|Adverse Event|0|||
148921630|NCT01451437|537196297|FG002|Overall Study|Adverse Event|0|||
148921631|NCT01451437|537196298|FG003|Overall Study|Adverse Event|0|||
148921632|NCT01451437|537196299|FG004|Overall Study|Adverse Event|0|||
148921633|NCT01451437|537196300|FG005|Overall Study|Adverse Event|1|||
148921634|NCT01451437|537196301|FG006|Overall Study|Adverse Event|1|||
148921635|NCT01451437|537196302|FG007|Overall Study|Adverse Event|2|||
148921636|NCT01451437|537196303|FG008|Overall Study|Adverse Event|1|||
148921637|NCT01451437|537196295|FG000|Overall Study|Physician Decision|1|||
148921638|NCT01451437|537196296|FG001|Overall Study|Physician Decision|1|||
148921639|NCT01451437|537196297|FG002|Overall Study|Physician Decision|2|||
148921640|NCT01451437|537196298|FG003|Overall Study|Physician Decision|0|||
148921641|NCT01451437|537196299|FG004|Overall Study|Physician Decision|0|||
148921642|NCT01451437|537196300|FG005|Overall Study|Physician Decision|0|||
148921643|NCT01451437|537196301|FG006|Overall Study|Physician Decision|0|||
148921644|NCT01451437|537196302|FG007|Overall Study|Physician Decision|0|||
148921645|NCT01451437|537196303|FG008|Overall Study|Physician Decision|0|||
148921646|NCT01451437|537196295|FG000|Overall Study|Disease Progression|0|||
148921647|NCT01451437|537196296|FG001|Overall Study|Disease Progression|0|||
149157365|NCT02347176|538051833|FG003|Overall Study|Lost to Follow-up|1|||
149157366|NCT02347176|538051830|FG000|Overall Study|Withdrawal by Subject|9|||
149157367|NCT02347176|538051831|FG001|Overall Study|Withdrawal by Subject|5|||
149157368|NCT02347176|538051832|FG002|Overall Study|Withdrawal by Subject|5|||
149157369|NCT02347176|538051833|FG003|Overall Study|Withdrawal by Subject|3|||
149157370|NCT02347176|538051830|FG000|Overall Study|Other|1|||
149157371|NCT02347176|538051831|FG001|Overall Study|Other|2|||
148921648|NCT01451437|537196297|FG002|Overall Study|Disease Progression|1|||
148921649|NCT01451437|537196298|FG003|Overall Study|Disease Progression|1|||
148921650|NCT01451437|537196299|FG004|Overall Study|Disease Progression|3|||
148921651|NCT01451437|537196300|FG005|Overall Study|Disease Progression|2|||
148921652|NCT01451437|537196301|FG006|Overall Study|Disease Progression|3|||
148921653|NCT01451437|537196302|FG007|Overall Study|Disease Progression|1|||
148921654|NCT01451437|537196303|FG008|Overall Study|Disease Progression|3|||
148921655|NCT01451437|537196295|FG000|Overall Study|Protocol Violation|0|||
148921656|NCT01451437|537196296|FG001|Overall Study|Protocol Violation|0|||
148921657|NCT01451437|537196297|FG002|Overall Study|Protocol Violation|0|||
149157372|NCT02347176|538051832|FG002|Overall Study|Other|2|||
148921658|NCT01451437|537196298|FG003|Overall Study|Protocol Violation|0|||
148921659|NCT01451437|537196299|FG004|Overall Study|Protocol Violation|0|||
148921660|NCT01451437|537196300|FG005|Overall Study|Protocol Violation|0|||
149157373|NCT02347176|538051833|FG003|Overall Study|Other|0|||
149157374|NCT00411554|538051834|FG000|Overall Study|Adverse Event|2|||
149157375|NCT00411554|538051835|FG001|Overall Study|Adverse Event|4|||
149157376|NCT00411554|538051834|FG000|Overall Study|Lack of Efficacy|2|||
149157377|NCT00411554|538051835|FG001|Overall Study|Lack of Efficacy|5|||
148921661|NCT01451437|537196301|FG006|Overall Study|Protocol Violation|1|||
148921662|NCT01451437|537196302|FG007|Overall Study|Protocol Violation|0|||
149157378|NCT00411554|538051834|FG000|Overall Study|Withdrawal by Subject|3|||
149157379|NCT00411554|538051835|FG001|Overall Study|Withdrawal by Subject|0|||
149157380|NCT00411554|538051834|FG000|Overall Study|Patient Moved|1|||
149157381|NCT00411554|538051835|FG001|Overall Study|Patient Moved|0|||
149157382|NCT02556255|538051836|FG000|Overall Study|Lost to Follow-up|4|||
149157383|NCT01543087|538051837|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
148921663|NCT01451437|537196303|FG008|Overall Study|Protocol Violation|0|||
148921664|NCT01451437|537196295|FG000|Overall Study|Withdrawal by Subject|0|||
149157384|NCT01543087|538051838|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
149157385|NCT01543087|538051839|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
149157386|NCT01543087|538051840|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
149157387|NCT01543087|538051841|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
148921665|NCT01451437|537196296|FG001|Overall Study|Withdrawal by Subject|0|||
148921666|NCT01451437|537196297|FG002|Overall Study|Withdrawal by Subject|0|||
148921667|NCT01451437|537196298|FG003|Overall Study|Withdrawal by Subject|0|||
148921668|NCT01451437|537196299|FG004|Overall Study|Withdrawal by Subject|1|||
148921669|NCT01451437|537196300|FG005|Overall Study|Withdrawal by Subject|0|||
148921670|NCT01451437|537196301|FG006|Overall Study|Withdrawal by Subject|1|||
148921671|NCT01451437|537196302|FG007|Overall Study|Withdrawal by Subject|0|||
148921672|NCT01451437|537196303|FG008|Overall Study|Withdrawal by Subject|0|||
149157388|NCT01543087|538051842|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
148673546|NCT03359473|536275777|FG000|Overall Study|Physician Decision|0|||
148921673|NCT02081859|537196306|FG000|Overall Study|No fertilization|2|||
148921674|NCT02081859|537196307|FG001|Overall Study|No fertilization|2|||
148921675|NCT02081859|537196306|FG000|Overall Study|No sperm|1|||
148921676|NCT02081859|537196307|FG001|Overall Study|No sperm|0|||
148921677|NCT02081859|537196306|FG000|Overall Study|Unanticipated freeze all cycle|2|||
148921678|NCT02081859|537196307|FG001|Overall Study|Unanticipated freeze all cycle|6|||
148921679|NCT02081859|537196306|FG000|Overall Study|< 4 embryos|27|||
148921680|NCT02081859|537196307|FG001|Overall Study|< 4 embryos|23|||
148921681|NCT02081859|537196306|FG000|Overall Study|Other reasons|2|||
148921682|NCT02081859|537196307|FG001|Overall Study|Other reasons|0|||
148921683|NCT03384693|537197561|FG000|Overall Study|Adverse Event|3|||
148921684|NCT00883688|537197575|FG000|Overall Study|Ineligible|2|||
148921685|NCT00464490|537197577|FG000|Overall Study|Physician Decision|11|||
148921686|NCT00464490|537197578|FG001|Overall Study|Physician Decision|11|||
148921687|NCT03188042|537197579|FG000|Overall Study|Withdrawal by Subject|1|||
148921688|NCT03188042|537197580|FG001|Overall Study|Withdrawal by Subject|1|||
148921689|NCT00528970|537197587|FG000|Overall Study|Adverse Event|6|||
148921690|NCT00528970|537197588|FG001|Overall Study|Adverse Event|8|||
148921691|NCT00528970|537197589|FG002|Overall Study|Adverse Event|5|||
148921692|NCT00528970|537197587|FG000|Overall Study|Lost to Follow-up|0|||
148921693|NCT00528970|537197588|FG001|Overall Study|Lost to Follow-up|0|||
148921694|NCT00528970|537197589|FG002|Overall Study|Lost to Follow-up|1|||
148921695|NCT00528970|537197587|FG000|Overall Study|Other than specified|2|||
148921696|NCT00528970|537197588|FG001|Overall Study|Other than specified|3|||
148921697|NCT00528970|537197589|FG002|Overall Study|Other than specified|3|||
148921698|NCT00528970|537197587|FG000|Overall Study|Protocol Violation|2|||
148921699|NCT00528970|537197588|FG001|Overall Study|Protocol Violation|1|||
148921700|NCT00528970|537197589|FG002|Overall Study|Protocol Violation|4|||
148921701|NCT00528970|537197587|FG000|Overall Study|Lack of Efficacy|0|||
148921702|NCT00528970|537197588|FG001|Overall Study|Lack of Efficacy|0|||
148921703|NCT00528970|537197589|FG002|Overall Study|Lack of Efficacy|1|||
148921704|NCT00528970|537197587|FG000|Overall Study|Withdrawal by Subject|4|||
148921705|NCT00528970|537197588|FG001|Overall Study|Withdrawal by Subject|3|||
148921706|NCT00528970|537197589|FG002|Overall Study|Withdrawal by Subject|5|||
148921707|NCT00528970|537197587|FG000|Overall Study|Randomized but not treated|0|||
148921708|NCT00528970|537197588|FG001|Overall Study|Randomized but not treated|0|||
148921709|NCT00528970|537197589|FG002|Overall Study|Randomized but not treated|1|||
148921710|NCT03860935|537197590|FG000|Overall Study|Withdrawal of Consent|15|||
148921711|NCT03860935|537197591|FG001|Overall Study|Withdrawal of Consent|6|||
148921712|NCT03860935|537197590|FG000|Overall Study|Death|75|||
148921713|NCT03860935|537197591|FG001|Overall Study|Death|51|||
148921714|NCT03086967|537197596|FG000|Overall Study|Screen Failure|2|||
148921715|NCT03086967|537197597|FG001|Overall Study|Screen Failure|2|||
148921716|NCT01475071|537197599|FG000|Overall Study|Physician Decision|1|||
148921717|NCT01475071|537197599|FG000|Overall Study|Withdrawal by Subject|6|||
149157389|NCT01543087|538051837|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
149157390|NCT01543087|538051838|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
148921718|NCT01475071|537197599|FG000|Overall Study|Lost to Follow-up|1|||
148921719|NCT02230527|537197600|FG000|Overall Study|Withdrawal by Subject|1|||
148921720|NCT02230527|537197601|FG001|Overall Study|Withdrawal by Subject|1|||
148921721|NCT02230527|537197600|FG000|Overall Study|Death|1|||
148921722|NCT02230527|537197601|FG001|Overall Study|Death|0|||
148921723|NCT02230527|537197600|FG000|Overall Study|Lost to Follow-up|2|||
148921724|NCT02230527|537197601|FG001|Overall Study|Lost to Follow-up|1|||
148921725|NCT02230527|537197600|FG000|Overall Study|Other|1|||
148921726|NCT02230527|537197601|FG001|Overall Study|Other|0|||
148921727|NCT04461600|537197602|FG000|Overall Study|Death|6|||
148921728|NCT04461600|537197603|FG001|Overall Study|Death|5|||
148921729|NCT04461600|537197602|FG000|Overall Study|Withdrawal by Subject|0|||
148921730|NCT04461600|537197603|FG001|Overall Study|Withdrawal by Subject|1|||
148921731|NCT02278471|537197605|FG000|Overall Study|Lost to Follow-up|6|||
148921732|NCT02278471|537197606|FG001|Overall Study|Lost to Follow-up|15|||
148921733|NCT02278471|537197605|FG000|Overall Study|Death|2|||
148921734|NCT02278471|537197606|FG001|Overall Study|Death|2|||
148921735|NCT02278471|537197605|FG000|Overall Study|Withdrawal by Subject|0|||
148921736|NCT02278471|537197606|FG001|Overall Study|Withdrawal by Subject|3|||
148921737|NCT01437995|537197607|FG000|Overall Study|Lost to Follow-up|11|||
148921738|NCT01437995|537197608|FG001|Overall Study|Lost to Follow-up|18|||
148921739|NCT01437995|537197609|FG002|Overall Study|Lost to Follow-up|20|||
148921740|NCT04391049|537197610|FG000|Overall Study|Protocol Violation|1|||
148921741|NCT01895361|537197615|FG000|Overall Study|Adverse Event|1|||
148921742|NCT01895361|537197616|FG001|Overall Study|Adverse Event|1|||
148921743|NCT01895361|537197617|FG002|Overall Study|Adverse Event|3|||
148921744|NCT01895361|537197615|FG000|Overall Study|Death|2|||
148921745|NCT01895361|537197616|FG001|Overall Study|Death|1|||
148921746|NCT01895361|537197617|FG002|Overall Study|Death|2|||
148921747|NCT01895361|537197615|FG000|Overall Study|Lost to Follow-up|4|||
148921748|NCT01895361|537197616|FG001|Overall Study|Lost to Follow-up|4|||
148921749|NCT01895361|537197617|FG002|Overall Study|Lost to Follow-up|6|||
148921750|NCT01895361|537197615|FG000|Overall Study|Non-compliance with study|1|||
148921751|NCT01895361|537197616|FG001|Overall Study|Non-compliance with study|3|||
148921752|NCT01895361|537197617|FG002|Overall Study|Non-compliance with study|1|||
148921753|NCT01895361|537197615|FG000|Overall Study|Physician Decision|2|||
148921754|NCT01895361|537197616|FG001|Overall Study|Physician Decision|2|||
148921755|NCT01895361|537197617|FG002|Overall Study|Physician Decision|2|||
148921756|NCT01895361|537197615|FG000|Overall Study|Withdrawal by Subject|7|||
148921757|NCT01895361|537197616|FG001|Overall Study|Withdrawal by Subject|6|||
148921758|NCT01895361|537197617|FG002|Overall Study|Withdrawal by Subject|6|||
148921759|NCT01895361|537197615|FG000|Overall Study|Lack of Efficacy|0|||
148921760|NCT01895361|537197616|FG001|Overall Study|Lack of Efficacy|1|||
148921761|NCT01895361|537197617|FG002|Overall Study|Lack of Efficacy|0|||
148921762|NCT01895361|537197615|FG000|Overall Study|Reasons different from categories above|7|||
148921763|NCT01895361|537197616|FG001|Overall Study|Reasons different from categories above|3|||
148921764|NCT01895361|537197617|FG002|Overall Study|Reasons different from categories above|4|||
148921765|NCT03007888|537197624|FG000|First Intervention (14 Days)|Adverse Event|1|||
148921766|NCT03007888|537197625|FG001|First Intervention (14 Days)|Adverse Event|0|||
148921767|NCT00927940|537197626|FG000|Overall Study|Death|1|||
148921768|NCT00827931|537197628|FG000|Overall Study|Death|3|||
148921769|NCT00827931|537197629|FG001|Overall Study|Death|5|||
149157391|NCT01543087|538051839|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
148921770|NCT00827931|537197628|FG000|Overall Study|Adverse Event|1|||
148921771|NCT00827931|537197629|FG001|Overall Study|Adverse Event|0|||
148921772|NCT00827931|537197628|FG000|Overall Study|Lost to Follow-up|1|||
148921773|NCT00827931|537197629|FG001|Overall Study|Lost to Follow-up|0|||
148921774|NCT00827931|537197628|FG000|Overall Study|Withdrawal by Subject|0|||
148921775|NCT00827931|537197629|FG001|Overall Study|Withdrawal by Subject|1|||
148921776|NCT00827931|537197628|FG000|Overall Study|Other|1|||
148921777|NCT00827931|537197629|FG001|Overall Study|Other|0|||
148921778|NCT01870076|537197630|FG000|Overall Study|Withdrawal by Subject|1|||
148921779|NCT01870076|537197631|FG001|Overall Study|Withdrawal by Subject|0|||
148921780|NCT01870076|537197632|FG002|Overall Study|Withdrawal by Subject|1|||
148921781|NCT01870076|537197633|FG003|Overall Study|Withdrawal by Subject|0|||
149157392|NCT01543087|538051840|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
149157393|NCT01543087|538051841|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
149157394|NCT01543087|538051842|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
149157395|NCT01543087|538051837|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
149157396|NCT01543087|538051838|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
149157397|NCT01543087|538051839|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
149157398|NCT01543087|538051840|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
149157399|NCT01543087|538051841|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
149157400|NCT01543087|538051842|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
149157401|NCT01543087|538051837|FG000|Stage 1 (48 Months)|Other than specified|5|||
149157402|NCT01543087|538051838|FG001|Stage 1 (48 Months)|Other than specified|0|||
149157403|NCT01543087|538051839|FG002|Stage 1 (48 Months)|Other than specified|9|||
148921782|NCT00492063|537197634|FG000|Overall Study|Death|0|||
148921783|NCT00492063|537197635|FG001|Overall Study|Death|0|||
148921784|NCT00492063|537197636|FG002|Overall Study|Death|1|||
148921785|NCT00492063|537197637|FG003|Overall Study|Death|2|||
148921786|NCT00492063|537197634|FG000|Overall Study|Withdrawal by Subject|4|||
148921787|NCT00492063|537197635|FG001|Overall Study|Withdrawal by Subject|3|||
148921788|NCT00492063|537197636|FG002|Overall Study|Withdrawal by Subject|5|||
148921789|NCT00492063|537197637|FG003|Overall Study|Withdrawal by Subject|4|||
148921790|NCT00492063|537197634|FG000|Overall Study|Lost to Follow-up|6|||
148921791|NCT00492063|537197635|FG001|Overall Study|Lost to Follow-up|11|||
148921792|NCT00492063|537197636|FG002|Overall Study|Lost to Follow-up|5|||
148921793|NCT00492063|537197637|FG003|Overall Study|Lost to Follow-up|3|||
148921794|NCT00492063|537197634|FG000|Overall Study|Protocol Violation|0|||
148921795|NCT00492063|537197635|FG001|Overall Study|Protocol Violation|0|||
148921796|NCT00492063|537197636|FG002|Overall Study|Protocol Violation|0|||
148921797|NCT00492063|537197637|FG003|Overall Study|Protocol Violation|1|||
148921798|NCT00890045|537197640|FG000|Overall Study|Death|0|||
148921799|NCT00890045|537197641|FG001|Overall Study|Death|1|||
148921800|NCT00890045|537197640|FG000|Overall Study|Did not receive HeRO Graft|0|||
148921801|NCT00890045|537197641|FG001|Overall Study|Did not receive HeRO Graft|2|||
148921802|NCT00890045|537197640|FG000|Overall Study|Lost to Follow-up|5|||
148921803|NCT00890045|537197641|FG001|Overall Study|Lost to Follow-up|7|||
148921804|NCT01947855|537197642|FG000|Overall Study|Withdrawal by Subject|1|||
148921805|NCT01947855|537197643|FG001|Overall Study|Withdrawal by Subject|0|||
148921806|NCT01947855|537197644|FG002|Overall Study|Withdrawal by Subject|0|||
148921807|NCT00621621|537197647|FG000|Overall Study|Subjects were exited at EP study|30|||
148921808|NCT00621621|537197648|FG001|Overall Study|Subjects were exited at EP study|0|||
148921809|NCT00608569|537197649|FG000|Overall Study|Death|4|||
148921810|NCT00608569|537197650|FG001|Overall Study|Death|3|||
148921811|NCT00608569|537197649|FG000|Overall Study|Lost to Follow-up|4|||
148921812|NCT00608569|537197650|FG001|Overall Study|Lost to Follow-up|5|||
148921813|NCT00608569|537197649|FG000|Overall Study|Withdrawal by Subject|1|||
148921814|NCT00608569|537197650|FG001|Overall Study|Withdrawal by Subject|0|||
148921815|NCT00608569|537197649|FG000|Overall Study|Adverse Event|1|||
148921816|NCT00608569|537197650|FG001|Overall Study|Adverse Event|0|||
148921817|NCT00608569|537197649|FG000|Overall Study|Unable to adhere with study requirements|0|||
148921818|NCT00608569|537197650|FG001|Overall Study|Unable to adhere with study requirements|1|||
148921819|NCT02312687|537197653|FG000|Overall Study|Other, Not Specified|1|||
148921820|NCT03645434|537197662|FG000|Period 1|Adverse Event|0|||
148921821|NCT03645434|537197663|FG001|Period 1|Adverse Event|0|||
148921822|NCT03645434|537197664|FG002|Period 1|Adverse Event|0|||
148921823|NCT03645434|537197665|FG003|Period 1|Adverse Event|1|||
148921824|NCT03645434|537197666|FG004|Period 1|Adverse Event|0|||
148921825|NCT03645434|537197667|FG005|Period 1|Adverse Event|0|||
148921826|NCT03645434|537197662|FG000|Period 1|COPD exacerbation|0|||
149157404|NCT01543087|538051840|FG003|Stage 1 (48 Months)|Other than specified|0|||
149157405|NCT01543087|538051841|FG004|Stage 1 (48 Months)|Other than specified|0|||
149157406|NCT01543087|538051842|FG005|Stage 1 (48 Months)|Other than specified|0|||
149157407|NCT01543087|538051837|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
149157408|NCT01543087|538051838|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
149157409|NCT01543087|538051839|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
148921827|NCT03645434|537197663|FG001|Period 1|COPD exacerbation|0|||
148921828|NCT03645434|537197664|FG002|Period 1|COPD exacerbation|0|||
148921829|NCT03645434|537197665|FG003|Period 1|COPD exacerbation|0|||
148921830|NCT03645434|537197666|FG004|Period 1|COPD exacerbation|1|||
148921831|NCT03645434|537197667|FG005|Period 1|COPD exacerbation|0|||
148921832|NCT00167778|537197668|FG000|Overall Study|Withdrawal by Subject|1|||
148921833|NCT02654717|537197669|FG000|Overall Study|Adverse Event|2|||
148921834|NCT02654717|537197670|FG001|Overall Study|Adverse Event|2|||
148921835|NCT02654717|537197669|FG000|Overall Study|Protocol Violation|1|||
148921836|NCT02654717|537197670|FG001|Overall Study|Protocol Violation|2|||
148921837|NCT02654717|537197669|FG000|Overall Study|Withdrawal by Subject|0|||
148921838|NCT02654717|537197670|FG001|Overall Study|Withdrawal by Subject|1|||
148921839|NCT02654717|537197669|FG000|Overall Study|Non-permitted medication|3|||
148921840|NCT02654717|537197670|FG001|Overall Study|Non-permitted medication|0|||
148921841|NCT03603509|537199281|FG000|Overall Study|Lost to Follow-up|3|||
148921842|NCT03603509|537199282|FG001|Overall Study|Lost to Follow-up|4|||
148921843|NCT00773383|537199284|FG000|Overall Study|Adverse Event|4|||
148921844|NCT00773383|537199284|FG000|Overall Study|Death|1|||
149157410|NCT01543087|538051840|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
149157411|NCT01543087|538051841|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
148673547|NCT03359473|536275778|FG001|Overall Study|Physician Decision|1|||
148921845|NCT00773383|537199284|FG000|Overall Study|Progression of Disease|23|||
148921846|NCT00773383|537199284|FG000|Overall Study|Other|2|||
148921847|NCT00773383|537199284|FG000|Overall Study|No study dose received|1|||
148921848|NCT03811093|537199289|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
148921849|NCT03811093|537199290|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
148921850|NCT03811093|537199289|FG000|Overall Study|Unable to measure body fat percentage|2|||
148921851|NCT03811093|537199290|FG001|Overall Study|Unable to measure body fat percentage|0|||
148921852|NCT01095094|537199291|FG000|Overall Study|Withdrawal by Subject|1|||
148921853|NCT01095094|537199291|FG000|Overall Study|Death|1|||
148921854|NCT01095094|537199291|FG000|Overall Study|Physician Decision|1|||
148921855|NCT03699475|537199293|FG000|Overall Study|Death|1|||
148921856|NCT00137839|537199294|FG000|Overall Study|Adverse Event|7|||
148921857|NCT00137839|537199294|FG000|Overall Study|Physician Decision|7|||
148921858|NCT00137839|537199294|FG000|Overall Study|Death|8|||
148921859|NCT00137839|537199294|FG000|Overall Study|Disease Progression|60|||
148921860|NCT00137839|537199294|FG000|Overall Study|Not Start Treatment|1|||
148921861|NCT00137839|537199294|FG000|Overall Study|Prolonged Treatment Delay|1|||
148921862|NCT01122394|537199295|FG000|Overall Study|Withdrawal by Subject|1|||
148921863|NCT01122394|537199296|FG001|Overall Study|Withdrawal by Subject|1|||
148921864|NCT01122394|537199295|FG000|Overall Study|Lost to Follow-up|2|||
148921865|NCT01122394|537199296|FG001|Overall Study|Lost to Follow-up|2|||
148921866|NCT01122394|537199295|FG000|Overall Study|Adverse Event|0|||
148921867|NCT01122394|537199296|FG001|Overall Study|Adverse Event|1|||
148921868|NCT00640835|537199297|FG000|Overall Study|Adverse Event|5|||
148921869|NCT00640835|537199298|FG001|Overall Study|Adverse Event|3|||
148921870|NCT00640835|537199297|FG000|Overall Study|Withdrawal by Subject|12|||
148921871|NCT00640835|537199298|FG001|Overall Study|Withdrawal by Subject|14|||
148921872|NCT00640835|537199297|FG000|Overall Study|Physician Decision|10|||
148921873|NCT00640835|537199298|FG001|Overall Study|Physician Decision|14|||
148921874|NCT00640835|537199297|FG000|Overall Study|Sponsor's Decision|11|||
148921875|NCT00640835|537199298|FG001|Overall Study|Sponsor's Decision|7|||
148921876|NCT00640835|537199297|FG000|Overall Study|Protocol Violation|2|||
148921877|NCT00640835|537199298|FG001|Overall Study|Protocol Violation|2|||
148921878|NCT00640835|537199297|FG000|Overall Study|Lost to Follow-up|17|||
148921879|NCT00640835|537199298|FG001|Overall Study|Lost to Follow-up|13|||
148921880|NCT00640835|537199297|FG000|Overall Study|Other Reason|19|||
148921881|NCT00640835|537199298|FG001|Overall Study|Other Reason|4|||
148921882|NCT00775203|537199299|FG000|Overall Study|Adverse Event|25|||
148921883|NCT00775203|537199300|FG001|Overall Study|Adverse Event|6|||
148921884|NCT00775203|537199299|FG000|Overall Study|Lack of Efficacy|8|||
148921885|NCT00775203|537199300|FG001|Overall Study|Lack of Efficacy|9|||
148921886|NCT00775203|537199299|FG000|Overall Study|Withdrawal by Subject|11|||
148921887|NCT00775203|537199300|FG001|Overall Study|Withdrawal by Subject|9|||
148921888|NCT00775203|537199299|FG000|Overall Study|Lost to Follow-up|11|||
148921889|NCT00775203|537199300|FG001|Overall Study|Lost to Follow-up|15|||
148921890|NCT00775203|537199299|FG000|Overall Study|Administrative reason|2|||
148673548|NCT03359473|536275779|FG002|Overall Study|Physician Decision|0|||
148673549|NCT03359473|536275780|FG003|Overall Study|Physician Decision|1|||
148673550|NCT03359473|536275777|FG000|Overall Study|Withdrawal by Subject|1|||
148673551|NCT03359473|536275778|FG001|Overall Study|Withdrawal by Subject|2|||
148673552|NCT03359473|536275779|FG002|Overall Study|Withdrawal by Subject|1|||
148673553|NCT03359473|536275780|FG003|Overall Study|Withdrawal by Subject|0|||
148673554|NCT03359473|536275777|FG000|Overall Study|Protocol-defined stopping criteria|1|||
148921891|NCT00775203|537199300|FG001|Overall Study|Administrative reason|0|||
148921892|NCT00775203|537199299|FG000|Overall Study|Noncompliance|4|||
148921893|NCT00775203|537199300|FG001|Overall Study|Noncompliance|2|||
148921894|NCT00775203|537199299|FG000|Overall Study|Protocol Violation|0|||
148921895|NCT00775203|537199300|FG001|Overall Study|Protocol Violation|1|||
148921896|NCT00775203|537199299|FG000|Overall Study|Entered other study|1|||
148921897|NCT00775203|537199300|FG001|Overall Study|Entered other study|0|||
148921898|NCT00775203|537199299|FG000|Overall Study|Physician Decision|0|||
148921899|NCT00775203|537199300|FG001|Overall Study|Physician Decision|1|||
148673555|NCT03359473|536275778|FG001|Overall Study|Protocol-defined stopping criteria|0|||
148673556|NCT03359473|536275779|FG002|Overall Study|Protocol-defined stopping criteria|0|||
148921900|NCT00704522|537199301|FG000|Overall Study|Lack of Efficacy|65|||
148921901|NCT00704522|537199302|FG001|Overall Study|Lack of Efficacy|17|||
148921902|NCT00704522|537199301|FG000|Overall Study|Failure to appear again at hospital|56|||
148921903|NCT00704522|537199302|FG001|Overall Study|Failure to appear again at hospital|10|||
148921904|NCT00704522|537199301|FG000|Overall Study|Withdrawal by Subject|17|||
148921905|NCT00704522|537199302|FG001|Overall Study|Withdrawal by Subject|8|||
148921906|NCT00704522|537199301|FG000|Overall Study|Adverse Event|9|||
148921907|NCT00704522|537199302|FG001|Overall Study|Adverse Event|1|||
148921908|NCT00704522|537199301|FG000|Overall Study|Undefined causes|9|||
148921909|NCT00704522|537199302|FG001|Overall Study|Undefined causes|7|||
148921910|NCT00704522|537199301|FG000|Overall Study|No information on therapy end|27|||
148921911|NCT00704522|537199302|FG001|Overall Study|No information on therapy end|2|||
148921912|NCT04896229|537199303|FG000|Overall Study|Lost to Follow-up|113|||
148921913|NCT04896229|537199304|FG001|Overall Study|Lost to Follow-up|113|||
148673557|NCT03359473|536275780|FG003|Overall Study|Protocol-defined stopping criteria|1|||
148921914|NCT00045942|537199305|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
148921915|NCT00045942|537199306|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921916|NCT00045942|537199307|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921917|NCT00045942|537199308|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921918|NCT00045942|537199309|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921919|NCT00045942|537199310|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921920|NCT00045942|537199311|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921921|NCT00045942|537199312|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921922|NCT00045942|537199313|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
148921923|NCT00045942|537199305|FG000|PKC412A2104 (Core)|Adverse Event|5|||
148921924|NCT00045942|537199306|FG001|PKC412A2104 (Core)|Adverse Event|0|||
148921925|NCT00045942|537199307|FG002|PKC412A2104 (Core)|Adverse Event|0|||
148921926|NCT00045942|537199308|FG003|PKC412A2104 (Core)|Adverse Event|0|||
148921927|NCT00045942|537199309|FG004|PKC412A2104 (Core)|Adverse Event|0|||
148921928|NCT00045942|537199310|FG005|PKC412A2104 (Core)|Adverse Event|0|||
148921929|NCT00045942|537199311|FG006|PKC412A2104 (Core)|Adverse Event|0|||
148921930|NCT00045942|537199312|FG007|PKC412A2104 (Core)|Adverse Event|0|||
148921931|NCT00045942|537199313|FG008|PKC412A2104 (Core)|Adverse Event|0|||
148921932|NCT00045942|537199305|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
148921933|NCT00045942|537199306|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921934|NCT00045942|537199307|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921935|NCT00045942|537199308|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921936|NCT00045942|537199309|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921937|NCT00045942|537199310|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921938|NCT00045942|537199311|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921939|NCT00045942|537199312|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921940|NCT00045942|537199313|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
148921941|NCT00045942|537199305|FG000|PKC412A2104 (Core)|Death|1|||
148921942|NCT00045942|537199306|FG001|PKC412A2104 (Core)|Death|0|||
148921943|NCT00045942|537199307|FG002|PKC412A2104 (Core)|Death|0|||
148921944|NCT00045942|537199308|FG003|PKC412A2104 (Core)|Death|0|||
148921945|NCT00045942|537199309|FG004|PKC412A2104 (Core)|Death|0|||
148921946|NCT00045942|537199310|FG005|PKC412A2104 (Core)|Death|0|||
148921947|NCT00045942|537199311|FG006|PKC412A2104 (Core)|Death|0|||
148921948|NCT00045942|537199312|FG007|PKC412A2104 (Core)|Death|0|||
148921949|NCT00045942|537199313|FG008|PKC412A2104 (Core)|Death|0|||
148921950|NCT00045942|537199305|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
148921951|NCT00045942|537199306|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
148921952|NCT00045942|537199307|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
148921953|NCT00045942|537199308|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
148921954|NCT00045942|537199309|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
148921955|NCT00045942|537199310|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
148921956|NCT00045942|537199311|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
148921957|NCT00045942|537199312|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
148921958|NCT00045942|537199313|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
148921959|NCT00045942|537199305|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
148921960|NCT00045942|537199306|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
149157412|NCT01543087|538051842|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
149157413|NCT01543087|538051837|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
149157414|NCT01543087|538051838|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
149157415|NCT01543087|538051839|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
148921961|NCT00045942|537199307|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
148921962|NCT00045942|537199308|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
148921963|NCT00045942|537199309|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
148921964|NCT00045942|537199310|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
148921965|NCT00045942|537199311|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
148921966|NCT00045942|537199312|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
148921967|NCT00045942|537199313|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
148921968|NCT00045942|537199305|FG000|PKC412A2104E1|Lack of Efficacy|0|||
148921969|NCT00045942|537199306|FG001|PKC412A2104E1|Lack of Efficacy|11|||
148921970|NCT00045942|537199307|FG002|PKC412A2104E1|Lack of Efficacy|11|||
148921971|NCT00045942|537199308|FG003|PKC412A2104E1|Lack of Efficacy|23|||
148921972|NCT00045942|537199309|FG004|PKC412A2104E1|Lack of Efficacy|17|||
148921973|NCT00045942|537199310|FG005|PKC412A2104E1|Lack of Efficacy|0|||
148921974|NCT00045942|537199311|FG006|PKC412A2104E1|Lack of Efficacy|0|||
148921975|NCT00045942|537199312|FG007|PKC412A2104E1|Lack of Efficacy|0|||
149157416|NCT01543087|538051840|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
148921976|NCT00045942|537199313|FG008|PKC412A2104E1|Lack of Efficacy|0|||
148921977|NCT00045942|537199305|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
149157417|NCT01543087|538051841|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
149157418|NCT01543087|538051842|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
149157419|NCT01543087|538051837|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
149157420|NCT01543087|538051838|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
149157421|NCT01543087|538051839|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
149157422|NCT01543087|538051840|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
149157423|NCT01543087|538051841|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
149157424|NCT01543087|538051842|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
148921978|NCT00045942|537199306|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
148921979|NCT00045942|537199307|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
148921980|NCT00045942|537199308|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
148921981|NCT00045942|537199309|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
148921982|NCT00045942|537199310|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
148921983|NCT00045942|537199311|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
148921984|NCT00045942|537199312|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
148921985|NCT00045942|537199313|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
148921986|NCT00045942|537199305|FG000|PKC412A2104E1|Adverse Event|0|||
148921987|NCT00045942|537199306|FG001|PKC412A2104E1|Adverse Event|1|||
148921988|NCT00045942|537199307|FG002|PKC412A2104E1|Adverse Event|1|||
148921989|NCT00045942|537199308|FG003|PKC412A2104E1|Adverse Event|3|||
148921990|NCT00045942|537199309|FG004|PKC412A2104E1|Adverse Event|6|||
148921991|NCT00045942|537199310|FG005|PKC412A2104E1|Adverse Event|0|||
148921992|NCT00045942|537199311|FG006|PKC412A2104E1|Adverse Event|0|||
148921993|NCT00045942|537199312|FG007|PKC412A2104E1|Adverse Event|0|||
148921994|NCT00045942|537199313|FG008|PKC412A2104E1|Adverse Event|0|||
148921995|NCT00045942|537199305|FG000|PKC412A2104E1|Death|0|||
148921996|NCT00045942|537199306|FG001|PKC412A2104E1|Death|4|||
148921997|NCT00045942|537199307|FG002|PKC412A2104E1|Death|1|||
148921998|NCT00045942|537199308|FG003|PKC412A2104E1|Death|1|||
148921999|NCT00045942|537199309|FG004|PKC412A2104E1|Death|1|||
148922000|NCT00045942|537199310|FG005|PKC412A2104E1|Death|0|||
148922001|NCT00045942|537199311|FG006|PKC412A2104E1|Death|0|||
148922002|NCT00045942|537199312|FG007|PKC412A2104E1|Death|0|||
148922003|NCT00045942|537199313|FG008|PKC412A2104E1|Death|0|||
148922004|NCT00045942|537199305|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148922005|NCT00045942|537199306|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148922006|NCT00045942|537199307|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
148922007|NCT00045942|537199308|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
148922008|NCT00045942|537199309|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148922009|NCT00045942|537199310|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148673558|NCT05302414|536275781|FG000|Pretest to Posttest|Lost to Follow-up|12|||
148673559|NCT05302414|536275782|FG001|Pretest to Posttest|Lost to Follow-up|8|||
148673560|NCT05302414|536275783|FG002|Pretest to Posttest|Lost to Follow-up|8|||
148673561|NCT05302414|536275781|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
148673562|NCT05302414|536275782|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
148673563|NCT05302414|536275783|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
148673564|NCT03020966|536275784|FG000|Overall Study|Withdrawal by Subject|2|||
148673565|NCT03020966|536275785|FG001|Overall Study|Withdrawal by Subject|0|||
148673566|NCT00962013|536275793|FG000|Overall Study|Did not have surgery|1|||
148673567|NCT00962013|536275793|FG000|Overall Study|Death|8|||
148673568|NCT00962013|536275793|FG000|Overall Study|Lost to Follow-up|12|||
148922010|NCT00045942|537199311|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148922011|NCT00045942|537199312|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148922012|NCT00045942|537199313|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
148922013|NCT00045942|537199305|FG000|PKC412A2104E2|Lost to Follow-up|0|||
148922014|NCT00045942|537199306|FG001|PKC412A2104E2|Lost to Follow-up|0|||
148922015|NCT00045942|537199307|FG002|PKC412A2104E2|Lost to Follow-up|0|||
148922016|NCT00045942|537199308|FG003|PKC412A2104E2|Lost to Follow-up|0|||
148922017|NCT00045942|537199309|FG004|PKC412A2104E2|Lost to Follow-up|0|||
148922018|NCT00045942|537199310|FG005|PKC412A2104E2|Lost to Follow-up|0|||
148922019|NCT00045942|537199311|FG006|PKC412A2104E2|Lost to Follow-up|0|||
148922020|NCT00045942|537199312|FG007|PKC412A2104E2|Lost to Follow-up|3|||
148922021|NCT00045942|537199313|FG008|PKC412A2104E2|Lost to Follow-up|0|||
148922022|NCT00045942|537199305|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
148922023|NCT00045942|537199306|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
148673569|NCT00962013|536275793|FG000|Overall Study|Unable/Unwilling to return|6|||
148673570|NCT00962013|536275793|FG000|Overall Study|Withdrawal by Subject|8|||
148673571|NCT00962013|536275793|FG000|Overall Study|Removal of study device|3|||
148673572|NCT00962013|536275793|FG000|Overall Study|Site Termination|24|||
148922024|NCT00045942|537199307|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
148922025|NCT00045942|537199308|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
148922026|NCT00045942|537199309|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
148922027|NCT00045942|537199310|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
148922028|NCT00045942|537199311|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
148922029|NCT00045942|537199312|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
148922030|NCT00045942|537199313|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
148922031|NCT00045942|537199305|FG000|PKC412A2104E2|Lack of Efficacy|0|||
148922032|NCT00045942|537199306|FG001|PKC412A2104E2|Lack of Efficacy|0|||
148922033|NCT00045942|537199307|FG002|PKC412A2104E2|Lack of Efficacy|0|||
148922034|NCT00045942|537199308|FG003|PKC412A2104E2|Lack of Efficacy|0|||
148922035|NCT00045942|537199309|FG004|PKC412A2104E2|Lack of Efficacy|0|||
148922036|NCT00045942|537199310|FG005|PKC412A2104E2|Lack of Efficacy|3|||
148922037|NCT00045942|537199311|FG006|PKC412A2104E2|Lack of Efficacy|2|||
148922038|NCT00045942|537199312|FG007|PKC412A2104E2|Lack of Efficacy|2|||
148922039|NCT00045942|537199313|FG008|PKC412A2104E2|Lack of Efficacy|6|||
148922040|NCT00045942|537199305|FG000|PKC412A2104E2|Adverse Event|0|||
148922041|NCT00045942|537199306|FG001|PKC412A2104E2|Adverse Event|0|||
148922042|NCT00045942|537199307|FG002|PKC412A2104E2|Adverse Event|0|||
148922043|NCT00045942|537199308|FG003|PKC412A2104E2|Adverse Event|0|||
148922044|NCT00045942|537199309|FG004|PKC412A2104E2|Adverse Event|0|||
148922045|NCT00045942|537199310|FG005|PKC412A2104E2|Adverse Event|4|||
148922046|NCT00045942|537199311|FG006|PKC412A2104E2|Adverse Event|3|||
148922047|NCT00045942|537199312|FG007|PKC412A2104E2|Adverse Event|1|||
148922048|NCT00045942|537199313|FG008|PKC412A2104E2|Adverse Event|0|||
148922049|NCT00045942|537199305|FG000|PKC412A2104E2|Death|0|||
148922050|NCT00045942|537199306|FG001|PKC412A2104E2|Death|0|||
148922051|NCT00045942|537199307|FG002|PKC412A2104E2|Death|0|||
148922052|NCT00045942|537199308|FG003|PKC412A2104E2|Death|0|||
148922053|NCT00045942|537199309|FG004|PKC412A2104E2|Death|0|||
148922054|NCT00045942|537199310|FG005|PKC412A2104E2|Death|1|||
148922055|NCT00045942|537199311|FG006|PKC412A2104E2|Death|2|||
148922056|NCT00045942|537199312|FG007|PKC412A2104E2|Death|0|||
148922057|NCT00045942|537199313|FG008|PKC412A2104E2|Death|0|||
148922058|NCT01209832|537199317|FG000|Period 1|Sponsor Decision and was not dosed|1|||
148922059|NCT01209832|537199317|FG000|Period 2|Sponsor Decision|1|||
148922060|NCT01268579|537199318|FG000|Overall Study|Adverse Event|1|||
148922061|NCT01268579|537199318|FG000|Overall Study|Withdrawal by Subject|2|||
148922062|NCT02692651|537199319|FG000|Study Treatment|Death|7|||
148922063|NCT02692651|537199320|FG001|Study Treatment|Death|3|||
148922064|NCT02692651|537199319|FG000|Study Treatment|comfort care|1|||
148922065|NCT02692651|537199320|FG001|Study Treatment|comfort care|1|||
148922066|NCT02692651|537199319|FG000|Study Treatment|Protocol violation per treating team preference|8|||
148922067|NCT02692651|537199320|FG001|Study Treatment|Protocol violation per treating team preference|6|||
148922068|NCT02692651|537199319|FG000|Post Study Treatment Follow-up|Death|4|||
148922069|NCT02692651|537199320|FG001|Post Study Treatment Follow-up|Death|4|||
148922070|NCT03490981|537199321|FG000|Overall Study|Lost to Follow-up|1|||
148922071|NCT03490981|537199322|FG001|Overall Study|Lost to Follow-up|2|||
148922072|NCT02480712|537199323|FG000|Overall Study|Enrolled but Never Treated|1|||
148922073|NCT02480712|537199323|FG000|Overall Study|Lost to Follow-up|5|||
148922074|NCT02480712|537199323|FG000|Overall Study|Withdrew Consent|3|||
148922075|NCT02480712|537199323|FG000|Overall Study|Death|1|||
148922076|NCT02480712|537199323|FG000|Overall Study|Lack of Efficacy|1|||
148922077|NCT05463198|537199330|FG000|Overall Study|Withdrawal by Subject|19|||
148922078|NCT05463198|537199330|FG000|Overall Study|Procedure Notes Missing|18|||
148922079|NCT01860846|537199331|FG000|Overall Study|Lost to Follow-up|33|||
148922080|NCT02239120|537199334|FG000|Overall Study|Death|56|||
148922081|NCT02239120|537199335|FG001|Overall Study|Death|58|||
148922082|NCT02239120|537199334|FG000|Overall Study|Lost to Follow-up|19|||
148922083|NCT02239120|537199335|FG001|Overall Study|Lost to Follow-up|14|||
148922084|NCT00466687|537199336|FG000|Overall Study|Adverse Event|1|||
148922085|NCT00466687|537199336|FG000|Overall Study|Other complicating illness|3|||
148922086|NCT00466687|537199336|FG000|Overall Study|Withdrawal by Subject|1|||
148922087|NCT00466687|537199336|FG000|Overall Study|Disease progression|29|||
148922088|NCT00046891|537199339|FG000|Overall Study|Cancels|5|||
148922089|NCT00046891|537199340|FG001|Overall Study|Cancels|9|||
148922090|NCT00046891|537199339|FG000|Overall Study|Ineligible|1|||
148922091|NCT00046891|537199340|FG001|Overall Study|Ineligible|1|||
148922092|NCT00046891|537199339|FG000|Overall Study|Withdrawal by Subject|18|||
148922093|NCT00046891|537199340|FG001|Overall Study|Withdrawal by Subject|15|||
148922094|NCT00046891|537199339|FG000|Overall Study|Adverse Event|5|||
148922095|NCT00046891|537199340|FG001|Overall Study|Adverse Event|5|||
148922096|NCT00420641|537199343|FG000|Overall Study|Adverse Event|3|||
148922097|NCT00420641|537199344|FG001|Overall Study|Adverse Event|25|||
148922098|NCT00420641|537199345|FG002|Overall Study|Adverse Event|10|||
148922099|NCT00420641|537199343|FG000|Overall Study|Lost to Follow-up|2|||
148922100|NCT00420641|537199344|FG001|Overall Study|Lost to Follow-up|4|||
148922101|NCT00420641|537199345|FG002|Overall Study|Lost to Follow-up|2|||
148922102|NCT00420641|537199343|FG000|Overall Study|Protocol Violation|8|||
148922103|NCT00420641|537199344|FG001|Overall Study|Protocol Violation|8|||
148922104|NCT00420641|537199345|FG002|Overall Study|Protocol Violation|7|||
148922105|NCT00420641|537199343|FG000|Overall Study|Withdrawal by Subject|15|||
148922106|NCT00420641|537199344|FG001|Overall Study|Withdrawal by Subject|21|||
148922107|NCT00420641|537199345|FG002|Overall Study|Withdrawal by Subject|14|||
148922108|NCT00420641|537199343|FG000|Overall Study|Lack of Efficacy|6|||
148922109|NCT00420641|537199344|FG001|Overall Study|Lack of Efficacy|5|||
148922110|NCT00420641|537199345|FG002|Overall Study|Lack of Efficacy|4|||
148922111|NCT00420641|537199343|FG000|Overall Study|Non-compliance|7|||
148922112|NCT00420641|537199344|FG001|Overall Study|Non-compliance|5|||
148922113|NCT00420641|537199345|FG002|Overall Study|Non-compliance|4|||
148922114|NCT00420641|537199343|FG000|Overall Study|Other|4|||
148922115|NCT00420641|537199344|FG001|Overall Study|Other|4|||
148922116|NCT00420641|537199345|FG002|Overall Study|Other|3|||
148922117|NCT03459690|537199351|FG000|Overall Study|Lost to Follow-up|0|||
148922118|NCT03459690|537199352|FG001|Overall Study|Lost to Follow-up|1|||
148922119|NCT03459690|537199351|FG000|Overall Study|Withdrawal by Subject|1|||
148922120|NCT03459690|537199352|FG001|Overall Study|Withdrawal by Subject|1|||
148922121|NCT02586506|537199353|FG000|Overall Study|Protocol Violation|6|||
148922122|NCT02586506|537199353|FG000|Overall Study|Lost to Follow-up|1|||
148922123|NCT02586506|537199353|FG000|Overall Study|Other Reason|2|||
148922124|NCT02536404|537199357|FG000|Overall Study|Adverse Event|5|||
148922125|NCT02536404|537199358|FG001|Overall Study|Adverse Event|0|||
148922126|NCT02536404|537199357|FG000|Overall Study|Withdrawal by Subject|4|||
148922127|NCT02536404|537199358|FG001|Overall Study|Withdrawal by Subject|1|||
148922128|NCT02536404|537199357|FG000|Overall Study|Physician Decision|10|||
148922129|NCT02536404|537199358|FG001|Overall Study|Physician Decision|0|||
148922130|NCT02536404|537199357|FG000|Overall Study|Sponsor decision|1|||
148922131|NCT02536404|537199358|FG001|Overall Study|Sponsor decision|0|||
148922132|NCT02158364|537199359|FG000|Overall Study|Case report forms uncollected|10|||
148922133|NCT02158364|537199359|FG000|Overall Study|Protocol Deviation|50|||
148922134|NCT01944839|537199360|FG000|Overall Study|Physician Decision|2|||
148922135|NCT01944839|537199361|FG001|Overall Study|Physician Decision|2|||
148922136|NCT01944839|537199360|FG000|Overall Study|Protocol Violation|0|||
148922137|NCT01944839|537199361|FG001|Overall Study|Protocol Violation|1|||
148922138|NCT01944839|537199360|FG000|Overall Study|Adverse Event|10|||
148922139|NCT01944839|537199361|FG001|Overall Study|Adverse Event|5|||
148922140|NCT01944839|537199360|FG000|Overall Study|Withdrawal by Subject|9|||
148922141|NCT01944839|537199361|FG001|Overall Study|Withdrawal by Subject|17|||
148922142|NCT01944839|537199360|FG000|Overall Study|Lost to Follow-up|1|||
148922143|NCT01944839|537199361|FG001|Overall Study|Lost to Follow-up|0|||
148922144|NCT01944839|537199360|FG000|Overall Study|Subject non-compliance|0|||
148922145|NCT01944839|537199361|FG001|Overall Study|Subject non-compliance|3|||
148922146|NCT00609362|537199362|FG000|Overall Study|Withdrawal by Subject|2|||
148922147|NCT00609362|537199363|FG001|Overall Study|Withdrawal by Subject|1|||
148922148|NCT00609362|537199362|FG000|Overall Study|Adverse Event|1|||
148922149|NCT00609362|537199363|FG001|Overall Study|Adverse Event|0|||
148922150|NCT05093790|537199364|FG000|Overall Study|Failure to meet continuation criteria|0|||
148922151|NCT05093790|537199365|FG001|Overall Study|Failure to meet continuation criteria|0|||
148922152|NCT05093790|537199366|FG002|Overall Study|Failure to meet continuation criteria|1|||
148922153|NCT05093790|537199367|FG003|Overall Study|Failure to meet continuation criteria|0|||
148922154|NCT05093790|537199364|FG000|Overall Study|Adverse Event|1|||
148922155|NCT05093790|537199365|FG001|Overall Study|Adverse Event|0|||
148922156|NCT05093790|537199366|FG002|Overall Study|Adverse Event|0|||
148922157|NCT05093790|537199367|FG003|Overall Study|Adverse Event|0|||
148922158|NCT01239732|537199372|FG000|Overall Study|Termination of study per protocol|667|||
148922159|NCT01239732|537199372|FG000|Overall Study|Death|226|||
148922160|NCT01239732|537199372|FG000|Overall Study|Withdrawal by Subject|87|||
148922161|NCT01239732|537199372|FG000|Overall Study|Adverse Event|6|||
148922162|NCT01239732|537199372|FG000|Overall Study|Protocol Violation|3|||
148922163|NCT01239732|537199372|FG000|Overall Study|Participant non compliance|5|||
148922164|NCT01239732|537199372|FG000|Overall Study|Study termination by sponsor|2|||
148922165|NCT01239732|537199372|FG000|Overall Study|Investigator's decision|4|||
148922166|NCT01239732|537199372|FG000|Overall Study|Treatment failure|2|||
148922167|NCT01239732|537199372|FG000|Overall Study|Other|19|||
148922168|NCT01381562|537199373|FG000|Overall Study|Adverse Event|0|||
148922169|NCT01381562|537199374|FG001|Overall Study|Adverse Event|1|||
148922170|NCT01381562|537199375|FG002|Overall Study|Adverse Event|0|||
148922171|NCT00308581|537199379|FG000|Induction Phase|Adverse Event|0|||
148922172|NCT00308581|537199380|FG001|Induction Phase|Adverse Event|0|||
148922173|NCT00308581|537199381|FG002|Induction Phase|Adverse Event|37|||
148922174|NCT00308581|537199379|FG000|Induction Phase|Lack of Efficacy|0|||
148922175|NCT00308581|537199380|FG001|Induction Phase|Lack of Efficacy|0|||
148922176|NCT00308581|537199381|FG002|Induction Phase|Lack of Efficacy|121|||
148922177|NCT00308581|537199379|FG000|Induction Phase|Withdrawal by Subject|0|||
149157425|NCT04673786|538051843|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
149157426|NCT04673786|538051844|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
149157427|NCT04673786|538051845|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
149157428|NCT04673786|538051843|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
149157429|NCT04673786|538051844|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
149157430|NCT04673786|538051845|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
149157431|NCT04673786|538051843|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
149157432|NCT04673786|538051844|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
149157433|NCT04673786|538051845|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
149157434|NCT04673786|538051843|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
149157435|NCT04673786|538051844|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
149157436|NCT04673786|538051845|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
149157437|NCT04673786|538051843|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
149157438|NCT04673786|538051844|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
148922178|NCT00308581|537199380|FG001|Induction Phase|Withdrawal by Subject|0|||
148922179|NCT00308581|537199381|FG002|Induction Phase|Withdrawal by Subject|5|||
148922180|NCT00308581|537199379|FG000|Induction Phase|Unknown reason|0|||
148922181|NCT00308581|537199380|FG001|Induction Phase|Unknown reason|0|||
148922182|NCT00308581|537199381|FG002|Induction Phase|Unknown reason|3|||
148922183|NCT00308581|537199379|FG000|Randomized Maintenance Phase|Adverse Event|10|||
148922184|NCT00308581|537199380|FG001|Randomized Maintenance Phase|Adverse Event|17|||
149157439|NCT04673786|538051845|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
149157440|NCT04673786|538051843|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
149157441|NCT04673786|538051844|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
149157442|NCT04673786|538051845|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
149157443|NCT00143455|538051846|FG000|Cohort 1|Adverse Event|8|||
149157444|NCT00143455|538051847|FG001|Cohort 1|Adverse Event|4|||
148922185|NCT00308581|537199381|FG002|Randomized Maintenance Phase|Adverse Event|0|||
148922186|NCT00308581|537199379|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
148922187|NCT00308581|537199380|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
148922188|NCT00308581|537199381|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
148922189|NCT00308581|537199379|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
148922190|NCT00308581|537199380|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
149157445|NCT00143455|538051848|FG002|Cohort 1|Adverse Event|0|||
149157446|NCT00143455|538051849|FG003|Cohort 1|Adverse Event|0|||
149157447|NCT00143455|538051846|FG000|Cohort 1|Death|5|||
148673573|NCT00962013|536275793|FG000|Overall Study|No 5 year evaluation|6|||
148673574|NCT00424632|536275796|FG000|Overall Study|Death|0|||
148673575|NCT00424632|536275797|FG001|Overall Study|Death|0|||
148922191|NCT00308581|537199381|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
148922192|NCT00308581|537199379|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
148922193|NCT00308581|537199380|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
148922194|NCT00308581|537199381|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
148922195|NCT00308581|537199379|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
148922196|NCT00308581|537199380|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
148922197|NCT00308581|537199381|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
148922198|NCT00308581|537199379|FG000|Randomized Maintenance Phase|Unknown reason|3|||
148922199|NCT00308581|537199380|FG001|Randomized Maintenance Phase|Unknown reason|0|||
148922200|NCT00308581|537199381|FG002|Randomized Maintenance Phase|Unknown reason|0|||
148922201|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
148922202|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
148922203|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
148922204|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
148922205|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
148922206|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
148922207|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
148922208|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
148922209|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
148922210|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
148922211|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
148922212|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
148922213|NCT01087788|537199382|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
148922214|NCT01087788|537199383|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
148922215|NCT01087788|537199384|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
148922216|NCT01087788|537199382|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
148922217|NCT01087788|537199383|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
148922218|NCT01087788|537199384|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
148922219|NCT01087788|537199382|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
148922220|NCT01087788|537199383|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
148922221|NCT01087788|537199384|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
148922222|NCT01087788|537199382|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
148922223|NCT01087788|537199383|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
148922224|NCT01087788|537199384|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
148922225|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
148922226|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
148922227|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
148922228|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
148922229|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
148922230|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
148922231|NCT01087788|537199382|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
148922232|NCT01087788|537199383|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
148922233|NCT01087788|537199384|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
148922234|NCT01087788|537199382|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
148922235|NCT01087788|537199383|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
148922236|NCT01087788|537199384|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
148922237|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
148922238|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
148922239|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
148922240|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
148922241|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
148922242|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
148922243|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
148922244|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
148922245|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
148922246|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
148922247|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
148922248|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
149157448|NCT00143455|538051847|FG001|Cohort 1|Death|2|||
149157449|NCT00143455|538051848|FG002|Cohort 1|Death|0|||
149157450|NCT00143455|538051849|FG003|Cohort 1|Death|0|||
149157451|NCT00143455|538051846|FG000|Cohort 1|Progressive Disease|0|||
149157452|NCT00143455|538051847|FG001|Cohort 1|Progressive Disease|6|||
149157453|NCT00143455|538051848|FG002|Cohort 1|Progressive Disease|0|||
149157454|NCT00143455|538051849|FG003|Cohort 1|Progressive Disease|0|||
149157455|NCT00143455|538051846|FG000|Cohort 1|Withdrawal by Subject|1|||
149157456|NCT00143455|538051847|FG001|Cohort 1|Withdrawal by Subject|4|||
149157457|NCT00143455|538051848|FG002|Cohort 1|Withdrawal by Subject|0|||
149157458|NCT00143455|538051849|FG003|Cohort 1|Withdrawal by Subject|0|||
149157459|NCT00143455|538051846|FG000|Cohort 1|Randomized But Not Treated|0|||
149157460|NCT00143455|538051847|FG001|Cohort 1|Randomized But Not Treated|1|||
149157461|NCT00143455|538051848|FG002|Cohort 1|Randomized But Not Treated|0|||
149157462|NCT00143455|538051849|FG003|Cohort 1|Randomized But Not Treated|0|||
149157463|NCT00143455|538051846|FG000|Cohort 2|Adverse Event|0|||
149157464|NCT00143455|538051847|FG001|Cohort 2|Adverse Event|0|||
149157465|NCT00143455|538051848|FG002|Cohort 2|Adverse Event|42|||
149157466|NCT00143455|538051849|FG003|Cohort 2|Adverse Event|30|||
149157467|NCT00143455|538051846|FG000|Cohort 2|No Longer Required Study Treatment|0|||
149157468|NCT00143455|538051847|FG001|Cohort 2|No Longer Required Study Treatment|0|||
149157469|NCT00143455|538051848|FG002|Cohort 2|No Longer Required Study Treatment|1|||
149157470|NCT00143455|538051849|FG003|Cohort 2|No Longer Required Study Treatment|0|||
148922249|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
148922250|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
148922251|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
148922252|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
148922253|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
148922254|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
148922255|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
148922256|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
148922257|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
148922258|NCT01087788|537199382|FG000|24-weeks Dose-blind Period|Patient moved|0|||
148922259|NCT01087788|537199383|FG001|24-weeks Dose-blind Period|Patient moved|0|||
148922260|NCT01087788|537199384|FG002|24-weeks Dose-blind Period|Patient moved|1|||
148922261|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
148922262|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
148922263|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
149157471|NCT00143455|538051846|FG000|Cohort 2|Protocol Violation|0|||
149157472|NCT00143455|538051847|FG001|Cohort 2|Protocol Violation|0|||
149157473|NCT00143455|538051848|FG002|Cohort 2|Protocol Violation|1|||
148922264|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
149157474|NCT00143455|538051849|FG003|Cohort 2|Protocol Violation|1|||
148922265|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
148922266|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
148922267|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
148922268|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
148922269|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
148922270|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
148922271|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
148922272|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
148922273|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
148922274|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
148922275|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
148922276|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
148922277|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
148922278|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
148922279|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
148922280|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
148922281|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
148922282|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
148922283|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
148922284|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
148922285|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
148922286|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
148922287|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
148922288|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
148922289|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
148922290|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
148922291|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
148922292|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
148922293|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
148922294|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
148922295|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
148922296|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
148922297|NCT01087788|537199382|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
148922298|NCT01087788|537199383|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
148922299|NCT01087788|537199384|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
149157475|NCT00143455|538051846|FG000|Cohort 2|Lost to Follow-up|0|||
149157476|NCT00143455|538051847|FG001|Cohort 2|Lost to Follow-up|0|||
149157477|NCT00143455|538051848|FG002|Cohort 2|Lost to Follow-up|1|||
149157478|NCT00143455|538051849|FG003|Cohort 2|Lost to Follow-up|4|||
149157479|NCT00143455|538051846|FG000|Cohort 2|Death|0|||
149157480|NCT00143455|538051847|FG001|Cohort 2|Death|0|||
149157481|NCT00143455|538051848|FG002|Cohort 2|Death|20|||
149157482|NCT00143455|538051849|FG003|Cohort 2|Death|12|||
149157483|NCT00143455|538051846|FG000|Cohort 2|Progressive Disease|0|||
149157484|NCT00143455|538051847|FG001|Cohort 2|Progressive Disease|0|||
149157485|NCT00143455|538051848|FG002|Cohort 2|Progressive Disease|20|||
149157486|NCT00143455|538051849|FG003|Cohort 2|Progressive Disease|27|||
149157487|NCT00143455|538051846|FG000|Cohort 2|Withdrawal by Subject|0|||
149157488|NCT00143455|538051847|FG001|Cohort 2|Withdrawal by Subject|0|||
149157489|NCT00143455|538051848|FG002|Cohort 2|Withdrawal by Subject|13|||
148922300|NCT04604132|537199385|FG000|Overall Study|Adverse Event|2|||
148922301|NCT04604132|537199386|FG001|Overall Study|Adverse Event|0|||
148922302|NCT04604132|537199387|FG002|Overall Study|Adverse Event|0|||
148922303|NCT04604132|537199388|FG003|Overall Study|Adverse Event|1|||
148922304|NCT04604132|537199389|FG004|Overall Study|Adverse Event|2|||
148922305|NCT04604132|537199385|FG000|Overall Study|Study terminated by sponsor|0|||
148922306|NCT04604132|537199386|FG001|Overall Study|Study terminated by sponsor|0|||
148922307|NCT04604132|537199387|FG002|Overall Study|Study terminated by sponsor|0|||
148922308|NCT04604132|537199388|FG003|Overall Study|Study terminated by sponsor|0|||
148922309|NCT04604132|537199389|FG004|Overall Study|Study terminated by sponsor|1|||
149157490|NCT00143455|538051849|FG003|Cohort 2|Withdrawal by Subject|12|||
149157491|NCT00143455|538051846|FG000|Cohort 2|Other|0|||
149157492|NCT00143455|538051847|FG001|Cohort 2|Other|0|||
149157493|NCT00143455|538051848|FG002|Cohort 2|Other|7|||
149157494|NCT00143455|538051849|FG003|Cohort 2|Other|6|||
149157495|NCT00143455|538051846|FG000|Cohort 2|Randomized But Not Treated|0|||
149157496|NCT00143455|538051847|FG001|Cohort 2|Randomized But Not Treated|0|||
148922310|NCT04604132|537199385|FG000|Overall Study|Progressive disease: Clinical progression|0|||
148922311|NCT04604132|537199386|FG001|Overall Study|Progressive disease: Clinical progression|0|||
148922312|NCT04604132|537199387|FG002|Overall Study|Progressive disease: Clinical progression|1|||
148922313|NCT04604132|537199388|FG003|Overall Study|Progressive disease: Clinical progression|0|||
148922314|NCT04604132|537199389|FG004|Overall Study|Progressive disease: Clinical progression|0|||
148922315|NCT04604132|537199385|FG000|Overall Study|Progressive disease: Radiological progression|8|||
148922316|NCT04604132|537199386|FG001|Overall Study|Progressive disease: Radiological progression|7|||
148922317|NCT04604132|537199387|FG002|Overall Study|Progressive disease: Radiological progression|10|||
148922318|NCT04604132|537199388|FG003|Overall Study|Progressive disease: Radiological progression|4|||
148922319|NCT04604132|537199389|FG004|Overall Study|Progressive disease: Radiological progression|3|||
148922320|NCT04604132|537199385|FG000|Overall Study|Death|3|||
148922321|NCT04604132|537199386|FG001|Overall Study|Death|1|||
148922322|NCT04604132|537199387|FG002|Overall Study|Death|2|||
148922323|NCT04604132|537199388|FG003|Overall Study|Death|1|||
148922324|NCT04604132|537199389|FG004|Overall Study|Death|0|||
148922325|NCT00952380|537199390|FG000|Overall Study|Other|0|||
148922326|NCT00952380|537199391|FG001|Overall Study|Other|0|||
148922327|NCT00952380|537199392|FG002|Overall Study|Other|0|||
148922328|NCT00952380|537199393|FG003|Overall Study|Other|0|||
148922329|NCT00952380|537199394|FG004|Overall Study|Other|1|||
148922330|NCT00952380|537199390|FG000|Overall Study|Withdrawal by Subject|0|||
148922331|NCT00952380|537199391|FG001|Overall Study|Withdrawal by Subject|0|||
149157497|NCT00143455|538051848|FG002|Cohort 2|Randomized But Not Treated|1|||
149157498|NCT00143455|538051849|FG003|Cohort 2|Randomized But Not Treated|1|||
148922332|NCT00952380|537199392|FG002|Overall Study|Withdrawal by Subject|1|||
148922333|NCT00952380|537199393|FG003|Overall Study|Withdrawal by Subject|0|||
148922334|NCT00952380|537199394|FG004|Overall Study|Withdrawal by Subject|2|||
148922335|NCT00952380|537199390|FG000|Overall Study|Adverse Event|0|||
148922336|NCT00952380|537199391|FG001|Overall Study|Adverse Event|1|||
148922337|NCT00952380|537199392|FG002|Overall Study|Adverse Event|0|||
148922338|NCT00952380|537199393|FG003|Overall Study|Adverse Event|0|||
148922339|NCT00952380|537199394|FG004|Overall Study|Adverse Event|3|||
148922340|NCT00952380|537199390|FG000|Overall Study|Physician Decision|0|||
148922341|NCT00952380|537199391|FG001|Overall Study|Physician Decision|0|||
148922342|NCT00952380|537199392|FG002|Overall Study|Physician Decision|1|||
148922343|NCT00952380|537199393|FG003|Overall Study|Physician Decision|2|||
148922344|NCT00952380|537199394|FG004|Overall Study|Physician Decision|0|||
148922345|NCT00952380|537199390|FG000|Overall Study|Non-compliant to protocol|0|||
148922346|NCT00952380|537199391|FG001|Overall Study|Non-compliant to protocol|0|||
148922347|NCT00952380|537199392|FG002|Overall Study|Non-compliant to protocol|0|||
148922348|NCT00952380|537199393|FG003|Overall Study|Non-compliant to protocol|1|||
148922349|NCT00952380|537199394|FG004|Overall Study|Non-compliant to protocol|0|||
148922350|NCT00534313|537199396|FG000|Short-term Period|Adverse Event|1|||
148922351|NCT00534313|537199397|FG001|Short-term Period|Adverse Event|2|||
148922352|NCT00534313|537199398|FG002|Short-term Period|Adverse Event|1|||
148922353|NCT00534313|537199399|FG003|Short-term Period|Adverse Event|3|||
148922354|NCT00534313|537199396|FG000|Short-term Period|Lack of Efficacy|3|||
148922355|NCT00534313|537199397|FG001|Short-term Period|Lack of Efficacy|4|||
148922356|NCT00534313|537199398|FG002|Short-term Period|Lack of Efficacy|0|||
148922357|NCT00534313|537199399|FG003|Short-term Period|Lack of Efficacy|3|||
148922358|NCT00534313|537199396|FG000|Short-term Period|Participant not meeting study criteria|0|||
148922359|NCT00534313|537199397|FG001|Short-term Period|Participant not meeting study criteria|0|||
148922360|NCT00534313|537199398|FG002|Short-term Period|Participant not meeting study criteria|0|||
148922361|NCT00534313|537199399|FG003|Short-term Period|Participant not meeting study criteria|1|||
148922362|NCT00534313|537199396|FG000|Short-term Period|Participant withdrew consent|2|||
148922363|NCT00534313|537199397|FG001|Short-term Period|Participant withdrew consent|0|||
148922364|NCT00534313|537199398|FG002|Short-term Period|Participant withdrew consent|0|||
148922365|NCT00534313|537199399|FG003|Short-term Period|Participant withdrew consent|2|||
148922366|NCT00534313|537199396|FG000|Short-term Period|Pregnancy|0|||
148922367|NCT00534313|537199397|FG001|Short-term Period|Pregnancy|0|||
148922368|NCT00534313|537199398|FG002|Short-term Period|Pregnancy|1|||
148922369|NCT00534313|537199399|FG003|Short-term Period|Pregnancy|0|||
148922370|NCT00534313|537199396|FG000|Long-term Period|Adverse Event|2|||
148922371|NCT00534313|537199397|FG001|Long-term Period|Adverse Event|1|||
148922372|NCT00534313|537199398|FG002|Long-term Period|Adverse Event|0|||
148922373|NCT00534313|537199399|FG003|Long-term Period|Adverse Event|1|||
148922374|NCT00534313|537199396|FG000|Long-term Period|Lack of Efficacy|14|||
148922375|NCT00534313|537199397|FG001|Long-term Period|Lack of Efficacy|10|||
148922376|NCT00534313|537199398|FG002|Long-term Period|Lack of Efficacy|14|||
148922377|NCT00534313|537199399|FG003|Long-term Period|Lack of Efficacy|12|||
148922378|NCT00534313|537199396|FG000|Long-term Period|Lost to Follow-up|1|||
148922379|NCT00534313|537199397|FG001|Long-term Period|Lost to Follow-up|2|||
148922380|NCT00534313|537199398|FG002|Long-term Period|Lost to Follow-up|0|||
148922381|NCT00534313|537199399|FG003|Long-term Period|Lost to Follow-up|0|||
148922382|NCT00534313|537199396|FG000|Long-term Period|Withdrawal by Subject|2|||
148922383|NCT00534313|537199397|FG001|Long-term Period|Withdrawal by Subject|2|||
148922384|NCT00534313|537199398|FG002|Long-term Period|Withdrawal by Subject|0|||
148922385|NCT00534313|537199399|FG003|Long-term Period|Withdrawal by Subject|0|||
148922386|NCT00534313|537199396|FG000|Long-term Period|No longer meets study criteria|0|||
148922387|NCT00534313|537199397|FG001|Long-term Period|No longer meets study criteria|1|||
148922388|NCT00534313|537199398|FG002|Long-term Period|No longer meets study criteria|0|||
148922389|NCT00534313|537199399|FG003|Long-term Period|No longer meets study criteria|0|||
148922390|NCT00534313|537199396|FG000|Long-term Period|Poor compliance/noncompliance|0|||
148922391|NCT00534313|537199397|FG001|Long-term Period|Poor compliance/noncompliance|1|||
148922392|NCT00534313|537199398|FG002|Long-term Period|Poor compliance/noncompliance|1|||
148922393|NCT00534313|537199399|FG003|Long-term Period|Poor compliance/noncompliance|0|||
148922394|NCT00534313|537199396|FG000|Long-term Period|Administrative reason by sponsor|17|||
148922395|NCT00534313|537199397|FG001|Long-term Period|Administrative reason by sponsor|15|||
148922396|NCT00534313|537199398|FG002|Long-term Period|Administrative reason by sponsor|26|||
148922397|NCT00534313|537199399|FG003|Long-term Period|Administrative reason by sponsor|18|||
148922398|NCT00534313|537199396|FG000|Long-term Period|Other|1|||
148922399|NCT00534313|537199397|FG001|Long-term Period|Other|2|||
148922400|NCT00534313|537199398|FG002|Long-term Period|Other|2|||
148922401|NCT00534313|537199399|FG003|Long-term Period|Other|2|||
148922402|NCT01892384|537199401|FG000|Overall Study|Withdrawal by Subject|1|||
148922403|NCT01892384|537199402|FG001|Overall Study|Withdrawal by Subject|1|||
148922404|NCT01892384|537199403|FG002|Overall Study|Withdrawal by Subject|0|||
148922405|NCT01892384|537199404|FG003|Overall Study|Withdrawal by Subject|0|||
148922406|NCT00592774|537199405|FG000|Overall Study|Adverse Event|5|||
148922407|NCT00592774|537199406|FG001|Overall Study|Adverse Event|19|||
148922408|NCT00592774|537199407|FG002|Overall Study|Adverse Event|2|||
148922409|NCT00592774|537199408|FG003|Overall Study|Adverse Event|14|||
148922410|NCT00592774|537199409|FG004|Overall Study|Adverse Event|8|||
148922411|NCT00592774|537199405|FG000|Overall Study|Protocol Violation|0|||
148922412|NCT00592774|537199406|FG001|Overall Study|Protocol Violation|1|||
148922413|NCT00592774|537199407|FG002|Overall Study|Protocol Violation|0|||
148922414|NCT00592774|537199408|FG003|Overall Study|Protocol Violation|0|||
148922415|NCT00592774|537199409|FG004|Overall Study|Protocol Violation|1|||
148922416|NCT00592774|537199405|FG000|Overall Study|Withdrawal by Subject|3|||
148922417|NCT00592774|537199406|FG001|Overall Study|Withdrawal by Subject|7|||
148922418|NCT00592774|537199407|FG002|Overall Study|Withdrawal by Subject|0|||
148922419|NCT00592774|537199408|FG003|Overall Study|Withdrawal by Subject|0|||
148922420|NCT00592774|537199409|FG004|Overall Study|Withdrawal by Subject|0|||
148922421|NCT00592774|537199405|FG000|Overall Study|Lack of Efficacy|3|||
148922422|NCT00592774|537199406|FG001|Overall Study|Lack of Efficacy|3|||
148922423|NCT00592774|537199407|FG002|Overall Study|Lack of Efficacy|0|||
148922424|NCT00592774|537199408|FG003|Overall Study|Lack of Efficacy|0|||
148922425|NCT00592774|537199409|FG004|Overall Study|Lack of Efficacy|2|||
148922426|NCT00592774|537199405|FG000|Overall Study|Physician Decision|0|||
148922427|NCT00592774|537199406|FG001|Overall Study|Physician Decision|1|||
148922428|NCT00592774|537199407|FG002|Overall Study|Physician Decision|1|||
148922429|NCT00592774|537199408|FG003|Overall Study|Physician Decision|0|||
148922430|NCT00592774|537199409|FG004|Overall Study|Physician Decision|1|||
148922431|NCT00592774|537199405|FG000|Overall Study|Other|0|||
148922432|NCT00592774|537199406|FG001|Overall Study|Other|1|||
148922433|NCT00592774|537199407|FG002|Overall Study|Other|1|||
148922434|NCT00592774|537199408|FG003|Overall Study|Other|0|||
148922435|NCT00592774|537199409|FG004|Overall Study|Other|2|||
148922436|NCT01077375|537199415|FG000|Overall Study|Adverse Event|2|||
148922437|NCT01077375|537199416|FG001|Overall Study|Adverse Event|15|||
148922438|NCT01077375|537199415|FG000|Overall Study|Lack of Efficacy|6|||
148922439|NCT01077375|537199416|FG001|Overall Study|Lack of Efficacy|8|||
148922440|NCT01077375|537199415|FG000|Overall Study|Withdrawal by Subject|0|||
148922441|NCT01077375|537199416|FG001|Overall Study|Withdrawal by Subject|6|||
148922442|NCT01077375|537199415|FG000|Overall Study|Lost to Follow-up|2|||
148922443|NCT01077375|537199416|FG001|Overall Study|Lost to Follow-up|5|||
148922444|NCT01077375|537199415|FG000|Overall Study|Other Reason|0|||
148922445|NCT01077375|537199416|FG001|Overall Study|Other Reason|1|||
148922446|NCT01924429|537199417|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
148922447|NCT01924429|537199418|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
148922448|NCT03985878|537199421|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
148922449|NCT03985878|537199421|FG000|Overall Study|Study Terminated by Sponsor|12|||
148922450|NCT03985878|537199421|FG000|Overall Study|Withdrawal by Subject|1|||
148922451|NCT01514370|537199423|FG000|Overall Study|Protocol Violation|2|||
148922452|NCT01514370|537199424|FG001|Overall Study|Protocol Violation|3|||
148922453|NCT01514370|537199423|FG000|Overall Study|Lost to Follow-up|0|||
148922454|NCT01514370|537199424|FG001|Overall Study|Lost to Follow-up|2|||
148922455|NCT01514370|537199423|FG000|Overall Study|Withdrawal by Subject|2|||
148922456|NCT01514370|537199424|FG001|Overall Study|Withdrawal by Subject|1|||
148922457|NCT01514370|537199423|FG000|Overall Study|Adverse Event|1|||
148922458|NCT01514370|537199424|FG001|Overall Study|Adverse Event|3|||
148922459|NCT01514370|537199423|FG000|Overall Study|Other|6|||
148922460|NCT01514370|537199424|FG001|Overall Study|Other|7|||
148922461|NCT00129311|537199428|FG000|Overall Study|Withdrawal by Subject|12|||
148922462|NCT00129311|537199429|FG001|Overall Study|Withdrawal by Subject|19|||
148922463|NCT00534599|537199430|FG000|Overall Study|Adverse Event|25|||
148922464|NCT00534599|537199431|FG001|Overall Study|Adverse Event|4|||
148922465|NCT00534599|537199430|FG000|Overall Study|Incorrect enrollment|2|||
148922466|NCT00534599|537199431|FG001|Overall Study|Incorrect enrollment|1|||
148922467|NCT00534599|537199430|FG000|Overall Study|Mis-randomization|2|||
148922468|NCT00534599|537199431|FG001|Overall Study|Mis-randomization|2|||
148922469|NCT00534599|537199430|FG000|Overall Study|Developed study-specific d/c criteria|5|||
148922470|NCT00534599|537199431|FG001|Overall Study|Developed study-specific d/c criteria|0|||
148922471|NCT00534599|537199430|FG000|Overall Study|Lack of Efficacy|0|||
148922472|NCT00534599|537199431|FG001|Overall Study|Lack of Efficacy|1|||
148922473|NCT00534599|537199430|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
148922474|NCT00534599|537199431|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
148922475|NCT00534599|537199430|FG000|Overall Study|Protocol Violation|1|||
148922476|NCT00534599|537199431|FG001|Overall Study|Protocol Violation|3|||
148922477|NCT00534599|537199430|FG000|Overall Study|Lost to Follow-up|11|||
148922478|NCT00534599|537199431|FG001|Overall Study|Lost to Follow-up|14|||
148922479|NCT00534599|537199430|FG000|Overall Study|Withdrawal by Subject|4|||
148922480|NCT00534599|537199431|FG001|Overall Study|Withdrawal by Subject|6|||
148922481|NCT00534599|537199430|FG000|Overall Study|Other|7|||
148922482|NCT00534599|537199431|FG001|Overall Study|Other|0|||
148922483|NCT00853970|537199434|FG000|Overall Study|Withdrawal by Subject|2|||
148922484|NCT00853970|537199435|FG001|Overall Study|Withdrawal by Subject|1|||
148922485|NCT00853970|537199434|FG000|Overall Study|Cancelled surgery|4|||
148922486|NCT00853970|537199435|FG001|Overall Study|Cancelled surgery|2|||
148956472|NCT04532099|537324430|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
148956473|NCT04532099|537324431|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
148956474|NCT04532099|537324432|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
148956475|NCT01949051|537324442|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
148956476|NCT01949051|537324443|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
148956477|NCT01949051|537324444|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
148956478|NCT01949051|537324445|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
148956479|NCT01949051|537324446|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
148956480|NCT01949051|537324447|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
148956481|NCT01949051|537324442|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
148956482|NCT01949051|537324443|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
148956483|NCT01949051|537324444|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
148956484|NCT01949051|537324445|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
148956485|NCT01949051|537324446|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
148956486|NCT01949051|537324447|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
148956487|NCT01949051|537324442|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
148956488|NCT01949051|537324443|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
148956489|NCT01949051|537324444|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
148956490|NCT01949051|537324445|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
148956491|NCT01949051|537324446|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
148922487|NCT00003830|537201140|FG000|Overall Study|No follow up data|3|||
148922488|NCT00003830|537201141|FG001|Overall Study|No follow up data|0|||
148922489|NCT00003830|537201140|FG000|Overall Study|Sentinel node positive patients|829|||
148922490|NCT00003830|537201141|FG001|Overall Study|Sentinel node positive patients|793|||
148922491|NCT05347147|537201142|FG000|Overall Study|Lost to Follow-up|0|||
148922492|NCT05347147|537201143|FG001|Overall Study|Lost to Follow-up|1|||
148922493|NCT05347147|537201142|FG000|Overall Study|Sponsor request|3|||
148922494|NCT05347147|537201143|FG001|Overall Study|Sponsor request|3|||
148922495|NCT05347147|537201142|FG000|Overall Study|Study termination|2|||
148922496|NCT05347147|537201143|FG001|Overall Study|Study termination|1|||
148922497|NCT03739242|537201147|FG000|Overall Study|Withdrawal by Subject|1|||
148922498|NCT03739242|537201148|FG001|Overall Study|Withdrawal by Subject|1|||
148922499|NCT03739242|537201147|FG000|Overall Study|Protocol Violation|0|||
148922500|NCT03739242|537201148|FG001|Overall Study|Protocol Violation|1|||
148922501|NCT02446743|537201149|FG000|Overall Study|Withdrawal by Subject|1|||
148922502|NCT02446743|537201150|FG001|Overall Study|Withdrawal by Subject|1|||
148922503|NCT02446743|537201149|FG000|Overall Study|Lost to Follow-up|1|||
148922504|NCT02446743|537201150|FG001|Overall Study|Lost to Follow-up|0|||
148922505|NCT02446743|537201149|FG000|Overall Study|Adverse Event|1|||
148922506|NCT02446743|537201150|FG001|Overall Study|Adverse Event|1|||
148922507|NCT02446743|537201149|FG000|Overall Study|Other|2|||
148922508|NCT02446743|537201150|FG001|Overall Study|Other|3|||
148922509|NCT00039871|537201151|FG000|Overall Study|Adverse Event|165|||
148922510|NCT00039871|537201151|FG000|Overall Study|Lost to Follow-up|18|||
148922511|NCT00039871|537201151|FG000|Overall Study|Protocol Violation|24|||
148922512|NCT00039871|537201151|FG000|Overall Study|Withdrawal by Subject|97|||
148922513|NCT00039871|537201151|FG000|Overall Study|Did not meet eligibility criteria|11|||
148922514|NCT00039871|537201151|FG000|Overall Study|Administrative|1|||
148922515|NCT00039871|537201151|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
148922516|NCT00039871|537201151|FG000|Overall Study|Never entered follow-up|7|||
148922517|NCT03361176|537201152|FG000|Overall Study|Lost to Follow-up|1|||
148922518|NCT03361176|537201153|FG001|Overall Study|Lost to Follow-up|2|||
148922519|NCT03361176|537201152|FG000|Overall Study|Adverse Event|0|||
148922520|NCT03361176|537201153|FG001|Overall Study|Adverse Event|2|||
148922521|NCT03361176|537201152|FG000|Overall Study|Withdrawal by Subject|0|||
148922522|NCT03361176|537201153|FG001|Overall Study|Withdrawal by Subject|1|||
148922523|NCT02478398|537201154|FG000|Overall Study|Adverse Event|20|||
148922524|NCT02478398|537201155|FG001|Overall Study|Adverse Event|5|||
148922525|NCT02478398|537201154|FG000|Overall Study|Lost to Follow-up|5|||
148922526|NCT02478398|537201155|FG001|Overall Study|Lost to Follow-up|4|||
148922527|NCT02478398|537201154|FG000|Overall Study|Non-Compliance With Study Drug|5|||
148922528|NCT02478398|537201155|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148922529|NCT02478398|537201154|FG000|Overall Study|Protocol Violation|3|||
148922530|NCT02478398|537201155|FG001|Overall Study|Protocol Violation|1|||
148922531|NCT02478398|537201154|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
148922532|NCT02478398|537201155|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
148922533|NCT02478398|537201154|FG000|Overall Study|Withdrawal By Participant|10|||
148922534|NCT02478398|537201155|FG001|Overall Study|Withdrawal By Participant|4|||
148922535|NCT00923364|537201162|FG000|Overall Study|Death|3|||
148922536|NCT00923364|537201163|FG001|Overall Study|Death|0|||
148922537|NCT00923364|537201162|FG000|Overall Study|Did not go to transplant|1|||
148922538|NCT00923364|537201163|FG001|Overall Study|Did not go to transplant|0|||
148922539|NCT03023046|537201165|FG000|Overall Study|Withdrawal by Subject|1|||
148922540|NCT01205581|537201166|FG000|Overall Study|Withdrawal by Subject|1|||
148922541|NCT01205581|537201167|FG001|Overall Study|Withdrawal by Subject|0|||
148922542|NCT01205581|537201168|FG002|Overall Study|Withdrawal by Subject|0|||
148922543|NCT01205581|537201169|FG003|Overall Study|Withdrawal by Subject|0|||
148922544|NCT01205581|537201170|FG004|Overall Study|Withdrawal by Subject|0|||
148922545|NCT01205581|537201171|FG005|Overall Study|Withdrawal by Subject|0|||
148922546|NCT04395001|537201172|FG000|Overall Study|Lost to Follow-up|8|||
148922547|NCT04395001|537201173|FG001|Overall Study|Lost to Follow-up|9|||
148922548|NCT04395001|537201174|FG002|Overall Study|Lost to Follow-up|5|||
148922549|NCT04395001|537201172|FG000|Overall Study|Withdrawal by Subject|3|||
148922550|NCT04395001|537201173|FG001|Overall Study|Withdrawal by Subject|1|||
148922551|NCT04395001|537201174|FG002|Overall Study|Withdrawal by Subject|3|||
148922552|NCT04395001|537201172|FG000|Overall Study|missed appointment|7|||
148922553|NCT04395001|537201173|FG001|Overall Study|missed appointment|4|||
148922554|NCT04395001|537201174|FG002|Overall Study|missed appointment|1|||
148922555|NCT04418661|537201175|FG000|Overall Study|Adverse Event|0|||
148922556|NCT04418661|537201176|FG001|Overall Study|Adverse Event|1|||
148922557|NCT04418661|537201177|FG002|Overall Study|Adverse Event|5|||
148922558|NCT04418661|537201178|FG003|Overall Study|Adverse Event|3|||
148922559|NCT04418661|537201179|FG004|Overall Study|Adverse Event|0|||
148922560|NCT04418661|537201180|FG005|Overall Study|Adverse Event|2|||
148922561|NCT04418661|537201175|FG000|Overall Study|Progressive disease|4|||
148922562|NCT04418661|537201176|FG001|Overall Study|Progressive disease|11|||
148922563|NCT04418661|537201177|FG002|Overall Study|Progressive disease|6|||
148922564|NCT04418661|537201178|FG003|Overall Study|Progressive disease|11|||
148922565|NCT04418661|537201179|FG004|Overall Study|Progressive disease|1|||
148922566|NCT04418661|537201180|FG005|Overall Study|Progressive disease|12|||
148922567|NCT04418661|537201175|FG000|Overall Study|Withdrawal by Subject|0|||
148922568|NCT04418661|537201176|FG001|Overall Study|Withdrawal by Subject|1|||
148922569|NCT04418661|537201177|FG002|Overall Study|Withdrawal by Subject|0|||
148922570|NCT04418661|537201178|FG003|Overall Study|Withdrawal by Subject|1|||
148922571|NCT04418661|537201179|FG004|Overall Study|Withdrawal by Subject|0|||
148922572|NCT04418661|537201180|FG005|Overall Study|Withdrawal by Subject|0|||
148922573|NCT04418661|537201175|FG000|Overall Study|Other|0|||
148922574|NCT04418661|537201176|FG001|Overall Study|Other|0|||
148922575|NCT04418661|537201177|FG002|Overall Study|Other|1|||
148922576|NCT04418661|537201178|FG003|Overall Study|Other|3|||
148922577|NCT04418661|537201179|FG004|Overall Study|Other|0|||
148922578|NCT04418661|537201180|FG005|Overall Study|Other|1|||
148922579|NCT00635024|537201183|FG000|Overall Study|Adverse Event|1|||
148922580|NCT00713310|537201185|FG000|Overall Study|Adverse Event|5|||
148922581|NCT00713310|537201186|FG001|Overall Study|Adverse Event|2|||
148922582|NCT00713310|537201185|FG000|Overall Study|Lack of Efficacy|0|||
148922583|NCT00713310|537201186|FG001|Overall Study|Lack of Efficacy|2|||
148922584|NCT00713310|537201185|FG000|Overall Study|Withdrawal by Subject|0|||
148922585|NCT00713310|537201186|FG001|Overall Study|Withdrawal by Subject|2|||
148922586|NCT00329901|537201187|FG000|Overall Study|Withdrawal by Subject|4|||
148922587|NCT00329901|537201188|FG001|Overall Study|Withdrawal by Subject|3|||
148922588|NCT00329901|537201189|FG002|Overall Study|Withdrawal by Subject|2|||
148922589|NCT00329901|537201187|FG000|Overall Study|Lost to Follow-up|2|||
148922590|NCT00329901|537201188|FG001|Overall Study|Lost to Follow-up|0|||
148922591|NCT00329901|537201189|FG002|Overall Study|Lost to Follow-up|1|||
148922592|NCT00329901|537201187|FG000|Overall Study|Protocol Violation|1|||
148922593|NCT00329901|537201188|FG001|Overall Study|Protocol Violation|0|||
148922594|NCT00329901|537201189|FG002|Overall Study|Protocol Violation|1|||
148922595|NCT00329901|537201187|FG000|Overall Study|Unable to classify|2|||
148922596|NCT00329901|537201188|FG001|Overall Study|Unable to classify|2|||
148922597|NCT00329901|537201189|FG002|Overall Study|Unable to classify|0|||
148922598|NCT00992589|537201190|FG000|Open-Label Phase|Adverse Event|4|||
148922599|NCT00992589|537201191|FG001|Open-Label Phase|Adverse Event|0|||
148922600|NCT00992589|537201192|FG002|Open-Label Phase|Adverse Event|0|||
148922601|NCT00992589|537201193|FG003|Open-Label Phase|Adverse Event|0|||
148922602|NCT00992589|537201190|FG000|Open-Label Phase|Withdrawal by Subject|20|||
148922603|NCT00992589|537201191|FG001|Open-Label Phase|Withdrawal by Subject|0|||
148922604|NCT00992589|537201192|FG002|Open-Label Phase|Withdrawal by Subject|0|||
148922605|NCT00992589|537201193|FG003|Open-Label Phase|Withdrawal by Subject|0|||
148922606|NCT00992589|537201190|FG000|Open-Label Phase|Lost to Follow-up|1|||
148922607|NCT00992589|537201191|FG001|Open-Label Phase|Lost to Follow-up|0|||
148922608|NCT00992589|537201192|FG002|Open-Label Phase|Lost to Follow-up|0|||
148922609|NCT00992589|537201193|FG003|Open-Label Phase|Lost to Follow-up|0|||
148922610|NCT00992589|537201190|FG000|Open-Label Phase|Protocol Violation|3|||
148922611|NCT00992589|537201191|FG001|Open-Label Phase|Protocol Violation|0|||
149157499|NCT01325428|538051850|FG000|Part A|Progressive disease according to RECIST|9|||
148922612|NCT00992589|537201192|FG002|Open-Label Phase|Protocol Violation|0|||
148922613|NCT00992589|537201193|FG003|Open-Label Phase|Protocol Violation|0|||
148922614|NCT00992589|537201190|FG000|Open-Label Phase|Physician Decision|4|||
148922615|NCT00992589|537201191|FG001|Open-Label Phase|Physician Decision|0|||
148922616|NCT00992589|537201192|FG002|Open-Label Phase|Physician Decision|0|||
148922617|NCT00992589|537201193|FG003|Open-Label Phase|Physician Decision|0|||
148922618|NCT00992589|537201190|FG000|Open-Label Phase|Other|45|||
148922619|NCT00992589|537201191|FG001|Open-Label Phase|Other|0|||
148922620|NCT00992589|537201192|FG002|Open-Label Phase|Other|0|||
148922621|NCT00992589|537201193|FG003|Open-Label Phase|Other|0|||
149157500|NCT01325428|538051850|FG000|Part A|Clinical signs, symptoms of progression|2|||
149157501|NCT01325428|538051850|FG000|Part A|Other adverse event|1|||
149157502|NCT01325428|538051850|FG000|Part A|Refused continue taking trial medication|2|||
149157503|NCT01325428|538051850|FG000|Part A|Other reason not defined above|2|||
149157504|NCT01325428|538051850|FG000|Part B|Refused continue taking trial medication|2|||
149157505|NCT01325428|538051850|FG000|Part B|Other reason not defined above|1|||
149157506|NCT01298492|538051851|FG000|Overall Study|Death|2|||
149157507|NCT01298492|538051851|FG000|Overall Study|Insufficient Clinical Response|22|||
149157508|NCT01298492|538051851|FG000|Overall Study|Lost to Follow-up|12|||
149157509|NCT01298492|538051851|FG000|Overall Study|Withdrawal by Subject|47|||
149157510|NCT01298492|538051851|FG000|Overall Study|Other (Unspecified)|7|||
149157511|NCT01298492|538051851|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
149157512|NCT01298492|538051851|FG000|Overall Study|Protocol Violation|2|||
149157513|NCT01298492|538051851|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
149157514|NCT01298492|538051851|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
149157515|NCT02004873|538051852|FG000|Overall Study|Implant unsuccessful|6|||
149157516|NCT02004873|538051852|FG000|Overall Study|Awaiting 6-month visit|390|||
149157517|NCT02004873|538051852|FG000|Overall Study|Missed 6-month visit|4|||
149157518|NCT02004873|538051852|FG000|Overall Study|Death|23|||
148922622|NCT00992589|537201190|FG000|Double-Blind Phase|Adverse Event|0|||
148922623|NCT00992589|537201191|FG001|Double-Blind Phase|Adverse Event|6|||
148922624|NCT00992589|537201192|FG002|Double-Blind Phase|Adverse Event|2|||
148922625|NCT00992589|537201193|FG003|Double-Blind Phase|Adverse Event|3|||
148922626|NCT00992589|537201190|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
148922627|NCT00992589|537201191|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
148922628|NCT00992589|537201192|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
148922629|NCT00992589|537201193|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
148922630|NCT00992589|537201190|FG000|Double-Blind Phase|Lost to Follow-up|0|||
148922631|NCT00992589|537201191|FG001|Double-Blind Phase|Lost to Follow-up|0|||
148922632|NCT00992589|537201192|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148922633|NCT00992589|537201193|FG003|Double-Blind Phase|Lost to Follow-up|2|||
148922634|NCT00992589|537201190|FG000|Double-Blind Phase|Other|0|||
148922635|NCT00992589|537201191|FG001|Double-Blind Phase|Other|1|||
148922636|NCT00992589|537201192|FG002|Double-Blind Phase|Other|6|||
148922637|NCT00992589|537201193|FG003|Double-Blind Phase|Other|3|||
148922638|NCT05508074|537201194|FG000|Overall Study|Death|2|||
148922639|NCT05508074|537201195|FG001|Overall Study|Death|5|||
148922640|NCT05508074|537201194|FG000|Overall Study|Withdrawal by Subject|1|||
148922641|NCT05508074|537201195|FG001|Overall Study|Withdrawal by Subject|2|||
148922642|NCT05508074|537201194|FG000|Overall Study|Adverse Event|0|||
148922643|NCT05508074|537201195|FG001|Overall Study|Adverse Event|1|||
148922644|NCT05508074|537201194|FG000|Overall Study|Physician Decision|0|||
148922645|NCT05508074|537201195|FG001|Overall Study|Physician Decision|1|||
148922646|NCT05508074|537201194|FG000|Overall Study|wrongly randomized|0|||
148922647|NCT05508074|537201195|FG001|Overall Study|wrongly randomized|1|||
148922648|NCT05508074|537201194|FG000|Overall Study|non-compliance|0|||
148922649|NCT05508074|537201195|FG001|Overall Study|non-compliance|1|||
148922650|NCT02142387|537201196|FG000|Overall Study|<19 years old|49|||
148922651|NCT02142387|537201197|FG001|Overall Study|<19 years old|326|||
148922652|NCT02142387|537201196|FG000|Overall Study|non-cardiac etiology|504|||
148922653|NCT02142387|537201197|FG001|Overall Study|non-cardiac etiology|3431|||
148922654|NCT02142387|537201196|FG000|Overall Study|CPR not performed|74|||
148922655|NCT02142387|537201197|FG001|Overall Study|CPR not performed|473|||
148922656|NCT02142387|537201196|FG000|Overall Study|witnessed by paramedic|139|||
148922657|NCT02142387|537201197|FG001|Overall Study|witnessed by paramedic|917|||
148922658|NCT02142387|537201196|FG000|Overall Study|incomplete data|1|||
148922659|NCT02142387|537201197|FG001|Overall Study|incomplete data|9|||
148922660|NCT02142387|537201196|FG000|Overall Study|occurred not at home|298|||
148922661|NCT02142387|537201197|FG001|Overall Study|occurred not at home|2474|||
148922662|NCT02984943|537201198|FG000|Overall Study|Withdrawal by Subject|3|||
148922663|NCT02984943|537201198|FG000|Overall Study|Physician Decision|1|||
148922664|NCT04381988|537201206|FG000|Overall Study|The study was terminated|4|||
148922665|NCT04381988|537201207|FG001|Overall Study|The study was terminated|0|||
148922666|NCT03915860|537201208|FG000|Overall Study|Adverse Event|3|||
148922667|NCT03915860|537201208|FG000|Overall Study|Withdrawal by Subject|6|||
148922668|NCT03915860|537201208|FG000|Overall Study|Lost to Follow-up|2|||
148922669|NCT03915860|537201208|FG000|Overall Study|Other than specified|3|||
148922670|NCT01009281|537201212|FG000|Overall Study|Administrative problems|7|||
148922671|NCT00548405|537201213|FG000|Overall Study|Adverse Event|6|||
148922672|NCT00548405|537201214|FG001|Overall Study|Adverse Event|2|||
148922673|NCT00548405|537201215|FG002|Overall Study|Adverse Event|0|||
148922674|NCT00548405|537201213|FG000|Overall Study|Lack of Efficacy|6|||
148922675|NCT00548405|537201214|FG001|Overall Study|Lack of Efficacy|0|||
148922676|NCT00548405|537201215|FG002|Overall Study|Lack of Efficacy|0|||
148922677|NCT00548405|537201213|FG000|Overall Study|Physician Decision|3|||
148922678|NCT00548405|537201214|FG001|Overall Study|Physician Decision|4|||
148922679|NCT00548405|537201215|FG002|Overall Study|Physician Decision|1|||
148922680|NCT00548405|537201213|FG000|Overall Study|Pregnancy|1|||
148922681|NCT00548405|537201214|FG001|Overall Study|Pregnancy|0|||
148922682|NCT00548405|537201215|FG002|Overall Study|Pregnancy|0|||
148922683|NCT00548405|537201213|FG000|Overall Study|Protocol Violation|1|||
148922684|NCT00548405|537201214|FG001|Overall Study|Protocol Violation|0|||
148922685|NCT00548405|537201215|FG002|Overall Study|Protocol Violation|0|||
148922686|NCT00548405|537201213|FG000|Overall Study|Withdrawal by Subject|36|||
148922687|NCT00548405|537201214|FG001|Overall Study|Withdrawal by Subject|12|||
148922688|NCT00548405|537201215|FG002|Overall Study|Withdrawal by Subject|5|||
148922689|NCT00548405|537201213|FG000|Overall Study|Lost to Follow-up|1|||
148922690|NCT00548405|537201214|FG001|Overall Study|Lost to Follow-up|1|||
148922691|NCT00548405|537201215|FG002|Overall Study|Lost to Follow-up|2|||
148922692|NCT00548405|537201213|FG000|Overall Study|Death|0|||
148922693|NCT00548405|537201214|FG001|Overall Study|Death|1|||
148922694|NCT00548405|537201215|FG002|Overall Study|Death|1|||
148922695|NCT00548405|537201213|FG000|Overall Study|Sponsor decision|1|||
148922696|NCT00548405|537201214|FG001|Overall Study|Sponsor decision|0|||
148922697|NCT00548405|537201215|FG002|Overall Study|Sponsor decision|0|||
148922698|NCT00548405|537201213|FG000|Overall Study|Randomized but not treated|1|||
148922699|NCT00548405|537201214|FG001|Overall Study|Randomized but not treated|0|||
148922700|NCT00548405|537201215|FG002|Overall Study|Randomized but not treated|0|||
148922701|NCT00924170|537201216|FG000|Overall Study|Refused further treatment|0|||
148922702|NCT00924170|537201217|FG001|Overall Study|Refused further treatment|1|||
148922703|NCT00924170|537201216|FG000|Overall Study|Physician Decision|0|||
148922704|NCT00924170|537201217|FG001|Overall Study|Physician Decision|1|||
148922705|NCT00924170|537201216|FG000|Overall Study|Progressive disease|3|||
148922706|NCT00924170|537201217|FG001|Overall Study|Progressive disease|6|||
148922707|NCT00924170|537201216|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
148922708|NCT00924170|537201217|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
148922709|NCT00924170|537201216|FG000|Overall Study|Death|1|||
148922710|NCT00924170|537201217|FG001|Overall Study|Death|0|||
148922711|NCT01624870|537201220|FG000|Overall Study|Death|19|||
148922712|NCT01624870|537201220|FG000|Overall Study|Withdrawal by Subject|1|||
148922713|NCT01624870|537201220|FG000|Overall Study|CoreValve not implanted|6|||
148922714|NCT01624870|537201220|FG000|Overall Study|Lost to follow up|1|||
148922715|NCT03901456|537201221|FG000|Overall Study|Withdrawal by Subject|0|||
148922716|NCT03901456|537201222|FG001|Overall Study|Withdrawal by Subject|0|||
148922717|NCT03901456|537201223|FG002|Overall Study|Withdrawal by Subject|1|||
148922718|NCT03901456|537201221|FG000|Overall Study|Lost to Follow-up|0|||
148922719|NCT03901456|537201222|FG001|Overall Study|Lost to Follow-up|1|||
148922720|NCT03901456|537201223|FG002|Overall Study|Lost to Follow-up|0|||
148922721|NCT01302834|537201225|FG000|Overall Study|Protocol Violation|17|||
148922722|NCT01302834|537201226|FG001|Overall Study|Protocol Violation|23|||
148922723|NCT01302834|537201225|FG000|Overall Study|HIV positive|1|||
148922724|NCT01302834|537201226|FG001|Overall Study|HIV positive|3|||
148922725|NCT00899392|537201227|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
148922726|NCT00899392|537201228|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
148922727|NCT02437110|537201229|FG000|Screening|Lost to Follow-up|3|||
148922728|NCT02437110|537201229|FG000|Screening|Physician Decision|1|||
148922729|NCT02437110|537201229|FG000|ART|Adverse Event|3|||
148922730|NCT02437110|537201229|FG000|ART|Protocol Violation|3|||
148922731|NCT02437110|537201229|FG000|ART|Withdrawal by Subject|4|||
148922732|NCT02437110|537201229|FG000|ART|Lost to follow-up prior to start of intervention|1|||
148922733|NCT02437110|537201229|FG000|ART|Physician decision prior to start of intervention|2|||
148922734|NCT02437110|537201229|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
148922735|NCT02437110|537201229|FG000|Post-ART|Lost to Follow-up|3|||
148922736|NCT02437110|537201229|FG000|Post-ART|Protocol Violation|4|||
148922737|NCT02437110|537201229|FG000|Post-ART|Withdrawal by Subject|3|||
148922738|NCT02660138|537201231|FG000|Overall Study|Adverse Event|0|||
148922739|NCT02660138|537201232|FG001|Overall Study|Adverse Event|3|||
148922740|NCT02660138|537201233|FG002|Overall Study|Adverse Event|2|||
148922741|NCT02660138|537201231|FG000|Overall Study|Lack of Efficacy|1|||
148922742|NCT02660138|537201232|FG001|Overall Study|Lack of Efficacy|2|||
148922743|NCT02660138|537201233|FG002|Overall Study|Lack of Efficacy|1|||
148922744|NCT02660138|537201231|FG000|Overall Study|Withdrawal by Subject|7|||
148922745|NCT02660138|537201232|FG001|Overall Study|Withdrawal by Subject|6|||
148922746|NCT02660138|537201233|FG002|Overall Study|Withdrawal by Subject|6|||
148922747|NCT02660138|537201231|FG000|Overall Study|Lost to Follow-up|4|||
148922748|NCT02660138|537201232|FG001|Overall Study|Lost to Follow-up|4|||
148922749|NCT02660138|537201233|FG002|Overall Study|Lost to Follow-up|1|||
148922750|NCT02660138|537201231|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
148922751|NCT02660138|537201232|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
148922752|NCT02660138|537201233|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
148922753|NCT02660138|537201231|FG000|Overall Study|Other|1|||
148922754|NCT02660138|537201232|FG001|Overall Study|Other|1|||
148922755|NCT02660138|537201233|FG002|Overall Study|Other|0|||
148922756|NCT02660138|537201231|FG000|Overall Study|Not treated|0|||
148922757|NCT02660138|537201232|FG001|Overall Study|Not treated|1|||
148922758|NCT02660138|537201233|FG002|Overall Study|Not treated|0|||
148922759|NCT03400956|537201242|FG000|Treatment Period 1|Adverse Event|0|||
148922760|NCT03400956|537201243|FG001|Treatment Period 1|Adverse Event|1|||
148922761|NCT03400956|537201244|FG002|Treatment Period 1|Adverse Event|0|||
148922762|NCT03400956|537201242|FG000|Treatment Period 1|Lost to Follow-up|0|||
148922763|NCT03400956|537201243|FG001|Treatment Period 1|Lost to Follow-up|0|||
148922764|NCT03400956|537201244|FG002|Treatment Period 1|Lost to Follow-up|1|||
148922765|NCT03400956|537201242|FG000|Treatment Period 1|Protocol Violation|0|||
148922766|NCT03400956|537201243|FG001|Treatment Period 1|Protocol Violation|2|||
148922767|NCT03400956|537201244|FG002|Treatment Period 1|Protocol Violation|0|||
148922768|NCT03400956|537201242|FG000|Treatment Period 1|Study terminated by sponsor|3|||
148922769|NCT03400956|537201243|FG001|Treatment Period 1|Study terminated by sponsor|1|||
148922770|NCT03400956|537201244|FG002|Treatment Period 1|Study terminated by sponsor|1|||
148922771|NCT03400956|537201242|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148922772|NCT03400956|537201243|FG001|Treatment Period 1|Withdrawal by Subject|2|||
148922773|NCT03400956|537201244|FG002|Treatment Period 1|Withdrawal by Subject|4|||
148922774|NCT03400956|537201242|FG000|Treatment Period 1|Other|1|||
148922775|NCT03400956|537201243|FG001|Treatment Period 1|Other|2|||
148922776|NCT03400956|537201244|FG002|Treatment Period 1|Other|3|||
148922777|NCT03400956|537201242|FG000|Post-treatment Period 1|Adverse Event|0|||
148922778|NCT03400956|537201243|FG001|Post-treatment Period 1|Adverse Event|0|||
148922779|NCT03400956|537201244|FG002|Post-treatment Period 1|Adverse Event|1|||
148922780|NCT03400956|537201242|FG000|Post-treatment Period 1|Physician Decision|2|||
148922781|NCT03400956|537201243|FG001|Post-treatment Period 1|Physician Decision|3|||
148922782|NCT03400956|537201244|FG002|Post-treatment Period 1|Physician Decision|0|||
148922783|NCT03400956|537201242|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
148922784|NCT03400956|537201243|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
148922785|NCT03400956|537201244|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
148922786|NCT03400956|537201242|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
148922787|NCT03400956|537201243|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
148922788|NCT03400956|537201244|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
148922789|NCT03400956|537201242|FG000|Post-treatment Period 1|Other|4|||
148922790|NCT03400956|537201243|FG001|Post-treatment Period 1|Other|3|||
148922791|NCT03400956|537201244|FG002|Post-treatment Period 1|Other|4|||
148922792|NCT03400956|537201242|FG000|Treatment Period 2|Adverse Event|2|||
148922793|NCT03400956|537201243|FG001|Treatment Period 2|Adverse Event|1|||
148922794|NCT03400956|537201244|FG002|Treatment Period 2|Adverse Event|1|||
148922795|NCT03400956|537201242|FG000|Treatment Period 2|Lost to Follow-up|1|||
148922796|NCT03400956|537201243|FG001|Treatment Period 2|Lost to Follow-up|1|||
148922797|NCT03400956|537201244|FG002|Treatment Period 2|Lost to Follow-up|0|||
148922798|NCT03400956|537201242|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148922799|NCT03400956|537201243|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148922800|NCT03400956|537201244|FG002|Treatment Period 2|Withdrawal by Subject|3|||
148922801|NCT03400956|537201242|FG000|Treatment Period 2|Other|1|||
148922802|NCT03400956|537201243|FG001|Treatment Period 2|Other|1|||
148922803|NCT03400956|537201244|FG002|Treatment Period 2|Other|0|||
148922804|NCT03400956|537201242|FG000|Follow-up Period|Withdrawal by Subject|0|||
148922805|NCT03400956|537201243|FG001|Follow-up Period|Withdrawal by Subject|0|||
148922806|NCT03400956|537201244|FG002|Follow-up Period|Withdrawal by Subject|1|||
148922807|NCT03400956|537201242|FG000|Follow-up Period|Other|0|||
148922808|NCT03400956|537201243|FG001|Follow-up Period|Other|0|||
148922809|NCT03400956|537201244|FG002|Follow-up Period|Other|1|||
148922810|NCT02048241|537201245|FG000|Overall Study|Withdrawal by Subject|0|||
148922811|NCT02048241|537201246|FG001|Overall Study|Withdrawal by Subject|1|||
148922812|NCT03044574|537201247|FG000|Overall Study|Lost to Follow-up|37|||
148922813|NCT03044574|537201248|FG001|Overall Study|Lost to Follow-up|45|||
148922814|NCT01700439|537201252|FG000|Overall Study|Lost to Follow-up|47|||
148922815|NCT01700439|537201252|FG000|Overall Study|Withdrawal by Subject|183|||
148922816|NCT01700439|537201252|FG000|Overall Study|Death|186|||
148922817|NCT01829243|537201259|FG000|First Intervention|Screen Failure|4|||
148922818|NCT01829243|537201260|FG001|First Intervention|Screen Failure|2|||
148922819|NCT00053898|537201268|FG000|Overall Study|No follow-up data from any source|9|||
148922820|NCT00053898|537201269|FG001|Overall Study|No follow-up data from any source|12|||
148922821|NCT00053898|537201268|FG000|Overall Study|Follow-up from telephone contact only|5|||
148922822|NCT00053898|537201269|FG001|Overall Study|Follow-up from telephone contact only|1|||
148922823|NCT00266877|537201270|FG000|Overall Study|Death|1|||
148922824|NCT00266877|537201271|FG001|Overall Study|Death|1|||
148922825|NCT00266877|537201272|FG002|Overall Study|Death|1|||
148922826|NCT00266877|537201270|FG000|Overall Study|Adverse Event|6|||
148922827|NCT00266877|537201271|FG001|Overall Study|Adverse Event|4|||
148922828|NCT00266877|537201272|FG002|Overall Study|Adverse Event|1|||
148922829|NCT00266877|537201270|FG000|Overall Study|Physician Decision|2|||
148922830|NCT00266877|537201271|FG001|Overall Study|Physician Decision|1|||
148922831|NCT00266877|537201272|FG002|Overall Study|Physician Decision|1|||
148922832|NCT00266877|537201270|FG000|Overall Study|Withdrawal by Subject|3|||
148922833|NCT00266877|537201271|FG001|Overall Study|Withdrawal by Subject|1|||
148922834|NCT00266877|537201272|FG002|Overall Study|Withdrawal by Subject|1|||
148922835|NCT00266877|537201270|FG000|Overall Study|Disease Progression|72|||
148922836|NCT00266877|537201271|FG001|Overall Study|Disease Progression|37|||
148922837|NCT00266877|537201272|FG002|Overall Study|Disease Progression|23|||
148922838|NCT00266877|537201270|FG000|Overall Study|Symptomatic Deterioration|6|||
148922839|NCT00266877|537201271|FG001|Overall Study|Symptomatic Deterioration|3|||
148922840|NCT00266877|537201272|FG002|Overall Study|Symptomatic Deterioration|1|||
148922841|NCT00266877|537201270|FG000|Overall Study|Hospitalization|1|||
148922842|NCT00266877|537201271|FG001|Overall Study|Hospitalization|0|||
148922843|NCT00266877|537201272|FG002|Overall Study|Hospitalization|0|||
148922844|NCT00266877|537201270|FG000|Overall Study|Concomitant Radiotherapy|0|||
148922845|NCT00266877|537201271|FG001|Overall Study|Concomitant Radiotherapy|1|||
148922846|NCT00266877|537201272|FG002|Overall Study|Concomitant Radiotherapy|0|||
148922847|NCT01089361|537201277|FG000|Overall Study|Death|1|||
148922848|NCT01089361|537201278|FG001|Overall Study|Death|0|||
148922849|NCT01606878|537201279|FG000|Overall Study|Adverse Event|1|||
148922850|NCT01606878|537201280|FG001|Overall Study|Adverse Event|1|||
148922851|NCT01606878|537201281|FG002|Overall Study|Adverse Event|0|||
148922852|NCT01606878|537201282|FG003|Overall Study|Adverse Event|0|||
148922853|NCT01606878|537201283|FG004|Overall Study|Adverse Event|0|||
148922854|NCT01606878|537201284|FG005|Overall Study|Adverse Event|0|||
148922855|NCT01606878|537201285|FG006|Overall Study|Adverse Event|1|||
148922856|NCT01606878|537201286|FG007|Overall Study|Adverse Event|0|||
148922857|NCT01606878|537201287|FG008|Overall Study|Adverse Event|1|||
148922858|NCT01606878|537201288|FG009|Overall Study|Adverse Event|3|||
148922859|NCT01606878|537201289|FG010|Overall Study|Adverse Event|0|||
148922860|NCT01606878|537201279|FG000|Overall Study|Lack of Efficacy|1|||
148922861|NCT01606878|537201280|FG001|Overall Study|Lack of Efficacy|1|||
148922862|NCT01606878|537201281|FG002|Overall Study|Lack of Efficacy|1|||
148922863|NCT01606878|537201282|FG003|Overall Study|Lack of Efficacy|2|||
148922864|NCT01606878|537201283|FG004|Overall Study|Lack of Efficacy|1|||
148922865|NCT01606878|537201284|FG005|Overall Study|Lack of Efficacy|2|||
148922866|NCT01606878|537201285|FG006|Overall Study|Lack of Efficacy|1|||
148922867|NCT01606878|537201286|FG007|Overall Study|Lack of Efficacy|2|||
148922868|NCT01606878|537201287|FG008|Overall Study|Lack of Efficacy|2|||
148922869|NCT01606878|537201288|FG009|Overall Study|Lack of Efficacy|0|||
148922870|NCT01606878|537201289|FG010|Overall Study|Lack of Efficacy|1|||
148922871|NCT01606878|537201279|FG000|Overall Study|Physician Decision|1|||
148922872|NCT01606878|537201280|FG001|Overall Study|Physician Decision|0|||
148922873|NCT01606878|537201281|FG002|Overall Study|Physician Decision|2|||
148922874|NCT01606878|537201282|FG003|Overall Study|Physician Decision|1|||
148922875|NCT01606878|537201283|FG004|Overall Study|Physician Decision|1|||
148922876|NCT01606878|537201284|FG005|Overall Study|Physician Decision|1|||
148922877|NCT01606878|537201285|FG006|Overall Study|Physician Decision|2|||
148922878|NCT01606878|537201286|FG007|Overall Study|Physician Decision|0|||
148922879|NCT01606878|537201287|FG008|Overall Study|Physician Decision|1|||
148922880|NCT01606878|537201288|FG009|Overall Study|Physician Decision|0|||
148922881|NCT01606878|537201289|FG010|Overall Study|Physician Decision|0|||
148922882|NCT01606878|537201279|FG000|Overall Study|Withdrawal by Subject|3|||
148922883|NCT01606878|537201280|FG001|Overall Study|Withdrawal by Subject|2|||
148922884|NCT01606878|537201281|FG002|Overall Study|Withdrawal by Subject|2|||
148922885|NCT01606878|537201282|FG003|Overall Study|Withdrawal by Subject|0|||
148922886|NCT01606878|537201283|FG004|Overall Study|Withdrawal by Subject|1|||
148922887|NCT01606878|537201284|FG005|Overall Study|Withdrawal by Subject|1|||
148922888|NCT01606878|537201285|FG006|Overall Study|Withdrawal by Subject|2|||
148922889|NCT01606878|537201286|FG007|Overall Study|Withdrawal by Subject|1|||
148922890|NCT01606878|537201287|FG008|Overall Study|Withdrawal by Subject|2|||
148922891|NCT01606878|537201288|FG009|Overall Study|Withdrawal by Subject|0|||
148922892|NCT01606878|537201289|FG010|Overall Study|Withdrawal by Subject|2|||
148922893|NCT01159431|537201290|FG000|Overall Study|Adverse Event|1|||
148922894|NCT01159431|537201291|FG001|Overall Study|Adverse Event|2|||
148922895|NCT01159431|537201290|FG000|Overall Study|non-compliance|1|||
148922896|NCT01159431|537201291|FG001|Overall Study|non-compliance|1|||
148922897|NCT01159431|537201290|FG000|Overall Study|Lack of Efficacy|0|||
148922898|NCT01159431|537201291|FG001|Overall Study|Lack of Efficacy|3|||
148922899|NCT03353740|537201292|FG000|Overall Study|Images for these participants not viable|52|||
148922900|NCT00604214|537201294|FG000|Baseline to Day 28|Death|223|||
148922901|NCT00604214|537201295|FG001|Baseline to Day 28|Death|202|||
148922902|NCT00604214|537201294|FG000|Baseline to Day 28|Lost to Follow-up|2|||
148922903|NCT00604214|537201295|FG001|Baseline to Day 28|Lost to Follow-up|4|||
148922904|NCT00604214|537201294|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
148922905|NCT00604214|537201295|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
148922906|NCT00604214|537201294|FG000|Day 29 to Day 90|Death|64|||
148922907|NCT00604214|537201295|FG001|Day 29 to Day 90|Death|67|||
148922908|NCT00604214|537201294|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
148922909|NCT00604214|537201295|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
148922910|NCT00604214|537201294|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
148922911|NCT00604214|537201295|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
148922912|NCT00604214|537201294|FG000|Day 91 to Day 180|Death|19|||
148922913|NCT00604214|537201295|FG001|Day 91 to Day 180|Death|23|||
148922914|NCT00604214|537201294|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
148922915|NCT00604214|537201295|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
148922916|NCT00604214|537201294|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
148922917|NCT00604214|537201295|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
148922918|NCT00130442|537202953|FG000|Overall Study|Withdrawal by Subject|0|||
148922919|NCT00130442|537202954|FG001|Overall Study|Withdrawal by Subject|1|||
148922920|NCT00130442|537202953|FG000|Overall Study|did not meet criteria|1|||
148922921|NCT00130442|537202954|FG001|Overall Study|did not meet criteria|1|||
148922922|NCT00814333|537202955|FG000|Enrollment|Lost to Follow-up|1|||
148922923|NCT00814333|537202956|FG001|Enrollment|Lost to Follow-up|0|||
148922924|NCT01527357|537202957|FG000|Overall Study|Death|8|||
148922925|NCT01527357|537202958|FG001|Overall Study|Death|2|||
148922926|NCT01527357|537202957|FG000|Overall Study|Lost to Follow-up|6|||
148922927|NCT01527357|537202958|FG001|Overall Study|Lost to Follow-up|4|||
148922928|NCT01527357|537202957|FG000|Overall Study|Withdrew Consent|1|||
148922929|NCT01527357|537202958|FG001|Overall Study|Withdrew Consent|1|||
148922930|NCT01527357|537202957|FG000|Overall Study|Non-compliance|0|||
148922931|NCT01527357|537202958|FG001|Overall Study|Non-compliance|1|||
148922932|NCT01527357|537202957|FG000|Overall Study|No Day 29 Visit|0|||
148922933|NCT01527357|537202958|FG001|Overall Study|No Day 29 Visit|1|||
148922934|NCT01527357|537202957|FG000|Overall Study|Did Not Receive Treatment|2|||
148922935|NCT01527357|537202958|FG001|Overall Study|Did Not Receive Treatment|0|||
148922936|NCT00910247|537202959|FG000|Overall Study|Adverse Event|15|||
148922937|NCT00910247|537202959|FG000|Overall Study|Death|2|||
148922938|NCT00910247|537202959|FG000|Overall Study|Lost to Follow-up|10|||
148922939|NCT00910247|537202959|FG000|Overall Study|Physician Decision|3|||
148922940|NCT00910247|537202959|FG000|Overall Study|Protocol Violation|10|||
148922941|NCT00910247|537202959|FG000|Overall Study|Withdrawal by Subject|25|||
148922942|NCT00910247|537202959|FG000|Overall Study|Not collected|4|||
148922943|NCT02519855|537202960|FG000|Overall Study|Adverse Event|0|||
148922944|NCT02519855|537202961|FG001|Overall Study|Adverse Event|1|||
148922945|NCT02519855|537202960|FG000|Overall Study|Lost to Follow-up|3|||
148922946|NCT02519855|537202961|FG001|Overall Study|Lost to Follow-up|3|||
148922947|NCT03565367|537202962|FG000|Overall Study|No scan due to technical issues|4|||
148922948|NCT03565367|537202963|FG001|Overall Study|No scan due to technical issues|0|||
148922949|NCT01397825|537202968|FG000|Overall Study|Progressive Disease|10|||
148922950|NCT01397825|537202969|FG001|Overall Study|Progressive Disease|3|||
148922951|NCT01397825|537202970|FG002|Overall Study|Progressive Disease|11|||
148922952|NCT01397825|537202971|FG003|Overall Study|Progressive Disease|1|||
148922953|NCT01397825|537202972|FG004|Overall Study|Progressive Disease|0|||
148922954|NCT01397825|537202968|FG000|Overall Study|Symptomatic Deterioration|2|||
148922955|NCT01397825|537202969|FG001|Overall Study|Symptomatic Deterioration|0|||
148922956|NCT01397825|537202970|FG002|Overall Study|Symptomatic Deterioration|4|||
148922957|NCT01397825|537202971|FG003|Overall Study|Symptomatic Deterioration|0|||
148922958|NCT01397825|537202972|FG004|Overall Study|Symptomatic Deterioration|0|||
148922959|NCT01397825|537202968|FG000|Overall Study|Adverse Event|0|||
148922960|NCT01397825|537202969|FG001|Overall Study|Adverse Event|1|||
148922961|NCT01397825|537202970|FG002|Overall Study|Adverse Event|5|||
148922962|NCT01397825|537202971|FG003|Overall Study|Adverse Event|1|||
148922963|NCT01397825|537202972|FG004|Overall Study|Adverse Event|0|||
148922964|NCT01397825|537202968|FG000|Overall Study|Withdrawal by Subject|1|||
148922965|NCT01397825|537202969|FG001|Overall Study|Withdrawal by Subject|0|||
148922966|NCT01397825|537202970|FG002|Overall Study|Withdrawal by Subject|5|||
148922967|NCT01397825|537202971|FG003|Overall Study|Withdrawal by Subject|1|||
148922968|NCT01397825|537202972|FG004|Overall Study|Withdrawal by Subject|0|||
148922969|NCT01931670|537202973|FG000|Treatment Period|Exclusionary Medication Received|1|||
148922970|NCT01931670|537202974|FG001|Treatment Period|Exclusionary Medication Received|1|||
148922971|NCT01931670|537202975|FG002|Treatment Period|Exclusionary Medication Received|1|||
148922972|NCT01931670|537202973|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
148922973|NCT01931670|537202974|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
148922974|NCT01931670|537202975|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
148922975|NCT01931670|537202973|FG000|Treatment Period|Subject Noncompliant|4|||
148922976|NCT01931670|537202974|FG001|Treatment Period|Subject Noncompliant|9|||
148922977|NCT01931670|537202975|FG002|Treatment Period|Subject Noncompliant|5|||
148922978|NCT01931670|537202973|FG000|Treatment Period|Adverse Event|19|||
148922979|NCT01931670|537202974|FG001|Treatment Period|Adverse Event|8|||
148922980|NCT01931670|537202975|FG002|Treatment Period|Adverse Event|21|||
148922981|NCT01931670|537202973|FG000|Treatment Period|Lack of Efficacy|11|||
148922982|NCT01931670|537202974|FG001|Treatment Period|Lack of Efficacy|2|||
148922983|NCT01931670|537202975|FG002|Treatment Period|Lack of Efficacy|2|||
148922984|NCT01931670|537202973|FG000|Treatment Period|Pregnancy|7|||
148922985|NCT01931670|537202974|FG001|Treatment Period|Pregnancy|2|||
148922986|NCT01931670|537202975|FG002|Treatment Period|Pregnancy|0|||
148922987|NCT01931670|537202973|FG000|Treatment Period|Other|8|||
148922988|NCT01931670|537202974|FG001|Treatment Period|Other|7|||
148922989|NCT01931670|537202975|FG002|Treatment Period|Other|2|||
148922990|NCT01931670|537202973|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
148922991|NCT01931670|537202974|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
148922992|NCT01931670|537202975|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
148922993|NCT01931670|537202973|FG000|Treatment Period|Lost to Follow-up|19|||
148922994|NCT01931670|537202974|FG001|Treatment Period|Lost to Follow-up|5|||
148922995|NCT01931670|537202975|FG002|Treatment Period|Lost to Follow-up|7|||
148922996|NCT01931670|537202973|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
148922997|NCT01931670|537202974|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
148922998|NCT01931670|537202975|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
148922999|NCT01931670|537202973|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
148923000|NCT01931670|537202974|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
148923001|NCT01931670|537202975|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
148923002|NCT01931670|537202973|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
148923003|NCT01931670|537202974|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
148923004|NCT01931670|537202975|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
148923005|NCT01931670|537202973|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
148923006|NCT01931670|537202974|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
148923007|NCT01931670|537202975|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
148923008|NCT01931670|537202973|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
148923009|NCT01931670|537202974|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
148923010|NCT01931670|537202975|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
148923011|NCT01931670|537202973|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
148923012|NCT01931670|537202974|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
148923013|NCT01931670|537202975|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
148923014|NCT00976508|537202977|FG000|Overall Study|Death|7|||
148923015|NCT00976508|537202978|FG001|Overall Study|Death|1|||
148923016|NCT00976508|537202977|FG000|Overall Study|Lost to Follow-up|1|||
148923017|NCT00976508|537202978|FG001|Overall Study|Lost to Follow-up|0|||
148923018|NCT00976508|537202977|FG000|Overall Study|Withdrawal by Subject|1|||
148923019|NCT00976508|537202978|FG001|Overall Study|Withdrawal by Subject|0|||
148923020|NCT00976508|537202977|FG000|Overall Study|Disease Progression|4|||
148923021|NCT00976508|537202978|FG001|Overall Study|Disease Progression|4|||
148923022|NCT00976508|537202977|FG000|Overall Study|Subject Enrolled in Hospice|1|||
148923023|NCT00976508|537202978|FG001|Overall Study|Subject Enrolled in Hospice|0|||
148923024|NCT00976508|537202977|FG000|Overall Study|Terminated by the Sponsor|0|||
148923025|NCT00976508|537202978|FG001|Overall Study|Terminated by the Sponsor|1|||
148923026|NCT04352127|537202979|FG000|Overall Study|Unable to obtain readings|4|||
148923027|NCT04352127|537202980|FG001|Overall Study|Unable to obtain readings|1|||
148923028|NCT01992159|537202981|FG000|Overall Study|Withdrawal by Subject|4|||
148923029|NCT01992159|537202982|FG001|Overall Study|Withdrawal by Subject|7|||
148923030|NCT01992159|537202983|FG002|Overall Study|Withdrawal by Subject|0|||
148923031|NCT01992159|537202984|FG003|Overall Study|Withdrawal by Subject|3|||
148923032|NCT01992159|537202981|FG000|Overall Study|Adverse Event|0|||
148923033|NCT01992159|537202982|FG001|Overall Study|Adverse Event|1|||
148923034|NCT01992159|537202983|FG002|Overall Study|Adverse Event|0|||
148923035|NCT01992159|537202984|FG003|Overall Study|Adverse Event|1|||
148923036|NCT01992159|537202981|FG000|Overall Study|Death|0|||
148923037|NCT01992159|537202982|FG001|Overall Study|Death|0|||
148923038|NCT01992159|537202983|FG002|Overall Study|Death|1|||
148923039|NCT01992159|537202984|FG003|Overall Study|Death|0|||
148923040|NCT02160002|537202987|FG000|Overall Study|Withdrawal by Subject|2|||
148923041|NCT02160002|537202988|FG001|Overall Study|Withdrawal by Subject|1|||
148923042|NCT05028361|537202989|FG000|Overall Study|Withdrawal by Subject|1|||
148923043|NCT05028361|537202990|FG001|Overall Study|Withdrawal by Subject|0|||
148923044|NCT00779259|537202991|FG000|Quinine Alone|Adverse Event|2|||
148923045|NCT00282464|537202994|FG000|Overall Study|Adverse Event|26|||
148923046|NCT00282464|537202995|FG001|Overall Study|Adverse Event|20|||
148923047|NCT00282464|537202994|FG000|Overall Study|Lack of Efficacy|8|||
148923048|NCT00282464|537202995|FG001|Overall Study|Lack of Efficacy|8|||
148923049|NCT00282464|537202994|FG000|Overall Study|Lost to Follow-up|10|||
148923050|NCT00282464|537202995|FG001|Overall Study|Lost to Follow-up|10|||
148923051|NCT00282464|537202994|FG000|Overall Study|Withdrawal by Subject|24|||
148673576|NCT00424632|536275798|FG002|Overall Study|Death|0|||
148673577|NCT00424632|536275799|FG003|Overall Study|Death|0|||
148923052|NCT00282464|537202995|FG001|Overall Study|Withdrawal by Subject|10|||
148923053|NCT00282464|537202994|FG000|Overall Study|laboratory abnormality|1|||
148923054|NCT00282464|537202995|FG001|Overall Study|laboratory abnormality|2|||
148923055|NCT00282464|537202994|FG000|Overall Study|Protocol Violation|0|||
148923056|NCT00282464|537202995|FG001|Overall Study|Protocol Violation|7|||
148923057|NCT00282464|537202994|FG000|Overall Study|Patient moved|1|||
148923058|NCT00282464|537202995|FG001|Overall Study|Patient moved|0|||
148923059|NCT00282464|537202994|FG000|Overall Study|patient non-compliant|3|||
148923060|NCT00282464|537202995|FG001|Overall Study|patient non-compliant|0|||
148923061|NCT00282464|537202994|FG000|Overall Study|patient no show|0|||
148923062|NCT00282464|537202995|FG001|Overall Study|patient no show|1|||
148923063|NCT00282464|537202994|FG000|Overall Study|patient incarcerated|0|||
148923064|NCT00282464|537202995|FG001|Overall Study|patient incarcerated|1|||
148923065|NCT00282464|537202994|FG000|Overall Study|family crisis|0|||
148923066|NCT00282464|537202995|FG001|Overall Study|family crisis|1|||
148923067|NCT00282464|537202994|FG000|Overall Study|dispensed wrong kit|0|||
148923068|NCT00282464|537202995|FG001|Overall Study|dispensed wrong kit|1|||
148923069|NCT00282464|537202994|FG000|Overall Study|dropped due to missed visits|0|||
148923070|NCT00282464|537202995|FG001|Overall Study|dropped due to missed visits|1|||
148923071|NCT01214174|537202996|FG000|Overall Study|Withdrawal by Subject|0|||
148923072|NCT01214174|537202997|FG001|Overall Study|Withdrawal by Subject|0|||
148923073|NCT01214174|537202998|FG002|Overall Study|Withdrawal by Subject|1|||
148923074|NCT02963831|537203001|FG000|Overall Study|Progressive Disease|3|||
148923075|NCT02963831|537203002|FG001|Overall Study|Progressive Disease|3|||
148923076|NCT02963831|537203003|FG002|Overall Study|Progressive Disease|16|||
148923077|NCT02963831|537203004|FG003|Overall Study|Progressive Disease|27|||
148923078|NCT02963831|537203001|FG000|Overall Study|Withdrawal by Subject|1|||
148923079|NCT02963831|537203002|FG001|Overall Study|Withdrawal by Subject|0|||
148923080|NCT02963831|537203003|FG002|Overall Study|Withdrawal by Subject|2|||
148923081|NCT02963831|537203004|FG003|Overall Study|Withdrawal by Subject|4|||
148923082|NCT02963831|537203001|FG000|Overall Study|Adverse Event|0|||
148923083|NCT02963831|537203002|FG001|Overall Study|Adverse Event|1|||
148923084|NCT02963831|537203003|FG002|Overall Study|Adverse Event|1|||
148923085|NCT02963831|537203004|FG003|Overall Study|Adverse Event|2|||
148923086|NCT02963831|537203001|FG000|Overall Study|Death|0|||
148923087|NCT02963831|537203002|FG001|Overall Study|Death|0|||
148923088|NCT02963831|537203003|FG002|Overall Study|Death|0|||
148923089|NCT02963831|537203004|FG003|Overall Study|Death|2|||
148923090|NCT01966432|537203005|FG000|Overall Study|Lost to Follow-up|3|||
148923091|NCT01966432|537203006|FG001|Overall Study|Lost to Follow-up|2|||
148923092|NCT01966432|537203007|FG002|Overall Study|Lost to Follow-up|5|||
148923093|NCT01966432|537203005|FG000|Overall Study|Withdrawal by Subject|1|||
148923094|NCT01966432|537203006|FG001|Overall Study|Withdrawal by Subject|3|||
148923095|NCT01966432|537203007|FG002|Overall Study|Withdrawal by Subject|0|||
148923096|NCT01966432|537203005|FG000|Overall Study|Subject Incarcerated|0|||
148923097|NCT01966432|537203006|FG001|Overall Study|Subject Incarcerated|0|||
148923098|NCT01966432|537203007|FG002|Overall Study|Subject Incarcerated|1|||
148923099|NCT01966432|537203005|FG000|Overall Study|SBIRT program ended|1|||
148923100|NCT01966432|537203006|FG001|Overall Study|SBIRT program ended|8|||
148923101|NCT01966432|537203007|FG002|Overall Study|SBIRT program ended|20|||
148923102|NCT02815280|537203008|FG000|Double-Blind Phase|Adverse Event|1|||
148923103|NCT02815280|537203009|FG001|Double-Blind Phase|Adverse Event|1|||
148923104|NCT02815280|537203008|FG000|Double-Blind Phase|Lost to Follow-up|10|||
148923105|NCT02815280|537203009|FG001|Double-Blind Phase|Lost to Follow-up|9|||
148923106|NCT02815280|537203008|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
148923107|NCT02815280|537203009|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
148923108|NCT02815280|537203008|FG000|Double-Blind Phase|Protocol Violation|2|||
148923109|NCT02815280|537203009|FG001|Double-Blind Phase|Protocol Violation|2|||
148923110|NCT02815280|537203008|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
148923111|NCT02815280|537203009|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
148923112|NCT02815280|537203008|FG000|Open-Label Phase|Adverse Event|2|||
148923113|NCT02815280|537203009|FG001|Open-Label Phase|Adverse Event|3|||
148923114|NCT02815280|537203008|FG000|Open-Label Phase|Lost to Follow-up|18|||
148923115|NCT02815280|537203009|FG001|Open-Label Phase|Lost to Follow-up|9|||
148923116|NCT02815280|537203008|FG000|Open-Label Phase|Withdrawal by Subject|33|||
148923117|NCT02815280|537203009|FG001|Open-Label Phase|Withdrawal by Subject|18|||
148923118|NCT02815280|537203008|FG000|Open-Label Phase|Protocol Violation|3|||
148923119|NCT02815280|537203009|FG001|Open-Label Phase|Protocol Violation|0|||
148923120|NCT02815280|537203008|FG000|Open-Label Phase|Administrative|26|||
148923121|NCT02815280|537203009|FG001|Open-Label Phase|Administrative|12|||
148923122|NCT02815280|537203008|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
148923123|NCT02815280|537203009|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
148923124|NCT02514473|537203017|FG000|Overall Study|Adverse Event|0|||
148923125|NCT02514473|537203018|FG001|Overall Study|Adverse Event|2|||
148923126|NCT02514473|537203017|FG000|Overall Study|Withdrawal by Subject|2|||
148923127|NCT02514473|537203018|FG001|Overall Study|Withdrawal by Subject|1|||
148923128|NCT02514473|537203017|FG000|Overall Study|Lost to Follow-up|0|||
148923129|NCT02514473|537203018|FG001|Overall Study|Lost to Follow-up|1|||
148923130|NCT02514473|537203017|FG000|Overall Study|Other|1|||
148923131|NCT02514473|537203018|FG001|Overall Study|Other|1|||
148923132|NCT01107379|537203021|FG000|Overall Study|Withdrawal by Subject|18|||
148923133|NCT01107379|537203021|FG000|Overall Study|Lost to Follow-up|3|||
148923134|NCT04559529|537203022|FG000|First Intervention (1 Day)|Adverse Event|0|||
148923135|NCT04559529|537203023|FG001|First Intervention (1 Day)|Adverse Event|0|||
148923136|NCT04559529|537203024|FG002|First Intervention (1 Day)|Adverse Event|0|||
148673578|NCT00424632|536275800|FG004|Overall Study|Death|0|||
148673579|NCT00424632|536275801|FG005|Overall Study|Death|2|||
148673580|NCT00424632|536275802|FG006|Overall Study|Death|0|||
148673581|NCT00424632|536275803|FG007|Overall Study|Death|0|||
148923137|NCT04559529|537203025|FG003|First Intervention (1 Day)|Adverse Event|1|||
148923138|NCT04559529|537203022|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
148923139|NCT04559529|537203023|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
148923140|NCT04559529|537203024|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
148923141|NCT04559529|537203025|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
148923142|NCT04559529|537203022|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
148923143|NCT04559529|537203023|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
148923144|NCT04559529|537203024|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
148923145|NCT04559529|537203025|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
148923146|NCT04098224|537203028|FG000|Overall Study|Adverse Event|1|||
148923147|NCT04098224|537203029|FG001|Overall Study|Adverse Event|0|||
148923148|NCT04098224|537203028|FG000|Overall Study|Physician Decision|1|||
148923149|NCT04098224|537203029|FG001|Overall Study|Physician Decision|0|||
148923150|NCT04098224|537203028|FG000|Overall Study|Patient not required enteral feeding|1|||
148923151|NCT04098224|537203029|FG001|Overall Study|Patient not required enteral feeding|0|||
148923152|NCT04098224|537203028|FG000|Overall Study|Patient failure nasogastric tube|1|||
148923153|NCT04098224|537203029|FG001|Overall Study|Patient failure nasogastric tube|0|||
148923154|NCT04098224|537203028|FG000|Overall Study|Patient early extubation|1|||
148923155|NCT04098224|537203029|FG001|Overall Study|Patient early extubation|3|||
148923156|NCT01203852|537203033|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
148923157|NCT01203852|537203033|FG000|Washout 2 Weeks|Physician Decision|46|||
148923158|NCT02582684|537203036|FG000|Overall Study|Unable to contact subject/parent|4|||
148923159|NCT02582684|537203036|FG000|Overall Study|Subject not able to get to clinic|10|||
148923160|NCT02582684|537203036|FG000|Overall Study|Subject withdrew consent|1|||
148923161|NCT02582684|537203036|FG000|Overall Study|Found to be ineligible after enrollment|2|||
148923162|NCT01878149|537203037|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
148923163|NCT01878149|537203038|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
148923164|NCT04672252|537203041|FG000|Overall Study|Protocol Violation|1|||
148923165|NCT04672252|537203042|FG001|Overall Study|Protocol Violation|0|||
148923166|NCT01587898|537203047|FG000|Overall Study|Adverse Event|1|||
148923167|NCT01587898|537203048|FG001|Overall Study|Adverse Event|1|||
148923168|NCT01587898|537203049|FG002|Overall Study|Adverse Event|0|||
148923169|NCT01587898|537203050|FG003|Overall Study|Adverse Event|0|||
148923170|NCT01587898|537203047|FG000|Overall Study|Protocol Violation|0|||
148923171|NCT01587898|537203048|FG001|Overall Study|Protocol Violation|2|||
148923172|NCT01587898|537203049|FG002|Overall Study|Protocol Violation|1|||
148923173|NCT01587898|537203050|FG003|Overall Study|Protocol Violation|1|||
148923174|NCT01587898|537203047|FG000|Overall Study|Lost to Follow-up|0|||
148923175|NCT01587898|537203048|FG001|Overall Study|Lost to Follow-up|0|||
148923176|NCT01587898|537203049|FG002|Overall Study|Lost to Follow-up|0|||
148923177|NCT01587898|537203050|FG003|Overall Study|Lost to Follow-up|1|||
148923178|NCT01587898|537203047|FG000|Overall Study|Withdrawal by Subject|2|||
148923179|NCT01587898|537203048|FG001|Overall Study|Withdrawal by Subject|1|||
148923180|NCT01587898|537203049|FG002|Overall Study|Withdrawal by Subject|0|||
148923181|NCT01587898|537203050|FG003|Overall Study|Withdrawal by Subject|0|||
148923182|NCT01587898|537203047|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
148923183|NCT01587898|537203048|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
148923184|NCT01587898|537203049|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
148923185|NCT01587898|537203050|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
148923186|NCT01738477|537203051|FG000|Overall Study|Lost to Follow-up|1|||
148923187|NCT01738477|537203052|FG001|Overall Study|Lost to Follow-up|4|||
148673582|NCT00424632|536275804|FG008|Overall Study|Death|0|||
148673583|NCT00424632|536275805|FG009|Overall Study|Death|0|||
148673584|NCT00424632|536275796|FG000|Overall Study|Adverse Event|0|||
148673585|NCT00424632|536275797|FG001|Overall Study|Adverse Event|0|||
148923188|NCT00502203|537203053|FG000|Overall Study|Inevaluable|1|||
148923189|NCT01903252|537203056|FG000|Double-Blind Induction|Adverse Event|20|||
148923190|NCT01903252|537203057|FG001|Double-Blind Induction|Adverse Event|18|||
148923191|NCT01903252|537203058|FG002|Double-Blind Induction|Adverse Event|0|||
148923192|NCT01903252|537203059|FG003|Double-Blind Induction|Adverse Event|0|||
148923193|NCT01903252|537203060|FG004|Double-Blind Induction|Adverse Event|0|||
148923194|NCT01903252|537203061|FG005|Double-Blind Induction|Adverse Event|0|||
148923195|NCT01903252|537203056|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
148923196|NCT01903252|537203057|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
148923197|NCT01903252|537203058|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
148923198|NCT01903252|537203059|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
148923199|NCT01903252|537203060|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
148923200|NCT01903252|537203061|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
148923201|NCT01903252|537203056|FG000|Double-Blind Induction|Physician Decision|2|||
148923202|NCT01903252|537203057|FG001|Double-Blind Induction|Physician Decision|3|||
148923203|NCT01903252|537203058|FG002|Double-Blind Induction|Physician Decision|0|||
148923204|NCT01903252|537203059|FG003|Double-Blind Induction|Physician Decision|0|||
148923205|NCT01903252|537203060|FG004|Double-Blind Induction|Physician Decision|0|||
148923206|NCT01903252|537203061|FG005|Double-Blind Induction|Physician Decision|0|||
148923207|NCT01903252|537203056|FG000|Double-Blind Induction|non-compliance,|7|||
148923208|NCT01903252|537203057|FG001|Double-Blind Induction|non-compliance,|7|||
148923209|NCT01903252|537203058|FG002|Double-Blind Induction|non-compliance,|0|||
148923210|NCT01903252|537203059|FG003|Double-Blind Induction|non-compliance,|0|||
148923211|NCT01903252|537203060|FG004|Double-Blind Induction|non-compliance,|0|||
148923212|NCT01903252|537203061|FG005|Double-Blind Induction|non-compliance,|0|||
148923213|NCT01903252|537203056|FG000|Extended Induction, Open-Label|Adverse Event|0|||
148923214|NCT01903252|537203057|FG001|Extended Induction, Open-Label|Adverse Event|0|||
148923215|NCT01903252|537203058|FG002|Extended Induction, Open-Label|Adverse Event|17|||
148923216|NCT01903252|537203059|FG003|Extended Induction, Open-Label|Adverse Event|0|||
148923217|NCT01903252|537203060|FG004|Extended Induction, Open-Label|Adverse Event|0|||
148923218|NCT01903252|537203061|FG005|Extended Induction, Open-Label|Adverse Event|0|||
148923219|NCT01903252|537203056|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
148923220|NCT01903252|537203057|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
148923221|NCT01903252|537203058|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
148923222|NCT01903252|537203059|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
148923223|NCT01903252|537203060|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
148923224|NCT01903252|537203061|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
148923225|NCT01903252|537203056|FG000|Extended Induction, Open-Label|Physician Decision|0|||
148923226|NCT01903252|537203057|FG001|Extended Induction, Open-Label|Physician Decision|0|||
148923227|NCT01903252|537203058|FG002|Extended Induction, Open-Label|Physician Decision|1|||
148923228|NCT01903252|537203059|FG003|Extended Induction, Open-Label|Physician Decision|0|||
148923229|NCT01903252|537203060|FG004|Extended Induction, Open-Label|Physician Decision|0|||
148923230|NCT01903252|537203061|FG005|Extended Induction, Open-Label|Physician Decision|0|||
148923231|NCT01903252|537203056|FG000|Maintenance, Open-Label|Adverse Event|0|||
148923232|NCT01903252|537203057|FG001|Maintenance, Open-Label|Adverse Event|0|||
148923233|NCT01903252|537203058|FG002|Maintenance, Open-Label|Adverse Event|0|||
148923234|NCT01903252|537203059|FG003|Maintenance, Open-Label|Adverse Event|3|||
148923235|NCT01903252|537203060|FG004|Maintenance, Open-Label|Adverse Event|9|||
148923236|NCT01903252|537203061|FG005|Maintenance, Open-Label|Adverse Event|14|||
148923237|NCT01903252|537203056|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
148923238|NCT01903252|537203057|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
148923239|NCT01903252|537203058|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
148923240|NCT01903252|537203059|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
148923241|NCT01903252|537203060|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
148923242|NCT01903252|537203061|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
148923243|NCT01903252|537203056|FG000|Maintenance, Open-Label|Other|0|||
148923244|NCT01903252|537203057|FG001|Maintenance, Open-Label|Other|0|||
148923245|NCT01903252|537203058|FG002|Maintenance, Open-Label|Other|0|||
148923246|NCT01903252|537203059|FG003|Maintenance, Open-Label|Other|2|||
148923247|NCT01903252|537203060|FG004|Maintenance, Open-Label|Other|6|||
148923248|NCT01903252|537203061|FG005|Maintenance, Open-Label|Other|2|||
148923249|NCT03735238|537203062|FG000|Overall Study|Did not want to participate in research|3|||
148923250|NCT03735238|537203062|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
148923251|NCT01431638|537203063|FG000|Overall Study|Adverse Event|1|||
149157519|NCT02004873|538051852|FG000|Overall Study|Withdrawal by Subject|1|||
149157520|NCT01353703|538051853|FG000|Overall Study|Migrated/moved from study area|1|||
148923252|NCT01431638|537203064|FG001|Overall Study|Adverse Event|3|||
148923253|NCT01431638|537203065|FG002|Overall Study|Adverse Event|1|||
148923254|NCT01431638|537203063|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148923255|NCT01431638|537203064|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148923256|NCT01431638|537203065|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
148923257|NCT01431638|537203063|FG000|Overall Study|Participants condition no longer requires study drug|0|||
148923258|NCT01431638|537203064|FG001|Overall Study|Participants condition no longer requires study drug|1|||
148923259|NCT01431638|537203065|FG002|Overall Study|Participants condition no longer requires study drug|0|||
148923260|NCT01431638|537203063|FG000|Overall Study|Participant withdrew consent|14|||
148923261|NCT01431638|537203064|FG001|Overall Study|Participant withdrew consent|5|||
149157521|NCT01353703|538051854|FG001|Overall Study|Migrated/moved from study area|0|||
149157522|NCT00512798|538051856|FG000|Overall Study|Death|0|||
149157523|NCT00512798|538051857|FG001|Overall Study|Death|3|||
149157524|NCT00512798|538051856|FG000|Overall Study|Adverse Event|2|||
149157525|NCT00512798|538051857|FG001|Overall Study|Adverse Event|4|||
148923262|NCT01431638|537203065|FG002|Overall Study|Participant withdrew consent|8|||
149157526|NCT00512798|538051856|FG000|Overall Study|Progression of disease|14|||
149157527|NCT00512798|538051857|FG001|Overall Study|Progression of disease|20|||
149157528|NCT00512798|538051856|FG000|Overall Study|Withdrawal by Subject|3|||
149157529|NCT00512798|538051857|FG001|Overall Study|Withdrawal by Subject|0|||
149157530|NCT01984268|538051866|FG000|Overall Study|Study Terminated|15|||
149157531|NCT04622046|538051867|FG000|Intervention Period|Adverse Event|1|||
149157532|NCT04622046|538051867|FG000|Intervention Period|Withdrawal by Subject|2|||
149157533|NCT04622046|538051867|FG000|Extension Period|Ongoing in the Extension Period|21|||
149157534|NCT03505021|538051868|FG000|Overall Study|Protocol Violation|1|||
149157535|NCT03505021|538051869|FG001|Overall Study|Protocol Violation|0|||
149157536|NCT03505021|538051868|FG000|Overall Study|Death|9|||
148923263|NCT01431638|537203063|FG000|Overall Study|Lost to Follow-up|7|||
148923264|NCT01431638|537203064|FG001|Overall Study|Lost to Follow-up|9|||
148923265|NCT01431638|537203065|FG002|Overall Study|Lost to Follow-up|7|||
148923266|NCT01431638|537203063|FG000|Overall Study|Administrative problems|1|||
148923267|NCT01431638|537203064|FG001|Overall Study|Administrative problems|4|||
148923268|NCT01431638|537203065|FG002|Overall Study|Administrative problems|6|||
148923269|NCT01431638|537203063|FG000|Overall Study|Death|1|||
148923270|NCT01431638|537203064|FG001|Overall Study|Death|0|||
148923271|NCT01431638|537203065|FG002|Overall Study|Death|0|||
148923272|NCT01431638|537203063|FG000|Overall Study|Protocol deviation|1|||
148923273|NCT01431638|537203064|FG001|Overall Study|Protocol deviation|1|||
148923274|NCT01431638|537203065|FG002|Overall Study|Protocol deviation|4|||
148923275|NCT01431638|537203063|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
148923276|NCT01431638|537203064|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
148923277|NCT01431638|537203065|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
148923278|NCT01261780|537203066|FG000|Overall Study|Withdrawal by Subject|1|||
148923279|NCT01261780|537203067|FG001|Overall Study|Withdrawal by Subject|0|||
148923280|NCT01261780|537203066|FG000|Overall Study|Event not related to subject|1|||
148923281|NCT01261780|537203067|FG001|Overall Study|Event not related to subject|2|||
148923282|NCT03836001|537203068|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
148923283|NCT03836001|537203069|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
148923284|NCT03836001|537203070|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
148923285|NCT03836001|537203068|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
148923286|NCT03836001|537203069|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
148923287|NCT03836001|537203070|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
148923288|NCT03836001|537203068|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
148923289|NCT03836001|537203069|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
148923290|NCT03836001|537203070|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
148923291|NCT03836001|537203068|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
148923292|NCT03836001|537203069|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
148923293|NCT03836001|537203070|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
148923294|NCT01642732|537203071|FG000|Overall Study|Withdrawal by Subject|1|||
148923295|NCT00899353|537203072|FG000|Overall Study|Adverse Event|2|||
148923296|NCT00899353|537203072|FG000|Overall Study|Lost to Follow-up|1|||
148923297|NCT00899353|537203072|FG000|Overall Study|Withdrawal by Subject|2|||
148923298|NCT03562767|537203077|FG000|Overall Study|Physician Decision|2|||
148923299|NCT03562767|537203078|FG001|Overall Study|Physician Decision|0|||
148923300|NCT03562767|537203079|FG002|Overall Study|Physician Decision|0|||
148923301|NCT03562767|537203077|FG000|Overall Study|Logistic Reason|1|||
148923302|NCT03562767|537203078|FG001|Overall Study|Logistic Reason|3|||
148923303|NCT03562767|537203079|FG002|Overall Study|Logistic Reason|0|||
148923304|NCT00402233|537203084|FG000|Overall Study|Adverse Event|1|||
148923305|NCT00402233|537203085|FG001|Overall Study|Adverse Event|7|||
148923306|NCT00402233|537203086|FG002|Overall Study|Adverse Event|9|||
148923307|NCT00402233|537203087|FG003|Overall Study|Adverse Event|9|||
148923308|NCT00402233|537203084|FG000|Overall Study|Protocol Violation|0|||
148923309|NCT00402233|537203085|FG001|Overall Study|Protocol Violation|1|||
148923310|NCT00402233|537203086|FG002|Overall Study|Protocol Violation|0|||
148923311|NCT00402233|537203087|FG003|Overall Study|Protocol Violation|0|||
148923312|NCT00402233|537203084|FG000|Overall Study|Withdrawal by Subject|2|||
148923313|NCT00402233|537203085|FG001|Overall Study|Withdrawal by Subject|1|||
148923314|NCT00402233|537203086|FG002|Overall Study|Withdrawal by Subject|2|||
148923315|NCT00402233|537203087|FG003|Overall Study|Withdrawal by Subject|2|||
148923316|NCT00402233|537203084|FG000|Overall Study|Worsening of disease under study|2|||
148923317|NCT00402233|537203085|FG001|Overall Study|Worsening of disease under study|0|||
148923318|NCT00402233|537203086|FG002|Overall Study|Worsening of disease under study|0|||
148923319|NCT00402233|537203087|FG003|Overall Study|Worsening of disease under study|0|||
148923320|NCT00402233|537203084|FG000|Overall Study|Worsening of other pre-existing disease|0|||
148923321|NCT00402233|537203085|FG001|Overall Study|Worsening of other pre-existing disease|1|||
149157537|NCT03505021|538051869|FG001|Overall Study|Death|8|||
149157538|NCT03505021|538051868|FG000|Overall Study|Consent withdrawn by subject|6|||
148923322|NCT00402233|537203086|FG002|Overall Study|Worsening of other pre-existing disease|0|||
148923323|NCT00402233|537203087|FG003|Overall Study|Worsening of other pre-existing disease|0|||
148923324|NCT04658940|537203091|FG000|Overall Study|Withdrawal by Subject|1|||
148923325|NCT00821327|537203094|FG000|Overall Study|Adverse Event|13|||
148923326|NCT00821327|537203094|FG000|Overall Study|Patient Request|1|||
148923327|NCT00821327|537203094|FG000|Overall Study|Investigator Request|2|||
148923328|NCT00821327|537203094|FG000|Overall Study|Sponsor Request|1|||
148923329|NCT00821327|537203094|FG000|Overall Study|Disease Progression|13|||
148923330|NCT00821327|537203094|FG000|Overall Study|Other/Unknown|5|||
148923331|NCT02119676|537203095|FG000|Overall Study|Adverse Event|9|||
148923332|NCT02119676|537203096|FG001|Overall Study|Adverse Event|17|||
148923333|NCT02119676|537203097|FG002|Overall Study|Adverse Event|10|||
148923334|NCT02119676|537203098|FG003|Overall Study|Adverse Event|10|||
148923335|NCT02119676|537203095|FG000|Overall Study|Disease progression|53|||
148923336|NCT02119676|537203096|FG001|Overall Study|Disease progression|55|||
148923337|NCT02119676|537203097|FG002|Overall Study|Disease progression|68|||
148923338|NCT02119676|537203098|FG003|Overall Study|Disease progression|73|||
148923339|NCT02119676|537203095|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
148923340|NCT02119676|537203096|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
148923341|NCT02119676|537203097|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
148923342|NCT02119676|537203098|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
148923343|NCT02119676|537203095|FG000|Overall Study|Physician Decision|4|||
148923344|NCT02119676|537203096|FG001|Overall Study|Physician Decision|2|||
148923345|NCT02119676|537203097|FG002|Overall Study|Physician Decision|3|||
148923346|NCT02119676|537203098|FG003|Overall Study|Physician Decision|2|||
148923347|NCT02119676|537203095|FG000|Overall Study|Death|9|||
148923348|NCT02119676|537203096|FG001|Overall Study|Death|3|||
148923349|NCT02119676|537203097|FG002|Overall Study|Death|2|||
148923350|NCT02119676|537203098|FG003|Overall Study|Death|1|||
148923351|NCT02119676|537203095|FG000|Overall Study|Noncompliance|0|||
148923352|NCT02119676|537203096|FG001|Overall Study|Noncompliance|1|||
148923353|NCT02119676|537203097|FG002|Overall Study|Noncompliance|0|||
148923354|NCT02119676|537203098|FG003|Overall Study|Noncompliance|0|||
148923355|NCT02119676|537203095|FG000|Overall Study|Lost to Follow-up|0|||
148923356|NCT02119676|537203096|FG001|Overall Study|Lost to Follow-up|0|||
148923357|NCT02119676|537203097|FG002|Overall Study|Lost to Follow-up|1|||
148923358|NCT02119676|537203098|FG003|Overall Study|Lost to Follow-up|0|||
148923359|NCT02119676|537203095|FG000|Overall Study|Protocol deviation|0|||
148923360|NCT02119676|537203096|FG001|Overall Study|Protocol deviation|0|||
148923361|NCT02119676|537203097|FG002|Overall Study|Protocol deviation|1|||
148923362|NCT02119676|537203098|FG003|Overall Study|Protocol deviation|0|||
148923363|NCT02119676|537203095|FG000|Overall Study|Other, unspecified|2|||
148923364|NCT02119676|537203096|FG001|Overall Study|Other, unspecified|1|||
148923365|NCT02119676|537203097|FG002|Overall Study|Other, unspecified|3|||
148923366|NCT02119676|537203098|FG003|Overall Study|Other, unspecified|4|||
148923367|NCT02119676|537203095|FG000|Overall Study|Did not receive study med|2|||
148923368|NCT02119676|537203096|FG001|Overall Study|Did not receive study med|2|||
148923369|NCT02119676|537203097|FG002|Overall Study|Did not receive study med|4|||
148923370|NCT02119676|537203098|FG003|Overall Study|Did not receive study med|5|||
148923371|NCT01007253|537203101|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
148923372|NCT01007253|537203102|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
148923373|NCT01007253|537203103|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
148923374|NCT01007253|537203104|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
148923375|NCT02232880|537203105|FG000|Overall Study|study stopped prior to randomization|1|||
148923376|NCT04085367|537204581|FG000|Overall Study|Adverse Event|1|||
148923377|NCT04085367|537204582|FG001|Overall Study|Adverse Event|1|||
148923378|NCT04085367|537204581|FG000|Overall Study|Withdrawal by Subject|13|||
148923379|NCT04085367|537204582|FG001|Overall Study|Withdrawal by Subject|4|||
148923380|NCT04085367|537204581|FG000|Overall Study|Lost to Follow-up|3|||
148923381|NCT04085367|537204582|FG001|Overall Study|Lost to Follow-up|1|||
148923382|NCT04085367|537204581|FG000|Overall Study|Other unspecified|2|||
148923383|NCT04085367|537204582|FG001|Overall Study|Other unspecified|1|||
148923384|NCT04085367|537204581|FG000|Overall Study|Status Unknown|1|||
148923385|NCT04085367|537204582|FG001|Overall Study|Status Unknown|1|||
148923386|NCT02233946|537204583|FG000|Baseline|Withdrawal by Subject|2|||
148923387|NCT02233946|537204584|FG001|Baseline|Withdrawal by Subject|0|||
148923388|NCT02233946|537204583|FG000|3-months Follow-up|Lost to Follow-up|53|||
148923389|NCT02233946|537204584|FG001|3-months Follow-up|Lost to Follow-up|29|||
148923390|NCT02233946|537204583|FG000|6-months Follow-up|Lost to Follow-up|21|||
148923391|NCT02233946|537204584|FG001|6-months Follow-up|Lost to Follow-up|2|||
148923392|NCT02233946|537204583|FG000|9-month Follow-up|Lost to Follow-up|20|||
148923393|NCT02233946|537204584|FG001|9-month Follow-up|Lost to Follow-up|11|||
148923394|NCT02233946|537204583|FG000|12-month Follow-up|Lost to Follow-up|28|||
148923395|NCT02233946|537204584|FG001|12-month Follow-up|Lost to Follow-up|11|||
148923396|NCT01879579|537204587|FG000|Overall Study|Phone incompatible with texting platform|3|||
148923397|NCT01879579|537204588|FG001|Overall Study|Phone incompatible with texting platform|0|||
148923398|NCT01879579|537204587|FG000|Overall Study|Did not enroll in texting platform|1|||
148923399|NCT01879579|537204588|FG001|Overall Study|Did not enroll in texting platform|0|||
148923400|NCT01879579|537204587|FG000|Overall Study|Did not initiate insulin treatment|1|||
148923401|NCT01879579|537204588|FG001|Overall Study|Did not initiate insulin treatment|0|||
148923402|NCT01879579|537204587|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
148923403|NCT01879579|537204588|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
148923404|NCT01879579|537204587|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
148923405|NCT01879579|537204588|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
148923406|NCT02927067|537204589|FG000|Overall Study|Withdrawn Consent|20|||
148923407|NCT02927067|537204590|FG001|Overall Study|Withdrawn Consent|12|||
148923408|NCT02927067|537204589|FG000|Overall Study|Death|18|||
148923409|NCT02927067|537204590|FG001|Overall Study|Death|31|||
148923410|NCT02927067|537204589|FG000|Overall Study|Adverse Event|13|||
148923411|NCT02927067|537204590|FG001|Overall Study|Adverse Event|10|||
148923412|NCT02927067|537204589|FG000|Overall Study|Noncompliance|5|||
148923413|NCT02927067|537204590|FG001|Overall Study|Noncompliance|2|||
148923414|NCT02927067|537204589|FG000|Overall Study|Reason not Specified|4|||
148923415|NCT02927067|537204590|FG001|Overall Study|Reason not Specified|6|||
148923416|NCT02292784|537204593|FG000|Overall Study|Lost to Follow-up|1|||
148923417|NCT02292784|537204594|FG001|Overall Study|Lost to Follow-up|17|||
148923418|NCT02292784|537204595|FG002|Overall Study|Lost to Follow-up|18|||
148923419|NCT02292784|537204593|FG000|Overall Study|Withdrawal by Subject|0|||
148923420|NCT02292784|537204594|FG001|Overall Study|Withdrawal by Subject|3|||
148923421|NCT02292784|537204595|FG002|Overall Study|Withdrawal by Subject|3|||
148923422|NCT00134784|537204596|FG000|Overall Study|Withdrawal by Subject|2|||
148923423|NCT00134784|537204597|FG001|Overall Study|Withdrawal by Subject|2|||
148923424|NCT00134784|537204598|FG002|Overall Study|Withdrawal by Subject|2|||
148923425|NCT00134784|537204599|FG003|Overall Study|Withdrawal by Subject|1|||
148923426|NCT02919969|537204600|FG000|Overall Study|Lack of Efficacy|22|||
148923427|NCT02919969|537204600|FG000|Overall Study|Death|4|||
148923428|NCT02919969|537204600|FG000|Overall Study|Physician Decision|3|||
148923429|NCT02919969|537204600|FG000|Overall Study|Withdrawal by Subject|2|||
148923430|NCT03621475|537204601|FG000|Overall Study|No longer required restraints at initiation|0|||
148923431|NCT03621475|537204602|FG001|Overall Study|No longer required restraints at initiation|1|||
148923432|NCT01842633|537204603|FG000|Overall Study|Screen Failure|1|||
148923433|NCT01842633|537204604|FG001|Overall Study|Screen Failure|0|||
148923434|NCT01842633|537204605|FG002|Overall Study|Screen Failure|0|||
148923435|NCT01842633|537204603|FG000|Overall Study|Adverse Event|1|||
148923436|NCT01842633|537204604|FG001|Overall Study|Adverse Event|1|||
148923437|NCT01842633|537204605|FG002|Overall Study|Adverse Event|0|||
148923438|NCT01842633|537204603|FG000|Overall Study|Withdrawal by Subject|0|||
148923439|NCT01842633|537204604|FG001|Overall Study|Withdrawal by Subject|1|||
148923440|NCT01842633|537204605|FG002|Overall Study|Withdrawal by Subject|0|||
148923441|NCT01842633|537204603|FG000|Overall Study|Technical issues|1|||
148923442|NCT01842633|537204604|FG001|Overall Study|Technical issues|0|||
148923443|NCT01842633|537204605|FG002|Overall Study|Technical issues|0|||
148923444|NCT02093351|537204609|FG000|Part A|Adverse Event|0|||
148923445|NCT02093351|537204610|FG001|Part A|Adverse Event|1|||
148923446|NCT02093351|537204611|FG002|Part A|Adverse Event|1|||
148923447|NCT02093351|537204612|FG003|Part A|Adverse Event|0|||
148923448|NCT02093351|537204609|FG000|Part A|Condition under investigation worsened|2|||
148923449|NCT02093351|537204610|FG001|Part A|Condition under investigation worsened|0|||
148923450|NCT02093351|537204611|FG002|Part A|Condition under investigation worsened|2|||
148923451|NCT02093351|537204612|FG003|Part A|Condition under investigation worsened|0|||
148923452|NCT02093351|537204609|FG000|Part A|Death|0|||
148923453|NCT02093351|537204610|FG001|Part A|Death|1|||
148923454|NCT02093351|537204611|FG002|Part A|Death|0|||
148923455|NCT02093351|537204612|FG003|Part A|Death|0|||
148923456|NCT02093351|537204609|FG000|Part B|Patient decision|0|||
148923457|NCT02093351|537204610|FG001|Part B|Patient decision|0|||
148923458|NCT02093351|537204611|FG002|Part B|Patient decision|0|||
148923459|NCT02093351|537204612|FG003|Part B|Patient decision|3|||
148923460|NCT02093351|537204609|FG000|Part B|Disease progression|0|||
148923461|NCT02093351|537204610|FG001|Part B|Disease progression|0|||
148923462|NCT02093351|537204611|FG002|Part B|Disease progression|0|||
148923463|NCT02093351|537204612|FG003|Part B|Disease progression|4|||
148923464|NCT02093351|537204609|FG000|Part B|Complete response|0|||
148923465|NCT02093351|537204610|FG001|Part B|Complete response|0|||
148923466|NCT02093351|537204611|FG002|Part B|Complete response|0|||
148923467|NCT02093351|537204612|FG003|Part B|Complete response|1|||
148923468|NCT02093351|537204609|FG000|Part B|Adverse event + disease progression|0|||
148923469|NCT02093351|537204610|FG001|Part B|Adverse event + disease progression|0|||
148923470|NCT02093351|537204611|FG002|Part B|Adverse event + disease progression|0|||
148923471|NCT02093351|537204612|FG003|Part B|Adverse event + disease progression|1|||
148923472|NCT02093351|537204609|FG000|Part B|Lack of therapeutic response|0|||
148923473|NCT02093351|537204610|FG001|Part B|Lack of therapeutic response|0|||
148923474|NCT02093351|537204611|FG002|Part B|Lack of therapeutic response|0|||
148923475|NCT02093351|537204612|FG003|Part B|Lack of therapeutic response|12|||
148923476|NCT02093351|537204609|FG000|Part B|Condition under investigation worsened|0|||
148923477|NCT02093351|537204610|FG001|Part B|Condition under investigation worsened|0|||
148923478|NCT02093351|537204611|FG002|Part B|Condition under investigation worsened|0|||
148923479|NCT02093351|537204612|FG003|Part B|Condition under investigation worsened|39|||
148923480|NCT02093351|537204609|FG000|Part B|Adverse Event|0|||
148923481|NCT02093351|537204610|FG001|Part B|Adverse Event|0|||
148923482|NCT02093351|537204611|FG002|Part B|Adverse Event|0|||
148923483|NCT02093351|537204612|FG003|Part B|Adverse Event|2|||
148923484|NCT02093351|537204609|FG000|Part B|Death|0|||
148923485|NCT02093351|537204610|FG001|Part B|Death|0|||
148923486|NCT02093351|537204611|FG002|Part B|Death|0|||
148923487|NCT02093351|537204612|FG003|Part B|Death|1|||
148923488|NCT01099709|537204613|FG000|Period 1|Withdrawal by Subject|0|||
148923489|NCT01099709|537204614|FG001|Period 1|Withdrawal by Subject|1|||
148923490|NCT01099709|537204613|FG000|Period 1|Positive cotinine test|0|||
148923491|NCT01099709|537204614|FG001|Period 1|Positive cotinine test|1|||
148923492|NCT01099709|537204613|FG000|Period 1|Adverse Event|1|||
148923493|NCT01099709|537204614|FG001|Period 1|Adverse Event|0|||
148923494|NCT00706849|537204617|FG000|Treatment Period|Adverse Event|0|||
148923495|NCT00706849|537204618|FG001|Treatment Period|Adverse Event|9|||
148923496|NCT00706849|537204617|FG000|Treatment Period|Other|0|||
148923497|NCT00706849|537204618|FG001|Treatment Period|Other|1|||
148923498|NCT00706849|537204617|FG000|Follow-up Period|Withdrawal by Subject|0|||
148923499|NCT00706849|537204618|FG001|Follow-up Period|Withdrawal by Subject|2|||
148923500|NCT00706849|537204617|FG000|Follow-up Period|Protocol non-compliance|0|||
148923501|NCT00706849|537204618|FG001|Follow-up Period|Protocol non-compliance|1|||
148923502|NCT01611454|537204619|FG000|Overall Study|Lack of Efficacy|18|||
148923503|NCT01611454|537204620|FG001|Overall Study|Lack of Efficacy|10|||
149012839|NCT01468922|537525821|FG008|Overall Study|Enrolled on new protocol|0|||
148923504|NCT00920907|537204621|FG000|Induction Period|Adverse Event|0|||
148923505|NCT00920907|537204622|FG001|Induction Period|Adverse Event|2|||
148923506|NCT00920907|537204621|FG000|Induction Period|Death|1|||
148923507|NCT00920907|537204622|FG001|Induction Period|Death|1|||
148923508|NCT00920907|537204621|FG000|Induction Period|Disease Progression|12|||
148923509|NCT00920907|537204622|FG001|Induction Period|Disease Progression|11|||
148923510|NCT00920907|537204621|FG000|Induction Period|Study Drug Toxicity|8|||
148923511|NCT00920907|537204622|FG001|Induction Period|Study Drug Toxicity|6|||
148923512|NCT00920907|537204621|FG000|Induction Period|No longer meets study criteria|0|||
148923513|NCT00920907|537204622|FG001|Induction Period|No longer meets study criteria|1|||
148923514|NCT00920907|537204621|FG000|Induction Period|Withdrawal by Subject|1|||
148923515|NCT00920907|537204622|FG001|Induction Period|Withdrawal by Subject|1|||
148923516|NCT00920907|537204621|FG000|Maintenance Period|Disease Progression|3|||
148923517|NCT00920907|537204622|FG001|Maintenance Period|Disease Progression|7|||
148923518|NCT00920907|537204621|FG000|Maintenance Period|Administrative (study closure)|7|||
148923519|NCT00920907|537204622|FG001|Maintenance Period|Administrative (study closure)|2|||
148923520|NCT00920907|537204621|FG000|Maintenance Period|Study Drug Toxicity|0|||
148923521|NCT00920907|537204622|FG001|Maintenance Period|Study Drug Toxicity|2|||
148923522|NCT00920907|537204621|FG000|Maintenance Period|Death|1|||
148923523|NCT00920907|537204622|FG001|Maintenance Period|Death|1|||
148923524|NCT00920907|537204621|FG000|Maintenance Period|Withdrawal by Subject|1|||
148923525|NCT00920907|537204622|FG001|Maintenance Period|Withdrawal by Subject|0|||
148923526|NCT00920907|537204621|FG000|Maintenance Period|Adverse Event|0|||
148923527|NCT00920907|537204622|FG001|Maintenance Period|Adverse Event|1|||
148923528|NCT02616601|537204623|FG000|Overall Study|Withdrawal by Subject|4|||
148923529|NCT02616601|537204624|FG001|Overall Study|Withdrawal by Subject|4|||
148923530|NCT02616601|537204625|FG002|Overall Study|Withdrawal by Subject|3|||
148923531|NCT02616601|537204623|FG000|Overall Study|Adverse Event|2|||
148923532|NCT02616601|537204624|FG001|Overall Study|Adverse Event|0|||
148923533|NCT02616601|537204625|FG002|Overall Study|Adverse Event|2|||
148923534|NCT02616601|537204623|FG000|Overall Study|Death|1|||
148923535|NCT02616601|537204624|FG001|Overall Study|Death|0|||
148923536|NCT02616601|537204625|FG002|Overall Study|Death|0|||
148923537|NCT02616601|537204623|FG000|Overall Study|Lost to Follow-up|1|||
148923538|NCT02616601|537204624|FG001|Overall Study|Lost to Follow-up|0|||
148923539|NCT02616601|537204625|FG002|Overall Study|Lost to Follow-up|1|||
148923540|NCT02616601|537204623|FG000|Overall Study|Non-Compliance with Test Article|1|||
148923541|NCT02616601|537204624|FG001|Overall Study|Non-Compliance with Test Article|0|||
148923542|NCT02616601|537204625|FG002|Overall Study|Non-Compliance with Test Article|1|||
148923543|NCT01275339|537204626|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
148923544|NCT01275339|537204627|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
148923545|NCT01275339|537204628|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
148923546|NCT01275339|537204629|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
148923547|NCT01275339|537204626|FG000|Overall Study|Withdrawal by Subject|0|||
148923548|NCT01275339|537204627|FG001|Overall Study|Withdrawal by Subject|0|||
148923549|NCT01275339|537204628|FG002|Overall Study|Withdrawal by Subject|1|||
148923550|NCT01275339|537204629|FG003|Overall Study|Withdrawal by Subject|0|||
148923551|NCT03718299|537204630|FG000|Overall Study|Adverse Event|1|||
148923552|NCT03718299|537204630|FG000|Overall Study|Withdrawal by Subject|6|||
148923553|NCT03718299|537204630|FG000|Overall Study|Physician Decision|2|||
148923554|NCT03718299|537204630|FG000|Overall Study|Lost to Follow-up|1|||
148923555|NCT04389970|537204631|FG000|Overall Study|Lost to Follow-up|1|||
148923556|NCT01343823|537204632|FG000|Overall Study|Study Terminated|1|||
148923557|NCT01343823|537204633|FG001|Overall Study|Study Terminated|0|||
148923558|NCT01343823|537204634|FG002|Overall Study|Study Terminated|0|||
148923559|NCT01343823|537204635|FG003|Overall Study|Study Terminated|1|||
148923560|NCT01343823|537204632|FG000|Overall Study|Withdrawal by Subject|1|||
148923561|NCT01343823|537204633|FG001|Overall Study|Withdrawal by Subject|0|||
148923562|NCT01343823|537204634|FG002|Overall Study|Withdrawal by Subject|0|||
148923563|NCT01343823|537204635|FG003|Overall Study|Withdrawal by Subject|0|||
148923564|NCT00718081|537204638|FG000|Overall Study|Adverse Event|0|||
148923565|NCT00718081|537204639|FG001|Overall Study|Adverse Event|1|||
148923566|NCT00718081|537204640|FG002|Overall Study|Adverse Event|0|||
148923567|NCT00718081|537204638|FG000|Overall Study|Lack of Efficacy|7|||
148923568|NCT00718081|537204639|FG001|Overall Study|Lack of Efficacy|3|||
148923569|NCT00718081|537204640|FG002|Overall Study|Lack of Efficacy|21|||
148923570|NCT00815516|537204641|FG000|Overall Study|Death|3|||
148923571|NCT00815516|537204642|FG001|Overall Study|Death|1|||
148923572|NCT00815516|537204641|FG000|Overall Study|Physician Decision|1|||
148923573|NCT00815516|537204642|FG001|Overall Study|Physician Decision|0|||
148923574|NCT01236118|537204653|FG000|Overall Study|Adverse Event|2|||
148923575|NCT01236118|537204654|FG001|Overall Study|Adverse Event|0|||
148923576|NCT01236118|537204655|FG002|Overall Study|Adverse Event|2|||
148923577|NCT01236118|537204653|FG000|Overall Study|Physician Decision|0|||
148923578|NCT01236118|537204654|FG001|Overall Study|Physician Decision|1|||
148923579|NCT01236118|537204655|FG002|Overall Study|Physician Decision|0|||
149012840|NCT01468922|537525813|FG000|Overall Study|Adverse Event|0|||
148923580|NCT01236118|537204653|FG000|Overall Study|Withdrawal by Subject|0|||
148923581|NCT01236118|537204654|FG001|Overall Study|Withdrawal by Subject|0|||
148923582|NCT01236118|537204655|FG002|Overall Study|Withdrawal by Subject|1|||
148923583|NCT04535167|537204656|FG000|Treatment|Adverse Event|0|||
148923584|NCT04535167|537204657|FG001|Treatment|Adverse Event|0|||
148923585|NCT04535167|537204658|FG002|Treatment|Adverse Event|0|||
148923586|NCT04535167|537204659|FG003|Treatment|Adverse Event|0|||
148923587|NCT04535167|537204660|FG004|Treatment|Adverse Event|0|||
148923588|NCT04535167|537204661|FG005|Treatment|Adverse Event|0|||
148923589|NCT04535167|537204662|FG006|Treatment|Adverse Event|1|||
148923590|NCT04535167|537204656|FG000|Follow-Up|Death|0|||
148923591|NCT04535167|537204657|FG001|Follow-Up|Death|0|||
148923592|NCT04535167|537204658|FG002|Follow-Up|Death|0|||
148923593|NCT04535167|537204659|FG003|Follow-Up|Death|0|||
148923594|NCT04535167|537204660|FG004|Follow-Up|Death|0|||
148923595|NCT04535167|537204661|FG005|Follow-Up|Death|0|||
148923596|NCT04535167|537204662|FG006|Follow-Up|Death|1|||
148923597|NCT04535167|537204656|FG000|Follow-Up|Lost to Follow-up|0|||
148923598|NCT04535167|537204657|FG001|Follow-Up|Lost to Follow-up|0|||
148923599|NCT04535167|537204658|FG002|Follow-Up|Lost to Follow-up|0|||
148923600|NCT04535167|537204659|FG003|Follow-Up|Lost to Follow-up|1|||
148923601|NCT04535167|537204660|FG004|Follow-Up|Lost to Follow-up|0|||
148923602|NCT04535167|537204661|FG005|Follow-Up|Lost to Follow-up|0|||
148923603|NCT04535167|537204662|FG006|Follow-Up|Lost to Follow-up|0|||
148923604|NCT03404960|537204664|FG000|Overall Study|Adverse Event|0|||
148923605|NCT03404960|537204665|FG001|Overall Study|Adverse Event|2|||
148923606|NCT03404960|537204664|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
148923607|NCT03404960|537204665|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
148923608|NCT03404960|537204664|FG000|Overall Study|Bowel obstruction|0|||
148923609|NCT03404960|537204665|FG001|Overall Study|Bowel obstruction|1|||
148923610|NCT03404960|537204664|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
148923611|NCT03404960|537204665|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
148923612|NCT00075270|537204666|FG000|Overall Study|Withdrawal by Subject|28|||
148923613|NCT00075270|537204667|FG001|Overall Study|Withdrawal by Subject|21|||
148923614|NCT00075270|537204666|FG000|Overall Study|Lost to Follow-up|25|||
148923615|NCT00075270|537204667|FG001|Overall Study|Lost to Follow-up|28|||
148923616|NCT00075270|537204666|FG000|Overall Study|Protocol Violation|0|||
148923617|NCT00075270|537204667|FG001|Overall Study|Protocol Violation|2|||
148923618|NCT00075270|537204666|FG000|Overall Study|Death|198|||
148923619|NCT00075270|537204667|FG001|Overall Study|Death|215|||
148923620|NCT00075270|537204666|FG000|Overall Study|Other/Unknown|9|||
148923621|NCT00075270|537204667|FG001|Overall Study|Other/Unknown|5|||
148923622|NCT00075270|537204666|FG000|Overall Study|Missing|26|||
148923623|NCT00075270|537204667|FG001|Overall Study|Missing|13|||
148923624|NCT00246571|537204668|FG000|Overall Study|Adverse Event|7|||
148923625|NCT00246571|537204669|FG001|Overall Study|Adverse Event|0|||
148923626|NCT00246571|537204668|FG000|Overall Study|Protocol Violation|0|||
148923627|NCT00246571|537204669|FG001|Overall Study|Protocol Violation|1|||
148923628|NCT00246571|537204668|FG000|Overall Study|Withdrawal by Subject|2|||
148923629|NCT00246571|537204669|FG001|Overall Study|Withdrawal by Subject|3|||
148923630|NCT00246571|537204668|FG000|Overall Study|Lack of Efficacy|84|||
148923631|NCT00246571|537204669|FG001|Overall Study|Lack of Efficacy|21|||
148923632|NCT00246571|537204668|FG000|Overall Study|Death|17|||
148923633|NCT00246571|537204669|FG001|Overall Study|Death|3|||
148923634|NCT00246571|537204668|FG000|Overall Study|Sponsor|0|||
148923635|NCT00246571|537204669|FG001|Overall Study|Sponsor|1|||
148923636|NCT00246571|537204668|FG000|Overall Study|Did not meet entrance criteria|2|||
148923637|NCT00246571|537204669|FG001|Overall Study|Did not meet entrance criteria|1|||
148923638|NCT00246571|537204668|FG000|Overall Study|Laboratory abnormalities|1|||
148923639|NCT00246571|537204669|FG001|Overall Study|Laboratory abnormalities|0|||
148923640|NCT00246571|537204668|FG000|Overall Study|Crossover participants|0|||
148923641|NCT00246571|537204669|FG001|Overall Study|Crossover participants|74|||
148923642|NCT03422627|537204670|FG000|Overall Study|Protocol-specified Criteria|1|||
148923643|NCT03422627|537204671|FG001|Overall Study|Protocol-specified Criteria|1|||
148923644|NCT03422627|537204672|FG002|Overall Study|Protocol-specified Criteria|0|||
148923645|NCT03422627|537204673|FG003|Overall Study|Protocol-specified Criteria|0|||
148923646|NCT03422627|537204674|FG004|Overall Study|Protocol-specified Criteria|2|||
148923647|NCT03422627|537204670|FG000|Overall Study|Requirement for Alternative Therapy|1|||
148923648|NCT03422627|537204671|FG001|Overall Study|Requirement for Alternative Therapy|1|||
148923649|NCT03422627|537204672|FG002|Overall Study|Requirement for Alternative Therapy|2|||
148923650|NCT03422627|537204673|FG003|Overall Study|Requirement for Alternative Therapy|0|||
148923651|NCT03422627|537204674|FG004|Overall Study|Requirement for Alternative Therapy|0|||
148923652|NCT03422627|537204670|FG000|Overall Study|Disease Progression|1|||
148923653|NCT03422627|537204671|FG001|Overall Study|Disease Progression|0|||
148923654|NCT03422627|537204672|FG002|Overall Study|Disease Progression|1|||
148923655|NCT03422627|537204673|FG003|Overall Study|Disease Progression|2|||
148923656|NCT03422627|537204674|FG004|Overall Study|Disease Progression|0|||
148923657|NCT03422627|537204670|FG000|Overall Study|Adverse Event|2|||
148923658|NCT03422627|537204671|FG001|Overall Study|Adverse Event|1|||
148923659|NCT03422627|537204672|FG002|Overall Study|Adverse Event|0|||
148923660|NCT03422627|537204673|FG003|Overall Study|Adverse Event|0|||
148923661|NCT03422627|537204674|FG004|Overall Study|Adverse Event|2|||
148923662|NCT03422627|537204670|FG000|Overall Study|Ineligibility Determined|0|||
148923663|NCT03422627|537204671|FG001|Overall Study|Ineligibility Determined|1|||
148923664|NCT03422627|537204672|FG002|Overall Study|Ineligibility Determined|0|||
148923665|NCT03422627|537204673|FG003|Overall Study|Ineligibility Determined|0|||
148923666|NCT03422627|537204674|FG004|Overall Study|Ineligibility Determined|0|||
148923667|NCT03422627|537204670|FG000|Overall Study|Death|0|||
148923668|NCT03422627|537204671|FG001|Overall Study|Death|1|||
148923669|NCT03422627|537204672|FG002|Overall Study|Death|1|||
148923670|NCT03422627|537204673|FG003|Overall Study|Death|0|||
148923671|NCT03422627|537204674|FG004|Overall Study|Death|0|||
148923672|NCT03422627|537204670|FG000|Overall Study|Withdrawal by Subject|0|||
148923673|NCT03422627|537204671|FG001|Overall Study|Withdrawal by Subject|0|||
148923674|NCT03422627|537204672|FG002|Overall Study|Withdrawal by Subject|0|||
148923675|NCT03422627|537204673|FG003|Overall Study|Withdrawal by Subject|1|||
148923676|NCT03422627|537204674|FG004|Overall Study|Withdrawal by Subject|0|||
148923677|NCT02455557|537204675|FG000|Overall Study|Withdrawal by Subject|2|||
148923678|NCT01993836|537204684|FG000|Overall Study|Surgery Cancelled|3|||
148923679|NCT01993836|537204685|FG001|Overall Study|Surgery Cancelled|0|||
148923680|NCT01993836|537204686|FG002|Overall Study|Surgery Cancelled|0|||
148923681|NCT01993836|537204684|FG000|Overall Study|Physician Decision|2|||
148923682|NCT01993836|537204685|FG001|Overall Study|Physician Decision|1|||
148923683|NCT01993836|537204686|FG002|Overall Study|Physician Decision|0|||
148923684|NCT01993836|537204684|FG000|Overall Study|Death|0|||
148923685|NCT01993836|537204685|FG001|Overall Study|Death|2|||
148923686|NCT01993836|537204686|FG002|Overall Study|Death|0|||
148923687|NCT01993836|537204684|FG000|Overall Study|Withdrawal by Subject|12|||
148923688|NCT01993836|537204685|FG001|Overall Study|Withdrawal by Subject|10|||
148923689|NCT01993836|537204686|FG002|Overall Study|Withdrawal by Subject|5|||
148923690|NCT02195687|537204690|FG000|Overall Study|Personal Reasons|1|||
148923691|NCT02195687|537204691|FG001|Overall Study|Personal Reasons|1|||
148923692|NCT02195687|537204690|FG000|Overall Study|Lost to Follow-up|4|||
148923693|NCT02195687|537204691|FG001|Overall Study|Lost to Follow-up|1|||
148923694|NCT00686634|537204692|FG000|Overall Study|Protocol Violation|6|||
148923695|NCT02047318|537204695|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
148923696|NCT02047318|537204695|FG000|Core Study Period|Adverse Event|1|||
148923697|NCT02047318|537204695|FG000|Core Study Period|Withdrawal by caregiver|3|||
148923698|NCT02047318|537204695|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
148923699|NCT02296138|537204696|FG000|Overall Study|Adverse Event|348|||
148923700|NCT02296138|537204697|FG001|Overall Study|Adverse Event|259|||
148923701|NCT02296138|537204696|FG000|Overall Study|Lack of Efficacy|59|||
148923702|NCT02296138|537204697|FG001|Overall Study|Lack of Efficacy|37|||
148923703|NCT02296138|537204696|FG000|Overall Study|Protocol Violation|35|||
148923704|NCT02296138|537204697|FG001|Overall Study|Protocol Violation|36|||
148923705|NCT02296138|537204696|FG000|Overall Study|Lost to Follow-up|9|||
148923706|NCT02296138|537204697|FG001|Overall Study|Lost to Follow-up|12|||
148923707|NCT02296138|537204696|FG000|Overall Study|Withdrawal by Subject|184|||
148923708|NCT02296138|537204697|FG001|Overall Study|Withdrawal by Subject|131|||
148923709|NCT02296138|537204696|FG000|Overall Study|Not Treated|1|||
148923710|NCT02296138|537204697|FG001|Overall Study|Not Treated|1|||
148923711|NCT02296138|537204696|FG000|Overall Study|Patients with data irregularities|10|||
148923712|NCT02296138|537204697|FG001|Overall Study|Patients with data irregularities|11|||
148923713|NCT02296138|537204696|FG000|Overall Study|Other than specified|15|||
148923714|NCT02296138|537204697|FG001|Overall Study|Other than specified|13|||
148923715|NCT04369924|537204698|FG000|Overall Study|Lost to Follow-up|302|||
148923716|NCT04369924|537204699|FG001|Overall Study|Lost to Follow-up|339|||
148923717|NCT01653132|537204700|FG000|First Intervention|Protocol Violation|1|||
148923718|NCT01653132|537204701|FG001|First Intervention|Protocol Violation|0|||
148923719|NCT03828370|537204702|FG000|3 Month Follow-up|Lost to Follow-up|4|||
148923720|NCT03828370|537204703|FG001|3 Month Follow-up|Lost to Follow-up|12|||
148923721|NCT03828370|537204702|FG000|9 Month Follow up|Lost to Follow-up|12|||
148923722|NCT03828370|537204703|FG001|9 Month Follow up|Lost to Follow-up|20|||
148923723|NCT02677324|537204704|FG000|Overall Study|Disease Progression|6|||
148923724|NCT02677324|537204704|FG000|Overall Study|Inability to Swallow pills|1|||
148923725|NCT02677324|537204704|FG000|Overall Study|Non-compliance|1|||
148923726|NCT02677324|537204704|FG000|Overall Study|Lack of Efficacy|1|||
148923727|NCT02677324|537204704|FG000|Overall Study|Medical insurance coverage|1|||
148923728|NCT02677324|537204704|FG000|Overall Study|Adverse Event|1|||
148923729|NCT02677324|537204704|FG000|Overall Study|IgM Myeloma diagnosis|1|||
148923730|NCT00761150|537204707|FG000|Open-label Period|Adverse Event|36|||
148923731|NCT00761150|537204708|FG001|Open-label Period|Adverse Event|0|||
148923732|NCT00761150|537204709|FG002|Open-label Period|Adverse Event|0|||
148923733|NCT00761150|537204707|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
148923734|NCT00761150|537204708|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
148923735|NCT00761150|537204709|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
148923736|NCT00761150|537204707|FG000|Open-label Period|Lost to Follow-up|7|||
148923737|NCT00761150|537204708|FG001|Open-label Period|Lost to Follow-up|0|||
148923738|NCT00761150|537204709|FG002|Open-label Period|Lost to Follow-up|0|||
148923739|NCT00761150|537204707|FG000|Open-label Period|Lack of Efficacy|4|||
148923740|NCT00761150|537204708|FG001|Open-label Period|Lack of Efficacy|0|||
148923741|NCT00761150|537204709|FG002|Open-label Period|Lack of Efficacy|0|||
148923742|NCT00761150|537204707|FG000|Open-label Period|Withdrawal by Subject|5|||
148923743|NCT00761150|537204708|FG001|Open-label Period|Withdrawal by Subject|0|||
148923744|NCT00761150|537204709|FG002|Open-label Period|Withdrawal by Subject|0|||
148923745|NCT00761150|537204707|FG000|Open-label Period|Noncompliance|2|||
148923746|NCT00761150|537204708|FG001|Open-label Period|Noncompliance|0|||
148923747|NCT00761150|537204709|FG002|Open-label Period|Noncompliance|0|||
148923748|NCT00761150|537204707|FG000|Open-label Period|Other|5|||
148923749|NCT00761150|537204708|FG001|Open-label Period|Other|0|||
148923750|NCT00761150|537204709|FG002|Open-label Period|Other|0|||
148923751|NCT00761150|537204707|FG000|Double-blind Period|Lack of Efficacy|0|||
148923752|NCT00761150|537204708|FG001|Double-blind Period|Lack of Efficacy|2|||
148923753|NCT00761150|537204709|FG002|Double-blind Period|Lack of Efficacy|19|||
148923754|NCT00761150|537204707|FG000|Double-blind Period|Adverse Event|0|||
148923755|NCT00761150|537204708|FG001|Double-blind Period|Adverse Event|3|||
148923756|NCT00761150|537204709|FG002|Double-blind Period|Adverse Event|3|||
148923757|NCT00761150|537204707|FG000|Double-blind Period|Withdrawal by Subject|0|||
148923758|NCT00761150|537204708|FG001|Double-blind Period|Withdrawal by Subject|3|||
148923759|NCT00761150|537204709|FG002|Double-blind Period|Withdrawal by Subject|2|||
148923760|NCT00761150|537204707|FG000|Double-blind Period|Lost to Follow-up|0|||
148923761|NCT00761150|537204708|FG001|Double-blind Period|Lost to Follow-up|2|||
148923762|NCT00761150|537204709|FG002|Double-blind Period|Lost to Follow-up|1|||
148923763|NCT00761150|537204707|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
148923764|NCT00761150|537204708|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
148923765|NCT00761150|537204709|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
148923766|NCT00761150|537204707|FG000|Double-blind Period|Noncompliance|0|||
148923767|NCT00761150|537204708|FG001|Double-blind Period|Noncompliance|1|||
148923768|NCT00761150|537204709|FG002|Double-blind Period|Noncompliance|0|||
148923769|NCT00761150|537204707|FG000|Double-blind Period|Other|0|||
148923770|NCT00761150|537204708|FG001|Double-blind Period|Other|3|||
148923771|NCT00761150|537204709|FG002|Double-blind Period|Other|3|||
148923772|NCT03312751|537204710|FG000|Overall Study|Death|7|||
148923773|NCT03312751|537204711|FG001|Overall Study|Death|9|||
148923774|NCT03312751|537204710|FG000|Overall Study|Study discontinuation due to other reason|0|||
148923775|NCT03312751|537204711|FG001|Overall Study|Study discontinuation due to other reason|1|||
148923776|NCT00475423|537204712|FG000|Overall Study|Protocol Violation|5|||
148923777|NCT00475423|537204712|FG000|Overall Study|Adverse Event|4|||
148923778|NCT00475423|537204712|FG000|Overall Study|Withdrawal by Subject|6|||
148923779|NCT00475423|537204712|FG000|Overall Study|Lack of Efficacy|8|||
148923780|NCT00475423|537204712|FG000|Overall Study|Death|1|||
148923781|NCT00475423|537204712|FG000|Overall Study|Reason not specified|1|||
148923782|NCT00475423|537204712|FG000|Overall Study|Lost to Follow-up|7|||
148923783|NCT02106923|537204722|FG000|Overall Study|Protocol Violation|0|||
148923784|NCT02106923|537204723|FG001|Overall Study|Protocol Violation|0|||
148923785|NCT02106923|537204724|FG002|Overall Study|Protocol Violation|0|||
148923786|NCT02106923|537204725|FG003|Overall Study|Protocol Violation|0|||
148923787|NCT02106923|537204726|FG004|Overall Study|Protocol Violation|0|||
148923788|NCT02106923|537204727|FG005|Overall Study|Protocol Violation|1|||
148923789|NCT02217527|537204728|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
148923790|NCT02217527|537204729|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
148923791|NCT02217527|537204728|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
148923792|NCT02217527|537204729|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
148923793|NCT06390839|537204730|FG000|Overall Study|Ineligible|2|||
148923794|NCT06390839|537204730|FG000|Overall Study|Never start protocol therapy|3|||
148923795|NCT06390839|537204730|FG000|Overall Study|Adverse Event|1|||
148923796|NCT06390839|537204730|FG000|Overall Study|Alternative therapy|2|||
148923797|NCT06390839|537204730|FG000|Overall Study|Death|3|||
148923798|NCT06390839|537204730|FG000|Overall Study|Disease progression|28|||
148923799|NCT06390839|537204730|FG000|Overall Study|Withdrawal by Subject|2|||
148923800|NCT06390839|537204730|FG000|Overall Study|Complicating disease|1|||
148923801|NCT06390839|537204730|FG000|Overall Study|Noncompliance|1|||
148923802|NCT02720094|537204733|FG000|Overall Study|Ongoing|2210|||
148923803|NCT02720094|537204734|FG001|Overall Study|Ongoing|2203|||
148923804|NCT02720094|537204733|FG000|Overall Study|Scheduled exit visit/end of study|2|||
148923805|NCT02720094|537204734|FG001|Overall Study|Scheduled exit visit/end of study|1|||
148923806|NCT02720094|537204733|FG000|Overall Study|Death|4|||
148923807|NCT02720094|537204734|FG001|Overall Study|Death|7|||
148923808|NCT02720094|537204733|FG000|Overall Study|Withdrawal by Subject|55|||
148923809|NCT02720094|537204734|FG001|Overall Study|Withdrawal by Subject|56|||
148923810|NCT02720094|537204733|FG000|Overall Study|Lost to Follow-up|2|||
148923811|NCT02720094|537204734|FG001|Overall Study|Lost to Follow-up|7|||
148923812|NCT02720094|537204733|FG000|Overall Study|Physician Decision|1|||
148923813|NCT02720094|537204734|FG001|Overall Study|Physician Decision|3|||
148923814|NCT02720094|537204733|FG000|Overall Study|Inappropriate enrollment|1|||
148923815|NCT02720094|537204734|FG001|Overall Study|Inappropriate enrollment|3|||
148923816|NCT02720094|537204733|FG000|Overall Study|Relocation|1|||
148923817|NCT02720094|537204734|FG001|Overall Study|Relocation|1|||
148923818|NCT00732940|537204735|FG000|Overall Study|Withdrawal by Subject|1|||
148923819|NCT00732940|537204736|FG001|Overall Study|Withdrawal by Subject|2|||
148923820|NCT00732940|537204735|FG000|Overall Study|Adverse Event|0|||
148923821|NCT00732940|537204736|FG001|Overall Study|Adverse Event|1|||
148923822|NCT00732940|537204735|FG000|Overall Study|Lost to Follow-up|1|||
148923823|NCT00732940|537204736|FG001|Overall Study|Lost to Follow-up|0|||
148923824|NCT00938886|537204737|FG000|Overall Study|Death|0|||
148923825|NCT00938886|537204738|FG001|Overall Study|Death|1|||
148923826|NCT00938886|537204737|FG000|Overall Study|Withdrawal by Subject|4|||
148923827|NCT00938886|537204738|FG001|Overall Study|Withdrawal by Subject|7|||
148923828|NCT00938886|537204737|FG000|Overall Study|Lost to Follow-up|3|||
148923829|NCT00938886|537204738|FG001|Overall Study|Lost to Follow-up|2|||
148923830|NCT04268823|537204739|FG000|Overall Study|Adverse Event|1|||
148923831|NCT04268823|537204740|FG001|Overall Study|Adverse Event|0|||
148923832|NCT04268823|537204739|FG000|Overall Study|Participant Decision|1|||
148923833|NCT04268823|537204740|FG001|Overall Study|Participant Decision|0|||
148923834|NCT00622739|537206470|FG000|Overall Study|Physician Decision|1|||
148923835|NCT00622739|537206471|FG001|Overall Study|Physician Decision|0|||
148923836|NCT00622739|537206470|FG000|Overall Study|Adverse Event|1|||
148923837|NCT00622739|537206471|FG001|Overall Study|Adverse Event|2|||
148923838|NCT00622739|537206470|FG000|Overall Study|Lack of Efficacy|0|||
148923839|NCT00622739|537206471|FG001|Overall Study|Lack of Efficacy|2|||
148923840|NCT00622739|537206470|FG000|Overall Study|Withdrawal by Subject|0|||
148923841|NCT00622739|537206471|FG001|Overall Study|Withdrawal by Subject|1|||
148923842|NCT00622739|537206470|FG000|Overall Study|Lost to Follow-up|0|||
148923843|NCT00622739|537206471|FG001|Overall Study|Lost to Follow-up|1|||
148923844|NCT00290407|537206472|FG000|Overall Study|Physician Decision|2|||
148805984|NCT05911841|536768051|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
148923845|NCT01933789|537206481|FG000|Overall Study|Death|0|||
148923846|NCT01933789|537206482|FG001|Overall Study|Death|0|||
148923847|NCT01933789|537206483|FG002|Overall Study|Death|0|||
148923848|NCT01933789|537206484|FG003|Overall Study|Death|0|||
148923849|NCT01933789|537206485|FG004|Overall Study|Death|21|||
148923850|NCT01933789|537206486|FG005|Overall Study|Death|32|||
148923851|NCT01933789|537206487|FG006|Overall Study|Death|0|||
148923852|NCT01933789|537206488|FG007|Overall Study|Death|0|||
148805985|NCT05911841|536768052|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
148923853|NCT01933789|537206489|FG008|Overall Study|Death|0|||
148923854|NCT01933789|537206481|FG000|Overall Study|Lost to Follow-up|0|||
148923855|NCT01933789|537206482|FG001|Overall Study|Lost to Follow-up|0|||
148923856|NCT01933789|537206483|FG002|Overall Study|Lost to Follow-up|0|||
148923857|NCT01933789|537206484|FG003|Overall Study|Lost to Follow-up|1|||
148923858|NCT01933789|537206485|FG004|Overall Study|Lost to Follow-up|8|||
148923859|NCT01933789|537206486|FG005|Overall Study|Lost to Follow-up|9|||
148923860|NCT01933789|537206487|FG006|Overall Study|Lost to Follow-up|1|||
148923861|NCT01933789|537206488|FG007|Overall Study|Lost to Follow-up|4|||
148923862|NCT01933789|537206489|FG008|Overall Study|Lost to Follow-up|0|||
148923863|NCT01933789|537206481|FG000|Overall Study|Withdrawal by Subject|2|||
148923864|NCT01933789|537206482|FG001|Overall Study|Withdrawal by Subject|1|||
148923865|NCT01933789|537206483|FG002|Overall Study|Withdrawal by Subject|0|||
148923866|NCT01933789|537206484|FG003|Overall Study|Withdrawal by Subject|0|||
148923867|NCT01933789|537206485|FG004|Overall Study|Withdrawal by Subject|17|||
148923868|NCT01933789|537206486|FG005|Overall Study|Withdrawal by Subject|16|||
148923869|NCT01933789|537206487|FG006|Overall Study|Withdrawal by Subject|1|||
148923870|NCT01933789|537206488|FG007|Overall Study|Withdrawal by Subject|4|||
148923871|NCT01933789|537206489|FG008|Overall Study|Withdrawal by Subject|0|||
148923872|NCT01933789|537206481|FG000|Overall Study|Became Ineligible|4|||
148923873|NCT01933789|537206482|FG001|Overall Study|Became Ineligible|0|||
148923874|NCT01933789|537206483|FG002|Overall Study|Became Ineligible|0|||
148923875|NCT01933789|537206484|FG003|Overall Study|Became Ineligible|0|||
148923876|NCT01933789|537206485|FG004|Overall Study|Became Ineligible|13|||
148923877|NCT01933789|537206486|FG005|Overall Study|Became Ineligible|10|||
148923878|NCT01933789|537206487|FG006|Overall Study|Became Ineligible|13|||
148923879|NCT01933789|537206488|FG007|Overall Study|Became Ineligible|6|||
148923880|NCT01933789|537206489|FG008|Overall Study|Became Ineligible|0|||
148923881|NCT01925989|537206494|FG000|Period 1|Sponsor Decision|1|||
148923882|NCT01925989|537206495|FG001|Period 1|Sponsor Decision|1|||
148923883|NCT01925989|537206496|FG002|Period 1|Sponsor Decision|0|||
148923884|NCT01925989|537206494|FG000|Period 1|Withdrawal by Subject|0|||
148923885|NCT01925989|537206495|FG001|Period 1|Withdrawal by Subject|1|||
148923886|NCT01925989|537206496|FG002|Period 1|Withdrawal by Subject|0|||
148923887|NCT00868517|537206497|FG000|Overall Study|Withdrawal by Subject|3|||
148923888|NCT00868517|537206498|FG001|Overall Study|Withdrawal by Subject|3|||
148923889|NCT00868517|537206499|FG002|Overall Study|Withdrawal by Subject|2|||
148923890|NCT00868517|537206497|FG000|Overall Study|Protocol Violation|1|||
148923891|NCT00868517|537206498|FG001|Overall Study|Protocol Violation|1|||
148923892|NCT00868517|537206499|FG002|Overall Study|Protocol Violation|0|||
149012841|NCT01468922|537525814|FG001|Overall Study|Adverse Event|0|||
149157539|NCT03505021|538051869|FG001|Overall Study|Consent withdrawn by subject|1|||
149157540|NCT03505021|538051868|FG000|Overall Study|Lost to Follow-up|5|||
149157541|NCT03505021|538051869|FG001|Overall Study|Lost to Follow-up|3|||
149157542|NCT03505021|538051868|FG000|Overall Study|Adverse Event|26|||
149157543|NCT03505021|538051869|FG001|Overall Study|Adverse Event|9|||
149157544|NCT03505021|538051868|FG000|Overall Study|Disease progression|33|||
149157545|NCT03505021|538051869|FG001|Overall Study|Disease progression|17|||
149157546|NCT03505021|538051868|FG000|Overall Study|Other|11|||
149157547|NCT03505021|538051869|FG001|Overall Study|Other|5|||
149157548|NCT03505021|538051868|FG000|Overall Study|Personal reason|21|||
149157549|NCT03505021|538051869|FG001|Overall Study|Personal reason|12|||
149157550|NCT04341948|538051870|FG000|Overall Study|Adverse Event|0|||
149157551|NCT04341948|538051871|FG001|Overall Study|Adverse Event|1|||
149157552|NCT04341948|538051870|FG000|Overall Study|Lost to Follow-up|6|||
149157553|NCT04341948|538051871|FG001|Overall Study|Lost to Follow-up|1|||
149157554|NCT04341948|538051870|FG000|Overall Study|Physician Decision|1|||
149157555|NCT04341948|538051871|FG001|Overall Study|Physician Decision|2|||
149157556|NCT04341948|538051870|FG000|Overall Study|Withdrawal by Participant|6|||
149157557|NCT04341948|538051871|FG001|Overall Study|Withdrawal by Participant|3|||
149157558|NCT04341948|538051870|FG000|Overall Study|Lack of compliance by Participant|1|||
149157559|NCT04341948|538051871|FG001|Overall Study|Lack of compliance by Participant|0|||
149157560|NCT03718143|538054165|FG000|Overall Study|Death|1|||
149157561|NCT03718143|538054166|FG001|Overall Study|Death|0|||
149157562|NCT03718143|538054167|FG002|Overall Study|Death|0|||
149157563|NCT03718143|538054165|FG000|Overall Study|Progression of Disease|1|||
149157564|NCT03718143|538054166|FG001|Overall Study|Progression of Disease|0|||
149157565|NCT03718143|538054167|FG002|Overall Study|Progression of Disease|0|||
149157566|NCT03718143|538054165|FG000|Overall Study|Withdrawal of Informed Consent|1|||
149157567|NCT03718143|538054166|FG001|Overall Study|Withdrawal of Informed Consent|2|||
149157568|NCT03718143|538054167|FG002|Overall Study|Withdrawal of Informed Consent|1|||
149157569|NCT00805740|538054168|FG000|Overall Study|Death|7|||
149157570|NCT00805740|538054169|FG001|Overall Study|Death|4|||
149157571|NCT00805740|538054168|FG000|Overall Study|Withdrawal by Subject|1|||
149157572|NCT00805740|538054169|FG001|Overall Study|Withdrawal by Subject|0|||
149157573|NCT00805740|538054168|FG000|Overall Study|Lost to Follow-up|1|||
149157574|NCT00805740|538054169|FG001|Overall Study|Lost to Follow-up|0|||
149157575|NCT00805740|538054168|FG000|Overall Study|Randomized, but not treated|2|||
148923893|NCT02496676|537206500|FG000|Phase 1 - Period 1|Adverse Event|0|||
149012842|NCT01468922|537525815|FG002|Overall Study|Adverse Event|0|||
149157576|NCT00805740|538054169|FG001|Overall Study|Randomized, but not treated|0|||
149157577|NCT05227690|538054179|FG000|Overall Study|Adverse Event|5|||
148923894|NCT02496676|537206501|FG001|Phase 1 - Period 1|Adverse Event|1|||
148923895|NCT02496676|537206500|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
148923896|NCT02496676|537206501|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
148923897|NCT05442775|537206502|FG000|Overall Study|Trial terminated|61|||
149157578|NCT05227690|538054180|FG001|Overall Study|Adverse Event|6|||
149157579|NCT05227690|538054181|FG002|Overall Study|Adverse Event|10|||
149157580|NCT05227690|538054179|FG000|Overall Study|Lack of Efficacy|2|||
149157581|NCT05227690|538054180|FG001|Overall Study|Lack of Efficacy|4|||
149157582|NCT05227690|538054181|FG002|Overall Study|Lack of Efficacy|1|||
149157583|NCT05227690|538054179|FG000|Overall Study|Physician Decision|6|||
149157584|NCT05227690|538054180|FG001|Overall Study|Physician Decision|0|||
149157585|NCT05227690|538054181|FG002|Overall Study|Physician Decision|4|||
149157586|NCT05227690|538054179|FG000|Overall Study|Withdrawal of consent|28|||
149157587|NCT05227690|538054180|FG001|Overall Study|Withdrawal of consent|27|||
149157588|NCT05227690|538054181|FG002|Overall Study|Withdrawal of consent|21|||
149157589|NCT05227690|538054179|FG000|Overall Study|Other, not specified|2|||
149157590|NCT05227690|538054180|FG001|Overall Study|Other, not specified|2|||
149157591|NCT05227690|538054181|FG002|Overall Study|Other, not specified|1|||
149157592|NCT05499559|538054182|FG000|Overall Study|Lost to Follow-up|467|||
148923898|NCT05442775|537206502|FG000|Overall Study|Lack of Efficacy|4|||
148923899|NCT05442775|537206502|FG000|Overall Study|Withdrawal by Subject|4|||
148923900|NCT05442775|537206502|FG000|Overall Study|Death|1|||
148923901|NCT05442775|537206502|FG000|Overall Study|Participant removed at Sponsor request|1|||
148923902|NCT01323920|537206507|FG000|Overall Study|Death|5|||
148923903|NCT01323920|537206507|FG000|Overall Study|Withdrawal by Subject|1|||
148923904|NCT03579602|537206519|FG000|Overall Study|Subject unable to receive study drug|0|||
148923905|NCT03579602|537206520|FG001|Overall Study|Subject unable to receive study drug|2|||
148923906|NCT03579602|537206519|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
148923907|NCT03579602|537206520|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
148923908|NCT02518464|537206522|FG000|Overall Study|Adverse Event|2|||
148923909|NCT01120067|537206525|FG000|Overall Study|Lost to Follow-up|3|||
148923910|NCT01120067|537206526|FG001|Overall Study|Lost to Follow-up|1|||
148923911|NCT01120067|537206525|FG000|Overall Study|fail to engage >3 sessions|2|||
148923912|NCT01120067|537206526|FG001|Overall Study|fail to engage >3 sessions|0|||
148923913|NCT03021564|537206533|FG000|Overall Study|Death|84|||
148923914|NCT03021564|537206534|FG001|Overall Study|Death|466|||
148923915|NCT03021564|537206533|FG000|Overall Study|Lost to Follow-up|0|||
148923916|NCT03021564|537206534|FG001|Overall Study|Lost to Follow-up|2|||
148923917|NCT02889562|537206535|FG000|Overall Study|Physician Decision|0|||
148923918|NCT02889562|537206536|FG001|Overall Study|Physician Decision|1|||
148923919|NCT02889562|537206535|FG000|Overall Study|Withdrawal by Subject|0|||
148923920|NCT02889562|537206536|FG001|Overall Study|Withdrawal by Subject|1|||
148923921|NCT01470989|537206539|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
148923922|NCT01470989|537206540|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
148923923|NCT01470989|537206539|FG000|Overall Study|Adverse Event|2|||
148923924|NCT01470989|537206540|FG001|Overall Study|Adverse Event|5|||
148923925|NCT01470989|537206539|FG000|Overall Study|Abnormal laboratory value|1|||
148923926|NCT01470989|537206540|FG001|Overall Study|Abnormal laboratory value|1|||
148923927|NCT01470989|537206539|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148923928|NCT01470989|537206540|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
148923929|NCT01470989|537206539|FG000|Overall Study|Withdrawal by Subject|19|||
148923930|NCT01470989|537206540|FG001|Overall Study|Withdrawal by Subject|17|||
148923931|NCT01470989|537206539|FG000|Overall Study|Lost to Follow-up|18|||
149157593|NCT00223496|538054185|FG000|Overall Study|screen failure|9|||
149157594|NCT00223496|538054185|FG000|Overall Study|Lost to Follow-up|4|||
149157595|NCT00223496|538054185|FG000|Overall Study|Lack of Efficacy|6|||
148923932|NCT01470989|537206540|FG001|Overall Study|Lost to Follow-up|13|||
148923933|NCT01470989|537206539|FG000|Overall Study|Administrative problems|2|||
149157596|NCT00223496|538054185|FG000|Overall Study|Withdrawal by Subject|1|||
149157597|NCT00223496|538054185|FG000|Overall Study|Physician Decision|2|||
149157598|NCT02971202|538054188|FG000|Overall Study|Pregnancy|1|||
149157599|NCT02971202|538054189|FG001|Overall Study|Pregnancy|0|||
149157600|NCT02971202|538054190|FG002|Overall Study|Pregnancy|0|||
149157601|NCT02971202|538054188|FG000|Overall Study|screen fail after consent|1|||
149157602|NCT02971202|538054189|FG001|Overall Study|screen fail after consent|0|||
149157603|NCT02971202|538054190|FG002|Overall Study|screen fail after consent|1|||
148923934|NCT01470989|537206540|FG001|Overall Study|Administrative problems|4|||
148923935|NCT01470989|537206539|FG000|Overall Study|Death|2|||
148923936|NCT01470989|537206540|FG001|Overall Study|Death|2|||
148923937|NCT01470989|537206539|FG000|Overall Study|Protocol deviation|1|||
148923938|NCT01470989|537206540|FG001|Overall Study|Protocol deviation|2|||
148923939|NCT00969280|537206541|FG000|Overall Study|Protocol Violation|2|||
148923940|NCT00969280|537206542|FG001|Overall Study|Protocol Violation|1|||
148923941|NCT00969280|537206541|FG000|Overall Study|Withdrawal by Subject|0|||
149157604|NCT02723201|538054191|FG000|Second Intervention Period|Protocol Violation|1|||
149157605|NCT02723201|538054192|FG001|Second Intervention Period|Protocol Violation|0|||
149157606|NCT02723201|538054193|FG002|Second Intervention Period|Protocol Violation|0|||
149157607|NCT02723201|538054191|FG000|Second Intervention Period|Adverse Event|1|||
149157608|NCT02723201|538054192|FG001|Second Intervention Period|Adverse Event|0|||
149157609|NCT02723201|538054193|FG002|Second Intervention Period|Adverse Event|0|||
149157610|NCT01414257|538054199|FG000|Overall Study|No Visit After First Day of Treatment|12|||
149157611|NCT01414257|538054199|FG000|Overall Study|Protocol Violation|10|||
149157612|NCT01534676|538054200|FG000|Overall Study|Study closed due to poor enrollment|2|||
149157613|NCT01534676|538054201|FG001|Overall Study|Study closed due to poor enrollment|1|||
149157614|NCT02634580|538054202|FG000|Double-blind Treatment Period|Subject Request|1|||
149157615|NCT02634580|538054203|FG001|Double-blind Treatment Period|Subject Request|0|||
149157616|NCT02634580|538054204|FG002|Double-blind Treatment Period|Subject Request|1|||
149157617|NCT02634580|538054205|FG003|Double-blind Treatment Period|Subject Request|1|||
149157618|NCT02634580|538054202|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
149157619|NCT02634580|538054203|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
149157620|NCT02634580|538054204|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
149157621|NCT02634580|538054205|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
149157622|NCT02908880|538054207|FG000|Overall Study|Lost to Follow-up|4|||
148923942|NCT00969280|537206542|FG001|Overall Study|Withdrawal by Subject|1|||
148923943|NCT00969280|537206541|FG000|Overall Study|infection of influenza A(H1N1)|0|||
148923944|NCT00969280|537206542|FG001|Overall Study|infection of influenza A(H1N1)|1|||
148923945|NCT00217464|537206543|FG000|Overall Study|Progression|15|||
148923946|NCT00217464|537206543|FG000|Overall Study|Other|2|||
148923947|NCT00459979|537206544|FG000|Overall Study|Withdrawal by Subject|1|||
148923948|NCT00459979|537206544|FG000|Overall Study|Protocol Violation|1|||
148923949|NCT00989573|537206545|FG000|Overall Study|Adverse Event|8|||
148923950|NCT00989573|537206546|FG001|Overall Study|Adverse Event|12|||
148923951|NCT00989573|537206547|FG002|Overall Study|Adverse Event|4|||
148923952|NCT00989573|537206545|FG000|Overall Study|Physician Decision|0|||
148923953|NCT00989573|537206546|FG001|Overall Study|Physician Decision|2|||
149157623|NCT02908880|538054207|FG000|Overall Study|Explantation of the device|1|||
149157624|NCT02908880|538054207|FG000|Overall Study|Withdrawal by Subject|17|||
149157625|NCT02908880|538054207|FG000|Overall Study|Death|5|||
149157626|NCT01396005|538054210|FG000|Overall Study|Withdrawal by Subject|0|||
149157627|NCT01396005|538054211|FG001|Overall Study|Withdrawal by Subject|1|||
149157628|NCT01396005|538054210|FG000|Overall Study|Non-compliance with protocol|0|||
148923954|NCT00989573|537206547|FG002|Overall Study|Physician Decision|0|||
148923955|NCT00989573|537206545|FG000|Overall Study|Protocol Violation|1|||
148923956|NCT00989573|537206546|FG001|Overall Study|Protocol Violation|1|||
148923957|NCT00989573|537206547|FG002|Overall Study|Protocol Violation|1|||
148673586|NCT00424632|536275798|FG002|Overall Study|Adverse Event|0|||
148673587|NCT00424632|536275799|FG003|Overall Study|Adverse Event|0|||
148673588|NCT00424632|536275800|FG004|Overall Study|Adverse Event|0|||
148673589|NCT00424632|536275801|FG005|Overall Study|Adverse Event|0|||
149157629|NCT01396005|538054211|FG001|Overall Study|Non-compliance with protocol|1|||
148673590|NCT00424632|536275802|FG006|Overall Study|Adverse Event|0|||
148673591|NCT00424632|536275803|FG007|Overall Study|Adverse Event|0|||
148923958|NCT00989573|537206545|FG000|Overall Study|Withdrawal by Subject|4|||
148923959|NCT00989573|537206546|FG001|Overall Study|Withdrawal by Subject|7|||
148923960|NCT00989573|537206547|FG002|Overall Study|Withdrawal by Subject|3|||
148923961|NCT00278915|537206550|FG000|Overall Study|Disease progression|1|||
148923962|NCT05214573|537206551|FG000|Overall Study|Physician Decision|5924|||
148673592|NCT00424632|536275804|FG008|Overall Study|Adverse Event|3|||
148673593|NCT00424632|536275805|FG009|Overall Study|Adverse Event|2|||
148673594|NCT00424632|536275796|FG000|Overall Study|Global deterioration of health status|0|||
148673595|NCT00424632|536275797|FG001|Overall Study|Global deterioration of health status|0|||
148673596|NCT00424632|536275798|FG002|Overall Study|Global deterioration of health status|0|||
148673597|NCT00424632|536275799|FG003|Overall Study|Global deterioration of health status|1|||
148673598|NCT00424632|536275800|FG004|Overall Study|Global deterioration of health status|1|||
148673599|NCT00424632|536275801|FG005|Overall Study|Global deterioration of health status|0|||
148673600|NCT00424632|536275802|FG006|Overall Study|Global deterioration of health status|0|||
148673601|NCT00424632|536275803|FG007|Overall Study|Global deterioration of health status|0|||
148673602|NCT00424632|536275804|FG008|Overall Study|Global deterioration of health status|0|||
148673603|NCT00424632|536275805|FG009|Overall Study|Global deterioration of health status|0|||
148923963|NCT05214573|537206552|FG001|Overall Study|Physician Decision|0|||
148923964|NCT00814801|537206553|FG000|Overall Study|Adverse Event|15|||
148923965|NCT00814801|537206554|FG001|Overall Study|Adverse Event|16|||
148923966|NCT00814801|537206555|FG002|Overall Study|Adverse Event|19|||
148923967|NCT00814801|537206553|FG000|Overall Study|Withdrawal by Subject|9|||
148923968|NCT00814801|537206554|FG001|Overall Study|Withdrawal by Subject|11|||
148923969|NCT00814801|537206555|FG002|Overall Study|Withdrawal by Subject|14|||
148923970|NCT00814801|537206553|FG000|Overall Study|Inappropriate as a subject|1|||
148673604|NCT00424632|536275796|FG000|Overall Study|Objective progression or relapse|1|||
148673605|NCT00424632|536275797|FG001|Overall Study|Objective progression or relapse|1|||
148805986|NCT05911841|536768053|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
148923971|NCT00814801|537206554|FG001|Overall Study|Inappropriate as a subject|1|||
148923972|NCT00814801|537206555|FG002|Overall Study|Inappropriate as a subject|1|||
148923973|NCT00814801|537206553|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
148673606|NCT00424632|536275798|FG002|Overall Study|Objective progression or relapse|1|||
148923974|NCT00814801|537206554|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
148923975|NCT00814801|537206555|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
148923976|NCT00814801|537206553|FG000|Overall Study|Missing or change of caregiver|6|||
148923977|NCT00814801|537206554|FG001|Overall Study|Missing or change of caregiver|2|||
148923978|NCT00814801|537206555|FG002|Overall Study|Missing or change of caregiver|4|||
148923979|NCT00814801|537206553|FG000|Overall Study|Non-compliance|0|||
148923980|NCT00814801|537206554|FG001|Overall Study|Non-compliance|1|||
148923981|NCT00814801|537206555|FG002|Overall Study|Non-compliance|1|||
148923982|NCT00814801|537206553|FG000|Overall Study|Other|2|||
148923983|NCT00814801|537206554|FG001|Overall Study|Other|6|||
148923984|NCT00814801|537206555|FG002|Overall Study|Other|4|||
148923985|NCT02486718|537206558|FG000|Enrollment Phase|Death|19|||
148923986|NCT02486718|537206559|FG001|Enrollment Phase|Death|0|||
148923987|NCT02486718|537206560|FG002|Enrollment Phase|Death|0|||
149157630|NCT05689047|538054216|FG000|Overall Study|Lost to Follow-up|0|||
149157631|NCT05689047|538054217|FG001|Overall Study|Lost to Follow-up|1|||
148923988|NCT02486718|537206558|FG000|Enrollment Phase|Symptomatic deterioration|1|||
148923989|NCT02486718|537206559|FG001|Enrollment Phase|Symptomatic deterioration|0|||
148923990|NCT02486718|537206560|FG002|Enrollment Phase|Symptomatic deterioration|0|||
148923991|NCT02486718|537206558|FG000|Enrollment Phase|Withdrawal by Subject|86|||
148923992|NCT02486718|537206559|FG001|Enrollment Phase|Withdrawal by Subject|0|||
148923993|NCT02486718|537206560|FG002|Enrollment Phase|Withdrawal by Subject|0|||
148923994|NCT02486718|537206558|FG000|Enrollment Phase|Protocol Violation|18|||
148923995|NCT02486718|537206559|FG001|Enrollment Phase|Protocol Violation|0|||
148923996|NCT02486718|537206560|FG002|Enrollment Phase|Protocol Violation|0|||
148923997|NCT02486718|537206558|FG000|Enrollment Phase|Physician Decision|18|||
148923998|NCT02486718|537206559|FG001|Enrollment Phase|Physician Decision|0|||
148923999|NCT02486718|537206560|FG002|Enrollment Phase|Physician Decision|0|||
148924000|NCT02486718|537206558|FG000|Enrollment Phase|Reason not provided|41|||
148924001|NCT02486718|537206559|FG001|Enrollment Phase|Reason not provided|0|||
148924002|NCT02486718|537206560|FG002|Enrollment Phase|Reason not provided|0|||
148924003|NCT02486718|537206558|FG000|Enrollment Phase|Disease relapse|54|||
148924004|NCT02486718|537206559|FG001|Enrollment Phase|Disease relapse|0|||
148924005|NCT02486718|537206560|FG002|Enrollment Phase|Disease relapse|0|||
148924006|NCT02486718|537206558|FG000|Enrollment Phase|Lost to Follow-up|4|||
148924007|NCT02486718|537206559|FG001|Enrollment Phase|Lost to Follow-up|0|||
148924008|NCT02486718|537206560|FG002|Enrollment Phase|Lost to Follow-up|0|||
148924009|NCT02486718|537206558|FG000|Enrollment Phase|Adverse Event|34|||
148924010|NCT02486718|537206559|FG001|Enrollment Phase|Adverse Event|0|||
148924011|NCT02486718|537206560|FG002|Enrollment Phase|Adverse Event|0|||
148924012|NCT02486718|537206558|FG000|Randomized Phase|Withdrawal by Subject|0|||
148924013|NCT02486718|537206559|FG001|Randomized Phase|Withdrawal by Subject|44|||
148924014|NCT02486718|537206560|FG002|Randomized Phase|Withdrawal by Subject|47|||
148924015|NCT02486718|537206558|FG000|Randomized Phase|Protocol Violation|0|||
148924016|NCT02486718|537206559|FG001|Randomized Phase|Protocol Violation|2|||
148924017|NCT02486718|537206560|FG002|Randomized Phase|Protocol Violation|0|||
148924018|NCT02486718|537206558|FG000|Randomized Phase|Physician Decision|0|||
148924019|NCT02486718|537206559|FG001|Randomized Phase|Physician Decision|0|||
148924020|NCT02486718|537206560|FG002|Randomized Phase|Physician Decision|3|||
148924021|NCT02486718|537206558|FG000|Randomized Phase|Lost to Follow-up|0|||
148924022|NCT02486718|537206559|FG001|Randomized Phase|Lost to Follow-up|5|||
148924023|NCT02486718|537206560|FG002|Randomized Phase|Lost to Follow-up|11|||
148924024|NCT02486718|537206558|FG000|Randomized Phase|Disease Relapse|0|||
148924025|NCT02486718|537206559|FG001|Randomized Phase|Disease Relapse|1|||
148924026|NCT02486718|537206560|FG002|Randomized Phase|Disease Relapse|0|||
148924027|NCT02486718|537206558|FG000|Randomized Phase|Death|0|||
148924028|NCT02486718|537206559|FG001|Randomized Phase|Death|154|||
148924029|NCT02486718|537206560|FG002|Randomized Phase|Death|155|||
148924030|NCT02486718|537206558|FG000|Randomized Phase|Ongoing|0|||
148924031|NCT02486718|537206559|FG001|Randomized Phase|Ongoing|301|||
148924032|NCT02486718|537206560|FG002|Randomized Phase|Ongoing|282|||
148924033|NCT02520089|537206561|FG000|Overall Study|Lost to Follow-up|3|||
148924034|NCT02520089|537206562|FG001|Overall Study|Lost to Follow-up|4|||
148924035|NCT01037088|537206565|FG000|Overall Study|Withdrawal by Subject|3|||
148924036|NCT02216812|537206568|FG000|Overall Study|Lost to Follow-up|10|||
148805987|NCT05911841|536768044|FG000|Maintenance Period|Withdrawal by Subject|0|||
148924037|NCT02216812|537206569|FG001|Overall Study|Lost to Follow-up|5|||
148924038|NCT00527488|537206574|FG000|Overall Study|Withdrawn prior to dosing|0|||
148924039|NCT00527488|537206575|FG001|Overall Study|Withdrawn prior to dosing|1|||
148924040|NCT00527488|537206576|FG002|Overall Study|Withdrawn prior to dosing|1|||
148924041|NCT00527488|537206577|FG003|Overall Study|Withdrawn prior to dosing|0|||
148924042|NCT01958827|537206578|FG000|Overall Study|Adverse Event|3|||
148924043|NCT01958827|537206578|FG000|Overall Study|Lack of Efficacy|6|||
148924044|NCT01958827|537206578|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
148924045|NCT03036800|537206579|FG000|Overall Study|Protocol Violation|1|||
148924046|NCT03036800|537206580|FG001|Overall Study|Protocol Violation|0|||
148924047|NCT03036800|537206579|FG000|Overall Study|Non-compliance|1|||
149157632|NCT05689047|538054216|FG000|Overall Study|Protocol Deviation|1|||
148924048|NCT03036800|537206580|FG001|Overall Study|Non-compliance|0|||
148924049|NCT03036800|537206579|FG000|Overall Study|Lost to Follow-up|1|||
148924050|NCT03036800|537206580|FG001|Overall Study|Lost to Follow-up|0|||
148924051|NCT03036800|537206579|FG000|Overall Study|Death|1|||
148924052|NCT03036800|537206580|FG001|Overall Study|Death|0|||
148924053|NCT03036800|537206579|FG000|Overall Study|Tolerance|5|||
148924054|NCT03036800|537206580|FG001|Overall Study|Tolerance|0|||
148924055|NCT03036800|537206579|FG000|Overall Study|Unknown/no reason given|50|||
148924056|NCT03036800|537206580|FG001|Overall Study|Unknown/no reason given|39|||
148924057|NCT01077154|537206585|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
148924058|NCT01077154|537206586|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
148924059|NCT01077154|537206585|FG000|Overall Study|Withdrawal by Subject|369|||
148924060|NCT01077154|537206586|FG001|Overall Study|Withdrawal by Subject|385|||
148924061|NCT01077154|537206585|FG000|Overall Study|Death|215|||
148924062|NCT01077154|537206586|FG001|Overall Study|Death|214|||
148924063|NCT01077154|537206585|FG000|Overall Study|Lost to Follow-up|43|||
148924064|NCT01077154|537206586|FG001|Overall Study|Lost to Follow-up|35|||
148924065|NCT01077154|537206585|FG000|Overall Study|Noncompliance|22|||
148924066|NCT01077154|537206586|FG001|Overall Study|Noncompliance|20|||
148924067|NCT01077154|537206585|FG000|Overall Study|Disease Progression|18|||
148924068|NCT01077154|537206586|FG001|Overall Study|Disease Progression|20|||
148924069|NCT01077154|537206585|FG000|Overall Study|Ineligibility Determined|10|||
148924070|NCT01077154|537206586|FG001|Overall Study|Ineligibility Determined|14|||
148924071|NCT01077154|537206585|FG000|Overall Study|Other|14|||
148924072|NCT01077154|537206586|FG001|Overall Study|Other|11|||
148924073|NCT01077154|537206585|FG000|Overall Study|Adverse Event|9|||
148924074|NCT01077154|537206586|FG001|Overall Study|Adverse Event|9|||
148924075|NCT01077154|537206585|FG000|Overall Study|Administrative Decision|1|||
148924076|NCT01077154|537206586|FG001|Overall Study|Administrative Decision|6|||
148924077|NCT01077154|537206585|FG000|Overall Study|Protocol Deviation|1|||
148924078|NCT01077154|537206586|FG001|Overall Study|Protocol Deviation|0|||
148924079|NCT02545543|537206587|FG000|Overall Study|Lost to Follow-up|67|||
148924080|NCT02545543|537206588|FG001|Overall Study|Lost to Follow-up|25|||
148924081|NCT02545543|537206587|FG000|Overall Study|Physician Decision|3|||
148924082|NCT02545543|537206588|FG001|Overall Study|Physician Decision|0|||
148924083|NCT02545543|537206587|FG000|Overall Study|Withdrawal by Subject|9|||
148924084|NCT02545543|537206588|FG001|Overall Study|Withdrawal by Subject|8|||
148924085|NCT02545543|537206587|FG000|Overall Study|Noncomplaince|1|||
148924086|NCT02545543|537206588|FG001|Overall Study|Noncomplaince|0|||
148924087|NCT02545543|537206587|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
148924088|NCT02545543|537206588|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
148924089|NCT02829944|537206596|FG000|Overall Study|Physician Decision|0|||
149012843|NCT01468922|537525816|FG003|Overall Study|Adverse Event|0|||
149157633|NCT05689047|538054217|FG001|Overall Study|Protocol Deviation|0|||
149157634|NCT01604512|538054218|FG000|Overall Study|Withdrawal by Subject|3|||
149157635|NCT01604512|538054218|FG000|Overall Study|Not treated|4|||
149157636|NCT03083886|538054219|FG000|Overall Study|Withdrawal by Subject|51|||
149157637|NCT03083886|538054220|FG001|Overall Study|Withdrawal by Subject|73|||
149157638|NCT03083886|538054221|FG002|Overall Study|Withdrawal by Subject|104|||
149157639|NCT03083886|538054219|FG000|Overall Study|Missing Baseline data|43|||
149157640|NCT03083886|538054220|FG001|Overall Study|Missing Baseline data|42|||
149157641|NCT03083886|538054221|FG002|Overall Study|Missing Baseline data|31|||
149157642|NCT03083886|538054219|FG000|Overall Study|Investigator terminated|1|||
149157643|NCT03083886|538054220|FG001|Overall Study|Investigator terminated|6|||
148673607|NCT00424632|536275799|FG003|Overall Study|Objective progression or relapse|2|||
148673608|NCT00424632|536275800|FG004|Overall Study|Objective progression or relapse|2|||
148673609|NCT00424632|536275801|FG005|Overall Study|Objective progression or relapse|13|||
148673610|NCT00424632|536275802|FG006|Overall Study|Objective progression or relapse|7|||
148673611|NCT00424632|536275803|FG007|Overall Study|Objective progression or relapse|3|||
148673612|NCT00424632|536275804|FG008|Overall Study|Objective progression or relapse|12|||
148673613|NCT00424632|536275805|FG009|Overall Study|Objective progression or relapse|4|||
148673614|NCT00424632|536275796|FG000|Overall Study|Other|0|||
148673615|NCT00424632|536275797|FG001|Overall Study|Other|0|||
149157644|NCT03083886|538054221|FG002|Overall Study|Investigator terminated|3|||
149157645|NCT03178487|538054225|FG000|Period 1|Adverse Event|1|||
149157646|NCT03178487|538054226|FG001|Period 1|Adverse Event|2|||
149157647|NCT03178487|538054225|FG000|Period 1|Withdrawal by Subject|2|||
149157648|NCT03178487|538054226|FG001|Period 1|Withdrawal by Subject|1|||
149157649|NCT03178487|538054225|FG000|Period 1|Lost to Follow-up|1|||
149157650|NCT03178487|538054226|FG001|Period 1|Lost to Follow-up|0|||
148673616|NCT00424632|536275798|FG002|Overall Study|Other|0|||
148924090|NCT02829944|537206597|FG001|Overall Study|Physician Decision|1|||
148924091|NCT02829944|537206596|FG000|Overall Study|Screen Failure|2|||
149157651|NCT03178487|538054225|FG000|Period 1|Other|0|||
148673617|NCT00424632|536275799|FG003|Overall Study|Other|1|||
148924092|NCT02829944|537206597|FG001|Overall Study|Screen Failure|2|||
148924093|NCT02829944|537206596|FG000|Overall Study|Inadequate Neuraxial Block|1|||
148924094|NCT02829944|537206597|FG001|Overall Study|Inadequate Neuraxial Block|1|||
149157652|NCT03178487|538054226|FG001|Period 1|Other|1|||
148924095|NCT02829944|537206596|FG000|Overall Study|Withdrawal by Subject|2|||
148924096|NCT02829944|537206597|FG001|Overall Study|Withdrawal by Subject|1|||
148924097|NCT02829944|537206596|FG000|Overall Study|Catheter Displacement|1|||
149157653|NCT03178487|538054225|FG000|Period 2|Adverse Event|4|||
149157654|NCT03178487|538054226|FG001|Period 2|Adverse Event|4|||
149157655|NCT03178487|538054225|FG000|Period 2|Withdrawal by Subject|6|||
149157656|NCT03178487|538054226|FG001|Period 2|Withdrawal by Subject|6|||
149157657|NCT03178487|538054225|FG000|Period 2|Lost to Follow-up|2|||
149157658|NCT03178487|538054226|FG001|Period 2|Lost to Follow-up|2|||
149157659|NCT03178487|538054225|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
149157660|NCT03178487|538054226|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
149157661|NCT03178487|538054225|FG000|Period 2|Other|8|||
149157662|NCT03178487|538054226|FG001|Period 2|Other|7|||
149157663|NCT01453855|538054227|FG000|Overall Study|Adverse Event|3|||
149157664|NCT01453855|538054228|FG001|Overall Study|Adverse Event|4|||
149157665|NCT01453855|538054227|FG000|Overall Study|Lost to Follow-up|2|||
149157666|NCT01453855|538054228|FG001|Overall Study|Lost to Follow-up|1|||
149157667|NCT01453855|538054227|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
149157668|NCT01453855|538054228|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
149157669|NCT01453855|538054227|FG000|Overall Study|Noncompliance|1|||
149157670|NCT01453855|538054228|FG001|Overall Study|Noncompliance|0|||
149157671|NCT01453855|538054227|FG000|Overall Study|Inadequate Control of IOP|1|||
149157672|NCT01453855|538054228|FG001|Overall Study|Inadequate Control of IOP|5|||
149157673|NCT01453855|538054227|FG000|Overall Study|Other|0|||
149157674|NCT01453855|538054228|FG001|Overall Study|Other|1|||
149157675|NCT04161495|538054229|FG000|Overall Study|Withdrawal by Subject|3|||
148924098|NCT02829944|537206597|FG001|Overall Study|Catheter Displacement|0|||
148924099|NCT02829944|537206596|FG000|Overall Study|Catheter broke|0|||
148924100|NCT02829944|537206597|FG001|Overall Study|Catheter broke|1|||
148924101|NCT02829944|537206596|FG000|Overall Study|Staff unavailable|0|||
148924102|NCT02829944|537206597|FG001|Overall Study|Staff unavailable|1|||
148924103|NCT04675151|537206599|FG000|Overall Study|Protocol Violation|1|||
148924104|NCT04675151|537206600|FG001|Overall Study|Protocol Violation|0|||
148924105|NCT04675151|537206601|FG002|Overall Study|Protocol Violation|0|||
148924106|NCT04675151|537206602|FG003|Overall Study|Protocol Violation|1|||
148924107|NCT04035486|537206603|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
148924108|NCT04035486|537206604|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
148924109|NCT04035486|537206605|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
148924110|NCT04035486|537206606|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
148924111|NCT04035486|537206603|FG000|Overall Study|Death|6|||
148924112|NCT04035486|537206604|FG001|Overall Study|Death|3|||
148924113|NCT04035486|537206605|FG002|Overall Study|Death|70|||
148924114|NCT04035486|537206606|FG003|Overall Study|Death|77|||
148924115|NCT04035486|537206603|FG000|Overall Study|Screen Failure|0|||
148924116|NCT04035486|537206604|FG001|Overall Study|Screen Failure|0|||
148924117|NCT04035486|537206605|FG002|Overall Study|Screen Failure|1|||
148924118|NCT04035486|537206606|FG003|Overall Study|Screen Failure|1|||
148924119|NCT04035486|537206603|FG000|Overall Study|Withdrawal by Subject|1|||
148924120|NCT04035486|537206604|FG001|Overall Study|Withdrawal by Subject|1|||
148924121|NCT04035486|537206605|FG002|Overall Study|Withdrawal by Subject|11|||
148924122|NCT04035486|537206606|FG003|Overall Study|Withdrawal by Subject|9|||
148924123|NCT01730937|537206607|FG000|Overall Study|Protocol Violation|5|||
148924124|NCT01730937|537206608|FG001|Overall Study|Protocol Violation|11|||
148924125|NCT03947684|537206609|FG000|Overall Study|Lost to Follow-up|13|||
148924126|NCT03947684|537206610|FG001|Overall Study|Lost to Follow-up|5|||
148924127|NCT03947684|537206611|FG002|Overall Study|Lost to Follow-up|1|||
148924128|NCT03947684|537206609|FG000|Overall Study|Withdrawal by Subject|11|||
148924129|NCT03947684|537206610|FG001|Overall Study|Withdrawal by Subject|4|||
148924130|NCT03947684|537206611|FG002|Overall Study|Withdrawal by Subject|0|||
148924131|NCT03947684|537206609|FG000|Overall Study|Physician Decision|1|||
148924132|NCT03947684|537206610|FG001|Overall Study|Physician Decision|0|||
148924133|NCT03947684|537206611|FG002|Overall Study|Physician Decision|0|||
148924134|NCT03947684|537206609|FG000|Overall Study|Lack of adherence to study protocol|2|||
148924135|NCT03947684|537206610|FG001|Overall Study|Lack of adherence to study protocol|0|||
148924136|NCT03947684|537206611|FG002|Overall Study|Lack of adherence to study protocol|0|||
148924137|NCT03875235|537206612|FG000|Overall Study|Ongoing study treatment|63|||
148924138|NCT03875235|537206613|FG001|Overall Study|Ongoing study treatment|20|||
148924139|NCT03875235|537206612|FG000|Overall Study|Off treatment|77|||
149157676|NCT04161495|538054230|FG001|Overall Study|Withdrawal by Subject|0|||
149157677|NCT04161495|538054229|FG000|Overall Study|Protocol Violation|1|||
149157678|NCT04161495|538054230|FG001|Overall Study|Protocol Violation|0|||
149157679|NCT04161495|538054229|FG000|Overall Study|Prohibited concomitant medication|3|||
148924140|NCT03875235|537206613|FG001|Overall Study|Off treatment|91|||
148924141|NCT03875235|537206612|FG000|Overall Study|Withdrawal by Subject|3|||
148924142|NCT03875235|537206613|FG001|Overall Study|Withdrawal by Subject|10|||
148924143|NCT03875235|537206612|FG000|Overall Study|Death|198|||
148924144|NCT03875235|537206613|FG001|Overall Study|Death|223|||
148924145|NCT01395784|537206623|FG000|Overall Study|Lost to Follow-up|7|||
148924146|NCT01395784|537206623|FG000|Overall Study|Withdrawal by Subject|3|||
148924147|NCT01395784|537206623|FG000|Overall Study|Physician Decision|5|||
148924148|NCT05772702|537206624|FG000|Overall Study|Adverse Event|1|||
148924149|NCT00884377|537207798|FG000|Overall Study|Withdrawal by Subject|1|||
148924150|NCT00884377|537207799|FG001|Overall Study|Withdrawal by Subject|0|||
148924151|NCT00884377|537207798|FG000|Overall Study|Could not confirm diagnosis|1|||
148924152|NCT00884377|537207799|FG001|Overall Study|Could not confirm diagnosis|0|||
148924153|NCT00884377|537207798|FG000|Overall Study|Physician Decision|0|||
148924154|NCT00884377|537207799|FG001|Overall Study|Physician Decision|1|||
148924155|NCT03123185|537207807|FG000|Overall Study|Withdrawal by Subject|0|||
148924156|NCT03123185|537207808|FG001|Overall Study|Withdrawal by Subject|0|||
148924157|NCT03123185|537207809|FG002|Overall Study|Withdrawal by Subject|0|||
148924158|NCT03123185|537207810|FG003|Overall Study|Withdrawal by Subject|0|||
148924159|NCT03123185|537207811|FG004|Overall Study|Withdrawal by Subject|0|||
148924160|NCT03123185|537207812|FG005|Overall Study|Withdrawal by Subject|0|||
148924161|NCT03123185|537207813|FG006|Overall Study|Withdrawal by Subject|0|||
148924162|NCT03123185|537207814|FG007|Overall Study|Withdrawal by Subject|0|||
148924163|NCT03123185|537207815|FG008|Overall Study|Withdrawal by Subject|0|||
148924164|NCT03123185|537207816|FG009|Overall Study|Withdrawal by Subject|0|||
148924165|NCT03123185|537207817|FG010|Overall Study|Withdrawal by Subject|0|||
148924166|NCT03123185|537207818|FG011|Overall Study|Withdrawal by Subject|0|||
148924167|NCT03123185|537207819|FG012|Overall Study|Withdrawal by Subject|1|||
148924168|NCT03123185|537207820|FG013|Overall Study|Withdrawal by Subject|0|||
148924169|NCT03468543|537207824|FG000|Overall Study|Protocol stopping rules met|3|||
148924170|NCT00470158|537207825|FG000|Overall Study|Death|0|||
148924171|NCT00470158|537207826|FG001|Overall Study|Death|0|||
148924172|NCT00470158|537207827|FG002|Overall Study|Death|0|||
148924173|NCT00470158|537207828|FG003|Overall Study|Death|0|||
148924174|NCT00470158|537207829|FG004|Overall Study|Death|2|||
148924175|NCT00470158|537207825|FG000|Overall Study|Lost to Follow-up|7|||
148924176|NCT00470158|537207826|FG001|Overall Study|Lost to Follow-up|8|||
148924177|NCT00470158|537207827|FG002|Overall Study|Lost to Follow-up|8|||
148924178|NCT00470158|537207828|FG003|Overall Study|Lost to Follow-up|5|||
148924179|NCT00470158|537207829|FG004|Overall Study|Lost to Follow-up|4|||
148924180|NCT00470158|537207825|FG000|Overall Study|Protocol Violation|1|||
148924181|NCT00470158|537207826|FG001|Overall Study|Protocol Violation|0|||
148924182|NCT00470158|537207827|FG002|Overall Study|Protocol Violation|0|||
148924183|NCT00470158|537207828|FG003|Overall Study|Protocol Violation|0|||
148924184|NCT00470158|537207829|FG004|Overall Study|Protocol Violation|0|||
148924185|NCT01249118|537207830|FG000|First Washout Period|Physician Decision|0|||
148924186|NCT01249118|537207831|FG001|First Washout Period|Physician Decision|1|||
148924187|NCT01249118|537207832|FG002|First Washout Period|Physician Decision|0|||
148924188|NCT00880685|537207833|FG000|Memantine 10mg|Lost to Follow-up|2|||
148924189|NCT00880685|537207833|FG000|Memantine 20mg|Withdrawal by Subject|1|||
148924190|NCT04179890|537207834|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
148924191|NCT04179890|537207835|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
148924192|NCT04179890|537207834|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
148924193|NCT04179890|537207835|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
148924194|NCT04179890|537207834|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
148924195|NCT04179890|537207835|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
148924196|NCT04179890|537207834|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
148924197|NCT04179890|537207835|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
148924198|NCT04179890|537207834|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
148924199|NCT04179890|537207835|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
148924200|NCT04179890|537207834|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
148924201|NCT04179890|537207835|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
148924202|NCT04179890|537207834|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
148924203|NCT04179890|537207835|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
148924204|NCT04179890|537207834|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
148924205|NCT04179890|537207835|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
148924206|NCT04179890|537207834|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
148924207|NCT04179890|537207835|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
148924208|NCT00978432|537207837|FG000|Overall Study|Withdrawal by Subject|0|||
148924209|NCT00978432|537207838|FG001|Overall Study|Withdrawal by Subject|0|||
148924210|NCT00978432|537207839|FG002|Overall Study|Withdrawal by Subject|1|||
148924211|NCT00978432|537207837|FG000|Overall Study|Lack of Efficacy|1|||
148924212|NCT00978432|537207838|FG001|Overall Study|Lack of Efficacy|1|||
148924213|NCT00978432|537207839|FG002|Overall Study|Lack of Efficacy|3|||
148924214|NCT00978432|537207837|FG000|Overall Study|Adverse Event|2|||
148924215|NCT00978432|537207838|FG001|Overall Study|Adverse Event|0|||
148924216|NCT00978432|537207839|FG002|Overall Study|Adverse Event|1|||
148924217|NCT02579928|537207840|FG000|Overall Study|Withdrawal by Subject|1|||
148924218|NCT02579928|537207841|FG001|Overall Study|Withdrawal by Subject|0|||
148924219|NCT04300751|537207844|FG000|Overall Study|Withdrawal by Subject|1|||
148924220|NCT02311582|537207847|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
148924221|NCT02311582|537207848|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
148924222|NCT02311582|537207849|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
148924223|NCT02311582|537207850|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
148924224|NCT02311582|537207851|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
148924225|NCT04972630|537207854|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
148924226|NCT04972630|537207855|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
148924227|NCT04972630|537207856|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
148924228|NCT05247398|537207862|FG000|Overall Study|Withdrawal by Subject|1|||
148924229|NCT04251156|537207863|FG000|Overall Study|Lost to Follow-up|1|||
148924230|NCT04251156|537207864|FG001|Overall Study|Lost to Follow-up|1|||
148924231|NCT04251156|537207863|FG000|Overall Study|Withdrawal by Subject|4|||
148924232|NCT04251156|537207864|FG001|Overall Study|Withdrawal by Subject|4|||
148924233|NCT04656275|537207865|FG000|Overall Study|Study terminated by sponsor|2|||
148924234|NCT04656275|537207866|FG001|Overall Study|Study terminated by sponsor|4|||
148924235|NCT05954143|537207868|FG000|Overall Study|Progressive Disease|1|||
148924236|NCT05954143|537207869|FG001|Overall Study|Progressive Disease|0|||
148924237|NCT05954143|537207868|FG000|Overall Study|Physician Decision|1|||
148924238|NCT05954143|537207869|FG001|Overall Study|Physician Decision|0|||
148924239|NCT05954143|537207868|FG000|Overall Study|Study Terminated by Sponsor|2|||
148924240|NCT05954143|537207869|FG001|Overall Study|Study Terminated by Sponsor|4|||
148924241|NCT05954143|537207868|FG000|Overall Study|Death|1|||
148924242|NCT05954143|537207869|FG001|Overall Study|Death|0|||
148924243|NCT05954143|537207868|FG000|Overall Study|Withdrawal by Subject|0|||
148924244|NCT05954143|537207869|FG001|Overall Study|Withdrawal by Subject|1|||
148924245|NCT05954143|537207868|FG000|Overall Study|Other|1|||
148924246|NCT05954143|537207869|FG001|Overall Study|Other|0|||
148924247|NCT01129024|537207870|FG000|Overall Study|Physician Decision|5|||
148924248|NCT01129024|537207870|FG000|Overall Study|Study Terminated by Sponsor|8|||
148924249|NCT01129024|537207870|FG000|Overall Study|Withdrawal by Subject|2|||
148924250|NCT01129024|537207870|FG000|Overall Study|Lack of Efficacy|3|||
148924251|NCT01129024|537207870|FG000|Overall Study|Needed a Platelet Transfusion|1|||
148924252|NCT00934648|537207873|FG000|Overall Study|Failure to return|8|||
148924253|NCT00934648|537207873|FG000|Overall Study|Withdrawal by Subject|1|||
148924254|NCT02361580|537207874|FG000|Overall Study|Lost to Follow-up|6|||
148924255|NCT02361580|537207875|FG001|Overall Study|Lost to Follow-up|3|||
148924256|NCT00708201|537207876|FG000|Overall Study|Adverse Event|4|||
148924257|NCT00708201|537207877|FG001|Overall Study|Adverse Event|4|||
148924258|NCT00708201|537207876|FG000|Overall Study|Withdrawal by Subject|1|||
148924259|NCT00708201|537207877|FG001|Overall Study|Withdrawal by Subject|1|||
149157680|NCT04161495|538054230|FG001|Overall Study|Prohibited concomitant medication|0|||
149157681|NCT04161495|538054229|FG000|Overall Study|Adverse Event|1|||
148924260|NCT00708201|537207876|FG000|Overall Study|Lost to Follow-up|2|||
148924261|NCT00708201|537207877|FG001|Overall Study|Lost to Follow-up|0|||
148924262|NCT00708201|537207876|FG000|Overall Study|Protocol Violation|0|||
148924263|NCT00708201|537207877|FG001|Overall Study|Protocol Violation|1|||
148924264|NCT00761748|537207878|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
149157682|NCT04161495|538054230|FG001|Overall Study|Adverse Event|0|||
149157683|NCT04161495|538054229|FG000|Overall Study|Other - Unspecified|1|||
149157684|NCT04161495|538054230|FG001|Overall Study|Other - Unspecified|0|||
149157685|NCT04161495|538054229|FG000|Overall Study|Death|0|||
148924265|NCT00761748|537207879|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
149157686|NCT04161495|538054230|FG001|Overall Study|Death|1|||
148924266|NCT00761748|537207878|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
149157687|NCT03529773|538054233|FG000|Overall Study|Adverse Event|0|||
149157688|NCT03529773|538054234|FG001|Overall Study|Adverse Event|0|||
149157689|NCT03529773|538054235|FG002|Overall Study|Adverse Event|0|||
149157690|NCT03529773|538054236|FG003|Overall Study|Adverse Event|0|||
149157691|NCT03529773|538054237|FG004|Overall Study|Adverse Event|0|||
149157692|NCT03529773|538054238|FG005|Overall Study|Adverse Event|0|||
148924267|NCT00761748|537207879|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
148924268|NCT01857310|537207880|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
148924269|NCT01857310|537207881|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
148924270|NCT00998764|537207882|FG000|Overall Study|Lack of Efficacy|3|||
148924271|NCT00998764|537207883|FG001|Overall Study|Lack of Efficacy|6|||
148924272|NCT00998764|537207882|FG000|Overall Study|Adverse Event|17|||
148924273|NCT00998764|537207883|FG001|Overall Study|Adverse Event|12|||
148924274|NCT00998764|537207882|FG000|Overall Study|Withdrawal by Subject|19|||
148924275|NCT00998764|537207883|FG001|Overall Study|Withdrawal by Subject|25|||
148924276|NCT00998764|537207882|FG000|Overall Study|Physician Decision|3|||
148924277|NCT00998764|537207883|FG001|Overall Study|Physician Decision|3|||
148924278|NCT00998764|537207882|FG000|Overall Study|Death|3|||
148924279|NCT00998764|537207883|FG001|Overall Study|Death|1|||
148924280|NCT00998764|537207882|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
148924281|NCT00998764|537207883|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
148924282|NCT00998764|537207882|FG000|Overall Study|Protocol Violation|0|||
148924283|NCT00998764|537207883|FG001|Overall Study|Protocol Violation|1|||
148924284|NCT00998764|537207882|FG000|Overall Study|Failed to Return|1|||
148924285|NCT00998764|537207883|FG001|Overall Study|Failed to Return|1|||
148924286|NCT00998764|537207882|FG000|Overall Study|Lost to Follow-up|1|||
148924287|NCT00998764|537207883|FG001|Overall Study|Lost to Follow-up|1|||
148924288|NCT00998764|537207882|FG000|Overall Study|Loss of Caregiver|0|||
148924289|NCT00998764|537207883|FG001|Overall Study|Loss of Caregiver|3|||
148924290|NCT00998764|537207882|FG000|Overall Study|Other|4|||
148924291|NCT00998764|537207883|FG001|Overall Study|Other|4|||
148924292|NCT00998764|537207882|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
148924293|NCT00998764|537207883|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
148924294|NCT04761627|537207886|FG000|Run-in Period|Death|1|||
148924295|NCT04761627|537207887|FG001|Run-in Period|Death|0|||
148924296|NCT04761627|537207888|FG002|Run-in Period|Death|0|||
148924297|NCT04761627|537207886|FG000|Run-in Period|Required alternative therapy|2|||
148924298|NCT04761627|537207887|FG001|Run-in Period|Required alternative therapy|0|||
149157693|NCT03529773|538054239|FG006|Overall Study|Adverse Event|0|||
149157694|NCT03529773|538054240|FG007|Overall Study|Adverse Event|0|||
149157695|NCT03529773|538054241|FG008|Overall Study|Adverse Event|0|||
149157696|NCT03529773|538054242|FG009|Overall Study|Adverse Event|0|||
149157697|NCT03529773|538054243|FG010|Overall Study|Adverse Event|0|||
149157698|NCT03529773|538054244|FG011|Overall Study|Adverse Event|0|||
149157699|NCT03529773|538054245|FG012|Overall Study|Adverse Event|0|||
149157700|NCT03529773|538054246|FG013|Overall Study|Adverse Event|0|||
149157701|NCT03529773|538054247|FG014|Overall Study|Adverse Event|0|||
149157702|NCT03529773|538054248|FG015|Overall Study|Adverse Event|0|||
149157703|NCT03529773|538054249|FG016|Overall Study|Adverse Event|0|||
149157704|NCT03529773|538054250|FG017|Overall Study|Adverse Event|0|||
149157705|NCT03529773|538054251|FG018|Overall Study|Adverse Event|0|||
149157706|NCT03529773|538054252|FG019|Overall Study|Adverse Event|0|||
149157707|NCT03529773|538054253|FG020|Overall Study|Adverse Event|0|||
149157708|NCT03529773|538054254|FG021|Overall Study|Adverse Event|0|||
149157709|NCT03529773|538054255|FG022|Overall Study|Adverse Event|0|||
149157710|NCT03529773|538054256|FG023|Overall Study|Adverse Event|0|||
149157711|NCT03529773|538054257|FG024|Overall Study|Adverse Event|0|||
149157712|NCT03529773|538054258|FG025|Overall Study|Adverse Event|0|||
149157713|NCT03529773|538054259|FG026|Overall Study|Adverse Event|0|||
149157714|NCT03529773|538054260|FG027|Overall Study|Adverse Event|0|||
149157715|NCT03529773|538054261|FG028|Overall Study|Adverse Event|0|||
149157716|NCT03529773|538054262|FG029|Overall Study|Adverse Event|0|||
149157717|NCT03529773|538054263|FG030|Overall Study|Adverse Event|1|||
149157718|NCT03529773|538054264|FG031|Overall Study|Adverse Event|0|||
149157719|NCT03529773|538054265|FG032|Overall Study|Adverse Event|0|||
149157720|NCT03529773|538054266|FG033|Overall Study|Adverse Event|0|||
149157721|NCT03529773|538054267|FG034|Overall Study|Adverse Event|0|||
149157722|NCT03529773|538054268|FG035|Overall Study|Adverse Event|1|||
149157723|NCT03529773|538054269|FG036|Overall Study|Adverse Event|0|||
149157724|NCT03529773|538054270|FG037|Overall Study|Adverse Event|0|||
149157725|NCT03529773|538054271|FG038|Overall Study|Adverse Event|1|||
149157726|NCT03529773|538054272|FG039|Overall Study|Adverse Event|1|||
148924299|NCT04761627|537207888|FG002|Run-in Period|Required alternative therapy|0|||
148924300|NCT04761627|537207886|FG000|Run-in Period|Lost to Follow-up|2|||
148924301|NCT04761627|537207887|FG001|Run-in Period|Lost to Follow-up|0|||
149157727|NCT03529773|538054233|FG000|Overall Study|Death|0|||
149157728|NCT03529773|538054234|FG001|Overall Study|Death|0|||
149157729|NCT03529773|538054235|FG002|Overall Study|Death|0|||
149157730|NCT03529773|538054236|FG003|Overall Study|Death|0|||
149157731|NCT03529773|538054237|FG004|Overall Study|Death|0|||
148924302|NCT04761627|537207888|FG002|Run-in Period|Lost to Follow-up|0|||
148924303|NCT04761627|537207886|FG000|Run-in Period|Protocol Violation|3|||
148924304|NCT04761627|537207887|FG001|Run-in Period|Protocol Violation|0|||
148924305|NCT04761627|537207888|FG002|Run-in Period|Protocol Violation|0|||
148924306|NCT04761627|537207886|FG000|Run-in Period|Abnormal liver function|1|||
148924307|NCT04761627|537207887|FG001|Run-in Period|Abnormal liver function|0|||
149157732|NCT03529773|538054238|FG005|Overall Study|Death|0|||
149157733|NCT03529773|538054239|FG006|Overall Study|Death|0|||
149157734|NCT03529773|538054240|FG007|Overall Study|Death|0|||
149157735|NCT03529773|538054241|FG008|Overall Study|Death|0|||
149157736|NCT03529773|538054242|FG009|Overall Study|Death|0|||
149157737|NCT03529773|538054243|FG010|Overall Study|Death|0|||
149157738|NCT03529773|538054244|FG011|Overall Study|Death|0|||
149157739|NCT03529773|538054245|FG012|Overall Study|Death|1|||
149157740|NCT03529773|538054246|FG013|Overall Study|Death|0|||
149157741|NCT03529773|538054247|FG014|Overall Study|Death|0|||
149157742|NCT03529773|538054248|FG015|Overall Study|Death|0|||
149157743|NCT03529773|538054249|FG016|Overall Study|Death|0|||
149157744|NCT03529773|538054250|FG017|Overall Study|Death|0|||
149157745|NCT03529773|538054251|FG018|Overall Study|Death|0|||
149157746|NCT03529773|538054252|FG019|Overall Study|Death|1|||
149157747|NCT03529773|538054253|FG020|Overall Study|Death|0|||
149157748|NCT03529773|538054254|FG021|Overall Study|Death|0|||
149157749|NCT03529773|538054255|FG022|Overall Study|Death|1|||
149157750|NCT03529773|538054256|FG023|Overall Study|Death|0|||
149157751|NCT03529773|538054257|FG024|Overall Study|Death|0|||
149157752|NCT03529773|538054258|FG025|Overall Study|Death|0|||
149157753|NCT03529773|538054259|FG026|Overall Study|Death|0|||
149157754|NCT03529773|538054260|FG027|Overall Study|Death|0|||
149157755|NCT03529773|538054261|FG028|Overall Study|Death|0|||
149157756|NCT03529773|538054262|FG029|Overall Study|Death|0|||
149157757|NCT03529773|538054263|FG030|Overall Study|Death|0|||
149157758|NCT03529773|538054264|FG031|Overall Study|Death|0|||
149157759|NCT03529773|538054265|FG032|Overall Study|Death|0|||
149157760|NCT03529773|538054266|FG033|Overall Study|Death|1|||
149157761|NCT03529773|538054267|FG034|Overall Study|Death|1|||
149157762|NCT03529773|538054268|FG035|Overall Study|Death|0|||
149157763|NCT03529773|538054269|FG036|Overall Study|Death|1|||
149157764|NCT03529773|538054270|FG037|Overall Study|Death|0|||
149157765|NCT03529773|538054271|FG038|Overall Study|Death|0|||
149157766|NCT03529773|538054272|FG039|Overall Study|Death|0|||
149157767|NCT03529773|538054233|FG000|Overall Study|Lost to Follow-up|0|||
149157768|NCT03529773|538054234|FG001|Overall Study|Lost to Follow-up|0|||
149157769|NCT03529773|538054235|FG002|Overall Study|Lost to Follow-up|1|||
149157770|NCT03529773|538054236|FG003|Overall Study|Lost to Follow-up|0|||
149157771|NCT03529773|538054237|FG004|Overall Study|Lost to Follow-up|1|||
149157772|NCT03529773|538054238|FG005|Overall Study|Lost to Follow-up|1|||
149157773|NCT03529773|538054239|FG006|Overall Study|Lost to Follow-up|0|||
149157774|NCT03529773|538054240|FG007|Overall Study|Lost to Follow-up|0|||
149157775|NCT03529773|538054241|FG008|Overall Study|Lost to Follow-up|0|||
149157776|NCT03529773|538054242|FG009|Overall Study|Lost to Follow-up|0|||
149157777|NCT03529773|538054243|FG010|Overall Study|Lost to Follow-up|0|||
149157778|NCT03529773|538054244|FG011|Overall Study|Lost to Follow-up|0|||
149157779|NCT03529773|538054245|FG012|Overall Study|Lost to Follow-up|0|||
149157780|NCT03529773|538054246|FG013|Overall Study|Lost to Follow-up|1|||
149157781|NCT03529773|538054247|FG014|Overall Study|Lost to Follow-up|4|||
149157782|NCT03529773|538054248|FG015|Overall Study|Lost to Follow-up|1|||
149157783|NCT03529773|538054249|FG016|Overall Study|Lost to Follow-up|1|||
149157784|NCT03529773|538054250|FG017|Overall Study|Lost to Follow-up|0|||
149157785|NCT03529773|538054251|FG018|Overall Study|Lost to Follow-up|1|||
149157786|NCT03529773|538054252|FG019|Overall Study|Lost to Follow-up|1|||
149157787|NCT03529773|538054253|FG020|Overall Study|Lost to Follow-up|2|||
149157788|NCT03529773|538054254|FG021|Overall Study|Lost to Follow-up|4|||
149157789|NCT03529773|538054255|FG022|Overall Study|Lost to Follow-up|3|||
148924308|NCT04761627|537207888|FG002|Run-in Period|Abnormal liver function|0|||
149157790|NCT03529773|538054256|FG023|Overall Study|Lost to Follow-up|4|||
149157791|NCT03529773|538054257|FG024|Overall Study|Lost to Follow-up|3|||
149157792|NCT03529773|538054258|FG025|Overall Study|Lost to Follow-up|5|||
149157793|NCT03529773|538054259|FG026|Overall Study|Lost to Follow-up|5|||
149157794|NCT03529773|538054260|FG027|Overall Study|Lost to Follow-up|0|||
149157795|NCT03529773|538054261|FG028|Overall Study|Lost to Follow-up|0|||
149157796|NCT03529773|538054262|FG029|Overall Study|Lost to Follow-up|0|||
149157797|NCT03529773|538054263|FG030|Overall Study|Lost to Follow-up|1|||
149157798|NCT03529773|538054264|FG031|Overall Study|Lost to Follow-up|0|||
148924309|NCT04761627|537207886|FG000|Run-in Period|Adverse Event|6|||
149157799|NCT03529773|538054265|FG032|Overall Study|Lost to Follow-up|0|||
149157800|NCT03529773|538054266|FG033|Overall Study|Lost to Follow-up|1|||
149157801|NCT03529773|538054267|FG034|Overall Study|Lost to Follow-up|1|||
149157802|NCT03529773|538054268|FG035|Overall Study|Lost to Follow-up|0|||
149157803|NCT03529773|538054269|FG036|Overall Study|Lost to Follow-up|0|||
149157804|NCT03529773|538054270|FG037|Overall Study|Lost to Follow-up|3|||
149157805|NCT03529773|538054271|FG038|Overall Study|Lost to Follow-up|1|||
149157806|NCT03529773|538054272|FG039|Overall Study|Lost to Follow-up|1|||
149157807|NCT03529773|538054233|FG000|Overall Study|No longer meets eligibility criteria|0|||
149157808|NCT03529773|538054234|FG001|Overall Study|No longer meets eligibility criteria|0|||
149157809|NCT03529773|538054235|FG002|Overall Study|No longer meets eligibility criteria|0|||
149157810|NCT03529773|538054236|FG003|Overall Study|No longer meets eligibility criteria|0|||
149157811|NCT03529773|538054237|FG004|Overall Study|No longer meets eligibility criteria|0|||
149157812|NCT03529773|538054238|FG005|Overall Study|No longer meets eligibility criteria|0|||
149157813|NCT03529773|538054239|FG006|Overall Study|No longer meets eligibility criteria|0|||
149157814|NCT03529773|538054240|FG007|Overall Study|No longer meets eligibility criteria|0|||
149157815|NCT03529773|538054241|FG008|Overall Study|No longer meets eligibility criteria|0|||
149157816|NCT03529773|538054242|FG009|Overall Study|No longer meets eligibility criteria|0|||
149157817|NCT03529773|538054243|FG010|Overall Study|No longer meets eligibility criteria|0|||
149157818|NCT03529773|538054244|FG011|Overall Study|No longer meets eligibility criteria|0|||
149157819|NCT03529773|538054245|FG012|Overall Study|No longer meets eligibility criteria|0|||
149157820|NCT03529773|538054246|FG013|Overall Study|No longer meets eligibility criteria|0|||
149157821|NCT03529773|538054247|FG014|Overall Study|No longer meets eligibility criteria|0|||
149157822|NCT03529773|538054248|FG015|Overall Study|No longer meets eligibility criteria|0|||
149157823|NCT03529773|538054249|FG016|Overall Study|No longer meets eligibility criteria|0|||
149157824|NCT03529773|538054250|FG017|Overall Study|No longer meets eligibility criteria|0|||
149157825|NCT03529773|538054251|FG018|Overall Study|No longer meets eligibility criteria|0|||
149157826|NCT03529773|538054252|FG019|Overall Study|No longer meets eligibility criteria|0|||
149157827|NCT03529773|538054253|FG020|Overall Study|No longer meets eligibility criteria|0|||
149157828|NCT03529773|538054254|FG021|Overall Study|No longer meets eligibility criteria|0|||
149157829|NCT03529773|538054255|FG022|Overall Study|No longer meets eligibility criteria|1|||
149157830|NCT03529773|538054256|FG023|Overall Study|No longer meets eligibility criteria|0|||
149157831|NCT03529773|538054257|FG024|Overall Study|No longer meets eligibility criteria|0|||
149157832|NCT03529773|538054258|FG025|Overall Study|No longer meets eligibility criteria|0|||
149157833|NCT03529773|538054259|FG026|Overall Study|No longer meets eligibility criteria|0|||
149157834|NCT03529773|538054260|FG027|Overall Study|No longer meets eligibility criteria|0|||
149157835|NCT03529773|538054261|FG028|Overall Study|No longer meets eligibility criteria|0|||
149157836|NCT03529773|538054262|FG029|Overall Study|No longer meets eligibility criteria|0|||
149157837|NCT03529773|538054263|FG030|Overall Study|No longer meets eligibility criteria|0|||
149157838|NCT03529773|538054264|FG031|Overall Study|No longer meets eligibility criteria|0|||
149157839|NCT03529773|538054265|FG032|Overall Study|No longer meets eligibility criteria|0|||
149157840|NCT03529773|538054266|FG033|Overall Study|No longer meets eligibility criteria|0|||
149157841|NCT03529773|538054267|FG034|Overall Study|No longer meets eligibility criteria|0|||
149157842|NCT03529773|538054268|FG035|Overall Study|No longer meets eligibility criteria|0|||
149157843|NCT03529773|538054269|FG036|Overall Study|No longer meets eligibility criteria|0|||
149157844|NCT03529773|538054270|FG037|Overall Study|No longer meets eligibility criteria|0|||
149157845|NCT03529773|538054271|FG038|Overall Study|No longer meets eligibility criteria|1|||
149157846|NCT03529773|538054272|FG039|Overall Study|No longer meets eligibility criteria|0|||
149157847|NCT03529773|538054233|FG000|Overall Study|Other|0|||
149157848|NCT03529773|538054234|FG001|Overall Study|Other|0|||
149157849|NCT03529773|538054235|FG002|Overall Study|Other|0|||
149157850|NCT03529773|538054236|FG003|Overall Study|Other|0|||
149157851|NCT03529773|538054237|FG004|Overall Study|Other|0|||
149157852|NCT03529773|538054238|FG005|Overall Study|Other|0|||
149157853|NCT03529773|538054239|FG006|Overall Study|Other|0|||
149157854|NCT03529773|538054240|FG007|Overall Study|Other|0|||
149157855|NCT03529773|538054241|FG008|Overall Study|Other|0|||
149157856|NCT03529773|538054242|FG009|Overall Study|Other|0|||
149157857|NCT03529773|538054243|FG010|Overall Study|Other|0|||
149157858|NCT03529773|538054244|FG011|Overall Study|Other|0|||
149157859|NCT03529773|538054245|FG012|Overall Study|Other|1|||
149157860|NCT03529773|538054246|FG013|Overall Study|Other|0|||
149157861|NCT03529773|538054247|FG014|Overall Study|Other|2|||
149157862|NCT03529773|538054248|FG015|Overall Study|Other|0|||
149157863|NCT03529773|538054249|FG016|Overall Study|Other|0|||
149157864|NCT03529773|538054250|FG017|Overall Study|Other|3|||
149157865|NCT03529773|538054251|FG018|Overall Study|Other|0|||
149157866|NCT03529773|538054252|FG019|Overall Study|Other|0|||
149157867|NCT03529773|538054253|FG020|Overall Study|Other|1|||
149157868|NCT03529773|538054254|FG021|Overall Study|Other|0|||
149157869|NCT03529773|538054255|FG022|Overall Study|Other|1|||
149157870|NCT03529773|538054256|FG023|Overall Study|Other|0|||
149157871|NCT03529773|538054257|FG024|Overall Study|Other|3|||
149157872|NCT03529773|538054258|FG025|Overall Study|Other|2|||
149157873|NCT03529773|538054259|FG026|Overall Study|Other|2|||
149157874|NCT03529773|538054260|FG027|Overall Study|Other|0|||
149157875|NCT03529773|538054261|FG028|Overall Study|Other|0|||
149157876|NCT03529773|538054262|FG029|Overall Study|Other|0|||
149157877|NCT03529773|538054263|FG030|Overall Study|Other|0|||
149157878|NCT03529773|538054264|FG031|Overall Study|Other|0|||
149157879|NCT03529773|538054265|FG032|Overall Study|Other|0|||
149157880|NCT03529773|538054266|FG033|Overall Study|Other|0|||
149157881|NCT03529773|538054267|FG034|Overall Study|Other|1|||
149157882|NCT03529773|538054268|FG035|Overall Study|Other|1|||
149157883|NCT03529773|538054269|FG036|Overall Study|Other|0|||
149157884|NCT03529773|538054270|FG037|Overall Study|Other|0|||
149157885|NCT03529773|538054271|FG038|Overall Study|Other|0|||
149157886|NCT03529773|538054272|FG039|Overall Study|Other|0|||
149157887|NCT03529773|538054233|FG000|Overall Study|Physician Decision|0|||
149157888|NCT03529773|538054234|FG001|Overall Study|Physician Decision|0|||
149157889|NCT03529773|538054235|FG002|Overall Study|Physician Decision|0|||
149157890|NCT03529773|538054236|FG003|Overall Study|Physician Decision|0|||
149157891|NCT03529773|538054237|FG004|Overall Study|Physician Decision|0|||
149157892|NCT03529773|538054238|FG005|Overall Study|Physician Decision|0|||
149157893|NCT03529773|538054239|FG006|Overall Study|Physician Decision|0|||
149157894|NCT03529773|538054240|FG007|Overall Study|Physician Decision|0|||
149157895|NCT03529773|538054241|FG008|Overall Study|Physician Decision|0|||
149157896|NCT03529773|538054242|FG009|Overall Study|Physician Decision|0|||
149157897|NCT03529773|538054243|FG010|Overall Study|Physician Decision|0|||
149157898|NCT03529773|538054244|FG011|Overall Study|Physician Decision|0|||
149157899|NCT03529773|538054245|FG012|Overall Study|Physician Decision|0|||
149157900|NCT03529773|538054246|FG013|Overall Study|Physician Decision|0|||
149157901|NCT03529773|538054247|FG014|Overall Study|Physician Decision|0|||
149157902|NCT03529773|538054248|FG015|Overall Study|Physician Decision|0|||
149157903|NCT03529773|538054249|FG016|Overall Study|Physician Decision|0|||
149157904|NCT03529773|538054250|FG017|Overall Study|Physician Decision|0|||
149157905|NCT03529773|538054251|FG018|Overall Study|Physician Decision|0|||
149157906|NCT03529773|538054252|FG019|Overall Study|Physician Decision|1|||
149157907|NCT03529773|538054253|FG020|Overall Study|Physician Decision|1|||
148673618|NCT00424632|536275800|FG004|Overall Study|Other|0|||
148673619|NCT00424632|536275801|FG005|Overall Study|Other|0|||
148673620|NCT00424632|536275802|FG006|Overall Study|Other|0|||
148673621|NCT00424632|536275803|FG007|Overall Study|Other|0|||
148673622|NCT00424632|536275804|FG008|Overall Study|Other|1|||
149157908|NCT03529773|538054254|FG021|Overall Study|Physician Decision|0|||
148673623|NCT00424632|536275805|FG009|Overall Study|Other|0|||
148673624|NCT02628418|536275806|FG000|Overall Study|Lost to Follow-up|1|||
148673625|NCT02628418|536275807|FG001|Overall Study|Lost to Follow-up|2|||
148673626|NCT03159611|536275811|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
148673627|NCT03159611|536275812|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
148673628|NCT03159611|536275811|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
148673629|NCT03159611|536275812|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
148673630|NCT03159611|536275811|FG000|Overall Study|Protocol Violation|7|||
148673631|NCT03159611|536275812|FG001|Overall Study|Protocol Violation|4|||
148673632|NCT03159611|536275811|FG000|Overall Study|Adverse Event|1|||
148673633|NCT03159611|536275812|FG001|Overall Study|Adverse Event|0|||
148673634|NCT03159611|536275811|FG000|Overall Study|Withdrawal by Subject|1|||
148673635|NCT03159611|536275812|FG001|Overall Study|Withdrawal by Subject|1|||
148673636|NCT03159611|536275811|FG000|Overall Study|Non-compliance with protocol requirement|3|||
148673637|NCT03159611|536275812|FG001|Overall Study|Non-compliance with protocol requirement|2|||
148673638|NCT03159611|536275811|FG000|Overall Study|Inability to perform procedures|1|||
148673639|NCT03159611|536275812|FG001|Overall Study|Inability to perform procedures|0|||
148673640|NCT02072174|536275815|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
148924310|NCT04761627|537207887|FG001|Run-in Period|Adverse Event|0|||
148924311|NCT04761627|537207888|FG002|Run-in Period|Adverse Event|0|||
149157909|NCT03529773|538054255|FG022|Overall Study|Physician Decision|0|||
149157910|NCT03529773|538054256|FG023|Overall Study|Physician Decision|0|||
149157911|NCT03529773|538054257|FG024|Overall Study|Physician Decision|0|||
149157912|NCT03529773|538054258|FG025|Overall Study|Physician Decision|0|||
149157913|NCT03529773|538054259|FG026|Overall Study|Physician Decision|0|||
149157914|NCT03529773|538054260|FG027|Overall Study|Physician Decision|0|||
149157915|NCT03529773|538054261|FG028|Overall Study|Physician Decision|0|||
149157916|NCT03529773|538054262|FG029|Overall Study|Physician Decision|0|||
149157917|NCT03529773|538054263|FG030|Overall Study|Physician Decision|0|||
149157918|NCT03529773|538054264|FG031|Overall Study|Physician Decision|0|||
149157919|NCT03529773|538054265|FG032|Overall Study|Physician Decision|0|||
148673641|NCT02072174|536275816|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
149157920|NCT03529773|538054266|FG033|Overall Study|Physician Decision|0|||
149157921|NCT03529773|538054267|FG034|Overall Study|Physician Decision|0|||
148673642|NCT02072174|536275815|FG000|Overall Study|Protocol Violation|16|||
148673643|NCT02072174|536275816|FG001|Overall Study|Protocol Violation|23|||
148673644|NCT02072174|536275815|FG000|Overall Study|Physician Decision|0|||
148673645|NCT02072174|536275816|FG001|Overall Study|Physician Decision|1|||
149157922|NCT03529773|538054268|FG035|Overall Study|Physician Decision|0|||
149157923|NCT03529773|538054269|FG036|Overall Study|Physician Decision|0|||
149157924|NCT03529773|538054270|FG037|Overall Study|Physician Decision|0|||
149157925|NCT03529773|538054271|FG038|Overall Study|Physician Decision|0|||
149157926|NCT03529773|538054272|FG039|Overall Study|Physician Decision|0|||
149157927|NCT03529773|538054233|FG000|Overall Study|Protocol Violation|0|||
149157928|NCT03529773|538054234|FG001|Overall Study|Protocol Violation|0|||
149157929|NCT03529773|538054235|FG002|Overall Study|Protocol Violation|0|||
149157930|NCT03529773|538054236|FG003|Overall Study|Protocol Violation|0|||
149157931|NCT03529773|538054237|FG004|Overall Study|Protocol Violation|0|||
149157932|NCT03529773|538054238|FG005|Overall Study|Protocol Violation|0|||
149157933|NCT03529773|538054239|FG006|Overall Study|Protocol Violation|0|||
149157934|NCT03529773|538054240|FG007|Overall Study|Protocol Violation|0|||
149157935|NCT03529773|538054241|FG008|Overall Study|Protocol Violation|0|||
149157936|NCT03529773|538054242|FG009|Overall Study|Protocol Violation|0|||
149157937|NCT03529773|538054243|FG010|Overall Study|Protocol Violation|0|||
149157938|NCT03529773|538054244|FG011|Overall Study|Protocol Violation|0|||
149157939|NCT03529773|538054245|FG012|Overall Study|Protocol Violation|0|||
149157940|NCT03529773|538054246|FG013|Overall Study|Protocol Violation|0|||
149157941|NCT03529773|538054247|FG014|Overall Study|Protocol Violation|0|||
149157942|NCT03529773|538054248|FG015|Overall Study|Protocol Violation|0|||
149157943|NCT03529773|538054249|FG016|Overall Study|Protocol Violation|0|||
149157944|NCT03529773|538054250|FG017|Overall Study|Protocol Violation|0|||
149157945|NCT03529773|538054251|FG018|Overall Study|Protocol Violation|0|||
149157946|NCT03529773|538054252|FG019|Overall Study|Protocol Violation|0|||
149157947|NCT03529773|538054253|FG020|Overall Study|Protocol Violation|0|||
149157948|NCT03529773|538054254|FG021|Overall Study|Protocol Violation|0|||
149157949|NCT03529773|538054255|FG022|Overall Study|Protocol Violation|0|||
149157950|NCT03529773|538054256|FG023|Overall Study|Protocol Violation|0|||
149157951|NCT03529773|538054257|FG024|Overall Study|Protocol Violation|0|||
149157952|NCT03529773|538054258|FG025|Overall Study|Protocol Violation|0|||
149157953|NCT03529773|538054259|FG026|Overall Study|Protocol Violation|0|||
149157954|NCT03529773|538054260|FG027|Overall Study|Protocol Violation|0|||
149157955|NCT03529773|538054261|FG028|Overall Study|Protocol Violation|0|||
149157956|NCT03529773|538054262|FG029|Overall Study|Protocol Violation|0|||
149157957|NCT03529773|538054263|FG030|Overall Study|Protocol Violation|1|||
149157958|NCT03529773|538054264|FG031|Overall Study|Protocol Violation|0|||
149157959|NCT03529773|538054265|FG032|Overall Study|Protocol Violation|0|||
149157960|NCT03529773|538054266|FG033|Overall Study|Protocol Violation|0|||
149157961|NCT03529773|538054267|FG034|Overall Study|Protocol Violation|0|||
149157962|NCT03529773|538054268|FG035|Overall Study|Protocol Violation|0|||
149157963|NCT03529773|538054269|FG036|Overall Study|Protocol Violation|0|||
149157964|NCT03529773|538054270|FG037|Overall Study|Protocol Violation|0|||
149157965|NCT03529773|538054271|FG038|Overall Study|Protocol Violation|0|||
149157966|NCT03529773|538054272|FG039|Overall Study|Protocol Violation|0|||
149157967|NCT03529773|538054233|FG000|Overall Study|Withdrawal by Subject|0|||
149157968|NCT03529773|538054234|FG001|Overall Study|Withdrawal by Subject|0|||
148924312|NCT04761627|537207886|FG000|Run-in Period|Withdrawal by Subject|7|||
148924313|NCT04761627|537207887|FG001|Run-in Period|Withdrawal by Subject|0|||
148924314|NCT04761627|537207888|FG002|Run-in Period|Withdrawal by Subject|0|||
148924315|NCT04761627|537207886|FG000|Run-in Period|Did not meet PASI 50|15|||
148924316|NCT04761627|537207887|FG001|Run-in Period|Did not meet PASI 50|0|||
148924317|NCT04761627|537207888|FG002|Run-in Period|Did not meet PASI 50|0|||
148924318|NCT04761627|537207886|FG000|Run-in Period|Study site closure|2|||
148924319|NCT04761627|537207887|FG001|Run-in Period|Study site closure|0|||
148924320|NCT04761627|537207888|FG002|Run-in Period|Study site closure|0|||
148924321|NCT04761627|537207886|FG000|Run-in Period|Pregnancy|2|||
148924322|NCT04761627|537207887|FG001|Run-in Period|Pregnancy|0|||
148924323|NCT04761627|537207888|FG002|Run-in Period|Pregnancy|0|||
148924324|NCT04761627|537207886|FG000|Post-randomization Period|Military service|0|||
148924325|NCT04761627|537207887|FG001|Post-randomization Period|Military service|1|||
148924326|NCT04761627|537207888|FG002|Post-randomization Period|Military service|0|||
148924327|NCT04761627|537207886|FG000|Post-randomization Period|Adverse Event|0|||
148924328|NCT04761627|537207887|FG001|Post-randomization Period|Adverse Event|4|||
148924329|NCT04761627|537207888|FG002|Post-randomization Period|Adverse Event|2|||
148924330|NCT04761627|537207886|FG000|Post-randomization Period|Lost to Follow-up|0|||
148924331|NCT04761627|537207887|FG001|Post-randomization Period|Lost to Follow-up|6|||
148924332|NCT04761627|537207888|FG002|Post-randomization Period|Lost to Follow-up|6|||
148924333|NCT04761627|537207886|FG000|Post-randomization Period|Withdrawal by Subject|0|||
148924334|NCT04761627|537207887|FG001|Post-randomization Period|Withdrawal by Subject|7|||
148924335|NCT04761627|537207888|FG002|Post-randomization Period|Withdrawal by Subject|6|||
148924336|NCT04761627|537207886|FG000|Post-randomization Period|Pregnancy|0|||
149157969|NCT03529773|538054235|FG002|Overall Study|Withdrawal by Subject|0|||
149157970|NCT03529773|538054236|FG003|Overall Study|Withdrawal by Subject|0|||
148924337|NCT04761627|537207887|FG001|Post-randomization Period|Pregnancy|0|||
148924338|NCT04761627|537207888|FG002|Post-randomization Period|Pregnancy|1|||
149012844|NCT01468922|537525817|FG004|Overall Study|Adverse Event|0|||
149012845|NCT01468922|537525818|FG005|Overall Study|Adverse Event|0|||
149157971|NCT03529773|538054237|FG004|Overall Study|Withdrawal by Subject|0|||
149157972|NCT03529773|538054238|FG005|Overall Study|Withdrawal by Subject|0|||
149157973|NCT03529773|538054239|FG006|Overall Study|Withdrawal by Subject|0|||
149157974|NCT03529773|538054240|FG007|Overall Study|Withdrawal by Subject|1|||
149157975|NCT03529773|538054241|FG008|Overall Study|Withdrawal by Subject|0|||
149157976|NCT03529773|538054242|FG009|Overall Study|Withdrawal by Subject|1|||
149157977|NCT03529773|538054243|FG010|Overall Study|Withdrawal by Subject|1|||
149157978|NCT03529773|538054244|FG011|Overall Study|Withdrawal by Subject|0|||
149157979|NCT03529773|538054245|FG012|Overall Study|Withdrawal by Subject|0|||
149157980|NCT03529773|538054246|FG013|Overall Study|Withdrawal by Subject|0|||
149157981|NCT03529773|538054247|FG014|Overall Study|Withdrawal by Subject|0|||
149157982|NCT03529773|538054248|FG015|Overall Study|Withdrawal by Subject|3|||
149157983|NCT03529773|538054249|FG016|Overall Study|Withdrawal by Subject|0|||
149157984|NCT03529773|538054250|FG017|Overall Study|Withdrawal by Subject|2|||
149157985|NCT03529773|538054251|FG018|Overall Study|Withdrawal by Subject|3|||
149157986|NCT03529773|538054252|FG019|Overall Study|Withdrawal by Subject|1|||
149157987|NCT03529773|538054253|FG020|Overall Study|Withdrawal by Subject|3|||
149157988|NCT03529773|538054254|FG021|Overall Study|Withdrawal by Subject|1|||
149157989|NCT03529773|538054255|FG022|Overall Study|Withdrawal by Subject|1|||
149157990|NCT03529773|538054256|FG023|Overall Study|Withdrawal by Subject|2|||
149157991|NCT03529773|538054257|FG024|Overall Study|Withdrawal by Subject|2|||
149157992|NCT03529773|538054258|FG025|Overall Study|Withdrawal by Subject|4|||
149157993|NCT03529773|538054259|FG026|Overall Study|Withdrawal by Subject|2|||
149157994|NCT03529773|538054260|FG027|Overall Study|Withdrawal by Subject|1|||
149157995|NCT03529773|538054261|FG028|Overall Study|Withdrawal by Subject|1|||
149157996|NCT03529773|538054262|FG029|Overall Study|Withdrawal by Subject|0|||
149157997|NCT03529773|538054263|FG030|Overall Study|Withdrawal by Subject|0|||
149157998|NCT03529773|538054264|FG031|Overall Study|Withdrawal by Subject|0|||
149157999|NCT03529773|538054265|FG032|Overall Study|Withdrawal by Subject|0|||
149158000|NCT03529773|538054266|FG033|Overall Study|Withdrawal by Subject|0|||
149158001|NCT03529773|538054267|FG034|Overall Study|Withdrawal by Subject|1|||
149158002|NCT03529773|538054268|FG035|Overall Study|Withdrawal by Subject|2|||
149158003|NCT03529773|538054269|FG036|Overall Study|Withdrawal by Subject|0|||
149158004|NCT03529773|538054270|FG037|Overall Study|Withdrawal by Subject|2|||
149158005|NCT03529773|538054271|FG038|Overall Study|Withdrawal by Subject|1|||
149158006|NCT03529773|538054272|FG039|Overall Study|Withdrawal by Subject|1|||
149158007|NCT03529773|538054233|FG000|Overall Study|Screen Failure|0|||
149158008|NCT03529773|538054234|FG001|Overall Study|Screen Failure|0|||
149158009|NCT03529773|538054235|FG002|Overall Study|Screen Failure|0|||
149158010|NCT03529773|538054236|FG003|Overall Study|Screen Failure|0|||
149158011|NCT03529773|538054237|FG004|Overall Study|Screen Failure|0|||
149158012|NCT03529773|538054238|FG005|Overall Study|Screen Failure|0|||
149158013|NCT03529773|538054239|FG006|Overall Study|Screen Failure|0|||
149158014|NCT03529773|538054240|FG007|Overall Study|Screen Failure|0|||
149158015|NCT03529773|538054241|FG008|Overall Study|Screen Failure|0|||
149158016|NCT03529773|538054242|FG009|Overall Study|Screen Failure|0|||
149158017|NCT03529773|538054243|FG010|Overall Study|Screen Failure|0|||
149158018|NCT03529773|538054244|FG011|Overall Study|Screen Failure|0|||
149158019|NCT03529773|538054245|FG012|Overall Study|Screen Failure|0|||
149158020|NCT03529773|538054246|FG013|Overall Study|Screen Failure|0|||
149158021|NCT03529773|538054247|FG014|Overall Study|Screen Failure|0|||
149158022|NCT03529773|538054248|FG015|Overall Study|Screen Failure|0|||
149158023|NCT03529773|538054249|FG016|Overall Study|Screen Failure|0|||
149158024|NCT03529773|538054250|FG017|Overall Study|Screen Failure|0|||
149158025|NCT03529773|538054251|FG018|Overall Study|Screen Failure|0|||
149158026|NCT03529773|538054252|FG019|Overall Study|Screen Failure|0|||
149158027|NCT03529773|538054253|FG020|Overall Study|Screen Failure|0|||
149158028|NCT03529773|538054254|FG021|Overall Study|Screen Failure|0|||
149158029|NCT03529773|538054255|FG022|Overall Study|Screen Failure|0|||
149158030|NCT03529773|538054256|FG023|Overall Study|Screen Failure|0|||
149158031|NCT03529773|538054257|FG024|Overall Study|Screen Failure|0|||
149158032|NCT03529773|538054258|FG025|Overall Study|Screen Failure|0|||
149158033|NCT03529773|538054259|FG026|Overall Study|Screen Failure|0|||
149158034|NCT03529773|538054260|FG027|Overall Study|Screen Failure|0|||
149158035|NCT03529773|538054261|FG028|Overall Study|Screen Failure|0|||
149158036|NCT03529773|538054262|FG029|Overall Study|Screen Failure|0|||
149158037|NCT03529773|538054263|FG030|Overall Study|Screen Failure|0|||
149158038|NCT03529773|538054264|FG031|Overall Study|Screen Failure|0|||
149158039|NCT03529773|538054265|FG032|Overall Study|Screen Failure|0|||
149158040|NCT03529773|538054266|FG033|Overall Study|Screen Failure|0|||
149158041|NCT03529773|538054267|FG034|Overall Study|Screen Failure|0|||
149158042|NCT03529773|538054268|FG035|Overall Study|Screen Failure|0|||
149158043|NCT03529773|538054269|FG036|Overall Study|Screen Failure|1|||
149158044|NCT03529773|538054270|FG037|Overall Study|Screen Failure|1|||
149158045|NCT03529773|538054271|FG038|Overall Study|Screen Failure|0|||
149158046|NCT03529773|538054272|FG039|Overall Study|Screen Failure|1|||
149158047|NCT03529773|538054233|FG000|Overall Study|Randomized but not vaccinated|0|||
149158048|NCT03529773|538054234|FG001|Overall Study|Randomized but not vaccinated|0|||
149158049|NCT03529773|538054235|FG002|Overall Study|Randomized but not vaccinated|0|||
149158050|NCT03529773|538054236|FG003|Overall Study|Randomized but not vaccinated|0|||
149158051|NCT03529773|538054237|FG004|Overall Study|Randomized but not vaccinated|0|||
149158052|NCT03529773|538054238|FG005|Overall Study|Randomized but not vaccinated|0|||
149158053|NCT03529773|538054239|FG006|Overall Study|Randomized but not vaccinated|0|||
149158054|NCT03529773|538054240|FG007|Overall Study|Randomized but not vaccinated|0|||
149158055|NCT03529773|538054241|FG008|Overall Study|Randomized but not vaccinated|0|||
149158056|NCT03529773|538054242|FG009|Overall Study|Randomized but not vaccinated|0|||
149158057|NCT03529773|538054243|FG010|Overall Study|Randomized but not vaccinated|0|||
149158058|NCT03529773|538054244|FG011|Overall Study|Randomized but not vaccinated|0|||
149158059|NCT03529773|538054245|FG012|Overall Study|Randomized but not vaccinated|0|||
149158060|NCT03529773|538054246|FG013|Overall Study|Randomized but not vaccinated|0|||
149158061|NCT03529773|538054247|FG014|Overall Study|Randomized but not vaccinated|0|||
149158062|NCT03529773|538054248|FG015|Overall Study|Randomized but not vaccinated|0|||
149158063|NCT03529773|538054249|FG016|Overall Study|Randomized but not vaccinated|0|||
149158064|NCT03529773|538054250|FG017|Overall Study|Randomized but not vaccinated|1|||
149158065|NCT03529773|538054251|FG018|Overall Study|Randomized but not vaccinated|0|||
149158066|NCT03529773|538054252|FG019|Overall Study|Randomized but not vaccinated|0|||
149158067|NCT03529773|538054253|FG020|Overall Study|Randomized but not vaccinated|0|||
149158068|NCT03529773|538054254|FG021|Overall Study|Randomized but not vaccinated|0|||
149158069|NCT03529773|538054255|FG022|Overall Study|Randomized but not vaccinated|0|||
149158070|NCT03529773|538054256|FG023|Overall Study|Randomized but not vaccinated|0|||
149158071|NCT03529773|538054257|FG024|Overall Study|Randomized but not vaccinated|0|||
149158072|NCT03529773|538054258|FG025|Overall Study|Randomized but not vaccinated|0|||
149158073|NCT03529773|538054259|FG026|Overall Study|Randomized but not vaccinated|0|||
149158074|NCT03529773|538054260|FG027|Overall Study|Randomized but not vaccinated|1|||
149158075|NCT03529773|538054261|FG028|Overall Study|Randomized but not vaccinated|0|||
149158076|NCT03529773|538054262|FG029|Overall Study|Randomized but not vaccinated|0|||
149158077|NCT03529773|538054263|FG030|Overall Study|Randomized but not vaccinated|0|||
149158078|NCT03529773|538054264|FG031|Overall Study|Randomized but not vaccinated|0|||
149158079|NCT03529773|538054265|FG032|Overall Study|Randomized but not vaccinated|0|||
149158080|NCT03529773|538054266|FG033|Overall Study|Randomized but not vaccinated|0|||
148924339|NCT04761627|537207886|FG000|Post-randomization Period|Study site closure|0|||
148924340|NCT04761627|537207887|FG001|Post-randomization Period|Study site closure|0|||
148924341|NCT04761627|537207888|FG002|Post-randomization Period|Study site closure|1|||
148924342|NCT04761627|537207886|FG000|Post-randomization Period|Family planning|0|||
148924343|NCT04761627|537207887|FG001|Post-randomization Period|Family planning|1|||
148924344|NCT04761627|537207888|FG002|Post-randomization Period|Family planning|0|||
148924345|NCT00723203|537207889|FG000|Overall Study|Withdrawal by Subject|3|||
148924346|NCT00274924|537207890|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
148924347|NCT00274924|537207891|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
148924348|NCT00274924|537207892|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
148924349|NCT00274924|537207890|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
148924350|NCT00274924|537207891|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
148924351|NCT00274924|537207892|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
148924352|NCT00274924|537207890|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
149012846|NCT01468922|537525819|FG006|Overall Study|Adverse Event|0|||
149158081|NCT03529773|538054267|FG034|Overall Study|Randomized but not vaccinated|0|||
149158082|NCT03529773|538054268|FG035|Overall Study|Randomized but not vaccinated|0|||
149158083|NCT03529773|538054269|FG036|Overall Study|Randomized but not vaccinated|0|||
149158084|NCT03529773|538054270|FG037|Overall Study|Randomized but not vaccinated|0|||
149158085|NCT03529773|538054271|FG038|Overall Study|Randomized but not vaccinated|0|||
149158086|NCT03529773|538054272|FG039|Overall Study|Randomized but not vaccinated|0|||
149158087|NCT01496066|538054274|FG000|Overall Study|Lost to Follow-up|8|||
149158088|NCT01496066|538054275|FG001|Overall Study|Lost to Follow-up|5|||
149158089|NCT01496066|538054274|FG000|Overall Study|Explant|3|||
149012847|NCT01468922|537525820|FG007|Overall Study|Adverse Event|1|||
149158090|NCT01496066|538054275|FG001|Overall Study|Explant|0|||
149158091|NCT01496066|538054274|FG000|Overall Study|Death|1|||
149158092|NCT01496066|538054275|FG001|Overall Study|Death|4|||
149158093|NCT00253630|538054276|FG000|Overall Study|ineligible|2|||
149158094|NCT00209339|538054279|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
149158095|NCT00209339|538054279|FG000|At 12 Months Follow-up|Death|1|||
149158096|NCT00209339|538054279|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
149158097|NCT00209339|538054279|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
149158098|NCT00209339|538054279|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
149158099|NCT00209339|538054279|FG000|At 24 Months Follow-up|Death|1|||
149158100|NCT00209339|538054279|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
149158101|NCT00209339|538054279|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
149158102|NCT00209339|538054279|FG000|At 4 Years Follow-up|Death|1|||
149158103|NCT00209339|538054279|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
149158104|NCT00209339|538054279|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
148924353|NCT00274924|537207891|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
148924354|NCT00274924|537207892|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
148924355|NCT00274924|537207890|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
149158105|NCT00209339|538054279|FG000|At 5 Years Follow-up|Death|1|||
149158106|NCT00429858|538054280|FG000|Overall Study|Withdrawal by Subject|1|||
149158107|NCT00429858|538054280|FG000|Overall Study|Study Termination|1|||
149158108|NCT01587079|538054281|FG000|Overall Study|Protocol-specified criteria|9|||
149158109|NCT01587079|538054281|FG000|Overall Study|Protocol Violation|5|||
149158110|NCT01587079|538054281|FG000|Overall Study|Lost to Follow-up|2|||
149158111|NCT01587079|538054281|FG000|Overall Study|Physician Decision|2|||
149158112|NCT01587079|538054281|FG000|Overall Study|Withdrawal by Subject|7|||
149158113|NCT01587079|538054281|FG000|Overall Study|Adverse Event|14|||
149158114|NCT02475655|538054283|FG000|Overall Study|Lost to Follow-up|0|||
149158115|NCT02475655|538054284|FG001|Overall Study|Lost to Follow-up|1|||
149158116|NCT00257010|538054285|FG000|Overall Study|Lack of Efficacy|11|||
149158117|NCT00257010|538054285|FG000|Overall Study|Lost to Follow-up|53|||
149158118|NCT00257010|538054285|FG000|Overall Study|Withdrawal by Subject|34|||
149158119|NCT00257010|538054285|FG000|Overall Study|Adverse Event|10|||
149158120|NCT00257010|538054285|FG000|Overall Study|various|11|||
149158121|NCT00257010|538054285|FG000|Overall Study|no headache reported|9|||
149158122|NCT00441545|538054289|FG000|First Intervention|Adverse Event|6|||
149158123|NCT00441545|538054290|FG001|First Intervention|Adverse Event|5|||
149158124|NCT00441545|538054289|FG000|First Intervention|Protocol Violation|2|||
149158125|NCT00441545|538054290|FG001|First Intervention|Protocol Violation|2|||
149158126|NCT00441545|538054289|FG000|First Intervention|Withdrawal by Subject|3|||
149158127|NCT00441545|538054290|FG001|First Intervention|Withdrawal by Subject|3|||
149158128|NCT00441545|538054289|FG000|First Intervention|Kidney transplant|1|||
149158129|NCT00441545|538054290|FG001|First Intervention|Kidney transplant|1|||
149158130|NCT00441545|538054289|FG000|First Intervention|Lack of Efficacy|2|||
149158131|NCT00441545|538054290|FG001|First Intervention|Lack of Efficacy|0|||
149158132|NCT00441545|538054289|FG000|First Intervention|Subject exceeded safety criteria|0|||
149158133|NCT00441545|538054290|FG001|First Intervention|Subject exceeded safety criteria|1|||
149158134|NCT00441545|538054289|FG000|First Intervention|Subject met an exclusionary criteria|1|||
149158135|NCT00441545|538054290|FG001|First Intervention|Subject met an exclusionary criteria|0|||
149158136|NCT00441545|538054289|FG000|First Intervention|Extended hospitalization|1|||
149158137|NCT00441545|538054290|FG001|First Intervention|Extended hospitalization|0|||
149158138|NCT00441545|538054289|FG000|First Intervention|Site error|1|||
149158139|NCT00441545|538054290|FG001|First Intervention|Site error|0|||
149158140|NCT00441545|538054289|FG000|First Intervention|Sponsor's request|1|||
149158141|NCT00441545|538054290|FG001|First Intervention|Sponsor's request|0|||
149158142|NCT00441545|538054289|FG000|Second Intervention|Adverse Event|5|||
149158143|NCT00441545|538054290|FG001|Second Intervention|Adverse Event|2|||
149158144|NCT00441545|538054289|FG000|Second Intervention|Protocol Violation|4|||
149158145|NCT00441545|538054290|FG001|Second Intervention|Protocol Violation|1|||
149158146|NCT00441545|538054289|FG000|Second Intervention|Withdrawal by Subject|1|||
149158147|NCT00441545|538054290|FG001|Second Intervention|Withdrawal by Subject|1|||
149158148|NCT00441545|538054289|FG000|Second Intervention|Kidney Transplant|1|||
149158149|NCT00441545|538054290|FG001|Second Intervention|Kidney Transplant|1|||
149158150|NCT00441545|538054289|FG000|Second Intervention|Lack of Efficacy|0|||
149158151|NCT00441545|538054290|FG001|Second Intervention|Lack of Efficacy|1|||
149158152|NCT00441545|538054289|FG000|Second Intervention|Subject exceeded safety criteria|1|||
149158153|NCT00441545|538054290|FG001|Second Intervention|Subject exceeded safety criteria|0|||
149158154|NCT00441545|538054289|FG000|Second Intervention|Subject moved|0|||
149158155|NCT00441545|538054290|FG001|Second Intervention|Subject moved|1|||
149158156|NCT00939692|538054297|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
149158157|NCT00939692|538054298|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
149158158|NCT00939692|538054297|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
149158159|NCT00939692|538054298|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
149158160|NCT00699907|538054303|FG000|Overall Study|Withdrawal by Subject|2|||
149158161|NCT00699907|538054304|FG001|Overall Study|Withdrawal by Subject|1|||
149158162|NCT00699907|538054305|FG002|Overall Study|Withdrawal by Subject|0|||
149158163|NCT00699907|538054303|FG000|Overall Study|No usable sample|0|||
149158164|NCT00699907|538054304|FG001|Overall Study|No usable sample|9|||
149158165|NCT00699907|538054305|FG002|Overall Study|No usable sample|8|||
149158166|NCT00430508|538054306|FG000|Overall Study|Adverse Event|2|||
149158167|NCT00430508|538054307|FG001|Overall Study|Adverse Event|3|||
149158168|NCT00430508|538054308|FG002|Overall Study|Adverse Event|5|||
149158169|NCT00430508|538054309|FG003|Overall Study|Adverse Event|3|||
149158170|NCT00430508|538054306|FG000|Overall Study|Withdrawal by Subject|0|||
149158171|NCT00430508|538054307|FG001|Overall Study|Withdrawal by Subject|1|||
149158172|NCT00430508|538054308|FG002|Overall Study|Withdrawal by Subject|1|||
149158173|NCT00430508|538054309|FG003|Overall Study|Withdrawal by Subject|1|||
149158174|NCT00430508|538054306|FG000|Overall Study|responder at visit 4|0|||
149158175|NCT00430508|538054307|FG001|Overall Study|responder at visit 4|0|||
149158176|NCT00430508|538054308|FG002|Overall Study|responder at visit 4|2|||
149158177|NCT00430508|538054309|FG003|Overall Study|responder at visit 4|0|||
149158178|NCT00430508|538054306|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
149158179|NCT00430508|538054307|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
149158180|NCT00430508|538054308|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
149158181|NCT00430508|538054309|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
149158182|NCT00430508|538054306|FG000|Overall Study|Other|1|||
149158183|NCT00430508|538054307|FG001|Overall Study|Other|1|||
149158184|NCT00430508|538054308|FG002|Overall Study|Other|3|||
149158185|NCT00430508|538054309|FG003|Overall Study|Other|0|||
149158186|NCT03889639|538054312|FG000|Overall Study|Withdrawal by Subject|0|||
149158187|NCT03889639|538054313|FG001|Overall Study|Withdrawal by Subject|0|||
149158188|NCT03889639|538054314|FG002|Overall Study|Withdrawal by Subject|0|||
149158189|NCT03889639|538054315|FG003|Overall Study|Withdrawal by Subject|0|||
149158190|NCT03889639|538054316|FG004|Overall Study|Withdrawal by Subject|0|||
149158191|NCT03889639|538054317|FG005|Overall Study|Withdrawal by Subject|0|||
149158192|NCT03889639|538054318|FG006|Overall Study|Withdrawal by Subject|0|||
149158193|NCT03889639|538054319|FG007|Overall Study|Withdrawal by Subject|1|||
149158194|NCT01703858|538054320|FG000|Overall Study|Withdrawal by Subject|0|||
149158195|NCT01703858|538054321|FG001|Overall Study|Withdrawal by Subject|1|||
149158196|NCT01703858|538054322|FG002|Overall Study|Withdrawal by Subject|0|||
149158197|NCT02340663|538054329|FG000|Overall Study|Lost to Follow-up|1|||
149158198|NCT02340663|538054330|FG001|Overall Study|Lost to Follow-up|0|||
149158199|NCT02340663|538054329|FG000|Overall Study|Protocol Violation|1|||
149158200|NCT02340663|538054330|FG001|Overall Study|Protocol Violation|0|||
149158201|NCT02340663|538054329|FG000|Overall Study|Withdrawal by Subject|3|||
149158202|NCT02340663|538054330|FG001|Overall Study|Withdrawal by Subject|1|||
149158203|NCT00516737|538054353|FG000|Overall Study|Lost to Follow-up|2|||
149158204|NCT00516737|538054354|FG001|Overall Study|Lost to Follow-up|0|||
149158205|NCT00516737|538054353|FG000|Overall Study|Physician Decision|0|||
149158206|NCT00516737|538054354|FG001|Overall Study|Physician Decision|1|||
149158207|NCT00516737|538054353|FG000|Overall Study|Withdrawal by Subject|0|||
149158208|NCT00516737|538054354|FG001|Overall Study|Withdrawal by Subject|1|||
149158209|NCT00516737|538054353|FG000|Overall Study|Lack of Qualifying Event|9|||
149158210|NCT00516737|538054354|FG001|Overall Study|Lack of Qualifying Event|6|||
149158211|NCT00848354|538054355|FG000|Phase 1|Adverse Event|5|||
149158212|NCT00848354|538054356|FG001|Phase 1|Adverse Event|4|||
149158213|NCT00848354|538054355|FG000|Phase 1|Discontinuation of study by sponsor|2|||
149158214|NCT00848354|538054356|FG001|Phase 1|Discontinuation of study by sponsor|1|||
149158215|NCT00848354|538054355|FG000|Phase 1|Failed to return|0|||
149158216|NCT00848354|538054356|FG001|Phase 1|Failed to return|1|||
149158217|NCT00848354|538054355|FG000|Phase 1|Lost to Follow-up|1|||
149158218|NCT00848354|538054356|FG001|Phase 1|Lost to Follow-up|1|||
149158219|NCT00848354|538054355|FG000|Phase 1|Unspecified Reason|1|||
148805988|NCT05911841|536768045|FG001|Maintenance Period|Withdrawal by Subject|0|||
149158220|NCT00848354|538054356|FG001|Phase 1|Unspecified Reason|1|||
149158221|NCT00848354|538054355|FG000|Phase 1|Protocol Violation|1|||
149158222|NCT00848354|538054356|FG001|Phase 1|Protocol Violation|1|||
149158223|NCT00848354|538054355|FG000|Phase 1|Withdrawal by Subject|2|||
149158224|NCT00848354|538054356|FG001|Phase 1|Withdrawal by Subject|4|||
149158225|NCT00848354|538054355|FG000|Phase 1|Lack of Efficacy|0|||
149158226|NCT00848354|538054356|FG001|Phase 1|Lack of Efficacy|1|||
149158227|NCT00848354|538054355|FG000|Phase 2 Year 1|Adverse Event|7|||
149158228|NCT00848354|538054356|FG001|Phase 2 Year 1|Adverse Event|2|||
149158229|NCT00848354|538054355|FG000|Phase 2 Year 1|Death|1|||
149158230|NCT00848354|538054356|FG001|Phase 2 Year 1|Death|0|||
149158231|NCT00848354|538054355|FG000|Phase 2 Year 1|Failed to Return|1|||
149158232|NCT00848354|538054356|FG001|Phase 2 Year 1|Failed to Return|1|||
149158233|NCT00848354|538054355|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
149158234|NCT00848354|538054356|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
149158235|NCT00848354|538054355|FG000|Phase 2 Year 1|Unspecified Reason|3|||
149158236|NCT00848354|538054356|FG001|Phase 2 Year 1|Unspecified Reason|0|||
149158237|NCT00848354|538054355|FG000|Phase 2 Year 1|Protocol Violation|4|||
149158238|NCT00848354|538054356|FG001|Phase 2 Year 1|Protocol Violation|1|||
149158239|NCT00848354|538054355|FG000|Phase 2 Year 1|Subject Request|1|||
149158240|NCT00848354|538054356|FG001|Phase 2 Year 1|Subject Request|2|||
149158241|NCT00848354|538054355|FG000|Phase 2 Year 2|Adverse Event|12|||
149158242|NCT00848354|538054356|FG001|Phase 2 Year 2|Adverse Event|2|||
149158243|NCT00848354|538054355|FG000|Phase 2 Year 2|Death|2|||
149158244|NCT00848354|538054356|FG001|Phase 2 Year 2|Death|0|||
149158245|NCT00848354|538054355|FG000|Phase 2 Year 2|Failed to return|3|||
149158246|NCT00848354|538054356|FG001|Phase 2 Year 2|Failed to return|0|||
149158247|NCT00848354|538054355|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
149158248|NCT00848354|538054356|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
149158249|NCT00848354|538054355|FG000|Phase 2 Year 2|Unspecified Reason|1|||
149158250|NCT00848354|538054356|FG001|Phase 2 Year 2|Unspecified Reason|0|||
149158251|NCT00848354|538054355|FG000|Phase 2 Year 2|Protocol Violation|1|||
149158252|NCT00848354|538054356|FG001|Phase 2 Year 2|Protocol Violation|1|||
149158253|NCT00848354|538054355|FG000|Phase 2 Year 2|Subject Request|1|||
149158254|NCT00848354|538054356|FG001|Phase 2 Year 2|Subject Request|1|||
149158255|NCT00848354|538054355|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
149158256|NCT00848354|538054356|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
149158257|NCT00915343|538054359|FG000|Part B - Open Label Period|Treatment switch|0|||
149158258|NCT00915343|538054360|FG001|Part B - Open Label Period|Treatment switch|0|||
149158259|NCT00915343|538054361|FG002|Part B - Open Label Period|Treatment switch|1|||
149158260|NCT00915343|538054359|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
149158261|NCT00915343|538054360|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
149158262|NCT00915343|538054361|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
149158263|NCT00626093|538054363|FG000|Overall Study|Lost to Follow-up|5|||
149158264|NCT00626093|538054363|FG000|Overall Study|Death|1|||
149158265|NCT00626093|538054363|FG000|Overall Study|Physician Decision|4|||
149158266|NCT00626093|538054363|FG000|Overall Study|Withdrawal by Subject|6|||
149158267|NCT00626093|538054363|FG000|Overall Study|Protocol Violation|1|||
149158268|NCT00626093|538054363|FG000|Overall Study|One of the required devices not implante|6|||
148673646|NCT02072174|536275815|FG000|Overall Study|Non-compliance with protocol requirement|2|||
148673647|NCT02072174|536275816|FG001|Overall Study|Non-compliance with protocol requirement|0|||
148673648|NCT03506425|536275820|FG000|Overall Study|Adverse Event|1|||
148673649|NCT03506425|536275821|FG001|Overall Study|Adverse Event|3|||
148673650|NCT03506425|536275822|FG002|Overall Study|Adverse Event|0|||
148673651|NCT03506425|536275820|FG000|Overall Study|Death|1|||
148673652|NCT03506425|536275821|FG001|Overall Study|Death|0|||
148673653|NCT03506425|536275822|FG002|Overall Study|Death|0|||
148673654|NCT03506425|536275820|FG000|Overall Study|Withdrawal by Subject|0|||
149158269|NCT00911989|538054364|FG000|Overall Study|Adverse Event|1|||
149158270|NCT03064841|538054365|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
149158271|NCT03064841|538054365|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
148673655|NCT03506425|536275821|FG001|Overall Study|Withdrawal by Subject|0|||
148673656|NCT03506425|536275822|FG002|Overall Study|Withdrawal by Subject|1|||
148673657|NCT00090259|536275826|FG000|Overall Study|Lost to Follow-up|30|||
148673658|NCT00090259|536275827|FG001|Overall Study|Lost to Follow-up|26|||
149158272|NCT03064841|538054365|FG000|Overall Study|Screen failure|2|||
149158273|NCT03434977|538054366|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
149158274|NCT03434977|538054367|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
149158275|NCT01145066|538054368|FG000|Overall Study|To resume NSAIDs|2|||
149158276|NCT01145066|538054369|FG001|Overall Study|To resume NSAIDs|2|||
148673659|NCT00090259|536275826|FG000|Overall Study|Withdrawal by Subject|21|||
148673660|NCT00090259|536275827|FG001|Overall Study|Withdrawal by Subject|15|||
148673661|NCT00090259|536275826|FG000|Overall Study|Investigator site closed|11|||
148673662|NCT00090259|536275827|FG001|Overall Study|Investigator site closed|7|||
148924356|NCT00274924|537207891|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
148924357|NCT00274924|537207892|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
149158277|NCT01145066|538054370|FG002|Overall Study|To resume NSAIDs|1|||
149158278|NCT01145066|538054368|FG000|Overall Study|Non-related surgery|0|||
149158279|NCT01145066|538054369|FG001|Overall Study|Non-related surgery|0|||
148673663|NCT02380248|536275830|FG000|Overall Study|Lost to Follow-up|11|||
148673664|NCT02380248|536275830|FG000|Overall Study|Withdrawal by Subject|3|||
148673665|NCT00865306|536275833|FG000|Controlled Trial|Lost to Follow-up|1|||
148673666|NCT00865306|536275834|FG001|Controlled Trial|Lost to Follow-up|1|||
148673667|NCT00865306|536275833|FG000|Controlled Trial|Difficulty commuting|2|||
149158280|NCT01145066|538054370|FG002|Overall Study|Non-related surgery|1|||
149158281|NCT01145066|538054368|FG000|Overall Study|Withdrawal by Subject|0|||
149158282|NCT01145066|538054369|FG001|Overall Study|Withdrawal by Subject|0|||
149158283|NCT01145066|538054370|FG002|Overall Study|Withdrawal by Subject|2|||
149158284|NCT01145066|538054368|FG000|Overall Study|To start new med|1|||
149158285|NCT01145066|538054369|FG001|Overall Study|To start new med|0|||
149158286|NCT01145066|538054370|FG002|Overall Study|To start new med|0|||
149158287|NCT01145066|538054368|FG000|Overall Study|problems swallowing capsule|1|||
149158288|NCT01145066|538054369|FG001|Overall Study|problems swallowing capsule|0|||
149158289|NCT01145066|538054370|FG002|Overall Study|problems swallowing capsule|0|||
149158290|NCT01145066|538054368|FG000|Overall Study|Abdominal discomfort|0|||
149158291|NCT01145066|538054369|FG001|Overall Study|Abdominal discomfort|1|||
149158292|NCT01145066|538054370|FG002|Overall Study|Abdominal discomfort|0|||
149158293|NCT01145066|538054368|FG000|Overall Study|Low platelet count|0|||
149158294|NCT01145066|538054369|FG001|Overall Study|Low platelet count|1|||
149158295|NCT01145066|538054370|FG002|Overall Study|Low platelet count|0|||
149158296|NCT03920670|538054371|FG000|Overall Study|Protocol Violation|2|||
149158297|NCT03920670|538054372|FG001|Overall Study|Protocol Violation|2|||
149158298|NCT03920670|538054371|FG000|Overall Study|Adverse Event|1|||
149158299|NCT03920670|538054372|FG001|Overall Study|Adverse Event|0|||
149158300|NCT00573794|538054378|FG000|Overall Study|Adverse Event|81|||
149158301|NCT00573794|538054378|FG000|Overall Study|Withdrew Consent|90|||
149158302|NCT00573794|538054378|FG000|Overall Study|Lost to Follow-up|13|||
149158303|NCT00573794|538054378|FG000|Overall Study|Protocol Violation|6|||
149158304|NCT00573794|538054378|FG000|Overall Study|Lack of Efficacy|94|||
149158305|NCT00573794|538054378|FG000|Overall Study|Other|46|||
149158306|NCT03266016|538055790|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
149158307|NCT03266016|538055791|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
149158308|NCT03266016|538055792|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
149158309|NCT03266016|538055793|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
149158310|NCT03266016|538055790|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
149158311|NCT03266016|538055791|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
149158312|NCT03266016|538055792|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
149158313|NCT03266016|538055793|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
149158314|NCT03160560|538055794|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
149158315|NCT03160560|538055795|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149158316|NCT03160560|538055796|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149158317|NCT03160560|538055797|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
149158318|NCT03160560|538055794|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
149158319|NCT03160560|538055795|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149158320|NCT03160560|538055796|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149158321|NCT03160560|538055797|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149158322|NCT01978093|538055798|FG000|Overall Study|Death|1|||
149158323|NCT01978093|538055799|FG001|Overall Study|Death|0|||
149158324|NCT01978093|538055798|FG000|Overall Study|Adverse Event|0|||
149158325|NCT01978093|538055799|FG001|Overall Study|Adverse Event|5|||
149158326|NCT01978093|538055798|FG000|Overall Study|Protocol Violation|8|||
149158327|NCT01978093|538055799|FG001|Overall Study|Protocol Violation|2|||
149158328|NCT01978093|538055798|FG000|Overall Study|Withdrawal by Subject|29|||
149158329|NCT01978093|538055799|FG001|Overall Study|Withdrawal by Subject|25|||
149158330|NCT01978093|538055798|FG000|Overall Study|Lost to Follow-up|11|||
149158331|NCT01978093|538055799|FG001|Overall Study|Lost to Follow-up|15|||
149158332|NCT01978093|538055798|FG000|Overall Study|Migrated/moved from study area|11|||
149158333|NCT01978093|538055799|FG001|Overall Study|Migrated/moved from study area|13|||
149158334|NCT01978093|538055798|FG000|Overall Study|Loss of kaiser coverage|4|||
149158335|NCT01978093|538055799|FG001|Overall Study|Loss of kaiser coverage|10|||
149158336|NCT01978093|538055798|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
149158337|NCT01978093|538055799|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
149158338|NCT01978093|538055798|FG000|Overall Study|Mother lost custody of child|0|||
149158339|NCT01978093|538055799|FG001|Overall Study|Mother lost custody of child|1|||
149158340|NCT01978093|538055798|FG000|Overall Study|Child was in care of grandmother|0|||
149158341|NCT01978093|538055799|FG001|Overall Study|Child was in care of grandmother|1|||
149158342|NCT01978093|538055798|FG000|Overall Study|N/A for vaccine administration|0|||
149158343|NCT01978093|538055799|FG001|Overall Study|N/A for vaccine administration|1|||
149158344|NCT00424827|538055804|FG000|Overall Study|Adverse Event|1|||
149158345|NCT00491179|538055805|FG000|Overall Study|Adverse Event|5|||
149158346|NCT00491179|538055806|FG001|Overall Study|Adverse Event|1|||
149158347|NCT00491179|538055805|FG000|Overall Study|Withdrawal by Subject|2|||
149158348|NCT00491179|538055806|FG001|Overall Study|Withdrawal by Subject|1|||
149158349|NCT02009878|538055808|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
149158350|NCT02009878|538055809|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
149158351|NCT02009878|538055810|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
149158352|NCT01790048|538055812|FG000|Overall Study|Incorrect Age|9|||
149158353|NCT01790048|538055813|FG001|Overall Study|Incorrect Age|14|||
149158354|NCT01790048|538055812|FG000|Overall Study|data entry error|0|||
149158355|NCT01790048|538055813|FG001|Overall Study|data entry error|1|||
148805989|NCT05911841|536768046|FG002|Maintenance Period|Withdrawal by Subject|0|||
148924358|NCT00274924|537207890|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
149158356|NCT01790048|538055812|FG000|Overall Study|Other|0|||
149158357|NCT01790048|538055813|FG001|Overall Study|Other|2|||
149158358|NCT01790048|538055812|FG000|Overall Study|SAM at Enrollment|2|||
149158359|NCT01790048|538055813|FG001|Overall Study|SAM at Enrollment|0|||
149158360|NCT01790048|538055812|FG000|Overall Study|Measurement error|1|||
149158361|NCT01790048|538055813|FG001|Overall Study|Measurement error|0|||
149158362|NCT00584233|538055814|FG000|Overall Study|Withdrawal by Subject|5|||
149158363|NCT00584233|538055814|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
149158364|NCT00159432|538055815|FG000|Overall Study|Adverse Event|1|||
149158365|NCT00159432|538055815|FG000|Overall Study|Death|1|||
149158366|NCT00159432|538055815|FG000|Overall Study|Lack of Efficacy|8|||
149158367|NCT04537208|538055818|FG000|Overall Study|Adverse Event|0|||
149158368|NCT04537208|538055819|FG001|Overall Study|Adverse Event|0|||
149158369|NCT04537208|538055820|FG002|Overall Study|Adverse Event|0|||
149158370|NCT04537208|538055821|FG003|Overall Study|Adverse Event|0|||
149158371|NCT04537208|538055822|FG004|Overall Study|Adverse Event|0|||
149158372|NCT04537208|538055823|FG005|Overall Study|Adverse Event|0|||
149158373|NCT04537208|538055824|FG006|Overall Study|Adverse Event|0|||
149158374|NCT04537208|538055825|FG007|Overall Study|Adverse Event|0|||
149158375|NCT04537208|538055826|FG008|Overall Study|Adverse Event|1|||
149158376|NCT04537208|538055827|FG009|Overall Study|Adverse Event|0|||
149158377|NCT04537208|538055828|FG010|Overall Study|Adverse Event|0|||
149158378|NCT04537208|538055818|FG000|Overall Study|Protocol deviation|0|||
149158379|NCT04537208|538055819|FG001|Overall Study|Protocol deviation|0|||
149158380|NCT04537208|538055820|FG002|Overall Study|Protocol deviation|2|||
149158381|NCT04537208|538055821|FG003|Overall Study|Protocol deviation|0|||
149158382|NCT04537208|538055822|FG004|Overall Study|Protocol deviation|0|||
149158383|NCT04537208|538055823|FG005|Overall Study|Protocol deviation|2|||
149158384|NCT04537208|538055824|FG006|Overall Study|Protocol deviation|4|||
149158385|NCT04537208|538055825|FG007|Overall Study|Protocol deviation|0|||
149158386|NCT04537208|538055826|FG008|Overall Study|Protocol deviation|1|||
149158387|NCT04537208|538055827|FG009|Overall Study|Protocol deviation|0|||
149158388|NCT04537208|538055828|FG010|Overall Study|Protocol deviation|2|||
149158389|NCT04537208|538055818|FG000|Overall Study|Withdrawal by Subject|4|||
149158390|NCT04537208|538055819|FG001|Overall Study|Withdrawal by Subject|2|||
149158391|NCT04537208|538055820|FG002|Overall Study|Withdrawal by Subject|1|||
148924359|NCT00274924|537207891|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
148924360|NCT00274924|537207892|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
148924361|NCT00274924|537207890|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
148924362|NCT00274924|537207891|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
148924363|NCT00274924|537207892|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
148924364|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
148924365|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
148924366|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
148924367|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
149158392|NCT04537208|538055821|FG003|Overall Study|Withdrawal by Subject|3|||
149158393|NCT04537208|538055822|FG004|Overall Study|Withdrawal by Subject|5|||
149158394|NCT04537208|538055823|FG005|Overall Study|Withdrawal by Subject|1|||
149158395|NCT04537208|538055824|FG006|Overall Study|Withdrawal by Subject|6|||
149158396|NCT04537208|538055825|FG007|Overall Study|Withdrawal by Subject|1|||
149158397|NCT04537208|538055826|FG008|Overall Study|Withdrawal by Subject|7|||
149158398|NCT04537208|538055827|FG009|Overall Study|Withdrawal by Subject|2|||
148924368|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
148924369|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
149158399|NCT04537208|538055828|FG010|Overall Study|Withdrawal by Subject|4|||
149158400|NCT04537208|538055818|FG000|Overall Study|Lost to Follow-up|4|||
149158401|NCT04537208|538055819|FG001|Overall Study|Lost to Follow-up|1|||
149158402|NCT04537208|538055820|FG002|Overall Study|Lost to Follow-up|3|||
149158403|NCT04537208|538055821|FG003|Overall Study|Lost to Follow-up|4|||
149158404|NCT04537208|538055822|FG004|Overall Study|Lost to Follow-up|3|||
149158405|NCT04537208|538055823|FG005|Overall Study|Lost to Follow-up|2|||
149158406|NCT04537208|538055824|FG006|Overall Study|Lost to Follow-up|3|||
149158407|NCT04537208|538055825|FG007|Overall Study|Lost to Follow-up|2|||
149158408|NCT04537208|538055826|FG008|Overall Study|Lost to Follow-up|7|||
149158409|NCT04537208|538055827|FG009|Overall Study|Lost to Follow-up|2|||
149158410|NCT04537208|538055828|FG010|Overall Study|Lost to Follow-up|2|||
149158411|NCT03655756|538055829|FG000|Overall Study|Death|1|||
149158412|NCT03237065|538055830|FG000|Overall Study|Adverse Event|0|||
149158413|NCT03237065|538055831|FG001|Overall Study|Adverse Event|2|||
149158414|NCT03237065|538055830|FG000|Overall Study|Protocol Violation|0|||
149158415|NCT03237065|538055831|FG001|Overall Study|Protocol Violation|1|||
149158416|NCT03237065|538055830|FG000|Overall Study|Withdrawal by Subject|3|||
149158417|NCT03237065|538055831|FG001|Overall Study|Withdrawal by Subject|0|||
149158418|NCT03237065|538055830|FG000|Overall Study|Lost to Follow-up|1|||
149158419|NCT03237065|538055831|FG001|Overall Study|Lost to Follow-up|0|||
149158420|NCT03237065|538055830|FG000|Overall Study|Unable to obtain venous access|0|||
149158421|NCT03237065|538055831|FG001|Overall Study|Unable to obtain venous access|1|||
149158422|NCT00704964|538055833|FG000|Overall Study|Not completed on time|328|||
149158423|NCT04317274|538055834|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
148673668|NCT00865306|536275834|FG001|Controlled Trial|Difficulty commuting|0|||
148673669|NCT00865306|536275833|FG000|Controlled Trial|Improved btw baseline and first session|1|||
148673670|NCT00865306|536275834|FG001|Controlled Trial|Improved btw baseline and first session|0|||
148673671|NCT00865306|536275833|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
148673672|NCT00865306|536275834|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
148673673|NCT00865306|536275833|FG000|Controlled Trial|Withdrawal by Subject|0|||
148673674|NCT00865306|536275834|FG001|Controlled Trial|Withdrawal by Subject|1|||
148673675|NCT02704130|536275835|FG000|Overall Study|Physician Decision|5|||
149158424|NCT04317274|538055835|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
149158425|NCT04317274|538055836|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
149158426|NCT04317274|538055837|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
149158427|NCT02161211|538055840|FG000|Overall Study|Lost to Follow-up|21|||
149158428|NCT02161211|538055841|FG001|Overall Study|Lost to Follow-up|27|||
149158429|NCT02161211|538055842|FG002|Overall Study|Lost to Follow-up|21|||
149158430|NCT02161211|538055840|FG000|Overall Study|Dropped|12|||
149158431|NCT02161211|538055841|FG001|Overall Study|Dropped|5|||
149158432|NCT02161211|538055842|FG002|Overall Study|Dropped|9|||
149158433|NCT00993031|538055855|FG000|Overall Study|Death|0|||
149158434|NCT00993031|538055856|FG001|Overall Study|Death|1|||
149158435|NCT00993031|538055855|FG000|Overall Study|Physician Decision|0|||
149158436|NCT00993031|538055856|FG001|Overall Study|Physician Decision|2|||
149158437|NCT00993031|538055855|FG000|Overall Study|Withdrawal by Subject|3|||
149158438|NCT00993031|538055856|FG001|Overall Study|Withdrawal by Subject|3|||
149158439|NCT00993031|538055855|FG000|Overall Study|Lost to Follow-up|19|||
149158440|NCT00993031|538055856|FG001|Overall Study|Lost to Follow-up|13|||
149158441|NCT01834729|538055859|FG000|Overall Study|Did not return bowel diaries|0|||
149158442|NCT01834729|538055860|FG001|Overall Study|Did not return bowel diaries|0|||
149158443|NCT01834729|538055861|FG002|Overall Study|Did not return bowel diaries|3|||
149158444|NCT01834729|538055862|FG003|Overall Study|Did not return bowel diaries|0|||
149158445|NCT01834729|538055859|FG000|Overall Study|Withdrawal by Subject|1|||
149158446|NCT01834729|538055860|FG001|Overall Study|Withdrawal by Subject|1|||
149158447|NCT01834729|538055861|FG002|Overall Study|Withdrawal by Subject|0|||
149158448|NCT01834729|538055862|FG003|Overall Study|Withdrawal by Subject|0|||
149158449|NCT01834729|538055859|FG000|Overall Study|Adverse Event|0|||
149158450|NCT01834729|538055860|FG001|Overall Study|Adverse Event|0|||
149158451|NCT01834729|538055861|FG002|Overall Study|Adverse Event|0|||
149158452|NCT01834729|538055862|FG003|Overall Study|Adverse Event|2|||
149158453|NCT00288080|538055863|FG000|Overall Study|Withdrawal by Subject|1|||
149158454|NCT00288080|538055864|FG001|Overall Study|Withdrawal by Subject|3|||
149158455|NCT00288080|538055863|FG000|Overall Study|Protocol Violation|25|||
149158456|NCT00288080|538055864|FG001|Overall Study|Protocol Violation|20|||
149158457|NCT03403192|538055865|FG000|Overall Study|Lost to Follow-up|1|||
148673676|NCT02704130|536275836|FG001|Overall Study|Physician Decision|3|||
148924370|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
149158458|NCT03403192|538055866|FG001|Overall Study|Lost to Follow-up|2|||
149158459|NCT03403192|538055867|FG002|Overall Study|Lost to Follow-up|0|||
149158460|NCT03403192|538055868|FG003|Overall Study|Lost to Follow-up|0|||
149158461|NCT03403192|538055865|FG000|Overall Study|Unable to respond|0|||
149158462|NCT03403192|538055866|FG001|Overall Study|Unable to respond|1|||
149158463|NCT03403192|538055867|FG002|Overall Study|Unable to respond|0|||
149158464|NCT03403192|538055868|FG003|Overall Study|Unable to respond|0|||
149158465|NCT03403192|538055865|FG000|Overall Study|Incomplete|3|||
148673677|NCT01306968|536275839|FG000|Overall Study|Lost to Follow-up|1|||
148673678|NCT01306968|536275840|FG001|Overall Study|Lost to Follow-up|1|||
149158466|NCT03403192|538055866|FG001|Overall Study|Incomplete|1|||
149158467|NCT03403192|538055867|FG002|Overall Study|Incomplete|3|||
149158468|NCT03403192|538055868|FG003|Overall Study|Incomplete|6|||
149158469|NCT02387580|538055870|FG000|Overall Study|Withdrawal by Subject|0|||
149158470|NCT02387580|538055871|FG001|Overall Study|Withdrawal by Subject|0|||
149158471|NCT02387580|538055872|FG002|Overall Study|Withdrawal by Subject|0|||
149158472|NCT02387580|538055873|FG003|Overall Study|Withdrawal by Subject|1|||
149158473|NCT02387580|538055874|FG004|Overall Study|Withdrawal by Subject|0|||
149158474|NCT02387580|538055875|FG005|Overall Study|Withdrawal by Subject|0|||
149158475|NCT00087646|538055876|FG000|Overall Study|Adverse Event|37|||
149158476|NCT00087646|538055877|FG001|Overall Study|Adverse Event|6|||
149158477|NCT00087646|538055878|FG002|Overall Study|Adverse Event|18|||
149158478|NCT00087646|538055879|FG003|Overall Study|Adverse Event|20|||
149158479|NCT00087646|538055876|FG000|Overall Study|Death|0|||
149158480|NCT00087646|538055877|FG001|Overall Study|Death|1|||
149158481|NCT00087646|538055878|FG002|Overall Study|Death|0|||
149158482|NCT00087646|538055879|FG003|Overall Study|Death|0|||
149158483|NCT00087646|538055876|FG000|Overall Study|Withdrawal by Subject|6|||
149158484|NCT00087646|538055877|FG001|Overall Study|Withdrawal by Subject|1|||
149158485|NCT00087646|538055878|FG002|Overall Study|Withdrawal by Subject|2|||
149158486|NCT00087646|538055879|FG003|Overall Study|Withdrawal by Subject|2|||
149158487|NCT00087646|538055876|FG000|Overall Study|Insufficient therapeutic response|64|||
149158488|NCT00087646|538055877|FG001|Overall Study|Insufficient therapeutic response|24|||
149158489|NCT00087646|538055878|FG002|Overall Study|Insufficient therapeutic response|38|||
149158490|NCT00087646|538055879|FG003|Overall Study|Insufficient therapeutic response|51|||
149158491|NCT00087646|538055876|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
149158492|NCT00087646|538055877|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
149158493|NCT00087646|538055878|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
149158494|NCT00087646|538055879|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
149158495|NCT00087646|538055876|FG000|Overall Study|Failure to Return|5|||
149158496|NCT00087646|538055877|FG001|Overall Study|Failure to Return|2|||
149158497|NCT00087646|538055878|FG002|Overall Study|Failure to Return|2|||
149158498|NCT00087646|538055879|FG003|Overall Study|Failure to Return|3|||
149158499|NCT00087646|538055876|FG000|Overall Study|Administrative/Other|6|||
149158500|NCT00087646|538055877|FG001|Overall Study|Administrative/Other|1|||
149158501|NCT00087646|538055878|FG002|Overall Study|Administrative/Other|1|||
149158502|NCT00087646|538055879|FG003|Overall Study|Administrative/Other|2|||
149158503|NCT00087646|538055876|FG000|Overall Study|Other Protocol Violation|3|||
149158504|NCT00087646|538055877|FG001|Overall Study|Other Protocol Violation|1|||
149158505|NCT00087646|538055878|FG002|Overall Study|Other Protocol Violation|0|||
149158506|NCT00087646|538055879|FG003|Overall Study|Other Protocol Violation|0|||
149158507|NCT00087646|538055876|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
149158508|NCT00087646|538055877|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
149158509|NCT00087646|538055878|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
149158510|NCT00087646|538055879|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
149158511|NCT03033875|538055883|FG000|Overall Study|Withdrawal by Subject|5|||
149158512|NCT03033875|538055884|FG001|Overall Study|Withdrawal by Subject|9|||
149158513|NCT03033875|538055885|FG002|Overall Study|Withdrawal by Subject|4|||
149158514|NCT03033875|538055883|FG000|Overall Study|Other|14|||
149158515|NCT03033875|538055884|FG001|Overall Study|Other|15|||
149158516|NCT03033875|538055885|FG002|Overall Study|Other|8|||
149158517|NCT04925752|538055887|FG000|Overall Study|Still on Study|1826|||
149158518|NCT04925752|538055888|FG001|Overall Study|Still on Study|926|||
149158519|NCT04925752|538055887|FG000|Overall Study|Withdrew Consent|128|||
149158520|NCT04925752|538055888|FG001|Overall Study|Withdrew Consent|59|||
149158521|NCT04925752|538055887|FG000|Overall Study|Lost to Follow-up|73|||
149158522|NCT04925752|538055888|FG001|Overall Study|Lost to Follow-up|47|||
149158523|NCT04925752|538055887|FG000|Overall Study|Randomized but Never Treated|12|||
149158524|NCT04925752|538055888|FG001|Overall Study|Randomized but Never Treated|9|||
149158525|NCT04925752|538055887|FG000|Overall Study|Hiv-1 Infection|6|||
149158526|NCT04925752|538055888|FG001|Overall Study|Hiv-1 Infection|7|||
149158527|NCT04925752|538055887|FG000|Overall Study|Investigator's discretion|8|||
149158528|NCT04925752|538055888|FG001|Overall Study|Investigator's discretion|5|||
149158529|NCT04925752|538055887|FG000|Overall Study|Non-compliance with Study Drug|8|||
149158530|NCT04925752|538055888|FG001|Overall Study|Non-compliance with Study Drug|5|||
149158531|NCT04925752|538055887|FG000|Overall Study|Adverse Event|5|||
149158532|NCT04925752|538055888|FG001|Overall Study|Adverse Event|2|||
149158533|NCT04925752|538055887|FG000|Overall Study|Death|4|||
149158534|NCT04925752|538055888|FG001|Overall Study|Death|2|||
149158535|NCT04925752|538055887|FG000|Overall Study|Protocol Violation|1|||
149158536|NCT04925752|538055888|FG001|Overall Study|Protocol Violation|3|||
149158537|NCT04925752|538055887|FG000|Overall Study|Withdrew Assent|1|||
149158538|NCT04925752|538055888|FG001|Overall Study|Withdrew Assent|0|||
149158539|NCT02286947|538055891|FG000|Overall Study|Withdrawal by Subject|2|||
149158540|NCT04202679|538055894|FG000|Overall Study|Adverse Event|2|||
149158541|NCT04202679|538055895|FG001|Overall Study|Adverse Event|0|||
149158542|NCT04202679|538055894|FG000|Overall Study|Poor compliance to protocol|1|||
149158543|NCT04202679|538055895|FG001|Overall Study|Poor compliance to protocol|0|||
149158544|NCT04202679|538055894|FG000|Overall Study|Withdrawal by Subject|23|||
149158545|NCT04202679|538055895|FG001|Overall Study|Withdrawal by Subject|6|||
149158546|NCT05902364|538055896|FG000|Overall Study|Adverse Event|1|||
149158547|NCT05902364|538055897|FG001|Overall Study|Adverse Event|0|||
149158548|NCT02270242|538055898|FG000|Overall Study|Withdrawal by Subject|18|||
149158549|NCT02270242|538055899|FG001|Overall Study|Withdrawal by Subject|25|||
149158550|NCT02270242|538055898|FG000|Overall Study|Lost to Follow-up|41|||
149158551|NCT02270242|538055899|FG001|Overall Study|Lost to Follow-up|27|||
149158552|NCT02270242|538055898|FG000|Overall Study|Physician Decision|0|||
149158553|NCT02270242|538055899|FG001|Overall Study|Physician Decision|1|||
149158554|NCT02482129|538055900|FG000|Overall Study|Adverse Event-prior to treatment|0|||
149158555|NCT02482129|538055901|FG001|Overall Study|Adverse Event-prior to treatment|1|||
149158556|NCT02482129|538055900|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
149158557|NCT02482129|538055901|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
149158558|NCT02482129|538055900|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
149158559|NCT02482129|538055901|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
149158560|NCT02482129|538055900|FG000|Overall Study|Criteria not met-prior to treatment|1|||
149158561|NCT02482129|538055901|FG001|Overall Study|Criteria not met-prior to treatment|0|||
149158562|NCT02482129|538055900|FG000|Overall Study|Adverse Event|1|||
149158563|NCT02482129|538055901|FG001|Overall Study|Adverse Event|0|||
149158564|NCT02482129|538055900|FG000|Overall Study|Withdrawal by Subject|2|||
149158565|NCT02482129|538055901|FG001|Overall Study|Withdrawal by Subject|0|||
149158566|NCT02482129|538055900|FG000|Overall Study|Criteria not met|1|||
149158567|NCT02482129|538055901|FG001|Overall Study|Criteria not met|0|||
149158568|NCT01877083|538055902|FG000|Treatment Phase|Disease Progression|10|||
149158569|NCT01877083|538055902|FG000|Treatment Phase|Clinical Progression|1|||
149158570|NCT01877083|538055902|FG000|Treatment Phase|Adverse Event|6|||
149158571|NCT01877083|538055902|FG000|Treatment Phase|Withdrawal by Subject|2|||
149158572|NCT01877083|538055902|FG000|Treatment Phase|Lost to Follow-up|1|||
149158573|NCT01877083|538055902|FG000|Extension Phase|Disease Progression|3|||
149158574|NCT01877083|538055902|FG000|Extension Phase|Adverse Event|2|||
149158575|NCT00429585|538055905|FG000|Overall Study|Death|1|||
149158576|NCT00429585|538055906|FG001|Overall Study|Death|0|||
149158577|NCT00429585|538055905|FG000|Overall Study|Lost to Follow-up|27|||
149158578|NCT00429585|538055906|FG001|Overall Study|Lost to Follow-up|20|||
149158579|NCT00429585|538055905|FG000|Overall Study|Physician Decision|2|||
149158580|NCT00429585|538055906|FG001|Overall Study|Physician Decision|0|||
149158581|NCT01582308|538055907|FG000|Period 1|Withdrawal by Subject|0|||
149158582|NCT01582308|538055908|FG001|Period 1|Withdrawal by Subject|0|||
149158583|NCT01582308|538055909|FG002|Period 1|Withdrawal by Subject|0|||
149158584|NCT01582308|538055910|FG003|Period 1|Withdrawal by Subject|0|||
149158585|NCT01582308|538055911|FG004|Period 1|Withdrawal by Subject|0|||
149158586|NCT01582308|538055912|FG005|Period 1|Withdrawal by Subject|0|||
149158587|NCT01582308|538055913|FG006|Period 1|Withdrawal by Subject|1|||
149158588|NCT01582308|538055914|FG007|Period 1|Withdrawal by Subject|0|||
149158589|NCT01582308|538055915|FG008|Period 1|Withdrawal by Subject|0|||
149158590|NCT01582308|538055916|FG009|Period 1|Withdrawal by Subject|0|||
149158591|NCT01582308|538055907|FG000|10-day Washout Following Period 1|Physician Decision|0|||
149158592|NCT01582308|538055908|FG001|10-day Washout Following Period 1|Physician Decision|0|||
149158593|NCT01582308|538055909|FG002|10-day Washout Following Period 1|Physician Decision|0|||
148673679|NCT01306968|536275841|FG002|Overall Study|Lost to Follow-up|0|||
148673680|NCT01306968|536275842|FG003|Overall Study|Lost to Follow-up|0|||
148924371|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
148924372|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
148924373|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
148924374|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
148924375|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
148924376|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
149158594|NCT01582308|538055910|FG003|10-day Washout Following Period 1|Physician Decision|0|||
149158595|NCT01582308|538055911|FG004|10-day Washout Following Period 1|Physician Decision|1|||
149158596|NCT01582308|538055912|FG005|10-day Washout Following Period 1|Physician Decision|0|||
149158597|NCT01582308|538055913|FG006|10-day Washout Following Period 1|Physician Decision|0|||
149158598|NCT01582308|538055914|FG007|10-day Washout Following Period 1|Physician Decision|0|||
149158599|NCT01582308|538055915|FG008|10-day Washout Following Period 1|Physician Decision|0|||
149158600|NCT01582308|538055916|FG009|10-day Washout Following Period 1|Physician Decision|0|||
149158601|NCT01582308|538055907|FG000|Period 4|Physician Decision|1|||
149158602|NCT01582308|538055908|FG001|Period 4|Physician Decision|0|||
149158603|NCT01582308|538055909|FG002|Period 4|Physician Decision|0|||
149158604|NCT01582308|538055910|FG003|Period 4|Physician Decision|0|||
149158605|NCT01582308|538055911|FG004|Period 4|Physician Decision|0|||
149158606|NCT01582308|538055912|FG005|Period 4|Physician Decision|1|||
149158607|NCT01582308|538055913|FG006|Period 4|Physician Decision|0|||
149158608|NCT01582308|538055914|FG007|Period 4|Physician Decision|0|||
148673681|NCT01306968|536275839|FG000|Overall Study|Physician Decision|0|||
149158609|NCT01582308|538055915|FG008|Period 4|Physician Decision|0|||
149158610|NCT01582308|538055916|FG009|Period 4|Physician Decision|1|||
149158611|NCT03631706|538055923|FG000|Overall Study|Randomized, not treated|1|||
149158612|NCT03631706|538055924|FG001|Overall Study|Randomized, not treated|0|||
149158613|NCT01354028|538058257|FG000|Overall Study|Physician Decision|0|||
149158614|NCT01354028|538058258|FG001|Overall Study|Physician Decision|2|||
149158615|NCT01354028|538058257|FG000|Overall Study|Discharged before study start|2|||
149158616|NCT01354028|538058258|FG001|Overall Study|Discharged before study start|2|||
149158617|NCT01354028|538058257|FG000|Overall Study|No quiet alert state|0|||
149158618|NCT01354028|538058258|FG001|Overall Study|No quiet alert state|1|||
149158619|NCT00975156|538058259|FG000|Overall Study|Protocol Violation|0|||
149158620|NCT00975156|538058260|FG001|Overall Study|Protocol Violation|1|||
149158621|NCT03472560|538058263|FG000|Overall Study|Subject transfer to continuation protocol|0|||
149158622|NCT03472560|538058264|FG001|Overall Study|Subject transfer to continuation protocol|1|||
149158623|NCT03472560|538058263|FG000|Overall Study|Withdrawal by Subject|4|||
149158624|NCT03472560|538058264|FG001|Overall Study|Withdrawal by Subject|0|||
149158625|NCT03472560|538058263|FG000|Overall Study|Progressive disease|24|||
149158626|NCT03472560|538058264|FG001|Overall Study|Progressive disease|8|||
149158627|NCT03472560|538058263|FG000|Overall Study|Physician Decision|1|||
149158628|NCT03472560|538058264|FG001|Overall Study|Physician Decision|0|||
149158629|NCT03472560|538058263|FG000|Overall Study|Death|7|||
149158630|NCT03472560|538058264|FG001|Overall Study|Death|4|||
149158631|NCT03472560|538058263|FG000|Overall Study|Adverse Event|5|||
149158632|NCT03472560|538058264|FG001|Overall Study|Adverse Event|3|||
149158633|NCT03472560|538058263|FG000|Overall Study|Global deterioration of health status|0|||
149158634|NCT03472560|538058264|FG001|Overall Study|Global deterioration of health status|4|||
149158635|NCT01946178|538058265|FG000|Overall Study|Pregnancy|1|||
149158636|NCT01946178|538058265|FG000|Overall Study|Lost to Follow-up|1|||
149158637|NCT05425563|538058266|FG000|Overall Study|Withdrawal by Subject|17|||
149158638|NCT02494596|538058269|FG000|Overall Study|Insufficient Therapeutic Response|3|||
149158639|NCT02494596|538058270|FG001|Overall Study|Insufficient Therapeutic Response|3|||
149158640|NCT02494596|538058271|FG002|Overall Study|Insufficient Therapeutic Response|1|||
149158641|NCT02494596|538058269|FG000|Overall Study|Adverse Event|0|||
149158642|NCT02494596|538058270|FG001|Overall Study|Adverse Event|1|||
149158643|NCT02494596|538058271|FG002|Overall Study|Adverse Event|0|||
149158644|NCT02494596|538058269|FG000|Overall Study|Refused Treatment|0|||
149158645|NCT02494596|538058270|FG001|Overall Study|Refused Treatment|1|||
149158646|NCT02494596|538058271|FG002|Overall Study|Refused Treatment|0|||
149158647|NCT02222714|538058272|FG000|Overall Study|Death|0|||
149158648|NCT02222714|538058273|FG001|Overall Study|Death|2|||
149158649|NCT02222714|538058274|FG002|Overall Study|Death|3|||
149158650|NCT02222714|538058275|FG003|Overall Study|Death|4|||
149158651|NCT02222714|538058276|FG004|Overall Study|Death|6|||
149158652|NCT02222714|538058272|FG000|Overall Study|Withdrawal by Subject|0|||
149158653|NCT02222714|538058273|FG001|Overall Study|Withdrawal by Subject|0|||
149158654|NCT02222714|538058274|FG002|Overall Study|Withdrawal by Subject|1|||
149158655|NCT02222714|538058275|FG003|Overall Study|Withdrawal by Subject|0|||
149158656|NCT02222714|538058276|FG004|Overall Study|Withdrawal by Subject|1|||
149158657|NCT01340209|538058279|FG000|Overall Study|Adverse Event|1|||
149158658|NCT01340209|538058280|FG001|Overall Study|Adverse Event|1|||
149158659|NCT01340209|538058281|FG002|Overall Study|Adverse Event|2|||
149158660|NCT01340209|538058279|FG000|Overall Study|Protocol Violation|1|||
149158661|NCT01340209|538058280|FG001|Overall Study|Protocol Violation|2|||
148924377|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
149158662|NCT01340209|538058281|FG002|Overall Study|Protocol Violation|1|||
148924378|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
148924379|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
148924380|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
149158663|NCT01340209|538058279|FG000|Overall Study|Withdrawal by Subject|0|||
149158664|NCT01340209|538058280|FG001|Overall Study|Withdrawal by Subject|0|||
149158665|NCT01340209|538058281|FG002|Overall Study|Withdrawal by Subject|1|||
149158666|NCT01340209|538058279|FG000|Overall Study|Other reason not defined above|3|||
149158667|NCT01340209|538058280|FG001|Overall Study|Other reason not defined above|5|||
148673682|NCT01306968|536275840|FG001|Overall Study|Physician Decision|1|||
149158668|NCT01340209|538058281|FG002|Overall Study|Other reason not defined above|4|||
149158669|NCT01537211|538058282|FG000|Overall Study|Lost to Follow-up|0|||
149158670|NCT01537211|538058283|FG001|Overall Study|Lost to Follow-up|1|||
149158671|NCT02161562|538058285|FG000|Overall Study|Withdrawal by Subject|5|||
149158672|NCT02161562|538058286|FG001|Overall Study|Withdrawal by Subject|8|||
149158673|NCT02161562|538058285|FG000|Overall Study|Protocol Violation|9|||
149158674|NCT02161562|538058286|FG001|Overall Study|Protocol Violation|4|||
149158675|NCT02161562|538058285|FG000|Overall Study|Pregnancy|1|||
149158676|NCT02161562|538058286|FG001|Overall Study|Pregnancy|2|||
149158677|NCT02161562|538058285|FG000|Overall Study|Lost to Follow-up|3|||
149158678|NCT02161562|538058286|FG001|Overall Study|Lost to Follow-up|1|||
149158679|NCT02161562|538058285|FG000|Overall Study|Lack of Efficacy|4|||
149158680|NCT02161562|538058286|FG001|Overall Study|Lack of Efficacy|1|||
149158681|NCT02161562|538058285|FG000|Overall Study|Adverse Event|1|||
149158682|NCT02161562|538058286|FG001|Overall Study|Adverse Event|1|||
149158683|NCT02161562|538058285|FG000|Overall Study|Participant moved back to home country|1|||
149158684|NCT02161562|538058286|FG001|Overall Study|Participant moved back to home country|0|||
149158685|NCT02161562|538058285|FG000|Overall Study|Withdrew due to being out of the country|1|||
149158686|NCT02161562|538058286|FG001|Overall Study|Withdrew due to being out of the country|0|||
149158687|NCT02161562|538058285|FG000|Overall Study|Participant moved out of province|1|||
149158688|NCT02161562|538058286|FG001|Overall Study|Participant moved out of province|0|||
149158689|NCT00343512|538058311|FG000|Overall Study|Withdrawal by Subject|2|||
149158690|NCT00197054|538058312|FG000|Overall Study|Withdrawal by Subject|9|||
149158691|NCT00197054|538058313|FG001|Overall Study|Withdrawal by Subject|3|||
149158692|NCT00197054|538058314|FG002|Overall Study|Withdrawal by Subject|3|||
149158693|NCT00197054|538058312|FG000|Overall Study|Moved from area|7|||
149158694|NCT00197054|538058313|FG001|Overall Study|Moved from area|14|||
149158695|NCT00197054|538058314|FG002|Overall Study|Moved from area|9|||
149158696|NCT00197054|538058312|FG000|Overall Study|Lost to Follow-up|1|||
149158697|NCT00197054|538058313|FG001|Overall Study|Lost to Follow-up|4|||
149158698|NCT00197054|538058314|FG002|Overall Study|Lost to Follow-up|0|||
149158699|NCT00323557|538058315|FG000|Overall Study|Physician Decision|1|||
149158700|NCT00323557|538058316|FG001|Overall Study|Physician Decision|0|||
149158701|NCT00684515|538058317|FG000|Overall Study|Adverse Event|3|||
149158702|NCT00684515|538058318|FG001|Overall Study|Adverse Event|3|||
149158703|NCT00684515|538058319|FG002|Overall Study|Adverse Event|1|||
149158704|NCT00684515|538058317|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
149158705|NCT00684515|538058318|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
149158706|NCT00684515|538058319|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
149158707|NCT02450578|538058320|FG000|Overall Study|ECG abnormality so not treated|1|||
149158708|NCT02450578|538058321|FG001|Overall Study|ECG abnormality so not treated|0|||
149158709|NCT02450578|538058322|FG002|Overall Study|ECG abnormality so not treated|0|||
149158710|NCT02450578|538058323|FG003|Overall Study|ECG abnormality so not treated|0|||
149158711|NCT04428411|538058324|FG000|Overall Study|Lost to Follow-up|114|||
149158712|NCT02918019|538058325|FG000|Overall Study|Death|0|||
149158713|NCT02918019|538058326|FG001|Overall Study|Death|0|||
149158714|NCT02918019|538058327|FG002|Overall Study|Death|1|||
149158715|NCT02918019|538058328|FG003|Overall Study|Death|0|||
149158716|NCT02918019|538058325|FG000|Overall Study|Lost to Follow-up|1|||
149158717|NCT02918019|538058326|FG001|Overall Study|Lost to Follow-up|1|||
149158718|NCT02918019|538058327|FG002|Overall Study|Lost to Follow-up|0|||
149158719|NCT02918019|538058328|FG003|Overall Study|Lost to Follow-up|1|||
149158720|NCT02918019|538058325|FG000|Overall Study|Principal investigator request|0|||
149158721|NCT02918019|538058326|FG001|Overall Study|Principal investigator request|0|||
149158722|NCT02918019|538058327|FG002|Overall Study|Principal investigator request|0|||
149158723|NCT02918019|538058328|FG003|Overall Study|Principal investigator request|1|||
149158724|NCT02918019|538058325|FG000|Overall Study|Physician Decision|1|||
149158725|NCT02918019|538058326|FG001|Overall Study|Physician Decision|3|||
149158726|NCT02918019|538058327|FG002|Overall Study|Physician Decision|2|||
149158727|NCT02918019|538058328|FG003|Overall Study|Physician Decision|0|||
149158728|NCT02918019|538058325|FG000|Overall Study|Protocol deviation|1|||
149158729|NCT02918019|538058326|FG001|Overall Study|Protocol deviation|1|||
149158730|NCT02918019|538058327|FG002|Overall Study|Protocol deviation|0|||
149158731|NCT02918019|538058328|FG003|Overall Study|Protocol deviation|2|||
149158732|NCT02918019|538058325|FG000|Overall Study|Withdrawal by Subject|3|||
149158733|NCT02918019|538058326|FG001|Overall Study|Withdrawal by Subject|4|||
149158734|NCT02918019|538058327|FG002|Overall Study|Withdrawal by Subject|6|||
149158735|NCT02918019|538058328|FG003|Overall Study|Withdrawal by Subject|4|||
149158736|NCT02918019|538058325|FG000|Overall Study|Adverse Event|0|||
149158737|NCT02918019|538058326|FG001|Overall Study|Adverse Event|1|||
149158738|NCT02918019|538058327|FG002|Overall Study|Adverse Event|0|||
149158739|NCT02918019|538058328|FG003|Overall Study|Adverse Event|1|||
149158740|NCT00662792|538058329|FG000|Period 1|Personal Reasons|0|||
149158741|NCT00662792|538058330|FG001|Period 1|Personal Reasons|0|||
149158742|NCT00662792|538058331|FG002|Period 1|Personal Reasons|1|||
149158743|NCT00662792|538058332|FG003|Period 1|Personal Reasons|0|||
149158744|NCT00662792|538058329|FG000|Period 1|Refused continuing medication|0|||
149158745|NCT00662792|538058330|FG001|Period 1|Refused continuing medication|1|||
149158746|NCT00662792|538058331|FG002|Period 1|Refused continuing medication|1|||
149158747|NCT00662792|538058332|FG003|Period 1|Refused continuing medication|0|||
149158748|NCT00662792|538058329|FG000|Period 1|Lost to Follow-up|1|||
149158749|NCT00662792|538058330|FG001|Period 1|Lost to Follow-up|0|||
149158750|NCT00662792|538058331|FG002|Period 1|Lost to Follow-up|0|||
149158751|NCT00662792|538058332|FG003|Period 1|Lost to Follow-up|0|||
149158752|NCT00662792|538058329|FG000|Period 1|Other adverse event (AE)|0|||
149158753|NCT00662792|538058330|FG001|Period 1|Other adverse event (AE)|2|||
149158754|NCT00662792|538058331|FG002|Period 1|Other adverse event (AE)|0|||
149158755|NCT00662792|538058332|FG003|Period 1|Other adverse event (AE)|0|||
149158756|NCT00662792|538058329|FG000|Period 1|Worsening of disease under study (AE)|1|||
149158757|NCT00662792|538058330|FG001|Period 1|Worsening of disease under study (AE)|3|||
149158758|NCT00662792|538058331|FG002|Period 1|Worsening of disease under study (AE)|2|||
149158759|NCT00662792|538058332|FG003|Period 1|Worsening of disease under study (AE)|0|||
149158760|NCT00662792|538058329|FG000|Period 1|Not treated|0|||
149158761|NCT00662792|538058330|FG001|Period 1|Not treated|1|||
149158762|NCT00662792|538058331|FG002|Period 1|Not treated|0|||
149158763|NCT00662792|538058332|FG003|Period 1|Not treated|0|||
149158764|NCT00662792|538058329|FG000|Period 2|Worsening of disease under study|1|||
149158765|NCT00662792|538058330|FG001|Period 2|Worsening of disease under study|0|||
149158766|NCT00662792|538058331|FG002|Period 2|Worsening of disease under study|0|||
149158767|NCT00662792|538058332|FG003|Period 2|Worsening of disease under study|3|||
149158768|NCT00662792|538058329|FG000|Period 3|Refused continuing medication|1|||
149158769|NCT00662792|538058330|FG001|Period 3|Refused continuing medication|0|||
149158770|NCT00662792|538058331|FG002|Period 3|Refused continuing medication|1|||
149158771|NCT00662792|538058332|FG003|Period 3|Refused continuing medication|0|||
149158772|NCT00662792|538058329|FG000|Period 3|Other adverse event (AE)|0|||
149158773|NCT00662792|538058330|FG001|Period 3|Other adverse event (AE)|0|||
149158774|NCT00662792|538058331|FG002|Period 3|Other adverse event (AE)|1|||
149158775|NCT00662792|538058332|FG003|Period 3|Other adverse event (AE)|1|||
149158776|NCT00662792|538058329|FG000|Period 4|Refused continuing medication|0|||
149158777|NCT00662792|538058330|FG001|Period 4|Refused continuing medication|1|||
149158778|NCT00662792|538058331|FG002|Period 4|Refused continuing medication|0|||
149158779|NCT00662792|538058332|FG003|Period 4|Refused continuing medication|0|||
149158780|NCT00662792|538058329|FG000|Period 4|Other adverse event (AE)|1|||
149158781|NCT00662792|538058330|FG001|Period 4|Other adverse event (AE)|0|||
149158782|NCT00662792|538058331|FG002|Period 4|Other adverse event (AE)|0|||
149158783|NCT00662792|538058332|FG003|Period 4|Other adverse event (AE)|0|||
149158784|NCT00662792|538058329|FG000|Period 4|Worsening of disease under study (AE)|0|||
149158785|NCT00662792|538058330|FG001|Period 4|Worsening of disease under study (AE)|0|||
149158786|NCT00662792|538058331|FG002|Period 4|Worsening of disease under study (AE)|0|||
149158787|NCT00662792|538058332|FG003|Period 4|Worsening of disease under study (AE)|1|||
149158788|NCT01699087|538058333|FG000|Overall Study|Lost to Follow-up|7|||
149158789|NCT01699087|538058333|FG000|Overall Study|Screen failure (prior to treatment)|15|||
149158790|NCT01699087|538058333|FG000|Overall Study|Unable to make future visits|2|||
149158791|NCT00094757|538058339|FG000|Overall Study|Adverse Event|11|||
149158792|NCT00094757|538058340|FG001|Overall Study|Adverse Event|9|||
149158793|NCT00094757|538058341|FG002|Overall Study|Adverse Event|6|||
149158794|NCT00094757|538058339|FG000|Overall Study|Lack of Efficacy|11|||
149158795|NCT00094757|538058340|FG001|Overall Study|Lack of Efficacy|15|||
149158796|NCT00094757|538058341|FG002|Overall Study|Lack of Efficacy|8|||
149158797|NCT00094757|538058339|FG000|Overall Study|Lost to Follow-up|3|||
149158798|NCT00094757|538058340|FG001|Overall Study|Lost to Follow-up|5|||
149158799|NCT00094757|538058341|FG002|Overall Study|Lost to Follow-up|6|||
149158800|NCT00094757|538058339|FG000|Overall Study|Patient Moved|2|||
149158801|NCT00094757|538058340|FG001|Overall Study|Patient Moved|1|||
149158802|NCT00094757|538058341|FG002|Overall Study|Patient Moved|1|||
149158803|NCT00094757|538058339|FG000|Overall Study|Protocol Violation|8|||
149158804|NCT00094757|538058340|FG001|Overall Study|Protocol Violation|5|||
149158805|NCT00094757|538058341|FG002|Overall Study|Protocol Violation|3|||
149158806|NCT00094757|538058339|FG000|Overall Study|Withdrawal by Subject|14|||
149158807|NCT00094757|538058340|FG001|Overall Study|Withdrawal by Subject|21|||
149158808|NCT00094757|538058341|FG002|Overall Study|Withdrawal by Subject|5|||
149158809|NCT00094757|538058339|FG000|Overall Study|Other|3|||
149158810|NCT00094757|538058340|FG001|Overall Study|Other|3|||
149158811|NCT00094757|538058341|FG002|Overall Study|Other|1|||
149158812|NCT00094757|538058339|FG000|Overall Study|Protocol specified discontinuation|1|||
149158813|NCT00094757|538058340|FG001|Overall Study|Protocol specified discontinuation|3|||
149158814|NCT00094757|538058341|FG002|Overall Study|Protocol specified discontinuation|0|||
149158815|NCT03021642|538058342|FG000|Washout Period (21 Days)|Adverse Event|1|||
149158816|NCT03021642|538058343|FG001|Washout Period (21 Days)|Adverse Event|1|||
149158817|NCT00090545|538058344|FG000|Overall Study|Disease progression on study|21|||
149158818|NCT00090545|538058345|FG001|Overall Study|Disease progression on study|17|||
149158819|NCT00090545|538058344|FG000|Overall Study|Refused further treatment|1|||
149158820|NCT00090545|538058345|FG001|Overall Study|Refused further treatment|4|||
149158821|NCT00090545|538058344|FG000|Overall Study|Death|0|||
149158822|NCT00090545|538058345|FG001|Overall Study|Death|1|||
149158823|NCT00090545|538058344|FG000|Overall Study|Adverse Event|0|||
149158824|NCT00090545|538058345|FG001|Overall Study|Adverse Event|2|||
148673683|NCT01306968|536275841|FG002|Overall Study|Physician Decision|0|||
149158825|NCT02474082|538058346|FG000|Overall Study|Adverse Event|2|||
149158826|NCT02474082|538058347|FG001|Overall Study|Adverse Event|32|||
149158827|NCT02474082|538058346|FG000|Overall Study|Withdrawal of informed consent|1|||
149158828|NCT02474082|538058347|FG001|Overall Study|Withdrawal of informed consent|11|||
149158829|NCT02474082|538058346|FG000|Overall Study|Lost to Follow-up|2|||
149158830|NCT02474082|538058347|FG001|Overall Study|Lost to Follow-up|2|||
149158831|NCT02474082|538058346|FG000|Overall Study|Dose tapering not achieved|0|||
149158832|NCT02474082|538058347|FG001|Overall Study|Dose tapering not achieved|4|||
149158833|NCT02474082|538058346|FG000|Overall Study|Participant/guardian decision|1|||
149158834|NCT02474082|538058347|FG001|Overall Study|Participant/guardian decision|2|||
149158835|NCT02474082|538058346|FG000|Overall Study|Non-compliance with study treatment|0|||
149158836|NCT02474082|538058347|FG001|Overall Study|Non-compliance with study treatment|2|||
149158837|NCT02474082|538058346|FG000|Overall Study|Protocol deviation|0|||
149158838|NCT02474082|538058347|FG001|Overall Study|Protocol deviation|1|||
149158839|NCT01463098|538058350|FG000|Part A (11 Days)|Participant Choice|2|||
149158840|NCT01463098|538058351|FG001|Part A (11 Days)|Participant Choice|0|||
149158841|NCT01463098|538058352|FG002|Part A (11 Days)|Participant Choice|0|||
149158842|NCT01463098|538058353|FG003|Part A (11 Days)|Participant Choice|0|||
149158843|NCT01463098|538058354|FG004|Part A (11 Days)|Participant Choice|0|||
149158844|NCT01463098|538058355|FG005|Part A (11 Days)|Participant Choice|0|||
149158845|NCT01463098|538058356|FG006|Part A (11 Days)|Participant Choice|0|||
149158846|NCT01463098|538058357|FG007|Part A (11 Days)|Participant Choice|0|||
149158847|NCT01463098|538058358|FG008|Part A (11 Days)|Participant Choice|1|||
149158848|NCT01463098|538058359|FG009|Part A (11 Days)|Participant Choice|0|||
149158849|NCT01463098|538058360|FG010|Part A (11 Days)|Participant Choice|0|||
149158850|NCT01463098|538058361|FG011|Part A (11 Days)|Participant Choice|0|||
149158851|NCT01463098|538058362|FG012|Part A (11 Days)|Participant Choice|0|||
149158852|NCT01463098|538058363|FG013|Part A (11 Days)|Participant Choice|0|||
149158853|NCT01463098|538058350|FG000|Part A (11 Days)|Lost to Follow-up|0|||
149158854|NCT01463098|538058351|FG001|Part A (11 Days)|Lost to Follow-up|0|||
149158855|NCT01463098|538058352|FG002|Part A (11 Days)|Lost to Follow-up|0|||
149158856|NCT01463098|538058353|FG003|Part A (11 Days)|Lost to Follow-up|0|||
149158857|NCT01463098|538058354|FG004|Part A (11 Days)|Lost to Follow-up|1|||
149158858|NCT01463098|538058355|FG005|Part A (11 Days)|Lost to Follow-up|0|||
149158859|NCT01463098|538058356|FG006|Part A (11 Days)|Lost to Follow-up|0|||
149158860|NCT01463098|538058357|FG007|Part A (11 Days)|Lost to Follow-up|0|||
149158861|NCT01463098|538058358|FG008|Part A (11 Days)|Lost to Follow-up|0|||
149158862|NCT01463098|538058359|FG009|Part A (11 Days)|Lost to Follow-up|0|||
149158863|NCT01463098|538058360|FG010|Part A (11 Days)|Lost to Follow-up|0|||
149158864|NCT01463098|538058361|FG011|Part A (11 Days)|Lost to Follow-up|0|||
149158865|NCT01463098|538058362|FG012|Part A (11 Days)|Lost to Follow-up|0|||
149158866|NCT01463098|538058363|FG013|Part A (11 Days)|Lost to Follow-up|0|||
149158867|NCT01463098|538058350|FG000|Part B (11 Days)|Participant Choice|0|||
149158868|NCT01463098|538058351|FG001|Part B (11 Days)|Participant Choice|0|||
149158869|NCT01463098|538058352|FG002|Part B (11 Days)|Participant Choice|0|||
149158870|NCT01463098|538058353|FG003|Part B (11 Days)|Participant Choice|0|||
149158871|NCT01463098|538058354|FG004|Part B (11 Days)|Participant Choice|0|||
149158872|NCT01463098|538058355|FG005|Part B (11 Days)|Participant Choice|0|||
149158873|NCT01463098|538058356|FG006|Part B (11 Days)|Participant Choice|0|||
149158874|NCT01463098|538058357|FG007|Part B (11 Days)|Participant Choice|0|||
149158875|NCT01463098|538058358|FG008|Part B (11 Days)|Participant Choice|0|||
149158876|NCT01463098|538058359|FG009|Part B (11 Days)|Participant Choice|0|||
149158877|NCT01463098|538058360|FG010|Part B (11 Days)|Participant Choice|0|||
149158878|NCT01463098|538058361|FG011|Part B (11 Days)|Participant Choice|1|||
149158879|NCT01463098|538058362|FG012|Part B (11 Days)|Participant Choice|0|||
149158880|NCT01463098|538058363|FG013|Part B (11 Days)|Participant Choice|0|||
149158881|NCT01528787|538058364|FG000|Overall Study|Withdrawal by Subject|0|||
149158882|NCT01528787|538058365|FG001|Overall Study|Withdrawal by Subject|0|||
149158883|NCT01528787|538058366|FG002|Overall Study|Withdrawal by Subject|0|||
149158884|NCT01528787|538058367|FG003|Overall Study|Withdrawal by Subject|1|||
149158885|NCT01528787|538058364|FG000|Overall Study|Family Emergency|0|||
149158886|NCT01528787|538058365|FG001|Overall Study|Family Emergency|0|||
149158887|NCT01528787|538058366|FG002|Overall Study|Family Emergency|1|||
148924381|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
149158888|NCT01528787|538058367|FG003|Overall Study|Family Emergency|0|||
149158889|NCT03433781|538058368|FG000|Overall Study|Progression of Disease|1|||
149158890|NCT03433781|538058369|FG001|Overall Study|Progression of Disease|0|||
149158891|NCT03433781|538058370|FG002|Overall Study|Progression of Disease|0|||
149158892|NCT03433781|538058368|FG000|Overall Study|Physician Decision|0|||
149158893|NCT03433781|538058369|FG001|Overall Study|Physician Decision|1|||
149158894|NCT03433781|538058370|FG002|Overall Study|Physician Decision|0|||
149158895|NCT00797823|538058371|FG000|First Period (Initial Randomization)|Physician Decision|1|||
149158896|NCT00797823|538058372|FG001|First Period (Initial Randomization)|Physician Decision|0|||
149158897|NCT00797823|538058373|FG002|First Period (Initial Randomization)|Physician Decision|0|||
149158898|NCT02809833|538058374|FG000|Overall Study|Death|3|||
149158899|NCT02809833|538058374|FG000|Overall Study|Intolerance|54|||
149158900|NCT02809833|538058374|FG000|Overall Study|Lack of Efficacy|89|||
149158901|NCT02809833|538058374|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
149158902|NCT02809833|538058374|FG000|Overall Study|Noncompliance|1|||
149158903|NCT02809833|538058374|FG000|Overall Study|Withdrawal by Subject|34|||
149158904|NCT02809833|538058374|FG000|Overall Study|Lost to Follow-up|35|||
149158905|NCT02809833|538058374|FG000|Overall Study|Adverse Event (AE)|24|||
149158906|NCT02809833|538058374|FG000|Overall Study|Other|5|||
149158907|NCT02809833|538058374|FG000|Overall Study|Missing Information|52|||
149158908|NCT02971670|538058377|FG000|Overall Study|Withdrawal by Subject|4|||
149158909|NCT02971670|538058378|FG001|Overall Study|Withdrawal by Subject|1|||
149158910|NCT02971670|538058379|FG002|Overall Study|Withdrawal by Subject|1|||
149158911|NCT02971670|538058380|FG003|Overall Study|Withdrawal by Subject|2|||
149158912|NCT02793232|538058381|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158913|NCT02793232|538058382|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158914|NCT02793232|538058383|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158915|NCT02793232|538058384|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158916|NCT02793232|538058385|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
149158917|NCT02793232|538058386|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158918|NCT02793232|538058387|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
149158919|NCT02793232|538058388|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158920|NCT02793232|538058389|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
149158921|NCT04849780|538058390|FG000|Period 1|Covid-19 Related|1|||
149158922|NCT04849780|538058391|FG001|Period 1|Covid-19 Related|0|||
149158923|NCT04849780|538058390|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
149158924|NCT04849780|538058391|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
149158925|NCT04849780|538058390|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
149158926|NCT04849780|538058391|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
149158927|NCT03979274|538058398|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149158928|NCT03979274|538058399|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149158929|NCT02302963|538058400|FG000|Overall Study|Withdrawal by Subject|2|||
149158930|NCT02302963|538058401|FG001|Overall Study|Withdrawal by Subject|1|||
149158931|NCT02302963|538058400|FG000|Overall Study|Steroid injection|0|||
149158932|NCT02302963|538058401|FG001|Overall Study|Steroid injection|1|||
149158933|NCT02302963|538058400|FG000|Overall Study|Physician Decision|1|||
149158934|NCT02302963|538058401|FG001|Overall Study|Physician Decision|0|||
149158935|NCT01614093|538058404|FG000|Overall Study|Withdrawal by Subject|1|||
149158936|NCT01816243|538058405|FG000|Overall Study|Adverse Event|6|||
149158937|NCT01816243|538058405|FG000|Overall Study|Lost to Follow-up|1|||
149158938|NCT01816243|538058405|FG000|Overall Study|Lack of Efficacy|1|||
149158939|NCT01816243|538058405|FG000|Overall Study|Not eligible for the study|1|||
149158940|NCT01816243|538058405|FG000|Overall Study|Amputation|3|||
149158941|NCT00603915|538058409|FG000|Overall Study|Physician Decision|1|||
149158942|NCT03687502|538058410|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
149158943|NCT03687502|538058410|FG000|Overall Study|Lumason not available|1|||
149158944|NCT01724528|538058411|FG000|Overall Study|Death|3|||
149158945|NCT01724528|538058412|FG001|Overall Study|Death|0|||
148924382|NCT00274924|537207890|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
148924383|NCT00274924|537207891|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
148924384|NCT00274924|537207892|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
148924385|NCT01055496|537207893|FG000|Overall Study|Withdrawal by Subject|2|||
148924386|NCT01055496|537207894|FG001|Overall Study|Withdrawal by Subject|4|||
148924387|NCT01055496|537207893|FG000|Overall Study|Death|13|||
148924388|NCT01055496|537207894|FG001|Overall Study|Death|23|||
148924389|NCT01055496|537207893|FG000|Overall Study|Lost to Follow-up|0|||
148924390|NCT01055496|537207894|FG001|Overall Study|Lost to Follow-up|2|||
149158946|NCT01724528|538058411|FG000|Overall Study|Withdrawal by Subject|0|||
149158947|NCT01724528|538058412|FG001|Overall Study|Withdrawal by Subject|2|||
149158948|NCT01724528|538058411|FG000|Overall Study|Protocol Violation|0|||
148924391|NCT01055496|537207893|FG000|Overall Study|Other - Unspecified|0|||
148924392|NCT01055496|537207894|FG001|Overall Study|Other - Unspecified|1|||
148924393|NCT00584740|537207895|FG000|Overall Study|Adverse Event|1|||
149158949|NCT01724528|538058412|FG001|Overall Study|Protocol Violation|1|||
149158950|NCT01724528|538058411|FG000|Overall Study|Patient refused to attend last visit|1|||
149158951|NCT01724528|538058412|FG001|Overall Study|Patient refused to attend last visit|0|||
149158952|NCT05574062|538058416|FG000|Pre Run-In|Screening failure|3|||
149158953|NCT05574062|538058417|FG001|Pre Run-In|Screening failure|0|||
149158954|NCT05574062|538058418|FG002|Pre Run-In|Screening failure|0|||
149158955|NCT05574062|538058419|FG003|Pre Run-In|Screening failure|0|||
149158956|NCT05574062|538058420|FG004|Pre Run-In|Screening failure|0|||
149158957|NCT05574062|538058416|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
149158958|NCT05574062|538058417|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
149158959|NCT05574062|538058418|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
149158960|NCT05574062|538058419|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
149158961|NCT05574062|538058420|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
149158962|NCT05574062|538058416|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
149158963|NCT05574062|538058417|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
149158964|NCT05574062|538058418|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
149158965|NCT05574062|538058419|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
149158966|NCT05574062|538058420|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
149158967|NCT05574062|538058416|FG000|Continuation Phase Period 1|Physician Decision|1|||
149158968|NCT05574062|538058417|FG001|Continuation Phase Period 1|Physician Decision|0|||
149158969|NCT05574062|538058418|FG002|Continuation Phase Period 1|Physician Decision|0|||
149158970|NCT05574062|538058419|FG003|Continuation Phase Period 1|Physician Decision|0|||
149158971|NCT05574062|538058420|FG004|Continuation Phase Period 1|Physician Decision|0|||
149158972|NCT05574062|538058416|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
149158973|NCT05574062|538058417|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
149158974|NCT05574062|538058418|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
149158975|NCT05574062|538058419|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
149158976|NCT05574062|538058420|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
149158977|NCT05574062|538058416|FG000|Continuation Phase Period 1|Adverse Event|1|||
149158978|NCT05574062|538058417|FG001|Continuation Phase Period 1|Adverse Event|0|||
149158979|NCT05574062|538058418|FG002|Continuation Phase Period 1|Adverse Event|0|||
149158980|NCT05574062|538058419|FG003|Continuation Phase Period 1|Adverse Event|0|||
149158981|NCT05574062|538058420|FG004|Continuation Phase Period 1|Adverse Event|0|||
149158982|NCT05574062|538058416|FG000|Continuation Phase Period 1|Death|1|||
149158983|NCT05574062|538058417|FG001|Continuation Phase Period 1|Death|0|||
149158984|NCT05574062|538058418|FG002|Continuation Phase Period 1|Death|0|||
149158985|NCT05574062|538058419|FG003|Continuation Phase Period 1|Death|0|||
149158986|NCT05574062|538058420|FG004|Continuation Phase Period 1|Death|0|||
149158987|NCT05574062|538058416|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
149158988|NCT05574062|538058417|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
149158989|NCT05574062|538058418|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
149158990|NCT05574062|538058419|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
149158991|NCT05574062|538058420|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
149158992|NCT04820309|538058423|FG000|Overall Study|Adverse Event|96|||
149158993|NCT04820309|538058423|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
149158994|NCT04820309|538058423|FG000|Overall Study|Consent Withdrawn|93|||
149158995|NCT04820309|538058423|FG000|Overall Study|failure to adhere to protocol|32|||
149158996|NCT04820309|538058423|FG000|Overall Study|alcohol or drug use|6|||
149158997|NCT04820309|538058423|FG000|Overall Study|Lost to Follow-up|46|||
149158998|NCT04820309|538058423|FG000|Overall Study|Death|2|||
149158999|NCT04820309|538058423|FG000|Overall Study|Pregnancy|1|||
149159000|NCT04820309|538058423|FG000|Overall Study|Other reasons|12|||
149159001|NCT04811716|538058428|FG000|Overall Study|Withdrawal by Subject|2|||
149159002|NCT04811716|538058429|FG001|Overall Study|Withdrawal by Subject|0|||
149159003|NCT03864653|538058430|FG000|Overall Study|Withdrawal by Subject|1|||
149159004|NCT03048422|538058431|FG000|Overall Study|Death|1|||
149159005|NCT03048422|538058432|FG001|Overall Study|Death|0|||
149159006|NCT03048422|538058433|FG002|Overall Study|Death|0|||
149159007|NCT03048422|538058431|FG000|Overall Study|Lost to Follow-up|5|||
149159008|NCT03048422|538058432|FG001|Overall Study|Lost to Follow-up|0|||
149159009|NCT03048422|538058433|FG002|Overall Study|Lost to Follow-up|1|||
149159010|NCT03048422|538058431|FG000|Overall Study|Withdrawal by Subject|5|||
149159011|NCT03048422|538058432|FG001|Overall Study|Withdrawal by Subject|7|||
149159012|NCT03048422|538058433|FG002|Overall Study|Withdrawal by Subject|4|||
149159013|NCT03048422|538058431|FG000|Overall Study|Moved|3|||
149159014|NCT03048422|538058432|FG001|Overall Study|Moved|2|||
149159015|NCT03048422|538058433|FG002|Overall Study|Moved|2|||
149159016|NCT03048422|538058431|FG000|Overall Study|Noncompliant with Study Requirements|2|||
149159017|NCT03048422|538058432|FG001|Overall Study|Noncompliant with Study Requirements|1|||
149159018|NCT03048422|538058433|FG002|Overall Study|Noncompliant with Study Requirements|2|||
149159019|NCT03048422|538058431|FG000|Overall Study|Not Able to Get to Clinic|1|||
149159020|NCT03048422|538058432|FG001|Overall Study|Not Able to Get to Clinic|0|||
149159021|NCT03048422|538058433|FG002|Overall Study|Not Able to Get to Clinic|0|||
149159022|NCT01928381|538058434|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
149159023|NCT01928381|538058435|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149159024|NCT01928381|538058436|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149159025|NCT01928381|538058437|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149159026|NCT01928381|538058438|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149159027|NCT01928381|538058439|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149159028|NCT01928381|538058440|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
149159029|NCT01928381|538058434|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
149159030|NCT01928381|538058435|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
149159031|NCT01928381|538058436|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
149159032|NCT01928381|538058437|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
149159033|NCT01928381|538058438|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
149159034|NCT01928381|538058439|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
149159035|NCT01928381|538058440|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
149159036|NCT01928381|538058434|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
149159037|NCT01928381|538058435|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
149159038|NCT01928381|538058436|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
149159039|NCT01928381|538058437|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
149159040|NCT01928381|538058438|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
149159041|NCT01928381|538058439|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
149159042|NCT01928381|538058440|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
149159043|NCT01928381|538058434|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
149159044|NCT01928381|538058435|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
149159045|NCT01928381|538058436|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
149159046|NCT01928381|538058437|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
149159047|NCT01928381|538058438|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
149159048|NCT01928381|538058439|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
149159049|NCT01928381|538058440|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
149159050|NCT01928381|538058434|FG000|Part 1 - Pain Training|Protocol Violation|1|||
149159051|NCT01928381|538058435|FG001|Part 1 - Pain Training|Protocol Violation|0|||
149159052|NCT01928381|538058436|FG002|Part 1 - Pain Training|Protocol Violation|0|||
149159053|NCT01928381|538058437|FG003|Part 1 - Pain Training|Protocol Violation|0|||
149159054|NCT01928381|538058438|FG004|Part 1 - Pain Training|Protocol Violation|0|||
149159055|NCT01928381|538058439|FG005|Part 1 - Pain Training|Protocol Violation|0|||
149159056|NCT01928381|538058440|FG006|Part 1 - Pain Training|Protocol Violation|0|||
149159057|NCT01928381|538058434|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
149159058|NCT01928381|538058435|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149159059|NCT01928381|538058436|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149159060|NCT01928381|538058437|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149159061|NCT01928381|538058438|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149159062|NCT01928381|538058439|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149159063|NCT01928381|538058440|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
149159064|NCT01928381|538058434|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
149159065|NCT01928381|538058435|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149159066|NCT01928381|538058436|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149159067|NCT01928381|538058437|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149159068|NCT01928381|538058438|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149159069|NCT01928381|538058439|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149159070|NCT01928381|538058440|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
149159071|NCT01928381|538058434|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
149159072|NCT01928381|538058435|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149159073|NCT01928381|538058436|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149159074|NCT01928381|538058437|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149159075|NCT01928381|538058438|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149159076|NCT01928381|538058439|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149159077|NCT01928381|538058440|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
149159078|NCT01928381|538058434|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
149159079|NCT01928381|538058435|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149159080|NCT01928381|538058436|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149159081|NCT01928381|538058437|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149159082|NCT01928381|538058438|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149159083|NCT01928381|538058439|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149159084|NCT01928381|538058440|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
149159085|NCT01928381|538058434|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
149159086|NCT01928381|538058435|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
149159087|NCT01928381|538058436|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
149159088|NCT01928381|538058437|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
149159089|NCT01928381|538058438|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
149159090|NCT01928381|538058439|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
149159091|NCT01928381|538058440|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
149159092|NCT01928381|538058434|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149159093|NCT01928381|538058435|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149159094|NCT01928381|538058436|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
149159095|NCT01928381|538058437|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149159096|NCT01928381|538058438|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149159097|NCT01928381|538058439|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149159098|NCT01928381|538058440|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
149159099|NCT01928381|538058434|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
149159100|NCT01928381|538058435|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
149159101|NCT01928381|538058436|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
149159102|NCT01928381|538058437|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
149159103|NCT01928381|538058438|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
149159104|NCT01928381|538058439|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
149159105|NCT01928381|538058440|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
149159106|NCT01928381|538058434|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
149159107|NCT01928381|538058435|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
149159108|NCT01928381|538058436|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
149159109|NCT01928381|538058437|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
149159110|NCT01928381|538058438|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
149159111|NCT01928381|538058439|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
149159112|NCT01928381|538058440|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
149159113|NCT01928381|538058434|FG000|Washout First Intervention|Protocol Violation|0|||
149159114|NCT01928381|538058435|FG001|Washout First Intervention|Protocol Violation|0|||
149159115|NCT01928381|538058436|FG002|Washout First Intervention|Protocol Violation|0|||
149159116|NCT01928381|538058437|FG003|Washout First Intervention|Protocol Violation|0|||
149159117|NCT01928381|538058438|FG004|Washout First Intervention|Protocol Violation|1|||
149159118|NCT01928381|538058439|FG005|Washout First Intervention|Protocol Violation|0|||
149159119|NCT01928381|538058440|FG006|Washout First Intervention|Protocol Violation|0|||
149159120|NCT01928381|538058434|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
149159121|NCT01928381|538058435|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
149159122|NCT01928381|538058436|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
149159123|NCT01928381|538058437|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
149159124|NCT01928381|538058438|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
149159125|NCT01928381|538058439|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
149159126|NCT01928381|538058440|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
149159127|NCT01928381|538058434|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
149159128|NCT01928381|538058435|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
149159129|NCT01928381|538058436|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
149159130|NCT01928381|538058437|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
149159131|NCT01928381|538058438|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
149159132|NCT01928381|538058439|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
149159133|NCT01928381|538058440|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
149159134|NCT03406897|538058441|FG000|Overall Study|Lost to Follow-up|1|||
149159135|NCT03406897|538058442|FG001|Overall Study|Lost to Follow-up|2|||
149159136|NCT03406897|538058441|FG000|Overall Study|Withdrawal by Subject|4|||
149159137|NCT03406897|538058442|FG001|Overall Study|Withdrawal by Subject|4|||
149159138|NCT03406897|538058441|FG000|Overall Study|Physician Decision|0|||
149159139|NCT03406897|538058442|FG001|Overall Study|Physician Decision|1|||
149159140|NCT04484285|538059589|FG000|Overall Study|Unable to operate stimulator|3|||
149159141|NCT04484285|538059590|FG001|Overall Study|Unable to operate stimulator|0|||
149159142|NCT01227902|538059592|FG000|Overall Study|Adverse Event|12|||
149159143|NCT01227902|538059593|FG001|Overall Study|Adverse Event|8|||
149159144|NCT01227902|538059594|FG002|Overall Study|Adverse Event|11|||
149159145|NCT01227902|538059595|FG003|Overall Study|Adverse Event|4|||
149159146|NCT01227902|538059592|FG000|Overall Study|Lack of Efficacy|1|||
149159147|NCT01227902|538059593|FG001|Overall Study|Lack of Efficacy|2|||
149159148|NCT01227902|538059594|FG002|Overall Study|Lack of Efficacy|2|||
149159149|NCT01227902|538059595|FG003|Overall Study|Lack of Efficacy|1|||
149159150|NCT01227902|538059592|FG000|Overall Study|Protocol Violation|1|||
149159151|NCT01227902|538059593|FG001|Overall Study|Protocol Violation|0|||
149159152|NCT01227902|538059594|FG002|Overall Study|Protocol Violation|0|||
149159153|NCT01227902|538059595|FG003|Overall Study|Protocol Violation|0|||
149159154|NCT01227902|538059592|FG000|Overall Study|Lost to Follow-up|0|||
149159155|NCT01227902|538059593|FG001|Overall Study|Lost to Follow-up|0|||
149159156|NCT01227902|538059594|FG002|Overall Study|Lost to Follow-up|1|||
149159157|NCT01227902|538059595|FG003|Overall Study|Lost to Follow-up|2|||
149159158|NCT01227902|538059592|FG000|Overall Study|Physician Decision|0|||
149159159|NCT01227902|538059593|FG001|Overall Study|Physician Decision|1|||
149159160|NCT01227902|538059594|FG002|Overall Study|Physician Decision|1|||
149159161|NCT01227902|538059595|FG003|Overall Study|Physician Decision|0|||
149159162|NCT01227902|538059592|FG000|Overall Study|Withdrawal by Subject|4|||
149159163|NCT01227902|538059593|FG001|Overall Study|Withdrawal by Subject|2|||
149159164|NCT01227902|538059594|FG002|Overall Study|Withdrawal by Subject|4|||
149159165|NCT01227902|538059595|FG003|Overall Study|Withdrawal by Subject|3|||
149159166|NCT05280756|538059596|FG000|Overall Study|Lost to Follow-up|1|||
149159167|NCT05280756|538059597|FG001|Overall Study|Lost to Follow-up|1|||
149159168|NCT02363478|538059598|FG000|Overall Study|Lost to Follow-up|4|||
148673684|NCT01306968|536275842|FG003|Overall Study|Physician Decision|0|||
148673685|NCT01306968|536275839|FG000|Overall Study|Relocated and left active duty|0|||
148673686|NCT01306968|536275840|FG001|Overall Study|Relocated and left active duty|1|||
148673687|NCT01306968|536275841|FG002|Overall Study|Relocated and left active duty|1|||
148924394|NCT00584740|537207896|FG001|Overall Study|Adverse Event|1|||
148924395|NCT00584740|537207895|FG000|Overall Study|Lack of Efficacy|8|||
148924396|NCT00584740|537207896|FG001|Overall Study|Lack of Efficacy|2|||
148924397|NCT00584740|537207895|FG000|Overall Study|Withdrawal by Subject|3|||
148924398|NCT00584740|537207896|FG001|Overall Study|Withdrawal by Subject|2|||
148924399|NCT00584740|537207895|FG000|Overall Study|Lost to Follow-up|0|||
149159169|NCT02363478|538059598|FG000|Overall Study|Adverse Event|4|||
149159170|NCT00768898|538059599|FG000|Overall Study|Unrelated injury|1|||
149159171|NCT00768898|538059599|FG000|Overall Study|Headache|1|||
149012848|NCT01468922|537525821|FG008|Overall Study|Adverse Event|0|||
149159172|NCT02527707|538059600|FG000|Overall Study|Adverse Event|1|||
149159173|NCT02527707|538059600|FG000|Overall Study|Adverse Event|1|||
149159174|NCT00930059|538059601|FG000|Overall Study|Death|1|||
149159175|NCT00930059|538059602|FG001|Overall Study|Death|0|||
149159176|NCT00930059|538059601|FG000|Overall Study|Did not meet entrance criteria|1|||
149159177|NCT00930059|538059602|FG001|Overall Study|Did not meet entrance criteria|1|||
149159178|NCT00930059|538059601|FG000|Overall Study|Withdrawal by Subject|3|||
149159179|NCT00930059|538059602|FG001|Overall Study|Withdrawal by Subject|4|||
149159180|NCT00930059|538059601|FG000|Overall Study|Other|1|||
149159181|NCT00930059|538059602|FG001|Overall Study|Other|0|||
149159182|NCT00930059|538059601|FG000|Overall Study|1 site terminated by sponsor|1|||
149159183|NCT00930059|538059602|FG001|Overall Study|1 site terminated by sponsor|1|||
149159184|NCT00930059|538059601|FG000|Overall Study|Adverse Event|1|||
149159185|NCT00930059|538059602|FG001|Overall Study|Adverse Event|6|||
149159186|NCT01299766|538059603|FG000|Overall Study|Death|5|||
149159187|NCT01299766|538059604|FG001|Overall Study|Death|4|||
149159188|NCT01299766|538059603|FG000|Overall Study|Withdrawal by Subject|29|||
149159189|NCT01299766|538059604|FG001|Overall Study|Withdrawal by Subject|19|||
149159190|NCT04002310|538059605|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
149159191|NCT04002310|538059606|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
149159192|NCT04002310|538059607|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
149159193|NCT04002310|538059608|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
149159194|NCT04002310|538059609|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
149159195|NCT00542997|538059610|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
149159196|NCT00542997|538059610|FG000|Wash in / Wash Out Period|Adverse Event|3|||
149159197|NCT00542997|538059610|FG000|Efficacy Period|Adverse Event|3|||
149159198|NCT00352534|538059611|FG000|Initial Staging|Ineligible|8|||
149159199|NCT00352534|538059612|FG001|Initial Staging|Ineligible|9|||
149159200|NCT00352534|538059613|FG002|Initial Staging|Ineligible|0|||
149159201|NCT00352534|538059614|FG003|Initial Staging|Ineligible|0|||
149159202|NCT00352534|538059615|FG004|Initial Staging|Ineligible|0|||
149159203|NCT00352534|538059616|FG005|Initial Staging|Ineligible|0|||
149159204|NCT00352534|538059617|FG006|Initial Staging|Ineligible|0|||
149159205|NCT00352534|538059611|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
149159206|NCT00352534|538059612|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
149159207|NCT00352534|538059613|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
149159208|NCT00352534|538059614|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
149159209|NCT00352534|538059615|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
149159210|NCT00352534|538059616|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
149159211|NCT00352534|538059617|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
149159212|NCT00352534|538059611|FG000|Final Risk Group Assignment|Physician Decision|0|||
149159213|NCT00352534|538059612|FG001|Final Risk Group Assignment|Physician Decision|0|||
149159214|NCT00352534|538059613|FG002|Final Risk Group Assignment|Physician Decision|0|||
148673688|NCT01306968|536275842|FG003|Overall Study|Relocated and left active duty|1|||
148673689|NCT01306968|536275839|FG000|Overall Study|Withdrew - time commitment|0|||
149159215|NCT00352534|538059614|FG003|Final Risk Group Assignment|Physician Decision|0|||
149159216|NCT00352534|538059615|FG004|Final Risk Group Assignment|Physician Decision|0|||
149159217|NCT00352534|538059616|FG005|Final Risk Group Assignment|Physician Decision|8|||
148924400|NCT00584740|537207896|FG001|Overall Study|Lost to Follow-up|1|||
148924401|NCT01673282|537207898|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
149012849|NCT01468922|537525813|FG000|Overall Study|Infection of blood|0|||
149159218|NCT00352534|538059617|FG006|Final Risk Group Assignment|Physician Decision|0|||
149159219|NCT00352534|538059611|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
149159220|NCT00352534|538059612|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
149159221|NCT00352534|538059613|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
149159222|NCT00352534|538059614|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
149159223|NCT00352534|538059615|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
149159224|NCT00352534|538059616|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
149159225|NCT00352534|538059617|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
149159226|NCT00352534|538059611|FG000|Final Risk Group Assignment|Ineligible|0|||
149159227|NCT00352534|538059612|FG001|Final Risk Group Assignment|Ineligible|0|||
149159228|NCT00352534|538059613|FG002|Final Risk Group Assignment|Ineligible|3|||
149159229|NCT00352534|538059614|FG003|Final Risk Group Assignment|Ineligible|1|||
149159230|NCT00352534|538059615|FG004|Final Risk Group Assignment|Ineligible|0|||
149159231|NCT00352534|538059616|FG005|Final Risk Group Assignment|Ineligible|13|||
149159232|NCT00352534|538059617|FG006|Final Risk Group Assignment|Ineligible|0|||
149159233|NCT00352534|538059611|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149159234|NCT00352534|538059612|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149159235|NCT00352534|538059613|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149159236|NCT00352534|538059614|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149159237|NCT00352534|538059615|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149159238|NCT00352534|538059616|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
149159239|NCT00352534|538059617|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
149159240|NCT00352534|538059611|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149159241|NCT00352534|538059612|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149159242|NCT00352534|538059613|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149159243|NCT00352534|538059614|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149159244|NCT00352534|538059615|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149159245|NCT00352534|538059616|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
149159246|NCT00352534|538059617|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
149159247|NCT00352534|538059611|FG000|Final Risk Group Assignment|Death|0|||
149159248|NCT00352534|538059612|FG001|Final Risk Group Assignment|Death|0|||
149159249|NCT00352534|538059613|FG002|Final Risk Group Assignment|Death|0|||
149159250|NCT00352534|538059614|FG003|Final Risk Group Assignment|Death|0|||
149159251|NCT00352534|538059615|FG004|Final Risk Group Assignment|Death|0|||
149159252|NCT00352534|538059616|FG005|Final Risk Group Assignment|Death|2|||
149159253|NCT00352534|538059617|FG006|Final Risk Group Assignment|Death|0|||
149159254|NCT00544869|538059620|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
149159255|NCT00544869|538059621|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
149159256|NCT00544869|538059622|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
149159257|NCT00544869|538059620|FG000|Overall Study|Adverse Event|6|||
149159258|NCT00544869|538059621|FG001|Overall Study|Adverse Event|1|||
149159259|NCT00544869|538059622|FG002|Overall Study|Adverse Event|0|||
149159260|NCT00544869|538059620|FG000|Overall Study|Lack of Efficacy|1|||
149159261|NCT00544869|538059621|FG001|Overall Study|Lack of Efficacy|1|||
149159262|NCT00544869|538059622|FG002|Overall Study|Lack of Efficacy|0|||
149159263|NCT00544869|538059620|FG000|Overall Study|Physician Decision|2|||
149159264|NCT00544869|538059621|FG001|Overall Study|Physician Decision|0|||
149159265|NCT00544869|538059622|FG002|Overall Study|Physician Decision|0|||
149159266|NCT00619502|538059633|FG000|Overall Study|Lost to Follow-up|8|||
149159267|NCT00619502|538059634|FG001|Overall Study|Lost to Follow-up|10|||
149159268|NCT01777763|538059635|FG000|Overall Study|Adverse Event|2|||
149159269|NCT01777763|538059636|FG001|Overall Study|Adverse Event|32|||
149159270|NCT01777763|538059635|FG000|Overall Study|Protocol Violation|1|||
149159271|NCT01777763|538059636|FG001|Overall Study|Protocol Violation|7|||
149159272|NCT01777763|538059635|FG000|Overall Study|Withdrawal by Subject|0|||
148924402|NCT01673282|537207899|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
148924403|NCT01673282|537207898|FG000|Overall Study|Lack of Efficacy|9|||
148924404|NCT01673282|537207899|FG001|Overall Study|Lack of Efficacy|2|||
149159273|NCT01777763|538059636|FG001|Overall Study|Withdrawal by Subject|2|||
149159274|NCT01777763|538059635|FG000|Overall Study|Treatment Failure|1|||
149159275|NCT01777763|538059636|FG001|Overall Study|Treatment Failure|6|||
148924405|NCT01673282|537207898|FG000|Overall Study|Lost to Follow-up|11|||
149159276|NCT03968419|538059637|FG000|Treatment Period|Adverse Event|0|||
149159277|NCT03968419|538059638|FG001|Treatment Period|Adverse Event|0|||
149159278|NCT03968419|538059639|FG002|Treatment Period|Adverse Event|1|||
149159279|NCT03968419|538059637|FG000|Safety Follow-up Period|Death|3|||
149159280|NCT03968419|538059638|FG001|Safety Follow-up Period|Death|2|||
149159281|NCT03968419|538059639|FG002|Safety Follow-up Period|Death|1|||
149159282|NCT03968419|538059637|FG000|Safety Follow-up Period|Subject Decision|2|||
149159283|NCT03968419|538059638|FG001|Safety Follow-up Period|Subject Decision|1|||
148924406|NCT01673282|537207899|FG001|Overall Study|Lost to Follow-up|10|||
149159284|NCT03968419|538059639|FG002|Safety Follow-up Period|Subject Decision|0|||
149159285|NCT00935883|538059642|FG000|Treatment Period|Physician Decision|1|||
149159286|NCT00935883|538059643|FG001|Treatment Period|Physician Decision|0|||
149159287|NCT00935883|538059642|FG000|Treatment Period|Withdrawal by Subject|0|||
149159288|NCT00935883|538059643|FG001|Treatment Period|Withdrawal by Subject|2|||
149159289|NCT01641939|538059646|FG000|Overall Study|Death|90|||
149159290|NCT01641939|538059647|FG001|Overall Study|Death|187|||
149159291|NCT01641939|538059648|FG002|Overall Study|Death|61|||
149159292|NCT01641939|538059646|FG000|Overall Study|Lost to Follow-up|3|||
149159293|NCT01641939|538059647|FG001|Overall Study|Lost to Follow-up|2|||
149159294|NCT01641939|538059648|FG002|Overall Study|Lost to Follow-up|1|||
149159295|NCT01641939|538059646|FG000|Overall Study|Withdrawal by Subject|14|||
149159296|NCT01641939|538059647|FG001|Overall Study|Withdrawal by Subject|11|||
149159297|NCT01641939|538059648|FG002|Overall Study|Withdrawal by Subject|5|||
149159298|NCT01641939|538059646|FG000|Overall Study|Study Terminated by Sponsor|10|||
149159299|NCT01641939|538059647|FG001|Overall Study|Study Terminated by Sponsor|28|||
149159300|NCT01641939|538059648|FG002|Overall Study|Study Terminated by Sponsor|3|||
149159301|NCT02894840|538059649|FG000|Overall Study|Lost to Follow-up|1|||
149159302|NCT02894840|538059650|FG001|Overall Study|Lost to Follow-up|0|||
149159303|NCT02894840|538059651|FG002|Overall Study|Lost to Follow-up|3|||
149159304|NCT02894840|538059652|FG003|Overall Study|Lost to Follow-up|0|||
149159305|NCT00804687|538059656|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
149159306|NCT00804687|538059657|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
149159307|NCT00804687|538059658|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
149159308|NCT00804687|538059659|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
149159309|NCT00804687|538059660|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
149159310|NCT00804687|538059661|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
149159311|NCT00804687|538059656|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
149159312|NCT00804687|538059657|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
149159313|NCT00804687|538059658|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
149159314|NCT00804687|538059659|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
149159315|NCT00804687|538059660|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
149159316|NCT00804687|538059661|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
149159317|NCT00804687|538059656|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
149159318|NCT00804687|538059657|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
149159319|NCT00804687|538059658|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
149159320|NCT00804687|538059659|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
149159321|NCT00804687|538059660|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
149159322|NCT00804687|538059661|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
149159323|NCT00804687|538059656|FG000|Period 5: Treatment Period|Positive drug test|1|||
149012850|NCT01468922|537525814|FG001|Overall Study|Infection of blood|0|||
149159324|NCT00804687|538059657|FG001|Period 5: Treatment Period|Positive drug test|0|||
149159325|NCT00804687|538059658|FG002|Period 5: Treatment Period|Positive drug test|0|||
149159326|NCT00804687|538059659|FG003|Period 5: Treatment Period|Positive drug test|0|||
149159327|NCT00804687|538059660|FG004|Period 5: Treatment Period|Positive drug test|0|||
149159328|NCT00804687|538059661|FG005|Period 5: Treatment Period|Positive drug test|0|||
149159329|NCT02397473|538059667|FG000|Treatment Phase|Adverse Event|1|||
148673690|NCT01306968|536275840|FG001|Overall Study|Withdrew - time commitment|0|||
149159330|NCT02397473|538059668|FG001|Treatment Phase|Adverse Event|2|||
149159331|NCT02397473|538059667|FG000|Treatment Phase|Lack of Efficacy|8|||
148673691|NCT01306968|536275841|FG002|Overall Study|Withdrew - time commitment|0|||
148673692|NCT01306968|536275842|FG003|Overall Study|Withdrew - time commitment|2|||
148673693|NCT01306968|536275839|FG000|Overall Study|Withdrew over privacy concerns|0|||
148673694|NCT01306968|536275840|FG001|Overall Study|Withdrew over privacy concerns|0|||
148673695|NCT01306968|536275841|FG002|Overall Study|Withdrew over privacy concerns|0|||
148673696|NCT01306968|536275842|FG003|Overall Study|Withdrew over privacy concerns|1|||
148673697|NCT01381068|536275843|FG000|Overall Study|Death|1|||
148673698|NCT01381068|536275844|FG001|Overall Study|Death|0|||
148673699|NCT00797316|536275845|FG000|Overall Study|Administrative problems|1|||
148673700|NCT00797316|536275846|FG001|Overall Study|Administrative problems|0|||
148673701|NCT00797316|536275845|FG000|Overall Study|Adverse Event|5|||
148673702|NCT00797316|536275846|FG001|Overall Study|Adverse Event|3|||
148673703|NCT00797316|536275845|FG000|Overall Study|Lost to Follow-up|4|||
148673704|NCT00797316|536275846|FG001|Overall Study|Lost to Follow-up|8|||
149159332|NCT02397473|538059668|FG001|Treatment Phase|Lack of Efficacy|1|||
149159333|NCT02397473|538059667|FG000|Treatment Phase|Lost to Follow-up|1|||
149159334|NCT02397473|538059668|FG001|Treatment Phase|Lost to Follow-up|0|||
149159335|NCT02397473|538059667|FG000|Treatment Phase|Withdrawal by Subject|2|||
149159336|NCT02397473|538059668|FG001|Treatment Phase|Withdrawal by Subject|1|||
149159337|NCT02397473|538059667|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
149159338|NCT02397473|538059668|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
149159339|NCT02397473|538059667|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
149159340|NCT02397473|538059668|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
149159341|NCT02397473|538059667|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
149159342|NCT02397473|538059668|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
149159343|NCT02397473|538059667|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
149159344|NCT02397473|538059668|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
149159345|NCT02397473|538059667|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
149159346|NCT02397473|538059668|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
149159347|NCT01580397|538059669|FG000|Overall Study|Lack of Efficacy|14|||
149159348|NCT01405053|538059672|FG000|Overall Study|Adverse Event|3|||
149159349|NCT01405053|538059673|FG001|Overall Study|Adverse Event|0|||
149159350|NCT01405053|538059672|FG000|Overall Study|Lost to Follow-up|0|||
149159351|NCT01405053|538059673|FG001|Overall Study|Lost to Follow-up|1|||
149159352|NCT01405053|538059672|FG000|Overall Study|Participant choice|2|||
149159353|NCT01405053|538059673|FG001|Overall Study|Participant choice|1|||
149159354|NCT01405053|538059672|FG000|Overall Study|Inadequate therapeutic effect|2|||
149159355|NCT01405053|538059673|FG001|Overall Study|Inadequate therapeutic effect|1|||
149159356|NCT01405053|538059672|FG000|Overall Study|Withdrawal by Subject|3|||
149159357|NCT01405053|538059673|FG001|Overall Study|Withdrawal by Subject|4|||
149159358|NCT01405053|538059672|FG000|Overall Study|Other|0|||
148924407|NCT01673282|537207898|FG000|Overall Study|Withdrawal by Subject|3|||
148924408|NCT01673282|537207899|FG001|Overall Study|Withdrawal by Subject|3|||
148924409|NCT01673282|537207898|FG000|Overall Study|Other|1|||
148924410|NCT01673282|537207899|FG001|Overall Study|Other|6|||
148924411|NCT03485495|537207900|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
149159359|NCT01405053|538059673|FG001|Overall Study|Other|1|||
149159360|NCT00357500|538059687|FG000|Overall Study|Adverse Event|3|||
149159361|NCT00357500|538059687|FG000|Overall Study|Withdrawal by Subject|5|||
149159362|NCT00357500|538059687|FG000|Overall Study|Progressive Disease|65|||
149159363|NCT00357500|538059687|FG000|Overall Study|Not Started Protocol Therapy|4|||
149159364|NCT02301403|538059688|FG000|Overall Study|Withdrawal by Subject|28|||
149159365|NCT02301403|538059689|FG001|Overall Study|Withdrawal by Subject|41|||
149159366|NCT01060059|538059690|FG000|Overall Study|Adverse Event|1|||
149159367|NCT01060059|538059691|FG001|Overall Study|Adverse Event|1|||
149159368|NCT01060059|538059690|FG000|Overall Study|Death|2|||
149159369|NCT01060059|538059691|FG001|Overall Study|Death|3|||
149159370|NCT01060059|538059690|FG000|Overall Study|Lost to Follow-up|18|||
149159371|NCT01060059|538059691|FG001|Overall Study|Lost to Follow-up|34|||
149159372|NCT01060059|538059690|FG000|Overall Study|entry criteria not met|4|||
149159373|NCT01060059|538059691|FG001|Overall Study|entry criteria not met|3|||
149159374|NCT01060059|538059690|FG000|Overall Study|Withdrawal by Subject|35|||
149159375|NCT01060059|538059691|FG001|Overall Study|Withdrawal by Subject|23|||
149159376|NCT01060059|538059690|FG000|Overall Study|lack of glycemic control|2|||
149159377|NCT01060059|538059691|FG001|Overall Study|lack of glycemic control|1|||
149159378|NCT01060059|538059690|FG000|Overall Study|lack of compliance|5|||
149159379|NCT01060059|538059691|FG001|Overall Study|lack of compliance|2|||
149159380|NCT01920711|538059696|FG000|Overall Study|Death|347|||
149159381|NCT01920711|538059697|FG001|Overall Study|Death|356|||
149159382|NCT01920711|538059696|FG000|Overall Study|Lost to Follow-up|13|||
149159383|NCT01920711|538059697|FG001|Overall Study|Lost to Follow-up|14|||
149159384|NCT01920711|538059696|FG000|Overall Study|Withdrawal by Subject|4|||
149159385|NCT01920711|538059697|FG001|Overall Study|Withdrawal by Subject|3|||
149159386|NCT01777581|538059703|FG000|Overall Study|Lost to Follow-up|1|||
149159387|NCT01777581|538059704|FG001|Overall Study|Lost to Follow-up|1|||
149159388|NCT01777581|538059703|FG000|Overall Study|Adverse Event|2|||
149159389|NCT01777581|538059704|FG001|Overall Study|Adverse Event|0|||
149159390|NCT01777581|538059703|FG000|Overall Study|Lack of Efficacy|0|||
149159391|NCT01777581|538059704|FG001|Overall Study|Lack of Efficacy|1|||
149159392|NCT05702736|538059705|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
149159393|NCT05702736|538059706|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
149159394|NCT05702736|538059705|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
149159395|NCT05702736|538059706|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
149159396|NCT02321436|538059707|FG000|Overall Study|Withdrawal by Subject|1|||
149159397|NCT02321436|538059708|FG001|Overall Study|Withdrawal by Subject|0|||
149159398|NCT02321436|538059707|FG000|Overall Study|Lost to Follow-up|0|||
149159399|NCT02321436|538059708|FG001|Overall Study|Lost to Follow-up|1|||
149159400|NCT00546052|538059709|FG000|Overall Study|Adverse Event|47|||
149159401|NCT00546052|538059709|FG000|Overall Study|Lost to Follow-up|144|||
149159402|NCT00546052|538059709|FG000|Overall Study|Protocol Violation|9|||
149159403|NCT00546052|538059709|FG000|Overall Study|Withdrawal by Subject|20|||
149159404|NCT00546052|538059709|FG000|Overall Study|Non Compliance|7|||
149159405|NCT00772668|538059712|FG000|Overall Study|Physician Decision|3|||
149159406|NCT00865020|538059718|FG000|Overall Study|Withdrawal by Subject|22|||
149159407|NCT00865020|538059719|FG001|Overall Study|Withdrawal by Subject|16|||
149159408|NCT00865020|538059718|FG000|Overall Study|Adverse Event|9|||
149159409|NCT00865020|538059719|FG001|Overall Study|Adverse Event|14|||
148924412|NCT03485495|537207901|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
148924413|NCT02915874|537207902|FG000|Overall Study|Lost to Follow-up|5|||
148924414|NCT02915874|537207903|FG001|Overall Study|Lost to Follow-up|4|||
149159410|NCT00865020|538059718|FG000|Overall Study|Abnormal test procedure result(s)|6|||
149159411|NCT00865020|538059719|FG001|Overall Study|Abnormal test procedure result(s)|8|||
149159412|NCT00865020|538059718|FG000|Overall Study|Lost to Follow-up|6|||
149159413|NCT00865020|538059719|FG001|Overall Study|Lost to Follow-up|4|||
149159414|NCT00865020|538059718|FG000|Overall Study|Protocol deviation|4|||
149159415|NCT00865020|538059719|FG001|Overall Study|Protocol deviation|1|||
149159416|NCT00865020|538059718|FG000|Overall Study|Administrative problems|0|||
149159417|NCT00865020|538059719|FG001|Overall Study|Administrative problems|2|||
149159418|NCT00865020|538059718|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149159419|NCT00865020|538059719|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149159420|NCT00865020|538059718|FG000|Overall Study|Death|0|||
149159421|NCT00865020|538059719|FG001|Overall Study|Death|1|||
149159422|NCT00865020|538059718|FG000|Overall Study|Randomized but discontinued|2|||
149159423|NCT00865020|538059719|FG001|Overall Study|Randomized but discontinued|4|||
149159424|NCT00684957|538059720|FG000|Overall Study|Withdrawal by Subject|1|||
149159425|NCT00684957|538059721|FG001|Overall Study|Withdrawal by Subject|1|||
149159426|NCT00684957|538059720|FG000|Overall Study|Lost to Follow-up|1|||
149159427|NCT00684957|538059721|FG001|Overall Study|Lost to Follow-up|0|||
149159428|NCT01001702|538061361|FG000|Overall Study|Lost to Follow-up|7|||
149159429|NCT01001702|538061361|FG000|Overall Study|Adverse Event|7|||
149159430|NCT01001702|538061361|FG000|Overall Study|Sponsor Discontinued Study|4|||
149159431|NCT01001702|538061361|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
149159432|NCT01001702|538061361|FG000|Overall Study|Investigator withdrew Subject|10|||
149159433|NCT01001702|538061361|FG000|Overall Study|Withdrawal by Subject|19|||
149159434|NCT01001702|538061361|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
149159435|NCT02624492|538061364|FG000|Overall Study|Adverse Event|2|||
149159436|NCT02624492|538061365|FG001|Overall Study|Adverse Event|2|||
149159437|NCT02624492|538061366|FG002|Overall Study|Adverse Event|2|||
149159438|NCT02624492|538061364|FG000|Overall Study|Progressive disease|0|||
149159439|NCT02624492|538061365|FG001|Overall Study|Progressive disease|2|||
149159440|NCT02624492|538061366|FG002|Overall Study|Progressive disease|3|||
149159441|NCT01163786|538061369|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
149159442|NCT01163786|538061369|FG000|Treatment With Bortezomib|Adverse Event|2|||
149159443|NCT01163786|538061369|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
149159444|NCT00634569|538061370|FG000|Overall Study|Withdrawal by Subject|0|||
149159445|NCT00634569|538061371|FG001|Overall Study|Withdrawal by Subject|4|||
149159446|NCT00634569|538061370|FG000|Overall Study|Physician Decision|0|||
149159447|NCT00634569|538061371|FG001|Overall Study|Physician Decision|1|||
149159448|NCT01212185|538061372|FG000|Overall Study|Protocol Violation|2|||
149159449|NCT01212185|538061373|FG001|Overall Study|Protocol Violation|1|||
149159450|NCT02167945|538061374|FG000|Overall Study|Adverse Event|16|||
149159451|NCT02167945|538061374|FG000|Overall Study|Withdrew Consent|42|||
149159452|NCT02167945|538061374|FG000|Overall Study|Lost to Follow-up|122|||
149159453|NCT02167945|538061374|FG000|Overall Study|COVID-19 logistical restrictions|6|||
149159454|NCT02167945|538061374|FG000|Overall Study|Other, not specified|63|||
149159455|NCT01192347|538061375|FG000|Overall Study|Death|3|||
149159456|NCT01192347|538061375|FG000|Overall Study|Lost to Follow-up|3|||
149159457|NCT01192347|538061375|FG000|Overall Study|Withdrawal by Subject|1|||
149159458|NCT01192347|538061375|FG000|Overall Study|Adverse Event|1|||
149159459|NCT01192347|538061375|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
149159460|NCT01192347|538061375|FG000|Overall Study|Patient seen in different hospital|1|||
149159461|NCT01192347|538061375|FG000|Overall Study|Patient not visiting hospital regularly|1|||
149159462|NCT01192347|538061375|FG000|Overall Study|Patient did not show up for visits|1|||
149159463|NCT02623335|538061376|FG000|Overall Study|Death|8|||
149159464|NCT02623335|538061377|FG001|Overall Study|Death|7|||
149159465|NCT02623335|538061376|FG000|Overall Study|Lost to Follow-up|15|||
149159466|NCT02623335|538061377|FG001|Overall Study|Lost to Follow-up|23|||
149159467|NCT02623335|538061376|FG000|Overall Study|Withdrawal by Subject|2|||
149159468|NCT02623335|538061377|FG001|Overall Study|Withdrawal by Subject|5|||
149159469|NCT02623335|538061376|FG000|Overall Study|Protocol Violation|2|||
149159470|NCT02623335|538061377|FG001|Overall Study|Protocol Violation|1|||
149159471|NCT00395967|538061378|FG000|Treatment Period|Failed Mobilization|1|||
149159472|NCT00395967|538061378|FG000|Follow-up Period|Death|1|||
149159473|NCT00395967|538061378|FG000|Follow-up Period|Lost to Follow-up|1|||
149159474|NCT02400255|538061379|FG000|Overall Study|Relapse|4|||
149159475|NCT02400255|538061380|FG001|Overall Study|Relapse|1|||
149159476|NCT02400255|538061381|FG002|Overall Study|Relapse|1|||
149159477|NCT02400255|538061382|FG003|Overall Study|Relapse|2|||
149159478|NCT02400255|538061379|FG000|Overall Study|Adverse Event|6|||
149159479|NCT02400255|538061380|FG001|Overall Study|Adverse Event|3|||
149159480|NCT02400255|538061381|FG002|Overall Study|Adverse Event|0|||
149159481|NCT02400255|538061382|FG003|Overall Study|Adverse Event|0|||
149159482|NCT02400255|538061379|FG000|Overall Study|Physician Decision|6|||
149159483|NCT02400255|538061380|FG001|Overall Study|Physician Decision|0|||
149159484|NCT02400255|538061381|FG002|Overall Study|Physician Decision|0|||
148924415|NCT02915874|537207902|FG000|Overall Study|Withdrawal by Subject|1|||
148924416|NCT02915874|537207903|FG001|Overall Study|Withdrawal by Subject|1|||
148924417|NCT02915874|537207902|FG000|Overall Study|Started New Anxiety Medication|0|||
148924418|NCT02915874|537207903|FG001|Overall Study|Started New Anxiety Medication|1|||
148924419|NCT05318183|537207905|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
148924420|NCT05318183|537207906|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
148924421|NCT05318183|537207905|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
148924422|NCT05318183|537207906|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148924423|NCT05318183|537207905|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
148924424|NCT05318183|537207906|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
148924425|NCT05318183|537207905|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
148924426|NCT05318183|537207906|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
148924427|NCT06400251|537207908|FG000|Overall Study|Never Start Protocol Therapy|1|||
148924428|NCT06400251|537207908|FG000|Overall Study|Ineligible|2|||
148924429|NCT06400251|537207908|FG000|Overall Study|Mutation Status Not Confirmed|3|||
148924430|NCT06400251|537207908|FG000|Overall Study|Disease Progression|25|||
148924431|NCT06400251|537207908|FG000|Overall Study|Adverse Event|1|||
148924432|NCT06400251|537207908|FG000|Overall Study|Complicating Disease|1|||
148924433|NCT06400251|537207908|FG000|Overall Study|Physician Decision|2|||
148924434|NCT01150474|537207909|FG000|Overall Study|Withdrawal by Subject|5|||
148924435|NCT01150474|537207910|FG001|Overall Study|Withdrawal by Subject|2|||
148924436|NCT01150474|537207909|FG000|Overall Study|Cancer found|1|||
148924437|NCT01150474|537207910|FG001|Overall Study|Cancer found|0|||
148924438|NCT01150474|537207909|FG000|Overall Study|Multiple Studies|0|||
148924439|NCT01150474|537207910|FG001|Overall Study|Multiple Studies|1|||
148924440|NCT01150474|537207909|FG000|Overall Study|Rectotomy|1|||
148924441|NCT01150474|537207910|FG001|Overall Study|Rectotomy|0|||
148924442|NCT01150474|537207909|FG000|Overall Study|Drug did not arrive in time|1|||
148924443|NCT01150474|537207910|FG001|Overall Study|Drug did not arrive in time|0|||
148924444|NCT01150474|537207909|FG000|Overall Study|Drug not administered|1|||
148924445|NCT01150474|537207910|FG001|Overall Study|Drug not administered|0|||
148924446|NCT01150474|537207909|FG000|Overall Study|Surgery Changed|1|||
148924447|NCT01150474|537207910|FG001|Overall Study|Surgery Changed|0|||
148924448|NCT02207946|537207911|FG000|Overall Study|Lost to Follow-up|1|||
148924449|NCT02207946|537207912|FG001|Overall Study|Lost to Follow-up|0|||
148924450|NCT02207946|537207911|FG000|Overall Study|Adverse Event|0|||
148924451|NCT02207946|537207912|FG001|Overall Study|Adverse Event|1|||
148924452|NCT04214288|537208536|FG000|Overall Study|Ongoing in the study|41|||
148924453|NCT04214288|537208537|FG001|Overall Study|Ongoing in the study|51|||
148924454|NCT04214288|537208538|FG002|Overall Study|Ongoing in the study|12|||
148924455|NCT04214288|537208539|FG003|Overall Study|Ongoing in the study|39|||
148924456|NCT04214288|537208536|FG000|Overall Study|Adverse Event|1|||
148924457|NCT04214288|537208537|FG001|Overall Study|Adverse Event|0|||
148924458|NCT04214288|537208538|FG002|Overall Study|Adverse Event|0|||
148924459|NCT04214288|537208539|FG003|Overall Study|Adverse Event|0|||
148924460|NCT04214288|537208536|FG000|Overall Study|Death|22|||
148673705|NCT00797316|536275845|FG000|Overall Study|Protocol Deviation|1|||
148924461|NCT04214288|537208537|FG001|Overall Study|Death|13|||
148924462|NCT04214288|537208538|FG002|Overall Study|Death|7|||
148924463|NCT04214288|537208539|FG003|Overall Study|Death|19|||
148924464|NCT04214288|537208536|FG000|Overall Study|Lost to Follow-up|1|||
148924465|NCT04214288|537208537|FG001|Overall Study|Lost to Follow-up|2|||
148924466|NCT04214288|537208538|FG002|Overall Study|Lost to Follow-up|1|||
148924467|NCT04214288|537208539|FG003|Overall Study|Lost to Follow-up|0|||
148924468|NCT04214288|537208536|FG000|Overall Study|Other|1|||
148924469|NCT04214288|537208537|FG001|Overall Study|Other|2|||
148924470|NCT04214288|537208538|FG002|Overall Study|Other|0|||
148924471|NCT04214288|537208539|FG003|Overall Study|Other|6|||
148924472|NCT04214288|537208536|FG000|Overall Study|Protocol Violation|0|||
148924473|NCT04214288|537208537|FG001|Overall Study|Protocol Violation|1|||
148924474|NCT04214288|537208538|FG002|Overall Study|Protocol Violation|0|||
148924475|NCT04214288|537208539|FG003|Overall Study|Protocol Violation|0|||
148924476|NCT04214288|537208536|FG000|Overall Study|Withdrawal by Subject|8|||
148924477|NCT04214288|537208537|FG001|Overall Study|Withdrawal by Subject|4|||
148924478|NCT04214288|537208538|FG002|Overall Study|Withdrawal by Subject|0|||
148924479|NCT04214288|537208539|FG003|Overall Study|Withdrawal by Subject|9|||
148924480|NCT00807027|537208540|FG000|Overall Study|Withdrawal by Subject|13|||
149159485|NCT02400255|538061382|FG003|Overall Study|Physician Decision|0|||
149159486|NCT02400255|538061379|FG000|Overall Study|Loss of insurance|1|||
149159487|NCT02400255|538061380|FG001|Overall Study|Loss of insurance|0|||
149159488|NCT02400255|538061381|FG002|Overall Study|Loss of insurance|0|||
148673706|NCT00797316|536275846|FG001|Overall Study|Protocol Deviation|2|||
148673707|NCT00797316|536275845|FG000|Overall Study|Patient withdrew consent|12|||
148673708|NCT00797316|536275846|FG001|Overall Study|Patient withdrew consent|6|||
148673709|NCT00797316|536275845|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148673710|NCT00797316|536275846|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
148673711|NCT00690573|536275856|FG000|Overall Study|Lack of Efficacy|8|||
148673712|NCT00690573|536275856|FG000|Overall Study|Withdrawal by Subject|1|||
148673713|NCT01126359|536275859|FG000|First Intervention (20-minutes)|Physician Decision|0|||
148673714|NCT01126359|536275860|FG001|First Intervention (20-minutes)|Physician Decision|1|||
148673715|NCT00902486|536275861|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
148673716|NCT00902486|536275862|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
148673717|NCT00902486|536275863|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
148673718|NCT00902486|536275864|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
148673719|NCT00902486|536275865|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
148673720|NCT00902486|536275866|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
148673721|NCT00902486|536275861|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
148673722|NCT00902486|536275862|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
148673723|NCT00902486|536275863|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
148673724|NCT00902486|536275864|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
148673725|NCT00902486|536275865|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
148673726|NCT00902486|536275866|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
148673727|NCT00902486|536275861|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
148673728|NCT00902486|536275862|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
148673729|NCT00902486|536275863|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
148673730|NCT00902486|536275864|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
148673731|NCT00902486|536275865|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
148673732|NCT00902486|536275866|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
148673733|NCT00902486|536275861|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
148673734|NCT00902486|536275862|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
148673735|NCT00902486|536275863|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
148673736|NCT00902486|536275864|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
148673737|NCT00902486|536275865|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
148673738|NCT00902486|536275866|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
148673739|NCT00902486|536275861|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
148673740|NCT00902486|536275862|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
148673741|NCT00902486|536275863|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
148673742|NCT00902486|536275864|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
148673743|NCT00902486|536275865|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
148673744|NCT00902486|536275866|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
148673745|NCT00902486|536275861|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
148673746|NCT00902486|536275862|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
148673747|NCT00902486|536275863|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
148673748|NCT00902486|536275864|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
148673749|NCT00902486|536275865|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
148673750|NCT00902486|536275866|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
148673751|NCT00902486|536275861|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
148673752|NCT00902486|536275862|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
148673753|NCT00902486|536275863|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
148673754|NCT00902486|536275864|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
148673755|NCT00902486|536275865|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
148805990|NCT05911841|536768047|FG003|Maintenance Period|Withdrawal by Subject|0|||
148805991|NCT05911841|536768048|FG004|Maintenance Period|Withdrawal by Subject|0|||
148805992|NCT05911841|536768049|FG005|Maintenance Period|Withdrawal by Subject|1|||
148805993|NCT05911841|536768050|FG006|Maintenance Period|Withdrawal by Subject|0|||
148805994|NCT05911841|536768051|FG007|Maintenance Period|Withdrawal by Subject|1|||
148924481|NCT00807027|537208541|FG001|Overall Study|Withdrawal by Subject|14|||
148924482|NCT00807027|537208540|FG000|Overall Study|Protocol Violation|1|||
148924483|NCT00807027|537208541|FG001|Overall Study|Protocol Violation|1|||
148924484|NCT00807027|537208540|FG000|Overall Study|Adverse Event|2|||
148924485|NCT00807027|537208541|FG001|Overall Study|Adverse Event|2|||
149159489|NCT02400255|538061382|FG003|Overall Study|Loss of insurance|0|||
149159490|NCT02568046|538061383|FG000|Overall Study|Adverse Event|0|||
149159491|NCT02568046|538061384|FG001|Overall Study|Adverse Event|1|||
149159492|NCT02568046|538061383|FG000|Overall Study|Death|2|||
149159493|NCT02568046|538061384|FG001|Overall Study|Death|0|||
148924486|NCT03997383|537208542|FG000|Double-blind Treatment Period|Adverse Event|4|||
148924487|NCT03997383|537208543|FG001|Double-blind Treatment Period|Adverse Event|3|||
148924488|NCT03997383|537208542|FG000|Double-blind Treatment Period|Death|4|||
148924489|NCT03997383|537208543|FG001|Double-blind Treatment Period|Death|4|||
148924490|NCT03997383|537208542|FG000|Double-blind Treatment Period|Physician Decision|2|||
148924491|NCT03997383|537208543|FG001|Double-blind Treatment Period|Physician Decision|0|||
148924492|NCT03997383|537208542|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
148924493|NCT03997383|537208543|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
148924494|NCT03997383|537208542|FG000|Open-label Extension Period|Ongoing|148|||
148924495|NCT03997383|537208543|FG001|Open-label Extension Period|Ongoing|151|||
148924496|NCT03997383|537208542|FG000|Open-label Extension Period|Adverse Event|4|||
148924497|NCT03997383|537208543|FG001|Open-label Extension Period|Adverse Event|1|||
148924498|NCT03997383|537208542|FG000|Open-label Extension Period|Death|8|||
148924499|NCT03997383|537208543|FG001|Open-label Extension Period|Death|9|||
148924500|NCT03997383|537208542|FG000|Open-label Extension Period|Physician Decision|1|||
148924501|NCT03997383|537208543|FG001|Open-label Extension Period|Physician Decision|1|||
148924502|NCT03997383|537208542|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
148924503|NCT03997383|537208543|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
148924504|NCT03997383|537208542|FG000|Open-label Extension Period|Reason Not Specified|2|||
148924505|NCT03997383|537208543|FG001|Open-label Extension Period|Reason Not Specified|0|||
148924507|NCT00924781|537208545|FG000|Overall Study|Study terminated by sponsor|12|||
148924508|NCT00924781|537208546|FG001|Overall Study|Study terminated by sponsor|10|||
148924509|NCT02554279|537208547|FG000|Overall Study|Adverse Event|2|||
148924510|NCT02554279|537208548|FG001|Overall Study|Adverse Event|5|||
148924511|NCT02554279|537208547|FG000|Overall Study|Lost to Follow-up|3|||
148924512|NCT02554279|537208548|FG001|Overall Study|Lost to Follow-up|2|||
148924513|NCT02554279|537208547|FG000|Overall Study|Withdrawal by Subject|6|||
148924514|NCT02554279|537208548|FG001|Overall Study|Withdrawal by Subject|4|||
148924515|NCT02554279|537208547|FG000|Overall Study|Protocol Violation|2|||
148924516|NCT02554279|537208548|FG001|Overall Study|Protocol Violation|1|||
148924517|NCT02554279|537208547|FG000|Overall Study|Other reason|19|||
148924518|NCT02554279|537208548|FG001|Overall Study|Other reason|6|||
148924519|NCT00812487|537208549|FG000|Overall Study|Lost to Follow-up|2|||
148924520|NCT00812487|537208550|FG001|Overall Study|Lost to Follow-up|0|||
148924521|NCT00812487|537208549|FG000|Overall Study|Withdrawal by Subject|3|||
148924522|NCT00812487|537208550|FG001|Overall Study|Withdrawal by Subject|2|||
148924523|NCT00812487|537208549|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
148924524|NCT00812487|537208550|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
148924525|NCT00812487|537208549|FG000|Overall Study|Protocol Violation|0|||
148924526|NCT00812487|537208550|FG001|Overall Study|Protocol Violation|1|||
148924527|NCT01117792|537208551|FG000|Overall Study|Death|1|||
148924528|NCT01117792|537208551|FG000|Overall Study|Adverse Event|3|||
148924529|NCT05867342|537208552|FG000|Overall Study|Investigator Decision|3|||
148924530|NCT05867342|537208553|FG001|Overall Study|Investigator Decision|3|||
148924531|NCT01163032|537208554|FG000|Randomization Phase|Withdrawal by Subject|2|||
148924532|NCT01163032|537208555|FG001|Randomization Phase|Withdrawal by Subject|3|||
148924533|NCT01163032|537208556|FG002|Randomization Phase|Withdrawal by Subject|0|||
148924534|NCT01163032|537208554|FG000|Randomization Phase|Adverse Event|3|||
148924535|NCT01163032|537208555|FG001|Randomization Phase|Adverse Event|3|||
148924536|NCT01163032|537208556|FG002|Randomization Phase|Adverse Event|0|||
148924537|NCT01163032|537208554|FG000|Randomization Phase|Protocol Violation|0|||
148924538|NCT01163032|537208555|FG001|Randomization Phase|Protocol Violation|1|||
148924539|NCT01163032|537208556|FG002|Randomization Phase|Protocol Violation|0|||
148924540|NCT01163032|537208554|FG000|Randomization Phase|Various*|5|||
148924541|NCT01163032|537208555|FG001|Randomization Phase|Various*|4|||
148924542|NCT01163032|537208556|FG002|Randomization Phase|Various*|0|||
149159494|NCT02568046|538061383|FG000|Overall Study|Progressive Disease|1|||
149159495|NCT02568046|538061384|FG001|Overall Study|Progressive Disease|0|||
148924543|NCT01163032|537208554|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
148924544|NCT01163032|537208555|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
148924545|NCT01163032|537208556|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
148924546|NCT01163032|537208554|FG000|Open Label Extension Phase|Adverse Event|0|||
148924547|NCT01163032|537208555|FG001|Open Label Extension Phase|Adverse Event|0|||
148924548|NCT01163032|537208556|FG002|Open Label Extension Phase|Adverse Event|3|||
148924549|NCT01163032|537208554|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
148924550|NCT01163032|537208555|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
148924551|NCT01163032|537208556|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
148924552|NCT01163032|537208554|FG000|Open Label Extension Phase|Protocol Violation|0|||
148924553|NCT01163032|537208555|FG001|Open Label Extension Phase|Protocol Violation|0|||
148924554|NCT01163032|537208556|FG002|Open Label Extension Phase|Protocol Violation|1|||
148924555|NCT01163032|537208554|FG000|Open Label Extension Phase|Study Termination|0|||
148924556|NCT01163032|537208555|FG001|Open Label Extension Phase|Study Termination|0|||
148924557|NCT01163032|537208556|FG002|Open Label Extension Phase|Study Termination|7|||
148924558|NCT01163032|537208554|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
148924559|NCT01163032|537208555|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
148924560|NCT01163032|537208556|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
148924561|NCT02751931|537208557|FG000|Overall Study|Adverse Event|3|||
148924562|NCT02751931|537208558|FG001|Overall Study|Adverse Event|0|||
148924563|NCT02751931|537208557|FG000|Overall Study|Other: Miscelleneous|10|||
148924564|NCT02751931|537208558|FG001|Overall Study|Other: Miscelleneous|8|||
148924565|NCT03473548|537208564|FG000|Overall Study|Did not attempt HST testing|3|||
148924566|NCT03473548|537208565|FG001|Overall Study|Did not attempt HST testing|0|||
148924567|NCT01986933|537208572|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
148924568|NCT01986933|537208573|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
148924569|NCT01986933|537208574|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
148924570|NCT01986933|537208575|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
148924571|NCT01986933|537208576|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
148924572|NCT01986933|537208572|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
148924573|NCT01986933|537208573|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
148924574|NCT01986933|537208574|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
148924575|NCT01986933|537208575|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
148924576|NCT01986933|537208576|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
148924577|NCT01986933|537208572|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
148924578|NCT01986933|537208573|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
148924579|NCT01986933|537208574|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
148924580|NCT01986933|537208575|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
148924581|NCT01986933|537208576|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
148924582|NCT01986933|537208572|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
148924583|NCT01986933|537208573|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
148924584|NCT01986933|537208574|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
148924585|NCT01986933|537208575|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
148924586|NCT01986933|537208576|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
148924587|NCT01986933|537208572|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
148924588|NCT01986933|537208573|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
148924589|NCT01986933|537208574|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
148924590|NCT01986933|537208575|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
148924591|NCT01986933|537208576|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
148924592|NCT01986933|537208572|FG000|Active-to-active (Part B)|Adverse Event|0|||
148924593|NCT01986933|537208573|FG001|Active-to-active (Part B)|Adverse Event|2|||
148924594|NCT01986933|537208574|FG002|Active-to-active (Part B)|Adverse Event|0|||
148924595|NCT01986933|537208575|FG003|Active-to-active (Part B)|Adverse Event|1|||
148924596|NCT01986933|537208576|FG004|Active-to-active (Part B)|Adverse Event|3|||
148924597|NCT01986933|537208572|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
148924598|NCT01986933|537208573|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
148924599|NCT01986933|537208574|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
148924600|NCT01986933|537208575|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
148924601|NCT01986933|537208576|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
148924602|NCT01986933|537208572|FG000|Active-to-active (Part B)|Pregnancy|0|||
148924603|NCT01986933|537208573|FG001|Active-to-active (Part B)|Pregnancy|0|||
148924604|NCT01986933|537208574|FG002|Active-to-active (Part B)|Pregnancy|0|||
148924605|NCT01986933|537208575|FG003|Active-to-active (Part B)|Pregnancy|0|||
148924606|NCT01986933|537208576|FG004|Active-to-active (Part B)|Pregnancy|1|||
148924607|NCT01986933|537208572|FG000|Active-to-active (Part B)|Physician Decision|0|||
148924608|NCT01986933|537208573|FG001|Active-to-active (Part B)|Physician Decision|0|||
148924609|NCT01986933|537208574|FG002|Active-to-active (Part B)|Physician Decision|1|||
148924610|NCT01986933|537208575|FG003|Active-to-active (Part B)|Physician Decision|1|||
148924611|NCT01986933|537208576|FG004|Active-to-active (Part B)|Physician Decision|0|||
149159496|NCT02568046|538061383|FG000|Overall Study|Withdrawal by Subject|2|||
149159497|NCT02568046|538061384|FG001|Overall Study|Withdrawal by Subject|1|||
149159498|NCT02568046|538061383|FG000|Overall Study|Other Events|0|||
149159499|NCT02568046|538061384|FG001|Overall Study|Other Events|1|||
149159500|NCT00523991|538061385|FG000|Overall Study|Adverse Event|6|||
149159501|NCT00523991|538061386|FG001|Overall Study|Adverse Event|5|||
149159502|NCT00523991|538061385|FG000|Overall Study|Protocol Violation|1|||
149159503|NCT00523991|538061386|FG001|Overall Study|Protocol Violation|4|||
148924612|NCT01986933|537208572|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
148924613|NCT01986933|537208573|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
148924614|NCT01986933|537208574|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
148924615|NCT01986933|537208575|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
148924616|NCT01986933|537208576|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
148924617|NCT01986933|537208572|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
148924618|NCT01986933|537208573|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
149159504|NCT00523991|538061385|FG000|Overall Study|Lost to Follow-up|4|||
149159505|NCT00523991|538061386|FG001|Overall Study|Lost to Follow-up|1|||
149159506|NCT00523991|538061385|FG000|Overall Study|Withdrawal by Subject|7|||
148673756|NCT00902486|536275866|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
148673757|NCT00902486|536275861|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
148673758|NCT00902486|536275862|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
148673759|NCT00902486|536275863|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
148673760|NCT00902486|536275864|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
148673761|NCT00902486|536275865|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
148673762|NCT00902486|536275866|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
148673763|NCT00902486|536275861|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
148673764|NCT00902486|536275862|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
148673765|NCT00902486|536275863|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
148673766|NCT00902486|536275864|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
148673767|NCT00902486|536275865|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
148673768|NCT00902486|536275866|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
148673769|NCT00902486|536275861|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
148673770|NCT00902486|536275862|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
148673771|NCT00902486|536275863|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
148673772|NCT00902486|536275864|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
148673773|NCT00902486|536275865|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
148673774|NCT00902486|536275866|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
148673775|NCT00902486|536275861|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
148673776|NCT00902486|536275862|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
148673777|NCT00902486|536275863|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
148673778|NCT00902486|536275864|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
148673779|NCT00902486|536275865|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
148924619|NCT01986933|537208574|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
149159507|NCT00523991|538061386|FG001|Overall Study|Withdrawal by Subject|17|||
149159508|NCT00523991|538061385|FG000|Overall Study|Other reason (not specified)|3|||
149159509|NCT00523991|538061386|FG001|Overall Study|Other reason (not specified)|0|||
149159510|NCT03261531|538061387|FG000|Overall Study|Withdrawal by Subject|4|||
149159511|NCT01700192|538061388|FG000|Overall Study|Adverse Event|73|||
149159512|NCT01700192|538061389|FG001|Overall Study|Adverse Event|18|||
149159513|NCT01700192|538061388|FG000|Overall Study|Lack of Efficacy|1|||
149159514|NCT01700192|538061389|FG001|Overall Study|Lack of Efficacy|0|||
149159515|NCT01700192|538061388|FG000|Overall Study|Lost to Follow-up|42|||
149159516|NCT01700192|538061389|FG001|Overall Study|Lost to Follow-up|29|||
149159517|NCT01700192|538061388|FG000|Overall Study|Noncompliance with study drug|0|||
149159518|NCT01700192|538061389|FG001|Overall Study|Noncompliance with study drug|5|||
148805995|NCT05911841|536768052|FG008|Maintenance Period|Withdrawal by Subject|0|||
148805996|NCT05911841|536768053|FG009|Maintenance Period|Withdrawal by Subject|0|||
148805997|NCT05911841|536768044|FG000|Maintenance Period|Adverse Event|0|||
148805998|NCT05911841|536768045|FG001|Maintenance Period|Adverse Event|0|||
148805999|NCT05911841|536768046|FG002|Maintenance Period|Adverse Event|0|||
148806000|NCT05911841|536768047|FG003|Maintenance Period|Adverse Event|0|||
148806001|NCT05911841|536768048|FG004|Maintenance Period|Adverse Event|0|||
148806002|NCT05911841|536768049|FG005|Maintenance Period|Adverse Event|0|||
148924620|NCT01986933|537208575|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
149159519|NCT01700192|538061388|FG000|Overall Study|Physician Decision|2|||
149159520|NCT01700192|538061389|FG001|Overall Study|Physician Decision|3|||
149159521|NCT01700192|538061388|FG000|Overall Study|Pregnancy|1|||
149159522|NCT01700192|538061389|FG001|Overall Study|Pregnancy|4|||
148806003|NCT05911841|536768050|FG006|Maintenance Period|Adverse Event|0|||
148806004|NCT05911841|536768051|FG007|Maintenance Period|Adverse Event|1|||
148806005|NCT05911841|536768052|FG008|Maintenance Period|Adverse Event|0|||
148806006|NCT05911841|536768053|FG009|Maintenance Period|Adverse Event|0|||
148806007|NCT05911841|536768044|FG000|Escape Period|Adverse Event|0|||
148806008|NCT05911841|536768045|FG001|Escape Period|Adverse Event|0|||
148806009|NCT05911841|536768046|FG002|Escape Period|Adverse Event|0|||
148806010|NCT05911841|536768047|FG003|Escape Period|Adverse Event|0|||
148806011|NCT05911841|536768048|FG004|Escape Period|Adverse Event|0|||
148806012|NCT05911841|536768049|FG005|Escape Period|Adverse Event|0|||
148806013|NCT05911841|536768050|FG006|Escape Period|Adverse Event|0|||
148806014|NCT05911841|536768051|FG007|Escape Period|Adverse Event|0|||
148806015|NCT05911841|536768052|FG008|Escape Period|Adverse Event|0|||
148806016|NCT05911841|536768053|FG009|Escape Period|Adverse Event|1|||
148806017|NCT05911841|536768044|FG000|Escape Period|Lack of Efficacy|0|||
148806018|NCT05911841|536768045|FG001|Escape Period|Lack of Efficacy|0|||
148806019|NCT05911841|536768046|FG002|Escape Period|Lack of Efficacy|0|||
148806020|NCT05911841|536768047|FG003|Escape Period|Lack of Efficacy|0|||
148806021|NCT05911841|536768048|FG004|Escape Period|Lack of Efficacy|0|||
149159523|NCT01700192|538061388|FG000|Overall Study|Progressive disease|1|||
149159524|NCT01700192|538061389|FG001|Overall Study|Progressive disease|0|||
149159525|NCT01700192|538061388|FG000|Overall Study|Protocol Violation|3|||
149159526|NCT01700192|538061389|FG001|Overall Study|Protocol Violation|4|||
149159527|NCT01700192|538061388|FG000|Overall Study|Technical problems|0|||
149159528|NCT01700192|538061389|FG001|Overall Study|Technical problems|1|||
149159529|NCT01700192|538061388|FG000|Overall Study|Withdrawal by Subject|56|||
149159530|NCT01700192|538061389|FG001|Overall Study|Withdrawal by Subject|64|||
149159531|NCT01700192|538061388|FG000|Overall Study|Never received study drug|1|||
149159532|NCT01700192|538061389|FG001|Overall Study|Never received study drug|0|||
149159533|NCT00744874|538061391|FG000|Overall Study|Lost to Follow-up|1|||
149159534|NCT00744874|538061391|FG000|Overall Study|Withdrawal by Subject|1|||
149159535|NCT00744874|538061391|FG000|Overall Study|Study Device not available at procedure|1|||
149159536|NCT00744874|538061391|FG000|Overall Study|Unable to accomodate schedule|1|||
149159537|NCT00379795|538061397|FG000|Overall Study|Death|31|||
148806022|NCT05911841|536768049|FG005|Escape Period|Lack of Efficacy|0|||
148806023|NCT05911841|536768050|FG006|Escape Period|Lack of Efficacy|0|||
148806024|NCT05911841|536768051|FG007|Escape Period|Lack of Efficacy|0|||
148806025|NCT05911841|536768052|FG008|Escape Period|Lack of Efficacy|0|||
148806026|NCT05911841|536768053|FG009|Escape Period|Lack of Efficacy|31|||
149159538|NCT00379795|538061398|FG001|Overall Study|Death|8|||
148806027|NCT05911841|536768044|FG000|Escape Period|Lost to Follow-up|0|||
148806028|NCT05911841|536768045|FG001|Escape Period|Lost to Follow-up|0|||
149159539|NCT00379795|538061399|FG002|Overall Study|Death|6|||
148924621|NCT01986933|537208576|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
148924622|NCT01986933|537208572|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
148924623|NCT01986933|537208573|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
148924624|NCT01986933|537208574|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
148924625|NCT01986933|537208575|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
148924626|NCT01986933|537208576|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
148924627|NCT01986933|537208572|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
148924628|NCT01986933|537208573|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
148924629|NCT01986933|537208574|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
148924630|NCT01986933|537208575|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
148924631|NCT01986933|537208576|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
148924632|NCT01986933|537208572|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
148924633|NCT01986933|537208573|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
148924634|NCT01986933|537208574|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
148924635|NCT01986933|537208575|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
148924636|NCT01986933|537208576|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
148924637|NCT01986933|537208572|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
148924638|NCT01986933|537208573|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
148924639|NCT01986933|537208574|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
149159540|NCT00379795|538061400|FG003|Overall Study|Death|4|||
149159541|NCT00379795|538061401|FG004|Overall Study|Death|7|||
149159542|NCT00379795|538061397|FG000|Overall Study|Adverse Event|17|||
149159543|NCT00379795|538061398|FG001|Overall Study|Adverse Event|3|||
149159544|NCT00379795|538061399|FG002|Overall Study|Adverse Event|3|||
148924640|NCT01986933|537208575|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
148924641|NCT01986933|537208576|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
148924642|NCT01986933|537208572|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
148924643|NCT01986933|537208573|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
148924644|NCT01986933|537208574|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
148924645|NCT01986933|537208575|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
148924646|NCT01986933|537208576|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
148924647|NCT01986933|537208572|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
148924648|NCT01986933|537208573|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
148924649|NCT01986933|537208574|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
148924650|NCT01986933|537208575|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
148924651|NCT01986933|537208576|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
148924652|NCT04030026|537208579|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
148924653|NCT04030026|537208580|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
148924654|NCT04030026|537208579|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
148924655|NCT04030026|537208580|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
148924656|NCT04030026|537208579|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
148924657|NCT04030026|537208580|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
148924658|NCT04030026|537208579|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
148924659|NCT04030026|537208580|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
148924660|NCT04030026|537208579|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
148924661|NCT04030026|537208580|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
148924662|NCT04030026|537208579|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
148924663|NCT04030026|537208580|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
148924664|NCT04030026|537208579|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
148924665|NCT04030026|537208580|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
148924666|NCT00811642|537208581|FG000|Overall Study|Adverse Event|3|||
148924667|NCT00811642|537208581|FG000|Overall Study|Protocol Violation|1|||
148924668|NCT00811642|537208581|FG000|Overall Study|Death|2|||
148924669|NCT00811642|537208581|FG000|Overall Study|Withdrawal by Subject|7|||
148924670|NCT00811642|537208581|FG000|Overall Study|Cumulative use of antifungal agent|2|||
148924671|NCT01006603|537208584|FG000|Overall Study|Withdrawal by Subject|17|||
148924672|NCT01006603|537208585|FG001|Overall Study|Withdrawal by Subject|19|||
148924673|NCT01006603|537208584|FG000|Overall Study|Lost to Follow-up|0|||
148924674|NCT01006603|537208585|FG001|Overall Study|Lost to Follow-up|1|||
148924675|NCT01006603|537208584|FG000|Overall Study|Safety reason|1|||
148924676|NCT01006603|537208585|FG001|Overall Study|Safety reason|1|||
149159545|NCT00379795|538061400|FG003|Overall Study|Adverse Event|1|||
149159546|NCT00379795|538061401|FG004|Overall Study|Adverse Event|4|||
148924677|NCT01006603|537208584|FG000|Overall Study|Protocol Violation|1|||
148924678|NCT01006603|537208585|FG001|Overall Study|Protocol Violation|3|||
149159547|NCT00379795|538061397|FG000|Overall Study|Lost to Follow-up|8|||
149159548|NCT00379795|538061398|FG001|Overall Study|Lost to Follow-up|1|||
149159549|NCT00379795|538061399|FG002|Overall Study|Lost to Follow-up|2|||
148673780|NCT00902486|536275866|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
149159550|NCT00379795|538061400|FG003|Overall Study|Lost to Follow-up|1|||
149159551|NCT00379795|538061401|FG004|Overall Study|Lost to Follow-up|4|||
148673781|NCT02332655|536275867|FG000|Overall Study|Lack of Efficacy|1|||
149159552|NCT00379795|538061397|FG000|Overall Study|Physician Decision|25|||
149159553|NCT00379795|538061398|FG001|Overall Study|Physician Decision|0|||
149159554|NCT00379795|538061399|FG002|Overall Study|Physician Decision|2|||
149159555|NCT00379795|538061400|FG003|Overall Study|Physician Decision|2|||
149159556|NCT00379795|538061401|FG004|Overall Study|Physician Decision|2|||
149159557|NCT00379795|538061397|FG000|Overall Study|Withdrawal by Subject|94|||
149159558|NCT00379795|538061398|FG001|Overall Study|Withdrawal by Subject|11|||
149159559|NCT00379795|538061399|FG002|Overall Study|Withdrawal by Subject|19|||
149159560|NCT00379795|538061400|FG003|Overall Study|Withdrawal by Subject|7|||
149159561|NCT00379795|538061401|FG004|Overall Study|Withdrawal by Subject|14|||
149159562|NCT00379795|538061397|FG000|Overall Study|Subject non-compliance|7|||
149159563|NCT00379795|538061398|FG001|Overall Study|Subject non-compliance|2|||
149159564|NCT00379795|538061399|FG002|Overall Study|Subject non-compliance|0|||
149159565|NCT00379795|538061400|FG003|Overall Study|Subject non-compliance|0|||
149159566|NCT00379795|538061401|FG004|Overall Study|Subject non-compliance|1|||
149159567|NCT00379795|538061397|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
149159568|NCT00379795|538061398|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
149159569|NCT00379795|538061399|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
149159570|NCT00379795|538061400|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
149159571|NCT00379795|538061401|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
149159572|NCT00379795|538061397|FG000|Overall Study|Subjects condition mandated intervention|34|||
149159573|NCT00379795|538061398|FG001|Overall Study|Subjects condition mandated intervention|9|||
149159574|NCT00379795|538061399|FG002|Overall Study|Subjects condition mandated intervention|7|||
149159575|NCT00379795|538061400|FG003|Overall Study|Subjects condition mandated intervention|5|||
149159576|NCT00379795|538061401|FG004|Overall Study|Subjects condition mandated intervention|7|||
149159577|NCT00379795|538061397|FG000|Overall Study|Sponsor's decision|257|||
149159578|NCT00379795|538061398|FG001|Overall Study|Sponsor's decision|17|||
149159579|NCT00379795|538061399|FG002|Overall Study|Sponsor's decision|54|||
149159580|NCT00379795|538061400|FG003|Overall Study|Sponsor's decision|47|||
149159581|NCT00379795|538061401|FG004|Overall Study|Sponsor's decision|10|||
149159582|NCT02435849|538061402|FG000|Overall Study|Death|23|||
149159583|NCT02435849|538061403|FG001|Overall Study|Death|0|||
149159584|NCT02435849|538061402|FG000|Overall Study|Lack of Efficacy|10|||
148673782|NCT01298661|536275868|FG000|Overall Study|Withdrawal by Subject|2|||
148673783|NCT01298661|536275869|FG001|Overall Study|Withdrawal by Subject|0|||
148673784|NCT01298661|536275870|FG002|Overall Study|Withdrawal by Subject|2|||
148673785|NCT01563029|536277093|FG000|Overall Study|Adverse Event|1|||
148673786|NCT01563029|536277094|FG001|Overall Study|Adverse Event|0|||
148673787|NCT01563029|536277095|FG002|Overall Study|Adverse Event|1|||
148673788|NCT01563029|536277096|FG003|Overall Study|Adverse Event|2|||
148673789|NCT01563029|536277097|FG004|Overall Study|Adverse Event|1|||
148673790|NCT01563029|536277093|FG000|Overall Study|Lack of Efficacy|42|||
148673791|NCT01563029|536277094|FG001|Overall Study|Lack of Efficacy|16|||
148673792|NCT01563029|536277095|FG002|Overall Study|Lack of Efficacy|23|||
148673793|NCT01563029|536277096|FG003|Overall Study|Lack of Efficacy|21|||
148673794|NCT01563029|536277097|FG004|Overall Study|Lack of Efficacy|19|||
148673795|NCT01563029|536277093|FG000|Overall Study|Protocol Violation|1|||
148673796|NCT01563029|536277094|FG001|Overall Study|Protocol Violation|2|||
148673797|NCT01563029|536277095|FG002|Overall Study|Protocol Violation|3|||
148673798|NCT01563029|536277096|FG003|Overall Study|Protocol Violation|1|||
148673799|NCT01563029|536277097|FG004|Overall Study|Protocol Violation|3|||
148673800|NCT01563029|536277093|FG000|Overall Study|Protocol defined stopping criteria|1|||
148673801|NCT01563029|536277094|FG001|Overall Study|Protocol defined stopping criteria|0|||
148673802|NCT01563029|536277095|FG002|Overall Study|Protocol defined stopping criteria|0|||
148673803|NCT01563029|536277096|FG003|Overall Study|Protocol defined stopping criteria|0|||
148673804|NCT01563029|536277097|FG004|Overall Study|Protocol defined stopping criteria|0|||
148673805|NCT01563029|536277093|FG000|Overall Study|Lost to Follow-up|1|||
148673806|NCT01563029|536277094|FG001|Overall Study|Lost to Follow-up|0|||
148673807|NCT01563029|536277095|FG002|Overall Study|Lost to Follow-up|1|||
148673808|NCT01563029|536277096|FG003|Overall Study|Lost to Follow-up|1|||
148673809|NCT01563029|536277097|FG004|Overall Study|Lost to Follow-up|1|||
148673810|NCT01563029|536277093|FG000|Overall Study|Physician Decision|3|||
148673811|NCT01563029|536277094|FG001|Overall Study|Physician Decision|5|||
148673812|NCT01563029|536277095|FG002|Overall Study|Physician Decision|2|||
148673813|NCT01563029|536277096|FG003|Overall Study|Physician Decision|4|||
148673814|NCT01563029|536277097|FG004|Overall Study|Physician Decision|2|||
148673815|NCT01563029|536277093|FG000|Overall Study|Withdrawal by Subject|4|||
148673816|NCT01563029|536277094|FG001|Overall Study|Withdrawal by Subject|1|||
148673817|NCT01563029|536277095|FG002|Overall Study|Withdrawal by Subject|3|||
148673818|NCT01563029|536277096|FG003|Overall Study|Withdrawal by Subject|4|||
148673819|NCT01563029|536277097|FG004|Overall Study|Withdrawal by Subject|3|||
148673820|NCT01569594|536277098|FG000|Overall Study|Physician Decision|4|||
148673821|NCT01569594|536277098|FG000|Overall Study|Death|13|||
148673822|NCT01569594|536277098|FG000|Overall Study|Lost to Follow-up|22|||
148673823|NCT01569594|536277098|FG000|Overall Study|Adverse Event|2|||
148673824|NCT01569594|536277098|FG000|Overall Study|Withdrawal by Subject|13|||
148673825|NCT01569594|536277098|FG000|Overall Study|Other|4|||
148673826|NCT01569594|536277098|FG000|Overall Study|No ECM used|9|||
148673827|NCT03069365|536277099|FG000|Overall Study|Adverse Event|1|||
148673828|NCT02861534|536277100|FG000|Overall Study|Death|541|||
148673829|NCT02861534|536277101|FG001|Overall Study|Death|552|||
148673830|NCT02861534|536277100|FG000|Overall Study|Lost to Follow-up|14|||
148673831|NCT02861534|536277101|FG001|Overall Study|Lost to Follow-up|14|||
148673832|NCT02861534|536277100|FG000|Overall Study|Site Terminated by Sponsor|4|||
148673833|NCT02861534|536277101|FG001|Overall Study|Site Terminated by Sponsor|3|||
148673834|NCT02861534|536277100|FG000|Overall Study|Withdrawal by Subject|15|||
148673835|NCT02861534|536277101|FG001|Overall Study|Withdrawal by Subject|18|||
148673836|NCT02780115|536277102|FG000|Overall Study|Withdrawal by Subject|0|||
148673837|NCT02780115|536277103|FG001|Overall Study|Withdrawal by Subject|1|||
148673838|NCT02780115|536277104|FG002|Overall Study|Withdrawal by Subject|1|||
148673839|NCT02780115|536277105|FG003|Overall Study|Withdrawal by Subject|0|||
148673840|NCT02780115|536277106|FG004|Overall Study|Withdrawal by Subject|0|||
148673841|NCT02780115|536277102|FG000|Overall Study|Adverse Event|0|||
148673842|NCT02780115|536277103|FG001|Overall Study|Adverse Event|0|||
148673843|NCT02780115|536277104|FG002|Overall Study|Adverse Event|0|||
148924679|NCT01006603|537208584|FG000|Overall Study|Incorrect enrolment|0|||
148924680|NCT01006603|537208585|FG001|Overall Study|Incorrect enrolment|2|||
148673844|NCT02780115|536277105|FG003|Overall Study|Adverse Event|1|||
148673845|NCT02780115|536277106|FG004|Overall Study|Adverse Event|1|||
148673846|NCT02086968|536277110|FG000|Overall Study|Adverse Event|1|||
148673847|NCT02086968|536277111|FG001|Overall Study|Adverse Event|5|||
148673848|NCT02086968|536277110|FG000|Overall Study|Lost to Follow-up|2|||
148673849|NCT02086968|536277111|FG001|Overall Study|Lost to Follow-up|3|||
148673850|NCT02086968|536277110|FG000|Overall Study|Study drug received outside protocol|0|||
148924681|NCT01006603|537208584|FG000|Overall Study|Adverse Event|15|||
148673851|NCT02086968|536277111|FG001|Overall Study|Study drug received outside protocol|1|||
148673852|NCT02086968|536277110|FG000|Overall Study|Physician Decision|4|||
148673853|NCT02086968|536277111|FG001|Overall Study|Physician Decision|0|||
148673854|NCT02086968|536277110|FG000|Overall Study|Withdrawal by Subject|1|||
148673855|NCT02086968|536277111|FG001|Overall Study|Withdrawal by Subject|4|||
148673856|NCT03387735|536277115|FG000|Overall Study|Lost to Follow-up|4|||
148673857|NCT03387735|536277116|FG001|Overall Study|Lost to Follow-up|8|||
148924682|NCT01006603|537208585|FG001|Overall Study|Adverse Event|7|||
148924683|NCT01006603|537208584|FG000|Overall Study|Death|1|||
148924684|NCT01006603|537208585|FG001|Overall Study|Death|1|||
148924685|NCT01006603|537208584|FG000|Overall Study|Study specific discontinuation criteria|33|||
148924686|NCT01006603|537208585|FG001|Overall Study|Study specific discontinuation criteria|34|||
148924687|NCT01006603|537208584|FG000|Overall Study|Other|3|||
148924688|NCT01006603|537208585|FG001|Overall Study|Other|7|||
148924689|NCT01892722|537208588|FG000|Overall Study|Protocol deviation|0|||
148924690|NCT01892722|537208589|FG001|Overall Study|Protocol deviation|1|||
148924691|NCT01892722|537208588|FG000|Overall Study|Administrative problems|0|||
148924692|NCT01892722|537208589|FG001|Overall Study|Administrative problems|1|||
148924693|NCT01892722|537208588|FG000|Overall Study|Patient/guardian decision|0|||
148924694|NCT01892722|537208589|FG001|Overall Study|Patient/guardian decision|2|||
148924695|NCT01892722|537208588|FG000|Overall Study|Physician Decision|1|||
148924696|NCT01892722|537208589|FG001|Overall Study|Physician Decision|2|||
148924697|NCT01892722|537208588|FG000|Overall Study|Adverse Event|3|||
148924698|NCT01892722|537208589|FG001|Overall Study|Adverse Event|2|||
148924699|NCT01892722|537208588|FG000|Overall Study|Lack of Efficacy|0|||
148924700|NCT01892722|537208589|FG001|Overall Study|Lack of Efficacy|7|||
148924701|NCT01892722|537208588|FG000|Overall Study|Withdrawal by Subject|3|||
148924702|NCT01892722|537208589|FG001|Overall Study|Withdrawal by Subject|5|||
148924703|NCT02477696|537208592|FG000|Overall Study|Death|89|||
148924704|NCT02477696|537208593|FG001|Overall Study|Death|106|||
148924705|NCT02477696|537208592|FG000|Overall Study|Lost to Follow-up|7|||
148924706|NCT02477696|537208593|FG001|Overall Study|Lost to Follow-up|5|||
148924707|NCT02477696|537208592|FG000|Overall Study|Withdrawal by Subject|37|||
148924708|NCT02477696|537208593|FG001|Overall Study|Withdrawal by Subject|34|||
148924709|NCT02477696|537208592|FG000|Overall Study|Physician Decision|7|||
148924710|NCT02477696|537208593|FG001|Overall Study|Physician Decision|9|||
148924711|NCT02477696|537208592|FG000|Overall Study|Study terminated by sponsor|103|||
148924712|NCT02477696|537208593|FG001|Overall Study|Study terminated by sponsor|99|||
148924713|NCT02477696|537208592|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
148924714|NCT02477696|537208593|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
148924715|NCT02477696|537208592|FG000|Overall Study|Missing/Unknown|2|||
149159585|NCT02435849|538061403|FG001|Overall Study|Lack of Efficacy|0|||
149159586|NCT02435849|538061402|FG000|Overall Study|New therapy for study indication|8|||
149159587|NCT02435849|538061403|FG001|Overall Study|New therapy for study indication|0|||
149159588|NCT02435849|538061402|FG000|Overall Study|Subject/guardian decision|5|||
149159589|NCT02435849|538061403|FG001|Overall Study|Subject/guardian decision|1|||
149159590|NCT02435849|538061402|FG000|Overall Study|Lost to Follow-up|1|||
149159591|NCT02435849|538061403|FG001|Overall Study|Lost to Follow-up|0|||
149159592|NCT02435849|538061402|FG000|Overall Study|Physician Decision|1|||
149159593|NCT02435849|538061403|FG001|Overall Study|Physician Decision|0|||
149159594|NCT00763321|538061404|FG000|Open-label Period|Adverse Event|24|||
149159595|NCT00763321|538061405|FG001|Open-label Period|Adverse Event|0|||
149159596|NCT00763321|538061406|FG002|Open-label Period|Adverse Event|0|||
149159597|NCT00763321|538061404|FG000|Open-label Period|Lost to Follow-up|14|||
149159598|NCT00763321|538061405|FG001|Open-label Period|Lost to Follow-up|0|||
149159599|NCT00763321|538061406|FG002|Open-label Period|Lost to Follow-up|0|||
149159600|NCT00763321|538061404|FG000|Open-label Period|Withdrawal by Subject|7|||
149159601|NCT00763321|538061405|FG001|Open-label Period|Withdrawal by Subject|0|||
149159602|NCT00763321|538061406|FG002|Open-label Period|Withdrawal by Subject|0|||
149159603|NCT00763321|538061404|FG000|Open-label Period|Subject noncompliant|7|||
149159604|NCT00763321|538061405|FG001|Open-label Period|Subject noncompliant|0|||
149159605|NCT00763321|538061406|FG002|Open-label Period|Subject noncompliant|0|||
149159606|NCT00763321|538061404|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
149159607|NCT00763321|538061405|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
149159608|NCT00763321|538061406|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
149159609|NCT00763321|538061404|FG000|Open-label Period|Lack of Efficacy|2|||
148806029|NCT05911841|536768046|FG002|Escape Period|Lost to Follow-up|0|||
149159610|NCT00763321|538061405|FG001|Open-label Period|Lack of Efficacy|0|||
148806030|NCT05911841|536768047|FG003|Escape Period|Lost to Follow-up|0|||
148806031|NCT05911841|536768048|FG004|Escape Period|Lost to Follow-up|0|||
148806032|NCT05911841|536768049|FG005|Escape Period|Lost to Follow-up|0|||
148924716|NCT02477696|537208593|FG001|Overall Study|Missing/Unknown|0|||
148924717|NCT04153149|537208596|FG000|Double Blind Period|Death|63|||
148924718|NCT04153149|537208597|FG001|Double Blind Period|Death|49|||
149159611|NCT00763321|538061406|FG002|Open-label Period|Lack of Efficacy|0|||
149159612|NCT00763321|538061404|FG000|Open-label Period|Other|4|||
149159613|NCT00763321|538061405|FG001|Open-label Period|Other|0|||
149159614|NCT00763321|538061406|FG002|Open-label Period|Other|0|||
149159615|NCT00763321|538061404|FG000|Double-blind Period|Lack of Efficacy|0|||
148924719|NCT04153149|537208598|FG002|Double Blind Period|Death|0|||
148924720|NCT04153149|537208599|FG003|Double Blind Period|Death|0|||
148924721|NCT04153149|537208596|FG000|Double Blind Period|Withdrawal by Subject|16|||
148924722|NCT04153149|537208597|FG001|Double Blind Period|Withdrawal by Subject|11|||
148924723|NCT04153149|537208598|FG002|Double Blind Period|Withdrawal by Subject|0|||
148924724|NCT04153149|537208599|FG003|Double Blind Period|Withdrawal by Subject|0|||
148924725|NCT04153149|537208596|FG000|Double Blind Period|Adverse Event|6|||
148924726|NCT04153149|537208597|FG001|Double Blind Period|Adverse Event|2|||
148924727|NCT04153149|537208598|FG002|Double Blind Period|Adverse Event|0|||
148924728|NCT04153149|537208599|FG003|Double Blind Period|Adverse Event|0|||
148924729|NCT04153149|537208596|FG000|Double Blind Period|Lost to Follow-up|2|||
148924730|NCT04153149|537208597|FG001|Double Blind Period|Lost to Follow-up|1|||
148924731|NCT04153149|537208598|FG002|Double Blind Period|Lost to Follow-up|0|||
148924732|NCT04153149|537208599|FG003|Double Blind Period|Lost to Follow-up|0|||
148924733|NCT04153149|537208596|FG000|Double Blind Period|Withdrawal by guardian|0|||
148924734|NCT04153149|537208597|FG001|Double Blind Period|Withdrawal by guardian|2|||
148924735|NCT04153149|537208598|FG002|Double Blind Period|Withdrawal by guardian|0|||
148924736|NCT04153149|537208599|FG003|Double Blind Period|Withdrawal by guardian|0|||
148924737|NCT04153149|537208596|FG000|Double Blind Period|Reason Not Specified|5|||
148924738|NCT04153149|537208597|FG001|Double Blind Period|Reason Not Specified|4|||
148924739|NCT04153149|537208598|FG002|Double Blind Period|Reason Not Specified|0|||
148924740|NCT04153149|537208599|FG003|Double Blind Period|Reason Not Specified|0|||
148924741|NCT04153149|537208596|FG000|Double Blind Period|Physician Decision|2|||
148924742|NCT04153149|537208597|FG001|Double Blind Period|Physician Decision|0|||
148924743|NCT04153149|537208598|FG002|Double Blind Period|Physician Decision|0|||
148924744|NCT04153149|537208599|FG003|Double Blind Period|Physician Decision|0|||
148924745|NCT04153149|537208596|FG000|Open Label Extension Period|Death|0|||
148924746|NCT04153149|537208597|FG001|Open Label Extension Period|Death|0|||
148924747|NCT04153149|537208598|FG002|Open Label Extension Period|Death|7|||
148924748|NCT04153149|537208599|FG003|Open Label Extension Period|Death|3|||
148924749|NCT04153149|537208596|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
148924750|NCT04153149|537208597|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
148924751|NCT04153149|537208598|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
148924752|NCT04153149|537208599|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
148924753|NCT04153149|537208596|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
148924754|NCT04153149|537208597|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
148924755|NCT04153149|537208598|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
148924756|NCT04153149|537208599|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
148924757|NCT04153149|537208596|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
148924758|NCT04153149|537208597|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
148806033|NCT05911841|536768050|FG006|Escape Period|Lost to Follow-up|0|||
148806034|NCT05911841|536768051|FG007|Escape Period|Lost to Follow-up|0|||
148924759|NCT04153149|537208598|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
148924760|NCT04153149|537208599|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
148924761|NCT02003365|537209064|FG000|Overall Study|Lost to Follow-up|0|||
148924762|NCT02003365|537209065|FG001|Overall Study|Lost to Follow-up|0|||
148924763|NCT02003365|537209066|FG002|Overall Study|Lost to Follow-up|1|||
148924764|NCT00625742|537209067|FG000|Overall Study|Disease Progression|2|||
148924765|NCT00625742|537209067|FG000|Overall Study|Withdrawal by Subject|1|||
148924766|NCT00625742|537209067|FG000|Overall Study|Adverse Event|4|||
148924767|NCT00625742|537209067|FG000|Overall Study|Lost to Follow-up|4|||
148924768|NCT00625742|537209067|FG000|Overall Study|Ineligible|1|||
148924769|NCT02316548|537209068|FG000|Overall Study|Protocol Violation|0|||
148924770|NCT02316548|537209069|FG001|Overall Study|Protocol Violation|1|||
148924771|NCT00371761|537209070|FG000|Overall Study|Adverse Event|1|||
148924772|NCT00371761|537209071|FG001|Overall Study|Adverse Event|1|||
148924773|NCT00371761|537209070|FG000|Overall Study|Withdrawal by Subject|1|||
148924774|NCT00371761|537209071|FG001|Overall Study|Withdrawal by Subject|3|||
148924775|NCT00371761|537209070|FG000|Overall Study|Investigator Judgment|2|||
148924776|NCT00371761|537209071|FG001|Overall Study|Investigator Judgment|3|||
148924777|NCT00371761|537209070|FG000|Overall Study|Study termination|4|||
148924778|NCT00371761|537209071|FG001|Overall Study|Study termination|3|||
148924779|NCT05171816|537209075|FG000|Overall Study|Death|18|||
148924780|NCT05171816|537209076|FG001|Overall Study|Death|16|||
148924781|NCT02937571|537209077|FG000|Overall Study|Adverse Event|0|||
148924782|NCT02937571|537209078|FG001|Overall Study|Adverse Event|0|||
148924783|NCT02937571|537209079|FG002|Overall Study|Adverse Event|4|||
148924784|NCT02937571|537209077|FG000|Overall Study|Withdrawal by Subject|0|||
148924785|NCT02937571|537209078|FG001|Overall Study|Withdrawal by Subject|0|||
148924786|NCT02937571|537209079|FG002|Overall Study|Withdrawal by Subject|3|||
148924787|NCT03675321|537209080|FG000|Overall Study|Lack of Efficacy|2|||
148924788|NCT03675321|537209081|FG001|Overall Study|Lack of Efficacy|2|||
148924789|NCT03675321|537209080|FG000|Overall Study|Withdrawal by Subject|1|||
148924790|NCT03675321|537209081|FG001|Overall Study|Withdrawal by Subject|3|||
148924791|NCT05040971|537209085|FG000|Overall Study|Withdrawal by Subject|0|||
148924792|NCT05040971|537209086|FG001|Overall Study|Withdrawal by Subject|2|||
148924793|NCT05040971|537209085|FG000|Overall Study|Lost to Follow-up|8|||
148924794|NCT05040971|537209086|FG001|Overall Study|Lost to Follow-up|3|||
148924795|NCT05040971|537209085|FG000|Overall Study|Death|2|||
148924796|NCT05040971|537209086|FG001|Overall Study|Death|0|||
148924797|NCT04391569|537209092|FG000|Overall Study|Death|15|||
148924798|NCT04391569|537209093|FG001|Overall Study|Death|10|||
148924799|NCT04391569|537209092|FG000|Overall Study|Withdrawal by Subject|1|||
148924800|NCT04391569|537209093|FG001|Overall Study|Withdrawal by Subject|0|||
148924801|NCT04391569|537209092|FG000|Overall Study|Lost to Follow-up|3|||
148924802|NCT04391569|537209093|FG001|Overall Study|Lost to Follow-up|2|||
148924803|NCT04391569|537209092|FG000|Overall Study|Lack of Efficacy|0|||
148924804|NCT04391569|537209093|FG001|Overall Study|Lack of Efficacy|1|||
148924805|NCT04391569|537209092|FG000|Overall Study|Participant discharged to hospice facility|0|||
148924806|NCT04391569|537209093|FG001|Overall Study|Participant discharged to hospice facility|1|||
149159616|NCT00763321|538061405|FG001|Double-blind Period|Lack of Efficacy|9|||
149159617|NCT00763321|538061406|FG002|Double-blind Period|Lack of Efficacy|17|||
149159618|NCT00763321|538061404|FG000|Double-blind Period|Adverse Event|0|||
149159619|NCT00763321|538061405|FG001|Double-blind Period|Adverse Event|4|||
148924807|NCT04391569|537209092|FG000|Overall Study|Participant family decision|1|||
149159620|NCT00763321|538061406|FG002|Double-blind Period|Adverse Event|4|||
148924808|NCT04391569|537209093|FG001|Overall Study|Participant family decision|0|||
148924809|NCT04391569|537209092|FG000|Overall Study|Participant discharged prematurely|1|||
149159621|NCT00763321|538061404|FG000|Double-blind Period|Lost to Follow-up|0|||
149159622|NCT00763321|538061405|FG001|Double-blind Period|Lost to Follow-up|4|||
148924810|NCT04391569|537209093|FG001|Overall Study|Participant discharged prematurely|0|||
148924811|NCT01589770|537209110|FG000|Overall Study|EGFR <60ml/min|6|||
148924812|NCT01589770|537209111|FG001|Overall Study|EGFR <60ml/min|4|||
148924813|NCT01589770|537209110|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
148924814|NCT01589770|537209111|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
148924815|NCT02283177|537209114|FG000|Overall Study|Withdrawal by Subject|1|||
148924816|NCT02283177|537209115|FG001|Overall Study|Withdrawal by Subject|1|||
148924817|NCT01101191|537209116|FG000|Period 1|Withdrawal by Subject|1|||
148924818|NCT01101191|537209117|FG001|Period 1|Withdrawal by Subject|0|||
148924819|NCT01101191|537209116|FG000|Period 1|Adverse Event|1|||
148924820|NCT01101191|537209117|FG001|Period 1|Adverse Event|2|||
149159623|NCT00763321|538061406|FG002|Double-blind Period|Lost to Follow-up|2|||
149159624|NCT00763321|538061404|FG000|Double-blind Period|Withdrawal by Subject|0|||
149159625|NCT00763321|538061405|FG001|Double-blind Period|Withdrawal by Subject|2|||
149159626|NCT00763321|538061406|FG002|Double-blind Period|Withdrawal by Subject|3|||
149159627|NCT00763321|538061404|FG000|Double-blind Period|Other|0|||
149159628|NCT00763321|538061405|FG001|Double-blind Period|Other|2|||
149159629|NCT00763321|538061406|FG002|Double-blind Period|Other|3|||
149159630|NCT03175549|538061407|FG000|Overall Study|Lost to Follow-up|2|||
149159631|NCT03175549|538061408|FG001|Overall Study|Lost to Follow-up|2|||
149159632|NCT03175549|538061407|FG000|Overall Study|Medication non-compliance|2|||
149159633|NCT03175549|538061408|FG001|Overall Study|Medication non-compliance|2|||
149159634|NCT02486757|538061409|FG000|Overall Study|Lost to Follow-up|1|||
149159635|NCT00725075|538061410|FG000|Overall Study|Use of Excluded Medication|0|||
149159636|NCT00725075|538061411|FG001|Overall Study|Use of Excluded Medication|1|||
149159637|NCT00725075|538061412|FG002|Overall Study|Use of Excluded Medication|0|||
149159638|NCT00725075|538061410|FG000|Overall Study|Protocol Violation|0|||
149159639|NCT00725075|538061411|FG001|Overall Study|Protocol Violation|0|||
149159640|NCT00725075|538061412|FG002|Overall Study|Protocol Violation|1|||
149159641|NCT00725075|538061410|FG000|Overall Study|Lost to Follow-up|1|||
149159642|NCT00725075|538061411|FG001|Overall Study|Lost to Follow-up|0|||
149159643|NCT00725075|538061412|FG002|Overall Study|Lost to Follow-up|0|||
149159644|NCT00725075|538061410|FG000|Overall Study|Withdrawal by Subject|4|||
149159645|NCT00725075|538061411|FG001|Overall Study|Withdrawal by Subject|5|||
149159646|NCT00725075|538061412|FG002|Overall Study|Withdrawal by Subject|4|||
149159647|NCT00725075|538061410|FG000|Overall Study|Adverse Event|2|||
149159648|NCT00725075|538061411|FG001|Overall Study|Adverse Event|1|||
149159649|NCT00725075|538061412|FG002|Overall Study|Adverse Event|1|||
149159650|NCT00725075|538061410|FG000|Overall Study|Worsening of Disease|2|||
149159651|NCT00725075|538061411|FG001|Overall Study|Worsening of Disease|1|||
149159652|NCT00725075|538061412|FG002|Overall Study|Worsening of Disease|2|||
149159653|NCT00725075|538061410|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
149159654|NCT00725075|538061411|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
149159655|NCT00725075|538061412|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
149159656|NCT00725075|538061410|FG000|Overall Study|Other|1|||
149159657|NCT00725075|538061411|FG001|Overall Study|Other|0|||
149159658|NCT00725075|538061412|FG002|Overall Study|Other|0|||
149159659|NCT03984305|538061413|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
149159660|NCT03984305|538061414|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
149159661|NCT03984305|538061413|FG000|Overall Study|Withdrawal by Subject|3|||
149159662|NCT03984305|538061414|FG001|Overall Study|Withdrawal by Subject|3|||
149159663|NCT03984305|538061413|FG000|Overall Study|Lost to Follow-up|1|||
149159664|NCT03984305|538061414|FG001|Overall Study|Lost to Follow-up|0|||
149159665|NCT00352105|538061415|FG000|Overall Study|Death|5|||
149159666|NCT00352105|538061415|FG000|Overall Study|Withdrawal by Subject|5|||
149159667|NCT00352105|538061415|FG000|Overall Study|Lack of Efficacy|9|||
149159668|NCT00352105|538061415|FG000|Overall Study|Adverse Event|19|||
149159669|NCT00352105|538061415|FG000|Overall Study|Protocol Violation|2|||
149159670|NCT02979431|538061416|FG000|Overall Study|Parent/guardian withdrew consent|2|||
149159671|NCT02979431|538061417|FG001|Overall Study|Parent/guardian withdrew consent|1|||
149159672|NCT02979431|538061418|FG002|Overall Study|Parent/guardian withdrew consent|1|||
149159673|NCT02979431|538061419|FG003|Overall Study|Parent/guardian withdrew consent|1|||
149159674|NCT02979431|538061416|FG000|Overall Study|Randomized but received no study drug|1|||
149159675|NCT02979431|538061417|FG001|Overall Study|Randomized but received no study drug|1|||
149159676|NCT02979431|538061418|FG002|Overall Study|Randomized but received no study drug|0|||
149159677|NCT02979431|538061419|FG003|Overall Study|Randomized but received no study drug|0|||
149159678|NCT02979431|538061416|FG000|Overall Study|Adverse Event|0|||
149159679|NCT02979431|538061417|FG001|Overall Study|Adverse Event|0|||
148806035|NCT05911841|536768052|FG008|Escape Period|Lost to Follow-up|0|||
149159680|NCT02979431|538061418|FG002|Overall Study|Adverse Event|1|||
149159681|NCT02979431|538061419|FG003|Overall Study|Adverse Event|0|||
149159682|NCT02979431|538061416|FG000|Overall Study|Subject left country after Day14|1|||
149159683|NCT02979431|538061417|FG001|Overall Study|Subject left country after Day14|0|||
149159684|NCT02979431|538061418|FG002|Overall Study|Subject left country after Day14|0|||
149159685|NCT02979431|538061419|FG003|Overall Study|Subject left country after Day14|0|||
149159686|NCT01656434|538061420|FG000|Overall Study|Adverse Event|199|||
149159687|NCT01656434|538061421|FG001|Overall Study|Adverse Event|63|||
149159688|NCT01656434|538061420|FG000|Overall Study|Enrollment terminated at trial site|2|||
149159689|NCT01656434|538061421|FG001|Overall Study|Enrollment terminated at trial site|0|||
149159690|NCT01656434|538061420|FG000|Overall Study|Lost to Follow-up|309|||
149159691|NCT01656434|538061421|FG001|Overall Study|Lost to Follow-up|76|||
149159692|NCT01656434|538061420|FG000|Overall Study|Site discontinued study participation|24|||
149159693|NCT01656434|538061421|FG001|Overall Study|Site discontinued study participation|9|||
149159694|NCT01656434|538061420|FG000|Overall Study|Screen failure|2|||
149159695|NCT01656434|538061421|FG001|Overall Study|Screen failure|0|||
149159696|NCT01656434|538061420|FG000|Overall Study|Protocol Violation|7|||
149159697|NCT01656434|538061421|FG001|Overall Study|Protocol Violation|0|||
149159698|NCT01656434|538061420|FG000|Overall Study|Pregnancy wish|18|||
149159699|NCT01656434|538061421|FG001|Overall Study|Pregnancy wish|6|||
149159700|NCT01656434|538061420|FG000|Overall Study|Pregnancy|45|||
149159701|NCT01656434|538061421|FG001|Overall Study|Pregnancy|10|||
149159702|NCT01656434|538061420|FG000|Overall Study|Physician Decision|7|||
149159703|NCT01656434|538061421|FG001|Overall Study|Physician Decision|2|||
149159704|NCT01656434|538061420|FG000|Overall Study|Non-compliance with study drug|48|||
149159705|NCT01656434|538061421|FG001|Overall Study|Non-compliance with study drug|9|||
149159706|NCT01656434|538061420|FG000|Overall Study|Study terminated by sponsor|1501|||
149159707|NCT01656434|538061421|FG001|Overall Study|Study terminated by sponsor|348|||
149159708|NCT01656434|538061420|FG000|Overall Study|Participant discontinued; drug related|13|||
149159709|NCT01656434|538061421|FG001|Overall Study|Participant discontinued; drug related|4|||
149159710|NCT01656434|538061420|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
149159711|NCT01656434|538061421|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
149159712|NCT01656434|538061420|FG000|Overall Study|Non-compliance with protocol|39|||
149159713|NCT01656434|538061421|FG001|Overall Study|Non-compliance with protocol|15|||
149159714|NCT01656434|538061420|FG000|Overall Study|Participant moved|40|||
149159715|NCT01656434|538061421|FG001|Overall Study|Participant moved|12|||
149159716|NCT01656434|538061420|FG000|Overall Study|Participant withdrew consent|28|||
149159717|NCT01656434|538061421|FG001|Overall Study|Participant withdrew consent|9|||
149159718|NCT01656434|538061420|FG000|Overall Study|Withdrawal by Subject|64|||
149159719|NCT01656434|538061421|FG001|Overall Study|Withdrawal by Subject|7|||
149159720|NCT01235962|538061422|FG000|Overall Study|Withdrawal by Subject|20|||
149159721|NCT01235962|538061423|FG001|Overall Study|Withdrawal by Subject|19|||
149159722|NCT01235962|538061424|FG002|Overall Study|Withdrawal by Subject|62|||
149159723|NCT01235962|538061425|FG003|Overall Study|Withdrawal by Subject|49|||
149159724|NCT01235962|538061422|FG000|Overall Study|Lost to Follow-up|21|||
149159725|NCT01235962|538061423|FG001|Overall Study|Lost to Follow-up|16|||
149159726|NCT01235962|538061424|FG002|Overall Study|Lost to Follow-up|47|||
149159727|NCT01235962|538061425|FG003|Overall Study|Lost to Follow-up|32|||
149159728|NCT01235962|538061422|FG000|Overall Study|Physician Decision|5|||
149159729|NCT01235962|538061423|FG001|Overall Study|Physician Decision|0|||
149159730|NCT01235962|538061424|FG002|Overall Study|Physician Decision|9|||
149159731|NCT01235962|538061425|FG003|Overall Study|Physician Decision|5|||
149159732|NCT02883244|538061426|FG000|Overall Study|Lost to Follow-up|0|||
149159733|NCT02883244|538061427|FG001|Overall Study|Lost to Follow-up|1|||
149159734|NCT01727258|538061428|FG000|Overall Study|Adverse Event|0|||
149159735|NCT01727258|538061429|FG001|Overall Study|Adverse Event|2|||
149159736|NCT01727258|538061430|FG002|Overall Study|Adverse Event|0|||
149159737|NCT01727258|538061428|FG000|Overall Study|Noncompliance with Study Drug|0|||
149159738|NCT01727258|538061429|FG001|Overall Study|Noncompliance with Study Drug|0|||
149159739|NCT01727258|538061430|FG002|Overall Study|Noncompliance with Study Drug|1|||
149159740|NCT01727258|538061428|FG000|Overall Study|Withdrawal by Subject|1|||
149159741|NCT01727258|538061429|FG001|Overall Study|Withdrawal by Subject|1|||
148806036|NCT05911841|536768053|FG009|Escape Period|Lost to Follow-up|1|||
149159742|NCT01727258|538061430|FG002|Overall Study|Withdrawal by Subject|0|||
149159743|NCT01727258|538061428|FG000|Overall Study|Lost to Follow-up|1|||
149159744|NCT01727258|538061429|FG001|Overall Study|Lost to Follow-up|0|||
149159745|NCT01727258|538061430|FG002|Overall Study|Lost to Follow-up|0|||
149159746|NCT06098729|538061437|FG000|Overall Study|Withdrawal by Subject|1|||
149159747|NCT00993928|538061446|FG000|Overall Study|Withdrawal by Subject|4|||
149159748|NCT00993928|538061447|FG001|Overall Study|Withdrawal by Subject|7|||
149159749|NCT00993928|538061446|FG000|Overall Study|ineligible|1|||
149159750|NCT00993928|538061447|FG001|Overall Study|ineligible|0|||
149159751|NCT01665144|538061448|FG000|Core Part|Withdrawal by Subject|96|||
149159752|NCT01665144|538061449|FG001|Core Part|Withdrawal by Subject|77|||
149159753|NCT01665144|538061450|FG002|Core Part|Withdrawal by Subject|0|||
149159754|NCT01665144|538061448|FG000|Core Part|Adverse Event|45|||
149159755|NCT01665144|538061449|FG001|Core Part|Adverse Event|18|||
149159756|NCT01665144|538061450|FG002|Core Part|Adverse Event|0|||
149159757|NCT01665144|538061448|FG000|Core Part|Lack of Efficacy|16|||
149159758|NCT01665144|538061449|FG001|Core Part|Lack of Efficacy|11|||
149159759|NCT01665144|538061450|FG002|Core Part|Lack of Efficacy|0|||
149159760|NCT01665144|538061448|FG000|Core Part|Lost to Follow-up|9|||
149159761|NCT01665144|538061449|FG001|Core Part|Lost to Follow-up|8|||
149159762|NCT01665144|538061450|FG002|Core Part|Lost to Follow-up|0|||
149159763|NCT01665144|538061448|FG000|Core Part|Physician Decision|13|||
149159764|NCT01665144|538061449|FG001|Core Part|Physician Decision|1|||
149159765|NCT01665144|538061450|FG002|Core Part|Physician Decision|0|||
148924821|NCT00219544|537209120|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
148924822|NCT00219544|537209121|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
148924823|NCT00219544|537209120|FG000|Single Blind Treatment Period|Adverse Event|9|||
148924824|NCT00219544|537209121|FG001|Single Blind Treatment Period|Adverse Event|0|||
148924825|NCT00219544|537209120|FG000|Single Blind Treatment Period|Protocol Violation|4|||
148924826|NCT00219544|537209121|FG001|Single Blind Treatment Period|Protocol Violation|0|||
148924827|NCT00219544|537209120|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
149159766|NCT01665144|538061448|FG000|Core Part|Progressive disease|8|||
149159767|NCT01665144|538061449|FG001|Core Part|Progressive disease|4|||
149159768|NCT01665144|538061450|FG002|Core Part|Progressive disease|0|||
149159769|NCT01665144|538061448|FG000|Core Part|Non-compliance with study treatment|5|||
149159770|NCT01665144|538061449|FG001|Core Part|Non-compliance with study treatment|0|||
149159771|NCT01665144|538061450|FG002|Core Part|Non-compliance with study treatment|0|||
148924828|NCT00219544|537209121|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
148924829|NCT00219544|537209120|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
148924830|NCT00219544|537209121|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
148924831|NCT00219544|537209120|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
148924832|NCT00219544|537209121|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
148924833|NCT03764033|537209122|FG000|Treatment Phase|Withdrawal by Subject|8|||
148924834|NCT03764033|537209123|FG001|Treatment Phase|Withdrawal by Subject|3|||
148924835|NCT03764033|537209122|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
148924836|NCT03764033|537209123|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
148924837|NCT03764033|537209122|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
148924838|NCT03764033|537209123|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
148924839|NCT01602666|537209124|FG000|Induction Chemotherapy|Death|2|||
148924840|NCT01602666|537209125|FG001|Induction Chemotherapy|Death|1|||
148924841|NCT01602666|537209124|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
148924842|NCT01602666|537209125|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
148924843|NCT01602666|537209124|FG000|Induction Chemotherapy|Physician Decision|12|||
148924844|NCT01602666|537209125|FG001|Induction Chemotherapy|Physician Decision|5|||
148924845|NCT01602666|537209124|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
148924846|NCT01602666|537209125|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
148924847|NCT01602666|537209124|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
148924848|NCT01602666|537209125|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
148924849|NCT01602666|537209124|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
148924850|NCT01602666|537209125|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
148924851|NCT01602666|537209124|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
148924852|NCT01602666|537209125|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
148924853|NCT01602666|537209124|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
148924854|NCT01602666|537209125|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
148924855|NCT01602666|537209124|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
148924856|NCT01602666|537209125|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
148924857|NCT01602666|537209124|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
148924858|NCT01602666|537209125|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
148924859|NCT01602666|537209124|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
148924860|NCT01602666|537209125|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
148924861|NCT05856760|537209126|FG000|Overall Study|Adverse Event|2|||
148924862|NCT05856760|537209126|FG000|Overall Study|Physician Decision|1|||
148924863|NCT05856760|537209126|FG000|Overall Study|Protocol Violation|1|||
148924864|NCT05856760|537209126|FG000|Overall Study|Withdrawal by Subject|3|||
148924865|NCT00562627|537210880|FG000|Overall Study|Protocol Violation|1|||
149159772|NCT01665144|538061448|FG000|Core Part|Death|3|||
149159773|NCT01665144|538061449|FG001|Core Part|Death|1|||
149159774|NCT01665144|538061450|FG002|Core Part|Death|0|||
149159775|NCT01665144|538061448|FG000|Core Part|Protocol deviation|3|||
149159776|NCT01665144|538061449|FG001|Core Part|Protocol deviation|1|||
149159777|NCT01665144|538061450|FG002|Core Part|Protocol deviation|0|||
149159778|NCT01665144|538061448|FG000|Core Part|New therapy for study indication|2|||
149159779|NCT01665144|538061449|FG001|Core Part|New therapy for study indication|1|||
149159780|NCT01665144|538061450|FG002|Core Part|New therapy for study indication|0|||
148924866|NCT00562627|537210881|FG001|Overall Study|Protocol Violation|1|||
148924867|NCT00562627|537210882|FG002|Overall Study|Protocol Violation|1|||
148924868|NCT00997438|537210883|FG000|Overall Study|Blood draw difficulty|2|||
148924869|NCT00997438|537210884|FG001|Overall Study|Blood draw difficulty|0|||
148924870|NCT00997438|537210885|FG002|Overall Study|Blood draw difficulty|1|||
148924871|NCT00997438|537210883|FG000|Overall Study|Withdrawal by Subject|1|||
148924872|NCT00997438|537210884|FG001|Overall Study|Withdrawal by Subject|1|||
148924873|NCT00997438|537210885|FG002|Overall Study|Withdrawal by Subject|0|||
148924874|NCT00997438|537210883|FG000|Overall Study|Exclusion criteria at visit 1|2|||
148924875|NCT00997438|537210884|FG001|Overall Study|Exclusion criteria at visit 1|2|||
148924876|NCT00997438|537210885|FG002|Overall Study|Exclusion criteria at visit 1|3|||
148924877|NCT04393298|537210886|FG000|Overall Study|Adverse Event|0|||
148924878|NCT04393298|537210887|FG001|Overall Study|Adverse Event|0|||
148924879|NCT04393298|537210888|FG002|Overall Study|Adverse Event|0|||
148924880|NCT04393298|537210889|FG003|Overall Study|Adverse Event|0|||
148924881|NCT04393298|537210890|FG004|Overall Study|Adverse Event|1|||
148924882|NCT04393298|537210891|FG005|Overall Study|Adverse Event|0|||
148924883|NCT04393298|537210892|FG006|Overall Study|Adverse Event|0|||
148924884|NCT04393298|537210893|FG007|Overall Study|Adverse Event|0|||
148924885|NCT04393298|537210894|FG008|Overall Study|Adverse Event|2|||
149159781|NCT01665144|538061448|FG000|Core Part|Technical problems|2|||
149159782|NCT01665144|538061449|FG001|Core Part|Technical problems|0|||
149159783|NCT01665144|538061450|FG002|Core Part|Technical problems|0|||
148924886|NCT04393298|537210895|FG009|Overall Study|Adverse Event|0|||
148924887|NCT04393298|537210896|FG010|Overall Study|Adverse Event|0|||
148924888|NCT04393298|537210897|FG011|Overall Study|Adverse Event|0|||
148924889|NCT04393298|537210898|FG012|Overall Study|Adverse Event|1|||
148924890|NCT04393298|537210899|FG013|Overall Study|Adverse Event|1|||
148924891|NCT04393298|537210900|FG014|Overall Study|Adverse Event|0|||
148924892|NCT04393298|537210886|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924893|NCT04393298|537210887|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924894|NCT04393298|537210888|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
148924895|NCT04393298|537210889|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924896|NCT04393298|537210890|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924897|NCT04393298|537210891|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924898|NCT04393298|537210892|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924899|NCT04393298|537210893|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924900|NCT04393298|537210894|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924901|NCT04393298|537210895|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924902|NCT04393298|537210896|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
149159784|NCT01665144|538061448|FG000|Extension Part|Patient/guardian decision|180|||
149159785|NCT01665144|538061449|FG001|Extension Part|Patient/guardian decision|0|||
149159786|NCT01665144|538061450|FG002|Extension Part|Patient/guardian decision|98|||
149159787|NCT01665144|538061448|FG000|Extension Part|Adverse Event|104|||
149159788|NCT01665144|538061449|FG001|Extension Part|Adverse Event|0|||
149159789|NCT01665144|538061450|FG002|Extension Part|Adverse Event|59|||
149159790|NCT01665144|538061448|FG000|Extension Part|Study closed early|42|||
149159791|NCT01665144|538061449|FG001|Extension Part|Study closed early|0|||
149159792|NCT01665144|538061450|FG002|Extension Part|Study closed early|19|||
149159793|NCT01665144|538061448|FG000|Extension Part|Progressive disease|36|||
149159794|NCT01665144|538061449|FG001|Extension Part|Progressive disease|0|||
149159795|NCT01665144|538061450|FG002|Extension Part|Progressive disease|14|||
149159796|NCT01665144|538061448|FG000|Extension Part|Lack of Efficacy|37|||
149159797|NCT01665144|538061449|FG001|Extension Part|Lack of Efficacy|0|||
149159798|NCT01665144|538061450|FG002|Extension Part|Lack of Efficacy|12|||
149159799|NCT01665144|538061448|FG000|Extension Part|Physician Decision|29|||
149159800|NCT01665144|538061449|FG001|Extension Part|Physician Decision|0|||
149159801|NCT01665144|538061450|FG002|Extension Part|Physician Decision|13|||
149159802|NCT01665144|538061448|FG000|Extension Part|Technical problems|20|||
149159803|NCT01665144|538061449|FG001|Extension Part|Technical problems|0|||
149159804|NCT01665144|538061450|FG002|Extension Part|Technical problems|8|||
148673858|NCT03387735|536277115|FG000|Overall Study|Death|4|||
148924903|NCT04393298|537210897|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
149159805|NCT01665144|538061448|FG000|Extension Part|Death|20|||
149159806|NCT01665144|538061449|FG001|Extension Part|Death|0|||
149159807|NCT01665144|538061450|FG002|Extension Part|Death|4|||
149159808|NCT01665144|538061448|FG000|Extension Part|Missing|12|||
149159809|NCT01665144|538061449|FG001|Extension Part|Missing|0|||
149159810|NCT01665144|538061450|FG002|Extension Part|Missing|6|||
149159811|NCT01665144|538061448|FG000|Extension Part|Lost to Follow-up|9|||
149159812|NCT01665144|538061449|FG001|Extension Part|Lost to Follow-up|0|||
148924904|NCT04393298|537210898|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924905|NCT04393298|537210899|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
148924906|NCT04393298|537210900|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
148924907|NCT04393298|537210886|FG000|Overall Study|Lack of Efficacy|0|||
148924908|NCT04393298|537210887|FG001|Overall Study|Lack of Efficacy|0|||
148924909|NCT04393298|537210888|FG002|Overall Study|Lack of Efficacy|0|||
148924910|NCT04393298|537210889|FG003|Overall Study|Lack of Efficacy|0|||
148924911|NCT04393298|537210890|FG004|Overall Study|Lack of Efficacy|0|||
148924912|NCT04393298|537210891|FG005|Overall Study|Lack of Efficacy|0|||
148924913|NCT04393298|537210892|FG006|Overall Study|Lack of Efficacy|0|||
148924914|NCT04393298|537210893|FG007|Overall Study|Lack of Efficacy|0|||
148924915|NCT04393298|537210894|FG008|Overall Study|Lack of Efficacy|0|||
148924916|NCT04393298|537210895|FG009|Overall Study|Lack of Efficacy|0|||
148924917|NCT04393298|537210896|FG010|Overall Study|Lack of Efficacy|0|||
148924918|NCT04393298|537210897|FG011|Overall Study|Lack of Efficacy|0|||
148924919|NCT04393298|537210898|FG012|Overall Study|Lack of Efficacy|0|||
148924920|NCT04393298|537210899|FG013|Overall Study|Lack of Efficacy|0|||
148924921|NCT04393298|537210900|FG014|Overall Study|Lack of Efficacy|1|||
148924922|NCT04393298|537210886|FG000|Overall Study|Progression|1|||
148924923|NCT04393298|537210887|FG001|Overall Study|Progression|0|||
148924924|NCT04393298|537210888|FG002|Overall Study|Progression|0|||
148924925|NCT04393298|537210889|FG003|Overall Study|Progression|0|||
148924926|NCT04393298|537210890|FG004|Overall Study|Progression|0|||
148924927|NCT04393298|537210891|FG005|Overall Study|Progression|0|||
148924928|NCT04393298|537210892|FG006|Overall Study|Progression|0|||
148924929|NCT04393298|537210893|FG007|Overall Study|Progression|0|||
148924930|NCT04393298|537210894|FG008|Overall Study|Progression|0|||
148924931|NCT04393298|537210895|FG009|Overall Study|Progression|0|||
148924932|NCT04393298|537210896|FG010|Overall Study|Progression|1|||
148924933|NCT04393298|537210897|FG011|Overall Study|Progression|1|||
148924934|NCT04393298|537210898|FG012|Overall Study|Progression|0|||
148924935|NCT04393298|537210899|FG013|Overall Study|Progression|0|||
148924936|NCT04393298|537210900|FG014|Overall Study|Progression|0|||
148924937|NCT04393298|537210886|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
148924938|NCT04393298|537210887|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924939|NCT04393298|537210888|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924940|NCT04393298|537210889|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924941|NCT04393298|537210890|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924942|NCT04393298|537210891|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924943|NCT04393298|537210892|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924944|NCT04393298|537210893|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924945|NCT04393298|537210894|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924946|NCT04393298|537210895|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924947|NCT04393298|537210896|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924948|NCT04393298|537210897|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924949|NCT04393298|537210898|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924950|NCT04393298|537210899|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924951|NCT04393298|537210900|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
148924952|NCT04393298|537210886|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924953|NCT04393298|537210887|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
148924954|NCT04393298|537210888|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924955|NCT04393298|537210889|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924956|NCT04393298|537210890|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924957|NCT04393298|537210891|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924958|NCT04393298|537210892|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
149159813|NCT01665144|538061450|FG002|Extension Part|Lost to Follow-up|5|||
149159814|NCT01665144|538061448|FG000|Extension Part|New therapy for study indication|3|||
149159815|NCT01665144|538061449|FG001|Extension Part|New therapy for study indication|0|||
149159816|NCT01665144|538061450|FG002|Extension Part|New therapy for study indication|2|||
149159817|NCT01665144|538061448|FG000|Extension Part|Protocol deviation|3|||
149159818|NCT01665144|538061449|FG001|Extension Part|Protocol deviation|0|||
149159819|NCT01665144|538061450|FG002|Extension Part|Protocol deviation|0|||
149159820|NCT01972074|538061453|FG000|Overall Study|Adverse Event|4|||
149159821|NCT01972074|538061454|FG001|Overall Study|Adverse Event|1|||
149159822|NCT01972074|538061455|FG002|Overall Study|Adverse Event|0|||
149159823|NCT01972074|538061453|FG000|Overall Study|Lack of Efficacy|1|||
149159824|NCT01972074|538061454|FG001|Overall Study|Lack of Efficacy|1|||
149159825|NCT01972074|538061455|FG002|Overall Study|Lack of Efficacy|0|||
149159826|NCT01972074|538061453|FG000|Overall Study|Lost to Follow-up|0|||
149159827|NCT01972074|538061454|FG001|Overall Study|Lost to Follow-up|1|||
149159828|NCT01972074|538061455|FG002|Overall Study|Lost to Follow-up|1|||
149159829|NCT01972074|538061453|FG000|Overall Study|Withdrawal by Subject|1|||
149159830|NCT01972074|538061454|FG001|Overall Study|Withdrawal by Subject|1|||
149159831|NCT01972074|538061455|FG002|Overall Study|Withdrawal by Subject|1|||
149159832|NCT01972074|538061453|FG000|Overall Study|Scanner Unavailable|0|||
149159833|NCT01972074|538061454|FG001|Overall Study|Scanner Unavailable|0|||
149159834|NCT01972074|538061455|FG002|Overall Study|Scanner Unavailable|1|||
149159835|NCT02317562|538061456|FG000|Overall Study|Physician Decision|1|||
149159836|NCT02317562|538061456|FG000|Overall Study|early termination of the study|8|||
149159837|NCT02317562|538061456|FG000|Overall Study|Lack of Efficacy|4|||
149159838|NCT02317562|538061456|FG000|Overall Study|Withdrawal by Subject|1|||
149159839|NCT03551743|538061457|FG000|Overall Study|Adverse Event|1|||
149159840|NCT03551743|538061458|FG001|Overall Study|Adverse Event|0|||
149159841|NCT03551743|538061459|FG002|Overall Study|Adverse Event|0|||
149159842|NCT03551743|538061460|FG003|Overall Study|Adverse Event|0|||
149159843|NCT03551743|538061457|FG000|Overall Study|Withdrawal by Subject|1|||
149159844|NCT03551743|538061458|FG001|Overall Study|Withdrawal by Subject|0|||
149159845|NCT03551743|538061459|FG002|Overall Study|Withdrawal by Subject|0|||
149159846|NCT03551743|538061460|FG003|Overall Study|Withdrawal by Subject|0|||
149159847|NCT02319044|538061461|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
149159848|NCT02319044|538061462|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
149159849|NCT02319044|538061463|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
149159850|NCT02319044|538061461|FG000|Overall Study|Withdrawal by Subject|3|||
149159851|NCT02319044|538061462|FG001|Overall Study|Withdrawal by Subject|3|||
149159852|NCT02319044|538061463|FG002|Overall Study|Withdrawal by Subject|6|||
149159853|NCT02319044|538061461|FG000|Overall Study|Condition under investigation worsened|100|||
149159854|NCT02319044|538061462|FG001|Overall Study|Condition under investigation worsened|50|||
149159855|NCT02319044|538061463|FG002|Overall Study|Condition under investigation worsened|46|||
149159856|NCT02319044|538061461|FG000|Overall Study|Adverse Event|17|||
149159857|NCT02319044|538061462|FG001|Overall Study|Adverse Event|2|||
149159858|NCT02319044|538061463|FG002|Overall Study|Adverse Event|8|||
149159859|NCT02319044|538061461|FG000|Overall Study|Study specific discontinuation criteria|2|||
149159860|NCT02319044|538061462|FG001|Overall Study|Study specific discontinuation criteria|2|||
149159861|NCT02319044|538061463|FG002|Overall Study|Study specific discontinuation criteria|1|||
149159862|NCT02319044|538061461|FG000|Overall Study|Not treated|0|||
149159863|NCT02319044|538061462|FG001|Overall Study|Not treated|2|||
148673859|NCT03387735|536277116|FG001|Overall Study|Death|8|||
148673860|NCT00537056|536277117|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
148673861|NCT01257737|536277118|FG000|Overall Study|Lost to Follow-up|1|||
148673862|NCT01257737|536277119|FG001|Overall Study|Lost to Follow-up|2|||
148673863|NCT01257737|536277118|FG000|Overall Study|Liver transplant|1|||
148673864|NCT01257737|536277119|FG001|Overall Study|Liver transplant|0|||
149159864|NCT02319044|538061463|FG002|Overall Study|Not treated|2|||
149159865|NCT03891901|538061464|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
149159866|NCT03891901|538061465|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
148673865|NCT01257737|536277118|FG000|Overall Study|Relocation out of the country|0|||
148673866|NCT01257737|536277119|FG001|Overall Study|Relocation out of the country|1|||
149012851|NCT01468922|537525815|FG002|Overall Study|Infection of blood|0|||
148673867|NCT01257737|536277118|FG000|Overall Study|Withdrew from study|0|||
149159867|NCT03891901|538061466|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159868|NCT03891901|538061467|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159869|NCT03891901|538061468|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159870|NCT03891901|538061469|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159871|NCT03891901|538061470|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159872|NCT03891901|538061471|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159873|NCT03891901|538061472|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
149159874|NCT03891901|538061464|FG000|Overall Study|Adverse Event|2|||
149159875|NCT03891901|538061465|FG001|Overall Study|Adverse Event|2|||
149159876|NCT03891901|538061466|FG002|Overall Study|Adverse Event|0|||
149159877|NCT03891901|538061467|FG003|Overall Study|Adverse Event|0|||
149159878|NCT03891901|538061468|FG004|Overall Study|Adverse Event|0|||
149159879|NCT03891901|538061469|FG005|Overall Study|Adverse Event|0|||
149159880|NCT03891901|538061470|FG006|Overall Study|Adverse Event|0|||
149159881|NCT03891901|538061471|FG007|Overall Study|Adverse Event|0|||
149159882|NCT03891901|538061472|FG008|Overall Study|Adverse Event|0|||
148673868|NCT01257737|536277119|FG001|Overall Study|Withdrew from study|1|||
148673869|NCT00742859|536277122|FG000|Overall Study|Adverse Event|5|||
148673870|NCT00742859|536277123|FG001|Overall Study|Adverse Event|6|||
148673871|NCT00742859|536277124|FG002|Overall Study|Adverse Event|3|||
148673872|NCT00742859|536277125|FG003|Overall Study|Adverse Event|1|||
148673873|NCT00742859|536277122|FG000|Overall Study|Death|1|||
148673874|NCT00742859|536277123|FG001|Overall Study|Death|0|||
148673875|NCT00742859|536277124|FG002|Overall Study|Death|0|||
148673876|NCT00742859|536277125|FG003|Overall Study|Death|1|||
148673877|NCT00742859|536277122|FG000|Overall Study|Physician Decision|1|||
148673878|NCT00742859|536277123|FG001|Overall Study|Physician Decision|2|||
148673879|NCT00742859|536277124|FG002|Overall Study|Physician Decision|0|||
148673880|NCT00742859|536277125|FG003|Overall Study|Physician Decision|0|||
148673881|NCT00742859|536277122|FG000|Overall Study|Withdrawal by Subject|4|||
148673882|NCT00742859|536277123|FG001|Overall Study|Withdrawal by Subject|2|||
148673883|NCT00742859|536277124|FG002|Overall Study|Withdrawal by Subject|4|||
148673884|NCT00742859|536277125|FG003|Overall Study|Withdrawal by Subject|1|||
148673885|NCT00742859|536277122|FG000|Overall Study|Endpoint|0|||
148673886|NCT00742859|536277123|FG001|Overall Study|Endpoint|1|||
148673887|NCT00742859|536277124|FG002|Overall Study|Endpoint|1|||
148673888|NCT00742859|536277125|FG003|Overall Study|Endpoint|2|||
148673889|NCT00742859|536277122|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
148673890|NCT00742859|536277123|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
148673891|NCT00742859|536277124|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
148673892|NCT00742859|536277125|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
148673893|NCT00742859|536277122|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
148673894|NCT00742859|536277123|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
148673895|NCT00742859|536277124|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
148673896|NCT00742859|536277125|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
148673897|NCT00742859|536277122|FG000|Overall Study|Sponsor request patient out of town|0|||
148673898|NCT00742859|536277123|FG001|Overall Study|Sponsor request patient out of town|0|||
148673899|NCT00742859|536277124|FG002|Overall Study|Sponsor request patient out of town|1|||
148673900|NCT00742859|536277125|FG003|Overall Study|Sponsor request patient out of town|1|||
148673901|NCT00742859|536277122|FG000|Overall Study|Site error|0|||
148673902|NCT00742859|536277123|FG001|Overall Study|Site error|0|||
148673903|NCT00742859|536277124|FG002|Overall Study|Site error|1|||
148673904|NCT00742859|536277125|FG003|Overall Study|Site error|1|||
148673905|NCT00445458|536277131|FG000|Overall Study|Disease Progression|3|||
148673906|NCT00445458|536277132|FG001|Overall Study|Disease Progression|4|||
148673907|NCT00445458|536277133|FG002|Overall Study|Disease Progression|54|||
148673908|NCT00445458|536277134|FG003|Overall Study|Disease Progression|27|||
148924959|NCT04393298|537210893|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924960|NCT04393298|537210894|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924961|NCT04393298|537210895|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924962|NCT04393298|537210896|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924963|NCT04393298|537210897|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924964|NCT04393298|537210898|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
149159883|NCT03891901|538061464|FG000|Overall Study|Poor venous access|1|||
149159884|NCT03891901|538061465|FG001|Overall Study|Poor venous access|0|||
149159885|NCT03891901|538061466|FG002|Overall Study|Poor venous access|0|||
149159886|NCT03891901|538061467|FG003|Overall Study|Poor venous access|0|||
149159887|NCT03891901|538061468|FG004|Overall Study|Poor venous access|0|||
149159888|NCT03891901|538061469|FG005|Overall Study|Poor venous access|0|||
149159889|NCT03891901|538061470|FG006|Overall Study|Poor venous access|0|||
149159890|NCT03891901|538061471|FG007|Overall Study|Poor venous access|0|||
149159891|NCT03891901|538061472|FG008|Overall Study|Poor venous access|0|||
149159892|NCT03891901|538061464|FG000|Overall Study|Withdrawal by Subject|0|||
148673909|NCT00445458|536277131|FG000|Overall Study|Withdrawal by Subject|0|||
148673910|NCT00445458|536277132|FG001|Overall Study|Withdrawal by Subject|0|||
148673911|NCT00445458|536277133|FG002|Overall Study|Withdrawal by Subject|7|||
148673912|NCT00445458|536277134|FG003|Overall Study|Withdrawal by Subject|0|||
148673913|NCT00445458|536277131|FG000|Overall Study|Adverse Event|0|||
148673914|NCT00445458|536277132|FG001|Overall Study|Adverse Event|0|||
148673915|NCT00445458|536277133|FG002|Overall Study|Adverse Event|3|||
148673916|NCT00445458|536277134|FG003|Overall Study|Adverse Event|0|||
148673917|NCT00445458|536277131|FG000|Overall Study|Death|0|||
148673918|NCT00445458|536277132|FG001|Overall Study|Death|1|||
148673919|NCT00445458|536277133|FG002|Overall Study|Death|2|||
148673920|NCT00445458|536277134|FG003|Overall Study|Death|0|||
148673921|NCT00445458|536277131|FG000|Overall Study|Physician Decision|0|||
148673922|NCT00445458|536277132|FG001|Overall Study|Physician Decision|0|||
148673923|NCT00445458|536277133|FG002|Overall Study|Physician Decision|1|||
148673924|NCT00445458|536277134|FG003|Overall Study|Physician Decision|1|||
148673925|NCT00445458|536277131|FG000|Overall Study|Surgery|0|||
148673926|NCT00445458|536277132|FG001|Overall Study|Surgery|0|||
148673927|NCT00445458|536277133|FG002|Overall Study|Surgery|1|||
148673928|NCT00445458|536277134|FG003|Overall Study|Surgery|0|||
148673929|NCT01071083|536277137|FG000|Overall Study|Adverse Event|1|||
148673930|NCT01071083|536277138|FG001|Overall Study|Adverse Event|0|||
148673931|NCT01071083|536277139|FG002|Overall Study|Adverse Event|1|||
149159893|NCT03891901|538061465|FG001|Overall Study|Withdrawal by Subject|2|||
149159894|NCT03891901|538061466|FG002|Overall Study|Withdrawal by Subject|0|||
149159895|NCT03891901|538061467|FG003|Overall Study|Withdrawal by Subject|0|||
149159896|NCT03891901|538061468|FG004|Overall Study|Withdrawal by Subject|0|||
149159897|NCT03891901|538061469|FG005|Overall Study|Withdrawal by Subject|0|||
149159898|NCT03891901|538061470|FG006|Overall Study|Withdrawal by Subject|0|||
149159899|NCT03891901|538061471|FG007|Overall Study|Withdrawal by Subject|0|||
149159900|NCT03891901|538061472|FG008|Overall Study|Withdrawal by Subject|0|||
148673932|NCT01071083|536277140|FG003|Overall Study|Adverse Event|0|||
148673933|NCT01071083|536277141|FG004|Overall Study|Adverse Event|1|||
148673934|NCT01071083|536277137|FG000|Overall Study|Withdrawal by Subject|3|||
148673935|NCT01071083|536277138|FG001|Overall Study|Withdrawal by Subject|0|||
148673936|NCT01071083|536277139|FG002|Overall Study|Withdrawal by Subject|2|||
148673937|NCT01071083|536277140|FG003|Overall Study|Withdrawal by Subject|0|||
148673938|NCT01071083|536277141|FG004|Overall Study|Withdrawal by Subject|3|||
148673939|NCT01071083|536277137|FG000|Overall Study|Physician Decision|1|||
148673940|NCT01071083|536277138|FG001|Overall Study|Physician Decision|0|||
148673941|NCT01071083|536277139|FG002|Overall Study|Physician Decision|0|||
148673942|NCT01071083|536277140|FG003|Overall Study|Physician Decision|1|||
148673943|NCT01071083|536277141|FG004|Overall Study|Physician Decision|1|||
148673944|NCT01071083|536277137|FG000|Overall Study|Early Rescue|1|||
148673945|NCT01071083|536277138|FG001|Overall Study|Early Rescue|0|||
148673946|NCT01071083|536277139|FG002|Overall Study|Early Rescue|0|||
148673947|NCT01071083|536277140|FG003|Overall Study|Early Rescue|0|||
148673948|NCT01071083|536277141|FG004|Overall Study|Early Rescue|1|||
148673949|NCT01071083|536277137|FG000|Overall Study|Subject Moved|0|||
148673950|NCT01071083|536277138|FG001|Overall Study|Subject Moved|1|||
148673951|NCT01071083|536277139|FG002|Overall Study|Subject Moved|0|||
148673952|NCT01071083|536277140|FG003|Overall Study|Subject Moved|0|||
148673953|NCT01071083|536277141|FG004|Overall Study|Subject Moved|0|||
148673954|NCT01071083|536277137|FG000|Overall Study|Images Not Usable (Motion)|0|||
148673955|NCT01071083|536277138|FG001|Overall Study|Images Not Usable (Motion)|1|||
148673956|NCT01071083|536277139|FG002|Overall Study|Images Not Usable (Motion)|0|||
148673957|NCT01071083|536277140|FG003|Overall Study|Images Not Usable (Motion)|0|||
148673958|NCT01071083|536277141|FG004|Overall Study|Images Not Usable (Motion)|0|||
148673959|NCT01071083|536277137|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
148673960|NCT01071083|536277138|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
148673961|NCT01071083|536277139|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
148673962|NCT01071083|536277140|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
148673963|NCT01071083|536277141|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
148673964|NCT01071083|536277137|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
148673965|NCT01071083|536277138|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
148673966|NCT01071083|536277139|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
148673967|NCT01071083|536277140|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
148673968|NCT01071083|536277141|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
148673969|NCT01071083|536277137|FG000|Overall Study|Subject Refused to Continue|1|||
148673970|NCT01071083|536277138|FG001|Overall Study|Subject Refused to Continue|0|||
148924965|NCT04393298|537210899|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
149159901|NCT02154087|538061477|FG000|Overall Study|Study Termination|1|||
148673971|NCT01071083|536277139|FG002|Overall Study|Subject Refused to Continue|0|||
148811245|NCT01995201|536787050|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
149159902|NCT04949841|538061480|FG000|Overall Study|Adverse Event|7|||
148673972|NCT01071083|536277140|FG003|Overall Study|Subject Refused to Continue|0|||
148673973|NCT01071083|536277141|FG004|Overall Study|Subject Refused to Continue|0|||
148673974|NCT03972709|536277142|FG000|Overall Study|Withdrawal by Subject|18|||
148673975|NCT03972709|536277143|FG001|Overall Study|Withdrawal by Subject|7|||
148673976|NCT03972709|536277144|FG002|Overall Study|Withdrawal by Subject|14|||
148673977|NCT03972709|536277142|FG000|Overall Study|Study Terminated by Sponsor|48|||
148673978|NCT03972709|536277143|FG001|Overall Study|Study Terminated by Sponsor|25|||
148673979|NCT03972709|536277144|FG002|Overall Study|Study Terminated by Sponsor|50|||
148673980|NCT03972709|536277142|FG000|Overall Study|Physician Decision|1|||
148673981|NCT03972709|536277143|FG001|Overall Study|Physician Decision|0|||
148673982|NCT03972709|536277144|FG002|Overall Study|Physician Decision|0|||
148673983|NCT03972709|536277142|FG000|Overall Study|COVID-19|0|||
148673984|NCT03972709|536277143|FG001|Overall Study|COVID-19|1|||
148673985|NCT03972709|536277144|FG002|Overall Study|COVID-19|1|||
148924966|NCT04393298|537210900|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
148924967|NCT04393298|537210886|FG000|Overall Study|Clinical Progression|0|||
148924968|NCT04393298|537210887|FG001|Overall Study|Clinical Progression|2|||
148924969|NCT04393298|537210888|FG002|Overall Study|Clinical Progression|0|||
148924970|NCT04393298|537210889|FG003|Overall Study|Clinical Progression|0|||
148924971|NCT04393298|537210890|FG004|Overall Study|Clinical Progression|0|||
148924972|NCT04393298|537210891|FG005|Overall Study|Clinical Progression|0|||
148924973|NCT04393298|537210892|FG006|Overall Study|Clinical Progression|0|||
148924974|NCT04393298|537210893|FG007|Overall Study|Clinical Progression|0|||
148924975|NCT04393298|537210894|FG008|Overall Study|Clinical Progression|0|||
148924976|NCT04393298|537210895|FG009|Overall Study|Clinical Progression|0|||
148924977|NCT04393298|537210896|FG010|Overall Study|Clinical Progression|0|||
148924978|NCT04393298|537210897|FG011|Overall Study|Clinical Progression|0|||
148924979|NCT04393298|537210898|FG012|Overall Study|Clinical Progression|0|||
148924980|NCT04393298|537210899|FG013|Overall Study|Clinical Progression|0|||
148924981|NCT04393298|537210900|FG014|Overall Study|Clinical Progression|0|||
148924982|NCT04393298|537210886|FG000|Overall Study|Disease Progression|0|||
148924983|NCT04393298|537210887|FG001|Overall Study|Disease Progression|1|||
148924984|NCT04393298|537210888|FG002|Overall Study|Disease Progression|0|||
148924985|NCT04393298|537210889|FG003|Overall Study|Disease Progression|0|||
148924986|NCT04393298|537210890|FG004|Overall Study|Disease Progression|0|||
148924987|NCT04393298|537210891|FG005|Overall Study|Disease Progression|3|||
148924988|NCT04393298|537210892|FG006|Overall Study|Disease Progression|2|||
148924989|NCT04393298|537210893|FG007|Overall Study|Disease Progression|1|||
148924990|NCT04393298|537210894|FG008|Overall Study|Disease Progression|2|||
148924991|NCT04393298|537210895|FG009|Overall Study|Disease Progression|1|||
148924992|NCT04393298|537210896|FG010|Overall Study|Disease Progression|0|||
148924993|NCT04393298|537210897|FG011|Overall Study|Disease Progression|3|||
148924994|NCT04393298|537210898|FG012|Overall Study|Disease Progression|0|||
148924995|NCT04393298|537210899|FG013|Overall Study|Disease Progression|0|||
148924996|NCT04393298|537210900|FG014|Overall Study|Disease Progression|1|||
148924997|NCT04393298|537210886|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148924998|NCT04393298|537210887|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148924999|NCT04393298|537210888|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
148925000|NCT04393298|537210889|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925001|NCT04393298|537210890|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925002|NCT04393298|537210891|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925003|NCT04393298|537210892|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925004|NCT04393298|537210893|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925005|NCT04393298|537210894|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925006|NCT04393298|537210895|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925007|NCT04393298|537210896|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925008|NCT04393298|537210897|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925009|NCT04393298|537210898|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925010|NCT04393298|537210899|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925011|NCT04393298|537210900|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
148925012|NCT04393298|537210886|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925013|NCT04393298|537210887|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925014|NCT04393298|537210888|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
148925015|NCT04393298|537210889|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925016|NCT04393298|537210890|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925017|NCT04393298|537210891|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925018|NCT04393298|537210892|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925019|NCT04393298|537210893|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925020|NCT04393298|537210894|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925021|NCT04393298|537210895|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925022|NCT04393298|537210896|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925023|NCT04393298|537210897|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925024|NCT04393298|537210898|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925025|NCT04393298|537210899|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
149159903|NCT04949841|538061480|FG000|Overall Study|Death|1|||
148925026|NCT04393298|537210900|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
148925027|NCT04393298|537210886|FG000|Overall Study|Progressive Disease (PD)|0|||
148925028|NCT04393298|537210887|FG001|Overall Study|Progressive Disease (PD)|0|||
149159904|NCT04949841|538061480|FG000|Overall Study|Withdrawal by Subject|52|||
149159905|NCT04949841|538061480|FG000|Overall Study|Pregnancy|4|||
148925029|NCT04393298|537210888|FG002|Overall Study|Progressive Disease (PD)|0|||
148925030|NCT04393298|537210889|FG003|Overall Study|Progressive Disease (PD)|3|||
149159906|NCT04949841|538061480|FG000|Overall Study|Lost to Follow-up|9|||
149159907|NCT04949841|538061480|FG000|Overall Study|Lack of Efficacy|55|||
148673986|NCT03972709|536277142|FG000|Overall Study|Lost to Follow-up|6|||
148673987|NCT03972709|536277143|FG001|Overall Study|Lost to Follow-up|1|||
148673988|NCT03972709|536277144|FG002|Overall Study|Lost to Follow-up|2|||
148673989|NCT03972709|536277142|FG000|Overall Study|Death|5|||
148673990|NCT03972709|536277143|FG001|Overall Study|Death|1|||
148673991|NCT03972709|536277144|FG002|Overall Study|Death|4|||
148673992|NCT03972709|536277142|FG000|Overall Study|Adverse Event|3|||
148673993|NCT03972709|536277143|FG001|Overall Study|Adverse Event|1|||
148673994|NCT03972709|536277144|FG002|Overall Study|Adverse Event|4|||
148673995|NCT03972709|536277142|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
148673996|NCT03972709|536277143|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
148673997|NCT03972709|536277144|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
148673998|NCT03972709|536277142|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
148673999|NCT03972709|536277143|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
148674000|NCT03972709|536277144|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
148674001|NCT03972709|536277142|FG000|Overall Study|Subject Unable to be Contacted|0|||
148674002|NCT03972709|536277143|FG001|Overall Study|Subject Unable to be Contacted|1|||
148674003|NCT03972709|536277144|FG002|Overall Study|Subject Unable to be Contacted|0|||
148674004|NCT03972709|536277142|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
148674005|NCT03972709|536277143|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
148674006|NCT03972709|536277144|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
148674007|NCT03972709|536277142|FG000|Overall Study|Subject Moved|0|||
148674008|NCT03972709|536277143|FG001|Overall Study|Subject Moved|1|||
148674009|NCT03972709|536277144|FG002|Overall Study|Subject Moved|0|||
148674010|NCT03972709|536277142|FG000|Overall Study|Missed Study Visits|1|||
148674011|NCT03972709|536277143|FG001|Overall Study|Missed Study Visits|0|||
148674012|NCT03972709|536277144|FG002|Overall Study|Missed Study Visits|0|||
148674013|NCT04732728|536277145|FG000|Overall Study|Death|12|||
148674014|NCT04732728|536277145|FG000|Overall Study|Withdrawn|136|||
148674015|NCT01523301|536277146|FG000|Overall Study|Adverse Event|25|||
148674016|NCT01523301|536277147|FG001|Overall Study|Adverse Event|16|||
148674017|NCT01523301|536277146|FG000|Overall Study|Lack of Efficacy|0|||
148674018|NCT01523301|536277147|FG001|Overall Study|Lack of Efficacy|2|||
148674019|NCT01523301|536277146|FG000|Overall Study|Protocol Violation|3|||
148674020|NCT01523301|536277147|FG001|Overall Study|Protocol Violation|4|||
148674021|NCT01523301|536277146|FG000|Overall Study|Lost to Follow-up|1|||
148674022|NCT01523301|536277147|FG001|Overall Study|Lost to Follow-up|0|||
148674023|NCT01523301|536277146|FG000|Overall Study|Withdrawal by Subject|6|||
148674024|NCT01523301|536277147|FG001|Overall Study|Withdrawal by Subject|8|||
148674025|NCT01523301|536277146|FG000|Overall Study|Other Reason|0|||
148674026|NCT01523301|536277147|FG001|Overall Study|Other Reason|2|||
148674027|NCT01339000|536277148|FG000|Overall Study|study closed due to lack of drug supply|1|||
148674028|NCT01339000|536277149|FG001|Overall Study|study closed due to lack of drug supply|0|||
148674029|NCT00728988|536277150|FG000|Overall Study|Not Treated|2|||
148674030|NCT00728988|536277151|FG001|Overall Study|Not Treated|2|||
148674031|NCT00728988|536277150|FG000|Overall Study|Death|1|||
148674032|NCT00728988|536277151|FG001|Overall Study|Death|1|||
148674033|NCT00728988|536277150|FG000|Overall Study|Adverse Event|3|||
148674034|NCT00728988|536277151|FG001|Overall Study|Adverse Event|2|||
148674035|NCT00728988|536277150|FG000|Overall Study|Other|85|||
148674036|NCT00728988|536277151|FG001|Overall Study|Other|77|||
148674037|NCT00728988|536277150|FG000|Overall Study|Withdrawal by Subject|2|||
148674038|NCT00728988|536277151|FG001|Overall Study|Withdrawal by Subject|6|||
148674039|NCT05674721|536277152|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
148674040|NCT05674721|536277153|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
148674041|NCT05674721|536277152|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
148674042|NCT05674721|536277153|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
148674043|NCT05013749|536277164|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
148674044|NCT05013749|536277165|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
148674045|NCT05013749|536277164|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
148674046|NCT05013749|536277165|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
148674047|NCT02017535|536277168|FG000|Overall Study|Withdrawal by Subject|1|||
148674048|NCT02017535|536277169|FG001|Overall Study|Withdrawal by Subject|0|||
148674049|NCT02017535|536277170|FG002|Overall Study|Withdrawal by Subject|0|||
148674050|NCT02017535|536277171|FG003|Overall Study|Withdrawal by Subject|0|||
148674051|NCT02426125|536277172|FG000|Overall Study|Lost to Follow-up|14|||
148674052|NCT02426125|536277173|FG001|Overall Study|Lost to Follow-up|12|||
148674053|NCT02426125|536277172|FG000|Overall Study|Withdrawal by Subject|13|||
148674054|NCT02426125|536277173|FG001|Overall Study|Withdrawal by Subject|14|||
148674055|NCT02426125|536277172|FG000|Overall Study|Death|185|||
148674056|NCT02426125|536277173|FG001|Overall Study|Death|200|||
148674057|NCT02426125|536277172|FG000|Overall Study|Randomized, But Never Treated|5|||
148674058|NCT02426125|536277173|FG001|Overall Study|Randomized, But Never Treated|2|||
149159908|NCT04949841|538061480|FG000|Overall Study|Various reasons|9|||
149159909|NCT03110900|538061486|FG000|Overall Study|Sponsor withdrew|1|||
149159910|NCT03110900|538061487|FG001|Overall Study|Sponsor withdrew|1|||
149159911|NCT00644787|538061488|FG000|Period 1: Titration Phase|Adverse Event|11|||
149159912|NCT00644787|538061489|FG001|Period 1: Titration Phase|Adverse Event|0|||
149159913|NCT00644787|538061490|FG002|Period 1: Titration Phase|Adverse Event|0|||
149159914|NCT00644787|538061488|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
149159915|NCT00644787|538061489|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
149159916|NCT00644787|538061490|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
149159917|NCT00644787|538061488|FG000|Period 1: Titration Phase|Physician Decision|1|||
149159918|NCT00644787|538061489|FG001|Period 1: Titration Phase|Physician Decision|0|||
149159919|NCT00644787|538061490|FG002|Period 1: Titration Phase|Physician Decision|0|||
149159920|NCT00644787|538061488|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
149159921|NCT00644787|538061489|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
149159922|NCT00644787|538061490|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
149159923|NCT00644787|538061488|FG000|Period 1: Titration Phase|Worsening of complications|1|||
149159924|NCT00644787|538061489|FG001|Period 1: Titration Phase|Worsening of complications|0|||
149159925|NCT00644787|538061490|FG002|Period 1: Titration Phase|Worsening of complications|0|||
148806037|NCT05911841|536768044|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
148925031|NCT04393298|537210890|FG004|Overall Study|Progressive Disease (PD)|0|||
148925032|NCT04393298|537210891|FG005|Overall Study|Progressive Disease (PD)|0|||
148925033|NCT04393298|537210892|FG006|Overall Study|Progressive Disease (PD)|0|||
148925034|NCT04393298|537210893|FG007|Overall Study|Progressive Disease (PD)|0|||
149159926|NCT00644787|538061488|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
149159927|NCT00644787|538061489|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
149159928|NCT00644787|538061490|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
149159929|NCT00644787|538061488|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
149159930|NCT00644787|538061489|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
149159931|NCT00644787|538061490|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
149159932|NCT00644787|538061488|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
149159933|NCT00644787|538061489|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
149159934|NCT00644787|538061490|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
149159935|NCT00644787|538061488|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
149159936|NCT00644787|538061489|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
149159937|NCT00644787|538061490|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
149159938|NCT00644787|538061488|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
149159939|NCT00644787|538061489|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
149159940|NCT00644787|538061490|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
149159941|NCT00644787|538061488|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
149159942|NCT00644787|538061489|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
149159943|NCT00644787|538061490|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
149159944|NCT00644787|538061488|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
149159945|NCT00644787|538061489|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
149159946|NCT00644787|538061490|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
149159947|NCT03355300|538061491|FG000|Overall Study|Physician Decision|0|||
149159948|NCT03355300|538061492|FG001|Overall Study|Physician Decision|1|||
149159949|NCT03355300|538061491|FG000|Overall Study|Lack of Efficacy|2|||
149159950|NCT03355300|538061492|FG001|Overall Study|Lack of Efficacy|1|||
149159951|NCT03355300|538061491|FG000|Overall Study|Other reason|1|||
149159952|NCT03355300|538061492|FG001|Overall Study|Other reason|0|||
149159953|NCT01031446|538061498|FG000|Overall Study|Disease Progression|38|||
149159954|NCT01031446|538061498|FG000|Overall Study|Adverse Event|9|||
149159955|NCT01031446|538061498|FG000|Overall Study|Physician Decision|4|||
149159956|NCT01031446|538061498|FG000|Overall Study|Withdrawal by Subject|3|||
149159957|NCT01031446|538061498|FG000|Overall Study|Still on treatment|1|||
149159958|NCT00500682|538061499|FG000|Overall Study|Adverse Event|37|||
149159959|NCT00500682|538061500|FG001|Overall Study|Adverse Event|29|||
149159960|NCT00500682|538061499|FG000|Overall Study|Death|25|||
149159961|NCT00500682|538061500|FG001|Overall Study|Death|16|||
149159962|NCT00500682|538061499|FG000|Overall Study|Lost to Follow-up|11|||
149159963|NCT00500682|538061500|FG001|Overall Study|Lost to Follow-up|11|||
149159964|NCT00500682|538061499|FG000|Overall Study|Physician Decision|6|||
148925035|NCT04393298|537210894|FG008|Overall Study|Progressive Disease (PD)|0|||
149159965|NCT00500682|538061500|FG001|Overall Study|Physician Decision|10|||
149159966|NCT00500682|538061499|FG000|Overall Study|Pregnancy|2|||
149159967|NCT00500682|538061500|FG001|Overall Study|Pregnancy|0|||
149159968|NCT00500682|538061499|FG000|Overall Study|Protocol Violation|1|||
149159969|NCT00500682|538061500|FG001|Overall Study|Protocol Violation|3|||
149159970|NCT00500682|538061499|FG000|Overall Study|Withdrawal by Subject|80|||
149159971|NCT00500682|538061500|FG001|Overall Study|Withdrawal by Subject|74|||
149159972|NCT00500682|538061499|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
148925036|NCT04393298|537210895|FG009|Overall Study|Progressive Disease (PD)|0|||
149159973|NCT00500682|538061500|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
149159974|NCT02531646|538061503|FG000|Overall Study|equip. image processing issue|5|||
149159975|NCT02531646|538061504|FG001|Overall Study|equip. image processing issue|1|||
149159976|NCT02531646|538061505|FG002|Overall Study|equip. image processing issue|0|||
149159977|NCT03344003|538061509|FG000|Overall Study|Switched to alternative treatment|1|||
149159978|NCT03344003|538061510|FG001|Overall Study|Switched to alternative treatment|0|||
149159979|NCT03344003|538061509|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
149159980|NCT03344003|538061510|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
149159981|NCT01182428|538061511|FG000|Overall Study|Physician Decision|1|||
149159982|NCT01182428|538061512|FG001|Overall Study|Physician Decision|0|||
149159983|NCT01182428|538061511|FG000|Overall Study|Lost to Follow-up|9|||
149159984|NCT01182428|538061512|FG001|Overall Study|Lost to Follow-up|1|||
149159985|NCT01182428|538061511|FG000|Overall Study|Withdrawal by Subject|1|||
149159986|NCT01182428|538061512|FG001|Overall Study|Withdrawal by Subject|0|||
149159987|NCT06272370|538062883|FG000|Overall Study|Lost to Follow-up|0|||
149159988|NCT06272370|538062884|FG001|Overall Study|Lost to Follow-up|3|||
149159989|NCT06272370|538062885|FG002|Overall Study|Lost to Follow-up|1|||
149159990|NCT06272370|538062886|FG003|Overall Study|Lost to Follow-up|1|||
149159991|NCT02949128|538062889|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
149159992|NCT02949128|538062889|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
149159993|NCT02949128|538062889|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
149159994|NCT02949128|538062889|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
149159995|NCT02949128|538062889|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
149159996|NCT02949128|538062889|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
149159997|NCT02949128|538062889|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
149159998|NCT02949128|538062889|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
149159999|NCT02949128|538062889|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
149160000|NCT02949128|538062889|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
149160001|NCT01916980|538062890|FG000|Overall Study|Adverse Event|4|||
149160002|NCT01916980|538062891|FG001|Overall Study|Adverse Event|2|||
149160003|NCT01916980|538062890|FG000|Overall Study|Lack of Efficacy|2|||
149160004|NCT01916980|538062891|FG001|Overall Study|Lack of Efficacy|2|||
149160005|NCT01916980|538062890|FG000|Overall Study|Withdrawal by Subject|1|||
149160006|NCT01916980|538062891|FG001|Overall Study|Withdrawal by Subject|0|||
149160007|NCT03521791|538062892|FG000|Overall Study|Protocol Violation|7|||
149160008|NCT03521791|538062893|FG001|Overall Study|Protocol Violation|17|||
149160009|NCT03064763|538062894|FG000|Overall Study|Lost to Follow-up|1|||
149160010|NCT03064763|538062894|FG000|Overall Study|Death|8|||
149160011|NCT00680836|538062895|FG000|Overall Study|Withdrawal by Subject|3|||
149160012|NCT00680836|538062896|FG001|Overall Study|Withdrawal by Subject|0|||
149160013|NCT00680836|538062895|FG000|Overall Study|Lost to Follow-up|3|||
149160014|NCT00680836|538062896|FG001|Overall Study|Lost to Follow-up|1|||
149160015|NCT00680836|538062895|FG000|Overall Study|Physician Decision|2|||
149160016|NCT00680836|538062896|FG001|Overall Study|Physician Decision|1|||
149160017|NCT03786432|538062897|FG000|Overall Study|Screen Failure after consent|1|||
149160018|NCT03786432|538062897|FG000|Overall Study|Lost to Follow-up|4|||
149160019|NCT03786432|538062897|FG000|Overall Study|did not complete 12 month CT scan|1|||
149160020|NCT03038308|538062898|FG000|Overall Study|Surgical resection|1|||
149160021|NCT03038308|538062898|FG000|Overall Study|Withdrawal by Subject|2|||
149160022|NCT03038308|538062898|FG000|Overall Study|Lost to Follow-up|1|||
149160023|NCT03593915|538062901|FG000|Overall Study|Adverse Event|0|||
149160024|NCT03593915|538062902|FG001|Overall Study|Adverse Event|0|||
149160025|NCT03593915|538062903|FG002|Overall Study|Adverse Event|0|||
149160026|NCT03593915|538062904|FG003|Overall Study|Adverse Event|1|||
149160027|NCT03593915|538062905|FG004|Overall Study|Adverse Event|0|||
149160028|NCT03593915|538062906|FG005|Overall Study|Adverse Event|0|||
149160029|NCT03593915|538062901|FG000|Overall Study|Physician Decision|0|||
149160030|NCT03593915|538062902|FG001|Overall Study|Physician Decision|0|||
149160031|NCT03593915|538062903|FG002|Overall Study|Physician Decision|0|||
149160032|NCT03593915|538062904|FG003|Overall Study|Physician Decision|0|||
149160033|NCT03593915|538062905|FG004|Overall Study|Physician Decision|0|||
149160034|NCT03593915|538062906|FG005|Overall Study|Physician Decision|1|||
149160035|NCT01583179|538062907|FG000|Overall Study|Screen failure|1|||
149160036|NCT01583179|538062908|FG001|Overall Study|Screen failure|2|||
149160037|NCT01220414|538062909|FG000|Overall Study|Withdrawal by Subject|1|||
149160038|NCT01220414|538062910|FG001|Overall Study|Withdrawal by Subject|0|||
149160039|NCT01220414|538062911|FG002|Overall Study|Withdrawal by Subject|0|||
149160040|NCT01220414|538062912|FG003|Overall Study|Withdrawal by Subject|1|||
149160041|NCT00623831|538062913|FG000|Overall Study|Withdrawal by Subject|1|||
149160042|NCT00623831|538062914|FG001|Overall Study|Withdrawal by Subject|0|||
149160043|NCT00623831|538062913|FG000|Overall Study|Progressive Disease|0|||
149160044|NCT00623831|538062914|FG001|Overall Study|Progressive Disease|1|||
149160045|NCT03555266|538062917|FG000|Overall Study|Protocol Violation|6|||
149160046|NCT03555266|538062918|FG001|Overall Study|Protocol Violation|4|||
149160047|NCT03370770|538062919|FG000|Overall Study|Patient was followed in another hospital center|1|||
149160048|NCT03370770|538062919|FG000|Overall Study|Progressive Disease|98|||
149160049|NCT03370770|538062919|FG000|Overall Study|Adverse Event|2|||
149160050|NCT03370770|538062919|FG000|Overall Study|Death|5|||
149160051|NCT00132730|538062923|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
149160052|NCT00132730|538062924|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
149160053|NCT00132730|538062925|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
149160054|NCT00132730|538062926|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
149160055|NCT00132730|538062927|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
149160056|NCT00132730|538062928|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
149160057|NCT00132730|538062923|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
149160058|NCT00132730|538062924|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
149160059|NCT00132730|538062925|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149160060|NCT00132730|538062926|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149160061|NCT00132730|538062927|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149160062|NCT00132730|538062928|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
149160063|NCT00132730|538062923|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
149160064|NCT00132730|538062924|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
149160065|NCT00132730|538062925|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
149160066|NCT00132730|538062926|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
149160067|NCT00132730|538062927|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
149160068|NCT00132730|538062928|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
149160069|NCT00132730|538062923|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149160070|NCT00132730|538062924|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149160071|NCT00132730|538062925|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
149160072|NCT00132730|538062926|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
149160073|NCT00132730|538062927|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149160074|NCT00132730|538062928|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
149160075|NCT00132730|538062923|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149160076|NCT00132730|538062924|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149160077|NCT00132730|538062925|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
149160078|NCT00132730|538062926|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
149160079|NCT00132730|538062927|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149160080|NCT00132730|538062928|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
149160081|NCT00132730|538062923|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149160082|NCT00132730|538062924|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
148925037|NCT04393298|537210896|FG010|Overall Study|Progressive Disease (PD)|0|||
148925038|NCT04393298|537210897|FG011|Overall Study|Progressive Disease (PD)|0|||
148925039|NCT04393298|537210898|FG012|Overall Study|Progressive Disease (PD)|0|||
148925040|NCT04393298|537210899|FG013|Overall Study|Progressive Disease (PD)|0|||
149160083|NCT00132730|538062925|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149160084|NCT00132730|538062926|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
149160085|NCT00132730|538062927|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149160086|NCT00132730|538062928|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
149160087|NCT00132730|538062923|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149012852|NCT01468922|537525816|FG003|Overall Study|Infection of blood|0|||
149160088|NCT00132730|538062924|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149160089|NCT00132730|538062925|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
149160090|NCT00132730|538062926|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
149160091|NCT00132730|538062927|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149160092|NCT00132730|538062928|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
149160093|NCT00132730|538062923|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149160094|NCT00132730|538062924|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149160095|NCT00132730|538062925|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149160096|NCT00132730|538062926|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
149160097|NCT00132730|538062927|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
149160098|NCT00132730|538062928|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
149160099|NCT00132730|538062923|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149160100|NCT00132730|538062924|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149160101|NCT00132730|538062925|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149160102|NCT00132730|538062926|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149160103|NCT00132730|538062927|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
149160104|NCT00132730|538062928|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
149160105|NCT00132730|538062923|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149160106|NCT00132730|538062924|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149160107|NCT00132730|538062925|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149160108|NCT00132730|538062926|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149160109|NCT00132730|538062927|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
149160110|NCT00132730|538062928|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
149160111|NCT00132730|538062923|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149160112|NCT00132730|538062924|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149160113|NCT00132730|538062925|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149160114|NCT00132730|538062926|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149160115|NCT00132730|538062927|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
149160116|NCT00132730|538062928|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
149160117|NCT00132730|538062923|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149160118|NCT00132730|538062924|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149160119|NCT00132730|538062925|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149160120|NCT00132730|538062926|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
149160121|NCT00132730|538062927|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
149160122|NCT00132730|538062928|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
149160123|NCT00179959|538062929|FG000|Overall Study|Lost to Follow-up|3|||
149160124|NCT00179959|538062930|FG001|Overall Study|Lost to Follow-up|1|||
149160125|NCT00179959|538062929|FG000|Overall Study|Withdrawal by Subject|3|||
149160126|NCT00179959|538062930|FG001|Overall Study|Withdrawal by Subject|2|||
149160127|NCT01262976|538062931|FG000|Up to Month 2|Serious Adverse Event|0|||
149160128|NCT01262976|538062932|FG001|Up to Month 2|Serious Adverse Event|0|||
149160129|NCT01262976|538062933|FG002|Up to Month 2|Serious Adverse Event|1|||
149160130|NCT01262976|538062934|FG003|Up to Month 2|Serious Adverse Event|0|||
149160131|NCT01262976|538062935|FG004|Up to Month 2|Serious Adverse Event|0|||
149160132|NCT01262976|538062936|FG005|Up to Month 2|Serious Adverse Event|0|||
149160133|NCT01262976|538062931|FG000|Up to Month 2|Withdrawal by Subject|1|||
149160134|NCT01262976|538062932|FG001|Up to Month 2|Withdrawal by Subject|0|||
149160135|NCT01262976|538062933|FG002|Up to Month 2|Withdrawal by Subject|0|||
149160136|NCT01262976|538062934|FG003|Up to Month 2|Withdrawal by Subject|0|||
149160137|NCT01262976|538062935|FG004|Up to Month 2|Withdrawal by Subject|0|||
149160138|NCT01262976|538062936|FG005|Up to Month 2|Withdrawal by Subject|0|||
149160139|NCT01262976|538062931|FG000|Up to Month 2|Migrated/moved from study area|0|||
149160140|NCT01262976|538062932|FG001|Up to Month 2|Migrated/moved from study area|1|||
149160141|NCT01262976|538062933|FG002|Up to Month 2|Migrated/moved from study area|0|||
149160142|NCT01262976|538062934|FG003|Up to Month 2|Migrated/moved from study area|0|||
149160143|NCT01262976|538062935|FG004|Up to Month 2|Migrated/moved from study area|1|||
149160144|NCT01262976|538062936|FG005|Up to Month 2|Migrated/moved from study area|1|||
149160145|NCT01262976|538062931|FG000|Up to Month 2|Lost to Follow-up|1|||
149160146|NCT01262976|538062932|FG001|Up to Month 2|Lost to Follow-up|0|||
149160147|NCT01262976|538062933|FG002|Up to Month 2|Lost to Follow-up|0|||
149160148|NCT01262976|538062934|FG003|Up to Month 2|Lost to Follow-up|1|||
149160149|NCT01262976|538062935|FG004|Up to Month 2|Lost to Follow-up|1|||
149160150|NCT01262976|538062936|FG005|Up to Month 2|Lost to Follow-up|1|||
149160151|NCT01262976|538062931|FG000|Up to Month 2|Other|1|||
149160152|NCT01262976|538062932|FG001|Up to Month 2|Other|0|||
149160153|NCT01262976|538062933|FG002|Up to Month 2|Other|0|||
149160154|NCT01262976|538062934|FG003|Up to Month 2|Other|1|||
148674059|NCT00938015|536277174|FG000|Overall Study|Death|2|||
148674060|NCT00938015|536277174|FG000|Overall Study|Lost to Follow-up|32|||
148674061|NCT00938015|536277174|FG000|Overall Study|Adverse Event|32|||
148674062|NCT00938015|536277174|FG000|Overall Study|Non-responder|52|||
148674063|NCT00938015|536277174|FG000|Overall Study|Reason not related to Etanercept|29|||
148674064|NCT02341482|536277175|FG000|Overall Study|Adverse Event|1|||
148674065|NCT03186794|536277176|FG000|Overall Study|Physician Decision|2|||
148674066|NCT03186794|536277176|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
148674067|NCT00440193|536277178|FG000|Treatment Period|Adverse Event|74|||
148674068|NCT00440193|536277179|FG001|Treatment Period|Adverse Event|67|||
148674069|NCT00440193|536277178|FG000|Treatment Period|Death|19|||
148674070|NCT00440193|536277179|FG001|Treatment Period|Death|22|||
148674071|NCT00440193|536277178|FG000|Treatment Period|Lack of Efficacy|0|||
148674072|NCT00440193|536277179|FG001|Treatment Period|Lack of Efficacy|1|||
148806038|NCT05911841|536768045|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
148806039|NCT05911841|536768046|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149160155|NCT01262976|538062935|FG004|Up to Month 2|Other|0|||
149160156|NCT01262976|538062936|FG005|Up to Month 2|Other|2|||
149160157|NCT01262976|538062931|FG000|Up to Month 7|Serious Adverse Event|0|||
149160158|NCT01262976|538062932|FG001|Up to Month 7|Serious Adverse Event|0|||
149160159|NCT01262976|538062933|FG002|Up to Month 7|Serious Adverse Event|2|||
149160160|NCT01262976|538062934|FG003|Up to Month 7|Serious Adverse Event|0|||
149160161|NCT01262976|538062935|FG004|Up to Month 7|Serious Adverse Event|0|||
149160162|NCT01262976|538062936|FG005|Up to Month 7|Serious Adverse Event|0|||
149160163|NCT01262976|538062931|FG000|Up to Month 7|Withdrawal by Subject|1|||
149160164|NCT01262976|538062932|FG001|Up to Month 7|Withdrawal by Subject|0|||
149160165|NCT01262976|538062933|FG002|Up to Month 7|Withdrawal by Subject|0|||
149160166|NCT01262976|538062934|FG003|Up to Month 7|Withdrawal by Subject|0|||
149160167|NCT01262976|538062935|FG004|Up to Month 7|Withdrawal by Subject|0|||
149160168|NCT01262976|538062936|FG005|Up to Month 7|Withdrawal by Subject|0|||
149160169|NCT01262976|538062931|FG000|Up to Month 7|Migrated/moved from study area|0|||
149160170|NCT01262976|538062932|FG001|Up to Month 7|Migrated/moved from study area|0|||
149160171|NCT01262976|538062933|FG002|Up to Month 7|Migrated/moved from study area|1|||
149160172|NCT01262976|538062934|FG003|Up to Month 7|Migrated/moved from study area|3|||
149160173|NCT01262976|538062935|FG004|Up to Month 7|Migrated/moved from study area|1|||
149160174|NCT01262976|538062936|FG005|Up to Month 7|Migrated/moved from study area|1|||
149160175|NCT01262976|538062931|FG000|Up to Month 7|Lost to Follow-up|1|||
149160176|NCT01262976|538062932|FG001|Up to Month 7|Lost to Follow-up|0|||
149160177|NCT01262976|538062933|FG002|Up to Month 7|Lost to Follow-up|1|||
149160178|NCT01262976|538062934|FG003|Up to Month 7|Lost to Follow-up|3|||
149160179|NCT01262976|538062935|FG004|Up to Month 7|Lost to Follow-up|1|||
149160180|NCT01262976|538062936|FG005|Up to Month 7|Lost to Follow-up|3|||
149160181|NCT01262976|538062931|FG000|Up to Month 7|Other|3|||
149160182|NCT01262976|538062932|FG001|Up to Month 7|Other|0|||
149160183|NCT01262976|538062933|FG002|Up to Month 7|Other|2|||
149160184|NCT01262976|538062934|FG003|Up to Month 7|Other|0|||
149160185|NCT01262976|538062935|FG004|Up to Month 7|Other|0|||
149160186|NCT01262976|538062936|FG005|Up to Month 7|Other|0|||
149160187|NCT01262976|538062931|FG000|Up to Year 1|Serious Adverse Event|0|||
149160188|NCT01262976|538062932|FG001|Up to Year 1|Serious Adverse Event|0|||
149160189|NCT01262976|538062933|FG002|Up to Year 1|Serious Adverse Event|2|||
149160190|NCT01262976|538062934|FG003|Up to Year 1|Serious Adverse Event|0|||
149160191|NCT01262976|538062935|FG004|Up to Year 1|Serious Adverse Event|0|||
149160192|NCT01262976|538062936|FG005|Up to Year 1|Serious Adverse Event|0|||
149160193|NCT01262976|538062931|FG000|Up to Year 1|Withdrawal by Subject|1|||
149160194|NCT01262976|538062932|FG001|Up to Year 1|Withdrawal by Subject|0|||
149160195|NCT01262976|538062933|FG002|Up to Year 1|Withdrawal by Subject|0|||
149160196|NCT01262976|538062934|FG003|Up to Year 1|Withdrawal by Subject|0|||
149160197|NCT01262976|538062935|FG004|Up to Year 1|Withdrawal by Subject|0|||
149160198|NCT01262976|538062936|FG005|Up to Year 1|Withdrawal by Subject|0|||
149160199|NCT01262976|538062931|FG000|Up to Year 1|Migrated/moved from study area|1|||
149160200|NCT01262976|538062932|FG001|Up to Year 1|Migrated/moved from study area|0|||
149160201|NCT01262976|538062933|FG002|Up to Year 1|Migrated/moved from study area|0|||
149160202|NCT01262976|538062934|FG003|Up to Year 1|Migrated/moved from study area|3|||
149160203|NCT01262976|538062935|FG004|Up to Year 1|Migrated/moved from study area|3|||
149160204|NCT01262976|538062936|FG005|Up to Year 1|Migrated/moved from study area|2|||
148674073|NCT00440193|536277178|FG000|Treatment Period|Lost to Follow-up|12|||
148674074|NCT00440193|536277179|FG001|Treatment Period|Lost to Follow-up|18|||
148674075|NCT00440193|536277178|FG000|Treatment Period|Physician Decision|3|||
148674076|NCT00440193|536277179|FG001|Treatment Period|Physician Decision|6|||
148674077|NCT00440193|536277178|FG000|Treatment Period|Protocol Violation|16|||
149160205|NCT01262976|538062931|FG000|Up to Year 1|Lost to Follow-up|4|||
148674078|NCT00440193|536277179|FG001|Treatment Period|Protocol Violation|19|||
149160206|NCT01262976|538062932|FG001|Up to Year 1|Lost to Follow-up|0|||
149160207|NCT01262976|538062933|FG002|Up to Year 1|Lost to Follow-up|0|||
149160208|NCT01262976|538062934|FG003|Up to Year 1|Lost to Follow-up|1|||
149160209|NCT01262976|538062935|FG004|Up to Year 1|Lost to Follow-up|6|||
149160210|NCT01262976|538062936|FG005|Up to Year 1|Lost to Follow-up|5|||
149160211|NCT01262976|538062931|FG000|Up to Year 1|Other|3|||
149160212|NCT01262976|538062932|FG001|Up to Year 1|Other|1|||
149160213|NCT01262976|538062933|FG002|Up to Year 1|Other|0|||
149160214|NCT01262976|538062934|FG003|Up to Year 1|Other|0|||
149160215|NCT01262976|538062935|FG004|Up to Year 1|Other|2|||
149160216|NCT01262976|538062936|FG005|Up to Year 1|Other|1|||
149160217|NCT01262976|538062931|FG000|Up to Year 1|Subjects with unknown completion status|0|||
149160218|NCT01262976|538062932|FG001|Up to Year 1|Subjects with unknown completion status|0|||
149160219|NCT01262976|538062933|FG002|Up to Year 1|Subjects with unknown completion status|1|||
149160220|NCT01262976|538062934|FG003|Up to Year 1|Subjects with unknown completion status|0|||
149160221|NCT01262976|538062935|FG004|Up to Year 1|Subjects with unknown completion status|0|||
149160222|NCT01262976|538062936|FG005|Up to Year 1|Subjects with unknown completion status|1|||
149160223|NCT01262976|538062931|FG000|Up to Year 2|Serious Adverse Event|0|||
149160224|NCT01262976|538062932|FG001|Up to Year 2|Serious Adverse Event|0|||
149160225|NCT01262976|538062933|FG002|Up to Year 2|Serious Adverse Event|2|||
149160226|NCT01262976|538062934|FG003|Up to Year 2|Serious Adverse Event|0|||
149160227|NCT01262976|538062935|FG004|Up to Year 2|Serious Adverse Event|0|||
149160228|NCT01262976|538062936|FG005|Up to Year 2|Serious Adverse Event|0|||
149160229|NCT01262976|538062931|FG000|Up to Year 2|Withdrawal by Subject|1|||
149160230|NCT01262976|538062932|FG001|Up to Year 2|Withdrawal by Subject|0|||
149160231|NCT01262976|538062933|FG002|Up to Year 2|Withdrawal by Subject|0|||
149160232|NCT01262976|538062934|FG003|Up to Year 2|Withdrawal by Subject|0|||
149160233|NCT01262976|538062935|FG004|Up to Year 2|Withdrawal by Subject|0|||
149160234|NCT01262976|538062936|FG005|Up to Year 2|Withdrawal by Subject|0|||
149160235|NCT01262976|538062931|FG000|Up to Year 2|Migrated/moved from study area|0|||
149160236|NCT01262976|538062932|FG001|Up to Year 2|Migrated/moved from study area|0|||
149160237|NCT01262976|538062933|FG002|Up to Year 2|Migrated/moved from study area|0|||
149160238|NCT01262976|538062934|FG003|Up to Year 2|Migrated/moved from study area|2|||
149160239|NCT01262976|538062935|FG004|Up to Year 2|Migrated/moved from study area|1|||
149160240|NCT01262976|538062936|FG005|Up to Year 2|Migrated/moved from study area|2|||
149160241|NCT01262976|538062931|FG000|Up to Year 2|Lost to Follow-up|1|||
149160242|NCT01262976|538062932|FG001|Up to Year 2|Lost to Follow-up|1|||
149160243|NCT01262976|538062933|FG002|Up to Year 2|Lost to Follow-up|2|||
149160244|NCT01262976|538062934|FG003|Up to Year 2|Lost to Follow-up|2|||
149160245|NCT01262976|538062935|FG004|Up to Year 2|Lost to Follow-up|3|||
148925041|NCT04393298|537210900|FG014|Overall Study|Progressive Disease (PD)|0|||
148925042|NCT04393298|537210886|FG000|Overall Study|Started a New Cancer Treatment|0|||
148925043|NCT04393298|537210887|FG001|Overall Study|Started a New Cancer Treatment|0|||
148925044|NCT04393298|537210888|FG002|Overall Study|Started a New Cancer Treatment|0|||
148925045|NCT04393298|537210889|FG003|Overall Study|Started a New Cancer Treatment|0|||
149160246|NCT01262976|538062936|FG005|Up to Year 2|Lost to Follow-up|3|||
149160247|NCT01262976|538062931|FG000|Up to Year 2|Subjects with unknown completion status|0|||
149160248|NCT01262976|538062932|FG001|Up to Year 2|Subjects with unknown completion status|0|||
149160249|NCT01262976|538062933|FG002|Up to Year 2|Subjects with unknown completion status|1|||
149160250|NCT01262976|538062934|FG003|Up to Year 2|Subjects with unknown completion status|0|||
149160251|NCT01262976|538062935|FG004|Up to Year 2|Subjects with unknown completion status|0|||
149160252|NCT01262976|538062936|FG005|Up to Year 2|Subjects with unknown completion status|0|||
149160253|NCT01262976|538062931|FG000|Up to Year 2|Other|3|||
149160254|NCT01262976|538062932|FG001|Up to Year 2|Other|0|||
149160255|NCT01262976|538062933|FG002|Up to Year 2|Other|0|||
149160256|NCT01262976|538062934|FG003|Up to Year 2|Other|0|||
149160257|NCT01262976|538062935|FG004|Up to Year 2|Other|0|||
149160258|NCT01262976|538062936|FG005|Up to Year 2|Other|0|||
149160259|NCT01262976|538062931|FG000|Up to Year 3|Serious Adverse Event|0|||
149160260|NCT01262976|538062932|FG001|Up to Year 3|Serious Adverse Event|0|||
149160261|NCT01262976|538062933|FG002|Up to Year 3|Serious Adverse Event|2|||
149160262|NCT01262976|538062934|FG003|Up to Year 3|Serious Adverse Event|0|||
149160263|NCT01262976|538062935|FG004|Up to Year 3|Serious Adverse Event|0|||
149160264|NCT01262976|538062936|FG005|Up to Year 3|Serious Adverse Event|0|||
149160265|NCT01262976|538062931|FG000|Up to Year 3|Withdrawal by Subject|1|||
149160266|NCT01262976|538062932|FG001|Up to Year 3|Withdrawal by Subject|0|||
149160267|NCT01262976|538062933|FG002|Up to Year 3|Withdrawal by Subject|0|||
149160268|NCT01262976|538062934|FG003|Up to Year 3|Withdrawal by Subject|0|||
149160269|NCT01262976|538062935|FG004|Up to Year 3|Withdrawal by Subject|0|||
149160270|NCT01262976|538062936|FG005|Up to Year 3|Withdrawal by Subject|0|||
149160271|NCT01262976|538062931|FG000|Up to Year 3|Migrated/moved from study area|0|||
149160272|NCT01262976|538062932|FG001|Up to Year 3|Migrated/moved from study area|0|||
149160273|NCT01262976|538062933|FG002|Up to Year 3|Migrated/moved from study area|0|||
149160274|NCT01262976|538062934|FG003|Up to Year 3|Migrated/moved from study area|2|||
149160275|NCT01262976|538062935|FG004|Up to Year 3|Migrated/moved from study area|1|||
149160276|NCT01262976|538062936|FG005|Up to Year 3|Migrated/moved from study area|1|||
149160277|NCT01262976|538062931|FG000|Up to Year 3|Lost to Follow-up|2|||
149160278|NCT01262976|538062932|FG001|Up to Year 3|Lost to Follow-up|2|||
149160279|NCT01262976|538062933|FG002|Up to Year 3|Lost to Follow-up|4|||
149160280|NCT01262976|538062934|FG003|Up to Year 3|Lost to Follow-up|3|||
149160281|NCT01262976|538062935|FG004|Up to Year 3|Lost to Follow-up|1|||
148925046|NCT04393298|537210890|FG004|Overall Study|Started a New Cancer Treatment|1|||
148925047|NCT04393298|537210891|FG005|Overall Study|Started a New Cancer Treatment|0|||
148925048|NCT04393298|537210892|FG006|Overall Study|Started a New Cancer Treatment|0|||
149160282|NCT01262976|538062936|FG005|Up to Year 3|Lost to Follow-up|3|||
149160283|NCT01262976|538062931|FG000|Up to Year 3|Subjects with unknown completion status|0|||
149160284|NCT01262976|538062932|FG001|Up to Year 3|Subjects with unknown completion status|0|||
149160285|NCT01262976|538062933|FG002|Up to Year 3|Subjects with unknown completion status|1|||
149160286|NCT01262976|538062934|FG003|Up to Year 3|Subjects with unknown completion status|0|||
149160287|NCT01262976|538062935|FG004|Up to Year 3|Subjects with unknown completion status|0|||
149160288|NCT01262976|538062936|FG005|Up to Year 3|Subjects with unknown completion status|0|||
148925049|NCT04393298|537210893|FG007|Overall Study|Started a New Cancer Treatment|0|||
148925050|NCT04393298|537210894|FG008|Overall Study|Started a New Cancer Treatment|0|||
148925051|NCT04393298|537210895|FG009|Overall Study|Started a New Cancer Treatment|0|||
148925052|NCT04393298|537210896|FG010|Overall Study|Started a New Cancer Treatment|0|||
148925053|NCT04393298|537210897|FG011|Overall Study|Started a New Cancer Treatment|0|||
148925054|NCT04393298|537210898|FG012|Overall Study|Started a New Cancer Treatment|0|||
148925055|NCT04393298|537210899|FG013|Overall Study|Started a New Cancer Treatment|0|||
148925056|NCT04393298|537210900|FG014|Overall Study|Started a New Cancer Treatment|0|||
148925057|NCT04393298|537210886|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925058|NCT04393298|537210887|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925059|NCT04393298|537210888|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925060|NCT04393298|537210889|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925061|NCT04393298|537210890|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
148925062|NCT04393298|537210891|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925063|NCT04393298|537210892|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925064|NCT04393298|537210893|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925065|NCT04393298|537210894|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925066|NCT04393298|537210895|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925067|NCT04393298|537210896|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925068|NCT04393298|537210897|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925069|NCT04393298|537210898|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925070|NCT04393298|537210899|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925071|NCT04393298|537210900|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
148925072|NCT04393298|537210886|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925073|NCT04393298|537210887|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925074|NCT04393298|537210888|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925075|NCT04393298|537210889|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925076|NCT04393298|537210890|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925077|NCT04393298|537210891|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
148925078|NCT04393298|537210892|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925079|NCT04393298|537210893|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925080|NCT04393298|537210894|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925081|NCT04393298|537210895|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925082|NCT04393298|537210896|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925083|NCT04393298|537210897|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925084|NCT04393298|537210898|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925085|NCT04393298|537210899|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925086|NCT04393298|537210900|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
148925087|NCT04393298|537210886|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925088|NCT04393298|537210887|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925089|NCT04393298|537210888|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925090|NCT04393298|537210889|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925091|NCT04393298|537210890|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925092|NCT04393298|537210891|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
148925093|NCT04393298|537210892|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925094|NCT04393298|537210893|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925095|NCT04393298|537210894|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925096|NCT04393298|537210895|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925097|NCT04393298|537210896|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925098|NCT04393298|537210897|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925099|NCT04393298|537210898|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
149160289|NCT01262976|538062931|FG000|Up to Year 3|Other|3|||
149160290|NCT01262976|538062932|FG001|Up to Year 3|Other|0|||
149160291|NCT01262976|538062933|FG002|Up to Year 3|Other|0|||
149160292|NCT01262976|538062934|FG003|Up to Year 3|Other|0|||
148925100|NCT04393298|537210899|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
148925101|NCT04393298|537210900|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
148925102|NCT04393298|537210886|FG000|Overall Study|Death|0|||
149160293|NCT01262976|538062935|FG004|Up to Year 3|Other|0|||
149160294|NCT01262976|538062936|FG005|Up to Year 3|Other|0|||
149160295|NCT00236080|538062937|FG000|Overall Study|Adverse Event|0|||
149160296|NCT00236080|538062938|FG001|Overall Study|Adverse Event|0|||
149160297|NCT00236080|538062939|FG002|Overall Study|Adverse Event|3|||
149160298|NCT00236080|538062940|FG003|Overall Study|Adverse Event|1|||
149160299|NCT00236080|538062941|FG004|Overall Study|Adverse Event|0|||
149160300|NCT00236080|538062937|FG000|Overall Study|Lost to Follow-up|0|||
149160301|NCT00236080|538062938|FG001|Overall Study|Lost to Follow-up|1|||
149160302|NCT00236080|538062939|FG002|Overall Study|Lost to Follow-up|0|||
149160303|NCT00236080|538062940|FG003|Overall Study|Lost to Follow-up|0|||
149160304|NCT00236080|538062941|FG004|Overall Study|Lost to Follow-up|0|||
149160305|NCT00236080|538062937|FG000|Overall Study|Physician Decision|1|||
149160306|NCT00236080|538062938|FG001|Overall Study|Physician Decision|0|||
149160307|NCT00236080|538062939|FG002|Overall Study|Physician Decision|1|||
149160308|NCT00236080|538062940|FG003|Overall Study|Physician Decision|1|||
149160309|NCT00236080|538062941|FG004|Overall Study|Physician Decision|1|||
149160310|NCT00236080|538062937|FG000|Overall Study|Withdrawal by Subject|1|||
149160311|NCT00236080|538062938|FG001|Overall Study|Withdrawal by Subject|0|||
149160312|NCT00236080|538062939|FG002|Overall Study|Withdrawal by Subject|0|||
149160313|NCT00236080|538062940|FG003|Overall Study|Withdrawal by Subject|0|||
149160314|NCT00236080|538062941|FG004|Overall Study|Withdrawal by Subject|0|||
149160315|NCT00236080|538062937|FG000|Overall Study|Miscellaneous|0|||
149160316|NCT00236080|538062938|FG001|Overall Study|Miscellaneous|0|||
149160317|NCT00236080|538062939|FG002|Overall Study|Miscellaneous|1|||
148925103|NCT04393298|537210887|FG001|Overall Study|Death|0|||
148925104|NCT04393298|537210888|FG002|Overall Study|Death|0|||
148925105|NCT04393298|537210889|FG003|Overall Study|Death|0|||
149160318|NCT00236080|538062940|FG003|Overall Study|Miscellaneous|0|||
149160319|NCT00236080|538062941|FG004|Overall Study|Miscellaneous|0|||
149160320|NCT01214044|538062942|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
149160321|NCT01214044|538062942|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
149160322|NCT01214044|538062942|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
149160323|NCT01214044|538062942|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
149160324|NCT01214044|538062942|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
149160325|NCT01214044|538062942|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
149160326|NCT00408694|538062943|FG000|Overall Study|Ineligible|1|||
149160327|NCT00408694|538062943|FG000|Overall Study|No protocol treatment|1|||
149160328|NCT01961544|538062944|FG000|Overall Study|Protocol Violation|1|||
148925106|NCT04393298|537210890|FG004|Overall Study|Death|0|||
148925107|NCT04393298|537210891|FG005|Overall Study|Death|1|||
149160329|NCT01961544|538062944|FG000|Overall Study|Withdrawal by Subject|7|||
149160330|NCT01961544|538062944|FG000|Overall Study|Adverse Event|1|||
149160331|NCT01961544|538062944|FG000|Overall Study|Physician Decision|2|||
149160332|NCT01961544|538062944|FG000|Overall Study|Poor Tolerance|1|||
149160333|NCT01961544|538062944|FG000|Overall Study|Aggravation of Steral Pain|1|||
149160334|NCT00193063|538062945|FG000|Overall Study|Lack of Efficacy|3|||
149160335|NCT00193063|538062945|FG000|Overall Study|Adverse Event|1|||
149160336|NCT01127165|538062946|FG000|Overall Study|Adverse Event|2|||
149160337|NCT01127165|538062947|FG001|Overall Study|Adverse Event|2|||
149160338|NCT01127165|538062946|FG000|Overall Study|Lack of Efficacy|10|||
149160339|NCT01127165|538062947|FG001|Overall Study|Lack of Efficacy|8|||
149160340|NCT01127165|538062946|FG000|Overall Study|Lost to Follow-up|3|||
149160341|NCT01127165|538062947|FG001|Overall Study|Lost to Follow-up|5|||
149160342|NCT01127165|538062946|FG000|Overall Study|Withdrawal by Subject|1|||
149160343|NCT01127165|538062947|FG001|Overall Study|Withdrawal by Subject|3|||
149160344|NCT01127165|538062946|FG000|Overall Study|Protocol Violation|0|||
149160345|NCT01127165|538062947|FG001|Overall Study|Protocol Violation|1|||
149160346|NCT01017952|538062948|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
149160347|NCT01017952|538062949|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149160348|NCT01017952|538062950|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
148925108|NCT04393298|537210892|FG006|Overall Study|Death|1|||
149160349|NCT01017952|538062951|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149160350|NCT01017952|538062952|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149160351|NCT01017952|538062948|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
149160352|NCT01017952|538062949|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
149160353|NCT01017952|538062950|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
149160354|NCT01017952|538062951|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
149160355|NCT01017952|538062952|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
149160356|NCT01017952|538062948|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
149160357|NCT01017952|538062949|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149160358|NCT01017952|538062950|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149160359|NCT01017952|538062951|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149160360|NCT01017952|538062952|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
149160361|NCT01017952|538062948|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
149160362|NCT01017952|538062949|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149160363|NCT01017952|538062950|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149160364|NCT01017952|538062951|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149160365|NCT01017952|538062952|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149160366|NCT01017952|538062948|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
149160367|NCT01017952|538062949|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
149160368|NCT01017952|538062950|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
149160369|NCT01017952|538062951|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
149160370|NCT01017952|538062952|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
149160371|NCT01017952|538062948|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
149160372|NCT01017952|538062949|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149160373|NCT01017952|538062950|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149160374|NCT01017952|538062951|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149160375|NCT01017952|538062952|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149160376|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
149160377|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
149160378|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
149160379|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
149160380|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
149160381|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149160382|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
149160383|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
149160384|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
149160385|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
149160386|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149160387|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
149160388|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
149160389|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
148925109|NCT04393298|537210893|FG007|Overall Study|Death|0|||
148925110|NCT04393298|537210894|FG008|Overall Study|Death|1|||
148925111|NCT04393298|537210895|FG009|Overall Study|Death|1|||
148925112|NCT04393298|537210896|FG010|Overall Study|Death|0|||
148925113|NCT04393298|537210897|FG011|Overall Study|Death|1|||
148925114|NCT04393298|537210898|FG012|Overall Study|Death|1|||
148925115|NCT04393298|537210899|FG013|Overall Study|Death|0|||
148925116|NCT04393298|537210900|FG014|Overall Study|Death|1|||
148925117|NCT04393298|537210886|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925118|NCT04393298|537210887|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925119|NCT04393298|537210888|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925120|NCT04393298|537210889|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925121|NCT04393298|537210890|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925122|NCT04393298|537210891|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
148925123|NCT04393298|537210892|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925124|NCT04393298|537210893|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925125|NCT04393298|537210894|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925126|NCT04393298|537210895|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925127|NCT04393298|537210896|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925128|NCT04393298|537210897|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925129|NCT04393298|537210898|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925130|NCT04393298|537210899|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925131|NCT04393298|537210900|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
148925132|NCT04393298|537210886|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
148925133|NCT04393298|537210887|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
148925134|NCT04393298|537210888|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
148925135|NCT04393298|537210889|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
148925136|NCT04393298|537210890|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
148925137|NCT04393298|537210891|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
148925138|NCT04393298|537210892|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
148925139|NCT04393298|537210893|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
148925140|NCT04393298|537210894|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
148925141|NCT04393298|537210895|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
148925142|NCT04393298|537210896|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
148925143|NCT04393298|537210897|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
148925144|NCT04393298|537210898|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
148925145|NCT04393298|537210899|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
149012853|NCT01468922|537525817|FG004|Overall Study|Infection of blood|0|||
148925146|NCT04393298|537210900|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
148925147|NCT04393298|537210886|FG000|Overall Study|Patient Passed Away|0|||
148925148|NCT04393298|537210887|FG001|Overall Study|Patient Passed Away|0|||
148925149|NCT04393298|537210888|FG002|Overall Study|Patient Passed Away|0|||
148925150|NCT04393298|537210889|FG003|Overall Study|Patient Passed Away|0|||
148925151|NCT04393298|537210890|FG004|Overall Study|Patient Passed Away|0|||
148925152|NCT04393298|537210891|FG005|Overall Study|Patient Passed Away|0|||
148925153|NCT04393298|537210892|FG006|Overall Study|Patient Passed Away|0|||
148925154|NCT04393298|537210893|FG007|Overall Study|Patient Passed Away|1|||
148925155|NCT04393298|537210894|FG008|Overall Study|Patient Passed Away|0|||
148925156|NCT04393298|537210895|FG009|Overall Study|Patient Passed Away|0|||
148925157|NCT04393298|537210896|FG010|Overall Study|Patient Passed Away|0|||
148925158|NCT04393298|537210897|FG011|Overall Study|Patient Passed Away|0|||
148925159|NCT04393298|537210898|FG012|Overall Study|Patient Passed Away|0|||
148925160|NCT04393298|537210899|FG013|Overall Study|Patient Passed Away|0|||
148925161|NCT04393298|537210900|FG014|Overall Study|Patient Passed Away|0|||
148925162|NCT04393298|537210886|FG000|Overall Study|Patient Deceased|0|||
148925163|NCT04393298|537210887|FG001|Overall Study|Patient Deceased|0|||
148925164|NCT04393298|537210888|FG002|Overall Study|Patient Deceased|0|||
148925165|NCT04393298|537210889|FG003|Overall Study|Patient Deceased|0|||
148925166|NCT04393298|537210890|FG004|Overall Study|Patient Deceased|0|||
148925167|NCT04393298|537210891|FG005|Overall Study|Patient Deceased|0|||
148925168|NCT04393298|537210892|FG006|Overall Study|Patient Deceased|0|||
148925169|NCT04393298|537210893|FG007|Overall Study|Patient Deceased|1|||
148925170|NCT04393298|537210894|FG008|Overall Study|Patient Deceased|0|||
148925171|NCT04393298|537210895|FG009|Overall Study|Patient Deceased|0|||
148925172|NCT04393298|537210896|FG010|Overall Study|Patient Deceased|0|||
148925173|NCT04393298|537210897|FG011|Overall Study|Patient Deceased|0|||
148925174|NCT04393298|537210898|FG012|Overall Study|Patient Deceased|0|||
148925175|NCT04393298|537210899|FG013|Overall Study|Patient Deceased|0|||
148925176|NCT04393298|537210900|FG014|Overall Study|Patient Deceased|0|||
148925177|NCT04393298|537210886|FG000|Overall Study|Patient Discharged to Hospice|0|||
148925178|NCT04393298|537210887|FG001|Overall Study|Patient Discharged to Hospice|0|||
148925179|NCT04393298|537210888|FG002|Overall Study|Patient Discharged to Hospice|0|||
148925180|NCT04393298|537210889|FG003|Overall Study|Patient Discharged to Hospice|0|||
148925181|NCT04393298|537210890|FG004|Overall Study|Patient Discharged to Hospice|0|||
148925182|NCT04393298|537210891|FG005|Overall Study|Patient Discharged to Hospice|0|||
148925183|NCT04393298|537210892|FG006|Overall Study|Patient Discharged to Hospice|0|||
148925184|NCT04393298|537210893|FG007|Overall Study|Patient Discharged to Hospice|0|||
148925185|NCT04393298|537210894|FG008|Overall Study|Patient Discharged to Hospice|1|||
148925186|NCT04393298|537210895|FG009|Overall Study|Patient Discharged to Hospice|0|||
148925187|NCT04393298|537210896|FG010|Overall Study|Patient Discharged to Hospice|0|||
148925188|NCT04393298|537210897|FG011|Overall Study|Patient Discharged to Hospice|0|||
148925189|NCT04393298|537210898|FG012|Overall Study|Patient Discharged to Hospice|0|||
148925190|NCT04393298|537210899|FG013|Overall Study|Patient Discharged to Hospice|0|||
148925191|NCT04393298|537210900|FG014|Overall Study|Patient Discharged to Hospice|0|||
149160390|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
149160391|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
149160392|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
149160393|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
149160394|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
149160395|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
149160396|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149160397|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
149160398|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
149160399|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
149160400|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
149160401|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
148925192|NCT04393298|537210886|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925193|NCT04393298|537210887|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925194|NCT04393298|537210888|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925195|NCT04393298|537210889|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925196|NCT04393298|537210890|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925197|NCT04393298|537210891|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925198|NCT04393298|537210892|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925199|NCT04393298|537210893|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925200|NCT04393298|537210894|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925201|NCT04393298|537210895|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
148925202|NCT04393298|537210896|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925203|NCT04393298|537210897|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925204|NCT04393298|537210898|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925205|NCT04393298|537210899|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925206|NCT04393298|537210900|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
148925207|NCT04393298|537210886|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
148925208|NCT04393298|537210887|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
148925209|NCT04393298|537210888|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
148925210|NCT04393298|537210889|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
148925211|NCT04393298|537210890|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
148925212|NCT04393298|537210891|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
148925213|NCT04393298|537210892|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
148925214|NCT04393298|537210893|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
148925215|NCT04393298|537210894|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
148925216|NCT04393298|537210895|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
148925217|NCT04393298|537210896|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
148925218|NCT04393298|537210897|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
148925219|NCT04393298|537210898|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
148925220|NCT04393298|537210899|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
148925221|NCT04393298|537210900|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
148925222|NCT03754972|537210903|FG000|Overall Study|Protocol Violation|25|||
148925223|NCT05128929|537210905|FG000|Overall Study|Adverse Event|0|||
148925224|NCT05128929|537210906|FG001|Overall Study|Adverse Event|1|||
149160402|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
149160403|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
149160404|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149160405|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149160406|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149160407|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
149160408|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
149160409|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
149160410|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
149160411|NCT01017952|538062948|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
149160412|NCT01017952|538062949|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
149160413|NCT01017952|538062950|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
149160414|NCT01017952|538062951|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
149160415|NCT01017952|538062952|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
148811246|NCT01995201|536787051|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
148925225|NCT02278341|537210911|FG000|Overall Study|Randomized but never received study drug|1|||
149160416|NCT01064167|538062953|FG000|Overall Study|Protocol Violation|14|||
149160417|NCT01064167|538062954|FG001|Overall Study|Protocol Violation|15|||
149160418|NCT03543410|538062959|FG000|Overall Study|Adverse Event|10|||
149160419|NCT03543410|538062960|FG001|Overall Study|Adverse Event|8|||
149160420|NCT03543410|538062961|FG002|Overall Study|Adverse Event|2|||
149160421|NCT03543410|538062959|FG000|Overall Study|Lack of Efficacy|0|||
149160422|NCT03543410|538062960|FG001|Overall Study|Lack of Efficacy|1|||
149160423|NCT03543410|538062961|FG002|Overall Study|Lack of Efficacy|0|||
149160424|NCT03543410|538062959|FG000|Overall Study|Lost to Follow-up|0|||
149160425|NCT03543410|538062960|FG001|Overall Study|Lost to Follow-up|1|||
149160426|NCT03543410|538062961|FG002|Overall Study|Lost to Follow-up|0|||
149160427|NCT03543410|538062959|FG000|Overall Study|Withdrawal by Subject|5|||
149160428|NCT03543410|538062960|FG001|Overall Study|Withdrawal by Subject|2|||
149160429|NCT03543410|538062961|FG002|Overall Study|Withdrawal by Subject|8|||
149160430|NCT03543410|538062959|FG000|Overall Study|Protocol Violation|0|||
149160431|NCT03543410|538062960|FG001|Overall Study|Protocol Violation|1|||
149160432|NCT03543410|538062961|FG002|Overall Study|Protocol Violation|0|||
149160433|NCT03543410|538062959|FG000|Overall Study|Due to COVID-19|4|||
149160434|NCT03543410|538062960|FG001|Overall Study|Due to COVID-19|0|||
149160435|NCT03543410|538062961|FG002|Overall Study|Due to COVID-19|2|||
149160436|NCT03543410|538062959|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
149160437|NCT03543410|538062960|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
149160438|NCT03543410|538062961|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
149160439|NCT03543410|538062959|FG000|Overall Study|Not Due to COVID-19|2|||
149160440|NCT03543410|538062960|FG001|Overall Study|Not Due to COVID-19|0|||
149160441|NCT03543410|538062961|FG002|Overall Study|Not Due to COVID-19|1|||
149160442|NCT02435914|538062962|FG000|Overall Study|Ocular Adverse Event|1|||
149160443|NCT02435914|538062963|FG001|Overall Study|Ocular Adverse Event|0|||
149160444|NCT02435914|538062964|FG002|Overall Study|Ocular Adverse Event|0|||
149160445|NCT02435914|538062965|FG003|Overall Study|Ocular Adverse Event|0|||
149160446|NCT02435914|538062962|FG000|Overall Study|Withdrawal by Subject|0|||
149160447|NCT02435914|538062963|FG001|Overall Study|Withdrawal by Subject|1|||
149160448|NCT02435914|538062964|FG002|Overall Study|Withdrawal by Subject|0|||
149160449|NCT02435914|538062965|FG003|Overall Study|Withdrawal by Subject|0|||
149160450|NCT02435914|538062962|FG000|Overall Study|Other Miscellaneous Reason|0|||
149160451|NCT02435914|538062963|FG001|Overall Study|Other Miscellaneous Reason|0|||
149160452|NCT02435914|538062964|FG002|Overall Study|Other Miscellaneous Reason|1|||
149160453|NCT02435914|538062965|FG003|Overall Study|Other Miscellaneous Reason|0|||
149160454|NCT01818726|538062968|FG000|Overall Study|Administrative reasons|5|||
149160455|NCT01818726|538062969|FG001|Overall Study|Administrative reasons|1|||
149160456|NCT01818726|538062968|FG000|Overall Study|Withdrawal by Subject|0|||
149160457|NCT01818726|538062969|FG001|Overall Study|Withdrawal by Subject|1|||
149160458|NCT01818726|538062968|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
149160459|NCT01818726|538062969|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
149160460|NCT04871711|538062970|FG000|Overall Study|Withdrawal by Subject|11|||
149160461|NCT04871711|538062971|FG001|Overall Study|Withdrawal by Subject|5|||
149160462|NCT04871711|538062970|FG000|Overall Study|Lack of Efficacy|5|||
149160463|NCT04871711|538062971|FG001|Overall Study|Lack of Efficacy|7|||
149160464|NCT04871711|538062970|FG000|Overall Study|Adverse Event|2|||
149160465|NCT04871711|538062971|FG001|Overall Study|Adverse Event|6|||
149160466|NCT04871711|538062970|FG000|Overall Study|Various reasons|2|||
149012854|NCT01468922|537525818|FG005|Overall Study|Infection of blood|0|||
149160467|NCT04871711|538062971|FG001|Overall Study|Various reasons|1|||
149160468|NCT04871711|538062970|FG000|Overall Study|Lost to Follow-up|0|||
149160469|NCT04871711|538062971|FG001|Overall Study|Lost to Follow-up|2|||
149160470|NCT01913483|538062972|FG000|Overall Study|Withdrawal by Subject|1|||
149160471|NCT01913483|538062973|FG001|Overall Study|Withdrawal by Subject|2|||
149160472|NCT01913483|538062972|FG000|Overall Study|Lost to Follow-up|6|||
149160473|NCT01913483|538062973|FG001|Overall Study|Lost to Follow-up|3|||
149160474|NCT01913483|538062972|FG000|Overall Study|Death|14|||
149160475|NCT01913483|538062973|FG001|Overall Study|Death|17|||
149160476|NCT01469000|538062977|FG000|Overall Study|Withdrawal by Subject|16|||
149160477|NCT01469000|538062978|FG001|Overall Study|Withdrawal by Subject|3|||
149160478|NCT01469000|538062977|FG000|Overall Study|Sponsor Decision|4|||
148925226|NCT02278341|537210912|FG001|Overall Study|Randomized but never received study drug|1|||
148925227|NCT02278341|537210911|FG000|Overall Study|Adverse Event|3|||
148925228|NCT02278341|537210912|FG001|Overall Study|Adverse Event|0|||
148925229|NCT02278341|537210911|FG000|Overall Study|Death|68|||
148925230|NCT02278341|537210912|FG001|Overall Study|Death|56|||
148925231|NCT02278341|537210911|FG000|Overall Study|Withdrawal by Subject|30|||
148925232|NCT02278341|537210912|FG001|Overall Study|Withdrawal by Subject|19|||
149160479|NCT01469000|538062978|FG001|Overall Study|Sponsor Decision|1|||
149160480|NCT02026063|538062981|FG000|Overall Study|Physician Decision|0|||
149160481|NCT02026063|538062982|FG001|Overall Study|Physician Decision|10|||
149160482|NCT02026063|538062981|FG000|Overall Study|Noncompliance with Study Drug|1|||
149160483|NCT02026063|538062982|FG001|Overall Study|Noncompliance with Study Drug|1|||
149160484|NCT02026063|538062981|FG000|Overall Study|Withdrawal of Consent|1|||
149160485|NCT02026063|538062982|FG001|Overall Study|Withdrawal of Consent|6|||
149160486|NCT02026063|538062981|FG000|Overall Study|Adverse Event|5|||
149160487|NCT02026063|538062982|FG001|Overall Study|Adverse Event|20|||
149160488|NCT02026063|538062981|FG000|Overall Study|Lack of Efficacy|0|||
149160489|NCT02026063|538062982|FG001|Overall Study|Lack of Efficacy|4|||
149160490|NCT02026063|538062981|FG000|Overall Study|Lost to Follow-up|0|||
149160491|NCT02026063|538062982|FG001|Overall Study|Lost to Follow-up|1|||
149160492|NCT02026063|538062981|FG000|Overall Study|Reason not Specified|2|||
149160493|NCT02026063|538062982|FG001|Overall Study|Reason not Specified|7|||
149160494|NCT00486278|538062989|FG000|Overall Study|Adverse Event|5|||
149160495|NCT00486278|538062989|FG000|Overall Study|Withdrawal by Subject|2|||
149160496|NCT00486278|538062989|FG000|Overall Study|Physician Decision|2|||
149160497|NCT02183519|538062995|FG000|Overall Study|computer error|3|||
149160498|NCT02183519|538062996|FG001|Overall Study|computer error|0|||
149160499|NCT02183519|538062995|FG000|Overall Study|Did not respond to cough inducter|0|||
149160500|NCT02183519|538062996|FG001|Overall Study|Did not respond to cough inducter|3|||
149160501|NCT04556617|538062997|FG000|Overall Study|progressive disease|0|||
149160502|NCT04556617|538062998|FG001|Overall Study|progressive disease|2|||
149160503|NCT04556617|538062999|FG002|Overall Study|progressive disease|2|||
149160504|NCT04556617|538063000|FG003|Overall Study|progressive disease|1|||
149160505|NCT04556617|538063001|FG004|Overall Study|progressive disease|1|||
149160506|NCT04556617|538062997|FG000|Overall Study|Physician Decision|0|||
149160507|NCT04556617|538062998|FG001|Overall Study|Physician Decision|0|||
149160508|NCT04556617|538062999|FG002|Overall Study|Physician Decision|2|||
149160509|NCT04556617|538063000|FG003|Overall Study|Physician Decision|0|||
149160510|NCT04556617|538063001|FG004|Overall Study|Physician Decision|0|||
149160511|NCT04556617|538062997|FG000|Overall Study|Adverse Event|0|||
149160512|NCT04556617|538062998|FG001|Overall Study|Adverse Event|0|||
149160513|NCT04556617|538062999|FG002|Overall Study|Adverse Event|2|||
149160514|NCT04556617|538063000|FG003|Overall Study|Adverse Event|3|||
149160515|NCT04556617|538063001|FG004|Overall Study|Adverse Event|0|||
149160516|NCT04556617|538062997|FG000|Overall Study|Withdrawal by Subject|0|||
149160517|NCT04556617|538062998|FG001|Overall Study|Withdrawal by Subject|2|||
149160518|NCT04556617|538062999|FG002|Overall Study|Withdrawal by Subject|1|||
149160519|NCT04556617|538063000|FG003|Overall Study|Withdrawal by Subject|1|||
149160520|NCT04556617|538063001|FG004|Overall Study|Withdrawal by Subject|0|||
149160521|NCT04556617|538062997|FG000|Overall Study|PSA increase|0|||
149160522|NCT04556617|538062998|FG001|Overall Study|PSA increase|1|||
149160523|NCT04556617|538062999|FG002|Overall Study|PSA increase|0|||
149160524|NCT04556617|538063000|FG003|Overall Study|PSA increase|0|||
149160525|NCT04556617|538063001|FG004|Overall Study|PSA increase|0|||
149160526|NCT04556617|538062997|FG000|Overall Study|Sponsor study termination|1|||
149160527|NCT04556617|538062998|FG001|Overall Study|Sponsor study termination|0|||
149160528|NCT04556617|538062999|FG002|Overall Study|Sponsor study termination|0|||
149160529|NCT04556617|538063000|FG003|Overall Study|Sponsor study termination|0|||
149160530|NCT04556617|538063001|FG004|Overall Study|Sponsor study termination|0|||
149160531|NCT05168267|538063004|FG000|Overall Study|Withdrawal by Subject|2|||
149160532|NCT05168267|538063005|FG001|Overall Study|Withdrawal by Subject|1|||
149160533|NCT05168267|538063004|FG000|Overall Study|Withdrawn by Therapist|1|||
149160534|NCT05168267|538063005|FG001|Overall Study|Withdrawn by Therapist|1|||
148925233|NCT02278341|537210911|FG000|Overall Study|Lost to Follow-up|0|||
148925234|NCT02278341|537210912|FG001|Overall Study|Lost to Follow-up|1|||
149160535|NCT05168267|538063004|FG000|Overall Study|Left Facility|1|||
148925235|NCT02278341|537210911|FG000|Overall Study|Physician Decision|1|||
148925236|NCT02278341|537210912|FG001|Overall Study|Physician Decision|1|||
149160536|NCT05168267|538063005|FG001|Overall Study|Left Facility|0|||
149160537|NCT00695565|538063006|FG000|Overall Study|Lost to Follow-up|4|||
149160538|NCT00695565|538063007|FG001|Overall Study|Lost to Follow-up|4|||
149160539|NCT00695565|538063006|FG000|Overall Study|Adverse Event|3|||
149160540|NCT00695565|538063007|FG001|Overall Study|Adverse Event|1|||
149160541|NCT00695565|538063006|FG000|Overall Study|Protocol Violation|3|||
149160542|NCT00695565|538063007|FG001|Overall Study|Protocol Violation|1|||
149160543|NCT00695565|538063006|FG000|Overall Study|Withdrawal by Subject|1|||
149160544|NCT00695565|538063007|FG001|Overall Study|Withdrawal by Subject|1|||
149160545|NCT00695565|538063006|FG000|Overall Study|Lack of Efficacy|1|||
149160546|NCT00695565|538063007|FG001|Overall Study|Lack of Efficacy|1|||
149160547|NCT00695565|538063006|FG000|Overall Study|Subject did not follow instructions|1|||
149160548|NCT00695565|538063007|FG001|Overall Study|Subject did not follow instructions|1|||
149160549|NCT02937350|538063008|FG000|Overall Study|Withdrawal by Subject|0|||
149160550|NCT02937350|538063009|FG001|Overall Study|Withdrawal by Subject|1|||
149160551|NCT02937350|538063010|FG002|Overall Study|Withdrawal by Subject|0|||
149160552|NCT01462266|538063011|FG000|Overall Study|Adverse Event|7|||
149160553|NCT01462266|538063012|FG001|Overall Study|Adverse Event|6|||
149160554|NCT01462266|538063011|FG000|Overall Study|Death|2|||
149160555|NCT01462266|538063012|FG001|Overall Study|Death|1|||
149160556|NCT01462266|538063011|FG000|Overall Study|Lack of Efficacy|0|||
149160557|NCT01462266|538063012|FG001|Overall Study|Lack of Efficacy|2|||
149160558|NCT01462266|538063011|FG000|Overall Study|Lost to Follow-up|4|||
149160559|NCT01462266|538063012|FG001|Overall Study|Lost to Follow-up|3|||
149160560|NCT01462266|538063011|FG000|Overall Study|Non-compliance with study drug|3|||
149160561|NCT01462266|538063012|FG001|Overall Study|Non-compliance with study drug|0|||
149160562|NCT01462266|538063011|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
149160563|NCT01462266|538063012|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
149160564|NCT01462266|538063011|FG000|Overall Study|Physician Decision|2|||
149160565|NCT01462266|538063012|FG001|Overall Study|Physician Decision|5|||
149160566|NCT01462266|538063011|FG000|Overall Study|Protocol Violation|1|||
149160567|NCT01462266|538063012|FG001|Overall Study|Protocol Violation|3|||
149160568|NCT01462266|538063011|FG000|Overall Study|Withdrawal by Subject|7|||
149160569|NCT01462266|538063012|FG001|Overall Study|Withdrawal by Subject|2|||
149160570|NCT01462266|538063011|FG000|Overall Study|Screen failure|1|||
149160571|NCT01462266|538063012|FG001|Overall Study|Screen failure|1|||
149160572|NCT01106846|538063013|FG000|Overall Study|Change in surgical procedure|0|||
149160573|NCT01106846|538063014|FG001|Overall Study|Change in surgical procedure|1|||
149160574|NCT04698629|538063028|FG000|Overall Study|Adverse Event|1|||
149160575|NCT02320487|538063029|FG000|Overall Study|Reason not Specified|1|||
149160576|NCT02320487|538063029|FG000|Overall Study|Physician Decision|5|||
149160577|NCT02320487|538063029|FG000|Overall Study|Withdrawal by Subject|1|||
149160578|NCT02320487|538063029|FG000|Overall Study|Death|3|||
149160579|NCT02320487|538063029|FG000|Overall Study|Adverse Event|11|||
149160580|NCT06228586|538063030|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
149160581|NCT06228586|538063031|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
149160582|NCT05888103|538064696|FG000|Overall Study|Participant decision|3|||
149160583|NCT05888103|538064697|FG001|Overall Study|Participant decision|3|||
149160584|NCT05900115|538064698|FG000|Overall Study|Lost to Follow-up|129|||
149160585|NCT05900115|538064699|FG001|Overall Study|Lost to Follow-up|98|||
149160586|NCT01602341|538064700|FG000|Overall Study|Adverse Event|0|||
149160587|NCT01602341|538064701|FG001|Overall Study|Adverse Event|1|||
149160588|NCT02152345|538064702|FG000|Overall Study|Case Cancellations|2|||
149160589|NCT02152345|538064703|FG001|Overall Study|Case Cancellations|4|||
149160590|NCT02152345|538064702|FG000|Overall Study|Withdrawal by Subject|2|||
149160591|NCT02152345|538064703|FG001|Overall Study|Withdrawal by Subject|1|||
149160592|NCT02554929|538064705|FG000|Overall Study|Lost to Follow-up|4|||
149160593|NCT02554929|538064706|FG001|Overall Study|Lost to Follow-up|4|||
149160594|NCT02554929|538064705|FG000|Overall Study|Withdrawal by Subject|2|||
149160595|NCT02554929|538064706|FG001|Overall Study|Withdrawal by Subject|8|||
149160596|NCT02324270|538064707|FG000|Overall Study|Withdrawal by Subject|0|||
149160597|NCT02324270|538064708|FG001|Overall Study|Withdrawal by Subject|1|||
149160598|NCT02324270|538064709|FG002|Overall Study|Withdrawal by Subject|0|||
149160599|NCT02324270|538064707|FG000|Overall Study|Lost to Follow-up|4|||
149160600|NCT02324270|538064708|FG001|Overall Study|Lost to Follow-up|3|||
149160601|NCT02324270|538064709|FG002|Overall Study|Lost to Follow-up|4|||
149160602|NCT02324270|538064707|FG000|Overall Study|Protocol Violation|0|||
149160603|NCT02324270|538064708|FG001|Overall Study|Protocol Violation|1|||
149160604|NCT02324270|538064709|FG002|Overall Study|Protocol Violation|1|||
149160605|NCT02324270|538064707|FG000|Overall Study|Non Compliance with Study Drug|1|||
149160606|NCT02324270|538064708|FG001|Overall Study|Non Compliance with Study Drug|2|||
149160607|NCT02324270|538064709|FG002|Overall Study|Non Compliance with Study Drug|0|||
149160608|NCT00546364|538064710|FG000|Overall Study|Disease progression|5|||
149160609|NCT00546364|538064711|FG001|Overall Study|Disease progression|11|||
149160610|NCT00546364|538064712|FG002|Overall Study|Disease progression|8|||
149160611|NCT00546364|538064710|FG000|Overall Study|Completed and off treatment|1|||
149160612|NCT00546364|538064711|FG001|Overall Study|Completed and off treatment|0|||
149160613|NCT00546364|538064712|FG002|Overall Study|Completed and off treatment|2|||
149160614|NCT00546364|538064710|FG000|Overall Study|Administrative reason by sponsor|1|||
149160615|NCT00546364|538064711|FG001|Overall Study|Administrative reason by sponsor|0|||
149160616|NCT00546364|538064712|FG002|Overall Study|Administrative reason by sponsor|0|||
149160617|NCT00546364|538064710|FG000|Overall Study|Poor compliance/noncompliance|0|||
149160618|NCT00546364|538064711|FG001|Overall Study|Poor compliance/noncompliance|0|||
149160619|NCT00546364|538064712|FG002|Overall Study|Poor compliance/noncompliance|1|||
149160620|NCT00546364|538064710|FG000|Overall Study|No longer meets study criteria|1|||
149160621|NCT00546364|538064711|FG001|Overall Study|No longer meets study criteria|1|||
149160622|NCT00546364|538064712|FG002|Overall Study|No longer meets study criteria|0|||
148925237|NCT02278341|537210911|FG000|Overall Study|Miscellaneous|15|||
148925238|NCT02278341|537210912|FG001|Overall Study|Miscellaneous|14|||
148925239|NCT04902326|537210913|FG000|Overall Study|Withdrawal by Subject|1|||
148925240|NCT04902326|537210914|FG001|Overall Study|Withdrawal by Subject|3|||
148925241|NCT04902326|537210915|FG002|Overall Study|Withdrawal by Subject|0|||
148925242|NCT04902326|537210916|FG003|Overall Study|Withdrawal by Subject|1|||
148925243|NCT04902326|537210913|FG000|Overall Study|Lost to Follow-up|14|||
148925244|NCT04902326|537210914|FG001|Overall Study|Lost to Follow-up|14|||
148925245|NCT04902326|537210915|FG002|Overall Study|Lost to Follow-up|14|||
148925246|NCT04902326|537210916|FG003|Overall Study|Lost to Follow-up|6|||
148925247|NCT01487577|537210918|FG000|Overall Study|Became ineligible after signing consent|1|||
148925248|NCT01479985|537210922|FG000|Overall Study|Tablet malfunction, no data saved|1|||
148925249|NCT01479985|537210923|FG001|Overall Study|Tablet malfunction, no data saved|1|||
148925250|NCT01479985|537210922|FG000|Overall Study|No decisional conflict scale responses|0|||
148925251|NCT01479985|537210923|FG001|Overall Study|No decisional conflict scale responses|2|||
148925252|NCT01479985|537210922|FG000|Overall Study|No post-visit survey|5|||
148925253|NCT01479985|537210923|FG001|Overall Study|No post-visit survey|3|||
148925254|NCT01653782|537210924|FG000|Overall Study|Withdrawal by Subject|9|||
149160623|NCT00546364|538064710|FG000|Overall Study|Withdrawal by Subject|5|||
149160624|NCT00546364|538064711|FG001|Overall Study|Withdrawal by Subject|6|||
149160625|NCT00546364|538064712|FG002|Overall Study|Withdrawal by Subject|3|||
148925255|NCT01653782|537210925|FG001|Overall Study|Withdrawal by Subject|15|||
148925256|NCT01653782|537210926|FG002|Overall Study|Withdrawal by Subject|4|||
148925257|NCT01653782|537210924|FG000|Overall Study|Lost to Follow-up|7|||
149160626|NCT00546364|538064710|FG000|Overall Study|Prior taxotere|1|||
149160627|NCT00546364|538064711|FG001|Overall Study|Prior taxotere|0|||
149160628|NCT00546364|538064712|FG002|Overall Study|Prior taxotere|0|||
149160629|NCT00546364|538064710|FG000|Overall Study|Mixed response|1|||
149160630|NCT00546364|538064711|FG001|Overall Study|Mixed response|0|||
149160631|NCT00546364|538064712|FG002|Overall Study|Mixed response|0|||
149160632|NCT00546364|538064710|FG000|Overall Study|Palliative treatment|1|||
149160633|NCT00546364|538064711|FG001|Overall Study|Palliative treatment|0|||
149160634|NCT00546364|538064712|FG002|Overall Study|Palliative treatment|1|||
149160635|NCT00546364|538064710|FG000|Overall Study|Target lesions resected|1|||
149160636|NCT00546364|538064711|FG001|Overall Study|Target lesions resected|0|||
149160637|NCT00546364|538064712|FG002|Overall Study|Target lesions resected|0|||
149160638|NCT00546364|538064710|FG000|Overall Study|Physician Decision|0|||
149160639|NCT00546364|538064711|FG001|Overall Study|Physician Decision|0|||
149160640|NCT00546364|538064712|FG002|Overall Study|Physician Decision|1|||
149160641|NCT00546364|538064710|FG000|Overall Study|Sponsor decision|0|||
149160642|NCT00546364|538064711|FG001|Overall Study|Sponsor decision|0|||
149160643|NCT00546364|538064712|FG002|Overall Study|Sponsor decision|1|||
149160644|NCT02090855|538064713|FG000|Overall Study|no evaluable Standard of Truth results|2|||
149160645|NCT00388947|538064715|FG000|Overall Study|Protocol Violation|47|||
149160646|NCT04187092|538064716|FG000|Overall Study|Lost to Follow-up|1|||
149160647|NCT04187092|538064717|FG001|Overall Study|Lost to Follow-up|1|||
149160648|NCT04187092|538064716|FG000|Overall Study|Withdrawal by Subject|1|||
149160649|NCT04187092|538064717|FG001|Overall Study|Withdrawal by Subject|1|||
149160650|NCT04187092|538064716|FG000|Overall Study|Adverse Event|0|||
149160651|NCT04187092|538064717|FG001|Overall Study|Adverse Event|1|||
149160652|NCT01475734|538064719|FG000|Overall Study|Withdrawal by Subject|1|||
149160653|NCT01475734|538064720|FG001|Overall Study|Withdrawal by Subject|0|||
149160654|NCT01475734|538064719|FG000|Overall Study|Protocol Violation|1|||
149160655|NCT01475734|538064720|FG001|Overall Study|Protocol Violation|0|||
149160656|NCT01475734|538064719|FG000|Overall Study|Physician Decision|0|||
149160657|NCT01475734|538064720|FG001|Overall Study|Physician Decision|1|||
149160658|NCT00771472|538064721|FG000|Overall Study|Physician Decision|2|||
149160659|NCT00771472|538064722|FG001|Overall Study|Physician Decision|3|||
149160660|NCT00771472|538064721|FG000|Overall Study|Progressive Disease|3|||
149160661|NCT00771472|538064722|FG001|Overall Study|Progressive Disease|1|||
149160662|NCT00771472|538064721|FG000|Overall Study|Protocol Violation|1|||
149160663|NCT00771472|538064722|FG001|Overall Study|Protocol Violation|0|||
149160664|NCT00880750|538064726|FG000|First Intervention|Adverse Event|1|||
149160665|NCT00880750|538064727|FG001|First Intervention|Adverse Event|0|||
149160666|NCT00880750|538064726|FG000|First Intervention|Unable to collect urine|4|||
149160667|NCT00880750|538064727|FG001|First Intervention|Unable to collect urine|0|||
149160668|NCT00880750|538064726|FG000|First Intervention|Non-compliance with meals|0|||
149160669|NCT00880750|538064727|FG001|First Intervention|Non-compliance with meals|1|||
149160670|NCT00880750|538064726|FG000|First Intervention|Withdrawal by Subject|2|||
149160671|NCT00880750|538064727|FG001|First Intervention|Withdrawal by Subject|0|||
149160672|NCT00880750|538064726|FG000|First Intervention|Lost to Follow-up|2|||
149160673|NCT00880750|538064727|FG001|First Intervention|Lost to Follow-up|0|||
149160674|NCT00880750|538064726|FG000|Second Intervention|Withdrawal by Subject|2|||
149160675|NCT00880750|538064727|FG001|Second Intervention|Withdrawal by Subject|2|||
149160676|NCT00880750|538064726|FG000|Second Intervention|Protocol Violation|1|||
149160677|NCT00880750|538064727|FG001|Second Intervention|Protocol Violation|0|||
149160678|NCT00880750|538064726|FG000|Second Intervention|Unable to collect urine|1|||
149160679|NCT00880750|538064727|FG001|Second Intervention|Unable to collect urine|0|||
149160680|NCT00483327|538064732|FG000|Overall Study|Adverse Event|1|||
149160681|NCT00483327|538064732|FG000|Overall Study|Withdrawal by Subject|3|||
149160682|NCT00483327|538064732|FG000|Overall Study|Lost to Follow-up|4|||
149160683|NCT00483327|538064732|FG000|Overall Study|Patient Non Compliance|2|||
149160684|NCT01390389|538064733|FG000|Overall Study|Withdrawal by Subject|2|||
149160685|NCT01390389|538064734|FG001|Overall Study|Withdrawal by Subject|0|||
149160686|NCT01390389|538064733|FG000|Overall Study|Screen Fail|2|||
149160687|NCT01390389|538064734|FG001|Overall Study|Screen Fail|1|||
149160688|NCT01246206|538064735|FG000|Overall Study|Patient did not receive study regiments.|1|||
149160689|NCT02002975|538064736|FG000|Overall Study|Case Report Forms Uncollected|135|||
149160690|NCT02002975|538064736|FG000|Overall Study|Protocol Deviation|437|||
149160691|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
149160692|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
149160693|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
149160694|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
149160695|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
149160696|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
149160697|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
149160698|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
149160699|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
149160700|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
149160701|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
149160702|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
149160703|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
149160704|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
149160705|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
149160706|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
148925258|NCT01653782|537210925|FG001|Overall Study|Lost to Follow-up|3|||
148925259|NCT01653782|537210926|FG002|Overall Study|Lost to Follow-up|2|||
148925260|NCT01155479|537210932|FG000|Part I|Adverse Event|13|||
148925261|NCT01155479|537210933|FG001|Part I|Adverse Event|8|||
149160707|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
149160708|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
149160709|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
149160710|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
149160711|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
149160712|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
149160713|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
149160714|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
149160715|NCT04660643|538064737|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
149160716|NCT04660643|538064738|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
149160717|NCT04660643|538064739|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
149160718|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
149160719|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
149160720|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
149160721|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
149160722|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
149160723|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
149160724|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
149160725|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
149160726|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
149160727|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
149160728|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
149160729|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
149160730|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
149160731|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
149160732|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
149160733|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
149160734|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
149160735|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
149160736|NCT04660643|538064737|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
149160737|NCT04660643|538064738|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
149160738|NCT04660643|538064739|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
149160739|NCT03988907|538064740|FG000|Overall Study|Unable to complete visit|0|||
149160740|NCT03988907|538064741|FG001|Overall Study|Unable to complete visit|1|||
149160741|NCT03609619|538064747|FG000|Overall Study|Adverse Event|1|||
149160742|NCT03609619|538064748|FG001|Overall Study|Adverse Event|0|||
149160743|NCT03609619|538064747|FG000|Overall Study|Lack of Efficacy|1|||
149160744|NCT03609619|538064748|FG001|Overall Study|Lack of Efficacy|2|||
149160745|NCT03609619|538064747|FG000|Overall Study|Protocol Violation|5|||
149160746|NCT03609619|538064748|FG001|Overall Study|Protocol Violation|0|||
149160747|NCT03609619|538064747|FG000|Overall Study|Withdrawal by Subject|2|||
149160748|NCT03609619|538064748|FG001|Overall Study|Withdrawal by Subject|3|||
149160749|NCT03609619|538064747|FG000|Overall Study|Lost to Follow-up|1|||
149160750|NCT03609619|538064748|FG001|Overall Study|Lost to Follow-up|1|||
149160751|NCT05162066|538064749|FG000|Overall Study|Adverse Event|1|||
149160752|NCT05162066|538064750|FG001|Overall Study|Adverse Event|0|||
149160753|NCT05162066|538064751|FG002|Overall Study|Adverse Event|0|||
149160754|NCT05162066|538064749|FG000|Overall Study|Perceived lack of efficacy|1|||
149160755|NCT05162066|538064750|FG001|Overall Study|Perceived lack of efficacy|0|||
149160756|NCT05162066|538064751|FG002|Overall Study|Perceived lack of efficacy|0|||
149160757|NCT00167245|538064752|FG000|Overall Study|Lost to Follow-up|20|||
149160758|NCT00167245|538064753|FG001|Overall Study|Lost to Follow-up|31|||
149160759|NCT00167245|538064752|FG000|Overall Study|Withdrawal by Subject|5|||
149160760|NCT00167245|538064753|FG001|Overall Study|Withdrawal by Subject|8|||
149160761|NCT00167245|538064752|FG000|Overall Study|Incarcerated|3|||
149160762|NCT00167245|538064753|FG001|Overall Study|Incarcerated|2|||
149160763|NCT00167245|538064752|FG000|Overall Study|Drowsy|1|||
149160764|NCT00167245|538064753|FG001|Overall Study|Drowsy|0|||
149160765|NCT00568555|538064754|FG000|Overall Study|Withdrawal by Subject|1|||
149160766|NCT00568555|538064755|FG001|Overall Study|Withdrawal by Subject|1|||
149160767|NCT01871090|538064756|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
149160768|NCT01871090|538064757|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
149160769|NCT01871090|538064756|FG000|Overall Study|Interrogation not completed correctly|1|||
148925262|NCT01155479|537210934|FG002|Part I|Adverse Event|18|||
148925263|NCT01155479|537210935|FG003|Part I|Adverse Event|7|||
148925264|NCT01155479|537210936|FG004|Part I|Adverse Event|6|||
149160770|NCT01871090|538064757|FG001|Overall Study|Interrogation not completed correctly|0|||
149160771|NCT01871090|538064756|FG000|Overall Study|Subject Non-Compliance|0|||
149160772|NCT01871090|538064757|FG001|Overall Study|Subject Non-Compliance|1|||
149160773|NCT01231555|538064758|FG000|Overall Study|Study terminated|8|||
149160774|NCT01231555|538064759|FG001|Overall Study|Study terminated|5|||
149160775|NCT01231555|538064760|FG002|Overall Study|Study terminated|8|||
149160776|NCT01231555|538064758|FG000|Overall Study|Withdrawal by Subject|0|||
149160777|NCT01231555|538064759|FG001|Overall Study|Withdrawal by Subject|2|||
149160778|NCT01231555|538064760|FG002|Overall Study|Withdrawal by Subject|0|||
148925265|NCT01155479|537210932|FG000|Part I|Administrative|2|||
148925266|NCT01155479|537210933|FG001|Part I|Administrative|2|||
148806040|NCT05911841|536768047|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
148806041|NCT05911841|536768048|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
148806042|NCT05911841|536768049|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
148806043|NCT05911841|536768050|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
148806044|NCT05911841|536768051|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149160779|NCT01773421|538064763|FG000|Treatment Phase|Other|0|||
149160780|NCT01773421|538064764|FG001|Treatment Phase|Other|0|||
149160781|NCT01773421|538064765|FG002|Treatment Phase|Other|2|||
149160782|NCT01773421|538064766|FG003|Treatment Phase|Other|0|||
149160783|NCT01773421|538064767|FG004|Treatment Phase|Other|0|||
149160784|NCT01773421|538064768|FG005|Treatment Phase|Other|0|||
149160785|NCT01773421|538064769|FG006|Treatment Phase|Other|0|||
149160786|NCT01773421|538064763|FG000|Treatment Phase|Adverse Event|0|||
149160787|NCT01773421|538064764|FG001|Treatment Phase|Adverse Event|0|||
149160788|NCT01773421|538064765|FG002|Treatment Phase|Adverse Event|3|||
149160789|NCT01773421|538064766|FG003|Treatment Phase|Adverse Event|1|||
149160790|NCT01773421|538064767|FG004|Treatment Phase|Adverse Event|0|||
149160791|NCT01773421|538064768|FG005|Treatment Phase|Adverse Event|0|||
149160792|NCT01773421|538064769|FG006|Treatment Phase|Adverse Event|0|||
149160793|NCT01773421|538064763|FG000|Treatment Phase|Withdrawal by Subject|0|||
149160794|NCT01773421|538064764|FG001|Treatment Phase|Withdrawal by Subject|0|||
149160795|NCT01773421|538064765|FG002|Treatment Phase|Withdrawal by Subject|1|||
149160796|NCT01773421|538064766|FG003|Treatment Phase|Withdrawal by Subject|1|||
149160797|NCT01773421|538064767|FG004|Treatment Phase|Withdrawal by Subject|0|||
149160798|NCT01773421|538064768|FG005|Treatment Phase|Withdrawal by Subject|0|||
149160799|NCT01773421|538064769|FG006|Treatment Phase|Withdrawal by Subject|0|||
149160800|NCT01773421|538064763|FG000|Extension Phase|Other|0|||
149160801|NCT01773421|538064764|FG001|Extension Phase|Other|0|||
149160802|NCT01773421|538064765|FG002|Extension Phase|Other|0|||
149160803|NCT01773421|538064766|FG003|Extension Phase|Other|0|||
149160804|NCT01773421|538064767|FG004|Extension Phase|Other|1|||
149160805|NCT01773421|538064768|FG005|Extension Phase|Other|2|||
149160806|NCT01773421|538064769|FG006|Extension Phase|Other|0|||
149160807|NCT01773421|538064763|FG000|Extension Phase|Adverse Event|0|||
149160808|NCT01773421|538064764|FG001|Extension Phase|Adverse Event|0|||
149160809|NCT01773421|538064765|FG002|Extension Phase|Adverse Event|0|||
149160810|NCT01773421|538064766|FG003|Extension Phase|Adverse Event|0|||
149160811|NCT01773421|538064767|FG004|Extension Phase|Adverse Event|2|||
149160812|NCT01773421|538064768|FG005|Extension Phase|Adverse Event|0|||
149160813|NCT01773421|538064769|FG006|Extension Phase|Adverse Event|0|||
149160814|NCT00688909|538064770|FG000|Overall Study|Adverse Event|28|||
149160815|NCT00688909|538064770|FG000|Overall Study|Patient withdrew consent|2|||
149160816|NCT00688909|538064770|FG000|Overall Study|Administrative problems|1|||
149160817|NCT00688909|538064770|FG000|Overall Study|Protocol Violation|2|||
149160818|NCT03502330|538064771|FG000|Overall Study|Adverse Event|2|||
149160819|NCT03502330|538064772|FG001|Overall Study|Adverse Event|1|||
149160820|NCT03502330|538064773|FG002|Overall Study|Adverse Event|0|||
149160821|NCT03502330|538064774|FG003|Overall Study|Adverse Event|0|||
149160822|NCT03502330|538064775|FG004|Overall Study|Adverse Event|1|||
149160823|NCT03502330|538064776|FG005|Overall Study|Adverse Event|0|||
149160824|NCT03502330|538064777|FG006|Overall Study|Adverse Event|1|||
149160825|NCT03502330|538064778|FG007|Overall Study|Adverse Event|1|||
149160826|NCT03502330|538064779|FG008|Overall Study|Adverse Event|0|||
149160827|NCT03502330|538064771|FG000|Overall Study|Lack of Efficacy|1|||
149160828|NCT03502330|538064772|FG001|Overall Study|Lack of Efficacy|5|||
148806045|NCT05911841|536768052|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
149160829|NCT03502330|538064773|FG002|Overall Study|Lack of Efficacy|3|||
149160830|NCT03502330|538064774|FG003|Overall Study|Lack of Efficacy|5|||
149160831|NCT03502330|538064775|FG004|Overall Study|Lack of Efficacy|1|||
149160832|NCT03502330|538064776|FG005|Overall Study|Lack of Efficacy|5|||
149160833|NCT03502330|538064777|FG006|Overall Study|Lack of Efficacy|5|||
149160834|NCT03502330|538064778|FG007|Overall Study|Lack of Efficacy|6|||
149160835|NCT03502330|538064779|FG008|Overall Study|Lack of Efficacy|0|||
149160836|NCT03502330|538064771|FG000|Overall Study|Physician Decision|0|||
149160837|NCT03502330|538064772|FG001|Overall Study|Physician Decision|0|||
149160838|NCT03502330|538064773|FG002|Overall Study|Physician Decision|0|||
149160839|NCT03502330|538064774|FG003|Overall Study|Physician Decision|0|||
149160840|NCT03502330|538064775|FG004|Overall Study|Physician Decision|1|||
149160841|NCT03502330|538064776|FG005|Overall Study|Physician Decision|0|||
149160842|NCT03502330|538064777|FG006|Overall Study|Physician Decision|0|||
149160843|NCT03502330|538064778|FG007|Overall Study|Physician Decision|0|||
149160844|NCT03502330|538064779|FG008|Overall Study|Physician Decision|0|||
149160845|NCT03502330|538064771|FG000|Overall Study|Withdrawal by Subject|0|||
149160846|NCT03502330|538064772|FG001|Overall Study|Withdrawal by Subject|0|||
149160847|NCT03502330|538064773|FG002|Overall Study|Withdrawal by Subject|0|||
149160848|NCT03502330|538064774|FG003|Overall Study|Withdrawal by Subject|0|||
149160849|NCT03502330|538064775|FG004|Overall Study|Withdrawal by Subject|0|||
149160850|NCT03502330|538064776|FG005|Overall Study|Withdrawal by Subject|1|||
149160851|NCT03502330|538064777|FG006|Overall Study|Withdrawal by Subject|0|||
149160852|NCT03502330|538064778|FG007|Overall Study|Withdrawal by Subject|1|||
149160853|NCT03502330|538064779|FG008|Overall Study|Withdrawal by Subject|0|||
149160854|NCT03502330|538064771|FG000|Overall Study|Death|0|||
149160855|NCT03502330|538064772|FG001|Overall Study|Death|0|||
149160856|NCT03502330|538064773|FG002|Overall Study|Death|0|||
149160857|NCT03502330|538064774|FG003|Overall Study|Death|0|||
149160858|NCT03502330|538064775|FG004|Overall Study|Death|0|||
149160859|NCT03502330|538064776|FG005|Overall Study|Death|0|||
148806046|NCT05911841|536768053|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
148806047|NCT05911841|536768044|FG000|Escape Period|Site Terminated by Sponsor|0|||
148806048|NCT05911841|536768045|FG001|Escape Period|Site Terminated by Sponsor|0|||
148806049|NCT05911841|536768046|FG002|Escape Period|Site Terminated by Sponsor|0|||
149160860|NCT03502330|538064777|FG006|Overall Study|Death|2|||
148806050|NCT05911841|536768047|FG003|Escape Period|Site Terminated by Sponsor|0|||
148925267|NCT01155479|537210934|FG002|Part I|Administrative|2|||
149160861|NCT03502330|538064778|FG007|Overall Study|Death|0|||
149160862|NCT03502330|538064779|FG008|Overall Study|Death|0|||
149160863|NCT02472847|538064789|FG000|Overall Study|Withdrawal by Subject|1|||
149160864|NCT02472847|538064790|FG001|Overall Study|Withdrawal by Subject|5|||
149160865|NCT00669617|538064791|FG000|Period 1|Withdrawal by Subject|0|||
149160866|NCT00669617|538064792|FG001|Period 1|Withdrawal by Subject|0|||
149160867|NCT00669617|538064793|FG002|Period 1|Withdrawal by Subject|1|||
148806051|NCT05911841|536768048|FG004|Escape Period|Site Terminated by Sponsor|0|||
148925268|NCT01155479|537210935|FG003|Part I|Administrative|0|||
149160868|NCT00669617|538064794|FG003|Period 1|Withdrawal by Subject|0|||
149160869|NCT00669617|538064795|FG004|Period 1|Withdrawal by Subject|0|||
149160870|NCT00669617|538064791|FG000|Period 1|Protocol Deviation|0|||
149160871|NCT00669617|538064792|FG001|Period 1|Protocol Deviation|0|||
149160872|NCT00669617|538064793|FG002|Period 1|Protocol Deviation|0|||
149160873|NCT00669617|538064794|FG003|Period 1|Protocol Deviation|0|||
149160874|NCT00669617|538064795|FG004|Period 1|Protocol Deviation|1|||
149160875|NCT00669617|538064791|FG000|Period 3|Lost to Follow-up|1|||
149160876|NCT00669617|538064792|FG001|Period 3|Lost to Follow-up|0|||
149160877|NCT00669617|538064793|FG002|Period 3|Lost to Follow-up|0|||
149160878|NCT00669617|538064794|FG003|Period 3|Lost to Follow-up|0|||
149160879|NCT00669617|538064795|FG004|Period 3|Lost to Follow-up|0|||
149160880|NCT01276821|538064796|FG000|Overall Study|Protocol Violation|0|||
149160881|NCT01276821|538064797|FG001|Overall Study|Protocol Violation|1|||
149160882|NCT03980938|538064798|FG000|Treatment Period 1|Study Terminated|1|||
149160883|NCT03980938|538064799|FG001|Treatment Period 1|Study Terminated|1|||
149160884|NCT03980938|538064798|FG000|Treatment Period 2|Study Terminated|2|||
149160885|NCT03980938|538064799|FG001|Treatment Period 2|Study Terminated|2|||
149160886|NCT02939131|538064800|FG000|Overall Study|Unable to get to clinic|6|||
149160887|NCT02939131|538064801|FG001|Overall Study|Unable to get to clinic|4|||
149160888|NCT02939131|538064800|FG000|Overall Study|Lost to Follow-up|2|||
149160889|NCT02939131|538064801|FG001|Overall Study|Lost to Follow-up|4|||
149160890|NCT02939131|538064800|FG000|Overall Study|severe debilitation|1|||
149160891|NCT02939131|538064801|FG001|Overall Study|severe debilitation|0|||
149160892|NCT02939131|538064800|FG000|Overall Study|Other|0|||
149160893|NCT02939131|538064801|FG001|Overall Study|Other|1|||
149160894|NCT02939131|538064800|FG000|Overall Study|not willing to adhere to protocol|2|||
149160895|NCT02939131|538064801|FG001|Overall Study|not willing to adhere to protocol|0|||
149160896|NCT03569202|538064805|FG000|Part 3|Physician Decision|1|||
149160897|NCT03569202|538064806|FG001|Part 3|Physician Decision|0|||
149160898|NCT03569202|538064805|FG000|Part 3|Other|1|||
149160899|NCT03569202|538064806|FG001|Part 3|Other|1|||
149160900|NCT00420511|538064807|FG000|Overall Study|Adverse Event|1|||
149160901|NCT00420511|538064808|FG001|Overall Study|Adverse Event|1|||
149160902|NCT00420511|538064807|FG000|Overall Study|Lost to Follow-up|1|||
149160903|NCT00420511|538064808|FG001|Overall Study|Lost to Follow-up|0|||
149160904|NCT02415712|538064809|FG000|Overall Study|Protocol Violation|16|||
149160905|NCT01668654|538064810|FG000|Overall Study|Study Closed/Terminated|3|||
149160906|NCT01668654|538064810|FG000|Overall Study|Withdrawal by Subject|1|||
149160907|NCT04557384|538064811|FG000|Overall Study|Study Terminated by Sponsor|1|||
149160908|NCT04557384|538064811|FG000|Overall Study|Death|1|||
149160909|NCT00454779|538064813|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
149160910|NCT00454779|538064814|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
149160911|NCT00454779|538064813|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
149160912|NCT00454779|538064814|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
149160913|NCT00454779|538064813|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
149160914|NCT00454779|538064814|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
149160915|NCT00454779|538064813|FG000|First-line Treatment Phase|Protocol Violation|0|||
149160916|NCT00454779|538064814|FG001|First-line Treatment Phase|Protocol Violation|1|||
149160917|NCT00454779|538064813|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
149160918|NCT00454779|538064814|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
149160919|NCT00454779|538064813|FG000|First-line Treatment Phase|Ongoing|1|||
149160920|NCT00454779|538064814|FG001|First-line Treatment Phase|Ongoing|0|||
149160921|NCT00454779|538064813|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
149160922|NCT00454779|538064814|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
149160923|NCT00454779|538064813|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
149160924|NCT00454779|538064814|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
149160925|NCT00454779|538064813|FG000|Second-line Treatment Phase|Ongoing|0|||
149160926|NCT00454779|538064814|FG001|Second-line Treatment Phase|Ongoing|1|||
149160927|NCT01337973|538064816|FG000|Overall Study|Lost to Follow-up|2|||
149160928|NCT01337973|538064817|FG001|Overall Study|Lost to Follow-up|4|||
149160929|NCT01337973|538064818|FG002|Overall Study|Lost to Follow-up|3|||
149160930|NCT01337973|538064816|FG000|Overall Study|Death|1|||
149160931|NCT01337973|538064817|FG001|Overall Study|Death|2|||
149160932|NCT01337973|538064818|FG002|Overall Study|Death|1|||
149160933|NCT01337973|538064816|FG000|Overall Study|Withdrawal by Subject|10|||
149160934|NCT01337973|538064817|FG001|Overall Study|Withdrawal by Subject|8|||
149160935|NCT01337973|538064818|FG002|Overall Study|Withdrawal by Subject|4|||
149160936|NCT01337973|538064816|FG000|Overall Study|missing data on primary outcome|3|||
149160937|NCT01337973|538064817|FG001|Overall Study|missing data on primary outcome|1|||
149160938|NCT01337973|538064818|FG002|Overall Study|missing data on primary outcome|3|||
149160939|NCT04173741|538064821|FG000|Overall Study|IVC measurement cannot be done|1|||
149160940|NCT04173741|538064822|FG001|Overall Study|IVC measurement cannot be done|1|||
149160941|NCT02522767|538064823|FG000|Double-blind|Withdrawal by Subject|8|||
149160942|NCT02522767|538064824|FG001|Double-blind|Withdrawal by Subject|11|||
149160943|NCT02522767|538064823|FG000|Double-blind|Lost to Follow-up|1|||
149160944|NCT02522767|538064824|FG001|Double-blind|Lost to Follow-up|0|||
149160945|NCT02522767|538064823|FG000|Double-blind|Adverse Event|1|||
149160946|NCT02522767|538064824|FG001|Double-blind|Adverse Event|10|||
149160947|NCT02522767|538064823|FG000|Double-blind|Protocol Violation|0|||
149160948|NCT02522767|538064824|FG001|Double-blind|Protocol Violation|1|||
148925269|NCT01155479|537210936|FG004|Part I|Administrative|0|||
148925270|NCT01155479|537210932|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
148925271|NCT01155479|537210933|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
148925272|NCT01155479|537210934|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
148925273|NCT01155479|537210935|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
148925274|NCT01155479|537210936|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
148925275|NCT01155479|537210932|FG000|Part I|Withdrawal by Subject|11|||
148925276|NCT01155479|537210933|FG001|Part I|Withdrawal by Subject|13|||
148925277|NCT01155479|537210934|FG002|Part I|Withdrawal by Subject|8|||
148925278|NCT01155479|537210935|FG003|Part I|Withdrawal by Subject|8|||
148925279|NCT01155479|537210936|FG004|Part I|Withdrawal by Subject|9|||
148925280|NCT01155479|537210932|FG000|Part I|Lost to Follow-up|0|||
148925281|NCT01155479|537210933|FG001|Part I|Lost to Follow-up|0|||
148925282|NCT01155479|537210934|FG002|Part I|Lost to Follow-up|1|||
148925283|NCT01155479|537210935|FG003|Part I|Lost to Follow-up|1|||
148925284|NCT01155479|537210936|FG004|Part I|Lost to Follow-up|0|||
148925285|NCT01155479|537210932|FG000|Part I|Treatment Failure|3|||
148925286|NCT01155479|537210933|FG001|Part I|Treatment Failure|0|||
148925287|NCT01155479|537210934|FG002|Part I|Treatment Failure|3|||
148925288|NCT01155479|537210935|FG003|Part I|Treatment Failure|1|||
148925289|NCT01155479|537210936|FG004|Part I|Treatment Failure|2|||
148925290|NCT01155479|537210932|FG000|Part I|Did Not Receive Treatment|4|||
148925291|NCT01155479|537210933|FG001|Part I|Did Not Receive Treatment|2|||
148925292|NCT01155479|537210934|FG002|Part I|Did Not Receive Treatment|2|||
148925293|NCT01155479|537210935|FG003|Part I|Did Not Receive Treatment|6|||
148925294|NCT01155479|537210936|FG004|Part I|Did Not Receive Treatment|1|||
148925295|NCT01155479|537210932|FG000|Part I|Non-Compliance with Protocol|2|||
148925296|NCT01155479|537210933|FG001|Part I|Non-Compliance with Protocol|1|||
148925297|NCT01155479|537210934|FG002|Part I|Non-Compliance with Protocol|3|||
148925298|NCT01155479|537210935|FG003|Part I|Non-Compliance with Protocol|3|||
148925299|NCT01155479|537210936|FG004|Part I|Non-Compliance with Protocol|2|||
148925300|NCT01155479|537210932|FG000|Part II|Adverse Event|7|||
148925301|NCT01155479|537210933|FG001|Part II|Adverse Event|6|||
148925302|NCT01155479|537210934|FG002|Part II|Adverse Event|8|||
148925303|NCT01155479|537210935|FG003|Part II|Adverse Event|3|||
148925304|NCT01155479|537210936|FG004|Part II|Adverse Event|4|||
148925305|NCT01155479|537210932|FG000|Part II|Administrative|43|||
148925306|NCT01155479|537210933|FG001|Part II|Administrative|49|||
148925307|NCT01155479|537210934|FG002|Part II|Administrative|36|||
148925308|NCT01155479|537210935|FG003|Part II|Administrative|38|||
148925309|NCT01155479|537210936|FG004|Part II|Administrative|46|||
149160949|NCT02522767|538064823|FG000|Double-blind|Lack of Efficacy|0|||
149160950|NCT02522767|538064824|FG001|Double-blind|Lack of Efficacy|2|||
149160951|NCT02522767|538064823|FG000|Double-blind|Protocol Deviation|1|||
148674079|NCT00440193|536277178|FG000|Treatment Period|Withdrawal by Subject|36|||
148674080|NCT00440193|536277179|FG001|Treatment Period|Withdrawal by Subject|77|||
148674081|NCT00440193|536277178|FG000|Treatment Period|Clinical endpoint reached|28|||
148674082|NCT00440193|536277179|FG001|Treatment Period|Clinical endpoint reached|25|||
148674083|NCT00440193|536277178|FG000|Treatment Period|Study terminated by sponsor|102|||
148674084|NCT00440193|536277179|FG001|Treatment Period|Study terminated by sponsor|94|||
148674085|NCT00440193|536277178|FG000|Treatment Period|Protocol driven decision point|2|||
148674086|NCT00440193|536277179|FG001|Treatment Period|Protocol driven decision point|2|||
148674087|NCT00440193|536277178|FG000|Treatment Period|Switch to commercial drug|0|||
148674088|NCT00440193|536277179|FG001|Treatment Period|Switch to commercial drug|2|||
148674089|NCT00440193|536277178|FG000|Treatment Period|Technical problems|1|||
148674090|NCT00440193|536277179|FG001|Treatment Period|Technical problems|1|||
148674091|NCT00440193|536277178|FG000|Treatment Period|Participant convenience|5|||
148674092|NCT00440193|536277179|FG001|Treatment Period|Participant convenience|2|||
148674093|NCT00440193|536277178|FG000|Treatment Period|Participant did not receive treatment|7|||
148674094|NCT00440193|536277179|FG001|Treatment Period|Participant did not receive treatment|13|||
148674095|NCT00440193|536277178|FG000|Treatment Period|Site closed by investigator|0|||
148674096|NCT00440193|536277179|FG001|Treatment Period|Site closed by investigator|2|||
148674097|NCT00440193|536277178|FG000|Observational Period|Adverse Event|2|||
148674098|NCT00440193|536277179|FG001|Observational Period|Adverse Event|2|||
148674099|NCT00440193|536277178|FG000|Observational Period|Death|15|||
148674100|NCT00440193|536277179|FG001|Observational Period|Death|20|||
148674101|NCT00440193|536277178|FG000|Observational Period|Lost to Follow-up|12|||
148674102|NCT00440193|536277179|FG001|Observational Period|Lost to Follow-up|8|||
148674103|NCT00440193|536277178|FG000|Observational Period|Protocol Violation|1|||
148674104|NCT00440193|536277179|FG001|Observational Period|Protocol Violation|0|||
148925310|NCT01155479|537210932|FG000|Part II|Withdrawal by Subject|8|||
148925311|NCT01155479|537210933|FG001|Part II|Withdrawal by Subject|4|||
148925312|NCT01155479|537210934|FG002|Part II|Withdrawal by Subject|12|||
148925313|NCT01155479|537210935|FG003|Part II|Withdrawal by Subject|7|||
148925314|NCT01155479|537210936|FG004|Part II|Withdrawal by Subject|3|||
148674105|NCT00440193|536277178|FG000|Observational Period|Withdrawal by Subject|11|||
148806052|NCT05911841|536768049|FG005|Escape Period|Site Terminated by Sponsor|0|||
148925315|NCT01155479|537210932|FG000|Part II|Lost to Follow-up|1|||
148925316|NCT01155479|537210933|FG001|Part II|Lost to Follow-up|0|||
149012855|NCT01468922|537525819|FG006|Overall Study|Infection of blood|0|||
149012856|NCT01468922|537525820|FG007|Overall Study|Infection of blood|1|||
149012857|NCT01468922|537525821|FG008|Overall Study|Infection of blood|0|||
149012858|NCT01468922|537525813|FG000|Overall Study|Patient choice - surgery|0|||
149012859|NCT01468922|537525814|FG001|Overall Study|Patient choice - surgery|0|||
149012860|NCT01468922|537525815|FG002|Overall Study|Patient choice - surgery|0|||
149012861|NCT01468922|537525816|FG003|Overall Study|Patient choice - surgery|0|||
149012862|NCT01468922|537525817|FG004|Overall Study|Patient choice - surgery|0|||
149012863|NCT01468922|537525818|FG005|Overall Study|Patient choice - surgery|0|||
149012864|NCT01468922|537525819|FG006|Overall Study|Patient choice - surgery|0|||
149012865|NCT01468922|537525820|FG007|Overall Study|Patient choice - surgery|1|||
149012866|NCT01468922|537525821|FG008|Overall Study|Patient choice - surgery|0|||
149012867|NCT01468922|537525813|FG000|Overall Study|Refused further treatment|0|||
149012868|NCT01468922|537525814|FG001|Overall Study|Refused further treatment|0|||
149160952|NCT02522767|538064824|FG001|Double-blind|Protocol Deviation|0|||
149160953|NCT02522767|538064823|FG000|Open-label|Withdrawal by Subject|2|||
149160954|NCT02522767|538064824|FG001|Open-label|Withdrawal by Subject|3|||
149160955|NCT02522767|538064823|FG000|Open-label|Lost to Follow-up|0|||
149160956|NCT02522767|538064824|FG001|Open-label|Lost to Follow-up|1|||
149160957|NCT02522767|538064823|FG000|Open-label|Adverse Event|2|||
149160958|NCT02522767|538064824|FG001|Open-label|Adverse Event|1|||
149160959|NCT02522767|538064823|FG000|Open-label|Lack of Efficacy|1|||
149160960|NCT02522767|538064824|FG001|Open-label|Lack of Efficacy|1|||
149160961|NCT02522767|538064823|FG000|Open-label|Protocol Violation|0|||
149160962|NCT02522767|538064824|FG001|Open-label|Protocol Violation|1|||
149160963|NCT00254566|538064826|FG000|Overall Study|Death|1|||
149160964|NCT00254566|538064827|FG001|Overall Study|Death|0|||
149160965|NCT00254566|538064826|FG000|Overall Study|Adverse Event|5|||
149160966|NCT00254566|538064827|FG001|Overall Study|Adverse Event|4|||
149160967|NCT00254566|538064826|FG000|Overall Study|Lack of Efficacy|12|||
149160968|NCT00254566|538064827|FG001|Overall Study|Lack of Efficacy|9|||
149160969|NCT00254566|538064826|FG000|Overall Study|Other|1|||
149160970|NCT00254566|538064827|FG001|Overall Study|Other|5|||
149160971|NCT00254566|538064826|FG000|Overall Study|Withdrawal by Subject|5|||
149160972|NCT00254566|538064827|FG001|Overall Study|Withdrawal by Subject|6|||
149160973|NCT00254566|538064826|FG000|Overall Study|Lost to Follow-up|7|||
149160974|NCT00254566|538064827|FG001|Overall Study|Lost to Follow-up|2|||
149160975|NCT00059202|538064828|FG000|Overall Study|Withdrawal by Subject|5|||
149160976|NCT00059202|538064829|FG001|Overall Study|Withdrawal by Subject|9|||
149160977|NCT00059202|538064828|FG000|Overall Study|Protocol Violation|1|||
149160978|NCT00059202|538064829|FG001|Overall Study|Protocol Violation|3|||
149160979|NCT00059202|538064828|FG000|Overall Study|drug toxicity|0|||
149160980|NCT00059202|538064829|FG001|Overall Study|drug toxicity|3|||
149160981|NCT00548548|538064832|FG000|Overall Study|Death|345|||
149160982|NCT00548548|538064833|FG001|Overall Study|Death|348|||
149160983|NCT00548548|538064832|FG000|Overall Study|Lost to Follow-up|17|||
149160984|NCT00548548|538064833|FG001|Overall Study|Lost to Follow-up|18|||
149160985|NCT01940484|538064834|FG000|Overall Study|Withdrawal by Subject|3|||
149160986|NCT01940484|538064834|FG000|Overall Study|Underwent transplantation|4|||
149160987|NCT01940484|538064834|FG000|Overall Study|Death|2|||
149160988|NCT01940484|538064834|FG000|Overall Study|Adverse Event|1|||
149160989|NCT01705691|538064837|FG000|Overall Study|Death|1|||
149160990|NCT01705691|538064838|FG001|Overall Study|Death|2|||
149160991|NCT01705691|538064837|FG000|Overall Study|Withdrawal by Subject|1|||
149160992|NCT01705691|538064838|FG001|Overall Study|Withdrawal by Subject|2|||
149160993|NCT01705691|538064837|FG000|Overall Study|Lost to Follow-up|1|||
149160994|NCT01705691|538064838|FG001|Overall Study|Lost to Follow-up|1|||
149160995|NCT01705691|538064837|FG000|Overall Study|Other|0|||
149160996|NCT01705691|538064838|FG001|Overall Study|Other|1|||
149160997|NCT02658448|538064839|FG000|Overall Study|Lost to Follow-up|1|||
149160998|NCT00841763|538064840|FG000|Overall Study|Withdrawal by Subject|60|||
149160999|NCT00841763|538064841|FG001|Overall Study|Withdrawal by Subject|17|||
149161000|NCT00841763|538064842|FG002|Overall Study|Withdrawal by Subject|4|||
149012869|NCT01468922|537525815|FG002|Overall Study|Refused further treatment|0|||
149012870|NCT01468922|537525816|FG003|Overall Study|Refused further treatment|0|||
149012871|NCT01468922|537525817|FG004|Overall Study|Refused further treatment|0|||
149161001|NCT00841763|538064843|FG003|Overall Study|Withdrawal by Subject|1|||
149161002|NCT00841763|538064840|FG000|Overall Study|Adverse Event|9|||
149161003|NCT00841763|538064841|FG001|Overall Study|Adverse Event|10|||
149161004|NCT00841763|538064842|FG002|Overall Study|Adverse Event|3|||
149161005|NCT00841763|538064843|FG003|Overall Study|Adverse Event|2|||
149161006|NCT00841763|538064840|FG000|Overall Study|Lost to Follow-up|63|||
149161007|NCT00841763|538064841|FG001|Overall Study|Lost to Follow-up|25|||
149161008|NCT00841763|538064842|FG002|Overall Study|Lost to Follow-up|0|||
149161009|NCT00841763|538064843|FG003|Overall Study|Lost to Follow-up|0|||
149161010|NCT00841763|538064840|FG000|Overall Study|Protocol Violation|20|||
149161011|NCT00841763|538064841|FG001|Overall Study|Protocol Violation|3|||
149161012|NCT00841763|538064842|FG002|Overall Study|Protocol Violation|1|||
149161013|NCT00841763|538064843|FG003|Overall Study|Protocol Violation|0|||
149161014|NCT00841763|538064840|FG000|Overall Study|Administrative Reasons|3|||
148925317|NCT01155479|537210934|FG002|Part II|Lost to Follow-up|0|||
148925318|NCT01155479|537210935|FG003|Part II|Lost to Follow-up|0|||
148925319|NCT01155479|537210936|FG004|Part II|Lost to Follow-up|1|||
148925320|NCT01155479|537210932|FG000|Part II|Treatment Failure|0|||
148925321|NCT01155479|537210933|FG001|Part II|Treatment Failure|1|||
148925322|NCT01155479|537210934|FG002|Part II|Treatment Failure|2|||
148925323|NCT01155479|537210935|FG003|Part II|Treatment Failure|0|||
148925324|NCT01155479|537210936|FG004|Part II|Treatment Failure|1|||
148925325|NCT01155479|537210932|FG000|Part II|Non-Compliance with Protocol|0|||
148925326|NCT01155479|537210933|FG001|Part II|Non-Compliance with Protocol|1|||
148925327|NCT01155479|537210934|FG002|Part II|Non-Compliance with Protocol|0|||
148925328|NCT01155479|537210935|FG003|Part II|Non-Compliance with Protocol|2|||
148925329|NCT01155479|537210936|FG004|Part II|Non-Compliance with Protocol|0|||
148925330|NCT02360605|537210937|FG000|Overall Study|Withdrawal by Subject|4|||
148925331|NCT02360605|537210938|FG001|Overall Study|Withdrawal by Subject|9|||
148925332|NCT02360605|537210937|FG000|Overall Study|Lost to Follow-up|7|||
148925333|NCT02360605|537210938|FG001|Overall Study|Lost to Follow-up|8|||
148925334|NCT02360605|537210937|FG000|Overall Study|Death|0|||
148925335|NCT02360605|537210938|FG001|Overall Study|Death|1|||
148925336|NCT01634178|537210941|FG000|Treatment Period 1|Adverse Event|0|||
148925337|NCT01634178|537210942|FG001|Treatment Period 1|Adverse Event|1|||
148925338|NCT01634178|537210941|FG000|Treatment Period 2|Adverse Event|1|||
148925339|NCT01634178|537210942|FG001|Treatment Period 2|Adverse Event|0|||
148925340|NCT01721577|537210947|FG000|Overall Study|Lack of Efficacy|1|||
148925341|NCT01721577|537210948|FG001|Overall Study|Lack of Efficacy|0|||
148925342|NCT01721577|537210947|FG000|Overall Study|Death|1|||
149161015|NCT00841763|538064841|FG001|Overall Study|Administrative Reasons|1|||
149161016|NCT00841763|538064842|FG002|Overall Study|Administrative Reasons|0|||
149161017|NCT00841763|538064843|FG003|Overall Study|Administrative Reasons|0|||
149161018|NCT00841763|538064840|FG000|Overall Study|Unable to Classify|7|||
149161019|NCT00841763|538064841|FG001|Overall Study|Unable to Classify|1|||
149161020|NCT00841763|538064842|FG002|Overall Study|Unable to Classify|0|||
149161021|NCT00841763|538064843|FG003|Overall Study|Unable to Classify|0|||
149161022|NCT03634800|538064844|FG000|Overall Study|Adverse Event|1|||
149161023|NCT03634800|538064844|FG000|Overall Study|Disease Progression|4|||
149161024|NCT03634800|538064844|FG000|Overall Study|Withdrawal by Subject|1|||
149161025|NCT00191451|538064849|FG000|Overall Study|Withdrawal by Subject|2|||
149161026|NCT00191451|538064850|FG001|Overall Study|Withdrawal by Subject|3|||
149161027|NCT00191451|538064851|FG002|Overall Study|Withdrawal by Subject|5|||
149161028|NCT00191451|538064849|FG000|Overall Study|Physician Decision|2|||
149161029|NCT00191451|538064850|FG001|Overall Study|Physician Decision|9|||
149161030|NCT00191451|538064851|FG002|Overall Study|Physician Decision|6|||
149161031|NCT00191451|538064849|FG000|Overall Study|Sponsor Decision|1|||
148925343|NCT01721577|537210948|FG001|Overall Study|Death|0|||
149161032|NCT00191451|538064850|FG001|Overall Study|Sponsor Decision|0|||
149161033|NCT00191451|538064851|FG002|Overall Study|Sponsor Decision|0|||
149161034|NCT00191451|538064849|FG000|Overall Study|Ineligible|0|||
148925344|NCT01721577|537210947|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
148925345|NCT01721577|537210948|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
148925346|NCT01721577|537210947|FG000|Overall Study|Adverse Event|0|||
148925347|NCT01721577|537210948|FG001|Overall Study|Adverse Event|2|||
149161035|NCT00191451|538064850|FG001|Overall Study|Ineligible|1|||
149161036|NCT00191451|538064851|FG002|Overall Study|Ineligible|0|||
149161037|NCT00191451|538064849|FG000|Overall Study|Reason Not Specified|2|||
149161038|NCT00191451|538064850|FG001|Overall Study|Reason Not Specified|1|||
149161039|NCT00191451|538064851|FG002|Overall Study|Reason Not Specified|3|||
148925348|NCT02497976|537210949|FG000|Overall Study|Withdrawal by Subject|2|||
148925349|NCT02497976|537210950|FG001|Overall Study|Withdrawal by Subject|0|||
148925350|NCT02497976|537210949|FG000|Overall Study|Moved out of area|0|||
149161040|NCT00272987|538064853|FG000|Overall Study|Adverse Event|1|||
149161041|NCT00272987|538064854|FG001|Overall Study|Adverse Event|0|||
149161042|NCT00272987|538064855|FG002|Overall Study|Adverse Event|0|||
149161043|NCT00272987|538064853|FG000|Overall Study|Lost to Follow-up|3|||
149161044|NCT00272987|538064854|FG001|Overall Study|Lost to Follow-up|1|||
149161045|NCT00272987|538064855|FG002|Overall Study|Lost to Follow-up|1|||
149161046|NCT00272987|538064853|FG000|Overall Study|Withdrawal by Subject|1|||
149161047|NCT00272987|538064854|FG001|Overall Study|Withdrawal by Subject|0|||
149161048|NCT00272987|538064855|FG002|Overall Study|Withdrawal by Subject|3|||
149161049|NCT00272987|538064853|FG000|Overall Study|Sponsor Terminated study|0|||
149161050|NCT00272987|538064854|FG001|Overall Study|Sponsor Terminated study|1|||
149161051|NCT00272987|538064855|FG002|Overall Study|Sponsor Terminated study|1|||
149161052|NCT00272987|538064853|FG000|Overall Study|Disease progression|1|||
149161053|NCT00272987|538064854|FG001|Overall Study|Disease progression|1|||
149161054|NCT00272987|538064855|FG002|Overall Study|Disease progression|2|||
149161055|NCT00272987|538064853|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
149161056|NCT00272987|538064854|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
149161057|NCT00272987|538064855|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
149161058|NCT00272987|538064853|FG000|Overall Study|Death|1|||
149161059|NCT00272987|538064854|FG001|Overall Study|Death|0|||
149161060|NCT00272987|538064855|FG002|Overall Study|Death|0|||
149161061|NCT03739528|538064861|FG000|Overall Study|Not treated|8|||
149161062|NCT03739528|538064862|FG001|Overall Study|Not treated|12|||
149161063|NCT03739528|538064861|FG000|Overall Study|Treatment and study discontinued|6|||
149161064|NCT03739528|538064862|FG001|Overall Study|Treatment and study discontinued|2|||
149161065|NCT03739528|538064861|FG000|Overall Study|Treatment discontinued + study completed|1|||
149161066|NCT03739528|538064862|FG001|Overall Study|Treatment discontinued + study completed|3|||
149161067|NCT03072160|538064863|FG000|Overall Study|Adverse Event|3|||
149161068|NCT03072160|538064864|FG001|Overall Study|Adverse Event|1|||
149161069|NCT03072160|538064863|FG000|Overall Study|Refused further treatment|6|||
149161070|NCT03072160|538064864|FG001|Overall Study|Refused further treatment|1|||
149161071|NCT03072160|538064863|FG000|Overall Study|Physician Decision|1|||
149161072|NCT03072160|538064864|FG001|Overall Study|Physician Decision|0|||
149161073|NCT03072160|538064863|FG000|Overall Study|Disease progression on study|1|||
149161074|NCT03072160|538064864|FG001|Overall Study|Disease progression on study|1|||
149161075|NCT03072160|538064863|FG000|Overall Study|No contact|0|||
149161076|NCT03072160|538064864|FG001|Overall Study|No contact|1|||
149161077|NCT01109940|538064865|FG000|Overall Study|Administrative problems|2|||
149161078|NCT01109940|538064866|FG001|Overall Study|Administrative problems|0|||
149161079|NCT01109940|538064867|FG002|Overall Study|Administrative problems|0|||
149161080|NCT01109940|538064868|FG003|Overall Study|Administrative problems|0|||
149161081|NCT01109940|538064865|FG000|Overall Study|Serious Adverse Event|2|||
149161082|NCT01109940|538064866|FG001|Overall Study|Serious Adverse Event|1|||
149161083|NCT01109940|538064867|FG002|Overall Study|Serious Adverse Event|0|||
149161084|NCT01109940|538064868|FG003|Overall Study|Serious Adverse Event|0|||
149161085|NCT01109940|538064865|FG000|Overall Study|Lost to Follow-up|1|||
149161086|NCT01109940|538064866|FG001|Overall Study|Lost to Follow-up|0|||
149161087|NCT01109940|538064867|FG002|Overall Study|Lost to Follow-up|0|||
149161088|NCT01109940|538064868|FG003|Overall Study|Lost to Follow-up|0|||
149161089|NCT01109940|538064865|FG000|Overall Study|Patient withdrew consent|1|||
149161090|NCT01109940|538064866|FG001|Overall Study|Patient withdrew consent|1|||
149161091|NCT01109940|538064867|FG002|Overall Study|Patient withdrew consent|0|||
149161092|NCT01109940|538064868|FG003|Overall Study|Patient withdrew consent|0|||
149161093|NCT01109940|538064865|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149161094|NCT01109940|538064866|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149161095|NCT01109940|538064867|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
149161096|NCT01109940|538064868|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149161097|NCT02419508|538064869|FG000|Overall Study|Adverse Event|9|||
149161098|NCT02419508|538064870|FG001|Overall Study|Adverse Event|3|||
149161099|NCT02419508|538064869|FG000|Overall Study|Withdrawal by Subject|1|||
149161100|NCT02419508|538064870|FG001|Overall Study|Withdrawal by Subject|0|||
149161101|NCT02419508|538064869|FG000|Overall Study|Other - Reason not specified|0|||
149161102|NCT02419508|538064870|FG001|Overall Study|Other - Reason not specified|1|||
149161103|NCT01748071|538066878|FG000|Overall Study|Adverse Event|2|||
149161104|NCT01748071|538066879|FG001|Overall Study|Adverse Event|2|||
149161105|NCT01748071|538066880|FG002|Overall Study|Adverse Event|0|||
149161106|NCT03068325|538066881|FG000|Overall Study|Lost to Follow-up|5|||
149161107|NCT00066690|538066882|FG000|Overall Study|Adverse Event|145|||
149161108|NCT00066690|538066883|FG001|Overall Study|Adverse Event|58|||
149161109|NCT00066690|538066884|FG002|Overall Study|Adverse Event|126|||
149161110|NCT00066690|538066882|FG000|Overall Study|Death|3|||
149161111|NCT00066690|538066883|FG001|Overall Study|Death|0|||
148925351|NCT02497976|537210950|FG001|Overall Study|Moved out of area|1|||
149161112|NCT00066690|538066884|FG002|Overall Study|Death|2|||
149161113|NCT00066690|538066882|FG000|Overall Study|Lack of Efficacy|114|||
149161114|NCT00066690|538066883|FG001|Overall Study|Lack of Efficacy|110|||
149161115|NCT00066690|538066884|FG002|Overall Study|Lack of Efficacy|76|||
149161116|NCT00066690|538066882|FG000|Overall Study|Lost to Follow-up|40|||
149161117|NCT00066690|538066883|FG001|Overall Study|Lost to Follow-up|21|||
149161118|NCT00066690|538066884|FG002|Overall Study|Lost to Follow-up|29|||
149161119|NCT00066690|538066882|FG000|Overall Study|Withdrawal by Subject|50|||
149161120|NCT00066690|538066883|FG001|Overall Study|Withdrawal by Subject|55|||
149161121|NCT00066690|538066884|FG002|Overall Study|Withdrawal by Subject|49|||
149161122|NCT00066690|538066882|FG000|Overall Study|Treatment Ongoing|246|||
149161123|NCT00066690|538066883|FG001|Overall Study|Treatment Ongoing|278|||
149161124|NCT00066690|538066884|FG002|Overall Study|Treatment Ongoing|282|||
149161125|NCT00700180|538066885|FG000|Overall Study|Death|99|||
149161126|NCT00700180|538066886|FG001|Overall Study|Death|114|||
149161127|NCT00700180|538066885|FG000|Overall Study|Alive on treatment|5|||
149161128|NCT00700180|538066886|FG001|Overall Study|Alive on treatment|3|||
149161129|NCT00700180|538066885|FG000|Overall Study|Alive in follow-up|46|||
149161130|NCT00700180|538066886|FG001|Overall Study|Alive in follow-up|27|||
149161131|NCT00700180|538066885|FG000|Overall Study|Lost to Follow-up|4|||
149161132|NCT00700180|538066886|FG001|Overall Study|Lost to Follow-up|5|||
149161133|NCT01613326|538066887|FG000|Overall Study|Adverse Event|7|||
149161134|NCT01613326|538066888|FG001|Overall Study|Adverse Event|5|||
149161135|NCT01613326|538066887|FG000|Overall Study|Withdrawal by Subject|3|||
149161136|NCT01613326|538066888|FG001|Overall Study|Withdrawal by Subject|4|||
149161137|NCT01613326|538066887|FG000|Overall Study|Abnormal test procedure result(s)|2|||
149161138|NCT01613326|538066888|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149161139|NCT01613326|538066887|FG000|Overall Study|inability to use device|1|||
149161140|NCT01613326|538066888|FG001|Overall Study|inability to use device|0|||
149161141|NCT01613326|538066887|FG000|Overall Study|Lack of Efficacy|0|||
149161142|NCT01613326|538066888|FG001|Overall Study|Lack of Efficacy|1|||
149161143|NCT01613326|538066887|FG000|Overall Study|Lost to Follow-up|0|||
149161144|NCT01613326|538066888|FG001|Overall Study|Lost to Follow-up|1|||
149161145|NCT01613326|538066887|FG000|Overall Study|Administrative|0|||
149161146|NCT01613326|538066888|FG001|Overall Study|Administrative|2|||
149161147|NCT01613326|538066887|FG000|Overall Study|Protocol Violation|0|||
149161148|NCT01613326|538066888|FG001|Overall Study|Protocol Violation|1|||
149161149|NCT00605267|538066891|FG000|Overall Study|Adverse Event|0|||
149161150|NCT00605267|538066892|FG001|Overall Study|Adverse Event|1|||
149161151|NCT00605267|538066891|FG000|Overall Study|Lack of Efficacy|1|||
149161152|NCT00605267|538066892|FG001|Overall Study|Lack of Efficacy|5|||
149161153|NCT00605267|538066891|FG000|Overall Study|Withdrawal by Subject|2|||
149161154|NCT00605267|538066892|FG001|Overall Study|Withdrawal by Subject|3|||
149161155|NCT00168831|538066893|FG000|Overall Study|Adverse Event|36|||
149161156|NCT00168831|538066894|FG001|Overall Study|Adverse Event|47|||
149161157|NCT00168831|538066895|FG002|Overall Study|Adverse Event|74|||
149161158|NCT00168831|538066893|FG000|Overall Study|Lost to Follow-up|5|||
149161159|NCT00168831|538066894|FG001|Overall Study|Lost to Follow-up|6|||
149161160|NCT00168831|538066895|FG002|Overall Study|Lost to Follow-up|4|||
149161161|NCT00168831|538066893|FG000|Overall Study|Withdrawal by Subject|7|||
149161162|NCT00168831|538066894|FG001|Overall Study|Withdrawal by Subject|14|||
149161163|NCT00168831|538066895|FG002|Overall Study|Withdrawal by Subject|19|||
149161164|NCT00168831|538066893|FG000|Overall Study|Protocol Violation|6|||
149161165|NCT00168831|538066894|FG001|Overall Study|Protocol Violation|11|||
149161166|NCT00168831|538066895|FG002|Overall Study|Protocol Violation|11|||
149161167|NCT00168831|538066893|FG000|Overall Study|Other|6|||
149161168|NCT00168831|538066894|FG001|Overall Study|Other|3|||
149161169|NCT00168831|538066895|FG002|Overall Study|Other|6|||
148925352|NCT00058539|537210951|FG000|Overall Study|Disease progression|24|||
148925353|NCT00058539|537210951|FG000|Overall Study|Adverse Event|3|||
149161170|NCT01505894|538066896|FG000|Overall Study|Adverse Event|1|||
149161171|NCT01505894|538066897|FG001|Overall Study|Adverse Event|0|||
148925354|NCT00058539|537210951|FG000|Overall Study|Withdrawal by Subject|5|||
148925355|NCT00058539|537210951|FG000|Overall Study|Physician Decision|9|||
149161172|NCT01505894|538066898|FG002|Overall Study|Adverse Event|0|||
148925356|NCT00058539|537210951|FG000|Overall Study|Death|1|||
149161173|NCT01505894|538066899|FG003|Overall Study|Adverse Event|0|||
149161174|NCT01505894|538066900|FG004|Overall Study|Adverse Event|0|||
148925357|NCT01903525|537210954|FG000|Overall Study|Lost to Follow-up|5|||
149161175|NCT01505894|538066901|FG005|Overall Study|Adverse Event|0|||
149161176|NCT01505894|538066902|FG006|Overall Study|Adverse Event|0|||
149161177|NCT01505894|538066903|FG007|Overall Study|Adverse Event|0|||
149161178|NCT01505894|538066904|FG008|Overall Study|Adverse Event|0|||
149161179|NCT01505894|538066896|FG000|Overall Study|Other than specified|0|||
149161180|NCT01505894|538066897|FG001|Overall Study|Other than specified|0|||
149161181|NCT01505894|538066898|FG002|Overall Study|Other than specified|0|||
149161182|NCT01505894|538066899|FG003|Overall Study|Other than specified|0|||
149161183|NCT01505894|538066900|FG004|Overall Study|Other than specified|1|||
149161184|NCT01505894|538066901|FG005|Overall Study|Other than specified|0|||
148925358|NCT01903525|537210955|FG001|Overall Study|Lost to Follow-up|9|||
148925359|NCT01903525|537210954|FG000|Overall Study|Adverse Event|0|||
148925360|NCT01903525|537210955|FG001|Overall Study|Adverse Event|1|||
148925361|NCT03977454|537210956|FG000|Overall Study|immediate postoperative revision|2|||
148925362|NCT03977454|537210957|FG001|Overall Study|immediate postoperative revision|2|||
148925363|NCT02483533|537210960|FG000|Overall Study|Lack of Efficacy|50|||
148925364|NCT02483533|537210961|FG001|Overall Study|Lack of Efficacy|50|||
148925365|NCT04365257|537210962|FG000|Overall Study|Physician Decision|1|||
148925366|NCT04365257|537210963|FG001|Overall Study|Physician Decision|0|||
148925367|NCT04365257|537210962|FG000|Overall Study|Patient Noncompliance|1|||
148925368|NCT04365257|537210963|FG001|Overall Study|Patient Noncompliance|0|||
148925369|NCT04365257|537210962|FG000|Overall Study|Withdrawal by Subject|0|||
148925370|NCT04365257|537210963|FG001|Overall Study|Withdrawal by Subject|1|||
148925371|NCT02129777|537210964|FG000|Double-Blind Period|Adverse Event|0|||
149161185|NCT01505894|538066902|FG006|Overall Study|Other than specified|0|||
149161186|NCT01505894|538066903|FG007|Overall Study|Other than specified|0|||
148925372|NCT02129777|537210965|FG001|Double-Blind Period|Adverse Event|0|||
148925373|NCT02129777|537210966|FG002|Double-Blind Period|Adverse Event|0|||
148925374|NCT02129777|537210967|FG003|Double-Blind Period|Adverse Event|0|||
148925375|NCT02129777|537210968|FG004|Double-Blind Period|Adverse Event|1|||
148925376|NCT02129777|537210969|FG005|Double-Blind Period|Adverse Event|0|||
148925377|NCT02129777|537210970|FG006|Double-Blind Period|Adverse Event|0|||
148925378|NCT02129777|537210964|FG000|Double-Blind Period|Lost to Follow-up|1|||
148925379|NCT02129777|537210965|FG001|Double-Blind Period|Lost to Follow-up|1|||
149161187|NCT01505894|538066904|FG008|Overall Study|Other than specified|0|||
149161188|NCT01622569|538066905|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
149161189|NCT01622569|538066906|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
149161190|NCT01622569|538066907|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
149161191|NCT01622569|538066908|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
149161192|NCT01622569|538066905|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
149161193|NCT01622569|538066906|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
149161194|NCT01622569|538066907|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
149161195|NCT01622569|538066908|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
149161196|NCT01622569|538066905|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
149161197|NCT01622569|538066906|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
149161198|NCT01622569|538066907|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
149161199|NCT01622569|538066908|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
149161200|NCT01622569|538066905|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149161201|NCT01622569|538066906|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
149161202|NCT01622569|538066907|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
149161203|NCT01622569|538066908|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
149161204|NCT01622569|538066905|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
149161205|NCT01622569|538066906|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
149161206|NCT01622569|538066907|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
149161207|NCT01622569|538066908|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
149161208|NCT01622569|538066905|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
149161209|NCT01622569|538066906|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
149161210|NCT01622569|538066907|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
149161211|NCT01622569|538066908|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
149161212|NCT01622569|538066905|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
149161213|NCT01622569|538066906|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
149161214|NCT01622569|538066907|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
149161215|NCT01622569|538066908|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
149161216|NCT01622569|538066905|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149161217|NCT01622569|538066906|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149161218|NCT01622569|538066907|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
149161219|NCT01622569|538066908|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
149161220|NCT03106779|538066909|FG000|Overall Study|Lack of Efficacy|33|||
149161221|NCT03106779|538066910|FG001|Overall Study|Lack of Efficacy|24|||
149161222|NCT03106779|538066909|FG000|Overall Study|Adverse Event|8|||
149161223|NCT03106779|538066910|FG001|Overall Study|Adverse Event|16|||
149161224|NCT03106779|538066909|FG000|Overall Study|Physician Decision|10|||
149161225|NCT03106779|538066910|FG001|Overall Study|Physician Decision|6|||
149161226|NCT03106779|538066909|FG000|Overall Study|Patient/guardian decision|4|||
148925380|NCT02129777|537210966|FG002|Double-Blind Period|Lost to Follow-up|1|||
148925381|NCT02129777|537210967|FG003|Double-Blind Period|Lost to Follow-up|2|||
149161227|NCT03106779|538066910|FG001|Overall Study|Patient/guardian decision|3|||
149161228|NCT03106779|538066909|FG000|Overall Study|Progressive disease|1|||
148925382|NCT02129777|537210968|FG004|Double-Blind Period|Lost to Follow-up|0|||
148925383|NCT02129777|537210969|FG005|Double-Blind Period|Lost to Follow-up|0|||
148925384|NCT02129777|537210970|FG006|Double-Blind Period|Lost to Follow-up|0|||
149161229|NCT03106779|538066910|FG001|Overall Study|Progressive disease|3|||
149161230|NCT03106779|538066909|FG000|Overall Study|Lost to Follow-up|1|||
149161231|NCT03106779|538066910|FG001|Overall Study|Lost to Follow-up|2|||
149161232|NCT03106779|538066909|FG000|Overall Study|Death|1|||
149161233|NCT03106779|538066910|FG001|Overall Study|Death|0|||
149161234|NCT03106779|538066909|FG000|Overall Study|Protocol Violation|1|||
149161235|NCT03106779|538066910|FG001|Overall Study|Protocol Violation|0|||
149161236|NCT03106779|538066909|FG000|Overall Study|Not treated|1|||
149161237|NCT03106779|538066910|FG001|Overall Study|Not treated|0|||
149161238|NCT04088409|538066911|FG000|Part A|Withdrawal by Subject|2|||
149161239|NCT04088409|538066912|FG001|Part A|Withdrawal by Subject|1|||
149161240|NCT04088409|538066911|FG000|Part A|Did Not Meet Randomization Criteria|2|||
149161241|NCT04088409|538066912|FG001|Part A|Did Not Meet Randomization Criteria|0|||
149161242|NCT04088409|538066911|FG000|Part A|Lack of Efficacy|9|||
149161243|NCT04088409|538066912|FG001|Part A|Lack of Efficacy|0|||
149161244|NCT04088409|538066911|FG000|Part A|Lost to Follow-up|1|||
149161245|NCT04088409|538066912|FG001|Part A|Lost to Follow-up|0|||
149161246|NCT04088409|538066911|FG000|Part A|Adverse Event|1|||
149161247|NCT04088409|538066912|FG001|Part A|Adverse Event|0|||
149161248|NCT04088409|538066911|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
149161249|NCT04088409|538066912|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
149161250|NCT04088409|538066911|FG000|Part B|Ongoing Treatment|10|||
149161251|NCT04088409|538066912|FG001|Part B|Ongoing Treatment|0|||
149161252|NCT04233229|538066913|FG000|Overall Study|Withdrawal by Subject|0|||
149161253|NCT04233229|538066914|FG001|Overall Study|Withdrawal by Subject|1|||
149161254|NCT04233229|538066913|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
149161255|NCT04233229|538066914|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
149161256|NCT04233229|538066913|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
149161257|NCT04233229|538066914|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
149161258|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
149161259|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
149161260|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
149161261|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
149161262|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
149161263|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
149161264|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
149161265|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
149161266|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
149161267|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
149161268|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
149161269|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
149161270|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
149161271|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
149161272|NCT02288247|538066915|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
148925385|NCT02129777|537210964|FG000|Double-Blind Period|Withdrawal by Subject|2|||
148925386|NCT02129777|537210965|FG001|Double-Blind Period|Withdrawal by Subject|4|||
148925387|NCT02129777|537210966|FG002|Double-Blind Period|Withdrawal by Subject|3|||
148925388|NCT02129777|537210967|FG003|Double-Blind Period|Withdrawal by Subject|2|||
148925389|NCT02129777|537210968|FG004|Double-Blind Period|Withdrawal by Subject|3|||
148925390|NCT02129777|537210969|FG005|Double-Blind Period|Withdrawal by Subject|0|||
148925391|NCT02129777|537210970|FG006|Double-Blind Period|Withdrawal by Subject|0|||
148925392|NCT02129777|537210964|FG000|Double-Blind Period|Pregnancy|0|||
148925393|NCT02129777|537210965|FG001|Double-Blind Period|Pregnancy|0|||
148925394|NCT02129777|537210966|FG002|Double-Blind Period|Pregnancy|0|||
148925395|NCT02129777|537210967|FG003|Double-Blind Period|Pregnancy|0|||
148925396|NCT02129777|537210968|FG004|Double-Blind Period|Pregnancy|1|||
149161273|NCT02288247|538066916|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
149161274|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
149161275|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
149161276|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
149161277|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
148806053|NCT05911841|536768050|FG006|Escape Period|Site Terminated by Sponsor|0|||
148925397|NCT02129777|537210969|FG005|Double-Blind Period|Pregnancy|0|||
148925398|NCT02129777|537210970|FG006|Double-Blind Period|Pregnancy|0|||
148925399|NCT02129777|537210964|FG000|Double-Blind Period|Lack of Efficacy|3|||
148925400|NCT02129777|537210965|FG001|Double-Blind Period|Lack of Efficacy|1|||
148925401|NCT02129777|537210966|FG002|Double-Blind Period|Lack of Efficacy|0|||
148925402|NCT02129777|537210967|FG003|Double-Blind Period|Lack of Efficacy|3|||
148925403|NCT02129777|537210968|FG004|Double-Blind Period|Lack of Efficacy|2|||
148925404|NCT02129777|537210969|FG005|Double-Blind Period|Lack of Efficacy|0|||
148925405|NCT02129777|537210970|FG006|Double-Blind Period|Lack of Efficacy|0|||
148925406|NCT02129777|537210964|FG000|Double-Blind Period|Other|1|||
148925407|NCT02129777|537210965|FG001|Double-Blind Period|Other|2|||
148925408|NCT02129777|537210966|FG002|Double-Blind Period|Other|0|||
148925409|NCT02129777|537210967|FG003|Double-Blind Period|Other|0|||
148925410|NCT02129777|537210968|FG004|Double-Blind Period|Other|0|||
148925411|NCT02129777|537210969|FG005|Double-Blind Period|Other|0|||
148925412|NCT02129777|537210970|FG006|Double-Blind Period|Other|0|||
148925413|NCT02129777|537210964|FG000|Open-Label Period|Lack of Efficacy|0|||
148925414|NCT02129777|537210965|FG001|Open-Label Period|Lack of Efficacy|0|||
148925415|NCT02129777|537210966|FG002|Open-Label Period|Lack of Efficacy|0|||
148925416|NCT02129777|537210967|FG003|Open-Label Period|Lack of Efficacy|0|||
148925417|NCT02129777|537210968|FG004|Open-Label Period|Lack of Efficacy|0|||
148925418|NCT02129777|537210969|FG005|Open-Label Period|Lack of Efficacy|0|||
148925419|NCT02129777|537210970|FG006|Open-Label Period|Lack of Efficacy|5|||
148925420|NCT02129777|537210964|FG000|Open-Label Period|Lost to Follow-up|0|||
148925421|NCT02129777|537210965|FG001|Open-Label Period|Lost to Follow-up|0|||
148925422|NCT02129777|537210966|FG002|Open-Label Period|Lost to Follow-up|0|||
148925423|NCT02129777|537210967|FG003|Open-Label Period|Lost to Follow-up|0|||
148925424|NCT02129777|537210968|FG004|Open-Label Period|Lost to Follow-up|0|||
148925425|NCT02129777|537210969|FG005|Open-Label Period|Lost to Follow-up|1|||
148925426|NCT02129777|537210970|FG006|Open-Label Period|Lost to Follow-up|1|||
148925427|NCT02129777|537210964|FG000|Open-Label Period|Withdrawal by Subject|0|||
148925428|NCT02129777|537210965|FG001|Open-Label Period|Withdrawal by Subject|0|||
148925429|NCT02129777|537210966|FG002|Open-Label Period|Withdrawal by Subject|0|||
148925430|NCT02129777|537210967|FG003|Open-Label Period|Withdrawal by Subject|0|||
148925431|NCT02129777|537210968|FG004|Open-Label Period|Withdrawal by Subject|0|||
148925432|NCT02129777|537210969|FG005|Open-Label Period|Withdrawal by Subject|1|||
148925433|NCT02129777|537210970|FG006|Open-Label Period|Withdrawal by Subject|3|||
148925434|NCT02129777|537210964|FG000|Open-Label Period|Study Termination|0|||
148925435|NCT02129777|537210965|FG001|Open-Label Period|Study Termination|0|||
148925436|NCT02129777|537210966|FG002|Open-Label Period|Study Termination|0|||
148925437|NCT02129777|537210967|FG003|Open-Label Period|Study Termination|0|||
148925438|NCT02129777|537210968|FG004|Open-Label Period|Study Termination|0|||
148925439|NCT02129777|537210969|FG005|Open-Label Period|Study Termination|10|||
148925440|NCT02129777|537210970|FG006|Open-Label Period|Study Termination|39|||
148925441|NCT01609478|537210975|FG000|Overall Study|Adverse Event|3|||
148925442|NCT01609478|537210976|FG001|Overall Study|Adverse Event|1|||
148925443|NCT01609478|537210977|FG002|Overall Study|Adverse Event|5|||
148925444|NCT01609478|537210975|FG000|Overall Study|Protocol Deviation|0|||
148925445|NCT01609478|537210976|FG001|Overall Study|Protocol Deviation|1|||
148925446|NCT01609478|537210977|FG002|Overall Study|Protocol Deviation|1|||
148925447|NCT01609478|537210975|FG000|Overall Study|Non-Compliance with study treatment|1|||
148925448|NCT01609478|537210976|FG001|Overall Study|Non-Compliance with study treatment|0|||
148925449|NCT01609478|537210977|FG002|Overall Study|Non-Compliance with study treatment|0|||
148925450|NCT01609478|537210975|FG000|Overall Study|Physician Decision|1|||
148925451|NCT01609478|537210976|FG001|Overall Study|Physician Decision|0|||
149161278|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
149161279|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
149161280|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
148925452|NCT01609478|537210977|FG002|Overall Study|Physician Decision|1|||
148925453|NCT01609478|537210975|FG000|Overall Study|Withdrawal by Subject|2|||
148925454|NCT01609478|537210976|FG001|Overall Study|Withdrawal by Subject|0|||
148925455|NCT01609478|537210977|FG002|Overall Study|Withdrawal by Subject|2|||
148925456|NCT03116347|537210978|FG000|Overall Study|Withdrawal by Subject|1|||
148925457|NCT03116347|537210979|FG001|Overall Study|Withdrawal by Subject|2|||
148925458|NCT00476047|537210980|FG000|Overall Study|Lost to Follow-up|1|||
148925459|NCT03761797|537210981|FG000|Overall Study|Changing hospital|11|||
148925460|NCT03761797|537210981|FG000|Overall Study|Improvement/remission|6|||
148925461|NCT03761797|537210981|FG000|Overall Study|Withdrawal by Subject|19|||
148925462|NCT03761797|537210981|FG000|Overall Study|Lost to Follow-up|33|||
148925463|NCT03761797|537210981|FG000|Overall Study|Adverse Event|37|||
149012872|NCT01468922|537525818|FG005|Overall Study|Refused further treatment|0|||
149161281|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
149161282|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
149161283|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
149161284|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
149161285|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
149161286|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
149161287|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
149161288|NCT02288247|538066915|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
149161289|NCT02288247|538066916|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
148925464|NCT03761797|537210981|FG000|Overall Study|Case report form (CRF) not collected|5|||
149161290|NCT04652804|538066917|FG000|Overall Study|Ineligible post randomization|1|||
149161291|NCT04652804|538066918|FG001|Overall Study|Ineligible post randomization|0|||
149161292|NCT04652804|538066919|FG002|Overall Study|Ineligible post randomization|1|||
149161293|NCT04652804|538066920|FG003|Overall Study|Ineligible post randomization|0|||
149161294|NCT04652804|538066921|FG004|Overall Study|Ineligible post randomization|1|||
149161295|NCT04652804|538066922|FG005|Overall Study|Ineligible post randomization|1|||
149161296|NCT04652804|538066917|FG000|Overall Study|Missing SVR lab results|2|||
149161297|NCT04652804|538066918|FG001|Overall Study|Missing SVR lab results|0|||
149161298|NCT04652804|538066919|FG002|Overall Study|Missing SVR lab results|0|||
149161299|NCT04652804|538066920|FG003|Overall Study|Missing SVR lab results|0|||
149161300|NCT04652804|538066921|FG004|Overall Study|Missing SVR lab results|0|||
149161301|NCT04652804|538066922|FG005|Overall Study|Missing SVR lab results|0|||
149161302|NCT00584194|538066923|FG000|Overall Study|Other|135|||
149161303|NCT04093531|538066924|FG000|Overall Study|failed screening|4|||
148806054|NCT05911841|536768051|FG007|Escape Period|Site Terminated by Sponsor|0|||
148925465|NCT03761797|537210981|FG000|Overall Study|No patient visit after entry|13|||
148925466|NCT03761797|537210981|FG000|Overall Study|Switch to other diabetes medication|10|||
148925467|NCT03761797|537210981|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
148925468|NCT03761797|537210981|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
148925469|NCT03761797|537210981|FG000|Overall Study|Insufficient effectives|2|||
148925470|NCT03761797|537210981|FG000|Overall Study|Excessive alcohol intake|1|||
148925471|NCT00879879|537210986|FG000|Overall Study|Death|1|||
148925472|NCT00879879|537210986|FG000|Overall Study|Withdrawal by Subject|1|||
148925473|NCT00879879|537210986|FG000|Overall Study|Physician Decision|1|||
148925474|NCT00645788|537210989|FG000|Overall Study|Did not receive study drug|1|||
148925475|NCT00645788|537210990|FG001|Overall Study|Did not receive study drug|1|||
148925476|NCT00645788|537210991|FG002|Overall Study|Did not receive study drug|0|||
148925477|NCT00645788|537210992|FG003|Overall Study|Did not receive study drug|0|||
148925478|NCT00645788|537210989|FG000|Overall Study|Adverse Event|4|||
148925479|NCT00645788|537210990|FG001|Overall Study|Adverse Event|9|||
148925480|NCT00645788|537210991|FG002|Overall Study|Adverse Event|5|||
148925481|NCT00645788|537210992|FG003|Overall Study|Adverse Event|3|||
148925482|NCT00645788|537210989|FG000|Overall Study|Lost to Follow-up|1|||
148925483|NCT00645788|537210990|FG001|Overall Study|Lost to Follow-up|0|||
148925484|NCT00645788|537210991|FG002|Overall Study|Lost to Follow-up|0|||
148925485|NCT00645788|537210992|FG003|Overall Study|Lost to Follow-up|0|||
148925486|NCT00645788|537210989|FG000|Overall Study|Protocol Violation|1|||
148925487|NCT00645788|537210990|FG001|Overall Study|Protocol Violation|0|||
148925488|NCT00645788|537210991|FG002|Overall Study|Protocol Violation|2|||
148925489|NCT00645788|537210992|FG003|Overall Study|Protocol Violation|0|||
148925490|NCT00645788|537210989|FG000|Overall Study|Withdrawal by Subject|0|||
148925491|NCT00645788|537210990|FG001|Overall Study|Withdrawal by Subject|1|||
148925492|NCT00645788|537210991|FG002|Overall Study|Withdrawal by Subject|0|||
148925493|NCT00645788|537210992|FG003|Overall Study|Withdrawal by Subject|2|||
148925494|NCT00645788|537210989|FG000|Overall Study|Pulmonary exacerbation|13|||
148925495|NCT00645788|537210990|FG001|Overall Study|Pulmonary exacerbation|16|||
148925496|NCT00645788|537210991|FG002|Overall Study|Pulmonary exacerbation|11|||
148925497|NCT00645788|537210992|FG003|Overall Study|Pulmonary exacerbation|9|||
148925498|NCT03149848|537210994|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
148925499|NCT03149848|537210994|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
148925500|NCT00400153|537210995|FG000|Overall Study|AE due to study disease worsening|14|||
148925501|NCT00400153|537210996|FG001|Overall Study|AE due to study disease worsening|19|||
148925502|NCT00400153|537210997|FG002|Overall Study|AE due to study disease worsening|20|||
148925503|NCT00400153|537210995|FG000|Overall Study|AE due to other disease worsening|2|||
148925504|NCT00400153|537210996|FG001|Overall Study|AE due to other disease worsening|1|||
148925505|NCT00400153|537210997|FG002|Overall Study|AE due to other disease worsening|0|||
148925506|NCT00400153|537210995|FG000|Overall Study|AE due to other condition|3|||
148925507|NCT00400153|537210996|FG001|Overall Study|AE due to other condition|14|||
148925508|NCT00400153|537210997|FG002|Overall Study|AE due to other condition|15|||
148925509|NCT00400153|537210995|FG000|Overall Study|Protocol Violation|7|||
149161304|NCT00927368|538066925|FG000|Overall Study|enrollment in another study|1|||
149161305|NCT00927368|538066926|FG001|Overall Study|enrollment in another study|1|||
149161306|NCT00927368|538066927|FG002|Overall Study|enrollment in another study|2|||
148925510|NCT00400153|537210996|FG001|Overall Study|Protocol Violation|4|||
148925511|NCT00400153|537210997|FG002|Overall Study|Protocol Violation|9|||
148925512|NCT00400153|537210995|FG000|Overall Study|Lost to Follow-up|2|||
148925513|NCT00400153|537210996|FG001|Overall Study|Lost to Follow-up|1|||
148925514|NCT00400153|537210997|FG002|Overall Study|Lost to Follow-up|4|||
148925515|NCT00400153|537210995|FG000|Overall Study|Withdrawal by Subject|12|||
148925516|NCT00400153|537210996|FG001|Overall Study|Withdrawal by Subject|11|||
148925517|NCT00400153|537210997|FG002|Overall Study|Withdrawal by Subject|10|||
148925518|NCT00400153|537210995|FG000|Overall Study|Other reasons - not mentioned above|8|||
148925519|NCT00400153|537210996|FG001|Overall Study|Other reasons - not mentioned above|5|||
148925520|NCT00400153|537210997|FG002|Overall Study|Other reasons - not mentioned above|3|||
148925521|NCT00327470|537211000|FG000|Overall Study|Randomized, but not treated|0|||
148925522|NCT00327470|537211001|FG001|Overall Study|Randomized, but not treated|2|||
148925523|NCT00327470|537211000|FG000|Overall Study|Adverse Event|9|||
148925524|NCT00327470|537211001|FG001|Overall Study|Adverse Event|14|||
148925525|NCT00327470|537211000|FG000|Overall Study|Lack of Efficacy|7|||
148925526|NCT00327470|537211001|FG001|Overall Study|Lack of Efficacy|19|||
148925527|NCT00327470|537211000|FG000|Overall Study|Other|5|||
148925528|NCT00327470|537211001|FG001|Overall Study|Other|9|||
148925529|NCT00327470|537211000|FG000|Overall Study|Lost to Follow-up|1|||
148925530|NCT00327470|537211001|FG001|Overall Study|Lost to Follow-up|3|||
148925531|NCT00327470|537211000|FG000|Overall Study|Withdrawal by Subject|6|||
148925532|NCT00327470|537211001|FG001|Overall Study|Withdrawal by Subject|12|||
148925533|NCT00327470|537211000|FG000|Overall Study|Death|1|||
148925534|NCT00327470|537211001|FG001|Overall Study|Death|4|||
148925535|NCT04738318|537211002|FG000|Overall Study|Protocol Violation|1|||
148925536|NCT04738318|537211003|FG001|Overall Study|Protocol Violation|0|||
148925537|NCT02290431|537211004|FG000|Overall Study|Adverse Event|20|||
148925538|NCT02290431|537211004|FG000|Overall Study|Progressive disease|4|||
148925539|NCT02290431|537211004|FG000|Overall Study|Study terminated by Sponsor|1|||
148925540|NCT02290431|537211004|FG000|Overall Study|Physician Decision|2|||
148925541|NCT02197234|537211005|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
148925542|NCT02197234|537211005|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
148925543|NCT02197234|537211005|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
148925544|NCT02197234|537211005|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
148925545|NCT02197234|537211005|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
148925546|NCT02197234|537211005|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
148806055|NCT05911841|536768052|FG008|Escape Period|Site Terminated by Sponsor|0|||
148806056|NCT05911841|536768053|FG009|Escape Period|Site Terminated by Sponsor|1|||
148925547|NCT03783702|537211006|FG000|Overall Study|Lost to Follow-up|6|||
148925548|NCT03783702|537211007|FG001|Overall Study|Lost to Follow-up|8|||
148925549|NCT03783702|537211006|FG000|Overall Study|Protocol Violation|1|||
148925550|NCT03783702|537211007|FG001|Overall Study|Protocol Violation|3|||
148925551|NCT02274038|537211008|FG000|Overall Study|Death|1|||
148925552|NCT02361346|537211009|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925553|NCT02361346|537211010|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925554|NCT02361346|537211011|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925555|NCT02361346|537211012|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
148925556|NCT02361346|537211013|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925557|NCT02361346|537211014|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
148806057|NCT05911841|536768044|FG000|Escape Period|Study Terminated by Sponsor|0|||
148806058|NCT05911841|536768045|FG001|Escape Period|Study Terminated by Sponsor|0|||
148806059|NCT05911841|536768046|FG002|Escape Period|Study Terminated by Sponsor|0|||
148925558|NCT02361346|537211015|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925559|NCT02361346|537211016|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925560|NCT02361346|537211017|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
148925561|NCT02361346|537211009|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925562|NCT02361346|537211010|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925563|NCT02361346|537211011|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
149161307|NCT00927368|538066925|FG000|Overall Study|Lost to Follow-up|4|||
149161308|NCT00927368|538066926|FG001|Overall Study|Lost to Follow-up|0|||
149161309|NCT00927368|538066927|FG002|Overall Study|Lost to Follow-up|0|||
149161310|NCT00927368|538066925|FG000|Overall Study|equipment failure|1|||
149161311|NCT00927368|538066926|FG001|Overall Study|equipment failure|0|||
149161312|NCT00927368|538066927|FG002|Overall Study|equipment failure|0|||
149161313|NCT00927368|538066925|FG000|Overall Study|ineligible post randomization|0|||
149161314|NCT00927368|538066926|FG001|Overall Study|ineligible post randomization|3|||
149161315|NCT00927368|538066927|FG002|Overall Study|ineligible post randomization|1|||
149161316|NCT00927368|538066925|FG000|Overall Study|cancellation of surgery|0|||
149161317|NCT00927368|538066926|FG001|Overall Study|cancellation of surgery|1|||
149161318|NCT00927368|538066927|FG002|Overall Study|cancellation of surgery|2|||
149161319|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
149161320|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
149161321|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
149161322|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
148925564|NCT02361346|537211012|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925565|NCT02361346|537211013|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
148925566|NCT02361346|537211014|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925567|NCT02361346|537211015|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925568|NCT02361346|537211016|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925569|NCT02361346|537211017|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
148925570|NCT02361346|537211009|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
148925571|NCT02361346|537211010|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
148925572|NCT02361346|537211011|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
148925573|NCT02361346|537211012|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
148925574|NCT02361346|537211013|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
148925575|NCT02361346|537211014|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
148925576|NCT02361346|537211015|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
148925577|NCT02361346|537211016|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
148925578|NCT02361346|537211017|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
148925579|NCT02361346|537211009|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925580|NCT02361346|537211010|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925581|NCT02361346|537211011|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925582|NCT02361346|537211012|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925583|NCT02361346|537211013|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925584|NCT02361346|537211014|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925585|NCT02361346|537211015|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925586|NCT02361346|537211016|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
148925587|NCT02361346|537211017|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
148925588|NCT02361346|537211009|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925589|NCT02361346|537211010|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925590|NCT02361346|537211011|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925591|NCT02361346|537211012|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
149161323|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
149161324|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
149161325|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
149161326|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
148925592|NCT02361346|537211013|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925593|NCT02361346|537211014|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925594|NCT02361346|537211015|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925595|NCT02361346|537211016|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
148925596|NCT02361346|537211017|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
148925597|NCT02361346|537211009|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925598|NCT02361346|537211010|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925599|NCT02361346|537211011|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925600|NCT02361346|537211012|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925601|NCT02361346|537211013|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925602|NCT02361346|537211014|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925603|NCT02361346|537211015|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925604|NCT02361346|537211016|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
148925605|NCT02361346|537211017|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
148925606|NCT01163318|537211018|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
148925607|NCT01163318|537211018|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
148925608|NCT01163318|537211018|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
148925609|NCT01163318|537211018|FG000|Overall Study|Participants Without Case Report Form|7|||
148925610|NCT01163318|537211018|FG000|Overall Study|Multiple Reasons Per Participant|224|||
148925611|NCT03587727|537211023|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
148925612|NCT03587727|537211023|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
149161327|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
149161328|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
149161329|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
149161330|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
149161331|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
149161332|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
149161333|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
149161334|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
149161335|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
149161336|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
149161337|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
149161338|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
149161339|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
149161340|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
149161341|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
149161342|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
149161343|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Death|2|||
149161344|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Death|1|||
149161345|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Death|2|||
149161346|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Graft loss|0|||
149161347|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Graft loss|2|||
149161348|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Graft loss|0|||
149161349|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
149161350|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
149161351|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
149161352|NCT01114529|538066933|FG000|Completed Study Medication at Month 24|Missing|2|||
149161353|NCT01114529|538066934|FG001|Completed Study Medication at Month 24|Missing|0|||
149161354|NCT01114529|538066935|FG002|Completed Study Medication at Month 24|Missing|0|||
149161355|NCT01114529|538066933|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
149161356|NCT01114529|538066934|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
149161357|NCT01114529|538066935|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
149161358|NCT01114529|538066933|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
149161359|NCT01114529|538066934|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
149161360|NCT01114529|538066935|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
149161361|NCT01114529|538066933|FG000|Completed Study Phase at Month 24|Death|8|||
149161362|NCT01114529|538066934|FG001|Completed Study Phase at Month 24|Death|5|||
149161363|NCT01114529|538066935|FG002|Completed Study Phase at Month 24|Death|4|||
149161364|NCT01114529|538066933|FG000|Completed Study Phase at Month 24|Other|2|||
149161365|NCT01114529|538066934|FG001|Completed Study Phase at Month 24|Other|0|||
149161366|NCT01114529|538066935|FG002|Completed Study Phase at Month 24|Other|0|||
149161367|NCT01114529|538066933|FG000|Completed Study Phase at Month 24|Missing|2|||
149161368|NCT01114529|538066934|FG001|Completed Study Phase at Month 24|Missing|0|||
149161369|NCT01114529|538066935|FG002|Completed Study Phase at Month 24|Missing|0|||
149161370|NCT02614079|538066937|FG000|Overall Study|Withdrawal by Subject|1|||
149161371|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
149161372|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
149161373|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
149161374|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Death|28|||
149161375|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Death|0|||
149161376|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Death|0|||
149161377|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
149161378|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
149161379|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
149161380|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
149161381|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
149161382|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
149161383|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
149161384|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
149161385|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
149161386|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
149161387|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
149161388|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
149161389|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
149161390|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
149161391|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
149161392|NCT00820755|538066938|FG000|Period 1: Combination Therapy Phase|Other|11|||
149161393|NCT00820755|538066939|FG001|Period 1: Combination Therapy Phase|Other|0|||
149161394|NCT00820755|538066940|FG002|Period 1: Combination Therapy Phase|Other|0|||
149161395|NCT00820755|538066938|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
149161396|NCT00820755|538066939|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
149161397|NCT00820755|538066940|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
148806060|NCT05911841|536768047|FG003|Escape Period|Study Terminated by Sponsor|0|||
148806061|NCT05911841|536768048|FG004|Escape Period|Study Terminated by Sponsor|0|||
149161398|NCT00130286|538066941|FG000|Overall Study|Withdrawal by Subject|0|||
149161399|NCT00130286|538066942|FG001|Overall Study|Withdrawal by Subject|1|||
149161400|NCT00130286|538066943|FG002|Overall Study|Withdrawal by Subject|2|||
149161401|NCT00130286|538066944|FG003|Overall Study|Withdrawal by Subject|2|||
149161402|NCT00130286|538066941|FG000|Overall Study|Adverse Event|0|||
149161403|NCT00130286|538066942|FG001|Overall Study|Adverse Event|0|||
149161404|NCT00130286|538066943|FG002|Overall Study|Adverse Event|2|||
149161405|NCT00130286|538066944|FG003|Overall Study|Adverse Event|0|||
149161406|NCT00130286|538066941|FG000|Overall Study|Missing lab specimens|0|||
149161407|NCT00130286|538066942|FG001|Overall Study|Missing lab specimens|2|||
149161408|NCT00130286|538066943|FG002|Overall Study|Missing lab specimens|0|||
149161409|NCT00130286|538066944|FG003|Overall Study|Missing lab specimens|0|||
149161410|NCT02211261|538066945|FG000|Overall Study|Withdrawal by Subject|0|||
149161411|NCT02211261|538066946|FG001|Overall Study|Withdrawal by Subject|0|||
149161412|NCT02211261|538066947|FG002|Overall Study|Withdrawal by Subject|1|||
149161413|NCT02211261|538066948|FG003|Overall Study|Withdrawal by Subject|0|||
149161414|NCT02211261|538066949|FG004|Overall Study|Withdrawal by Subject|2|||
149161415|NCT02211261|538066950|FG005|Overall Study|Withdrawal by Subject|0|||
149161416|NCT02211261|538066951|FG006|Overall Study|Withdrawal by Subject|0|||
149161417|NCT02211261|538066952|FG007|Overall Study|Withdrawal by Subject|0|||
149161418|NCT02211261|538066953|FG008|Overall Study|Withdrawal by Subject|0|||
149161419|NCT02211261|538066954|FG009|Overall Study|Withdrawal by Subject|0|||
149161420|NCT02211261|538066955|FG010|Overall Study|Withdrawal by Subject|0|||
149161421|NCT02211261|538066945|FG000|Overall Study|Other|0|||
149161422|NCT02211261|538066946|FG001|Overall Study|Other|0|||
149161423|NCT02211261|538066947|FG002|Overall Study|Other|0|||
149161424|NCT02211261|538066948|FG003|Overall Study|Other|0|||
149161425|NCT02211261|538066949|FG004|Overall Study|Other|0|||
149161426|NCT02211261|538066950|FG005|Overall Study|Other|1|||
149161427|NCT02211261|538066951|FG006|Overall Study|Other|0|||
149161428|NCT02211261|538066952|FG007|Overall Study|Other|0|||
149161429|NCT02211261|538066953|FG008|Overall Study|Other|0|||
149161430|NCT02211261|538066954|FG009|Overall Study|Other|2|||
149161431|NCT02211261|538066955|FG010|Overall Study|Other|0|||
149161432|NCT02211261|538066945|FG000|Overall Study|Lost to Follow-up|0|||
149161433|NCT02211261|538066946|FG001|Overall Study|Lost to Follow-up|0|||
149161434|NCT02211261|538066947|FG002|Overall Study|Lost to Follow-up|0|||
149161435|NCT02211261|538066948|FG003|Overall Study|Lost to Follow-up|0|||
149161436|NCT02211261|538066949|FG004|Overall Study|Lost to Follow-up|0|||
149161437|NCT02211261|538066950|FG005|Overall Study|Lost to Follow-up|0|||
149161438|NCT02211261|538066951|FG006|Overall Study|Lost to Follow-up|0|||
149161439|NCT02211261|538066952|FG007|Overall Study|Lost to Follow-up|1|||
149161440|NCT02211261|538066953|FG008|Overall Study|Lost to Follow-up|0|||
149161441|NCT02211261|538066954|FG009|Overall Study|Lost to Follow-up|0|||
149161442|NCT02211261|538066955|FG010|Overall Study|Lost to Follow-up|0|||
149161443|NCT02817087|538066956|FG000|Overall Study|Withdrawal by Subject|2|||
149161444|NCT02817087|538066957|FG001|Overall Study|Withdrawal by Subject|0|||
149161445|NCT02251912|538066959|FG000|Overall Study|Withdrawal by Subject|2|||
149161446|NCT02251912|538066960|FG001|Overall Study|Withdrawal by Subject|3|||
149161447|NCT02251912|538066959|FG000|Overall Study|Adverse Event|0|||
149161448|NCT02251912|538066960|FG001|Overall Study|Adverse Event|2|||
149161449|NCT00480857|538066961|FG000|Overall Study|Lack of Efficacy|2|||
149161450|NCT02551159|538066962|FG000|Overall Study|Death|352|||
149161451|NCT02551159|538066963|FG001|Overall Study|Death|174|||
149161452|NCT02551159|538066964|FG002|Overall Study|Death|161|||
149161453|NCT02551159|538066962|FG000|Overall Study|Withdrawal by Subject|8|||
149161454|NCT02551159|538066963|FG001|Overall Study|Withdrawal by Subject|5|||
149161455|NCT02551159|538066964|FG002|Overall Study|Withdrawal by Subject|16|||
149161456|NCT02551159|538066962|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
149161457|NCT02551159|538066963|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
149161458|NCT02551159|538066964|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
149161459|NCT00243659|538066965|FG000|Overall Study|Withdrawal by Subject|1|||
149161460|NCT00243659|538066966|FG001|Overall Study|Withdrawal by Subject|1|||
149161461|NCT00243659|538066965|FG000|Overall Study|Protocol Violation|1|||
149161462|NCT00243659|538066966|FG001|Overall Study|Protocol Violation|2|||
149161463|NCT00268242|538066967|FG000|Overall Study|Death|1|||
149161464|NCT02175680|538066968|FG000|Overall Study|non-compliance|1|||
149161465|NCT02175680|538066968|FG000|Overall Study|other non-medical reason|1|||
149161466|NCT03969888|538066969|FG000|Overall Study|Never Received Study Drug|0|||
149161467|NCT03969888|538066970|FG001|Overall Study|Never Received Study Drug|0|||
149161468|NCT03969888|538066971|FG002|Overall Study|Never Received Study Drug|1|||
149161469|NCT03969888|538066972|FG003|Overall Study|Never Received Study Drug|0|||
149161470|NCT03969888|538066973|FG004|Overall Study|Never Received Study Drug|0|||
149161471|NCT03969888|538066974|FG005|Overall Study|Never Received Study Drug|0|||
149161472|NCT03969888|538066975|FG006|Overall Study|Never Received Study Drug|1|||
149161473|NCT03969888|538066976|FG007|Overall Study|Never Received Study Drug|0|||
149161474|NCT03969888|538066969|FG000|Overall Study|Reason Not Specified|0|||
149161475|NCT03969888|538066970|FG001|Overall Study|Reason Not Specified|0|||
149161476|NCT03969888|538066971|FG002|Overall Study|Reason Not Specified|0|||
149161477|NCT03969888|538066972|FG003|Overall Study|Reason Not Specified|0|||
149161478|NCT03969888|538066973|FG004|Overall Study|Reason Not Specified|0|||
149161479|NCT03969888|538066974|FG005|Overall Study|Reason Not Specified|0|||
149161480|NCT03969888|538066975|FG006|Overall Study|Reason Not Specified|0|||
149161481|NCT03969888|538066976|FG007|Overall Study|Reason Not Specified|1|||
149161482|NCT00464178|538066977|FG000|Overall Study|Protocol Violation|1|||
149161483|NCT00464178|538066977|FG000|Overall Study|Withdrawal by Subject|1|||
149161484|NCT04506294|538066980|FG000|Overall Study|Lost to Follow-up|70|||
149161485|NCT04506294|538066981|FG001|Overall Study|Lost to Follow-up|20|||
148674106|NCT00440193|536277179|FG001|Observational Period|Withdrawal by Subject|8|||
148674107|NCT00440193|536277178|FG000|Observational Period|Physician Decision|1|||
148674108|NCT00440193|536277179|FG001|Observational Period|Physician Decision|0|||
148674109|NCT00440193|536277178|FG000|Observational Period|Clinical endpoint reached|1|||
148674110|NCT00440193|536277179|FG001|Observational Period|Clinical endpoint reached|0|||
148674111|NCT00440193|536277178|FG000|Observational Period|Participant convenience|2|||
148674112|NCT00440193|536277179|FG001|Observational Period|Participant convenience|0|||
148674113|NCT00834366|536277180|FG000|Treatment Period 1|Adverse Event|1|||
148674114|NCT00834366|536277181|FG001|Treatment Period 1|Adverse Event|1|||
148674115|NCT03014570|536277184|FG000|Overall Study|COVID-19 Restrictions|38|||
148674116|NCT03014570|536277185|FG001|Overall Study|COVID-19 Restrictions|24|||
148674117|NCT03014570|536277184|FG000|Overall Study|Death|70|||
149161486|NCT04506294|538066980|FG000|Overall Study|Withdrawal by Subject|16|||
149161487|NCT04506294|538066981|FG001|Overall Study|Withdrawal by Subject|2|||
149161488|NCT00946309|538066982|FG000|Overall Study|Protocol Violation|1|||
149161489|NCT00946309|538066983|FG001|Overall Study|Protocol Violation|0|||
149161490|NCT00946309|538066982|FG000|Overall Study|Lost to Follow-up|0|||
149161491|NCT00946309|538066983|FG001|Overall Study|Lost to Follow-up|1|||
149161492|NCT00946309|538066982|FG000|Overall Study|Procedure cancelled/discontinued|0|||
149161493|NCT00946309|538066983|FG001|Overall Study|Procedure cancelled/discontinued|3|||
149161494|NCT01465659|538066987|FG000|Completed 1 Cycle of Treatment|Death|0|||
148674118|NCT03014570|536277185|FG001|Overall Study|Death|79|||
148674119|NCT03014570|536277184|FG000|Overall Study|Transfer from facility|11|||
148674120|NCT03014570|536277185|FG001|Overall Study|Transfer from facility|14|||
148674121|NCT03014570|536277184|FG000|Overall Study|Hospitalized|5|||
148674122|NCT03014570|536277185|FG001|Overall Study|Hospitalized|3|||
148674123|NCT03014570|536277184|FG000|Overall Study|Transfer within facility|1|||
148674124|NCT03014570|536277185|FG001|Overall Study|Transfer within facility|0|||
148674125|NCT03014570|536277184|FG000|Overall Study|Site refusal|0|||
148925619|NCT03576274|537211032|FG000|Overall Study|Lost to Follow-up|3|||
148925620|NCT03576274|537211033|FG001|Overall Study|Lost to Follow-up|2|||
148925621|NCT03576274|537211034|FG002|Overall Study|Lost to Follow-up|3|||
148925622|NCT03576274|537211035|FG003|Overall Study|Lost to Follow-up|1|||
148925623|NCT03576274|537211036|FG004|Overall Study|Lost to Follow-up|3|||
148925624|NCT03576274|537211032|FG000|Overall Study|Withdrawal by Subject|5|||
148925625|NCT03576274|537211033|FG001|Overall Study|Withdrawal by Subject|3|||
148925626|NCT03576274|537211034|FG002|Overall Study|Withdrawal by Subject|2|||
148925627|NCT03576274|537211035|FG003|Overall Study|Withdrawal by Subject|8|||
148925628|NCT03576274|537211036|FG004|Overall Study|Withdrawal by Subject|6|||
148925629|NCT04704154|537212202|FG000|Overall Study|Adverse Event|3|||
148925630|NCT04704154|537212203|FG001|Overall Study|Adverse Event|2|||
148925631|NCT04704154|537212204|FG002|Overall Study|Adverse Event|4|||
148925632|NCT04704154|537212205|FG003|Overall Study|Adverse Event|2|||
148925633|NCT04704154|537212206|FG004|Overall Study|Adverse Event|3|||
148674126|NCT03014570|536277185|FG001|Overall Study|Site refusal|11|||
148674127|NCT04797637|536277188|FG000|Overall Study|Lost to Follow-up|23|||
148806062|NCT05911841|536768049|FG005|Escape Period|Study Terminated by Sponsor|0|||
148925634|NCT04704154|537212207|FG005|Overall Study|Adverse Event|0|||
148925635|NCT04704154|537212202|FG000|Overall Study|Death|3|||
148925636|NCT04704154|537212203|FG001|Overall Study|Death|0|||
148925637|NCT04704154|537212204|FG002|Overall Study|Death|0|||
148925638|NCT04704154|537212205|FG003|Overall Study|Death|0|||
149161495|NCT01465659|538066988|FG001|Completed 1 Cycle of Treatment|Death|1|||
149161496|NCT01465659|538066989|FG002|Completed 1 Cycle of Treatment|Death|0|||
149161497|NCT01465659|538066990|FG003|Completed 1 Cycle of Treatment|Death|0|||
149161498|NCT01465659|538066987|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
149161499|NCT01465659|538066988|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
149161500|NCT01465659|538066989|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
149161501|NCT01465659|538066990|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
148674128|NCT04797637|536277189|FG001|Overall Study|Lost to Follow-up|32|||
149161502|NCT01465659|538066987|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
149161503|NCT01465659|538066988|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
149161504|NCT01465659|538066989|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
149161505|NCT01465659|538066990|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
149161506|NCT01465659|538066987|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
149161507|NCT01465659|538066988|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
149161508|NCT01465659|538066989|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
149161509|NCT01465659|538066990|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
149161510|NCT01465659|538066987|FG000|Completed Follow for 1 Year|Death|6|||
149161511|NCT01465659|538066988|FG001|Completed Follow for 1 Year|Death|3|||
148674129|NCT04797637|536277188|FG000|Overall Study|Withdrawal by Subject|0|||
148674130|NCT04797637|536277189|FG001|Overall Study|Withdrawal by Subject|1|||
149161512|NCT01465659|538066989|FG002|Completed Follow for 1 Year|Death|2|||
149161513|NCT01465659|538066990|FG003|Completed Follow for 1 Year|Death|4|||
149161514|NCT03434379|538066991|FG000|Global Period|Lost to Follow-up|3|||
149161515|NCT03434379|538066992|FG001|Global Period|Lost to Follow-up|6|||
149161516|NCT03434379|538066993|FG002|Global Period|Lost to Follow-up|0|||
148674131|NCT01275170|536277190|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
148674132|NCT01275170|536277191|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674133|NCT01275170|536277192|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674134|NCT01275170|536277193|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674135|NCT01275170|536277194|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674136|NCT01275170|536277195|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674137|NCT01275170|536277196|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674138|NCT01275170|536277197|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
148674139|NCT00960687|536277198|FG000|Washout Period of 7 Days|Adverse Event|3|||
148674140|NCT00960687|536277199|FG001|Washout Period of 7 Days|Adverse Event|2|||
148674141|NCT00960687|536277198|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
148674142|NCT00960687|536277199|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
148674143|NCT02362646|536277200|FG000|Overall Study|Death|15|||
148674144|NCT02362646|536277201|FG001|Overall Study|Death|8|||
148674145|NCT02362646|536277200|FG000|Overall Study|Withdrawal by Subject|2|||
148674146|NCT02362646|536277201|FG001|Overall Study|Withdrawal by Subject|2|||
148674147|NCT02362646|536277200|FG000|Overall Study|received transplant|21|||
148674148|NCT02362646|536277201|FG001|Overall Study|received transplant|14|||
148674149|NCT02666768|536277208|FG000|Overall Study|Withdrawal by Subject|4|||
148674150|NCT01023022|536277209|FG000|Overall Study|Death|5|||
148674151|NCT01023022|536277209|FG000|Overall Study|Lost to Follow-up|7|||
148674152|NCT01023022|536277209|FG000|Overall Study|due to technical issues|2|||
148674153|NCT03728257|536277210|FG000|Overall Study|Death|3|||
148674154|NCT03728257|536277211|FG001|Overall Study|Death|0|||
148674155|NCT00402779|536277214|FG000|Overall Study|Screen Failure|77|||
148674156|NCT00402779|536277215|FG001|Overall Study|Screen Failure|76|||
148674157|NCT03239340|536277216|FG000|Overall Study|Other|26|||
148674158|NCT03239340|536277216|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
148674159|NCT03239340|536277216|FG000|Overall Study|Death|40|||
148674160|NCT03239340|536277216|FG000|Overall Study|Lost to Follow-up|2|||
148674161|NCT03239340|536277216|FG000|Overall Study|Physician Decision|16|||
148674162|NCT03239340|536277216|FG000|Overall Study|Withdrawal by Subject|27|||
148925639|NCT04704154|537212206|FG004|Overall Study|Death|3|||
148925640|NCT04704154|537212207|FG005|Overall Study|Death|0|||
148925641|NCT04704154|537212202|FG000|Overall Study|Physician Decision|1|||
148925642|NCT04704154|537212203|FG001|Overall Study|Physician Decision|0|||
148925643|NCT04704154|537212204|FG002|Overall Study|Physician Decision|1|||
148925644|NCT04704154|537212205|FG003|Overall Study|Physician Decision|0|||
148925645|NCT04704154|537212206|FG004|Overall Study|Physician Decision|2|||
148925646|NCT04704154|537212207|FG005|Overall Study|Physician Decision|0|||
148925647|NCT04704154|537212202|FG000|Overall Study|Participant Decision|1|||
148925648|NCT04704154|537212203|FG001|Overall Study|Participant Decision|1|||
149161517|NCT03434379|538066994|FG003|Global Period|Lost to Follow-up|0|||
148674163|NCT00777920|536277221|FG000|Overall Study|Adverse Event|39|||
148674164|NCT00777920|536277221|FG000|Overall Study|Withdrawal of Consent|4|||
149161518|NCT03434379|538066991|FG000|Global Period|Death|115|||
148674165|NCT00777920|536277221|FG000|Overall Study|Lost to Follow-up|1|||
148674166|NCT00777920|536277221|FG000|Overall Study|Investigator's discretion|1|||
148674167|NCT00777920|536277221|FG000|Overall Study|Clinical status did not improve|1|||
148674168|NCT00777920|536277221|FG000|Overall Study|Other, not specified|4|||
148674169|NCT02392377|536277222|FG000|Overall Study|Withdrawal by Subject|0|||
148674170|NCT02392377|536277223|FG001|Overall Study|Withdrawal by Subject|1|||
148674171|NCT00526227|536277224|FG000|Overall Study|Device not implanted|1|||
148925649|NCT04704154|537212204|FG002|Overall Study|Participant Decision|0|||
149161519|NCT03434379|538066992|FG001|Global Period|Death|228|||
148925650|NCT04704154|537212205|FG003|Overall Study|Participant Decision|0|||
149161520|NCT03434379|538066993|FG002|Global Period|Death|0|||
149161521|NCT03434379|538066994|FG003|Global Period|Death|0|||
148925651|NCT04704154|537212206|FG004|Overall Study|Participant Decision|0|||
148674172|NCT00526227|536277224|FG000|Overall Study|Death|1|||
148674173|NCT05378269|536279412|FG000|Overall Study|Protocol Violation|1|||
148674174|NCT05378269|536279413|FG001|Overall Study|Protocol Violation|0|||
148674175|NCT05378269|536279414|FG002|Overall Study|Protocol Violation|2|||
148674176|NCT05378269|536279415|FG003|Overall Study|Protocol Violation|0|||
148674177|NCT05378269|536279416|FG004|Overall Study|Protocol Violation|0|||
148674178|NCT00684645|536279417|FG000|Overall Study|Death|2|||
148674179|NCT00684645|536279417|FG000|Overall Study|Progressive disease|67|||
148674180|NCT00684645|536279417|FG000|Overall Study|Adverse Event|27|||
148674181|NCT00684645|536279417|FG000|Overall Study|Lost to Follow-up|3|||
148674182|NCT00684645|536279417|FG000|Overall Study|Other|15|||
148674183|NCT01186744|536279418|FG000|Overall Study|Lack of Efficacy|156|||
148674184|NCT01186744|536279419|FG001|Overall Study|Lack of Efficacy|99|||
148674185|NCT01186744|536279420|FG002|Overall Study|Lack of Efficacy|0|||
148674186|NCT01186744|536279421|FG003|Overall Study|Lack of Efficacy|2|||
149161522|NCT03434379|538066991|FG000|Global Period|Withdrawal by Subject|20|||
149161523|NCT03434379|538066992|FG001|Global Period|Withdrawal by Subject|21|||
149161524|NCT03434379|538066993|FG002|Global Period|Withdrawal by Subject|0|||
149161525|NCT03434379|538066994|FG003|Global Period|Withdrawal by Subject|0|||
149161526|NCT03434379|538066991|FG000|Global Period|Reason Unspecified|0|||
149161527|NCT03434379|538066992|FG001|Global Period|Reason Unspecified|1|||
149161528|NCT03434379|538066993|FG002|Global Period|Reason Unspecified|0|||
149161529|NCT03434379|538066994|FG003|Global Period|Reason Unspecified|0|||
149161530|NCT03434379|538066991|FG000|Global Period|Study Ended by Sponsor|26|||
149161531|NCT03434379|538066992|FG001|Global Period|Study Ended by Sponsor|80|||
149161532|NCT03434379|538066993|FG002|Global Period|Study Ended by Sponsor|0|||
149161533|NCT03434379|538066994|FG003|Global Period|Study Ended by Sponsor|0|||
149161534|NCT03434379|538066991|FG000|Global Period|Physician Decision|1|||
149161535|NCT03434379|538066992|FG001|Global Period|Physician Decision|0|||
149161536|NCT03434379|538066993|FG002|Global Period|Physician Decision|0|||
149161537|NCT03434379|538066994|FG003|Global Period|Physician Decision|0|||
149161538|NCT03434379|538066991|FG000|China Extension Period|Lost to Follow-up|0|||
149161539|NCT03434379|538066992|FG001|China Extension Period|Lost to Follow-up|0|||
149161540|NCT03434379|538066993|FG002|China Extension Period|Lost to Follow-up|2|||
149161541|NCT03434379|538066994|FG003|China Extension Period|Lost to Follow-up|3|||
149161542|NCT03434379|538066991|FG000|China Extension Period|Death|0|||
149161543|NCT03434379|538066992|FG001|China Extension Period|Death|0|||
149161544|NCT03434379|538066993|FG002|China Extension Period|Death|46|||
149161545|NCT03434379|538066994|FG003|China Extension Period|Death|88|||
149161546|NCT03434379|538066991|FG000|China Extension Period|Withdrawal by Subject|0|||
149161547|NCT03434379|538066992|FG001|China Extension Period|Withdrawal by Subject|0|||
149161548|NCT03434379|538066993|FG002|China Extension Period|Withdrawal by Subject|8|||
149161549|NCT03434379|538066994|FG003|China Extension Period|Withdrawal by Subject|6|||
149161550|NCT03434379|538066991|FG000|China Extension Period|Study Ended by Sponsor|0|||
149161551|NCT03434379|538066992|FG001|China Extension Period|Study Ended by Sponsor|0|||
149161552|NCT03434379|538066993|FG002|China Extension Period|Study Ended by Sponsor|5|||
149161553|NCT03434379|538066994|FG003|China Extension Period|Study Ended by Sponsor|36|||
149161554|NCT00428597|538066997|FG000|Overall Study|Randomized but not treated|3|||
149161555|NCT00428597|538066998|FG001|Overall Study|Randomized but not treated|3|||
149161556|NCT00428597|538066997|FG000|Overall Study|Objective Progression or Relapse|19|||
149161557|NCT00428597|538066998|FG001|Overall Study|Objective Progression or Relapse|47|||
149161558|NCT00428597|538066997|FG000|Overall Study|Study Terminated by Sponsor|41|||
149161559|NCT00428597|538066998|FG001|Overall Study|Study Terminated by Sponsor|16|||
149161560|NCT00428597|538066997|FG000|Overall Study|Adverse Event|15|||
149161561|NCT00428597|538066998|FG001|Overall Study|Adverse Event|7|||
149161562|NCT00428597|538066997|FG000|Overall Study|Global Deterioration of Health Status|1|||
149161563|NCT00428597|538066998|FG001|Overall Study|Global Deterioration of Health Status|5|||
149161564|NCT00428597|538066997|FG000|Overall Study|Protocol Violation|2|||
149161565|NCT00428597|538066998|FG001|Overall Study|Protocol Violation|1|||
148806063|NCT05911841|536768050|FG006|Escape Period|Study Terminated by Sponsor|0|||
148806064|NCT05911841|536768051|FG007|Escape Period|Study Terminated by Sponsor|0|||
148806065|NCT05911841|536768052|FG008|Escape Period|Study Terminated by Sponsor|0|||
149161566|NCT00428597|538066997|FG000|Overall Study|Withdrawal by Subject|2|||
149161567|NCT00428597|538066998|FG001|Overall Study|Withdrawal by Subject|1|||
149161568|NCT00428597|538066997|FG000|Overall Study|Other|1|||
149161569|NCT00428597|538066998|FG001|Overall Study|Other|1|||
149161570|NCT00428597|538066997|FG000|Overall Study|Lost to Follow-up|0|||
148674187|NCT01186744|536279422|FG004|Overall Study|Lack of Efficacy|2|||
148674188|NCT01186744|536279423|FG005|Overall Study|Lack of Efficacy|5|||
148674189|NCT01186744|536279418|FG000|Overall Study|Protocol Violation|1|||
148674190|NCT01186744|536279419|FG001|Overall Study|Protocol Violation|2|||
148674191|NCT01186744|536279420|FG002|Overall Study|Protocol Violation|0|||
148806066|NCT05911841|536768053|FG009|Escape Period|Study Terminated by Sponsor|34|||
148806067|NCT05911841|536768044|FG000|Escape Period|Withdrawal by Subject|0|||
148806068|NCT05911841|536768045|FG001|Escape Period|Withdrawal by Subject|0|||
149161571|NCT00428597|538066998|FG001|Overall Study|Lost to Follow-up|1|||
149161572|NCT00428597|538066997|FG000|Overall Study|Pregnancy|1|||
149161573|NCT00428597|538066998|FG001|Overall Study|Pregnancy|0|||
148925652|NCT04704154|537212207|FG005|Overall Study|Participant Decision|0|||
148925653|NCT04704154|537212202|FG000|Overall Study|Progressive Disease|19|||
148925654|NCT04704154|537212203|FG001|Overall Study|Progressive Disease|17|||
148925655|NCT04704154|537212204|FG002|Overall Study|Progressive Disease|20|||
148925656|NCT04704154|537212205|FG003|Overall Study|Progressive Disease|18|||
148925657|NCT04704154|537212206|FG004|Overall Study|Progressive Disease|36|||
148925658|NCT04704154|537212207|FG005|Overall Study|Progressive Disease|30|||
148925659|NCT04704154|537212202|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
148925660|NCT04704154|537212203|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
148925661|NCT04704154|537212204|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
148925662|NCT04704154|537212205|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
148925663|NCT04704154|537212206|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
148925664|NCT04704154|537212207|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
148925665|NCT04704154|537212202|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
148925666|NCT04704154|537212203|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
148925667|NCT04704154|537212204|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
148925668|NCT04704154|537212205|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
148925669|NCT04704154|537212206|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
148925670|NCT04704154|537212207|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
148925671|NCT04950608|537212208|FG000|Overall Study|Withdrawal by Subject|2|||
148925672|NCT04950608|537212208|FG000|Overall Study|Physician Decision|3|||
148925673|NCT04626310|537212213|FG000|Overall Study|4-miss from treatment|6|||
148925674|NCT04626310|537212214|FG001|Overall Study|4-miss from treatment|5|||
148925675|NCT04626310|537212215|FG002|Overall Study|4-miss from treatment|5|||
148925676|NCT04626310|537212213|FG000|Overall Study|Withdrawal by Subject|1|||
148925677|NCT04626310|537212214|FG001|Overall Study|Withdrawal by Subject|0|||
149161574|NCT00428597|538066997|FG000|Overall Study|Death|1|||
149161575|NCT00428597|538066998|FG001|Overall Study|Death|3|||
149161576|NCT00769119|538067004|FG000|Overall Study|Voluntary discontinuation|0|||
149161577|NCT00769119|538067005|FG001|Overall Study|Voluntary discontinuation|2|||
149161578|NCT00769119|538067004|FG000|Overall Study|Adverse Event|1|||
149161579|NCT00769119|538067005|FG001|Overall Study|Adverse Event|1|||
149161580|NCT00769119|538067004|FG000|Overall Study|Disallowed medication|1|||
149161581|NCT00769119|538067005|FG001|Overall Study|Disallowed medication|0|||
149161582|NCT00686647|538067006|FG000|Overall Study|Lost to Follow-up|1|||
149161583|NCT00686647|538067006|FG000|Overall Study|Death|1|||
149161584|NCT01116544|538067010|FG000|Overall Study|Protocol Violation|1|||
148674192|NCT01186744|536279421|FG003|Overall Study|Protocol Violation|1|||
148925678|NCT04626310|537212215|FG002|Overall Study|Withdrawal by Subject|3|||
148925679|NCT02604017|537212216|FG000|Overall Study|Withdrew Consent|0|||
148925680|NCT02604017|537212217|FG001|Overall Study|Withdrew Consent|2|||
148925681|NCT02604017|537212216|FG000|Overall Study|Lost to Follow-up|5|||
149012873|NCT01468922|537525819|FG006|Overall Study|Refused further treatment|0|||
149161585|NCT01116544|538067011|FG001|Overall Study|Protocol Violation|0|||
149161586|NCT01116544|538067010|FG000|Overall Study|Withdrawal by Subject|1|||
149161587|NCT01116544|538067011|FG001|Overall Study|Withdrawal by Subject|1|||
149161588|NCT00578643|538067012|FG000|Overall Study|Death|1|||
149161589|NCT00578643|538067012|FG000|Overall Study|Lost to Follow-up|1|||
149161590|NCT01725750|538067013|FG000|Overall Study|Adverse Event|1|||
148674193|NCT01186744|536279422|FG004|Overall Study|Protocol Violation|1|||
148925682|NCT02604017|537212217|FG001|Overall Study|Lost to Follow-up|6|||
148925683|NCT02604017|537212216|FG000|Overall Study|Other|1|||
148925684|NCT02604017|537212217|FG001|Overall Study|Other|0|||
148925685|NCT01850602|537212218|FG000|Overall Study|Adverse Event|7|||
148925686|NCT01850602|537212219|FG001|Overall Study|Adverse Event|10|||
148925687|NCT01850602|537212218|FG000|Overall Study|Physician Decision|2|||
148925688|NCT01850602|537212219|FG001|Overall Study|Physician Decision|1|||
148925689|NCT01850602|537212218|FG000|Overall Study|Withdrawal by Subject|2|||
148925690|NCT01850602|537212219|FG001|Overall Study|Withdrawal by Subject|4|||
148925691|NCT01850602|537212218|FG000|Overall Study|Decrease in serum calcium|2|||
148925692|NCT01850602|537212219|FG001|Overall Study|Decrease in serum calcium|3|||
148925693|NCT01850602|537212218|FG000|Overall Study|Increase in serum ferritin|1|||
148925694|NCT01850602|537212219|FG001|Overall Study|Increase in serum ferritin|0|||
148925695|NCT00367770|537212220|FG000|Overall Study|Adverse Event|1|||
148925696|NCT00367770|537212220|FG000|Overall Study|Withdrawal by Subject|1|||
148925697|NCT01315236|537212221|FG000|Double-blind Phase|Death|1|||
148925698|NCT01315236|537212222|FG001|Double-blind Phase|Death|0|||
148925699|NCT01315236|537212221|FG000|Double-blind Phase|Adverse Event|1|||
148925700|NCT01315236|537212222|FG001|Double-blind Phase|Adverse Event|0|||
148925701|NCT01315236|537212221|FG000|Double-blind Phase|Withdrawal of Consent|1|||
148925702|NCT01315236|537212222|FG001|Double-blind Phase|Withdrawal of Consent|0|||
148925703|NCT01315236|537212221|FG000|Double-blind Phase|Lost to Follow-up|1|||
148925704|NCT01315236|537212222|FG001|Double-blind Phase|Lost to Follow-up|0|||
148925705|NCT01315236|537212221|FG000|Open-label Phase|Death|1|||
148925706|NCT01315236|537212222|FG001|Open-label Phase|Death|0|||
148925707|NCT01315236|537212221|FG000|Open-label Phase|Adverse Event|0|||
148925708|NCT01315236|537212222|FG001|Open-label Phase|Adverse Event|1|||
148925709|NCT01315236|537212221|FG000|Open-label Phase|Other|0|||
148925710|NCT01315236|537212222|FG001|Open-label Phase|Other|1|||
148925711|NCT01315236|537212221|FG000|12-Month Follow-up Period|Death|0|||
148925712|NCT01315236|537212222|FG001|12-Month Follow-up Period|Death|1|||
148925713|NCT01315236|537212221|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
148925714|NCT01315236|537212222|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
148925715|NCT00287079|537212223|FG000|Overall Study|Qualifying relapse|12|||
148925716|NCT00287079|537212224|FG001|Overall Study|Qualifying relapse|1|||
148925717|NCT00287079|537212223|FG000|Overall Study|Non-qualifying relapse|1|||
148925718|NCT00287079|537212224|FG001|Overall Study|Non-qualifying relapse|0|||
148925719|NCT00287079|537212223|FG000|Overall Study|Adverse Event|5|||
148925720|NCT00287079|537212224|FG001|Overall Study|Adverse Event|0|||
148925721|NCT00287079|537212223|FG000|Overall Study|Protocol Violation|1|||
148925722|NCT00287079|537212224|FG001|Overall Study|Protocol Violation|0|||
148925723|NCT00287079|537212223|FG000|Overall Study|Other|3|||
148925724|NCT00287079|537212224|FG001|Overall Study|Other|0|||
148925725|NCT00470184|537212225|FG000|Overall Study|Not Treated(became ineligible)|4|||
148925726|NCT00470184|537212225|FG000|Overall Study|Not treated (other)|1|||
148925727|NCT00470184|537212225|FG000|Overall Study|disease Progression|4|||
148925728|NCT00470184|537212225|FG000|Overall Study|Adverse Event|3|||
148925729|NCT00470184|537212225|FG000|Overall Study|Withdrawal by Subject|4|||
148925730|NCT00470184|537212225|FG000|Overall Study|other|5|||
148925731|NCT00470184|537212225|FG000|Overall Study|recurrence|1|||
148925732|NCT03282565|537212228|FG000|Overall Study|COVID-19 Research Shutdown|0|||
148925733|NCT03282565|537212229|FG001|Overall Study|COVID-19 Research Shutdown|2|||
148925734|NCT03282565|537212230|FG002|Overall Study|COVID-19 Research Shutdown|2|||
148925735|NCT00740051|537212231|FG000|Overall Study|Lack of Efficacy|2|||
148925736|NCT00740051|537212232|FG001|Overall Study|Lack of Efficacy|5|||
148925737|NCT00740051|537212231|FG000|Overall Study|Adverse Event|1|||
148925738|NCT00740051|537212232|FG001|Overall Study|Adverse Event|4|||
148925739|NCT00740051|537212231|FG000|Overall Study|Protocol Violation|2|||
148925740|NCT00740051|537212232|FG001|Overall Study|Protocol Violation|6|||
148925741|NCT00740051|537212231|FG000|Overall Study|Lost to Follow-up|3|||
148925742|NCT00740051|537212232|FG001|Overall Study|Lost to Follow-up|8|||
148925743|NCT00740051|537212231|FG000|Overall Study|Withdrawal by Subject|6|||
148925744|NCT00740051|537212232|FG001|Overall Study|Withdrawal by Subject|8|||
148925745|NCT00740051|537212231|FG000|Overall Study|Other reason (not specified)|4|||
148925746|NCT00740051|537212232|FG001|Overall Study|Other reason (not specified)|1|||
149161591|NCT01725750|538067014|FG001|Overall Study|Adverse Event|0|||
149161592|NCT01725750|538067013|FG000|Overall Study|Lost to Follow-up|1|||
149161593|NCT01725750|538067014|FG001|Overall Study|Lost to Follow-up|1|||
149161594|NCT01725750|538067013|FG000|Overall Study|Withdrawal by Subject|0|||
149161595|NCT01725750|538067014|FG001|Overall Study|Withdrawal by Subject|9|||
149161596|NCT03828487|538067017|FG000|Overall Study|Physician Decision|1|||
149161597|NCT03179436|538067020|FG000|Overall Study|Withdrawal by Subject|1|||
149161598|NCT03179436|538067021|FG001|Overall Study|Withdrawal by Subject|0|||
149161599|NCT03179436|538067022|FG002|Overall Study|Withdrawal by Subject|0|||
149161600|NCT03179436|538067023|FG003|Overall Study|Withdrawal by Subject|4|||
149161601|NCT03179436|538067024|FG004|Overall Study|Withdrawal by Subject|2|||
149161602|NCT03179436|538067025|FG005|Overall Study|Withdrawal by Subject|2|||
149161603|NCT03179436|538067026|FG006|Overall Study|Withdrawal by Subject|5|||
148925747|NCT02011893|537212233|FG000|Enrollment to Randomization|Adverse Event|2|||
148925748|NCT02011893|537212234|FG001|Enrollment to Randomization|Adverse Event|0|||
148925749|NCT02011893|537212235|FG002|Enrollment to Randomization|Adverse Event|0|||
148925750|NCT02011893|537212233|FG000|Enrollment to Randomization|Physician Decision|10|||
148925751|NCT02011893|537212234|FG001|Enrollment to Randomization|Physician Decision|0|||
148925752|NCT02011893|537212235|FG002|Enrollment to Randomization|Physician Decision|0|||
148925753|NCT02011893|537212233|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
148925754|NCT02011893|537212234|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
148925755|NCT02011893|537212235|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
148925756|NCT02011893|537212233|FG000|Enrollment to Randomization|Screening Failure|29|||
148925757|NCT02011893|537212234|FG001|Enrollment to Randomization|Screening Failure|0|||
148925758|NCT02011893|537212235|FG002|Enrollment to Randomization|Screening Failure|0|||
148925759|NCT02011893|537212233|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
148925760|NCT02011893|537212234|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
148925761|NCT02011893|537212235|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
148925762|NCT02011893|537212233|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
148925763|NCT02011893|537212234|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
148925764|NCT02011893|537212235|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
148925765|NCT02011893|537212233|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
148925766|NCT02011893|537212234|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
148925767|NCT02011893|537212235|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
148925768|NCT02011893|537212233|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
148925769|NCT02011893|537212234|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
148925770|NCT02011893|537212235|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
148925771|NCT02011893|537212233|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
148925772|NCT02011893|537212234|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
148925773|NCT02011893|537212235|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
149161604|NCT03179436|538067027|FG007|Overall Study|Withdrawal by Subject|0|||
149161605|NCT03179436|538067028|FG008|Overall Study|Withdrawal by Subject|3|||
149161606|NCT03179436|538067029|FG009|Overall Study|Withdrawal by Subject|0|||
149161607|NCT03179436|538067030|FG010|Overall Study|Withdrawal by Subject|0|||
149161608|NCT03179436|538067031|FG011|Overall Study|Withdrawal by Subject|0|||
149161609|NCT03179436|538067020|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148925774|NCT00518973|537212236|FG000|Overall Study|Withdrawal by Subject|3|||
148925775|NCT00518973|537212237|FG001|Overall Study|Withdrawal by Subject|2|||
149161610|NCT03179436|538067021|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148925776|NCT01565499|537212242|FG000|Overall Study|Physician Decision|1|||
148925777|NCT01565499|537212242|FG000|Overall Study|Adverse Event|5|||
149161611|NCT03179436|538067022|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149161612|NCT03179436|538067023|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149161613|NCT03179436|538067024|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149161614|NCT03179436|538067025|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
149161615|NCT03179436|538067026|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
149161616|NCT03179436|538067027|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
149161617|NCT03179436|538067028|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
149161618|NCT03179436|538067029|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
149161619|NCT03179436|538067030|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
149161620|NCT03179436|538067031|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
149161621|NCT03179436|538067020|FG000|Overall Study|Sponsor Decision|0|||
149161622|NCT03179436|538067021|FG001|Overall Study|Sponsor Decision|0|||
149161623|NCT03179436|538067022|FG002|Overall Study|Sponsor Decision|1|||
149161624|NCT03179436|538067023|FG003|Overall Study|Sponsor Decision|3|||
149161625|NCT03179436|538067024|FG004|Overall Study|Sponsor Decision|9|||
149161626|NCT03179436|538067025|FG005|Overall Study|Sponsor Decision|7|||
149161627|NCT03179436|538067026|FG006|Overall Study|Sponsor Decision|2|||
149161628|NCT03179436|538067027|FG007|Overall Study|Sponsor Decision|4|||
149161629|NCT03179436|538067028|FG008|Overall Study|Sponsor Decision|23|||
149161630|NCT03179436|538067029|FG009|Overall Study|Sponsor Decision|6|||
149161631|NCT03179436|538067030|FG010|Overall Study|Sponsor Decision|7|||
149161632|NCT03179436|538067031|FG011|Overall Study|Sponsor Decision|5|||
149161633|NCT03179436|538067020|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161634|NCT03179436|538067021|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
149161635|NCT03179436|538067022|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161636|NCT03179436|538067023|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161637|NCT03179436|538067024|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161638|NCT03179436|538067025|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
149161639|NCT03179436|538067026|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161640|NCT03179436|538067027|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161641|NCT03179436|538067028|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161642|NCT03179436|538067029|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161643|NCT03179436|538067030|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161644|NCT03179436|538067031|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
149161645|NCT03179436|538067020|FG000|Overall Study|Lost to Follow-up|1|||
149161646|NCT03179436|538067021|FG001|Overall Study|Lost to Follow-up|0|||
149161647|NCT03179436|538067022|FG002|Overall Study|Lost to Follow-up|0|||
149161648|NCT03179436|538067023|FG003|Overall Study|Lost to Follow-up|1|||
149161649|NCT03179436|538067024|FG004|Overall Study|Lost to Follow-up|0|||
149161650|NCT03179436|538067025|FG005|Overall Study|Lost to Follow-up|1|||
149161651|NCT03179436|538067026|FG006|Overall Study|Lost to Follow-up|0|||
149161652|NCT03179436|538067027|FG007|Overall Study|Lost to Follow-up|0|||
149161653|NCT03179436|538067028|FG008|Overall Study|Lost to Follow-up|1|||
149161654|NCT03179436|538067029|FG009|Overall Study|Lost to Follow-up|1|||
149161655|NCT03179436|538067030|FG010|Overall Study|Lost to Follow-up|0|||
149161656|NCT03179436|538067031|FG011|Overall Study|Lost to Follow-up|0|||
149161657|NCT03179436|538067020|FG000|Overall Study|Death|12|||
149161658|NCT03179436|538067021|FG001|Overall Study|Death|17|||
149161659|NCT03179436|538067022|FG002|Overall Study|Death|7|||
149161660|NCT03179436|538067023|FG003|Overall Study|Death|32|||
148925778|NCT01565499|537212242|FG000|Overall Study|Withdrawal by Subject|2|||
148925779|NCT01255787|537212245|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
149012874|NCT01468922|537525820|FG007|Overall Study|Refused further treatment|1|||
148925780|NCT01255787|537212246|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
148925781|NCT01255787|537212247|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
148925782|NCT01255787|537212248|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
148925783|NCT01255787|537212245|FG000|Overall Study|Major Protocol Deviation|1|||
148925784|NCT01255787|537212246|FG001|Overall Study|Major Protocol Deviation|1|||
148925785|NCT01255787|537212247|FG002|Overall Study|Major Protocol Deviation|0|||
148925786|NCT01255787|537212248|FG003|Overall Study|Major Protocol Deviation|4|||
148925787|NCT01255787|537212245|FG000|Overall Study|Lost to Follow-up|1|||
148925788|NCT01255787|537212246|FG001|Overall Study|Lost to Follow-up|2|||
148925789|NCT01255787|537212247|FG002|Overall Study|Lost to Follow-up|4|||
149012875|NCT01468922|537525821|FG008|Overall Study|Refused further treatment|0|||
148925790|NCT01255787|537212248|FG003|Overall Study|Lost to Follow-up|2|||
148925791|NCT01255787|537212245|FG000|Overall Study|Withdrawal of Consent|3|||
148925792|NCT01255787|537212246|FG001|Overall Study|Withdrawal of Consent|9|||
148925793|NCT01255787|537212247|FG002|Overall Study|Withdrawal of Consent|3|||
148925794|NCT01255787|537212248|FG003|Overall Study|Withdrawal of Consent|4|||
148925795|NCT01255787|537212245|FG000|Overall Study|Pregnancy|0|||
148925796|NCT01255787|537212246|FG001|Overall Study|Pregnancy|0|||
148925797|NCT01255787|537212247|FG002|Overall Study|Pregnancy|0|||
148925798|NCT01255787|537212248|FG003|Overall Study|Pregnancy|1|||
148925799|NCT01255787|537212245|FG000|Overall Study|Lack of Efficacy|2|||
148925800|NCT01255787|537212246|FG001|Overall Study|Lack of Efficacy|2|||
148925801|NCT01255787|537212247|FG002|Overall Study|Lack of Efficacy|2|||
148925802|NCT01255787|537212248|FG003|Overall Study|Lack of Efficacy|2|||
148925803|NCT01255787|537212245|FG000|Overall Study|Noncompliance with Study Drug|3|||
148925804|NCT01255787|537212246|FG001|Overall Study|Noncompliance with Study Drug|1|||
148925805|NCT01255787|537212247|FG002|Overall Study|Noncompliance with Study Drug|0|||
148925806|NCT01255787|537212248|FG003|Overall Study|Noncompliance with Study Drug|0|||
148925807|NCT03170232|537212249|FG000|Overall Study|Adverse Event|0|||
148925808|NCT03170232|537212250|FG001|Overall Study|Adverse Event|1|||
148925809|NCT03170232|537212249|FG000|Overall Study|Protocol Violation|0|||
148925810|NCT03170232|537212250|FG001|Overall Study|Protocol Violation|1|||
148925811|NCT03170232|537212249|FG000|Overall Study|Lack of Efficacy|0|||
148925812|NCT03170232|537212250|FG001|Overall Study|Lack of Efficacy|1|||
148925813|NCT03170232|537212249|FG000|Overall Study|Study closed/terminated|26|||
148925814|NCT03170232|537212250|FG001|Overall Study|Study closed/terminated|23|||
148925815|NCT03170232|537212249|FG000|Overall Study|Lost to Follow-up|1|||
148925816|NCT03170232|537212250|FG001|Overall Study|Lost to Follow-up|0|||
148925817|NCT03170232|537212249|FG000|Overall Study|Withdrawal by Subject|0|||
148925818|NCT03170232|537212250|FG001|Overall Study|Withdrawal by Subject|1|||
148925819|NCT04966741|537212251|FG000|Overall Study|Lost to Follow-up|1|||
148925820|NCT04966741|537212252|FG001|Overall Study|Lost to Follow-up|0|||
148925821|NCT02241889|537212259|FG000|Overall Study|device issues|0|||
148925822|NCT02241889|537212260|FG001|Overall Study|device issues|0|||
148925823|NCT02241889|537212261|FG002|Overall Study|device issues|1|||
148925824|NCT02241889|537212262|FG003|Overall Study|device issues|0|||
148925825|NCT02241889|537212263|FG004|Overall Study|device issues|0|||
148925826|NCT02241889|537212264|FG005|Overall Study|device issues|0|||
149161661|NCT03179436|538067024|FG004|Overall Study|Death|29|||
149161662|NCT03179436|538067025|FG005|Overall Study|Death|30|||
148674194|NCT01186744|536279423|FG005|Overall Study|Protocol Violation|2|||
148674195|NCT01186744|536279418|FG000|Overall Study|Lost to Follow-up|15|||
148674196|NCT01186744|536279419|FG001|Overall Study|Lost to Follow-up|16|||
148925827|NCT02241889|537212259|FG000|Overall Study|Withdrawal by Subject|0|||
148925828|NCT02241889|537212260|FG001|Overall Study|Withdrawal by Subject|0|||
148925829|NCT02241889|537212261|FG002|Overall Study|Withdrawal by Subject|0|||
148925830|NCT02241889|537212262|FG003|Overall Study|Withdrawal by Subject|0|||
149161663|NCT03179436|538067026|FG006|Overall Study|Death|33|||
148674197|NCT01186744|536279420|FG002|Overall Study|Lost to Follow-up|2|||
148925831|NCT02241889|537212263|FG004|Overall Study|Withdrawal by Subject|0|||
148925832|NCT02241889|537212264|FG005|Overall Study|Withdrawal by Subject|1|||
148925833|NCT00773838|537212265|FG000|Overall Study|Adverse Event|29|||
148925834|NCT00773838|537212265|FG000|Overall Study|Lost to Follow-up|1|||
148925835|NCT00773838|537212265|FG000|Overall Study|Physician Decision|8|||
149161664|NCT03179436|538067027|FG007|Overall Study|Death|9|||
149161665|NCT03179436|538067028|FG008|Overall Study|Death|84|||
149161666|NCT03179436|538067029|FG009|Overall Study|Death|33|||
149161667|NCT03179436|538067030|FG010|Overall Study|Death|22|||
149161668|NCT03179436|538067031|FG011|Overall Study|Death|15|||
149161669|NCT02887521|538067032|FG000|Overall Study|Withdrawal by Subject|0|||
149161670|NCT02887521|538067033|FG001|Overall Study|Withdrawal by Subject|3|||
149161671|NCT01634555|538067044|FG000|Overall Study|Adverse Event|3|||
149161672|NCT01634555|538067044|FG000|Overall Study|Physician Decision|1|||
149161673|NCT01738971|538067045|FG000|Overall Study|Lost to Follow-up|19|||
149161674|NCT01738971|538067046|FG001|Overall Study|Lost to Follow-up|30|||
149161675|NCT01738971|538067047|FG002|Overall Study|Lost to Follow-up|17|||
149161676|NCT00618722|538069352|FG000|Overall Study|Refusal of Treatment|0|||
149161677|NCT00618722|538069353|FG001|Overall Study|Refusal of Treatment|0|||
149161678|NCT00618722|538069354|FG002|Overall Study|Refusal of Treatment|1|||
149161679|NCT00618722|538069355|FG003|Overall Study|Refusal of Treatment|0|||
149161680|NCT00618722|538069352|FG000|Overall Study|Patient Request|1|||
149161681|NCT00618722|538069353|FG001|Overall Study|Patient Request|1|||
149161682|NCT00618722|538069354|FG002|Overall Study|Patient Request|1|||
149161683|NCT00618722|538069355|FG003|Overall Study|Patient Request|1|||
149161684|NCT00618722|538069352|FG000|Overall Study|Inability to Complete Study Procedure|0|||
149161685|NCT00618722|538069353|FG001|Overall Study|Inability to Complete Study Procedure|1|||
149161686|NCT00618722|538069354|FG002|Overall Study|Inability to Complete Study Procedure|0|||
148925836|NCT00773838|537212265|FG000|Overall Study|Progressive Disease|82|||
148925837|NCT00773838|537212265|FG000|Overall Study|Protocol Violation|2|||
148925838|NCT00773838|537212265|FG000|Overall Study|Withdrawal by Subject|21|||
148925839|NCT00509262|537212267|FG000|Overall Study|Adverse Event|16|||
148925840|NCT00509262|537212268|FG001|Overall Study|Adverse Event|18|||
148925841|NCT00509262|537212267|FG000|Overall Study|Other|2|||
148925842|NCT00509262|537212268|FG001|Overall Study|Other|2|||
148925843|NCT00509262|537212267|FG000|Overall Study|Lack of Efficacy|1|||
148925844|NCT00509262|537212268|FG001|Overall Study|Lack of Efficacy|0|||
148925845|NCT00509262|537212267|FG000|Overall Study|Lost to Follow-up|1|||
148925846|NCT00509262|537212268|FG001|Overall Study|Lost to Follow-up|6|||
148925847|NCT00509262|537212267|FG000|Overall Study|Physician Decision|1|||
148925848|NCT00509262|537212268|FG001|Overall Study|Physician Decision|3|||
148925849|NCT00509262|537212267|FG000|Overall Study|Protocol Violation|2|||
148925850|NCT00509262|537212268|FG001|Overall Study|Protocol Violation|2|||
148925851|NCT00509262|537212267|FG000|Overall Study|Withdrawal by Subject|24|||
148925852|NCT00509262|537212268|FG001|Overall Study|Withdrawal by Subject|11|||
148925853|NCT01853618|537212269|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
148925854|NCT01853618|537212270|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
148925855|NCT01853618|537212271|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
148925856|NCT01853618|537212272|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
148925857|NCT01853618|537212273|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
148925858|NCT01853618|537212269|FG000|Overall Study|Progressive disease|1|||
148925859|NCT01853618|537212270|FG001|Overall Study|Progressive disease|1|||
148925860|NCT01853618|537212271|FG002|Overall Study|Progressive disease|1|||
148925861|NCT01853618|537212272|FG003|Overall Study|Progressive disease|1|||
148925862|NCT01853618|537212273|FG004|Overall Study|Progressive disease|2|||
148925863|NCT01853618|537212269|FG000|Overall Study|Physician Decision|0|||
148925864|NCT01853618|537212270|FG001|Overall Study|Physician Decision|1|||
148925865|NCT01853618|537212271|FG002|Overall Study|Physician Decision|1|||
148925866|NCT01853618|537212272|FG003|Overall Study|Physician Decision|0|||
148925867|NCT01853618|537212273|FG004|Overall Study|Physician Decision|0|||
148925868|NCT01853618|537212269|FG000|Overall Study|Refused further treatment|0|||
148925869|NCT01853618|537212270|FG001|Overall Study|Refused further treatment|0|||
148925870|NCT01853618|537212271|FG002|Overall Study|Refused further treatment|0|||
148925871|NCT01853618|537212272|FG003|Overall Study|Refused further treatment|0|||
148925872|NCT01853618|537212273|FG004|Overall Study|Refused further treatment|1|||
148925873|NCT02398227|537212278|FG000|Overall Study|Lost to Follow-up|21|||
148925874|NCT02398227|537212279|FG001|Overall Study|Lost to Follow-up|12|||
148925875|NCT02398227|537212278|FG000|Overall Study|Withdrawal by Subject|5|||
148925876|NCT02398227|537212279|FG001|Overall Study|Withdrawal by Subject|6|||
148925877|NCT02398227|537212278|FG000|Overall Study|Removed from treatment and dropped out|1|||
148925878|NCT02398227|537212279|FG001|Overall Study|Removed from treatment and dropped out|0|||
148925879|NCT01715129|537212280|FG000|Overall Study|Adverse Event, fatal|1|||
148925880|NCT01715129|537212280|FG000|Overall Study|Lack of Efficacy|3|||
148925881|NCT01715129|537212280|FG000|Overall Study|Protocol Violation|1|||
148925882|NCT01715129|537212280|FG000|Overall Study|Consent Withdrawn|2|||
148925883|NCT01715129|537212280|FG000|Overall Study|Lost to Follow-up|1|||
148925884|NCT01715129|537212280|FG000|Overall Study|Other|1|||
148925885|NCT02009384|537212281|FG000|Overall Study|Death|2|||
148925886|NCT01146860|537212282|FG000|Overall Study|Withdrawal by Subject|0|||
148925887|NCT01146860|537212283|FG001|Overall Study|Withdrawal by Subject|1|||
148925888|NCT01092832|537212284|FG000|Overall Study|Other|1|||
148925889|NCT01092832|537212285|FG001|Overall Study|Other|0|||
148925890|NCT02674854|537212286|FG000|Overall Study|Adverse Event|17|||
148925891|NCT02674854|537212287|FG001|Overall Study|Adverse Event|15|||
148925892|NCT02674854|537212288|FG002|Overall Study|Adverse Event|5|||
148925893|NCT02674854|537212286|FG000|Overall Study|Withdrawal by Subject|1|||
148925894|NCT02674854|537212287|FG001|Overall Study|Withdrawal by Subject|5|||
148925895|NCT02674854|537212288|FG002|Overall Study|Withdrawal by Subject|4|||
148925896|NCT02674854|537212286|FG000|Overall Study|No-compliant subject|1|||
148925897|NCT02674854|537212287|FG001|Overall Study|No-compliant subject|0|||
148925898|NCT02674854|537212288|FG002|Overall Study|No-compliant subject|1|||
148925899|NCT02674854|537212286|FG000|Overall Study|Lost to Follow-up|1|||
148925900|NCT02674854|537212287|FG001|Overall Study|Lost to Follow-up|0|||
148925901|NCT02674854|537212288|FG002|Overall Study|Lost to Follow-up|2|||
148925902|NCT02674854|537212286|FG000|Overall Study|Lack of Efficacy|0|||
148925903|NCT02674854|537212287|FG001|Overall Study|Lack of Efficacy|3|||
148925904|NCT02674854|537212288|FG002|Overall Study|Lack of Efficacy|0|||
148925905|NCT02674854|537212286|FG000|Overall Study|Disallowed Concurrent Medication|2|||
148925906|NCT02674854|537212287|FG001|Overall Study|Disallowed Concurrent Medication|2|||
148925907|NCT02674854|537212288|FG002|Overall Study|Disallowed Concurrent Medication|0|||
148925908|NCT02674854|537212286|FG000|Overall Study|Protocol Violation|1|||
148925909|NCT02674854|537212287|FG001|Overall Study|Protocol Violation|1|||
148925910|NCT02674854|537212288|FG002|Overall Study|Protocol Violation|2|||
148925911|NCT02674854|537212286|FG000|Overall Study|Death|0|||
148925912|NCT02674854|537212287|FG001|Overall Study|Death|1|||
148925913|NCT02674854|537212288|FG002|Overall Study|Death|0|||
148925914|NCT02674854|537212286|FG000|Overall Study|Subject missed V6.2|1|||
148925915|NCT02674854|537212287|FG001|Overall Study|Subject missed V6.2|0|||
148925916|NCT02674854|537212288|FG002|Overall Study|Subject missed V6.2|0|||
149161687|NCT00618722|538069355|FG003|Overall Study|Inability to Complete Study Procedure|0|||
149161688|NCT00618722|538069352|FG000|Overall Study|Lost to Follow-up|2|||
149161689|NCT00618722|538069353|FG001|Overall Study|Lost to Follow-up|0|||
149161690|NCT00618722|538069354|FG002|Overall Study|Lost to Follow-up|0|||
149161691|NCT00618722|538069355|FG003|Overall Study|Lost to Follow-up|2|||
149161692|NCT00618722|538069352|FG000|Overall Study|Miscellaneous Reasons|0|||
149161693|NCT00618722|538069353|FG001|Overall Study|Miscellaneous Reasons|0|||
149161694|NCT00618722|538069354|FG002|Overall Study|Miscellaneous Reasons|1|||
149161695|NCT00618722|538069355|FG003|Overall Study|Miscellaneous Reasons|1|||
149161696|NCT00200057|538069356|FG000|Overall Study|Lack of Efficacy|3|||
149161697|NCT00200057|538069356|FG000|Overall Study|Exited due to terminal illness of PI|2|||
149161698|NCT00200057|538069356|FG000|Overall Study|Withdrawal by Subject|1|||
149161699|NCT00200057|538069356|FG000|Overall Study|Change in medical condition|1|||
149161700|NCT00200057|538069356|FG000|Overall Study|Infection|1|||
149161701|NCT00200057|538069356|FG000|Overall Study|Death|1|||
149161702|NCT05512949|538069357|FG000|Overall Study|Lost to Follow-up|4|||
149161703|NCT05512949|538069358|FG001|Overall Study|Lost to Follow-up|6|||
149161704|NCT05512949|538069359|FG002|Overall Study|Lost to Follow-up|2|||
149161705|NCT05512949|538069357|FG000|Overall Study|Protocol Violation|0|||
149161706|NCT05512949|538069358|FG001|Overall Study|Protocol Violation|0|||
149161707|NCT05512949|538069359|FG002|Overall Study|Protocol Violation|1|||
149161708|NCT05512949|538069357|FG000|Overall Study|Withdrawal by Subject|1|||
149161709|NCT05512949|538069358|FG001|Overall Study|Withdrawal by Subject|1|||
149161710|NCT05512949|538069359|FG002|Overall Study|Withdrawal by Subject|2|||
149161711|NCT05512949|538069357|FG000|Overall Study|Completion status unknown|1|||
149161712|NCT05512949|538069358|FG001|Overall Study|Completion status unknown|3|||
149161713|NCT05512949|538069359|FG002|Overall Study|Completion status unknown|0|||
149161714|NCT02810964|538069360|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
149161715|NCT02810964|538069361|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
149161716|NCT02810964|538069360|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
149161717|NCT02810964|538069361|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
149161718|NCT02810964|538069360|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
149161719|NCT02810964|538069361|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
149161720|NCT02810964|538069360|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
149161721|NCT02810964|538069361|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
149161722|NCT03523351|538069362|FG000|Overall Study|Death|13|||
149161723|NCT03523351|538069363|FG001|Overall Study|Death|11|||
149161724|NCT03523351|538069362|FG000|Overall Study|Lost to Follow-up|2|||
149161725|NCT03523351|538069363|FG001|Overall Study|Lost to Follow-up|3|||
149161726|NCT03523351|538069362|FG000|Overall Study|Withdrawal by Subject|4|||
149161727|NCT03523351|538069363|FG001|Overall Study|Withdrawal by Subject|0|||
149012876|NCT01923389|537525822|FG000|Overall Study|Protocol Violation|1|||
149161728|NCT03523351|538069362|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
149161729|NCT03523351|538069363|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
149161730|NCT01430442|538069364|FG000|Overall Study|Subject Withdrew Consent|3|||
149161731|NCT01430442|538069365|FG001|Overall Study|Subject Withdrew Consent|0|||
149161732|NCT01430442|538069366|FG002|Overall Study|Subject Withdrew Consent|1|||
148674198|NCT01186744|536279421|FG003|Overall Study|Lost to Follow-up|1|||
149012877|NCT01923389|537525823|FG001|Overall Study|Protocol Violation|0|||
149012878|NCT03662997|537525830|FG000|Overall Study|Adverse Event|0|||
149161733|NCT01430442|538069367|FG003|Overall Study|Subject Withdrew Consent|0|||
149161734|NCT01430442|538069368|FG004|Overall Study|Subject Withdrew Consent|2|||
149161735|NCT01430442|538069369|FG005|Overall Study|Subject Withdrew Consent|1|||
149161736|NCT01430442|538069370|FG006|Overall Study|Subject Withdrew Consent|5|||
149161737|NCT01430442|538069371|FG007|Overall Study|Subject Withdrew Consent|2|||
149161738|NCT01430442|538069364|FG000|Overall Study|Lost to Follow-up|2|||
149161739|NCT01430442|538069365|FG001|Overall Study|Lost to Follow-up|0|||
149161740|NCT01430442|538069366|FG002|Overall Study|Lost to Follow-up|1|||
149161741|NCT01430442|538069367|FG003|Overall Study|Lost to Follow-up|2|||
149161742|NCT01430442|538069368|FG004|Overall Study|Lost to Follow-up|2|||
149161743|NCT01430442|538069369|FG005|Overall Study|Lost to Follow-up|1|||
149161744|NCT01430442|538069370|FG006|Overall Study|Lost to Follow-up|5|||
149161745|NCT01430442|538069371|FG007|Overall Study|Lost to Follow-up|1|||
149161746|NCT01430442|538069364|FG000|Overall Study|Pregnancy|1|||
148925917|NCT02635646|537212290|FG000|Overall Study|Lost to Follow-up|24|||
148925918|NCT02635646|537212291|FG001|Overall Study|Lost to Follow-up|25|||
148925919|NCT02635646|537212290|FG000|Overall Study|Pregnancy|1|||
148925920|NCT02635646|537212291|FG001|Overall Study|Pregnancy|1|||
148925921|NCT00913692|537212292|FG000|Screening (4 Months)|Physician Decision|3|||
148925922|NCT00913692|537212292|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
148925923|NCT00913692|537212292|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
148925924|NCT01423604|537212298|FG000|Safety Run-In|Adverse Event|3|||
148925925|NCT01423604|537212299|FG001|Safety Run-In|Adverse Event|0|||
148925926|NCT01423604|537212298|FG000|Safety Run-In|Death|1|||
148925927|NCT01423604|537212299|FG001|Safety Run-In|Death|0|||
148925928|NCT01423604|537212298|FG000|Safety Run-In|Physician Decision|1|||
148925929|NCT01423604|537212299|FG001|Safety Run-In|Physician Decision|0|||
149161747|NCT01430442|538069365|FG001|Overall Study|Pregnancy|0|||
149161748|NCT01430442|538069366|FG002|Overall Study|Pregnancy|0|||
149161749|NCT01430442|538069367|FG003|Overall Study|Pregnancy|0|||
149161750|NCT01430442|538069368|FG004|Overall Study|Pregnancy|0|||
148925930|NCT01423604|537212298|FG000|Safety Run-In|Disease progression|3|||
148925931|NCT01423604|537212299|FG001|Safety Run-In|Disease progression|0|||
148925932|NCT01423604|537212298|FG000|Safety Run-In|Patient decision|1|||
148925933|NCT01423604|537212299|FG001|Safety Run-In|Patient decision|0|||
149161751|NCT01430442|538069369|FG005|Overall Study|Pregnancy|1|||
149161752|NCT01430442|538069370|FG006|Overall Study|Pregnancy|0|||
148925934|NCT01423604|537212298|FG000|Randomized|Adverse Event|4|||
148925935|NCT01423604|537212299|FG001|Randomized|Adverse Event|10|||
148925936|NCT01423604|537212298|FG000|Randomized|Death|1|||
148925937|NCT01423604|537212299|FG001|Randomized|Death|0|||
148925938|NCT01423604|537212298|FG000|Randomized|Physician Decision|16|||
148925939|NCT01423604|537212299|FG001|Randomized|Physician Decision|13|||
148925940|NCT01423604|537212298|FG000|Randomized|Other - unspecified|37|||
148806069|NCT05911841|536768046|FG002|Escape Period|Withdrawal by Subject|0|||
148806070|NCT05911841|536768047|FG003|Escape Period|Withdrawal by Subject|0|||
148806071|NCT05911841|536768048|FG004|Escape Period|Withdrawal by Subject|0|||
148806072|NCT05911841|536768049|FG005|Escape Period|Withdrawal by Subject|0|||
148806073|NCT05911841|536768050|FG006|Escape Period|Withdrawal by Subject|0|||
148925941|NCT01423604|537212299|FG001|Randomized|Other - unspecified|31|||
148925942|NCT01423604|537212298|FG000|Randomized|Patient decision|5|||
148925943|NCT01423604|537212299|FG001|Randomized|Patient decision|9|||
148925944|NCT01226121|537212300|FG000|Overall Study|Lost to Follow-up|2|||
148925945|NCT01226121|537212301|FG001|Overall Study|Lost to Follow-up|0|||
148925946|NCT01226121|537212302|FG002|Overall Study|Lost to Follow-up|1|||
148925947|NCT04231981|537212303|FG000|Overall Study|Adverse Event|1|||
148925948|NCT04231981|537212303|FG000|Overall Study|Death|16|||
148925949|NCT04231981|537212303|FG000|Overall Study|Lost to Follow-up|1|||
148925950|NCT02581943|537212304|FG000|Overall Study|Death|5|||
148925951|NCT02581943|537212305|FG001|Overall Study|Death|2|||
148925952|NCT02581943|537212304|FG000|Overall Study|Disease Progression|12|||
148925953|NCT02581943|537212305|FG001|Overall Study|Disease Progression|15|||
148925954|NCT02581943|537212304|FG000|Overall Study|Withdrawal by Subject|1|||
148925955|NCT02581943|537212305|FG001|Overall Study|Withdrawal by Subject|2|||
148925956|NCT00378079|537212306|FG000|Overall Study|Lost to Follow-up|6|||
148925957|NCT00378079|537212307|FG001|Overall Study|Lost to Follow-up|1|||
148925958|NCT00378079|537212308|FG002|Overall Study|Lost to Follow-up|0|||
148925959|NCT01233687|537212309|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
148925960|NCT01233687|537212309|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
148806074|NCT05911841|536768051|FG007|Escape Period|Withdrawal by Subject|0|||
148806075|NCT05911841|536768052|FG008|Escape Period|Withdrawal by Subject|0|||
148806076|NCT05911841|536768053|FG009|Escape Period|Withdrawal by Subject|10|||
148925961|NCT01233687|537212309|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
148925962|NCT04473482|537212314|FG000|Overall Study|Death|0|||
148925963|NCT04473482|537212315|FG001|Overall Study|Death|3|||
148925964|NCT04473482|537212314|FG000|Overall Study|Lost to Follow-up|9|||
148925965|NCT04473482|537212315|FG001|Overall Study|Lost to Follow-up|7|||
148925966|NCT04473482|537212314|FG000|Overall Study|Withdrawal by Subject|2|||
148925967|NCT04473482|537212315|FG001|Overall Study|Withdrawal by Subject|1|||
148925968|NCT00745615|537212322|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
148925969|NCT00745615|537212323|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
148925970|NCT00745615|537212324|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
149012879|NCT03662997|537525831|FG001|Overall Study|Adverse Event|2|||
149161753|NCT01430442|538069371|FG007|Overall Study|Pregnancy|0|||
149161754|NCT01430442|538069364|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
149161755|NCT01430442|538069365|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
149161756|NCT01430442|538069366|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
149161757|NCT01430442|538069367|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
149161758|NCT01430442|538069368|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
149161759|NCT01430442|538069369|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
149161760|NCT01430442|538069370|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
149161761|NCT01430442|538069371|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
149161762|NCT00772629|538069373|FG000|Overall Study|Subject was not vaccinated|1|||
149161763|NCT00772629|538069374|FG001|Overall Study|Subject was not vaccinated|0|||
149161764|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
149161765|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
149161766|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
149161767|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149161768|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149161769|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149161770|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149161771|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149161772|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
149161773|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
149161774|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
149161775|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149161776|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149161777|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149161778|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149161779|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
148925971|NCT00745615|537212325|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
148925972|NCT00745615|537212326|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
148925973|NCT00745615|537212327|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
148925974|NCT00745615|537212322|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
148925975|NCT00745615|537212323|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
148925976|NCT00745615|537212324|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
148806077|NCT05595369|536768054|FG000|Overall Study|Adverse Event|2|||
148806078|NCT05595369|536768055|FG001|Overall Study|Adverse Event|0|||
148806079|NCT05595369|536768056|FG002|Overall Study|Adverse Event|0|||
148925977|NCT00745615|537212325|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
149161780|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
149161781|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
149161782|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
149161783|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149161784|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149161785|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149161786|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149161787|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149161788|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
149161789|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
149161790|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
149161791|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149161792|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149161793|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149161794|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149161795|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149161796|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
149161797|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
149161798|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
149161799|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149161800|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149161801|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149161802|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149161803|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149161804|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
149161805|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
149161806|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149161807|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149161808|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149161809|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149161810|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149161811|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149161812|NCT01097629|538069378|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
149161813|NCT01097629|538069379|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
149161814|NCT01097629|538069380|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
149161815|NCT01097629|538069381|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149161816|NCT01097629|538069382|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149161817|NCT01097629|538069383|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149161818|NCT01097629|538069384|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149161819|NCT01097629|538069385|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
148925978|NCT00745615|537212326|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
148925979|NCT00745615|537212327|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
148925980|NCT00745615|537212322|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
148925981|NCT00745615|537212323|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
148925982|NCT00745615|537212324|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
148925983|NCT00745615|537212325|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
148925984|NCT00745615|537212326|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
148925985|NCT00745615|537212327|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
148925986|NCT00745615|537212322|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
148925987|NCT00745615|537212323|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
148925988|NCT00745615|537212324|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
148925989|NCT00745615|537212325|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
148925990|NCT00745615|537212326|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
148925991|NCT00745615|537212327|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
148925992|NCT00745615|537212322|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
148925993|NCT00745615|537212323|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
148925994|NCT00745615|537212324|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
148925995|NCT00745615|537212325|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
148925996|NCT00745615|537212326|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
148925997|NCT00745615|537212327|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
148925998|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
148925999|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
148926000|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
148926001|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
148926002|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
148926003|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
148926004|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
148926005|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
148926006|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
148926007|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
148926008|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
148926009|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
148926010|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
148926011|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
148926012|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
148926013|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
148926014|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
148926015|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
148926016|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
148926017|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
148926018|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
148926019|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
148926020|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
148926021|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
148926022|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
148926023|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
148926024|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
148926025|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
148926026|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
148926027|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
148926028|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
148926029|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
148926030|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
148926031|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
148926032|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
148926033|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
148926034|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
148926035|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
148926036|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
148926037|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
148926038|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
148926039|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
148926040|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
148926041|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
148926042|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
148926043|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
148926044|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
148926045|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
148926046|NCT00745615|537212322|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
148926047|NCT00745615|537212323|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
148926048|NCT00745615|537212324|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
148926049|NCT00745615|537212325|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
148926050|NCT00745615|537212326|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
148926051|NCT00745615|537212327|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
148926052|NCT00570232|537212328|FG000|Overall Study|Adverse Event|10|||
148926053|NCT00570232|537212328|FG000|Overall Study|discontinued due to medical condition|3|||
148926054|NCT00570232|537212328|FG000|Overall Study|discontinued due to recurrence|8|||
148926055|NCT00570232|537212328|FG000|Overall Study|discontinued due to noncompliance|2|||
148926056|NCT01076075|537212329|FG000|Overall Study|Adverse Event|3|||
148926057|NCT01076075|537212330|FG001|Overall Study|Adverse Event|9|||
148926058|NCT01076075|537212329|FG000|Overall Study|Lack of Efficacy|5|||
148926059|NCT01076075|537212330|FG001|Overall Study|Lack of Efficacy|4|||
148926060|NCT01076075|537212329|FG000|Overall Study|Lost to Follow-up|6|||
148926061|NCT01076075|537212330|FG001|Overall Study|Lost to Follow-up|5|||
148926062|NCT01076075|537212329|FG000|Overall Study|other|19|||
148926063|NCT01076075|537212330|FG001|Overall Study|other|9|||
148926064|NCT01076075|537212329|FG000|Overall Study|Protocol Violation|0|||
148926065|NCT01076075|537212330|FG001|Overall Study|Protocol Violation|1|||
148926066|NCT01076075|537212329|FG000|Overall Study|Withdrawal by Subject|8|||
148926067|NCT01076075|537212330|FG001|Overall Study|Withdrawal by Subject|19|||
148926068|NCT01445886|537212336|FG000|Overall Study|Lost to Follow-up|2|||
148926069|NCT01445886|537212336|FG000|Overall Study|Protocol Violation|3|||
148926070|NCT00586664|537212337|FG000|Overall Study|Withdrawal by Subject|3|||
148926071|NCT00586664|537212338|FG001|Overall Study|Withdrawal by Subject|7|||
148926072|NCT00586664|537212339|FG002|Overall Study|Withdrawal by Subject|1|||
148926073|NCT00586664|537212337|FG000|Overall Study|Exclusion criteria met|2|||
148926074|NCT00586664|537212338|FG001|Overall Study|Exclusion criteria met|0|||
148926075|NCT00586664|537212339|FG002|Overall Study|Exclusion criteria met|0|||
148926076|NCT01394718|537213493|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
148926077|NCT01394718|537213494|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
148926078|NCT03387150|537213495|FG000|Overall Study|Withdrawal by Subject|3|||
148926079|NCT03387150|537213496|FG001|Overall Study|Withdrawal by Subject|0|||
148926080|NCT03387150|537213497|FG002|Overall Study|Withdrawal by Subject|3|||
148926081|NCT03387150|537213498|FG003|Overall Study|Withdrawal by Subject|4|||
148926082|NCT03387150|537213499|FG004|Overall Study|Withdrawal by Subject|1|||
148926083|NCT03387150|537213500|FG005|Overall Study|Withdrawal by Subject|2|||
148926084|NCT03387150|537213501|FG006|Overall Study|Withdrawal by Subject|0|||
148926085|NCT03387150|537213495|FG000|Overall Study|Lost to Follow-up|3|||
148926086|NCT03387150|537213496|FG001|Overall Study|Lost to Follow-up|2|||
148926087|NCT03387150|537213497|FG002|Overall Study|Lost to Follow-up|2|||
148926088|NCT03387150|537213498|FG003|Overall Study|Lost to Follow-up|3|||
148926089|NCT03387150|537213499|FG004|Overall Study|Lost to Follow-up|3|||
148926090|NCT03387150|537213500|FG005|Overall Study|Lost to Follow-up|3|||
148926091|NCT03387150|537213501|FG006|Overall Study|Lost to Follow-up|0|||
148926092|NCT03387150|537213495|FG000|Overall Study|Participant unable to adhere to visit|0|||
148926093|NCT03387150|537213496|FG001|Overall Study|Participant unable to adhere to visit|1|||
148926094|NCT03387150|537213497|FG002|Overall Study|Participant unable to adhere to visit|0|||
148926095|NCT03387150|537213498|FG003|Overall Study|Participant unable to adhere to visit|0|||
148926096|NCT03387150|537213499|FG004|Overall Study|Participant unable to adhere to visit|2|||
148926097|NCT03387150|537213500|FG005|Overall Study|Participant unable to adhere to visit|2|||
148926098|NCT03387150|537213501|FG006|Overall Study|Participant unable to adhere to visit|0|||
148926099|NCT04078178|537213502|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
148926100|NCT04078178|537213503|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
148926101|NCT04078178|537213502|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
148926102|NCT04078178|537213503|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
148926103|NCT04078178|537213502|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
148926104|NCT04078178|537213503|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
148926105|NCT04078178|537213502|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
148926106|NCT04078178|537213503|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
148926107|NCT04078178|537213502|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
148926108|NCT04078178|537213503|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
148926109|NCT04006119|537213504|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
148926110|NCT04006119|537213504|FG000|End of Treatment Veledimex|Adverse Event|2|||
148926111|NCT04006119|537213504|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
149161820|NCT01097629|538069378|FG000|DB RO Phase|Withdrawal by Subject|0|||
149161821|NCT01097629|538069379|FG001|DB RO Phase|Withdrawal by Subject|0|||
149161822|NCT01097629|538069380|FG002|DB RO Phase|Withdrawal by Subject|0|||
149161823|NCT01097629|538069381|FG003|DB RO Phase|Withdrawal by Subject|0|||
149161824|NCT01097629|538069382|FG004|DB RO Phase|Withdrawal by Subject|0|||
149161825|NCT01097629|538069383|FG005|DB RO Phase|Withdrawal by Subject|0|||
149161826|NCT01097629|538069384|FG006|DB RO Phase|Withdrawal by Subject|0|||
149161827|NCT01097629|538069385|FG007|DB RO Phase|Withdrawal by Subject|1|||
149161828|NCT01097629|538069378|FG000|DB RO Phase|Protocol Violation|0|||
149161829|NCT01097629|538069379|FG001|DB RO Phase|Protocol Violation|0|||
149161830|NCT01097629|538069380|FG002|DB RO Phase|Protocol Violation|0|||
149161831|NCT01097629|538069381|FG003|DB RO Phase|Protocol Violation|1|||
149161832|NCT01097629|538069382|FG004|DB RO Phase|Protocol Violation|0|||
149161833|NCT01097629|538069383|FG005|DB RO Phase|Protocol Violation|1|||
149161834|NCT01097629|538069384|FG006|DB RO Phase|Protocol Violation|1|||
149161835|NCT01097629|538069385|FG007|DB RO Phase|Protocol Violation|0|||
149161836|NCT01097629|538069378|FG000|DB RO Phase|Lost to Follow-up|0|||
149161837|NCT01097629|538069379|FG001|DB RO Phase|Lost to Follow-up|0|||
149161838|NCT01097629|538069380|FG002|DB RO Phase|Lost to Follow-up|0|||
149161839|NCT01097629|538069381|FG003|DB RO Phase|Lost to Follow-up|0|||
148926112|NCT04006119|537213504|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
148926113|NCT04006119|537213504|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
148926114|NCT04006119|537213504|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
148926115|NCT04617795|537213505|FG000|Main Study|Lost to Follow-up|1|||
148926116|NCT04617795|537213506|FG001|Main Study|Lost to Follow-up|0|||
148926117|NCT00472459|537213507|FG000|Overall Study|Adverse Event|13|||
148926118|NCT00472459|537213508|FG001|Overall Study|Adverse Event|13|||
148926119|NCT00472459|537213507|FG000|Overall Study|Withdrawal by Subject|5|||
148926120|NCT00472459|537213508|FG001|Overall Study|Withdrawal by Subject|5|||
148926121|NCT00472459|537213507|FG000|Overall Study|Protocol Violation|3|||
148926122|NCT00472459|537213508|FG001|Overall Study|Protocol Violation|3|||
148926123|NCT00472459|537213507|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
148926124|NCT00472459|537213508|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
148926125|NCT00472459|537213507|FG000|Overall Study|Lost to Follow-up|1|||
148926126|NCT00472459|537213508|FG001|Overall Study|Lost to Follow-up|1|||
148926127|NCT04850313|537213509|FG000|Overall Study|Withdrawal by Subject|0|||
148926128|NCT04850313|537213510|FG001|Overall Study|Withdrawal by Subject|1|||
148926129|NCT03269552|537213513|FG000|Overall Study|Adverse Event|2|||
148926130|NCT02186301|537213514|FG000|Overall Study|Progressive Disease|7|||
148926131|NCT02186301|537213515|FG001|Overall Study|Progressive Disease|22|||
148926132|NCT02186301|537213516|FG002|Overall Study|Progressive Disease|27|||
148926133|NCT02186301|537213514|FG000|Overall Study|Adverse Event|5|||
148926134|NCT02186301|537213515|FG001|Overall Study|Adverse Event|5|||
148926135|NCT02186301|537213516|FG002|Overall Study|Adverse Event|5|||
148926136|NCT02186301|537213514|FG000|Overall Study|Death|1|||
148926137|NCT02186301|537213515|FG001|Overall Study|Death|0|||
148926138|NCT02186301|537213516|FG002|Overall Study|Death|0|||
148926139|NCT02186301|537213514|FG000|Overall Study|Withdrawal by Subject|5|||
148926140|NCT02186301|537213515|FG001|Overall Study|Withdrawal by Subject|1|||
148926141|NCT02186301|537213516|FG002|Overall Study|Withdrawal by Subject|3|||
148926142|NCT02186301|537213514|FG000|Overall Study|Physician Decision|1|||
148926143|NCT02186301|537213515|FG001|Overall Study|Physician Decision|0|||
148926144|NCT02186301|537213516|FG002|Overall Study|Physician Decision|1|||
148926145|NCT02186301|537213514|FG000|Overall Study|Study Terminated by Sponsor|1|||
148926146|NCT02186301|537213515|FG001|Overall Study|Study Terminated by Sponsor|0|||
148926147|NCT02186301|537213516|FG002|Overall Study|Study Terminated by Sponsor|11|||
148926148|NCT02186301|537213514|FG000|Overall Study|Protocol Deviation|0|||
148926149|NCT02186301|537213515|FG001|Overall Study|Protocol Deviation|2|||
148926150|NCT02186301|537213516|FG002|Overall Study|Protocol Deviation|0|||
148926151|NCT02186301|537213514|FG000|Overall Study|Missing|0|||
148926152|NCT02186301|537213515|FG001|Overall Study|Missing|0|||
148926153|NCT02186301|537213516|FG002|Overall Study|Missing|2|||
148926154|NCT02186301|537213514|FG000|Overall Study|Other|0|||
148926155|NCT02186301|537213515|FG001|Overall Study|Other|0|||
148926156|NCT02186301|537213516|FG002|Overall Study|Other|1|||
148926157|NCT03560739|537213518|FG000|Overall Study|Adverse Event|0|||
148926158|NCT03560739|537213519|FG001|Overall Study|Adverse Event|1|||
148926159|NCT03560739|537213520|FG002|Overall Study|Adverse Event|0|||
148926160|NCT03560739|537213521|FG003|Overall Study|Adverse Event|0|||
148926161|NCT01362595|537213522|FG000|Overall Study|Screen failure|10|||
148926162|NCT01362595|537213522|FG000|Overall Study|Withdrawal by Subject|2|||
148926163|NCT00959374|537213523|FG000|Overall Study|Withdrawal by Subject|2|||
148926164|NCT00959374|537213523|FG000|Overall Study|Lost to Follow-up|14|||
148926165|NCT00959374|537213523|FG000|Overall Study|Death|1|||
148926166|NCT00959374|537213523|FG000|Overall Study|Protocol Violation|1|||
148926167|NCT00959374|537213523|FG000|Overall Study|Implant Removed/Not Replaced|4|||
149161840|NCT01097629|538069382|FG004|DB RO Phase|Lost to Follow-up|0|||
149161841|NCT01097629|538069383|FG005|DB RO Phase|Lost to Follow-up|0|||
149161842|NCT01097629|538069384|FG006|DB RO Phase|Lost to Follow-up|2|||
149161843|NCT01097629|538069385|FG007|DB RO Phase|Lost to Follow-up|0|||
149161844|NCT00132041|538069388|FG000|Baseline|Ineligible|6|||
149161845|NCT00132041|538069388|FG000|3 Months Post Ablation|Transplant|1|||
149161846|NCT00132041|538069388|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
149161847|NCT00132041|538069388|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
149161848|NCT00132041|538069388|FG000|6 Months Post Ablation|Death|2|||
149161849|NCT00132041|538069388|FG000|6 Months Post Ablation|Transplant|6|||
149161850|NCT00132041|538069388|FG000|9 Months Post Ablation|Death|1|||
149161851|NCT00132041|538069388|FG000|9 Months Post Ablation|Transplant|1|||
149161852|NCT00132041|538069388|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
149161853|NCT00132041|538069388|FG000|12 Months Post Ablation|Death|1|||
149161854|NCT00132041|538069388|FG000|12 Months Post Ablation|Transplant|1|||
149161855|NCT00132041|538069388|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
149161856|NCT00132041|538069388|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
149161857|NCT00132041|538069388|FG000|15 Months Post Ablation|Death|1|||
149161858|NCT00132041|538069388|FG000|15 Months Post Ablation|Transplant|5|||
149161859|NCT00132041|538069388|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
149161860|NCT00132041|538069388|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
149161861|NCT00132041|538069388|FG000|18 Months Post Ablation|Transplant|1|||
149161862|NCT00132041|538069388|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
149161863|NCT00132041|538069388|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
149161864|NCT01171820|538069389|FG000|Overall Study|Death|3|||
149161865|NCT01171820|538069390|FG001|Overall Study|Death|3|||
149161866|NCT01171820|538069389|FG000|Overall Study|Lost to Follow-up|0|||
149161867|NCT01171820|538069390|FG001|Overall Study|Lost to Follow-up|1|||
149161868|NCT01171820|538069389|FG000|Overall Study|Withdrawal by Subject|2|||
149161869|NCT01171820|538069390|FG001|Overall Study|Withdrawal by Subject|0|||
149161870|NCT01171820|538069389|FG000|Overall Study|Physician Decision|0|||
149161871|NCT01171820|538069390|FG001|Overall Study|Physician Decision|1|||
149161872|NCT01171820|538069389|FG000|Overall Study|1-Year Missed Visit|1|||
149161873|NCT01171820|538069390|FG001|Overall Study|1-Year Missed Visit|1|||
149161874|NCT03969875|538069391|FG000|Overall Study|did not receive allocated intervention|3|||
149161875|NCT03969875|538069392|FG001|Overall Study|did not receive allocated intervention|3|||
149161876|NCT03969875|538069393|FG002|Overall Study|did not receive allocated intervention|4|||
149161877|NCT03969875|538069391|FG000|Overall Study|Protocol Violation|4|||
149161878|NCT03969875|538069392|FG001|Overall Study|Protocol Violation|2|||
149161879|NCT03969875|538069393|FG002|Overall Study|Protocol Violation|2|||
149161880|NCT02327260|538069395|FG000|Overall Study|Lost to Follow-up|2|||
149161881|NCT02327260|538069396|FG001|Overall Study|Lost to Follow-up|3|||
149161882|NCT02327260|538069397|FG002|Overall Study|Lost to Follow-up|2|||
149161883|NCT02327260|538069395|FG000|Overall Study|invalid phone number|1|||
149161884|NCT02327260|538069396|FG001|Overall Study|invalid phone number|1|||
149161885|NCT02327260|538069397|FG002|Overall Study|invalid phone number|0|||
149161886|NCT02327260|538069395|FG000|Overall Study|non-adherence to protocol|2|||
149161887|NCT02327260|538069396|FG001|Overall Study|non-adherence to protocol|0|||
149161888|NCT02327260|538069397|FG002|Overall Study|non-adherence to protocol|0|||
149161889|NCT02327260|538069395|FG000|Overall Study|cognitive concerns|1|||
149161890|NCT02327260|538069396|FG001|Overall Study|cognitive concerns|0|||
149161891|NCT02327260|538069397|FG002|Overall Study|cognitive concerns|0|||
149161892|NCT02804763|538069400|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
149161893|NCT02804763|538069401|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
149161894|NCT02804763|538069402|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
149161895|NCT02804763|538069403|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
149161896|NCT02804763|538069400|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
149161897|NCT02804763|538069401|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
149161898|NCT02804763|538069402|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
149161899|NCT02804763|538069403|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
149161900|NCT02804763|538069400|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
149161901|NCT02804763|538069401|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
149161902|NCT02804763|538069402|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
149161903|NCT02804763|538069403|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
149161904|NCT02804763|538069400|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
149161905|NCT02804763|538069401|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
149161906|NCT02804763|538069402|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
149161907|NCT02804763|538069403|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
149161908|NCT02804763|538069400|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
149161909|NCT02804763|538069401|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
149161910|NCT02804763|538069402|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
149161911|NCT02804763|538069403|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
149161912|NCT02804763|538069400|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
149161913|NCT02804763|538069401|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
148926168|NCT00959374|537213523|FG000|Overall Study|Physician Decision|1|||
148926169|NCT02448680|537213524|FG000|Overall Study|Physician Decision|1|||
148926170|NCT02448680|537213525|FG001|Overall Study|Physician Decision|1|||
148926171|NCT02448680|537213524|FG000|Overall Study|Withdrawal by Subject|0|||
148926172|NCT02448680|537213525|FG001|Overall Study|Withdrawal by Subject|2|||
148926173|NCT01741012|537213529|FG000|Overall Study|Lost to Follow-up|1|||
148926174|NCT01741012|537213529|FG000|Overall Study|Withdrawal by Subject|2|||
148926175|NCT00095238|537213530|FG000|Overall Study|Lack of Efficacy|9|||
148926176|NCT00095238|537213531|FG001|Overall Study|Lack of Efficacy|9|||
148926177|NCT00095238|537213530|FG000|Overall Study|Adverse Event|331|||
148926178|NCT00095238|537213531|FG001|Overall Study|Adverse Event|287|||
148926179|NCT00095238|537213530|FG000|Overall Study|Subject Withdrew Consent|208|||
148926180|NCT00095238|537213531|FG001|Overall Study|Subject Withdrew Consent|223|||
148926181|NCT00095238|537213530|FG000|Overall Study|Death|154|||
148926182|NCT00095238|537213531|FG001|Overall Study|Death|170|||
148926183|NCT00095238|537213530|FG000|Overall Study|Lost to Follow-up|19|||
148926184|NCT00095238|537213531|FG001|Overall Study|Lost to Follow-up|24|||
148926185|NCT00095238|537213530|FG000|Overall Study|Noncompliance|44|||
149012880|NCT03662997|537525832|FG002|Overall Study|Adverse Event|0|||
149012881|NCT03662997|537525833|FG003|Overall Study|Adverse Event|0|||
149161914|NCT02804763|538069402|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
149161915|NCT02804763|538069403|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
149161916|NCT00793793|538069404|FG000|Overall Study|Adverse Event|0|||
149161917|NCT00793793|538069405|FG001|Overall Study|Adverse Event|0|||
149161918|NCT00793793|538069406|FG002|Overall Study|Adverse Event|1|||
149161919|NCT00793793|538069407|FG003|Overall Study|Adverse Event|1|||
149161920|NCT00793793|538069408|FG004|Overall Study|Adverse Event|0|||
149161921|NCT00793793|538069409|FG005|Overall Study|Adverse Event|1|||
149161922|NCT00793793|538069410|FG006|Overall Study|Adverse Event|2|||
149161923|NCT00793793|538069411|FG007|Overall Study|Adverse Event|0|||
149161924|NCT00793793|538069412|FG008|Overall Study|Adverse Event|0|||
149161925|NCT00793793|538069413|FG009|Overall Study|Adverse Event|0|||
149161926|NCT00793793|538069414|FG010|Overall Study|Adverse Event|0|||
149161927|NCT00793793|538069415|FG011|Overall Study|Adverse Event|2|||
149161928|NCT00793793|538069404|FG000|Overall Study|Protocol Violation|0|||
149161929|NCT00793793|538069405|FG001|Overall Study|Protocol Violation|0|||
149161930|NCT00793793|538069406|FG002|Overall Study|Protocol Violation|0|||
149161931|NCT00793793|538069407|FG003|Overall Study|Protocol Violation|1|||
149161932|NCT00793793|538069408|FG004|Overall Study|Protocol Violation|0|||
149161933|NCT00793793|538069409|FG005|Overall Study|Protocol Violation|0|||
149161934|NCT00793793|538069410|FG006|Overall Study|Protocol Violation|0|||
149161935|NCT00793793|538069411|FG007|Overall Study|Protocol Violation|0|||
149161936|NCT00793793|538069412|FG008|Overall Study|Protocol Violation|0|||
149161937|NCT00793793|538069413|FG009|Overall Study|Protocol Violation|0|||
149161938|NCT00793793|538069414|FG010|Overall Study|Protocol Violation|0|||
149012882|NCT00007475|537525834|FG000|Overall Study|Withdrawal by Subject|1|||
149012883|NCT00007475|537525835|FG001|Overall Study|Withdrawal by Subject|0|||
149012884|NCT00007475|537525836|FG002|Overall Study|Withdrawal by Subject|0|||
149012885|NCT00007475|537525837|FG003|Overall Study|Withdrawal by Subject|0|||
149161939|NCT00793793|538069415|FG011|Overall Study|Protocol Violation|0|||
149161940|NCT00793793|538069404|FG000|Overall Study|Lost to Follow-up|0|||
149161941|NCT00793793|538069405|FG001|Overall Study|Lost to Follow-up|0|||
149161942|NCT00793793|538069406|FG002|Overall Study|Lost to Follow-up|1|||
148926186|NCT00095238|537213531|FG001|Overall Study|Noncompliance|45|||
148926187|NCT00095238|537213530|FG000|Overall Study|No longer met study criteria|4|||
148926188|NCT00095238|537213531|FG001|Overall Study|No longer met study criteria|5|||
148926189|NCT00095238|537213530|FG000|Overall Study|Study terminated by sponsor|0|||
148926190|NCT00095238|537213531|FG001|Overall Study|Study terminated by sponsor|1|||
149012886|NCT00007475|537525834|FG000|Overall Study|Adverse Event|3|||
148926191|NCT00095238|537213530|FG000|Overall Study|Missing|1|||
148926192|NCT00095238|537213531|FG001|Overall Study|Missing|0|||
148926193|NCT00095238|537213530|FG000|Overall Study|Other Reasons|87|||
148926194|NCT00095238|537213531|FG001|Overall Study|Other Reasons|88|||
148926195|NCT03505671|537213532|FG000|Overall Study|Withdrawal by Subject|2|||
149161943|NCT00793793|538069407|FG003|Overall Study|Lost to Follow-up|0|||
149161944|NCT00793793|538069408|FG004|Overall Study|Lost to Follow-up|0|||
149012887|NCT00007475|537525835|FG001|Overall Study|Adverse Event|0|||
149161945|NCT00793793|538069409|FG005|Overall Study|Lost to Follow-up|0|||
149161946|NCT00793793|538069410|FG006|Overall Study|Lost to Follow-up|0|||
149161947|NCT00793793|538069411|FG007|Overall Study|Lost to Follow-up|0|||
149161948|NCT00793793|538069412|FG008|Overall Study|Lost to Follow-up|1|||
149161949|NCT00793793|538069413|FG009|Overall Study|Lost to Follow-up|3|||
149161950|NCT00793793|538069414|FG010|Overall Study|Lost to Follow-up|1|||
149161951|NCT00793793|538069415|FG011|Overall Study|Lost to Follow-up|0|||
149161952|NCT00793793|538069404|FG000|Overall Study|Withdrawal by Subject|0|||
149161953|NCT00793793|538069405|FG001|Overall Study|Withdrawal by Subject|0|||
149161954|NCT00793793|538069406|FG002|Overall Study|Withdrawal by Subject|0|||
149161955|NCT00793793|538069407|FG003|Overall Study|Withdrawal by Subject|0|||
149161956|NCT00793793|538069408|FG004|Overall Study|Withdrawal by Subject|1|||
149161957|NCT00793793|538069409|FG005|Overall Study|Withdrawal by Subject|0|||
149161958|NCT00793793|538069410|FG006|Overall Study|Withdrawal by Subject|0|||
149161959|NCT00793793|538069411|FG007|Overall Study|Withdrawal by Subject|0|||
149161960|NCT00793793|538069412|FG008|Overall Study|Withdrawal by Subject|1|||
149161961|NCT00793793|538069413|FG009|Overall Study|Withdrawal by Subject|0|||
149161962|NCT00793793|538069414|FG010|Overall Study|Withdrawal by Subject|0|||
148674199|NCT01186744|536279422|FG004|Overall Study|Lost to Follow-up|1|||
148674200|NCT01186744|536279423|FG005|Overall Study|Lost to Follow-up|4|||
148674201|NCT01186744|536279418|FG000|Overall Study|Screen failure|1|||
148674202|NCT01186744|536279419|FG001|Overall Study|Screen failure|1|||
148674203|NCT01186744|536279420|FG002|Overall Study|Screen failure|0|||
148674204|NCT01186744|536279421|FG003|Overall Study|Screen failure|1|||
148674205|NCT01186744|536279422|FG004|Overall Study|Screen failure|0|||
148674206|NCT01186744|536279423|FG005|Overall Study|Screen failure|0|||
148674207|NCT01186744|536279418|FG000|Overall Study|Withdrawal by Subject|14|||
148674208|NCT01186744|536279419|FG001|Overall Study|Withdrawal by Subject|10|||
148674209|NCT01186744|536279420|FG002|Overall Study|Withdrawal by Subject|2|||
148674210|NCT01186744|536279421|FG003|Overall Study|Withdrawal by Subject|5|||
148674211|NCT01186744|536279422|FG004|Overall Study|Withdrawal by Subject|0|||
149012888|NCT00007475|537525836|FG002|Overall Study|Adverse Event|0|||
149161963|NCT00793793|538069415|FG011|Overall Study|Withdrawal by Subject|0|||
149161964|NCT00793793|538069404|FG000|Overall Study|reason not specified|0|||
149161965|NCT00793793|538069405|FG001|Overall Study|reason not specified|1|||
149161966|NCT00793793|538069406|FG002|Overall Study|reason not specified|0|||
149161967|NCT00793793|538069407|FG003|Overall Study|reason not specified|1|||
149161968|NCT00793793|538069408|FG004|Overall Study|reason not specified|1|||
149161969|NCT00793793|538069409|FG005|Overall Study|reason not specified|1|||
149161970|NCT00793793|538069410|FG006|Overall Study|reason not specified|2|||
149161971|NCT00793793|538069411|FG007|Overall Study|reason not specified|0|||
149161972|NCT00793793|538069412|FG008|Overall Study|reason not specified|7|||
149161973|NCT00793793|538069413|FG009|Overall Study|reason not specified|6|||
149161974|NCT00793793|538069414|FG010|Overall Study|reason not specified|2|||
149161975|NCT00793793|538069415|FG011|Overall Study|reason not specified|4|||
149161976|NCT00840827|538069416|FG000|Overall Study|Adverse Event|1|||
149161977|NCT00840827|538069416|FG000|Overall Study|Lack of Efficacy|4|||
149161978|NCT00840827|538069416|FG000|Overall Study|Physician Decision|1|||
149161979|NCT01445535|538069418|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
149161980|NCT01445535|538069419|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
149161981|NCT01445535|538069420|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
149161982|NCT01445535|538069421|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
149161983|NCT01445535|538069418|FG000|Overall Study|Disease progression|1|||
149161984|NCT01445535|538069419|FG001|Overall Study|Disease progression|0|||
149161985|NCT01445535|538069420|FG002|Overall Study|Disease progression|1|||
149161986|NCT01445535|538069421|FG003|Overall Study|Disease progression|0|||
149161987|NCT01445535|538069418|FG000|Overall Study|PI discretion|0|||
148674212|NCT01186744|536279423|FG005|Overall Study|Withdrawal by Subject|6|||
149012889|NCT00007475|537525837|FG003|Overall Study|Adverse Event|0|||
148674213|NCT01186744|536279418|FG000|Overall Study|Study terminated by Sponsor|1|||
148674214|NCT01186744|536279419|FG001|Overall Study|Study terminated by Sponsor|0|||
148674215|NCT01186744|536279420|FG002|Overall Study|Study terminated by Sponsor|0|||
148674216|NCT01186744|536279421|FG003|Overall Study|Study terminated by Sponsor|0|||
149161988|NCT01445535|538069419|FG001|Overall Study|PI discretion|0|||
149161989|NCT01445535|538069420|FG002|Overall Study|PI discretion|0|||
149161990|NCT01445535|538069421|FG003|Overall Study|PI discretion|1|||
149161991|NCT00364689|538069426|FG000|Overall Study|Lost to Follow-up|1|||
149161992|NCT00331409|538069432|FG000|Overall Study|Lack of Efficacy|4|||
149161993|NCT01482910|538069433|FG000|Overall Study|Adverse Event|6|||
149161994|NCT01482910|538069434|FG001|Overall Study|Adverse Event|5|||
148926196|NCT03505671|537213533|FG001|Overall Study|Withdrawal by Subject|1|||
148926197|NCT03505671|537213532|FG000|Overall Study|Lost to Follow-up|1|||
149161995|NCT01482910|538069433|FG000|Overall Study|Lost to Follow-up|0|||
149161996|NCT01482910|538069434|FG001|Overall Study|Lost to Follow-up|1|||
149161997|NCT01482910|538069433|FG000|Overall Study|Protocol Violation|1|||
149161998|NCT01482910|538069434|FG001|Overall Study|Protocol Violation|1|||
149161999|NCT01482910|538069433|FG000|Overall Study|Withdrawal by Subject|7|||
149162000|NCT01482910|538069434|FG001|Overall Study|Withdrawal by Subject|2|||
149162001|NCT01482910|538069433|FG000|Overall Study|Death|1|||
149162002|NCT01482910|538069434|FG001|Overall Study|Death|0|||
149162003|NCT03222349|538069438|FG000|Overall Study|Treatment B not done|5|||
149162004|NCT03222349|538069439|FG001|Overall Study|Treatment B not done|0|||
148926198|NCT03505671|537213533|FG001|Overall Study|Lost to Follow-up|0|||
148926199|NCT02038829|537213536|FG000|Washout Period 1|Death|0|||
148926200|NCT02038829|537213537|FG001|Washout Period 1|Death|0|||
148926201|NCT02038829|537213538|FG002|Washout Period 1|Death|0|||
149162005|NCT03222349|538069438|FG000|Overall Study|Lost to Follow-up|1|||
149162006|NCT03222349|538069439|FG001|Overall Study|Lost to Follow-up|2|||
149162007|NCT03222349|538069438|FG000|Overall Study|Withdrawal by Subject|1|||
148926202|NCT02038829|537213539|FG003|Washout Period 1|Death|0|||
148926203|NCT02038829|537213540|FG004|Washout Period 1|Death|1|||
149162008|NCT03222349|538069439|FG001|Overall Study|Withdrawal by Subject|0|||
149162009|NCT03222349|538069438|FG000|Overall Study|Treatment A not done|0|||
149162010|NCT03222349|538069439|FG001|Overall Study|Treatment A not done|5|||
149162011|NCT03222349|538069438|FG000|Overall Study|Study terminated by sponsor|1|||
149162012|NCT03222349|538069439|FG001|Overall Study|Study terminated by sponsor|0|||
149162013|NCT02769624|538069440|FG000|Overall Study|Lost to Follow-up|0|||
149162014|NCT02769624|538069441|FG001|Overall Study|Lost to Follow-up|1|||
149162015|NCT01552681|538069442|FG000|Overall Study|Withdrawal by Subject|4|||
149162016|NCT01552681|538069443|FG001|Overall Study|Withdrawal by Subject|0|||
149162017|NCT01552681|538069442|FG000|Overall Study|Physician Decision|1|||
149162018|NCT01552681|538069443|FG001|Overall Study|Physician Decision|0|||
149162019|NCT01552681|538069442|FG000|Overall Study|Subject moved away|0|||
149162020|NCT01552681|538069443|FG001|Overall Study|Subject moved away|1|||
149162021|NCT01987908|538069453|FG000|Placebo Lead-in Period|Adverse Event|2|||
149162022|NCT01987908|538069454|FG001|Placebo Lead-in Period|Adverse Event|0|||
149162023|NCT01987908|538069455|FG002|Placebo Lead-in Period|Adverse Event|0|||
149162024|NCT01987908|538069453|FG000|Placebo Lead-in Period|Physician Decision|2|||
149162025|NCT01987908|538069454|FG001|Placebo Lead-in Period|Physician Decision|0|||
149162026|NCT01987908|538069455|FG002|Placebo Lead-in Period|Physician Decision|0|||
149162027|NCT01987908|538069453|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
149162028|NCT01987908|538069454|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
149162029|NCT01987908|538069455|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
149162030|NCT01987908|538069453|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
148926204|NCT02038829|537213541|FG005|Washout Period 1|Death|0|||
148926205|NCT02038829|537213542|FG006|Washout Period 1|Death|0|||
148926206|NCT02038829|537213543|FG007|Washout Period 1|Death|0|||
148926207|NCT02038829|537213544|FG008|Washout Period 1|Death|0|||
148926208|NCT02038829|537213545|FG009|Washout Period 1|Death|0|||
148926209|NCT02038829|537213546|FG010|Washout Period 1|Death|0|||
148926210|NCT02038829|537213547|FG011|Washout Period 1|Death|0|||
148926211|NCT02038829|537213536|FG000|Treatment Period 2|Adverse Event|0|||
148926212|NCT02038829|537213537|FG001|Treatment Period 2|Adverse Event|0|||
148926213|NCT02038829|537213538|FG002|Treatment Period 2|Adverse Event|0|||
148926214|NCT02038829|537213539|FG003|Treatment Period 2|Adverse Event|0|||
148926215|NCT02038829|537213540|FG004|Treatment Period 2|Adverse Event|0|||
148926216|NCT02038829|537213541|FG005|Treatment Period 2|Adverse Event|0|||
148926217|NCT02038829|537213542|FG006|Treatment Period 2|Adverse Event|0|||
148926218|NCT02038829|537213543|FG007|Treatment Period 2|Adverse Event|0|||
148926219|NCT02038829|537213544|FG008|Treatment Period 2|Adverse Event|0|||
148926220|NCT02038829|537213545|FG009|Treatment Period 2|Adverse Event|0|||
148926221|NCT02038829|537213546|FG010|Treatment Period 2|Adverse Event|1|||
149162031|NCT01987908|538069454|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
149162032|NCT01987908|538069455|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
149162033|NCT01987908|538069453|FG000|Treatment Period|Adverse Event|0|||
149162034|NCT01987908|538069454|FG001|Treatment Period|Adverse Event|1|||
149162035|NCT01987908|538069455|FG002|Treatment Period|Adverse Event|1|||
149162036|NCT01987908|538069453|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
149162037|NCT01987908|538069454|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
149162038|NCT01987908|538069455|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
148674217|NCT01186744|536279422|FG004|Overall Study|Study terminated by Sponsor|0|||
148806080|NCT05595369|536768054|FG000|Overall Study|Lost to Follow-up|11|||
148926222|NCT02038829|537213547|FG011|Treatment Period 2|Adverse Event|0|||
148926223|NCT02038829|537213536|FG000|Treatment Period 2|Withdrawal by Subject|1|||
148926224|NCT02038829|537213537|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148926225|NCT02038829|537213538|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148926226|NCT02038829|537213539|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148926227|NCT02038829|537213540|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148926228|NCT02038829|537213541|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148926229|NCT02038829|537213542|FG006|Treatment Period 2|Withdrawal by Subject|0|||
148926230|NCT02038829|537213543|FG007|Treatment Period 2|Withdrawal by Subject|0|||
149162039|NCT01987908|538069453|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
148926231|NCT02038829|537213544|FG008|Treatment Period 2|Withdrawal by Subject|0|||
148926232|NCT02038829|537213545|FG009|Treatment Period 2|Withdrawal by Subject|0|||
148926233|NCT02038829|537213546|FG010|Treatment Period 2|Withdrawal by Subject|0|||
148926234|NCT02038829|537213547|FG011|Treatment Period 2|Withdrawal by Subject|0|||
148926235|NCT02038829|537213536|FG000|Washout Period 2|Adverse Event|0|||
148926236|NCT02038829|537213537|FG001|Washout Period 2|Adverse Event|0|||
148926237|NCT02038829|537213538|FG002|Washout Period 2|Adverse Event|0|||
148926238|NCT02038829|537213539|FG003|Washout Period 2|Adverse Event|0|||
148926239|NCT02038829|537213540|FG004|Washout Period 2|Adverse Event|0|||
148926240|NCT02038829|537213541|FG005|Washout Period 2|Adverse Event|0|||
148926241|NCT02038829|537213542|FG006|Washout Period 2|Adverse Event|0|||
148926242|NCT02038829|537213543|FG007|Washout Period 2|Adverse Event|0|||
148926243|NCT02038829|537213544|FG008|Washout Period 2|Adverse Event|1|||
148926244|NCT02038829|537213545|FG009|Washout Period 2|Adverse Event|0|||
148926245|NCT02038829|537213546|FG010|Washout Period 2|Adverse Event|0|||
148926246|NCT02038829|537213547|FG011|Washout Period 2|Adverse Event|0|||
148926247|NCT02038829|537213536|FG000|Washout Period 2|Withdrawal by Subject|0|||
148926248|NCT02038829|537213537|FG001|Washout Period 2|Withdrawal by Subject|0|||
148926249|NCT02038829|537213538|FG002|Washout Period 2|Withdrawal by Subject|0|||
148926250|NCT02038829|537213539|FG003|Washout Period 2|Withdrawal by Subject|0|||
148926251|NCT02038829|537213540|FG004|Washout Period 2|Withdrawal by Subject|0|||
148926252|NCT02038829|537213541|FG005|Washout Period 2|Withdrawal by Subject|1|||
148926253|NCT02038829|537213542|FG006|Washout Period 2|Withdrawal by Subject|0|||
148926254|NCT02038829|537213543|FG007|Washout Period 2|Withdrawal by Subject|0|||
148926255|NCT02038829|537213544|FG008|Washout Period 2|Withdrawal by Subject|0|||
148926256|NCT02038829|537213545|FG009|Washout Period 2|Withdrawal by Subject|0|||
148926257|NCT02038829|537213546|FG010|Washout Period 2|Withdrawal by Subject|0|||
148926258|NCT02038829|537213547|FG011|Washout Period 2|Withdrawal by Subject|0|||
148926259|NCT02038829|537213536|FG000|Treatment Period 4|Adverse Event|0|||
148926260|NCT02038829|537213537|FG001|Treatment Period 4|Adverse Event|1|||
148926261|NCT02038829|537213538|FG002|Treatment Period 4|Adverse Event|0|||
148926262|NCT02038829|537213539|FG003|Treatment Period 4|Adverse Event|0|||
148926263|NCT02038829|537213540|FG004|Treatment Period 4|Adverse Event|0|||
148674218|NCT01186744|536279423|FG005|Overall Study|Study terminated by Sponsor|0|||
148674219|NCT01186744|536279418|FG000|Overall Study|Other|9|||
148674220|NCT01186744|536279419|FG001|Overall Study|Other|10|||
148674221|NCT01186744|536279420|FG002|Overall Study|Other|1|||
148674222|NCT01186744|536279421|FG003|Overall Study|Other|2|||
148674223|NCT01186744|536279422|FG004|Overall Study|Other|1|||
148674224|NCT01186744|536279423|FG005|Overall Study|Other|5|||
148674225|NCT01186744|536279418|FG000|Overall Study|Adverse Event|10|||
148674226|NCT01186744|536279419|FG001|Overall Study|Adverse Event|14|||
148674227|NCT01186744|536279420|FG002|Overall Study|Adverse Event|1|||
148674228|NCT01186744|536279421|FG003|Overall Study|Adverse Event|0|||
148674229|NCT01186744|536279422|FG004|Overall Study|Adverse Event|1|||
148674230|NCT01186744|536279423|FG005|Overall Study|Adverse Event|4|||
148674231|NCT01186744|536279418|FG000|Overall Study|Death|1|||
148674232|NCT01186744|536279419|FG001|Overall Study|Death|0|||
148674233|NCT01186744|536279420|FG002|Overall Study|Death|0|||
148674234|NCT01186744|536279421|FG003|Overall Study|Death|0|||
148674235|NCT01186744|536279422|FG004|Overall Study|Death|0|||
148674236|NCT01186744|536279423|FG005|Overall Study|Death|0|||
148674237|NCT02325401|536279426|FG000|Overall Study|Withdrawal by Subject|0|||
148674238|NCT02325401|536279427|FG001|Overall Study|Withdrawal by Subject|1|||
148674239|NCT02325401|536279428|FG002|Overall Study|Withdrawal by Subject|1|||
148674240|NCT03284424|536279430|FG000|Overall Study|Death|70|||
148674241|NCT03284424|536279431|FG001|Overall Study|Death|24|||
148674242|NCT03284424|536279430|FG000|Overall Study|Lost to Follow-up|3|||
148674243|NCT03284424|536279431|FG001|Overall Study|Lost to Follow-up|1|||
148674244|NCT03284424|536279430|FG000|Overall Study|Physician Decision|1|||
148926264|NCT02038829|537213541|FG005|Treatment Period 4|Adverse Event|0|||
148926265|NCT02038829|537213542|FG006|Treatment Period 4|Adverse Event|0|||
148926266|NCT02038829|537213543|FG007|Treatment Period 4|Adverse Event|0|||
148926267|NCT02038829|537213544|FG008|Treatment Period 4|Adverse Event|0|||
148926268|NCT02038829|537213545|FG009|Treatment Period 4|Adverse Event|0|||
148926269|NCT02038829|537213546|FG010|Treatment Period 4|Adverse Event|0|||
148926270|NCT02038829|537213547|FG011|Treatment Period 4|Adverse Event|0|||
148926271|NCT02038829|537213536|FG000|Washout Period 4|Adverse Event|0|||
148926272|NCT02038829|537213537|FG001|Washout Period 4|Adverse Event|0|||
148926273|NCT02038829|537213538|FG002|Washout Period 4|Adverse Event|0|||
148926274|NCT02038829|537213539|FG003|Washout Period 4|Adverse Event|0|||
148926275|NCT02038829|537213540|FG004|Washout Period 4|Adverse Event|0|||
148926276|NCT02038829|537213541|FG005|Washout Period 4|Adverse Event|0|||
148926277|NCT02038829|537213542|FG006|Washout Period 4|Adverse Event|1|||
148674245|NCT03284424|536279431|FG001|Overall Study|Physician Decision|2|||
148674246|NCT03284424|536279430|FG000|Overall Study|Withdrawal by Subject|4|||
148674247|NCT03284424|536279431|FG001|Overall Study|Withdrawal by Subject|5|||
148674248|NCT03284424|536279430|FG000|Overall Study|Sponsor's decision|27|||
148674249|NCT03284424|536279431|FG001|Overall Study|Sponsor's decision|22|||
148926278|NCT02038829|537213543|FG007|Washout Period 4|Adverse Event|0|||
148926279|NCT02038829|537213544|FG008|Washout Period 4|Adverse Event|0|||
148926280|NCT02038829|537213545|FG009|Washout Period 4|Adverse Event|0|||
148926281|NCT02038829|537213546|FG010|Washout Period 4|Adverse Event|0|||
149162040|NCT01987908|538069454|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
149162041|NCT01987908|538069455|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
149162042|NCT01869348|538069457|FG000|Overall Study|Withdrawal by Subject|1|||
149162043|NCT01869348|538069458|FG001|Overall Study|Withdrawal by Subject|1|||
149162044|NCT02789657|538069459|FG000|Overall Study|Withdrawal by Subject|2|||
149162045|NCT02789657|538069460|FG001|Overall Study|Withdrawal by Subject|0|||
149162046|NCT02789657|538069461|FG002|Overall Study|Withdrawal by Subject|0|||
149162047|NCT02789657|538069462|FG003|Overall Study|Withdrawal by Subject|0|||
149162048|NCT00448708|538069463|FG000|Overall Study|Death|21|||
149162049|NCT00448708|538069464|FG001|Overall Study|Death|17|||
148926282|NCT02038829|537213547|FG011|Washout Period 4|Adverse Event|0|||
148926283|NCT02038829|537213536|FG000|Treatment Period 6|Adverse Event|0|||
148926284|NCT02038829|537213537|FG001|Treatment Period 6|Adverse Event|0|||
148926285|NCT02038829|537213538|FG002|Treatment Period 6|Adverse Event|1|||
149162050|NCT00448708|538069463|FG000|Overall Study|Withdrawal by Subject|8|||
149162051|NCT00448708|538069464|FG001|Overall Study|Withdrawal by Subject|4|||
149162052|NCT00448708|538069463|FG000|Overall Study|Lost to Follow-up|6|||
148806081|NCT05595369|536768055|FG001|Overall Study|Lost to Follow-up|10|||
149162053|NCT00448708|538069464|FG001|Overall Study|Lost to Follow-up|8|||
149162054|NCT00448708|538069463|FG000|Overall Study|not listed|0|||
149162055|NCT00448708|538069464|FG001|Overall Study|not listed|2|||
149162056|NCT04698525|538069465|FG000|Overall Study|Lost to Follow-up|1|||
149162057|NCT04698525|538069466|FG001|Overall Study|Lost to Follow-up|2|||
149162058|NCT04698525|538069465|FG000|Overall Study|Three suffered of Covid-19|2|||
149162059|NCT04698525|538069466|FG001|Overall Study|Three suffered of Covid-19|1|||
149162060|NCT01731678|538069469|FG000|Overall Study|Withdrawal by Subject|3|||
149162061|NCT01731678|538069469|FG000|Overall Study|Did not meet inclusion criteria|1|||
149162062|NCT01731678|538069469|FG000|Overall Study|RMT too high, making TMS difficult|3|||
149162063|NCT03665285|538069472|FG000|Overall Study|Started New Anticancer Treatment|1|||
149162064|NCT03665285|538069473|FG001|Overall Study|Started New Anticancer Treatment|1|||
149162065|NCT03665285|538069474|FG002|Overall Study|Started New Anticancer Treatment|2|||
149162066|NCT03665285|538069475|FG003|Overall Study|Started New Anticancer Treatment|4|||
149162067|NCT03665285|538069476|FG004|Overall Study|Started New Anticancer Treatment|1|||
149162068|NCT03665285|538069477|FG005|Overall Study|Started New Anticancer Treatment|1|||
149162069|NCT03665285|538069478|FG006|Overall Study|Started New Anticancer Treatment|2|||
149162070|NCT03665285|538069479|FG007|Overall Study|Started New Anticancer Treatment|15|||
149162071|NCT03665285|538069480|FG008|Overall Study|Started New Anticancer Treatment|1|||
149162072|NCT03665285|538069472|FG000|Overall Study|Disease Progression|0|||
149162073|NCT03665285|538069473|FG001|Overall Study|Disease Progression|0|||
149162074|NCT03665285|538069474|FG002|Overall Study|Disease Progression|3|||
149162075|NCT03665285|538069475|FG003|Overall Study|Disease Progression|1|||
149162076|NCT03665285|538069476|FG004|Overall Study|Disease Progression|0|||
149162077|NCT03665285|538069477|FG005|Overall Study|Disease Progression|0|||
149162078|NCT03665285|538069478|FG006|Overall Study|Disease Progression|0|||
149162079|NCT03665285|538069479|FG007|Overall Study|Disease Progression|7|||
149162080|NCT03665285|538069480|FG008|Overall Study|Disease Progression|1|||
149162081|NCT03665285|538069472|FG000|Overall Study|Hospice|0|||
149162082|NCT03665285|538069473|FG001|Overall Study|Hospice|0|||
149162083|NCT03665285|538069474|FG002|Overall Study|Hospice|0|||
149162084|NCT03665285|538069475|FG003|Overall Study|Hospice|0|||
149162085|NCT03665285|538069476|FG004|Overall Study|Hospice|0|||
149162086|NCT03665285|538069477|FG005|Overall Study|Hospice|0|||
149162087|NCT03665285|538069478|FG006|Overall Study|Hospice|0|||
149162088|NCT03665285|538069479|FG007|Overall Study|Hospice|2|||
149162089|NCT03665285|538069480|FG008|Overall Study|Hospice|0|||
149162090|NCT03665285|538069472|FG000|Overall Study|Withdrawal by Subject|0|||
149162091|NCT03665285|538069473|FG001|Overall Study|Withdrawal by Subject|0|||
149162092|NCT03665285|538069474|FG002|Overall Study|Withdrawal by Subject|0|||
149162093|NCT03665285|538069475|FG003|Overall Study|Withdrawal by Subject|0|||
149162094|NCT03665285|538069476|FG004|Overall Study|Withdrawal by Subject|1|||
149162095|NCT03665285|538069477|FG005|Overall Study|Withdrawal by Subject|0|||
149162096|NCT03665285|538069478|FG006|Overall Study|Withdrawal by Subject|0|||
149162097|NCT03665285|538069479|FG007|Overall Study|Withdrawal by Subject|2|||
149162098|NCT03665285|538069480|FG008|Overall Study|Withdrawal by Subject|0|||
149162099|NCT03665285|538069472|FG000|Overall Study|Physician Decision|0|||
149162100|NCT03665285|538069473|FG001|Overall Study|Physician Decision|0|||
149162101|NCT03665285|538069474|FG002|Overall Study|Physician Decision|0|||
149162102|NCT03665285|538069475|FG003|Overall Study|Physician Decision|0|||
149162103|NCT03665285|538069476|FG004|Overall Study|Physician Decision|0|||
149162104|NCT03665285|538069477|FG005|Overall Study|Physician Decision|0|||
149162105|NCT03665285|538069478|FG006|Overall Study|Physician Decision|0|||
149162106|NCT03665285|538069479|FG007|Overall Study|Physician Decision|2|||
149162107|NCT03665285|538069480|FG008|Overall Study|Physician Decision|0|||
149162108|NCT00354601|538069481|FG000|Overall Study|Protocol Violation|1|||
149162109|NCT00354601|538069481|FG000|Overall Study|progression|1|||
149162110|NCT03603652|538069482|FG000|Overall Study|Death|2|||
149162111|NCT02058147|538069483|FG000|Overall Study|Randomized but not treated|0|||
149162112|NCT02058147|538069484|FG001|Overall Study|Randomized but not treated|0|||
149162113|NCT02058147|538069485|FG002|Overall Study|Randomized but not treated|1|||
149162114|NCT02058147|538069483|FG000|Overall Study|Adverse Event|12|||
149162115|NCT02058147|538069484|FG001|Overall Study|Adverse Event|9|||
148926286|NCT02038829|537213539|FG003|Treatment Period 6|Adverse Event|0|||
149162116|NCT02058147|538069485|FG002|Overall Study|Adverse Event|21|||
149162117|NCT02058147|538069483|FG000|Overall Study|Lack of Efficacy|1|||
149162118|NCT02058147|538069484|FG001|Overall Study|Lack of Efficacy|0|||
149162119|NCT02058147|538069485|FG002|Overall Study|Lack of Efficacy|3|||
149162120|NCT02058147|538069483|FG000|Overall Study|Poor compliance to protocol|8|||
149162121|NCT02058147|538069484|FG001|Overall Study|Poor compliance to protocol|9|||
149162122|NCT02058147|538069485|FG002|Overall Study|Poor compliance to protocol|4|||
149162123|NCT02058147|538069483|FG000|Overall Study|Other than specified|8|||
149162124|NCT02058147|538069484|FG001|Overall Study|Other than specified|9|||
149162125|NCT02058147|538069485|FG002|Overall Study|Other than specified|0|||
149162126|NCT01486199|538069488|FG000|Two Year Period Between Study Days|Physician Decision|1|||
149162127|NCT01486199|538069489|FG001|Two Year Period Between Study Days|Physician Decision|0|||
149162128|NCT03604445|538069493|FG000|Overall Study|Death|0|||
149162129|NCT03604445|538069494|FG001|Overall Study|Death|0|||
149162130|NCT03604445|538069495|FG002|Overall Study|Death|0|||
149162131|NCT03604445|538069496|FG003|Overall Study|Death|0|||
149162132|NCT03604445|538069497|FG004|Overall Study|Death|0|||
149162133|NCT03604445|538069498|FG005|Overall Study|Death|0|||
149162134|NCT03604445|538069499|FG006|Overall Study|Death|0|||
149162135|NCT03604445|538069500|FG007|Overall Study|Death|0|||
149162136|NCT03604445|538069501|FG008|Overall Study|Death|1|||
149162137|NCT03604445|538069493|FG000|Overall Study|Withdrawal by Subject|0|||
149162138|NCT03604445|538069494|FG001|Overall Study|Withdrawal by Subject|0|||
149162139|NCT03604445|538069495|FG002|Overall Study|Withdrawal by Subject|0|||
149162140|NCT03604445|538069496|FG003|Overall Study|Withdrawal by Subject|0|||
149162141|NCT03604445|538069497|FG004|Overall Study|Withdrawal by Subject|0|||
149162142|NCT03604445|538069498|FG005|Overall Study|Withdrawal by Subject|0|||
149162143|NCT03604445|538069499|FG006|Overall Study|Withdrawal by Subject|1|||
149162144|NCT03604445|538069500|FG007|Overall Study|Withdrawal by Subject|0|||
149162145|NCT03604445|538069501|FG008|Overall Study|Withdrawal by Subject|0|||
149162146|NCT03604445|538069493|FG000|Overall Study|Missing visit|0|||
149162147|NCT03604445|538069494|FG001|Overall Study|Missing visit|0|||
149162148|NCT03604445|538069495|FG002|Overall Study|Missing visit|0|||
149162149|NCT03604445|538069496|FG003|Overall Study|Missing visit|0|||
149162150|NCT03604445|538069497|FG004|Overall Study|Missing visit|0|||
148926287|NCT02038829|537213540|FG004|Treatment Period 6|Adverse Event|0|||
149162151|NCT03604445|538069498|FG005|Overall Study|Missing visit|1|||
149162152|NCT03604445|538069499|FG006|Overall Study|Missing visit|0|||
149162153|NCT03604445|538069500|FG007|Overall Study|Missing visit|1|||
149162154|NCT03604445|538069501|FG008|Overall Study|Missing visit|0|||
149162155|NCT03604445|538069493|FG000|Overall Study|Adverse Event|0|||
149162156|NCT03604445|538069494|FG001|Overall Study|Adverse Event|0|||
149162157|NCT03604445|538069495|FG002|Overall Study|Adverse Event|0|||
149162158|NCT03604445|538069496|FG003|Overall Study|Adverse Event|1|||
148926288|NCT02038829|537213541|FG005|Treatment Period 6|Adverse Event|0|||
148926289|NCT02038829|537213542|FG006|Treatment Period 6|Adverse Event|0|||
148926290|NCT02038829|537213543|FG007|Treatment Period 6|Adverse Event|0|||
148926291|NCT02038829|537213544|FG008|Treatment Period 6|Adverse Event|0|||
148674250|NCT00457418|536279434|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
148926292|NCT02038829|537213545|FG009|Treatment Period 6|Adverse Event|0|||
148926293|NCT02038829|537213546|FG010|Treatment Period 6|Adverse Event|0|||
148926294|NCT02038829|537213547|FG011|Treatment Period 6|Adverse Event|0|||
149162159|NCT03604445|538069497|FG004|Overall Study|Adverse Event|0|||
149162160|NCT03604445|538069498|FG005|Overall Study|Adverse Event|0|||
149162161|NCT03604445|538069499|FG006|Overall Study|Adverse Event|0|||
149162162|NCT03604445|538069500|FG007|Overall Study|Adverse Event|0|||
149162163|NCT03604445|538069501|FG008|Overall Study|Adverse Event|1|||
149162164|NCT01360645|538069502|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
149162165|NCT01360645|538069503|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
148926295|NCT00749580|537213548|FG000|Overall Study|Lost to Follow-up|4|||
149162166|NCT01360645|538069504|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
149162167|NCT01360645|538069505|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
149162168|NCT01360645|538069502|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
149162169|NCT01360645|538069503|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
149162170|NCT01360645|538069504|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
149162171|NCT01360645|538069505|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
149162172|NCT01360645|538069502|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
149162173|NCT01360645|538069503|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
149162174|NCT01360645|538069504|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
149162175|NCT01360645|538069505|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
149162176|NCT01360645|538069502|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
149162177|NCT01360645|538069503|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
149162178|NCT01360645|538069504|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
149162179|NCT01360645|538069505|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
149162180|NCT01360645|538069502|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
149162181|NCT01360645|538069503|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
149162182|NCT01360645|538069504|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
149162183|NCT01360645|538069505|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
149162184|NCT01360645|538069502|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
149162185|NCT01360645|538069503|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
149162186|NCT01360645|538069504|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
149162187|NCT01360645|538069505|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
149162188|NCT01360645|538069502|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
149162189|NCT01360645|538069503|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
149162190|NCT01360645|538069504|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
149162191|NCT01360645|538069505|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
149162192|NCT01360645|538069502|FG000|Phase B (6 Weeks)|Adverse Event|0|||
149162193|NCT01360645|538069503|FG001|Phase B (6 Weeks)|Adverse Event|6|||
149162194|NCT01360645|538069504|FG002|Phase B (6 Weeks)|Adverse Event|0|||
149162195|NCT01360645|538069505|FG003|Phase B (6 Weeks)|Adverse Event|0|||
149162196|NCT01360645|538069502|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
149162197|NCT01360645|538069503|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
149162198|NCT01360645|538069504|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
149162199|NCT01360645|538069505|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
149162200|NCT01360645|538069502|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
149162201|NCT01360645|538069503|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
149162202|NCT01360645|538069504|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
149162203|NCT01360645|538069505|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
149162204|NCT01360645|538069502|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
149162205|NCT01360645|538069503|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
149162206|NCT01360645|538069504|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
149162207|NCT01360645|538069505|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
149162208|NCT01360645|538069502|FG000|Phase A+|Lost to Follow-up|0|||
149162209|NCT01360645|538069503|FG001|Phase A+|Lost to Follow-up|0|||
149162210|NCT01360645|538069504|FG002|Phase A+|Lost to Follow-up|0|||
149162211|NCT01360645|538069505|FG003|Phase A+|Lost to Follow-up|7|||
149162212|NCT01360645|538069502|FG000|Phase A+|Adverse Event|0|||
149162213|NCT01360645|538069503|FG001|Phase A+|Adverse Event|0|||
149162214|NCT01360645|538069504|FG002|Phase A+|Adverse Event|0|||
149162215|NCT01360645|538069505|FG003|Phase A+|Adverse Event|2|||
149162216|NCT01360645|538069502|FG000|Phase A+|Met Withdrawal Criteria|0|||
149162217|NCT01360645|538069503|FG001|Phase A+|Met Withdrawal Criteria|0|||
149162218|NCT01360645|538069504|FG002|Phase A+|Met Withdrawal Criteria|0|||
149162219|NCT01360645|538069505|FG003|Phase A+|Met Withdrawal Criteria|4|||
149162220|NCT01360645|538069502|FG000|Phase A+|Physician Decision|0|||
149162221|NCT01360645|538069503|FG001|Phase A+|Physician Decision|0|||
149162222|NCT01360645|538069504|FG002|Phase A+|Physician Decision|0|||
148674251|NCT00457418|536279434|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
148674252|NCT00457418|536279434|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
148674253|NCT00457418|536279434|FG000|Post PK Maintenance|Adverse Event|10|||
148674254|NCT00457418|536279434|FG000|Post PK Maintenance|Progression of Disease|6|||
148674255|NCT00457418|536279434|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
148674256|NCT00457418|536279434|FG000|Post PK Maintenance|Lost to Follow-up|1|||
148674257|NCT04854707|536279436|FG000|Overall Study|Lack of Efficacy|78|||
148674258|NCT04854707|536279437|FG001|Overall Study|Lack of Efficacy|59|||
148674259|NCT04854707|536279438|FG002|Overall Study|Lack of Efficacy|30|||
148674260|NCT01346501|536279442|FG000|Overall Study|Initiated Other Biological Agents|3|||
148674261|NCT01346501|536279443|FG001|Overall Study|Initiated Other Biological Agents|1|||
149162223|NCT01360645|538069505|FG003|Phase A+|Physician Decision|2|||
149162224|NCT01360645|538069502|FG000|Phase A+|Withdrawal by Subject|0|||
149162225|NCT01360645|538069503|FG001|Phase A+|Withdrawal by Subject|0|||
149162226|NCT01360645|538069504|FG002|Phase A+|Withdrawal by Subject|0|||
149162227|NCT01360645|538069505|FG003|Phase A+|Withdrawal by Subject|5|||
148674262|NCT01346501|536279442|FG000|Overall Study|Other|8|||
149162228|NCT01360645|538069502|FG000|Phase A+|Protocol Deviation|0|||
148926296|NCT00749580|537213549|FG001|Overall Study|Lost to Follow-up|8|||
148926297|NCT00749580|537213548|FG000|Overall Study|Adverse Event|0|||
148926298|NCT00749580|537213549|FG001|Overall Study|Adverse Event|1|||
149162229|NCT01360645|538069503|FG001|Phase A+|Protocol Deviation|0|||
149162230|NCT01360645|538069504|FG002|Phase A+|Protocol Deviation|0|||
149162231|NCT01360645|538069505|FG003|Phase A+|Protocol Deviation|4|||
149162232|NCT00773279|538069506|FG000|Period 1|Adverse Event|2|||
149162233|NCT00773279|538069507|FG001|Period 1|Adverse Event|1|||
149162234|NCT00773279|538069506|FG000|Period 1|Lack of Efficacy|0|||
149162235|NCT00773279|538069507|FG001|Period 1|Lack of Efficacy|2|||
149162236|NCT00773279|538069506|FG000|Period 1|Unclassified|5|||
149162237|NCT00773279|538069507|FG001|Period 1|Unclassified|1|||
149162238|NCT00773279|538069506|FG000|Period 2|Adverse Event|0|||
149162239|NCT00773279|538069507|FG001|Period 2|Adverse Event|1|||
149162240|NCT00773279|538069506|FG000|Period 2|Lack of Efficacy|1|||
149162241|NCT00773279|538069507|FG001|Period 2|Lack of Efficacy|0|||
149162242|NCT00773279|538069506|FG000|Period 2|Protocol Violation|0|||
149162243|NCT00773279|538069507|FG001|Period 2|Protocol Violation|3|||
149162244|NCT00773279|538069506|FG000|Period 2|Unclassified|2|||
149162245|NCT00773279|538069507|FG001|Period 2|Unclassified|2|||
149162246|NCT00611247|538069512|FG000|Overall Study|Death|1|||
149162247|NCT00611247|538069513|FG001|Overall Study|Death|5|||
149162248|NCT00611247|538069512|FG000|Overall Study|Lack of Efficacy|1|||
149162249|NCT00611247|538069513|FG001|Overall Study|Lack of Efficacy|16|||
149162250|NCT01890421|538069514|FG000|Overall Study|Adverse Event|1|||
149162251|NCT01890421|538069514|FG000|Overall Study|Other reason|10|||
149162252|NCT01446419|538069518|FG000|Overall Study|Death|1|||
149162253|NCT01446419|538069519|FG001|Overall Study|Death|0|||
148926299|NCT06460493|537213555|FG000|Overall Study|Withdrawal by Subject|2|||
149162254|NCT01446419|538069518|FG000|Overall Study|Withdrawal by Subject|1|||
149162255|NCT01446419|538069519|FG001|Overall Study|Withdrawal by Subject|1|||
148926300|NCT02987660|537213556|FG000|Overall Study|Study terminated by sponsor|10|||
148926301|NCT02987660|537213557|FG001|Overall Study|Study terminated by sponsor|10|||
149162256|NCT01446419|538069518|FG000|Overall Study|Terminated per protocol|3|||
149162257|NCT01446419|538069519|FG001|Overall Study|Terminated per protocol|0|||
149162258|NCT01557166|538069520|FG000|Overall Study|Adverse Event|20|||
149162259|NCT01557166|538069521|FG001|Overall Study|Adverse Event|6|||
149162260|NCT01557166|538069520|FG000|Overall Study|Lack of Efficacy|2|||
149162261|NCT01557166|538069521|FG001|Overall Study|Lack of Efficacy|1|||
149162262|NCT01557166|538069520|FG000|Overall Study|Protocol Violation|8|||
149162263|NCT01557166|538069521|FG001|Overall Study|Protocol Violation|5|||
149162264|NCT01557166|538069520|FG000|Overall Study|Withdrawn consent|12|||
149162265|NCT01557166|538069521|FG001|Overall Study|Withdrawn consent|20|||
149162266|NCT01557166|538069520|FG000|Overall Study|Target dose not tolerated|1|||
149162267|NCT01557166|538069521|FG001|Overall Study|Target dose not tolerated|0|||
149162268|NCT01557166|538069520|FG000|Overall Study|Psychiatric disorder|1|||
149162269|NCT01557166|538069521|FG001|Overall Study|Psychiatric disorder|0|||
149162270|NCT01557166|538069520|FG000|Overall Study|Unclassified|2|||
149162271|NCT01557166|538069521|FG001|Overall Study|Unclassified|5|||
149162272|NCT02445586|538069526|FG000|Overall Study|Death|14|||
149162273|NCT02445586|538069526|FG000|Overall Study|Withdrawal by Subject|13|||
149162274|NCT02445586|538069526|FG000|Overall Study|Disease Progression|10|||
149162275|NCT02445586|538069526|FG000|Overall Study|Protocol Violation|1|||
149162276|NCT02445586|538069526|FG000|Overall Study|Medical Condition|1|||
149162277|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
149162278|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
149162279|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
149162280|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149162281|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149162282|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149162283|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149162284|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149162285|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
149162286|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
149162287|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
149162288|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
149162289|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149162290|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149162291|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149162292|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149162293|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149162294|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
149162295|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
148674263|NCT01346501|536279443|FG001|Overall Study|Other|12|||
149162296|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
149162297|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149162298|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148806082|NCT05595369|536768056|FG002|Overall Study|Lost to Follow-up|10|||
149233889|NCT00948896|538324946|FG002|24 Months of Age to 36 Months of Age|Death|2|||
149233890|NCT00948896|538324947|FG003|24 Months of Age to 36 Months of Age|Death|0|||
149233891|NCT00948896|538324948|FG004|24 Months of Age to 36 Months of Age|Death|0|||
149233892|NCT00948896|538324949|FG005|24 Months of Age to 36 Months of Age|Death|1|||
149233893|NCT00948896|538324950|FG006|24 Months of Age to 36 Months of Age|Death|0|||
149233894|NCT00948896|538324951|FG007|24 Months of Age to 36 Months of Age|Death|0|||
149233895|NCT00948896|538324944|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
149233896|NCT00948896|538324945|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149233897|NCT00948896|538324946|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
149233898|NCT00948896|538324947|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
149233899|NCT00948896|538324948|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149233900|NCT00948896|538324949|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149233901|NCT00948896|538324950|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149233902|NCT00948896|538324951|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
149233903|NCT00948896|538324944|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
149233904|NCT00948896|538324945|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149233905|NCT00948896|538324946|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
149233906|NCT00948896|538324947|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149233907|NCT00948896|538324948|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
149233908|NCT00948896|538324949|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149233909|NCT00948896|538324950|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149233910|NCT00948896|538324951|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
149233911|NCT00948896|538324944|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149233912|NCT00948896|538324945|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149233913|NCT00948896|538324946|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
149233914|NCT00948896|538324947|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149162299|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149162300|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149162301|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149162302|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149162303|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
149162304|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
149162305|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
149162306|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
149162307|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149162308|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149162309|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149162310|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149162311|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149162312|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
149162313|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
149162314|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
149162315|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162316|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162317|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162318|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162319|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162320|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162321|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
149162322|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162323|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162324|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
149162325|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162326|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162327|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162328|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162329|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162330|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
149162331|NCT01583374|538069527|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162332|NCT01583374|538069528|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
149162333|NCT01583374|538069529|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162334|NCT01583374|538069530|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162335|NCT01583374|538069531|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162336|NCT01583374|538069532|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162337|NCT01583374|538069533|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162338|NCT01583374|538069534|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162339|NCT01583374|538069535|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
149162340|NCT01583374|538069527|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162341|NCT01583374|538069528|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162342|NCT01583374|538069529|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162343|NCT01583374|538069530|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162344|NCT01583374|538069531|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162345|NCT01583374|538069532|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162346|NCT01583374|538069533|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162347|NCT01583374|538069534|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
149162348|NCT01583374|538069535|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149162349|NCT01583374|538069527|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149162350|NCT01583374|538069528|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149162351|NCT01583374|538069529|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
149162352|NCT01583374|538069530|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149162353|NCT01583374|538069531|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149162354|NCT01583374|538069532|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149162355|NCT01583374|538069533|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149162356|NCT01583374|538069534|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149162357|NCT01583374|538069535|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
149162358|NCT01583374|538069527|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
149162359|NCT01583374|538069528|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
149162360|NCT01583374|538069529|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
149162361|NCT01583374|538069530|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
149162362|NCT01583374|538069531|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
149162363|NCT01583374|538069532|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
149162364|NCT01583374|538069533|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
149162365|NCT01583374|538069534|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
149162366|NCT01583374|538069535|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
149162367|NCT01583374|538069527|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149162368|NCT01583374|538069528|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
149162369|NCT01583374|538069529|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
149162370|NCT01583374|538069530|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149162371|NCT01583374|538069531|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
149162372|NCT01583374|538069532|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149162373|NCT01583374|538069533|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149162374|NCT01583374|538069534|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149162375|NCT01583374|538069535|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
149162376|NCT01583374|538069527|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149162377|NCT01583374|538069528|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149162378|NCT01583374|538069529|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
149162379|NCT01583374|538069530|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149162380|NCT01583374|538069531|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
149162381|NCT01583374|538069532|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
149162382|NCT01583374|538069533|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149162383|NCT01583374|538069534|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149162384|NCT01583374|538069535|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149162385|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
149162386|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
149162387|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149162388|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149162389|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
149162390|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149162391|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
149162392|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
148926302|NCT03707184|537213558|FG000|Overall Study|Withdrawal by Subject|2|||
149162393|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
149162394|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
149162395|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
149162396|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
149162397|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
149162398|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
149162399|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
148926303|NCT05007717|537213559|FG000|Overall Study|Death|3|||
148926304|NCT05007717|537213560|FG001|Overall Study|Death|2|||
149162400|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
149162401|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
149162402|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
149162403|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149162404|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149162405|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149162406|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
149162407|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
149162408|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
148926305|NCT03553836|537213561|FG000|Overall Study|Ongoing in Study|460|||
148926306|NCT03553836|537213562|FG001|Overall Study|Ongoing in Study|459|||
148926307|NCT03553836|537213561|FG000|Overall Study|Withdrawal by Subject|9|||
148926308|NCT03553836|537213562|FG001|Overall Study|Withdrawal by Subject|10|||
148674264|NCT04101721|536279444|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
148674265|NCT04101721|536279445|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
148674266|NCT04101721|536279444|FG000|Overall Study|Death|0|||
148674267|NCT04101721|536279445|FG001|Overall Study|Death|1|||
148674268|NCT04101721|536279444|FG000|Overall Study|Lost to Follow-up|0|||
148674269|NCT04101721|536279445|FG001|Overall Study|Lost to Follow-up|3|||
148674270|NCT02564952|536279448|FG000|Overall Study|Adverse Event|6|||
148674271|NCT02564952|536279448|FG000|Overall Study|Lost to Follow-up|1|||
148674272|NCT02564952|536279448|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
148674273|NCT02564952|536279448|FG000|Overall Study|Withdrawal by Subject|1|||
148674274|NCT02564952|536279448|FG000|Overall Study|Low Efficacy|1|||
148674275|NCT02564952|536279448|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
148674276|NCT00756652|536279449|FG000|Original Phase|Withdrawal by Subject|864|||
148674277|NCT00756652|536279450|FG001|Original Phase|Withdrawal by Subject|23|||
148674278|NCT00756652|536279449|FG000|Original Phase|Lost to Follow-up|601|||
148674279|NCT00756652|536279450|FG001|Original Phase|Lost to Follow-up|0|||
148674280|NCT00756652|536279449|FG000|Original Phase|Other Discontinuation|797|||
148674281|NCT00756652|536279450|FG001|Original Phase|Other Discontinuation|5|||
148674282|NCT00756652|536279449|FG000|Original Phase|Participant Noncompliance|18622|||
148674283|NCT00756652|536279450|FG001|Original Phase|Participant Noncompliance|424|||
148674284|NCT00756652|536279449|FG000|Original Phase|Unknown Discontinuation Reason|2|||
148674285|NCT00756652|536279450|FG001|Original Phase|Unknown Discontinuation Reason|0|||
148674286|NCT00756652|536279449|FG000|Original Phase|Participants without data|3259|||
148674287|NCT00756652|536279450|FG001|Original Phase|Participants without data|466|||
148674288|NCT00756652|536279449|FG000|Original Phase|Death|168|||
148674289|NCT00756652|536279450|FG001|Original Phase|Death|1|||
148674290|NCT00756652|536279449|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
148674291|NCT00756652|536279450|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
148674292|NCT00756652|536279449|FG000|Re-Op Phase|Withdrawal by Subject|62|||
148674293|NCT00756652|536279450|FG001|Re-Op Phase|Withdrawal by Subject|0|||
148674294|NCT00756652|536279449|FG000|Re-Op Phase|Death|6|||
148674295|NCT00756652|536279450|FG001|Re-Op Phase|Death|0|||
148674296|NCT00756652|536279449|FG000|Re-Op Phase|Lost to Follow-up|340|||
148674297|NCT00756652|536279450|FG001|Re-Op Phase|Lost to Follow-up|0|||
148674298|NCT00756652|536279449|FG000|Re-Op Phase|Site Closed|2454|||
148674299|NCT00756652|536279450|FG001|Re-Op Phase|Site Closed|0|||
148674300|NCT00756652|536279449|FG000|Re-Op Phase|Withdrawn after explant|14|||
148674301|NCT00756652|536279450|FG001|Re-Op Phase|Withdrawn after explant|0|||
148674302|NCT01215955|536279455|FG000|Overall Study|Adverse Event|1|||
148674303|NCT01215955|536279456|FG001|Overall Study|Adverse Event|4|||
148674304|NCT01215955|536279457|FG002|Overall Study|Adverse Event|2|||
148674305|NCT01215955|536279458|FG003|Overall Study|Adverse Event|3|||
148674306|NCT01215955|536279455|FG000|Overall Study|Death|2|||
148674307|NCT01215955|536279456|FG001|Overall Study|Death|0|||
148674308|NCT01215955|536279457|FG002|Overall Study|Death|1|||
148674309|NCT01215955|536279458|FG003|Overall Study|Death|3|||
148674310|NCT01215955|536279455|FG000|Overall Study|Entry Criteria Not Met|1|||
148674311|NCT01215955|536279456|FG001|Overall Study|Entry Criteria Not Met|3|||
148674312|NCT01215955|536279457|FG002|Overall Study|Entry Criteria Not Met|4|||
148674313|NCT01215955|536279458|FG003|Overall Study|Entry Criteria Not Met|7|||
148674314|NCT01215955|536279455|FG000|Overall Study|Lack of Efficacy|1|||
148674315|NCT01215955|536279456|FG001|Overall Study|Lack of Efficacy|2|||
148674316|NCT01215955|536279457|FG002|Overall Study|Lack of Efficacy|1|||
148674317|NCT01215955|536279458|FG003|Overall Study|Lack of Efficacy|0|||
148674318|NCT01215955|536279455|FG000|Overall Study|Lost to Follow-up|4|||
148674319|NCT01215955|536279456|FG001|Overall Study|Lost to Follow-up|4|||
148674320|NCT01215955|536279457|FG002|Overall Study|Lost to Follow-up|8|||
148674321|NCT01215955|536279458|FG003|Overall Study|Lost to Follow-up|9|||
148674322|NCT01215955|536279455|FG000|Overall Study|Physician Decision|4|||
148674323|NCT01215955|536279456|FG001|Overall Study|Physician Decision|10|||
148674324|NCT01215955|536279457|FG002|Overall Study|Physician Decision|8|||
148674325|NCT01215955|536279458|FG003|Overall Study|Physician Decision|11|||
148674326|NCT01215955|536279455|FG000|Overall Study|Protocol Violation|17|||
148674327|NCT01215955|536279456|FG001|Overall Study|Protocol Violation|13|||
148674328|NCT01215955|536279457|FG002|Overall Study|Protocol Violation|8|||
148674329|NCT01215955|536279458|FG003|Overall Study|Protocol Violation|8|||
148674330|NCT01215955|536279455|FG000|Overall Study|Sponsor Decision|1|||
149162409|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
148674331|NCT01215955|536279456|FG001|Overall Study|Sponsor Decision|2|||
148674332|NCT01215955|536279457|FG002|Overall Study|Sponsor Decision|0|||
148674333|NCT01215955|536279458|FG003|Overall Study|Sponsor Decision|1|||
148674334|NCT01215955|536279455|FG000|Overall Study|Withdrawal by Subject|14|||
148674335|NCT01215955|536279456|FG001|Overall Study|Withdrawal by Subject|15|||
148674336|NCT01215955|536279457|FG002|Overall Study|Withdrawal by Subject|13|||
148674337|NCT01215955|536279458|FG003|Overall Study|Withdrawal by Subject|9|||
148674338|NCT01215955|536279455|FG000|Overall Study|Quality Issues|0|||
148674339|NCT01215955|536279456|FG001|Overall Study|Quality Issues|0|||
148674340|NCT01215955|536279457|FG002|Overall Study|Quality Issues|3|||
148674341|NCT01215955|536279458|FG003|Overall Study|Quality Issues|2|||
149162410|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
148674342|NCT00038467|536279459|FG000|Overall Study|Adverse Event|170|||
148674343|NCT00038467|536279460|FG001|Overall Study|Adverse Event|145|||
148674344|NCT00038467|536279459|FG000|Overall Study|Withdrawal by Subject|150|||
148674345|NCT00038467|536279460|FG001|Overall Study|Withdrawal by Subject|107|||
148674346|NCT00038467|536279459|FG000|Overall Study|Protocol Violation|19|||
148674347|NCT00038467|536279460|FG001|Overall Study|Protocol Violation|22|||
148674348|NCT00038467|536279459|FG000|Overall Study|Death|22|||
148674349|NCT00038467|536279460|FG001|Overall Study|Death|16|||
148674350|NCT00038467|536279459|FG000|Overall Study|Lost to Follow-up|15|||
148674351|NCT00038467|536279460|FG001|Overall Study|Lost to Follow-up|10|||
148674352|NCT00038467|536279459|FG000|Overall Study|Recurrence|109|||
148674353|NCT00038467|536279460|FG001|Overall Study|Recurrence|179|||
148674354|NCT00038467|536279459|FG000|Overall Study|Randomized, but not treated|31|||
149162411|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
149162412|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
149162413|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
149162414|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
149162415|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
149162416|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
149162417|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
149162418|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
149162419|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
149162420|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
149162421|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162422|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162423|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162424|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162425|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
149162426|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162427|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
149162428|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162429|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
149162430|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149162431|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149162432|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149162433|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149162434|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149162435|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149162436|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
149162437|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149162438|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
149162439|NCT01583374|538069527|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
149162440|NCT01583374|538069528|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
149162441|NCT01583374|538069529|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
149162442|NCT01583374|538069530|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
149162443|NCT01583374|538069531|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
149162444|NCT01583374|538069532|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
149162445|NCT01583374|538069533|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
149162446|NCT01583374|538069534|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
149162447|NCT01583374|538069535|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
149162448|NCT02447848|538069536|FG000|Overall Study|Patient discharged|3|||
149162449|NCT02447848|538069536|FG000|Overall Study|Lack of Efficacy|4|||
149162450|NCT02447848|538069536|FG000|Overall Study|Withdrawal by Subject|4|||
149162451|NCT02307370|538069537|FG000|Overall Study|Death|5|||
149162452|NCT02307370|538069537|FG000|Overall Study|Lost to Follow-up|1|||
149162453|NCT02307370|538069537|FG000|Overall Study|Withdrawal by Subject|1|||
149162454|NCT02307370|538069537|FG000|Overall Study|Declined Addendum ICF|6|||
148674355|NCT00038467|536279460|FG001|Overall Study|Randomized, but not treated|35|||
148674356|NCT00038467|536279459|FG000|Overall Study|Other|26|||
148674357|NCT00038467|536279460|FG001|Overall Study|Other|28|||
148806083|NCT05595369|536768054|FG000|Overall Study|Physician Decision|1|||
148806084|NCT05595369|536768055|FG001|Overall Study|Physician Decision|0|||
148806085|NCT05595369|536768056|FG002|Overall Study|Physician Decision|0|||
148806086|NCT05595369|536768054|FG000|Overall Study|Withdrawal by Subject|5|||
149162455|NCT02307370|538069537|FG000|Overall Study|No response during telephone contact|5|||
149162456|NCT02307370|538069537|FG000|Overall Study|Protocol Violation|1|||
149162457|NCT01506882|538069538|FG000|Overall Study|Lack of Efficacy|4|||
149162458|NCT01506882|538069539|FG001|Overall Study|Lack of Efficacy|3|||
148674358|NCT01393626|536279461|FG000|Overall Study|Adverse Event|2|||
148674359|NCT01393626|536279462|FG001|Overall Study|Adverse Event|1|||
149162459|NCT01506882|538069538|FG000|Overall Study|Lost to Follow-up|1|||
149162460|NCT01506882|538069539|FG001|Overall Study|Lost to Follow-up|0|||
149162461|NCT01506882|538069538|FG000|Overall Study|Withdrawal by Subject|9|||
149162462|NCT01506882|538069539|FG001|Overall Study|Withdrawal by Subject|3|||
149162463|NCT01506882|538069538|FG000|Overall Study|SAE, non-fatal|2|||
149162464|NCT01506882|538069539|FG001|Overall Study|SAE, non-fatal|0|||
149162465|NCT01506882|538069538|FG000|Overall Study|AE, non-serious non-fatal|3|||
149162466|NCT01506882|538069539|FG001|Overall Study|AE, non-serious non-fatal|1|||
149162467|NCT01506882|538069538|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
149162468|NCT01506882|538069539|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
149162469|NCT01506882|538069538|FG000|Overall Study|Other Reason|2|||
148926309|NCT03553836|537213561|FG000|Overall Study|Lost to Follow-up|1|||
148926310|NCT03553836|537213562|FG001|Overall Study|Lost to Follow-up|3|||
148926311|NCT03553836|537213561|FG000|Overall Study|Death|17|||
148926312|NCT03553836|537213562|FG001|Overall Study|Death|17|||
148926313|NCT03220438|537213563|FG000|Overall Study|Lost to Follow-up|0|||
148926314|NCT03220438|537213564|FG001|Overall Study|Lost to Follow-up|0|||
148926315|NCT03220438|537213565|FG002|Overall Study|Lost to Follow-up|1|||
148926316|NCT03220438|537213566|FG003|Overall Study|Lost to Follow-up|0|||
148926317|NCT04062123|537213567|FG000|Overall Study|Withdrawal by Subject|0|||
148926318|NCT04062123|537213568|FG001|Overall Study|Withdrawal by Subject|1|||
148926319|NCT04062123|537213569|FG002|Overall Study|Withdrawal by Subject|0|||
148926320|NCT01041495|537213572|FG000|Overall Study|Withdrawal by Subject|2|||
148926321|NCT01041495|537213573|FG001|Overall Study|Withdrawal by Subject|5|||
148926322|NCT01041495|537213572|FG000|Overall Study|Adverse Event|2|||
148926323|NCT01041495|537213573|FG001|Overall Study|Adverse Event|1|||
148926324|NCT01041495|537213572|FG000|Overall Study|Lost to Follow-up|0|||
148926325|NCT01041495|537213573|FG001|Overall Study|Lost to Follow-up|1|||
148926326|NCT03584373|537213574|FG000|Overall Study|Lost to Follow-up|7|||
148926327|NCT03584373|537213575|FG001|Overall Study|Lost to Follow-up|8|||
148926328|NCT03780400|537213576|FG000|Overall Study|Lost to Follow-up|5|||
148926329|NCT03780400|537213576|FG000|Overall Study|Withdrawal by Subject|2|||
148926330|NCT01282203|537213580|FG000|Overall Study|Adverse Event|1|||
148926331|NCT00930982|537213583|FG000|Overall Study|Adverse Event|19|||
148926332|NCT00930982|537213584|FG001|Overall Study|Adverse Event|23|||
148926333|NCT00930982|537213583|FG000|Overall Study|Protocol Violation|1|||
148806087|NCT05595369|536768055|FG001|Overall Study|Withdrawal by Subject|7|||
148926334|NCT00930982|537213584|FG001|Overall Study|Protocol Violation|5|||
148926335|NCT00930982|537213583|FG000|Overall Study|Withdrawal by Subject|1|||
148926336|NCT00930982|537213584|FG001|Overall Study|Withdrawal by Subject|1|||
148926337|NCT00991952|537213585|FG000|Overall Study|Adverse Event|0|||
148926338|NCT00991952|537213586|FG001|Overall Study|Adverse Event|1|||
148926339|NCT03452527|537213587|FG000|Overall Study|Withdrawal by Subject|1|||
148926340|NCT03452527|537213588|FG001|Overall Study|Withdrawal by Subject|1|||
148806088|NCT05595369|536768056|FG002|Overall Study|Withdrawal by Subject|6|||
148926341|NCT03452527|537213587|FG000|Overall Study|Study Terminated|2|||
148926342|NCT03452527|537213588|FG001|Overall Study|Study Terminated|3|||
148926343|NCT00582816|537213589|FG000|Overall Study|Engraftment Failure|3|||
148926344|NCT01658813|537213591|FG000|Overall Study|Disease progression|3|||
148926345|NCT00722371|537213593|FG000|Overall Study|Adverse Event|6|||
148926346|NCT00722371|537213594|FG001|Overall Study|Adverse Event|13|||
148926347|NCT00722371|537213595|FG002|Overall Study|Adverse Event|9|||
148926348|NCT00722371|537213596|FG003|Overall Study|Adverse Event|10|||
149162470|NCT01506882|538069539|FG001|Overall Study|Other Reason|0|||
149162471|NCT00667576|538071563|FG000|Overall Study|Withdrawal by Subject|1|||
149162472|NCT00667576|538071564|FG001|Overall Study|Withdrawal by Subject|0|||
149162473|NCT00667576|538071565|FG002|Overall Study|Withdrawal by Subject|1|||
149162474|NCT00667576|538071566|FG003|Overall Study|Withdrawal by Subject|1|||
149162475|NCT00667576|538071567|FG004|Overall Study|Withdrawal by Subject|1|||
149162476|NCT00667576|538071563|FG000|Overall Study|Adverse Event|1|||
149162477|NCT00667576|538071564|FG001|Overall Study|Adverse Event|1|||
149162478|NCT00667576|538071565|FG002|Overall Study|Adverse Event|0|||
149162479|NCT00667576|538071566|FG003|Overall Study|Adverse Event|0|||
149162480|NCT00667576|538071567|FG004|Overall Study|Adverse Event|0|||
149162481|NCT00667576|538071563|FG000|Overall Study|Lost to Follow-up|0|||
149162482|NCT00667576|538071564|FG001|Overall Study|Lost to Follow-up|0|||
149162483|NCT00667576|538071565|FG002|Overall Study|Lost to Follow-up|1|||
149162484|NCT00667576|538071566|FG003|Overall Study|Lost to Follow-up|0|||
149162485|NCT00667576|538071567|FG004|Overall Study|Lost to Follow-up|0|||
149162486|NCT00667576|538071563|FG000|Overall Study|Protocol Violation|0|||
149162487|NCT00667576|538071564|FG001|Overall Study|Protocol Violation|0|||
149162488|NCT00667576|538071565|FG002|Overall Study|Protocol Violation|0|||
149162489|NCT00667576|538071566|FG003|Overall Study|Protocol Violation|1|||
149162490|NCT00667576|538071567|FG004|Overall Study|Protocol Violation|0|||
149162491|NCT00667576|538071563|FG000|Overall Study|Physician Decision|0|||
149162492|NCT00667576|538071564|FG001|Overall Study|Physician Decision|0|||
149162493|NCT00667576|538071565|FG002|Overall Study|Physician Decision|0|||
149162494|NCT00667576|538071566|FG003|Overall Study|Physician Decision|1|||
148926349|NCT00722371|537213597|FG004|Overall Study|Adverse Event|6|||
148926350|NCT00722371|537213598|FG005|Overall Study|Adverse Event|8|||
148926351|NCT00722371|537213599|FG006|Overall Study|Adverse Event|4|||
148926352|NCT00722371|537213593|FG000|Overall Study|Contraindication|0|||
148926353|NCT00722371|537213594|FG001|Overall Study|Contraindication|0|||
148926354|NCT00722371|537213595|FG002|Overall Study|Contraindication|1|||
148926355|NCT00722371|537213596|FG003|Overall Study|Contraindication|0|||
148926356|NCT00722371|537213597|FG004|Overall Study|Contraindication|0|||
148926357|NCT00722371|537213598|FG005|Overall Study|Contraindication|0|||
148926358|NCT00722371|537213599|FG006|Overall Study|Contraindication|0|||
148926359|NCT00722371|537213593|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
148926360|NCT00722371|537213594|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
148926361|NCT00722371|537213595|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
148926362|NCT00722371|537213596|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
148926363|NCT00722371|537213597|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
148926364|NCT00722371|537213598|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
148926365|NCT00722371|537213599|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
148926366|NCT00722371|537213593|FG000|Overall Study|Excluded medication|0|||
148926367|NCT00722371|537213594|FG001|Overall Study|Excluded medication|1|||
148926368|NCT00722371|537213595|FG002|Overall Study|Excluded medication|1|||
148926369|NCT00722371|537213596|FG003|Overall Study|Excluded medication|0|||
148926370|NCT00722371|537213597|FG004|Overall Study|Excluded medication|0|||
148926371|NCT00722371|537213598|FG005|Overall Study|Excluded medication|0|||
148926372|NCT00722371|537213599|FG006|Overall Study|Excluded medication|1|||
148926373|NCT00722371|537213593|FG000|Overall Study|Hyperglycemia|2|||
148926374|NCT00722371|537213594|FG001|Overall Study|Hyperglycemia|6|||
148926375|NCT00722371|537213595|FG002|Overall Study|Hyperglycemia|4|||
148926376|NCT00722371|537213596|FG003|Overall Study|Hyperglycemia|2|||
148926377|NCT00722371|537213597|FG004|Overall Study|Hyperglycemia|5|||
148926378|NCT00722371|537213598|FG005|Overall Study|Hyperglycemia|1|||
148674360|NCT01393626|536279463|FG002|Overall Study|Adverse Event|5|||
148674361|NCT01393626|536279464|FG003|Overall Study|Adverse Event|0|||
148674362|NCT01393626|536279461|FG000|Overall Study|Did not meet entrance criteria|1|||
148674363|NCT01393626|536279462|FG001|Overall Study|Did not meet entrance criteria|0|||
148674364|NCT01393626|536279463|FG002|Overall Study|Did not meet entrance criteria|0|||
148926379|NCT00722371|537213599|FG006|Overall Study|Hyperglycemia|1|||
148926380|NCT00722371|537213593|FG000|Overall Study|Hypoglycemia|1|||
148806089|NCT05595369|536768054|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
148926381|NCT00722371|537213594|FG001|Overall Study|Hypoglycemia|0|||
148926382|NCT00722371|537213595|FG002|Overall Study|Hypoglycemia|0|||
148926383|NCT00722371|537213596|FG003|Overall Study|Hypoglycemia|0|||
148926384|NCT00722371|537213597|FG004|Overall Study|Hypoglycemia|0|||
148926385|NCT00722371|537213598|FG005|Overall Study|Hypoglycemia|0|||
148926386|NCT00722371|537213599|FG006|Overall Study|Hypoglycemia|0|||
148926387|NCT00722371|537213593|FG000|Overall Study|Lack of Efficacy|4|||
148926388|NCT00722371|537213594|FG001|Overall Study|Lack of Efficacy|6|||
148926389|NCT00722371|537213595|FG002|Overall Study|Lack of Efficacy|6|||
148926390|NCT00722371|537213596|FG003|Overall Study|Lack of Efficacy|6|||
148926391|NCT00722371|537213597|FG004|Overall Study|Lack of Efficacy|2|||
148926392|NCT00722371|537213598|FG005|Overall Study|Lack of Efficacy|3|||
148674365|NCT01393626|536279464|FG003|Overall Study|Did not meet entrance criteria|0|||
148926393|NCT00722371|537213599|FG006|Overall Study|Lack of Efficacy|0|||
148926394|NCT00722371|537213593|FG000|Overall Study|Lost to Follow-up|11|||
148926395|NCT00722371|537213594|FG001|Overall Study|Lost to Follow-up|14|||
148926396|NCT00722371|537213595|FG002|Overall Study|Lost to Follow-up|21|||
148926397|NCT00722371|537213596|FG003|Overall Study|Lost to Follow-up|13|||
148926398|NCT00722371|537213597|FG004|Overall Study|Lost to Follow-up|8|||
148926399|NCT00722371|537213598|FG005|Overall Study|Lost to Follow-up|16|||
148926400|NCT00722371|537213599|FG006|Overall Study|Lost to Follow-up|13|||
148926401|NCT00722371|537213593|FG000|Overall Study|Physician Decision|5|||
148926402|NCT00722371|537213594|FG001|Overall Study|Physician Decision|2|||
148926403|NCT00722371|537213595|FG002|Overall Study|Physician Decision|2|||
148926404|NCT00722371|537213596|FG003|Overall Study|Physician Decision|5|||
148926405|NCT00722371|537213597|FG004|Overall Study|Physician Decision|2|||
148926406|NCT00722371|537213598|FG005|Overall Study|Physician Decision|3|||
148926407|NCT00722371|537213599|FG006|Overall Study|Physician Decision|4|||
148926408|NCT00722371|537213593|FG000|Overall Study|Pregnancy|1|||
148926409|NCT00722371|537213594|FG001|Overall Study|Pregnancy|1|||
148926410|NCT00722371|537213595|FG002|Overall Study|Pregnancy|0|||
148926411|NCT00722371|537213596|FG003|Overall Study|Pregnancy|0|||
148926412|NCT00722371|537213597|FG004|Overall Study|Pregnancy|0|||
148926413|NCT00722371|537213598|FG005|Overall Study|Pregnancy|1|||
148926414|NCT00722371|537213599|FG006|Overall Study|Pregnancy|0|||
148926415|NCT00722371|537213593|FG000|Overall Study|Protocol Violation|6|||
148926416|NCT00722371|537213594|FG001|Overall Study|Protocol Violation|1|||
148926417|NCT00722371|537213595|FG002|Overall Study|Protocol Violation|0|||
148926418|NCT00722371|537213596|FG003|Overall Study|Protocol Violation|1|||
148926419|NCT00722371|537213597|FG004|Overall Study|Protocol Violation|4|||
148926420|NCT00722371|537213598|FG005|Overall Study|Protocol Violation|2|||
148926421|NCT00722371|537213599|FG006|Overall Study|Protocol Violation|1|||
148926422|NCT00722371|537213593|FG000|Overall Study|Withdrawal by Subject|18|||
148926423|NCT00722371|537213594|FG001|Overall Study|Withdrawal by Subject|27|||
148926424|NCT00722371|537213595|FG002|Overall Study|Withdrawal by Subject|19|||
148926425|NCT00722371|537213596|FG003|Overall Study|Withdrawal by Subject|23|||
148926426|NCT00722371|537213597|FG004|Overall Study|Withdrawal by Subject|19|||
148926427|NCT00722371|537213598|FG005|Overall Study|Withdrawal by Subject|18|||
148926428|NCT00722371|537213599|FG006|Overall Study|Withdrawal by Subject|26|||
148926429|NCT01075191|537213600|FG000|Overall Study|Death|1|||
148926430|NCT01075191|537213600|FG000|Overall Study|Intensification|3|||
148926431|NCT01075191|537213600|FG000|Overall Study|Co-morbidities|1|||
148926432|NCT01075191|537213600|FG000|Overall Study|Adverse Event|4|||
148926433|NCT01075191|537213600|FG000|Overall Study|Noncompliance|3|||
148926434|NCT01075191|537213600|FG000|Overall Study|Therapy Break|3|||
148926435|NCT01075191|537213600|FG000|Overall Study|Patient's Wish|2|||
148926436|NCT01075191|537213600|FG000|Overall Study|Unknown Reasons|1|||
148926437|NCT00718237|537213605|FG000|Overall Study|Adverse Event|1|||
148926438|NCT00718237|537213606|FG001|Overall Study|Adverse Event|3|||
148926439|NCT00718237|537213605|FG000|Overall Study|Lost to Follow-up|2|||
148926440|NCT00718237|537213606|FG001|Overall Study|Lost to Follow-up|2|||
148926441|NCT00718237|537213605|FG000|Overall Study|Physician Decision|1|||
148926442|NCT00718237|537213606|FG001|Overall Study|Physician Decision|0|||
148926443|NCT00718237|537213605|FG000|Overall Study|Withdrawal by Subject|9|||
148926444|NCT00718237|537213606|FG001|Overall Study|Withdrawal by Subject|10|||
148926445|NCT03324581|537213608|FG000|Overall Study|Adverse Event|18|||
148926446|NCT03324581|537213609|FG001|Overall Study|Adverse Event|11|||
148926447|NCT03324581|537213610|FG002|Overall Study|Adverse Event|7|||
148926448|NCT03324581|537213608|FG000|Overall Study|Lack of Efficacy|0|||
148926449|NCT03324581|537213609|FG001|Overall Study|Lack of Efficacy|1|||
148926450|NCT03324581|537213610|FG002|Overall Study|Lack of Efficacy|0|||
148926451|NCT03324581|537213608|FG000|Overall Study|Lost to Follow-up|5|||
148926452|NCT03324581|537213609|FG001|Overall Study|Lost to Follow-up|3|||
148926453|NCT03324581|537213610|FG002|Overall Study|Lost to Follow-up|6|||
148926454|NCT03324581|537213608|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
148926455|NCT03324581|537213609|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
148926456|NCT03324581|537213610|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
148926457|NCT03324581|537213608|FG000|Overall Study|Physician Decision|0|||
148926458|NCT03324581|537213609|FG001|Overall Study|Physician Decision|1|||
148926459|NCT03324581|537213610|FG002|Overall Study|Physician Decision|2|||
148926460|NCT03324581|537213608|FG000|Overall Study|Protocol Deviation|8|||
148926461|NCT03324581|537213609|FG001|Overall Study|Protocol Deviation|9|||
148926462|NCT03324581|537213610|FG002|Overall Study|Protocol Deviation|4|||
148926463|NCT03324581|537213608|FG000|Overall Study|Withdrawal by Subject|6|||
148926464|NCT03324581|537213609|FG001|Overall Study|Withdrawal by Subject|8|||
148926465|NCT03324581|537213610|FG002|Overall Study|Withdrawal by Subject|6|||
148926466|NCT03324581|537213608|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
148926467|NCT03324581|537213609|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
148926468|NCT03324581|537213610|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
148926469|NCT00321893|537213612|FG000|Overall Study|Non-Compliance/Refusal|16|||
148926470|NCT00321893|537213613|FG001|Overall Study|Non-Compliance/Refusal|10|||
148926471|NCT00321893|537213612|FG000|Overall Study|Lost to Follow-up|2|||
148926472|NCT00321893|537213613|FG001|Overall Study|Lost to Follow-up|1|||
148926473|NCT00321893|537213612|FG000|Overall Study|Adverse Event|6|||
148926474|NCT00321893|537213613|FG001|Overall Study|Adverse Event|3|||
148926475|NCT03455764|537213614|FG000|Overall Study|Adverse Event|1|||
148926476|NCT03455764|537213615|FG001|Overall Study|Adverse Event|0|||
148926477|NCT03455764|537213616|FG002|Overall Study|Adverse Event|0|||
148926478|NCT03455764|537213617|FG003|Overall Study|Adverse Event|0|||
148926479|NCT03455764|537213618|FG004|Overall Study|Adverse Event|0|||
148926480|NCT03455764|537213614|FG000|Overall Study|Disease Progression|4|||
148926481|NCT03455764|537213615|FG001|Overall Study|Disease Progression|0|||
148926482|NCT03455764|537213616|FG002|Overall Study|Disease Progression|0|||
148926483|NCT03455764|537213617|FG003|Overall Study|Disease Progression|0|||
148926484|NCT03455764|537213618|FG004|Overall Study|Disease Progression|0|||
148926485|NCT03455764|537213614|FG000|Overall Study|On Treatment|1|||
148926486|NCT03455764|537213615|FG001|Overall Study|On Treatment|0|||
148926487|NCT03455764|537213616|FG002|Overall Study|On Treatment|0|||
148926488|NCT03455764|537213617|FG003|Overall Study|On Treatment|0|||
148926489|NCT03455764|537213618|FG004|Overall Study|On Treatment|0|||
148926490|NCT01585584|537213624|FG000|Overall Study|Lack of Efficacy|1|||
148926491|NCT01585584|537213624|FG000|Overall Study|Withdrawal by Subject|1|||
148926492|NCT01585584|537213624|FG000|Overall Study|Physician Decision|2|||
148926493|NCT00686998|537213625|FG000|Overall Study|Adverse Event|3|||
148926494|NCT00686998|537213626|FG001|Overall Study|Adverse Event|2|||
148926495|NCT00686998|537213627|FG002|Overall Study|Adverse Event|1|||
149162495|NCT00667576|538071567|FG004|Overall Study|Physician Decision|0|||
148926496|NCT00686998|537213625|FG000|Overall Study|Withdrawal by Subject|2|||
149162496|NCT00667576|538071563|FG000|Overall Study|Missed Visit|0|||
149162497|NCT00667576|538071564|FG001|Overall Study|Missed Visit|0|||
149162498|NCT00667576|538071565|FG002|Overall Study|Missed Visit|0|||
149162499|NCT00667576|538071566|FG003|Overall Study|Missed Visit|1|||
149162500|NCT00667576|538071567|FG004|Overall Study|Missed Visit|0|||
149162501|NCT00778830|538071571|FG000|Overall Study|Ongoing at data cut-off|0|||
149162502|NCT00778830|538071572|FG001|Overall Study|Ongoing at data cut-off|1|||
149162503|NCT01891643|538071573|FG000|Overall Study|Adverse event unrelated to study drug|2|||
149162504|NCT01891643|538071574|FG001|Overall Study|Adverse event unrelated to study drug|5|||
149162505|NCT01891643|538071573|FG000|Overall Study|Disease Progression|4|||
149162506|NCT01891643|538071574|FG001|Overall Study|Disease Progression|3|||
149162507|NCT01891643|538071573|FG000|Overall Study|Study Drug Toxicity|3|||
149162508|NCT01891643|538071574|FG001|Overall Study|Study Drug Toxicity|0|||
149162509|NCT01891643|538071573|FG000|Overall Study|Maximum Clinical Benefit|0|||
149162510|NCT01891643|538071574|FG001|Overall Study|Maximum Clinical Benefit|1|||
149162511|NCT01891643|538071573|FG000|Overall Study|Poor/Non-compliance|0|||
149162512|NCT01891643|538071574|FG001|Overall Study|Poor/Non-compliance|1|||
149162513|NCT01891643|538071573|FG000|Overall Study|Participant request to discontinue|1|||
149162514|NCT01891643|538071574|FG001|Overall Study|Participant request to discontinue|0|||
149162515|NCT01307033|538071578|FG000|8-week Double-blind Period|Adverse Event|2|||
148674366|NCT01393626|536279461|FG000|Overall Study|Lack of Efficacy|6|||
148674367|NCT01393626|536279462|FG001|Overall Study|Lack of Efficacy|6|||
148674368|NCT01393626|536279463|FG002|Overall Study|Lack of Efficacy|4|||
148674369|NCT01393626|536279464|FG003|Overall Study|Lack of Efficacy|1|||
148674370|NCT01393626|536279461|FG000|Overall Study|Lost to Follow-up|1|||
148674371|NCT01393626|536279462|FG001|Overall Study|Lost to Follow-up|1|||
148674372|NCT01393626|536279463|FG002|Overall Study|Lost to Follow-up|1|||
148674373|NCT01393626|536279464|FG003|Overall Study|Lost to Follow-up|0|||
148674374|NCT01393626|536279461|FG000|Overall Study|Withdrawal by Subject|6|||
148674375|NCT01393626|536279462|FG001|Overall Study|Withdrawal by Subject|4|||
148674376|NCT01393626|536279463|FG002|Overall Study|Withdrawal by Subject|0|||
148674377|NCT01393626|536279464|FG003|Overall Study|Withdrawal by Subject|0|||
148674378|NCT01393626|536279461|FG000|Overall Study|Other|1|||
148674379|NCT01393626|536279462|FG001|Overall Study|Other|0|||
148674380|NCT01393626|536279463|FG002|Overall Study|Other|0|||
148674381|NCT01393626|536279464|FG003|Overall Study|Other|0|||
148674382|NCT01393626|536279461|FG000|Overall Study|Protocol Violation|1|||
148674383|NCT01393626|536279462|FG001|Overall Study|Protocol Violation|0|||
148674384|NCT01393626|536279463|FG002|Overall Study|Protocol Violation|2|||
148674385|NCT01393626|536279464|FG003|Overall Study|Protocol Violation|0|||
148674386|NCT02858076|536279465|FG000|Overall Study|Death|6|||
148674387|NCT02858076|536279466|FG001|Overall Study|Death|3|||
148674388|NCT02858076|536279465|FG000|Overall Study|Withdrawal by Subject|1|||
148674389|NCT02858076|536279466|FG001|Overall Study|Withdrawal by Subject|5|||
148674390|NCT02858076|536279465|FG000|Overall Study|Lost to Follow-up|2|||
148674391|NCT02858076|536279466|FG001|Overall Study|Lost to Follow-up|7|||
148674392|NCT02858076|536279465|FG000|Overall Study|Completed Out of Window|1|||
148674393|NCT02858076|536279466|FG001|Overall Study|Completed Out of Window|3|||
148674394|NCT00943384|536279469|FG000|Overall Study|Dispositioned prior to treatment|23|||
148674395|NCT00943384|536279469|FG000|Overall Study|Treated off protocol-protocol violation|5|||
148674396|NCT00943384|536279469|FG000|Overall Study|Lost to Follow-up|16|||
148674397|NCT00943384|536279469|FG000|Overall Study|Withdrawal by Subject|5|||
148674398|NCT00664066|536279478|FG000|Overall Study|Study terminated|3|||
148674399|NCT02575807|536279479|FG000|Overall Study|Death|8|||
148674400|NCT02575807|536279480|FG001|Overall Study|Death|3|||
148674401|NCT02575807|536279481|FG002|Overall Study|Death|7|||
148674402|NCT02575807|536279482|FG003|Overall Study|Death|0|||
148674403|NCT02575807|536279483|FG004|Overall Study|Death|1|||
148674404|NCT02575807|536279479|FG000|Overall Study|Study terminated by Sponsor|0|||
148674405|NCT02575807|536279480|FG001|Overall Study|Study terminated by Sponsor|1|||
148674406|NCT02575807|536279481|FG002|Overall Study|Study terminated by Sponsor|7|||
148674407|NCT02575807|536279482|FG003|Overall Study|Study terminated by Sponsor|0|||
148674408|NCT02575807|536279483|FG004|Overall Study|Study terminated by Sponsor|1|||
148674409|NCT02575807|536279479|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
148674410|NCT02575807|536279480|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
148926497|NCT00686998|537213626|FG001|Overall Study|Withdrawal by Subject|1|||
148926498|NCT00686998|537213627|FG002|Overall Study|Withdrawal by Subject|2|||
148926499|NCT00686998|537213625|FG000|Overall Study|Lack of Efficacy|7|||
148926500|NCT00686998|537213626|FG001|Overall Study|Lack of Efficacy|5|||
148926501|NCT00686998|537213627|FG002|Overall Study|Lack of Efficacy|0|||
148926502|NCT00686998|537213625|FG000|Overall Study|Other|0|||
148926503|NCT00686998|537213626|FG001|Overall Study|Other|0|||
148926504|NCT00686998|537213627|FG002|Overall Study|Other|1|||
148926505|NCT00686998|537213625|FG000|Overall Study|Safety Reasons|1|||
148926506|NCT00686998|537213626|FG001|Overall Study|Safety Reasons|0|||
148926507|NCT00686998|537213627|FG002|Overall Study|Safety Reasons|0|||
148926508|NCT05985980|537213628|FG000|Overall Study|Withdrawal by Subject|1|||
148926509|NCT05985980|537213628|FG000|Overall Study|Withdrawal by Subject|1|||
148926510|NCT05985980|537213628|FG000|Overall Study|Withdrawal by Subject|1|||
148926511|NCT05985980|537213628|FG000|Overall Study|Withdrawal by Subject|1|||
148926512|NCT04285580|537215367|FG000|Overall Study|Protocol Violation|0|||
148926513|NCT04285580|537215368|FG001|Overall Study|Protocol Violation|1|||
148926514|NCT02582255|537215369|FG000|Overall Study|Protocol Violation|0|||
148926515|NCT02582255|537215370|FG001|Overall Study|Protocol Violation|3|||
148926516|NCT04854642|537215371|FG000|Overall Study|Adverse Event|1|||
148926517|NCT04854642|537215372|FG001|Overall Study|Adverse Event|2|||
148926518|NCT04854642|537215371|FG000|Overall Study|Withdrawal by Subject|0|||
148926519|NCT04854642|537215372|FG001|Overall Study|Withdrawal by Subject|1|||
148674411|NCT02575807|536279481|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
148674412|NCT02575807|536279482|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
148674413|NCT02575807|536279483|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
148674414|NCT02575807|536279479|FG000|Overall Study|Terminated due to physician decision|0|||
148674415|NCT02575807|536279480|FG001|Overall Study|Terminated due to physician decision|0|||
148674416|NCT02575807|536279481|FG002|Overall Study|Terminated due to physician decision|1|||
148674417|NCT02575807|536279482|FG003|Overall Study|Terminated due to physician decision|0|||
148674418|NCT02575807|536279483|FG004|Overall Study|Terminated due to physician decision|0|||
148926520|NCT01709578|537215375|FG000|Overall Study|Rescued and entered in long term safety|63|||
148926521|NCT01709578|537215376|FG001|Overall Study|Rescued and entered in long term safety|25|||
148926522|NCT01709578|537215377|FG002|Overall Study|Rescued and entered in long term safety|26|||
148674419|NCT02575807|536279479|FG000|Overall Study|Subject ineligible - medical implant|0|||
148674420|NCT02575807|536279480|FG001|Overall Study|Subject ineligible - medical implant|0|||
148674421|NCT02575807|536279481|FG002|Overall Study|Subject ineligible - medical implant|0|||
148674422|NCT02575807|536279482|FG003|Overall Study|Subject ineligible - medical implant|1|||
148674423|NCT02575807|536279483|FG004|Overall Study|Subject ineligible - medical implant|0|||
148674424|NCT02575807|536279479|FG000|Overall Study|Withdrawal by Subject|0|||
148674425|NCT02575807|536279480|FG001|Overall Study|Withdrawal by Subject|0|||
148674426|NCT02575807|536279481|FG002|Overall Study|Withdrawal by Subject|1|||
148674427|NCT02575807|536279482|FG003|Overall Study|Withdrawal by Subject|1|||
148674428|NCT02575807|536279483|FG004|Overall Study|Withdrawal by Subject|2|||
148674429|NCT02180659|536279484|FG000|Overall Study|Adverse Event|1|||
148674430|NCT02180659|536279485|FG001|Overall Study|Adverse Event|0|||
148674431|NCT02180659|536279484|FG000|Overall Study|Lost to Follow-up|4|||
148926523|NCT01709578|537215375|FG000|Overall Study|Adverse Event|9|||
148926524|NCT01709578|537215376|FG001|Overall Study|Adverse Event|18|||
148926525|NCT01709578|537215377|FG002|Overall Study|Adverse Event|17|||
148926526|NCT01709578|537215375|FG000|Overall Study|Lack of Efficacy|5|||
148926527|NCT01709578|537215376|FG001|Overall Study|Lack of Efficacy|4|||
148926528|NCT01709578|537215377|FG002|Overall Study|Lack of Efficacy|2|||
148926529|NCT01709578|537215375|FG000|Overall Study|Poor compliance to protocol|1|||
148926530|NCT01709578|537215376|FG001|Overall Study|Poor compliance to protocol|2|||
148926531|NCT01709578|537215377|FG002|Overall Study|Poor compliance to protocol|1|||
148674432|NCT02180659|536279485|FG001|Overall Study|Lost to Follow-up|2|||
148674433|NCT02180659|536279484|FG000|Overall Study|Subject incarcerated during conduct|1|||
148674434|NCT02180659|536279485|FG001|Overall Study|Subject incarcerated during conduct|0|||
148674435|NCT02180659|536279484|FG000|Overall Study|Withdrawal by Subject|0|||
148674436|NCT02180659|536279485|FG001|Overall Study|Withdrawal by Subject|2|||
148674437|NCT02180659|536279484|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
148674438|NCT02180659|536279485|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
148674439|NCT03000075|536279486|FG000|Part A|Adverse Event|4|||
148674440|NCT03000075|536279487|FG001|Part A|Adverse Event|0|||
148674441|NCT03000075|536279488|FG002|Part A|Adverse Event|0|||
148674442|NCT03000075|536279489|FG003|Part A|Adverse Event|0|||
148674443|NCT03000075|536279490|FG004|Part A|Adverse Event|0|||
148674444|NCT03000075|536279491|FG005|Part A|Adverse Event|0|||
148674445|NCT03000075|536279492|FG006|Part A|Adverse Event|0|||
148674446|NCT03000075|536279486|FG000|Part B|Not dosed due to AE|0|||
148674447|NCT03000075|536279487|FG001|Part B|Not dosed due to AE|0|||
148674448|NCT03000075|536279488|FG002|Part B|Not dosed due to AE|0|||
148674449|NCT03000075|536279489|FG003|Part B|Not dosed due to AE|0|||
148674450|NCT03000075|536279490|FG004|Part B|Not dosed due to AE|0|||
148674451|NCT03000075|536279491|FG005|Part B|Not dosed due to AE|2|||
148674452|NCT03000075|536279492|FG006|Part B|Not dosed due to AE|1|||
148674453|NCT03000075|536279486|FG000|Part B|Adverse Event|0|||
148674454|NCT03000075|536279487|FG001|Part B|Adverse Event|0|||
148674455|NCT03000075|536279488|FG002|Part B|Adverse Event|0|||
148674456|NCT03000075|536279489|FG003|Part B|Adverse Event|0|||
148674457|NCT03000075|536279490|FG004|Part B|Adverse Event|1|||
148674458|NCT03000075|536279491|FG005|Part B|Adverse Event|0|||
148674459|NCT03000075|536279492|FG006|Part B|Adverse Event|0|||
148674460|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
148674461|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
148674462|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Death|5|||
148674463|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Death|2|||
148674464|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
148674465|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
148674466|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
148674467|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
148674468|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
148674469|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
148674470|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Relapse|1|||
148674471|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Relapse|0|||
148926532|NCT01709578|537215375|FG000|Overall Study|Other, not related to safety or efficacy|2|||
148926533|NCT01709578|537215376|FG001|Overall Study|Other, not related to safety or efficacy|7|||
148926534|NCT01709578|537215377|FG002|Overall Study|Other, not related to safety or efficacy|5|||
148674472|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
148674473|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
148674474|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
148674475|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
148674476|NCT00111007|536279493|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
148926535|NCT04050371|537215378|FG000|Overall Study|Withdrawal by Subject|1|||
148926536|NCT04050371|537215379|FG001|Overall Study|Withdrawal by Subject|0|||
148674477|NCT00111007|536279494|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
148674478|NCT00111007|536279493|FG000|Active Follow-up|Adverse Event|1|||
148926537|NCT01107418|537215380|FG000|Overall Study|Disease Progression|45|||
148674479|NCT00111007|536279494|FG001|Active Follow-up|Adverse Event|0|||
148674480|NCT00111007|536279493|FG000|Active Follow-up|Death|2|||
148674481|NCT00111007|536279494|FG001|Active Follow-up|Death|0|||
148674482|NCT00111007|536279493|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
148674483|NCT00111007|536279494|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
148674484|NCT00111007|536279493|FG000|Long Term Follow-up|Death|34|||
148674485|NCT00111007|536279494|FG001|Long Term Follow-up|Death|39|||
148674486|NCT00111007|536279493|FG000|Long Term Follow-up|Lost to Follow-up|1|||
148674487|NCT00111007|536279494|FG001|Long Term Follow-up|Lost to Follow-up|1|||
148674488|NCT00111007|536279493|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
148674489|NCT00111007|536279494|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
148674490|NCT00111007|536279493|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
148674491|NCT00111007|536279494|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
148674492|NCT00111007|536279493|FG000|Long Term Follow-up|Missing|10|||
148674493|NCT00111007|536279494|FG001|Long Term Follow-up|Missing|3|||
148674494|NCT01495793|536279495|FG000|Overall Study|Lost to Follow-up|1|||
148674495|NCT01495793|536279495|FG000|Overall Study|Violation of inclusion criteria|1|||
148674496|NCT01154673|536279501|FG000|Overall Study|Lost to Follow-up|1|||
148674497|NCT01154673|536279502|FG001|Overall Study|Lost to Follow-up|0|||
148674498|NCT01154673|536279501|FG000|Overall Study|moved out of province|1|||
148674499|NCT01154673|536279502|FG001|Overall Study|moved out of province|0|||
148674500|NCT00478673|536279503|FG000|30-Days Post-Procedure|Death|2|||
148674501|NCT00478673|536279503|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
148674502|NCT00478673|536279503|FG000|30-Days Post-Procedure|Missed Visit|7|||
148674503|NCT00478673|536279503|FG000|12-Months Post-Procedure|Death|23|||
148674504|NCT00478673|536279503|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
148674505|NCT00478673|536279503|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
148674506|NCT00478673|536279503|FG000|12-Months Post-Procedure|Missed Visit|25|||
148674507|NCT00478673|536279503|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
148674508|NCT03083639|536279505|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
148674509|NCT03083639|536279506|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
148674510|NCT03083639|536279505|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
148674511|NCT03083639|536279506|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
148674512|NCT01216319|536279513|FG000|Overall Study|Lost to Follow-up|2|||
148674513|NCT01216319|536279513|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
148674514|NCT03611751|536279514|FG000|Pre-treatment|Randomized but not treated|1|||
148674515|NCT03611751|536279515|FG001|Pre-treatment|Randomized but not treated|1|||
148674516|NCT03611751|536279516|FG002|Pre-treatment|Randomized but not treated|0|||
148674517|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
148674518|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
148674519|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
148674520|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
148674521|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
148674522|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
148674523|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
148674524|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
148674525|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
148674526|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
148674527|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
148674528|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
148674529|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
148674530|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
148674531|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
148674532|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
148674533|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
148926538|NCT01107418|537215380|FG000|Overall Study|Adverse Event|3|||
148926539|NCT01107418|537215380|FG000|Overall Study|Withdrawal by Subject|1|||
148926540|NCT01107418|537215380|FG000|Overall Study|Study Closing|1|||
148926541|NCT01107418|537215380|FG000|Overall Study|Started Other Therapy|1|||
148926542|NCT01107418|537215380|FG000|Overall Study|Entered Extension Study|1|||
148926543|NCT00597701|537215381|FG000|Overall Study|Withdrawal by Subject|5|||
148926544|NCT00597701|537215382|FG001|Overall Study|Withdrawal by Subject|5|||
148674534|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
148926545|NCT00597701|537215381|FG000|Overall Study|Death|0|||
148926546|NCT00597701|537215382|FG001|Overall Study|Death|1|||
148926547|NCT00597701|537215381|FG000|Overall Study|Physician Decision|2|||
148674535|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
148674536|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
148674537|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
148674538|NCT03611751|536279514|FG000|Treatment Week 0 - Week 16|Death|0|||
148674539|NCT03611751|536279515|FG001|Treatment Week 0 - Week 16|Death|0|||
148674540|NCT03611751|536279516|FG002|Treatment Week 0 - Week 16|Death|1|||
148926548|NCT00597701|537215382|FG001|Overall Study|Physician Decision|0|||
148674541|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
148674542|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
148674543|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
148674544|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
148674545|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
148674546|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
148674547|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
148674548|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
148674549|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
148674550|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
148674551|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
148674552|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
148674553|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
148674554|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
148674555|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
148674556|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
148674557|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
148674558|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
148674559|NCT03611751|536279514|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
148674560|NCT03611751|536279515|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
148674561|NCT03611751|536279516|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
148674562|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
148674563|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
148674564|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
148674565|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
148674566|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
148674567|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
148674568|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
148674569|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
148674570|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
148674571|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
148674572|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
148674573|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
148674574|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
148674575|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
148674576|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
148674577|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
148674578|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
148674579|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
148674580|NCT03611751|536279514|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
148674581|NCT03611751|536279515|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
148674582|NCT03611751|536279516|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
148674583|NCT00929864|536279517|FG000|Overall Study|Death|1|||
148674584|NCT00929864|536279518|FG001|Overall Study|Death|1|||
148674585|NCT00929864|536279517|FG000|Overall Study|Adverse Event|11|||
148674586|NCT00929864|536279518|FG001|Overall Study|Adverse Event|30|||
148674587|NCT00929864|536279517|FG000|Overall Study|Lack of Efficacy|19|||
148674588|NCT00929864|536279518|FG001|Overall Study|Lack of Efficacy|16|||
148674589|NCT00929864|536279517|FG000|Overall Study|Lost to Follow-up|7|||
148806090|NCT05595369|536768055|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
148806091|NCT05595369|536768056|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
148806092|NCT05595369|536768054|FG000|Overall Study|Study Drug Non-compliance|0|||
148806093|NCT05595369|536768055|FG001|Overall Study|Study Drug Non-compliance|1|||
148806094|NCT05595369|536768056|FG002|Overall Study|Study Drug Non-compliance|0|||
148806095|NCT05595369|536768054|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
148806096|NCT05595369|536768055|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
148806097|NCT05595369|536768056|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
148806098|NCT04530552|536768060|FG000|Overall Study|Physician Decision|0|||
148806099|NCT04530552|536768061|FG001|Overall Study|Physician Decision|1|||
148806100|NCT04530552|536768060|FG000|Overall Study|Withdrawal by Subject|0|||
148806101|NCT04530552|536768061|FG001|Overall Study|Withdrawal by Subject|1|||
148806102|NCT04530552|536768060|FG000|Overall Study|Adverse Event|0|||
148806103|NCT04530552|536768061|FG001|Overall Study|Adverse Event|1|||
148806104|NCT04530552|536768060|FG000|Overall Study|No surgery|0|||
148806105|NCT04530552|536768061|FG001|Overall Study|No surgery|1|||
148806106|NCT03025035|536768075|FG000|Overall Study|Death|2|||
148806107|NCT03025035|536768075|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
148806108|NCT05063448|536768078|FG000|Overall Study|Withdrawal by Subject|1|||
148926549|NCT00597701|537215381|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
148926550|NCT00597701|537215382|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
148926551|NCT01155219|537215386|FG000|Overall Study|Adverse Event|3|||
148806113|NCT04004000|536768084|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
148806114|NCT06121609|536768085|FG000|Overall Study|Lack of Efficacy|0|||
148806115|NCT06121609|536768086|FG001|Overall Study|Lack of Efficacy|0|||
148926552|NCT01155219|537215387|FG001|Overall Study|Adverse Event|1|||
148926553|NCT01155219|537215386|FG000|Overall Study|non-medical reason|1|||
148926554|NCT01155219|537215387|FG001|Overall Study|non-medical reason|2|||
148926555|NCT01314911|537215389|FG000|Overall Study|Lost to Follow-up|3|||
148926556|NCT01314911|537215390|FG001|Overall Study|Lost to Follow-up|2|||
148926557|NCT01314911|537215389|FG000|Overall Study|Withdrawal by Subject|1|||
148926558|NCT01314911|537215390|FG001|Overall Study|Withdrawal by Subject|3|||
148926559|NCT01314911|537215389|FG000|Overall Study|Received Non-randomized Study Drug|0|||
148926560|NCT01314911|537215390|FG001|Overall Study|Received Non-randomized Study Drug|1|||
148926561|NCT01314911|537215389|FG000|Overall Study|Never Started Treatment|1|||
149162516|NCT01307033|538071579|FG001|8-week Double-blind Period|Adverse Event|0|||
149162517|NCT01307033|538071580|FG002|8-week Double-blind Period|Adverse Event|0|||
149162518|NCT01307033|538071581|FG003|8-week Double-blind Period|Adverse Event|0|||
149162519|NCT01307033|538071578|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
149162520|NCT01307033|538071579|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
149162521|NCT01307033|538071580|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
149162522|NCT01307033|538071581|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
149162523|NCT01307033|538071578|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
149162524|NCT01307033|538071579|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
149162525|NCT01307033|538071580|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
149162526|NCT01307033|538071581|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
149162527|NCT01307033|538071578|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
149162528|NCT01307033|538071579|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
149162529|NCT01307033|538071580|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
149162530|NCT01307033|538071581|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
148806116|NCT06121609|536768087|FG002|Overall Study|Lack of Efficacy|45|||
148926562|NCT01314911|537215390|FG001|Overall Study|Never Started Treatment|0|||
149162531|NCT01307033|538071578|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
149162532|NCT01307033|538071579|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
148806117|NCT06494761|536768088|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
148806118|NCT06494761|536768088|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
148806119|NCT04865289|536768090|FG000|Overall Study|Death|34|||
148806120|NCT04865289|536768091|FG001|Overall Study|Death|25|||
148806121|NCT04865289|536768090|FG000|Overall Study|Physician Decision|27|||
148806122|NCT04865289|536768091|FG001|Overall Study|Physician Decision|27|||
148806123|NCT04865289|536768090|FG000|Overall Study|Sponsor Decision|11|||
148806124|NCT04865289|536768091|FG001|Overall Study|Sponsor Decision|1|||
148806125|NCT04865289|536768090|FG000|Overall Study|Withdrawal by Subject|2|||
148806126|NCT04865289|536768091|FG001|Overall Study|Withdrawal by Subject|3|||
148806127|NCT03210714|536768092|FG000|Overall Study|Adverse Event|6|||
148806128|NCT03210714|536768092|FG000|Overall Study|Physician Decision|1|||
148806129|NCT03210714|536768092|FG000|Overall Study|Progressive disease|11|||
148806130|NCT03210714|536768092|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
148806131|NCT02867592|536768093|FG000|Overall Study|Adverse Event|3|||
148806132|NCT02867592|536768094|FG001|Overall Study|Adverse Event|0|||
148806133|NCT02867592|536768095|FG002|Overall Study|Adverse Event|2|||
148674590|NCT00929864|536279518|FG001|Overall Study|Lost to Follow-up|12|||
148674591|NCT00929864|536279517|FG000|Overall Study|Withdrawal by Subject|20|||
148674592|NCT00929864|536279518|FG001|Overall Study|Withdrawal by Subject|9|||
148674593|NCT00929864|536279517|FG000|Overall Study|No longer met criteria|2|||
148674594|NCT00929864|536279518|FG001|Overall Study|No longer met criteria|1|||
148674595|NCT00929864|536279517|FG000|Overall Study|Poor or non-compliance|3|||
148674596|NCT00929864|536279518|FG001|Overall Study|Poor or non-compliance|3|||
148674597|NCT00929864|536279517|FG000|Overall Study|Pregnancy|0|||
148674598|NCT00929864|536279518|FG001|Overall Study|Pregnancy|3|||
148674599|NCT00929864|536279517|FG000|Overall Study|Administrative reason by Sponsor|1|||
148674600|NCT00929864|536279518|FG001|Overall Study|Administrative reason by Sponsor|1|||
148674601|NCT00929864|536279517|FG000|Overall Study|Non-specified|2|||
148674602|NCT00929864|536279518|FG001|Overall Study|Non-specified|7|||
148674603|NCT03940742|536279521|FG000|Overall Study|Lost to Follow-up|0|||
148674604|NCT03940742|536279522|FG001|Overall Study|Lost to Follow-up|0|||
148674605|NCT03940742|536279523|FG002|Overall Study|Lost to Follow-up|0|||
148674606|NCT03940742|536279524|FG003|Overall Study|Lost to Follow-up|1|||
148674607|NCT03428217|536279525|FG000|Overall Study|Death|89|||
148674608|NCT03428217|536279526|FG001|Overall Study|Death|93|||
148674609|NCT03428217|536279525|FG000|Overall Study|Withdrawal by Subject|8|||
148674610|NCT03428217|536279526|FG001|Overall Study|Withdrawal by Subject|7|||
148674611|NCT03428217|536279525|FG000|Overall Study|Lost to Follow-up|1|||
148674612|NCT03428217|536279526|FG001|Overall Study|Lost to Follow-up|3|||
148674613|NCT03428217|536279525|FG000|Overall Study|Study terminated by sponsor|124|||
148674614|NCT03428217|536279526|FG001|Overall Study|Study terminated by sponsor|118|||
148674615|NCT03428217|536279525|FG000|Overall Study|Other, Not Specified|1|||
148674616|NCT03428217|536279526|FG001|Overall Study|Other, Not Specified|0|||
148674617|NCT03889197|536279527|FG000|Overall Study|Withdrawal by Subject|1|||
148674618|NCT03889197|536279528|FG001|Overall Study|Withdrawal by Subject|0|||
148674619|NCT03889197|536279527|FG000|Overall Study|Physician Decision|0|||
148674620|NCT03889197|536279528|FG001|Overall Study|Physician Decision|1|||
148674621|NCT03889197|536279527|FG000|Overall Study|met exclusion criteria|0|||
148674622|NCT03889197|536279528|FG001|Overall Study|met exclusion criteria|1|||
148674623|NCT03889197|536279527|FG000|Overall Study|Protocol Violation|1|||
148674624|NCT03889197|536279528|FG001|Overall Study|Protocol Violation|0|||
148674625|NCT00621309|536279529|FG000|Overall Study|Withdrawal by Subject|2|||
148674626|NCT00621309|536279530|FG001|Overall Study|Withdrawal by Subject|0|||
148674627|NCT00621309|536279531|FG002|Overall Study|Withdrawal by Subject|1|||
148674628|NCT00621309|536279532|FG003|Overall Study|Withdrawal by Subject|1|||
148674629|NCT00621309|536279533|FG004|Overall Study|Withdrawal by Subject|1|||
148674630|NCT00621309|536279534|FG005|Overall Study|Withdrawal by Subject|1|||
148674631|NCT05246111|536279535|FG000|Period 01|NOT ELIGIBLE IC5|1|||
148674632|NCT05246111|536279536|FG001|Period 01|NOT ELIGIBLE IC5|0|||
148674633|NCT01329562|536279539|FG000|Overall Study|Protocol Violation|5|||
148674634|NCT01329562|536279540|FG001|Overall Study|Protocol Violation|3|||
148674635|NCT01329562|536279539|FG000|Overall Study|Lost to Follow-up|1|||
148674636|NCT01329562|536279540|FG001|Overall Study|Lost to Follow-up|1|||
148674637|NCT01329562|536279539|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
148674638|NCT01329562|536279540|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
148674639|NCT01329562|536279539|FG000|Overall Study|Physician Decision|0|||
148674640|NCT01329562|536279540|FG001|Overall Study|Physician Decision|1|||
149162533|NCT01307033|538071580|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
149162534|NCT01307033|538071581|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
148674641|NCT03151226|536279541|FG000|Overall Study|Withdrawal by Subject|2|||
148674642|NCT03151226|536279541|FG000|Overall Study|not wear device correctly|1|||
148674643|NCT00061568|536279542|FG000|Overall Study|Lost to Follow-up|12|||
148674644|NCT00061568|536279543|FG001|Overall Study|Lost to Follow-up|0|||
148674645|NCT00061568|536279542|FG000|Overall Study|Death|6|||
148806134|NCT02867592|536768096|FG003|Overall Study|Adverse Event|1|||
148674646|NCT00061568|536279543|FG001|Overall Study|Death|0|||
148806135|NCT02867592|536768097|FG004|Overall Study|Adverse Event|1|||
148926563|NCT04478123|537215395|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
148926564|NCT04478123|537215395|FG000|Overall Study|NE|1|||
148926565|NCT02395016|537215396|FG000|Overall Study|Adverse Event|4|||
148926566|NCT02395016|537215397|FG001|Overall Study|Adverse Event|3|||
148926567|NCT02395016|537215396|FG000|Overall Study|Withdrawal by Subject|9|||
148926568|NCT02395016|537215397|FG001|Overall Study|Withdrawal by Subject|6|||
148926569|NCT02395016|537215396|FG000|Overall Study|Protocol Violation|2|||
148926570|NCT02395016|537215397|FG001|Overall Study|Protocol Violation|3|||
148926571|NCT04444895|537215398|FG000|Overall Study|Adverse Event|2|||
148926572|NCT04444895|537215398|FG000|Overall Study|Lost to Follow-up|2|||
148926573|NCT04444895|537215398|FG000|Overall Study|Withdrawal by Subject|5|||
148926574|NCT01547780|537215399|FG000|Baseline PET Scan|Physician Decision|1|||
148926575|NCT01547780|537215400|FG001|Baseline PET Scan|Physician Decision|0|||
148926576|NCT01547780|537215401|FG002|Baseline PET Scan|Physician Decision|1|||
148926577|NCT01547780|537215402|FG003|Baseline PET Scan|Physician Decision|0|||
148926578|NCT01547780|537215399|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
148926579|NCT01547780|537215400|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
148926580|NCT01547780|537215401|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
148926581|NCT01547780|537215402|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
148926582|NCT00719264|537215403|FG000|Overall Study|Adverse Event|41|||
148926583|NCT00719264|537215404|FG001|Overall Study|Adverse Event|49|||
148926584|NCT00719264|537215403|FG000|Overall Study|Death|13|||
148926585|NCT00719264|537215404|FG001|Overall Study|Death|10|||
148926586|NCT00719264|537215403|FG000|Overall Study|Administrative Problems|6|||
148926587|NCT00719264|537215404|FG001|Overall Study|Administrative Problems|4|||
148926588|NCT00719264|537215403|FG000|Overall Study|Lost to Follow-up|1|||
148926589|NCT00719264|537215404|FG001|Overall Study|Lost to Follow-up|1|||
148926590|NCT00719264|537215403|FG000|Overall Study|Withdrawal by Subject|12|||
148926591|NCT00719264|537215404|FG001|Overall Study|Withdrawal by Subject|7|||
148926592|NCT00719264|537215403|FG000|Overall Study|Protocol Deviation|1|||
148926593|NCT00719264|537215404|FG001|Overall Study|Protocol Deviation|3|||
148926594|NCT00719264|537215403|FG000|Overall Study|New Cancer Therapy|4|||
148926595|NCT00719264|537215404|FG001|Overall Study|New Cancer Therapy|2|||
149162535|NCT01307033|538071578|FG000|44-week Open-label Extension|Adverse Event|0|||
148926596|NCT00719264|537215403|FG000|Overall Study|Disease Progression|104|||
148926597|NCT00719264|537215404|FG001|Overall Study|Disease Progression|107|||
148926598|NCT00814879|537215406|FG000|By Week 24|Cancer Diagnosis|1|||
148926599|NCT00814879|537215407|FG001|By Week 24|Cancer Diagnosis|0|||
148926600|NCT00814879|537215406|FG000|By Week 24|Incarceration|0|||
148926601|NCT00814879|537215407|FG001|By Week 24|Incarceration|1|||
149162536|NCT01307033|538071579|FG001|44-week Open-label Extension|Adverse Event|0|||
149162537|NCT01307033|538071580|FG002|44-week Open-label Extension|Adverse Event|2|||
149162538|NCT01307033|538071581|FG003|44-week Open-label Extension|Adverse Event|1|||
148926602|NCT00814879|537215406|FG000|By Week 48|Lost to Follow-up|2|||
148926603|NCT00814879|537215407|FG001|By Week 48|Lost to Follow-up|2|||
148926604|NCT00814879|537215406|FG000|By Week 48|Death|0|||
148926605|NCT00814879|537215407|FG001|By Week 48|Death|1|||
148926606|NCT00588952|537215408|FG000|Overall Study|Adverse Event|0|||
149162539|NCT01307033|538071578|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
149162540|NCT01307033|538071579|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
149162541|NCT01307033|538071580|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
149162542|NCT01307033|538071581|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
149162543|NCT01307033|538071578|FG000|44-week Open-label Extension|Physician Decision|0|||
149162544|NCT01307033|538071579|FG001|44-week Open-label Extension|Physician Decision|0|||
149162545|NCT01307033|538071580|FG002|44-week Open-label Extension|Physician Decision|1|||
149162546|NCT01307033|538071581|FG003|44-week Open-label Extension|Physician Decision|0|||
149162547|NCT01307033|538071578|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
149162548|NCT01307033|538071579|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
149162549|NCT01307033|538071580|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
149162550|NCT01307033|538071581|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
149162551|NCT01307033|538071578|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
149162552|NCT01307033|538071579|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
149162553|NCT01307033|538071580|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
149162554|NCT01307033|538071581|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
149162555|NCT01307033|538071578|FG000|44-week Open-label Extension|Death|0|||
149162556|NCT01307033|538071579|FG001|44-week Open-label Extension|Death|0|||
149162557|NCT01307033|538071580|FG002|44-week Open-label Extension|Death|0|||
149162558|NCT01307033|538071581|FG003|44-week Open-label Extension|Death|1|||
149162559|NCT01400932|538071584|FG000|Overall Study|Adverse Event|10|||
148926607|NCT00588952|537215409|FG001|Overall Study|Adverse Event|2|||
148926608|NCT00588952|537215408|FG000|Overall Study|Withdrawal by Subject|3|||
148926609|NCT00588952|537215409|FG001|Overall Study|Withdrawal by Subject|5|||
148926610|NCT01277042|537215410|FG000|Overall Study|Adverse Event|4|||
148926611|NCT01277042|537215411|FG001|Overall Study|Adverse Event|3|||
148926612|NCT01277042|537215410|FG000|Overall Study|Lost to Follow-up|2|||
148926613|NCT01277042|537215411|FG001|Overall Study|Lost to Follow-up|2|||
148926614|NCT01277042|537215410|FG000|Overall Study|Withdrawal by Subject|2|||
148926615|NCT01277042|537215411|FG001|Overall Study|Withdrawal by Subject|0|||
148926616|NCT01461057|537215412|FG000|Overall Study|Death|10|||
148926617|NCT01461057|537215413|FG001|Overall Study|Death|9|||
148926618|NCT01461057|537215412|FG000|Overall Study|Withdrawal by Subject|2|||
148926619|NCT01461057|537215413|FG001|Overall Study|Withdrawal by Subject|3|||
148926620|NCT01461057|537215412|FG000|Overall Study|Physician Decision|0|||
148926621|NCT01461057|537215413|FG001|Overall Study|Physician Decision|2|||
148926622|NCT01461057|537215412|FG000|Overall Study|Adverse Event|0|||
148926623|NCT01461057|537215413|FG001|Overall Study|Adverse Event|1|||
148926624|NCT01461057|537215412|FG000|Overall Study|Progression of Disease|1|||
148926625|NCT01461057|537215413|FG001|Overall Study|Progression of Disease|0|||
148926626|NCT01461057|537215412|FG000|Overall Study|Study Terminated by Sponsor|2|||
148926627|NCT01461057|537215413|FG001|Overall Study|Study Terminated by Sponsor|0|||
148926628|NCT03034200|537215414|FG000|Overall Study|Disease progression|8|||
148926629|NCT03034200|537215415|FG001|Overall Study|Disease progression|10|||
148926630|NCT03034200|537215416|FG002|Overall Study|Disease progression|4|||
148926631|NCT03034200|537215414|FG000|Overall Study|Physician Decision|2|||
148926632|NCT03034200|537215415|FG001|Overall Study|Physician Decision|0|||
148926633|NCT03034200|537215416|FG002|Overall Study|Physician Decision|3|||
148926634|NCT03034200|537215414|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
148926635|NCT03034200|537215415|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
148926636|NCT03034200|537215416|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
148926637|NCT03034200|537215414|FG000|Overall Study|Adjuvant Therapy|0|||
148926638|NCT03034200|537215415|FG001|Overall Study|Adjuvant Therapy|0|||
148926639|NCT03034200|537215416|FG002|Overall Study|Adjuvant Therapy|1|||
148926640|NCT01288976|537215417|FG000|Overall Study|Withdrawal by Subject|58|||
148926641|NCT01288976|537215418|FG001|Overall Study|Withdrawal by Subject|12|||
148926642|NCT01288976|537215419|FG002|Overall Study|Withdrawal by Subject|9|||
148926643|NCT01288976|537215417|FG000|Overall Study|Death|98|||
148926644|NCT01288976|537215418|FG001|Overall Study|Death|6|||
148926645|NCT01288976|537215419|FG002|Overall Study|Death|4|||
148926646|NCT01288976|537215417|FG000|Overall Study|Data unavailable|22|||
148926647|NCT01288976|537215418|FG001|Overall Study|Data unavailable|9|||
148926648|NCT01288976|537215419|FG002|Overall Study|Data unavailable|7|||
148926649|NCT01736657|537215420|FG000|Overall Study|insufficient vascular access|1|||
148926650|NCT00642473|537215429|FG000|Overall Study|Withdrawal by Subject|0|||
148926651|NCT00642473|537215430|FG001|Overall Study|Withdrawal by Subject|5|||
148926652|NCT00642473|537215429|FG000|Overall Study|Progression or death|2|||
148674647|NCT00061568|536279542|FG000|Overall Study|Withdrawal by Subject|1|||
148674648|NCT00061568|536279543|FG001|Overall Study|Withdrawal by Subject|0|||
148674649|NCT02061293|536279553|FG000|Overall Study|Elevated Blood Pressure|1|||
148674650|NCT02061293|536279554|FG001|Overall Study|Elevated Blood Pressure|1|||
148674651|NCT00483717|536279555|FG000|Overall Study|Protocol Violation|5|||
148674652|NCT00483717|536279556|FG001|Overall Study|Protocol Violation|7|||
148674653|NCT00483717|536279555|FG000|Overall Study|Time of dosing missing|1|||
148674654|NCT00483717|536279556|FG001|Overall Study|Time of dosing missing|1|||
148674655|NCT00483717|536279555|FG000|Overall Study|No treatment for migraine|16|||
148674656|NCT00483717|536279556|FG001|Overall Study|No treatment for migraine|13|||
148674657|NCT00483717|536279555|FG000|Overall Study|Lost to Follow-up|1|||
148926653|NCT00642473|537215430|FG001|Overall Study|Progression or death|4|||
148926654|NCT00642473|537215429|FG000|Overall Study|Other|2|||
148926655|NCT00642473|537215430|FG001|Overall Study|Other|2|||
148926656|NCT04123665|537215431|FG000|Overall Study|Withdrawal by Subject|7|||
148926657|NCT04123665|537215432|FG001|Overall Study|Withdrawal by Subject|0|||
148926658|NCT04123665|537215431|FG000|Overall Study|Lost to Follow-up|1|||
148926659|NCT04123665|537215432|FG001|Overall Study|Lost to Follow-up|0|||
148926660|NCT01711879|537215437|FG000|Overall Study|Death|1|||
148926661|NCT01711879|537215438|FG001|Overall Study|Death|0|||
148926662|NCT00958789|537215439|FG000|Overall Study|Death|5|||
148926663|NCT00958789|537215439|FG000|Overall Study|Lost to Follow-up|14|||
148674658|NCT00483717|536279556|FG001|Overall Study|Lost to Follow-up|0|||
148674659|NCT00483717|536279555|FG000|Overall Study|Withdrawal by Subject|1|||
148674660|NCT00483717|536279556|FG001|Overall Study|Withdrawal by Subject|0|||
148674661|NCT00604175|536279557|FG000|Entry Through Week 28|Death|2|||
148806136|NCT02867592|536768098|FG005|Overall Study|Adverse Event|5|||
148806137|NCT02867592|536768093|FG000|Overall Study|Death|0|||
148926664|NCT00958789|537215439|FG000|Overall Study|Withdrawal by Subject|17|||
148926665|NCT00958789|537215439|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
148806138|NCT02867592|536768094|FG001|Overall Study|Death|0|||
148926666|NCT00958789|537215439|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
148926667|NCT00958789|537215439|FG000|Overall Study|Subject terminated|2|||
148926668|NCT00958789|537215439|FG000|Overall Study|Revision|7|||
148926669|NCT00478881|537215442|FG000|Overall Study|Adverse Event|31|||
148926670|NCT00478881|537215443|FG001|Overall Study|Adverse Event|12|||
148926671|NCT00478881|537215442|FG000|Overall Study|Lack of Efficacy|0|||
148926672|NCT00478881|537215443|FG001|Overall Study|Lack of Efficacy|3|||
148806139|NCT02867592|536768095|FG002|Overall Study|Death|0|||
148806140|NCT02867592|536768096|FG003|Overall Study|Death|1|||
148806141|NCT02867592|536768097|FG004|Overall Study|Death|0|||
148806142|NCT02867592|536768098|FG005|Overall Study|Death|1|||
148806143|NCT02867592|536768093|FG000|Overall Study|Lack of Efficacy|8|||
148806144|NCT02867592|536768094|FG001|Overall Study|Lack of Efficacy|10|||
148806145|NCT02867592|536768095|FG002|Overall Study|Lack of Efficacy|8|||
148806146|NCT02867592|536768096|FG003|Overall Study|Lack of Efficacy|8|||
148806147|NCT02867592|536768097|FG004|Overall Study|Lack of Efficacy|12|||
148806148|NCT02867592|536768098|FG005|Overall Study|Lack of Efficacy|17|||
148806149|NCT02867592|536768093|FG000|Overall Study|Physician Decision|1|||
148806150|NCT02867592|536768094|FG001|Overall Study|Physician Decision|2|||
148806151|NCT02867592|536768095|FG002|Overall Study|Physician Decision|2|||
148806152|NCT02867592|536768096|FG003|Overall Study|Physician Decision|0|||
148806153|NCT02867592|536768097|FG004|Overall Study|Physician Decision|5|||
148806154|NCT02867592|536768098|FG005|Overall Study|Physician Decision|1|||
148806155|NCT02867592|536768093|FG000|Overall Study|Protocol Violation|0|||
148806156|NCT02867592|536768094|FG001|Overall Study|Protocol Violation|0|||
148806157|NCT02867592|536768095|FG002|Overall Study|Protocol Violation|0|||
148806158|NCT02867592|536768096|FG003|Overall Study|Protocol Violation|0|||
148806159|NCT02867592|536768097|FG004|Overall Study|Protocol Violation|1|||
148806160|NCT02867592|536768098|FG005|Overall Study|Protocol Violation|1|||
148806161|NCT02867592|536768093|FG000|Overall Study|Withdrawal by Subject|0|||
148806162|NCT02867592|536768094|FG001|Overall Study|Withdrawal by Subject|1|||
148806163|NCT02867592|536768095|FG002|Overall Study|Withdrawal by Subject|0|||
148806164|NCT02867592|536768096|FG003|Overall Study|Withdrawal by Subject|1|||
148806165|NCT02867592|536768097|FG004|Overall Study|Withdrawal by Subject|3|||
148806166|NCT02867592|536768098|FG005|Overall Study|Withdrawal by Subject|3|||
148806167|NCT02867592|536768093|FG000|Overall Study|Ineligible|1|||
148674662|NCT00604175|536279558|FG001|Entry Through Week 28|Death|0|||
148674663|NCT00604175|536279559|FG002|Entry Through Week 28|Death|0|||
148674664|NCT00604175|536279557|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
148674665|NCT00604175|536279558|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
148674666|NCT00604175|536279559|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
148674667|NCT00604175|536279557|FG000|Entry Through Week 28|Lost to Follow-up|4|||
148674668|NCT00604175|536279558|FG001|Entry Through Week 28|Lost to Follow-up|3|||
148674669|NCT00604175|536279559|FG002|Entry Through Week 28|Lost to Follow-up|0|||
148674670|NCT00604175|536279557|FG000|Entry Through Week 28|Ineligible|1|||
148674671|NCT00604175|536279558|FG001|Entry Through Week 28|Ineligible|0|||
148674672|NCT00604175|536279559|FG002|Entry Through Week 28|Ineligible|0|||
148674673|NCT00604175|536279557|FG000|Entry Through Week 28|Did not start intervention|2|||
148674674|NCT00604175|536279558|FG001|Entry Through Week 28|Did not start intervention|0|||
148674675|NCT00604175|536279559|FG002|Entry Through Week 28|Did not start intervention|1|||
148674676|NCT00604175|536279557|FG000|Week 29 Through Week 72|Death|0|||
148674677|NCT00604175|536279558|FG001|Week 29 Through Week 72|Death|0|||
148674678|NCT00604175|536279559|FG002|Week 29 Through Week 72|Death|1|||
148674679|NCT00604175|536279557|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
148806168|NCT02867592|536768094|FG001|Overall Study|Ineligible|1|||
148806169|NCT02867592|536768095|FG002|Overall Study|Ineligible|0|||
148674680|NCT00604175|536279558|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
148674681|NCT00604175|536279559|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
148674682|NCT00604175|536279557|FG000|Week 29 Through Week 72|Site closure|0|||
148674683|NCT00604175|536279558|FG001|Week 29 Through Week 72|Site closure|1|||
148806170|NCT02867592|536768096|FG003|Overall Study|Ineligible|0|||
148806171|NCT02867592|536768097|FG004|Overall Study|Ineligible|2|||
148806172|NCT02867592|536768098|FG005|Overall Study|Ineligible|0|||
148806173|NCT02867592|536768093|FG000|Overall Study|No Treatment|1|||
148806174|NCT02867592|536768094|FG001|Overall Study|No Treatment|0|||
148806175|NCT02867592|536768095|FG002|Overall Study|No Treatment|0|||
148806176|NCT02867592|536768096|FG003|Overall Study|No Treatment|0|||
148806177|NCT02867592|536768097|FG004|Overall Study|No Treatment|0|||
148806178|NCT02867592|536768098|FG005|Overall Study|No Treatment|0|||
149012890|NCT01719224|537525838|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
149162560|NCT01400932|538071585|FG001|Overall Study|Adverse Event|5|||
149162561|NCT01400932|538071584|FG000|Overall Study|Lack of Efficacy|0|||
149162562|NCT01400932|538071585|FG001|Overall Study|Lack of Efficacy|3|||
149162563|NCT01400932|538071584|FG000|Overall Study|Withdrawal by Subject|2|||
149162564|NCT01400932|538071585|FG001|Overall Study|Withdrawal by Subject|6|||
149162565|NCT01400932|538071584|FG000|Overall Study|Lost to Follow-up|1|||
149162566|NCT01400932|538071585|FG001|Overall Study|Lost to Follow-up|0|||
149162567|NCT01400932|538071584|FG000|Overall Study|Protocol Deviation|0|||
149162568|NCT01400932|538071585|FG001|Overall Study|Protocol Deviation|1|||
149162569|NCT01400932|538071584|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149162570|NCT01400932|538071585|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149162571|NCT00860158|538071586|FG000|Overall Study|Study Terminated|1|||
149162572|NCT04656990|538071587|FG000|Baseline|pandemic|20|||
149162573|NCT04656990|538071588|FG001|Baseline|pandemic|24|||
149162574|NCT04656990|538071587|FG000|Follow Up Period|Lost to Follow-up|61|||
149162575|NCT04656990|538071588|FG001|Follow Up Period|Lost to Follow-up|73|||
149162576|NCT03244059|538071589|FG000|Specific Aim 1|Physician Decision|1|||
149162577|NCT03244059|538071590|FG001|Specific Aim 1|Physician Decision|0|||
149162578|NCT03244059|538071589|FG000|Specific Aim 2|Physician Decision|1|||
149162579|NCT03244059|538071590|FG001|Specific Aim 2|Physician Decision|0|||
149162580|NCT05499520|538071592|FG000|Overall Study|Lost to Follow-up|0|||
149162581|NCT05499520|538071593|FG001|Overall Study|Lost to Follow-up|0|||
149162582|NCT05499520|538071594|FG002|Overall Study|Lost to Follow-up|38|||
149162583|NCT05499520|538071595|FG003|Overall Study|Lost to Follow-up|41|||
149162584|NCT05499520|538071596|FG004|Overall Study|Lost to Follow-up|46|||
149162585|NCT05499520|538071597|FG005|Overall Study|Lost to Follow-up|0|||
149012891|NCT01719224|537525839|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
149162586|NCT05499520|538071598|FG006|Overall Study|Lost to Follow-up|31|||
149162587|NCT05499520|538071599|FG007|Overall Study|Lost to Follow-up|45|||
149162588|NCT05499520|538071600|FG008|Overall Study|Lost to Follow-up|42|||
149162589|NCT05499520|538071601|FG009|Overall Study|Lost to Follow-up|0|||
149162590|NCT05499520|538071602|FG010|Overall Study|Lost to Follow-up|0|||
149012892|NCT00152971|537525841|FG000|Overall Study|Adverse Event|12|||
149162591|NCT05499520|538071603|FG011|Overall Study|Lost to Follow-up|37|||
149162592|NCT05499520|538071604|FG012|Overall Study|Lost to Follow-up|53|||
149162593|NCT05499520|538071605|FG013|Overall Study|Lost to Follow-up|49|||
149012893|NCT00152971|537525842|FG001|Overall Study|Adverse Event|10|||
149012894|NCT00152971|537525843|FG002|Overall Study|Adverse Event|9|||
149162594|NCT05499520|538071606|FG014|Overall Study|Lost to Follow-up|0|||
149162595|NCT05499520|538071607|FG015|Overall Study|Lost to Follow-up|36|||
149162596|NCT05499520|538071608|FG016|Overall Study|Lost to Follow-up|58|||
149162597|NCT05499520|538071609|FG017|Overall Study|Lost to Follow-up|53|||
149162598|NCT00282243|538071610|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
149162599|NCT00282243|538071610|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
149162600|NCT00282243|538071610|FG000|Extension Treatment Period|Adverse Event|15|||
149162601|NCT00282243|538071610|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
149162602|NCT00282243|538071610|FG000|Extension Treatment Period|Non-compliance|2|||
149162603|NCT00282243|538071610|FG000|Extension Treatment Period|Physician Decision|1|||
149162604|NCT00686127|538071611|FG000|Overall Study|Withdrawal by Subject|14|||
149162605|NCT00686127|538071612|FG001|Overall Study|Withdrawal by Subject|6|||
149162606|NCT03588741|538071615|FG000|Overall Study|Withdrawal by Subject|1|||
149162607|NCT02487108|538071617|FG000|Overall Study|Adverse Event|1|||
149162608|NCT02487108|538071618|FG001|Overall Study|Adverse Event|6|||
149162609|NCT02487108|538071619|FG002|Overall Study|Adverse Event|12|||
149162610|NCT02487108|538071620|FG003|Overall Study|Adverse Event|6|||
149162611|NCT02487108|538071617|FG000|Overall Study|Withdrawal by Subject|8|||
149162612|NCT02487108|538071618|FG001|Overall Study|Withdrawal by Subject|5|||
149162613|NCT02487108|538071619|FG002|Overall Study|Withdrawal by Subject|5|||
149162614|NCT02487108|538071620|FG003|Overall Study|Withdrawal by Subject|0|||
149162615|NCT02487108|538071617|FG000|Overall Study|Non-compliance to study medication|3|||
149162616|NCT02487108|538071618|FG001|Overall Study|Non-compliance to study medication|2|||
149162617|NCT02487108|538071619|FG002|Overall Study|Non-compliance to study medication|5|||
149162618|NCT02487108|538071620|FG003|Overall Study|Non-compliance to study medication|4|||
149162619|NCT02487108|538071617|FG000|Overall Study|Protocol Violation|1|||
148806179|NCT02867592|536768093|FG000|Overall Study|Still on Therapy|0|||
148926673|NCT00478881|537215442|FG000|Overall Study|Lost to Follow-up|0|||
148926674|NCT00478881|537215443|FG001|Overall Study|Lost to Follow-up|1|||
148926675|NCT00478881|537215442|FG000|Overall Study|Protocol Violation|2|||
148926676|NCT00478881|537215443|FG001|Overall Study|Protocol Violation|2|||
149162620|NCT02487108|538071618|FG001|Overall Study|Protocol Violation|1|||
149162621|NCT02487108|538071619|FG002|Overall Study|Protocol Violation|2|||
149162622|NCT02487108|538071620|FG003|Overall Study|Protocol Violation|0|||
148926677|NCT00478881|537215442|FG000|Overall Study|Withdrawal by Subject|6|||
149162623|NCT02487108|538071617|FG000|Overall Study|Non-compliance to study procedures|0|||
149162624|NCT02487108|538071618|FG001|Overall Study|Non-compliance to study procedures|0|||
149162625|NCT02487108|538071619|FG002|Overall Study|Non-compliance to study procedures|0|||
149162626|NCT02487108|538071620|FG003|Overall Study|Non-compliance to study procedures|1|||
149162627|NCT02487108|538071617|FG000|Overall Study|Other than specified|3|||
149162628|NCT02487108|538071618|FG001|Overall Study|Other than specified|2|||
149162629|NCT02487108|538071619|FG002|Overall Study|Other than specified|2|||
149162630|NCT02487108|538071620|FG003|Overall Study|Other than specified|0|||
149162631|NCT00883493|538071621|FG000|Overall Study|Adverse Event|11|||
149162632|NCT00883493|538071622|FG001|Overall Study|Adverse Event|12|||
149162633|NCT00883493|538071621|FG000|Overall Study|Lack of Efficacy|4|||
149162634|NCT00883493|538071622|FG001|Overall Study|Lack of Efficacy|3|||
149162635|NCT00883493|538071621|FG000|Overall Study|Lost to Follow-up|7|||
149162636|NCT00883493|538071622|FG001|Overall Study|Lost to Follow-up|6|||
149162637|NCT00883493|538071621|FG000|Overall Study|Withdrawal by Subject|11|||
149162638|NCT00883493|538071622|FG001|Overall Study|Withdrawal by Subject|20|||
149162639|NCT00883493|538071621|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
149162640|NCT00883493|538071622|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
149162641|NCT00883493|538071621|FG000|Overall Study|Study specific disc. criteria|2|||
149162642|NCT00883493|538071622|FG001|Overall Study|Study specific disc. criteria|0|||
149162643|NCT00883493|538071621|FG000|Overall Study|Other|5|||
149162644|NCT00883493|538071622|FG001|Overall Study|Other|3|||
149162645|NCT00400400|538071623|FG000|Overall Study|Adverse Event|9|||
149162646|NCT00400400|538071624|FG001|Overall Study|Adverse Event|8|||
149162647|NCT00400400|538071623|FG000|Overall Study|Protocol Violation|2|||
149162648|NCT00400400|538071624|FG001|Overall Study|Protocol Violation|0|||
149162649|NCT00400400|538071623|FG000|Overall Study|Withdrawal by Subject|1|||
149162650|NCT00400400|538071624|FG001|Overall Study|Withdrawal by Subject|3|||
149162651|NCT00400400|538071623|FG000|Overall Study|Administrative Problem|1|||
149162652|NCT00400400|538071624|FG001|Overall Study|Administrative Problem|0|||
148926678|NCT00478881|537215443|FG001|Overall Study|Withdrawal by Subject|2|||
148926679|NCT00478881|537215442|FG000|Overall Study|Non-Compliance with Study Medication|0|||
148926680|NCT00478881|537215443|FG001|Overall Study|Non-Compliance with Study Medication|2|||
148926681|NCT01466179|537215444|FG000|Overall Study|Ongoing in core study|2|||
149162653|NCT00400400|538071623|FG000|Overall Study|Lost to Follow-up|0|||
149162654|NCT00400400|538071624|FG001|Overall Study|Lost to Follow-up|1|||
149162655|NCT00400400|538071623|FG000|Overall Study|Did not receive study drug|1|||
149162656|NCT00400400|538071624|FG001|Overall Study|Did not receive study drug|3|||
149162657|NCT00648167|538071625|FG000|Overall Study|Adverse Event|6|||
149162658|NCT00648167|538071625|FG000|Overall Study|unable to swallow tablets|1|||
149162659|NCT01688050|538071626|FG000|Overall Study|Death|7|||
149162660|NCT01688050|538071626|FG000|Overall Study|Conversion to open repair|1|||
149162661|NCT01688050|538071626|FG000|Overall Study|Lost to Follow-up|13|||
148674684|NCT00604175|536279559|FG002|Week 29 Through Week 72|Site closure|0|||
148806180|NCT02867592|536768094|FG001|Overall Study|Still on Therapy|0|||
149162662|NCT01688050|538071626|FG000|Overall Study|Withdrawal by Subject|10|||
149162663|NCT05099640|538071632|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
149162664|NCT05099640|538071633|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
149162665|NCT05099640|538071634|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
148926682|NCT01466179|537215444|FG000|Overall Study|Physician Decision|46|||
148926683|NCT01466179|537215444|FG000|Overall Study|Progressive disease|43|||
148926684|NCT01466179|537215444|FG000|Overall Study|Adverse Event|32|||
148926685|NCT01466179|537215444|FG000|Overall Study|Disease relapse|23|||
148926686|NCT01466179|537215444|FG000|Overall Study|Lack of Efficacy|14|||
148926687|NCT01466179|537215444|FG000|Overall Study|Death|7|||
148926688|NCT01466179|537215444|FG000|Overall Study|Withdrawal by Subject|7|||
148926689|NCT01466179|537215444|FG000|Overall Study|Protocol Violation|2|||
148926690|NCT01466179|537215444|FG000|Overall Study|Other|3|||
148926691|NCT01083173|537215447|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
148926692|NCT01083173|537215448|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
148926693|NCT01083173|537215447|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
148926694|NCT01083173|537215448|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
148926695|NCT01083173|537215447|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
148926696|NCT01083173|537215448|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
148926697|NCT01083173|537215447|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
148926698|NCT01083173|537215448|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
148926699|NCT01083173|537215447|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
148926700|NCT01083173|537215448|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
148926701|NCT01083173|537215447|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
148926702|NCT01083173|537215448|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
148926703|NCT01083173|537215447|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
148926704|NCT01083173|537215448|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
148926705|NCT01083173|537215447|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
148926706|NCT01083173|537215448|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
148926707|NCT01083173|537215447|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
148926708|NCT01083173|537215448|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
148926709|NCT01083173|537215447|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
148926710|NCT01083173|537215448|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
148926711|NCT01083173|537215447|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
148926712|NCT01083173|537215448|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
148926713|NCT03410823|537215449|FG000|Overall Study|Death|1|||
148926714|NCT03410823|537215449|FG000|Overall Study|Withdrawal by Subject|2|||
148926715|NCT03410823|537215449|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
149162666|NCT05099640|538071632|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
149162667|NCT05099640|538071633|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
149162668|NCT05099640|538071634|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
149162669|NCT05099640|538071632|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
149162670|NCT05099640|538071633|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
149162671|NCT05099640|538071634|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
149162672|NCT05099640|538071632|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
149162673|NCT05099640|538071633|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
149162674|NCT05099640|538071634|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
149162675|NCT05099640|538071632|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
149162676|NCT05099640|538071633|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
149162677|NCT05099640|538071634|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
149162678|NCT05099640|538071632|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
149162679|NCT05099640|538071633|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
149162680|NCT05099640|538071634|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
149162681|NCT00189462|538071635|FG000|Overall Study|Lack of Efficacy|5|||
149162682|NCT00189462|538071636|FG001|Overall Study|Lack of Efficacy|1|||
149162683|NCT00189462|538071635|FG000|Overall Study|Lost to Follow-up|18|||
148926716|NCT04565236|537215451|FG000|Overall Study|Patient/Guardian Decision|0|||
148926717|NCT04565236|537215452|FG001|Overall Study|Patient/Guardian Decision|0|||
148926718|NCT04565236|537215453|FG002|Overall Study|Patient/Guardian Decision|1|||
148926719|NCT04565236|537215454|FG003|Overall Study|Patient/Guardian Decision|0|||
148926720|NCT01923168|537215456|FG000|Overall Study|Protocol Violation|1|||
148926721|NCT01923168|537215457|FG001|Overall Study|Protocol Violation|1|||
148926722|NCT01923168|537215458|FG002|Overall Study|Protocol Violation|0|||
148926723|NCT01923168|537215456|FG000|Overall Study|Subject/guardian decision|14|||
148926724|NCT01923168|537215457|FG001|Overall Study|Subject/guardian decision|14|||
148926725|NCT01923168|537215458|FG002|Overall Study|Subject/guardian decision|4|||
148926726|NCT01923168|537215456|FG000|Overall Study|Adverse Event|12|||
148926727|NCT01923168|537215457|FG001|Overall Study|Adverse Event|12|||
148926728|NCT01923168|537215458|FG002|Overall Study|Adverse Event|0|||
148926729|NCT01923168|537215456|FG000|Overall Study|Physician Decision|6|||
148926730|NCT01923168|537215457|FG001|Overall Study|Physician Decision|9|||
148926731|NCT01923168|537215458|FG002|Overall Study|Physician Decision|5|||
148926732|NCT01923168|537215456|FG000|Overall Study|Progressive disease|4|||
148926733|NCT01923168|537215457|FG001|Overall Study|Progressive disease|3|||
148926734|NCT01923168|537215458|FG002|Overall Study|Progressive disease|7|||
148926735|NCT01923168|537215456|FG000|Overall Study|Death|0|||
148926736|NCT01923168|537215457|FG001|Overall Study|Death|0|||
148926737|NCT01923168|537215458|FG002|Overall Study|Death|1|||
148926738|NCT00768469|537215459|FG000|Overall Study|Adverse Event|0|||
148926739|NCT00768469|537215460|FG001|Overall Study|Adverse Event|2|||
148926740|NCT00768469|537215459|FG000|Overall Study|Disease Progression|3|||
148926741|NCT00768469|537215460|FG001|Overall Study|Disease Progression|4|||
148926742|NCT00768469|537215459|FG000|Overall Study|Withdrawal by Subject|0|||
148926743|NCT00768469|537215460|FG001|Overall Study|Withdrawal by Subject|1|||
148926744|NCT01582854|537215463|FG000|Overall Study|Death|8|||
148926745|NCT01582854|537215464|FG001|Overall Study|Death|5|||
148926746|NCT01582854|537215463|FG000|Overall Study|Adverse Event|2|||
148926747|NCT01582854|537215464|FG001|Overall Study|Adverse Event|3|||
148926748|NCT01582854|537215463|FG000|Overall Study|Withdrawal by Participant|8|||
148926749|NCT01582854|537215464|FG001|Overall Study|Withdrawal by Participant|11|||
148926750|NCT01582854|537215463|FG000|Overall Study|Lost to Follow-up|1|||
148926751|NCT01582854|537215464|FG001|Overall Study|Lost to Follow-up|2|||
148926752|NCT01582854|537215463|FG000|Overall Study|Physician Decision|0|||
148926753|NCT01582854|537215464|FG001|Overall Study|Physician Decision|1|||
148926754|NCT01582854|537215463|FG000|Overall Study|Recurrent Stroke|13|||
148926755|NCT01582854|537215464|FG001|Overall Study|Recurrent Stroke|8|||
148926756|NCT01582854|537215463|FG000|Overall Study|Disallowed Concomitant Medication|3|||
148926757|NCT01582854|537215464|FG001|Overall Study|Disallowed Concomitant Medication|2|||
148926758|NCT01582854|537215463|FG000|Overall Study|Carotid or Neurosurgery|0|||
148926759|NCT01582854|537215464|FG001|Overall Study|Carotid or Neurosurgery|1|||
148926760|NCT01582854|537215463|FG000|Overall Study|General Anaesthesia|0|||
148926761|NCT01582854|537215464|FG001|Overall Study|General Anaesthesia|1|||
148926762|NCT01582854|537215463|FG000|Overall Study|Other Miscellaneous Reason|1|||
148926763|NCT01582854|537215464|FG001|Overall Study|Other Miscellaneous Reason|0|||
148926764|NCT02953509|537215465|FG000|Overall Study|Death|1|||
148926765|NCT02953509|537215466|FG001|Overall Study|Death|3|||
148926766|NCT02953509|537215467|FG002|Overall Study|Death|3|||
148926767|NCT02953509|537215468|FG003|Overall Study|Death|4|||
148926768|NCT02953509|537215469|FG004|Overall Study|Death|12|||
148926769|NCT02953509|537215470|FG005|Overall Study|Death|3|||
148926770|NCT02953509|537215471|FG006|Overall Study|Death|25|||
148926771|NCT02953509|537215472|FG007|Overall Study|Death|10|||
148926772|NCT02953509|537215473|FG008|Overall Study|Death|21|||
148926773|NCT02953509|537215474|FG009|Overall Study|Death|20|||
148926774|NCT02953509|537215465|FG000|Overall Study|Reason Not Specified|0|||
148926775|NCT02953509|537215466|FG001|Overall Study|Reason Not Specified|2|||
148926776|NCT02953509|537215467|FG002|Overall Study|Reason Not Specified|8|||
148926777|NCT02953509|537215468|FG003|Overall Study|Reason Not Specified|2|||
148926778|NCT02953509|537215469|FG004|Overall Study|Reason Not Specified|11|||
148926779|NCT02953509|537215470|FG005|Overall Study|Reason Not Specified|4|||
148926780|NCT02953509|537215471|FG006|Overall Study|Reason Not Specified|12|||
148926781|NCT02953509|537215472|FG007|Overall Study|Reason Not Specified|2|||
148926782|NCT02953509|537215473|FG008|Overall Study|Reason Not Specified|7|||
148926783|NCT02953509|537215474|FG009|Overall Study|Reason Not Specified|2|||
148926784|NCT02953509|537215465|FG000|Overall Study|Consent Withdrawn|1|||
148926785|NCT02953509|537215466|FG001|Overall Study|Consent Withdrawn|1|||
148926786|NCT02953509|537215467|FG002|Overall Study|Consent Withdrawn|2|||
148926787|NCT02953509|537215468|FG003|Overall Study|Consent Withdrawn|1|||
148926788|NCT02953509|537215469|FG004|Overall Study|Consent Withdrawn|3|||
148926789|NCT02953509|537215470|FG005|Overall Study|Consent Withdrawn|0|||
148926790|NCT02953509|537215471|FG006|Overall Study|Consent Withdrawn|4|||
148806181|NCT02867592|536768095|FG002|Overall Study|Still on Therapy|0|||
148926791|NCT02953509|537215472|FG007|Overall Study|Consent Withdrawn|1|||
148926792|NCT02953509|537215473|FG008|Overall Study|Consent Withdrawn|1|||
148926793|NCT02953509|537215474|FG009|Overall Study|Consent Withdrawn|4|||
148926794|NCT02953509|537215465|FG000|Overall Study|Lost to Follow-up|0|||
148926795|NCT02953509|537215466|FG001|Overall Study|Lost to Follow-up|0|||
148926796|NCT02953509|537215467|FG002|Overall Study|Lost to Follow-up|0|||
148926797|NCT02953509|537215468|FG003|Overall Study|Lost to Follow-up|0|||
148926798|NCT02953509|537215469|FG004|Overall Study|Lost to Follow-up|0|||
148926799|NCT02953509|537215470|FG005|Overall Study|Lost to Follow-up|0|||
148926800|NCT02953509|537215471|FG006|Overall Study|Lost to Follow-up|1|||
148926801|NCT02953509|537215472|FG007|Overall Study|Lost to Follow-up|1|||
148926802|NCT02953509|537215473|FG008|Overall Study|Lost to Follow-up|1|||
148926803|NCT02953509|537215474|FG009|Overall Study|Lost to Follow-up|1|||
148926804|NCT02953509|537215465|FG000|Overall Study|Study terminated by sponsor|1|||
148926805|NCT02953509|537215466|FG001|Overall Study|Study terminated by sponsor|0|||
148926806|NCT02953509|537215467|FG002|Overall Study|Study terminated by sponsor|0|||
148926807|NCT02953509|537215468|FG003|Overall Study|Study terminated by sponsor|0|||
148926808|NCT02953509|537215469|FG004|Overall Study|Study terminated by sponsor|0|||
148926809|NCT02953509|537215470|FG005|Overall Study|Study terminated by sponsor|0|||
148674685|NCT00604175|536279557|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
148674686|NCT00604175|536279558|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
148674687|NCT00604175|536279559|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
148674688|NCT03353415|536279560|FG000|Masked CGM Wear|Lost to Follow-up|2|||
148674689|NCT03353415|536279560|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
148674690|NCT00975000|536279561|FG000|Overall Study|Other|1|||
148674691|NCT00975000|536279562|FG001|Overall Study|Other|0|||
148674692|NCT00975000|536279561|FG000|Overall Study|Adverse Event|1|||
148674693|NCT00975000|536279562|FG001|Overall Study|Adverse Event|1|||
148674694|NCT00975000|536279561|FG000|Overall Study|Withdrawal by Subject|2|||
148674695|NCT00975000|536279562|FG001|Overall Study|Withdrawal by Subject|2|||
148674696|NCT00975000|536279561|FG000|Overall Study|Lost to Follow-up|0|||
148674697|NCT00975000|536279562|FG001|Overall Study|Lost to Follow-up|1|||
148674698|NCT00975000|536279561|FG000|Overall Study|Protocol-specified Criteria|1|||
148674699|NCT00975000|536279562|FG001|Overall Study|Protocol-specified Criteria|0|||
148674700|NCT00975000|536279561|FG000|Overall Study|Non-compliance|0|||
148674701|NCT00975000|536279562|FG001|Overall Study|Non-compliance|1|||
148674702|NCT00359073|536281425|FG000|Overall Study|Withdrawal by Subject|1|||
148674703|NCT00359073|536281426|FG001|Overall Study|Withdrawal by Subject|1|||
148674704|NCT00359073|536281425|FG000|Overall Study|Eligibility criteria no longer met|3|||
148926810|NCT02953509|537215471|FG006|Overall Study|Study terminated by sponsor|1|||
148926811|NCT02953509|537215472|FG007|Overall Study|Study terminated by sponsor|0|||
148926812|NCT02953509|537215473|FG008|Overall Study|Study terminated by sponsor|1|||
148926813|NCT02953509|537215474|FG009|Overall Study|Study terminated by sponsor|1|||
148926814|NCT00484185|537215477|FG000|Overall Study|Lost to Follow-up|44|||
148926815|NCT00484185|537215477|FG000|Overall Study|Other|20|||
148926816|NCT00484185|537215477|FG000|Overall Study|Randomized but not treated|5|||
148926817|NCT00484185|537215477|FG000|Overall Study|Death|2|||
148926818|NCT00459056|537215478|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
148926819|NCT00459056|537215479|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
148926820|NCT02522871|537215480|FG000|Overall Study|Protocol Violation|1|||
148926821|NCT02522871|537215481|FG001|Overall Study|Protocol Violation|4|||
148926822|NCT02522871|537215480|FG000|Overall Study|Treated without randomization|1|||
148926823|NCT02522871|537215481|FG001|Overall Study|Treated without randomization|0|||
148926824|NCT02522871|537215480|FG000|Overall Study|Death|9|||
148926825|NCT02522871|537215481|FG001|Overall Study|Death|9|||
148926826|NCT02522871|537215480|FG000|Overall Study|Died in operating room prior to transplant|0|||
148926827|NCT02522871|537215481|FG001|Overall Study|Died in operating room prior to transplant|1|||
148926828|NCT01222403|537215484|FG000|Overall Study|Inappropriate enrollment|0|||
148926829|NCT01222403|537215485|FG001|Overall Study|Inappropriate enrollment|2|||
148926830|NCT00725842|537215486|FG000|Overall Study|Lost to Follow-up|19|||
148926831|NCT00725842|537215486|FG000|Overall Study|Death|1|||
148926832|NCT00725842|537215486|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
148926833|NCT00725842|537215486|FG000|Overall Study|Consent date prior to study start date|5|||
148926834|NCT00725842|537215486|FG000|Overall Study|Inclusion criterion not met|1|||
149012895|NCT00152971|537525841|FG000|Overall Study|Protocol Violation|10|||
149012896|NCT00152971|537525842|FG001|Overall Study|Protocol Violation|11|||
148674705|NCT00359073|536281426|FG001|Overall Study|Eligibility criteria no longer met|0|||
148674706|NCT00359073|536281425|FG000|Overall Study|developed RV16 antibody|0|||
148674707|NCT00359073|536281426|FG001|Overall Study|developed RV16 antibody|1|||
148674708|NCT01371006|536281427|FG000|Overall Study|Adverse Event|1|||
148674709|NCT01371006|536281428|FG001|Overall Study|Adverse Event|0|||
148674710|NCT00891527|536281429|FG000|Overall Study|Withdrawal by Subject|2|||
148926835|NCT00725842|537215486|FG000|Overall Study|No Visit 1 data|1|||
148926836|NCT02793622|537215489|FG000|Overall Study|Lost to Follow-up|31|||
148926837|NCT02793622|537215490|FG001|Overall Study|Lost to Follow-up|19|||
148926838|NCT02793622|537215489|FG000|Overall Study|Withdrawal by Subject|21|||
148926839|NCT02793622|537215490|FG001|Overall Study|Withdrawal by Subject|17|||
148926840|NCT02793622|537215489|FG000|Overall Study|Adverse Event|0|||
148926841|NCT02793622|537215490|FG001|Overall Study|Adverse Event|1|||
148926842|NCT02793622|537215489|FG000|Overall Study|Protocol Violation|1|||
149012897|NCT00152971|537525843|FG002|Overall Study|Protocol Violation|8|||
149162684|NCT00189462|538071636|FG001|Overall Study|Lost to Follow-up|20|||
149162685|NCT00849667|538071640|FG000|Overall Study|Withdrawal by Subject|16|||
149162686|NCT00849667|538071641|FG001|Overall Study|Withdrawal by Subject|33|||
149162687|NCT00849667|538071642|FG002|Overall Study|Withdrawal by Subject|35|||
149162688|NCT00849667|538071640|FG000|Overall Study|Lost to Follow-up|8|||
149162689|NCT00849667|538071641|FG001|Overall Study|Lost to Follow-up|8|||
149162690|NCT00849667|538071642|FG002|Overall Study|Lost to Follow-up|8|||
149162691|NCT00849667|538071640|FG000|Overall Study|Adverse Event|1|||
149162692|NCT00849667|538071641|FG001|Overall Study|Adverse Event|2|||
149162693|NCT00849667|538071642|FG002|Overall Study|Adverse Event|0|||
149162694|NCT00849667|538071640|FG000|Overall Study|Other|18|||
149162695|NCT00849667|538071641|FG001|Overall Study|Other|19|||
149162696|NCT00849667|538071642|FG002|Overall Study|Other|18|||
149162697|NCT00849667|538071640|FG000|Overall Study|Progressive disease|119|||
149162698|NCT00849667|538071641|FG001|Overall Study|Progressive disease|100|||
149162699|NCT00849667|538071642|FG002|Overall Study|Progressive disease|112|||
149162700|NCT00849667|538071640|FG000|Overall Study|Sponsor decision|208|||
149162701|NCT00849667|538071641|FG001|Overall Study|Sponsor decision|204|||
149162702|NCT00849667|538071642|FG002|Overall Study|Sponsor decision|190|||
149162703|NCT00849667|538071640|FG000|Overall Study|Investigator discretion|0|||
149162704|NCT00849667|538071641|FG001|Overall Study|Investigator discretion|0|||
149162705|NCT00849667|538071642|FG002|Overall Study|Investigator discretion|1|||
149162706|NCT00553462|538071643|FG000|Overall Study|Adverse Event|4|||
149162707|NCT00553462|538071643|FG000|Overall Study|Progression|4|||
149162708|NCT00553462|538071643|FG000|Overall Study|Withdrawal by Subject|5|||
149162709|NCT00553462|538071643|FG000|Overall Study|Physician Decision|1|||
149162710|NCT01262625|538071644|FG000|Overall Study|Administrative Error|1|||
149162711|NCT01262625|538071645|FG001|Overall Study|Administrative Error|1|||
149162712|NCT01262625|538071644|FG000|Overall Study|Site Closed|1|||
149162713|NCT01262625|538071645|FG001|Overall Study|Site Closed|0|||
149162714|NCT03075163|538071646|FG000|Overall Study|not eligible for treatment limb|138|||
149162715|NCT03075163|538071647|FG001|Overall Study|not eligible for treatment limb|138|||
149162716|NCT04398732|538071648|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
149162717|NCT03882424|538071651|FG000|Overall Study|Lost to Follow-up|3|||
149162718|NCT03882424|538071652|FG001|Overall Study|Lost to Follow-up|0|||
149162719|NCT03882424|538071653|FG002|Overall Study|Lost to Follow-up|0|||
149162720|NCT03882424|538071651|FG000|Overall Study|schedule conflict|1|||
149162721|NCT03882424|538071652|FG001|Overall Study|schedule conflict|0|||
149162722|NCT03882424|538071653|FG002|Overall Study|schedule conflict|0|||
148674711|NCT03515837|536281431|FG000|Overall Study|Death|219|||
148674712|NCT03515837|536281432|FG001|Overall Study|Death|227|||
148674713|NCT03515837|536281431|FG000|Overall Study|Lost to Follow-up|0|||
148674714|NCT03515837|536281432|FG001|Overall Study|Lost to Follow-up|1|||
148674715|NCT03515837|536281431|FG000|Overall Study|Withdrawal by Subject|0|||
148674716|NCT03515837|536281432|FG001|Overall Study|Withdrawal by Subject|4|||
148674717|NCT03515837|536281431|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
148806182|NCT02867592|536768096|FG003|Overall Study|Still on Therapy|0|||
148806183|NCT02867592|536768097|FG004|Overall Study|Still on Therapy|1|||
148806184|NCT02867592|536768098|FG005|Overall Study|Still on Therapy|0|||
148806185|NCT02867592|536768093|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
148806186|NCT02867592|536768094|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
148806187|NCT02867592|536768095|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
148806188|NCT02867592|536768096|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
148806189|NCT02867592|536768097|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
148806190|NCT02867592|536768098|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
148806191|NCT02867592|536768093|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
149162723|NCT02772757|538071659|FG000|Overall Study|Withdrawal by Subject|1|||
149162724|NCT02772757|538071660|FG001|Overall Study|Withdrawal by Subject|0|||
148806192|NCT02867592|536768094|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
148806193|NCT02867592|536768095|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
149162725|NCT02772757|538071661|FG002|Overall Study|Withdrawal by Subject|1|||
149162726|NCT02772757|538071659|FG000|Overall Study|Protocol Violation|0|||
149162727|NCT02772757|538071660|FG001|Overall Study|Protocol Violation|0|||
148674718|NCT03515837|536281432|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
149162728|NCT02772757|538071661|FG002|Overall Study|Protocol Violation|1|||
149162729|NCT02772757|538071659|FG000|Overall Study|Physician Decision|0|||
149162730|NCT02772757|538071660|FG001|Overall Study|Physician Decision|3|||
149162731|NCT02772757|538071661|FG002|Overall Study|Physician Decision|3|||
149162732|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Adverse Event|21|||
149162733|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Adverse Event|6|||
149162734|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
149162735|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
149162736|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
149162737|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
149162738|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
149162739|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
149162740|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Physician Decision|0|||
149162741|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Physician Decision|3|||
149162742|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
149162743|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
149162744|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
149162745|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
149162746|NCT00510276|538071663|FG000|Acute Double-Blind Phase|Subject Decision|26|||
149162747|NCT00510276|538071664|FG001|Acute Double-Blind Phase|Subject Decision|28|||
149162748|NCT00510276|538071663|FG000|Extension Open-Label Phase|Adverse Event|9|||
149162749|NCT00510276|538071664|FG001|Extension Open-Label Phase|Adverse Event|18|||
149162750|NCT00510276|538071663|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
149162751|NCT00510276|538071664|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
149162752|NCT00510276|538071663|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
149162753|NCT00510276|538071664|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
149162754|NCT00510276|538071663|FG000|Extension Open-Label Phase|Physician Decision|2|||
149162755|NCT00510276|538071664|FG001|Extension Open-Label Phase|Physician Decision|3|||
149162756|NCT00510276|538071663|FG000|Extension Open-Label Phase|Protocol Violation|0|||
149162757|NCT00510276|538071664|FG001|Extension Open-Label Phase|Protocol Violation|1|||
149162758|NCT00510276|538071663|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
149162759|NCT00510276|538071664|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
149162760|NCT00510276|538071663|FG000|Extension Open-Label Phase|Subject Decision|7|||
149162761|NCT00510276|538071664|FG001|Extension Open-Label Phase|Subject Decision|9|||
149162762|NCT03486392|538071667|FG000|Overall Study|Lost to Follow-up|0|||
149162763|NCT03486392|538071668|FG001|Overall Study|Lost to Follow-up|0|||
149162764|NCT03486392|538071669|FG002|Overall Study|Lost to Follow-up|8|||
149162765|NCT03486392|538071670|FG003|Overall Study|Lost to Follow-up|5|||
148674719|NCT01964898|536281433|FG000|Overall Study|ineligible post-randomization|1|||
148674720|NCT01964898|536281434|FG001|Overall Study|ineligible post-randomization|1|||
149162766|NCT03486392|538071671|FG004|Overall Study|Lost to Follow-up|2|||
149162767|NCT03486392|538071667|FG000|Overall Study|Withdrawal by Subject|3|||
149162768|NCT03486392|538071668|FG001|Overall Study|Withdrawal by Subject|0|||
149162769|NCT03486392|538071669|FG002|Overall Study|Withdrawal by Subject|6|||
149162770|NCT03486392|538071670|FG003|Overall Study|Withdrawal by Subject|4|||
149162771|NCT03486392|538071671|FG004|Overall Study|Withdrawal by Subject|1|||
149162772|NCT03486392|538071667|FG000|Overall Study|Death|0|||
149162773|NCT03486392|538071668|FG001|Overall Study|Death|0|||
149162774|NCT03486392|538071669|FG002|Overall Study|Death|0|||
149162775|NCT03486392|538071670|FG003|Overall Study|Death|0|||
149162776|NCT03486392|538071671|FG004|Overall Study|Death|1|||
149162777|NCT01500057|538071672|FG000|Overall Study|Lost to Follow-up|6|||
149162778|NCT01500057|538071673|FG001|Overall Study|Lost to Follow-up|4|||
149162779|NCT00441792|538071674|FG000|Overall Study|Lost to Follow-up|0|||
149162780|NCT00441792|538071675|FG001|Overall Study|Lost to Follow-up|2|||
149162781|NCT00888355|538071678|FG000|Overall Study|Adverse Event|10|||
149162782|NCT00888355|538071679|FG001|Overall Study|Adverse Event|0|||
149162783|NCT00888355|538071680|FG002|Overall Study|Adverse Event|3|||
149162784|NCT00888355|538071681|FG003|Overall Study|Adverse Event|3|||
149162785|NCT00888355|538071678|FG000|Overall Study|Lack of Efficacy|9|||
149162786|NCT00888355|538071679|FG001|Overall Study|Lack of Efficacy|2|||
149162787|NCT00888355|538071680|FG002|Overall Study|Lack of Efficacy|5|||
149162788|NCT00888355|538071681|FG003|Overall Study|Lack of Efficacy|2|||
149162789|NCT00888355|538071678|FG000|Overall Study|Lost to Follow-up|0|||
149162790|NCT00888355|538071679|FG001|Overall Study|Lost to Follow-up|2|||
149162791|NCT00888355|538071680|FG002|Overall Study|Lost to Follow-up|2|||
149162792|NCT00888355|538071681|FG003|Overall Study|Lost to Follow-up|0|||
149162793|NCT00888355|538071678|FG000|Overall Study|Protocol Violation|3|||
149162794|NCT00888355|538071679|FG001|Overall Study|Protocol Violation|2|||
149162795|NCT00888355|538071680|FG002|Overall Study|Protocol Violation|1|||
149162796|NCT00888355|538071681|FG003|Overall Study|Protocol Violation|2|||
149162797|NCT00888355|538071678|FG000|Overall Study|Withdrawal by Subject|0|||
149162798|NCT00888355|538071679|FG001|Overall Study|Withdrawal by Subject|3|||
149162799|NCT00888355|538071680|FG002|Overall Study|Withdrawal by Subject|1|||
149162800|NCT00888355|538071681|FG003|Overall Study|Withdrawal by Subject|3|||
149162801|NCT00666926|538071683|FG000|Overall Study|Adverse Event|0|||
149162802|NCT00666926|538071684|FG001|Overall Study|Adverse Event|0|||
149162803|NCT00666926|538071685|FG002|Overall Study|Adverse Event|0|||
149162804|NCT00666926|538071686|FG003|Overall Study|Adverse Event|0|||
149162805|NCT00666926|538071687|FG004|Overall Study|Adverse Event|0|||
149162806|NCT00666926|538071688|FG005|Overall Study|Adverse Event|0|||
149162807|NCT00666926|538071689|FG006|Overall Study|Adverse Event|0|||
149162808|NCT00666926|538071690|FG007|Overall Study|Adverse Event|0|||
149162809|NCT00666926|538071691|FG008|Overall Study|Adverse Event|0|||
149162810|NCT00666926|538071692|FG009|Overall Study|Adverse Event|2|||
149162811|NCT00666926|538071693|FG010|Overall Study|Adverse Event|2|||
149162812|NCT00666926|538071694|FG011|Overall Study|Adverse Event|2|||
149162813|NCT00666926|538071695|FG012|Overall Study|Adverse Event|0|||
149162814|NCT00666926|538071696|FG013|Overall Study|Adverse Event|1|||
149162815|NCT00666926|538071697|FG014|Overall Study|Adverse Event|0|||
149162816|NCT00666926|538071698|FG015|Overall Study|Adverse Event|0|||
149162817|NCT00666926|538071683|FG000|Overall Study|Laboratory abnormality|0|||
149162818|NCT00666926|538071684|FG001|Overall Study|Laboratory abnormality|0|||
149162819|NCT00666926|538071685|FG002|Overall Study|Laboratory abnormality|0|||
149162820|NCT00666926|538071686|FG003|Overall Study|Laboratory abnormality|0|||
149162821|NCT00666926|538071687|FG004|Overall Study|Laboratory abnormality|0|||
149162822|NCT00666926|538071688|FG005|Overall Study|Laboratory abnormality|0|||
149162823|NCT00666926|538071689|FG006|Overall Study|Laboratory abnormality|0|||
149162824|NCT00666926|538071690|FG007|Overall Study|Laboratory abnormality|0|||
149162825|NCT00666926|538071691|FG008|Overall Study|Laboratory abnormality|0|||
149162826|NCT00666926|538071692|FG009|Overall Study|Laboratory abnormality|0|||
149162827|NCT00666926|538071693|FG010|Overall Study|Laboratory abnormality|1|||
149162828|NCT00666926|538071694|FG011|Overall Study|Laboratory abnormality|0|||
149162829|NCT00666926|538071695|FG012|Overall Study|Laboratory abnormality|0|||
149162830|NCT00666926|538071696|FG013|Overall Study|Laboratory abnormality|0|||
149162831|NCT00666926|538071697|FG014|Overall Study|Laboratory abnormality|0|||
149162832|NCT00666926|538071698|FG015|Overall Study|Laboratory abnormality|1|||
149162833|NCT00666926|538071683|FG000|Overall Study|Lack of Efficacy|0|||
149162834|NCT00666926|538071684|FG001|Overall Study|Lack of Efficacy|0|||
149162835|NCT00666926|538071685|FG002|Overall Study|Lack of Efficacy|0|||
149162836|NCT00666926|538071686|FG003|Overall Study|Lack of Efficacy|0|||
149162837|NCT00666926|538071687|FG004|Overall Study|Lack of Efficacy|0|||
149162838|NCT00666926|538071688|FG005|Overall Study|Lack of Efficacy|1|||
149162839|NCT00666926|538071689|FG006|Overall Study|Lack of Efficacy|0|||
149162840|NCT00666926|538071690|FG007|Overall Study|Lack of Efficacy|0|||
149162841|NCT00666926|538071691|FG008|Overall Study|Lack of Efficacy|0|||
149162842|NCT00666926|538071692|FG009|Overall Study|Lack of Efficacy|0|||
149162843|NCT00666926|538071693|FG010|Overall Study|Lack of Efficacy|0|||
149162844|NCT00666926|538071694|FG011|Overall Study|Lack of Efficacy|1|||
149162845|NCT00666926|538071695|FG012|Overall Study|Lack of Efficacy|0|||
149162846|NCT00666926|538071696|FG013|Overall Study|Lack of Efficacy|0|||
149162847|NCT00666926|538071697|FG014|Overall Study|Lack of Efficacy|0|||
149162848|NCT00666926|538071698|FG015|Overall Study|Lack of Efficacy|0|||
149162849|NCT00666926|538071683|FG000|Overall Study|Lost to Follow-up|0|||
149162850|NCT00666926|538071684|FG001|Overall Study|Lost to Follow-up|0|||
149162851|NCT00666926|538071685|FG002|Overall Study|Lost to Follow-up|0|||
149162852|NCT00666926|538071686|FG003|Overall Study|Lost to Follow-up|1|||
149162853|NCT00666926|538071687|FG004|Overall Study|Lost to Follow-up|0|||
149162854|NCT00666926|538071688|FG005|Overall Study|Lost to Follow-up|0|||
149162855|NCT00666926|538071689|FG006|Overall Study|Lost to Follow-up|0|||
149162856|NCT00666926|538071690|FG007|Overall Study|Lost to Follow-up|0|||
149162857|NCT00666926|538071691|FG008|Overall Study|Lost to Follow-up|0|||
149162858|NCT00666926|538071692|FG009|Overall Study|Lost to Follow-up|0|||
149162859|NCT00666926|538071693|FG010|Overall Study|Lost to Follow-up|0|||
149162860|NCT00666926|538071694|FG011|Overall Study|Lost to Follow-up|0|||
149162861|NCT00666926|538071695|FG012|Overall Study|Lost to Follow-up|0|||
149162862|NCT00666926|538071696|FG013|Overall Study|Lost to Follow-up|0|||
149162863|NCT00666926|538071697|FG014|Overall Study|Lost to Follow-up|0|||
149162864|NCT00666926|538071698|FG015|Overall Study|Lost to Follow-up|0|||
149162865|NCT00666926|538071683|FG000|Overall Study|Other|2|||
149162866|NCT00666926|538071684|FG001|Overall Study|Other|4|||
149162867|NCT00666926|538071685|FG002|Overall Study|Other|3|||
149162868|NCT00666926|538071686|FG003|Overall Study|Other|3|||
149162869|NCT00666926|538071687|FG004|Overall Study|Other|3|||
149162870|NCT00666926|538071688|FG005|Overall Study|Other|3|||
149162871|NCT00666926|538071689|FG006|Overall Study|Other|4|||
149162872|NCT00666926|538071690|FG007|Overall Study|Other|0|||
149162873|NCT00666926|538071691|FG008|Overall Study|Other|3|||
149162874|NCT00666926|538071692|FG009|Overall Study|Other|5|||
149162875|NCT00666926|538071693|FG010|Overall Study|Other|3|||
149162876|NCT00666926|538071694|FG011|Overall Study|Other|26|||
149162877|NCT00666926|538071695|FG012|Overall Study|Other|3|||
149162878|NCT00666926|538071696|FG013|Overall Study|Other|2|||
149162879|NCT00666926|538071697|FG014|Overall Study|Other|4|||
149162880|NCT00666926|538071698|FG015|Overall Study|Other|4|||
149162881|NCT00666926|538071683|FG000|Overall Study|Withdrawal by Subject|0|||
149162882|NCT00666926|538071684|FG001|Overall Study|Withdrawal by Subject|0|||
149162883|NCT00666926|538071685|FG002|Overall Study|Withdrawal by Subject|0|||
149162884|NCT00666926|538071686|FG003|Overall Study|Withdrawal by Subject|0|||
149162885|NCT00666926|538071687|FG004|Overall Study|Withdrawal by Subject|0|||
149162886|NCT00666926|538071688|FG005|Overall Study|Withdrawal by Subject|0|||
149162887|NCT00666926|538071689|FG006|Overall Study|Withdrawal by Subject|0|||
149162888|NCT00666926|538071690|FG007|Overall Study|Withdrawal by Subject|1|||
149162889|NCT00666926|538071691|FG008|Overall Study|Withdrawal by Subject|0|||
149162890|NCT00666926|538071692|FG009|Overall Study|Withdrawal by Subject|3|||
149162891|NCT00666926|538071693|FG010|Overall Study|Withdrawal by Subject|0|||
149162892|NCT00666926|538071694|FG011|Overall Study|Withdrawal by Subject|3|||
149162893|NCT00666926|538071695|FG012|Overall Study|Withdrawal by Subject|0|||
149162894|NCT00666926|538071696|FG013|Overall Study|Withdrawal by Subject|1|||
149162895|NCT00666926|538071697|FG014|Overall Study|Withdrawal by Subject|3|||
149162896|NCT00666926|538071698|FG015|Overall Study|Withdrawal by Subject|3|||
149162897|NCT00666926|538071683|FG000|Overall Study|Death|0|||
149162898|NCT00666926|538071684|FG001|Overall Study|Death|0|||
149162899|NCT00666926|538071685|FG002|Overall Study|Death|0|||
149162900|NCT00666926|538071686|FG003|Overall Study|Death|0|||
149162901|NCT00666926|538071687|FG004|Overall Study|Death|0|||
149162902|NCT00666926|538071688|FG005|Overall Study|Death|0|||
149162903|NCT00666926|538071689|FG006|Overall Study|Death|0|||
149162904|NCT00666926|538071690|FG007|Overall Study|Death|0|||
149162905|NCT00666926|538071691|FG008|Overall Study|Death|0|||
149162906|NCT00666926|538071692|FG009|Overall Study|Death|0|||
149162907|NCT00666926|538071693|FG010|Overall Study|Death|0|||
149162908|NCT00666926|538071694|FG011|Overall Study|Death|1|||
149162909|NCT00666926|538071695|FG012|Overall Study|Death|0|||
149162910|NCT00666926|538071696|FG013|Overall Study|Death|0|||
149162911|NCT00666926|538071697|FG014|Overall Study|Death|0|||
149162912|NCT00666926|538071698|FG015|Overall Study|Death|0|||
149162913|NCT01960855|538071699|FG000|Overall Study|Subject noncompliant|1|||
149162914|NCT01960855|538071700|FG001|Overall Study|Subject noncompliant|0|||
149162915|NCT01960855|538071701|FG002|Overall Study|Subject noncompliant|0|||
149162916|NCT01960855|538071702|FG003|Overall Study|Subject noncompliant|0|||
149162917|NCT01960855|538071703|FG004|Overall Study|Subject noncompliant|0|||
149162918|NCT01960855|538071699|FG000|Overall Study|Adverse Event|2|||
149162919|NCT01960855|538071700|FG001|Overall Study|Adverse Event|0|||
149162920|NCT01960855|538071701|FG002|Overall Study|Adverse Event|6|||
149162921|NCT01960855|538071702|FG003|Overall Study|Adverse Event|2|||
149162922|NCT01960855|538071703|FG004|Overall Study|Adverse Event|2|||
149162923|NCT01960855|538071699|FG000|Overall Study|Lack of Efficacy|1|||
149162924|NCT01960855|538071700|FG001|Overall Study|Lack of Efficacy|1|||
149162925|NCT01960855|538071701|FG002|Overall Study|Lack of Efficacy|0|||
149162926|NCT01960855|538071702|FG003|Overall Study|Lack of Efficacy|0|||
149162927|NCT01960855|538071703|FG004|Overall Study|Lack of Efficacy|0|||
149162928|NCT01960855|538071699|FG000|Overall Study|Other|2|||
149162929|NCT01960855|538071700|FG001|Overall Study|Other|1|||
149162930|NCT01960855|538071701|FG002|Overall Study|Other|1|||
149162931|NCT01960855|538071702|FG003|Overall Study|Other|1|||
149162932|NCT01960855|538071703|FG004|Overall Study|Other|0|||
149162933|NCT01960855|538071699|FG000|Overall Study|Consent withdrawn by subject|3|||
149162934|NCT01960855|538071700|FG001|Overall Study|Consent withdrawn by subject|1|||
149162935|NCT01960855|538071701|FG002|Overall Study|Consent withdrawn by subject|2|||
149162936|NCT01960855|538071702|FG003|Overall Study|Consent withdrawn by subject|1|||
149162937|NCT01960855|538071703|FG004|Overall Study|Consent withdrawn by subject|1|||
149162938|NCT01960855|538071699|FG000|Overall Study|Lost to Follow-up|2|||
149162939|NCT01960855|538071700|FG001|Overall Study|Lost to Follow-up|1|||
149162940|NCT01960855|538071701|FG002|Overall Study|Lost to Follow-up|0|||
148674721|NCT01964898|536281433|FG000|Overall Study|did not receive the allocated interventi|2|||
149162941|NCT01960855|538071702|FG003|Overall Study|Lost to Follow-up|0|||
149162942|NCT01960855|538071703|FG004|Overall Study|Lost to Follow-up|2|||
149162943|NCT01318122|538071704|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148674722|NCT01964898|536281434|FG001|Overall Study|did not receive the allocated interventi|1|||
149162944|NCT01318122|538071705|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149162945|NCT01318122|538071706|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
149162946|NCT01318122|538071707|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
149162947|NCT01318122|538071704|FG000|Enrolled - Long-Term Extension Study|Other|1|||
149162948|NCT01318122|538071705|FG001|Enrolled - Long-Term Extension Study|Other|0|||
149162949|NCT01318122|538071706|FG002|Enrolled - Long-Term Extension Study|Other|0|||
149162950|NCT01318122|538071707|FG003|Enrolled - Long-Term Extension Study|Other|0|||
148674723|NCT01964898|536281433|FG000|Overall Study|Lost to Follow-up|3|||
149162951|NCT01318122|538071704|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
149162952|NCT01318122|538071705|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
149162953|NCT01318122|538071706|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
149162954|NCT01318122|538071707|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
149162955|NCT01318122|538071704|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
149162956|NCT01318122|538071705|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149162957|NCT01318122|538071706|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149162958|NCT01318122|538071707|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149162959|NCT01318122|538071704|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149162960|NCT01318122|538071705|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
149162961|NCT01318122|538071706|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149162962|NCT01318122|538071707|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149162963|NCT01318122|538071704|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149162964|NCT01318122|538071705|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
149162965|NCT01318122|538071706|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
149162966|NCT01318122|538071707|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149162967|NCT02471716|538071708|FG000|Overall Study|Withdrawal by Subject|0|||
149162968|NCT02471716|538071709|FG001|Overall Study|Withdrawal by Subject|1|||
149162969|NCT02471716|538071710|FG002|Overall Study|Withdrawal by Subject|0|||
149162970|NCT02471716|538071711|FG003|Overall Study|Withdrawal by Subject|2|||
149162971|NCT02471716|538071712|FG004|Overall Study|Withdrawal by Subject|5|||
149162972|NCT02471716|538071708|FG000|Overall Study|Study Terminiated by sponsor|0|||
149162973|NCT02471716|538071709|FG001|Overall Study|Study Terminiated by sponsor|0|||
149162974|NCT02471716|538071710|FG002|Overall Study|Study Terminiated by sponsor|0|||
149162975|NCT02471716|538071711|FG003|Overall Study|Study Terminiated by sponsor|1|||
149162976|NCT02471716|538071712|FG004|Overall Study|Study Terminiated by sponsor|0|||
149162977|NCT02471716|538071708|FG000|Overall Study|Lost to Follow-up|0|||
149162978|NCT02471716|538071709|FG001|Overall Study|Lost to Follow-up|0|||
149162979|NCT02471716|538071710|FG002|Overall Study|Lost to Follow-up|0|||
149162980|NCT02471716|538071711|FG003|Overall Study|Lost to Follow-up|3|||
149162981|NCT02471716|538071712|FG004|Overall Study|Lost to Follow-up|2|||
149162982|NCT02471716|538071708|FG000|Overall Study|Death|0|||
149162983|NCT02471716|538071709|FG001|Overall Study|Death|0|||
149162984|NCT02471716|538071710|FG002|Overall Study|Death|0|||
149162985|NCT02471716|538071711|FG003|Overall Study|Death|1|||
149162986|NCT02471716|538071712|FG004|Overall Study|Death|0|||
149162987|NCT02471716|538071708|FG000|Overall Study|Other|0|||
149162988|NCT02471716|538071709|FG001|Overall Study|Other|0|||
149162989|NCT02471716|538071710|FG002|Overall Study|Other|0|||
149162990|NCT02471716|538071711|FG003|Overall Study|Other|8|||
149162991|NCT02471716|538071712|FG004|Overall Study|Other|9|||
149162992|NCT01014585|538071718|FG000|Overall Study|Adverse Event|0|||
149162993|NCT01014585|538071719|FG001|Overall Study|Adverse Event|2|||
149162994|NCT01014585|538071720|FG002|Overall Study|Adverse Event|0|||
149162995|NCT01014585|538071721|FG003|Overall Study|Adverse Event|3|||
149162996|NCT01014585|538071718|FG000|Overall Study|Withdrawal by Subject|2|||
149162997|NCT01014585|538071719|FG001|Overall Study|Withdrawal by Subject|0|||
149162998|NCT01014585|538071720|FG002|Overall Study|Withdrawal by Subject|1|||
149162999|NCT01014585|538071721|FG003|Overall Study|Withdrawal by Subject|3|||
148926843|NCT02793622|537215490|FG001|Overall Study|Protocol Violation|5|||
148926844|NCT02068768|537215492|FG000|Overall Study|Lost to Follow-up|5|||
149163000|NCT01014585|538071718|FG000|Overall Study|Lost to Follow-up|0|||
149163001|NCT01014585|538071719|FG001|Overall Study|Lost to Follow-up|0|||
148926845|NCT02068768|537215492|FG000|Overall Study|Early Termination by Sponsor|2|||
148926846|NCT01262352|537215493|FG000|Period 1|Illness after randomization|1|||
148926847|NCT01262352|537215494|FG001|Period 1|Illness after randomization|0|||
148926848|NCT01262352|537215493|FG000|Washout|Adverse Event|1|||
149163002|NCT01014585|538071720|FG002|Overall Study|Lost to Follow-up|0|||
149163003|NCT01014585|538071721|FG003|Overall Study|Lost to Follow-up|2|||
149163004|NCT01014585|538071718|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
149163005|NCT01014585|538071719|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
149163006|NCT01014585|538071720|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
149163007|NCT01014585|538071721|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
149163008|NCT02154425|538071722|FG000|Screening Period|Adverse Event|1|||
149163009|NCT01481896|538071723|FG000|Overall Study|Lost to Follow-up|12|||
149163010|NCT01162421|538071726|FG000|Overall Study|Did not receive study drug|2|||
149163011|NCT01162421|538071727|FG001|Overall Study|Did not receive study drug|1|||
148926849|NCT01262352|537215494|FG001|Washout|Adverse Event|1|||
148926850|NCT01262352|537215493|FG000|Washout|Extended Washout|0|||
149163012|NCT01162421|538071726|FG000|Overall Study|Adverse Event|2|||
148674724|NCT01964898|536281434|FG001|Overall Study|Lost to Follow-up|5|||
148674725|NCT01964898|536281433|FG000|Overall Study|Withdrawal by Subject|1|||
148674726|NCT01964898|536281434|FG001|Overall Study|Withdrawal by Subject|0|||
148674727|NCT02957682|536281437|FG000|Overall Study|Adverse Event|64|||
148674728|NCT02957682|536281438|FG001|Overall Study|Adverse Event|67|||
148674729|NCT02957682|536281437|FG000|Overall Study|Poor Compliance to Protocol|30|||
148674730|NCT02957682|536281438|FG001|Overall Study|Poor Compliance to Protocol|26|||
148674731|NCT02957682|536281437|FG000|Overall Study|Physician Decision|4|||
148674732|NCT02957682|536281438|FG001|Overall Study|Physician Decision|4|||
148674733|NCT02957682|536281437|FG000|Overall Study|Study Terminated by Sponsor|4|||
148674734|NCT02957682|536281438|FG001|Overall Study|Study Terminated by Sponsor|3|||
148674735|NCT02957682|536281437|FG000|Overall Study|Subject Moved|10|||
148674736|NCT02957682|536281438|FG001|Overall Study|Subject Moved|16|||
148674737|NCT02957682|536281437|FG000|Overall Study|Withdrawal by Subject|64|||
148674738|NCT02957682|536281438|FG001|Overall Study|Withdrawal by Subject|33|||
148674739|NCT02957682|536281437|FG000|Overall Study|Related to IMP Administration|3|||
148674740|NCT02957682|536281438|FG001|Overall Study|Related to IMP Administration|6|||
148674741|NCT02957682|536281437|FG000|Overall Study|Non-disclosed|16|||
148674742|NCT02957682|536281438|FG001|Overall Study|Non-disclosed|12|||
148674743|NCT02957682|536281437|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
148674744|NCT02957682|536281438|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
148674745|NCT02953262|536281445|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
148674746|NCT02953262|536281446|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
148674747|NCT02953262|536281447|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
148674748|NCT02953262|536281448|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
148674749|NCT00934622|536281449|FG000|Overall Study|Lost to Follow-up|7|||
148674750|NCT00934622|536281449|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
148674751|NCT03349437|536281450|FG000|Screening|Screen Fail|4|||
148674752|NCT03349437|536281451|FG001|Screening|Screen Fail|0|||
148674753|NCT03349437|536281452|FG002|Screening|Screen Fail|0|||
148674754|NCT03349437|536281450|FG000|Screening|Withdrawn|1|||
148674755|NCT03349437|536281451|FG001|Screening|Withdrawn|0|||
148674756|NCT03349437|536281452|FG002|Screening|Withdrawn|0|||
148674757|NCT03976076|536281453|FG000|Overall Study|Withdrawal by Subject|2|||
148674758|NCT02406742|536281454|FG000|Overall Study|Progression of Disease|5|||
148674759|NCT02406742|536281455|FG001|Overall Study|Progression of Disease|1|||
148674760|NCT02406742|536281456|FG002|Overall Study|Progression of Disease|6|||
148674761|NCT02406742|536281454|FG000|Overall Study|Adverse Event|3|||
148674762|NCT02406742|536281455|FG001|Overall Study|Adverse Event|0|||
148674763|NCT02406742|536281456|FG002|Overall Study|Adverse Event|2|||
148674764|NCT02406742|536281454|FG000|Overall Study|Death|1|||
148674765|NCT02406742|536281455|FG001|Overall Study|Death|0|||
148674766|NCT02406742|536281456|FG002|Overall Study|Death|0|||
148674767|NCT02406742|536281454|FG000|Overall Study|Lack of Efficacy|0|||
148674768|NCT02406742|536281455|FG001|Overall Study|Lack of Efficacy|0|||
148674769|NCT02406742|536281456|FG002|Overall Study|Lack of Efficacy|1|||
148674770|NCT02406742|536281454|FG000|Overall Study|Withdrawal by Participant|1|||
148674771|NCT02406742|536281455|FG001|Overall Study|Withdrawal by Participant|2|||
148674772|NCT02406742|536281456|FG002|Overall Study|Withdrawal by Participant|0|||
148674773|NCT02406742|536281454|FG000|Overall Study|Physician Decision|1|||
148674774|NCT02406742|536281455|FG001|Overall Study|Physician Decision|2|||
148674775|NCT02406742|536281456|FG002|Overall Study|Physician Decision|1|||
148674776|NCT02406742|536281454|FG000|Overall Study|Transition to other treatment|2|||
148674777|NCT02406742|536281455|FG001|Overall Study|Transition to other treatment|0|||
149163013|NCT01162421|538071727|FG001|Overall Study|Adverse Event|5|||
148674778|NCT02406742|536281456|FG002|Overall Study|Transition to other treatment|1|||
148674779|NCT02406742|536281454|FG000|Overall Study|Other Reasons|1|||
148674780|NCT02406742|536281455|FG001|Overall Study|Other Reasons|11|||
148806194|NCT02867592|536768096|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
148806195|NCT02867592|536768097|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
148926851|NCT01262352|537215494|FG001|Washout|Extended Washout|1|||
148926852|NCT01185834|537215495|FG000|Overall Study|Lost to Follow-up|2|||
148926853|NCT01185834|537215495|FG000|Overall Study|Discomfort|4|||
148806196|NCT02867592|536768098|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
148926854|NCT01185834|537215495|FG000|Overall Study|Biomicroscopy|4|||
149163014|NCT01162421|538071726|FG000|Overall Study|Lost to Follow-up|0|||
148674781|NCT02406742|536281456|FG002|Overall Study|Other Reasons|5|||
148674782|NCT00765999|536281457|FG000|Overall Study|Adverse Event|203|||
148674783|NCT00765999|536281457|FG000|Overall Study|Insufficient Therapeutic Response|100|||
149163015|NCT01162421|538071727|FG001|Overall Study|Lost to Follow-up|2|||
148674784|NCT00765999|536281457|FG000|Overall Study|Protocol Violation|95|||
148674785|NCT00765999|536281457|FG000|Overall Study|Consent Withdrawn|202|||
148674786|NCT00765999|536281457|FG000|Overall Study|Lost to Follow-up|131|||
148674787|NCT00765999|536281457|FG000|Overall Study|Study Terminated by Sponsor|2|||
148674788|NCT00765999|536281457|FG000|Overall Study|Other Miscellaneous Reasons|51|||
149163016|NCT01162421|538071726|FG000|Overall Study|Lack of Efficacy|2|||
149163017|NCT01162421|538071727|FG001|Overall Study|Lack of Efficacy|2|||
149163018|NCT01162421|538071726|FG000|Overall Study|Other|2|||
149163019|NCT01162421|538071727|FG001|Overall Study|Other|3|||
149163020|NCT03336502|538071728|FG000|Overall Study|Physician Decision|0|||
149163021|NCT03336502|538071729|FG001|Overall Study|Physician Decision|1|||
149163022|NCT03336502|538071728|FG000|Overall Study|Prohibited Drugs|1|||
149163023|NCT03336502|538071729|FG001|Overall Study|Prohibited Drugs|1|||
149163024|NCT03336502|538071728|FG000|Overall Study|Death|1|||
149163025|NCT03336502|538071729|FG001|Overall Study|Death|2|||
149163026|NCT03336502|538071728|FG000|Overall Study|Adverse Event|2|||
149163027|NCT03336502|538071729|FG001|Overall Study|Adverse Event|5|||
149163028|NCT01133171|538071733|FG000|Overall Study|Withdrawal by Subject|1|||
149163029|NCT01133171|538071734|FG001|Overall Study|Withdrawal by Subject|2|||
149163030|NCT01133171|538071735|FG002|Overall Study|Withdrawal by Subject|0|||
149163031|NCT02526550|538071736|FG000|Overall Study|Lost to Follow-up|1|||
149163032|NCT02542072|538071737|FG000|First Intervention (1 Month)|Adverse Event|1|||
149163033|NCT02542072|538071738|FG001|First Intervention (1 Month)|Adverse Event|1|||
149163034|NCT02542072|538071737|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
149163035|NCT02542072|538071738|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
149163036|NCT02542072|538071737|FG000|First Intervention (1 Month)|Lens discomfort|1|||
149163037|NCT02542072|538071738|FG001|First Intervention (1 Month)|Lens discomfort|2|||
149163038|NCT02542072|538071737|FG000|First Intervention (1 Month)|Protocol Violation|1|||
149163039|NCT02542072|538071738|FG001|First Intervention (1 Month)|Protocol Violation|0|||
149163040|NCT02542072|538071737|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
149163041|NCT02542072|538071738|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
149163042|NCT02542072|538071737|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
149163043|NCT02542072|538071738|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
149163044|NCT00654498|538071741|FG000|Overall Study|Not Treated|1|||
149163045|NCT00654498|538071742|FG001|Overall Study|Not Treated|0|||
149163046|NCT00654498|538071741|FG000|Overall Study|Adverse Event|6|||
149163047|NCT00654498|538071742|FG001|Overall Study|Adverse Event|1|||
149163048|NCT00654498|538071741|FG000|Overall Study|Protocol Violation|1|||
149163049|NCT00654498|538071742|FG001|Overall Study|Protocol Violation|1|||
149163050|NCT00654498|538071741|FG000|Overall Study|Lost to Follow-up|1|||
149163051|NCT00654498|538071742|FG001|Overall Study|Lost to Follow-up|5|||
149163052|NCT00654498|538071741|FG000|Overall Study|Withdrawal by Subject|1|||
149163053|NCT00654498|538071742|FG001|Overall Study|Withdrawal by Subject|0|||
149163054|NCT00654498|538071741|FG000|Overall Study|Other reason not defined above|4|||
149163055|NCT00654498|538071742|FG001|Overall Study|Other reason not defined above|5|||
149163056|NCT01990261|538071743|FG000|Overall Study|Death Before Treatment Start|2|||
149163057|NCT01990261|538071743|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
149163058|NCT01990261|538071743|FG000|Overall Study|Death From other Causes|1|||
149163059|NCT01990261|538071743|FG000|Overall Study|Disease Progression (PD)|8|||
149163060|NCT01990261|538071743|FG000|Overall Study|PD Before Treatment Start|1|||
149163061|NCT01990261|538071743|FG000|Overall Study|Dossier not Approved|1|||
149163062|NCT01990261|538071743|FG000|Overall Study|Lost to Follow-up|2|||
148926855|NCT01185834|537215495|FG000|Overall Study|Time/Job Conflict|2|||
148926856|NCT01185834|537215495|FG000|Overall Study|Early exit - Site error|2|||
148926857|NCT03189381|537215496|FG000|Overall Study|Death|1|||
148926858|NCT03189381|537215497|FG001|Overall Study|Death|0|||
148926859|NCT01401959|537215498|FG000|Enrolled|Withdrawal by Subject|1|||
149163063|NCT01609842|538071744|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
149163064|NCT01609842|538071745|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
149163065|NCT02474329|538071747|FG000|Overall Study|Withdraw or did not contribute data.|13|||
149163066|NCT00670007|538073570|FG000|Overall Study|Drug abuse|1|||
149163067|NCT00670007|538073570|FG000|Overall Study|Lung transplant|1|||
149163068|NCT00670007|538073570|FG000|Overall Study|Travel/Vacation|1|||
149163069|NCT00670007|538073570|FG000|Overall Study|Adverse event, serious fatal|1|||
149163070|NCT00670007|538073570|FG000|Overall Study|Adverse Event|1|||
149163071|NCT00670007|538073570|FG000|Overall Study|Withdrawal by Subject|4|||
149163072|NCT00127127|538073573|FG000|Overall Study|Adverse Event|0|||
149163073|NCT00127127|538073574|FG001|Overall Study|Adverse Event|2|||
149163074|NCT00127127|538073575|FG002|Overall Study|Adverse Event|0|||
149163075|NCT00127127|538073576|FG003|Overall Study|Adverse Event|1|||
149163076|NCT00127127|538073573|FG000|Overall Study|Lack of Efficacy|1|||
149163077|NCT00127127|538073574|FG001|Overall Study|Lack of Efficacy|3|||
148674789|NCT02367729|536281458|FG000|Overall Study|Organic disorder diagnosed|2|||
148674790|NCT02367729|536281459|FG001|Overall Study|Organic disorder diagnosed|1|||
148674791|NCT02367729|536281458|FG000|Overall Study|Adverse Event|1|||
148674792|NCT02367729|536281459|FG001|Overall Study|Adverse Event|2|||
148674793|NCT02367729|536281458|FG000|Overall Study|Withdrawal by Subject|0|||
148674794|NCT02367729|536281459|FG001|Overall Study|Withdrawal by Subject|5|||
148674795|NCT00759174|536281464|FG000|Overall Study|Other|0|||
148674796|NCT00759174|536281465|FG001|Overall Study|Other|2|||
148674797|NCT01890109|536281466|FG000|Overall Study|Withdrawal by Subject|0|||
148674798|NCT01890109|536281467|FG001|Overall Study|Withdrawal by Subject|3|||
148674799|NCT01890109|536281466|FG000|Overall Study|Lost to Follow-up|1|||
148674800|NCT01890109|536281467|FG001|Overall Study|Lost to Follow-up|2|||
148674801|NCT01643928|536281468|FG000|Overall Study|Lost to Follow-up|1|||
148674802|NCT01643928|536281469|FG001|Overall Study|Lost to Follow-up|0|||
148674803|NCT01643928|536281470|FG002|Overall Study|Lost to Follow-up|2|||
148674804|NCT01643928|536281471|FG003|Overall Study|Lost to Follow-up|0|||
148674805|NCT01643928|536281472|FG004|Overall Study|Lost to Follow-up|0|||
148674806|NCT01643928|536281468|FG000|Overall Study|Withdrawal by Subject|2|||
148674807|NCT01643928|536281469|FG001|Overall Study|Withdrawal by Subject|0|||
148674808|NCT01643928|536281470|FG002|Overall Study|Withdrawal by Subject|0|||
148674809|NCT01643928|536281471|FG003|Overall Study|Withdrawal by Subject|1|||
148674810|NCT01643928|536281472|FG004|Overall Study|Withdrawal by Subject|0|||
148674811|NCT01643928|536281468|FG000|Overall Study|Pregnancy|0|||
148674812|NCT01643928|536281469|FG001|Overall Study|Pregnancy|0|||
148674813|NCT01643928|536281470|FG002|Overall Study|Pregnancy|0|||
149163078|NCT00127127|538073575|FG002|Overall Study|Lack of Efficacy|0|||
149163079|NCT00127127|538073576|FG003|Overall Study|Lack of Efficacy|2|||
149163080|NCT01059448|538073578|FG000|Overall Study|Adverse Event|1|||
149163081|NCT01059448|538073579|FG001|Overall Study|Adverse Event|3|||
149163082|NCT01059448|538073580|FG002|Overall Study|Adverse Event|0|||
149163083|NCT01059448|538073581|FG003|Overall Study|Adverse Event|1|||
149163084|NCT01059448|538073578|FG000|Overall Study|Withdrawal by Subject|2|||
149163085|NCT01059448|538073579|FG001|Overall Study|Withdrawal by Subject|0|||
149163086|NCT01059448|538073580|FG002|Overall Study|Withdrawal by Subject|2|||
149163087|NCT01059448|538073581|FG003|Overall Study|Withdrawal by Subject|4|||
148674814|NCT01643928|536281471|FG003|Overall Study|Pregnancy|1|||
148674815|NCT01643928|536281472|FG004|Overall Study|Pregnancy|0|||
148674816|NCT01643928|536281468|FG000|Overall Study|Other|5|||
148674817|NCT01643928|536281469|FG001|Overall Study|Other|1|||
148674818|NCT01643928|536281470|FG002|Overall Study|Other|1|||
148674819|NCT01643928|536281471|FG003|Overall Study|Other|0|||
148674820|NCT01643928|536281472|FG004|Overall Study|Other|0|||
148674821|NCT01643928|536281468|FG000|Overall Study|Adverse Event|2|||
148674822|NCT01643928|536281469|FG001|Overall Study|Adverse Event|1|||
149163088|NCT01059448|538073578|FG000|Overall Study|Disease Progression|2|||
149163089|NCT01059448|538073579|FG001|Overall Study|Disease Progression|1|||
149163090|NCT01059448|538073580|FG002|Overall Study|Disease Progression|4|||
149163091|NCT01059448|538073581|FG003|Overall Study|Disease Progression|2|||
149163092|NCT01059448|538073578|FG000|Overall Study|Administrative Decision|43|||
149163093|NCT01059448|538073579|FG001|Overall Study|Administrative Decision|49|||
149163094|NCT01059448|538073580|FG002|Overall Study|Administrative Decision|45|||
149163095|NCT01059448|538073581|FG003|Overall Study|Administrative Decision|46|||
149163096|NCT01059448|538073578|FG000|Overall Study|Lost to Follow-up|0|||
149163097|NCT01059448|538073579|FG001|Overall Study|Lost to Follow-up|0|||
149163098|NCT01059448|538073580|FG002|Overall Study|Lost to Follow-up|2|||
149163099|NCT01059448|538073581|FG003|Overall Study|Lost to Follow-up|0|||
149163100|NCT01059448|538073578|FG000|Overall Study|Death|0|||
149163101|NCT01059448|538073579|FG001|Overall Study|Death|1|||
149163102|NCT01059448|538073580|FG002|Overall Study|Death|0|||
148674823|NCT01643928|536281470|FG002|Overall Study|Adverse Event|0|||
148674824|NCT01643928|536281471|FG003|Overall Study|Adverse Event|1|||
148674825|NCT01643928|536281472|FG004|Overall Study|Adverse Event|2|||
148674826|NCT03692078|536281474|FG000|Overall Study|Adverse Event|0|||
148674827|NCT03692078|536281475|FG001|Overall Study|Adverse Event|0|||
148806197|NCT00803179|536768099|FG000|Overall Study|Lost to Follow-up|3|||
148806198|NCT04158648|536768100|FG000|Overall Study|Ongoing in the Study|69|||
149163103|NCT01059448|538073581|FG003|Overall Study|Death|0|||
149163104|NCT01059448|538073578|FG000|Overall Study|Other|1|||
149163105|NCT01059448|538073579|FG001|Overall Study|Other|1|||
149163106|NCT01059448|538073580|FG002|Overall Study|Other|0|||
149163107|NCT01059448|538073581|FG003|Overall Study|Other|1|||
148674828|NCT03692078|536281476|FG002|Overall Study|Adverse Event|0|||
148674829|NCT03692078|536281477|FG003|Overall Study|Adverse Event|0|||
148674830|NCT03692078|536281478|FG004|Overall Study|Adverse Event|0|||
148674831|NCT03692078|536281479|FG005|Overall Study|Adverse Event|1|||
148674832|NCT03692078|536281480|FG006|Overall Study|Adverse Event|0|||
149163108|NCT02591615|538073584|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
149163109|NCT02591615|538073585|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
149163110|NCT02591615|538073586|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
149163111|NCT02591615|538073587|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
149163112|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
149163113|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
149163114|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
149163115|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
149163116|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
149163117|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
149163118|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
149163119|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
149163120|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
149163121|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
149163122|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
149163123|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
149163124|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
149163125|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
149163126|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
149163127|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
149163128|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
149163129|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
149163130|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
149163131|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
149163132|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
149163133|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
149163134|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
148926860|NCT01401959|537215499|FG001|Enrolled|Withdrawal by Subject|0|||
149163135|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
149163136|NCT02591615|538073584|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
149163137|NCT02591615|538073585|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
149163138|NCT02591615|538073586|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
149163139|NCT02591615|538073587|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
149163140|NCT02591615|538073584|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
149163141|NCT02591615|538073585|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
149163142|NCT02591615|538073586|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
149163143|NCT02591615|538073587|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
149163144|NCT02591615|538073584|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
149163145|NCT02591615|538073585|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
149163146|NCT02591615|538073586|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
149163147|NCT02591615|538073587|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
149163148|NCT02591615|538073584|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
149163149|NCT02591615|538073585|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
149163150|NCT02591615|538073586|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
149163151|NCT02591615|538073587|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
149163152|NCT02591615|538073584|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
149163153|NCT02591615|538073585|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
149163154|NCT02591615|538073586|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
149163155|NCT02591615|538073587|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
149163156|NCT02591615|538073584|FG000|Maintenance MK-3475|Adverse Event|0|||
149163157|NCT02591615|538073585|FG001|Maintenance MK-3475|Adverse Event|3|||
149163158|NCT02591615|538073586|FG002|Maintenance MK-3475|Adverse Event|1|||
148926861|NCT01401959|537215500|FG002|Enrolled|Withdrawal by Subject|0|||
148926862|NCT01401959|537215498|FG000|Treated|Disease Progression|2|||
148926863|NCT01401959|537215499|FG001|Treated|Disease Progression|2|||
148926864|NCT01401959|537215500|FG002|Treated|Disease Progression|1|||
149163159|NCT02591615|538073587|FG003|Maintenance MK-3475|Adverse Event|2|||
149163160|NCT02591615|538073584|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
149163161|NCT02591615|538073585|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
149163162|NCT02591615|538073586|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
149163163|NCT02591615|538073587|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
149163164|NCT02591615|538073584|FG000|Maintenance MK-3475|Death|0|||
149163165|NCT02591615|538073585|FG001|Maintenance MK-3475|Death|1|||
149163166|NCT02591615|538073586|FG002|Maintenance MK-3475|Death|1|||
149163167|NCT02591615|538073587|FG003|Maintenance MK-3475|Death|0|||
149163168|NCT02591615|538073584|FG000|Maintenance MK-3475|Physician discretion|0|||
149163169|NCT02591615|538073585|FG001|Maintenance MK-3475|Physician discretion|0|||
149163170|NCT02591615|538073586|FG002|Maintenance MK-3475|Physician discretion|1|||
149163171|NCT02591615|538073587|FG003|Maintenance MK-3475|Physician discretion|0|||
149163172|NCT02591615|538073584|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
149163173|NCT02591615|538073585|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
149163174|NCT02591615|538073586|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
149163175|NCT02591615|538073587|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
149163176|NCT02591615|538073584|FG000|Maintenance MK-3475|In active treatment|2|||
149163177|NCT02591615|538073585|FG001|Maintenance MK-3475|In active treatment|0|||
149163178|NCT02591615|538073586|FG002|Maintenance MK-3475|In active treatment|0|||
149163179|NCT02591615|538073587|FG003|Maintenance MK-3475|In active treatment|1|||
149163180|NCT04188197|538073588|FG000|Overall Study|Lost to Follow-up|4|||
149163181|NCT04188197|538073589|FG001|Overall Study|Lost to Follow-up|1|||
149163182|NCT04188197|538073588|FG000|Overall Study|Withdrawal by Subject|1|||
149163183|NCT04188197|538073589|FG001|Overall Study|Withdrawal by Subject|1|||
149163184|NCT04188197|538073588|FG000|Overall Study|Pregnancy|0|||
149163185|NCT04188197|538073589|FG001|Overall Study|Pregnancy|1|||
149163186|NCT00956943|538073599|FG000|Overall Study|Lost to Follow-up|9|||
149163187|NCT00956943|538073600|FG001|Overall Study|Lost to Follow-up|10|||
149163188|NCT02613208|538073601|FG000|Overall Study|Withdrawal by Subject|1|||
149163189|NCT02613208|538073601|FG000|Overall Study|Change of address|2|||
149163190|NCT02613208|538073601|FG000|Overall Study|Physician Decision|2|||
149163191|NCT02613208|538073601|FG000|Overall Study|Lost to Follow-up|5|||
149163192|NCT02613208|538073601|FG000|Overall Study|Death|37|||
149163193|NCT02663895|538073602|FG000|Overall Study|Adverse Event|3|||
149163194|NCT02663895|538073602|FG000|Overall Study|Physician Decision|2|||
149163195|NCT02663895|538073602|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
149163196|NCT02663895|538073602|FG000|Overall Study|Withdrawal by Subject|1|||
149163197|NCT02911688|538073608|FG000|Washout|Lost to Follow-up|1|||
149163198|NCT02911688|538073609|FG001|Washout|Lost to Follow-up|1|||
149163199|NCT02911688|538073608|FG000|Washout|Withdrawal by Subject|0|||
149163200|NCT02911688|538073609|FG001|Washout|Withdrawal by Subject|1|||
149163201|NCT00809328|538073610|FG000|Overall Study|Lack of Efficacy|18|||
149163202|NCT00809328|538073610|FG000|Overall Study|Adverse Event|6|||
149163203|NCT00809328|538073610|FG000|Overall Study|Protocol Violation|3|||
149163204|NCT00809328|538073610|FG000|Overall Study|Withdrawal by Subject|2|||
149163205|NCT00947531|538073611|FG000|Overall Study|Withdrawal by Subject|10|||
149163206|NCT00947531|538073612|FG001|Overall Study|Withdrawal by Subject|7|||
149163207|NCT00947531|538073611|FG000|Overall Study|Administrative Reason|0|||
149163208|NCT00947531|538073612|FG001|Overall Study|Administrative Reason|1|||
149163209|NCT00947531|538073611|FG000|Overall Study|Adverse Event|2|||
149163210|NCT00947531|538073612|FG001|Overall Study|Adverse Event|2|||
149163211|NCT00947531|538073611|FG000|Overall Study|Lack of Efficacy|1|||
149163212|NCT00947531|538073612|FG001|Overall Study|Lack of Efficacy|0|||
149163213|NCT00947531|538073611|FG000|Overall Study|Other|1|||
149163214|NCT00947531|538073612|FG001|Overall Study|Other|1|||
149163215|NCT06441877|538073613|FG000|Overall Study|Withdrawal by Subject|0|||
149163216|NCT06441877|538073614|FG001|Overall Study|Withdrawal by Subject|2|||
149163217|NCT06441877|538073615|FG002|Overall Study|Withdrawal by Subject|0|||
149163218|NCT06441877|538073616|FG003|Overall Study|Withdrawal by Subject|0|||
149163219|NCT03706365|538073621|FG000|Overall Study|Lost to Follow-up|7|||
149163220|NCT03706365|538073622|FG001|Overall Study|Lost to Follow-up|0|||
149163221|NCT03706365|538073621|FG000|Overall Study|Withdrawal by Subject|17|||
149163222|NCT03706365|538073622|FG001|Overall Study|Withdrawal by Subject|15|||
149163223|NCT03706365|538073621|FG000|Overall Study|On Study Treatment|51|||
149163224|NCT03706365|538073622|FG001|Overall Study|On Study Treatment|51|||
149163225|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
149163226|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
149163227|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
149163228|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
149163229|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
149163230|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
149233915|NCT00948896|538324948|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149233916|NCT00948896|538324949|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
149233917|NCT00948896|538324950|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
149233918|NCT00948896|538324951|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
148806199|NCT04158648|536768100|FG000|Overall Study|Withdrawal by Subject|4|||
148806200|NCT04589650|536768101|FG000|Overall Study|Subject decision|6|||
148926865|NCT01401959|537215498|FG000|Treated|Adverse Event|4|||
148926866|NCT01401959|537215499|FG001|Treated|Adverse Event|3|||
148926867|NCT01401959|537215500|FG002|Treated|Adverse Event|2|||
148926868|NCT01401959|537215498|FG000|Treated|Withdrawal by Subject|1|||
148926869|NCT01401959|537215499|FG001|Treated|Withdrawal by Subject|2|||
148926870|NCT01401959|537215500|FG002|Treated|Withdrawal by Subject|2|||
148926871|NCT01401959|537215498|FG000|Treated|Protocol Violation|0|||
148926872|NCT01401959|537215499|FG001|Treated|Protocol Violation|1|||
148926873|NCT01401959|537215500|FG002|Treated|Protocol Violation|0|||
148926874|NCT00251004|537215501|FG000|Overall Study|Withdrawal by Subject|23|||
148926875|NCT00251004|537215502|FG001|Overall Study|Withdrawal by Subject|16|||
148926876|NCT00251004|537215503|FG002|Overall Study|Withdrawal by Subject|14|||
148926877|NCT00251004|537215501|FG000|Overall Study|Death|9|||
148926878|NCT00251004|537215502|FG001|Overall Study|Death|10|||
148926879|NCT00251004|537215503|FG002|Overall Study|Death|8|||
148926880|NCT00251004|537215501|FG000|Overall Study|Lost to Follow-up|1|||
148926881|NCT00251004|537215502|FG001|Overall Study|Lost to Follow-up|2|||
148926882|NCT00251004|537215503|FG002|Overall Study|Lost to Follow-up|1|||
148926883|NCT00251004|537215501|FG000|Overall Study|Graft Loss|12|||
148926884|NCT00251004|537215502|FG001|Overall Study|Graft Loss|13|||
148926885|NCT00251004|537215503|FG002|Overall Study|Graft Loss|8|||
148926886|NCT02694718|537215504|FG000|Overall Study|Death|1|||
148926887|NCT02694718|537215504|FG000|Overall Study|Withdrawal by Subject|1|||
148926888|NCT02925793|537215505|FG000|Overall Study|Adverse Event|3|||
148926889|NCT02925793|537215506|FG001|Overall Study|Adverse Event|3|||
148926890|NCT02925793|537215507|FG002|Overall Study|Adverse Event|6|||
148926891|NCT02925793|537215505|FG000|Overall Study|Withdrawal by Subject|16|||
148926892|NCT02925793|537215506|FG001|Overall Study|Withdrawal by Subject|15|||
148926893|NCT02925793|537215507|FG002|Overall Study|Withdrawal by Subject|13|||
148926894|NCT02925793|537215505|FG000|Overall Study|Investigator Discretion|0|||
148926895|NCT02925793|537215506|FG001|Overall Study|Investigator Discretion|1|||
148926896|NCT02925793|537215507|FG002|Overall Study|Investigator Discretion|1|||
148926897|NCT02925793|537215505|FG000|Overall Study|Lost to Follow-up|2|||
148926898|NCT02925793|537215506|FG001|Overall Study|Lost to Follow-up|3|||
148926899|NCT02925793|537215507|FG002|Overall Study|Lost to Follow-up|1|||
148926900|NCT02925793|537215505|FG000|Overall Study|Lack of Efficacy|2|||
148926901|NCT02925793|537215506|FG001|Overall Study|Lack of Efficacy|6|||
148926902|NCT02925793|537215507|FG002|Overall Study|Lack of Efficacy|4|||
148926903|NCT02925793|537215505|FG000|Overall Study|Other:|2|||
148926904|NCT02925793|537215506|FG001|Overall Study|Other:|1|||
148926905|NCT02925793|537215507|FG002|Overall Study|Other:|3|||
148926906|NCT01244490|537215508|FG000|Overall Study|Lack of Efficacy|14|||
148926907|NCT01244490|537215509|FG001|Overall Study|Lack of Efficacy|5|||
148926908|NCT01244490|537215510|FG002|Overall Study|Lack of Efficacy|5|||
148926909|NCT01244490|537215508|FG000|Overall Study|Withdrawal by Subject|4|||
148926910|NCT01244490|537215509|FG001|Overall Study|Withdrawal by Subject|4|||
148926911|NCT01244490|537215510|FG002|Overall Study|Withdrawal by Subject|9|||
148926912|NCT01244490|537215508|FG000|Overall Study|Adverse Event|1|||
148926913|NCT01244490|537215509|FG001|Overall Study|Adverse Event|9|||
148926914|NCT01244490|537215510|FG002|Overall Study|Adverse Event|5|||
148926915|NCT01244490|537215508|FG000|Overall Study|Lost to Follow-up|0|||
148926916|NCT01244490|537215509|FG001|Overall Study|Lost to Follow-up|6|||
148926917|NCT01244490|537215510|FG002|Overall Study|Lost to Follow-up|3|||
148806201|NCT04589650|536768102|FG001|Overall Study|Subject decision|2|||
148926918|NCT01244490|537215508|FG000|Overall Study|Other|0|||
148926919|NCT01244490|537215509|FG001|Overall Study|Other|0|||
148926920|NCT01244490|537215510|FG002|Overall Study|Other|1|||
148926921|NCT01683019|537217329|FG000|Overall Study|Withdrawal by Subject|2|||
148926922|NCT01683019|537217330|FG001|Overall Study|Withdrawal by Subject|1|||
148926923|NCT01683019|537217331|FG002|Overall Study|Withdrawal by Subject|4|||
148926924|NCT00543855|537217332|FG000|Overall Study|Adverse Event|3|||
148926925|NCT00543855|537217333|FG001|Overall Study|Adverse Event|1|||
148926926|NCT00543855|537217334|FG002|Overall Study|Adverse Event|3|||
148926927|NCT00543855|537217335|FG003|Overall Study|Adverse Event|4|||
148926928|NCT00543855|537217332|FG000|Overall Study|Lost to Follow-up|0|||
148926929|NCT00543855|537217333|FG001|Overall Study|Lost to Follow-up|0|||
149163231|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
149163232|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
149163233|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149163234|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
149163235|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149163236|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
149163237|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
148674833|NCT03692078|536281474|FG000|Overall Study|Enrollment Closed|5|||
149163238|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149163239|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149163240|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
149163241|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
149163242|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
149163243|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149163244|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149163245|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
149163246|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
148674834|NCT03692078|536281475|FG001|Overall Study|Enrollment Closed|0|||
149163247|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149163248|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149163249|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
149163250|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
149163251|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
149163252|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
149163253|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
149163254|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
149163255|NCT05195528|538073623|FG000|Placebo-controlled Treatment Period|Other|0|||
149163256|NCT05195528|538073624|FG001|Placebo-controlled Treatment Period|Other|0|||
149163257|NCT05195528|538073625|FG002|Placebo-controlled Treatment Period|Other|1|||
149163258|NCT05195528|538073626|FG003|Placebo-controlled Treatment Period|Other|0|||
149163259|NCT05195528|538073627|FG004|Placebo-controlled Treatment Period|Other|0|||
149163260|NCT05195528|538073623|FG000|Extension Period|PTE or AE or SAE|0|||
149163261|NCT05195528|538073624|FG001|Extension Period|PTE or AE or SAE|4|||
149163262|NCT05195528|538073625|FG002|Extension Period|PTE or AE or SAE|5|||
149163263|NCT05195528|538073626|FG003|Extension Period|PTE or AE or SAE|4|||
149163264|NCT05195528|538073627|FG004|Extension Period|PTE or AE or SAE|4|||
149163265|NCT05195528|538073623|FG000|Extension Period|Protocol Violation|0|||
149163266|NCT05195528|538073624|FG001|Extension Period|Protocol Violation|2|||
149163267|NCT05195528|538073625|FG002|Extension Period|Protocol Violation|1|||
149163268|NCT05195528|538073626|FG003|Extension Period|Protocol Violation|0|||
149163269|NCT05195528|538073627|FG004|Extension Period|Protocol Violation|1|||
149163270|NCT05195528|538073623|FG000|Extension Period|Lost to Follow-up|0|||
149163271|NCT05195528|538073624|FG001|Extension Period|Lost to Follow-up|6|||
149163272|NCT05195528|538073625|FG002|Extension Period|Lost to Follow-up|13|||
149163273|NCT05195528|538073626|FG003|Extension Period|Lost to Follow-up|3|||
149163274|NCT05195528|538073627|FG004|Extension Period|Lost to Follow-up|7|||
149163275|NCT05195528|538073623|FG000|Extension Period|Withdrawal by Subject|0|||
149163276|NCT05195528|538073624|FG001|Extension Period|Withdrawal by Subject|12|||
149163277|NCT05195528|538073625|FG002|Extension Period|Withdrawal by Subject|9|||
149163278|NCT05195528|538073626|FG003|Extension Period|Withdrawal by Subject|6|||
149163279|NCT05195528|538073627|FG004|Extension Period|Withdrawal by Subject|5|||
149163280|NCT05195528|538073623|FG000|Extension Period|Lack of Efficacy|0|||
149163281|NCT05195528|538073624|FG001|Extension Period|Lack of Efficacy|3|||
149163282|NCT05195528|538073625|FG002|Extension Period|Lack of Efficacy|0|||
149163283|NCT05195528|538073626|FG003|Extension Period|Lack of Efficacy|0|||
149163284|NCT05195528|538073627|FG004|Extension Period|Lack of Efficacy|2|||
149163285|NCT05195528|538073623|FG000|Extension Period|Not Treated|0|||
149163286|NCT05195528|538073624|FG001|Extension Period|Not Treated|0|||
149163287|NCT05195528|538073625|FG002|Extension Period|Not Treated|2|||
149163288|NCT05195528|538073626|FG003|Extension Period|Not Treated|3|||
149163289|NCT05195528|538073627|FG004|Extension Period|Not Treated|0|||
149163290|NCT05195528|538073623|FG000|Extension Period|Other|0|||
149163291|NCT05195528|538073624|FG001|Extension Period|Other|1|||
149163292|NCT05195528|538073625|FG002|Extension Period|Other|1|||
149163293|NCT05195528|538073626|FG003|Extension Period|Other|0|||
149163294|NCT05195528|538073627|FG004|Extension Period|Other|0|||
149163295|NCT01552902|538073628|FG000|Overall Study|Adverse Event|1|||
149163296|NCT01552902|538073629|FG001|Overall Study|Adverse Event|15|||
149163297|NCT01552902|538073630|FG002|Overall Study|Adverse Event|14|||
149163298|NCT01552902|538073628|FG000|Overall Study|Protocol Violation|3|||
149163299|NCT01552902|538073629|FG001|Overall Study|Protocol Violation|3|||
149163300|NCT01552902|538073630|FG002|Overall Study|Protocol Violation|3|||
149163301|NCT01552902|538073628|FG000|Overall Study|Lack of Efficacy|4|||
149163302|NCT01552902|538073629|FG001|Overall Study|Lack of Efficacy|3|||
148674835|NCT03692078|536281476|FG002|Overall Study|Enrollment Closed|0|||
148926930|NCT00543855|537217334|FG002|Overall Study|Lost to Follow-up|1|||
148926931|NCT00543855|537217335|FG003|Overall Study|Lost to Follow-up|0|||
148926932|NCT00543855|537217332|FG000|Overall Study|Withdrawal by Subject|0|||
149163303|NCT01552902|538073630|FG002|Overall Study|Lack of Efficacy|1|||
149163304|NCT01552902|538073628|FG000|Overall Study|Withdrawal by Subject|1|||
149163305|NCT01552902|538073629|FG001|Overall Study|Withdrawal by Subject|9|||
148674836|NCT03692078|536281477|FG003|Overall Study|Enrollment Closed|0|||
148926933|NCT00543855|537217333|FG001|Overall Study|Withdrawal by Subject|1|||
148926934|NCT00543855|537217334|FG002|Overall Study|Withdrawal by Subject|2|||
148926935|NCT00543855|537217335|FG003|Overall Study|Withdrawal by Subject|0|||
149163306|NCT01552902|538073630|FG002|Overall Study|Withdrawal by Subject|6|||
149163307|NCT01552902|538073628|FG000|Overall Study|Lost to Follow-up|1|||
149163308|NCT01552902|538073629|FG001|Overall Study|Lost to Follow-up|3|||
149163309|NCT01552902|538073630|FG002|Overall Study|Lost to Follow-up|6|||
149163310|NCT01552902|538073628|FG000|Overall Study|Other|3|||
149163311|NCT01552902|538073629|FG001|Overall Study|Other|4|||
149163312|NCT01552902|538073630|FG002|Overall Study|Other|3|||
149163313|NCT02720757|538073631|FG000|Overall Study|Other reason|5|||
148674837|NCT03692078|536281478|FG004|Overall Study|Enrollment Closed|0|||
149163314|NCT02720757|538073631|FG000|Overall Study|Loss of contact|4|||
149163315|NCT02720757|538073631|FG000|Overall Study|Informed consent withdrawal|1|||
149163316|NCT02720757|538073631|FG000|Overall Study|Patients wish to withdraw|2|||
149163317|NCT02720757|538073631|FG000|Overall Study|Missing|3|||
149163318|NCT02720757|538073631|FG000|Overall Study|General exclusion|3|||
149163319|NCT02631538|538073632|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
149163320|NCT02631538|538073633|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
149163321|NCT02631538|538073634|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
149163322|NCT02631538|538073635|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
149163323|NCT02631538|538073632|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
149163324|NCT02631538|538073633|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
149163325|NCT02631538|538073634|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
149163326|NCT02631538|538073635|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
149163327|NCT02631538|538073632|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
149163328|NCT02631538|538073633|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
149163329|NCT02631538|538073634|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
149163330|NCT02631538|538073635|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
149163331|NCT02631538|538073632|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
149163332|NCT02631538|538073633|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
149163333|NCT02631538|538073634|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
149163334|NCT02631538|538073635|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
149163335|NCT02631538|538073632|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
149163336|NCT02631538|538073633|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
149163337|NCT02631538|538073634|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
149163338|NCT02631538|538073635|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
149163339|NCT02631538|538073632|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
149163340|NCT02631538|538073633|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
149163341|NCT02631538|538073634|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
149163342|NCT02631538|538073635|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
149163343|NCT01554579|538073636|FG000|Overall Study|Adverse Event|6|||
149163344|NCT01554579|538073637|FG001|Overall Study|Adverse Event|25|||
149163345|NCT01554579|538073636|FG000|Overall Study|Lack of Efficacy|2|||
149163346|NCT01554579|538073637|FG001|Overall Study|Lack of Efficacy|1|||
149163347|NCT01554579|538073636|FG000|Overall Study|Withdrawal by Subject|2|||
149163348|NCT01554579|538073637|FG001|Overall Study|Withdrawal by Subject|1|||
149163349|NCT00234039|538073638|FG000|Overall Study|Adverse Event|2|||
149163350|NCT00234039|538073638|FG000|Overall Study|Progression/relapse|34|||
149163351|NCT00234039|538073638|FG000|Overall Study|Other - Not Protocol Specified|3|||
149163352|NCT00234039|538073638|FG000|Overall Study|Ineligible|9|||
149163353|NCT00234039|538073638|FG000|Overall Study|No Protocol Treatment Received|2|||
149163354|NCT00110019|538073639|FG000|Overall Study|Lack of Efficacy|253|||
149163355|NCT00110019|538073640|FG001|Overall Study|Lack of Efficacy|285|||
149163356|NCT00110019|538073639|FG000|Overall Study|Adverse Event|61|||
149163357|NCT00110019|538073640|FG001|Overall Study|Adverse Event|40|||
149163358|NCT00110019|538073639|FG000|Overall Study|Death|13|||
149163359|NCT00110019|538073640|FG001|Overall Study|Death|15|||
149163360|NCT00110019|538073639|FG000|Overall Study|Withdrawal by Subject|21|||
149163361|NCT00110019|538073640|FG001|Overall Study|Withdrawal by Subject|9|||
149163362|NCT00110019|538073639|FG000|Overall Study|alternative therapy|5|||
149163363|NCT00110019|538073640|FG001|Overall Study|alternative therapy|1|||
149163364|NCT00110019|538073639|FG000|Overall Study|complicating disease|1|||
149163365|NCT00110019|538073640|FG001|Overall Study|complicating disease|1|||
149163366|NCT00110019|538073639|FG000|Overall Study|symptom deterioration|13|||
149163367|NCT00110019|538073640|FG001|Overall Study|symptom deterioration|16|||
149163368|NCT00110019|538073639|FG000|Overall Study|Not start protocol therapy|17|||
149163369|NCT00110019|538073640|FG001|Overall Study|Not start protocol therapy|16|||
149163370|NCT00110019|538073639|FG000|Overall Study|other reasons|22|||
149163371|NCT00110019|538073640|FG001|Overall Study|other reasons|30|||
149163372|NCT02239263|538073643|FG000|Overall Study|Protocol Violation|6|||
149163373|NCT01046695|538073644|FG000|Overall Study|Subject had a pacemaker|0|||
149163374|NCT01046695|538073645|FG001|Overall Study|Subject had a pacemaker|1|||
149163375|NCT01046695|538073644|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
149163376|NCT01046695|538073645|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
149163377|NCT04426695|538073646|FG000|Overall Study|Death|2|||
149163378|NCT04426695|538073647|FG001|Overall Study|Death|0|||
149163379|NCT04426695|538073648|FG002|Overall Study|Death|1|||
149163380|NCT04426695|538073649|FG003|Overall Study|Death|27|||
149163381|NCT04426695|538073650|FG004|Overall Study|Death|25|||
149163382|NCT04426695|538073651|FG005|Overall Study|Death|21|||
149163383|NCT04426695|538073652|FG006|Overall Study|Death|42|||
149163384|NCT04426695|538073653|FG007|Overall Study|Death|23|||
149163385|NCT04426695|538073654|FG008|Overall Study|Death|37|||
149163386|NCT04426695|538073655|FG009|Overall Study|Death|14|||
149163387|NCT04426695|538073656|FG010|Overall Study|Death|8|||
149163388|NCT04426695|538073657|FG011|Overall Study|Death|7|||
149163389|NCT04426695|538073658|FG012|Overall Study|Death|13|||
149163390|NCT04426695|538073659|FG013|Overall Study|Death|25|||
149163391|NCT04426695|538073660|FG014|Overall Study|Death|19|||
149163392|NCT04426695|538073661|FG015|Overall Study|Death|7|||
149163393|NCT04426695|538073662|FG016|Overall Study|Death|8|||
149163394|NCT04426695|538073663|FG017|Overall Study|Death|4|||
149163395|NCT04426695|538073646|FG000|Overall Study|Lost to Follow-up|2|||
148926936|NCT00543855|537217332|FG000|Overall Study|Protocol Violation|1|||
148926937|NCT00543855|537217333|FG001|Overall Study|Protocol Violation|0|||
149163396|NCT04426695|538073647|FG001|Overall Study|Lost to Follow-up|4|||
149163397|NCT04426695|538073648|FG002|Overall Study|Lost to Follow-up|1|||
149163398|NCT04426695|538073649|FG003|Overall Study|Lost to Follow-up|19|||
149163399|NCT04426695|538073650|FG004|Overall Study|Lost to Follow-up|10|||
149163400|NCT04426695|538073651|FG005|Overall Study|Lost to Follow-up|14|||
149163401|NCT04426695|538073652|FG006|Overall Study|Lost to Follow-up|5|||
149163402|NCT04426695|538073653|FG007|Overall Study|Lost to Follow-up|14|||
149163403|NCT04426695|538073654|FG008|Overall Study|Lost to Follow-up|10|||
149163404|NCT04426695|538073655|FG009|Overall Study|Lost to Follow-up|11|||
149163405|NCT04426695|538073656|FG010|Overall Study|Lost to Follow-up|12|||
149163406|NCT04426695|538073657|FG011|Overall Study|Lost to Follow-up|6|||
149163407|NCT04426695|538073658|FG012|Overall Study|Lost to Follow-up|2|||
149163408|NCT04426695|538073659|FG013|Overall Study|Lost to Follow-up|2|||
149163409|NCT04426695|538073660|FG014|Overall Study|Lost to Follow-up|2|||
149163410|NCT04426695|538073661|FG015|Overall Study|Lost to Follow-up|0|||
149163411|NCT04426695|538073662|FG016|Overall Study|Lost to Follow-up|0|||
149163412|NCT04426695|538073663|FG017|Overall Study|Lost to Follow-up|0|||
148926938|NCT00543855|537217334|FG002|Overall Study|Protocol Violation|0|||
149163413|NCT04426695|538073646|FG000|Overall Study|Participant Decision|1|||
149163414|NCT04426695|538073647|FG001|Overall Study|Participant Decision|2|||
149163415|NCT04426695|538073648|FG002|Overall Study|Participant Decision|2|||
149163416|NCT04426695|538073649|FG003|Overall Study|Participant Decision|12|||
149163417|NCT04426695|538073650|FG004|Overall Study|Participant Decision|18|||
149163418|NCT04426695|538073651|FG005|Overall Study|Participant Decision|22|||
149163419|NCT04426695|538073652|FG006|Overall Study|Participant Decision|13|||
149163420|NCT04426695|538073653|FG007|Overall Study|Participant Decision|13|||
149163421|NCT04426695|538073654|FG008|Overall Study|Participant Decision|10|||
149163422|NCT04426695|538073655|FG009|Overall Study|Participant Decision|15|||
149163423|NCT04426695|538073656|FG010|Overall Study|Participant Decision|16|||
149163424|NCT04426695|538073657|FG011|Overall Study|Participant Decision|17|||
149163425|NCT04426695|538073658|FG012|Overall Study|Participant Decision|2|||
149163426|NCT04426695|538073659|FG013|Overall Study|Participant Decision|1|||
149163427|NCT04426695|538073660|FG014|Overall Study|Participant Decision|2|||
149163428|NCT04426695|538073661|FG015|Overall Study|Participant Decision|0|||
149163429|NCT04426695|538073662|FG016|Overall Study|Participant Decision|0|||
149163430|NCT04426695|538073663|FG017|Overall Study|Participant Decision|0|||
149163431|NCT04426695|538073646|FG000|Overall Study|Adverse Event|0|||
149163432|NCT04426695|538073647|FG001|Overall Study|Adverse Event|0|||
149163433|NCT04426695|538073648|FG002|Overall Study|Adverse Event|0|||
149163434|NCT04426695|538073649|FG003|Overall Study|Adverse Event|0|||
149163435|NCT04426695|538073650|FG004|Overall Study|Adverse Event|0|||
149163436|NCT04426695|538073651|FG005|Overall Study|Adverse Event|0|||
149163437|NCT04426695|538073652|FG006|Overall Study|Adverse Event|0|||
149163438|NCT04426695|538073653|FG007|Overall Study|Adverse Event|1|||
149163439|NCT04426695|538073654|FG008|Overall Study|Adverse Event|0|||
148926939|NCT00543855|537217335|FG003|Overall Study|Protocol Violation|0|||
149163440|NCT04426695|538073655|FG009|Overall Study|Adverse Event|0|||
149163441|NCT04426695|538073656|FG010|Overall Study|Adverse Event|1|||
148674838|NCT03692078|536281479|FG005|Overall Study|Enrollment Closed|0|||
148926940|NCT03139604|537217336|FG000|Overall Study|Other|7|||
148926941|NCT03139604|537217337|FG001|Overall Study|Other|3|||
148926942|NCT03139604|537217336|FG000|Overall Study|Withdrawal by Subject|16|||
149163442|NCT04426695|538073657|FG011|Overall Study|Adverse Event|1|||
149163443|NCT04426695|538073658|FG012|Overall Study|Adverse Event|0|||
149163444|NCT04426695|538073659|FG013|Overall Study|Adverse Event|0|||
149163445|NCT04426695|538073660|FG014|Overall Study|Adverse Event|0|||
149163446|NCT04426695|538073661|FG015|Overall Study|Adverse Event|0|||
148806202|NCT04589650|536768103|FG002|Overall Study|Subject decision|2|||
149163447|NCT04426695|538073662|FG016|Overall Study|Adverse Event|0|||
148926943|NCT03139604|537217337|FG001|Overall Study|Withdrawal by Subject|17|||
148926944|NCT03139604|537217336|FG000|Overall Study|Physician Decision|1|||
149163448|NCT04426695|538073663|FG017|Overall Study|Adverse Event|0|||
149163449|NCT04426695|538073646|FG000|Overall Study|Sponsor Request|0|||
149163450|NCT04426695|538073647|FG001|Overall Study|Sponsor Request|0|||
149163451|NCT04426695|538073648|FG002|Overall Study|Sponsor Request|0|||
149163452|NCT04426695|538073649|FG003|Overall Study|Sponsor Request|0|||
149163453|NCT04426695|538073650|FG004|Overall Study|Sponsor Request|0|||
149163454|NCT04426695|538073651|FG005|Overall Study|Sponsor Request|0|||
149163455|NCT04426695|538073652|FG006|Overall Study|Sponsor Request|1|||
149163456|NCT04426695|538073653|FG007|Overall Study|Sponsor Request|0|||
149163457|NCT04426695|538073654|FG008|Overall Study|Sponsor Request|0|||
149163458|NCT04426695|538073655|FG009|Overall Study|Sponsor Request|0|||
149163459|NCT04426695|538073656|FG010|Overall Study|Sponsor Request|0|||
149163460|NCT04426695|538073657|FG011|Overall Study|Sponsor Request|0|||
149163461|NCT04426695|538073658|FG012|Overall Study|Sponsor Request|0|||
149163462|NCT04426695|538073659|FG013|Overall Study|Sponsor Request|0|||
149163463|NCT04426695|538073660|FG014|Overall Study|Sponsor Request|0|||
149163464|NCT04426695|538073661|FG015|Overall Study|Sponsor Request|0|||
149163465|NCT04426695|538073662|FG016|Overall Study|Sponsor Request|0|||
149163466|NCT04426695|538073663|FG017|Overall Study|Sponsor Request|0|||
149163467|NCT04426695|538073646|FG000|Overall Study|Physician Decision|0|||
149163468|NCT04426695|538073647|FG001|Overall Study|Physician Decision|0|||
149163469|NCT04426695|538073648|FG002|Overall Study|Physician Decision|0|||
149163470|NCT04426695|538073649|FG003|Overall Study|Physician Decision|0|||
149163471|NCT04426695|538073650|FG004|Overall Study|Physician Decision|0|||
149163472|NCT04426695|538073651|FG005|Overall Study|Physician Decision|0|||
149163473|NCT04426695|538073652|FG006|Overall Study|Physician Decision|0|||
149163474|NCT04426695|538073653|FG007|Overall Study|Physician Decision|0|||
149163475|NCT04426695|538073654|FG008|Overall Study|Physician Decision|0|||
149163476|NCT04426695|538073655|FG009|Overall Study|Physician Decision|1|||
149163477|NCT04426695|538073656|FG010|Overall Study|Physician Decision|0|||
149163478|NCT04426695|538073657|FG011|Overall Study|Physician Decision|0|||
149163479|NCT04426695|538073658|FG012|Overall Study|Physician Decision|1|||
149163480|NCT04426695|538073659|FG013|Overall Study|Physician Decision|0|||
149163481|NCT04426695|538073660|FG014|Overall Study|Physician Decision|0|||
149163482|NCT04426695|538073661|FG015|Overall Study|Physician Decision|0|||
149163483|NCT04426695|538073662|FG016|Overall Study|Physician Decision|0|||
149163484|NCT04426695|538073663|FG017|Overall Study|Physician Decision|0|||
148926945|NCT03139604|537217337|FG001|Overall Study|Physician Decision|2|||
148926946|NCT03139604|537217336|FG000|Overall Study|Lost to Follow-up|3|||
148926947|NCT03139604|537217337|FG001|Overall Study|Lost to Follow-up|1|||
148926948|NCT03139604|537217336|FG000|Overall Study|Death|65|||
149163485|NCT04426695|538073646|FG000|Overall Study|Randomized but Never Treated|3|||
149163486|NCT04426695|538073647|FG001|Overall Study|Randomized but Never Treated|1|||
149163487|NCT04426695|538073648|FG002|Overall Study|Randomized but Never Treated|0|||
149163488|NCT04426695|538073649|FG003|Overall Study|Randomized but Never Treated|4|||
149163489|NCT04426695|538073650|FG004|Overall Study|Randomized but Never Treated|5|||
149163490|NCT04426695|538073651|FG005|Overall Study|Randomized but Never Treated|5|||
149163491|NCT04426695|538073652|FG006|Overall Study|Randomized but Never Treated|4|||
149163492|NCT04426695|538073653|FG007|Overall Study|Randomized but Never Treated|6|||
148674839|NCT03692078|536281480|FG006|Overall Study|Enrollment Closed|0|||
148674840|NCT03692078|536281474|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
148674841|NCT03692078|536281475|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
148674842|NCT03692078|536281476|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
148674843|NCT03692078|536281477|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
148674844|NCT03692078|536281478|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
148674845|NCT03692078|536281479|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
148674846|NCT03692078|536281480|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
148674847|NCT03692078|536281474|FG000|Overall Study|Withdrawal by Subject|0|||
148674848|NCT03692078|536281475|FG001|Overall Study|Withdrawal by Subject|2|||
148674849|NCT03692078|536281476|FG002|Overall Study|Withdrawal by Subject|0|||
148674850|NCT03692078|536281477|FG003|Overall Study|Withdrawal by Subject|1|||
148674851|NCT03692078|536281478|FG004|Overall Study|Withdrawal by Subject|5|||
148674852|NCT03692078|536281479|FG005|Overall Study|Withdrawal by Subject|3|||
148674853|NCT03692078|536281480|FG006|Overall Study|Withdrawal by Subject|3|||
148674854|NCT05723835|536281484|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
148674855|NCT05723835|536281485|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
148674856|NCT05723835|536281486|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
148674857|NCT05723835|536281487|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
148674858|NCT05723835|536281488|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
148674859|NCT05723835|536281489|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
148674860|NCT05723835|536281490|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
148674861|NCT05723835|536281491|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
148674862|NCT05226286|536281492|FG000|Overall Study|Screen failures prior to implant|62|||
148674863|NCT05226286|536281492|FG000|Overall Study|Withdrawal by Subject|13|||
148674864|NCT05226286|536281492|FG000|Overall Study|Lost to Follow-up|3|||
148674865|NCT05226286|536281492|FG000|Overall Study|Physician Decision|1|||
148674866|NCT05226286|536281492|FG000|Overall Study|Adverse Event|1|||
148674867|NCT05226286|536281492|FG000|Overall Study|Death|1|||
148674868|NCT05226286|536281492|FG000|Overall Study|Device explant with no planned replacement|1|||
148674869|NCT05226286|536281492|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
149163493|NCT04426695|538073654|FG008|Overall Study|Randomized but Never Treated|6|||
148674870|NCT05226286|536281492|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
148674871|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
148674872|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
148674873|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
148674874|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
148674875|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
148674876|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
148674877|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
148674878|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
148674879|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
148674880|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
148674881|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
148674882|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
148674883|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
148674884|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
148674885|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
148674886|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
148674887|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
148674888|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
148674889|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
148674890|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
148674891|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
148674892|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
148674893|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
148674894|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
148674895|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
148674896|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
148674897|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
148674898|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
149012898|NCT00152971|537525841|FG000|Overall Study|Lost to Follow-up|17|||
148926949|NCT03139604|537217337|FG001|Overall Study|Death|67|||
148926950|NCT03139604|537217336|FG000|Overall Study|Study Terminated by Sponsor|122|||
148926951|NCT03139604|537217337|FG001|Overall Study|Study Terminated by Sponsor|127|||
148926952|NCT03139604|537217336|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
148926953|NCT03139604|537217337|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
149163494|NCT04426695|538073655|FG009|Overall Study|Randomized but Never Treated|3|||
149163495|NCT04426695|538073656|FG010|Overall Study|Randomized but Never Treated|3|||
149163496|NCT04426695|538073657|FG011|Overall Study|Randomized but Never Treated|6|||
149163497|NCT04426695|538073658|FG012|Overall Study|Randomized but Never Treated|1|||
149163498|NCT04426695|538073659|FG013|Overall Study|Randomized but Never Treated|2|||
149163499|NCT04426695|538073660|FG014|Overall Study|Randomized but Never Treated|0|||
149163500|NCT04426695|538073661|FG015|Overall Study|Randomized but Never Treated|0|||
149163501|NCT04426695|538073662|FG016|Overall Study|Randomized but Never Treated|0|||
149163502|NCT04426695|538073663|FG017|Overall Study|Randomized but Never Treated|0|||
149163503|NCT04303000|538073664|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
149163504|NCT04303000|538073665|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
149163505|NCT04303000|538073666|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
149163506|NCT04276207|538073668|FG000|Period 1|Withdrawal by Subject|0|||
149163507|NCT04276207|538073669|FG001|Period 1|Withdrawal by Subject|1|||
149163508|NCT05655377|538073670|FG000|Overall Study|Withdrawal by Subject|2|||
149163509|NCT01256177|538073671|FG000|Overall Study|Withdrawal by Subject|23|||
149163510|NCT01256177|538073672|FG001|Overall Study|Withdrawal by Subject|22|||
149163511|NCT01256177|538073671|FG000|Overall Study|Lost to Follow-up|2|||
149163512|NCT01256177|538073672|FG001|Overall Study|Lost to Follow-up|2|||
149163513|NCT01256177|538073671|FG000|Overall Study|Adverse Event|8|||
149163514|NCT01256177|538073672|FG001|Overall Study|Adverse Event|9|||
149163515|NCT01256177|538073671|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
149163516|NCT01256177|538073672|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
149163517|NCT01256177|538073671|FG000|Overall Study|Condition under Investigation Worsened|1|||
149163518|NCT01256177|538073672|FG001|Overall Study|Condition under Investigation Worsened|0|||
149163519|NCT01256177|538073671|FG000|Overall Study|Lack of Efficacy|11|||
149163520|NCT01256177|538073672|FG001|Overall Study|Lack of Efficacy|2|||
149163521|NCT01256177|538073671|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
149163522|NCT01256177|538073672|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
149163523|NCT03118947|538073673|FG000|Overall Study|Adverse Event|7|||
149163524|NCT03118947|538073673|FG000|Overall Study|Death|3|||
149163525|NCT03118947|538073673|FG000|Overall Study|Lack of Efficacy|4|||
149163526|NCT03118947|538073673|FG000|Overall Study|Non-compliance with study drug|1|||
149163527|NCT03118947|538073673|FG000|Overall Study|Protocol Violation|2|||
149163528|NCT03118947|538073673|FG000|Overall Study|Withdrawal by Subject|3|||
149163529|NCT03118947|538073673|FG000|Overall Study|Withdrawal by caregiver|3|||
149163530|NCT03118947|538073673|FG000|Overall Study|Change in patient's living situation|4|||
149163531|NCT03118947|538073673|FG000|Overall Study|Lost to Follow-up|2|||
149163532|NCT03653390|538073674|FG000|Overall Study|Lost to Follow-up|12|||
149163533|NCT03653390|538073675|FG001|Overall Study|Lost to Follow-up|8|||
149163534|NCT03653390|538073676|FG002|Overall Study|Lost to Follow-up|7|||
149163535|NCT03653390|538073674|FG000|Overall Study|Withdrawal by Subject|6|||
149163536|NCT03653390|538073675|FG001|Overall Study|Withdrawal by Subject|1|||
149163537|NCT03653390|538073676|FG002|Overall Study|Withdrawal by Subject|1|||
149163538|NCT03653390|538073674|FG000|Overall Study|Death|1|||
149163539|NCT03653390|538073675|FG001|Overall Study|Death|0|||
149163540|NCT03653390|538073676|FG002|Overall Study|Death|0|||
149163541|NCT03653390|538073674|FG000|Overall Study|Paper Survey Lost|1|||
149163542|NCT03653390|538073675|FG001|Overall Study|Paper Survey Lost|0|||
149163543|NCT03653390|538073676|FG002|Overall Study|Paper Survey Lost|0|||
149163544|NCT04451330|538073679|FG000|Overall Study|Adverse Event|1|||
149163545|NCT04451330|538073680|FG001|Overall Study|Adverse Event|2|||
149163546|NCT04451330|538073679|FG000|Overall Study|Lost to Follow-up|5|||
149163547|NCT04451330|538073680|FG001|Overall Study|Lost to Follow-up|0|||
149163548|NCT04451330|538073679|FG000|Overall Study|Withdrawal by Subject|3|||
149163549|NCT04451330|538073680|FG001|Overall Study|Withdrawal by Subject|1|||
149163550|NCT04451330|538073679|FG000|Overall Study|Withdrawal by parent/guardian|1|||
149163551|NCT04451330|538073680|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149163552|NCT04451330|538073679|FG000|Overall Study|Other than specified|0|||
149163553|NCT04451330|538073680|FG001|Overall Study|Other than specified|1|||
149163554|NCT00531960|538073685|FG000|Overall Study|Adverse Event|5|||
149163555|NCT00531960|538073686|FG001|Overall Study|Adverse Event|4|||
149163556|NCT00531960|538073685|FG000|Overall Study|Death|3|||
149163557|NCT00531960|538073686|FG001|Overall Study|Death|2|||
149163558|NCT00531960|538073685|FG000|Overall Study|Lack of Efficacy|42|||
149163559|NCT00531960|538073686|FG001|Overall Study|Lack of Efficacy|41|||
149163560|NCT00531960|538073685|FG000|Overall Study|Violation of Selection Criteria|2|||
149163561|NCT00531960|538073686|FG001|Overall Study|Violation of Selection Criteria|0|||
149163562|NCT00531960|538073685|FG000|Overall Study|Refused Treatment|5|||
149163563|NCT00531960|538073686|FG001|Overall Study|Refused Treatment|6|||
149163564|NCT00531960|538073685|FG000|Overall Study|Other|4|||
149163565|NCT00531960|538073686|FG001|Overall Study|Other|10|||
149163566|NCT00331006|538073689|FG000|Screening Phase|Withdrawal by Subject|1|||
149163567|NCT00331006|538073689|FG000|Screening Phase|enrollment halted|1|||
149163568|NCT00331006|538073689|FG000|Screening Phase|Lost to Follow-up|1|||
148674899|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
148674900|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
148674901|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
148674902|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
148674903|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
148674904|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
148674905|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
148674906|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
148674907|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
148674908|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
148926954|NCT00740246|537217341|FG000|Overall Study|Received Blood Transfusion|0|||
148926955|NCT00740246|537217342|FG001|Overall Study|Received Blood Transfusion|1|||
149163569|NCT00331006|538073689|FG000|Screening Phase|Ineligible for treatment phase|4|||
148926956|NCT00740246|537217341|FG000|Overall Study|Adverse Event|1|||
148926957|NCT00740246|537217342|FG001|Overall Study|Adverse Event|2|||
149163570|NCT00331006|538073689|FG000|Treatment Phase|Withdrawal by Subject|1|||
149163571|NCT00331006|538073689|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
148674909|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
148806203|NCT04589650|536768104|FG003|Overall Study|Subject decision|0|||
148926958|NCT00740246|537217341|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
148926959|NCT00740246|537217342|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
149163572|NCT00331006|538073689|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
149163573|NCT02532855|538073695|FG000|Overall Study|Lost to Follow-up|4|||
148926960|NCT00740246|537217341|FG000|Overall Study|Lost to Follow-up|2|||
149163574|NCT02532855|538073696|FG001|Overall Study|Lost to Follow-up|3|||
149163575|NCT02532855|538073695|FG000|Overall Study|Withdrawal by Subject|4|||
149163576|NCT02532855|538073696|FG001|Overall Study|Withdrawal by Subject|8|||
149163577|NCT04178772|538073718|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
149163578|NCT04178772|538073718|FG000|Overall Study|study terminated early due to COVID-19|7|||
149163579|NCT04897867|538073719|FG000|Overall Study|Withdrawal of Consent|1|||
149163580|NCT04897867|538073719|FG000|Overall Study|Pregnancy|1|||
149163581|NCT04897867|538073719|FG000|Overall Study|Lost to Follow-up|7|||
149163582|NCT04897867|538073719|FG000|Overall Study|Reason not Specified|2|||
149163583|NCT00508391|538073720|FG000|First Treatment|Withdrawal by Subject|6|||
149163584|NCT00508391|538073721|FG001|First Treatment|Withdrawal by Subject|3|||
149163585|NCT00508391|538073720|FG000|Second Treatment|Withdrawal by Subject|2|||
149163586|NCT00508391|538073721|FG001|Second Treatment|Withdrawal by Subject|0|||
149163587|NCT00880256|538073722|FG000|Overall Study|Lost to Follow-up|28|||
149163588|NCT00802360|538073723|FG000|Overall Study|Stimulation failure|4|||
149163589|NCT00802360|538073724|FG001|Overall Study|Stimulation failure|0|||
149163590|NCT00802360|538073725|FG002|Overall Study|Stimulation failure|3|||
149163591|NCT00802360|538073726|FG003|Overall Study|Stimulation failure|3|||
149163592|NCT00802360|538073723|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
149163593|NCT00802360|538073724|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
149163594|NCT00802360|538073725|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
149163595|NCT00802360|538073726|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
149163596|NCT00802360|538073723|FG000|Overall Study|Cycle cancelled|0|||
149163597|NCT00802360|538073724|FG001|Overall Study|Cycle cancelled|1|||
149163598|NCT00802360|538073725|FG002|Overall Study|Cycle cancelled|1|||
149163599|NCT00802360|538073726|FG003|Overall Study|Cycle cancelled|1|||
149163600|NCT00802360|538073723|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
149163601|NCT00802360|538073724|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
149163602|NCT00802360|538073725|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
149163603|NCT00802360|538073726|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
149163604|NCT00802360|538073723|FG000|Overall Study|No positive serum pregnancy|17|||
149163605|NCT00802360|538073724|FG001|Overall Study|No positive serum pregnancy|20|||
149163606|NCT00802360|538073725|FG002|Overall Study|No positive serum pregnancy|14|||
149163607|NCT00802360|538073726|FG003|Overall Study|No positive serum pregnancy|10|||
149163608|NCT00802360|538073723|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
149163609|NCT00802360|538073724|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
149163610|NCT00802360|538073725|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
149163611|NCT00802360|538073726|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
149163612|NCT00802360|538073723|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
149163613|NCT00802360|538073724|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
149163614|NCT00802360|538073725|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
149163615|NCT00802360|538073726|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
149163616|NCT00802360|538073723|FG000|Overall Study|Other|2|||
149163617|NCT00802360|538073724|FG001|Overall Study|Other|3|||
149163618|NCT00802360|538073725|FG002|Overall Study|Other|6|||
149163619|NCT00802360|538073726|FG003|Overall Study|Other|3|||
149163620|NCT02041962|538073727|FG000|Overall Study|Lost Aetna Coverage|43|||
149163621|NCT02041962|538073728|FG001|Overall Study|Lost Aetna Coverage|40|||
149163622|NCT02041962|538073727|FG000|Overall Study|Death|1|||
149163623|NCT02041962|538073728|FG001|Overall Study|Death|1|||
149163624|NCT02041962|538073727|FG000|Overall Study|Lost to Follow-up|37|||
149163625|NCT02041962|538073728|FG001|Overall Study|Lost to Follow-up|32|||
149163626|NCT02041962|538073727|FG000|Overall Study|Withdrawal by Subject|0|||
149163627|NCT02041962|538073728|FG001|Overall Study|Withdrawal by Subject|11|||
149163628|NCT00330187|538073731|FG000|Overall Study|Lost to Follow-up|12|||
149163629|NCT00330187|538073732|FG001|Overall Study|Lost to Follow-up|13|||
149163630|NCT00330187|538073733|FG002|Overall Study|Lost to Follow-up|14|||
149163631|NCT00330187|538073734|FG003|Overall Study|Lost to Follow-up|10|||
149163632|NCT00330187|538073731|FG000|Overall Study|Withdrawal by Subject|8|||
149163633|NCT00330187|538073732|FG001|Overall Study|Withdrawal by Subject|5|||
149163634|NCT00330187|538073733|FG002|Overall Study|Withdrawal by Subject|4|||
149163635|NCT00330187|538073734|FG003|Overall Study|Withdrawal by Subject|4|||
149163636|NCT02908516|538073735|FG000|Overall Study|Study Terminated|3|||
149163637|NCT02908516|538073736|FG001|Overall Study|Study Terminated|3|||
149163638|NCT01225562|538073737|FG000|Overall Study|Withdrawal by Subject|52|||
149163639|NCT01225562|538073738|FG001|Overall Study|Withdrawal by Subject|50|||
149163640|NCT01225562|538073739|FG002|Overall Study|Withdrawal by Subject|52|||
149163641|NCT01225562|538073737|FG000|Overall Study|Lost to Follow-up|3|||
149163642|NCT01225562|538073738|FG001|Overall Study|Lost to Follow-up|6|||
149163643|NCT01225562|538073739|FG002|Overall Study|Lost to Follow-up|1|||
149163644|NCT02601573|538073742|FG000|Overall Study|Lost to Follow-up|0|||
149163645|NCT02601573|538073743|FG001|Overall Study|Lost to Follow-up|3|||
148926961|NCT00740246|537217342|FG001|Overall Study|Lost to Follow-up|2|||
148926962|NCT00740246|537217341|FG000|Overall Study|Withdrawal by Subject|4|||
148926963|NCT00740246|537217342|FG001|Overall Study|Withdrawal by Subject|3|||
148926964|NCT00740246|537217341|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
148926965|NCT00740246|537217342|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
148926966|NCT00740246|537217341|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
148926967|NCT00740246|537217342|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
148926968|NCT00740246|537217341|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
148926969|NCT00740246|537217342|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
148926970|NCT00740246|537217341|FG000|Overall Study|Unable To Comply With Study Visits|2|||
148926971|NCT00740246|537217342|FG001|Overall Study|Unable To Comply With Study Visits|0|||
148926972|NCT00740246|537217341|FG000|Overall Study|Unable to Access Vein|0|||
148926973|NCT00740246|537217342|FG001|Overall Study|Unable to Access Vein|2|||
148926974|NCT00740246|537217341|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
148926975|NCT00740246|537217342|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
148926976|NCT01117051|537217345|FG000|Overall Study|Withdrawal by Subject|5|||
148926977|NCT01117051|537217346|FG001|Overall Study|Withdrawal by Subject|3|||
148926978|NCT01117051|537217345|FG000|Overall Study|Adverse Event|4|||
148926979|NCT01117051|537217346|FG001|Overall Study|Adverse Event|3|||
148926980|NCT01117051|537217345|FG000|Overall Study|Lost to Follow-up|0|||
148926981|NCT01117051|537217346|FG001|Overall Study|Lost to Follow-up|1|||
148926982|NCT01117051|537217345|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
148926983|NCT01117051|537217346|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
148926984|NCT01117051|537217345|FG000|Overall Study|Sponsor's decision|3|||
148926985|NCT01117051|537217346|FG001|Overall Study|Sponsor's decision|1|||
148926986|NCT01117051|537217345|FG000|Overall Study|Surgical procedure|0|||
148926987|NCT01117051|537217346|FG001|Overall Study|Surgical procedure|1|||
148926988|NCT01117051|537217345|FG000|Overall Study|Randomized by mistake|0|||
148926989|NCT01117051|537217346|FG001|Overall Study|Randomized by mistake|1|||
148926990|NCT01117051|537217345|FG000|Overall Study|Convenience issue|1|||
148926991|NCT01117051|537217346|FG001|Overall Study|Convenience issue|0|||
148926992|NCT00662532|537217348|FG000|Overall Study|Adverse Event|0|||
148926993|NCT00662532|537217349|FG001|Overall Study|Adverse Event|1|||
148926994|NCT00662532|537217348|FG000|Overall Study|Lost to Follow-up|0|||
148926995|NCT00662532|537217349|FG001|Overall Study|Lost to Follow-up|1|||
148926996|NCT00366340|537217350|FG000|Infant Series|Protocol Violation|3|||
148926997|NCT00366340|537217351|FG001|Infant Series|Protocol Violation|4|||
148926998|NCT00366340|537217350|FG000|Infant Series|Withdrawal by Subject|3|||
148926999|NCT00366340|537217351|FG001|Infant Series|Withdrawal by Subject|3|||
148927000|NCT00366340|537217350|FG000|Infant Series|Adverse Event|0|||
148927001|NCT00366340|537217351|FG001|Infant Series|Adverse Event|2|||
148927002|NCT00366340|537217350|FG000|Infant Series|Lost to Follow-up|1|||
148927003|NCT00366340|537217351|FG001|Infant Series|Lost to Follow-up|1|||
148927004|NCT00366340|537217350|FG000|Infant Series|Failure to return|1|||
148927005|NCT00366340|537217351|FG001|Infant Series|Failure to return|0|||
148927006|NCT00366340|537217350|FG000|After the Infant Series|Parent/legal guardian request|1|||
148927007|NCT00366340|537217351|FG001|After the Infant Series|Parent/legal guardian request|1|||
148927008|NCT00366340|537217350|FG000|After the Infant Series|Failed to return|0|||
148927009|NCT00366340|537217351|FG001|After the Infant Series|Failed to return|1|||
148927010|NCT00366340|537217350|FG000|After the Infant Series|Protocol Violation|2|||
148927011|NCT00366340|537217351|FG001|After the Infant Series|Protocol Violation|2|||
148927012|NCT00366340|537217350|FG000|After the Infant Series|Adverse Event|0|||
148927013|NCT00366340|537217351|FG001|After the Infant Series|Adverse Event|1|||
148927014|NCT00366340|537217350|FG000|After the Infant Series|Lost to Follow-up|0|||
148927015|NCT00366340|537217351|FG001|After the Infant Series|Lost to Follow-up|1|||
148927016|NCT00366340|537217350|FG000|Toddler Dose|Failed to return|1|||
148927017|NCT00366340|537217351|FG001|Toddler Dose|Failed to return|0|||
148927018|NCT00366340|537217350|FG000|Toddler Dose|Parent/legal guardian request|0|||
148927019|NCT00366340|537217351|FG001|Toddler Dose|Parent/legal guardian request|1|||
148927020|NCT00442468|537217352|FG000|Overall Study|Adverse Event|4|||
149163646|NCT02601573|538073744|FG002|Overall Study|Lost to Follow-up|1|||
149163647|NCT02601573|538073745|FG003|Overall Study|Lost to Follow-up|0|||
149163648|NCT02601573|538073746|FG004|Overall Study|Lost to Follow-up|2|||
149163649|NCT02601573|538073742|FG000|Overall Study|Withdrawal by Subject|0|||
149163650|NCT02601573|538073743|FG001|Overall Study|Withdrawal by Subject|1|||
149163651|NCT02601573|538073744|FG002|Overall Study|Withdrawal by Subject|0|||
149163652|NCT02601573|538073745|FG003|Overall Study|Withdrawal by Subject|1|||
149163653|NCT02601573|538073746|FG004|Overall Study|Withdrawal by Subject|0|||
149163654|NCT01107444|538073747|FG000|Overall Study|Withdrawal by Subject|8|||
149163655|NCT01107444|538073748|FG001|Overall Study|Withdrawal by Subject|12|||
149163656|NCT01107444|538073747|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
149163657|NCT01107444|538073748|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
149163658|NCT01948830|538073749|FG000|Overall Study|Physician Decision|1|||
149163659|NCT01948830|538073750|FG001|Overall Study|Physician Decision|3|||
149163660|NCT01948830|538073749|FG000|Overall Study|Protocol deviation|1|||
149163661|NCT01948830|538073750|FG001|Overall Study|Protocol deviation|2|||
149163662|NCT01948830|538073749|FG000|Overall Study|Lost to Follow-up|5|||
149163663|NCT01948830|538073750|FG001|Overall Study|Lost to Follow-up|4|||
149163664|NCT01948830|538073749|FG000|Overall Study|Withdrawal by Subject|14|||
149163665|NCT01948830|538073750|FG001|Overall Study|Withdrawal by Subject|17|||
149163666|NCT01948830|538073749|FG000|Overall Study|Adverse Event|9|||
149163667|NCT01948830|538073750|FG001|Overall Study|Adverse Event|2|||
149163668|NCT01948830|538073749|FG000|Overall Study|Death|3|||
149163669|NCT01948830|538073750|FG001|Overall Study|Death|4|||
149163670|NCT03310970|538073752|FG000|Overall Study|Withdrawal by Subject|0|||
148927021|NCT00442468|537217352|FG000|Overall Study|Withdrawal by Subject|91|||
148927022|NCT00442468|537217352|FG000|Overall Study|Did not complete all study procedures|88|||
149163671|NCT03310970|538073753|FG001|Overall Study|Withdrawal by Subject|1|||
149163672|NCT04062214|538073757|FG000|Week 12|Death|1|||
149163673|NCT04062214|538073758|FG001|Week 12|Death|1|||
149163674|NCT04062214|538073757|FG000|Week 12|Withdrawal by Subject|14|||
149163675|NCT04062214|538073758|FG001|Week 12|Withdrawal by Subject|13|||
149163676|NCT04062214|538073757|FG000|Week 12|Lost to Follow-up|55|||
149163677|NCT04062214|538073758|FG001|Week 12|Lost to Follow-up|68|||
149163678|NCT04062214|538073757|FG000|Week 12|Intermittent missing|31|||
149163679|NCT04062214|538073758|FG001|Week 12|Intermittent missing|29|||
149163680|NCT04062214|538073757|FG000|Week 36|Withdrawal by Subject|4|||
149163681|NCT04062214|538073758|FG001|Week 36|Withdrawal by Subject|5|||
149163682|NCT04062214|538073757|FG000|Week 36|Lost to Follow-up|50|||
149163683|NCT04062214|538073758|FG001|Week 36|Lost to Follow-up|46|||
149163684|NCT04062214|538073757|FG000|Week 36|Death|0|||
149163685|NCT04062214|538073758|FG001|Week 36|Death|1|||
149163686|NCT00091832|538073759|FG000|Overall Study|Physician Decision|1|||
149163687|NCT00091832|538073760|FG001|Overall Study|Physician Decision|0|||
149163688|NCT00091832|538073761|FG002|Overall Study|Physician Decision|0|||
148927023|NCT00589784|537217353|FG000|Overall Study|Withdrawal by Subject|0|||
148927024|NCT00589784|537217354|FG001|Overall Study|Withdrawal by Subject|6|||
148927025|NCT00589784|537217353|FG000|Overall Study|Patient inevaluable|1|||
148927026|NCT00589784|537217354|FG001|Overall Study|Patient inevaluable|0|||
148927027|NCT00589784|537217353|FG000|Overall Study|Adverse Event|0|||
148927028|NCT00589784|537217354|FG001|Overall Study|Adverse Event|4|||
148927029|NCT03823378|537217355|FG000|Overall Study|Adverse Event|2|||
148927030|NCT03823378|537217356|FG001|Overall Study|Adverse Event|2|||
148927031|NCT03823378|537217357|FG002|Overall Study|Adverse Event|0|||
148927032|NCT03823378|537217358|FG003|Overall Study|Adverse Event|0|||
148927033|NCT03823378|537217359|FG004|Overall Study|Adverse Event|0|||
148927034|NCT03823378|537217360|FG005|Overall Study|Adverse Event|0|||
148927035|NCT03823378|537217355|FG000|Overall Study|Lost to Follow-up|0|||
148927036|NCT03823378|537217356|FG001|Overall Study|Lost to Follow-up|1|||
148927037|NCT03823378|537217357|FG002|Overall Study|Lost to Follow-up|0|||
148927038|NCT03823378|537217358|FG003|Overall Study|Lost to Follow-up|0|||
148927039|NCT03823378|537217359|FG004|Overall Study|Lost to Follow-up|1|||
149163689|NCT00091832|538073762|FG003|Overall Study|Physician Decision|0|||
149163690|NCT00091832|538073763|FG004|Overall Study|Physician Decision|0|||
149163691|NCT00091832|538073764|FG005|Overall Study|Physician Decision|0|||
149163692|NCT00091832|538073759|FG000|Overall Study|Adverse Event|0|||
149163693|NCT00091832|538073760|FG001|Overall Study|Adverse Event|0|||
149163694|NCT00091832|538073761|FG002|Overall Study|Adverse Event|0|||
149163695|NCT00091832|538073762|FG003|Overall Study|Adverse Event|1|||
149163696|NCT00091832|538073763|FG004|Overall Study|Adverse Event|3|||
149163697|NCT00091832|538073764|FG005|Overall Study|Adverse Event|0|||
149163698|NCT00091832|538073759|FG000|Overall Study|Withdrawal by Subject|4|||
149163699|NCT00091832|538073760|FG001|Overall Study|Withdrawal by Subject|5|||
149163700|NCT00091832|538073761|FG002|Overall Study|Withdrawal by Subject|0|||
149163701|NCT00091832|538073762|FG003|Overall Study|Withdrawal by Subject|1|||
149163702|NCT00091832|538073763|FG004|Overall Study|Withdrawal by Subject|3|||
149163703|NCT00091832|538073764|FG005|Overall Study|Withdrawal by Subject|1|||
149163704|NCT00091832|538073759|FG000|Overall Study|Death|6|||
149163705|NCT00091832|538073760|FG001|Overall Study|Death|4|||
149163706|NCT00091832|538073761|FG002|Overall Study|Death|5|||
149163707|NCT00091832|538073762|FG003|Overall Study|Death|8|||
148927040|NCT03823378|537217360|FG005|Overall Study|Lost to Follow-up|0|||
148927041|NCT03823378|537217355|FG000|Overall Study|Withdrawal by Subject|0|||
148927042|NCT03823378|537217356|FG001|Overall Study|Withdrawal by Subject|1|||
148927043|NCT03823378|537217357|FG002|Overall Study|Withdrawal by Subject|4|||
149012899|NCT00152971|537525842|FG001|Overall Study|Lost to Follow-up|14|||
149012900|NCT00152971|537525843|FG002|Overall Study|Lost to Follow-up|13|||
149012901|NCT00152971|537525841|FG000|Overall Study|Withdrawal by Subject|9|||
149163708|NCT00091832|538073763|FG004|Overall Study|Death|5|||
149163709|NCT00091832|538073764|FG005|Overall Study|Death|6|||
149163710|NCT00091832|538073759|FG000|Overall Study|Disease Progression|2|||
149163711|NCT00091832|538073760|FG001|Overall Study|Disease Progression|0|||
149163712|NCT00091832|538073761|FG002|Overall Study|Disease Progression|0|||
148927044|NCT03823378|537217358|FG003|Overall Study|Withdrawal by Subject|2|||
148927045|NCT03823378|537217359|FG004|Overall Study|Withdrawal by Subject|0|||
148927046|NCT03823378|537217360|FG005|Overall Study|Withdrawal by Subject|1|||
148927047|NCT03823378|537217355|FG000|Overall Study|Other, not specified|19|||
148927048|NCT03823378|537217356|FG001|Overall Study|Other, not specified|12|||
148927049|NCT03823378|537217357|FG002|Overall Study|Other, not specified|6|||
149163713|NCT00091832|538073762|FG003|Overall Study|Disease Progression|1|||
149163714|NCT00091832|538073763|FG004|Overall Study|Disease Progression|1|||
149163715|NCT00091832|538073764|FG005|Overall Study|Disease Progression|2|||
149163716|NCT00091832|538073759|FG000|Overall Study|Ineligibility Determined|0|||
149163717|NCT00091832|538073760|FG001|Overall Study|Ineligibility Determined|0|||
149163718|NCT00091832|538073761|FG002|Overall Study|Ineligibility Determined|1|||
148927050|NCT03823378|537217358|FG003|Overall Study|Other, not specified|8|||
148927051|NCT03823378|537217359|FG004|Overall Study|Other, not specified|17|||
148927052|NCT03823378|537217360|FG005|Overall Study|Other, not specified|7|||
148927053|NCT01606254|537217361|FG000|Overall Study|Withdrawal by Subject|1|||
148927054|NCT01606254|537217362|FG001|Overall Study|Withdrawal by Subject|3|||
149012902|NCT00152971|537525842|FG001|Overall Study|Withdrawal by Subject|8|||
149012903|NCT00152971|537525843|FG002|Overall Study|Withdrawal by Subject|14|||
149012904|NCT00152971|537525841|FG000|Overall Study|Other|3|||
149012905|NCT00152971|537525842|FG001|Overall Study|Other|5|||
149012906|NCT00152971|537525843|FG002|Overall Study|Other|5|||
149012907|NCT00152971|537525841|FG000|Treatment|Adverse Event|49|||
149012908|NCT00152971|537525842|FG001|Treatment|Adverse Event|40|||
149012909|NCT00152971|537525843|FG002|Treatment|Adverse Event|54|||
149012910|NCT00152971|537525841|FG000|Treatment|Protocol Violation|8|||
149012911|NCT00152971|537525842|FG001|Treatment|Protocol Violation|6|||
149012912|NCT00152971|537525843|FG002|Treatment|Protocol Violation|10|||
148927055|NCT01606254|537217363|FG002|Overall Study|Withdrawal by Subject|0|||
148927056|NCT01606254|537217364|FG003|Overall Study|Withdrawal by Subject|2|||
148927057|NCT01606254|537217361|FG000|Overall Study|Adverse Event|1|||
148927058|NCT01606254|537217362|FG001|Overall Study|Adverse Event|1|||
148927059|NCT01606254|537217363|FG002|Overall Study|Adverse Event|0|||
149163719|NCT00091832|538073762|FG003|Overall Study|Ineligibility Determined|0|||
149163720|NCT00091832|538073763|FG004|Overall Study|Ineligibility Determined|1|||
149163721|NCT00091832|538073764|FG005|Overall Study|Ineligibility Determined|0|||
149163722|NCT00091832|538073759|FG000|Overall Study|Lost to Follow-up|1|||
149163723|NCT00091832|538073760|FG001|Overall Study|Lost to Follow-up|0|||
149163724|NCT00091832|538073761|FG002|Overall Study|Lost to Follow-up|3|||
149163725|NCT00091832|538073762|FG003|Overall Study|Lost to Follow-up|3|||
149163726|NCT00091832|538073763|FG004|Overall Study|Lost to Follow-up|2|||
149163727|NCT00091832|538073764|FG005|Overall Study|Lost to Follow-up|1|||
149163728|NCT00091832|538073759|FG000|Overall Study|Noncompliance|0|||
149163729|NCT00091832|538073760|FG001|Overall Study|Noncompliance|1|||
149163730|NCT00091832|538073761|FG002|Overall Study|Noncompliance|0|||
149163731|NCT00091832|538073762|FG003|Overall Study|Noncompliance|0|||
149163732|NCT00091832|538073763|FG004|Overall Study|Noncompliance|0|||
149163733|NCT00091832|538073764|FG005|Overall Study|Noncompliance|0|||
149163734|NCT00091832|538073759|FG000|Overall Study|Other|0|||
149163735|NCT00091832|538073760|FG001|Overall Study|Other|1|||
149163736|NCT00091832|538073761|FG002|Overall Study|Other|2|||
149163737|NCT00091832|538073762|FG003|Overall Study|Other|0|||
149163738|NCT00091832|538073763|FG004|Overall Study|Other|0|||
149163739|NCT00091832|538073764|FG005|Overall Study|Other|0|||
149163740|NCT00091832|538073759|FG000|Overall Study|Protocol Violation|0|||
149163741|NCT00091832|538073760|FG001|Overall Study|Protocol Violation|0|||
149163742|NCT00091832|538073761|FG002|Overall Study|Protocol Violation|1|||
149163743|NCT00091832|538073762|FG003|Overall Study|Protocol Violation|0|||
149163744|NCT00091832|538073763|FG004|Overall Study|Protocol Violation|0|||
149163745|NCT00091832|538073764|FG005|Overall Study|Protocol Violation|1|||
149163746|NCT01356589|538073771|FG000|Overall Study|Enrolled, but not treated|3|||
149163747|NCT01356589|538073771|FG000|Overall Study|Dose data not recorded|2|||
149163748|NCT04343651|538073772|FG000|Overall Study|Physician Decision|2|||
149163749|NCT04343651|538073773|FG001|Overall Study|Physician Decision|1|||
149163750|NCT04343651|538073772|FG000|Overall Study|Lost to Follow-up|2|||
149163751|NCT04343651|538073773|FG001|Overall Study|Lost to Follow-up|1|||
149163752|NCT04343651|538073772|FG000|Overall Study|Protocol Violation|4|||
149163753|NCT04343651|538073773|FG001|Overall Study|Protocol Violation|6|||
149163754|NCT04343651|538073772|FG000|Overall Study|Missing|3|||
149163755|NCT04343651|538073773|FG001|Overall Study|Missing|9|||
149163756|NCT04343651|538073772|FG000|Overall Study|Withdrawal by Subject|0|||
149163757|NCT04343651|538073773|FG001|Overall Study|Withdrawal by Subject|4|||
149163758|NCT04343651|538073772|FG000|Overall Study|Death|0|||
149163759|NCT04343651|538073773|FG001|Overall Study|Death|1|||
149163760|NCT04343651|538073772|FG000|Overall Study|Did not start treatment|1|||
149163761|NCT04343651|538073773|FG001|Overall Study|Did not start treatment|1|||
149163762|NCT04343651|538073772|FG000|Overall Study|Patient did not complete visits 3-6|0|||
149163763|NCT04343651|538073773|FG001|Overall Study|Patient did not complete visits 3-6|1|||
149163764|NCT04025632|538075646|FG000|Overall Study|Adverse Event|1|||
149163765|NCT04025632|538075647|FG001|Overall Study|Adverse Event|1|||
149163766|NCT04025632|538075646|FG000|Overall Study|Withdrawal by Subject|1|||
149012913|NCT00152971|537525841|FG000|Treatment|Lost to Follow-up|1|||
149012914|NCT00152971|537525842|FG001|Treatment|Lost to Follow-up|2|||
149012915|NCT00152971|537525843|FG002|Treatment|Lost to Follow-up|1|||
149012916|NCT00152971|537525841|FG000|Treatment|Withdrawal by Subject|4|||
149163767|NCT04025632|538075647|FG001|Overall Study|Withdrawal by Subject|1|||
149163768|NCT04025632|538075646|FG000|Overall Study|Study Terminated by Sponsor|10|||
149163769|NCT04025632|538075647|FG001|Overall Study|Study Terminated by Sponsor|9|||
149163770|NCT04025632|538075646|FG000|Overall Study|Physician Decision|3|||
149163771|NCT04025632|538075647|FG001|Overall Study|Physician Decision|1|||
149163772|NCT00376961|538075648|FG000|Initial Registration|Adverse Event|1|||
149163773|NCT00376961|538075649|FG001|Initial Registration|Adverse Event|0|||
148927060|NCT01606254|537217364|FG003|Overall Study|Adverse Event|1|||
148927061|NCT01001299|537217365|FG000|Overall Study|Insufficient Therapeutic Response|20|||
148927062|NCT01001299|537217365|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
148927063|NCT01001299|537217365|FG000|Overall Study|Death|1|||
148927064|NCT01001299|537217365|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
148674910|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
148674911|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
148674912|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
148674913|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
148674914|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
148674915|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
148674916|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
148674917|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
148674918|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
148674919|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
148674920|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
148674921|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
148674922|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
148674923|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
148674924|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
148674925|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
148674926|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
148674927|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
148674928|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
148674929|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
148927065|NCT01001299|537217365|FG000|Overall Study|Withdrew Consent|1|||
148927066|NCT02195011|537217367|FG000|Overall Study|Adverse Event|4|||
148927067|NCT02195011|537217368|FG001|Overall Study|Adverse Event|0|||
148674930|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
148674931|NCT03395197|536281493|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
148674932|NCT03395197|536281494|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
148674933|NCT03395197|536281495|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
148674934|NCT03395197|536281496|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
148674935|NCT03395197|536281497|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
148674936|NCT03395197|536281498|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
148674937|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Death|0|||
148674938|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Death|0|||
148674939|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Death|0|||
148674940|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Death|0|||
148674941|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Death|1|||
148674942|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Death|4|||
148674943|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
148674944|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
148674945|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
148674946|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
148674947|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
148674948|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
148674949|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
148674950|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
148674951|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
148674952|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
148674953|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
148674954|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
148674955|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
148674956|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
148674957|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
148927068|NCT02195011|537217367|FG000|Overall Study|Progressive Disease|18|||
148927069|NCT02195011|537217368|FG001|Overall Study|Progressive Disease|1|||
148927070|NCT02195011|537217367|FG000|Overall Study|Withdrawal by Subject|3|||
148927071|NCT02195011|537217368|FG001|Overall Study|Withdrawal by Subject|0|||
148927072|NCT00174291|537217369|FG000|Overall Study|Lost to Follow-up|1|||
148927073|NCT00174291|537217370|FG001|Overall Study|Lost to Follow-up|1|||
148927074|NCT00174291|537217369|FG000|Overall Study|Protocol Violation|0|||
148927075|NCT00174291|537217370|FG001|Overall Study|Protocol Violation|2|||
148927076|NCT00174291|537217369|FG000|Overall Study|Study terminated by sponsor|1|||
148927077|NCT00174291|537217370|FG001|Overall Study|Study terminated by sponsor|0|||
148674958|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
148674959|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
148674960|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
148674961|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
148674962|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
148674963|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
148674964|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
148674965|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
148674966|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
148674967|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
148674968|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
148674969|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
148674970|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
148674971|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
148674972|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
148674973|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
148674974|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
148674975|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
148674976|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
148674977|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
148674978|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
148674979|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Other|0|||
148674980|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Other|0|||
148674981|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Other|0|||
148674982|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Other|0|||
148674983|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Other|3|||
148674984|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Other|3|||
148674985|NCT03395197|536281493|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
148674986|NCT03395197|536281494|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
148674987|NCT03395197|536281495|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
148674988|NCT03395197|536281496|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
148674989|NCT03395197|536281497|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
148674990|NCT03395197|536281498|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
148674991|NCT00602641|536281499|FG000|Overall Study|Never started protocol therapy|6|||
148674992|NCT00602641|536281500|FG001|Overall Study|Never started protocol therapy|2|||
148674993|NCT00602641|536281499|FG000|Overall Study|Still on treatment at time of analysis|8|||
148674994|NCT00602641|536281500|FG001|Overall Study|Still on treatment at time of analysis|15|||
148674995|NCT00602641|536281499|FG000|Overall Study|Adverse Event|62|||
148674996|NCT00602641|536281500|FG001|Overall Study|Adverse Event|53|||
148674997|NCT00602641|536281499|FG000|Overall Study|Disease progression|38|||
148674998|NCT00602641|536281500|FG001|Overall Study|Disease progression|55|||
148674999|NCT00602641|536281499|FG000|Overall Study|Death|6|||
148675000|NCT00602641|536281500|FG001|Overall Study|Death|5|||
148675001|NCT00602641|536281499|FG000|Overall Study|Withdrawal by Subject|15|||
148675002|NCT00602641|536281500|FG001|Overall Study|Withdrawal by Subject|12|||
148675003|NCT00602641|536281499|FG000|Overall Study|Alternative therapy|5|||
148675004|NCT00602641|536281500|FG001|Overall Study|Alternative therapy|2|||
148675005|NCT00602641|536281499|FG000|Overall Study|Other Complicating Disease|5|||
148675006|NCT00602641|536281500|FG001|Overall Study|Other Complicating Disease|2|||
148675007|NCT00602641|536281499|FG000|Overall Study|Physician Decision|5|||
148675008|NCT00602641|536281500|FG001|Overall Study|Physician Decision|4|||
148675009|NCT00602641|536281499|FG000|Overall Study|Administrative Closure|1|||
148675010|NCT00602641|536281500|FG001|Overall Study|Administrative Closure|1|||
148675011|NCT00602641|536281499|FG000|Overall Study|Other|3|||
148675012|NCT00602641|536281500|FG001|Overall Study|Other|1|||
148675013|NCT01785472|536281502|FG000|Overall Study|Adverse Event|5|||
148675014|NCT01785472|536281503|FG001|Overall Study|Adverse Event|4|||
148675015|NCT01785472|536281504|FG002|Overall Study|Adverse Event|6|||
148675016|NCT01785472|536281502|FG000|Overall Study|Lack of Efficacy|2|||
148675017|NCT01785472|536281503|FG001|Overall Study|Lack of Efficacy|0|||
148675018|NCT01785472|536281504|FG002|Overall Study|Lack of Efficacy|1|||
148675019|NCT01785472|536281502|FG000|Overall Study|Lost to Follow-up|1|||
148927078|NCT00174291|537217369|FG000|Overall Study|Withdrawal by Subject|3|||
148927079|NCT00174291|537217370|FG001|Overall Study|Withdrawal by Subject|3|||
148927080|NCT00450112|537217371|FG000|Overall Study|Other Treatment Required|5|||
148927081|NCT00450112|537217372|FG001|Overall Study|Other Treatment Required|1|||
148675020|NCT01785472|536281503|FG001|Overall Study|Lost to Follow-up|2|||
148927082|NCT00450112|537217371|FG000|Overall Study|Withdrawal by Subject|4|||
148927083|NCT00450112|537217372|FG001|Overall Study|Withdrawal by Subject|1|||
148927084|NCT00450112|537217371|FG000|Overall Study|Lost to Follow-up|2|||
149163774|NCT00376961|538075648|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
149163775|NCT00376961|538075649|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149163776|NCT00376961|538075648|FG000|Initial Registration|Progression/relapse|1|||
149163777|NCT00376961|538075649|FG001|Initial Registration|Progression/relapse|0|||
149163778|NCT00376961|538075648|FG000|Initial Registration|Ineligible|3|||
149163779|NCT00376961|538075649|FG001|Initial Registration|Ineligible|0|||
149163780|NCT00376961|538075648|FG000|Maintenance|Adverse Event|0|||
149163781|NCT00376961|538075649|FG001|Maintenance|Adverse Event|1|||
149163782|NCT00376961|538075648|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
149163783|NCT00376961|538075649|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
149163784|NCT00376961|538075648|FG000|Maintenance|Progression/relapse|0|||
149163785|NCT00376961|538075649|FG001|Maintenance|Progression/relapse|18|||
149163786|NCT00376961|538075648|FG000|Maintenance|Ineligible|0|||
149163787|NCT00376961|538075649|FG001|Maintenance|Ineligible|3|||
149163788|NCT00925600|538075650|FG000|Overall Study|Withdrawal by Subject|16|||
149163789|NCT00925600|538075651|FG001|Overall Study|Withdrawal by Subject|14|||
149163790|NCT00925600|538075650|FG000|Overall Study|Death|4|||
149163791|NCT00925600|538075651|FG001|Overall Study|Death|3|||
149163792|NCT00925600|538075650|FG000|Overall Study|Lost to Follow-up|2|||
149163793|NCT00925600|538075651|FG001|Overall Study|Lost to Follow-up|2|||
149163794|NCT00925600|538075650|FG000|Overall Study|Disease Progression|1|||
149163795|NCT00925600|538075651|FG001|Overall Study|Disease Progression|3|||
149163796|NCT00925600|538075650|FG000|Overall Study|Administrative Decision|1|||
149163797|NCT00925600|538075651|FG001|Overall Study|Administrative Decision|1|||
149163798|NCT00925600|538075650|FG000|Overall Study|Noncompliance|2|||
149163799|NCT00925600|538075651|FG001|Overall Study|Noncompliance|0|||
149163800|NCT00925600|538075650|FG000|Overall Study|Ineligibility Determined|2|||
149163801|NCT00925600|538075651|FG001|Overall Study|Ineligibility Determined|0|||
149163802|NCT00925600|538075650|FG000|Overall Study|Protocol Deviation|0|||
149163803|NCT00925600|538075651|FG001|Overall Study|Protocol Deviation|1|||
149163804|NCT00925600|538075650|FG000|Overall Study|Requirement for Alternative Therapy|0|||
149163805|NCT00925600|538075651|FG001|Overall Study|Requirement for Alternative Therapy|1|||
149163806|NCT00925600|538075650|FG000|Overall Study|Other|3|||
149163807|NCT00925600|538075651|FG001|Overall Study|Other|1|||
149163808|NCT00925600|538075650|FG000|Overall Study|Adverse Event|1|||
149163809|NCT00925600|538075651|FG001|Overall Study|Adverse Event|2|||
149163810|NCT04047797|538075654|FG000|Overall Study|Progressive Disease|1|||
149163811|NCT01793792|538075655|FG000|Overall Study|Death|5|||
149163812|NCT01793792|538075655|FG000|Overall Study|Lost to Follow-up|5|||
149163813|NCT01793792|538075655|FG000|Overall Study|Withdrawal by Subject|1|||
149163814|NCT01793792|538075655|FG000|Overall Study|Device Not Implanted|1|||
149163815|NCT00851903|538075658|FG000|Overall Study|Withdrawal by Subject|2|||
149163816|NCT00270894|538075659|FG000|Overall Study|Adverse Event|1|||
149163817|NCT00270894|538075659|FG000|Overall Study|Withdrawal by Subject|1|||
149163818|NCT01070329|538075660|FG000|Overall Study|Adverse Event|13|||
149163819|NCT01070329|538075661|FG001|Overall Study|Adverse Event|10|||
149163820|NCT01070329|538075660|FG000|Overall Study|Lost to Follow-up|22|||
149163821|NCT01070329|538075661|FG001|Overall Study|Lost to Follow-up|12|||
149163822|NCT01070329|538075660|FG000|Overall Study|Withdrawal by Subject|9|||
149163823|NCT01070329|538075661|FG001|Overall Study|Withdrawal by Subject|11|||
149163824|NCT01070329|538075660|FG000|Overall Study|Protocol Violation|3|||
149163825|NCT01070329|538075661|FG001|Overall Study|Protocol Violation|8|||
149163826|NCT01070329|538075660|FG000|Overall Study|Lack of Efficacy|2|||
149163827|NCT01070329|538075661|FG001|Overall Study|Lack of Efficacy|6|||
149163828|NCT01070329|538075660|FG000|Overall Study|Physician Decision|2|||
149163829|NCT01070329|538075661|FG001|Overall Study|Physician Decision|1|||
149163830|NCT01070329|538075660|FG000|Overall Study|Entry Criteria Not Met|1|||
149163831|NCT01070329|538075661|FG001|Overall Study|Entry Criteria Not Met|0|||
149163832|NCT01070329|538075660|FG000|Overall Study|Sponsor Decision|0|||
149163833|NCT01070329|538075661|FG001|Overall Study|Sponsor Decision|1|||
149163834|NCT02863848|538075662|FG000|Overall Study|Lost to Follow-up|1|||
148675021|NCT01785472|536281504|FG002|Overall Study|Lost to Follow-up|0|||
149163835|NCT02863848|538075663|FG001|Overall Study|Lost to Follow-up|1|||
149163836|NCT02863848|538075662|FG000|Overall Study|Protocol Violation|1|||
149163837|NCT02863848|538075663|FG001|Overall Study|Protocol Violation|2|||
149163838|NCT03116113|538075666|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163839|NCT03116113|538075667|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163840|NCT03116113|538075668|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163841|NCT03116113|538075669|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163842|NCT03116113|538075670|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163843|NCT03116113|538075671|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163844|NCT03116113|538075672|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
149163845|NCT03116113|538075673|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
149163846|NCT03116113|538075674|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
149163847|NCT01254669|538075675|FG000|Overall Study|Withdrawal by Subject|0|||
149163848|NCT01254669|538075676|FG001|Overall Study|Withdrawal by Subject|1|||
148675022|NCT01785472|536281502|FG000|Overall Study|Physician Decision|1|||
148675023|NCT01785472|536281503|FG001|Overall Study|Physician Decision|1|||
149163849|NCT01254669|538075675|FG000|Overall Study|time constraint|2|||
149163850|NCT01254669|538075676|FG001|Overall Study|time constraint|2|||
149163851|NCT01254669|538075675|FG000|Overall Study|called to clinic during intervention|1|||
149163852|NCT01254669|538075676|FG001|Overall Study|called to clinic during intervention|1|||
149163853|NCT02367521|538075677|FG000|Overall Study|severe headache after intervention|2|||
149163854|NCT02367521|538075678|FG001|Overall Study|severe headache after intervention|0|||
149163855|NCT02367521|538075677|FG000|Overall Study|unable to find transportation|2|||
149163856|NCT02367521|538075678|FG001|Overall Study|unable to find transportation|0|||
149163857|NCT00600171|538075679|FG000|Overall Study|Adverse Event|0|||
149163858|NCT00600171|538075680|FG001|Overall Study|Adverse Event|1|||
149163859|NCT00600171|538075681|FG002|Overall Study|Adverse Event|0|||
149163860|NCT00600171|538075682|FG003|Overall Study|Adverse Event|0|||
149163861|NCT00600171|538075683|FG004|Overall Study|Adverse Event|1|||
149163862|NCT00600171|538075684|FG005|Overall Study|Adverse Event|0|||
149163863|NCT00600171|538075679|FG000|Overall Study|Lack of Efficacy|9|||
149163864|NCT00600171|538075680|FG001|Overall Study|Lack of Efficacy|12|||
149163865|NCT00600171|538075681|FG002|Overall Study|Lack of Efficacy|3|||
149163866|NCT00600171|538075682|FG003|Overall Study|Lack of Efficacy|5|||
149163867|NCT00600171|538075683|FG004|Overall Study|Lack of Efficacy|4|||
149163868|NCT00600171|538075684|FG005|Overall Study|Lack of Efficacy|0|||
149163869|NCT00600171|538075679|FG000|Overall Study|Protocol Violation|1|||
149163870|NCT00600171|538075680|FG001|Overall Study|Protocol Violation|2|||
149163871|NCT00600171|538075681|FG002|Overall Study|Protocol Violation|0|||
149163872|NCT00600171|538075682|FG003|Overall Study|Protocol Violation|1|||
149163873|NCT00600171|538075683|FG004|Overall Study|Protocol Violation|0|||
149163874|NCT00600171|538075684|FG005|Overall Study|Protocol Violation|0|||
149163875|NCT00600171|538075679|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
149163876|NCT00600171|538075680|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149163877|NCT00600171|538075681|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
149163878|NCT00600171|538075682|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
149163879|NCT00600171|538075683|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
149163880|NCT00600171|538075684|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
149163881|NCT00600171|538075679|FG000|Overall Study|Withdrawal by Subject|3|||
149163882|NCT00600171|538075680|FG001|Overall Study|Withdrawal by Subject|0|||
149163883|NCT00600171|538075681|FG002|Overall Study|Withdrawal by Subject|0|||
148675024|NCT01785472|536281504|FG002|Overall Study|Physician Decision|1|||
149163884|NCT00600171|538075682|FG003|Overall Study|Withdrawal by Subject|1|||
149163885|NCT00600171|538075683|FG004|Overall Study|Withdrawal by Subject|1|||
149163886|NCT00600171|538075684|FG005|Overall Study|Withdrawal by Subject|1|||
149163887|NCT00600171|538075679|FG000|Overall Study|Physician Decision|0|||
149163888|NCT00600171|538075680|FG001|Overall Study|Physician Decision|1|||
149163889|NCT00600171|538075681|FG002|Overall Study|Physician Decision|0|||
149163890|NCT00600171|538075682|FG003|Overall Study|Physician Decision|1|||
149163891|NCT00600171|538075683|FG004|Overall Study|Physician Decision|0|||
148675025|NCT01785472|536281502|FG000|Overall Study|Protocol deviation|0|||
149163892|NCT00600171|538075684|FG005|Overall Study|Physician Decision|2|||
149163893|NCT00600171|538075679|FG000|Overall Study|Lost to Follow-up|0|||
148927085|NCT00450112|537217372|FG001|Overall Study|Lost to Follow-up|1|||
148927086|NCT00450112|537217371|FG000|Overall Study|Others|2|||
148927087|NCT00450112|537217372|FG001|Overall Study|Others|3|||
148927088|NCT03418571|537217373|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
148927089|NCT03418571|537217374|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
148927090|NCT01056380|537217375|FG000|Overall Study|Lost to Follow-up|2|||
149163894|NCT00600171|538075680|FG001|Overall Study|Lost to Follow-up|0|||
149163895|NCT00600171|538075681|FG002|Overall Study|Lost to Follow-up|0|||
149163896|NCT00600171|538075682|FG003|Overall Study|Lost to Follow-up|1|||
149163897|NCT00600171|538075683|FG004|Overall Study|Lost to Follow-up|0|||
149163898|NCT00600171|538075684|FG005|Overall Study|Lost to Follow-up|0|||
149163899|NCT00542191|538075685|FG000|Overall Study|Death|3|||
149163900|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163901|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
149163902|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163903|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163904|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163905|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
149163906|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
149163907|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
149163908|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
149163909|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
149163910|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149163911|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149163912|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149163913|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149163914|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149163915|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149163916|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149163917|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149163918|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
149163919|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
149163920|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163921|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163922|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163923|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149163924|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163925|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
148675026|NCT01785472|536281503|FG001|Overall Study|Protocol deviation|2|||
148675027|NCT01785472|536281504|FG002|Overall Study|Protocol deviation|2|||
148675028|NCT01785472|536281502|FG000|Overall Study|Subject/guardian decision|15|||
148675029|NCT01785472|536281503|FG001|Overall Study|Subject/guardian decision|10|||
148675030|NCT01785472|536281504|FG002|Overall Study|Subject/guardian decision|11|||
148675031|NCT01785472|536281502|FG000|Overall Study|Technical problems|0|||
148675032|NCT01785472|536281503|FG001|Overall Study|Technical problems|0|||
148675033|NCT01785472|536281504|FG002|Overall Study|Technical problems|1|||
148675034|NCT03099161|536281507|FG000|Overall Study|Adverse Event|0|||
148675035|NCT03099161|536281508|FG001|Overall Study|Adverse Event|0|||
148675036|NCT03099161|536281509|FG002|Overall Study|Adverse Event|2|||
148675037|NCT03099161|536281507|FG000|Overall Study|Physician Decision|2|||
148675038|NCT03099161|536281508|FG001|Overall Study|Physician Decision|0|||
148675039|NCT03099161|536281509|FG002|Overall Study|Physician Decision|0|||
148675040|NCT03099161|536281507|FG000|Overall Study|Progressive Disease|1|||
148675041|NCT03099161|536281508|FG001|Overall Study|Progressive Disease|4|||
148675042|NCT03099161|536281509|FG002|Overall Study|Progressive Disease|1|||
148675043|NCT00110084|536281510|FG000|Overall Study|Adverse Event|9|||
148675044|NCT00110084|536281510|FG000|Overall Study|Death|1|||
148675045|NCT00110084|536281510|FG000|Overall Study|Patient Refusal|10|||
148675046|NCT00110084|536281510|FG000|Overall Study|Alternate Therapy|5|||
148675047|NCT00110084|536281510|FG000|Overall Study|Intercurrent Illness|1|||
148675048|NCT00110084|536281510|FG000|Overall Study|Other|2|||
148675049|NCT05004181|536281512|FG000|Overall Study|Withdrawal of consent|0|||
148675050|NCT05004181|536281513|FG001|Overall Study|Withdrawal of consent|0|||
148675051|NCT05004181|536281514|FG002|Overall Study|Withdrawal of consent|1|||
148675052|NCT05004181|536281515|FG003|Overall Study|Withdrawal of consent|3|||
148675053|NCT05004181|536281516|FG004|Overall Study|Withdrawal of consent|3|||
148675054|NCT05004181|536281517|FG005|Overall Study|Withdrawal of consent|0|||
148675055|NCT05004181|536281518|FG006|Overall Study|Withdrawal of consent|30|||
148675056|NCT05004181|536281519|FG007|Overall Study|Withdrawal of consent|9|||
148675057|NCT05004181|536281520|FG008|Overall Study|Withdrawal of consent|3|||
148675058|NCT05004181|536281521|FG009|Overall Study|Withdrawal of consent|2|||
148675059|NCT05004181|536281522|FG010|Overall Study|Withdrawal of consent|5|||
148675060|NCT05004181|536281523|FG011|Overall Study|Withdrawal of consent|1|||
148675061|NCT05004181|536281512|FG000|Overall Study|Lost to Follow-up|2|||
148675062|NCT05004181|536281513|FG001|Overall Study|Lost to Follow-up|4|||
148675063|NCT05004181|536281514|FG002|Overall Study|Lost to Follow-up|2|||
148675064|NCT05004181|536281515|FG003|Overall Study|Lost to Follow-up|3|||
148675065|NCT05004181|536281516|FG004|Overall Study|Lost to Follow-up|5|||
148675066|NCT05004181|536281517|FG005|Overall Study|Lost to Follow-up|2|||
148675067|NCT05004181|536281518|FG006|Overall Study|Lost to Follow-up|15|||
148675068|NCT05004181|536281519|FG007|Overall Study|Lost to Follow-up|12|||
148675069|NCT05004181|536281520|FG008|Overall Study|Lost to Follow-up|38|||
148675070|NCT05004181|536281521|FG009|Overall Study|Lost to Follow-up|6|||
148675071|NCT05004181|536281522|FG010|Overall Study|Lost to Follow-up|6|||
148675072|NCT05004181|536281523|FG011|Overall Study|Lost to Follow-up|0|||
148675073|NCT05004181|536281512|FG000|Overall Study|Death|0|||
148675074|NCT05004181|536281513|FG001|Overall Study|Death|0|||
148675075|NCT05004181|536281514|FG002|Overall Study|Death|0|||
148675076|NCT05004181|536281515|FG003|Overall Study|Death|0|||
148675077|NCT05004181|536281516|FG004|Overall Study|Death|0|||
148675078|NCT05004181|536281517|FG005|Overall Study|Death|0|||
148675079|NCT05004181|536281518|FG006|Overall Study|Death|1|||
148675080|NCT05004181|536281519|FG007|Overall Study|Death|0|||
148675081|NCT05004181|536281520|FG008|Overall Study|Death|2|||
148675082|NCT05004181|536281521|FG009|Overall Study|Death|0|||
148675083|NCT05004181|536281522|FG010|Overall Study|Death|0|||
148675084|NCT05004181|536281523|FG011|Overall Study|Death|0|||
148675085|NCT05004181|536281512|FG000|Overall Study|Physician Decision|0|||
148675086|NCT05004181|536281513|FG001|Overall Study|Physician Decision|0|||
148675087|NCT05004181|536281514|FG002|Overall Study|Physician Decision|0|||
148675088|NCT05004181|536281515|FG003|Overall Study|Physician Decision|0|||
148675089|NCT05004181|536281516|FG004|Overall Study|Physician Decision|0|||
148675090|NCT05004181|536281517|FG005|Overall Study|Physician Decision|0|||
148675091|NCT05004181|536281518|FG006|Overall Study|Physician Decision|2|||
148675092|NCT05004181|536281519|FG007|Overall Study|Physician Decision|0|||
148675093|NCT05004181|536281520|FG008|Overall Study|Physician Decision|7|||
148675094|NCT05004181|536281521|FG009|Overall Study|Physician Decision|0|||
148675095|NCT05004181|536281522|FG010|Overall Study|Physician Decision|0|||
148675096|NCT05004181|536281523|FG011|Overall Study|Physician Decision|0|||
148675097|NCT05004181|536281512|FG000|Overall Study|Withdrawal by Subject|2|||
148675098|NCT05004181|536281513|FG001|Overall Study|Withdrawal by Subject|3|||
148675099|NCT05004181|536281514|FG002|Overall Study|Withdrawal by Subject|2|||
148675100|NCT05004181|536281515|FG003|Overall Study|Withdrawal by Subject|2|||
148675101|NCT05004181|536281516|FG004|Overall Study|Withdrawal by Subject|4|||
148675102|NCT05004181|536281517|FG005|Overall Study|Withdrawal by Subject|2|||
148675103|NCT05004181|536281518|FG006|Overall Study|Withdrawal by Subject|4|||
148675104|NCT05004181|536281519|FG007|Overall Study|Withdrawal by Subject|22|||
148675105|NCT05004181|536281520|FG008|Overall Study|Withdrawal by Subject|8|||
148675106|NCT05004181|536281521|FG009|Overall Study|Withdrawal by Subject|1|||
149163926|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
149163927|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149163928|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149163929|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149163930|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
149163931|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
149163932|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
149163933|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
149163934|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
148675107|NCT05004181|536281522|FG010|Overall Study|Withdrawal by Subject|3|||
149163935|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149163936|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
149163937|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
149163938|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
149163939|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149163940|NCT00289913|538075688|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
149163941|NCT00289913|538075689|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149163942|NCT00289913|538075690|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
149163943|NCT00289913|538075691|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149163944|NCT00289913|538075692|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149163945|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163946|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163947|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
149163948|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163949|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149163950|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
149163951|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
149163952|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
149163953|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
149163954|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
149163955|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149163956|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
149163957|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149163958|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149163959|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
149163960|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
149163961|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
149163962|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
149163963|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149163964|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149163965|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149163966|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163967|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149163968|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163969|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149163970|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149163971|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
149163972|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
149163973|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
149163974|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
149163975|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
149163976|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
149163977|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
149163978|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
149163979|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
149163980|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
149163981|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
149163982|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
149163983|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
149163984|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
149163985|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
149163986|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149163987|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149163988|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149163989|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
149163990|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149163991|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149163992|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149163993|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
149163994|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
149163995|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149163996|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149163997|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149163998|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
149163999|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
149164000|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149164001|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149164002|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149164003|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
149164004|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
149164005|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149164006|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149164007|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149164008|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
149164009|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
149164010|NCT00289913|538075688|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149164011|NCT00289913|538075689|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149164012|NCT00289913|538075690|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149164013|NCT00289913|538075691|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
149164014|NCT00289913|538075692|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
149164015|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149164016|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
149164017|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149164018|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149164019|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
149164020|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
149012917|NCT00152971|537525842|FG001|Treatment|Withdrawal by Subject|4|||
149164021|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
149164022|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
149164023|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
149164024|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
149164025|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149164026|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149164027|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149164028|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
149164029|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
149164030|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149164031|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149164032|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149164033|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
149164034|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
149164035|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
149164036|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
149164037|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
149164038|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
149164039|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
149164040|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149164041|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
149164042|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
149164043|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149164044|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
149164045|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149164046|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149164047|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149164048|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
149012918|NCT00152971|537525843|FG002|Treatment|Withdrawal by Subject|5|||
149164049|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
149164050|NCT00289913|538075688|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149164051|NCT00289913|538075689|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
149164052|NCT00289913|538075690|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149164053|NCT00289913|538075691|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149164054|NCT00289913|538075692|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
149012919|NCT00152971|537525841|FG000|Treatment|Other|9|||
149164055|NCT03822884|538075693|FG000|Overall Study|Withdrawal by Subject|0|||
149164056|NCT03822884|538075694|FG001|Overall Study|Withdrawal by Subject|0|||
149164057|NCT03822884|538075695|FG002|Overall Study|Withdrawal by Subject|0|||
149164058|NCT03822884|538075696|FG003|Overall Study|Withdrawal by Subject|0|||
149164059|NCT03822884|538075697|FG004|Overall Study|Withdrawal by Subject|1|||
149164060|NCT03822884|538075698|FG005|Overall Study|Withdrawal by Subject|0|||
149164061|NCT02357420|538075704|FG000|Overall Study|Adverse Event|3|||
149164062|NCT02357420|538075705|FG001|Overall Study|Adverse Event|3|||
149164063|NCT02357420|538075706|FG002|Overall Study|Adverse Event|8|||
149164064|NCT02357420|538075707|FG003|Overall Study|Adverse Event|9|||
149164065|NCT02357420|538075704|FG000|Overall Study|Investigator Decision|1|||
149164066|NCT02357420|538075705|FG001|Overall Study|Investigator Decision|0|||
149164067|NCT02357420|538075706|FG002|Overall Study|Investigator Decision|0|||
149164068|NCT02357420|538075707|FG003|Overall Study|Investigator Decision|0|||
148927091|NCT01056380|537217376|FG001|Overall Study|Lost to Follow-up|3|||
148927092|NCT00586326|537217377|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
148927093|NCT00586326|537217377|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
148927094|NCT00586326|537217377|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
148927095|NCT00586326|537217377|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
148927096|NCT00586326|537217377|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
148927097|NCT00586326|537217377|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
148927098|NCT00586326|537217377|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
148927099|NCT00586326|537217377|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
148927100|NCT00586326|537217377|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
148927101|NCT00586326|537217377|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
148927102|NCT00586326|537217377|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
148927103|NCT00586326|537217377|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
148927104|NCT00586326|537217377|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
148927105|NCT00586326|537217377|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
148927106|NCT00586326|537217377|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
148927107|NCT00586326|537217377|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
148927108|NCT00586326|537217377|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
148927109|NCT03595774|537217378|FG000|Overall Study|Adverse Event|1|||
148927110|NCT03595774|537217379|FG001|Overall Study|Adverse Event|0|||
148927111|NCT03595774|537217380|FG002|Overall Study|Adverse Event|1|||
148927112|NCT03595774|537217381|FG003|Overall Study|Adverse Event|0|||
148927113|NCT03595774|537217378|FG000|Overall Study|screen failure|0|||
148927114|NCT03595774|537217379|FG001|Overall Study|screen failure|1|||
148927115|NCT03595774|537217380|FG002|Overall Study|screen failure|0|||
148927116|NCT03595774|537217381|FG003|Overall Study|screen failure|1|||
148927117|NCT03882008|537217382|FG000|Overall Study|Withdrawal by Subject|1|||
148927118|NCT03882008|537217382|FG000|Overall Study|Lost to Follow-up|1|||
148927119|NCT04068896|537217384|FG000|Overall Study|Adverse Event|2|||
148927120|NCT04068896|537217385|FG001|Overall Study|Adverse Event|0|||
148927121|NCT04068896|537217386|FG002|Overall Study|Adverse Event|1|||
148927122|NCT04068896|537217387|FG003|Overall Study|Adverse Event|0|||
148927123|NCT04068896|537217388|FG004|Overall Study|Adverse Event|0|||
148927124|NCT04068896|537217389|FG005|Overall Study|Adverse Event|0|||
148927125|NCT04068896|537217384|FG000|Overall Study|Death|3|||
148927126|NCT04068896|537217385|FG001|Overall Study|Death|1|||
148927127|NCT04068896|537217386|FG002|Overall Study|Death|3|||
148927128|NCT04068896|537217387|FG003|Overall Study|Death|19|||
148927129|NCT04068896|537217388|FG004|Overall Study|Death|17|||
148927130|NCT04068896|537217389|FG005|Overall Study|Death|0|||
148927131|NCT04068896|537217384|FG000|Overall Study|Physician Decision|0|||
149164069|NCT02357420|538075704|FG000|Overall Study|Prohibited Medication|1|||
149164070|NCT02357420|538075705|FG001|Overall Study|Prohibited Medication|1|||
149164071|NCT02357420|538075706|FG002|Overall Study|Prohibited Medication|0|||
149164072|NCT02357420|538075707|FG003|Overall Study|Prohibited Medication|0|||
148927132|NCT04068896|537217385|FG001|Overall Study|Physician Decision|0|||
148927133|NCT04068896|537217386|FG002|Overall Study|Physician Decision|0|||
148927134|NCT04068896|537217387|FG003|Overall Study|Physician Decision|1|||
148927135|NCT04068896|537217388|FG004|Overall Study|Physician Decision|0|||
148927136|NCT04068896|537217389|FG005|Overall Study|Physician Decision|0|||
148927137|NCT04068896|537217384|FG000|Overall Study|progressive disease|3|||
148927138|NCT04068896|537217385|FG001|Overall Study|progressive disease|5|||
148927139|NCT04068896|537217386|FG002|Overall Study|progressive disease|3|||
148927140|NCT04068896|537217387|FG003|Overall Study|progressive disease|2|||
148927141|NCT04068896|537217388|FG004|Overall Study|progressive disease|1|||
148927142|NCT04068896|537217389|FG005|Overall Study|progressive disease|2|||
148927143|NCT04068896|537217384|FG000|Overall Study|Study terminated by sponsor|0|||
149164073|NCT02357420|538075704|FG000|Overall Study|Protocol Non-compliance|0|||
149164074|NCT02357420|538075705|FG001|Overall Study|Protocol Non-compliance|0|||
149164075|NCT02357420|538075706|FG002|Overall Study|Protocol Non-compliance|0|||
149164076|NCT02357420|538075707|FG003|Overall Study|Protocol Non-compliance|1|||
149164077|NCT02357420|538075704|FG000|Overall Study|Withdrawn Consent|4|||
149164078|NCT02357420|538075705|FG001|Overall Study|Withdrawn Consent|8|||
149164079|NCT02357420|538075706|FG002|Overall Study|Withdrawn Consent|6|||
149164080|NCT02357420|538075707|FG003|Overall Study|Withdrawn Consent|6|||
149164081|NCT02357420|538075704|FG000|Overall Study|Lost to Follow-up|3|||
149164082|NCT02357420|538075705|FG001|Overall Study|Lost to Follow-up|0|||
149164083|NCT02357420|538075706|FG002|Overall Study|Lost to Follow-up|2|||
149164084|NCT02357420|538075707|FG003|Overall Study|Lost to Follow-up|3|||
149164085|NCT03617705|538075708|FG000|Overall Study|Withdrawal by Subject|2|||
149164086|NCT03617705|538075708|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
149164087|NCT03617705|538075708|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
149164088|NCT00214461|538075709|FG000|Overall Study|Adverse Event|0|||
149164089|NCT00214461|538075710|FG001|Overall Study|Adverse Event|0|||
149164090|NCT00214461|538075711|FG002|Overall Study|Adverse Event|1|||
149164091|NCT00214461|538075712|FG003|Overall Study|Adverse Event|1|||
149164092|NCT00214461|538075709|FG000|Overall Study|Withdrawal by Subject|0|||
149164093|NCT00214461|538075710|FG001|Overall Study|Withdrawal by Subject|0|||
149164094|NCT00214461|538075711|FG002|Overall Study|Withdrawal by Subject|1|||
149164095|NCT00214461|538075712|FG003|Overall Study|Withdrawal by Subject|0|||
149164096|NCT01061008|538075713|FG000|Overall Study|Badiocephalic fistula failed|3|||
149164097|NCT01061008|538075714|FG001|Overall Study|Badiocephalic fistula failed|2|||
149164098|NCT01061008|538075713|FG000|Overall Study|Death|1|||
149164099|NCT01061008|538075714|FG001|Overall Study|Death|0|||
149164100|NCT01061008|538075713|FG000|Overall Study|Withdrawal by Subject|1|||
149164101|NCT01061008|538075714|FG001|Overall Study|Withdrawal by Subject|3|||
149164102|NCT01061008|538075713|FG000|Overall Study|Unable to exercise following surgery|1|||
149164103|NCT01061008|538075714|FG001|Overall Study|Unable to exercise following surgery|0|||
149164104|NCT01061008|538075713|FG000|Overall Study|Adverse Event|0|||
149164105|NCT01061008|538075714|FG001|Overall Study|Adverse Event|1|||
149164106|NCT02908100|538075716|FG000|Overall Study|Adverse Event|7|||
149164107|NCT02908100|538075717|FG001|Overall Study|Adverse Event|6|||
149164108|NCT02908100|538075718|FG002|Overall Study|Adverse Event|9|||
149164109|NCT02908100|538075716|FG000|Overall Study|Death|2|||
149164110|NCT02908100|538075717|FG001|Overall Study|Death|0|||
149164111|NCT02908100|538075718|FG002|Overall Study|Death|0|||
149164112|NCT02908100|538075716|FG000|Overall Study|Lack of Efficacy|2|||
149164113|NCT02908100|538075717|FG001|Overall Study|Lack of Efficacy|3|||
149164114|NCT02908100|538075718|FG002|Overall Study|Lack of Efficacy|3|||
149164115|NCT02908100|538075716|FG000|Overall Study|Lost to Follow-up|0|||
149164116|NCT02908100|538075717|FG001|Overall Study|Lost to Follow-up|1|||
149164117|NCT02908100|538075718|FG002|Overall Study|Lost to Follow-up|2|||
149164118|NCT02908100|538075716|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149164119|NCT02908100|538075717|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149164120|NCT02908100|538075718|FG002|Overall Study|Non-Compliance With Study Drug|2|||
149164121|NCT02908100|538075716|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
149164122|NCT02908100|538075717|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
149164123|NCT02908100|538075718|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
149164124|NCT02908100|538075716|FG000|Overall Study|Physician Decision|0|||
149164125|NCT02908100|538075717|FG001|Overall Study|Physician Decision|1|||
149164126|NCT02908100|538075718|FG002|Overall Study|Physician Decision|0|||
149164127|NCT02908100|538075716|FG000|Overall Study|Pregnancy|1|||
149164128|NCT02908100|538075717|FG001|Overall Study|Pregnancy|2|||
149164129|NCT02908100|538075718|FG002|Overall Study|Pregnancy|0|||
149164130|NCT02908100|538075716|FG000|Overall Study|Withdrawal by Subject|8|||
149164131|NCT02908100|538075717|FG001|Overall Study|Withdrawal by Subject|7|||
149164132|NCT02908100|538075718|FG002|Overall Study|Withdrawal by Subject|5|||
149164133|NCT02908100|538075716|FG000|Overall Study|Randomised in Error|1|||
149164134|NCT02908100|538075717|FG001|Overall Study|Randomised in Error|0|||
149164135|NCT02908100|538075718|FG002|Overall Study|Randomised in Error|0|||
149164136|NCT02024971|538075719|FG000|Overall Study|Data Not Available|30|||
149164137|NCT02024971|538075719|FG000|Overall Study|Lost to Follow-up|6|||
149164138|NCT05254418|538075721|FG000|Overall Study|Adverse Event|2|||
149164139|NCT00440726|538075722|FG000|Phase 1|Dose-Limiting Toxicity|0|||
149164140|NCT00440726|538075723|FG001|Phase 1|Dose-Limiting Toxicity|1|||
149164141|NCT00440726|538075724|FG002|Phase 1|Dose-Limiting Toxicity|0|||
149164142|NCT00440726|538075722|FG000|Phase 1|Physician Decision|1|||
149164143|NCT00440726|538075723|FG001|Phase 1|Physician Decision|0|||
149164144|NCT00440726|538075724|FG002|Phase 1|Physician Decision|0|||
149164145|NCT00440726|538075722|FG000|Phase 2|Death|0|||
149164146|NCT00440726|538075723|FG001|Phase 2|Death|0|||
149164147|NCT00440726|538075724|FG002|Phase 2|Death|1|||
149164148|NCT00440726|538075722|FG000|Phase 2|Adverse Event|0|||
149164149|NCT00440726|538075723|FG001|Phase 2|Adverse Event|0|||
149164150|NCT00440726|538075724|FG002|Phase 2|Adverse Event|1|||
149164151|NCT01808612|538075725|FG000|Treatment Period|Adverse Event|8|||
149164152|NCT01808612|538075726|FG001|Treatment Period|Adverse Event|4|||
149164153|NCT01808612|538075727|FG002|Treatment Period|Adverse Event|3|||
149164154|NCT01808612|538075725|FG000|Treatment Period|Lost to Follow-up|2|||
149164155|NCT01808612|538075726|FG001|Treatment Period|Lost to Follow-up|2|||
149164156|NCT01808612|538075727|FG002|Treatment Period|Lost to Follow-up|1|||
149164157|NCT01808612|538075725|FG000|Treatment Period|Protocol Violation|1|||
149164158|NCT01808612|538075726|FG001|Treatment Period|Protocol Violation|0|||
149164159|NCT01808612|538075727|FG002|Treatment Period|Protocol Violation|0|||
149164160|NCT01808612|538075725|FG000|Treatment Period|Withdrawal by Subject|1|||
149164161|NCT01808612|538075726|FG001|Treatment Period|Withdrawal by Subject|0|||
149164162|NCT01808612|538075727|FG002|Treatment Period|Withdrawal by Subject|4|||
149164163|NCT01808612|538075725|FG000|Treatment Period|Physician Decision|1|||
149164164|NCT01808612|538075726|FG001|Treatment Period|Physician Decision|0|||
149164165|NCT01808612|538075727|FG002|Treatment Period|Physician Decision|4|||
149164166|NCT01808612|538075725|FG000|Treatment Period|Sponsor Decision|1|||
149164167|NCT01808612|538075726|FG001|Treatment Period|Sponsor Decision|0|||
149164168|NCT01808612|538075727|FG002|Treatment Period|Sponsor Decision|0|||
149164169|NCT01808612|538075725|FG000|Treatment Period|Lack of Efficacy|1|||
149164170|NCT01808612|538075726|FG001|Treatment Period|Lack of Efficacy|1|||
149164171|NCT01808612|538075727|FG002|Treatment Period|Lack of Efficacy|2|||
149164172|NCT01808612|538075725|FG000|Discontinuation Period|Adverse Event|1|||
149164173|NCT01808612|538075726|FG001|Discontinuation Period|Adverse Event|0|||
149164174|NCT01808612|538075727|FG002|Discontinuation Period|Adverse Event|0|||
149164175|NCT01808612|538075725|FG000|Discontinuation Period|Physician Decision|1|||
149164176|NCT01808612|538075726|FG001|Discontinuation Period|Physician Decision|0|||
149164177|NCT01808612|538075727|FG002|Discontinuation Period|Physician Decision|0|||
149164178|NCT01808612|538075725|FG000|Discontinuation Period|Lost to Follow-up|0|||
149164179|NCT01808612|538075726|FG001|Discontinuation Period|Lost to Follow-up|1|||
149164180|NCT01808612|538075727|FG002|Discontinuation Period|Lost to Follow-up|0|||
149164181|NCT03683394|538075728|FG000|Overall Study|Withdrawal by Subject|4|||
149164182|NCT03683394|538075729|FG001|Overall Study|Withdrawal by Subject|8|||
149164183|NCT03683394|538075728|FG000|Overall Study|Lost to Follow-up|7|||
149164184|NCT03683394|538075729|FG001|Overall Study|Lost to Follow-up|0|||
149164185|NCT03683394|538075728|FG000|Overall Study|Death|3|||
149164186|NCT03683394|538075729|FG001|Overall Study|Death|1|||
149164187|NCT00559273|538075730|FG000|Correction Period (20 Weeks)|Death|3|||
149164188|NCT00559273|538075731|FG001|Correction Period (20 Weeks)|Death|4|||
149164189|NCT00559273|538075730|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
149164190|NCT00559273|538075731|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
149164191|NCT00559273|538075730|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
149164192|NCT00559273|538075731|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
149164193|NCT00559273|538075730|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
149164194|NCT00559273|538075731|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
149164195|NCT00559273|538075730|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
149164196|NCT00559273|538075731|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
149164197|NCT00559273|538075730|FG000|Evaluation Period (8 Weeks)|Death|1|||
149164198|NCT00559273|538075731|FG001|Evaluation Period (8 Weeks)|Death|3|||
149164199|NCT00559273|538075730|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
149164200|NCT00559273|538075731|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
149164201|NCT00559273|538075730|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
149164202|NCT00559273|538075731|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
149164203|NCT00559273|538075730|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
149012920|NCT00152971|537525842|FG001|Treatment|Other|11|||
149164204|NCT00559273|538075731|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
149164205|NCT01925209|538075734|FG000|Treatment Epoch|Physician Decision|1|||
149164206|NCT01925209|538075735|FG001|Treatment Epoch|Physician Decision|0|||
149164207|NCT01925209|538075736|FG002|Treatment Epoch|Physician Decision|0|||
149164208|NCT01925209|538075737|FG003|Treatment Epoch|Physician Decision|0|||
149164209|NCT01925209|538075734|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
149164210|NCT01925209|538075735|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
149164211|NCT01925209|538075736|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
149012921|NCT00152971|537525843|FG002|Treatment|Other|10|||
149164212|NCT01925209|538075737|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
149164213|NCT01925209|538075734|FG000|Treatment Epoch|Death|1|||
149164214|NCT01925209|538075735|FG001|Treatment Epoch|Death|0|||
149164215|NCT01925209|538075736|FG002|Treatment Epoch|Death|0|||
149164216|NCT01925209|538075737|FG003|Treatment Epoch|Death|0|||
149164217|NCT01925209|538075734|FG000|Treatment Epoch|Protocol deviation|0|||
149164218|NCT01925209|538075735|FG001|Treatment Epoch|Protocol deviation|0|||
149164219|NCT01925209|538075736|FG002|Treatment Epoch|Protocol deviation|1|||
149164220|NCT01925209|538075737|FG003|Treatment Epoch|Protocol deviation|1|||
149164221|NCT01925209|538075734|FG000|Treatment Epoch|Withdrawal by Subject|4|||
149164222|NCT01925209|538075735|FG001|Treatment Epoch|Withdrawal by Subject|3|||
149164223|NCT01925209|538075736|FG002|Treatment Epoch|Withdrawal by Subject|3|||
149164224|NCT01925209|538075737|FG003|Treatment Epoch|Withdrawal by Subject|2|||
149164225|NCT01925209|538075734|FG000|Treatment Epoch|Adverse Event|3|||
149164226|NCT01925209|538075735|FG001|Treatment Epoch|Adverse Event|5|||
149164227|NCT01925209|538075736|FG002|Treatment Epoch|Adverse Event|3|||
149164228|NCT01925209|538075737|FG003|Treatment Epoch|Adverse Event|1|||
149164229|NCT01925209|538075734|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
149164230|NCT01925209|538075735|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
149164231|NCT01925209|538075736|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
149164232|NCT01925209|538075737|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
149164233|NCT01925209|538075734|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
149164234|NCT01925209|538075735|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
149164235|NCT01925209|538075736|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
149164236|NCT01925209|538075737|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
149164237|NCT01925209|538075734|FG000|Follow-up|Adverse Event|1|||
149164238|NCT01925209|538075735|FG001|Follow-up|Adverse Event|4|||
149164239|NCT01925209|538075736|FG002|Follow-up|Adverse Event|0|||
149164240|NCT01925209|538075737|FG003|Follow-up|Adverse Event|1|||
149164241|NCT01925209|538075734|FG000|Follow-up|Physician Decision|0|||
149164242|NCT01925209|538075735|FG001|Follow-up|Physician Decision|0|||
149164243|NCT01925209|538075736|FG002|Follow-up|Physician Decision|1|||
149164244|NCT01925209|538075737|FG003|Follow-up|Physician Decision|0|||
149164245|NCT01925209|538075734|FG000|Follow-up|Non-compliance with study treatment|0|||
149164246|NCT01925209|538075735|FG001|Follow-up|Non-compliance with study treatment|0|||
149164247|NCT01925209|538075736|FG002|Follow-up|Non-compliance with study treatment|0|||
149164248|NCT01925209|538075737|FG003|Follow-up|Non-compliance with study treatment|1|||
149164249|NCT01925209|538075734|FG000|Follow-up|Withdrawal by Subject|0|||
149164250|NCT01925209|538075735|FG001|Follow-up|Withdrawal by Subject|2|||
149164251|NCT01925209|538075736|FG002|Follow-up|Withdrawal by Subject|0|||
149164252|NCT01925209|538075737|FG003|Follow-up|Withdrawal by Subject|2|||
149164253|NCT00110994|538075738|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
149164254|NCT00110994|538075739|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
149164255|NCT00110994|538075738|FG000|Double-blind (DB) Treatment|Death|1|||
149164256|NCT00110994|538075739|FG001|Double-blind (DB) Treatment|Death|0|||
149164257|NCT00110994|538075738|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
149164258|NCT00110994|538075739|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
149164259|NCT00110994|538075738|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
149164260|NCT00110994|538075739|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
149164261|NCT00110994|538075738|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
149164262|NCT00110994|538075739|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
149164263|NCT00110994|538075738|FG000|Double-blind (DB) Treatment|other reasons|2|||
149164264|NCT00110994|538075739|FG001|Double-blind (DB) Treatment|other reasons|3|||
149164265|NCT00110994|538075738|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
149164266|NCT00110994|538075739|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
149164267|NCT00110994|538075738|FG000|Active Follow-up|Other reasons|0|||
149164268|NCT00110994|538075739|FG001|Active Follow-up|Other reasons|2|||
149164269|NCT00110994|538075738|FG000|Long Term Follow-up|Death|19|||
149164270|NCT00110994|538075739|FG001|Long Term Follow-up|Death|17|||
148806204|NCT04589650|536768105|FG004|Overall Study|Subject decision|0|||
148806205|NCT04589650|536768106|FG005|Overall Study|Subject decision|0|||
149164271|NCT01299727|538075740|FG000|Overall Study|Withdrawal by Subject|1|||
149164272|NCT01299727|538075741|FG001|Overall Study|Withdrawal by Subject|0|||
149164273|NCT01299727|538075742|FG002|Overall Study|Withdrawal by Subject|0|||
149164274|NCT01299727|538075740|FG000|Overall Study|Adverse Event|0|||
149164275|NCT01299727|538075741|FG001|Overall Study|Adverse Event|0|||
149164276|NCT01299727|538075742|FG002|Overall Study|Adverse Event|1|||
149164277|NCT01299727|538075740|FG000|Overall Study|Completed the Treatment Period|3|||
149164278|NCT01299727|538075741|FG001|Overall Study|Completed the Treatment Period|4|||
149164279|NCT01299727|538075742|FG002|Overall Study|Completed the Treatment Period|3|||
149164280|NCT03157531|538075754|FG000|Overall Study|Death|2|||
149164281|NCT03157531|538075754|FG000|Overall Study|Lost to Follow-up|4|||
149164282|NCT03213366|538075759|FG000|Overall Study|Lost to Follow-up|9|||
149164283|NCT03213366|538075760|FG001|Overall Study|Lost to Follow-up|4|||
148806206|NCT04589650|536768101|FG000|Overall Study|Adverse Event|3|||
149164284|NCT01879410|538075761|FG000|Overall Study|Adverse Event|9|||
149164285|NCT01879410|538075762|FG001|Overall Study|Adverse Event|14|||
149164286|NCT01879410|538075761|FG000|Overall Study|Lack of Efficacy|4|||
149164287|NCT01879410|538075762|FG001|Overall Study|Lack of Efficacy|6|||
149164288|NCT01879410|538075761|FG000|Overall Study|Protocol Violation|1|||
149164289|NCT01879410|538075762|FG001|Overall Study|Protocol Violation|7|||
149164290|NCT01879410|538075761|FG000|Overall Study|Lost to Follow-up|2|||
149164291|NCT01879410|538075762|FG001|Overall Study|Lost to Follow-up|1|||
149164292|NCT01879410|538075761|FG000|Overall Study|Withdrawal by Subject|7|||
149164293|NCT01879410|538075762|FG001|Overall Study|Withdrawal by Subject|8|||
149164294|NCT01879410|538075761|FG000|Overall Study|Randomised in Error|1|||
149164295|NCT01879410|538075762|FG001|Overall Study|Randomised in Error|2|||
149164296|NCT01737931|538075767|FG000|Overall Study|Withdrawal by Subject|0|||
149164297|NCT01737931|538075768|FG001|Overall Study|Withdrawal by Subject|1|||
149164298|NCT01737931|538075769|FG002|Overall Study|Withdrawal by Subject|1|||
149164299|NCT01737931|538075767|FG000|Overall Study|Physician Decision|0|||
149164300|NCT01737931|538075768|FG001|Overall Study|Physician Decision|1|||
149164301|NCT01737931|538075769|FG002|Overall Study|Physician Decision|0|||
149164302|NCT01573910|538075770|FG000|Overall Study|Adverse Event|4|||
149164303|NCT01573910|538075771|FG001|Overall Study|Adverse Event|4|||
149164304|NCT01573910|538075770|FG000|Overall Study|Lost to Follow-up|2|||
149164305|NCT01573910|538075771|FG001|Overall Study|Lost to Follow-up|1|||
149164306|NCT01573910|538075770|FG000|Overall Study|Withdrawal by Subject|0|||
149164307|NCT01573910|538075771|FG001|Overall Study|Withdrawal by Subject|1|||
149164308|NCT01573910|538075770|FG000|Overall Study|Protocol Violation|3|||
149164309|NCT01573910|538075771|FG001|Overall Study|Protocol Violation|0|||
149164310|NCT01573910|538075770|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
149164311|NCT01573910|538075771|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
149164312|NCT00364182|538075772|FG000|First Intervention|Secondary prophylaxis|1|||
149164313|NCT00364182|538075773|FG001|First Intervention|Secondary prophylaxis|0|||
149164314|NCT00364182|538075774|FG002|First Intervention|Secondary prophylaxis|0|||
149164315|NCT00364182|538075772|FG000|First Intervention|Withdrawal by Subject|2|||
149164316|NCT00364182|538075773|FG001|First Intervention|Withdrawal by Subject|0|||
149164317|NCT00364182|538075774|FG002|First Intervention|Withdrawal by Subject|0|||
149164318|NCT00364182|538075772|FG000|Second Intervention|non-compliance|0|||
149164319|NCT00364182|538075773|FG001|Second Intervention|non-compliance|1|||
149164320|NCT00364182|538075774|FG002|Second Intervention|non-compliance|1|||
149164321|NCT00364182|538075772|FG000|Second Intervention|Protocol Violation|0|||
149164322|NCT00364182|538075773|FG001|Second Intervention|Protocol Violation|1|||
149164323|NCT00364182|538075774|FG002|Second Intervention|Protocol Violation|0|||
149164324|NCT00364182|538075772|FG000|Second Intervention|Adverse Event|0|||
149164325|NCT00364182|538075773|FG001|Second Intervention|Adverse Event|0|||
149164326|NCT00364182|538075774|FG002|Second Intervention|Adverse Event|1|||
149164327|NCT00364182|538075772|FG000|Third Intervention|non-compliance|0|||
149164328|NCT00364182|538075773|FG001|Third Intervention|non-compliance|1|||
149164329|NCT00364182|538075774|FG002|Third Intervention|non-compliance|0|||
149164330|NCT00364182|538075772|FG000|Third Intervention|Lost to Follow-up|0|||
149164331|NCT00364182|538075773|FG001|Third Intervention|Lost to Follow-up|0|||
149164332|NCT00364182|538075774|FG002|Third Intervention|Lost to Follow-up|1|||
149164333|NCT01439945|538075798|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
149164334|NCT01439945|538075799|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
149164335|NCT01439945|538075800|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
149164336|NCT01439945|538075801|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
149164337|NCT01439945|538075798|FG000|Double-Blind Treatment Phase|Ineligible|1|||
149164338|NCT01439945|538075799|FG001|Double-Blind Treatment Phase|Ineligible|2|||
149164339|NCT01439945|538075800|FG002|Double-Blind Treatment Phase|Ineligible|0|||
149164340|NCT01439945|538075801|FG003|Double-Blind Treatment Phase|Ineligible|1|||
149164341|NCT04082663|538075802|FG000|Overall Study|Adverse Event|6|||
149164342|NCT04082663|538075802|FG000|Overall Study|Lost to Follow-up|1|||
149164343|NCT00705263|538075805|FG000|Overall Study|Withdrawal by Subject|2|||
149164344|NCT05501119|538075806|FG000|Overall Study|Withdrawal by Subject|2|||
149164345|NCT05501119|538075806|FG000|Overall Study|Lost to Follow-up|5|||
149164346|NCT05032950|538075810|FG000|Overall Study|Adverse Event|0|||
149164347|NCT05032950|538075811|FG001|Overall Study|Adverse Event|0|||
149164348|NCT05032950|538075812|FG002|Overall Study|Adverse Event|1|||
149164349|NCT05032950|538075813|FG003|Overall Study|Adverse Event|1|||
149164350|NCT05032950|538075814|FG004|Overall Study|Adverse Event|0|||
149164351|NCT05032950|538075815|FG005|Overall Study|Adverse Event|0|||
149164352|NCT02959814|538075816|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
149164353|NCT02959814|538075816|FG000|Overall Study|Excluded based on anatomical criteria|2|||
149164354|NCT02959814|538075816|FG000|Overall Study|Protocol Violation|7|||
149164355|NCT02959814|538075816|FG000|Overall Study|FFR not measured|2|||
149164356|NCT02959814|538075816|FG000|Overall Study|In-procedure QFR not computed|6|||
149164357|NCT02959814|538075816|FG000|Overall Study|Excluded by FFR core-lab|24|||
149164358|NCT01078805|538075826|FG000|Overall Study|Clinically significant abnormal lab|5|||
149164359|NCT01078805|538075826|FG000|Overall Study|Death|134|||
149164360|NCT01078805|538075826|FG000|Overall Study|Lost to Follow-up|676|||
149164361|NCT01078805|538075826|FG000|Overall Study|Physician Decision|169|||
149164362|NCT01078805|538075826|FG000|Overall Study|Serious adverse event|26|||
149164363|NCT01078805|538075826|FG000|Overall Study|Sponsor decision|46|||
149164364|NCT01078805|538075826|FG000|Overall Study|Withdrawal by Subject|739|||
149164365|NCT01078805|538075826|FG000|Overall Study|Other|173|||
149164366|NCT01078805|538075826|FG000|Overall Study|Didn't take study drug|82|||
149164367|NCT01445678|538075827|FG000|Overall Study|Adverse Event|12|||
149164368|NCT01445678|538075828|FG001|Overall Study|Adverse Event|8|||
149164369|NCT01445678|538075827|FG000|Overall Study|Lack of Efficacy|0|||
149164370|NCT01445678|538075828|FG001|Overall Study|Lack of Efficacy|2|||
149164371|NCT01445678|538075827|FG000|Overall Study|Lost to Follow-up|8|||
149164372|NCT01445678|538075828|FG001|Overall Study|Lost to Follow-up|5|||
149164373|NCT01445678|538075827|FG000|Overall Study|Protocol Violation|1|||
149164374|NCT01445678|538075828|FG001|Overall Study|Protocol Violation|1|||
149164375|NCT01445678|538075827|FG000|Overall Study|Withdrawal by Subject|9|||
149164376|NCT01445678|538075828|FG001|Overall Study|Withdrawal by Subject|5|||
149164377|NCT02159807|538077792|FG000|Overall Study|Adverse Event|0|||
149164378|NCT02159807|538077793|FG001|Overall Study|Adverse Event|0|||
149164379|NCT02159807|538077794|FG002|Overall Study|Adverse Event|1|||
149164380|NCT02159807|538077792|FG000|Overall Study|No CSF|1|||
149164381|NCT02159807|538077793|FG001|Overall Study|No CSF|1|||
149164382|NCT02159807|538077794|FG002|Overall Study|No CSF|1|||
149164383|NCT02159807|538077792|FG000|Overall Study|elevated blood pressure|0|||
149164384|NCT02159807|538077793|FG001|Overall Study|elevated blood pressure|0|||
149164385|NCT02159807|538077794|FG002|Overall Study|elevated blood pressure|1|||
149164386|NCT00950170|538077795|FG000|Overall Study|Parent/Legal Guardian Request|1|||
149164387|NCT00950170|538077795|FG000|Overall Study|Adverse Event|2|||
149164388|NCT00950170|538077795|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
149164389|NCT00469612|538077801|FG000|Overall Study|Study terminated before data collected|2|||
149164390|NCT00469612|538077802|FG001|Overall Study|Study terminated before data collected|0|||
149164391|NCT01279057|538077806|FG000|Overall Study|Adverse Event|1|||
149164392|NCT01279057|538077807|FG001|Overall Study|Adverse Event|0|||
149164393|NCT01279057|538077808|FG002|Overall Study|Adverse Event|1|||
149164394|NCT01279057|538077806|FG000|Overall Study|Insufficient therapeutic response|0|||
149164395|NCT01279057|538077807|FG001|Overall Study|Insufficient therapeutic response|0|||
149164396|NCT01279057|538077808|FG002|Overall Study|Insufficient therapeutic response|1|||
149164397|NCT01279057|538077806|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
149164398|NCT01279057|538077807|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
149164399|NCT01279057|538077808|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
149164400|NCT01279057|538077806|FG000|Overall Study|Withdrew consent|2|||
149164401|NCT01279057|538077807|FG001|Overall Study|Withdrew consent|0|||
149164402|NCT01279057|538077808|FG002|Overall Study|Withdrew consent|1|||
149164403|NCT01279057|538077806|FG000|Overall Study|Pregnancy|0|||
149164404|NCT01279057|538077807|FG001|Overall Study|Pregnancy|1|||
149164405|NCT01279057|538077808|FG002|Overall Study|Pregnancy|0|||
149164406|NCT01279057|538077806|FG000|Overall Study|Other|3|||
149164407|NCT01279057|538077807|FG001|Overall Study|Other|3|||
149164408|NCT01279057|538077808|FG002|Overall Study|Other|0|||
149164409|NCT01427309|538077810|FG000|Overall Study|Lost to Follow-up|130|||
149164410|NCT01427309|538077811|FG001|Overall Study|Lost to Follow-up|145|||
149164411|NCT01427309|538077812|FG002|Overall Study|Lost to Follow-up|122|||
149164412|NCT01427309|538077813|FG003|Overall Study|Lost to Follow-up|135|||
149164413|NCT01427309|538077810|FG000|Overall Study|Protocol Violation|42|||
149164414|NCT01427309|538077811|FG001|Overall Study|Protocol Violation|69|||
149164415|NCT01427309|538077812|FG002|Overall Study|Protocol Violation|125|||
149164416|NCT01427309|538077813|FG003|Overall Study|Protocol Violation|124|||
149164417|NCT01427309|538077810|FG000|Overall Study|Adverse Event|0|||
149164418|NCT01427309|538077811|FG001|Overall Study|Adverse Event|0|||
149164419|NCT01427309|538077812|FG002|Overall Study|Adverse Event|3|||
149164420|NCT01427309|538077813|FG003|Overall Study|Adverse Event|1|||
149164421|NCT01427309|538077810|FG000|Overall Study|Serious adverse event|52|||
149164422|NCT01427309|538077811|FG001|Overall Study|Serious adverse event|45|||
149164423|NCT01427309|538077812|FG002|Overall Study|Serious adverse event|50|||
149164424|NCT01427309|538077813|FG003|Overall Study|Serious adverse event|61|||
149164425|NCT01427309|538077810|FG000|Overall Study|Withdrawal by Subject|148|||
149164426|NCT01427309|538077811|FG001|Overall Study|Withdrawal by Subject|148|||
149164427|NCT01427309|538077812|FG002|Overall Study|Withdrawal by Subject|61|||
149164428|NCT01427309|538077813|FG003|Overall Study|Withdrawal by Subject|55|||
149164429|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
149012922|NCT00675506|537525844|FG000|Overall Study|Lost to Follow-up|1|||
149164430|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
149164431|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
149164432|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
149164433|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
149164434|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
149164435|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
149164436|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
149164437|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
149164438|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
149164439|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
149164440|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
149164441|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
149164442|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
149164443|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
149164444|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
149164445|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
149164446|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
149164447|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
149164448|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
149164449|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
149164450|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
149164451|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
149164452|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
149164453|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
149164454|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
149164455|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
149164456|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
149164457|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
149164458|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
149164459|NCT00849017|538077814|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
149164460|NCT00849017|538077815|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
149164461|NCT00849017|538077816|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
149164462|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
149164463|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
149164464|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
149164465|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
149164466|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
149164467|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
149164468|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
149164469|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
149164470|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
149164471|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
149164472|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
149164473|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
149164474|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
149164475|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
149164476|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
149164477|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
149164478|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
149164479|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
149164480|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
149164481|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
149164482|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
149164483|NCT00849017|538077814|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
149164484|NCT00849017|538077815|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
149164485|NCT00849017|538077816|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
149164486|NCT02913313|538077817|FG000|Overall Study|DISEASE PROGRESSION|1|||
149164487|NCT02913313|538077818|FG001|Overall Study|DISEASE PROGRESSION|2|||
148675108|NCT05004181|536281523|FG011|Overall Study|Withdrawal by Subject|2|||
148675109|NCT05004181|536281512|FG000|Overall Study|Protocol Violation|2|||
148675110|NCT05004181|536281513|FG001|Overall Study|Protocol Violation|3|||
148675111|NCT05004181|536281514|FG002|Overall Study|Protocol Violation|0|||
149012923|NCT00675506|537525845|FG001|Overall Study|Lost to Follow-up|5|||
149012924|NCT00675506|537525844|FG000|Overall Study|Lost interest|3|||
149164488|NCT02913313|538077819|FG002|Overall Study|DISEASE PROGRESSION|2|||
149164489|NCT02913313|538077820|FG003|Overall Study|DISEASE PROGRESSION|4|||
149164490|NCT02913313|538077821|FG004|Overall Study|DISEASE PROGRESSION|6|||
149164491|NCT02913313|538077822|FG005|Overall Study|DISEASE PROGRESSION|4|||
149164492|NCT02913313|538077823|FG006|Overall Study|DISEASE PROGRESSION|19|||
149164493|NCT02913313|538077824|FG007|Overall Study|DISEASE PROGRESSION|3|||
149164494|NCT02913313|538077825|FG008|Overall Study|DISEASE PROGRESSION|4|||
149164495|NCT02913313|538077826|FG009|Overall Study|DISEASE PROGRESSION|4|||
149164496|NCT02913313|538077827|FG010|Overall Study|DISEASE PROGRESSION|11|||
149164497|NCT02913313|538077828|FG011|Overall Study|DISEASE PROGRESSION|5|||
149164498|NCT02913313|538077829|FG012|Overall Study|DISEASE PROGRESSION|14|||
149164499|NCT02913313|538077830|FG013|Overall Study|DISEASE PROGRESSION|3|||
148675112|NCT05004181|536281515|FG003|Overall Study|Protocol Violation|0|||
149164500|NCT02913313|538077817|FG000|Overall Study|Not Reported|0|||
149164501|NCT02913313|538077818|FG001|Overall Study|Not Reported|0|||
149164502|NCT02913313|538077819|FG002|Overall Study|Not Reported|0|||
149164503|NCT02913313|538077820|FG003|Overall Study|Not Reported|0|||
149164504|NCT02913313|538077821|FG004|Overall Study|Not Reported|1|||
149164505|NCT02913313|538077822|FG005|Overall Study|Not Reported|0|||
149164506|NCT02913313|538077823|FG006|Overall Study|Not Reported|0|||
149164507|NCT02913313|538077824|FG007|Overall Study|Not Reported|0|||
149164508|NCT02913313|538077825|FG008|Overall Study|Not Reported|0|||
149164509|NCT02913313|538077826|FG009|Overall Study|Not Reported|0|||
149164510|NCT02913313|538077827|FG010|Overall Study|Not Reported|4|||
149164511|NCT02913313|538077828|FG011|Overall Study|Not Reported|0|||
149164512|NCT02913313|538077829|FG012|Overall Study|Not Reported|0|||
149164513|NCT02913313|538077830|FG013|Overall Study|Not Reported|0|||
149164514|NCT02913313|538077817|FG000|Overall Study|Other reasons|0|||
149164515|NCT02913313|538077818|FG001|Overall Study|Other reasons|0|||
149164516|NCT02913313|538077819|FG002|Overall Study|Other reasons|0|||
149164517|NCT02913313|538077820|FG003|Overall Study|Other reasons|0|||
149164518|NCT02913313|538077821|FG004|Overall Study|Other reasons|1|||
149164519|NCT02913313|538077822|FG005|Overall Study|Other reasons|0|||
149164520|NCT02913313|538077823|FG006|Overall Study|Other reasons|0|||
149164521|NCT02913313|538077824|FG007|Overall Study|Other reasons|0|||
149164522|NCT02913313|538077825|FG008|Overall Study|Other reasons|0|||
149164523|NCT02913313|538077826|FG009|Overall Study|Other reasons|0|||
149164524|NCT02913313|538077827|FG010|Overall Study|Other reasons|1|||
149164525|NCT02913313|538077828|FG011|Overall Study|Other reasons|0|||
149164526|NCT02913313|538077829|FG012|Overall Study|Other reasons|0|||
149164527|NCT02913313|538077830|FG013|Overall Study|Other reasons|0|||
149164528|NCT02913313|538077817|FG000|Overall Study|Withdrawal by Subject|0|||
149164529|NCT02913313|538077818|FG001|Overall Study|Withdrawal by Subject|0|||
149164530|NCT02913313|538077819|FG002|Overall Study|Withdrawal by Subject|1|||
149164531|NCT02913313|538077820|FG003|Overall Study|Withdrawal by Subject|0|||
149164532|NCT02913313|538077821|FG004|Overall Study|Withdrawal by Subject|0|||
149164533|NCT02913313|538077822|FG005|Overall Study|Withdrawal by Subject|0|||
149164534|NCT02913313|538077823|FG006|Overall Study|Withdrawal by Subject|1|||
149164535|NCT02913313|538077824|FG007|Overall Study|Withdrawal by Subject|1|||
149164536|NCT02913313|538077825|FG008|Overall Study|Withdrawal by Subject|0|||
149164537|NCT02913313|538077826|FG009|Overall Study|Withdrawal by Subject|0|||
149164538|NCT02913313|538077827|FG010|Overall Study|Withdrawal by Subject|1|||
149164539|NCT02913313|538077828|FG011|Overall Study|Withdrawal by Subject|0|||
149164540|NCT02913313|538077829|FG012|Overall Study|Withdrawal by Subject|0|||
149164541|NCT02913313|538077830|FG013|Overall Study|Withdrawal by Subject|0|||
149164542|NCT02913313|538077817|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164543|NCT02913313|538077818|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164544|NCT02913313|538077819|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164545|NCT02913313|538077820|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164546|NCT02913313|538077821|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164547|NCT02913313|538077822|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164548|NCT02913313|538077823|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164549|NCT02913313|538077824|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164550|NCT02913313|538077825|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164551|NCT02913313|538077826|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164552|NCT02913313|538077827|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
149164553|NCT02913313|538077828|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
149164554|NCT02913313|538077829|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
149164555|NCT02913313|538077830|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
149164556|NCT02913313|538077817|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
149164557|NCT02913313|538077818|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
149164558|NCT02913313|538077819|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
149164559|NCT02913313|538077820|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
149164560|NCT02913313|538077821|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
148927144|NCT04068896|537217385|FG001|Overall Study|Study terminated by sponsor|0|||
148927145|NCT04068896|537217386|FG002|Overall Study|Study terminated by sponsor|1|||
149164561|NCT02913313|538077822|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
149164562|NCT02913313|538077823|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
148927146|NCT04068896|537217387|FG003|Overall Study|Study terminated by sponsor|2|||
149164563|NCT02913313|538077824|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
149164564|NCT02913313|538077825|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
149164565|NCT02913313|538077826|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
149164566|NCT02913313|538077827|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
149164567|NCT02913313|538077828|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
148927147|NCT04068896|537217388|FG004|Overall Study|Study terminated by sponsor|1|||
149164568|NCT02913313|538077829|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
149164569|NCT02913313|538077830|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
149164570|NCT06118385|538077832|FG000|Overall Study|Protocol Violation|0|||
149164571|NCT06118385|538077833|FG001|Overall Study|Protocol Violation|0|||
149164572|NCT06118385|538077834|FG002|Overall Study|Protocol Violation|0|||
149164573|NCT06118385|538077835|FG003|Overall Study|Protocol Violation|0|||
149164574|NCT06118385|538077836|FG004|Overall Study|Protocol Violation|0|||
149164575|NCT06118385|538077837|FG005|Overall Study|Protocol Violation|0|||
149164576|NCT06118385|538077838|FG006|Overall Study|Protocol Violation|0|||
149164577|NCT06118385|538077839|FG007|Overall Study|Protocol Violation|0|||
149164578|NCT06118385|538077840|FG008|Overall Study|Protocol Violation|1|||
149164579|NCT06118385|538077841|FG009|Overall Study|Protocol Violation|0|||
149164580|NCT06118385|538077842|FG010|Overall Study|Protocol Violation|0|||
149164581|NCT06118385|538077843|FG011|Overall Study|Protocol Violation|0|||
149164582|NCT06118385|538077832|FG000|Overall Study|Out-of-range blood tests|0|||
149164583|NCT06118385|538077833|FG001|Overall Study|Out-of-range blood tests|0|||
149164584|NCT06118385|538077834|FG002|Overall Study|Out-of-range blood tests|0|||
149164585|NCT06118385|538077835|FG003|Overall Study|Out-of-range blood tests|0|||
149164586|NCT06118385|538077836|FG004|Overall Study|Out-of-range blood tests|0|||
149164587|NCT06118385|538077837|FG005|Overall Study|Out-of-range blood tests|0|||
149164588|NCT06118385|538077838|FG006|Overall Study|Out-of-range blood tests|0|||
149164589|NCT06118385|538077839|FG007|Overall Study|Out-of-range blood tests|0|||
149164590|NCT06118385|538077840|FG008|Overall Study|Out-of-range blood tests|1|||
149164591|NCT06118385|538077841|FG009|Overall Study|Out-of-range blood tests|0|||
149164592|NCT06118385|538077842|FG010|Overall Study|Out-of-range blood tests|0|||
149164593|NCT06118385|538077843|FG011|Overall Study|Out-of-range blood tests|0|||
149164594|NCT02411448|538077844|FG000|Overall Study|Withdrawal by Subject|1|||
149164595|NCT02411448|538077845|FG001|Overall Study|Withdrawal by Subject|14|||
149164596|NCT02411448|538077846|FG002|Overall Study|Withdrawal by Subject|9|||
149164597|NCT02411448|538077844|FG000|Overall Study|Other|0|||
149164598|NCT02411448|538077845|FG001|Overall Study|Other|2|||
149164599|NCT02411448|538077846|FG002|Overall Study|Other|0|||
149164600|NCT02411448|538077844|FG000|Overall Study|Did not receive study treatment|0|||
149164601|NCT02411448|538077845|FG001|Overall Study|Did not receive study treatment|3|||
149164602|NCT02411448|538077846|FG002|Overall Study|Did not receive study treatment|0|||
149164603|NCT02411448|538077844|FG000|Overall Study|Alive on study treatment|3|||
149164604|NCT02411448|538077845|FG001|Overall Study|Alive on study treatment|64|||
149164605|NCT02411448|538077846|FG002|Overall Study|Alive on study treatment|43|||
149164606|NCT01848145|538077847|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
149164607|NCT01848145|538077847|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
149164608|NCT01848145|538077847|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
149164609|NCT01848145|538077847|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
149164610|NCT01848145|538077847|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
149164611|NCT01848145|538077847|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
149164612|NCT01848145|538077847|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
148675113|NCT05004181|536281516|FG004|Overall Study|Protocol Violation|1|||
149012925|NCT00675506|537525845|FG001|Overall Study|Lost interest|5|||
149164613|NCT01058096|538077848|FG000|Double-blind Treatment Phase|Adverse Event|11|||
149012926|NCT00675506|537525844|FG000|Overall Study|Elevated fasting glucose|2|||
149164614|NCT01058096|538077849|FG001|Double-blind Treatment Phase|Adverse Event|15|||
149164615|NCT01058096|538077848|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
149164616|NCT01058096|538077849|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
149164617|NCT01058096|538077848|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
149164618|NCT01058096|538077849|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
148927148|NCT04068896|537217389|FG005|Overall Study|Study terminated by sponsor|4|||
148927149|NCT04068896|537217384|FG000|Overall Study|Protocol Violation|0|||
148927150|NCT04068896|537217385|FG001|Overall Study|Protocol Violation|0|||
148927151|NCT04068896|537217386|FG002|Overall Study|Protocol Violation|0|||
148927152|NCT04068896|537217387|FG003|Overall Study|Protocol Violation|1|||
148927153|NCT04068896|537217388|FG004|Overall Study|Protocol Violation|0|||
149164619|NCT01058096|538077848|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
149164620|NCT01058096|538077849|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
149164621|NCT01058096|538077848|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
149164622|NCT01058096|538077849|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
149164623|NCT01058096|538077848|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
149164624|NCT01058096|538077849|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
149164625|NCT02690194|538077856|FG000|Overall Study|Withdrawal by Subject|1|||
149164626|NCT02690194|538077857|FG001|Overall Study|Withdrawal by Subject|4|||
149164627|NCT02690194|538077858|FG002|Overall Study|Withdrawal by Subject|0|||
149164628|NCT03624946|538077859|FG000|Overall Study|Lost to Follow-up|0|||
149164629|NCT03624946|538077860|FG001|Overall Study|Lost to Follow-up|1|||
149164630|NCT01728779|538077861|FG000|Overall Study|Withdrawal by Subject|1|||
149164631|NCT00624520|538077862|FG000|Overall Study|Withdrawal by Subject|12|||
149164632|NCT00624520|538077863|FG001|Overall Study|Withdrawal by Subject|7|||
149164633|NCT00624520|538077862|FG000|Overall Study|Death|0|||
149164634|NCT00624520|538077863|FG001|Overall Study|Death|1|||
148927154|NCT04068896|537217389|FG005|Overall Study|Protocol Violation|0|||
148927155|NCT04068896|537217384|FG000|Overall Study|Withdrawal by Subject|0|||
148927156|NCT04068896|537217385|FG001|Overall Study|Withdrawal by Subject|3|||
148927157|NCT04068896|537217386|FG002|Overall Study|Withdrawal by Subject|0|||
149164635|NCT00675025|538077864|FG000|Overall Study|Study Terminated by Sponsor|38|||
149164636|NCT00675025|538077865|FG001|Overall Study|Study Terminated by Sponsor|42|||
148927158|NCT04068896|537217387|FG003|Overall Study|Withdrawal by Subject|2|||
148927159|NCT04068896|537217388|FG004|Overall Study|Withdrawal by Subject|1|||
148927160|NCT04068896|537217389|FG005|Overall Study|Withdrawal by Subject|0|||
148927161|NCT04068896|537217384|FG000|Overall Study|Symptomatic deterioration|2|||
149164637|NCT00675025|538077864|FG000|Overall Study|Adverse Event|6|||
149164638|NCT00675025|538077865|FG001|Overall Study|Adverse Event|11|||
149164639|NCT00675025|538077864|FG000|Overall Study|Lost to Follow-up|6|||
149164640|NCT00675025|538077865|FG001|Overall Study|Lost to Follow-up|4|||
149164641|NCT00675025|538077864|FG000|Overall Study|Withdrawal by Subject|4|||
149164642|NCT00675025|538077865|FG001|Overall Study|Withdrawal by Subject|6|||
149164643|NCT00944034|538077870|FG000|Overall Study|Inappropriate enrollment|0|||
149164644|NCT00944034|538077871|FG001|Overall Study|Inappropriate enrollment|1|||
149164645|NCT00944034|538077872|FG002|Overall Study|Inappropriate enrollment|0|||
149164646|NCT00944034|538077873|FG003|Overall Study|Inappropriate enrollment|1|||
149164647|NCT00944034|538077874|FG004|Overall Study|Inappropriate enrollment|2|||
149164648|NCT00944034|538077875|FG005|Overall Study|Inappropriate enrollment|1|||
149164649|NCT00944034|538077876|FG006|Overall Study|Inappropriate enrollment|0|||
149164650|NCT00944034|538077877|FG007|Overall Study|Inappropriate enrollment|0|||
148927162|NCT04068896|537217385|FG001|Overall Study|Symptomatic deterioration|0|||
148927163|NCT04068896|537217386|FG002|Overall Study|Symptomatic deterioration|0|||
148927164|NCT04068896|537217387|FG003|Overall Study|Symptomatic deterioration|0|||
148927165|NCT04068896|537217388|FG004|Overall Study|Symptomatic deterioration|0|||
148927166|NCT04068896|537217389|FG005|Overall Study|Symptomatic deterioration|0|||
148927167|NCT00555425|537217390|FG000|Overall Study|Missed Medication > 1 wk|34|||
148927168|NCT00555425|537217391|FG001|Overall Study|Missed Medication > 1 wk|15|||
148927169|NCT00555425|537217390|FG000|Overall Study|Missed 3 physician management visits|1|||
148927170|NCT00555425|537217391|FG001|Overall Study|Missed 3 physician management visits|0|||
148927171|NCT00555425|537217390|FG000|Overall Study|Met criteria for protective transfer|16|||
148927172|NCT00555425|537217391|FG001|Overall Study|Met criteria for protective transfer|3|||
148927173|NCT00555425|537217390|FG000|Overall Study|Became pregnant and transferred care|0|||
148927174|NCT00555425|537217391|FG001|Overall Study|Became pregnant and transferred care|1|||
148927175|NCT00393042|537217396|FG000|First Intervention|Withdrawal by Subject|1|||
148927176|NCT00393042|537217397|FG001|First Intervention|Withdrawal by Subject|2|||
148927177|NCT00393042|537217396|FG000|First Intervention|Lost to Follow-up|3|||
148927178|NCT00393042|537217397|FG001|First Intervention|Lost to Follow-up|3|||
148927179|NCT00393042|537217396|FG000|First Intervention|Protocol Violation|1|||
148927180|NCT00393042|537217397|FG001|First Intervention|Protocol Violation|0|||
148927181|NCT00393042|537217396|FG000|First Intervention|Adverse Event|0|||
148927182|NCT00393042|537217397|FG001|First Intervention|Adverse Event|1|||
148927183|NCT00393042|537217396|FG000|Second Intervetion|Adverse Event|0|||
148927184|NCT00393042|537217397|FG001|Second Intervetion|Adverse Event|3|||
148927185|NCT00393042|537217396|FG000|Second Intervetion|Withdrawal by Subject|0|||
148927186|NCT00393042|537217397|FG001|Second Intervetion|Withdrawal by Subject|2|||
148927187|NCT00393042|537217396|FG000|Second Intervetion|Lack of Efficacy|1|||
148927188|NCT00393042|537217397|FG001|Second Intervetion|Lack of Efficacy|0|||
148927189|NCT00393042|537217396|FG000|Second Intervetion|Lost to Follow-up|0|||
148927190|NCT00393042|537217397|FG001|Second Intervetion|Lost to Follow-up|2|||
148927191|NCT00393042|537217396|FG000|Second Intervetion|Protocol Violation|1|||
148927192|NCT00393042|537217397|FG001|Second Intervetion|Protocol Violation|1|||
148927193|NCT02045303|537217398|FG000|Overall Study|Protocol Violation|2|||
148927194|NCT02045303|537217399|FG001|Overall Study|Protocol Violation|1|||
148927195|NCT02045303|537217400|FG002|Overall Study|Protocol Violation|0|||
148927196|NCT02045303|537217398|FG000|Overall Study|Withdrawal by Subject|0|||
148927197|NCT02045303|537217399|FG001|Overall Study|Withdrawal by Subject|2|||
148927198|NCT02045303|537217400|FG002|Overall Study|Withdrawal by Subject|0|||
148927199|NCT00829283|537217401|FG000|Overall Study|Lost to Follow-up|7|||
148927200|NCT00829283|537217402|FG001|Overall Study|Lost to Follow-up|25|||
148927201|NCT00256282|537217403|FG000|Overall Study|Disease progression, relapse during acti|12|||
148927202|NCT00256282|537217403|FG000|Overall Study|Adverse Event|3|||
148927203|NCT00256282|537217403|FG000|Overall Study|Physician Decision|1|||
148927204|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
148927205|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
148927206|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
148927207|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
148927208|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
148927209|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
148927210|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
148927211|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
148927212|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
148927213|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
149164651|NCT00944034|538077878|FG008|Overall Study|Inappropriate enrollment|1|||
149164652|NCT00944034|538077879|FG009|Overall Study|Inappropriate enrollment|1|||
149164653|NCT00944034|538077880|FG010|Overall Study|Inappropriate enrollment|0|||
149164654|NCT00944034|538077881|FG011|Overall Study|Inappropriate enrollment|0|||
149164655|NCT00944034|538077870|FG000|Overall Study|Withdrawal by Subject|3|||
149164656|NCT00944034|538077871|FG001|Overall Study|Withdrawal by Subject|2|||
149164657|NCT00944034|538077872|FG002|Overall Study|Withdrawal by Subject|6|||
149164658|NCT00944034|538077873|FG003|Overall Study|Withdrawal by Subject|2|||
149164659|NCT00944034|538077874|FG004|Overall Study|Withdrawal by Subject|5|||
149164660|NCT00944034|538077875|FG005|Overall Study|Withdrawal by Subject|8|||
149164661|NCT00944034|538077876|FG006|Overall Study|Withdrawal by Subject|2|||
149164662|NCT00944034|538077877|FG007|Overall Study|Withdrawal by Subject|2|||
149164663|NCT00944034|538077878|FG008|Overall Study|Withdrawal by Subject|3|||
149164664|NCT00944034|538077879|FG009|Overall Study|Withdrawal by Subject|4|||
148927214|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
149164665|NCT00944034|538077880|FG010|Overall Study|Withdrawal by Subject|0|||
149164666|NCT00944034|538077881|FG011|Overall Study|Withdrawal by Subject|4|||
149164667|NCT00944034|538077870|FG000|Overall Study|Lost to Follow-up|0|||
149164668|NCT00944034|538077871|FG001|Overall Study|Lost to Follow-up|4|||
149164669|NCT00944034|538077872|FG002|Overall Study|Lost to Follow-up|2|||
149164670|NCT00944034|538077873|FG003|Overall Study|Lost to Follow-up|0|||
149164671|NCT00944034|538077874|FG004|Overall Study|Lost to Follow-up|5|||
149164672|NCT00944034|538077875|FG005|Overall Study|Lost to Follow-up|7|||
149164673|NCT00944034|538077876|FG006|Overall Study|Lost to Follow-up|0|||
149164674|NCT00944034|538077877|FG007|Overall Study|Lost to Follow-up|1|||
149164675|NCT00944034|538077878|FG008|Overall Study|Lost to Follow-up|5|||
149164676|NCT00944034|538077879|FG009|Overall Study|Lost to Follow-up|1|||
149164677|NCT00944034|538077880|FG010|Overall Study|Lost to Follow-up|1|||
149164678|NCT00944034|538077881|FG011|Overall Study|Lost to Follow-up|0|||
149164679|NCT00944034|538077870|FG000|Overall Study|Death|0|||
149164680|NCT00944034|538077871|FG001|Overall Study|Death|0|||
149164681|NCT00944034|538077872|FG002|Overall Study|Death|1|||
149164682|NCT00944034|538077873|FG003|Overall Study|Death|0|||
149164683|NCT00944034|538077874|FG004|Overall Study|Death|0|||
149164684|NCT00944034|538077875|FG005|Overall Study|Death|0|||
149164685|NCT00944034|538077876|FG006|Overall Study|Death|0|||
149164686|NCT00944034|538077877|FG007|Overall Study|Death|0|||
149164687|NCT00944034|538077878|FG008|Overall Study|Death|0|||
149164688|NCT00944034|538077879|FG009|Overall Study|Death|0|||
149164689|NCT00944034|538077880|FG010|Overall Study|Death|0|||
149164690|NCT00944034|538077881|FG011|Overall Study|Death|0|||
149164691|NCT00944034|538077870|FG000|Overall Study|Protocol Violation|2|||
149164692|NCT00944034|538077871|FG001|Overall Study|Protocol Violation|0|||
149164693|NCT00944034|538077872|FG002|Overall Study|Protocol Violation|0|||
149164694|NCT00944034|538077873|FG003|Overall Study|Protocol Violation|1|||
149164695|NCT00944034|538077874|FG004|Overall Study|Protocol Violation|2|||
149164696|NCT00944034|538077875|FG005|Overall Study|Protocol Violation|3|||
149164697|NCT00944034|538077876|FG006|Overall Study|Protocol Violation|0|||
149164698|NCT00944034|538077877|FG007|Overall Study|Protocol Violation|1|||
149164699|NCT00944034|538077878|FG008|Overall Study|Protocol Violation|1|||
149164700|NCT00944034|538077879|FG009|Overall Study|Protocol Violation|4|||
149164701|NCT00944034|538077880|FG010|Overall Study|Protocol Violation|0|||
149164702|NCT00944034|538077881|FG011|Overall Study|Protocol Violation|0|||
149164703|NCT00944034|538077870|FG000|Overall Study|Unable to classify|0|||
149164704|NCT00944034|538077871|FG001|Overall Study|Unable to classify|0|||
149164705|NCT00944034|538077872|FG002|Overall Study|Unable to classify|0|||
148927215|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
149164706|NCT00944034|538077873|FG003|Overall Study|Unable to classify|0|||
149164707|NCT00944034|538077874|FG004|Overall Study|Unable to classify|0|||
149164708|NCT00944034|538077875|FG005|Overall Study|Unable to classify|1|||
149164709|NCT00944034|538077876|FG006|Overall Study|Unable to classify|1|||
149164710|NCT00944034|538077877|FG007|Overall Study|Unable to classify|1|||
149164711|NCT00944034|538077878|FG008|Overall Study|Unable to classify|0|||
149164712|NCT00944034|538077879|FG009|Overall Study|Unable to classify|0|||
149164713|NCT00944034|538077880|FG010|Overall Study|Unable to classify|0|||
149164714|NCT00944034|538077881|FG011|Overall Study|Unable to classify|0|||
149164715|NCT00944034|538077870|FG000|Overall Study|Administrative reason|0|||
149164716|NCT00944034|538077871|FG001|Overall Study|Administrative reason|0|||
149164717|NCT00944034|538077872|FG002|Overall Study|Administrative reason|0|||
149164718|NCT00944034|538077873|FG003|Overall Study|Administrative reason|0|||
149164719|NCT00944034|538077874|FG004|Overall Study|Administrative reason|0|||
149164720|NCT00944034|538077875|FG005|Overall Study|Administrative reason|0|||
149164721|NCT00944034|538077876|FG006|Overall Study|Administrative reason|1|||
149164722|NCT00944034|538077877|FG007|Overall Study|Administrative reason|0|||
149164723|NCT00944034|538077878|FG008|Overall Study|Administrative reason|0|||
148927216|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
149164724|NCT00944034|538077879|FG009|Overall Study|Administrative reason|0|||
149164725|NCT00944034|538077880|FG010|Overall Study|Administrative reason|0|||
149164726|NCT00944034|538077881|FG011|Overall Study|Administrative reason|0|||
149164727|NCT01596257|538077882|FG000|Overall Study|Inadequate Collection|23|||
149164728|NCT01596257|538077883|FG001|Overall Study|Inadequate Collection|19|||
149164729|NCT01570244|538077884|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
149164730|NCT00238264|538077890|FG000|Overall Study|Death|7|||
149164731|NCT00238264|538077890|FG000|Overall Study|Lost to Follow-up|18|||
149164732|NCT00238264|538077890|FG000|Overall Study|Withdrawal by Subject|4|||
149164733|NCT00238264|538077890|FG000|Overall Study|Ineligible|7|||
149164734|NCT00713219|538077891|FG000|Overall Study|Death|1|||
149164735|NCT00713219|538077891|FG000|Overall Study|Protocol Violation|1|||
149164736|NCT03183128|538077897|FG000|Overall Study|Adverse Event|1|||
149164737|NCT03183128|538077898|FG001|Overall Study|Adverse Event|2|||
148927217|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
148927218|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
149164738|NCT03183128|538077897|FG000|Overall Study|Withdrawal by Subject|1|||
149164739|NCT03183128|538077898|FG001|Overall Study|Withdrawal by Subject|8|||
149164740|NCT03183128|538077897|FG000|Overall Study|Protocol Violation|2|||
149164741|NCT03183128|538077898|FG001|Overall Study|Protocol Violation|0|||
149164742|NCT03183128|538077897|FG000|Overall Study|Lack of Efficacy|4|||
149164743|NCT03183128|538077898|FG001|Overall Study|Lack of Efficacy|27|||
149164744|NCT03183128|538077897|FG000|Overall Study|Lost to Follow-up|1|||
149164745|NCT03183128|538077898|FG001|Overall Study|Lost to Follow-up|0|||
149164746|NCT03183128|538077897|FG000|Overall Study|Death|2|||
149164747|NCT03183128|538077898|FG001|Overall Study|Death|0|||
149164748|NCT03183128|538077897|FG000|Overall Study|Physician Decision|1|||
149164749|NCT03183128|538077898|FG001|Overall Study|Physician Decision|0|||
149164750|NCT02978222|538077901|FG000|Overall Study|Withdrawal by Subject|2|||
149164751|NCT02978222|538077902|FG001|Overall Study|Withdrawal by Subject|2|||
149164752|NCT02978222|538077901|FG000|Overall Study|Physician Decision|2|||
149164753|NCT02978222|538077902|FG001|Overall Study|Physician Decision|0|||
149164754|NCT02978222|538077901|FG000|Overall Study|Adverse Event|0|||
149164755|NCT02978222|538077902|FG001|Overall Study|Adverse Event|1|||
149164756|NCT02978222|538077901|FG000|Overall Study|Death|1|||
149164757|NCT02978222|538077902|FG001|Overall Study|Death|0|||
149164758|NCT02978222|538077901|FG000|Overall Study|Disease Progression|32|||
149164759|NCT02978222|538077902|FG001|Overall Study|Disease Progression|32|||
149164760|NCT02978222|538077901|FG000|Overall Study|Early Study Termination|24|||
149164761|NCT02978222|538077902|FG001|Overall Study|Early Study Termination|21|||
149164762|NCT01686568|538077903|FG000|Main Study|Withdrawal by Subject|1|||
149164763|NCT01686568|538077904|FG001|Main Study|Withdrawal by Subject|3|||
149164764|NCT01686568|538077903|FG000|Main Study|Noncompliance with protocol|0|||
149164765|NCT01686568|538077904|FG001|Main Study|Noncompliance with protocol|1|||
149164766|NCT01686568|538077903|FG000|Main Study|Liver enzymes above range of exclusion|1|||
149164767|NCT01686568|538077904|FG001|Main Study|Liver enzymes above range of exclusion|0|||
149164768|NCT01686568|538077903|FG000|Sub-Study|Not consented for sub-study|2|||
149164769|NCT01686568|538077904|FG001|Sub-Study|Not consented for sub-study|2|||
149164770|NCT03258814|538077905|FG000|Overall Study|Early Termination|4|||
149164771|NCT03258814|538077906|FG001|Overall Study|Early Termination|3|||
149164772|NCT03258814|538077907|FG002|Overall Study|Early Termination|10|||
149164773|NCT01413958|538077908|FG000|Overall Study|Lost to Follow-up|0|||
149164774|NCT01413958|538077909|FG001|Overall Study|Lost to Follow-up|1|||
149164775|NCT01900002|538077910|FG000|Overall Study|Withdrawal by Subject|2|||
149164776|NCT01900002|538077910|FG000|Overall Study|ineligible for Y-90|4|||
149164777|NCT00706628|538077917|FG000|Overall Study|Other Adverse Event|16|||
149164778|NCT00706628|538077918|FG001|Overall Study|Other Adverse Event|5|||
149164779|NCT00706628|538077919|FG002|Overall Study|Other Adverse Event|5|||
149164780|NCT00706628|538077920|FG003|Overall Study|Other Adverse Event|2|||
149164781|NCT00706628|538077917|FG000|Overall Study|Non compliant with protocol|0|||
148675114|NCT05004181|536281517|FG005|Overall Study|Protocol Violation|0|||
148927219|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
148927220|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
148927221|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
149164782|NCT00706628|538077918|FG001|Overall Study|Non compliant with protocol|1|||
149164783|NCT00706628|538077919|FG002|Overall Study|Non compliant with protocol|0|||
149164784|NCT00706628|538077920|FG003|Overall Study|Non compliant with protocol|0|||
149164785|NCT00706628|538077917|FG000|Overall Study|Consent withdrawn|6|||
149164786|NCT00706628|538077918|FG001|Overall Study|Consent withdrawn|1|||
149164787|NCT00706628|538077919|FG002|Overall Study|Consent withdrawn|3|||
149164788|NCT00706628|538077920|FG003|Overall Study|Consent withdrawn|0|||
149164789|NCT00706628|538077917|FG000|Overall Study|Progressive disease|20|||
149164790|NCT00706628|538077918|FG001|Overall Study|Progressive disease|13|||
149164791|NCT00706628|538077919|FG002|Overall Study|Progressive disease|8|||
149164792|NCT00706628|538077920|FG003|Overall Study|Progressive disease|1|||
149164793|NCT00706628|538077917|FG000|Overall Study|Other than those stated above|4|||
149164794|NCT00706628|538077918|FG001|Overall Study|Other than those stated above|0|||
149164795|NCT00706628|538077919|FG002|Overall Study|Other than those stated above|0|||
149164796|NCT00706628|538077920|FG003|Overall Study|Other than those stated above|0|||
149164797|NCT00706628|538077917|FG000|Overall Study|Not treated|1|||
148675115|NCT05004181|536281518|FG006|Overall Study|Protocol Violation|16|||
149164798|NCT00706628|538077918|FG001|Overall Study|Not treated|1|||
149164799|NCT00706628|538077919|FG002|Overall Study|Not treated|0|||
149164800|NCT00706628|538077920|FG003|Overall Study|Not treated|0|||
149164801|NCT02921425|538077921|FG000|Overall Study|Protocol Violation|9|||
149164802|NCT01145560|538077922|FG000|Overall Study|Withdrawal by Subject|2|||
149164803|NCT01145560|538077923|FG001|Overall Study|Withdrawal by Subject|1|||
149164804|NCT01145560|538077924|FG002|Overall Study|Withdrawal by Subject|0|||
149164805|NCT01145560|538077922|FG000|Overall Study|Lost to Follow-up|1|||
149164806|NCT01145560|538077923|FG001|Overall Study|Lost to Follow-up|1|||
149164807|NCT01145560|538077924|FG002|Overall Study|Lost to Follow-up|1|||
149164808|NCT01145560|538077922|FG000|Overall Study|No study drug by 24h after organ failure|1|||
149164809|NCT01145560|538077923|FG001|Overall Study|No study drug by 24h after organ failure|0|||
149164810|NCT01145560|538077924|FG002|Overall Study|No study drug by 24h after organ failure|0|||
149164811|NCT01145560|538077922|FG000|Overall Study|Accidental unblinding of study treatment|0|||
149164812|NCT01145560|538077923|FG001|Overall Study|Accidental unblinding of study treatment|1|||
149164813|NCT01145560|538077924|FG002|Overall Study|Accidental unblinding of study treatment|0|||
149164814|NCT01145560|538077922|FG000|Overall Study|False insurance information|0|||
149164815|NCT01145560|538077923|FG001|Overall Study|False insurance information|1|||
149164816|NCT01145560|538077924|FG002|Overall Study|False insurance information|0|||
149164817|NCT01145560|538077922|FG000|Overall Study|Withdrawal of therapy|0|||
149164818|NCT01145560|538077923|FG001|Overall Study|Withdrawal of therapy|0|||
149164819|NCT01145560|538077924|FG002|Overall Study|Withdrawal of therapy|1|||
149164820|NCT00712348|538077925|FG000|Overall Study|Withdrawal by Subject|1|||
149164821|NCT01375764|538077930|FG000|Overall Study|Lost to Follow-up|0|||
149164822|NCT01375764|538077931|FG001|Overall Study|Lost to Follow-up|1|||
149164823|NCT01375764|538077932|FG002|Overall Study|Lost to Follow-up|0|||
149164824|NCT01375764|538077933|FG003|Overall Study|Lost to Follow-up|0|||
149164825|NCT01375764|538077934|FG004|Overall Study|Lost to Follow-up|0|||
149164826|NCT01375764|538077930|FG000|Overall Study|Withdrawal by Subject|2|||
149164827|NCT01375764|538077931|FG001|Overall Study|Withdrawal by Subject|0|||
149164828|NCT01375764|538077932|FG002|Overall Study|Withdrawal by Subject|0|||
149164829|NCT01375764|538077933|FG003|Overall Study|Withdrawal by Subject|0|||
149164830|NCT01375764|538077934|FG004|Overall Study|Withdrawal by Subject|1|||
149164831|NCT01375764|538077930|FG000|Overall Study|Other|0|||
149164832|NCT01375764|538077931|FG001|Overall Study|Other|0|||
149164833|NCT01375764|538077932|FG002|Overall Study|Other|0|||
149164834|NCT01375764|538077933|FG003|Overall Study|Other|1|||
149164835|NCT01375764|538077934|FG004|Overall Study|Other|0|||
149164836|NCT02867761|538077936|FG000|Overall Study|Participant withdrawn by investigator|0|||
149164837|NCT02867761|538077937|FG001|Overall Study|Participant withdrawn by investigator|1|||
149164838|NCT02867761|538077936|FG000|Overall Study|Lost to Follow-up|25|||
149164839|NCT02867761|538077937|FG001|Overall Study|Lost to Follow-up|18|||
149164840|NCT02867761|538077936|FG000|Overall Study|Unable to complete protocol|3|||
149164841|NCT02867761|538077937|FG001|Overall Study|Unable to complete protocol|7|||
149164842|NCT03595280|538077938|FG000|Overall Study|Lost to Follow-up|6|||
149164843|NCT03595280|538077939|FG001|Overall Study|Lost to Follow-up|9|||
149164844|NCT03595280|538077940|FG002|Overall Study|Lost to Follow-up|15|||
149164845|NCT02675075|538077941|FG000|Overall Study|Lost to Follow-up|3|||
149164846|NCT02675075|538077942|FG001|Overall Study|Lost to Follow-up|0|||
149164847|NCT02292212|538077943|FG000|ViE Phase|Withdrawal by Subject|1|||
149164848|NCT02292212|538077943|FG000|ViE Phase|Protocol Violation|2|||
149164849|NCT02411747|538077944|FG000|Overall Study|Withdrawal by Subject|1|||
149164850|NCT02411747|538077945|FG001|Overall Study|Withdrawal by Subject|0|||
149164851|NCT02411747|538077944|FG000|Overall Study|Protocol Violation|2|||
149164852|NCT02411747|538077945|FG001|Overall Study|Protocol Violation|4|||
149164853|NCT02149810|538077946|FG000|Overall Study|Physician Decision|1|||
149164854|NCT02149810|538077947|FG001|Overall Study|Physician Decision|2|||
149164855|NCT02149810|538077946|FG000|Overall Study|Lost to Follow-up|2|||
149164856|NCT02149810|538077947|FG001|Overall Study|Lost to Follow-up|1|||
149164857|NCT02149810|538077946|FG000|Overall Study|Withdrawal by Subject|5|||
148675116|NCT05004181|536281519|FG007|Overall Study|Protocol Violation|18|||
148675117|NCT05004181|536281520|FG008|Overall Study|Protocol Violation|2|||
149164858|NCT02149810|538077947|FG001|Overall Study|Withdrawal by Subject|1|||
149164859|NCT00675597|538077948|FG000|Overall Study|Withdrawal by Subject|3|||
149164860|NCT01176916|538077949|FG000|Overall Study|Adverse Event|61|||
149164861|NCT01176916|538077949|FG000|Overall Study|Death|1|||
149164862|NCT01176916|538077949|FG000|Overall Study|Lost to Follow-up|15|||
149164863|NCT01176916|538077949|FG000|Overall Study|Objective progression or relapse|17|||
148675118|NCT05004181|536281521|FG009|Overall Study|Protocol Violation|2|||
149164864|NCT01176916|538077949|FG000|Overall Study|Protocol Violation|24|||
149164865|NCT01176916|538077949|FG000|Overall Study|Withdrawal by Subject|37|||
149164866|NCT01176916|538077949|FG000|Overall Study|Other|6|||
149164867|NCT01176916|538077949|FG000|Overall Study|Withdrawal prior to Treatment|6|||
149164868|NCT03158220|538077952|FG000|Overall Study|Screen Failure|0|||
149164869|NCT03158220|538077953|FG001|Overall Study|Screen Failure|1|||
149164870|NCT03158220|538077952|FG000|Overall Study|Withdrawal by Subject|8|||
149164871|NCT03158220|538077953|FG001|Overall Study|Withdrawal by Subject|9|||
149164872|NCT03158220|538077952|FG000|Overall Study|Status unknown|0|||
149164873|NCT03158220|538077953|FG001|Overall Study|Status unknown|1|||
149164874|NCT03158220|538077952|FG000|Overall Study|Lost to Follow-up|8|||
149164875|NCT03158220|538077953|FG001|Overall Study|Lost to Follow-up|5|||
149164876|NCT03158220|538077952|FG000|Overall Study|Physician Decision|1|||
149164877|NCT03158220|538077953|FG001|Overall Study|Physician Decision|0|||
149164878|NCT00848120|538077956|FG000|Overall Study|Adverse Event|1|||
149164879|NCT00560755|538077957|FG000|Overall Study|Protocol Violation|15|||
149164880|NCT00560755|538077957|FG000|Overall Study|Withdrawal by Subject|26|||
149164881|NCT00560755|538077957|FG000|Overall Study|Lost to Follow-up|9|||
149164882|NCT00560755|538077957|FG000|Overall Study|Adverse Event|8|||
149164883|NCT00560755|538077957|FG000|Overall Study|Physician Decision|2|||
149164884|NCT01961115|538077964|FG000|Overall Study|Disease Progression|1|||
149164885|NCT01961115|538077965|FG001|Overall Study|Disease Progression|0|||
149164886|NCT01961115|538077966|FG002|Overall Study|Disease Progression|3|||
149164887|NCT01961115|538077964|FG000|Overall Study|Adverse Event|1|||
149164888|NCT01961115|538077965|FG001|Overall Study|Adverse Event|0|||
149164889|NCT01961115|538077966|FG002|Overall Study|Adverse Event|1|||
149164890|NCT01752023|538077967|FG000|Overall Study|Physician Decision|2|||
149164891|NCT01752023|538077968|FG001|Overall Study|Physician Decision|1|||
149164892|NCT02440581|538077969|FG000|Overall Study|Death|0|||
149164893|NCT02440581|538077970|FG001|Overall Study|Death|0|||
149164894|NCT02440581|538077971|FG002|Overall Study|Death|7|||
149164895|NCT02440581|538077972|FG003|Overall Study|Death|5|||
149164896|NCT02440581|538077969|FG000|Overall Study|Transplanted|1|||
149164897|NCT02440581|538077970|FG001|Overall Study|Transplanted|0|||
149164898|NCT02440581|538077971|FG002|Overall Study|Transplanted|3|||
149164899|NCT02440581|538077972|FG003|Overall Study|Transplanted|2|||
149164900|NCT02440581|538077969|FG000|Overall Study|Withdrawal by Subject|4|||
149164901|NCT02440581|538077970|FG001|Overall Study|Withdrawal by Subject|11|||
149164902|NCT02440581|538077971|FG002|Overall Study|Withdrawal by Subject|3|||
149164903|NCT02440581|538077972|FG003|Overall Study|Withdrawal by Subject|7|||
149164904|NCT01974817|538079342|FG000|Overall Study|Death|4|||
149164905|NCT01974817|538079342|FG000|Overall Study|Lost to Follow-up|2|||
149164906|NCT01974817|538079342|FG000|Overall Study|Protocol Violation|2|||
149164907|NCT00224016|538079348|FG000|Titration Period|Withdrawal by Subject|0|||
149164908|NCT00224016|538079349|FG001|Titration Period|Withdrawal by Subject|1|||
149164909|NCT00224016|538079348|FG000|Titration Period|Lost to Follow-up|1|||
149164910|NCT00224016|538079349|FG001|Titration Period|Lost to Follow-up|0|||
149164911|NCT00224016|538079348|FG000|Maintenance Period|Withdrawal by Subject|2|||
149164912|NCT00224016|538079349|FG001|Maintenance Period|Withdrawal by Subject|0|||
149164913|NCT00224016|538079348|FG000|Maintenance Period|Lost to Follow-up|0|||
149164914|NCT00224016|538079349|FG001|Maintenance Period|Lost to Follow-up|1|||
149164915|NCT01524991|538079352|FG000|Overall Study|Adverse Event|12|||
149164916|NCT01524991|538079352|FG000|Overall Study|Death|1|||
149164917|NCT01524991|538079352|FG000|Overall Study|Disease ProgressionDu|17|||
149164918|NCT01524991|538079352|FG000|Overall Study|Other complicating disease|1|||
149164919|NCT01524991|538079352|FG000|Overall Study|Withdrawal by Subject|2|||
149164920|NCT01524991|538079352|FG000|Overall Study|Symptomatic Deterioration|1|||
149164921|NCT05742984|538079355|FG000|Overall Study|Adverse Event|0|||
149164922|NCT05742984|538079356|FG001|Overall Study|Adverse Event|0|||
149164923|NCT05742984|538079357|FG002|Overall Study|Adverse Event|1|||
149164924|NCT05742984|538079358|FG003|Overall Study|Adverse Event|0|||
149164925|NCT05742984|538079359|FG004|Overall Study|Adverse Event|1|||
149164926|NCT05742984|538079360|FG005|Overall Study|Adverse Event|1|||
149164927|NCT05742984|538079355|FG000|Overall Study|Withdrawal by Subject|0|||
149164928|NCT05742984|538079356|FG001|Overall Study|Withdrawal by Subject|1|||
149164929|NCT05742984|538079357|FG002|Overall Study|Withdrawal by Subject|0|||
149164930|NCT05742984|538079358|FG003|Overall Study|Withdrawal by Subject|0|||
149164931|NCT05742984|538079359|FG004|Overall Study|Withdrawal by Subject|0|||
149164932|NCT05742984|538079360|FG005|Overall Study|Withdrawal by Subject|2|||
149164933|NCT02162862|538079361|FG000|Overall Study|Lost to Follow-up|0|||
149164934|NCT02162862|538079362|FG001|Overall Study|Lost to Follow-up|11|||
149164935|NCT02162862|538079363|FG002|Overall Study|Lost to Follow-up|0|||
149164936|NCT02162862|538079361|FG000|Overall Study|Subject did not feel the med was needed|0|||
149164937|NCT02162862|538079362|FG001|Overall Study|Subject did not feel the med was needed|0|||
149164938|NCT02162862|538079363|FG002|Overall Study|Subject did not feel the med was needed|4|||
148675119|NCT05004181|536281522|FG010|Overall Study|Protocol Violation|2|||
148675120|NCT05004181|536281523|FG011|Overall Study|Protocol Violation|1|||
148675121|NCT05004181|536281512|FG000|Overall Study|Not further specified|1|||
148675122|NCT05004181|536281513|FG001|Overall Study|Not further specified|0|||
148675123|NCT05004181|536281514|FG002|Overall Study|Not further specified|0|||
148675124|NCT05004181|536281515|FG003|Overall Study|Not further specified|0|||
148675125|NCT05004181|536281516|FG004|Overall Study|Not further specified|0|||
148675126|NCT05004181|536281517|FG005|Overall Study|Not further specified|0|||
148675127|NCT05004181|536281518|FG006|Overall Study|Not further specified|1|||
148675128|NCT05004181|536281519|FG007|Overall Study|Not further specified|0|||
148675129|NCT05004181|536281520|FG008|Overall Study|Not further specified|2|||
148675130|NCT05004181|536281521|FG009|Overall Study|Not further specified|1|||
148675131|NCT05004181|536281522|FG010|Overall Study|Not further specified|0|||
149164939|NCT00988247|538079366|FG000|Overall Study|Adverse Event|17|||
149164940|NCT00988247|538079367|FG001|Overall Study|Adverse Event|3|||
149164941|NCT00988247|538079366|FG000|Overall Study|Withdrawal by Subject|44|||
148675132|NCT05004181|536281523|FG011|Overall Study|Not further specified|1|||
148806207|NCT04589650|536768102|FG001|Overall Study|Adverse Event|1|||
149164942|NCT00988247|538079367|FG001|Overall Study|Withdrawal by Subject|13|||
149164943|NCT00988247|538079366|FG000|Overall Study|Pregnancy|1|||
149164944|NCT00988247|538079367|FG001|Overall Study|Pregnancy|2|||
149164945|NCT00988247|538079366|FG000|Overall Study|Lost to Follow-up|11|||
148675133|NCT03868059|536281525|FG000|Overall Study|Adverse Event|3|||
149164946|NCT00988247|538079367|FG001|Overall Study|Lost to Follow-up|2|||
148675134|NCT03868059|536281525|FG000|Overall Study|Lost to Follow-up|3|||
149164947|NCT00988247|538079366|FG000|Overall Study|Protocol Violation|4|||
149164948|NCT00988247|538079367|FG001|Overall Study|Protocol Violation|5|||
149164949|NCT00988247|538079366|FG000|Overall Study|Sponsor requested withdrawal|3|||
149164950|NCT00988247|538079367|FG001|Overall Study|Sponsor requested withdrawal|1|||
149164951|NCT00988247|538079366|FG000|Overall Study|Other|3|||
149164952|NCT00988247|538079367|FG001|Overall Study|Other|0|||
149164953|NCT01409928|538079368|FG000|Overall Study|Physician Decision|12|||
149164954|NCT01703000|538079369|FG000|Overall Study|Death|1|||
149164955|NCT03502187|538079372|FG000|Overall Study|Withdrawal by Subject|4|||
149164956|NCT03502187|538079373|FG001|Overall Study|Withdrawal by Subject|3|||
149164957|NCT03502187|538079374|FG002|Overall Study|Withdrawal by Subject|3|||
149164958|NCT03502187|538079372|FG000|Overall Study|Lost to Follow-up|5|||
149164959|NCT03502187|538079373|FG001|Overall Study|Lost to Follow-up|4|||
149164960|NCT03502187|538079374|FG002|Overall Study|Lost to Follow-up|5|||
149164961|NCT01950819|538079378|FG000|Overall Study|Graft Loss|35|||
149164962|NCT01950819|538079379|FG001|Overall Study|Graft Loss|30|||
149164963|NCT01950819|538079378|FG000|Overall Study|Death|29|||
149164964|NCT01950819|538079379|FG001|Overall Study|Death|34|||
149164965|NCT01950819|538079378|FG000|Overall Study|Subject / Gardian decision|54|||
149164966|NCT01950819|538079379|FG001|Overall Study|Subject / Gardian decision|51|||
149164967|NCT01950819|538079378|FG000|Overall Study|technical problems|2|||
149164968|NCT01950819|538079379|FG001|Overall Study|technical problems|0|||
149164969|NCT01950819|538079378|FG000|Overall Study|Pregnancy|0|||
149164970|NCT01950819|538079379|FG001|Overall Study|Pregnancy|2|||
149164971|NCT01950819|538079378|FG000|Overall Study|Lost to Follow-up|9|||
149164972|NCT01950819|538079379|FG001|Overall Study|Lost to Follow-up|17|||
149164973|NCT00781365|538079380|FG000|Overall Study|Withdrawal by Subject|13|||
149164974|NCT00781365|538079381|FG001|Overall Study|Withdrawal by Subject|8|||
149164975|NCT00781365|538079380|FG000|Overall Study|Did Not Attend Visit|20|||
149164976|NCT00781365|538079381|FG001|Overall Study|Did Not Attend Visit|28|||
149164977|NCT00781365|538079380|FG000|Overall Study|Language barrier|1|||
149164978|NCT00781365|538079381|FG001|Overall Study|Language barrier|0|||
149164979|NCT02649634|538079382|FG000|Overall Study|Withdrawal by Subject|3|||
149164980|NCT02649634|538079383|FG001|Overall Study|Withdrawal by Subject|5|||
149164981|NCT02649634|538079382|FG000|Overall Study|Lost to Follow-up|0|||
149164982|NCT02649634|538079383|FG001|Overall Study|Lost to Follow-up|1|||
149164983|NCT01662648|538079384|FG000|Overall Study|Death|1|||
149164984|NCT01662648|538079385|FG001|Overall Study|Death|3|||
149164985|NCT01662648|538079384|FG000|Overall Study|Adverse Event|40|||
149164986|NCT01662648|538079385|FG001|Overall Study|Adverse Event|37|||
149164987|NCT01662648|538079384|FG000|Overall Study|Lack of Efficacy|17|||
149164988|NCT01662648|538079385|FG001|Overall Study|Lack of Efficacy|16|||
149164989|NCT01662648|538079384|FG000|Overall Study|Participant ineligible to continue trial|1|||
149164990|NCT01662648|538079385|FG001|Overall Study|Participant ineligible to continue trial|1|||
149164991|NCT01662648|538079384|FG000|Overall Study|Lost to Follow-up|24|||
149164992|NCT01662648|538079385|FG001|Overall Study|Lost to Follow-up|36|||
149164993|NCT01662648|538079384|FG000|Overall Study|Withdrawal by Subject|36|||
149164994|NCT01662648|538079385|FG001|Overall Study|Withdrawal by Subject|53|||
149164995|NCT01662648|538079384|FG000|Overall Study|Participant non-compliant|16|||
149164996|NCT01662648|538079385|FG001|Overall Study|Participant non-compliant|20|||
149164997|NCT01662648|538079384|FG000|Overall Study|Other|8|||
149164998|NCT01662648|538079385|FG001|Overall Study|Other|11|||
149164999|NCT01662648|538079384|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
149165000|NCT01662648|538079385|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
149165001|NCT01662648|538079384|FG000|Overall Study|LOE and other reason unspecified|1|||
149165002|NCT01662648|538079385|FG001|Overall Study|LOE and other reason unspecified|0|||
149165003|NCT01662648|538079384|FG000|Overall Study|LOE and Participant non-compliant|0|||
149165004|NCT01662648|538079385|FG001|Overall Study|LOE and Participant non-compliant|1|||
149165005|NCT02928952|538079388|FG000|Overall Study|Lost to Follow-up|5|||
149165006|NCT02928952|538079389|FG001|Overall Study|Lost to Follow-up|5|||
149165007|NCT02928952|538079388|FG000|Overall Study|Withdrawal by Subject|5|||
149165008|NCT02928952|538079389|FG001|Overall Study|Withdrawal by Subject|1|||
149165009|NCT02928952|538079388|FG000|Overall Study|Physician Decision|0|||
149165010|NCT02928952|538079389|FG001|Overall Study|Physician Decision|1|||
148675135|NCT03868059|536281525|FG000|Overall Study|Withdrawal by Subject|6|||
149165011|NCT00974220|538079390|FG000|Treatment Period 1|Adverse Event|2|||
149165012|NCT00974220|538079391|FG001|Treatment Period 1|Adverse Event|1|||
149165013|NCT00974220|538079390|FG000|Treatment Period 1|noncompliant subjects|0|||
149165014|NCT00974220|538079391|FG001|Treatment Period 1|noncompliant subjects|1|||
148675136|NCT04066894|536281526|FG000|Overall Study|Lack of Efficacy|1|||
149165015|NCT01850615|538079392|FG000|Overall Study|Protocol Violation|4|||
149165016|NCT01850615|538079393|FG001|Overall Study|Protocol Violation|1|||
149165017|NCT01850615|538079392|FG000|Overall Study|Adverse Event|2|||
149165018|NCT01850615|538079393|FG001|Overall Study|Adverse Event|1|||
149165019|NCT01850615|538079392|FG000|Overall Study|Withdrawal by Subject|3|||
149165020|NCT01850615|538079393|FG001|Overall Study|Withdrawal by Subject|1|||
149165021|NCT01850615|538079392|FG000|Overall Study|Lost to Follow-up|0|||
149165022|NCT01850615|538079393|FG001|Overall Study|Lost to Follow-up|1|||
149165023|NCT01850615|538079392|FG000|Overall Study|Unclassified|0|||
149165024|NCT01850615|538079393|FG001|Overall Study|Unclassified|1|||
149165025|NCT01227967|538079394|FG000|Overall Study|Protocol Violation|3|||
149165026|NCT01227967|538079395|FG001|Overall Study|Protocol Violation|1|||
149165027|NCT01227967|538079394|FG000|Overall Study|Death|0|||
149165028|NCT01227967|538079395|FG001|Overall Study|Death|1|||
149165029|NCT01227967|538079394|FG000|Overall Study|Lost to Follow-up|8|||
149165030|NCT01227967|538079395|FG001|Overall Study|Lost to Follow-up|3|||
149165031|NCT01227967|538079394|FG000|Overall Study|Withdrawal by Subject|4|||
149165032|NCT01227967|538079395|FG001|Overall Study|Withdrawal by Subject|3|||
149165033|NCT01227967|538079394|FG000|Overall Study|Physician Decision|0|||
149165034|NCT01227967|538079395|FG001|Overall Study|Physician Decision|1|||
149165035|NCT01227967|538079394|FG000|Overall Study|Never Started Treatment|0|||
149165036|NCT01227967|538079395|FG001|Overall Study|Never Started Treatment|4|||
149165037|NCT01227967|538079394|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
149165038|NCT01227967|538079395|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
149165039|NCT03403400|538079396|FG000|Overall Study|Lost to Follow-up|1|||
149165040|NCT03403400|538079397|FG001|Overall Study|Lost to Follow-up|0|||
149165041|NCT03403400|538079398|FG002|Overall Study|Lost to Follow-up|1|||
149165042|NCT03403400|538079396|FG000|Overall Study|Hospitalization|1|||
149165043|NCT03403400|538079397|FG001|Overall Study|Hospitalization|0|||
149165044|NCT03403400|538079398|FG002|Overall Study|Hospitalization|0|||
149165045|NCT03403400|538079396|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
149165046|NCT03403400|538079397|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
149165047|NCT03403400|538079398|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
149165048|NCT02266433|538079399|FG000|Overall Study|Lost to Follow-up|54|||
149165049|NCT02266433|538079400|FG001|Overall Study|Lost to Follow-up|46|||
149165050|NCT02266433|538079399|FG000|Overall Study|Withdrawal by Subject|5|||
149165051|NCT02266433|538079400|FG001|Overall Study|Withdrawal by Subject|7|||
149165052|NCT01273064|538079401|FG000|Overall Study|Adverse Event|5|||
149165053|NCT01273064|538079402|FG001|Overall Study|Adverse Event|1|||
149165054|NCT01273064|538079403|FG002|Overall Study|Adverse Event|3|||
149165055|NCT01273064|538079404|FG003|Overall Study|Adverse Event|2|||
149165056|NCT01273064|538079405|FG004|Overall Study|Adverse Event|1|||
149165057|NCT01273064|538079401|FG000|Overall Study|Withdrawal by Subject|4|||
149165058|NCT01273064|538079402|FG001|Overall Study|Withdrawal by Subject|2|||
149165059|NCT01273064|538079403|FG002|Overall Study|Withdrawal by Subject|2|||
149165060|NCT01273064|538079404|FG003|Overall Study|Withdrawal by Subject|2|||
149165061|NCT01273064|538079405|FG004|Overall Study|Withdrawal by Subject|0|||
149165062|NCT01273064|538079401|FG000|Overall Study|Study Termination|13|||
149165063|NCT01273064|538079402|FG001|Overall Study|Study Termination|27|||
149165064|NCT01273064|538079403|FG002|Overall Study|Study Termination|26|||
149165065|NCT01273064|538079404|FG003|Overall Study|Study Termination|16|||
149165066|NCT01273064|538079405|FG004|Overall Study|Study Termination|8|||
149165067|NCT01273064|538079401|FG000|Overall Study|Lost to Follow-up|1|||
149165068|NCT01273064|538079402|FG001|Overall Study|Lost to Follow-up|0|||
149165069|NCT01273064|538079403|FG002|Overall Study|Lost to Follow-up|0|||
149165070|NCT01273064|538079404|FG003|Overall Study|Lost to Follow-up|0|||
149165071|NCT01273064|538079405|FG004|Overall Study|Lost to Follow-up|0|||
149165072|NCT01273064|538079401|FG000|Overall Study|Physician Decision|0|||
149165073|NCT01273064|538079402|FG001|Overall Study|Physician Decision|0|||
149165074|NCT01273064|538079403|FG002|Overall Study|Physician Decision|0|||
149165075|NCT01273064|538079404|FG003|Overall Study|Physician Decision|0|||
149165076|NCT01273064|538079405|FG004|Overall Study|Physician Decision|1|||
148806208|NCT04589650|536768103|FG002|Overall Study|Adverse Event|1|||
148927222|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
148927223|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
148927224|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
149165077|NCT01931059|538079406|FG000|Day 1|Pregnancy|0|||
149165078|NCT01931059|538079407|FG001|Day 1|Pregnancy|1|||
149165079|NCT01931059|538079406|FG000|Day3|Lost to Follow-up|1|||
149165080|NCT01931059|538079407|FG001|Day3|Lost to Follow-up|0|||
149165081|NCT01988090|538079412|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
149165082|NCT01988090|538079413|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
149165083|NCT01988090|538079412|FG000|Start Treament After Randomization|Protocol Violation|0|||
149165084|NCT01988090|538079413|FG001|Start Treament After Randomization|Protocol Violation|1|||
149165085|NCT01988090|538079412|FG000|Complete Study After Start|Withdrawal by Subject|2|||
149165086|NCT01988090|538079413|FG001|Complete Study After Start|Withdrawal by Subject|0|||
149165087|NCT01988090|538079412|FG000|Complete Study After Start|Protocol Violation|1|||
149165088|NCT01988090|538079413|FG001|Complete Study After Start|Protocol Violation|1|||
149165089|NCT03887130|538079421|FG000|Overall Study|Progressive disease|23|||
149165090|NCT03887130|538079422|FG001|Overall Study|Progressive disease|14|||
149165091|NCT03887130|538079423|FG002|Overall Study|Progressive disease|7|||
148806209|NCT04589650|536768104|FG003|Overall Study|Adverse Event|1|||
149165092|NCT03887130|538079421|FG000|Overall Study|Protocol Violation|3|||
149165093|NCT03887130|538079422|FG001|Overall Study|Protocol Violation|1|||
149165094|NCT03887130|538079423|FG002|Overall Study|Protocol Violation|2|||
149165095|NCT03887130|538079421|FG000|Overall Study|Drug related toxicity|7|||
149165096|NCT03887130|538079422|FG001|Overall Study|Drug related toxicity|7|||
149165097|NCT03887130|538079423|FG002|Overall Study|Drug related toxicity|13|||
149165098|NCT03887130|538079421|FG000|Overall Study|Non drug related toxicity|3|||
149165099|NCT03887130|538079422|FG001|Overall Study|Non drug related toxicity|0|||
149165100|NCT03887130|538079423|FG002|Overall Study|Non drug related toxicity|0|||
149165101|NCT03887130|538079421|FG000|Overall Study|Death|2|||
149165102|NCT03887130|538079422|FG001|Overall Study|Death|2|||
149165103|NCT03887130|538079423|FG002|Overall Study|Death|1|||
149165104|NCT03887130|538079421|FG000|Overall Study|Withdrawal by Subject|7|||
149165105|NCT03887130|538079422|FG001|Overall Study|Withdrawal by Subject|6|||
149165106|NCT03887130|538079423|FG002|Overall Study|Withdrawal by Subject|11|||
149165107|NCT03887130|538079421|FG000|Overall Study|other reason|6|||
149165108|NCT03887130|538079422|FG001|Overall Study|other reason|20|||
149165109|NCT03887130|538079423|FG002|Overall Study|other reason|17|||
149165110|NCT02497001|538079424|FG000|Overall Study|Lost to Follow-up|10|||
149165111|NCT02497001|538079425|FG001|Overall Study|Lost to Follow-up|2|||
149165112|NCT02497001|538079426|FG002|Overall Study|Lost to Follow-up|0|||
149165113|NCT02497001|538079427|FG003|Overall Study|Lost to Follow-up|2|||
149165114|NCT02497001|538079424|FG000|Overall Study|Adverse Event|28|||
149165115|NCT02497001|538079425|FG001|Overall Study|Adverse Event|30|||
149165116|NCT02497001|538079426|FG002|Overall Study|Adverse Event|11|||
149165117|NCT02497001|538079427|FG003|Overall Study|Adverse Event|11|||
149165118|NCT02497001|538079424|FG000|Overall Study|Withdrawal by Subject|14|||
149165119|NCT02497001|538079425|FG001|Overall Study|Withdrawal by Subject|37|||
149165120|NCT02497001|538079426|FG002|Overall Study|Withdrawal by Subject|19|||
149165121|NCT02497001|538079427|FG003|Overall Study|Withdrawal by Subject|15|||
149165122|NCT02497001|538079424|FG000|Overall Study|Physician Decision|5|||
149165123|NCT02497001|538079425|FG001|Overall Study|Physician Decision|11|||
149165124|NCT02497001|538079426|FG002|Overall Study|Physician Decision|5|||
149165125|NCT02497001|538079427|FG003|Overall Study|Physician Decision|1|||
149165126|NCT02497001|538079424|FG000|Overall Study|subjects that were not treated|1|||
149165127|NCT02497001|538079425|FG001|Overall Study|subjects that were not treated|2|||
149165128|NCT02497001|538079426|FG002|Overall Study|subjects that were not treated|2|||
149165129|NCT02497001|538079427|FG003|Overall Study|subjects that were not treated|1|||
149165130|NCT02497001|538079424|FG000|Overall Study|Major Protocol Deviation|3|||
149165131|NCT02497001|538079425|FG001|Overall Study|Major Protocol Deviation|4|||
149165132|NCT02497001|538079426|FG002|Overall Study|Major Protocol Deviation|4|||
149165133|NCT02497001|538079427|FG003|Overall Study|Major Protocol Deviation|4|||
149165134|NCT02497001|538079424|FG000|Overall Study|Lack of Efficacy|10|||
149165135|NCT02497001|538079425|FG001|Overall Study|Lack of Efficacy|16|||
149165136|NCT02497001|538079426|FG002|Overall Study|Lack of Efficacy|6|||
149165137|NCT02497001|538079427|FG003|Overall Study|Lack of Efficacy|6|||
149165138|NCT02497001|538079424|FG000|Overall Study|Protocol Violation|3|||
149165139|NCT02497001|538079425|FG001|Overall Study|Protocol Violation|1|||
149165140|NCT02497001|538079426|FG002|Overall Study|Protocol Violation|3|||
149165141|NCT02497001|538079427|FG003|Overall Study|Protocol Violation|1|||
149165142|NCT01889602|538079429|FG000|First Intervention|Adverse Event|1|||
149165143|NCT01889602|538079430|FG001|First Intervention|Adverse Event|1|||
149165144|NCT01889602|538079431|FG002|First Intervention|Adverse Event|1|||
149165145|NCT01889602|538079429|FG000|First Intervention|Protocol Violation|0|||
149165146|NCT01889602|538079430|FG001|First Intervention|Protocol Violation|1|||
149165147|NCT01889602|538079431|FG002|First Intervention|Protocol Violation|1|||
149165148|NCT01889602|538079429|FG000|First Intervention|Study ending|0|||
149165149|NCT01889602|538079430|FG001|First Intervention|Study ending|1|||
149165150|NCT01889602|538079431|FG002|First Intervention|Study ending|0|||
149165151|NCT01889602|538079429|FG000|Second Intervention|Adverse Event|0|||
149012927|NCT00675506|537525845|FG001|Overall Study|Elevated fasting glucose|1|||
149165152|NCT01889602|538079430|FG001|Second Intervention|Adverse Event|0|||
149165153|NCT01889602|538079431|FG002|Second Intervention|Adverse Event|1|||
149165154|NCT01889602|538079429|FG000|Second Intervention|Study ending|1|||
149165155|NCT01889602|538079430|FG001|Second Intervention|Study ending|0|||
149165156|NCT01889602|538079431|FG002|Second Intervention|Study ending|0|||
149165157|NCT01889602|538079429|FG000|Second Intervention|Withdrawal by Subject|0|||
149165158|NCT01889602|538079430|FG001|Second Intervention|Withdrawal by Subject|0|||
149165159|NCT01889602|538079431|FG002|Second Intervention|Withdrawal by Subject|1|||
149165160|NCT01889602|538079429|FG000|Third Intervention|Protocol Violation|1|||
149165161|NCT01889602|538079430|FG001|Third Intervention|Protocol Violation|0|||
149165162|NCT01889602|538079431|FG002|Third Intervention|Protocol Violation|0|||
149165163|NCT01889602|538079429|FG000|Third Intervention|Withdrawal by Subject|2|||
149165164|NCT01889602|538079430|FG001|Third Intervention|Withdrawal by Subject|2|||
149165165|NCT01889602|538079431|FG002|Third Intervention|Withdrawal by Subject|0|||
149165166|NCT00961961|538079432|FG000|Phase I|Withdrawal by Subject|7|||
149165167|NCT00961961|538079433|FG001|Phase I|Withdrawal by Subject|0|||
149165168|NCT00961961|538079434|FG002|Phase I|Withdrawal by Subject|0|||
149165169|NCT00961961|538079435|FG003|Phase I|Withdrawal by Subject|0|||
149165170|NCT00961961|538079432|FG000|Phase I|Lost to Follow-up|10|||
149165171|NCT00961961|538079433|FG001|Phase I|Lost to Follow-up|0|||
149165172|NCT00961961|538079434|FG002|Phase I|Lost to Follow-up|0|||
149165173|NCT00961961|538079435|FG003|Phase I|Lost to Follow-up|0|||
149165174|NCT00961961|538079432|FG000|Phase I|Lack of Efficacy|94|||
149165175|NCT00961961|538079433|FG001|Phase I|Lack of Efficacy|0|||
149165176|NCT00961961|538079434|FG002|Phase I|Lack of Efficacy|0|||
149165177|NCT00961961|538079435|FG003|Phase I|Lack of Efficacy|0|||
149165178|NCT00961961|538079432|FG000|Phase I|Adverse Event|7|||
149165179|NCT00961961|538079433|FG001|Phase I|Adverse Event|0|||
149165180|NCT00961961|538079434|FG002|Phase I|Adverse Event|0|||
149165181|NCT00961961|538079435|FG003|Phase I|Adverse Event|0|||
149165182|NCT00961961|538079432|FG000|Phase I|Physician Decision|8|||
149165183|NCT00961961|538079433|FG001|Phase I|Physician Decision|0|||
149165184|NCT00961961|538079434|FG002|Phase I|Physician Decision|0|||
149165185|NCT00961961|538079435|FG003|Phase I|Physician Decision|0|||
149165186|NCT00961961|538079432|FG000|Phase II|Lost to Follow-up|0|||
149165187|NCT00961961|538079433|FG001|Phase II|Lost to Follow-up|0|||
149165188|NCT00961961|538079434|FG002|Phase II|Lost to Follow-up|10|||
149165189|NCT00961961|538079435|FG003|Phase II|Lost to Follow-up|7|||
149165190|NCT00961961|538079432|FG000|Phase II|Adverse Event|0|||
149165191|NCT00961961|538079433|FG001|Phase II|Adverse Event|0|||
149165192|NCT00961961|538079434|FG002|Phase II|Adverse Event|0|||
149165193|NCT00961961|538079435|FG003|Phase II|Adverse Event|1|||
149165194|NCT00961961|538079432|FG000|Phase II|Physician Decision|0|||
149165195|NCT00961961|538079433|FG001|Phase II|Physician Decision|0|||
149165196|NCT00961961|538079434|FG002|Phase II|Physician Decision|1|||
149165197|NCT00961961|538079435|FG003|Phase II|Physician Decision|0|||
149165198|NCT00961961|538079432|FG000|Phase II|Withdrawal by Subject|0|||
149165199|NCT00961961|538079433|FG001|Phase II|Withdrawal by Subject|0|||
149165200|NCT00961961|538079434|FG002|Phase II|Withdrawal by Subject|1|||
149165201|NCT00961961|538079435|FG003|Phase II|Withdrawal by Subject|0|||
149165202|NCT01245673|538079436|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
149165203|NCT04722991|538079437|FG000|Overall Study|Adverse Event|12|||
149165204|NCT04722991|538079438|FG001|Overall Study|Adverse Event|4|||
149165205|NCT04722991|538079437|FG000|Overall Study|Death|2|||
149165206|NCT04722991|538079438|FG001|Overall Study|Death|0|||
149165207|NCT04722991|538079437|FG000|Overall Study|Lost to Follow-up|1|||
149165208|NCT04722991|538079438|FG001|Overall Study|Lost to Follow-up|1|||
149165209|NCT04722991|538079437|FG000|Overall Study|Withdrawal cirterion met|2|||
149165210|NCT04722991|538079438|FG001|Overall Study|Withdrawal cirterion met|2|||
149165211|NCT04722991|538079437|FG000|Overall Study|Other|1|||
149165212|NCT04722991|538079438|FG001|Overall Study|Other|0|||
149165213|NCT04722991|538079437|FG000|Overall Study|Non-compliance|0|||
149165214|NCT04722991|538079438|FG001|Overall Study|Non-compliance|1|||
149165215|NCT04722991|538079437|FG000|Overall Study|Withdrawal by Subject|0|||
149165216|NCT04722991|538079438|FG001|Overall Study|Withdrawal by Subject|1|||
148927225|NCT02431247|537217404|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
148927226|NCT02431247|537217405|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
148927227|NCT02431247|537217406|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
148927228|NCT02431247|537217404|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
148927229|NCT02431247|537217405|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
148927230|NCT02431247|537217406|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
148927231|NCT02431247|537217404|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
148927232|NCT02431247|537217405|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
149165217|NCT03186989|538079439|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165218|NCT03186989|538079440|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165219|NCT03186989|538079441|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
149165220|NCT03186989|538079442|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
148927233|NCT02431247|537217406|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
148927234|NCT02431247|537217404|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
149165221|NCT03186989|538079443|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
149165222|NCT03186989|538079444|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165223|NCT03186989|538079445|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165224|NCT03186989|538079446|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165225|NCT03186989|538079447|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165226|NCT03186989|538079448|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165227|NCT03186989|538079449|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
149165228|NCT03186989|538079439|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165229|NCT03186989|538079440|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165230|NCT03186989|538079441|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165231|NCT03186989|538079442|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165232|NCT03186989|538079443|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165233|NCT03186989|538079444|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
149165234|NCT03186989|538079445|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165235|NCT03186989|538079446|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165236|NCT03186989|538079447|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165237|NCT03186989|538079448|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165238|NCT03186989|538079449|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
149165239|NCT03186989|538079439|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165240|NCT03186989|538079440|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165241|NCT03186989|538079441|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165242|NCT03186989|538079442|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165243|NCT03186989|538079443|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165244|NCT03186989|538079444|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165245|NCT03186989|538079445|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
149165246|NCT03186989|538079446|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165247|NCT03186989|538079447|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165248|NCT03186989|538079448|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165249|NCT03186989|538079449|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
149165250|NCT03186989|538079439|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165251|NCT03186989|538079440|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165252|NCT03186989|538079441|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165253|NCT03186989|538079442|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165254|NCT03186989|538079443|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165255|NCT03186989|538079444|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
149165256|NCT03186989|538079445|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
149165257|NCT03186989|538079446|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165258|NCT03186989|538079447|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
149165259|NCT03186989|538079448|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165260|NCT03186989|538079449|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
149165261|NCT02246621|538079451|FG000|Overall Study|Withdrawal by Subject|28|||
149165262|NCT02246621|538079452|FG001|Overall Study|Withdrawal by Subject|16|||
149165263|NCT02246621|538079451|FG000|Overall Study|Lost to Follow-up|1|||
149165264|NCT02246621|538079452|FG001|Overall Study|Lost to Follow-up|0|||
149165265|NCT02246621|538079451|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
149165266|NCT02246621|538079452|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
149165267|NCT01292057|538079453|FG000|Overall Study|Protocol Violation|1|||
149165268|NCT01292057|538079454|FG001|Overall Study|Protocol Violation|1|||
149165269|NCT01292057|538079453|FG000|Overall Study|Lost to Follow-up|1|||
148675137|NCT04066894|536281526|FG000|Overall Study|Screen Failure|1|||
148675138|NCT04278872|536281527|FG000|Overall Study|Adverse Event|1|||
148675139|NCT04278872|536281528|FG001|Overall Study|Adverse Event|0|||
148675140|NCT04278872|536281527|FG000|Overall Study|Protocol Violation|0|||
148675141|NCT04278872|536281528|FG001|Overall Study|Protocol Violation|1|||
148675142|NCT04278872|536281527|FG000|Overall Study|Study Termination|2|||
148675143|NCT04278872|536281528|FG001|Overall Study|Study Termination|0|||
148675144|NCT01283282|536281533|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
148675145|NCT01283282|536281534|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
149165270|NCT01292057|538079454|FG001|Overall Study|Lost to Follow-up|1|||
149165271|NCT01459614|538079455|FG000|Overall Study|Adverse Event|1|||
149165272|NCT01459614|538079456|FG001|Overall Study|Adverse Event|0|||
149165273|NCT00630331|538079460|FG000|Overall Study|Death|2|||
149165274|NCT00630331|538079461|FG001|Overall Study|Death|1|||
149165275|NCT00630331|538079462|FG002|Overall Study|Death|1|||
149165276|NCT00630331|538079460|FG000|Overall Study|Adverse Event|1|||
149165277|NCT00630331|538079461|FG001|Overall Study|Adverse Event|0|||
149165278|NCT00630331|538079462|FG002|Overall Study|Adverse Event|0|||
149165279|NCT00630331|538079460|FG000|Overall Study|Withdrawal by Subject|12|||
148675146|NCT01283282|536281533|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
148675147|NCT01283282|536281534|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
148675148|NCT01283282|536281533|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
148927235|NCT02431247|537217405|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
148927236|NCT02431247|537217406|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
149165280|NCT00630331|538079461|FG001|Overall Study|Withdrawal by Subject|7|||
149165281|NCT00630331|538079462|FG002|Overall Study|Withdrawal by Subject|5|||
149165282|NCT00630331|538079460|FG000|Overall Study|Lost to Follow-up|175|||
149165283|NCT00630331|538079461|FG001|Overall Study|Lost to Follow-up|143|||
149165284|NCT00630331|538079462|FG002|Overall Study|Lost to Follow-up|170|||
148806210|NCT04589650|536768105|FG004|Overall Study|Adverse Event|0|||
149165285|NCT00630331|538079460|FG000|Overall Study|Inappropriate enrollment|3|||
149165286|NCT00630331|538079461|FG001|Overall Study|Inappropriate enrollment|6|||
149165287|NCT00630331|538079462|FG002|Overall Study|Inappropriate enrollment|3|||
149165288|NCT00630331|538079460|FG000|Overall Study|Unable to classify|9|||
149165289|NCT00630331|538079461|FG001|Overall Study|Unable to classify|4|||
149165290|NCT00630331|538079462|FG002|Overall Study|Unable to classify|3|||
149165291|NCT00630331|538079460|FG000|Overall Study|Protocol Violation|4|||
149165292|NCT00630331|538079461|FG001|Overall Study|Protocol Violation|5|||
149165293|NCT00630331|538079462|FG002|Overall Study|Protocol Violation|6|||
149165294|NCT02425098|538079469|FG000|Overall Study|Lost to Follow-up|7|||
149165295|NCT02425098|538079470|FG001|Overall Study|Lost to Follow-up|7|||
149165296|NCT02425098|538079469|FG000|Overall Study|Withdrawal by Subject|4|||
149165297|NCT02425098|538079470|FG001|Overall Study|Withdrawal by Subject|8|||
149165298|NCT02425098|538079469|FG000|Overall Study|Pregnancy|2|||
149165299|NCT02425098|538079470|FG001|Overall Study|Pregnancy|0|||
149165300|NCT02425098|538079469|FG000|Overall Study|Reason not Specified|0|||
149165301|NCT02425098|538079470|FG001|Overall Study|Reason not Specified|1|||
149165302|NCT02078219|538079471|FG000|Overall Study|Other|2|||
149165303|NCT02078219|538079472|FG001|Overall Study|Other|2|||
149165304|NCT02078219|538079473|FG002|Overall Study|Other|3|||
149165305|NCT02078219|538079474|FG003|Overall Study|Other|0|||
149165306|NCT02078219|538079475|FG004|Overall Study|Other|1|||
149165307|NCT02078219|538079471|FG000|Overall Study|Withdrawal by Subject|0|||
149165308|NCT02078219|538079472|FG001|Overall Study|Withdrawal by Subject|1|||
149165309|NCT02078219|538079473|FG002|Overall Study|Withdrawal by Subject|0|||
149165310|NCT02078219|538079474|FG003|Overall Study|Withdrawal by Subject|1|||
149165311|NCT02078219|538079475|FG004|Overall Study|Withdrawal by Subject|1|||
149165312|NCT02078219|538079471|FG000|Overall Study|Protocol Violation|0|||
149165313|NCT02078219|538079472|FG001|Overall Study|Protocol Violation|0|||
149165314|NCT02078219|538079473|FG002|Overall Study|Protocol Violation|0|||
149165315|NCT02078219|538079474|FG003|Overall Study|Protocol Violation|1|||
149165316|NCT02078219|538079475|FG004|Overall Study|Protocol Violation|0|||
149165317|NCT02078219|538079471|FG000|Overall Study|Death|0|||
149165318|NCT02078219|538079472|FG001|Overall Study|Death|0|||
149165319|NCT02078219|538079473|FG002|Overall Study|Death|0|||
149165320|NCT02078219|538079474|FG003|Overall Study|Death|1|||
149165321|NCT02078219|538079475|FG004|Overall Study|Death|0|||
149165322|NCT02078219|538079471|FG000|Overall Study|Adverse Event|1|||
149165323|NCT02078219|538079472|FG001|Overall Study|Adverse Event|1|||
149165324|NCT02078219|538079473|FG002|Overall Study|Adverse Event|3|||
149165325|NCT02078219|538079474|FG003|Overall Study|Adverse Event|1|||
148927237|NCT02431247|537217404|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
148927238|NCT02431247|537217405|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
148927239|NCT02431247|537217406|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
148927240|NCT02431247|537217404|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
148927241|NCT02431247|537217405|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
148927242|NCT02431247|537217406|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
148927243|NCT02431247|537217404|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
149165326|NCT02078219|538079475|FG004|Overall Study|Adverse Event|0|||
149165327|NCT00821678|538079476|FG000|Overall Study|Withdrawal by Subject|8|||
149165328|NCT00821678|538079477|FG001|Overall Study|Withdrawal by Subject|0|||
149165329|NCT00821678|538079476|FG000|Overall Study|Lost to Follow-up|13|||
149165330|NCT00821678|538079477|FG001|Overall Study|Lost to Follow-up|12|||
149165331|NCT00821678|538079476|FG000|Overall Study|Death|0|||
149165332|NCT00821678|538079477|FG001|Overall Study|Death|2|||
149165333|NCT03136107|538079484|FG000|Overall Study|Other (Not specified)|1|||
149165334|NCT03641560|538079489|FG000|Overall Study|Withdrawal by Subject|6|||
149165335|NCT03641560|538079489|FG000|Overall Study|Progressive disease|40|||
149165336|NCT03641560|538079489|FG000|Overall Study|Death|6|||
149165337|NCT03219164|538082057|FG000|Overall Study|Study Terminated by Sponsor|16|||
149165338|NCT03219164|538082058|FG001|Overall Study|Study Terminated by Sponsor|12|||
149165339|NCT03219164|538082057|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
149165340|NCT03219164|538082058|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
149165341|NCT03219164|538082057|FG000|Overall Study|Lost to Follow-up|1|||
149165342|NCT03219164|538082058|FG001|Overall Study|Lost to Follow-up|1|||
149165343|NCT03219164|538082057|FG000|Overall Study|Adverse Event|1|||
149165344|NCT03219164|538082058|FG001|Overall Study|Adverse Event|0|||
149165345|NCT03219164|538082057|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149165346|NCT03219164|538082058|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149165347|NCT03219164|538082057|FG000|Overall Study|Protocol Violation|0|||
149165348|NCT03219164|538082058|FG001|Overall Study|Protocol Violation|1|||
149165349|NCT03219164|538082057|FG000|Overall Study|Withdrew Assent|1|||
149165350|NCT03219164|538082058|FG001|Overall Study|Withdrew Assent|0|||
149165351|NCT02689492|538082059|FG000|Overall Study|Lost to Follow-up|61|||
149165352|NCT02689492|538082059|FG000|Overall Study|Withdrawal by Subject|11|||
149165353|NCT02689492|538082059|FG000|Overall Study|Death|9|||
149165354|NCT02689492|538082059|FG000|Overall Study|Physician Decision|2|||
149165355|NCT02689492|538082059|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
149165356|NCT02689492|538082059|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
149165357|NCT02689492|538082059|FG000|Overall Study|Other than listed|1|||
149165358|NCT02732951|538082060|FG000|Overall Study|Other than listed|1|||
149165359|NCT02732951|538082061|FG001|Overall Study|Other than listed|0|||
149165360|NCT02732951|538082060|FG000|Overall Study|Lost to Follow-up|0|||
149165361|NCT02732951|538082061|FG001|Overall Study|Lost to Follow-up|1|||
149165362|NCT02732951|538082060|FG000|Overall Study|Adverse Event|4|||
149165363|NCT02732951|538082061|FG001|Overall Study|Adverse Event|4|||
149165364|NCT02732951|538082060|FG000|Overall Study|Protocol Violation|0|||
149165365|NCT02732951|538082061|FG001|Overall Study|Protocol Violation|1|||
149165366|NCT01750918|538082062|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
149165367|NCT01750918|538082063|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
149165368|NCT01750918|538082064|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
149165369|NCT01750918|538082065|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
149165370|NCT01750918|538082066|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
149165371|NCT01750918|538082067|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
149165372|NCT01750918|538082068|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
149165373|NCT01750918|538082069|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
149165374|NCT01750918|538082062|FG000|Overall Study|Lost to Follow-up|0|||
149165375|NCT01750918|538082063|FG001|Overall Study|Lost to Follow-up|0|||
149165376|NCT01750918|538082064|FG002|Overall Study|Lost to Follow-up|2|||
149165377|NCT01750918|538082065|FG003|Overall Study|Lost to Follow-up|2|||
149165378|NCT01750918|538082066|FG004|Overall Study|Lost to Follow-up|0|||
149165379|NCT01750918|538082067|FG005|Overall Study|Lost to Follow-up|0|||
149165380|NCT01750918|538082068|FG006|Overall Study|Lost to Follow-up|0|||
148927244|NCT02431247|537217405|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
149165381|NCT01750918|538082069|FG007|Overall Study|Lost to Follow-up|1|||
149165382|NCT01750918|538082062|FG000|Overall Study|Withdrawal by Subject|0|||
148927245|NCT02431247|537217406|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
148927246|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
148927247|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
148927248|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Other|2|||
148927249|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Other|2|||
149165383|NCT01750918|538082063|FG001|Overall Study|Withdrawal by Subject|0|||
149165384|NCT01750918|538082064|FG002|Overall Study|Withdrawal by Subject|1|||
149165385|NCT01750918|538082065|FG003|Overall Study|Withdrawal by Subject|2|||
149165386|NCT01750918|538082066|FG004|Overall Study|Withdrawal by Subject|1|||
149165387|NCT01750918|538082067|FG005|Overall Study|Withdrawal by Subject|1|||
149165388|NCT01750918|538082068|FG006|Overall Study|Withdrawal by Subject|2|||
149165389|NCT01750918|538082069|FG007|Overall Study|Withdrawal by Subject|2|||
149165390|NCT04840667|538082077|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
149165391|NCT00110305|538082083|FG000|Overall Study|Adverse Event|46|||
149165392|NCT00110305|538082084|FG001|Overall Study|Adverse Event|13|||
149165393|NCT00110305|538082083|FG000|Overall Study|Sponsors Decision|1|||
149165394|NCT00110305|538082084|FG001|Overall Study|Sponsors Decision|0|||
149165395|NCT00110305|538082083|FG000|Overall Study|Subject Non-Compliant|9|||
149165396|NCT00110305|538082084|FG001|Overall Study|Subject Non-Compliant|2|||
149165397|NCT00110305|538082083|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
149165398|NCT00110305|538082084|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
149165399|NCT00110305|538082083|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
149165400|NCT00110305|538082084|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
149165401|NCT00110305|538082083|FG000|Overall Study|Protocol Violation|0|||
149165402|NCT00110305|538082084|FG001|Overall Study|Protocol Violation|1|||
149165403|NCT00110305|538082083|FG000|Overall Study|Withdrawal by Subject|7|||
149165404|NCT00110305|538082084|FG001|Overall Study|Withdrawal by Subject|7|||
149165405|NCT00110305|538082083|FG000|Overall Study|Lost to Follow-up|20|||
149165406|NCT00110305|538082084|FG001|Overall Study|Lost to Follow-up|3|||
149165407|NCT00110305|538082083|FG000|Overall Study|Other|8|||
149165408|NCT00110305|538082084|FG001|Overall Study|Other|2|||
149165409|NCT01805180|538082096|FG000|Lead-in Donor Phase|screen failure|1|||
149165410|NCT01805180|538082097|FG001|Lead-in Donor Phase|screen failure|0|||
149165411|NCT01805180|538082098|FG002|Lead-in Donor Phase|screen failure|0|||
149165412|NCT04574999|538082101|FG000|Overall Study|Adverse Event|1|||
149165413|NCT04574999|538082102|FG001|Overall Study|Adverse Event|0|||
149165414|NCT04574999|538082101|FG000|Overall Study|Lack of Efficacy|2|||
149165415|NCT04574999|538082102|FG001|Overall Study|Lack of Efficacy|3|||
149165416|NCT04574999|538082101|FG000|Overall Study|Protocol Violation|1|||
149165417|NCT04574999|538082102|FG001|Overall Study|Protocol Violation|0|||
149165418|NCT04574999|538082101|FG000|Overall Study|Withdrawal by Subject|2|||
149165419|NCT04574999|538082102|FG001|Overall Study|Withdrawal by Subject|2|||
149165420|NCT04574999|538082101|FG000|Overall Study|Lost to Follow-up|1|||
149165421|NCT04574999|538082102|FG001|Overall Study|Lost to Follow-up|0|||
149165422|NCT04574999|538082101|FG000|Overall Study|Personal problems|1|||
149165423|NCT04574999|538082102|FG001|Overall Study|Personal problems|0|||
149165424|NCT04574999|538082101|FG000|Overall Study|Previous planned surgery|1|||
149165425|NCT04574999|538082102|FG001|Overall Study|Previous planned surgery|0|||
148675149|NCT01283282|536281534|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
149165426|NCT00206726|538082106|FG000|Overall Study|Delayed recovery of blood counts|1|||
149165427|NCT00206726|538082106|FG000|Overall Study|Progressive disease or relapsed disease|18|||
149165428|NCT00206726|538082106|FG000|Overall Study|Placed on new protocol|1|||
149165429|NCT00206726|538082106|FG000|Overall Study|Bone marrow transplant|1|||
148675150|NCT00096031|536281535|FG000|Overall Study|Adverse Event|3|||
148675151|NCT00096031|536281535|FG000|Overall Study|Lack of Efficacy|42|||
148675152|NCT00096031|536281535|FG000|Overall Study|Death|4|||
148675153|NCT00096031|536281535|FG000|Overall Study|Withdrawal by Subject|1|||
148675154|NCT00096031|536281535|FG000|Overall Study|Ineligible|8|||
148675155|NCT00096031|536281535|FG000|Overall Study|Not protocol specified|5|||
148675156|NCT00083226|536281536|FG000|Overall Study|Lack of Efficacy|19|||
148675157|NCT00083226|536281536|FG000|Overall Study|Adverse Event|9|||
148927250|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Personal reasons|2|||
149165430|NCT00206726|538082106|FG000|Overall Study|Adverse Event|17|||
149165431|NCT00206726|538082106|FG000|Overall Study|Death|4|||
149165432|NCT00206726|538082106|FG000|Overall Study|Protocol Violation|1|||
149165433|NCT00206726|538082106|FG000|Overall Study|Withdrawal by Subject|8|||
149165434|NCT00008385|538082107|FG000|Overall Study|Off treatment reasons not reported|79|||
149165435|NCT00008385|538082108|FG001|Overall Study|Off treatment reasons not reported|70|||
149165436|NCT00008385|538082107|FG000|Overall Study|Progressive disease|52|||
149165437|NCT00008385|538082108|FG001|Overall Study|Progressive disease|117|||
149165438|NCT00008385|538082107|FG000|Overall Study|Adverse Event|8|||
149165439|NCT00008385|538082108|FG001|Overall Study|Adverse Event|20|||
149165440|NCT00008385|538082107|FG000|Overall Study|Death|12|||
149165441|NCT00008385|538082108|FG001|Overall Study|Death|18|||
149165442|NCT00008385|538082107|FG000|Overall Study|Withdrawal by Subject|67|||
149165443|NCT00008385|538082108|FG001|Overall Study|Withdrawal by Subject|157|||
149165444|NCT00008385|538082107|FG000|Overall Study|Start non-protocol therapy|3|||
149165445|NCT00008385|538082108|FG001|Overall Study|Start non-protocol therapy|1|||
149165446|NCT00008385|538082107|FG000|Overall Study|Other complicating disease|17|||
149165447|NCT00008385|538082108|FG001|Overall Study|Other complicating disease|30|||
149165448|NCT00008385|538082107|FG000|Overall Study|Maximum dose reached|0|||
149165449|NCT00008385|538082108|FG001|Overall Study|Maximum dose reached|2|||
149165450|NCT00008385|538082107|FG000|Overall Study|Other|105|||
149165451|NCT00008385|538082108|FG001|Overall Study|Other|212|||
149165452|NCT00008385|538082107|FG000|Overall Study|Not start protocol therapy|44|||
149165453|NCT00008385|538082108|FG001|Overall Study|Not start protocol therapy|175|||
149165454|NCT05148884|538082109|FG000|Overall Study|Withdrawal by Subject|3|||
149165455|NCT05148884|538082110|FG001|Overall Study|Withdrawal by Subject|0|||
149165456|NCT05148884|538082109|FG000|Overall Study|Deep brain stimulation operation|0|||
149165457|NCT05148884|538082110|FG001|Overall Study|Deep brain stimulation operation|1|||
149165458|NCT00582556|538082111|FG000|Overall Study|Withdrawal by Subject|0|||
149165459|NCT00582556|538082112|FG001|Overall Study|Withdrawal by Subject|1|||
148675158|NCT00083226|536281536|FG000|Overall Study|Death|4|||
148675159|NCT00083226|536281536|FG000|Overall Study|Withdrawal by Subject|4|||
148927251|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Personal reasons|2|||
148927252|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
148927253|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
148927254|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
148675160|NCT00083226|536281536|FG000|Overall Study|Other|2|||
148927255|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
148927256|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
148927257|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
149165460|NCT00582556|538082113|FG002|Overall Study|Withdrawal by Subject|1|||
149165461|NCT00582556|538082111|FG000|Overall Study|Physician Decision|0|||
149165462|NCT00582556|538082112|FG001|Overall Study|Physician Decision|0|||
149165463|NCT00582556|538082113|FG002|Overall Study|Physician Decision|1|||
149165464|NCT01993888|538082116|FG000|Overall Study|Death|1|||
149165465|NCT01993888|538082117|FG001|Overall Study|Death|1|||
149165466|NCT01993888|538082116|FG000|Overall Study|Lost to Follow-up|1|||
149165467|NCT01993888|538082117|FG001|Overall Study|Lost to Follow-up|1|||
149165468|NCT01993888|538082116|FG000|Overall Study|Withdrawal by Subject|0|||
149165469|NCT01993888|538082117|FG001|Overall Study|Withdrawal by Subject|1|||
149165470|NCT01341457|538082118|FG000|Overall Study|Adverse Event|2|||
149165471|NCT01341457|538082119|FG001|Overall Study|Adverse Event|0|||
149165472|NCT00365989|538082120|FG000|Overall Study|Withdrawal by Subject|1|||
149165473|NCT00365989|538082120|FG000|Overall Study|Non-compliance|1|||
149165474|NCT00832819|538082123|FG000|Overall Study|Adverse Event|0|||
149165475|NCT00832819|538082124|FG001|Overall Study|Adverse Event|1|||
149165476|NCT00832819|538082125|FG002|Overall Study|Adverse Event|0|||
149165477|NCT00832819|538082123|FG000|Overall Study|Protocol Violation|0|||
149165478|NCT00832819|538082124|FG001|Overall Study|Protocol Violation|0|||
149165479|NCT00832819|538082125|FG002|Overall Study|Protocol Violation|1|||
149165480|NCT00317044|538082126|FG000|Overall Study|Protocol Violation|28|||
149165481|NCT00317044|538082127|FG001|Overall Study|Protocol Violation|22|||
149165482|NCT00317044|538082128|FG002|Overall Study|Protocol Violation|20|||
149165483|NCT00317044|538082126|FG000|Overall Study|Adverse Event|4|||
149165484|NCT00317044|538082127|FG001|Overall Study|Adverse Event|7|||
149165485|NCT00317044|538082128|FG002|Overall Study|Adverse Event|4|||
149165486|NCT00317044|538082126|FG000|Overall Study|Withdrawal by Subject|10|||
149165487|NCT00317044|538082127|FG001|Overall Study|Withdrawal by Subject|7|||
149165488|NCT00317044|538082128|FG002|Overall Study|Withdrawal by Subject|12|||
149165489|NCT00317044|538082126|FG000|Overall Study|Lost to Follow-up|0|||
149165490|NCT00317044|538082127|FG001|Overall Study|Lost to Follow-up|2|||
149165491|NCT00317044|538082128|FG002|Overall Study|Lost to Follow-up|3|||
149165492|NCT00317044|538082126|FG000|Overall Study|Multiple Reasons|6|||
149165493|NCT00317044|538082127|FG001|Overall Study|Multiple Reasons|2|||
149165494|NCT00317044|538082128|FG002|Overall Study|Multiple Reasons|6|||
149165495|NCT04317690|538082131|FG000|Overall Study|did not have complete information for primary outcome|0|||
149165496|NCT04317690|538082132|FG001|Overall Study|did not have complete information for primary outcome|4|||
149165497|NCT04317690|538082133|FG002|Overall Study|did not have complete information for primary outcome|0|||
149165498|NCT04317690|538082134|FG003|Overall Study|did not have complete information for primary outcome|2|||
149165499|NCT04317690|538082135|FG004|Overall Study|did not have complete information for primary outcome|0|||
149165500|NCT02318095|538082136|FG000|Overall Study|Adverse Event|1|||
149165501|NCT01717638|538082137|FG000|Overall Study|Lost to Follow-up|0|||
149165502|NCT01717638|538082138|FG001|Overall Study|Lost to Follow-up|0|||
149165503|NCT01717638|538082139|FG002|Overall Study|Lost to Follow-up|0|||
149165504|NCT01717638|538082140|FG003|Overall Study|Lost to Follow-up|0|||
149165505|NCT01717638|538082141|FG004|Overall Study|Lost to Follow-up|0|||
149165506|NCT01717638|538082142|FG005|Overall Study|Lost to Follow-up|1|||
149165507|NCT01717638|538082143|FG006|Overall Study|Lost to Follow-up|0|||
149165508|NCT01717638|538082144|FG007|Overall Study|Lost to Follow-up|0|||
149165509|NCT01717638|538082145|FG008|Overall Study|Lost to Follow-up|0|||
149165510|NCT01717638|538082146|FG009|Overall Study|Lost to Follow-up|0|||
149165511|NCT01717638|538082147|FG010|Overall Study|Lost to Follow-up|0|||
149165512|NCT01717638|538082148|FG011|Overall Study|Lost to Follow-up|0|||
149165513|NCT01717638|538082149|FG012|Overall Study|Lost to Follow-up|0|||
149165514|NCT01717638|538082137|FG000|Overall Study|Father in hospital|0|||
149165515|NCT01717638|538082138|FG001|Overall Study|Father in hospital|0|||
149165516|NCT01717638|538082139|FG002|Overall Study|Father in hospital|0|||
149165517|NCT01717638|538082140|FG003|Overall Study|Father in hospital|0|||
149165518|NCT01717638|538082141|FG004|Overall Study|Father in hospital|0|||
149165519|NCT01717638|538082142|FG005|Overall Study|Father in hospital|0|||
149165520|NCT01717638|538082143|FG006|Overall Study|Father in hospital|0|||
149165521|NCT01717638|538082144|FG007|Overall Study|Father in hospital|0|||
149165522|NCT01717638|538082145|FG008|Overall Study|Father in hospital|0|||
149165523|NCT01717638|538082146|FG009|Overall Study|Father in hospital|0|||
149165524|NCT01717638|538082147|FG010|Overall Study|Father in hospital|0|||
149165525|NCT01717638|538082148|FG011|Overall Study|Father in hospital|0|||
149165526|NCT01717638|538082149|FG012|Overall Study|Father in hospital|1|||
149165527|NCT01717638|538082137|FG000|Overall Study|Withdrawal by Subject|0|||
149165528|NCT01717638|538082138|FG001|Overall Study|Withdrawal by Subject|1|||
149165529|NCT01717638|538082139|FG002|Overall Study|Withdrawal by Subject|1|||
149165530|NCT01717638|538082140|FG003|Overall Study|Withdrawal by Subject|0|||
149165531|NCT01717638|538082141|FG004|Overall Study|Withdrawal by Subject|1|||
149165532|NCT01717638|538082142|FG005|Overall Study|Withdrawal by Subject|0|||
149165533|NCT01717638|538082143|FG006|Overall Study|Withdrawal by Subject|2|||
149165534|NCT01717638|538082144|FG007|Overall Study|Withdrawal by Subject|1|||
149165535|NCT01717638|538082145|FG008|Overall Study|Withdrawal by Subject|2|||
149165536|NCT01717638|538082146|FG009|Overall Study|Withdrawal by Subject|1|||
149165537|NCT01717638|538082147|FG010|Overall Study|Withdrawal by Subject|0|||
149165538|NCT01717638|538082148|FG011|Overall Study|Withdrawal by Subject|0|||
149165539|NCT01717638|538082149|FG012|Overall Study|Withdrawal by Subject|18|||
148806211|NCT04589650|536768106|FG005|Overall Study|Adverse Event|1|||
149165540|NCT01719757|538082151|FG000|Overall Study|Adverse Event|38|||
148806212|NCT04589650|536768101|FG000|Overall Study|Physician Decision|1|||
149165541|NCT01719757|538082151|FG000|Overall Study|Withdrawal by Subject|15|||
149165542|NCT01719757|538082151|FG000|Overall Study|Lost to Follow-up|20|||
149165543|NCT01719757|538082151|FG000|Overall Study|Protocol Violation|1|||
149165544|NCT01719757|538082151|FG000|Overall Study|well controlled pain|27|||
149165545|NCT02626338|538082152|FG000|Overall Study|Lack of Efficacy|3|||
149165546|NCT02626338|538082153|FG001|Overall Study|Lack of Efficacy|2|||
149165547|NCT02626338|538082154|FG002|Overall Study|Lack of Efficacy|0|||
149165548|NCT03312218|538082160|FG000|Overall Study|Never signed in to access the app|54|||
149165549|NCT03312218|538082161|FG001|Overall Study|Never signed in to access the app|58|||
149165550|NCT01901224|538082162|FG000|Overall Study|study was not funded and terminated|2|||
149165551|NCT00103012|538082166|FG000|Overall Study|Withdrawal by Subject|2|||
149165552|NCT00103012|538082167|FG001|Overall Study|Withdrawal by Subject|1|||
149165553|NCT00103012|538082168|FG002|Overall Study|Withdrawal by Subject|2|||
149165554|NCT00103012|538082166|FG000|Overall Study|Pregnancy|1|||
149165555|NCT00103012|538082167|FG001|Overall Study|Pregnancy|0|||
149165556|NCT00103012|538082168|FG002|Overall Study|Pregnancy|0|||
149165557|NCT00103012|538082166|FG000|Overall Study|Adverse Event|0|||
149165558|NCT00103012|538082167|FG001|Overall Study|Adverse Event|0|||
149165559|NCT00103012|538082168|FG002|Overall Study|Adverse Event|1|||
149165560|NCT00103012|538082166|FG000|Overall Study|Subject non-compliant with medications|0|||
149165561|NCT00103012|538082167|FG001|Overall Study|Subject non-compliant with medications|0|||
149165562|NCT00103012|538082168|FG002|Overall Study|Subject non-compliant with medications|1|||
149165563|NCT05211336|538082171|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
149165564|NCT05211336|538082172|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
149165565|NCT05211336|538082171|FG000|Overall Study|Progressive disease|0|||
149165566|NCT05211336|538082172|FG001|Overall Study|Progressive disease|4|||
149165567|NCT05211336|538082171|FG000|Overall Study|Death due to myocardial infarction|0|||
149165568|NCT05211336|538082172|FG001|Overall Study|Death due to myocardial infarction|1|||
149165569|NCT05211336|538082171|FG000|Overall Study|Death due to unknown cause|0|||
149165570|NCT05211336|538082172|FG001|Overall Study|Death due to unknown cause|1|||
149165571|NCT05211336|538082171|FG000|Overall Study|Worsening kidney function and quality of response|0|||
149165572|NCT05211336|538082172|FG001|Overall Study|Worsening kidney function and quality of response|1|||
149165573|NCT00393718|538082173|FG000|Overall Study|Adverse Event|20|||
149165574|NCT00393718|538082174|FG001|Overall Study|Adverse Event|8|||
149165575|NCT00393718|538082173|FG000|Overall Study|Protocol Violation|1|||
149165576|NCT00393718|538082174|FG001|Overall Study|Protocol Violation|2|||
149165577|NCT00393718|538082173|FG000|Overall Study|Lack of Efficacy|10|||
149165578|NCT00393718|538082174|FG001|Overall Study|Lack of Efficacy|9|||
149165579|NCT00393718|538082173|FG000|Overall Study|Hypoglycaemia|3|||
149165580|NCT00393718|538082174|FG001|Overall Study|Hypoglycaemia|2|||
149165581|NCT00393718|538082173|FG000|Overall Study|Subject decision|5|||
149165582|NCT00393718|538082174|FG001|Overall Study|Subject decision|0|||
149165583|NCT00393718|538082173|FG000|Overall Study|Withdrawal of consent|2|||
149165584|NCT00393718|538082174|FG001|Overall Study|Withdrawal of consent|1|||
149165585|NCT00393718|538082173|FG000|Overall Study|Missed measurement|1|||
149165586|NCT00393718|538082174|FG001|Overall Study|Missed measurement|0|||
149165587|NCT00393718|538082173|FG000|Overall Study|Move|1|||
149165588|NCT00393718|538082174|FG001|Overall Study|Move|0|||
149165589|NCT01084551|538082179|FG000|Overall Study|Adverse Event|2|||
149165590|NCT01084551|538082180|FG001|Overall Study|Adverse Event|9|||
149165591|NCT01084551|538082181|FG002|Overall Study|Adverse Event|4|||
149165592|NCT01084551|538082179|FG000|Overall Study|Lack of Efficacy|2|||
149165593|NCT01084551|538082180|FG001|Overall Study|Lack of Efficacy|0|||
149165594|NCT01084551|538082181|FG002|Overall Study|Lack of Efficacy|1|||
149165595|NCT01084551|538082179|FG000|Overall Study|Withdrawal by Subject|2|||
149165596|NCT01084551|538082180|FG001|Overall Study|Withdrawal by Subject|1|||
149165597|NCT01084551|538082181|FG002|Overall Study|Withdrawal by Subject|0|||
149165598|NCT01084551|538082179|FG000|Overall Study|Protocol Violation|2|||
149165599|NCT01084551|538082180|FG001|Overall Study|Protocol Violation|4|||
149165600|NCT01084551|538082181|FG002|Overall Study|Protocol Violation|0|||
149165601|NCT01084551|538082179|FG000|Overall Study|Lost to Follow-up|0|||
149165602|NCT01084551|538082180|FG001|Overall Study|Lost to Follow-up|0|||
149165603|NCT01084551|538082181|FG002|Overall Study|Lost to Follow-up|3|||
149165604|NCT01084551|538082179|FG000|Overall Study|Physician Decision|1|||
149165605|NCT01084551|538082180|FG001|Overall Study|Physician Decision|0|||
149165606|NCT01084551|538082181|FG002|Overall Study|Physician Decision|0|||
149165607|NCT04684420|538082182|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149165608|NCT04684420|538082183|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149165609|NCT04684420|538082184|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
149165610|NCT04684420|538082185|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
149165611|NCT04684420|538082182|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
149165612|NCT04684420|538082183|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
149165613|NCT04684420|538082184|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
149165614|NCT04684420|538082185|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
149165615|NCT00463476|538082186|FG000|Overall Study|Withdrawal by Subject|1|||
149165616|NCT00463476|538082187|FG001|Overall Study|Withdrawal by Subject|2|||
149165617|NCT00463476|538082186|FG000|Overall Study|Lost to Follow-up|1|||
149165618|NCT00463476|538082187|FG001|Overall Study|Lost to Follow-up|1|||
149165619|NCT00434967|538082188|FG000|Overall Study|Adverse Event|2|||
149165620|NCT00434967|538082189|FG001|Overall Study|Adverse Event|4|||
149165621|NCT00434967|538082190|FG002|Overall Study|Adverse Event|3|||
149165622|NCT00434967|538082191|FG003|Overall Study|Adverse Event|3|||
149165623|NCT00434967|538082188|FG000|Overall Study|Lost to Follow-up|0|||
149165624|NCT00434967|538082189|FG001|Overall Study|Lost to Follow-up|0|||
149165625|NCT00434967|538082190|FG002|Overall Study|Lost to Follow-up|1|||
149165626|NCT00434967|538082191|FG003|Overall Study|Lost to Follow-up|0|||
149165627|NCT00434967|538082188|FG000|Overall Study|Withdrawal by Subject|2|||
149165628|NCT00434967|538082189|FG001|Overall Study|Withdrawal by Subject|2|||
149165629|NCT00434967|538082190|FG002|Overall Study|Withdrawal by Subject|4|||
149165630|NCT00434967|538082191|FG003|Overall Study|Withdrawal by Subject|6|||
149165631|NCT00434967|538082188|FG000|Overall Study|Randomized in error|0|||
149165632|NCT00434967|538082189|FG001|Overall Study|Randomized in error|0|||
149165633|NCT00434967|538082190|FG002|Overall Study|Randomized in error|0|||
149165634|NCT00434967|538082191|FG003|Overall Study|Randomized in error|1|||
149165635|NCT00434967|538082188|FG000|Overall Study|Protocol Violation|0|||
149165636|NCT00434967|538082189|FG001|Overall Study|Protocol Violation|1|||
149165637|NCT00434967|538082190|FG002|Overall Study|Protocol Violation|0|||
149165638|NCT00434967|538082191|FG003|Overall Study|Protocol Violation|1|||
149165639|NCT00434967|538082188|FG000|Overall Study|Physician Decision|1|||
149165640|NCT00434967|538082189|FG001|Overall Study|Physician Decision|1|||
148927258|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
148927259|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
148927260|NCT00667446|537217407|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
148927261|NCT00667446|537217408|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
148927262|NCT00667446|537217407|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
148927263|NCT00667446|537217408|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
148927264|NCT00322153|537217409|FG000|Overall Study|Adverse Event|21|||
148927265|NCT00322153|537217410|FG001|Overall Study|Adverse Event|34|||
148927266|NCT00322153|537217409|FG000|Overall Study|Protocol Violation|6|||
149165641|NCT00434967|538082190|FG002|Overall Study|Physician Decision|1|||
149165642|NCT00434967|538082191|FG003|Overall Study|Physician Decision|0|||
149165643|NCT00434967|538082188|FG000|Overall Study|Patient Disposition Challenges|2|||
149165644|NCT00434967|538082189|FG001|Overall Study|Patient Disposition Challenges|0|||
149165645|NCT00434967|538082190|FG002|Overall Study|Patient Disposition Challenges|0|||
149165646|NCT00434967|538082191|FG003|Overall Study|Patient Disposition Challenges|3|||
149165647|NCT01551693|538082194|FG000|Overall Study|Disease Progression|1|||
149165648|NCT01551693|538082195|FG001|Overall Study|Disease Progression|0|||
149165649|NCT01551693|538082194|FG000|Overall Study|Adverse Event|0|||
149165650|NCT01551693|538082195|FG001|Overall Study|Adverse Event|1|||
149165651|NCT01551693|538082194|FG000|Overall Study|Withdrawal by Subject|0|||
149165652|NCT01551693|538082195|FG001|Overall Study|Withdrawal by Subject|1|||
149165653|NCT01838044|538082196|FG000|Overall Study|Adverse Event|4|||
149165654|NCT01838044|538082197|FG001|Overall Study|Adverse Event|6|||
149165655|NCT01838044|538082196|FG000|Overall Study|Protocol Violation|3|||
149165656|NCT01838044|538082197|FG001|Overall Study|Protocol Violation|3|||
149165657|NCT01838044|538082196|FG000|Overall Study|Withdrawal by Subject|0|||
149165658|NCT01838044|538082197|FG001|Overall Study|Withdrawal by Subject|2|||
149165659|NCT01838044|538082196|FG000|Overall Study|Insufficient clinical response|1|||
149165660|NCT01838044|538082197|FG001|Overall Study|Insufficient clinical response|2|||
149165661|NCT01838044|538082196|FG000|Overall Study|Medication error without associated AE|0|||
149165662|NCT01838044|538082197|FG001|Overall Study|Medication error without associated AE|1|||
149165663|NCT01838044|538082196|FG000|Overall Study|Lost to Follow-up|0|||
149165664|NCT01838044|538082197|FG001|Overall Study|Lost to Follow-up|2|||
149165665|NCT00737529|538082202|FG000|Overall Study|Disease Progression|95|||
149165666|NCT00737529|538082202|FG000|Overall Study|Adverse Event|24|||
149165667|NCT00737529|538082202|FG000|Overall Study|Withdrawal by Subject|5|||
148927267|NCT00322153|537217410|FG001|Overall Study|Protocol Violation|14|||
148927268|NCT00322153|537217409|FG000|Overall Study|Withdrawal by Subject|18|||
148927269|NCT00322153|537217410|FG001|Overall Study|Withdrawal by Subject|10|||
148927270|NCT00322153|537217409|FG000|Overall Study|Lack of Efficacy|8|||
149165668|NCT00737529|538082202|FG000|Overall Study|Death|4|||
149165669|NCT00737529|538082202|FG000|Overall Study|Protocol Violation|1|||
149165670|NCT00737529|538082202|FG000|Overall Study|Other|4|||
149165671|NCT00565617|538082203|FG000|Overall Study|Withdrawal by Subject|1|||
149165672|NCT04666038|538082206|FG000|Overall Study|Progressive Disease|2|||
149165673|NCT04666038|538082207|FG001|Overall Study|Progressive Disease|0|||
149165674|NCT04666038|538082206|FG000|Overall Study|Death|38|||
149165675|NCT04666038|538082207|FG001|Overall Study|Death|32|||
149165676|NCT04666038|538082206|FG000|Overall Study|Withdrawal by Subject|10|||
149165677|NCT04666038|538082207|FG001|Overall Study|Withdrawal by Subject|19|||
149165678|NCT04666038|538082206|FG000|Overall Study|Lost to Follow-up|0|||
149165679|NCT04666038|538082207|FG001|Overall Study|Lost to Follow-up|2|||
149165680|NCT04666038|538082206|FG000|Overall Study|On Study Treatment|46|||
149165681|NCT04666038|538082207|FG001|Overall Study|On Study Treatment|5|||
149165682|NCT04666038|538082206|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
149165683|NCT04666038|538082207|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
149165684|NCT02658812|538082208|FG000|Overall Study|Disease Progression|7|||
149165685|NCT02658812|538082208|FG000|Overall Study|Unrelated to study treatment|1|||
149165686|NCT02658812|538082208|FG000|Overall Study|Adverse Event|1|||
149165687|NCT01512264|538082211|FG000|Overall Study|Lost to Follow-up|0|||
149165688|NCT01512264|538082212|FG001|Overall Study|Lost to Follow-up|0|||
149165689|NCT01512264|538082213|FG002|Overall Study|Lost to Follow-up|0|||
149165690|NCT01512264|538082214|FG003|Overall Study|Lost to Follow-up|1|||
149165691|NCT01194440|538082215|FG000|Baseline (First Dose)|Reason not specified|4|||
149165692|NCT01194440|538082215|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
149165693|NCT01194440|538082215|FG000|Baseline (First Dose)|Change in therapy|1|||
149165694|NCT01194440|538082215|FG000|Baseline (First Dose)|Adverse Event|1|||
149165695|NCT01194440|538082215|FG000|6-months (2nd Dose)|Change in therapy|4|||
149165696|NCT00854828|538082216|FG000|Overall Study|Death|1|||
149165697|NCT00854828|538082217|FG001|Overall Study|Death|0|||
149165698|NCT00854828|538082218|FG002|Overall Study|Death|0|||
149165699|NCT00854828|538082219|FG003|Overall Study|Death|0|||
149165700|NCT00854828|538082216|FG000|Overall Study|Withdrawal by Subject|1|||
149165701|NCT00854828|538082217|FG001|Overall Study|Withdrawal by Subject|1|||
149165702|NCT00854828|538082218|FG002|Overall Study|Withdrawal by Subject|0|||
149165703|NCT00854828|538082219|FG003|Overall Study|Withdrawal by Subject|9|||
148806213|NCT04589650|536768102|FG001|Overall Study|Physician Decision|1|||
148806214|NCT04589650|536768103|FG002|Overall Study|Physician Decision|0|||
148927271|NCT00322153|537217410|FG001|Overall Study|Lack of Efficacy|3|||
148927272|NCT00322153|537217409|FG000|Overall Study|Lost to Follow-up|5|||
148927273|NCT00322153|537217410|FG001|Overall Study|Lost to Follow-up|4|||
149165704|NCT00854828|538082216|FG000|Overall Study|Missed 24mo visit|1|||
149165705|NCT00854828|538082217|FG001|Overall Study|Missed 24mo visit|1|||
149165706|NCT00854828|538082218|FG002|Overall Study|Missed 24mo visit|8|||
149165707|NCT00854828|538082219|FG003|Overall Study|Missed 24mo visit|8|||
149165708|NCT04957290|538082229|FG000|Overall Study|Progressive disease|3|||
149165709|NCT04957290|538082230|FG001|Overall Study|Progressive disease|3|||
149165710|NCT04957290|538082231|FG002|Overall Study|Progressive disease|2|||
148806215|NCT04589650|536768104|FG003|Overall Study|Physician Decision|0|||
149165711|NCT04957290|538082232|FG003|Overall Study|Progressive disease|0|||
149165712|NCT04957290|538082233|FG004|Overall Study|Progressive disease|0|||
149165713|NCT04957290|538082234|FG005|Overall Study|Progressive disease|0|||
149165714|NCT04957290|538082229|FG000|Overall Study|Withdrawal by Subject|1|||
149165715|NCT04957290|538082230|FG001|Overall Study|Withdrawal by Subject|0|||
149165716|NCT04957290|538082231|FG002|Overall Study|Withdrawal by Subject|1|||
149165717|NCT04957290|538082232|FG003|Overall Study|Withdrawal by Subject|0|||
149165718|NCT04957290|538082233|FG004|Overall Study|Withdrawal by Subject|0|||
149165719|NCT04957290|538082234|FG005|Overall Study|Withdrawal by Subject|0|||
149165720|NCT04957290|538082229|FG000|Overall Study|Death|0|||
149165721|NCT04957290|538082230|FG001|Overall Study|Death|2|||
149165722|NCT04957290|538082231|FG002|Overall Study|Death|1|||
149165723|NCT04957290|538082232|FG003|Overall Study|Death|0|||
149165724|NCT04957290|538082233|FG004|Overall Study|Death|0|||
149165725|NCT04957290|538082234|FG005|Overall Study|Death|0|||
149165726|NCT04957290|538082229|FG000|Overall Study|non compliance with study drug|0|||
149165727|NCT04957290|538082230|FG001|Overall Study|non compliance with study drug|1|||
149165728|NCT04957290|538082231|FG002|Overall Study|non compliance with study drug|0|||
149165729|NCT04957290|538082232|FG003|Overall Study|non compliance with study drug|0|||
149165730|NCT04957290|538082233|FG004|Overall Study|non compliance with study drug|0|||
149165731|NCT04957290|538082234|FG005|Overall Study|non compliance with study drug|0|||
149165732|NCT04957290|538082229|FG000|Overall Study|none specified.|0|||
149165733|NCT04957290|538082230|FG001|Overall Study|none specified.|1|||
149165734|NCT04957290|538082231|FG002|Overall Study|none specified.|2|||
149165735|NCT04957290|538082232|FG003|Overall Study|none specified.|0|||
149165736|NCT04957290|538082233|FG004|Overall Study|none specified.|0|||
149165737|NCT04957290|538082234|FG005|Overall Study|none specified.|0|||
149165738|NCT04957290|538082229|FG000|Overall Study|unacceptable toxicity|0|||
149165739|NCT04957290|538082230|FG001|Overall Study|unacceptable toxicity|0|||
149165740|NCT04957290|538082231|FG002|Overall Study|unacceptable toxicity|1|||
149165741|NCT04957290|538082232|FG003|Overall Study|unacceptable toxicity|0|||
149165742|NCT04957290|538082233|FG004|Overall Study|unacceptable toxicity|0|||
149165743|NCT04957290|538082234|FG005|Overall Study|unacceptable toxicity|0|||
149165744|NCT04957290|538082229|FG000|Overall Study|Adverse Event|0|||
149165745|NCT04957290|538082230|FG001|Overall Study|Adverse Event|0|||
149165746|NCT04957290|538082231|FG002|Overall Study|Adverse Event|1|||
149165747|NCT04957290|538082232|FG003|Overall Study|Adverse Event|0|||
149165748|NCT04957290|538082233|FG004|Overall Study|Adverse Event|0|||
149165749|NCT04957290|538082234|FG005|Overall Study|Adverse Event|0|||
149165750|NCT04957290|538082229|FG000|Overall Study|study terminated by sponsor|0|||
149165751|NCT04957290|538082230|FG001|Overall Study|study terminated by sponsor|0|||
149165752|NCT04957290|538082231|FG002|Overall Study|study terminated by sponsor|2|||
149165753|NCT04957290|538082232|FG003|Overall Study|study terminated by sponsor|0|||
149165754|NCT04957290|538082233|FG004|Overall Study|study terminated by sponsor|0|||
149165755|NCT04957290|538082234|FG005|Overall Study|study terminated by sponsor|0|||
149165756|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165757|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149012928|NCT00675506|537525844|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
149165758|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165759|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
149165760|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165761|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
149165762|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165763|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
148806216|NCT04589650|536768105|FG004|Overall Study|Physician Decision|0|||
148806217|NCT04589650|536768106|FG005|Overall Study|Physician Decision|0|||
148806218|NCT04589650|536768101|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149165764|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
148675161|NCT00083226|536281536|FG000|Overall Study|ineligible or not receiving treatment|4|||
148675162|NCT00909857|536281537|FG000|Overall Study|Withdrawal by Subject|6|||
148675163|NCT00909857|536281538|FG001|Overall Study|Withdrawal by Subject|10|||
148675164|NCT00909857|536281537|FG000|Overall Study|Adverse Event|5|||
148675165|NCT00909857|536281538|FG001|Overall Study|Adverse Event|5|||
148675166|NCT00909857|536281537|FG000|Overall Study|Lost to Follow-up|2|||
148675167|NCT00909857|536281538|FG001|Overall Study|Lost to Follow-up|5|||
148675168|NCT00909857|536281537|FG000|Overall Study|Protocol Violation|2|||
148675169|NCT00909857|536281538|FG001|Overall Study|Protocol Violation|1|||
148675170|NCT00909857|536281537|FG000|Overall Study|Pregnancy|1|||
148675171|NCT00909857|536281538|FG001|Overall Study|Pregnancy|0|||
148675172|NCT00909857|536281537|FG000|Overall Study|Other|1|||
148675173|NCT00909857|536281538|FG001|Overall Study|Other|0|||
148675174|NCT00909857|536281537|FG000|Overall Study|Did not receive study medication|19|||
148675175|NCT00909857|536281538|FG001|Overall Study|Did not receive study medication|24|||
148675176|NCT03878108|536281539|FG000|Overall Study|Adverse Event|1|||
148675177|NCT03878108|536281540|FG001|Overall Study|Adverse Event|0|||
148675178|NCT01682681|536281547|FG000|Overall Study|Lack of Efficacy|62|||
148675179|NCT01682681|536281547|FG000|Overall Study|Withdrawal by Subject|1|||
148675180|NCT01682681|536281547|FG000|Overall Study|Moved to other hospital|10|||
148675181|NCT01682681|536281547|FG000|Overall Study|Lost to Follow-up|174|||
148675182|NCT01682681|536281547|FG000|Overall Study|Adverse Event|46|||
148675183|NCT01682681|536281547|FG000|Overall Study|tapering of topiramate|5|||
148675184|NCT01682681|536281547|FG000|Overall Study|Other|21|||
148675185|NCT01682681|536281547|FG000|Overall Study|Low compliance|13|||
148675186|NCT02044094|536281548|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
148675187|NCT02044094|536281548|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
148675188|NCT02044094|536281548|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
148675189|NCT02044094|536281548|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
148675190|NCT02044094|536281548|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
148675191|NCT02044094|536281548|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
148675192|NCT02044094|536281548|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
148675193|NCT02044094|536281548|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
148675194|NCT03205163|536281549|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
148675195|NCT03205163|536281550|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
148675196|NCT04502862|536281551|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
148675197|NCT04502862|536281552|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
148675198|NCT04502862|536281551|FG000|Overall Study|Withdrawal by Subject|1|||
148675199|NCT04502862|536281552|FG001|Overall Study|Withdrawal by Subject|0|||
148675200|NCT04502862|536281551|FG000|Overall Study|Adverse Event|1|||
148675201|NCT04502862|536281552|FG001|Overall Study|Adverse Event|1|||
148675202|NCT00391092|536282920|FG000|Overall Study|Death|78|||
148927274|NCT00322153|537217409|FG000|Overall Study|Withdrawn for other reasons|5|||
148927275|NCT00322153|537217410|FG001|Overall Study|Withdrawn for other reasons|4|||
148675203|NCT00391092|536282921|FG001|Overall Study|Death|81|||
148675204|NCT00391092|536282920|FG000|Overall Study|Lost to Follow-up|13|||
149165765|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165766|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165767|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165768|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165769|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165770|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165771|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165772|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165773|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165774|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165775|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165776|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165777|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165778|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
149165779|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149165780|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
149165781|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149165782|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
149165783|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149165784|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149165785|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
149165786|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165787|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165788|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165789|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165790|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165791|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165792|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165793|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165794|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165795|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165796|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165797|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165798|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165799|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165800|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165801|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
149165802|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149165803|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
149165804|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149165805|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
149165806|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
149165807|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
149165808|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149165809|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
149165810|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165811|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165812|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165813|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165814|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165815|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165816|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165817|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165818|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165819|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165820|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165821|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165822|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165823|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165824|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
149165825|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165826|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165827|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
149165828|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165829|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
149165830|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165831|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165832|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165833|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165834|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149012929|NCT00675506|537525845|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
149165835|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
148806219|NCT04589650|536768102|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148806220|NCT04589650|536768103|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
148806221|NCT04589650|536768104|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149165836|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165837|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165838|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165839|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165840|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165841|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165842|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165843|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165844|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165845|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165846|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165847|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
149165848|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
149165849|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165850|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165851|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
149165852|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165853|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165854|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165855|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165856|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165857|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165858|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165859|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165860|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165861|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165862|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165863|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165864|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165865|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165866|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165867|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165868|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165869|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165870|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
149165871|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165872|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165873|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
149165874|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165875|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165876|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165877|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165878|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165879|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165880|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165881|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165882|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165883|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165884|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
148927276|NCT02414139|537217413|FG000|Treatment Period|Adverse Event|11|||
148927277|NCT02414139|537217414|FG001|Treatment Period|Adverse Event|6|||
148927278|NCT02414139|537217415|FG002|Treatment Period|Adverse Event|8|||
148927279|NCT02414139|537217416|FG003|Treatment Period|Adverse Event|5|||
148927280|NCT02414139|537217417|FG004|Treatment Period|Adverse Event|14|||
148927281|NCT02414139|537217418|FG005|Treatment Period|Adverse Event|3|||
148927282|NCT02414139|537217419|FG006|Treatment Period|Adverse Event|6|||
148927283|NCT02414139|537217420|FG007|Treatment Period|Adverse Event|1|||
148927284|NCT02414139|537217421|FG008|Treatment Period|Adverse Event|6|||
149165885|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165886|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165887|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165888|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165889|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165890|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165891|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165892|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165893|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
149165894|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165895|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165896|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
148927285|NCT02414139|537217422|FG009|Treatment Period|Adverse Event|8|||
148927286|NCT02414139|537217413|FG000|Treatment Period|Death|0|||
148927287|NCT02414139|537217414|FG001|Treatment Period|Death|0|||
148927288|NCT02414139|537217415|FG002|Treatment Period|Death|1|||
148927289|NCT02414139|537217416|FG003|Treatment Period|Death|1|||
148927290|NCT02414139|537217417|FG004|Treatment Period|Death|0|||
148927291|NCT02414139|537217418|FG005|Treatment Period|Death|0|||
148927292|NCT02414139|537217419|FG006|Treatment Period|Death|0|||
148927293|NCT02414139|537217420|FG007|Treatment Period|Death|0|||
148927294|NCT02414139|537217421|FG008|Treatment Period|Death|0|||
148927295|NCT02414139|537217422|FG009|Treatment Period|Death|1|||
148927296|NCT02414139|537217413|FG000|Treatment Period|Physician Decision|5|||
148927297|NCT02414139|537217414|FG001|Treatment Period|Physician Decision|4|||
148927298|NCT02414139|537217415|FG002|Treatment Period|Physician Decision|6|||
148927299|NCT02414139|537217416|FG003|Treatment Period|Physician Decision|1|||
149165897|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165898|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165899|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165900|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165901|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165902|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165903|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165904|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165905|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165906|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165907|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165908|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165909|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165910|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165911|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165912|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165913|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165914|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165915|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165916|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
149165917|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
148927300|NCT02414139|537217417|FG004|Treatment Period|Physician Decision|4|||
148927301|NCT02414139|537217418|FG005|Treatment Period|Physician Decision|0|||
148927302|NCT02414139|537217419|FG006|Treatment Period|Physician Decision|2|||
148927303|NCT02414139|537217420|FG007|Treatment Period|Physician Decision|0|||
149165918|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165919|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165920|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
149165921|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165922|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165923|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165924|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
148927304|NCT02414139|537217421|FG008|Treatment Period|Physician Decision|1|||
149165925|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165926|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165927|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165928|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165929|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165930|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165931|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165932|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165933|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165934|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165935|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
148927305|NCT02414139|537217422|FG009|Treatment Period|Physician Decision|4|||
148927306|NCT02414139|537217413|FG000|Treatment Period|Progressive disease|48|||
148927307|NCT02414139|537217414|FG001|Treatment Period|Progressive disease|31|||
148927308|NCT02414139|537217415|FG002|Treatment Period|Progressive disease|37|||
148927309|NCT02414139|537217416|FG003|Treatment Period|Progressive disease|21|||
148927310|NCT02414139|537217417|FG004|Treatment Period|Progressive disease|43|||
148927311|NCT02414139|537217418|FG005|Treatment Period|Progressive disease|12|||
148927312|NCT02414139|537217419|FG006|Treatment Period|Progressive disease|16|||
148927313|NCT02414139|537217420|FG007|Treatment Period|Progressive disease|2|||
149165936|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165937|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165938|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165939|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
149165940|NCT00896532|538082235|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165941|NCT00896532|538082236|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
149165942|NCT00896532|538082237|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165943|NCT00896532|538082238|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
149165944|NCT00896532|538082239|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
149165945|NCT00896532|538082240|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165946|NCT00896532|538082241|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165947|NCT00896532|538082242|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165948|NCT00896532|538082243|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165949|NCT00896532|538082244|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165950|NCT00896532|538082245|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165951|NCT00896532|538082246|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165952|NCT00896532|538082247|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165953|NCT00896532|538082248|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165954|NCT00896532|538082249|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165955|NCT00896532|538082250|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165956|NCT00896532|538082251|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165957|NCT00896532|538082252|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165958|NCT00896532|538082253|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165959|NCT00896532|538082254|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165960|NCT00896532|538082255|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165961|NCT00896532|538082256|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165962|NCT00896532|538082257|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
149165963|NCT00896532|538082235|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165964|NCT00896532|538082236|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165965|NCT00896532|538082237|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165966|NCT00896532|538082238|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165967|NCT00896532|538082239|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
148675205|NCT00391092|536282921|FG001|Overall Study|Lost to Follow-up|18|||
148675206|NCT00391092|536282920|FG000|Overall Study|Alive on treatment|29|||
148675207|NCT00391092|536282921|FG001|Overall Study|Alive on treatment|33|||
148675208|NCT00391092|536282920|FG000|Overall Study|Alive in follow-up|88|||
148675209|NCT00391092|536282921|FG001|Overall Study|Alive in follow-up|84|||
148675210|NCT00858234|536282922|FG000|Overall Study|Adverse Event|6|||
148675211|NCT00858234|536282922|FG000|Overall Study|Progressive disease|2|||
148675212|NCT00858234|536282922|FG000|Overall Study|Status unknown|1|||
148675213|NCT02428231|536282925|FG000|Overall Study|Other|10|||
148675214|NCT02428231|536282926|FG001|Overall Study|Other|16|||
148675215|NCT02428231|536282925|FG000|Overall Study|Required Symptomatic Therapy|0|||
148675216|NCT02428231|536282926|FG001|Overall Study|Required Symptomatic Therapy|1|||
148675217|NCT02428231|536282925|FG000|Overall Study|Adverse Event|3|||
148675218|NCT02428231|536282926|FG001|Overall Study|Adverse Event|0|||
148675219|NCT01652573|536282927|FG000|Overall Study|Adverse Event|0|||
148675220|NCT01652573|536282928|FG001|Overall Study|Adverse Event|1|||
148675221|NCT01052038|536282932|FG000|Overall Study|Lost to Follow-up|2|||
148675222|NCT01052038|536282933|FG001|Overall Study|Lost to Follow-up|3|||
148675223|NCT01052038|536282934|FG002|Overall Study|Lost to Follow-up|1|||
148675224|NCT01052038|536282932|FG000|Overall Study|Protocol Violation|2|||
148675225|NCT01052038|536282933|FG001|Overall Study|Protocol Violation|3|||
148675226|NCT01052038|536282934|FG002|Overall Study|Protocol Violation|3|||
148675227|NCT03901352|536282935|FG000|Double-blind Phase|Adverse Event|6|||
148675228|NCT03901352|536282936|FG001|Double-blind Phase|Adverse Event|4|||
148675229|NCT03901352|536282935|FG000|Double-blind Phase|Death|1|||
148675230|NCT03901352|536282936|FG001|Double-blind Phase|Death|0|||
148675231|NCT03901352|536282935|FG000|Double-blind Phase|Lack of Efficacy|0|||
148675232|NCT03901352|536282936|FG001|Double-blind Phase|Lack of Efficacy|1|||
149012930|NCT00675506|537525844|FG000|Overall Study|Elevated IGF-1|2|||
149012931|NCT00675506|537525845|FG001|Overall Study|Elevated IGF-1|0|||
149012932|NCT00675506|537525844|FG000|Overall Study|Hypersensitivity Reaction|1|||
149012933|NCT00675506|537525845|FG001|Overall Study|Hypersensitivity Reaction|0|||
149012934|NCT00675506|537525844|FG000|Overall Study|Disclosed history of cancer|1|||
149012935|NCT00675506|537525845|FG001|Overall Study|Disclosed history of cancer|0|||
149012936|NCT00675506|537525844|FG000|Overall Study|Declined participation|1|||
148675233|NCT03901352|536282935|FG000|Double-blind Phase|Protocol Violation|0|||
148675234|NCT03901352|536282936|FG001|Double-blind Phase|Protocol Violation|1|||
148675235|NCT03901352|536282935|FG000|Double-blind Phase|Withdrawal by Subject|10|||
148675236|NCT03901352|536282936|FG001|Double-blind Phase|Withdrawal by Subject|8|||
148675237|NCT03901352|536282935|FG000|Open-label Extension Phase|Adverse Event|24|||
148675238|NCT03901352|536282936|FG001|Open-label Extension Phase|Adverse Event|0|||
148675239|NCT03901352|536282935|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
148675240|NCT03901352|536282936|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
148675241|NCT03901352|536282935|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
148675242|NCT03901352|536282936|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
148675243|NCT03901352|536282935|FG000|Open-label Extension Phase|Other|1|||
148675244|NCT03901352|536282936|FG001|Open-label Extension Phase|Other|0|||
148675245|NCT01615822|536282939|FG000|Period 1|Withdrawal by Subject|0|||
148675246|NCT01615822|536282940|FG001|Period 1|Withdrawal by Subject|1|||
148675247|NCT01615822|536282941|FG002|Period 1|Withdrawal by Subject|0|||
148675248|NCT01615822|536282939|FG000|Period 1|Adverse Event|1|||
149012937|NCT00675506|537525845|FG001|Overall Study|Declined participation|0|||
149012938|NCT00675506|537525844|FG000|Overall Study|Schedule conflict|0|||
149012939|NCT00675506|537525845|FG001|Overall Study|Schedule conflict|1|||
149012940|NCT03151395|537525846|FG000|Overall Study|Adverse Event|2|||
149165968|NCT00896532|538082240|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165969|NCT00896532|538082241|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
148675249|NCT01615822|536282940|FG001|Period 1|Adverse Event|1|||
148675250|NCT01615822|536282941|FG002|Period 1|Adverse Event|0|||
148675251|NCT01615822|536282939|FG000|Period 2|Lost to Follow-up|0|||
148675252|NCT01615822|536282940|FG001|Period 2|Lost to Follow-up|1|||
148675253|NCT01615822|536282941|FG002|Period 2|Lost to Follow-up|2|||
148675254|NCT03901339|536282942|FG000|Overall Study|Death|220|||
148675255|NCT03901339|536282943|FG001|Overall Study|Death|192|||
148675256|NCT03901339|536282942|FG000|Overall Study|Informed consent withdrawn|13|||
149012941|NCT03151395|537525846|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
149165970|NCT00896532|538082242|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165971|NCT00896532|538082243|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
148927314|NCT02414139|537217421|FG008|Treatment Period|Progressive disease|20|||
148927315|NCT02414139|537217422|FG009|Treatment Period|Progressive disease|14|||
148927316|NCT02414139|537217413|FG000|Treatment Period|Protocol deviation|0|||
148927317|NCT02414139|537217414|FG001|Treatment Period|Protocol deviation|0|||
148927318|NCT02414139|537217415|FG002|Treatment Period|Protocol deviation|1|||
148927319|NCT02414139|537217416|FG003|Treatment Period|Protocol deviation|0|||
148927320|NCT02414139|537217417|FG004|Treatment Period|Protocol deviation|0|||
148927321|NCT02414139|537217418|FG005|Treatment Period|Protocol deviation|0|||
148927322|NCT02414139|537217419|FG006|Treatment Period|Protocol deviation|0|||
148927323|NCT02414139|537217420|FG007|Treatment Period|Protocol deviation|0|||
148927324|NCT02414139|537217421|FG008|Treatment Period|Protocol deviation|0|||
148927325|NCT02414139|537217422|FG009|Treatment Period|Protocol deviation|0|||
148927326|NCT02414139|537217413|FG000|Treatment Period|Subject/Guardian decision|5|||
148927327|NCT02414139|537217414|FG001|Treatment Period|Subject/Guardian decision|1|||
148927328|NCT02414139|537217415|FG002|Treatment Period|Subject/Guardian decision|1|||
148927329|NCT02414139|537217416|FG003|Treatment Period|Subject/Guardian decision|2|||
148927330|NCT02414139|537217417|FG004|Treatment Period|Subject/Guardian decision|5|||
148927331|NCT02414139|537217418|FG005|Treatment Period|Subject/Guardian decision|0|||
149165972|NCT00896532|538082244|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165973|NCT00896532|538082245|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165974|NCT00896532|538082246|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165975|NCT00896532|538082247|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165976|NCT00896532|538082248|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165977|NCT00896532|538082249|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165978|NCT00896532|538082250|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165979|NCT00896532|538082251|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165980|NCT00896532|538082252|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165981|NCT00896532|538082253|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165982|NCT00896532|538082254|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165983|NCT00896532|538082255|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165984|NCT00896532|538082256|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165985|NCT00896532|538082257|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
149165986|NCT00896532|538082235|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165987|NCT00896532|538082236|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165988|NCT00896532|538082237|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165989|NCT00896532|538082238|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165990|NCT00896532|538082239|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165991|NCT00896532|538082240|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165992|NCT00896532|538082241|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165993|NCT00896532|538082242|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165994|NCT00896532|538082243|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165995|NCT00896532|538082244|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165996|NCT00896532|538082245|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165997|NCT00896532|538082246|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149165998|NCT00896532|538082247|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
149165999|NCT00896532|538082248|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166000|NCT00896532|538082249|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166001|NCT00896532|538082250|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166002|NCT00896532|538082251|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166003|NCT00896532|538082252|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166004|NCT00896532|538082253|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166005|NCT00896532|538082254|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166006|NCT00896532|538082255|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166007|NCT00896532|538082256|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166008|NCT00896532|538082257|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
149166009|NCT00896532|538082235|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166010|NCT00896532|538082236|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149012942|NCT03151395|537525846|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
149012943|NCT03151395|537525846|FG000|Overall Study|Unspecified reason|4|||
149012944|NCT02494206|537525860|FG000|Overall Study|Adverse Event|1|||
149012945|NCT02494206|537525860|FG000|Overall Study|Disease Progression|1|||
149012946|NCT04986982|537525863|FG000|Overall Study|Withdrawal by Subject|3|||
149012947|NCT04986982|537525864|FG001|Overall Study|Withdrawal by Subject|1|||
149012948|NCT04986982|537525863|FG000|Overall Study|Lack of Efficacy|0|||
149012949|NCT04986982|537525864|FG001|Overall Study|Lack of Efficacy|2|||
149012950|NCT04986982|537525863|FG000|Overall Study|Ineligibility|3|||
149012951|NCT04986982|537525864|FG001|Overall Study|Ineligibility|0|||
149012952|NCT04986982|537525863|FG000|Overall Study|Adverse Event|4|||
149012953|NCT04986982|537525864|FG001|Overall Study|Adverse Event|4|||
149012954|NCT04986982|537525863|FG000|Overall Study|Lost to Follow-up|0|||
149012955|NCT04986982|537525864|FG001|Overall Study|Lost to Follow-up|1|||
149012956|NCT04986982|537525863|FG000|Overall Study|Sponsor's discretion|1|||
149012957|NCT04986982|537525864|FG001|Overall Study|Sponsor's discretion|0|||
149012958|NCT05229653|537525865|FG000|Overall Study|Lost to Follow-up|1|||
149012959|NCT05229653|537525866|FG001|Overall Study|Lost to Follow-up|0|||
149012960|NCT01845974|537525867|FG000|Overall Study|screen failure|1|||
149012961|NCT01845974|537525868|FG001|Overall Study|screen failure|0|||
149012962|NCT01103960|537525871|FG000|Overall Study|Adverse Event|2|||
149012963|NCT01103960|537525872|FG001|Overall Study|Adverse Event|1|||
149012964|NCT01103960|537525871|FG000|Overall Study|Withdrawal by Subject|2|||
149012965|NCT01103960|537525872|FG001|Overall Study|Withdrawal by Subject|1|||
149012966|NCT01103960|537525871|FG000|Overall Study|Other|1|||
149012967|NCT01103960|537525872|FG001|Overall Study|Other|0|||
149012968|NCT02294474|537525875|FG000|Overall Study|Adverse Event|7|||
149012969|NCT02294474|537525876|FG001|Overall Study|Adverse Event|7|||
149012970|NCT02294474|537525875|FG000|Overall Study|Lack of Efficacy|2|||
149012971|NCT02294474|537525876|FG001|Overall Study|Lack of Efficacy|1|||
149012972|NCT02294474|537525875|FG000|Overall Study|Protocol Violation|4|||
149012973|NCT02294474|537525876|FG001|Overall Study|Protocol Violation|2|||
149012974|NCT02294474|537525875|FG000|Overall Study|Other than specified above|12|||
149012975|NCT02294474|537525876|FG001|Overall Study|Other than specified above|12|||
149012976|NCT01338012|537525882|FG000|Overall Study|Death|4|||
149012977|NCT01338012|537525882|FG000|Overall Study|Study terminated|4|||
149012978|NCT02714205|537525883|FG000|Overall Study|Cannot tolerate medication|1|||
149012979|NCT02714205|537525884|FG001|Overall Study|Cannot tolerate medication|0|||
149012980|NCT02714205|537525883|FG000|Overall Study|Adverse Event|2|||
149012981|NCT02714205|537525884|FG001|Overall Study|Adverse Event|0|||
149012982|NCT02714205|537525883|FG000|Overall Study|Too busy|1|||
148927332|NCT02414139|537217419|FG006|Treatment Period|Subject/Guardian decision|2|||
148927333|NCT02414139|537217420|FG007|Treatment Period|Subject/Guardian decision|0|||
148927334|NCT02414139|537217421|FG008|Treatment Period|Subject/Guardian decision|1|||
148927335|NCT02414139|537217422|FG009|Treatment Period|Subject/Guardian decision|1|||
148927336|NCT02414139|537217413|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
148927337|NCT02414139|537217414|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
148927338|NCT02414139|537217415|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
148927339|NCT02414139|537217416|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
148927340|NCT02414139|537217417|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
148927341|NCT02414139|537217418|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
148927342|NCT02414139|537217419|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
148927343|NCT02414139|537217420|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
148927344|NCT02414139|537217421|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
148927345|NCT02414139|537217422|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
148927346|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
148927347|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927348|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927349|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927350|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
148927351|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927352|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927353|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927354|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927355|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148927356|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Death|0|||
148927357|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Death|1|||
148927358|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Death|0|||
148927359|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Death|0|||
148927360|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Death|1|||
148927361|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Death|0|||
148927362|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Death|0|||
148927363|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Death|0|||
148927364|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Death|0|||
148927365|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Death|1|||
148927366|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
148927367|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927368|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927369|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927370|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927371|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927372|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927373|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927374|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927375|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148927376|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
148927377|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
149012983|NCT02714205|537525884|FG001|Overall Study|Too busy|0|||
148806222|NCT04589650|536768105|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
148927378|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
148927379|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
148927380|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
148806223|NCT04589650|536768106|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
148806224|NCT04589650|536768101|FG000|Overall Study|Death|0|||
148806225|NCT04589650|536768102|FG001|Overall Study|Death|0|||
148806226|NCT04589650|536768103|FG002|Overall Study|Death|0|||
148927381|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
148806227|NCT04589650|536768104|FG003|Overall Study|Death|1|||
148806228|NCT04589650|536768105|FG004|Overall Study|Death|0|||
148806229|NCT04589650|536768106|FG005|Overall Study|Death|0|||
148806230|NCT04589650|536768101|FG000|Overall Study|Guardian Decision|0|||
148927382|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
148927383|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
148927384|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
148675257|NCT03901339|536282943|FG001|Overall Study|Informed consent withdrawn|40|||
148675258|NCT03901339|536282942|FG000|Overall Study|Sponsor request|30|||
148675259|NCT03901339|536282943|FG001|Overall Study|Sponsor request|23|||
148675260|NCT03901339|536282942|FG000|Overall Study|Reason not specified|5|||
148675261|NCT03901339|536282943|FG001|Overall Study|Reason not specified|7|||
148675262|NCT03901339|536282942|FG000|Overall Study|Lost to Follow-up|4|||
148675263|NCT03901339|536282943|FG001|Overall Study|Lost to Follow-up|7|||
148675264|NCT03901339|536282942|FG000|Overall Study|Covid19|0|||
148675265|NCT03901339|536282943|FG001|Overall Study|Covid19|2|||
148675266|NCT03981614|536282944|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
148675267|NCT03981614|536282945|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
148675268|NCT03981614|536282946|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
148675269|NCT01988337|536282949|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
148675270|NCT02742818|536282950|FG000|Overall Study|Adverse Event|0|||
148675271|NCT02742818|536282951|FG001|Overall Study|Adverse Event|1|||
148675272|NCT02742818|536282950|FG000|Overall Study|Protocol Violation|0|||
148675273|NCT02742818|536282951|FG001|Overall Study|Protocol Violation|1|||
148675274|NCT04701658|536282952|FG000|Overall Study|Lost to Follow-up|6|||
148675275|NCT01787188|536282953|FG000|Overall Study|Adverse Event|2|||
148675276|NCT01787188|536282954|FG001|Overall Study|Adverse Event|4|||
148675277|NCT01787188|536282955|FG002|Overall Study|Adverse Event|6|||
148675278|NCT01787188|536282953|FG000|Overall Study|Lack of Efficacy|7|||
148675279|NCT01787188|536282954|FG001|Overall Study|Lack of Efficacy|3|||
148675280|NCT01787188|536282955|FG002|Overall Study|Lack of Efficacy|5|||
148675281|NCT01787188|536282953|FG000|Overall Study|Non-compliance with Study Drug|0|||
148675282|NCT01787188|536282954|FG001|Overall Study|Non-compliance with Study Drug|1|||
148675283|NCT01787188|536282955|FG002|Overall Study|Non-compliance with Study Drug|0|||
148675284|NCT01787188|536282953|FG000|Overall Study|Withdrawal by Subject|4|||
148675285|NCT01787188|536282954|FG001|Overall Study|Withdrawal by Subject|3|||
148675286|NCT01787188|536282955|FG002|Overall Study|Withdrawal by Subject|2|||
148675287|NCT01787188|536282953|FG000|Overall Study|Protocol Violation|3|||
148675288|NCT01787188|536282954|FG001|Overall Study|Protocol Violation|2|||
148675289|NCT01787188|536282955|FG002|Overall Study|Protocol Violation|3|||
148675290|NCT01787188|536282953|FG000|Overall Study|Lost to Follow-up|1|||
148675291|NCT01787188|536282954|FG001|Overall Study|Lost to Follow-up|2|||
148675292|NCT01787188|536282955|FG002|Overall Study|Lost to Follow-up|2|||
148675293|NCT01787188|536282953|FG000|Overall Study|Other, including patient moved|0|||
148675294|NCT01787188|536282954|FG001|Overall Study|Other, including patient moved|3|||
148675295|NCT01787188|536282955|FG002|Overall Study|Other, including patient moved|0|||
148675296|NCT05511428|536282956|FG000|Overall Study|Withdrawal by Subject|1|||
148675297|NCT05511428|536282956|FG000|Overall Study|Adverse Event|1|||
148675298|NCT02643394|536282957|FG000|Overall Study|Protocol Violation|4|||
148675299|NCT02643394|536282958|FG001|Overall Study|Protocol Violation|5|||
148675300|NCT04088734|536282959|FG000|Overall Study|Other, Not Specified|5|||
148675301|NCT00096200|536282960|FG000|Overall Study|Adverse Event|0|||
148675302|NCT00096200|536282961|FG001|Overall Study|Adverse Event|4|||
148675303|NCT00096200|536282962|FG002|Overall Study|Adverse Event|0|||
148675304|NCT00096200|536282960|FG000|Overall Study|Withdrawal by Subject|1|||
148675305|NCT00096200|536282961|FG001|Overall Study|Withdrawal by Subject|2|||
148675306|NCT00096200|536282962|FG002|Overall Study|Withdrawal by Subject|0|||
148675307|NCT00096200|536282960|FG000|Overall Study|Ineligible pathology|0|||
148675308|NCT00096200|536282961|FG001|Overall Study|Ineligible pathology|1|||
148675309|NCT00096200|536282962|FG002|Overall Study|Ineligible pathology|0|||
148675310|NCT00835068|536282965|FG000|Overall Study|Death|1|||
148675311|NCT00835068|536282966|FG001|Overall Study|Death|0|||
148675312|NCT00835068|536282965|FG000|Overall Study|Adverse Event|0|||
148675313|NCT00835068|536282966|FG001|Overall Study|Adverse Event|1|||
148675314|NCT00835068|536282965|FG000|Overall Study|Other|8|||
148675315|NCT00835068|536282966|FG001|Overall Study|Other|0|||
148675316|NCT00835068|536282965|FG000|Overall Study|Withdrawal by Subject|1|||
148927385|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
148927386|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
148927387|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
148927388|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
148927389|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
148675317|NCT00835068|536282966|FG001|Overall Study|Withdrawal by Subject|0|||
148675318|NCT04971226|536282969|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
148927390|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
148675319|NCT04971226|536282970|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
148675320|NCT04971226|536282971|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
148675321|NCT04971226|536282972|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
148675322|NCT04971226|536282969|FG000|Overall Study|Adverse Event|6|||
148675323|NCT04971226|536282970|FG001|Overall Study|Adverse Event|5|||
148675324|NCT04971226|536282971|FG002|Overall Study|Adverse Event|11|||
148675325|NCT04971226|536282972|FG003|Overall Study|Adverse Event|10|||
148675326|NCT04971226|536282969|FG000|Overall Study|Progressive disease|2|||
149166011|NCT00896532|538082237|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166012|NCT00896532|538082238|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166013|NCT00896532|538082239|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166014|NCT00896532|538082240|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166015|NCT00896532|538082241|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166016|NCT00896532|538082242|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166017|NCT00896532|538082243|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166018|NCT00896532|538082244|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166019|NCT00896532|538082245|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
149166020|NCT00896532|538082246|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166021|NCT00896532|538082247|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
149166022|NCT00896532|538082248|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166023|NCT00896532|538082249|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166024|NCT00896532|538082250|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166025|NCT00896532|538082251|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166026|NCT00896532|538082252|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166027|NCT00896532|538082253|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166028|NCT00896532|538082254|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166029|NCT00896532|538082255|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166030|NCT00896532|538082256|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166031|NCT00896532|538082257|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
149166032|NCT00896532|538082235|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166033|NCT00896532|538082236|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166034|NCT00896532|538082237|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166035|NCT00896532|538082238|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166036|NCT00896532|538082239|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166037|NCT00896532|538082240|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166038|NCT00896532|538082241|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166039|NCT00896532|538082242|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166040|NCT00896532|538082243|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166041|NCT00896532|538082244|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166042|NCT00896532|538082245|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166043|NCT00896532|538082246|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166044|NCT00896532|538082247|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
149166045|NCT00896532|538082248|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
149166046|NCT00896532|538082249|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166047|NCT00896532|538082250|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166048|NCT00896532|538082251|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166049|NCT00896532|538082252|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166050|NCT00896532|538082253|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166051|NCT00896532|538082254|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166052|NCT00896532|538082255|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166053|NCT00896532|538082256|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166054|NCT00896532|538082257|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
149166055|NCT00896532|538082235|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
149166056|NCT00896532|538082236|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
149166057|NCT00896532|538082237|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
149166058|NCT00896532|538082238|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
149166059|NCT00896532|538082239|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
149166060|NCT00896532|538082240|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
149166061|NCT00896532|538082241|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
149166062|NCT00896532|538082242|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
149166063|NCT00896532|538082243|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
149166064|NCT00896532|538082244|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
149166065|NCT00896532|538082245|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
149166066|NCT00896532|538082246|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
149166067|NCT00896532|538082247|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
149166068|NCT00896532|538082248|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
149166069|NCT00896532|538082249|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
149166070|NCT00896532|538082250|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
149166071|NCT00896532|538082251|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
149166072|NCT00896532|538082252|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
149166073|NCT00896532|538082253|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
149166074|NCT00896532|538082254|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
149166075|NCT00896532|538082255|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
149012984|NCT02714205|537525883|FG000|Overall Study|Incomplete outcome data|0|||
149012985|NCT02714205|537525884|FG001|Overall Study|Incomplete outcome data|1|||
149012986|NCT05879198|537525885|FG000|Overall Study|Lost to Follow-up|1|||
148806231|NCT04589650|536768102|FG001|Overall Study|Guardian Decision|0|||
149012987|NCT02906683|537527758|FG000|Overall Study|Adverse Event|0|||
149012988|NCT02906683|537527759|FG001|Overall Study|Adverse Event|1|||
149012989|NCT02906683|537527760|FG002|Overall Study|Adverse Event|0|||
149166076|NCT00896532|538082256|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
149166077|NCT00896532|538082257|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
149166078|NCT00896532|538082235|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166079|NCT00896532|538082236|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166080|NCT00896532|538082237|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166081|NCT00896532|538082238|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166082|NCT00896532|538082239|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166083|NCT00896532|538082240|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166084|NCT00896532|538082241|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166085|NCT00896532|538082242|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166086|NCT00896532|538082243|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166087|NCT00896532|538082244|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166088|NCT00896532|538082245|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166089|NCT00896532|538082246|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166090|NCT00896532|538082247|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166091|NCT00896532|538082248|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166092|NCT00896532|538082249|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166093|NCT00896532|538082250|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
149166094|NCT00896532|538082251|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
149166095|NCT00896532|538082252|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166096|NCT00896532|538082253|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166097|NCT00896532|538082254|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166098|NCT00896532|538082255|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166099|NCT00896532|538082256|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166100|NCT00896532|538082257|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
149166101|NCT00896532|538082235|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166102|NCT00896532|538082236|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166103|NCT00896532|538082237|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166104|NCT00896532|538082238|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166105|NCT00896532|538082239|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166106|NCT00896532|538082240|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166107|NCT00896532|538082241|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166108|NCT00896532|538082242|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166109|NCT00896532|538082243|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166110|NCT00896532|538082244|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166111|NCT00896532|538082245|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166112|NCT00896532|538082246|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166113|NCT00896532|538082247|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166114|NCT00896532|538082248|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166115|NCT00896532|538082249|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166116|NCT00896532|538082250|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
149166117|NCT00896532|538082251|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
149166118|NCT00896532|538082252|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
149166119|NCT00896532|538082253|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166120|NCT00896532|538082254|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166121|NCT00896532|538082255|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166122|NCT00896532|538082256|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166123|NCT00896532|538082257|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
149166124|NCT00896532|538082235|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166125|NCT00896532|538082236|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166126|NCT00896532|538082237|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166127|NCT00896532|538082238|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166128|NCT00896532|538082239|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166129|NCT00896532|538082240|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166130|NCT00896532|538082241|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166131|NCT00896532|538082242|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149012990|NCT02906683|537527758|FG000|Overall Study|Physician Decision|0|||
149012991|NCT02906683|537527759|FG001|Overall Study|Physician Decision|1|||
149012992|NCT02906683|537527760|FG002|Overall Study|Physician Decision|1|||
148806232|NCT04589650|536768103|FG002|Overall Study|Guardian Decision|0|||
148806233|NCT04589650|536768104|FG003|Overall Study|Guardian Decision|1|||
148806234|NCT04589650|536768105|FG004|Overall Study|Guardian Decision|0|||
148806235|NCT04589650|536768106|FG005|Overall Study|Guardian Decision|0|||
148675327|NCT04971226|536282970|FG001|Overall Study|Progressive disease|0|||
148675328|NCT04971226|536282971|FG002|Overall Study|Progressive disease|3|||
148675329|NCT04971226|536282972|FG003|Overall Study|Progressive disease|1|||
148675330|NCT04971226|536282969|FG000|Overall Study|Protocol Deviation|1|||
148675331|NCT04971226|536282970|FG001|Overall Study|Protocol Deviation|0|||
148675332|NCT04971226|536282971|FG002|Overall Study|Protocol Deviation|1|||
148675333|NCT04971226|536282972|FG003|Overall Study|Protocol Deviation|1|||
148675334|NCT04971226|536282969|FG000|Overall Study|Subject Decision|0|||
148675335|NCT04971226|536282970|FG001|Overall Study|Subject Decision|1|||
148927391|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
148927392|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
148927393|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
148927394|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
148675336|NCT04971226|536282971|FG002|Overall Study|Subject Decision|1|||
148675337|NCT04971226|536282972|FG003|Overall Study|Subject Decision|1|||
148675338|NCT04971226|536282969|FG000|Overall Study|Pregnancy|0|||
148675339|NCT04971226|536282970|FG001|Overall Study|Pregnancy|0|||
148675340|NCT04971226|536282971|FG002|Overall Study|Pregnancy|0|||
148675341|NCT04971226|536282972|FG003|Overall Study|Pregnancy|1|||
148675342|NCT04971226|536282969|FG000|Overall Study|Participants not treated|1|||
148675343|NCT04971226|536282970|FG001|Overall Study|Participants not treated|0|||
148675344|NCT04971226|536282971|FG002|Overall Study|Participants not treated|2|||
148675345|NCT04971226|536282972|FG003|Overall Study|Participants not treated|1|||
148675346|NCT04439149|536282973|FG000|Overall Study|Ineligible|1|||
148675347|NCT04439149|536282973|FG000|Overall Study|Never start protocol therapy|1|||
148675348|NCT04439149|536282973|FG000|Overall Study|Adverse Event|4|||
148675349|NCT04439149|536282973|FG000|Overall Study|Disease Progression|14|||
148675350|NCT04439149|536282973|FG000|Overall Study|Complicating disease|1|||
148675351|NCT04439149|536282973|FG000|Overall Study|Withdrawal by Subject|3|||
148675352|NCT05264506|536282976|FG000|Overall Study|Adverse Event|59|||
148675353|NCT05264506|536282976|FG000|Overall Study|Lost to Follow-up|204|||
148675354|NCT05264506|536282976|FG000|Overall Study|Protocol Violation|185|||
148675355|NCT05264506|536282976|FG000|Overall Study|Pregnancy|60|||
148675356|NCT05264506|536282976|FG000|Overall Study|Physician Decision|6|||
148675357|NCT05264506|536282976|FG000|Overall Study|Non-compliance with Study Drug|29|||
148675358|NCT05264506|536282976|FG000|Overall Study|Study termination|677|||
148675359|NCT05264506|536282976|FG000|Overall Study|Withdrawal by Subject|208|||
148675360|NCT05264506|536282976|FG000|Overall Study|Discontinued prior treatment|89|||
148675361|NCT02032823|536282984|FG000|Overall Study|Death|75|||
148675362|NCT02032823|536282985|FG001|Overall Study|Death|109|||
148675363|NCT02032823|536282984|FG000|Overall Study|Lost to Follow-up|18|||
148675364|NCT02032823|536282985|FG001|Overall Study|Lost to Follow-up|17|||
148675365|NCT02032823|536282984|FG000|Overall Study|Withdrawal by Subject|70|||
148675366|NCT02032823|536282985|FG001|Overall Study|Withdrawal by Subject|53|||
148675367|NCT02032823|536282984|FG000|Overall Study|Ongoing study at data cut-off|755|||
148675368|NCT02032823|536282985|FG001|Overall Study|Ongoing study at data cut-off|731|||
148675369|NCT02032823|536282984|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
148675370|NCT02032823|536282985|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
148675371|NCT05919823|536282986|FG000|Pre-Treatment Period|Screen failure|1|||
148675372|NCT05919823|536282987|FG001|Pre-Treatment Period|Screen failure|0|||
148675373|NCT05919823|536282988|FG002|Pre-Treatment Period|Screen failure|0|||
148675374|NCT05919823|536282989|FG003|Pre-Treatment Period|Screen failure|0|||
148675375|NCT05919823|536282986|FG000|Pre-Treatment Period|Protocol Violation|0|||
148675376|NCT05919823|536282987|FG001|Pre-Treatment Period|Protocol Violation|1|||
148675377|NCT05919823|536282988|FG002|Pre-Treatment Period|Protocol Violation|0|||
148675378|NCT05919823|536282989|FG003|Pre-Treatment Period|Protocol Violation|0|||
148675379|NCT05919823|536282986|FG000|Double-Blind Period|Adverse Event|8|||
148927395|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
148927396|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927397|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
148927398|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927399|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148675380|NCT05919823|536282987|FG001|Double-Blind Period|Adverse Event|9|||
148675381|NCT05919823|536282988|FG002|Double-Blind Period|Adverse Event|0|||
148675382|NCT05919823|536282989|FG003|Double-Blind Period|Adverse Event|0|||
148675383|NCT05919823|536282986|FG000|Double-Blind Period|Protocol Violation|2|||
148675384|NCT05919823|536282987|FG001|Double-Blind Period|Protocol Violation|1|||
148675385|NCT05919823|536282988|FG002|Double-Blind Period|Protocol Violation|0|||
148675386|NCT05919823|536282989|FG003|Double-Blind Period|Protocol Violation|0|||
148675387|NCT05919823|536282986|FG000|Double-Blind Period|Participant withdrew consent|11|||
148806236|NCT01294046|536768923|FG000|Overall Study|Infection and surgical explant|1|||
148675388|NCT05919823|536282987|FG001|Double-Blind Period|Participant withdrew consent|7|||
148675389|NCT05919823|536282988|FG002|Double-Blind Period|Participant withdrew consent|0|||
148675390|NCT05919823|536282989|FG003|Double-Blind Period|Participant withdrew consent|0|||
148927400|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927401|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927402|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927403|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927404|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
148927405|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
148927406|NCT02414139|537217413|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
148927407|NCT02414139|537217414|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
148675391|NCT05919823|536282986|FG000|Double-Blind Period|Other reasons|2|||
149012993|NCT02906683|537527758|FG000|Overall Study|Withdrawal by Subject|0|||
148675392|NCT05919823|536282987|FG001|Double-Blind Period|Other reasons|3|||
148675393|NCT05919823|536282988|FG002|Double-Blind Period|Other reasons|0|||
148675394|NCT05919823|536282989|FG003|Double-Blind Period|Other reasons|0|||
148675395|NCT05919823|536282986|FG000|Open Label Period|Adverse Event|0|||
148675396|NCT05919823|536282987|FG001|Open Label Period|Adverse Event|0|||
148675397|NCT05919823|536282988|FG002|Open Label Period|Adverse Event|2|||
149166132|NCT00896532|538082243|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166133|NCT00896532|538082244|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166134|NCT00896532|538082245|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166135|NCT00896532|538082246|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166136|NCT00896532|538082247|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166137|NCT00896532|538082248|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166138|NCT00896532|538082249|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166139|NCT00896532|538082250|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166140|NCT00896532|538082251|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
149166141|NCT00896532|538082252|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166142|NCT00896532|538082253|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166143|NCT00896532|538082254|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166144|NCT00896532|538082255|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166145|NCT00896532|538082256|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166146|NCT00896532|538082257|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
149166147|NCT00896532|538082235|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
149166148|NCT00896532|538082236|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
149166149|NCT00896532|538082237|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
149166150|NCT00896532|538082238|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
149166151|NCT00896532|538082239|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
149166152|NCT00896532|538082240|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
149166153|NCT00896532|538082241|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
149166154|NCT00896532|538082242|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
149166155|NCT00896532|538082243|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
149166156|NCT00896532|538082244|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
149166157|NCT00896532|538082245|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
149166158|NCT00896532|538082246|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
149166159|NCT00896532|538082247|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
149166160|NCT00896532|538082248|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
149166161|NCT00896532|538082249|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
149166162|NCT00896532|538082250|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
149166163|NCT00896532|538082251|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
149166164|NCT00896532|538082252|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
149166165|NCT00896532|538082253|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
149166166|NCT00896532|538082254|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
149166167|NCT00896532|538082255|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
149166168|NCT00896532|538082256|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
149166169|NCT00896532|538082257|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
149166170|NCT00896532|538082235|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166171|NCT00896532|538082236|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166172|NCT00896532|538082237|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166173|NCT00896532|538082238|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166174|NCT00896532|538082239|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166175|NCT00896532|538082240|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166176|NCT00896532|538082241|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166177|NCT00896532|538082242|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166178|NCT00896532|538082243|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
148675398|NCT05919823|536282989|FG003|Open Label Period|Adverse Event|4|||
148675399|NCT05919823|536282986|FG000|Open Label Period|Lost to Follow-up|0|||
148675400|NCT05919823|536282987|FG001|Open Label Period|Lost to Follow-up|0|||
149012994|NCT02906683|537527759|FG001|Overall Study|Withdrawal by Subject|2|||
149012995|NCT02906683|537527760|FG002|Overall Study|Withdrawal by Subject|1|||
149012996|NCT02906683|537527758|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
149166179|NCT00896532|538082244|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
148675401|NCT05919823|536282988|FG002|Open Label Period|Lost to Follow-up|1|||
148675402|NCT05919823|536282989|FG003|Open Label Period|Lost to Follow-up|0|||
148675403|NCT05919823|536282986|FG000|Open Label Period|Protocol Violation|0|||
149166180|NCT00896532|538082245|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166181|NCT00896532|538082246|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166182|NCT00896532|538082247|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166183|NCT00896532|538082248|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166184|NCT00896532|538082249|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166185|NCT00896532|538082250|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166186|NCT00896532|538082251|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
149166187|NCT00896532|538082252|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166188|NCT00896532|538082253|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166189|NCT00896532|538082254|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166190|NCT00896532|538082255|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166191|NCT00896532|538082256|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166192|NCT00896532|538082257|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
149166193|NCT00896532|538082235|FG000|Months 48-72: Follow-on Phase|Death|0|||
149166194|NCT00896532|538082236|FG001|Months 48-72: Follow-on Phase|Death|0|||
149166195|NCT00896532|538082237|FG002|Months 48-72: Follow-on Phase|Death|0|||
149166196|NCT00896532|538082238|FG003|Months 48-72: Follow-on Phase|Death|0|||
149166197|NCT00896532|538082239|FG004|Months 48-72: Follow-on Phase|Death|0|||
149166198|NCT00896532|538082240|FG005|Months 48-72: Follow-on Phase|Death|0|||
149166199|NCT00896532|538082241|FG006|Months 48-72: Follow-on Phase|Death|0|||
149166200|NCT00896532|538082242|FG007|Months 48-72: Follow-on Phase|Death|0|||
149166201|NCT00896532|538082243|FG008|Months 48-72: Follow-on Phase|Death|0|||
149166202|NCT00896532|538082244|FG009|Months 48-72: Follow-on Phase|Death|0|||
149166203|NCT00896532|538082245|FG010|Months 48-72: Follow-on Phase|Death|0|||
149166204|NCT00896532|538082246|FG011|Months 48-72: Follow-on Phase|Death|0|||
149166205|NCT00896532|538082247|FG012|Months 48-72: Follow-on Phase|Death|0|||
149166206|NCT00896532|538082248|FG013|Months 48-72: Follow-on Phase|Death|0|||
149166207|NCT00896532|538082249|FG014|Months 48-72: Follow-on Phase|Death|0|||
149166208|NCT00896532|538082250|FG015|Months 48-72: Follow-on Phase|Death|0|||
149166209|NCT00896532|538082251|FG016|Months 48-72: Follow-on Phase|Death|0|||
149166210|NCT00896532|538082252|FG017|Months 48-72: Follow-on Phase|Death|0|||
149166211|NCT00896532|538082253|FG018|Months 48-72: Follow-on Phase|Death|1|||
149166212|NCT00896532|538082254|FG019|Months 48-72: Follow-on Phase|Death|0|||
149166213|NCT00896532|538082255|FG020|Months 48-72: Follow-on Phase|Death|0|||
149166214|NCT00896532|538082256|FG021|Months 48-72: Follow-on Phase|Death|0|||
149166215|NCT00896532|538082257|FG022|Months 48-72: Follow-on Phase|Death|0|||
149166216|NCT00896532|538082235|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166217|NCT00896532|538082236|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
148927408|NCT02414139|537217415|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
149166218|NCT00896532|538082237|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166219|NCT00896532|538082238|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166220|NCT00896532|538082239|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166221|NCT00896532|538082240|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166222|NCT00896532|538082241|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166223|NCT00896532|538082242|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166224|NCT00896532|538082243|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166225|NCT00896532|538082244|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166226|NCT00896532|538082245|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166227|NCT00896532|538082246|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166228|NCT00896532|538082247|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166229|NCT00896532|538082248|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166230|NCT00896532|538082249|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166231|NCT00896532|538082250|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166232|NCT00896532|538082251|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166233|NCT00896532|538082252|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166234|NCT00896532|538082253|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166235|NCT00896532|538082254|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166236|NCT00896532|538082255|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166237|NCT00896532|538082256|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
149166238|NCT00896532|538082257|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
149166239|NCT00896532|538082235|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166240|NCT00896532|538082236|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166241|NCT00896532|538082237|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166242|NCT00896532|538082238|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166243|NCT00896532|538082239|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
148927409|NCT02414139|537217416|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
149166244|NCT00896532|538082240|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166245|NCT00896532|538082241|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166246|NCT00896532|538082242|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166247|NCT00896532|538082243|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166248|NCT00896532|538082244|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166249|NCT00896532|538082245|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166250|NCT00896532|538082246|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166251|NCT00896532|538082247|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166252|NCT00896532|538082248|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166253|NCT00896532|538082249|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166254|NCT00896532|538082250|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166255|NCT00896532|538082251|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166256|NCT00896532|538082252|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166257|NCT00896532|538082253|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166258|NCT00896532|538082254|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166259|NCT00896532|538082255|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166260|NCT00896532|538082256|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
148927410|NCT02414139|537217417|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
149166261|NCT00896532|538082257|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
149166262|NCT01671280|538082258|FG000|Overall Study|Withdrawal by Subject|2|||
149166263|NCT01959165|538082259|FG000|Overall Study|Adverse Event|0|||
149166264|NCT01959165|538082260|FG001|Overall Study|Adverse Event|0|||
149166265|NCT01959165|538082261|FG002|Overall Study|Adverse Event|0|||
149166266|NCT01959165|538082262|FG003|Overall Study|Adverse Event|1|||
149166267|NCT01959165|538082259|FG000|Overall Study|Lack of Efficacy|1|||
149166268|NCT01959165|538082260|FG001|Overall Study|Lack of Efficacy|0|||
149166269|NCT01959165|538082261|FG002|Overall Study|Lack of Efficacy|0|||
149166270|NCT01959165|538082262|FG003|Overall Study|Lack of Efficacy|0|||
149166271|NCT01959165|538082259|FG000|Overall Study|overdose|0|||
149166272|NCT01959165|538082260|FG001|Overall Study|overdose|0|||
149166273|NCT01959165|538082261|FG002|Overall Study|overdose|0|||
149166274|NCT01959165|538082262|FG003|Overall Study|overdose|1|||
149166275|NCT01959165|538082259|FG000|Overall Study|Welfare recipient|0|||
149166276|NCT01959165|538082260|FG001|Overall Study|Welfare recipient|1|||
149166277|NCT01959165|538082261|FG002|Overall Study|Welfare recipient|0|||
149166278|NCT01959165|538082262|FG003|Overall Study|Welfare recipient|0|||
149166279|NCT03686969|538082263|FG000|Overall Study|Study terminated|1|||
149166280|NCT03686969|538082264|FG001|Overall Study|Study terminated|0|||
149166281|NCT02899156|538082265|FG000|Overall Study|Death|1|||
149166282|NCT02899156|538082266|FG001|Overall Study|Death|0|||
149166283|NCT02899156|538082265|FG000|Overall Study|Physician Decision|0|||
149166284|NCT02899156|538082266|FG001|Overall Study|Physician Decision|1|||
149166285|NCT00787787|538082267|FG000|Overall Study|Lack of Efficacy|4|||
149166286|NCT00787787|538082267|FG000|Overall Study|Adverse Event|3|||
149166287|NCT01468987|538082268|FG000|Overall Study|Adverse Event|12|||
149166288|NCT01468987|538082269|FG001|Overall Study|Adverse Event|9|||
149166289|NCT01468987|538082268|FG000|Overall Study|Death|4|||
149166290|NCT01468987|538082269|FG001|Overall Study|Death|1|||
149166291|NCT01468987|538082268|FG000|Overall Study|Lost to Follow-up|10|||
149166292|NCT01468987|538082269|FG001|Overall Study|Lost to Follow-up|5|||
149166293|NCT01468987|538082268|FG000|Overall Study|Protocol Violation|8|||
149166294|NCT01468987|538082269|FG001|Overall Study|Protocol Violation|2|||
149166295|NCT01468987|538082268|FG000|Overall Study|Withdrawal by Subject|28|||
149166296|NCT01468987|538082269|FG001|Overall Study|Withdrawal by Subject|28|||
149166297|NCT01468987|538082268|FG000|Overall Study|Physician Decision|8|||
149166298|NCT01468987|538082269|FG001|Overall Study|Physician Decision|15|||
149166299|NCT01468987|538082268|FG000|Overall Study|Sponsor Decision|1|||
149166300|NCT01468987|538082269|FG001|Overall Study|Sponsor Decision|0|||
149166301|NCT03430986|538082270|FG000|24-week Control Period|Adverse Event|1|||
149166302|NCT03430986|538082271|FG001|24-week Control Period|Adverse Event|0|||
149166303|NCT03430986|538082270|FG000|24-week Control Period|Lost to Follow-up|2|||
149166304|NCT03430986|538082271|FG001|24-week Control Period|Lost to Follow-up|2|||
149166305|NCT03430986|538082270|FG000|24-week Control Period|Withdrawal by Participant|5|||
149166306|NCT03430986|538082271|FG001|24-week Control Period|Withdrawal by Participant|0|||
149166307|NCT03430986|538082270|FG000|24-week Control Period|Protocol Deviation|0|||
149166308|NCT03430986|538082271|FG001|24-week Control Period|Protocol Deviation|2|||
149166309|NCT03430986|538082270|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
149166310|NCT03430986|538082271|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
149166311|NCT03430986|538082270|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
149166312|NCT03430986|538082271|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
149166313|NCT02116621|538082275|FG000|Baseline|Withdrawal by Subject|0|||
149166314|NCT02116621|538082276|FG001|Baseline|Withdrawal by Subject|4|||
149166315|NCT02116621|538082275|FG000|Three Month Follow-up|Death|1|||
149166316|NCT02116621|538082276|FG001|Three Month Follow-up|Death|1|||
149166317|NCT02116621|538082275|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
148675404|NCT05919823|536282987|FG001|Open Label Period|Protocol Violation|0|||
148675405|NCT05919823|536282988|FG002|Open Label Period|Protocol Violation|0|||
148675406|NCT05919823|536282989|FG003|Open Label Period|Protocol Violation|1|||
148675407|NCT05919823|536282986|FG000|Open Label Period|Participant withdrew consent|0|||
148675408|NCT05919823|536282987|FG001|Open Label Period|Participant withdrew consent|0|||
148675409|NCT05919823|536282988|FG002|Open Label Period|Participant withdrew consent|8|||
148675410|NCT05919823|536282989|FG003|Open Label Period|Participant withdrew consent|6|||
148675411|NCT05919823|536282986|FG000|Open Label Period|Death|0|||
148675412|NCT05919823|536282987|FG001|Open Label Period|Death|0|||
148675413|NCT05919823|536282988|FG002|Open Label Period|Death|0|||
148675414|NCT05919823|536282989|FG003|Open Label Period|Death|1|||
148675415|NCT05919823|536282986|FG000|Open Label Period|Other reasons|0|||
148675416|NCT05919823|536282987|FG001|Open Label Period|Other reasons|0|||
148675417|NCT05919823|536282988|FG002|Open Label Period|Other reasons|9|||
148675418|NCT05919823|536282989|FG003|Open Label Period|Other reasons|5|||
148675419|NCT04521608|536282990|FG000|Overall Study|Death|8|||
148675420|NCT04521608|536282991|FG001|Overall Study|Death|9|||
148675421|NCT04521608|536282990|FG000|Overall Study|Withdrawal by Subject|25|||
148675422|NCT04521608|536282991|FG001|Overall Study|Withdrawal by Subject|18|||
148675423|NCT04521608|536282990|FG000|Overall Study|Disease Progression|3|||
148675424|NCT04521608|536282991|FG001|Overall Study|Disease Progression|10|||
148675425|NCT04521608|536282990|FG000|Overall Study|Complicating Disease|6|||
148675426|NCT04521608|536282991|FG001|Overall Study|Complicating Disease|3|||
148675427|NCT04521608|536282990|FG000|Overall Study|Lost Contact|25|||
148675428|NCT04521608|536282991|FG001|Overall Study|Lost Contact|27|||
148675429|NCT04521608|536282990|FG000|Overall Study|Ineligible|1|||
148675430|NCT04521608|536282991|FG001|Overall Study|Ineligible|0|||
148675431|NCT04521608|536282990|FG000|Overall Study|Refused Further Study Participation|13|||
148675432|NCT04521608|536282991|FG001|Overall Study|Refused Further Study Participation|7|||
148675433|NCT02588651|536282992|FG000|Overall Study|Adverse Event|1|||
148675434|NCT02588651|536282992|FG000|Overall Study|Withdrawal by Subject|2|||
148675435|NCT02588651|536282992|FG000|Overall Study|Death|1|||
148675436|NCT02588651|536282992|FG000|Overall Study|Lack of Efficacy|13|||
148675437|NCT02588651|536282992|FG000|Overall Study|Lost to Follow-up|1|||
148675438|NCT02588651|536282992|FG000|Overall Study|Physician Decision|1|||
148675439|NCT02588651|536282992|FG000|Overall Study|Disease progression|2|||
148675440|NCT04083378|536282995|FG000|Overall Study|Death|18|||
148675441|NCT04083378|536282996|FG001|Overall Study|Death|4|||
148675442|NCT04083378|536282995|FG000|Overall Study|Lost to Follow-up|4|||
149166318|NCT02116621|538082276|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
149166319|NCT02116621|538082275|FG000|Three Month Follow-up|Lost to Follow-up|0|||
149166320|NCT02116621|538082276|FG001|Three Month Follow-up|Lost to Follow-up|1|||
149166321|NCT02116621|538082275|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
149166322|NCT02116621|538082276|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
148675443|NCT04083378|536282996|FG001|Overall Study|Lost to Follow-up|0|||
148675444|NCT04803214|536282997|FG000|Overall Study|Adverse Event|1|||
148675445|NCT04803214|536282998|FG001|Overall Study|Adverse Event|0|||
148675446|NCT04803214|536282997|FG000|Overall Study|Withdrawal by Subject|1|||
149166323|NCT02116621|538082275|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
149166324|NCT02116621|538082276|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
148675447|NCT04803214|536282998|FG001|Overall Study|Withdrawal by Subject|2|||
148675448|NCT04803214|536282997|FG000|Overall Study|Lost to Follow-up|2|||
148675449|NCT04803214|536282998|FG001|Overall Study|Lost to Follow-up|4|||
149166325|NCT02116621|538082275|FG000|Six Month Follow-up|Lost to Follow-up|2|||
149166326|NCT02116621|538082276|FG001|Six Month Follow-up|Lost to Follow-up|1|||
148675450|NCT04803214|536282997|FG000|Overall Study|Physician Decision|1|||
148675451|NCT04803214|536282998|FG001|Overall Study|Physician Decision|1|||
148675452|NCT04803214|536282997|FG000|Overall Study|Missed 12 month visit|0|||
148675453|NCT04803214|536282998|FG001|Overall Study|Missed 12 month visit|3|||
148675454|NCT00644228|536282999|FG000|Randomization & Eligibility|Ineligible|31|||
148675455|NCT00644228|536283000|FG001|Randomization & Eligibility|Ineligible|21|||
148675456|NCT00644228|536282999|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
148675457|NCT00644228|536283000|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
148675458|NCT00644228|536282999|FG000|Randomization & Eligibility|Invalid Consent|0|||
149166327|NCT02116621|538082275|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
149166328|NCT02116621|538082276|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
149166329|NCT02116621|538082275|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
149166330|NCT02116621|538082276|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
149166331|NCT02116621|538082275|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
149166332|NCT02116621|538082276|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
149166333|NCT02116621|538082275|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
149166334|NCT02116621|538082276|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
149166335|NCT02116621|538082275|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
149166336|NCT02116621|538082276|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
149166337|NCT01412957|538082277|FG000|Overall Study|Withdrawal by Subject|6|||
149166338|NCT01412957|538082278|FG001|Overall Study|Withdrawal by Subject|22|||
149166339|NCT01412957|538082277|FG000|Overall Study|Lost to Follow-up|7|||
149166340|NCT01412957|538082278|FG001|Overall Study|Lost to Follow-up|2|||
149166341|NCT01412957|538082277|FG000|Overall Study|Death|136|||
149166342|NCT01412957|538082278|FG001|Overall Study|Death|133|||
149166343|NCT00484315|538082279|FG000|12-Month Clinical Follow-up|Death|6|||
149166344|NCT00484315|538082280|FG001|12-Month Clinical Follow-up|Death|2|||
149166345|NCT00484315|538082279|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
149166346|NCT00484315|538082280|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
149166347|NCT00484315|538082279|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
149166348|NCT00484315|538082280|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
149166349|NCT00484315|538082279|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
149166350|NCT00484315|538082280|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
149166351|NCT00484315|538082279|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
149166352|NCT00484315|538082280|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
149166353|NCT00484315|538082279|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
149166354|NCT00484315|538082280|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
149166355|NCT00484315|538082279|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
149166356|NCT00484315|538082280|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
149166357|NCT00943683|538082281|FG000|Overall Study|Adverse Event|3|||
149166358|NCT00943683|538082282|FG001|Overall Study|Adverse Event|3|||
149166359|NCT00943683|538082281|FG000|Overall Study|Lost to Follow-up|1|||
149166360|NCT00943683|538082282|FG001|Overall Study|Lost to Follow-up|1|||
149166361|NCT00943683|538082281|FG000|Overall Study|Protocol Violation|1|||
149166362|NCT00943683|538082282|FG001|Overall Study|Protocol Violation|2|||
149166363|NCT00943683|538082281|FG000|Overall Study|Withdrawal by Subject|1|||
149166364|NCT00943683|538082282|FG001|Overall Study|Withdrawal by Subject|0|||
149166365|NCT00943683|538082281|FG000|Overall Study|Patient Moved|1|||
149166366|NCT00943683|538082282|FG001|Overall Study|Patient Moved|0|||
149166367|NCT03283085|538082301|FG000|Overall Study|Adverse Event|18|||
149166368|NCT03283085|538082302|FG001|Overall Study|Adverse Event|3|||
149166369|NCT03283085|538082303|FG002|Overall Study|Adverse Event|13|||
149166370|NCT03283085|538082304|FG003|Overall Study|Adverse Event|0|||
149166371|NCT03283085|538082305|FG004|Overall Study|Adverse Event|0|||
149166372|NCT03283085|538082306|FG005|Overall Study|Adverse Event|5|||
149166373|NCT03283085|538082301|FG000|Overall Study|Death|0|||
149166374|NCT03283085|538082302|FG001|Overall Study|Death|0|||
149166375|NCT03283085|538082303|FG002|Overall Study|Death|3|||
149166376|NCT03283085|538082304|FG003|Overall Study|Death|1|||
148927411|NCT02414139|537217418|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
148927412|NCT02414139|537217419|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
149166377|NCT03283085|538082305|FG004|Overall Study|Death|0|||
149166378|NCT03283085|538082306|FG005|Overall Study|Death|0|||
149166379|NCT03283085|538082301|FG000|Overall Study|Withdrawal by Subject|42|||
149166380|NCT03283085|538082302|FG001|Overall Study|Withdrawal by Subject|21|||
149166381|NCT03283085|538082303|FG002|Overall Study|Withdrawal by Subject|66|||
149166382|NCT03283085|538082304|FG003|Overall Study|Withdrawal by Subject|3|||
149166383|NCT03283085|538082305|FG004|Overall Study|Withdrawal by Subject|3|||
149166384|NCT03283085|538082306|FG005|Overall Study|Withdrawal by Subject|5|||
149166385|NCT03283085|538082301|FG000|Overall Study|Physician Decision|14|||
149166386|NCT03283085|538082302|FG001|Overall Study|Physician Decision|8|||
149166387|NCT03283085|538082303|FG002|Overall Study|Physician Decision|19|||
148927413|NCT02414139|537217420|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
149166388|NCT03283085|538082304|FG003|Overall Study|Physician Decision|0|||
149166389|NCT03283085|538082305|FG004|Overall Study|Physician Decision|0|||
149166390|NCT03283085|538082306|FG005|Overall Study|Physician Decision|2|||
149166391|NCT03283085|538082301|FG000|Overall Study|Site Terminated by Sponsor|1|||
149166392|NCT03283085|538082302|FG001|Overall Study|Site Terminated by Sponsor|0|||
148927414|NCT02414139|537217421|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
149166393|NCT03283085|538082303|FG002|Overall Study|Site Terminated by Sponsor|3|||
149166394|NCT03283085|538082304|FG003|Overall Study|Site Terminated by Sponsor|0|||
149166395|NCT03283085|538082305|FG004|Overall Study|Site Terminated by Sponsor|0|||
149166396|NCT03283085|538082306|FG005|Overall Study|Site Terminated by Sponsor|0|||
148927415|NCT02414139|537217422|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
148927416|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
148927417|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
148927418|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
148927419|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
148927420|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
148927421|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
148927422|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
148927423|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
148927424|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
149166397|NCT03283085|538082301|FG000|Overall Study|Lost to Follow-up|2|||
149166398|NCT03283085|538082302|FG001|Overall Study|Lost to Follow-up|0|||
149166399|NCT03283085|538082303|FG002|Overall Study|Lost to Follow-up|2|||
149166400|NCT03283085|538082304|FG003|Overall Study|Lost to Follow-up|0|||
149166401|NCT03283085|538082305|FG004|Overall Study|Lost to Follow-up|0|||
149166402|NCT03283085|538082306|FG005|Overall Study|Lost to Follow-up|1|||
149166403|NCT03283085|538082301|FG000|Overall Study|Pregnancy|0|||
149166404|NCT03283085|538082302|FG001|Overall Study|Pregnancy|0|||
149166405|NCT03283085|538082303|FG002|Overall Study|Pregnancy|1|||
149166406|NCT03283085|538082304|FG003|Overall Study|Pregnancy|0|||
149166407|NCT03283085|538082305|FG004|Overall Study|Pregnancy|0|||
149166408|NCT03283085|538082306|FG005|Overall Study|Pregnancy|0|||
149166409|NCT03283085|538082301|FG000|Overall Study|Lack of Efficacy|12|||
149166410|NCT03283085|538082302|FG001|Overall Study|Lack of Efficacy|6|||
149166411|NCT03283085|538082303|FG002|Overall Study|Lack of Efficacy|24|||
149166412|NCT03283085|538082304|FG003|Overall Study|Lack of Efficacy|1|||
149166413|NCT03283085|538082305|FG004|Overall Study|Lack of Efficacy|1|||
149166414|NCT03283085|538082306|FG005|Overall Study|Lack of Efficacy|0|||
149166415|NCT03283085|538082301|FG000|Overall Study|Reason not Specified|0|||
149166416|NCT03283085|538082302|FG001|Overall Study|Reason not Specified|4|||
149166417|NCT03283085|538082303|FG002|Overall Study|Reason not Specified|8|||
149166418|NCT03283085|538082304|FG003|Overall Study|Reason not Specified|0|||
149166419|NCT03283085|538082305|FG004|Overall Study|Reason not Specified|0|||
149166420|NCT03283085|538082306|FG005|Overall Study|Reason not Specified|1|||
149166421|NCT02292771|538082307|FG000|Overall Study|Withdrawal by Subject|2|||
149166422|NCT02292771|538082308|FG001|Overall Study|Withdrawal by Subject|1|||
149166423|NCT02292771|538082307|FG000|Overall Study|Lost to Follow-up|2|||
149166424|NCT02292771|538082308|FG001|Overall Study|Lost to Follow-up|1|||
149166425|NCT01468311|538082309|FG000|Overall Study|mobilization failure|1|||
149166426|NCT01468311|538082309|FG000|Overall Study|Withdrawal by Subject|1|||
149166427|NCT05047523|538084297|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149166428|NCT05047523|538084298|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149166429|NCT05047523|538084299|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
149166430|NCT05047523|538084300|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149166431|NCT05047523|538084301|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149166432|NCT05047523|538084302|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
149166433|NCT05047523|538084297|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149166434|NCT05047523|538084298|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
149166435|NCT05047523|538084299|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149166436|NCT05047523|538084300|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149166437|NCT05047523|538084301|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149166438|NCT05047523|538084302|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
149166439|NCT05047523|538084297|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
149166440|NCT05047523|538084298|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
149166441|NCT05047523|538084299|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
149166442|NCT05047523|538084300|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
149166443|NCT05047523|538084301|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
149166444|NCT05047523|538084302|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
149166445|NCT05047523|538084297|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
149166446|NCT05047523|538084298|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149166447|NCT05047523|538084299|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149166448|NCT05047523|538084300|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149166449|NCT05047523|538084301|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149166450|NCT05047523|538084302|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
149166451|NCT05047523|538084297|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149166452|NCT05047523|538084298|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149166453|NCT05047523|538084299|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149166454|NCT05047523|538084300|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
149166455|NCT05047523|538084301|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
149166456|NCT05047523|538084302|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
149166457|NCT05047523|538084297|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
149166458|NCT05047523|538084298|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
148675459|NCT00644228|536283000|FG001|Randomization & Eligibility|Invalid Consent|1|||
149166459|NCT05047523|538084299|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
149166460|NCT05047523|538084300|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
149166461|NCT05047523|538084301|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
149166462|NCT05047523|538084302|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
149166463|NCT03658889|538084303|FG000|Overall Study|Protocol Violation|2|||
149166464|NCT03658889|538084304|FG001|Overall Study|Protocol Violation|0|||
149166465|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
149166466|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
149166467|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
149166468|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
149166469|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
149166470|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
149166471|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
149166472|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
149166473|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
149166474|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
149166475|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
149166476|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
149166477|NCT02747927|538084324|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
149166478|NCT02747927|538084325|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
149166479|NCT02747927|538084324|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
149166480|NCT02747927|538084325|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
149166481|NCT02747927|538084324|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
149166482|NCT02747927|538084325|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
149166483|NCT02747927|538084324|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
149166484|NCT02747927|538084325|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
149166485|NCT02747927|538084324|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
149166486|NCT02747927|538084325|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
149166487|NCT02747927|538084324|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
149166488|NCT02747927|538084325|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
149166489|NCT02747927|538084324|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
149166490|NCT02747927|538084325|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
149166491|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
149166492|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
149166493|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
149166494|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
149166495|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
149166496|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
149166497|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
149166498|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
149166499|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
149166500|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
149166501|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
149166502|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
149166503|NCT02747927|538084324|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
149166504|NCT02747927|538084325|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
149166505|NCT02747927|538084324|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
149166506|NCT02747927|538084325|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
149166507|NCT02747927|538084324|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
149166508|NCT02747927|538084325|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
149166509|NCT02747927|538084324|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
149166510|NCT02747927|538084325|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
149166511|NCT02747927|538084324|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
149166512|NCT02747927|538084325|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
149166513|NCT02747927|538084324|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
149166514|NCT02747927|538084325|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
149166515|NCT02747927|538084324|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
149166516|NCT02747927|538084325|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
148927425|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
148927426|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
148927427|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
148927428|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
148927429|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
149166517|NCT02747927|538084324|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
149166518|NCT02747927|538084325|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
149166519|NCT02747927|538084324|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
149166520|NCT02747927|538084325|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
149166521|NCT02747927|538084324|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
149166522|NCT02747927|538084325|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
149166523|NCT02747927|538084324|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
149166524|NCT02747927|538084325|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
149166525|NCT02747927|538084324|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
149166526|NCT02747927|538084325|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
149166527|NCT02747927|538084324|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
149166528|NCT02747927|538084325|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
149166529|NCT00522392|538084329|FG000|Overall Study|Disease progression|0|||
149166530|NCT00522392|538084330|FG001|Overall Study|Disease progression|3|||
149166531|NCT00522392|538084329|FG000|Overall Study|Adverse Event|7|||
149166532|NCT00522392|538084330|FG001|Overall Study|Adverse Event|7|||
149166533|NCT00522392|538084329|FG000|Overall Study|Withdrawal by Subject|1|||
149166534|NCT00522392|538084330|FG001|Overall Study|Withdrawal by Subject|1|||
149166535|NCT00522392|538084329|FG000|Overall Study|Physician Decision|0|||
149166536|NCT00522392|538084330|FG001|Overall Study|Physician Decision|1|||
149166537|NCT00522392|538084329|FG000|Overall Study|Non-compliance|0|||
149166538|NCT00522392|538084330|FG001|Overall Study|Non-compliance|1|||
149166539|NCT00430755|538084333|FG000|Overall Study|Withdrawal by Subject|53|||
149166540|NCT03902080|538084340|FG000|Overall Study|Adverse Event|17|||
149166541|NCT03902080|538084341|FG001|Overall Study|Adverse Event|15|||
149166542|NCT03902080|538084340|FG000|Overall Study|Withdrawal by Subject|28|||
149166543|NCT03902080|538084341|FG001|Overall Study|Withdrawal by Subject|35|||
149166544|NCT03902080|538084340|FG000|Overall Study|Lost to Follow-up|6|||
149166545|NCT03902080|538084341|FG001|Overall Study|Lost to Follow-up|7|||
149166546|NCT03902080|538084340|FG000|Overall Study|Other|3|||
149166547|NCT03902080|538084341|FG001|Overall Study|Other|5|||
149166548|NCT03902080|538084340|FG000|Overall Study|Non compliance|4|||
149166549|NCT03902080|538084341|FG001|Overall Study|Non compliance|3|||
149166550|NCT03902080|538084340|FG000|Overall Study|Physician Decision|5|||
149166551|NCT03902080|538084341|FG001|Overall Study|Physician Decision|1|||
149166552|NCT03902080|538084340|FG000|Overall Study|Protocol Violation|3|||
149166553|NCT03902080|538084341|FG001|Overall Study|Protocol Violation|3|||
149166554|NCT03902080|538084340|FG000|Overall Study|Lack of Efficacy|1|||
149166555|NCT03902080|538084341|FG001|Overall Study|Lack of Efficacy|3|||
149166556|NCT03902080|538084340|FG000|Overall Study|Withdrawn prior to dosing|0|||
149166557|NCT03902080|538084341|FG001|Overall Study|Withdrawn prior to dosing|1|||
149166558|NCT03575104|538084342|FG000|Overall Study|Adverse Event|4|||
149166559|NCT03575104|538084343|FG001|Overall Study|Adverse Event|3|||
149166560|NCT03575104|538084344|FG002|Overall Study|Adverse Event|4|||
149166561|NCT03575104|538084342|FG000|Overall Study|Withdrawal by Subject|13|||
149166562|NCT03575104|538084343|FG001|Overall Study|Withdrawal by Subject|16|||
149166563|NCT03575104|538084344|FG002|Overall Study|Withdrawal by Subject|11|||
149166564|NCT03575104|538084342|FG000|Overall Study|Other reasons|6|||
149166565|NCT03575104|538084343|FG001|Overall Study|Other reasons|8|||
149166566|NCT03575104|538084344|FG002|Overall Study|Other reasons|6|||
149166567|NCT03575104|538084342|FG000|Overall Study|Lost to Follow-up|1|||
149166568|NCT03575104|538084343|FG001|Overall Study|Lost to Follow-up|2|||
149166569|NCT03575104|538084344|FG002|Overall Study|Lost to Follow-up|1|||
149166570|NCT02661594|538084345|FG000|Overall Study|Protocol Violation|1|||
149166571|NCT02661594|538084346|FG001|Overall Study|Protocol Violation|0|||
149166572|NCT02661594|538084347|FG002|Overall Study|Protocol Violation|1|||
149166573|NCT02661594|538084348|FG003|Overall Study|Protocol Violation|0|||
149166574|NCT01169779|538084351|FG000|Overall Study|Adverse Event|3|||
149166575|NCT01169779|538084352|FG001|Overall Study|Adverse Event|11|||
149166576|NCT01169779|538084351|FG000|Overall Study|Lack of Efficacy|1|||
149166577|NCT01169779|538084352|FG001|Overall Study|Lack of Efficacy|0|||
149166578|NCT01169779|538084351|FG000|Overall Study|Protocol Violation|1|||
149166579|NCT01169779|538084352|FG001|Overall Study|Protocol Violation|1|||
149166580|NCT01169779|538084351|FG000|Overall Study|Withdrawal by Subject|3|||
149166581|NCT01169779|538084352|FG001|Overall Study|Withdrawal by Subject|2|||
149166582|NCT01169779|538084351|FG000|Overall Study|Familial and personal reasons|3|||
149166583|NCT01169779|538084352|FG001|Overall Study|Familial and personal reasons|3|||
149166584|NCT01354132|538084353|FG000|Randomization|Physician Decision|1|||
149166585|NCT01354132|538084354|FG001|Randomization|Physician Decision|0|||
149166586|NCT01354132|538084353|FG000|Randomization|Withdrawal by Subject|0|||
149166587|NCT01354132|538084354|FG001|Randomization|Withdrawal by Subject|1|||
149166588|NCT01354132|538084353|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
149166589|NCT01354132|538084354|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
149166590|NCT01354132|538084353|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
149166591|NCT01354132|538084354|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
148675460|NCT00644228|536282999|FG000|Induction Therapy|Adverse Event|22|||
149166592|NCT01354132|538084353|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
149166593|NCT01354132|538084354|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
149166594|NCT00928070|538084357|FG000|Overall Study|Lost to Follow-up|1|||
149166595|NCT00928070|538084358|FG001|Overall Study|Lost to Follow-up|2|||
149166596|NCT00928070|538084357|FG000|Overall Study|Withdrawal by Subject|10|||
149166597|NCT00928070|538084358|FG001|Overall Study|Withdrawal by Subject|3|||
149166598|NCT00928070|538084357|FG000|Overall Study|Adverse Event|14|||
149166599|NCT00928070|538084358|FG001|Overall Study|Adverse Event|26|||
149166600|NCT00928070|538084357|FG000|Overall Study|Lack of Efficacy|9|||
149166601|NCT00928070|538084358|FG001|Overall Study|Lack of Efficacy|5|||
149166602|NCT00928070|538084357|FG000|Overall Study|Did not meet entrance criteria|16|||
149166603|NCT00928070|538084358|FG001|Overall Study|Did not meet entrance criteria|9|||
149166604|NCT00928070|538084357|FG000|Overall Study|Protocol Violation|6|||
149166605|NCT00928070|538084358|FG001|Overall Study|Protocol Violation|5|||
149166606|NCT00928070|538084357|FG000|Overall Study|Randomized but not treated|2|||
149166607|NCT00928070|538084358|FG001|Overall Study|Randomized but not treated|2|||
149166608|NCT00928070|538084357|FG000|Overall Study|Other|5|||
149166609|NCT00928070|538084358|FG001|Overall Study|Other|5|||
149166610|NCT00191854|538084359|FG000|Overall Study|Death|26|||
149166611|NCT00191854|538084360|FG001|Overall Study|Death|23|||
148675461|NCT00644228|536283000|FG001|Induction Therapy|Adverse Event|55|||
148675462|NCT00644228|536282999|FG000|Induction Therapy|Withdrawal by Subject|10|||
148675463|NCT00644228|536283000|FG001|Induction Therapy|Withdrawal by Subject|3|||
148675464|NCT00644228|536282999|FG000|Induction Therapy|Progression/Relapse|24|||
148675465|NCT00644228|536283000|FG001|Induction Therapy|Progression/Relapse|12|||
148675466|NCT00644228|536282999|FG000|Induction Therapy|Death|3|||
148675467|NCT00644228|536283000|FG001|Induction Therapy|Death|7|||
148675468|NCT00644228|536282999|FG000|Induction Therapy|Not Protocol-Specified|24|||
148927430|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
148927431|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
148927432|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
148927433|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
148927434|NCT00591578|537217423|FG000|Double-Blind Treatment Phase|Other|4|||
148927435|NCT00591578|537217424|FG001|Double-Blind Treatment Phase|Other|9|||
148927436|NCT00591578|537217425|FG002|Double-Blind Treatment Phase|Other|4|||
148927437|NCT00591578|537217423|FG000|Open-Label Extension Phase|Adverse Event|3|||
148927438|NCT00591578|537217424|FG001|Open-Label Extension Phase|Adverse Event|5|||
148675469|NCT00644228|536283000|FG001|Induction Therapy|Not Protocol-Specified|28|||
148675470|NCT00644228|536282999|FG000|Maintenance|Adverse Event|27|||
148675471|NCT00644228|536283000|FG001|Maintenance|Adverse Event|31|||
148675472|NCT00644228|536282999|FG000|Maintenance|Withdrawal by Subject|6|||
148675473|NCT00644228|536283000|FG001|Maintenance|Withdrawal by Subject|4|||
148675474|NCT00644228|536282999|FG000|Maintenance|Progression/Relapse|67|||
148675475|NCT00644228|536283000|FG001|Maintenance|Progression/Relapse|42|||
148675476|NCT00644228|536282999|FG000|Maintenance|Death|3|||
148675477|NCT00644228|536283000|FG001|Maintenance|Death|3|||
148675478|NCT00644228|536282999|FG000|Maintenance|Not Protocol-Specified|14|||
148675479|NCT00644228|536283000|FG001|Maintenance|Not Protocol-Specified|15|||
148675480|NCT00644228|536282999|FG000|Maintenance|On Treatment|26|||
148675481|NCT00644228|536283000|FG001|Maintenance|On Treatment|40|||
148927439|NCT00591578|537217425|FG002|Open-Label Extension Phase|Adverse Event|0|||
148927440|NCT00591578|537217423|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
148927441|NCT00591578|537217424|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
148927442|NCT00591578|537217425|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
148927443|NCT00591578|537217423|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
148927444|NCT00591578|537217424|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
149012997|NCT02906683|537527759|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
148675482|NCT06078124|536283001|FG000|Overall Study|Lost to Follow-up|14|||
148806237|NCT01294046|536768923|FG000|Overall Study|Eligibility criteria expanded|1|||
149166612|NCT00191854|538084361|FG002|Overall Study|Death|29|||
149166613|NCT00191854|538084359|FG000|Overall Study|Lost to Follow-up|7|||
149166614|NCT00191854|538084360|FG001|Overall Study|Lost to Follow-up|5|||
149166615|NCT00191854|538084361|FG002|Overall Study|Lost to Follow-up|5|||
149166616|NCT00191854|538084359|FG000|Overall Study|Withdrawal by Subject|4|||
149166617|NCT00191854|538084360|FG001|Overall Study|Withdrawal by Subject|2|||
149166618|NCT00191854|538084361|FG002|Overall Study|Withdrawal by Subject|3|||
149166619|NCT00191854|538084359|FG000|Overall Study|Sponsor Decision|0|||
149166620|NCT00191854|538084360|FG001|Overall Study|Sponsor Decision|0|||
149166621|NCT00191854|538084361|FG002|Overall Study|Sponsor Decision|1|||
149166622|NCT00191854|538084359|FG000|Overall Study|Screen Failure|0|||
149166623|NCT00191854|538084360|FG001|Overall Study|Screen Failure|0|||
148675483|NCT06078124|536283002|FG001|Overall Study|Lost to Follow-up|14|||
148675484|NCT05824273|536283003|FG000|Overall Study|Lost to Follow-up|16|||
149166624|NCT00191854|538084361|FG002|Overall Study|Screen Failure|1|||
148675485|NCT05824273|536283004|FG001|Overall Study|Lost to Follow-up|13|||
148675486|NCT02736695|536283005|FG000|Overall Study|Ineligible|6|||
148927445|NCT00591578|537217425|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
148927446|NCT00591578|537217423|FG000|Open-Label Extension Phase|Other|1|||
148675487|NCT02736695|536283006|FG001|Overall Study|Ineligible|0|||
148675488|NCT00285012|536283007|FG000|Assigned to Study Treatment (Tx)|Other|2|||
148675489|NCT00285012|536283008|FG001|Assigned to Study Treatment (Tx)|Other|3|||
148675490|NCT00285012|536283007|FG000|Received Study Tx|Death|2|||
148675491|NCT00285012|536283008|FG001|Received Study Tx|Death|1|||
148675492|NCT00285012|536283007|FG000|Received Study Tx|Adverse Event|5|||
148675493|NCT00285012|536283008|FG001|Received Study Tx|Adverse Event|11|||
148675494|NCT00285012|536283007|FG000|Received Study Tx|Lack of Efficacy|0|||
148675495|NCT00285012|536283008|FG001|Received Study Tx|Lack of Efficacy|3|||
148675496|NCT00285012|536283007|FG000|Received Study Tx|Lost to Follow-up|29|||
148675497|NCT00285012|536283008|FG001|Received Study Tx|Lost to Follow-up|31|||
148675498|NCT00285012|536283007|FG000|Received Study Tx|Withdrawal by Subject|31|||
148675499|NCT00285012|536283008|FG001|Received Study Tx|Withdrawal by Subject|43|||
148675500|NCT00285012|536283007|FG000|Received Study Tx|Other|5|||
148927447|NCT00591578|537217424|FG001|Open-Label Extension Phase|Other|0|||
148927448|NCT00591578|537217425|FG002|Open-Label Extension Phase|Other|0|||
148927449|NCT03523000|537217429|FG000|Overall Study|Withdrawal by Subject|3|||
148927450|NCT03523000|537217430|FG001|Overall Study|Withdrawal by Subject|0|||
148927451|NCT03523000|537217429|FG000|Overall Study|Unsuccessful trial|2|||
148927452|NCT03523000|537217430|FG001|Overall Study|Unsuccessful trial|0|||
148927453|NCT00772070|537217431|FG000|Overall Study|Lost to Follow-up|0|||
148927454|NCT00772070|537217432|FG001|Overall Study|Lost to Follow-up|8|||
148927455|NCT00772070|537217431|FG000|Overall Study|Withdrawal by Subject|0|||
148927456|NCT00772070|537217432|FG001|Overall Study|Withdrawal by Subject|2|||
148927457|NCT00772070|537217431|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
148927458|NCT00772070|537217432|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
148927459|NCT01309308|537217433|FG000|Overall Study|Lost to Follow-up|6|||
148927460|NCT01309308|537217434|FG001|Overall Study|Lost to Follow-up|4|||
148927461|NCT00495131|537217435|FG000|Overall Study|Adverse Event|6|||
148927462|NCT00495131|537217436|FG001|Overall Study|Adverse Event|2|||
148927463|NCT00495131|537217435|FG000|Overall Study|Lack of Efficacy|0|||
148927464|NCT00495131|537217436|FG001|Overall Study|Lack of Efficacy|2|||
148927465|NCT00495131|537217435|FG000|Overall Study|Lost to Follow-up|0|||
148927466|NCT00495131|537217436|FG001|Overall Study|Lost to Follow-up|2|||
148927467|NCT00495131|537217435|FG000|Overall Study|Withdrawal by Subject|1|||
148927468|NCT00495131|537217436|FG001|Overall Study|Withdrawal by Subject|0|||
148675501|NCT00285012|536283008|FG001|Received Study Tx|Other|5|||
148927469|NCT01307020|537217438|FG000|Overall Study|Lost to Follow-up|0|||
148927470|NCT01307020|537217439|FG001|Overall Study|Lost to Follow-up|0|||
148927471|NCT01307020|537217440|FG002|Overall Study|Lost to Follow-up|1|||
148927472|NCT01307020|537217441|FG003|Overall Study|Lost to Follow-up|1|||
148927473|NCT01307020|537217442|FG004|Overall Study|Lost to Follow-up|0|||
148927474|NCT01307020|537217443|FG005|Overall Study|Lost to Follow-up|0|||
148927475|NCT01307020|537217444|FG006|Overall Study|Lost to Follow-up|1|||
148927476|NCT01307020|537217445|FG007|Overall Study|Lost to Follow-up|0|||
148675502|NCT04050293|536283012|FG000|Overall Study|Lost to Follow-up|1|||
148675503|NCT04050293|536283013|FG001|Overall Study|Lost to Follow-up|2|||
148927477|NCT01307020|537217446|FG008|Overall Study|Lost to Follow-up|0|||
148927478|NCT01307020|537217447|FG009|Overall Study|Lost to Follow-up|0|||
148927479|NCT01307020|537217438|FG000|Overall Study|Electronic data capture failure|0|||
148927480|NCT01307020|537217439|FG001|Overall Study|Electronic data capture failure|1|||
148675504|NCT04050293|536283012|FG000|Overall Study|Withdrawal by Subject|2|||
148675505|NCT04050293|536283013|FG001|Overall Study|Withdrawal by Subject|0|||
148675506|NCT05631093|536283016|FG000|Overall Study|Death|0|||
148927481|NCT01307020|537217440|FG002|Overall Study|Electronic data capture failure|0|||
148927482|NCT01307020|537217441|FG003|Overall Study|Electronic data capture failure|0|||
148927483|NCT01307020|537217442|FG004|Overall Study|Electronic data capture failure|0|||
148927484|NCT01307020|537217443|FG005|Overall Study|Electronic data capture failure|0|||
148927485|NCT01307020|537217444|FG006|Overall Study|Electronic data capture failure|0|||
148927486|NCT01307020|537217445|FG007|Overall Study|Electronic data capture failure|0|||
148927487|NCT01307020|537217446|FG008|Overall Study|Electronic data capture failure|0|||
148927488|NCT01307020|537217447|FG009|Overall Study|Electronic data capture failure|0|||
148927489|NCT02380690|537217448|FG000|Overall Study|Lost to Follow-up|14|||
148927490|NCT02380690|537217449|FG001|Overall Study|Lost to Follow-up|4|||
148927491|NCT02380690|537217448|FG000|Overall Study|Withdrawal by Subject|20|||
148927492|NCT02380690|537217449|FG001|Overall Study|Withdrawal by Subject|8|||
148927493|NCT00266864|537217450|FG000|Overall Study|Lost to Follow-up|4|||
148927494|NCT00266864|537217451|FG001|Overall Study|Lost to Follow-up|1|||
148927495|NCT00266864|537217450|FG000|Overall Study|Withdrawal by Subject|1|||
148927496|NCT00266864|537217451|FG001|Overall Study|Withdrawal by Subject|1|||
148927497|NCT00727532|537217452|FG000|Overall Study|Adverse Event|1|||
148927498|NCT00727532|537217452|FG000|Overall Study|Withdrawal by Subject|1|||
148927499|NCT00829933|537217453|FG000|Overall Study|Adverse Event|2|||
148927500|NCT00829933|537217454|FG001|Overall Study|Adverse Event|3|||
148927501|NCT00829933|537217455|FG002|Overall Study|Adverse Event|2|||
148927502|NCT00829933|537217456|FG003|Overall Study|Adverse Event|1|||
148927503|NCT00829933|537217453|FG000|Overall Study|Death|0|||
148927504|NCT00829933|537217454|FG001|Overall Study|Death|0|||
148927505|NCT00829933|537217455|FG002|Overall Study|Death|1|||
148927506|NCT00829933|537217456|FG003|Overall Study|Death|1|||
148927507|NCT00829933|537217453|FG000|Overall Study|Lack of Efficacy|0|||
148927508|NCT00829933|537217454|FG001|Overall Study|Lack of Efficacy|1|||
148927509|NCT00829933|537217455|FG002|Overall Study|Lack of Efficacy|0|||
148927510|NCT00829933|537217456|FG003|Overall Study|Lack of Efficacy|0|||
148927511|NCT00829933|537217453|FG000|Overall Study|Physician Decision|5|||
148927512|NCT00829933|537217454|FG001|Overall Study|Physician Decision|7|||
148927513|NCT00829933|537217455|FG002|Overall Study|Physician Decision|8|||
148927514|NCT00829933|537217456|FG003|Overall Study|Physician Decision|1|||
148927515|NCT00829933|537217453|FG000|Overall Study|Pregnancy|0|||
148927516|NCT00829933|537217454|FG001|Overall Study|Pregnancy|0|||
149166625|NCT02360098|538084362|FG000|Overall Study|Physician Decision|7|||
149166626|NCT00862251|538084366|FG000|Overall Study|Adverse Event|8|||
149166627|NCT00862251|538084367|FG001|Overall Study|Adverse Event|3|||
149166628|NCT00862251|538084368|FG002|Overall Study|Adverse Event|1|||
149166629|NCT00862251|538084366|FG000|Overall Study|Lost to Follow-up|0|||
149166630|NCT00862251|538084367|FG001|Overall Study|Lost to Follow-up|0|||
148675507|NCT05631093|536283017|FG001|Overall Study|Death|1|||
148927517|NCT00829933|537217455|FG002|Overall Study|Pregnancy|0|||
148927518|NCT00829933|537217456|FG003|Overall Study|Pregnancy|2|||
148927519|NCT00829933|537217453|FG000|Overall Study|Protocol Violation|2|||
148927520|NCT00829933|537217454|FG001|Overall Study|Protocol Violation|1|||
148927521|NCT00829933|537217455|FG002|Overall Study|Protocol Violation|0|||
148927522|NCT00829933|537217456|FG003|Overall Study|Protocol Violation|0|||
149166631|NCT00862251|538084368|FG002|Overall Study|Lost to Follow-up|1|||
149166632|NCT00862251|538084366|FG000|Overall Study|Protocol Violation|2|||
149166633|NCT00862251|538084367|FG001|Overall Study|Protocol Violation|0|||
149166634|NCT00862251|538084368|FG002|Overall Study|Protocol Violation|1|||
149166635|NCT00862251|538084366|FG000|Overall Study|Withdrawal by Subject|9|||
149166636|NCT00862251|538084367|FG001|Overall Study|Withdrawal by Subject|2|||
149166637|NCT00862251|538084368|FG002|Overall Study|Withdrawal by Subject|6|||
149166638|NCT02796755|538084369|FG000|Overall Study|Adverse Event|2|||
149166639|NCT02796755|538084370|FG001|Overall Study|Adverse Event|0|||
149166640|NCT00556426|538084371|FG000|Overall Study|Withdrawal by Subject|3|||
149166641|NCT00556426|538084371|FG000|Overall Study|Death|6|||
149166642|NCT02347631|538084373|FG000|First Intervention (2 Months)|Adverse Event|1|||
149166643|NCT02347631|538084374|FG001|First Intervention (2 Months)|Adverse Event|1|||
149166644|NCT02347631|538084373|FG000|First Intervention (2 Months)|Pregnancy|1|||
148675508|NCT05631093|536283016|FG000|Overall Study|Lost to Follow-up|1|||
148675509|NCT05631093|536283017|FG001|Overall Study|Lost to Follow-up|2|||
148927523|NCT00829933|537217453|FG000|Overall Study|withdrew before treatment started|5|||
148927524|NCT00829933|537217454|FG001|Overall Study|withdrew before treatment started|1|||
148927525|NCT00829933|537217455|FG002|Overall Study|withdrew before treatment started|2|||
148927526|NCT00829933|537217456|FG003|Overall Study|withdrew before treatment started|9|||
148927527|NCT03687970|537217464|FG000|Overall Study|visit scheduling conflicts|2|||
148927528|NCT03687970|537217465|FG001|Overall Study|visit scheduling conflicts|0|||
149166645|NCT02347631|538084374|FG001|First Intervention (2 Months)|Pregnancy|0|||
149166646|NCT02347631|538084373|FG000|First Intervention (2 Months)|Moved out of area|0|||
149166647|NCT02347631|538084374|FG001|First Intervention (2 Months)|Moved out of area|2|||
149166648|NCT02347631|538084373|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
148927529|NCT00523367|537217474|FG000|Overall Study|19 screen failures|19|||
148927530|NCT00523367|537217474|FG000|Overall Study|4 Withdrawn by PI|4|||
148927531|NCT00356122|537217478|FG000|TREATMENT|Lack of Efficacy|26|||
148675510|NCT05631093|536283016|FG000|Overall Study|Physician Decision|1|||
148675511|NCT05631093|536283017|FG001|Overall Study|Physician Decision|0|||
148675512|NCT05631093|536283016|FG000|Overall Study|Withdrawal by Subject|4|||
148675513|NCT05631093|536283017|FG001|Overall Study|Withdrawal by Subject|1|||
148675514|NCT05631093|536283016|FG000|Overall Study|Ongoing|353|||
148927532|NCT00356122|537217478|FG000|TREATMENT|Adverse Event|10|||
148927533|NCT00356122|537217478|FG000|TREATMENT|Subject's request|4|||
148927534|NCT00356122|537217478|FG000|TREATMENT|Other|4|||
148927535|NCT00356122|537217478|FG000|TREATMENT|Did not receive study medication|1|||
148927536|NCT00356122|537217478|FG000|FOLLOW-UP|Death|37|||
148927537|NCT00356122|537217478|FG000|FOLLOW-UP|Lost to Follow-up|2|||
148927538|NCT00356122|537217478|FG000|FOLLOW-UP|Other|2|||
148927539|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
148927540|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
148675515|NCT05631093|536283017|FG001|Overall Study|Ongoing|177|||
148675516|NCT05631093|536283016|FG000|Overall Study|Adverse Event|0|||
148927541|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
148927542|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
148927543|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
148927544|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
148675517|NCT05631093|536283017|FG001|Overall Study|Adverse Event|1|||
148675518|NCT04223193|536283020|FG000|Overall Study|Adverse Event|6|||
148675519|NCT04223193|536283021|FG001|Overall Study|Adverse Event|36|||
148675520|NCT04223193|536283020|FG000|Overall Study|Lack of Efficacy|2|||
148927545|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
148927546|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
148927547|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
148927548|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
148927549|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
148927550|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
148927551|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
148927552|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
148927553|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
148927554|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
148927555|NCT00491556|537217479|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
149119478|NCT01327495|537916352|FG001|Overall Study|Withdrawal by Subject|1|||
148675521|NCT04223193|536283021|FG001|Overall Study|Lack of Efficacy|2|||
148675522|NCT04223193|536283020|FG000|Overall Study|Lost to Follow-up|1|||
148675523|NCT04223193|536283021|FG001|Overall Study|Lost to Follow-up|1|||
149119479|NCT01327495|537916353|FG002|Overall Study|Withdrawal by Subject|1|||
149119480|NCT01327495|537916354|FG003|Overall Study|Withdrawal by Subject|0|||
149119481|NCT01327495|537916355|FG004|Overall Study|Withdrawal by Subject|1|||
149119482|NCT01327495|537916356|FG005|Overall Study|Withdrawal by Subject|0|||
149119483|NCT01327495|537916351|FG000|Overall Study|Physician Decision|0|||
149119484|NCT01327495|537916352|FG001|Overall Study|Physician Decision|0|||
149119485|NCT01327495|537916353|FG002|Overall Study|Physician Decision|0|||
149119486|NCT01327495|537916354|FG003|Overall Study|Physician Decision|0|||
149119487|NCT01327495|537916355|FG004|Overall Study|Physician Decision|2|||
149119488|NCT01327495|537916356|FG005|Overall Study|Physician Decision|0|||
149119489|NCT00560066|537916362|FG000|Overall Study|Death|2|||
149119490|NCT00560066|537916363|FG001|Overall Study|Death|1|||
149119491|NCT00560066|537916362|FG000|Overall Study|Withdrawal by Subject|0|||
149119492|NCT00560066|537916363|FG001|Overall Study|Withdrawal by Subject|3|||
149119493|NCT00560066|537916362|FG000|Overall Study|Lost to Follow-up|4|||
149119494|NCT00560066|537916363|FG001|Overall Study|Lost to Follow-up|10|||
149119495|NCT00560066|537916362|FG000|Overall Study|Protocol Violation|0|||
149119496|NCT00560066|537916363|FG001|Overall Study|Protocol Violation|1|||
149119497|NCT00560066|537916362|FG000|Overall Study|Administrative reason|0|||
149119498|NCT00560066|537916363|FG001|Overall Study|Administrative reason|5|||
149119499|NCT00560066|537916362|FG000|Overall Study|Missing primary reason|0|||
149119500|NCT00560066|537916363|FG001|Overall Study|Missing primary reason|2|||
149119501|NCT00506441|537916364|FG000|Period 1; Open-label Period|Adverse Event|21|||
149119502|NCT00506441|537916365|FG001|Period 1; Open-label Period|Adverse Event|0|||
149119503|NCT00506441|537916364|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
149119504|NCT00506441|537916365|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
149119505|NCT00506441|537916364|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
149119506|NCT00506441|537916365|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
149119507|NCT00506441|537916364|FG000|Period 1; Open-label Period|Physician Decision|5|||
149119508|NCT00506441|537916365|FG001|Period 1; Open-label Period|Physician Decision|0|||
149119509|NCT00506441|537916364|FG000|Period 1; Open-label Period|Protocol Violation|9|||
149119510|NCT00506441|537916365|FG001|Period 1; Open-label Period|Protocol Violation|0|||
149119511|NCT00506441|537916364|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
149119512|NCT00506441|537916365|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
148806238|NCT01294046|536768923|FG000|Overall Study|Stimulation response inadqequate|1|||
148927556|NCT00491556|537217480|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
148927557|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
148927558|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
148927559|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
148806239|NCT00420745|536768924|FG000|Overall Study|Adverse Event|2|||
148927560|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
148927561|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
148927562|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
148927563|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
148927564|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
148927565|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
148927566|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
148927567|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
148927568|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
148927569|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
148927570|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
148927571|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
148927572|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
148927573|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
148927574|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
148927575|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
148927576|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
148927577|NCT00491556|537217479|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
148927578|NCT00491556|537217480|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
148927579|NCT00782795|537217481|FG000|Overall Study|Withdrawal by Subject|1|||
148927580|NCT00782795|537217482|FG001|Overall Study|Withdrawal by Subject|2|||
148927581|NCT04480424|537217483|FG000|Overall Study|Withdrawal by Subject|0|||
148927582|NCT04480424|537217484|FG001|Overall Study|Withdrawal by Subject|2|||
148927583|NCT04480424|537217483|FG000|Overall Study|Lost to Follow-up|3|||
148927584|NCT04480424|537217484|FG001|Overall Study|Lost to Follow-up|3|||
148927585|NCT04480424|537217483|FG000|Overall Study|Death|14|||
148927586|NCT04480424|537217484|FG001|Overall Study|Death|16|||
148927587|NCT04480424|537217483|FG000|Overall Study|Reason not Specified|5|||
148927588|NCT04480424|537217484|FG001|Overall Study|Reason not Specified|5|||
148927589|NCT01909453|537217488|FG000|Overall Study|Ongoing|118|||
148927590|NCT01909453|537217489|FG001|Overall Study|Ongoing|103|||
148927591|NCT01909453|537217490|FG002|Overall Study|Ongoing|83|||
148927592|NCT01909453|537217491|FG003|Overall Study|Ongoing|164|||
148927593|NCT01909453|537217492|FG004|Overall Study|Ongoing|50|||
148927594|NCT01909453|537217488|FG000|Overall Study|Death|69|||
148927595|NCT01909453|537217489|FG001|Overall Study|Death|74|||
148927596|NCT01909453|537217490|FG002|Overall Study|Death|88|||
148927597|NCT01909453|537217491|FG003|Overall Study|Death|86|||
148927598|NCT01909453|537217492|FG004|Overall Study|Death|29|||
148927599|NCT01909453|537217488|FG000|Overall Study|Lost to Follow-up|3|||
148927600|NCT01909453|537217489|FG001|Overall Study|Lost to Follow-up|4|||
148927601|NCT01909453|537217490|FG002|Overall Study|Lost to Follow-up|4|||
148927602|NCT01909453|537217491|FG003|Overall Study|Lost to Follow-up|3|||
148927603|NCT01909453|537217492|FG004|Overall Study|Lost to Follow-up|3|||
148927604|NCT01909453|537217488|FG000|Overall Study|Withdrawal by Subject|2|||
148927605|NCT01909453|537217489|FG001|Overall Study|Withdrawal by Subject|13|||
148927606|NCT01909453|537217490|FG002|Overall Study|Withdrawal by Subject|16|||
148927607|NCT01909453|537217491|FG003|Overall Study|Withdrawal by Subject|5|||
148927608|NCT01909453|537217492|FG004|Overall Study|Withdrawal by Subject|4|||
148806240|NCT00420745|536768925|FG001|Overall Study|Adverse Event|2|||
148927609|NCT00076024|537219359|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
148927610|NCT00076024|537219360|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
148927611|NCT00076024|537219361|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
148927612|NCT00076024|537219362|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
148927613|NCT00076024|537219359|FG000|Phase 1, Lead-in|Adverse Event|1|||
148927614|NCT00076024|537219360|FG001|Phase 1, Lead-in|Adverse Event|0|||
148927615|NCT00076024|537219361|FG002|Phase 1, Lead-in|Adverse Event|0|||
148927616|NCT00076024|537219362|FG003|Phase 1, Lead-in|Adverse Event|0|||
148927617|NCT00076024|537219359|FG000|Phase 1, Lead-in|Clinical progression|1|||
148927618|NCT00076024|537219360|FG001|Phase 1, Lead-in|Clinical progression|0|||
148927619|NCT00076024|537219361|FG002|Phase 1, Lead-in|Clinical progression|0|||
148927620|NCT00076024|537219362|FG003|Phase 1, Lead-in|Clinical progression|0|||
148927621|NCT00076024|537219359|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
148927622|NCT00076024|537219360|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
148927623|NCT00076024|537219361|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
148927624|NCT00076024|537219362|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
149166649|NCT02347631|538084374|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
149166650|NCT02347631|538084373|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
148927625|NCT00076024|537219359|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
148927626|NCT00076024|537219360|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
148927627|NCT00076024|537219361|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
148927628|NCT00076024|537219362|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
148927629|NCT00076024|537219359|FG000|Phase 2, Double-blind|Adverse Event|0|||
149166651|NCT02347631|538084374|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
149166652|NCT02347631|538084373|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
149166653|NCT02347631|538084374|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
149166654|NCT02347631|538084373|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
149166655|NCT02347631|538084374|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
149166656|NCT02347631|538084373|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
149166657|NCT02347631|538084374|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
149166658|NCT02318784|538084376|FG000|Overall Study|Adverse Event|13|||
149166659|NCT02318784|538084376|FG000|Overall Study|Death|2|||
149166660|NCT02318784|538084376|FG000|Overall Study|Progressive Disease|37|||
149166661|NCT02318784|538084376|FG000|Overall Study|Withdrawal by Subject|10|||
149166662|NCT02304926|538084377|FG000|Overall Study|Lost to Follow-up|2|||
149166663|NCT02304926|538084378|FG001|Overall Study|Lost to Follow-up|1|||
149166664|NCT02388295|538084379|FG000|Dose Escalation Week 1|Adverse Event|1|||
149166665|NCT02388295|538084380|FG001|Dose Escalation Week 1|Adverse Event|2|||
149166666|NCT02388295|538084381|FG002|Dose Escalation Week 1|Adverse Event|1|||
149166667|NCT02388295|538084379|FG000|Dose Escalation Week 1|Determined not eligible|1|||
149166668|NCT02388295|538084380|FG001|Dose Escalation Week 1|Determined not eligible|1|||
149166669|NCT02388295|538084381|FG002|Dose Escalation Week 1|Determined not eligible|1|||
149166670|NCT02388295|538084379|FG000|Dose Escalation Week 2|Protocol Violation|0|||
149166671|NCT02388295|538084380|FG001|Dose Escalation Week 2|Protocol Violation|1|||
149166672|NCT02388295|538084381|FG002|Dose Escalation Week 2|Protocol Violation|0|||
149166673|NCT02388295|538084379|FG000|Dose Escalation Week 2|Determined not eligible|1|||
149166674|NCT02388295|538084380|FG001|Dose Escalation Week 2|Determined not eligible|1|||
149166675|NCT02388295|538084381|FG002|Dose Escalation Week 2|Determined not eligible|1|||
148927630|NCT00076024|537219360|FG001|Phase 2, Double-blind|Adverse Event|25|||
148927631|NCT00076024|537219361|FG002|Phase 2, Double-blind|Adverse Event|6|||
148927632|NCT00076024|537219362|FG003|Phase 2, Double-blind|Adverse Event|0|||
148927633|NCT00076024|537219359|FG000|Phase 2, Double-blind|Un-specified|0|||
148927634|NCT00076024|537219360|FG001|Phase 2, Double-blind|Un-specified|14|||
148927635|NCT00076024|537219361|FG002|Phase 2, Double-blind|Un-specified|6|||
148927636|NCT00076024|537219362|FG003|Phase 2, Double-blind|Un-specified|0|||
148927637|NCT00076024|537219359|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
148927638|NCT00076024|537219360|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
148927639|NCT00076024|537219361|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
148927640|NCT00076024|537219362|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
148927641|NCT00076024|537219359|FG000|Phase 2, Open-label|Adverse Event|0|||
148927642|NCT00076024|537219360|FG001|Phase 2, Open-label|Adverse Event|0|||
148927643|NCT00076024|537219361|FG002|Phase 2, Open-label|Adverse Event|0|||
148927644|NCT00076024|537219362|FG003|Phase 2, Open-label|Adverse Event|2|||
148927645|NCT00076024|537219359|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
148927646|NCT00076024|537219360|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
148927647|NCT00076024|537219361|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
148927648|NCT00076024|537219362|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
148927649|NCT00076024|537219359|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
148927650|NCT00076024|537219360|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
148927651|NCT00076024|537219361|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
148927652|NCT00076024|537219362|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
148927653|NCT00076024|537219359|FG000|Phase 2, Open-label|Other|0|||
148927654|NCT00076024|537219360|FG001|Phase 2, Open-label|Other|0|||
148927655|NCT00076024|537219361|FG002|Phase 2, Open-label|Other|0|||
148927656|NCT00076024|537219362|FG003|Phase 2, Open-label|Other|2|||
148927657|NCT00301821|537219367|FG000|Overall Study|Ineligible|25|||
148927658|NCT00301821|537219367|FG000|Overall Study|Cancel|1|||
148927659|NCT02294773|537219368|FG000|Overall Study|Withdrawal by Subject|0|||
148927660|NCT02294773|537219369|FG001|Overall Study|Withdrawal by Subject|2|||
148927661|NCT03052764|537219370|FG000|Double-Blind Treatment Period|Adverse Event|2|||
148927662|NCT03052764|537219371|FG001|Double-Blind Treatment Period|Adverse Event|0|||
148927663|NCT03052764|537219370|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
148927664|NCT03052764|537219371|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
148927665|NCT03052764|537219370|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
148927666|NCT03052764|537219371|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
148927667|NCT03052764|537219370|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
148927668|NCT03052764|537219371|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148927669|NCT03052764|537219370|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
148927670|NCT03052764|537219371|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
148927671|NCT03150485|537219372|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
148927672|NCT03150485|537219373|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
148927673|NCT03150485|537219374|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
148927674|NCT03150485|537219375|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
148927675|NCT03150485|537219376|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
148927676|NCT03150485|537219377|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
148927677|NCT05828095|537219379|FG000|Overall Study|Lost to Follow-up|1|||
148927678|NCT05828095|537219380|FG001|Overall Study|Lost to Follow-up|0|||
148927679|NCT05828095|537219379|FG000|Overall Study|Reactogenicity symptom|0|||
148927680|NCT05828095|537219380|FG001|Overall Study|Reactogenicity symptom|1|||
148927681|NCT03206073|537219383|FG000|Overall Study|Participant Noncompliance|0|||
149166676|NCT02388295|538084379|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
149166677|NCT02388295|538084380|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
148675524|NCT04223193|536283020|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
148675525|NCT04223193|536283021|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
148675526|NCT04223193|536283020|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
148675527|NCT04223193|536283021|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
148675528|NCT04223193|536283020|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148675529|NCT04223193|536283021|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148675530|NCT04223193|536283020|FG000|Overall Study|Physician Decision|0|||
148675531|NCT04223193|536283021|FG001|Overall Study|Physician Decision|1|||
148675532|NCT04223193|536283020|FG000|Overall Study|Protocol Violation|1|||
148675533|NCT04223193|536283021|FG001|Overall Study|Protocol Violation|1|||
148675534|NCT04223193|536283020|FG000|Overall Study|Site Terminated by Sponsor|1|||
148675535|NCT04223193|536283021|FG001|Overall Study|Site Terminated by Sponsor|3|||
148675536|NCT04223193|536283020|FG000|Overall Study|Withdrawal by Subject|5|||
148675537|NCT04223193|536283021|FG001|Overall Study|Withdrawal by Subject|6|||
148675538|NCT04223193|536283020|FG000|Overall Study|Other|3|||
148675539|NCT04223193|536283021|FG001|Overall Study|Other|6|||
148675540|NCT03193190|536283024|FG000|Stage 1|Arm Terminated by Sponsor|0|||
148675541|NCT03193190|536283025|FG001|Stage 1|Arm Terminated by Sponsor|0|||
148675542|NCT03193190|536283026|FG002|Stage 1|Arm Terminated by Sponsor|0|||
148675543|NCT03193190|536283027|FG003|Stage 1|Arm Terminated by Sponsor|1|||
148675544|NCT03193190|536283028|FG004|Stage 1|Arm Terminated by Sponsor|0|||
148675545|NCT03193190|536283029|FG005|Stage 1|Arm Terminated by Sponsor|2|||
148675546|NCT03193190|536283030|FG006|Stage 1|Arm Terminated by Sponsor|0|||
148675547|NCT03193190|536283031|FG007|Stage 1|Arm Terminated by Sponsor|0|||
148675548|NCT03193190|536283032|FG008|Stage 1|Arm Terminated by Sponsor|0|||
148675549|NCT03193190|536283033|FG009|Stage 1|Arm Terminated by Sponsor|0|||
148675550|NCT03193190|536283034|FG010|Stage 1|Arm Terminated by Sponsor|0|||
148675551|NCT03193190|536283035|FG011|Stage 1|Arm Terminated by Sponsor|0|||
148675552|NCT03193190|536283036|FG012|Stage 1|Arm Terminated by Sponsor|0|||
148675553|NCT03193190|536283037|FG013|Stage 1|Arm Terminated by Sponsor|0|||
148675554|NCT03193190|536283038|FG014|Stage 1|Arm Terminated by Sponsor|0|||
148675555|NCT03193190|536283039|FG015|Stage 1|Arm Terminated by Sponsor|0|||
148675556|NCT03193190|536283024|FG000|Stage 1|Death|22|||
148675557|NCT03193190|536283025|FG001|Stage 1|Death|8|||
148675558|NCT03193190|536283026|FG002|Stage 1|Death|23|||
148675559|NCT03193190|536283027|FG003|Stage 1|Death|14|||
148675560|NCT03193190|536283028|FG004|Stage 1|Death|34|||
148675561|NCT03193190|536283029|FG005|Stage 1|Death|28|||
148675562|NCT03193190|536283030|FG006|Stage 1|Death|19|||
148675563|NCT03193190|536283031|FG007|Stage 1|Death|21|||
148675564|NCT03193190|536283032|FG008|Stage 1|Death|14|||
148675565|NCT03193190|536283033|FG009|Stage 1|Death|10|||
148675566|NCT03193190|536283034|FG010|Stage 1|Death|59|||
148675567|NCT03193190|536283035|FG011|Stage 1|Death|14|||
148675568|NCT03193190|536283036|FG012|Stage 1|Death|14|||
148675569|NCT03193190|536283037|FG013|Stage 1|Death|0|||
148675570|NCT03193190|536283038|FG014|Stage 1|Death|0|||
148675571|NCT03193190|536283039|FG015|Stage 1|Death|0|||
148675572|NCT03193190|536283024|FG000|Stage 1|Lost to Follow-up|2|||
148675573|NCT03193190|536283025|FG001|Stage 1|Lost to Follow-up|1|||
148675574|NCT03193190|536283026|FG002|Stage 1|Lost to Follow-up|1|||
149166678|NCT02388295|538084381|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
148675575|NCT03193190|536283027|FG003|Stage 1|Lost to Follow-up|0|||
148675576|NCT03193190|536283028|FG004|Stage 1|Lost to Follow-up|0|||
148675577|NCT03193190|536283029|FG005|Stage 1|Lost to Follow-up|0|||
148675578|NCT03193190|536283030|FG006|Stage 1|Lost to Follow-up|1|||
148675579|NCT03193190|536283031|FG007|Stage 1|Lost to Follow-up|0|||
148675580|NCT03193190|536283032|FG008|Stage 1|Lost to Follow-up|0|||
148675581|NCT03193190|536283033|FG009|Stage 1|Lost to Follow-up|0|||
148675582|NCT03193190|536283034|FG010|Stage 1|Lost to Follow-up|0|||
148675583|NCT03193190|536283035|FG011|Stage 1|Lost to Follow-up|0|||
148675584|NCT03193190|536283036|FG012|Stage 1|Lost to Follow-up|0|||
148675585|NCT03193190|536283037|FG013|Stage 1|Lost to Follow-up|0|||
148675586|NCT03193190|536283038|FG014|Stage 1|Lost to Follow-up|0|||
148927682|NCT03206073|537219384|FG001|Overall Study|Participant Noncompliance|1|||
148927683|NCT03206073|537219385|FG002|Overall Study|Participant Noncompliance|0|||
149166679|NCT03804684|538084383|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
148675587|NCT03193190|536283039|FG015|Stage 1|Lost to Follow-up|0|||
148675588|NCT03193190|536283024|FG000|Stage 1|Reason not Specified|1|||
148675589|NCT03193190|536283025|FG001|Stage 1|Reason not Specified|0|||
148675590|NCT03193190|536283026|FG002|Stage 1|Reason not Specified|0|||
148675591|NCT03193190|536283027|FG003|Stage 1|Reason not Specified|1|||
148675592|NCT03193190|536283028|FG004|Stage 1|Reason not Specified|0|||
148675593|NCT03193190|536283029|FG005|Stage 1|Reason not Specified|1|||
148675594|NCT03193190|536283030|FG006|Stage 1|Reason not Specified|2|||
148675595|NCT03193190|536283031|FG007|Stage 1|Reason not Specified|2|||
148675596|NCT03193190|536283032|FG008|Stage 1|Reason not Specified|0|||
148927684|NCT03206073|537219386|FG003|Overall Study|Participant Noncompliance|0|||
148927685|NCT03206073|537219383|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
148927686|NCT03206073|537219384|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
148927687|NCT03206073|537219385|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
148927688|NCT03206073|537219386|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
148927689|NCT03206073|537219383|FG000|Overall Study|Death|0|||
148927690|NCT03206073|537219384|FG001|Overall Study|Death|0|||
148927691|NCT03206073|537219385|FG002|Overall Study|Death|1|||
148927692|NCT03206073|537219386|FG003|Overall Study|Death|0|||
148927693|NCT03206073|537219383|FG000|Overall Study|Taken off active treatment|0|||
148927694|NCT03206073|537219384|FG001|Overall Study|Taken off active treatment|0|||
148927695|NCT03206073|537219385|FG002|Overall Study|Taken off active treatment|3|||
148927696|NCT03206073|537219386|FG003|Overall Study|Taken off active treatment|0|||
148927697|NCT03332771|537219388|FG000|Overall Study|Adverse Event|6|||
148927698|NCT03332771|537219389|FG001|Overall Study|Adverse Event|4|||
148927699|NCT03332771|537219390|FG002|Overall Study|Adverse Event|1|||
148927700|NCT03332771|537219391|FG003|Overall Study|Adverse Event|3|||
149166680|NCT03804684|538084384|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
149166681|NCT02429856|538084385|FG000|Overall Study|Death|12|||
149166682|NCT02429856|538084386|FG001|Overall Study|Death|13|||
149166683|NCT02429856|538084385|FG000|Overall Study|Lost to Follow-up|6|||
149166684|NCT02429856|538084386|FG001|Overall Study|Lost to Follow-up|5|||
149166685|NCT02429856|538084385|FG000|Overall Study|Withdrawal by Subject|1|||
149166686|NCT02429856|538084386|FG001|Overall Study|Withdrawal by Subject|1|||
149166687|NCT04134494|538084390|FG000|Overall Study|Lost to Follow-up|2|||
149166688|NCT00763009|538084392|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
149166689|NCT01111604|538084393|FG000|Overall Study|Lost to Follow-up|0|||
149166690|NCT01111604|538084394|FG001|Overall Study|Lost to Follow-up|0|||
149166691|NCT01111604|538084395|FG002|Overall Study|Lost to Follow-up|1|||
149166692|NCT01111604|538084393|FG000|Overall Study|Withdrew Consent|3|||
149166693|NCT01111604|538084394|FG001|Overall Study|Withdrew Consent|0|||
149166694|NCT01111604|538084395|FG002|Overall Study|Withdrew Consent|2|||
149166695|NCT01111604|538084393|FG000|Overall Study|Withdrawal by Subject|2|||
149166696|NCT01111604|538084394|FG001|Overall Study|Withdrawal by Subject|0|||
149166697|NCT01111604|538084395|FG002|Overall Study|Withdrawal by Subject|0|||
149166698|NCT01111604|538084393|FG000|Overall Study|Death|1|||
149166699|NCT01111604|538084394|FG001|Overall Study|Death|0|||
149166700|NCT01111604|538084395|FG002|Overall Study|Death|0|||
149166701|NCT01111604|538084393|FG000|Overall Study|Met Exclusion Criteria|2|||
149166702|NCT01111604|538084394|FG001|Overall Study|Met Exclusion Criteria|0|||
149166703|NCT01111604|538084395|FG002|Overall Study|Met Exclusion Criteria|0|||
149166704|NCT01355289|538084396|FG000|Core Study|Adverse Event, Non-Fatal|1|||
149166705|NCT01355289|538084397|FG001|Core Study|Adverse Event, Non-Fatal|0|||
149166706|NCT01355289|538084398|FG002|Core Study|Adverse Event, Non-Fatal|0|||
149166707|NCT01355289|538084399|FG003|Core Study|Adverse Event, Non-Fatal|0|||
149166708|NCT01355289|538084400|FG004|Core Study|Adverse Event, Non-Fatal|0|||
149166709|NCT01355289|538084396|FG000|Core Study|Inadequate Therapeutic Effect|0|||
149166710|NCT01355289|538084397|FG001|Core Study|Inadequate Therapeutic Effect|0|||
149166711|NCT01355289|538084398|FG002|Core Study|Inadequate Therapeutic Effect|0|||
149166712|NCT01355289|538084399|FG003|Core Study|Inadequate Therapeutic Effect|1|||
149166713|NCT01355289|538084400|FG004|Core Study|Inadequate Therapeutic Effect|0|||
149166714|NCT01355289|538084396|FG000|Core Study|Other|0|||
149166715|NCT01355289|538084397|FG001|Core Study|Other|0|||
149166716|NCT01355289|538084398|FG002|Core Study|Other|0|||
149166717|NCT01355289|538084399|FG003|Core Study|Other|1|||
149166718|NCT01355289|538084400|FG004|Core Study|Other|0|||
149166719|NCT01355289|538084396|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
149166720|NCT01355289|538084397|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
149166721|NCT01355289|538084398|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
149166722|NCT01355289|538084399|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
149166723|NCT01355289|538084400|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
149166724|NCT01355289|538084396|FG000|Open Label Extension|Lost to Follow-up|0|||
149166725|NCT01355289|538084397|FG001|Open Label Extension|Lost to Follow-up|0|||
149166726|NCT01355289|538084398|FG002|Open Label Extension|Lost to Follow-up|0|||
148675597|NCT03193190|536283033|FG009|Stage 1|Reason not Specified|1|||
148927701|NCT03332771|537219388|FG000|Overall Study|Poor Compliance to Protocol|0|||
148927702|NCT03332771|537219389|FG001|Overall Study|Poor Compliance to Protocol|1|||
148927703|NCT03332771|537219390|FG002|Overall Study|Poor Compliance to Protocol|0|||
148927704|NCT03332771|537219391|FG003|Overall Study|Poor Compliance to Protocol|1|||
149166727|NCT01355289|538084399|FG003|Open Label Extension|Lost to Follow-up|0|||
149166728|NCT01355289|538084400|FG004|Open Label Extension|Lost to Follow-up|1|||
149166729|NCT01355289|538084396|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
149166730|NCT01355289|538084397|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
149166731|NCT01355289|538084398|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
148927705|NCT03332771|537219388|FG000|Overall Study|Lost to Follow-up|2|||
148927706|NCT03332771|537219389|FG001|Overall Study|Lost to Follow-up|2|||
148927707|NCT03332771|537219390|FG002|Overall Study|Lost to Follow-up|1|||
148927708|NCT03332771|537219391|FG003|Overall Study|Lost to Follow-up|2|||
148927709|NCT03332771|537219388|FG000|Overall Study|At the Participant's own request|20|||
148927710|NCT03332771|537219389|FG001|Overall Study|At the Participant's own request|26|||
148927711|NCT03332771|537219390|FG002|Overall Study|At the Participant's own request|14|||
148927712|NCT03332771|537219391|FG003|Overall Study|At the Participant's own request|23|||
148927713|NCT03332771|537219388|FG000|Overall Study|Reason Not Specified|6|||
148927714|NCT03332771|537219389|FG001|Overall Study|Reason Not Specified|18|||
148927715|NCT03332771|537219390|FG002|Overall Study|Reason Not Specified|16|||
148927716|NCT03332771|537219391|FG003|Overall Study|Reason Not Specified|19|||
148927717|NCT00096954|537219394|FG000|Overall Study|Adverse Event|3|||
148927718|NCT00096954|537219395|FG001|Overall Study|Adverse Event|1|||
148927719|NCT00096954|537219394|FG000|Overall Study|Withdrawal by Subject|9|||
148927720|NCT00096954|537219395|FG001|Overall Study|Withdrawal by Subject|8|||
148927721|NCT00096954|537219394|FG000|Overall Study|Physician Decision|1|||
148927722|NCT00096954|537219395|FG001|Overall Study|Physician Decision|1|||
148927723|NCT00096954|537219394|FG000|Overall Study|Sponsors Decision|1|||
148927724|NCT00096954|537219395|FG001|Overall Study|Sponsors Decision|1|||
148927725|NCT00096954|537219394|FG000|Overall Study|Pregnancy|1|||
149166732|NCT01355289|538084399|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
148675598|NCT03193190|536283034|FG010|Stage 1|Reason not Specified|3|||
148675599|NCT03193190|536283035|FG011|Stage 1|Reason not Specified|0|||
148675600|NCT03193190|536283036|FG012|Stage 1|Reason not Specified|1|||
148675601|NCT03193190|536283037|FG013|Stage 1|Reason not Specified|0|||
148675602|NCT03193190|536283038|FG014|Stage 1|Reason not Specified|0|||
148675603|NCT03193190|536283039|FG015|Stage 1|Reason not Specified|0|||
148675604|NCT03193190|536283024|FG000|Stage 1|Physician Decision|0|||
148675605|NCT03193190|536283025|FG001|Stage 1|Physician Decision|0|||
148675606|NCT03193190|536283026|FG002|Stage 1|Physician Decision|0|||
148675607|NCT03193190|536283027|FG003|Stage 1|Physician Decision|0|||
148675608|NCT03193190|536283028|FG004|Stage 1|Physician Decision|0|||
148675609|NCT03193190|536283029|FG005|Stage 1|Physician Decision|0|||
148675610|NCT03193190|536283030|FG006|Stage 1|Physician Decision|0|||
148675611|NCT03193190|536283031|FG007|Stage 1|Physician Decision|0|||
148675612|NCT03193190|536283032|FG008|Stage 1|Physician Decision|0|||
148675613|NCT03193190|536283033|FG009|Stage 1|Physician Decision|0|||
148675614|NCT03193190|536283034|FG010|Stage 1|Physician Decision|0|||
148675615|NCT03193190|536283035|FG011|Stage 1|Physician Decision|1|||
148675616|NCT03193190|536283036|FG012|Stage 1|Physician Decision|0|||
148675617|NCT03193190|536283037|FG013|Stage 1|Physician Decision|0|||
148675618|NCT03193190|536283038|FG014|Stage 1|Physician Decision|0|||
148675619|NCT03193190|536283039|FG015|Stage 1|Physician Decision|0|||
148675620|NCT03193190|536283024|FG000|Stage 1|Progressive Disease|1|||
148675621|NCT03193190|536283025|FG001|Stage 1|Progressive Disease|0|||
148675622|NCT03193190|536283026|FG002|Stage 1|Progressive Disease|0|||
148675623|NCT03193190|536283027|FG003|Stage 1|Progressive Disease|0|||
148675624|NCT03193190|536283028|FG004|Stage 1|Progressive Disease|0|||
148675625|NCT03193190|536283029|FG005|Stage 1|Progressive Disease|0|||
148675626|NCT03193190|536283030|FG006|Stage 1|Progressive Disease|0|||
148675627|NCT03193190|536283031|FG007|Stage 1|Progressive Disease|0|||
148675628|NCT03193190|536283032|FG008|Stage 1|Progressive Disease|0|||
148675629|NCT03193190|536283033|FG009|Stage 1|Progressive Disease|0|||
148675630|NCT03193190|536283034|FG010|Stage 1|Progressive Disease|0|||
148675631|NCT03193190|536283035|FG011|Stage 1|Progressive Disease|0|||
148675632|NCT03193190|536283036|FG012|Stage 1|Progressive Disease|0|||
148675633|NCT03193190|536283037|FG013|Stage 1|Progressive Disease|0|||
148675634|NCT03193190|536283038|FG014|Stage 1|Progressive Disease|0|||
148675635|NCT03193190|536283039|FG015|Stage 1|Progressive Disease|0|||
148927726|NCT00096954|537219395|FG001|Overall Study|Pregnancy|1|||
148927727|NCT00096954|537219394|FG000|Overall Study|Initiation of immunotherapy|1|||
148927728|NCT00096954|537219395|FG001|Overall Study|Initiation of immunotherapy|0|||
149166733|NCT01355289|538084400|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
149166734|NCT01355289|538084396|FG000|Open Label Extension|Other|0|||
148675636|NCT03193190|536283024|FG000|Stage 1|Study Terminated By Sponsor|3|||
148675637|NCT03193190|536283025|FG001|Stage 1|Study Terminated By Sponsor|0|||
148675638|NCT03193190|536283026|FG002|Stage 1|Study Terminated By Sponsor|0|||
148675639|NCT03193190|536283027|FG003|Stage 1|Study Terminated By Sponsor|0|||
148675640|NCT03193190|536283028|FG004|Stage 1|Study Terminated By Sponsor|6|||
148675641|NCT03193190|536283029|FG005|Stage 1|Study Terminated By Sponsor|0|||
148675642|NCT03193190|536283030|FG006|Stage 1|Study Terminated By Sponsor|0|||
148675643|NCT03193190|536283031|FG007|Stage 1|Study Terminated By Sponsor|0|||
149166735|NCT01355289|538084397|FG001|Open Label Extension|Other|0|||
148675644|NCT03193190|536283032|FG008|Stage 1|Study Terminated By Sponsor|0|||
148927729|NCT00096954|537219394|FG000|Overall Study|Non-compliance|0|||
148927730|NCT00096954|537219395|FG001|Overall Study|Non-compliance|3|||
148675645|NCT03193190|536283033|FG009|Stage 1|Study Terminated By Sponsor|0|||
148675646|NCT03193190|536283034|FG010|Stage 1|Study Terminated By Sponsor|0|||
148675647|NCT03193190|536283035|FG011|Stage 1|Study Terminated By Sponsor|0|||
148927731|NCT00096954|537219394|FG000|Overall Study|Lost to Follow-up|8|||
148927732|NCT00096954|537219395|FG001|Overall Study|Lost to Follow-up|5|||
148927733|NCT03442764|537219396|FG000|Overall Study|Adverse Event|1|||
148927734|NCT03442764|537219397|FG001|Overall Study|Adverse Event|0|||
148927735|NCT03442764|537219398|FG002|Overall Study|Adverse Event|0|||
148927736|NCT05523323|537219405|FG000|Overall Study|Death|26|||
148927737|NCT05523323|537219406|FG001|Overall Study|Death|21|||
148927738|NCT05523323|537219405|FG000|Overall Study|Ongoing participants|35|||
149166736|NCT01355289|538084398|FG002|Open Label Extension|Other|0|||
149166737|NCT01355289|538084399|FG003|Open Label Extension|Other|0|||
149166738|NCT01355289|538084400|FG004|Open Label Extension|Other|3|||
149166739|NCT01756456|538084406|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
149166740|NCT01756456|538084407|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
149166741|NCT01756456|538084408|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
149166742|NCT01756456|538084409|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
149166743|NCT01756456|538084410|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
148927739|NCT05523323|537219406|FG001|Overall Study|Ongoing participants|30|||
148927740|NCT02469038|537219407|FG000|Overall Study|Physician Decision|4|||
148927741|NCT02469038|537219408|FG001|Overall Study|Physician Decision|5|||
148927742|NCT03435640|537219409|FG000|Overall Study|Withdrawal by Subject|0|||
148927743|NCT03435640|537219410|FG001|Overall Study|Withdrawal by Subject|1|||
148927744|NCT03435640|537219411|FG002|Overall Study|Withdrawal by Subject|0|||
148927745|NCT03435640|537219412|FG003|Overall Study|Withdrawal by Subject|2|||
148927746|NCT03435640|537219413|FG004|Overall Study|Withdrawal by Subject|0|||
148927747|NCT03435640|537219414|FG005|Overall Study|Withdrawal by Subject|0|||
148927748|NCT03435640|537219415|FG006|Overall Study|Withdrawal by Subject|3|||
148927749|NCT03435640|537219416|FG007|Overall Study|Withdrawal by Subject|0|||
148927750|NCT03435640|537219417|FG008|Overall Study|Withdrawal by Subject|0|||
148927751|NCT03435640|537219418|FG009|Overall Study|Withdrawal by Subject|2|||
148927752|NCT03435640|537219419|FG010|Overall Study|Withdrawal by Subject|3|||
148927753|NCT03435640|537219409|FG000|Overall Study|Lost to Follow-up|0|||
148927754|NCT03435640|537219410|FG001|Overall Study|Lost to Follow-up|0|||
149166744|NCT01756456|538084411|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
149166745|NCT01756456|538084406|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149166746|NCT01756456|538084407|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149166747|NCT01756456|538084408|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149166748|NCT01756456|538084409|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
149166749|NCT01756456|538084410|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
149166750|NCT01756456|538084411|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
149166751|NCT01756456|538084406|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149166752|NCT01756456|538084407|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
149166753|NCT01756456|538084408|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149166754|NCT01756456|538084409|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149166755|NCT01756456|538084410|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149166756|NCT01756456|538084411|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
149166757|NCT01756456|538084406|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
149166758|NCT01756456|538084407|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
149166759|NCT01756456|538084408|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
149166760|NCT01756456|538084409|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
149166761|NCT01756456|538084410|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
149166762|NCT01756456|538084411|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
149166763|NCT01756456|538084406|FG000|Treatment Period: Phase I/II|Other causes|0|||
148927755|NCT03435640|537219411|FG002|Overall Study|Lost to Follow-up|1|||
148927756|NCT03435640|537219412|FG003|Overall Study|Lost to Follow-up|0|||
148927757|NCT03435640|537219413|FG004|Overall Study|Lost to Follow-up|0|||
148927758|NCT03435640|537219414|FG005|Overall Study|Lost to Follow-up|0|||
148927759|NCT03435640|537219415|FG006|Overall Study|Lost to Follow-up|0|||
148927760|NCT03435640|537219416|FG007|Overall Study|Lost to Follow-up|0|||
148927761|NCT03435640|537219417|FG008|Overall Study|Lost to Follow-up|0|||
148927762|NCT03435640|537219418|FG009|Overall Study|Lost to Follow-up|0|||
148927763|NCT03435640|537219419|FG010|Overall Study|Lost to Follow-up|0|||
149166764|NCT01756456|538084407|FG001|Treatment Period: Phase I/II|Other causes|0|||
149166765|NCT01756456|538084408|FG002|Treatment Period: Phase I/II|Other causes|0|||
149166766|NCT01756456|538084409|FG003|Treatment Period: Phase I/II|Other causes|1|||
149166767|NCT01756456|538084410|FG004|Treatment Period: Phase I/II|Other causes|2|||
149166768|NCT01756456|538084411|FG005|Treatment Period: Phase I/II|Other causes|2|||
148927764|NCT00636987|537219420|FG000|Overall Study|Death|44|||
148927765|NCT00636987|537219420|FG000|Overall Study|Explanted|13|||
148927766|NCT00636987|537219420|FG000|Overall Study|Lost to Follow-up|63|||
148927767|NCT00636987|537219420|FG000|Overall Study|5 year visit window not complete|69|||
148927768|NCT01251146|537219421|FG000|Overall Study|Lost to Follow-up|3|||
148927769|NCT01251146|537219422|FG001|Overall Study|Lost to Follow-up|10|||
148927770|NCT01739400|537219423|FG000|Overall Study|Physician Decision|3|||
148927771|NCT01739400|537219424|FG001|Overall Study|Physician Decision|0|||
148927772|NCT01739400|537219423|FG000|Overall Study|Lost to Follow-up|2|||
148927773|NCT01739400|537219424|FG001|Overall Study|Lost to Follow-up|0|||
149166769|NCT01756456|538084406|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
148927774|NCT01739400|537219423|FG000|Overall Study|Death|5|||
148927775|NCT01739400|537219424|FG001|Overall Study|Death|2|||
149166770|NCT01756456|538084407|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
149166771|NCT01756456|538084408|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
149166772|NCT01756456|538084409|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
149166773|NCT01756456|538084410|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
149166774|NCT01756456|538084411|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
149166775|NCT01756456|538084406|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149166776|NCT01756456|538084407|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
148927776|NCT01739400|537219423|FG000|Overall Study|Withdrawal by Subject|7|||
148927777|NCT01739400|537219424|FG001|Overall Study|Withdrawal by Subject|7|||
148927778|NCT03350984|537219425|FG000|Overall Study|Death|1|||
148927779|NCT03350984|537219426|FG001|Overall Study|Death|0|||
148927780|NCT03350984|537219425|FG000|Overall Study|Lost to Follow-up|5|||
148927781|NCT03350984|537219426|FG001|Overall Study|Lost to Follow-up|6|||
149012998|NCT02906683|537527760|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
149012999|NCT02906683|537527758|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
149013000|NCT02906683|537527759|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
149013001|NCT02906683|537527760|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
149013002|NCT02791490|537527765|FG000|Overall Study|Lost to Follow-up|1|||
149013003|NCT02791490|537527766|FG001|Overall Study|Lost to Follow-up|2|||
149013004|NCT02791490|537527765|FG000|Overall Study|Withdrawal by Subject|2|||
149013005|NCT02791490|537527766|FG001|Overall Study|Withdrawal by Subject|6|||
149013006|NCT01189890|537527767|FG000|Overall Study|Adverse Event|3|||
149013007|NCT01189890|537527768|FG001|Overall Study|Adverse Event|4|||
149013008|NCT01189890|537527767|FG000|Overall Study|Lack of Efficacy|7|||
149013009|NCT01189890|537527768|FG001|Overall Study|Lack of Efficacy|2|||
149013010|NCT01189890|537527767|FG000|Overall Study|Lost to Follow-up|1|||
149013011|NCT01189890|537527768|FG001|Overall Study|Lost to Follow-up|7|||
149013012|NCT01189890|537527767|FG000|Overall Study|Protocol Violation|1|||
149166777|NCT01756456|538084408|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149166778|NCT01756456|538084409|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
148927782|NCT03350984|537219425|FG000|Overall Study|Protocol Violation|1|||
148927783|NCT03350984|537219426|FG001|Overall Study|Protocol Violation|2|||
148927784|NCT03350984|537219425|FG000|Overall Study|Physician Decision|1|||
149013013|NCT01189890|537527768|FG001|Overall Study|Protocol Violation|5|||
149166779|NCT01756456|538084410|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
149166780|NCT01756456|538084411|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
148927785|NCT03350984|537219426|FG001|Overall Study|Physician Decision|0|||
148927786|NCT01347307|537219427|FG000|Overall Study|Death|0|||
148927787|NCT01347307|537219428|FG001|Overall Study|Death|4|||
148927788|NCT01347307|537219427|FG000|Overall Study|Physician Decision|0|||
148927789|NCT01347307|537219428|FG001|Overall Study|Physician Decision|1|||
148927790|NCT00920829|537219430|FG000|Allocation|No post randomization data|3|||
149166781|NCT01756456|538084406|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149166782|NCT01756456|538084407|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149166783|NCT01756456|538084408|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149166784|NCT01756456|538084409|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149166785|NCT01756456|538084410|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
149166786|NCT01756456|538084411|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
149166787|NCT01756456|538084406|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
149166788|NCT01756456|538084407|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
149166789|NCT01756456|538084408|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
149166790|NCT01756456|538084409|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
149013014|NCT01189890|537527767|FG000|Overall Study|Withdrawal by Subject|15|||
149013015|NCT01189890|537527768|FG001|Overall Study|Withdrawal by Subject|11|||
149166791|NCT01756456|538084410|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
149166792|NCT01756456|538084411|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
149013016|NCT01189890|537527767|FG000|Overall Study|Non Compliance|0|||
148927791|NCT00920829|537219431|FG001|Allocation|No post randomization data|1|||
148927792|NCT00920829|537219432|FG002|Allocation|No post randomization data|0|||
148927793|NCT00920829|537219433|FG003|Allocation|No post randomization data|2|||
148927794|NCT00920829|537219430|FG000|Available for Analysis|Withdrawal by Subject|6|||
148927795|NCT00920829|537219431|FG001|Available for Analysis|Withdrawal by Subject|6|||
148927796|NCT00920829|537219432|FG002|Available for Analysis|Withdrawal by Subject|6|||
148927797|NCT00920829|537219433|FG003|Available for Analysis|Withdrawal by Subject|10|||
148927798|NCT00920829|537219430|FG000|Available for Analysis|Required Medical Treatment|0|||
148927799|NCT00920829|537219431|FG001|Available for Analysis|Required Medical Treatment|1|||
148927800|NCT00920829|537219432|FG002|Available for Analysis|Required Medical Treatment|2|||
148927801|NCT00920829|537219433|FG003|Available for Analysis|Required Medical Treatment|0|||
148927802|NCT00920829|537219430|FG000|Available for Analysis|Adverse Event|1|||
148927803|NCT00920829|537219431|FG001|Available for Analysis|Adverse Event|2|||
148927804|NCT00920829|537219432|FG002|Available for Analysis|Adverse Event|1|||
148927805|NCT00920829|537219433|FG003|Available for Analysis|Adverse Event|0|||
148927806|NCT00920829|537219430|FG000|Available for Analysis|Death|1|||
148927807|NCT00920829|537219431|FG001|Available for Analysis|Death|0|||
148927808|NCT00920829|537219432|FG002|Available for Analysis|Death|0|||
148927809|NCT00920829|537219433|FG003|Available for Analysis|Death|0|||
148927810|NCT00920829|537219430|FG000|Available for Analysis|Protocol Violation|0|||
149013017|NCT01189890|537527768|FG001|Overall Study|Non Compliance|1|||
149013018|NCT01189890|537527767|FG000|Overall Study|Physician Decision|5|||
148927811|NCT00920829|537219431|FG001|Available for Analysis|Protocol Violation|0|||
149166793|NCT01756456|538084406|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
149166794|NCT01756456|538084407|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
149166795|NCT01756456|538084408|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
148927812|NCT00920829|537219432|FG002|Available for Analysis|Protocol Violation|1|||
148927813|NCT00920829|537219433|FG003|Available for Analysis|Protocol Violation|0|||
148927814|NCT00920829|537219430|FG000|Available for Analysis|Required more treatment|0|||
148927815|NCT00920829|537219431|FG001|Available for Analysis|Required more treatment|2|||
148927816|NCT00920829|537219432|FG002|Available for Analysis|Required more treatment|0|||
148927817|NCT00920829|537219433|FG003|Available for Analysis|Required more treatment|1|||
148927818|NCT04533880|537219434|FG000|Overall Study|Lost to Follow-up|0|||
148927819|NCT04533880|537219435|FG001|Overall Study|Lost to Follow-up|1|||
148927820|NCT04533880|537219436|FG002|Overall Study|Lost to Follow-up|1|||
148927821|NCT02284178|537219439|FG000|Overall Study|Met exclusion criteria|49|||
148927822|NCT02284178|537219440|FG001|Overall Study|Met exclusion criteria|54|||
148927823|NCT01483690|537219443|FG000|Overall Study|Adverse Event|1|||
148675648|NCT03193190|536283036|FG012|Stage 1|Study Terminated By Sponsor|0|||
148675649|NCT03193190|536283037|FG013|Stage 1|Study Terminated By Sponsor|0|||
148675650|NCT03193190|536283038|FG014|Stage 1|Study Terminated By Sponsor|0|||
148675651|NCT03193190|536283039|FG015|Stage 1|Study Terminated By Sponsor|0|||
148675652|NCT03193190|536283024|FG000|Stage 1|Withdrawal by Subject|6|||
148675653|NCT03193190|536283025|FG001|Stage 1|Withdrawal by Subject|0|||
148675654|NCT03193190|536283026|FG002|Stage 1|Withdrawal by Subject|1|||
148675655|NCT03193190|536283027|FG003|Stage 1|Withdrawal by Subject|0|||
148675656|NCT03193190|536283028|FG004|Stage 1|Withdrawal by Subject|2|||
148675657|NCT03193190|536283029|FG005|Stage 1|Withdrawal by Subject|0|||
148675658|NCT03193190|536283030|FG006|Stage 1|Withdrawal by Subject|3|||
148675659|NCT03193190|536283031|FG007|Stage 1|Withdrawal by Subject|2|||
148675660|NCT03193190|536283032|FG008|Stage 1|Withdrawal by Subject|2|||
148675661|NCT03193190|536283033|FG009|Stage 1|Withdrawal by Subject|4|||
148675662|NCT03193190|536283034|FG010|Stage 1|Withdrawal by Subject|9|||
148675663|NCT03193190|536283035|FG011|Stage 1|Withdrawal by Subject|1|||
148675664|NCT03193190|536283036|FG012|Stage 1|Withdrawal by Subject|0|||
148675665|NCT03193190|536283037|FG013|Stage 1|Withdrawal by Subject|0|||
148675666|NCT03193190|536283038|FG014|Stage 1|Withdrawal by Subject|0|||
148675667|NCT03193190|536283039|FG015|Stage 1|Withdrawal by Subject|0|||
148675668|NCT03193190|536283024|FG000|Stage 2|Death|0|||
148675669|NCT03193190|536283025|FG001|Stage 2|Death|0|||
148675670|NCT03193190|536283026|FG002|Stage 2|Death|0|||
148675671|NCT03193190|536283027|FG003|Stage 2|Death|0|||
148675672|NCT03193190|536283028|FG004|Stage 2|Death|0|||
148675673|NCT03193190|536283029|FG005|Stage 2|Death|0|||
148675674|NCT03193190|536283030|FG006|Stage 2|Death|0|||
148675675|NCT03193190|536283031|FG007|Stage 2|Death|0|||
148675676|NCT03193190|536283032|FG008|Stage 2|Death|0|||
148675677|NCT03193190|536283033|FG009|Stage 2|Death|0|||
148675678|NCT03193190|536283034|FG010|Stage 2|Death|0|||
148675679|NCT03193190|536283035|FG011|Stage 2|Death|0|||
148675680|NCT03193190|536283036|FG012|Stage 2|Death|0|||
148675681|NCT03193190|536283037|FG013|Stage 2|Death|14|||
148675682|NCT03193190|536283038|FG014|Stage 2|Death|4|||
148675683|NCT03193190|536283039|FG015|Stage 2|Death|1|||
148675684|NCT03193190|536283024|FG000|Stage 2|Lost to Follow-up|0|||
148675685|NCT03193190|536283025|FG001|Stage 2|Lost to Follow-up|0|||
148675686|NCT03193190|536283026|FG002|Stage 2|Lost to Follow-up|0|||
148675687|NCT03193190|536283027|FG003|Stage 2|Lost to Follow-up|0|||
148675688|NCT03193190|536283028|FG004|Stage 2|Lost to Follow-up|0|||
148675689|NCT03193190|536283029|FG005|Stage 2|Lost to Follow-up|0|||
148675690|NCT03193190|536283030|FG006|Stage 2|Lost to Follow-up|0|||
148675691|NCT03193190|536283031|FG007|Stage 2|Lost to Follow-up|0|||
148927824|NCT01483690|537219444|FG001|Overall Study|Adverse Event|2|||
148927825|NCT01483690|537219443|FG000|Overall Study|clinical deterioration|1|||
148675692|NCT03193190|536283032|FG008|Stage 2|Lost to Follow-up|0|||
148675693|NCT03193190|536283033|FG009|Stage 2|Lost to Follow-up|0|||
148675694|NCT03193190|536283034|FG010|Stage 2|Lost to Follow-up|0|||
148675695|NCT03193190|536283035|FG011|Stage 2|Lost to Follow-up|0|||
148675696|NCT03193190|536283036|FG012|Stage 2|Lost to Follow-up|0|||
148675697|NCT03193190|536283037|FG013|Stage 2|Lost to Follow-up|0|||
148927826|NCT01483690|537219444|FG001|Overall Study|clinical deterioration|0|||
148927827|NCT01483690|537219443|FG000|Overall Study|Physician Decision|0|||
148927828|NCT01483690|537219444|FG001|Overall Study|Physician Decision|2|||
148927829|NCT01483690|537219443|FG000|Overall Study|exclusionary procedure|0|||
148675698|NCT03193190|536283038|FG014|Stage 2|Lost to Follow-up|1|||
148927830|NCT01483690|537219444|FG001|Overall Study|exclusionary procedure|1|||
148675699|NCT03193190|536283039|FG015|Stage 2|Lost to Follow-up|0|||
148675700|NCT03193190|536283024|FG000|Stage 2|Withdrawal by Subject|0|||
148675701|NCT03193190|536283025|FG001|Stage 2|Withdrawal by Subject|0|||
148927831|NCT02239224|537219453|FG000|Overall Study|Administrative|0|||
148927832|NCT02239224|537219454|FG001|Overall Study|Administrative|0|||
148927833|NCT02239224|537219455|FG002|Overall Study|Administrative|3|||
148675702|NCT03193190|536283026|FG002|Stage 2|Withdrawal by Subject|0|||
148675703|NCT03193190|536283027|FG003|Stage 2|Withdrawal by Subject|0|||
148675704|NCT03193190|536283028|FG004|Stage 2|Withdrawal by Subject|0|||
148675705|NCT03193190|536283029|FG005|Stage 2|Withdrawal by Subject|0|||
148675706|NCT03193190|536283030|FG006|Stage 2|Withdrawal by Subject|0|||
148675707|NCT03193190|536283031|FG007|Stage 2|Withdrawal by Subject|0|||
148675708|NCT03193190|536283032|FG008|Stage 2|Withdrawal by Subject|0|||
148927834|NCT02239224|537219456|FG003|Overall Study|Administrative|1|||
148927835|NCT03228420|537219470|FG000|Overall Study|Lost to Follow-up|5|||
148927836|NCT03228420|537219471|FG001|Overall Study|Lost to Follow-up|3|||
148927837|NCT03228420|537219470|FG000|Overall Study|Withdrawal by Subject|10|||
148927838|NCT03228420|537219471|FG001|Overall Study|Withdrawal by Subject|0|||
148927839|NCT03228420|537219470|FG000|Overall Study|Adverse Event|5|||
148927840|NCT03228420|537219471|FG001|Overall Study|Adverse Event|2|||
148927841|NCT03954041|537219475|FG000|Overall Study|Lost to Follow-up|3|||
148927842|NCT03954041|537219476|FG001|Overall Study|Lost to Follow-up|3|||
148927843|NCT03954041|537219477|FG002|Overall Study|Lost to Follow-up|6|||
148927844|NCT03954041|537219475|FG000|Overall Study|Death|4|||
149166796|NCT01756456|538084409|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
149166797|NCT01756456|538084410|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
149166798|NCT01756456|538084411|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
149166799|NCT01756456|538084406|FG000|Follow Up Period Phase I/II|Other causes|0|||
149166800|NCT01756456|538084407|FG001|Follow Up Period Phase I/II|Other causes|0|||
149166801|NCT01756456|538084408|FG002|Follow Up Period Phase I/II|Other causes|0|||
149166802|NCT01756456|538084409|FG003|Follow Up Period Phase I/II|Other causes|1|||
149166803|NCT01756456|538084410|FG004|Follow Up Period Phase I/II|Other causes|3|||
149166804|NCT01756456|538084411|FG005|Follow Up Period Phase I/II|Other causes|5|||
149166805|NCT02706938|538084412|FG000|First Period, 6 Weeks|Adverse Event|8|||
149166806|NCT02706938|538084413|FG001|First Period, 6 Weeks|Adverse Event|0|||
149166807|NCT02706938|538084412|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
149166808|NCT02706938|538084413|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
149166809|NCT02706938|538084412|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
149166810|NCT02706938|538084413|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
149166811|NCT02706938|538084412|FG000|Second Period, 6 Weeks|Adverse Event|0|||
149166812|NCT02706938|538084413|FG001|Second Period, 6 Weeks|Adverse Event|7|||
149166813|NCT02706938|538084412|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
149166814|NCT02706938|538084413|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
149166815|NCT02507349|538084418|FG000|Overall Study|Death|12|||
149166816|NCT02507349|538084419|FG001|Overall Study|Death|16|||
149166817|NCT02507349|538084418|FG000|Overall Study|Withdrawal by Subject|1|||
149166818|NCT02507349|538084419|FG001|Overall Study|Withdrawal by Subject|1|||
149166819|NCT02507349|538084418|FG000|Overall Study|Lost to Follow-up|174|||
149166820|NCT02507349|538084419|FG001|Overall Study|Lost to Follow-up|144|||
149166821|NCT00813995|538084420|FG000|Overall Study|Clinical adverse event|9|||
149166822|NCT00813995|538084421|FG001|Overall Study|Clinical adverse event|3|||
149166823|NCT00813995|538084420|FG000|Overall Study|Laboratory adverse event|0|||
149166824|NCT00813995|538084421|FG001|Overall Study|Laboratory adverse event|2|||
149166825|NCT00813995|538084420|FG000|Overall Study|Lack of Efficacy|1|||
149166826|NCT00813995|538084421|FG001|Overall Study|Lack of Efficacy|0|||
149166827|NCT00813995|538084420|FG000|Overall Study|Lost to Follow-up|4|||
149166828|NCT00813995|538084421|FG001|Overall Study|Lost to Follow-up|2|||
149166829|NCT00813995|538084420|FG000|Overall Study|Other reason|2|||
149166830|NCT00813995|538084421|FG001|Overall Study|Other reason|2|||
149166831|NCT00813995|538084420|FG000|Overall Study|Protocol Violation|3|||
149166832|NCT00813995|538084421|FG001|Overall Study|Protocol Violation|2|||
149166833|NCT00813995|538084420|FG000|Overall Study|Subject moved|4|||
149166834|NCT00813995|538084421|FG001|Overall Study|Subject moved|0|||
149166835|NCT00813995|538084420|FG000|Overall Study|Withdrawal by Subject|0|||
149166836|NCT00813995|538084421|FG001|Overall Study|Withdrawal by Subject|5|||
149166837|NCT01614964|538084422|FG000|Overall Study|Withdrawal by Subject|2|||
149166838|NCT01614964|538084423|FG001|Overall Study|Withdrawal by Subject|0|||
149166839|NCT01614964|538084422|FG000|Overall Study|Lost to Follow-up|3|||
149166840|NCT01614964|538084423|FG001|Overall Study|Lost to Follow-up|0|||
149166841|NCT00860470|538084426|FG000|Overall Study|Death|6|||
149166842|NCT00860470|538084427|FG001|Overall Study|Death|10|||
149166843|NCT00860470|538084426|FG000|Overall Study|Moved away|8|||
149166844|NCT00860470|538084427|FG001|Overall Study|Moved away|10|||
149166845|NCT00860470|538084426|FG000|Overall Study|Lost to Follow-up|34|||
149166846|NCT00860470|538084427|FG001|Overall Study|Lost to Follow-up|39|||
149166847|NCT00348140|538084428|FG000|Overall Study|Adverse Event|46|||
149166848|NCT00348140|538084429|FG001|Overall Study|Adverse Event|49|||
149166849|NCT00348140|538084430|FG002|Overall Study|Adverse Event|78|||
148927845|NCT03954041|537219476|FG001|Overall Study|Death|0|||
148927846|NCT03954041|537219477|FG002|Overall Study|Death|1|||
149013019|NCT01189890|537527768|FG001|Overall Study|Physician Decision|4|||
149166850|NCT00348140|538084428|FG000|Overall Study|Lost to Follow-up|4|||
149166851|NCT00348140|538084429|FG001|Overall Study|Lost to Follow-up|4|||
149166852|NCT00348140|538084430|FG002|Overall Study|Lost to Follow-up|4|||
149166853|NCT00348140|538084428|FG000|Overall Study|Protocol Violation|12|||
149166854|NCT00348140|538084429|FG001|Overall Study|Protocol Violation|13|||
149166855|NCT00348140|538084430|FG002|Overall Study|Protocol Violation|14|||
149166856|NCT00348140|538084428|FG000|Overall Study|Withdrawal by Subject|32|||
149166857|NCT00348140|538084429|FG001|Overall Study|Withdrawal by Subject|40|||
149166858|NCT00348140|538084430|FG002|Overall Study|Withdrawal by Subject|40|||
149166859|NCT00348140|538084428|FG000|Overall Study|Non-compliance|8|||
149166860|NCT00348140|538084429|FG001|Overall Study|Non-compliance|13|||
149013020|NCT01189890|537527767|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
149013021|NCT01189890|537527768|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
149013022|NCT02802319|537527771|FG000|Overall Study|Physician Decision|2|||
149013023|NCT02802319|537527772|FG001|Overall Study|Physician Decision|1|||
149013024|NCT02802319|537527771|FG000|Overall Study|Lost to Follow-up|0|||
149013025|NCT02802319|537527772|FG001|Overall Study|Lost to Follow-up|4|||
149013026|NCT04651114|537527773|FG000|Overall Study|Withdrawal by Subject|8|||
149013027|NCT00077636|537527774|FG000|Overall Study|Refused Treatment|9|||
149013028|NCT00077636|537527775|FG001|Overall Study|Refused Treatment|31|||
149013029|NCT00077636|537527774|FG000|Overall Study|Admin|3|||
149166861|NCT00348140|538084430|FG002|Overall Study|Non-compliance|5|||
149013030|NCT00077636|537527775|FG001|Overall Study|Admin|3|||
149013031|NCT00077636|537527774|FG000|Overall Study|Withdrawal by Subject|2|||
149166862|NCT00348140|538084428|FG000|Overall Study|Participant at risk due to study drug|2|||
149166863|NCT00348140|538084429|FG001|Overall Study|Participant at risk due to study drug|0|||
149166864|NCT00348140|538084430|FG002|Overall Study|Participant at risk due to study drug|0|||
149166865|NCT00348140|538084428|FG000|Overall Study|Conditional medication increased dose|1|||
149166866|NCT00348140|538084429|FG001|Overall Study|Conditional medication increased dose|0|||
149166867|NCT00348140|538084430|FG002|Overall Study|Conditional medication increased dose|0|||
149166868|NCT00348140|538084428|FG000|Overall Study|Caregiver related|4|||
149166869|NCT00348140|538084429|FG001|Overall Study|Caregiver related|7|||
149166870|NCT00348140|538084430|FG002|Overall Study|Caregiver related|3|||
149166871|NCT00348140|538084428|FG000|Overall Study|Participant hospitalised|3|||
149166872|NCT00348140|538084429|FG001|Overall Study|Participant hospitalised|0|||
149166873|NCT00348140|538084430|FG002|Overall Study|Participant hospitalised|0|||
149166874|NCT00348140|538084428|FG000|Overall Study|Efficacy related|1|||
149166875|NCT00348140|538084429|FG001|Overall Study|Efficacy related|1|||
149166876|NCT00348140|538084430|FG002|Overall Study|Efficacy related|0|||
149166877|NCT00348140|538084428|FG000|Overall Study|Administration related|3|||
149166878|NCT00348140|538084429|FG001|Overall Study|Administration related|1|||
149166879|NCT00348140|538084430|FG002|Overall Study|Administration related|1|||
149166880|NCT00348140|538084428|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
149166881|NCT00348140|538084429|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
149166882|NCT00348140|538084430|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
149166883|NCT00348140|538084428|FG000|Overall Study|Participant unwell|1|||
149166884|NCT00348140|538084429|FG001|Overall Study|Participant unwell|0|||
149166885|NCT00348140|538084430|FG002|Overall Study|Participant unwell|0|||
149166886|NCT00348140|538084428|FG000|Overall Study|Screen failure|1|||
149166887|NCT00348140|538084429|FG001|Overall Study|Screen failure|0|||
149166888|NCT00348140|538084430|FG002|Overall Study|Screen failure|0|||
149166889|NCT00348140|538084428|FG000|Overall Study|Investigator decided to discontinue|4|||
149166890|NCT00348140|538084429|FG001|Overall Study|Investigator decided to discontinue|1|||
149166891|NCT00348140|538084430|FG002|Overall Study|Investigator decided to discontinue|4|||
149166892|NCT00348140|538084428|FG000|Overall Study|Decided to discontinue on their own|1|||
149166893|NCT00348140|538084429|FG001|Overall Study|Decided to discontinue on their own|4|||
149166894|NCT00348140|538084430|FG002|Overall Study|Decided to discontinue on their own|1|||
149166895|NCT00348140|538084428|FG000|Overall Study|Use of prohibited drug|1|||
149166896|NCT00348140|538084429|FG001|Overall Study|Use of prohibited drug|0|||
149166897|NCT00348140|538084430|FG002|Overall Study|Use of prohibited drug|2|||
149166898|NCT00348140|538084428|FG000|Overall Study|Disease progression|1|||
149166899|NCT00348140|538084429|FG001|Overall Study|Disease progression|2|||
149166900|NCT00348140|538084430|FG002|Overall Study|Disease progression|5|||
149166901|NCT00348140|538084428|FG000|Overall Study|Increased risk of cardiac infarction|0|||
149166902|NCT00348140|538084429|FG001|Overall Study|Increased risk of cardiac infarction|1|||
149166903|NCT00348140|538084430|FG002|Overall Study|Increased risk of cardiac infarction|0|||
149166904|NCT00348140|538084428|FG000|Overall Study|Serious adverse event|0|||
149166905|NCT00348140|538084429|FG001|Overall Study|Serious adverse event|1|||
149166906|NCT00348140|538084430|FG002|Overall Study|Serious adverse event|0|||
149166907|NCT00348140|538084428|FG000|Overall Study|Abnormal ECG|0|||
149166908|NCT00348140|538084429|FG001|Overall Study|Abnormal ECG|1|||
149166909|NCT00348140|538084430|FG002|Overall Study|Abnormal ECG|3|||
149166910|NCT00348140|538084428|FG000|Overall Study|Participant died|0|||
149166911|NCT00348140|538084429|FG001|Overall Study|Participant died|1|||
149166912|NCT00348140|538084430|FG002|Overall Study|Participant died|0|||
149166913|NCT00348140|538084428|FG000|Overall Study|Exclusion criteria met|0|||
149166914|NCT00348140|538084429|FG001|Overall Study|Exclusion criteria met|0|||
149166915|NCT00348140|538084430|FG002|Overall Study|Exclusion criteria met|1|||
149166916|NCT00348140|538084428|FG000|Overall Study|Memory declined|0|||
149166917|NCT00348140|538084429|FG001|Overall Study|Memory declined|0|||
149013032|NCT00077636|537527775|FG001|Overall Study|Withdrawal by Subject|2|||
148927847|NCT03954041|537219475|FG000|Overall Study|Death by neurologic criteria|0|||
148927848|NCT03954041|537219476|FG001|Overall Study|Death by neurologic criteria|0|||
148927849|NCT03954041|537219477|FG002|Overall Study|Death by neurologic criteria|1|||
148927850|NCT03954041|537219475|FG000|Overall Study|Reason not specified|7|||
148927851|NCT03954041|537219476|FG001|Overall Study|Reason not specified|4|||
148927852|NCT03954041|537219477|FG002|Overall Study|Reason not specified|2|||
148927853|NCT03954041|537219475|FG000|Overall Study|Withdrew prior to dosing|4|||
148927854|NCT03954041|537219476|FG001|Overall Study|Withdrew prior to dosing|2|||
148927855|NCT03954041|537219477|FG002|Overall Study|Withdrew prior to dosing|0|||
148927856|NCT03868124|537219480|FG000|Overall Study|Withdrawal by Subject|4|||
148927857|NCT03868124|537219481|FG001|Overall Study|Withdrawal by Subject|0|||
148927858|NCT03868124|537219482|FG002|Overall Study|Withdrawal by Subject|1|||
148927859|NCT03868124|537219480|FG000|Overall Study|Physician Decision|1|||
148927860|NCT03868124|537219481|FG001|Overall Study|Physician Decision|0|||
148927861|NCT03868124|537219482|FG002|Overall Study|Physician Decision|1|||
148927862|NCT03868124|537219480|FG000|Overall Study|Lost to Follow-up|1|||
148927863|NCT03868124|537219481|FG001|Overall Study|Lost to Follow-up|1|||
148927864|NCT03868124|537219482|FG002|Overall Study|Lost to Follow-up|2|||
148927865|NCT03868124|537219480|FG000|Overall Study|Death|1|||
148927866|NCT03868124|537219481|FG001|Overall Study|Death|1|||
148927867|NCT03868124|537219482|FG002|Overall Study|Death|2|||
148927868|NCT03868124|537219480|FG000|Overall Study|Adverse Event|0|||
148927869|NCT03868124|537219481|FG001|Overall Study|Adverse Event|0|||
148927870|NCT03868124|537219482|FG002|Overall Study|Adverse Event|3|||
148927871|NCT03868124|537219480|FG000|Overall Study|Explanted|2|||
148927872|NCT03868124|537219481|FG001|Overall Study|Explanted|1|||
148927873|NCT03868124|537219482|FG002|Overall Study|Explanted|0|||
148927874|NCT03868124|537219480|FG000|Overall Study|Ongoing in study|176|||
148927875|NCT03868124|537219481|FG001|Overall Study|Ongoing in study|180|||
148927876|NCT03868124|537219482|FG002|Overall Study|Ongoing in study|183|||
148927877|NCT04177355|537219483|FG000|Overall Study|Lost to Follow-up|0|||
148927878|NCT04177355|537219484|FG001|Overall Study|Lost to Follow-up|2|||
148927879|NCT04177355|537219485|FG002|Overall Study|Lost to Follow-up|0|||
148927880|NCT04177355|537219486|FG003|Overall Study|Lost to Follow-up|1|||
148927881|NCT04177355|537219487|FG004|Overall Study|Lost to Follow-up|2|||
148927882|NCT04177355|537219488|FG005|Overall Study|Lost to Follow-up|0|||
148927883|NCT04177355|537219489|FG006|Overall Study|Lost to Follow-up|1|||
148927884|NCT04177355|537219490|FG007|Overall Study|Lost to Follow-up|0|||
148927885|NCT04177355|537219491|FG008|Overall Study|Lost to Follow-up|0|||
148927886|NCT04177355|537219492|FG009|Overall Study|Lost to Follow-up|0|||
148927887|NCT04177355|537219493|FG010|Overall Study|Lost to Follow-up|0|||
148927888|NCT04177355|537219483|FG000|Overall Study|Withdrawal by Subject|0|||
148927889|NCT04177355|537219484|FG001|Overall Study|Withdrawal by Subject|0|||
148927890|NCT04177355|537219485|FG002|Overall Study|Withdrawal by Subject|0|||
148927891|NCT04177355|537219486|FG003|Overall Study|Withdrawal by Subject|1|||
148927892|NCT04177355|537219487|FG004|Overall Study|Withdrawal by Subject|1|||
148927893|NCT04177355|537219488|FG005|Overall Study|Withdrawal by Subject|0|||
149166918|NCT00348140|538084430|FG002|Overall Study|Memory declined|1|||
148927894|NCT04177355|537219489|FG006|Overall Study|Withdrawal by Subject|0|||
148927895|NCT04177355|537219490|FG007|Overall Study|Withdrawal by Subject|0|||
148927896|NCT04177355|537219491|FG008|Overall Study|Withdrawal by Subject|1|||
148927897|NCT04177355|537219492|FG009|Overall Study|Withdrawal by Subject|0|||
148927898|NCT04177355|537219493|FG010|Overall Study|Withdrawal by Subject|0|||
148927899|NCT03981822|537219494|FG000|Overall Study|Lost to Follow-up|0|||
148927900|NCT03981822|537219495|FG001|Overall Study|Lost to Follow-up|1|||
148927901|NCT03981822|537219496|FG002|Overall Study|Lost to Follow-up|1|||
148927902|NCT03981822|537219497|FG003|Overall Study|Lost to Follow-up|0|||
148927903|NCT03981822|537219498|FG004|Overall Study|Lost to Follow-up|6|||
148927904|NCT03981822|537219499|FG005|Overall Study|Lost to Follow-up|4|||
148927905|NCT03981822|537219500|FG006|Overall Study|Lost to Follow-up|4|||
148927906|NCT03981822|537219501|FG007|Overall Study|Lost to Follow-up|2|||
149166919|NCT00619957|538084431|FG000|Month 24 Double-Blind|Adverse Event|9|||
149166920|NCT00619957|538084432|FG001|Month 24 Double-Blind|Adverse Event|7|||
149166921|NCT00619957|538084431|FG000|Month 24 Double-Blind|Protocol Violation|1|||
149166922|NCT00619957|538084432|FG001|Month 24 Double-Blind|Protocol Violation|0|||
149166923|NCT00619957|538084431|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
148927907|NCT03981822|537219494|FG000|Overall Study|Withdrawal by Subject|0|||
148927908|NCT03981822|537219495|FG001|Overall Study|Withdrawal by Subject|1|||
148927909|NCT03981822|537219496|FG002|Overall Study|Withdrawal by Subject|0|||
148927910|NCT03981822|537219497|FG003|Overall Study|Withdrawal by Subject|0|||
148927911|NCT03981822|537219498|FG004|Overall Study|Withdrawal by Subject|0|||
148927912|NCT03981822|537219499|FG005|Overall Study|Withdrawal by Subject|1|||
148927913|NCT03981822|537219500|FG006|Overall Study|Withdrawal by Subject|0|||
148927914|NCT03981822|537219501|FG007|Overall Study|Withdrawal by Subject|2|||
148927915|NCT03981822|537219494|FG000|Overall Study|COVID-19 Related|0|||
148927916|NCT03981822|537219495|FG001|Overall Study|COVID-19 Related|0|||
148927917|NCT03981822|537219496|FG002|Overall Study|COVID-19 Related|0|||
148927918|NCT03981822|537219497|FG003|Overall Study|COVID-19 Related|0|||
148927919|NCT03981822|537219498|FG004|Overall Study|COVID-19 Related|2|||
148927920|NCT03981822|537219499|FG005|Overall Study|COVID-19 Related|1|||
148927921|NCT03981822|537219500|FG006|Overall Study|COVID-19 Related|2|||
148927922|NCT03981822|537219501|FG007|Overall Study|COVID-19 Related|1|||
148927923|NCT02742246|537219502|FG000|Overall Study|Never initiated treatment|5|||
148927924|NCT02742246|537219503|FG001|Overall Study|Never initiated treatment|3|||
148927925|NCT02742246|537219504|FG002|Overall Study|Never initiated treatment|1|||
148927926|NCT02742246|537219502|FG000|Overall Study|dropped out during treatment|7|||
148927927|NCT02742246|537219503|FG001|Overall Study|dropped out during treatment|13|||
148927928|NCT02742246|537219504|FG002|Overall Study|dropped out during treatment|10|||
148927929|NCT02742246|537219502|FG000|Overall Study|Death|1|||
148927930|NCT02742246|537219503|FG001|Overall Study|Death|0|||
148927931|NCT02742246|537219504|FG002|Overall Study|Death|0|||
148927932|NCT03489551|537219505|FG000|Overall Study|Withdrawal by Subject|2|||
148927933|NCT00054717|537219507|FG000|Overall Study|Randomized but not treated|2|||
148927934|NCT00054717|537219508|FG001|Overall Study|Randomized but not treated|8|||
148927935|NCT00054717|537219507|FG000|Overall Study|Adverse Event|70|||
148927936|NCT00054717|537219508|FG001|Overall Study|Adverse Event|22|||
148927937|NCT00054717|537219507|FG000|Overall Study|Protocol Violation|18|||
148927938|NCT00054717|537219508|FG001|Overall Study|Protocol Violation|19|||
148927939|NCT00054717|537219507|FG000|Overall Study|Lost to Follow-up|23|||
149166924|NCT00619957|538084432|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
149166925|NCT00619957|538084431|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
149166926|NCT00619957|538084432|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
149166927|NCT00619957|538084431|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
149166928|NCT00619957|538084432|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
149166929|NCT00619957|538084431|FG000|Month 48 Open-Label|Adverse Event|4|||
149166930|NCT00619957|538084432|FG001|Month 48 Open-Label|Adverse Event|4|||
149166931|NCT00619957|538084431|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
149166932|NCT00619957|538084432|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
149166933|NCT00619957|538084431|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
149166934|NCT00619957|538084432|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
149166935|NCT00868790|538084433|FG000|Period 1|Adverse Event|1|||
149166936|NCT00868790|538084434|FG001|Period 1|Adverse Event|0|||
149166937|NCT00868790|538084435|FG002|Period 1|Adverse Event|0|||
149166938|NCT00868790|538084436|FG003|Period 1|Adverse Event|0|||
149166939|NCT00868790|538084437|FG004|Period 1|Adverse Event|0|||
149166940|NCT00868790|538084438|FG005|Period 1|Adverse Event|0|||
149166941|NCT00868790|538084439|FG006|Period 1|Adverse Event|0|||
149166942|NCT00868790|538084440|FG007|Period 1|Adverse Event|3|||
149166943|NCT00868790|538084441|FG008|Period 1|Adverse Event|1|||
149166944|NCT00868790|538084442|FG009|Period 1|Adverse Event|0|||
149166945|NCT00868790|538084443|FG010|Period 1|Adverse Event|0|||
149166946|NCT00868790|538084444|FG011|Period 1|Adverse Event|0|||
149166947|NCT00868790|538084445|FG012|Period 1|Adverse Event|0|||
149166948|NCT00868790|538084446|FG013|Period 1|Adverse Event|1|||
149166949|NCT00868790|538084433|FG000|Period 1|Protocol Violation|1|||
149166950|NCT00868790|538084434|FG001|Period 1|Protocol Violation|0|||
149166951|NCT00868790|538084435|FG002|Period 1|Protocol Violation|0|||
149166952|NCT00868790|538084436|FG003|Period 1|Protocol Violation|0|||
149166953|NCT00868790|538084437|FG004|Period 1|Protocol Violation|0|||
149166954|NCT00868790|538084438|FG005|Period 1|Protocol Violation|0|||
149166955|NCT00868790|538084439|FG006|Period 1|Protocol Violation|0|||
149166956|NCT00868790|538084440|FG007|Period 1|Protocol Violation|0|||
148806241|NCT00420745|536768924|FG000|Overall Study|Lost to Follow-up|10|||
148927940|NCT00054717|537219508|FG001|Overall Study|Lost to Follow-up|13|||
148927941|NCT00054717|537219507|FG000|Overall Study|Withdrawal by Subject|32|||
149166957|NCT00868790|538084441|FG008|Period 1|Protocol Violation|0|||
149166958|NCT00868790|538084442|FG009|Period 1|Protocol Violation|0|||
149166959|NCT00868790|538084443|FG010|Period 1|Protocol Violation|0|||
149166960|NCT00868790|538084444|FG011|Period 1|Protocol Violation|0|||
149166961|NCT00868790|538084445|FG012|Period 1|Protocol Violation|0|||
149166962|NCT00868790|538084446|FG013|Period 1|Protocol Violation|0|||
148927942|NCT00054717|537219508|FG001|Overall Study|Withdrawal by Subject|20|||
148927943|NCT00054717|537219507|FG000|Overall Study|Other reason not defined above|117|||
148927944|NCT00054717|537219508|FG001|Overall Study|Other reason not defined above|217|||
149166963|NCT00868790|538084433|FG000|Period 1|Withdrawal by Subject|0|||
149166964|NCT00868790|538084434|FG001|Period 1|Withdrawal by Subject|1|||
149166965|NCT00868790|538084435|FG002|Period 1|Withdrawal by Subject|0|||
149166966|NCT00868790|538084436|FG003|Period 1|Withdrawal by Subject|0|||
149166967|NCT00868790|538084437|FG004|Period 1|Withdrawal by Subject|0|||
149166968|NCT00868790|538084438|FG005|Period 1|Withdrawal by Subject|0|||
149166969|NCT00868790|538084439|FG006|Period 1|Withdrawal by Subject|0|||
149166970|NCT00868790|538084440|FG007|Period 1|Withdrawal by Subject|0|||
149166971|NCT00868790|538084441|FG008|Period 1|Withdrawal by Subject|0|||
149166972|NCT00868790|538084442|FG009|Period 1|Withdrawal by Subject|0|||
149166973|NCT00868790|538084443|FG010|Period 1|Withdrawal by Subject|0|||
149166974|NCT00868790|538084444|FG011|Period 1|Withdrawal by Subject|0|||
149166975|NCT00868790|538084445|FG012|Period 1|Withdrawal by Subject|0|||
149166976|NCT00868790|538084446|FG013|Period 1|Withdrawal by Subject|1|||
149166977|NCT00868790|538084433|FG000|Period 1|Abnormal Triglycerides|0|||
149166978|NCT00868790|538084434|FG001|Period 1|Abnormal Triglycerides|0|||
149166979|NCT00868790|538084435|FG002|Period 1|Abnormal Triglycerides|0|||
149166980|NCT00868790|538084436|FG003|Period 1|Abnormal Triglycerides|0|||
149166981|NCT00868790|538084437|FG004|Period 1|Abnormal Triglycerides|1|||
149166982|NCT00868790|538084438|FG005|Period 1|Abnormal Triglycerides|0|||
149166983|NCT00868790|538084439|FG006|Period 1|Abnormal Triglycerides|0|||
149166984|NCT00868790|538084440|FG007|Period 1|Abnormal Triglycerides|0|||
149166985|NCT00868790|538084441|FG008|Period 1|Abnormal Triglycerides|0|||
149166986|NCT00868790|538084442|FG009|Period 1|Abnormal Triglycerides|0|||
149166987|NCT00868790|538084443|FG010|Period 1|Abnormal Triglycerides|0|||
149166988|NCT00868790|538084444|FG011|Period 1|Abnormal Triglycerides|0|||
149166989|NCT00868790|538084445|FG012|Period 1|Abnormal Triglycerides|0|||
149166990|NCT00868790|538084446|FG013|Period 1|Abnormal Triglycerides|0|||
149166991|NCT00868790|538084433|FG000|Period 1|Lost to Follow-up|0|||
149166992|NCT00868790|538084434|FG001|Period 1|Lost to Follow-up|0|||
149166993|NCT00868790|538084435|FG002|Period 1|Lost to Follow-up|0|||
149166994|NCT00868790|538084436|FG003|Period 1|Lost to Follow-up|0|||
149166995|NCT00868790|538084437|FG004|Period 1|Lost to Follow-up|0|||
149166996|NCT00868790|538084438|FG005|Period 1|Lost to Follow-up|1|||
149166997|NCT00868790|538084439|FG006|Period 1|Lost to Follow-up|0|||
149166998|NCT00868790|538084440|FG007|Period 1|Lost to Follow-up|0|||
149166999|NCT00868790|538084441|FG008|Period 1|Lost to Follow-up|0|||
149167000|NCT00868790|538084442|FG009|Period 1|Lost to Follow-up|0|||
149167001|NCT00868790|538084443|FG010|Period 1|Lost to Follow-up|0|||
149167002|NCT00868790|538084444|FG011|Period 1|Lost to Follow-up|0|||
149167003|NCT00868790|538084445|FG012|Period 1|Lost to Follow-up|0|||
149167004|NCT00868790|538084446|FG013|Period 1|Lost to Follow-up|0|||
149167005|NCT00868790|538084433|FG000|Period 2|Adverse Event|0|||
149167006|NCT00868790|538084434|FG001|Period 2|Adverse Event|0|||
149167007|NCT00868790|538084435|FG002|Period 2|Adverse Event|0|||
149167008|NCT00868790|538084436|FG003|Period 2|Adverse Event|0|||
149167009|NCT00868790|538084437|FG004|Period 2|Adverse Event|0|||
149167010|NCT00868790|538084438|FG005|Period 2|Adverse Event|0|||
149167011|NCT00868790|538084439|FG006|Period 2|Adverse Event|0|||
149167012|NCT00868790|538084440|FG007|Period 2|Adverse Event|0|||
149167013|NCT00868790|538084441|FG008|Period 2|Adverse Event|1|||
149167014|NCT00868790|538084442|FG009|Period 2|Adverse Event|0|||
149167015|NCT00868790|538084443|FG010|Period 2|Adverse Event|0|||
149167016|NCT00868790|538084444|FG011|Period 2|Adverse Event|0|||
149167017|NCT00868790|538084445|FG012|Period 2|Adverse Event|0|||
149167018|NCT00868790|538084446|FG013|Period 2|Adverse Event|0|||
149167019|NCT00868790|538084433|FG000|Period 2|Lost to Follow-up|0|||
149167020|NCT00868790|538084434|FG001|Period 2|Lost to Follow-up|1|||
149167021|NCT00868790|538084435|FG002|Period 2|Lost to Follow-up|0|||
149167022|NCT00868790|538084436|FG003|Period 2|Lost to Follow-up|0|||
149167023|NCT00868790|538084437|FG004|Period 2|Lost to Follow-up|0|||
149167024|NCT00868790|538084438|FG005|Period 2|Lost to Follow-up|1|||
149167025|NCT00868790|538084439|FG006|Period 2|Lost to Follow-up|0|||
149167026|NCT00868790|538084440|FG007|Period 2|Lost to Follow-up|0|||
149167027|NCT00868790|538084441|FG008|Period 2|Lost to Follow-up|0|||
149167028|NCT00868790|538084442|FG009|Period 2|Lost to Follow-up|0|||
149167029|NCT00868790|538084443|FG010|Period 2|Lost to Follow-up|0|||
149167030|NCT00868790|538084444|FG011|Period 2|Lost to Follow-up|0|||
149167031|NCT00868790|538084445|FG012|Period 2|Lost to Follow-up|0|||
149167032|NCT00868790|538084446|FG013|Period 2|Lost to Follow-up|0|||
149167033|NCT00868790|538084433|FG000|Period 2|Withdrawal by Subject|0|||
149167034|NCT00868790|538084434|FG001|Period 2|Withdrawal by Subject|0|||
149167035|NCT00868790|538084435|FG002|Period 2|Withdrawal by Subject|0|||
149167036|NCT00868790|538084436|FG003|Period 2|Withdrawal by Subject|0|||
149167037|NCT00868790|538084437|FG004|Period 2|Withdrawal by Subject|0|||
149167038|NCT00868790|538084438|FG005|Period 2|Withdrawal by Subject|0|||
149167039|NCT00868790|538084439|FG006|Period 2|Withdrawal by Subject|0|||
149167040|NCT00868790|538084440|FG007|Period 2|Withdrawal by Subject|0|||
149167041|NCT00868790|538084441|FG008|Period 2|Withdrawal by Subject|1|||
149167042|NCT00868790|538084442|FG009|Period 2|Withdrawal by Subject|0|||
149167043|NCT00868790|538084443|FG010|Period 2|Withdrawal by Subject|0|||
149167044|NCT00868790|538084444|FG011|Period 2|Withdrawal by Subject|0|||
149167045|NCT00868790|538084445|FG012|Period 2|Withdrawal by Subject|0|||
149167046|NCT00868790|538084446|FG013|Period 2|Withdrawal by Subject|1|||
149167047|NCT00868790|538084433|FG000|Period 3|Adverse Event|0|||
149167048|NCT00868790|538084434|FG001|Period 3|Adverse Event|0|||
149167049|NCT00868790|538084435|FG002|Period 3|Adverse Event|0|||
149167050|NCT00868790|538084436|FG003|Period 3|Adverse Event|0|||
149167051|NCT00868790|538084437|FG004|Period 3|Adverse Event|0|||
149167052|NCT00868790|538084438|FG005|Period 3|Adverse Event|0|||
149167053|NCT00868790|538084439|FG006|Period 3|Adverse Event|0|||
149167054|NCT00868790|538084440|FG007|Period 3|Adverse Event|0|||
149167055|NCT00868790|538084441|FG008|Period 3|Adverse Event|0|||
149167056|NCT00868790|538084442|FG009|Period 3|Adverse Event|1|||
149167057|NCT00868790|538084443|FG010|Period 3|Adverse Event|0|||
149167058|NCT00868790|538084444|FG011|Period 3|Adverse Event|0|||
149167059|NCT00868790|538084445|FG012|Period 3|Adverse Event|0|||
149167060|NCT00868790|538084446|FG013|Period 3|Adverse Event|0|||
148927945|NCT00206076|537219511|FG000|Overall Study|Physician Decision|2|||
148927946|NCT00206076|537219512|FG001|Overall Study|Physician Decision|0|||
149167061|NCT00868790|538084433|FG000|Period 3|Protocol Violation|0|||
149167062|NCT00868790|538084434|FG001|Period 3|Protocol Violation|0|||
149167063|NCT00868790|538084435|FG002|Period 3|Protocol Violation|0|||
149167064|NCT00868790|538084436|FG003|Period 3|Protocol Violation|0|||
148927947|NCT00206076|537219511|FG000|Overall Study|Withdrawal by Subject|1|||
149167065|NCT00868790|538084437|FG004|Period 3|Protocol Violation|0|||
149167066|NCT00868790|538084438|FG005|Period 3|Protocol Violation|0|||
149167067|NCT00868790|538084439|FG006|Period 3|Protocol Violation|0|||
149167068|NCT00868790|538084440|FG007|Period 3|Protocol Violation|0|||
149167069|NCT00868790|538084441|FG008|Period 3|Protocol Violation|0|||
149167070|NCT00868790|538084442|FG009|Period 3|Protocol Violation|0|||
149167071|NCT00868790|538084443|FG010|Period 3|Protocol Violation|1|||
149167072|NCT00868790|538084444|FG011|Period 3|Protocol Violation|0|||
149167073|NCT00868790|538084445|FG012|Period 3|Protocol Violation|0|||
149167074|NCT00868790|538084446|FG013|Period 3|Protocol Violation|0|||
149167075|NCT00868790|538084433|FG000|Period 3|Study Terminated by Sponsor|0|||
149167076|NCT00868790|538084434|FG001|Period 3|Study Terminated by Sponsor|0|||
149167077|NCT00868790|538084435|FG002|Period 3|Study Terminated by Sponsor|0|||
149167078|NCT00868790|538084436|FG003|Period 3|Study Terminated by Sponsor|1|||
148927948|NCT00206076|537219512|FG001|Overall Study|Withdrawal by Subject|1|||
148927949|NCT00427960|537219514|FG000|Overall Study|Adverse Event|2|||
148927950|NCT00427960|537219515|FG001|Overall Study|Adverse Event|0|||
148927951|NCT00427960|537219514|FG000|Overall Study|Withdrawal by Subject|0|||
148927952|NCT00427960|537219515|FG001|Overall Study|Withdrawal by Subject|3|||
148927953|NCT00427960|537219514|FG000|Overall Study|Other|0|||
148927954|NCT00427960|537219515|FG001|Overall Study|Other|1|||
148927955|NCT03190369|537219518|FG000|Overall Study|Poor compliance to protocol|0|||
148927956|NCT03190369|537219519|FG001|Overall Study|Poor compliance to protocol|1|||
148927957|NCT03190369|537219518|FG000|Overall Study|Withdraw before treatment|1|||
148927958|NCT03190369|537219519|FG001|Overall Study|Withdraw before treatment|5|||
148927959|NCT03190369|537219518|FG000|Overall Study|Randomized but not treated|0|||
148927960|NCT03190369|537219519|FG001|Overall Study|Randomized but not treated|2|||
148927961|NCT04543409|537219520|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148927962|NCT04543409|537219521|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148927963|NCT04543409|537219520|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
149167079|NCT00868790|538084437|FG004|Period 3|Study Terminated by Sponsor|0|||
149167080|NCT00868790|538084438|FG005|Period 3|Study Terminated by Sponsor|0|||
149167081|NCT00868790|538084439|FG006|Period 3|Study Terminated by Sponsor|0|||
149167082|NCT00868790|538084440|FG007|Period 3|Study Terminated by Sponsor|0|||
149167083|NCT00868790|538084441|FG008|Period 3|Study Terminated by Sponsor|0|||
148927964|NCT04543409|537219521|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
148927965|NCT04543409|537219520|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
148927966|NCT04543409|537219521|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
148927967|NCT04543409|537219520|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
148927968|NCT04543409|537219521|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
148927969|NCT04543409|537219520|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
148927970|NCT04543409|537219521|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
148927971|NCT04543409|537219520|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
148927972|NCT04543409|537219521|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
148927973|NCT04543409|537219520|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
148927974|NCT04543409|537219521|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
148927975|NCT04543409|537219520|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
148927976|NCT04543409|537219521|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
148927977|NCT04543409|537219520|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
148927978|NCT04543409|537219521|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
148927979|NCT04543409|537219520|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
148927980|NCT04543409|537219521|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
148927981|NCT04543409|537219520|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
148927982|NCT04543409|537219521|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
148927983|NCT01289782|537219522|FG000|Overall Study|Lost to Follow-up|14|||
148927984|NCT01289782|537219523|FG001|Overall Study|Lost to Follow-up|7|||
148927985|NCT01289782|537219522|FG000|Overall Study|Protocol Violation|1|||
148927986|NCT01289782|537219523|FG001|Overall Study|Protocol Violation|1|||
148927987|NCT01289782|537219522|FG000|Overall Study|Withdrawal by Subject|8|||
149013033|NCT00077636|537527774|FG000|Overall Study|Adverse Event|17|||
149167084|NCT00868790|538084442|FG009|Period 3|Study Terminated by Sponsor|0|||
149167085|NCT00868790|538084443|FG010|Period 3|Study Terminated by Sponsor|0|||
148927988|NCT01289782|537219523|FG001|Overall Study|Withdrawal by Subject|2|||
149167086|NCT00868790|538084444|FG011|Period 3|Study Terminated by Sponsor|0|||
149167087|NCT00868790|538084445|FG012|Period 3|Study Terminated by Sponsor|0|||
149167088|NCT00868790|538084446|FG013|Period 3|Study Terminated by Sponsor|0|||
148927989|NCT01289782|537219522|FG000|Overall Study|Sponsor's Decision|1|||
148927990|NCT01289782|537219523|FG001|Overall Study|Sponsor's Decision|0|||
148927991|NCT01289782|537219522|FG000|Overall Study|Reason not specified|1|||
148927992|NCT01289782|537219523|FG001|Overall Study|Reason not specified|2|||
148927993|NCT02131532|537219524|FG000|Overall Study|Withdrawal by Subject|1|||
148927994|NCT02131532|537219524|FG000|Overall Study|Physician Decision|1|||
148927995|NCT02131532|537219524|FG000|Overall Study|Other health conditions|2|||
148927996|NCT02093026|537219525|FG000|Overall Study|Adverse Event|26|||
148927997|NCT02093026|537219525|FG000|Overall Study|Death|10|||
148927998|NCT02093026|537219525|FG000|Overall Study|Other|157|||
148927999|NCT03519386|537219545|FG000|Overall Study|Withdrawal by Subject|4|||
148928000|NCT03519386|537219546|FG001|Overall Study|Withdrawal by Subject|1|||
148928001|NCT03519386|537219547|FG002|Overall Study|Withdrawal by Subject|2|||
148928002|NCT03519386|537219545|FG000|Overall Study|Physician Decision|1|||
149167089|NCT00868790|538084433|FG000|Period 4|Adverse Event|0|||
149167090|NCT00868790|538084434|FG001|Period 4|Adverse Event|0|||
149167091|NCT00868790|538084435|FG002|Period 4|Adverse Event|0|||
148928003|NCT03519386|537219546|FG001|Overall Study|Physician Decision|1|||
148928004|NCT03519386|537219547|FG002|Overall Study|Physician Decision|1|||
148928005|NCT03519386|537219545|FG000|Overall Study|Lost to Follow-up|0|||
148928006|NCT03519386|537219546|FG001|Overall Study|Lost to Follow-up|1|||
148928007|NCT03519386|537219547|FG002|Overall Study|Lost to Follow-up|1|||
148928008|NCT03519386|537219545|FG000|Overall Study|Death|1|||
148928009|NCT03519386|537219546|FG001|Overall Study|Death|0|||
148928010|NCT03519386|537219547|FG002|Overall Study|Death|4|||
148928011|NCT03519386|537219545|FG000|Overall Study|Adverse Event|2|||
148928012|NCT03519386|537219546|FG001|Overall Study|Adverse Event|1|||
148928013|NCT03519386|537219547|FG002|Overall Study|Adverse Event|2|||
148928014|NCT03519386|537219545|FG000|Overall Study|Explanted|2|||
148928015|NCT03519386|537219546|FG001|Overall Study|Explanted|1|||
148928016|NCT03519386|537219547|FG002|Overall Study|Explanted|0|||
148928017|NCT03519386|537219545|FG000|Overall Study|Ongoing in study|190|||
148928018|NCT03519386|537219546|FG001|Overall Study|Ongoing in study|192|||
148928019|NCT03519386|537219547|FG002|Overall Study|Ongoing in study|183|||
148928020|NCT03101267|537219549|FG000|Primary Study Period|Withdrawal by Subject|1|||
148928021|NCT03101267|537219550|FG001|Primary Study Period|Withdrawal by Subject|2|||
148928022|NCT03101267|537219551|FG002|Primary Study Period|Withdrawal by Subject|3|||
148928023|NCT03101267|537219549|FG000|Primary Study Period|Miscellaneous|2|||
148928024|NCT03101267|537219550|FG001|Primary Study Period|Miscellaneous|0|||
148928025|NCT03101267|537219551|FG002|Primary Study Period|Miscellaneous|0|||
148928026|NCT01975831|537219552|FG000|Overall Study|Adverse Event|1|||
148928027|NCT01975831|537219553|FG001|Overall Study|Adverse Event|2|||
148928028|NCT01975831|537219554|FG002|Overall Study|Adverse Event|2|||
149167092|NCT00868790|538084436|FG003|Period 4|Adverse Event|0|||
149167093|NCT00868790|538084437|FG004|Period 4|Adverse Event|0|||
149167094|NCT00868790|538084438|FG005|Period 4|Adverse Event|0|||
149167095|NCT00868790|538084439|FG006|Period 4|Adverse Event|0|||
149167096|NCT00868790|538084440|FG007|Period 4|Adverse Event|1|||
149167097|NCT00868790|538084441|FG008|Period 4|Adverse Event|0|||
149167098|NCT00868790|538084442|FG009|Period 4|Adverse Event|0|||
149167099|NCT00868790|538084443|FG010|Period 4|Adverse Event|1|||
149167100|NCT00868790|538084444|FG011|Period 4|Adverse Event|0|||
149167101|NCT00868790|538084445|FG012|Period 4|Adverse Event|1|||
149167102|NCT00868790|538084446|FG013|Period 4|Adverse Event|0|||
149167103|NCT00868790|538084433|FG000|Period 4|Lost to Follow-up|0|||
149167104|NCT00868790|538084434|FG001|Period 4|Lost to Follow-up|0|||
149167105|NCT00868790|538084435|FG002|Period 4|Lost to Follow-up|0|||
149167106|NCT00868790|538084436|FG003|Period 4|Lost to Follow-up|0|||
149167107|NCT00868790|538084437|FG004|Period 4|Lost to Follow-up|0|||
149167108|NCT00868790|538084438|FG005|Period 4|Lost to Follow-up|0|||
149167109|NCT00868790|538084439|FG006|Period 4|Lost to Follow-up|0|||
149167110|NCT00868790|538084440|FG007|Period 4|Lost to Follow-up|1|||
149167111|NCT00868790|538084441|FG008|Period 4|Lost to Follow-up|0|||
149167112|NCT00868790|538084442|FG009|Period 4|Lost to Follow-up|0|||
149167113|NCT00868790|538084443|FG010|Period 4|Lost to Follow-up|0|||
149167114|NCT00868790|538084444|FG011|Period 4|Lost to Follow-up|0|||
149167115|NCT00868790|538084445|FG012|Period 4|Lost to Follow-up|0|||
148675709|NCT03193190|536283033|FG009|Stage 2|Withdrawal by Subject|0|||
148928029|NCT01975831|537219555|FG003|Overall Study|Adverse Event|0|||
148928030|NCT01975831|537219556|FG004|Overall Study|Adverse Event|1|||
148928031|NCT01975831|537219557|FG005|Overall Study|Adverse Event|1|||
148928032|NCT01975831|537219558|FG006|Overall Study|Adverse Event|3|||
148928033|NCT01975831|537219559|FG007|Overall Study|Adverse Event|4|||
148928034|NCT01975831|537219560|FG008|Overall Study|Adverse Event|1|||
149167116|NCT00868790|538084446|FG013|Period 4|Lost to Follow-up|0|||
148928035|NCT01975831|537219552|FG000|Overall Study|Death|1|||
148928036|NCT01975831|537219553|FG001|Overall Study|Death|1|||
149167117|NCT00868790|538084433|FG000|Period 4|Study Terminated by Sponsor|2|||
149167118|NCT00868790|538084434|FG001|Period 4|Study Terminated by Sponsor|0|||
149167119|NCT00868790|538084435|FG002|Period 4|Study Terminated by Sponsor|0|||
148928037|NCT01975831|537219554|FG002|Overall Study|Death|0|||
148928038|NCT01975831|537219555|FG003|Overall Study|Death|0|||
148928039|NCT01975831|537219556|FG004|Overall Study|Death|1|||
148928040|NCT01975831|537219557|FG005|Overall Study|Death|0|||
148928041|NCT01975831|537219558|FG006|Overall Study|Death|1|||
148928042|NCT01975831|537219559|FG007|Overall Study|Death|0|||
148928043|NCT01975831|537219560|FG008|Overall Study|Death|0|||
148928044|NCT01975831|537219552|FG000|Overall Study|Progressive Disease|1|||
148928045|NCT01975831|537219553|FG001|Overall Study|Progressive Disease|3|||
148928046|NCT01975831|537219554|FG002|Overall Study|Progressive Disease|2|||
148928047|NCT01975831|537219555|FG003|Overall Study|Progressive Disease|4|||
148928048|NCT01975831|537219556|FG004|Overall Study|Progressive Disease|13|||
148928049|NCT01975831|537219557|FG005|Overall Study|Progressive Disease|9|||
148928050|NCT01975831|537219558|FG006|Overall Study|Progressive Disease|10|||
148928051|NCT01975831|537219559|FG007|Overall Study|Progressive Disease|8|||
148928052|NCT01975831|537219560|FG008|Overall Study|Progressive Disease|10|||
148928053|NCT01975831|537219552|FG000|Overall Study|Withdrawal by Subject|0|||
148928054|NCT01975831|537219553|FG001|Overall Study|Withdrawal by Subject|3|||
148928055|NCT01975831|537219554|FG002|Overall Study|Withdrawal by Subject|0|||
148928056|NCT01975831|537219555|FG003|Overall Study|Withdrawal by Subject|0|||
148928057|NCT01975831|537219556|FG004|Overall Study|Withdrawal by Subject|3|||
148928058|NCT01975831|537219557|FG005|Overall Study|Withdrawal by Subject|1|||
148928059|NCT01975831|537219558|FG006|Overall Study|Withdrawal by Subject|1|||
148928060|NCT01975831|537219559|FG007|Overall Study|Withdrawal by Subject|0|||
148928061|NCT01975831|537219560|FG008|Overall Study|Withdrawal by Subject|0|||
148928062|NCT01975831|537219552|FG000|Overall Study|Physician Decision|0|||
148928063|NCT01975831|537219553|FG001|Overall Study|Physician Decision|0|||
148928064|NCT01975831|537219554|FG002|Overall Study|Physician Decision|0|||
148928065|NCT01975831|537219555|FG003|Overall Study|Physician Decision|0|||
148928066|NCT01975831|537219556|FG004|Overall Study|Physician Decision|0|||
148928067|NCT01975831|537219557|FG005|Overall Study|Physician Decision|1|||
148928068|NCT01975831|537219558|FG006|Overall Study|Physician Decision|0|||
148928069|NCT01975831|537219559|FG007|Overall Study|Physician Decision|1|||
148928070|NCT01975831|537219560|FG008|Overall Study|Physician Decision|0|||
148928071|NCT01975831|537219552|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
148928072|NCT01975831|537219553|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
148928073|NCT01975831|537219554|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
148928074|NCT01975831|537219555|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
148928075|NCT01975831|537219556|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
148928076|NCT01975831|537219557|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
148928077|NCT01975831|537219558|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
148928078|NCT01975831|537219559|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
149167120|NCT00868790|538084436|FG003|Period 4|Study Terminated by Sponsor|0|||
149167121|NCT00868790|538084437|FG004|Period 4|Study Terminated by Sponsor|0|||
149167122|NCT00868790|538084438|FG005|Period 4|Study Terminated by Sponsor|0|||
149167123|NCT00868790|538084439|FG006|Period 4|Study Terminated by Sponsor|0|||
149167124|NCT00868790|538084440|FG007|Period 4|Study Terminated by Sponsor|1|||
149167125|NCT00868790|538084441|FG008|Period 4|Study Terminated by Sponsor|2|||
149167126|NCT00868790|538084442|FG009|Period 4|Study Terminated by Sponsor|0|||
149167127|NCT00868790|538084443|FG010|Period 4|Study Terminated by Sponsor|2|||
149167128|NCT00868790|538084444|FG011|Period 4|Study Terminated by Sponsor|1|||
149167129|NCT00868790|538084445|FG012|Period 4|Study Terminated by Sponsor|0|||
149167130|NCT00868790|538084446|FG013|Period 4|Study Terminated by Sponsor|1|||
149167131|NCT00868790|538084433|FG000|Period 4|Abnormal ALT/AST|0|||
149167132|NCT00868790|538084434|FG001|Period 4|Abnormal ALT/AST|0|||
149167133|NCT00868790|538084435|FG002|Period 4|Abnormal ALT/AST|1|||
149167134|NCT00868790|538084436|FG003|Period 4|Abnormal ALT/AST|0|||
149167135|NCT00868790|538084437|FG004|Period 4|Abnormal ALT/AST|0|||
149167136|NCT00868790|538084438|FG005|Period 4|Abnormal ALT/AST|0|||
149167137|NCT00868790|538084439|FG006|Period 4|Abnormal ALT/AST|0|||
149167138|NCT00868790|538084440|FG007|Period 4|Abnormal ALT/AST|0|||
149167139|NCT00868790|538084441|FG008|Period 4|Abnormal ALT/AST|0|||
149167140|NCT00868790|538084442|FG009|Period 4|Abnormal ALT/AST|0|||
149167141|NCT00868790|538084443|FG010|Period 4|Abnormal ALT/AST|0|||
149167142|NCT00868790|538084444|FG011|Period 4|Abnormal ALT/AST|0|||
149167143|NCT00868790|538084445|FG012|Period 4|Abnormal ALT/AST|0|||
149167144|NCT00868790|538084446|FG013|Period 4|Abnormal ALT/AST|0|||
148928079|NCT01975831|537219560|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
148928080|NCT01975831|537219552|FG000|Overall Study|Entered Hospice|0|||
148928081|NCT01975831|537219553|FG001|Overall Study|Entered Hospice|0|||
148928082|NCT01975831|537219554|FG002|Overall Study|Entered Hospice|0|||
148928083|NCT01975831|537219555|FG003|Overall Study|Entered Hospice|0|||
148928084|NCT01975831|537219556|FG004|Overall Study|Entered Hospice|0|||
148928085|NCT01975831|537219557|FG005|Overall Study|Entered Hospice|1|||
148928086|NCT01975831|537219558|FG006|Overall Study|Entered Hospice|0|||
149013034|NCT00077636|537527775|FG001|Overall Study|Adverse Event|34|||
149167145|NCT00868790|538084433|FG000|Post-study|Withdrawal by Subject|0|||
149167146|NCT00868790|538084434|FG001|Post-study|Withdrawal by Subject|0|||
148928087|NCT01975831|537219559|FG007|Overall Study|Entered Hospice|0|||
149167147|NCT00868790|538084435|FG002|Post-study|Withdrawal by Subject|0|||
148928088|NCT01975831|537219560|FG008|Overall Study|Entered Hospice|0|||
148928089|NCT01975831|537219552|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928090|NCT01975831|537219553|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928091|NCT01975831|537219554|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928092|NCT01975831|537219555|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928093|NCT01975831|537219556|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928094|NCT01975831|537219557|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928095|NCT01975831|537219558|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
148928096|NCT01975831|537219559|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
148928097|NCT01975831|537219560|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
148928098|NCT03437512|537221296|FG000|Randomized|Withdrawal by Subject|0|||
148928099|NCT03437512|537221297|FG001|Randomized|Withdrawal by Subject|2|||
148928100|NCT03437512|537221296|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
148928101|NCT03437512|537221297|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
148928102|NCT01897714|537221298|FG000|Phase I (Dose Escalation)|Disease progression|3|||
148928103|NCT01897714|537221299|FG001|Phase I (Dose Escalation)|Disease progression|5|||
148928104|NCT01897714|537221300|FG002|Phase I (Dose Escalation)|Disease progression|1|||
148928105|NCT01897714|537221301|FG003|Phase I (Dose Escalation)|Disease progression|3|||
148928106|NCT01897714|537221302|FG004|Phase I (Dose Escalation)|Disease progression|0|||
148928107|NCT01897714|537221303|FG005|Phase I (Dose Escalation)|Disease progression|0|||
148928108|NCT01897714|537221298|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
148928109|NCT01897714|537221299|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
148928110|NCT01897714|537221300|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
148928111|NCT01897714|537221301|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
148928112|NCT01897714|537221302|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
148928113|NCT01897714|537221303|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
148806242|NCT00420745|536768925|FG001|Overall Study|Lost to Follow-up|2|||
148928114|NCT01897714|537221298|FG000|Phase I (Dose Escalation)|Other|0|||
148928115|NCT01897714|537221299|FG001|Phase I (Dose Escalation)|Other|1|||
148928116|NCT01897714|537221300|FG002|Phase I (Dose Escalation)|Other|0|||
148928117|NCT01897714|537221301|FG003|Phase I (Dose Escalation)|Other|0|||
148928118|NCT01897714|537221302|FG004|Phase I (Dose Escalation)|Other|0|||
148928119|NCT01897714|537221303|FG005|Phase I (Dose Escalation)|Other|0|||
148928120|NCT01897714|537221298|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
148928121|NCT01897714|537221299|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
149013035|NCT00077636|537527774|FG000|Overall Study|Protocol Violation|0|||
149167148|NCT00868790|538084436|FG003|Post-study|Withdrawal by Subject|0|||
149167149|NCT00868790|538084437|FG004|Post-study|Withdrawal by Subject|1|||
149167150|NCT00868790|538084438|FG005|Post-study|Withdrawal by Subject|0|||
149167151|NCT00868790|538084439|FG006|Post-study|Withdrawal by Subject|0|||
149167152|NCT00868790|538084440|FG007|Post-study|Withdrawal by Subject|0|||
149167153|NCT00868790|538084441|FG008|Post-study|Withdrawal by Subject|0|||
149167154|NCT00868790|538084442|FG009|Post-study|Withdrawal by Subject|0|||
149167155|NCT00868790|538084443|FG010|Post-study|Withdrawal by Subject|0|||
149167156|NCT00868790|538084444|FG011|Post-study|Withdrawal by Subject|0|||
149167157|NCT00868790|538084445|FG012|Post-study|Withdrawal by Subject|0|||
149167158|NCT00868790|538084446|FG013|Post-study|Withdrawal by Subject|0|||
149167159|NCT00868790|538084433|FG000|Post-study|Excluded Medication|0|||
149167160|NCT00868790|538084434|FG001|Post-study|Excluded Medication|0|||
149167161|NCT00868790|538084435|FG002|Post-study|Excluded Medication|0|||
149167162|NCT00868790|538084436|FG003|Post-study|Excluded Medication|0|||
149167163|NCT00868790|538084437|FG004|Post-study|Excluded Medication|0|||
149167164|NCT00868790|538084438|FG005|Post-study|Excluded Medication|0|||
148928122|NCT01897714|537221300|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
148928123|NCT01897714|537221301|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
148928124|NCT01897714|537221302|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
148928125|NCT01897714|537221303|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
148928126|NCT01897714|537221298|FG000|Phase II (MTD)|Lost to Follow-up|0|||
148928127|NCT01897714|537221299|FG001|Phase II (MTD)|Lost to Follow-up|0|||
148928128|NCT01897714|537221300|FG002|Phase II (MTD)|Lost to Follow-up|0|||
148928129|NCT01897714|537221301|FG003|Phase II (MTD)|Lost to Follow-up|0|||
148928130|NCT01897714|537221302|FG004|Phase II (MTD)|Lost to Follow-up|1|||
148928131|NCT01897714|537221303|FG005|Phase II (MTD)|Lost to Follow-up|0|||
148928132|NCT01897714|537221298|FG000|Phase II (MTD)|Death|0|||
148928133|NCT01897714|537221299|FG001|Phase II (MTD)|Death|0|||
148928134|NCT01897714|537221300|FG002|Phase II (MTD)|Death|0|||
148928135|NCT01897714|537221301|FG003|Phase II (MTD)|Death|0|||
148928136|NCT01897714|537221302|FG004|Phase II (MTD)|Death|25|||
148928137|NCT01897714|537221303|FG005|Phase II (MTD)|Death|10|||
149167165|NCT00868790|538084439|FG006|Post-study|Excluded Medication|0|||
149167166|NCT00868790|538084440|FG007|Post-study|Excluded Medication|2|||
149167167|NCT00868790|538084441|FG008|Post-study|Excluded Medication|0|||
149167168|NCT00868790|538084442|FG009|Post-study|Excluded Medication|1|||
149167169|NCT00868790|538084443|FG010|Post-study|Excluded Medication|0|||
149167170|NCT00868790|538084444|FG011|Post-study|Excluded Medication|0|||
149167171|NCT00868790|538084445|FG012|Post-study|Excluded Medication|0|||
148675710|NCT03193190|536283034|FG010|Stage 2|Withdrawal by Subject|0|||
148675711|NCT03193190|536283035|FG011|Stage 2|Withdrawal by Subject|0|||
148675712|NCT03193190|536283036|FG012|Stage 2|Withdrawal by Subject|0|||
148675713|NCT03193190|536283037|FG013|Stage 2|Withdrawal by Subject|1|||
148675714|NCT03193190|536283038|FG014|Stage 2|Withdrawal by Subject|1|||
148675715|NCT03193190|536283039|FG015|Stage 2|Withdrawal by Subject|0|||
148675716|NCT03532295|536283040|FG000|Overall Study|Did not start treatment|0|||
148675717|NCT03532295|536283041|FG001|Overall Study|Did not start treatment|2|||
148675718|NCT03732677|536283045|FG000|Overall Study|Terminated the study|154|||
148675719|NCT03732677|536283046|FG001|Overall Study|Terminated the study|197|||
148675720|NCT03732677|536283045|FG000|Overall Study|Continuing study off treatment|379|||
148675721|NCT03732677|536283046|FG001|Overall Study|Continuing study off treatment|333|||
148675722|NCT04644237|536283047|FG000|Overall Study|Death|4|||
148675723|NCT04644237|536283048|FG001|Overall Study|Death|2|||
148675724|NCT04644237|536283047|FG000|Overall Study|Adverse Event|18|||
148675725|NCT04644237|536283048|FG001|Overall Study|Adverse Event|19|||
148675726|NCT04644237|536283047|FG000|Overall Study|Progressive Disease|61|||
148675727|NCT04644237|536283048|FG001|Overall Study|Progressive Disease|23|||
148675728|NCT04644237|536283047|FG000|Overall Study|Clinical Progression|4|||
148675729|NCT04644237|536283048|FG001|Overall Study|Clinical Progression|1|||
149167172|NCT00868790|538084446|FG013|Post-study|Excluded Medication|0|||
149167173|NCT01763164|538084447|FG000|Treatment Phase|Participant/Guardian decision|26|||
149167174|NCT01763164|538084448|FG001|Treatment Phase|Participant/Guardian decision|14|||
149167175|NCT01763164|538084447|FG000|Treatment Phase|Protocol Violation|1|||
149167176|NCT01763164|538084448|FG001|Treatment Phase|Protocol Violation|1|||
148675730|NCT04644237|536283047|FG000|Overall Study|Withdrawal by Subject|4|||
148928138|NCT01897714|537221298|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
148928139|NCT01897714|537221299|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
148675731|NCT04644237|536283048|FG001|Overall Study|Withdrawal by Subject|2|||
148675732|NCT04644237|536283047|FG000|Overall Study|Physician Decision|4|||
148675733|NCT04644237|536283048|FG001|Overall Study|Physician Decision|0|||
148928140|NCT01897714|537221300|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
148928141|NCT01897714|537221301|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
149167177|NCT01763164|538084447|FG000|Treatment Phase|Progressive Disease|142|||
149167178|NCT01763164|538084448|FG001|Treatment Phase|Progressive Disease|76|||
149167179|NCT01763164|538084447|FG000|Treatment Phase|Physician Decision|24|||
149167180|NCT01763164|538084448|FG001|Treatment Phase|Physician Decision|13|||
149167181|NCT01763164|538084447|FG000|Treatment Phase|Death|10|||
149167182|NCT01763164|538084448|FG001|Treatment Phase|Death|1|||
149167183|NCT01763164|538084447|FG000|Treatment Phase|Adverse Event|66|||
149167184|NCT01763164|538084448|FG001|Treatment Phase|Adverse Event|8|||
149167185|NCT01763164|538084447|FG000|Treatment Phase|Randomized but not Treated|0|||
149167186|NCT01763164|538084448|FG001|Treatment Phase|Randomized but not Treated|19|||
149167187|NCT01763164|538084447|FG000|Treatment Phase|Other|0|||
149167188|NCT01763164|538084448|FG001|Treatment Phase|Other|1|||
149167189|NCT01763164|538084447|FG000|Follow up Phase|New therapy for study indication|12|||
149167190|NCT01763164|538084448|FG001|Follow up Phase|New therapy for study indication|3|||
149167191|NCT01763164|538084447|FG000|Follow up Phase|Death|21|||
149167192|NCT01763164|538084448|FG001|Follow up Phase|Death|4|||
148675734|NCT04644237|536283047|FG000|Overall Study|Other|6|||
148675735|NCT04644237|536283048|FG001|Overall Study|Other|3|||
148675736|NCT04644237|536283047|FG000|Overall Study|Randomized but not Treated|1|||
148675737|NCT04644237|536283048|FG001|Overall Study|Randomized but not Treated|0|||
148675738|NCT02949219|536283056|FG000|Overall Study|Withdrawal by Subject|1|||
149167193|NCT01763164|538084447|FG000|Follow up Phase|Subject/guardian decision|9|||
149167194|NCT01763164|538084448|FG001|Follow up Phase|Subject/guardian decision|2|||
149167195|NCT01763164|538084447|FG000|Follow up Phase|Progressive disease|127|||
149167196|NCT01763164|538084448|FG001|Follow up Phase|Progressive disease|62|||
149167197|NCT01763164|538084447|FG000|Follow up Phase|Physician Decision|10|||
149167198|NCT01763164|538084448|FG001|Follow up Phase|Physician Decision|3|||
149167199|NCT01763164|538084447|FG000|Follow up Phase|Lost to Follow-up|1|||
149167200|NCT01763164|538084448|FG001|Follow up Phase|Lost to Follow-up|0|||
149167201|NCT01763164|538084447|FG000|Follow up Phase|Adverse Event|17|||
149167202|NCT01763164|538084448|FG001|Follow up Phase|Adverse Event|1|||
149167203|NCT03377634|538084449|FG000|Study Period|Adverse Event|1|||
149167204|NCT03377634|538084450|FG001|Study Period|Adverse Event|0|||
149167205|NCT03377634|538084449|FG000|Study Period|Withdrawal by Subject|1|||
149167206|NCT03377634|538084450|FG001|Study Period|Withdrawal by Subject|0|||
149167207|NCT01264939|538084451|FG000|Overall Study|Adverse Event|1|||
149167208|NCT01264939|538084452|FG001|Overall Study|Adverse Event|3|||
149167209|NCT01264939|538084451|FG000|Overall Study|Lost to Follow-up|0|||
149167210|NCT01264939|538084452|FG001|Overall Study|Lost to Follow-up|3|||
149167211|NCT01264939|538084451|FG000|Overall Study|Physician Decision|1|||
149167212|NCT01264939|538084452|FG001|Overall Study|Physician Decision|1|||
149167213|NCT01264939|538084451|FG000|Overall Study|Patient/Guardian Decision|8|||
149167214|NCT01264939|538084452|FG001|Overall Study|Patient/Guardian Decision|10|||
149167215|NCT01264939|538084451|FG000|Overall Study|Disease Progression|8|||
149167216|NCT01264939|538084452|FG001|Overall Study|Disease Progression|11|||
148675739|NCT00005879|536283062|FG000|Overall Study|Withdrawal by Subject|8|||
148675740|NCT00005879|536283063|FG001|Overall Study|Withdrawal by Subject|10|||
148675741|NCT01238172|536283064|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
148675742|NCT01238172|536283065|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
148675743|NCT01238172|536283064|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
148675744|NCT01238172|536283065|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
148675745|NCT05022121|536283066|FG000|Overall Study|Lack of Efficacy|1|||
148675746|NCT05022121|536283067|FG001|Overall Study|Lack of Efficacy|0|||
148675747|NCT05022121|536283066|FG000|Overall Study|Lost to Follow-up|0|||
148675748|NCT05022121|536283067|FG001|Overall Study|Lost to Follow-up|2|||
148675749|NCT02038959|536283684|FG000|Overall Study|Withdrawal by Subject|6|||
148675750|NCT02038959|536283685|FG001|Overall Study|Withdrawal by Subject|8|||
148675751|NCT00819091|536283691|FG000|Overall Study|Adverse Event|3|||
148675752|NCT00819091|536283692|FG001|Overall Study|Adverse Event|5|||
148675753|NCT00819091|536283691|FG000|Overall Study|Protocol Violation|0|||
148675754|NCT00819091|536283692|FG001|Overall Study|Protocol Violation|1|||
148675755|NCT00819091|536283691|FG000|Overall Study|Lost to Follow-up|2|||
148675756|NCT00819091|536283692|FG001|Overall Study|Lost to Follow-up|0|||
149167217|NCT01384292|538084456|FG000|Part B|Severe non-compliance to protocol|1|||
149167218|NCT01384292|538084457|FG001|Part B|Severe non-compliance to protocol|0|||
149167219|NCT01384292|538084458|FG002|Part B|Severe non-compliance to protocol|0|||
149167220|NCT01171612|538084463|FG000|Overall Study|Lost to Follow-up|51|||
149167221|NCT01282229|538084464|FG000|Overall Study|Protocol Violation|2|||
149167222|NCT00996203|538084465|FG000|Overall Study|Adverse Event|3|||
149167223|NCT00996203|538084465|FG000|Overall Study|Lost to Follow-up|1|||
149167224|NCT00996203|538084465|FG000|Overall Study|Lack of Efficacy|1|||
149167225|NCT00996203|538084465|FG000|Overall Study|Protocol Violation|2|||
149167226|NCT03094195|538084466|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
149167227|NCT03094195|538084467|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
148675757|NCT00819091|536283691|FG000|Overall Study|Withdrawal by Subject|1|||
148806243|NCT00420745|536768924|FG000|Overall Study|Protocol Violation|1|||
148675758|NCT00819091|536283692|FG001|Overall Study|Withdrawal by Subject|2|||
148675759|NCT00819091|536283691|FG000|Overall Study|Other|1|||
148675760|NCT00819091|536283692|FG001|Overall Study|Other|2|||
148675761|NCT03911960|536283693|FG000|Overall Study|Lost to Follow-up|5|||
149167228|NCT03094195|538084468|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
149167229|NCT03094195|538084469|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149167230|NCT03094195|538084470|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149167231|NCT03094195|538084471|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149167232|NCT03094195|538084472|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149167233|NCT03094195|538084473|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
149167234|NCT03094195|538084466|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
149167235|NCT03094195|538084467|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
148675762|NCT03911960|536283694|FG001|Overall Study|Lost to Follow-up|3|||
148675763|NCT06065176|536283697|FG000|Overall Study|Lost to Follow-up|11|||
148675764|NCT06065176|536283698|FG001|Overall Study|Lost to Follow-up|11|||
148675765|NCT06065176|536283699|FG002|Overall Study|Lost to Follow-up|10|||
148675766|NCT06065176|536283697|FG000|Overall Study|Withdrawal by Subject|1|||
148675767|NCT06065176|536283698|FG001|Overall Study|Withdrawal by Subject|1|||
148675768|NCT06065176|536283699|FG002|Overall Study|Withdrawal by Subject|2|||
148675769|NCT06065176|536283697|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
148675770|NCT06065176|536283698|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
148675771|NCT06065176|536283699|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
148675772|NCT03131817|536283704|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
148675773|NCT03494816|536283705|FG000|Overall Study|Protocol Violation|2|||
148675774|NCT03494816|536283705|FG000|Overall Study|Physician Decision|2|||
148675775|NCT03494816|536283705|FG000|Overall Study|Did not start trial treatment|1|||
148675776|NCT03494816|536283705|FG000|Overall Study|Adverse Event|1|||
148675777|NCT05838755|536283708|FG000|Overall Study|Adverse Event|1|||
148675778|NCT05838755|536283709|FG001|Overall Study|Adverse Event|0|||
148675779|NCT05838755|536283710|FG002|Overall Study|Adverse Event|0|||
148675780|NCT05838755|536283708|FG000|Overall Study|Lack of Efficacy|1|||
148675781|NCT05838755|536283709|FG001|Overall Study|Lack of Efficacy|0|||
148675782|NCT05838755|536283710|FG002|Overall Study|Lack of Efficacy|1|||
148675783|NCT05838755|536283708|FG000|Overall Study|Lost to Follow-up|0|||
148675784|NCT05838755|536283709|FG001|Overall Study|Lost to Follow-up|1|||
148675785|NCT05838755|536283710|FG002|Overall Study|Lost to Follow-up|4|||
148675786|NCT05838755|536283708|FG000|Overall Study|Withdrawal by Subject|0|||
148675787|NCT05838755|536283709|FG001|Overall Study|Withdrawal by Subject|2|||
148675788|NCT05838755|536283710|FG002|Overall Study|Withdrawal by Subject|0|||
148675789|NCT05838755|536283708|FG000|Overall Study|Study terminated by sponsor|26|||
148675790|NCT05838755|536283709|FG001|Overall Study|Study terminated by sponsor|27|||
148675791|NCT05838755|536283710|FG002|Overall Study|Study terminated by sponsor|26|||
148675792|NCT05838755|536283708|FG000|Overall Study|Randomized, not treated|2|||
148675793|NCT05838755|536283709|FG001|Overall Study|Randomized, not treated|0|||
148675794|NCT05838755|536283710|FG002|Overall Study|Randomized, not treated|1|||
148675795|NCT05838755|536283708|FG000|Overall Study|Pregnancy|0|||
148675796|NCT05838755|536283709|FG001|Overall Study|Pregnancy|1|||
148675797|NCT05838755|536283710|FG002|Overall Study|Pregnancy|0|||
148675798|NCT04439110|536283711|FG000|Overall Study|Ineligible|2|||
148675799|NCT04439110|536283711|FG000|Overall Study|Adverse Event|4|||
148675800|NCT04439110|536283711|FG000|Overall Study|Death|2|||
148675801|NCT04439110|536283711|FG000|Overall Study|Disease proression|25|||
148675802|NCT04439110|536283711|FG000|Overall Study|Withdrawal by Subject|1|||
148675803|NCT04439110|536283711|FG000|Overall Study|Alternative therapy|1|||
148675804|NCT04439110|536283711|FG000|Overall Study|Other complicating disease|1|||
148675805|NCT04439110|536283711|FG000|Overall Study|Personal reasons|1|||
148675806|NCT04439110|536283711|FG000|Overall Study|Still on treatment|1|||
148675807|NCT00131937|536283712|FG000|Overall Study|Adverse Event|3|||
148675808|NCT00131937|536283712|FG000|Overall Study|Withdrawal by Subject|2|||
148675809|NCT00131937|536283712|FG000|Overall Study|Physician Decision|1|||
148675810|NCT00131937|536283712|FG000|Overall Study|Disease Progression|7|||
148675811|NCT00131937|536283712|FG000|Overall Study|Alternative therapy|1|||
148675812|NCT04647253|536283719|FG000|Overall Study|Death ≤ 365 Days|16|||
148675813|NCT04647253|536283720|FG001|Overall Study|Death ≤ 365 Days|7|||
148675814|NCT04647253|536283719|FG000|Overall Study|Physician Decision|0|||
148675815|NCT04647253|536283720|FG001|Overall Study|Physician Decision|1|||
148675816|NCT04647253|536283719|FG000|Overall Study|Withdrawal by Subject|7|||
148675817|NCT04647253|536283720|FG001|Overall Study|Withdrawal by Subject|2|||
148675818|NCT04647253|536283719|FG000|Overall Study|Missed 12-Month Visit|9|||
148675819|NCT04647253|536283720|FG001|Overall Study|Missed 12-Month Visit|7|||
148675820|NCT04647253|536283719|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
148675821|NCT04647253|536283720|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
148675822|NCT02706353|536283725|FG000|Dose Level 1|Disease Progression|1|||
148675823|NCT02706353|536283726|FG001|Dose Level 1|Disease Progression|0|||
148675824|NCT02706353|536283727|FG002|Dose Level 1|Disease Progression|0|||
148675825|NCT02706353|536283728|FG003|Dose Level 1|Disease Progression|0|||
148675826|NCT02706353|536283729|FG004|Dose Level 1|Disease Progression|0|||
148675827|NCT02706353|536283730|FG005|Dose Level 1|Disease Progression|0|||
149167236|NCT03094195|538084468|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
149167237|NCT03094195|538084469|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149167238|NCT03094195|538084470|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149167239|NCT03094195|538084471|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
148675828|NCT02706353|536283725|FG000|Dose Level 3|Disease Progression|0|||
148675829|NCT02706353|536283726|FG001|Dose Level 3|Disease Progression|0|||
148675830|NCT02706353|536283727|FG002|Dose Level 3|Disease Progression|2|||
148675831|NCT02706353|536283728|FG003|Dose Level 3|Disease Progression|0|||
148675832|NCT02706353|536283729|FG004|Dose Level 3|Disease Progression|0|||
148675833|NCT02706353|536283730|FG005|Dose Level 3|Disease Progression|0|||
148675834|NCT02706353|536283725|FG000|Dose Level 4|Disease Progression|0|||
148675835|NCT02706353|536283726|FG001|Dose Level 4|Disease Progression|0|||
148675836|NCT02706353|536283727|FG002|Dose Level 4|Disease Progression|0|||
148675837|NCT02706353|536283728|FG003|Dose Level 4|Disease Progression|1|||
148675838|NCT02706353|536283729|FG004|Dose Level 4|Disease Progression|0|||
148675839|NCT02706353|536283730|FG005|Dose Level 4|Disease Progression|0|||
148675840|NCT02706353|536283725|FG000|Dose Level 4|Toxicity|0|||
148675841|NCT02706353|536283726|FG001|Dose Level 4|Toxicity|0|||
148675842|NCT02706353|536283727|FG002|Dose Level 4|Toxicity|0|||
148675843|NCT02706353|536283728|FG003|Dose Level 4|Toxicity|1|||
148675844|NCT02706353|536283729|FG004|Dose Level 4|Toxicity|0|||
148675845|NCT02706353|536283730|FG005|Dose Level 4|Toxicity|0|||
148675846|NCT02706353|536283725|FG000|Dose Level 4|Death|0|||
148675847|NCT02706353|536283726|FG001|Dose Level 4|Death|0|||
148675848|NCT02706353|536283727|FG002|Dose Level 4|Death|0|||
148675849|NCT02706353|536283728|FG003|Dose Level 4|Death|1|||
148675850|NCT02706353|536283729|FG004|Dose Level 4|Death|0|||
148675851|NCT02706353|536283730|FG005|Dose Level 4|Death|0|||
148675852|NCT02706353|536283725|FG000|Dose Level 5|Toxicity|0|||
148675853|NCT02706353|536283726|FG001|Dose Level 5|Toxicity|0|||
148675854|NCT02706353|536283727|FG002|Dose Level 5|Toxicity|0|||
148675855|NCT02706353|536283728|FG003|Dose Level 5|Toxicity|0|||
148675856|NCT02706353|536283729|FG004|Dose Level 5|Toxicity|1|||
148675857|NCT02706353|536283730|FG005|Dose Level 5|Toxicity|0|||
148675858|NCT02706353|536283725|FG000|Dose Level 5|Disease Progression|0|||
148675859|NCT02706353|536283726|FG001|Dose Level 5|Disease Progression|0|||
148675860|NCT02706353|536283727|FG002|Dose Level 5|Disease Progression|0|||
148675861|NCT02706353|536283728|FG003|Dose Level 5|Disease Progression|0|||
148675862|NCT02706353|536283729|FG004|Dose Level 5|Disease Progression|3|||
148675863|NCT02706353|536283730|FG005|Dose Level 5|Disease Progression|2|||
148675864|NCT02706353|536283725|FG000|Dose Level 5|Death|0|||
148675865|NCT02706353|536283726|FG001|Dose Level 5|Death|0|||
148675866|NCT02706353|536283727|FG002|Dose Level 5|Death|0|||
148675867|NCT02706353|536283728|FG003|Dose Level 5|Death|0|||
148675868|NCT02706353|536283729|FG004|Dose Level 5|Death|1|||
148675869|NCT02706353|536283730|FG005|Dose Level 5|Death|6|||
148675870|NCT02706353|536283725|FG000|Dose Level 5|Withdrawal by Subject|0|||
148675871|NCT02706353|536283726|FG001|Dose Level 5|Withdrawal by Subject|0|||
148675872|NCT02706353|536283727|FG002|Dose Level 5|Withdrawal by Subject|0|||
148675873|NCT02706353|536283728|FG003|Dose Level 5|Withdrawal by Subject|0|||
148675874|NCT02706353|536283729|FG004|Dose Level 5|Withdrawal by Subject|0|||
148675875|NCT02706353|536283730|FG005|Dose Level 5|Withdrawal by Subject|2|||
148675876|NCT03560466|536283731|FG000|Overall Study|Adverse Event|1|||
148675877|NCT03560466|536283732|FG001|Overall Study|Adverse Event|2|||
148675878|NCT03560466|536283733|FG002|Overall Study|Adverse Event|0|||
148675879|NCT03560466|536283731|FG000|Overall Study|Poor Compliance to Protocol|0|||
148675880|NCT03560466|536283732|FG001|Overall Study|Poor Compliance to Protocol|2|||
148675881|NCT03560466|536283733|FG002|Overall Study|Poor Compliance to Protocol|0|||
148675882|NCT03560466|536283731|FG000|Overall Study|Other|6|||
148675883|NCT03560466|536283732|FG001|Overall Study|Other|8|||
148675884|NCT03560466|536283733|FG002|Overall Study|Other|1|||
148675885|NCT05257109|536283736|FG000|Overall Study|Withdrawal by Subject|1|||
149167240|NCT03094195|538084472|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149167241|NCT03094195|538084473|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
149167242|NCT03094195|538084466|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149167243|NCT03094195|538084467|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149167244|NCT03094195|538084468|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
149167245|NCT03094195|538084469|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149167246|NCT03094195|538084470|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149167247|NCT03094195|538084471|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
149167248|NCT03094195|538084472|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
148675886|NCT05257109|536283737|FG001|Overall Study|Withdrawal by Subject|0|||
148675887|NCT05257109|536283738|FG002|Overall Study|Withdrawal by Subject|0|||
148675888|NCT05257109|536283739|FG003|Overall Study|Withdrawal by Subject|0|||
148675889|NCT00424515|536285168|FG000|Overall Study|Progressive Disease|10|||
148675890|NCT00424515|536285169|FG001|Overall Study|Progressive Disease|11|||
148675891|NCT00424515|536285168|FG000|Overall Study|Adverse Event|0|||
148675892|NCT00424515|536285169|FG001|Overall Study|Adverse Event|1|||
148675893|NCT00424515|536285168|FG000|Overall Study|Intercurrent Illness|0|||
148675894|NCT00424515|536285169|FG001|Overall Study|Intercurrent Illness|1|||
148675895|NCT00424515|536285168|FG000|Overall Study|Withdrawal by Subject|1|||
148675896|NCT00424515|536285169|FG001|Overall Study|Withdrawal by Subject|0|||
148675897|NCT04071366|536285170|FG000|Part 1: Open-label (29 Days)|Death|4|||
148675898|NCT04071366|536285171|FG001|Part 1: Open-label (29 Days)|Death|2|||
148675899|NCT04071366|536285172|FG002|Part 1: Open-label (29 Days)|Death|8|||
148675900|NCT04071366|536285173|FG003|Part 1: Open-label (29 Days)|Death|0|||
148675901|NCT04071366|536285174|FG004|Part 1: Open-label (29 Days)|Death|0|||
148675902|NCT04071366|536285170|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
148675903|NCT04071366|536285171|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
148675904|NCT04071366|536285172|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
148675905|NCT04071366|536285173|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
148675906|NCT04071366|536285174|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
148675907|NCT04071366|536285170|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
149167249|NCT03094195|538084473|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
148675908|NCT04071366|536285171|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
149167250|NCT03094195|538084466|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
148675909|NCT04071366|536285172|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
148675910|NCT04071366|536285173|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
148675911|NCT04071366|536285174|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
148675912|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Death|0|||
148675913|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Death|0|||
148675914|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Death|0|||
148675915|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Death|2|||
148675916|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Death|2|||
148675917|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
148675918|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
148675919|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
148675920|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
148675921|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
148675922|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
148675923|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
148675924|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
148675925|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
148675926|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
148675927|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
148675928|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
148675929|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
148675930|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
148675931|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
148675932|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
148675933|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
148675934|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
148675935|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
148675936|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
148675937|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
148675938|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
148675939|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
148675940|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
148675941|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
148675942|NCT04071366|536285170|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
148675943|NCT04071366|536285171|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
148675944|NCT04071366|536285172|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
148675945|NCT04071366|536285173|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
148675946|NCT04071366|536285174|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
148675947|NCT02239692|536285175|FG000|Overall Study|Incomplete colonoscopy|1|||
149167251|NCT03094195|538084467|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
148675948|NCT02239692|536285176|FG001|Overall Study|Incomplete colonoscopy|2|||
148675949|NCT02239692|536285175|FG000|Overall Study|Adverse Event|0|||
148675950|NCT02239692|536285176|FG001|Overall Study|Adverse Event|1|||
148675951|NCT02239692|536285175|FG000|Overall Study|Physician Decision|0|||
148675952|NCT02239692|536285176|FG001|Overall Study|Physician Decision|1|||
148675953|NCT02239692|536285175|FG000|Overall Study|Lost to Follow-up|1|||
148675954|NCT02239692|536285176|FG001|Overall Study|Lost to Follow-up|4|||
148675955|NCT02239692|536285175|FG000|Overall Study|Withdrawal by Subject|3|||
148675956|NCT02239692|536285176|FG001|Overall Study|Withdrawal by Subject|5|||
148675957|NCT02239692|536285175|FG000|Overall Study|Other reason|1|||
148675958|NCT02239692|536285176|FG001|Overall Study|Other reason|0|||
148675959|NCT01678924|536285177|FG000|Overall Study|Adverse Event|1|||
148806244|NCT00420745|536768925|FG001|Overall Study|Protocol Violation|0|||
148675960|NCT01678924|536285178|FG001|Overall Study|Adverse Event|1|||
148675961|NCT01678924|536285179|FG002|Overall Study|Adverse Event|0|||
148675962|NCT01678924|536285180|FG003|Overall Study|Adverse Event|1|||
148675963|NCT01678924|536285177|FG000|Overall Study|Lack of Efficacy|7|||
148675964|NCT01678924|536285178|FG001|Overall Study|Lack of Efficacy|2|||
148675965|NCT01678924|536285179|FG002|Overall Study|Lack of Efficacy|0|||
148675966|NCT01678924|536285180|FG003|Overall Study|Lack of Efficacy|5|||
148675967|NCT01678924|536285177|FG000|Overall Study|Lost to Follow-up|0|||
148675968|NCT01678924|536285178|FG001|Overall Study|Lost to Follow-up|4|||
148675969|NCT01678924|536285179|FG002|Overall Study|Lost to Follow-up|0|||
148675970|NCT01678924|536285180|FG003|Overall Study|Lost to Follow-up|2|||
148675971|NCT01678924|536285177|FG000|Overall Study|Personal Reasons|2|||
148675972|NCT01678924|536285178|FG001|Overall Study|Personal Reasons|2|||
148675973|NCT01678924|536285179|FG002|Overall Study|Personal Reasons|2|||
148675974|NCT01678924|536285180|FG003|Overall Study|Personal Reasons|7|||
148675975|NCT01678924|536285177|FG000|Overall Study|Withdrawal by Subject|0|||
148675976|NCT01678924|536285178|FG001|Overall Study|Withdrawal by Subject|3|||
148675977|NCT01678924|536285179|FG002|Overall Study|Withdrawal by Subject|0|||
148675978|NCT01678924|536285180|FG003|Overall Study|Withdrawal by Subject|2|||
148675979|NCT01678924|536285177|FG000|Overall Study|Unable to attend scheduled visits|0|||
148675980|NCT01678924|536285178|FG001|Overall Study|Unable to attend scheduled visits|0|||
148675981|NCT01678924|536285179|FG002|Overall Study|Unable to attend scheduled visits|0|||
149167252|NCT03094195|538084468|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
149167253|NCT03094195|538084469|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149167254|NCT03094195|538084470|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149167255|NCT03094195|538084471|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149167256|NCT03094195|538084472|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149167257|NCT03094195|538084473|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
149167258|NCT00927563|538084474|FG000|Overall Study|Lost to Follow-up|1|||
149167259|NCT00927563|538084474|FG000|Overall Study|Withdrawal by Subject|1|||
148675982|NCT01678924|536285180|FG003|Overall Study|Unable to attend scheduled visits|1|||
148675983|NCT02156466|536285185|FG000|Overall Study|Adverse Event|0|||
148675984|NCT02156466|536285186|FG001|Overall Study|Adverse Event|0|||
148675985|NCT02156466|536285187|FG002|Overall Study|Adverse Event|1|||
148675986|NCT02156466|536285188|FG003|Overall Study|Adverse Event|1|||
148675987|NCT02156466|536285189|FG004|Overall Study|Adverse Event|0|||
148675988|NCT02156466|536285185|FG000|Overall Study|Quantiferon Positivity|0|||
148675989|NCT02156466|536285186|FG001|Overall Study|Quantiferon Positivity|0|||
148675990|NCT02156466|536285187|FG002|Overall Study|Quantiferon Positivity|0|||
148675991|NCT02156466|536285188|FG003|Overall Study|Quantiferon Positivity|1|||
148675992|NCT02156466|536285189|FG004|Overall Study|Quantiferon Positivity|0|||
148675993|NCT01784419|536285190|FG000|Overall Study|Adverse Event|3|||
148675994|NCT00080288|536285191|FG000|Overall Study|Adverse Event|7|||
148675995|NCT00080288|536285192|FG001|Overall Study|Adverse Event|4|||
148675996|NCT00080288|536285191|FG000|Overall Study|Lost to Follow-up|3|||
148675997|NCT00080288|536285192|FG001|Overall Study|Lost to Follow-up|5|||
148675998|NCT00080288|536285191|FG000|Overall Study|Physician Decision|6|||
148675999|NCT00080288|536285192|FG001|Overall Study|Physician Decision|2|||
148676000|NCT00080288|536285191|FG000|Overall Study|Withdrawal by Subject|3|||
148676001|NCT00080288|536285192|FG001|Overall Study|Withdrawal by Subject|16|||
148676002|NCT00080288|536285191|FG000|Overall Study|Miscellaneous|11|||
148676003|NCT00080288|536285192|FG001|Overall Study|Miscellaneous|11|||
148676004|NCT02576054|536285193|FG000|Overall Study|Withdrawal by Subject|1|||
148676005|NCT03978117|536285194|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
148676006|NCT03978117|536285195|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
148676007|NCT03978117|536285194|FG000|Overall Study|Lost to Follow-up|4|||
148676008|NCT03978117|536285195|FG001|Overall Study|Lost to Follow-up|4|||
148676009|NCT00791154|536285196|FG000|Overall Study|Noncompliance|0|||
148676010|NCT00791154|536285197|FG001|Overall Study|Noncompliance|1|||
148676011|NCT00791154|536285198|FG002|Overall Study|Noncompliance|0|||
148676012|NCT00791154|536285199|FG003|Overall Study|Noncompliance|0|||
149167260|NCT01870739|538084479|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
149167261|NCT01870739|538084480|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
148676013|NCT00791154|536285200|FG004|Overall Study|Noncompliance|1|||
148676014|NCT00791154|536285201|FG005|Overall Study|Noncompliance|1|||
148676015|NCT00791154|536285202|FG006|Overall Study|Noncompliance|1|||
148676016|NCT00791154|536285196|FG000|Overall Study|Adverse Event|0|||
148676017|NCT00791154|536285197|FG001|Overall Study|Adverse Event|0|||
148676018|NCT00791154|536285198|FG002|Overall Study|Adverse Event|0|||
148806245|NCT00420745|536768924|FG000|Overall Study|Physician Decision|1|||
148676019|NCT00791154|536285199|FG003|Overall Study|Adverse Event|0|||
148676020|NCT00791154|536285200|FG004|Overall Study|Adverse Event|2|||
148676021|NCT00791154|536285201|FG005|Overall Study|Adverse Event|0|||
148806246|NCT00420745|536768925|FG001|Overall Study|Physician Decision|1|||
148806247|NCT00420745|536768924|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
149167262|NCT01870739|538084479|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
148676022|NCT00791154|536285202|FG006|Overall Study|Adverse Event|1|||
148676023|NCT00791154|536285196|FG000|Overall Study|Full Consent withdrawn|1|||
148676024|NCT00791154|536285197|FG001|Overall Study|Full Consent withdrawn|3|||
148676025|NCT00791154|536285198|FG002|Overall Study|Full Consent withdrawn|0|||
148676026|NCT00791154|536285199|FG003|Overall Study|Full Consent withdrawn|0|||
148676027|NCT00791154|536285200|FG004|Overall Study|Full Consent withdrawn|1|||
148676028|NCT00791154|536285201|FG005|Overall Study|Full Consent withdrawn|3|||
148676029|NCT00791154|536285202|FG006|Overall Study|Full Consent withdrawn|1|||
148676030|NCT00791154|536285196|FG000|Overall Study|Lost to Follow-up|0|||
148676031|NCT00791154|536285197|FG001|Overall Study|Lost to Follow-up|0|||
148676032|NCT00791154|536285198|FG002|Overall Study|Lost to Follow-up|0|||
148676033|NCT00791154|536285199|FG003|Overall Study|Lost to Follow-up|1|||
148676034|NCT00791154|536285200|FG004|Overall Study|Lost to Follow-up|2|||
148676035|NCT00791154|536285201|FG005|Overall Study|Lost to Follow-up|0|||
148676036|NCT00791154|536285202|FG006|Overall Study|Lost to Follow-up|4|||
148676037|NCT00791154|536285196|FG000|Overall Study|Death|5|||
148676038|NCT00791154|536285197|FG001|Overall Study|Death|4|||
148676039|NCT00791154|536285198|FG002|Overall Study|Death|4|||
148676040|NCT00791154|536285199|FG003|Overall Study|Death|7|||
148676041|NCT00791154|536285200|FG004|Overall Study|Death|54|||
148676042|NCT00791154|536285201|FG005|Overall Study|Death|54|||
148676043|NCT00791154|536285202|FG006|Overall Study|Death|52|||
148676044|NCT00791154|536285196|FG000|Overall Study|Other event|0|||
148676045|NCT00791154|536285197|FG001|Overall Study|Other event|0|||
148676046|NCT00791154|536285198|FG002|Overall Study|Other event|2|||
148676047|NCT00791154|536285199|FG003|Overall Study|Other event|0|||
148676048|NCT00791154|536285200|FG004|Overall Study|Other event|2|||
148676049|NCT00791154|536285201|FG005|Overall Study|Other event|4|||
148676050|NCT00791154|536285202|FG006|Overall Study|Other event|2|||
148676051|NCT00414011|536285203|FG000|Overall Study|Physician Decision|3|||
148676052|NCT00414011|536285203|FG000|Overall Study|Withdrawal by Subject|2|||
148676053|NCT00817778|536285207|FG000|Overall Study|Adverse Event|1|||
148676054|NCT00817778|536285208|FG001|Overall Study|Adverse Event|0|||
148676055|NCT00817778|536285207|FG000|Overall Study|Withdrawal by Subject|1|||
148676056|NCT00817778|536285208|FG001|Overall Study|Withdrawal by Subject|1|||
148676057|NCT00817778|536285207|FG000|Overall Study|Protocol Violation|0|||
148676058|NCT00817778|536285208|FG001|Overall Study|Protocol Violation|1|||
148676059|NCT00817778|536285207|FG000|Overall Study|Study-specific discontinuation criteria|0|||
148676060|NCT00817778|536285208|FG001|Overall Study|Study-specific discontinuation criteria|1|||
148676061|NCT00817778|536285207|FG000|Overall Study|Poor venous access|1|||
148676062|NCT00817778|536285208|FG001|Overall Study|Poor venous access|0|||
148676063|NCT03343054|536285209|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
148676064|NCT03343054|536285210|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
148676065|NCT03343054|536285211|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
148676066|NCT03343054|536285209|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
148676067|NCT03343054|536285210|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
148676068|NCT03343054|536285211|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
148676069|NCT03343054|536285209|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
148676070|NCT03343054|536285210|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
148676071|NCT03343054|536285211|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
148676072|NCT03343054|536285209|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
148676073|NCT03343054|536285210|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
148676074|NCT03343054|536285211|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
148676075|NCT01286207|536285216|FG000|Overall Study|Adverse Event|27|||
148676076|NCT01286207|536285217|FG001|Overall Study|Adverse Event|41|||
148676077|NCT01286207|536285218|FG002|Overall Study|Adverse Event|8|||
148676078|NCT01286207|536285216|FG000|Overall Study|Lost to Follow-up|49|||
148676079|NCT01286207|536285217|FG001|Overall Study|Lost to Follow-up|43|||
148676080|NCT01286207|536285218|FG002|Overall Study|Lost to Follow-up|20|||
148676081|NCT01286207|536285216|FG000|Overall Study|Withdrawal by Subject|93|||
148676082|NCT01286207|536285217|FG001|Overall Study|Withdrawal by Subject|79|||
148676083|NCT01286207|536285218|FG002|Overall Study|Withdrawal by Subject|41|||
148676084|NCT01286207|536285216|FG000|Overall Study|Lack of Response|92|||
148676085|NCT01286207|536285217|FG001|Overall Study|Lack of Response|38|||
148676086|NCT01286207|536285218|FG002|Overall Study|Lack of Response|8|||
148676087|NCT01286207|536285216|FG000|Overall Study|Other|37|||
148676088|NCT01286207|536285217|FG001|Overall Study|Other|47|||
148676089|NCT01286207|536285218|FG002|Overall Study|Other|13|||
148676090|NCT00981409|536285219|FG000|Overall Study|Adverse Event|4|||
148676091|NCT00981409|536285220|FG001|Overall Study|Adverse Event|0|||
148676092|NCT00981409|536285219|FG000|Overall Study|Protocol Violation|0|||
148676093|NCT00981409|536285220|FG001|Overall Study|Protocol Violation|1|||
148676094|NCT00981409|536285219|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
148676095|NCT00981409|536285220|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
148676096|NCT00450177|536285221|FG000|Overall Study|Adverse Event|7|||
148676097|NCT00450177|536285222|FG001|Overall Study|Adverse Event|4|||
148676098|NCT00450177|536285221|FG000|Overall Study|Withdrawal by Subject|1|||
148676099|NCT00450177|536285222|FG001|Overall Study|Withdrawal by Subject|6|||
148676100|NCT00450177|536285221|FG000|Overall Study|Withdrawal by Primary Team|1|||
148676101|NCT00450177|536285222|FG001|Overall Study|Withdrawal by Primary Team|1|||
148676102|NCT02923115|536285223|FG000|Overall Study|Lost to Follow-up|0|||
148676103|NCT02923115|536285224|FG001|Overall Study|Lost to Follow-up|0|||
148676104|NCT02923115|536285225|FG002|Overall Study|Lost to Follow-up|0|||
148676105|NCT02923115|536285226|FG003|Overall Study|Lost to Follow-up|1|||
148676106|NCT02923115|536285227|FG004|Overall Study|Lost to Follow-up|0|||
148676107|NCT02923115|536285228|FG005|Overall Study|Lost to Follow-up|0|||
148676108|NCT02923115|536285223|FG000|Overall Study|Withdrawal by Subject|0|||
148676109|NCT02923115|536285224|FG001|Overall Study|Withdrawal by Subject|1|||
148676110|NCT02923115|536285225|FG002|Overall Study|Withdrawal by Subject|0|||
148676111|NCT02923115|536285226|FG003|Overall Study|Withdrawal by Subject|0|||
148806248|NCT00420745|536768925|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
148806249|NCT00420745|536768924|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
148806250|NCT00420745|536768925|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
148676112|NCT02923115|536285227|FG004|Overall Study|Withdrawal by Subject|0|||
148676113|NCT02923115|536285228|FG005|Overall Study|Withdrawal by Subject|0|||
148676114|NCT02923115|536285223|FG000|Overall Study|Randomized, but not dosed|0|||
148676115|NCT02923115|536285224|FG001|Overall Study|Randomized, but not dosed|0|||
148676116|NCT02923115|536285225|FG002|Overall Study|Randomized, but not dosed|3|||
148676117|NCT02923115|536285226|FG003|Overall Study|Randomized, but not dosed|1|||
148676118|NCT02923115|536285227|FG004|Overall Study|Randomized, but not dosed|5|||
148676119|NCT02923115|536285228|FG005|Overall Study|Randomized, but not dosed|0|||
148676120|NCT03869684|536285231|FG000|Overall Study|Adverse Event|0|||
148676121|NCT03869684|536285232|FG001|Overall Study|Adverse Event|3|||
148676122|NCT03869684|536285233|FG002|Overall Study|Adverse Event|1|||
148676123|NCT03869684|536285231|FG000|Overall Study|Withdrawal by Subject|1|||
148676124|NCT03869684|536285232|FG001|Overall Study|Withdrawal by Subject|0|||
148676125|NCT03869684|536285233|FG002|Overall Study|Withdrawal by Subject|0|||
148676126|NCT03869684|536285231|FG000|Overall Study|Lost to Follow-up|1|||
148676127|NCT03869684|536285232|FG001|Overall Study|Lost to Follow-up|0|||
148676128|NCT03869684|536285233|FG002|Overall Study|Lost to Follow-up|0|||
148676129|NCT03869684|536285231|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
148676130|NCT03869684|536285232|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
148676131|NCT03869684|536285233|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
148676132|NCT04056299|536285234|FG000|Overall Study|Sponsor discontinued study|3|||
148676133|NCT04056299|536285235|FG001|Overall Study|Sponsor discontinued study|3|||
148676134|NCT01296152|536285242|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
148676135|NCT04840901|536285243|FG000|Overall Study|Lost to Follow-up|3|||
148676136|NCT04840901|536285244|FG001|Overall Study|Lost to Follow-up|1|||
148676137|NCT04840901|536285243|FG000|Overall Study|Moved|1|||
148676138|NCT04840901|536285244|FG001|Overall Study|Moved|0|||
148676139|NCT04840901|536285243|FG000|Overall Study|Unable to comply with study schedule|0|||
148676140|NCT04840901|536285244|FG001|Overall Study|Unable to comply with study schedule|1|||
148676141|NCT04840901|536285243|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
148676142|NCT04840901|536285244|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
148676143|NCT01268683|536285245|FG000|Overall Study|Lost to Follow-up|1|||
148676144|NCT01268683|536285245|FG000|Overall Study|Death|1|||
148676145|NCT04256759|536285246|FG000|Overall Study|Physician Decision|1|||
148676146|NCT04256759|536285246|FG000|Overall Study|Lack of Efficacy|1|||
148676147|NCT04075292|536285251|FG000|Overall Study|Withdrawal by Subject|1|||
148676148|NCT04075292|536285252|FG001|Overall Study|Withdrawal by Subject|9|||
148676149|NCT04075292|536285251|FG000|Overall Study|Death|2|||
148676150|NCT04075292|536285252|FG001|Overall Study|Death|5|||
148676151|NCT04075292|536285251|FG000|Overall Study|Remained on study at time of DCO|74|||
148676152|NCT04075292|536285252|FG001|Overall Study|Remained on study at time of DCO|64|||
148676153|NCT01826201|536285253|FG000|Overall Study|Non compliance with protocol|4|||
148676154|NCT00103259|536285257|FG000|Overall Study|Death|3|||
148676155|NCT00103259|536285258|FG001|Overall Study|Death|2|||
148676156|NCT00103259|536285257|FG000|Overall Study|Withdrawal by Subject|2|||
148676157|NCT00103259|536285258|FG001|Overall Study|Withdrawal by Subject|3|||
148676158|NCT00103259|536285257|FG000|Overall Study|alternative therapy|1|||
148676159|NCT00103259|536285258|FG001|Overall Study|alternative therapy|0|||
148676160|NCT00103259|536285257|FG000|Overall Study|other (reasons were not specified)|2|||
148676161|NCT00103259|536285258|FG001|Overall Study|other (reasons were not specified)|1|||
148676162|NCT00103259|536285257|FG000|Overall Study|ineligible/no protocol therapy|4|||
148676163|NCT00103259|536285258|FG001|Overall Study|ineligible/no protocol therapy|6|||
148676164|NCT03224234|536285261|FG000|Main Study|Lost to Follow-up|5|||
148676165|NCT03224234|536285262|FG001|Main Study|Lost to Follow-up|5|||
148676166|NCT02610842|536285263|FG000|Overall Study|Lost to Follow-up|5|||
148676167|NCT05349188|536285268|FG000|Overall Study|Withdrawal by Subject|1|||
148676168|NCT05349188|536285269|FG001|Overall Study|Withdrawal by Subject|0|||
148676169|NCT03829462|536285270|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
148676170|NCT03829462|536285271|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
148676171|NCT03829462|536285270|FG000|Overall Study|No treatment due to progression disease|0|||
148676172|NCT03829462|536285271|FG001|Overall Study|No treatment due to progression disease|1|||
148676173|NCT00481871|536285272|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
148676174|NCT00481871|536285273|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
148676175|NCT00481871|536285274|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
149167263|NCT01870739|538084480|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
149167264|NCT01870739|538084479|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
149167265|NCT01870739|538084480|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
149167266|NCT01870739|538084479|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
149167267|NCT01870739|538084480|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
149167268|NCT01870739|538084479|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
149167269|NCT01870739|538084480|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
149167270|NCT01870739|538084479|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
149167271|NCT01870739|538084480|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
149167272|NCT01870739|538084479|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
149167273|NCT01870739|538084480|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
149167274|NCT01986062|538084481|FG000|Overall Study|Lost to Follow-up|1|||
149167275|NCT01986062|538084482|FG001|Overall Study|Lost to Follow-up|0|||
149167276|NCT01986062|538084481|FG000|Overall Study|Withdrawal by Subject|0|||
149167277|NCT01986062|538084482|FG001|Overall Study|Withdrawal by Subject|1|||
149167278|NCT03538743|538084483|FG000|Overall Study|Adverse Event|0|||
149167279|NCT03538743|538084484|FG001|Overall Study|Adverse Event|0|||
148676176|NCT00481871|536285275|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
148676177|NCT00481871|536285276|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
148676178|NCT03985293|536285279|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
148676179|NCT03985293|536285280|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
148676180|NCT03985293|536285281|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
148676181|NCT03985293|536285282|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
148676182|NCT03985293|536285283|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
148676183|NCT03985293|536285284|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
148676184|NCT03985293|536285279|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
148676185|NCT03985293|536285280|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
148676186|NCT03985293|536285281|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
148676187|NCT03985293|536285282|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
148676188|NCT03985293|536285283|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
148676189|NCT03985293|536285284|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
148676190|NCT03985293|536285279|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
148676191|NCT03985293|536285280|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
148676192|NCT03985293|536285281|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
148676193|NCT03985293|536285282|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
148676194|NCT03985293|536285283|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
148676195|NCT03985293|536285284|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
148676196|NCT03985293|536285279|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
148676197|NCT03985293|536285280|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
148676198|NCT03985293|536285281|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
148676199|NCT03985293|536285282|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
148676200|NCT03985293|536285283|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
148676201|NCT03985293|536285284|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
148676202|NCT03985293|536285279|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
148676203|NCT03985293|536285280|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
148676204|NCT03985293|536285281|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
148676205|NCT03985293|536285282|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
148676206|NCT03985293|536285283|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
148676207|NCT03985293|536285284|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
148676208|NCT03985293|536285279|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
148676209|NCT03985293|536285280|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
148676210|NCT03985293|536285281|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
148676211|NCT03985293|536285282|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
148676212|NCT03985293|536285283|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
148676213|NCT03985293|536285284|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
148676214|NCT03985293|536285279|FG000|FOLLOW-UP|Lost to Follow-up|0|||
148676215|NCT03985293|536285280|FG001|FOLLOW-UP|Lost to Follow-up|0|||
148676216|NCT03985293|536285281|FG002|FOLLOW-UP|Lost to Follow-up|1|||
148676217|NCT03985293|536285282|FG003|FOLLOW-UP|Lost to Follow-up|0|||
148676218|NCT03985293|536285283|FG004|FOLLOW-UP|Lost to Follow-up|0|||
148676219|NCT03985293|536285284|FG005|FOLLOW-UP|Lost to Follow-up|0|||
148676220|NCT03107715|536285285|FG000|Overall Study|did not deliver at the home hospital|4|||
148676221|NCT03107715|536285286|FG001|Overall Study|did not deliver at the home hospital|6|||
148676222|NCT03107715|536285285|FG000|Overall Study|infant stillborn|0|||
148676223|NCT03107715|536285286|FG001|Overall Study|infant stillborn|1|||
148676224|NCT01907516|536285287|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
148676225|NCT01907516|536285288|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
148676226|NCT01907516|536285287|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
148676227|NCT01907516|536285288|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
148676228|NCT01907516|536285287|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
148676229|NCT01907516|536285288|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
148676230|NCT01907516|536285287|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
148676231|NCT01907516|536285288|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
148676232|NCT01211613|536286818|FG000|Overall Study|Lost to Follow-up|2|||
148676233|NCT01211613|536286819|FG001|Overall Study|Lost to Follow-up|2|||
148676234|NCT01211613|536286820|FG002|Overall Study|Lost to Follow-up|2|||
148676235|NCT01211613|536286818|FG000|Overall Study|Withdrawal by Subject|1|||
148676236|NCT01211613|536286819|FG001|Overall Study|Withdrawal by Subject|0|||
148676237|NCT01211613|536286820|FG002|Overall Study|Withdrawal by Subject|0|||
148676238|NCT01020773|536286821|FG000|Overall Study|Withdrawal by Subject|4|||
148676239|NCT01020773|536286822|FG001|Overall Study|Withdrawal by Subject|3|||
148676240|NCT03853213|536286823|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
148676241|NCT03853213|536286824|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
148676242|NCT03853213|536286823|FG000|Overall Study|Other (e.g., too busy)|0|||
148676243|NCT03853213|536286824|FG001|Overall Study|Other (e.g., too busy)|2|||
148676244|NCT03302299|536286825|FG000|Overall Study|Protocol Violation|1|||
148676245|NCT01458132|536286826|FG000|Overall Study|Other|15|||
148676246|NCT01458132|536286827|FG001|Overall Study|Other|3|||
148676247|NCT01788163|536286832|FG000|Overall Study|Other|53|||
148676248|NCT01788163|536286833|FG001|Overall Study|Other|0|||
148676249|NCT01788163|536286834|FG002|Overall Study|Other|0|||
148676250|NCT01788163|536286835|FG003|Overall Study|Other|0|||
149167280|NCT03538743|538084485|FG002|Overall Study|Adverse Event|1|||
149167281|NCT03538743|538084486|FG003|Overall Study|Adverse Event|1|||
149167282|NCT03538743|538084487|FG004|Overall Study|Adverse Event|0|||
149167283|NCT03538743|538084488|FG005|Overall Study|Adverse Event|0|||
149167284|NCT03538743|538084489|FG006|Overall Study|Adverse Event|0|||
149167285|NCT03538743|538084490|FG007|Overall Study|Adverse Event|0|||
149167286|NCT03538743|538084491|FG008|Overall Study|Adverse Event|0|||
149167287|NCT03538743|538084483|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
149167288|NCT03538743|538084484|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
149167289|NCT03538743|538084485|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
149167290|NCT03538743|538084486|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
149167291|NCT03538743|538084487|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
149167292|NCT03538743|538084488|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
149167293|NCT03538743|538084489|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
149167294|NCT03538743|538084490|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
149167295|NCT03538743|538084491|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
149167296|NCT03538743|538084483|FG000|Overall Study|Withdrawal by Subject|0|||
149167297|NCT03538743|538084484|FG001|Overall Study|Withdrawal by Subject|0|||
149167298|NCT03538743|538084485|FG002|Overall Study|Withdrawal by Subject|0|||
149167299|NCT03538743|538084486|FG003|Overall Study|Withdrawal by Subject|1|||
149167300|NCT03538743|538084487|FG004|Overall Study|Withdrawal by Subject|0|||
149167301|NCT03538743|538084488|FG005|Overall Study|Withdrawal by Subject|0|||
148676251|NCT01788163|536286836|FG004|Overall Study|Other|0|||
148676252|NCT01788163|536286837|FG005|Overall Study|Other|7|||
148676253|NCT01788163|536286838|FG006|Overall Study|Other|1|||
148676254|NCT01788163|536286839|FG007|Overall Study|Other|48|||
148676255|NCT01788163|536286840|FG008|Overall Study|Other|15|||
148676256|NCT01788163|536286832|FG000|Overall Study|Withdrawal by Subject|2|||
148676257|NCT01788163|536286833|FG001|Overall Study|Withdrawal by Subject|0|||
148676258|NCT01788163|536286834|FG002|Overall Study|Withdrawal by Subject|0|||
148676259|NCT01788163|536286835|FG003|Overall Study|Withdrawal by Subject|0|||
148676260|NCT01788163|536286836|FG004|Overall Study|Withdrawal by Subject|0|||
148676261|NCT01788163|536286837|FG005|Overall Study|Withdrawal by Subject|0|||
148676262|NCT01788163|536286838|FG006|Overall Study|Withdrawal by Subject|0|||
148676263|NCT01788163|536286839|FG007|Overall Study|Withdrawal by Subject|0|||
148676264|NCT01788163|536286840|FG008|Overall Study|Withdrawal by Subject|1|||
148676265|NCT00545441|536286841|FG000|Overall Study|Fistula draining at 6 months|2|||
148676266|NCT00545441|536286842|FG001|Overall Study|Fistula draining at 6 months|4|||
148676267|NCT00545441|536286841|FG000|Overall Study|Lost to Follow-up|9|||
148676268|NCT00545441|536286842|FG001|Overall Study|Lost to Follow-up|5|||
148676269|NCT00545441|536286841|FG000|Overall Study|Technical failure|0|||
148676270|NCT00545441|536286842|FG001|Overall Study|Technical failure|1|||
148676271|NCT00545441|536286841|FG000|Overall Study|Withdrawal by Subject|1|||
148676272|NCT00545441|536286842|FG001|Overall Study|Withdrawal by Subject|1|||
148676273|NCT00545441|536286841|FG000|Overall Study|Persistence or recurrence of fistula|5|||
148676274|NCT00545441|536286842|FG001|Overall Study|Persistence or recurrence of fistula|2|||
148676275|NCT00545441|536286841|FG000|Overall Study|Patients were not treated|1|||
148676276|NCT00545441|536286842|FG001|Overall Study|Patients were not treated|3|||
148676277|NCT00265239|536286843|FG000|Overall Study|Adverse Event|2|||
148676278|NCT00265239|536286844|FG001|Overall Study|Adverse Event|1|||
148676279|NCT02803138|536286845|FG000|Overall Study|Failure to return|38|||
148676280|NCT02803138|536286845|FG000|Overall Study|Insufficient virological response|2|||
148676281|NCT02803138|536286845|FG000|Overall Study|Withdrawn consent|1|||
148676282|NCT02803138|536286845|FG000|Overall Study|Death|1|||
148676283|NCT02803138|536286845|FG000|Overall Study|Other, not specified|28|||
148676284|NCT04318535|536286846|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
148676285|NCT04318535|536286847|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
148676286|NCT04318535|536286848|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
148676287|NCT00021229|536286851|FG000|Overall Study|Adverse Event|10|||
148676288|NCT00021229|536286852|FG001|Overall Study|Adverse Event|5|||
148676289|NCT00021229|536286853|FG002|Overall Study|Adverse Event|2|||
149013036|NCT00077636|537527775|FG001|Overall Study|Protocol Violation|2|||
149013037|NCT00077636|537527774|FG000|Overall Study|Lost to Follow-up|10|||
149013038|NCT00077636|537527775|FG001|Overall Study|Lost to Follow-up|18|||
149013039|NCT00077636|537527774|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
149013040|NCT00077636|537527775|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
149013041|NCT01923896|537527780|FG000|Overall Study|Adverse Event|1|||
149013042|NCT01923896|537527781|FG001|Overall Study|Adverse Event|0|||
149013043|NCT00592319|537527782|FG000|Overall Study|Lost to Follow-up|0|||
149013044|NCT00592319|537527783|FG001|Overall Study|Lost to Follow-up|3|||
149013045|NCT03545113|537527786|FG000|Overall Study|Surgery Cancelled|1|||
149013046|NCT03545113|537527787|FG001|Overall Study|Surgery Cancelled|0|||
149013047|NCT03545113|537527786|FG000|Overall Study|Death|1|||
149013048|NCT03545113|537527787|FG001|Overall Study|Death|0|||
149013049|NCT03545113|537527786|FG000|Overall Study|Adverse Event|2|||
149013050|NCT03545113|537527787|FG001|Overall Study|Adverse Event|0|||
149013051|NCT03545113|537527786|FG000|Overall Study|Received different surgery|1|||
149013052|NCT03545113|537527787|FG001|Overall Study|Received different surgery|0|||
149013053|NCT00235443|537527788|FG000|Overall Study|Adverse Event|4|||
149013054|NCT00235443|537527789|FG001|Overall Study|Adverse Event|12|||
149167302|NCT03538743|538084489|FG006|Overall Study|Withdrawal by Subject|0|||
148676290|NCT00021229|536286851|FG000|Overall Study|Death|0|||
148676291|NCT00021229|536286852|FG001|Overall Study|Death|1|||
148676292|NCT00021229|536286853|FG002|Overall Study|Death|0|||
148676293|NCT00021229|536286851|FG000|Overall Study|Withdrawal by Subject|7|||
148676294|NCT00021229|536286852|FG001|Overall Study|Withdrawal by Subject|7|||
148676295|NCT00021229|536286853|FG002|Overall Study|Withdrawal by Subject|1|||
148676296|NCT00021229|536286851|FG000|Overall Study|Progressive Disease|15|||
148676297|NCT00021229|536286852|FG001|Overall Study|Progressive Disease|19|||
148676298|NCT00021229|536286853|FG002|Overall Study|Progressive Disease|12|||
149013055|NCT00235443|537527790|FG002|Overall Study|Adverse Event|17|||
149013056|NCT00235443|537527791|FG003|Overall Study|Adverse Event|44|||
149013057|NCT00235443|537527792|FG004|Overall Study|Adverse Event|10|||
149013058|NCT00235443|537527793|FG005|Overall Study|Adverse Event|15|||
149013059|NCT00235443|537527788|FG000|Overall Study|Lack of Efficacy|0|||
149013060|NCT00235443|537527789|FG001|Overall Study|Lack of Efficacy|1|||
149013061|NCT00235443|537527790|FG002|Overall Study|Lack of Efficacy|5|||
149013062|NCT00235443|537527791|FG003|Overall Study|Lack of Efficacy|12|||
149167303|NCT03538743|538084490|FG007|Overall Study|Withdrawal by Subject|0|||
148676299|NCT00021229|536286851|FG000|Overall Study|Protocol Violation|1|||
148806251|NCT01588509|536768927|FG000|Overall Study|Lost to Follow-up|1|||
148676300|NCT00021229|536286852|FG001|Overall Study|Protocol Violation|1|||
148676301|NCT00021229|536286853|FG002|Overall Study|Protocol Violation|0|||
148676302|NCT00021229|536286851|FG000|Overall Study|Physician Decision|0|||
148676303|NCT00021229|536286852|FG001|Overall Study|Physician Decision|0|||
148676304|NCT00021229|536286853|FG002|Overall Study|Physician Decision|1|||
148676305|NCT00021229|536286851|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
148676306|NCT00021229|536286852|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
148676307|NCT00021229|536286853|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
148676308|NCT02675426|536286857|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
148676309|NCT02675426|536286858|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
148676310|NCT02675426|536286859|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
148676311|NCT02675426|536286860|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
148676312|NCT02675426|536286857|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
148676313|NCT02675426|536286858|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
148676314|NCT02675426|536286859|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
148676315|NCT02675426|536286860|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
148676316|NCT02675426|536286857|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
148676317|NCT02675426|536286858|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
148676318|NCT02675426|536286859|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
148676319|NCT02675426|536286860|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
148676320|NCT02675426|536286857|FG000|Period 1: Week 1 to Week 12|Other|2|||
148676321|NCT02675426|536286858|FG001|Period 1: Week 1 to Week 12|Other|1|||
148676322|NCT02675426|536286859|FG002|Period 1: Week 1 to Week 12|Other|0|||
148676323|NCT02675426|536286860|FG003|Period 1: Week 1 to Week 12|Other|2|||
148676324|NCT02675426|536286857|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
148676325|NCT02675426|536286858|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
148676326|NCT02675426|536286859|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
148676327|NCT02675426|536286860|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
148676328|NCT02675426|536286857|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
148676329|NCT02675426|536286858|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
148676330|NCT02675426|536286859|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
149167304|NCT03538743|538084491|FG008|Overall Study|Withdrawal by Subject|0|||
149167305|NCT01565980|538084493|FG000|Overall Study|Death|1|||
149167306|NCT01565980|538084494|FG001|Overall Study|Death|0|||
149167307|NCT01565980|538084493|FG000|Overall Study|Lost to Follow-up|1|||
149167308|NCT01565980|538084494|FG001|Overall Study|Lost to Follow-up|0|||
149167309|NCT01565980|538084493|FG000|Overall Study|health complications|1|||
149167310|NCT01565980|538084494|FG001|Overall Study|health complications|1|||
149167311|NCT01565980|538084493|FG000|Overall Study|stopped medical treatment|1|||
149167312|NCT01565980|538084494|FG001|Overall Study|stopped medical treatment|0|||
149167313|NCT01565980|538084493|FG000|Overall Study|Withdrawal by Subject|0|||
149167314|NCT01565980|538084494|FG001|Overall Study|Withdrawal by Subject|3|||
149167315|NCT01929135|538084496|FG000|Overall Study|Lost to Follow-up|1|||
149167316|NCT01929135|538084497|FG001|Overall Study|Lost to Follow-up|1|||
149167317|NCT01926626|538084503|FG000|Overall Study|Withdrawal by Subject|15|||
149167318|NCT01926626|538084503|FG000|Overall Study|Lost to Follow-up|7|||
149167319|NCT04439279|538086059|FG000|Overall Study|Adverse Event|7|||
149167320|NCT04439279|538086059|FG000|Overall Study|Death|4|||
149167321|NCT04439279|538086059|FG000|Overall Study|Disease progression|17|||
149167322|NCT04439279|538086059|FG000|Overall Study|Complicating disease|3|||
149167323|NCT04439279|538086059|FG000|Overall Study|Withdrawal by Subject|2|||
149167324|NCT04439279|538086059|FG000|Overall Study|Ineligible|1|||
149167325|NCT04439279|538086059|FG000|Overall Study|Treatment still ongoing|1|||
149167326|NCT02031679|538086060|FG000|Overall Study|Protocol Violation|0|||
149167327|NCT02031679|538086061|FG001|Overall Study|Protocol Violation|1|||
149167328|NCT02031679|538086060|FG000|Overall Study|Lack of Efficacy|0|||
149167329|NCT02031679|538086061|FG001|Overall Study|Lack of Efficacy|1|||
149167330|NCT02338843|538086068|FG000|Overall Study|Adverse Event|2|||
149167331|NCT02338843|538086069|FG001|Overall Study|Adverse Event|1|||
149167332|NCT02338843|538086068|FG000|Overall Study|Death|40|||
149167333|NCT02338843|538086069|FG001|Overall Study|Death|53|||
149167334|NCT02338843|538086068|FG000|Overall Study|Physician Decision|1|||
149167335|NCT02338843|538086069|FG001|Overall Study|Physician Decision|0|||
149167336|NCT02338843|538086068|FG000|Overall Study|Withdrawal by Subject|0|||
149167337|NCT02338843|538086069|FG001|Overall Study|Withdrawal by Subject|2|||
149167338|NCT02338843|538086068|FG000|Overall Study|Subject Recovered|0|||
149167339|NCT02338843|538086069|FG001|Overall Study|Subject Recovered|2|||
148676331|NCT02675426|536286860|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
148676332|NCT02675426|536286857|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
148676333|NCT02675426|536286858|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
149167340|NCT02338843|538086068|FG000|Overall Study|Discontinued prior to randomizat|1|||
149167341|NCT02338843|538086069|FG001|Overall Study|Discontinued prior to randomizat|0|||
149167342|NCT00023322|538086070|FG000|Overall Study|Lost to Follow-up|1|||
149167343|NCT01609933|538086071|FG000|Overall Study|Adverse Event|1|||
149167344|NCT01609933|538086071|FG000|Overall Study|Withdrawal by Subject|3|||
149167345|NCT01252966|538086072|FG000|Overall Study|Lost to Follow-up|16|||
148676334|NCT02675426|536286859|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
148676335|NCT02675426|536286860|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
148676336|NCT02675426|536286857|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
148676337|NCT02675426|536286858|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
148676338|NCT02675426|536286859|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
148676339|NCT02675426|536286860|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
148676340|NCT02675426|536286857|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
148676341|NCT02675426|536286858|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
148676342|NCT02675426|536286859|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
148676343|NCT02675426|536286860|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
148676344|NCT02675426|536286857|FG000|Period 2: Week 12 to Week 260|Other|8|||
148676345|NCT02675426|536286858|FG001|Period 2: Week 12 to Week 260|Other|12|||
148676346|NCT02675426|536286859|FG002|Period 2: Week 12 to Week 260|Other|23|||
148676347|NCT02675426|536286860|FG003|Period 2: Week 12 to Week 260|Other|15|||
148676348|NCT03724968|536286861|FG000|Overall Study|Insurance issues|0|||
148676349|NCT03724968|536286862|FG001|Overall Study|Insurance issues|1|||
148676350|NCT03724968|536286861|FG000|Overall Study|Study closed|0|||
148676351|NCT03724968|536286862|FG001|Overall Study|Study closed|1|||
148676352|NCT01858558|536286863|FG000|Overall Study|Death|1|||
148676353|NCT01858558|536286864|FG001|Overall Study|Death|1|||
148676354|NCT01858558|536286863|FG000|Overall Study|Lost to Follow-up|1|||
148676355|NCT01858558|536286864|FG001|Overall Study|Lost to Follow-up|0|||
148676356|NCT01858558|536286863|FG000|Overall Study|Disease progression|3|||
148676357|NCT01858558|536286864|FG001|Overall Study|Disease progression|1|||
148676358|NCT01858558|536286863|FG000|Overall Study|Product contamination|2|||
148676359|NCT01858558|536286864|FG001|Overall Study|Product contamination|0|||
148676360|NCT01858558|536286863|FG000|Overall Study|Failed expansion of cell product|2|||
148676361|NCT01858558|536286864|FG001|Overall Study|Failed expansion of cell product|0|||
148676362|NCT02237118|536286865|FG000|Overall Study|Protocol Violation|0|||
148676363|NCT02237118|536286866|FG001|Overall Study|Protocol Violation|1|||
148676364|NCT02237118|536286865|FG000|Overall Study|consent withdrawn|1|||
148676365|NCT02237118|536286866|FG001|Overall Study|consent withdrawn|0|||
148676366|NCT02253654|536286869|FG000|Overall Study|Withdrawal by Subject|12|||
148676367|NCT02253654|536286870|FG001|Overall Study|Withdrawal by Subject|4|||
148676368|NCT02253654|536286869|FG000|Overall Study|Decision by Sponsor|1|||
148676369|NCT02253654|536286870|FG001|Overall Study|Decision by Sponsor|1|||
148676370|NCT02253654|536286869|FG000|Overall Study|Lost to Follow-up|2|||
148676371|NCT02253654|536286870|FG001|Overall Study|Lost to Follow-up|5|||
148676372|NCT02253654|536286869|FG000|Overall Study|Death|4|||
148676373|NCT02253654|536286870|FG001|Overall Study|Death|7|||
148676374|NCT02253654|536286869|FG000|Overall Study|Did Not Receive Study Treatment|4|||
148676375|NCT02253654|536286870|FG001|Overall Study|Did Not Receive Study Treatment|1|||
148676376|NCT03044431|536286873|FG000|Overall Study|Lost to Follow-up|59|||
148676377|NCT03456726|536286874|FG000|Overall Study|Disease Progression|6|||
148676378|NCT03456726|536286875|FG001|Overall Study|Disease Progression|1|||
148676379|NCT03456726|536286874|FG000|Overall Study|Adverse Event|4|||
148676380|NCT03456726|536286875|FG001|Overall Study|Adverse Event|2|||
148676381|NCT03456726|536286874|FG000|Overall Study|Withdrawal by Subject|1|||
148676382|NCT03456726|536286875|FG001|Overall Study|Withdrawal by Subject|0|||
149167346|NCT01252966|538086073|FG001|Overall Study|Lost to Follow-up|10|||
149167347|NCT01252966|538086072|FG000|Overall Study|Withdrawal by Subject|7|||
149167348|NCT01252966|538086073|FG001|Overall Study|Withdrawal by Subject|3|||
149167349|NCT05194345|538086075|FG000|Overall Study|Withdrawal by Subject|6|||
149167350|NCT05194345|538086076|FG001|Overall Study|Withdrawal by Subject|4|||
149167351|NCT05194345|538086077|FG002|Overall Study|Withdrawal by Subject|0|||
149167352|NCT05194345|538086075|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
149167353|NCT05194345|538086076|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
149167354|NCT05194345|538086077|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
148676383|NCT03456726|536286874|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
148676384|NCT03456726|536286875|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
148676385|NCT01614925|536286876|FG000|Overall Study|Withdrawal by Subject|1|||
148676386|NCT01614925|536286877|FG001|Overall Study|Withdrawal by Subject|0|||
148676387|NCT01614925|536286876|FG000|Overall Study|Protocol Violation|3|||
148676388|NCT01614925|536286877|FG001|Overall Study|Protocol Violation|2|||
148676389|NCT04470622|536286878|FG000|Overall Study|Withdrawal by Subject|0|||
148676390|NCT04470622|536286879|FG001|Overall Study|Withdrawal by Subject|1|||
148676391|NCT04470622|536286878|FG000|Overall Study|Screen Failure|0|||
148676392|NCT04470622|536286879|FG001|Overall Study|Screen Failure|1|||
148676393|NCT04470622|536286878|FG000|Overall Study|Death|0|||
148676394|NCT04470622|536286879|FG001|Overall Study|Death|1|||
149167355|NCT02300129|538086079|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
148676395|NCT00399490|536286882|FG000|Overall Study|Adverse Event|19|||
148676396|NCT00399490|536286882|FG000|Overall Study|Lack of Efficacy|31|||
148676397|NCT00399490|536286882|FG000|Overall Study|Lost to Follow-up|5|||
149167356|NCT02300129|538086080|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
149167357|NCT02300129|538086081|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
149167358|NCT02300129|538086082|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
148676398|NCT00399490|536286882|FG000|Overall Study|Withdrawal by Subject|18|||
148676399|NCT00399490|536286882|FG000|Overall Study|Other|25|||
148676400|NCT02328547|536286883|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
148676401|NCT02328547|536286884|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
148676402|NCT02328547|536286883|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
148676403|NCT02328547|536286884|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
148676404|NCT00344305|536286888|FG000|Overall Study|Lost to Follow-up|2|||
148676405|NCT00344305|536286889|FG001|Overall Study|Lost to Follow-up|0|||
148676406|NCT00344305|536286888|FG000|Overall Study|Participant was not contacted in window|0|||
148676407|NCT00344305|536286889|FG001|Overall Study|Participant was not contacted in window|1|||
148676408|NCT01190098|536286890|FG000|Overall Study|Adverse Event|2|||
148676409|NCT01190098|536286891|FG001|Overall Study|Adverse Event|0|||
148676410|NCT01190098|536286890|FG000|Overall Study|Patient coomorbidity|0|||
148676411|NCT01190098|536286891|FG001|Overall Study|Patient coomorbidity|1|||
148676412|NCT01190098|536286890|FG000|Overall Study|Lack of transportation|1|||
148676413|NCT01190098|536286891|FG001|Overall Study|Lack of transportation|0|||
148676414|NCT01190098|536286890|FG000|Overall Study|Other|0|||
148676415|NCT01190098|536286891|FG001|Overall Study|Other|1|||
148676416|NCT01586624|536286897|FG000|Overall Study|Adverse Event|3|||
148676417|NCT01586624|536286898|FG001|Overall Study|Adverse Event|0|||
148676418|NCT01586624|536286899|FG002|Overall Study|Adverse Event|2|||
148676419|NCT01586624|536286900|FG003|Overall Study|Adverse Event|1|||
148806252|NCT01588509|536768928|FG001|Overall Study|Lost to Follow-up|0|||
148806253|NCT01983930|536768929|FG000|Overall Study|Withdrawal by Subject|9|||
148806254|NCT01983930|536768930|FG001|Overall Study|Withdrawal by Subject|8|||
149167359|NCT02300129|538086079|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
149167360|NCT02300129|538086080|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
149167361|NCT02300129|538086081|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
149167362|NCT02300129|538086082|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
149167363|NCT02300129|538086079|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
149167364|NCT02300129|538086080|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
149167365|NCT02300129|538086081|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
149167366|NCT02300129|538086082|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
149167367|NCT01887912|538086083|FG000|Overall Study|Serious adverse event|400|||
149167368|NCT01887912|538086084|FG001|Overall Study|Serious adverse event|198|||
149167369|NCT01887912|538086083|FG000|Overall Study|Other Adverse Event|34|||
149167370|NCT01887912|538086084|FG001|Overall Study|Other Adverse Event|15|||
149167371|NCT01887912|538086083|FG000|Overall Study|Protocol Violation|67|||
149167372|NCT01887912|538086084|FG001|Overall Study|Protocol Violation|37|||
149167373|NCT01887912|538086083|FG000|Overall Study|Lost to Follow-up|163|||
149167374|NCT01887912|538086084|FG001|Overall Study|Lost to Follow-up|74|||
149167375|NCT01887912|538086083|FG000|Overall Study|Withdrawal by Subject|606|||
149167376|NCT01887912|538086084|FG001|Overall Study|Withdrawal by Subject|349|||
149167377|NCT01887912|538086083|FG000|Overall Study|Other|122|||
149167378|NCT01887912|538086084|FG001|Overall Study|Other|58|||
149167379|NCT01154101|538086088|FG000|Overall Study|Adverse Event|0|||
149167380|NCT01154101|538086089|FG001|Overall Study|Adverse Event|2|||
149167381|NCT01154101|538086090|FG002|Overall Study|Adverse Event|1|||
149167382|NCT01154101|538086091|FG003|Overall Study|Adverse Event|1|||
149167383|NCT01154101|538086092|FG004|Overall Study|Adverse Event|0|||
149167384|NCT01154101|538086088|FG000|Overall Study|Lost to Follow-up|0|||
149167385|NCT01154101|538086089|FG001|Overall Study|Lost to Follow-up|1|||
149167386|NCT01154101|538086090|FG002|Overall Study|Lost to Follow-up|0|||
149167387|NCT01154101|538086091|FG003|Overall Study|Lost to Follow-up|1|||
149167388|NCT01154101|538086092|FG004|Overall Study|Lost to Follow-up|0|||
149167389|NCT01154101|538086088|FG000|Overall Study|Withdrawal by Subject|0|||
149167390|NCT01154101|538086089|FG001|Overall Study|Withdrawal by Subject|1|||
149167391|NCT01154101|538086090|FG002|Overall Study|Withdrawal by Subject|2|||
149167392|NCT01154101|538086091|FG003|Overall Study|Withdrawal by Subject|0|||
149167393|NCT01154101|538086092|FG004|Overall Study|Withdrawal by Subject|1|||
149167394|NCT05019131|538086093|FG000|Overall Study|Lost to Follow-up|0|||
149167395|NCT05019131|538086094|FG001|Overall Study|Lost to Follow-up|3|||
149167396|NCT00432237|538086095|FG000|Overall Study|Adverse Event|0|||
149167397|NCT00432237|538086096|FG001|Overall Study|Adverse Event|0|||
149167398|NCT00432237|538086097|FG002|Overall Study|Adverse Event|0|||
149167399|NCT00432237|538086098|FG003|Overall Study|Adverse Event|1|||
149167400|NCT00432237|538086095|FG000|Overall Study|Lack of Efficacy|0|||
149167401|NCT00432237|538086096|FG001|Overall Study|Lack of Efficacy|0|||
149167402|NCT00432237|538086097|FG002|Overall Study|Lack of Efficacy|0|||
149167403|NCT00432237|538086098|FG003|Overall Study|Lack of Efficacy|1|||
149167404|NCT00432237|538086095|FG000|Overall Study|Lost to Follow-up|10|||
149167405|NCT00432237|538086096|FG001|Overall Study|Lost to Follow-up|10|||
148676420|NCT01586624|536286901|FG004|Overall Study|Adverse Event|3|||
148676421|NCT01586624|536286902|FG005|Overall Study|Adverse Event|3|||
149167406|NCT00432237|538086097|FG002|Overall Study|Lost to Follow-up|18|||
149167407|NCT00432237|538086098|FG003|Overall Study|Lost to Follow-up|18|||
149167408|NCT00432237|538086095|FG000|Overall Study|Physician Decision|1|||
149167409|NCT00432237|538086096|FG001|Overall Study|Physician Decision|3|||
149167410|NCT00432237|538086097|FG002|Overall Study|Physician Decision|2|||
149167411|NCT00432237|538086098|FG003|Overall Study|Physician Decision|1|||
149167412|NCT00432237|538086095|FG000|Overall Study|Pregnancy|0|||
149167413|NCT00432237|538086096|FG001|Overall Study|Pregnancy|1|||
149167414|NCT00432237|538086097|FG002|Overall Study|Pregnancy|0|||
149167415|NCT00432237|538086098|FG003|Overall Study|Pregnancy|0|||
149167416|NCT00432237|538086095|FG000|Overall Study|Protocol Violation|13|||
149013063|NCT00235443|537527792|FG004|Overall Study|Lack of Efficacy|2|||
149013064|NCT00235443|537527793|FG005|Overall Study|Lack of Efficacy|9|||
149167417|NCT00432237|538086096|FG001|Overall Study|Protocol Violation|10|||
149167418|NCT00432237|538086097|FG002|Overall Study|Protocol Violation|11|||
149167419|NCT00432237|538086098|FG003|Overall Study|Protocol Violation|8|||
148676422|NCT01586624|536286903|FG006|Overall Study|Adverse Event|2|||
148676423|NCT01586624|536286904|FG007|Overall Study|Adverse Event|3|||
148676424|NCT01586624|536286897|FG000|Overall Study|Physician Decision|0|||
148676425|NCT01586624|536286898|FG001|Overall Study|Physician Decision|1|||
148676426|NCT01586624|536286899|FG002|Overall Study|Physician Decision|1|||
148676427|NCT01586624|536286900|FG003|Overall Study|Physician Decision|0|||
148676428|NCT01586624|536286901|FG004|Overall Study|Physician Decision|2|||
148676429|NCT01586624|536286902|FG005|Overall Study|Physician Decision|0|||
148676430|NCT01586624|536286903|FG006|Overall Study|Physician Decision|1|||
148676431|NCT01586624|536286904|FG007|Overall Study|Physician Decision|1|||
148676432|NCT01586624|536286897|FG000|Overall Study|Withdrawal by Subject|0|||
148676433|NCT01586624|536286898|FG001|Overall Study|Withdrawal by Subject|0|||
148676434|NCT01586624|536286899|FG002|Overall Study|Withdrawal by Subject|0|||
148676435|NCT01586624|536286900|FG003|Overall Study|Withdrawal by Subject|1|||
148676436|NCT01586624|536286901|FG004|Overall Study|Withdrawal by Subject|0|||
148676437|NCT01586624|536286902|FG005|Overall Study|Withdrawal by Subject|0|||
148676438|NCT01586624|536286903|FG006|Overall Study|Withdrawal by Subject|0|||
148676439|NCT01586624|536286904|FG007|Overall Study|Withdrawal by Subject|0|||
148676440|NCT01586624|536286897|FG000|Overall Study|Evidence of disease progression|1|||
148676441|NCT01586624|536286898|FG001|Overall Study|Evidence of disease progression|3|||
148676442|NCT01586624|536286899|FG002|Overall Study|Evidence of disease progression|2|||
148676443|NCT01586624|536286900|FG003|Overall Study|Evidence of disease progression|5|||
148676444|NCT01586624|536286901|FG004|Overall Study|Evidence of disease progression|3|||
148676445|NCT01586624|536286902|FG005|Overall Study|Evidence of disease progression|5|||
148676446|NCT01586624|536286903|FG006|Overall Study|Evidence of disease progression|4|||
148676447|NCT01586624|536286904|FG007|Overall Study|Evidence of disease progression|6|||
148676448|NCT01586624|536286897|FG000|Overall Study|Screen failure (no treatment received)|0|||
148676449|NCT01586624|536286898|FG001|Overall Study|Screen failure (no treatment received)|0|||
148676450|NCT01586624|536286899|FG002|Overall Study|Screen failure (no treatment received)|0|||
148676451|NCT01586624|536286900|FG003|Overall Study|Screen failure (no treatment received)|0|||
148676452|NCT01586624|536286901|FG004|Overall Study|Screen failure (no treatment received)|0|||
148676453|NCT01586624|536286902|FG005|Overall Study|Screen failure (no treatment received)|0|||
148676454|NCT01586624|536286903|FG006|Overall Study|Screen failure (no treatment received)|1|||
148676455|NCT01586624|536286904|FG007|Overall Study|Screen failure (no treatment received)|0|||
148676456|NCT00953927|536286907|FG000|Overall Study|Lost to Follow-up|61|||
148676457|NCT00953927|536286908|FG001|Overall Study|Lost to Follow-up|65|||
148676458|NCT00953927|536286907|FG000|Overall Study|Withdrawal by Subject|36|||
148676459|NCT00953927|536286908|FG001|Overall Study|Withdrawal by Subject|25|||
148676460|NCT00953927|536286907|FG000|Overall Study|Death|7|||
148676461|NCT00953927|536286908|FG001|Overall Study|Death|4|||
148676462|NCT00953927|536286907|FG000|Overall Study|Other study discontinuation|1|||
148676463|NCT00953927|536286908|FG001|Overall Study|Other study discontinuation|1|||
148676464|NCT01396161|536286909|FG000|Overall Study|Withdrawal by Subject|0|||
148676465|NCT01396161|536286910|FG001|Overall Study|Withdrawal by Subject|0|||
148676466|NCT01396161|536286911|FG002|Overall Study|Withdrawal by Subject|0|||
148676467|NCT01396161|536286912|FG003|Overall Study|Withdrawal by Subject|0|||
148676468|NCT01396161|536286913|FG004|Overall Study|Withdrawal by Subject|1|||
148676469|NCT01396161|536286914|FG005|Overall Study|Withdrawal by Subject|0|||
148676470|NCT01396161|536286915|FG006|Overall Study|Withdrawal by Subject|0|||
148676471|NCT01396161|536286909|FG000|Overall Study|Other|0|||
148676472|NCT01396161|536286910|FG001|Overall Study|Other|0|||
148676473|NCT01396161|536286911|FG002|Overall Study|Other|0|||
148676474|NCT01396161|536286912|FG003|Overall Study|Other|0|||
148676475|NCT01396161|536286913|FG004|Overall Study|Other|0|||
148676476|NCT01396161|536286914|FG005|Overall Study|Other|0|||
148676477|NCT01396161|536286915|FG006|Overall Study|Other|1|||
148676478|NCT02962739|536286920|FG000|Overall Study|Withdrawal by Subject|0|||
148676479|NCT02962739|536286921|FG001|Overall Study|Withdrawal by Subject|1|||
148676480|NCT02962739|536286922|FG002|Overall Study|Withdrawal by Subject|0|||
148806255|NCT01983930|536768929|FG000|Overall Study|Adverse Event|0|||
148806256|NCT01983930|536768930|FG001|Overall Study|Adverse Event|1|||
148806257|NCT01454284|536768931|FG000|Overall Study|Adverse Event|20|||
148676481|NCT02962739|536286923|FG003|Overall Study|Withdrawal by Subject|0|||
148676482|NCT02962739|536286924|FG004|Overall Study|Withdrawal by Subject|0|||
148676483|NCT02962739|536286925|FG005|Overall Study|Withdrawal by Subject|0|||
148676484|NCT02962739|536286920|FG000|Overall Study|Protocol Violation|0|||
148676485|NCT02962739|536286921|FG001|Overall Study|Protocol Violation|0|||
148676486|NCT02962739|536286922|FG002|Overall Study|Protocol Violation|1|||
148676487|NCT02962739|536286923|FG003|Overall Study|Protocol Violation|0|||
148676488|NCT02962739|536286924|FG004|Overall Study|Protocol Violation|1|||
148676489|NCT02962739|536286925|FG005|Overall Study|Protocol Violation|0|||
148806258|NCT01454284|536768932|FG001|Overall Study|Adverse Event|7|||
149167420|NCT00432237|538086095|FG000|Overall Study|Withdrawal by Subject|5|||
148676490|NCT00306852|536286928|FG000|Overall Study|Death|14|||
148676491|NCT00306852|536286929|FG001|Overall Study|Death|14|||
148676492|NCT00306852|536286928|FG000|Overall Study|Lost to Follow-up|15|||
148676493|NCT00306852|536286929|FG001|Overall Study|Lost to Follow-up|24|||
148676494|NCT03578276|536286930|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
148676495|NCT03578276|536286931|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
148676496|NCT02360397|536286934|FG000|Overall Study|Incomplete screening|3|||
148676497|NCT02360397|536286934|FG000|Overall Study|Adverse Event|1|||
148676498|NCT01537549|536286935|FG000|Overall Study|Lost to Follow-up|1|||
148676499|NCT01537549|536286935|FG000|Overall Study|Withdrawal by Subject|2|||
148676500|NCT00883740|536286936|FG000|First Intervention|Lost to Follow-up|1|||
148676501|NCT00883740|536286937|FG001|First Intervention|Lost to Follow-up|0|||
148676502|NCT00883740|536286936|FG000|First Intervention|No longer willing to participate|2|||
148676503|NCT00883740|536286937|FG001|First Intervention|No longer willing to participate|0|||
148676504|NCT00883740|536286936|FG000|First Intervention|Protocol Violation|3|||
148676505|NCT00883740|536286937|FG001|First Intervention|Protocol Violation|6|||
148676506|NCT00883740|536286936|FG000|First Intervention|Adverse Event|1|||
148676507|NCT00883740|536286937|FG001|First Intervention|Adverse Event|2|||
148676508|NCT00883740|536286936|FG000|Second Intervention|Protocol Violation|1|||
148676509|NCT00883740|536286937|FG001|Second Intervention|Protocol Violation|0|||
148676510|NCT00883740|536286936|FG000|Second Intervention|No longer willing to participate|0|||
148676511|NCT00883740|536286937|FG001|Second Intervention|No longer willing to participate|1|||
148676512|NCT01227954|536286938|FG000|Overall Study|Protocol Violation|6|||
148676513|NCT01227954|536286938|FG000|Overall Study|No protocol treatment|7|||
148676514|NCT00078312|536286939|FG000|Overall Study|Adverse Event|43|||
148676515|NCT00078312|536286939|FG000|Overall Study|Lack of Efficacy|15|||
148676516|NCT00078312|536286939|FG000|Overall Study|Lost to Follow-up|41|||
148676517|NCT00078312|536286939|FG000|Overall Study|Physician Decision|9|||
148676518|NCT00078312|536286939|FG000|Overall Study|Protocol Violation|3|||
148676519|NCT00078312|536286939|FG000|Overall Study|Withdrawal by Subject|33|||
148676520|NCT00078312|536286939|FG000|Overall Study|Miscellaneous|33|||
148676521|NCT03332212|536286942|FG000|Overall Study|Not treated|0|||
148676522|NCT03332212|536286943|FG001|Overall Study|Not treated|1|||
148676523|NCT03332212|536286944|FG002|Overall Study|Not treated|0|||
148676524|NCT03332212|536286945|FG003|Overall Study|Not treated|0|||
148676525|NCT03332212|536286942|FG000|Overall Study|Adverse Event|0|||
148676526|NCT03332212|536286943|FG001|Overall Study|Adverse Event|0|||
148676527|NCT03332212|536286944|FG002|Overall Study|Adverse Event|0|||
148676528|NCT03332212|536286945|FG003|Overall Study|Adverse Event|1|||
148676529|NCT03332212|536286942|FG000|Overall Study|worsening of disease under study|1|||
148676530|NCT03332212|536286943|FG001|Overall Study|worsening of disease under study|1|||
148676531|NCT03332212|536286944|FG002|Overall Study|worsening of disease under study|0|||
148676532|NCT03332212|536286945|FG003|Overall Study|worsening of disease under study|0|||
148676533|NCT02125734|536286949|FG000|Period 2|Adverse Event|0|||
148676534|NCT02125734|536286950|FG001|Period 2|Adverse Event|1|||
148676535|NCT01308762|536286951|FG000|Overall Study|Protocol Violation|0|||
148676536|NCT01308762|536286952|FG001|Overall Study|Protocol Violation|1|||
148676537|NCT01308762|536286953|FG002|Overall Study|Protocol Violation|0|||
148676538|NCT02617446|536286954|FG000|Overall Study|Withdrawal by Subject|0|||
148676539|NCT02617446|536286955|FG001|Overall Study|Withdrawal by Subject|2|||
148676540|NCT02617446|536286956|FG002|Overall Study|Withdrawal by Subject|0|||
148676541|NCT02617446|536286954|FG000|Overall Study|Adverse Event|1|||
148676542|NCT02617446|536286955|FG001|Overall Study|Adverse Event|0|||
148676543|NCT02617446|536286956|FG002|Overall Study|Adverse Event|5|||
148676544|NCT02617446|536286954|FG000|Overall Study|Lost to Follow-up|3|||
148676545|NCT02617446|536286955|FG001|Overall Study|Lost to Follow-up|0|||
148676546|NCT02617446|536286956|FG002|Overall Study|Lost to Follow-up|0|||
148676547|NCT02617446|536286954|FG000|Overall Study|Death|0|||
148676548|NCT02617446|536286955|FG001|Overall Study|Death|0|||
148676549|NCT02617446|536286956|FG002|Overall Study|Death|2|||
148676550|NCT01556490|536286965|FG000|Randomized Patients Summary|Protocol Violation|22|||
148676551|NCT01556490|536286966|FG001|Randomized Patients Summary|Protocol Violation|23|||
148676552|NCT01556490|536286965|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
148676553|NCT01556490|536286966|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
148676554|NCT02058368|536286967|FG000|Overall Study|Adverse Event|15|||
148676555|NCT02058368|536286968|FG001|Overall Study|Adverse Event|20|||
148676556|NCT02058368|536286967|FG000|Overall Study|Lack of Efficacy|0|||
148676557|NCT02058368|536286968|FG001|Overall Study|Lack of Efficacy|1|||
148676558|NCT02058368|536286967|FG000|Overall Study|Protocol Violation|0|||
148676559|NCT02058368|536286968|FG001|Overall Study|Protocol Violation|4|||
148676560|NCT02058368|536286967|FG000|Overall Study|Lost to Follow-up|2|||
148676561|NCT02058368|536286968|FG001|Overall Study|Lost to Follow-up|0|||
148676562|NCT02058368|536286967|FG000|Overall Study|Physician Decision|2|||
148676563|NCT02058368|536286968|FG001|Overall Study|Physician Decision|3|||
148676564|NCT02058368|536286967|FG000|Overall Study|Withdrawal by Subject|22|||
148676565|NCT02058368|536286968|FG001|Overall Study|Withdrawal by Subject|26|||
148676566|NCT01652872|536286969|FG000|Overall Study|Death|36|||
148676567|NCT01652872|536286970|FG001|Overall Study|Death|39|||
148676568|NCT01652872|536286969|FG000|Overall Study|Lost to Follow-up|28|||
148676569|NCT01652872|536286970|FG001|Overall Study|Lost to Follow-up|23|||
148676570|NCT01652872|536286969|FG000|Overall Study|Decision by sponsor|5|||
148676571|NCT01652872|536286970|FG001|Overall Study|Decision by sponsor|7|||
148676572|NCT01652872|536286969|FG000|Overall Study|Withdrawal by Subject|76|||
148676573|NCT01652872|536286970|FG001|Overall Study|Withdrawal by Subject|84|||
148676574|NCT02587325|536286971|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
148676575|NCT02587325|536286972|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
148676576|NCT02587325|536286973|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
148676577|NCT02587325|536286974|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
148676578|NCT02587325|536286975|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
148676579|NCT02587325|536286971|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
148676580|NCT02587325|536286972|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
148676581|NCT02587325|536286973|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
148676582|NCT02587325|536286974|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
148676583|NCT02587325|536286975|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
148676584|NCT02587325|536286971|FG000|32-Week Optional Extension Part|Adverse Event|0|||
148676585|NCT02587325|536286972|FG001|32-Week Optional Extension Part|Adverse Event|0|||
148676586|NCT02587325|536286973|FG002|32-Week Optional Extension Part|Adverse Event|1|||
148676587|NCT02587325|536286974|FG003|32-Week Optional Extension Part|Adverse Event|0|||
148676588|NCT02587325|536286975|FG004|32-Week Optional Extension Part|Adverse Event|0|||
148676589|NCT02587325|536286971|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
148676590|NCT02587325|536286972|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
148676591|NCT02587325|536286973|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
148676592|NCT02587325|536286974|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
148676593|NCT02587325|536286975|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
148676594|NCT00390572|536286976|FG000|Overall Study|Lost to Follow-up|8|||
148676595|NCT00390572|536286977|FG001|Overall Study|Lost to Follow-up|4|||
148676596|NCT00390572|536286976|FG000|Overall Study|health condition|0|||
148676597|NCT00390572|536286977|FG001|Overall Study|health condition|1|||
148676598|NCT02913261|536286984|FG000|Overall Study|Technical problems|0|||
148676599|NCT02913261|536286985|FG001|Overall Study|Technical problems|1|||
148676600|NCT02913261|536286984|FG000|Overall Study|Lack of Efficacy|32|||
148676601|NCT02913261|536286985|FG001|Overall Study|Lack of Efficacy|69|||
148676602|NCT02913261|536286984|FG000|Overall Study|Adverse Event|27|||
148676603|NCT02913261|536286985|FG001|Overall Study|Adverse Event|5|||
148676604|NCT02913261|536286984|FG000|Overall Study|Death|25|||
148676605|NCT02913261|536286985|FG001|Overall Study|Death|22|||
148676606|NCT02913261|536286984|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
148676607|NCT02913261|536286985|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
148676608|NCT02913261|536286984|FG000|Overall Study|Disease relapse|8|||
148676609|NCT02913261|536286985|FG001|Overall Study|Disease relapse|13|||
148676610|NCT02913261|536286984|FG000|Overall Study|Physician Decision|8|||
148676611|NCT02913261|536286985|FG001|Overall Study|Physician Decision|9|||
148676612|NCT02913261|536286984|FG000|Overall Study|Subject/guardian decision|4|||
148676613|NCT02913261|536286985|FG001|Overall Study|Subject/guardian decision|6|||
148676614|NCT02913261|536286984|FG000|Overall Study|Graft loss|2|||
148676615|NCT02913261|536286985|FG001|Overall Study|Graft loss|0|||
148676616|NCT03078192|536286987|FG000|Overall Study|Withdrawal by Subject|2|||
148676617|NCT03078192|536286988|FG001|Overall Study|Withdrawal by Subject|1|||
148676618|NCT03078192|536286987|FG000|Overall Study|screen failure|0|||
149013065|NCT00235443|537527788|FG000|Overall Study|Withdrawal by Subject|3|||
148676619|NCT03078192|536286988|FG001|Overall Study|screen failure|3|||
148676620|NCT03703297|536286989|FG000|Overall Study|Death|115|||
148676621|NCT03703297|536286990|FG001|Overall Study|Death|0|||
149167421|NCT00432237|538086096|FG001|Overall Study|Withdrawal by Subject|6|||
148676622|NCT03703297|536286991|FG002|Overall Study|Death|144|||
148676623|NCT03703297|536286989|FG000|Overall Study|Withdrawal by Subject|9|||
148676624|NCT03703297|536286990|FG001|Overall Study|Withdrawal by Subject|0|||
148676625|NCT03703297|536286991|FG002|Overall Study|Withdrawal by Subject|11|||
148676626|NCT03703297|536286989|FG000|Overall Study|Ongoing at the time of DCO|140|||
148676627|NCT03703297|536286990|FG001|Overall Study|Ongoing at the time of DCO|200|||
148676628|NCT03703297|536286991|FG002|Overall Study|Ongoing at the time of DCO|111|||
148676629|NCT01901146|536289068|FG000|Neoadjuvant Phase|Death|1|||
148676630|NCT01901146|536289069|FG001|Neoadjuvant Phase|Death|2|||
148676631|NCT01901146|536289070|FG002|Neoadjuvant Phase|Death|0|||
148676632|NCT01901146|536289071|FG003|Neoadjuvant Phase|Death|0|||
148676633|NCT01901146|536289072|FG004|Neoadjuvant Phase|Death|0|||
148676634|NCT01901146|536289068|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
148676635|NCT01901146|536289069|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
148676636|NCT01901146|536289070|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
148676637|NCT01901146|536289071|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
148676638|NCT01901146|536289072|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
148676639|NCT01901146|536289068|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
148676640|NCT01901146|536289069|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
148676641|NCT01901146|536289070|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
148676642|NCT01901146|536289071|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
148676643|NCT01901146|536289072|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
148676644|NCT01901146|536289068|FG000|Neoadjuvant Phase|Physician Decision|1|||
148676645|NCT01901146|536289069|FG001|Neoadjuvant Phase|Physician Decision|2|||
148676646|NCT01901146|536289070|FG002|Neoadjuvant Phase|Physician Decision|0|||
148676647|NCT01901146|536289071|FG003|Neoadjuvant Phase|Physician Decision|0|||
148676648|NCT01901146|536289072|FG004|Neoadjuvant Phase|Physician Decision|0|||
148676649|NCT01901146|536289068|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
148676650|NCT01901146|536289069|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
148676651|NCT01901146|536289070|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
148676652|NCT01901146|536289071|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
148676653|NCT01901146|536289072|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
148676654|NCT01901146|536289068|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
148676655|NCT01901146|536289069|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
148676656|NCT01901146|536289070|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
148676657|NCT01901146|536289071|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
148676658|NCT01901146|536289072|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
148676659|NCT01901146|536289068|FG000|Adjuvant Phase|Other|0|||
148676660|NCT01901146|536289069|FG001|Adjuvant Phase|Other|0|||
148676661|NCT01901146|536289070|FG002|Adjuvant Phase|Other|1|||
148676662|NCT01901146|536289071|FG003|Adjuvant Phase|Other|0|||
148676663|NCT01901146|536289072|FG004|Adjuvant Phase|Other|0|||
148676664|NCT01901146|536289068|FG000|Adjuvant Phase|Death|0|||
148676665|NCT01901146|536289069|FG001|Adjuvant Phase|Death|0|||
148676666|NCT01901146|536289070|FG002|Adjuvant Phase|Death|0|||
148676667|NCT01901146|536289071|FG003|Adjuvant Phase|Death|0|||
148676668|NCT01901146|536289072|FG004|Adjuvant Phase|Death|3|||
148676669|NCT01901146|536289068|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
148676670|NCT01901146|536289069|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
148676671|NCT01901146|536289070|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
148676672|NCT01901146|536289071|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
148676673|NCT01901146|536289072|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
148676674|NCT01901146|536289068|FG000|Adjuvant Phase|Physician Decision|0|||
148676675|NCT01901146|536289069|FG001|Adjuvant Phase|Physician Decision|0|||
148676676|NCT01901146|536289070|FG002|Adjuvant Phase|Physician Decision|9|||
148676677|NCT01901146|536289071|FG003|Adjuvant Phase|Physician Decision|2|||
148676678|NCT01901146|536289072|FG004|Adjuvant Phase|Physician Decision|4|||
148676679|NCT01901146|536289068|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
148676680|NCT01901146|536289069|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
148676681|NCT01901146|536289070|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
148676682|NCT01901146|536289071|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
148676683|NCT01901146|536289072|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
148676684|NCT00297492|536289073|FG000|Set Quit Date|Lost to Follow-up|7|||
148676685|NCT00297492|536289074|FG001|Set Quit Date|Lost to Follow-up|13|||
148676686|NCT00297492|536289075|FG002|Set Quit Date|Lost to Follow-up|5|||
148676687|NCT00297492|536289073|FG000|6 Month Follow-up|Lost to Follow-up|63|||
148676688|NCT00297492|536289074|FG001|6 Month Follow-up|Lost to Follow-up|49|||
148676689|NCT00297492|536289075|FG002|6 Month Follow-up|Lost to Follow-up|27|||
148676690|NCT00569231|536289076|FG000|Overall Study|Study unrelated surgery|1|||
148676691|NCT00569231|536289076|FG000|Overall Study|Airfare expense|2|||
148676692|NCT00569231|536289076|FG000|Overall Study|Withdrawal by Subject|1|||
148676693|NCT00569231|536289076|FG000|Overall Study|Car accident injury|1|||
148676694|NCT00569231|536289076|FG000|Overall Study|Non-compliance|2|||
148676695|NCT01875991|536289083|FG000|Overall Study|Withdrawal by Subject|6|||
148676696|NCT01875991|536289084|FG001|Overall Study|Withdrawal by Subject|6|||
148676697|NCT01875991|536289083|FG000|Overall Study|Sponsor Decision|1|||
148676698|NCT01875991|536289084|FG001|Overall Study|Sponsor Decision|0|||
148676699|NCT00902265|536289087|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
148676700|NCT00902265|536289087|FG000|Overall Study|Adverse Event|2|||
148676701|NCT00902265|536289087|FG000|Overall Study|Lack of Efficacy|2|||
148676702|NCT00902265|536289087|FG000|Overall Study|Protocol Violation|1|||
148676703|NCT02866695|536289088|FG000|Overall Study|Adverse Event|1|||
148676704|NCT02866695|536289088|FG000|Overall Study|Lost to Follow-up|1|||
148676705|NCT05016765|536289089|FG000|Overall Study|Lost to Follow-up|4|||
148676706|NCT01988493|536289090|FG000|Overall Study|Randomized but not treated|0|||
148676707|NCT01988493|536289091|FG001|Overall Study|Randomized but not treated|0|||
148676708|NCT01988493|536289092|FG002|Overall Study|Randomized but not treated|0|||
148676709|NCT01988493|536289093|FG003|Overall Study|Randomized but not treated|0|||
148676710|NCT01988493|536289094|FG004|Overall Study|Randomized but not treated|1|||
148676711|NCT01447628|536289097|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
148676712|NCT01447628|536289098|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
148676713|NCT01447628|536289099|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
148676714|NCT01447628|536289100|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
148676715|NCT00185731|536289101|FG000|Overall Study|Withdrawal by Subject|1|||
148676716|NCT00185731|536289101|FG000|Overall Study|Not Eligible|1|||
148676717|NCT03087773|536289102|FG000|Overall Study|Withdrawal by Subject|8|||
148676718|NCT03087773|536289103|FG001|Overall Study|Withdrawal by Subject|4|||
148676719|NCT03087773|536289102|FG000|Overall Study|Lost to Follow-up|12|||
148676720|NCT03087773|536289103|FG001|Overall Study|Lost to Follow-up|8|||
148676721|NCT02494583|536289106|FG000|Overall Study|Death|224|||
148676722|NCT02494583|536289107|FG001|Overall Study|Death|214|||
148676723|NCT02494583|536289108|FG002|Overall Study|Death|225|||
148676724|NCT02494583|536289106|FG000|Overall Study|Lost to Follow-up|1|||
148676725|NCT02494583|536289107|FG001|Overall Study|Lost to Follow-up|0|||
148676726|NCT02494583|536289108|FG002|Overall Study|Lost to Follow-up|0|||
148676727|NCT02494583|536289106|FG000|Overall Study|Protocol Violation|1|||
148676728|NCT02494583|536289107|FG001|Overall Study|Protocol Violation|2|||
148676729|NCT02494583|536289108|FG002|Overall Study|Protocol Violation|0|||
148676730|NCT02494583|536289106|FG000|Overall Study|Screen Failure|0|||
148676731|NCT02494583|536289107|FG001|Overall Study|Screen Failure|1|||
148676732|NCT02494583|536289108|FG002|Overall Study|Screen Failure|0|||
148676733|NCT02494583|536289106|FG000|Overall Study|Transferred to Extension Study|15|||
148676734|NCT02494583|536289107|FG001|Overall Study|Transferred to Extension Study|15|||
148676735|NCT02494583|536289108|FG002|Overall Study|Transferred to Extension Study|6|||
148676736|NCT02494583|536289106|FG000|Overall Study|Did Not Continue on Extension Study|8|||
148676737|NCT02494583|536289107|FG001|Overall Study|Did Not Continue on Extension Study|10|||
148676738|NCT02494583|536289108|FG002|Overall Study|Did Not Continue on Extension Study|4|||
148676739|NCT02494583|536289106|FG000|Overall Study|Withdrawal by Subject|7|||
148676740|NCT02494583|536289107|FG001|Overall Study|Withdrawal by Subject|15|||
148676741|NCT02494583|536289108|FG002|Overall Study|Withdrawal by Subject|15|||
148676742|NCT05144477|536289109|FG000|Overall Study|Withdrawal by Subject|1|||
148676743|NCT05144477|536289110|FG001|Overall Study|Withdrawal by Subject|1|||
148676744|NCT00627458|536289115|FG000|Overall Study|Migrated from study area|1|||
148676745|NCT00627458|536289116|FG001|Overall Study|Migrated from study area|0|||
148676746|NCT00627458|536289117|FG002|Overall Study|Migrated from study area|1|||
149013066|NCT00235443|537527789|FG001|Overall Study|Withdrawal by Subject|9|||
148676747|NCT00627458|536289115|FG000|Overall Study|Withdrawal by Subject|2|||
148676748|NCT00627458|536289116|FG001|Overall Study|Withdrawal by Subject|6|||
148676749|NCT00627458|536289117|FG002|Overall Study|Withdrawal by Subject|5|||
148676750|NCT00627458|536289115|FG000|Overall Study|Lost to Follow-up|1|||
148676751|NCT00627458|536289116|FG001|Overall Study|Lost to Follow-up|1|||
148676752|NCT00627458|536289117|FG002|Overall Study|Lost to Follow-up|0|||
148676753|NCT03891875|536289118|FG000|Overall Study|Withdrawal by Subject|20|||
148676754|NCT03891875|536289119|FG001|Overall Study|Withdrawal by Subject|3|||
148676755|NCT03891875|536289118|FG000|Overall Study|Adverse Event|10|||
148676756|NCT03891875|536289119|FG001|Overall Study|Adverse Event|4|||
148676757|NCT03891875|536289118|FG000|Overall Study|Physician Decision|1|||
148676758|NCT03891875|536289119|FG001|Overall Study|Physician Decision|1|||
148676759|NCT03891875|536289118|FG000|Overall Study|Protocol Violation|1|||
148676760|NCT03891875|536289119|FG001|Overall Study|Protocol Violation|0|||
148676761|NCT03891875|536289118|FG000|Overall Study|Lost to Follow-up|1|||
148676762|NCT03891875|536289119|FG001|Overall Study|Lost to Follow-up|0|||
148676763|NCT03891875|536289118|FG000|Overall Study|COVID-19 infection|1|||
148676764|NCT03891875|536289119|FG001|Overall Study|COVID-19 infection|0|||
148676765|NCT00854607|536289120|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
148676766|NCT00965263|536289125|FG000|Overall Study|Physician Decision|2|||
148676767|NCT00965263|536289126|FG001|Overall Study|Physician Decision|0|||
148676768|NCT00965263|536289125|FG000|Overall Study|Family emergency|0|||
148676769|NCT00965263|536289126|FG001|Overall Study|Family emergency|1|||
148676770|NCT00965263|536289125|FG000|Overall Study|Protocol Violation|0|||
148676771|NCT00965263|536289126|FG001|Overall Study|Protocol Violation|2|||
148676772|NCT02756078|536289127|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
148676773|NCT02756078|536289128|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
148676774|NCT02756078|536289127|FG000|Period 1|Lost to Follow-up|0|||
148676775|NCT02756078|536289128|FG001|Period 1|Lost to Follow-up|2|||
148676776|NCT02756078|536289127|FG000|Period 1|Protocol Violation|0|||
148676777|NCT02756078|536289128|FG001|Period 1|Protocol Violation|1|||
148676778|NCT02756078|536289127|FG000|Period 1|Adverse Event|1|||
148676779|NCT02756078|536289128|FG001|Period 1|Adverse Event|10|||
148676780|NCT02756078|536289127|FG000|Period 1|Withdrawal by Subject|6|||
148676781|NCT02756078|536289128|FG001|Period 1|Withdrawal by Subject|6|||
148676782|NCT02756078|536289127|FG000|Period 1|Lens Discomfort|2|||
148676783|NCT02756078|536289128|FG001|Period 1|Lens Discomfort|2|||
148676784|NCT02756078|536289127|FG000|Period 2|Adverse Event|3|||
148676785|NCT02756078|536289128|FG001|Period 2|Adverse Event|5|||
148676786|NCT02756078|536289127|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
148676787|NCT02756078|536289128|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
149013067|NCT00235443|537527790|FG002|Overall Study|Withdrawal by Subject|25|||
149013068|NCT00235443|537527791|FG003|Overall Study|Withdrawal by Subject|24|||
149013069|NCT00235443|537527792|FG004|Overall Study|Withdrawal by Subject|10|||
149013070|NCT00235443|537527793|FG005|Overall Study|Withdrawal by Subject|12|||
149013071|NCT00235443|537527788|FG000|Overall Study|Lost to Follow-up|0|||
149013072|NCT00235443|537527789|FG001|Overall Study|Lost to Follow-up|8|||
149013073|NCT00235443|537527790|FG002|Overall Study|Lost to Follow-up|6|||
149013074|NCT00235443|537527791|FG003|Overall Study|Lost to Follow-up|6|||
149013075|NCT00235443|537527792|FG004|Overall Study|Lost to Follow-up|4|||
149013076|NCT00235443|537527793|FG005|Overall Study|Lost to Follow-up|3|||
149013077|NCT00235443|537527788|FG000|Overall Study|Unsatisfactory compliance|0|||
149167422|NCT00432237|538086097|FG002|Overall Study|Withdrawal by Subject|9|||
149167423|NCT00432237|538086098|FG003|Overall Study|Withdrawal by Subject|11|||
148676788|NCT02756078|536289127|FG000|Period 2|Withdrawal by Subject|3|||
148676789|NCT02756078|536289128|FG001|Period 2|Withdrawal by Subject|1|||
148676790|NCT02268045|536289129|FG000|Overall Study|Death|4|||
148676791|NCT02268045|536289130|FG001|Overall Study|Death|4|||
149013078|NCT00235443|537527789|FG001|Overall Study|Unsatisfactory compliance|2|||
149167424|NCT00432237|538086095|FG000|Overall Study|Lack of Qualifying Event|38|||
149167425|NCT00432237|538086096|FG001|Overall Study|Lack of Qualifying Event|71|||
149167426|NCT00432237|538086097|FG002|Overall Study|Lack of Qualifying Event|69|||
149167427|NCT00432237|538086098|FG003|Overall Study|Lack of Qualifying Event|84|||
149167428|NCT03293654|538086101|FG000|Overall Study|Lost to Follow-up|0|||
149167429|NCT03293654|538086102|FG001|Overall Study|Lost to Follow-up|1|||
149167430|NCT03293654|538086103|FG002|Overall Study|Lost to Follow-up|0|||
149167431|NCT01919307|538086104|FG000|Overall Study|Withdrawal by Subject|9|||
149167432|NCT02157883|538086108|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
149167433|NCT02157883|538086108|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
149167434|NCT02157883|538086108|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
148676792|NCT02268045|536289129|FG000|Overall Study|Disease Progression|2|||
148676793|NCT02268045|536289130|FG001|Overall Study|Disease Progression|1|||
148676794|NCT02268045|536289129|FG000|Overall Study|Adverse Event|7|||
148676795|NCT02268045|536289130|FG001|Overall Study|Adverse Event|7|||
148676796|NCT02268045|536289129|FG000|Overall Study|Withdrawal by Subject|2|||
148676797|NCT02268045|536289130|FG001|Overall Study|Withdrawal by Subject|6|||
148676798|NCT02268045|536289129|FG000|Overall Study|Physician Decision|0|||
149013079|NCT00235443|537527790|FG002|Overall Study|Unsatisfactory compliance|3|||
149167435|NCT02157883|538086108|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
148676799|NCT02268045|536289130|FG001|Overall Study|Physician Decision|1|||
148676800|NCT02268045|536289129|FG000|Overall Study|Protocol Violation|1|||
148676801|NCT02268045|536289130|FG001|Overall Study|Protocol Violation|1|||
148676802|NCT03151707|536289133|FG000|Overall Study|Lost to Follow-up|6|||
148676803|NCT00646282|536289135|FG000|Overall Study|Protocol terminated|4|||
148676804|NCT00646282|536289136|FG001|Overall Study|Protocol terminated|4|||
148676805|NCT00530088|536289137|FG000|Overall Study|Disease Progression|4|||
148676806|NCT00530088|536289137|FG000|Overall Study|Physician Decision|4|||
148676807|NCT00530088|536289137|FG000|Overall Study|Other Not Specified|2|||
148676808|NCT02181842|536289142|FG000|Overall Study|Case Report Forms Uncollected|2|||
148676809|NCT00758706|536289143|FG000|Overall Study|Adverse Event|4|||
148676810|NCT00758706|536289144|FG001|Overall Study|Adverse Event|4|||
148676811|NCT02304302|536289179|FG000|Overall Study|Adverse Event|2|||
148676812|NCT02304302|536289180|FG001|Overall Study|Adverse Event|3|||
148676813|NCT02304302|536289179|FG000|Overall Study|Lost to Follow-up|1|||
148676814|NCT02304302|536289180|FG001|Overall Study|Lost to Follow-up|4|||
148676815|NCT02304302|536289179|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
148676816|NCT02304302|536289180|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
148676817|NCT00391118|536289181|FG000|Overall Study|Adverse Event|3|||
148676818|NCT00391118|536289182|FG001|Overall Study|Adverse Event|10|||
148676819|NCT00391118|536289183|FG002|Overall Study|Adverse Event|7|||
148676820|NCT00391118|536289181|FG000|Overall Study|Lost to Follow-up|0|||
148676821|NCT00391118|536289182|FG001|Overall Study|Lost to Follow-up|2|||
148676822|NCT00391118|536289183|FG002|Overall Study|Lost to Follow-up|3|||
148676823|NCT00391118|536289181|FG000|Overall Study|Withdrawal by Subject|0|||
148676824|NCT00391118|536289182|FG001|Overall Study|Withdrawal by Subject|9|||
148676825|NCT00391118|536289183|FG002|Overall Study|Withdrawal by Subject|1|||
148676826|NCT00391118|536289181|FG000|Overall Study|Death|0|||
148676827|NCT00391118|536289182|FG001|Overall Study|Death|1|||
148676828|NCT00391118|536289183|FG002|Overall Study|Death|0|||
148676829|NCT00391118|536289181|FG000|Overall Study|Physician Decision|0|||
148676830|NCT00391118|536289182|FG001|Overall Study|Physician Decision|3|||
148676831|NCT00391118|536289183|FG002|Overall Study|Physician Decision|0|||
148676832|NCT00391118|536289181|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
149167436|NCT02157883|538086108|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
149167437|NCT03155997|538086109|FG000|Overall Study|Withdrawal by Subject|119|||
149167438|NCT03155997|538086110|FG001|Overall Study|Withdrawal by Subject|134|||
149167439|NCT03155997|538086109|FG000|Overall Study|Lost to Follow-up|12|||
149167440|NCT03155997|538086110|FG001|Overall Study|Lost to Follow-up|13|||
149167441|NCT03155997|538086109|FG000|Overall Study|Missing disposition data|0|||
149167442|NCT03155997|538086110|FG001|Overall Study|Missing disposition data|1|||
149167443|NCT03155997|538086109|FG000|Overall Study|On study treatment|2027|||
149167444|NCT03155997|538086110|FG001|Overall Study|On study treatment|2074|||
149167445|NCT04067518|538086113|FG000|Overall Study|Adverse Event|1|||
149167446|NCT04067518|538086114|FG001|Overall Study|Adverse Event|3|||
149167447|NCT04067518|538086113|FG000|Overall Study|Screen failures|0|||
149167448|NCT04067518|538086114|FG001|Overall Study|Screen failures|1|||
149167449|NCT04067518|538086113|FG000|Overall Study|Enrolled but not treated|0|||
149167450|NCT04067518|538086114|FG001|Overall Study|Enrolled but not treated|1|||
149167451|NCT02771522|538086115|FG000|Overall Study|Lost to Follow-up|3|||
149167452|NCT02771522|538086115|FG000|Overall Study|Withdrawal by Subject|2|||
149167453|NCT02771522|538086115|FG000|Overall Study|No white spot lesions|3|||
149167454|NCT00934102|538086119|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
149167455|NCT00934102|538086120|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
149167456|NCT00934102|538086121|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
149167457|NCT04258579|538086122|FG000|Overall Study|Withdrawal by Subject|7|||
149167458|NCT04258579|538086122|FG000|Overall Study|Lost to Follow-up|3|||
149167459|NCT04258579|538086122|FG000|Overall Study|Protocol Violation|2|||
149167460|NCT04258579|538086122|FG000|Overall Study|Adverse Event|1|||
148676833|NCT00391118|536289182|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
148676834|NCT00391118|536289183|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
148676835|NCT00391118|536289181|FG000|Overall Study|Progressive Disease|7|||
148676836|NCT00391118|536289182|FG001|Overall Study|Progressive Disease|26|||
148676837|NCT00391118|536289183|FG002|Overall Study|Progressive Disease|43|||
148676838|NCT00391118|536289181|FG000|Overall Study|Sponsor Decision|0|||
148676839|NCT00391118|536289182|FG001|Overall Study|Sponsor Decision|1|||
148676840|NCT00391118|536289183|FG002|Overall Study|Sponsor Decision|3|||
148676841|NCT00391118|536289181|FG000|Overall Study|Protocol Violation|1|||
149167461|NCT04007159|538086123|FG000|Induction Phase|(missed study visits)|16|||
149167462|NCT04007159|538086123|FG000|Induction Phase|Withdrawal by Subject|4|||
148676842|NCT00391118|536289182|FG001|Overall Study|Protocol Violation|0|||
148676843|NCT00391118|536289183|FG002|Overall Study|Protocol Violation|0|||
148676844|NCT01892020|536289185|FG000|Period 1|Adverse Event|1|||
148676845|NCT01892020|536289186|FG001|Period 1|Adverse Event|1|||
148676846|NCT01892020|536289185|FG000|Period 1|Protocol Violation|2|||
149167463|NCT04007159|538086123|FG000|Induction Phase|Adverse Event|2|||
149167464|NCT04007159|538086123|FG000|Challenge Phase|missed study visits|3|||
149167465|NCT02076165|538086124|FG000|Overall Study|Lost to Follow-up|7|||
148676847|NCT01892020|536289186|FG001|Period 1|Protocol Violation|4|||
148676848|NCT01892020|536289185|FG000|Period 1|Unclassified|0|||
148676849|NCT01892020|536289186|FG001|Period 1|Unclassified|1|||
148676850|NCT01892020|536289185|FG000|Period 2|Protocol Violation|1|||
148676851|NCT01892020|536289186|FG001|Period 2|Protocol Violation|0|||
148676852|NCT03252756|536289192|FG000|Overall Study|Protocol Violation|2|||
148676853|NCT03252756|536289193|FG001|Overall Study|Protocol Violation|4|||
148676854|NCT03252756|536289192|FG000|Overall Study|COVID-19 Pandemic|1|||
148676855|NCT03252756|536289193|FG001|Overall Study|COVID-19 Pandemic|1|||
148676856|NCT03252756|536289192|FG000|Overall Study|Study Drug Expiration|0|||
148676857|NCT03252756|536289193|FG001|Overall Study|Study Drug Expiration|1|||
148676858|NCT03594175|536289194|FG000|Overall Study|Not treated|8|||
148676859|NCT03594175|536289195|FG001|Overall Study|Not treated|1|||
148676860|NCT03594175|536289196|FG002|Overall Study|Not treated|5|||
148676861|NCT03594175|536289194|FG000|Overall Study|Adverse Event|3|||
148676862|NCT03594175|536289195|FG001|Overall Study|Adverse Event|0|||
148676863|NCT03594175|536289196|FG002|Overall Study|Adverse Event|0|||
148676864|NCT03594175|536289194|FG000|Overall Study|Withdrawal by Subject|3|||
148676865|NCT03594175|536289195|FG001|Overall Study|Withdrawal by Subject|0|||
148676866|NCT03594175|536289196|FG002|Overall Study|Withdrawal by Subject|0|||
148676867|NCT03594175|536289194|FG000|Overall Study|Protocol Violation|2|||
148676868|NCT03594175|536289195|FG001|Overall Study|Protocol Violation|2|||
148676869|NCT03594175|536289196|FG002|Overall Study|Protocol Violation|2|||
148676870|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676871|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676872|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676873|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
148676874|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
148676875|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676876|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676877|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676878|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676879|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
148676880|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676881|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676882|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
148676883|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
148676884|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
148676885|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
148676886|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
148676887|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
148676888|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
148676889|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676890|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676891|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676892|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676893|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676894|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
148676895|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676896|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676897|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676898|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
148676899|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676900|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676901|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676902|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
148676903|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
148676904|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
148806259|NCT01454284|536768931|FG000|Overall Study|Death|0|||
148676905|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
148676906|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
148676907|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
148676908|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
148676909|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676910|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676911|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676912|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676913|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
148676914|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676915|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676916|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676917|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676918|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676919|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676920|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676921|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676922|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
148676923|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676924|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676925|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
148676926|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
148676927|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676928|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676929|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676930|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676931|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676932|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676933|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676934|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676935|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676936|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676937|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
148676938|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148806260|NCT01454284|536768932|FG001|Overall Study|Death|3|||
148676939|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676940|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
148676941|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676942|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676943|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
148676944|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
148676945|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
148676946|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
148676947|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
148676948|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676949|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
148676950|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676951|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676952|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
148676953|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676954|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676955|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676956|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
148676957|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676958|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
148676959|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
148676960|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
148676961|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
148676962|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
148676963|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
148676964|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
148676965|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676966|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676967|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
148676968|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676969|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676970|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676971|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676972|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676973|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676974|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676975|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676976|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676977|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676978|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676979|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676980|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
148676981|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
148676982|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
148676983|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
148676984|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676985|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676986|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676987|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676988|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
148676989|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676990|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676991|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676992|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676993|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
148676994|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676995|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676996|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148676997|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148806261|NCT01454284|536768931|FG000|Overall Study|Lost to Follow-up|13|||
148806262|NCT01454284|536768932|FG001|Overall Study|Lost to Follow-up|8|||
148806263|NCT01454284|536768931|FG000|Overall Study|Protocol Violation|9|||
148806264|NCT01454284|536768932|FG001|Overall Study|Protocol Violation|6|||
148676998|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149167466|NCT02076165|538086125|FG001|Overall Study|Lost to Follow-up|5|||
149167467|NCT02076165|538086124|FG000|Overall Study|Refused follow-up assessment|1|||
149167468|NCT02076165|538086125|FG001|Overall Study|Refused follow-up assessment|1|||
149167469|NCT00486603|538086126|FG000|Overall Study|Withdrawal by Subject|1|||
149167470|NCT00486603|538086127|FG001|Overall Study|Withdrawal by Subject|0|||
149167471|NCT00486603|538086128|FG002|Overall Study|Withdrawal by Subject|0|||
149167472|NCT00486603|538086129|FG003|Overall Study|Withdrawal by Subject|0|||
149167473|NCT00486603|538086130|FG004|Overall Study|Withdrawal by Subject|0|||
149167474|NCT00486603|538086126|FG000|Overall Study|Physician Decision|0|||
149167475|NCT00486603|538086127|FG001|Overall Study|Physician Decision|1|||
149167476|NCT00486603|538086128|FG002|Overall Study|Physician Decision|0|||
149167477|NCT00486603|538086129|FG003|Overall Study|Physician Decision|0|||
149013080|NCT00235443|537527791|FG003|Overall Study|Unsatisfactory compliance|4|||
149013081|NCT00235443|537527792|FG004|Overall Study|Unsatisfactory compliance|1|||
148676999|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
149013082|NCT00235443|537527793|FG005|Overall Study|Unsatisfactory compliance|0|||
149013083|NCT00235443|537527788|FG000|Overall Study|Other reasons for premature termination|1|||
149013084|NCT00235443|537527789|FG001|Overall Study|Other reasons for premature termination|6|||
149013085|NCT00235443|537527790|FG002|Overall Study|Other reasons for premature termination|6|||
149013086|NCT00235443|537527791|FG003|Overall Study|Other reasons for premature termination|7|||
149013087|NCT00235443|537527792|FG004|Overall Study|Other reasons for premature termination|3|||
149013088|NCT00235443|537527793|FG005|Overall Study|Other reasons for premature termination|6|||
149013089|NCT02032173|537527794|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
149013090|NCT00603265|537527797|FG000|Overall Study|Adverse Event|2|||
149013091|NCT00603265|537527798|FG001|Overall Study|Adverse Event|11|||
149013092|NCT00603265|537527799|FG002|Overall Study|Adverse Event|1|||
149013093|NCT00603265|537527797|FG000|Overall Study|Withdrawal by Subject|1|||
149013094|NCT00603265|537527798|FG001|Overall Study|Withdrawal by Subject|2|||
149013095|NCT00603265|537527799|FG002|Overall Study|Withdrawal by Subject|1|||
149013096|NCT00603265|537527797|FG000|Overall Study|Lack of Efficacy|3|||
149013097|NCT00603265|537527798|FG001|Overall Study|Lack of Efficacy|0|||
149013098|NCT00603265|537527799|FG002|Overall Study|Lack of Efficacy|3|||
149013099|NCT00603265|537527797|FG000|Overall Study|Lost to Follow-up|0|||
149013100|NCT00603265|537527798|FG001|Overall Study|Lost to Follow-up|1|||
149013101|NCT00603265|537527799|FG002|Overall Study|Lost to Follow-up|0|||
149013102|NCT00603265|537527797|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
149013103|NCT00603265|537527798|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
149013104|NCT00603265|537527799|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
149013105|NCT00603265|537527797|FG000|Overall Study|Participant Left Country, No Responses|0|||
149013106|NCT00603265|537527798|FG001|Overall Study|Participant Left Country, No Responses|1|||
149013107|NCT00603265|537527799|FG002|Overall Study|Participant Left Country, No Responses|0|||
149013108|NCT00603265|537527797|FG000|Overall Study|Protocol Violation|1|||
149013109|NCT00603265|537527798|FG001|Overall Study|Protocol Violation|0|||
149013110|NCT00603265|537527799|FG002|Overall Study|Protocol Violation|0|||
149013111|NCT04399551|537527801|FG000|Overall Study|Adverse Event|15|||
149013112|NCT04399551|537527801|FG000|Overall Study|Withdrawal by Subject|6|||
149013113|NCT04399551|537527801|FG000|Overall Study|Physician Decision|3|||
149013114|NCT04399551|537527801|FG000|Overall Study|Lost to Follow-up|2|||
149013115|NCT04399551|537527801|FG000|Overall Study|Protocol Deviation|2|||
149013116|NCT01642602|537527817|FG000|Overall Study|Adverse Event|2|||
149013117|NCT01112514|537527818|FG000|Overall Study|Lost to Follow-up|1|||
149013118|NCT01118455|537527819|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
149013119|NCT01118455|537527820|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
149013120|NCT01973491|537527821|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
149013121|NCT01973491|537527821|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
149013122|NCT01973491|537527821|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
149013123|NCT01987596|537527825|FG000|Overall Study|Physician Decision|1|||
149013124|NCT01987596|537527826|FG001|Overall Study|Physician Decision|0|||
148677000|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148677001|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148677002|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
148677003|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
148677004|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
148677005|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
148677006|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
148677007|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
148677008|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
148677009|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
148677010|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
148677011|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149013125|NCT01987596|537527825|FG000|Overall Study|Progressive Disease; missing all period|0|||
149013126|NCT01987596|537527826|FG001|Overall Study|Progressive Disease; missing all period|1|||
149013127|NCT00854295|537527827|FG000|Overall Study|Death|7|||
149013128|NCT00854295|537527828|FG001|Overall Study|Death|0|||
149013129|NCT00854295|537527829|FG002|Overall Study|Death|1|||
149013130|NCT00854295|537527830|FG003|Overall Study|Death|1|||
149013131|NCT00854295|537527827|FG000|Overall Study|Adverse Event|6|||
149013132|NCT00854295|537527828|FG001|Overall Study|Adverse Event|1|||
149013133|NCT00854295|537527829|FG002|Overall Study|Adverse Event|1|||
149013134|NCT00854295|537527830|FG003|Overall Study|Adverse Event|3|||
149013135|NCT00854295|537527827|FG000|Overall Study|Lost to Follow-up|18|||
149013136|NCT00854295|537527828|FG001|Overall Study|Lost to Follow-up|5|||
149013137|NCT00854295|537527829|FG002|Overall Study|Lost to Follow-up|21|||
149013138|NCT00854295|537527830|FG003|Overall Study|Lost to Follow-up|21|||
149013139|NCT00854295|537527827|FG000|Overall Study|Physician Decision|10|||
149013140|NCT00854295|537527828|FG001|Overall Study|Physician Decision|0|||
149167478|NCT00486603|538086130|FG004|Overall Study|Physician Decision|0|||
149167479|NCT00888238|538086145|FG000|Washout Period After Period 2|Adverse Event|0|||
149167480|NCT00888238|538086146|FG001|Washout Period After Period 2|Adverse Event|0|||
149167481|NCT00888238|538086147|FG002|Washout Period After Period 2|Adverse Event|1|||
149167482|NCT02700984|538086148|FG000|Overall Study|Death|2|||
149167483|NCT02700984|538086149|FG001|Overall Study|Death|1|||
149167484|NCT02700984|538086148|FG000|Overall Study|Lost to Follow-up|2|||
149167485|NCT02700984|538086149|FG001|Overall Study|Lost to Follow-up|1|||
149167486|NCT02700984|538086148|FG000|Overall Study|Physician Decision|0|||
149167487|NCT02700984|538086149|FG001|Overall Study|Physician Decision|1|||
149167488|NCT02700984|538086148|FG000|Overall Study|Withdrawal by Subject|8|||
149167489|NCT02700984|538086149|FG001|Overall Study|Withdrawal by Subject|9|||
149167490|NCT02700984|538086148|FG000|Overall Study|Reason not specified|3|||
149167491|NCT02700984|538086149|FG001|Overall Study|Reason not specified|2|||
149167492|NCT01032629|538086151|FG000|Overall Study|Closed Site|21|||
149167493|NCT01032629|538086152|FG001|Overall Study|Closed Site|18|||
149167494|NCT01032629|538086153|FG002|Overall Study|Closed Site|16|||
149167495|NCT01032629|538086151|FG000|Overall Study|Withdrawal by Subject|50|||
149167496|NCT01032629|538086152|FG001|Overall Study|Withdrawal by Subject|36|||
149167497|NCT01032629|538086153|FG002|Overall Study|Withdrawal by Subject|35|||
149167498|NCT01032629|538086151|FG000|Overall Study|Lost to Follow-up|74|||
149167499|NCT01032629|538086152|FG001|Overall Study|Lost to Follow-up|47|||
149167500|NCT01032629|538086153|FG002|Overall Study|Lost to Follow-up|37|||
149167501|NCT02868892|538086156|FG000|Overall Study|Investigator left site and no follow-up|6|||
149167502|NCT00723957|538086157|FG000|Overall Study|Adverse event unrelated to study drug|1|||
149167503|NCT00723957|538086158|FG001|Overall Study|Adverse event unrelated to study drug|4|||
149167504|NCT00723957|538086157|FG000|Overall Study|Death|3|||
149167505|NCT00723957|538086158|FG001|Overall Study|Death|4|||
149167506|NCT00723957|538086157|FG000|Overall Study|Disease progression|27|||
149167507|NCT00723957|538086158|FG001|Overall Study|Disease progression|25|||
149167508|NCT00723957|538086157|FG000|Overall Study|Maximum clinical benefit|4|||
149167509|NCT00723957|538086158|FG001|Overall Study|Maximum clinical benefit|5|||
149167510|NCT00723957|538086157|FG000|Overall Study|Investigator decision|1|||
149167511|NCT00723957|538086158|FG001|Overall Study|Investigator decision|1|||
149167512|NCT00723957|538086157|FG000|Overall Study|Study drug toxicity|4|||
149167513|NCT00723957|538086158|FG001|Overall Study|Study drug toxicity|6|||
149167514|NCT00723957|538086157|FG000|Overall Study|Withdrawal by Subject|7|||
149167515|NCT00723957|538086158|FG001|Overall Study|Withdrawal by Subject|5|||
149167516|NCT00723957|538086157|FG000|Overall Study|Reason not analyzed|1|||
149167517|NCT00723957|538086158|FG001|Overall Study|Reason not analyzed|0|||
149167518|NCT00723957|538086157|FG000|Overall Study|Never received treatment|3|||
149167519|NCT00723957|538086158|FG001|Overall Study|Never received treatment|3|||
149167520|NCT01360996|538086160|FG000|Overall Study|Withdrawal by Subject|4|||
149167521|NCT01360996|538086161|FG001|Overall Study|Withdrawal by Subject|3|||
149167522|NCT01360996|538086162|FG002|Overall Study|Withdrawal by Subject|2|||
149167523|NCT01360996|538086160|FG000|Overall Study|Noncompliant|2|||
149167524|NCT01360996|538086161|FG001|Overall Study|Noncompliant|0|||
149167525|NCT01360996|538086162|FG002|Overall Study|Noncompliant|0|||
149167526|NCT01454076|538086163|FG000|Overall Study|Other|2|||
149167527|NCT01454076|538086164|FG001|Overall Study|Other|0|||
149167528|NCT01454076|538086165|FG002|Overall Study|Other|0|||
149167529|NCT01454076|538086166|FG003|Overall Study|Other|1|||
149167530|NCT01454076|538086167|FG004|Overall Study|Other|2|||
149167531|NCT01454076|538086163|FG000|Overall Study|Withdrawal by Subject|3|||
149167532|NCT01454076|538086164|FG001|Overall Study|Withdrawal by Subject|4|||
149167533|NCT01454076|538086165|FG002|Overall Study|Withdrawal by Subject|2|||
149167534|NCT01454076|538086166|FG003|Overall Study|Withdrawal by Subject|1|||
149167535|NCT01454076|538086167|FG004|Overall Study|Withdrawal by Subject|2|||
149167536|NCT01454076|538086163|FG000|Overall Study|Adverse Event|8|||
149167537|NCT01454076|538086164|FG001|Overall Study|Adverse Event|2|||
149167538|NCT01454076|538086165|FG002|Overall Study|Adverse Event|7|||
149167539|NCT01454076|538086166|FG003|Overall Study|Adverse Event|0|||
149167540|NCT01454076|538086167|FG004|Overall Study|Adverse Event|2|||
149167541|NCT00291551|538086168|FG000|Overall Study|Death|7|||
149167542|NCT00291551|538086168|FG000|Overall Study|Withdrawal by Subject|6|||
149167543|NCT01015833|538086169|FG000|Overall Study|Death|1|||
149167544|NCT01015833|538086170|FG001|Overall Study|Death|0|||
149167545|NCT01015833|538086169|FG000|Overall Study|Withdrawal by Subject|3|||
149167546|NCT01015833|538086170|FG001|Overall Study|Withdrawal by Subject|2|||
149167547|NCT01015833|538086169|FG000|Overall Study|Adverse Event|0|||
149167548|NCT01015833|538086170|FG001|Overall Study|Adverse Event|1|||
149167549|NCT01015833|538086169|FG000|Overall Study|Physician Decision|2|||
149167550|NCT01015833|538086170|FG001|Overall Study|Physician Decision|0|||
149167551|NCT01015833|538086169|FG000|Overall Study|Symptomatic deterioration|0|||
149167552|NCT01015833|538086170|FG001|Overall Study|Symptomatic deterioration|1|||
149167553|NCT01015833|538086169|FG000|Overall Study|Other|5|||
149167554|NCT01015833|538086170|FG001|Overall Study|Other|1|||
149167555|NCT01015833|538086169|FG000|Overall Study|Motor Vehicle Accidents|1|||
149167556|NCT01015833|538086170|FG001|Overall Study|Motor Vehicle Accidents|0|||
149167557|NCT01015833|538086169|FG000|Overall Study|Did not start treatment|1|||
149167558|NCT01015833|538086170|FG001|Overall Study|Did not start treatment|0|||
149167559|NCT01651780|538086176|FG000|Overall Study|Physician decision: No 30-day visit|2|||
149167560|NCT01651780|538086177|FG001|Overall Study|Physician decision: No 30-day visit|1|||
149167561|NCT01651780|538086176|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
149167562|NCT01651780|538086177|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
149167563|NCT01651780|538086176|FG000|Overall Study|Withdrawal by Subject|2|||
149167564|NCT01651780|538086177|FG001|Overall Study|Withdrawal by Subject|0|||
149167565|NCT01651780|538086176|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
149167566|NCT01651780|538086177|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149167567|NCT01651780|538086176|FG000|Overall Study|Lost to Follow-up|1|||
149167568|NCT01651780|538086177|FG001|Overall Study|Lost to Follow-up|2|||
149167569|NCT01651780|538086176|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
149167570|NCT01651780|538086177|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
149167571|NCT03898063|538086178|FG000|Overall Study|Withdrawal by Subject|10|||
149167572|NCT03898063|538086179|FG001|Overall Study|Withdrawal by Subject|8|||
149167573|NCT02949830|538086180|FG000|Overall Study|Adverse Event|1|||
149167574|NCT02949830|538086180|FG000|Overall Study|Withdrawal by Subject|1|||
149167575|NCT01290887|538086181|FG000|Overall Study|Adverse Event|6|||
149167576|NCT01290887|538086182|FG001|Overall Study|Adverse Event|11|||
149167577|NCT01290887|538086181|FG000|Overall Study|Lack of Efficacy|4|||
149167578|NCT01290887|538086182|FG001|Overall Study|Lack of Efficacy|5|||
149167579|NCT01290887|538086181|FG000|Overall Study|Withdrawal by Subject|26|||
149167580|NCT01290887|538086182|FG001|Overall Study|Withdrawal by Subject|32|||
149167581|NCT01290887|538086181|FG000|Overall Study|Protocol Violation|2|||
149167582|NCT01290887|538086182|FG001|Overall Study|Protocol Violation|1|||
149167583|NCT01290887|538086181|FG000|Overall Study|Lost to Follow-up|4|||
149167584|NCT01290887|538086182|FG001|Overall Study|Lost to Follow-up|4|||
149167585|NCT01290887|538086181|FG000|Overall Study|Non-compliance to study procedures|0|||
149167586|NCT01290887|538086182|FG001|Overall Study|Non-compliance to study procedures|1|||
149167587|NCT01290887|538086181|FG000|Overall Study|Non-compliance to study medications|1|||
149167588|NCT01290887|538086182|FG001|Overall Study|Non-compliance to study medications|0|||
149167589|NCT01290887|538086181|FG000|Overall Study|Sponsor closure of study|420|||
148677012|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
149167590|NCT01290887|538086182|FG001|Overall Study|Sponsor closure of study|476|||
149167591|NCT01290887|538086181|FG000|Overall Study|Other|3|||
149167592|NCT01290887|538086182|FG001|Overall Study|Other|6|||
149167593|NCT01628926|538086183|FG000|Overall Study|Adverse Event|13|||
149167594|NCT01628926|538086184|FG001|Overall Study|Adverse Event|11|||
149167595|NCT01628926|538086185|FG002|Overall Study|Adverse Event|9|||
149167596|NCT01628926|538086183|FG000|Overall Study|Lack of Efficacy|2|||
148677013|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
148677014|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
148677015|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
148677016|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
148677017|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
148677018|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
148677019|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
148677020|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
148677021|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
148677022|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677023|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677024|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677025|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677026|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677027|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677028|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677029|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677030|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677031|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677032|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
148677033|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677034|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677035|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677036|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677037|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677038|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677039|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677040|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
148677041|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
148677042|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
148677043|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677044|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677045|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
148677046|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
148677047|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677048|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
148677049|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677050|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
148677051|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677052|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677053|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
148677054|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
148677055|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
148677056|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
148677057|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
148677058|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
148677059|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
148677060|NCT01915498|536289197|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
148677061|NCT01915498|536289198|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
148677062|NCT01915498|536289199|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
148677063|NCT01915498|536289200|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
148677064|NCT01915498|536289201|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
148677065|NCT01915498|536289202|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
148677066|NCT01915498|536289203|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
148677067|NCT01915498|536289204|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
148677068|NCT01915498|536289205|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
148677069|NCT01915498|536289206|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
148677070|NCT01915498|536289207|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
148677071|NCT01915498|536289208|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
148677072|NCT01915498|536289209|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
148677073|NCT01915498|536289210|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
148677074|NCT01915498|536289211|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
148677075|NCT01915498|536289212|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
148677076|NCT01915498|536289213|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
148677077|NCT01915498|536289214|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
148677078|NCT01915498|536289215|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
149167597|NCT01628926|538086184|FG001|Overall Study|Lack of Efficacy|1|||
149167598|NCT01628926|538086185|FG002|Overall Study|Lack of Efficacy|5|||
149167599|NCT01628926|538086183|FG000|Overall Study|Withdrawal by Subject|6|||
149167600|NCT01628926|538086184|FG001|Overall Study|Withdrawal by Subject|4|||
149167601|NCT01628926|538086185|FG002|Overall Study|Withdrawal by Subject|2|||
149167602|NCT01628926|538086183|FG000|Overall Study|Protocol Violation|0|||
149167603|NCT01628926|538086184|FG001|Overall Study|Protocol Violation|1|||
149167604|NCT01628926|538086185|FG002|Overall Study|Protocol Violation|0|||
149167605|NCT01628926|538086183|FG000|Overall Study|Discontinuation criteria|3|||
149167606|NCT01628926|538086184|FG001|Overall Study|Discontinuation criteria|4|||
149167607|NCT01628926|538086185|FG002|Overall Study|Discontinuation criteria|0|||
149167608|NCT01628926|538086183|FG000|Overall Study|Physician Decision|2|||
149167609|NCT01628926|538086184|FG001|Overall Study|Physician Decision|2|||
149167610|NCT01628926|538086185|FG002|Overall Study|Physician Decision|1|||
149167611|NCT03437447|538086186|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149167612|NCT03437447|538086187|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149167613|NCT03437447|538086188|FG002|Treatment Period 1|Withdrawal by Subject|1|||
149167614|NCT02040142|538086189|FG000|Overall Study|Lost to Follow-up|5|||
149167615|NCT02040142|538086189|FG000|Overall Study|Death|17|||
149167616|NCT02040142|538086189|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
149167617|NCT04752384|538086190|FG000|Overall Study|Withdrawal by Subject|1|||
149167618|NCT04752384|538086190|FG000|Overall Study|Death|1|||
149167619|NCT00413959|538086191|FG000|Overall Study|Pt had only one cycle.|1|||
149167620|NCT01817790|538086197|FG000|Overall Study|Adverse Event|0|||
149167621|NCT01817790|538086198|FG001|Overall Study|Adverse Event|2|||
149167622|NCT01817790|538086197|FG000|Overall Study|Lost to Follow-up|0|||
149167623|NCT01817790|538086198|FG001|Overall Study|Lost to Follow-up|1|||
149167624|NCT01817790|538086197|FG000|Overall Study|Protocol Violation|2|||
149167625|NCT01817790|538086198|FG001|Overall Study|Protocol Violation|1|||
149167626|NCT01817790|538086197|FG000|Overall Study|Withdrawal by Subject|1|||
149167627|NCT01817790|538086198|FG001|Overall Study|Withdrawal by Subject|3|||
149167628|NCT01817790|538086197|FG000|Overall Study|Other: Could not attend appointment|1|||
149167629|NCT01817790|538086198|FG001|Overall Study|Other: Could not attend appointment|1|||
149167630|NCT01671345|538086199|FG000|Overall Study|Lost to Follow-up|10|||
149167631|NCT01671345|538086200|FG001|Overall Study|Lost to Follow-up|6|||
149167632|NCT01671345|538086199|FG000|Overall Study|visit with non-participating physician|3|||
149167633|NCT01671345|538086200|FG001|Overall Study|visit with non-participating physician|3|||
149167634|NCT03636906|538086201|FG000|Overall Study|Adverse Event|0|||
149167635|NCT03636906|538086202|FG001|Overall Study|Adverse Event|0|||
149167636|NCT03636906|538086203|FG002|Overall Study|Adverse Event|1|||
149167637|NCT03636906|538086201|FG000|Overall Study|Lost to Follow-up|1|||
149167638|NCT03636906|538086202|FG001|Overall Study|Lost to Follow-up|0|||
149167639|NCT03636906|538086203|FG002|Overall Study|Lost to Follow-up|0|||
149167640|NCT03636906|538086201|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
149167641|NCT03636906|538086202|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
149167642|NCT03636906|538086203|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
149167643|NCT03636906|538086201|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
149167644|NCT03636906|538086202|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
149167645|NCT03636906|538086203|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
149167646|NCT03636906|538086201|FG000|Overall Study|Other|0|||
149167647|NCT03636906|538086202|FG001|Overall Study|Other|0|||
149167648|NCT03636906|538086203|FG002|Overall Study|Other|1|||
149167649|NCT00891202|538086204|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
149167650|NCT00891202|538086205|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
149167651|NCT00891202|538086206|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
149167652|NCT00891202|538086207|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
149167653|NCT00891202|538086204|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
149167654|NCT00891202|538086205|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
149167655|NCT00891202|538086206|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
149167656|NCT00891202|538086207|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
149167657|NCT00891202|538086204|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
149167658|NCT00891202|538086205|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
149167659|NCT00891202|538086206|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
149167660|NCT00891202|538086207|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
149167661|NCT00891202|538086204|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
149167662|NCT00891202|538086205|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
149167663|NCT00891202|538086206|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
149167664|NCT00891202|538086207|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
148928142|NCT01897714|537221302|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
149167665|NCT03690869|538086212|FG000|Overall Study|Adverse Event|0|||
149167666|NCT03690869|538086213|FG001|Overall Study|Adverse Event|0|||
149167667|NCT03690869|538086214|FG002|Overall Study|Adverse Event|0|||
149167668|NCT03690869|538086215|FG003|Overall Study|Adverse Event|1|||
149167669|NCT03690869|538086216|FG004|Overall Study|Adverse Event|0|||
149167670|NCT03690869|538086217|FG005|Overall Study|Adverse Event|0|||
149167671|NCT03690869|538086218|FG006|Overall Study|Adverse Event|0|||
149167672|NCT03690869|538086219|FG007|Overall Study|Adverse Event|1|||
149167673|NCT03690869|538086220|FG008|Overall Study|Adverse Event|0|||
149167674|NCT03690869|538086221|FG009|Overall Study|Adverse Event|1|||
149167675|NCT03690869|538086212|FG000|Overall Study|Death|1|||
149167676|NCT03690869|538086213|FG001|Overall Study|Death|1|||
149167677|NCT03690869|538086214|FG002|Overall Study|Death|1|||
149167678|NCT03690869|538086215|FG003|Overall Study|Death|4|||
149167679|NCT03690869|538086216|FG004|Overall Study|Death|2|||
149167680|NCT03690869|538086217|FG005|Overall Study|Death|5|||
149167681|NCT03690869|538086218|FG006|Overall Study|Death|3|||
149167682|NCT03690869|538086219|FG007|Overall Study|Death|2|||
149167683|NCT03690869|538086220|FG008|Overall Study|Death|0|||
149167684|NCT03690869|538086221|FG009|Overall Study|Death|3|||
149167685|NCT03690869|538086212|FG000|Overall Study|Lost to Follow-up|0|||
149167686|NCT03690869|538086213|FG001|Overall Study|Lost to Follow-up|0|||
149167687|NCT03690869|538086214|FG002|Overall Study|Lost to Follow-up|1|||
149167688|NCT03690869|538086215|FG003|Overall Study|Lost to Follow-up|0|||
149167689|NCT03690869|538086216|FG004|Overall Study|Lost to Follow-up|0|||
149167690|NCT03690869|538086217|FG005|Overall Study|Lost to Follow-up|0|||
149167691|NCT03690869|538086218|FG006|Overall Study|Lost to Follow-up|0|||
149167692|NCT03690869|538086219|FG007|Overall Study|Lost to Follow-up|0|||
149167693|NCT03690869|538086220|FG008|Overall Study|Lost to Follow-up|0|||
149167694|NCT03690869|538086221|FG009|Overall Study|Lost to Follow-up|0|||
149167695|NCT03690869|538086212|FG000|Overall Study|Other Treatment|1|||
149167696|NCT03690869|538086213|FG001|Overall Study|Other Treatment|1|||
149167697|NCT03690869|538086214|FG002|Overall Study|Other Treatment|1|||
149167698|NCT03690869|538086215|FG003|Overall Study|Other Treatment|2|||
149167699|NCT03690869|538086216|FG004|Overall Study|Other Treatment|3|||
149167700|NCT03690869|538086217|FG005|Overall Study|Other Treatment|1|||
149167701|NCT03690869|538086218|FG006|Overall Study|Other Treatment|2|||
149167702|NCT03690869|538086219|FG007|Overall Study|Other Treatment|7|||
149167703|NCT03690869|538086220|FG008|Overall Study|Other Treatment|0|||
149167704|NCT03690869|538086221|FG009|Overall Study|Other Treatment|3|||
149167705|NCT03690869|538086212|FG000|Overall Study|Physician Decision|0|||
149167706|NCT03690869|538086213|FG001|Overall Study|Physician Decision|1|||
149167707|NCT03690869|538086214|FG002|Overall Study|Physician Decision|0|||
149167708|NCT03690869|538086215|FG003|Overall Study|Physician Decision|0|||
149167709|NCT03690869|538086216|FG004|Overall Study|Physician Decision|0|||
149167710|NCT03690869|538086217|FG005|Overall Study|Physician Decision|0|||
149167711|NCT03690869|538086218|FG006|Overall Study|Physician Decision|0|||
149167712|NCT03690869|538086219|FG007|Overall Study|Physician Decision|0|||
149167713|NCT03690869|538086220|FG008|Overall Study|Physician Decision|0|||
149167714|NCT03690869|538086221|FG009|Overall Study|Physician Decision|0|||
149167715|NCT03690869|538086212|FG000|Overall Study|Progressive Disease|1|||
149167716|NCT03690869|538086213|FG001|Overall Study|Progressive Disease|2|||
149167717|NCT03690869|538086214|FG002|Overall Study|Progressive Disease|0|||
149167718|NCT03690869|538086215|FG003|Overall Study|Progressive Disease|1|||
149167719|NCT03690869|538086216|FG004|Overall Study|Progressive Disease|0|||
149167720|NCT03690869|538086217|FG005|Overall Study|Progressive Disease|0|||
149167721|NCT03690869|538086218|FG006|Overall Study|Progressive Disease|0|||
148677079|NCT01915498|536289197|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677080|NCT01915498|536289198|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149167722|NCT03690869|538086219|FG007|Overall Study|Progressive Disease|0|||
149167723|NCT03690869|538086220|FG008|Overall Study|Progressive Disease|1|||
149167724|NCT03690869|538086221|FG009|Overall Study|Progressive Disease|1|||
149167725|NCT03690869|538086212|FG000|Overall Study|Subject Decision|0|||
149167726|NCT03690869|538086213|FG001|Overall Study|Subject Decision|0|||
149167727|NCT03690869|538086214|FG002|Overall Study|Subject Decision|0|||
149167728|NCT03690869|538086215|FG003|Overall Study|Subject Decision|1|||
149167729|NCT03690869|538086216|FG004|Overall Study|Subject Decision|0|||
149167730|NCT03690869|538086217|FG005|Overall Study|Subject Decision|0|||
149167731|NCT03690869|538086218|FG006|Overall Study|Subject Decision|0|||
149167732|NCT03690869|538086219|FG007|Overall Study|Subject Decision|1|||
149167733|NCT03690869|538086220|FG008|Overall Study|Subject Decision|0|||
149167734|NCT03690869|538086221|FG009|Overall Study|Subject Decision|0|||
149167735|NCT06001307|538087622|FG000|Overall Study|Lost to Follow-up|1|||
149167736|NCT06001307|538087623|FG001|Overall Study|Lost to Follow-up|2|||
149167737|NCT03532100|538087624|FG000|Overall Study|Intervention malfunction|1|||
149167742|NCT03263806|538087629|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
149167743|NCT03263806|538087630|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
149013141|NCT00854295|537527829|FG002|Overall Study|Physician Decision|0|||
149167744|NCT03263806|538087629|FG000|Overall Study|Withdrawal by Subject|0|||
149167745|NCT03263806|538087630|FG001|Overall Study|Withdrawal by Subject|1|||
149167746|NCT03263806|538087629|FG000|Overall Study|Study Termination|5|||
149167747|NCT03263806|538087630|FG001|Overall Study|Study Termination|6|||
149167748|NCT04854499|538087639|FG000|Overall Study|Study Terminated by Sponsor|5|||
149167749|NCT04854499|538087640|FG001|Overall Study|Study Terminated by Sponsor|27|||
149167750|NCT04854499|538087641|FG002|Overall Study|Study Terminated by Sponsor|28|||
149167751|NCT04854499|538087642|FG003|Overall Study|Study Terminated by Sponsor|19|||
149167752|NCT04854499|538087643|FG004|Overall Study|Study Terminated by Sponsor|1|||
149167753|NCT04854499|538087644|FG005|Overall Study|Study Terminated by Sponsor|10|||
149167754|NCT04854499|538087639|FG000|Overall Study|Death|1|||
149167755|NCT04854499|538087640|FG001|Overall Study|Death|23|||
149167756|NCT04854499|538087641|FG002|Overall Study|Death|21|||
149167757|NCT04854499|538087642|FG003|Overall Study|Death|7|||
149167758|NCT04854499|538087643|FG004|Overall Study|Death|6|||
149167759|NCT04854499|538087644|FG005|Overall Study|Death|24|||
149167760|NCT04854499|538087639|FG000|Overall Study|Investigator's Discretion|0|||
149167761|NCT04854499|538087640|FG001|Overall Study|Investigator's Discretion|1|||
149167762|NCT04854499|538087641|FG002|Overall Study|Investigator's Discretion|3|||
149167763|NCT04854499|538087642|FG003|Overall Study|Investigator's Discretion|4|||
149167764|NCT04854499|538087643|FG004|Overall Study|Investigator's Discretion|1|||
149167765|NCT04854499|538087644|FG005|Overall Study|Investigator's Discretion|5|||
149167766|NCT04854499|538087639|FG000|Overall Study|Withdrew Consent|0|||
149167767|NCT04854499|538087640|FG001|Overall Study|Withdrew Consent|1|||
149167768|NCT04854499|538087641|FG002|Overall Study|Withdrew Consent|2|||
149167769|NCT04854499|538087642|FG003|Overall Study|Withdrew Consent|2|||
149167770|NCT04854499|538087643|FG004|Overall Study|Withdrew Consent|0|||
149167771|NCT04854499|538087644|FG005|Overall Study|Withdrew Consent|1|||
149167772|NCT04854499|538087639|FG000|Overall Study|Lost to Follow-up|0|||
149167773|NCT04854499|538087640|FG001|Overall Study|Lost to Follow-up|0|||
149167774|NCT04854499|538087641|FG002|Overall Study|Lost to Follow-up|0|||
149167775|NCT04854499|538087642|FG003|Overall Study|Lost to Follow-up|0|||
149167776|NCT04854499|538087643|FG004|Overall Study|Lost to Follow-up|0|||
149167777|NCT04854499|538087644|FG005|Overall Study|Lost to Follow-up|1|||
149167778|NCT05415449|538087645|FG000|Overall Study|Lost to Follow-up|2|||
149167779|NCT05415449|538087645|FG000|Overall Study|Withdrawal by Subject|4|||
149167780|NCT02185521|538087649|FG000|Overall Study|Withdrawal by Subject|1|||
149167781|NCT02185521|538087649|FG000|Overall Study|Protocol Violation|1|||
149167782|NCT00398112|538087650|FG000|Overall Study|Adverse Event|4|||
149167783|NCT00398112|538087650|FG000|Overall Study|Disease progression|9|||
149167784|NCT00398112|538087650|FG000|Overall Study|Alternative treatment|1|||
149167785|NCT00398112|538087650|FG000|Overall Study|Withdrawal by Subject|3|||
149167786|NCT00398112|538087650|FG000|Overall Study|Death|1|||
149167787|NCT03932812|538087651|FG000|Overall Study|Lost to Follow-up|12|||
149167788|NCT03932812|538087652|FG001|Overall Study|Lost to Follow-up|14|||
149167789|NCT03932812|538087651|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
149167790|NCT03932812|538087652|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
149013142|NCT00854295|537527830|FG003|Overall Study|Physician Decision|0|||
149013143|NCT00709592|537527831|FG000|Overall Study|Unable to proceed to transplant|0|||
149167791|NCT00332709|538087653|FG000|Overall Study|Adverse Event|11|||
149167792|NCT00332709|538087654|FG001|Overall Study|Adverse Event|14|||
149167793|NCT00332709|538087653|FG000|Overall Study|Withdrawal by Subject|2|||
149167794|NCT00332709|538087654|FG001|Overall Study|Withdrawal by Subject|3|||
149167795|NCT00332709|538087653|FG000|Overall Study|Lost to Follow-up|2|||
149167796|NCT00332709|538087654|FG001|Overall Study|Lost to Follow-up|0|||
149167797|NCT00332709|538087653|FG000|Overall Study|Administrative Problems|0|||
149013144|NCT00709592|537527832|FG001|Overall Study|Unable to proceed to transplant|1|||
149167798|NCT00332709|538087654|FG001|Overall Study|Administrative Problems|3|||
149167799|NCT00332709|538087653|FG000|Overall Study|Abnormal test procedure result|1|||
149167800|NCT00332709|538087654|FG001|Overall Study|Abnormal test procedure result|0|||
149167801|NCT01933932|538087655|FG000|Overall Study|Death|173|||
149167802|NCT01933932|538087656|FG001|Overall Study|Death|163|||
149167803|NCT01933932|538087655|FG000|Overall Study|Withdrawal by Subject|11|||
149167804|NCT01933932|538087656|FG001|Overall Study|Withdrawal by Subject|14|||
149167805|NCT01933932|538087655|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149167806|NCT01933932|538087656|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149167807|NCT04454489|538087659|FG000|Overall Study|Disease progression|12|||
149167808|NCT04454489|538087659|FG000|Overall Study|Death|4|||
149167809|NCT04454489|538087659|FG000|Overall Study|Adverse Event|1|||
149167810|NCT04454489|538087659|FG000|Overall Study|Physician Decision|1|||
149167811|NCT01323478|538087660|FG000|Overall Study|Adverse Event|7|||
149167812|NCT01323478|538087660|FG000|Overall Study|Lack of Efficacy|4|||
149167813|NCT01323478|538087660|FG000|Overall Study|Non-compliance With Study Product|3|||
149167814|NCT01323478|538087660|FG000|Overall Study|Protocol Violation|1|||
149167815|NCT01323478|538087660|FG000|Overall Study|Withdrawal of Consent|1|||
149167816|NCT01323478|538087660|FG000|Overall Study|Administrative or Other Reasons|8|||
149167817|NCT02054702|538087665|FG000|Overall Study|Lost to Follow-up|3|||
149167818|NCT02054702|538087666|FG001|Overall Study|Lost to Follow-up|5|||
149167819|NCT02054702|538087665|FG000|Overall Study|Adverse Event|3|||
149167820|NCT02054702|538087666|FG001|Overall Study|Adverse Event|1|||
149167821|NCT02054702|538087665|FG000|Overall Study|Met Withdrawal Criteria|4|||
149167822|NCT02054702|538087666|FG001|Overall Study|Met Withdrawal Criteria|1|||
149167823|NCT02054702|538087665|FG000|Overall Study|Physician Decision|0|||
149167824|NCT02054702|538087666|FG001|Overall Study|Physician Decision|1|||
149167825|NCT02054702|538087665|FG000|Overall Study|Withdrawal by Subject|14|||
149167826|NCT02054702|538087666|FG001|Overall Study|Withdrawal by Subject|4|||
149167827|NCT01262898|538087667|FG000|Overall Study|Protocol Violation|1|||
149167828|NCT01262898|538087668|FG001|Overall Study|Protocol Violation|1|||
149167829|NCT01262898|538087669|FG002|Overall Study|Protocol Violation|0|||
149167830|NCT01262898|538087670|FG003|Overall Study|Protocol Violation|0|||
149167831|NCT01262898|538087667|FG000|Overall Study|Lost to Follow-up|1|||
149167832|NCT01262898|538087668|FG001|Overall Study|Lost to Follow-up|0|||
149167833|NCT01262898|538087669|FG002|Overall Study|Lost to Follow-up|0|||
149167834|NCT01262898|538087670|FG003|Overall Study|Lost to Follow-up|0|||
149167835|NCT01262898|538087667|FG000|Overall Study|Withdrawal by Subject|1|||
148677081|NCT01915498|536289199|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677082|NCT01915498|536289200|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149167836|NCT01262898|538087668|FG001|Overall Study|Withdrawal by Subject|1|||
149167837|NCT01262898|538087669|FG002|Overall Study|Withdrawal by Subject|0|||
149167838|NCT01262898|538087670|FG003|Overall Study|Withdrawal by Subject|0|||
148677083|NCT01915498|536289201|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677084|NCT01915498|536289202|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
149013145|NCT00451217|537527834|FG000|Overall Study|Lost to Follow-up|0|||
149167839|NCT01295125|538087673|FG000|Overall Study|Study stopped prematurely|9|||
149167840|NCT03838484|538087674|FG000|Overall Study|Lost to Follow-up|0|||
149167841|NCT03838484|538087675|FG001|Overall Study|Lost to Follow-up|1|||
149167842|NCT03838484|538087676|FG002|Overall Study|Lost to Follow-up|0|||
149167843|NCT03838484|538087677|FG003|Overall Study|Lost to Follow-up|0|||
149167844|NCT04964258|538087685|FG000|Overall Study|Lost to Follow-up|1|||
149167845|NCT04964258|538087686|FG001|Overall Study|Lost to Follow-up|0|||
149167846|NCT04964258|538087687|FG002|Overall Study|Lost to Follow-up|0|||
149167847|NCT04964258|538087688|FG003|Overall Study|Lost to Follow-up|0|||
149167848|NCT04964258|538087689|FG004|Overall Study|Lost to Follow-up|0|||
149167849|NCT04964258|538087690|FG005|Overall Study|Lost to Follow-up|1|||
149167850|NCT04964258|538087691|FG006|Overall Study|Lost to Follow-up|0|||
149167851|NCT04964258|538087692|FG007|Overall Study|Lost to Follow-up|0|||
149167852|NCT04964258|538087693|FG008|Overall Study|Lost to Follow-up|0|||
149167853|NCT04964258|538087694|FG009|Overall Study|Lost to Follow-up|0|||
149167854|NCT04964258|538087695|FG010|Overall Study|Lost to Follow-up|0|||
149167855|NCT04525703|538087696|FG000|Overall Study|Lost to Follow-up|6|||
149167856|NCT04525703|538087697|FG001|Overall Study|Lost to Follow-up|15|||
149167857|NCT04525703|538087698|FG002|Overall Study|Lost to Follow-up|8|||
149167858|NCT01285349|538087699|FG000|Overall Study|Lost to Follow-up|27|||
149167859|NCT01285349|538087700|FG001|Overall Study|Lost to Follow-up|20|||
149167860|NCT01285349|538087701|FG002|Overall Study|Lost to Follow-up|27|||
149167861|NCT03040024|538087702|FG000|Overall Study|Adverse Event|0|||
149167862|NCT03040024|538087703|FG001|Overall Study|Adverse Event|1|||
149167863|NCT03040024|538087704|FG002|Overall Study|Adverse Event|0|||
149167864|NCT03040024|538087702|FG000|Overall Study|Death|0|||
149167865|NCT03040024|538087703|FG001|Overall Study|Death|1|||
149167866|NCT03040024|538087704|FG002|Overall Study|Death|0|||
149167867|NCT03040024|538087702|FG000|Overall Study|Physician Decision|0|||
149167868|NCT03040024|538087703|FG001|Overall Study|Physician Decision|0|||
149167869|NCT03040024|538087704|FG002|Overall Study|Physician Decision|1|||
149167870|NCT02452762|538087709|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
149167871|NCT02452762|538087710|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
149167872|NCT02452762|538087709|FG000|Overall Study|Withdrawal by Subject|1|||
149167873|NCT02452762|538087710|FG001|Overall Study|Withdrawal by Subject|0|||
149167874|NCT03682120|538087711|FG000|Overall Study|Lost to Follow-up|11|||
149167875|NCT03682120|538087712|FG001|Overall Study|Lost to Follow-up|4|||
149167876|NCT03682120|538087713|FG002|Overall Study|Lost to Follow-up|5|||
149167877|NCT03682120|538087714|FG003|Overall Study|Lost to Follow-up|2|||
149167878|NCT03682120|538087711|FG000|Overall Study|Physician Decision|1|||
149167879|NCT03682120|538087712|FG001|Overall Study|Physician Decision|0|||
149167880|NCT03682120|538087713|FG002|Overall Study|Physician Decision|0|||
149167881|NCT03682120|538087714|FG003|Overall Study|Physician Decision|0|||
149167882|NCT03682120|538087711|FG000|Overall Study|Withdrawal by Subject|1|||
149167883|NCT03682120|538087712|FG001|Overall Study|Withdrawal by Subject|2|||
149167884|NCT03682120|538087713|FG002|Overall Study|Withdrawal by Subject|3|||
149167885|NCT03682120|538087714|FG003|Overall Study|Withdrawal by Subject|0|||
149167886|NCT03682120|538087711|FG000|Overall Study|Death|0|||
149167887|NCT03682120|538087712|FG001|Overall Study|Death|1|||
149167888|NCT03682120|538087713|FG002|Overall Study|Death|0|||
149167889|NCT03682120|538087714|FG003|Overall Study|Death|0|||
149167890|NCT03682120|538087711|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
149167891|NCT03682120|538087712|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
149167892|NCT03682120|538087713|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
149167893|NCT03682120|538087714|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
149167894|NCT01957137|538087723|FG000|Randomized Portion|Adverse Event|1|||
149167895|NCT01957137|538087723|FG000|Randomized Portion|Withdrawal by Subject|1|||
149167896|NCT00054132|538087724|FG000|Overall Study|Not Treated|1|||
149167897|NCT02330419|538087732|FG000|Overall Study|Lost to Follow-up|3|||
149167898|NCT02330419|538087733|FG001|Overall Study|Lost to Follow-up|7|||
149167899|NCT02875223|538087734|FG000|Overall Study|Other reasons|0|||
149167900|NCT02875223|538087735|FG001|Overall Study|Other reasons|0|||
149013146|NCT00451217|537527835|FG001|Overall Study|Lost to Follow-up|1|||
149013147|NCT00451217|537527836|FG002|Overall Study|Lost to Follow-up|1|||
149167901|NCT02875223|538087736|FG002|Overall Study|Other reasons|1|||
149167902|NCT02875223|538087737|FG003|Overall Study|Other reasons|0|||
149167903|NCT02875223|538087738|FG004|Overall Study|Other reasons|1|||
149167904|NCT02875223|538087739|FG005|Overall Study|Other reasons|2|||
149167905|NCT02875223|538087740|FG006|Overall Study|Other reasons|0|||
149167906|NCT02875223|538087741|FG007|Overall Study|Other reasons|2|||
149167907|NCT02875223|538087742|FG008|Overall Study|Other reasons|0|||
149167908|NCT02875223|538087743|FG009|Overall Study|Other reasons|0|||
149167909|NCT02875223|538087744|FG010|Overall Study|Other reasons|0|||
149167910|NCT02875223|538087745|FG011|Overall Study|Other reasons|0|||
149167911|NCT02875223|538087746|FG012|Overall Study|Other reasons|0|||
149167912|NCT02875223|538087734|FG000|Overall Study|Withdrawal by Subject|0|||
149013148|NCT00451217|537527837|FG003|Overall Study|Lost to Follow-up|1|||
149167913|NCT02875223|538087735|FG001|Overall Study|Withdrawal by Subject|0|||
149167914|NCT02875223|538087736|FG002|Overall Study|Withdrawal by Subject|0|||
149167915|NCT02875223|538087737|FG003|Overall Study|Withdrawal by Subject|0|||
149167916|NCT02875223|538087738|FG004|Overall Study|Withdrawal by Subject|1|||
149167917|NCT02875223|538087739|FG005|Overall Study|Withdrawal by Subject|1|||
149167918|NCT02875223|538087740|FG006|Overall Study|Withdrawal by Subject|0|||
149167919|NCT02875223|538087741|FG007|Overall Study|Withdrawal by Subject|0|||
148677085|NCT01915498|536289203|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677086|NCT01915498|536289204|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677087|NCT01915498|536289205|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677088|NCT01915498|536289206|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677089|NCT01915498|536289207|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677090|NCT01915498|536289208|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677091|NCT01915498|536289209|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677092|NCT01915498|536289210|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677093|NCT01915498|536289211|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677094|NCT01915498|536289212|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677095|NCT01915498|536289213|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677096|NCT01915498|536289214|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
148677097|NCT01915498|536289215|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
148677098|NCT01915498|536289197|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677099|NCT01915498|536289198|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677100|NCT01915498|536289199|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677101|NCT01915498|536289200|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677102|NCT01915498|536289201|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677103|NCT01915498|536289202|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677104|NCT01915498|536289203|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677105|NCT01915498|536289204|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677106|NCT01915498|536289205|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677107|NCT01915498|536289206|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677108|NCT01915498|536289207|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677109|NCT01915498|536289208|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677110|NCT01915498|536289209|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677111|NCT01915498|536289210|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677112|NCT01915498|536289211|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677113|NCT01915498|536289212|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677114|NCT01915498|536289213|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677115|NCT01915498|536289214|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
148677116|NCT01915498|536289215|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
148677117|NCT01915498|536289197|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677118|NCT01915498|536289198|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677119|NCT01915498|536289199|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677120|NCT01915498|536289200|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677121|NCT01915498|536289201|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677122|NCT01915498|536289202|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677123|NCT01915498|536289203|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677124|NCT01915498|536289204|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677125|NCT01915498|536289205|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677126|NCT01915498|536289206|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677127|NCT01915498|536289207|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677128|NCT01915498|536289208|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677129|NCT01915498|536289209|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677130|NCT01915498|536289210|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677131|NCT01915498|536289211|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677132|NCT01915498|536289212|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677133|NCT01915498|536289213|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677134|NCT01915498|536289214|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
148677135|NCT01915498|536289215|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
148677136|NCT01500434|536289216|FG000|Overall Study|Death|1|||
148677137|NCT01500434|536289216|FG000|Overall Study|Withdrawal by Subject|1|||
148677138|NCT01500434|536289216|FG000|Overall Study|Missed 12-month follow-up|5|||
148677139|NCT01336608|536291078|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
148677140|NCT01336608|536291079|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148677141|NCT01336608|536291080|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148677142|NCT01336608|536291081|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148677143|NCT01336608|536291078|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
148677144|NCT01336608|536291079|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148677145|NCT01336608|536291080|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148677146|NCT01336608|536291081|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148677147|NCT01336608|536291078|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
149167920|NCT02875223|538087742|FG008|Overall Study|Withdrawal by Subject|1|||
149167921|NCT02875223|538087743|FG009|Overall Study|Withdrawal by Subject|0|||
149167922|NCT02875223|538087744|FG010|Overall Study|Withdrawal by Subject|0|||
149167923|NCT02875223|538087745|FG011|Overall Study|Withdrawal by Subject|0|||
149167924|NCT02875223|538087746|FG012|Overall Study|Withdrawal by Subject|0|||
149167925|NCT02875223|538087734|FG000|Overall Study|Progressive disease|0|||
149167926|NCT02875223|538087735|FG001|Overall Study|Progressive disease|0|||
149167927|NCT02875223|538087736|FG002|Overall Study|Progressive disease|1|||
149167928|NCT02875223|538087737|FG003|Overall Study|Progressive disease|0|||
149167929|NCT02875223|538087738|FG004|Overall Study|Progressive disease|0|||
149167930|NCT02875223|538087739|FG005|Overall Study|Progressive disease|0|||
149167931|NCT02875223|538087740|FG006|Overall Study|Progressive disease|0|||
149167932|NCT02875223|538087741|FG007|Overall Study|Progressive disease|0|||
149167933|NCT02875223|538087742|FG008|Overall Study|Progressive disease|0|||
149167934|NCT02875223|538087743|FG009|Overall Study|Progressive disease|12|||
149167935|NCT02875223|538087744|FG010|Overall Study|Progressive disease|2|||
149167936|NCT02875223|538087745|FG011|Overall Study|Progressive disease|3|||
149167937|NCT02875223|538087746|FG012|Overall Study|Progressive disease|6|||
149167938|NCT02875223|538087734|FG000|Overall Study|Death|4|||
149167939|NCT02875223|538087735|FG001|Overall Study|Death|4|||
149167940|NCT02875223|538087736|FG002|Overall Study|Death|3|||
149167941|NCT02875223|538087737|FG003|Overall Study|Death|4|||
149167942|NCT02875223|538087738|FG004|Overall Study|Death|2|||
149167943|NCT02875223|538087739|FG005|Overall Study|Death|3|||
149167944|NCT02875223|538087740|FG006|Overall Study|Death|5|||
149167945|NCT02875223|538087741|FG007|Overall Study|Death|7|||
149167946|NCT02875223|538087742|FG008|Overall Study|Death|3|||
149167947|NCT02875223|538087743|FG009|Overall Study|Death|2|||
149167948|NCT02875223|538087744|FG010|Overall Study|Death|0|||
149167949|NCT02875223|538087745|FG011|Overall Study|Death|0|||
149167950|NCT02875223|538087746|FG012|Overall Study|Death|0|||
149167951|NCT02875223|538087734|FG000|Overall Study|Lost to Follow-up|0|||
149167952|NCT02875223|538087735|FG001|Overall Study|Lost to Follow-up|1|||
149167953|NCT02875223|538087736|FG002|Overall Study|Lost to Follow-up|1|||
149167954|NCT02875223|538087737|FG003|Overall Study|Lost to Follow-up|0|||
149167955|NCT02875223|538087738|FG004|Overall Study|Lost to Follow-up|1|||
149167956|NCT02875223|538087739|FG005|Overall Study|Lost to Follow-up|0|||
149167957|NCT02875223|538087740|FG006|Overall Study|Lost to Follow-up|1|||
149167958|NCT02875223|538087741|FG007|Overall Study|Lost to Follow-up|1|||
149167959|NCT02875223|538087742|FG008|Overall Study|Lost to Follow-up|0|||
149167960|NCT02875223|538087743|FG009|Overall Study|Lost to Follow-up|0|||
149167961|NCT02875223|538087744|FG010|Overall Study|Lost to Follow-up|0|||
149167962|NCT02875223|538087745|FG011|Overall Study|Lost to Follow-up|0|||
149167963|NCT02875223|538087746|FG012|Overall Study|Lost to Follow-up|0|||
149167964|NCT01955707|538087751|FG000|Overall Study|Adverse Event|1|||
149167965|NCT01955707|538087752|FG001|Overall Study|Adverse Event|2|||
149167966|NCT01955707|538087751|FG000|Overall Study|Lost to Follow-up|2|||
149167967|NCT01955707|538087752|FG001|Overall Study|Lost to Follow-up|1|||
149167968|NCT01955707|538087751|FG000|Overall Study|Withdrawal by Subject|0|||
149167969|NCT01955707|538087752|FG001|Overall Study|Withdrawal by Subject|3|||
149167970|NCT01955707|538087751|FG000|Overall Study|Death|13|||
149167971|NCT01955707|538087752|FG001|Overall Study|Death|14|||
149167972|NCT01955707|538087751|FG000|Overall Study|Other|4|||
149167973|NCT01955707|538087752|FG001|Overall Study|Other|2|||
149167974|NCT04280081|538087757|FG000|Overall Study|Adverse Event|4|||
149167975|NCT04280081|538087757|FG000|Overall Study|Death|2|||
149167976|NCT04280081|538087757|FG000|Overall Study|Progressive Disease|6|||
149167977|NCT03896581|538089543|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
149167978|NCT03896581|538089544|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
149167979|NCT03896581|538089543|FG000|Overall Study|Withdrawal by Subject|4|||
149167980|NCT03896581|538089544|FG001|Overall Study|Withdrawal by Subject|1|||
149167981|NCT03896581|538089543|FG000|Overall Study|Lost to Follow-up|1|||
149167982|NCT03896581|538089544|FG001|Overall Study|Lost to Follow-up|0|||
149167983|NCT03896581|538089543|FG000|Overall Study|Lack of Efficacy|2|||
149167984|NCT03896581|538089544|FG001|Overall Study|Lack of Efficacy|1|||
149167985|NCT03896581|538089543|FG000|Overall Study|Adverse event, non-fatal|0|||
149167986|NCT03896581|538089544|FG001|Overall Study|Adverse event, non-fatal|2|||
149167987|NCT02029976|538089546|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
149167988|NCT02029976|538089547|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
149167989|NCT02029976|538089546|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
149167990|NCT02029976|538089547|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
149167991|NCT02029976|538089546|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
149167992|NCT02029976|538089547|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
149167993|NCT02029976|538089546|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
149167994|NCT02029976|538089547|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
149167995|NCT01445171|538089548|FG000|Overall Study|Lost to Follow-up|11|||
149167996|NCT01445171|538089548|FG000|Overall Study|Withdrawal by Subject|16|||
149167997|NCT01445171|538089548|FG000|Overall Study|Death|51|||
149167998|NCT01445171|538089548|FG000|Overall Study|Subjects declined to return for followup|9|||
149167999|NCT01445171|538089548|FG000|Overall Study|Consented but did not receive device|8|||
149168000|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
149168001|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
149168002|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
148677148|NCT01336608|536291079|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
148677149|NCT01336608|536291080|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
148677150|NCT01336608|536291081|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
148677151|NCT01336608|536291078|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
148677152|NCT01336608|536291079|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
148677153|NCT01336608|536291080|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
148677154|NCT01336608|536291081|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
148677155|NCT01336608|536291078|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
148677156|NCT01336608|536291079|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148677157|NCT01336608|536291080|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148677158|NCT01336608|536291081|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148677159|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
148677160|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
148677161|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
148677162|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
148677163|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148677164|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
148677165|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148677166|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
149168003|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
149168004|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
149168005|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
149168006|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
149168007|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
149168008|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
149168009|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
148677167|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
148677168|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
148677169|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
148677170|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
148677171|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
148677172|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
148677173|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
148677174|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
148677175|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
148677176|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
148677177|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
148677178|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
148677179|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148677180|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
148677181|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148677182|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148677183|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
148677184|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
149168010|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
149168011|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149168012|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149168013|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149168014|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
149168015|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149168016|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
148677185|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
148677186|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
148677187|NCT01336608|536291078|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
148677188|NCT01336608|536291079|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
148677189|NCT01336608|536291080|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
148677190|NCT01336608|536291081|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
148677191|NCT02437890|536291086|FG000|Overall Study|Non-compliance to study drug|0|||
148677192|NCT02437890|536291087|FG001|Overall Study|Non-compliance to study drug|1|||
148677193|NCT02437890|536291088|FG002|Overall Study|Non-compliance to study drug|0|||
148677194|NCT02437890|536291089|FG003|Overall Study|Non-compliance to study drug|0|||
148677195|NCT02437890|536291090|FG004|Overall Study|Non-compliance to study drug|1|||
148677196|NCT02437890|536291086|FG000|Overall Study|Sponsor's decision|1|||
148677197|NCT02437890|536291087|FG001|Overall Study|Sponsor's decision|1|||
148677198|NCT02437890|536291088|FG002|Overall Study|Sponsor's decision|4|||
148677199|NCT02437890|536291089|FG003|Overall Study|Sponsor's decision|0|||
148677200|NCT02437890|536291090|FG004|Overall Study|Sponsor's decision|2|||
148677201|NCT02437890|536291086|FG000|Overall Study|Physician Decision|0|||
148677202|NCT02437890|536291087|FG001|Overall Study|Physician Decision|0|||
148677203|NCT02437890|536291088|FG002|Overall Study|Physician Decision|0|||
148677204|NCT02437890|536291089|FG003|Overall Study|Physician Decision|1|||
148677205|NCT02437890|536291090|FG004|Overall Study|Physician Decision|0|||
148677206|NCT02437890|536291086|FG000|Overall Study|Unable to attend visit(s)|1|||
148677207|NCT02437890|536291087|FG001|Overall Study|Unable to attend visit(s)|0|||
148677208|NCT02437890|536291088|FG002|Overall Study|Unable to attend visit(s)|0|||
148677209|NCT02437890|536291089|FG003|Overall Study|Unable to attend visit(s)|0|||
148677210|NCT02437890|536291090|FG004|Overall Study|Unable to attend visit(s)|0|||
148677211|NCT02437890|536291086|FG000|Overall Study|Lack of Efficacy|1|||
148677212|NCT02437890|536291087|FG001|Overall Study|Lack of Efficacy|3|||
148677213|NCT02437890|536291088|FG002|Overall Study|Lack of Efficacy|0|||
148677214|NCT02437890|536291089|FG003|Overall Study|Lack of Efficacy|3|||
148677215|NCT02437890|536291090|FG004|Overall Study|Lack of Efficacy|1|||
148677216|NCT02437890|536291086|FG000|Overall Study|Adverse Event|4|||
148677217|NCT02437890|536291087|FG001|Overall Study|Adverse Event|9|||
148677218|NCT02437890|536291088|FG002|Overall Study|Adverse Event|5|||
148677219|NCT02437890|536291089|FG003|Overall Study|Adverse Event|11|||
148677220|NCT02437890|536291090|FG004|Overall Study|Adverse Event|7|||
148677221|NCT02437890|536291086|FG000|Overall Study|Withdrawal by Subject|1|||
148677222|NCT02437890|536291087|FG001|Overall Study|Withdrawal by Subject|2|||
148677223|NCT02437890|536291088|FG002|Overall Study|Withdrawal by Subject|6|||
149168017|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
148677224|NCT02437890|536291089|FG003|Overall Study|Withdrawal by Subject|5|||
148677225|NCT02437890|536291090|FG004|Overall Study|Withdrawal by Subject|5|||
148677226|NCT02437890|536291086|FG000|Overall Study|Death|0|||
149168018|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149168019|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
149168020|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
149168021|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
149168022|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
149168023|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
149168024|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
149168025|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
149168026|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
149168027|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
149168028|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
149168029|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
149168030|NCT02660580|538089549|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
149168031|NCT02660580|538089550|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
149168032|NCT02660580|538089551|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
149168033|NCT02660580|538089552|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
149168034|NCT02660580|538089553|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
149168035|NCT02660580|538089549|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
149168036|NCT02660580|538089550|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
149168037|NCT02660580|538089551|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
149168038|NCT02660580|538089552|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
149168039|NCT02660580|538089553|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
149168040|NCT02660580|538089549|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
149168041|NCT02660580|538089550|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
149168042|NCT02660580|538089551|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
149168043|NCT02660580|538089552|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
149168044|NCT02660580|538089553|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
149168045|NCT02660580|538089549|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
149168046|NCT02660580|538089550|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
149168047|NCT02660580|538089551|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
149168048|NCT02660580|538089552|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
149168049|NCT02660580|538089553|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
149168050|NCT02660580|538089549|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
149168051|NCT02660580|538089550|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
149168052|NCT02660580|538089551|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
149168053|NCT02660580|538089552|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
149168054|NCT02660580|538089553|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
149168055|NCT02660580|538089549|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
149168056|NCT02660580|538089550|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
148677227|NCT02437890|536291087|FG001|Overall Study|Death|0|||
148677228|NCT02437890|536291088|FG002|Overall Study|Death|0|||
148677229|NCT02437890|536291089|FG003|Overall Study|Death|2|||
148677230|NCT02437890|536291090|FG004|Overall Study|Death|0|||
148677231|NCT04723173|536291091|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
148677232|NCT02996448|536291092|FG000|Overall Study|Study terminated due to adverse effects|3|||
148677233|NCT00303316|536291095|FG000|Overall Study|Protocol Violation|1|||
148677234|NCT00303316|536291096|FG001|Overall Study|Protocol Violation|0|||
148677235|NCT00303316|536291095|FG000|Overall Study|Lost to Follow-up|0|||
148677236|NCT00303316|536291096|FG001|Overall Study|Lost to Follow-up|1|||
148677237|NCT00303316|536291095|FG000|Overall Study|Withdrawal by Subject|1|||
148677238|NCT00303316|536291096|FG001|Overall Study|Withdrawal by Subject|2|||
148677239|NCT01160198|536291100|FG000|Overall Study|Withdrawal by Subject|2|||
148677240|NCT01160198|536291101|FG001|Overall Study|Withdrawal by Subject|1|||
148677241|NCT01160198|536291102|FG002|Overall Study|Withdrawal by Subject|0|||
148677242|NCT01160198|536291100|FG000|Overall Study|Adverse Event|0|||
148677243|NCT01160198|536291101|FG001|Overall Study|Adverse Event|1|||
148677244|NCT01160198|536291102|FG002|Overall Study|Adverse Event|0|||
148677245|NCT01160198|536291100|FG000|Overall Study|Lost to Follow-up|0|||
148677246|NCT01160198|536291101|FG001|Overall Study|Lost to Follow-up|1|||
148677247|NCT01160198|536291102|FG002|Overall Study|Lost to Follow-up|0|||
148677248|NCT01160198|536291100|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
148677249|NCT01160198|536291101|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
148677250|NCT01160198|536291102|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
148677251|NCT01796860|536291104|FG000|Overall Study|Withdrawal by Subject|3|||
148677252|NCT02016755|536291105|FG000|Overall Study|Major amputation of index limb|2|||
148677253|NCT02016755|536291105|FG000|Overall Study|Adverse Event|2|||
148677254|NCT02016755|536291105|FG000|Overall Study|Physician Decision|1|||
148677255|NCT02016755|536291105|FG000|Overall Study|Death|2|||
148677256|NCT02748616|536291133|FG000|Overall Study|Lost to Follow-up|1|||
148677257|NCT02748616|536291133|FG000|Overall Study|Withdrawal by Subject|2|||
148677258|NCT02748616|536291133|FG000|Overall Study|Physician Decision|2|||
149168057|NCT02660580|538089551|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
149168058|NCT02660580|538089552|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
149168059|NCT02660580|538089553|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
149168060|NCT02660580|538089549|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
149168061|NCT02660580|538089550|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
149168062|NCT02660580|538089551|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
149168063|NCT02660580|538089552|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
149168064|NCT02660580|538089553|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
149168065|NCT04462536|538089554|FG000|Overall Study|Withdrawal by Subject|3|||
149168066|NCT04462536|538089555|FG001|Overall Study|Withdrawal by Subject|9|||
149168067|NCT04462536|538089554|FG000|Overall Study|Lost to Follow-up|2|||
149168068|NCT04462536|538089555|FG001|Overall Study|Lost to Follow-up|4|||
149168069|NCT00450580|538089558|FG000|Overall Study|Adverse Event|5|||
149168070|NCT00450580|538089559|FG001|Overall Study|Adverse Event|7|||
149168071|NCT00450580|538089558|FG000|Overall Study|Lost to Follow-up|4|||
149168072|NCT00450580|538089559|FG001|Overall Study|Lost to Follow-up|5|||
149168073|NCT00450580|538089558|FG000|Overall Study|Withdrawal by Subject|2|||
149168074|NCT00450580|538089559|FG001|Overall Study|Withdrawal by Subject|2|||
149168075|NCT00450580|538089558|FG000|Overall Study|Protocol Violation|1|||
149168076|NCT00450580|538089559|FG001|Overall Study|Protocol Violation|1|||
149168077|NCT00450580|538089558|FG000|Overall Study|Protocol-defined virologic failure|1|||
149168078|NCT00450580|538089559|FG001|Overall Study|Protocol-defined virologic failure|0|||
149168079|NCT00450580|538089558|FG000|Overall Study|Could not comply with scheduled visits|1|||
149168080|NCT00450580|538089559|FG001|Overall Study|Could not comply with scheduled visits|0|||
149168081|NCT00450580|538089558|FG000|Overall Study|Patient went to Brazil|1|||
149168082|NCT00450580|538089559|FG001|Overall Study|Patient went to Brazil|0|||
149168083|NCT00450580|538089558|FG000|Overall Study|Patient could not swallow Norvir|1|||
149168084|NCT00450580|538089559|FG001|Overall Study|Patient could not swallow Norvir|0|||
149168085|NCT00450580|538089558|FG000|Overall Study|Withdrawal due to pregnancy|0|||
149168086|NCT00450580|538089559|FG001|Overall Study|Withdrawal due to pregnancy|1|||
149168087|NCT04572633|538089568|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
149168088|NCT03480802|538089569|FG000|Overall Study|Lost to Follow-up|5|||
149168089|NCT03480802|538089570|FG001|Overall Study|Lost to Follow-up|1|||
149168090|NCT03480802|538089569|FG000|Overall Study|Withdrawal by Subject|2|||
149168091|NCT03480802|538089570|FG001|Overall Study|Withdrawal by Subject|1|||
149168092|NCT03480802|538089569|FG000|Overall Study|Relocated|0|||
149168093|NCT03480802|538089570|FG001|Overall Study|Relocated|1|||
149168094|NCT04439266|538089573|FG000|Overall Study|Ineligible|1|||
149168095|NCT04439266|538089573|FG000|Overall Study|Adverse Event|1|||
149168096|NCT04439266|538089573|FG000|Overall Study|Death|1|||
149168097|NCT04439266|538089573|FG000|Overall Study|Disease progression|1|||
149168098|NCT04439266|538089573|FG000|Overall Study|Still on treatment|1|||
149168099|NCT05424276|538089576|FG000|Overall Study|Adverse Event|1|||
149168100|NCT05424276|538089577|FG001|Overall Study|Adverse Event|0|||
149168101|NCT05424276|538089578|FG002|Overall Study|Adverse Event|0|||
149168102|NCT05424276|538089579|FG003|Overall Study|Adverse Event|2|||
148677259|NCT02748616|536291133|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
148677260|NCT02216214|536291135|FG000|Overall Study|Randomized Never Received Study Drug|1|||
148677261|NCT02216214|536291136|FG001|Overall Study|Randomized Never Received Study Drug|0|||
148677262|NCT02216214|536291135|FG000|Overall Study|Adverse Event|10|||
148677263|NCT02216214|536291136|FG001|Overall Study|Adverse Event|8|||
148677264|NCT02216214|536291135|FG000|Overall Study|Lack of Efficacy|2|||
148677265|NCT02216214|536291136|FG001|Overall Study|Lack of Efficacy|2|||
148677266|NCT02216214|536291135|FG000|Overall Study|Lost to Follow-up|3|||
148677267|NCT02216214|536291136|FG001|Overall Study|Lost to Follow-up|2|||
149168103|NCT05424276|538089576|FG000|Overall Study|Withdrawal by Subject|0|||
149168104|NCT05424276|538089577|FG001|Overall Study|Withdrawal by Subject|0|||
149168105|NCT05424276|538089578|FG002|Overall Study|Withdrawal by Subject|2|||
149168106|NCT05424276|538089579|FG003|Overall Study|Withdrawal by Subject|0|||
149168107|NCT05424276|538089576|FG000|Overall Study|Protocol Violation|0|||
149168108|NCT05424276|538089577|FG001|Overall Study|Protocol Violation|1|||
149168109|NCT05424276|538089578|FG002|Overall Study|Protocol Violation|0|||
149168110|NCT05424276|538089579|FG003|Overall Study|Protocol Violation|0|||
148677268|NCT02216214|536291135|FG000|Overall Study|Protocol Violation|4|||
149168111|NCT05424276|538089576|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
149168112|NCT05424276|538089577|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
149168113|NCT05424276|538089578|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
149168114|NCT05424276|538089579|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
149168115|NCT03049449|538089581|FG000|Overall Study|Did not receive treatment.|0|||
149168116|NCT03049449|538089582|FG001|Overall Study|Did not receive treatment.|0|||
149168117|NCT03049449|538089583|FG002|Overall Study|Did not receive treatment.|0|||
149168118|NCT03049449|538089584|FG003|Overall Study|Did not receive treatment.|0|||
149168119|NCT03049449|538089585|FG004|Overall Study|Did not receive treatment.|0|||
149168120|NCT03049449|538089586|FG005|Overall Study|Did not receive treatment.|0|||
149168121|NCT03049449|538089587|FG006|Overall Study|Did not receive treatment.|0|||
149168122|NCT03049449|538089588|FG007|Overall Study|Did not receive treatment.|0|||
149168123|NCT03049449|538089589|FG008|Overall Study|Did not receive treatment.|1|||
149168124|NCT03049449|538089590|FG009|Overall Study|Did not receive treatment.|0|||
149168125|NCT03049449|538089581|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
149168126|NCT03049449|538089582|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
149168127|NCT03049449|538089583|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
149168128|NCT03049449|538089584|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
149168129|NCT03049449|538089585|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
149168130|NCT03049449|538089586|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
149168131|NCT03049449|538089587|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
149168132|NCT03049449|538089588|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
148677269|NCT02216214|536291136|FG001|Overall Study|Protocol Violation|2|||
148677270|NCT02216214|536291135|FG000|Overall Study|Withdrawal by Subject|22|||
148677271|NCT02216214|536291136|FG001|Overall Study|Withdrawal by Subject|20|||
148677272|NCT02216214|536291135|FG000|Overall Study|Study Terminated By Sponsor|0|||
148677273|NCT02216214|536291136|FG001|Overall Study|Study Terminated By Sponsor|1|||
148677274|NCT02216214|536291135|FG000|Overall Study|Miscellaneous|1|||
148677275|NCT02216214|536291136|FG001|Overall Study|Miscellaneous|1|||
148677276|NCT05354206|536291137|FG000|Overall Study|Withdrawal by Subject|1|||
148677277|NCT05354206|536291138|FG001|Overall Study|Withdrawal by Subject|0|||
148677278|NCT01414062|536291139|FG000|Overall Study|Lost to Follow-up|3|||
148677279|NCT01414062|536291140|FG001|Overall Study|Lost to Follow-up|2|||
148677280|NCT01414062|536291139|FG000|Overall Study|Left Country|1|||
148677281|NCT01414062|536291140|FG001|Overall Study|Left Country|1|||
148677282|NCT01414062|536291139|FG000|Overall Study|Family Disapproval|1|||
148677283|NCT01414062|536291140|FG001|Overall Study|Family Disapproval|0|||
148677284|NCT01414062|536291139|FG000|Overall Study|Withdrawal by Subject|0|||
148677285|NCT01414062|536291140|FG001|Overall Study|Withdrawal by Subject|1|||
148677286|NCT04285983|536291141|FG000|Overall Study|Protocol Violation|6|||
148677287|NCT04936334|536291142|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
148677288|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
148677289|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
148677290|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
148677291|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
148677292|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
148677293|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
148677294|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
148677295|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
148677296|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
148677297|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
148677298|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
148677299|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
148677300|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
148677301|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
148677302|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
148677303|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
148677304|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
148677305|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
148677306|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
148677307|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
148677308|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
148677309|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
148677310|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
148677311|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
149168133|NCT03049449|538089589|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
149168134|NCT03049449|538089590|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
149168135|NCT03049449|538089581|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
148677312|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
149168136|NCT03049449|538089582|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
148677313|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
148677314|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
148677315|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
148677316|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
148806265|NCT01454284|536768931|FG000|Overall Study|Withdrawal by Subject|58|||
148806266|NCT01454284|536768932|FG001|Overall Study|Withdrawal by Subject|36|||
148677317|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
148677318|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
148677319|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
148677320|NCT03747939|536291147|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
148677321|NCT03747939|536291148|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
148677322|NCT03747939|536291149|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
148677323|NCT03747939|536291150|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
148677324|NCT03747939|536291147|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
148677325|NCT03747939|536291148|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
148677326|NCT03747939|536291149|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
148677327|NCT03747939|536291150|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
148677328|NCT03747939|536291147|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
148677329|NCT03747939|536291148|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
148677330|NCT03747939|536291149|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
148677331|NCT03747939|536291150|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
148677332|NCT03747939|536291147|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
148677333|NCT03747939|536291148|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
148677334|NCT03747939|536291149|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
148677335|NCT03747939|536291150|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
148677336|NCT03747939|536291147|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
148677337|NCT03747939|536291148|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
148677338|NCT03747939|536291149|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
148677339|NCT03747939|536291150|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
148677340|NCT03747939|536291147|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
148677341|NCT03747939|536291148|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
148677342|NCT03747939|536291149|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
148677343|NCT03747939|536291150|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
148677344|NCT04529096|536291151|FG000|Overall Study|Adverse Event|6|||
148677345|NCT04529096|536291152|FG001|Overall Study|Adverse Event|1|||
148677346|NCT04529096|536291151|FG000|Overall Study|Lack of Efficacy|1|||
148677347|NCT04529096|536291152|FG001|Overall Study|Lack of Efficacy|0|||
148677348|NCT04529096|536291151|FG000|Overall Study|Lost to Follow-up|1|||
148677349|NCT04529096|536291152|FG001|Overall Study|Lost to Follow-up|1|||
148677350|NCT04529096|536291151|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148677351|NCT04529096|536291152|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148677352|NCT04529096|536291151|FG000|Overall Study|Physician Decision|1|||
148677353|NCT04529096|536291152|FG001|Overall Study|Physician Decision|3|||
148677354|NCT04529096|536291151|FG000|Overall Study|Withdrawal by Subject|5|||
148677355|NCT04529096|536291152|FG001|Overall Study|Withdrawal by Subject|0|||
148677356|NCT01289990|536291153|FG000|Overall Study|Death|0|||
148677357|NCT01289990|536291154|FG001|Overall Study|Death|0|||
148677358|NCT01289990|536291155|FG002|Overall Study|Death|0|||
148677359|NCT01289990|536291156|FG003|Overall Study|Death|1|||
148677360|NCT01289990|536291157|FG004|Overall Study|Death|2|||
148677361|NCT01289990|536291158|FG005|Overall Study|Death|1|||
148677362|NCT01289990|536291159|FG006|Overall Study|Death|0|||
148677363|NCT01289990|536291160|FG007|Overall Study|Death|0|||
148677364|NCT01289990|536291161|FG008|Overall Study|Death|0|||
148677365|NCT01289990|536291162|FG009|Overall Study|Death|0|||
148677366|NCT01289990|536291163|FG010|Overall Study|Death|0|||
148677367|NCT01289990|536291164|FG011|Overall Study|Death|1|||
148677368|NCT01289990|536291165|FG012|Overall Study|Death|0|||
148677369|NCT01289990|536291153|FG000|Overall Study|Lost to Follow-up|3|||
148677370|NCT01289990|536291154|FG001|Overall Study|Lost to Follow-up|2|||
148677371|NCT01289990|536291155|FG002|Overall Study|Lost to Follow-up|5|||
148677372|NCT01289990|536291156|FG003|Overall Study|Lost to Follow-up|5|||
148677373|NCT01289990|536291157|FG004|Overall Study|Lost to Follow-up|3|||
148677374|NCT01289990|536291158|FG005|Overall Study|Lost to Follow-up|4|||
148677375|NCT01289990|536291159|FG006|Overall Study|Lost to Follow-up|2|||
149168137|NCT03049449|538089583|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149168138|NCT03049449|538089584|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149168139|NCT03049449|538089585|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
148677376|NCT01289990|536291160|FG007|Overall Study|Lost to Follow-up|2|||
148677377|NCT01289990|536291161|FG008|Overall Study|Lost to Follow-up|1|||
148677378|NCT01289990|536291162|FG009|Overall Study|Lost to Follow-up|4|||
148677379|NCT01289990|536291163|FG010|Overall Study|Lost to Follow-up|2|||
148677380|NCT01289990|536291164|FG011|Overall Study|Lost to Follow-up|1|||
148677381|NCT01289990|536291165|FG012|Overall Study|Lost to Follow-up|2|||
148677382|NCT01289990|536291153|FG000|Overall Study|Withdrawal by Subject|15|||
148677383|NCT01289990|536291154|FG001|Overall Study|Withdrawal by Subject|14|||
148677384|NCT01289990|536291155|FG002|Overall Study|Withdrawal by Subject|12|||
148677385|NCT01289990|536291156|FG003|Overall Study|Withdrawal by Subject|13|||
148806267|NCT01454284|536768931|FG000|Overall Study|Physician Decision|16|||
149168140|NCT03049449|538089586|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149168141|NCT03049449|538089587|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149168142|NCT03049449|538089588|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
149168143|NCT03049449|538089589|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
149168144|NCT03049449|538089590|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
149168145|NCT00792298|538089592|FG000|Treatment Period 1|Adverse Event|0|||
149168146|NCT00792298|538089593|FG001|Treatment Period 1|Adverse Event|1|||
149168147|NCT00792298|538089594|FG002|Treatment Period 1|Adverse Event|0|||
149168148|NCT00792298|538089595|FG003|Treatment Period 1|Adverse Event|1|||
149168149|NCT00792298|538089596|FG004|Treatment Period 1|Adverse Event|0|||
149168150|NCT00792298|538089597|FG005|Treatment Period 1|Adverse Event|1|||
148806268|NCT01454284|536768932|FG001|Overall Study|Physician Decision|11|||
149168151|NCT00792298|538089598|FG006|Treatment Period 1|Adverse Event|1|||
149168152|NCT00792298|538089599|FG007|Treatment Period 1|Adverse Event|0|||
149168153|NCT00792298|538089592|FG000|Treatment Period 1|Lack of Efficacy|0|||
149168154|NCT00792298|538089593|FG001|Treatment Period 1|Lack of Efficacy|0|||
149168155|NCT00792298|538089594|FG002|Treatment Period 1|Lack of Efficacy|1|||
149168156|NCT00792298|538089595|FG003|Treatment Period 1|Lack of Efficacy|0|||
149168157|NCT00792298|538089596|FG004|Treatment Period 1|Lack of Efficacy|0|||
149168158|NCT00792298|538089597|FG005|Treatment Period 1|Lack of Efficacy|0|||
149168159|NCT00792298|538089598|FG006|Treatment Period 1|Lack of Efficacy|0|||
149168160|NCT00792298|538089599|FG007|Treatment Period 1|Lack of Efficacy|0|||
149168161|NCT00792298|538089592|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149168162|NCT00792298|538089593|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149168163|NCT00792298|538089594|FG002|Treatment Period 1|Withdrawal by Subject|1|||
149168164|NCT00792298|538089595|FG003|Treatment Period 1|Withdrawal by Subject|2|||
149168165|NCT00792298|538089596|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149168166|NCT00792298|538089597|FG005|Treatment Period 1|Withdrawal by Subject|2|||
149168167|NCT00792298|538089598|FG006|Treatment Period 1|Withdrawal by Subject|1|||
149168168|NCT00792298|538089599|FG007|Treatment Period 1|Withdrawal by Subject|0|||
149168169|NCT00792298|538089592|FG000|Treatment Period 1|Lost to Follow-up|0|||
149168170|NCT00792298|538089593|FG001|Treatment Period 1|Lost to Follow-up|0|||
149168171|NCT00792298|538089594|FG002|Treatment Period 1|Lost to Follow-up|0|||
149168172|NCT00792298|538089595|FG003|Treatment Period 1|Lost to Follow-up|0|||
149168173|NCT00792298|538089596|FG004|Treatment Period 1|Lost to Follow-up|0|||
149168174|NCT00792298|538089597|FG005|Treatment Period 1|Lost to Follow-up|0|||
149168175|NCT00792298|538089598|FG006|Treatment Period 1|Lost to Follow-up|1|||
149168176|NCT00792298|538089599|FG007|Treatment Period 1|Lost to Follow-up|0|||
149168177|NCT00792298|538089592|FG000|Treatment Period 1|Physician Decision|0|||
149168178|NCT00792298|538089593|FG001|Treatment Period 1|Physician Decision|0|||
149168179|NCT00792298|538089594|FG002|Treatment Period 1|Physician Decision|0|||
149168180|NCT00792298|538089595|FG003|Treatment Period 1|Physician Decision|1|||
149168181|NCT00792298|538089596|FG004|Treatment Period 1|Physician Decision|0|||
149168182|NCT00792298|538089597|FG005|Treatment Period 1|Physician Decision|0|||
148806269|NCT01454284|536768931|FG000|Overall Study|Sponsor Decision|0|||
149168183|NCT00792298|538089598|FG006|Treatment Period 1|Physician Decision|1|||
149168184|NCT00792298|538089599|FG007|Treatment Period 1|Physician Decision|0|||
149168185|NCT00792298|538089592|FG000|Treatment Period 1|Protocol Violation|0|||
149168186|NCT00792298|538089593|FG001|Treatment Period 1|Protocol Violation|0|||
149168187|NCT00792298|538089594|FG002|Treatment Period 1|Protocol Violation|0|||
149168188|NCT00792298|538089595|FG003|Treatment Period 1|Protocol Violation|0|||
149168189|NCT00792298|538089596|FG004|Treatment Period 1|Protocol Violation|0|||
149168190|NCT00792298|538089597|FG005|Treatment Period 1|Protocol Violation|0|||
149168191|NCT00792298|538089598|FG006|Treatment Period 1|Protocol Violation|0|||
149168192|NCT00792298|538089599|FG007|Treatment Period 1|Protocol Violation|1|||
148677386|NCT01289990|536291157|FG004|Overall Study|Withdrawal by Subject|8|||
149168193|NCT00792298|538089592|FG000|Washout|Adverse Event|0|||
149168194|NCT00792298|538089593|FG001|Washout|Adverse Event|0|||
149168195|NCT00792298|538089594|FG002|Washout|Adverse Event|0|||
149168196|NCT00792298|538089595|FG003|Washout|Adverse Event|0|||
149168197|NCT00792298|538089596|FG004|Washout|Adverse Event|0|||
149168198|NCT00792298|538089597|FG005|Washout|Adverse Event|1|||
149168199|NCT00792298|538089598|FG006|Washout|Adverse Event|0|||
149168200|NCT00792298|538089599|FG007|Washout|Adverse Event|0|||
149168201|NCT00792298|538089592|FG000|Washout|Withdrawal by Subject|0|||
149168202|NCT00792298|538089593|FG001|Washout|Withdrawal by Subject|0|||
149168203|NCT00792298|538089594|FG002|Washout|Withdrawal by Subject|1|||
149168204|NCT00792298|538089595|FG003|Washout|Withdrawal by Subject|0|||
149168205|NCT00792298|538089596|FG004|Washout|Withdrawal by Subject|0|||
149168206|NCT00792298|538089597|FG005|Washout|Withdrawal by Subject|1|||
149168207|NCT00792298|538089598|FG006|Washout|Withdrawal by Subject|0|||
149168208|NCT00792298|538089599|FG007|Washout|Withdrawal by Subject|0|||
149168209|NCT00792298|538089592|FG000|Treatment Period 2|Lack of Efficacy|0|||
149168210|NCT00792298|538089593|FG001|Treatment Period 2|Lack of Efficacy|0|||
149168211|NCT00792298|538089594|FG002|Treatment Period 2|Lack of Efficacy|0|||
149168212|NCT00792298|538089595|FG003|Treatment Period 2|Lack of Efficacy|0|||
149168213|NCT00792298|538089596|FG004|Treatment Period 2|Lack of Efficacy|1|||
149168214|NCT00792298|538089597|FG005|Treatment Period 2|Lack of Efficacy|0|||
149168215|NCT00792298|538089598|FG006|Treatment Period 2|Lack of Efficacy|0|||
149168216|NCT00792298|538089599|FG007|Treatment Period 2|Lack of Efficacy|0|||
149168217|NCT00792298|538089592|FG000|Treatment Period 2|Physician Decision|0|||
149168218|NCT00792298|538089593|FG001|Treatment Period 2|Physician Decision|0|||
149168219|NCT00792298|538089594|FG002|Treatment Period 2|Physician Decision|0|||
149168220|NCT00792298|538089595|FG003|Treatment Period 2|Physician Decision|0|||
149168221|NCT00792298|538089596|FG004|Treatment Period 2|Physician Decision|0|||
149168222|NCT00792298|538089597|FG005|Treatment Period 2|Physician Decision|0|||
149168223|NCT00792298|538089598|FG006|Treatment Period 2|Physician Decision|1|||
149168224|NCT00792298|538089599|FG007|Treatment Period 2|Physician Decision|0|||
149168225|NCT00792298|538089592|FG000|Treatment Period 2|Pregnancy|0|||
149168226|NCT00792298|538089593|FG001|Treatment Period 2|Pregnancy|0|||
149168227|NCT00792298|538089594|FG002|Treatment Period 2|Pregnancy|1|||
149168228|NCT00792298|538089595|FG003|Treatment Period 2|Pregnancy|0|||
148677387|NCT01289990|536291158|FG005|Overall Study|Withdrawal by Subject|7|||
149168229|NCT00792298|538089596|FG004|Treatment Period 2|Pregnancy|0|||
148677388|NCT01289990|536291159|FG006|Overall Study|Withdrawal by Subject|13|||
148677389|NCT01289990|536291160|FG007|Overall Study|Withdrawal by Subject|9|||
148806270|NCT01454284|536768932|FG001|Overall Study|Sponsor Decision|2|||
148677390|NCT01289990|536291161|FG008|Overall Study|Withdrawal by Subject|12|||
149168230|NCT00792298|538089597|FG005|Treatment Period 2|Pregnancy|0|||
149168231|NCT00792298|538089598|FG006|Treatment Period 2|Pregnancy|0|||
149168232|NCT00792298|538089599|FG007|Treatment Period 2|Pregnancy|0|||
149168233|NCT00792298|538089592|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149168234|NCT00792298|538089593|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149168235|NCT00792298|538089594|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149168236|NCT00792298|538089595|FG003|Treatment Period 2|Withdrawal by Subject|2|||
149168237|NCT00792298|538089596|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149168238|NCT00792298|538089597|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149168239|NCT00792298|538089598|FG006|Treatment Period 2|Withdrawal by Subject|0|||
149168240|NCT00792298|538089599|FG007|Treatment Period 2|Withdrawal by Subject|2|||
149168241|NCT03304522|538089607|FG000|Overall Study|Adverse Event|0|||
149168242|NCT03304522|538089608|FG001|Overall Study|Adverse Event|4|||
149168243|NCT03304522|538089607|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
149168244|NCT03304522|538089608|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
148677391|NCT01289990|536291162|FG009|Overall Study|Withdrawal by Subject|13|||
148677392|NCT01289990|536291163|FG010|Overall Study|Withdrawal by Subject|11|||
148677393|NCT01289990|536291164|FG011|Overall Study|Withdrawal by Subject|13|||
148677394|NCT01289990|536291165|FG012|Overall Study|Withdrawal by Subject|16|||
148677395|NCT01289990|536291153|FG000|Overall Study|discontinued in preceding trial|18|||
148677396|NCT01289990|536291154|FG001|Overall Study|discontinued in preceding trial|20|||
148806271|NCT00393367|536768933|FG000|Overall Study|Protocol Violation|2|||
149168245|NCT03304522|538089607|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
149168246|NCT03304522|538089608|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
149168247|NCT03304522|538089607|FG000|Overall Study|Other|0|||
149168248|NCT03304522|538089608|FG001|Overall Study|Other|1|||
149168249|NCT03371355|538089613|FG000|Overall Study|Investigator judgment|0|||
149168250|NCT03371355|538089614|FG001|Overall Study|Investigator judgment|0|||
149168251|NCT03371355|538089615|FG002|Overall Study|Investigator judgment|1|||
149168252|NCT03371355|538089616|FG003|Overall Study|Investigator judgment|1|||
149168253|NCT03371355|538089613|FG000|Overall Study|Voluntary withdrawal|1|||
149168254|NCT03371355|538089614|FG001|Overall Study|Voluntary withdrawal|0|||
149168255|NCT03371355|538089615|FG002|Overall Study|Voluntary withdrawal|1|||
149168256|NCT03371355|538089616|FG003|Overall Study|Voluntary withdrawal|2|||
149168257|NCT03371355|538089613|FG000|Overall Study|Adverse Event|0|||
148677397|NCT01289990|536291155|FG002|Overall Study|discontinued in preceding trial|41|||
148677398|NCT01289990|536291156|FG003|Overall Study|discontinued in preceding trial|17|||
149168258|NCT03371355|538089614|FG001|Overall Study|Adverse Event|1|||
149168259|NCT03371355|538089615|FG002|Overall Study|Adverse Event|2|||
149168260|NCT03371355|538089616|FG003|Overall Study|Adverse Event|3|||
148806272|NCT00393367|536768934|FG001|Overall Study|Protocol Violation|5|||
149168261|NCT03371355|538089613|FG000|Overall Study|Reason not Specified|0|||
149168262|NCT03371355|538089614|FG001|Overall Study|Reason not Specified|1|||
149168263|NCT03371355|538089615|FG002|Overall Study|Reason not Specified|0|||
149168264|NCT03371355|538089616|FG003|Overall Study|Reason not Specified|1|||
149168265|NCT02965378|538089618|FG000|Overall Study|Progression|16|||
148806273|NCT00393367|536768933|FG000|Overall Study|Withdrawal by Subject|0|||
149168266|NCT02965378|538089619|FG001|Overall Study|Progression|4|||
149168267|NCT02965378|538089618|FG000|Overall Study|Adverse Event|5|||
149168268|NCT02965378|538089619|FG001|Overall Study|Adverse Event|2|||
149168269|NCT02965378|538089618|FG000|Overall Study|Death|2|||
149168270|NCT02965378|538089619|FG001|Overall Study|Death|0|||
149168271|NCT02965378|538089618|FG000|Overall Study|Refusal|2|||
149168272|NCT02965378|538089619|FG001|Overall Study|Refusal|1|||
149168273|NCT02965378|538089618|FG000|Overall Study|Not protocol specified|0|||
149168274|NCT02965378|538089619|FG001|Overall Study|Not protocol specified|2|||
149168275|NCT02909153|538089620|FG000|Overall Study|Withdrawal by Subject|0|||
149168276|NCT02909153|538089621|FG001|Overall Study|Withdrawal by Subject|1|||
149168277|NCT02909153|538089622|FG002|Overall Study|Withdrawal by Subject|0|||
149168278|NCT02909153|538089623|FG003|Overall Study|Withdrawal by Subject|0|||
149168279|NCT02909153|538089624|FG004|Overall Study|Withdrawal by Subject|0|||
149168280|NCT01526148|538089627|FG000|Overall Study|Adverse Event|6|||
149168281|NCT01526148|538089628|FG001|Overall Study|Adverse Event|5|||
149168282|NCT01526148|538089627|FG000|Overall Study|Lost to Follow-up|3|||
149168283|NCT01526148|538089628|FG001|Overall Study|Lost to Follow-up|6|||
149168284|NCT01526148|538089627|FG000|Overall Study|Withdrawal by Subject|2|||
149168285|NCT01526148|538089628|FG001|Overall Study|Withdrawal by Subject|0|||
149168286|NCT01526148|538089627|FG000|Overall Study|Unstable Medical Condition|1|||
149168287|NCT01526148|538089628|FG001|Overall Study|Unstable Medical Condition|0|||
149168288|NCT01526148|538089627|FG000|Overall Study|Unable to discontinue concomitant med|1|||
149168289|NCT01526148|538089628|FG001|Overall Study|Unable to discontinue concomitant med|0|||
149168290|NCT01526148|538089627|FG000|Overall Study|Moved out of state|1|||
149168291|NCT01526148|538089628|FG001|Overall Study|Moved out of state|0|||
149168292|NCT01526148|538089627|FG000|Overall Study|Incarcerated|0|||
149168293|NCT01526148|538089628|FG001|Overall Study|Incarcerated|2|||
149168294|NCT01173653|538089629|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
149168295|NCT01173653|538089630|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
149168296|NCT00584870|538089631|FG000|Overall Study|Adverse Event|4|||
149168297|NCT00584870|538089632|FG001|Overall Study|Adverse Event|3|||
149168298|NCT00584870|538089633|FG002|Overall Study|Adverse Event|2|||
149168299|NCT00584870|538089631|FG000|Overall Study|Lost to Follow-up|4|||
149168300|NCT00584870|538089632|FG001|Overall Study|Lost to Follow-up|1|||
149168301|NCT00584870|538089633|FG002|Overall Study|Lost to Follow-up|1|||
149168302|NCT00584870|538089631|FG000|Overall Study|Lack of Efficacy|7|||
149168303|NCT00584870|538089632|FG001|Overall Study|Lack of Efficacy|14|||
149168304|NCT00584870|538089633|FG002|Overall Study|Lack of Efficacy|8|||
149168305|NCT00584870|538089631|FG000|Overall Study|Withdrawal by Subject|10|||
149168306|NCT00584870|538089632|FG001|Overall Study|Withdrawal by Subject|5|||
149168307|NCT00584870|538089633|FG002|Overall Study|Withdrawal by Subject|3|||
149168308|NCT00584870|538089631|FG000|Overall Study|Protocol Violation|1|||
149168309|NCT00584870|538089632|FG001|Overall Study|Protocol Violation|1|||
149168310|NCT00584870|538089633|FG002|Overall Study|Protocol Violation|2|||
149168311|NCT00584870|538089631|FG000|Overall Study|Did not met entrance criteria|1|||
149168312|NCT00584870|538089632|FG001|Overall Study|Did not met entrance criteria|0|||
149168313|NCT00584870|538089633|FG002|Overall Study|Did not met entrance criteria|0|||
149168314|NCT00584870|538089631|FG000|Overall Study|Other|2|||
149168315|NCT00584870|538089632|FG001|Overall Study|Other|0|||
149168316|NCT00584870|538089633|FG002|Overall Study|Other|0|||
149168317|NCT00584870|538089631|FG000|Overall Study|Randomized but not treated|0|||
149168318|NCT00584870|538089632|FG001|Overall Study|Randomized but not treated|1|||
149168319|NCT00584870|538089633|FG002|Overall Study|Randomized but not treated|2|||
149168320|NCT00631137|538089634|FG000|Overall Study|Withdrawal by Subject|1|||
149168321|NCT00631137|538089635|FG001|Overall Study|Withdrawal by Subject|0|||
149168322|NCT03308188|538089636|FG000|Overall Study|Withdrawal by Subject|0|||
149168323|NCT03308188|538089637|FG001|Overall Study|Withdrawal by Subject|3|||
149168324|NCT03308188|538089636|FG000|Overall Study|Death|0|||
149168325|NCT03308188|538089637|FG001|Overall Study|Death|1|||
149168326|NCT00481065|538089638|FG000|Overall Study|Adverse event or death|1|||
149168327|NCT00481065|538089639|FG001|Overall Study|Adverse event or death|1|||
149168328|NCT00481065|538089640|FG002|Overall Study|Adverse event or death|3|||
149168329|NCT00481065|538089641|FG003|Overall Study|Adverse event or death|0|||
149168330|NCT00481065|538089642|FG004|Overall Study|Adverse event or death|2|||
149168331|NCT00481065|538089643|FG005|Overall Study|Adverse event or death|0|||
149168332|NCT00481065|538089644|FG006|Overall Study|Adverse event or death|1|||
149168333|NCT00481065|538089645|FG007|Overall Study|Adverse event or death|1|||
148677399|NCT01289990|536291157|FG004|Overall Study|discontinued in preceding trial|11|||
148677400|NCT01289990|536291158|FG005|Overall Study|discontinued in preceding trial|12|||
148677401|NCT01289990|536291159|FG006|Overall Study|discontinued in preceding trial|18|||
148677402|NCT01289990|536291160|FG007|Overall Study|discontinued in preceding trial|8|||
148677403|NCT01289990|536291161|FG008|Overall Study|discontinued in preceding trial|17|||
148677404|NCT01289990|536291162|FG009|Overall Study|discontinued in preceding trial|21|||
148677405|NCT01289990|536291163|FG010|Overall Study|discontinued in preceding trial|17|||
148677406|NCT01289990|536291164|FG011|Overall Study|discontinued in preceding trial|17|||
148677407|NCT01289990|536291165|FG012|Overall Study|discontinued in preceding trial|24|||
148677408|NCT01289990|536291153|FG000|Overall Study|did not continue in extension|41|||
148677409|NCT01289990|536291154|FG001|Overall Study|did not continue in extension|45|||
148677410|NCT01289990|536291155|FG002|Overall Study|did not continue in extension|51|||
148677411|NCT01289990|536291156|FG003|Overall Study|did not continue in extension|51|||
148677412|NCT01289990|536291157|FG004|Overall Study|did not continue in extension|48|||
148677413|NCT01289990|536291158|FG005|Overall Study|did not continue in extension|50|||
148677414|NCT01289990|536291159|FG006|Overall Study|did not continue in extension|54|||
148677415|NCT01289990|536291160|FG007|Overall Study|did not continue in extension|36|||
148677416|NCT01289990|536291161|FG008|Overall Study|did not continue in extension|44|||
148677417|NCT01289990|536291162|FG009|Overall Study|did not continue in extension|48|||
148677418|NCT01289990|536291163|FG010|Overall Study|did not continue in extension|45|||
148677419|NCT01289990|536291164|FG011|Overall Study|did not continue in extension|34|||
148677420|NCT01289990|536291165|FG012|Overall Study|did not continue in extension|56|||
148677421|NCT01289990|536291153|FG000|Overall Study|Not treated|0|||
148677422|NCT01289990|536291154|FG001|Overall Study|Not treated|0|||
148677423|NCT01289990|536291155|FG002|Overall Study|Not treated|0|||
148677424|NCT01289990|536291156|FG003|Overall Study|Not treated|0|||
148677425|NCT01289990|536291157|FG004|Overall Study|Not treated|0|||
148677426|NCT01289990|536291158|FG005|Overall Study|Not treated|0|||
148677427|NCT01289990|536291159|FG006|Overall Study|Not treated|1|||
148677428|NCT01289990|536291160|FG007|Overall Study|Not treated|0|||
148677429|NCT01289990|536291161|FG008|Overall Study|Not treated|1|||
148677430|NCT01289990|536291162|FG009|Overall Study|Not treated|0|||
148677431|NCT01289990|536291163|FG010|Overall Study|Not treated|1|||
148677432|NCT01289990|536291164|FG011|Overall Study|Not treated|2|||
148677433|NCT01289990|536291165|FG012|Overall Study|Not treated|0|||
148677434|NCT03454672|536291166|FG000|Overall Study|Adverse Event|1|||
148677435|NCT03454672|536291167|FG001|Overall Study|Adverse Event|1|||
148677436|NCT03454672|536291166|FG000|Overall Study|Lost to Follow-up|1|||
148677437|NCT03454672|536291167|FG001|Overall Study|Lost to Follow-up|3|||
148677438|NCT03454672|536291166|FG000|Overall Study|painful|1|||
148677439|NCT03454672|536291167|FG001|Overall Study|painful|2|||
148677440|NCT03454672|536291166|FG000|Overall Study|Non-compliance|2|||
148677441|NCT03454672|536291167|FG001|Overall Study|Non-compliance|4|||
148677442|NCT03454672|536291166|FG000|Overall Study|personal reasons|3|||
148677443|NCT03454672|536291167|FG001|Overall Study|personal reasons|2|||
148677444|NCT03454672|536291166|FG000|Overall Study|Withdrawal by Subject|1|||
148677445|NCT03454672|536291167|FG001|Overall Study|Withdrawal by Subject|0|||
148677446|NCT01488071|536291168|FG000|Overall Study|Adverse Event|15|||
148677447|NCT01488071|536291169|FG001|Overall Study|Adverse Event|23|||
148677448|NCT01488071|536291168|FG000|Overall Study|Lack of Efficacy|11|||
148677449|NCT01488071|536291169|FG001|Overall Study|Lack of Efficacy|17|||
148677450|NCT01488071|536291168|FG000|Overall Study|Non-compliance with study drug|2|||
148677451|NCT01488071|536291169|FG001|Overall Study|Non-compliance with study drug|0|||
148677452|NCT01488071|536291168|FG000|Overall Study|Protocol Violation|5|||
148677453|NCT01488071|536291169|FG001|Overall Study|Protocol Violation|7|||
148677454|NCT01488071|536291168|FG000|Overall Study|Withdrawal of Consent|14|||
148677455|NCT01488071|536291169|FG001|Overall Study|Withdrawal of Consent|12|||
148677456|NCT01488071|536291168|FG000|Overall Study|Lost to Follow-up|1|||
148677457|NCT01488071|536291169|FG001|Overall Study|Lost to Follow-up|0|||
148677458|NCT01488071|536291168|FG000|Overall Study|Administrative or Other Reason(s)|5|||
148677459|NCT01488071|536291169|FG001|Overall Study|Administrative or Other Reason(s)|4|||
148677460|NCT02139306|536291170|FG000|Overall Study|Withdrawal by Subject|4|||
148677461|NCT02139306|536291171|FG001|Overall Study|Withdrawal by Subject|6|||
148677462|NCT02139306|536291170|FG000|Overall Study|Adverse Event|3|||
148677463|NCT02139306|536291171|FG001|Overall Study|Adverse Event|4|||
148677464|NCT02139306|536291170|FG000|Overall Study|Physician Decision|0|||
148677465|NCT02139306|536291171|FG001|Overall Study|Physician Decision|1|||
148677466|NCT02139306|536291170|FG000|Overall Study|Other Unspecified|2|||
148677467|NCT02139306|536291171|FG001|Overall Study|Other Unspecified|3|||
148677468|NCT02139306|536291170|FG000|Overall Study|Protocol Violation|4|||
148677469|NCT02139306|536291171|FG001|Overall Study|Protocol Violation|0|||
148677470|NCT04449354|536291172|FG000|Overall Study|Withdrawal by Subject|1|||
148677471|NCT05899218|536291173|FG000|Overall Study|Lost to Follow-up|2|||
148677472|NCT05899218|536291174|FG001|Overall Study|Lost to Follow-up|2|||
148677473|NCT05899218|536291173|FG000|Overall Study|deemed ineligible out of country|1|||
148677474|NCT05899218|536291174|FG001|Overall Study|deemed ineligible out of country|0|||
148677475|NCT01220128|536291175|FG000|Overall Study|Progressive disease|0|||
148677476|NCT01220128|536291176|FG001|Overall Study|Progressive disease|0|||
148677477|NCT01220128|536291177|FG002|Overall Study|Progressive disease|2|||
148677478|NCT01220128|536291178|FG003|Overall Study|Progressive disease|0|||
148677479|NCT01220128|536291179|FG004|Overall Study|Progressive disease|0|||
148677480|NCT01220128|536291180|FG005|Overall Study|Progressive disease|0|||
148677481|NCT01220128|536291181|FG006|Overall Study|Progressive disease|0|||
148677482|NCT01220128|536291175|FG000|Overall Study|Sponsor study termination|0|||
148677483|NCT01220128|536291176|FG001|Overall Study|Sponsor study termination|1|||
148677484|NCT01220128|536291177|FG002|Overall Study|Sponsor study termination|0|||
148677485|NCT01220128|536291178|FG003|Overall Study|Sponsor study termination|0|||
148677486|NCT01220128|536291179|FG004|Overall Study|Sponsor study termination|0|||
148677487|NCT01220128|536291180|FG005|Overall Study|Sponsor study termination|0|||
148677488|NCT01220128|536291181|FG006|Overall Study|Sponsor study termination|1|||
148677489|NCT01220128|536291175|FG000|Overall Study|Adverse event, serious fatal|2|||
148677490|NCT01220128|536291176|FG001|Overall Study|Adverse event, serious fatal|0|||
148677491|NCT01220128|536291177|FG002|Overall Study|Adverse event, serious fatal|0|||
148677492|NCT01220128|536291178|FG003|Overall Study|Adverse event, serious fatal|0|||
148677493|NCT01220128|536291179|FG004|Overall Study|Adverse event, serious fatal|0|||
148677494|NCT01220128|536291180|FG005|Overall Study|Adverse event, serious fatal|0|||
148677495|NCT01220128|536291181|FG006|Overall Study|Adverse event, serious fatal|1|||
148677496|NCT01220128|536291175|FG000|Overall Study|Adverse event, non-fatal|1|||
148677497|NCT01220128|536291176|FG001|Overall Study|Adverse event, non-fatal|0|||
148677498|NCT01220128|536291177|FG002|Overall Study|Adverse event, non-fatal|0|||
148677499|NCT01220128|536291178|FG003|Overall Study|Adverse event, non-fatal|0|||
148677500|NCT01220128|536291179|FG004|Overall Study|Adverse event, non-fatal|0|||
148677501|NCT01220128|536291180|FG005|Overall Study|Adverse event, non-fatal|0|||
148677502|NCT01220128|536291181|FG006|Overall Study|Adverse event, non-fatal|3|||
148677503|NCT01220128|536291175|FG000|Overall Study|Other|0|||
148677504|NCT01220128|536291176|FG001|Overall Study|Other|0|||
148677505|NCT01220128|536291177|FG002|Overall Study|Other|1|||
148677506|NCT01220128|536291178|FG003|Overall Study|Other|0|||
148677507|NCT01220128|536291179|FG004|Overall Study|Other|0|||
148677508|NCT01220128|536291180|FG005|Overall Study|Other|0|||
148677509|NCT01220128|536291181|FG006|Overall Study|Other|0|||
148677510|NCT01220128|536291175|FG000|Overall Study|Consent withdrawn by subject|1|||
148677511|NCT01220128|536291176|FG001|Overall Study|Consent withdrawn by subject|0|||
148677512|NCT01220128|536291177|FG002|Overall Study|Consent withdrawn by subject|0|||
148677513|NCT01220128|536291178|FG003|Overall Study|Consent withdrawn by subject|0|||
148677514|NCT01220128|536291179|FG004|Overall Study|Consent withdrawn by subject|0|||
148677515|NCT01220128|536291180|FG005|Overall Study|Consent withdrawn by subject|0|||
148677516|NCT01220128|536291181|FG006|Overall Study|Consent withdrawn by subject|0|||
148677517|NCT02873195|536291184|FG000|Overall Study|Ineligible|5|||
148677518|NCT02873195|536291185|FG001|Overall Study|Ineligible|0|||
148677519|NCT02508649|536291186|FG000|Overall Study|Withdrawal by Subject|4|||
148677520|NCT02508649|536291187|FG001|Overall Study|Withdrawal by Subject|6|||
148677521|NCT02508649|536291188|FG002|Overall Study|Withdrawal by Subject|5|||
148677522|NCT02508649|536291189|FG003|Overall Study|Withdrawal by Subject|6|||
148677523|NCT02508649|536291186|FG000|Overall Study|Investigator withdrew the subject|1|||
148677524|NCT02508649|536291187|FG001|Overall Study|Investigator withdrew the subject|2|||
148677525|NCT02508649|536291188|FG002|Overall Study|Investigator withdrew the subject|1|||
148677526|NCT02508649|536291189|FG003|Overall Study|Investigator withdrew the subject|0|||
148677527|NCT02508649|536291186|FG000|Overall Study|Post randomization screening failure|12|||
148677528|NCT02508649|536291187|FG001|Overall Study|Post randomization screening failure|4|||
148677529|NCT02508649|536291188|FG002|Overall Study|Post randomization screening failure|9|||
148677530|NCT02508649|536291189|FG003|Overall Study|Post randomization screening failure|3|||
148677531|NCT02508649|536291186|FG000|Overall Study|Lost to Follow-up|1|||
148677532|NCT02508649|536291187|FG001|Overall Study|Lost to Follow-up|1|||
148677533|NCT02508649|536291188|FG002|Overall Study|Lost to Follow-up|0|||
148677534|NCT02508649|536291189|FG003|Overall Study|Lost to Follow-up|1|||
148677535|NCT02149199|536291193|FG000|Overall Study|Study specific withdrawal criteria|4|||
148677536|NCT02149199|536291194|FG001|Overall Study|Study specific withdrawal criteria|21|||
148677537|NCT02149199|536291195|FG002|Overall Study|Study specific withdrawal criteria|6|||
148677538|NCT02149199|536291193|FG000|Overall Study|Other|20|||
148677539|NCT02149199|536291194|FG001|Overall Study|Other|25|||
148677540|NCT02149199|536291195|FG002|Overall Study|Other|20|||
148677541|NCT02149199|536291193|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
148677542|NCT02149199|536291194|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
148677543|NCT02149199|536291195|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
148677544|NCT02149199|536291193|FG000|Overall Study|Withdrawal by Subject|75|||
148677545|NCT02149199|536291194|FG001|Overall Study|Withdrawal by Subject|93|||
148677546|NCT02149199|536291195|FG002|Overall Study|Withdrawal by Subject|77|||
148677547|NCT02149199|536291193|FG000|Overall Study|Protocol Violation|16|||
148677548|NCT02149199|536291194|FG001|Overall Study|Protocol Violation|13|||
148677549|NCT02149199|536291195|FG002|Overall Study|Protocol Violation|15|||
148677550|NCT02149199|536291193|FG000|Overall Study|Lost to Follow-up|3|||
148677551|NCT02149199|536291194|FG001|Overall Study|Lost to Follow-up|12|||
148677552|NCT02149199|536291195|FG002|Overall Study|Lost to Follow-up|11|||
148677553|NCT02149199|536291193|FG000|Overall Study|Death|0|||
148677554|NCT02149199|536291194|FG001|Overall Study|Death|0|||
148677555|NCT02149199|536291195|FG002|Overall Study|Death|1|||
149168334|NCT00481065|538089638|FG000|Overall Study|Withdrawal by Subject|11|||
149168335|NCT00481065|538089639|FG001|Overall Study|Withdrawal by Subject|12|||
149168336|NCT00481065|538089640|FG002|Overall Study|Withdrawal by Subject|7|||
149168337|NCT00481065|538089641|FG003|Overall Study|Withdrawal by Subject|11|||
149168338|NCT00481065|538089642|FG004|Overall Study|Withdrawal by Subject|13|||
149168339|NCT00481065|538089643|FG005|Overall Study|Withdrawal by Subject|12|||
148677556|NCT02149199|536291193|FG000|Overall Study|Adverse Event|6|||
148677557|NCT02149199|536291194|FG001|Overall Study|Adverse Event|15|||
149168340|NCT00481065|538089644|FG006|Overall Study|Withdrawal by Subject|9|||
149168341|NCT00481065|538089645|FG007|Overall Study|Withdrawal by Subject|10|||
149168342|NCT00481065|538089638|FG000|Overall Study|Lost to Follow-up|4|||
149168343|NCT00481065|538089639|FG001|Overall Study|Lost to Follow-up|2|||
149168344|NCT00481065|538089640|FG002|Overall Study|Lost to Follow-up|4|||
149168345|NCT00481065|538089641|FG003|Overall Study|Lost to Follow-up|3|||
149168346|NCT00481065|538089642|FG004|Overall Study|Lost to Follow-up|3|||
148677558|NCT02149199|536291195|FG002|Overall Study|Adverse Event|9|||
148677559|NCT00752895|536291199|FG000|Overall Study|Withdrawal by Subject|8|||
148677560|NCT00752895|536291200|FG001|Overall Study|Withdrawal by Subject|3|||
148677561|NCT00633217|536291201|FG000|Overall Study|Adverse Event|5|||
148677562|NCT00633217|536291202|FG001|Overall Study|Adverse Event|9|||
148677563|NCT00633217|536291201|FG000|Overall Study|Lack of Efficacy|0|||
148677564|NCT00633217|536291202|FG001|Overall Study|Lack of Efficacy|2|||
148677565|NCT00633217|536291201|FG000|Overall Study|Protocol Violation|3|||
148677566|NCT00633217|536291202|FG001|Overall Study|Protocol Violation|7|||
148677567|NCT00633217|536291201|FG000|Overall Study|Lost to Follow-up|2|||
148677568|NCT00633217|536291202|FG001|Overall Study|Lost to Follow-up|2|||
148677569|NCT00633217|536291201|FG000|Overall Study|Investigator Discretion|2|||
148677570|NCT00633217|536291202|FG001|Overall Study|Investigator Discretion|0|||
148677571|NCT00633217|536291201|FG000|Overall Study|Withdrew Consent|3|||
148677572|NCT00633217|536291202|FG001|Overall Study|Withdrew Consent|3|||
148677573|NCT00314262|536291203|FG000|Overall Study|Adverse Event|2|||
148677574|NCT00314262|536291203|FG000|Overall Study|Withdrawal by Subject|2|||
149168347|NCT00481065|538089643|FG005|Overall Study|Lost to Follow-up|3|||
149168348|NCT00481065|538089644|FG006|Overall Study|Lost to Follow-up|2|||
149168349|NCT00481065|538089645|FG007|Overall Study|Lost to Follow-up|5|||
149168350|NCT00481065|538089638|FG000|Overall Study|Inappropriate enrollment|4|||
149168351|NCT00481065|538089639|FG001|Overall Study|Inappropriate enrollment|0|||
149168352|NCT00481065|538089640|FG002|Overall Study|Inappropriate enrollment|2|||
149168353|NCT00481065|538089641|FG003|Overall Study|Inappropriate enrollment|0|||
148677575|NCT00314262|536291203|FG000|Overall Study|Physician Decision|1|||
148677576|NCT04881448|536291204|FG000|Overall Study|Study cancelled by sponsor|220|||
148677577|NCT04881448|536291204|FG000|Overall Study|Withdrawal by Subject|2|||
148677578|NCT04881448|536291204|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
148677579|NCT01966107|536291205|FG000|Overall Study|excluded from FAS|21|||
148677580|NCT01966107|536291206|FG001|Overall Study|excluded from FAS|20|||
148677581|NCT01966107|536291205|FG000|Overall Study|discontinued treatment|345|||
148677582|NCT01966107|536291206|FG001|Overall Study|discontinued treatment|372|||
148677583|NCT01966107|536291205|FG000|Overall Study|due to study closure|164|||
148677584|NCT01966107|536291206|FG001|Overall Study|due to study closure|186|||
148677585|NCT01966107|536291205|FG000|Overall Study|withdrew from the study|272|||
148677586|NCT01966107|536291206|FG001|Overall Study|withdrew from the study|303|||
148677587|NCT00532779|536291207|FG000|Overall Study|Adverse Event|122|||
148677588|NCT00532779|536291208|FG001|Overall Study|Adverse Event|112|||
149168354|NCT00481065|538089642|FG004|Overall Study|Inappropriate enrollment|2|||
148677589|NCT00532779|536291209|FG002|Overall Study|Adverse Event|56|||
148677590|NCT00532779|536291207|FG000|Overall Study|Lost to Follow-up|76|||
148677591|NCT00532779|536291208|FG001|Overall Study|Lost to Follow-up|65|||
148677592|NCT00532779|536291209|FG002|Overall Study|Lost to Follow-up|66|||
148677593|NCT00532779|536291207|FG000|Overall Study|Withdrawal by Subject|63|||
148677594|NCT00532779|536291208|FG001|Overall Study|Withdrawal by Subject|60|||
148806274|NCT00393367|536768934|FG001|Overall Study|Withdrawal by Subject|2|||
149168355|NCT00481065|538089643|FG005|Overall Study|Inappropriate enrollment|1|||
149168356|NCT00481065|538089644|FG006|Overall Study|Inappropriate enrollment|0|||
149168357|NCT00481065|538089645|FG007|Overall Study|Inappropriate enrollment|1|||
149168358|NCT00481065|538089638|FG000|Overall Study|Administrative reason|0|||
148677595|NCT00532779|536291209|FG002|Overall Study|Withdrawal by Subject|90|||
148677596|NCT00532779|536291207|FG000|Overall Study|Lack of Efficacy|12|||
148677597|NCT00532779|536291208|FG001|Overall Study|Lack of Efficacy|12|||
148677598|NCT00532779|536291209|FG002|Overall Study|Lack of Efficacy|40|||
148677599|NCT00532779|536291207|FG000|Overall Study|Protocol Violation|5|||
148677600|NCT00532779|536291208|FG001|Overall Study|Protocol Violation|9|||
148677601|NCT00532779|536291209|FG002|Overall Study|Protocol Violation|7|||
148677602|NCT00532779|536291207|FG000|Overall Study|Pregnancy|2|||
148677603|NCT00532779|536291208|FG001|Overall Study|Pregnancy|5|||
149168359|NCT00481065|538089639|FG001|Overall Study|Administrative reason|0|||
149168360|NCT00481065|538089640|FG002|Overall Study|Administrative reason|0|||
149168361|NCT00481065|538089641|FG003|Overall Study|Administrative reason|0|||
149168362|NCT00481065|538089642|FG004|Overall Study|Administrative reason|0|||
149168363|NCT00481065|538089643|FG005|Overall Study|Administrative reason|2|||
149168364|NCT00481065|538089644|FG006|Overall Study|Administrative reason|1|||
149168365|NCT00481065|538089645|FG007|Overall Study|Administrative reason|0|||
149168366|NCT00481065|538089638|FG000|Overall Study|Protocol Violation|2|||
149168367|NCT00481065|538089639|FG001|Overall Study|Protocol Violation|1|||
149168368|NCT00481065|538089640|FG002|Overall Study|Protocol Violation|1|||
149168369|NCT00481065|538089641|FG003|Overall Study|Protocol Violation|1|||
149168370|NCT00481065|538089642|FG004|Overall Study|Protocol Violation|2|||
149168371|NCT00481065|538089643|FG005|Overall Study|Protocol Violation|6|||
149168372|NCT00481065|538089644|FG006|Overall Study|Protocol Violation|3|||
149168373|NCT00481065|538089645|FG007|Overall Study|Protocol Violation|2|||
149168374|NCT00481065|538089638|FG000|Overall Study|Unable to classify|0|||
149168375|NCT00481065|538089639|FG001|Overall Study|Unable to classify|1|||
149168376|NCT00481065|538089640|FG002|Overall Study|Unable to classify|2|||
149168377|NCT00481065|538089641|FG003|Overall Study|Unable to classify|0|||
149168378|NCT00481065|538089642|FG004|Overall Study|Unable to classify|1|||
149168379|NCT00481065|538089643|FG005|Overall Study|Unable to classify|0|||
149168380|NCT00481065|538089644|FG006|Overall Study|Unable to classify|0|||
149168381|NCT00481065|538089645|FG007|Overall Study|Unable to classify|0|||
149168382|NCT00772447|538089646|FG000|Overall Study|Withdrawal by Subject|9|||
149168383|NCT00772447|538089647|FG001|Overall Study|Withdrawal by Subject|5|||
149168384|NCT00772447|538089646|FG000|Overall Study|Physician Decision|4|||
149168385|NCT00772447|538089647|FG001|Overall Study|Physician Decision|8|||
149168386|NCT00772447|538089646|FG000|Overall Study|Lost to Follow-up|2|||
149168387|NCT00772447|538089647|FG001|Overall Study|Lost to Follow-up|4|||
149168388|NCT00772447|538089646|FG000|Overall Study|incorrect enrolment|3|||
149168389|NCT00772447|538089647|FG001|Overall Study|incorrect enrolment|4|||
149168390|NCT00772447|538089646|FG000|Overall Study|Protocol Violation|0|||
149168391|NCT00772447|538089647|FG001|Overall Study|Protocol Violation|1|||
149168392|NCT00772447|538089646|FG000|Overall Study|all others|2|||
149168393|NCT00772447|538089647|FG001|Overall Study|all others|2|||
149168394|NCT03529409|538089650|FG000|Randomized|Lost to Follow-up|0|||
149168395|NCT03529409|538089651|FG001|Randomized|Lost to Follow-up|0|||
149168396|NCT03529409|538089652|FG002|Randomized|Lost to Follow-up|4|||
149168397|NCT03529409|538089650|FG000|Randomized|Excluded|0|||
149168398|NCT03529409|538089651|FG001|Randomized|Excluded|0|||
149168399|NCT03529409|538089652|FG002|Randomized|Excluded|1|||
149168400|NCT03529409|538089650|FG000|Post-treatment Assessment|Death|1|||
149168401|NCT03529409|538089651|FG001|Post-treatment Assessment|Death|0|||
149168402|NCT03529409|538089652|FG002|Post-treatment Assessment|Death|0|||
149168403|NCT03529409|538089650|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
149168404|NCT03529409|538089651|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
149168405|NCT03529409|538089652|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
149168406|NCT03529409|538089650|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
149168407|NCT03529409|538089651|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
149168408|NCT03529409|538089652|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
149168409|NCT03529409|538089650|FG000|Follow-up Assessment|Death|1|||
149168410|NCT03529409|538089651|FG001|Follow-up Assessment|Death|0|||
149168411|NCT03529409|538089652|FG002|Follow-up Assessment|Death|0|||
149168412|NCT03529409|538089650|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
149168413|NCT03529409|538089651|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
149168414|NCT03529409|538089652|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
149168415|NCT01497262|538089653|FG000|Overall Study|Abnormal Lab Values|4|||
149168416|NCT01497262|538089653|FG000|Overall Study|Abnormal Test Procedure Result|1|||
149168417|NCT01497262|538089653|FG000|Overall Study|Physician Decision|1|||
149168418|NCT01497262|538089653|FG000|Overall Study|Withdrawal by Subject|2|||
149168419|NCT01497262|538089653|FG000|Overall Study|Adverse Event|2|||
149168420|NCT01497262|538089653|FG000|Overall Study|Protocol Violation|1|||
149168421|NCT00454207|538089654|FG000|Overall Study|Adverse Event|3|||
149168422|NCT00454207|538089655|FG001|Overall Study|Adverse Event|1|||
149168423|NCT00454207|538089654|FG000|Overall Study|Lack of Efficacy|1|||
149168424|NCT00454207|538089655|FG001|Overall Study|Lack of Efficacy|0|||
149168425|NCT00454207|538089654|FG000|Overall Study|Protocol Violation|0|||
149168426|NCT00454207|538089655|FG001|Overall Study|Protocol Violation|1|||
149168427|NCT01795547|538089656|FG000|Overall Study|Adverse Event|16|||
149168428|NCT01795547|538089657|FG001|Overall Study|Adverse Event|27|||
149168429|NCT01795547|538089656|FG000|Overall Study|Lack of Efficacy|8|||
149168430|NCT01795547|538089657|FG001|Overall Study|Lack of Efficacy|3|||
149168431|NCT01795547|538089656|FG000|Overall Study|Protocol Violation|6|||
149168432|NCT01795547|538089657|FG001|Overall Study|Protocol Violation|4|||
149168433|NCT01795547|538089656|FG000|Overall Study|Lost to Follow-up|2|||
149168434|NCT01795547|538089657|FG001|Overall Study|Lost to Follow-up|5|||
149168435|NCT01795547|538089656|FG000|Overall Study|Withdrawal of consent|7|||
149168436|NCT01795547|538089657|FG001|Overall Study|Withdrawal of consent|12|||
148677604|NCT00532779|536291209|FG002|Overall Study|Pregnancy|3|||
148677605|NCT00532779|536291207|FG000|Overall Study|Death|0|||
148677606|NCT00532779|536291208|FG001|Overall Study|Death|1|||
148677607|NCT00532779|536291209|FG002|Overall Study|Death|0|||
148677608|NCT00532779|536291207|FG000|Overall Study|Drug noncompliance, moved, other|14|||
148677609|NCT00532779|536291208|FG001|Overall Study|Drug noncompliance, moved, other|23|||
148677610|NCT00532779|536291209|FG002|Overall Study|Drug noncompliance, moved, other|29|||
148677611|NCT02662556|536291210|FG000|Overall Study|Adverse Event|4|||
148677612|NCT02662556|536291210|FG000|Overall Study|Lack of Efficacy|4|||
148677613|NCT00828516|536291221|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
148677614|NCT00689273|536291222|FG000|Overall Study|Adverse Event|3|||
148677615|NCT00689273|536291223|FG001|Overall Study|Adverse Event|1|||
148677616|NCT00689273|536291222|FG000|Overall Study|Lack of Efficacy|3|||
148677617|NCT00689273|536291223|FG001|Overall Study|Lack of Efficacy|0|||
148677618|NCT00689273|536291222|FG000|Overall Study|Lost to Follow-up|0|||
148677619|NCT00689273|536291223|FG001|Overall Study|Lost to Follow-up|2|||
149168437|NCT01795547|538089656|FG000|Overall Study|Not Treated|4|||
149168438|NCT01795547|538089657|FG001|Overall Study|Not Treated|10|||
149168439|NCT01795547|538089656|FG000|Overall Study|Non-compliance with IMP|1|||
149168440|NCT01795547|538089657|FG001|Overall Study|Non-compliance with IMP|1|||
149168441|NCT01795547|538089656|FG000|Overall Study|Others|4|||
149168442|NCT01795547|538089657|FG001|Overall Study|Others|1|||
149168443|NCT01795547|538089656|FG000|Overall Study|Not stated|0|||
149168444|NCT01795547|538089657|FG001|Overall Study|Not stated|1|||
149168445|NCT00151892|538089658|FG000|Overall Study|Lack of Efficacy|50|||
149168446|NCT00151892|538089659|FG001|Overall Study|Lack of Efficacy|57|||
149168447|NCT00151892|538089658|FG000|Overall Study|Patient request|10|||
149168448|NCT00151892|538089659|FG001|Overall Study|Patient request|7|||
149168449|NCT00151892|538089658|FG000|Overall Study|Lost to Follow-up|5|||
149168450|NCT00151892|538089659|FG001|Overall Study|Lost to Follow-up|10|||
149168451|NCT00151892|538089658|FG000|Overall Study|Adverse Event|6|||
149168452|NCT00151892|538089659|FG001|Overall Study|Adverse Event|3|||
149168453|NCT00151892|538089658|FG000|Overall Study|Protocol Violation|3|||
149168454|NCT00151892|538089659|FG001|Overall Study|Protocol Violation|3|||
149168455|NCT00151892|538089658|FG000|Overall Study|Non-compliance|0|||
149168456|NCT00151892|538089659|FG001|Overall Study|Non-compliance|1|||
149168457|NCT00151892|538089658|FG000|Overall Study|Pregnancy|0|||
149168458|NCT00151892|538089659|FG001|Overall Study|Pregnancy|1|||
149168459|NCT00151892|538089658|FG000|Overall Study|Did not return for a visit|1|||
149168460|NCT00151892|538089659|FG001|Overall Study|Did not return for a visit|0|||
149168461|NCT00151892|538089658|FG000|Overall Study|Used prohibited corticosteroids|1|||
149168462|NCT00151892|538089659|FG001|Overall Study|Used prohibited corticosteroids|0|||
149168463|NCT00151892|538089658|FG000|Overall Study|Lack of study medication at center|0|||
149168464|NCT00151892|538089659|FG001|Overall Study|Lack of study medication at center|1|||
149168465|NCT01551745|538089662|FG000|Overall Study|Withdrawal by Subject|1|||
149168466|NCT01551745|538089662|FG000|Overall Study|Disease Progression|2|||
149168467|NCT02764541|538089663|FG000|Overall Study|Withdrawal by Subject|0|||
149168468|NCT02764541|538089664|FG001|Overall Study|Withdrawal by Subject|0|||
148677620|NCT00689273|536291222|FG000|Overall Study|Other|6|||
148677621|NCT00689273|536291223|FG001|Overall Study|Other|2|||
148677622|NCT00689273|536291222|FG000|Overall Study|Randomized but not Treated|1|||
148677623|NCT00689273|536291223|FG001|Overall Study|Randomized but not Treated|0|||
148677624|NCT00700310|536293516|FG000|Overall Study|Adverse Event|6|||
149168469|NCT02764541|538089665|FG002|Overall Study|Withdrawal by Subject|0|||
149168470|NCT02764541|538089666|FG003|Overall Study|Withdrawal by Subject|0|||
149168471|NCT02764541|538089667|FG004|Overall Study|Withdrawal by Subject|1|||
149168472|NCT02764541|538089668|FG005|Overall Study|Withdrawal by Subject|1|||
149168473|NCT02764541|538089669|FG006|Overall Study|Withdrawal by Subject|0|||
149168474|NCT02764541|538089670|FG007|Overall Study|Withdrawal by Subject|1|||
149168475|NCT02764541|538089663|FG000|Overall Study|Adverse Event|1|||
149168476|NCT02764541|538089664|FG001|Overall Study|Adverse Event|0|||
149168477|NCT02764541|538089665|FG002|Overall Study|Adverse Event|0|||
149168478|NCT02764541|538089666|FG003|Overall Study|Adverse Event|0|||
149168479|NCT02764541|538089667|FG004|Overall Study|Adverse Event|0|||
149168480|NCT02764541|538089668|FG005|Overall Study|Adverse Event|0|||
149168481|NCT02764541|538089669|FG006|Overall Study|Adverse Event|1|||
149168482|NCT02764541|538089670|FG007|Overall Study|Adverse Event|0|||
149168483|NCT02764541|538089663|FG000|Overall Study|Metastasis|1|||
149168484|NCT02764541|538089664|FG001|Overall Study|Metastasis|0|||
149168485|NCT02764541|538089665|FG002|Overall Study|Metastasis|0|||
149168486|NCT02764541|538089666|FG003|Overall Study|Metastasis|0|||
149168487|NCT02764541|538089667|FG004|Overall Study|Metastasis|0|||
149168488|NCT02764541|538089668|FG005|Overall Study|Metastasis|0|||
148677625|NCT00700310|536293517|FG001|Overall Study|Adverse Event|10|||
148677626|NCT00700310|536293518|FG002|Overall Study|Adverse Event|5|||
148677627|NCT00700310|536293519|FG003|Overall Study|Adverse Event|11|||
149168489|NCT02764541|538089669|FG006|Overall Study|Metastasis|0|||
149168490|NCT02764541|538089670|FG007|Overall Study|Metastasis|0|||
148677628|NCT00700310|536293516|FG000|Overall Study|Lost to Follow-up|4|||
148677629|NCT00700310|536293517|FG001|Overall Study|Lost to Follow-up|1|||
149168491|NCT02764541|538089663|FG000|Overall Study|Disease progression|1|||
149168492|NCT02764541|538089664|FG001|Overall Study|Disease progression|1|||
149168493|NCT02764541|538089665|FG002|Overall Study|Disease progression|0|||
149168494|NCT02764541|538089666|FG003|Overall Study|Disease progression|0|||
149168495|NCT02764541|538089667|FG004|Overall Study|Disease progression|0|||
149168496|NCT02764541|538089668|FG005|Overall Study|Disease progression|0|||
149168497|NCT02764541|538089669|FG006|Overall Study|Disease progression|0|||
149168498|NCT02764541|538089670|FG007|Overall Study|Disease progression|1|||
149168499|NCT02764541|538089663|FG000|Overall Study|Protocol Violation|0|||
149168500|NCT02764541|538089664|FG001|Overall Study|Protocol Violation|0|||
149168501|NCT02764541|538089665|FG002|Overall Study|Protocol Violation|0|||
149168502|NCT02764541|538089666|FG003|Overall Study|Protocol Violation|1|||
149168503|NCT02764541|538089667|FG004|Overall Study|Protocol Violation|0|||
149168504|NCT02764541|538089668|FG005|Overall Study|Protocol Violation|1|||
149168505|NCT02764541|538089669|FG006|Overall Study|Protocol Violation|0|||
149168506|NCT02764541|538089670|FG007|Overall Study|Protocol Violation|0|||
149168507|NCT02764541|538089663|FG000|Overall Study|Physician Decision|0|||
149168508|NCT02764541|538089664|FG001|Overall Study|Physician Decision|0|||
149168509|NCT02764541|538089665|FG002|Overall Study|Physician Decision|0|||
149168510|NCT02764541|538089666|FG003|Overall Study|Physician Decision|1|||
149168511|NCT02764541|538089667|FG004|Overall Study|Physician Decision|0|||
149168512|NCT02764541|538089668|FG005|Overall Study|Physician Decision|0|||
149168513|NCT02764541|538089669|FG006|Overall Study|Physician Decision|0|||
149168514|NCT02764541|538089670|FG007|Overall Study|Physician Decision|1|||
149168515|NCT02764541|538089663|FG000|Overall Study|Three Cycles completed before surgery|0|||
149168516|NCT02764541|538089664|FG001|Overall Study|Three Cycles completed before surgery|0|||
149168517|NCT02764541|538089665|FG002|Overall Study|Three Cycles completed before surgery|0|||
149168518|NCT02764541|538089666|FG003|Overall Study|Three Cycles completed before surgery|1|||
149168519|NCT02764541|538089667|FG004|Overall Study|Three Cycles completed before surgery|0|||
149168520|NCT02764541|538089668|FG005|Overall Study|Three Cycles completed before surgery|0|||
149168521|NCT02764541|538089669|FG006|Overall Study|Three Cycles completed before surgery|0|||
149168522|NCT02764541|538089670|FG007|Overall Study|Three Cycles completed before surgery|0|||
149168523|NCT02764541|538089663|FG000|Overall Study|Patient Compliance|0|||
149168524|NCT02764541|538089664|FG001|Overall Study|Patient Compliance|0|||
149168525|NCT02764541|538089665|FG002|Overall Study|Patient Compliance|1|||
149168526|NCT02764541|538089666|FG003|Overall Study|Patient Compliance|0|||
149168527|NCT02764541|538089667|FG004|Overall Study|Patient Compliance|0|||
149168528|NCT02764541|538089668|FG005|Overall Study|Patient Compliance|0|||
149168529|NCT02764541|538089669|FG006|Overall Study|Patient Compliance|0|||
149168530|NCT02764541|538089670|FG007|Overall Study|Patient Compliance|0|||
149168531|NCT02764541|538089663|FG000|Overall Study|Death|0|||
149168532|NCT02764541|538089664|FG001|Overall Study|Death|0|||
149168533|NCT02764541|538089665|FG002|Overall Study|Death|0|||
149168534|NCT02764541|538089666|FG003|Overall Study|Death|0|||
149168535|NCT02764541|538089667|FG004|Overall Study|Death|0|||
149168536|NCT02764541|538089668|FG005|Overall Study|Death|0|||
149168537|NCT02764541|538089669|FG006|Overall Study|Death|1|||
149168538|NCT02764541|538089670|FG007|Overall Study|Death|0|||
149168539|NCT02764541|538089663|FG000|Overall Study|Insurance reasons|0|||
149168540|NCT02764541|538089664|FG001|Overall Study|Insurance reasons|0|||
149168541|NCT02764541|538089665|FG002|Overall Study|Insurance reasons|0|||
149168542|NCT02764541|538089666|FG003|Overall Study|Insurance reasons|0|||
149168543|NCT02764541|538089667|FG004|Overall Study|Insurance reasons|0|||
149168544|NCT02764541|538089668|FG005|Overall Study|Insurance reasons|0|||
149168545|NCT02764541|538089669|FG006|Overall Study|Insurance reasons|1|||
149168546|NCT02764541|538089670|FG007|Overall Study|Insurance reasons|0|||
149168547|NCT00749190|538089673|FG000|Overall Study|Adverse Event|0|||
148677630|NCT00700310|536293518|FG002|Overall Study|Lost to Follow-up|0|||
148677631|NCT00700310|536293519|FG003|Overall Study|Lost to Follow-up|1|||
148677632|NCT00700310|536293516|FG000|Overall Study|Withdrawal by Subject|8|||
148677633|NCT00700310|536293517|FG001|Overall Study|Withdrawal by Subject|9|||
149168548|NCT00749190|538089674|FG001|Overall Study|Adverse Event|2|||
149168549|NCT00749190|538089675|FG002|Overall Study|Adverse Event|0|||
149168550|NCT00749190|538089676|FG003|Overall Study|Adverse Event|4|||
149168551|NCT00749190|538089677|FG004|Overall Study|Adverse Event|0|||
149168552|NCT00749190|538089678|FG005|Overall Study|Adverse Event|3|||
149168553|NCT00749190|538089679|FG006|Overall Study|Adverse Event|0|||
149168554|NCT00749190|538089673|FG000|Overall Study|Lack of Efficacy|3|||
149168555|NCT00749190|538089674|FG001|Overall Study|Lack of Efficacy|1|||
149168556|NCT00749190|538089675|FG002|Overall Study|Lack of Efficacy|1|||
149168557|NCT00749190|538089676|FG003|Overall Study|Lack of Efficacy|0|||
149168558|NCT00749190|538089677|FG004|Overall Study|Lack of Efficacy|0|||
149168559|NCT00749190|538089678|FG005|Overall Study|Lack of Efficacy|1|||
148677634|NCT00700310|536293518|FG002|Overall Study|Withdrawal by Subject|8|||
149168560|NCT00749190|538089679|FG006|Overall Study|Lack of Efficacy|0|||
149168561|NCT00749190|538089673|FG000|Overall Study|Withdrawal by Subject|2|||
149168562|NCT00749190|538089674|FG001|Overall Study|Withdrawal by Subject|1|||
149168563|NCT00749190|538089675|FG002|Overall Study|Withdrawal by Subject|0|||
149168564|NCT00749190|538089676|FG003|Overall Study|Withdrawal by Subject|0|||
149168565|NCT00749190|538089677|FG004|Overall Study|Withdrawal by Subject|0|||
149168566|NCT00749190|538089678|FG005|Overall Study|Withdrawal by Subject|1|||
149168567|NCT00749190|538089679|FG006|Overall Study|Withdrawal by Subject|0|||
149168568|NCT00749190|538089673|FG000|Overall Study|Protocol Violation|0|||
149168569|NCT00749190|538089674|FG001|Overall Study|Protocol Violation|1|||
149168570|NCT00749190|538089675|FG002|Overall Study|Protocol Violation|0|||
149168571|NCT00749190|538089676|FG003|Overall Study|Protocol Violation|0|||
149168572|NCT00749190|538089677|FG004|Overall Study|Protocol Violation|0|||
149168573|NCT00749190|538089678|FG005|Overall Study|Protocol Violation|0|||
149168574|NCT00749190|538089679|FG006|Overall Study|Protocol Violation|1|||
149168575|NCT00749190|538089673|FG000|Overall Study|Other reason not defined above|0|||
149168576|NCT00749190|538089674|FG001|Overall Study|Other reason not defined above|0|||
149168577|NCT00749190|538089675|FG002|Overall Study|Other reason not defined above|0|||
149168578|NCT00749190|538089676|FG003|Overall Study|Other reason not defined above|1|||
149168579|NCT00749190|538089677|FG004|Overall Study|Other reason not defined above|0|||
149168580|NCT00749190|538089678|FG005|Overall Study|Other reason not defined above|0|||
149168581|NCT00749190|538089679|FG006|Overall Study|Other reason not defined above|0|||
149168582|NCT00784758|538089680|FG000|Overall Study|Withdrawal by Subject|3|||
149168583|NCT00784758|538089681|FG001|Overall Study|Withdrawal by Subject|0|||
149168584|NCT00784758|538089680|FG000|Overall Study|Adverse Event|1|||
149168585|NCT00784758|538089681|FG001|Overall Study|Adverse Event|0|||
149168586|NCT04439331|538089688|FG000|Overall Study|Never Start Protocol Therapy|2|||
149168587|NCT04439331|538089688|FG000|Overall Study|Ineligible|2|||
149168588|NCT04439331|538089688|FG000|Overall Study|Mutation Status Not Confirmed|1|||
149168589|NCT04439331|538089688|FG000|Overall Study|Adverse Event|1|||
149168590|NCT04439331|538089688|FG000|Overall Study|Death|1|||
149168591|NCT04439331|538089688|FG000|Overall Study|Disease Progression|20|||
149168592|NCT04439331|538089688|FG000|Overall Study|Withdrawal by Subject|6|||
149168593|NCT04439331|538089688|FG000|Overall Study|Physician Decision|1|||
149168594|NCT04439331|538089688|FG000|Overall Study|Other Complicating Disease|1|||
149168595|NCT03726268|538089690|FG000|Overall Study|Physician Decision|2|||
149168596|NCT03726268|538089691|FG001|Overall Study|Physician Decision|8|||
149168597|NCT03726268|538089692|FG002|Overall Study|Physician Decision|6|||
149168598|NCT03726268|538089693|FG003|Overall Study|Physician Decision|3|||
149168599|NCT03726268|538089690|FG000|Overall Study|Withdrawal by Subject|11|||
149168600|NCT03726268|538089691|FG001|Overall Study|Withdrawal by Subject|5|||
149168601|NCT03726268|538089692|FG002|Overall Study|Withdrawal by Subject|9|||
149168602|NCT03726268|538089693|FG003|Overall Study|Withdrawal by Subject|8|||
149168603|NCT04696861|538089694|FG000|Overall Study|Death|1|||
149168604|NCT04696861|538089695|FG001|Overall Study|Death|0|||
149168605|NCT04696861|538089694|FG000|Overall Study|Lost to Follow-up|3|||
149168606|NCT04696861|538089695|FG001|Overall Study|Lost to Follow-up|0|||
149168607|NCT03952559|538089696|FG000|Double Blind Treatment Period|Adverse Event|0|||
149168608|NCT03952559|538089697|FG001|Double Blind Treatment Period|Adverse Event|2|||
149168609|NCT03952559|538089698|FG002|Double Blind Treatment Period|Adverse Event|1|||
149168610|NCT03952559|538089699|FG003|Double Blind Treatment Period|Adverse Event|0|||
149168611|NCT03952559|538089700|FG004|Double Blind Treatment Period|Adverse Event|1|||
149168612|NCT03952559|538089696|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
149168613|NCT03952559|538089697|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
149168614|NCT03952559|538089698|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
149168615|NCT03952559|538089699|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
149168616|NCT03952559|538089700|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
149168617|NCT03952559|538089696|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
149168618|NCT03952559|538089697|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
149168619|NCT03952559|538089698|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
149168620|NCT03952559|538089699|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
149168621|NCT03952559|538089700|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
149168622|NCT03952559|538089696|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
149168623|NCT03952559|538089697|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
149168624|NCT03952559|538089698|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
149168625|NCT03952559|538089699|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
149168626|NCT03952559|538089700|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
149168627|NCT01827384|538089701|FG000|Overall Study|Switched to alternative treatment|0|||
149168628|NCT01827384|538089702|FG001|Overall Study|Switched to alternative treatment|0|||
149168629|NCT01827384|538089703|FG002|Overall Study|Switched to alternative treatment|0|||
149168630|NCT01827384|538089704|FG003|Overall Study|Switched to alternative treatment|0|||
149168631|NCT01827384|538089705|FG004|Overall Study|Switched to alternative treatment|0|||
149168632|NCT01827384|538089706|FG005|Overall Study|Switched to alternative treatment|0|||
149168633|NCT01827384|538089707|FG006|Overall Study|Switched to alternative treatment|0|||
149168634|NCT01827384|538089708|FG007|Overall Study|Switched to alternative treatment|0|||
149168635|NCT01827384|538089709|FG008|Overall Study|Switched to alternative treatment|0|||
149168636|NCT01827384|538089710|FG009|Overall Study|Switched to alternative treatment|0|||
149168637|NCT01827384|538089711|FG010|Overall Study|Switched to alternative treatment|0|||
149168638|NCT01827384|538089712|FG011|Overall Study|Switched to alternative treatment|0|||
149168639|NCT01827384|538089713|FG012|Overall Study|Switched to alternative treatment|0|||
149168640|NCT01827384|538089714|FG013|Overall Study|Switched to alternative treatment|2|||
149168641|NCT01827384|538089701|FG000|Overall Study|Disease progression before treatment|0|||
149168642|NCT01827384|538089702|FG001|Overall Study|Disease progression before treatment|0|||
149168643|NCT01827384|538089703|FG002|Overall Study|Disease progression before treatment|0|||
149168644|NCT01827384|538089704|FG003|Overall Study|Disease progression before treatment|0|||
149168645|NCT01827384|538089705|FG004|Overall Study|Disease progression before treatment|0|||
149168646|NCT01827384|538089706|FG005|Overall Study|Disease progression before treatment|0|||
149168647|NCT01827384|538089707|FG006|Overall Study|Disease progression before treatment|0|||
149168648|NCT01827384|538089708|FG007|Overall Study|Disease progression before treatment|0|||
149168649|NCT01827384|538089709|FG008|Overall Study|Disease progression before treatment|0|||
149168650|NCT01827384|538089710|FG009|Overall Study|Disease progression before treatment|0|||
149168651|NCT01827384|538089711|FG010|Overall Study|Disease progression before treatment|0|||
149168652|NCT01827384|538089712|FG011|Overall Study|Disease progression before treatment|0|||
149168653|NCT01827384|538089713|FG012|Overall Study|Disease progression before treatment|0|||
149168654|NCT01827384|538089714|FG013|Overall Study|Disease progression before treatment|4|||
149168655|NCT01827384|538089701|FG000|Overall Study|Ineligible|0|||
149168656|NCT01827384|538089702|FG001|Overall Study|Ineligible|0|||
149168657|NCT01827384|538089703|FG002|Overall Study|Ineligible|0|||
149168658|NCT01827384|538089704|FG003|Overall Study|Ineligible|0|||
149168659|NCT01827384|538089705|FG004|Overall Study|Ineligible|0|||
149168660|NCT01827384|538089706|FG005|Overall Study|Ineligible|0|||
149168661|NCT01827384|538089707|FG006|Overall Study|Ineligible|0|||
149168662|NCT01827384|538089708|FG007|Overall Study|Ineligible|0|||
149168663|NCT01827384|538089709|FG008|Overall Study|Ineligible|0|||
149168664|NCT01827384|538089710|FG009|Overall Study|Ineligible|0|||
149168665|NCT01827384|538089711|FG010|Overall Study|Ineligible|0|||
149168666|NCT01827384|538089712|FG011|Overall Study|Ineligible|0|||
149168667|NCT01827384|538089713|FG012|Overall Study|Ineligible|0|||
149168668|NCT01827384|538089714|FG013|Overall Study|Ineligible|19|||
149168669|NCT01827384|538089701|FG000|Overall Study|Participant died before treatment|0|||
149168670|NCT01827384|538089702|FG001|Overall Study|Participant died before treatment|0|||
149168671|NCT01827384|538089703|FG002|Overall Study|Participant died before treatment|0|||
149168672|NCT01827384|538089704|FG003|Overall Study|Participant died before treatment|0|||
149168673|NCT01827384|538089705|FG004|Overall Study|Participant died before treatment|0|||
149168674|NCT01827384|538089706|FG005|Overall Study|Participant died before treatment|0|||
149168675|NCT01827384|538089707|FG006|Overall Study|Participant died before treatment|0|||
149168676|NCT01827384|538089708|FG007|Overall Study|Participant died before treatment|0|||
149168677|NCT01827384|538089709|FG008|Overall Study|Participant died before treatment|0|||
149168678|NCT01827384|538089710|FG009|Overall Study|Participant died before treatment|0|||
149168679|NCT01827384|538089711|FG010|Overall Study|Participant died before treatment|0|||
149168680|NCT01827384|538089712|FG011|Overall Study|Participant died before treatment|0|||
149168681|NCT01827384|538089713|FG012|Overall Study|Participant died before treatment|0|||
149168682|NCT01827384|538089714|FG013|Overall Study|Participant died before treatment|5|||
149168683|NCT01827384|538089701|FG000|Overall Study|Insufficient tumor cells|0|||
149168684|NCT01827384|538089702|FG001|Overall Study|Insufficient tumor cells|0|||
149168685|NCT01827384|538089703|FG002|Overall Study|Insufficient tumor cells|0|||
149168686|NCT01827384|538089704|FG003|Overall Study|Insufficient tumor cells|0|||
149168687|NCT01827384|538089705|FG004|Overall Study|Insufficient tumor cells|0|||
149168688|NCT01827384|538089706|FG005|Overall Study|Insufficient tumor cells|0|||
149168689|NCT01827384|538089707|FG006|Overall Study|Insufficient tumor cells|0|||
149168690|NCT01827384|538089708|FG007|Overall Study|Insufficient tumor cells|0|||
149168691|NCT01827384|538089709|FG008|Overall Study|Insufficient tumor cells|0|||
149168692|NCT01827384|538089710|FG009|Overall Study|Insufficient tumor cells|0|||
149168693|NCT01827384|538089711|FG010|Overall Study|Insufficient tumor cells|0|||
149168694|NCT01827384|538089712|FG011|Overall Study|Insufficient tumor cells|0|||
149168695|NCT01827384|538089713|FG012|Overall Study|Insufficient tumor cells|0|||
149168696|NCT01827384|538089714|FG013|Overall Study|Insufficient tumor cells|13|||
149168697|NCT01827384|538089701|FG000|Overall Study|No actionable mutation|0|||
149168698|NCT01827384|538089702|FG001|Overall Study|No actionable mutation|0|||
149168699|NCT01827384|538089703|FG002|Overall Study|No actionable mutation|0|||
149168700|NCT01827384|538089704|FG003|Overall Study|No actionable mutation|0|||
149168701|NCT01827384|538089705|FG004|Overall Study|No actionable mutation|0|||
149168702|NCT01827384|538089706|FG005|Overall Study|No actionable mutation|0|||
149168703|NCT01827384|538089707|FG006|Overall Study|No actionable mutation|0|||
149168704|NCT01827384|538089708|FG007|Overall Study|No actionable mutation|0|||
149168705|NCT01827384|538089709|FG008|Overall Study|No actionable mutation|0|||
149168706|NCT01827384|538089710|FG009|Overall Study|No actionable mutation|0|||
149168707|NCT01827384|538089711|FG010|Overall Study|No actionable mutation|0|||
149168708|NCT01827384|538089712|FG011|Overall Study|No actionable mutation|0|||
149168709|NCT01827384|538089713|FG012|Overall Study|No actionable mutation|0|||
149168710|NCT01827384|538089714|FG013|Overall Study|No actionable mutation|73|||
149168711|NCT01827384|538089701|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
149168712|NCT01827384|538089702|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
149168713|NCT01827384|538089703|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
149168714|NCT01827384|538089704|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
149168715|NCT01827384|538089705|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
149168716|NCT01827384|538089706|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
149168717|NCT01827384|538089707|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
149168718|NCT01827384|538089708|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
149168719|NCT01827384|538089709|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
149168720|NCT01827384|538089710|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
149168721|NCT01827384|538089711|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
149168722|NCT01827384|538089712|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
149168723|NCT01827384|538089713|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
149168724|NCT01827384|538089714|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
149168725|NCT03498521|538089719|FG000|Overall Study|Death|227|||
149168726|NCT03498521|538089720|FG001|Overall Study|Death|79|||
149168727|NCT03498521|538089721|FG002|Overall Study|Death|84|||
149168728|NCT03498521|538089719|FG000|Overall Study|Exclusion criteria|1|||
149168729|NCT03498521|538089720|FG001|Overall Study|Exclusion criteria|0|||
149168730|NCT03498521|538089721|FG002|Overall Study|Exclusion criteria|0|||
149168731|NCT03498521|538089719|FG000|Overall Study|Lost to Follow-up|4|||
149168732|NCT03498521|538089720|FG001|Overall Study|Lost to Follow-up|3|||
149168733|NCT03498521|538089721|FG002|Overall Study|Lost to Follow-up|3|||
149168734|NCT03498521|538089719|FG000|Overall Study|No profile due to technical failure|1|||
149168735|NCT03498521|538089720|FG001|Overall Study|No profile due to technical failure|0|||
149168736|NCT03498521|538089721|FG002|Overall Study|No profile due to technical failure|0|||
149168737|NCT03498521|538089719|FG000|Overall Study|Physician Decision|3|||
149168738|NCT03498521|538089720|FG001|Overall Study|Physician Decision|1|||
149168739|NCT03498521|538089721|FG002|Overall Study|Physician Decision|0|||
149168740|NCT03498521|538089719|FG000|Overall Study|Withdrawal by Subject|11|||
149168741|NCT03498521|538089720|FG001|Overall Study|Withdrawal by Subject|6|||
149168742|NCT03498521|538089721|FG002|Overall Study|Withdrawal by Subject|2|||
149168743|NCT03498521|538089719|FG000|Overall Study|Study terminated by sponsor|79|||
149168744|NCT03498521|538089720|FG001|Overall Study|Study terminated by sponsor|21|||
149168745|NCT03498521|538089721|FG002|Overall Study|Study terminated by sponsor|4|||
149168746|NCT04167345|538089722|FG000|Overall Study|Other|1|||
149168747|NCT04167345|538089723|FG001|Overall Study|Other|1|||
149168748|NCT04167345|538089724|FG002|Overall Study|Other|0|||
149168749|NCT04167345|538089725|FG003|Overall Study|Other|0|||
149168750|NCT04167345|538089726|FG004|Overall Study|Other|0|||
149168751|NCT00960076|538090777|FG000|Overall Study|Adverse Event|1|||
149168752|NCT00960076|538090778|FG001|Overall Study|Adverse Event|7|||
149168753|NCT00960076|538090777|FG000|Overall Study|No longer met study criteria|1|||
149168754|NCT00960076|538090778|FG001|Overall Study|No longer met study criteria|5|||
149168755|NCT00960076|538090777|FG000|Overall Study|Withdrawal by Subject|1|||
149168756|NCT00960076|538090778|FG001|Overall Study|Withdrawal by Subject|2|||
149168757|NCT00960076|538090777|FG000|Overall Study|Lost to Follow-up|3|||
149168758|NCT00960076|538090778|FG001|Overall Study|Lost to Follow-up|3|||
149168759|NCT00960076|538090777|FG000|Overall Study|Severe non-compliance to protocol|1|||
149168760|NCT00960076|538090778|FG001|Overall Study|Severe non-compliance to protocol|2|||
149168761|NCT00960076|538090777|FG000|Overall Study|Hyperglycemia|1|||
149168762|NCT00960076|538090778|FG001|Overall Study|Hyperglycemia|5|||
149013149|NCT00451217|537527834|FG000|Overall Study|Withdrawal by Subject|1|||
149013150|NCT00451217|537527835|FG001|Overall Study|Withdrawal by Subject|0|||
149168763|NCT00960076|538090777|FG000|Overall Study|Did not attend the termination visit|0|||
149168764|NCT00960076|538090778|FG001|Overall Study|Did not attend the termination visit|1|||
149168765|NCT01028352|538090781|FG000|Overall Study|Ineligible due to baseline average pain|5|||
149168766|NCT01028352|538090781|FG000|Overall Study|Withdrawal by Subject|1|||
149168767|NCT05052723|538090784|FG000|Overall Study|Death|19|||
149168768|NCT06161012|538090785|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
149168769|NCT06161012|538090786|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
149168770|NCT02601950|538090787|FG000|Overall Study|Participant enrolled in rollover study|0|||
149168771|NCT02601950|538090788|FG001|Overall Study|Participant enrolled in rollover study|0|||
149168772|NCT02601950|538090789|FG002|Overall Study|Participant enrolled in rollover study|1|||
149168773|NCT02601950|538090790|FG003|Overall Study|Participant enrolled in rollover study|0|||
149168774|NCT02601950|538090791|FG004|Overall Study|Participant enrolled in rollover study|1|||
149168775|NCT02601950|538090792|FG005|Overall Study|Participant enrolled in rollover study|1|||
149168776|NCT02601950|538090793|FG006|Overall Study|Participant enrolled in rollover study|1|||
149168777|NCT02601950|538090794|FG007|Overall Study|Participant enrolled in rollover study|0|||
149168778|NCT02601950|538090787|FG000|Overall Study|Disease progression - radiological|21|||
149168779|NCT02601950|538090788|FG001|Overall Study|Disease progression - radiological|26|||
149168780|NCT02601950|538090789|FG002|Overall Study|Disease progression - radiological|22|||
149168781|NCT02601950|538090790|FG003|Overall Study|Disease progression - radiological|11|||
149168782|NCT02601950|538090791|FG004|Overall Study|Disease progression - radiological|46|||
149168783|NCT02601950|538090792|FG005|Overall Study|Disease progression - radiological|52|||
149168784|NCT02601950|538090793|FG006|Overall Study|Disease progression - radiological|7|||
149168785|NCT02601950|538090794|FG007|Overall Study|Disease progression - radiological|5|||
149168786|NCT02601950|538090787|FG000|Overall Study|Disease progression - clinical|3|||
149168787|NCT02601950|538090788|FG001|Overall Study|Disease progression - clinical|5|||
149168788|NCT02601950|538090789|FG002|Overall Study|Disease progression - clinical|4|||
149168789|NCT02601950|538090790|FG003|Overall Study|Disease progression - clinical|2|||
149168790|NCT02601950|538090791|FG004|Overall Study|Disease progression - clinical|6|||
149168791|NCT02601950|538090792|FG005|Overall Study|Disease progression - clinical|6|||
149168792|NCT02601950|538090793|FG006|Overall Study|Disease progression - clinical|5|||
149168793|NCT02601950|538090794|FG007|Overall Study|Disease progression - clinical|1|||
149168794|NCT02601950|538090787|FG000|Overall Study|Death|6|||
149168795|NCT02601950|538090788|FG001|Overall Study|Death|0|||
149168796|NCT02601950|538090789|FG002|Overall Study|Death|3|||
149168797|NCT02601950|538090790|FG003|Overall Study|Death|1|||
149168798|NCT02601950|538090791|FG004|Overall Study|Death|4|||
149168799|NCT02601950|538090792|FG005|Overall Study|Death|1|||
149168800|NCT02601950|538090793|FG006|Overall Study|Death|0|||
149168801|NCT02601950|538090794|FG007|Overall Study|Death|0|||
149168802|NCT02601950|538090787|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168803|NCT02601950|538090788|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168804|NCT02601950|538090789|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168805|NCT02601950|538090790|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168806|NCT02601950|538090791|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168807|NCT02601950|538090792|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
149168808|NCT02601950|538090793|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168809|NCT02601950|538090794|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
149168810|NCT02601950|538090787|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
149168811|NCT02601950|538090788|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
149168812|NCT02601950|538090789|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
149168813|NCT02601950|538090790|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
149168814|NCT02601950|538090791|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
149168815|NCT02601950|538090792|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
149168816|NCT02601950|538090793|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
149168817|NCT02601950|538090794|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
149168818|NCT02601950|538090787|FG000|Overall Study|Non-compliance|0|||
149168819|NCT02601950|538090788|FG001|Overall Study|Non-compliance|1|||
149168820|NCT02601950|538090789|FG002|Overall Study|Non-compliance|0|||
149168821|NCT02601950|538090790|FG003|Overall Study|Non-compliance|0|||
149168822|NCT02601950|538090791|FG004|Overall Study|Non-compliance|0|||
149168823|NCT02601950|538090792|FG005|Overall Study|Non-compliance|1|||
149168824|NCT02601950|538090793|FG006|Overall Study|Non-compliance|1|||
149168825|NCT02601950|538090794|FG007|Overall Study|Non-compliance|0|||
149168826|NCT02601950|538090787|FG000|Overall Study|Participant refused further study treatment|0|||
149168827|NCT02601950|538090788|FG001|Overall Study|Participant refused further study treatment|1|||
149168828|NCT02601950|538090789|FG002|Overall Study|Participant refused further study treatment|1|||
149168829|NCT02601950|538090790|FG003|Overall Study|Participant refused further study treatment|0|||
149168830|NCT02601950|538090791|FG004|Overall Study|Participant refused further study treatment|2|||
149168831|NCT02601950|538090792|FG005|Overall Study|Participant refused further study treatment|2|||
149168832|NCT02601950|538090793|FG006|Overall Study|Participant refused further study treatment|2|||
149168833|NCT02601950|538090794|FG007|Overall Study|Participant refused further study treatment|1|||
149168834|NCT02601950|538090787|FG000|Overall Study|Investigator discretion|1|||
149168835|NCT02601950|538090788|FG001|Overall Study|Investigator discretion|0|||
149168836|NCT02601950|538090789|FG002|Overall Study|Investigator discretion|1|||
149168837|NCT02601950|538090790|FG003|Overall Study|Investigator discretion|0|||
149168838|NCT02601950|538090791|FG004|Overall Study|Investigator discretion|1|||
149168839|NCT02601950|538090792|FG005|Overall Study|Investigator discretion|1|||
149168840|NCT02601950|538090793|FG006|Overall Study|Investigator discretion|1|||
149168841|NCT02601950|538090794|FG007|Overall Study|Investigator discretion|0|||
149168842|NCT02601950|538090787|FG000|Overall Study|Other|0|||
149168843|NCT02601950|538090788|FG001|Overall Study|Other|0|||
149168844|NCT02601950|538090789|FG002|Overall Study|Other|0|||
149168845|NCT02601950|538090790|FG003|Overall Study|Other|0|||
149168846|NCT02601950|538090791|FG004|Overall Study|Other|2|||
149168847|NCT02601950|538090792|FG005|Overall Study|Other|2|||
149168848|NCT02601950|538090793|FG006|Overall Study|Other|1|||
149168849|NCT02601950|538090794|FG007|Overall Study|Other|0|||
149168850|NCT00408005|538090795|FG000|Induction|Adverse Event|19|||
149168851|NCT00408005|538090796|FG001|Induction|Adverse Event|3|||
149168852|NCT00408005|538090797|FG002|Induction|Adverse Event|0|||
149168853|NCT00408005|538090798|FG003|Induction|Adverse Event|0|||
149168854|NCT00408005|538090799|FG004|Induction|Adverse Event|0|||
149168855|NCT00408005|538090800|FG005|Induction|Adverse Event|0|||
149168856|NCT00408005|538090801|FG006|Induction|Adverse Event|0|||
149168857|NCT00408005|538090802|FG007|Induction|Adverse Event|0|||
149168858|NCT00408005|538090795|FG000|Induction|Death|6|||
149168859|NCT00408005|538090796|FG001|Induction|Death|0|||
149168860|NCT00408005|538090797|FG002|Induction|Death|0|||
149168861|NCT00408005|538090798|FG003|Induction|Death|0|||
149168862|NCT00408005|538090799|FG004|Induction|Death|0|||
149168863|NCT00408005|538090800|FG005|Induction|Death|0|||
149168864|NCT00408005|538090801|FG006|Induction|Death|0|||
149168865|NCT00408005|538090802|FG007|Induction|Death|0|||
149168866|NCT00408005|538090795|FG000|Induction|Physician Decision|83|||
149168867|NCT00408005|538090796|FG001|Induction|Physician Decision|9|||
149168868|NCT00408005|538090797|FG002|Induction|Physician Decision|0|||
149168869|NCT00408005|538090798|FG003|Induction|Physician Decision|0|||
148806275|NCT05001620|536768937|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
149168870|NCT00408005|538090799|FG004|Induction|Physician Decision|0|||
149168871|NCT00408005|538090800|FG005|Induction|Physician Decision|0|||
149168872|NCT00408005|538090801|FG006|Induction|Physician Decision|0|||
149168873|NCT00408005|538090802|FG007|Induction|Physician Decision|0|||
149168874|NCT00408005|538090795|FG000|Induction|Withdrawal by Subject|2|||
149168875|NCT00408005|538090796|FG001|Induction|Withdrawal by Subject|4|||
149168876|NCT00408005|538090797|FG002|Induction|Withdrawal by Subject|0|||
149168877|NCT00408005|538090798|FG003|Induction|Withdrawal by Subject|0|||
149168878|NCT00408005|538090799|FG004|Induction|Withdrawal by Subject|0|||
149168879|NCT00408005|538090800|FG005|Induction|Withdrawal by Subject|0|||
149168880|NCT00408005|538090801|FG006|Induction|Withdrawal by Subject|0|||
149168881|NCT00408005|538090802|FG007|Induction|Withdrawal by Subject|0|||
149168882|NCT00408005|538090795|FG000|Induction|Ineligible|33|||
149168883|NCT00408005|538090796|FG001|Induction|Ineligible|14|||
149168884|NCT00408005|538090797|FG002|Induction|Ineligible|0|||
149168885|NCT00408005|538090798|FG003|Induction|Ineligible|0|||
149168886|NCT00408005|538090799|FG004|Induction|Ineligible|0|||
149168887|NCT00408005|538090800|FG005|Induction|Ineligible|0|||
149168888|NCT00408005|538090801|FG006|Induction|Ineligible|0|||
149168889|NCT00408005|538090802|FG007|Induction|Ineligible|0|||
149168890|NCT00408005|538090795|FG000|Induction|Refusal of Further Protocol Therapy|225|||
149168891|NCT00408005|538090796|FG001|Induction|Refusal of Further Protocol Therapy|44|||
149168892|NCT00408005|538090797|FG002|Induction|Refusal of Further Protocol Therapy|0|||
149168893|NCT00408005|538090798|FG003|Induction|Refusal of Further Protocol Therapy|0|||
149168894|NCT00408005|538090799|FG004|Induction|Refusal of Further Protocol Therapy|0|||
149168895|NCT00408005|538090800|FG005|Induction|Refusal of Further Protocol Therapy|0|||
149168896|NCT00408005|538090801|FG006|Induction|Refusal of Further Protocol Therapy|0|||
149168897|NCT00408005|538090802|FG007|Induction|Refusal of Further Protocol Therapy|0|||
149168898|NCT00408005|538090795|FG000|Induction|Entered another COG therapeutic protocol|4|||
149168899|NCT00408005|538090796|FG001|Induction|Entered another COG therapeutic protocol|0|||
149168900|NCT00408005|538090797|FG002|Induction|Entered another COG therapeutic protocol|0|||
149168901|NCT00408005|538090798|FG003|Induction|Entered another COG therapeutic protocol|0|||
149168902|NCT00408005|538090799|FG004|Induction|Entered another COG therapeutic protocol|0|||
149168903|NCT00408005|538090800|FG005|Induction|Entered another COG therapeutic protocol|0|||
149168904|NCT00408005|538090801|FG006|Induction|Entered another COG therapeutic protocol|0|||
149168905|NCT00408005|538090802|FG007|Induction|Entered another COG therapeutic protocol|0|||
149168906|NCT00408005|538090795|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
149168907|NCT00408005|538090796|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
149168908|NCT00408005|538090797|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
149168909|NCT00408005|538090798|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
149168910|NCT00408005|538090799|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
149168911|NCT00408005|538090800|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
149168912|NCT00408005|538090801|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
149168913|NCT00408005|538090802|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
149168914|NCT00408005|538090795|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
149168915|NCT00408005|538090796|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
149168916|NCT00408005|538090797|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
149168917|NCT00408005|538090798|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
149168918|NCT00408005|538090799|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
149168919|NCT00408005|538090800|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
149168920|NCT00408005|538090801|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
149168921|NCT00408005|538090802|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
149168922|NCT00408005|538090795|FG000|Induction|Progressive Disease|0|||
149168923|NCT00408005|538090796|FG001|Induction|Progressive Disease|1|||
149168924|NCT00408005|538090797|FG002|Induction|Progressive Disease|0|||
149168925|NCT00408005|538090798|FG003|Induction|Progressive Disease|0|||
149168926|NCT00408005|538090799|FG004|Induction|Progressive Disease|0|||
149168927|NCT00408005|538090800|FG005|Induction|Progressive Disease|0|||
149168928|NCT00408005|538090801|FG006|Induction|Progressive Disease|0|||
149168929|NCT00408005|538090802|FG007|Induction|Progressive Disease|0|||
149168930|NCT00408005|538090795|FG000|Induction|Inevaluable|18|||
149168931|NCT00408005|538090796|FG001|Induction|Inevaluable|14|||
149168932|NCT00408005|538090797|FG002|Induction|Inevaluable|0|||
149168933|NCT00408005|538090798|FG003|Induction|Inevaluable|0|||
149168934|NCT00408005|538090799|FG004|Induction|Inevaluable|0|||
149168935|NCT00408005|538090800|FG005|Induction|Inevaluable|0|||
149168936|NCT00408005|538090801|FG006|Induction|Inevaluable|0|||
149168937|NCT00408005|538090802|FG007|Induction|Inevaluable|0|||
149168938|NCT00408005|538090795|FG000|Induction|Failed to Complete Randomization|3|||
149168939|NCT00408005|538090796|FG001|Induction|Failed to Complete Randomization|2|||
149168940|NCT00408005|538090797|FG002|Induction|Failed to Complete Randomization|0|||
149168941|NCT00408005|538090798|FG003|Induction|Failed to Complete Randomization|0|||
149168942|NCT00408005|538090799|FG004|Induction|Failed to Complete Randomization|0|||
149168943|NCT00408005|538090800|FG005|Induction|Failed to Complete Randomization|0|||
149168944|NCT00408005|538090801|FG006|Induction|Failed to Complete Randomization|0|||
149168945|NCT00408005|538090802|FG007|Induction|Failed to Complete Randomization|0|||
149168946|NCT00408005|538090795|FG000|Induction|Protocol Deviation|3|||
149168947|NCT00408005|538090796|FG001|Induction|Protocol Deviation|1|||
149168948|NCT00408005|538090797|FG002|Induction|Protocol Deviation|0|||
149168949|NCT00408005|538090798|FG003|Induction|Protocol Deviation|0|||
149168950|NCT00408005|538090799|FG004|Induction|Protocol Deviation|0|||
149168951|NCT00408005|538090800|FG005|Induction|Protocol Deviation|0|||
149168952|NCT00408005|538090801|FG006|Induction|Protocol Deviation|0|||
149168953|NCT00408005|538090802|FG007|Induction|Protocol Deviation|0|||
149168954|NCT00408005|538090795|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
149168955|NCT00408005|538090796|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168956|NCT00408005|538090797|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168957|NCT00408005|538090798|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168958|NCT00408005|538090799|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168959|NCT00408005|538090800|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168960|NCT00408005|538090801|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168961|NCT00408005|538090802|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
149168962|NCT00408005|538090795|FG000|Induction|Recurrent leukemia|1|||
149168963|NCT00408005|538090796|FG001|Induction|Recurrent leukemia|0|||
149168964|NCT00408005|538090797|FG002|Induction|Recurrent leukemia|0|||
149168965|NCT00408005|538090798|FG003|Induction|Recurrent leukemia|0|||
149168966|NCT00408005|538090799|FG004|Induction|Recurrent leukemia|0|||
149168967|NCT00408005|538090800|FG005|Induction|Recurrent leukemia|0|||
149168968|NCT00408005|538090801|FG006|Induction|Recurrent leukemia|0|||
149168969|NCT00408005|538090802|FG007|Induction|Recurrent leukemia|0|||
149168970|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149168971|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149168972|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
149168973|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
149168974|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
149168975|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
149168976|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
149168977|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
149168978|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
149168979|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
149168980|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
149168981|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
149168982|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
149168983|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
149168984|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
149168985|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
149168986|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149168987|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149168988|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
149168989|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149168990|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
149168991|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149168992|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149168993|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
149168994|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
149168995|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
149168996|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
149168997|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
149168998|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
149168999|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
149169000|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
149169001|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
149169002|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149169003|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149169004|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
149169005|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
149169006|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149169007|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
149169008|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149169009|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
149169010|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
149169011|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
149169012|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
149169013|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
149169014|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
149169015|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
149169016|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
149169017|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
149169018|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169019|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169020|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169021|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169022|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
149169023|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169024|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169025|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
149169026|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149169027|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149169028|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
149169029|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
149169030|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
149169031|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149169032|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
149169033|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
149169034|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149169035|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149169036|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149169037|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149169038|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
149169039|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
149169040|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
149169041|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
149169042|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149169043|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149169044|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149169045|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
148677635|NCT00700310|536293519|FG003|Overall Study|Withdrawal by Subject|8|||
148677636|NCT00700310|536293516|FG000|Overall Study|Lack of Efficacy|0|||
148677637|NCT00700310|536293517|FG001|Overall Study|Lack of Efficacy|3|||
148677638|NCT00700310|536293518|FG002|Overall Study|Lack of Efficacy|0|||
148677639|NCT00700310|536293519|FG003|Overall Study|Lack of Efficacy|1|||
148677640|NCT00700310|536293516|FG000|Overall Study|Administrative/Other|1|||
148677641|NCT00700310|536293517|FG001|Overall Study|Administrative/Other|3|||
148677642|NCT00700310|536293518|FG002|Overall Study|Administrative/Other|1|||
148677643|NCT00700310|536293519|FG003|Overall Study|Administrative/Other|3|||
148677644|NCT00700310|536293516|FG000|Overall Study|Randomized, Not Treated|2|||
149169046|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149169047|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
148677645|NCT00700310|536293517|FG001|Overall Study|Randomized, Not Treated|0|||
148677646|NCT00700310|536293518|FG002|Overall Study|Randomized, Not Treated|2|||
148677647|NCT00700310|536293519|FG003|Overall Study|Randomized, Not Treated|2|||
148677648|NCT02082262|536293520|FG000|Overall Study|Withdrawal by Subject|3|||
148677649|NCT02082262|536293520|FG000|Overall Study|Adverse Event|48|||
148677650|NCT01726335|536293523|FG000|Overall Study|Lost to Follow-up|2|||
148677651|NCT01726335|536293523|FG000|Overall Study|Withdrawal by Subject|15|||
149169048|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149169049|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
149169050|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149169051|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149169052|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
149169053|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
149169054|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
148677652|NCT01726335|536293523|FG000|Overall Study|Adverse Event|4|||
148677653|NCT01726335|536293523|FG000|Overall Study|Lost to Follow-up|2|||
149169055|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
149169056|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149169057|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
149169058|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149169059|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149169060|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149169061|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149169062|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
149169063|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
149169064|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
148677654|NCT01726335|536293523|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
148677655|NCT01074307|536293525|FG000|Overall Study|No primary endpoint evaluation|14|||
148677656|NCT01074307|536293526|FG001|Overall Study|No primary endpoint evaluation|6|||
148677657|NCT01074307|536293525|FG000|Overall Study|Exclusion criterion|0|||
148677658|NCT01074307|536293526|FG001|Overall Study|Exclusion criterion|1|||
148677659|NCT01074307|536293525|FG000|Overall Study|Protocol Violation|8|||
148677660|NCT01074307|536293526|FG001|Overall Study|Protocol Violation|5|||
148677661|NCT02162511|536293532|FG000|Overall Study|Lack of Efficacy|0|||
148677662|NCT02162511|536293533|FG001|Overall Study|Lack of Efficacy|0|||
148677663|NCT02162511|536293534|FG002|Overall Study|Lack of Efficacy|2|||
148677664|NCT01408576|536293536|FG000|Overall Study|Lack of Efficacy|17|||
148677665|NCT01408576|536293537|FG001|Overall Study|Lack of Efficacy|30|||
148677666|NCT01408576|536293538|FG002|Overall Study|Lack of Efficacy|48|||
148677667|NCT01408576|536293536|FG000|Overall Study|Protocol Violation|1|||
148677668|NCT01408576|536293537|FG001|Overall Study|Protocol Violation|2|||
148677669|NCT01408576|536293538|FG002|Overall Study|Protocol Violation|2|||
148677670|NCT01408576|536293536|FG000|Overall Study|Lost to Follow-up|10|||
148677671|NCT01408576|536293537|FG001|Overall Study|Lost to Follow-up|9|||
148677672|NCT01408576|536293538|FG002|Overall Study|Lost to Follow-up|17|||
148677673|NCT01408576|536293536|FG000|Overall Study|Withdrawal by Subject|34|||
148677674|NCT01408576|536293537|FG001|Overall Study|Withdrawal by Subject|60|||
148677675|NCT01408576|536293538|FG002|Overall Study|Withdrawal by Subject|66|||
148677676|NCT01408576|536293536|FG000|Overall Study|Sponsor terminated study|89|||
148677677|NCT01408576|536293537|FG001|Overall Study|Sponsor terminated study|333|||
148677678|NCT01408576|536293538|FG002|Overall Study|Sponsor terminated study|330|||
148677679|NCT01408576|536293536|FG000|Overall Study|AE, serious fatal|4|||
148677680|NCT01408576|536293537|FG001|Overall Study|AE, serious fatal|4|||
148677681|NCT01408576|536293538|FG002|Overall Study|AE, serious fatal|1|||
148677682|NCT01408576|536293536|FG000|Overall Study|SAE, non-fatal|11|||
148677683|NCT01408576|536293537|FG001|Overall Study|SAE, non-fatal|23|||
148677684|NCT01408576|536293538|FG002|Overall Study|SAE, non-fatal|14|||
148677685|NCT01408576|536293536|FG000|Overall Study|AE, non-serious non-fatal|12|||
148677686|NCT01408576|536293537|FG001|Overall Study|AE, non-serious non-fatal|19|||
148677687|NCT01408576|536293538|FG002|Overall Study|AE, non-serious non-fatal|11|||
148677688|NCT01408576|536293536|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
148677689|NCT01408576|536293537|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148677690|NCT01408576|536293538|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148677691|NCT01408576|536293536|FG000|Overall Study|AE, unknown type|0|||
148677692|NCT01408576|536293537|FG001|Overall Study|AE, unknown type|1|||
148677693|NCT01408576|536293538|FG002|Overall Study|AE, unknown type|0|||
148677694|NCT01408576|536293536|FG000|Overall Study|Other|10|||
148677695|NCT01408576|536293537|FG001|Overall Study|Other|16|||
148677696|NCT01408576|536293538|FG002|Overall Study|Other|18|||
148677697|NCT00802529|536293539|FG000|Overall Study|Lost to Follow-up|0|||
148677698|NCT00802529|536293540|FG001|Overall Study|Lost to Follow-up|1|||
148677699|NCT02703454|536293544|FG000|Overall Study|Not treated|1|||
148677700|NCT02703454|536293545|FG001|Overall Study|Not treated|3|||
148677701|NCT02703454|536293544|FG000|Overall Study|Withdrawal by Subject|4|||
148677702|NCT02703454|536293545|FG001|Overall Study|Withdrawal by Subject|3|||
148677703|NCT02703454|536293544|FG000|Overall Study|Lost to Follow-up|1|||
148677704|NCT02703454|536293545|FG001|Overall Study|Lost to Follow-up|2|||
148677705|NCT02703454|536293544|FG000|Overall Study|Study discontinuation|5|||
148677706|NCT02703454|536293545|FG001|Overall Study|Study discontinuation|8|||
148677707|NCT02284373|536293546|FG000|Overall Study|Withdrawal by Subject|0|||
148677708|NCT02284373|536293547|FG001|Overall Study|Withdrawal by Subject|1|||
148677709|NCT02284373|536293548|FG002|Overall Study|Withdrawal by Subject|0|||
148677710|NCT02284373|536293546|FG000|Overall Study|Other|0|||
148677711|NCT02284373|536293547|FG001|Overall Study|Other|1|||
148677712|NCT02284373|536293548|FG002|Overall Study|Other|0|||
148677713|NCT02284373|536293546|FG000|Overall Study|Lost to Follow-up|0|||
148677714|NCT02284373|536293547|FG001|Overall Study|Lost to Follow-up|1|||
148677715|NCT02284373|536293548|FG002|Overall Study|Lost to Follow-up|0|||
148677716|NCT02476851|536293550|FG000|Overall Study|Protocol Violation|1|||
148677717|NCT02476851|536293551|FG001|Overall Study|Protocol Violation|1|||
148677718|NCT01399125|536293552|FG000|Overall Study|Adverse Event|32|||
149169065|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
149169066|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
149169067|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
149169068|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
149169069|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
149169070|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
149169071|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
149169072|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
149169073|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
149169074|NCT00408005|538090795|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149169075|NCT00408005|538090796|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149169076|NCT00408005|538090797|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
149169077|NCT00408005|538090798|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
149169078|NCT00408005|538090799|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
149169079|NCT00408005|538090800|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
149169080|NCT00408005|538090801|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149169081|NCT00408005|538090802|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
149169082|NCT05113940|538090803|FG000|Part A (18 Days)|Adverse Event|0|||
149169083|NCT05113940|538090804|FG001|Part A (18 Days)|Adverse Event|0|||
149169084|NCT05113940|538090805|FG002|Part A (18 Days)|Adverse Event|1|||
149169085|NCT05113940|538090806|FG003|Part A (18 Days)|Adverse Event|1|||
149169086|NCT05113940|538090807|FG004|Part A (18 Days)|Adverse Event|1|||
149169087|NCT05113940|538090808|FG005|Part A (18 Days)|Adverse Event|0|||
149169088|NCT05113940|538090809|FG006|Part A (18 Days)|Adverse Event|0|||
149169089|NCT05113940|538090810|FG007|Part A (18 Days)|Adverse Event|0|||
149169090|NCT05113940|538090811|FG008|Part A (18 Days)|Adverse Event|0|||
149169091|NCT05113940|538090812|FG009|Part A (18 Days)|Adverse Event|0|||
149169092|NCT05113940|538090813|FG010|Part A (18 Days)|Adverse Event|0|||
149169093|NCT05113940|538090814|FG011|Part A (18 Days)|Adverse Event|2|||
149169094|NCT05113940|538090815|FG012|Part A (18 Days)|Adverse Event|0|||
149169095|NCT05113940|538090816|FG013|Part A (18 Days)|Adverse Event|0|||
149169096|NCT05113940|538090817|FG014|Part A (18 Days)|Adverse Event|0|||
149169097|NCT05113940|538090803|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169098|NCT05113940|538090804|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169099|NCT05113940|538090805|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169100|NCT05113940|538090806|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169101|NCT05113940|538090807|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169102|NCT05113940|538090808|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169103|NCT05113940|538090809|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169104|NCT05113940|538090810|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169105|NCT05113940|538090811|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169106|NCT05113940|538090812|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169107|NCT05113940|538090813|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169108|NCT05113940|538090814|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169109|NCT05113940|538090815|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169110|NCT05113940|538090816|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
149169111|NCT05113940|538090817|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
149169112|NCT01701258|538090818|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
149169113|NCT01701258|538090819|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
149169114|NCT01701258|538090820|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
149169115|NCT01701258|538090821|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
149169116|NCT01701258|538090822|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
149169117|NCT01701258|538090823|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
149169118|NCT01701258|538090824|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
149169119|NCT01701258|538090825|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
149169120|NCT01701258|538090826|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
149169121|NCT01701258|538090827|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
149169122|NCT01701258|538090828|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
149169123|NCT01701258|538090829|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
149169124|NCT01701258|538090830|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
149169125|NCT01701258|538090818|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
149169126|NCT01701258|538090819|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
149169127|NCT01701258|538090820|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
149169128|NCT01701258|538090821|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
149013151|NCT00451217|537527836|FG002|Overall Study|Withdrawal by Subject|0|||
149013152|NCT00451217|537527837|FG003|Overall Study|Withdrawal by Subject|0|||
149169129|NCT01701258|538090822|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
149169130|NCT01701258|538090823|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
149169131|NCT01701258|538090824|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
149169132|NCT01701258|538090825|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
149169133|NCT01701258|538090826|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
149169134|NCT01701258|538090827|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
149169135|NCT01701258|538090828|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
149169136|NCT01701258|538090829|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
149169137|NCT01701258|538090830|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
149169138|NCT01701258|538090818|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
149169139|NCT01701258|538090819|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
149169140|NCT01701258|538090820|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
149169141|NCT01701258|538090821|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
149169142|NCT01701258|538090822|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
149169143|NCT01701258|538090823|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
149169144|NCT01701258|538090824|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
149169145|NCT01701258|538090825|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
149169146|NCT01701258|538090826|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
149169147|NCT01701258|538090827|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
149169148|NCT01701258|538090828|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
149169149|NCT01701258|538090829|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
149169150|NCT01701258|538090830|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
149169151|NCT01701258|538090818|FG000|Assessment and Scheduling|Investigator Terminated|2|||
149169152|NCT01701258|538090819|FG001|Assessment and Scheduling|Investigator Terminated|0|||
149169153|NCT01701258|538090820|FG002|Assessment and Scheduling|Investigator Terminated|0|||
149169154|NCT01701258|538090821|FG003|Assessment and Scheduling|Investigator Terminated|0|||
149169155|NCT01701258|538090822|FG004|Assessment and Scheduling|Investigator Terminated|0|||
149169156|NCT01701258|538090823|FG005|Assessment and Scheduling|Investigator Terminated|0|||
149169157|NCT01701258|538090824|FG006|Assessment and Scheduling|Investigator Terminated|0|||
149169158|NCT01701258|538090825|FG007|Assessment and Scheduling|Investigator Terminated|0|||
149169159|NCT01701258|538090826|FG008|Assessment and Scheduling|Investigator Terminated|0|||
149169160|NCT01701258|538090827|FG009|Assessment and Scheduling|Investigator Terminated|0|||
149169161|NCT01701258|538090828|FG010|Assessment and Scheduling|Investigator Terminated|0|||
149169162|NCT01701258|538090829|FG011|Assessment and Scheduling|Investigator Terminated|0|||
149169163|NCT01701258|538090830|FG012|Assessment and Scheduling|Investigator Terminated|0|||
149169164|NCT02542267|538090833|FG000|Overall Study|Withdrawal by Subject|10|||
149169165|NCT02542267|538090833|FG000|Overall Study|Physician Decision|6|||
149169166|NCT02542267|538090833|FG000|Overall Study|Lost to Follow-up|4|||
149169167|NCT02542267|538090833|FG000|Overall Study|Death|13|||
149169168|NCT02542267|538090833|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
149169169|NCT02542267|538090833|FG000|Overall Study|Other|9|||
149169170|NCT00442598|538090834|FG000|Overall Study|Adverse Event|1|||
149169171|NCT00442598|538090835|FG001|Overall Study|Adverse Event|0|||
149169172|NCT00442598|538090836|FG002|Overall Study|Adverse Event|0|||
149169173|NCT00442598|538090834|FG000|Overall Study|Tumor progression|3|||
149169174|NCT00442598|538090835|FG001|Overall Study|Tumor progression|4|||
149169175|NCT00442598|538090836|FG002|Overall Study|Tumor progression|0|||
149169176|NCT00442598|538090834|FG000|Overall Study|Clinical deterioration|1|||
149169177|NCT00442598|538090835|FG001|Overall Study|Clinical deterioration|2|||
149169178|NCT00442598|538090836|FG002|Overall Study|Clinical deterioration|0|||
149169179|NCT00442598|538090834|FG000|Overall Study|CA125 progression|0|||
149169180|NCT00442598|538090835|FG001|Overall Study|CA125 progression|1|||
149169181|NCT00442598|538090836|FG002|Overall Study|CA125 progression|0|||
149169182|NCT00442598|538090834|FG000|Overall Study|Reduced creatinine clearance|1|||
149169183|NCT00442598|538090835|FG001|Overall Study|Reduced creatinine clearance|0|||
149169184|NCT00442598|538090836|FG002|Overall Study|Reduced creatinine clearance|0|||
149169185|NCT00442598|538090834|FG000|Overall Study|Death|0|||
149169186|NCT00442598|538090835|FG001|Overall Study|Death|1|||
149169187|NCT00442598|538090836|FG002|Overall Study|Death|0|||
149169188|NCT00501228|538090839|FG000|Overall Study|Withdrawal by Subject|1|||
149169189|NCT01756274|538090842|FG000|Overall Study|Protocol Violation|2|||
149169190|NCT01756274|538090842|FG000|Overall Study|Laboratory error|1|||
149169191|NCT01147926|538090843|FG000|Overall Study|Subject Withdrew Consent|9|||
149169192|NCT01147926|538090844|FG001|Overall Study|Subject Withdrew Consent|10|||
149169193|NCT01147926|538090843|FG000|Overall Study|Adverse Event|7|||
149169194|NCT01147926|538090844|FG001|Overall Study|Adverse Event|6|||
149169195|NCT01147926|538090843|FG000|Overall Study|Subject Non-Compliant|5|||
149169196|NCT01147926|538090844|FG001|Overall Study|Subject Non-Compliant|4|||
149169197|NCT01147926|538090843|FG000|Overall Study|Principal investigator left hospital|1|||
149169198|NCT01147926|538090844|FG001|Overall Study|Principal investigator left hospital|3|||
149169199|NCT01147926|538090843|FG000|Overall Study|Selection criteria not met|3|||
149169200|NCT01147926|538090844|FG001|Overall Study|Selection criteria not met|1|||
149169201|NCT01147926|538090843|FG000|Overall Study|Lost to Follow-up|0|||
149169202|NCT01147926|538090844|FG001|Overall Study|Lost to Follow-up|2|||
149169203|NCT01147926|538090843|FG000|Overall Study|Sponsor's Decision|0|||
149169204|NCT01147926|538090844|FG001|Overall Study|Sponsor's Decision|1|||
149169205|NCT01147926|538090843|FG000|Overall Study|Lack of Efficacy|1|||
149169206|NCT01147926|538090844|FG001|Overall Study|Lack of Efficacy|0|||
149169207|NCT01147926|538090843|FG000|Overall Study|Too busy, no time for study|1|||
149169208|NCT01147926|538090844|FG001|Overall Study|Too busy, no time for study|0|||
149169209|NCT01147926|538090843|FG000|Overall Study|Went on holiday|0|||
149169210|NCT01147926|538090844|FG001|Overall Study|Went on holiday|1|||
149169211|NCT01147926|538090843|FG000|Overall Study|Colonoscopy result|0|||
148677719|NCT01399125|536293553|FG001|Overall Study|Adverse Event|30|||
148677720|NCT01399125|536293552|FG000|Overall Study|Abnormal Lab values|0|||
148677721|NCT01399125|536293553|FG001|Overall Study|Abnormal Lab values|1|||
148677722|NCT01399125|536293552|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148677723|NCT01399125|536293553|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
148677724|NCT01399125|536293552|FG000|Overall Study|Withdrawal by Subject|5|||
148677725|NCT01399125|536293553|FG001|Overall Study|Withdrawal by Subject|8|||
148677726|NCT01399125|536293552|FG000|Overall Study|Lost to Follow-up|2|||
148677727|NCT01399125|536293553|FG001|Overall Study|Lost to Follow-up|3|||
148677728|NCT01399125|536293552|FG000|Overall Study|Administrative Problems|7|||
148677729|NCT01399125|536293553|FG001|Overall Study|Administrative Problems|11|||
148677730|NCT01399125|536293552|FG000|Overall Study|Death|0|||
149169212|NCT01147926|538090844|FG001|Overall Study|Colonoscopy result|1|||
149169213|NCT01670994|538090847|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
149169214|NCT01670994|538090848|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
149169215|NCT01670994|538090847|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
149169216|NCT01670994|538090848|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
149169217|NCT01670994|538090847|FG000|Overall Study|Patient experienced DLT|0|||
149169218|NCT01670994|538090848|FG001|Overall Study|Patient experienced DLT|1|||
149169219|NCT00891735|538090850|FG000|Overall Study|Adverse Event|2|||
149169220|NCT00891735|538090851|FG001|Overall Study|Adverse Event|0|||
149169221|NCT00891735|538090852|FG002|Overall Study|Adverse Event|2|||
149169222|NCT00891735|538090853|FG003|Overall Study|Adverse Event|0|||
149169223|NCT00891735|538090850|FG000|Overall Study|Death|8|||
149169224|NCT00891735|538090851|FG001|Overall Study|Death|5|||
149169225|NCT00891735|538090852|FG002|Overall Study|Death|4|||
149169226|NCT00891735|538090853|FG003|Overall Study|Death|5|||
149169227|NCT00891735|538090850|FG000|Overall Study|Lost to Follow-up|2|||
149169228|NCT00891735|538090851|FG001|Overall Study|Lost to Follow-up|2|||
149169229|NCT00891735|538090852|FG002|Overall Study|Lost to Follow-up|2|||
149169230|NCT00891735|538090853|FG003|Overall Study|Lost to Follow-up|2|||
149169231|NCT00891735|538090850|FG000|Overall Study|Physician's decision to withdraw patient|1|||
149169232|NCT00891735|538090851|FG001|Overall Study|Physician's decision to withdraw patient|0|||
149169233|NCT00891735|538090852|FG002|Overall Study|Physician's decision to withdraw patient|0|||
149169234|NCT00891735|538090853|FG003|Overall Study|Physician's decision to withdraw patient|0|||
149169235|NCT00891735|538090850|FG000|Overall Study|Patient's decision to withdraw|4|||
148677731|NCT01399125|536293553|FG001|Overall Study|Death|1|||
149169236|NCT00891735|538090851|FG001|Overall Study|Patient's decision to withdraw|9|||
149169237|NCT00891735|538090852|FG002|Overall Study|Patient's decision to withdraw|4|||
149169238|NCT00891735|538090853|FG003|Overall Study|Patient's decision to withdraw|8|||
148677732|NCT01399125|536293552|FG000|Overall Study|Protocol Deviation|5|||
148677733|NCT01399125|536293553|FG001|Overall Study|Protocol Deviation|2|||
148677734|NCT00647426|536293554|FG000|Overall Study|Withdrawal by Subject|2|||
148677735|NCT00563524|536293557|FG000|Overall Study|Adverse Event|0|||
148677736|NCT00563524|536293558|FG001|Overall Study|Adverse Event|1|||
148677737|NCT00563524|536293559|FG002|Overall Study|Adverse Event|0|||
148677738|NCT00563524|536293560|FG003|Overall Study|Adverse Event|0|||
149169239|NCT00885365|538090856|FG000|4 Weeks ON Treatment|Adverse Event|2|||
149169240|NCT00885365|538090857|FG001|4 Weeks ON Treatment|Adverse Event|4|||
149169241|NCT00885365|538090856|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
149169242|NCT00885365|538090857|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
149169243|NCT00885365|538090856|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
149169244|NCT00885365|538090857|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
149169245|NCT01824979|538090858|FG000|Overall Study|Withdrawal by Subject|5|||
149169246|NCT01824979|538090859|FG001|Overall Study|Withdrawal by Subject|0|||
149169247|NCT01824979|538090858|FG000|Overall Study|Physician Decision|2|||
149169248|NCT01824979|538090859|FG001|Overall Study|Physician Decision|0|||
149169249|NCT01824979|538090858|FG000|Overall Study|Protocol Violation|6|||
149169250|NCT01824979|538090859|FG001|Overall Study|Protocol Violation|13|||
149169251|NCT03751111|538090866|FG000|Overall Study|Lack of Efficacy|9|||
149169252|NCT03751111|538090867|FG001|Overall Study|Lack of Efficacy|30|||
149169253|NCT03751111|538090866|FG000|Overall Study|Adverse Event|3|||
149169254|NCT03751111|538090867|FG001|Overall Study|Adverse Event|2|||
149169255|NCT03406962|538090872|FG000|Overall Study|Death|2|||
149169256|NCT03406962|538090872|FG000|Overall Study|Adverse Event|1|||
149169257|NCT03853694|538090873|FG000|Overall Study|Protocol Violation|3|||
149169258|NCT03853694|538090874|FG001|Overall Study|Protocol Violation|5|||
149169259|NCT03853694|538090875|FG002|Overall Study|Protocol Violation|3|||
149169260|NCT03853694|538090873|FG000|Overall Study|Delivered early|0|||
148677739|NCT00563524|536293561|FG004|Overall Study|Adverse Event|2|||
148677740|NCT00563524|536293562|FG005|Overall Study|Adverse Event|0|||
148677741|NCT00563524|536293557|FG000|Overall Study|Lost to Follow-up|1|||
148677742|NCT00563524|536293558|FG001|Overall Study|Lost to Follow-up|0|||
148677743|NCT00563524|536293559|FG002|Overall Study|Lost to Follow-up|0|||
148677744|NCT00563524|536293560|FG003|Overall Study|Lost to Follow-up|0|||
148677745|NCT00563524|536293561|FG004|Overall Study|Lost to Follow-up|0|||
148677746|NCT00563524|536293562|FG005|Overall Study|Lost to Follow-up|0|||
148677747|NCT00563524|536293557|FG000|Overall Study|Protocol Violation|0|||
148677748|NCT00563524|536293558|FG001|Overall Study|Protocol Violation|1|||
149169261|NCT03853694|538090874|FG001|Overall Study|Delivered early|1|||
149169262|NCT03853694|538090875|FG002|Overall Study|Delivered early|0|||
149169263|NCT03853694|538090873|FG000|Overall Study|not suitable to proceed|0|||
149169264|NCT03853694|538090874|FG001|Overall Study|not suitable to proceed|1|||
149169265|NCT03853694|538090875|FG002|Overall Study|not suitable to proceed|0|||
149169266|NCT03853694|538090873|FG000|Overall Study|difficult surgery|0|||
148677749|NCT00563524|536293559|FG002|Overall Study|Protocol Violation|0|||
149169267|NCT03853694|538090874|FG001|Overall Study|difficult surgery|0|||
149169268|NCT03853694|538090875|FG002|Overall Study|difficult surgery|1|||
149169269|NCT03853694|538090873|FG000|Overall Study|Lost to Follow-up|0|||
149169270|NCT03853694|538090874|FG001|Overall Study|Lost to Follow-up|1|||
149169271|NCT03853694|538090875|FG002|Overall Study|Lost to Follow-up|0|||
149169272|NCT03853694|538090873|FG000|Overall Study|Withdrawal by Subject|0|||
149169273|NCT03853694|538090874|FG001|Overall Study|Withdrawal by Subject|1|||
149169274|NCT03853694|538090875|FG002|Overall Study|Withdrawal by Subject|0|||
149169275|NCT01791855|538090876|FG000|Overall Study|Adverse Event|0|||
149169276|NCT01791855|538090877|FG001|Overall Study|Adverse Event|0|||
149169277|NCT01791855|538090878|FG002|Overall Study|Adverse Event|0|||
149169278|NCT01791855|538090879|FG003|Overall Study|Adverse Event|1|||
149169279|NCT01791855|538090876|FG000|Overall Study|Randomized, not treated|0|||
149169280|NCT01791855|538090877|FG001|Overall Study|Randomized, not treated|1|||
149169281|NCT01791855|538090878|FG002|Overall Study|Randomized, not treated|0|||
149169282|NCT01791855|538090879|FG003|Overall Study|Randomized, not treated|0|||
149169283|NCT01672957|538090880|FG000|Overall Study|Protocol Violation|48|||
149169284|NCT01672957|538090880|FG000|Overall Study|Death|2|||
149169285|NCT01672957|538090880|FG000|Overall Study|ICF Signed After Transplantation|5|||
149169286|NCT00591734|538090881|FG000|Overall Study|Lack of Efficacy|35|||
149169287|NCT00591734|538090881|FG000|Overall Study|Adverse Event|5|||
149169288|NCT00591734|538090881|FG000|Overall Study|Physician Decision|5|||
149169289|NCT00591734|538090881|FG000|Overall Study|Intercurrent Illness|8|||
149169290|NCT04370509|538090885|FG000|Overall Study|Adverse Event|1|||
149169291|NCT04370509|538090886|FG001|Overall Study|Adverse Event|0|||
149169292|NCT04370509|538090885|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
149169293|NCT04370509|538090886|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
149169294|NCT02612909|538092216|FG000|Phase 2|Withdrawal by Subject|2|||
149169295|NCT02612909|538092217|FG001|Phase 2|Withdrawal by Subject|5|||
149169296|NCT02612909|538092218|FG002|Phase 2|Withdrawal by Subject|0|||
149169297|NCT02612909|538092219|FG003|Phase 2|Withdrawal by Subject|0|||
148677750|NCT00563524|536293560|FG003|Overall Study|Protocol Violation|0|||
148677751|NCT00563524|536293561|FG004|Overall Study|Protocol Violation|0|||
148677752|NCT00563524|536293562|FG005|Overall Study|Protocol Violation|0|||
148677753|NCT00563524|536293557|FG000|Overall Study|Withdrawal by Subject|1|||
149169298|NCT02612909|538092220|FG004|Phase 2|Withdrawal by Subject|0|||
149169299|NCT02612909|538092216|FG000|Phase 2|Pregnancy|0|||
149169300|NCT02612909|538092217|FG001|Phase 2|Pregnancy|0|||
149169301|NCT02612909|538092218|FG002|Phase 2|Pregnancy|1|||
149169302|NCT02612909|538092219|FG003|Phase 2|Pregnancy|0|||
149169303|NCT02612909|538092220|FG004|Phase 2|Pregnancy|0|||
149169304|NCT02612909|538092216|FG000|Phase 3|Withdrawal by Subject|0|||
149169305|NCT02612909|538092217|FG001|Phase 3|Withdrawal by Subject|0|||
149169306|NCT02612909|538092218|FG002|Phase 3|Withdrawal by Subject|0|||
149169307|NCT02612909|538092219|FG003|Phase 3|Withdrawal by Subject|1|||
149169308|NCT02612909|538092220|FG004|Phase 3|Withdrawal by Subject|0|||
149169309|NCT00826748|538092223|FG000|Overall Study|Withdrawal by Subject|0|||
149169310|NCT00826748|538092224|FG001|Overall Study|Withdrawal by Subject|0|||
149169311|NCT00826748|538092225|FG002|Overall Study|Withdrawal by Subject|2|||
149169312|NCT00826748|538092223|FG000|Overall Study|Physician Decision|0|||
149169313|NCT00826748|538092224|FG001|Overall Study|Physician Decision|0|||
149169314|NCT00826748|538092225|FG002|Overall Study|Physician Decision|1|||
149169315|NCT00826748|538092223|FG000|Overall Study|Samples Did Not pass QC|0|||
149169316|NCT00826748|538092224|FG001|Overall Study|Samples Did Not pass QC|0|||
149169317|NCT00826748|538092225|FG002|Overall Study|Samples Did Not pass QC|1|||
149169318|NCT05224258|538092226|FG000|Overall Study|Withdrawal by Subject|1|||
149169319|NCT05224258|538092227|FG001|Overall Study|Withdrawal by Subject|1|||
149169320|NCT05224258|538092226|FG000|Overall Study|Physician Decision|1|||
149169321|NCT05224258|538092227|FG001|Overall Study|Physician Decision|1|||
149169322|NCT05224258|538092226|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149169323|NCT05224258|538092227|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149169324|NCT05224258|538092226|FG000|Overall Study|Study Product No Longer in Use|1|||
149169325|NCT05224258|538092227|FG001|Overall Study|Study Product No Longer in Use|0|||
149169326|NCT05224258|538092226|FG000|Overall Study|Adverse Event|0|||
149169327|NCT05224258|538092227|FG001|Overall Study|Adverse Event|1|||
149169328|NCT05224258|538092226|FG000|Overall Study|Protocol Deviation|0|||
149169329|NCT05224258|538092227|FG001|Overall Study|Protocol Deviation|1|||
149169330|NCT05067127|538092228|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
149169331|NCT05067127|538092229|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
149169332|NCT05067127|538092230|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
149169333|NCT05067127|538092231|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
149169334|NCT05067127|538092228|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
149169335|NCT05067127|538092229|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
149169336|NCT05067127|538092230|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
149169337|NCT05067127|538092231|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
149169338|NCT05067127|538092228|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
149169339|NCT05067127|538092229|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149169340|NCT05067127|538092230|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149169341|NCT05067127|538092231|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149169342|NCT05067127|538092228|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
149169343|NCT05067127|538092229|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
149169344|NCT05067127|538092230|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
149169345|NCT05067127|538092231|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
149169346|NCT05067127|538092228|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
149169347|NCT05067127|538092229|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
149169348|NCT05067127|538092230|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
149169349|NCT05067127|538092231|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
149169350|NCT05067127|538092228|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
149169351|NCT05067127|538092229|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
149169352|NCT05067127|538092230|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
149169353|NCT05067127|538092231|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
149169354|NCT05067127|538092228|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149169355|NCT05067127|538092229|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
149169356|NCT05067127|538092230|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
149169357|NCT05067127|538092231|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
149169358|NCT05540652|538092232|FG000|Overall Study|Withdrawal by Subject|1|||
149169359|NCT03367871|538092233|FG000|Overall Study|Lost to Follow-up|1|||
149169360|NCT02013544|538092235|FG000|Overall Study|Adverse Event|5|||
149169361|NCT02013544|538092236|FG001|Overall Study|Adverse Event|5|||
149169362|NCT02013544|538092235|FG000|Overall Study|Lost to Follow-up|2|||
149169363|NCT02013544|538092236|FG001|Overall Study|Lost to Follow-up|3|||
149169364|NCT02013544|538092235|FG000|Overall Study|Withdrawal by Subject|2|||
149169365|NCT02013544|538092236|FG001|Overall Study|Withdrawal by Subject|8|||
149169366|NCT02013544|538092235|FG000|Overall Study|Physician Decision|0|||
149169367|NCT02013544|538092236|FG001|Overall Study|Physician Decision|1|||
149169368|NCT02013544|538092235|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
149169369|NCT02013544|538092236|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
149169370|NCT03514914|538092237|FG000|Overall Study|Death|3|||
149169371|NCT03514914|538092238|FG001|Overall Study|Death|3|||
149169372|NCT03514914|538092237|FG000|Overall Study|Lost to Follow-up|117|||
149169373|NCT03514914|538092238|FG001|Overall Study|Lost to Follow-up|89|||
149169374|NCT00473876|538092239|FG000|Overall Study|Lost to Follow-up|3|||
149169375|NCT00473876|538092240|FG001|Overall Study|Lost to Follow-up|1|||
149169376|NCT00755079|538092244|FG000|Overall Study|Lost to Follow-up|1|||
149169377|NCT00755079|538092245|FG001|Overall Study|Lost to Follow-up|3|||
149169378|NCT00755079|538092244|FG000|Overall Study|Adverse Event|0|||
149169379|NCT00755079|538092245|FG001|Overall Study|Adverse Event|1|||
149169380|NCT00755079|538092244|FG000|Overall Study|Withdrawal by Subject|0|||
149169381|NCT00755079|538092245|FG001|Overall Study|Withdrawal by Subject|2|||
149169382|NCT01276288|538092246|FG000|Overall Study|Adverse Event|1|||
149169383|NCT01276288|538092247|FG001|Overall Study|Adverse Event|1|||
149169384|NCT01276288|538092248|FG002|Overall Study|Adverse Event|0|||
149169385|NCT01276288|538092249|FG003|Overall Study|Adverse Event|0|||
149169386|NCT01276288|538092246|FG000|Overall Study|not treated|1|||
149169387|NCT01276288|538092247|FG001|Overall Study|not treated|0|||
149169388|NCT01276288|538092248|FG002|Overall Study|not treated|0|||
149169389|NCT01276288|538092249|FG003|Overall Study|not treated|0|||
149169390|NCT00629083|538092256|FG000|Overall Study|Adverse Event|0|||
149169391|NCT00629083|538092257|FG001|Overall Study|Adverse Event|2|||
149169392|NCT00629083|538092256|FG000|Overall Study|Lack of Efficacy|3|||
149169393|NCT00629083|538092257|FG001|Overall Study|Lack of Efficacy|1|||
149169394|NCT00629083|538092256|FG000|Overall Study|Withdrawal by Subject|10|||
149169395|NCT00629083|538092257|FG001|Overall Study|Withdrawal by Subject|2|||
149169396|NCT00629083|538092256|FG000|Overall Study|Lost to Follow-up|12|||
149169397|NCT00629083|538092257|FG001|Overall Study|Lost to Follow-up|8|||
149169398|NCT00629083|538092256|FG000|Overall Study|Moved out of country/state|2|||
149169399|NCT00629083|538092257|FG001|Overall Study|Moved out of country/state|1|||
149169400|NCT00629083|538092256|FG000|Overall Study|Refused to return for 12 month visit|1|||
149169401|NCT00629083|538092257|FG001|Overall Study|Refused to return for 12 month visit|0|||
149169402|NCT01193686|538092258|FG000|Overall Study|Withdrawal by Subject|4|||
149169403|NCT01193686|538092259|FG001|Overall Study|Withdrawal by Subject|1|||
149169404|NCT01193686|538092258|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
149169405|NCT01193686|538092259|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
149169406|NCT03401749|538092260|FG000|Overall Study|Lost to Follow-up|20|||
149169407|NCT03401749|538092261|FG001|Overall Study|Lost to Follow-up|16|||
149169408|NCT03401749|538092262|FG002|Overall Study|Lost to Follow-up|26|||
149169409|NCT01818297|538092264|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
149169410|NCT01818297|538092265|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
149169411|NCT01818297|538092264|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
149169412|NCT01818297|538092265|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
149169413|NCT01818297|538092264|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
149169414|NCT01818297|538092265|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
149169415|NCT04439344|538092266|FG000|Overall Study|Never started threapy|3|||
149169416|NCT04439344|538092266|FG000|Overall Study|Ineligible|3|||
149169417|NCT04439344|538092266|FG000|Overall Study|Adverse Event|13|||
149169418|NCT04439344|538092266|FG000|Overall Study|Death|2|||
149169419|NCT04439344|538092266|FG000|Overall Study|Disease progression|29|||
149169420|NCT04439344|538092266|FG000|Overall Study|Withdrawal by Subject|2|||
149169421|NCT04439344|538092266|FG000|Overall Study|Alternative therapy|1|||
149169422|NCT03770403|538092267|FG000|Overall Study|Adverse Event|8|||
149169423|NCT03770403|538092267|FG000|Overall Study|Death|5|||
149169424|NCT03770403|538092267|FG000|Overall Study|Physician Decision|1|||
149169425|NCT03770403|538092267|FG000|Overall Study|Sponsor decision|1|||
149169426|NCT03770403|538092267|FG000|Overall Study|Study terminated by Sponsor|1|||
149169427|NCT03770403|538092267|FG000|Overall Study|Withdrawal by Subject|13|||
149169428|NCT03770403|538092267|FG000|Overall Study|Other|88|||
149169429|NCT03896295|538092268|FG000|Overall Study|Adverse Event|0|||
149169430|NCT03896295|538092269|FG001|Overall Study|Adverse Event|1|||
149169431|NCT03896295|538092268|FG000|Overall Study|COVID-19|7|||
149169432|NCT03896295|538092269|FG001|Overall Study|COVID-19|29|||
149169433|NCT00552110|538092270|FG000|Overall Study|Serious or Life-Threatening AE|0|||
149169434|NCT00552110|538092271|FG001|Overall Study|Serious or Life-Threatening AE|0|||
149169435|NCT00552110|538092272|FG002|Overall Study|Serious or Life-Threatening AE|1|||
149169436|NCT00552110|538092273|FG003|Overall Study|Serious or Life-Threatening AE|0|||
149169437|NCT00552110|538092274|FG004|Overall Study|Serious or Life-Threatening AE|0|||
149169438|NCT00552110|538092270|FG000|Overall Study|Lack of Efficacy|1|||
149169439|NCT00552110|538092271|FG001|Overall Study|Lack of Efficacy|0|||
149169440|NCT00552110|538092272|FG002|Overall Study|Lack of Efficacy|0|||
149169441|NCT00552110|538092273|FG003|Overall Study|Lack of Efficacy|1|||
149169442|NCT00552110|538092274|FG004|Overall Study|Lack of Efficacy|4|||
149169443|NCT00552110|538092270|FG000|Overall Study|Withdrawal by Subject|0|||
149169444|NCT00552110|538092271|FG001|Overall Study|Withdrawal by Subject|2|||
149169445|NCT00552110|538092272|FG002|Overall Study|Withdrawal by Subject|0|||
149169446|NCT00552110|538092273|FG003|Overall Study|Withdrawal by Subject|3|||
149013153|NCT00451217|537527834|FG000|Overall Study|Not Treated|1|||
149169447|NCT00552110|538092274|FG004|Overall Study|Withdrawal by Subject|2|||
149169448|NCT00552110|538092270|FG000|Overall Study|Lost to Follow-up|0|||
149169449|NCT00552110|538092271|FG001|Overall Study|Lost to Follow-up|0|||
149169450|NCT00552110|538092272|FG002|Overall Study|Lost to Follow-up|0|||
149169451|NCT00552110|538092273|FG003|Overall Study|Lost to Follow-up|1|||
149169452|NCT00552110|538092274|FG004|Overall Study|Lost to Follow-up|1|||
149169453|NCT00552110|538092270|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
149169454|NCT00552110|538092271|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
149169455|NCT00552110|538092272|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
149169456|NCT00552110|538092273|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
149169457|NCT00552110|538092274|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
149169458|NCT00552110|538092270|FG000|Overall Study|Withdrawn per Sponsor|0|||
149169459|NCT00552110|538092271|FG001|Overall Study|Withdrawn per Sponsor|1|||
149169460|NCT00552110|538092272|FG002|Overall Study|Withdrawn per Sponsor|0|||
149169461|NCT00552110|538092273|FG003|Overall Study|Withdrawn per Sponsor|0|||
149169462|NCT00552110|538092274|FG004|Overall Study|Withdrawn per Sponsor|1|||
149169463|NCT00552110|538092270|FG000|Overall Study|Use of Prohibited Medication|1|||
149169464|NCT00552110|538092271|FG001|Overall Study|Use of Prohibited Medication|1|||
149169465|NCT00552110|538092272|FG002|Overall Study|Use of Prohibited Medication|0|||
149169466|NCT00552110|538092273|FG003|Overall Study|Use of Prohibited Medication|0|||
149169467|NCT00552110|538092274|FG004|Overall Study|Use of Prohibited Medication|0|||
149169468|NCT00552110|538092270|FG000|Overall Study|Delay of Study due to Relabeling|0|||
149169469|NCT00552110|538092271|FG001|Overall Study|Delay of Study due to Relabeling|0|||
149169470|NCT00552110|538092272|FG002|Overall Study|Delay of Study due to Relabeling|0|||
149169471|NCT00552110|538092273|FG003|Overall Study|Delay of Study due to Relabeling|1|||
149169472|NCT00552110|538092274|FG004|Overall Study|Delay of Study due to Relabeling|0|||
149169473|NCT00552110|538092270|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
149169474|NCT00552110|538092271|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
149169475|NCT00552110|538092272|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
149169476|NCT00552110|538092273|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
149169477|NCT00552110|538092274|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
149169478|NCT00552110|538092270|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
149169479|NCT00552110|538092271|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
149169480|NCT00552110|538092272|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
149169481|NCT00552110|538092273|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
149169482|NCT00552110|538092274|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
149169483|NCT03029832|538092284|FG000|Overall Study|Safety Follow-Up Completed|2|||
149169484|NCT03029832|538092285|FG001|Overall Study|Safety Follow-Up Completed|0|||
149169485|NCT03029832|538092284|FG000|Overall Study|Death due to Disease Progression|1|||
149169486|NCT03029832|538092285|FG001|Overall Study|Death due to Disease Progression|0|||
149169487|NCT03029832|538092284|FG000|Overall Study|Study Terminated By Sponsor|1|||
149169488|NCT03029832|538092285|FG001|Overall Study|Study Terminated By Sponsor|1|||
149169489|NCT04373460|538092286|FG000|Overall Study|Did not receive tranfusion|18|||
149169490|NCT04373460|538092287|FG001|Overall Study|Did not receive tranfusion|26|||
149169491|NCT01412229|538092288|FG000|Overall Study|Physician Decision|1|||
149169492|NCT00700804|538092291|FG000|Overall Study|Withdrawal by Subject|1|||
149169493|NCT00700804|538092292|FG001|Overall Study|Withdrawal by Subject|2|||
149169494|NCT00700804|538092291|FG000|Overall Study|Protocol Violation|1|||
149169495|NCT00700804|538092292|FG001|Overall Study|Protocol Violation|1|||
149169496|NCT00700804|538092291|FG000|Overall Study|Loose Stools|1|||
149169497|NCT00700804|538092292|FG001|Overall Study|Loose Stools|1|||
149169498|NCT02901431|538092293|FG000|PK Part|Adverse Event|0|||
149169499|NCT02901431|538092294|FG001|PK Part|Adverse Event|1|||
149169500|NCT02901431|538092295|FG002|PK Part|Adverse Event|0|||
149169501|NCT02901431|538092296|FG003|PK Part|Adverse Event|0|||
149169502|NCT02901431|538092297|FG004|PK Part|Adverse Event|0|||
149169503|NCT02901431|538092298|FG005|PK Part|Adverse Event|0|||
149169504|NCT02901431|538092299|FG006|PK Part|Adverse Event|0|||
149169505|NCT02901431|538092300|FG007|PK Part|Adverse Event|0|||
149169506|NCT02901431|538092301|FG008|PK Part|Adverse Event|0|||
149169507|NCT02901431|538092302|FG009|PK Part|Adverse Event|0|||
149169508|NCT02901431|538092303|FG010|PK Part|Adverse Event|0|||
149169509|NCT02901431|538092304|FG011|PK Part|Adverse Event|0|||
149169510|NCT02901431|538092305|FG012|PK Part|Adverse Event|0|||
149169511|NCT02901431|538092293|FG000|PK Part|Lost to Follow-up|0|||
149169512|NCT02901431|538092294|FG001|PK Part|Lost to Follow-up|0|||
149169513|NCT02901431|538092295|FG002|PK Part|Lost to Follow-up|1|||
149169514|NCT02901431|538092296|FG003|PK Part|Lost to Follow-up|0|||
148677754|NCT00563524|536293558|FG001|Overall Study|Withdrawal by Subject|1|||
148677755|NCT00563524|536293559|FG002|Overall Study|Withdrawal by Subject|3|||
148677756|NCT00563524|536293560|FG003|Overall Study|Withdrawal by Subject|0|||
148677757|NCT00563524|536293561|FG004|Overall Study|Withdrawal by Subject|0|||
148677758|NCT00563524|536293562|FG005|Overall Study|Withdrawal by Subject|1|||
148677759|NCT01084603|536293566|FG000|Baseline|Withdrawal by Subject|2|||
148677760|NCT01084603|536293566|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
148677761|NCT01084603|536293566|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
148677762|NCT01084603|536293566|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
148677763|NCT01084603|536293566|FG000|Washout Period 4|Adverse Event|1|||
148677764|NCT00948025|536293568|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
148677765|NCT00948025|536293569|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
148677766|NCT00948025|536293568|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
148677767|NCT00948025|536293569|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
148677768|NCT00948025|536293568|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
148677769|NCT00948025|536293569|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
148677770|NCT01508325|536293570|FG000|Overall Study|Withdrawal by Subject|8|||
148677771|NCT01508325|536293571|FG001|Overall Study|Withdrawal by Subject|9|||
148677772|NCT01508325|536293570|FG000|Overall Study|Protocol Violation|0|||
149169515|NCT02901431|538092297|FG004|PK Part|Lost to Follow-up|0|||
149169516|NCT02901431|538092298|FG005|PK Part|Lost to Follow-up|0|||
149169517|NCT02901431|538092299|FG006|PK Part|Lost to Follow-up|0|||
149169518|NCT02901431|538092300|FG007|PK Part|Lost to Follow-up|0|||
149169519|NCT02901431|538092301|FG008|PK Part|Lost to Follow-up|0|||
149169520|NCT02901431|538092302|FG009|PK Part|Lost to Follow-up|0|||
149169521|NCT02901431|538092303|FG010|PK Part|Lost to Follow-up|0|||
149169522|NCT02901431|538092304|FG011|PK Part|Lost to Follow-up|0|||
148677773|NCT01508325|536293571|FG001|Overall Study|Protocol Violation|3|||
148677774|NCT01508325|536293570|FG000|Overall Study|Physician Decision|2|||
148677775|NCT01508325|536293571|FG001|Overall Study|Physician Decision|1|||
148677776|NCT01508325|536293570|FG000|Overall Study|Adverse Event|1|||
149169523|NCT02901431|538092305|FG012|PK Part|Lost to Follow-up|0|||
149169524|NCT02901431|538092293|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
149169525|NCT02901431|538092294|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169526|NCT02901431|538092295|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169527|NCT02901431|538092296|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169528|NCT02901431|538092297|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169529|NCT02901431|538092298|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169530|NCT02901431|538092299|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169531|NCT02901431|538092300|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169532|NCT02901431|538092301|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169533|NCT02901431|538092302|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169534|NCT02901431|538092303|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169535|NCT02901431|538092304|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169536|NCT02901431|538092305|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
149169537|NCT02901431|538092293|FG000|PK Part|Pending dose confirmation|0|||
149169538|NCT02901431|538092294|FG001|PK Part|Pending dose confirmation|1|||
149169539|NCT02901431|538092295|FG002|PK Part|Pending dose confirmation|0|||
149169540|NCT02901431|538092296|FG003|PK Part|Pending dose confirmation|0|||
149169541|NCT02901431|538092297|FG004|PK Part|Pending dose confirmation|0|||
149169542|NCT02901431|538092298|FG005|PK Part|Pending dose confirmation|0|||
149169543|NCT02901431|538092299|FG006|PK Part|Pending dose confirmation|0|||
149169544|NCT02901431|538092300|FG007|PK Part|Pending dose confirmation|0|||
149169545|NCT02901431|538092301|FG008|PK Part|Pending dose confirmation|0|||
149169546|NCT02901431|538092302|FG009|PK Part|Pending dose confirmation|0|||
149169547|NCT02901431|538092303|FG010|PK Part|Pending dose confirmation|0|||
149169548|NCT02901431|538092304|FG011|PK Part|Pending dose confirmation|0|||
149169549|NCT02901431|538092305|FG012|PK Part|Pending dose confirmation|0|||
149169550|NCT02901431|538092293|FG000|PK Part|8 weeks of treatment ran out|2|||
149169551|NCT02901431|538092294|FG001|PK Part|8 weeks of treatment ran out|0|||
149169552|NCT02901431|538092295|FG002|PK Part|8 weeks of treatment ran out|0|||
149169553|NCT02901431|538092296|FG003|PK Part|8 weeks of treatment ran out|0|||
149169554|NCT02901431|538092297|FG004|PK Part|8 weeks of treatment ran out|0|||
149169555|NCT02901431|538092298|FG005|PK Part|8 weeks of treatment ran out|0|||
149169556|NCT02901431|538092299|FG006|PK Part|8 weeks of treatment ran out|0|||
149169557|NCT02901431|538092300|FG007|PK Part|8 weeks of treatment ran out|0|||
149169558|NCT02901431|538092301|FG008|PK Part|8 weeks of treatment ran out|0|||
149169559|NCT02901431|538092302|FG009|PK Part|8 weeks of treatment ran out|0|||
149169560|NCT02901431|538092303|FG010|PK Part|8 weeks of treatment ran out|0|||
149169561|NCT02901431|538092304|FG011|PK Part|8 weeks of treatment ran out|0|||
149169562|NCT02901431|538092305|FG012|PK Part|8 weeks of treatment ran out|0|||
149169563|NCT02901431|538092293|FG000|PK Part|Stopped treatment after 8 weeks|1|||
149169564|NCT02901431|538092294|FG001|PK Part|Stopped treatment after 8 weeks|0|||
149169565|NCT02901431|538092295|FG002|PK Part|Stopped treatment after 8 weeks|1|||
149169566|NCT02901431|538092296|FG003|PK Part|Stopped treatment after 8 weeks|0|||
149169567|NCT02901431|538092297|FG004|PK Part|Stopped treatment after 8 weeks|0|||
149169568|NCT02901431|538092298|FG005|PK Part|Stopped treatment after 8 weeks|0|||
149169569|NCT02901431|538092299|FG006|PK Part|Stopped treatment after 8 weeks|0|||
149169570|NCT02901431|538092300|FG007|PK Part|Stopped treatment after 8 weeks|0|||
149169571|NCT02901431|538092301|FG008|PK Part|Stopped treatment after 8 weeks|0|||
149169572|NCT02901431|538092302|FG009|PK Part|Stopped treatment after 8 weeks|0|||
149169573|NCT02901431|538092303|FG010|PK Part|Stopped treatment after 8 weeks|0|||
149169574|NCT02901431|538092304|FG011|PK Part|Stopped treatment after 8 weeks|0|||
149169575|NCT02901431|538092305|FG012|PK Part|Stopped treatment after 8 weeks|0|||
149169576|NCT02901431|538092293|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
149169577|NCT02901431|538092294|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169578|NCT02901431|538092295|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
149169579|NCT02901431|538092296|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169580|NCT02901431|538092297|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169581|NCT02901431|538092298|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169582|NCT02901431|538092299|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169583|NCT02901431|538092300|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169584|NCT02901431|538092301|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169585|NCT02901431|538092302|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169586|NCT02901431|538092303|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169587|NCT02901431|538092304|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169588|NCT02901431|538092305|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
149169589|NCT02901431|538092293|FG000|PK Part|Discontinued per Sponsor|0|||
149169590|NCT02901431|538092294|FG001|PK Part|Discontinued per Sponsor|3|||
149169591|NCT02901431|538092295|FG002|PK Part|Discontinued per Sponsor|0|||
148677777|NCT01508325|536293571|FG001|Overall Study|Adverse Event|0|||
148677778|NCT01508325|536293570|FG000|Overall Study|Lost to Follow-up|5|||
149169592|NCT02901431|538092296|FG003|PK Part|Discontinued per Sponsor|0|||
149169593|NCT02901431|538092297|FG004|PK Part|Discontinued per Sponsor|0|||
149169594|NCT02901431|538092298|FG005|PK Part|Discontinued per Sponsor|0|||
148677779|NCT01508325|536293571|FG001|Overall Study|Lost to Follow-up|6|||
148677780|NCT01508325|536293570|FG000|Overall Study|Other|2|||
148677781|NCT01508325|536293571|FG001|Overall Study|Other|2|||
148677782|NCT01392170|536293572|FG000|Overall Study|Withdrawal by Subject|1|||
148677783|NCT01392170|536293572|FG000|Overall Study|Ineligible|1|||
148677784|NCT03543046|536293578|FG000|Overall Study|Adverse Event|1|||
148677785|NCT03543046|536293579|FG001|Overall Study|Adverse Event|1|||
148677786|NCT03543046|536293578|FG000|Overall Study|Physician Decision|1|||
148677787|NCT03543046|536293579|FG001|Overall Study|Physician Decision|1|||
148677788|NCT03543046|536293578|FG000|Overall Study|Protocol Violation|1|||
148677789|NCT03543046|536293579|FG001|Overall Study|Protocol Violation|0|||
148677790|NCT00520494|536293580|FG000|Overall Study|Withdrawal by Subject|1|||
149169595|NCT02901431|538092299|FG006|PK Part|Discontinued per Sponsor|0|||
149169596|NCT02901431|538092300|FG007|PK Part|Discontinued per Sponsor|0|||
149169597|NCT02901431|538092301|FG008|PK Part|Discontinued per Sponsor|0|||
149169598|NCT02901431|538092302|FG009|PK Part|Discontinued per Sponsor|0|||
149169599|NCT02901431|538092303|FG010|PK Part|Discontinued per Sponsor|0|||
149169600|NCT02901431|538092304|FG011|PK Part|Discontinued per Sponsor|0|||
149169601|NCT02901431|538092305|FG012|PK Part|Discontinued per Sponsor|0|||
149169602|NCT02901431|538092293|FG000|PK Part|Withdrawal by Subject|1|||
149169603|NCT02901431|538092294|FG001|PK Part|Withdrawal by Subject|1|||
149169604|NCT02901431|538092295|FG002|PK Part|Withdrawal by Subject|3|||
149169605|NCT02901431|538092296|FG003|PK Part|Withdrawal by Subject|0|||
149169606|NCT02901431|538092297|FG004|PK Part|Withdrawal by Subject|0|||
149169607|NCT02901431|538092298|FG005|PK Part|Withdrawal by Subject|0|||
149169608|NCT02901431|538092299|FG006|PK Part|Withdrawal by Subject|0|||
149169609|NCT02901431|538092300|FG007|PK Part|Withdrawal by Subject|0|||
148677791|NCT04247594|536293581|FG000|Overall Study|Withdrawal by Subject|4|||
148677792|NCT00713830|536293582|FG000|Overall Study|Adverse Event|23|||
148677793|NCT00713830|536293583|FG001|Overall Study|Adverse Event|71|||
148677794|NCT00713830|536293582|FG000|Overall Study|Lack of Efficacy|24|||
148677795|NCT00713830|536293583|FG001|Overall Study|Lack of Efficacy|16|||
148677796|NCT00713830|536293582|FG000|Overall Study|Lost to Follow-up|2|||
148677797|NCT00713830|536293583|FG001|Overall Study|Lost to Follow-up|9|||
148677798|NCT00713830|536293582|FG000|Overall Study|Withdrawal by Subject|13|||
148677799|NCT00713830|536293583|FG001|Overall Study|Withdrawal by Subject|23|||
148677800|NCT00713830|536293582|FG000|Overall Study|Poor Compliance to Protocol|7|||
149169610|NCT02901431|538092301|FG008|PK Part|Withdrawal by Subject|0|||
149169611|NCT02901431|538092302|FG009|PK Part|Withdrawal by Subject|0|||
149169612|NCT02901431|538092303|FG010|PK Part|Withdrawal by Subject|0|||
149169613|NCT02901431|538092304|FG011|PK Part|Withdrawal by Subject|0|||
149169614|NCT02901431|538092305|FG012|PK Part|Withdrawal by Subject|0|||
149169615|NCT02901431|538092293|FG000|Main Treatment Part|Adverse Event|0|||
149169616|NCT02901431|538092294|FG001|Main Treatment Part|Adverse Event|0|||
149169617|NCT02901431|538092295|FG002|Main Treatment Part|Adverse Event|0|||
149169618|NCT02901431|538092296|FG003|Main Treatment Part|Adverse Event|3|||
149169619|NCT02901431|538092297|FG004|Main Treatment Part|Adverse Event|3|||
149169620|NCT02901431|538092298|FG005|Main Treatment Part|Adverse Event|4|||
149169621|NCT02901431|538092299|FG006|Main Treatment Part|Adverse Event|1|||
149169622|NCT02901431|538092300|FG007|Main Treatment Part|Adverse Event|0|||
149169623|NCT02901431|538092301|FG008|Main Treatment Part|Adverse Event|0|||
149169624|NCT02901431|538092302|FG009|Main Treatment Part|Adverse Event|0|||
149169625|NCT02901431|538092303|FG010|Main Treatment Part|Adverse Event|0|||
149169626|NCT02901431|538092304|FG011|Main Treatment Part|Adverse Event|0|||
148677801|NCT00713830|536293583|FG001|Overall Study|Poor Compliance to Protocol|14|||
148677802|NCT00713830|536293582|FG000|Overall Study|Familial and Personal Reasons|9|||
148677803|NCT00713830|536293583|FG001|Overall Study|Familial and Personal Reasons|34|||
148677804|NCT00713830|536293582|FG000|Overall Study|Sponsor Decision|4|||
148677805|NCT00713830|536293583|FG001|Overall Study|Sponsor Decision|10|||
148677806|NCT00422058|536293584|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
148677807|NCT00422058|536293585|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
148677808|NCT00422058|536293586|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
148677809|NCT00422058|536293587|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
149169627|NCT02901431|538092305|FG012|Main Treatment Part|Adverse Event|0|||
149169628|NCT02901431|538092293|FG000|Main Treatment Part|Lack of Efficacy|0|||
148677810|NCT00422058|536293588|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
148677811|NCT00422058|536293589|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
149169629|NCT02901431|538092294|FG001|Main Treatment Part|Lack of Efficacy|0|||
149169630|NCT02901431|538092295|FG002|Main Treatment Part|Lack of Efficacy|0|||
149169631|NCT02901431|538092296|FG003|Main Treatment Part|Lack of Efficacy|1|||
149169632|NCT02901431|538092297|FG004|Main Treatment Part|Lack of Efficacy|0|||
149169633|NCT02901431|538092298|FG005|Main Treatment Part|Lack of Efficacy|0|||
149169634|NCT02901431|538092299|FG006|Main Treatment Part|Lack of Efficacy|0|||
149169635|NCT02901431|538092300|FG007|Main Treatment Part|Lack of Efficacy|0|||
149169636|NCT02901431|538092301|FG008|Main Treatment Part|Lack of Efficacy|0|||
149169637|NCT02901431|538092302|FG009|Main Treatment Part|Lack of Efficacy|0|||
149169638|NCT02901431|538092303|FG010|Main Treatment Part|Lack of Efficacy|0|||
149169639|NCT02901431|538092304|FG011|Main Treatment Part|Lack of Efficacy|0|||
149169640|NCT02901431|538092305|FG012|Main Treatment Part|Lack of Efficacy|0|||
149169641|NCT02901431|538092293|FG000|Main Treatment Part|Lost to Follow-up|0|||
149169642|NCT02901431|538092294|FG001|Main Treatment Part|Lost to Follow-up|0|||
149169643|NCT02901431|538092295|FG002|Main Treatment Part|Lost to Follow-up|0|||
149169644|NCT02901431|538092296|FG003|Main Treatment Part|Lost to Follow-up|3|||
149169645|NCT02901431|538092297|FG004|Main Treatment Part|Lost to Follow-up|1|||
149169646|NCT02901431|538092298|FG005|Main Treatment Part|Lost to Follow-up|2|||
149169647|NCT02901431|538092299|FG006|Main Treatment Part|Lost to Follow-up|3|||
149169648|NCT02901431|538092300|FG007|Main Treatment Part|Lost to Follow-up|0|||
149169649|NCT02901431|538092301|FG008|Main Treatment Part|Lost to Follow-up|0|||
149169650|NCT02901431|538092302|FG009|Main Treatment Part|Lost to Follow-up|0|||
149169651|NCT02901431|538092303|FG010|Main Treatment Part|Lost to Follow-up|0|||
149169652|NCT02901431|538092304|FG011|Main Treatment Part|Lost to Follow-up|0|||
149169653|NCT02901431|538092305|FG012|Main Treatment Part|Lost to Follow-up|0|||
149169654|NCT02901431|538092293|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
149169655|NCT02901431|538092294|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
149169656|NCT02901431|538092295|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
149169657|NCT02901431|538092296|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
149169658|NCT02901431|538092297|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
149169659|NCT02901431|538092298|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
149169660|NCT02901431|538092299|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
149169661|NCT02901431|538092300|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
149169662|NCT02901431|538092301|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
149169663|NCT02901431|538092302|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
149169664|NCT02901431|538092303|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
149169665|NCT02901431|538092304|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
149169666|NCT02901431|538092305|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
149169667|NCT02901431|538092293|FG000|Main Treatment Part|Physician Decision|0|||
149169668|NCT02901431|538092294|FG001|Main Treatment Part|Physician Decision|0|||
149169669|NCT02901431|538092295|FG002|Main Treatment Part|Physician Decision|0|||
149169670|NCT02901431|538092296|FG003|Main Treatment Part|Physician Decision|1|||
149169671|NCT02901431|538092297|FG004|Main Treatment Part|Physician Decision|0|||
149169672|NCT02901431|538092298|FG005|Main Treatment Part|Physician Decision|0|||
149169673|NCT02901431|538092299|FG006|Main Treatment Part|Physician Decision|1|||
149169674|NCT02901431|538092300|FG007|Main Treatment Part|Physician Decision|0|||
149169675|NCT02901431|538092301|FG008|Main Treatment Part|Physician Decision|0|||
149169676|NCT02901431|538092302|FG009|Main Treatment Part|Physician Decision|0|||
149169677|NCT02901431|538092303|FG010|Main Treatment Part|Physician Decision|0|||
149169678|NCT02901431|538092304|FG011|Main Treatment Part|Physician Decision|0|||
149169679|NCT02901431|538092305|FG012|Main Treatment Part|Physician Decision|0|||
149169680|NCT02901431|538092293|FG000|Main Treatment Part|Withdrawal by Subject|0|||
149169681|NCT02901431|538092294|FG001|Main Treatment Part|Withdrawal by Subject|0|||
149169682|NCT02901431|538092295|FG002|Main Treatment Part|Withdrawal by Subject|0|||
149169683|NCT02901431|538092296|FG003|Main Treatment Part|Withdrawal by Subject|18|||
149169684|NCT02901431|538092297|FG004|Main Treatment Part|Withdrawal by Subject|3|||
149169685|NCT02901431|538092298|FG005|Main Treatment Part|Withdrawal by Subject|5|||
149169686|NCT02901431|538092299|FG006|Main Treatment Part|Withdrawal by Subject|6|||
149169687|NCT02901431|538092300|FG007|Main Treatment Part|Withdrawal by Subject|0|||
149169688|NCT02901431|538092301|FG008|Main Treatment Part|Withdrawal by Subject|0|||
149169689|NCT02901431|538092302|FG009|Main Treatment Part|Withdrawal by Subject|0|||
149169690|NCT02901431|538092303|FG010|Main Treatment Part|Withdrawal by Subject|0|||
149169691|NCT02901431|538092304|FG011|Main Treatment Part|Withdrawal by Subject|0|||
149169692|NCT02901431|538092305|FG012|Main Treatment Part|Withdrawal by Subject|0|||
149169693|NCT02901431|538092293|FG000|Open Label Part|Adverse Event|0|||
149169694|NCT02901431|538092294|FG001|Open Label Part|Adverse Event|0|||
149169695|NCT02901431|538092295|FG002|Open Label Part|Adverse Event|0|||
149169696|NCT02901431|538092296|FG003|Open Label Part|Adverse Event|0|||
149169697|NCT02901431|538092297|FG004|Open Label Part|Adverse Event|0|||
149169698|NCT02901431|538092298|FG005|Open Label Part|Adverse Event|0|||
149169699|NCT02901431|538092299|FG006|Open Label Part|Adverse Event|0|||
149169700|NCT02901431|538092300|FG007|Open Label Part|Adverse Event|0|||
149169701|NCT02901431|538092301|FG008|Open Label Part|Adverse Event|4|||
149169702|NCT02901431|538092302|FG009|Open Label Part|Adverse Event|4|||
149169703|NCT02901431|538092303|FG010|Open Label Part|Adverse Event|0|||
149169704|NCT02901431|538092304|FG011|Open Label Part|Adverse Event|4|||
149169705|NCT02901431|538092305|FG012|Open Label Part|Adverse Event|1|||
149169706|NCT02901431|538092293|FG000|Open Label Part|Lost to Follow-up|0|||
149169707|NCT02901431|538092294|FG001|Open Label Part|Lost to Follow-up|0|||
149169708|NCT02901431|538092295|FG002|Open Label Part|Lost to Follow-up|0|||
149169709|NCT02901431|538092296|FG003|Open Label Part|Lost to Follow-up|0|||
149169710|NCT02901431|538092297|FG004|Open Label Part|Lost to Follow-up|0|||
149169711|NCT02901431|538092298|FG005|Open Label Part|Lost to Follow-up|0|||
149169712|NCT02901431|538092299|FG006|Open Label Part|Lost to Follow-up|0|||
149169713|NCT02901431|538092300|FG007|Open Label Part|Lost to Follow-up|0|||
149169714|NCT02901431|538092301|FG008|Open Label Part|Lost to Follow-up|2|||
149169715|NCT02901431|538092302|FG009|Open Label Part|Lost to Follow-up|2|||
149169716|NCT02901431|538092303|FG010|Open Label Part|Lost to Follow-up|1|||
149169717|NCT02901431|538092304|FG011|Open Label Part|Lost to Follow-up|1|||
149169718|NCT02901431|538092305|FG012|Open Label Part|Lost to Follow-up|1|||
149169719|NCT02901431|538092293|FG000|Open Label Part|Physician Decision|0|||
149169720|NCT02901431|538092294|FG001|Open Label Part|Physician Decision|0|||
149169721|NCT02901431|538092295|FG002|Open Label Part|Physician Decision|0|||
149169722|NCT02901431|538092296|FG003|Open Label Part|Physician Decision|0|||
149169723|NCT02901431|538092297|FG004|Open Label Part|Physician Decision|0|||
149169724|NCT02901431|538092298|FG005|Open Label Part|Physician Decision|0|||
149169725|NCT02901431|538092299|FG006|Open Label Part|Physician Decision|0|||
149169726|NCT02901431|538092300|FG007|Open Label Part|Physician Decision|0|||
149169727|NCT02901431|538092301|FG008|Open Label Part|Physician Decision|1|||
149169728|NCT02901431|538092302|FG009|Open Label Part|Physician Decision|1|||
149169729|NCT02901431|538092303|FG010|Open Label Part|Physician Decision|0|||
149169730|NCT02901431|538092304|FG011|Open Label Part|Physician Decision|0|||
149169731|NCT02901431|538092305|FG012|Open Label Part|Physician Decision|0|||
149169732|NCT02901431|538092293|FG000|Open Label Part|Study Terminated By Sponsor|0|||
149169733|NCT02901431|538092294|FG001|Open Label Part|Study Terminated By Sponsor|0|||
149169734|NCT02901431|538092295|FG002|Open Label Part|Study Terminated By Sponsor|0|||
149169735|NCT02901431|538092296|FG003|Open Label Part|Study Terminated By Sponsor|0|||
149169736|NCT02901431|538092297|FG004|Open Label Part|Study Terminated By Sponsor|0|||
149169737|NCT02901431|538092298|FG005|Open Label Part|Study Terminated By Sponsor|0|||
149169738|NCT02901431|538092299|FG006|Open Label Part|Study Terminated By Sponsor|0|||
149169739|NCT02901431|538092300|FG007|Open Label Part|Study Terminated By Sponsor|0|||
149169740|NCT02901431|538092301|FG008|Open Label Part|Study Terminated By Sponsor|35|||
149169741|NCT02901431|538092302|FG009|Open Label Part|Study Terminated By Sponsor|12|||
149169742|NCT02901431|538092303|FG010|Open Label Part|Study Terminated By Sponsor|21|||
149169743|NCT02901431|538092304|FG011|Open Label Part|Study Terminated By Sponsor|31|||
149169744|NCT02901431|538092305|FG012|Open Label Part|Study Terminated By Sponsor|0|||
149169745|NCT02901431|538092293|FG000|Open Label Part|Withdrawal by Subject|0|||
149169746|NCT02901431|538092294|FG001|Open Label Part|Withdrawal by Subject|0|||
149169747|NCT02901431|538092295|FG002|Open Label Part|Withdrawal by Subject|0|||
148677812|NCT00422058|536293584|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
148677813|NCT00422058|536293585|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
149169748|NCT02901431|538092296|FG003|Open Label Part|Withdrawal by Subject|0|||
148677814|NCT00422058|536293586|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
148677815|NCT00422058|536293587|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
148677816|NCT00422058|536293588|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
149169749|NCT02901431|538092297|FG004|Open Label Part|Withdrawal by Subject|0|||
149169750|NCT02901431|538092298|FG005|Open Label Part|Withdrawal by Subject|0|||
149169751|NCT02901431|538092299|FG006|Open Label Part|Withdrawal by Subject|0|||
149169752|NCT02901431|538092300|FG007|Open Label Part|Withdrawal by Subject|0|||
149169753|NCT02901431|538092301|FG008|Open Label Part|Withdrawal by Subject|6|||
149169754|NCT02901431|538092302|FG009|Open Label Part|Withdrawal by Subject|5|||
149169755|NCT02901431|538092303|FG010|Open Label Part|Withdrawal by Subject|7|||
149169756|NCT02901431|538092304|FG011|Open Label Part|Withdrawal by Subject|3|||
149169757|NCT02901431|538092305|FG012|Open Label Part|Withdrawal by Subject|1|||
149169758|NCT03440944|538092306|FG000|Overall Study|Physician Decision|1|||
149169759|NCT03440944|538092307|FG001|Overall Study|Physician Decision|0|||
149169760|NCT03440944|538092306|FG000|Overall Study|No Acceptable Vasculature|0|||
149169761|NCT03440944|538092307|FG001|Overall Study|No Acceptable Vasculature|1|||
149169762|NCT04672083|538092308|FG000|Overall Study|Lost to Follow-up|1|||
149169763|NCT04672083|538092309|FG001|Overall Study|Lost to Follow-up|0|||
149169764|NCT04672083|538092310|FG002|Overall Study|Lost to Follow-up|0|||
149169765|NCT04672083|538092311|FG003|Overall Study|Lost to Follow-up|0|||
149169766|NCT04672083|538092312|FG004|Overall Study|Lost to Follow-up|0|||
149169767|NCT01661790|538092313|FG000|Overall Study|Lost to Follow-up|0|||
149169768|NCT01661790|538092314|FG001|Overall Study|Lost to Follow-up|2|||
149169769|NCT02048904|538092317|FG000|Overall Study|Withdrawal by Subject|7|||
149169770|NCT02048904|538092317|FG000|Overall Study|Physician Decision|70|||
149169771|NCT03832387|538092320|FG000|Overall Study|Protocol Violation|2|||
149169772|NCT03832387|538092321|FG001|Overall Study|Protocol Violation|6|||
149169773|NCT03832387|538092320|FG000|Overall Study|EXCLUSION CRITERIA|3|||
149169774|NCT03832387|538092321|FG001|Overall Study|EXCLUSION CRITERIA|1|||
149169775|NCT05775289|538092322|FG000|Overall Study|Study Ongoing|20|||
149169776|NCT05775289|538092323|FG001|Overall Study|Study Ongoing|53|||
149169777|NCT05775289|538092324|FG002|Overall Study|Study Ongoing|15|||
149169778|NCT05775289|538092325|FG003|Overall Study|Study Ongoing|55|||
149169779|NCT05775289|538092322|FG000|Overall Study|Death|4|||
149169780|NCT05775289|538092323|FG001|Overall Study|Death|11|||
149169781|NCT05775289|538092324|FG002|Overall Study|Death|8|||
149169782|NCT05775289|538092325|FG003|Overall Study|Death|12|||
149169783|NCT05775289|538092322|FG000|Overall Study|Lost to Follow-up|0|||
149169784|NCT05775289|538092323|FG001|Overall Study|Lost to Follow-up|1|||
149169785|NCT05775289|538092324|FG002|Overall Study|Lost to Follow-up|0|||
149169786|NCT05775289|538092325|FG003|Overall Study|Lost to Follow-up|0|||
149169787|NCT05775289|538092322|FG000|Overall Study|Progressive Disease|0|||
149169788|NCT05775289|538092323|FG001|Overall Study|Progressive Disease|0|||
149169789|NCT05775289|538092324|FG002|Overall Study|Progressive Disease|1|||
149169790|NCT05775289|538092325|FG003|Overall Study|Progressive Disease|0|||
149169791|NCT05775289|538092322|FG000|Overall Study|Withdrawal by Subject|1|||
149169792|NCT05775289|538092323|FG001|Overall Study|Withdrawal by Subject|1|||
149169793|NCT05775289|538092324|FG002|Overall Study|Withdrawal by Subject|0|||
149169794|NCT05775289|538092325|FG003|Overall Study|Withdrawal by Subject|0|||
149169795|NCT00490542|538092327|FG000|Overall Study|Lost to Follow-up|3|||
149169796|NCT00490542|538092328|FG001|Overall Study|Lost to Follow-up|0|||
149169797|NCT00490542|538092327|FG000|Overall Study|Adverse Event|3|||
149169798|NCT00490542|538092328|FG001|Overall Study|Adverse Event|3|||
149169799|NCT00490542|538092327|FG000|Overall Study|Lack of Efficacy|1|||
149169800|NCT00490542|538092328|FG001|Overall Study|Lack of Efficacy|1|||
149169801|NCT04743856|538092329|FG000|Overall Study|Lost to Follow-up|6|||
149169802|NCT04743856|538092330|FG001|Overall Study|Lost to Follow-up|7|||
149169803|NCT04743856|538092329|FG000|Overall Study|Withdrawal by Subject|1|||
149169804|NCT04743856|538092330|FG001|Overall Study|Withdrawal by Subject|0|||
149169805|NCT04439188|538092331|FG000|Overall Study|Ineligible|3|||
149169806|NCT04439188|538092331|FG000|Overall Study|Adverse Event|4|||
149169807|NCT04439188|538092331|FG000|Overall Study|Death|1|||
149169808|NCT04439188|538092331|FG000|Overall Study|Disease Progression|25|||
149169809|NCT04439188|538092331|FG000|Overall Study|Withdrawal by Subject|2|||
149169810|NCT01813890|538092334|FG000|Overall Study|Adverse Event|0|||
149169811|NCT01813890|538092335|FG001|Overall Study|Adverse Event|3|||
149169812|NCT01813890|538092336|FG002|Overall Study|Adverse Event|4|||
149169813|NCT01813890|538092334|FG000|Overall Study|Lack of Efficacy|9|||
149169814|NCT01813890|538092335|FG001|Overall Study|Lack of Efficacy|1|||
149169815|NCT01813890|538092336|FG002|Overall Study|Lack of Efficacy|2|||
149169816|NCT04482647|538092337|FG000|Overall Study|Time constraints|2|||
149169817|NCT04482647|538092337|FG000|Overall Study|Health issues|1|||
149169818|NCT04482647|538092337|FG000|Overall Study|Death in the family|1|||
149169819|NCT04482647|538092337|FG000|Overall Study|Disliked the intervention|1|||
149169820|NCT04482647|538092337|FG000|Overall Study|No reasons specified|7|||
149169821|NCT00655928|538092342|FG000|Overall Study|Withdrawal by Subject|2|||
149169822|NCT00655928|538092343|FG001|Overall Study|Withdrawal by Subject|1|||
149169823|NCT00655928|538092342|FG000|Overall Study|Physician Decision|1|||
149169824|NCT00655928|538092343|FG001|Overall Study|Physician Decision|1|||
149169825|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
149169826|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
149169827|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
149169828|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
149169829|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
149169830|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
149169831|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
149169832|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
149169833|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
149169834|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
149169835|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
149169836|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
149169837|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
149169838|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
149169839|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
149169840|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
149169841|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
149169842|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
149169843|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
149169844|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149169845|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149169846|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149169847|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149169848|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
149169849|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
149169850|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
149169851|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
149169852|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
149169853|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
149169854|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
149169855|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
149169856|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
149169857|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
149169858|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
149169859|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
149169860|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
149169861|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
149169862|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
149169863|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
149169864|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
149169865|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
149169866|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
149169867|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
148677817|NCT00422058|536293589|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
148677818|NCT00422058|536293584|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
148677819|NCT00422058|536293585|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
148677820|NCT00422058|536293586|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
148677821|NCT00422058|536293587|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
148677822|NCT00422058|536293588|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
148677823|NCT00422058|536293589|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
149169868|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
149169869|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
149169870|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
149169871|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
149169872|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
149169873|NCT01707992|538092344|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
149169874|NCT01707992|538092345|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
149169875|NCT01707992|538092346|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
149169876|NCT01707992|538092347|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
149169877|NCT01707992|538092348|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
149169878|NCT01707992|538092349|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
149169879|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
149169880|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
149169881|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
149169882|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
149169883|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
149169884|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
149169885|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
149169886|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
149169887|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
149169888|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
149169889|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
149169890|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
149169891|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
149169892|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
149169893|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
149169894|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
149169895|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
149169896|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
149169897|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
149169898|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
149169899|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
149169900|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
149169901|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
149169902|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
149169903|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
149169904|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
149169905|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
149169906|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
149169907|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
149169908|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
149169909|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Death|0|||
149169910|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Death|0|||
149169911|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Death|0|||
149169912|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Death|2|||
149169913|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Death|0|||
149169914|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Death|0|||
149169915|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
149169916|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
149169917|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
149169918|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
149169919|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
149169920|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
149169921|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
149169922|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
149169923|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
149169924|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
149169925|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
149169926|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
149169927|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
149169928|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
149169929|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
149169930|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
149169931|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
149169932|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
149169933|NCT01707992|538092344|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149169934|NCT01707992|538092345|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149169935|NCT01707992|538092346|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149169936|NCT01707992|538092347|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149169937|NCT01707992|538092348|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
149169938|NCT01707992|538092349|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
149169939|NCT00998738|538092351|FG000|Overall Study|Uknown|1|||
149169940|NCT04211337|538092352|FG000|Overall Study|On Treatment|175|||
149169941|NCT04211337|538092353|FG001|Overall Study|On Treatment|40|||
149169942|NCT04211337|538092352|FG000|Overall Study|Withdrawal by Subject|0|||
149169943|NCT04211337|538092353|FG001|Overall Study|Withdrawal by Subject|2|||
149169944|NCT04980391|538092356|FG000|Overall Study|Death|0|||
149169945|NCT04980391|538092357|FG001|Overall Study|Death|0|||
149169946|NCT04980391|538092358|FG002|Overall Study|Death|1|||
149169947|NCT04980391|538092359|FG003|Overall Study|Death|1|||
149169948|NCT04980391|538092356|FG000|Overall Study|Lost to Follow-up|3|||
149169949|NCT04980391|538092357|FG001|Overall Study|Lost to Follow-up|3|||
149169950|NCT04980391|538092358|FG002|Overall Study|Lost to Follow-up|2|||
149169951|NCT04980391|538092359|FG003|Overall Study|Lost to Follow-up|3|||
149169952|NCT04980391|538092356|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
149169953|NCT04980391|538092357|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
149169954|NCT04980391|538092358|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
149169955|NCT04980391|538092359|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
149169956|NCT04980391|538092356|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149169957|NCT04980391|538092357|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149169958|NCT04980391|538092358|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
149169959|NCT04980391|538092359|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149169960|NCT04980391|538092356|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
149169961|NCT04980391|538092357|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
149169962|NCT04980391|538092358|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
149169963|NCT04980391|538092359|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
149169964|NCT00162773|538094344|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
149169965|NCT00215150|538094347|FG000|Open Label Phase|Lost to Follow-up|7|||
149169966|NCT00215150|538094347|FG000|Open Label Phase|Withdrawal by Subject|1|||
149169967|NCT00215150|538094347|FG000|Open Label Phase|Did not complete a post base visit|13|||
149169968|NCT00215150|538094347|FG000|Open Label Phase|Did not meet randomization criteria|9|||
149169969|NCT00215150|538094347|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
149169970|NCT00215150|538094347|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
149169971|NCT00215150|538094347|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
149169972|NCT03124459|538094353|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
148806276|NCT05001620|536768938|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
149169973|NCT03124459|538094354|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149169974|NCT03124459|538094355|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149169975|NCT03124459|538094356|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149169976|NCT03124459|538094357|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
149169977|NCT03124459|538094358|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
149169978|NCT03124459|538094353|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149169979|NCT03124459|538094354|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149169980|NCT03124459|538094355|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149169981|NCT03124459|538094356|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149169982|NCT03124459|538094357|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
149169983|NCT03124459|538094358|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
149169984|NCT03124459|538094353|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149169985|NCT03124459|538094354|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149169986|NCT03124459|538094355|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149169987|NCT03124459|538094356|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
149169988|NCT03124459|538094357|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
149169989|NCT03124459|538094358|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
149169990|NCT03124459|538094353|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149169991|NCT03124459|538094354|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149169992|NCT03124459|538094355|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149169993|NCT03124459|538094356|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
149169994|NCT03124459|538094357|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
149169995|NCT03124459|538094358|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
149169996|NCT03124459|538094353|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149169997|NCT03124459|538094354|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149169998|NCT03124459|538094355|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149169999|NCT03124459|538094356|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149170000|NCT03124459|538094357|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
149170001|NCT03124459|538094358|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
149170002|NCT03124459|538094353|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149170003|NCT03124459|538094354|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149170004|NCT03124459|538094355|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149170005|NCT03124459|538094356|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149170006|NCT03124459|538094357|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
149170007|NCT03124459|538094358|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
149170008|NCT01903876|538094359|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
149170009|NCT01903876|538094360|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
149170010|NCT01903876|538094359|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
149170011|NCT01903876|538094360|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
149170012|NCT00278629|538094368|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
149170013|NCT00603239|538094373|FG000|Overall Study|Adverse Event|4|||
149170014|NCT00603239|538094374|FG001|Overall Study|Adverse Event|1|||
149170015|NCT00603239|538094373|FG000|Overall Study|Entry criteria not met|0|||
149170016|NCT00603239|538094374|FG001|Overall Study|Entry criteria not met|1|||
149170017|NCT00603239|538094373|FG000|Overall Study|Loss of glucose control|3|||
149170018|NCT00603239|538094374|FG001|Overall Study|Loss of glucose control|0|||
149170019|NCT00603239|538094373|FG000|Overall Study|Lost to Follow-up|2|||
149170020|NCT00603239|538094374|FG001|Overall Study|Lost to Follow-up|1|||
149170021|NCT00603239|538094373|FG000|Overall Study|Physician Decision|2|||
149170022|NCT00603239|538094374|FG001|Overall Study|Physician Decision|0|||
149170023|NCT00603239|538094373|FG000|Overall Study|Protocol Violation|2|||
149170024|NCT00603239|538094374|FG001|Overall Study|Protocol Violation|0|||
149170025|NCT00603239|538094373|FG000|Overall Study|Subject decision|2|||
149170026|NCT00603239|538094374|FG001|Overall Study|Subject decision|1|||
149170027|NCT01562028|538094376|FG000|Overall Study|Withdrawal by Subject|1|||
149170028|NCT01562028|538094377|FG001|Overall Study|Withdrawal by Subject|1|||
149170029|NCT01562028|538094376|FG000|Overall Study|Lost to Follow-up|2|||
149170030|NCT01562028|538094377|FG001|Overall Study|Lost to Follow-up|1|||
149170031|NCT03093402|538094380|FG000|Overall Study|Lost to Follow-up|1|||
149170032|NCT03093402|538094381|FG001|Overall Study|Lost to Follow-up|0|||
149170033|NCT03093402|538094382|FG002|Overall Study|Lost to Follow-up|0|||
149170034|NCT03093402|538094383|FG003|Overall Study|Lost to Follow-up|0|||
149170035|NCT03093402|538094380|FG000|Overall Study|Withdrawal by Subject|3|||
149170036|NCT03093402|538094381|FG001|Overall Study|Withdrawal by Subject|3|||
149170037|NCT03093402|538094382|FG002|Overall Study|Withdrawal by Subject|0|||
149170038|NCT03093402|538094383|FG003|Overall Study|Withdrawal by Subject|1|||
149170039|NCT03093402|538094380|FG000|Overall Study|Withdrew prior to dosing|2|||
149170040|NCT03093402|538094381|FG001|Overall Study|Withdrew prior to dosing|1|||
149170041|NCT03093402|538094382|FG002|Overall Study|Withdrew prior to dosing|2|||
149170042|NCT03093402|538094383|FG003|Overall Study|Withdrew prior to dosing|3|||
149170043|NCT03093402|538094380|FG000|Overall Study|Ineligible for study|1|||
148677824|NCT00422058|536293584|FG000|Double-Blind, Week 0-20|Other|11|||
148677825|NCT00422058|536293585|FG001|Double-Blind, Week 0-20|Other|3|||
148677826|NCT00422058|536293586|FG002|Double-Blind, Week 0-20|Other|8|||
148677827|NCT00422058|536293587|FG003|Double-Blind, Week 0-20|Other|8|||
148677828|NCT00422058|536293588|FG004|Double-Blind, Week 0-20|Other|4|||
148677829|NCT00422058|536293589|FG005|Double-Blind, Week 0-20|Other|10|||
148677830|NCT00422058|536293584|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
148677831|NCT00422058|536293585|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
148677832|NCT00422058|536293586|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
148677833|NCT00422058|536293587|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
148677834|NCT00422058|536293588|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
148677835|NCT00422058|536293589|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
148677836|NCT00422058|536293584|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
148677837|NCT00422058|536293585|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
148677838|NCT00422058|536293586|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
148677839|NCT00422058|536293587|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
148677840|NCT00422058|536293588|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
148677841|NCT00422058|536293589|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
148677842|NCT00422058|536293584|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
148677843|NCT00422058|536293585|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
148677844|NCT00422058|536293586|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
148677845|NCT00422058|536293587|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
148677846|NCT00422058|536293588|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
148677847|NCT00422058|536293589|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
148677848|NCT00422058|536293584|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
148677849|NCT00422058|536293585|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
148677850|NCT00422058|536293586|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
148677851|NCT00422058|536293587|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
148677852|NCT00422058|536293588|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
148677853|NCT00422058|536293589|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
148677854|NCT00422058|536293584|FG000|Open-Label Extension, Week 20-104|Other|13|||
148677855|NCT00422058|536293585|FG001|Open-Label Extension, Week 20-104|Other|14|||
148677856|NCT00422058|536293586|FG002|Open-Label Extension, Week 20-104|Other|6|||
148677857|NCT00422058|536293587|FG003|Open-Label Extension, Week 20-104|Other|13|||
148677858|NCT00422058|536293588|FG004|Open-Label Extension, Week 20-104|Other|16|||
148677859|NCT00422058|536293589|FG005|Open-Label Extension, Week 20-104|Other|18|||
148677860|NCT02787785|536293590|FG000|Overall Study|Death|3|||
148677861|NCT02787785|536293591|FG001|Overall Study|Death|4|||
148677862|NCT02787785|536293590|FG000|Overall Study|Lost to Follow-up|1|||
148677863|NCT02787785|536293591|FG001|Overall Study|Lost to Follow-up|1|||
148677864|NCT02787785|536293590|FG000|Overall Study|Withdrawal by Subject|0|||
148677865|NCT02787785|536293591|FG001|Overall Study|Withdrawal by Subject|5|||
148677866|NCT02030834|536293592|FG000|Overall Study|Death|4|||
148677867|NCT02030834|536293593|FG001|Overall Study|Death|0|||
148677868|NCT02030834|536293594|FG002|Overall Study|Death|0|||
148677869|NCT02030834|536293592|FG000|Overall Study|Manufacturing failure|2|||
148677870|NCT02030834|536293593|FG001|Overall Study|Manufacturing failure|0|||
148677871|NCT02030834|536293594|FG002|Overall Study|Manufacturing failure|1|||
148677872|NCT02030834|536293592|FG000|Overall Study|Disease progression|2|||
148677873|NCT02030834|536293593|FG001|Overall Study|Disease progression|0|||
148677874|NCT02030834|536293594|FG002|Overall Study|Disease progression|2|||
148677875|NCT02030834|536293592|FG000|Overall Study|Lost to Follow-up|1|||
148677876|NCT02030834|536293593|FG001|Overall Study|Lost to Follow-up|0|||
148677877|NCT02030834|536293594|FG002|Overall Study|Lost to Follow-up|0|||
148677878|NCT02030834|536293592|FG000|Overall Study|Withdrawal by Subject|1|||
148677879|NCT02030834|536293593|FG001|Overall Study|Withdrawal by Subject|0|||
148677880|NCT02030834|536293594|FG002|Overall Study|Withdrawal by Subject|0|||
148677881|NCT02030834|536293592|FG000|Overall Study|Lack of funding|1|||
148677882|NCT02030834|536293593|FG001|Overall Study|Lack of funding|0|||
148677883|NCT02030834|536293594|FG002|Overall Study|Lack of funding|0|||
148677884|NCT01766310|536293603|FG000|Overall Study|Lost to Follow-up|1|||
148677885|NCT01766310|536293604|FG001|Overall Study|Lost to Follow-up|3|||
148677886|NCT01591499|536293605|FG000|Baseline Visit|Withdrawal by Subject|0|||
148677887|NCT01591499|536293606|FG001|Baseline Visit|Withdrawal by Subject|2|||
148677888|NCT01591499|536293607|FG002|Baseline Visit|Withdrawal by Subject|0|||
148677889|NCT01591499|536293608|FG003|Baseline Visit|Withdrawal by Subject|2|||
148677890|NCT01591499|536293605|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
148677891|NCT01591499|536293606|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
148677892|NCT01591499|536293607|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
148677893|NCT01591499|536293608|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
148677894|NCT01591499|536293605|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
148677895|NCT01591499|536293606|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
149170044|NCT03093402|538094381|FG001|Overall Study|Ineligible for study|0|||
149170045|NCT03093402|538094382|FG002|Overall Study|Ineligible for study|0|||
149170046|NCT03093402|538094383|FG003|Overall Study|Ineligible for study|0|||
149170047|NCT03093402|538094380|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
149170048|NCT03093402|538094381|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
149170049|NCT03093402|538094382|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
149170050|NCT03093402|538094383|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
149170051|NCT02731742|538094386|FG000|Overall Study|Death|1|||
149170052|NCT02731742|538094387|FG001|Overall Study|Death|2|||
149170053|NCT02731742|538094388|FG002|Overall Study|Death|5|||
149170054|NCT02731742|538094389|FG003|Overall Study|Death|0|||
149170055|NCT02731742|538094386|FG000|Overall Study|Physician Decision|0|||
149170056|NCT02731742|538094387|FG001|Overall Study|Physician Decision|0|||
149170057|NCT02731742|538094388|FG002|Overall Study|Physician Decision|0|||
149170058|NCT02731742|538094389|FG003|Overall Study|Physician Decision|1|||
149170059|NCT02731742|538094386|FG000|Overall Study|Study Terminated by Sponsor|2|||
149170060|NCT02731742|538094387|FG001|Overall Study|Study Terminated by Sponsor|1|||
149170061|NCT02731742|538094388|FG002|Overall Study|Study Terminated by Sponsor|1|||
149170062|NCT02731742|538094389|FG003|Overall Study|Study Terminated by Sponsor|1|||
149170063|NCT00461175|538094392|FG000|Overall Study|Protocol Violation|522|||
149170064|NCT00461175|538094393|FG001|Overall Study|Protocol Violation|365|||
149170065|NCT03093155|538094394|FG000|Overall Study|Not Eligible|1|||
149170066|NCT03093155|538094395|FG001|Overall Study|Not Eligible|0|||
149170067|NCT03093155|538094394|FG000|Overall Study|Withdrawal by Subject|0|||
149170068|NCT03093155|538094395|FG001|Overall Study|Withdrawal by Subject|1|||
149170069|NCT04336163|538094396|FG000|Overall Study|Lost to Follow-up|55|||
149170070|NCT04336163|538094397|FG001|Overall Study|Lost to Follow-up|0|||
149170071|NCT00826514|538094398|FG000|Overall Study|Adverse Event|1|||
149170072|NCT00826514|538094399|FG001|Overall Study|Adverse Event|1|||
149170073|NCT00826514|538094398|FG000|Overall Study|Lack of Efficacy|0|||
149170074|NCT00826514|538094399|FG001|Overall Study|Lack of Efficacy|1|||
149170075|NCT00826514|538094398|FG000|Overall Study|Withdrawal by Subject|2|||
149170076|NCT00826514|538094399|FG001|Overall Study|Withdrawal by Subject|3|||
149170077|NCT01773473|538094400|FG000|Overall Study|Adverse Event|3|||
149170078|NCT01773473|538094401|FG001|Overall Study|Adverse Event|2|||
149170079|NCT01773473|538094400|FG000|Overall Study|Protocol Violation|0|||
149170080|NCT01773473|538094401|FG001|Overall Study|Protocol Violation|4|||
149170081|NCT01773473|538094400|FG000|Overall Study|Physician Decision|3|||
149170082|NCT01773473|538094401|FG001|Overall Study|Physician Decision|5|||
149170083|NCT01773473|538094400|FG000|Overall Study|Sponsor Decision|2|||
149170084|NCT01773473|538094401|FG001|Overall Study|Sponsor Decision|0|||
149170085|NCT01773473|538094400|FG000|Overall Study|Lack of Efficacy|0|||
149170086|NCT01773473|538094401|FG001|Overall Study|Lack of Efficacy|1|||
149170087|NCT01773473|538094400|FG000|Overall Study|Non-Compliance with study drug|1|||
149170088|NCT01773473|538094401|FG001|Overall Study|Non-Compliance with study drug|4|||
149170089|NCT01773473|538094400|FG000|Overall Study|Withdrawal by Subject|5|||
149170090|NCT01773473|538094401|FG001|Overall Study|Withdrawal by Subject|3|||
149170091|NCT01773473|538094400|FG000|Overall Study|Lost to Follow-up|2|||
149170092|NCT01773473|538094401|FG001|Overall Study|Lost to Follow-up|0|||
149170093|NCT01085682|538094402|FG000|Overall Study|Withdrawal by Subject|25|||
149170094|NCT01085682|538094403|FG001|Overall Study|Withdrawal by Subject|25|||
149170095|NCT03926143|538094404|FG000|Overall Study|Physician Decision|3|||
148677896|NCT01591499|536293607|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
149170096|NCT03926143|538094404|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
149170097|NCT03926143|538094404|FG000|Overall Study|Adverse Event|2|||
149170098|NCT03926143|538094404|FG000|Overall Study|Progressive disease|3|||
149170099|NCT02207907|538094415|FG000|Overall Study|Lost to Follow-up|3|||
148677897|NCT01591499|536293608|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
148806277|NCT00819039|536768939|FG000|Overall Study|Physician Decision|1|||
149170100|NCT02207907|538094416|FG001|Overall Study|Lost to Follow-up|1|||
149170101|NCT02207907|538094415|FG000|Overall Study|Withdrawal by Subject|5|||
149170102|NCT02207907|538094416|FG001|Overall Study|Withdrawal by Subject|6|||
149170103|NCT02207907|538094415|FG000|Overall Study|Did not meet study criteria|3|||
149170104|NCT02207907|538094416|FG001|Overall Study|Did not meet study criteria|0|||
149170105|NCT02207907|538094415|FG000|Overall Study|Pregnancy|0|||
149170106|NCT02207907|538094416|FG001|Overall Study|Pregnancy|1|||
149170107|NCT01025635|538094422|FG000|Overall Study|Withdrawal by Subject|6|||
149170108|NCT01025635|538094423|FG001|Overall Study|Withdrawal by Subject|7|||
149170109|NCT01025635|538094422|FG000|Overall Study|Protocol Violation|4|||
149170110|NCT01025635|538094423|FG001|Overall Study|Protocol Violation|2|||
149170111|NCT01025635|538094422|FG000|Overall Study|Lack of Efficacy|0|||
149170112|NCT01025635|538094423|FG001|Overall Study|Lack of Efficacy|1|||
149170113|NCT01025635|538094422|FG000|Overall Study|Lost to Follow-up|9|||
149170114|NCT01025635|538094423|FG001|Overall Study|Lost to Follow-up|13|||
149170115|NCT01025635|538094422|FG000|Overall Study|Reason not known|4|||
149170116|NCT01025635|538094423|FG001|Overall Study|Reason not known|2|||
149170117|NCT02393209|538094424|FG000|Overall Study|Study Terminated by Sponsor|1|||
149170118|NCT02393209|538094425|FG001|Overall Study|Study Terminated by Sponsor|1|||
149170119|NCT02393209|538094426|FG002|Overall Study|Study Terminated by Sponsor|0|||
149170120|NCT02393209|538094427|FG003|Overall Study|Study Terminated by Sponsor|0|||
149170121|NCT02393209|538094424|FG000|Overall Study|Withdrawal by Patient|1|||
149170122|NCT02393209|538094425|FG001|Overall Study|Withdrawal by Patient|0|||
149170123|NCT02393209|538094426|FG002|Overall Study|Withdrawal by Patient|0|||
149170124|NCT02393209|538094427|FG003|Overall Study|Withdrawal by Patient|0|||
149170125|NCT02393209|538094424|FG000|Overall Study|Death|2|||
149170126|NCT02393209|538094425|FG001|Overall Study|Death|2|||
149170127|NCT02393209|538094426|FG002|Overall Study|Death|0|||
149170128|NCT02393209|538094427|FG003|Overall Study|Death|0|||
149170129|NCT02393209|538094424|FG000|Overall Study|Death due to Disease Progression|2|||
149170130|NCT02393209|538094425|FG001|Overall Study|Death due to Disease Progression|2|||
149170131|NCT02393209|538094426|FG002|Overall Study|Death due to Disease Progression|0|||
149170132|NCT02393209|538094427|FG003|Overall Study|Death due to Disease Progression|0|||
149170133|NCT02393209|538094424|FG000|Overall Study|Death from Legionella Infection|0|||
149170134|NCT02393209|538094425|FG001|Overall Study|Death from Legionella Infection|1|||
149170135|NCT02393209|538094426|FG002|Overall Study|Death from Legionella Infection|0|||
149170136|NCT02393209|538094427|FG003|Overall Study|Death from Legionella Infection|0|||
149170137|NCT02393209|538094424|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
149170138|NCT02393209|538094425|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
149170139|NCT02393209|538094426|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
149170140|NCT02393209|538094427|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
149170141|NCT02393209|538094424|FG000|Overall Study|Lost to Follow-up|0|||
149170142|NCT02393209|538094425|FG001|Overall Study|Lost to Follow-up|1|||
149170143|NCT02393209|538094426|FG002|Overall Study|Lost to Follow-up|0|||
149170144|NCT02393209|538094427|FG003|Overall Study|Lost to Follow-up|0|||
149170145|NCT00727402|538094428|FG000|Overall Study|Physician Decision|116|||
149170146|NCT03545282|538094429|FG000|Overall Study|Lost to Follow-up|15|||
149170147|NCT03545282|538094430|FG001|Overall Study|Lost to Follow-up|10|||
149170148|NCT03545282|538094429|FG000|Overall Study|Withdrawal by Subject|2|||
149170149|NCT03545282|538094430|FG001|Overall Study|Withdrawal by Subject|2|||
149170150|NCT02209506|538094431|FG000|Overall Study|Withdrawal by Subject|0|||
149170151|NCT02209506|538094432|FG001|Overall Study|Withdrawal by Subject|0|||
149170152|NCT02209506|538094433|FG002|Overall Study|Withdrawal by Subject|0|||
149170153|NCT02209506|538094434|FG003|Overall Study|Withdrawal by Subject|0|||
149170154|NCT02209506|538094435|FG004|Overall Study|Withdrawal by Subject|1|||
149170155|NCT02582671|538094436|FG000|Overall Study|Failure to return|1|||
149170156|NCT02582671|538094436|FG000|Overall Study|Other, not specified|1|||
149170157|NCT02537678|538094443|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
149170158|NCT02537678|538094444|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
149170159|NCT02537678|538094443|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
149170160|NCT02537678|538094444|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
149170161|NCT02537678|538094443|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
149170162|NCT02537678|538094444|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
149170163|NCT02537678|538094443|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
149170164|NCT02537678|538094444|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
149170165|NCT02537678|538094443|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
149170166|NCT02537678|538094444|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
149013154|NCT00451217|537527835|FG001|Overall Study|Not Treated|1|||
149170167|NCT02537678|538094443|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
149170168|NCT02537678|538094444|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
149170169|NCT02537678|538094443|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
149170170|NCT02537678|538094444|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
149170171|NCT01499290|538094445|FG000|Overall Study|Withdrawal by Subject|22|||
149170172|NCT01499290|538094446|FG001|Overall Study|Withdrawal by Subject|15|||
149170173|NCT01499290|538094445|FG000|Overall Study|Not specified in study report|11|||
149170174|NCT01499290|538094446|FG001|Overall Study|Not specified in study report|5|||
149170175|NCT01499290|538094445|FG000|Overall Study|Condition improved/subject recovered|1|||
149170176|NCT01499290|538094446|FG001|Overall Study|Condition improved/subject recovered|0|||
149170177|NCT01499290|538094445|FG000|Overall Study|Lack of Efficacy|7|||
149170178|NCT01499290|538094446|FG001|Overall Study|Lack of Efficacy|8|||
149170179|NCT01499290|538094445|FG000|Overall Study|Adverse Event|14|||
149170180|NCT01499290|538094446|FG001|Overall Study|Adverse Event|7|||
149170181|NCT02209766|538094447|FG000|Overall Study|Withdrawal by Subject|0|||
149170182|NCT02209766|538094448|FG001|Overall Study|Withdrawal by Subject|0|||
149170183|NCT02209766|538094449|FG002|Overall Study|Withdrawal by Subject|0|||
149170184|NCT02209766|538094450|FG003|Overall Study|Withdrawal by Subject|1|||
149170185|NCT02209766|538094451|FG004|Overall Study|Withdrawal by Subject|0|||
149170186|NCT00327444|538094452|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
149170187|NCT00327444|538094453|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
149170188|NCT00327444|538094452|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
149170189|NCT00327444|538094453|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
149170190|NCT00327444|538094452|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
148677898|NCT00902278|536293609|FG000|Overall Study|Physician Decision|1|||
148677899|NCT00902278|536293610|FG001|Overall Study|Physician Decision|0|||
148677900|NCT00902278|536293611|FG002|Overall Study|Physician Decision|2|||
148677901|NCT00902278|536293612|FG003|Overall Study|Physician Decision|0|||
148677902|NCT00902278|536293613|FG004|Overall Study|Physician Decision|1|||
148677903|NCT00902278|536293609|FG000|Overall Study|Lost to Follow-up|3|||
149170191|NCT00327444|538094453|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
149170192|NCT00327444|538094452|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
149170193|NCT00327444|538094453|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
149170194|NCT00327444|538094452|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
149170195|NCT00327444|538094453|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
149170196|NCT00327444|538094452|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
149170197|NCT00327444|538094453|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
149170198|NCT00327444|538094452|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
149170199|NCT00327444|538094453|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
149170200|NCT00327444|538094452|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
149170201|NCT00327444|538094453|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
149170202|NCT00805207|538094454|FG000|Overall Study|Protocol Violation|0|||
149170203|NCT00805207|538094455|FG001|Overall Study|Protocol Violation|0|||
149170204|NCT00805207|538094456|FG002|Overall Study|Protocol Violation|1|||
149170205|NCT00805207|538094457|FG003|Overall Study|Protocol Violation|0|||
149170206|NCT00805207|538094458|FG004|Overall Study|Protocol Violation|0|||
149170207|NCT00805207|538094459|FG005|Overall Study|Protocol Violation|0|||
149170208|NCT00805207|538094460|FG006|Overall Study|Protocol Violation|0|||
149170209|NCT00805207|538094461|FG007|Overall Study|Protocol Violation|0|||
149170210|NCT00805207|538094462|FG008|Overall Study|Protocol Violation|0|||
149170211|NCT00805207|538094454|FG000|Overall Study|Physician Decision|0|||
149170212|NCT00805207|538094455|FG001|Overall Study|Physician Decision|1|||
149170213|NCT00805207|538094456|FG002|Overall Study|Physician Decision|0|||
149170214|NCT00805207|538094457|FG003|Overall Study|Physician Decision|0|||
149170215|NCT00805207|538094458|FG004|Overall Study|Physician Decision|0|||
149170216|NCT00805207|538094459|FG005|Overall Study|Physician Decision|1|||
149170217|NCT00805207|538094460|FG006|Overall Study|Physician Decision|0|||
149170218|NCT00805207|538094461|FG007|Overall Study|Physician Decision|0|||
149170219|NCT00805207|538094462|FG008|Overall Study|Physician Decision|0|||
149170220|NCT00805207|538094454|FG000|Overall Study|Withdrawal by Subject|0|||
149170221|NCT00805207|538094455|FG001|Overall Study|Withdrawal by Subject|1|||
149170222|NCT00805207|538094456|FG002|Overall Study|Withdrawal by Subject|0|||
148677904|NCT00902278|536293610|FG001|Overall Study|Lost to Follow-up|2|||
148677905|NCT00902278|536293611|FG002|Overall Study|Lost to Follow-up|3|||
149170223|NCT00805207|538094457|FG003|Overall Study|Withdrawal by Subject|0|||
149170224|NCT00805207|538094458|FG004|Overall Study|Withdrawal by Subject|1|||
149170225|NCT00805207|538094459|FG005|Overall Study|Withdrawal by Subject|2|||
149170226|NCT00805207|538094460|FG006|Overall Study|Withdrawal by Subject|0|||
149170227|NCT00805207|538094461|FG007|Overall Study|Withdrawal by Subject|0|||
149170228|NCT00805207|538094462|FG008|Overall Study|Withdrawal by Subject|0|||
149170229|NCT00064701|538094463|FG000|One Year Post-transplant|Did not receive study drug|7|||
149170230|NCT00064701|538094464|FG001|One Year Post-transplant|Did not receive study drug|12|||
149170231|NCT00064701|538094465|FG002|One Year Post-transplant|Did not receive study drug|11|||
149170232|NCT00064701|538094463|FG000|One Year Post-transplant|Adverse Event|23|||
149170233|NCT00064701|538094464|FG001|One Year Post-transplant|Adverse Event|19|||
149170234|NCT00064701|538094465|FG002|One Year Post-transplant|Adverse Event|37|||
149170235|NCT00064701|538094463|FG000|One Year Post-transplant|Rejection|0|||
149170236|NCT00064701|538094464|FG001|One Year Post-transplant|Rejection|1|||
149170237|NCT00064701|538094465|FG002|One Year Post-transplant|Rejection|16|||
149170238|NCT00064701|538094463|FG000|One Year Post-transplant|Non-compliance|4|||
149170239|NCT00064701|538094464|FG001|One Year Post-transplant|Non-compliance|2|||
149170240|NCT00064701|538094465|FG002|One Year Post-transplant|Non-compliance|5|||
149170241|NCT00064701|538094463|FG000|One Year Post-transplant|Graft Failure|3|||
149170242|NCT00064701|538094464|FG001|One Year Post-transplant|Graft Failure|2|||
149170243|NCT00064701|538094465|FG002|One Year Post-transplant|Graft Failure|1|||
149170244|NCT00064701|538094463|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
149170245|NCT00064701|538094464|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
149170246|NCT00064701|538094465|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
149170247|NCT00064701|538094463|FG000|One Year Post-transplant|Lost to Follow-up|1|||
149170248|NCT00064701|538094464|FG001|One Year Post-transplant|Lost to Follow-up|0|||
148677906|NCT00902278|536293612|FG003|Overall Study|Lost to Follow-up|0|||
148677907|NCT00902278|536293613|FG004|Overall Study|Lost to Follow-up|1|||
149170249|NCT00064701|538094465|FG002|One Year Post-transplant|Lost to Follow-up|0|||
149170250|NCT00064701|538094463|FG000|One Year Post-transplant|Converted to rapamycin|1|||
149170251|NCT00064701|538094464|FG001|One Year Post-transplant|Converted to rapamycin|0|||
149170252|NCT00064701|538094465|FG002|One Year Post-transplant|Converted to rapamycin|0|||
149170253|NCT00064701|538094463|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
149170254|NCT00064701|538094464|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
149170255|NCT00064701|538094465|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
149170256|NCT00064701|538094463|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
149170257|NCT00064701|538094464|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
149170258|NCT00064701|538094465|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
149170259|NCT00064701|538094463|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
149170260|NCT00064701|538094464|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
149170261|NCT00064701|538094465|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
149170262|NCT00064701|538094463|FG000|One Year Post-transplant|Poor absorption|0|||
149170263|NCT00064701|538094464|FG001|One Year Post-transplant|Poor absorption|1|||
149170264|NCT00064701|538094465|FG002|One Year Post-transplant|Poor absorption|0|||
149170265|NCT00064701|538094463|FG000|One Year Post-transplant|Pancreas transplant|0|||
149170266|NCT00064701|538094464|FG001|One Year Post-transplant|Pancreas transplant|0|||
149170267|NCT00064701|538094465|FG002|One Year Post-transplant|Pancreas transplant|1|||
149170268|NCT00064701|538094463|FG000|Clinical Continuation Phase|Adverse Event|12|||
149170269|NCT00064701|538094464|FG001|Clinical Continuation Phase|Adverse Event|21|||
149170270|NCT00064701|538094465|FG002|Clinical Continuation Phase|Adverse Event|14|||
149170271|NCT00064701|538094463|FG000|Clinical Continuation Phase|Non-compliance|8|||
149170272|NCT00064701|538094464|FG001|Clinical Continuation Phase|Non-compliance|6|||
149170273|NCT00064701|538094465|FG002|Clinical Continuation Phase|Non-compliance|7|||
149170274|NCT00064701|538094463|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
149170275|NCT00064701|538094464|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
149170276|NCT00064701|538094465|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
149170277|NCT00064701|538094463|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
149170278|NCT00064701|538094464|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
149170279|NCT00064701|538094465|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
149170280|NCT00064701|538094463|FG000|Clinical Continuation Phase|Graft Failure|5|||
149170281|NCT00064701|538094464|FG001|Clinical Continuation Phase|Graft Failure|5|||
149170282|NCT00064701|538094465|FG002|Clinical Continuation Phase|Graft Failure|2|||
149170283|NCT00064701|538094463|FG000|Clinical Continuation Phase|Rejection|1|||
149170284|NCT00064701|538094464|FG001|Clinical Continuation Phase|Rejection|2|||
149170285|NCT00064701|538094465|FG002|Clinical Continuation Phase|Rejection|2|||
149170286|NCT00064701|538094463|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
149170287|NCT00064701|538094464|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
149170288|NCT00064701|538094465|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
149170289|NCT00064701|538094463|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
149170290|NCT00064701|538094464|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
149170291|NCT00064701|538094465|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
149170292|NCT00064701|538094463|FG000|Clinical Continuation Phase|Physician Decision|1|||
149170293|NCT00064701|538094464|FG001|Clinical Continuation Phase|Physician Decision|3|||
149170294|NCT00064701|538094465|FG002|Clinical Continuation Phase|Physician Decision|0|||
149170295|NCT00064701|538094463|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
149170296|NCT00064701|538094464|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
149170297|NCT00064701|538094465|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
149170298|NCT00064701|538094463|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
149170299|NCT00064701|538094464|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
149170300|NCT00064701|538094465|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
149170301|NCT00064701|538094463|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
149170302|NCT00064701|538094464|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
149170303|NCT00064701|538094465|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
149170304|NCT00064701|538094463|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
149170305|NCT00064701|538094464|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
149170306|NCT00064701|538094465|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
149170307|NCT00064701|538094463|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
149170308|NCT00064701|538094464|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
149170309|NCT00064701|538094465|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
149170310|NCT00064701|538094463|FG000|Clinical Continuation Phase|Patient opted out|0|||
149170311|NCT00064701|538094464|FG001|Clinical Continuation Phase|Patient opted out|0|||
149170312|NCT00064701|538094465|FG002|Clinical Continuation Phase|Patient opted out|1|||
149170313|NCT04223609|538094467|FG000|Overall Study|Adverse Event|0|||
149170314|NCT04223609|538094468|FG001|Overall Study|Adverse Event|1|||
149170315|NCT04223609|538094467|FG000|Overall Study|Missed last visit|0|||
149170316|NCT04223609|538094468|FG001|Overall Study|Missed last visit|1|||
149170317|NCT00355121|538094469|FG000|Overall Study|Did not receive study vaccine|1|||
149170318|NCT00355121|538094470|FG001|Overall Study|Did not receive study vaccine|0|||
149170319|NCT00355121|538094471|FG002|Overall Study|Did not receive study vaccine|1|||
149170320|NCT00355121|538094469|FG000|Overall Study|Adverse Event|0|||
149170321|NCT00355121|538094470|FG001|Overall Study|Adverse Event|1|||
149170322|NCT00355121|538094471|FG002|Overall Study|Adverse Event|0|||
149170323|NCT00355121|538094469|FG000|Overall Study|Protocol Violation|7|||
149170324|NCT00355121|538094470|FG001|Overall Study|Protocol Violation|9|||
149170325|NCT00355121|538094471|FG002|Overall Study|Protocol Violation|1|||
149170326|NCT00355121|538094469|FG000|Overall Study|Lost to Follow-up|4|||
149170327|NCT00355121|538094470|FG001|Overall Study|Lost to Follow-up|7|||
149170328|NCT00355121|538094471|FG002|Overall Study|Lost to Follow-up|1|||
149170329|NCT00355121|538094469|FG000|Overall Study|Withdrawal by Subject|9|||
149170330|NCT00355121|538094470|FG001|Overall Study|Withdrawal by Subject|10|||
149170331|NCT00355121|538094471|FG002|Overall Study|Withdrawal by Subject|2|||
149170332|NCT00355121|538094469|FG000|Overall Study|Serious adverse events|0|||
149170333|NCT00355121|538094470|FG001|Overall Study|Serious adverse events|2|||
149170334|NCT00355121|538094471|FG002|Overall Study|Serious adverse events|0|||
149170335|NCT03313050|538094472|FG000|Stage 2: 12 Months|Adverse Event|0|||
149170336|NCT03313050|538094473|FG001|Stage 2: 12 Months|Adverse Event|0|||
149170337|NCT03313050|538094474|FG002|Stage 2: 12 Months|Adverse Event|0|||
149170338|NCT03313050|538094475|FG003|Stage 2: 12 Months|Adverse Event|1|||
149170339|NCT03313050|538094472|FG000|Stage 2: 12 Months|Death|0|||
149170340|NCT03313050|538094473|FG001|Stage 2: 12 Months|Death|0|||
149170341|NCT03313050|538094474|FG002|Stage 2: 12 Months|Death|3|||
149170342|NCT03313050|538094475|FG003|Stage 2: 12 Months|Death|0|||
149170343|NCT03313050|538094472|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
149170344|NCT03313050|538094473|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
149170345|NCT03313050|538094474|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
149170346|NCT03313050|538094475|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
149170347|NCT03313050|538094472|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
149170348|NCT03313050|538094473|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
149170349|NCT03313050|538094474|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
149170350|NCT03313050|538094475|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
149170351|NCT03313050|538094472|FG000|Stage 2: 12 Months|Protocol deviation|0|||
149170352|NCT03313050|538094473|FG001|Stage 2: 12 Months|Protocol deviation|0|||
149170353|NCT03313050|538094474|FG002|Stage 2: 12 Months|Protocol deviation|7|||
149170354|NCT03313050|538094475|FG003|Stage 2: 12 Months|Protocol deviation|7|||
149170355|NCT03313050|538094472|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
149170356|NCT03313050|538094473|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
149170357|NCT03313050|538094474|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
149170358|NCT03313050|538094475|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
149170359|NCT03313050|538094472|FG000|Stage 2: 12 Months|Other|0|||
149170360|NCT03313050|538094473|FG001|Stage 2: 12 Months|Other|0|||
149170361|NCT03313050|538094474|FG002|Stage 2: 12 Months|Other|0|||
149170362|NCT03313050|538094475|FG003|Stage 2: 12 Months|Other|1|||
149170363|NCT01291017|538094482|FG000|Overall Study|Lost to Follow-up|2|||
149170364|NCT01291017|538094482|FG000|Overall Study|Withdrawal by Subject|3|||
149170365|NCT02847598|538094483|FG000|Overall Study|Adverse Event|0|||
149170366|NCT02847598|538094484|FG001|Overall Study|Adverse Event|0|||
149170367|NCT02847598|538094485|FG002|Overall Study|Adverse Event|0|||
149170368|NCT02847598|538094486|FG003|Overall Study|Adverse Event|0|||
149170369|NCT02847598|538094487|FG004|Overall Study|Adverse Event|0|||
149170370|NCT02847598|538094488|FG005|Overall Study|Adverse Event|0|||
149170371|NCT02847598|538094489|FG006|Overall Study|Adverse Event|0|||
149170372|NCT02847598|538094490|FG007|Overall Study|Adverse Event|1|||
149170373|NCT02847598|538094483|FG000|Overall Study|Consent withdrawn|2|||
149170374|NCT02847598|538094484|FG001|Overall Study|Consent withdrawn|0|||
149170375|NCT02847598|538094485|FG002|Overall Study|Consent withdrawn|0|||
149170376|NCT02847598|538094486|FG003|Overall Study|Consent withdrawn|4|||
149170377|NCT02847598|538094487|FG004|Overall Study|Consent withdrawn|3|||
149170378|NCT02847598|538094488|FG005|Overall Study|Consent withdrawn|2|||
149170379|NCT02847598|538094489|FG006|Overall Study|Consent withdrawn|1|||
149170380|NCT02847598|538094490|FG007|Overall Study|Consent withdrawn|3|||
149170381|NCT02847598|538094483|FG000|Overall Study|Death|3|||
149170382|NCT02847598|538094484|FG001|Overall Study|Death|0|||
149013155|NCT00451217|537527836|FG002|Overall Study|Not Treated|3|||
149170383|NCT02847598|538094485|FG002|Overall Study|Death|0|||
149170384|NCT02847598|538094486|FG003|Overall Study|Death|0|||
149170385|NCT02847598|538094487|FG004|Overall Study|Death|0|||
149170386|NCT02847598|538094488|FG005|Overall Study|Death|0|||
149170387|NCT02847598|538094489|FG006|Overall Study|Death|0|||
149170388|NCT02847598|538094490|FG007|Overall Study|Death|0|||
149170389|NCT02847598|538094483|FG000|Overall Study|Lost to Follow-up|0|||
149170390|NCT02847598|538094484|FG001|Overall Study|Lost to Follow-up|0|||
149170391|NCT02847598|538094485|FG002|Overall Study|Lost to Follow-up|0|||
149170392|NCT02847598|538094486|FG003|Overall Study|Lost to Follow-up|0|||
149170393|NCT02847598|538094487|FG004|Overall Study|Lost to Follow-up|0|||
149170394|NCT02847598|538094488|FG005|Overall Study|Lost to Follow-up|1|||
149170395|NCT02847598|538094489|FG006|Overall Study|Lost to Follow-up|1|||
149170396|NCT02847598|538094490|FG007|Overall Study|Lost to Follow-up|0|||
149170397|NCT02848833|538094491|FG000|Overall Study|subject who are duplicated|1|||
149013156|NCT00451217|537527837|FG003|Overall Study|Not Treated|4|||
149013157|NCT03154359|537527838|FG000|Overall Study|Adverse Event|1|||
149013158|NCT03154359|537527838|FG000|Overall Study|Lack of Efficacy|2|||
149013159|NCT03154359|537527838|FG000|Overall Study|Lost to Follow-up|3|||
149013160|NCT03154359|537527838|FG000|Overall Study|Physician Decision|3|||
149013161|NCT03154359|537527838|FG000|Overall Study|Protocol Violation|4|||
149013162|NCT03154359|537527838|FG000|Overall Study|Withdrawal by Subject|5|||
149013163|NCT03154359|537527838|FG000|Overall Study|Disruption of study due to COVID-19|4|||
149013164|NCT01129336|537527839|FG000|Overall Study|Protocol Violation|1|||
149013165|NCT01129336|537527840|FG001|Overall Study|Protocol Violation|0|||
149013166|NCT01129336|537527839|FG000|Overall Study|Disease Progression|1|||
149013167|NCT01129336|537527840|FG001|Overall Study|Disease Progression|4|||
149013168|NCT01129336|537527839|FG000|Overall Study|Lost to Follow-up|1|||
149013169|NCT01129336|537527840|FG001|Overall Study|Lost to Follow-up|0|||
149013170|NCT01129336|537527839|FG000|Overall Study|Withdrawal by Subject|7|||
149013171|NCT01129336|537527840|FG001|Overall Study|Withdrawal by Subject|4|||
149013172|NCT01129336|537527839|FG000|Overall Study|Adverse Event|0|||
149013173|NCT01129336|537527840|FG001|Overall Study|Adverse Event|1|||
149013174|NCT01129336|537527839|FG000|Overall Study|Missing Study Completion Status|2|||
149013175|NCT01129336|537527840|FG001|Overall Study|Missing Study Completion Status|3|||
149013176|NCT01129336|537527839|FG000|Overall Study|Death|0|||
149013177|NCT01129336|537527840|FG001|Overall Study|Death|4|||
149013178|NCT00569803|537527841|FG000|Overall Study|Lost to Follow-up|1|||
149013179|NCT00569803|537527842|FG001|Overall Study|Lost to Follow-up|0|||
149013180|NCT00569803|537527843|FG002|Overall Study|Lost to Follow-up|0|||
149013181|NCT00569803|537527844|FG003|Overall Study|Lost to Follow-up|0|||
149013182|NCT00569803|537527845|FG004|Overall Study|Lost to Follow-up|0|||
149013183|NCT00569803|537527846|FG005|Overall Study|Lost to Follow-up|0|||
149013184|NCT00569803|537527847|FG006|Overall Study|Lost to Follow-up|0|||
149170398|NCT02848833|538094491|FG000|Overall Study|have not taken the study drug|11|||
149170399|NCT02848833|538094491|FG000|Overall Study|follow-up failure|6|||
149170400|NCT02848833|538094491|FG000|Overall Study|Protocol Violation|119|||
149013185|NCT00569803|537527848|FG007|Overall Study|Lost to Follow-up|0|||
149013186|NCT00569803|537527841|FG000|Overall Study|injection syringe leaked during dosing|0|||
149013187|NCT00569803|537527842|FG001|Overall Study|injection syringe leaked during dosing|0|||
149013188|NCT00569803|537527843|FG002|Overall Study|injection syringe leaked during dosing|0|||
149170401|NCT04375761|538096638|FG000|Overall Study|Death|1|||
149170402|NCT04375761|538096639|FG001|Overall Study|Death|2|||
149170403|NCT04375761|538096638|FG000|Overall Study|Lost to Follow-up|203|||
149170404|NCT04375761|538096639|FG001|Overall Study|Lost to Follow-up|380|||
149170405|NCT04375761|538096638|FG000|Overall Study|Withdrawal by Subject|47|||
149170406|NCT04375761|538096639|FG001|Overall Study|Withdrawal by Subject|98|||
149170407|NCT04375761|538096638|FG000|Overall Study|Noncompliance with study procedure|121|||
149170408|NCT04375761|538096639|FG001|Overall Study|Noncompliance with study procedure|251|||
149170409|NCT04375761|538096638|FG000|Overall Study|Reimbursement not enough|1|||
149170410|NCT04375761|538096639|FG001|Overall Study|Reimbursement not enough|2|||
149170411|NCT04375761|538096638|FG000|Overall Study|Unforeseen family circumstances|1|||
149170412|NCT04375761|538096639|FG001|Overall Study|Unforeseen family circumstances|3|||
149170413|NCT04375761|538096638|FG000|Overall Study|Test too painful|1|||
149170414|NCT04375761|538096639|FG001|Overall Study|Test too painful|1|||
149170415|NCT04375761|538096638|FG000|Overall Study|Moved|0|||
149170416|NCT04375761|538096639|FG001|Overall Study|Moved|2|||
149170417|NCT04375761|538096638|FG000|Overall Study|Nonresponsive|0|||
149170418|NCT04375761|538096639|FG001|Overall Study|Nonresponsive|5|||
149170419|NCT03797001|538096640|FG000|Overall Study|Withdrawn due to COVID19|4|||
149170420|NCT03797001|538096641|FG001|Overall Study|Withdrawn due to COVID19|0|||
149170421|NCT03797001|538096640|FG000|Overall Study|Withdrawal by Subject|7|||
149170422|NCT03797001|538096641|FG001|Overall Study|Withdrawal by Subject|6|||
149170423|NCT03797001|538096640|FG000|Overall Study|Adverse Event|0|||
149170424|NCT03797001|538096641|FG001|Overall Study|Adverse Event|1|||
149170425|NCT05556616|538096644|FG000|Overall Study|Withdrawal by Subject|1|||
149013189|NCT00569803|537527844|FG003|Overall Study|injection syringe leaked during dosing|1|||
149170426|NCT05556616|538096645|FG001|Overall Study|Withdrawal by Subject|0|||
149170427|NCT05556616|538096646|FG002|Overall Study|Withdrawal by Subject|0|||
149170428|NCT05556616|538096647|FG003|Overall Study|Withdrawal by Subject|0|||
149170429|NCT05556616|538096648|FG004|Overall Study|Withdrawal by Subject|0|||
149170430|NCT05556616|538096649|FG005|Overall Study|Withdrawal by Subject|0|||
149170431|NCT05556616|538096650|FG006|Overall Study|Withdrawal by Subject|0|||
149170432|NCT05556616|538096644|FG000|Overall Study|Death|0|||
149170433|NCT05556616|538096645|FG001|Overall Study|Death|0|||
149170434|NCT05556616|538096646|FG002|Overall Study|Death|2|||
149170435|NCT05556616|538096647|FG003|Overall Study|Death|1|||
149170436|NCT05556616|538096648|FG004|Overall Study|Death|0|||
149170437|NCT05556616|538096649|FG005|Overall Study|Death|0|||
149170438|NCT05556616|538096650|FG006|Overall Study|Death|0|||
149170439|NCT05556616|538096644|FG000|Overall Study|Study Terminated by Sponsor|0|||
149170440|NCT05556616|538096645|FG001|Overall Study|Study Terminated by Sponsor|3|||
149170441|NCT05556616|538096646|FG002|Overall Study|Study Terminated by Sponsor|0|||
149170442|NCT05556616|538096647|FG003|Overall Study|Study Terminated by Sponsor|0|||
149170443|NCT05556616|538096648|FG004|Overall Study|Study Terminated by Sponsor|0|||
149170444|NCT05556616|538096649|FG005|Overall Study|Study Terminated by Sponsor|0|||
149170445|NCT05556616|538096650|FG006|Overall Study|Study Terminated by Sponsor|0|||
149170446|NCT00500266|538096652|FG000|Overall Study|Death|3|||
149170447|NCT00500266|538096652|FG000|Overall Study|Lost to Follow-up|3|||
149170448|NCT00500266|538096652|FG000|Overall Study|Withdrawal by Subject|3|||
149170449|NCT00500266|538096652|FG000|Overall Study|Assigned, not treated|4|||
149170450|NCT01431287|538096653|FG000|Overall Study|not treated|0|||
149170451|NCT01431287|538096654|FG001|Overall Study|not treated|0|||
149170452|NCT01431287|538096655|FG002|Overall Study|not treated|1|||
149170453|NCT01431287|538096656|FG003|Overall Study|not treated|0|||
149170454|NCT01431287|538096657|FG004|Overall Study|not treated|0|||
149170455|NCT01431287|538096653|FG000|Overall Study|Adverse Event|59|||
149170456|NCT01431287|538096654|FG001|Overall Study|Adverse Event|57|||
149170457|NCT01431287|538096655|FG002|Overall Study|Adverse Event|53|||
149170458|NCT01431287|538096656|FG003|Overall Study|Adverse Event|33|||
149170459|NCT01431287|538096657|FG004|Overall Study|Adverse Event|41|||
149170460|NCT01431287|538096653|FG000|Overall Study|Non compliant with protocol|6|||
149170461|NCT01431287|538096654|FG001|Overall Study|Non compliant with protocol|6|||
149170462|NCT01431287|538096655|FG002|Overall Study|Non compliant with protocol|5|||
149170463|NCT01431287|538096656|FG003|Overall Study|Non compliant with protocol|6|||
149170464|NCT01431287|538096657|FG004|Overall Study|Non compliant with protocol|5|||
149170465|NCT01431287|538096653|FG000|Overall Study|Lost to Follow-up|0|||
149170466|NCT01431287|538096654|FG001|Overall Study|Lost to Follow-up|3|||
149170467|NCT01431287|538096655|FG002|Overall Study|Lost to Follow-up|2|||
149170468|NCT01431287|538096656|FG003|Overall Study|Lost to Follow-up|3|||
149170469|NCT01431287|538096657|FG004|Overall Study|Lost to Follow-up|1|||
149170470|NCT01431287|538096653|FG000|Overall Study|Consent withdrawn not due to AE|29|||
149170471|NCT01431287|538096654|FG001|Overall Study|Consent withdrawn not due to AE|30|||
149170472|NCT01431287|538096655|FG002|Overall Study|Consent withdrawn not due to AE|34|||
149170473|NCT01431287|538096656|FG003|Overall Study|Consent withdrawn not due to AE|19|||
149170474|NCT01431287|538096657|FG004|Overall Study|Consent withdrawn not due to AE|29|||
149170475|NCT01431287|538096653|FG000|Overall Study|not stated above|4|||
149170476|NCT01431287|538096654|FG001|Overall Study|not stated above|2|||
149170477|NCT01431287|538096655|FG002|Overall Study|not stated above|2|||
149170478|NCT01431287|538096656|FG003|Overall Study|not stated above|2|||
149170479|NCT01431287|538096657|FG004|Overall Study|not stated above|1|||
149170480|NCT02251743|538096658|FG000|Overall Study|Withdrawal by Subject|1|||
149170481|NCT02251743|538096659|FG001|Overall Study|Withdrawal by Subject|1|||
148928143|NCT01897714|537221303|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
149170482|NCT03615222|538096670|FG000|Overall Study|Ineligible|26|||
149170483|NCT03615222|538096670|FG000|Overall Study|Withdrawal by Subject|7|||
149170484|NCT03615222|538096670|FG000|Overall Study|Death|1|||
149170485|NCT01552057|538096671|FG000|Overall Study|Adverse Event|14|||
149170486|NCT01552057|538096672|FG001|Overall Study|Adverse Event|15|||
149170487|NCT01552057|538096671|FG000|Overall Study|Lack of Efficacy|8|||
149170488|NCT01552057|538096672|FG001|Overall Study|Lack of Efficacy|23|||
149170489|NCT01552057|538096671|FG000|Overall Study|Withdrawal by Subject|5|||
149170490|NCT01552057|538096672|FG001|Overall Study|Withdrawal by Subject|8|||
149170491|NCT01552057|538096671|FG000|Overall Study|Entry Criteria Not Met|2|||
149170492|NCT01552057|538096672|FG001|Overall Study|Entry Criteria Not Met|2|||
149170493|NCT01552057|538096671|FG000|Overall Study|Physician Decision|1|||
149170494|NCT01552057|538096672|FG001|Overall Study|Physician Decision|0|||
149170495|NCT00476086|538096673|FG000|Overall Study|Alternative therapy|1|||
149170496|NCT00476086|538096673|FG000|Overall Study|Progressive Disease|4|||
149170497|NCT02900092|538096674|FG000|Overall Study|Adverse Event|1|||
149170498|NCT03895203|538096675|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
149170499|NCT03895203|538096676|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
149170500|NCT03895203|538096677|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
149170501|NCT03895203|538096678|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
149170502|NCT03895203|538096679|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
149170503|NCT03895203|538096680|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
149170504|NCT03895203|538096675|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
149170505|NCT03895203|538096676|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149170506|NCT03895203|538096677|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149170507|NCT03895203|538096678|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149170508|NCT03895203|538096679|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149170509|NCT03895203|538096680|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
149170510|NCT03895203|538096675|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
149170511|NCT03895203|538096676|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149170512|NCT03895203|538096677|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149170513|NCT03895203|538096678|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149170514|NCT03895203|538096679|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149170515|NCT03895203|538096680|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
149170516|NCT03895203|538096675|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
149170517|NCT03895203|538096676|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
149170518|NCT03895203|538096677|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
149170519|NCT03895203|538096678|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
149170520|NCT03895203|538096679|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
149170521|NCT03895203|538096680|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
149170522|NCT03895203|538096675|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149170523|NCT03895203|538096676|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
149170524|NCT03895203|538096677|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149170525|NCT03895203|538096678|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149170526|NCT03895203|538096679|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149170527|NCT03895203|538096680|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
149170528|NCT03895203|538096675|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149170529|NCT03895203|538096676|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
149170530|NCT03895203|538096677|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149170531|NCT03895203|538096678|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149170532|NCT03895203|538096679|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149170533|NCT03895203|538096680|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
149170534|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149170535|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149170536|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149170537|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
149170538|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149170539|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
149170540|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
149170541|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
149170542|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
149170543|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
149170544|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
149170545|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
149170546|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
149170547|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
149170548|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
149170549|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
149170550|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
149170551|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
149170552|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149170553|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149170554|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149170555|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
149170556|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
149170557|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
149170558|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
149170559|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
149170560|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
148677908|NCT01311505|536293616|FG000|First Intervention Period|Protocol Violation|0|||
149170561|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
149170562|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
149170563|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
149170564|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149170565|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149170566|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149170567|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
149170568|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
148806278|NCT00819039|536768940|FG001|Overall Study|Physician Decision|0|||
149013190|NCT00569803|537527845|FG004|Overall Study|injection syringe leaked during dosing|0|||
149013191|NCT00569803|537527846|FG005|Overall Study|injection syringe leaked during dosing|0|||
149013192|NCT00569803|537527847|FG006|Overall Study|injection syringe leaked during dosing|0|||
149013193|NCT00569803|537527848|FG007|Overall Study|injection syringe leaked during dosing|0|||
149013194|NCT00569803|537527841|FG000|Overall Study|Withdrawal by Subject|0|||
149013195|NCT00569803|537527842|FG001|Overall Study|Withdrawal by Subject|0|||
149013196|NCT00569803|537527843|FG002|Overall Study|Withdrawal by Subject|0|||
149013197|NCT00569803|537527844|FG003|Overall Study|Withdrawal by Subject|0|||
149013198|NCT00569803|537527845|FG004|Overall Study|Withdrawal by Subject|0|||
149013199|NCT00569803|537527846|FG005|Overall Study|Withdrawal by Subject|0|||
149013200|NCT00569803|537527847|FG006|Overall Study|Withdrawal by Subject|0|||
149013201|NCT00569803|537527848|FG007|Overall Study|Withdrawal by Subject|1|||
149013202|NCT01993823|537527849|FG000|Overall Study|Requested by the patient|6|||
149013203|NCT01993823|537527850|FG001|Overall Study|Requested by the patient|11|||
149013204|NCT01993823|537527849|FG000|Overall Study|Protocol Violation|0|||
149013205|NCT01993823|537527850|FG001|Overall Study|Protocol Violation|1|||
149170569|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
149170570|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149013206|NCT01993823|537527849|FG000|Overall Study|Lost to Follow-up|1|||
149013207|NCT01993823|537527850|FG001|Overall Study|Lost to Follow-up|4|||
149013208|NCT01622348|537527852|FG000|Overall Study|Withdrawal by Subject|1|||
149013209|NCT01622348|537527853|FG001|Overall Study|Withdrawal by Subject|0|||
149013210|NCT01622348|537527854|FG002|Overall Study|Withdrawal by Subject|1|||
149013211|NCT00791921|537527857|FG000|Overall Study|Protocol planed|24|||
149013212|NCT00791921|537527858|FG001|Overall Study|Protocol planed|88|||
149013213|NCT00791921|537527857|FG000|Overall Study|Withdrawal by Subject|1|||
149170571|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149233919|NCT00948896|538324944|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233920|NCT00948896|538324945|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233921|NCT00948896|538324946|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233922|NCT00948896|538324947|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
149233923|NCT00948896|538324948|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233924|NCT00948896|538324949|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233925|NCT00948896|538324950|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233926|NCT00948896|538324951|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
149233927|NCT00945815|538324952|FG000|Overall Study|Death|3|||
149233928|NCT00945815|538324952|FG000|Overall Study|Not protocol specified|1|||
149233929|NCT00945815|538324952|FG000|Overall Study|Ineligible|3|||
149233930|NCT00945815|538324952|FG000|Overall Study|Did not begin protocol therapy|1|||
149233931|NCT01590810|538324955|FG000|Overall Study|Physician Decision|0|||
149233932|NCT01590810|538324956|FG001|Overall Study|Physician Decision|1|||
149233933|NCT01590810|538324957|FG002|Overall Study|Physician Decision|1|||
149233934|NCT01590810|538324958|FG003|Overall Study|Physician Decision|0|||
149233935|NCT01590810|538324959|FG004|Overall Study|Physician Decision|0|||
149233936|NCT02400281|538324960|FG000|Overall Study|Adverse Event|0|||
149233937|NCT02400281|538324961|FG001|Overall Study|Adverse Event|0|||
149233938|NCT02400281|538324962|FG002|Overall Study|Adverse Event|1|||
149233939|NCT02400281|538324963|FG003|Overall Study|Adverse Event|0|||
149233940|NCT02400281|538324964|FG004|Overall Study|Adverse Event|1|||
149233941|NCT02400281|538324965|FG005|Overall Study|Adverse Event|0|||
149233942|NCT02400281|538324960|FG000|Overall Study|Physician Decision|0|||
149233943|NCT02400281|538324961|FG001|Overall Study|Physician Decision|0|||
149233944|NCT02400281|538324962|FG002|Overall Study|Physician Decision|1|||
149233945|NCT02400281|538324963|FG003|Overall Study|Physician Decision|0|||
149233946|NCT02400281|538324964|FG004|Overall Study|Physician Decision|0|||
149233947|NCT02400281|538324965|FG005|Overall Study|Physician Decision|0|||
149233948|NCT00412360|538324966|FG000|Overall Study|Lost to Follow-up|0|||
149233949|NCT00412360|538324967|FG001|Overall Study|Lost to Follow-up|1|||
149233950|NCT00412360|538324966|FG000|Overall Study|Not Transplanted|1|||
149233951|NCT00412360|538324967|FG001|Overall Study|Not Transplanted|2|||
149233952|NCT04678557|538324968|FG000|Overall Study|Withdrawal by Subject|1|||
148928144|NCT01897714|537221298|FG000|Phase II (MTD)|Other|0|||
149170572|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149170573|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
149170574|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149170575|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
149170576|NCT03895203|538096675|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149170577|NCT03895203|538096676|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149170578|NCT03895203|538096677|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149170579|NCT03895203|538096678|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149170580|NCT03895203|538096679|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
149170581|NCT03895203|538096680|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
149170582|NCT01389245|538096681|FG000|Overall Study|Protocol Violation|10|||
149170583|NCT01389245|538096681|FG000|Overall Study|Lost to Follow-up|3|||
149170584|NCT01389245|538096681|FG000|Overall Study|Withdrawal by Subject|2|||
149170585|NCT02292849|538096682|FG000|Overall Study|Lost to Follow-up|0|||
149170586|NCT02292849|538096683|FG001|Overall Study|Lost to Follow-up|2|||
149170587|NCT02292849|538096684|FG002|Overall Study|Lost to Follow-up|2|||
149170588|NCT02292849|538096682|FG000|Overall Study|Physician Decision|4|||
149170589|NCT02292849|538096683|FG001|Overall Study|Physician Decision|0|||
149170590|NCT02292849|538096684|FG002|Overall Study|Physician Decision|0|||
149170591|NCT04125680|538096685|FG000|Overall Study|Lost to Follow-up|15|||
149170592|NCT00097539|538096686|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
149170593|NCT00097539|538096687|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
149170594|NCT00097539|538096688|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
149170595|NCT00097539|538096689|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
149170596|NCT00097539|538096690|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
149170597|NCT00097539|538096691|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
149170598|NCT00097539|538096692|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
149170599|NCT00097539|538096686|FG000|Overall Study|Withdrawal by Subject|925|||
149170600|NCT00097539|538096687|FG001|Overall Study|Withdrawal by Subject|323|||
149170601|NCT00097539|538096688|FG002|Overall Study|Withdrawal by Subject|346|||
149170602|NCT00097539|538096689|FG003|Overall Study|Withdrawal by Subject|217|||
149170603|NCT00097539|538096690|FG004|Overall Study|Withdrawal by Subject|68|||
149170604|NCT00097539|538096691|FG005|Overall Study|Withdrawal by Subject|229|||
148928145|NCT01897714|537221299|FG001|Phase II (MTD)|Other|0|||
149170605|NCT00097539|538096692|FG006|Overall Study|Withdrawal by Subject|3|||
149170606|NCT00097539|538096686|FG000|Overall Study|Participant Non-compliant|2140|||
149170607|NCT00097539|538096687|FG001|Overall Study|Participant Non-compliant|567|||
149170608|NCT00097539|538096688|FG002|Overall Study|Participant Non-compliant|1067|||
149170609|NCT00097539|538096689|FG003|Overall Study|Participant Non-compliant|353|||
149170610|NCT00097539|538096690|FG004|Overall Study|Participant Non-compliant|136|||
149170611|NCT00097539|538096691|FG005|Overall Study|Participant Non-compliant|543|||
149170612|NCT00097539|538096692|FG006|Overall Study|Participant Non-compliant|18|||
149170613|NCT00097539|538096686|FG000|Overall Study|Lack of Efficacy|249|||
149170614|NCT00097539|538096687|FG001|Overall Study|Lack of Efficacy|122|||
149170615|NCT00097539|538096688|FG002|Overall Study|Lack of Efficacy|202|||
149170616|NCT00097539|538096689|FG003|Overall Study|Lack of Efficacy|105|||
149170617|NCT00097539|538096690|FG004|Overall Study|Lack of Efficacy|45|||
149170618|NCT00097539|538096691|FG005|Overall Study|Lack of Efficacy|228|||
149170619|NCT00097539|538096692|FG006|Overall Study|Lack of Efficacy|5|||
149170620|NCT00097539|538096686|FG000|Overall Study|Adverse Event|78|||
149170621|NCT00097539|538096687|FG001|Overall Study|Adverse Event|133|||
149170622|NCT00097539|538096688|FG002|Overall Study|Adverse Event|37|||
149170623|NCT00097539|538096689|FG003|Overall Study|Adverse Event|27|||
149170624|NCT00097539|538096690|FG004|Overall Study|Adverse Event|30|||
149170625|NCT00097539|538096691|FG005|Overall Study|Adverse Event|59|||
149170626|NCT00097539|538096692|FG006|Overall Study|Adverse Event|1|||
149170627|NCT00097539|538096686|FG000|Overall Study|Death|2|||
149170628|NCT00097539|538096687|FG001|Overall Study|Death|7|||
149170629|NCT00097539|538096688|FG002|Overall Study|Death|0|||
149170630|NCT00097539|538096689|FG003|Overall Study|Death|0|||
149013214|NCT00791921|537527858|FG001|Overall Study|Withdrawal by Subject|2|||
149013215|NCT00791921|537527857|FG000|Overall Study|Adverse Event|8|||
149013216|NCT00791921|537527858|FG001|Overall Study|Adverse Event|2|||
149013217|NCT00791921|537527857|FG000|Overall Study|Lack of Efficacy|0|||
149013218|NCT00791921|537527858|FG001|Overall Study|Lack of Efficacy|2|||
149013219|NCT00791921|537527857|FG000|Overall Study|Lack of study drug administration|1|||
149013220|NCT00791921|537527858|FG001|Overall Study|Lack of study drug administration|1|||
149013221|NCT00791921|537527857|FG000|Overall Study|Reason other than those above|0|||
149013222|NCT00791921|537527858|FG001|Overall Study|Reason other than those above|1|||
149013223|NCT01592695|537527862|FG000|Overall Study|Lost to Follow-up|8|||
149013224|NCT01592695|537527863|FG001|Overall Study|Lost to Follow-up|4|||
149013225|NCT00422799|537527864|FG000|Overall Study|Withdrawal by Subject|6|||
149013226|NCT00422799|537527864|FG000|Overall Study|Adverse Event|7|||
149013227|NCT00467142|537527867|FG000|Overall Study|Withdrawal by Subject|1|||
149013228|NCT00467142|537527867|FG000|Overall Study|Adverse Event|1|||
149013229|NCT00467142|537527867|FG000|Overall Study|Protocol Violation|1|||
149013230|NCT04537897|537527868|FG000|Overall Study|Other than listed|0|||
149013231|NCT04537897|537527869|FG001|Overall Study|Other than listed|0|||
149013232|NCT04537897|537527870|FG002|Overall Study|Other than listed|0|||
149170631|NCT00097539|538096690|FG004|Overall Study|Death|1|||
149170632|NCT00097539|538096691|FG005|Overall Study|Death|3|||
149170633|NCT00097539|538096692|FG006|Overall Study|Death|0|||
149170634|NCT00097539|538096686|FG000|Overall Study|Reasons Other Than Above|3602|||
149170635|NCT00097539|538096687|FG001|Overall Study|Reasons Other Than Above|1382|||
149170636|NCT00097539|538096688|FG002|Overall Study|Reasons Other Than Above|1757|||
149170637|NCT00097539|538096689|FG003|Overall Study|Reasons Other Than Above|692|||
149170638|NCT00097539|538096690|FG004|Overall Study|Reasons Other Than Above|361|||
149170639|NCT00097539|538096691|FG005|Overall Study|Reasons Other Than Above|1244|||
149170640|NCT00097539|538096692|FG006|Overall Study|Reasons Other Than Above|34|||
149170641|NCT00097539|538096686|FG000|Overall Study|Reason not Specified|111|||
149170642|NCT00097539|538096687|FG001|Overall Study|Reason not Specified|49|||
149170643|NCT00097539|538096688|FG002|Overall Study|Reason not Specified|53|||
149170644|NCT00097539|538096689|FG003|Overall Study|Reason not Specified|21|||
149013233|NCT04537897|537527871|FG003|Overall Study|Other than listed|0|||
149013234|NCT04537897|537527872|FG004|Overall Study|Other than listed|0|||
149013235|NCT04537897|537527873|FG005|Overall Study|Other than listed|0|||
149013236|NCT04537897|537527874|FG006|Overall Study|Other than listed|1|||
149013237|NCT04537897|537527875|FG007|Overall Study|Other than listed|0|||
149170645|NCT00097539|538096690|FG004|Overall Study|Reason not Specified|11|||
149170646|NCT00097539|538096691|FG005|Overall Study|Reason not Specified|40|||
149013238|NCT04537897|537527876|FG008|Overall Study|Other than listed|0|||
149170647|NCT00097539|538096692|FG006|Overall Study|Reason not Specified|2|||
149170648|NCT04938648|538096693|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
149170649|NCT04938648|538096694|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
149170650|NCT04938648|538096693|FG000|Overall Study|Patient too ill|0|||
149170651|NCT04938648|538096694|FG001|Overall Study|Patient too ill|1|||
149170652|NCT04938648|538096693|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
149170653|NCT04938648|538096694|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
149170654|NCT04938648|538096693|FG000|Overall Study|Patient did not have memory problems|1|||
149170655|NCT04938648|538096694|FG001|Overall Study|Patient did not have memory problems|1|||
149170656|NCT04938648|538096693|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
149170657|NCT04938648|538096694|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
149170658|NCT04938648|538096693|FG000|Overall Study|Care partner could not be reached|0|||
149170659|NCT04938648|538096694|FG001|Overall Study|Care partner could not be reached|1|||
149170660|NCT04938648|538096693|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
149170661|NCT04938648|538096694|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
149170662|NCT04938648|538096693|FG000|Overall Study|Withdrawal by Subject|2|||
149170663|NCT04938648|538096694|FG001|Overall Study|Withdrawal by Subject|1|||
149170664|NCT00364793|538096695|FG000|Overall Study|Adverse Event|2|||
149170665|NCT00364793|538096696|FG001|Overall Study|Adverse Event|0|||
149170666|NCT00364793|538096697|FG002|Overall Study|Adverse Event|0|||
149170667|NCT00364793|538096698|FG003|Overall Study|Adverse Event|0|||
149170668|NCT00364793|538096695|FG000|Overall Study|Death|1|||
149170669|NCT00364793|538096696|FG001|Overall Study|Death|0|||
149170670|NCT00364793|538096697|FG002|Overall Study|Death|1|||
149170671|NCT00364793|538096698|FG003|Overall Study|Death|0|||
149170672|NCT00364793|538096695|FG000|Overall Study|Lack of Efficacy|3|||
149170673|NCT00364793|538096696|FG001|Overall Study|Lack of Efficacy|3|||
149170674|NCT00364793|538096697|FG002|Overall Study|Lack of Efficacy|1|||
149170675|NCT00364793|538096698|FG003|Overall Study|Lack of Efficacy|1|||
149170676|NCT00364793|538096695|FG000|Overall Study|Lost to Follow-up|1|||
149170677|NCT00364793|538096696|FG001|Overall Study|Lost to Follow-up|0|||
149170678|NCT00364793|538096697|FG002|Overall Study|Lost to Follow-up|2|||
149170679|NCT00364793|538096698|FG003|Overall Study|Lost to Follow-up|0|||
149170680|NCT00364793|538096695|FG000|Overall Study|Poor or non-compliance|1|||
149170681|NCT00364793|538096696|FG001|Overall Study|Poor or non-compliance|1|||
149170682|NCT00364793|538096697|FG002|Overall Study|Poor or non-compliance|0|||
149170683|NCT00364793|538096698|FG003|Overall Study|Poor or non-compliance|1|||
148928146|NCT01897714|537221300|FG002|Phase II (MTD)|Other|0|||
149170684|NCT00364793|538096695|FG000|Overall Study|No longer meets criteria|0|||
149170685|NCT00364793|538096696|FG001|Overall Study|No longer meets criteria|0|||
149170686|NCT00364793|538096697|FG002|Overall Study|No longer meets criteria|0|||
149170687|NCT00364793|538096698|FG003|Overall Study|No longer meets criteria|1|||
149170688|NCT00364793|538096695|FG000|Overall Study|Withdrawal by Subject|0|||
149170689|NCT00364793|538096696|FG001|Overall Study|Withdrawal by Subject|1|||
149170690|NCT00364793|538096697|FG002|Overall Study|Withdrawal by Subject|0|||
149170691|NCT00364793|538096698|FG003|Overall Study|Withdrawal by Subject|0|||
149170692|NCT00391976|538096699|FG000|Overall Study|Adverse Event|0|||
149170693|NCT00391976|538096700|FG001|Overall Study|Adverse Event|0|||
149170694|NCT00391976|538096701|FG002|Overall Study|Adverse Event|1|||
149170695|NCT00391976|538096699|FG000|Overall Study|Withdrawal of consent|0|||
149170696|NCT00391976|538096700|FG001|Overall Study|Withdrawal of consent|1|||
149170697|NCT00391976|538096701|FG002|Overall Study|Withdrawal of consent|1|||
149170698|NCT00391976|538096699|FG000|Overall Study|Lost to Follow-up|1|||
149170699|NCT00391976|538096700|FG001|Overall Study|Lost to Follow-up|2|||
149170700|NCT00391976|538096701|FG002|Overall Study|Lost to Follow-up|0|||
149170701|NCT00391976|538096699|FG000|Overall Study|Inappropriate enrollment|1|||
149170702|NCT00391976|538096700|FG001|Overall Study|Inappropriate enrollment|1|||
149170703|NCT00391976|538096701|FG002|Overall Study|Inappropriate enrollment|0|||
149170704|NCT00391976|538096699|FG000|Overall Study|Protocol deviation/violation|4|||
149170705|NCT00391976|538096700|FG001|Overall Study|Protocol deviation/violation|2|||
149170706|NCT00391976|538096701|FG002|Overall Study|Protocol deviation/violation|1|||
149170707|NCT00391976|538096699|FG000|Overall Study|Recurrence/no eradication of infection|21|||
149170708|NCT00391976|538096700|FG001|Overall Study|Recurrence/no eradication of infection|19|||
149170709|NCT00391976|538096701|FG002|Overall Study|Recurrence/no eradication of infection|0|||
149170710|NCT00391976|538096699|FG000|Overall Study|Unable to classify|0|||
149170711|NCT00391976|538096700|FG001|Overall Study|Unable to classify|0|||
149170712|NCT00391976|538096701|FG002|Overall Study|Unable to classify|1|||
149170713|NCT00391976|538096699|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
149170714|NCT00391976|538096700|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
149170715|NCT00391976|538096701|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
149170716|NCT05127486|538096702|FG000|Overall Study|Adverse Event|2|||
149170717|NCT05127486|538096703|FG001|Overall Study|Adverse Event|4|||
149170718|NCT05127486|538096702|FG000|Overall Study|Lack of Efficacy|1|||
149170719|NCT05127486|538096703|FG001|Overall Study|Lack of Efficacy|0|||
149170720|NCT05127486|538096702|FG000|Overall Study|Pregnancy|0|||
149170721|NCT05127486|538096703|FG001|Overall Study|Pregnancy|1|||
149170722|NCT05127486|538096702|FG000|Overall Study|Physician Decision|4|||
149170723|NCT05127486|538096703|FG001|Overall Study|Physician Decision|1|||
149170724|NCT05127486|538096702|FG000|Overall Study|Withdrawal by Subject|14|||
149170725|NCT05127486|538096703|FG001|Overall Study|Withdrawal by Subject|13|||
149170726|NCT05127486|538096702|FG000|Overall Study|Lost to Follow-up|5|||
149170727|NCT05127486|538096703|FG001|Overall Study|Lost to Follow-up|8|||
149170728|NCT00049127|538096704|FG000|Overall Study|Withdrawal by Subject|0|||
149170729|NCT00049127|538096705|FG001|Overall Study|Withdrawal by Subject|0|||
149170730|NCT00049127|538096706|FG002|Overall Study|Withdrawal by Subject|1|||
149170731|NCT00049127|538096707|FG003|Overall Study|Withdrawal by Subject|0|||
149170732|NCT00049127|538096708|FG004|Overall Study|Withdrawal by Subject|0|||
149170733|NCT02582515|538096711|FG000|Overall Study|Withdrawal by Subject|0|||
149170734|NCT02582515|538096712|FG001|Overall Study|Withdrawal by Subject|1|||
149170735|NCT01287754|538096716|FG000|Overall Study|Death|2|||
149170736|NCT01287754|538096717|FG001|Overall Study|Death|12|||
149170737|NCT01287754|538096716|FG000|Overall Study|Lost to Follow-up|1|||
149170738|NCT01287754|538096717|FG001|Overall Study|Lost to Follow-up|6|||
149170739|NCT01287754|538096716|FG000|Overall Study|Protocol Violation|0|||
149170740|NCT01287754|538096717|FG001|Overall Study|Protocol Violation|3|||
149170741|NCT05027802|538096728|FG000|Overall Study|Adverse Event|2|||
149170742|NCT05027802|538096728|FG000|Overall Study|Withdrawal by Subject|18|||
149170743|NCT05027802|538096728|FG000|Overall Study|Death|2|||
149170744|NCT05027802|538096728|FG000|Overall Study|Other|1|||
149170745|NCT00001337|538096729|FG000|Overall Study|Switched to alternate treatment|2|||
149170746|NCT00001337|538096730|FG001|Overall Study|Switched to alternate treatment|2|||
149170747|NCT00001337|538096731|FG002|Overall Study|Switched to alternate treatment|0|||
149170748|NCT00001337|538096729|FG000|Overall Study|Refused further treatment|2|||
149170749|NCT00001337|538096730|FG001|Overall Study|Refused further treatment|1|||
149170750|NCT00001337|538096731|FG002|Overall Study|Refused further treatment|0|||
149170751|NCT00001337|538096729|FG000|Overall Study|Began other Tx|1|||
149170752|NCT00001337|538096730|FG001|Overall Study|Began other Tx|0|||
149170753|NCT00001337|538096731|FG002|Overall Study|Began other Tx|0|||
149170754|NCT00001337|538096729|FG000|Overall Study|Physician Decision|3|||
149170755|NCT00001337|538096730|FG001|Overall Study|Physician Decision|1|||
149170756|NCT00001337|538096731|FG002|Overall Study|Physician Decision|0|||
149170757|NCT00001337|538096729|FG000|Overall Study|Doesn't have NHL|0|||
149170758|NCT00001337|538096730|FG001|Overall Study|Doesn't have NHL|1|||
149170759|NCT00001337|538096731|FG002|Overall Study|Doesn't have NHL|0|||
149170760|NCT00001337|538096729|FG000|Overall Study|Non protocol tx needed|3|||
149170761|NCT00001337|538096730|FG001|Overall Study|Non protocol tx needed|1|||
149170762|NCT00001337|538096731|FG002|Overall Study|Non protocol tx needed|0|||
149170763|NCT00001337|538096729|FG000|Overall Study|Protocol change|1|||
149170764|NCT00001337|538096730|FG001|Overall Study|Protocol change|0|||
149170765|NCT00001337|538096731|FG002|Overall Study|Protocol change|0|||
149170766|NCT00001337|538096729|FG000|Overall Study|2nd primary disease|0|||
148677909|NCT01311505|536293617|FG001|First Intervention Period|Protocol Violation|1|||
148677910|NCT00446134|536293618|FG000|Overall Study|Adverse Event|7|||
148677911|NCT00446134|536293619|FG001|Overall Study|Adverse Event|17|||
148677912|NCT00446134|536293620|FG002|Overall Study|Adverse Event|13|||
149170767|NCT00001337|538096730|FG001|Overall Study|2nd primary disease|0|||
149170768|NCT00001337|538096731|FG002|Overall Study|2nd primary disease|1|||
149170769|NCT00001337|538096729|FG000|Overall Study|Death during follow up period|9|||
149170770|NCT00001337|538096730|FG001|Overall Study|Death during follow up period|4|||
149170771|NCT00001337|538096731|FG002|Overall Study|Death during follow up period|0|||
149170772|NCT00001337|538096729|FG000|Overall Study|Death on study|19|||
149170773|NCT00001337|538096730|FG001|Overall Study|Death on study|9|||
149170774|NCT00001337|538096731|FG002|Overall Study|Death on study|0|||
149170775|NCT00001337|538096729|FG000|Overall Study|Disease progression during follow-up period|3|||
149170776|NCT00001337|538096730|FG001|Overall Study|Disease progression during follow-up period|1|||
149170777|NCT00001337|538096731|FG002|Overall Study|Disease progression during follow-up period|0|||
149170778|NCT00001337|538096729|FG000|Overall Study|Disease progression on study|33|||
148677913|NCT00446134|536293621|FG003|Overall Study|Adverse Event|18|||
148677914|NCT00446134|536293618|FG000|Overall Study|Lack of Efficacy|19|||
148677915|NCT00446134|536293619|FG001|Overall Study|Lack of Efficacy|19|||
149170779|NCT00001337|538096730|FG001|Overall Study|Disease progression on study|41|||
148677916|NCT00446134|536293620|FG002|Overall Study|Lack of Efficacy|24|||
148677917|NCT00446134|536293621|FG003|Overall Study|Lack of Efficacy|19|||
148677918|NCT00446134|536293618|FG000|Overall Study|Protocol Violation|0|||
148677919|NCT00446134|536293619|FG001|Overall Study|Protocol Violation|2|||
149170780|NCT00001337|538096731|FG002|Overall Study|Disease progression on study|0|||
149170781|NCT00001337|538096729|FG000|Overall Study|Lost to further follow-up|10|||
149170782|NCT00001337|538096730|FG001|Overall Study|Lost to further follow-up|6|||
149170783|NCT00001337|538096731|FG002|Overall Study|Lost to further follow-up|0|||
149170784|NCT00001337|538096729|FG000|Overall Study|2nd malignancy|1|||
149170785|NCT00001337|538096730|FG001|Overall Study|2nd malignancy|0|||
149170786|NCT00001337|538096731|FG002|Overall Study|2nd malignancy|0|||
149170787|NCT00001337|538096729|FG000|Overall Study|Treatment for second lymphoma|0|||
149170788|NCT00001337|538096730|FG001|Overall Study|Treatment for second lymphoma|1|||
149170789|NCT00001337|538096731|FG002|Overall Study|Treatment for second lymphoma|0|||
149170790|NCT00001337|538096729|FG000|Overall Study|Transfer to transplant|0|||
149170791|NCT00001337|538096730|FG001|Overall Study|Transfer to transplant|1|||
149170792|NCT00001337|538096731|FG002|Overall Study|Transfer to transplant|0|||
149170793|NCT05817045|538096736|FG000|Overall Study|Protocol Violation|0|||
149170794|NCT05817045|538096737|FG001|Overall Study|Protocol Violation|3|||
149170795|NCT05817045|538096736|FG000|Overall Study|Withdrawal by Subject|10|||
149170796|NCT05817045|538096737|FG001|Overall Study|Withdrawal by Subject|7|||
149170797|NCT05817045|538096736|FG000|Overall Study|Physician Decision|3|||
149170798|NCT05817045|538096737|FG001|Overall Study|Physician Decision|0|||
148677920|NCT00446134|536293620|FG002|Overall Study|Protocol Violation|1|||
148677921|NCT00446134|536293621|FG003|Overall Study|Protocol Violation|0|||
148677922|NCT00446134|536293618|FG000|Overall Study|Lost to Follow-up|1|||
148677923|NCT00446134|536293619|FG001|Overall Study|Lost to Follow-up|3|||
148677924|NCT00446134|536293620|FG002|Overall Study|Lost to Follow-up|1|||
148677925|NCT00446134|536293621|FG003|Overall Study|Lost to Follow-up|1|||
148677926|NCT00446134|536293618|FG000|Overall Study|Withdrawal by Subject|3|||
148677927|NCT00446134|536293619|FG001|Overall Study|Withdrawal by Subject|3|||
148677928|NCT00446134|536293620|FG002|Overall Study|Withdrawal by Subject|1|||
148677929|NCT00446134|536293621|FG003|Overall Study|Withdrawal by Subject|3|||
148677930|NCT00446134|536293618|FG000|Overall Study|Physician Decision|0|||
148677931|NCT00446134|536293619|FG001|Overall Study|Physician Decision|0|||
148677932|NCT00446134|536293620|FG002|Overall Study|Physician Decision|0|||
148677933|NCT00446134|536293621|FG003|Overall Study|Physician Decision|2|||
148677934|NCT00446134|536293618|FG000|Overall Study|Adverse Event-Diarrhea|1|||
148677935|NCT00446134|536293619|FG001|Overall Study|Adverse Event-Diarrhea|1|||
148677936|NCT00446134|536293620|FG002|Overall Study|Adverse Event-Diarrhea|2|||
148677937|NCT00446134|536293621|FG003|Overall Study|Adverse Event-Diarrhea|0|||
148677938|NCT00446134|536293618|FG000|Overall Study|Reason Not Completed|3|||
148677939|NCT00446134|536293619|FG001|Overall Study|Reason Not Completed|0|||
148677940|NCT00446134|536293620|FG002|Overall Study|Reason Not Completed|1|||
148677941|NCT00446134|536293621|FG003|Overall Study|Reason Not Completed|2|||
148677942|NCT00567996|536293625|FG000|Overall Study|Adverse Event|18|||
148677943|NCT00567996|536293626|FG001|Overall Study|Adverse Event|16|||
148677944|NCT00567996|536293627|FG002|Overall Study|Adverse Event|13|||
148677945|NCT00567996|536293625|FG000|Overall Study|Protocol Deviation|9|||
148677946|NCT00567996|536293626|FG001|Overall Study|Protocol Deviation|11|||
148677947|NCT00567996|536293627|FG002|Overall Study|Protocol Deviation|13|||
148677948|NCT00567996|536293625|FG000|Overall Study|Withdrawal by Subject|8|||
148677949|NCT00567996|536293626|FG001|Overall Study|Withdrawal by Subject|12|||
148677950|NCT00567996|536293627|FG002|Overall Study|Withdrawal by Subject|22|||
148677951|NCT00567996|536293625|FG000|Overall Study|Abnormal Lab value(s)|2|||
148677952|NCT00567996|536293626|FG001|Overall Study|Abnormal Lab value(s)|1|||
148677953|NCT00567996|536293627|FG002|Overall Study|Abnormal Lab value(s)|2|||
148677954|NCT00567996|536293625|FG000|Overall Study|Abnormal test procedure result(s)|2|||
148677955|NCT00567996|536293626|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148677956|NCT00567996|536293627|FG002|Overall Study|Abnormal test procedure result(s)|1|||
148677957|NCT00567996|536293625|FG000|Overall Study|Lost to Follow-up|2|||
148677958|NCT00567996|536293626|FG001|Overall Study|Lost to Follow-up|5|||
148677959|NCT00567996|536293627|FG002|Overall Study|Lost to Follow-up|2|||
148806279|NCT00819039|536768941|FG002|Overall Study|Physician Decision|1|||
149170799|NCT05817045|538096736|FG000|Overall Study|Lost to Follow-up|0|||
149170800|NCT05817045|538096737|FG001|Overall Study|Lost to Follow-up|1|||
148677960|NCT00567996|536293625|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148677961|NCT00567996|536293626|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148677962|NCT00567996|536293627|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
148677963|NCT00567996|536293625|FG000|Overall Study|Administrative problems|1|||
148677964|NCT00567996|536293626|FG001|Overall Study|Administrative problems|1|||
148677965|NCT00567996|536293627|FG002|Overall Study|Administrative problems|0|||
148806280|NCT00819039|536768939|FG000|Overall Study|Protocol Violation|1|||
149170801|NCT05817045|538096736|FG000|Overall Study|Device Deficiency|1|||
149170802|NCT05817045|538096737|FG001|Overall Study|Device Deficiency|0|||
148677966|NCT00567996|536293625|FG000|Overall Study|Death|1|||
148677967|NCT00567996|536293626|FG001|Overall Study|Death|0|||
148677968|NCT00567996|536293627|FG002|Overall Study|Death|2|||
149170803|NCT05817045|538096736|FG000|Overall Study|System Error|1|||
149170804|NCT05817045|538096737|FG001|Overall Study|System Error|0|||
149170805|NCT02688647|538096738|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
149170806|NCT02688647|538096739|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
149170807|NCT02688647|538096738|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
149170808|NCT02688647|538096739|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
149170809|NCT02688647|538096738|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
149170810|NCT02688647|538096739|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
149170811|NCT02688647|538096738|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
149170812|NCT02688647|538096739|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
149170813|NCT02688647|538096738|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
149170814|NCT02688647|538096739|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
149170815|NCT02688647|538096738|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
149170816|NCT02688647|538096739|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
149170817|NCT02688647|538096738|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
149170818|NCT02688647|538096739|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
149170819|NCT03619213|538096740|FG000|Overall Study|Lost to Follow-up|2|||
149170820|NCT03619213|538096741|FG001|Overall Study|Lost to Follow-up|1|||
149170821|NCT03619213|538096740|FG000|Overall Study|Withdrawal by Subject|8|||
149170822|NCT03619213|538096741|FG001|Overall Study|Withdrawal by Subject|10|||
149170823|NCT02886702|538096742|FG000|Overall Study|Other|4|||
149170824|NCT02886702|538096743|FG001|Overall Study|Other|3|||
149170825|NCT02886702|538096744|FG002|Overall Study|Other|9|||
149170826|NCT02886702|538096742|FG000|Overall Study|Withdrawal by Subject|24|||
149170827|NCT02886702|538096743|FG001|Overall Study|Withdrawal by Subject|18|||
149170828|NCT02886702|538096744|FG002|Overall Study|Withdrawal by Subject|22|||
149170829|NCT02886702|538096742|FG000|Overall Study|Significant Worsening of Condition|0|||
149170830|NCT02886702|538096743|FG001|Overall Study|Significant Worsening of Condition|1|||
149170831|NCT02886702|538096744|FG002|Overall Study|Significant Worsening of Condition|0|||
149170832|NCT02886702|538096742|FG000|Overall Study|Protocol Violation|2|||
149170833|NCT02886702|538096743|FG001|Overall Study|Protocol Violation|2|||
149170834|NCT02886702|538096744|FG002|Overall Study|Protocol Violation|1|||
149170835|NCT02886702|538096742|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149170836|NCT02886702|538096743|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149170837|NCT02886702|538096744|FG002|Overall Study|Non-Compliance With Study Drug|4|||
149170838|NCT02886702|538096742|FG000|Overall Study|Lost to Follow-up|11|||
149170839|NCT02886702|538096743|FG001|Overall Study|Lost to Follow-up|13|||
149170840|NCT02886702|538096744|FG002|Overall Study|Lost to Follow-up|8|||
149170841|NCT02886702|538096742|FG000|Overall Study|Lack of Efficacy|3|||
149170842|NCT02886702|538096743|FG001|Overall Study|Lack of Efficacy|4|||
149170843|NCT02886702|538096744|FG002|Overall Study|Lack of Efficacy|5|||
149170844|NCT02886702|538096742|FG000|Overall Study|Adverse Event|4|||
149170845|NCT02886702|538096743|FG001|Overall Study|Adverse Event|9|||
149170846|NCT02886702|538096744|FG002|Overall Study|Adverse Event|3|||
149170847|NCT02886702|538096742|FG000|Overall Study|Administrative Reasons|0|||
149170848|NCT02886702|538096743|FG001|Overall Study|Administrative Reasons|0|||
149170849|NCT02886702|538096744|FG002|Overall Study|Administrative Reasons|1|||
148677969|NCT00567996|536293625|FG000|Overall Study|Patient's inability to use the device|0|||
149170850|NCT01147497|538096748|FG000|Overall Study|failed insertion|2|||
148806281|NCT00819039|536768940|FG001|Overall Study|Protocol Violation|0|||
149170851|NCT01147497|538096749|FG001|Overall Study|failed insertion|0|||
149170852|NCT04026568|538096752|FG000|Overall Study|study terminated|0|||
149170853|NCT04026568|538096753|FG001|Overall Study|study terminated|1|||
149170854|NCT00331760|538096754|FG000|Overall Study|Ineligible / no protocol treatment|15|||
149170855|NCT00331760|538096755|FG001|Overall Study|Ineligible / no protocol treatment|8|||
149170856|NCT03417440|538096757|FG000|Overall Study|Lost to Follow-up|0|||
149170857|NCT03417440|538096758|FG001|Overall Study|Lost to Follow-up|1|||
149170858|NCT03417440|538096759|FG002|Overall Study|Lost to Follow-up|0|||
149170859|NCT03417440|538096760|FG003|Overall Study|Lost to Follow-up|0|||
149170860|NCT03417440|538096761|FG004|Overall Study|Lost to Follow-up|1|||
149170861|NCT03417440|538096762|FG005|Overall Study|Lost to Follow-up|0|||
149170862|NCT03417440|538096763|FG006|Overall Study|Lost to Follow-up|0|||
149170863|NCT03417440|538096764|FG007|Overall Study|Lost to Follow-up|0|||
149170864|NCT03417440|538096757|FG000|Overall Study|Withdrawal by Subject|2|||
149170865|NCT03417440|538096758|FG001|Overall Study|Withdrawal by Subject|0|||
149170866|NCT03417440|538096759|FG002|Overall Study|Withdrawal by Subject|2|||
149170867|NCT03417440|538096760|FG003|Overall Study|Withdrawal by Subject|1|||
149170868|NCT03417440|538096761|FG004|Overall Study|Withdrawal by Subject|1|||
149170869|NCT03417440|538096762|FG005|Overall Study|Withdrawal by Subject|0|||
149170870|NCT03417440|538096763|FG006|Overall Study|Withdrawal by Subject|0|||
149170871|NCT03417440|538096764|FG007|Overall Study|Withdrawal by Subject|1|||
149170872|NCT02786901|538096765|FG000|Overall Study|Adverse Event|1|||
149170873|NCT02786901|538096766|FG001|Overall Study|Adverse Event|1|||
149170874|NCT02786901|538096767|FG002|Overall Study|Adverse Event|2|||
149170875|NCT02786901|538096765|FG000|Overall Study|Physician Decision|1|||
149170876|NCT02786901|538096766|FG001|Overall Study|Physician Decision|0|||
149170877|NCT02786901|538096767|FG002|Overall Study|Physician Decision|0|||
149170878|NCT02786901|538096765|FG000|Overall Study|Rescue Therapy Use|71|||
149170879|NCT02786901|538096766|FG001|Overall Study|Rescue Therapy Use|49|||
149170880|NCT02786901|538096767|FG002|Overall Study|Rescue Therapy Use|33|||
149170881|NCT02786901|538096765|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
149170882|NCT02786901|538096766|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
149170883|NCT02786901|538096767|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
149170884|NCT02786901|538096765|FG000|Overall Study|Disallowed medication|1|||
149170885|NCT02786901|538096766|FG001|Overall Study|Disallowed medication|1|||
149170886|NCT02786901|538096767|FG002|Overall Study|Disallowed medication|0|||
149170887|NCT02786901|538096765|FG000|Overall Study|Randomized in error|2|||
149170888|NCT02786901|538096766|FG001|Overall Study|Randomized in error|0|||
149170889|NCT02786901|538096767|FG002|Overall Study|Randomized in error|1|||
149170890|NCT00607048|538096769|FG000|Overall Study|Adverse Event|0|||
149170891|NCT00607048|538096770|FG001|Overall Study|Adverse Event|1|||
149170892|NCT00607048|538096771|FG002|Overall Study|Adverse Event|0|||
149170893|NCT00607048|538096772|FG003|Overall Study|Adverse Event|0|||
149170894|NCT00607048|538096773|FG004|Overall Study|Adverse Event|4|||
149170895|NCT00607048|538096774|FG005|Overall Study|Adverse Event|0|||
149170896|NCT00607048|538096769|FG000|Overall Study|Global deterioration of health|1|||
149170897|NCT00607048|538096770|FG001|Overall Study|Global deterioration of health|0|||
149170898|NCT00607048|538096771|FG002|Overall Study|Global deterioration of health|0|||
149170899|NCT00607048|538096772|FG003|Overall Study|Global deterioration of health|0|||
149170900|NCT00607048|538096773|FG004|Overall Study|Global deterioration of health|0|||
149170901|NCT00607048|538096774|FG005|Overall Study|Global deterioration of health|0|||
149170902|NCT00607048|538096769|FG000|Overall Study|Objective disease progression - relapse|1|||
149170903|NCT00607048|538096770|FG001|Overall Study|Objective disease progression - relapse|2|||
149170904|NCT00607048|538096771|FG002|Overall Study|Objective disease progression - relapse|4|||
149170905|NCT00607048|538096772|FG003|Overall Study|Objective disease progression - relapse|2|||
149170906|NCT00607048|538096773|FG004|Overall Study|Objective disease progression - relapse|2|||
149170907|NCT00607048|538096774|FG005|Overall Study|Objective disease progression - relapse|2|||
149170908|NCT00607048|538096769|FG000|Overall Study|Withdrawal by Subject|0|||
149170909|NCT00607048|538096770|FG001|Overall Study|Withdrawal by Subject|0|||
149170910|NCT00607048|538096771|FG002|Overall Study|Withdrawal by Subject|0|||
149170911|NCT00607048|538096772|FG003|Overall Study|Withdrawal by Subject|1|||
149170912|NCT00607048|538096773|FG004|Overall Study|Withdrawal by Subject|0|||
149170913|NCT00607048|538096774|FG005|Overall Study|Withdrawal by Subject|2|||
149170914|NCT00607048|538096769|FG000|Overall Study|Other|1|||
149170915|NCT00607048|538096770|FG001|Overall Study|Other|1|||
149170916|NCT00607048|538096771|FG002|Overall Study|Other|0|||
149170917|NCT00607048|538096772|FG003|Overall Study|Other|0|||
149170918|NCT00607048|538096773|FG004|Overall Study|Other|0|||
149170919|NCT00607048|538096774|FG005|Overall Study|Other|1|||
149170920|NCT01451645|538096775|FG000|Overall Study|Protocol Violation|1|||
148677970|NCT00567996|536293626|FG001|Overall Study|Patient's inability to use the device|1|||
149170921|NCT01451645|538096776|FG001|Overall Study|Protocol Violation|0|||
148677971|NCT00567996|536293627|FG002|Overall Study|Patient's inability to use the device|0|||
149170922|NCT01451645|538096775|FG000|Overall Study|Adverse Event|0|||
148677972|NCT02956005|536293628|FG000|Overall Study|Not eligible|1|||
148677973|NCT02956005|536293628|FG000|Overall Study|Withdrawal by Subject|3|||
148677974|NCT02956005|536293628|FG000|Overall Study|Physician Decision|12|||
148677975|NCT02524665|536293631|FG000|Overall Study|Lost to Follow-up|1|||
148677976|NCT02602080|536293634|FG000|Overall Study|Protocol Violation|6|||
148677977|NCT02602080|536293635|FG001|Overall Study|Protocol Violation|1|||
148677978|NCT02602080|536293636|FG002|Overall Study|Protocol Violation|3|||
148677979|NCT02574260|536293646|FG000|Overall Study|Disease Progression|1|||
148677980|NCT01066039|536293647|FG000|Overall Study|Adverse Event|6|||
148677981|NCT01066039|536293647|FG000|Overall Study|Withdrawal by Subject|17|||
148677982|NCT01066039|536293647|FG000|Overall Study|Protocol Violation|2|||
148677983|NCT01066039|536293647|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
148677984|NCT01066039|536293647|FG000|Overall Study|Investigator's Request|1|||
148677985|NCT01066039|536293647|FG000|Overall Study|Dropout due to Insulin Administration|1|||
148677986|NCT01066039|536293647|FG000|Overall Study|Additional Antihypertensive Required|4|||
148677987|NCT01066039|536293647|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
148677988|NCT01066039|536293647|FG000|Overall Study|Failure to Control Blood Pressure|1|||
148677989|NCT01066039|536293647|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
148677990|NCT03022799|536293650|FG000|Overall Study|Adverse Event|0|||
148677991|NCT03022799|536293651|FG001|Overall Study|Adverse Event|0|||
148677992|NCT03022799|536293652|FG002|Overall Study|Adverse Event|0|||
148677993|NCT03022799|536293653|FG003|Overall Study|Adverse Event|0|||
148677994|NCT03022799|536293654|FG004|Overall Study|Adverse Event|0|||
148677995|NCT03022799|536293655|FG005|Overall Study|Adverse Event|0|||
148677996|NCT03022799|536293656|FG006|Overall Study|Adverse Event|0|||
148677997|NCT03022799|536293657|FG007|Overall Study|Adverse Event|0|||
148677998|NCT03022799|536293658|FG008|Overall Study|Adverse Event|0|||
148677999|NCT03022799|536293659|FG009|Overall Study|Adverse Event|1|||
148678000|NCT03022799|536293660|FG010|Overall Study|Adverse Event|1|||
148678001|NCT03022799|536293661|FG011|Overall Study|Adverse Event|0|||
148678002|NCT03022799|536293662|FG012|Overall Study|Adverse Event|0|||
148678003|NCT00883129|536293666|FG000|Overall Study|Adverse Event|7|||
148678004|NCT00883129|536293667|FG001|Overall Study|Adverse Event|15|||
148678005|NCT00883129|536293666|FG000|Overall Study|Withdrawal by Subject|8|||
148678006|NCT00883129|536293667|FG001|Overall Study|Withdrawal by Subject|9|||
148678007|NCT00883129|536293666|FG000|Overall Study|Non-compliance|3|||
148678008|NCT00883129|536293667|FG001|Overall Study|Non-compliance|6|||
148678009|NCT00883129|536293666|FG000|Overall Study|Lost to Follow-up|1|||
148678010|NCT00883129|536293667|FG001|Overall Study|Lost to Follow-up|2|||
148678011|NCT00883129|536293666|FG000|Overall Study|Death|1|||
148678012|NCT00883129|536293667|FG001|Overall Study|Death|2|||
148678013|NCT00883129|536293666|FG000|Overall Study|Defined Treatment Failure|0|||
148678014|NCT00883129|536293667|FG001|Overall Study|Defined Treatment Failure|2|||
148678015|NCT03273257|536293668|FG000|Overall Study|Death|0|||
148678016|NCT03273257|536293669|FG001|Overall Study|Death|1|||
148678017|NCT03273257|536293668|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
148678018|NCT03273257|536293669|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
148678019|NCT03273257|536293668|FG000|Overall Study|Study terminated|3|||
148678020|NCT03273257|536293669|FG001|Overall Study|Study terminated|2|||
148678021|NCT01185639|536293671|FG000|Overall Study|Progressed and didn't receive therapy|2|||
148678022|NCT02200614|536293672|FG000|Double Blind Treatment|Adverse Event|86|||
148678023|NCT02200614|536293673|FG001|Double Blind Treatment|Adverse Event|48|||
148678024|NCT02200614|536293672|FG000|Double Blind Treatment|Confirmed metastasis|120|||
148678025|NCT02200614|536293673|FG001|Double Blind Treatment|Confirmed metastasis|140|||
148678026|NCT02200614|536293672|FG000|Double Blind Treatment|Judgment of the investigator|59|||
148678027|NCT02200614|536293673|FG001|Double Blind Treatment|Judgment of the investigator|99|||
148678028|NCT02200614|536293672|FG000|Double Blind Treatment|Metastasis by local reading|1|||
148678029|NCT02200614|536293673|FG001|Double Blind Treatment|Metastasis by local reading|3|||
148678030|NCT02200614|536293672|FG000|Double Blind Treatment|Other reason|6|||
148678031|NCT02200614|536293673|FG001|Double Blind Treatment|Other reason|2|||
148678032|NCT02200614|536293672|FG000|Double Blind Treatment|Personal reason|77|||
148678033|NCT02200614|536293673|FG001|Double Blind Treatment|Personal reason|85|||
148678034|NCT02200614|536293672|FG000|Double Blind Treatment|Protocol deviation|14|||
148678035|NCT02200614|536293673|FG001|Double Blind Treatment|Protocol deviation|7|||
148678036|NCT02200614|536293672|FG000|Double Blind Treatment|Not treated|1|||
148678037|NCT02200614|536293673|FG001|Double Blind Treatment|Not treated|0|||
148678038|NCT02200614|536293672|FG000|Open Label|Adverse Event|41|||
148678039|NCT02200614|536293673|FG001|Open Label|Adverse Event|11|||
148678040|NCT02200614|536293672|FG000|Open Label|Confirmed metastasis|1|||
148678041|NCT02200614|536293673|FG001|Open Label|Confirmed metastasis|0|||
148678042|NCT02200614|536293672|FG000|Open Label|Judgment of the investigator|29|||
148678043|NCT02200614|536293673|FG001|Open Label|Judgment of the investigator|2|||
148678044|NCT02200614|536293672|FG000|Open Label|Metastasis by local reading|138|||
148678045|NCT02200614|536293673|FG001|Open Label|Metastasis by local reading|27|||
148678046|NCT02200614|536293672|FG000|Open Label|Other reason|22|||
148678047|NCT02200614|536293673|FG001|Open Label|Other reason|4|||
149170923|NCT01451645|538096776|FG001|Overall Study|Adverse Event|3|||
149170924|NCT01451645|538096775|FG000|Overall Study|Withdrawal by Subject|4|||
149170925|NCT01451645|538096776|FG001|Overall Study|Withdrawal by Subject|2|||
149170926|NCT01451645|538096775|FG000|Overall Study|Lost to Follow-up|4|||
149170927|NCT01451645|538096776|FG001|Overall Study|Lost to Follow-up|3|||
149170928|NCT03663166|538096779|FG000|Overall Study|Withdrawal by Subject|1|||
148678048|NCT02200614|536293672|FG000|Open Label|Personal reason|60|||
149170929|NCT02561156|538096786|FG000|Part 2|Adverse Event|0|||
149170930|NCT02561156|538096787|FG001|Part 2|Adverse Event|0|||
149170931|NCT02561156|538096788|FG002|Part 2|Adverse Event|0|||
149170932|NCT02561156|538096789|FG003|Part 2|Adverse Event|0|||
149170933|NCT02561156|538096790|FG004|Part 2|Adverse Event|0|||
149170934|NCT02561156|538096791|FG005|Part 2|Adverse Event|0|||
149170935|NCT02561156|538096792|FG006|Part 2|Adverse Event|0|||
149170936|NCT02561156|538096793|FG007|Part 2|Adverse Event|0|||
149170937|NCT02561156|538096794|FG008|Part 2|Adverse Event|0|||
149170938|NCT02561156|538096795|FG009|Part 2|Adverse Event|0|||
149170939|NCT02561156|538096796|FG010|Part 2|Adverse Event|0|||
149170940|NCT02561156|538096797|FG011|Part 2|Adverse Event|1|||
149170941|NCT02561156|538096798|FG012|Part 2|Adverse Event|0|||
148678049|NCT02200614|536293673|FG001|Open Label|Personal reason|8|||
148678050|NCT02200614|536293672|FG000|Open Label|Protocol deviation|3|||
148678051|NCT02200614|536293673|FG001|Open Label|Protocol deviation|2|||
148678052|NCT02200614|536293672|FG000|Open Label|Missing|2|||
148678053|NCT02200614|536293673|FG001|Open Label|Missing|2|||
148678054|NCT01898884|536293674|FG000|Multiple Dose Period|Adverse Event|0|||
148678055|NCT01898884|536293675|FG001|Multiple Dose Period|Adverse Event|0|||
148678056|NCT01898884|536293676|FG002|Multiple Dose Period|Adverse Event|0|||
148678057|NCT01898884|536293677|FG003|Multiple Dose Period|Adverse Event|0|||
148678058|NCT01898884|536293678|FG004|Multiple Dose Period|Adverse Event|0|||
148678059|NCT01898884|536293679|FG005|Multiple Dose Period|Adverse Event|0|||
148678060|NCT01898884|536293680|FG006|Multiple Dose Period|Adverse Event|1|||
148678061|NCT01898884|536293681|FG007|Multiple Dose Period|Adverse Event|0|||
148678062|NCT01898884|536293682|FG008|Multiple Dose Period|Adverse Event|0|||
148678063|NCT01898884|536293674|FG000|Multiple Dose Period|Randomized Not Treated|0|||
148678064|NCT01898884|536293675|FG001|Multiple Dose Period|Randomized Not Treated|0|||
148678065|NCT01898884|536293676|FG002|Multiple Dose Period|Randomized Not Treated|0|||
148678066|NCT01898884|536293677|FG003|Multiple Dose Period|Randomized Not Treated|0|||
148678067|NCT01898884|536293678|FG004|Multiple Dose Period|Randomized Not Treated|0|||
148678068|NCT01898884|536293679|FG005|Multiple Dose Period|Randomized Not Treated|0|||
148678069|NCT01898884|536293680|FG006|Multiple Dose Period|Randomized Not Treated|0|||
148678070|NCT01898884|536293681|FG007|Multiple Dose Period|Randomized Not Treated|0|||
148678071|NCT01898884|536293682|FG008|Multiple Dose Period|Randomized Not Treated|1|||
148678072|NCT00434148|536293683|FG000|Overall Study|Adverse Event|18|||
148678073|NCT00434148|536293684|FG001|Overall Study|Adverse Event|18|||
148678074|NCT00434148|536293683|FG000|Overall Study|Lack of Efficacy|25|||
148678075|NCT00434148|536293684|FG001|Overall Study|Lack of Efficacy|28|||
148678076|NCT00434148|536293683|FG000|Overall Study|Withdrawal by Subject|15|||
148678077|NCT00434148|536293684|FG001|Overall Study|Withdrawal by Subject|15|||
148678078|NCT00434148|536293683|FG000|Overall Study|Protocol Violation|4|||
148806282|NCT00819039|536768941|FG002|Overall Study|Protocol Violation|0|||
149170942|NCT01071070|538096799|FG000|Overall Study|Adverse Event|0|||
149170943|NCT01071070|538096800|FG001|Overall Study|Adverse Event|3|||
148678079|NCT00434148|536293684|FG001|Overall Study|Protocol Violation|0|||
148678080|NCT00434148|536293683|FG000|Overall Study|Administrative problems|6|||
148678081|NCT00434148|536293684|FG001|Overall Study|Administrative problems|10|||
148678082|NCT00434148|536293683|FG000|Overall Study|Lost to Follow-up|0|||
148678083|NCT00434148|536293684|FG001|Overall Study|Lost to Follow-up|1|||
148678084|NCT00434148|536293683|FG000|Overall Study|Condition no longer requires study drug|1|||
149170944|NCT01071070|538096799|FG000|Overall Study|Withdrawal by Subject|1|||
149170945|NCT01071070|538096800|FG001|Overall Study|Withdrawal by Subject|0|||
149170946|NCT01071070|538096799|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
149170947|NCT01071070|538096800|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
149170948|NCT01071070|538096799|FG000|Overall Study|Hypercalcemia|1|||
149170949|NCT01071070|538096800|FG001|Overall Study|Hypercalcemia|0|||
148678085|NCT00434148|536293684|FG001|Overall Study|Condition no longer requires study drug|0|||
148806283|NCT04796415|536768942|FG000|Overall Study|not interested|12|||
149170950|NCT00158184|538096801|FG000|Overall Study|personal issues|3|||
149170951|NCT00158184|538096802|FG001|Overall Study|personal issues|1|||
149170952|NCT00158184|538096801|FG000|Overall Study|failed for follow unit/study rules|2|||
149170953|NCT00158184|538096802|FG001|Overall Study|failed for follow unit/study rules|0|||
149170954|NCT00158184|538096801|FG000|Overall Study|Adverse Event|1|||
149170955|NCT00158184|538096802|FG001|Overall Study|Adverse Event|1|||
149170956|NCT01147809|538096803|FG000|Phase I (168 Days)|Adverse Event|0|||
149170957|NCT01147809|538096804|FG001|Phase I (168 Days)|Adverse Event|0|||
149170958|NCT01147809|538096805|FG002|Phase I (168 Days)|Adverse Event|0|||
149170959|NCT01147809|538096806|FG003|Phase I (168 Days)|Adverse Event|1|||
149170960|NCT01147809|538096807|FG004|Phase I (168 Days)|Adverse Event|0|||
149170961|NCT01147809|538096808|FG005|Phase I (168 Days)|Adverse Event|0|||
149170962|NCT01147809|538096803|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
149170963|NCT01147809|538096804|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
149170964|NCT01147809|538096805|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
149170965|NCT01147809|538096806|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
149170966|NCT01147809|538096807|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
149170967|NCT01147809|538096808|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
149170968|NCT01147809|538096803|FG000|Phase I (168 Days)|Physician Decision|0|||
149170969|NCT01147809|538096804|FG001|Phase I (168 Days)|Physician Decision|1|||
149170970|NCT01147809|538096805|FG002|Phase I (168 Days)|Physician Decision|2|||
149170971|NCT01147809|538096806|FG003|Phase I (168 Days)|Physician Decision|0|||
149170972|NCT01147809|538096807|FG004|Phase I (168 Days)|Physician Decision|0|||
149170973|NCT01147809|538096808|FG005|Phase I (168 Days)|Physician Decision|0|||
149170974|NCT01147809|538096803|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
149170975|NCT01147809|538096804|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
149170976|NCT01147809|538096805|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
149170977|NCT01147809|538096806|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
149170978|NCT01147809|538096807|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
149170979|NCT01147809|538096808|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
149170980|NCT01147809|538096803|FG000|Phase II (168 Days)|Adverse Event|0|||
149170981|NCT01147809|538096804|FG001|Phase II (168 Days)|Adverse Event|0|||
149170982|NCT01147809|538096805|FG002|Phase II (168 Days)|Adverse Event|0|||
149170983|NCT01147809|538096806|FG003|Phase II (168 Days)|Adverse Event|0|||
149170984|NCT01147809|538096807|FG004|Phase II (168 Days)|Adverse Event|3|||
149170985|NCT01147809|538096808|FG005|Phase II (168 Days)|Adverse Event|6|||
149170986|NCT01147809|538096803|FG000|Phase II (168 Days)|Protocol Violation|0|||
149170987|NCT01147809|538096804|FG001|Phase II (168 Days)|Protocol Violation|0|||
149170988|NCT01147809|538096805|FG002|Phase II (168 Days)|Protocol Violation|0|||
149170989|NCT01147809|538096806|FG003|Phase II (168 Days)|Protocol Violation|0|||
149170990|NCT01147809|538096807|FG004|Phase II (168 Days)|Protocol Violation|0|||
149170991|NCT01147809|538096808|FG005|Phase II (168 Days)|Protocol Violation|1|||
149170992|NCT01147809|538096803|FG000|Phase II (168 Days)|Physician Decision|0|||
149170993|NCT01147809|538096804|FG001|Phase II (168 Days)|Physician Decision|0|||
149170994|NCT01147809|538096805|FG002|Phase II (168 Days)|Physician Decision|0|||
149170995|NCT01147809|538096806|FG003|Phase II (168 Days)|Physician Decision|0|||
149170996|NCT01147809|538096807|FG004|Phase II (168 Days)|Physician Decision|5|||
149170997|NCT01147809|538096808|FG005|Phase II (168 Days)|Physician Decision|11|||
149170998|NCT01147809|538096803|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
149170999|NCT01147809|538096804|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
149171000|NCT01147809|538096805|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
149171001|NCT01147809|538096806|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
149171002|NCT01147809|538096807|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
149171003|NCT01147809|538096808|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
149171004|NCT01147809|538096803|FG000|Phase II (168 Days)|Ongoing|0|||
149171005|NCT01147809|538096804|FG001|Phase II (168 Days)|Ongoing|0|||
149171006|NCT01147809|538096805|FG002|Phase II (168 Days)|Ongoing|0|||
149171007|NCT01147809|538096806|FG003|Phase II (168 Days)|Ongoing|0|||
149171008|NCT01147809|538096807|FG004|Phase II (168 Days)|Ongoing|1|||
149171009|NCT01147809|538096808|FG005|Phase II (168 Days)|Ongoing|0|||
149171010|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
149171011|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
149171012|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
149171013|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149171014|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149171015|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149171016|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149171017|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149171018|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149171019|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
149171020|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
149171021|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
149171022|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149171023|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149171024|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149171025|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149171026|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149171027|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149171028|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
149171029|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
149171030|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
149171031|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149171032|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149171033|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149171034|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149171035|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149171036|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149171037|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171038|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171039|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
149171040|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171041|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171042|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171043|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171044|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171045|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149171046|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
149171047|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
149171048|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
149171049|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149171050|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149171051|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149171052|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149171053|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149171054|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149171055|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
149171056|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171057|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171058|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171059|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171060|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171061|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171062|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171063|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149171064|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
149171065|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
149171066|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171067|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171068|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171069|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171070|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171071|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171072|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149171073|NCT01307423|538096809|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171074|NCT01307423|538096810|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
149171075|NCT01307423|538096811|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
149171076|NCT01307423|538096812|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171077|NCT01307423|538096813|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171078|NCT01307423|538096814|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171079|NCT01307423|538096815|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171080|NCT01307423|538096816|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171081|NCT01307423|538096817|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
149171082|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149171083|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
149171084|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
148678086|NCT00434148|536293683|FG000|Overall Study|Abnormal test procedure result|0|||
148678087|NCT00434148|536293684|FG001|Overall Study|Abnormal test procedure result|1|||
148678088|NCT01556165|536293685|FG000|Overall Study|Adverse Event|5|||
148678089|NCT01556165|536293686|FG001|Overall Study|Adverse Event|3|||
148678090|NCT01556165|536293685|FG000|Overall Study|Protocol Violation|0|||
148678091|NCT01556165|536293686|FG001|Overall Study|Protocol Violation|3|||
148678092|NCT01556165|536293685|FG000|Overall Study|Withdrawal of Consent|7|||
148678093|NCT01556165|536293686|FG001|Overall Study|Withdrawal of Consent|1|||
148678094|NCT02531698|536293689|FG000|Overall Study|Adverse Event|2|||
148678095|NCT02531698|536293690|FG001|Overall Study|Adverse Event|1|||
148678096|NCT02531698|536293689|FG000|Overall Study|Withdrawal by Subject|6|||
148678097|NCT02531698|536293690|FG001|Overall Study|Withdrawal by Subject|1|||
148678098|NCT02531698|536293689|FG000|Overall Study|Protocol Violation|2|||
148678099|NCT02531698|536293690|FG001|Overall Study|Protocol Violation|0|||
148678100|NCT02531698|536293689|FG000|Overall Study|Lost to Follow-up|1|||
148678101|NCT02531698|536293690|FG001|Overall Study|Lost to Follow-up|0|||
148678102|NCT02395536|536293696|FG000|Overall Study|Lost to Follow-up|4|||
148678103|NCT02395536|536293697|FG001|Overall Study|Lost to Follow-up|4|||
148678104|NCT02395536|536293696|FG000|Overall Study|Death|2|||
148678105|NCT02395536|536293697|FG001|Overall Study|Death|0|||
148678106|NCT02395536|536293696|FG000|Overall Study|Physician Decision|4|||
148678107|NCT02395536|536293697|FG001|Overall Study|Physician Decision|6|||
148678108|NCT02395536|536293696|FG000|Overall Study|Withdrawal by Subject|9|||
148678109|NCT02395536|536293697|FG001|Overall Study|Withdrawal by Subject|17|||
148678110|NCT02395536|536293696|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
148678111|NCT02395536|536293697|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
148678112|NCT02395536|536293696|FG000|Overall Study|Insurance issue|0|||
148678113|NCT02395536|536293697|FG001|Overall Study|Insurance issue|1|||
148678114|NCT00701558|536293698|FG000|Overall Study|Death|7|||
148678115|NCT00701558|536293698|FG000|Overall Study|Lost to Follow-up|8|||
148678116|NCT01640964|536293699|FG000|Overall Study|Lost to Follow-up|0|||
148678117|NCT01640964|536293700|FG001|Overall Study|Lost to Follow-up|0|||
148678118|NCT01640964|536293701|FG002|Overall Study|Lost to Follow-up|1|||
148678119|NCT01640964|536293699|FG000|Overall Study|Protocol Deviation|1|||
148678120|NCT01640964|536293700|FG001|Overall Study|Protocol Deviation|1|||
148678121|NCT01640964|536293701|FG002|Overall Study|Protocol Deviation|2|||
148678122|NCT02787746|536293702|FG000|Overall Study|Adverse Event|42|||
148678123|NCT02787746|536293702|FG000|Overall Study|Withdrawal by Subject|65|||
148678124|NCT02787746|536293702|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
148678125|NCT04822701|536293705|FG000|Overall Study|Not treated|2|||
148678126|NCT04822701|536293706|FG001|Overall Study|Not treated|0|||
148678127|NCT04822701|536293705|FG000|Overall Study|Lost to Follow-up|1|||
148678128|NCT04822701|536293706|FG001|Overall Study|Lost to Follow-up|0|||
148678129|NCT04822701|536293705|FG000|Overall Study|Withdrawal by Subject|1|||
148678130|NCT04822701|536293706|FG001|Overall Study|Withdrawal by Subject|0|||
148678131|NCT01422720|536295310|FG000|Overall Study|Adverse Event|16|||
148678132|NCT01422720|536295310|FG000|Overall Study|Lack of Efficacy|1|||
148678133|NCT01422720|536295310|FG000|Overall Study|Withdrawal by Subject|4|||
148678134|NCT01422720|536295310|FG000|Overall Study|Ineligibility|1|||
148678135|NCT00606801|536295311|FG000|Intervention|Protocol Violation|3|||
148678136|NCT00606801|536295312|FG001|Intervention|Protocol Violation|3|||
148678137|NCT02499406|536295314|FG000|Overall Study|missed 3 treatment sessions|4|||
148678138|NCT00552617|536295318|FG000|Overall Study|Not Treated|0|||
148678139|NCT00552617|536295319|FG001|Overall Study|Not Treated|0|||
148678140|NCT00552617|536295320|FG002|Overall Study|Not Treated|1|||
148678141|NCT00552617|536295321|FG003|Overall Study|Not Treated|0|||
148678142|NCT00552617|536295322|FG004|Overall Study|Not Treated|0|||
148678143|NCT00552617|536295323|FG005|Overall Study|Not Treated|0|||
148678144|NCT00552617|536295324|FG006|Overall Study|Not Treated|0|||
148678145|NCT00552617|536295325|FG007|Overall Study|Not Treated|0|||
148678146|NCT00552617|536295326|FG008|Overall Study|Not Treated|0|||
148678147|NCT00552617|536295327|FG009|Overall Study|Not Treated|1|||
148678148|NCT00552617|536295318|FG000|Overall Study|Lost to Follow-up|0|||
148678149|NCT00552617|536295319|FG001|Overall Study|Lost to Follow-up|0|||
148678150|NCT00552617|536295320|FG002|Overall Study|Lost to Follow-up|0|||
148678151|NCT00552617|536295321|FG003|Overall Study|Lost to Follow-up|1|||
148678152|NCT00552617|536295322|FG004|Overall Study|Lost to Follow-up|0|||
148678153|NCT00552617|536295323|FG005|Overall Study|Lost to Follow-up|2|||
148678154|NCT00552617|536295324|FG006|Overall Study|Lost to Follow-up|0|||
149013239|NCT04537897|537527868|FG000|Overall Study|Adverse Event|0|||
148678155|NCT00552617|536295325|FG007|Overall Study|Lost to Follow-up|0|||
148678156|NCT00552617|536295326|FG008|Overall Study|Lost to Follow-up|2|||
148678157|NCT00552617|536295327|FG009|Overall Study|Lost to Follow-up|0|||
148678158|NCT04651218|536295328|FG000|Overall Study|Withdrawal by Subject|0|||
148678159|NCT04651218|536295329|FG001|Overall Study|Withdrawal by Subject|2|||
148678160|NCT00337129|536295332|FG000|Overall Study|Adverse Event|4|||
148678161|NCT00337129|536295332|FG000|Overall Study|Withdrawal by Subject|1|||
148678162|NCT00337129|536295332|FG000|Overall Study|Lack of Efficacy|32|||
148678163|NCT00337129|536295332|FG000|Overall Study|Death|2|||
148678164|NCT00337129|536295332|FG000|Overall Study|not protocol specified|1|||
148678165|NCT01467570|536295333|FG000|Overall Study|Lost to Follow-up|8|||
149171085|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
149171086|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
149171087|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
148678166|NCT01467570|536295334|FG001|Overall Study|Lost to Follow-up|9|||
148678167|NCT02626182|536295337|FG000|Overall Study|Adverse Event|2|||
149171088|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
148678168|NCT02626182|536295338|FG001|Overall Study|Adverse Event|0|||
149171089|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149171090|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
149171091|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149171092|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
149171093|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
149171094|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
148678169|NCT03836729|536295347|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
148678170|NCT02239601|536295351|FG000|Overall Study|Withdrawal by Subject|3|||
149171095|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
148678171|NCT02239601|536295352|FG001|Overall Study|Withdrawal by Subject|4|||
148678172|NCT02239601|536295351|FG000|Overall Study|Protocol Violation|4|||
148678173|NCT02239601|536295352|FG001|Overall Study|Protocol Violation|2|||
148678174|NCT03174925|536295359|FG000|Overall Study|Elastographic images not retrievable|2|||
148678175|NCT03174925|536295359|FG000|Overall Study|Elastography image not interpretable|1|||
148678176|NCT01791127|536295360|FG000|Overall Study|Death|356|||
148678177|NCT01791127|536295360|FG000|Overall Study|Patient has withdrawn from study|293|||
148678178|NCT01791127|536295360|FG000|Overall Study|Lost to Follow-up|42|||
148678179|NCT01791127|536295360|FG000|Overall Study|All Siello leads are explanted|31|||
148678180|NCT01791127|536295360|FG000|Overall Study|Completion of 30 day safety registry|1|||
148678181|NCT01791127|536295360|FG000|Overall Study|Study terminated for EP Passion|749|||
148678182|NCT00068406|536295364|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
148678183|NCT00068406|536295364|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
148678184|NCT02018042|536295365|FG000|Overall Study|Withdrawal by Subject|1|||
148678185|NCT00589693|536295370|FG000|Overall Study|randomized in error|12|||
148678186|NCT00589693|536295371|FG001|Overall Study|randomized in error|6|||
148678187|NCT00589693|536295370|FG000|Overall Study|Adverse Event|4|||
148678188|NCT00589693|536295371|FG001|Overall Study|Adverse Event|4|||
148678189|NCT00589693|536295370|FG000|Overall Study|Death|26|||
149171096|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149171097|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149171098|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149171099|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
149171100|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171101|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171102|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171103|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171104|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171105|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
149171106|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171107|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171108|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
149171109|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149171110|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
149171111|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
149171112|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149171113|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149171114|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
149171115|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
148678190|NCT00589693|536295371|FG001|Overall Study|Death|16|||
148678191|NCT00589693|536295370|FG000|Overall Study|Lack of Efficacy|0|||
148678192|NCT00589693|536295371|FG001|Overall Study|Lack of Efficacy|1|||
148678193|NCT00589693|536295370|FG000|Overall Study|Lost to Follow-up|1|||
148678194|NCT00589693|536295371|FG001|Overall Study|Lost to Follow-up|0|||
148678195|NCT00589693|536295370|FG000|Overall Study|Physician Decision|0|||
148678196|NCT00589693|536295371|FG001|Overall Study|Physician Decision|1|||
148678197|NCT00589693|536295370|FG000|Overall Study|Protocol Violation|1|||
148678198|NCT00589693|536295371|FG001|Overall Study|Protocol Violation|1|||
148678199|NCT03231709|536295372|FG000|Treatment Period 1|Reason not Specified|0|||
148678200|NCT03231709|536295373|FG001|Treatment Period 1|Reason not Specified|1|||
148678201|NCT03231709|536295372|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
148678202|NCT03231709|536295373|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
148678203|NCT02609178|536295374|FG000|First Crown|Withdrawal by Subject|0|||
148678204|NCT02609178|536295375|FG001|First Crown|Withdrawal by Subject|0|||
148678205|NCT02609178|536295376|FG002|First Crown|Withdrawal by Subject|1|||
148678206|NCT02609178|536295377|FG003|First Crown|Withdrawal by Subject|1|||
148678207|NCT02609178|536295378|FG004|First Crown|Withdrawal by Subject|0|||
148678208|NCT02609178|536295379|FG005|First Crown|Withdrawal by Subject|0|||
148678209|NCT01128153|536295380|FG000|Overall Study|Adverse Event|1|||
148678210|NCT01128153|536295381|FG001|Overall Study|Adverse Event|3|||
148678211|NCT01128153|536295380|FG000|Overall Study|Condition under investigation worsened|8|||
148678212|NCT01128153|536295381|FG001|Overall Study|Condition under investigation worsened|7|||
148678213|NCT01128153|536295380|FG000|Overall Study|Withdrawal by Subject|2|||
148678214|NCT01128153|536295381|FG001|Overall Study|Withdrawal by Subject|3|||
148678215|NCT01128153|536295380|FG000|Overall Study|Incorrect enrolment to study|2|||
148678216|NCT01128153|536295381|FG001|Overall Study|Incorrect enrolment to study|1|||
148928147|NCT01897714|537221301|FG003|Phase II (MTD)|Other|0|||
148678217|NCT01128153|536295380|FG000|Overall Study|Protocol Violation|2|||
148678218|NCT01128153|536295381|FG001|Overall Study|Protocol Violation|0|||
148678219|NCT01128153|536295380|FG000|Overall Study|Developed discontinuation criteria|1|||
148928148|NCT01897714|537221302|FG004|Phase II (MTD)|Other|3|||
148678220|NCT01128153|536295381|FG001|Overall Study|Developed discontinuation criteria|1|||
149171116|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149171117|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
149171118|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171119|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171120|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171121|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
149171122|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171123|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171124|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171125|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171126|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
149171127|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
149171128|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
149171129|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
149171130|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
149171131|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
149171132|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
149171133|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
149171134|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
149171135|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
149171136|NCT01307423|538096809|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171137|NCT01307423|538096810|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171138|NCT01307423|538096811|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171139|NCT01307423|538096812|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171140|NCT01307423|538096813|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171141|NCT01307423|538096814|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
149171142|NCT01307423|538096815|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171143|NCT01307423|538096816|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171144|NCT01307423|538096817|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
149171145|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149171146|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
149171147|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
149171148|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149171149|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149171150|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149171151|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
149171152|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
149171153|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
149171154|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149171155|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
149171156|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
149171157|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149171158|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149171159|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149171160|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
149171161|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
149171162|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
149171163|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171164|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171165|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
149171166|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171167|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171168|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171169|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
148678221|NCT01954082|536295382|FG000|Overall Study|Study Suspension|42|||
148678222|NCT01954082|536295383|FG001|Overall Study|Study Suspension|36|||
149171170|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171171|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
149171172|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149171173|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
149171174|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
149171175|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149171176|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149171177|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149171178|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149171179|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
149171180|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
149171181|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149171182|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
149171183|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149171184|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149171185|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149171186|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149171187|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
149171188|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
149171189|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
149171190|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149171191|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
149171192|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
149171193|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149171194|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149171195|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149171196|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
149171197|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
149171198|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
149171199|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149171200|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
149171201|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
149171202|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149171203|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149171204|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149171205|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
149171206|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
149171207|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
149171208|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171209|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
149171210|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
149171211|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171212|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171213|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171214|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171215|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171216|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
149171217|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149171218|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
149171219|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
149171220|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149171221|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149171222|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149171223|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149171224|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
149171225|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
149171226|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149171227|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
149171228|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
149171229|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149171230|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148678223|NCT01954082|536295382|FG000|Overall Study|Adverse Event|10|||
148678224|NCT01954082|536295383|FG001|Overall Study|Adverse Event|4|||
148678225|NCT01954082|536295382|FG000|Overall Study|Intolerance|0|||
148678226|NCT01954082|536295383|FG001|Overall Study|Intolerance|1|||
149171231|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149171232|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
149171233|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
149171234|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
149171235|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171236|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
149171237|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171238|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171239|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171240|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171241|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171242|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
149171243|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
149171244|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171245|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
149171246|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171247|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171248|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171249|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171250|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171251|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171252|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
149171253|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171254|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
149171255|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171256|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171257|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171258|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171259|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171260|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
149171261|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
149171262|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149171263|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
149171264|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
149171265|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149171266|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149171267|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149171268|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149171269|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
149171270|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
149171271|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171272|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171273|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
149171274|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171275|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171276|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171277|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171278|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171279|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
149171280|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171281|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171282|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171283|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171284|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171285|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171286|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171287|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
149171288|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
149171289|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149171290|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
149171291|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
149171292|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149171293|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149171294|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149171295|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149171296|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
149171297|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
149171298|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171299|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
149171300|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
149171301|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171302|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171303|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171304|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171305|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171306|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
149171307|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149171308|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
149171309|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
149013240|NCT04537897|537527869|FG001|Overall Study|Adverse Event|0|||
149171310|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149171311|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149171312|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149171313|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149013241|NCT04537897|537527870|FG002|Overall Study|Adverse Event|0|||
148678227|NCT01954082|536295382|FG000|Overall Study|Non-compliance|6|||
148678228|NCT01954082|536295383|FG001|Overall Study|Non-compliance|4|||
148678229|NCT01954082|536295382|FG000|Overall Study|Physician Decision|2|||
149171314|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149171315|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
149171316|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171317|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
149171318|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171319|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171320|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171321|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171322|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171323|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171324|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
149171325|NCT01307423|538096809|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149171326|NCT01307423|538096810|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149171327|NCT01307423|538096811|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
149171328|NCT01307423|538096812|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149171329|NCT01307423|538096813|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149171330|NCT01307423|538096814|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149171331|NCT01307423|538096815|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
149171332|NCT01307423|538096816|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
149171333|NCT01307423|538096817|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
149171334|NCT02500537|538096818|FG000|Overall Study|Death|2|||
149171335|NCT02500537|538096819|FG001|Overall Study|Death|0|||
149171336|NCT02500537|538096818|FG000|Overall Study|Lost to Follow-up|0|||
149171337|NCT02500537|538096819|FG001|Overall Study|Lost to Follow-up|1|||
148678230|NCT01954082|536295383|FG001|Overall Study|Physician Decision|0|||
148678231|NCT01954082|536295382|FG000|Overall Study|Parent Decision|1|||
148678232|NCT01954082|536295383|FG001|Overall Study|Parent Decision|0|||
148678233|NCT01954082|536295382|FG000|Overall Study|Withdrawal by Subject|0|||
148678234|NCT01954082|536295383|FG001|Overall Study|Withdrawal by Subject|1|||
148678235|NCT01954082|536295382|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
148678236|NCT01954082|536295383|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
148678237|NCT01954082|536295382|FG000|Overall Study|Redirection of Care|0|||
148678238|NCT01954082|536295383|FG001|Overall Study|Redirection of Care|2|||
148678239|NCT01954082|536295382|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
148678240|NCT01954082|536295383|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
148678241|NCT01954082|536295382|FG000|Overall Study|Comfort Care|0|||
148678242|NCT01954082|536295383|FG001|Overall Study|Comfort Care|1|||
148678243|NCT01954082|536295382|FG000|Overall Study|Infant Moved|0|||
148678244|NCT01954082|536295383|FG001|Overall Study|Infant Moved|1|||
148678245|NCT01954082|536295382|FG000|Overall Study|Randomized not Treated|4|||
148678246|NCT01954082|536295383|FG001|Overall Study|Randomized not Treated|2|||
148678247|NCT02419469|536295384|FG000|Overall Study|Withdrawal by Subject|1|||
148678248|NCT01682512|536295385|FG000|Overall Study|Adverse Event|6|||
148678249|NCT01682512|536295386|FG001|Overall Study|Adverse Event|5|||
148678250|NCT01682512|536295387|FG002|Overall Study|Adverse Event|2|||
148678251|NCT01682512|536295385|FG000|Overall Study|Withdrawal by Subject|2|||
148678252|NCT01682512|536295386|FG001|Overall Study|Withdrawal by Subject|6|||
148678253|NCT01682512|536295387|FG002|Overall Study|Withdrawal by Subject|3|||
148678254|NCT01682512|536295385|FG000|Overall Study|Physician Decision|0|||
148678255|NCT01682512|536295386|FG001|Overall Study|Physician Decision|2|||
148678256|NCT01682512|536295387|FG002|Overall Study|Physician Decision|0|||
148678257|NCT01682512|536295385|FG000|Overall Study|Study terminated by sponsor|46|||
148678258|NCT01682512|536295386|FG001|Overall Study|Study terminated by sponsor|43|||
149013242|NCT04537897|537527871|FG003|Overall Study|Adverse Event|1|||
149171338|NCT02500537|538096818|FG000|Overall Study|Withdrawal by Subject|1|||
149171339|NCT02500537|538096819|FG001|Overall Study|Withdrawal by Subject|0|||
149171340|NCT01587989|538096820|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
148928149|NCT01897714|537221303|FG005|Phase II (MTD)|Other|0|||
149171341|NCT01587989|538096821|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
149171342|NCT01587989|538096822|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
149171343|NCT01587989|538096820|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
149171344|NCT01587989|538096821|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
149171345|NCT01587989|538096822|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
149171346|NCT01587989|538096820|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
149171347|NCT01587989|538096821|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
149171348|NCT01587989|538096822|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
149171349|NCT01587989|538096820|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
149171350|NCT01587989|538096821|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
149171351|NCT01587989|538096822|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
149171352|NCT01587989|538096820|FG000|Randomized Study Treatment|Screening failure|0|||
149171353|NCT01587989|538096821|FG001|Randomized Study Treatment|Screening failure|1|||
149171354|NCT01587989|538096822|FG002|Randomized Study Treatment|Screening failure|0|||
149171355|NCT01587989|538096820|FG000|Randomized Study Treatment|Physician Decision|0|||
149171356|NCT01587989|538096821|FG001|Randomized Study Treatment|Physician Decision|0|||
149171357|NCT01587989|538096822|FG002|Randomized Study Treatment|Physician Decision|1|||
149171358|NCT06119191|538096823|FG000|Overall Study|Adverse Event|0|||
149171359|NCT06119191|538096824|FG001|Overall Study|Adverse Event|1|||
149171360|NCT06119191|538096823|FG000|Overall Study|Protocol Violation|1|||
149171361|NCT06119191|538096824|FG001|Overall Study|Protocol Violation|0|||
149171362|NCT05630846|538099525|FG000|Overall Study|Death|1|||
149171363|NCT05630846|538099526|FG001|Overall Study|Death|0|||
149171364|NCT05630846|538099527|FG002|Overall Study|Death|0|||
149171365|NCT05630846|538099528|FG003|Overall Study|Death|0|||
149171366|NCT05630846|538099525|FG000|Overall Study|Withdrawal by Subject|3|||
149171367|NCT05630846|538099526|FG001|Overall Study|Withdrawal by Subject|3|||
149171368|NCT05630846|538099527|FG002|Overall Study|Withdrawal by Subject|4|||
149171369|NCT05630846|538099528|FG003|Overall Study|Withdrawal by Subject|1|||
149171370|NCT05630846|538099525|FG000|Overall Study|Lost to Follow-up|6|||
149171371|NCT05630846|538099526|FG001|Overall Study|Lost to Follow-up|5|||
149171372|NCT05630846|538099527|FG002|Overall Study|Lost to Follow-up|2|||
149171373|NCT05630846|538099528|FG003|Overall Study|Lost to Follow-up|5|||
149171374|NCT05630846|538099525|FG000|Overall Study|Other|1|||
149171375|NCT05630846|538099526|FG001|Overall Study|Other|0|||
149171376|NCT05630846|538099527|FG002|Overall Study|Other|0|||
149171377|NCT05630846|538099528|FG003|Overall Study|Other|0|||
149171378|NCT01056107|538099530|FG000|Overall Study|Withdrawal by Subject|0|||
149171379|NCT01056107|538099531|FG001|Overall Study|Withdrawal by Subject|1|||
149171380|NCT01056107|538099532|FG002|Overall Study|Withdrawal by Subject|3|||
149171381|NCT01056107|538099533|FG003|Overall Study|Withdrawal by Subject|0|||
149171382|NCT00496366|538099541|FG000|Overall Study|Death|1|||
149171383|NCT00260208|538099544|FG000|Overall Study|Subject withdrew consent|11|||
149171384|NCT00260208|538099545|FG001|Overall Study|Subject withdrew consent|7|||
149171385|NCT00260208|538099544|FG000|Overall Study|Lost to Follow-up|6|||
149171386|NCT00260208|538099545|FG001|Overall Study|Lost to Follow-up|1|||
149171387|NCT00260208|538099544|FG000|Overall Study|Death|12|||
149171388|NCT00260208|538099545|FG001|Overall Study|Death|10|||
149171389|NCT00260208|538099544|FG000|Overall Study|Missing|18|||
149171390|NCT00260208|538099545|FG001|Overall Study|Missing|16|||
149171391|NCT02091440|538099546|FG000|Overall Study|Death|2|||
149171392|NCT00768222|538099547|FG000|Overall Study|Lost to Follow-up|1|||
149171393|NCT00768222|538099548|FG001|Overall Study|Lost to Follow-up|1|||
149171394|NCT00768222|538099547|FG000|Overall Study|Withdrawal by Subject|3|||
149171395|NCT00768222|538099548|FG001|Overall Study|Withdrawal by Subject|1|||
149171396|NCT00768222|538099547|FG000|Overall Study|Protocol Violation|0|||
149171397|NCT00768222|538099548|FG001|Overall Study|Protocol Violation|2|||
149171398|NCT03323749|538099555|FG000|Double-blind Period|Lost to Follow-up|4|||
149171399|NCT03323749|538099556|FG001|Double-blind Period|Lost to Follow-up|5|||
149171400|NCT03323749|538099555|FG000|Double-blind Period|Adverse Event|3|||
149171401|NCT03323749|538099556|FG001|Double-blind Period|Adverse Event|1|||
149171402|NCT03323749|538099555|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
149171403|NCT03323749|538099556|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
149171404|NCT03323749|538099555|FG000|Open-Label Period|Adverse Event|3|||
149171405|NCT03323749|538099556|FG001|Open-Label Period|Adverse Event|10|||
149171406|NCT03323749|538099555|FG000|Open-Label Period|Withdrawal by Subject|7|||
149171407|NCT03323749|538099556|FG001|Open-Label Period|Withdrawal by Subject|5|||
149171408|NCT03263091|538099558|FG000|OL Component|Withdrawal by Subject|1|||
149171409|NCT03263091|538099559|FG001|OL Component|Withdrawal by Subject|1|||
149171410|NCT03263091|538099560|FG002|OL Component|Withdrawal by Subject|0|||
149171411|NCT03263091|538099561|FG003|OL Component|Withdrawal by Subject|0|||
149171412|NCT03263091|538099562|FG004|OL Component|Withdrawal by Subject|0|||
149171413|NCT03263091|538099563|FG005|OL Component|Withdrawal by Subject|0|||
149171414|NCT03263091|538099558|FG000|OL Component|Physician Decision|0|||
149171415|NCT03263091|538099559|FG001|OL Component|Physician Decision|1|||
149171416|NCT03263091|538099560|FG002|OL Component|Physician Decision|2|||
148928150|NCT01994590|537221304|FG000|Overall Study|Adverse Event|1|||
148928151|NCT01994590|537221304|FG000|Overall Study|Trial Terminated|1|||
148928152|NCT01801072|537221305|FG000|Overall Study|Lost to Follow-up|17|||
148928153|NCT01801072|537221306|FG001|Overall Study|Lost to Follow-up|14|||
149171417|NCT03263091|538099561|FG003|OL Component|Physician Decision|0|||
149171418|NCT03263091|538099562|FG004|OL Component|Physician Decision|0|||
149171419|NCT03263091|538099563|FG005|OL Component|Physician Decision|0|||
149171420|NCT03263091|538099558|FG000|OL Component|Death|1|||
149171421|NCT03263091|538099559|FG001|OL Component|Death|0|||
149171422|NCT03263091|538099560|FG002|OL Component|Death|0|||
149171423|NCT03263091|538099561|FG003|OL Component|Death|0|||
149171424|NCT03263091|538099562|FG004|OL Component|Death|0|||
149171425|NCT03263091|538099563|FG005|OL Component|Death|0|||
149171426|NCT03263091|538099558|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
149171427|NCT03263091|538099559|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
149171428|NCT03263091|538099560|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
149171429|NCT03263091|538099561|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
149171430|NCT03263091|538099562|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
149171431|NCT03263091|538099563|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
149171432|NCT03263091|538099558|FG000|OL High-EPO Component|Physician Decision|0|||
149171433|NCT03263091|538099559|FG001|OL High-EPO Component|Physician Decision|0|||
149171434|NCT03263091|538099560|FG002|OL High-EPO Component|Physician Decision|0|||
149171435|NCT03263091|538099561|FG003|OL High-EPO Component|Physician Decision|1|||
149171436|NCT03263091|538099562|FG004|OL High-EPO Component|Physician Decision|0|||
149171437|NCT03263091|538099563|FG005|OL High-EPO Component|Physician Decision|0|||
149171438|NCT03263091|538099558|FG000|OL High-EPO Component|Death|0|||
149171439|NCT03263091|538099559|FG001|OL High-EPO Component|Death|0|||
149171440|NCT03263091|538099560|FG002|OL High-EPO Component|Death|0|||
149171441|NCT03263091|538099561|FG003|OL High-EPO Component|Death|3|||
149171442|NCT03263091|538099562|FG004|OL High-EPO Component|Death|0|||
149171443|NCT03263091|538099563|FG005|OL High-EPO Component|Death|0|||
149171444|NCT03263091|538099558|FG000|DB Component|Withdrawal by Subject|0|||
149171445|NCT03263091|538099559|FG001|DB Component|Withdrawal by Subject|0|||
149171446|NCT03263091|538099560|FG002|DB Component|Withdrawal by Subject|0|||
149171447|NCT03263091|538099561|FG003|DB Component|Withdrawal by Subject|0|||
149171448|NCT03263091|538099562|FG004|DB Component|Withdrawal by Subject|22|||
149171449|NCT03263091|538099563|FG005|DB Component|Withdrawal by Subject|8|||
149171450|NCT03263091|538099558|FG000|DB Component|Physician Decision|0|||
149171451|NCT03263091|538099559|FG001|DB Component|Physician Decision|0|||
149171452|NCT03263091|538099560|FG002|DB Component|Physician Decision|0|||
149171453|NCT03263091|538099561|FG003|DB Component|Physician Decision|0|||
149171454|NCT03263091|538099562|FG004|DB Component|Physician Decision|3|||
149171455|NCT03263091|538099563|FG005|DB Component|Physician Decision|1|||
149171456|NCT03263091|538099558|FG000|DB Component|Adverse Event|0|||
149171457|NCT03263091|538099559|FG001|DB Component|Adverse Event|0|||
149171458|NCT03263091|538099560|FG002|DB Component|Adverse Event|0|||
149171459|NCT03263091|538099561|FG003|DB Component|Adverse Event|0|||
149171460|NCT03263091|538099562|FG004|DB Component|Adverse Event|2|||
149171461|NCT03263091|538099563|FG005|DB Component|Adverse Event|1|||
149171462|NCT03263091|538099558|FG000|DB Component|Lost to Follow-up|0|||
149171463|NCT03263091|538099559|FG001|DB Component|Lost to Follow-up|0|||
149171464|NCT03263091|538099560|FG002|DB Component|Lost to Follow-up|0|||
149171465|NCT03263091|538099561|FG003|DB Component|Lost to Follow-up|0|||
149171466|NCT03263091|538099562|FG004|DB Component|Lost to Follow-up|2|||
149171467|NCT03263091|538099563|FG005|DB Component|Lost to Follow-up|1|||
149171468|NCT03263091|538099558|FG000|DB Component|Death|0|||
149171469|NCT03263091|538099559|FG001|DB Component|Death|0|||
149171470|NCT03263091|538099560|FG002|DB Component|Death|0|||
149171471|NCT03263091|538099561|FG003|DB Component|Death|0|||
149171472|NCT03263091|538099562|FG004|DB Component|Death|7|||
149171473|NCT03263091|538099563|FG005|DB Component|Death|4|||
149171474|NCT03263091|538099558|FG000|DB Component|Other than specified|0|||
149171475|NCT03263091|538099559|FG001|DB Component|Other than specified|0|||
149171476|NCT03263091|538099560|FG002|DB Component|Other than specified|0|||
149171477|NCT03263091|538099561|FG003|DB Component|Other than specified|0|||
149171478|NCT03263091|538099562|FG004|DB Component|Other than specified|8|||
149171479|NCT03263091|538099563|FG005|DB Component|Other than specified|6|||
149171480|NCT01821963|538099565|FG000|Overall Study|Adverse Event|1|||
149171481|NCT00783289|538099566|FG000|Overall Study|Protocol Violation|0|||
149171482|NCT00783289|538099567|FG001|Overall Study|Protocol Violation|1|||
149171483|NCT00783289|538099568|FG002|Overall Study|Protocol Violation|0|||
149171484|NCT00783289|538099569|FG003|Overall Study|Protocol Violation|0|||
149171485|NCT00506389|538099570|FG000|In-treatment Period|Other|3|||
149171486|NCT00506389|538099571|FG001|In-treatment Period|Other|3|||
149171487|NCT00506389|538099572|FG002|In-treatment Period|Other|4|||
149171488|NCT00506389|538099570|FG000|In-treatment Period|Lost to Follow-up|0|||
149171489|NCT00506389|538099571|FG001|In-treatment Period|Lost to Follow-up|0|||
149171490|NCT00506389|538099572|FG002|In-treatment Period|Lost to Follow-up|1|||
149171491|NCT00506389|538099570|FG000|In-treatment Period|Lack of compliance|1|||
149171492|NCT00506389|538099571|FG001|In-treatment Period|Lack of compliance|0|||
149171493|NCT00506389|538099572|FG002|In-treatment Period|Lack of compliance|0|||
149171494|NCT00506389|538099570|FG000|In-treatment Period|Reasons not related to trial|4|||
149171495|NCT00506389|538099571|FG001|In-treatment Period|Reasons not related to trial|1|||
149171496|NCT00506389|538099572|FG002|In-treatment Period|Reasons not related to trial|0|||
149171497|NCT00506389|538099570|FG000|In-treatment Period|Withdrawal by Subject|3|||
149171498|NCT00506389|538099571|FG001|In-treatment Period|Withdrawal by Subject|3|||
148806284|NCT04796415|536768942|FG000|Overall Study|health issue|8|||
149171499|NCT00506389|538099572|FG002|In-treatment Period|Withdrawal by Subject|4|||
149171500|NCT00506389|538099570|FG000|In-treatment Period|Lack of Efficacy|0|||
149171501|NCT00506389|538099571|FG001|In-treatment Period|Lack of Efficacy|2|||
149171502|NCT00506389|538099572|FG002|In-treatment Period|Lack of Efficacy|0|||
149171503|NCT00506389|538099570|FG000|In-treatment Period|Adverse Event|11|||
149171504|NCT00506389|538099571|FG001|In-treatment Period|Adverse Event|5|||
149171505|NCT00506389|538099572|FG002|In-treatment Period|Adverse Event|2|||
149171506|NCT00506389|538099570|FG000|In-treatment Period|Randomized but not treated|4|||
149171507|NCT00506389|538099571|FG001|In-treatment Period|Randomized but not treated|1|||
149171508|NCT00506389|538099572|FG002|In-treatment Period|Randomized but not treated|1|||
149171509|NCT03095703|538099575|FG000|Overall Study|Withdrawal by Subject|1|||
149171510|NCT03539432|538099576|FG000|Overall Study|Lost to Follow-up|0|||
149171511|NCT03539432|538099577|FG001|Overall Study|Lost to Follow-up|1|||
149171512|NCT01381094|538099578|FG000|Overall Study|Adverse Event|1|||
149171513|NCT01381094|538099579|FG001|Overall Study|Adverse Event|2|||
149171514|NCT01381094|538099580|FG002|Overall Study|Adverse Event|0|||
149171515|NCT01381094|538099581|FG003|Overall Study|Adverse Event|1|||
149171516|NCT01381094|538099582|FG004|Overall Study|Adverse Event|0|||
149171517|NCT01381094|538099578|FG000|Overall Study|Lost to Follow-up|0|||
149171518|NCT01381094|538099579|FG001|Overall Study|Lost to Follow-up|0|||
149171519|NCT01381094|538099580|FG002|Overall Study|Lost to Follow-up|0|||
149171520|NCT01381094|538099581|FG003|Overall Study|Lost to Follow-up|0|||
149171521|NCT01381094|538099582|FG004|Overall Study|Lost to Follow-up|1|||
149171522|NCT01381094|538099578|FG000|Overall Study|Withdrawal of informed consent|0|||
149171523|NCT01381094|538099579|FG001|Overall Study|Withdrawal of informed consent|1|||
149171524|NCT01381094|538099580|FG002|Overall Study|Withdrawal of informed consent|0|||
149171525|NCT01381094|538099581|FG003|Overall Study|Withdrawal of informed consent|0|||
149171526|NCT01381094|538099582|FG004|Overall Study|Withdrawal of informed consent|0|||
149171527|NCT01381094|538099578|FG000|Overall Study|Participant given Aranesp injection|1|||
149171528|NCT01381094|538099579|FG001|Overall Study|Participant given Aranesp injection|0|||
149171529|NCT01381094|538099580|FG002|Overall Study|Participant given Aranesp injection|0|||
149171530|NCT01381094|538099581|FG003|Overall Study|Participant given Aranesp injection|0|||
149171531|NCT01381094|538099582|FG004|Overall Study|Participant given Aranesp injection|0|||
149171532|NCT02443402|538099587|FG000|Overall Study|Withdrawal by Subject|3|||
149171533|NCT02443402|538099588|FG001|Overall Study|Withdrawal by Subject|1|||
149171534|NCT02443402|538099587|FG000|Overall Study|Screen Failure|1|||
149171535|NCT02443402|538099588|FG001|Overall Study|Screen Failure|2|||
149171536|NCT01934504|538099592|FG000|Overall Study|Protocol Deviation|0|||
149171537|NCT01934504|538099593|FG001|Overall Study|Protocol Deviation|0|||
149171538|NCT01934504|538099594|FG002|Overall Study|Protocol Deviation|0|||
149171539|NCT01934504|538099595|FG003|Overall Study|Protocol Deviation|2|||
149171540|NCT01934504|538099592|FG000|Overall Study|Study Terminated by Sponsor|1|||
149171541|NCT01934504|538099593|FG001|Overall Study|Study Terminated by Sponsor|0|||
149171542|NCT01934504|538099594|FG002|Overall Study|Study Terminated by Sponsor|5|||
149171543|NCT01934504|538099595|FG003|Overall Study|Study Terminated by Sponsor|5|||
149171544|NCT02665689|538099602|FG000|Overall Study|Adverse Event|1|||
149171545|NCT02665689|538099603|FG001|Overall Study|Adverse Event|0|||
149171546|NCT02665689|538099602|FG000|Overall Study|Trial termination|1|||
149171547|NCT02665689|538099603|FG001|Overall Study|Trial termination|1|||
149171548|NCT02665689|538099602|FG000|Overall Study|Lost to Follow-up|0|||
149171549|NCT02665689|538099603|FG001|Overall Study|Lost to Follow-up|1|||
149171550|NCT00824564|538099604|FG000|Overall Study|Lost to Follow-up|5|||
149171551|NCT00824564|538099605|FG001|Overall Study|Lost to Follow-up|7|||
149171552|NCT00824564|538099604|FG000|Overall Study|Withdrawal by Subject|1|||
149171553|NCT00824564|538099605|FG001|Overall Study|Withdrawal by Subject|1|||
149171554|NCT00824564|538099604|FG000|Overall Study|Other|1|||
149171555|NCT00824564|538099605|FG001|Overall Study|Other|2|||
149171556|NCT00824564|538099604|FG000|Overall Study|Randomized, but not treated|1|||
149171557|NCT00824564|538099605|FG001|Overall Study|Randomized, but not treated|0|||
149171558|NCT00775021|538099606|FG000|First Intervention|Lost to Follow-up|1|||
149171559|NCT00775021|538099607|FG001|First Intervention|Lost to Follow-up|0|||
149171560|NCT00775021|538099606|FG000|Second Intervention|Adverse Event|0|||
149171561|NCT00775021|538099607|FG001|Second Intervention|Adverse Event|1|||
149171562|NCT00363415|538099608|FG000|Overall Study|Progressive Disease|196|||
149171563|NCT00363415|538099609|FG001|Overall Study|Progressive Disease|107|||
149171564|NCT00363415|538099608|FG000|Overall Study|Sponsor Decision|67|||
149171565|NCT00363415|538099609|FG001|Overall Study|Sponsor Decision|31|||
149171566|NCT00363415|538099608|FG000|Overall Study|Death|32|||
149171567|NCT00363415|538099609|FG001|Overall Study|Death|29|||
149171568|NCT00363415|538099608|FG000|Overall Study|Adverse Event|24|||
149171569|NCT00363415|538099609|FG001|Overall Study|Adverse Event|15|||
149171570|NCT00363415|538099608|FG000|Overall Study|Physician Decision|18|||
149171571|NCT00363415|538099609|FG001|Overall Study|Physician Decision|35|||
149171572|NCT00363415|538099608|FG000|Overall Study|Entry Criteria Not Met|11|||
149171573|NCT00363415|538099609|FG001|Overall Study|Entry Criteria Not Met|10|||
149171574|NCT00363415|538099608|FG000|Overall Study|Withdrawal by Subject|9|||
149171575|NCT00363415|538099609|FG001|Overall Study|Withdrawal by Subject|15|||
149171576|NCT00363415|538099608|FG000|Overall Study|Lost to Follow-up|3|||
149171577|NCT00363415|538099609|FG001|Overall Study|Lost to Follow-up|3|||
149171578|NCT00363415|538099608|FG000|Overall Study|Protocol Violation|1|||
149171579|NCT00363415|538099609|FG001|Overall Study|Protocol Violation|4|||
149171580|NCT01506141|538099620|FG000|Overall Study|Adverse Event|0|||
149171581|NCT01506141|538099621|FG001|Overall Study|Adverse Event|2|||
149171582|NCT01506141|538099620|FG000|Overall Study|Participation Terminated by Investigator|1|||
149171583|NCT01506141|538099621|FG001|Overall Study|Participation Terminated by Investigator|1|||
149171584|NCT01506141|538099620|FG000|Overall Study|Site Terminated by Sponsor|2|||
149171585|NCT01506141|538099621|FG001|Overall Study|Site Terminated by Sponsor|0|||
149171586|NCT01506141|538099620|FG000|Overall Study|Reason Not Specified|4|||
149171587|NCT01506141|538099621|FG001|Overall Study|Reason Not Specified|2|||
149171588|NCT04889209|538099622|FG000|All Cohorts Except 15E|Adverse Event|0|||
149171589|NCT04889209|538099623|FG001|All Cohorts Except 15E|Adverse Event|0|||
149171590|NCT04889209|538099624|FG002|All Cohorts Except 15E|Adverse Event|0|||
149171591|NCT04889209|538099625|FG003|All Cohorts Except 15E|Adverse Event|0|||
149171592|NCT04889209|538099626|FG004|All Cohorts Except 15E|Adverse Event|0|||
149171593|NCT04889209|538099627|FG005|All Cohorts Except 15E|Adverse Event|0|||
149171594|NCT04889209|538099628|FG006|All Cohorts Except 15E|Adverse Event|1|||
149171595|NCT04889209|538099629|FG007|All Cohorts Except 15E|Adverse Event|0|||
149171596|NCT04889209|538099630|FG008|All Cohorts Except 15E|Adverse Event|0|||
149171597|NCT04889209|538099631|FG009|All Cohorts Except 15E|Adverse Event|0|||
149171598|NCT04889209|538099632|FG010|All Cohorts Except 15E|Adverse Event|0|||
149171599|NCT04889209|538099633|FG011|All Cohorts Except 15E|Adverse Event|0|||
149171600|NCT04889209|538099634|FG012|All Cohorts Except 15E|Adverse Event|0|||
149171601|NCT04889209|538099635|FG013|All Cohorts Except 15E|Adverse Event|0|||
149171602|NCT04889209|538099636|FG014|All Cohorts Except 15E|Adverse Event|0|||
149171603|NCT04889209|538099637|FG015|All Cohorts Except 15E|Adverse Event|0|||
149171604|NCT04889209|538099638|FG016|All Cohorts Except 15E|Adverse Event|0|||
149171605|NCT04889209|538099639|FG017|All Cohorts Except 15E|Adverse Event|0|||
149171606|NCT04889209|538099622|FG000|All Cohorts Except 15E|Death|0|||
149171607|NCT04889209|538099623|FG001|All Cohorts Except 15E|Death|1|||
149171608|NCT04889209|538099624|FG002|All Cohorts Except 15E|Death|0|||
149171609|NCT04889209|538099625|FG003|All Cohorts Except 15E|Death|0|||
149013243|NCT04537897|537527872|FG004|Overall Study|Adverse Event|0|||
149013244|NCT04537897|537527873|FG005|Overall Study|Adverse Event|0|||
149013245|NCT04537897|537527874|FG006|Overall Study|Adverse Event|0|||
149171610|NCT04889209|538099626|FG004|All Cohorts Except 15E|Death|0|||
149171611|NCT04889209|538099627|FG005|All Cohorts Except 15E|Death|0|||
149171612|NCT04889209|538099628|FG006|All Cohorts Except 15E|Death|0|||
149171613|NCT04889209|538099629|FG007|All Cohorts Except 15E|Death|0|||
149171614|NCT04889209|538099630|FG008|All Cohorts Except 15E|Death|0|||
149171615|NCT04889209|538099631|FG009|All Cohorts Except 15E|Death|0|||
149171616|NCT04889209|538099632|FG010|All Cohorts Except 15E|Death|0|||
149171617|NCT04889209|538099633|FG011|All Cohorts Except 15E|Death|0|||
149171618|NCT04889209|538099634|FG012|All Cohorts Except 15E|Death|0|||
149171619|NCT04889209|538099635|FG013|All Cohorts Except 15E|Death|0|||
149171620|NCT04889209|538099636|FG014|All Cohorts Except 15E|Death|0|||
149171621|NCT04889209|538099637|FG015|All Cohorts Except 15E|Death|0|||
149171622|NCT04889209|538099638|FG016|All Cohorts Except 15E|Death|0|||
149171623|NCT04889209|538099639|FG017|All Cohorts Except 15E|Death|0|||
149171624|NCT04889209|538099622|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
149171625|NCT04889209|538099623|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
149171626|NCT04889209|538099624|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
149171627|NCT04889209|538099625|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
149171628|NCT04889209|538099626|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
149171629|NCT04889209|538099627|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
149171630|NCT04889209|538099628|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
149171631|NCT04889209|538099629|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
149171632|NCT04889209|538099630|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
149171633|NCT04889209|538099631|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
149171634|NCT04889209|538099632|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
149171635|NCT04889209|538099633|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
149171636|NCT04889209|538099634|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
149171637|NCT04889209|538099635|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
149171638|NCT04889209|538099636|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
149171639|NCT04889209|538099637|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
149171640|NCT04889209|538099638|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
149171641|NCT04889209|538099639|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
149171642|NCT04889209|538099622|FG000|All Cohorts Except 15E|Physician Decision|0|||
149171643|NCT04889209|538099623|FG001|All Cohorts Except 15E|Physician Decision|0|||
149171644|NCT04889209|538099624|FG002|All Cohorts Except 15E|Physician Decision|0|||
149171645|NCT04889209|538099625|FG003|All Cohorts Except 15E|Physician Decision|0|||
149171646|NCT04889209|538099626|FG004|All Cohorts Except 15E|Physician Decision|1|||
149171647|NCT04889209|538099627|FG005|All Cohorts Except 15E|Physician Decision|0|||
149171648|NCT04889209|538099628|FG006|All Cohorts Except 15E|Physician Decision|0|||
149171649|NCT04889209|538099629|FG007|All Cohorts Except 15E|Physician Decision|1|||
149171650|NCT04889209|538099630|FG008|All Cohorts Except 15E|Physician Decision|0|||
149171651|NCT04889209|538099631|FG009|All Cohorts Except 15E|Physician Decision|1|||
149171652|NCT04889209|538099632|FG010|All Cohorts Except 15E|Physician Decision|0|||
149171653|NCT04889209|538099633|FG011|All Cohorts Except 15E|Physician Decision|1|||
149171654|NCT04889209|538099634|FG012|All Cohorts Except 15E|Physician Decision|1|||
149171655|NCT04889209|538099635|FG013|All Cohorts Except 15E|Physician Decision|0|||
149171656|NCT04889209|538099636|FG014|All Cohorts Except 15E|Physician Decision|0|||
149171657|NCT04889209|538099637|FG015|All Cohorts Except 15E|Physician Decision|0|||
149171658|NCT04889209|538099638|FG016|All Cohorts Except 15E|Physician Decision|0|||
149171659|NCT04889209|538099639|FG017|All Cohorts Except 15E|Physician Decision|0|||
149171660|NCT04889209|538099622|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
149171661|NCT04889209|538099623|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
149171662|NCT04889209|538099624|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
149171663|NCT04889209|538099625|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
149171664|NCT04889209|538099626|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
149171665|NCT04889209|538099627|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171666|NCT04889209|538099628|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171667|NCT04889209|538099629|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
149171668|NCT04889209|538099630|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171669|NCT04889209|538099631|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171670|NCT04889209|538099632|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171671|NCT04889209|538099633|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171672|NCT04889209|538099634|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
149171673|NCT04889209|538099635|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
149171674|NCT04889209|538099636|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
149171675|NCT04889209|538099637|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
149171676|NCT04889209|538099638|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
148678259|NCT01682512|536295387|FG002|Overall Study|Study terminated by sponsor|0|||
148678260|NCT01682512|536295385|FG000|Overall Study|Lost to Follow-up|3|||
148678261|NCT01682512|536295386|FG001|Overall Study|Lost to Follow-up|0|||
148678262|NCT01682512|536295387|FG002|Overall Study|Lost to Follow-up|2|||
148678263|NCT01682512|536295385|FG000|Overall Study|Protocol Violation|2|||
148678264|NCT01682512|536295386|FG001|Overall Study|Protocol Violation|3|||
148678265|NCT01682512|536295387|FG002|Overall Study|Protocol Violation|2|||
148678266|NCT01682512|536295385|FG000|Overall Study|Primary lack of efficacy|10|||
148678267|NCT01682512|536295386|FG001|Overall Study|Primary lack of efficacy|7|||
148678268|NCT01682512|536295387|FG002|Overall Study|Primary lack of efficacy|7|||
148678269|NCT01682512|536295385|FG000|Overall Study|Secondary lack of efficacy|1|||
148678270|NCT01682512|536295386|FG001|Overall Study|Secondary lack of efficacy|1|||
149171677|NCT04889209|538099639|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
149171678|NCT04889209|538099622|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
149171679|NCT04889209|538099623|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
149171680|NCT04889209|538099624|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171681|NCT04889209|538099625|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171682|NCT04889209|538099626|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171683|NCT04889209|538099627|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149171684|NCT04889209|538099628|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171685|NCT04889209|538099629|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149171686|NCT04889209|538099630|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171687|NCT04889209|538099631|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149171688|NCT04889209|538099632|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171689|NCT04889209|538099633|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171690|NCT04889209|538099634|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171691|NCT04889209|538099635|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171692|NCT04889209|538099636|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171693|NCT04889209|538099637|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171694|NCT04889209|538099638|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
149171695|NCT04889209|538099639|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
149171696|NCT04889209|538099622|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171697|NCT04889209|538099623|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171698|NCT04889209|538099624|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171699|NCT04889209|538099625|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
149171700|NCT04889209|538099626|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171701|NCT04889209|538099627|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171702|NCT04889209|538099628|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171703|NCT04889209|538099629|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171704|NCT04889209|538099630|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171705|NCT04889209|538099631|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171706|NCT04889209|538099632|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171707|NCT04889209|538099633|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171708|NCT04889209|538099634|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171709|NCT04889209|538099635|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171710|NCT04889209|538099636|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171711|NCT04889209|538099637|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171712|NCT04889209|538099638|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171713|NCT04889209|538099639|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
149171714|NCT04889209|538099622|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171715|NCT04889209|538099623|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171716|NCT04889209|538099624|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171717|NCT04889209|538099625|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171718|NCT04889209|538099626|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171719|NCT04889209|538099627|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171720|NCT04889209|538099628|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171721|NCT04889209|538099629|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171722|NCT04889209|538099630|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171723|NCT04889209|538099631|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171724|NCT04889209|538099632|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171725|NCT04889209|538099633|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171726|NCT04889209|538099634|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171727|NCT04889209|538099635|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171728|NCT04889209|538099636|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171729|NCT04889209|538099637|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171730|NCT04889209|538099638|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
149171731|NCT04889209|538099639|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
149171732|NCT04889209|538099622|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171733|NCT04889209|538099623|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171734|NCT04889209|538099624|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171735|NCT04889209|538099625|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
148806285|NCT04796415|536768942|FG000|Overall Study|Other|4|||
149171736|NCT04889209|538099626|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171737|NCT04889209|538099627|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171738|NCT04889209|538099628|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171739|NCT04889209|538099629|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171740|NCT04889209|538099630|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171741|NCT04889209|538099631|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171742|NCT04889209|538099632|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171743|NCT04889209|538099633|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171744|NCT04889209|538099634|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171745|NCT04889209|538099635|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171746|NCT04889209|538099636|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171747|NCT04889209|538099637|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171748|NCT04889209|538099638|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
149171749|NCT04889209|538099639|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
149171750|NCT04889209|538099622|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171751|NCT04889209|538099623|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171752|NCT04889209|538099624|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171753|NCT04889209|538099625|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171754|NCT04889209|538099626|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171755|NCT04889209|538099627|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171756|NCT04889209|538099628|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171757|NCT04889209|538099629|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171758|NCT04889209|538099630|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171759|NCT04889209|538099631|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171760|NCT04889209|538099632|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171761|NCT04889209|538099633|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171762|NCT04889209|538099634|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171763|NCT04889209|538099635|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171764|NCT04889209|538099636|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171765|NCT04889209|538099637|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171766|NCT04889209|538099638|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
149171767|NCT04889209|538099639|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
149171768|NCT04889209|538099622|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171769|NCT04889209|538099623|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171770|NCT04889209|538099624|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171771|NCT04889209|538099625|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171772|NCT04889209|538099626|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171773|NCT04889209|538099627|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171774|NCT04889209|538099628|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171775|NCT04889209|538099629|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171776|NCT04889209|538099630|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171777|NCT04889209|538099631|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171778|NCT04889209|538099632|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171779|NCT04889209|538099633|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171780|NCT04889209|538099634|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171781|NCT04889209|538099635|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171782|NCT04889209|538099636|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
149171783|NCT04889209|538099637|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171784|NCT04889209|538099638|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171785|NCT04889209|538099639|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
149171786|NCT04607408|538099640|FG000|Overall Study|Lost to Follow-up|0|||
149171787|NCT04607408|538099641|FG001|Overall Study|Lost to Follow-up|0|||
149171788|NCT04607408|538099642|FG002|Overall Study|Lost to Follow-up|0|||
149171789|NCT04607408|538099643|FG003|Overall Study|Lost to Follow-up|1|||
149171790|NCT04607408|538099644|FG004|Overall Study|Lost to Follow-up|0|||
149171791|NCT04607408|538099640|FG000|Overall Study|Withdrawal by Subject|0|||
149171792|NCT04607408|538099641|FG001|Overall Study|Withdrawal by Subject|1|||
149171793|NCT04607408|538099642|FG002|Overall Study|Withdrawal by Subject|0|||
149171794|NCT04607408|538099643|FG003|Overall Study|Withdrawal by Subject|1|||
149171795|NCT04607408|538099644|FG004|Overall Study|Withdrawal by Subject|0|||
149171796|NCT01725165|538099655|FG000|Overall Study|Death|11|||
149171797|NCT01725165|538099656|FG001|Overall Study|Death|18|||
149171798|NCT02725788|538099659|FG000|Overall Study|Lost to Follow-up|1|||
149171799|NCT02725788|538099660|FG001|Overall Study|Lost to Follow-up|1|||
149171800|NCT02725788|538099659|FG000|Overall Study|Protocol Violation|0|||
149171801|NCT02725788|538099660|FG001|Overall Study|Protocol Violation|1|||
148806286|NCT04796415|536768942|FG000|Overall Study|discharged from home health service|3|||
149171802|NCT05590377|538099661|FG000|Overall Study|Death|1|||
149171803|NCT05590377|538099662|FG001|Overall Study|Death|1|||
149171804|NCT05590377|538099663|FG002|Overall Study|Death|2|||
149171805|NCT05590377|538099664|FG003|Overall Study|Death|0|||
149171806|NCT05590377|538099665|FG004|Overall Study|Death|0|||
149171807|NCT05590377|538099661|FG000|Overall Study|Study Terminated by Sponsor|1|||
149171808|NCT05590377|538099662|FG001|Overall Study|Study Terminated by Sponsor|5|||
149171809|NCT05590377|538099663|FG002|Overall Study|Study Terminated by Sponsor|4|||
149171810|NCT05590377|538099664|FG003|Overall Study|Study Terminated by Sponsor|0|||
149171811|NCT05590377|538099665|FG004|Overall Study|Study Terminated by Sponsor|0|||
149171812|NCT05590377|538099661|FG000|Overall Study|Withdrawal by Subject|1|||
149171813|NCT05590377|538099662|FG001|Overall Study|Withdrawal by Subject|0|||
149171814|NCT05590377|538099663|FG002|Overall Study|Withdrawal by Subject|0|||
149171815|NCT05590377|538099664|FG003|Overall Study|Withdrawal by Subject|0|||
149171816|NCT05590377|538099665|FG004|Overall Study|Withdrawal by Subject|0|||
149171817|NCT00382967|538099666|FG000|Overall Study|Protocol Violation|1|||
149171818|NCT00382967|538099667|FG001|Overall Study|Protocol Violation|1|||
149171819|NCT02620020|538099678|FG000|Overall Study|Adverse Event|8|||
149171820|NCT02620020|538099679|FG001|Overall Study|Adverse Event|4|||
149171821|NCT02620020|538099680|FG002|Overall Study|Adverse Event|3|||
149171822|NCT02620020|538099681|FG003|Overall Study|Adverse Event|5|||
149171823|NCT02620020|538099678|FG000|Overall Study|Lost to Follow-up|4|||
149171824|NCT02620020|538099679|FG001|Overall Study|Lost to Follow-up|8|||
149171825|NCT02620020|538099680|FG002|Overall Study|Lost to Follow-up|1|||
149171826|NCT02620020|538099681|FG003|Overall Study|Lost to Follow-up|4|||
149171827|NCT02620020|538099678|FG000|Overall Study|Physician Decision|7|||
149171828|NCT02620020|538099679|FG001|Overall Study|Physician Decision|4|||
149171829|NCT02620020|538099680|FG002|Overall Study|Physician Decision|3|||
149171830|NCT02620020|538099681|FG003|Overall Study|Physician Decision|4|||
149171831|NCT02620020|538099678|FG000|Overall Study|Protocol Violation|5|||
149171832|NCT02620020|538099679|FG001|Overall Study|Protocol Violation|2|||
149171833|NCT02620020|538099680|FG002|Overall Study|Protocol Violation|1|||
149171834|NCT02620020|538099681|FG003|Overall Study|Protocol Violation|1|||
149171835|NCT02620020|538099678|FG000|Overall Study|Withdrawal by Subject|20|||
149171836|NCT02620020|538099679|FG001|Overall Study|Withdrawal by Subject|16|||
149171837|NCT02620020|538099680|FG002|Overall Study|Withdrawal by Subject|17|||
149171838|NCT02620020|538099681|FG003|Overall Study|Withdrawal by Subject|12|||
149171839|NCT02620020|538099678|FG000|Overall Study|Death|0|||
149171840|NCT02620020|538099679|FG001|Overall Study|Death|1|||
149171841|NCT02620020|538099680|FG002|Overall Study|Death|0|||
149171842|NCT02620020|538099681|FG003|Overall Study|Death|0|||
149171843|NCT03168867|538099684|FG000|Overall Study|Withdrawal by Subject|1|||
149171844|NCT03168867|538099685|FG001|Overall Study|Withdrawal by Subject|5|||
149171845|NCT04348851|538099686|FG000|Post-Test 1|Withdrawal by Subject|0|||
149171846|NCT04348851|538099687|FG001|Post-Test 1|Withdrawal by Subject|1|||
149171847|NCT04348851|538099688|FG002|Post-Test 1|Withdrawal by Subject|0|||
149171848|NCT04348851|538099689|FG003|Post-Test 1|Withdrawal by Subject|0|||
149171849|NCT04348851|538099686|FG000|Post-Test 1|Lost to Follow-up|0|||
149171850|NCT04348851|538099687|FG001|Post-Test 1|Lost to Follow-up|1|||
149171851|NCT04348851|538099688|FG002|Post-Test 1|Lost to Follow-up|0|||
149171852|NCT04348851|538099689|FG003|Post-Test 1|Lost to Follow-up|0|||
149171853|NCT04348851|538099686|FG000|Post-Test 2|Stroke survivor death|0|||
149171854|NCT04348851|538099687|FG001|Post-Test 2|Stroke survivor death|1|||
149171855|NCT04348851|538099688|FG002|Post-Test 2|Stroke survivor death|0|||
149171856|NCT04348851|538099689|FG003|Post-Test 2|Stroke survivor death|1|||
149171857|NCT00195650|538099690|FG000|Overall Study|Adverse Event|194|||
149171858|NCT00195650|538099690|FG000|Overall Study|Lack of Efficacy|99|||
149171859|NCT00195650|538099690|FG000|Overall Study|Withdrawal by Subject|67|||
149171860|NCT00195650|538099690|FG000|Overall Study|Lost to Follow-up|44|||
149171861|NCT00195650|538099690|FG000|Overall Study|Death|23|||
149171862|NCT00195650|538099690|FG000|Overall Study|Protocol Violation|15|||
149171863|NCT00195650|538099690|FG000|Overall Study|Administrative reasons|83|||
149171864|NCT01478958|538099691|FG000|Overall Study|Withdrawal by Subject|1|||
149171865|NCT01478958|538099692|FG001|Overall Study|Withdrawal by Subject|1|||
149171866|NCT01478958|538099693|FG002|Overall Study|Withdrawal by Subject|1|||
149171867|NCT01478958|538099691|FG000|Overall Study|Weight loss|1|||
149171868|NCT01478958|538099692|FG001|Overall Study|Weight loss|0|||
149171869|NCT01478958|538099693|FG002|Overall Study|Weight loss|0|||
149171870|NCT01478958|538099691|FG000|Overall Study|Re-located|0|||
149171871|NCT01478958|538099692|FG001|Overall Study|Re-located|1|||
149171872|NCT01478958|538099693|FG002|Overall Study|Re-located|0|||
149171873|NCT01478958|538099691|FG000|Overall Study|Unable to comply|0|||
149171874|NCT01478958|538099692|FG001|Overall Study|Unable to comply|0|||
149171875|NCT01478958|538099693|FG002|Overall Study|Unable to comply|2|||
149171876|NCT01709331|538099694|FG000|Overall Study|Adverse Event|1|||
149171877|NCT02305563|538099695|FG000|Treatment Period|Disease progression|0|||
148678271|NCT01682512|536295387|FG002|Overall Study|Secondary lack of efficacy|0|||
148678272|NCT01682512|536295385|FG000|Overall Study|Other than stated above|2|||
149171878|NCT02305563|538099696|FG001|Treatment Period|Disease progression|0|||
149171879|NCT02305563|538099697|FG002|Treatment Period|Disease progression|15|||
149171880|NCT02305563|538099698|FG003|Treatment Period|Disease progression|6|||
149171881|NCT02305563|538099699|FG004|Treatment Period|Disease progression|6|||
149171882|NCT02305563|538099695|FG000|Treatment Period|Study drug toxicity|0|||
149171883|NCT02305563|538099696|FG001|Treatment Period|Study drug toxicity|0|||
149171884|NCT02305563|538099697|FG002|Treatment Period|Study drug toxicity|0|||
149171885|NCT02305563|538099698|FG003|Treatment Period|Study drug toxicity|1|||
149171886|NCT02305563|538099699|FG004|Treatment Period|Study drug toxicity|2|||
149171887|NCT02305563|538099695|FG000|Treatment Period|Death|0|||
149171888|NCT02305563|538099696|FG001|Treatment Period|Death|0|||
149171889|NCT02305563|538099697|FG002|Treatment Period|Death|1|||
149171890|NCT02305563|538099698|FG003|Treatment Period|Death|2|||
149171891|NCT02305563|538099699|FG004|Treatment Period|Death|1|||
149171892|NCT02305563|538099695|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
149171893|NCT02305563|538099696|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
149171894|NCT02305563|538099697|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
149171895|NCT02305563|538099698|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
149171896|NCT02305563|538099699|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
149171897|NCT02305563|538099695|FG000|Treatment Period|Participant request to stop therapy|0|||
149171898|NCT02305563|538099696|FG001|Treatment Period|Participant request to stop therapy|2|||
148678273|NCT01682512|536295386|FG001|Overall Study|Other than stated above|4|||
148678274|NCT01682512|536295387|FG002|Overall Study|Other than stated above|2|||
149171899|NCT02305563|538099697|FG002|Treatment Period|Participant request to stop therapy|0|||
149171900|NCT02305563|538099698|FG003|Treatment Period|Participant request to stop therapy|1|||
149171901|NCT02305563|538099699|FG004|Treatment Period|Participant request to stop therapy|0|||
149171902|NCT02305563|538099695|FG000|Treatment Period|Participant withdrew consent|0|||
149171903|NCT02305563|538099696|FG001|Treatment Period|Participant withdrew consent|0|||
149171904|NCT02305563|538099697|FG002|Treatment Period|Participant withdrew consent|1|||
149171905|NCT02305563|538099698|FG003|Treatment Period|Participant withdrew consent|1|||
149171906|NCT02305563|538099699|FG004|Treatment Period|Participant withdrew consent|1|||
149171907|NCT02305563|538099695|FG000|Treatment Period|Maximum clinical benefit|0|||
149171908|NCT02305563|538099696|FG001|Treatment Period|Maximum clinical benefit|0|||
149171909|NCT02305563|538099697|FG002|Treatment Period|Maximum clinical benefit|0|||
148678275|NCT01377233|536295388|FG000|Open-label|Adverse Event|1|||
148678276|NCT01377233|536295389|FG001|Open-label|Adverse Event|0|||
149171910|NCT02305563|538099698|FG003|Treatment Period|Maximum clinical benefit|0|||
149171911|NCT02305563|538099699|FG004|Treatment Period|Maximum clinical benefit|1|||
149171912|NCT02305563|538099695|FG000|Treatment Period|Poor/non-compliance|0|||
149171913|NCT02305563|538099696|FG001|Treatment Period|Poor/non-compliance|0|||
149171914|NCT02305563|538099697|FG002|Treatment Period|Poor/non-compliance|0|||
149171915|NCT02305563|538099698|FG003|Treatment Period|Poor/non-compliance|0|||
149171916|NCT02305563|538099699|FG004|Treatment Period|Poor/non-compliance|1|||
149171917|NCT02305563|538099695|FG000|Treatment Period|Administrative reason by Sponsor|0|||
149171918|NCT02305563|538099696|FG001|Treatment Period|Administrative reason by Sponsor|0|||
149171919|NCT02305563|538099697|FG002|Treatment Period|Administrative reason by Sponsor|0|||
149171920|NCT02305563|538099698|FG003|Treatment Period|Administrative reason by Sponsor|0|||
149171921|NCT02305563|538099699|FG004|Treatment Period|Administrative reason by Sponsor|1|||
149171922|NCT02305563|538099695|FG000|Treatment Period|other reason|2|||
149171923|NCT02305563|538099696|FG001|Treatment Period|other reason|0|||
149171924|NCT02305563|538099697|FG002|Treatment Period|other reason|2|||
149171925|NCT02305563|538099698|FG003|Treatment Period|other reason|2|||
148678277|NCT01377233|536295390|FG002|Open-label|Adverse Event|0|||
148678278|NCT01377233|536295391|FG003|Open-label|Adverse Event|0|||
148678279|NCT01377233|536295392|FG004|Open-label|Adverse Event|0|||
148678280|NCT01377233|536295388|FG000|Open-label|Withdrawal by Subject|3|||
148928154|NCT01801072|537221305|FG000|Overall Study|Physician Decision|2|||
148928155|NCT01801072|537221306|FG001|Overall Study|Physician Decision|3|||
149171926|NCT02305563|538099699|FG004|Treatment Period|other reason|1|||
149171927|NCT02305563|538099695|FG000|Treatment Period|Randomized but not treated|0|||
149171928|NCT02305563|538099696|FG001|Treatment Period|Randomized but not treated|0|||
149171929|NCT02305563|538099697|FG002|Treatment Period|Randomized but not treated|0|||
149171930|NCT02305563|538099698|FG003|Treatment Period|Randomized but not treated|0|||
149171931|NCT02305563|538099699|FG004|Treatment Period|Randomized but not treated|2|||
149171932|NCT02305563|538099695|FG000|Treatment Period|added ULO, then disease progression|0|||
148678281|NCT01377233|536295389|FG001|Open-label|Withdrawal by Subject|0|||
149171933|NCT02305563|538099696|FG001|Treatment Period|added ULO, then disease progression|0|||
148678282|NCT01377233|536295390|FG002|Open-label|Withdrawal by Subject|0|||
148678283|NCT01377233|536295391|FG003|Open-label|Withdrawal by Subject|0|||
148928156|NCT01801072|537221305|FG000|Overall Study|Withdrawal by Subject|1|||
149171934|NCT02305563|538099697|FG002|Treatment Period|added ULO, then disease progression|0|||
149171935|NCT02305563|538099698|FG003|Treatment Period|added ULO, then disease progression|0|||
149171936|NCT02305563|538099699|FG004|Treatment Period|added ULO, then disease progression|4|||
149171937|NCT02305563|538099695|FG000|Treatment Period|added ULO; then other reason|0|||
149171938|NCT02305563|538099696|FG001|Treatment Period|added ULO; then other reason|0|||
149171939|NCT02305563|538099697|FG002|Treatment Period|added ULO; then other reason|0|||
149171940|NCT02305563|538099698|FG003|Treatment Period|added ULO; then other reason|0|||
149171941|NCT02305563|538099699|FG004|Treatment Period|added ULO; then other reason|1|||
149171942|NCT02305563|538099695|FG000|Treatment Period|added ULO, then request to stop|0|||
149171943|NCT02305563|538099696|FG001|Treatment Period|added ULO, then request to stop|0|||
149171944|NCT02305563|538099697|FG002|Treatment Period|added ULO, then request to stop|0|||
149171945|NCT02305563|538099698|FG003|Treatment Period|added ULO, then request to stop|0|||
149171946|NCT02305563|538099699|FG004|Treatment Period|added ULO, then request to stop|1|||
149171947|NCT02305563|538099695|FG000|Follow-up Period|Death|0|||
148678284|NCT01377233|536295392|FG004|Open-label|Withdrawal by Subject|0|||
148678285|NCT01377233|536295388|FG000|Double-blind|Adverse Event|0|||
148678286|NCT01377233|536295389|FG001|Double-blind|Adverse Event|1|||
148678287|NCT01377233|536295390|FG002|Double-blind|Adverse Event|2|||
148678288|NCT01377233|536295391|FG003|Double-blind|Adverse Event|2|||
148678289|NCT01377233|536295392|FG004|Double-blind|Adverse Event|0|||
148678290|NCT01377233|536295388|FG000|Double-blind|Protocol Violation|0|||
148678291|NCT01377233|536295389|FG001|Double-blind|Protocol Violation|0|||
148678292|NCT01377233|536295390|FG002|Double-blind|Protocol Violation|0|||
148678293|NCT01377233|536295391|FG003|Double-blind|Protocol Violation|0|||
148678294|NCT01377233|536295392|FG004|Double-blind|Protocol Violation|1|||
148678295|NCT01377233|536295388|FG000|Double-blind|Withdrawal by Subject|0|||
148678296|NCT01377233|536295389|FG001|Double-blind|Withdrawal by Subject|0|||
148678297|NCT01377233|536295390|FG002|Double-blind|Withdrawal by Subject|0|||
148678298|NCT01377233|536295391|FG003|Double-blind|Withdrawal by Subject|1|||
148678299|NCT01377233|536295392|FG004|Double-blind|Withdrawal by Subject|0|||
148678300|NCT01377233|536295388|FG000|Double-blind|Administrative or other|0|||
148678301|NCT01377233|536295389|FG001|Double-blind|Administrative or other|0|||
148678302|NCT01377233|536295390|FG002|Double-blind|Administrative or other|0|||
148678303|NCT01377233|536295391|FG003|Double-blind|Administrative or other|1|||
148678304|NCT01377233|536295392|FG004|Double-blind|Administrative or other|1|||
148678305|NCT01785875|536295393|FG000|Overall Study|Withdrawal by Subject|41|||
148678306|NCT01785875|536295394|FG001|Overall Study|Withdrawal by Subject|34|||
148678307|NCT01785875|536295395|FG002|Overall Study|Withdrawal by Subject|36|||
148928157|NCT01801072|537221306|FG001|Overall Study|Withdrawal by Subject|0|||
148678308|NCT01785875|536295393|FG000|Overall Study|Lost to Follow-up|19|||
148928158|NCT01801072|537221305|FG000|Overall Study|Protocol Violation|2|||
148928159|NCT01801072|537221306|FG001|Overall Study|Protocol Violation|0|||
148928160|NCT01801072|537221305|FG000|Overall Study|Death|7|||
148928161|NCT01801072|537221306|FG001|Overall Study|Death|8|||
148928162|NCT03693170|537221307|FG000|Overall Study|Disease Progression|48|||
148928163|NCT03693170|537221307|FG000|Overall Study|Adverse Event|16|||
148928164|NCT03693170|537221307|FG000|Overall Study|Physician Decision|6|||
148928165|NCT03693170|537221307|FG000|Overall Study|Protocol Violation|2|||
148928166|NCT03693170|537221307|FG000|Overall Study|Death|1|||
148928167|NCT03693170|537221307|FG000|Overall Study|Non compliance with study drug|1|||
148928168|NCT03693170|537221307|FG000|Overall Study|Withdrawal by Subject|1|||
149171948|NCT02305563|538099696|FG001|Follow-up Period|Death|0|||
149171949|NCT02305563|538099697|FG002|Follow-up Period|Death|5|||
148678309|NCT01785875|536295394|FG001|Overall Study|Lost to Follow-up|22|||
148678310|NCT01785875|536295395|FG002|Overall Study|Lost to Follow-up|6|||
148678311|NCT01785875|536295393|FG000|Overall Study|Death|27|||
148678312|NCT01785875|536295394|FG001|Overall Study|Death|16|||
148678313|NCT01785875|536295395|FG002|Overall Study|Death|7|||
148678314|NCT01785875|536295393|FG000|Overall Study|Sponsor Decision|0|||
148678315|NCT01785875|536295394|FG001|Overall Study|Sponsor Decision|2|||
148678316|NCT01785875|536295395|FG002|Overall Study|Sponsor Decision|0|||
148678317|NCT01785875|536295393|FG000|Overall Study|Protocol Specified Criteria|207|||
148678318|NCT01785875|536295394|FG001|Overall Study|Protocol Specified Criteria|214|||
148678319|NCT01785875|536295395|FG002|Overall Study|Protocol Specified Criteria|55|||
149171950|NCT02305563|538099698|FG003|Follow-up Period|Death|4|||
149171951|NCT02305563|538099699|FG004|Follow-up Period|Death|7|||
148678320|NCT01785875|536295393|FG000|Overall Study|Missing|0|||
148678321|NCT01785875|536295394|FG001|Overall Study|Missing|1|||
148678322|NCT01785875|536295395|FG002|Overall Study|Missing|3|||
148678323|NCT00417027|536295398|FG000|Overall Study|Protocol Violation|0|||
148678324|NCT00417027|536295399|FG001|Overall Study|Protocol Violation|5|||
148678325|NCT00417027|536295400|FG002|Overall Study|Protocol Violation|5|||
148928169|NCT00053365|537221308|FG000|Overall Study|Incorrect cell type|1|||
148928170|NCT00053365|537221308|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
148928171|NCT00053365|537221308|FG000|Overall Study|Never treated|4|||
148928172|NCT03183778|537221311|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
148678326|NCT03137082|536295401|FG000|Overall Study|Withdrawal by Subject|1|||
149171952|NCT02305563|538099695|FG000|Follow-up Period|Participant withdrew consent|0|||
149171953|NCT02305563|538099696|FG001|Follow-up Period|Participant withdrew consent|0|||
149171954|NCT02305563|538099697|FG002|Follow-up Period|Participant withdrew consent|2|||
149171955|NCT02305563|538099698|FG003|Follow-up Period|Participant withdrew consent|1|||
149171956|NCT02305563|538099699|FG004|Follow-up Period|Participant withdrew consent|0|||
149171957|NCT02305563|538099695|FG000|Follow-up Period|other reason|0|||
149171958|NCT02305563|538099696|FG001|Follow-up Period|other reason|0|||
149171959|NCT02305563|538099697|FG002|Follow-up Period|other reason|0|||
149171960|NCT02305563|538099698|FG003|Follow-up Period|other reason|0|||
149171961|NCT02305563|538099699|FG004|Follow-up Period|other reason|1|||
149171962|NCT02305563|538099695|FG000|Follow-up Period|Followup no longer required per protocol|3|||
149171963|NCT02305563|538099696|FG001|Follow-up Period|Followup no longer required per protocol|3|||
149171964|NCT02305563|538099697|FG002|Follow-up Period|Followup no longer required per protocol|4|||
149171965|NCT02305563|538099698|FG003|Follow-up Period|Followup no longer required per protocol|1|||
149171966|NCT02305563|538099699|FG004|Follow-up Period|Followup no longer required per protocol|4|||
149171967|NCT00642642|538099703|FG000|Treatment & Follow Up|Adverse Event|2|||
149171968|NCT00642642|538099703|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
149171969|NCT00642642|538099703|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
149171970|NCT04640766|538099704|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
149171971|NCT04906707|538099705|FG000|Overall Study|Withdrawal by Subject|2|||
149171972|NCT04906707|538099706|FG001|Overall Study|Withdrawal by Subject|0|||
149171973|NCT04906707|538099705|FG000|Overall Study|Withdrawal due to PI decision|1|||
149171974|NCT04906707|538099706|FG001|Overall Study|Withdrawal due to PI decision|0|||
149171975|NCT04906707|538099705|FG000|Overall Study|Lost to Follow-up|0|||
149171976|NCT04906707|538099706|FG001|Overall Study|Lost to Follow-up|1|||
149171977|NCT01976806|538099707|FG000|Overall Study|Lost to Follow-up|1|||
149171978|NCT01976806|538099708|FG001|Overall Study|Lost to Follow-up|4|||
149171979|NCT01976806|538099707|FG000|Overall Study|Adverse Event|1|||
149171980|NCT01976806|538099708|FG001|Overall Study|Adverse Event|1|||
149171981|NCT01976806|538099707|FG000|Overall Study|Withdrawal by Subject|1|||
149171982|NCT01976806|538099708|FG001|Overall Study|Withdrawal by Subject|1|||
149171983|NCT02654002|538099713|FG000|Overall Study|Adverse Event|0|||
149171984|NCT02654002|538099714|FG001|Overall Study|Adverse Event|0|||
149171985|NCT02654002|538099715|FG002|Overall Study|Adverse Event|0|||
149171986|NCT02654002|538099716|FG003|Overall Study|Adverse Event|0|||
149171987|NCT02654002|538099717|FG004|Overall Study|Adverse Event|0|||
149171988|NCT02654002|538099718|FG005|Overall Study|Adverse Event|0|||
149171989|NCT02654002|538099719|FG006|Overall Study|Adverse Event|1|||
149171990|NCT02654002|538099720|FG007|Overall Study|Adverse Event|0|||
149171991|NCT02654002|538099721|FG008|Overall Study|Adverse Event|0|||
149171992|NCT02654002|538099713|FG000|Overall Study|Withdrew Consent|0|||
149171993|NCT02654002|538099714|FG001|Overall Study|Withdrew Consent|0|||
149171994|NCT02654002|538099715|FG002|Overall Study|Withdrew Consent|0|||
149171995|NCT02654002|538099716|FG003|Overall Study|Withdrew Consent|0|||
149171996|NCT02654002|538099717|FG004|Overall Study|Withdrew Consent|0|||
149171997|NCT02654002|538099718|FG005|Overall Study|Withdrew Consent|1|||
148678327|NCT03137082|536295402|FG001|Overall Study|Withdrawal by Subject|1|||
148678328|NCT03137082|536295401|FG000|Overall Study|Lost to Follow-up|1|||
148678329|NCT03137082|536295402|FG001|Overall Study|Lost to Follow-up|0|||
148678330|NCT00707174|536295403|FG000|Overall Study|Adverse Event|1|||
148678331|NCT00707174|536295404|FG001|Overall Study|Adverse Event|6|||
148678332|NCT00707174|536295403|FG000|Overall Study|Withdrawal by Subject|4|||
148678333|NCT00707174|536295404|FG001|Overall Study|Withdrawal by Subject|1|||
148678334|NCT00544557|536295405|FG000|Overall Study|Adverse Event|140|||
148678335|NCT00544557|536295405|FG000|Overall Study|Lack of Efficacy|196|||
148678336|NCT00544557|536295405|FG000|Overall Study|Other|98|||
148678337|NCT04057118|536295409|FG000|Overall Study|Adverse Event|1|||
148678338|NCT04057118|536295410|FG001|Overall Study|Adverse Event|0|||
148678339|NCT04057118|536295411|FG002|Overall Study|Adverse Event|1|||
148678340|NCT04057118|536295412|FG003|Overall Study|Adverse Event|1|||
148678341|NCT04057118|536295409|FG000|Overall Study|Physician Decision|0|||
148678342|NCT04057118|536295410|FG001|Overall Study|Physician Decision|0|||
148678343|NCT04057118|536295411|FG002|Overall Study|Physician Decision|1|||
148678344|NCT04057118|536295412|FG003|Overall Study|Physician Decision|1|||
148678345|NCT04057118|536295409|FG000|Overall Study|Withdrawal by Subject|2|||
149171998|NCT02654002|538099719|FG006|Overall Study|Withdrew Consent|0|||
149171999|NCT02654002|538099720|FG007|Overall Study|Withdrew Consent|1|||
149172000|NCT02654002|538099721|FG008|Overall Study|Withdrew Consent|0|||
149172001|NCT00963807|538099727|FG000|Overall Study|Physician Decision|2|||
149172002|NCT00963807|538099727|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
149172003|NCT00963807|538099727|FG000|Overall Study|Disease progression|15|||
149172004|NCT00684177|538099730|FG000|Overall Study|Adverse Event|4|||
149172005|NCT00684177|538099731|FG001|Overall Study|Adverse Event|3|||
149172006|NCT00684177|538099730|FG000|Overall Study|Lack of Efficacy|10|||
148806287|NCT04796415|536768942|FG000|Overall Study|re-hospitalization|2|||
149172007|NCT00684177|538099731|FG001|Overall Study|Lack of Efficacy|15|||
149172008|NCT00684177|538099730|FG000|Overall Study|Protocol Violation|1|||
149172009|NCT00684177|538099731|FG001|Overall Study|Protocol Violation|0|||
149172010|NCT00684177|538099730|FG000|Overall Study|Lost to Follow-up|2|||
149172011|NCT00684177|538099731|FG001|Overall Study|Lost to Follow-up|1|||
149172012|NCT00684177|538099730|FG000|Overall Study|Physician Decision|2|||
149172013|NCT00684177|538099731|FG001|Overall Study|Physician Decision|0|||
149172014|NCT00684177|538099730|FG000|Overall Study|Withdrawal by Subject|1|||
149172015|NCT00684177|538099731|FG001|Overall Study|Withdrawal by Subject|2|||
149172016|NCT00684177|538099730|FG000|Overall Study|Other|1|||
149172017|NCT00684177|538099731|FG001|Overall Study|Other|2|||
149172018|NCT00075881|538101970|FG000|Overall Study|Lack of Efficacy|18|||
149172019|NCT00075881|538101970|FG000|Overall Study|Adverse Event|7|||
149172020|NCT00075881|538101970|FG000|Overall Study|Death|1|||
149172021|NCT00075881|538101970|FG000|Overall Study|Withdrawal by Subject|2|||
149172022|NCT00075881|538101970|FG000|Overall Study|Protocol Violation|4|||
149172023|NCT00075881|538101970|FG000|Overall Study|other complicating disease|3|||
149172024|NCT00075881|538101970|FG000|Overall Study|other|4|||
149172025|NCT00075881|538101970|FG000|Overall Study|missing data|2|||
149172026|NCT00075881|538101970|FG000|Overall Study|Ineligible|1|||
149172027|NCT00075881|538101970|FG000|Overall Study|never start protocol therapy|1|||
149172028|NCT02224664|538101971|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
148678346|NCT04057118|536295410|FG001|Overall Study|Withdrawal by Subject|2|||
149172029|NCT02224664|538101972|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149172030|NCT02224664|538101973|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149172031|NCT02224664|538101974|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149172032|NCT02224664|538101975|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
149172033|NCT02224664|538101971|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
149172034|NCT02224664|538101972|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
149172035|NCT02224664|538101973|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
149172036|NCT02224664|538101974|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
149172037|NCT02224664|538101975|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
149172038|NCT02224664|538101971|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
149172039|NCT02224664|538101972|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
149172040|NCT02224664|538101973|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
149172041|NCT02224664|538101974|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
149172042|NCT02224664|538101975|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
149172043|NCT03019549|538101976|FG000|Washout|DId not meet genotype criteria|11|||
149172044|NCT03019549|538101976|FG000|Period 2|Adverse Event|2|||
149172045|NCT03019549|538101976|FG000|Period 2|Physician Decision|2|||
149172046|NCT03019549|538101976|FG000|Period 2|Withdrawal by Subject|1|||
149172047|NCT04030195|538101979|FG000|Overall Study|Withdrawal by Subject|2|||
149172048|NCT04030195|538101980|FG001|Overall Study|Withdrawal by Subject|0|||
149172049|NCT04030195|538101981|FG002|Overall Study|Withdrawal by Subject|0|||
149172050|NCT01412879|538101982|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
149172051|NCT01412879|538101983|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
149172052|NCT01412879|538101984|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
149172053|NCT01412879|538101982|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
149172054|NCT01412879|538101983|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
149172055|NCT01412879|538101984|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
149172056|NCT01412879|538101982|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
149172057|NCT01412879|538101983|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
149172058|NCT01412879|538101984|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
149172059|NCT01412879|538101982|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
149172060|NCT01412879|538101983|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
149172061|NCT01412879|538101984|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
149172062|NCT01412879|538101982|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
149172063|NCT01412879|538101983|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
149172064|NCT01412879|538101984|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
149172065|NCT02109029|538101985|FG000|Part B|Adverse Event|0|||
149172066|NCT02109029|538101986|FG001|Part B|Adverse Event|0|||
148678347|NCT04057118|536295411|FG002|Overall Study|Withdrawal by Subject|0|||
148678348|NCT04057118|536295412|FG003|Overall Study|Withdrawal by Subject|2|||
148678349|NCT04057118|536295409|FG000|Overall Study|Not Specific|0|||
148678350|NCT04057118|536295410|FG001|Overall Study|Not Specific|0|||
149172067|NCT02109029|538101987|FG002|Part B|Adverse Event|0|||
149172068|NCT02109029|538101988|FG003|Part B|Adverse Event|0|||
149172069|NCT02109029|538101989|FG004|Part B|Adverse Event|1|||
149172070|NCT02109029|538101990|FG005|Part B|Adverse Event|1|||
149172071|NCT03195894|538101991|FG000|Overall Study|"An example is Started other treatment."|4|||
149172072|NCT03195894|538101992|FG001|Overall Study|"An example is Started other treatment."|5|||
149172073|NCT03195894|538101991|FG000|Overall Study|Withdrawal by Subject|15|||
149172074|NCT03195894|538101992|FG001|Overall Study|Withdrawal by Subject|4|||
149172075|NCT03195894|538101991|FG000|Overall Study|Lost to Follow-up|14|||
148678351|NCT04057118|536295411|FG002|Overall Study|Not Specific|1|||
148678352|NCT04057118|536295412|FG003|Overall Study|Not Specific|1|||
148678353|NCT01850108|536295418|FG000|Overall Study|Lost to Follow-up|4|||
148678354|NCT01850108|536295418|FG000|Overall Study|Not eligible|1|||
148678355|NCT01850108|536295418|FG000|Overall Study|Failed engraftment|2|||
148678356|NCT01850108|536295418|FG000|Overall Study|Physician Decision|1|||
148678357|NCT03273712|536295427|FG000|Overall Study|Death|5|||
149172076|NCT03195894|538101992|FG001|Overall Study|Lost to Follow-up|19|||
149172077|NCT00486902|538101996|FG000|Overall Study|Withdrawal by Subject|1|||
149172078|NCT00486902|538101997|FG001|Overall Study|Withdrawal by Subject|2|||
149172079|NCT00486902|538101996|FG000|Overall Study|decision for postpartum tubal ligation|3|||
149172080|NCT00486902|538101997|FG001|Overall Study|decision for postpartum tubal ligation|1|||
149172081|NCT00486902|538101996|FG000|Overall Study|spinal anesthetic protocal violation|1|||
149172082|NCT00486902|538101997|FG001|Overall Study|spinal anesthetic protocal violation|1|||
149172083|NCT00486902|538101996|FG000|Overall Study|Did not meet inclusion criteria|1|||
149172084|NCT00486902|538101997|FG001|Overall Study|Did not meet inclusion criteria|0|||
149172085|NCT00486902|538101996|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
149172086|NCT00486902|538101997|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
149172087|NCT01217606|538102000|FG000|Initial Treatment Phase|Other Reasons|0|||
149172088|NCT01217606|538102001|FG001|Initial Treatment Phase|Other Reasons|2|||
149172089|NCT01217606|538102000|FG000|Initial Treatment Phase|Protocol Violation|3|||
149172090|NCT01217606|538102001|FG001|Initial Treatment Phase|Protocol Violation|2|||
149172091|NCT01217606|538102000|FG000|Initial Treatment Phase|Personal Reasons|0|||
149172092|NCT01217606|538102001|FG001|Initial Treatment Phase|Personal Reasons|2|||
149172093|NCT01217606|538102000|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
149172094|NCT01217606|538102001|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
149172095|NCT01217606|538102000|FG000|Initial Treatment Phase|Adverse Event|10|||
149172096|NCT01217606|538102001|FG001|Initial Treatment Phase|Adverse Event|6|||
149172097|NCT01217606|538102000|FG000|9-Month Masked Extension|Adverse Event|3|||
149172098|NCT01217606|538102001|FG001|9-Month Masked Extension|Adverse Event|6|||
149172099|NCT01217606|538102000|FG000|9-Month Masked Extension|Other Reasons|4|||
149172100|NCT01217606|538102001|FG001|9-Month Masked Extension|Other Reasons|4|||
149172101|NCT01217606|538102000|FG000|9-Month Masked Extension|Personal Reasons|2|||
149172102|NCT01217606|538102001|FG001|9-Month Masked Extension|Personal Reasons|1|||
149172103|NCT01217606|538102000|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
149172104|NCT01217606|538102001|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
149172105|NCT01217606|538102000|FG000|9-Month Masked Extension|Pregnancy|1|||
149172106|NCT01217606|538102001|FG001|9-Month Masked Extension|Pregnancy|0|||
148678358|NCT03273712|536295427|FG000|Overall Study|Adverse Event|1|||
148678359|NCT03273712|536295427|FG000|Overall Study|Disease Progression|1|||
148678360|NCT04333199|536295428|FG000|Evaluated Patients|Lost to Follow-up|0|||
148678361|NCT04333199|536295429|FG001|Evaluated Patients|Lost to Follow-up|1|||
148678362|NCT04333199|536295430|FG002|Evaluated Patients|Lost to Follow-up|2|||
148678363|NCT00666718|536295432|FG000|Overall Study|Adverse Event|0|||
148678364|NCT00666718|536295433|FG001|Overall Study|Adverse Event|1|||
148678365|NCT00666718|536295432|FG000|Overall Study|Death|1|||
148678366|NCT00666718|536295433|FG001|Overall Study|Death|0|||
148678367|NCT00666718|536295432|FG000|Overall Study|Lost to Follow-up|1|||
148678368|NCT00666718|536295433|FG001|Overall Study|Lost to Follow-up|0|||
148678369|NCT00666718|536295432|FG000|Overall Study|Entry Criteria Not Met|2|||
148678370|NCT00666718|536295433|FG001|Overall Study|Entry Criteria Not Met|0|||
148678371|NCT00666718|536295432|FG000|Overall Study|Protocol Violation|1|||
148678372|NCT00666718|536295433|FG001|Overall Study|Protocol Violation|3|||
148678373|NCT00666718|536295432|FG000|Overall Study|Withdrawal by Subject|7|||
148678374|NCT00666718|536295433|FG001|Overall Study|Withdrawal by Subject|12|||
148678375|NCT00666718|536295432|FG000|Overall Study|Physician Decision|0|||
148678376|NCT00666718|536295433|FG001|Overall Study|Physician Decision|2|||
148678377|NCT00963599|536295434|FG000|Overall Study|Adverse Event|2|||
148678378|NCT00963599|536295435|FG001|Overall Study|Adverse Event|0|||
148678379|NCT00963599|536295436|FG002|Overall Study|Adverse Event|1|||
148678380|NCT00963599|536295437|FG003|Overall Study|Adverse Event|2|||
148678381|NCT00963599|536295434|FG000|Overall Study|Lack of Efficacy|0|||
149172107|NCT01217606|538102000|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
149172108|NCT01217606|538102001|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
149172109|NCT04178590|538102008|FG000|Overall Study|Pregnancy|1|||
149172110|NCT04178590|538102008|FG000|Overall Study|Lost to Follow-up|1|||
149172111|NCT00996840|538102009|FG000|Overall Study|Adverse Event|0|||
149172112|NCT00996840|538102010|FG001|Overall Study|Adverse Event|1|||
148678382|NCT00963599|536295435|FG001|Overall Study|Lack of Efficacy|2|||
148678383|NCT00963599|536295436|FG002|Overall Study|Lack of Efficacy|1|||
148678384|NCT00963599|536295437|FG003|Overall Study|Lack of Efficacy|4|||
148678385|NCT00963599|536295434|FG000|Overall Study|Lost to Follow-up|0|||
148678386|NCT00963599|536295435|FG001|Overall Study|Lost to Follow-up|1|||
148678387|NCT00963599|536295436|FG002|Overall Study|Lost to Follow-up|1|||
148678388|NCT00963599|536295437|FG003|Overall Study|Lost to Follow-up|1|||
148678389|NCT00963599|536295434|FG000|Overall Study|Protocol Violation|2|||
149172113|NCT00996840|538102011|FG002|Overall Study|Adverse Event|0|||
148806288|NCT04796415|536768942|FG000|Overall Study|moving to nursing home|1|||
149172114|NCT00996840|538102012|FG003|Overall Study|Adverse Event|0|||
149172115|NCT00996840|538102013|FG004|Overall Study|Adverse Event|0|||
149172116|NCT00996840|538102009|FG000|Overall Study|Physician Decision|0|||
149172117|NCT00996840|538102010|FG001|Overall Study|Physician Decision|0|||
149172118|NCT00996840|538102011|FG002|Overall Study|Physician Decision|1|||
149172119|NCT00996840|538102012|FG003|Overall Study|Physician Decision|1|||
149172120|NCT00996840|538102013|FG004|Overall Study|Physician Decision|2|||
149172121|NCT00996840|538102009|FG000|Overall Study|Withdrawal by Subject|1|||
149172122|NCT00996840|538102010|FG001|Overall Study|Withdrawal by Subject|1|||
149172123|NCT00996840|538102011|FG002|Overall Study|Withdrawal by Subject|0|||
149172124|NCT00996840|538102012|FG003|Overall Study|Withdrawal by Subject|0|||
149172125|NCT00996840|538102013|FG004|Overall Study|Withdrawal by Subject|0|||
149172126|NCT00474240|538102014|FG000|Overall Study|Withdrawal by Subject|1|||
149172127|NCT00474240|538102015|FG001|Overall Study|Withdrawal by Subject|1|||
149172128|NCT00474240|538102016|FG002|Overall Study|Withdrawal by Subject|0|||
149172129|NCT00474240|538102017|FG003|Overall Study|Withdrawal by Subject|2|||
149172130|NCT00474240|538102018|FG004|Overall Study|Withdrawal by Subject|3|||
149172131|NCT00474240|538102019|FG005|Overall Study|Withdrawal by Subject|1|||
149172132|NCT00474240|538102014|FG000|Overall Study|Adverse Event|0|||
149172133|NCT00474240|538102015|FG001|Overall Study|Adverse Event|0|||
148806289|NCT04796415|536768942|FG000|Overall Study|lost contact|1|||
148806290|NCT03185208|536768943|FG000|Overall Study|Did not start study medication|0|||
148806291|NCT03185208|536768944|FG001|Overall Study|Did not start study medication|3|||
148806292|NCT00961415|536768945|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
148806293|NCT00961415|536768946|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
148806294|NCT00961415|536768947|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
148806295|NCT00961415|536768945|FG000|Induction Treatment Phase|Death|77|||
148806296|NCT00961415|536768946|FG001|Induction Treatment Phase|Death|0|||
148806297|NCT00961415|536768947|FG002|Induction Treatment Phase|Death|0|||
148806298|NCT00961415|536768945|FG000|Induction Treatment Phase|Protocol Violation|1|||
148806299|NCT00961415|536768946|FG001|Induction Treatment Phase|Protocol Violation|0|||
148806300|NCT00961415|536768947|FG002|Induction Treatment Phase|Protocol Violation|0|||
148806301|NCT00961415|536768945|FG000|Induction Treatment Phase|Physician Decision|2|||
148806302|NCT00961415|536768946|FG001|Induction Treatment Phase|Physician Decision|0|||
148806303|NCT00961415|536768947|FG002|Induction Treatment Phase|Physician Decision|0|||
148806304|NCT00961415|536768945|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
148806305|NCT00961415|536768946|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
148806306|NCT00961415|536768947|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
149172134|NCT00474240|538102016|FG002|Overall Study|Adverse Event|9|||
148806307|NCT00961415|536768945|FG000|Induction Treatment Phase|Other Reason|5|||
148928173|NCT00737464|537221313|FG000|Overall Study|Adverse Event|1|||
148928174|NCT00737464|537221313|FG000|Overall Study|Death|6|||
148928175|NCT00737464|537221313|FG000|Overall Study|Other - Failure to Return|1|||
148928176|NCT00737464|537221313|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
148928177|NCT00737464|537221313|FG000|Overall Study|Other reasons|4|||
148928178|NCT00721123|537221314|FG000|Overall Study|Adverse Event|96|||
148928179|NCT00721123|537221314|FG000|Overall Study|Death|10|||
148928180|NCT00721123|537221314|FG000|Overall Study|Insufficient Therapeutic Response|21|||
148928181|NCT00721123|537221314|FG000|Overall Study|Protocol Violation|1|||
148928182|NCT00721123|537221314|FG000|Overall Study|Refused Treatment|41|||
148928183|NCT00721123|537221314|FG000|Overall Study|Failure to Return|9|||
148928184|NCT00721123|537221314|FG000|Overall Study|Withdrawal by Subject|5|||
148928185|NCT01142128|537221315|FG000|Overall Study|Physician Decision|1|||
148928186|NCT01142128|537221315|FG000|Overall Study|Lost to Follow-up|1|||
148928187|NCT01142128|537221315|FG000|Overall Study|Withdrawal by Subject|2|||
148928188|NCT03355664|537221316|FG000|Overall Study|Adverse Event|1|||
148928189|NCT03355664|537221317|FG001|Overall Study|Adverse Event|2|||
148928190|NCT03355664|537221316|FG000|Overall Study|Lost to Follow-up|11|||
148928191|NCT03355664|537221317|FG001|Overall Study|Lost to Follow-up|7|||
148928192|NCT03355664|537221316|FG000|Overall Study|Protocol Violation|1|||
148928193|NCT03355664|537221317|FG001|Overall Study|Protocol Violation|2|||
148928194|NCT03355664|537221316|FG000|Overall Study|Withdrawal by Subject|2|||
149013246|NCT04537897|537527875|FG007|Overall Study|Adverse Event|0|||
148928195|NCT03355664|537221317|FG001|Overall Study|Withdrawal by Subject|1|||
149172135|NCT00474240|538102017|FG003|Overall Study|Adverse Event|14|||
149172136|NCT00474240|538102018|FG004|Overall Study|Adverse Event|5|||
148928196|NCT00423670|537221323|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
148928197|NCT00423670|537221324|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
148928198|NCT00423670|537221325|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
148928199|NCT00423670|537221326|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
149172137|NCT00474240|538102019|FG005|Overall Study|Adverse Event|16|||
149172138|NCT00474240|538102014|FG000|Overall Study|Removed due to lab value|0|||
149172139|NCT00474240|538102015|FG001|Overall Study|Removed due to lab value|0|||
149172140|NCT00474240|538102016|FG002|Overall Study|Removed due to lab value|0|||
149172141|NCT00474240|538102017|FG003|Overall Study|Removed due to lab value|0|||
149172142|NCT00474240|538102018|FG004|Overall Study|Removed due to lab value|0|||
149172143|NCT00474240|538102019|FG005|Overall Study|Removed due to lab value|1|||
149172144|NCT00809133|538102020|FG000|Overall Study|Progressive disease|2|||
149172145|NCT00809133|538102021|FG001|Overall Study|Progressive disease|5|||
149172146|NCT00809133|538102022|FG002|Overall Study|Progressive disease|5|||
149172147|NCT00809133|538102023|FG003|Overall Study|Progressive disease|3|||
149172148|NCT00809133|538102024|FG004|Overall Study|Progressive disease|4|||
149172149|NCT00809133|538102025|FG005|Overall Study|Progressive disease|1|||
149172150|NCT00809133|538102026|FG006|Overall Study|Progressive disease|3|||
149172151|NCT00809133|538102027|FG007|Overall Study|Progressive disease|3|||
149172152|NCT00809133|538102028|FG008|Overall Study|Progressive disease|3|||
149172153|NCT00809133|538102029|FG009|Overall Study|Progressive disease|9|||
149172154|NCT00809133|538102030|FG010|Overall Study|Progressive disease|5|||
149172155|NCT00809133|538102031|FG011|Overall Study|Progressive disease|7|||
149172156|NCT00809133|538102032|FG012|Overall Study|Progressive disease|5|||
149172157|NCT00809133|538102033|FG013|Overall Study|Progressive disease|4|||
149172158|NCT00809133|538102020|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172159|NCT00809133|538102021|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172160|NCT00809133|538102022|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172161|NCT00809133|538102023|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172162|NCT00809133|538102024|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172163|NCT00809133|538102025|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149172164|NCT00809133|538102026|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149172165|NCT00809133|538102027|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149172166|NCT00809133|538102028|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172167|NCT00809133|538102029|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172168|NCT00809133|538102030|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172169|NCT00809133|538102031|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172170|NCT00809133|538102032|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149172171|NCT00809133|538102033|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
149172172|NCT00809133|538102020|FG000|Overall Study|Other adverse event|1|||
149172173|NCT00809133|538102021|FG001|Overall Study|Other adverse event|1|||
149172174|NCT00809133|538102022|FG002|Overall Study|Other adverse event|1|||
149172175|NCT00809133|538102023|FG003|Overall Study|Other adverse event|0|||
149172176|NCT00809133|538102024|FG004|Overall Study|Other adverse event|0|||
149172177|NCT00809133|538102025|FG005|Overall Study|Other adverse event|3|||
149172178|NCT00809133|538102026|FG006|Overall Study|Other adverse event|2|||
149013247|NCT04537897|537527876|FG008|Overall Study|Adverse Event|0|||
149013248|NCT04537897|537527868|FG000|Overall Study|Withdrawal by Subject|0|||
149013249|NCT04537897|537527869|FG001|Overall Study|Withdrawal by Subject|1|||
149013250|NCT04537897|537527870|FG002|Overall Study|Withdrawal by Subject|0|||
149013251|NCT04537897|537527871|FG003|Overall Study|Withdrawal by Subject|0|||
149013252|NCT04537897|537527872|FG004|Overall Study|Withdrawal by Subject|0|||
149013253|NCT04537897|537527873|FG005|Overall Study|Withdrawal by Subject|0|||
149172179|NCT00809133|538102027|FG007|Overall Study|Other adverse event|4|||
149172180|NCT00809133|538102028|FG008|Overall Study|Other adverse event|0|||
149172181|NCT00809133|538102029|FG009|Overall Study|Other adverse event|0|||
149172182|NCT00809133|538102030|FG010|Overall Study|Other adverse event|1|||
149172183|NCT00809133|538102031|FG011|Overall Study|Other adverse event|1|||
149172184|NCT00809133|538102032|FG012|Overall Study|Other adverse event|0|||
149172185|NCT00809133|538102033|FG013|Overall Study|Other adverse event|1|||
149172186|NCT00809133|538102020|FG000|Overall Study|Lost to Follow-up|0|||
149172187|NCT00809133|538102021|FG001|Overall Study|Lost to Follow-up|0|||
149172188|NCT00809133|538102022|FG002|Overall Study|Lost to Follow-up|0|||
149172189|NCT00809133|538102023|FG003|Overall Study|Lost to Follow-up|0|||
149172190|NCT00809133|538102024|FG004|Overall Study|Lost to Follow-up|0|||
149172191|NCT00809133|538102025|FG005|Overall Study|Lost to Follow-up|1|||
149172192|NCT00809133|538102026|FG006|Overall Study|Lost to Follow-up|0|||
149172193|NCT00809133|538102027|FG007|Overall Study|Lost to Follow-up|0|||
149172194|NCT00809133|538102028|FG008|Overall Study|Lost to Follow-up|0|||
149172195|NCT00809133|538102029|FG009|Overall Study|Lost to Follow-up|0|||
149172196|NCT00809133|538102030|FG010|Overall Study|Lost to Follow-up|0|||
149172197|NCT00809133|538102031|FG011|Overall Study|Lost to Follow-up|0|||
149172198|NCT00809133|538102032|FG012|Overall Study|Lost to Follow-up|0|||
149172199|NCT00809133|538102033|FG013|Overall Study|Lost to Follow-up|0|||
149172200|NCT00809133|538102020|FG000|Overall Study|Consent withdrawn|0|||
149172201|NCT00809133|538102021|FG001|Overall Study|Consent withdrawn|0|||
149172202|NCT00809133|538102022|FG002|Overall Study|Consent withdrawn|0|||
149172203|NCT00809133|538102023|FG003|Overall Study|Consent withdrawn|0|||
149172204|NCT00809133|538102024|FG004|Overall Study|Consent withdrawn|1|||
149172205|NCT00809133|538102025|FG005|Overall Study|Consent withdrawn|0|||
149172206|NCT00809133|538102026|FG006|Overall Study|Consent withdrawn|0|||
149172207|NCT00809133|538102027|FG007|Overall Study|Consent withdrawn|0|||
149172208|NCT00809133|538102028|FG008|Overall Study|Consent withdrawn|0|||
149172209|NCT00809133|538102029|FG009|Overall Study|Consent withdrawn|0|||
149172210|NCT00809133|538102030|FG010|Overall Study|Consent withdrawn|0|||
149172211|NCT00809133|538102031|FG011|Overall Study|Consent withdrawn|0|||
149172212|NCT00809133|538102032|FG012|Overall Study|Consent withdrawn|0|||
149172213|NCT00809133|538102033|FG013|Overall Study|Consent withdrawn|0|||
149172214|NCT00809133|538102020|FG000|Overall Study|Other not mentioned above|0|||
149172215|NCT00809133|538102021|FG001|Overall Study|Other not mentioned above|1|||
149172216|NCT00809133|538102022|FG002|Overall Study|Other not mentioned above|0|||
149172217|NCT00809133|538102023|FG003|Overall Study|Other not mentioned above|0|||
149172218|NCT00809133|538102024|FG004|Overall Study|Other not mentioned above|0|||
149172219|NCT00809133|538102025|FG005|Overall Study|Other not mentioned above|1|||
149172220|NCT00809133|538102026|FG006|Overall Study|Other not mentioned above|0|||
149172221|NCT00809133|538102027|FG007|Overall Study|Other not mentioned above|0|||
149172222|NCT00809133|538102028|FG008|Overall Study|Other not mentioned above|0|||
149172223|NCT00809133|538102029|FG009|Overall Study|Other not mentioned above|0|||
149172224|NCT00809133|538102030|FG010|Overall Study|Other not mentioned above|0|||
149172225|NCT00809133|538102031|FG011|Overall Study|Other not mentioned above|0|||
149172226|NCT00809133|538102032|FG012|Overall Study|Other not mentioned above|0|||
149172227|NCT00809133|538102033|FG013|Overall Study|Other not mentioned above|0|||
149172228|NCT00833092|538102034|FG000|Overall Study|Withdrawal by Subject|2|||
149172229|NCT00833092|538102035|FG001|Overall Study|Withdrawal by Subject|3|||
149172230|NCT00833092|538102034|FG000|Overall Study|Protocol Violation|2|||
149172231|NCT00833092|538102035|FG001|Overall Study|Protocol Violation|1|||
149172232|NCT00833092|538102034|FG000|Overall Study|Diarrhea|0|||
149172233|NCT00833092|538102035|FG001|Overall Study|Diarrhea|2|||
149172234|NCT00833092|538102034|FG000|Overall Study|constipation|0|||
149172235|NCT00833092|538102035|FG001|Overall Study|constipation|1|||
149172236|NCT00619229|538102036|FG000|Overall Study|Withdrawal by Subject|1|||
149172237|NCT00619229|538102037|FG001|Overall Study|Withdrawal by Subject|1|||
149172238|NCT00619229|538102036|FG000|Overall Study|Lost to Follow-up|1|||
149172239|NCT00619229|538102037|FG001|Overall Study|Lost to Follow-up|0|||
149172240|NCT00619229|538102036|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
149172241|NCT00619229|538102037|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
149172242|NCT00619229|538102036|FG000|Overall Study|Investigator planned Cataract Operation|1|||
149172243|NCT00619229|538102037|FG001|Overall Study|Investigator planned Cataract Operation|0|||
149172244|NCT01700829|538102038|FG000|Overall Study|Withdrawal by Subject|1|||
149172245|NCT01700829|538102039|FG001|Overall Study|Withdrawal by Subject|1|||
149172246|NCT01075178|538102040|FG000|Subject Matching|eligible but not matched|130|||
149172247|NCT01075178|538102041|FG001|Subject Matching|eligible but not matched|403|||
149172248|NCT01075178|538102040|FG000|Subject Chart Review|died before chart review period|0|||
149172249|NCT01075178|538102041|FG001|Subject Chart Review|died before chart review period|2|||
149172250|NCT01075178|538102040|FG000|Subject Chart Review|no data collected due to site closure|3|||
149172251|NCT01075178|538102041|FG001|Subject Chart Review|no data collected due to site closure|4|||
149172252|NCT01075178|538102040|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
149172253|NCT01075178|538102041|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
149172254|NCT02983604|538102042|FG000|Overall Study|Enrolled but not Treated|0|||
149172255|NCT02983604|538102043|FG001|Overall Study|Enrolled but not Treated|0|||
149172256|NCT02983604|538102044|FG002|Overall Study|Enrolled but not Treated|1|||
149172257|NCT02983604|538102045|FG003|Overall Study|Enrolled but not Treated|0|||
149172258|NCT00316264|538102046|FG000|Overall Study|Lost to Follow-up|0|||
149172259|NCT00316264|538102047|FG001|Overall Study|Lost to Follow-up|1|||
149172260|NCT00316264|538102048|FG002|Overall Study|Lost to Follow-up|0|||
149172261|NCT00316264|538102046|FG000|Overall Study|Withdrawal of Consent|3|||
149172262|NCT00316264|538102047|FG001|Overall Study|Withdrawal of Consent|5|||
149172263|NCT00316264|538102048|FG002|Overall Study|Withdrawal of Consent|6|||
149172264|NCT00316264|538102046|FG000|Overall Study|Death|2|||
149172265|NCT00316264|538102047|FG001|Overall Study|Death|0|||
149172266|NCT00316264|538102048|FG002|Overall Study|Death|0|||
149172267|NCT00316264|538102046|FG000|Overall Study|Other|1|||
149172268|NCT00316264|538102047|FG001|Overall Study|Other|1|||
149172269|NCT00316264|538102048|FG002|Overall Study|Other|0|||
149172270|NCT00355264|538102049|FG000|Extension (Variable Duration)|Adverse Event|1|||
149172271|NCT00355264|538102049|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
149172272|NCT00699192|538102050|FG000|Overall Study|Missing|1|||
149172273|NCT00699192|538102051|FG001|Overall Study|Missing|1|||
149172274|NCT00699192|538102052|FG002|Overall Study|Missing|1|||
149172275|NCT00699192|538102050|FG000|Overall Study|Adverse Event|9|||
149172276|NCT00699192|538102051|FG001|Overall Study|Adverse Event|4|||
149172277|NCT00699192|538102052|FG002|Overall Study|Adverse Event|3|||
149172278|NCT00699192|538102050|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149172279|NCT00699192|538102051|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149172280|NCT00699192|538102052|FG002|Overall Study|Abnormal test procedure result(s)|1|||
148678390|NCT00963599|536295435|FG001|Overall Study|Protocol Violation|2|||
149172281|NCT00699192|538102050|FG000|Overall Study|Lack of Efficacy|0|||
149172282|NCT00699192|538102051|FG001|Overall Study|Lack of Efficacy|0|||
149172283|NCT00699192|538102052|FG002|Overall Study|Lack of Efficacy|1|||
149172284|NCT00699192|538102050|FG000|Overall Study|Withdrawal by Subject|3|||
149172285|NCT00699192|538102051|FG001|Overall Study|Withdrawal by Subject|2|||
149172286|NCT00699192|538102052|FG002|Overall Study|Withdrawal by Subject|4|||
149172287|NCT00699192|538102050|FG000|Overall Study|Administrative problems|1|||
149172288|NCT00699192|538102051|FG001|Overall Study|Administrative problems|3|||
149172289|NCT00699192|538102052|FG002|Overall Study|Administrative problems|1|||
149172290|NCT00699192|538102050|FG000|Overall Study|Protocol Violation|2|||
149172291|NCT00699192|538102051|FG001|Overall Study|Protocol Violation|2|||
149172292|NCT00699192|538102052|FG002|Overall Study|Protocol Violation|0|||
149172293|NCT04927312|538102053|FG000|Overall Study|Adverse Event|1|||
149172294|NCT04927312|538102053|FG000|Overall Study|Death|1|||
149172295|NCT04927312|538102053|FG000|Overall Study|Withdrawal by Subject|1|||
149172296|NCT04927312|538102053|FG000|Overall Study|Other|1|||
149172297|NCT04919564|538102055|FG000|Overall Study|Lost to Follow-up|1|||
149172298|NCT04919564|538102056|FG001|Overall Study|Lost to Follow-up|0|||
148928200|NCT00423670|537221327|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
148928201|NCT00423670|537221328|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
148928202|NCT00423670|537221329|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
149172299|NCT04919564|538102055|FG000|Overall Study|Physician Decision|1|||
149172300|NCT04919564|538102056|FG001|Overall Study|Physician Decision|1|||
149172301|NCT00929240|538102057|FG000|Initial Treatment Phase|Adverse Event|31|||
149172302|NCT00929240|538102058|FG001|Initial Treatment Phase|Adverse Event|0|||
149172303|NCT00929240|538102059|FG002|Initial Treatment Phase|Adverse Event|0|||
149172304|NCT00929240|538102057|FG000|Initial Treatment Phase|Disease progression|41|||
149172305|NCT00929240|538102058|FG001|Initial Treatment Phase|Disease progression|0|||
149172306|NCT00929240|538102059|FG002|Initial Treatment Phase|Disease progression|0|||
149172307|NCT00929240|538102057|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
149172308|NCT00929240|538102058|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
149172309|NCT00929240|538102059|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
149172310|NCT00929240|538102057|FG000|Initial Treatment Phase|Protocol Violation|5|||
149172311|NCT00929240|538102058|FG001|Initial Treatment Phase|Protocol Violation|0|||
149172312|NCT00929240|538102059|FG002|Initial Treatment Phase|Protocol Violation|0|||
149172313|NCT00929240|538102057|FG000|Initial Treatment Phase|Death|2|||
149172314|NCT00929240|538102058|FG001|Initial Treatment Phase|Death|0|||
149172315|NCT00929240|538102059|FG002|Initial Treatment Phase|Death|0|||
149172316|NCT00929240|538102057|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
149172317|NCT00929240|538102058|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
149172318|NCT00929240|538102059|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
149172319|NCT00929240|538102057|FG000|Initial Treatment Phase|Physician Decision|4|||
149172320|NCT00929240|538102058|FG001|Initial Treatment Phase|Physician Decision|0|||
149172321|NCT00929240|538102059|FG002|Initial Treatment Phase|Physician Decision|0|||
149172322|NCT00929240|538102057|FG000|Maintenance Phase|Disease progression|0|||
149172323|NCT00929240|538102058|FG001|Maintenance Phase|Disease progression|73|||
149172324|NCT00929240|538102059|FG002|Maintenance Phase|Disease progression|60|||
149172325|NCT00929240|538102057|FG000|Maintenance Phase|Adverse Event|0|||
149172326|NCT00929240|538102058|FG001|Maintenance Phase|Adverse Event|9|||
149172327|NCT00929240|538102059|FG002|Maintenance Phase|Adverse Event|12|||
149172328|NCT00929240|538102057|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149172329|NCT00929240|538102058|FG001|Maintenance Phase|Withdrawal by Subject|2|||
149172330|NCT00929240|538102059|FG002|Maintenance Phase|Withdrawal by Subject|6|||
149172331|NCT00929240|538102057|FG000|Maintenance Phase|Protocol Violation|0|||
149172332|NCT00929240|538102058|FG001|Maintenance Phase|Protocol Violation|1|||
149172333|NCT00929240|538102059|FG002|Maintenance Phase|Protocol Violation|0|||
149172334|NCT00929240|538102057|FG000|Maintenance Phase|Health authority/Study termination|0|||
149172335|NCT00929240|538102058|FG001|Maintenance Phase|Health authority/Study termination|1|||
149172336|NCT00929240|538102059|FG002|Maintenance Phase|Health authority/Study termination|2|||
149172337|NCT00929240|538102057|FG000|Maintenance Phase|Physician Decision|0|||
149172338|NCT00929240|538102058|FG001|Maintenance Phase|Physician Decision|2|||
149172339|NCT00929240|538102059|FG002|Maintenance Phase|Physician Decision|1|||
149172340|NCT00929240|538102057|FG000|Maintenance Phase|Change of treatment|0|||
149172341|NCT00929240|538102058|FG001|Maintenance Phase|Change of treatment|4|||
149172342|NCT00929240|538102059|FG002|Maintenance Phase|Change of treatment|0|||
149172343|NCT00929240|538102057|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
149172344|NCT00929240|538102058|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
149172345|NCT00929240|538102059|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
149172346|NCT00929240|538102057|FG000|Maintenance Phase|Participant not treated|0|||
149172347|NCT00929240|538102058|FG001|Maintenance Phase|Participant not treated|2|||
149172348|NCT00929240|538102059|FG002|Maintenance Phase|Participant not treated|0|||
149172349|NCT01287104|538102060|FG000|Overall Study|Patient developed progressive disease|1|||
149172350|NCT01287104|538102061|FG001|Overall Study|Patient developed progressive disease|1|||
149172351|NCT01287104|538102062|FG002|Overall Study|Patient developed progressive disease|3|||
149172352|NCT01287104|538102063|FG003|Overall Study|Patient developed progressive disease|2|||
149172353|NCT01287104|538102060|FG000|Overall Study|Donor anaphylaxis|0|||
149172354|NCT01287104|538102061|FG001|Overall Study|Donor anaphylaxis|1|||
149172355|NCT01287104|538102062|FG002|Overall Study|Donor anaphylaxis|0|||
149172356|NCT01287104|538102063|FG003|Overall Study|Donor anaphylaxis|1|||
149172357|NCT01287104|538102060|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
149172358|NCT01287104|538102061|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
149172359|NCT01287104|538102062|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
149172360|NCT01287104|538102063|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
149172361|NCT01287104|538102060|FG000|Overall Study|Low donor chimerism|0|||
148806308|NCT00961415|536768946|FG001|Induction Treatment Phase|Other Reason|0|||
148806309|NCT00961415|536768947|FG002|Induction Treatment Phase|Other Reason|0|||
148806310|NCT00961415|536768945|FG000|Maintenance Treatment Phase|Death|0|||
148806311|NCT00961415|536768946|FG001|Maintenance Treatment Phase|Death|42|||
148806312|NCT00961415|536768947|FG002|Maintenance Treatment Phase|Death|34|||
148806313|NCT00961415|536768945|FG000|Maintenance Treatment Phase|Investigators decision|0|||
148806314|NCT00961415|536768946|FG001|Maintenance Treatment Phase|Investigators decision|2|||
148806315|NCT00961415|536768947|FG002|Maintenance Treatment Phase|Investigators decision|0|||
148806316|NCT00961415|536768945|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
148806317|NCT00961415|536768946|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
148806318|NCT00961415|536768947|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
148806319|NCT00961415|536768945|FG000|Maintenance Treatment Phase|Other reason|0|||
148806320|NCT00961415|536768946|FG001|Maintenance Treatment Phase|Other reason|1|||
148806321|NCT00961415|536768947|FG002|Maintenance Treatment Phase|Other reason|3|||
148806322|NCT00226655|536768948|FG000|Overall Study|Death|13|||
148806323|NCT00226655|536768948|FG000|Overall Study|Withdrawal by Subject|15|||
148806324|NCT00226655|536768948|FG000|Overall Study|Adverse Event|35|||
148806325|NCT00226655|536768948|FG000|Overall Study|Physician Decision|6|||
148806326|NCT00226655|536768948|FG000|Overall Study|Clinical deterioration|10|||
148806327|NCT04777331|536768949|FG000|DBT Period|Death|2|||
148806328|NCT04777331|536768950|FG001|DBT Period|Death|1|||
148806329|NCT04777331|536768951|FG002|DBT Period|Death|0|||
148806330|NCT04777331|536768949|FG000|DBT Period|Reason not Specified|1|||
148806331|NCT04777331|536768950|FG001|DBT Period|Reason not Specified|1|||
148806332|NCT04777331|536768951|FG002|DBT Period|Reason not Specified|0|||
148806333|NCT04777331|536768949|FG000|DBT Period|Physician Decision|4|||
148806334|NCT04777331|536768950|FG001|DBT Period|Physician Decision|0|||
148806335|NCT04777331|536768951|FG002|DBT Period|Physician Decision|0|||
148806336|NCT04777331|536768949|FG000|DBT Period|Withdrawal by Subject|12|||
148806337|NCT04777331|536768950|FG001|DBT Period|Withdrawal by Subject|11|||
148806338|NCT04777331|536768951|FG002|DBT Period|Withdrawal by Subject|0|||
148806339|NCT04777331|536768949|FG000|DBT Period|Randomized but not Treated|1|||
148806340|NCT04777331|536768950|FG001|DBT Period|Randomized but not Treated|3|||
148806341|NCT04777331|536768951|FG002|DBT Period|Randomized but not Treated|0|||
148806342|NCT04777331|536768949|FG000|OLE Period|Ongoing in OLE|0|||
148806343|NCT04777331|536768950|FG001|OLE Period|Ongoing in OLE|0|||
148806344|NCT04777331|536768951|FG002|OLE Period|Ongoing in OLE|534|||
148806345|NCT02642042|536768952|FG000|Overall Study|Adverse Event|22|||
148806346|NCT02642042|536768952|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
148806347|NCT02642042|536768952|FG000|Overall Study|Progression/Relapse|28|||
148806348|NCT02642042|536768952|FG000|Overall Study|Death|1|||
148806349|NCT02642042|536768952|FG000|Overall Study|Not Protocol Specified|2|||
148806350|NCT04108468|536768953|FG000|Overall Study|Physician Decision|0|||
148806351|NCT04108468|536768954|FG001|Overall Study|Physician Decision|1|||
148806352|NCT04108468|536768953|FG000|Overall Study|Lost to Follow-up|0|||
148806353|NCT04108468|536768954|FG001|Overall Study|Lost to Follow-up|1|||
148806354|NCT04108468|536768953|FG000|Overall Study|Non-compliance|1|||
148806355|NCT04108468|536768954|FG001|Overall Study|Non-compliance|1|||
148806356|NCT04108468|536768953|FG000|Overall Study|Unable to attend final visit|2|||
148806357|NCT04108468|536768954|FG001|Overall Study|Unable to attend final visit|0|||
148806358|NCT04108468|536768953|FG000|Overall Study|Missed study medication|0|||
148806359|NCT04108468|536768954|FG001|Overall Study|Missed study medication|1|||
148806360|NCT03260023|536768955|FG000|Overall Study|Adverse Event|0|||
148806361|NCT03260023|536768956|FG001|Overall Study|Adverse Event|0|||
148806362|NCT03260023|536768957|FG002|Overall Study|Adverse Event|4|||
148806363|NCT03260023|536768958|FG003|Overall Study|Adverse Event|4|||
148806364|NCT03260023|536768959|FG004|Overall Study|Adverse Event|4|||
148806365|NCT03260023|536768960|FG005|Overall Study|Adverse Event|1|||
148806366|NCT03260023|536768961|FG006|Overall Study|Adverse Event|2|||
148806367|NCT03260023|536768955|FG000|Overall Study|Clinical Progression|0|||
148806368|NCT03260023|536768956|FG001|Overall Study|Clinical Progression|1|||
148806369|NCT03260023|536768957|FG002|Overall Study|Clinical Progression|3|||
148806370|NCT03260023|536768958|FG003|Overall Study|Clinical Progression|1|||
148806371|NCT03260023|536768959|FG004|Overall Study|Clinical Progression|0|||
148806372|NCT03260023|536768960|FG005|Overall Study|Clinical Progression|0|||
148806373|NCT03260023|536768961|FG006|Overall Study|Clinical Progression|0|||
148806374|NCT03260023|536768955|FG000|Overall Study|Physician Decision|0|||
148806375|NCT03260023|536768956|FG001|Overall Study|Physician Decision|0|||
148806376|NCT03260023|536768957|FG002|Overall Study|Physician Decision|0|||
148806377|NCT03260023|536768958|FG003|Overall Study|Physician Decision|1|||
148806378|NCT03260023|536768959|FG004|Overall Study|Physician Decision|1|||
148806379|NCT03260023|536768960|FG005|Overall Study|Physician Decision|0|||
148806380|NCT03260023|536768961|FG006|Overall Study|Physician Decision|0|||
148806381|NCT03260023|536768955|FG000|Overall Study|Withdrawal by Subject|0|||
148806382|NCT03260023|536768956|FG001|Overall Study|Withdrawal by Subject|0|||
148806383|NCT03260023|536768957|FG002|Overall Study|Withdrawal by Subject|0|||
148806384|NCT03260023|536768958|FG003|Overall Study|Withdrawal by Subject|0|||
148806385|NCT03260023|536768959|FG004|Overall Study|Withdrawal by Subject|3|||
148806386|NCT03260023|536768960|FG005|Overall Study|Withdrawal by Subject|0|||
148806387|NCT03260023|536768961|FG006|Overall Study|Withdrawal by Subject|0|||
148806388|NCT03260023|536768955|FG000|Overall Study|Under trial intervention|0|||
148806389|NCT03260023|536768956|FG001|Overall Study|Under trial intervention|0|||
148806390|NCT03260023|536768957|FG002|Overall Study|Under trial intervention|2|||
148806391|NCT03260023|536768958|FG003|Overall Study|Under trial intervention|5|||
148806392|NCT03260023|536768959|FG004|Overall Study|Under trial intervention|3|||
148806393|NCT03260023|536768960|FG005|Overall Study|Under trial intervention|0|||
148806394|NCT03260023|536768961|FG006|Overall Study|Under trial intervention|0|||
148806395|NCT05035407|536768962|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
148806396|NCT05035407|536768963|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
148806397|NCT05035407|536768964|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
148806398|NCT05035407|536768965|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
148806399|NCT05035407|536768966|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
148806400|NCT05035407|536768967|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
148806401|NCT04220021|536768968|FG000|Overall Study|Withdrawal by Subject|11|||
148806402|NCT04220021|536768968|FG000|Overall Study|Physician Decision|2|||
148806403|NCT04220021|536768968|FG000|Overall Study|Non-study related illness|5|||
148806404|NCT04935879|536768970|FG000|Overall Study|Adverse Event|2|||
148806405|NCT04935879|536768971|FG001|Overall Study|Adverse Event|1|||
148806406|NCT04935879|536768970|FG000|Overall Study|Lost to Follow-up|1|||
148806407|NCT04935879|536768971|FG001|Overall Study|Lost to Follow-up|1|||
148806408|NCT04935879|536768970|FG000|Overall Study|Pregnancy|2|||
148806409|NCT04935879|536768971|FG001|Overall Study|Pregnancy|3|||
148806410|NCT04935879|536768970|FG000|Overall Study|Withdrawal by Subject|8|||
148806411|NCT04935879|536768971|FG001|Overall Study|Withdrawal by Subject|6|||
148806412|NCT04935879|536768970|FG000|Overall Study|Other|3|||
149172362|NCT01287104|538102061|FG001|Overall Study|Low donor chimerism|1|||
149172363|NCT01287104|538102062|FG002|Overall Study|Low donor chimerism|0|||
149172364|NCT01287104|538102063|FG003|Overall Study|Low donor chimerism|0|||
149172365|NCT01287104|538102060|FG000|Overall Study|NK cells did not meet release criteria|0|||
149172366|NCT01287104|538102061|FG001|Overall Study|NK cells did not meet release criteria|1|||
149172367|NCT01287104|538102062|FG002|Overall Study|NK cells did not meet release criteria|0|||
149172368|NCT01287104|538102063|FG003|Overall Study|NK cells did not meet release criteria|0|||
149172369|NCT00098787|538102066|FG000|Overall Study|Never started treatment|3|||
149172370|NCT00098787|538102067|FG001|Overall Study|Never started treatment|2|||
149172371|NCT00098787|538102068|FG002|Overall Study|Never started treatment|1|||
149172372|NCT00098787|538102066|FG000|Overall Study|Ineligible|9|||
148678391|NCT00963599|536295436|FG002|Overall Study|Protocol Violation|3|||
148678392|NCT00963599|536295437|FG003|Overall Study|Protocol Violation|4|||
148678393|NCT00963599|536295434|FG000|Overall Study|Withdrawal by Subject|2|||
148678394|NCT00963599|536295435|FG001|Overall Study|Withdrawal by Subject|1|||
148678395|NCT00963599|536295436|FG002|Overall Study|Withdrawal by Subject|3|||
148678396|NCT00963599|536295437|FG003|Overall Study|Withdrawal by Subject|3|||
148678397|NCT03959137|536295438|FG000|Overall Study|Protocol Violation|6|||
148678398|NCT00190684|536295445|FG000|Overall Study|Adverse Event|86|||
148806413|NCT04935879|536768971|FG001|Overall Study|Other|3|||
148806414|NCT06070610|536768974|FG000|Washout period|Adverse Event|1|||
149172373|NCT00098787|538102067|FG001|Overall Study|Ineligible|7|||
149172374|NCT00098787|538102068|FG002|Overall Study|Ineligible|3|||
149172375|NCT00098787|538102066|FG000|Overall Study|Disease progression|28|||
149172376|NCT00098787|538102067|FG001|Overall Study|Disease progression|17|||
149172377|NCT00098787|538102068|FG002|Overall Study|Disease progression|23|||
149172378|NCT00098787|538102066|FG000|Overall Study|Adverse Event|8|||
149172379|NCT00098787|538102067|FG001|Overall Study|Adverse Event|17|||
149172380|NCT00098787|538102068|FG002|Overall Study|Adverse Event|8|||
149172381|NCT00098787|538102066|FG000|Overall Study|Death|6|||
148806415|NCT06070610|536768974|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
148806416|NCT02485860|536768976|FG000|Overall Study|Lost to Follow-up|4|||
148806417|NCT02485860|536768977|FG001|Overall Study|Lost to Follow-up|1|||
149172382|NCT00098787|538102067|FG001|Overall Study|Death|1|||
149172383|NCT00098787|538102068|FG002|Overall Study|Death|0|||
149172384|NCT00098787|538102066|FG000|Overall Study|Withdrawal by Subject|4|||
149172385|NCT00098787|538102067|FG001|Overall Study|Withdrawal by Subject|12|||
149172386|NCT00098787|538102068|FG002|Overall Study|Withdrawal by Subject|6|||
149172387|NCT00098787|538102066|FG000|Overall Study|Alternative therapy|8|||
149172388|NCT00098787|538102067|FG001|Overall Study|Alternative therapy|13|||
148806418|NCT02485860|536768976|FG000|Overall Study|Physician Decision|1|||
148806419|NCT02485860|536768977|FG001|Overall Study|Physician Decision|2|||
148806420|NCT02485860|536768976|FG000|Overall Study|Health context (COVID-19)|1|||
148806421|NCT02485860|536768977|FG001|Overall Study|Health context (COVID-19)|0|||
149172389|NCT00098787|538102068|FG002|Overall Study|Alternative therapy|13|||
149172390|NCT00098787|538102066|FG000|Overall Study|Other|7|||
149172391|NCT00098787|538102067|FG001|Overall Study|Other|6|||
148806422|NCT02839707|536768983|FG000|Phase I|Not eligible for analysis|9|||
148806423|NCT02839707|536768984|FG001|Phase I|Not eligible for analysis|0|||
148806424|NCT02839707|536768985|FG002|Phase I|Not eligible for analysis|0|||
149172392|NCT00098787|538102068|FG002|Overall Study|Other|9|||
149172393|NCT02203149|538102069|FG000|Part 1|Adverse Event|0|||
149172394|NCT02203149|538102070|FG001|Part 1|Adverse Event|1|||
149172395|NCT02203149|538102071|FG002|Part 1|Adverse Event|0|||
149172396|NCT02203149|538102072|FG003|Part 1|Adverse Event|0|||
149172397|NCT02203149|538102073|FG004|Part 1|Adverse Event|0|||
149172398|NCT02203149|538102069|FG000|Part 2|Death|0|||
149172399|NCT02203149|538102070|FG001|Part 2|Death|0|||
149172400|NCT02203149|538102071|FG002|Part 2|Death|1|||
149172401|NCT02203149|538102072|FG003|Part 2|Death|1|||
149172402|NCT02203149|538102073|FG004|Part 2|Death|0|||
149172403|NCT02203149|538102069|FG000|Part 2|Withdrawal by Subject|0|||
149172404|NCT02203149|538102070|FG001|Part 2|Withdrawal by Subject|0|||
149172405|NCT02203149|538102071|FG002|Part 2|Withdrawal by Subject|0|||
149172406|NCT02203149|538102072|FG003|Part 2|Withdrawal by Subject|1|||
149172407|NCT02203149|538102073|FG004|Part 2|Withdrawal by Subject|0|||
148806425|NCT02839707|536768983|FG000|Phase II|Not treated according to protocol|4|||
149172408|NCT02203149|538102069|FG000|Part 2|Adverse Event|0|||
149172409|NCT02203149|538102070|FG001|Part 2|Adverse Event|0|||
149172410|NCT02203149|538102071|FG002|Part 2|Adverse Event|0|||
149172411|NCT02203149|538102072|FG003|Part 2|Adverse Event|1|||
149172412|NCT02203149|538102073|FG004|Part 2|Adverse Event|1|||
149172413|NCT00684814|538102076|FG000|Washout Period of 7 Days|Adverse Event|1|||
149172414|NCT00684814|538102077|FG001|Washout Period of 7 Days|Adverse Event|2|||
149172415|NCT00684814|538102076|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
149172416|NCT00684814|538102077|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
149172417|NCT00684814|538102076|FG000|Second Intervention|Adverse Event|1|||
149172418|NCT00684814|538102077|FG001|Second Intervention|Adverse Event|0|||
149172419|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
149172420|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
149172421|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
149172422|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
149172423|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
149172424|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
149172425|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
149172426|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
149172427|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
149172428|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
149172429|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
148678399|NCT00190684|536295445|FG000|Overall Study|Satisfactory response|80|||
149172430|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
149172431|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
149172432|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
149172433|NCT00446030|538102078|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
149172434|NCT00446030|538102079|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
149172435|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
149172436|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
149172437|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
149172438|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
149172439|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
149172440|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
149172441|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
149172442|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
149172443|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
149172444|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
149172445|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
149172446|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
149172447|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
149172448|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
149172449|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
149172450|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
149172451|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
149172452|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
149172453|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
149172454|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
148678400|NCT00190684|536295445|FG000|Overall Study|Lack of efficacy|204|||
148678401|NCT00190684|536295445|FG000|Overall Study|Lost to Follow-up|232|||
148678402|NCT00190684|536295445|FG000|Overall Study|Patient moved|60|||
149013254|NCT04537897|537527874|FG006|Overall Study|Withdrawal by Subject|0|||
149172455|NCT00446030|538102078|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
149172456|NCT00446030|538102079|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
149172457|NCT00858832|538102082|FG000|Overall Study|became ineligible: delivered vaginally|1|||
149172458|NCT00858832|538102083|FG001|Overall Study|became ineligible: delivered vaginally|0|||
149172459|NCT00858832|538102082|FG000|Overall Study|Adverse Event|0|||
149172460|NCT00858832|538102083|FG001|Overall Study|Adverse Event|1|||
149172461|NCT05292755|538102084|FG000|Overall Study|Lost to Follow-up|5|||
149172462|NCT05292755|538102085|FG001|Overall Study|Lost to Follow-up|9|||
149172463|NCT00432809|538102086|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
149172464|NCT00432809|538102087|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
149172465|NCT00432809|538102088|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
149172466|NCT00432809|538102086|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
149172467|NCT00432809|538102087|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
149172468|NCT00432809|538102088|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
149172469|NCT04052139|538102089|FG000|Overall Study|Lost to Follow-up|2|||
149172470|NCT04052139|538102090|FG001|Overall Study|Lost to Follow-up|0|||
149172471|NCT04052139|538102091|FG002|Overall Study|Lost to Follow-up|0|||
149172472|NCT04052139|538102089|FG000|Overall Study|Withdrawal by Subject|1|||
149172473|NCT04052139|538102090|FG001|Overall Study|Withdrawal by Subject|0|||
149172474|NCT04052139|538102091|FG002|Overall Study|Withdrawal by Subject|0|||
149172475|NCT04433117|538102092|FG000|Overall Study|Withdrawal by Subject|1|||
149172476|NCT04433117|538102093|FG001|Overall Study|Withdrawal by Subject|0|||
149172477|NCT00707577|538102094|FG000|Overall Study|Withdrawal by Subject|3|||
149172478|NCT00707577|538102095|FG001|Overall Study|Withdrawal by Subject|2|||
149172479|NCT00707577|538102094|FG000|Overall Study|Lost to Follow-up|34|||
149172480|NCT00707577|538102095|FG001|Overall Study|Lost to Follow-up|25|||
149172481|NCT00707577|538102094|FG000|Overall Study|Left employment|13|||
149172482|NCT00707577|538102095|FG001|Overall Study|Left employment|10|||
149172483|NCT00707577|538102094|FG000|Overall Study|Pregnancy|4|||
149172484|NCT00707577|538102095|FG001|Overall Study|Pregnancy|1|||
149172485|NCT00190775|538102096|FG000|Overall Study|Adverse Event|57|||
149172486|NCT00190775|538102097|FG001|Overall Study|Adverse Event|22|||
149172487|NCT00190775|538102096|FG000|Overall Study|Satisfactory Response|1|||
149172488|NCT00190775|538102097|FG001|Overall Study|Satisfactory Response|0|||
149172489|NCT00190775|538102096|FG000|Overall Study|Lack of Efficacy|28|||
149172490|NCT00190775|538102097|FG001|Overall Study|Lack of Efficacy|32|||
149172491|NCT00190775|538102096|FG000|Overall Study|Lost to Follow-up|31|||
149172492|NCT00190775|538102097|FG001|Overall Study|Lost to Follow-up|23|||
149172493|NCT00190775|538102096|FG000|Overall Study|Participant Moved|0|||
149172494|NCT00190775|538102097|FG001|Overall Study|Participant Moved|1|||
149172495|NCT00190775|538102096|FG000|Overall Study|Withdrawal by Subject|24|||
149172496|NCT00190775|538102097|FG001|Overall Study|Withdrawal by Subject|13|||
149172497|NCT00190775|538102096|FG000|Overall Study|Sponsor Decision|1|||
149172498|NCT00190775|538102097|FG001|Overall Study|Sponsor Decision|0|||
149172499|NCT00190775|538102096|FG000|Overall Study|Physician Decision|3|||
149172500|NCT00190775|538102097|FG001|Overall Study|Physician Decision|0|||
149172501|NCT00190775|538102096|FG000|Overall Study|Noncompliance|3|||
149172502|NCT00190775|538102097|FG001|Overall Study|Noncompliance|5|||
149172503|NCT00190775|538102096|FG000|Overall Study|Protocol Violation|0|||
149172504|NCT00190775|538102097|FG001|Overall Study|Protocol Violation|1|||
149172505|NCT00190775|538102096|FG000|Overall Study|Exclusion Criteria Met|1|||
149172506|NCT00190775|538102097|FG001|Overall Study|Exclusion Criteria Met|3|||
149172507|NCT01794780|538102098|FG000|Overall Study|Adverse Event|0|||
149172508|NCT01794780|538102099|FG001|Overall Study|Adverse Event|1|||
149172509|NCT01794780|538102100|FG002|Overall Study|Adverse Event|2|||
149172510|NCT01794780|538102101|FG003|Overall Study|Adverse Event|0|||
149172511|NCT01794780|538102102|FG004|Overall Study|Adverse Event|0|||
149172512|NCT01794780|538102103|FG005|Overall Study|Adverse Event|0|||
149172513|NCT01794780|538102104|FG006|Overall Study|Adverse Event|0|||
149172514|NCT01794780|538102105|FG007|Overall Study|Adverse Event|0|||
149172515|NCT01794780|538102098|FG000|Overall Study|Death|0|||
149172516|NCT01794780|538102099|FG001|Overall Study|Death|2|||
149172517|NCT01794780|538102100|FG002|Overall Study|Death|14|||
149172518|NCT01794780|538102101|FG003|Overall Study|Death|1|||
149172519|NCT01794780|538102102|FG004|Overall Study|Death|0|||
149172520|NCT01794780|538102103|FG005|Overall Study|Death|9|||
149172521|NCT01794780|538102104|FG006|Overall Study|Death|4|||
149172522|NCT01794780|538102105|FG007|Overall Study|Death|0|||
149172523|NCT01794780|538102098|FG000|Overall Study|Lost to Follow-up|10|||
149172524|NCT01794780|538102099|FG001|Overall Study|Lost to Follow-up|64|||
148928203|NCT00423670|537221330|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
148928204|NCT00423670|537221323|FG000|Treatment Period|Adverse Event|8|||
148928205|NCT00423670|537221324|FG001|Treatment Period|Adverse Event|12|||
149172525|NCT01794780|538102100|FG002|Overall Study|Lost to Follow-up|165|||
149172526|NCT01794780|538102101|FG003|Overall Study|Lost to Follow-up|53|||
149172527|NCT01794780|538102102|FG004|Overall Study|Lost to Follow-up|2|||
149172528|NCT01794780|538102103|FG005|Overall Study|Lost to Follow-up|99|||
149172529|NCT01794780|538102104|FG006|Overall Study|Lost to Follow-up|30|||
149172530|NCT01794780|538102105|FG007|Overall Study|Lost to Follow-up|5|||
149172531|NCT01794780|538102098|FG000|Overall Study|Withdrew informed consent|7|||
148928206|NCT00423670|537221325|FG002|Treatment Period|Adverse Event|15|||
148928207|NCT00423670|537221326|FG003|Treatment Period|Adverse Event|20|||
148928208|NCT00423670|537221327|FG004|Treatment Period|Adverse Event|9|||
149172532|NCT01794780|538102099|FG001|Overall Study|Withdrew informed consent|17|||
149172533|NCT01794780|538102100|FG002|Overall Study|Withdrew informed consent|36|||
149172534|NCT01794780|538102101|FG003|Overall Study|Withdrew informed consent|9|||
149172535|NCT01794780|538102102|FG004|Overall Study|Withdrew informed consent|0|||
149172536|NCT01794780|538102103|FG005|Overall Study|Withdrew informed consent|48|||
149172537|NCT01794780|538102104|FG006|Overall Study|Withdrew informed consent|4|||
149172538|NCT01794780|538102105|FG007|Overall Study|Withdrew informed consent|3|||
149172539|NCT01794780|538102098|FG000|Overall Study|Other|0|||
149172540|NCT01794780|538102099|FG001|Overall Study|Other|12|||
149172541|NCT01794780|538102100|FG002|Overall Study|Other|25|||
149172542|NCT01794780|538102101|FG003|Overall Study|Other|20|||
149172543|NCT01794780|538102102|FG004|Overall Study|Other|1|||
149172544|NCT01794780|538102103|FG005|Overall Study|Other|24|||
149172545|NCT01794780|538102104|FG006|Overall Study|Other|4|||
149172546|NCT01794780|538102105|FG007|Overall Study|Other|1|||
149172547|NCT00519077|538102106|FG000|Overall Study|Death|6|||
149172548|NCT00519077|538102106|FG000|Overall Study|Other|2|||
149172549|NCT01967225|538102107|FG000|Overall Study|Adverse Event|3|||
149172550|NCT01967225|538102108|FG001|Overall Study|Adverse Event|1|||
149172551|NCT01967225|538102107|FG000|Overall Study|Withdrawal by Subject|2|||
149172552|NCT01967225|538102108|FG001|Overall Study|Withdrawal by Subject|1|||
149172553|NCT01967225|538102107|FG000|Overall Study|Lack of Efficacy|1|||
149172554|NCT01967225|538102108|FG001|Overall Study|Lack of Efficacy|1|||
149172555|NCT01967225|538102107|FG000|Overall Study|Switching to other therapy|2|||
149172556|NCT01967225|538102108|FG001|Overall Study|Switching to other therapy|0|||
149172557|NCT01967225|538102107|FG000|Overall Study|Protocol driven decision point|1|||
149172558|NCT01967225|538102108|FG001|Overall Study|Protocol driven decision point|0|||
149172559|NCT01967225|538102107|FG000|Overall Study|Logistical difficulties|1|||
149172560|NCT01967225|538102108|FG001|Overall Study|Logistical difficulties|0|||
149172561|NCT01967225|538102107|FG000|Overall Study|Protocol Violation|2|||
149172562|NCT01967225|538102108|FG001|Overall Study|Protocol Violation|0|||
149172563|NCT01275222|538102114|FG000|Phase l by Treatment|Adverse Event|1|||
149172564|NCT01275222|538102115|FG001|Phase l by Treatment|Adverse Event|4|||
149172565|NCT01275222|538102116|FG002|Phase l by Treatment|Adverse Event|2|||
149172566|NCT01275222|538102117|FG003|Phase l by Treatment|Adverse Event|3|||
149172567|NCT01275222|538102118|FG004|Phase l by Treatment|Adverse Event|0|||
149172568|NCT01275222|538102119|FG005|Phase l by Treatment|Adverse Event|0|||
149172569|NCT01275222|538102114|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149172570|NCT01275222|538102115|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149172571|NCT01275222|538102116|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
149172572|NCT01275222|538102117|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149172573|NCT01275222|538102118|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149172574|NCT01275222|538102119|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
149172575|NCT01275222|538102114|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149172576|NCT01275222|538102115|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149172577|NCT01275222|538102116|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149172578|NCT01275222|538102117|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
149172579|NCT01275222|538102118|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149172580|NCT01275222|538102119|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
149172581|NCT01275222|538102114|FG000|Phase l by Treatment|Disease progression|12|||
149172582|NCT01275222|538102115|FG001|Phase l by Treatment|Disease progression|8|||
149172583|NCT01275222|538102116|FG002|Phase l by Treatment|Disease progression|2|||
149172584|NCT01275222|538102117|FG003|Phase l by Treatment|Disease progression|5|||
149172585|NCT01275222|538102118|FG004|Phase l by Treatment|Disease progression|0|||
149172586|NCT01275222|538102119|FG005|Phase l by Treatment|Disease progression|0|||
149172587|NCT01275222|538102114|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
149172588|NCT01275222|538102115|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
149172589|NCT01275222|538102116|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
149172590|NCT01275222|538102117|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
149172591|NCT01275222|538102118|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
149172592|NCT01275222|538102119|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
149172593|NCT01275222|538102114|FG000|Phase l by Treatment|Death|0|||
149172594|NCT01275222|538102115|FG001|Phase l by Treatment|Death|1|||
149172595|NCT01275222|538102116|FG002|Phase l by Treatment|Death|0|||
149172596|NCT01275222|538102117|FG003|Phase l by Treatment|Death|1|||
149172597|NCT01275222|538102118|FG004|Phase l by Treatment|Death|0|||
149172598|NCT01275222|538102119|FG005|Phase l by Treatment|Death|0|||
149172599|NCT01275222|538102114|FG000|Phase ll by Stratum|Adverse Event|0|||
149172600|NCT01275222|538102115|FG001|Phase ll by Stratum|Adverse Event|0|||
149172601|NCT01275222|538102116|FG002|Phase ll by Stratum|Adverse Event|0|||
149172602|NCT01275222|538102117|FG003|Phase ll by Stratum|Adverse Event|0|||
149172603|NCT01275222|538102118|FG004|Phase ll by Stratum|Adverse Event|2|||
149172604|NCT01275222|538102119|FG005|Phase ll by Stratum|Adverse Event|10|||
149172605|NCT01275222|538102114|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
149172606|NCT01275222|538102115|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
149172607|NCT01275222|538102116|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
149172608|NCT01275222|538102117|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
149172609|NCT01275222|538102118|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
149172610|NCT01275222|538102119|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
149172611|NCT01275222|538102114|FG000|Phase ll by Stratum|Disease progression|0|||
149172612|NCT01275222|538102115|FG001|Phase ll by Stratum|Disease progression|0|||
149172613|NCT01275222|538102116|FG002|Phase ll by Stratum|Disease progression|0|||
149172614|NCT01275222|538102117|FG003|Phase ll by Stratum|Disease progression|0|||
149172615|NCT01275222|538102118|FG004|Phase ll by Stratum|Disease progression|23|||
149172616|NCT01275222|538102119|FG005|Phase ll by Stratum|Disease progression|31|||
149172617|NCT01275222|538102114|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
149172618|NCT01275222|538102115|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
149172619|NCT01275222|538102116|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
149172620|NCT01275222|538102117|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
149172621|NCT01275222|538102118|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
149172622|NCT01275222|538102119|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
149172623|NCT01275222|538102114|FG000|Phase ll by Stratum|Death|0|||
149172624|NCT01275222|538102115|FG001|Phase ll by Stratum|Death|0|||
149172625|NCT01275222|538102116|FG002|Phase ll by Stratum|Death|0|||
149172626|NCT01275222|538102117|FG003|Phase ll by Stratum|Death|0|||
149172627|NCT01275222|538102118|FG004|Phase ll by Stratum|Death|1|||
149172628|NCT01275222|538102119|FG005|Phase ll by Stratum|Death|1|||
149172629|NCT00332202|538102120|FG000|Overall Study|Adverse Event|72|||
149172630|NCT00332202|538102121|FG001|Overall Study|Adverse Event|28|||
149172631|NCT00332202|538102120|FG000|Overall Study|Lost to Follow-up|2|||
149172632|NCT00332202|538102121|FG001|Overall Study|Lost to Follow-up|1|||
149172633|NCT00332202|538102120|FG000|Overall Study|Physician Decision|6|||
149172634|NCT00332202|538102121|FG001|Overall Study|Physician Decision|8|||
149172635|NCT00332202|538102120|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
149172636|NCT00332202|538102121|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
149172637|NCT00332202|538102120|FG000|Overall Study|Protocol Violation|7|||
149172638|NCT00332202|538102121|FG001|Overall Study|Protocol Violation|2|||
149172639|NCT00332202|538102120|FG000|Overall Study|Sponsor Decision|1|||
149172640|NCT00332202|538102121|FG001|Overall Study|Sponsor Decision|2|||
149172641|NCT00332202|538102120|FG000|Overall Study|Withdrawal by Subject|36|||
149172642|NCT00332202|538102121|FG001|Overall Study|Withdrawal by Subject|17|||
149172643|NCT00332202|538102120|FG000|Overall Study|Progressive Disease|106|||
149172644|NCT00332202|538102121|FG001|Overall Study|Progressive Disease|60|||
149172645|NCT00332202|538102120|FG000|Overall Study|Death|5|||
149172646|NCT00332202|538102121|FG001|Overall Study|Death|2|||
149172647|NCT00957853|538102122|FG000|Overall Study|Withdrawal by Subject|1|||
149172648|NCT00957853|538102123|FG001|Overall Study|Withdrawal by Subject|0|||
149172649|NCT00957853|538102124|FG002|Overall Study|Withdrawal by Subject|0|||
149172650|NCT02495948|538102127|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
149172651|NCT02495948|538102128|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
149172652|NCT02495948|538102127|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
149172653|NCT02495948|538102128|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
149172654|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
149172655|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149172656|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149172657|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149172658|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
149172659|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
149172660|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
149172661|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
149172662|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
149172663|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
149172664|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
149172665|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
149172666|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
149172667|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
149172668|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
149172669|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
149172670|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
149172671|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
149172672|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
149172673|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
148678403|NCT00190684|536295445|FG000|Overall Study|Patient Decision|432|||
149172674|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
149172675|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
149172676|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
149172677|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
149172678|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
149172679|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
149172680|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
149172681|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
149172682|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
149172683|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
149172684|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
149172685|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
149172686|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
149172687|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
149172688|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
149172689|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
149172690|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
149172691|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
149172692|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
149172693|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
149172694|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
149172695|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
149172696|NCT00100048|538102129|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149172697|NCT00100048|538102130|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149172698|NCT00100048|538102131|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149172699|NCT00100048|538102132|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
149172700|NCT00100048|538102133|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149172701|NCT00100048|538102134|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
149172702|NCT01822561|538102136|FG000|Overall Study|Withdrawal by Subject|2|||
149172703|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
149172704|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
149172705|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
149172706|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
149172707|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
149172708|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
149172709|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
149172710|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
149172711|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
149172712|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
149172713|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
149172714|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149172715|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149172716|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149172717|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
149172718|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
149172719|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149172720|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149172721|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149172722|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
149172723|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Death|0|||
149172724|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Death|1|||
149172725|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Death|0|||
149172726|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Death|0|||
149172727|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Death|0|||
149172728|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149172729|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
149172730|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149172731|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149172732|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
149172733|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
149172734|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149172735|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149172736|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149172737|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
149172738|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
149172739|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149172740|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149172741|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149172742|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
149172743|NCT05087030|538102137|FG000|Main Period (Week 0 to Week 52)|Other|1|||
149172744|NCT05087030|538102138|FG001|Main Period (Week 0 to Week 52)|Other|2|||
149172745|NCT05087030|538102139|FG002|Main Period (Week 0 to Week 52)|Other|0|||
149172746|NCT05087030|538102140|FG003|Main Period (Week 0 to Week 52)|Other|0|||
149172747|NCT05087030|538102141|FG004|Main Period (Week 0 to Week 52)|Other|0|||
149172748|NCT05087030|538102137|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149172749|NCT05087030|538102138|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149172750|NCT05087030|538102139|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149172751|NCT05087030|538102140|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
149172752|NCT05087030|538102141|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
149172753|NCT02722044|538102142|FG000|Overall Study|Adverse Event|2|||
149172754|NCT02722044|538102142|FG000|Overall Study|Physician Decision|1|||
149172755|NCT02722044|538102142|FG000|Overall Study|Withdrawal by Subject|1|||
149013255|NCT04537897|537527875|FG007|Overall Study|Withdrawal by Subject|0|||
149013256|NCT04537897|537527876|FG008|Overall Study|Withdrawal by Subject|0|||
149013257|NCT00919893|537527877|FG000|Overall Study|Protocol Violation|19|||
149013258|NCT00919893|537527878|FG001|Overall Study|Protocol Violation|9|||
149172756|NCT02722044|538102142|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
149013259|NCT03029780|537527887|FG000|Overall Study|Disease Progression|20|||
149013260|NCT03029780|537527888|FG001|Overall Study|Disease Progression|22|||
149013261|NCT03029780|537527887|FG000|Overall Study|Study Drug Toxicity|15|||
149172757|NCT00818259|538102146|FG000|Part I|Withdrawal by Subject|1|||
149172758|NCT00818259|538102147|FG001|Part I|Withdrawal by Subject|0|||
149172759|NCT00818259|538102148|FG002|Part I|Withdrawal by Subject|0|||
149172760|NCT00818259|538102149|FG003|Part I|Withdrawal by Subject|0|||
149172761|NCT00818259|538102150|FG004|Part I|Withdrawal by Subject|0|||
149172762|NCT00818259|538102151|FG005|Part I|Withdrawal by Subject|0|||
149172763|NCT00818259|538102152|FG006|Part I|Withdrawal by Subject|0|||
149172764|NCT00818259|538102153|FG007|Part I|Withdrawal by Subject|0|||
149172765|NCT00818259|538102154|FG008|Part I|Withdrawal by Subject|0|||
149172766|NCT00818259|538102146|FG000|Part II|Physician Decision|0|||
149172767|NCT00818259|538102147|FG001|Part II|Physician Decision|0|||
149172768|NCT00818259|538102148|FG002|Part II|Physician Decision|1|||
149172769|NCT00818259|538102149|FG003|Part II|Physician Decision|0|||
149172770|NCT00818259|538102150|FG004|Part II|Physician Decision|0|||
149172771|NCT00818259|538102151|FG005|Part II|Physician Decision|0|||
149172772|NCT00818259|538102152|FG006|Part II|Physician Decision|0|||
148678404|NCT00190684|536295445|FG000|Overall Study|Clinical relapse|67|||
148678405|NCT00190684|536295445|FG000|Overall Study|Sponsor's decision|17|||
148678406|NCT00190684|536295445|FG000|Overall Study|Physician Decision|84|||
148678407|NCT00190684|536295445|FG000|Overall Study|Protocol Violation|123|||
148678408|NCT00190684|536295445|FG000|Overall Study|Study Period III Completed|103|||
148678409|NCT00190684|536295445|FG000|Overall Study|Study Period V Completed|1|||
148678410|NCT03496207|536295446|FG000|Base Study|Adverse Event|0|||
148678411|NCT03496207|536295447|FG001|Base Study|Adverse Event|0|||
148678412|NCT03496207|536295448|FG002|Base Study|Adverse Event|1|||
148678413|NCT03496207|536295449|FG003|Base Study|Adverse Event|1|||
148678414|NCT03496207|536295450|FG004|Base Study|Adverse Event|4|||
148678415|NCT03496207|536295446|FG000|Base Study|Death|0|||
148678416|NCT03496207|536295447|FG001|Base Study|Death|0|||
148678417|NCT03496207|536295448|FG002|Base Study|Death|0|||
149172773|NCT00818259|538102153|FG007|Part II|Physician Decision|0|||
149172774|NCT00818259|538102154|FG008|Part II|Physician Decision|0|||
149172775|NCT00818259|538102146|FG000|Part II|Lack of Efficacy|0|||
149172776|NCT00818259|538102147|FG001|Part II|Lack of Efficacy|0|||
149172777|NCT00818259|538102148|FG002|Part II|Lack of Efficacy|0|||
149013262|NCT03029780|537527888|FG001|Overall Study|Study Drug Toxicity|11|||
148678418|NCT03496207|536295449|FG003|Base Study|Death|0|||
148678419|NCT03496207|536295450|FG004|Base Study|Death|1|||
148678420|NCT03496207|536295446|FG000|Base Study|Withdrawal by Subject|0|||
148678421|NCT03496207|536295447|FG001|Base Study|Withdrawal by Subject|0|||
148678422|NCT03496207|536295448|FG002|Base Study|Withdrawal by Subject|1|||
148678423|NCT03496207|536295449|FG003|Base Study|Withdrawal by Subject|0|||
148678424|NCT03496207|536295450|FG004|Base Study|Withdrawal by Subject|1|||
148678425|NCT03496207|536295446|FG000|Extension Period|Adverse Event|0|||
148678426|NCT03496207|536295447|FG001|Extension Period|Adverse Event|0|||
148678427|NCT03496207|536295448|FG002|Extension Period|Adverse Event|0|||
148678428|NCT03496207|536295449|FG003|Extension Period|Adverse Event|1|||
148678429|NCT03496207|536295450|FG004|Extension Period|Adverse Event|1|||
148678430|NCT03496207|536295446|FG000|Extension Period|Death|1|||
148678431|NCT03496207|536295447|FG001|Extension Period|Death|0|||
148678432|NCT03496207|536295448|FG002|Extension Period|Death|0|||
148678433|NCT03496207|536295449|FG003|Extension Period|Death|1|||
149172778|NCT00818259|538102149|FG003|Part II|Lack of Efficacy|1|||
149172779|NCT00818259|538102150|FG004|Part II|Lack of Efficacy|0|||
149172780|NCT00818259|538102151|FG005|Part II|Lack of Efficacy|0|||
149172781|NCT00818259|538102152|FG006|Part II|Lack of Efficacy|0|||
149172782|NCT00818259|538102153|FG007|Part II|Lack of Efficacy|0|||
149172783|NCT00818259|538102154|FG008|Part II|Lack of Efficacy|0|||
149172784|NCT00818259|538102146|FG000|Part II|Not Treated|0|||
149172785|NCT00818259|538102147|FG001|Part II|Not Treated|0|||
149172786|NCT00818259|538102148|FG002|Part II|Not Treated|0|||
149172787|NCT00818259|538102149|FG003|Part II|Not Treated|1|||
149172788|NCT00818259|538102150|FG004|Part II|Not Treated|0|||
149172789|NCT00818259|538102151|FG005|Part II|Not Treated|0|||
149172790|NCT00818259|538102152|FG006|Part II|Not Treated|0|||
149172791|NCT00818259|538102153|FG007|Part II|Not Treated|0|||
149172792|NCT00818259|538102154|FG008|Part II|Not Treated|0|||
149172793|NCT00818259|538102146|FG000|Part IV|Physician Decision|0|||
149172794|NCT00818259|538102147|FG001|Part IV|Physician Decision|0|||
149172795|NCT00818259|538102148|FG002|Part IV|Physician Decision|0|||
149172796|NCT00818259|538102149|FG003|Part IV|Physician Decision|0|||
149172797|NCT00818259|538102150|FG004|Part IV|Physician Decision|0|||
149172798|NCT00818259|538102151|FG005|Part IV|Physician Decision|1|||
149172799|NCT00818259|538102152|FG006|Part IV|Physician Decision|0|||
149172800|NCT00818259|538102153|FG007|Part IV|Physician Decision|0|||
149172801|NCT00818259|538102154|FG008|Part IV|Physician Decision|0|||
149172802|NCT00818259|538102146|FG000|Part V|Adverse Event|0|||
149172803|NCT00818259|538102147|FG001|Part V|Adverse Event|0|||
149172804|NCT00818259|538102148|FG002|Part V|Adverse Event|0|||
149172805|NCT00818259|538102149|FG003|Part V|Adverse Event|0|||
149172806|NCT00818259|538102150|FG004|Part V|Adverse Event|0|||
149172807|NCT00818259|538102151|FG005|Part V|Adverse Event|0|||
149172808|NCT00818259|538102152|FG006|Part V|Adverse Event|0|||
149172809|NCT00818259|538102153|FG007|Part V|Adverse Event|1|||
149172810|NCT00818259|538102154|FG008|Part V|Adverse Event|0|||
149172811|NCT00741819|538102155|FG000|Overall Study|Adverse Event|3|||
149172812|NCT00741819|538102155|FG000|Overall Study|Withdrawal by Subject|3|||
149172813|NCT00741819|538102155|FG000|Overall Study|Death|1|||
149172814|NCT00741819|538102155|FG000|Overall Study|Disease progression|1|||
149172815|NCT00686543|538102158|FG000|Overall Study|Adverse Event|9|||
149172816|NCT00686543|538102159|FG001|Overall Study|Adverse Event|1|||
149172817|NCT00686543|538102160|FG002|Overall Study|Adverse Event|3|||
149172818|NCT00686543|538102161|FG003|Overall Study|Adverse Event|2|||
149172819|NCT00686543|538102158|FG000|Overall Study|Withdrawal by Subject|2|||
149172820|NCT00686543|538102159|FG001|Overall Study|Withdrawal by Subject|0|||
149172821|NCT00686543|538102160|FG002|Overall Study|Withdrawal by Subject|0|||
149172822|NCT00686543|538102161|FG003|Overall Study|Withdrawal by Subject|0|||
149172823|NCT00686543|538102158|FG000|Overall Study|Protocol Violation|3|||
149172824|NCT00686543|538102159|FG001|Overall Study|Protocol Violation|0|||
149172825|NCT00686543|538102160|FG002|Overall Study|Protocol Violation|2|||
149172826|NCT00686543|538102161|FG003|Overall Study|Protocol Violation|1|||
149172827|NCT00609622|538102162|FG000|Overall Study|Adverse Event|14|||
149172828|NCT00609622|538102163|FG001|Overall Study|Adverse Event|10|||
149172829|NCT00609622|538102162|FG000|Overall Study|Withdrawal by Subject|4|||
149172830|NCT00609622|538102163|FG001|Overall Study|Withdrawal by Subject|20|||
149172831|NCT00609622|538102162|FG000|Overall Study|Death|1|||
149172832|NCT00609622|538102163|FG001|Overall Study|Death|4|||
149172833|NCT00609622|538102162|FG000|Overall Study|Protocol Violation|1|||
149172834|NCT00609622|538102163|FG001|Overall Study|Protocol Violation|1|||
149172835|NCT00609622|538102162|FG000|Overall Study|Objective progression or relapse|47|||
149172836|NCT00609622|538102163|FG001|Overall Study|Objective progression or relapse|41|||
149172837|NCT00609622|538102162|FG000|Overall Study|Study terminated by sponsor|16|||
149172838|NCT00609622|538102163|FG001|Overall Study|Study terminated by sponsor|3|||
149172839|NCT00609622|538102162|FG000|Overall Study|Other|7|||
148678434|NCT03496207|536295450|FG004|Extension Period|Death|2|||
148678435|NCT03496207|536295446|FG000|Extension Period|Withdrawal by Subject|1|||
148678436|NCT03496207|536295447|FG001|Extension Period|Withdrawal by Subject|0|||
148678437|NCT03496207|536295448|FG002|Extension Period|Withdrawal by Subject|0|||
148928209|NCT00423670|537221328|FG005|Treatment Period|Adverse Event|4|||
149172840|NCT00609622|538102163|FG001|Overall Study|Other|14|||
149172841|NCT00609622|538102162|FG000|Overall Study|Global deterioration of health status|6|||
148806426|NCT02839707|536768984|FG001|Phase II|Not treated according to protocol|0|||
148806427|NCT02839707|536768985|FG002|Phase II|Not treated according to protocol|2|||
148806428|NCT02839707|536768983|FG000|Phase III|Not treated according to protocol|0|||
148806429|NCT02839707|536768984|FG001|Phase III|Not treated according to protocol|0|||
148806430|NCT02839707|536768985|FG002|Phase III|Not treated according to protocol|4|||
148806431|NCT03586479|536768986|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
149172842|NCT00609622|538102163|FG001|Overall Study|Global deterioration of health status|2|||
149172843|NCT01237951|538102164|FG000|Overall Study|Death|1|||
149172844|NCT00924703|538102172|FG000|Overall Study|Withdrawal by Subject|11|||
149172845|NCT00924703|538102172|FG000|Overall Study|Physician Decision|5|||
149172846|NCT00924703|538102172|FG000|Overall Study|Lost to Follow-up|3|||
149172847|NCT00924703|538102172|FG000|Overall Study|Adverse Event|2|||
149172848|NCT00924703|538102172|FG000|Overall Study|Withdrawal by Sponsor|1|||
149172849|NCT00666562|538102173|FG000|Overall Study|Withdrawal by Subject|0|||
149172850|NCT00666562|538102174|FG001|Overall Study|Withdrawal by Subject|1|||
149172851|NCT00666562|538102175|FG002|Overall Study|Withdrawal by Subject|0|||
149172852|NCT00666562|538102173|FG000|Overall Study|Concomitant Medication|0|||
149172853|NCT00666562|538102174|FG001|Overall Study|Concomitant Medication|1|||
149172854|NCT00666562|538102175|FG002|Overall Study|Concomitant Medication|0|||
149172855|NCT01523873|538102176|FG000|Overall Study|Protocol Violation|422|||
149172856|NCT04429022|538102179|FG000|Overall Study|Protocol Violation|18|||
149172857|NCT04429022|538102180|FG001|Overall Study|Protocol Violation|1|||
149172858|NCT00275561|538102181|FG000|Overall Study|Withdrawal by Subject|0|||
149172859|NCT00275561|538102182|FG001|Overall Study|Withdrawal by Subject|1|||
149172860|NCT00275561|538102181|FG000|Overall Study|Travel|1|||
149172861|NCT00275561|538102182|FG001|Overall Study|Travel|1|||
149172862|NCT00275561|538102181|FG000|Overall Study|Scheduling|1|||
149172863|NCT00275561|538102182|FG001|Overall Study|Scheduling|2|||
149172864|NCT00275561|538102181|FG000|Overall Study|Family Issues|0|||
149172865|NCT00275561|538102182|FG001|Overall Study|Family Issues|2|||
149172866|NCT01769105|538102183|FG000|First Intervention|Protocol Violation|2|||
149172867|NCT01769105|538102184|FG001|First Intervention|Protocol Violation|2|||
149172868|NCT01769105|538102183|FG000|Cross-over|Lost to Follow-up|5|||
149172869|NCT01769105|538102184|FG001|Cross-over|Lost to Follow-up|0|||
149172870|NCT00377962|538103286|FG000|Core Study: 0-12 Months|Adverse Event|18|||
149172871|NCT00377962|538103287|FG001|Core Study: 0-12 Months|Adverse Event|2|||
149172872|NCT00377962|538103286|FG000|Core Study: 0-12 Months|Death|3|||
149172873|NCT00377962|538103287|FG001|Core Study: 0-12 Months|Death|0|||
149172874|NCT00377962|538103286|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
149172875|NCT00377962|538103287|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
149172876|NCT00377962|538103286|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
149172877|NCT00377962|538103287|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
149172878|NCT00377962|538103286|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
149172879|NCT00377962|538103287|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
149172880|NCT00377962|538103286|FG000|Extension Study: 12-24 Months|Death|1|||
149172881|NCT00377962|538103287|FG001|Extension Study: 12-24 Months|Death|1|||
149172882|NCT00377962|538103286|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
149172883|NCT00377962|538103287|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
149172884|NCT00377962|538103286|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
149172885|NCT00377962|538103287|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
149172886|NCT00377962|538103286|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
149172887|NCT00377962|538103287|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
149172888|NCT00686205|538103288|FG000|Overall Study|Protocol Violation|127|||
149172889|NCT00686205|538103289|FG001|Overall Study|Protocol Violation|0|||
149172890|NCT00686205|538103288|FG000|Overall Study|Withdrawal by Subject|2|||
148806432|NCT03586479|536768987|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
148806433|NCT03586479|536768988|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
148806434|NCT03586479|536768986|FG000|Overall Study|Protocol Violation|2|||
148806435|NCT03586479|536768987|FG001|Overall Study|Protocol Violation|0|||
148806436|NCT03586479|536768988|FG002|Overall Study|Protocol Violation|0|||
148806437|NCT03586479|536768986|FG000|Overall Study|Lost to Follow-up|1|||
148806438|NCT03586479|536768987|FG001|Overall Study|Lost to Follow-up|1|||
148806439|NCT03586479|536768988|FG002|Overall Study|Lost to Follow-up|2|||
148806440|NCT03586479|536768986|FG000|Overall Study|Behavioral Issues|1|||
148806441|NCT03586479|536768987|FG001|Overall Study|Behavioral Issues|0|||
148806442|NCT03586479|536768988|FG002|Overall Study|Behavioral Issues|0|||
149172891|NCT00686205|538103289|FG001|Overall Study|Withdrawal by Subject|0|||
149172892|NCT00686205|538103288|FG000|Overall Study|Specimen handling procedure altered|5878|||
149172893|NCT00686205|538103289|FG001|Overall Study|Specimen handling procedure altered|0|||
149172894|NCT00686205|538103288|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
149172895|NCT00686205|538103289|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
149172896|NCT02635204|538103290|FG000|Overall Study|Adverse Event|1|||
149172897|NCT02635204|538103291|FG001|Overall Study|Adverse Event|0|||
149172898|NCT02635204|538103290|FG000|Overall Study|Lost to Follow-up|1|||
149172899|NCT02635204|538103291|FG001|Overall Study|Lost to Follow-up|1|||
149172900|NCT03075839|538103298|FG000|Overall Study|Lost to Follow-up|4|||
149172901|NCT02469246|538103299|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
149172902|NCT02469246|538103300|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
149172903|NCT02469246|538103299|FG000|Double-Blind Phase|Adverse Event|12|||
148678438|NCT03496207|536295449|FG003|Extension Period|Withdrawal by Subject|1|||
149172904|NCT02469246|538103300|FG001|Double-Blind Phase|Adverse Event|9|||
149172905|NCT02469246|538103299|FG000|Double-Blind Phase|Death|2|||
149172906|NCT02469246|538103300|FG001|Double-Blind Phase|Death|0|||
149172907|NCT02469246|538103299|FG000|Double-Blind Phase|Lack of Efficacy|2|||
149172908|NCT02469246|538103300|FG001|Double-Blind Phase|Lack of Efficacy|1|||
149172909|NCT02469246|538103299|FG000|Double-Blind Phase|Investigator's Discretion|8|||
149172910|NCT02469246|538103300|FG001|Double-Blind Phase|Investigator's Discretion|8|||
149172911|NCT02469246|538103299|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
149172912|NCT02469246|538103300|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
149172913|NCT02469246|538103299|FG000|Double-Blind Phase|Protocol Violation|1|||
149172914|NCT02469246|538103300|FG001|Double-Blind Phase|Protocol Violation|1|||
149172915|NCT02469246|538103299|FG000|Double-Blind Phase|Withdrew Consent|25|||
149172916|NCT02469246|538103300|FG001|Double-Blind Phase|Withdrew Consent|25|||
149172917|NCT02469246|538103299|FG000|Double-Blind Phase|Lost to Follow-up|9|||
149172918|NCT02469246|538103300|FG001|Double-Blind Phase|Lost to Follow-up|5|||
149172919|NCT01658514|538103305|FG000|Overall Study|Protocol Violation|1|||
149172920|NCT01658514|538103306|FG001|Overall Study|Protocol Violation|0|||
149172921|NCT01658514|538103307|FG002|Overall Study|Protocol Violation|2|||
149172922|NCT00144170|538103309|FG000|Overall Study|Adverse Event|84|||
149172923|NCT00144170|538103310|FG001|Overall Study|Adverse Event|41|||
149172924|NCT00144170|538103309|FG000|Overall Study|Protocol Violation|23|||
149172925|NCT00144170|538103310|FG001|Overall Study|Protocol Violation|16|||
149172926|NCT00144170|538103309|FG000|Overall Study|Lost to Follow-up|5|||
149172927|NCT00144170|538103310|FG001|Overall Study|Lost to Follow-up|10|||
149172928|NCT00144170|538103309|FG000|Overall Study|Withdrawal by Subject|29|||
149172929|NCT00144170|538103310|FG001|Overall Study|Withdrawal by Subject|13|||
149172930|NCT00144170|538103309|FG000|Overall Study|Other reason not defined above|211|||
149172931|NCT00144170|538103310|FG001|Overall Study|Other reason not defined above|316|||
149172932|NCT03871491|538103313|FG000|Overall Study|Withdrawal by Subject|14|||
149172933|NCT03871491|538103314|FG001|Overall Study|Withdrawal by Subject|14|||
149172934|NCT03871491|538103315|FG002|Overall Study|Withdrawal by Subject|14|||
149172935|NCT03871491|538103316|FG003|Overall Study|Withdrawal by Subject|14|||
149172936|NCT03871491|538103313|FG000|Overall Study|Physician Decision|0|||
149172937|NCT03871491|538103314|FG001|Overall Study|Physician Decision|0|||
149172938|NCT03871491|538103315|FG002|Overall Study|Physician Decision|1|||
149172939|NCT03871491|538103316|FG003|Overall Study|Physician Decision|1|||
149172940|NCT03871491|538103313|FG000|Overall Study|Lost to Follow-up|50|||
149172941|NCT03871491|538103314|FG001|Overall Study|Lost to Follow-up|15|||
149172942|NCT03871491|538103315|FG002|Overall Study|Lost to Follow-up|36|||
149172943|NCT03871491|538103316|FG003|Overall Study|Lost to Follow-up|11|||
149172948|NCT05202808|538103319|FG000|Overall Study|Lost to Follow-up|3|||
149172949|NCT05202808|538103320|FG001|Overall Study|Lost to Follow-up|1|||
149172950|NCT04996797|538103321|FG000|Overall Study|Adverse Event|0|||
149172951|NCT04996797|538103322|FG001|Overall Study|Adverse Event|2|||
149172952|NCT04996797|538103323|FG002|Overall Study|Adverse Event|0|||
149172953|NCT04996797|538103324|FG003|Overall Study|Adverse Event|1|||
149172954|NCT04996797|538103321|FG000|Overall Study|Lack of Efficacy|0|||
149172955|NCT04996797|538103322|FG001|Overall Study|Lack of Efficacy|2|||
149172956|NCT04996797|538103323|FG002|Overall Study|Lack of Efficacy|0|||
149172957|NCT04996797|538103324|FG003|Overall Study|Lack of Efficacy|0|||
149172958|NCT04996797|538103321|FG000|Overall Study|Prohibited Medication|0|||
149172959|NCT04996797|538103322|FG001|Overall Study|Prohibited Medication|1|||
149172960|NCT04996797|538103323|FG002|Overall Study|Prohibited Medication|0|||
149172961|NCT04996797|538103324|FG003|Overall Study|Prohibited Medication|0|||
149172962|NCT04996797|538103321|FG000|Overall Study|Ongoing|68|||
149172963|NCT04996797|538103322|FG001|Overall Study|Ongoing|60|||
149172964|NCT04996797|538103323|FG002|Overall Study|Ongoing|22|||
149172965|NCT04996797|538103324|FG003|Overall Study|Ongoing|20|||
149172966|NCT04996797|538103321|FG000|Overall Study|Withdrawal by Subject|0|||
149172967|NCT04996797|538103322|FG001|Overall Study|Withdrawal by Subject|2|||
149172968|NCT04996797|538103323|FG002|Overall Study|Withdrawal by Subject|0|||
149172969|NCT04996797|538103324|FG003|Overall Study|Withdrawal by Subject|0|||
149172970|NCT04091217|538103325|FG000|Overall Study|Lost to Follow-up|2|||
149172971|NCT02747004|538103327|FG000|Overall Study|Withdrawal by Subject|8|||
149172972|NCT02747004|538103328|FG001|Overall Study|Withdrawal by Subject|5|||
149172973|NCT02747004|538103329|FG002|Overall Study|Withdrawal by Subject|4|||
149172974|NCT02747004|538103327|FG000|Overall Study|Lost to Follow-up|1|||
149172975|NCT02747004|538103328|FG001|Overall Study|Lost to Follow-up|2|||
149172976|NCT02747004|538103329|FG002|Overall Study|Lost to Follow-up|2|||
149172977|NCT02747004|538103327|FG000|Overall Study|on study treatment/follow-up|48|||
149172978|NCT02747004|538103328|FG001|Overall Study|on study treatment/follow-up|42|||
149172979|NCT02747004|538103329|FG002|Overall Study|on study treatment/follow-up|41|||
149172980|NCT01444300|538103330|FG000|Overall Study|Adverse Event|4|||
149172981|NCT01444300|538103331|FG001|Overall Study|Adverse Event|0|||
149172982|NCT04826900|538103332|FG000|Overall Study|Family factor|1|||
149172983|NCT04826900|538103333|FG001|Overall Study|Family factor|1|||
149172984|NCT04885257|538103334|FG000|Overall Study|Withdrawal by Subject|1|||
149172985|NCT04885257|538103335|FG001|Overall Study|Withdrawal by Subject|0|||
149172986|NCT02597062|538103336|FG000|Overall Study|Ineligible|1|||
149172987|NCT03372941|538103337|FG000|Overall Study|Lost to Follow-up|2|||
149172988|NCT03372941|538103338|FG001|Overall Study|Lost to Follow-up|4|||
149172989|NCT01708057|538103339|FG000|Overall Study|Withdrawal due to study termination.|1|||
149172990|NCT01708057|538103340|FG001|Overall Study|Withdrawal due to study termination.|1|||
149172991|NCT01708057|538103341|FG002|Overall Study|Withdrawal due to study termination.|1|||
149172992|NCT00752986|538103342|FG000|Overall Study|Withdrawal by Subject|2|||
149172993|NCT00752986|538103343|FG001|Overall Study|Withdrawal by Subject|1|||
149172994|NCT00752986|538103344|FG002|Overall Study|Withdrawal by Subject|2|||
149172995|NCT00752986|538103342|FG000|Overall Study|Protocol Violation|3|||
149172996|NCT00752986|538103343|FG001|Overall Study|Protocol Violation|0|||
148806467|NCT02634710|536768993|FG000|Overall Study|Death|4|||
148806468|NCT04530630|536770943|FG000|Overall Study|Physician Decision|1|||
148806469|NCT03675308|536770944|FG000|Overall Study|Adverse Event|3|||
148806470|NCT03675308|536770945|FG001|Overall Study|Adverse Event|2|||
148806471|NCT03675308|536770944|FG000|Overall Study|Withdrawal by Subject|6|||
148806472|NCT03675308|536770945|FG001|Overall Study|Withdrawal by Subject|4|||
148806473|NCT03675308|536770944|FG000|Overall Study|Lost to Follow-up|3|||
148806474|NCT03675308|536770945|FG001|Overall Study|Lost to Follow-up|0|||
148806475|NCT03675308|536770944|FG000|Overall Study|Lack of Efficacy|1|||
148806476|NCT03675308|536770945|FG001|Overall Study|Lack of Efficacy|1|||
148806477|NCT03675308|536770944|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
148806478|NCT03675308|536770945|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
148806479|NCT03675308|536770944|FG000|Overall Study|Other|0|||
148806480|NCT03675308|536770945|FG001|Overall Study|Other|1|||
148806481|NCT06125964|536770947|FG000|Overall Study|Lost to Follow-up|0|||
148806482|NCT06125964|536770948|FG001|Overall Study|Lost to Follow-up|1|||
148806483|NCT06125964|536770949|FG002|Overall Study|Lost to Follow-up|0|||
148806484|NCT06125964|536770950|FG003|Overall Study|Lost to Follow-up|0|||
148806485|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
148806486|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
148806487|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
148806488|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Death|1|||
148806489|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Death|1|||
148806490|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Death|0|||
148806491|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
148806492|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
148806493|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
148806494|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
149172997|NCT00752986|538103344|FG002|Overall Study|Protocol Violation|0|||
149172998|NCT01697345|538103345|FG000|Overall Study|Withdrawal by Subject|1|||
149172999|NCT02970929|538103346|FG000|Overall Study|Adverse Event|18|||
149173000|NCT02970929|538103346|FG000|Overall Study|Lack of Efficacy|8|||
149173001|NCT02970929|538103346|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
149173002|NCT02970929|538103346|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
149173003|NCT02970929|538103346|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
149173004|NCT02970929|538103346|FG000|Overall Study|LOST TO FOLLOWUP|6|||
149173005|NCT02970929|538103346|FG000|Overall Study|MOVED OUT OF STATE|1|||
148806495|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
148928210|NCT00423670|537221329|FG006|Treatment Period|Adverse Event|7|||
148928211|NCT00423670|537221330|FG007|Treatment Period|Adverse Event|2|||
148928212|NCT00423670|537221323|FG000|Treatment Period|Protocol-defined clinical event|0|||
148928213|NCT00423670|537221324|FG001|Treatment Period|Protocol-defined clinical event|7|||
148928214|NCT00423670|537221325|FG002|Treatment Period|Protocol-defined clinical event|4|||
149173006|NCT02970929|538103346|FG000|Overall Study|Withdrawal by Subject|16|||
148806496|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
148806497|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
149173007|NCT02370121|538103359|FG000|Overall Study|Lost to Follow-up|1|||
149173008|NCT02370121|538103360|FG001|Overall Study|Lost to Follow-up|1|||
149173009|NCT03929250|538103361|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
149173010|NCT03929250|538103362|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
149173011|NCT05262764|538103364|FG000|Overall Study|Case report form not collected|9|||
149173012|NCT05262764|538103364|FG000|Overall Study|No patient visits after entry|23|||
149173013|NCT05262764|538103364|FG000|Overall Study|Registration rule not followed|2|||
149173014|NCT05262764|538103364|FG000|Overall Study|Patient of non-chronic heart failure|1|||
149173015|NCT01392183|538103365|FG000|First Drug Administration|Adverse Event|3|||
149173016|NCT01392183|538103366|FG001|First Drug Administration|Adverse Event|2|||
149173017|NCT01392183|538103365|FG000|First Drug Administration|Death|1|||
149173018|NCT01392183|538103366|FG001|First Drug Administration|Death|0|||
149173019|NCT01392183|538103365|FG000|First Drug Administration|Withdrawal by Subject|10|||
149173020|NCT01392183|538103366|FG001|First Drug Administration|Withdrawal by Subject|17|||
149173021|NCT01024244|538104953|FG000|Overall Study|Adverse Event|1|||
149173022|NCT01024244|538104954|FG001|Overall Study|Adverse Event|2|||
149173023|NCT01024244|538104955|FG002|Overall Study|Adverse Event|0|||
149173024|NCT01024244|538104956|FG003|Overall Study|Adverse Event|1|||
149173025|NCT01024244|538104957|FG004|Overall Study|Adverse Event|2|||
149173026|NCT01024244|538104953|FG000|Overall Study|Entry Criteria Not Met|0|||
149173027|NCT01024244|538104954|FG001|Overall Study|Entry Criteria Not Met|1|||
149173028|NCT01024244|538104955|FG002|Overall Study|Entry Criteria Not Met|0|||
149173029|NCT01024244|538104956|FG003|Overall Study|Entry Criteria Not Met|0|||
149173030|NCT01024244|538104957|FG004|Overall Study|Entry Criteria Not Met|0|||
149173031|NCT01024244|538104953|FG000|Overall Study|Lack of Efficacy|1|||
149173032|NCT01024244|538104954|FG001|Overall Study|Lack of Efficacy|0|||
149173033|NCT01024244|538104955|FG002|Overall Study|Lack of Efficacy|0|||
149173034|NCT01024244|538104956|FG003|Overall Study|Lack of Efficacy|0|||
149173035|NCT01024244|538104957|FG004|Overall Study|Lack of Efficacy|0|||
149173036|NCT01024244|538104953|FG000|Overall Study|Protocol Violation|1|||
149173037|NCT01024244|538104954|FG001|Overall Study|Protocol Violation|0|||
149173038|NCT01024244|538104955|FG002|Overall Study|Protocol Violation|0|||
149173039|NCT01024244|538104956|FG003|Overall Study|Protocol Violation|0|||
149173040|NCT01024244|538104957|FG004|Overall Study|Protocol Violation|2|||
149173041|NCT01024244|538104953|FG000|Overall Study|Sponsor Decision|14|||
149173042|NCT01024244|538104954|FG001|Overall Study|Sponsor Decision|7|||
149173043|NCT01024244|538104955|FG002|Overall Study|Sponsor Decision|14|||
149173044|NCT01024244|538104956|FG003|Overall Study|Sponsor Decision|12|||
149173045|NCT01024244|538104957|FG004|Overall Study|Sponsor Decision|10|||
149173046|NCT01024244|538104953|FG000|Overall Study|Withdrawal by Subject|0|||
149173047|NCT01024244|538104954|FG001|Overall Study|Withdrawal by Subject|1|||
149173048|NCT01024244|538104955|FG002|Overall Study|Withdrawal by Subject|0|||
149173049|NCT01024244|538104956|FG003|Overall Study|Withdrawal by Subject|0|||
149173050|NCT01024244|538104957|FG004|Overall Study|Withdrawal by Subject|0|||
149173051|NCT00265941|538104963|FG000|Overall Study|Protocol Violation|22|||
149173052|NCT00265941|538104964|FG001|Overall Study|Protocol Violation|25|||
149173053|NCT00265941|538104963|FG000|Overall Study|Lost to Follow-up|1|||
149173054|NCT00265941|538104964|FG001|Overall Study|Lost to Follow-up|1|||
149173055|NCT02432807|538104967|FG000|Overall Study|Adverse Event|0|||
149173056|NCT02432807|538104968|FG001|Overall Study|Adverse Event|2|||
149173057|NCT02432807|538104967|FG000|Overall Study|Lost to Follow-up|1|||
149173058|NCT02432807|538104968|FG001|Overall Study|Lost to Follow-up|0|||
149173059|NCT02432807|538104967|FG000|Overall Study|Withdrawal by Subject|1|||
149173060|NCT02432807|538104968|FG001|Overall Study|Withdrawal by Subject|1|||
149173061|NCT02432807|538104967|FG000|Overall Study|Other|1|||
149173062|NCT02432807|538104968|FG001|Overall Study|Other|1|||
149173063|NCT03976401|538104969|FG000|Overall Study|Adverse Event|2|||
149173064|NCT03976401|538104970|FG001|Overall Study|Adverse Event|0|||
149173065|NCT03976401|538104971|FG002|Overall Study|Adverse Event|4|||
149173066|NCT03976401|538104972|FG003|Overall Study|Adverse Event|1|||
149173067|NCT03976401|538104973|FG004|Overall Study|Adverse Event|1|||
149173068|NCT03976401|538104974|FG005|Overall Study|Adverse Event|0|||
149173069|NCT03976401|538104969|FG000|Overall Study|Withdrawal by Subject|0|||
149173070|NCT03976401|538104970|FG001|Overall Study|Withdrawal by Subject|1|||
148678439|NCT03496207|536295450|FG004|Extension Period|Withdrawal by Subject|1|||
148678440|NCT03496207|536295446|FG000|Extension Period|Elevated hemoglobin levels|0|||
149173071|NCT03976401|538104971|FG002|Overall Study|Withdrawal by Subject|0|||
149173072|NCT03976401|538104972|FG003|Overall Study|Withdrawal by Subject|0|||
149173073|NCT03976401|538104973|FG004|Overall Study|Withdrawal by Subject|0|||
149173074|NCT03976401|538104974|FG005|Overall Study|Withdrawal by Subject|1|||
149173075|NCT03976401|538104969|FG000|Overall Study|Physician Decision|0|||
149173076|NCT03976401|538104970|FG001|Overall Study|Physician Decision|0|||
149173077|NCT03976401|538104971|FG002|Overall Study|Physician Decision|1|||
149173078|NCT03976401|538104972|FG003|Overall Study|Physician Decision|0|||
149173079|NCT03976401|538104973|FG004|Overall Study|Physician Decision|0|||
149173080|NCT03976401|538104974|FG005|Overall Study|Physician Decision|0|||
149173081|NCT03976401|538104969|FG000|Overall Study|Lost to Follow-up|1|||
149173082|NCT03976401|538104970|FG001|Overall Study|Lost to Follow-up|2|||
149173083|NCT03976401|538104971|FG002|Overall Study|Lost to Follow-up|0|||
149173084|NCT03976401|538104972|FG003|Overall Study|Lost to Follow-up|0|||
149173085|NCT03976401|538104973|FG004|Overall Study|Lost to Follow-up|0|||
149173086|NCT03976401|538104974|FG005|Overall Study|Lost to Follow-up|0|||
149173087|NCT03976401|538104969|FG000|Overall Study|Protocol Violation|0|||
149173088|NCT03976401|538104970|FG001|Overall Study|Protocol Violation|1|||
149173089|NCT03976401|538104971|FG002|Overall Study|Protocol Violation|0|||
149173090|NCT03976401|538104972|FG003|Overall Study|Protocol Violation|0|||
149173091|NCT03976401|538104973|FG004|Overall Study|Protocol Violation|0|||
149173092|NCT03976401|538104974|FG005|Overall Study|Protocol Violation|0|||
149173093|NCT03976401|538104969|FG000|Overall Study|Withdrew Consent|0|||
149173094|NCT03976401|538104970|FG001|Overall Study|Withdrew Consent|0|||
149173095|NCT03976401|538104971|FG002|Overall Study|Withdrew Consent|0|||
149173096|NCT03976401|538104972|FG003|Overall Study|Withdrew Consent|1|||
149173097|NCT03976401|538104973|FG004|Overall Study|Withdrew Consent|0|||
149173098|NCT03976401|538104974|FG005|Overall Study|Withdrew Consent|0|||
149173099|NCT02966314|538104975|FG000|Overall Study|Lost to Follow-up|1|||
149173100|NCT02966314|538104976|FG001|Overall Study|Lost to Follow-up|0|||
149173101|NCT00828464|538104977|FG000|Overall Study|Withdrawal by Subject|1|||
149173102|NCT02197377|538104978|FG000|Overall Study|Insertion Failure|0|||
149173103|NCT02197377|538104979|FG001|Overall Study|Insertion Failure|3|||
149173104|NCT00502840|538104980|FG000|Overall Study|Adverse Event|5|||
149173105|NCT00502840|538104980|FG000|Overall Study|Additional or changed therapy|48|||
149173106|NCT00502840|538104980|FG000|Overall Study|Lack of Efficacy|11|||
149173107|NCT00502840|538104980|FG000|Overall Study|Protocol Violation|4|||
149173108|NCT00502840|538104980|FG000|Overall Study|Withdrawal by Subject|5|||
149173109|NCT00502840|538104980|FG000|Overall Study|Lost to Follow-up|6|||
149173110|NCT00502840|538104980|FG000|Overall Study|Administrative problems|1|||
149173111|NCT00502840|538104980|FG000|Overall Study|Other|20|||
149173112|NCT01974323|538104981|FG000|Overall Study|Other Reasons|25|||
149173113|NCT01974323|538104982|FG001|Overall Study|Other Reasons|28|||
149173114|NCT01974323|538104981|FG000|Overall Study|Protocol Violation|2|||
149173115|NCT01974323|538104982|FG001|Overall Study|Protocol Violation|2|||
149173116|NCT01974323|538104981|FG000|Overall Study|Personal Reasons|15|||
149173117|NCT01974323|538104982|FG001|Overall Study|Personal Reasons|19|||
149173118|NCT01974323|538104981|FG000|Overall Study|Lost to Follow-up|45|||
149173119|NCT01974323|538104982|FG001|Overall Study|Lost to Follow-up|40|||
149173120|NCT01974323|538104981|FG000|Overall Study|Pregnancy|2|||
149173121|NCT01974323|538104982|FG001|Overall Study|Pregnancy|1|||
149173122|NCT01974323|538104981|FG000|Overall Study|Lack of Efficacy|1|||
149173123|NCT01974323|538104982|FG001|Overall Study|Lack of Efficacy|1|||
149173124|NCT01974323|538104981|FG000|Overall Study|Adverse Event|2|||
149173125|NCT01974323|538104982|FG001|Overall Study|Adverse Event|2|||
149173126|NCT00466505|538104984|FG000|Overall Study|disease progression|13|||
149173127|NCT00466505|538104984|FG000|Overall Study|Adverse Event|4|||
149173128|NCT01241786|538104992|FG000|Overall Study|Lack of Efficacy|5|||
149173129|NCT02886715|538104993|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148806498|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
148806499|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
149173130|NCT02886715|538104994|FG001|Overall Study|Non-Compliance With Study Drug|2|||
149173131|NCT02886715|538104995|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149173132|NCT02886715|538104993|FG000|Overall Study|Adverse Event|4|||
149173133|NCT02886715|538104994|FG001|Overall Study|Adverse Event|2|||
149173134|NCT02886715|538104995|FG002|Overall Study|Adverse Event|0|||
149173135|NCT02886715|538104993|FG000|Overall Study|Lack of Efficacy|0|||
149173136|NCT02886715|538104994|FG001|Overall Study|Lack of Efficacy|2|||
149173137|NCT02886715|538104995|FG002|Overall Study|Lack of Efficacy|1|||
149173138|NCT02886715|538104993|FG000|Overall Study|Lost to Follow-up|29|||
149173139|NCT02886715|538104994|FG001|Overall Study|Lost to Follow-up|26|||
149173140|NCT02886715|538104995|FG002|Overall Study|Lost to Follow-up|10|||
149173141|NCT02886715|538104993|FG000|Overall Study|Pregnancy|1|||
149173142|NCT02886715|538104994|FG001|Overall Study|Pregnancy|1|||
149173143|NCT02886715|538104995|FG002|Overall Study|Pregnancy|1|||
149173144|NCT02886715|538104993|FG000|Overall Study|Protocol Violation|3|||
149173145|NCT02886715|538104994|FG001|Overall Study|Protocol Violation|2|||
149173146|NCT02886715|538104995|FG002|Overall Study|Protocol Violation|1|||
149173147|NCT02886715|538104993|FG000|Overall Study|Withdrawal by Subject|20|||
148806500|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
149173148|NCT02886715|538104994|FG001|Overall Study|Withdrawal by Subject|18|||
149173149|NCT02886715|538104995|FG002|Overall Study|Withdrawal by Subject|5|||
149173150|NCT02886715|538104993|FG000|Overall Study|missing|7|||
149173151|NCT02886715|538104994|FG001|Overall Study|missing|2|||
149173152|NCT02886715|538104995|FG002|Overall Study|missing|2|||
149173153|NCT00503399|538104996|FG000|Overall Study|Death|2|||
149173154|NCT00503399|538104997|FG001|Overall Study|Death|1|||
149173155|NCT00503399|538104996|FG000|Overall Study|Protocol Violation|1|||
149173156|NCT00503399|538104997|FG001|Overall Study|Protocol Violation|0|||
149173157|NCT00503399|538104996|FG000|Overall Study|Withdrawal by Subject|4|||
149173158|NCT00503399|538104997|FG001|Overall Study|Withdrawal by Subject|2|||
149173159|NCT00503399|538104996|FG000|Overall Study|Adverse Event|0|||
149173160|NCT00503399|538104997|FG001|Overall Study|Adverse Event|3|||
149173161|NCT00503399|538104996|FG000|Overall Study|Lost to Follow-up|0|||
149173162|NCT00503399|538104997|FG001|Overall Study|Lost to Follow-up|2|||
149173163|NCT01676961|538104998|FG000|Overall Study|Death|3|||
149173164|NCT01676961|538104998|FG000|Overall Study|Lost to Follow-up|1|||
149173165|NCT01676961|538104998|FG000|Overall Study|Withdrawal by Subject|1|||
149173166|NCT03812510|538104999|FG000|Overall Study|Lost to Follow-up|39|||
149173167|NCT03812510|538104999|FG000|Overall Study|Withdrawal by Subject|42|||
149173168|NCT03812510|538104999|FG000|Overall Study|Physician Decision|2|||
149173169|NCT03812510|538104999|FG000|Overall Study|Study Terminated by Sponsor|9|||
149173170|NCT03812510|538104999|FG000|Overall Study|Did Not Start Study Medication|55|||
149173171|NCT03812510|538104999|FG000|Overall Study|Adverse Event|5|||
149173172|NCT00768560|538105002|FG000|Intervention Set 1|Adverse Event|0|||
149173173|NCT00768560|538105003|FG001|Intervention Set 1|Adverse Event|1|||
149173174|NCT00768560|538105004|FG002|Intervention Set 1|Adverse Event|0|||
149173175|NCT00768560|538105005|FG003|Intervention Set 1|Adverse Event|0|||
149173176|NCT00768560|538105006|FG004|Intervention Set 1|Adverse Event|0|||
149173177|NCT00768560|538105007|FG005|Intervention Set 1|Adverse Event|0|||
149173178|NCT00117312|538105008|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
149173179|NCT00117312|538105009|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
149173180|NCT00117312|538105010|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
149173181|NCT00117312|538105011|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
149173182|NCT00117312|538105008|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
149173183|NCT00117312|538105009|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
149173184|NCT00117312|538105010|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
149173185|NCT00117312|538105011|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
149173186|NCT00117312|538105008|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
149173187|NCT00117312|538105009|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
149173188|NCT00117312|538105010|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
149173189|NCT00117312|538105011|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
149173190|NCT00117312|538105008|FG000|Overall Study|Other|0|||
149173191|NCT00117312|538105009|FG001|Overall Study|Other|1|||
149173192|NCT00117312|538105010|FG002|Overall Study|Other|3|||
149173193|NCT00117312|538105011|FG003|Overall Study|Other|1|||
149173194|NCT00117312|538105008|FG000|Overall Study|Patient choice|0|||
149173195|NCT00117312|538105009|FG001|Overall Study|Patient choice|0|||
149173196|NCT00117312|538105010|FG002|Overall Study|Patient choice|2|||
149173197|NCT00117312|538105011|FG003|Overall Study|Patient choice|1|||
149173198|NCT00117312|538105008|FG000|Overall Study|Adverse Event|0|||
149173199|NCT00117312|538105009|FG001|Overall Study|Adverse Event|2|||
149173200|NCT00117312|538105010|FG002|Overall Study|Adverse Event|0|||
149173201|NCT00117312|538105011|FG003|Overall Study|Adverse Event|0|||
149173202|NCT00117312|538105008|FG000|Overall Study|Protocol Violation|0|||
149173203|NCT00117312|538105009|FG001|Overall Study|Protocol Violation|1|||
149173204|NCT00117312|538105010|FG002|Overall Study|Protocol Violation|3|||
149173205|NCT00117312|538105011|FG003|Overall Study|Protocol Violation|0|||
149173206|NCT00117312|538105008|FG000|Overall Study|PSA decrease <=50%|0|||
149173207|NCT00117312|538105009|FG001|Overall Study|PSA decrease <=50%|2|||
149173208|NCT00117312|538105010|FG002|Overall Study|PSA decrease <=50%|2|||
149173209|NCT00117312|538105011|FG003|Overall Study|PSA decrease <=50%|4|||
149173210|NCT00117312|538105008|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
149173211|NCT00117312|538105009|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
149173212|NCT00117312|538105010|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
149173213|NCT00117312|538105011|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
149173214|NCT00117312|538105008|FG000|Overall Study|Hepatic abnormality|0|||
149173215|NCT00117312|538105009|FG001|Overall Study|Hepatic abnormality|1|||
149173216|NCT00117312|538105010|FG002|Overall Study|Hepatic abnormality|0|||
149173217|NCT00117312|538105011|FG003|Overall Study|Hepatic abnormality|1|||
149173218|NCT00117312|538105008|FG000|Overall Study|Withdrawal by Subject|0|||
149173219|NCT00117312|538105009|FG001|Overall Study|Withdrawal by Subject|2|||
149173220|NCT00117312|538105010|FG002|Overall Study|Withdrawal by Subject|0|||
149173221|NCT00117312|538105011|FG003|Overall Study|Withdrawal by Subject|0|||
149173222|NCT01128387|538105012|FG000|Overall Study|Physician Decision|0|||
149173223|NCT01128387|538105013|FG001|Overall Study|Physician Decision|1|||
149173224|NCT01535235|538105015|FG000|Overall Study|Adverse Event|1|||
149173225|NCT01535235|538105016|FG001|Overall Study|Adverse Event|0|||
149173226|NCT00824421|538105021|FG000|Overall Study|Adverse Event|6|||
149173227|NCT00824421|538105022|FG001|Overall Study|Adverse Event|6|||
149173228|NCT00824421|538105023|FG002|Overall Study|Adverse Event|6|||
149173229|NCT00824421|538105021|FG000|Overall Study|Death|0|||
149173230|NCT00824421|538105022|FG001|Overall Study|Death|1|||
149173231|NCT00824421|538105023|FG002|Overall Study|Death|0|||
149173232|NCT00824421|538105021|FG000|Overall Study|Lack of Efficacy|5|||
149173233|NCT00824421|538105022|FG001|Overall Study|Lack of Efficacy|7|||
149173234|NCT00824421|538105023|FG002|Overall Study|Lack of Efficacy|4|||
149173235|NCT00824421|538105021|FG000|Overall Study|Lost to Follow-up|2|||
149173236|NCT00824421|538105022|FG001|Overall Study|Lost to Follow-up|3|||
149173237|NCT00824421|538105023|FG002|Overall Study|Lost to Follow-up|0|||
149173238|NCT00824421|538105021|FG000|Overall Study|Pregnancy|1|||
149173239|NCT00824421|538105022|FG001|Overall Study|Pregnancy|0|||
149173240|NCT00824421|538105023|FG002|Overall Study|Pregnancy|1|||
149173241|NCT00824421|538105021|FG000|Overall Study|Withdrawal by Subject|2|||
149173242|NCT00824421|538105022|FG001|Overall Study|Withdrawal by Subject|3|||
149173243|NCT00824421|538105023|FG002|Overall Study|Withdrawal by Subject|3|||
149173244|NCT00824421|538105021|FG000|Overall Study|Randomized but not Treated|1|||
149173245|NCT00824421|538105022|FG001|Overall Study|Randomized but not Treated|1|||
149173246|NCT00824421|538105023|FG002|Overall Study|Randomized but not Treated|0|||
149173247|NCT00824421|538105021|FG000|Overall Study|Other|0|||
149173248|NCT00824421|538105022|FG001|Overall Study|Other|1|||
149173249|NCT00824421|538105023|FG002|Overall Study|Other|0|||
149173250|NCT02499952|538105024|FG000|Overall Study|Lost to Follow-up|1|||
149173251|NCT02499952|538105024|FG000|Overall Study|Death|9|||
149173252|NCT05089708|538105025|FG000|Overall Study|Lost to Follow-up|9|||
149173253|NCT05089708|538105026|FG001|Overall Study|Lost to Follow-up|7|||
149173254|NCT05089708|538105025|FG000|Overall Study|Withdrawal by Subject|3|||
149173255|NCT05089708|538105026|FG001|Overall Study|Withdrawal by Subject|1|||
149173256|NCT05089708|538105025|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
149173257|NCT05089708|538105026|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
149173258|NCT05089708|538105025|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
149173259|NCT05089708|538105026|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
149173260|NCT02120417|538105027|FG000|Overall Study|Death|5|||
149173261|NCT02120417|538105028|FG001|Overall Study|Death|1|||
149173262|NCT02120417|538105027|FG000|Overall Study|Adverse Event|3|||
149173263|NCT02120417|538105028|FG001|Overall Study|Adverse Event|9|||
149173264|NCT02120417|538105027|FG000|Overall Study|Participant decision|4|||
149173265|NCT02120417|538105028|FG001|Overall Study|Participant decision|4|||
149173266|NCT02120417|538105027|FG000|Overall Study|Disease progression|41|||
149173267|NCT02120417|538105028|FG001|Overall Study|Disease progression|45|||
149173268|NCT02120417|538105027|FG000|Overall Study|Noncompliance with study treatment|0|||
149173269|NCT02120417|538105028|FG001|Overall Study|Noncompliance with study treatment|2|||
149173270|NCT02120417|538105027|FG000|Overall Study|Physician Decision|2|||
149173271|NCT02120417|538105028|FG001|Overall Study|Physician Decision|3|||
149173272|NCT02120417|538105027|FG000|Overall Study|Other unspecified|5|||
149173273|NCT02120417|538105028|FG001|Overall Study|Other unspecified|4|||
149173274|NCT00927485|538105029|FG000|Overall Study|Adverse Event|4|||
149173275|NCT00927485|538105030|FG001|Overall Study|Adverse Event|2|||
149173276|NCT00927485|538105029|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
149173277|NCT00927485|538105030|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
149173278|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
149173279|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
149173280|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
149173281|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
149173282|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
149173283|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
149173284|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Personal issues|2|||
149173285|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Personal issues|0|||
149173286|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Personal issues|0|||
149173287|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Too busy|7|||
149173288|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Too busy|1|||
149173289|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Too busy|0|||
149173290|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Pain|2|||
149173291|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Pain|0|||
149173292|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Pain|0|||
149173293|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Moved|1|||
149173294|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Moved|0|||
149173295|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Moved|0|||
149173296|NCT00594399|538105031|FG000|Initial 3 Month Counseling|Family illness|1|||
149173297|NCT00594399|538105032|FG001|Initial 3 Month Counseling|Family illness|0|||
149173298|NCT00594399|538105033|FG002|Initial 3 Month Counseling|Family illness|0|||
149173299|NCT00594399|538105031|FG000|Rerandomization Arm 1 Only|Death|2|||
149173300|NCT00594399|538105032|FG001|Rerandomization Arm 1 Only|Death|1|||
149173301|NCT00594399|538105033|FG002|Rerandomization Arm 1 Only|Death|0|||
149173302|NCT00594399|538105031|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
149173303|NCT00594399|538105032|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
149173304|NCT00594399|538105033|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
149173305|NCT01440101|538105034|FG000|Overall Study|Adverse Event|2|||
149173306|NCT01440101|538105035|FG001|Overall Study|Adverse Event|0|||
149173307|NCT01440101|538105036|FG002|Overall Study|Adverse Event|0|||
149173308|NCT01440101|538105034|FG000|Overall Study|Withdrawal by Subject|0|||
149173309|NCT01440101|538105035|FG001|Overall Study|Withdrawal by Subject|3|||
149173310|NCT01440101|538105036|FG002|Overall Study|Withdrawal by Subject|1|||
149173311|NCT01440101|538105034|FG000|Overall Study|Other|0|||
149173312|NCT01440101|538105035|FG001|Overall Study|Other|1|||
149173313|NCT01440101|538105036|FG002|Overall Study|Other|0|||
149173314|NCT00659438|538105037|FG000|Overall Study|Withdrawal by Subject|2|||
149173315|NCT00659438|538105038|FG001|Overall Study|Withdrawal by Subject|2|||
149173316|NCT00659438|538105037|FG000|Overall Study|Death|11|||
149173317|NCT00659438|538105038|FG001|Overall Study|Death|6|||
149173318|NCT00659438|538105037|FG000|Overall Study|Lost to Follow-up|1|||
149173319|NCT00659438|538105038|FG001|Overall Study|Lost to Follow-up|0|||
149173320|NCT01491945|538105042|FG000|Overall Study|Death|30|||
149173321|NCT01491945|538105042|FG000|Overall Study|Withdrwan/LTF|16|||
149173322|NCT01491945|538105042|FG000|Overall Study|Conversion|4|||
149173323|NCT01491945|538105042|FG000|Overall Study|Missed Visit|1|||
149173324|NCT02700451|538105043|FG000|Overall Study|Protocol Violation|2|||
149173325|NCT02700451|538105044|FG001|Overall Study|Protocol Violation|2|||
149173326|NCT02700451|538105045|FG002|Overall Study|Protocol Violation|3|||
149173327|NCT02700451|538105043|FG000|Overall Study|Discontinued intervention|14|||
148678441|NCT03496207|536295447|FG001|Extension Period|Elevated hemoglobin levels|0|||
148678442|NCT03496207|536295448|FG002|Extension Period|Elevated hemoglobin levels|0|||
148678443|NCT03496207|536295449|FG003|Extension Period|Elevated hemoglobin levels|0|||
148678444|NCT03496207|536295450|FG004|Extension Period|Elevated hemoglobin levels|1|||
148678445|NCT00810615|536295456|FG000|Overall Study|Withdrawal by Subject|1|||
149173328|NCT02700451|538105044|FG001|Overall Study|Discontinued intervention|15|||
148678446|NCT00810615|536295457|FG001|Overall Study|Withdrawal by Subject|1|||
149173329|NCT02700451|538105045|FG002|Overall Study|Discontinued intervention|14|||
149173330|NCT00404092|538105051|FG000|Overall Study|Death|1|||
149173331|NCT00404092|538105052|FG001|Overall Study|Death|0|||
149173332|NCT00404092|538105053|FG002|Overall Study|Death|0|||
149173333|NCT00404092|538105054|FG003|Overall Study|Death|0|||
149173334|NCT00404092|538105051|FG000|Overall Study|Adverse Event|0|||
149173335|NCT00404092|538105052|FG001|Overall Study|Adverse Event|0|||
149173336|NCT00404092|538105053|FG002|Overall Study|Adverse Event|1|||
149173337|NCT00404092|538105054|FG003|Overall Study|Adverse Event|0|||
149173338|NCT01511445|538105055|FG000|Overall Study|Lost to Follow-up|3|||
149173339|NCT01511445|538105056|FG001|Overall Study|Lost to Follow-up|1|||
149173340|NCT01511445|538105055|FG000|Overall Study|Protocol Violation|1|||
149173341|NCT01511445|538105056|FG001|Overall Study|Protocol Violation|3|||
149173342|NCT01511445|538105055|FG000|Overall Study|Protocol Violation|1|||
149173343|NCT01511445|538105056|FG001|Overall Study|Protocol Violation|0|||
149173344|NCT02344576|538105060|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
148806501|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
148806502|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
148806503|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
148806504|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
148806505|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
148806506|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
148806507|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
148806508|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
148806509|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
148806510|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
148806511|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
148806512|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
148678447|NCT02567266|536295458|FG000|Overall Study|Withdrawal by Subject|10|||
148678448|NCT02567266|536295459|FG001|Overall Study|Withdrawal by Subject|7|||
148806513|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
148678449|NCT02567266|536295460|FG002|Overall Study|Withdrawal by Subject|6|||
148678450|NCT02567266|536295458|FG000|Overall Study|Lost to Follow-up|13|||
148678451|NCT02567266|536295459|FG001|Overall Study|Lost to Follow-up|8|||
148806514|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
148806515|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Other|10|||
148806516|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Other|4|||
148806517|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Other|0|||
148806518|NCT04006457|536770951|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
148806519|NCT04006457|536770952|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
148806520|NCT04006457|536770953|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
148806521|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
148806522|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
148678452|NCT02567266|536295460|FG002|Overall Study|Lost to Follow-up|10|||
148678453|NCT00683904|536295465|FG000|Dose Level 1|Disease progression|2|||
148678454|NCT00683904|536295466|FG001|Dose Level 1|Disease progression|0|||
148678455|NCT00683904|536295465|FG000|Dose Level 1|Adverse Event|1|||
148678456|NCT00683904|536295466|FG001|Dose Level 1|Adverse Event|0|||
148678457|NCT00683904|536295465|FG000|Dose Level 2|Adverse Event|0|||
148678458|NCT00683904|536295466|FG001|Dose Level 2|Adverse Event|2|||
148678459|NCT02340078|536295467|FG000|Overall Study|Protocol Violation|1|||
148678460|NCT01831596|536295468|FG000|Overall Study|Other|8|||
148678461|NCT01142466|536297144|FG000|Overall Study|Adverse Event|2|||
148678462|NCT01142466|536297145|FG001|Overall Study|Adverse Event|1|||
148678463|NCT01142466|536297144|FG000|Overall Study|Withdrawal by Subject|1|||
148678464|NCT01142466|536297145|FG001|Overall Study|Withdrawal by Subject|1|||
148678465|NCT02414854|536297150|FG000|Overall Study|Adverse Event|9|||
148678466|NCT02414854|536297151|FG001|Overall Study|Adverse Event|7|||
148678467|NCT02414854|536297152|FG002|Overall Study|Adverse Event|1|||
148806523|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
148806524|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
148928215|NCT00423670|537221326|FG003|Treatment Period|Protocol-defined clinical event|12|||
148928216|NCT00423670|537221327|FG004|Treatment Period|Protocol-defined clinical event|5|||
148928217|NCT00423670|537221328|FG005|Treatment Period|Protocol-defined clinical event|4|||
148678468|NCT02414854|536297153|FG003|Overall Study|Adverse Event|12|||
148678469|NCT02414854|536297150|FG000|Overall Study|Poor compliance to protocol|1|||
148678470|NCT02414854|536297151|FG001|Overall Study|Poor compliance to protocol|1|||
148678471|NCT02414854|536297152|FG002|Overall Study|Poor compliance to protocol|2|||
148678472|NCT02414854|536297153|FG003|Overall Study|Poor compliance to protocol|2|||
148678473|NCT02414854|536297150|FG000|Overall Study|Other than specified above|12|||
148678474|NCT02414854|536297151|FG001|Overall Study|Other than specified above|37|||
148678475|NCT02414854|536297152|FG002|Overall Study|Other than specified above|17|||
148678476|NCT02414854|536297153|FG003|Overall Study|Other than specified above|37|||
148678477|NCT01355523|536297154|FG000|Overall Study|Withdrawal by Subject|1|||
148678478|NCT01355523|536297155|FG001|Overall Study|Withdrawal by Subject|4|||
148678479|NCT01355523|536297154|FG000|Overall Study|Lost to Follow-up|0|||
148678480|NCT01355523|536297155|FG001|Overall Study|Lost to Follow-up|2|||
148678481|NCT01355523|536297154|FG000|Overall Study|Protocol Violation|0|||
148928218|NCT00423670|537221329|FG006|Treatment Period|Protocol-defined clinical event|16|||
148928219|NCT00423670|537221330|FG007|Treatment Period|Protocol-defined clinical event|15|||
148928220|NCT00423670|537221323|FG000|Treatment Period|Lost to Follow-up|2|||
149173345|NCT02344576|538105061|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
149173346|NCT02344576|538105062|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
149173347|NCT02344576|538105063|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
149173348|NCT02344576|538105060|FG000|1-Month Follow-Up|Death|13|||
149173349|NCT02344576|538105061|FG001|1-Month Follow-Up|Death|8|||
149173350|NCT02344576|538105062|FG002|1-Month Follow-Up|Death|0|||
149173351|NCT02344576|538105063|FG003|1-Month Follow-Up|Death|0|||
149173352|NCT02344576|538105060|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
149173353|NCT02344576|538105061|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
149173354|NCT02344576|538105062|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
149173355|NCT02344576|538105063|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
149173356|NCT02344576|538105060|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
149173357|NCT02344576|538105061|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
149173358|NCT02344576|538105062|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
149173359|NCT02344576|538105063|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
149173360|NCT02344576|538105060|FG000|6-Month Follow-Up|Death|14|||
149173361|NCT02344576|538105061|FG001|6-Month Follow-Up|Death|14|||
149173362|NCT02344576|538105062|FG002|6-Month Follow-Up|Death|0|||
149173363|NCT02344576|538105063|FG003|6-Month Follow-Up|Death|0|||
149173364|NCT02344576|538105060|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
149173365|NCT02344576|538105061|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
149173366|NCT02344576|538105062|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
149173367|NCT02344576|538105063|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
149173368|NCT02344576|538105060|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
149173369|NCT02344576|538105061|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
149173370|NCT02344576|538105062|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
149173371|NCT02344576|538105063|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
149173372|NCT04233424|538105065|FG000|Overall Study|Death|15|||
149173373|NCT04233424|538105066|FG001|Overall Study|Death|16|||
149173374|NCT04233424|538105065|FG000|Overall Study|Withdrawal by Subject|2|||
149173375|NCT04233424|538105066|FG001|Overall Study|Withdrawal by Subject|8|||
149173376|NCT04233424|538105065|FG000|Overall Study|Physician Decision|1|||
149173377|NCT04233424|538105066|FG001|Overall Study|Physician Decision|3|||
149173378|NCT04233424|538105065|FG000|Overall Study|Protocol Violation|3|||
149173379|NCT04233424|538105066|FG001|Overall Study|Protocol Violation|1|||
149173380|NCT04233424|538105065|FG000|Overall Study|Lost to Follow-up|1|||
149173381|NCT04233424|538105066|FG001|Overall Study|Lost to Follow-up|3|||
149173382|NCT04233424|538105065|FG000|Overall Study|subject refuse to visit site|2|||
149173383|NCT04233424|538105066|FG001|Overall Study|subject refuse to visit site|0|||
149173384|NCT04325503|538105067|FG000|Overall Study|Withdrawal by Subject|1|||
149173385|NCT04325503|538105067|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
149173386|NCT02337387|538105068|FG000|Overall Study|Adverse Event|0|||
149173387|NCT02337387|538105069|FG001|Overall Study|Adverse Event|1|||
149173388|NCT02337387|538105070|FG002|Overall Study|Adverse Event|0|||
149173389|NCT02337387|538105071|FG003|Overall Study|Adverse Event|0|||
149173390|NCT02337387|538105068|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
149173391|NCT02337387|538105069|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
149173392|NCT02337387|538105070|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
149173393|NCT02337387|538105071|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
149173394|NCT01856114|538105072|FG000|Overall Study|Withdrawal by Subject|1|||
149173395|NCT01856114|538105073|FG001|Overall Study|Withdrawal by Subject|0|||
149173396|NCT01856114|538105072|FG000|Overall Study|Adverse Event|1|||
149173397|NCT01856114|538105073|FG001|Overall Study|Adverse Event|0|||
149173398|NCT02853760|538105074|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
149173399|NCT02853760|538105075|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
149173400|NCT02853760|538105076|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
149173401|NCT02853760|538105077|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
149173402|NCT02853760|538105078|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
149173403|NCT02853760|538105079|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
149173404|NCT01642212|538105080|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
149173405|NCT01642212|538105081|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149173406|NCT01642212|538105082|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149173407|NCT01642212|538105083|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149173408|NCT01642212|538105084|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
149173409|NCT01642212|538105080|FG000|Double-blind Treatment|Other|0|||
149173410|NCT01642212|538105081|FG001|Double-blind Treatment|Other|2|||
149173411|NCT01642212|538105082|FG002|Double-blind Treatment|Other|1|||
149173412|NCT01642212|538105083|FG003|Double-blind Treatment|Other|0|||
149173413|NCT01642212|538105084|FG004|Double-blind Treatment|Other|0|||
149173414|NCT01642212|538105080|FG000|Double-blind Treatment|Non-compliance|0|||
149173415|NCT01642212|538105081|FG001|Double-blind Treatment|Non-compliance|1|||
149173416|NCT01642212|538105082|FG002|Double-blind Treatment|Non-compliance|0|||
149173417|NCT01642212|538105083|FG003|Double-blind Treatment|Non-compliance|0|||
149173418|NCT01642212|538105084|FG004|Double-blind Treatment|Non-compliance|0|||
149173419|NCT01642212|538105080|FG000|Double-blind Treatment|Adverse Event|0|||
149173420|NCT01642212|538105081|FG001|Double-blind Treatment|Adverse Event|0|||
149173421|NCT01642212|538105082|FG002|Double-blind Treatment|Adverse Event|1|||
149173422|NCT01642212|538105083|FG003|Double-blind Treatment|Adverse Event|0|||
149173423|NCT01642212|538105084|FG004|Double-blind Treatment|Adverse Event|0|||
149173424|NCT01642212|538105080|FG000|Open-label Extension|Adverse Event|0|||
149173425|NCT01642212|538105081|FG001|Open-label Extension|Adverse Event|0|||
149173426|NCT01642212|538105082|FG002|Open-label Extension|Adverse Event|0|||
149173427|NCT01642212|538105083|FG003|Open-label Extension|Adverse Event|3|||
149173428|NCT01642212|538105084|FG004|Open-label Extension|Adverse Event|0|||
149173429|NCT01642212|538105080|FG000|Open-label Extension|Sponsor Decision|0|||
149173430|NCT01642212|538105081|FG001|Open-label Extension|Sponsor Decision|0|||
149173431|NCT01642212|538105082|FG002|Open-label Extension|Sponsor Decision|0|||
149173432|NCT01642212|538105083|FG003|Open-label Extension|Sponsor Decision|7|||
149173433|NCT01642212|538105084|FG004|Open-label Extension|Sponsor Decision|4|||
149173434|NCT01642212|538105080|FG000|Open-label Extension|Consent Withdrawn|0|||
149173435|NCT01642212|538105081|FG001|Open-label Extension|Consent Withdrawn|0|||
149173436|NCT01642212|538105082|FG002|Open-label Extension|Consent Withdrawn|0|||
148678482|NCT01355523|536297155|FG001|Overall Study|Protocol Violation|2|||
148678483|NCT01355523|536297154|FG000|Overall Study|Adverse Event|0|||
148678484|NCT01355523|536297155|FG001|Overall Study|Adverse Event|2|||
148678485|NCT02766088|536297156|FG000|Overall Study|Sponsor study termination|498|||
148678486|NCT02766088|536297156|FG000|Overall Study|Migrated/moved from the study area|1|||
148678487|NCT02766088|536297156|FG000|Overall Study|Lost to Follow-up|5|||
148678488|NCT02766088|536297156|FG000|Overall Study|Other|1|||
148928221|NCT00423670|537221324|FG001|Treatment Period|Lost to Follow-up|1|||
148928222|NCT00423670|537221325|FG002|Treatment Period|Lost to Follow-up|3|||
149173437|NCT01642212|538105083|FG003|Open-label Extension|Consent Withdrawn|0|||
149173438|NCT01642212|538105084|FG004|Open-label Extension|Consent Withdrawn|2|||
149173439|NCT01642212|538105080|FG000|Open-label Extension|Lost to Follow-up|0|||
149173440|NCT01642212|538105081|FG001|Open-label Extension|Lost to Follow-up|0|||
149173441|NCT01642212|538105082|FG002|Open-label Extension|Lost to Follow-up|0|||
149173442|NCT01642212|538105083|FG003|Open-label Extension|Lost to Follow-up|0|||
148678489|NCT02766088|536297156|FG000|Overall Study|Death|1|||
148678490|NCT01222715|536297157|FG000|Overall Study|Adverse Event|0|||
148678491|NCT01222715|536297158|FG001|Overall Study|Adverse Event|4|||
148678492|NCT01222715|536297157|FG000|Overall Study|Death|0|||
149173443|NCT01642212|538105084|FG004|Open-label Extension|Lost to Follow-up|1|||
149173444|NCT01642212|538105080|FG000|Open-label Extension|Other|0|||
149173445|NCT01642212|538105081|FG001|Open-label Extension|Other|0|||
148678493|NCT01222715|536297158|FG001|Overall Study|Death|1|||
148678494|NCT01222715|536297157|FG000|Overall Study|Lack of Efficacy|22|||
148678495|NCT01222715|536297158|FG001|Overall Study|Lack of Efficacy|14|||
148678496|NCT01222715|536297157|FG000|Overall Study|Physician Decision|12|||
148678497|NCT01222715|536297158|FG001|Overall Study|Physician Decision|2|||
148678498|NCT01222715|536297157|FG000|Overall Study|Refusal of further protocol therapy|0|||
148678499|NCT01222715|536297158|FG001|Overall Study|Refusal of further protocol therapy|4|||
148678500|NCT01222715|536297157|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
148678501|NCT01222715|536297158|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
148678502|NCT01222715|536297157|FG000|Overall Study|Ineligible|0|||
148678503|NCT01222715|536297158|FG001|Overall Study|Ineligible|1|||
148678504|NCT01222715|536297157|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
148678505|NCT01222715|536297158|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
148678506|NCT01440595|536297159|FG000|Overall Study|Lost to Follow-up|0|||
148678507|NCT01440595|536297160|FG001|Overall Study|Lost to Follow-up|1|||
148678508|NCT01440595|536297161|FG002|Overall Study|Lost to Follow-up|0|||
148678509|NCT01440595|536297159|FG000|Overall Study|Study terminated by sponsor.|1|||
148678510|NCT01440595|536297160|FG001|Overall Study|Study terminated by sponsor.|2|||
148678511|NCT01440595|536297161|FG002|Overall Study|Study terminated by sponsor.|1|||
148678512|NCT01347879|536297162|FG000|Overall Study|Adverse Event|0|||
149173446|NCT01642212|538105082|FG002|Open-label Extension|Other|0|||
149173447|NCT01642212|538105083|FG003|Open-label Extension|Other|0|||
149173448|NCT01642212|538105084|FG004|Open-label Extension|Other|1|||
149173449|NCT00981526|538105085|FG000|Overall Study|Withdrawal by Subject|0|||
149173450|NCT00981526|538105086|FG001|Overall Study|Withdrawal by Subject|2|||
149173451|NCT00981526|538105085|FG000|Overall Study|Physician Decision|4|||
149173452|NCT00981526|538105086|FG001|Overall Study|Physician Decision|4|||
149173453|NCT01243268|538105087|FG000|Overall Study|Lost to Follow-up|4|||
149173454|NCT01243268|538105087|FG000|Overall Study|Protocol Violation|51|||
149173455|NCT01243268|538105087|FG000|Overall Study|Deviation with contract date|7|||
149173456|NCT01243268|538105087|FG000|Overall Study|Duplicate subject|2|||
149173457|NCT02272790|538105088|FG000|Overall Study|Physician Decision|0|||
149173458|NCT02272790|538105089|FG001|Overall Study|Physician Decision|1|||
149173459|NCT02272790|538105090|FG002|Overall Study|Physician Decision|0|||
149173460|NCT02272790|538105091|FG003|Overall Study|Physician Decision|0|||
149173461|NCT02272790|538105092|FG004|Overall Study|Physician Decision|0|||
149173462|NCT02272790|538105093|FG005|Overall Study|Physician Decision|0|||
149173463|NCT00702143|538105094|FG000|Overall Study|Lost to Follow-up|0|||
149173464|NCT00702143|538105095|FG001|Overall Study|Lost to Follow-up|0|||
149173465|NCT00702143|538105096|FG002|Overall Study|Lost to Follow-up|1|||
149173466|NCT02793544|538105097|FG000|Overall Study|Death|10|||
149173467|NCT02793544|538105098|FG001|Overall Study|Death|8|||
149173468|NCT02793544|538105097|FG000|Overall Study|Lost to Follow-up|2|||
149173469|NCT02793544|538105098|FG001|Overall Study|Lost to Follow-up|0|||
149173470|NCT02793544|538105097|FG000|Overall Study|Withdrawal by Subject|1|||
149173471|NCT02793544|538105098|FG001|Overall Study|Withdrawal by Subject|0|||
149173472|NCT02382133|538105101|FG000|Overall Study|Death|22|||
149173473|NCT02382133|538105101|FG000|Overall Study|transfer out of ICU|4|||
149173474|NCT02382133|538105101|FG000|Overall Study|Physician Decision|2|||
149173475|NCT02382133|538105101|FG000|Overall Study|arterial catheter loss|4|||
149173476|NCT02382133|538105101|FG000|Overall Study|pressure injury both sites|1|||
149173477|NCT00045032|538105106|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
149173478|NCT00045032|538105107|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
149173479|NCT00045032|538105108|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
149173480|NCT00045032|538105106|FG000|Overall Study|Death|22|||
149173481|NCT00045032|538105107|FG001|Overall Study|Death|24|||
149173482|NCT00045032|538105108|FG002|Overall Study|Death|17|||
149173483|NCT00045032|538105106|FG000|Overall Study|Insufficient Therapeutic Response|542|||
149173484|NCT00045032|538105107|FG001|Overall Study|Insufficient Therapeutic Response|437|||
149173485|NCT00045032|538105108|FG002|Overall Study|Insufficient Therapeutic Response|445|||
149173486|NCT00045032|538105106|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
149173487|NCT00045032|538105107|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
149173488|NCT00045032|538105108|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
149173489|NCT00045032|538105106|FG000|Overall Study|Other Protocol Violation|2|||
149173490|NCT00045032|538105107|FG001|Overall Study|Other Protocol Violation|0|||
149173491|NCT00045032|538105108|FG002|Overall Study|Other Protocol Violation|1|||
149173492|NCT00045032|538105106|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
149173493|NCT00045032|538105107|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
149173494|NCT00045032|538105108|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
149173495|NCT00045032|538105106|FG000|Overall Study|Failure to Return|57|||
149173496|NCT00045032|538105107|FG001|Overall Study|Failure to Return|62|||
149173497|NCT00045032|538105108|FG002|Overall Study|Failure to Return|61|||
148678513|NCT01347879|536297163|FG001|Overall Study|Adverse Event|12|||
148678514|NCT01347879|536297162|FG000|Overall Study|Lost to Follow-up|2|||
148678515|NCT01347879|536297163|FG001|Overall Study|Lost to Follow-up|0|||
148678516|NCT01347879|536297162|FG000|Overall Study|Withdrawal by Subject|3|||
149173498|NCT00045032|538105106|FG000|Overall Study|Other|93|||
149173499|NCT00045032|538105107|FG001|Overall Study|Other|84|||
149173500|NCT00045032|538105108|FG002|Overall Study|Other|105|||
149173501|NCT02582658|538105109|FG000|Overall Study|Failure to Return|10|||
149173502|NCT02582658|538105109|FG000|Overall Study|Insufficient Virological Response|2|||
148928223|NCT00423670|537221326|FG003|Treatment Period|Lost to Follow-up|1|||
148928224|NCT00423670|537221327|FG004|Treatment Period|Lost to Follow-up|6|||
148928225|NCT00423670|537221328|FG005|Treatment Period|Lost to Follow-up|0|||
148928226|NCT00423670|537221329|FG006|Treatment Period|Lost to Follow-up|3|||
148928227|NCT00423670|537221330|FG007|Treatment Period|Lost to Follow-up|1|||
148928228|NCT00423670|537221323|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
148928229|NCT00423670|537221324|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
148928230|NCT00423670|537221325|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
148928231|NCT00423670|537221326|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
148928232|NCT00423670|537221327|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
148928233|NCT00423670|537221328|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
148928234|NCT00423670|537221329|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
148928235|NCT00423670|537221330|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
148928236|NCT00423670|537221323|FG000|Treatment Period|Investigator decision|0|||
148928237|NCT00423670|537221324|FG001|Treatment Period|Investigator decision|0|||
148928238|NCT00423670|537221325|FG002|Treatment Period|Investigator decision|0|||
148928239|NCT00423670|537221326|FG003|Treatment Period|Investigator decision|0|||
148928240|NCT00423670|537221327|FG004|Treatment Period|Investigator decision|0|||
148928241|NCT00423670|537221328|FG005|Treatment Period|Investigator decision|0|||
148928242|NCT00423670|537221329|FG006|Treatment Period|Investigator decision|0|||
148928243|NCT00423670|537221330|FG007|Treatment Period|Investigator decision|1|||
148928244|NCT00423670|537221323|FG000|Treatment Period|Non-compliance with protocol|3|||
148928245|NCT00423670|537221324|FG001|Treatment Period|Non-compliance with protocol|1|||
148928246|NCT00423670|537221325|FG002|Treatment Period|Non-compliance with protocol|1|||
148928247|NCT00423670|537221326|FG003|Treatment Period|Non-compliance with protocol|3|||
148928248|NCT00423670|537221327|FG004|Treatment Period|Non-compliance with protocol|2|||
148928249|NCT00423670|537221328|FG005|Treatment Period|Non-compliance with protocol|0|||
148928250|NCT00423670|537221329|FG006|Treatment Period|Non-compliance with protocol|2|||
148928251|NCT00423670|537221330|FG007|Treatment Period|Non-compliance with protocol|2|||
148928252|NCT00423670|537221323|FG000|Follow-up Period|Lost to Follow-up|0|||
148928253|NCT00423670|537221324|FG001|Follow-up Period|Lost to Follow-up|12|||
148928254|NCT00423670|537221325|FG002|Follow-up Period|Lost to Follow-up|8|||
148928255|NCT00423670|537221326|FG003|Follow-up Period|Lost to Follow-up|3|||
148928256|NCT00423670|537221327|FG004|Follow-up Period|Lost to Follow-up|1|||
148928257|NCT00423670|537221328|FG005|Follow-up Period|Lost to Follow-up|0|||
148928258|NCT00423670|537221329|FG006|Follow-up Period|Lost to Follow-up|5|||
148928259|NCT00423670|537221330|FG007|Follow-up Period|Lost to Follow-up|0|||
148928260|NCT00423670|537221323|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
148928261|NCT00423670|537221324|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
148928262|NCT00423670|537221325|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
148928263|NCT00423670|537221326|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
148928264|NCT00423670|537221327|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
148928265|NCT00423670|537221328|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
148928266|NCT00423670|537221329|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
148928267|NCT00423670|537221330|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
148928268|NCT00423670|537221323|FG000|Follow-up Period|Non-compliance with protocol|2|||
148928269|NCT00423670|537221324|FG001|Follow-up Period|Non-compliance with protocol|0|||
148928270|NCT00423670|537221325|FG002|Follow-up Period|Non-compliance with protocol|1|||
148928271|NCT00423670|537221326|FG003|Follow-up Period|Non-compliance with protocol|1|||
148928272|NCT00423670|537221327|FG004|Follow-up Period|Non-compliance with protocol|0|||
148928273|NCT00423670|537221328|FG005|Follow-up Period|Non-compliance with protocol|0|||
148928274|NCT00423670|537221329|FG006|Follow-up Period|Non-compliance with protocol|3|||
148928275|NCT00423670|537221330|FG007|Follow-up Period|Non-compliance with protocol|2|||
148928276|NCT04163718|537221331|FG000|Overall Study|Study terminated|12|||
148928277|NCT01466595|537221332|FG000|Overall Study|Withdrawal by Subject|0|||
148928278|NCT01466595|537221333|FG001|Overall Study|Withdrawal by Subject|1|||
148928279|NCT02376829|537221336|FG000|Overall Study|Withdrawal by Subject|27|||
148928280|NCT02376829|537221337|FG001|Overall Study|Withdrawal by Subject|44|||
148928281|NCT00107952|537221338|FG000|Overall Study|Death|75|||
148928282|NCT00107952|537221339|FG001|Overall Study|Death|61|||
149013263|NCT03029780|537527887|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
148928283|NCT00107952|537221338|FG000|Overall Study|Lost to Follow-up|0|||
148928284|NCT00107952|537221339|FG001|Overall Study|Lost to Follow-up|3|||
148928285|NCT00107952|537221338|FG000|Overall Study|Withdrawal by Subject|9|||
148928286|NCT00107952|537221339|FG001|Overall Study|Withdrawal by Subject|6|||
148928287|NCT00107952|537221338|FG000|Overall Study|Other|2|||
148928288|NCT00107952|537221339|FG001|Overall Study|Other|5|||
149173503|NCT02582658|538105109|FG000|Overall Study|Withdrawn Consent|1|||
149173504|NCT02582658|538105109|FG000|Overall Study|Death|1|||
148928289|NCT00107952|537221338|FG000|Overall Study|Never received study treatment|9|||
148928290|NCT00107952|537221339|FG001|Overall Study|Never received study treatment|6|||
148806525|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
148806526|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
148806527|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
148806528|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
148806529|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
148806530|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
148806531|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
148806532|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
148806533|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
148806534|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
148806535|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
148806536|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Other|2|||
148806537|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Other|3|||
148806538|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Other|0|||
148806539|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
148806540|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
148806541|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
148806542|NCT04006457|536770951|FG000|Main Study: Treatment Period 2|Ongoing|86|||
148806543|NCT04006457|536770952|FG001|Main Study: Treatment Period 2|Ongoing|96|||
148806544|NCT04006457|536770953|FG002|Main Study: Treatment Period 2|Ongoing|0|||
148806545|NCT04006457|536770951|FG000|Main Study Observation Period|Adverse Event|1|||
148806546|NCT04006457|536770952|FG001|Main Study Observation Period|Adverse Event|1|||
148806547|NCT04006457|536770953|FG002|Main Study Observation Period|Adverse Event|0|||
148806548|NCT04006457|536770951|FG000|Main Study Observation Period|Lost to Follow-up|0|||
148806549|NCT04006457|536770952|FG001|Main Study Observation Period|Lost to Follow-up|1|||
148806550|NCT04006457|536770953|FG002|Main Study Observation Period|Lost to Follow-up|0|||
148806551|NCT04006457|536770951|FG000|Main Study Observation Period|Pregnancy|1|||
148806552|NCT04006457|536770952|FG001|Main Study Observation Period|Pregnancy|0|||
148806553|NCT04006457|536770953|FG002|Main Study Observation Period|Pregnancy|0|||
148806554|NCT04006457|536770951|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
148806555|NCT04006457|536770952|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
148806556|NCT04006457|536770953|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
148806557|NCT04006457|536770951|FG000|Main Study Observation Period|Other|8|||
148806558|NCT04006457|536770952|FG001|Main Study Observation Period|Other|16|||
148806559|NCT04006457|536770953|FG002|Main Study Observation Period|Other|0|||
148806560|NCT04006457|536770951|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
148806561|NCT04006457|536770952|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
148806562|NCT04006457|536770953|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
148806563|NCT04006457|536770951|FG000|Main Study Observation Period|Ongoing|2|||
148806564|NCT04006457|536770952|FG001|Main Study Observation Period|Ongoing|1|||
148806565|NCT04006457|536770953|FG002|Main Study Observation Period|Ongoing|0|||
148806566|NCT04006457|536770951|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
148806567|NCT04006457|536770952|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
148806568|NCT04006457|536770953|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
148806569|NCT03729362|536770954|FG000|Overall Study|Withdrawal by Subject|2|||
148806570|NCT03729362|536770955|FG001|Overall Study|Withdrawal by Subject|0|||
148806571|NCT03729362|536770954|FG000|Overall Study|Physician Decision|1|||
148806572|NCT03729362|536770955|FG001|Overall Study|Physician Decision|0|||
148806573|NCT03729362|536770954|FG000|Overall Study|COVID-19 Pandemic|1|||
148806574|NCT03729362|536770955|FG001|Overall Study|COVID-19 Pandemic|0|||
148806575|NCT03729362|536770954|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
148806576|NCT03729362|536770955|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
148806577|NCT03729362|536770954|FG000|Overall Study|Adverse Event|0|||
148806578|NCT03729362|536770955|FG001|Overall Study|Adverse Event|1|||
148806579|NCT03729362|536770954|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
148806580|NCT03729362|536770955|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
148806581|NCT05172609|536770956|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
148806582|NCT05172609|536770957|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
148806583|NCT05172609|536770956|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
148806584|NCT05172609|536770957|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
148806585|NCT05172609|536770956|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
148806586|NCT05172609|536770957|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
148806587|NCT03737994|536770958|FG000|Overall Study|Withdrawal by Subject|0|||
148806588|NCT03737994|536770959|FG001|Overall Study|Withdrawal by Subject|0|||
148806589|NCT03737994|536770960|FG002|Overall Study|Withdrawal by Subject|0|||
148806590|NCT03737994|536770961|FG003|Overall Study|Withdrawal by Subject|0|||
148806591|NCT03737994|536770962|FG004|Overall Study|Withdrawal by Subject|0|||
148806592|NCT03737994|536770963|FG005|Overall Study|Withdrawal by Subject|0|||
148806593|NCT03737994|536770964|FG006|Overall Study|Withdrawal by Subject|1|||
148806594|NCT00548327|536770969|FG000|Overall Study|Adverse Event|0|||
148806595|NCT00548327|536770970|FG001|Overall Study|Adverse Event|1|||
148806596|NCT01673386|536770971|FG000|Overall Study|Study terminated by sponsor|16|||
148806597|NCT01673386|536770972|FG001|Overall Study|Study terminated by sponsor|22|||
148806598|NCT01673386|536770971|FG000|Overall Study|Adverse Event|5|||
148806599|NCT01673386|536770972|FG001|Overall Study|Adverse Event|2|||
148806600|NCT01673386|536770971|FG000|Overall Study|Progressive disease|4|||
148806601|NCT01673386|536770972|FG001|Overall Study|Progressive disease|1|||
148806602|NCT01673386|536770971|FG000|Overall Study|Withdrawal by Subject|0|||
148806603|NCT01673386|536770972|FG001|Overall Study|Withdrawal by Subject|2|||
148806604|NCT00109343|536770973|FG000|Overall Study|Adverse Event|1|||
148806605|NCT00109343|536770974|FG001|Overall Study|Adverse Event|0|||
148806606|NCT00109343|536770975|FG002|Overall Study|Adverse Event|2|||
148806607|NCT00109343|536770973|FG000|Overall Study|Lack of Efficacy|1|||
148806608|NCT00109343|536770974|FG001|Overall Study|Lack of Efficacy|0|||
148806609|NCT00109343|536770975|FG002|Overall Study|Lack of Efficacy|0|||
148806610|NCT00109343|536770973|FG000|Overall Study|Lost to Follow-up|35|||
148806611|NCT00109343|536770974|FG001|Overall Study|Lost to Follow-up|20|||
148806612|NCT00109343|536770975|FG002|Overall Study|Lost to Follow-up|14|||
148806613|NCT00109343|536770973|FG000|Overall Study|Protocol Violation|1|||
148806614|NCT00109343|536770974|FG001|Overall Study|Protocol Violation|2|||
148806615|NCT00109343|536770975|FG002|Overall Study|Protocol Violation|2|||
148806616|NCT00109343|536770973|FG000|Overall Study|Withdrawal by Subject|15|||
148806617|NCT00109343|536770974|FG001|Overall Study|Withdrawal by Subject|11|||
148806618|NCT00109343|536770975|FG002|Overall Study|Withdrawal by Subject|10|||
148806619|NCT00109343|536770973|FG000|Overall Study|Subject Moved|6|||
148806620|NCT00109343|536770974|FG001|Overall Study|Subject Moved|2|||
148806621|NCT00109343|536770975|FG002|Overall Study|Subject Moved|1|||
148806622|NCT00109343|536770973|FG000|Overall Study|Other|5|||
148928291|NCT01569464|537221342|FG000|Overall Study|Adverse Event|4|||
148928292|NCT01569464|537221343|FG001|Overall Study|Adverse Event|0|||
148928293|NCT01569464|537221342|FG000|Overall Study|Lack of Efficacy|1|||
148928294|NCT01569464|537221343|FG001|Overall Study|Lack of Efficacy|0|||
148928295|NCT01569464|537221342|FG000|Overall Study|Protocol Violation|1|||
148928296|NCT01569464|537221343|FG001|Overall Study|Protocol Violation|0|||
148928297|NCT01569464|537221342|FG000|Overall Study|Lost to Follow-up|2|||
148928298|NCT01569464|537221343|FG001|Overall Study|Lost to Follow-up|3|||
148928299|NCT01569464|537221342|FG000|Overall Study|Withdrawal by Subject|1|||
148928300|NCT01569464|537221343|FG001|Overall Study|Withdrawal by Subject|1|||
148928301|NCT01569464|537221342|FG000|Overall Study|Other|1|||
148928302|NCT01569464|537221343|FG001|Overall Study|Other|1|||
148928303|NCT03063203|537221349|FG000|Overall Study|Chose alternative therapy|3|||
148928304|NCT03063203|537221349|FG000|Overall Study|Death|2|||
148928305|NCT03063203|537221349|FG000|Overall Study|Disease progression|4|||
148928306|NCT03063203|537221349|FG000|Overall Study|Physician Decision|5|||
148928307|NCT01642407|537221350|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
148678517|NCT01347879|536297163|FG001|Overall Study|Withdrawal by Subject|2|||
148678518|NCT01347879|536297162|FG000|Overall Study|Other|2|||
148678519|NCT01347879|536297163|FG001|Overall Study|Other|3|||
148678520|NCT01466673|536297168|FG000|Overall Study|Non-compliance with study treatment|2|||
148678521|NCT01466673|536297169|FG001|Overall Study|Non-compliance with study treatment|0|||
148678522|NCT01466673|536297168|FG000|Overall Study|Lost to Follow-up|3|||
148678523|NCT01466673|536297169|FG001|Overall Study|Lost to Follow-up|5|||
148678524|NCT01466673|536297168|FG000|Overall Study|Adverse Event|2|||
148678525|NCT01466673|536297169|FG001|Overall Study|Adverse Event|1|||
148678526|NCT02981602|536297170|FG000|Overall Study|Adverse Event|0|||
148678527|NCT02981602|536297171|FG001|Overall Study|Adverse Event|0|||
148678528|NCT02981602|536297172|FG002|Overall Study|Adverse Event|0|||
148678529|NCT02981602|536297173|FG003|Overall Study|Adverse Event|1|||
148678530|NCT02981602|536297174|FG004|Overall Study|Adverse Event|0|||
148678531|NCT02725671|536297175|FG000|Overall Study|Lost to Follow-up|1|||
148678532|NCT02983227|536297178|FG000|Overall Study|Adverse Event|21|||
148678533|NCT02983227|536297179|FG001|Overall Study|Adverse Event|3|||
148678534|NCT02983227|536297178|FG000|Overall Study|Death|3|||
148928308|NCT01642407|537221350|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
148928309|NCT01642407|537221350|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
148928310|NCT01856023|537221351|FG000|Overall Study|Death|1|||
148928311|NCT01856023|537221352|FG001|Overall Study|Death|2|||
148928312|NCT01856023|537221351|FG000|Overall Study|Adverse Event|2|||
148928313|NCT01856023|537221352|FG001|Overall Study|Adverse Event|1|||
148928314|NCT01856023|537221351|FG000|Overall Study|Lack of Efficacy|5|||
148928315|NCT01856023|537221352|FG001|Overall Study|Lack of Efficacy|5|||
148928316|NCT01856023|537221351|FG000|Overall Study|non compliance, study closure|1|||
149173505|NCT02582658|538105109|FG000|Overall Study|Not further specified|11|||
149173506|NCT03277196|538105113|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
149173507|NCT03277196|538105113|FG000|Overall Study|Lost to Follow-up|3|||
149173508|NCT03277196|538105113|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
149173509|NCT03277196|538105113|FG000|Overall Study|Other|2|||
149173510|NCT00473694|538106470|FG000|Overall Study|Adverse Event|0|||
149173511|NCT00473694|538106471|FG001|Overall Study|Adverse Event|1|||
149173512|NCT00473694|538106472|FG002|Overall Study|Adverse Event|0|||
149173513|NCT00473694|538106473|FG003|Overall Study|Adverse Event|0|||
149173514|NCT00473694|538106470|FG000|Overall Study|Participants did not receive treatment|11|||
149173515|NCT00473694|538106471|FG001|Overall Study|Participants did not receive treatment|3|||
149173516|NCT00473694|538106472|FG002|Overall Study|Participants did not receive treatment|5|||
149173517|NCT00473694|538106473|FG003|Overall Study|Participants did not receive treatment|6|||
149173518|NCT00473694|538106470|FG000|Overall Study|Lost to Follow-up|0|||
148928317|NCT01856023|537221352|FG001|Overall Study|non compliance, study closure|3|||
148928318|NCT01856023|537221351|FG000|Overall Study|Withdrawal by Subject|1|||
148928319|NCT01856023|537221352|FG001|Overall Study|Withdrawal by Subject|1|||
148928320|NCT00424255|537221353|FG000|Overall Study|Death|115|||
148928321|NCT00424255|537221354|FG001|Overall Study|Death|111|||
148928322|NCT00424255|537221353|FG000|Overall Study|Lost to Follow-up|26|||
149173519|NCT00473694|538106471|FG001|Overall Study|Lost to Follow-up|0|||
148678535|NCT02983227|536297179|FG001|Overall Study|Death|0|||
148678536|NCT02983227|536297178|FG000|Overall Study|Lack of Efficacy|8|||
148678537|NCT02983227|536297179|FG001|Overall Study|Lack of Efficacy|1|||
148678538|NCT02983227|536297178|FG000|Overall Study|Lost to Follow-up|3|||
148678539|NCT02983227|536297179|FG001|Overall Study|Lost to Follow-up|0|||
148928323|NCT00424255|537221354|FG001|Overall Study|Lost to Follow-up|20|||
148928324|NCT00424255|537221353|FG000|Overall Study|Protocol Violation|0|||
148928325|NCT00424255|537221354|FG001|Overall Study|Protocol Violation|1|||
148928326|NCT00424255|537221353|FG000|Overall Study|Withdrawal by Subject|34|||
148928327|NCT00424255|537221354|FG001|Overall Study|Withdrawal by Subject|38|||
148928328|NCT00424255|537221353|FG000|Overall Study|Physician Decision|3|||
148928329|NCT00424255|537221354|FG001|Overall Study|Physician Decision|7|||
148928330|NCT00424255|537221353|FG000|Overall Study|Cognitive Disturbance|1|||
148928331|NCT00424255|537221354|FG001|Overall Study|Cognitive Disturbance|0|||
148928332|NCT00424255|537221353|FG000|Overall Study|Non-compliance by Participants|1|||
148928333|NCT00424255|537221354|FG001|Overall Study|Non-compliance by Participants|0|||
148928334|NCT00424255|537221353|FG000|Overall Study|Fatigue|1|||
148928335|NCT00424255|537221354|FG001|Overall Study|Fatigue|0|||
148928336|NCT00424255|537221353|FG000|Overall Study|Disease Progression|0|||
148928337|NCT00424255|537221354|FG001|Overall Study|Disease Progression|2|||
148928338|NCT00424255|537221353|FG000|Overall Study|Sponsor Terminated Study|161|||
148928339|NCT00424255|537221354|FG001|Overall Study|Sponsor Terminated Study|167|||
148928340|NCT02632838|537221356|FG000|Overall Study|Withdrawal by Subject|3|||
148928341|NCT02632838|537221357|FG001|Overall Study|Withdrawal by Subject|0|||
148928342|NCT02632838|537221356|FG000|Overall Study|Lost to Follow-up|0|||
148928343|NCT02632838|537221357|FG001|Overall Study|Lost to Follow-up|2|||
148928344|NCT03631355|537221358|FG000|Overall Study|Lost to Follow-up|1|||
148928345|NCT03631355|537221359|FG001|Overall Study|Lost to Follow-up|2|||
148928346|NCT02810340|537221360|FG000|Overall Study|Withdrawal by Subject|1|||
148928347|NCT02810340|537221361|FG001|Overall Study|Withdrawal by Subject|0|||
148928348|NCT02810340|537221362|FG002|Overall Study|Withdrawal by Subject|0|||
148928349|NCT02810340|537221360|FG000|Overall Study|Incarceration|0|||
148928350|NCT02810340|537221361|FG001|Overall Study|Incarceration|1|||
148928351|NCT02810340|537221362|FG002|Overall Study|Incarceration|0|||
148928352|NCT02810340|537221360|FG000|Overall Study|Lost to Follow-up|0|||
148928353|NCT02810340|537221361|FG001|Overall Study|Lost to Follow-up|0|||
148928354|NCT02810340|537221362|FG002|Overall Study|Lost to Follow-up|1|||
148928355|NCT03945175|537221365|FG000|Overall Study|Did not meet inclusion criteria|31|||
148928356|NCT03945175|537221365|FG000|Overall Study|Withdrew consent|2|||
148928357|NCT03945175|537221365|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
148928358|NCT03945175|537221365|FG000|Overall Study|Early termination during Mydayis treatment|1|||
148928359|NCT00870233|537221369|FG000|Overall Study|Withdrawal by Subject|18|||
148928360|NCT00870233|537221369|FG000|Overall Study|Did not undergo laparotomy|3|||
148928361|NCT00870233|537221369|FG000|Overall Study|Incompatible internet browser|2|||
148928362|NCT00870233|537221369|FG000|Overall Study|Death|1|||
148928363|NCT00769483|537221371|FG000|Overall Study|Withdrawal by Subject|0|||
148928364|NCT00769483|537221372|FG001|Overall Study|Withdrawal by Subject|1|||
148928365|NCT00769483|537221373|FG002|Overall Study|Withdrawal by Subject|0|||
148928366|NCT00769483|537221374|FG003|Overall Study|Withdrawal by Subject|0|||
148928367|NCT00769483|537221375|FG004|Overall Study|Withdrawal by Subject|1|||
148928368|NCT00769483|537221376|FG005|Overall Study|Withdrawal by Subject|0|||
148928369|NCT01306877|537221377|FG000|Overall Study|Lost to Follow-up|3|||
148928370|NCT01306877|537221378|FG001|Overall Study|Lost to Follow-up|3|||
148928371|NCT01306877|537221377|FG000|Overall Study|Physician Decision|0|||
148928372|NCT01306877|537221378|FG001|Overall Study|Physician Decision|1|||
148928373|NCT00006389|537221379|FG000|Overall Study|Adverse Event|1|||
148928374|NCT00999921|537221404|FG000|Overall Study|Lost to Follow-up|10|||
148928375|NCT00999921|537221405|FG001|Overall Study|Lost to Follow-up|19|||
148678540|NCT02983227|536297178|FG000|Overall Study|Multiple Reasons|2|||
148678541|NCT02983227|536297179|FG001|Overall Study|Multiple Reasons|1|||
148678542|NCT02983227|536297178|FG000|Overall Study|Physician Decision|3|||
148678543|NCT02983227|536297179|FG001|Overall Study|Physician Decision|1|||
148678544|NCT02983227|536297178|FG000|Overall Study|Withdrawal by Subject|19|||
148678545|NCT02983227|536297179|FG001|Overall Study|Withdrawal by Subject|8|||
148678546|NCT01706770|536297180|FG000|Overall Study|Lost to Follow-up|1|||
148678547|NCT01706770|536297181|FG001|Overall Study|Lost to Follow-up|0|||
148678548|NCT01706770|536297180|FG000|Overall Study|Physician Decision|1|||
148678549|NCT01706770|536297181|FG001|Overall Study|Physician Decision|0|||
148678550|NCT00068445|536297182|FG000|Randomization|Cancel|1|||
148678551|NCT00068445|536297183|FG001|Randomization|Cancel|3|||
148928376|NCT00704808|537221416|FG000|Overall Study|Discontinued prior to starting treatment|14|||
148928377|NCT00704808|537221416|FG000|Overall Study|Death|7|||
148928378|NCT00704808|537221416|FG000|Overall Study|Tumor progression|80|||
148928379|NCT00704808|537221416|FG000|Overall Study|Patient's decision|11|||
148928380|NCT00704808|537221416|FG000|Overall Study|Early therapy discontinuation|16|||
148928381|NCT00704808|537221416|FG000|Overall Study|Adverse Event|1|||
148928382|NCT00704808|537221416|FG000|Overall Study|Lost to Follow-up|1|||
148928383|NCT00704808|537221416|FG000|Overall Study|Treatment change|1|||
148928384|NCT00473746|537221424|FG000|Period 1 (Phase 1)|Adverse Event|1|||
148928385|NCT00473746|537221425|FG001|Period 1 (Phase 1)|Adverse Event|0|||
148928386|NCT00473746|537221426|FG002|Period 1 (Phase 1)|Adverse Event|0|||
148678552|NCT00068445|536297182|FG000|Randomization|Ineligible|1|||
148678553|NCT00068445|536297183|FG001|Randomization|Ineligible|1|||
148928387|NCT00473746|537221427|FG003|Period 1 (Phase 1)|Adverse Event|0|||
148928388|NCT00473746|537221428|FG004|Period 1 (Phase 1)|Adverse Event|0|||
148928389|NCT00473746|537221424|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
148928390|NCT00473746|537221425|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
148928391|NCT00473746|537221426|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
148928392|NCT00473746|537221427|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
148928393|NCT00473746|537221428|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
148928394|NCT00473746|537221424|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
148928395|NCT00473746|537221425|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
148928396|NCT00473746|537221426|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
148928397|NCT00473746|537221427|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
148928398|NCT00473746|537221428|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
148928399|NCT00473746|537221424|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
148928400|NCT00473746|537221425|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
148928401|NCT00473746|537221426|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
148928402|NCT00473746|537221427|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
148928403|NCT00473746|537221428|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
148928404|NCT00473746|537221424|FG000|Period 1 (Phase 1)|Reason not specified|0|||
148928405|NCT00473746|537221425|FG001|Period 1 (Phase 1)|Reason not specified|1|||
148928406|NCT00473746|537221426|FG002|Period 1 (Phase 1)|Reason not specified|0|||
148928407|NCT00473746|537221427|FG003|Period 1 (Phase 1)|Reason not specified|0|||
148928408|NCT00473746|537221428|FG004|Period 1 (Phase 1)|Reason not specified|0|||
148928409|NCT00473746|537221424|FG000|Period 2 (Phase 2)|Adverse Event|0|||
148928410|NCT00473746|537221425|FG001|Period 2 (Phase 2)|Adverse Event|0|||
148928411|NCT00473746|537221426|FG002|Period 2 (Phase 2)|Adverse Event|0|||
148928412|NCT00473746|537221427|FG003|Period 2 (Phase 2)|Adverse Event|0|||
148928413|NCT00473746|537221428|FG004|Period 2 (Phase 2)|Adverse Event|3|||
148928414|NCT00473746|537221424|FG000|Period 2 (Phase 2)|Death|0|||
148928415|NCT00473746|537221425|FG001|Period 2 (Phase 2)|Death|0|||
148928416|NCT00473746|537221426|FG002|Period 2 (Phase 2)|Death|0|||
148928417|NCT00473746|537221427|FG003|Period 2 (Phase 2)|Death|0|||
148928418|NCT00473746|537221428|FG004|Period 2 (Phase 2)|Death|1|||
148928419|NCT00473746|537221424|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
148928420|NCT00473746|537221425|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
148928421|NCT00473746|537221426|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
148928422|NCT00473746|537221427|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
148928423|NCT00473746|537221428|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
148928424|NCT00473746|537221424|FG000|Period 2 (Phase 2)|Reason not specified|0|||
148928425|NCT00473746|537221425|FG001|Period 2 (Phase 2)|Reason not specified|0|||
148928426|NCT00473746|537221426|FG002|Period 2 (Phase 2)|Reason not specified|0|||
148928427|NCT00473746|537221427|FG003|Period 2 (Phase 2)|Reason not specified|0|||
148928428|NCT00473746|537221428|FG004|Period 2 (Phase 2)|Reason not specified|3|||
148928429|NCT01962922|537221429|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
148928430|NCT01962922|537221430|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
148928431|NCT01962922|537221429|FG000|PK Portion Day 7|non-compliance|1|||
148928432|NCT01962922|537221430|FG001|PK Portion Day 7|non-compliance|0|||
148928433|NCT01962922|537221429|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
148928434|NCT01962922|537221430|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
148928435|NCT01962922|537221429|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
148928436|NCT01962922|537221430|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
148928437|NCT03224546|537221431|FG000|Overall Study|Lost to Follow-up|9|||
148928438|NCT03224546|537221432|FG001|Overall Study|Lost to Follow-up|8|||
148928439|NCT03224546|537221433|FG002|Overall Study|Lost to Follow-up|3|||
148928440|NCT03224546|537221431|FG000|Overall Study|Withdrawal by Subject|7|||
148928441|NCT03224546|537221432|FG001|Overall Study|Withdrawal by Subject|14|||
148928442|NCT03224546|537221433|FG002|Overall Study|Withdrawal by Subject|12|||
148928443|NCT00744471|537221434|FG000|Overall Study|Randomized but not treated|1|||
149013264|NCT03029780|537527888|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
149013265|NCT03029780|537527887|FG000|Overall Study|Participant request to discontinue study treatment|4|||
148928444|NCT00744471|537221435|FG001|Overall Study|Randomized but not treated|1|||
148928445|NCT00744471|537221436|FG002|Overall Study|Randomized but not treated|4|||
148928446|NCT00744471|537221437|FG003|Overall Study|Randomized but not treated|0|||
148928447|NCT00744471|537221434|FG000|Overall Study|Death|0|||
148928448|NCT00744471|537221435|FG001|Overall Study|Death|0|||
148928449|NCT00744471|537221436|FG002|Overall Study|Death|0|||
148928450|NCT00744471|537221437|FG003|Overall Study|Death|1|||
148928451|NCT00744471|537221434|FG000|Overall Study|Adverse Event|6|||
148928452|NCT00744471|537221435|FG001|Overall Study|Adverse Event|7|||
148928453|NCT00744471|537221436|FG002|Overall Study|Adverse Event|5|||
148928454|NCT00744471|537221437|FG003|Overall Study|Adverse Event|9|||
148928455|NCT00744471|537221434|FG000|Overall Study|Withdrawal by Subject|9|||
148928456|NCT00744471|537221435|FG001|Overall Study|Withdrawal by Subject|9|||
148928457|NCT00744471|537221436|FG002|Overall Study|Withdrawal by Subject|15|||
148928458|NCT00744471|537221437|FG003|Overall Study|Withdrawal by Subject|12|||
148928459|NCT00744471|537221434|FG000|Overall Study|Protocol Violation|1|||
148928460|NCT00744471|537221435|FG001|Overall Study|Protocol Violation|4|||
148928461|NCT00744471|537221436|FG002|Overall Study|Protocol Violation|1|||
148928462|NCT00744471|537221437|FG003|Overall Study|Protocol Violation|2|||
148928463|NCT00744471|537221434|FG000|Overall Study|Entered extension study|41|||
148928464|NCT00744471|537221435|FG001|Overall Study|Entered extension study|84|||
148928465|NCT00744471|537221436|FG002|Overall Study|Entered extension study|100|||
148928466|NCT00744471|537221437|FG003|Overall Study|Entered extension study|91|||
148928467|NCT00744471|537221434|FG000|Overall Study|Other|2|||
148928468|NCT00744471|537221435|FG001|Overall Study|Other|3|||
148928469|NCT00744471|537221436|FG002|Overall Study|Other|6|||
148928470|NCT00744471|537221437|FG003|Overall Study|Other|2|||
148928471|NCT00744471|537221434|FG000|Overall Study|Lack of Efficacy|83|||
148928472|NCT00744471|537221435|FG001|Overall Study|Lack of Efficacy|37|||
148928473|NCT00744471|537221436|FG002|Overall Study|Lack of Efficacy|19|||
148928474|NCT00744471|537221437|FG003|Overall Study|Lack of Efficacy|31|||
148928475|NCT00744471|537221434|FG000|Overall Study|Lost to Follow-up|0|||
148928476|NCT00744471|537221435|FG001|Overall Study|Lost to Follow-up|0|||
148928477|NCT00744471|537221436|FG002|Overall Study|Lost to Follow-up|2|||
148928478|NCT00744471|537221437|FG003|Overall Study|Lost to Follow-up|0|||
148928479|NCT04706416|537221438|FG000|Overall Study|Lost to Follow-up|2|||
148928480|NCT04706416|537221439|FG001|Overall Study|Lost to Follow-up|0|||
148928481|NCT00976573|537221447|FG000|Overall Study|Ineligible|0|||
148928482|NCT00976573|537221448|FG001|Overall Study|Ineligible|1|||
148928483|NCT00976573|537221447|FG000|Overall Study|Cancel prior to receiving treatment|4|||
148928484|NCT00976573|537221448|FG001|Overall Study|Cancel prior to receiving treatment|2|||
148928485|NCT02117427|537221449|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
148928486|NCT02117427|537221450|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
148928487|NCT02117427|537221451|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
148928488|NCT02117427|537221449|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
148928489|NCT02117427|537221450|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
148928490|NCT02117427|537221451|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
148928491|NCT02117427|537221449|FG000|Overall Study|Physician Decision|0|||
148928492|NCT02117427|537221450|FG001|Overall Study|Physician Decision|2|||
148928493|NCT02117427|537221451|FG002|Overall Study|Physician Decision|0|||
148928494|NCT02117427|537221449|FG000|Overall Study|No longer meets inclusion criteria|0|||
148928495|NCT02117427|537221450|FG001|Overall Study|No longer meets inclusion criteria|1|||
148928496|NCT02117427|537221451|FG002|Overall Study|No longer meets inclusion criteria|0|||
148928497|NCT02117427|537221449|FG000|Overall Study|Death|0|||
148928498|NCT02117427|537221450|FG001|Overall Study|Death|1|||
148928499|NCT02117427|537221451|FG002|Overall Study|Death|0|||
148928500|NCT02730208|537221452|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
148928501|NCT02730208|537221453|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
148928502|NCT00055471|537221454|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
148928503|NCT00055471|537221455|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
148928504|NCT00055471|537221456|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
148928505|NCT00055471|537221454|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
148928506|NCT00055471|537221455|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
148928507|NCT00055471|537221456|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
148928508|NCT00055471|537221454|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
148928509|NCT00055471|537221455|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
148928510|NCT00055471|537221456|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
148928511|NCT01854944|537221457|FG000|Overall Study|Withdrawal by Subject|0|||
148928512|NCT01854944|537221458|FG001|Overall Study|Withdrawal by Subject|0|||
148928513|NCT01854944|537221459|FG002|Overall Study|Withdrawal by Subject|1|||
148928514|NCT03581786|537223072|FG000|Overall Study|Death|67|||
148928515|NCT03581786|537223073|FG001|Overall Study|Death|47|||
149013266|NCT03029780|537527888|FG001|Overall Study|Participant request to discontinue study treatment|1|||
149013267|NCT03029780|537527887|FG000|Overall Study|Maximum clinical benefit|1|||
148928516|NCT03581786|537223072|FG000|Overall Study|Withdrawal by Subject|2|||
148928517|NCT03581786|537223073|FG001|Overall Study|Withdrawal by Subject|5|||
148928518|NCT03581786|537223072|FG000|Overall Study|Lost to Follow-up|7|||
148928519|NCT03581786|537223073|FG001|Overall Study|Lost to Follow-up|4|||
148928520|NCT03581786|537223072|FG000|Overall Study|reason other than specified above|0|||
148928521|NCT03581786|537223073|FG001|Overall Study|reason other than specified above|1|||
148928522|NCT00510874|537223074|FG000|Overall Study|Withdrawal by Subject|1|||
148928523|NCT00510874|537223075|FG001|Overall Study|Withdrawal by Subject|1|||
148928524|NCT00510874|537223076|FG002|Overall Study|Withdrawal by Subject|0|||
148928525|NCT00510874|537223077|FG003|Overall Study|Withdrawal by Subject|0|||
148928526|NCT00510874|537223078|FG004|Overall Study|Withdrawal by Subject|3|||
148928527|NCT00510874|537223079|FG005|Overall Study|Withdrawal by Subject|0|||
149013268|NCT03029780|537527888|FG001|Overall Study|Maximum clinical benefit|0|||
149013269|NCT03029780|537527887|FG000|Overall Study|Participant no longer meets study criteria|0|||
149013270|NCT03029780|537527888|FG001|Overall Study|Participant no longer meets study criteria|1|||
149013271|NCT03029780|537527887|FG000|Overall Study|Other reasons|6|||
149013272|NCT03029780|537527888|FG001|Overall Study|Other reasons|6|||
149013273|NCT03029780|537527887|FG000|Overall Study|Not reported|1|||
149013274|NCT03029780|537527888|FG001|Overall Study|Not reported|1|||
149013275|NCT03029780|537527887|FG000|Overall Study|Death|2|||
148928528|NCT00510874|537223080|FG006|Overall Study|Withdrawal by Subject|0|||
148928529|NCT00510874|537223074|FG000|Overall Study|Lost to Follow-up|2|||
148928530|NCT00510874|537223075|FG001|Overall Study|Lost to Follow-up|3|||
148928531|NCT00510874|537223076|FG002|Overall Study|Lost to Follow-up|1|||
148928532|NCT00510874|537223077|FG003|Overall Study|Lost to Follow-up|3|||
148928533|NCT00510874|537223078|FG004|Overall Study|Lost to Follow-up|4|||
148928534|NCT00510874|537223079|FG005|Overall Study|Lost to Follow-up|0|||
148928535|NCT00510874|537223080|FG006|Overall Study|Lost to Follow-up|1|||
148928536|NCT00397943|537223086|FG000|Overall Study|Unspecified reasons|12|||
148928537|NCT00397943|537223087|FG001|Overall Study|Unspecified reasons|9|||
148928538|NCT00397943|537223088|FG002|Overall Study|Unspecified reasons|0|||
148928539|NCT00397943|537223089|FG003|Overall Study|Unspecified reasons|0|||
148928540|NCT00397943|537223090|FG004|Overall Study|Unspecified reasons|0|||
149013276|NCT03029780|537527888|FG001|Overall Study|Death|6|||
149013277|NCT00197028|537527889|FG000|Overall Study|Adverse Event|2|||
148928541|NCT02806973|537223093|FG000|Period 1|Withdrawal by Subject|0|||
148928542|NCT02806973|537223094|FG001|Period 1|Withdrawal by Subject|2|||
148928543|NCT02806973|537223095|FG002|Period 1|Withdrawal by Subject|1|||
148928544|NCT02806973|537223096|FG003|Period 1|Withdrawal by Subject|1|||
148928545|NCT02806973|537223093|FG000|Period 1|Adverse Event|0|||
148928546|NCT02806973|537223094|FG001|Period 1|Adverse Event|0|||
149013278|NCT00197028|537527890|FG001|Overall Study|Adverse Event|2|||
149013279|NCT00197028|537527889|FG000|Overall Study|Protocol Violation|2|||
149013280|NCT00197028|537527890|FG001|Overall Study|Protocol Violation|1|||
148928547|NCT02806973|537223095|FG002|Period 1|Adverse Event|0|||
149013281|NCT00197028|537527889|FG000|Overall Study|Withdrawal by Subject|8|||
149013282|NCT00197028|537527890|FG001|Overall Study|Withdrawal by Subject|12|||
149013283|NCT00197028|537527889|FG000|Overall Study|Lost to Follow-up|1|||
149013284|NCT00197028|537527890|FG001|Overall Study|Lost to Follow-up|0|||
148928548|NCT02806973|537223096|FG003|Period 1|Adverse Event|1|||
148928549|NCT02806973|537223093|FG000|Period 3|Withdrawal by Subject|0|||
148928550|NCT02806973|537223094|FG001|Period 3|Withdrawal by Subject|0|||
148928551|NCT02806973|537223095|FG002|Period 3|Withdrawal by Subject|0|||
148928552|NCT02806973|537223096|FG003|Period 3|Withdrawal by Subject|3|||
148928553|NCT02806973|537223093|FG000|Period 3|Adverse Event|0|||
149013285|NCT00197028|537527889|FG000|Overall Study|Other|3|||
149013286|NCT00197028|537527890|FG001|Overall Study|Other|6|||
149013287|NCT00178256|537527891|FG000|Overall Study|Adverse Event|2|||
149013288|NCT00178256|537527892|FG001|Overall Study|Adverse Event|0|||
149013289|NCT00178256|537527893|FG002|Overall Study|Adverse Event|0|||
149013290|NCT00178256|537527894|FG003|Overall Study|Adverse Event|0|||
149013291|NCT00178256|537527891|FG000|Overall Study|Death|0|||
149013292|NCT00178256|537527892|FG001|Overall Study|Death|1|||
149013293|NCT00178256|537527893|FG002|Overall Study|Death|0|||
149013294|NCT00178256|537527894|FG003|Overall Study|Death|1|||
149013295|NCT00178256|537527891|FG000|Overall Study|Cancer progression|2|||
149013296|NCT00178256|537527892|FG001|Overall Study|Cancer progression|0|||
149013297|NCT00178256|537527893|FG002|Overall Study|Cancer progression|0|||
149013298|NCT00178256|537527894|FG003|Overall Study|Cancer progression|1|||
149013299|NCT01763788|537527895|FG000|Overall Study|Lost to Follow-up|0|||
149013300|NCT01763788|537527896|FG001|Overall Study|Lost to Follow-up|0|||
149013301|NCT01763788|537527897|FG002|Overall Study|Lost to Follow-up|1|||
149013302|NCT01763788|537527898|FG003|Overall Study|Lost to Follow-up|0|||
149013303|NCT03321006|537527899|FG000|Overall Study|Death|1|||
149013304|NCT03321006|537527900|FG001|Overall Study|Death|0|||
149013305|NCT03321006|537527899|FG000|Overall Study|Lack of Efficacy|1|||
148928554|NCT02806973|537223094|FG001|Period 3|Adverse Event|0|||
149013306|NCT03321006|537527900|FG001|Overall Study|Lack of Efficacy|0|||
148928555|NCT02806973|537223095|FG002|Period 3|Adverse Event|1|||
148928556|NCT02806973|537223096|FG003|Period 3|Adverse Event|0|||
148928557|NCT04209426|537223099|FG000|Overall Study|Lost to Follow-up|3|||
148928558|NCT04209426|537223100|FG001|Overall Study|Lost to Follow-up|2|||
148928559|NCT00900601|537223107|FG000|Overall Study|Physician Decision|1|||
148928560|NCT01052844|537223116|FG000|Overall Study|Adverse Event|0|||
149013307|NCT03303469|537527901|FG000|Overall Study|Lost to Follow-up|2|||
149013308|NCT03560258|537527904|FG000|Overall Study|Lost to Follow-up|3|||
149173520|NCT00473694|538106472|FG002|Overall Study|Lost to Follow-up|0|||
149173521|NCT00473694|538106473|FG003|Overall Study|Lost to Follow-up|1|||
149173522|NCT02468193|538106476|FG000|Overall Study|Adverse Event|4|||
149173523|NCT02468193|538106476|FG000|Overall Study|Subject/ Guardian decision|2|||
149173524|NCT00742781|538106477|FG000|Overall Study|Withdrawal by Subject|3|||
149173525|NCT04723537|538106480|FG000|Overall Study|Withdrawal by Subject|3|||
149173526|NCT04723537|538106481|FG001|Overall Study|Withdrawal by Subject|0|||
148928561|NCT01052844|537223117|FG001|Overall Study|Adverse Event|1|||
148928562|NCT01241240|537223118|FG000|Overall Study|Adverse Event|5|||
148928563|NCT01241240|537223119|FG001|Overall Study|Adverse Event|4|||
148928564|NCT01241240|537223118|FG000|Overall Study|Lost to Follow-up|2|||
148928565|NCT01241240|537223119|FG001|Overall Study|Lost to Follow-up|4|||
148928566|NCT01241240|537223118|FG000|Overall Study|Personal Reasons|1|||
148928567|NCT01241240|537223119|FG001|Overall Study|Personal Reasons|1|||
148928568|NCT01439347|537223120|FG000|Overall Study|Death|10|||
148928569|NCT01439347|537223121|FG001|Overall Study|Death|9|||
148928570|NCT01439347|537223120|FG000|Overall Study|Withdrawal by Subject|0|||
148928571|NCT01439347|537223121|FG001|Overall Study|Withdrawal by Subject|1|||
148928572|NCT01439347|537223120|FG000|Overall Study|Physician Decision|1|||
148928573|NCT01439347|537223121|FG001|Overall Study|Physician Decision|0|||
148928574|NCT01439347|537223120|FG000|Overall Study|Sponsor Terminated Study|2|||
148928575|NCT01439347|537223121|FG001|Overall Study|Sponsor Terminated Study|3|||
148928576|NCT02325791|537223125|FG000|Overall Study|Adverse Event|0|||
148928577|NCT02325791|537223126|FG001|Overall Study|Adverse Event|1|||
148928578|NCT02325791|537223127|FG002|Overall Study|Adverse Event|1|||
148928579|NCT02325791|537223128|FG003|Overall Study|Adverse Event|0|||
148928580|NCT02325791|537223125|FG000|Overall Study|Death|0|||
148928581|NCT02325791|537223126|FG001|Overall Study|Death|3|||
148928582|NCT02325791|537223127|FG002|Overall Study|Death|0|||
148928583|NCT02325791|537223128|FG003|Overall Study|Death|1|||
148928584|NCT02325791|537223125|FG000|Overall Study|Lost to Follow-up|0|||
148928585|NCT02325791|537223126|FG001|Overall Study|Lost to Follow-up|15|||
148928586|NCT02325791|537223127|FG002|Overall Study|Lost to Follow-up|14|||
148928587|NCT02325791|537223128|FG003|Overall Study|Lost to Follow-up|9|||
148928588|NCT02325791|537223125|FG000|Overall Study|Physician Decision|0|||
148928589|NCT02325791|537223126|FG001|Overall Study|Physician Decision|1|||
148928590|NCT02325791|537223127|FG002|Overall Study|Physician Decision|1|||
148928591|NCT02325791|537223128|FG003|Overall Study|Physician Decision|0|||
148928592|NCT02325791|537223125|FG000|Overall Study|Protocol Violation|0|||
148928593|NCT02325791|537223126|FG001|Overall Study|Protocol Violation|0|||
148928594|NCT02325791|537223127|FG002|Overall Study|Protocol Violation|1|||
149173527|NCT04723537|538106482|FG002|Overall Study|Withdrawal by Subject|0|||
148928595|NCT02325791|537223128|FG003|Overall Study|Protocol Violation|0|||
148928596|NCT02325791|537223125|FG000|Overall Study|Withdrawal by Subject|0|||
148928597|NCT02325791|537223126|FG001|Overall Study|Withdrawal by Subject|5|||
148928598|NCT02325791|537223127|FG002|Overall Study|Withdrawal by Subject|8|||
148928599|NCT02325791|537223128|FG003|Overall Study|Withdrawal by Subject|16|||
148928600|NCT01298193|537223129|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
148928601|NCT01298193|537223129|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
148928602|NCT01298193|537223129|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
148928603|NCT01298193|537223129|FG000|Efficacy Phase (Second Cycle)|Death|1|||
148928604|NCT03475875|537223130|FG000|Period 1|Lost to Follow-up|1|||
148928605|NCT03475875|537223131|FG001|Period 1|Lost to Follow-up|0|||
148928606|NCT03475875|537223130|FG000|Period 1|Adverse Event|2|||
148928607|NCT03475875|537223131|FG001|Period 1|Adverse Event|1|||
148928608|NCT03475875|537223130|FG000|Period 2|Adverse Event|3|||
148928609|NCT03475875|537223131|FG001|Period 2|Adverse Event|0|||
148928610|NCT03475875|537223130|FG000|Period 2|Protocol Violation|0|||
148928611|NCT03475875|537223131|FG001|Period 2|Protocol Violation|1|||
148928612|NCT04025710|537223132|FG000|Overall Study|Death|3|||
148928613|NCT04025710|537223132|FG000|Overall Study|Lost to Follow-up|5|||
148928614|NCT04025710|537223132|FG000|Overall Study|Withdrawal by Subject|1|||
148928615|NCT04025710|537223132|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
148928616|NCT04025710|537223132|FG000|Overall Study|Drop-out according to protocol|34|||
148928617|NCT00938964|537223135|FG000|Overall Study|Death|3|||
148928618|NCT00938964|537223136|FG001|Overall Study|Death|3|||
148928619|NCT00938964|537223135|FG000|Overall Study|Lost to Follow-up|2|||
148928620|NCT00938964|537223136|FG001|Overall Study|Lost to Follow-up|3|||
148928621|NCT00938964|537223135|FG000|Overall Study|Withdrawal by Subject|22|||
148928622|NCT00938964|537223136|FG001|Overall Study|Withdrawal by Subject|18|||
148928623|NCT00938964|537223135|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
148928624|NCT00938964|537223136|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
148928625|NCT00995865|537223138|FG000|Overall Study|Protocol Violation|2|||
148928626|NCT00995865|537223139|FG001|Overall Study|Protocol Violation|0|||
148928627|NCT00995865|537223140|FG002|Overall Study|Protocol Violation|0|||
148928628|NCT00995865|537223138|FG000|Overall Study|Lost to Follow-up|0|||
148928629|NCT00995865|537223139|FG001|Overall Study|Lost to Follow-up|0|||
148928630|NCT00995865|537223140|FG002|Overall Study|Lost to Follow-up|1|||
148928631|NCT00410202|537223142|FG000|On-Treatment|Continuing treatment|69|||
148928632|NCT00410202|537223143|FG001|On-Treatment|Continuing treatment|71|||
148928633|NCT00410202|537223144|FG002|On-Treatment|Continuing treatment|66|||
148928634|NCT00410202|537223142|FG000|On-Treatment|Adverse Event|1|||
148928635|NCT00410202|537223143|FG001|On-Treatment|Adverse Event|3|||
148928636|NCT00410202|537223144|FG002|On-Treatment|Adverse Event|2|||
148928637|NCT00410202|537223142|FG000|On-Treatment|Death|1|||
148928638|NCT00410202|537223143|FG001|On-Treatment|Death|0|||
148928639|NCT00410202|537223144|FG002|On-Treatment|Death|0|||
148928640|NCT00410202|537223142|FG000|On-Treatment|Lost to Follow-up|1|||
148928641|NCT00410202|537223143|FG001|On-Treatment|Lost to Follow-up|0|||
148928642|NCT00410202|537223144|FG002|On-Treatment|Lost to Follow-up|1|||
148928643|NCT00410202|537223142|FG000|On-Treatment|Lack of Efficacy|1|||
148928644|NCT00410202|537223143|FG001|On-Treatment|Lack of Efficacy|4|||
148928645|NCT00410202|537223144|FG002|On-Treatment|Lack of Efficacy|0|||
148928646|NCT00410202|537223142|FG000|On-Treatment|Withdrawal by Subject|2|||
148928647|NCT00410202|537223143|FG001|On-Treatment|Withdrawal by Subject|1|||
148928648|NCT00410202|537223144|FG002|On-Treatment|Withdrawal by Subject|1|||
148928649|NCT00410202|537223142|FG000|On-Treatment|Other Reason|0|||
148928650|NCT00410202|537223143|FG001|On-Treatment|Other Reason|0|||
148928651|NCT00410202|537223144|FG002|On-Treatment|Other Reason|1|||
148928652|NCT00410202|537223142|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
148928653|NCT00410202|537223143|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
148928654|NCT00410202|537223144|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
148928655|NCT00410202|537223142|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
148928656|NCT00410202|537223143|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
148928657|NCT00410202|537223144|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
148928658|NCT00410202|537223142|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
148928659|NCT00410202|537223143|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
148928660|NCT00410202|537223144|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
148928661|NCT00144027|537223145|FG000|Overall Study|Lost to Follow-up|1|||
148928662|NCT00144027|537223146|FG001|Overall Study|Lost to Follow-up|3|||
148928663|NCT00144027|537223145|FG000|Overall Study|Withdrawal by Subject|2|||
148928664|NCT00144027|537223146|FG001|Overall Study|Withdrawal by Subject|2|||
148928665|NCT00144027|537223145|FG000|Overall Study|did not complete baseline assessment|0|||
148928666|NCT00144027|537223146|FG001|Overall Study|did not complete baseline assessment|6|||
148928667|NCT05080660|537223147|FG000|Overall Study|Adverse Event|4|||
148928668|NCT05080660|537223148|FG001|Overall Study|Adverse Event|0|||
148928669|NCT05080660|537223147|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
148928670|NCT05080660|537223148|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
148928671|NCT05080660|537223147|FG000|Overall Study|Physician Decision|1|||
148928672|NCT05080660|537223148|FG001|Overall Study|Physician Decision|0|||
148928673|NCT05080660|537223147|FG000|Overall Study|Protocol Deviation|2|||
148928674|NCT05080660|537223148|FG001|Overall Study|Protocol Deviation|0|||
148928675|NCT05080660|537223147|FG000|Overall Study|Withdrawal by Subject|5|||
149173528|NCT04723537|538106480|FG000|Overall Study|Physician Decision|0|||
149173529|NCT04723537|538106481|FG001|Overall Study|Physician Decision|0|||
149173530|NCT04723537|538106482|FG002|Overall Study|Physician Decision|1|||
149173531|NCT04723537|538106480|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
149173532|NCT04723537|538106481|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
149173533|NCT04723537|538106482|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
149173534|NCT04645797|538106489|FG000|Overall Study|Disease Progression|3|||
149173535|NCT04645797|538106490|FG001|Overall Study|Disease Progression|3|||
149173536|NCT04645797|538106491|FG002|Overall Study|Disease Progression|1|||
149173537|NCT04645797|538106492|FG003|Overall Study|Disease Progression|0|||
149173538|NCT04645797|538106493|FG004|Overall Study|Disease Progression|0|||
149173539|NCT04645797|538106494|FG005|Overall Study|Disease Progression|0|||
149173540|NCT04645797|538106495|FG006|Overall Study|Disease Progression|0|||
148806623|NCT00109343|536770974|FG001|Overall Study|Other|2|||
148806624|NCT00109343|536770975|FG002|Overall Study|Other|1|||
148806625|NCT01721798|536770976|FG000|Overall Study|Death|0|||
148806626|NCT01721798|536770977|FG001|Overall Study|Death|0|||
148806627|NCT01721798|536770978|FG002|Overall Study|Death|1|||
148806628|NCT01721798|536770979|FG003|Overall Study|Death|1|||
148806629|NCT01721798|536770976|FG000|Overall Study|Lost to Follow-up|2|||
148806630|NCT01721798|536770977|FG001|Overall Study|Lost to Follow-up|2|||
148806631|NCT01721798|536770978|FG002|Overall Study|Lost to Follow-up|9|||
148806632|NCT01721798|536770979|FG003|Overall Study|Lost to Follow-up|9|||
148806633|NCT01721798|536770976|FG000|Overall Study|Pregnancy|0|||
148806634|NCT01721798|536770977|FG001|Overall Study|Pregnancy|0|||
148806635|NCT01721798|536770978|FG002|Overall Study|Pregnancy|1|||
148806636|NCT01721798|536770979|FG003|Overall Study|Pregnancy|1|||
148806637|NCT01721798|536770976|FG000|Overall Study|Withdrawal by Subject|1|||
148806638|NCT01721798|536770977|FG001|Overall Study|Withdrawal by Subject|0|||
148806639|NCT01721798|536770978|FG002|Overall Study|Withdrawal by Subject|2|||
148806640|NCT01721798|536770979|FG003|Overall Study|Withdrawal by Subject|1|||
148806641|NCT01721798|536770976|FG000|Overall Study|Not eligible for 24 month visit|1|||
148806642|NCT01721798|536770977|FG001|Overall Study|Not eligible for 24 month visit|0|||
148806643|NCT01721798|536770978|FG002|Overall Study|Not eligible for 24 month visit|8|||
148806644|NCT01721798|536770979|FG003|Overall Study|Not eligible for 24 month visit|7|||
148806645|NCT00336544|536770980|FG000|Overall Study|Lack of Efficacy|8|||
148806646|NCT00336544|536770981|FG001|Overall Study|Lack of Efficacy|5|||
148806647|NCT00336544|536770980|FG000|Overall Study|Adverse Event|4|||
148806648|NCT00336544|536770981|FG001|Overall Study|Adverse Event|9|||
148806649|NCT00336544|536770980|FG000|Overall Study|Withdrawal by Subject|4|||
148806650|NCT00336544|536770981|FG001|Overall Study|Withdrawal by Subject|3|||
148806651|NCT00336544|536770980|FG000|Overall Study|Other|3|||
148806652|NCT00336544|536770981|FG001|Overall Study|Other|5|||
148806653|NCT01649765|536770982|FG000|Overall Study|Adverse Event|5|||
148806654|NCT01649765|536770983|FG001|Overall Study|Adverse Event|3|||
148806655|NCT01649765|536770982|FG000|Overall Study|Lack of Efficacy|1|||
148806656|NCT01649765|536770983|FG001|Overall Study|Lack of Efficacy|1|||
148806657|NCT01649765|536770982|FG000|Overall Study|Physician Decision|0|||
148806658|NCT01649765|536770983|FG001|Overall Study|Physician Decision|3|||
148806659|NCT01649765|536770982|FG000|Overall Study|Protocol Violation|1|||
148806660|NCT01649765|536770983|FG001|Overall Study|Protocol Violation|0|||
148806661|NCT01649765|536770982|FG000|Overall Study|Withdrawal by Subject|2|||
148806662|NCT01649765|536770983|FG001|Overall Study|Withdrawal by Subject|1|||
148806663|NCT00961064|536770984|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
148806664|NCT00961064|536770984|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
148806665|NCT00961064|536770984|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
148806666|NCT00961064|536770984|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
148806667|NCT00961064|536770984|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
148806668|NCT00961064|536770984|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
148806669|NCT00961064|536770984|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
148806670|NCT00961064|536770984|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
148806671|NCT01408641|536770985|FG000|Overall Study|Physician Decision|1|||
148806672|NCT01408641|536770986|FG001|Overall Study|Physician Decision|0|||
148806673|NCT00715208|536770987|FG000|Overall Study|Withdrawal by Subject|1|||
148806674|NCT00715208|536770988|FG001|Overall Study|Withdrawal by Subject|1|||
149173541|NCT04645797|538106489|FG000|Overall Study|Death|3|||
148928676|NCT05080660|537223148|FG001|Overall Study|Withdrawal by Subject|2|||
149013309|NCT03560258|537527905|FG001|Overall Study|Lost to Follow-up|0|||
149013310|NCT03560258|537527906|FG002|Overall Study|Lost to Follow-up|0|||
149173542|NCT04645797|538106490|FG001|Overall Study|Death|1|||
149173543|NCT04645797|538106491|FG002|Overall Study|Death|0|||
149173544|NCT04645797|538106492|FG003|Overall Study|Death|0|||
149173545|NCT04645797|538106493|FG004|Overall Study|Death|0|||
149173546|NCT04645797|538106494|FG005|Overall Study|Death|0|||
149173547|NCT04645797|538106495|FG006|Overall Study|Death|0|||
149173548|NCT00942409|538106498|FG000|Overall Study|Lack of Efficacy|1|||
149173549|NCT00942409|538106498|FG000|Overall Study|study drug unavailable|2|||
149173550|NCT02015819|538106501|FG000|Overall Study|Rickham catheter was misaligned|0|||
149173551|NCT02015819|538106502|FG001|Overall Study|Rickham catheter was misaligned|0|||
149173552|NCT02015819|538106503|FG002|Overall Study|Rickham catheter was misaligned|0|||
149173553|NCT02015819|538106504|FG003|Overall Study|Rickham catheter was misaligned|1|||
149173554|NCT01697215|538106507|FG000|Overall Study|Physician Decision|5|||
149173555|NCT01697215|538106507|FG000|Overall Study|Malfunction|9|||
148806675|NCT00715208|536770987|FG000|Overall Study|Adverse Event|0|||
148806676|NCT00715208|536770988|FG001|Overall Study|Adverse Event|6|||
148806677|NCT00715208|536770987|FG000|Overall Study|Lack of Efficacy|0|||
148806678|NCT00715208|536770988|FG001|Overall Study|Lack of Efficacy|2|||
148806679|NCT01648764|536770989|FG000|Overall Study|Progressive Disease|0|||
148806680|NCT01648764|536770990|FG001|Overall Study|Progressive Disease|1|||
148806681|NCT01648764|536770991|FG002|Overall Study|Progressive Disease|0|||
148806682|NCT01648764|536770992|FG003|Overall Study|Progressive Disease|0|||
148806683|NCT01648764|536770993|FG004|Overall Study|Progressive Disease|0|||
148806684|NCT01648764|536770994|FG005|Overall Study|Progressive Disease|1|||
148806685|NCT01648764|536770995|FG006|Overall Study|Progressive Disease|1|||
148806686|NCT01648764|536770996|FG007|Overall Study|Progressive Disease|0|||
148806687|NCT01648764|536770997|FG008|Overall Study|Progressive Disease|0|||
148806688|NCT01648764|536770998|FG009|Overall Study|Progressive Disease|2|||
148806689|NCT01648764|536770999|FG010|Overall Study|Progressive Disease|0|||
148806690|NCT01648764|536771000|FG011|Overall Study|Progressive Disease|1|||
148806691|NCT01648764|536771001|FG012|Overall Study|Progressive Disease|2|||
148806692|NCT01648764|536771002|FG013|Overall Study|Progressive Disease|1|||
148806693|NCT01648764|536770989|FG000|Overall Study|Adverse Event|0|||
148806694|NCT01648764|536770990|FG001|Overall Study|Adverse Event|0|||
148806695|NCT01648764|536770991|FG002|Overall Study|Adverse Event|0|||
148806696|NCT01648764|536770992|FG003|Overall Study|Adverse Event|0|||
148806697|NCT01648764|536770993|FG004|Overall Study|Adverse Event|0|||
148806698|NCT01648764|536770994|FG005|Overall Study|Adverse Event|1|||
148806699|NCT01648764|536770995|FG006|Overall Study|Adverse Event|0|||
148806700|NCT01648764|536770996|FG007|Overall Study|Adverse Event|0|||
148806701|NCT01648764|536770997|FG008|Overall Study|Adverse Event|0|||
148806702|NCT01648764|536770998|FG009|Overall Study|Adverse Event|1|||
148806703|NCT01648764|536770999|FG010|Overall Study|Adverse Event|0|||
148806704|NCT01648764|536771000|FG011|Overall Study|Adverse Event|3|||
148806705|NCT01648764|536771001|FG012|Overall Study|Adverse Event|1|||
148806706|NCT01648764|536771002|FG013|Overall Study|Adverse Event|1|||
148806707|NCT01648764|536770989|FG000|Overall Study|Death|0|||
148806708|NCT01648764|536770990|FG001|Overall Study|Death|0|||
148806709|NCT01648764|536770991|FG002|Overall Study|Death|0|||
148806710|NCT01648764|536770992|FG003|Overall Study|Death|0|||
148806711|NCT01648764|536770993|FG004|Overall Study|Death|0|||
148806712|NCT01648764|536770994|FG005|Overall Study|Death|0|||
148806713|NCT01648764|536770995|FG006|Overall Study|Death|1|||
148806714|NCT01648764|536770996|FG007|Overall Study|Death|0|||
148806715|NCT01648764|536770997|FG008|Overall Study|Death|0|||
148806716|NCT01648764|536770998|FG009|Overall Study|Death|0|||
148806717|NCT01648764|536770999|FG010|Overall Study|Death|0|||
148806718|NCT01648764|536771000|FG011|Overall Study|Death|0|||
148806719|NCT01648764|536771001|FG012|Overall Study|Death|0|||
148806720|NCT01648764|536771002|FG013|Overall Study|Death|1|||
148806721|NCT01648764|536770989|FG000|Overall Study|Withdrawal by Subject|0|||
148806722|NCT01648764|536770990|FG001|Overall Study|Withdrawal by Subject|0|||
148806723|NCT01648764|536770991|FG002|Overall Study|Withdrawal by Subject|0|||
148806724|NCT01648764|536770992|FG003|Overall Study|Withdrawal by Subject|0|||
148806725|NCT01648764|536770993|FG004|Overall Study|Withdrawal by Subject|0|||
148806726|NCT01648764|536770994|FG005|Overall Study|Withdrawal by Subject|0|||
148806727|NCT01648764|536770995|FG006|Overall Study|Withdrawal by Subject|2|||
148806728|NCT01648764|536770996|FG007|Overall Study|Withdrawal by Subject|0|||
148806729|NCT01648764|536770997|FG008|Overall Study|Withdrawal by Subject|0|||
148806730|NCT01648764|536770998|FG009|Overall Study|Withdrawal by Subject|0|||
148806731|NCT01648764|536770999|FG010|Overall Study|Withdrawal by Subject|0|||
148806732|NCT01648764|536771000|FG011|Overall Study|Withdrawal by Subject|0|||
148806733|NCT01648764|536771001|FG012|Overall Study|Withdrawal by Subject|1|||
148806734|NCT01648764|536771002|FG013|Overall Study|Withdrawal by Subject|0|||
149173556|NCT01697215|538106507|FG000|Overall Study|CXR not available|9|||
148806735|NCT01648764|536770989|FG000|Overall Study|Investigator Decision|0|||
148806736|NCT01648764|536770990|FG001|Overall Study|Investigator Decision|0|||
149173557|NCT01929083|538106508|FG000|Intervention 1|Lost to Follow-up|2|||
148678554|NCT00068445|536297182|FG000|Treatment|Refused Further Treatment|13|||
148678555|NCT00068445|536297183|FG001|Treatment|Refused Further Treatment|10|||
148678556|NCT00068445|536297182|FG000|Treatment|Adverse Event|7|||
148678557|NCT00068445|536297183|FG001|Treatment|Adverse Event|1|||
148678558|NCT00068445|536297182|FG000|Treatment|Other (Specifics not available)|9|||
148928677|NCT04221230|537223153|FG000|Overall Study|Lost to Follow-up|12|||
148928678|NCT04221230|537223154|FG001|Overall Study|Lost to Follow-up|12|||
148928679|NCT04221230|537223153|FG000|Overall Study|Protocol Violation|2|||
148928680|NCT04221230|537223154|FG001|Overall Study|Protocol Violation|2|||
148928681|NCT04221230|537223153|FG000|Overall Study|Adverse Event|0|||
148928682|NCT04221230|537223154|FG001|Overall Study|Adverse Event|8|||
148928683|NCT04221230|537223153|FG000|Overall Study|Physician Decision|1|||
148928684|NCT04221230|537223154|FG001|Overall Study|Physician Decision|0|||
148928685|NCT04221230|537223153|FG000|Overall Study|Withdrawal by Subject|13|||
148928686|NCT04221230|537223154|FG001|Overall Study|Withdrawal by Subject|11|||
148928687|NCT04221230|537223153|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148928688|NCT04221230|537223154|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148928689|NCT04221230|537223153|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148928690|NCT04221230|537223154|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
148928691|NCT04221230|537223153|FG000|Overall Study|Pregnancy|0|||
148928692|NCT04221230|537223154|FG001|Overall Study|Pregnancy|1|||
148928693|NCT04221230|537223153|FG000|Overall Study|Other|1|||
148928694|NCT04221230|537223154|FG001|Overall Study|Other|2|||
148928695|NCT03119701|537223158|FG000|6-day Dosing|Death|4|||
148928696|NCT03119701|537223159|FG001|6-day Dosing|Death|1|||
148928697|NCT03119701|537223158|FG000|6-day Dosing|Adverse Event|3|||
148928698|NCT03119701|537223159|FG001|6-day Dosing|Adverse Event|0|||
148928699|NCT03119701|537223158|FG000|6-day Dosing|Physician Decision|0|||
148928700|NCT03119701|537223159|FG001|6-day Dosing|Physician Decision|1|||
148678559|NCT00068445|536297183|FG001|Treatment|Other (Specifics not available)|5|||
148678560|NCT01155284|536297184|FG000|Overall Study|Withdrawal by Subject|4|||
148678561|NCT01155284|536297185|FG001|Overall Study|Withdrawal by Subject|3|||
148928701|NCT03119701|537223158|FG000|6-day Dosing|Withdrawal by Subject|0|||
148928702|NCT03119701|537223159|FG001|6-day Dosing|Withdrawal by Subject|1|||
148928703|NCT03119701|537223158|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
148928704|NCT03119701|537223159|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
148928705|NCT00596362|537223161|FG000|Overall Study|Progressive Disease|1|||
148928706|NCT00817479|537223162|FG000|Overall Study|Physician Decision|1|||
148678562|NCT01155284|536297184|FG000|Overall Study|Lost to Follow-up|1|||
148928707|NCT00817479|537223163|FG001|Overall Study|Physician Decision|1|||
148928708|NCT02793128|537223169|FG000|Overall Study|Death|4|||
148928709|NCT02793128|537223169|FG000|Overall Study|Withdrawal by Subject|2|||
148928710|NCT02793128|537223169|FG000|Overall Study|Physician Decision|1|||
148928711|NCT02793128|537223169|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
149173558|NCT01929083|538106509|FG001|Intervention 1|Lost to Follow-up|0|||
149173559|NCT01929083|538106508|FG000|Intervention 1|Nonadherent to study medications|1|||
149173560|NCT01929083|538106509|FG001|Intervention 1|Nonadherent to study medications|0|||
149173561|NCT01929083|538106508|FG000|Intervention 2|Adverse Event|0|||
149173562|NCT01929083|538106509|FG001|Intervention 2|Adverse Event|1|||
149173563|NCT02599402|538106510|FG000|Overall Study|Disease progression|153|||
149173564|NCT02599402|538106510|FG000|Overall Study|Study drug toxicity|201|||
149173565|NCT02599402|538106510|FG000|Overall Study|Death|26|||
149173566|NCT02599402|538106510|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
149173567|NCT02599402|538106510|FG000|Overall Study|Participant request to discontinue study treatment|13|||
149173568|NCT02599402|538106510|FG000|Overall Study|Participant withdrew consent|5|||
149173569|NCT02599402|538106510|FG000|Overall Study|Lost to Follow-up|1|||
149173570|NCT02599402|538106510|FG000|Overall Study|Maximum Clinical Benefit|7|||
149173571|NCT02599402|538106510|FG000|Overall Study|Poor/non-compliance|1|||
149173572|NCT02599402|538106510|FG000|Overall Study|Pregnancy|1|||
149173573|NCT02599402|538106510|FG000|Overall Study|Participant no longer met study criteria|7|||
149173574|NCT02599402|538106510|FG000|Overall Study|Other Reasons|95|||
149173575|NCT05340504|538106515|FG000|Overall Study|Withdrawal by Subject|1|||
149173576|NCT05340504|538106516|FG001|Overall Study|Withdrawal by Subject|0|||
149173577|NCT03068715|538106517|FG000|Overall Study|No longer met inclusion criteria|1|||
149173578|NCT03068715|538106518|FG001|Overall Study|No longer met inclusion criteria|0|||
149173579|NCT02286102|538106519|FG000|Overall Study|Screen Failure|1|||
149173580|NCT02286102|538106520|FG001|Overall Study|Screen Failure|1|||
149173581|NCT03830281|538106521|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
149173582|NCT03830281|538106522|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
149173583|NCT03830281|538106521|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
149173584|NCT03830281|538106522|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
149173585|NCT03830281|538106521|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
149173586|NCT03830281|538106522|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
149173587|NCT03830281|538106521|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
149173588|NCT03830281|538106522|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
149173589|NCT03830281|538106521|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
149173590|NCT03830281|538106522|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
148928712|NCT02793128|537223169|FG000|Overall Study|Patient elected nephroureterectomy|1|||
148928713|NCT02359851|537223170|FG000|Overall Study|Death|1|||
148928714|NCT02359851|537223170|FG000|Overall Study|Disease progression|1|||
148928715|NCT00282347|537223173|FG000|Treatment Period|Death|2|||
148928716|NCT00282347|537223174|FG001|Treatment Period|Death|0|||
148928717|NCT00282347|537223173|FG000|Treatment Period|Lost to Follow-up|2|||
148928718|NCT00282347|537223174|FG001|Treatment Period|Lost to Follow-up|5|||
148928719|NCT00282347|537223173|FG000|Treatment Period|Withdrawal by Subject|1|||
148928720|NCT00282347|537223174|FG001|Treatment Period|Withdrawal by Subject|3|||
148928721|NCT00282347|537223173|FG000|Treatment Period|Physician Decision|0|||
148928722|NCT00282347|537223174|FG001|Treatment Period|Physician Decision|1|||
148928723|NCT00282347|537223173|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
148928724|NCT00282347|537223174|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
148928725|NCT00282347|537223173|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
148928726|NCT00282347|537223174|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
148928727|NCT00282347|537223173|FG000|Safety Follow-up Period|Physician Decision|1|||
148928728|NCT00282347|537223174|FG001|Safety Follow-up Period|Physician Decision|1|||
148928729|NCT00282347|537223173|FG000|Safety Follow-up Period|Protocol Deviation|0|||
148928730|NCT00282347|537223174|FG001|Safety Follow-up Period|Protocol Deviation|2|||
148928731|NCT00282347|537223173|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
148928732|NCT00282347|537223174|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
148928733|NCT00282347|537223173|FG000|B Cell Follow-up Period|Physician Decision|1|||
148928734|NCT00282347|537223174|FG001|B Cell Follow-up Period|Physician Decision|0|||
148928735|NCT00282347|537223173|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
148928736|NCT00282347|537223174|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
148928737|NCT02101112|537223175|FG000|Overall Study|Adverse Event|0|||
148928738|NCT02101112|537223176|FG001|Overall Study|Adverse Event|0|||
148928739|NCT02101112|537223177|FG002|Overall Study|Adverse Event|1|||
148928740|NCT02101112|537223178|FG003|Overall Study|Adverse Event|0|||
148928741|NCT02101112|537223179|FG004|Overall Study|Adverse Event|0|||
148928742|NCT02101112|537223180|FG005|Overall Study|Adverse Event|0|||
148928743|NCT02101112|537223175|FG000|Overall Study|Withdrawal by Subject|0|||
148928744|NCT02101112|537223176|FG001|Overall Study|Withdrawal by Subject|0|||
148928745|NCT02101112|537223177|FG002|Overall Study|Withdrawal by Subject|0|||
148928746|NCT02101112|537223178|FG003|Overall Study|Withdrawal by Subject|0|||
148928747|NCT02101112|537223179|FG004|Overall Study|Withdrawal by Subject|1|||
148928748|NCT02101112|537223180|FG005|Overall Study|Withdrawal by Subject|0|||
148928749|NCT02125604|537223181|FG000|Overall Study|Other|4|||
148928750|NCT02125604|537223181|FG000|Overall Study|Investigator Decision|1|||
148928751|NCT02125604|537223181|FG000|Overall Study|Lost to Follow-up|2|||
148928752|NCT02125604|537223181|FG000|Overall Study|Consent Withdrawn|4|||
148928753|NCT02125604|537223181|FG000|Overall Study|Adverse Event|20|||
148928754|NCT04340063|537223182|FG000|Overall Study|Withdrawal by Subject|1|||
148928755|NCT04340063|537223183|FG001|Overall Study|Withdrawal by Subject|2|||
148928756|NCT04340063|537223182|FG000|Overall Study|Lost to Follow-up|3|||
148928757|NCT04340063|537223183|FG001|Overall Study|Lost to Follow-up|1|||
148928758|NCT04340063|537223182|FG000|Overall Study|Protocol Violation|0|||
148928759|NCT04340063|537223183|FG001|Overall Study|Protocol Violation|1|||
148928760|NCT02782923|537223184|FG000|Overall Study|Lost to Follow-up|15|||
148928761|NCT02418156|537223185|FG000|Overall Study|Lost to Follow-up|12|||
148928762|NCT02418156|537223185|FG000|Overall Study|Death|2|||
148928763|NCT02418156|537223185|FG000|Overall Study|Physician Decision|1|||
148928764|NCT02418156|537223185|FG000|Overall Study|Withdrawal by Subject|1|||
148928765|NCT02418156|537223185|FG000|Overall Study|Subject refused to return|1|||
148928766|NCT00993044|537223188|FG000|Irinotecan 50 mg|Physician Decision|1|||
148928767|NCT00734747|537223190|FG000|SRS Procedure|No staples placed|3|||
148928768|NCT00734747|537223190|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
148928769|NCT05063318|537223196|FG000|Overall Study|Progressive disease|2|||
148928770|NCT05063318|537223197|FG001|Overall Study|Progressive disease|0|||
148928771|NCT05063318|537223198|FG002|Overall Study|Progressive disease|3|||
148928772|NCT05063318|537223196|FG000|Overall Study|Compassionate use|1|||
148928773|NCT05063318|537223197|FG001|Overall Study|Compassionate use|3|||
148928774|NCT05063318|537223198|FG002|Overall Study|Compassionate use|3|||
148928775|NCT05063318|537223196|FG000|Overall Study|Adverse Event|0|||
148928776|NCT05063318|537223197|FG001|Overall Study|Adverse Event|1|||
148928777|NCT05063318|537223198|FG002|Overall Study|Adverse Event|0|||
148928778|NCT05063318|537223196|FG000|Overall Study|Withdrawal by Subject|0|||
148928779|NCT05063318|537223197|FG001|Overall Study|Withdrawal by Subject|1|||
148928780|NCT05063318|537223198|FG002|Overall Study|Withdrawal by Subject|0|||
148928781|NCT03670836|537223199|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
148928782|NCT03670836|537223200|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
148928783|NCT03670836|537223199|FG000|Per Protocol Population (PP)|Physician Decision|9|||
149013311|NCT03560258|537527904|FG000|Overall Study|Protocol Violation|0|||
148928784|NCT03670836|537223200|FG001|Per Protocol Population (PP)|Physician Decision|10|||
148928785|NCT03670836|537223199|FG000|Per Protocol Population (PP)|Physician Decision|4|||
148928786|NCT03670836|537223200|FG001|Per Protocol Population (PP)|Physician Decision|6|||
148928787|NCT03670836|537223199|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
148928788|NCT03670836|537223200|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
148928789|NCT03287635|537223201|FG000|Overall Study|Lost to Follow-up|5|||
148928790|NCT03287635|537223201|FG000|Overall Study|Withdrawal by Subject|1|||
148928791|NCT03287635|537223201|FG000|Overall Study|Physician Decision|1|||
148928792|NCT00323869|537223204|FG000|Overall Study|Death|1|||
148928793|NCT01865084|537224805|FG000|Double Blind Period (DB)|Adverse Event|2|||
148928794|NCT01865084|537224806|FG001|Double Blind Period (DB)|Adverse Event|2|||
148928795|NCT01865084|537224807|FG002|Double Blind Period (DB)|Adverse Event|1|||
148928796|NCT01865084|537224805|FG000|Double Blind Period (DB)|Protocol Violation|0|||
148928797|NCT01865084|537224806|FG001|Double Blind Period (DB)|Protocol Violation|0|||
148928798|NCT01865084|537224807|FG002|Double Blind Period (DB)|Protocol Violation|1|||
148928799|NCT01865084|537224805|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
148928800|NCT01865084|537224806|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
148928801|NCT01865084|537224807|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
148928802|NCT01865084|537224805|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
148928803|NCT01865084|537224806|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
148928804|NCT01865084|537224807|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
148928805|NCT01865084|537224805|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
148928806|NCT01865084|537224806|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
148928807|NCT01865084|537224807|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
148928808|NCT01865084|537224805|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
148928809|NCT01865084|537224806|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
148928810|NCT01865084|537224807|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
148928811|NCT01865084|537224805|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
148928812|NCT01865084|537224806|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
148928813|NCT01865084|537224807|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
148928814|NCT01865084|537224805|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
148928815|NCT01865084|537224806|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
148928816|NCT01865084|537224807|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
148928817|NCT01865084|537224805|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
148928818|NCT01865084|537224806|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
148928819|NCT01865084|537224807|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
148928820|NCT01751802|537224808|FG000|Overall Study|Adverse Event|4|||
148928821|NCT01751802|537224809|FG001|Overall Study|Adverse Event|2|||
148928822|NCT00521001|537224810|FG000|Overall Study|Ineligible|1|||
148928823|NCT02821910|537224811|FG000|Overall Study|Withdrawal by Subject|0|||
148928824|NCT02821910|537224812|FG001|Overall Study|Withdrawal by Subject|0|||
148928825|NCT02821910|537224813|FG002|Overall Study|Withdrawal by Subject|1|||
148928826|NCT02821910|537224814|FG003|Overall Study|Withdrawal by Subject|0|||
148928827|NCT02821910|537224815|FG004|Overall Study|Withdrawal by Subject|0|||
148928828|NCT02821910|537224816|FG005|Overall Study|Withdrawal by Subject|1|||
148928829|NCT02821910|537224811|FG000|Overall Study|Other than specified|1|||
148928830|NCT02821910|537224812|FG001|Overall Study|Other than specified|0|||
148928831|NCT02821910|537224813|FG002|Overall Study|Other than specified|1|||
148928832|NCT02821910|537224814|FG003|Overall Study|Other than specified|0|||
148928833|NCT02821910|537224815|FG004|Overall Study|Other than specified|0|||
148928834|NCT02821910|537224816|FG005|Overall Study|Other than specified|0|||
148928835|NCT01082640|537224817|FG000|Overall Study|Adverse Event|9|||
148928836|NCT01082640|537224818|FG001|Overall Study|Adverse Event|5|||
148928837|NCT01082640|537224819|FG002|Overall Study|Adverse Event|3|||
148928838|NCT01082640|537224817|FG000|Overall Study|Withdrawal by Subject|3|||
148928839|NCT01082640|537224818|FG001|Overall Study|Withdrawal by Subject|3|||
148678563|NCT01155284|536297185|FG001|Overall Study|Lost to Follow-up|2|||
148678564|NCT01155284|536297184|FG000|Overall Study|Physician Decision|1|||
148678565|NCT01155284|536297185|FG001|Overall Study|Physician Decision|0|||
148678566|NCT01155284|536297184|FG000|Overall Study|Adverse Event|1|||
148678567|NCT01155284|536297185|FG001|Overall Study|Adverse Event|0|||
148678568|NCT01896700|536297186|FG000|Overall Study|Adverse Event|4|||
148678569|NCT01896700|536297187|FG001|Overall Study|Adverse Event|5|||
148928840|NCT01082640|537224819|FG002|Overall Study|Withdrawal by Subject|2|||
148928841|NCT01082640|537224817|FG000|Overall Study|Major protocol deviation|3|||
149173591|NCT03830281|538106521|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
149173592|NCT03830281|538106522|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
148678570|NCT01896700|536297186|FG000|Overall Study|Withdrawal by Subject|0|||
148678571|NCT01896700|536297187|FG001|Overall Study|Withdrawal by Subject|1|||
148806737|NCT01648764|536770991|FG002|Overall Study|Investigator Decision|0|||
148928842|NCT01082640|537224818|FG001|Overall Study|Major protocol deviation|3|||
148928843|NCT01082640|537224819|FG002|Overall Study|Major protocol deviation|0|||
149173593|NCT03830281|538106521|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
149173594|NCT03830281|538106522|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
149173595|NCT03830281|538106521|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
149173596|NCT03830281|538106522|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
149173597|NCT03830281|538106521|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
149173598|NCT03830281|538106522|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
149173599|NCT00201851|538106524|FG000|Overall Study|Lost to Follow-up|2|||
149173600|NCT00201851|538106525|FG001|Overall Study|Lost to Follow-up|1|||
149173601|NCT00201851|538106526|FG002|Overall Study|Lost to Follow-up|0|||
149173602|NCT00201851|538106524|FG000|Overall Study|Ineligible post enrollment|6|||
149173603|NCT00201851|538106525|FG001|Overall Study|Ineligible post enrollment|1|||
149173604|NCT00201851|538106526|FG002|Overall Study|Ineligible post enrollment|1|||
149173605|NCT03293680|538106527|FG000|Overall Study|Death|1|||
149173606|NCT03293680|538106527|FG000|Overall Study|Did not meet inclusion criteria|8|||
149173607|NCT00922935|538106528|FG000|Overall Study|Protocol Violation|0|||
149173608|NCT00922935|538106529|FG001|Overall Study|Protocol Violation|3|||
149173609|NCT00922935|538106530|FG002|Overall Study|Protocol Violation|0|||
149173610|NCT00922935|538106528|FG000|Overall Study|Physician Decision|1|||
149173611|NCT00922935|538106529|FG001|Overall Study|Physician Decision|1|||
149173612|NCT00922935|538106530|FG002|Overall Study|Physician Decision|0|||
149173613|NCT00922935|538106528|FG000|Overall Study|Lost to Follow-up|0|||
149173614|NCT00922935|538106529|FG001|Overall Study|Lost to Follow-up|1|||
149173615|NCT00922935|538106530|FG002|Overall Study|Lost to Follow-up|0|||
149173616|NCT02201940|538106531|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
149173617|NCT02201940|538106532|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
148928844|NCT01082640|537224817|FG000|Overall Study|Lost to Follow-up|0|||
148928845|NCT01082640|537224818|FG001|Overall Study|Lost to Follow-up|3|||
148928846|NCT01082640|537224819|FG002|Overall Study|Lost to Follow-up|0|||
148928847|NCT01082640|537224817|FG000|Overall Study|Other|2|||
148928848|NCT01082640|537224818|FG001|Overall Study|Other|1|||
148928849|NCT01082640|537224819|FG002|Overall Study|Other|3|||
148928850|NCT01025154|537224824|FG000|Overall Study|Lost to Follow-up|1|||
148928851|NCT01025154|537224824|FG000|Overall Study|Withdrawal by Subject|1|||
148928852|NCT01810432|537224825|FG000|Washout|Protocol Violation|0|||
148928853|NCT01810432|537224826|FG001|Washout|Protocol Violation|1|||
148928854|NCT01810432|537224825|FG000|Washout|Adverse Event|1|||
148928855|NCT01810432|537224826|FG001|Washout|Adverse Event|0|||
148928856|NCT01810432|537224825|FG000|Period 2|Withdrawal by Subject|2|||
148928857|NCT01810432|537224826|FG001|Period 2|Withdrawal by Subject|1|||
148928858|NCT01810432|537224825|FG000|Period 2|Physician Decision|1|||
148928859|NCT01810432|537224826|FG001|Period 2|Physician Decision|0|||
148928860|NCT01810432|537224825|FG000|Period 2|Lost to Follow-up|1|||
148928861|NCT01810432|537224826|FG001|Period 2|Lost to Follow-up|1|||
148928862|NCT00057954|537224827|FG000|Overall Study|Death|1|||
148928863|NCT00057954|537224827|FG000|Overall Study|Disease progression|1|||
148928864|NCT00559754|537224828|FG000|Overall Study|Disease progression|1|||
148928865|NCT00559754|537224828|FG000|Overall Study|Adverse Event|5|||
148928866|NCT00559754|537224828|FG000|Overall Study|Protocol Violation|1|||
148928867|NCT00559754|537224828|FG000|Overall Study|Investigator criteria|2|||
148928868|NCT00559754|537224828|FG000|Overall Study|Withdrawal by Subject|2|||
148928869|NCT01264016|537224829|FG000|Overall Study|Withdrawal by Subject|1|||
148928870|NCT01264016|537224829|FG000|Overall Study|Felt faint at sight of blood|1|||
148928871|NCT02117414|537224830|FG000|Overall Study|Death|5|||
148928872|NCT02117414|537224831|FG001|Overall Study|Death|2|||
149173618|NCT02201940|538106531|FG000|Overall Study|Lack of Efficacy|2|||
149173619|NCT02201940|538106532|FG001|Overall Study|Lack of Efficacy|113|||
149173620|NCT02201940|538106531|FG000|Overall Study|Lost to Follow-up|5|||
148678572|NCT00123487|536297188|FG000|Randomized|Death prior to starting treatment|0|||
149173621|NCT02201940|538106532|FG001|Overall Study|Lost to Follow-up|0|||
149173622|NCT02201940|538106531|FG000|Overall Study|Withdrew Consent|2|||
149173623|NCT02201940|538106532|FG001|Overall Study|Withdrew Consent|1|||
149173624|NCT02201940|538106531|FG000|Overall Study|Investigator's Discretion|1|||
148928873|NCT02117414|537224830|FG000|Overall Study|Withdrawal by Subject|10|||
148928874|NCT02117414|537224831|FG001|Overall Study|Withdrawal by Subject|4|||
148928875|NCT01629706|537224832|FG000|Phase 1 PureVision|Screen Failure|4|||
148928876|NCT01629706|537224832|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
148928877|NCT01629706|537224832|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
148928878|NCT01629706|537224832|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
148678573|NCT00123487|536297189|FG001|Randomized|Death prior to starting treatment|1|||
148678574|NCT00123487|536297188|FG000|Randomized|SAE prior to starting treatment|1|||
148678575|NCT00123487|536297189|FG001|Randomized|SAE prior to starting treatment|0|||
148678576|NCT00123487|536297188|FG000|Treated With Study Drug|Adverse Event|23|||
148678577|NCT00123487|536297189|FG001|Treated With Study Drug|Adverse Event|22|||
149173625|NCT02201940|538106532|FG001|Overall Study|Investigator's Discretion|1|||
149173626|NCT02201940|538106531|FG000|Overall Study|Death|1|||
149173627|NCT02201940|538106532|FG001|Overall Study|Death|0|||
149173628|NCT02201940|538106531|FG000|Overall Study|Adverse Event|0|||
149173629|NCT02201940|538106532|FG001|Overall Study|Adverse Event|1|||
149173630|NCT00636818|538106533|FG000|Overall Study|Adverse Event|1|||
148678578|NCT00123487|536297188|FG000|Treated With Study Drug|Disease Progression|141|||
149173631|NCT00636818|538106533|FG000|Overall Study|Lost to Follow-up|2|||
149173632|NCT00636818|538106533|FG000|Overall Study|Entry Criteria Exclusion|3|||
149173633|NCT00636818|538106533|FG000|Overall Study|Protocol Violation|1|||
149173634|NCT00636818|538106533|FG000|Overall Study|Withdrawal by Subject|4|||
149173635|NCT00074958|538106535|FG000|Overall Study|Adverse Event|1|||
149173636|NCT02690701|538106539|FG000|Treatment Period 1|Adverse Event|2|||
149173637|NCT02690701|538106540|FG001|Treatment Period 1|Adverse Event|2|||
149173638|NCT02690701|538106539|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149173639|NCT02690701|538106540|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149173640|NCT02690701|538106539|FG000|Treatment Period 2|Adverse Event|2|||
148678579|NCT00123487|536297189|FG001|Treated With Study Drug|Disease Progression|122|||
148678580|NCT00123487|536297188|FG000|Treated With Study Drug|Physician Decision|8|||
148678581|NCT00123487|536297189|FG001|Treated With Study Drug|Physician Decision|9|||
148678582|NCT00123487|536297188|FG000|Treated With Study Drug|Other|59|||
148678583|NCT00123487|536297189|FG001|Treated With Study Drug|Other|58|||
148678584|NCT00123487|536297188|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
148678585|NCT00123487|536297189|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
148678586|NCT00123487|536297188|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
148678587|NCT00123487|536297189|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
148678588|NCT00123487|536297188|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
148678589|NCT00123487|536297189|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
148678590|NCT00423488|536297190|FG000|Overall Study|No evidence of study drug intake|2|||
148678591|NCT00423488|536297191|FG001|Overall Study|No evidence of study drug intake|1|||
148678592|NCT00423488|536297190|FG000|Overall Study|No post baseline data|3|||
148678593|NCT00423488|536297191|FG001|Overall Study|No post baseline data|0|||
148678594|NCT00886782|536297192|FG000|Overall Study|Disease progression|3|||
148678595|NCT00886782|536297193|FG001|Overall Study|Disease progression|3|||
148806738|NCT01648764|536770992|FG003|Overall Study|Investigator Decision|0|||
148806739|NCT01648764|536770993|FG004|Overall Study|Investigator Decision|0|||
148806740|NCT01648764|536770994|FG005|Overall Study|Investigator Decision|0|||
148806741|NCT01648764|536770995|FG006|Overall Study|Investigator Decision|1|||
148806742|NCT01648764|536770996|FG007|Overall Study|Investigator Decision|0|||
148806743|NCT01648764|536770997|FG008|Overall Study|Investigator Decision|0|||
148806744|NCT01648764|536770998|FG009|Overall Study|Investigator Decision|0|||
148806745|NCT01648764|536770999|FG010|Overall Study|Investigator Decision|0|||
148806746|NCT01648764|536771000|FG011|Overall Study|Investigator Decision|1|||
148806747|NCT01648764|536771001|FG012|Overall Study|Investigator Decision|0|||
148806748|NCT01648764|536771002|FG013|Overall Study|Investigator Decision|0|||
148806749|NCT01316614|536771003|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
148806750|NCT01316614|536771003|FG000|Overall Study|Cytology slides not available for review|4|||
148806751|NCT01316614|536771003|FG000|Overall Study|Cystic lesion|5|||
148806752|NCT01316614|536771003|FG000|Overall Study|Inadequate number of passes|2|||
148806753|NCT01316614|536771003|FG000|Overall Study|Medically unstable|1|||
148806754|NCT00076570|536771004|FG000|Overall Study|Drug intolerance|8|||
148806755|NCT00076570|536771005|FG001|Overall Study|Drug intolerance|8|||
148806756|NCT03427411|536771006|FG000|Overall Study|Screen failure - platelets too low|0|||
149173641|NCT02690701|538106540|FG001|Treatment Period 2|Adverse Event|0|||
149173642|NCT02690701|538106539|FG000|Treatment Period 2|Lack of Efficacy|1|||
149173643|NCT02690701|538106540|FG001|Treatment Period 2|Lack of Efficacy|0|||
149173644|NCT02690701|538106539|FG000|Treatment Period 2|Lost to Follow-up|0|||
149173645|NCT02690701|538106540|FG001|Treatment Period 2|Lost to Follow-up|2|||
148678596|NCT00886782|536297194|FG002|Overall Study|Disease progression|3|||
148678597|NCT00886782|536297192|FG000|Overall Study|Study drug toxicity|0|||
148678598|NCT00886782|536297193|FG001|Overall Study|Study drug toxicity|0|||
148678599|NCT00886782|536297194|FG002|Overall Study|Study drug toxicity|1|||
148678600|NCT00886782|536297192|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
148678601|NCT00886782|536297193|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
148928879|NCT01629706|537224832|FG000|Phase 2 Habitual|Screen Failure|6|||
148928880|NCT01629706|537224832|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
148928881|NCT01629706|537224832|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
148928882|NCT01629706|537224832|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
148928883|NCT01629706|537224832|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
148928884|NCT02537574|537224834|FG000|Overall Study|Adverse Event|1|||
148928885|NCT02537574|537224835|FG001|Overall Study|Adverse Event|3|||
148928886|NCT02537574|537224836|FG002|Overall Study|Adverse Event|2|||
148928887|NCT02537574|537224834|FG000|Overall Study|Lost to Follow-up|40|||
148928888|NCT02537574|537224835|FG001|Overall Study|Lost to Follow-up|51|||
148928889|NCT02537574|537224836|FG002|Overall Study|Lost to Follow-up|55|||
148928890|NCT02537574|537224834|FG000|Overall Study|Noncompliance with study drug|0|||
148928891|NCT02537574|537224835|FG001|Overall Study|Noncompliance with study drug|1|||
148928892|NCT02537574|537224836|FG002|Overall Study|Noncompliance with study drug|1|||
148928893|NCT02537574|537224834|FG000|Overall Study|Physician Decision|2|||
148928894|NCT02537574|537224835|FG001|Overall Study|Physician Decision|0|||
148928895|NCT02537574|537224836|FG002|Overall Study|Physician Decision|0|||
148928896|NCT02537574|537224834|FG000|Overall Study|Protocol Violation|4|||
148928897|NCT02537574|537224835|FG001|Overall Study|Protocol Violation|2|||
148928898|NCT02537574|537224836|FG002|Overall Study|Protocol Violation|3|||
148928899|NCT02537574|537224834|FG000|Overall Study|Withdrawal by Subject|37|||
148928900|NCT02537574|537224835|FG001|Overall Study|Withdrawal by Subject|27|||
148928901|NCT02537574|537224836|FG002|Overall Study|Withdrawal by Subject|29|||
148928902|NCT02537574|537224834|FG000|Overall Study|Lack of Efficacy|14|||
148928903|NCT02537574|537224835|FG001|Overall Study|Lack of Efficacy|16|||
148928904|NCT02537574|537224836|FG002|Overall Study|Lack of Efficacy|15|||
148928905|NCT02537574|537224834|FG000|Overall Study|Duplicate Patient|1|||
148928906|NCT02537574|537224835|FG001|Overall Study|Duplicate Patient|0|||
148928907|NCT02537574|537224836|FG002|Overall Study|Duplicate Patient|0|||
148928908|NCT02537574|537224834|FG000|Overall Study|Patient not Stable|0|||
148928909|NCT02537574|537224835|FG001|Overall Study|Patient not Stable|1|||
148928910|NCT02537574|537224836|FG002|Overall Study|Patient not Stable|0|||
148928911|NCT02537574|537224834|FG000|Overall Study|Incarceration|0|||
148928912|NCT02537574|537224835|FG001|Overall Study|Incarceration|1|||
148928913|NCT02537574|537224836|FG002|Overall Study|Incarceration|0|||
148928914|NCT02537574|537224834|FG000|Overall Study|Failed Naloxone Challenge|0|||
148928915|NCT02537574|537224835|FG001|Overall Study|Failed Naloxone Challenge|1|||
148928916|NCT02537574|537224836|FG002|Overall Study|Failed Naloxone Challenge|0|||
148928917|NCT02537574|537224834|FG000|Overall Study|Transportation Issues|0|||
148928918|NCT02537574|537224835|FG001|Overall Study|Transportation Issues|0|||
148928919|NCT02537574|537224836|FG002|Overall Study|Transportation Issues|1|||
148928920|NCT02537574|537224834|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
148928921|NCT02537574|537224835|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
148928922|NCT02537574|537224836|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
148928923|NCT02537574|537224834|FG000|Overall Study|Noncompliance with Protocol|0|||
148928924|NCT02537574|537224835|FG001|Overall Study|Noncompliance with Protocol|0|||
148928925|NCT02537574|537224836|FG002|Overall Study|Noncompliance with Protocol|1|||
148928926|NCT02663687|537224837|FG000|Overall Study|Adverse Event|1|||
148678602|NCT00886782|536297194|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
148678603|NCT01255722|536297195|FG000|Overall Study|Adverse Event|0|||
148928927|NCT02663687|537224838|FG001|Overall Study|Adverse Event|0|||
148928928|NCT02663687|537224839|FG002|Overall Study|Adverse Event|0|||
148928929|NCT02663687|537224840|FG003|Overall Study|Adverse Event|0|||
148928930|NCT02663687|537224841|FG004|Overall Study|Adverse Event|0|||
148928931|NCT02663687|537224837|FG000|Overall Study|Other|1|||
148928932|NCT02663687|537224838|FG001|Overall Study|Other|0|||
148928933|NCT02663687|537224839|FG002|Overall Study|Other|1|||
148928934|NCT02663687|537224840|FG003|Overall Study|Other|0|||
148928935|NCT02663687|537224841|FG004|Overall Study|Other|0|||
148928936|NCT01151098|537224842|FG000|Overall Study|Adverse Event|82|||
148928937|NCT01151098|537224842|FG000|Overall Study|Lost to Follow-up|6|||
148928938|NCT01151098|537224842|FG000|Overall Study|Lack of Efficacy|15|||
148928939|NCT01151098|537224842|FG000|Overall Study|Protocol Violation|1|||
148928940|NCT01151098|537224842|FG000|Overall Study|Miscellaneous|13|||
148928941|NCT03343067|537224845|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
148928942|NCT03343067|537224846|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
148928943|NCT03343067|537224847|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
148928944|NCT00542451|537224848|FG000|Overall Study|Adverse Event|31|||
148928945|NCT00542451|537224848|FG000|Overall Study|Withdrawal by Subject|30|||
148678604|NCT01255722|536297196|FG001|Overall Study|Adverse Event|1|||
148928946|NCT00542451|537224848|FG000|Overall Study|Physician Decision|4|||
149173646|NCT02690701|538106539|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149173647|NCT02690701|538106540|FG001|Treatment Period 2|Withdrawal by Subject|2|||
149173648|NCT02690701|538106539|FG000|Treatment Period 2|Protocol Violation|0|||
149173649|NCT02690701|538106540|FG001|Treatment Period 2|Protocol Violation|1|||
149173650|NCT02115308|538106541|FG000|Overall Study|Safety Screening|2|||
149173651|NCT02115308|538106542|FG001|Overall Study|Safety Screening|2|||
149173652|NCT00749203|538106543|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
149173653|NCT00749203|538106544|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
149173654|NCT00749203|538106543|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
149173655|NCT00749203|538106544|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
149173656|NCT00749203|538106543|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
149173657|NCT00749203|538106544|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
149173658|NCT00749203|538106543|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
149173659|NCT00749203|538106544|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
149173660|NCT00749203|538106543|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
149173661|NCT00749203|538106544|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
149173662|NCT00749203|538106543|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
149173663|NCT00749203|538106544|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
149173664|NCT02698189|538106545|FG000|Overall Study|Physician Decision|3|||
149173665|NCT02698189|538106546|FG001|Overall Study|Physician Decision|0|||
149173666|NCT02698189|538106545|FG000|Overall Study|Progressive disease|0|||
149173667|NCT02698189|538106546|FG001|Overall Study|Progressive disease|5|||
149173668|NCT02698189|538106545|FG000|Overall Study|Study terminated by sponsor|0|||
149173669|NCT02698189|538106546|FG001|Overall Study|Study terminated by sponsor|1|||
149173670|NCT01564784|538106560|FG000|Overall Study|Other|1|||
149173671|NCT01564784|538106561|FG001|Overall Study|Other|0|||
149173672|NCT01564784|538106560|FG000|Overall Study|Subject refused further follow-up|1|||
149173673|NCT01564784|538106561|FG001|Overall Study|Subject refused further follow-up|6|||
149173674|NCT01564784|538106560|FG000|Overall Study|Lost to Follow-up|1|||
149173675|NCT01564784|538106561|FG001|Overall Study|Lost to Follow-up|1|||
149173676|NCT01564784|538106560|FG000|Overall Study|Death|131|||
149173677|NCT01564784|538106561|FG001|Overall Study|Death|126|||
149173678|NCT01624142|538106562|FG000|Overall Study|Withdrawal by Subject|14|||
149173679|NCT01624142|538106563|FG001|Overall Study|Withdrawal by Subject|4|||
149173680|NCT01624142|538106562|FG000|Overall Study|Death|3|||
149173681|NCT01624142|538106563|FG001|Overall Study|Death|6|||
149173682|NCT01624142|538106562|FG000|Overall Study|Study Closure|12|||
149173683|NCT01624142|538106563|FG001|Overall Study|Study Closure|6|||
149173684|NCT01624142|538106562|FG000|Overall Study|Lost to Follow-up|2|||
149173685|NCT01624142|538106563|FG001|Overall Study|Lost to Follow-up|0|||
149173686|NCT01624142|538106562|FG000|Overall Study|Other|1|||
149173687|NCT01624142|538106563|FG001|Overall Study|Other|0|||
149173688|NCT01053429|538106564|FG000|Overall Study|Adverse Event|64|||
149173689|NCT01053429|538106564|FG000|Overall Study|Other|309|||
149173690|NCT00947349|538106565|FG000|Triple Treatment Combination Period|Adverse Event|0|||
149173691|NCT00947349|538106566|FG001|Triple Treatment Combination Period|Adverse Event|1|||
149173692|NCT00947349|538106567|FG002|Triple Treatment Combination Period|Adverse Event|0|||
149173693|NCT00947349|538106568|FG003|Triple Treatment Combination Period|Adverse Event|0|||
149173694|NCT00947349|538106565|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
149173695|NCT00947349|538106566|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
149173696|NCT00947349|538106567|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
149173697|NCT00947349|538106568|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
149173698|NCT00947349|538106565|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
149173699|NCT00947349|538106566|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
149173700|NCT00947349|538106567|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
149173701|NCT00947349|538106568|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
149173702|NCT00947349|538106565|FG000|Overall Study Standard of Care|Other|0|||
149173703|NCT00947349|538106566|FG001|Overall Study Standard of Care|Other|0|||
149173704|NCT00947349|538106567|FG002|Overall Study Standard of Care|Other|0|||
149173705|NCT00947349|538106568|FG003|Overall Study Standard of Care|Other|1|||
149173706|NCT03430310|538106569|FG000|Overall Study|Protocol Violation|2|||
149173707|NCT03430310|538106570|FG001|Overall Study|Protocol Violation|0|||
149173708|NCT03430310|538106569|FG000|Overall Study|Withdrawal by Subject|3|||
149173709|NCT03430310|538106570|FG001|Overall Study|Withdrawal by Subject|2|||
149173710|NCT03430310|538106569|FG000|Overall Study|COVID shutdown March 2020|0|||
149173711|NCT03430310|538106570|FG001|Overall Study|COVID shutdown March 2020|1|||
149173712|NCT01446809|538106571|FG000|Overall Study|Adverse Event|0|||
149173713|NCT01446809|538106572|FG001|Overall Study|Adverse Event|0|||
149173714|NCT01446809|538106573|FG002|Overall Study|Adverse Event|1|||
149173715|NCT01446809|538106571|FG000|Overall Study|Failure to complete study procedures|0|||
149173716|NCT01446809|538106572|FG001|Overall Study|Failure to complete study procedures|0|||
149173717|NCT01446809|538106573|FG002|Overall Study|Failure to complete study procedures|1|||
149173718|NCT01331161|538106574|FG000|Overall Study|Physician Decision|1|||
149173719|NCT01331161|538106575|FG001|Overall Study|Physician Decision|0|||
149173720|NCT01331161|538106574|FG000|Overall Study|Lost to Follow-up|0|||
149173721|NCT01331161|538106575|FG001|Overall Study|Lost to Follow-up|1|||
149173722|NCT01331161|538106574|FG000|Overall Study|Pregnancy|0|||
149173723|NCT01331161|538106575|FG001|Overall Study|Pregnancy|1|||
149173724|NCT03972488|538106576|FG000|Overall Study|Progressive disease|42|||
149173725|NCT03972488|538106577|FG001|Overall Study|Progressive disease|44|||
149173726|NCT03972488|538106576|FG000|Overall Study|Physician Decision|13|||
149173727|NCT03972488|538106577|FG001|Overall Study|Physician Decision|7|||
149173728|NCT03972488|538106576|FG000|Overall Study|Adverse Event|8|||
149173729|NCT03972488|538106577|FG001|Overall Study|Adverse Event|1|||
149173730|NCT03972488|538106576|FG000|Overall Study|Death|4|||
149173731|NCT03972488|538106577|FG001|Overall Study|Death|4|||
149173732|NCT03972488|538106576|FG000|Overall Study|Withdrawal by Subject|3|||
149173733|NCT03972488|538106577|FG001|Overall Study|Withdrawal by Subject|4|||
149173734|NCT03972488|538106576|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
149173735|NCT03972488|538106577|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
149173736|NCT02770807|538106583|FG000|Overall Study|Adverse Event|3|||
149173737|NCT02770807|538106584|FG001|Overall Study|Adverse Event|3|||
149173738|NCT02770807|538106585|FG002|Overall Study|Adverse Event|1|||
149173739|NCT02770807|538106583|FG000|Overall Study|Withdrawal by Subject|7|||
149173740|NCT02770807|538106584|FG001|Overall Study|Withdrawal by Subject|3|||
149173741|NCT02770807|538106585|FG002|Overall Study|Withdrawal by Subject|4|||
149173742|NCT02770807|538106583|FG000|Overall Study|Other|0|||
149173743|NCT02770807|538106584|FG001|Overall Study|Other|1|||
149173744|NCT02770807|538106585|FG002|Overall Study|Other|0|||
149173745|NCT02770807|538106583|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
149173746|NCT02770807|538106584|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
149173747|NCT02770807|538106585|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
149173748|NCT02770807|538106583|FG000|Overall Study|Physician Decision|0|||
149173749|NCT02770807|538106584|FG001|Overall Study|Physician Decision|0|||
149173750|NCT02770807|538106585|FG002|Overall Study|Physician Decision|1|||
149173751|NCT00222105|538106588|FG000|Overall Study|Removed due to wrong diagnosis|1|||
149173752|NCT00222105|538106588|FG000|Overall Study|Withdrawal by Subject|1|||
149173753|NCT00222105|538106588|FG000|Overall Study|Adverse Event|8|||
149173754|NCT00222105|538106588|FG000|Overall Study|Treatment delays|2|||
149173755|NCT00222105|538106588|FG000|Overall Study|Death|2|||
149173756|NCT00374556|538108704|FG000|Overall Study|Lost to Follow-up|1|||
149173757|NCT00374556|538108705|FG001|Overall Study|Lost to Follow-up|0|||
149173758|NCT00374556|538108704|FG000|Overall Study|Removed at baseline due to medical cond|0|||
149173759|NCT00374556|538108705|FG001|Overall Study|Removed at baseline due to medical cond|1|||
149173760|NCT01416181|538108706|FG000|Part 1|Other|10|||
149173761|NCT01416181|538108707|FG001|Part 1|Other|24|||
148928947|NCT00542451|537224848|FG000|Overall Study|Recurrent disease|1|||
148928948|NCT00542451|537224848|FG000|Overall Study|unknown reason|1|||
148928949|NCT00542451|537224848|FG000|Overall Study|Death|2|||
148928950|NCT00542451|537224848|FG000|Overall Study|Lost to Follow-up|10|||
148928951|NCT00116168|537224849|FG000|Overall Study|Lost to Follow-up|6|||
148928952|NCT00116168|537224850|FG001|Overall Study|Lost to Follow-up|5|||
148928953|NCT00116168|537224851|FG002|Overall Study|Lost to Follow-up|0|||
149173762|NCT01416181|538108706|FG000|Part 1|Death|0|||
149173763|NCT01416181|538108707|FG001|Part 1|Death|1|||
149173764|NCT01416181|538108706|FG000|Part 1|Investigator Decision|7|||
149173765|NCT01416181|538108707|FG001|Part 1|Investigator Decision|6|||
149173766|NCT01416181|538108706|FG000|Part 1|Withdrawal by Subject|74|||
149173767|NCT01416181|538108707|FG001|Part 1|Withdrawal by Subject|48|||
149173768|NCT01416181|538108706|FG000|Part 1|Lack of Efficacy|16|||
149173769|NCT01416181|538108707|FG001|Part 1|Lack of Efficacy|8|||
149173770|NCT01416181|538108706|FG000|Part 1|Lost to Follow-up|1|||
149173771|NCT01416181|538108707|FG001|Part 1|Lost to Follow-up|1|||
148928954|NCT00116168|537224852|FG003|Overall Study|Lost to Follow-up|0|||
148928955|NCT02788474|537224853|FG000|Double Blind Treatment Period|Not treated|1|||
148928956|NCT02788474|537224854|FG001|Double Blind Treatment Period|Not treated|0|||
148928957|NCT02788474|537224853|FG000|Double Blind Treatment Period|Patient's refusal|3|||
148928958|NCT02788474|537224854|FG001|Double Blind Treatment Period|Patient's refusal|0|||
148928959|NCT02788474|537224853|FG000|Double Blind Treatment Period|Adverse Event|6|||
148928960|NCT02788474|537224854|FG001|Double Blind Treatment Period|Adverse Event|4|||
148928961|NCT02788474|537224853|FG000|Open Label Treatment Period|Adverse Event|29|||
148928962|NCT02788474|537224854|FG001|Open Label Treatment Period|Adverse Event|9|||
148928963|NCT02788474|537224853|FG000|Open Label Treatment Period|Other than reason specified|1|||
148928964|NCT02788474|537224854|FG001|Open Label Treatment Period|Other than reason specified|0|||
148928965|NCT02788474|537224853|FG000|Open Label Treatment Period|Patient's refusal|1|||
148928966|NCT02788474|537224854|FG001|Open Label Treatment Period|Patient's refusal|3|||
148928967|NCT02788474|537224853|FG000|Open Label Treatment Period|Non-compliance|1|||
148928968|NCT02788474|537224854|FG001|Open Label Treatment Period|Non-compliance|0|||
148928969|NCT05153473|537224855|FG000|Overall Study|Death|46|||
148928970|NCT05153473|537224855|FG000|Overall Study|Lost to Follow-up|3|||
148928971|NCT00048061|537224856|FG000|Overall Study|Adverse Event|41|||
148928972|NCT00048061|537224857|FG001|Overall Study|Adverse Event|32|||
149173772|NCT01416181|538108706|FG000|Part 1|Adverse Event|15|||
149173773|NCT01416181|538108707|FG001|Part 1|Adverse Event|18|||
149173774|NCT01416181|538108706|FG000|Part 1|Ongoing in Follow-Up|14|||
149173775|NCT01416181|538108707|FG001|Part 1|Ongoing in Follow-Up|8|||
149173776|NCT01416181|538108706|FG000|Part 2|Adverse Event|11|||
149173777|NCT01416181|538108707|FG001|Part 2|Adverse Event|4|||
149173778|NCT01416181|538108706|FG000|Part 2|Other|234|||
149173779|NCT01416181|538108707|FG001|Part 2|Other|267|||
149173780|NCT01416181|538108706|FG000|Part 2|Investigator Decision|6|||
149173781|NCT01416181|538108707|FG001|Part 2|Investigator Decision|7|||
149173782|NCT01416181|538108706|FG000|Part 2|Withdrawal by Subject|14|||
149173783|NCT01416181|538108707|FG001|Part 2|Withdrawal by Subject|5|||
149173784|NCT01416181|538108706|FG000|Part 2|Lack of Efficacy|4|||
149173785|NCT01416181|538108707|FG001|Part 2|Lack of Efficacy|1|||
149173786|NCT01416181|538108706|FG000|Part 2|Lost to Follow-up|2|||
149173787|NCT01416181|538108707|FG001|Part 2|Lost to Follow-up|2|||
149173788|NCT03874234|538108708|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173789|NCT03874234|538108709|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173790|NCT03874234|538108710|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173791|NCT03874234|538108711|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
149173792|NCT03874234|538108712|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173793|NCT03874234|538108713|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173794|NCT03874234|538108714|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173795|NCT03874234|538108715|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173796|NCT03874234|538108716|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173797|NCT03874234|538108717|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173798|NCT03874234|538108718|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173799|NCT03874234|538108719|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173800|NCT03874234|538108720|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
149173801|NCT03874234|538108708|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
149173802|NCT03874234|538108709|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173803|NCT03874234|538108710|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173804|NCT03874234|538108711|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173805|NCT03874234|538108712|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173806|NCT03874234|538108713|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173807|NCT03874234|538108714|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173808|NCT03874234|538108715|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173809|NCT03874234|538108716|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173810|NCT03874234|538108717|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173811|NCT03874234|538108718|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173812|NCT03874234|538108719|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173813|NCT03874234|538108720|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
149173814|NCT03874234|538108708|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173815|NCT03874234|538108709|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173816|NCT03874234|538108710|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173817|NCT03874234|538108711|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
149173818|NCT03874234|538108712|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173819|NCT03874234|538108713|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173820|NCT03874234|538108714|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173821|NCT03874234|538108715|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
148928973|NCT00048061|537224858|FG002|Overall Study|Adverse Event|44|||
148928974|NCT00048061|537224859|FG003|Overall Study|Adverse Event|37|||
148928975|NCT00048061|537224856|FG000|Overall Study|Lost to Follow-up|3|||
149173822|NCT03874234|538108716|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173823|NCT03874234|538108717|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173824|NCT03874234|538108718|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173825|NCT03874234|538108719|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173826|NCT03874234|538108720|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
149173827|NCT03874234|538108708|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173828|NCT03874234|538108709|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173829|NCT03874234|538108710|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173830|NCT03874234|538108711|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173831|NCT03874234|538108712|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
149173832|NCT03874234|538108713|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173833|NCT03874234|538108714|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173834|NCT03874234|538108715|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173835|NCT03874234|538108716|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173836|NCT03874234|538108717|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173837|NCT03874234|538108718|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173838|NCT03874234|538108719|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173839|NCT03874234|538108720|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
149173840|NCT03874234|538108708|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173841|NCT03874234|538108709|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173842|NCT03874234|538108710|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173843|NCT03874234|538108711|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173844|NCT03874234|538108712|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173845|NCT03874234|538108713|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173846|NCT03874234|538108714|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173847|NCT03874234|538108715|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
149173848|NCT03874234|538108716|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173849|NCT03874234|538108717|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173850|NCT03874234|538108718|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173851|NCT03874234|538108719|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173852|NCT03874234|538108720|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
149173853|NCT03874234|538108708|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173854|NCT03874234|538108709|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173855|NCT03874234|538108710|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
148928976|NCT00048061|537224857|FG001|Overall Study|Lost to Follow-up|2|||
148928977|NCT00048061|537224858|FG002|Overall Study|Lost to Follow-up|4|||
149173856|NCT03874234|538108711|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173857|NCT03874234|538108712|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
149173858|NCT03874234|538108713|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
149173859|NCT03874234|538108714|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173860|NCT03874234|538108715|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173861|NCT03874234|538108716|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173862|NCT03874234|538108717|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173863|NCT03874234|538108718|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
148928978|NCT00048061|537224859|FG003|Overall Study|Lost to Follow-up|5|||
148928979|NCT00048061|537224856|FG000|Overall Study|Withdrawal by Subject|20|||
148928980|NCT00048061|537224857|FG001|Overall Study|Withdrawal by Subject|29|||
148928981|NCT00048061|537224858|FG002|Overall Study|Withdrawal by Subject|29|||
148928982|NCT00048061|537224859|FG003|Overall Study|Withdrawal by Subject|32|||
148928983|NCT00048061|537224856|FG000|Overall Study|Did not follow-up|5|||
148928984|NCT00048061|537224857|FG001|Overall Study|Did not follow-up|5|||
148928985|NCT00048061|537224858|FG002|Overall Study|Did not follow-up|4|||
148928986|NCT00048061|537224859|FG003|Overall Study|Did not follow-up|5|||
148928987|NCT00048061|537224856|FG000|Overall Study|Early improvement|6|||
148928988|NCT00048061|537224857|FG001|Overall Study|Early improvement|5|||
148928989|NCT00048061|537224858|FG002|Overall Study|Early improvement|3|||
148928990|NCT00048061|537224859|FG003|Overall Study|Early improvement|0|||
148928991|NCT03555435|537224860|FG000|Overall Study|Lost to Follow-up|17|||
148928992|NCT03555435|537224861|FG001|Overall Study|Lost to Follow-up|19|||
148928993|NCT03555435|537224862|FG002|Overall Study|Lost to Follow-up|8|||
148928994|NCT00245583|537224867|FG000|Overall Study|Lost to Follow-up|1|||
148928995|NCT00245583|537224868|FG001|Overall Study|Lost to Follow-up|5|||
148928996|NCT00245583|537224867|FG000|Overall Study|Adverse Event|2|||
148928997|NCT00245583|537224868|FG001|Overall Study|Adverse Event|1|||
148928998|NCT00245583|537224867|FG000|Overall Study|Lack of Efficacy|1|||
148928999|NCT00245583|537224868|FG001|Overall Study|Lack of Efficacy|0|||
148929000|NCT00245583|537224867|FG000|Overall Study|Withdrawal by Subject|2|||
148929001|NCT00245583|537224868|FG001|Overall Study|Withdrawal by Subject|3|||
148929002|NCT04718103|537224869|FG000|Overall Study|Adverse Event|1|||
148678605|NCT01255722|536297197|FG002|Overall Study|Adverse Event|1|||
148929003|NCT04718103|537224870|FG001|Overall Study|Adverse Event|1|||
149173864|NCT03874234|538108719|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173865|NCT03874234|538108720|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
149173866|NCT03874234|538108708|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173867|NCT03874234|538108709|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173868|NCT03874234|538108710|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173869|NCT03874234|538108711|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173870|NCT03874234|538108712|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173871|NCT03874234|538108713|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173872|NCT03874234|538108714|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
149173873|NCT03874234|538108715|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173874|NCT03874234|538108716|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173875|NCT03874234|538108717|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173876|NCT03874234|538108718|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173877|NCT03874234|538108719|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173878|NCT03874234|538108720|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
149173879|NCT03874234|538108708|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173880|NCT03874234|538108709|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173881|NCT03874234|538108710|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173882|NCT03874234|538108711|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173883|NCT03874234|538108712|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
148929004|NCT04718103|537224869|FG000|Overall Study|Lack of Efficacy|4|||
148929005|NCT04718103|537224870|FG001|Overall Study|Lack of Efficacy|1|||
148929006|NCT04718103|537224869|FG000|Overall Study|Lost to Follow-up|2|||
148929007|NCT04718103|537224870|FG001|Overall Study|Lost to Follow-up|2|||
148929008|NCT04718103|537224869|FG000|Overall Study|Physician Decision|2|||
148929009|NCT04718103|537224870|FG001|Overall Study|Physician Decision|0|||
148929010|NCT04718103|537224869|FG000|Overall Study|Pregnancy|0|||
148929011|NCT04718103|537224870|FG001|Overall Study|Pregnancy|1|||
148929012|NCT04718103|537224869|FG000|Overall Study|Withdrawal by Subject|10|||
148929013|NCT04718103|537224870|FG001|Overall Study|Withdrawal by Subject|6|||
148929014|NCT04718103|537224869|FG000|Overall Study|Randomized, not treated|4|||
148929015|NCT04718103|537224870|FG001|Overall Study|Randomized, not treated|1|||
148929016|NCT04718103|537224869|FG000|Overall Study|GCP violations|7|||
148929017|NCT04718103|537224870|FG001|Overall Study|GCP violations|5|||
148929018|NCT01343901|537224872|FG000|Overall Study|Death|85|||
148929019|NCT01343901|537224872|FG000|Overall Study|Physician Decision|4|||
148929020|NCT01343901|537224872|FG000|Overall Study|Lost to Follow-up|12|||
148929021|NCT01343901|537224872|FG000|Overall Study|Management by another medical team|11|||
148929022|NCT01343901|537224872|FG000|Overall Study|Participant decision|1|||
148929023|NCT01369485|537224873|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
148929024|NCT01369485|537224874|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
148929025|NCT01369485|537224873|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
148929026|NCT01369485|537224874|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
148929027|NCT01369485|537224873|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
148929028|NCT01369485|537224874|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
148929029|NCT01369485|537224873|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
148929030|NCT01369485|537224874|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
148929031|NCT01369485|537224873|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
148929032|NCT01369485|537224874|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
148929033|NCT01369485|537224873|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
148929034|NCT01369485|537224874|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
148929035|NCT01369485|537224873|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
148929036|NCT01369485|537224874|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
148929037|NCT01369485|537224873|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
148929038|NCT01369485|537224874|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
148929039|NCT01369485|537224873|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
148929040|NCT01369485|537224874|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
148929041|NCT01369485|537224873|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
148929042|NCT01369485|537224874|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
148929043|NCT03370289|537224876|FG000|Overall Study|Screen Failure|1|||
148929044|NCT03370289|537224876|FG000|Overall Study|Sample Size Sufficient|4|||
148929045|NCT00873860|537224877|FG000|Overall Study|Lost to Follow-up|1|||
148929046|NCT00873860|537224878|FG001|Overall Study|Lost to Follow-up|0|||
148929047|NCT00873860|537224879|FG002|Overall Study|Lost to Follow-up|0|||
148929048|NCT00873860|537224880|FG003|Overall Study|Lost to Follow-up|1|||
148929049|NCT00873860|537224877|FG000|Overall Study|Withdrawal by Subject|1|||
148929050|NCT00873860|537224878|FG001|Overall Study|Withdrawal by Subject|0|||
148929051|NCT00873860|537224879|FG002|Overall Study|Withdrawal by Subject|2|||
148929052|NCT00873860|537224880|FG003|Overall Study|Withdrawal by Subject|0|||
148929053|NCT00873860|537224877|FG000|Overall Study|Death|1|||
148929054|NCT00873860|537224878|FG001|Overall Study|Death|0|||
148929055|NCT00873860|537224879|FG002|Overall Study|Death|0|||
148929056|NCT00873860|537224880|FG003|Overall Study|Death|0|||
148929057|NCT00873860|537224877|FG000|Overall Study|Other|1|||
148929058|NCT00873860|537224878|FG001|Overall Study|Other|0|||
148929059|NCT00873860|537224879|FG002|Overall Study|Other|1|||
148929060|NCT00873860|537224880|FG003|Overall Study|Other|0|||
148929061|NCT02764190|537224881|FG000|Overall Study|Lost to Follow-up|17|||
148929062|NCT02764190|537224882|FG001|Overall Study|Lost to Follow-up|13|||
148929063|NCT01484938|537224887|FG000|Overall Study|Adverse Event|2|||
148929064|NCT01484938|537224887|FG000|Overall Study|Lost to Follow-up|1|||
148929065|NCT01484938|537224887|FG000|Overall Study|Noncompliance|1|||
148929066|NCT02140775|537224889|FG000|Overall Study|Withdrawal by Subject|30|||
148929067|NCT02140775|537224890|FG001|Overall Study|Withdrawal by Subject|7|||
148929068|NCT02942576|537224892|FG000|Overall Study|Adverse Event|28|||
148929069|NCT02942576|537224893|FG001|Overall Study|Adverse Event|6|||
148929070|NCT02942576|537224892|FG000|Overall Study|Withdrawal by Subject|7|||
148929071|NCT02942576|537224893|FG001|Overall Study|Withdrawal by Subject|5|||
148929072|NCT02942576|537224892|FG000|Overall Study|Physician Decision|1|||
148929073|NCT02942576|537224893|FG001|Overall Study|Physician Decision|4|||
148929074|NCT02942576|537224892|FG000|Overall Study|Other|10|||
148929075|NCT02942576|537224893|FG001|Overall Study|Other|8|||
148929076|NCT01227564|537224898|FG000|Overall Study|No Longer Willing to Participate|4|||
148929077|NCT01227564|537224899|FG001|Overall Study|No Longer Willing to Participate|2|||
148929078|NCT01227564|537224900|FG002|Overall Study|No Longer Willing to Participate|5|||
149173884|NCT03874234|538108713|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173885|NCT03874234|538108714|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173886|NCT03874234|538108715|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173887|NCT03874234|538108716|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173888|NCT03874234|538108717|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173889|NCT03874234|538108718|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173890|NCT03874234|538108719|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173891|NCT03874234|538108720|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
149173892|NCT01896232|538108723|FG000|Overall Study|Death|6|||
149173893|NCT01896232|538108724|FG001|Overall Study|Death|10|||
149173894|NCT01896232|538108723|FG000|Overall Study|Withdrawal by Subject|32|||
149173895|NCT01896232|538108724|FG001|Overall Study|Withdrawal by Subject|31|||
149173896|NCT01896232|538108723|FG000|Overall Study|Sponsor Decision|2|||
149173897|NCT01896232|538108724|FG001|Overall Study|Sponsor Decision|0|||
149173898|NCT01896232|538108723|FG000|Overall Study|Lost to Follow-up|9|||
149173899|NCT01896232|538108724|FG001|Overall Study|Lost to Follow-up|12|||
149173900|NCT03816995|538108735|FG000|Overall Study|Withdrawal by Subject|3|||
149173901|NCT03816995|538108736|FG001|Overall Study|Withdrawal by Subject|1|||
149173902|NCT03816995|538108735|FG000|Overall Study|Cancelled Surgery|8|||
149173903|NCT03816995|538108736|FG001|Overall Study|Cancelled Surgery|12|||
149173904|NCT03816995|538108735|FG000|Overall Study|No wound protector used|11|||
149173905|NCT03816995|538108736|FG001|Overall Study|No wound protector used|17|||
149173906|NCT03816995|538108735|FG000|Overall Study|Protocol Violation|2|||
149173907|NCT03816995|538108736|FG001|Overall Study|Protocol Violation|3|||
149173908|NCT00541307|538108737|FG000|Overall Study|Death|5|||
149173909|NCT00541307|538108737|FG000|Overall Study|Physician Decision|3|||
149173910|NCT00541307|538108737|FG000|Overall Study|Withdrawal by Subject|6|||
149173911|NCT00541307|538108737|FG000|Overall Study|Lost to Follow-up|4|||
149173912|NCT00541307|538108737|FG000|Overall Study|Subject returned early (outside window)|1|||
149173913|NCT00541307|538108737|FG000|Overall Study|Surgical Bypass|5|||
149173914|NCT01324830|538108738|FG000|Overall Study|Progressive Disease|3|||
149173915|NCT01324830|538108739|FG001|Overall Study|Progressive Disease|2|||
149173916|NCT01324830|538108740|FG002|Overall Study|Progressive Disease|3|||
149173917|NCT01324830|538108741|FG003|Overall Study|Progressive Disease|3|||
148678606|NCT01255722|536297195|FG000|Overall Study|asymptomatic patient|1|||
149173918|NCT01324830|538108742|FG004|Overall Study|Progressive Disease|6|||
149173919|NCT01324830|538108743|FG005|Overall Study|Progressive Disease|6|||
149173920|NCT01324830|538108744|FG006|Overall Study|Progressive Disease|3|||
149173921|NCT01324830|538108745|FG007|Overall Study|Progressive Disease|3|||
149173922|NCT01324830|538108746|FG008|Overall Study|Progressive Disease|3|||
148678607|NCT01255722|536297196|FG001|Overall Study|asymptomatic patient|0|||
148929079|NCT01227564|537224898|FG000|Overall Study|Participant moved to another town|0|||
148929080|NCT01227564|537224899|FG001|Overall Study|Participant moved to another town|0|||
148929081|NCT01227564|537224900|FG002|Overall Study|Participant moved to another town|1|||
148929082|NCT04650854|537224901|FG000|Overall Study|Adverse Event|1|||
148929083|NCT04650854|537224902|FG001|Overall Study|Adverse Event|12|||
148929084|NCT04650854|537224903|FG002|Overall Study|Adverse Event|14|||
149173923|NCT01324830|538108747|FG009|Overall Study|Progressive Disease|6|||
149173924|NCT01324830|538108748|FG010|Overall Study|Progressive Disease|2|||
149173925|NCT01324830|538108749|FG011|Overall Study|Progressive Disease|1|||
148678608|NCT01255722|536297197|FG002|Overall Study|asymptomatic patient|0|||
148929085|NCT04650854|537224901|FG000|Overall Study|Lack of Efficacy|1|||
148929086|NCT04650854|537224902|FG001|Overall Study|Lack of Efficacy|3|||
148929087|NCT04650854|537224903|FG002|Overall Study|Lack of Efficacy|6|||
149173926|NCT01324830|538108750|FG012|Overall Study|Progressive Disease|1|||
149173927|NCT01324830|538108751|FG013|Overall Study|Progressive Disease|1|||
149173928|NCT01324830|538108752|FG014|Overall Study|Progressive Disease|1|||
149173929|NCT01324830|538108753|FG015|Overall Study|Progressive Disease|3|||
149173930|NCT01324830|538108754|FG016|Overall Study|Progressive Disease|2|||
149173931|NCT01324830|538108755|FG017|Overall Study|Progressive Disease|3|||
149173932|NCT01324830|538108756|FG018|Overall Study|Progressive Disease|4|||
149173933|NCT01324830|538108738|FG000|Overall Study|Dose limiting toxicity|0|||
149173934|NCT01324830|538108739|FG001|Overall Study|Dose limiting toxicity|0|||
149173935|NCT01324830|538108740|FG002|Overall Study|Dose limiting toxicity|0|||
149173936|NCT01324830|538108741|FG003|Overall Study|Dose limiting toxicity|0|||
149173937|NCT01324830|538108742|FG004|Overall Study|Dose limiting toxicity|1|||
149173938|NCT01324830|538108743|FG005|Overall Study|Dose limiting toxicity|0|||
149173939|NCT01324830|538108744|FG006|Overall Study|Dose limiting toxicity|0|||
149173940|NCT01324830|538108745|FG007|Overall Study|Dose limiting toxicity|0|||
149173941|NCT01324830|538108746|FG008|Overall Study|Dose limiting toxicity|0|||
149173942|NCT01324830|538108747|FG009|Overall Study|Dose limiting toxicity|0|||
149173943|NCT01324830|538108748|FG010|Overall Study|Dose limiting toxicity|0|||
149173944|NCT01324830|538108749|FG011|Overall Study|Dose limiting toxicity|0|||
149173945|NCT01324830|538108750|FG012|Overall Study|Dose limiting toxicity|0|||
149173946|NCT01324830|538108751|FG013|Overall Study|Dose limiting toxicity|0|||
149173947|NCT01324830|538108752|FG014|Overall Study|Dose limiting toxicity|0|||
149173948|NCT01324830|538108753|FG015|Overall Study|Dose limiting toxicity|0|||
149173949|NCT01324830|538108754|FG016|Overall Study|Dose limiting toxicity|1|||
149173950|NCT01324830|538108755|FG017|Overall Study|Dose limiting toxicity|1|||
149173951|NCT01324830|538108756|FG018|Overall Study|Dose limiting toxicity|1|||
149173952|NCT01324830|538108738|FG000|Overall Study|Reason not mentioned above|0|||
149173953|NCT01324830|538108739|FG001|Overall Study|Reason not mentioned above|0|||
149173954|NCT01324830|538108740|FG002|Overall Study|Reason not mentioned above|0|||
149173955|NCT01324830|538108741|FG003|Overall Study|Reason not mentioned above|0|||
149173956|NCT01324830|538108742|FG004|Overall Study|Reason not mentioned above|0|||
149173957|NCT01324830|538108743|FG005|Overall Study|Reason not mentioned above|0|||
149173958|NCT01324830|538108744|FG006|Overall Study|Reason not mentioned above|0|||
149173959|NCT01324830|538108745|FG007|Overall Study|Reason not mentioned above|0|||
149173960|NCT01324830|538108746|FG008|Overall Study|Reason not mentioned above|0|||
149173961|NCT01324830|538108747|FG009|Overall Study|Reason not mentioned above|0|||
149173962|NCT01324830|538108748|FG010|Overall Study|Reason not mentioned above|0|||
149173963|NCT01324830|538108749|FG011|Overall Study|Reason not mentioned above|0|||
149173964|NCT01324830|538108750|FG012|Overall Study|Reason not mentioned above|0|||
149173965|NCT01324830|538108751|FG013|Overall Study|Reason not mentioned above|0|||
149173966|NCT01324830|538108752|FG014|Overall Study|Reason not mentioned above|0|||
149173967|NCT01324830|538108753|FG015|Overall Study|Reason not mentioned above|0|||
149173968|NCT01324830|538108754|FG016|Overall Study|Reason not mentioned above|0|||
149173969|NCT01324830|538108755|FG017|Overall Study|Reason not mentioned above|1|||
149173970|NCT01324830|538108756|FG018|Overall Study|Reason not mentioned above|0|||
149173971|NCT01324830|538108738|FG000|Overall Study|Adverse Event, serious fatal|0|||
149173972|NCT01324830|538108739|FG001|Overall Study|Adverse Event, serious fatal|1|||
149173973|NCT01324830|538108740|FG002|Overall Study|Adverse Event, serious fatal|0|||
149173974|NCT01324830|538108741|FG003|Overall Study|Adverse Event, serious fatal|0|||
149173975|NCT01324830|538108742|FG004|Overall Study|Adverse Event, serious fatal|0|||
149173976|NCT01324830|538108743|FG005|Overall Study|Adverse Event, serious fatal|0|||
149173977|NCT01324830|538108744|FG006|Overall Study|Adverse Event, serious fatal|0|||
149173978|NCT01324830|538108745|FG007|Overall Study|Adverse Event, serious fatal|0|||
149173979|NCT01324830|538108746|FG008|Overall Study|Adverse Event, serious fatal|0|||
149173980|NCT01324830|538108747|FG009|Overall Study|Adverse Event, serious fatal|0|||
149013312|NCT03560258|537527905|FG001|Overall Study|Protocol Violation|1|||
149173981|NCT01324830|538108748|FG010|Overall Study|Adverse Event, serious fatal|0|||
149173982|NCT01324830|538108749|FG011|Overall Study|Adverse Event, serious fatal|0|||
149173983|NCT01324830|538108750|FG012|Overall Study|Adverse Event, serious fatal|0|||
149173984|NCT01324830|538108751|FG013|Overall Study|Adverse Event, serious fatal|0|||
149173985|NCT01324830|538108752|FG014|Overall Study|Adverse Event, serious fatal|0|||
149173986|NCT01324830|538108753|FG015|Overall Study|Adverse Event, serious fatal|0|||
149173987|NCT01324830|538108754|FG016|Overall Study|Adverse Event, serious fatal|0|||
149173988|NCT01324830|538108755|FG017|Overall Study|Adverse Event, serious fatal|0|||
149173989|NCT01324830|538108756|FG018|Overall Study|Adverse Event, serious fatal|0|||
149173990|NCT01324830|538108738|FG000|Overall Study|Adverse Event, non-fatal|0|||
148929088|NCT04650854|537224901|FG000|Overall Study|Lost to Follow-up|1|||
148929089|NCT04650854|537224902|FG001|Overall Study|Lost to Follow-up|1|||
148929090|NCT04650854|537224903|FG002|Overall Study|Lost to Follow-up|0|||
148929091|NCT04650854|537224901|FG000|Overall Study|Withdrawal by Subject|2|||
148929092|NCT04650854|537224902|FG001|Overall Study|Withdrawal by Subject|17|||
148929093|NCT04650854|537224903|FG002|Overall Study|Withdrawal by Subject|9|||
148929094|NCT04650854|537224901|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
148929095|NCT04650854|537224902|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
148929096|NCT04650854|537224903|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
148929097|NCT04650854|537224901|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
148929098|NCT04650854|537224902|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
148929099|NCT04650854|537224903|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
148929100|NCT04650854|537224901|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
148929101|NCT04650854|537224902|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
148929102|NCT04650854|537224903|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
148929103|NCT04650854|537224901|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
148929104|NCT04650854|537224902|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
148929105|NCT04650854|537224903|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
148929106|NCT04650854|537224901|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
148929107|NCT04650854|537224902|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
148929108|NCT04650854|537224903|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
148929109|NCT04650854|537224901|FG000|Overall Study|Use of Rescue Medication|0|||
148929110|NCT04650854|537224902|FG001|Overall Study|Use of Rescue Medication|0|||
148929111|NCT04650854|537224903|FG002|Overall Study|Use of Rescue Medication|1|||
148929112|NCT04650854|537224901|FG000|Overall Study|Last Treatment Per Sponsor|0|||
148929113|NCT04650854|537224902|FG001|Overall Study|Last Treatment Per Sponsor|0|||
148929114|NCT04650854|537224903|FG002|Overall Study|Last Treatment Per Sponsor|2|||
148929115|NCT04650854|537224901|FG000|Overall Study|Rescue Medication|0|||
148929116|NCT04650854|537224902|FG001|Overall Study|Rescue Medication|0|||
148929117|NCT04650854|537224903|FG002|Overall Study|Rescue Medication|1|||
148929118|NCT04650854|537224901|FG000|Overall Study|Participant Want to Start a Family|0|||
148929119|NCT04650854|537224902|FG001|Overall Study|Participant Want to Start a Family|0|||
149173991|NCT01324830|538108739|FG001|Overall Study|Adverse Event, non-fatal|0|||
148678609|NCT01255722|536297195|FG000|Overall Study|beta-blocker contraindicated|2|||
148678610|NCT01255722|536297196|FG001|Overall Study|beta-blocker contraindicated|0|||
148678611|NCT01255722|536297197|FG002|Overall Study|beta-blocker contraindicated|0|||
148678612|NCT02643966|536297198|FG000|First Screening Round|ineligible|1|||
148678613|NCT02643966|536297198|FG000|First Screening Round|excluded from analysis|2|||
148678614|NCT02643966|536297198|FG000|First Screening Round|Lost to Follow-up|56|||
148678615|NCT02643966|536297198|FG000|First Screening Round|Withdrawal by Subject|28|||
148678616|NCT02643966|536297198|FG000|First Screening Round|Death|1|||
148678617|NCT02643966|536297198|FG000|Between First and Second Screening|Lost to Follow-up|65|||
148678618|NCT02643966|536297198|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
148678619|NCT02643966|536297198|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
148678620|NCT02643966|536297198|FG000|Second Screening Round|Withdrawal by Subject|20|||
148678621|NCT02643966|536297198|FG000|Second Screening Round|Lost to Follow-up|57|||
148678622|NCT02643966|536297198|FG000|Second Screening Round|Physician Decision|2|||
148678623|NCT02643966|536297198|FG000|Second Screening Round|Death|4|||
148678624|NCT02643966|536297198|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
148678625|NCT02643966|536297198|FG000|Between Second and Third Screening|Death|1|||
148678626|NCT02643966|536297198|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
148678627|NCT02643966|536297198|FG000|Third Screening Round|PI excluded|2|||
149013313|NCT03560258|537527906|FG002|Overall Study|Protocol Violation|0|||
149173992|NCT01324830|538108740|FG002|Overall Study|Adverse Event, non-fatal|0|||
148678628|NCT02643966|536297198|FG000|Third Screening Round|Lost to Follow-up|241|||
149013314|NCT03560258|537527904|FG000|Overall Study|Withdrawal by Subject|0|||
148678629|NCT03835975|536297201|FG000|Overall Study|Lost to Follow-up|1|||
148678630|NCT03835975|536297202|FG001|Overall Study|Lost to Follow-up|1|||
148678631|NCT03835975|536297203|FG002|Overall Study|Lost to Follow-up|0|||
149013315|NCT03560258|537527905|FG001|Overall Study|Withdrawal by Subject|0|||
148678632|NCT03835975|536297204|FG003|Overall Study|Lost to Follow-up|0|||
148678633|NCT03835975|536297205|FG004|Overall Study|Lost to Follow-up|0|||
148929120|NCT04650854|537224903|FG002|Overall Study|Participant Want to Start a Family|1|||
148929121|NCT04650854|537224901|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
148929122|NCT04650854|537224902|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
148929123|NCT04650854|537224903|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
148929124|NCT04650854|537224901|FG000|Overall Study|Participant Screened For MG0020|0|||
148929125|NCT04650854|537224902|FG001|Overall Study|Participant Screened For MG0020|2|||
148929126|NCT04650854|537224903|FG002|Overall Study|Participant Screened For MG0020|3|||
148929127|NCT04650854|537224901|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
148929128|NCT04650854|537224902|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
148929129|NCT04650854|537224903|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
148929130|NCT04650854|537224901|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
148929131|NCT04650854|537224902|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
148929132|NCT04650854|537224903|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
148929133|NCT04650854|537224901|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
148929134|NCT04650854|537224902|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
148929135|NCT04650854|537224903|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
148929136|NCT04650854|537224901|FG000|Overall Study|End Of Study|0|||
148929137|NCT04650854|537224902|FG001|Overall Study|End Of Study|2|||
148929138|NCT04650854|537224903|FG002|Overall Study|End Of Study|1|||
148929139|NCT04650854|537224901|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
148929140|NCT04650854|537224902|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
148929141|NCT04650854|537224903|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
148929142|NCT04650854|537224901|FG000|Overall Study|Participant Received Rescue Medication|0|||
148678634|NCT03835975|536297201|FG000|Overall Study|No longer met eligibility criteria|0|||
148678635|NCT03835975|536297202|FG001|Overall Study|No longer met eligibility criteria|1|||
148678636|NCT03835975|536297203|FG002|Overall Study|No longer met eligibility criteria|0|||
148678637|NCT03835975|536297204|FG003|Overall Study|No longer met eligibility criteria|0|||
148678638|NCT03835975|536297205|FG004|Overall Study|No longer met eligibility criteria|0|||
148678639|NCT03835975|536297201|FG000|Overall Study|Protocol Violation|1|||
148678640|NCT03835975|536297202|FG001|Overall Study|Protocol Violation|1|||
148678641|NCT03835975|536297203|FG002|Overall Study|Protocol Violation|2|||
148678642|NCT03835975|536297204|FG003|Overall Study|Protocol Violation|0|||
148678643|NCT03835975|536297205|FG004|Overall Study|Protocol Violation|0|||
148678644|NCT03835975|536297201|FG000|Overall Study|Withdrawal by Subject|1|||
148678645|NCT03835975|536297202|FG001|Overall Study|Withdrawal by Subject|0|||
148678646|NCT03835975|536297203|FG002|Overall Study|Withdrawal by Subject|1|||
148678647|NCT03835975|536297204|FG003|Overall Study|Withdrawal by Subject|1|||
148929143|NCT04650854|537224902|FG001|Overall Study|Participant Received Rescue Medication|1|||
148929144|NCT04650854|537224903|FG002|Overall Study|Participant Received Rescue Medication|0|||
148929145|NCT04650854|537224901|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
148929146|NCT04650854|537224902|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
148929147|NCT04650854|537224903|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
148929148|NCT04650854|537224901|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
148929149|NCT04650854|537224902|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
148929150|NCT04650854|537224903|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
148929151|NCT04650854|537224901|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
148929152|NCT04650854|537224902|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
148929153|NCT04650854|537224903|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
148929154|NCT04650854|537224901|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
148678648|NCT03835975|536297205|FG004|Overall Study|Withdrawal by Subject|0|||
148929155|NCT04650854|537224902|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
148929156|NCT04650854|537224903|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
148929157|NCT04650854|537224901|FG000|Overall Study|Enrollment Cup|0|||
148929158|NCT04650854|537224902|FG001|Overall Study|Enrollment Cup|0|||
148929159|NCT04650854|537224903|FG002|Overall Study|Enrollment Cup|1|||
148929160|NCT00194675|537224904|FG000|Overall Study|Lost to Follow-up|1|||
148929161|NCT00194675|537224905|FG001|Overall Study|Lost to Follow-up|1|||
148929162|NCT00194675|537224904|FG000|Overall Study|lack of interest|1|||
148929163|NCT00194675|537224905|FG001|Overall Study|lack of interest|1|||
148929164|NCT00194675|537224904|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
148929165|NCT00194675|537224905|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
148929166|NCT00194675|537224904|FG000|Overall Study|Protocol Violation|1|||
148929167|NCT00194675|537224905|FG001|Overall Study|Protocol Violation|0|||
148929168|NCT00194675|537224904|FG000|Overall Study|Death|1|||
148678649|NCT03070431|536297208|FG000|Overall Study|Withdrawal by Subject|2|||
148929169|NCT00194675|537224905|FG001|Overall Study|Death|0|||
148929170|NCT05308290|537224906|FG000|Overall Study|Death|1|||
148929171|NCT05308290|537224907|FG001|Overall Study|Death|0|||
148929172|NCT05308290|537224906|FG000|Overall Study|Lost to Follow-up|2|||
148929173|NCT05308290|537224907|FG001|Overall Study|Lost to Follow-up|1|||
148929174|NCT05308290|537224906|FG000|Overall Study|still in study followup|0|||
148678650|NCT03070431|536297208|FG000|Overall Study|Lost to Follow-up|2|||
148678651|NCT01542736|536297211|FG000|Overall Study|Death|1|||
148678652|NCT01783483|536297212|FG000|Overall Study|Death|3|||
148678653|NCT01783483|536297213|FG001|Overall Study|Death|3|||
148678654|NCT01783483|536297212|FG000|Overall Study|Lost to Follow-up|14|||
148678655|NCT01783483|536297213|FG001|Overall Study|Lost to Follow-up|10|||
148929175|NCT05308290|537224907|FG001|Overall Study|still in study followup|1|||
148929176|NCT01285960|537224908|FG000|Overall Study|Withdrawal by Subject|2|||
148929177|NCT01285960|537224908|FG000|Overall Study|Lost to Follow-up|2|||
148929178|NCT01285960|537224908|FG000|Overall Study|2 subjects received less 10 sonications|2|||
148929179|NCT00667420|537224909|FG000|Overall Study|Adverse Event|2|||
148929180|NCT00667420|537224909|FG000|Overall Study|Lack of Efficacy|5|||
148929181|NCT00667420|537224909|FG000|Overall Study|Physician Decision|1|||
148929182|NCT00667420|537224909|FG000|Overall Study|Withdrawal by Subject|2|||
148929183|NCT01017575|537224910|FG000|Overall Study|Lack of Efficacy|0|||
148929184|NCT01017575|537224911|FG001|Overall Study|Lack of Efficacy|1|||
148929185|NCT01017575|537224912|FG002|Overall Study|Lack of Efficacy|0|||
148929186|NCT01017575|537224913|FG003|Overall Study|Lack of Efficacy|1|||
148929187|NCT01017575|537224914|FG004|Overall Study|Lack of Efficacy|1|||
148929188|NCT01017575|537224910|FG000|Overall Study|Adverse Event|0|||
148929189|NCT01017575|537224911|FG001|Overall Study|Adverse Event|1|||
148929190|NCT01017575|537224912|FG002|Overall Study|Adverse Event|0|||
148929191|NCT01017575|537224913|FG003|Overall Study|Adverse Event|0|||
148929192|NCT01017575|537224914|FG004|Overall Study|Adverse Event|2|||
148929193|NCT01017575|537224910|FG000|Overall Study|Withdrawal by Subject|1|||
148929194|NCT01017575|537224911|FG001|Overall Study|Withdrawal by Subject|0|||
148929195|NCT01017575|537224912|FG002|Overall Study|Withdrawal by Subject|0|||
148929196|NCT01017575|537224913|FG003|Overall Study|Withdrawal by Subject|0|||
148929197|NCT01017575|537224914|FG004|Overall Study|Withdrawal by Subject|0|||
148929198|NCT04437368|537224915|FG000|Overall Study|Death|3|||
148929199|NCT04437368|537224916|FG001|Overall Study|Death|0|||
148929200|NCT04437368|537224917|FG002|Overall Study|Death|2|||
148929201|NCT04437368|537224915|FG000|Overall Study|Study terminated by sponsor|16|||
148929202|NCT04437368|537224916|FG001|Overall Study|Study terminated by sponsor|1|||
148929203|NCT04437368|537224917|FG002|Overall Study|Study terminated by sponsor|25|||
148929204|NCT04437368|537224915|FG000|Overall Study|Withdrawal by Subject|4|||
148929205|NCT04437368|537224916|FG001|Overall Study|Withdrawal by Subject|0|||
148929206|NCT04437368|537224917|FG002|Overall Study|Withdrawal by Subject|3|||
148929207|NCT04437368|537224915|FG000|Overall Study|Sponsor instructions|23|||
148929208|NCT04437368|537224916|FG001|Overall Study|Sponsor instructions|0|||
148929209|NCT04437368|537224917|FG002|Overall Study|Sponsor instructions|0|||
148929210|NCT03500679|537224929|FG000|Overall Study|Lost to Follow-up|6|||
148929211|NCT03500679|537224930|FG001|Overall Study|Lost to Follow-up|3|||
148929212|NCT03500679|537224929|FG000|Overall Study|Withdrawal by Subject|3|||
148929213|NCT03500679|537224930|FG001|Overall Study|Withdrawal by Subject|0|||
148929214|NCT00095628|537224931|FG000|Overall Study|Disease progression prior to treatment|1|||
148929215|NCT04271280|537224932|FG000|Overall Study|Lost to Follow-up|300|||
148929216|NCT04271280|537224932|FG000|Overall Study|Death|153|||
148929217|NCT04271280|537224932|FG000|Overall Study|Withdrawal of consent by patient|59|||
148929218|NCT04271280|537224932|FG000|Overall Study|Other|51|||
148929219|NCT04271280|537224932|FG000|Overall Study|No end of study information|42|||
148929220|NCT01280955|537224938|FG000|Overall Study|Death|2|||
148929221|NCT01280955|537224938|FG000|Overall Study|Withdrawal by Subject|1|||
148929222|NCT01484054|537224939|FG000|Period 1|Withdrawal by Subject|0|||
148929223|NCT01484054|537224940|FG001|Period 1|Withdrawal by Subject|1|||
148929224|NCT01539317|537224941|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
148929225|NCT01539317|537224942|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
148678656|NCT01783483|536297212|FG000|Overall Study|Withdrawal by Subject|2|||
148678657|NCT01783483|536297213|FG001|Overall Study|Withdrawal by Subject|1|||
148678658|NCT01783483|536297212|FG000|Overall Study|Physician Decision|1|||
148929226|NCT02247531|537226241|FG000|Overall Study|Adverse Event|3|||
148929227|NCT02247531|537226242|FG001|Overall Study|Adverse Event|4|||
148929228|NCT02247531|537226243|FG002|Overall Study|Adverse Event|9|||
148929229|NCT02247531|537226241|FG000|Overall Study|Death|8|||
148929230|NCT02247531|537226242|FG001|Overall Study|Death|9|||
148929231|NCT02247531|537226243|FG002|Overall Study|Death|5|||
148929232|NCT02247531|537226241|FG000|Overall Study|Lost to Follow-up|1|||
148929233|NCT02247531|537226242|FG001|Overall Study|Lost to Follow-up|8|||
148929234|NCT02247531|537226243|FG002|Overall Study|Lost to Follow-up|3|||
148929235|NCT02247531|537226241|FG000|Overall Study|Non-compliance|2|||
148929236|NCT02247531|537226242|FG001|Overall Study|Non-compliance|2|||
148929237|NCT02247531|537226243|FG002|Overall Study|Non-compliance|0|||
148929238|NCT02247531|537226241|FG000|Overall Study|Withdrawal by Subject|26|||
148929239|NCT02247531|537226242|FG001|Overall Study|Withdrawal by Subject|31|||
148929240|NCT02247531|537226243|FG002|Overall Study|Withdrawal by Subject|25|||
148929241|NCT02247531|537226241|FG000|Overall Study|Study Terminated by Sponsor|64|||
148678659|NCT01783483|536297213|FG001|Overall Study|Physician Decision|1|||
148929242|NCT02247531|537226242|FG001|Overall Study|Study Terminated by Sponsor|66|||
148929243|NCT02247531|537226243|FG002|Overall Study|Study Terminated by Sponsor|62|||
148929244|NCT02247531|537226241|FG000|Overall Study|Physician Decision|0|||
148929245|NCT02247531|537226242|FG001|Overall Study|Physician Decision|2|||
148678660|NCT00370396|536297219|FG000|Overall Study|Withdrawal by Subject|0|||
148929246|NCT02247531|537226243|FG002|Overall Study|Physician Decision|2|||
148929247|NCT02247531|537226241|FG000|Overall Study|Unspecified Reason|2|||
148929248|NCT02247531|537226242|FG001|Overall Study|Unspecified Reason|3|||
148929249|NCT02247531|537226243|FG002|Overall Study|Unspecified Reason|4|||
148929250|NCT03875118|537226248|FG000|Overall Study|Withdrawal by Subject|4|||
148929251|NCT03875118|537226249|FG001|Overall Study|Withdrawal by Subject|4|||
148929252|NCT02237911|537226250|FG000|Overall Study|Withdrawal by Subject|4|||
148929253|NCT02237911|537226251|FG001|Overall Study|Withdrawal by Subject|7|||
148929254|NCT02237911|537226252|FG002|Overall Study|Withdrawal by Subject|2|||
148929255|NCT02237911|537226250|FG000|Overall Study|Lost to Follow-up|3|||
148929256|NCT02237911|537226251|FG001|Overall Study|Lost to Follow-up|1|||
148929257|NCT02237911|537226252|FG002|Overall Study|Lost to Follow-up|1|||
148929258|NCT02423109|537226253|FG000|Lens 1|Adverse Event|1|||
148929259|NCT02423109|537226254|FG001|Lens 1|Adverse Event|0|||
148929260|NCT02428608|537226255|FG000|Overall Study|Pregnancy|2|||
148929261|NCT02428608|537226255|FG000|Overall Study|Lost to Follow-up|37|||
148929262|NCT02428608|537226255|FG000|Overall Study|Withdrawal by Subject|2|||
148929263|NCT02428608|537226255|FG000|Overall Study|scheduling conflicts|15|||
148929264|NCT02428608|537226255|FG000|Overall Study|moved away|10|||
148929265|NCT02428608|537226255|FG000|Overall Study|Death|1|||
148929266|NCT02428608|537226255|FG000|Overall Study|various|16|||
148929267|NCT04521777|537226256|FG000|Overall Study|Death|2|||
148929268|NCT04521777|537226256|FG000|Overall Study|Withdrawal by Subject|2|||
148929269|NCT04060862|537226257|FG000|Overall Study|Symptomatic Deterioration|1|||
148929270|NCT04060862|537226257|FG000|Overall Study|Un-specified|6|||
148929271|NCT04060862|537226257|FG000|Overall Study|Progressive disease|12|||
148929272|NCT04060862|537226257|FG000|Overall Study|Physician Decision|1|||
148929273|NCT01143207|537226262|FG000|Overall Study|Lost to Follow-up|2|||
148929274|NCT01869725|537226263|FG000|Overall Study|ineligible after registration|1|||
148929275|NCT01869725|537226263|FG000|Overall Study|Death|1|||
148929276|NCT01869725|537226263|FG000|Overall Study|Lost to Follow-up|2|||
149173993|NCT01324830|538108741|FG003|Overall Study|Adverse Event, non-fatal|0|||
149173994|NCT01324830|538108742|FG004|Overall Study|Adverse Event, non-fatal|0|||
149173995|NCT01324830|538108743|FG005|Overall Study|Adverse Event, non-fatal|0|||
149173996|NCT01324830|538108744|FG006|Overall Study|Adverse Event, non-fatal|0|||
149173997|NCT01324830|538108745|FG007|Overall Study|Adverse Event, non-fatal|0|||
149173998|NCT01324830|538108746|FG008|Overall Study|Adverse Event, non-fatal|2|||
149173999|NCT01324830|538108747|FG009|Overall Study|Adverse Event, non-fatal|0|||
149174000|NCT01324830|538108748|FG010|Overall Study|Adverse Event, non-fatal|1|||
148929277|NCT03416374|537226270|FG000|Between Treatment Period I and II|Other|0|||
148929278|NCT03416374|537226271|FG001|Between Treatment Period I and II|Other|9|||
148929279|NCT03416374|537226270|FG000|Treatment Period II|Lack of Efficacy|3|||
148929280|NCT03416374|537226271|FG001|Treatment Period II|Lack of Efficacy|11|||
148929281|NCT03416374|537226270|FG000|Treatment Period II|Adverse Event|1|||
148929282|NCT03416374|537226271|FG001|Treatment Period II|Adverse Event|4|||
148929283|NCT03416374|537226270|FG000|Treatment Period II|Death|0|||
148929284|NCT03416374|537226271|FG001|Treatment Period II|Death|1|||
148929285|NCT03416374|537226270|FG000|Treatment Period II|Other|0|||
148929286|NCT03416374|537226271|FG001|Treatment Period II|Other|2|||
148929287|NCT03463031|537226274|FG000|Overall Study|Withdrawal by Subject|4|||
148929288|NCT03463031|537226275|FG001|Overall Study|Withdrawal by Subject|2|||
148929289|NCT03463031|537226274|FG000|Overall Study|Investigator/Sponsor Decision|0|||
148929290|NCT03463031|537226275|FG001|Overall Study|Investigator/Sponsor Decision|1|||
148929291|NCT03463031|537226274|FG000|Overall Study|Lost to Follow-up|1|||
148929292|NCT03463031|537226275|FG001|Overall Study|Lost to Follow-up|1|||
148929293|NCT03463031|537226274|FG000|Overall Study|Adverse Event|4|||
148929294|NCT03463031|537226275|FG001|Overall Study|Adverse Event|1|||
148929295|NCT03463031|537226274|FG000|Overall Study|Use of prohibited medication by subject|1|||
148929296|NCT03463031|537226275|FG001|Overall Study|Use of prohibited medication by subject|0|||
148929297|NCT01068652|537226276|FG000|Overall Study|Adverse Event|4|||
148929298|NCT01068652|537226277|FG001|Overall Study|Adverse Event|0|||
148929299|NCT01068652|537226276|FG000|Overall Study|Lack of Efficacy|0|||
148929300|NCT01068652|537226277|FG001|Overall Study|Lack of Efficacy|2|||
148929301|NCT01068652|537226276|FG000|Overall Study|Lost to Follow-up|2|||
148929302|NCT01068652|537226277|FG001|Overall Study|Lost to Follow-up|1|||
148929303|NCT01068652|537226276|FG000|Overall Study|Protocol Violation|3|||
148929304|NCT01068652|537226277|FG001|Overall Study|Protocol Violation|6|||
149174001|NCT01324830|538108749|FG011|Overall Study|Adverse Event, non-fatal|0|||
149174002|NCT01324830|538108750|FG012|Overall Study|Adverse Event, non-fatal|0|||
149174003|NCT01324830|538108751|FG013|Overall Study|Adverse Event, non-fatal|0|||
149174004|NCT01324830|538108752|FG014|Overall Study|Adverse Event, non-fatal|0|||
149174005|NCT01324830|538108753|FG015|Overall Study|Adverse Event, non-fatal|0|||
149174006|NCT01324830|538108754|FG016|Overall Study|Adverse Event, non-fatal|0|||
149174007|NCT01324830|538108755|FG017|Overall Study|Adverse Event, non-fatal|1|||
149174008|NCT01324830|538108756|FG018|Overall Study|Adverse Event, non-fatal|0|||
149174009|NCT01324830|538108738|FG000|Overall Study|Withdrawal by Subject|0|||
149174010|NCT01324830|538108739|FG001|Overall Study|Withdrawal by Subject|0|||
149174011|NCT01324830|538108740|FG002|Overall Study|Withdrawal by Subject|0|||
148929305|NCT01068652|537226276|FG000|Overall Study|Withdrawal criteria|1|||
148929306|NCT01068652|537226277|FG001|Overall Study|Withdrawal criteria|2|||
148929307|NCT01068652|537226276|FG000|Overall Study|Patient was not eligible|1|||
148929308|NCT01068652|537226277|FG001|Overall Study|Patient was not eligible|0|||
148929309|NCT01068652|537226276|FG000|Overall Study|Unclassified|7|||
148929310|NCT01068652|537226277|FG001|Overall Study|Unclassified|4|||
148929311|NCT01058265|537226278|FG000|Overall Study|Lost to Follow-up|11|||
148929312|NCT01058265|537226279|FG001|Overall Study|Lost to Follow-up|12|||
148929313|NCT02169284|537226282|FG000|Overall Study|Physician Decision|0|||
148929314|NCT02169284|537226283|FG001|Overall Study|Physician Decision|1|||
148929315|NCT03583073|537226284|FG000|Overall Study|Lost to Follow-up|8|||
148929316|NCT03583073|537226285|FG001|Overall Study|Lost to Follow-up|12|||
148929317|NCT02964507|537226286|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
148929318|NCT02964507|537226287|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
148929319|NCT02964507|537226288|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
148929320|NCT02964507|537226289|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
148929321|NCT02964507|537226290|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
148929322|NCT02964507|537226291|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
148929323|NCT02964507|537226292|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
148929324|NCT02964507|537226293|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
148929325|NCT02964507|537226286|FG000|Overall Study|Study terminated by Sponsor|9|||
148929326|NCT02964507|537226287|FG001|Overall Study|Study terminated by Sponsor|1|||
148929327|NCT02964507|537226288|FG002|Overall Study|Study terminated by Sponsor|9|||
148929328|NCT02964507|537226289|FG003|Overall Study|Study terminated by Sponsor|3|||
148929329|NCT02964507|537226290|FG004|Overall Study|Study terminated by Sponsor|3|||
148929330|NCT02964507|537226291|FG005|Overall Study|Study terminated by Sponsor|2|||
148929331|NCT02964507|537226292|FG006|Overall Study|Study terminated by Sponsor|0|||
148929332|NCT02964507|537226293|FG007|Overall Study|Study terminated by Sponsor|0|||
148929333|NCT02964507|537226286|FG000|Overall Study|Other|3|||
148929334|NCT02964507|537226287|FG001|Overall Study|Other|0|||
148929335|NCT02964507|537226288|FG002|Overall Study|Other|0|||
148929336|NCT02964507|537226289|FG003|Overall Study|Other|0|||
148929337|NCT02964507|537226290|FG004|Overall Study|Other|1|||
148929338|NCT02964507|537226291|FG005|Overall Study|Other|0|||
148929339|NCT02964507|537226292|FG006|Overall Study|Other|0|||
148929340|NCT02964507|537226293|FG007|Overall Study|Other|0|||
148929341|NCT02964507|537226286|FG000|Overall Study|Death|11|||
148929342|NCT02964507|537226287|FG001|Overall Study|Death|9|||
148929343|NCT02964507|537226288|FG002|Overall Study|Death|12|||
148929344|NCT02964507|537226289|FG003|Overall Study|Death|2|||
148929345|NCT02964507|537226290|FG004|Overall Study|Death|10|||
148929346|NCT02964507|537226291|FG005|Overall Study|Death|5|||
148929347|NCT02964507|537226292|FG006|Overall Study|Death|0|||
148929348|NCT02964507|537226293|FG007|Overall Study|Death|0|||
148929349|NCT02964507|537226286|FG000|Overall Study|Withdrawal by Subject|1|||
148929350|NCT02964507|537226287|FG001|Overall Study|Withdrawal by Subject|0|||
148929351|NCT02964507|537226288|FG002|Overall Study|Withdrawal by Subject|1|||
148929352|NCT02964507|537226289|FG003|Overall Study|Withdrawal by Subject|1|||
148929353|NCT02964507|537226290|FG004|Overall Study|Withdrawal by Subject|0|||
148929354|NCT02964507|537226291|FG005|Overall Study|Withdrawal by Subject|1|||
148929355|NCT02964507|537226292|FG006|Overall Study|Withdrawal by Subject|0|||
148929356|NCT02964507|537226293|FG007|Overall Study|Withdrawal by Subject|0|||
148929357|NCT02964507|537226286|FG000|Overall Study|Physician Decision|2|||
148929358|NCT02964507|537226287|FG001|Overall Study|Physician Decision|0|||
148929359|NCT02964507|537226288|FG002|Overall Study|Physician Decision|3|||
148929360|NCT02964507|537226289|FG003|Overall Study|Physician Decision|0|||
148929361|NCT02964507|537226290|FG004|Overall Study|Physician Decision|1|||
148929362|NCT02964507|537226291|FG005|Overall Study|Physician Decision|0|||
148929363|NCT02964507|537226292|FG006|Overall Study|Physician Decision|0|||
148929364|NCT02964507|537226293|FG007|Overall Study|Physician Decision|0|||
148929365|NCT04341662|537226295|FG000|Overall Study|Did not have source-verified blood loss data|423|||
148929366|NCT04341662|537226296|FG001|Overall Study|Did not have source-verified blood loss data|514|||
148929367|NCT05323656|537226297|FG000|Overall Study|Still On-Treatment|6|||
148929368|NCT05323656|537226298|FG001|Overall Study|Still On-Treatment|6|||
148929369|NCT05323656|537226297|FG000|Overall Study|Progressive Disease|15|||
148929370|NCT05323656|537226298|FG001|Overall Study|Progressive Disease|14|||
148929371|NCT05323656|537226297|FG000|Overall Study|Adverse Event|2|||
148929372|NCT05323656|537226298|FG001|Overall Study|Adverse Event|3|||
148929373|NCT05323656|537226297|FG000|Overall Study|Death|1|||
148929374|NCT05323656|537226298|FG001|Overall Study|Death|2|||
148929375|NCT05323656|537226297|FG000|Overall Study|Withdrawal by Subject|1|||
148929376|NCT05323656|537226298|FG001|Overall Study|Withdrawal by Subject|0|||
148929377|NCT05323656|537226297|FG000|Overall Study|Clinical disease progression|0|||
148929378|NCT05323656|537226298|FG001|Overall Study|Clinical disease progression|1|||
148929379|NCT05323656|537226297|FG000|Overall Study|Patient and Investigator decision|1|||
148929380|NCT05323656|537226298|FG001|Overall Study|Patient and Investigator decision|0|||
148929381|NCT05323656|537226297|FG000|Overall Study|Physician Decision|0|||
148929382|NCT05323656|537226298|FG001|Overall Study|Physician Decision|1|||
148929383|NCT03880461|537226302|FG000|Overall Study|Determined ineligible after enrollment|45|||
148929384|NCT03880461|537226303|FG001|Overall Study|Determined ineligible after enrollment|44|||
148929385|NCT03880461|537226302|FG000|Overall Study|No weight measurement after enrollment|24|||
148929386|NCT03880461|537226303|FG001|Overall Study|No weight measurement after enrollment|17|||
148929387|NCT01028378|537226305|FG000|Overall Study|Lost to Follow-up|12|||
148929388|NCT01028378|537226305|FG000|Overall Study|Withdrawal by Subject|1|||
148929389|NCT01028378|537226305|FG000|Overall Study|Adminstrative Reasons|4|||
148929390|NCT00064298|537226309|FG000|Overall Study|Withdrawal by Subject|2|||
148929391|NCT00064298|537226310|FG001|Overall Study|Withdrawal by Subject|1|||
148929392|NCT00064298|537226309|FG000|Overall Study|Lost to Follow-up|2|||
148929393|NCT00064298|537226310|FG001|Overall Study|Lost to Follow-up|2|||
148929394|NCT00064298|537226309|FG000|Overall Study|Death|0|||
148929395|NCT00064298|537226310|FG001|Overall Study|Death|1|||
148929396|NCT00064298|537226309|FG000|Overall Study|Disease Progression|2|||
148929397|NCT00064298|537226310|FG001|Overall Study|Disease Progression|1|||
148929398|NCT01390220|537226311|FG000|Test Dose Phase|Adverse Event|17|||
148929399|NCT01390220|537226312|FG001|Test Dose Phase|Adverse Event|0|||
148929400|NCT01390220|537226313|FG002|Test Dose Phase|Adverse Event|0|||
148929401|NCT01390220|537226311|FG000|Test Dose Phase|Withdrawal by Subject|8|||
148929402|NCT01390220|537226312|FG001|Test Dose Phase|Withdrawal by Subject|0|||
148929403|NCT01390220|537226313|FG002|Test Dose Phase|Withdrawal by Subject|0|||
148929404|NCT01390220|537226311|FG000|Test Dose Phase|Lost to Follow-up|2|||
148929405|NCT01390220|537226312|FG001|Test Dose Phase|Lost to Follow-up|0|||
148929406|NCT01390220|537226313|FG002|Test Dose Phase|Lost to Follow-up|0|||
148929407|NCT01390220|537226311|FG000|Test Dose Phase|Protocol Violation|8|||
148929408|NCT01390220|537226312|FG001|Test Dose Phase|Protocol Violation|0|||
148929409|NCT01390220|537226313|FG002|Test Dose Phase|Protocol Violation|0|||
148929410|NCT01390220|537226311|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
148929411|NCT01390220|537226312|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
148929412|NCT01390220|537226313|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
148929413|NCT01390220|537226311|FG000|Test Dose Phase|Study/Site closure|6|||
148929414|NCT01390220|537226312|FG001|Test Dose Phase|Study/Site closure|0|||
148929415|NCT01390220|537226313|FG002|Test Dose Phase|Study/Site closure|0|||
148929416|NCT01390220|537226311|FG000|Test Dose Phase|Caregiver no longer available|5|||
148929417|NCT01390220|537226312|FG001|Test Dose Phase|Caregiver no longer available|0|||
148929418|NCT01390220|537226313|FG002|Test Dose Phase|Caregiver no longer available|0|||
148929419|NCT01390220|537226311|FG000|Test Dose Phase|Noncompliance|2|||
148929420|NCT01390220|537226312|FG001|Test Dose Phase|Noncompliance|0|||
148929421|NCT01390220|537226313|FG002|Test Dose Phase|Noncompliance|0|||
148929422|NCT01390220|537226311|FG000|Test Dose Phase|Logistical|6|||
148929423|NCT01390220|537226312|FG001|Test Dose Phase|Logistical|0|||
148929424|NCT01390220|537226313|FG002|Test Dose Phase|Logistical|0|||
148929425|NCT01390220|537226311|FG000|Comparative Phase|Withdrawal by Subject|0|||
148929426|NCT01390220|537226312|FG001|Comparative Phase|Withdrawal by Subject|1|||
148929427|NCT01390220|537226313|FG002|Comparative Phase|Withdrawal by Subject|0|||
148929428|NCT02273739|537226314|FG000|Overall Study|Progression of Disease|3|||
148929429|NCT02273739|537226315|FG001|Overall Study|Progression of Disease|4|||
148929430|NCT02273739|537226316|FG002|Overall Study|Progression of Disease|5|||
148929431|NCT02273739|537226317|FG003|Overall Study|Progression of Disease|2|||
148929432|NCT02273739|537226314|FG000|Overall Study|Death|0|||
148678661|NCT00370396|536297220|FG001|Overall Study|Withdrawal by Subject|0|||
148678662|NCT00370396|536297221|FG002|Overall Study|Withdrawal by Subject|1|||
148929433|NCT02273739|537226315|FG001|Overall Study|Death|0|||
148929434|NCT02273739|537226316|FG002|Overall Study|Death|0|||
148929435|NCT02273739|537226317|FG003|Overall Study|Death|2|||
148929436|NCT02273739|537226314|FG000|Overall Study|Adverse Event|0|||
148929437|NCT02273739|537226315|FG001|Overall Study|Adverse Event|0|||
148929438|NCT02273739|537226316|FG002|Overall Study|Adverse Event|0|||
148929439|NCT02273739|537226317|FG003|Overall Study|Adverse Event|1|||
148929440|NCT02273739|537226314|FG000|Overall Study|Withdrawal by Subject|0|||
148929441|NCT02273739|537226315|FG001|Overall Study|Withdrawal by Subject|0|||
148929442|NCT02273739|537226316|FG002|Overall Study|Withdrawal by Subject|2|||
148929443|NCT02273739|537226317|FG003|Overall Study|Withdrawal by Subject|1|||
148929444|NCT02273739|537226314|FG000|Overall Study|Physician Decision|0|||
148678663|NCT00370396|536297219|FG000|Overall Study|Lost to Follow-up|11|||
148678664|NCT00370396|536297220|FG001|Overall Study|Lost to Follow-up|1|||
148678665|NCT00370396|536297221|FG002|Overall Study|Lost to Follow-up|0|||
148678666|NCT02065791|536297222|FG000|Overall Study|Closed Site|1|||
148678667|NCT02065791|536297223|FG001|Overall Study|Closed Site|1|||
148678668|NCT02065791|536297222|FG000|Overall Study|Withdrawal by Subject|11|||
148678669|NCT02065791|536297223|FG001|Overall Study|Withdrawal by Subject|5|||
148678670|NCT02065791|536297222|FG000|Overall Study|Lost to Follow-up|13|||
148678671|NCT02065791|536297223|FG001|Overall Study|Lost to Follow-up|9|||
148678672|NCT00995488|536297226|FG000|Overall Study|Withdrawal by Subject|1|||
148678673|NCT04529499|536297227|FG000|Overall Study|Withdrawal by Subject|9|||
148678674|NCT04529499|536297228|FG001|Overall Study|Withdrawal by Subject|11|||
148678675|NCT04529499|536297227|FG000|Overall Study|Physician Decision|1|||
148678676|NCT04529499|536297228|FG001|Overall Study|Physician Decision|2|||
148678677|NCT04529499|536297227|FG000|Overall Study|Adverse Event|4|||
148678678|NCT04529499|536297228|FG001|Overall Study|Adverse Event|4|||
148678679|NCT04529499|536297227|FG000|Overall Study|Death|14|||
148678680|NCT04529499|536297228|FG001|Overall Study|Death|11|||
148678681|NCT04529499|536297227|FG000|Overall Study|Lost to Follow-up|1|||
148678682|NCT04529499|536297228|FG001|Overall Study|Lost to Follow-up|1|||
148678683|NCT04529499|536297227|FG000|Overall Study|Others|7|||
148678684|NCT04529499|536297228|FG001|Overall Study|Others|11|||
148678685|NCT02441179|536297229|FG000|Overall Study|Withdrawal by Subject|1|||
148678686|NCT02441179|536297230|FG001|Overall Study|Withdrawal by Subject|1|||
148678687|NCT02702271|536297232|FG000|Overall Study|Death|36|||
148678688|NCT02702271|536297233|FG001|Overall Study|Death|7|||
148678689|NCT02702271|536297232|FG000|Overall Study|Lost to Follow-up|12|||
148678690|NCT02702271|536297233|FG001|Overall Study|Lost to Follow-up|0|||
148678691|NCT02702271|536297232|FG000|Overall Study|Withdrawal by Subject|8|||
148678692|NCT02702271|536297233|FG001|Overall Study|Withdrawal by Subject|1|||
148678693|NCT02702271|536297232|FG000|Overall Study|Physician Decision|2|||
148678694|NCT02702271|536297233|FG001|Overall Study|Physician Decision|0|||
148678695|NCT02702271|536297232|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
148678696|NCT02702271|536297233|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
148678697|NCT01494649|536297234|FG000|Overall Study|Lost to Follow-up|0|||
148678698|NCT01494649|536297235|FG001|Overall Study|Lost to Follow-up|1|||
148678699|NCT03091400|536297236|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
148678700|NCT03091400|536297237|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
148678701|NCT03467971|536297238|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148678702|NCT03467971|536297239|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148678703|NCT00975884|536297240|FG000|Overall Study|Adverse Event|1|||
148678704|NCT00975884|536297241|FG001|Overall Study|Adverse Event|0|||
148678705|NCT00975884|536297240|FG000|Overall Study|Lost to Follow-up|5|||
148678706|NCT00975884|536297241|FG001|Overall Study|Lost to Follow-up|3|||
148678707|NCT00975884|536297240|FG000|Overall Study|Withdrawal by Subject|9|||
148678708|NCT00975884|536297241|FG001|Overall Study|Withdrawal by Subject|9|||
148678709|NCT00975884|536297240|FG000|Overall Study|Other|1|||
148678710|NCT00975884|536297241|FG001|Overall Study|Other|3|||
148678711|NCT01656967|536297242|FG000|Overall Study|faulty monitor|1|||
148678712|NCT01656967|536297243|FG001|Overall Study|faulty monitor|0|||
148929445|NCT02273739|537226315|FG001|Overall Study|Physician Decision|0|||
148929446|NCT02273739|537226316|FG002|Overall Study|Physician Decision|0|||
148929447|NCT02273739|537226317|FG003|Overall Study|Physician Decision|1|||
148929448|NCT01309893|537226318|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
148929449|NCT01309893|537226319|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
148929450|NCT01309893|537226318|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
148929451|NCT01309893|537226319|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
148929452|NCT01858636|537226321|FG000|Overall Study|No Device Deployment Attempted|24|||
148929453|NCT01858636|537226321|FG000|Overall Study|Physician Decision|1|||
148929454|NCT01858636|537226321|FG000|Overall Study|Death|1|||
148929455|NCT01858636|537226321|FG000|Overall Study|Lost to Follow-up|1|||
148929456|NCT01858636|537226321|FG000|Overall Study|Withdrawal by Subject|1|||
148929457|NCT02862600|537226322|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
148678713|NCT01656967|536297242|FG000|Overall Study|unsuccessful ETT insertion|3|||
148678714|NCT01656967|536297243|FG001|Overall Study|unsuccessful ETT insertion|2|||
148678715|NCT00051636|536297244|FG000|Period 1 - Core|Adverse Event|2|||
148678716|NCT00051636|536297245|FG001|Period 1 - Core|Adverse Event|2|||
148678717|NCT00051636|536297244|FG000|Period 1 - Core|Protocol Violation|1|||
148678718|NCT00051636|536297245|FG001|Period 1 - Core|Protocol Violation|0|||
148678719|NCT00051636|536297244|FG000|Period 1 - Core|Withdrawal by Subject|1|||
148678720|NCT00051636|536297245|FG001|Period 1 - Core|Withdrawal by Subject|2|||
148678721|NCT00051636|536297244|FG000|Period 1 - Core|Lost to Follow-up|0|||
148678722|NCT00051636|536297245|FG001|Period 1 - Core|Lost to Follow-up|2|||
148678723|NCT00051636|536297244|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
148678724|NCT00051636|536297245|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
148678725|NCT00051636|536297244|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
148691440|NCT01325207|536344178|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
148929458|NCT02862600|537226322|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
148929459|NCT02862600|537226322|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
148929460|NCT02862600|537226322|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
148929461|NCT02280473|537226332|FG000|Overall Study|Adverse Event|1|||
148929462|NCT02280473|537226333|FG001|Overall Study|Adverse Event|1|||
148678726|NCT00051636|536297245|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
148929463|NCT02280473|537226332|FG000|Overall Study|Lack of Efficacy|0|||
148929464|NCT02280473|537226333|FG001|Overall Study|Lack of Efficacy|1|||
148929465|NCT02280473|537226332|FG000|Overall Study|Lost to Follow-up|0|||
148929466|NCT02280473|537226333|FG001|Overall Study|Lost to Follow-up|1|||
148929467|NCT04223232|537226336|FG000|Overall Study|Withdrawal by Subject|1|||
148929468|NCT00364130|537226337|FG000|Intervention Period|Lost to Follow-up|4|||
148929469|NCT00364130|537226338|FG001|Intervention Period|Lost to Follow-up|3|||
148929470|NCT00364130|537226337|FG000|Intervention Period|Pregnancy|1|||
148929471|NCT00364130|537226338|FG001|Intervention Period|Pregnancy|0|||
148929472|NCT00364130|537226337|FG000|Intervention Period|Withdrawal by Subject|4|||
148929473|NCT00364130|537226338|FG001|Intervention Period|Withdrawal by Subject|5|||
148929474|NCT00364130|537226337|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
148929475|NCT00364130|537226338|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
148929476|NCT05281601|537226339|FG000|Overall Study|Physician Decision|2|||
148929477|NCT05281601|537226340|FG001|Overall Study|Physician Decision|0|||
148929478|NCT05281601|537226339|FG000|Overall Study|Lost to Follow-up|2|||
148929479|NCT05281601|537226340|FG001|Overall Study|Lost to Follow-up|0|||
148929480|NCT05281601|537226339|FG000|Overall Study|Death|1|||
148929481|NCT05281601|537226340|FG001|Overall Study|Death|0|||
148929482|NCT05281601|537226339|FG000|Overall Study|Withdrawal by parent/guardian|2|||
148929483|NCT05281601|537226340|FG001|Overall Study|Withdrawal by parent/guardian|1|||
148929484|NCT00901927|537226341|FG000|Overall Study|Lack of Efficacy|1|||
148929485|NCT00901927|537226341|FG000|Overall Study|Protocol Violation|3|||
148929486|NCT00901927|537226341|FG000|Overall Study|Withdrawal by Subject|2|||
148929487|NCT01178073|537226348|FG000|Overall Study|Adverse Event|34|||
148929488|NCT01178073|537226349|FG001|Overall Study|Adverse Event|27|||
148929489|NCT01178073|537226350|FG002|Overall Study|Adverse Event|24|||
148929490|NCT01178073|537226348|FG000|Overall Study|Protocol Violation|1|||
148929491|NCT01178073|537226349|FG001|Overall Study|Protocol Violation|1|||
148929492|NCT01178073|537226350|FG002|Overall Study|Protocol Violation|1|||
148929493|NCT01178073|537226348|FG000|Overall Study|Lost to Follow-up|2|||
148929494|NCT01178073|537226349|FG001|Overall Study|Lost to Follow-up|0|||
148929495|NCT01178073|537226350|FG002|Overall Study|Lost to Follow-up|3|||
148929496|NCT01178073|537226348|FG000|Overall Study|Physician Decision|14|||
148929497|NCT01178073|537226349|FG001|Overall Study|Physician Decision|10|||
148929498|NCT01178073|537226350|FG002|Overall Study|Physician Decision|10|||
148929499|NCT01178073|537226348|FG000|Overall Study|Withdrawal by Subject|10|||
148678727|NCT00051636|536297244|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
148929500|NCT01178073|537226349|FG001|Overall Study|Withdrawal by Subject|6|||
148929501|NCT01178073|537226350|FG002|Overall Study|Withdrawal by Subject|8|||
149174012|NCT01324830|538108741|FG003|Overall Study|Withdrawal by Subject|0|||
149174013|NCT01324830|538108742|FG004|Overall Study|Withdrawal by Subject|0|||
149174014|NCT01324830|538108743|FG005|Overall Study|Withdrawal by Subject|1|||
149174015|NCT01324830|538108744|FG006|Overall Study|Withdrawal by Subject|0|||
149174016|NCT01324830|538108745|FG007|Overall Study|Withdrawal by Subject|0|||
149174017|NCT01324830|538108746|FG008|Overall Study|Withdrawal by Subject|0|||
149174018|NCT01324830|538108747|FG009|Overall Study|Withdrawal by Subject|0|||
149174019|NCT01324830|538108748|FG010|Overall Study|Withdrawal by Subject|1|||
149174020|NCT01324830|538108749|FG011|Overall Study|Withdrawal by Subject|0|||
149174021|NCT01324830|538108750|FG012|Overall Study|Withdrawal by Subject|0|||
149174022|NCT01324830|538108751|FG013|Overall Study|Withdrawal by Subject|0|||
149174023|NCT01324830|538108752|FG014|Overall Study|Withdrawal by Subject|0|||
149174024|NCT01324830|538108753|FG015|Overall Study|Withdrawal by Subject|0|||
149174025|NCT01324830|538108754|FG016|Overall Study|Withdrawal by Subject|0|||
149174026|NCT01324830|538108755|FG017|Overall Study|Withdrawal by Subject|0|||
149174027|NCT01324830|538108756|FG018|Overall Study|Withdrawal by Subject|1|||
149174028|NCT01485614|538108757|FG000|Randomization|Not Treated|1|||
149174029|NCT01485614|538108758|FG001|Randomization|Not Treated|0|||
149174030|NCT01485614|538108759|FG002|Randomization|Not Treated|0|||
149174031|NCT01485614|538108760|FG003|Randomization|Not Treated|0|||
149174032|NCT01485614|538108757|FG000|Weeks 0-20|Lost to Follow-up|2|||
148678728|NCT00051636|536297245|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
148929502|NCT01178073|537226348|FG000|Overall Study|Missing Completion Status|1|||
148929503|NCT01178073|537226349|FG001|Overall Study|Missing Completion Status|0|||
148929504|NCT01178073|537226350|FG002|Overall Study|Missing Completion Status|0|||
148929505|NCT01674634|537226353|FG000|Overall Study|Withdrawal by Subject|3|||
148929506|NCT01674634|537226353|FG000|Overall Study|Lost to Follow-up|3|||
148929507|NCT00937391|537226354|FG000|Stage 2|Withdrawal by Subject|1|||
148929508|NCT02021656|537226374|FG000|Overall Study|Adverse Event|1|||
148929509|NCT02021656|537226374|FG000|Overall Study|Lack of Efficacy|2|||
149174033|NCT01485614|538108758|FG001|Weeks 0-20|Lost to Follow-up|0|||
149174034|NCT01485614|538108759|FG002|Weeks 0-20|Lost to Follow-up|0|||
149174035|NCT01485614|538108760|FG003|Weeks 0-20|Lost to Follow-up|0|||
149174036|NCT01485614|538108757|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
149174037|NCT01485614|538108758|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
149174038|NCT01485614|538108759|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
149174039|NCT01485614|538108760|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
149174040|NCT01485614|538108757|FG000|Weeks 0-20|Withdrawal by Subject|3|||
149174041|NCT01485614|538108758|FG001|Weeks 0-20|Withdrawal by Subject|2|||
149174042|NCT01485614|538108759|FG002|Weeks 0-20|Withdrawal by Subject|1|||
149174043|NCT01485614|538108760|FG003|Weeks 0-20|Withdrawal by Subject|0|||
149174044|NCT01485614|538108757|FG000|Weeks 20-54|Lost to Follow-up|4|||
149174045|NCT01485614|538108758|FG001|Weeks 20-54|Lost to Follow-up|3|||
149174046|NCT01485614|538108759|FG002|Weeks 20-54|Lost to Follow-up|1|||
149174047|NCT01485614|538108760|FG003|Weeks 20-54|Lost to Follow-up|0|||
148929510|NCT02021656|537226374|FG000|Overall Study|Lost to Follow-up|1|||
148929511|NCT02021656|537226374|FG000|Overall Study|Withdrew Consent|2|||
148929512|NCT00510952|537226375|FG000|Overall Study|Adverse Event|1|||
148929513|NCT00510952|537226376|FG001|Overall Study|Adverse Event|0|||
148929514|NCT00510952|537226375|FG000|Overall Study|Entry Criteria Not Met|3|||
148929515|NCT00510952|537226376|FG001|Overall Study|Entry Criteria Not Met|1|||
148929516|NCT00510952|537226375|FG000|Overall Study|Lost to Follow-up|5|||
148929517|NCT00510952|537226376|FG001|Overall Study|Lost to Follow-up|3|||
148929518|NCT00510952|537226375|FG000|Overall Study|Physician Decision|1|||
148929519|NCT00510952|537226376|FG001|Overall Study|Physician Decision|1|||
148929520|NCT00510952|537226375|FG000|Overall Study|Protocol Violation|7|||
148929521|NCT00510952|537226376|FG001|Overall Study|Protocol Violation|4|||
148929522|NCT00510952|537226375|FG000|Overall Study|Sponsor Decision|1|||
148929523|NCT00510952|537226376|FG001|Overall Study|Sponsor Decision|0|||
148929524|NCT00510952|537226375|FG000|Overall Study|Withdrawal by Subject|6|||
148929525|NCT00510952|537226376|FG001|Overall Study|Withdrawal by Subject|7|||
148929526|NCT00510952|537226375|FG000|Overall Study|Did Not Receive Study Drug|2|||
149174048|NCT01485614|538108757|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
149174049|NCT01485614|538108758|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
149174050|NCT01485614|538108759|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
149174051|NCT01485614|538108760|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
149174052|NCT01485614|538108757|FG000|Weeks 20-54|Withdrawal by Subject|5|||
148678729|NCT00051636|536297244|FG000|Period 2- Extended Observation Period|Death|4|||
148678730|NCT00051636|536297245|FG001|Period 2- Extended Observation Period|Death|5|||
148678731|NCT00051636|536297244|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
148678732|NCT00051636|536297245|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
148678733|NCT01174368|536297246|FG000|Overall Study|Withdrawal by Subject|1|||
148678734|NCT00479765|536297247|FG000|Overall Study|study terminated|4|||
148678735|NCT05789420|536297250|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
148678736|NCT05789420|536297250|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
148678737|NCT05473247|536297251|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
148678738|NCT02392559|536297252|FG000|Overall Study|Withdrawal by Subject|0|||
148678739|NCT02392559|536297253|FG001|Overall Study|Withdrawal by Subject|1|||
148678740|NCT00944125|536297261|FG000|3 to 6 Months|Withdrawal by Subject|0|||
148678741|NCT00944125|536297262|FG001|3 to 6 Months|Withdrawal by Subject|2|||
148929527|NCT00510952|537226376|FG001|Overall Study|Did Not Receive Study Drug|0|||
148929528|NCT03172910|537228304|FG000|Overall Study|Adverse Event|0|||
148929529|NCT03172910|537228305|FG001|Overall Study|Adverse Event|0|||
148929530|NCT03172910|537228306|FG002|Overall Study|Adverse Event|0|||
148929531|NCT03172910|537228307|FG003|Overall Study|Adverse Event|0|||
148929532|NCT03172910|537228308|FG004|Overall Study|Adverse Event|1|||
149174053|NCT01485614|538108758|FG001|Weeks 20-54|Withdrawal by Subject|3|||
149174054|NCT01485614|538108759|FG002|Weeks 20-54|Withdrawal by Subject|0|||
149174055|NCT01485614|538108760|FG003|Weeks 20-54|Withdrawal by Subject|0|||
149174056|NCT00733902|538108761|FG000|Overall Study|Death|0|||
148929533|NCT01659658|537228310|FG000|Overall Study|Withdrawal by Patient|18|||
148929534|NCT01659658|537228311|FG001|Overall Study|Withdrawal by Patient|4|||
148929535|NCT01659658|537228312|FG002|Overall Study|Withdrawal by Patient|2|||
148929536|NCT01659658|537228313|FG003|Overall Study|Withdrawal by Patient|0|||
148929537|NCT01659658|537228314|FG004|Overall Study|Withdrawal by Patient|11|||
148929538|NCT01659658|537228310|FG000|Overall Study|Study Terminated by Sponsor|9|||
148929539|NCT01659658|537228311|FG001|Overall Study|Study Terminated by Sponsor|7|||
148929540|NCT01659658|537228312|FG002|Overall Study|Study Terminated by Sponsor|0|||
148929541|NCT01659658|537228313|FG003|Overall Study|Study Terminated by Sponsor|1|||
148929542|NCT01659658|537228314|FG004|Overall Study|Study Terminated by Sponsor|4|||
148929543|NCT01659658|537228310|FG000|Overall Study|Reason not Specified|61|||
148929544|NCT01659658|537228311|FG001|Overall Study|Reason not Specified|15|||
148929545|NCT01659658|537228312|FG002|Overall Study|Reason not Specified|8|||
148929546|NCT01659658|537228313|FG003|Overall Study|Reason not Specified|1|||
148929547|NCT01659658|537228314|FG004|Overall Study|Reason not Specified|34|||
148929548|NCT01659658|537228310|FG000|Overall Study|Lost to Follow-up|2|||
148929549|NCT01659658|537228311|FG001|Overall Study|Lost to Follow-up|0|||
148929550|NCT01659658|537228312|FG002|Overall Study|Lost to Follow-up|0|||
148929551|NCT01659658|537228313|FG003|Overall Study|Lost to Follow-up|0|||
148929552|NCT01659658|537228314|FG004|Overall Study|Lost to Follow-up|0|||
148929553|NCT01927341|537228316|FG000|Phase 1b|Lost to Follow-up|1|||
148929554|NCT01927341|537228317|FG001|Phase 1b|Lost to Follow-up|0|||
148929555|NCT01927341|537228318|FG002|Phase 1b|Lost to Follow-up|0|||
148929556|NCT01927341|537228319|FG003|Phase 1b|Lost to Follow-up|0|||
148929557|NCT01927341|537228320|FG004|Phase 1b|Lost to Follow-up|0|||
148929558|NCT01927341|537228316|FG000|Phase 1b|Death|2|||
148929559|NCT01927341|537228317|FG001|Phase 1b|Death|0|||
148929560|NCT01927341|537228318|FG002|Phase 1b|Death|0|||
148929561|NCT01927341|537228319|FG003|Phase 1b|Death|0|||
148929562|NCT01927341|537228320|FG004|Phase 1b|Death|0|||
148929563|NCT01927341|537228316|FG000|Phase 1b|Follow-up completed|7|||
148929564|NCT01927341|537228317|FG001|Phase 1b|Follow-up completed|0|||
148929565|NCT01927341|537228318|FG002|Phase 1b|Follow-up completed|0|||
148929566|NCT01927341|537228319|FG003|Phase 1b|Follow-up completed|0|||
148929567|NCT01927341|537228320|FG004|Phase 1b|Follow-up completed|0|||
148929568|NCT01927341|537228316|FG000|Phase 2|Lost to Follow-up|0|||
148929569|NCT01927341|537228317|FG001|Phase 2|Lost to Follow-up|1|||
148929570|NCT01927341|537228318|FG002|Phase 2|Lost to Follow-up|0|||
148929571|NCT01927341|537228319|FG003|Phase 2|Lost to Follow-up|0|||
148929572|NCT01927341|537228320|FG004|Phase 2|Lost to Follow-up|0|||
148929573|NCT01927341|537228316|FG000|Phase 2|Participant withdrew consent|0|||
148929574|NCT01927341|537228317|FG001|Phase 2|Participant withdrew consent|2|||
148929575|NCT01927341|537228318|FG002|Phase 2|Participant withdrew consent|1|||
148929576|NCT01927341|537228319|FG003|Phase 2|Participant withdrew consent|2|||
148929577|NCT01927341|537228320|FG004|Phase 2|Participant withdrew consent|3|||
148929578|NCT01927341|537228316|FG000|Phase 2|Death|0|||
148929579|NCT01927341|537228317|FG001|Phase 2|Death|4|||
148929580|NCT01927341|537228318|FG002|Phase 2|Death|0|||
148929581|NCT01927341|537228319|FG003|Phase 2|Death|3|||
148929582|NCT01927341|537228320|FG004|Phase 2|Death|2|||
148929583|NCT01927341|537228316|FG000|Phase 2|New cancer therapy|0|||
148929584|NCT01927341|537228317|FG001|Phase 2|New cancer therapy|1|||
148929585|NCT01927341|537228318|FG002|Phase 2|New cancer therapy|0|||
148929586|NCT01927341|537228319|FG003|Phase 2|New cancer therapy|4|||
148929587|NCT01927341|537228320|FG004|Phase 2|New cancer therapy|1|||
148929588|NCT01927341|537228316|FG000|Phase 2|Disease progression|0|||
148929589|NCT01927341|537228317|FG001|Phase 2|Disease progression|1|||
148929590|NCT01927341|537228318|FG002|Phase 2|Disease progression|1|||
148929591|NCT01927341|537228319|FG003|Phase 2|Disease progression|1|||
148929592|NCT01927341|537228320|FG004|Phase 2|Disease progression|0|||
148929593|NCT01927341|537228316|FG000|Phase 2|Follow-up completed|0|||
148929594|NCT01927341|537228317|FG001|Phase 2|Follow-up completed|6|||
148929595|NCT01927341|537228318|FG002|Phase 2|Follow-up completed|3|||
148929596|NCT01927341|537228319|FG003|Phase 2|Follow-up completed|5|||
148929597|NCT01927341|537228320|FG004|Phase 2|Follow-up completed|2|||
148929598|NCT01397201|537228321|FG000|Overall Study|Not treated|0|||
148929599|NCT01397201|537228322|FG001|Overall Study|Not treated|0|||
148929600|NCT01397201|537228323|FG002|Overall Study|Not treated|1|||
148929601|NCT01397201|537228324|FG003|Overall Study|Not treated|0|||
148929602|NCT01397201|537228325|FG004|Overall Study|Not treated|0|||
148929603|NCT01397201|537228321|FG000|Overall Study|Not yet defined|3|||
148929604|NCT01397201|537228322|FG001|Overall Study|Not yet defined|6|||
148929605|NCT01397201|537228323|FG002|Overall Study|Not yet defined|5|||
148929606|NCT01397201|537228324|FG003|Overall Study|Not yet defined|5|||
148929607|NCT01397201|537228325|FG004|Overall Study|Not yet defined|4|||
148929608|NCT01397201|537228321|FG000|Overall Study|Adverse Event|2|||
148929609|NCT01397201|537228322|FG001|Overall Study|Adverse Event|0|||
148929610|NCT01397201|537228323|FG002|Overall Study|Adverse Event|0|||
148929611|NCT01397201|537228324|FG003|Overall Study|Adverse Event|0|||
148929612|NCT01397201|537228325|FG004|Overall Study|Adverse Event|0|||
148929613|NCT00451451|537228334|FG000|Overall Study|Adverse Event|11|||
148929614|NCT00451451|537228335|FG001|Overall Study|Adverse Event|21|||
148929615|NCT00451451|537228336|FG002|Overall Study|Adverse Event|26|||
148929616|NCT00451451|537228337|FG003|Overall Study|Adverse Event|10|||
148929617|NCT00451451|537228334|FG000|Overall Study|Lost to Follow-up|11|||
148929618|NCT00451451|537228335|FG001|Overall Study|Lost to Follow-up|9|||
148929619|NCT00451451|537228336|FG002|Overall Study|Lost to Follow-up|8|||
148929620|NCT00451451|537228337|FG003|Overall Study|Lost to Follow-up|11|||
148929621|NCT00451451|537228334|FG000|Overall Study|Consent Withdrawn|14|||
148929622|NCT00451451|537228335|FG001|Overall Study|Consent Withdrawn|9|||
148929623|NCT00451451|537228336|FG002|Overall Study|Consent Withdrawn|17|||
148929624|NCT00451451|537228337|FG003|Overall Study|Consent Withdrawn|17|||
148929625|NCT00451451|537228334|FG000|Overall Study|Investigator Decision|6|||
148929626|NCT00451451|537228335|FG001|Overall Study|Investigator Decision|2|||
148929627|NCT00451451|537228336|FG002|Overall Study|Investigator Decision|1|||
148929628|NCT00451451|537228337|FG003|Overall Study|Investigator Decision|2|||
148929629|NCT00451451|537228334|FG000|Overall Study|Subject Non-Compliance|8|||
148929630|NCT00451451|537228335|FG001|Overall Study|Subject Non-Compliance|4|||
148929631|NCT00451451|537228336|FG002|Overall Study|Subject Non-Compliance|3|||
148929632|NCT00451451|537228337|FG003|Overall Study|Subject Non-Compliance|3|||
148929633|NCT00451451|537228334|FG000|Overall Study|Death|1|||
148929634|NCT00451451|537228335|FG001|Overall Study|Death|0|||
148929635|NCT00451451|537228336|FG002|Overall Study|Death|0|||
148929636|NCT00451451|537228337|FG003|Overall Study|Death|1|||
148929637|NCT00451451|537228334|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
148929638|NCT00451451|537228335|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
148929639|NCT00451451|537228336|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
149174057|NCT00733902|538108762|FG001|Overall Study|Death|0|||
148929640|NCT00451451|537228337|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
148929641|NCT00122278|537228338|FG000|Overall Study|Lost to Follow-up|2|||
148929642|NCT00122278|537228339|FG001|Overall Study|Lost to Follow-up|0|||
148929643|NCT01002482|537228340|FG000|Overall Study|Withdrawal by Subject|14|||
148929644|NCT01002482|537228341|FG001|Overall Study|Withdrawal by Subject|21|||
148929645|NCT01002482|537228340|FG000|Overall Study|Included twice|1|||
149174058|NCT00733902|538108763|FG002|Overall Study|Death|0|||
149174059|NCT00733902|538108764|FG003|Overall Study|Death|1|||
149174060|NCT00733902|538108761|FG000|Overall Study|Adverse Event|3|||
149174061|NCT00733902|538108762|FG001|Overall Study|Adverse Event|4|||
149174062|NCT00733902|538108763|FG002|Overall Study|Adverse Event|7|||
149174063|NCT00733902|538108764|FG003|Overall Study|Adverse Event|11|||
149174064|NCT00733902|538108761|FG000|Overall Study|Lack of Efficacy|56|||
149174065|NCT00733902|538108762|FG001|Overall Study|Lack of Efficacy|21|||
149174066|NCT00733902|538108763|FG002|Overall Study|Lack of Efficacy|34|||
149174067|NCT00733902|538108764|FG003|Overall Study|Lack of Efficacy|23|||
149174068|NCT00733902|538108761|FG000|Overall Study|Protocol Violation|4|||
149174069|NCT00733902|538108762|FG001|Overall Study|Protocol Violation|6|||
149174070|NCT00733902|538108763|FG002|Overall Study|Protocol Violation|3|||
149174071|NCT00733902|538108764|FG003|Overall Study|Protocol Violation|3|||
148678742|NCT00944125|536297261|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
148929646|NCT01002482|537228341|FG001|Overall Study|Included twice|0|||
148929647|NCT03347188|537228342|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
148929648|NCT03347188|537228343|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
148929649|NCT03347188|537228342|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
148929650|NCT03347188|537228343|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
148929651|NCT03347188|537228342|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
149174072|NCT00733902|538108761|FG000|Overall Study|Withdrawal by Subject|10|||
149174073|NCT00733902|538108762|FG001|Overall Study|Withdrawal by Subject|5|||
149174074|NCT00733902|538108763|FG002|Overall Study|Withdrawal by Subject|4|||
149174075|NCT00733902|538108764|FG003|Overall Study|Withdrawal by Subject|16|||
149174076|NCT00733902|538108761|FG000|Overall Study|Entered extension study|89|||
149174077|NCT00733902|538108762|FG001|Overall Study|Entered extension study|124|||
149174078|NCT00733902|538108763|FG002|Overall Study|Entered extension study|111|||
149174079|NCT00733902|538108764|FG003|Overall Study|Entered extension study|109|||
149174080|NCT00733902|538108761|FG000|Overall Study|Randomized but not treated|2|||
149174081|NCT00733902|538108762|FG001|Overall Study|Randomized but not treated|2|||
149174082|NCT00733902|538108763|FG002|Overall Study|Randomized but not treated|2|||
149174083|NCT00733902|538108764|FG003|Overall Study|Randomized but not treated|1|||
149174084|NCT02210780|538108765|FG000|Overall Study|Adverse Event|0|||
149174085|NCT02210780|538108766|FG001|Overall Study|Adverse Event|5|||
149174086|NCT02210780|538108765|FG000|Overall Study|Lost to Follow-up|2|||
148929652|NCT03347188|537228343|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
148929653|NCT03347188|537228342|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
148929654|NCT03347188|537228343|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
148929655|NCT03347188|537228342|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
148929656|NCT03347188|537228343|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
148929657|NCT03347188|537228342|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
148929658|NCT03347188|537228343|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
148929659|NCT03347188|537228342|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
148929660|NCT03347188|537228343|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
148929661|NCT03347188|537228342|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
148929662|NCT03347188|537228343|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
148929663|NCT03468985|537228344|FG000|Overall Study|Adverse Event|0|||
148929664|NCT03468985|537228345|FG001|Overall Study|Adverse Event|2|||
148929665|NCT03468985|537228346|FG002|Overall Study|Adverse Event|0|||
148929666|NCT03468985|537228347|FG003|Overall Study|Adverse Event|0|||
148929667|NCT03468985|537228344|FG000|Overall Study|Withdrawal by Subject|0|||
148929668|NCT03468985|537228345|FG001|Overall Study|Withdrawal by Subject|0|||
148929669|NCT03468985|537228346|FG002|Overall Study|Withdrawal by Subject|0|||
148929670|NCT03468985|537228347|FG003|Overall Study|Withdrawal by Subject|1|||
148929671|NCT00417482|537228348|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
148929672|NCT00417482|537228349|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
148929673|NCT00417482|537228350|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
148929674|NCT00417482|537228348|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
148929675|NCT00417482|537228349|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
148929676|NCT00417482|537228350|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
148929677|NCT00417482|537228348|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
148929678|NCT00417482|537228349|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
148929679|NCT00417482|537228350|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
148929680|NCT00417482|537228348|FG000|Phase B 1st 16 Weeks|Death|1|||
148929681|NCT00417482|537228349|FG001|Phase B 1st 16 Weeks|Death|0|||
148929682|NCT00417482|537228350|FG002|Phase B 1st 16 Weeks|Death|0|||
148929683|NCT00417482|537228348|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
149013316|NCT03560258|537527906|FG002|Overall Study|Withdrawal by Subject|1|||
149174087|NCT02210780|538108766|FG001|Overall Study|Lost to Follow-up|1|||
149174088|NCT02210780|538108765|FG000|Overall Study|Withdrawal by Subject|1|||
149174089|NCT02210780|538108766|FG001|Overall Study|Withdrawal by Subject|1|||
149174090|NCT02210780|538108765|FG000|Overall Study|Physician Decision|1|||
149174091|NCT02210780|538108766|FG001|Overall Study|Physician Decision|0|||
148929684|NCT00417482|537228349|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
148929685|NCT00417482|537228350|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
148929686|NCT00417482|537228348|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
148929687|NCT00417482|537228349|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
148929688|NCT00417482|537228350|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
148929689|NCT00417482|537228348|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
148929690|NCT00417482|537228349|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
148929691|NCT00417482|537228350|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
148929692|NCT00417482|537228348|FG000|Phase B 2nd 16 Weeks|Death|1|||
148929693|NCT00417482|537228349|FG001|Phase B 2nd 16 Weeks|Death|1|||
148929694|NCT00417482|537228350|FG002|Phase B 2nd 16 Weeks|Death|0|||
148929695|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
148929696|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
148929697|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
148929698|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
148929699|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
148929700|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
148929701|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
148929702|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
149174092|NCT02210780|538108765|FG000|Overall Study|Protocol Violation|1|||
149174093|NCT02210780|538108766|FG001|Overall Study|Protocol Violation|0|||
148929703|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
148929704|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
149174094|NCT02210780|538108765|FG000|Overall Study|Other than specified above|0|||
148929705|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
148929706|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
148929707|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
148929708|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
148929709|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
148929710|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
148929711|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Program Termination|3|||
148929712|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Program Termination|0|||
148929713|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Program Termination|1|||
148929714|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Program Termination|1|||
148929715|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
148929716|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
148929717|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
148929718|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
148929719|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
148929720|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
148929721|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
148929722|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
148929723|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
148929724|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
148929725|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
148929726|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
148929727|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
148929728|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
148929729|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
148929730|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
148929731|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
148929732|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
148929733|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
148929734|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
148929735|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
148929736|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
148929737|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
148929738|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
148929739|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
148929740|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
148929741|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
148929742|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
149013317|NCT01460160|537527907|FG000|Treatment Phase|Lack of Efficacy|3|||
149013318|NCT01460160|537527907|FG000|Treatment Phase|Study Drug Toxicity|2|||
148806757|NCT03427411|536771007|FG001|Overall Study|Screen failure - platelets too low|1|||
149013319|NCT01460160|537527907|FG000|Treatment Phase|Adverse Event|8|||
149174095|NCT02210780|538108766|FG001|Overall Study|Other than specified above|1|||
149174096|NCT01503021|538108773|FG000|Overall Study|Adverse Event|7|||
149174097|NCT01503021|538108774|FG001|Overall Study|Adverse Event|6|||
149174098|NCT01503021|538108773|FG000|Overall Study|Death|0|||
149174099|NCT01503021|538108774|FG001|Overall Study|Death|2|||
149174100|NCT01503021|538108773|FG000|Overall Study|Lost to Follow-up|2|||
149174101|NCT01503021|538108774|FG001|Overall Study|Lost to Follow-up|0|||
149174102|NCT01503021|538108773|FG000|Overall Study|Physician Decision|3|||
149174103|NCT01503021|538108774|FG001|Overall Study|Physician Decision|0|||
149174104|NCT01503021|538108773|FG000|Overall Study|Protocol Violation|1|||
149174105|NCT01503021|538108774|FG001|Overall Study|Protocol Violation|3|||
149174106|NCT01503021|538108773|FG000|Overall Study|Withdrawal by Subject|9|||
149174107|NCT01503021|538108774|FG001|Overall Study|Withdrawal by Subject|8|||
149174108|NCT01503021|538108773|FG000|Overall Study|Moved, received transplant, etc.|5|||
149174109|NCT01503021|538108774|FG001|Overall Study|Moved, received transplant, etc.|7|||
149174110|NCT03941548|538108775|FG000|Overall Study|Adverse Event|0|||
149174111|NCT03941548|538108776|FG001|Overall Study|Adverse Event|1|||
149174112|NCT03941548|538108775|FG000|Overall Study|Lost to Follow-up|0|||
149174113|NCT03941548|538108776|FG001|Overall Study|Lost to Follow-up|1|||
149174114|NCT03941548|538108775|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
149174115|NCT03941548|538108776|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
149174116|NCT01242111|538108777|FG000|Overall Study|Adverse Event|1|||
149174117|NCT01242111|538108777|FG000|Overall Study|Withdrawal by Subject|1|||
149174118|NCT01242111|538108777|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
149174119|NCT00870688|538108778|FG000|Overall Study|Lost to Follow-up|2|||
148929743|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
148929744|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
148929745|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
148929746|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
148929747|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
148929748|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
148929749|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
148929750|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
148929751|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
148929752|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
148929753|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
148929754|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
148929755|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
148929756|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
148929757|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
148929758|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
148929759|NCT03739840|537228351|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
148929760|NCT03739840|537228352|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
148929761|NCT03739840|537228353|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
148929762|NCT03739840|537228354|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
148929763|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
148929764|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
148929765|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
148929766|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
148929767|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
148929768|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
148929769|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
148929770|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
148929771|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
148929772|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
148929773|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
148929774|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
148929775|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
148929776|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
148929777|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
148929778|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
148929779|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
148929780|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
148929781|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
149013320|NCT01460160|537527907|FG000|Treatment Phase|Withdrawal by Subject|4|||
149013321|NCT01460160|537527907|FG000|Treatment Phase|Death|2|||
149174120|NCT00870688|538108778|FG000|Overall Study|Death, Unrelated|1|||
149174121|NCT00870688|538108778|FG000|Overall Study|Granules in the Stools|1|||
149174122|NCT02945657|538108781|FG000|Overall Study|Adverse Event|1|||
149174123|NCT02945657|538108781|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
149174124|NCT00087438|538108788|FG000|Overall Study|Ineligible / No protocol treatment|4|||
149174125|NCT01486264|538108789|FG000|Overall Study|Death|1|||
149174126|NCT01486264|538108790|FG001|Overall Study|Death|1|||
149174127|NCT01486264|538108789|FG000|Overall Study|Adverse Event|3|||
149174128|NCT01486264|538108790|FG001|Overall Study|Adverse Event|3|||
149174129|NCT01486264|538108789|FG000|Overall Study|Lack of Efficacy|6|||
149174130|NCT01486264|538108790|FG001|Overall Study|Lack of Efficacy|10|||
149174131|NCT01486264|538108789|FG000|Overall Study|Withdrawal by Subject|7|||
149174132|NCT01486264|538108790|FG001|Overall Study|Withdrawal by Subject|18|||
149174133|NCT01486264|538108789|FG000|Overall Study|Physician Decision|1|||
149174134|NCT01486264|538108790|FG001|Overall Study|Physician Decision|1|||
149174135|NCT01486264|538108789|FG000|Overall Study|Protocol Violation|3|||
149174136|NCT01486264|538108790|FG001|Overall Study|Protocol Violation|0|||
149174137|NCT01486264|538108789|FG000|Overall Study|Lost to Follow-up|3|||
149174138|NCT01486264|538108790|FG001|Overall Study|Lost to Follow-up|2|||
149174139|NCT01486264|538108789|FG000|Overall Study|Other|5|||
149174140|NCT01486264|538108790|FG001|Overall Study|Other|11|||
149174141|NCT01486264|538108789|FG000|Overall Study|Not treated|0|||
149174142|NCT01486264|538108790|FG001|Overall Study|Not treated|1|||
149174143|NCT00283387|538108791|FG000|First Intervention|Subject non-compliant|1|||
149174144|NCT00283387|538108792|FG001|First Intervention|Subject non-compliant|1|||
149174145|NCT00283387|538108791|FG000|First Intervention|Withdrawal by Subject|0|||
149174146|NCT00283387|538108792|FG001|First Intervention|Withdrawal by Subject|1|||
149174147|NCT03182738|538108793|FG000|Overall Study|Lost to Follow-up|9|||
149174148|NCT03182738|538108794|FG001|Overall Study|Lost to Follow-up|3|||
149174149|NCT03182738|538108793|FG000|Overall Study|Pregnancy|0|||
149174150|NCT03182738|538108794|FG001|Overall Study|Pregnancy|1|||
149174151|NCT03182738|538108793|FG000|Overall Study|Withdrawal by Subject|0|||
149174152|NCT03182738|538108794|FG001|Overall Study|Withdrawal by Subject|1|||
149174153|NCT03584009|538108795|FG000|Overall Study|Death|25|||
149174154|NCT03584009|538108796|FG001|Overall Study|Death|18|||
149174155|NCT03584009|538108795|FG000|Overall Study|Lost to Follow-up|0|||
149174156|NCT03584009|538108796|FG001|Overall Study|Lost to Follow-up|1|||
149174157|NCT03584009|538108795|FG000|Overall Study|Physician Decision|1|||
149174158|NCT03584009|538108796|FG001|Overall Study|Physician Decision|1|||
149174159|NCT03584009|538108795|FG000|Overall Study|Study Terminated by Sponsor|22|||
149174160|NCT03584009|538108796|FG001|Overall Study|Study Terminated by Sponsor|30|||
149174161|NCT03584009|538108795|FG000|Overall Study|Withdrawal by Subject|3|||
149174162|NCT03584009|538108796|FG001|Overall Study|Withdrawal by Subject|2|||
149174163|NCT00509106|538108799|FG000|Overall Study|Adverse Event|3|||
149174164|NCT00509106|538108800|FG001|Overall Study|Adverse Event|2|||
149174165|NCT00509106|538108799|FG000|Overall Study|Noncompliance|0|||
149174166|NCT00509106|538108800|FG001|Overall Study|Noncompliance|1|||
149174167|NCT00509106|538108799|FG000|Overall Study|At the request of sponsor/investigator|1|||
149174168|NCT00509106|538108800|FG001|Overall Study|At the request of sponsor/investigator|2|||
149174169|NCT00509106|538108799|FG000|Overall Study|Withdrew consent|4|||
149174170|NCT00509106|538108800|FG001|Overall Study|Withdrew consent|8|||
149174171|NCT00509106|538108799|FG000|Overall Study|Lost to Follow-up|16|||
149174172|NCT00509106|538108800|FG001|Overall Study|Lost to Follow-up|10|||
149174173|NCT00509106|538108799|FG000|Overall Study|Other|1|||
149174174|NCT00509106|538108800|FG001|Overall Study|Other|0|||
149174175|NCT00509106|538108799|FG000|Overall Study|Death|6|||
149174176|NCT00509106|538108800|FG001|Overall Study|Death|6|||
149174177|NCT03527043|538108801|FG000|Overall Study|Withdrawal by Subject|1|||
149174178|NCT03527043|538108802|FG001|Overall Study|Withdrawal by Subject|0|||
149174179|NCT01772134|538108808|FG000|Overall Study|Adverse Event|6|||
149174180|NCT01772134|538108809|FG001|Overall Study|Adverse Event|5|||
149174181|NCT01772134|538108810|FG002|Overall Study|Adverse Event|10|||
149174182|NCT01772134|538108808|FG000|Overall Study|Withdrew Consent|3|||
149174183|NCT01772134|538108809|FG001|Overall Study|Withdrew Consent|1|||
149174184|NCT01772134|538108810|FG002|Overall Study|Withdrew Consent|5|||
149174185|NCT01772134|538108808|FG000|Overall Study|Lost to Follow-up|2|||
149174186|NCT01772134|538108809|FG001|Overall Study|Lost to Follow-up|0|||
149174187|NCT01772134|538108810|FG002|Overall Study|Lost to Follow-up|0|||
149174188|NCT01772134|538108808|FG000|Overall Study|Protocol Deviation|4|||
149174189|NCT01772134|538108809|FG001|Overall Study|Protocol Deviation|3|||
149174190|NCT01772134|538108810|FG002|Overall Study|Protocol Deviation|3|||
149174191|NCT01772134|538108808|FG000|Overall Study|Lack of Efficacy|11|||
149174192|NCT01772134|538108809|FG001|Overall Study|Lack of Efficacy|5|||
149174193|NCT01772134|538108810|FG002|Overall Study|Lack of Efficacy|3|||
149174194|NCT01772134|538108808|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
149174195|NCT01772134|538108809|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
149174196|NCT01772134|538108810|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
149174197|NCT01772134|538108808|FG000|Overall Study|Randomized Study Medication Not Received|2|||
149174198|NCT01772134|538108809|FG001|Overall Study|Randomized Study Medication Not Received|0|||
149174199|NCT01772134|538108810|FG002|Overall Study|Randomized Study Medication Not Received|1|||
149174200|NCT02500550|538108811|FG000|Overall Study|Death|7|||
149174201|NCT01309737|538108813|FG000|Week 0 to 16|Death|1|||
149174202|NCT01309737|538108814|FG001|Week 0 to 16|Death|0|||
149174203|NCT01309737|538108815|FG002|Week 0 to 16|Death|1|||
149174204|NCT01309737|538108816|FG003|Week 0 to 16|Death|0|||
149174205|NCT01309737|538108817|FG004|Week 0 to 16|Death|0|||
149174206|NCT01309737|538108813|FG000|Week 0 to 16|Adverse Event|11|||
149174207|NCT01309737|538108814|FG001|Week 0 to 16|Adverse Event|10|||
149174208|NCT01309737|538108815|FG002|Week 0 to 16|Adverse Event|5|||
149174209|NCT01309737|538108816|FG003|Week 0 to 16|Adverse Event|0|||
149174210|NCT01309737|538108817|FG004|Week 0 to 16|Adverse Event|0|||
149174211|NCT01309737|538108813|FG000|Week 0 to 16|Lack of Efficacy|15|||
149174212|NCT01309737|538108814|FG001|Week 0 to 16|Lack of Efficacy|2|||
149174213|NCT01309737|538108815|FG002|Week 0 to 16|Lack of Efficacy|24|||
149174214|NCT01309737|538108816|FG003|Week 0 to 16|Lack of Efficacy|0|||
149174215|NCT01309737|538108817|FG004|Week 0 to 16|Lack of Efficacy|0|||
149174216|NCT01309737|538108813|FG000|Week 0 to 16|Lost to Follow-up|7|||
149174217|NCT01309737|538108814|FG001|Week 0 to 16|Lost to Follow-up|8|||
149174218|NCT01309737|538108815|FG002|Week 0 to 16|Lost to Follow-up|3|||
149174219|NCT01309737|538108816|FG003|Week 0 to 16|Lost to Follow-up|0|||
149174220|NCT01309737|538108817|FG004|Week 0 to 16|Lost to Follow-up|0|||
149174221|NCT01309737|538108813|FG000|Week 0 to 16|Withdrawal by Subject|7|||
149174222|NCT01309737|538108814|FG001|Week 0 to 16|Withdrawal by Subject|6|||
149174223|NCT01309737|538108815|FG002|Week 0 to 16|Withdrawal by Subject|7|||
149174224|NCT01309737|538108816|FG003|Week 0 to 16|Withdrawal by Subject|0|||
148678743|NCT00944125|536297262|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
148678744|NCT03125629|536297263|FG000|Overall Study|Withdrawal by Subject|2|||
148678745|NCT03125629|536297263|FG000|Overall Study|Equipment malfunction|1|||
148678746|NCT00743119|536297264|FG000|Overall Study|unreliable|3|||
148678747|NCT00743119|536297264|FG000|Overall Study|Withdrawal by Subject|1|||
148678748|NCT02989610|536297265|FG000|Overall Study|Withdrawal by Subject|20|||
148678749|NCT02989610|536297265|FG000|Overall Study|Departure of PI from Site|8|||
148678750|NCT02989610|536297265|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
148678751|NCT02989610|536297265|FG000|Overall Study|Lost to Follow-up|3|||
148678752|NCT02989610|536297265|FG000|Overall Study|Death|3|||
148678753|NCT02989610|536297265|FG000|Overall Study|System Explant|3|||
148929782|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
148929783|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
149174225|NCT01309737|538108817|FG004|Week 0 to 16|Withdrawal by Subject|0|||
149174226|NCT01309737|538108813|FG000|Week 0 to 16|Other|10|||
149174227|NCT01309737|538108814|FG001|Week 0 to 16|Other|14|||
149174228|NCT01309737|538108815|FG002|Week 0 to 16|Other|4|||
149174229|NCT01309737|538108816|FG003|Week 0 to 16|Other|0|||
149174230|NCT01309737|538108817|FG004|Week 0 to 16|Other|0|||
149174231|NCT01309737|538108813|FG000|Week 0 to 16|Randomized, but not treated|1|||
149174232|NCT01309737|538108814|FG001|Week 0 to 16|Randomized, but not treated|0|||
149174233|NCT01309737|538108815|FG002|Week 0 to 16|Randomized, but not treated|0|||
149174234|NCT01309737|538108816|FG003|Week 0 to 16|Randomized, but not treated|0|||
149174235|NCT01309737|538108817|FG004|Week 0 to 16|Randomized, but not treated|0|||
149174236|NCT01309737|538108813|FG000|Week 16 to 52|Death|0|||
149174237|NCT01309737|538108814|FG001|Week 16 to 52|Death|0|||
149174238|NCT01309737|538108815|FG002|Week 16 to 52|Death|0|||
149174239|NCT01309737|538108816|FG003|Week 16 to 52|Death|0|||
149174240|NCT01309737|538108817|FG004|Week 16 to 52|Death|1|||
149174241|NCT01309737|538108813|FG000|Week 16 to 52|Adverse Event|7|||
149174242|NCT01309737|538108814|FG001|Week 16 to 52|Adverse Event|7|||
149174243|NCT01309737|538108815|FG002|Week 16 to 52|Adverse Event|0|||
149174244|NCT01309737|538108816|FG003|Week 16 to 52|Adverse Event|6|||
149174245|NCT01309737|538108817|FG004|Week 16 to 52|Adverse Event|5|||
149174246|NCT01309737|538108813|FG000|Week 16 to 52|Lack of Efficacy|107|||
149174247|NCT01309737|538108814|FG001|Week 16 to 52|Lack of Efficacy|76|||
149174248|NCT01309737|538108815|FG002|Week 16 to 52|Lack of Efficacy|0|||
149174249|NCT01309737|538108816|FG003|Week 16 to 52|Lack of Efficacy|25|||
149174250|NCT01309737|538108817|FG004|Week 16 to 52|Lack of Efficacy|21|||
149174251|NCT01309737|538108813|FG000|Week 16 to 52|Lost to Follow-up|4|||
149174252|NCT01309737|538108814|FG001|Week 16 to 52|Lost to Follow-up|2|||
149174253|NCT01309737|538108815|FG002|Week 16 to 52|Lost to Follow-up|0|||
149174254|NCT01309737|538108816|FG003|Week 16 to 52|Lost to Follow-up|1|||
148678754|NCT02989610|536297265|FG000|Overall Study|Subject Non-Compliance|2|||
149174255|NCT01309737|538108817|FG004|Week 16 to 52|Lost to Follow-up|4|||
149174256|NCT01309737|538108813|FG000|Week 16 to 52|Withdrawal by Subject|5|||
149174257|NCT01309737|538108814|FG001|Week 16 to 52|Withdrawal by Subject|6|||
149174258|NCT01309737|538108815|FG002|Week 16 to 52|Withdrawal by Subject|0|||
149174259|NCT01309737|538108816|FG003|Week 16 to 52|Withdrawal by Subject|0|||
148678755|NCT02989610|536297265|FG000|Overall Study|System Revision|2|||
149174260|NCT01309737|538108817|FG004|Week 16 to 52|Withdrawal by Subject|2|||
149174261|NCT01309737|538108813|FG000|Week 16 to 52|Other|10|||
149174262|NCT01309737|538108814|FG001|Week 16 to 52|Other|12|||
149174263|NCT01309737|538108815|FG002|Week 16 to 52|Other|0|||
149174264|NCT01309737|538108816|FG003|Week 16 to 52|Other|2|||
149174265|NCT01309737|538108817|FG004|Week 16 to 52|Other|0|||
149174266|NCT01073943|538108827|FG000|Overall Study|Withdrawal by Subject|8|||
149174267|NCT01073943|538108828|FG001|Overall Study|Withdrawal by Subject|2|||
149174268|NCT01073943|538108827|FG000|Overall Study|Protocol Violation|2|||
149174269|NCT01073943|538108828|FG001|Overall Study|Protocol Violation|1|||
149174270|NCT01073943|538108827|FG000|Overall Study|Adverse Event|1|||
149174271|NCT01073943|538108828|FG001|Overall Study|Adverse Event|1|||
149174272|NCT01073943|538108827|FG000|Overall Study|Lost to Follow-up|0|||
149174273|NCT01073943|538108828|FG001|Overall Study|Lost to Follow-up|2|||
149174274|NCT01073943|538108827|FG000|Overall Study|Power outage; colonoscopy not done|1|||
149174275|NCT01073943|538108828|FG001|Overall Study|Power outage; colonoscopy not done|0|||
149174276|NCT01073943|538108827|FG000|Overall Study|Subject forgot|0|||
149174277|NCT01073943|538108828|FG001|Overall Study|Subject forgot|1|||
149174278|NCT01073943|538108827|FG000|Overall Study|Unable to return for follow-up|0|||
149174279|NCT01073943|538108828|FG001|Overall Study|Unable to return for follow-up|1|||
149174280|NCT01073943|538108827|FG000|Overall Study|Could not tolerate prep|1|||
149174281|NCT01073943|538108828|FG001|Overall Study|Could not tolerate prep|0|||
149174282|NCT05300087|538108829|FG000|Overall Study|Withdrawal by Subject|0|||
149174283|NCT05300087|538108830|FG001|Overall Study|Withdrawal by Subject|1|||
149174284|NCT00761215|538108831|FG000|Overall Study|Randomized but didn't receive drug|1|||
149174285|NCT00761215|538108832|FG001|Overall Study|Randomized but didn't receive drug|1|||
149174286|NCT00761215|538108833|FG002|Overall Study|Randomized but didn't receive drug|2|||
149174287|NCT00761215|538108831|FG000|Overall Study|Lost to Follow-up|6|||
149174288|NCT00761215|538108832|FG001|Overall Study|Lost to Follow-up|3|||
149174289|NCT00761215|538108833|FG002|Overall Study|Lost to Follow-up|6|||
149174290|NCT00761215|538108831|FG000|Overall Study|Withdrawal by Subject|1|||
149174291|NCT00761215|538108832|FG001|Overall Study|Withdrawal by Subject|0|||
149174292|NCT00761215|538108833|FG002|Overall Study|Withdrawal by Subject|0|||
149174293|NCT00761215|538108831|FG000|Overall Study|Bacteremia|1|||
149174294|NCT00761215|538108832|FG001|Overall Study|Bacteremia|0|||
149174295|NCT00761215|538108833|FG002|Overall Study|Bacteremia|0|||
149174296|NCT05662332|538108834|FG000|Overall Study|Death|3|||
149174297|NCT05662332|538108835|FG001|Overall Study|Death|3|||
149174298|NCT05662332|538108834|FG000|Overall Study|Lost to Follow-up|3|||
149174299|NCT05662332|538108835|FG001|Overall Study|Lost to Follow-up|8|||
149174300|NCT05662332|538108834|FG000|Overall Study|Physician Decision|1|||
149174301|NCT05662332|538108835|FG001|Overall Study|Physician Decision|2|||
149174302|NCT05662332|538108834|FG000|Overall Study|Protocol Deviation|2|||
149174303|NCT05662332|538108835|FG001|Overall Study|Protocol Deviation|1|||
149174304|NCT05662332|538108834|FG000|Overall Study|Withdrawal by Subject|14|||
148678756|NCT02989610|536297265|FG000|Overall Study|PI Left, Study Closing|1|||
148678757|NCT02989610|536297265|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
148678758|NCT02989610|536297265|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
148678759|NCT04508621|536297266|FG000|Overall Study|Adverse Event|39|||
148678760|NCT04508621|536297267|FG001|Overall Study|Adverse Event|16|||
148678761|NCT04508621|536297266|FG000|Overall Study|Lack of Efficacy|2|||
148678762|NCT04508621|536297267|FG001|Overall Study|Lack of Efficacy|8|||
148678763|NCT04508621|536297266|FG000|Overall Study|Physician Decision|0|||
148678764|NCT04508621|536297267|FG001|Overall Study|Physician Decision|1|||
148678765|NCT04508621|536297266|FG000|Overall Study|Withdrawal by Subject|10|||
148678766|NCT04508621|536297267|FG001|Overall Study|Withdrawal by Subject|14|||
148678767|NCT04508621|536297266|FG000|Overall Study|Lost to Follow-up|12|||
148929784|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
148929785|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
148929786|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
148929787|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
148929788|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
148929789|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
149174305|NCT05662332|538108835|FG001|Overall Study|Withdrawal by Subject|14|||
149174306|NCT05662332|538108834|FG000|Overall Study|Assigned Treatment by Mistake|5|||
148678768|NCT04508621|536297267|FG001|Overall Study|Lost to Follow-up|9|||
148678769|NCT04508621|536297266|FG000|Overall Study|COVID-19 related crisis|3|||
148678770|NCT04508621|536297267|FG001|Overall Study|COVID-19 related crisis|0|||
148678771|NCT04508621|536297266|FG000|Overall Study|Subject non-compliance|1|||
149013322|NCT01460160|537527907|FG000|Treatment Phase|Other reasons|9|||
149174307|NCT05662332|538108835|FG001|Overall Study|Assigned Treatment by Mistake|7|||
149174308|NCT05662332|538108834|FG000|Overall Study|Non-compliance with study drug|4|||
149174309|NCT05662332|538108835|FG001|Overall Study|Non-compliance with study drug|1|||
149174310|NCT05662332|538108834|FG000|Overall Study|Due to Bariatric surgery|1|||
149174311|NCT05662332|538108835|FG001|Overall Study|Due to Bariatric surgery|0|||
149174312|NCT05662332|538108834|FG000|Overall Study|Subject Moving out of State|0|||
149174313|NCT05662332|538108835|FG001|Overall Study|Subject Moving out of State|1|||
149174314|NCT05662332|538108834|FG000|Overall Study|Subject Missed the Schedule|1|||
149174315|NCT05662332|538108835|FG001|Overall Study|Subject Missed the Schedule|0|||
149174316|NCT05662332|538108834|FG000|Overall Study|The Patient Moved to Another City|1|||
149174317|NCT05662332|538108835|FG001|Overall Study|The Patient Moved to Another City|0|||
149174318|NCT00667277|538108836|FG000|Overall Study|Withdrawal by Subject|2|||
149174319|NCT03248128|538108837|FG000|Overall Study|Lost to Follow-up|1|||
149174320|NCT03248128|538108838|FG001|Overall Study|Lost to Follow-up|0|||
149174321|NCT03248128|538108837|FG000|Overall Study|Withdrawal by Subject|16|||
149174322|NCT03248128|538108838|FG001|Overall Study|Withdrawal by Subject|14|||
149174323|NCT03248128|538108837|FG000|Overall Study|Site Closed|4|||
149174324|NCT03248128|538108838|FG001|Overall Study|Site Closed|3|||
149174325|NCT03248128|538108837|FG000|Overall Study|Randomized, but did not receive treatment|1|||
149174326|NCT03248128|538108838|FG001|Overall Study|Randomized, but did not receive treatment|3|||
149174327|NCT01914679|538108839|FG000|Overall Study|Lack of Efficacy|1|||
149174328|NCT01914679|538108839|FG000|Overall Study|Sponsor terminated study|4|||
149174329|NCT01126580|538108843|FG000|Overall Study|Adverse Event|14|||
149174330|NCT01126580|538108844|FG001|Overall Study|Adverse Event|8|||
149174331|NCT01126580|538108845|FG002|Overall Study|Adverse Event|12|||
149174332|NCT01126580|538108843|FG000|Overall Study|Withdrawal by Subject|11|||
149174333|NCT01126580|538108844|FG001|Overall Study|Withdrawal by Subject|19|||
149174334|NCT01126580|538108845|FG002|Overall Study|Withdrawal by Subject|14|||
149174335|NCT01126580|538108843|FG000|Overall Study|Sponsor Decision|5|||
149174336|NCT01126580|538108844|FG001|Overall Study|Sponsor Decision|4|||
149174337|NCT01126580|538108845|FG002|Overall Study|Sponsor Decision|7|||
149174338|NCT01126580|538108843|FG000|Overall Study|Physician Decision|1|||
149174339|NCT01126580|538108844|FG001|Overall Study|Physician Decision|1|||
149174340|NCT01126580|538108845|FG002|Overall Study|Physician Decision|2|||
149174341|NCT01126580|538108843|FG000|Overall Study|Entry Criteria Not Met|1|||
149174342|NCT01126580|538108844|FG001|Overall Study|Entry Criteria Not Met|1|||
149174343|NCT01126580|538108845|FG002|Overall Study|Entry Criteria Not Met|2|||
149174344|NCT01126580|538108843|FG000|Overall Study|Lack of Efficacy|2|||
149174345|NCT01126580|538108844|FG001|Overall Study|Lack of Efficacy|3|||
149174346|NCT01126580|538108845|FG002|Overall Study|Lack of Efficacy|4|||
149174347|NCT01126580|538108843|FG000|Overall Study|Protocol Violation|0|||
149174348|NCT01126580|538108844|FG001|Overall Study|Protocol Violation|1|||
149174349|NCT01126580|538108845|FG002|Overall Study|Protocol Violation|2|||
149174350|NCT01126580|538108843|FG000|Overall Study|Lost to Follow-up|15|||
149174351|NCT01126580|538108844|FG001|Overall Study|Lost to Follow-up|13|||
149174352|NCT01126580|538108845|FG002|Overall Study|Lost to Follow-up|9|||
149174353|NCT01126580|538108843|FG000|Overall Study|Treatment Non-compliance|0|||
149174354|NCT01126580|538108844|FG001|Overall Study|Treatment Non-compliance|2|||
149174355|NCT01126580|538108845|FG002|Overall Study|Treatment Non-compliance|3|||
149174356|NCT01731002|538108855|FG000|Overall Study|Adverse Event|0|||
149174357|NCT01731002|538108856|FG001|Overall Study|Adverse Event|2|||
149174358|NCT01731002|538108857|FG002|Overall Study|Adverse Event|2|||
149174359|NCT01731002|538108855|FG000|Overall Study|Non-Compliant|0|||
149174360|NCT01731002|538108856|FG001|Overall Study|Non-Compliant|1|||
149174361|NCT01731002|538108857|FG002|Overall Study|Non-Compliant|0|||
149174362|NCT01731002|538108855|FG000|Overall Study|Lost to Follow-up|1|||
149174363|NCT01731002|538108856|FG001|Overall Study|Lost to Follow-up|0|||
149174364|NCT01731002|538108857|FG002|Overall Study|Lost to Follow-up|0|||
149174365|NCT01731002|538108855|FG000|Overall Study|Test Agent Discontinuation|0|||
149174366|NCT01731002|538108856|FG001|Overall Study|Test Agent Discontinuation|1|||
149174367|NCT01731002|538108857|FG002|Overall Study|Test Agent Discontinuation|0|||
148678772|NCT04508621|536297267|FG001|Overall Study|Subject non-compliance|0|||
148929790|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
148929791|NCT03739840|537228351|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
148929792|NCT03739840|537228352|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
148929793|NCT03739840|537228353|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
149174368|NCT01731002|538108855|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
149174369|NCT01731002|538108856|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
149174370|NCT01731002|538108857|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
149174371|NCT01731002|538108855|FG000|Overall Study|Elevated IOP|1|||
149174372|NCT01731002|538108856|FG001|Overall Study|Elevated IOP|0|||
149174373|NCT01731002|538108857|FG002|Overall Study|Elevated IOP|0|||
149174374|NCT01731002|538108855|FG000|Overall Study|Inappropriate use of study medications|0|||
149174375|NCT01731002|538108856|FG001|Overall Study|Inappropriate use of study medications|0|||
149174376|NCT01731002|538108857|FG002|Overall Study|Inappropriate use of study medications|1|||
149174377|NCT00538681|538108860|FG000|Overall Study|Progressive Disease|7|||
149174378|NCT00538681|538108861|FG001|Overall Study|Progressive Disease|0|||
148929794|NCT03739840|537228354|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
149174379|NCT00538681|538108862|FG002|Overall Study|Progressive Disease|1|||
149174380|NCT00538681|538108863|FG003|Overall Study|Progressive Disease|0|||
149174381|NCT00538681|538108860|FG000|Overall Study|Sponsor Decision|1|||
149174382|NCT00538681|538108861|FG001|Overall Study|Sponsor Decision|3|||
149174383|NCT00538681|538108862|FG002|Overall Study|Sponsor Decision|8|||
149174384|NCT00538681|538108863|FG003|Overall Study|Sponsor Decision|9|||
149174385|NCT00538681|538108860|FG000|Overall Study|Adverse Event|1|||
149174386|NCT00538681|538108861|FG001|Overall Study|Adverse Event|1|||
149174387|NCT00538681|538108862|FG002|Overall Study|Adverse Event|1|||
149174388|NCT00538681|538108863|FG003|Overall Study|Adverse Event|0|||
149174389|NCT00538681|538108860|FG000|Overall Study|Death|0|||
149174390|NCT00538681|538108861|FG001|Overall Study|Death|0|||
149174391|NCT00538681|538108862|FG002|Overall Study|Death|1|||
149174392|NCT00538681|538108863|FG003|Overall Study|Death|1|||
149174393|NCT00538681|538108860|FG000|Overall Study|Investigator Decision|0|||
149174394|NCT00538681|538108861|FG001|Overall Study|Investigator Decision|0|||
149174395|NCT00538681|538108862|FG002|Overall Study|Investigator Decision|0|||
149174396|NCT00538681|538108863|FG003|Overall Study|Investigator Decision|1|||
149174397|NCT02581995|538108868|FG000|Overall Study|Unspecified other|3|||
149174398|NCT02581995|538108868|FG000|Overall Study|Adverse Event|6|||
149174399|NCT02581995|538108868|FG000|Overall Study|Lost to Follow-up|5|||
149174400|NCT02581995|538108868|FG000|Overall Study|Withdrawal by participant|12|||
149174401|NCT02581995|538108868|FG000|Overall Study|Physician Decision|1|||
149174402|NCT02581995|538108868|FG000|Overall Study|Death|4|||
149174403|NCT03528681|538110706|FG000|Open-Label Phase|Physician Decision|2|||
149174404|NCT03528681|538110707|FG001|Open-Label Phase|Physician Decision|0|||
149174405|NCT03528681|538110708|FG002|Open-Label Phase|Physician Decision|0|||
149174406|NCT03528681|538110709|FG003|Open-Label Phase|Physician Decision|0|||
149174407|NCT03528681|538110706|FG000|Open-Label Phase|Withdrawal by Subject|8|||
149174408|NCT03528681|538110707|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149174409|NCT03528681|538110708|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149174410|NCT03528681|538110709|FG003|Open-Label Phase|Withdrawal by Subject|0|||
149174411|NCT03528681|538110706|FG000|Open-Label Phase|(Not collected)|4|||
149174412|NCT03528681|538110707|FG001|Open-Label Phase|(Not collected)|0|||
149174413|NCT03528681|538110708|FG002|Open-Label Phase|(Not collected)|0|||
149174414|NCT03528681|538110709|FG003|Open-Label Phase|(Not collected)|0|||
149174415|NCT03528681|538110706|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
149174416|NCT03528681|538110707|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
149174417|NCT03528681|538110708|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
149174418|NCT03528681|538110709|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
149174419|NCT03528681|538110706|FG000|Randomized Treatment Phase|Physician Decision|0|||
149174420|NCT03528681|538110707|FG001|Randomized Treatment Phase|Physician Decision|5|||
149174421|NCT03528681|538110708|FG002|Randomized Treatment Phase|Physician Decision|1|||
149174422|NCT03528681|538110709|FG003|Randomized Treatment Phase|Physician Decision|2|||
149174423|NCT03528681|538110706|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
149174424|NCT03528681|538110707|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
149174425|NCT03528681|538110708|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
149174426|NCT03528681|538110709|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
149174427|NCT03528681|538110706|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
149174428|NCT03528681|538110707|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
149174429|NCT03528681|538110708|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
149174430|NCT03528681|538110709|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
149174431|NCT03528681|538110706|FG000|Randomized Treatment Phase|(Not collected)|0|||
149174432|NCT03528681|538110707|FG001|Randomized Treatment Phase|(Not collected)|4|||
149174433|NCT03528681|538110708|FG002|Randomized Treatment Phase|(Not collected)|6|||
149174434|NCT03528681|538110709|FG003|Randomized Treatment Phase|(Not collected)|5|||
149174435|NCT01614457|538110715|FG000|Overall Study|Non-Compliance|1|||
149174436|NCT01614457|538110716|FG001|Overall Study|Non-Compliance|0|||
149174437|NCT01614457|538110715|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
149174438|NCT01614457|538110716|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
149174439|NCT03518840|538110717|FG000|Overall Study|Lost to Follow-up|6|||
149174440|NCT01531725|538110723|FG000|Overall Study|Protocol Violation|5|||
149174441|NCT00500071|538110727|FG000|Screening and Washout Phase|Protocol Violation|1|||
149174442|NCT00500071|538110727|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
149174443|NCT00500071|538110727|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
149174444|NCT00500071|538110727|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
149174445|NCT00500071|538110727|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
149174446|NCT00500071|538110727|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
149174447|NCT00500071|538110727|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
149174448|NCT01122927|538110728|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
149174449|NCT01122927|538110729|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
149174450|NCT01122927|538110728|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
149174451|NCT01122927|538110729|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
149174452|NCT01122927|538110728|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
149174453|NCT01122927|538110729|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
149174454|NCT01122927|538110728|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
149174455|NCT01122927|538110729|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
149174456|NCT01122927|538110728|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
149174457|NCT01122927|538110729|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
149174458|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
149174459|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
149174460|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
149174461|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
149174462|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
149174463|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
149174464|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
149174465|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
149174466|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
149174467|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
149174468|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
149174469|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
149174470|NCT01122927|538110728|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
149174471|NCT01122927|538110729|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
149174472|NCT00728416|538110738|FG000|Overall Study|Adverse Event|1|||
149174473|NCT00728416|538110739|FG001|Overall Study|Adverse Event|1|||
149174474|NCT00728416|538110738|FG000|Overall Study|Treatment Failure|0|||
149174475|NCT00728416|538110739|FG001|Overall Study|Treatment Failure|1|||
149174476|NCT00728416|538110738|FG000|Overall Study|Withdrawal by Subject|1|||
149174477|NCT00728416|538110739|FG001|Overall Study|Withdrawal by Subject|0|||
149174478|NCT00389207|538110740|FG000|Overall Study|Adverse Event|26|||
149174479|NCT00389207|538110741|FG001|Overall Study|Adverse Event|32|||
149174480|NCT00389207|538110742|FG002|Overall Study|Adverse Event|10|||
149174481|NCT00389207|538110740|FG000|Overall Study|Protocol Violation|3|||
149174482|NCT00389207|538110741|FG001|Overall Study|Protocol Violation|1|||
149174483|NCT00389207|538110742|FG002|Overall Study|Protocol Violation|4|||
149174484|NCT00389207|538110740|FG000|Overall Study|Lost to Follow-up|12|||
149174485|NCT00389207|538110741|FG001|Overall Study|Lost to Follow-up|9|||
148929795|NCT01323946|537228355|FG000|Overall Study|Lost to Follow-up|0|||
148929796|NCT01323946|537228356|FG001|Overall Study|Lost to Follow-up|1|||
148929797|NCT01323946|537228357|FG002|Overall Study|Lost to Follow-up|0|||
149174486|NCT00389207|538110742|FG002|Overall Study|Lost to Follow-up|7|||
149174487|NCT00389207|538110740|FG000|Overall Study|Withdrawal by Subject|5|||
149174488|NCT00389207|538110741|FG001|Overall Study|Withdrawal by Subject|7|||
149174489|NCT00389207|538110742|FG002|Overall Study|Withdrawal by Subject|11|||
149174490|NCT00389207|538110740|FG000|Overall Study|Other|17|||
148678773|NCT00833976|536298972|FG000|Overall Study|Withdrawal by Subject|5|||
148678774|NCT00833976|536298972|FG000|Overall Study|Lost to Follow-up|4|||
149174491|NCT00389207|538110741|FG001|Overall Study|Other|23|||
149174492|NCT00389207|538110742|FG002|Overall Study|Other|9|||
149174493|NCT02371629|538110752|FG000|Overall Study|Patient decision|14|||
149174494|NCT02371629|538110753|FG001|Overall Study|Patient decision|10|||
149174495|NCT02371629|538110752|FG000|Overall Study|Adverse Event|8|||
149174496|NCT02371629|538110753|FG001|Overall Study|Adverse Event|8|||
149174497|NCT02371629|538110752|FG000|Overall Study|Physician Decision|2|||
149174498|NCT02371629|538110753|FG001|Overall Study|Physician Decision|3|||
149174499|NCT02371629|538110752|FG000|Overall Study|Death|1|||
149174500|NCT02371629|538110753|FG001|Overall Study|Death|1|||
149174501|NCT02371629|538110752|FG000|Overall Study|Noncompliance with study treatment|1|||
149174502|NCT02371629|538110753|FG001|Overall Study|Noncompliance with study treatment|0|||
149174503|NCT02371629|538110752|FG000|Overall Study|Lack of Efficacy|0|||
149174504|NCT02371629|538110753|FG001|Overall Study|Lack of Efficacy|2|||
149174505|NCT02371629|538110752|FG000|Overall Study|Protocol deviation|0|||
149174506|NCT02371629|538110753|FG001|Overall Study|Protocol deviation|1|||
149174507|NCT05421754|538110756|FG000|Overall Study|Technical issue with sensor|1|||
149174508|NCT01051739|538110757|FG000|Overall Study|Death|3|||
149174509|NCT01051739|538110758|FG001|Overall Study|Death|3|||
149174510|NCT01051739|538110757|FG000|Overall Study|Withdrawal by Subject|25|||
149174511|NCT01051739|538110758|FG001|Overall Study|Withdrawal by Subject|10|||
149174512|NCT02604264|538110760|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
149174513|NCT02604264|538110761|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
149174514|NCT03192904|538110762|FG000|Overall Study|Physician Decision|3|||
149174515|NCT03192904|538110763|FG001|Overall Study|Physician Decision|1|||
149174516|NCT03192904|538110762|FG000|Overall Study|Lost to Follow-up|0|||
149174517|NCT03192904|538110763|FG001|Overall Study|Lost to Follow-up|1|||
149174518|NCT00424398|538110766|FG000|Overall Study|Withdrawal by Subject|2|||
149174519|NCT00424398|538110767|FG001|Overall Study|Withdrawal by Subject|1|||
149174520|NCT00424398|538110768|FG002|Overall Study|Withdrawal by Subject|0|||
149174521|NCT00424398|538110766|FG000|Overall Study|Subject met exclusion criteria|1|||
149174522|NCT00424398|538110767|FG001|Overall Study|Subject met exclusion criteria|0|||
149174523|NCT00424398|538110768|FG002|Overall Study|Subject met exclusion criteria|0|||
149174524|NCT01023789|538110769|FG000|3 - Year Visit|Death|29|||
149174525|NCT01023789|538110769|FG000|3 - Year Visit|Withdrawal of consent|1|||
149174526|NCT01023789|538110769|FG000|3 - Year Visit|Lost to Follow-up|13|||
149174527|NCT02034123|538110780|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174528|NCT02034123|538110781|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174529|NCT02034123|538110782|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174530|NCT02034123|538110783|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174531|NCT02034123|538110784|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
149174532|NCT02034123|538110785|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174533|NCT02034123|538110786|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174534|NCT02034123|538110787|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
149174535|NCT02034123|538110788|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
149174536|NCT02034123|538110789|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174537|NCT02034123|538110790|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174538|NCT02034123|538110791|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174539|NCT02034123|538110792|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174540|NCT02034123|538110793|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174541|NCT02034123|538110794|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174542|NCT02034123|538110795|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174543|NCT02034123|538110796|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
149174544|NCT02034123|538110797|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
148806758|NCT01311661|536771016|FG000|Overall Study|Adverse Event|2|||
148806759|NCT01311661|536771016|FG000|Overall Study|Protocol Violation|3|||
149174545|NCT02034123|538110780|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174546|NCT02034123|538110781|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174547|NCT02034123|538110782|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174548|NCT02034123|538110783|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
149174549|NCT02034123|538110784|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174550|NCT02034123|538110785|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174551|NCT02034123|538110786|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174552|NCT02034123|538110787|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174553|NCT02034123|538110788|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174554|NCT02034123|538110789|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174555|NCT02034123|538110790|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174556|NCT02034123|538110791|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174557|NCT02034123|538110792|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174558|NCT02034123|538110793|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174559|NCT02034123|538110794|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174560|NCT02034123|538110795|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174561|NCT02034123|538110796|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174562|NCT02034123|538110797|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
149174563|NCT02034123|538110780|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174564|NCT02034123|538110781|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174565|NCT02034123|538110782|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174566|NCT02034123|538110783|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174567|NCT02034123|538110784|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174568|NCT02034123|538110785|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174569|NCT02034123|538110786|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174570|NCT02034123|538110787|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174571|NCT02034123|538110788|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
149174572|NCT02034123|538110789|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174573|NCT02034123|538110790|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174574|NCT02034123|538110791|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174575|NCT02034123|538110792|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174576|NCT02034123|538110793|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174577|NCT02034123|538110794|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174578|NCT02034123|538110795|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174579|NCT02034123|538110796|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174580|NCT02034123|538110797|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
149174581|NCT02034123|538110780|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174582|NCT02034123|538110781|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174583|NCT02034123|538110782|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174584|NCT02034123|538110783|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
149174585|NCT02034123|538110784|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
149174586|NCT02034123|538110785|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174587|NCT02034123|538110786|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174588|NCT02034123|538110787|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174589|NCT02034123|538110788|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174590|NCT02034123|538110789|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174591|NCT02034123|538110790|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174592|NCT02034123|538110791|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174593|NCT02034123|538110792|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174594|NCT02034123|538110793|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174595|NCT02034123|538110794|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174596|NCT02034123|538110795|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174597|NCT02034123|538110796|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174598|NCT02034123|538110797|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
149174599|NCT00246259|538110798|FG000|Overall Study|Other|3|||
149174600|NCT00246259|538110799|FG001|Overall Study|Other|3|||
149174601|NCT00246259|538110798|FG000|Overall Study|Not stable by Week 18|2|||
149174602|NCT00246259|538110799|FG001|Overall Study|Not stable by Week 18|1|||
148929798|NCT01323946|537228355|FG000|Overall Study|Parents refused the last blood draw|1|||
148929799|NCT01323946|537228356|FG001|Overall Study|Parents refused the last blood draw|0|||
149174603|NCT00246259|538110798|FG000|Overall Study|Participant non-compliant|4|||
148929800|NCT01323946|537228357|FG002|Overall Study|Parents refused the last blood draw|0|||
148929801|NCT01323946|537228355|FG000|Overall Study|Withdrawal by Subject|2|||
148929802|NCT01323946|537228356|FG001|Overall Study|Withdrawal by Subject|2|||
149174604|NCT00246259|538110799|FG001|Overall Study|Participant non-compliant|9|||
149174605|NCT00246259|538110798|FG000|Overall Study|Lack of Efficacy|2|||
149174606|NCT00246259|538110799|FG001|Overall Study|Lack of Efficacy|2|||
149174607|NCT00246259|538110798|FG000|Overall Study|Investigator withdrew participant|2|||
149174608|NCT00246259|538110799|FG001|Overall Study|Investigator withdrew participant|0|||
149174609|NCT00246259|538110798|FG000|Overall Study|Adverse Event|5|||
149174610|NCT00246259|538110799|FG001|Overall Study|Adverse Event|0|||
149174611|NCT00246259|538110798|FG000|Overall Study|Lost to Follow-up|3|||
149174612|NCT00246259|538110799|FG001|Overall Study|Lost to Follow-up|4|||
149174613|NCT00246259|538110798|FG000|Overall Study|Withdrawal by Subject|5|||
149174614|NCT00246259|538110799|FG001|Overall Study|Withdrawal by Subject|1|||
149174615|NCT00246259|538110798|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
149174616|NCT00246259|538110799|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
149174617|NCT02240706|538110800|FG000|Overall Study|Lack of Efficacy|2|||
149174618|NCT02240706|538110801|FG001|Overall Study|Lack of Efficacy|2|||
149174619|NCT02240706|538110802|FG002|Overall Study|Lack of Efficacy|2|||
149174620|NCT02240706|538110803|FG003|Overall Study|Lack of Efficacy|2|||
149174621|NCT02240706|538110804|FG004|Overall Study|Lack of Efficacy|5|||
149174622|NCT02240706|538110805|FG005|Overall Study|Lack of Efficacy|0|||
149174623|NCT02240706|538110806|FG006|Overall Study|Lack of Efficacy|0|||
149174624|NCT02240706|538110800|FG000|Overall Study|Adverse Event|1|||
149174625|NCT02240706|538110801|FG001|Overall Study|Adverse Event|0|||
149174626|NCT02240706|538110802|FG002|Overall Study|Adverse Event|1|||
149174627|NCT02240706|538110803|FG003|Overall Study|Adverse Event|0|||
149174628|NCT02240706|538110804|FG004|Overall Study|Adverse Event|2|||
149174629|NCT02240706|538110805|FG005|Overall Study|Adverse Event|0|||
149174630|NCT02240706|538110806|FG006|Overall Study|Adverse Event|0|||
149174631|NCT02240706|538110800|FG000|Overall Study|Progressive disease|0|||
149174632|NCT02240706|538110801|FG001|Overall Study|Progressive disease|0|||
149174633|NCT02240706|538110802|FG002|Overall Study|Progressive disease|0|||
149174634|NCT02240706|538110803|FG003|Overall Study|Progressive disease|0|||
149174635|NCT02240706|538110804|FG004|Overall Study|Progressive disease|1|||
149174636|NCT02240706|538110805|FG005|Overall Study|Progressive disease|0|||
149174637|NCT02240706|538110806|FG006|Overall Study|Progressive disease|0|||
149174638|NCT02240706|538110800|FG000|Overall Study|Dose limiting toxicity|0|||
149174639|NCT02240706|538110801|FG001|Overall Study|Dose limiting toxicity|0|||
149174640|NCT02240706|538110802|FG002|Overall Study|Dose limiting toxicity|0|||
149174641|NCT02240706|538110803|FG003|Overall Study|Dose limiting toxicity|0|||
149174642|NCT02240706|538110804|FG004|Overall Study|Dose limiting toxicity|1|||
149174643|NCT02240706|538110805|FG005|Overall Study|Dose limiting toxicity|0|||
149174644|NCT02240706|538110806|FG006|Overall Study|Dose limiting toxicity|0|||
149174645|NCT02240706|538110800|FG000|Overall Study|Refused to continue taking medication|0|||
149174646|NCT02240706|538110801|FG001|Overall Study|Refused to continue taking medication|1|||
149174647|NCT02240706|538110802|FG002|Overall Study|Refused to continue taking medication|3|||
149174648|NCT02240706|538110803|FG003|Overall Study|Refused to continue taking medication|1|||
149174649|NCT02240706|538110804|FG004|Overall Study|Refused to continue taking medication|2|||
149174650|NCT02240706|538110805|FG005|Overall Study|Refused to continue taking medication|0|||
149174651|NCT02240706|538110806|FG006|Overall Study|Refused to continue taking medication|0|||
149174652|NCT02240706|538110800|FG000|Overall Study|Insurance billing concerns|0|||
149174653|NCT02240706|538110801|FG001|Overall Study|Insurance billing concerns|0|||
149174654|NCT02240706|538110802|FG002|Overall Study|Insurance billing concerns|0|||
149174655|NCT02240706|538110803|FG003|Overall Study|Insurance billing concerns|1|||
149174656|NCT02240706|538110804|FG004|Overall Study|Insurance billing concerns|0|||
149174657|NCT02240706|538110805|FG005|Overall Study|Insurance billing concerns|0|||
149174658|NCT02240706|538110806|FG006|Overall Study|Insurance billing concerns|0|||
149174659|NCT03022461|538110807|FG000|Overall Study|Death|3|||
149174660|NCT01076179|538110808|FG000|Overall Study|Withdrawal by Subject|1|||
149174661|NCT03459040|538110809|FG000|Overall Study|Death|8|||
148929803|NCT01323946|537228357|FG002|Overall Study|Withdrawal by Subject|0|||
148929804|NCT01243671|537228358|FG000|Overall Study|Adverse Event|3|||
148929805|NCT01243671|537228358|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
148929806|NCT01243671|537228358|FG000|Overall Study|Other|1|||
148929807|NCT02869438|537228359|FG000|Overall Study|Lost to Follow-up|1|||
149174662|NCT03459040|538110809|FG000|Overall Study|Withdrawal by Subject|1|||
149174663|NCT00986349|538110810|FG000|Overall Study|Unsuccessful implant procedure|3|||
149174664|NCT00986349|538110810|FG000|Overall Study|Adverse Event|2|||
149174665|NCT00986349|538110810|FG000|Overall Study|Physician Decision|1|||
149174666|NCT00986349|538110810|FG000|Overall Study|device migration|1|||
149174667|NCT02299934|538110811|FG000|Overall Study|Termination of study|13|||
149174668|NCT03815175|538110812|FG000|Overall Study|Subject Lost to Follow-up|6|||
149174669|NCT03815175|538110812|FG000|Overall Study|Subject Withdrew Consent|48|||
149174670|NCT03815175|538110812|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
149174671|NCT03815175|538110812|FG000|Overall Study|Death|86|||
149174672|NCT03815175|538110812|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
149174673|NCT03815175|538110812|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
149174674|NCT03815175|538110812|FG000|Overall Study|Other Status Change Reason|1|||
149174675|NCT03815175|538110812|FG000|Overall Study|Missed Visit|12|||
149174676|NCT03577990|538110813|FG000|Overall Study|Lost to Follow-up|4|||
149174677|NCT03577990|538110814|FG001|Overall Study|Lost to Follow-up|6|||
149174678|NCT03577990|538110813|FG000|Overall Study|Withdrawal by Subject|4|||
149174679|NCT03577990|538110814|FG001|Overall Study|Withdrawal by Subject|7|||
149174680|NCT00488631|538110815|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
149174681|NCT00488631|538110816|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
149174682|NCT00488631|538110817|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
149174683|NCT00488631|538110818|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
149174684|NCT00488631|538110819|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
149174685|NCT00488631|538110820|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
149174686|NCT00488631|538110821|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
149174687|NCT00488631|538110822|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
149174688|NCT00488631|538110823|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
149174689|NCT00488631|538110824|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
149174690|NCT00488631|538110815|FG000|Double Blind Period (Week 0-54)|Death|0|||
149174691|NCT00488631|538110816|FG001|Double Blind Period (Week 0-54)|Death|0|||
149174692|NCT00488631|538110817|FG002|Double Blind Period (Week 0-54)|Death|0|||
149174693|NCT00488631|538110818|FG003|Double Blind Period (Week 0-54)|Death|0|||
149174694|NCT00488631|538110819|FG004|Double Blind Period (Week 0-54)|Death|0|||
149174695|NCT00488631|538110820|FG005|Double Blind Period (Week 0-54)|Death|1|||
149174696|NCT00488631|538110821|FG006|Double Blind Period (Week 0-54)|Death|0|||
149174697|NCT00488631|538110822|FG007|Double Blind Period (Week 0-54)|Death|0|||
149174698|NCT00488631|538110823|FG008|Double Blind Period (Week 0-54)|Death|0|||
149174699|NCT00488631|538110824|FG009|Double Blind Period (Week 0-54)|Death|0|||
149174700|NCT00488631|538110815|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
149174701|NCT00488631|538110816|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
149174702|NCT00488631|538110817|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
149174703|NCT00488631|538110818|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
149174704|NCT00488631|538110819|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
149174705|NCT00488631|538110820|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
149174706|NCT00488631|538110821|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149174707|NCT00488631|538110822|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149174708|NCT00488631|538110823|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149174709|NCT00488631|538110824|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
149174710|NCT00488631|538110815|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
149174711|NCT00488631|538110816|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
149174712|NCT00488631|538110817|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
149174713|NCT00488631|538110818|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149174714|NCT00488631|538110819|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
149174715|NCT00488631|538110820|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
149174716|NCT00488631|538110821|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149174717|NCT00488631|538110822|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149174718|NCT00488631|538110823|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149174719|NCT00488631|538110824|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
149174720|NCT00488631|538110815|FG000|Double Blind Period (Week 0-54)|Other|6|||
149174721|NCT00488631|538110816|FG001|Double Blind Period (Week 0-54)|Other|12|||
149174722|NCT00488631|538110817|FG002|Double Blind Period (Week 0-54)|Other|10|||
149174723|NCT00488631|538110818|FG003|Double Blind Period (Week 0-54)|Other|11|||
149174724|NCT00488631|538110819|FG004|Double Blind Period (Week 0-54)|Other|14|||
149174725|NCT00488631|538110820|FG005|Double Blind Period (Week 0-54)|Other|34|||
149174726|NCT00488631|538110821|FG006|Double Blind Period (Week 0-54)|Other|0|||
149174727|NCT00488631|538110822|FG007|Double Blind Period (Week 0-54)|Other|0|||
149174728|NCT00488631|538110823|FG008|Double Blind Period (Week 0-54)|Other|0|||
149174729|NCT00488631|538110824|FG009|Double Blind Period (Week 0-54)|Other|0|||
149174730|NCT00488631|538110815|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174731|NCT00488631|538110816|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174732|NCT00488631|538110817|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174733|NCT00488631|538110818|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174734|NCT00488631|538110819|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174735|NCT00488631|538110820|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174736|NCT00488631|538110821|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
149174737|NCT00488631|538110822|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
148929808|NCT02869438|537228360|FG001|Overall Study|Lost to Follow-up|0|||
148929809|NCT02869438|537228359|FG000|Overall Study|Adverse Event|1|||
148929810|NCT02869438|537228360|FG001|Overall Study|Adverse Event|0|||
148929811|NCT02869438|537228359|FG000|Overall Study|Withdrawal by Subject|1|||
148929812|NCT02869438|537228360|FG001|Overall Study|Withdrawal by Subject|2|||
148929813|NCT02962765|537228361|FG000|Overall Study|Protocol Violation|9|||
148929814|NCT02962765|537228361|FG000|Overall Study|Withdrawal by Subject|3|||
148929815|NCT02962765|537228361|FG000|Overall Study|Lost to Follow-up|1|||
148929816|NCT02962765|537228361|FG000|Overall Study|Death|1|||
148929817|NCT02962765|537228361|FG000|Overall Study|Limited access to study medication|3|||
148929818|NCT00750880|537228364|FG000|Overall Study|Adverse Event|76|||
148929819|NCT00750880|537228364|FG000|Overall Study|Death|4|||
148929820|NCT00750880|537228364|FG000|Overall Study|Lack of Efficacy|46|||
148929821|NCT00750880|537228364|FG000|Overall Study|Lost to Follow-up|10|||
148929822|NCT00750880|537228364|FG000|Overall Study|Protocol Violation|15|||
149174738|NCT00488631|538110823|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
149174739|NCT00488631|538110824|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
149174740|NCT00488631|538110815|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
149174741|NCT00488631|538110816|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
149174742|NCT00488631|538110817|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
149174743|NCT00488631|538110818|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
149174744|NCT00488631|538110819|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
149174745|NCT00488631|538110820|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
149174746|NCT00488631|538110821|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
149174747|NCT00488631|538110822|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
148929823|NCT00750880|537228364|FG000|Overall Study|Withdrawal by Subject|33|||
148929824|NCT00750880|537228364|FG000|Overall Study|Physician Decision|20|||
149013323|NCT01460160|537527907|FG000|Follow-up Phase|Withdrawal by Subject|4|||
148929825|NCT00750880|537228364|FG000|Overall Study|Administrative|11|||
148929826|NCT02495233|537228370|FG000|Overall Study|Miscellaneous|0|||
148929827|NCT02495233|537228371|FG001|Overall Study|Miscellaneous|1|||
149174748|NCT00488631|538110823|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
149174749|NCT00488631|538110824|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
149174750|NCT00488631|538110815|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149174751|NCT00488631|538110816|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149174752|NCT00488631|538110817|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149174753|NCT00488631|538110818|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149174754|NCT00488631|538110819|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149174755|NCT00488631|538110820|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
149174756|NCT00488631|538110821|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
149174757|NCT00488631|538110822|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
149174758|NCT00488631|538110823|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
149174759|NCT00488631|538110824|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
149174760|NCT00488631|538110815|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174761|NCT00488631|538110816|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174762|NCT00488631|538110817|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174763|NCT00488631|538110818|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174764|NCT00488631|538110819|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174765|NCT00488631|538110820|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174766|NCT00488631|538110821|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
149174767|NCT00488631|538110822|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174768|NCT00488631|538110823|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
149174769|NCT00488631|538110824|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
149174770|NCT00488631|538110815|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174771|NCT00488631|538110816|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174772|NCT00488631|538110817|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174773|NCT00488631|538110818|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174774|NCT00488631|538110819|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174775|NCT00488631|538110820|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174776|NCT00488631|538110821|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
149174777|NCT00488631|538110822|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
149174778|NCT00488631|538110823|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
149174779|NCT00488631|538110824|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
149174780|NCT05369806|538110833|FG000|Overall Study|Lost to Follow-up|1|||
149174781|NCT00628355|538110834|FG000|Overall Study|Withdrawal by Subject|1|||
149174782|NCT00628355|538110835|FG001|Overall Study|Withdrawal by Subject|1|||
149174783|NCT00140855|538110836|FG000|Overall Study|Progressive disease|2|||
149174784|NCT03542682|538110841|FG000|Overall Study|COVID-19 Protocol|0|||
149174785|NCT03542682|538110842|FG001|Overall Study|COVID-19 Protocol|1|||
149174786|NCT04321343|538110844|FG000|Overall Study|Adverse Event|0|||
149174787|NCT04321343|538110845|FG001|Overall Study|Adverse Event|0|||
149174788|NCT04321343|538110846|FG002|Overall Study|Adverse Event|1|||
149174789|NCT04321343|538110847|FG003|Overall Study|Adverse Event|0|||
149174790|NCT04321343|538110844|FG000|Overall Study|Death|0|||
149174791|NCT04321343|538110845|FG001|Overall Study|Death|0|||
149174792|NCT04321343|538110846|FG002|Overall Study|Death|0|||
149174793|NCT04321343|538110847|FG003|Overall Study|Death|1|||
149174794|NCT04321343|538110844|FG000|Overall Study|Pregnancy|1|||
149174795|NCT04321343|538110845|FG001|Overall Study|Pregnancy|0|||
149174796|NCT04321343|538110846|FG002|Overall Study|Pregnancy|0|||
149174797|NCT04321343|538110847|FG003|Overall Study|Pregnancy|0|||
149174798|NCT04321343|538110844|FG000|Overall Study|Protocol Violation|1|||
149174799|NCT04321343|538110845|FG001|Overall Study|Protocol Violation|1|||
149174800|NCT04321343|538110846|FG002|Overall Study|Protocol Violation|1|||
149174801|NCT04321343|538110847|FG003|Overall Study|Protocol Violation|1|||
149174802|NCT04321343|538110844|FG000|Overall Study|Withdrawal by Subject|0|||
149174803|NCT04321343|538110845|FG001|Overall Study|Withdrawal by Subject|6|||
149174804|NCT04321343|538110846|FG002|Overall Study|Withdrawal by Subject|0|||
149174805|NCT04321343|538110847|FG003|Overall Study|Withdrawal by Subject|2|||
149174806|NCT04321343|538110844|FG000|Overall Study|Lost to Follow-up|2|||
149174807|NCT04321343|538110845|FG001|Overall Study|Lost to Follow-up|2|||
149174808|NCT04321343|538110846|FG002|Overall Study|Lost to Follow-up|1|||
149174809|NCT04321343|538110847|FG003|Overall Study|Lost to Follow-up|3|||
149174810|NCT04865731|538110856|FG000|Overall Study|Physician Decision|2|||
149174811|NCT04865731|538110857|FG001|Overall Study|Physician Decision|1|||
149174812|NCT04865731|538110856|FG000|Overall Study|Adverse Event|1|||
149174813|NCT04865731|538110857|FG001|Overall Study|Adverse Event|0|||
149174814|NCT04865731|538110856|FG000|Overall Study|Withdrawal by Subject|0|||
149174815|NCT04865731|538110857|FG001|Overall Study|Withdrawal by Subject|1|||
149174816|NCT04909463|538112599|FG000|Overall Study|Withdrawal by Subject|0|||
148806760|NCT01311661|536771016|FG000|Overall Study|Withdrawal by Subject|2|||
148806761|NCT00701363|536771017|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
148806762|NCT00701363|536771018|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
148806763|NCT00701363|536771019|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
148806764|NCT00701363|536771020|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
148806765|NCT00701363|536771017|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
148806766|NCT00701363|536771018|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
148806767|NCT00701363|536771019|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
148806768|NCT00701363|536771020|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
148806769|NCT00701363|536771017|FG000|Treatment Phase 1|Adverse Event|7|||
148806770|NCT00701363|536771018|FG001|Treatment Phase 1|Adverse Event|0|||
148806771|NCT00701363|536771019|FG002|Treatment Phase 1|Adverse Event|0|||
148806772|NCT00701363|536771020|FG003|Treatment Phase 1|Adverse Event|0|||
148806773|NCT00701363|536771017|FG000|Treatment Phase 1|Protocol Violation|1|||
148806774|NCT00701363|536771018|FG001|Treatment Phase 1|Protocol Violation|0|||
148806775|NCT00701363|536771019|FG002|Treatment Phase 1|Protocol Violation|0|||
148806776|NCT00701363|536771020|FG003|Treatment Phase 1|Protocol Violation|0|||
148806777|NCT00701363|536771017|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
148806778|NCT00701363|536771018|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
148806779|NCT00701363|536771019|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
148806780|NCT00701363|536771020|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
148806781|NCT00701363|536771017|FG000|Treatment Phase 1|Lack of Efficacy|1|||
148806782|NCT00701363|536771018|FG001|Treatment Phase 1|Lack of Efficacy|0|||
148806783|NCT00701363|536771019|FG002|Treatment Phase 1|Lack of Efficacy|0|||
148806784|NCT00701363|536771020|FG003|Treatment Phase 1|Lack of Efficacy|0|||
148806785|NCT00701363|536771017|FG000|Treatment Phase 2|Adverse Event|0|||
148806786|NCT00701363|536771018|FG001|Treatment Phase 2|Adverse Event|0|||
148806787|NCT00701363|536771019|FG002|Treatment Phase 2|Adverse Event|1|||
148806788|NCT00701363|536771020|FG003|Treatment Phase 2|Adverse Event|0|||
148806789|NCT00701363|536771017|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
148806790|NCT00701363|536771018|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
148806791|NCT00701363|536771019|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
148806792|NCT00701363|536771020|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
148806793|NCT04759131|536771021|FG000|Overall Study|Investigator's discretion|1|||
148806794|NCT04759131|536771022|FG001|Overall Study|Investigator's discretion|0|||
148806795|NCT04759131|536771021|FG000|Overall Study|Subject withdrawal|1|||
148806796|NCT04759131|536771022|FG001|Overall Study|Subject withdrawal|0|||
148806797|NCT05144945|536771023|FG000|Overall Study|Withdrawal by Subject|1|||
148806798|NCT05144945|536771024|FG001|Overall Study|Withdrawal by Subject|0|||
148806799|NCT00284856|536771025|FG000|Overall Study|Adverse Event|3|||
148806800|NCT00284856|536771026|FG001|Overall Study|Adverse Event|3|||
148806801|NCT00284856|536771027|FG002|Overall Study|Adverse Event|3|||
148806802|NCT00284856|536771025|FG000|Overall Study|Lack of Efficacy|2|||
148806803|NCT00284856|536771026|FG001|Overall Study|Lack of Efficacy|1|||
148806804|NCT00284856|536771027|FG002|Overall Study|Lack of Efficacy|8|||
148806805|NCT00284856|536771025|FG000|Overall Study|Lost to Follow-up|25|||
148806806|NCT00284856|536771026|FG001|Overall Study|Lost to Follow-up|21|||
148806807|NCT00284856|536771027|FG002|Overall Study|Lost to Follow-up|22|||
148806808|NCT00284856|536771025|FG000|Overall Study|Protocol Violation|5|||
148806809|NCT00284856|536771026|FG001|Overall Study|Protocol Violation|4|||
149174817|NCT04909463|538112600|FG001|Overall Study|Withdrawal by Subject|1|||
149174818|NCT04909463|538112601|FG002|Overall Study|Withdrawal by Subject|0|||
149174819|NCT04909463|538112602|FG003|Overall Study|Withdrawal by Subject|0|||
149174820|NCT04909463|538112599|FG000|Overall Study|Lost to Follow-up|2|||
148678775|NCT00833976|536298972|FG000|Overall Study|Did not meet eligibility criteria|41|||
148678776|NCT00833976|536298972|FG000|Overall Study|Physician Decision|1|||
148678777|NCT04575038|536298973|FG000|Overall Study|Withdrawal by Subject|1|||
148678778|NCT04575038|536298974|FG001|Overall Study|Withdrawal by Subject|1|||
148678779|NCT01902134|536298976|FG000|Overall Study|Adverse Event|3|||
148678780|NCT01902134|536298977|FG001|Overall Study|Adverse Event|1|||
148678781|NCT01902134|536298978|FG002|Overall Study|Adverse Event|2|||
148678782|NCT01902134|536298979|FG003|Overall Study|Adverse Event|1|||
148678783|NCT01902134|536298980|FG004|Overall Study|Adverse Event|1|||
148678784|NCT01902134|536298981|FG005|Overall Study|Adverse Event|3|||
148678785|NCT01902134|536298976|FG000|Overall Study|Lack of Efficacy|0|||
148678786|NCT01902134|536298977|FG001|Overall Study|Lack of Efficacy|0|||
148678787|NCT01902134|536298978|FG002|Overall Study|Lack of Efficacy|2|||
148678788|NCT01902134|536298979|FG003|Overall Study|Lack of Efficacy|0|||
148678789|NCT01902134|536298980|FG004|Overall Study|Lack of Efficacy|0|||
148678790|NCT01902134|536298981|FG005|Overall Study|Lack of Efficacy|1|||
148678791|NCT01902134|536298976|FG000|Overall Study|Physician Decision|0|||
148806810|NCT00284856|536771027|FG002|Overall Study|Protocol Violation|5|||
148806811|NCT00284856|536771025|FG000|Overall Study|Withdrawal by Subject|12|||
148806812|NCT00284856|536771026|FG001|Overall Study|Withdrawal by Subject|16|||
148806813|NCT00284856|536771027|FG002|Overall Study|Withdrawal by Subject|18|||
148806814|NCT00284856|536771025|FG000|Overall Study|Other|4|||
148806815|NCT00284856|536771026|FG001|Overall Study|Other|5|||
148929828|NCT01115803|537228373|FG000|Overall Study|Withdrawal by Subject|0|||
148929829|NCT01115803|537228374|FG001|Overall Study|Withdrawal by Subject|0|||
149174821|NCT04909463|538112600|FG001|Overall Study|Lost to Follow-up|1|||
149174822|NCT04909463|538112601|FG002|Overall Study|Lost to Follow-up|1|||
149174823|NCT04909463|538112602|FG003|Overall Study|Lost to Follow-up|0|||
149174824|NCT01672892|538112603|FG000|Overall Study|Protocol Violation|7|||
149174825|NCT01672892|538112604|FG001|Overall Study|Protocol Violation|3|||
149174826|NCT00875420|538112609|FG000|Overall Study|Adverse Event|0|||
148806816|NCT00284856|536771027|FG002|Overall Study|Other|4|||
148806817|NCT05853120|536771028|FG000|Overall Study|Lost to Follow-up|4|||
148806818|NCT05853120|536771029|FG001|Overall Study|Lost to Follow-up|4|||
148806819|NCT05853120|536771028|FG000|Overall Study|Physician Decision|3|||
148806820|NCT05853120|536771029|FG001|Overall Study|Physician Decision|0|||
148806821|NCT05853120|536771028|FG000|Overall Study|Withdrawal by Subject|5|||
148806822|NCT05853120|536771029|FG001|Overall Study|Withdrawal by Subject|2|||
148806823|NCT02592824|536771031|FG000|Overall Study|Protocol Violation|5|||
148806824|NCT02592824|536771032|FG001|Overall Study|Protocol Violation|3|||
148806825|NCT02592824|536771031|FG000|Overall Study|Lost to Follow-up|2|||
148806826|NCT02592824|536771032|FG001|Overall Study|Lost to Follow-up|1|||
148806827|NCT00465517|536771033|FG000|Overall Study|Adverse Event|7|||
148806828|NCT00465517|536771034|FG001|Overall Study|Adverse Event|3|||
148806829|NCT00465517|536771033|FG000|Overall Study|Lost to Follow-up|1|||
148806830|NCT00465517|536771034|FG001|Overall Study|Lost to Follow-up|0|||
148806831|NCT00465517|536771033|FG000|Overall Study|Withdrawal by Subject|4|||
148806832|NCT00465517|536771034|FG001|Overall Study|Withdrawal by Subject|1|||
148806833|NCT00289276|536771037|FG000|Second Part of FAST Study (Expansion)|Death|0|||
148806834|NCT00289276|536771038|FG001|Second Part of FAST Study (Expansion)|Death|2|||
148806835|NCT00289276|536771037|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
148806836|NCT00289276|536771038|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
148806837|NCT00869960|536771039|FG000|Overall Study|Lost to Follow-up|2|||
148806838|NCT00726609|536771042|FG000|Overall Study|Adverse Event|10|||
148806839|NCT00726609|536771042|FG000|Overall Study|Withdrawal by Subject|2|||
148806840|NCT00726609|536771042|FG000|Overall Study|Lack of Efficacy|25|||
148806841|NCT00726609|536771042|FG000|Overall Study|Other|16|||
148806842|NCT00726609|536771042|FG000|Overall Study|Missing|42|||
148806843|NCT00726609|536771042|FG000|Overall Study|Other|3|||
148806844|NCT00746551|536771046|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
148806845|NCT00746551|536771047|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
148806846|NCT00746551|536771046|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
148806847|NCT00746551|536771047|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
148806848|NCT00746551|536771046|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
148806849|NCT00746551|536771047|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
148806850|NCT02029417|536771048|FG000|Overall Study|Death|1|||
148806851|NCT02029417|536771048|FG000|Overall Study|Adverse Event|1|||
148806852|NCT00465179|536771051|FG000|Overall Study|Adverse Event|4|||
148806853|NCT00465179|536771051|FG000|Overall Study|Withdrawal by Subject|2|||
148806854|NCT00465179|536771051|FG000|Overall Study|Progression of Disease|47|||
148806855|NCT05219162|536771055|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
148806856|NCT05219162|536771055|FG000|Overall Study|Withdrawal by Subject|23|||
148806857|NCT00171249|536771058|FG000|Overall Study|Withdrawal by Subject|2|||
148806858|NCT00171249|536771059|FG001|Overall Study|Withdrawal by Subject|0|||
148929830|NCT01115803|537228375|FG002|Overall Study|Withdrawal by Subject|0|||
148929831|NCT01115803|537228376|FG003|Overall Study|Withdrawal by Subject|0|||
148929832|NCT01115803|537228377|FG004|Overall Study|Withdrawal by Subject|0|||
148929833|NCT01115803|537228378|FG005|Overall Study|Withdrawal by Subject|0|||
148929834|NCT01115803|537228379|FG006|Overall Study|Withdrawal by Subject|1|||
148929835|NCT01115803|537228373|FG000|Overall Study|Lost to Follow-up|0|||
148929836|NCT01115803|537228374|FG001|Overall Study|Lost to Follow-up|0|||
149174827|NCT00875420|538112610|FG001|Overall Study|Adverse Event|1|||
149174828|NCT00875420|538112611|FG002|Overall Study|Adverse Event|1|||
149174829|NCT00875420|538112612|FG003|Overall Study|Adverse Event|0|||
149174830|NCT00875420|538112613|FG004|Overall Study|Adverse Event|0|||
148806859|NCT00171249|536771060|FG002|Overall Study|Withdrawal by Subject|0|||
148806860|NCT00171249|536771061|FG003|Overall Study|Withdrawal by Subject|6|||
148806861|NCT00171249|536771062|FG004|Overall Study|Withdrawal by Subject|0|||
148806862|NCT00171249|536771063|FG005|Overall Study|Withdrawal by Subject|0|||
148806863|NCT00171249|536771064|FG006|Overall Study|Withdrawal by Subject|0|||
148929837|NCT01115803|537228375|FG002|Overall Study|Lost to Follow-up|1|||
148929838|NCT01115803|537228376|FG003|Overall Study|Lost to Follow-up|0|||
148929839|NCT01115803|537228377|FG004|Overall Study|Lost to Follow-up|0|||
148806864|NCT00171249|536771058|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
148806865|NCT00171249|536771059|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148806866|NCT00171249|536771060|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
148806867|NCT00171249|536771061|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
148929840|NCT01115803|537228378|FG005|Overall Study|Lost to Follow-up|0|||
148929841|NCT01115803|537228379|FG006|Overall Study|Lost to Follow-up|0|||
149174831|NCT00875420|538112609|FG000|Overall Study|Inability to complete study procedures|1|||
149174832|NCT00875420|538112610|FG001|Overall Study|Inability to complete study procedures|0|||
149174833|NCT00875420|538112611|FG002|Overall Study|Inability to complete study procedures|1|||
149174834|NCT00875420|538112612|FG003|Overall Study|Inability to complete study procedures|1|||
149174835|NCT00875420|538112613|FG004|Overall Study|Inability to complete study procedures|1|||
149174836|NCT00875420|538112609|FG000|Overall Study|Lost to Follow-up|1|||
149174837|NCT00875420|538112610|FG001|Overall Study|Lost to Follow-up|0|||
149174838|NCT00875420|538112611|FG002|Overall Study|Lost to Follow-up|0|||
149174839|NCT00875420|538112612|FG003|Overall Study|Lost to Follow-up|0|||
149174840|NCT00875420|538112613|FG004|Overall Study|Lost to Follow-up|0|||
149174841|NCT00875420|538112609|FG000|Overall Study|Personal reason|0|||
149174842|NCT00875420|538112610|FG001|Overall Study|Personal reason|0|||
149174843|NCT00875420|538112611|FG002|Overall Study|Personal reason|0|||
149174844|NCT00875420|538112612|FG003|Overall Study|Personal reason|0|||
149174845|NCT00875420|538112613|FG004|Overall Study|Personal reason|1|||
149174846|NCT00875420|538112609|FG000|Overall Study|Prohibited medication|0|||
149174847|NCT00875420|538112610|FG001|Overall Study|Prohibited medication|0|||
149174848|NCT00875420|538112611|FG002|Overall Study|Prohibited medication|0|||
149174849|NCT00875420|538112612|FG003|Overall Study|Prohibited medication|1|||
149174850|NCT00875420|538112613|FG004|Overall Study|Prohibited medication|0|||
149174851|NCT00875420|538112609|FG000|Overall Study|Sponsor decision|0|||
149174852|NCT00875420|538112610|FG001|Overall Study|Sponsor decision|1|||
149174853|NCT00875420|538112611|FG002|Overall Study|Sponsor decision|0|||
149174854|NCT00875420|538112612|FG003|Overall Study|Sponsor decision|0|||
148929842|NCT01115803|537228373|FG000|Overall Study|Progressive Disease during Cycle1|0|||
148929843|NCT01115803|537228374|FG001|Overall Study|Progressive Disease during Cycle1|0|||
148929844|NCT01115803|537228375|FG002|Overall Study|Progressive Disease during Cycle1|0|||
148929845|NCT01115803|537228376|FG003|Overall Study|Progressive Disease during Cycle1|0|||
148929846|NCT01115803|537228377|FG004|Overall Study|Progressive Disease during Cycle1|0|||
148929847|NCT01115803|537228378|FG005|Overall Study|Progressive Disease during Cycle1|0|||
148929848|NCT01115803|537228379|FG006|Overall Study|Progressive Disease during Cycle1|1|||
149174855|NCT00875420|538112613|FG004|Overall Study|Sponsor decision|0|||
149174856|NCT00875420|538112609|FG000|Overall Study|Withdrawal by Subject|0|||
149174857|NCT00875420|538112610|FG001|Overall Study|Withdrawal by Subject|0|||
149174858|NCT00875420|538112611|FG002|Overall Study|Withdrawal by Subject|1|||
149174859|NCT00875420|538112612|FG003|Overall Study|Withdrawal by Subject|0|||
149174860|NCT00875420|538112613|FG004|Overall Study|Withdrawal by Subject|0|||
149174861|NCT00886821|538112614|FG000|Stage 2|Adverse Event|0|||
149174862|NCT00886821|538112615|FG001|Stage 2|Adverse Event|0|||
149174863|NCT00886821|538112616|FG002|Stage 2|Adverse Event|0|||
149174864|NCT00886821|538112617|FG003|Stage 2|Adverse Event|0|||
149174865|NCT00886821|538112618|FG004|Stage 2|Adverse Event|0|||
149174866|NCT00886821|538112619|FG005|Stage 2|Adverse Event|0|||
149174867|NCT00886821|538112620|FG006|Stage 2|Adverse Event|0|||
149174868|NCT00886821|538112621|FG007|Stage 2|Adverse Event|0|||
149174869|NCT00886821|538112622|FG008|Stage 2|Adverse Event|0|||
149174870|NCT00886821|538112623|FG009|Stage 2|Adverse Event|0|||
149174871|NCT00886821|538112624|FG010|Stage 2|Adverse Event|0|||
149174872|NCT00886821|538112625|FG011|Stage 2|Adverse Event|1|||
149174873|NCT00886821|538112626|FG012|Stage 2|Adverse Event|3|||
149174874|NCT00886821|538112627|FG013|Stage 2|Adverse Event|0|||
149174875|NCT00886821|538112614|FG000|Stage 2|Lost to Follow-up|0|||
149174876|NCT00886821|538112615|FG001|Stage 2|Lost to Follow-up|0|||
149174877|NCT00886821|538112616|FG002|Stage 2|Lost to Follow-up|0|||
149174878|NCT00886821|538112617|FG003|Stage 2|Lost to Follow-up|0|||
149174879|NCT00886821|538112618|FG004|Stage 2|Lost to Follow-up|0|||
149174880|NCT00886821|538112619|FG005|Stage 2|Lost to Follow-up|0|||
149174881|NCT00886821|538112620|FG006|Stage 2|Lost to Follow-up|0|||
149174882|NCT00886821|538112621|FG007|Stage 2|Lost to Follow-up|0|||
148929849|NCT00450385|537228380|FG000|Overall Study|Death|3|||
149174883|NCT00886821|538112622|FG008|Stage 2|Lost to Follow-up|0|||
149174884|NCT00886821|538112623|FG009|Stage 2|Lost to Follow-up|0|||
149174885|NCT00886821|538112624|FG010|Stage 2|Lost to Follow-up|0|||
149174886|NCT00886821|538112625|FG011|Stage 2|Lost to Follow-up|0|||
149174887|NCT00886821|538112626|FG012|Stage 2|Lost to Follow-up|2|||
148929850|NCT00450385|537228380|FG000|Overall Study|Protocol Violation|1|||
149174888|NCT00886821|538112627|FG013|Stage 2|Lost to Follow-up|1|||
149174889|NCT00914628|538112628|FG000|Overall Study|Death|35|||
149174890|NCT00914628|538112629|FG001|Overall Study|Death|17|||
149174891|NCT00914628|538112628|FG000|Overall Study|Medical decision|4|||
148929851|NCT00450385|537228380|FG000|Overall Study|Withdrawal by Subject|2|||
148929852|NCT00450385|537228380|FG000|Overall Study|Lack of Efficacy|2|||
149174892|NCT00914628|538112629|FG001|Overall Study|Medical decision|0|||
149174893|NCT00914628|538112628|FG000|Overall Study|Protocol Violation|1|||
149174894|NCT00914628|538112629|FG001|Overall Study|Protocol Violation|0|||
149174895|NCT00914628|538112628|FG000|Overall Study|Lack of Efficacy|1|||
149174896|NCT00914628|538112629|FG001|Overall Study|Lack of Efficacy|0|||
149174897|NCT00914628|538112628|FG000|Overall Study|non-randomized|1|||
149174898|NCT00914628|538112629|FG001|Overall Study|non-randomized|0|||
149174899|NCT00914628|538112628|FG000|Overall Study|Relapse|1|||
149174900|NCT00914628|538112629|FG001|Overall Study|Relapse|2|||
149174901|NCT00914628|538112628|FG000|Overall Study|Study terminated by Sponsor|14|||
149174902|NCT00914628|538112629|FG001|Overall Study|Study terminated by Sponsor|8|||
149174903|NCT00914628|538112628|FG000|Overall Study|Patients who did not receive a single dose|7|||
149174904|NCT00914628|538112629|FG001|Overall Study|Patients who did not receive a single dose|1|||
149174905|NCT03311126|538112630|FG000|Induction|Death|1|||
149174906|NCT03311126|538112630|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
149174907|NCT00942162|538112631|FG000|Overall Study|Death|45|||
149174908|NCT00942162|538112632|FG001|Overall Study|Death|35|||
149174909|NCT00942162|538112633|FG002|Overall Study|Death|0|||
149174910|NCT00942162|538112631|FG000|Overall Study|Withdrawal by Subject|7|||
149174911|NCT00942162|538112632|FG001|Overall Study|Withdrawal by Subject|2|||
149174912|NCT00942162|538112633|FG002|Overall Study|Withdrawal by Subject|0|||
149174913|NCT00942162|538112631|FG000|Overall Study|Lost to Follow-up|4|||
149174914|NCT00942162|538112632|FG001|Overall Study|Lost to Follow-up|0|||
149174915|NCT00942162|538112633|FG002|Overall Study|Lost to Follow-up|0|||
149174916|NCT00942162|538112631|FG000|Overall Study|Other|14|||
149174917|NCT00942162|538112632|FG001|Overall Study|Other|13|||
149174918|NCT00942162|538112633|FG002|Overall Study|Other|2|||
149174919|NCT01006356|538112634|FG000|Overall Study|Adverse Event|6|||
149174920|NCT01006356|538112634|FG000|Overall Study|Physician Decision|1|||
149174921|NCT01006356|538112634|FG000|Overall Study|Paticipants did not cooperate|6|||
149174922|NCT01006356|538112634|FG000|Overall Study|Withdrawal by Subject|1|||
149174923|NCT01006356|538112634|FG000|Overall Study|Choice by participants|2|||
149174924|NCT01006356|538112634|FG000|Overall Study|Protocol Violation|3|||
149174925|NCT01006356|538112634|FG000|Overall Study|Other|23|||
149174926|NCT01756157|538112639|FG000|First Intervention Period|Withdrawal by Subject|1|||
149174927|NCT01756157|538112640|FG001|First Intervention Period|Withdrawal by Subject|0|||
149174928|NCT01756157|538112639|FG000|First Intervention Period|Lost to Follow-up|0|||
149174929|NCT01756157|538112640|FG001|First Intervention Period|Lost to Follow-up|2|||
149174930|NCT02799381|538112643|FG000|Overall Study|Withdrew consent|3|||
149174931|NCT02799381|538112644|FG001|Overall Study|Withdrew consent|2|||
149174932|NCT02799381|538112643|FG000|Overall Study|Adverse Event|0|||
149174933|NCT02799381|538112644|FG001|Overall Study|Adverse Event|1|||
149174934|NCT02799381|538112643|FG000|Overall Study|Participant did not take any study drug|1|||
149174935|NCT02799381|538112644|FG001|Overall Study|Participant did not take any study drug|0|||
149174936|NCT03368859|538112645|FG000|Overall Study|Withdrew Consent|5|||
149174937|NCT03368859|538112646|FG001|Overall Study|Withdrew Consent|4|||
149174938|NCT03368859|538112645|FG000|Overall Study|Death|12|||
149174939|NCT03368859|538112646|FG001|Overall Study|Death|6|||
149174940|NCT03368859|538112645|FG000|Overall Study|Study terminated by Sponsor|18|||
149174941|NCT03368859|538112646|FG001|Overall Study|Study terminated by Sponsor|23|||
149174942|NCT03368859|538112645|FG000|Overall Study|Other|1|||
149174943|NCT03368859|538112646|FG001|Overall Study|Other|1|||
149174944|NCT02698410|538112647|FG000|Overall Study|Adverse Event|2|||
149174945|NCT02698410|538112647|FG000|Overall Study|Withdrawal by Subject|1|||
149174946|NCT02698410|538112647|FG000|Overall Study|Other|1|||
149174947|NCT01713348|538112648|FG000|Overall Study|Withdrawal by Subject|3|||
149174948|NCT01713348|538112649|FG001|Overall Study|Withdrawal by Subject|2|||
149174949|NCT01713348|538112650|FG002|Overall Study|Withdrawal by Subject|2|||
149174950|NCT01713348|538112651|FG003|Overall Study|Withdrawal by Subject|0|||
149174951|NCT01713348|538112648|FG000|Overall Study|Lost to Follow-up|1|||
149174952|NCT01713348|538112649|FG001|Overall Study|Lost to Follow-up|0|||
149174953|NCT01713348|538112650|FG002|Overall Study|Lost to Follow-up|0|||
149174954|NCT01713348|538112651|FG003|Overall Study|Lost to Follow-up|0|||
149174955|NCT02638012|538112652|FG000|Overall Study|Lost to Follow-up|1|||
149174956|NCT00817414|538112654|FG000|Overall Study|Adverse Event|1|||
149174957|NCT00817414|538112655|FG001|Overall Study|Adverse Event|1|||
149174958|NCT00817414|538112656|FG002|Overall Study|Adverse Event|1|||
149174959|NCT00817414|538112657|FG003|Overall Study|Adverse Event|0|||
149174960|NCT00817414|538112658|FG004|Overall Study|Adverse Event|0|||
149174961|NCT00817414|538112654|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
149174962|NCT00817414|538112655|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
149174963|NCT00817414|538112656|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
149174964|NCT00817414|538112657|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
149174965|NCT00817414|538112658|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
149174966|NCT00817414|538112654|FG000|Overall Study|Withdrawal by Subject|1|||
149174967|NCT00817414|538112655|FG001|Overall Study|Withdrawal by Subject|1|||
149174968|NCT00817414|538112656|FG002|Overall Study|Withdrawal by Subject|0|||
149174969|NCT00817414|538112657|FG003|Overall Study|Withdrawal by Subject|0|||
149174970|NCT00817414|538112658|FG004|Overall Study|Withdrawal by Subject|0|||
149174971|NCT00817414|538112654|FG000|Overall Study|Lost to Follow-up|0|||
149174972|NCT00817414|538112655|FG001|Overall Study|Lost to Follow-up|0|||
149174973|NCT00817414|538112656|FG002|Overall Study|Lost to Follow-up|1|||
149174974|NCT00817414|538112657|FG003|Overall Study|Lost to Follow-up|1|||
148806868|NCT00171249|536771062|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148806869|NCT00171249|536771063|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
148806870|NCT00171249|536771064|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
148806871|NCT00171249|536771058|FG000|Overall Study|Death|7|||
148806872|NCT00171249|536771059|FG001|Overall Study|Death|1|||
148806873|NCT00171249|536771060|FG002|Overall Study|Death|0|||
148806874|NCT00171249|536771061|FG003|Overall Study|Death|4|||
148806875|NCT00171249|536771062|FG004|Overall Study|Death|0|||
148806876|NCT00171249|536771063|FG005|Overall Study|Death|3|||
148806877|NCT00171249|536771064|FG006|Overall Study|Death|1|||
148806878|NCT00171249|536771058|FG000|Overall Study|Other|10|||
148806879|NCT00171249|536771059|FG001|Overall Study|Other|0|||
148806880|NCT00171249|536771060|FG002|Overall Study|Other|0|||
148806881|NCT00171249|536771061|FG003|Overall Study|Other|43|||
148806882|NCT00171249|536771062|FG004|Overall Study|Other|0|||
148806883|NCT00171249|536771063|FG005|Overall Study|Other|2|||
148806884|NCT00171249|536771064|FG006|Overall Study|Other|0|||
148806885|NCT00171249|536771058|FG000|Overall Study|No Longer Requires Study Drug|4|||
148806886|NCT00171249|536771059|FG001|Overall Study|No Longer Requires Study Drug|0|||
148806887|NCT00171249|536771060|FG002|Overall Study|No Longer Requires Study Drug|0|||
148806888|NCT00171249|536771061|FG003|Overall Study|No Longer Requires Study Drug|3|||
148806889|NCT00171249|536771062|FG004|Overall Study|No Longer Requires Study Drug|0|||
148806890|NCT00171249|536771063|FG005|Overall Study|No Longer Requires Study Drug|5|||
149174975|NCT00817414|538112658|FG004|Overall Study|Lost to Follow-up|1|||
149174976|NCT00817414|538112654|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149174977|NCT00817414|538112655|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149174978|NCT00817414|538112656|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149174979|NCT00817414|538112657|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
149174980|NCT00817414|538112658|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
149174981|NCT00817414|538112654|FG000|Overall Study|Protocol Violation|0|||
149174982|NCT00817414|538112655|FG001|Overall Study|Protocol Violation|0|||
149174983|NCT00817414|538112656|FG002|Overall Study|Protocol Violation|0|||
149174984|NCT00817414|538112657|FG003|Overall Study|Protocol Violation|0|||
149174985|NCT00817414|538112658|FG004|Overall Study|Protocol Violation|1|||
149174986|NCT00886938|538112659|FG000|Overall Study|Adverse Event|1|||
149174987|NCT00886938|538112659|FG000|Overall Study|Withdrawal by Subject|1|||
149174988|NCT03872180|538112665|FG000|Overall Study|Adverse Event|4|||
149174989|NCT03872180|538112665|FG000|Overall Study|Lack of Efficacy|2|||
149174990|NCT01157117|538112668|FG000|Overall Study|Dosing Symptoms|0|||
149174991|NCT01157117|538112669|FG001|Overall Study|Dosing Symptoms|4|||
149174992|NCT01157117|538112670|FG002|Overall Study|Dosing Symptoms|0|||
149174993|NCT01157117|538112668|FG000|Overall Study|Withdrawal by Subject|4|||
149174994|NCT01157117|538112669|FG001|Overall Study|Withdrawal by Subject|1|||
149174995|NCT01157117|538112670|FG002|Overall Study|Withdrawal by Subject|1|||
149174996|NCT01157117|538112668|FG000|Overall Study|Lack of Efficacy|1|||
149174997|NCT01157117|538112669|FG001|Overall Study|Lack of Efficacy|1|||
149174998|NCT01157117|538112670|FG002|Overall Study|Lack of Efficacy|0|||
149174999|NCT01157117|538112668|FG000|Overall Study|Lost to Follow-up|0|||
149175000|NCT01157117|538112669|FG001|Overall Study|Lost to Follow-up|0|||
149175001|NCT01157117|538112670|FG002|Overall Study|Lost to Follow-up|1|||
149175002|NCT01157117|538112668|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
149175003|NCT01157117|538112669|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
149175004|NCT01157117|538112670|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
149175005|NCT01931865|538112671|FG000|Overall Study|Lost to Follow-up|2|||
149175006|NCT01931865|538112671|FG000|Overall Study|Withdrawal by Subject|2|||
149175007|NCT03215277|538112673|FG000|Overall Study|Adverse Event|2|||
149175008|NCT03215277|538112674|FG001|Overall Study|Adverse Event|3|||
149175009|NCT03215277|538112673|FG000|Overall Study|Death|1|||
149175010|NCT03215277|538112674|FG001|Overall Study|Death|0|||
149175011|NCT03215277|538112673|FG000|Overall Study|Lost to Follow-up|0|||
149175012|NCT03215277|538112674|FG001|Overall Study|Lost to Follow-up|1|||
149175013|NCT03215277|538112673|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
149175014|NCT03215277|538112674|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
149175015|NCT03596164|538112675|FG000|Overall Study|Adverse Event|0|||
149175016|NCT03596164|538112676|FG001|Overall Study|Adverse Event|1|||
148806891|NCT00171249|536771064|FG006|Overall Study|No Longer Requires Study Drug|0|||
149175017|NCT03596164|538112675|FG000|Overall Study|Death|1|||
149175018|NCT03596164|538112676|FG001|Overall Study|Death|0|||
149175019|NCT04112914|538112677|FG000|Overall Study|Lost to Follow-up|13|||
149175020|NCT04112914|538112678|FG001|Overall Study|Lost to Follow-up|9|||
149175021|NCT04112914|538112677|FG000|Overall Study|Withdrawal by Subject|1|||
149175022|NCT04112914|538112678|FG001|Overall Study|Withdrawal by Subject|0|||
149175023|NCT01120626|538112679|FG000|Overall Study|Withdrawal by Subject|1|||
149175024|NCT01120626|538112680|FG001|Overall Study|Withdrawal by Subject|0|||
148806892|NCT00171249|536771058|FG000|Overall Study|Administrative Problems|1|||
148806893|NCT00171249|536771059|FG001|Overall Study|Administrative Problems|0|||
149175025|NCT01244737|538112681|FG000|Overall Study|Physician Decision|2|||
149175026|NCT01244737|538112682|FG001|Overall Study|Physician Decision|18|||
149175027|NCT01244737|538112683|FG002|Overall Study|Physician Decision|5|||
149175028|NCT01244737|538112681|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
149175029|NCT01244737|538112682|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
149175030|NCT01244737|538112683|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
149175031|NCT01244737|538112681|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
149175032|NCT01244737|538112682|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
149175033|NCT01244737|538112683|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
149175034|NCT01244737|538112681|FG000|Overall Study|MIB immunopathology results not available|3|||
149175035|NCT01244737|538112682|FG001|Overall Study|MIB immunopathology results not available|2|||
149175036|NCT01244737|538112683|FG002|Overall Study|MIB immunopathology results not available|0|||
149175037|NCT01244737|538112681|FG000|Overall Study|PET data failure|0|||
149175038|NCT01244737|538112682|FG001|Overall Study|PET data failure|1|||
149175039|NCT01244737|538112683|FG002|Overall Study|PET data failure|0|||
149175040|NCT01244737|538112681|FG000|Overall Study|Withdrawal by Subject|0|||
149175041|NCT01244737|538112682|FG001|Overall Study|Withdrawal by Subject|0|||
149175042|NCT01244737|538112683|FG002|Overall Study|Withdrawal by Subject|1|||
149175043|NCT02835495|538112687|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
149175044|NCT02835495|538112688|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
149175045|NCT02835495|538112687|FG000|Overall Study|Declined in-person follow-up visit|4|||
149175046|NCT02835495|538112688|FG001|Overall Study|Declined in-person follow-up visit|2|||
149175047|NCT00356915|538112690|FG000|Overall Study|Non compliance|1|||
149175048|NCT00356915|538112691|FG001|Overall Study|Non compliance|2|||
149175049|NCT00356915|538112692|FG002|Overall Study|Non compliance|1|||
149175050|NCT00356915|538112690|FG000|Overall Study|Protocol Violation|2|||
149175051|NCT00356915|538112691|FG001|Overall Study|Protocol Violation|3|||
148929853|NCT00450385|537228380|FG000|Overall Study|Adverse Event|1|||
148929854|NCT00450385|537228380|FG000|Overall Study|Physician Decision|1|||
148929855|NCT00450385|537228380|FG000|Overall Study|Other|3|||
148929856|NCT03614975|537228381|FG000|Overall Study|Physician Decision|7|||
148929857|NCT03614975|537228382|FG001|Overall Study|Physician Decision|5|||
148929858|NCT03614975|537228381|FG000|Overall Study|Withdrawal by Subject|2|||
148929859|NCT03614975|537228382|FG001|Overall Study|Withdrawal by Subject|2|||
148929860|NCT03614975|537228381|FG000|Overall Study|Specimens not in lab batch shipment|1|||
148929861|NCT03614975|537228382|FG001|Overall Study|Specimens not in lab batch shipment|1|||
148929862|NCT03533686|537228383|FG000|Overall Study|Withdrawal by Subject|1|||
148929863|NCT03533686|537228384|FG001|Overall Study|Withdrawal by Subject|0|||
148929864|NCT03533686|537228385|FG002|Overall Study|Withdrawal by Subject|0|||
148929865|NCT03533686|537228386|FG003|Overall Study|Withdrawal by Subject|3|||
148929866|NCT03533686|537228387|FG004|Overall Study|Withdrawal by Subject|5|||
148929867|NCT03533686|537228388|FG005|Overall Study|Withdrawal by Subject|1|||
148929868|NCT03533686|537228383|FG000|Overall Study|Lost to Follow-up|0|||
148929869|NCT03533686|537228384|FG001|Overall Study|Lost to Follow-up|1|||
148929870|NCT03533686|537228385|FG002|Overall Study|Lost to Follow-up|0|||
148929871|NCT03533686|537228386|FG003|Overall Study|Lost to Follow-up|0|||
148929872|NCT03533686|537228387|FG004|Overall Study|Lost to Follow-up|2|||
148929873|NCT03533686|537228388|FG005|Overall Study|Lost to Follow-up|0|||
148929874|NCT03533686|537228383|FG000|Overall Study|Screen Failure|0|||
148929875|NCT03533686|537228384|FG001|Overall Study|Screen Failure|0|||
148929876|NCT03533686|537228385|FG002|Overall Study|Screen Failure|0|||
148929877|NCT03533686|537228386|FG003|Overall Study|Screen Failure|2|||
148929878|NCT03533686|537228387|FG004|Overall Study|Screen Failure|0|||
148929879|NCT03533686|537228388|FG005|Overall Study|Screen Failure|0|||
148929880|NCT00136604|537228389|FG000|Overall Study|Lost to Follow-up|1|||
148929881|NCT00136604|537228390|FG001|Overall Study|Lost to Follow-up|0|||
148929882|NCT00136604|537228391|FG002|Overall Study|Lost to Follow-up|0|||
148929883|NCT00136604|537228392|FG003|Overall Study|Lost to Follow-up|0|||
148929884|NCT00136604|537228393|FG004|Overall Study|Lost to Follow-up|1|||
148929885|NCT00136604|537228389|FG000|Overall Study|Migrated/moved from study area|0|||
148929886|NCT00136604|537228390|FG001|Overall Study|Migrated/moved from study area|1|||
148929887|NCT00136604|537228391|FG002|Overall Study|Migrated/moved from study area|0|||
148929888|NCT00136604|537228392|FG003|Overall Study|Migrated/moved from study area|0|||
148929889|NCT00136604|537228393|FG004|Overall Study|Migrated/moved from study area|0|||
148929890|NCT02017171|537228394|FG000|Overall Study|Death|10|||
148929891|NCT02017171|537228395|FG001|Overall Study|Death|4|||
148929892|NCT02017171|537228394|FG000|Overall Study|Withdrawal by Subject|23|||
148929893|NCT02017171|537228395|FG001|Overall Study|Withdrawal by Subject|17|||
148929894|NCT02017171|537228394|FG000|Overall Study|Lost to Follow-up|21|||
148929895|NCT02017171|537228395|FG001|Overall Study|Lost to Follow-up|20|||
148929896|NCT02017171|537228394|FG000|Overall Study|ESKD|6|||
148929897|NCT02017171|537228395|FG001|Overall Study|ESKD|2|||
148929898|NCT02017171|537228394|FG000|Overall Study|Miscellaneous|2|||
149175052|NCT00356915|538112692|FG002|Overall Study|Protocol Violation|2|||
149175053|NCT00356915|538112690|FG000|Overall Study|Withdrawal by Subject|14|||
149175054|NCT00356915|538112691|FG001|Overall Study|Withdrawal by Subject|14|||
149175055|NCT00356915|538112692|FG002|Overall Study|Withdrawal by Subject|10|||
149175056|NCT00356915|538112690|FG000|Overall Study|Lack of Efficacy|0|||
149175057|NCT00356915|538112691|FG001|Overall Study|Lack of Efficacy|0|||
149175058|NCT00356915|538112692|FG002|Overall Study|Lack of Efficacy|3|||
149175059|NCT00356915|538112690|FG000|Overall Study|Lost to Follow-up|27|||
149175060|NCT00356915|538112691|FG001|Overall Study|Lost to Follow-up|34|||
149175061|NCT00356915|538112692|FG002|Overall Study|Lost to Follow-up|14|||
149175062|NCT00356915|538112690|FG000|Overall Study|Administrative Decision|0|||
149175063|NCT00356915|538112691|FG001|Overall Study|Administrative Decision|0|||
149175064|NCT00356915|538112692|FG002|Overall Study|Administrative Decision|1|||
149175065|NCT00356915|538112690|FG000|Overall Study|Physician Decision|0|||
149175066|NCT00356915|538112691|FG001|Overall Study|Physician Decision|2|||
149175067|NCT00356915|538112692|FG002|Overall Study|Physician Decision|0|||
149175068|NCT00356915|538112690|FG000|Overall Study|Adverse Event|21|||
149175069|NCT00356915|538112691|FG001|Overall Study|Adverse Event|31|||
149175070|NCT00356915|538112692|FG002|Overall Study|Adverse Event|8|||
149175071|NCT00356915|538112690|FG000|Overall Study|Miscellaneous reasons|11|||
149175072|NCT00356915|538112691|FG001|Overall Study|Miscellaneous reasons|8|||
149175073|NCT00356915|538112692|FG002|Overall Study|Miscellaneous reasons|3|||
149175074|NCT01442181|538112701|FG000|Overall Study|patient refused surgery|1|||
149175075|NCT01442181|538112702|FG001|Overall Study|patient refused surgery|0|||
149175076|NCT01442181|538112701|FG000|Overall Study|no insurance for surgery|1|||
149175077|NCT01442181|538112702|FG001|Overall Study|no insurance for surgery|0|||
149175078|NCT01442181|538112701|FG000|Overall Study|low ejection factor|0|||
149175079|NCT01442181|538112702|FG001|Overall Study|low ejection factor|1|||
149175080|NCT01442181|538112701|FG000|Overall Study|Lost to Follow-up|1|||
149175081|NCT01442181|538112702|FG001|Overall Study|Lost to Follow-up|1|||
149175082|NCT01442181|538112701|FG000|Overall Study|patient in an additional study|1|||
149175083|NCT01442181|538112702|FG001|Overall Study|patient in an additional study|0|||
149175084|NCT01442181|538112701|FG000|Overall Study|atrial fibrillation not noted|0|||
149175085|NCT01442181|538112702|FG001|Overall Study|atrial fibrillation not noted|1|||
149175086|NCT00709202|538112703|FG000|Overall Study|Withdrawal by Subject|6|||
149175087|NCT00709202|538112704|FG001|Overall Study|Withdrawal by Subject|6|||
149175088|NCT03133767|538112705|FG000|Overall Study|Lost to Follow-up|38|||
149175089|NCT03133767|538112706|FG001|Overall Study|Lost to Follow-up|24|||
149175090|NCT03133767|538112705|FG000|Overall Study|Protocol Violation|0|||
149175091|NCT03133767|538112706|FG001|Overall Study|Protocol Violation|1|||
149175092|NCT03301857|538112711|FG000|Overall Study|Death|0|||
149175093|NCT03301857|538112712|FG001|Overall Study|Death|2|||
149175094|NCT03301857|538112711|FG000|Overall Study|Lost to Follow-up|4|||
149175095|NCT03301857|538112712|FG001|Overall Study|Lost to Follow-up|2|||
149175096|NCT03301857|538112711|FG000|Overall Study|Decision by Sponsor|6|||
149175097|NCT03301857|538112712|FG001|Overall Study|Decision by Sponsor|0|||
149175098|NCT03301857|538112711|FG000|Overall Study|Withdrawal by Subject|12|||
149175099|NCT03301857|538112712|FG001|Overall Study|Withdrawal by Subject|4|||
149175100|NCT00855439|538112713|FG000|Overall Study|Withdrawal by Subject|2|||
149175101|NCT00855439|538112714|FG001|Overall Study|Withdrawal by Subject|0|||
149175102|NCT00855439|538112713|FG000|Overall Study|Pregnancy|1|||
149175103|NCT00855439|538112714|FG001|Overall Study|Pregnancy|0|||
149175104|NCT05502289|538112715|FG000|Period 1|Out Of Window|1|||
149175105|NCT05502289|538112716|FG001|Period 1|Out Of Window|0|||
149175106|NCT02333227|538112722|FG000|Overall Study|Lost to Follow-up|137|||
149175107|NCT02333227|538112723|FG001|Overall Study|Lost to Follow-up|106|||
149175108|NCT02333227|538112722|FG000|Overall Study|Pregnancy Interrupted|42|||
149175109|NCT02333227|538112723|FG001|Overall Study|Pregnancy Interrupted|89|||
149175110|NCT02333227|538112722|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
149175111|NCT02333227|538112723|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
149175112|NCT04375878|538112726|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
149175113|NCT04375878|538112727|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
149175114|NCT04375878|538112728|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149175115|NCT04375878|538112729|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149175116|NCT04375878|538112730|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149175117|NCT04375878|538112731|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
149175118|NCT04375878|538112726|FG000|Crossover First and Second Interventions|Adverse Event|0|||
149175119|NCT04375878|538112727|FG001|Crossover First and Second Interventions|Adverse Event|0|||
149175120|NCT04375878|538112728|FG002|Crossover First and Second Interventions|Adverse Event|1|||
149175121|NCT04375878|538112729|FG003|Crossover First and Second Interventions|Adverse Event|0|||
149175122|NCT04375878|538112730|FG004|Crossover First and Second Interventions|Adverse Event|0|||
149175123|NCT04375878|538112731|FG005|Crossover First and Second Interventions|Adverse Event|0|||
149175124|NCT04375878|538112726|FG000|Extension Phase|Withdrawal by Subject|0|||
149175125|NCT04375878|538112727|FG001|Extension Phase|Withdrawal by Subject|0|||
149175126|NCT04375878|538112728|FG002|Extension Phase|Withdrawal by Subject|0|||
149175127|NCT04375878|538112729|FG003|Extension Phase|Withdrawal by Subject|0|||
149175128|NCT04375878|538112730|FG004|Extension Phase|Withdrawal by Subject|1|||
149175129|NCT04375878|538112731|FG005|Extension Phase|Withdrawal by Subject|0|||
149175130|NCT01982630|538112732|FG000|Overall Study|Adverse Event|2|||
149175131|NCT01982630|538112733|FG001|Overall Study|Adverse Event|0|||
149175132|NCT01982630|538112734|FG002|Overall Study|Adverse Event|1|||
149175133|NCT01982630|538112735|FG003|Overall Study|Adverse Event|0|||
149175134|NCT01982630|538112736|FG004|Overall Study|Adverse Event|1|||
149175135|NCT01982630|538112737|FG005|Overall Study|Adverse Event|2|||
149175136|NCT01982630|538112738|FG006|Overall Study|Adverse Event|1|||
149175137|NCT01982630|538112739|FG007|Overall Study|Adverse Event|0|||
149175138|NCT01982630|538112732|FG000|Overall Study|Physician Decision|1|||
149175139|NCT01982630|538112733|FG001|Overall Study|Physician Decision|0|||
149175140|NCT01982630|538112734|FG002|Overall Study|Physician Decision|2|||
149175141|NCT01982630|538112735|FG003|Overall Study|Physician Decision|1|||
149175142|NCT01982630|538112736|FG004|Overall Study|Physician Decision|2|||
149175143|NCT01982630|538112737|FG005|Overall Study|Physician Decision|0|||
149175144|NCT01982630|538112738|FG006|Overall Study|Physician Decision|0|||
149175145|NCT01982630|538112739|FG007|Overall Study|Physician Decision|0|||
149175146|NCT01982630|538112732|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175147|NCT01982630|538112733|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175148|NCT01982630|538112734|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
149175149|NCT01982630|538112735|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175150|NCT01982630|538112736|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175151|NCT01982630|538112737|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175152|NCT01982630|538112738|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175153|NCT01982630|538112739|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
149175154|NCT01982630|538112732|FG000|Overall Study|Withdrawal by Subject|0|||
149175155|NCT01982630|538112733|FG001|Overall Study|Withdrawal by Subject|0|||
149175156|NCT01982630|538112734|FG002|Overall Study|Withdrawal by Subject|0|||
149175157|NCT01982630|538112735|FG003|Overall Study|Withdrawal by Subject|0|||
149175158|NCT01982630|538112736|FG004|Overall Study|Withdrawal by Subject|0|||
149175159|NCT01982630|538112737|FG005|Overall Study|Withdrawal by Subject|1|||
149175160|NCT01982630|538112738|FG006|Overall Study|Withdrawal by Subject|0|||
149175161|NCT01982630|538112739|FG007|Overall Study|Withdrawal by Subject|0|||
149175162|NCT00561353|538112740|FG000|Overall Study|Subject reached a virologic endpoint|2|||
149175163|NCT00561353|538112741|FG001|Overall Study|Subject reached a virologic endpoint|1|||
149175164|NCT00561353|538112742|FG002|Overall Study|Subject reached a virologic endpoint|1|||
149175165|NCT00561353|538112743|FG003|Overall Study|Subject reached a virologic endpoint|4|||
149175166|NCT00561353|538112744|FG004|Overall Study|Subject reached a virologic endpoint|1|||
149175167|NCT00561353|538112745|FG005|Overall Study|Subject reached a virologic endpoint|3|||
149175168|NCT00561353|538112746|FG006|Overall Study|Subject reached a virologic endpoint|4|||
149175169|NCT00561353|538112747|FG007|Overall Study|Subject reached a virologic endpoint|4|||
149175170|NCT00561353|538112748|FG008|Overall Study|Subject reached a virologic endpoint|5|||
149175171|NCT00561353|538112749|FG009|Overall Study|Subject reached a virologic endpoint|0|||
149175172|NCT00561353|538112740|FG000|Overall Study|Subject ineligible to continue the trial|0|||
149175173|NCT00561353|538112741|FG001|Overall Study|Subject ineligible to continue the trial|0|||
149175174|NCT00561353|538112742|FG002|Overall Study|Subject ineligible to continue the trial|0|||
149175175|NCT00561353|538112743|FG003|Overall Study|Subject ineligible to continue the trial|0|||
149175176|NCT00561353|538112744|FG004|Overall Study|Subject ineligible to continue the trial|0|||
149175177|NCT00561353|538112745|FG005|Overall Study|Subject ineligible to continue the trial|1|||
149175178|NCT00561353|538112746|FG006|Overall Study|Subject ineligible to continue the trial|1|||
149175179|NCT00561353|538112747|FG007|Overall Study|Subject ineligible to continue the trial|0|||
149175180|NCT00561353|538112748|FG008|Overall Study|Subject ineligible to continue the trial|2|||
149175181|NCT00561353|538112749|FG009|Overall Study|Subject ineligible to continue the trial|1|||
149175182|NCT00561353|538112740|FG000|Overall Study|Other|1|||
149175183|NCT00561353|538112741|FG001|Overall Study|Other|0|||
149175184|NCT00561353|538112742|FG002|Overall Study|Other|1|||
149175185|NCT00561353|538112743|FG003|Overall Study|Other|0|||
149175186|NCT00561353|538112744|FG004|Overall Study|Other|0|||
149175187|NCT00561353|538112745|FG005|Overall Study|Other|2|||
149175188|NCT00561353|538112746|FG006|Overall Study|Other|0|||
149175189|NCT00561353|538112747|FG007|Overall Study|Other|0|||
149175190|NCT00561353|538112748|FG008|Overall Study|Other|0|||
149175191|NCT00561353|538112749|FG009|Overall Study|Other|0|||
149175192|NCT00561353|538112740|FG000|Overall Study|Adverse Event|0|||
149175193|NCT00561353|538112741|FG001|Overall Study|Adverse Event|0|||
149175194|NCT00561353|538112742|FG002|Overall Study|Adverse Event|0|||
149175195|NCT00561353|538112743|FG003|Overall Study|Adverse Event|2|||
149175196|NCT00561353|538112744|FG004|Overall Study|Adverse Event|0|||
148929899|NCT02017171|537228395|FG001|Overall Study|Miscellaneous|3|||
148929900|NCT01562873|537228396|FG000|Overall Study|Disease Progression per RECIST|10|||
148929901|NCT01562873|537228397|FG001|Overall Study|Disease Progression per RECIST|0|||
148929902|NCT01562873|537228396|FG000|Overall Study|Adverse Event|1|||
148929903|NCT01562873|537228397|FG001|Overall Study|Adverse Event|0|||
148929904|NCT01562873|537228396|FG000|Overall Study|Clinical Disease Progression|9|||
148929905|NCT01562873|537228397|FG001|Overall Study|Clinical Disease Progression|0|||
148929906|NCT01562873|537228396|FG000|Overall Study|Clinical PD and adverse event|1|||
148929907|NCT01562873|537228397|FG001|Overall Study|Clinical PD and adverse event|0|||
148929908|NCT02536833|537228400|FG000|Overall Study|Discontinued Before Treatment|0|||
148929909|NCT02536833|537228401|FG001|Overall Study|Discontinued Before Treatment|0|||
148929910|NCT02536833|537228402|FG002|Overall Study|Discontinued Before Treatment|1|||
148929911|NCT02536833|537228403|FG003|Overall Study|Discontinued Before Treatment|2|||
148929912|NCT02536833|537228400|FG000|Overall Study|Adverse Event|1|||
148929913|NCT02536833|537228401|FG001|Overall Study|Adverse Event|3|||
148929914|NCT02536833|537228402|FG002|Overall Study|Adverse Event|4|||
148929915|NCT02536833|537228403|FG003|Overall Study|Adverse Event|1|||
148929916|NCT02536833|537228400|FG000|Overall Study|Lost to Follow-up|2|||
148929917|NCT02536833|537228401|FG001|Overall Study|Lost to Follow-up|1|||
148929918|NCT02536833|537228402|FG002|Overall Study|Lost to Follow-up|2|||
148929919|NCT02536833|537228403|FG003|Overall Study|Lost to Follow-up|2|||
148929920|NCT02536833|537228400|FG000|Overall Study|Physician Decision|0|||
148929921|NCT02536833|537228401|FG001|Overall Study|Physician Decision|0|||
148929922|NCT02536833|537228402|FG002|Overall Study|Physician Decision|0|||
148929923|NCT02536833|537228403|FG003|Overall Study|Physician Decision|1|||
148929924|NCT02536833|537228400|FG000|Overall Study|Site Terminated by Sponsor|2|||
149013324|NCT01460160|537527907|FG000|Follow-up Phase|Death|14|||
149013325|NCT01460160|537527907|FG000|Follow-up Phase|Lost to Follow-up|7|||
149175197|NCT00561353|538112745|FG005|Overall Study|Adverse Event|0|||
149175198|NCT00561353|538112746|FG006|Overall Study|Adverse Event|1|||
149175199|NCT00561353|538112747|FG007|Overall Study|Adverse Event|0|||
149175200|NCT00561353|538112748|FG008|Overall Study|Adverse Event|0|||
149175201|NCT00561353|538112749|FG009|Overall Study|Adverse Event|1|||
149175202|NCT00561353|538112740|FG000|Overall Study|Lost to Follow-up|2|||
149175203|NCT00561353|538112741|FG001|Overall Study|Lost to Follow-up|0|||
149175204|NCT00561353|538112742|FG002|Overall Study|Lost to Follow-up|1|||
149175205|NCT00561353|538112743|FG003|Overall Study|Lost to Follow-up|0|||
149175206|NCT00561353|538112744|FG004|Overall Study|Lost to Follow-up|0|||
149175207|NCT00561353|538112745|FG005|Overall Study|Lost to Follow-up|0|||
149175208|NCT00561353|538112746|FG006|Overall Study|Lost to Follow-up|0|||
149175209|NCT00561353|538112747|FG007|Overall Study|Lost to Follow-up|0|||
149175210|NCT00561353|538112748|FG008|Overall Study|Lost to Follow-up|0|||
149175211|NCT00561353|538112749|FG009|Overall Study|Lost to Follow-up|0|||
149175212|NCT00561353|538112740|FG000|Overall Study|Withdrawal by Subject|0|||
149175213|NCT00561353|538112741|FG001|Overall Study|Withdrawal by Subject|2|||
149175214|NCT00561353|538112742|FG002|Overall Study|Withdrawal by Subject|0|||
149175215|NCT00561353|538112743|FG003|Overall Study|Withdrawal by Subject|0|||
148929925|NCT02536833|537228401|FG001|Overall Study|Site Terminated by Sponsor|2|||
148929926|NCT02536833|537228402|FG002|Overall Study|Site Terminated by Sponsor|2|||
148929927|NCT02536833|537228403|FG003|Overall Study|Site Terminated by Sponsor|2|||
148929928|NCT02536833|537228400|FG000|Overall Study|Subject Non-Compliance|0|||
148929929|NCT02536833|537228401|FG001|Overall Study|Subject Non-Compliance|1|||
148929930|NCT02536833|537228402|FG002|Overall Study|Subject Non-Compliance|1|||
148929931|NCT02536833|537228403|FG003|Overall Study|Subject Non-Compliance|0|||
149175216|NCT00561353|538112744|FG004|Overall Study|Withdrawal by Subject|0|||
149175217|NCT00561353|538112745|FG005|Overall Study|Withdrawal by Subject|0|||
149175218|NCT00561353|538112746|FG006|Overall Study|Withdrawal by Subject|0|||
149175219|NCT00561353|538112747|FG007|Overall Study|Withdrawal by Subject|0|||
149175220|NCT00561353|538112748|FG008|Overall Study|Withdrawal by Subject|0|||
149175221|NCT00561353|538112749|FG009|Overall Study|Withdrawal by Subject|0|||
149175222|NCT01273818|538112750|FG000|Overall Study|Physician Decision|13|||
149175223|NCT01273818|538112751|FG001|Overall Study|Physician Decision|2|||
149175224|NCT01273818|538112752|FG002|Overall Study|Physician Decision|9|||
149175225|NCT03934684|538112753|FG000|Overall Study|Participants continuing in study|11|||
149175226|NCT03934684|538112754|FG001|Overall Study|Participants continuing in study|4|||
149175227|NCT03934684|538112753|FG000|Overall Study|Discontinuation of carfilzomib|20|||
149175228|NCT03934684|538112754|FG001|Overall Study|Discontinuation of carfilzomib|30|||
149175229|NCT03934684|538112753|FG000|Overall Study|Death|2|||
149175230|NCT03934684|538112754|FG001|Overall Study|Death|2|||
149175231|NCT03934684|538112753|FG000|Overall Study|Lost to Follow-up|2|||
149175232|NCT03934684|538112754|FG001|Overall Study|Lost to Follow-up|5|||
149175233|NCT03934684|538112753|FG000|Overall Study|Withdrawal by Subject|7|||
149175234|NCT03934684|538112754|FG001|Overall Study|Withdrawal by Subject|8|||
149175235|NCT00256295|538112755|FG000|Overall Study|Withdrawal by Subject|3|||
149175236|NCT00256295|538112755|FG000|Overall Study|Death|1|||
149175237|NCT01097044|538112757|FG000|Overall Study|Withdrawal by Subject|4|||
149175238|NCT01097044|538112758|FG001|Overall Study|Withdrawal by Subject|4|||
149175239|NCT01097044|538112757|FG000|Overall Study|Lost to Follow-up|1|||
149175240|NCT01097044|538112758|FG001|Overall Study|Lost to Follow-up|0|||
149175241|NCT01097044|538112757|FG000|Overall Study|Withdrawal by Sponsor|0|||
149175242|NCT01097044|538112758|FG001|Overall Study|Withdrawal by Sponsor|1|||
149175243|NCT01682044|538112759|FG000|Overall Study|Death|1|||
149175244|NCT01682044|538112759|FG000|Overall Study|Progression|3|||
149175245|NCT05405166|538114944|FG000|Overall Study|Death|49|||
149175246|NCT05405166|538114945|FG001|Overall Study|Death|50|||
149175247|NCT05405166|538114944|FG000|Overall Study|Withdrawal by Subject|10|||
149175248|NCT05405166|538114945|FG001|Overall Study|Withdrawal by Subject|3|||
149175249|NCT05405166|538114944|FG000|Overall Study|Ongoing at the time of PCD|209|||
149175250|NCT05405166|538114945|FG001|Overall Study|Ongoing at the time of PCD|210|||
149175251|NCT01386385|538114946|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
149175252|NCT01386385|538114947|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175253|NCT01386385|538114948|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175254|NCT01386385|538114949|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175255|NCT01386385|538114950|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175256|NCT01386385|538114951|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175257|NCT01386385|538114952|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175258|NCT01386385|538114953|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
149175259|NCT01386385|538114946|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
149175260|NCT01386385|538114947|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175261|NCT01386385|538114948|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175262|NCT01386385|538114949|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175263|NCT01386385|538114950|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175264|NCT01386385|538114951|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175265|NCT01386385|538114952|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175266|NCT01386385|538114953|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
149175267|NCT01386385|538114946|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175268|NCT01386385|538114947|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175269|NCT01386385|538114948|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
149175270|NCT01386385|538114949|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175271|NCT01386385|538114950|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175272|NCT01386385|538114951|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175273|NCT01386385|538114952|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175274|NCT01386385|538114953|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
149175275|NCT01386385|538114946|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175276|NCT01386385|538114947|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175277|NCT01386385|538114948|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175278|NCT01386385|538114949|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175279|NCT01386385|538114950|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
149175280|NCT01386385|538114951|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175281|NCT01386385|538114952|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175282|NCT01386385|538114953|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
149175283|NCT01386385|538114946|FG000|Phase II Concurrent CRT|Adverse Event|0|||
149175284|NCT01386385|538114947|FG001|Phase II Concurrent CRT|Adverse Event|0|||
149175285|NCT01386385|538114948|FG002|Phase II Concurrent CRT|Adverse Event|0|||
149175286|NCT01386385|538114949|FG003|Phase II Concurrent CRT|Adverse Event|0|||
149175287|NCT01386385|538114950|FG004|Phase II Concurrent CRT|Adverse Event|0|||
149175288|NCT01386385|538114951|FG005|Phase II Concurrent CRT|Adverse Event|0|||
148929932|NCT02536833|537228400|FG000|Overall Study|Withdrawal by Subject|4|||
148929933|NCT02536833|537228401|FG001|Overall Study|Withdrawal by Subject|3|||
149175289|NCT01386385|538114952|FG006|Phase II Concurrent CRT|Adverse Event|3|||
149175290|NCT01386385|538114953|FG007|Phase II Concurrent CRT|Adverse Event|3|||
149175291|NCT01386385|538114946|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175292|NCT01386385|538114947|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175293|NCT01386385|538114948|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175294|NCT01386385|538114949|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175295|NCT01386385|538114950|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175296|NCT01386385|538114951|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175297|NCT01386385|538114952|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
149175298|NCT01386385|538114953|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
149175299|NCT01386385|538114946|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
149175300|NCT01386385|538114947|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
149175301|NCT01386385|538114948|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
149175302|NCT01386385|538114949|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
149175303|NCT01386385|538114950|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
149175304|NCT01386385|538114951|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
149175305|NCT01386385|538114952|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
149175306|NCT01386385|538114953|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
149175307|NCT01386385|538114946|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175308|NCT01386385|538114947|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175309|NCT01386385|538114948|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175310|NCT01386385|538114949|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175311|NCT01386385|538114950|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175312|NCT01386385|538114951|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175313|NCT01386385|538114952|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
149175314|NCT01386385|538114953|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
149175315|NCT01386385|538114946|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
149175316|NCT01386385|538114947|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
149175317|NCT01386385|538114948|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
149175318|NCT01386385|538114949|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
149175319|NCT01386385|538114950|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
149175320|NCT01386385|538114951|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
149175321|NCT01386385|538114952|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
149175322|NCT01386385|538114953|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
149175323|NCT01084252|538114956|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175324|NCT01084252|538114957|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175325|NCT01084252|538114958|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175326|NCT01084252|538114959|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175327|NCT01084252|538114960|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175328|NCT01084252|538114961|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175329|NCT01084252|538114962|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175330|NCT01084252|538114963|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175331|NCT01084252|538114964|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175332|NCT01084252|538114965|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175333|NCT01084252|538114966|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175334|NCT01084252|538114967|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175335|NCT01084252|538114968|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
149175336|NCT01084252|538114969|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
149175337|NCT00853632|538114970|FG000|Overall Study|Death|88|||
149175338|NCT00853632|538114970|FG000|Overall Study|Withdrawal by Subject|45|||
149175339|NCT00853632|538114970|FG000|Overall Study|Lost to Follow-up|30|||
149175340|NCT00853632|538114970|FG000|Overall Study|Reoperation/Explant|17|||
149175341|NCT00853632|538114970|FG000|Overall Study|Exit with other reason|22|||
149175342|NCT04364854|538114971|FG000|Overall Study|Withdrawal by Subject|1|||
149175343|NCT04364854|538114972|FG001|Overall Study|Withdrawal by Subject|0|||
149175344|NCT04364854|538114973|FG002|Overall Study|Withdrawal by Subject|1|||
149175345|NCT04364854|538114974|FG003|Overall Study|Withdrawal by Subject|3|||
149175346|NCT04364854|538114971|FG000|Overall Study|Death|1|||
149175347|NCT04364854|538114972|FG001|Overall Study|Death|0|||
149175348|NCT04364854|538114973|FG002|Overall Study|Death|0|||
149175349|NCT04364854|538114974|FG003|Overall Study|Death|0|||
149175350|NCT04364854|538114971|FG000|Overall Study|Lost to Follow-up|0|||
149175351|NCT04364854|538114972|FG001|Overall Study|Lost to Follow-up|0|||
149175352|NCT04364854|538114973|FG002|Overall Study|Lost to Follow-up|0|||
149175353|NCT04364854|538114974|FG003|Overall Study|Lost to Follow-up|1|||
149175354|NCT04493619|538114976|FG000|Overall Study|Death|4|||
149175355|NCT04493619|538114977|FG001|Overall Study|Death|3|||
149175356|NCT04493619|538114978|FG002|Overall Study|Death|3|||
149175357|NCT04493619|538114979|FG003|Overall Study|Death|4|||
149175358|NCT04493619|538114976|FG000|Overall Study|Study discontinued early|10|||
148678792|NCT01902134|536298977|FG001|Overall Study|Physician Decision|1|||
149175359|NCT04493619|538114977|FG001|Overall Study|Study discontinued early|0|||
149175360|NCT04493619|538114978|FG002|Overall Study|Study discontinued early|4|||
149175361|NCT04493619|538114979|FG003|Overall Study|Study discontinued early|8|||
149175362|NCT04493619|538114976|FG000|Overall Study|Lost to Follow-up|0|||
149175363|NCT04493619|538114977|FG001|Overall Study|Lost to Follow-up|0|||
149175364|NCT04493619|538114978|FG002|Overall Study|Lost to Follow-up|0|||
149175365|NCT04493619|538114979|FG003|Overall Study|Lost to Follow-up|1|||
149175366|NCT02017444|538114983|FG000|Overall Study|Physician Decision|1|||
149175367|NCT02017444|538114984|FG001|Overall Study|Physician Decision|0|||
149175368|NCT02017444|538114983|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
149175369|NCT02017444|538114984|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
149175370|NCT02342171|538114988|FG000|Overall Study|Death|4|||
149175371|NCT02342171|538114989|FG001|Overall Study|Death|87|||
149175372|NCT02342171|538114988|FG000|Overall Study|Received favipiravir|10|||
149175373|NCT02342171|538114989|FG001|Overall Study|Received favipiravir|0|||
149175374|NCT02342171|538114988|FG000|Overall Study|Missing cycle treshold value|1|||
148929934|NCT02536833|537228402|FG002|Overall Study|Withdrawal by Subject|5|||
148929935|NCT02536833|537228403|FG003|Overall Study|Withdrawal by Subject|11|||
148929936|NCT02220998|537228404|FG000|Overall Study|Randomized but Never Treated|1|||
148678793|NCT01902134|536298978|FG002|Overall Study|Physician Decision|0|||
148678794|NCT01902134|536298979|FG003|Overall Study|Physician Decision|0|||
148678795|NCT01902134|536298980|FG004|Overall Study|Physician Decision|0|||
148678796|NCT01902134|536298981|FG005|Overall Study|Physician Decision|0|||
148678797|NCT01902134|536298976|FG000|Overall Study|Protocol Violation|0|||
148678798|NCT01902134|536298977|FG001|Overall Study|Protocol Violation|0|||
148678799|NCT01902134|536298978|FG002|Overall Study|Protocol Violation|0|||
148678800|NCT01902134|536298979|FG003|Overall Study|Protocol Violation|0|||
148678801|NCT01902134|536298980|FG004|Overall Study|Protocol Violation|0|||
148678802|NCT01902134|536298981|FG005|Overall Study|Protocol Violation|1|||
148678803|NCT01902134|536298976|FG000|Overall Study|Withdrawal by Subject|4|||
148678804|NCT01902134|536298977|FG001|Overall Study|Withdrawal by Subject|8|||
148678805|NCT01902134|536298978|FG002|Overall Study|Withdrawal by Subject|9|||
148678806|NCT01902134|536298979|FG003|Overall Study|Withdrawal by Subject|1|||
148678807|NCT01902134|536298980|FG004|Overall Study|Withdrawal by Subject|5|||
148678808|NCT01902134|536298981|FG005|Overall Study|Withdrawal by Subject|4|||
148678809|NCT01902134|536298976|FG000|Overall Study|no compliance|1|||
148678810|NCT01902134|536298977|FG001|Overall Study|no compliance|0|||
148678811|NCT01902134|536298978|FG002|Overall Study|no compliance|0|||
148678812|NCT01902134|536298979|FG003|Overall Study|no compliance|0|||
148678813|NCT01902134|536298980|FG004|Overall Study|no compliance|0|||
148678814|NCT01902134|536298981|FG005|Overall Study|no compliance|0|||
148678815|NCT01902134|536298976|FG000|Overall Study|Other|0|||
148678816|NCT01902134|536298977|FG001|Overall Study|Other|1|||
148678817|NCT01902134|536298978|FG002|Overall Study|Other|2|||
148678818|NCT01902134|536298979|FG003|Overall Study|Other|0|||
148678819|NCT01902134|536298980|FG004|Overall Study|Other|1|||
148678820|NCT01902134|536298981|FG005|Overall Study|Other|0|||
148678821|NCT00305110|536298982|FG000|Overall Study|Missing data|29|||
148678822|NCT01272193|536298985|FG000|Overall Study|Adverse Event|1|||
148678823|NCT01272193|536298986|FG001|Overall Study|Adverse Event|1|||
148678824|NCT01272193|536298985|FG000|Overall Study|Lack of Efficacy|0|||
148678825|NCT01272193|536298986|FG001|Overall Study|Lack of Efficacy|3|||
148678826|NCT01272193|536298985|FG000|Overall Study|Withdrawal Criteria|1|||
148678827|NCT01272193|536298986|FG001|Overall Study|Withdrawal Criteria|1|||
148678828|NCT01272193|536298985|FG000|Overall Study|Unclassified|8|||
148678829|NCT01272193|536298986|FG001|Overall Study|Unclassified|7|||
148678830|NCT00350519|536298997|FG000|Overall Study|Death|0|||
148678831|NCT00350519|536298998|FG001|Overall Study|Death|1|||
148678832|NCT00350519|536298997|FG000|Overall Study|Physician Decision|0|||
148678833|NCT00350519|536298998|FG001|Overall Study|Physician Decision|1|||
148678834|NCT00350519|536298997|FG000|Overall Study|Protocol Violation|1|||
148678835|NCT00350519|536298998|FG001|Overall Study|Protocol Violation|2|||
148678836|NCT00350519|536298997|FG000|Overall Study|Withdrawal by Subject|3|||
148678837|NCT00350519|536298998|FG001|Overall Study|Withdrawal by Subject|2|||
148678838|NCT01637961|536299002|FG000|Overall Study|Ineligible: wrong primary|1|||
148678839|NCT01637961|536299002|FG000|Overall Study|Ineligible: inadequate pathology|1|||
148678840|NCT03101293|536299003|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
148678841|NCT03101293|536299004|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
148678842|NCT03555890|536299012|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148678843|NCT03555890|536299013|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148678844|NCT03555890|536299014|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148678845|NCT03555890|536299015|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
148678846|NCT03372369|536299016|FG000|Qualification Period|Withdrawal by Subject|16|||
148678847|NCT03372369|536299017|FG001|Qualification Period|Withdrawal by Subject|13|||
148678848|NCT03372369|536299016|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
148678849|NCT03372369|536299017|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
148678850|NCT03372369|536299016|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
148678851|NCT03372369|536299017|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
148678852|NCT04682639|536299018|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
148678853|NCT04682639|536299019|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
148678854|NCT04682639|536299020|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
148678855|NCT04682639|536299021|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
148678856|NCT04682639|536299022|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
148678857|NCT04682639|536299018|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
148678858|NCT04682639|536299019|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
148678859|NCT04682639|536299020|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
148678860|NCT04682639|536299021|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148678861|NCT04682639|536299022|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148678862|NCT04682639|536299018|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
148678863|NCT04682639|536299019|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
148678864|NCT04682639|536299020|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148678865|NCT04682639|536299021|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148678866|NCT04682639|536299022|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148929937|NCT02220998|537228405|FG001|Overall Study|Randomized but Never Treated|2|||
148929938|NCT02220998|537228404|FG000|Overall Study|Death|2|||
148929939|NCT02220998|537228405|FG001|Overall Study|Death|0|||
148929940|NCT02220998|537228404|FG000|Overall Study|Lack of Efficacy|0|||
148929941|NCT02220998|537228405|FG001|Overall Study|Lack of Efficacy|5|||
148929942|NCT02220998|537228404|FG000|Overall Study|Lost to Follow-up|4|||
148929943|NCT02220998|537228405|FG001|Overall Study|Lost to Follow-up|4|||
148929944|NCT01172275|537228406|FG000|Overall Study|Lost to Follow-up|1|||
148929945|NCT01172275|537228407|FG001|Overall Study|Lost to Follow-up|0|||
148929946|NCT01172275|537228406|FG000|Overall Study|Protocol Violation|1|||
149013326|NCT01460160|537527907|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
149013327|NCT01460160|537527907|FG000|Follow-up Phase|Other and not reported reasons|5|||
149013328|NCT03893825|537527908|FG000|Overall Study|Death|2|||
149013329|NCT03893825|537527909|FG001|Overall Study|Death|1|||
149013330|NCT03893825|537527908|FG000|Overall Study|Adverse Event|0|||
149013331|NCT03893825|537527909|FG001|Overall Study|Adverse Event|2|||
149013332|NCT03893825|537527908|FG000|Overall Study|Withdrawal by Subject|19|||
149013333|NCT03893825|537527909|FG001|Overall Study|Withdrawal by Subject|21|||
149013334|NCT03893825|537527908|FG000|Overall Study|Protocol deviation|1|||
149013335|NCT03893825|537527909|FG001|Overall Study|Protocol deviation|0|||
148929947|NCT01172275|537228407|FG001|Overall Study|Protocol Violation|0|||
148929948|NCT02961218|537228410|FG000|Overall Study|Lost to Follow-up|0|||
148929949|NCT02961218|537228411|FG001|Overall Study|Lost to Follow-up|2|||
148678867|NCT04682639|536299018|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
148678868|NCT04682639|536299019|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
148678869|NCT04682639|536299020|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
148678870|NCT04682639|536299021|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
148678871|NCT04682639|536299022|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
148678872|NCT04682639|536299018|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
148678873|NCT04682639|536299019|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
148678874|NCT04682639|536299020|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
148678875|NCT04682639|536299021|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
148678876|NCT04682639|536299022|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
148806894|NCT00171249|536771060|FG002|Overall Study|Administrative Problems|0|||
148806895|NCT00171249|536771061|FG003|Overall Study|Administrative Problems|2|||
148806896|NCT00171249|536771062|FG004|Overall Study|Administrative Problems|0|||
148806897|NCT00171249|536771063|FG005|Overall Study|Administrative Problems|0|||
148929950|NCT02961218|537228410|FG000|Overall Study|Physician Decision|0|||
148929951|NCT02961218|537228411|FG001|Overall Study|Physician Decision|2|||
148929952|NCT02961218|537228410|FG000|Overall Study|Subject/Guardian Decision|3|||
148929953|NCT02961218|537228411|FG001|Overall Study|Subject/Guardian Decision|1|||
148929954|NCT01462227|537228417|FG000|Second Assignment|Lost to Follow-up|1|||
148806898|NCT00171249|536771064|FG006|Overall Study|Administrative Problems|0|||
149175375|NCT02342171|538114989|FG001|Overall Study|Missing cycle treshold value|0|||
149175376|NCT02342171|538114988|FG000|Overall Study|Unknown outcome|0|||
149175377|NCT02342171|538114989|FG001|Overall Study|Unknown outcome|1|||
149175378|NCT02342171|538114988|FG000|Overall Study|Missing age data|0|||
149175379|NCT02342171|538114989|FG001|Overall Study|Missing age data|1|||
149175380|NCT03716726|538114992|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
149175381|NCT03716726|538114993|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
149175382|NCT03716726|538114992|FG000|12 Months Followup|Lost to Follow-up|10|||
149175383|NCT03716726|538114993|FG001|12 Months Followup|Lost to Follow-up|17|||
149175384|NCT00469079|538114994|FG000|Overall Study|Lack of Efficacy|3|||
149175385|NCT00469079|538114995|FG001|Overall Study|Lack of Efficacy|8|||
149175386|NCT00469079|538114996|FG002|Overall Study|Lack of Efficacy|5|||
149175387|NCT00469079|538114994|FG000|Overall Study|Adverse Event|1|||
149175388|NCT00469079|538114995|FG001|Overall Study|Adverse Event|3|||
149175389|NCT00469079|538114996|FG002|Overall Study|Adverse Event|2|||
149175390|NCT00469079|538114994|FG000|Overall Study|Lost to Follow-up|4|||
149175391|NCT00469079|538114995|FG001|Overall Study|Lost to Follow-up|8|||
149175392|NCT00469079|538114996|FG002|Overall Study|Lost to Follow-up|10|||
149175393|NCT00469079|538114994|FG000|Overall Study|Withdrawal by Subject|1|||
149175394|NCT00469079|538114995|FG001|Overall Study|Withdrawal by Subject|2|||
149175395|NCT00469079|538114996|FG002|Overall Study|Withdrawal by Subject|2|||
149175396|NCT00469079|538114994|FG000|Overall Study|Ineligible|0|||
149175397|NCT00469079|538114995|FG001|Overall Study|Ineligible|1|||
149175398|NCT00469079|538114996|FG002|Overall Study|Ineligible|0|||
149175399|NCT02981472|538114997|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
149175400|NCT02981472|538114998|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
149175401|NCT02981472|538114997|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149175402|NCT02981472|538114998|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149175403|NCT02981472|538114997|FG000|Treatment Period|Adverse Event|6|||
149175404|NCT02981472|538114998|FG001|Treatment Period|Adverse Event|1|||
149175405|NCT02981472|538114997|FG000|Treatment Period|Participant withdrew consent|1|||
149175406|NCT02981472|538114998|FG001|Treatment Period|Participant withdrew consent|0|||
148678877|NCT04682639|536299018|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
149175407|NCT02981472|538114997|FG000|Treatment Period|Lost to Follow-up|0|||
149175408|NCT02981472|538114998|FG001|Treatment Period|Lost to Follow-up|1|||
149175409|NCT03952130|538115001|FG000|Overall Study|Adverse Event|0|||
148678878|NCT04682639|536299019|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
148678879|NCT04682639|536299020|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
148678880|NCT04682639|536299021|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
148929955|NCT01462227|537228418|FG001|Second Assignment|Lost to Follow-up|0|||
148929956|NCT01462227|537228419|FG002|Second Assignment|Lost to Follow-up|0|||
148929957|NCT01462227|537228420|FG003|Second Assignment|Lost to Follow-up|0|||
148929958|NCT01462227|537228417|FG000|Second Assignment|Protocol Violation|0|||
148929959|NCT01462227|537228418|FG001|Second Assignment|Protocol Violation|1|||
148929960|NCT01462227|537228419|FG002|Second Assignment|Protocol Violation|1|||
148929961|NCT01462227|537228420|FG003|Second Assignment|Protocol Violation|0|||
148929962|NCT05298306|537228425|FG000|Overall Study|Physician Decision|0|||
148929963|NCT05298306|537228426|FG001|Overall Study|Physician Decision|0|||
148929964|NCT05298306|537228427|FG002|Overall Study|Physician Decision|0|||
148929965|NCT05298306|537228428|FG003|Overall Study|Physician Decision|1|||
149175410|NCT03952130|538115002|FG001|Overall Study|Adverse Event|1|||
149175411|NCT03952130|538115001|FG000|Overall Study|Lost to Follow-up|1|||
149175412|NCT03952130|538115002|FG001|Overall Study|Lost to Follow-up|0|||
149175413|NCT03952130|538115001|FG000|Overall Study|Withdrawal by Subject|1|||
149175414|NCT03952130|538115002|FG001|Overall Study|Withdrawal by Subject|5|||
149175415|NCT00621023|538115003|FG000|Overall Study|Death|5|||
149175416|NCT00621023|538115003|FG000|Overall Study|Follow up discontinued|1|||
149175417|NCT02559505|538115012|FG000|Overall Study|Lost to Follow-up|23|||
149175418|NCT02559505|538115013|FG001|Overall Study|Lost to Follow-up|20|||
149175419|NCT02559505|538115012|FG000|Overall Study|Withdrawal by Subject|4|||
149175420|NCT02559505|538115013|FG001|Overall Study|Withdrawal by Subject|2|||
149175421|NCT03523585|538115014|FG000|Overall Study|Progressive Disease|174|||
149175422|NCT03523585|538115015|FG001|Overall Study|Progressive Disease|64|||
149175423|NCT03523585|538115016|FG002|Overall Study|Progressive Disease|77|||
149175424|NCT03523585|538115014|FG000|Overall Study|Adverse Event|74|||
149175425|NCT03523585|538115015|FG001|Overall Study|Adverse Event|5|||
149175426|NCT03523585|538115016|FG002|Overall Study|Adverse Event|9|||
149175427|NCT03523585|538115014|FG000|Overall Study|Withdrawal by Subject|30|||
149175428|NCT03523585|538115015|FG001|Overall Study|Withdrawal by Subject|11|||
149175429|NCT03523585|538115016|FG002|Overall Study|Withdrawal by Subject|6|||
149175430|NCT03523585|538115014|FG000|Overall Study|Clinical Progression|23|||
149175431|NCT03523585|538115015|FG001|Overall Study|Clinical Progression|5|||
149175432|NCT03523585|538115016|FG002|Overall Study|Clinical Progression|10|||
149175433|NCT03523585|538115014|FG000|Overall Study|Death|4|||
149175434|NCT03523585|538115015|FG001|Overall Study|Death|0|||
149175435|NCT03523585|538115016|FG002|Overall Study|Death|1|||
149175436|NCT03523585|538115014|FG000|Overall Study|Physician Decision|2|||
149175437|NCT03523585|538115015|FG001|Overall Study|Physician Decision|1|||
149175438|NCT03523585|538115016|FG002|Overall Study|Physician Decision|0|||
149175439|NCT03523585|538115014|FG000|Overall Study|Lost to Follow-up|1|||
149175440|NCT03523585|538115015|FG001|Overall Study|Lost to Follow-up|0|||
149175441|NCT03523585|538115016|FG002|Overall Study|Lost to Follow-up|0|||
149175442|NCT03523585|538115014|FG000|Overall Study|Miscellaneous|1|||
149175443|NCT03523585|538115015|FG001|Overall Study|Miscellaneous|0|||
149175444|NCT03523585|538115016|FG002|Overall Study|Miscellaneous|0|||
148678881|NCT04682639|536299022|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
148929966|NCT05298306|537228429|FG004|Overall Study|Physician Decision|0|||
149175445|NCT03523585|538115014|FG000|Overall Study|Protocol Deviation|1|||
149175446|NCT03523585|538115015|FG001|Overall Study|Protocol Deviation|0|||
149175447|NCT03523585|538115016|FG002|Overall Study|Protocol Deviation|1|||
148929967|NCT05298306|537228430|FG005|Overall Study|Physician Decision|0|||
149175448|NCT03523585|538115014|FG000|Overall Study|Randomized But Not Treated|2|||
149175449|NCT03523585|538115015|FG001|Overall Study|Randomized But Not Treated|4|||
149175450|NCT03523585|538115016|FG002|Overall Study|Randomized But Not Treated|3|||
149175451|NCT00698516|538115017|FG000|Overall Study|Study Termination|2|||
149175452|NCT00698516|538115017|FG000|Overall Study|Withdrawal by Subject|3|||
149175453|NCT05882890|538115018|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
149175454|NCT04331899|538115024|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
149175455|NCT04331899|538115025|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
149175456|NCT01062399|538115028|FG000|Overall Study|Protocol Violation|0|||
149175457|NCT01062399|538115029|FG001|Overall Study|Protocol Violation|1|||
149175458|NCT01062399|538115030|FG002|Overall Study|Protocol Violation|0|||
149175459|NCT01062399|538115031|FG003|Overall Study|Protocol Violation|6|||
149175460|NCT01062399|538115032|FG004|Overall Study|Protocol Violation|4|||
149175461|NCT02424539|538115033|FG000|Overall Study|Adverse Event|0|||
149175462|NCT02424539|538115034|FG001|Overall Study|Adverse Event|0|||
149175463|NCT02424539|538115035|FG002|Overall Study|Adverse Event|1|||
149175464|NCT02424539|538115033|FG000|Overall Study|Physician Decision|0|||
149175465|NCT02424539|538115034|FG001|Overall Study|Physician Decision|0|||
149175466|NCT02424539|538115035|FG002|Overall Study|Physician Decision|1|||
149175467|NCT02424539|538115033|FG000|Overall Study|Withdrawal by Subject|3|||
149175468|NCT02424539|538115034|FG001|Overall Study|Withdrawal by Subject|1|||
149175469|NCT02424539|538115035|FG002|Overall Study|Withdrawal by Subject|0|||
149175470|NCT02424539|538115033|FG000|Overall Study|Other: Reached stopping criteria|11|||
149175471|NCT02424539|538115034|FG001|Overall Study|Other: Reached stopping criteria|7|||
149175472|NCT02424539|538115035|FG002|Overall Study|Other: Reached stopping criteria|6|||
149175473|NCT00719810|538115036|FG000|Overall Study|Adverse Event|0|||
149175474|NCT00719810|538115037|FG001|Overall Study|Adverse Event|2|||
149175475|NCT00719810|538115038|FG002|Overall Study|Adverse Event|3|||
149175476|NCT00719810|538115036|FG000|Overall Study|Lost to Follow-up|2|||
149175477|NCT00719810|538115037|FG001|Overall Study|Lost to Follow-up|0|||
149175478|NCT00719810|538115038|FG002|Overall Study|Lost to Follow-up|3|||
149175479|NCT00719810|538115036|FG000|Overall Study|Physician Decision|0|||
149175480|NCT00719810|538115037|FG001|Overall Study|Physician Decision|1|||
149175481|NCT00719810|538115038|FG002|Overall Study|Physician Decision|0|||
149175482|NCT00719810|538115036|FG000|Overall Study|Withdrawal by Subject|1|||
149175483|NCT00719810|538115037|FG001|Overall Study|Withdrawal by Subject|1|||
149175484|NCT00719810|538115038|FG002|Overall Study|Withdrawal by Subject|2|||
149175485|NCT04893265|538115061|FG000|Overall Study|Withdrawal by Subject|2|||
149175486|NCT04893265|538115062|FG001|Overall Study|Withdrawal by Subject|5|||
149175487|NCT04893265|538115061|FG000|Overall Study|Lost to Follow-up|0|||
149175488|NCT04893265|538115062|FG001|Overall Study|Lost to Follow-up|4|||
149175489|NCT00573131|538115064|FG000|Overall Study|Withdrawal by Subject|10|||
149175490|NCT00573131|538115065|FG001|Overall Study|Withdrawal by Subject|8|||
149175491|NCT03090191|538115066|FG000|Overall Study|Adverse Event|90|||
149175492|NCT03090191|538115067|FG001|Overall Study|Adverse Event|72|||
149175493|NCT03090191|538115066|FG000|Overall Study|Death|365|||
149175494|NCT03090191|538115067|FG001|Overall Study|Death|358|||
149175495|NCT03090191|538115066|FG000|Overall Study|Lost to Follow-up|382|||
149175496|NCT03090191|538115067|FG001|Overall Study|Lost to Follow-up|394|||
149175497|NCT03090191|538115066|FG000|Overall Study|Physician Decision|77|||
149175498|NCT03090191|538115067|FG001|Overall Study|Physician Decision|66|||
149175499|NCT03090191|538115066|FG000|Overall Study|Protocol Violation|43|||
149175500|NCT03090191|538115067|FG001|Overall Study|Protocol Violation|52|||
149175501|NCT03090191|538115066|FG000|Overall Study|Withdrawal by Subject|2160|||
149175502|NCT03090191|538115067|FG001|Overall Study|Withdrawal by Subject|2133|||
149175503|NCT03090191|538115066|FG000|Overall Study|Site terminated|7|||
149175504|NCT03090191|538115067|FG001|Overall Study|Site terminated|8|||
149175505|NCT03090191|538115066|FG000|Overall Study|Other|66|||
149175506|NCT03090191|538115067|FG001|Overall Study|Other|60|||
149175507|NCT03090191|538115066|FG000|Overall Study|Withdrawn before any study vaccination|43|||
149175508|NCT03090191|538115067|FG001|Overall Study|Withdrawn before any study vaccination|52|||
149175509|NCT00893789|538115069|FG000|Overall Study|Withdrawal by Subject|3|||
149175510|NCT00893789|538115070|FG001|Overall Study|Withdrawal by Subject|1|||
149175511|NCT00893789|538115071|FG002|Overall Study|Withdrawal by Subject|3|||
149175512|NCT00893789|538115072|FG003|Overall Study|Withdrawal by Subject|1|||
149175513|NCT00893789|538115069|FG000|Overall Study|Noncompliance With Study Drug|1|||
149175514|NCT00893789|538115070|FG001|Overall Study|Noncompliance With Study Drug|0|||
149175515|NCT00893789|538115071|FG002|Overall Study|Noncompliance With Study Drug|1|||
149175516|NCT00893789|538115072|FG003|Overall Study|Noncompliance With Study Drug|2|||
149175517|NCT00893789|538115069|FG000|Overall Study|Noncompliance With Study Procedures|1|||
149175518|NCT00893789|538115070|FG001|Overall Study|Noncompliance With Study Procedures|0|||
149175519|NCT00893789|538115071|FG002|Overall Study|Noncompliance With Study Procedures|0|||
149175520|NCT00893789|538115072|FG003|Overall Study|Noncompliance With Study Procedures|0|||
149175521|NCT00893789|538115069|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
149175522|NCT00893789|538115070|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
149175523|NCT00893789|538115071|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
148806899|NCT00171249|536771058|FG000|Overall Study|Adverse Event|3|||
149175524|NCT00893789|538115072|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
149175525|NCT00893789|538115069|FG000|Overall Study|Adverse Event|0|||
149175526|NCT00893789|538115070|FG001|Overall Study|Adverse Event|2|||
149175527|NCT00893789|538115071|FG002|Overall Study|Adverse Event|1|||
149175528|NCT00893789|538115072|FG003|Overall Study|Adverse Event|5|||
149175529|NCT00893789|538115069|FG000|Overall Study|Protocol Violation|0|||
149175530|NCT00893789|538115070|FG001|Overall Study|Protocol Violation|1|||
149175531|NCT00893789|538115071|FG002|Overall Study|Protocol Violation|1|||
149175532|NCT00893789|538115072|FG003|Overall Study|Protocol Violation|4|||
149175533|NCT00893789|538115069|FG000|Overall Study|Lost to Follow-up|0|||
149175534|NCT00893789|538115070|FG001|Overall Study|Lost to Follow-up|0|||
149175535|NCT00893789|538115071|FG002|Overall Study|Lost to Follow-up|0|||
149175536|NCT00893789|538115072|FG003|Overall Study|Lost to Follow-up|1|||
149175537|NCT01845025|538115073|FG000|Overall Study|Adverse Event|6|||
149175538|NCT01845025|538115074|FG001|Overall Study|Adverse Event|3|||
149175539|NCT01845025|538115073|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149175540|NCT01845025|538115074|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149175541|NCT01845025|538115073|FG000|Overall Study|Withdrawal by Subject|48|||
149175542|NCT01845025|538115074|FG001|Overall Study|Withdrawal by Subject|44|||
149175543|NCT01845025|538115073|FG000|Overall Study|Lost to Follow-up|13|||
149175544|NCT01845025|538115074|FG001|Overall Study|Lost to Follow-up|13|||
149175545|NCT01845025|538115073|FG000|Overall Study|Administrative problems|8|||
149175546|NCT01845025|538115074|FG001|Overall Study|Administrative problems|8|||
149175547|NCT01845025|538115073|FG000|Overall Study|Death|2|||
149175548|NCT01845025|538115074|FG001|Overall Study|Death|0|||
149175549|NCT01845025|538115073|FG000|Overall Study|Protocol deviation|3|||
149175550|NCT01845025|538115074|FG001|Overall Study|Protocol deviation|6|||
149175551|NCT01845025|538115073|FG000|Overall Study|Missing|1|||
149175552|NCT01845025|538115074|FG001|Overall Study|Missing|1|||
149175553|NCT01973283|538115077|FG000|Overall Study|Lost to Follow-up|4|||
149175554|NCT01126619|538115078|FG000|Overall Study|Not eligible for the study|2|||
149175555|NCT01126619|538115078|FG000|Overall Study|Investigator decision|4|||
149175556|NCT01126619|538115078|FG000|Overall Study|Serious adverse event|1|||
149175557|NCT01126619|538115078|FG000|Overall Study|Withdrawal by Subject|9|||
149175558|NCT01126619|538115078|FG000|Overall Study|Non-compliance|1|||
149175559|NCT00947154|538115079|FG000|Overall Study|Lost to Follow-up|1|||
149175560|NCT00900796|538115082|FG000|Phase 1|Lacked sufficient information|4|||
149175561|NCT00900796|538115082|FG000|Phase 1|Missing information at Week 16|7|||
149175562|NCT00900796|538115082|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
149175563|NCT00900796|538115082|FG000|Phase 2|Lost to Follow-up|5|||
149175564|NCT01829048|538115090|FG000|Overall Study|Withdrawal by Subject|0|||
149175565|NCT01829048|538115091|FG001|Overall Study|Withdrawal by Subject|0|||
149175566|NCT01829048|538115092|FG002|Overall Study|Withdrawal by Subject|0|||
149175567|NCT01829048|538115093|FG003|Overall Study|Withdrawal by Subject|2|||
149175568|NCT01829048|538115094|FG004|Overall Study|Withdrawal by Subject|0|||
149175569|NCT01121406|538115095|FG000|Overall Study|Progressive disease RECIST|44|||
149175570|NCT01121406|538115096|FG001|Overall Study|Progressive disease RECIST|28|||
149175571|NCT01121406|538115095|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
149175572|NCT01121406|538115096|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
149175573|NCT01121406|538115095|FG000|Overall Study|Other AE|3|||
149175574|NCT01121406|538115096|FG001|Overall Study|Other AE|10|||
149175575|NCT01121406|538115095|FG000|Overall Study|Non-compliant with protocol|0|||
149175576|NCT01121406|538115096|FG001|Overall Study|Non-compliant with protocol|2|||
149175577|NCT01121406|538115095|FG000|Overall Study|Lost to Follow-up|0|||
149175578|NCT01121406|538115096|FG001|Overall Study|Lost to Follow-up|1|||
149175579|NCT01121406|538115095|FG000|Overall Study|Refused continuation of study med.|1|||
149013336|NCT03893825|537527908|FG000|Overall Study|Lost to Follow-up|10|||
149175580|NCT01121406|538115096|FG001|Overall Study|Refused continuation of study med.|2|||
149175581|NCT01121406|538115095|FG000|Overall Study|Reason other than specified above|2|||
149175582|NCT01121406|538115096|FG001|Overall Study|Reason other than specified above|6|||
149175583|NCT01121406|538115095|FG000|Overall Study|Not treated|1|||
149175584|NCT01121406|538115096|FG001|Overall Study|Not treated|0|||
149175585|NCT00504257|538115097|FG000|Overall Study|Withdrawal by Subject|2|||
149175586|NCT00504257|538115097|FG000|Overall Study|ineligible histology|2|||
149175587|NCT02750410|538115100|FG000|Double-Blind Treatment Period|Adverse Event|2|||
149175588|NCT02750410|538115101|FG001|Double-Blind Treatment Period|Adverse Event|2|||
149175589|NCT02750410|538115100|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149175590|NCT02750410|538115101|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148678882|NCT04682639|536299018|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
148678883|NCT04682639|536299019|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
149175591|NCT02750410|538115100|FG000|Open-Label Extension Period|Adverse Event|5|||
149175592|NCT02750410|538115101|FG001|Open-Label Extension Period|Adverse Event|3|||
149175593|NCT02750410|538115100|FG000|Open-Label Extension Period|Protocol Violation|0|||
149175594|NCT02750410|538115101|FG001|Open-Label Extension Period|Protocol Violation|1|||
149175595|NCT02750410|538115100|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
149175596|NCT02750410|538115101|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
149175597|NCT02504541|538115102|FG000|Overall Study|Adverse Event|4|||
149175598|NCT02504541|538115102|FG000|Overall Study|Withdrawal by Subject|4|||
149175599|NCT02504541|538115102|FG000|Overall Study|Lost to Follow-up|1|||
149175600|NCT02504541|538115102|FG000|Overall Study|Met Stopping Criteria|1|||
149175601|NCT02504541|538115102|FG000|Overall Study|Protocol Violation|2|||
149175602|NCT02504541|538115102|FG000|Overall Study|Termination by Sponsor|1|||
149175603|NCT02504541|538115102|FG000|Overall Study|Other|2|||
149175604|NCT02504541|538115102|FG000|Overall Study|Multiple|5|||
149175605|NCT00472303|538115112|FG000|Titration Phase|Adverse Event|22|||
149175606|NCT00472303|538115113|FG001|Titration Phase|Adverse Event|12|||
149175607|NCT00472303|538115114|FG002|Titration Phase|Adverse Event|0|||
149175608|NCT00472303|538115112|FG000|Titration Phase|Death|4|||
149175609|NCT00472303|538115113|FG001|Titration Phase|Death|2|||
149175610|NCT00472303|538115114|FG002|Titration Phase|Death|0|||
149175611|NCT00472303|538115112|FG000|Titration Phase|Lack of Efficacy|10|||
149175612|NCT00472303|538115113|FG001|Titration Phase|Lack of Efficacy|0|||
149175613|NCT00472303|538115114|FG002|Titration Phase|Lack of Efficacy|0|||
149175614|NCT00472303|538115112|FG000|Titration Phase|Withdrawal by Subject|16|||
149175615|NCT00472303|538115113|FG001|Titration Phase|Withdrawal by Subject|13|||
149175616|NCT00472303|538115114|FG002|Titration Phase|Withdrawal by Subject|0|||
149175617|NCT00472303|538115112|FG000|Titration Phase|Trial Medication non-compliant|4|||
149175618|NCT00472303|538115113|FG001|Titration Phase|Trial Medication non-compliant|1|||
149175619|NCT00472303|538115114|FG002|Titration Phase|Trial Medication non-compliant|0|||
149175620|NCT00472303|538115112|FG000|Titration Phase|Other|3|||
149175621|NCT00472303|538115113|FG001|Titration Phase|Other|1|||
149175622|NCT00472303|538115114|FG002|Titration Phase|Other|0|||
149175623|NCT00472303|538115112|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
149175624|NCT00472303|538115113|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
149175625|NCT00472303|538115114|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
149175626|NCT00472303|538115112|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
149175627|NCT00472303|538115113|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
149175628|NCT00472303|538115114|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
149175629|NCT00472303|538115112|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
149175630|NCT00472303|538115113|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
149175631|NCT00472303|538115114|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
149175632|NCT00472303|538115112|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
149175633|NCT00472303|538115113|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
149175634|NCT00472303|538115114|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
149175635|NCT00472303|538115112|FG000|Discontinuations After Titration Phase|Other|5|||
149175636|NCT00472303|538115113|FG001|Discontinuations After Titration Phase|Other|0|||
149175637|NCT00472303|538115114|FG002|Discontinuations After Titration Phase|Other|0|||
149175638|NCT00472303|538115112|FG000|Maintenance Phase|Adverse Event|5|||
149175639|NCT00472303|538115113|FG001|Maintenance Phase|Adverse Event|6|||
149175640|NCT00472303|538115114|FG002|Maintenance Phase|Adverse Event|6|||
149175641|NCT00472303|538115112|FG000|Maintenance Phase|Death|3|||
149175642|NCT00472303|538115113|FG001|Maintenance Phase|Death|0|||
149175643|NCT00472303|538115114|FG002|Maintenance Phase|Death|2|||
149175644|NCT00472303|538115112|FG000|Maintenance Phase|Lack of Efficacy|2|||
149175645|NCT00472303|538115113|FG001|Maintenance Phase|Lack of Efficacy|2|||
149175646|NCT00472303|538115114|FG002|Maintenance Phase|Lack of Efficacy|4|||
149175647|NCT00472303|538115112|FG000|Maintenance Phase|Withdrawal by Subject|6|||
149175648|NCT00472303|538115113|FG001|Maintenance Phase|Withdrawal by Subject|7|||
149175649|NCT00472303|538115114|FG002|Maintenance Phase|Withdrawal by Subject|3|||
149175650|NCT00472303|538115112|FG000|Maintenance Phase|Trial medication non-compliant|0|||
149175651|NCT00472303|538115113|FG001|Maintenance Phase|Trial medication non-compliant|0|||
149175652|NCT00472303|538115114|FG002|Maintenance Phase|Trial medication non-compliant|1|||
149175653|NCT00472303|538115112|FG000|Maintenance Phase|Resolution of pain|0|||
149175654|NCT00472303|538115113|FG001|Maintenance Phase|Resolution of pain|0|||
149175655|NCT00472303|538115114|FG002|Maintenance Phase|Resolution of pain|1|||
149175656|NCT00472303|538115112|FG000|Maintenance Phase|Other|1|||
149013337|NCT03893825|537527909|FG001|Overall Study|Lost to Follow-up|10|||
149013338|NCT03893825|537527908|FG000|Overall Study|Other than specified|7|||
149013339|NCT03893825|537527909|FG001|Overall Study|Other than specified|6|||
149175657|NCT00472303|538115113|FG001|Maintenance Phase|Other|1|||
149175658|NCT00472303|538115114|FG002|Maintenance Phase|Other|0|||
149175659|NCT02580058|538115124|FG000|Overall Study|Adverse Event|16|||
149175660|NCT02580058|538115125|FG001|Overall Study|Adverse Event|30|||
149175661|NCT02580058|538115126|FG002|Overall Study|Adverse Event|20|||
149175662|NCT02580058|538115124|FG000|Overall Study|Death|4|||
149175663|NCT02580058|538115125|FG001|Overall Study|Death|4|||
149175664|NCT02580058|538115126|FG002|Overall Study|Death|5|||
149175665|NCT02580058|538115124|FG000|Overall Study|Physician Decision|1|||
149175666|NCT02580058|538115125|FG001|Overall Study|Physician Decision|3|||
149175667|NCT02580058|538115126|FG002|Overall Study|Physician Decision|11|||
149175668|NCT02580058|538115124|FG000|Overall Study|Other|5|||
149175669|NCT02580058|538115125|FG001|Overall Study|Other|1|||
149175670|NCT02580058|538115126|FG002|Overall Study|Other|3|||
149013340|NCT02006121|537527913|FG000|Double Blind Phase|Adverse Event|6|||
149175671|NCT02580058|538115124|FG000|Overall Study|Withdrawal by Subject|4|||
149175672|NCT02580058|538115125|FG001|Overall Study|Withdrawal by Subject|7|||
149175673|NCT02580058|538115126|FG002|Overall Study|Withdrawal by Subject|31|||
149175674|NCT02580058|538115124|FG000|Overall Study|Global Deterioration of Health Status|19|||
149175675|NCT02580058|538115125|FG001|Overall Study|Global Deterioration of Health Status|18|||
149175676|NCT02580058|538115126|FG002|Overall Study|Global Deterioration of Health Status|24|||
149175677|NCT02580058|538115124|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
149175678|NCT02580058|538115125|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
149175679|NCT02580058|538115126|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
149175680|NCT02580058|538115124|FG000|Overall Study|Progressive Disease|137|||
149175681|NCT02580058|538115125|FG001|Overall Study|Progressive Disease|125|||
149175682|NCT02580058|538115126|FG002|Overall Study|Progressive Disease|94|||
149175683|NCT02580058|538115124|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149175684|NCT02580058|538115125|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149175685|NCT02580058|538115126|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149175686|NCT00730236|538115127|FG000|Overall Study|Adverse Event|4|||
149175687|NCT00730236|538115127|FG000|Overall Study|Withdrawal by Subject|1|||
149175688|NCT00730236|538115127|FG000|Overall Study|Non-compliance|1|||
149175689|NCT03486314|538115128|FG000|Part A|Adverse Event|1|||
149175690|NCT03486314|538115129|FG001|Part A|Adverse Event|0|||
149175691|NCT03486314|538115130|FG002|Part A|Adverse Event|0|||
149175692|NCT03486314|538115128|FG000|Part A|Symptomatic Deterioration|2|||
149175693|NCT03486314|538115129|FG001|Part A|Symptomatic Deterioration|0|||
149175694|NCT03486314|538115130|FG002|Part A|Symptomatic Deterioration|0|||
149175695|NCT00613626|538115131|FG000|Overall Study|Ineligible|0|||
149175696|NCT00613626|538115132|FG001|Overall Study|Ineligible|1|||
149175697|NCT00613626|538115133|FG002|Overall Study|Ineligible|0|||
149175698|NCT05480514|538115134|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
149175699|NCT05480514|538115135|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
149175700|NCT05480514|538115134|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
149175701|NCT05480514|538115135|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
149175702|NCT05480514|538115134|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
149175703|NCT05480514|538115135|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
149175704|NCT05480514|538115134|FG000|Period 1|Covid-19 Related|1|||
149175705|NCT05480514|538115135|FG001|Period 1|Covid-19 Related|0|||
149175706|NCT05480514|538115134|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
149175707|NCT05480514|538115135|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
149175708|NCT00519532|538115136|FG000|Overall Study|Adverse Event|11|||
149175709|NCT00519532|538115136|FG000|Overall Study|Withdrawal by Subject|5|||
149175710|NCT00519532|538115136|FG000|Overall Study|Lost to Follow-up|2|||
148806900|NCT00171249|536771059|FG001|Overall Study|Adverse Event|1|||
149175711|NCT03232073|538115137|FG000|Overall Study|Death|1|||
149175712|NCT03232073|538115138|FG001|Overall Study|Death|0|||
149175713|NCT03232073|538115137|FG000|Overall Study|Adverse Event|7|||
149175714|NCT03232073|538115138|FG001|Overall Study|Adverse Event|12|||
149175715|NCT03232073|538115137|FG000|Overall Study|Lost to Follow-up|6|||
149175716|NCT03232073|538115138|FG001|Overall Study|Lost to Follow-up|6|||
149013341|NCT02006121|537527914|FG001|Double Blind Phase|Adverse Event|0|||
149175717|NCT03232073|538115137|FG000|Overall Study|Lack of Efficacy|10|||
149175718|NCT03232073|538115138|FG001|Overall Study|Lack of Efficacy|8|||
149175719|NCT03232073|538115137|FG000|Overall Study|Physician Decision|9|||
149175720|NCT03232073|538115138|FG001|Overall Study|Physician Decision|2|||
149175721|NCT03232073|538115137|FG000|Overall Study|Withdrawal by Subject|54|||
149175722|NCT03232073|538115138|FG001|Overall Study|Withdrawal by Subject|39|||
149175723|NCT03395210|538116753|FG000|Overall Study|Other|0|||
149175724|NCT03395210|538116754|FG001|Overall Study|Other|0|||
149175725|NCT03395210|538116755|FG002|Overall Study|Other|0|||
149175726|NCT03395210|538116756|FG003|Overall Study|Other|0|||
149175727|NCT03395210|538116757|FG004|Overall Study|Other|1|||
149175728|NCT03395210|538116753|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
149175729|NCT03395210|538116754|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
149175730|NCT03395210|538116755|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
149175731|NCT03395210|538116756|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
149175732|NCT03395210|538116757|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
149175733|NCT03395210|538116753|FG000|Overall Study|Adverse Event|1|||
149175734|NCT03395210|538116754|FG001|Overall Study|Adverse Event|0|||
149175735|NCT03395210|538116755|FG002|Overall Study|Adverse Event|2|||
149175736|NCT03395210|538116756|FG003|Overall Study|Adverse Event|4|||
149175737|NCT03395210|538116757|FG004|Overall Study|Adverse Event|3|||
149175738|NCT03395210|538116753|FG000|Overall Study|Need of Rescue Medication|1|||
149175739|NCT03395210|538116754|FG001|Overall Study|Need of Rescue Medication|0|||
149175740|NCT03395210|538116755|FG002|Overall Study|Need of Rescue Medication|1|||
149175741|NCT03395210|538116756|FG003|Overall Study|Need of Rescue Medication|4|||
149175742|NCT03395210|538116757|FG004|Overall Study|Need of Rescue Medication|0|||
149175743|NCT03395210|538116753|FG000|Overall Study|Lack of Response|0|||
149175744|NCT03395210|538116754|FG001|Overall Study|Lack of Response|0|||
149175745|NCT03395210|538116755|FG002|Overall Study|Lack of Response|0|||
149175746|NCT03395210|538116756|FG003|Overall Study|Lack of Response|5|||
149175747|NCT03395210|538116757|FG004|Overall Study|Lack of Response|5|||
149175748|NCT03395210|538116753|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
149175749|NCT03395210|538116754|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
149175750|NCT03395210|538116755|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
149175751|NCT03395210|538116756|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
149175752|NCT03395210|538116757|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
149175753|NCT03395210|538116753|FG000|Overall Study|Participant Decision|1|||
149175754|NCT03395210|538116754|FG001|Overall Study|Participant Decision|1|||
149175755|NCT03395210|538116755|FG002|Overall Study|Participant Decision|0|||
149175756|NCT03395210|538116756|FG003|Overall Study|Participant Decision|4|||
149175757|NCT03395210|538116757|FG004|Overall Study|Participant Decision|0|||
149175758|NCT03395210|538116753|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
149175759|NCT03395210|538116754|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
149175760|NCT03395210|538116755|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
149175761|NCT03395210|538116756|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
149175762|NCT03395210|538116757|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
149175763|NCT02579603|538116766|FG000|Overall Study|Not treated|1|||
149175764|NCT02579603|538116767|FG001|Overall Study|Not treated|0|||
149175765|NCT02579603|538116766|FG000|Overall Study|Adverse Event|2|||
149175766|NCT02579603|538116767|FG001|Overall Study|Adverse Event|2|||
149175767|NCT02579603|538116766|FG000|Overall Study|Other than stated|1|||
149175768|NCT02579603|538116767|FG001|Overall Study|Other than stated|0|||
149175769|NCT03199911|538116769|FG000|Overall Study|Lost to Follow-up|5|||
149175770|NCT03199911|538116770|FG001|Overall Study|Lost to Follow-up|5|||
149175771|NCT03199911|538116769|FG000|Overall Study|Did not proceed with surgery|2|||
149175772|NCT03199911|538116770|FG001|Overall Study|Did not proceed with surgery|1|||
149175773|NCT01473004|538116771|FG000|Overall Study|Incomplete Lobar Treatment|1|||
149175774|NCT01473004|538116772|FG001|Overall Study|Incomplete Lobar Treatment|0|||
149175775|NCT05309668|538116774|FG000|Overall Study|Ongoing at data cut-off|14|||
149175776|NCT05309668|538116775|FG001|Overall Study|Ongoing at data cut-off|17|||
149175777|NCT05309668|538116776|FG002|Overall Study|Ongoing at data cut-off|4|||
149175778|NCT01584024|538116779|FG000|Overall Study|Lost to Follow-up|10|||
149175779|NCT01584024|538116779|FG000|Overall Study|Withdrawal by Subject|3|||
149175780|NCT00613314|538116780|FG000|Overall Study|Adverse Event|5|||
149175781|NCT00613314|538116780|FG000|Overall Study|Protocol Violation|14|||
149175782|NCT00613314|538116780|FG000|Overall Study|Lost to Follow-up|46|||
149175783|NCT00613314|538116780|FG000|Overall Study|Other reason not defined above|90|||
149175784|NCT02465034|538116790|FG000|Overall Study|Withdrawal by Subject|1|||
149175785|NCT02465034|538116791|FG001|Overall Study|Withdrawal by Subject|1|||
149175786|NCT02465034|538116790|FG000|Overall Study|Screen fail|2|||
149175787|NCT02465034|538116791|FG001|Overall Study|Screen fail|0|||
149175788|NCT02465034|538116790|FG000|Overall Study|Could not be scheduled for study visit|0|||
149175789|NCT02465034|538116791|FG001|Overall Study|Could not be scheduled for study visit|5|||
149175790|NCT02401256|538116796|FG000|Overall Study|Adverse Event|5|||
149175791|NCT02401256|538116796|FG000|Overall Study|Withdrawal by Subject|12|||
149175792|NCT02024464|538116797|FG000|Overall Study|Discontinued|5|||
149175793|NCT02024464|538116798|FG001|Overall Study|Discontinued|4|||
149175794|NCT02024464|538116797|FG000|Overall Study|Missed Visits|1|||
149175795|NCT02024464|538116798|FG001|Overall Study|Missed Visits|0|||
149175796|NCT02024464|538116797|FG000|Overall Study|Lost to Follow-up|4|||
149175797|NCT02024464|538116798|FG001|Overall Study|Lost to Follow-up|7|||
149175798|NCT04419506|538116803|FG000|Overall Study|Adverse Event|0|||
149175799|NCT04419506|538116804|FG001|Overall Study|Adverse Event|10|||
149175800|NCT04419506|538116805|FG002|Overall Study|Adverse Event|0|||
149175801|NCT04419506|538116806|FG003|Overall Study|Adverse Event|3|||
149175802|NCT04419506|538116803|FG000|Overall Study|Withdrawal by Subject|0|||
149175803|NCT04419506|538116804|FG001|Overall Study|Withdrawal by Subject|0|||
149175804|NCT04419506|538116805|FG002|Overall Study|Withdrawal by Subject|0|||
149175805|NCT04419506|538116806|FG003|Overall Study|Withdrawal by Subject|1|||
149175806|NCT04419506|538116803|FG000|Overall Study|poor-compliance|0|||
149175807|NCT04419506|538116804|FG001|Overall Study|poor-compliance|0|||
149175808|NCT04419506|538116805|FG002|Overall Study|poor-compliance|0|||
149175809|NCT04419506|538116806|FG003|Overall Study|poor-compliance|1|||
149175810|NCT03293030|538116815|FG000|Overall Study|Withdrawal by Subject|3|||
149175811|NCT02586805|538116817|FG000|Overall Study|Withdrawal by Subject|3|||
149175812|NCT02586805|538116818|FG001|Overall Study|Withdrawal by Subject|1|||
149175813|NCT02586805|538116819|FG002|Overall Study|Withdrawal by Subject|1|||
149175814|NCT02586805|538116820|FG003|Overall Study|Withdrawal by Subject|2|||
149175815|NCT02586805|538116817|FG000|Overall Study|Adverse Event|2|||
149175816|NCT02586805|538116818|FG001|Overall Study|Adverse Event|0|||
149175817|NCT02586805|538116819|FG002|Overall Study|Adverse Event|1|||
149175818|NCT02586805|538116820|FG003|Overall Study|Adverse Event|0|||
149175819|NCT02586805|538116817|FG000|Overall Study|Lost to Follow-up|0|||
149175820|NCT02586805|538116818|FG001|Overall Study|Lost to Follow-up|0|||
149175821|NCT02586805|538116819|FG002|Overall Study|Lost to Follow-up|1|||
149175822|NCT02586805|538116820|FG003|Overall Study|Lost to Follow-up|0|||
149175823|NCT02586805|538116817|FG000|Overall Study|Physician Decision|1|||
148929968|NCT03497676|537228437|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
149175824|NCT02586805|538116818|FG001|Overall Study|Physician Decision|0|||
149175825|NCT02586805|538116819|FG002|Overall Study|Physician Decision|0|||
148929969|NCT03497676|537228438|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
149175826|NCT02586805|538116820|FG003|Overall Study|Physician Decision|0|||
149175827|NCT01859403|538116821|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
149175828|NCT01859403|538116822|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
148929970|NCT03497676|537228439|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
149175829|NCT01859403|538116821|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
149175830|NCT01859403|538116822|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
149175831|NCT01859403|538116821|FG000|Primary Endpoint Measure|Physician Decision|0|||
149175832|NCT01859403|538116822|FG001|Primary Endpoint Measure|Physician Decision|1|||
149175833|NCT01859403|538116821|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
149175834|NCT01859403|538116822|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
149175835|NCT00811252|538116823|FG000|Overall Study|Adverse Event|6|||
149175836|NCT00811252|538116824|FG001|Overall Study|Adverse Event|10|||
149175837|NCT00811252|538116825|FG002|Overall Study|Adverse Event|15|||
149175838|NCT00811252|538116823|FG000|Overall Study|Lack of Efficacy|7|||
149175839|NCT00811252|538116824|FG001|Overall Study|Lack of Efficacy|2|||
149175840|NCT00811252|538116825|FG002|Overall Study|Lack of Efficacy|0|||
149175841|NCT00811252|538116823|FG000|Overall Study|Protocol Violation|3|||
149175842|NCT00811252|538116824|FG001|Overall Study|Protocol Violation|3|||
149175843|NCT00811252|538116825|FG002|Overall Study|Protocol Violation|2|||
149175844|NCT00811252|538116823|FG000|Overall Study|Withdrawal of Consent|1|||
149175845|NCT00811252|538116824|FG001|Overall Study|Withdrawal of Consent|2|||
149175846|NCT00811252|538116825|FG002|Overall Study|Withdrawal of Consent|2|||
149175847|NCT00811252|538116823|FG000|Overall Study|Lost to Follow-up|0|||
149175848|NCT00811252|538116824|FG001|Overall Study|Lost to Follow-up|0|||
149175849|NCT00811252|538116825|FG002|Overall Study|Lost to Follow-up|2|||
149175850|NCT00811252|538116823|FG000|Overall Study|Administrative or Other Reasons|0|||
149175851|NCT00811252|538116824|FG001|Overall Study|Administrative or Other Reasons|3|||
149175852|NCT00811252|538116825|FG002|Overall Study|Administrative or Other Reasons|2|||
149175853|NCT03185130|538116826|FG000|Overall Study|Withdrawal by Subject|0|||
149175854|NCT03185130|538116827|FG001|Overall Study|Withdrawal by Subject|2|||
149175855|NCT02317510|538116831|FG000|Overall Study|Adverse Event|0|||
149175856|NCT02317510|538116832|FG001|Overall Study|Adverse Event|1|||
149175857|NCT02318602|538116833|FG000|Overall Study|Adverse Event|0|||
149175858|NCT02318602|538116834|FG001|Overall Study|Adverse Event|1|||
149175859|NCT02318602|538116835|FG002|Overall Study|Adverse Event|1|||
149175860|NCT02318602|538116833|FG000|Overall Study|Withdrawal by Subject|0|||
149175861|NCT02318602|538116834|FG001|Overall Study|Withdrawal by Subject|3|||
149175862|NCT02318602|538116835|FG002|Overall Study|Withdrawal by Subject|0|||
149175863|NCT02318602|538116833|FG000|Overall Study|Death|1|||
149175864|NCT02318602|538116834|FG001|Overall Study|Death|0|||
149175865|NCT02318602|538116835|FG002|Overall Study|Death|0|||
149175866|NCT02318602|538116833|FG000|Overall Study|Guardian decision to withdraw|0|||
149175867|NCT02318602|538116834|FG001|Overall Study|Guardian decision to withdraw|0|||
149175868|NCT02318602|538116835|FG002|Overall Study|Guardian decision to withdraw|1|||
149175869|NCT00465569|538116841|FG000|Overall Study|persistent eczema during dose escalation|1|||
149175870|NCT00465569|538116842|FG001|Overall Study|persistent eczema during dose escalation|0|||
149175871|NCT01985321|538116844|FG000|Overall Study|Protocol Violation|4|||
149175872|NCT01985321|538116845|FG001|Overall Study|Protocol Violation|3|||
149175873|NCT01985321|538116844|FG000|Overall Study|Withdrawal by Subject|1|||
149175874|NCT01985321|538116845|FG001|Overall Study|Withdrawal by Subject|0|||
149175875|NCT01985321|538116844|FG000|Overall Study|Lost to Follow-up|5|||
149175876|NCT01985321|538116845|FG001|Overall Study|Lost to Follow-up|2|||
149175877|NCT01985321|538116844|FG000|Overall Study|Subject treated wrong type of sore|1|||
149175878|NCT01985321|538116845|FG001|Overall Study|Subject treated wrong type of sore|0|||
149175879|NCT00482001|538116846|FG000|Overall Study|Protocol Violation|1|||
149175880|NCT00482001|538116847|FG001|Overall Study|Protocol Violation|1|||
149175881|NCT00542828|538116852|FG000|Overall Study|Physician Decision|1|||
149175882|NCT00542828|538116852|FG000|Overall Study|Need for Prohibited Treatment|3|||
149175883|NCT00542828|538116852|FG000|Overall Study|Study Prematurely Discontinued|7|||
149175884|NCT00542828|538116852|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
149175885|NCT00095303|538116853|FG000|Main Study|Lost to Follow-up|91|||
149175886|NCT00095303|538116854|FG001|Main Study|Lost to Follow-up|87|||
149175887|NCT00095303|538116853|FG000|Follow Up Study|Lost to Follow-up|59|||
149175888|NCT00095303|538116854|FG001|Follow Up Study|Lost to Follow-up|58|||
149175889|NCT01364467|538116855|FG000|Overall Study|Lost to Follow-up|1|||
149175890|NCT01364467|538116856|FG001|Overall Study|Lost to Follow-up|2|||
149175891|NCT03228186|538116859|FG000|Overall Study|Patient never started treatment|1|||
149175892|NCT01634243|538116860|FG000|Overall Study|Adverse Event|5|||
149175893|NCT01634243|538116861|FG001|Overall Study|Adverse Event|5|||
149175894|NCT01634243|538116860|FG000|Overall Study|Lack of Efficacy|1|||
149175895|NCT01634243|538116861|FG001|Overall Study|Lack of Efficacy|0|||
149175896|NCT03953118|538116864|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
149175897|NCT03953118|538116865|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
149175898|NCT04283461|538116866|FG000|Overall Study|Enrolled in separate trial|0|||
149175899|NCT04283461|538116867|FG001|Overall Study|Enrolled in separate trial|0|||
149175900|NCT04283461|538116868|FG002|Overall Study|Enrolled in separate trial|8|||
149175901|NCT04283461|538116869|FG003|Overall Study|Enrolled in separate trial|13|||
149175902|NCT04283461|538116870|FG004|Overall Study|Enrolled in separate trial|12|||
149175903|NCT04283461|538116871|FG005|Overall Study|Enrolled in separate trial|0|||
149175904|NCT04283461|538116872|FG006|Overall Study|Enrolled in separate trial|0|||
149175905|NCT04283461|538116873|FG007|Overall Study|Enrolled in separate trial|8|||
149175906|NCT04283461|538116874|FG008|Overall Study|Enrolled in separate trial|0|||
149175907|NCT04283461|538116875|FG009|Overall Study|Enrolled in separate trial|0|||
148929971|NCT03497676|537228440|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
149175908|NCT04283461|538116876|FG010|Overall Study|Enrolled in separate trial|0|||
149175909|NCT04283461|538116877|FG011|Overall Study|Enrolled in separate trial|7|||
149175910|NCT04283461|538116878|FG012|Overall Study|Enrolled in separate trial|0|||
149175911|NCT05490771|538116879|FG000|Overall Study|Disease progression|18|||
149175912|NCT05490771|538116879|FG000|Overall Study|Adverse Event|3|||
149175913|NCT05490771|538116879|FG000|Overall Study|Other complicating disease|1|||
149175914|NCT05490771|538116879|FG000|Overall Study|Withdrawal by Subject|3|||
149175915|NCT05490771|538116879|FG000|Overall Study|Physician Decision|1|||
149175916|NCT05490771|538116879|FG000|Overall Study|Still on treatment|2|||
149175917|NCT05490771|538116879|FG000|Overall Study|Never start protocol therapy|5|||
149175918|NCT05490771|538116879|FG000|Overall Study|Ineligible|2|||
149175919|NCT05139030|538116882|FG000|Overall Study|Withdrawal by Subject|1|||
149175920|NCT05139030|538116883|FG001|Overall Study|Withdrawal by Subject|3|||
149175921|NCT05139030|538116882|FG000|Overall Study|Adverse Event|0|||
149175922|NCT05139030|538116883|FG001|Overall Study|Adverse Event|1|||
149175923|NCT05139030|538116882|FG000|Overall Study|Failure to meet continuation criteria|0|||
149175924|NCT05139030|538116883|FG001|Overall Study|Failure to meet continuation criteria|1|||
149175925|NCT00816036|538116888|FG000|Overall Study|Death|47|||
149175926|NCT00816036|538116889|FG001|Overall Study|Death|28|||
149175927|NCT00816036|538116888|FG000|Overall Study|Lost to Follow-up|75|||
149175928|NCT00816036|538116889|FG001|Overall Study|Lost to Follow-up|57|||
149175929|NCT00816036|538116888|FG000|Overall Study|Withdrawal by Subject|54|||
149175930|NCT00816036|538116889|FG001|Overall Study|Withdrawal by Subject|23|||
149175931|NCT01299025|538116890|FG000|Overall Study|Withdrawal by Subject|2|||
149175932|NCT01299025|538116891|FG001|Overall Study|Withdrawal by Subject|1|||
149175933|NCT01299025|538116890|FG000|Overall Study|Lost to Follow-up|1|||
149175934|NCT01299025|538116891|FG001|Overall Study|Lost to Follow-up|0|||
149175935|NCT00004980|538116892|FG000|Overall Study|Withdrawal by Subject|1|||
149175936|NCT00004980|538116893|FG001|Overall Study|Withdrawal by Subject|0|||
149175937|NCT00004980|538116892|FG000|Overall Study|memory difficulties|1|||
149175938|NCT00004980|538116893|FG001|Overall Study|memory difficulties|1|||
149175939|NCT00004980|538116892|FG000|Overall Study|Physician Decision|0|||
149175940|NCT00004980|538116893|FG001|Overall Study|Physician Decision|1|||
149175941|NCT01624194|538116894|FG000|Overall Study|Lost to Follow-up|1|||
149175942|NCT01624194|538116895|FG001|Overall Study|Lost to Follow-up|0|||
149175943|NCT01624194|538116894|FG000|Overall Study|Withdrawal by Subject|1|||
149175944|NCT01624194|538116895|FG001|Overall Study|Withdrawal by Subject|0|||
149175945|NCT03212261|538116896|FG000|Overall Study|Became ineligible d/t tech|2|||
149175946|NCT03212261|538116896|FG000|Overall Study|Tech Trouble- No first study visit|1|||
149175947|NCT03212261|538116896|FG000|Overall Study|Lost to Follow-up|7|||
149175948|NCT03212261|538116896|FG000|Overall Study|Family Emergency|1|||
149175949|NCT03212261|538116896|FG000|Overall Study|Too busy/ No time|5|||
149175950|NCT00820040|538116897|FG000|Overall Study|Death|1|||
149175951|NCT00820040|538116897|FG000|Overall Study|Sponsor terminated study|1|||
149175952|NCT00820040|538116897|FG000|Overall Study|Screen failure|1|||
149175953|NCT01259466|538116902|FG000|Overall Study|Withdrawal by Subject|1|||
149175954|NCT01259466|538116903|FG001|Overall Study|Withdrawal by Subject|9|||
149175955|NCT02296840|538116904|FG000|Overall Study|Adverse Event|1|||
149175956|NCT02296840|538116905|FG001|Overall Study|Adverse Event|1|||
149175957|NCT02296840|538116904|FG000|Overall Study|Protocol Violation|2|||
149175958|NCT02296840|538116905|FG001|Overall Study|Protocol Violation|1|||
149175959|NCT02296840|538116904|FG000|Overall Study|Lost to Follow-up|6|||
149175960|NCT02296840|538116905|FG001|Overall Study|Lost to Follow-up|17|||
149175961|NCT00814710|538116910|FG000|Overall Study|Adverse Event|1|||
149175962|NCT00814710|538116911|FG001|Overall Study|Adverse Event|0|||
149175963|NCT00814710|538116910|FG000|Overall Study|Lost to Follow-up|7|||
149175964|NCT00814710|538116911|FG001|Overall Study|Lost to Follow-up|3|||
149175965|NCT03885284|538116912|FG000|Overall Study|Disease Progression|1|||
148929972|NCT03497676|537228437|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
148929973|NCT03497676|537228438|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
148929974|NCT03497676|537228439|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
148929975|NCT03497676|537228440|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
148929976|NCT03497676|537228437|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
149175966|NCT03885284|538116913|FG001|Overall Study|Disease Progression|3|||
149175967|NCT03885284|538116912|FG000|Overall Study|Physician Decision|0|||
149175968|NCT03885284|538116913|FG001|Overall Study|Physician Decision|1|||
149175969|NCT00002850|538116918|FG000|Overall Study|Death|4|||
149175970|NCT00002850|538116919|FG001|Overall Study|Death|1|||
149175971|NCT00002850|538116920|FG002|Overall Study|Death|3|||
149175972|NCT00002850|538116918|FG000|Overall Study|Protocol Violation|1|||
149175973|NCT00002850|538116919|FG001|Overall Study|Protocol Violation|0|||
149175974|NCT00002850|538116920|FG002|Overall Study|Protocol Violation|1|||
149175975|NCT00002850|538116918|FG000|Overall Study|Withdrawal by Subject|0|||
149175976|NCT00002850|538116919|FG001|Overall Study|Withdrawal by Subject|1|||
149175977|NCT00002850|538116920|FG002|Overall Study|Withdrawal by Subject|0|||
149175978|NCT02932267|538116921|FG000|Overall Study|Withdrawal by Subject|3|||
148806901|NCT00171249|536771060|FG002|Overall Study|Adverse Event|0|||
148806902|NCT00171249|536771061|FG003|Overall Study|Adverse Event|15|||
149175979|NCT02932267|538116921|FG000|Overall Study|Lost to Follow-up|4|||
149175980|NCT02932267|538116921|FG000|Overall Study|Pregnancy|1|||
149175981|NCT03476239|538116922|FG000|Overall Study|Withdrawal by Subject|10|||
149175982|NCT03476239|538116922|FG000|Overall Study|Death|80|||
149175983|NCT03476239|538116922|FG000|Overall Study|Lost to Follow-up|8|||
149175984|NCT00630032|538116923|FG000|Overall Study|Death|55|||
149175985|NCT00630032|538116924|FG001|Overall Study|Death|49|||
149175986|NCT00630032|538116923|FG000|Overall Study|Withdrawal by Subject|3|||
149175987|NCT00630032|538116924|FG001|Overall Study|Withdrawal by Subject|2|||
149175988|NCT00630032|538116923|FG000|Overall Study|Lost to Follow-up|18|||
149175989|NCT00630032|538116924|FG001|Overall Study|Lost to Follow-up|31|||
149175990|NCT00630032|538116923|FG000|Overall Study|Protocol Violation|1|||
149175991|NCT00630032|538116924|FG001|Overall Study|Protocol Violation|0|||
149175992|NCT00630032|538116923|FG000|Overall Study|Patient has moved|1|||
149175993|NCT00630032|538116924|FG001|Overall Study|Patient has moved|1|||
149175994|NCT00630032|538116923|FG000|Overall Study|Disease progression|1|||
149175995|NCT00630032|538116924|FG001|Overall Study|Disease progression|1|||
149175996|NCT00630032|538116923|FG000|Overall Study|End of monitoring in US centers|11|||
149175997|NCT00630032|538116924|FG001|Overall Study|End of monitoring in US centers|11|||
149175998|NCT03746080|538118385|FG000|Overall Study|In follow up|2|||
149175999|NCT03746080|538118385|FG000|Overall Study|Death|15|||
149176000|NCT05738486|538118386|FG000|Overall Study|Continuing Study|194|||
149176001|NCT05738486|538118387|FG001|Overall Study|Continuing Study|196|||
149176002|NCT05738486|538118388|FG002|Overall Study|Continuing Study|193|||
149176003|NCT05738486|538118389|FG003|Overall Study|Continuing Study|191|||
149176004|NCT05738486|538118386|FG000|Overall Study|Withdrawal by Subject|8|||
149176005|NCT05738486|538118387|FG001|Overall Study|Withdrawal by Subject|5|||
149176006|NCT05738486|538118388|FG002|Overall Study|Withdrawal by Subject|7|||
149176007|NCT05738486|538118389|FG003|Overall Study|Withdrawal by Subject|13|||
149176008|NCT05738486|538118386|FG000|Overall Study|Adverse Event|4|||
149176009|NCT05738486|538118387|FG001|Overall Study|Adverse Event|6|||
149176010|NCT05738486|538118388|FG002|Overall Study|Adverse Event|4|||
149176011|NCT05738486|538118389|FG003|Overall Study|Adverse Event|5|||
149176012|NCT05738486|538118386|FG000|Overall Study|Physician Decision|0|||
149176013|NCT05738486|538118387|FG001|Overall Study|Physician Decision|2|||
149176014|NCT05738486|538118388|FG002|Overall Study|Physician Decision|4|||
149176015|NCT05738486|538118389|FG003|Overall Study|Physician Decision|1|||
149176016|NCT05738486|538118386|FG000|Overall Study|Lost to Follow-up|1|||
149176017|NCT05738486|538118387|FG001|Overall Study|Lost to Follow-up|1|||
149176018|NCT05738486|538118388|FG002|Overall Study|Lost to Follow-up|2|||
149176019|NCT05738486|538118389|FG003|Overall Study|Lost to Follow-up|1|||
149176020|NCT05738486|538118386|FG000|Overall Study|Participant was Non-ambulatory|0|||
149176021|NCT05738486|538118387|FG001|Overall Study|Participant was Non-ambulatory|0|||
149176022|NCT05738486|538118388|FG002|Overall Study|Participant was Non-ambulatory|1|||
149176023|NCT05738486|538118389|FG003|Overall Study|Participant was Non-ambulatory|0|||
149176024|NCT05738486|538118386|FG000|Overall Study|Participant had Poor Venous Access|0|||
149176025|NCT05738486|538118387|FG001|Overall Study|Participant had Poor Venous Access|0|||
149176026|NCT05738486|538118388|FG002|Overall Study|Participant had Poor Venous Access|0|||
149176027|NCT05738486|538118389|FG003|Overall Study|Participant had Poor Venous Access|1|||
149176028|NCT05738486|538118386|FG000|Overall Study|Assigned Treatment by Mistake|0|||
149176029|NCT05738486|538118387|FG001|Overall Study|Assigned Treatment by Mistake|0|||
149176030|NCT05738486|538118388|FG002|Overall Study|Assigned Treatment by Mistake|0|||
149176031|NCT05738486|538118389|FG003|Overall Study|Assigned Treatment by Mistake|1|||
149176032|NCT05738486|538118386|FG000|Overall Study|Death|0|||
149176033|NCT05738486|538118387|FG001|Overall Study|Death|0|||
149176034|NCT05738486|538118388|FG002|Overall Study|Death|1|||
149176035|NCT05738486|538118389|FG003|Overall Study|Death|0|||
149176036|NCT05738486|538118386|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
149176037|NCT05738486|538118387|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149176038|NCT05738486|538118388|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
149176039|NCT05738486|538118389|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
148806903|NCT00171249|536771062|FG004|Overall Study|Adverse Event|0|||
148806904|NCT00171249|536771063|FG005|Overall Study|Adverse Event|2|||
148929977|NCT03497676|537228438|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
149176040|NCT00955110|538118390|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
149176041|NCT00955110|538118390|FG000|Treatment Phase|Adverse Event|2|||
148806905|NCT00171249|536771064|FG006|Overall Study|Adverse Event|0|||
149176042|NCT00955110|538118390|FG000|Treatment Phase|Administrative reasons|2|||
149176043|NCT00955110|538118390|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
149176044|NCT00955110|538118390|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
149176045|NCT02128490|538118391|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149176046|NCT02128490|538118392|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
149176047|NCT02128490|538118393|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
148806906|NCT00171249|536771058|FG000|Overall Study|Lost to Follow-up|5|||
149176048|NCT02128490|538118394|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
149176049|NCT02128490|538118395|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
149176050|NCT02128490|538118391|FG000|Overall Study|Major Protocol Deviation|1|||
149176051|NCT02128490|538118392|FG001|Overall Study|Major Protocol Deviation|2|||
149176052|NCT02128490|538118393|FG002|Overall Study|Major Protocol Deviation|0|||
149176053|NCT02128490|538118394|FG003|Overall Study|Major Protocol Deviation|2|||
149176054|NCT02128490|538118395|FG004|Overall Study|Major Protocol Deviation|2|||
149176055|NCT02128490|538118391|FG000|Overall Study|Lost to Follow-up|0|||
149176056|NCT02128490|538118392|FG001|Overall Study|Lost to Follow-up|0|||
149176057|NCT02128490|538118393|FG002|Overall Study|Lost to Follow-up|1|||
149176058|NCT02128490|538118394|FG003|Overall Study|Lost to Follow-up|1|||
149176059|NCT02128490|538118395|FG004|Overall Study|Lost to Follow-up|1|||
149176060|NCT02128490|538118391|FG000|Overall Study|Voluntary Withdrawal|3|||
149176061|NCT02128490|538118392|FG001|Overall Study|Voluntary Withdrawal|3|||
149176062|NCT02128490|538118393|FG002|Overall Study|Voluntary Withdrawal|1|||
149176063|NCT02128490|538118394|FG003|Overall Study|Voluntary Withdrawal|1|||
149176064|NCT02128490|538118395|FG004|Overall Study|Voluntary Withdrawal|2|||
149176065|NCT02128490|538118391|FG000|Overall Study|Lack of Efficacy|0|||
149176066|NCT02128490|538118392|FG001|Overall Study|Lack of Efficacy|1|||
149176067|NCT02128490|538118393|FG002|Overall Study|Lack of Efficacy|0|||
149176068|NCT02128490|538118394|FG003|Overall Study|Lack of Efficacy|0|||
149176069|NCT02128490|538118395|FG004|Overall Study|Lack of Efficacy|0|||
149176070|NCT02128490|538118391|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149176071|NCT02128490|538118392|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149176072|NCT02128490|538118393|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149176073|NCT02128490|538118394|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
149176074|NCT02128490|538118395|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
149176075|NCT02128490|538118391|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149176076|NCT02128490|538118392|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149176077|NCT02128490|538118393|FG002|Overall Study|Other Miscellaneous Reasons|2|||
149176078|NCT02128490|538118394|FG003|Overall Study|Other Miscellaneous Reasons|1|||
149176079|NCT02128490|538118395|FG004|Overall Study|Other Miscellaneous Reasons|1|||
149176080|NCT02243176|538118396|FG000|Overall Study|Other reason|1|||
149176081|NCT02243176|538118397|FG001|Overall Study|Other reason|2|||
149176082|NCT02243176|538118396|FG000|Overall Study|protocol specified withdrawal critera|1|||
149176083|NCT02243176|538118397|FG001|Overall Study|protocol specified withdrawal critera|3|||
149176084|NCT02243176|538118396|FG000|Overall Study|Protocol Violation|2|||
148806907|NCT00171249|536771059|FG001|Overall Study|Lost to Follow-up|0|||
148806908|NCT00171249|536771060|FG002|Overall Study|Lost to Follow-up|0|||
148806909|NCT00171249|536771061|FG003|Overall Study|Lost to Follow-up|9|||
148806910|NCT00171249|536771062|FG004|Overall Study|Lost to Follow-up|0|||
148806911|NCT00171249|536771063|FG005|Overall Study|Lost to Follow-up|0|||
148806912|NCT00171249|536771064|FG006|Overall Study|Lost to Follow-up|0|||
148929978|NCT03497676|537228439|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
148929979|NCT03497676|537228440|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
148929980|NCT03497676|537228437|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
149176085|NCT02243176|538118397|FG001|Overall Study|Protocol Violation|1|||
149176086|NCT02243176|538118396|FG000|Overall Study|Withdrawal by Subject|8|||
149176087|NCT02243176|538118397|FG001|Overall Study|Withdrawal by Subject|7|||
149176088|NCT02243176|538118396|FG000|Overall Study|Adverse Event|2|||
149176089|NCT02243176|538118397|FG001|Overall Study|Adverse Event|2|||
149176090|NCT03113500|538118398|FG000|Overall Study|Withdrawal by Subject|1|||
149176091|NCT02517515|538118401|FG000|Overall Study|Adverse Event|0|||
149176092|NCT02517515|538118402|FG001|Overall Study|Adverse Event|1|||
149176093|NCT02517515|538118401|FG000|Overall Study|Withdrew Consent|0|||
149176094|NCT02517515|538118402|FG001|Overall Study|Withdrew Consent|1|||
149176095|NCT02517515|538118401|FG000|Overall Study|Lost to Follow-up|1|||
149176096|NCT02517515|538118402|FG001|Overall Study|Lost to Follow-up|0|||
149176097|NCT02517515|538118401|FG000|Overall Study|Other|1|||
149176098|NCT02517515|538118402|FG001|Overall Study|Other|0|||
149176099|NCT01009463|538118410|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
149176100|NCT01009463|538118411|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149176101|NCT01009463|538118412|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149176102|NCT01009463|538118413|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149176103|NCT01009463|538118414|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
149176104|NCT01009463|538118410|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
148806913|NCT00471497|536771065|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
149176105|NCT01009463|538118411|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
149176106|NCT01009463|538118412|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
149176107|NCT01009463|538118413|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
148929981|NCT03497676|537228438|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
148806914|NCT00471497|536771066|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
149176108|NCT01009463|538118414|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
149176109|NCT01009463|538118410|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
149176110|NCT01009463|538118411|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149176111|NCT01009463|538118412|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149176112|NCT01009463|538118413|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149176113|NCT01009463|538118414|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
149176114|NCT01009463|538118410|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
149176115|NCT01009463|538118411|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
149176116|NCT01009463|538118412|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
149176117|NCT01009463|538118413|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
149176118|NCT01009463|538118414|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
149176119|NCT01009463|538118410|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
149176120|NCT01009463|538118411|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149176121|NCT01009463|538118412|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149176122|NCT01009463|538118413|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149176123|NCT01009463|538118414|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
149176124|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
149176125|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
149176126|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
149176127|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
149176128|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
149176129|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149176130|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
149176131|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
149176132|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
149176133|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
149176134|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149176135|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
149176136|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
149176137|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
149176138|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
149176139|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
149176140|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
149176141|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
149176142|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
149176143|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
149176144|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149176145|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
149176146|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
149176147|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
149176148|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
149176149|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149176150|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
149176151|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149176152|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
149176153|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
149176154|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149176155|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
149176156|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
149176157|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
149176158|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
149176159|NCT01009463|538118410|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
149176160|NCT01009463|538118411|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
149176161|NCT01009463|538118412|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
149176162|NCT01009463|538118413|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
149176163|NCT01009463|538118414|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
149176164|NCT04430348|538118417|FG000|Overall Study|Death|3|||
148929982|NCT03497676|537228439|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
148929983|NCT03497676|537228440|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
148929984|NCT03497676|537228437|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
148929985|NCT03497676|537228438|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
148929986|NCT03497676|537228439|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
148929987|NCT03497676|537228440|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
149176165|NCT04430348|538118418|FG001|Overall Study|Death|2|||
149176166|NCT04430348|538118419|FG002|Overall Study|Death|2|||
149176167|NCT04430348|538118420|FG003|Overall Study|Death|2|||
149176168|NCT04430348|538118421|FG004|Overall Study|Death|2|||
149176169|NCT04430348|538118422|FG005|Overall Study|Death|3|||
149176170|NCT04430348|538118417|FG000|Overall Study|Lost to Follow-up|0|||
149176171|NCT04430348|538118418|FG001|Overall Study|Lost to Follow-up|0|||
149176172|NCT04430348|538118419|FG002|Overall Study|Lost to Follow-up|0|||
149176173|NCT04430348|538118420|FG003|Overall Study|Lost to Follow-up|1|||
149176174|NCT04430348|538118421|FG004|Overall Study|Lost to Follow-up|0|||
149176175|NCT04430348|538118422|FG005|Overall Study|Lost to Follow-up|0|||
149176176|NCT04430348|538118417|FG000|Overall Study|Adverse Event|0|||
149176177|NCT04430348|538118418|FG001|Overall Study|Adverse Event|0|||
149176178|NCT04430348|538118419|FG002|Overall Study|Adverse Event|0|||
149176179|NCT04430348|538118420|FG003|Overall Study|Adverse Event|0|||
149176180|NCT04430348|538118421|FG004|Overall Study|Adverse Event|0|||
149176181|NCT04430348|538118422|FG005|Overall Study|Adverse Event|1|||
149176182|NCT04430348|538118417|FG000|Overall Study|Withdrawal by Subject|0|||
149176183|NCT04430348|538118418|FG001|Overall Study|Withdrawal by Subject|1|||
149176184|NCT04430348|538118419|FG002|Overall Study|Withdrawal by Subject|0|||
149176185|NCT04430348|538118420|FG003|Overall Study|Withdrawal by Subject|0|||
149176186|NCT04430348|538118421|FG004|Overall Study|Withdrawal by Subject|0|||
149176187|NCT04430348|538118422|FG005|Overall Study|Withdrawal by Subject|1|||
149176188|NCT04430348|538118417|FG000|Overall Study|Study Terminated by Sponsor|0|||
149176189|NCT04430348|538118418|FG001|Overall Study|Study Terminated by Sponsor|0|||
149176190|NCT04430348|538118419|FG002|Overall Study|Study Terminated by Sponsor|2|||
149176191|NCT04430348|538118420|FG003|Overall Study|Study Terminated by Sponsor|0|||
149176192|NCT04430348|538118421|FG004|Overall Study|Study Terminated by Sponsor|1|||
149176193|NCT04430348|538118422|FG005|Overall Study|Study Terminated by Sponsor|1|||
149176194|NCT02874794|538118425|FG000|Overall Study|Physician Decision|3|||
149176195|NCT02874794|538118426|FG001|Overall Study|Physician Decision|2|||
149176196|NCT02874794|538118425|FG000|Overall Study|Withdrawal by Subject|2|||
149176197|NCT02874794|538118426|FG001|Overall Study|Withdrawal by Subject|8|||
149176198|NCT02874794|538118425|FG000|Overall Study|Death|2|||
149176199|NCT02874794|538118426|FG001|Overall Study|Death|1|||
149176200|NCT01458340|538118429|FG000|Overall Study|Adverse Event|5|||
149176201|NCT01458340|538118430|FG001|Overall Study|Adverse Event|4|||
149176202|NCT01458340|538118431|FG002|Overall Study|Adverse Event|2|||
149176203|NCT01458340|538118429|FG000|Overall Study|Lost to Follow-up|3|||
149176204|NCT01458340|538118430|FG001|Overall Study|Lost to Follow-up|3|||
149176205|NCT01458340|538118431|FG002|Overall Study|Lost to Follow-up|10|||
149176206|NCT01458340|538118429|FG000|Overall Study|Miscellaneous|0|||
149176207|NCT01458340|538118430|FG001|Overall Study|Miscellaneous|1|||
149176208|NCT01458340|538118431|FG002|Overall Study|Miscellaneous|0|||
149176209|NCT01458340|538118429|FG000|Overall Study|Physician Decision|1|||
149176210|NCT01458340|538118430|FG001|Overall Study|Physician Decision|1|||
149176211|NCT01458340|538118431|FG002|Overall Study|Physician Decision|2|||
149176212|NCT01458340|538118429|FG000|Overall Study|Protocol Violation|6|||
149176213|NCT01458340|538118430|FG001|Overall Study|Protocol Violation|6|||
149176214|NCT01458340|538118431|FG002|Overall Study|Protocol Violation|5|||
149176215|NCT01458340|538118429|FG000|Overall Study|Withdrawal by Subject|12|||
149176216|NCT01458340|538118430|FG001|Overall Study|Withdrawal by Subject|6|||
149176217|NCT01458340|538118431|FG002|Overall Study|Withdrawal by Subject|4|||
149176218|NCT01021007|538118433|FG000|Overall Study|Lost to Follow-up|1|||
149176219|NCT01021007|538118434|FG001|Overall Study|Lost to Follow-up|1|||
149176220|NCT01021007|538118433|FG000|Overall Study|Adverse Event|1|||
149176221|NCT01021007|538118434|FG001|Overall Study|Adverse Event|3|||
149176222|NCT04876391|538118435|FG000|Overall Study|Withdrawal by Subject|1|||
149176223|NCT04876391|538118436|FG001|Overall Study|Withdrawal by Subject|10|||
149176224|NCT04876391|538118435|FG000|Overall Study|Lost to Follow-up|2|||
149176225|NCT04876391|538118436|FG001|Overall Study|Lost to Follow-up|4|||
149176226|NCT04876391|538118435|FG000|Overall Study|Lack of Efficacy|0|||
149176227|NCT04876391|538118436|FG001|Overall Study|Lack of Efficacy|2|||
149176228|NCT04876391|538118435|FG000|Overall Study|Adverse Event|3|||
149176229|NCT04876391|538118436|FG001|Overall Study|Adverse Event|1|||
149176230|NCT04876391|538118435|FG000|Overall Study|Patient non-compliance|0|||
149176231|NCT04876391|538118436|FG001|Overall Study|Patient non-compliance|1|||
149176232|NCT04876391|538118435|FG000|Overall Study|Personal reasons|0|||
149176233|NCT04876391|538118436|FG001|Overall Study|Personal reasons|1|||
149176234|NCT04876391|538118435|FG000|Overall Study|Withdrawn as per protocol|2|||
148806915|NCT00471497|536771067|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
149176235|NCT04876391|538118436|FG001|Overall Study|Withdrawn as per protocol|2|||
149176236|NCT04899271|538118437|FG000|Overall Study|Lost to Follow-up|1|||
149176237|NCT04899271|538118438|FG001|Overall Study|Lost to Follow-up|0|||
149176238|NCT04899271|538118437|FG000|Overall Study|Subject request/consent withdrawal|2|||
149176239|NCT04899271|538118438|FG001|Overall Study|Subject request/consent withdrawal|0|||
149176240|NCT00813748|538118439|FG000|Skin Test Substudy|Physician Decision|0|||
149176241|NCT00813748|538118440|FG001|Skin Test Substudy|Physician Decision|1|||
149176242|NCT00892437|538118441|FG000|Randomized Phase|Randomized but not treated|6|||
149176243|NCT00892437|538118442|FG001|Randomized Phase|Randomized but not treated|0|||
149176244|NCT00892437|538118441|FG000|Randomized Phase|Adverse Event|2|||
149176245|NCT00892437|538118442|FG001|Randomized Phase|Adverse Event|2|||
149176246|NCT00892437|538118441|FG000|Randomized Phase|Lost to Follow-up|1|||
149176247|NCT00892437|538118442|FG001|Randomized Phase|Lost to Follow-up|3|||
149176248|NCT00892437|538118441|FG000|Randomized Phase|Investigator's Discretion|1|||
149176249|NCT00892437|538118442|FG001|Randomized Phase|Investigator's Discretion|0|||
149176250|NCT00892437|538118441|FG000|Randomized Phase|Withdrew Consent|1|||
149176251|NCT00892437|538118442|FG001|Randomized Phase|Withdrew Consent|0|||
149176252|NCT00892437|538118441|FG000|Open-Label Extension Phase|Adverse Event|4|||
149176253|NCT00892437|538118442|FG001|Open-Label Extension Phase|Adverse Event|2|||
149176254|NCT00892437|538118441|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
149176255|NCT00892437|538118442|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
149176256|NCT00892437|538118441|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
149176257|NCT00892437|538118442|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
149176258|NCT00892437|538118441|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
149176259|NCT00892437|538118442|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
149176260|NCT00892437|538118441|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
149176261|NCT00892437|538118442|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
149176262|NCT02286960|538118443|FG000|Overall Study|Lost to Follow-up|3|||
149176263|NCT02286960|538118444|FG001|Overall Study|Lost to Follow-up|3|||
149176264|NCT03427073|538118446|FG000|Overall Study|Disease Progression|1|||
149176265|NCT03427073|538118447|FG001|Overall Study|Disease Progression|1|||
149176266|NCT03427073|538118448|FG002|Overall Study|Disease Progression|1|||
149176267|NCT03427073|538118449|FG003|Overall Study|Disease Progression|3|||
149176268|NCT03427073|538118450|FG004|Overall Study|Disease Progression|3|||
149176269|NCT03427073|538118451|FG005|Overall Study|Disease Progression|4|||
149176270|NCT03427073|538118452|FG006|Overall Study|Disease Progression|2|||
149176271|NCT03427073|538118453|FG007|Overall Study|Disease Progression|3|||
149176272|NCT03427073|538118446|FG000|Overall Study|Physician Decision|0|||
149176273|NCT03427073|538118447|FG001|Overall Study|Physician Decision|0|||
149176274|NCT03427073|538118448|FG002|Overall Study|Physician Decision|0|||
149176275|NCT03427073|538118449|FG003|Overall Study|Physician Decision|0|||
149176276|NCT03427073|538118450|FG004|Overall Study|Physician Decision|0|||
149176277|NCT03427073|538118451|FG005|Overall Study|Physician Decision|0|||
149176278|NCT03427073|538118452|FG006|Overall Study|Physician Decision|1|||
149176279|NCT03427073|538118453|FG007|Overall Study|Physician Decision|1|||
149176280|NCT01193335|538118454|FG000|After Infant Series|Lost to Follow-up|1|||
149176281|NCT01193335|538118455|FG001|After Infant Series|Lost to Follow-up|2|||
149176282|NCT01193335|538118454|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
149176283|NCT01193335|538118455|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
149176284|NCT01193335|538118454|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
149176285|NCT01193335|538118455|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
149176286|NCT01193335|538118454|FG000|1-Year Follow-up|Lost to Follow-up|4|||
149176287|NCT01193335|538118455|FG001|1-Year Follow-up|Lost to Follow-up|0|||
149176288|NCT01193335|538118454|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
149176289|NCT01193335|538118455|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
149176290|NCT01193335|538118454|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
149176291|NCT01193335|538118455|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
149176292|NCT01733329|538118456|FG000|Overall Study|Protocol Violation|1|||
149176293|NCT01733329|538118457|FG001|Overall Study|Protocol Violation|1|||
149176294|NCT01733329|538118456|FG000|Overall Study|Uterine artery injury|1|||
149176295|NCT01733329|538118457|FG001|Overall Study|Uterine artery injury|0|||
149176296|NCT02388776|538118458|FG000|Overall Study|Death|1|||
149176297|NCT02388776|538118458|FG000|Overall Study|Lost to Follow-up|1|||
149176298|NCT03826914|538118459|FG000|Overall Study|Withdrawal by Subject|1|||
149176299|NCT03826914|538118460|FG001|Overall Study|Withdrawal by Subject|1|||
149176300|NCT04246047|538118463|FG000|Overall Study|Death|50|||
149176301|NCT04246047|538118464|FG001|Overall Study|Death|77|||
149176302|NCT04246047|538118463|FG000|Overall Study|Lost to Follow-up|1|||
149176303|NCT04246047|538118464|FG001|Overall Study|Lost to Follow-up|3|||
149176304|NCT04246047|538118463|FG000|Overall Study|Physician Decision|4|||
148929988|NCT03497676|537228437|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
148929989|NCT03497676|537228438|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
149176305|NCT04246047|538118464|FG001|Overall Study|Physician Decision|10|||
149176306|NCT04246047|538118463|FG000|Overall Study|Withdrawal by Subject|19|||
149176307|NCT04246047|538118464|FG001|Overall Study|Withdrawal by Subject|26|||
149176308|NCT04246047|538118463|FG000|Overall Study|Ongoing|169|||
149176309|NCT04246047|538118464|FG001|Overall Study|Ongoing|135|||
149176310|NCT02502864|538118467|FG000|Overall Study|Withdrawal by Subject|1|||
149176311|NCT01824602|538118477|FG000|Overall Study|Withdrawal by Subject|0|||
149176312|NCT01824602|538118478|FG001|Overall Study|Withdrawal by Subject|0|||
149176313|NCT01824602|538118479|FG002|Overall Study|Withdrawal by Subject|1|||
149176314|NCT01824602|538118480|FG003|Overall Study|Withdrawal by Subject|2|||
148929990|NCT03497676|537228439|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
148929991|NCT03497676|537228440|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
148929992|NCT03497676|537228437|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
148929993|NCT03497676|537228438|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
148929994|NCT03497676|537228439|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
148929995|NCT03497676|537228440|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
148929996|NCT03497676|537228437|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
148929997|NCT03497676|537228438|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
148929998|NCT03497676|537228439|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
148929999|NCT03497676|537228440|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
148930000|NCT01977937|537228446|FG000|Overall Study|Withdrawal by Subject|2|||
148930001|NCT01977937|537228447|FG001|Overall Study|Withdrawal by Subject|1|||
148930002|NCT01977937|537228446|FG000|Overall Study|Adverse Event|1|||
148930003|NCT01977937|537228447|FG001|Overall Study|Adverse Event|0|||
148930004|NCT01977937|537228446|FG000|Overall Study|Physician Decision|0|||
148930005|NCT01977937|537228447|FG001|Overall Study|Physician Decision|1|||
148930006|NCT03004443|537228451|FG000|Overall Study|Pregnancy|0|||
148930007|NCT03004443|537228452|FG001|Overall Study|Pregnancy|1|||
148930008|NCT00828854|537228453|FG000|Overall Study|Disease Progression|17|||
148930009|NCT00828854|537228453|FG000|Overall Study|Adverse Event|9|||
148930010|NCT00828854|537228453|FG000|Overall Study|Reason not Specified|1|||
148930011|NCT00915356|537228454|FG000|Overall Study|Withdrawal by Subject|1|||
148930012|NCT00915356|537228455|FG001|Overall Study|Withdrawal by Subject|0|||
148930013|NCT00915356|537228456|FG002|Overall Study|Withdrawal by Subject|0|||
148930014|NCT00915356|537228457|FG003|Overall Study|Withdrawal by Subject|0|||
148930015|NCT00915356|537228458|FG004|Overall Study|Withdrawal by Subject|0|||
148930016|NCT00191646|537228461|FG000|Overall Study|Toxicity|26|||
148930017|NCT00191646|537228462|FG001|Overall Study|Toxicity|37|||
148930018|NCT00191646|537228461|FG000|Overall Study|Disease Progression|5|||
148930019|NCT00191646|537228462|FG001|Overall Study|Disease Progression|6|||
148930020|NCT00191646|537228461|FG000|Overall Study|Physician Decision|20|||
148930021|NCT00191646|537228462|FG001|Overall Study|Physician Decision|11|||
148930022|NCT00191646|537228461|FG000|Overall Study|Withdrawal by Subject|58|||
148930023|NCT00191646|537228462|FG001|Overall Study|Withdrawal by Subject|39|||
148930024|NCT00191646|537228461|FG000|Overall Study|Protocol Violation|5|||
148930025|NCT00191646|537228462|FG001|Overall Study|Protocol Violation|7|||
148930026|NCT00191646|537228461|FG000|Overall Study|Death|6|||
148930027|NCT00191646|537228462|FG001|Overall Study|Death|8|||
148930028|NCT00191646|537228461|FG000|Overall Study|Other|33|||
148930029|NCT00191646|537228462|FG001|Overall Study|Other|34|||
148930030|NCT00191646|537228461|FG000|Overall Study|Missing Data|18|||
148930031|NCT00191646|537228462|FG001|Overall Study|Missing Data|11|||
148930032|NCT03194490|537228464|FG000|Overall Study|Lost to Follow-up|1|||
148930033|NCT03194490|537228465|FG001|Overall Study|Lost to Follow-up|3|||
148930034|NCT03194490|537228464|FG000|Overall Study|participant developed specific neck pain|1|||
148930035|NCT03194490|537228465|FG001|Overall Study|participant developed specific neck pain|0|||
148930036|NCT01505647|537228466|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
148930037|NCT01505647|537228467|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
148930038|NCT01505647|537228466|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
148930039|NCT01505647|537228467|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
148930040|NCT01505647|537228466|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
148930041|NCT01505647|537228467|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
149176315|NCT01824602|538118477|FG000|Overall Study|Patient non-compliance|0|||
149176316|NCT01824602|538118478|FG001|Overall Study|Patient non-compliance|0|||
149176317|NCT01824602|538118479|FG002|Overall Study|Patient non-compliance|1|||
149176318|NCT01824602|538118480|FG003|Overall Study|Patient non-compliance|0|||
149176319|NCT01824602|538118477|FG000|Overall Study|Adverse Event|1|||
149176320|NCT01824602|538118478|FG001|Overall Study|Adverse Event|0|||
149176321|NCT01824602|538118479|FG002|Overall Study|Adverse Event|2|||
149176322|NCT01824602|538118480|FG003|Overall Study|Adverse Event|2|||
149176323|NCT01824602|538118477|FG000|Overall Study|Treatment failure|0|||
148930042|NCT01505647|537228466|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
148930043|NCT01505647|537228467|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
148930044|NCT01505647|537228466|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
148930045|NCT01505647|537228467|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
148930046|NCT01574079|537228468|FG000|Overall Study|Physician Decision|0|||
148930047|NCT01574079|537228469|FG001|Overall Study|Physician Decision|2|||
149176324|NCT01824602|538118478|FG001|Overall Study|Treatment failure|0|||
149176325|NCT01824602|538118479|FG002|Overall Study|Treatment failure|0|||
148930048|NCT01574079|537228468|FG000|Overall Study|Lost to Follow-up|1|||
148930049|NCT01574079|537228469|FG001|Overall Study|Lost to Follow-up|0|||
149176326|NCT01824602|538118480|FG003|Overall Study|Treatment failure|1|||
149176327|NCT00184054|538118481|FG000|Overall Study|Adverse Event|1|||
149176328|NCT00104871|538118484|FG000|Overall Study|Not evaluable|1|||
149176329|NCT02485717|538118485|FG000|Overall Study|Lost to Follow-up|6|||
149176330|NCT02485717|538118486|FG001|Overall Study|Lost to Follow-up|0|||
149176331|NCT02485717|538118487|FG002|Overall Study|Lost to Follow-up|0|||
149176332|NCT02485717|538118485|FG000|Overall Study|Withdrawal by Subject|0|||
149176333|NCT02485717|538118486|FG001|Overall Study|Withdrawal by Subject|0|||
149176334|NCT02485717|538118487|FG002|Overall Study|Withdrawal by Subject|1|||
149176335|NCT02485717|538118485|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
149176336|NCT02485717|538118486|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
149176337|NCT02485717|538118487|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
149176338|NCT02485717|538118485|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
149176339|NCT02485717|538118486|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
149176340|NCT02485717|538118487|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
149176341|NCT02192359|538118488|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
149176342|NCT02192359|538118489|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
149176343|NCT02192359|538118490|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
149176344|NCT02192359|538118491|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
149176345|NCT02192359|538118488|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
149176346|NCT02192359|538118489|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
149176347|NCT02192359|538118490|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
149176348|NCT02192359|538118491|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
149176349|NCT02192359|538118488|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
149176350|NCT02192359|538118489|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
149176351|NCT02192359|538118490|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
149176352|NCT02192359|538118491|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
149176353|NCT00457639|538118495|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
149176354|NCT00457639|538118496|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
149176355|NCT00457639|538118495|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
149176356|NCT00457639|538118496|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
149176357|NCT00457639|538118495|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
149176358|NCT00457639|538118496|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
149176359|NCT02117687|538118497|FG000|Overall Study|Lost to Follow-up|0|||
149176360|NCT02117687|538118498|FG001|Overall Study|Lost to Follow-up|1|||
149176361|NCT02117687|538118497|FG000|Overall Study|Adverse Event|0|||
149176362|NCT02117687|538118498|FG001|Overall Study|Adverse Event|2|||
149176363|NCT02117687|538118497|FG000|Overall Study|Other Reasons|1|||
149176364|NCT02117687|538118498|FG001|Overall Study|Other Reasons|1|||
149176365|NCT01450540|538118499|FG000|Overall Study|Withdrawal by Subject|19|||
149176366|NCT01450540|538118500|FG001|Overall Study|Withdrawal by Subject|13|||
149176367|NCT01450540|538118499|FG000|Overall Study|protocol deviation|3|||
149176368|NCT01450540|538118500|FG001|Overall Study|protocol deviation|23|||
149176369|NCT01687673|538118512|FG000|Overall Study|Physician Decision|1|||
149176370|NCT02234622|538118513|FG000|Overall Study|Withdrawal by Subject|16|||
149176371|NCT02234622|538118514|FG001|Overall Study|Withdrawal by Subject|22|||
149176372|NCT02234622|538118513|FG000|Overall Study|Lost to Follow-up|27|||
149176373|NCT02234622|538118514|FG001|Overall Study|Lost to Follow-up|14|||
149176374|NCT00618956|538118515|FG000|Overall Study|Adverse Event|10|||
149176375|NCT00618956|538118516|FG001|Overall Study|Adverse Event|34|||
149176376|NCT00618956|538118515|FG000|Overall Study|Lack of Efficacy|2|||
149176377|NCT00618956|538118516|FG001|Overall Study|Lack of Efficacy|1|||
149176378|NCT00618956|538118515|FG000|Overall Study|Withdrawal by Subject|5|||
149176379|NCT00618956|538118516|FG001|Overall Study|Withdrawal by Subject|7|||
149176380|NCT00618956|538118515|FG000|Overall Study|Lost to Follow-up|4|||
149176381|NCT00618956|538118516|FG001|Overall Study|Lost to Follow-up|5|||
149176382|NCT00618956|538118515|FG000|Overall Study|Protocol Violation|2|||
149176383|NCT00618956|538118516|FG001|Overall Study|Protocol Violation|2|||
149176384|NCT00618956|538118515|FG000|Overall Study|did not meet criteria, non-compliance|2|||
149176385|NCT00618956|538118516|FG001|Overall Study|did not meet criteria, non-compliance|1|||
149176386|NCT03598777|538118517|FG000|Overall Study|Study Terminated by Sponsor|3|||
149176387|NCT03598777|538118518|FG001|Overall Study|Study Terminated by Sponsor|0|||
148806916|NCT00471497|536771065|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
149176388|NCT03598777|538118519|FG002|Overall Study|Study Terminated by Sponsor|0|||
149176389|NCT03598777|538118520|FG003|Overall Study|Study Terminated by Sponsor|0|||
149176390|NCT03598777|538118521|FG004|Overall Study|Study Terminated by Sponsor|15|||
149176391|NCT03598777|538118517|FG000|Overall Study|Withdrawal by Subject|1|||
149176392|NCT03598777|538118518|FG001|Overall Study|Withdrawal by Subject|1|||
149176393|NCT03598777|538118519|FG002|Overall Study|Withdrawal by Subject|0|||
149176394|NCT03598777|538118520|FG003|Overall Study|Withdrawal by Subject|0|||
149176395|NCT03598777|538118521|FG004|Overall Study|Withdrawal by Subject|0|||
149013342|NCT02006121|537527913|FG000|Double Blind Phase|Lack of Efficacy|1|||
149013343|NCT02006121|537527914|FG001|Double Blind Phase|Lack of Efficacy|16|||
149013344|NCT02006121|537527913|FG000|Double Blind Phase|Withdrawal by Subject|3|||
149013345|NCT02006121|537527914|FG001|Double Blind Phase|Withdrawal by Subject|4|||
149013346|NCT02006121|537527913|FG000|Double Blind Phase|Non-compliance with study drug|1|||
149013347|NCT02006121|537527914|FG001|Double Blind Phase|Non-compliance with study drug|3|||
149013348|NCT02006121|537527913|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
149013349|NCT02006121|537527914|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
149013350|NCT02006121|537527913|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
149013351|NCT02006121|537527914|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
149013352|NCT02006121|537527913|FG000|Open Label Phase|Adverse Event|15|||
149013353|NCT02006121|537527914|FG001|Open Label Phase|Adverse Event|0|||
149013354|NCT02006121|537527913|FG000|Open Label Phase|Lack of Efficacy|2|||
149013355|NCT02006121|537527914|FG001|Open Label Phase|Lack of Efficacy|0|||
149013356|NCT02006121|537527913|FG000|Open Label Phase|Protocol Violation|2|||
149013357|NCT02006121|537527914|FG001|Open Label Phase|Protocol Violation|0|||
149013358|NCT02006121|537527913|FG000|Open Label Phase|Withdrawal by Subject|3|||
149013359|NCT02006121|537527914|FG001|Open Label Phase|Withdrawal by Subject|0|||
149013360|NCT02006121|537527913|FG000|Open Label Phase|Non-compliance with study drug|3|||
149013361|NCT02006121|537527914|FG001|Open Label Phase|Non-compliance with study drug|0|||
149013362|NCT01737996|537527923|FG000|Overall Study|Adverse Event|0|||
149013363|NCT01737996|537527924|FG001|Overall Study|Adverse Event|1|||
149013364|NCT01737996|537527925|FG002|Overall Study|Adverse Event|1|||
149013365|NCT01737996|537527923|FG000|Overall Study|Withdrawal by Subject|0|||
149013366|NCT01737996|537527924|FG001|Overall Study|Withdrawal by Subject|0|||
149013367|NCT01737996|537527925|FG002|Overall Study|Withdrawal by Subject|1|||
149013368|NCT03000673|537527926|FG000|Overall Study|Withdrawal by Subject|1|||
149013369|NCT03000673|537527927|FG001|Overall Study|Withdrawal by Subject|0|||
149013370|NCT03000673|537527928|FG002|Overall Study|Withdrawal by Subject|0|||
149013371|NCT03000673|537527929|FG003|Overall Study|Withdrawal by Subject|0|||
149013372|NCT01512745|537527931|FG000|Overall Study|Adverse Event|22|||
149176396|NCT03598777|538118517|FG000|Overall Study|Adverse Event|1|||
149176397|NCT03598777|538118518|FG001|Overall Study|Adverse Event|0|||
149176398|NCT03598777|538118519|FG002|Overall Study|Adverse Event|0|||
149176399|NCT03598777|538118520|FG003|Overall Study|Adverse Event|0|||
149176400|NCT03598777|538118521|FG004|Overall Study|Adverse Event|0|||
149176401|NCT03598777|538118517|FG000|Overall Study|Lost to Follow-up|1|||
149176402|NCT03598777|538118518|FG001|Overall Study|Lost to Follow-up|0|||
149176403|NCT03598777|538118519|FG002|Overall Study|Lost to Follow-up|0|||
149176404|NCT03598777|538118520|FG003|Overall Study|Lost to Follow-up|0|||
149176405|NCT03598777|538118521|FG004|Overall Study|Lost to Follow-up|0|||
149176406|NCT02006576|538118522|FG000|Overall Study|Withdrawal by Subject|4|||
149176407|NCT02006576|538118523|FG001|Overall Study|Withdrawal by Subject|6|||
149176408|NCT02006576|538118524|FG002|Overall Study|Withdrawal by Subject|2|||
149176409|NCT02006576|538118522|FG000|Overall Study|Death|0|||
149176410|NCT02006576|538118523|FG001|Overall Study|Death|0|||
149176411|NCT02006576|538118524|FG002|Overall Study|Death|1|||
149176412|NCT02006576|538118522|FG000|Overall Study|Lost to Follow-up|1|||
149176413|NCT02006576|538118523|FG001|Overall Study|Lost to Follow-up|0|||
149176414|NCT02006576|538118524|FG002|Overall Study|Lost to Follow-up|1|||
149176415|NCT02006576|538118522|FG000|Overall Study|Screen Failure, too sick, other|13|||
149176416|NCT02006576|538118523|FG001|Overall Study|Screen Failure, too sick, other|1|||
149176417|NCT02006576|538118524|FG002|Overall Study|Screen Failure, too sick, other|13|||
149176418|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
149176419|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
149176420|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
149176421|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
149176422|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
149176423|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149176424|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149176425|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149176426|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149176427|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
149176428|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149176429|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149013373|NCT01512745|537527932|FG001|Overall Study|Adverse Event|3|||
149013374|NCT01512745|537527931|FG000|Overall Study|Death|9|||
149013375|NCT01512745|537527932|FG001|Overall Study|Death|13|||
149013376|NCT01512745|537527931|FG000|Overall Study|Withdrawal by Subject|2|||
149013377|NCT01512745|537527932|FG001|Overall Study|Withdrawal by Subject|2|||
149176430|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
149176431|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
149013378|NCT01512745|537527931|FG000|Overall Study|Lost to Follow-up|4|||
149013379|NCT01512745|537527932|FG001|Overall Study|Lost to Follow-up|0|||
149176432|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
148678884|NCT04682639|536299020|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
148678885|NCT04682639|536299021|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
148678886|NCT04682639|536299022|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
148678887|NCT04682639|536299018|FG000|OLE Period (28 Weeks)|Other|1|||
148678888|NCT04682639|536299019|FG001|OLE Period (28 Weeks)|Other|2|||
148678889|NCT04682639|536299020|FG002|OLE Period (28 Weeks)|Other|0|||
148678890|NCT04682639|536299021|FG003|OLE Period (28 Weeks)|Other|0|||
148678891|NCT04682639|536299022|FG004|OLE Period (28 Weeks)|Other|1|||
148678892|NCT04682639|536299018|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
148678893|NCT04682639|536299019|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
148678894|NCT04682639|536299020|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
148678895|NCT04682639|536299021|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
148678896|NCT04682639|536299022|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
148678897|NCT04682639|536299018|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
148678898|NCT04682639|536299019|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
148678899|NCT04682639|536299020|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148678900|NCT04682639|536299021|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148678901|NCT04682639|536299022|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148678902|NCT04682639|536299018|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
148678903|NCT04682639|536299019|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
148678904|NCT04682639|536299020|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148678905|NCT04682639|536299021|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148678906|NCT04682639|536299022|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148678907|NCT04682639|536299018|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
148678908|NCT04682639|536299019|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
148678909|NCT04682639|536299020|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
148678910|NCT04682639|536299021|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
148678911|NCT04682639|536299022|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
148678912|NCT01383954|536299023|FG000|Overall Study|Lack of Efficacy|2|||
148678913|NCT01383954|536299023|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
148678914|NCT01383954|536299023|FG000|Overall Study|Adverse Event|1|||
148678915|NCT01383954|536299023|FG000|Overall Study|Reason Not Specified|9|||
148678916|NCT00763269|536299024|FG000|Overall Study|Lost to Follow-up|12|||
148678917|NCT00763269|536299025|FG001|Overall Study|Lost to Follow-up|13|||
148678918|NCT04388527|536299026|FG000|Overall Study|Death|14|||
148678919|NCT04388527|536299026|FG000|Overall Study|Withdrawal by Subject|2|||
148678920|NCT04388527|536299026|FG000|Overall Study|Lost to Follow-up|1|||
148678921|NCT03471182|536299027|FG000|Overall Study|Withdrawal by Subject|1|||
148678922|NCT03471182|536299028|FG001|Overall Study|Withdrawal by Subject|1|||
148678923|NCT03471182|536299029|FG002|Overall Study|Withdrawal by Subject|0|||
148678924|NCT03471182|536299027|FG000|Overall Study|Technical failure|2|||
148678925|NCT03471182|536299028|FG001|Overall Study|Technical failure|0|||
148678926|NCT03471182|536299029|FG002|Overall Study|Technical failure|0|||
148678927|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
149176433|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
149176434|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
149176435|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
149176436|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
149176437|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
148678928|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
148678929|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
148678930|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
148678931|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
148678932|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
148678933|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
148678934|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
148678935|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
148678936|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
148678937|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
148678938|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
148678939|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
148678940|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
148678941|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
148678942|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
148678943|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
148678944|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
148678945|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
148806917|NCT00471497|536771066|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
148806918|NCT00471497|536771067|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
149176438|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
149176439|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
149176440|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
149176441|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
149176442|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
149176443|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
149176444|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
149176445|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
149176446|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
149176447|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
149176448|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
149176449|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
149176450|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
149176451|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
149176452|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
149176453|NCT00785577|538118525|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
149176454|NCT00785577|538118526|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
149176455|NCT00785577|538118527|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
149176456|NCT00785577|538118528|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
149176457|NCT00785577|538118529|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
149176458|NCT00785577|538118525|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149176459|NCT00785577|538118526|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149176460|NCT00785577|538118527|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149176461|NCT00785577|538118528|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
149176462|NCT00785577|538118529|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
149176463|NCT00785577|538118525|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
149176464|NCT00785577|538118526|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
149176465|NCT00785577|538118527|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
149176466|NCT00785577|538118528|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
149176467|NCT00785577|538118529|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
149176468|NCT02452359|538118535|FG000|Overall Study|Adverse Event|1|||
149176469|NCT02452359|538118535|FG000|Overall Study|Lost to Follow-up|15|||
149176470|NCT02452359|538118535|FG000|Overall Study|Pregnancy|1|||
149176471|NCT02452359|538118535|FG000|Overall Study|Withdrawal by Subject|4|||
149176472|NCT01887210|538118536|FG000|Overall Study|Withdrawal by Subject|1|||
149176473|NCT01887210|538118537|FG001|Overall Study|Withdrawal by Subject|3|||
149176474|NCT01887210|538118536|FG000|Overall Study|Lost to Follow-up|0|||
149176475|NCT01887210|538118537|FG001|Overall Study|Lost to Follow-up|1|||
149176476|NCT02515669|538118542|FG000|228 Week Open-Label Phase|Other|0|||
149176477|NCT02515669|538118543|FG001|228 Week Open-Label Phase|Other|0|||
149176478|NCT02515669|538118544|FG002|228 Week Open-Label Phase|Other|1|||
149176479|NCT02515669|538118545|FG003|228 Week Open-Label Phase|Other|4|||
149176480|NCT02515669|538118542|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
149176481|NCT02515669|538118543|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
149176482|NCT02515669|538118544|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
149176483|NCT02515669|538118545|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
149176484|NCT02515669|538118542|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
149176485|NCT02515669|538118543|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
149176486|NCT02515669|538118544|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
149176487|NCT02515669|538118545|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
149176488|NCT02515669|538118542|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
149176489|NCT02515669|538118543|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
149176490|NCT02515669|538118544|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
149176491|NCT02515669|538118545|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
149176492|NCT02515669|538118542|FG000|228 Week Open-Label Phase|Missing|0|||
149176493|NCT02515669|538118543|FG001|228 Week Open-Label Phase|Missing|2|||
149176494|NCT02515669|538118544|FG002|228 Week Open-Label Phase|Missing|2|||
149176495|NCT02515669|538118545|FG003|228 Week Open-Label Phase|Missing|2|||
149176496|NCT01901328|538118551|FG000|Overall Study|Lost to Follow-up|1|||
149176497|NCT01901328|538118552|FG001|Overall Study|Lost to Follow-up|0|||
149176498|NCT01901328|538118551|FG000|Overall Study|Physician Decision|0|||
149176499|NCT01901328|538118552|FG001|Overall Study|Physician Decision|1|||
149176500|NCT01901328|538118551|FG000|Overall Study|Protocol Violation|1|||
149176501|NCT01901328|538118552|FG001|Overall Study|Protocol Violation|1|||
149176502|NCT01901328|538118551|FG000|Overall Study|Study Terminated by Sponsor|19|||
149176503|NCT01901328|538118552|FG001|Overall Study|Study Terminated by Sponsor|16|||
149176504|NCT01901328|538118551|FG000|Overall Study|Withdrawal by Subject|1|||
149176505|NCT01901328|538118552|FG001|Overall Study|Withdrawal by Subject|2|||
149176506|NCT01901328|538118551|FG000|Overall Study|Lack of Efficacy|0|||
149176507|NCT01901328|538118552|FG001|Overall Study|Lack of Efficacy|1|||
149176508|NCT03439345|538120486|FG000|Overall Study|Lost to Follow-up|0|||
149176509|NCT03439345|538120487|FG001|Overall Study|Lost to Follow-up|1|||
149013380|NCT01512745|537527931|FG000|Overall Study|Lack of Efficacy|2|||
149176510|NCT03439345|538120486|FG000|Overall Study|Consent withdrawn|0|||
149176511|NCT03439345|538120487|FG001|Overall Study|Consent withdrawn|1|||
149176512|NCT01826214|538120493|FG000|Overall Study|Adverse Event|7|||
149013381|NCT01512745|537527932|FG001|Overall Study|Lack of Efficacy|2|||
149013382|NCT01512745|537527931|FG000|Overall Study|Protocol Violation|1|||
149176513|NCT01826214|538120494|FG001|Overall Study|Adverse Event|6|||
149176514|NCT01826214|538120493|FG000|Overall Study|Death|3|||
149176515|NCT01826214|538120494|FG001|Overall Study|Death|1|||
149176516|NCT01826214|538120493|FG000|Overall Study|Lost to Follow-up|1|||
149176517|NCT01826214|538120494|FG001|Overall Study|Lost to Follow-up|0|||
149176518|NCT01826214|538120493|FG000|Overall Study|Physician Decision|0|||
149176519|NCT01826214|538120494|FG001|Overall Study|Physician Decision|2|||
149176520|NCT01826214|538120493|FG000|Overall Study|Progressive disease|22|||
149176521|NCT01826214|538120494|FG001|Overall Study|Progressive disease|21|||
149176522|NCT01826214|538120493|FG000|Overall Study|Study terminated by Sponsor|0|||
149176523|NCT01826214|538120494|FG001|Overall Study|Study terminated by Sponsor|1|||
149176524|NCT01826214|538120493|FG000|Overall Study|Subject/guardian decision|2|||
149176525|NCT01826214|538120494|FG001|Overall Study|Subject/guardian decision|3|||
149176526|NCT06400238|538120495|FG000|Overall Study|Started Protocol Therapy|2|||
149176527|NCT06400238|538120495|FG000|Overall Study|Adverse Event|1|||
149176528|NCT06400238|538120495|FG000|Overall Study|Death|1|||
149176529|NCT06400238|538120495|FG000|Overall Study|Disease Progression|27|||
149176530|NCT06400238|538120495|FG000|Overall Study|Withdrawal by Subject|2|||
149176531|NCT06400238|538120495|FG000|Overall Study|Physician Decision|2|||
149176532|NCT01981187|538120498|FG000|Overall Study|Participant/guardian decision|2|||
149176533|NCT01981187|538120498|FG000|Overall Study|Physician Decision|1|||
148678946|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
148678947|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
148678948|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
148678949|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
148678950|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
148678951|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
148678952|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
148678953|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
148678954|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
148678955|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
148678956|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
148678957|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
148678958|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
148678959|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
148678960|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
148678961|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
148678962|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
148678963|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
148678964|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
148678965|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
148678966|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
148678967|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
148678968|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
148678969|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
148678970|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
148678971|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
149013383|NCT01512745|537527932|FG001|Overall Study|Protocol Violation|0|||
149013384|NCT02357810|537527933|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
149176534|NCT01981187|538120498|FG000|Overall Study|Disease progression|2|||
149176535|NCT01981187|538120498|FG000|Overall Study|Adverse Event|7|||
149176536|NCT03839524|538120501|FG000|Overall Study|Adverse Event|1|||
149176537|NCT04329949|538120502|FG000|Overall Study|Death|36|||
149176538|NCT04329949|538120502|FG000|Overall Study|Withdrawal by Subject|4|||
148678972|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
148678973|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
148678974|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
148678975|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
148678976|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
149013385|NCT02357810|537527933|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
149013386|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Adverse Event|5|||
149176539|NCT04329949|538120502|FG000|Overall Study|Termination of study by sponsor|3|||
149176540|NCT02037919|538120503|FG000|Overall Study|Lost to Follow-up|30|||
149176541|NCT02037919|538120504|FG001|Overall Study|Lost to Follow-up|45|||
149176542|NCT00345605|538120509|FG000|Arm 1|Adverse Event|0|||
149176543|NCT00345605|538120510|FG001|Arm 1|Adverse Event|1|||
149176544|NCT00345605|538120509|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
149176545|NCT00345605|538120510|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
149013387|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
149013388|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
149013389|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
149013390|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Death|1|||
149013391|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Physician Decision|1|||
149013392|NCT02357810|537527933|FG000|Reached 12 Weeks Response|Other|1|||
149013393|NCT02357810|537527933|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
149013394|NCT02357810|537527933|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
149013395|NCT02357810|537527933|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
149013396|NCT02357810|537527933|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
149013397|NCT02357810|537527933|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
149013398|NCT02357810|537527933|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
149013399|NCT03679767|537527934|FG000|Overall Study|Death|16|||
149013400|NCT03679767|537527935|FG001|Overall Study|Death|11|||
149013401|NCT03679767|537527936|FG002|Overall Study|Death|17|||
149013402|NCT03679767|537527937|FG003|Overall Study|Death|10|||
149176546|NCT00917384|538120516|FG000|Overall Study|Lost to Follow-up|4|||
149176547|NCT00917384|538120517|FG001|Overall Study|Lost to Follow-up|2|||
149176548|NCT00917384|538120516|FG000|Overall Study|Withdrawal by Subject|10|||
149176549|NCT00917384|538120517|FG001|Overall Study|Withdrawal by Subject|2|||
149176550|NCT01451515|538120520|FG000|Overall Study|Death|0|||
149176551|NCT01451515|538120521|FG001|Overall Study|Death|1|||
149176552|NCT01451515|538120522|FG002|Overall Study|Death|0|||
149176553|NCT01451515|538120520|FG000|Overall Study|Withdrawal by Subject|0|||
149176554|NCT01451515|538120521|FG001|Overall Study|Withdrawal by Subject|1|||
149176555|NCT01451515|538120522|FG002|Overall Study|Withdrawal by Subject|0|||
149176556|NCT01451515|538120520|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
149176557|NCT01451515|538120521|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
149176558|NCT01451515|538120522|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
149176559|NCT01451515|538120520|FG000|Overall Study|Relapse (except CNS)|1|||
149176560|NCT01451515|538120521|FG001|Overall Study|Relapse (except CNS)|1|||
149176561|NCT01451515|538120522|FG002|Overall Study|Relapse (except CNS)|0|||
149176562|NCT03717922|538120523|FG000|Overall Study|Lost to Follow-up|2|||
149176563|NCT03717922|538120524|FG001|Overall Study|Lost to Follow-up|2|||
149176564|NCT01702805|538120525|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
149176565|NCT01702805|538120526|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
149176566|NCT01702805|538120525|FG000|Overall Study|Incomplete Follow-up|18|||
149176567|NCT01702805|538120526|FG001|Overall Study|Incomplete Follow-up|15|||
149176568|NCT01702805|538120525|FG000|Overall Study|Vital Status Assessment Only|40|||
149176569|NCT01702805|538120526|FG001|Overall Study|Vital Status Assessment Only|39|||
149176570|NCT01702805|538120525|FG000|Overall Study|Lost to Follow-up|5|||
149176571|NCT01702805|538120526|FG001|Overall Study|Lost to Follow-up|5|||
149176572|NCT01238120|538120527|FG000|Overall Study|Withdrawal by Subject|4|||
149176573|NCT01238120|538120528|FG001|Overall Study|Withdrawal by Subject|1|||
149176574|NCT01238120|538120529|FG002|Overall Study|Withdrawal by Subject|2|||
149176575|NCT01238120|538120530|FG003|Overall Study|Withdrawal by Subject|5|||
149176576|NCT01238120|538120527|FG000|Overall Study|Lost to Follow-up|2|||
149176577|NCT01238120|538120528|FG001|Overall Study|Lost to Follow-up|0|||
149176578|NCT01238120|538120529|FG002|Overall Study|Lost to Follow-up|1|||
149176579|NCT01238120|538120530|FG003|Overall Study|Lost to Follow-up|1|||
149013403|NCT03679767|537527934|FG000|Overall Study|Lost to Follow-up|1|||
149013404|NCT03679767|537527935|FG001|Overall Study|Lost to Follow-up|1|||
149013405|NCT03679767|537527936|FG002|Overall Study|Lost to Follow-up|1|||
149013406|NCT03679767|537527937|FG003|Overall Study|Lost to Follow-up|1|||
149013407|NCT03679767|537527934|FG000|Overall Study|Withdrawal by Subject|0|||
149013408|NCT03679767|537527935|FG001|Overall Study|Withdrawal by Subject|0|||
149013409|NCT03679767|537527936|FG002|Overall Study|Withdrawal by Subject|0|||
149013410|NCT03679767|537527937|FG003|Overall Study|Withdrawal by Subject|1|||
149013411|NCT03679767|537527934|FG000|Overall Study|Follow-up Completed|18|||
149013412|NCT03679767|537527935|FG001|Overall Study|Follow-up Completed|11|||
149013413|NCT03679767|537527936|FG002|Overall Study|Follow-up Completed|11|||
149176580|NCT01238120|538120527|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
149176581|NCT01238120|538120528|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
149176582|NCT01238120|538120529|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
149176583|NCT01238120|538120530|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
149176584|NCT00693706|538120535|FG000|Overall Study|Protocol Violation|0|||
149176585|NCT00693706|538120536|FG001|Overall Study|Protocol Violation|1|||
149176586|NCT04786210|538120539|FG000|Overall Study|Lost to Follow-up|2|||
148678977|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
148678978|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
149013414|NCT03679767|537527937|FG003|Overall Study|Follow-up Completed|20|||
149176587|NCT04786210|538120539|FG000|Overall Study|Withdrawal by Subject|4|||
149013415|NCT03679767|537527934|FG000|Overall Study|Entered Hospice Care|0|||
149176588|NCT04334148|538120540|FG000|Overall Study|positive nasal swab at baseline|0|||
149176589|NCT04334148|538120541|FG001|Overall Study|positive nasal swab at baseline|1|||
149176590|NCT00498173|538120542|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
149176591|NCT00498173|538120543|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
149176592|NCT00498173|538120544|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
149176593|NCT00258154|538120545|FG000|Overall Study|Adverse Event|1|||
149176594|NCT00258154|538120546|FG001|Overall Study|Adverse Event|0|||
149176595|NCT00258154|538120545|FG000|Overall Study|Lost to Follow-up|0|||
149176596|NCT00258154|538120546|FG001|Overall Study|Lost to Follow-up|1|||
149176597|NCT00258154|538120545|FG000|Overall Study|Protocol Violation|2|||
149176598|NCT00258154|538120546|FG001|Overall Study|Protocol Violation|1|||
149176599|NCT00258154|538120545|FG000|Overall Study|Withdrawal by Subject|3|||
149176600|NCT00258154|538120546|FG001|Overall Study|Withdrawal by Subject|4|||
149176601|NCT00258154|538120545|FG000|Overall Study|Patient Moved|3|||
149176602|NCT00258154|538120546|FG001|Overall Study|Patient Moved|1|||
149176603|NCT03772327|538120550|FG000|Overall Study|Lost to Follow-up|3|||
149176604|NCT03772327|538120551|FG001|Overall Study|Lost to Follow-up|4|||
149176605|NCT03772327|538120550|FG000|Overall Study|Withdrawal by Subject|2|||
149176606|NCT03772327|538120551|FG001|Overall Study|Withdrawal by Subject|3|||
149176607|NCT04689828|538120552|FG000|Overall Study|Subject decision|5|||
149176608|NCT04689828|538120553|FG001|Overall Study|Subject decision|5|||
149176609|NCT04689828|538120552|FG000|Overall Study|Adverse Event|12|||
149176610|NCT04689828|538120553|FG001|Overall Study|Adverse Event|12|||
149176611|NCT04689828|538120552|FG000|Overall Study|Physician Decision|24|||
149176612|NCT04689828|538120553|FG001|Overall Study|Physician Decision|32|||
149176613|NCT04689828|538120552|FG000|Overall Study|Progressive disease|54|||
149176614|NCT04689828|538120553|FG001|Overall Study|Progressive disease|173|||
149176615|NCT04689828|538120552|FG000|Overall Study|Death|0|||
149176616|NCT04689828|538120553|FG001|Overall Study|Death|1|||
149176617|NCT04689828|538120552|FG000|Overall Study|Lost to Follow-up|1|||
149176618|NCT04689828|538120553|FG001|Overall Study|Lost to Follow-up|0|||
149176619|NCT04689828|538120552|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
149176620|NCT04689828|538120553|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
149176621|NCT04689828|538120552|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
149176622|NCT04689828|538120553|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
149176623|NCT04689828|538120552|FG000|Overall Study|Participants not treated|7|||
149176624|NCT04689828|538120553|FG001|Overall Study|Participants not treated|2|||
149176625|NCT00195351|538120567|FG000|Overall Study|Lost to Follow-up|9|||
149176626|NCT00195351|538120568|FG001|Overall Study|Lost to Follow-up|9|||
149176627|NCT00195351|538120567|FG000|Overall Study|Withdrawal by Subject|6|||
149176628|NCT00195351|538120568|FG001|Overall Study|Withdrawal by Subject|3|||
149176629|NCT00195351|538120567|FG000|Overall Study|Protocol Deviation|3|||
149176630|NCT00195351|538120568|FG001|Overall Study|Protocol Deviation|2|||
149176631|NCT00195351|538120567|FG000|Overall Study|Death|3|||
148930050|NCT00406718|537228470|FG000|Overall Study|Withdrawal by Subject|2|||
148930051|NCT00406718|537228471|FG001|Overall Study|Withdrawal by Subject|9|||
148930052|NCT00406718|537228472|FG002|Overall Study|Withdrawal by Subject|4|||
148930053|NCT00406718|537228470|FG000|Overall Study|Lost to Follow-up|2|||
148930054|NCT00406718|537228471|FG001|Overall Study|Lost to Follow-up|5|||
148930055|NCT00406718|537228472|FG002|Overall Study|Lost to Follow-up|4|||
148930056|NCT01888003|537228473|FG000|Overall Study|Study Terminated|5|||
148930057|NCT01888003|537228474|FG001|Overall Study|Study Terminated|6|||
148930058|NCT01888003|537228475|FG002|Overall Study|Study Terminated|40|||
148930059|NCT03187756|537228476|FG000|Overall Study|Termination of study|4|||
148930060|NCT01931202|537228480|FG000|Overall Study|Withdrawal by Subject|0|||
148930061|NCT01931202|537228481|FG001|Overall Study|Withdrawal by Subject|0|||
148930062|NCT01931202|537228482|FG002|Overall Study|Withdrawal by Subject|2|||
148930063|NCT01931202|537228480|FG000|Overall Study|Lost to Follow-up|0|||
148930064|NCT01931202|537228481|FG001|Overall Study|Lost to Follow-up|5|||
148930065|NCT01931202|537228482|FG002|Overall Study|Lost to Follow-up|2|||
149176632|NCT00195351|538120568|FG001|Overall Study|Death|1|||
149176633|NCT00195351|538120567|FG000|Overall Study|Lack of Efficacy|0|||
148930066|NCT04597918|537228485|FG000|Overall Study|Withdrawal by Subject|6|||
149176634|NCT00195351|538120568|FG001|Overall Study|Lack of Efficacy|1|||
149176635|NCT02111369|538120569|FG000|Overall Study|Lost to Follow-up|2|||
149176636|NCT02111369|538120569|FG000|Overall Study|Withdrawal by Subject|1|||
149176637|NCT02493751|538120575|FG000|Overall Study|Withdrawal by Subject|2|||
149176638|NCT02493751|538120576|FG001|Overall Study|Withdrawal by Subject|8|||
149176639|NCT02493751|538120575|FG000|Overall Study|Death|6|||
149176640|NCT02493751|538120576|FG001|Overall Study|Death|13|||
149176641|NCT02493751|538120575|FG000|Overall Study|Lost to Follow-up|2|||
148930067|NCT04597918|537228485|FG000|Overall Study|Lost to Follow-up|3|||
148930068|NCT04597918|537228485|FG000|Overall Study|Death|1|||
149176642|NCT02493751|538120576|FG001|Overall Study|Lost to Follow-up|3|||
149176643|NCT02493751|538120575|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
149176644|NCT02493751|538120576|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
149176645|NCT01480180|538120577|FG000|Main Phase|Withdrawal criteria|12|||
149176646|NCT01480180|538120578|FG001|Main Phase|Withdrawal criteria|1|||
149176647|NCT01480180|538120579|FG002|Main Phase|Withdrawal criteria|0|||
149176648|NCT01480180|538120580|FG003|Main Phase|Withdrawal criteria|0|||
149176649|NCT01480180|538120581|FG004|Main Phase|Withdrawal criteria|0|||
149176650|NCT01480180|538120582|FG005|Main Phase|Withdrawal criteria|0|||
149176651|NCT01480180|538120577|FG000|Main Phase|Lack of Efficacy|1|||
149176652|NCT01480180|538120578|FG001|Main Phase|Lack of Efficacy|0|||
149176653|NCT01480180|538120579|FG002|Main Phase|Lack of Efficacy|0|||
149176654|NCT01480180|538120580|FG003|Main Phase|Lack of Efficacy|0|||
149176655|NCT01480180|538120581|FG004|Main Phase|Lack of Efficacy|0|||
149176656|NCT01480180|538120582|FG005|Main Phase|Lack of Efficacy|0|||
149176657|NCT01480180|538120577|FG000|Main Phase|Non-compliance|3|||
149176658|NCT01480180|538120578|FG001|Main Phase|Non-compliance|0|||
149176659|NCT01480180|538120579|FG002|Main Phase|Non-compliance|0|||
149176660|NCT01480180|538120580|FG003|Main Phase|Non-compliance|0|||
149176661|NCT01480180|538120581|FG004|Main Phase|Non-compliance|0|||
149176662|NCT01480180|538120582|FG005|Main Phase|Non-compliance|0|||
149176663|NCT01480180|538120577|FG000|Main Phase|Unclassified|3|||
149176664|NCT01480180|538120578|FG001|Main Phase|Unclassified|0|||
149176665|NCT01480180|538120579|FG002|Main Phase|Unclassified|0|||
149176666|NCT01480180|538120580|FG003|Main Phase|Unclassified|0|||
149176667|NCT01480180|538120581|FG004|Main Phase|Unclassified|0|||
149176668|NCT01480180|538120582|FG005|Main Phase|Unclassified|0|||
149176669|NCT01480180|538120577|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
149176670|NCT01480180|538120578|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
149176671|NCT01480180|538120579|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
149176672|NCT01480180|538120580|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
149176673|NCT01480180|538120581|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
149176674|NCT01480180|538120582|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
149176675|NCT01480180|538120577|FG000|Extension Phase, Part 1|Unclassified|0|||
149176676|NCT01480180|538120578|FG001|Extension Phase, Part 1|Unclassified|0|||
149176677|NCT01480180|538120579|FG002|Extension Phase, Part 1|Unclassified|1|||
149176678|NCT01480180|538120580|FG003|Extension Phase, Part 1|Unclassified|0|||
149176679|NCT01480180|538120581|FG004|Extension Phase, Part 1|Unclassified|0|||
149176680|NCT01480180|538120582|FG005|Extension Phase, Part 1|Unclassified|0|||
149176681|NCT01480180|538120577|FG000|Extension Phase, Part 1|Adverse Event|0|||
149176682|NCT01480180|538120578|FG001|Extension Phase, Part 1|Adverse Event|0|||
149176683|NCT01480180|538120579|FG002|Extension Phase, Part 1|Adverse Event|4|||
149176684|NCT01480180|538120580|FG003|Extension Phase, Part 1|Adverse Event|1|||
149176685|NCT01480180|538120581|FG004|Extension Phase, Part 1|Adverse Event|0|||
149176686|NCT01480180|538120582|FG005|Extension Phase, Part 1|Adverse Event|0|||
148678979|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
148678980|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
148678981|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
148678982|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
148678983|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
148678984|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
149176687|NCT01480180|538120577|FG000|Extension Phase, Part 1|Change of treatment|0|||
149176688|NCT01480180|538120578|FG001|Extension Phase, Part 1|Change of treatment|0|||
149176689|NCT01480180|538120579|FG002|Extension Phase, Part 1|Change of treatment|0|||
149176690|NCT01480180|538120580|FG003|Extension Phase, Part 1|Change of treatment|9|||
149176691|NCT01480180|538120581|FG004|Extension Phase, Part 1|Change of treatment|0|||
149176692|NCT01480180|538120582|FG005|Extension Phase, Part 1|Change of treatment|0|||
149176693|NCT01480180|538120577|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
149176694|NCT01480180|538120578|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
149176695|NCT01480180|538120579|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
149176696|NCT01480180|538120580|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
149176697|NCT01480180|538120581|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
149176698|NCT01480180|538120582|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
149176699|NCT01480180|538120577|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
148678985|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
148678986|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
149176700|NCT01480180|538120578|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
149176701|NCT01480180|538120579|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
149176702|NCT01480180|538120580|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
149176703|NCT01480180|538120581|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
149176704|NCT01480180|538120582|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
149176705|NCT01480180|538120577|FG000|Extension Phase, Part 2|Unclassified|0|||
149176706|NCT01480180|538120578|FG001|Extension Phase, Part 2|Unclassified|0|||
149176707|NCT01480180|538120579|FG002|Extension Phase, Part 2|Unclassified|3|||
149176708|NCT01480180|538120580|FG003|Extension Phase, Part 2|Unclassified|1|||
149176709|NCT01480180|538120581|FG004|Extension Phase, Part 2|Unclassified|1|||
149176710|NCT01480180|538120582|FG005|Extension Phase, Part 2|Unclassified|0|||
149176711|NCT00828451|538120589|FG000|Overall Study|Death|2|||
149176712|NCT00828451|538120589|FG000|Overall Study|Lack of intravenous line|7|||
149176713|NCT00828451|538120589|FG000|Overall Study|Withdrawal by Subject|1|||
149176714|NCT00828451|538120589|FG000|Overall Study|Deterioration in clinical status|1|||
149176715|NCT02827877|538120590|FG000|Overall Study|Withdrawal by Subject|1|||
149176716|NCT01650805|538120593|FG000|Overall Study|Withdrawal by Subject|1|||
149176717|NCT01650805|538120594|FG001|Overall Study|Withdrawal by Subject|0|||
149176718|NCT00840463|538120600|FG000|Overall Study|Adverse Event|1|||
149176719|NCT00840463|538120601|FG001|Overall Study|Adverse Event|0|||
149176720|NCT03414359|538120602|FG000|Overall Study|Lack of Efficacy|1|||
149176721|NCT03414359|538120603|FG001|Overall Study|Lack of Efficacy|1|||
149176722|NCT03414359|538120602|FG000|Overall Study|Protocol Violation|0|||
149176723|NCT03414359|538120603|FG001|Overall Study|Protocol Violation|1|||
149176724|NCT03750838|538120608|FG000|Overall Study|Lost to Follow-up|10|||
149176725|NCT03750838|538120609|FG001|Overall Study|Lost to Follow-up|6|||
149176726|NCT02332915|538120610|FG000|Overall Study|Moved out of region|3|||
149176727|NCT02332915|538120611|FG001|Overall Study|Moved out of region|0|||
149176728|NCT02332915|538120610|FG000|Overall Study|Unrelated illness|1|||
149176729|NCT02332915|538120611|FG001|Overall Study|Unrelated illness|1|||
149176730|NCT02332915|538120610|FG000|Overall Study|Travel distance prohibitive|0|||
149176731|NCT02332915|538120611|FG001|Overall Study|Travel distance prohibitive|1|||
149176732|NCT02332915|538120610|FG000|Overall Study|did not meet inclusion criteria|2|||
149176733|NCT02332915|538120611|FG001|Overall Study|did not meet inclusion criteria|4|||
149176734|NCT02462889|538120612|FG000|Overall Study|Withdrawal by Subject|2|||
149176735|NCT02462889|538120613|FG001|Overall Study|Withdrawal by Subject|6|||
149176736|NCT02462889|538120612|FG000|Overall Study|Death|1|||
148806919|NCT00471497|536771065|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
148678987|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
148678988|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
148678989|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
148678990|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
148678991|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
148678992|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
148806920|NCT00471497|536771066|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
148930069|NCT01876810|537228486|FG000|Overall Study|Physician Decision|0|||
148930070|NCT01876810|537228487|FG001|Overall Study|Physician Decision|1|||
148930071|NCT01442038|537230188|FG000|Overall Study|Death|35|||
148930072|NCT01442038|537230189|FG001|Overall Study|Death|29|||
148930073|NCT01442038|537230188|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
148930074|NCT01442038|537230189|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
148930075|NCT01442038|537230188|FG000|Overall Study|Participant Withdrew Consent|137|||
148930076|NCT01442038|537230189|FG001|Overall Study|Participant Withdrew Consent|102|||
148930077|NCT01442038|537230188|FG000|Overall Study|Lost to Follow-up|37|||
148930078|NCT01442038|537230189|FG001|Overall Study|Lost to Follow-up|51|||
149013416|NCT03679767|537527935|FG001|Overall Study|Entered Hospice Care|0|||
149176737|NCT02462889|538120613|FG001|Overall Study|Death|5|||
149176738|NCT03497689|538120617|FG000|Overall Study|Adverse Event|2|||
149176739|NCT03497689|538120617|FG000|Overall Study|Death|1|||
149176740|NCT03497689|538120617|FG000|Overall Study|Physician Decision|1|||
149176741|NCT03497689|538120617|FG000|Overall Study|Withdrawal by Subject|1|||
149176742|NCT03497689|538120617|FG000|Overall Study|Protocol Violation|2|||
149176743|NCT02032875|538120618|FG000|Treatment Period|Adverse Event|1|||
149176744|NCT02032875|538120619|FG001|Treatment Period|Adverse Event|0|||
149176745|NCT02032875|538120618|FG000|Treatment Period|Liver transplant, No extension needed|0|||
149176746|NCT02032875|538120619|FG001|Treatment Period|Liver transplant, No extension needed|1|||
149176747|NCT02032875|538120618|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
149176748|NCT02032875|538120619|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
149176749|NCT02032875|538120618|FG000|Follow-up Period|Death|0|||
149176750|NCT02032875|538120619|FG001|Follow-up Period|Death|1|||
149176751|NCT02032875|538120618|FG000|Follow-up Period|Virologic Relapse|3|||
149176752|NCT02032875|538120619|FG001|Follow-up Period|Virologic Relapse|10|||
149176753|NCT04636177|538120624|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
149176754|NCT04636177|538120625|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
149176755|NCT04636177|538120624|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
149176756|NCT04636177|538120625|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
149176757|NCT04636177|538120624|FG000|Single-arm portion|Withdrawal by Subject|1|||
149176758|NCT04636177|538120625|FG001|Single-arm portion|Withdrawal by Subject|0|||
149176759|NCT04636177|538120624|FG000|Single-arm portion|Adverse Event|1|||
149176760|NCT04636177|538120625|FG001|Single-arm portion|Adverse Event|0|||
149176761|NCT03191786|538120626|FG000|Overall Study|Death|236|||
149176762|NCT03191786|538120627|FG001|Overall Study|Death|127|||
149176763|NCT03191786|538120626|FG000|Overall Study|Lost to Follow-up|9|||
149176764|NCT03191786|538120627|FG001|Overall Study|Lost to Follow-up|3|||
149176765|NCT03191786|538120626|FG000|Overall Study|Physician Decision|1|||
149176766|NCT03191786|538120627|FG001|Overall Study|Physician Decision|0|||
149176767|NCT03191786|538120626|FG000|Overall Study|Moved to Post Trial Access Program|30|||
148930079|NCT01442038|537230188|FG000|Overall Study|Adverse Event|26|||
149176768|NCT03191786|538120627|FG001|Overall Study|Moved to Post Trial Access Program|5|||
149176769|NCT03191786|538120626|FG000|Overall Study|Withdrawal by Subject|26|||
149176770|NCT03191786|538120627|FG001|Overall Study|Withdrawal by Subject|16|||
149176771|NCT05847881|538120628|FG000|Overall Study|Principal Investigator Decision|8|||
149176772|NCT05847881|538120628|FG000|Overall Study|Withdrawal by Subject|2|||
149176773|NCT01348919|538122088|FG000|Overall Study|Adverse Event|3|||
149176774|NCT01348919|538122089|FG001|Overall Study|Adverse Event|1|||
149176775|NCT01348919|538122090|FG002|Overall Study|Adverse Event|0|||
149176776|NCT01348919|538122088|FG000|Overall Study|Withdrawal by Subject|0|||
149176777|NCT01348919|538122089|FG001|Overall Study|Withdrawal by Subject|1|||
149176778|NCT01348919|538122090|FG002|Overall Study|Withdrawal by Subject|0|||
148930080|NCT01442038|537230189|FG001|Overall Study|Adverse Event|15|||
148930081|NCT01442038|537230188|FG000|Overall Study|Protocol Deviation|9|||
148678993|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
148678994|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
148930082|NCT01442038|537230189|FG001|Overall Study|Protocol Deviation|20|||
149176779|NCT01348919|538122088|FG000|Overall Study|Disease progression|0|||
149176780|NCT01348919|538122089|FG001|Overall Study|Disease progression|1|||
149176781|NCT01348919|538122090|FG002|Overall Study|Disease progression|1|||
149176782|NCT01362322|538122091|FG000|Overall Study|Withdrawal by Subject|3|||
149176783|NCT01362322|538122092|FG001|Overall Study|Withdrawal by Subject|1|||
149176784|NCT01362322|538122091|FG000|Overall Study|Lost to Follow-up|2|||
149176785|NCT01362322|538122092|FG001|Overall Study|Lost to Follow-up|6|||
149176786|NCT01943539|538122093|FG000|Overall Study|Non-compliance with at-home intervention|4|||
148930083|NCT01442038|537230188|FG000|Overall Study|Investigator's Discretion|13|||
148930084|NCT01442038|537230189|FG001|Overall Study|Investigator's Discretion|16|||
148930085|NCT01442038|537230188|FG000|Overall Study|Study Terminated By Sponsor|2|||
148930086|NCT01442038|537230189|FG001|Overall Study|Study Terminated By Sponsor|3|||
148930087|NCT00089284|537230190|FG000|Overall Study|Adverse event before starting treatment|0|||
148930088|NCT00089284|537230191|FG001|Overall Study|Adverse event before starting treatment|0|||
148930089|NCT00089284|537230192|FG002|Overall Study|Adverse event before starting treatment|0|||
148930090|NCT00089284|537230193|FG003|Overall Study|Adverse event before starting treatment|0|||
148930091|NCT00089284|537230194|FG004|Overall Study|Adverse event before starting treatment|0|||
148930092|NCT00089284|537230195|FG005|Overall Study|Adverse event before starting treatment|0|||
148930093|NCT00089284|537230196|FG006|Overall Study|Adverse event before starting treatment|1|||
148930094|NCT03956056|537230197|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
148930095|NCT03956056|537230197|FG000|Overall Study|Lack of Efficacy|1|||
148930096|NCT01298531|537230201|FG000|Overall Study|Lack of Efficacy|0|||
148930097|NCT01298531|537230202|FG001|Overall Study|Lack of Efficacy|1|||
148930098|NCT01298531|537230201|FG000|Overall Study|Lost to Follow-up|2|||
149176787|NCT01943539|538122094|FG001|Overall Study|Non-compliance with at-home intervention|0|||
149176788|NCT03715465|538122099|FG000|Overall Study|Withdrawal by Subject|1|||
148678995|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
148930099|NCT01298531|537230202|FG001|Overall Study|Lost to Follow-up|0|||
148930100|NCT01298531|537230201|FG000|Overall Study|Protocol Violation|1|||
148930101|NCT01298531|537230202|FG001|Overall Study|Protocol Violation|1|||
148930102|NCT01298531|537230201|FG000|Overall Study|Adverse Event|4|||
149176789|NCT03715465|538122100|FG001|Overall Study|Withdrawal by Subject|2|||
149176790|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
149176791|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
149176792|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
149176793|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
149176794|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
149176795|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
149176796|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
148678996|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
148678997|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
149176797|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
149176798|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
149176799|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
149176800|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
149176801|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
149176802|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
149176803|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
149176804|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
149176805|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
149176806|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
149176807|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
149176808|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Death|0|||
149176809|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Death|1|||
149176810|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Death|0|||
149176811|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
149176812|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
149176813|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
149176814|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
149176815|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
149176816|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
149176817|NCT00430781|538122101|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
149176818|NCT00430781|538122102|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
149176819|NCT00430781|538122103|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
149176820|NCT00430781|538122101|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
149176821|NCT00430781|538122102|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
149176822|NCT00430781|538122103|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
149176823|NCT00430781|538122101|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
149176824|NCT00430781|538122102|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
149176825|NCT00430781|538122103|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
149176826|NCT00430781|538122101|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
149176827|NCT00430781|538122102|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
149176828|NCT00430781|538122103|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
149176829|NCT00430781|538122101|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
149176830|NCT00430781|538122102|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
149176831|NCT00430781|538122103|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
149176832|NCT00430781|538122101|FG000|Final Analysis; 31 July 2008|Other|0|||
149176833|NCT00430781|538122102|FG001|Final Analysis; 31 July 2008|Other|1|||
149176834|NCT00430781|538122103|FG002|Final Analysis; 31 July 2008|Other|0|||
149176835|NCT00430781|538122101|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
149176836|NCT00430781|538122102|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
149176837|NCT00430781|538122103|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
149176838|NCT00430781|538122101|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
149176839|NCT00430781|538122102|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
149176840|NCT00430781|538122103|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
149176841|NCT00430781|538122101|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
149176842|NCT00430781|538122102|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
149176843|NCT00430781|538122103|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
149176844|NCT00430781|538122101|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
149176845|NCT00430781|538122102|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
149176846|NCT00430781|538122103|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
149176847|NCT00430781|538122101|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
149176848|NCT00430781|538122102|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
149176849|NCT00430781|538122103|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
149176850|NCT00430781|538122101|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
149176851|NCT00430781|538122102|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
149176852|NCT00430781|538122103|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
149176853|NCT00430781|538122101|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
149176854|NCT00430781|538122102|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
149176855|NCT00430781|538122103|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
148930103|NCT01298531|537230202|FG001|Overall Study|Adverse Event|3|||
149176856|NCT05408858|538122106|FG000|Overall Study|no longer met eligibility criteria|1|||
149176857|NCT02158533|538122108|FG000|Stage 1|Adverse Event|6|||
149176858|NCT02158533|538122109|FG001|Stage 1|Adverse Event|4|||
149176859|NCT02158533|538122110|FG002|Stage 1|Adverse Event|7|||
149176860|NCT02158533|538122111|FG003|Stage 1|Adverse Event|0|||
149176861|NCT02158533|538122112|FG004|Stage 1|Adverse Event|0|||
149176862|NCT02158533|538122113|FG005|Stage 1|Adverse Event|0|||
149176863|NCT02158533|538122108|FG000|Stage 1|Withdrawal by Subject|3|||
149176864|NCT02158533|538122109|FG001|Stage 1|Withdrawal by Subject|2|||
149176865|NCT02158533|538122110|FG002|Stage 1|Withdrawal by Subject|1|||
149176866|NCT02158533|538122111|FG003|Stage 1|Withdrawal by Subject|0|||
149176867|NCT02158533|538122112|FG004|Stage 1|Withdrawal by Subject|0|||
149176868|NCT02158533|538122113|FG005|Stage 1|Withdrawal by Subject|0|||
149176869|NCT02158533|538122108|FG000|Stage 1|Lack of Efficacy|1|||
149176870|NCT02158533|538122109|FG001|Stage 1|Lack of Efficacy|0|||
149176871|NCT02158533|538122110|FG002|Stage 1|Lack of Efficacy|0|||
149176872|NCT02158533|538122111|FG003|Stage 1|Lack of Efficacy|0|||
149176873|NCT02158533|538122112|FG004|Stage 1|Lack of Efficacy|0|||
149176874|NCT02158533|538122113|FG005|Stage 1|Lack of Efficacy|0|||
149176875|NCT02158533|538122108|FG000|Stage 1|Lost to Follow-up|3|||
149176876|NCT02158533|538122109|FG001|Stage 1|Lost to Follow-up|1|||
149176877|NCT02158533|538122110|FG002|Stage 1|Lost to Follow-up|0|||
149176878|NCT02158533|538122111|FG003|Stage 1|Lost to Follow-up|0|||
149176879|NCT02158533|538122112|FG004|Stage 1|Lost to Follow-up|0|||
149176880|NCT02158533|538122113|FG005|Stage 1|Lost to Follow-up|0|||
149176881|NCT02158533|538122108|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
149176882|NCT02158533|538122109|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
149176883|NCT02158533|538122110|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
149176884|NCT02158533|538122111|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
149176885|NCT02158533|538122112|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
149176886|NCT02158533|538122113|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
149176887|NCT02158533|538122108|FG000|Stage 1|Non-compliance with study visits|1|||
149176888|NCT02158533|538122109|FG001|Stage 1|Non-compliance with study visits|0|||
149176889|NCT02158533|538122110|FG002|Stage 1|Non-compliance with study visits|0|||
149176890|NCT02158533|538122111|FG003|Stage 1|Non-compliance with study visits|0|||
149176891|NCT02158533|538122112|FG004|Stage 1|Non-compliance with study visits|0|||
149176892|NCT02158533|538122113|FG005|Stage 1|Non-compliance with study visits|0|||
149176893|NCT02158533|538122108|FG000|Stage 2|Adverse Event|0|||
149176894|NCT02158533|538122109|FG001|Stage 2|Adverse Event|0|||
149176895|NCT02158533|538122110|FG002|Stage 2|Adverse Event|0|||
149176896|NCT02158533|538122111|FG003|Stage 2|Adverse Event|0|||
149176897|NCT02158533|538122112|FG004|Stage 2|Adverse Event|0|||
149176898|NCT02158533|538122113|FG005|Stage 2|Adverse Event|1|||
149176899|NCT02158533|538122108|FG000|Stage 2|Lack of Efficacy|0|||
149176900|NCT02158533|538122109|FG001|Stage 2|Lack of Efficacy|0|||
149176901|NCT02158533|538122110|FG002|Stage 2|Lack of Efficacy|0|||
149176902|NCT02158533|538122111|FG003|Stage 2|Lack of Efficacy|0|||
149176903|NCT02158533|538122112|FG004|Stage 2|Lack of Efficacy|1|||
149176904|NCT02158533|538122113|FG005|Stage 2|Lack of Efficacy|0|||
149176905|NCT02158533|538122108|FG000|Stage 2|Lost to Follow-up|0|||
149176906|NCT02158533|538122109|FG001|Stage 2|Lost to Follow-up|0|||
149013417|NCT03679767|537527936|FG002|Overall Study|Entered Hospice Care|0|||
149013418|NCT03679767|537527937|FG003|Overall Study|Entered Hospice Care|1|||
149176907|NCT02158533|538122110|FG002|Stage 2|Lost to Follow-up|0|||
149176908|NCT02158533|538122111|FG003|Stage 2|Lost to Follow-up|1|||
149176909|NCT02158533|538122112|FG004|Stage 2|Lost to Follow-up|1|||
149176910|NCT02158533|538122113|FG005|Stage 2|Lost to Follow-up|2|||
149176911|NCT02158533|538122108|FG000|Stage 2|Withdrawal by Subject|0|||
149176912|NCT02158533|538122109|FG001|Stage 2|Withdrawal by Subject|0|||
149176913|NCT02158533|538122110|FG002|Stage 2|Withdrawal by Subject|0|||
149176914|NCT02158533|538122111|FG003|Stage 2|Withdrawal by Subject|0|||
149176915|NCT02158533|538122112|FG004|Stage 2|Withdrawal by Subject|1|||
149176916|NCT02158533|538122113|FG005|Stage 2|Withdrawal by Subject|2|||
149176917|NCT02158533|538122108|FG000|Stage 2|Physician Decision|0|||
149176918|NCT02158533|538122109|FG001|Stage 2|Physician Decision|0|||
149176919|NCT02158533|538122110|FG002|Stage 2|Physician Decision|0|||
149176920|NCT02158533|538122111|FG003|Stage 2|Physician Decision|0|||
149013419|NCT03679767|537527934|FG000|Overall Study|Progressive Disease|0|||
149176921|NCT02158533|538122112|FG004|Stage 2|Physician Decision|1|||
149176922|NCT02158533|538122113|FG005|Stage 2|Physician Decision|0|||
149176923|NCT02158533|538122108|FG000|Stage 2|Pregnancy|0|||
149176924|NCT02158533|538122109|FG001|Stage 2|Pregnancy|0|||
149176925|NCT02158533|538122110|FG002|Stage 2|Pregnancy|0|||
149176926|NCT02158533|538122111|FG003|Stage 2|Pregnancy|1|||
149176927|NCT02158533|538122112|FG004|Stage 2|Pregnancy|0|||
149176928|NCT02158533|538122113|FG005|Stage 2|Pregnancy|0|||
149176929|NCT02158533|538122108|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
149176930|NCT02158533|538122109|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
149176931|NCT02158533|538122110|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
149176932|NCT02158533|538122111|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
149176933|NCT02158533|538122112|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
149176934|NCT02158533|538122113|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
149176935|NCT02158533|538122108|FG000|Stage 2|Non-adherence with study visits|0|||
149176936|NCT02158533|538122109|FG001|Stage 2|Non-adherence with study visits|0|||
149176937|NCT02158533|538122110|FG002|Stage 2|Non-adherence with study visits|0|||
149176938|NCT02158533|538122111|FG003|Stage 2|Non-adherence with study visits|0|||
149176939|NCT02158533|538122112|FG004|Stage 2|Non-adherence with study visits|0|||
149176940|NCT02158533|538122113|FG005|Stage 2|Non-adherence with study visits|1|||
149176941|NCT00384956|538122116|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
149176942|NCT03126227|538122119|FG000|Overall Study|Adverse Event|43|||
149176943|NCT03126227|538122120|FG001|Overall Study|Adverse Event|4|||
149176944|NCT03126227|538122119|FG000|Overall Study|Death|0|||
149176945|NCT03126227|538122120|FG001|Overall Study|Death|1|||
149176946|NCT03126227|538122119|FG000|Overall Study|Lost to Follow-up|0|||
149176947|NCT03126227|538122120|FG001|Overall Study|Lost to Follow-up|1|||
149176948|NCT03126227|538122119|FG000|Overall Study|Physician Decision|2|||
148678998|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
148678999|NCT04440163|536299032|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
148679000|NCT04440163|536299033|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
148679001|NCT04440163|536299034|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
148679002|NCT04440163|536299035|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
148679003|NCT04440163|536299036|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
148679004|NCT04440163|536299037|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
148679005|NCT04440163|536299038|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
148679006|NCT04440163|536299039|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
148679007|NCT04440163|536299032|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
148679008|NCT04440163|536299033|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
148679009|NCT04440163|536299034|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
148679010|NCT04440163|536299035|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
148679011|NCT04440163|536299036|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
148679012|NCT04440163|536299037|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
148679013|NCT04440163|536299038|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
148679014|NCT04440163|536299039|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
148679015|NCT04440163|536299032|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
148679016|NCT04440163|536299033|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
148679017|NCT04440163|536299034|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
148679018|NCT04440163|536299035|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
148679019|NCT04440163|536299036|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149176949|NCT03126227|538122120|FG001|Overall Study|Physician Decision|0|||
149176950|NCT03126227|538122119|FG000|Overall Study|Protocol Violation|1|||
149176951|NCT03126227|538122120|FG001|Overall Study|Protocol Violation|0|||
149176952|NCT03126227|538122119|FG000|Overall Study|Withdrawal by Subject|19|||
149176953|NCT03126227|538122120|FG001|Overall Study|Withdrawal by Subject|3|||
149176954|NCT03126227|538122119|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
149176955|NCT03126227|538122120|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
149176956|NCT03126227|538122119|FG000|Overall Study|Lack of dosing compliance|2|||
149176957|NCT03126227|538122120|FG001|Overall Study|Lack of dosing compliance|0|||
149176958|NCT03126227|538122119|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
149176959|NCT03126227|538122120|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
149176960|NCT03126227|538122119|FG000|Overall Study|Scheduling conflict|1|||
149176961|NCT03126227|538122120|FG001|Overall Study|Scheduling conflict|0|||
149176962|NCT01575548|538122125|FG000|Overall Study|Adverse Event|15|||
149176963|NCT01575548|538122126|FG001|Overall Study|Adverse Event|2|||
149176964|NCT01575548|538122125|FG000|Overall Study|Disease progression|12|||
149176965|NCT01575548|538122126|FG001|Overall Study|Disease progression|25|||
149176966|NCT01575548|538122125|FG000|Overall Study|Death|1|||
149176967|NCT01575548|538122126|FG001|Overall Study|Death|0|||
149176968|NCT01575548|538122125|FG000|Overall Study|Other complicating disease|1|||
149176969|NCT01575548|538122126|FG001|Overall Study|Other complicating disease|0|||
149176970|NCT01575548|538122125|FG000|Overall Study|Withdrawal by Subject|7|||
149176971|NCT01575548|538122126|FG001|Overall Study|Withdrawal by Subject|3|||
149176972|NCT01575548|538122125|FG000|Overall Study|Noncompliance|1|||
149176973|NCT01575548|538122126|FG001|Overall Study|Noncompliance|0|||
149176974|NCT01575548|538122125|FG000|Overall Study|Anticipated surgery|0|||
149176975|NCT01575548|538122126|FG001|Overall Study|Anticipated surgery|1|||
149176976|NCT01575548|538122125|FG000|Overall Study|Never started protocol therapy|3|||
149176977|NCT01575548|538122126|FG001|Overall Study|Never started protocol therapy|2|||
149176978|NCT03230097|538122129|FG000|Overall Study|Adverse Event|2|||
149176979|NCT03230097|538122130|FG001|Overall Study|Adverse Event|1|||
149176980|NCT03230097|538122129|FG000|Overall Study|non-compliance|0|||
149176981|NCT03230097|538122130|FG001|Overall Study|non-compliance|1|||
149176982|NCT03230097|538122129|FG000|Overall Study|Lost to Follow-up|2|||
149176983|NCT03230097|538122130|FG001|Overall Study|Lost to Follow-up|4|||
148806921|NCT00471497|536771067|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
148806922|NCT00471497|536771065|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
148806923|NCT00471497|536771066|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
148806924|NCT00471497|536771067|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
149176984|NCT03230097|538122129|FG000|Overall Study|Withdrawal by Subject|7|||
148806925|NCT00471497|536771065|FG000|Core Treatment Phase|Lost to Follow-up|6|||
149176985|NCT03230097|538122130|FG001|Overall Study|Withdrawal by Subject|3|||
149176986|NCT03230097|538122129|FG000|Overall Study|Trial termination|4|||
149176987|NCT03230097|538122130|FG001|Overall Study|Trial termination|5|||
149176988|NCT03230097|538122129|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
149176989|NCT03230097|538122130|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
149176990|NCT03230097|538122129|FG000|Overall Study|outcome event|0|||
149176991|NCT03230097|538122130|FG001|Overall Study|outcome event|1|||
149176992|NCT00635102|538122139|FG000|Overall Study|Withdrawal by Subject|7|||
149176993|NCT00635102|538122140|FG001|Overall Study|Withdrawal by Subject|8|||
149176994|NCT00440401|538122142|FG000|Overall Study|Adverse Event|2|||
148806926|NCT00471497|536771066|FG001|Core Treatment Phase|Lost to Follow-up|6|||
148806927|NCT00471497|536771067|FG002|Core Treatment Phase|Lost to Follow-up|3|||
148806928|NCT00471497|536771065|FG000|Core Treatment Phase|Death|3|||
148806929|NCT00471497|536771066|FG001|Core Treatment Phase|Death|9|||
148806930|NCT00471497|536771067|FG002|Core Treatment Phase|Death|3|||
148806931|NCT00471497|536771065|FG000|Core Treatment Phase|Disease Progression|10|||
148806932|NCT00471497|536771066|FG001|Core Treatment Phase|Disease Progression|2|||
148806933|NCT00471497|536771067|FG002|Core Treatment Phase|Disease Progression|4|||
148806934|NCT00471497|536771065|FG000|Core Treatment Phase|Protocol Violation|6|||
148806935|NCT00471497|536771066|FG001|Core Treatment Phase|Protocol Violation|15|||
148806936|NCT00471497|536771067|FG002|Core Treatment Phase|Protocol Violation|11|||
148806937|NCT00471497|536771065|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
148806938|NCT00471497|536771066|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
148806939|NCT00471497|536771067|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
148806940|NCT00471497|536771065|FG000|Core Treatment Phase|Administrative problems|14|||
148806941|NCT00471497|536771066|FG001|Core Treatment Phase|Administrative problems|14|||
148806942|NCT00471497|536771067|FG002|Core Treatment Phase|Administrative problems|12|||
148806943|NCT00471497|536771065|FG000|Core Treatment Phase|Adverse Event|43|||
148930104|NCT01298531|537230201|FG000|Overall Study|Does not meet entrance criteria|0|||
148930105|NCT01298531|537230202|FG001|Overall Study|Does not meet entrance criteria|1|||
148930106|NCT01298531|537230201|FG000|Overall Study|Other|2|||
148930107|NCT01298531|537230202|FG001|Overall Study|Other|1|||
148930108|NCT01092507|537230203|FG000|Overall Study|Withdrawal by Subject|2|||
149176995|NCT00440401|538122143|FG001|Overall Study|Adverse Event|1|||
149176996|NCT00440401|538122142|FG000|Overall Study|Other|2|||
149176997|NCT00440401|538122143|FG001|Overall Study|Other|5|||
149176998|NCT01925703|538122144|FG000|Overall Study|Physician Decision|1|||
149176999|NCT01925703|538122144|FG000|Overall Study|Lost to Follow-up|2|||
149177000|NCT01925703|538122144|FG000|Overall Study|Discharge prior to full iron repletion|1|||
149177001|NCT01937312|538122145|FG000|Overall Study|Adverse Event|10|||
149177002|NCT01937312|538122146|FG001|Overall Study|Adverse Event|1|||
149177003|NCT01937312|538122145|FG000|Overall Study|Lack of Efficacy|0|||
148806944|NCT00471497|536771066|FG001|Core Treatment Phase|Adverse Event|53|||
148806945|NCT00471497|536771067|FG002|Core Treatment Phase|Adverse Event|89|||
148806946|NCT00471497|536771065|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
148806947|NCT00471497|536771066|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
149177004|NCT01937312|538122146|FG001|Overall Study|Lack of Efficacy|1|||
149177005|NCT01937312|538122145|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
148806948|NCT00471497|536771067|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
148806949|NCT00471497|536771065|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
148806950|NCT00471497|536771066|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
148806951|NCT00471497|536771067|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
148806952|NCT00471497|536771065|FG000|Extension Phase|Adverse Event|9|||
148806953|NCT00471497|536771066|FG001|Extension Phase|Adverse Event|5|||
148806954|NCT00471497|536771067|FG002|Extension Phase|Adverse Event|1|||
148806955|NCT00471497|536771065|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
148806956|NCT00471497|536771066|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
149177006|NCT01937312|538122146|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
148806957|NCT00471497|536771067|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
149177007|NCT00881205|538122148|FG000|Overall Study|Adverse Event|8|||
149177008|NCT00881205|538122149|FG001|Overall Study|Adverse Event|3|||
148930109|NCT01092507|537230204|FG001|Overall Study|Withdrawal by Subject|0|||
149177009|NCT00881205|538122148|FG000|Overall Study|Withdrawal by Subject|1|||
149177010|NCT00881205|538122149|FG001|Overall Study|Withdrawal by Subject|2|||
149177011|NCT00881205|538122148|FG000|Overall Study|Lost to Follow-up|0|||
148930110|NCT03646643|537230205|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
149177012|NCT00881205|538122149|FG001|Overall Study|Lost to Follow-up|1|||
149177013|NCT00881205|538122148|FG000|Overall Study|Administrative problems|1|||
149177014|NCT00881205|538122149|FG001|Overall Study|Administrative problems|1|||
149177015|NCT00881205|538122148|FG000|Overall Study|Condition no longer requires drug|1|||
149177016|NCT00881205|538122149|FG001|Overall Study|Condition no longer requires drug|0|||
149177017|NCT02498652|538122150|FG000|Overall Study|Protocol Violation|0|||
149177018|NCT02498652|538122151|FG001|Overall Study|Protocol Violation|1|||
149177019|NCT06129487|538122153|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
149177020|NCT06129487|538122154|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
149177021|NCT00847613|538122157|FG000|Overall Study|Ongoing at cut-off date|250|||
149177022|NCT00847613|538122158|FG001|Overall Study|Ongoing at cut-off date|265|||
149177023|NCT00847613|538122159|FG002|Overall Study|Ongoing at cut-off date|64|||
149177024|NCT00847613|538122160|FG003|Overall Study|Ongoing at cut-off date|64|||
149177025|NCT00847613|538122157|FG000|Overall Study|Death|1|||
149177026|NCT00847613|538122158|FG001|Overall Study|Death|1|||
149177027|NCT00847613|538122159|FG002|Overall Study|Death|0|||
149177028|NCT00847613|538122160|FG003|Overall Study|Death|0|||
149177029|NCT00847613|538122157|FG000|Overall Study|Adverse Event|36|||
149177030|NCT00847613|538122158|FG001|Overall Study|Adverse Event|26|||
149177031|NCT00847613|538122159|FG002|Overall Study|Adverse Event|5|||
149177032|NCT00847613|538122160|FG003|Overall Study|Adverse Event|6|||
149177033|NCT00847613|538122157|FG000|Overall Study|Lack of Efficacy|7|||
149177034|NCT00847613|538122158|FG001|Overall Study|Lack of Efficacy|3|||
149177035|NCT00847613|538122159|FG002|Overall Study|Lack of Efficacy|3|||
149177036|NCT00847613|538122160|FG003|Overall Study|Lack of Efficacy|1|||
149177037|NCT00847613|538122157|FG000|Overall Study|Study terminated by Sponsor|1|||
149177038|NCT00847613|538122158|FG001|Overall Study|Study terminated by Sponsor|0|||
149177039|NCT00847613|538122159|FG002|Overall Study|Study terminated by Sponsor|2|||
149177040|NCT00847613|538122160|FG003|Overall Study|Study terminated by Sponsor|1|||
149177041|NCT00847613|538122157|FG000|Overall Study|Lost to Follow-up|5|||
149177042|NCT00847613|538122158|FG001|Overall Study|Lost to Follow-up|0|||
149177043|NCT00847613|538122159|FG002|Overall Study|Lost to Follow-up|0|||
149177044|NCT00847613|538122160|FG003|Overall Study|Lost to Follow-up|3|||
149177045|NCT00847613|538122157|FG000|Overall Study|Protocol Violation|6|||
149177046|NCT00847613|538122158|FG001|Overall Study|Protocol Violation|6|||
149177047|NCT00847613|538122159|FG002|Overall Study|Protocol Violation|3|||
149177048|NCT00847613|538122160|FG003|Overall Study|Protocol Violation|1|||
149177049|NCT00847613|538122157|FG000|Overall Study|Pregnancy|1|||
149177050|NCT00847613|538122158|FG001|Overall Study|Pregnancy|1|||
149177051|NCT00847613|538122159|FG002|Overall Study|Pregnancy|0|||
149177052|NCT00847613|538122160|FG003|Overall Study|Pregnancy|0|||
149177053|NCT00847613|538122157|FG000|Overall Study|Site closure|1|||
149177054|NCT00847613|538122158|FG001|Overall Study|Site closure|0|||
149177055|NCT00847613|538122159|FG002|Overall Study|Site closure|0|||
149177056|NCT00847613|538122160|FG003|Overall Study|Site closure|1|||
149177057|NCT00847613|538122157|FG000|Overall Study|Withdrawal by Subject|8|||
149177058|NCT00847613|538122158|FG001|Overall Study|Withdrawal by Subject|11|||
149177059|NCT00847613|538122159|FG002|Overall Study|Withdrawal by Subject|2|||
149177060|NCT00847613|538122160|FG003|Overall Study|Withdrawal by Subject|2|||
149177061|NCT00847613|538122157|FG000|Overall Study|Participant moved|4|||
149177062|NCT00847613|538122158|FG001|Overall Study|Participant moved|1|||
149177063|NCT00847613|538122159|FG002|Overall Study|Participant moved|0|||
149177064|NCT00847613|538122160|FG003|Overall Study|Participant moved|0|||
149177065|NCT00847613|538122157|FG000|Overall Study|Sponsor request|0|||
149177066|NCT00847613|538122158|FG001|Overall Study|Sponsor request|1|||
149177067|NCT00847613|538122159|FG002|Overall Study|Sponsor request|0|||
149177068|NCT00847613|538122160|FG003|Overall Study|Sponsor request|0|||
149177069|NCT00847613|538122157|FG000|Overall Study|Randomized, but not treated|0|||
149177070|NCT00847613|538122158|FG001|Overall Study|Randomized, but not treated|3|||
149177071|NCT00847613|538122159|FG002|Overall Study|Randomized, but not treated|0|||
149177072|NCT00847613|538122160|FG003|Overall Study|Randomized, but not treated|0|||
149177073|NCT00847613|538122157|FG000|Overall Study|Other|1|||
149177074|NCT00847613|538122158|FG001|Overall Study|Other|1|||
149177075|NCT00847613|538122159|FG002|Overall Study|Other|2|||
149177076|NCT00847613|538122160|FG003|Overall Study|Other|0|||
149177077|NCT00587223|538122164|FG000|Overall Study|Adverse Event|1|||
149177078|NCT04332419|538122165|FG000|Overall Study|Withdrawal by Subject|1|||
149177079|NCT00519623|538122166|FG000|Overall Study|Adverse Event|1|||
149177080|NCT03819140|538122167|FG000|Overall Study|Lost to Follow-up|1|||
149177081|NCT03819140|538122168|FG001|Overall Study|Lost to Follow-up|2|||
149177082|NCT03819140|538122167|FG000|Overall Study|Withdrawal by Subject|3|||
149177083|NCT03819140|538122168|FG001|Overall Study|Withdrawal by Subject|2|||
149177084|NCT03819140|538122167|FG000|Overall Study|Adverse Event|0|||
149177085|NCT03819140|538122168|FG001|Overall Study|Adverse Event|1|||
149177086|NCT03819140|538122167|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
149177087|NCT03819140|538122168|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
149177088|NCT03819140|538122167|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
149177089|NCT03819140|538122168|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
149177090|NCT00658333|538122169|FG000|Overall Study|Adverse Event|2|||
149177091|NCT00658333|538122170|FG001|Overall Study|Adverse Event|1|||
149177092|NCT05755438|538122171|FG000|12-week DBVC Period|Adverse Event|4|||
149177093|NCT05755438|538122172|FG001|12-week DBVC Period|Adverse Event|1|||
149177094|NCT05755438|538122171|FG000|12-week DBVC Period|Physician Decision|1|||
149177095|NCT05755438|538122172|FG001|12-week DBVC Period|Physician Decision|1|||
149177096|NCT05755438|538122171|FG000|12-week DBVC Period|Protocol Violation|4|||
149177097|NCT05755438|538122172|FG001|12-week DBVC Period|Protocol Violation|2|||
149177098|NCT05755438|538122171|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
149177099|NCT05755438|538122172|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
149177100|NCT05755438|538122171|FG000|12-week DBVC Period|Sponsor Decision|1|||
149177101|NCT05755438|538122172|FG001|12-week DBVC Period|Sponsor Decision|0|||
149177102|NCT05755438|538122171|FG000|40-week OLE Period|Adverse Event|0|||
149177103|NCT05755438|538122172|FG001|40-week OLE Period|Adverse Event|2|||
149177104|NCT05755438|538122171|FG000|40-week OLE Period|Lack of Efficacy|1|||
149177105|NCT05755438|538122172|FG001|40-week OLE Period|Lack of Efficacy|1|||
149177106|NCT05755438|538122171|FG000|40-week OLE Period|Lost to Follow-up|1|||
149177107|NCT05755438|538122172|FG001|40-week OLE Period|Lost to Follow-up|0|||
149177108|NCT05755438|538122171|FG000|40-week OLE Period|Physician Decision|1|||
149177109|NCT05755438|538122172|FG001|40-week OLE Period|Physician Decision|1|||
149177110|NCT05755438|538122171|FG000|40-week OLE Period|Protocol Violation|1|||
149177111|NCT05755438|538122172|FG001|40-week OLE Period|Protocol Violation|1|||
149177112|NCT05755438|538122171|FG000|40-week OLE Period|Withdrawal by Subject|6|||
149177113|NCT05755438|538122172|FG001|40-week OLE Period|Withdrawal by Subject|6|||
149177114|NCT05755438|538122171|FG000|40-week OLE Period|Sponsor Decision|3|||
149177115|NCT05755438|538122172|FG001|40-week OLE Period|Sponsor Decision|0|||
149177116|NCT05755438|538122171|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
149177117|NCT05755438|538122172|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
149177118|NCT05755438|538122171|FG000|40-week OLE Period|Ongoing|46|||
149177119|NCT05755438|538122172|FG001|40-week OLE Period|Ongoing|58|||
149177120|NCT03914300|538122174|FG000|Overall Study|Adverse Event|1|||
149177121|NCT01548638|538122182|FG000|Overall Study|Protocol Violation|3|||
149177122|NCT01548638|538122182|FG000|Overall Study|Withdrawal by Subject|1|||
149177123|NCT05445843|538122183|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
149177124|NCT05445843|538122184|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
149177125|NCT05445843|538122183|FG000|Overall Study|Progressive disease|17|||
149177126|NCT05445843|538122184|FG001|Overall Study|Progressive disease|9|||
149177127|NCT05445843|538122183|FG000|Overall Study|Physician Decision|16|||
149177128|NCT05445843|538122184|FG001|Overall Study|Physician Decision|4|||
149177129|NCT05445843|538122183|FG000|Overall Study|Death|6|||
149177130|NCT05445843|538122184|FG001|Overall Study|Death|3|||
149177131|NCT05445843|538122183|FG000|Overall Study|Subject decision|6|||
149177132|NCT05445843|538122184|FG001|Overall Study|Subject decision|2|||
149177133|NCT05445843|538122183|FG000|Overall Study|Adverse Event|2|||
149177134|NCT05445843|538122184|FG001|Overall Study|Adverse Event|0|||
149177135|NCT04090164|538122197|FG000|Overall Study|incomplete data on file|245|||
149177136|NCT04090164|538122198|FG001|Overall Study|incomplete data on file|0|||
149177137|NCT02277444|538122200|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
149177138|NCT02277444|538122200|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
149177139|NCT02277444|538122200|FG000|Treatment Period (Week 0-52)|Other|1|||
149177140|NCT02277444|538122200|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
149177141|NCT02277444|538122200|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
149177142|NCT02277444|538122200|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
149177143|NCT02277444|538122200|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
149177144|NCT02277444|538122200|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
149177145|NCT02277444|538122200|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
149177146|NCT05278104|538122201|FG000|Overall Study|Not treated|1|||
149177147|NCT05278104|538122202|FG001|Overall Study|Not treated|0|||
149177148|NCT05278104|538122201|FG000|Overall Study|Adverse Event|2|||
149177149|NCT05278104|538122202|FG001|Overall Study|Adverse Event|1|||
149177150|NCT05278104|538122201|FG000|Overall Study|Exclusion criteria not met|1|||
149177151|NCT05278104|538122202|FG001|Overall Study|Exclusion criteria not met|0|||
149177152|NCT05781542|538123778|FG000|Overall Study|Lost to Follow-up|1|||
149177153|NCT05781542|538123779|FG001|Overall Study|Lost to Follow-up|0|||
149177154|NCT05781542|538123780|FG002|Overall Study|Lost to Follow-up|1|||
149177155|NCT03704051|538123787|FG000|Overall Study|Withdrawal by Subject|4|||
149177156|NCT03704051|538123788|FG001|Overall Study|Withdrawal by Subject|0|||
149177157|NCT02495077|538123789|FG000|Overall Study|Adverse Event|0|||
149177158|NCT02495077|538123790|FG001|Overall Study|Adverse Event|1|||
149177159|NCT02495077|538123791|FG002|Overall Study|Adverse Event|1|||
149177160|NCT02495077|538123792|FG003|Overall Study|Adverse Event|0|||
149177161|NCT02495077|538123789|FG000|Overall Study|Death|3|||
149177162|NCT02495077|538123790|FG001|Overall Study|Death|5|||
149177163|NCT02495077|538123791|FG002|Overall Study|Death|0|||
149177164|NCT02495077|538123792|FG003|Overall Study|Death|0|||
149177165|NCT02495077|538123789|FG000|Overall Study|Lost to Follow-up|6|||
149177166|NCT02495077|538123790|FG001|Overall Study|Lost to Follow-up|4|||
149177167|NCT02495077|538123791|FG002|Overall Study|Lost to Follow-up|0|||
149177168|NCT02495077|538123792|FG003|Overall Study|Lost to Follow-up|0|||
149177169|NCT02495077|538123789|FG000|Overall Study|Physician Decision|2|||
149177170|NCT02495077|538123790|FG001|Overall Study|Physician Decision|1|||
149177171|NCT02495077|538123791|FG002|Overall Study|Physician Decision|4|||
149177172|NCT02495077|538123792|FG003|Overall Study|Physician Decision|0|||
149177173|NCT02495077|538123789|FG000|Overall Study|Protocol Violation|0|||
149177174|NCT02495077|538123790|FG001|Overall Study|Protocol Violation|1|||
149177175|NCT02495077|538123791|FG002|Overall Study|Protocol Violation|0|||
149177176|NCT02495077|538123792|FG003|Overall Study|Protocol Violation|0|||
149177177|NCT02495077|538123789|FG000|Overall Study|Screen Failure|0|||
149177178|NCT02495077|538123790|FG001|Overall Study|Screen Failure|0|||
149177179|NCT02495077|538123791|FG002|Overall Study|Screen Failure|0|||
149177180|NCT02495077|538123792|FG003|Overall Study|Screen Failure|48|||
149177181|NCT02495077|538123789|FG000|Overall Study|Withdrawal by Subject|7|||
149177182|NCT02495077|538123790|FG001|Overall Study|Withdrawal by Subject|7|||
149177183|NCT02495077|538123791|FG002|Overall Study|Withdrawal by Subject|7|||
149177184|NCT02495077|538123792|FG003|Overall Study|Withdrawal by Subject|0|||
149177185|NCT02495077|538123789|FG000|Overall Study|Covid-19 research restrictions|1|||
149177186|NCT02495077|538123790|FG001|Overall Study|Covid-19 research restrictions|0|||
149177187|NCT02495077|538123791|FG002|Overall Study|Covid-19 research restrictions|0|||
149177188|NCT02495077|538123792|FG003|Overall Study|Covid-19 research restrictions|0|||
149177189|NCT02495077|538123789|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
149177190|NCT02495077|538123790|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
149177191|NCT02495077|538123791|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
149177192|NCT02495077|538123792|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
149177193|NCT02495077|538123789|FG000|Overall Study|Incarcerated|0|||
149177194|NCT02495077|538123790|FG001|Overall Study|Incarcerated|1|||
149177195|NCT02495077|538123791|FG002|Overall Study|Incarcerated|0|||
149177196|NCT02495077|538123792|FG003|Overall Study|Incarcerated|0|||
149177197|NCT02495077|538123789|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
149177198|NCT02495077|538123790|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
149177199|NCT02495077|538123791|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
149177200|NCT02495077|538123792|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
149177201|NCT02495077|538123789|FG000|Overall Study|Timing of transplant and randomization|0|||
149177202|NCT02495077|538123790|FG001|Overall Study|Timing of transplant and randomization|0|||
149177203|NCT02495077|538123791|FG002|Overall Study|Timing of transplant and randomization|5|||
149177204|NCT02495077|538123792|FG003|Overall Study|Timing of transplant and randomization|0|||
149177205|NCT02742649|538123793|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
148930111|NCT03646643|537230206|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
148930112|NCT03646643|537230205|FG000|Overall Study|Lost to Follow-up|0|||
148930113|NCT03646643|537230206|FG001|Overall Study|Lost to Follow-up|1|||
148930114|NCT05314478|537230209|FG000|Overall Study|Physician Decision|1|||
148930115|NCT02007512|537230210|FG000|Double Blind Treatment Period|Adverse Event|4|||
148930116|NCT02007512|537230211|FG001|Double Blind Treatment Period|Adverse Event|6|||
148930117|NCT02007512|537230212|FG002|Double Blind Treatment Period|Adverse Event|2|||
148930118|NCT02007512|537230213|FG003|Double Blind Treatment Period|Adverse Event|2|||
148930119|NCT02007512|537230210|FG000|Double Blind Treatment Period|Death|1|||
148930120|NCT02007512|537230211|FG001|Double Blind Treatment Period|Death|0|||
148930121|NCT02007512|537230212|FG002|Double Blind Treatment Period|Death|0|||
148930122|NCT02007512|537230213|FG003|Double Blind Treatment Period|Death|0|||
148930123|NCT02007512|537230210|FG000|Double Blind Treatment Period|Disease progression|51|||
148930124|NCT02007512|537230211|FG001|Double Blind Treatment Period|Disease progression|50|||
148930125|NCT02007512|537230212|FG002|Double Blind Treatment Period|Disease progression|57|||
148930126|NCT02007512|537230213|FG003|Double Blind Treatment Period|Disease progression|52|||
149177206|NCT02742649|538123794|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149177207|NCT02742649|538123795|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149177208|NCT02742649|538123796|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149177209|NCT02742649|538123797|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
149177210|NCT02742649|538123793|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149177211|NCT02742649|538123794|FG001|Double-Blind Treatment Period|Adverse Event|1|||
149177212|NCT02742649|538123795|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149177213|NCT02742649|538123796|FG003|Double-Blind Treatment Period|Adverse Event|0|||
149177214|NCT02742649|538123797|FG004|Double-Blind Treatment Period|Adverse Event|0|||
149177215|NCT02742649|538123793|FG000|Open-Label Period|Lost to Follow-up|0|||
149177216|NCT02742649|538123794|FG001|Open-Label Period|Lost to Follow-up|0|||
149177217|NCT02742649|538123795|FG002|Open-Label Period|Lost to Follow-up|0|||
149177218|NCT02742649|538123796|FG003|Open-Label Period|Lost to Follow-up|0|||
149177219|NCT02742649|538123797|FG004|Open-Label Period|Lost to Follow-up|1|||
149177220|NCT03167619|538123800|FG000|Overall Study|Death|11|||
149177221|NCT03167619|538123801|FG001|Overall Study|Death|8|||
149177222|NCT03167619|538123800|FG000|Overall Study|Withdrawal by Subject|1|||
149177223|NCT03167619|538123801|FG001|Overall Study|Withdrawal by Subject|2|||
149177224|NCT03167619|538123800|FG000|Overall Study|Physician Decision|0|||
149177225|NCT03167619|538123801|FG001|Overall Study|Physician Decision|1|||
149177226|NCT01335971|538123804|FG000|Overall Study|Withdrawal by Subject|1|||
149177227|NCT01335971|538123805|FG001|Overall Study|Withdrawal by Subject|0|||
149177228|NCT01335971|538123806|FG002|Overall Study|Withdrawal by Subject|0|||
149177229|NCT01335971|538123804|FG000|Overall Study|Did not complete bronchoscopy|1|||
149177230|NCT01335971|538123805|FG001|Overall Study|Did not complete bronchoscopy|1|||
149177231|NCT01335971|538123806|FG002|Overall Study|Did not complete bronchoscopy|1|||
149177232|NCT03056287|538123807|FG000|Overall Study|Withdrawal by Subject|0|||
149177233|NCT03056287|538123808|FG001|Overall Study|Withdrawal by Subject|1|||
149177234|NCT03056287|538123809|FG002|Overall Study|Withdrawal by Subject|0|||
149177235|NCT03056287|538123810|FG003|Overall Study|Withdrawal by Subject|0|||
149177236|NCT03056287|538123807|FG000|Overall Study|move out of area|0|||
149177237|NCT03056287|538123808|FG001|Overall Study|move out of area|0|||
149177238|NCT03056287|538123809|FG002|Overall Study|move out of area|1|||
149177239|NCT03056287|538123810|FG003|Overall Study|move out of area|1|||
149177240|NCT01938625|538123818|FG000|Overall Study|Withdrawal by Subject|0|||
149177241|NCT01938625|538123819|FG001|Overall Study|Withdrawal by Subject|1|||
149177242|NCT01938625|538123818|FG000|Overall Study|Adverse Event|0|||
149177243|NCT01938625|538123819|FG001|Overall Study|Adverse Event|1|||
149177244|NCT01486238|538123822|FG000|Overall Study|Death|0|||
149177245|NCT01486238|538123823|FG001|Overall Study|Death|2|||
149177246|NCT01486238|538123822|FG000|Overall Study|Withdrawal by Subject|2|||
149177247|NCT01486238|538123823|FG001|Overall Study|Withdrawal by Subject|1|||
149177248|NCT01486238|538123822|FG000|Overall Study|Lost to Follow-up|0|||
149013420|NCT03679767|537527935|FG001|Overall Study|Progressive Disease|0|||
149013421|NCT03679767|537527936|FG002|Overall Study|Progressive Disease|0|||
149013422|NCT03679767|537527937|FG003|Overall Study|Progressive Disease|1|||
149013423|NCT05408468|537527938|FG000|Overall Study|Lost to Follow-up|3|||
149013424|NCT05408468|537527939|FG001|Overall Study|Lost to Follow-up|1|||
149013425|NCT05408468|537527938|FG000|Overall Study|Physician Decision|1|||
149013426|NCT05408468|537527939|FG001|Overall Study|Physician Decision|0|||
149013427|NCT05408468|537527938|FG000|Overall Study|Overwhelmed by clinical situation|3|||
149013428|NCT05408468|537527939|FG001|Overall Study|Overwhelmed by clinical situation|0|||
149013429|NCT05408468|537527938|FG000|Overall Study|Personal illness precluding participation|1|||
149013430|NCT05408468|537527939|FG001|Overall Study|Personal illness precluding participation|0|||
149013431|NCT05408468|537527938|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
149013432|NCT05408468|537527939|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
149013433|NCT02781506|537529148|FG000|Overall Study|Adverse Event|5|||
149013434|NCT01340482|537529150|FG000|Overall Study|Adverse Event|2|||
149013435|NCT01340482|537529151|FG001|Overall Study|Adverse Event|0|||
149013436|NCT01340482|537529152|FG002|Overall Study|Adverse Event|0|||
149013437|NCT02593539|537529153|FG000|Overall Study|Adverse Event|1|||
149013438|NCT04424290|537529156|FG000|Overall Study|Not treated|0|||
149013439|NCT04424290|537529157|FG001|Overall Study|Not treated|0|||
149013440|NCT04424290|537529158|FG002|Overall Study|Not treated|1|||
149013441|NCT04424290|537529159|FG003|Overall Study|Not treated|0|||
149013442|NCT04424290|537529160|FG004|Overall Study|Not treated|1|||
149013443|NCT04424290|537529156|FG000|Overall Study|Adverse Event|0|||
149177249|NCT01486238|538123823|FG001|Overall Study|Lost to Follow-up|3|||
149177250|NCT01184989|538123826|FG000|Overall Study|Adverse Event|11|||
149177251|NCT01184989|538123826|FG000|Overall Study|Withdrawal by Subject|1|||
149177252|NCT01570491|538123827|FG000|Overall Study|Lost to Follow-up|3|||
149013444|NCT04424290|537529157|FG001|Overall Study|Adverse Event|0|||
149013445|NCT04424290|537529158|FG002|Overall Study|Adverse Event|0|||
149177253|NCT01570491|538123828|FG001|Overall Study|Lost to Follow-up|1|||
149177254|NCT01570491|538123827|FG000|Overall Study|treatment: not given or discontinued|2|||
149013446|NCT04424290|537529159|FG003|Overall Study|Adverse Event|2|||
149177255|NCT01570491|538123828|FG001|Overall Study|treatment: not given or discontinued|0|||
149177256|NCT05370157|538123829|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
149177257|NCT05370157|538123830|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
149177258|NCT05370157|538123829|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
149177259|NCT05370157|538123830|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
149177260|NCT01508676|538123831|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
148679020|NCT04440163|536299037|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
149013447|NCT04424290|537529160|FG004|Overall Study|Adverse Event|0|||
149013448|NCT04424290|537529156|FG000|Overall Study|Withdrawal by Subject|0|||
149177261|NCT01508676|538123832|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
149177262|NCT01508676|538123831|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
149177263|NCT01508676|538123832|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
149177264|NCT01508676|538123831|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
149177265|NCT01508676|538123832|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
149177266|NCT01508676|538123831|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
149177267|NCT01508676|538123832|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
149177268|NCT01508676|538123831|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
149177269|NCT01508676|538123832|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
149177270|NCT00754390|538123836|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
149177271|NCT00754390|538123836|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
149177272|NCT00754390|538123836|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
149177273|NCT00754390|538123836|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
149177274|NCT00845429|538123837|FG000|Overall Study|Protocol Violation|5|||
149177275|NCT00845429|538123838|FG001|Overall Study|Protocol Violation|4|||
149177276|NCT00845429|538123839|FG002|Overall Study|Protocol Violation|7|||
149177277|NCT00845429|538123837|FG000|Overall Study|Lost to Follow-up|7|||
149177278|NCT00845429|538123838|FG001|Overall Study|Lost to Follow-up|9|||
149177279|NCT00845429|538123839|FG002|Overall Study|Lost to Follow-up|10|||
149177280|NCT00845429|538123837|FG000|Overall Study|Withdrawal by Subject|2|||
149177281|NCT00845429|538123838|FG001|Overall Study|Withdrawal by Subject|2|||
149177282|NCT00845429|538123839|FG002|Overall Study|Withdrawal by Subject|2|||
149177283|NCT00845429|538123837|FG000|Overall Study|Serious adverse event|0|||
149177284|NCT00845429|538123838|FG001|Overall Study|Serious adverse event|0|||
149177285|NCT00845429|538123839|FG002|Overall Study|Serious adverse event|1|||
149177286|NCT00971321|538123840|FG000|Up to Month 7|Withdrawal by Subject|1|||
149177287|NCT00971321|538123841|FG001|Up to Month 7|Withdrawal by Subject|0|||
149177288|NCT00971321|538123840|FG000|Up to Month 7|Migrated/moved from study area|3|||
149177289|NCT00971321|538123841|FG001|Up to Month 7|Migrated/moved from study area|2|||
149177290|NCT00971321|538123840|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
149177291|NCT00971321|538123841|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
149177292|NCT00971321|538123840|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
149177293|NCT00971321|538123841|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
149177294|NCT00971321|538123840|FG000|Up to Month 11-12|Lost to Follow-up|1|||
149177295|NCT00971321|538123841|FG001|Up to Month 11-12|Lost to Follow-up|0|||
149177296|NCT04222725|538123842|FG000|Overall Study|Adverse Event|0|||
149177297|NCT04222725|538123843|FG001|Overall Study|Adverse Event|1|||
149177298|NCT04222725|538123844|FG002|Overall Study|Adverse Event|0|||
149177299|NCT04222725|538123845|FG003|Overall Study|Adverse Event|0|||
149177300|NCT03519178|538123846|FG000|PF-06873600 Treatment|Adverse Event|0|||
149177301|NCT03519178|538123847|FG001|PF-06873600 Treatment|Adverse Event|0|||
149177302|NCT03519178|538123848|FG002|PF-06873600 Treatment|Adverse Event|0|||
149177303|NCT03519178|538123849|FG003|PF-06873600 Treatment|Adverse Event|0|||
149177304|NCT03519178|538123850|FG004|PF-06873600 Treatment|Adverse Event|0|||
149177305|NCT03519178|538123851|FG005|PF-06873600 Treatment|Adverse Event|0|||
149177306|NCT03519178|538123852|FG006|PF-06873600 Treatment|Adverse Event|0|||
149177307|NCT03519178|538123853|FG007|PF-06873600 Treatment|Adverse Event|2|||
149177308|NCT03519178|538123854|FG008|PF-06873600 Treatment|Adverse Event|1|||
149177309|NCT03519178|538123855|FG009|PF-06873600 Treatment|Adverse Event|0|||
149177310|NCT03519178|538123856|FG010|PF-06873600 Treatment|Adverse Event|0|||
149177311|NCT03519178|538123857|FG011|PF-06873600 Treatment|Adverse Event|0|||
149177312|NCT03519178|538123858|FG012|PF-06873600 Treatment|Adverse Event|1|||
149177313|NCT03519178|538123859|FG013|PF-06873600 Treatment|Adverse Event|3|||
149177314|NCT03519178|538123860|FG014|PF-06873600 Treatment|Adverse Event|2|||
149177315|NCT03519178|538123846|FG000|PF-06873600 Treatment|Death|0|||
149177316|NCT03519178|538123847|FG001|PF-06873600 Treatment|Death|0|||
149177317|NCT03519178|538123848|FG002|PF-06873600 Treatment|Death|0|||
149177318|NCT03519178|538123849|FG003|PF-06873600 Treatment|Death|0|||
149177319|NCT03519178|538123850|FG004|PF-06873600 Treatment|Death|0|||
149177320|NCT03519178|538123851|FG005|PF-06873600 Treatment|Death|0|||
149177321|NCT03519178|538123852|FG006|PF-06873600 Treatment|Death|0|||
149177322|NCT03519178|538123853|FG007|PF-06873600 Treatment|Death|0|||
149177323|NCT03519178|538123854|FG008|PF-06873600 Treatment|Death|1|||
149177324|NCT03519178|538123855|FG009|PF-06873600 Treatment|Death|1|||
149177325|NCT03519178|538123856|FG010|PF-06873600 Treatment|Death|0|||
149177326|NCT03519178|538123857|FG011|PF-06873600 Treatment|Death|0|||
149177327|NCT03519178|538123858|FG012|PF-06873600 Treatment|Death|0|||
149177328|NCT03519178|538123859|FG013|PF-06873600 Treatment|Death|0|||
149177329|NCT03519178|538123860|FG014|PF-06873600 Treatment|Death|1|||
149177330|NCT03519178|538123846|FG000|PF-06873600 Treatment|Physician Decision|0|||
149177331|NCT03519178|538123847|FG001|PF-06873600 Treatment|Physician Decision|0|||
149177332|NCT03519178|538123848|FG002|PF-06873600 Treatment|Physician Decision|0|||
149177333|NCT03519178|538123849|FG003|PF-06873600 Treatment|Physician Decision|0|||
149177334|NCT03519178|538123850|FG004|PF-06873600 Treatment|Physician Decision|0|||
149177335|NCT03519178|538123851|FG005|PF-06873600 Treatment|Physician Decision|0|||
149177336|NCT03519178|538123852|FG006|PF-06873600 Treatment|Physician Decision|0|||
149177337|NCT03519178|538123853|FG007|PF-06873600 Treatment|Physician Decision|1|||
149177338|NCT03519178|538123854|FG008|PF-06873600 Treatment|Physician Decision|0|||
149177339|NCT03519178|538123855|FG009|PF-06873600 Treatment|Physician Decision|0|||
149177340|NCT03519178|538123856|FG010|PF-06873600 Treatment|Physician Decision|1|||
149177341|NCT03519178|538123857|FG011|PF-06873600 Treatment|Physician Decision|0|||
149177342|NCT03519178|538123858|FG012|PF-06873600 Treatment|Physician Decision|0|||
149177343|NCT03519178|538123859|FG013|PF-06873600 Treatment|Physician Decision|4|||
149177344|NCT03519178|538123860|FG014|PF-06873600 Treatment|Physician Decision|1|||
149177345|NCT03519178|538123846|FG000|PF-06873600 Treatment|Progressive disease|1|||
149177346|NCT03519178|538123847|FG001|PF-06873600 Treatment|Progressive disease|1|||
149177347|NCT03519178|538123848|FG002|PF-06873600 Treatment|Progressive disease|1|||
149177348|NCT03519178|538123849|FG003|PF-06873600 Treatment|Progressive disease|1|||
149177349|NCT03519178|538123850|FG004|PF-06873600 Treatment|Progressive disease|6|||
149177350|NCT03519178|538123851|FG005|PF-06873600 Treatment|Progressive disease|7|||
149177351|NCT03519178|538123852|FG006|PF-06873600 Treatment|Progressive disease|3|||
149177352|NCT03519178|538123853|FG007|PF-06873600 Treatment|Progressive disease|7|||
149177353|NCT03519178|538123854|FG008|PF-06873600 Treatment|Progressive disease|3|||
149177354|NCT03519178|538123855|FG009|PF-06873600 Treatment|Progressive disease|5|||
149177355|NCT03519178|538123856|FG010|PF-06873600 Treatment|Progressive disease|4|||
149177356|NCT03519178|538123857|FG011|PF-06873600 Treatment|Progressive disease|3|||
149177357|NCT03519178|538123858|FG012|PF-06873600 Treatment|Progressive disease|4|||
149177358|NCT03519178|538123859|FG013|PF-06873600 Treatment|Progressive disease|28|||
149177359|NCT03519178|538123860|FG014|PF-06873600 Treatment|Progressive disease|8|||
149177360|NCT03519178|538123846|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
149177361|NCT03519178|538123847|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
149177362|NCT03519178|538123848|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
149177363|NCT03519178|538123849|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
149177364|NCT03519178|538123850|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
149177365|NCT03519178|538123851|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
149177366|NCT03519178|538123852|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
149177367|NCT03519178|538123853|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
149177368|NCT03519178|538123854|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
149177369|NCT03519178|538123855|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
149177370|NCT03519178|538123856|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
149013449|NCT04424290|537529157|FG001|Overall Study|Withdrawal by Subject|0|||
149013450|NCT04424290|537529158|FG002|Overall Study|Withdrawal by Subject|0|||
149013451|NCT04424290|537529159|FG003|Overall Study|Withdrawal by Subject|0|||
149013452|NCT04424290|537529160|FG004|Overall Study|Withdrawal by Subject|1|||
149013453|NCT04424290|537529156|FG000|Overall Study|Other than listed|0|||
149013454|NCT04424290|537529157|FG001|Overall Study|Other than listed|0|||
149013455|NCT04424290|537529158|FG002|Overall Study|Other than listed|0|||
149013456|NCT04424290|537529159|FG003|Overall Study|Other than listed|1|||
149013457|NCT04424290|537529160|FG004|Overall Study|Other than listed|0|||
149013458|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
149013459|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
149013460|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
149013461|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
149013462|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
149013463|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
149013464|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Death|0|||
149013465|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Death|1|||
149013466|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Adverse Event|11|||
149013467|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Adverse Event|11|||
149013468|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
149013469|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
149013470|NCT02936037|537529161|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149013471|NCT02936037|537529162|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149177371|NCT03519178|538123857|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
149177372|NCT03519178|538123858|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
149177373|NCT03519178|538123859|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
149177374|NCT03519178|538123860|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
149177375|NCT03519178|538123846|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
149177376|NCT03519178|538123847|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
149177377|NCT03519178|538123848|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
149177378|NCT03519178|538123849|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
149177379|NCT03519178|538123850|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
149177380|NCT03519178|538123851|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
149177381|NCT03519178|538123852|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
149177382|NCT03519178|538123853|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
149177383|NCT03519178|538123854|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
149013472|NCT02936037|537529161|FG000|Open Label Extension|Adverse Event|0|||
149013473|NCT02936037|537529162|FG001|Open Label Extension|Adverse Event|3|||
149177384|NCT03519178|538123855|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
149177385|NCT03519178|538123856|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
149177386|NCT03519178|538123857|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
149177387|NCT03519178|538123858|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
149177388|NCT03519178|538123859|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
149177389|NCT03519178|538123860|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
149177390|NCT03519178|538123846|FG000|PF-06873600 Treatment|Refused further treatment|0|||
149177391|NCT03519178|538123847|FG001|PF-06873600 Treatment|Refused further treatment|1|||
149177392|NCT03519178|538123848|FG002|PF-06873600 Treatment|Refused further treatment|0|||
149177393|NCT03519178|538123849|FG003|PF-06873600 Treatment|Refused further treatment|0|||
149177394|NCT03519178|538123850|FG004|PF-06873600 Treatment|Refused further treatment|1|||
149177395|NCT03519178|538123851|FG005|PF-06873600 Treatment|Refused further treatment|0|||
149177396|NCT03519178|538123852|FG006|PF-06873600 Treatment|Refused further treatment|0|||
149177397|NCT03519178|538123853|FG007|PF-06873600 Treatment|Refused further treatment|0|||
149177398|NCT03519178|538123854|FG008|PF-06873600 Treatment|Refused further treatment|0|||
149177399|NCT03519178|538123855|FG009|PF-06873600 Treatment|Refused further treatment|0|||
149177400|NCT03519178|538123856|FG010|PF-06873600 Treatment|Refused further treatment|0|||
149177401|NCT03519178|538123857|FG011|PF-06873600 Treatment|Refused further treatment|0|||
149177402|NCT03519178|538123858|FG012|PF-06873600 Treatment|Refused further treatment|0|||
149177403|NCT03519178|538123859|FG013|PF-06873600 Treatment|Refused further treatment|0|||
149177404|NCT03519178|538123860|FG014|PF-06873600 Treatment|Refused further treatment|1|||
149177405|NCT03519178|538123846|FG000|PF-06873600 Treatment|Other|0|||
149177406|NCT03519178|538123847|FG001|PF-06873600 Treatment|Other|0|||
149177407|NCT03519178|538123848|FG002|PF-06873600 Treatment|Other|0|||
149177408|NCT03519178|538123849|FG003|PF-06873600 Treatment|Other|0|||
149177409|NCT03519178|538123850|FG004|PF-06873600 Treatment|Other|0|||
149177410|NCT03519178|538123851|FG005|PF-06873600 Treatment|Other|0|||
149177411|NCT03519178|538123852|FG006|PF-06873600 Treatment|Other|0|||
149177412|NCT03519178|538123853|FG007|PF-06873600 Treatment|Other|0|||
149177413|NCT03519178|538123854|FG008|PF-06873600 Treatment|Other|1|||
149177414|NCT03519178|538123855|FG009|PF-06873600 Treatment|Other|0|||
149177415|NCT03519178|538123856|FG010|PF-06873600 Treatment|Other|0|||
149177416|NCT03519178|538123857|FG011|PF-06873600 Treatment|Other|0|||
149177417|NCT03519178|538123858|FG012|PF-06873600 Treatment|Other|0|||
149177418|NCT03519178|538123859|FG013|PF-06873600 Treatment|Other|1|||
149177419|NCT03519178|538123860|FG014|PF-06873600 Treatment|Other|3|||
149177420|NCT03519178|538123846|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
149177421|NCT03519178|538123847|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
149177422|NCT03519178|538123848|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
149177423|NCT03519178|538123849|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
149177424|NCT03519178|538123850|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
149177425|NCT03519178|538123851|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
149177426|NCT03519178|538123852|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
149177427|NCT03519178|538123853|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
149177428|NCT03519178|538123854|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
149177429|NCT03519178|538123855|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
149177430|NCT03519178|538123856|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
149177431|NCT03519178|538123857|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
149177432|NCT03519178|538123858|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
149177433|NCT03519178|538123859|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
149177434|NCT03519178|538123860|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
149177435|NCT03519178|538123846|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177436|NCT03519178|538123847|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177437|NCT03519178|538123848|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177438|NCT03519178|538123849|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177439|NCT03519178|538123850|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177440|NCT03519178|538123851|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177441|NCT03519178|538123852|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177442|NCT03519178|538123853|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177443|NCT03519178|538123854|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177444|NCT03519178|538123855|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177445|NCT03519178|538123856|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177446|NCT03519178|538123857|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177447|NCT03519178|538123858|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
149177448|NCT03519178|538123859|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
149177449|NCT03519178|538123860|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
149177450|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Adverse Event|0|||
149177451|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Adverse Event|0|||
149177452|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Adverse Event|0|||
149177453|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Adverse Event|0|||
149177454|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Adverse Event|0|||
149177455|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Adverse Event|0|||
149177456|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Adverse Event|0|||
149177457|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Adverse Event|0|||
149177458|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Adverse Event|0|||
149177459|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Adverse Event|0|||
149177460|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Adverse Event|0|||
149177461|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Adverse Event|0|||
149177462|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Adverse Event|0|||
149177463|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Adverse Event|1|||
149177464|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Adverse Event|0|||
149177465|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Death|0|||
149177466|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Death|0|||
149177467|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Death|0|||
149177468|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Death|0|||
149177469|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Death|0|||
149177470|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Death|0|||
149177471|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Death|0|||
149177472|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Death|0|||
149177473|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Death|0|||
149177474|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Death|1|||
149177475|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Death|0|||
149177476|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Death|0|||
149177477|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Death|0|||
149177478|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Death|0|||
149177479|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Death|1|||
149177480|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177481|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177482|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177483|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177484|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177485|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177486|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177487|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177488|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177489|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177490|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177491|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177492|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177493|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
149177494|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
149177495|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Physician Decision|0|||
149177496|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Physician Decision|0|||
149177497|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Physician Decision|0|||
149177498|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Physician Decision|0|||
149177499|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Physician Decision|0|||
149177500|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Physician Decision|0|||
149177501|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Physician Decision|0|||
149177502|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Physician Decision|0|||
149177503|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Physician Decision|0|||
149177504|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Physician Decision|0|||
149177505|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Physician Decision|0|||
149177506|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Physician Decision|0|||
149177507|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Physician Decision|0|||
149177508|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Physician Decision|4|||
149177509|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Physician Decision|2|||
149177510|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Progressive disease|0|||
149177511|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Progressive disease|0|||
149177512|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Progressive disease|0|||
149177513|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Progressive disease|0|||
149177514|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Progressive disease|0|||
149177515|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Progressive disease|0|||
149177516|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Progressive disease|0|||
149177517|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Progressive disease|0|||
149177518|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Progressive disease|0|||
149177519|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Progressive disease|5|||
149177520|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Progressive disease|0|||
149177521|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Progressive disease|0|||
149177522|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Progressive disease|0|||
149177523|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Progressive disease|30|||
149177524|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Progressive disease|8|||
149177525|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177526|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177527|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177528|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177529|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177530|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177531|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177532|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177533|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177534|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177535|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177536|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177537|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
149177538|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
149177539|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
149177540|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177541|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177542|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177543|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177544|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177545|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177546|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177547|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177548|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177549|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
149177550|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177551|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177552|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
149177553|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
149177554|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
149177555|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177556|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177557|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177558|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177559|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177560|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177561|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177562|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177563|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177564|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
149177565|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177566|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177567|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177568|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
149177569|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
149177570|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
149177571|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
149177572|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
148679021|NCT04440163|536299038|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
148679022|NCT04440163|536299039|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
148679023|NCT03451331|536299044|FG000|Overall Study|Withdrawal by Subject|1|||
148679024|NCT03451331|536299045|FG001|Overall Study|Withdrawal by Subject|0|||
148679025|NCT03451331|536299044|FG000|Overall Study|Unable to start treatment.|1|||
148679026|NCT03451331|536299045|FG001|Overall Study|Unable to start treatment.|1|||
148679027|NCT00289731|536299046|FG000|Overall Study|Adverse Event|1|||
148679028|NCT00289731|536299047|FG001|Overall Study|Adverse Event|2|||
148679029|NCT00289731|536299048|FG002|Overall Study|Adverse Event|2|||
148679030|NCT00289731|536299046|FG000|Overall Study|Other|1|||
148679031|NCT00289731|536299047|FG001|Overall Study|Other|0|||
149177573|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
149177574|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
149177575|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
149177576|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
149177577|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
149177578|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
149177579|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
149177580|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
149177581|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
149177582|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
149177583|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
149177584|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
149177585|NCT03519178|538123846|FG000|Fulvestrant. Treatment|Other|0|||
149177586|NCT03519178|538123847|FG001|Fulvestrant. Treatment|Other|0|||
149177587|NCT03519178|538123848|FG002|Fulvestrant. Treatment|Other|0|||
149177588|NCT03519178|538123849|FG003|Fulvestrant. Treatment|Other|0|||
149177589|NCT03519178|538123850|FG004|Fulvestrant. Treatment|Other|0|||
149177590|NCT03519178|538123851|FG005|Fulvestrant. Treatment|Other|0|||
149177591|NCT03519178|538123852|FG006|Fulvestrant. Treatment|Other|0|||
149177592|NCT03519178|538123853|FG007|Fulvestrant. Treatment|Other|0|||
149177593|NCT03519178|538123854|FG008|Fulvestrant. Treatment|Other|0|||
149177594|NCT03519178|538123855|FG009|Fulvestrant. Treatment|Other|0|||
149177595|NCT03519178|538123856|FG010|Fulvestrant. Treatment|Other|0|||
149177596|NCT03519178|538123857|FG011|Fulvestrant. Treatment|Other|0|||
149177597|NCT03519178|538123858|FG012|Fulvestrant. Treatment|Other|0|||
149177598|NCT03519178|538123859|FG013|Fulvestrant. Treatment|Other|1|||
149177599|NCT03519178|538123860|FG014|Fulvestrant. Treatment|Other|3|||
149177600|NCT03519178|538123846|FG000|Letrozole Treatment|Physician Decision|0|||
149177601|NCT03519178|538123847|FG001|Letrozole Treatment|Physician Decision|0|||
149177602|NCT03519178|538123848|FG002|Letrozole Treatment|Physician Decision|0|||
149177603|NCT03519178|538123849|FG003|Letrozole Treatment|Physician Decision|0|||
149177604|NCT03519178|538123850|FG004|Letrozole Treatment|Physician Decision|0|||
149177605|NCT03519178|538123851|FG005|Letrozole Treatment|Physician Decision|0|||
149177606|NCT03519178|538123852|FG006|Letrozole Treatment|Physician Decision|0|||
149177607|NCT03519178|538123853|FG007|Letrozole Treatment|Physician Decision|0|||
149177608|NCT03519178|538123854|FG008|Letrozole Treatment|Physician Decision|0|||
149177609|NCT03519178|538123855|FG009|Letrozole Treatment|Physician Decision|0|||
149177610|NCT03519178|538123856|FG010|Letrozole Treatment|Physician Decision|1|||
149177611|NCT03519178|538123857|FG011|Letrozole Treatment|Physician Decision|0|||
149177612|NCT03519178|538123858|FG012|Letrozole Treatment|Physician Decision|0|||
149177613|NCT03519178|538123859|FG013|Letrozole Treatment|Physician Decision|0|||
149177614|NCT03519178|538123860|FG014|Letrozole Treatment|Physician Decision|0|||
149177615|NCT03519178|538123846|FG000|Letrozole Treatment|Progressive disease|0|||
149177616|NCT03519178|538123847|FG001|Letrozole Treatment|Progressive disease|0|||
149177617|NCT03519178|538123848|FG002|Letrozole Treatment|Progressive disease|0|||
149177618|NCT03519178|538123849|FG003|Letrozole Treatment|Progressive disease|0|||
149177619|NCT03519178|538123850|FG004|Letrozole Treatment|Progressive disease|0|||
149177620|NCT03519178|538123851|FG005|Letrozole Treatment|Progressive disease|0|||
149177621|NCT03519178|538123852|FG006|Letrozole Treatment|Progressive disease|0|||
149177622|NCT03519178|538123853|FG007|Letrozole Treatment|Progressive disease|0|||
149177623|NCT03519178|538123854|FG008|Letrozole Treatment|Progressive disease|0|||
149177624|NCT03519178|538123855|FG009|Letrozole Treatment|Progressive disease|0|||
149177625|NCT03519178|538123856|FG010|Letrozole Treatment|Progressive disease|4|||
149177626|NCT03519178|538123857|FG011|Letrozole Treatment|Progressive disease|0|||
149177627|NCT03519178|538123858|FG012|Letrozole Treatment|Progressive disease|0|||
149177628|NCT03519178|538123859|FG013|Letrozole Treatment|Progressive disease|0|||
149177629|NCT03519178|538123860|FG014|Letrozole Treatment|Progressive disease|0|||
149177630|NCT03519178|538123846|FG000|Letrozole Treatment|Global deterioration of health status|0|||
149177631|NCT03519178|538123847|FG001|Letrozole Treatment|Global deterioration of health status|0|||
149177632|NCT03519178|538123848|FG002|Letrozole Treatment|Global deterioration of health status|0|||
149177633|NCT03519178|538123849|FG003|Letrozole Treatment|Global deterioration of health status|0|||
149177634|NCT03519178|538123850|FG004|Letrozole Treatment|Global deterioration of health status|0|||
149177635|NCT03519178|538123851|FG005|Letrozole Treatment|Global deterioration of health status|0|||
149177636|NCT03519178|538123852|FG006|Letrozole Treatment|Global deterioration of health status|0|||
149177637|NCT03519178|538123853|FG007|Letrozole Treatment|Global deterioration of health status|0|||
149177638|NCT03519178|538123854|FG008|Letrozole Treatment|Global deterioration of health status|0|||
149177639|NCT03519178|538123855|FG009|Letrozole Treatment|Global deterioration of health status|0|||
149177640|NCT03519178|538123856|FG010|Letrozole Treatment|Global deterioration of health status|2|||
149177641|NCT03519178|538123857|FG011|Letrozole Treatment|Global deterioration of health status|0|||
149177642|NCT03519178|538123858|FG012|Letrozole Treatment|Global deterioration of health status|0|||
149177643|NCT03519178|538123859|FG013|Letrozole Treatment|Global deterioration of health status|0|||
149177644|NCT03519178|538123860|FG014|Letrozole Treatment|Global deterioration of health status|0|||
149177645|NCT03519178|538123846|FG000|Follow-Up|Death|0|||
149177646|NCT03519178|538123847|FG001|Follow-Up|Death|0|||
149177647|NCT03519178|538123848|FG002|Follow-Up|Death|0|||
149177648|NCT03519178|538123849|FG003|Follow-Up|Death|0|||
149177649|NCT03519178|538123850|FG004|Follow-Up|Death|0|||
149177650|NCT03519178|538123851|FG005|Follow-Up|Death|0|||
149177651|NCT03519178|538123852|FG006|Follow-Up|Death|0|||
149177652|NCT03519178|538123853|FG007|Follow-Up|Death|0|||
149177653|NCT03519178|538123854|FG008|Follow-Up|Death|3|||
149177654|NCT03519178|538123855|FG009|Follow-Up|Death|1|||
149177655|NCT03519178|538123856|FG010|Follow-Up|Death|0|||
149177656|NCT03519178|538123857|FG011|Follow-Up|Death|0|||
149177657|NCT03519178|538123858|FG012|Follow-Up|Death|2|||
149177658|NCT03519178|538123859|FG013|Follow-Up|Death|0|||
149177659|NCT03519178|538123860|FG014|Follow-Up|Death|0|||
149177660|NCT03519178|538123846|FG000|Follow-Up|Lost to Follow-up|0|||
148806958|NCT00471497|536771065|FG000|Extension Phase|Withdrawal by Subject|3|||
148806959|NCT00471497|536771066|FG001|Extension Phase|Withdrawal by Subject|1|||
148806960|NCT00471497|536771067|FG002|Extension Phase|Withdrawal by Subject|0|||
148806961|NCT00471497|536771065|FG000|Extension Phase|Lost to Follow-up|2|||
149177661|NCT03519178|538123847|FG001|Follow-Up|Lost to Follow-up|0|||
149177662|NCT03519178|538123848|FG002|Follow-Up|Lost to Follow-up|0|||
149177663|NCT03519178|538123849|FG003|Follow-Up|Lost to Follow-up|0|||
149177664|NCT03519178|538123850|FG004|Follow-Up|Lost to Follow-up|0|||
148806962|NCT00471497|536771066|FG001|Extension Phase|Lost to Follow-up|0|||
148806963|NCT00471497|536771067|FG002|Extension Phase|Lost to Follow-up|0|||
148806964|NCT00471497|536771065|FG000|Extension Phase|Death|1|||
148806965|NCT00471497|536771066|FG001|Extension Phase|Death|0|||
148806966|NCT00471497|536771067|FG002|Extension Phase|Death|0|||
148806967|NCT00471497|536771065|FG000|Extension Phase|Disease progression|2|||
148806968|NCT00471497|536771066|FG001|Extension Phase|Disease progression|0|||
148806969|NCT00471497|536771067|FG002|Extension Phase|Disease progression|0|||
148806970|NCT00471497|536771065|FG000|Extension Phase|Protocol Violation|2|||
148806971|NCT00471497|536771066|FG001|Extension Phase|Protocol Violation|2|||
148806972|NCT00471497|536771067|FG002|Extension Phase|Protocol Violation|0|||
148806973|NCT00392223|536771068|FG000|Overall Study|Adverse Event|5|||
148806974|NCT00392223|536771069|FG001|Overall Study|Adverse Event|4|||
148806975|NCT00392223|536771068|FG000|Overall Study|Lost to Follow-up|1|||
148806976|NCT00392223|536771069|FG001|Overall Study|Lost to Follow-up|4|||
148806977|NCT00392223|536771068|FG000|Overall Study|Protocol Violation|0|||
148806978|NCT00392223|536771069|FG001|Overall Study|Protocol Violation|3|||
148806979|NCT00392223|536771068|FG000|Overall Study|Withdrawal by Subject|3|||
148806980|NCT00392223|536771069|FG001|Overall Study|Withdrawal by Subject|2|||
148806981|NCT02814526|536771071|FG000|Overall Study|Adverse Event|4|||
148806982|NCT02814526|536771072|FG001|Overall Study|Adverse Event|3|||
148806983|NCT02814526|536771071|FG000|Overall Study|Death|1|||
148806984|NCT02814526|536771072|FG001|Overall Study|Death|1|||
148806985|NCT02814526|536771071|FG000|Overall Study|Lost to Follow-up|3|||
148806986|NCT02814526|536771072|FG001|Overall Study|Lost to Follow-up|4|||
148806987|NCT02814526|536771071|FG000|Overall Study|non site physician decision|1|||
148806988|NCT02814526|536771072|FG001|Overall Study|non site physician decision|0|||
148806989|NCT02814526|536771071|FG000|Overall Study|participant noncompliance|1|||
148806990|NCT02814526|536771072|FG001|Overall Study|participant noncompliance|1|||
148806991|NCT02814526|536771071|FG000|Overall Study|Withdrawal by Subject|20|||
148806992|NCT02814526|536771072|FG001|Overall Study|Withdrawal by Subject|14|||
148806993|NCT02814526|536771071|FG000|Overall Study|safety risk|2|||
148806994|NCT02814526|536771072|FG001|Overall Study|safety risk|1|||
148806995|NCT02814526|536771071|FG000|Overall Study|early termination-study terminated|1|||
148806996|NCT02814526|536771072|FG001|Overall Study|early termination-study terminated|2|||
148806997|NCT02814526|536771071|FG000|Overall Study|Other|0|||
148806998|NCT02814526|536771072|FG001|Overall Study|Other|4|||
148806999|NCT01420536|536771078|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
149177665|NCT03519178|538123851|FG005|Follow-Up|Lost to Follow-up|3|||
149177666|NCT03519178|538123852|FG006|Follow-Up|Lost to Follow-up|1|||
149177667|NCT03519178|538123853|FG007|Follow-Up|Lost to Follow-up|4|||
149177668|NCT03519178|538123854|FG008|Follow-Up|Lost to Follow-up|1|||
148807000|NCT01420536|536771079|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
148807001|NCT04711005|536771080|FG000|Overall Study|Withdrawal by Subject|0|||
148807002|NCT04711005|536771081|FG001|Overall Study|Withdrawal by Subject|0|||
148807003|NCT04711005|536771082|FG002|Overall Study|Withdrawal by Subject|0|||
148807004|NCT04711005|536771083|FG003|Overall Study|Withdrawal by Subject|0|||
149013474|NCT02936037|537529161|FG000|Open Label Extension|Other|0|||
149013475|NCT02936037|537529162|FG001|Open Label Extension|Other|3|||
149177669|NCT03519178|538123855|FG009|Follow-Up|Lost to Follow-up|0|||
149177670|NCT03519178|538123856|FG010|Follow-Up|Lost to Follow-up|0|||
149177671|NCT03519178|538123857|FG011|Follow-Up|Lost to Follow-up|0|||
149177672|NCT03519178|538123858|FG012|Follow-Up|Lost to Follow-up|0|||
148807005|NCT04711005|536771084|FG004|Overall Study|Withdrawal by Subject|0|||
148807006|NCT04711005|536771085|FG005|Overall Study|Withdrawal by Subject|0|||
148807007|NCT04711005|536771086|FG006|Overall Study|Withdrawal by Subject|0|||
149177673|NCT03519178|538123859|FG013|Follow-Up|Lost to Follow-up|0|||
149177674|NCT03519178|538123860|FG014|Follow-Up|Lost to Follow-up|0|||
149177675|NCT03519178|538123846|FG000|Follow-Up|Withdrawal by Subject|1|||
149177676|NCT03519178|538123847|FG001|Follow-Up|Withdrawal by Subject|2|||
149177677|NCT03519178|538123848|FG002|Follow-Up|Withdrawal by Subject|2|||
149177678|NCT03519178|538123849|FG003|Follow-Up|Withdrawal by Subject|3|||
149177679|NCT03519178|538123850|FG004|Follow-Up|Withdrawal by Subject|5|||
149177680|NCT03519178|538123851|FG005|Follow-Up|Withdrawal by Subject|1|||
149177681|NCT03519178|538123852|FG006|Follow-Up|Withdrawal by Subject|2|||
149177682|NCT03519178|538123853|FG007|Follow-Up|Withdrawal by Subject|6|||
149177683|NCT03519178|538123854|FG008|Follow-Up|Withdrawal by Subject|5|||
149177684|NCT03519178|538123855|FG009|Follow-Up|Withdrawal by Subject|2|||
149177685|NCT03519178|538123856|FG010|Follow-Up|Withdrawal by Subject|3|||
149177686|NCT03519178|538123857|FG011|Follow-Up|Withdrawal by Subject|5|||
149177687|NCT03519178|538123858|FG012|Follow-Up|Withdrawal by Subject|2|||
149177688|NCT03519178|538123859|FG013|Follow-Up|Withdrawal by Subject|0|||
149177689|NCT03519178|538123860|FG014|Follow-Up|Withdrawal by Subject|0|||
149177690|NCT03519178|538123846|FG000|Follow-Up|Other|0|||
149177691|NCT03519178|538123847|FG001|Follow-Up|Other|0|||
149177692|NCT03519178|538123848|FG002|Follow-Up|Other|0|||
149177693|NCT03519178|538123849|FG003|Follow-Up|Other|0|||
149177694|NCT03519178|538123850|FG004|Follow-Up|Other|0|||
149177695|NCT03519178|538123851|FG005|Follow-Up|Other|0|||
148679032|NCT00289731|536299048|FG002|Overall Study|Other|0|||
148679033|NCT01017029|536299049|FG000|Overall Study|Lost to Follow-up|1|||
148679034|NCT01017029|536299050|FG001|Overall Study|Lost to Follow-up|0|||
148679035|NCT01017029|536299049|FG000|Overall Study|Administrative problem|0|||
148679036|NCT01017029|536299050|FG001|Overall Study|Administrative problem|1|||
149177696|NCT03519178|538123852|FG006|Follow-Up|Other|0|||
149177697|NCT03519178|538123853|FG007|Follow-Up|Other|1|||
149177698|NCT03519178|538123854|FG008|Follow-Up|Other|0|||
148679037|NCT01017029|536299049|FG000|Overall Study|Death|3|||
148679038|NCT01017029|536299050|FG001|Overall Study|Death|1|||
148679039|NCT02770716|536299053|FG000|Overall Study|Death|101|||
148679040|NCT02770716|536299054|FG001|Overall Study|Death|45|||
148679041|NCT02770716|536299053|FG000|Overall Study|Withdrawal by Subject|4|||
148679042|NCT02770716|536299054|FG001|Overall Study|Withdrawal by Subject|2|||
148679043|NCT02770716|536299053|FG000|Overall Study|Lost to Follow-up|1|||
148679044|NCT02770716|536299054|FG001|Overall Study|Lost to Follow-up|0|||
148679045|NCT02770716|536299053|FG000|Overall Study|Various reasons|6|||
148679046|NCT02770716|536299054|FG001|Overall Study|Various reasons|2|||
148679047|NCT02753400|536299056|FG000|Overall Study|Adverse Event|3|||
148679048|NCT02753400|536299057|FG001|Overall Study|Adverse Event|0|||
148679049|NCT02753400|536299056|FG000|Overall Study|Withdrawal by Subject|2|||
148679050|NCT02753400|536299057|FG001|Overall Study|Withdrawal by Subject|1|||
148679051|NCT03989115|536299058|FG000|Overall Study|Withdrawal by Subject|2|||
148679052|NCT03989115|536299059|FG001|Overall Study|Withdrawal by Subject|1|||
148679053|NCT03989115|536299060|FG002|Overall Study|Withdrawal by Subject|3|||
148679054|NCT03989115|536299061|FG003|Overall Study|Withdrawal by Subject|0|||
148679055|NCT03989115|536299062|FG004|Overall Study|Withdrawal by Subject|17|||
148679056|NCT03989115|536299063|FG005|Overall Study|Withdrawal by Subject|1|||
148679057|NCT03989115|536299064|FG006|Overall Study|Withdrawal by Subject|0|||
148930127|NCT02007512|537230210|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
148930128|NCT02007512|537230211|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
149177699|NCT03519178|538123855|FG009|Follow-Up|Other|0|||
149177700|NCT03519178|538123856|FG010|Follow-Up|Other|0|||
148679058|NCT03989115|536299065|FG007|Overall Study|Withdrawal by Subject|0|||
148679059|NCT03989115|536299058|FG000|Overall Study|Sponsor decision to terminate the study|1|||
148679060|NCT03989115|536299059|FG001|Overall Study|Sponsor decision to terminate the study|1|||
148679061|NCT03989115|536299060|FG002|Overall Study|Sponsor decision to terminate the study|0|||
148679062|NCT03989115|536299061|FG003|Overall Study|Sponsor decision to terminate the study|1|||
148679063|NCT03989115|536299062|FG004|Overall Study|Sponsor decision to terminate the study|11|||
148679064|NCT03989115|536299063|FG005|Overall Study|Sponsor decision to terminate the study|0|||
148679065|NCT03989115|536299064|FG006|Overall Study|Sponsor decision to terminate the study|2|||
148679066|NCT03989115|536299065|FG007|Overall Study|Sponsor decision to terminate the study|1|||
148930129|NCT02007512|537230212|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
148930130|NCT02007512|537230213|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
148930131|NCT02007512|537230210|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149177701|NCT03519178|538123857|FG011|Follow-Up|Other|0|||
149177702|NCT03519178|538123858|FG012|Follow-Up|Other|0|||
149177703|NCT03519178|538123859|FG013|Follow-Up|Other|0|||
148679067|NCT03989115|536299058|FG000|Overall Study|Lost to Follow-up|2|||
148679068|NCT03989115|536299059|FG001|Overall Study|Lost to Follow-up|0|||
148679069|NCT03989115|536299060|FG002|Overall Study|Lost to Follow-up|0|||
148679070|NCT03989115|536299061|FG003|Overall Study|Lost to Follow-up|0|||
148679071|NCT03989115|536299062|FG004|Overall Study|Lost to Follow-up|1|||
149177704|NCT03519178|538123860|FG014|Follow-Up|Other|0|||
149177705|NCT03519178|538123846|FG000|Long-term Follow-up|Death|0|||
149177706|NCT03519178|538123847|FG001|Long-term Follow-up|Death|0|||
149177707|NCT03519178|538123848|FG002|Long-term Follow-up|Death|0|||
149177708|NCT03519178|538123849|FG003|Long-term Follow-up|Death|0|||
149177709|NCT03519178|538123850|FG004|Long-term Follow-up|Death|0|||
149177710|NCT03519178|538123851|FG005|Long-term Follow-up|Death|0|||
149177711|NCT03519178|538123852|FG006|Long-term Follow-up|Death|0|||
148807008|NCT04711005|536771087|FG007|Overall Study|Withdrawal by Subject|1|||
148807009|NCT04711005|536771088|FG008|Overall Study|Withdrawal by Subject|0|||
148807010|NCT04711005|536771089|FG009|Overall Study|Withdrawal by Subject|0|||
148807011|NCT04711005|536771080|FG000|Overall Study|Physician Decision|0|||
148807012|NCT04711005|536771081|FG001|Overall Study|Physician Decision|0|||
148807013|NCT04711005|536771082|FG002|Overall Study|Physician Decision|0|||
148807014|NCT04711005|536771083|FG003|Overall Study|Physician Decision|0|||
148807015|NCT04711005|536771084|FG004|Overall Study|Physician Decision|0|||
148807016|NCT04711005|536771085|FG005|Overall Study|Physician Decision|0|||
148807017|NCT04711005|536771086|FG006|Overall Study|Physician Decision|0|||
148930132|NCT02007512|537230211|FG001|Double Blind Treatment Period|Protocol Violation|0|||
148930133|NCT02007512|537230212|FG002|Double Blind Treatment Period|Protocol Violation|0|||
149177712|NCT03519178|538123853|FG007|Long-term Follow-up|Death|0|||
149177713|NCT03519178|538123854|FG008|Long-term Follow-up|Death|0|||
149177714|NCT03519178|538123855|FG009|Long-term Follow-up|Death|0|||
149177715|NCT03519178|538123856|FG010|Long-term Follow-up|Death|0|||
149177716|NCT03519178|538123857|FG011|Long-term Follow-up|Death|0|||
149177717|NCT03519178|538123858|FG012|Long-term Follow-up|Death|0|||
149177718|NCT03519178|538123859|FG013|Long-term Follow-up|Death|4|||
149177719|NCT03519178|538123860|FG014|Long-term Follow-up|Death|4|||
149177720|NCT03519178|538123846|FG000|Long-term Follow-up|Lost to Follow-up|0|||
149177721|NCT03519178|538123847|FG001|Long-term Follow-up|Lost to Follow-up|0|||
149177722|NCT03519178|538123848|FG002|Long-term Follow-up|Lost to Follow-up|0|||
149177723|NCT03519178|538123849|FG003|Long-term Follow-up|Lost to Follow-up|0|||
149177724|NCT03519178|538123850|FG004|Long-term Follow-up|Lost to Follow-up|0|||
149177725|NCT03519178|538123851|FG005|Long-term Follow-up|Lost to Follow-up|0|||
149177726|NCT03519178|538123852|FG006|Long-term Follow-up|Lost to Follow-up|0|||
149177727|NCT03519178|538123853|FG007|Long-term Follow-up|Lost to Follow-up|0|||
149177728|NCT03519178|538123854|FG008|Long-term Follow-up|Lost to Follow-up|0|||
149177729|NCT03519178|538123855|FG009|Long-term Follow-up|Lost to Follow-up|0|||
149177730|NCT03519178|538123856|FG010|Long-term Follow-up|Lost to Follow-up|0|||
149177731|NCT03519178|538123857|FG011|Long-term Follow-up|Lost to Follow-up|0|||
149177732|NCT03519178|538123858|FG012|Long-term Follow-up|Lost to Follow-up|0|||
149177733|NCT03519178|538123859|FG013|Long-term Follow-up|Lost to Follow-up|1|||
149177734|NCT03519178|538123860|FG014|Long-term Follow-up|Lost to Follow-up|1|||
149177735|NCT03519178|538123846|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
149177736|NCT03519178|538123847|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
149177737|NCT03519178|538123848|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
149177738|NCT03519178|538123849|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
149177739|NCT03519178|538123850|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
149177740|NCT03519178|538123851|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
149177741|NCT03519178|538123852|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
149177742|NCT03519178|538123853|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
149177743|NCT03519178|538123854|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
149177744|NCT03519178|538123855|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
149177745|NCT03519178|538123856|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
149177746|NCT03519178|538123857|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
149177747|NCT03519178|538123858|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
149177748|NCT03519178|538123859|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
149177749|NCT03519178|538123860|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
149177750|NCT03519178|538123846|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
149177751|NCT03519178|538123847|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
149177752|NCT03519178|538123848|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
149177753|NCT03519178|538123849|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
149177754|NCT03519178|538123850|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
149177755|NCT03519178|538123851|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
149177756|NCT03519178|538123852|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
149177757|NCT03519178|538123853|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
149177758|NCT03519178|538123854|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
149177759|NCT03519178|538123855|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
149177760|NCT03519178|538123856|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
149177761|NCT03519178|538123857|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
148807018|NCT04711005|536771087|FG007|Overall Study|Physician Decision|2|||
148930134|NCT02007512|537230213|FG003|Double Blind Treatment Period|Protocol Violation|1|||
148930135|NCT02007512|537230210|FG000|Double Blind Treatment Period|Other|2|||
148930136|NCT02007512|537230211|FG001|Double Blind Treatment Period|Other|1|||
148930137|NCT02007512|537230212|FG002|Double Blind Treatment Period|Other|1|||
149177762|NCT03519178|538123858|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
149177763|NCT03519178|538123859|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
149177764|NCT03519178|538123860|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
148807019|NCT04711005|536771088|FG008|Overall Study|Physician Decision|1|||
148807020|NCT04711005|536771089|FG009|Overall Study|Physician Decision|0|||
149177765|NCT03519178|538123846|FG000|Long-term Follow-up|Other|0|||
149177766|NCT03519178|538123847|FG001|Long-term Follow-up|Other|0|||
149177767|NCT03519178|538123848|FG002|Long-term Follow-up|Other|0|||
149177768|NCT03519178|538123849|FG003|Long-term Follow-up|Other|0|||
149177769|NCT03519178|538123850|FG004|Long-term Follow-up|Other|0|||
149177770|NCT03519178|538123851|FG005|Long-term Follow-up|Other|0|||
149177771|NCT03519178|538123852|FG006|Long-term Follow-up|Other|0|||
149177772|NCT03519178|538123853|FG007|Long-term Follow-up|Other|0|||
149177773|NCT03519178|538123854|FG008|Long-term Follow-up|Other|0|||
149177774|NCT03519178|538123855|FG009|Long-term Follow-up|Other|0|||
149177775|NCT03519178|538123856|FG010|Long-term Follow-up|Other|0|||
149177776|NCT03519178|538123857|FG011|Long-term Follow-up|Other|0|||
149177777|NCT03519178|538123858|FG012|Long-term Follow-up|Other|0|||
149177778|NCT03519178|538123859|FG013|Long-term Follow-up|Other|0|||
149177779|NCT03519178|538123860|FG014|Long-term Follow-up|Other|1|||
149177780|NCT03519178|538123846|FG000|Long-term Follow-up|Global deterioration of health status|0|||
149177781|NCT03519178|538123847|FG001|Long-term Follow-up|Global deterioration of health status|0|||
149177782|NCT03519178|538123848|FG002|Long-term Follow-up|Global deterioration of health status|0|||
149177783|NCT03519178|538123849|FG003|Long-term Follow-up|Global deterioration of health status|0|||
149177784|NCT03519178|538123850|FG004|Long-term Follow-up|Global deterioration of health status|0|||
149177785|NCT03519178|538123851|FG005|Long-term Follow-up|Global deterioration of health status|0|||
149177786|NCT03519178|538123852|FG006|Long-term Follow-up|Global deterioration of health status|0|||
149177787|NCT03519178|538123853|FG007|Long-term Follow-up|Global deterioration of health status|0|||
149177788|NCT03519178|538123854|FG008|Long-term Follow-up|Global deterioration of health status|0|||
149177789|NCT03519178|538123855|FG009|Long-term Follow-up|Global deterioration of health status|0|||
149177790|NCT03519178|538123856|FG010|Long-term Follow-up|Global deterioration of health status|0|||
149177791|NCT03519178|538123857|FG011|Long-term Follow-up|Global deterioration of health status|0|||
149177792|NCT03519178|538123858|FG012|Long-term Follow-up|Global deterioration of health status|0|||
149177793|NCT03519178|538123859|FG013|Long-term Follow-up|Global deterioration of health status|1|||
149177794|NCT03519178|538123860|FG014|Long-term Follow-up|Global deterioration of health status|0|||
149177795|NCT03256539|538123861|FG000|Overall Study|Withdrawal by Subject|0|||
149177796|NCT03256539|538123862|FG001|Overall Study|Withdrawal by Subject|3|||
149177797|NCT03256539|538123861|FG000|Overall Study|Unexpected closure of study components|8|||
149177798|NCT03256539|538123862|FG001|Overall Study|Unexpected closure of study components|4|||
149177799|NCT01591330|538123867|FG000|Period 1|Adverse Event|1|||
149177800|NCT01591330|538123868|FG001|Period 1|Adverse Event|0|||
149177801|NCT01591330|538123869|FG002|Period 1|Adverse Event|0|||
149177802|NCT01591330|538123870|FG003|Period 1|Adverse Event|0|||
149177803|NCT01591330|538123867|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
149177804|NCT01591330|538123868|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
149177805|NCT01591330|538123869|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
149177806|NCT01591330|538123870|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
149177807|NCT01591330|538123867|FG000|Period 2|Adverse Event|1|||
149177808|NCT01591330|538123868|FG001|Period 2|Adverse Event|0|||
149177809|NCT01591330|538123869|FG002|Period 2|Adverse Event|0|||
149177810|NCT01591330|538123870|FG003|Period 2|Adverse Event|0|||
149177811|NCT02782715|538123871|FG000|Overall Study|Withdrawal by Subject|1|||
149177812|NCT01919411|538123881|FG000|Overall Study|Lost to Follow-up|2|||
149177813|NCT01919411|538123882|FG001|Overall Study|Lost to Follow-up|4|||
149177814|NCT01919411|538123881|FG000|Overall Study|Physician Decision|1|||
149177815|NCT01919411|538123882|FG001|Overall Study|Physician Decision|0|||
149177816|NCT01919411|538123881|FG000|Overall Study|Protocol Violation|2|||
149177817|NCT01919411|538123882|FG001|Overall Study|Protocol Violation|1|||
149177818|NCT00144300|538123883|FG000|Overall Study|Adverse Event|18|||
149177819|NCT00144300|538123884|FG001|Overall Study|Adverse Event|16|||
149177820|NCT00144300|538123883|FG000|Overall Study|Protocol Violation|1|||
149177821|NCT00144300|538123884|FG001|Overall Study|Protocol Violation|3|||
148930138|NCT02007512|537230213|FG003|Double Blind Treatment Period|Other|2|||
149177822|NCT00144300|538123883|FG000|Overall Study|Lost to Follow-up|3|||
149177823|NCT00144300|538123884|FG001|Overall Study|Lost to Follow-up|0|||
149177824|NCT00144300|538123883|FG000|Overall Study|Withdrawal by Subject|6|||
149177825|NCT00144300|538123884|FG001|Overall Study|Withdrawal by Subject|6|||
149177826|NCT00144300|538123883|FG000|Overall Study|Other reason (not specified)|1|||
149177827|NCT00144300|538123884|FG001|Overall Study|Other reason (not specified)|3|||
149177828|NCT00957372|538123892|FG000|PART I|Lost to Follow-up|0|||
148930139|NCT02007512|537230210|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
148930140|NCT02007512|537230211|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
148930141|NCT02007512|537230212|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
148930142|NCT02007512|537230213|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
148930143|NCT02007512|537230210|FG000|Open Label Treatment Period|Adverse Event|1|||
148930144|NCT02007512|537230211|FG001|Open Label Treatment Period|Adverse Event|0|||
148930145|NCT02007512|537230212|FG002|Open Label Treatment Period|Adverse Event|0|||
148930146|NCT02007512|537230213|FG003|Open Label Treatment Period|Adverse Event|0|||
148930147|NCT02007512|537230210|FG000|Open Label Treatment Period|Other|1|||
149177829|NCT00957372|538123893|FG001|PART I|Lost to Follow-up|0|||
149177830|NCT00957372|538123894|FG002|PART I|Lost to Follow-up|1|||
148930148|NCT02007512|537230211|FG001|Open Label Treatment Period|Other|1|||
149177831|NCT00957372|538123895|FG003|PART I|Lost to Follow-up|0|||
149177832|NCT00957372|538123892|FG000|PART II|Withdrawal by Subject|0|||
149177833|NCT00957372|538123893|FG001|PART II|Withdrawal by Subject|0|||
149177834|NCT00957372|538123894|FG002|PART II|Withdrawal by Subject|0|||
149177835|NCT00957372|538123895|FG003|PART II|Withdrawal by Subject|8|||
149177836|NCT00957372|538123892|FG000|PART II|Physician Decision|0|||
149177837|NCT00957372|538123893|FG001|PART II|Physician Decision|0|||
149177838|NCT00957372|538123894|FG002|PART II|Physician Decision|0|||
149177839|NCT00957372|538123895|FG003|PART II|Physician Decision|1|||
149177840|NCT00957372|538123892|FG000|PART II|Pregnancy|0|||
149177841|NCT00957372|538123893|FG001|PART II|Pregnancy|0|||
149177842|NCT00957372|538123894|FG002|PART II|Pregnancy|0|||
149177843|NCT00957372|538123895|FG003|PART II|Pregnancy|1|||
149177844|NCT00957372|538123892|FG000|PART II|Not Know|0|||
149177845|NCT00957372|538123893|FG001|PART II|Not Know|0|||
149177846|NCT00957372|538123894|FG002|PART II|Not Know|0|||
149177847|NCT00957372|538123895|FG003|PART II|Not Know|20|||
149177848|NCT00957372|538123892|FG000|PART II|Adverse Event|0|||
149177849|NCT00957372|538123893|FG001|PART II|Adverse Event|0|||
149177850|NCT00957372|538123894|FG002|PART II|Adverse Event|0|||
149177851|NCT00957372|538123895|FG003|PART II|Adverse Event|10|||
149177852|NCT00957372|538123892|FG000|PART II|Patient non-compliance|0|||
149177853|NCT00957372|538123893|FG001|PART II|Patient non-compliance|0|||
149177854|NCT00957372|538123894|FG002|PART II|Patient non-compliance|0|||
149177855|NCT00957372|538123895|FG003|PART II|Patient non-compliance|4|||
148679072|NCT03989115|536299063|FG005|Overall Study|Lost to Follow-up|0|||
148930149|NCT02007512|537230212|FG002|Open Label Treatment Period|Other|0|||
148930150|NCT02007512|537230213|FG003|Open Label Treatment Period|Other|0|||
148930151|NCT02007512|537230210|FG000|Open Label Treatment Period|Disease progression|23|||
148930152|NCT02007512|537230211|FG001|Open Label Treatment Period|Disease progression|11|||
148930153|NCT02007512|537230212|FG002|Open Label Treatment Period|Disease progression|0|||
148930154|NCT02007512|537230213|FG003|Open Label Treatment Period|Disease progression|0|||
148930155|NCT04629508|537230214|FG000|Overall Study|Adverse Event|1|||
148930156|NCT04629508|537230214|FG000|Overall Study|Death|2|||
148930157|NCT04629508|537230214|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
148930158|NCT04073368|537230219|FG000|Overall Study|Adverse Event|2|||
148930159|NCT04073368|537230220|FG001|Overall Study|Adverse Event|0|||
148930160|NCT04073368|537230221|FG002|Overall Study|Adverse Event|1|||
148930161|NCT04073368|537230222|FG003|Overall Study|Adverse Event|1|||
149177856|NCT01444391|538123898|FG000|Overall Study|Death|1|||
149177857|NCT01877655|538123899|FG000|Overall Study|Death|57|||
148679073|NCT03989115|536299064|FG006|Overall Study|Lost to Follow-up|0|||
148679074|NCT03989115|536299065|FG007|Overall Study|Lost to Follow-up|0|||
148679075|NCT03989115|536299058|FG000|Overall Study|Death|2|||
148679076|NCT03989115|536299059|FG001|Overall Study|Death|2|||
148679077|NCT03989115|536299060|FG002|Overall Study|Death|9|||
148679078|NCT03989115|536299061|FG003|Overall Study|Death|6|||
148679079|NCT03989115|536299062|FG004|Overall Study|Death|31|||
148679080|NCT03989115|536299063|FG005|Overall Study|Death|6|||
148679081|NCT03989115|536299064|FG006|Overall Study|Death|2|||
148679082|NCT03989115|536299065|FG007|Overall Study|Death|3|||
148679083|NCT03989115|536299058|FG000|Overall Study|Other|1|||
148679084|NCT03989115|536299059|FG001|Overall Study|Other|2|||
148679085|NCT03989115|536299060|FG002|Overall Study|Other|0|||
148679086|NCT03989115|536299061|FG003|Overall Study|Other|0|||
148679087|NCT03989115|536299062|FG004|Overall Study|Other|5|||
148679088|NCT03989115|536299063|FG005|Overall Study|Other|0|||
148679089|NCT03989115|536299064|FG006|Overall Study|Other|0|||
148679090|NCT03989115|536299065|FG007|Overall Study|Other|0|||
148679091|NCT00572156|536299073|FG000|Overall Study|Adverse Event|3|||
148679092|NCT00572156|536299074|FG001|Overall Study|Adverse Event|1|||
148679093|NCT00572156|536299075|FG002|Overall Study|Adverse Event|5|||
148679094|NCT00572156|536299076|FG003|Overall Study|Adverse Event|1|||
148679095|NCT00572156|536299073|FG000|Overall Study|Lost to Follow-up|1|||
148679096|NCT00572156|536299074|FG001|Overall Study|Lost to Follow-up|1|||
148679097|NCT00572156|536299075|FG002|Overall Study|Lost to Follow-up|1|||
148679098|NCT00572156|536299076|FG003|Overall Study|Lost to Follow-up|0|||
148679099|NCT00572156|536299073|FG000|Overall Study|Protocol Violation|1|||
148679100|NCT00572156|536299074|FG001|Overall Study|Protocol Violation|2|||
148679101|NCT00572156|536299075|FG002|Overall Study|Protocol Violation|0|||
149177858|NCT01877655|538123900|FG001|Overall Study|Death|52|||
148679102|NCT00572156|536299076|FG003|Overall Study|Protocol Violation|2|||
148930162|NCT04073368|537230219|FG000|Overall Study|Withdrawal by Subject|2|||
148930163|NCT04073368|537230220|FG001|Overall Study|Withdrawal by Subject|2|||
148930164|NCT04073368|537230221|FG002|Overall Study|Withdrawal by Subject|1|||
148679103|NCT00572156|536299073|FG000|Overall Study|Patient/Parent Decision|1|||
148679104|NCT00572156|536299074|FG001|Overall Study|Patient/Parent Decision|6|||
148679105|NCT00572156|536299075|FG002|Overall Study|Patient/Parent Decision|4|||
148679106|NCT00572156|536299076|FG003|Overall Study|Patient/Parent Decision|3|||
148679107|NCT00572156|536299073|FG000|Overall Study|Sponsor Decision|20|||
148930165|NCT04073368|537230222|FG003|Overall Study|Withdrawal by Subject|1|||
149177859|NCT01877655|538123899|FG000|Overall Study|Withdrawal by Subject|18|||
149177860|NCT01877655|538123900|FG001|Overall Study|Withdrawal by Subject|26|||
149177861|NCT01877655|538123899|FG000|Overall Study|Physician Decision|11|||
149177862|NCT01877655|538123900|FG001|Overall Study|Physician Decision|10|||
149177863|NCT01877655|538123899|FG000|Overall Study|Miscellaneous|4|||
148930166|NCT04073368|537230219|FG000|Overall Study|Lost to Follow-up|1|||
148930167|NCT04073368|537230220|FG001|Overall Study|Lost to Follow-up|1|||
148930168|NCT04073368|537230221|FG002|Overall Study|Lost to Follow-up|1|||
148930169|NCT04073368|537230222|FG003|Overall Study|Lost to Follow-up|0|||
148930170|NCT04073368|537230219|FG000|Overall Study|Protocol Violation|0|||
148930171|NCT04073368|537230220|FG001|Overall Study|Protocol Violation|1|||
148930172|NCT04073368|537230221|FG002|Overall Study|Protocol Violation|0|||
148930173|NCT04073368|537230222|FG003|Overall Study|Protocol Violation|0|||
148930174|NCT04073368|537230219|FG000|Overall Study|Subject noncompliance|7|||
148930175|NCT04073368|537230220|FG001|Overall Study|Subject noncompliance|4|||
148930176|NCT04073368|537230221|FG002|Overall Study|Subject noncompliance|0|||
148930177|NCT04073368|537230222|FG003|Overall Study|Subject noncompliance|0|||
148930178|NCT00145600|537230223|FG000|Overall Study|Death|1|||
148930179|NCT00145600|537230224|FG001|Overall Study|Death|2|||
148930180|NCT00145600|537230225|FG002|Overall Study|Death|2|||
148930181|NCT00145600|537230226|FG003|Overall Study|Death|6|||
148930182|NCT00145600|537230223|FG000|Overall Study|Ineligible|3|||
148930183|NCT00145600|537230224|FG001|Overall Study|Ineligible|0|||
148930184|NCT00145600|537230225|FG002|Overall Study|Ineligible|1|||
148930185|NCT00145600|537230226|FG003|Overall Study|Ineligible|5|||
148930186|NCT00145600|537230223|FG000|Overall Study|Lost to Follow-up|2|||
148930187|NCT00145600|537230224|FG001|Overall Study|Lost to Follow-up|6|||
148930188|NCT00145600|537230225|FG002|Overall Study|Lost to Follow-up|2|||
148930189|NCT00145600|537230226|FG003|Overall Study|Lost to Follow-up|4|||
148930190|NCT00145600|537230223|FG000|Overall Study|Noncompliance|1|||
148930191|NCT00145600|537230224|FG001|Overall Study|Noncompliance|0|||
148930192|NCT00145600|537230225|FG002|Overall Study|Noncompliance|0|||
148930193|NCT00145600|537230226|FG003|Overall Study|Noncompliance|0|||
148930194|NCT00145600|537230223|FG000|Overall Study|Withdrawal by Subject|1|||
148930195|NCT00145600|537230224|FG001|Overall Study|Withdrawal by Subject|2|||
148930196|NCT00145600|537230225|FG002|Overall Study|Withdrawal by Subject|0|||
148930197|NCT00145600|537230226|FG003|Overall Study|Withdrawal by Subject|1|||
148930198|NCT01229397|537230227|FG000|Overall Study|Withdrawal by Subject|3|||
148930199|NCT01229397|537230228|FG001|Overall Study|Withdrawal by Subject|3|||
148930200|NCT01229397|537230227|FG000|Overall Study|Lost to Follow-up|7|||
149013476|NCT02936037|537529161|FG000|Open Label Extension|Withdrawal by Subject|0|||
149013477|NCT02936037|537529162|FG001|Open Label Extension|Withdrawal by Subject|4|||
148930201|NCT01229397|537230228|FG001|Overall Study|Lost to Follow-up|6|||
148930202|NCT01229397|537230227|FG000|Overall Study|Migrated/moved from study area|1|||
148930203|NCT01229397|537230228|FG001|Overall Study|Migrated/moved from study area|0|||
148930204|NCT00608543|537230229|FG000|Overall Study|Adverse Event|4|||
148930205|NCT01251744|537230234|FG000|Overall Study|Lost to Follow-up|1|||
148930206|NCT01251744|537230235|FG001|Overall Study|Lost to Follow-up|0|||
148930207|NCT00214500|537230236|FG000|Treatment Period|Adverse Event|1|||
148930208|NCT00214500|537230236|FG000|Extension Period|Withdrawal by Subject|2|||
148930209|NCT02147184|537230237|FG000|Overall Study|Lost to Follow-up|28|||
148930210|NCT02147184|537230238|FG001|Overall Study|Lost to Follow-up|15|||
148930211|NCT02147184|537230237|FG000|Overall Study|Study Burden|11|||
148930212|NCT02147184|537230238|FG001|Overall Study|Study Burden|7|||
148930213|NCT02147184|537230237|FG000|Overall Study|Pregnancy|6|||
148930214|NCT02147184|537230238|FG001|Overall Study|Pregnancy|0|||
149177864|NCT01877655|538123900|FG001|Overall Study|Miscellaneous|4|||
149177865|NCT01877655|538123899|FG000|Overall Study|Randomized but Never Received Drug|8|||
149177866|NCT01877655|538123900|FG001|Overall Study|Randomized but Never Received Drug|5|||
149177867|NCT00538733|538123903|FG000|Overall Study|Adverse Event|8|||
149177868|NCT00538733|538123903|FG000|Overall Study|Death|1|||
149177869|NCT00538733|538123903|FG000|Overall Study|declined to participate|2|||
149177870|NCT00538733|538123903|FG000|Overall Study|still on therapy|1|||
149177871|NCT00095121|538123904|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
149177872|NCT00095121|538123905|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
149177873|NCT00095121|538123904|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
148930215|NCT02147184|537230237|FG000|Overall Study|Moved out of state|3|||
148930216|NCT02147184|537230238|FG001|Overall Study|Moved out of state|3|||
148930217|NCT02147184|537230237|FG000|Overall Study|Physician Decision|0|||
148930218|NCT02147184|537230238|FG001|Overall Study|Physician Decision|2|||
148930219|NCT02147184|537230237|FG000|Overall Study|Other|1|||
148930220|NCT02147184|537230238|FG001|Overall Study|Other|0|||
148679108|NCT00572156|536299074|FG001|Overall Study|Sponsor Decision|16|||
148679109|NCT00572156|536299075|FG002|Overall Study|Sponsor Decision|17|||
148679110|NCT00572156|536299076|FG003|Overall Study|Sponsor Decision|19|||
148679111|NCT00720304|536299077|FG000|Overall Study|Withdrawal by Subject|14|||
148679112|NCT00720304|536299078|FG001|Overall Study|Withdrawal by Subject|1|||
148679113|NCT00720304|536299077|FG000|Overall Study|Death|1|||
148679114|NCT00720304|536299078|FG001|Overall Study|Death|0|||
148679115|NCT00720304|536299077|FG000|Overall Study|Physician Decision|5|||
148679116|NCT00720304|536299078|FG001|Overall Study|Physician Decision|2|||
148679117|NCT00720304|536299077|FG000|Overall Study|Adverse Event|3|||
148679118|NCT00720304|536299078|FG001|Overall Study|Adverse Event|1|||
148807021|NCT00764790|536771090|FG000|Overall Study|Protocol Violation|0|||
148807022|NCT00764790|536771091|FG001|Overall Study|Protocol Violation|0|||
148807023|NCT00764790|536771092|FG002|Overall Study|Protocol Violation|1|||
148679119|NCT00720304|536299077|FG000|Overall Study|Disease progression|6|||
148679120|NCT00720304|536299078|FG001|Overall Study|Disease progression|1|||
148679121|NCT04330482|536299081|FG000|Overall Study|Lost to Follow-up|2|||
148930221|NCT06400979|537230243|FG000|Overall Study|Lost to Follow-up|29|||
148930222|NCT06400979|537230243|FG000|Overall Study|Withdrawal by Subject|1|||
148930223|NCT00117286|537230246|FG000|Overall Study|Adverse Event|12|||
148930224|NCT00117286|537230247|FG001|Overall Study|Adverse Event|6|||
148930225|NCT00117286|537230246|FG000|Overall Study|Lost to Follow-up|2|||
148930226|NCT00117286|537230247|FG001|Overall Study|Lost to Follow-up|0|||
148930227|NCT00117286|537230246|FG000|Overall Study|Protocol Violation|3|||
148930228|NCT00117286|537230247|FG001|Overall Study|Protocol Violation|3|||
148930229|NCT00117286|537230246|FG000|Overall Study|Withdrawal by Subject|6|||
148930230|NCT00117286|537230247|FG001|Overall Study|Withdrawal by Subject|2|||
148930231|NCT00117286|537230246|FG000|Overall Study|Physician Decision|3|||
148930232|NCT00117286|537230247|FG001|Overall Study|Physician Decision|7|||
148930233|NCT00117286|537230246|FG000|Overall Study|Lack of Efficacy|2|||
148930234|NCT00117286|537230247|FG001|Overall Study|Lack of Efficacy|1|||
148930235|NCT00117286|537230246|FG000|Overall Study|Research site closing|0|||
148930236|NCT00117286|537230247|FG001|Overall Study|Research site closing|2|||
148930237|NCT02675231|537230248|FG000|Overall Study|Withdrawal by Subject|2|||
148930238|NCT02675231|537230249|FG001|Overall Study|Withdrawal by Subject|4|||
148930239|NCT02675231|537230250|FG002|Overall Study|Withdrawal by Subject|2|||
148930240|NCT02675231|537230248|FG000|Overall Study|Lost to Follow-up|3|||
148930241|NCT02675231|537230249|FG001|Overall Study|Lost to Follow-up|4|||
149013478|NCT01017120|537529165|FG000|Overall Study|Adverse Event|9|||
149177874|NCT00095121|538123905|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
149177875|NCT04070378|538123908|FG000|Overall Study|Withdrawal by Subject|2|||
149177876|NCT04070378|538123908|FG000|Overall Study|Screen Failure|6|||
148679122|NCT04330482|536299082|FG001|Overall Study|Lost to Follow-up|1|||
148807024|NCT00764790|536771090|FG000|Overall Study|Withdrawal by Subject|10|||
148930242|NCT02675231|537230250|FG002|Overall Study|Lost to Follow-up|3|||
148930243|NCT00887744|537230251|FG000|Overall Study|Adverse Event|3|||
148930244|NCT00887744|537230251|FG000|Overall Study|Death|1|||
149013479|NCT01017120|537529166|FG001|Overall Study|Adverse Event|0|||
149177877|NCT04070378|538123908|FG000|Overall Study|Physician Decision|1|||
148679123|NCT04330482|536299081|FG000|Overall Study|Withdrawal by Subject|0|||
148930245|NCT00887744|537230251|FG000|Overall Study|Lost to Follow-up|3|||
148930246|NCT00887744|537230251|FG000|Overall Study|Withdrawal by Subject|18|||
148930247|NCT00887744|537230251|FG000|Overall Study|Various reasons|9|||
148930248|NCT00591266|537230252|FG000|Overall Study|Adverse Event|2|||
149013480|NCT01017120|537529165|FG000|Overall Study|Lost to Follow-up|13|||
148807025|NCT00764790|536771091|FG001|Overall Study|Withdrawal by Subject|12|||
148930249|NCT00591266|537230253|FG001|Overall Study|Adverse Event|2|||
148930250|NCT00591266|537230254|FG002|Overall Study|Adverse Event|3|||
148930251|NCT00591266|537230252|FG000|Overall Study|Lost to Follow-up|0|||
148930252|NCT00591266|537230253|FG001|Overall Study|Lost to Follow-up|1|||
149177878|NCT04070378|538123908|FG000|Overall Study|Adverse Event|1|||
148679124|NCT04330482|536299082|FG001|Overall Study|Withdrawal by Subject|3|||
148930253|NCT00591266|537230254|FG002|Overall Study|Lost to Follow-up|0|||
148930254|NCT00591266|537230252|FG000|Overall Study|Protocol Violation|0|||
148930255|NCT00591266|537230253|FG001|Overall Study|Protocol Violation|0|||
148930256|NCT00591266|537230254|FG002|Overall Study|Protocol Violation|1|||
148930257|NCT00591266|537230252|FG000|Overall Study|Withdrawal by Subject|6|||
148930258|NCT00591266|537230253|FG001|Overall Study|Withdrawal by Subject|2|||
148930259|NCT00591266|537230254|FG002|Overall Study|Withdrawal by Subject|5|||
148930260|NCT00591266|537230252|FG000|Overall Study|Lack of Efficacy|0|||
148930261|NCT00591266|537230253|FG001|Overall Study|Lack of Efficacy|2|||
148930262|NCT00591266|537230254|FG002|Overall Study|Lack of Efficacy|0|||
148930263|NCT00591266|537230252|FG000|Overall Study|Other|1|||
148930264|NCT00591266|537230253|FG001|Overall Study|Other|4|||
148930265|NCT00591266|537230254|FG002|Overall Study|Other|5|||
148930266|NCT00586846|537230255|FG000|Overall Study|Physician Decision|1|||
148930267|NCT00586846|537230255|FG000|Overall Study|Death|1|||
148930268|NCT00586846|537230255|FG000|Overall Study|Evaluable for Toxicity Only|4|||
148930269|NCT01226043|537230262|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
148930270|NCT01226043|537230263|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
148930271|NCT01226043|537230264|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
148930272|NCT01226043|537230265|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
148930273|NCT01226043|537230262|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
148930274|NCT01226043|537230263|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
148930275|NCT01226043|537230264|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
148930276|NCT01226043|537230265|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
148930277|NCT01226043|537230262|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
148930278|NCT01226043|537230263|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
148930279|NCT01226043|537230264|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
148930280|NCT01226043|537230265|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
148930281|NCT01226043|537230262|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
148930282|NCT01226043|537230263|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
148930283|NCT01226043|537230264|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
148930284|NCT01226043|537230265|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
148930285|NCT01226043|537230262|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
148930286|NCT01226043|537230263|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
148930287|NCT01226043|537230264|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
148930288|NCT01226043|537230265|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
148930289|NCT01226043|537230262|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
148930290|NCT01226043|537230263|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
148930291|NCT01226043|537230264|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
148930292|NCT01226043|537230265|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
148930293|NCT01226043|537230262|FG000|6-week Re-randomization Phase|Adverse Event|0|||
148930294|NCT01226043|537230263|FG001|6-week Re-randomization Phase|Adverse Event|0|||
148930295|NCT01226043|537230264|FG002|6-week Re-randomization Phase|Adverse Event|1|||
148930296|NCT01226043|537230265|FG003|6-week Re-randomization Phase|Adverse Event|1|||
148930297|NCT01226043|537230262|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
148930298|NCT01226043|537230263|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
148930299|NCT01226043|537230264|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
148930300|NCT01226043|537230265|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
148930301|NCT01226043|537230262|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
148930302|NCT01226043|537230263|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
148930303|NCT01226043|537230264|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
148930304|NCT01226043|537230265|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
148930305|NCT01226043|537230262|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
148930306|NCT01226043|537230263|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
148930307|NCT01226043|537230264|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
148930308|NCT01226043|537230265|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
148930309|NCT01226043|537230262|FG000|6-week Re-randomization Phase|Physician Decision|0|||
148930310|NCT01226043|537230263|FG001|6-week Re-randomization Phase|Physician Decision|0|||
148930311|NCT01226043|537230264|FG002|6-week Re-randomization Phase|Physician Decision|3|||
148930312|NCT01226043|537230265|FG003|6-week Re-randomization Phase|Physician Decision|2|||
148930313|NCT01226043|537230262|FG000|6-week Re-randomization Phase|completed in error|0|||
148930314|NCT01226043|537230263|FG001|6-week Re-randomization Phase|completed in error|0|||
148930315|NCT01226043|537230264|FG002|6-week Re-randomization Phase|completed in error|0|||
148930316|NCT01226043|537230265|FG003|6-week Re-randomization Phase|completed in error|1|||
148930317|NCT01226043|537230262|FG000|30-week Observational Phase|Adverse Event|0|||
148930318|NCT01226043|537230263|FG001|30-week Observational Phase|Adverse Event|0|||
148930319|NCT01226043|537230264|FG002|30-week Observational Phase|Adverse Event|1|||
148930320|NCT01226043|537230265|FG003|30-week Observational Phase|Adverse Event|1|||
148930321|NCT01226043|537230262|FG000|30-week Observational Phase|Protocol Violation|0|||
148930322|NCT01226043|537230263|FG001|30-week Observational Phase|Protocol Violation|0|||
148930323|NCT01226043|537230264|FG002|30-week Observational Phase|Protocol Violation|0|||
149177879|NCT03567187|538123909|FG000|Overall Study|Lost to Follow-up|18|||
149177880|NCT03596645|538123912|FG000|Overall Study|Adverse Event|17|||
149177881|NCT03596645|538123913|FG001|Overall Study|Adverse Event|0|||
149177882|NCT03596645|538123912|FG000|Overall Study|Lack of Efficacy|8|||
149177883|NCT03596645|538123913|FG001|Overall Study|Lack of Efficacy|0|||
149177884|NCT03596645|538123912|FG000|Overall Study|Lost to Follow-up|1|||
149177885|NCT03596645|538123913|FG001|Overall Study|Lost to Follow-up|1|||
149177886|NCT03596645|538123912|FG000|Overall Study|Physician Decision|1|||
149177887|NCT03596645|538123913|FG001|Overall Study|Physician Decision|1|||
149177888|NCT03596645|538123912|FG000|Overall Study|Protocol Violation|1|||
149177889|NCT03596645|538123913|FG001|Overall Study|Protocol Violation|0|||
149013481|NCT01017120|537529166|FG001|Overall Study|Lost to Follow-up|11|||
149013482|NCT01017120|537529165|FG000|Overall Study|Lack of Efficacy|1|||
149013483|NCT01017120|537529166|FG001|Overall Study|Lack of Efficacy|0|||
149013484|NCT01017120|537529165|FG000|Overall Study|Withdrawal by Subject|39|||
149013485|NCT01017120|537529166|FG001|Overall Study|Withdrawal by Subject|21|||
149013486|NCT01017120|537529165|FG000|Overall Study|Pregnancy|1|||
149013487|NCT01017120|537529166|FG001|Overall Study|Pregnancy|1|||
149013488|NCT01017120|537529165|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
149013489|NCT01017120|537529166|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
149013490|NCT01017120|537529165|FG000|Overall Study|Relocated Out of Town|0|||
149013491|NCT01017120|537529166|FG001|Overall Study|Relocated Out of Town|2|||
149013492|NCT01017120|537529165|FG000|Overall Study|Protocol Violation|1|||
149013493|NCT01017120|537529166|FG001|Overall Study|Protocol Violation|0|||
149013494|NCT01017120|537529165|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
149013495|NCT01017120|537529166|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
149013496|NCT01912222|537529169|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
149013497|NCT01912222|537529170|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
149013498|NCT01912222|537529171|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
149013499|NCT01912222|537529169|FG000|Part B: Treatment Period|Progressive disease|10|||
149013500|NCT01912222|537529170|FG001|Part B: Treatment Period|Progressive disease|12|||
149013501|NCT01912222|537529171|FG002|Part B: Treatment Period|Progressive disease|15|||
149013502|NCT01912222|537529169|FG000|Part B: Treatment Period|Adverse Event|1|||
149013503|NCT01912222|537529170|FG001|Part B: Treatment Period|Adverse Event|2|||
149013504|NCT01912222|537529171|FG002|Part B: Treatment Period|Adverse Event|3|||
149013505|NCT01912222|537529169|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
149013506|NCT01912222|537529170|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
149013507|NCT01912222|537529171|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
149013508|NCT02961881|537529172|FG000|Overall Study|Adverse Event|1|||
149013509|NCT02961881|537529173|FG001|Overall Study|Adverse Event|2|||
149013510|NCT02961881|537529174|FG002|Overall Study|Adverse Event|2|||
149013511|NCT02961881|537529175|FG003|Overall Study|Adverse Event|0|||
149013512|NCT02961881|537529176|FG004|Overall Study|Adverse Event|1|||
149013513|NCT02961881|537529172|FG000|Overall Study|Participant request|0|||
149013514|NCT02961881|537529173|FG001|Overall Study|Participant request|2|||
149013515|NCT02961881|537529174|FG002|Overall Study|Participant request|0|||
149013516|NCT02961881|537529175|FG003|Overall Study|Participant request|0|||
149013517|NCT02961881|537529176|FG004|Overall Study|Participant request|0|||
149013518|NCT02961881|537529172|FG000|Overall Study|Disease progression|1|||
149013519|NCT02961881|537529173|FG001|Overall Study|Disease progression|0|||
149013520|NCT02961881|537529174|FG002|Overall Study|Disease progression|1|||
149013521|NCT02961881|537529175|FG003|Overall Study|Disease progression|0|||
149013522|NCT02961881|537529176|FG004|Overall Study|Disease progression|0|||
149013523|NCT04668989|537529187|FG000|First Intervention|Covid-19 related self-isolation|0|||
149013524|NCT04668989|537529188|FG001|First Intervention|Covid-19 related self-isolation|1|||
149013525|NCT04668989|537529187|FG000|Second Intervention|Adverse Event|0|||
149013526|NCT04668989|537529188|FG001|Second Intervention|Adverse Event|1|||
149013527|NCT05033743|537529192|FG000|Overall Study|Lost to Follow-up|1|||
149013528|NCT05033743|537529192|FG000|Overall Study|Protocol Violation|2|||
149013529|NCT05033743|537529192|FG000|Overall Study|Withdrawal by Subject|1|||
149013530|NCT01965158|537529193|FG000|Overall Study|Adverse Event|14|||
149013531|NCT01965158|537529194|FG001|Overall Study|Adverse Event|5|||
149013532|NCT01965158|537529193|FG000|Overall Study|Withdrawal by Subject|16|||
149013533|NCT01965158|537529194|FG001|Overall Study|Withdrawal by Subject|24|||
149013534|NCT01965158|537529193|FG000|Overall Study|Lost to Follow-up|7|||
149013535|NCT01965158|537529194|FG001|Overall Study|Lost to Follow-up|5|||
149177890|NCT03596645|538123912|FG000|Overall Study|Initiated Prohibited Medication|1|||
149177891|NCT03596645|538123913|FG001|Overall Study|Initiated Prohibited Medication|0|||
149177892|NCT03596645|538123912|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149177893|NCT03596645|538123913|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149177894|NCT03596645|538123912|FG000|Overall Study|No mucosal healing achieved|1|||
149177895|NCT03596645|538123913|FG001|Overall Study|No mucosal healing achieved|0|||
149177896|NCT03596645|538123912|FG000|Overall Study|Disease progression|1|||
149177897|NCT03596645|538123913|FG001|Overall Study|Disease progression|0|||
149013536|NCT01965158|537529193|FG000|Overall Study|Protocol Violation|1|||
149013537|NCT01965158|537529194|FG001|Overall Study|Protocol Violation|1|||
149177898|NCT03596645|538123912|FG000|Overall Study|Ongoing|37|||
149013538|NCT01965158|537529193|FG000|Overall Study|Other - Miscellaneous|3|||
149013539|NCT01965158|537529194|FG001|Overall Study|Other - Miscellaneous|0|||
149013540|NCT03066622|537529199|FG000|Overall Study|Lost to Follow-up|24|||
149177899|NCT03596645|538123913|FG001|Overall Study|Ongoing|12|||
149177900|NCT03596645|538123912|FG000|Overall Study|Randomized but not treated|0|||
149013541|NCT03066622|537529200|FG001|Overall Study|Lost to Follow-up|25|||
149013542|NCT03066622|537529199|FG000|Overall Study|Withdrawal by Subject|2|||
149013543|NCT03066622|537529200|FG001|Overall Study|Withdrawal by Subject|1|||
149177901|NCT03596645|538123913|FG001|Overall Study|Randomized but not treated|1|||
149177902|NCT04358458|538123914|FG000|Overall Study|Death|1|||
149177903|NCT04358458|538123915|FG001|Overall Study|Death|1|||
149177904|NCT04358458|538123916|FG002|Overall Study|Death|3|||
149177905|NCT04358458|538123917|FG003|Overall Study|Death|8|||
149177906|NCT04358458|538123918|FG004|Overall Study|Death|1|||
149177907|NCT04358458|538123919|FG005|Overall Study|Death|6|||
149177908|NCT04358458|538123920|FG006|Overall Study|Death|2|||
149177909|NCT04358458|538123921|FG007|Overall Study|Death|3|||
149177910|NCT04358458|538123914|FG000|Overall Study|Lost to Follow-up|0|||
149177911|NCT04358458|538123915|FG001|Overall Study|Lost to Follow-up|0|||
149177912|NCT04358458|538123916|FG002|Overall Study|Lost to Follow-up|0|||
149177913|NCT04358458|538123917|FG003|Overall Study|Lost to Follow-up|0|||
149177914|NCT04358458|538123918|FG004|Overall Study|Lost to Follow-up|0|||
149177915|NCT04358458|538123919|FG005|Overall Study|Lost to Follow-up|0|||
149177916|NCT04358458|538123920|FG006|Overall Study|Lost to Follow-up|0|||
149177917|NCT04358458|538123921|FG007|Overall Study|Lost to Follow-up|1|||
149177918|NCT04358458|538123914|FG000|Overall Study|Site is closing study participation|0|||
149177919|NCT04358458|538123915|FG001|Overall Study|Site is closing study participation|0|||
149177920|NCT04358458|538123916|FG002|Overall Study|Site is closing study participation|0|||
149177921|NCT04358458|538123917|FG003|Overall Study|Site is closing study participation|1|||
149177922|NCT04358458|538123918|FG004|Overall Study|Site is closing study participation|0|||
149177923|NCT04358458|538123919|FG005|Overall Study|Site is closing study participation|0|||
149177924|NCT04358458|538123920|FG006|Overall Study|Site is closing study participation|0|||
149177925|NCT04358458|538123921|FG007|Overall Study|Site is closing study participation|0|||
149177926|NCT04358458|538123914|FG000|Overall Study|Sponsor request|2|||
148930324|NCT01226043|537230265|FG003|30-week Observational Phase|Protocol Violation|1|||
149177927|NCT04358458|538123915|FG001|Overall Study|Sponsor request|3|||
149177928|NCT04358458|538123916|FG002|Overall Study|Sponsor request|3|||
149177929|NCT04358458|538123917|FG003|Overall Study|Sponsor request|0|||
149177930|NCT04358458|538123918|FG004|Overall Study|Sponsor request|2|||
149177931|NCT04358458|538123919|FG005|Overall Study|Sponsor request|3|||
149177932|NCT04358458|538123920|FG006|Overall Study|Sponsor request|1|||
149177933|NCT04358458|538123921|FG007|Overall Study|Sponsor request|1|||
149177934|NCT04358458|538123914|FG000|Overall Study|Withdrawal by Subject|0|||
149177935|NCT04358458|538123915|FG001|Overall Study|Withdrawal by Subject|0|||
149177936|NCT04358458|538123916|FG002|Overall Study|Withdrawal by Subject|1|||
149177937|NCT04358458|538123917|FG003|Overall Study|Withdrawal by Subject|1|||
149177938|NCT04358458|538123918|FG004|Overall Study|Withdrawal by Subject|0|||
149177939|NCT04358458|538123919|FG005|Overall Study|Withdrawal by Subject|1|||
149177940|NCT04358458|538123920|FG006|Overall Study|Withdrawal by Subject|0|||
148930325|NCT01226043|537230262|FG000|30-week Observational Phase|Lost to Follow-up|0|||
148930326|NCT01226043|537230263|FG001|30-week Observational Phase|Lost to Follow-up|0|||
149177941|NCT04358458|538123921|FG007|Overall Study|Withdrawal by Subject|1|||
149177942|NCT01843374|538125774|FG000|Overall Study|Death|155|||
149177943|NCT01843374|538125775|FG001|Overall Study|Death|313|||
149177944|NCT01843374|538125774|FG000|Overall Study|Withdrawal by Subject|14|||
149177945|NCT01843374|538125775|FG001|Overall Study|Withdrawal by Subject|20|||
149177946|NCT01843374|538125774|FG000|Overall Study|Withdrawing due to Other reason|20|||
149177947|NCT01843374|538125775|FG001|Overall Study|Withdrawing due to Other reason|46|||
149177948|NCT01123889|538125779|FG000|Overall Study|Lost to Follow-up|3|||
149177949|NCT01123889|538125780|FG001|Overall Study|Lost to Follow-up|1|||
149177950|NCT00443560|538125782|FG000|Overall Study|No intrathecal dose|58|||
149177951|NCT00443560|538125783|FG001|Overall Study|No intrathecal dose|26|||
149177952|NCT00443560|538125782|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
149177953|NCT00443560|538125783|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
149177954|NCT02082184|538125784|FG000|Overall Study|Adverse Event|1|||
149177955|NCT02082184|538125785|FG001|Overall Study|Adverse Event|0|||
149177956|NCT02082184|538125784|FG000|Overall Study|Medical diagnosis|1|||
149177957|NCT02082184|538125785|FG001|Overall Study|Medical diagnosis|2|||
149177958|NCT02082184|538125784|FG000|Overall Study|Device associated symptoms|5|||
149177959|NCT02082184|538125785|FG001|Overall Study|Device associated symptoms|0|||
148930327|NCT01226043|537230264|FG002|30-week Observational Phase|Lost to Follow-up|2|||
148930328|NCT01226043|537230265|FG003|30-week Observational Phase|Lost to Follow-up|2|||
149177960|NCT02082184|538125784|FG000|Overall Study|Withdrawal by Subject|3|||
149177961|NCT02082184|538125785|FG001|Overall Study|Withdrawal by Subject|2|||
149177962|NCT02082184|538125784|FG000|Overall Study|Protocol Violation|0|||
149177963|NCT02082184|538125785|FG001|Overall Study|Protocol Violation|6|||
149177964|NCT02082184|538125784|FG000|Overall Study|Lost to Follow-up|0|||
149177965|NCT02082184|538125785|FG001|Overall Study|Lost to Follow-up|2|||
149177966|NCT02082184|538125784|FG000|Overall Study|Subject non-compliance|0|||
149177967|NCT02082184|538125785|FG001|Overall Study|Subject non-compliance|1|||
149177968|NCT02413255|538125794|FG000|Overall Study|Voluntary Withdrawal|0|||
149177969|NCT02413255|538125795|FG001|Overall Study|Voluntary Withdrawal|0|||
149177970|NCT02413255|538125796|FG002|Overall Study|Voluntary Withdrawal|0|||
149177971|NCT02413255|538125797|FG003|Overall Study|Voluntary Withdrawal|0|||
149177972|NCT02413255|538125798|FG004|Overall Study|Voluntary Withdrawal|0|||
149177973|NCT02413255|538125799|FG005|Overall Study|Voluntary Withdrawal|0|||
149177974|NCT02413255|538125800|FG006|Overall Study|Voluntary Withdrawal|0|||
149177975|NCT02413255|538125801|FG007|Overall Study|Voluntary Withdrawal|0|||
149177976|NCT02413255|538125802|FG008|Overall Study|Voluntary Withdrawal|0|||
149177977|NCT02413255|538125803|FG009|Overall Study|Voluntary Withdrawal|0|||
149177978|NCT02413255|538125804|FG010|Overall Study|Voluntary Withdrawal|0|||
149177979|NCT02413255|538125805|FG011|Overall Study|Voluntary Withdrawal|0|||
148930329|NCT01226043|537230262|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
148930330|NCT01226043|537230263|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
148930331|NCT01226043|537230264|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
148930332|NCT01226043|537230265|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
148930333|NCT01226043|537230262|FG000|30-week Observational Phase|Physician Decision|0|||
148930334|NCT01226043|537230263|FG001|30-week Observational Phase|Physician Decision|0|||
148930335|NCT01226043|537230264|FG002|30-week Observational Phase|Physician Decision|2|||
148930336|NCT01226043|537230265|FG003|30-week Observational Phase|Physician Decision|2|||
148930337|NCT02204007|537230266|FG000|Overall Study|Surgery Canceled|1|||
148930338|NCT02204007|537230267|FG001|Overall Study|Surgery Canceled|1|||
148930339|NCT01702571|537230268|FG000|Overall Study|Death|1067|||
148930340|NCT01702571|537230269|FG001|Overall Study|Death|76|||
148930341|NCT01702571|537230268|FG000|Overall Study|Lost to Follow-up|144|||
148930342|NCT01702571|537230269|FG001|Overall Study|Lost to Follow-up|10|||
148930343|NCT01702571|537230268|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
148930344|NCT01702571|537230269|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
148930345|NCT01702571|537230268|FG000|Overall Study|Investigator Decision|5|||
148930346|NCT01702571|537230269|FG001|Overall Study|Investigator Decision|0|||
148930347|NCT01702571|537230268|FG000|Overall Study|Not Classifiable|1|||
148930348|NCT01702571|537230269|FG001|Overall Study|Not Classifiable|0|||
148930349|NCT01702571|537230268|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
148930350|NCT01702571|537230269|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
148930351|NCT01702571|537230268|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
148930352|NCT01702571|537230269|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
148930353|NCT01702571|537230268|FG000|Overall Study|Progressive Disease|3|||
148930354|NCT01702571|537230269|FG001|Overall Study|Progressive Disease|0|||
148930355|NCT01702571|537230268|FG000|Overall Study|Protocol Violation|2|||
148930356|NCT01702571|537230269|FG001|Overall Study|Protocol Violation|0|||
148930357|NCT01702571|537230268|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
148930358|NCT01702571|537230269|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
148930359|NCT01702571|537230268|FG000|Overall Study|Termination By Sponsor|4|||
148930360|NCT01702571|537230269|FG001|Overall Study|Termination By Sponsor|0|||
148930361|NCT01702571|537230268|FG000|Overall Study|Withdrawal by Subject|177|||
148930362|NCT01702571|537230269|FG001|Overall Study|Withdrawal by Subject|29|||
148930363|NCT00910988|537230270|FG000|Overall Study|Lost to Follow-up|2|||
148930364|NCT00910988|537230271|FG001|Overall Study|Lost to Follow-up|4|||
148930365|NCT00910988|537230272|FG002|Overall Study|Lost to Follow-up|3|||
148930366|NCT00910988|537230273|FG003|Overall Study|Lost to Follow-up|0|||
148930367|NCT05211284|537230281|FG000|Overall Study|Study Terminated|3|||
148930368|NCT05211284|537230282|FG001|Overall Study|Study Terminated|1|||
148930369|NCT03911843|537230287|FG000|Overall Study|Adverse Event|2|||
148930370|NCT03911843|537230288|FG001|Overall Study|Adverse Event|0|||
148930371|NCT03911843|537230287|FG000|Overall Study|Protocol Violation|2|||
148930372|NCT03911843|537230288|FG001|Overall Study|Protocol Violation|0|||
148930373|NCT03911843|537230287|FG000|Overall Study|Lost to Follow-up|0|||
148930374|NCT03911843|537230288|FG001|Overall Study|Lost to Follow-up|1|||
148930375|NCT02819518|537230289|FG000|Overall Study|Death|9|||
148930376|NCT02819518|537230290|FG001|Overall Study|Death|12|||
148930377|NCT02819518|537230291|FG002|Overall Study|Death|9|||
149013544|NCT00641719|537529201|FG000|Overall Study|Lack of Efficacy|1|||
149013545|NCT00641719|537529202|FG001|Overall Study|Lack of Efficacy|2|||
149013546|NCT00641719|537529201|FG000|Overall Study|Adverse Event|24|||
149013547|NCT00641719|537529202|FG001|Overall Study|Adverse Event|29|||
149013548|NCT00641719|537529201|FG000|Overall Study|Withdrawal by Subject|4|||
149177980|NCT02413255|538125806|FG012|Overall Study|Voluntary Withdrawal|0|||
148930378|NCT02819518|537230292|FG003|Overall Study|Death|475|||
148930379|NCT02819518|537230293|FG004|Overall Study|Death|244|||
148930380|NCT02819518|537230289|FG000|Overall Study|Withdrawal by Subject|0|||
148930381|NCT02819518|537230290|FG001|Overall Study|Withdrawal by Subject|0|||
148930382|NCT02819518|537230291|FG002|Overall Study|Withdrawal by Subject|0|||
149177981|NCT02413255|538125807|FG013|Overall Study|Voluntary Withdrawal|0|||
149177982|NCT02413255|538125808|FG014|Overall Study|Voluntary Withdrawal|1|||
148930383|NCT02819518|537230292|FG003|Overall Study|Withdrawal by Subject|25|||
148930384|NCT02819518|537230293|FG004|Overall Study|Withdrawal by Subject|8|||
148930385|NCT02819518|537230289|FG000|Overall Study|Lost to Follow-up|0|||
149013549|NCT00641719|537529202|FG001|Overall Study|Withdrawal by Subject|4|||
149013550|NCT00641719|537529201|FG000|Overall Study|Reason Not Specified|1|||
149177983|NCT02413255|538125809|FG015|Overall Study|Voluntary Withdrawal|0|||
148930386|NCT02819518|537230290|FG001|Overall Study|Lost to Follow-up|0|||
149013551|NCT00641719|537529202|FG001|Overall Study|Reason Not Specified|2|||
148930387|NCT02819518|537230291|FG002|Overall Study|Lost to Follow-up|0|||
148679125|NCT00996918|536299083|FG000|Overall Study|Lack of Efficacy|1|||
148679126|NCT00996918|536299084|FG001|Overall Study|Lack of Efficacy|1|||
148679127|NCT00996918|536299085|FG002|Overall Study|Lack of Efficacy|2|||
148679128|NCT00996918|536299086|FG003|Overall Study|Lack of Efficacy|2|||
148679129|NCT00996918|536299087|FG004|Overall Study|Lack of Efficacy|0|||
148679130|NCT00996918|536299083|FG000|Overall Study|Adverse Event|2|||
148679131|NCT00996918|536299084|FG001|Overall Study|Adverse Event|5|||
148679132|NCT00996918|536299085|FG002|Overall Study|Adverse Event|2|||
148679133|NCT00996918|536299086|FG003|Overall Study|Adverse Event|6|||
148679134|NCT00996918|536299087|FG004|Overall Study|Adverse Event|0|||
148679135|NCT00996918|536299083|FG000|Overall Study|Withdrawal by Subject|1|||
148679136|NCT00996918|536299084|FG001|Overall Study|Withdrawal by Subject|4|||
148679137|NCT00996918|536299085|FG002|Overall Study|Withdrawal by Subject|3|||
148679138|NCT00996918|536299086|FG003|Overall Study|Withdrawal by Subject|3|||
148679139|NCT00996918|536299087|FG004|Overall Study|Withdrawal by Subject|2|||
148679140|NCT00996918|536299083|FG000|Overall Study|Physician Decision|1|||
148679141|NCT00996918|536299084|FG001|Overall Study|Physician Decision|0|||
148679142|NCT00996918|536299085|FG002|Overall Study|Physician Decision|0|||
148679143|NCT00996918|536299086|FG003|Overall Study|Physician Decision|0|||
148679144|NCT00996918|536299087|FG004|Overall Study|Physician Decision|0|||
148679145|NCT00996918|536299083|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
148679146|NCT00996918|536299084|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
148679147|NCT00996918|536299085|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
148679148|NCT00996918|536299086|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
148679149|NCT00996918|536299087|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
148679150|NCT00996918|536299083|FG000|Overall Study|Loss of Caregiver|0|||
148679151|NCT00996918|536299084|FG001|Overall Study|Loss of Caregiver|1|||
148679152|NCT00996918|536299085|FG002|Overall Study|Loss of Caregiver|0|||
148679153|NCT00996918|536299086|FG003|Overall Study|Loss of Caregiver|0|||
148679154|NCT00996918|536299087|FG004|Overall Study|Loss of Caregiver|0|||
148679155|NCT00996918|536299083|FG000|Overall Study|Other|3|||
148679156|NCT00996918|536299084|FG001|Overall Study|Other|1|||
148679157|NCT00996918|536299085|FG002|Overall Study|Other|0|||
148679158|NCT00996918|536299086|FG003|Overall Study|Other|0|||
148679159|NCT00996918|536299087|FG004|Overall Study|Other|0|||
148679160|NCT01333475|536299090|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
148679161|NCT01333475|536299091|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
148679162|NCT01333475|536299090|FG000|Overall Study|Toxicity|1|||
148679163|NCT01333475|536299091|FG001|Overall Study|Toxicity|3|||
148679164|NCT04440007|536299092|FG000|Overall Study|Adverse Event|0|||
148679165|NCT04440007|536299093|FG001|Overall Study|Adverse Event|1|||
148679166|NCT04440007|536299092|FG000|Overall Study|Lost to Follow-up|1|||
148679167|NCT04440007|536299093|FG001|Overall Study|Lost to Follow-up|3|||
148679168|NCT04440007|536299092|FG000|Overall Study|Death|7|||
148679169|NCT04440007|536299093|FG001|Overall Study|Death|2|||
148679170|NCT04440007|536299092|FG000|Overall Study|Physician Decision|1|||
148679171|NCT04440007|536299093|FG001|Overall Study|Physician Decision|1|||
148679172|NCT04440007|536299092|FG000|Overall Study|Withdrawal by Subject|2|||
148679173|NCT04440007|536299093|FG001|Overall Study|Withdrawal by Subject|1|||
148679174|NCT04440007|536299092|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
148679175|NCT04440007|536299093|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
148679176|NCT04440007|536299092|FG000|Overall Study|Discontinued prior to dosing|0|||
148679177|NCT04440007|536299093|FG001|Overall Study|Discontinued prior to dosing|2|||
148930388|NCT02819518|537230292|FG003|Overall Study|Lost to Follow-up|0|||
148930389|NCT02819518|537230293|FG004|Overall Study|Lost to Follow-up|1|||
148679178|NCT03118765|536299094|FG000|Overall Study|Withdrawal by Subject|0|||
148679179|NCT03118765|536299095|FG001|Overall Study|Withdrawal by Subject|0|||
148679180|NCT03118765|536299096|FG002|Overall Study|Withdrawal by Subject|1|||
148679181|NCT03118765|536299097|FG003|Overall Study|Withdrawal by Subject|0|||
148679182|NCT03118765|536299098|FG004|Overall Study|Withdrawal by Subject|0|||
148930390|NCT02819518|537230289|FG000|Overall Study|Sponsor Decision|1|||
148679183|NCT03118765|536299094|FG000|Overall Study|Adverse Event|1|||
148679184|NCT03118765|536299095|FG001|Overall Study|Adverse Event|1|||
149177984|NCT02413255|538125810|FG016|Overall Study|Voluntary Withdrawal|0|||
149177985|NCT02333331|538125811|FG000|Overall Study|Adverse Event|1|||
149177986|NCT02333331|538125812|FG001|Overall Study|Adverse Event|0|||
149177987|NCT02333331|538125813|FG002|Overall Study|Adverse Event|4|||
149177988|NCT02333331|538125814|FG003|Overall Study|Adverse Event|1|||
149177989|NCT02333331|538125811|FG000|Overall Study|Death|0|||
149177990|NCT02333331|538125812|FG001|Overall Study|Death|0|||
149177991|NCT02333331|538125813|FG002|Overall Study|Death|2|||
149177992|NCT02333331|538125814|FG003|Overall Study|Death|0|||
149177993|NCT02333331|538125811|FG000|Overall Study|Lost to Follow-up|0|||
149177994|NCT02333331|538125812|FG001|Overall Study|Lost to Follow-up|0|||
149177995|NCT02333331|538125813|FG002|Overall Study|Lost to Follow-up|1|||
149177996|NCT02333331|538125814|FG003|Overall Study|Lost to Follow-up|0|||
149177997|NCT02333331|538125811|FG000|Overall Study|Physician Decision|0|||
149177998|NCT02333331|538125812|FG001|Overall Study|Physician Decision|1|||
149177999|NCT02333331|538125813|FG002|Overall Study|Physician Decision|0|||
149178000|NCT02333331|538125814|FG003|Overall Study|Physician Decision|0|||
149178001|NCT02333331|538125811|FG000|Overall Study|Protocol Deviation|0|||
149178002|NCT02333331|538125812|FG001|Overall Study|Protocol Deviation|3|||
149178003|NCT02333331|538125813|FG002|Overall Study|Protocol Deviation|2|||
149178004|NCT02333331|538125814|FG003|Overall Study|Protocol Deviation|1|||
149178005|NCT02333331|538125811|FG000|Overall Study|Patient/Guardian Decision|1|||
149178006|NCT02333331|538125812|FG001|Overall Study|Patient/Guardian Decision|2|||
149178007|NCT02333331|538125813|FG002|Overall Study|Patient/Guardian Decision|9|||
149178008|NCT02333331|538125814|FG003|Overall Study|Patient/Guardian Decision|1|||
149178009|NCT02413398|538125815|FG000|Overall Study|Lost to Follow-up|2|||
149178010|NCT02413398|538125816|FG001|Overall Study|Lost to Follow-up|4|||
149178011|NCT02413398|538125815|FG000|Overall Study|Withdrawal by Subject|1|||
149178012|NCT02413398|538125816|FG001|Overall Study|Withdrawal by Subject|1|||
149178013|NCT02413398|538125815|FG000|Overall Study|Other Eligibility criteria|1|||
149178014|NCT02413398|538125816|FG001|Overall Study|Other Eligibility criteria|2|||
149178015|NCT01494038|538125817|FG000|Overall Study|Protocol Violation|1|||
149178016|NCT01494038|538125818|FG001|Overall Study|Protocol Violation|1|||
149178017|NCT01494038|538125817|FG000|Overall Study|Lost to Follow-up|18|||
149178018|NCT01494038|538125818|FG001|Overall Study|Lost to Follow-up|20|||
149178019|NCT01494038|538125817|FG000|Overall Study|Withdrawal by Subject|44|||
149178020|NCT01494038|538125818|FG001|Overall Study|Withdrawal by Subject|34|||
149178021|NCT01494038|538125817|FG000|Overall Study|Not able to get to clinic|21|||
149178022|NCT01494038|538125818|FG001|Overall Study|Not able to get to clinic|15|||
149178023|NCT01494038|538125817|FG000|Overall Study|Not willing to adhere to reqs|2|||
149178024|NCT01494038|538125818|FG001|Overall Study|Not willing to adhere to reqs|9|||
149178025|NCT01494038|538125817|FG000|Overall Study|Death|2|||
149178026|NCT01494038|538125818|FG001|Overall Study|Death|4|||
149178027|NCT00537940|538125821|FG000|Overall Study|Adverse Event|20|||
149178028|NCT00537940|538125822|FG001|Overall Study|Adverse Event|19|||
149178029|NCT00537940|538125821|FG000|Overall Study|Lack of Efficacy|8|||
149178030|NCT00537940|538125822|FG001|Overall Study|Lack of Efficacy|16|||
149178031|NCT00537940|538125821|FG000|Overall Study|Lost to Follow-up|23|||
149178032|NCT00537940|538125822|FG001|Overall Study|Lost to Follow-up|29|||
149178033|NCT00537940|538125821|FG000|Overall Study|Withdrawal by Subject|113|||
149178034|NCT00537940|538125822|FG001|Overall Study|Withdrawal by Subject|95|||
149178035|NCT00537940|538125821|FG000|Overall Study|Protocol Violation|6|||
149178036|NCT00537940|538125822|FG001|Overall Study|Protocol Violation|4|||
149178037|NCT00537940|538125821|FG000|Overall Study|Pregnancy|1|||
149178038|NCT00537940|538125822|FG001|Overall Study|Pregnancy|1|||
149178039|NCT00537940|538125821|FG000|Overall Study|Study terminated by sponsor|2|||
149178040|NCT00537940|538125822|FG001|Overall Study|Study terminated by sponsor|3|||
149178041|NCT00537940|538125821|FG000|Overall Study|Other|10|||
149013552|NCT00885352|537529207|FG000|Overall Study|Adverse Event|2|||
149013553|NCT00885352|537529208|FG001|Overall Study|Adverse Event|3|||
149178042|NCT00537940|538125822|FG001|Overall Study|Other|12|||
149178043|NCT00685178|538125829|FG000|Overall Study|Adverse Event|1|||
149178044|NCT00685178|538125830|FG001|Overall Study|Adverse Event|5|||
149178045|NCT00685178|538125831|FG002|Overall Study|Adverse Event|2|||
149178046|NCT00685178|538125832|FG003|Overall Study|Adverse Event|4|||
149178047|NCT00685178|538125829|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
149178048|NCT00685178|538125830|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
149178049|NCT00685178|538125831|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
149178050|NCT00685178|538125832|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
149178051|NCT00685178|538125829|FG000|Overall Study|voluntary study discharge|4|||
149178052|NCT00685178|538125830|FG001|Overall Study|voluntary study discharge|5|||
149178053|NCT00685178|538125831|FG002|Overall Study|voluntary study discharge|1|||
149178054|NCT00685178|538125832|FG003|Overall Study|voluntary study discharge|1|||
149013554|NCT00885352|537529207|FG000|Overall Study|Lost to Follow-up|2|||
149178055|NCT00685178|538125829|FG000|Overall Study|incarcerated|1|||
149178056|NCT00685178|538125830|FG001|Overall Study|incarcerated|3|||
149178057|NCT00685178|538125831|FG002|Overall Study|incarcerated|7|||
149178058|NCT00685178|538125832|FG003|Overall Study|incarcerated|0|||
149178059|NCT00685178|538125829|FG000|Overall Study|administrative (disciplinary) discharge|0|||
148930391|NCT02819518|537230290|FG001|Overall Study|Sponsor Decision|1|||
148930392|NCT02819518|537230291|FG002|Overall Study|Sponsor Decision|0|||
148930393|NCT02819518|537230292|FG003|Overall Study|Sponsor Decision|34|||
148930394|NCT02819518|537230293|FG004|Overall Study|Sponsor Decision|17|||
148930395|NCT02819518|537230289|FG000|Overall Study|Transferred to extension study|1|||
148930396|NCT02819518|537230290|FG001|Overall Study|Transferred to extension study|1|||
148930397|NCT02819518|537230291|FG002|Overall Study|Transferred to extension study|1|||
148930398|NCT02819518|537230292|FG003|Overall Study|Transferred to extension study|32|||
148930399|NCT02819518|537230293|FG004|Overall Study|Transferred to extension study|11|||
148930400|NCT00880165|537230294|FG000|Overall Study|Withdrawal by Subject|27|||
148930401|NCT00880165|537230295|FG001|Overall Study|Withdrawal by Subject|23|||
148930402|NCT00880165|537230294|FG000|Overall Study|Not diagnosed with OSA|14|||
148930403|NCT00880165|537230295|FG001|Overall Study|Not diagnosed with OSA|8|||
149178060|NCT00685178|538125830|FG001|Overall Study|administrative (disciplinary) discharge|1|||
149178061|NCT00685178|538125831|FG002|Overall Study|administrative (disciplinary) discharge|0|||
149178062|NCT00685178|538125832|FG003|Overall Study|administrative (disciplinary) discharge|2|||
149178063|NCT00685178|538125829|FG000|Overall Study|Pregnancy|0|||
149178064|NCT00685178|538125830|FG001|Overall Study|Pregnancy|0|||
149178065|NCT00685178|538125831|FG002|Overall Study|Pregnancy|0|||
149178066|NCT00685178|538125832|FG003|Overall Study|Pregnancy|1|||
149178067|NCT00077623|538125838|FG000|Overall Study|Adverse Event|1|||
149178068|NCT00077623|538125839|FG001|Overall Study|Adverse Event|0|||
149178069|NCT00077623|538125840|FG002|Overall Study|Adverse Event|1|||
149178070|NCT00077623|538125838|FG000|Overall Study|Withdrawal by Subject|2|||
149178071|NCT00077623|538125839|FG001|Overall Study|Withdrawal by Subject|10|||
149178072|NCT00077623|538125840|FG002|Overall Study|Withdrawal by Subject|1|||
149178073|NCT00077623|538125838|FG000|Overall Study|Other-Non safety reason|18|||
149178074|NCT00077623|538125839|FG001|Overall Study|Other-Non safety reason|15|||
149178075|NCT00077623|538125840|FG002|Overall Study|Other-Non safety reason|19|||
149178076|NCT00077623|538125838|FG000|Overall Study|Insufficient therapeutic response|2|||
149178077|NCT00077623|538125839|FG001|Overall Study|Insufficient therapeutic response|0|||
149178078|NCT00077623|538125840|FG002|Overall Study|Insufficient therapeutic response|0|||
149178079|NCT00077623|538125838|FG000|Overall Study|Death|12|||
149178080|NCT00077623|538125839|FG001|Overall Study|Death|18|||
149178081|NCT00077623|538125840|FG002|Overall Study|Death|11|||
149178082|NCT00077623|538125838|FG000|Overall Study|Failure to return|1|||
149178083|NCT00077623|538125839|FG001|Overall Study|Failure to return|0|||
149178084|NCT00077623|538125840|FG002|Overall Study|Failure to return|0|||
149178085|NCT01334125|538125841|FG000|Overall Study|Lost to Follow-up|3|||
149178086|NCT01334125|538125842|FG001|Overall Study|Lost to Follow-up|3|||
149178087|NCT02138110|538125846|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
149178088|NCT02138110|538125846|FG000|Overall Scaffold Implantation|Death|3|||
149178089|NCT00882713|538125848|FG000|Overall Study|Adverse Event|2|||
149178090|NCT00882713|538125848|FG000|Overall Study|Death|3|||
149178091|NCT00882713|538125848|FG000|Overall Study|Administrative reasons|4|||
149178092|NCT00882713|538125848|FG000|Overall Study|refused treatment/withdrew consent|4|||
148679185|NCT03118765|536299096|FG002|Overall Study|Adverse Event|1|||
148679186|NCT03118765|536299097|FG003|Overall Study|Adverse Event|1|||
148679187|NCT03118765|536299098|FG004|Overall Study|Adverse Event|1|||
148679188|NCT03118765|536299094|FG000|Overall Study|Non compliance with Study Procedures|0|||
148679189|NCT03118765|536299095|FG001|Overall Study|Non compliance with Study Procedures|0|||
148930404|NCT00880165|537230294|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
148930405|NCT00880165|537230295|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
148930406|NCT00880165|537230294|FG000|Overall Study|Lost to follow|9|||
149178093|NCT00882713|538125848|FG000|Overall Study|Blood transfusion|2|||
149178094|NCT00882713|538125848|FG000|Overall Study|Insufficient therapeutic response|3|||
149178095|NCT00882713|538125848|FG000|Overall Study|Failure to return|2|||
149178096|NCT00882713|538125848|FG000|Overall Study|Other - Reasons|2|||
149178097|NCT05299892|538125851|FG000|Overall Study|Withdrawal by Subject|2|||
149178098|NCT01059812|538125852|FG000|Overall Study|Adverse Event|9|||
149178099|NCT01059812|538125853|FG001|Overall Study|Adverse Event|5|||
148807026|NCT00764790|536771092|FG002|Overall Study|Withdrawal by Subject|6|||
148807027|NCT00764790|536771090|FG000|Overall Study|Lost to Follow-up|28|||
148807028|NCT00764790|536771091|FG001|Overall Study|Lost to Follow-up|29|||
148807029|NCT00764790|536771092|FG002|Overall Study|Lost to Follow-up|23|||
148807030|NCT03533751|536771093|FG000|Overall Study|Withdrawal by Subject|12|||
148807031|NCT03533751|536771094|FG001|Overall Study|Withdrawal by Subject|6|||
148807032|NCT03533751|536771095|FG002|Overall Study|Withdrawal by Subject|11|||
148807033|NCT03533751|536771096|FG003|Overall Study|Withdrawal by Subject|9|||
148807034|NCT03533751|536771097|FG004|Overall Study|Withdrawal by Subject|10|||
148807035|NCT03533751|536771093|FG000|Overall Study|Adverse Event|4|||
148807036|NCT03533751|536771094|FG001|Overall Study|Adverse Event|7|||
148807037|NCT03533751|536771095|FG002|Overall Study|Adverse Event|2|||
148807038|NCT03533751|536771096|FG003|Overall Study|Adverse Event|4|||
148807039|NCT03533751|536771097|FG004|Overall Study|Adverse Event|5|||
148807040|NCT03533751|536771093|FG000|Overall Study|Physician Decision|0|||
148807041|NCT03533751|536771094|FG001|Overall Study|Physician Decision|2|||
148807042|NCT03533751|536771095|FG002|Overall Study|Physician Decision|1|||
148807043|NCT03533751|536771096|FG003|Overall Study|Physician Decision|2|||
149013555|NCT00885352|537529208|FG001|Overall Study|Lost to Follow-up|2|||
149178100|NCT01059812|538125852|FG000|Overall Study|Lack of Efficacy|2|||
149178101|NCT01059812|538125853|FG001|Overall Study|Lack of Efficacy|2|||
149178102|NCT01059812|538125852|FG000|Overall Study|Protocol Violation|3|||
149178103|NCT01059812|538125853|FG001|Overall Study|Protocol Violation|1|||
149178104|NCT01059812|538125852|FG000|Overall Study|Withdrawal Criteria|9|||
149178105|NCT01059812|538125853|FG001|Overall Study|Withdrawal Criteria|4|||
149178106|NCT01059812|538125852|FG000|Overall Study|Unclassified|14|||
149178107|NCT01059812|538125853|FG001|Overall Study|Unclassified|4|||
149178108|NCT01389128|538125854|FG000|Overall Study|Fetal distress|1|||
149178109|NCT01389128|538125855|FG001|Overall Study|Fetal distress|0|||
149178110|NCT01389128|538125854|FG000|Overall Study|Cervix dilation stop|1|||
149178111|NCT01389128|538125855|FG001|Overall Study|Cervix dilation stop|2|||
149178112|NCT01389128|538125854|FG000|Overall Study|Rapid labor evolution|3|||
149178113|NCT01389128|538125855|FG001|Overall Study|Rapid labor evolution|2|||
149178114|NCT01389128|538125854|FG000|Overall Study|Intolerance to procedure|0|||
149178115|NCT01389128|538125855|FG001|Overall Study|Intolerance to procedure|2|||
149013556|NCT00885352|537529207|FG000|Overall Study|Physician Decision|0|||
149178116|NCT03180736|538125857|FG000|Overall Study|Adverse Event|3|||
149178117|NCT03180736|538125858|FG001|Overall Study|Adverse Event|4|||
149178118|NCT03180736|538125857|FG000|Overall Study|Death|10|||
148679190|NCT03118765|536299096|FG002|Overall Study|Non compliance with Study Procedures|0|||
148679191|NCT03118765|536299097|FG003|Overall Study|Non compliance with Study Procedures|1|||
148679192|NCT03118765|536299098|FG004|Overall Study|Non compliance with Study Procedures|0|||
148679193|NCT03118765|536299094|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
148679194|NCT03118765|536299095|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
148679195|NCT03118765|536299096|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
148679196|NCT03118765|536299097|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
148679197|NCT03118765|536299098|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
148679198|NCT03118765|536299094|FG000|Overall Study|COPD Exacerbation|1|||
149178119|NCT03180736|538125858|FG001|Overall Study|Death|7|||
148679199|NCT03118765|536299095|FG001|Overall Study|COPD Exacerbation|0|||
148679200|NCT03118765|536299096|FG002|Overall Study|COPD Exacerbation|0|||
148679201|NCT03118765|536299097|FG003|Overall Study|COPD Exacerbation|1|||
148679202|NCT03118765|536299098|FG004|Overall Study|COPD Exacerbation|0|||
148679203|NCT03118765|536299094|FG000|Overall Study|Lost to Follow-up|1|||
148679204|NCT03118765|536299095|FG001|Overall Study|Lost to Follow-up|0|||
148679205|NCT03118765|536299096|FG002|Overall Study|Lost to Follow-up|1|||
148679206|NCT03118765|536299097|FG003|Overall Study|Lost to Follow-up|0|||
148679207|NCT03118765|536299098|FG004|Overall Study|Lost to Follow-up|0|||
148679208|NCT03118765|536299094|FG000|Overall Study|Sponsor Decision|1|||
148679209|NCT03118765|536299095|FG001|Overall Study|Sponsor Decision|0|||
148679210|NCT03118765|536299096|FG002|Overall Study|Sponsor Decision|1|||
148679211|NCT03118765|536299097|FG003|Overall Study|Sponsor Decision|0|||
148679212|NCT03118765|536299098|FG004|Overall Study|Sponsor Decision|1|||
148679213|NCT03674827|536299099|FG000|Treatment Phase|Adverse Event|0|||
148679214|NCT03674827|536299100|FG001|Treatment Phase|Adverse Event|0|||
148679215|NCT03674827|536299101|FG002|Treatment Phase|Adverse Event|0|||
148679216|NCT03674827|536299102|FG003|Treatment Phase|Adverse Event|0|||
148679217|NCT03674827|536299103|FG004|Treatment Phase|Adverse Event|0|||
148679218|NCT03674827|536299104|FG005|Treatment Phase|Adverse Event|2|||
148679219|NCT03674827|536299099|FG000|Treatment Phase|Death|2|||
148679220|NCT03674827|536299100|FG001|Treatment Phase|Death|0|||
148679221|NCT03674827|536299101|FG002|Treatment Phase|Death|0|||
148679222|NCT03674827|536299102|FG003|Treatment Phase|Death|0|||
148679223|NCT03674827|536299103|FG004|Treatment Phase|Death|1|||
148679224|NCT03674827|536299104|FG005|Treatment Phase|Death|0|||
148679225|NCT03674827|536299099|FG000|Treatment Phase|Progressive Disease|0|||
148679226|NCT03674827|536299100|FG001|Treatment Phase|Progressive Disease|4|||
148679227|NCT03674827|536299101|FG002|Treatment Phase|Progressive Disease|3|||
148679228|NCT03674827|536299102|FG003|Treatment Phase|Progressive Disease|4|||
148679229|NCT03674827|536299103|FG004|Treatment Phase|Progressive Disease|4|||
148679230|NCT03674827|536299104|FG005|Treatment Phase|Progressive Disease|9|||
148679231|NCT03674827|536299099|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
148679232|NCT03674827|536299100|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
148679233|NCT03674827|536299101|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
148679234|NCT03674827|536299102|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
149178120|NCT03180736|538125857|FG000|Overall Study|Withdrawal by Subject|5|||
149178121|NCT03180736|538125858|FG001|Overall Study|Withdrawal by Subject|12|||
149178122|NCT03180736|538125857|FG000|Overall Study|Lost to Follow-up|1|||
149178123|NCT03180736|538125858|FG001|Overall Study|Lost to Follow-up|0|||
149178124|NCT03180736|538125857|FG000|Overall Study|Lack of Efficacy|66|||
149178125|NCT03180736|538125858|FG001|Overall Study|Lack of Efficacy|87|||
149178126|NCT03180736|538125857|FG000|Overall Study|Physician Decision|4|||
149178127|NCT03180736|538125858|FG001|Overall Study|Physician Decision|7|||
149178128|NCT03180736|538125857|FG000|Overall Study|randomized but not treated|2|||
149178129|NCT03180736|538125858|FG001|Overall Study|randomized but not treated|3|||
148679235|NCT03674827|536299103|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
149013557|NCT00885352|537529208|FG001|Overall Study|Physician Decision|3|||
149178130|NCT00149214|538125859|FG000|Overall Study|Adverse Event|12|||
148679236|NCT03674827|536299104|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
148679237|NCT03674827|536299099|FG000|Treatment Phase|Withdrawal by Subject|0|||
148679238|NCT03674827|536299100|FG001|Treatment Phase|Withdrawal by Subject|0|||
148679239|NCT03674827|536299101|FG002|Treatment Phase|Withdrawal by Subject|0|||
148679240|NCT03674827|536299102|FG003|Treatment Phase|Withdrawal by Subject|0|||
148679241|NCT03674827|536299103|FG004|Treatment Phase|Withdrawal by Subject|0|||
148679242|NCT03674827|536299104|FG005|Treatment Phase|Withdrawal by Subject|1|||
148679243|NCT03674827|536299099|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
148679244|NCT03674827|536299100|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
149178131|NCT00149214|538125860|FG001|Overall Study|Adverse Event|9|||
149178132|NCT00149214|538125859|FG000|Overall Study|Withdrawal by Subject|4|||
149178133|NCT00149214|538125860|FG001|Overall Study|Withdrawal by Subject|1|||
148679245|NCT03674827|536299101|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
148679246|NCT03674827|536299102|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
148679247|NCT03674827|536299103|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
148679248|NCT03674827|536299104|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
148679249|NCT03674827|536299099|FG000|Treatment Phase|Other|0|||
148679250|NCT03674827|536299100|FG001|Treatment Phase|Other|1|||
148679251|NCT03674827|536299101|FG002|Treatment Phase|Other|0|||
148679252|NCT03674827|536299102|FG003|Treatment Phase|Other|0|||
148679253|NCT03674827|536299103|FG004|Treatment Phase|Other|0|||
148679254|NCT03674827|536299104|FG005|Treatment Phase|Other|1|||
148679255|NCT03674827|536299099|FG000|Long-Term Follow-up Phase|Death|2|||
148679256|NCT03674827|536299100|FG001|Long-Term Follow-up Phase|Death|4|||
148679257|NCT03674827|536299101|FG002|Long-Term Follow-up Phase|Death|2|||
148679258|NCT03674827|536299102|FG003|Long-Term Follow-up Phase|Death|3|||
148679259|NCT03674827|536299103|FG004|Long-Term Follow-up Phase|Death|2|||
148679260|NCT03674827|536299104|FG005|Long-Term Follow-up Phase|Death|6|||
148679261|NCT03674827|536299099|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
148679262|NCT03674827|536299100|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
148679263|NCT03674827|536299101|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
148679264|NCT03674827|536299102|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
148679265|NCT03674827|536299103|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
148679266|NCT03674827|536299104|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
148679267|NCT03674827|536299099|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
148679268|NCT03674827|536299100|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
148679269|NCT03674827|536299101|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
148679270|NCT03674827|536299102|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
148679271|NCT03674827|536299103|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
148679272|NCT03674827|536299104|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
148679273|NCT00363129|536299109|FG000|Overall Study|Withdrawal by Subject|11|||
148679274|NCT00363129|536299110|FG001|Overall Study|Withdrawal by Subject|18|||
148679275|NCT00363129|536299109|FG000|Overall Study|Adverse Event|8|||
148679276|NCT00363129|536299110|FG001|Overall Study|Adverse Event|3|||
148679277|NCT00363129|536299109|FG000|Overall Study|Alternate Treatment|2|||
148679278|NCT00363129|536299110|FG001|Overall Study|Alternate Treatment|4|||
149178134|NCT00149214|538125859|FG000|Overall Study|Physician Decision|3|||
149178135|NCT00149214|538125860|FG001|Overall Study|Physician Decision|3|||
149178136|NCT00149214|538125859|FG000|Overall Study|Sponsor Decision|0|||
149178137|NCT00149214|538125860|FG001|Overall Study|Sponsor Decision|1|||
149178138|NCT00149214|538125859|FG000|Overall Study|Progressive Disease|7|||
149178139|NCT00149214|538125860|FG001|Overall Study|Progressive Disease|3|||
149178140|NCT00756002|538125864|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
149178141|NCT00756002|538125865|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
149178142|NCT00756002|538125864|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149178143|NCT00756002|538125865|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149178144|NCT00756002|538125864|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
149178145|NCT00756002|538125865|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
149178146|NCT00756002|538125864|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
149178147|NCT00756002|538125865|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
149178148|NCT00756002|538125864|FG000|Double-Blind Treatment Period|Other|2|||
149178149|NCT00756002|538125865|FG001|Double-Blind Treatment Period|Other|2|||
149178150|NCT00174941|538125871|FG000|Overall Study|Adverse Event|1|||
148679279|NCT00363129|536299109|FG000|Overall Study|Other Medical Problems|2|||
148679280|NCT00363129|536299110|FG001|Overall Study|Other Medical Problems|4|||
148679281|NCT00363129|536299109|FG000|Overall Study|Death|0|||
148679282|NCT00363129|536299110|FG001|Overall Study|Death|1|||
148679283|NCT00363129|536299109|FG000|Overall Study|Other Reasons|6|||
148679284|NCT00363129|536299110|FG001|Overall Study|Other Reasons|3|||
148679285|NCT03707522|536299111|FG000|Overall Study|Lost to Follow-up|24|||
148679286|NCT03707522|536299112|FG001|Overall Study|Lost to Follow-up|27|||
148930407|NCT00880165|537230295|FG001|Overall Study|Lost to follow|15|||
148930408|NCT01907100|537230296|FG000|Overall Study|PD based on modified RECIST criteria|31|||
148930409|NCT01907100|537230297|FG001|Overall Study|PD based on modified RECIST criteria|32|||
148930410|NCT01907100|537230298|FG002|Overall Study|PD based on modified RECIST criteria|95|||
148930411|NCT01907100|537230299|FG003|Overall Study|PD based on modified RECIST criteria|92|||
148930412|NCT01907100|537230296|FG000|Overall Study|Withdrawal by Subject|2|||
149178151|NCT00174941|538125872|FG001|Overall Study|Adverse Event|10|||
149178152|NCT00174941|538125873|FG002|Overall Study|Adverse Event|2|||
149178153|NCT00174941|538125874|FG003|Overall Study|Adverse Event|13|||
149178154|NCT00174941|538125871|FG000|Overall Study|Protocol Violation|0|||
148679287|NCT03707522|536299113|FG002|Overall Study|Lost to Follow-up|41|||
148679288|NCT03707522|536299114|FG003|Overall Study|Lost to Follow-up|36|||
148679289|NCT05166512|536299115|FG000|Randomized|Lost to Follow-up|2|||
148679290|NCT05166512|536299116|FG001|Randomized|Lost to Follow-up|0|||
148679291|NCT05166512|536299115|FG000|Randomized|Withdrawal by Subject|1|||
148930413|NCT01907100|537230297|FG001|Overall Study|Withdrawal by Subject|5|||
149178155|NCT00174941|538125872|FG001|Overall Study|Protocol Violation|1|||
149178156|NCT00174941|538125873|FG002|Overall Study|Protocol Violation|0|||
149178157|NCT00174941|538125874|FG003|Overall Study|Protocol Violation|1|||
148679292|NCT05166512|536299116|FG001|Randomized|Withdrawal by Subject|0|||
148679293|NCT05166512|536299115|FG000|Baseline Data Collection|Lost to Follow-up|0|||
148807044|NCT03533751|536771097|FG004|Overall Study|Physician Decision|1|||
149178158|NCT00174941|538125871|FG000|Overall Study|Lost to Follow-up|0|||
149178159|NCT00174941|538125872|FG001|Overall Study|Lost to Follow-up|3|||
149178160|NCT00174941|538125873|FG002|Overall Study|Lost to Follow-up|2|||
149178161|NCT00174941|538125874|FG003|Overall Study|Lost to Follow-up|5|||
149178162|NCT00174941|538125871|FG000|Overall Study|Personal Reason(s)|0|||
149178163|NCT00174941|538125872|FG001|Overall Study|Personal Reason(s)|14|||
149178164|NCT00174941|538125873|FG002|Overall Study|Personal Reason(s)|8|||
149178165|NCT00174941|538125874|FG003|Overall Study|Personal Reason(s)|22|||
149178166|NCT00174941|538125871|FG000|Overall Study|Gout Flare|0|||
149178167|NCT00174941|538125872|FG001|Overall Study|Gout Flare|4|||
149178168|NCT00174941|538125873|FG002|Overall Study|Gout Flare|4|||
149178169|NCT00174941|538125874|FG003|Overall Study|Gout Flare|8|||
149178170|NCT00174941|538125871|FG000|Overall Study|Reason Not Specified|1|||
149178171|NCT00174941|538125872|FG001|Overall Study|Reason Not Specified|6|||
149178172|NCT00174941|538125873|FG002|Overall Study|Reason Not Specified|2|||
149178173|NCT00174941|538125874|FG003|Overall Study|Reason Not Specified|9|||
149178174|NCT01844076|538125886|FG000|Overall Study|Adverse Event|1|||
149178175|NCT01844076|538125887|FG001|Overall Study|Adverse Event|0|||
149178176|NCT01844076|538125888|FG002|Overall Study|Adverse Event|0|||
149178177|NCT01844076|538125889|FG003|Overall Study|Adverse Event|0|||
149178178|NCT01844076|538125886|FG000|Overall Study|Withdrawal by Subject|1|||
149178179|NCT01844076|538125887|FG001|Overall Study|Withdrawal by Subject|0|||
149178180|NCT01844076|538125888|FG002|Overall Study|Withdrawal by Subject|0|||
149178181|NCT01844076|538125889|FG003|Overall Study|Withdrawal by Subject|0|||
149178182|NCT03794986|538125896|FG000|Overall Study|0 Sessions Attended|34|||
149178183|NCT03794986|538125897|FG001|Overall Study|0 Sessions Attended|37|||
149178184|NCT03794986|538125896|FG000|Overall Study|Withdrawal by Subject|4|||
149178185|NCT03794986|538125897|FG001|Overall Study|Withdrawal by Subject|6|||
149178186|NCT03794986|538125896|FG000|Overall Study|Protocol Violation|1|||
149178187|NCT03794986|538125897|FG001|Overall Study|Protocol Violation|0|||
149178188|NCT05309083|538125898|FG000|Overall Study|Withdrawal by Subject|2|||
149178189|NCT00474253|538125899|FG000|Overall Study|Withdrew consent|2|||
149178190|NCT00474253|538125900|FG001|Overall Study|Withdrew consent|0|||
149178191|NCT00474253|538125899|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
149178192|NCT00474253|538125900|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
149178193|NCT00474253|538125899|FG000|Overall Study|Lost to Follow-up|1|||
149178194|NCT00474253|538125900|FG001|Overall Study|Lost to Follow-up|0|||
149178195|NCT00474253|538125899|FG000|Overall Study|Discharged prior to study completion|0|||
149178196|NCT00474253|538125900|FG001|Overall Study|Discharged prior to study completion|1|||
149178197|NCT01165229|538125901|FG000|Overall Study|Serious Adverse Event|456|||
149178198|NCT01165229|538125902|FG001|Overall Study|Serious Adverse Event|487|||
149178199|NCT01165229|538125901|FG000|Overall Study|Non-Serious Adverse Event|47|||
149178200|NCT01165229|538125902|FG001|Overall Study|Non-Serious Adverse Event|15|||
149178201|NCT01165229|538125901|FG000|Overall Study|Protocol Violation|6|||
149178202|NCT01165229|538125902|FG001|Overall Study|Protocol Violation|8|||
149178203|NCT01165229|538125901|FG000|Overall Study|Withdrawal by Subject|387|||
149178204|NCT01165229|538125902|FG001|Overall Study|Withdrawal by Subject|396|||
149178205|NCT01165229|538125901|FG000|Overall Study|Migrated/moved from study area|51|||
149178206|NCT01165229|538125902|FG001|Overall Study|Migrated/moved from study area|46|||
149178207|NCT01165229|538125901|FG000|Overall Study|Lost to Follow-up|123|||
149178208|NCT01165229|538125902|FG001|Overall Study|Lost to Follow-up|133|||
149178209|NCT01165229|538125901|FG000|Overall Study|Suspected HZ Episode|2|||
148930414|NCT01907100|537230298|FG002|Overall Study|Withdrawal by Subject|10|||
148930415|NCT01907100|537230299|FG003|Overall Study|Withdrawal by Subject|13|||
148930416|NCT01907100|537230296|FG000|Overall Study|Protocol Violation|0|||
148930417|NCT01907100|537230297|FG001|Overall Study|Protocol Violation|0|||
148930418|NCT01907100|537230298|FG002|Overall Study|Protocol Violation|1|||
149178210|NCT01165229|538125902|FG001|Overall Study|Suspected HZ Episode|2|||
149178211|NCT01165229|538125901|FG000|Overall Study|No reason from the subject|108|||
149178212|NCT01165229|538125902|FG001|Overall Study|No reason from the subject|102|||
149178213|NCT01165229|538125901|FG000|Overall Study|Unknown completion status|0|||
149178214|NCT01165229|538125902|FG001|Overall Study|Unknown completion status|1|||
149178215|NCT00550238|538125906|FG000|Overall Study|Adverse Event|88|||
149178216|NCT00550238|538125906|FG000|Overall Study|Death|34|||
149178217|NCT00550238|538125906|FG000|Overall Study|Disease progression|46|||
149178218|NCT00550238|538125906|FG000|Overall Study|Withdrawal by Subject|167|||
149178219|NCT00550238|538125906|FG000|Overall Study|Physician Decision|31|||
149178220|NCT00550238|538125906|FG000|Overall Study|Patient noncompliance|25|||
149178221|NCT00550238|538125906|FG000|Overall Study|Lost to Follow-up|13|||
149178222|NCT00550238|538125906|FG000|Overall Study|Sponsor decision|55|||
149178223|NCT03133481|538125907|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
149178224|NCT03133481|538125908|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
149178225|NCT03000452|538125913|FG000|Treatment Period|Death|1|||
149178226|NCT03000452|538125913|FG000|Treatment Period|Progressive Disease (PD)|14|||
149178227|NCT03000452|538125913|FG000|Treatment Period|Physician Decision|1|||
148930419|NCT01907100|537230299|FG003|Overall Study|Protocol Violation|1|||
149178228|NCT03000452|538125913|FG000|Treatment Period|Miscellaneous|2|||
148930420|NCT01907100|537230296|FG000|Overall Study|Lost to Follow-up|0|||
149013558|NCT00885352|537529207|FG000|Overall Study|Protocol Violation|0|||
149013559|NCT00885352|537529208|FG001|Overall Study|Protocol Violation|2|||
149178229|NCT03000452|538125913|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
149178230|NCT03000452|538125913|FG000|Follow-Up Period|Death|3|||
148930421|NCT01907100|537230297|FG001|Overall Study|Lost to Follow-up|0|||
148930422|NCT01907100|537230298|FG002|Overall Study|Lost to Follow-up|0|||
148930423|NCT01907100|537230299|FG003|Overall Study|Lost to Follow-up|1|||
148930424|NCT01907100|537230296|FG000|Overall Study|Not treated|2|||
148930425|NCT01907100|537230297|FG001|Overall Study|Not treated|0|||
148930426|NCT01907100|537230298|FG002|Overall Study|Not treated|1|||
148930427|NCT01907100|537230299|FG003|Overall Study|Not treated|2|||
148930428|NCT01907100|537230296|FG000|Overall Study|Other than reasons specified|1|||
149013560|NCT00885352|537529207|FG000|Overall Study|Withdrawal by Subject|1|||
149178231|NCT03000452|538125913|FG000|Follow-Up Period|Withdrawal by Subject|3|||
149178232|NCT05372315|538125916|FG000|Overall Study|Withdrawal by Subject|1|||
149178233|NCT05372315|538125917|FG001|Overall Study|Withdrawal by Subject|0|||
149178234|NCT00537745|538125918|FG000|Overall Study|Did not meet eligibility criteria|2|||
149178235|NCT00537745|538125918|FG000|Overall Study|Withdrawal by Subject|2|||
149178236|NCT00537745|538125918|FG000|Overall Study|Subject unable to provide Interlock info|1|||
149178237|NCT01512368|538125919|FG000|Overall Study|Protocol Violation|3|||
149178238|NCT03700892|538125924|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
149178239|NCT03700892|538125925|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
149178240|NCT03700892|538125926|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
149178241|NCT00849212|538125927|FG000|Overall Study|Lack of Efficacy|1|||
149178242|NCT00849212|538125927|FG000|Overall Study|Withdrawal by Subject|3|||
149178243|NCT00849212|538125927|FG000|Overall Study|Adverse Event|2|||
149178244|NCT00849212|538125927|FG000|Overall Study|Miscellaneous|1|||
149178245|NCT04407507|538125928|FG000|Overall Study|Withdrawal by Subject|0|||
149178246|NCT04407507|538125929|FG001|Overall Study|Withdrawal by Subject|1|||
149178247|NCT01499576|538125930|FG000|Overall Study|Physician Decision|12|||
149178248|NCT01499576|538125930|FG000|Overall Study|Withdrawal by Subject|9|||
149178249|NCT01662999|538125934|FG000|Period 3|Withdrawal by Subject|0|||
149178250|NCT01662999|538125935|FG001|Period 3|Withdrawal by Subject|1|||
149178251|NCT01662999|538125936|FG002|Period 3|Withdrawal by Subject|0|||
149178252|NCT01662999|538125937|FG003|Period 3|Withdrawal by Subject|0|||
149178253|NCT01662999|538125938|FG004|Period 3|Withdrawal by Subject|0|||
149178254|NCT01662999|538125939|FG005|Period 3|Withdrawal by Subject|0|||
149178255|NCT02426086|538125940|FG000|Overall Study|Death|33|||
149178256|NCT02426086|538125941|FG001|Overall Study|Death|36|||
149178257|NCT02426086|538125940|FG000|Overall Study|Lost to Follow-up|2|||
149178258|NCT02426086|538125941|FG001|Overall Study|Lost to Follow-up|0|||
149178259|NCT02426086|538125940|FG000|Overall Study|Study Terminated by Sponsor|5|||
149178260|NCT02426086|538125941|FG001|Overall Study|Study Terminated by Sponsor|14|||
149178261|NCT02426086|538125940|FG000|Overall Study|Withdrawal by Subject|8|||
149178262|NCT02426086|538125941|FG001|Overall Study|Withdrawal by Subject|9|||
149178263|NCT00524303|538125942|FG000|Overall Study|Lost to Follow-up|6|||
148930429|NCT01907100|537230297|FG001|Overall Study|Other than reasons specified|0|||
148930430|NCT01907100|537230298|FG002|Overall Study|Other than reasons specified|10|||
148930431|NCT01907100|537230299|FG003|Overall Study|Other than reasons specified|6|||
149178264|NCT00524303|538125943|FG001|Overall Study|Lost to Follow-up|0|||
149178265|NCT00524303|538125944|FG002|Overall Study|Lost to Follow-up|3|||
149178266|NCT00524303|538125942|FG000|Overall Study|Protocol Violation|0|||
149178267|NCT00524303|538125943|FG001|Overall Study|Protocol Violation|1|||
149178268|NCT00524303|538125944|FG002|Overall Study|Protocol Violation|1|||
149178269|NCT00524303|538125942|FG000|Overall Study|Withdrawal by Subject|3|||
149178270|NCT00524303|538125943|FG001|Overall Study|Withdrawal by Subject|0|||
149178271|NCT00524303|538125944|FG002|Overall Study|Withdrawal by Subject|4|||
149178272|NCT00524303|538125942|FG000|Overall Study|Death|0|||
149178273|NCT00524303|538125943|FG001|Overall Study|Death|2|||
149178274|NCT00524303|538125944|FG002|Overall Study|Death|3|||
149013561|NCT00885352|537529208|FG001|Overall Study|Withdrawal by Subject|5|||
149178275|NCT00524303|538125942|FG000|Overall Study|Adverse Event|1|||
148679294|NCT05166512|536299116|FG001|Baseline Data Collection|Lost to Follow-up|3|||
148679295|NCT05166512|536299115|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
148679296|NCT05166512|536299116|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
148807045|NCT03533751|536771093|FG000|Overall Study|Sponsor Decision|0|||
148807046|NCT03533751|536771094|FG001|Overall Study|Sponsor Decision|0|||
148807047|NCT03533751|536771095|FG002|Overall Study|Sponsor Decision|1|||
148807048|NCT03533751|536771096|FG003|Overall Study|Sponsor Decision|1|||
148807049|NCT03533751|536771097|FG004|Overall Study|Sponsor Decision|0|||
148807050|NCT03533751|536771093|FG000|Overall Study|Lost to Follow-up|3|||
148807051|NCT03533751|536771094|FG001|Overall Study|Lost to Follow-up|7|||
148807052|NCT03533751|536771095|FG002|Overall Study|Lost to Follow-up|6|||
148807053|NCT03533751|536771096|FG003|Overall Study|Lost to Follow-up|4|||
148807054|NCT03533751|536771097|FG004|Overall Study|Lost to Follow-up|3|||
148807055|NCT03533751|536771093|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
148807056|NCT03533751|536771094|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
148807057|NCT03533751|536771095|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
148807058|NCT03533751|536771096|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
148807059|NCT03533751|536771097|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
148807060|NCT03533751|536771093|FG000|Overall Study|Other|0|||
148807061|NCT03533751|536771094|FG001|Overall Study|Other|2|||
148807062|NCT03533751|536771095|FG002|Overall Study|Other|1|||
148807063|NCT03533751|536771096|FG003|Overall Study|Other|0|||
148807064|NCT03533751|536771097|FG004|Overall Study|Other|3|||
148807065|NCT03082729|536771100|FG000|Overall Study|Lost to Follow-up|7|||
148807066|NCT03082729|536771100|FG000|Overall Study|Physician Decision|2|||
148807067|NCT03082729|536771100|FG000|Overall Study|Withdrawal by Subject|1|||
148807068|NCT03082729|536771100|FG000|Overall Study|Lack of Efficacy|9|||
148930432|NCT01907100|537230296|FG000|Overall Study|Adverse event (AE)|6|||
148679297|NCT05166512|536299115|FG000|Baseline Data Collection|Protocol Violation|2|||
148679298|NCT05166512|536299116|FG001|Baseline Data Collection|Protocol Violation|0|||
148679299|NCT05166512|536299115|FG000|4 Month Data Collection|Lost to Follow-up|1|||
148679300|NCT05166512|536299116|FG001|4 Month Data Collection|Lost to Follow-up|0|||
148679301|NCT05166512|536299115|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
148679302|NCT05166512|536299116|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
148679303|NCT05166512|536299115|FG000|12 Month Data Collection|Lost to Follow-up|3|||
148679304|NCT05166512|536299116|FG001|12 Month Data Collection|Lost to Follow-up|1|||
148679305|NCT05166512|536299115|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
148679306|NCT05166512|536299116|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
148679307|NCT00383019|536299117|FG000|Overall Study|Adverse Event|5|||
148679308|NCT00383019|536299118|FG001|Overall Study|Adverse Event|1|||
148679309|NCT00383019|536299117|FG000|Overall Study|Withdrawal by Subject|0|||
148679310|NCT00383019|536299118|FG001|Overall Study|Withdrawal by Subject|1|||
148679311|NCT00420849|536299119|FG000|Overall Study|Lack of Efficacy|154|||
148679312|NCT00420849|536299119|FG000|Overall Study|Adverse Event|107|||
148679313|NCT00420849|536299119|FG000|Overall Study|Withdrawal by Subject|28|||
148679314|NCT00420849|536299119|FG000|Overall Study|Death|18|||
148679315|NCT00420849|536299119|FG000|Overall Study|Other|14|||
148679316|NCT00420849|536299119|FG000|Overall Study|Transplant|8|||
148679317|NCT00420849|536299119|FG000|Overall Study|Protocol Violation|1|||
148679318|NCT00420849|536299119|FG000|Overall Study|Lost to Follow-up|1|||
148679319|NCT02278952|536299120|FG000|Overall Study|Insufficient Sample|6|||
148679320|NCT00659581|536299121|FG000|Overall Study|Adverse Event|1006|||
148679321|NCT00659581|536299121|FG000|Overall Study|Lack of Efficacy|1183|||
148679322|NCT00659581|536299121|FG000|Overall Study|Other|6393|||
148679323|NCT00725725|536299125|FG000|Overall Study|Adverse Event|1|||
148679324|NCT00725725|536299126|FG001|Overall Study|Adverse Event|3|||
148679325|NCT00725725|536299127|FG002|Overall Study|Adverse Event|2|||
148679326|NCT00725725|536299125|FG000|Overall Study|Lost to Follow-up|2|||
148679327|NCT00725725|536299126|FG001|Overall Study|Lost to Follow-up|0|||
148679328|NCT00725725|536299127|FG002|Overall Study|Lost to Follow-up|2|||
148679329|NCT00725725|536299125|FG000|Overall Study|Withdrawal by Subject|1|||
148679330|NCT00725725|536299126|FG001|Overall Study|Withdrawal by Subject|0|||
148930433|NCT01907100|537230297|FG001|Overall Study|Adverse event (AE)|3|||
148930434|NCT01907100|537230298|FG002|Overall Study|Adverse event (AE)|22|||
148930435|NCT01907100|537230299|FG003|Overall Study|Adverse event (AE)|23|||
148679331|NCT00725725|536299127|FG002|Overall Study|Withdrawal by Subject|1|||
148679332|NCT00725725|536299125|FG000|Overall Study|Protocol Violation|0|||
148679333|NCT00725725|536299126|FG001|Overall Study|Protocol Violation|1|||
148679334|NCT00725725|536299127|FG002|Overall Study|Protocol Violation|0|||
148807069|NCT03082729|536771100|FG000|Overall Study|Adverse Event|4|||
148930436|NCT01907100|537230296|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
148679335|NCT01619085|536299128|FG000|Overall Study|Adverse Event|231|||
148679336|NCT01619085|536299128|FG000|Overall Study|Protocol Violation|4|||
148807070|NCT03082729|536771100|FG000|Overall Study|Protocol Violation|6|||
148930437|NCT01907100|537230297|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
148807071|NCT03082729|536771100|FG000|Overall Study|Fear of study procedure|1|||
148807072|NCT03082729|536771100|FG000|Overall Study|Scheduling conflict|1|||
148807073|NCT03454555|536773167|FG000|Overall Study|Death|6|||
148930438|NCT01907100|537230298|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
149178276|NCT00524303|538125943|FG001|Overall Study|Adverse Event|2|||
149178277|NCT00524303|538125944|FG002|Overall Study|Adverse Event|3|||
149178278|NCT00524303|538125942|FG000|Overall Study|Did not Complete Study Dosing|1|||
149178279|NCT00524303|538125943|FG001|Overall Study|Did not Complete Study Dosing|0|||
149178280|NCT00524303|538125944|FG002|Overall Study|Did not Complete Study Dosing|0|||
149178281|NCT00524303|538125942|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
149178282|NCT00524303|538125943|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
149178283|NCT00524303|538125944|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
149178284|NCT00524303|538125942|FG000|Overall Study|Disease Progression|0|||
149178285|NCT00524303|538125943|FG001|Overall Study|Disease Progression|4|||
149178286|NCT00524303|538125944|FG002|Overall Study|Disease Progression|1|||
149178287|NCT00524303|538125942|FG000|Overall Study|Disease Recurrence|0|||
149178288|NCT00524303|538125943|FG001|Overall Study|Disease Recurrence|1|||
149178289|NCT00524303|538125944|FG002|Overall Study|Disease Recurrence|0|||
149178290|NCT00524303|538125942|FG000|Overall Study|Sponsor Request|0|||
149178291|NCT00524303|538125943|FG001|Overall Study|Sponsor Request|0|||
149178292|NCT00524303|538125944|FG002|Overall Study|Sponsor Request|1|||
149178293|NCT00524303|538125942|FG000|Overall Study|Physician Decision|0|||
149178294|NCT00524303|538125943|FG001|Overall Study|Physician Decision|0|||
149178295|NCT00524303|538125944|FG002|Overall Study|Physician Decision|1|||
149178296|NCT00524303|538125942|FG000|Overall Study|Completed 5 years|0|||
149178297|NCT00524303|538125943|FG001|Overall Study|Completed 5 years|0|||
149178298|NCT00524303|538125944|FG002|Overall Study|Completed 5 years|1|||
149178299|NCT03478683|538125945|FG000|Overall Study|Adverse Event|5|||
149178300|NCT03478683|538125946|FG001|Overall Study|Adverse Event|3|||
149178301|NCT03478683|538125945|FG000|Overall Study|Lost to Follow-up|0|||
149178302|NCT03478683|538125946|FG001|Overall Study|Lost to Follow-up|5|||
149178303|NCT03478683|538125945|FG000|Overall Study|Physician Decision|1|||
149178304|NCT03478683|538125946|FG001|Overall Study|Physician Decision|3|||
149178305|NCT03478683|538125945|FG000|Overall Study|Withdrawal by Subject|7|||
149178306|NCT03478683|538125946|FG001|Overall Study|Withdrawal by Subject|7|||
149178307|NCT01769404|538125947|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
149178308|NCT01769404|538125948|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
149178309|NCT01769404|538125947|FG000|Treatment Period 1|Withdrawal by Subject|3|||
149178310|NCT01769404|538125948|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149178311|NCT01769404|538125947|FG000|Treatment Period 1|Sponsor decision|1|||
149178312|NCT01769404|538125948|FG001|Treatment Period 1|Sponsor decision|0|||
149178313|NCT01769404|538125947|FG000|Treatment Period 2|Sponsor decision|7|||
149178314|NCT01769404|538125948|FG001|Treatment Period 2|Sponsor decision|0|||
149233953|NCT04678557|538324969|FG001|Overall Study|Withdrawal by Subject|0|||
149233954|NCT04678557|538324968|FG000|Overall Study|Lack of Efficacy|0|||
149233955|NCT04678557|538324969|FG001|Overall Study|Lack of Efficacy|13|||
149233956|NCT04678557|538324968|FG000|Overall Study|Safety Evaluation|0|||
149233957|NCT04678557|538324969|FG001|Overall Study|Safety Evaluation|1|||
149233958|NCT00509223|538326342|FG000|Overall Study|Lost to Follow-up|1|||
149233959|NCT00509223|538326343|FG001|Overall Study|Lost to Follow-up|1|||
149233960|NCT00509223|538326342|FG000|Overall Study|Adverse Event|1|||
149233961|NCT00509223|538326343|FG001|Overall Study|Adverse Event|1|||
149233962|NCT00509223|538326342|FG000|Overall Study|Withdrawal by Subject|25|||
149233963|NCT00509223|538326343|FG001|Overall Study|Withdrawal by Subject|6|||
149233964|NCT00509223|538326342|FG000|Overall Study|Including: subject change of address|5|||
149233965|NCT00509223|538326343|FG001|Overall Study|Including: subject change of address|2|||
149233966|NCT00509223|538326342|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
149233967|NCT00509223|538326343|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
149233968|NCT01339273|538326344|FG000|Overall Study|Lost to Follow-up|8|||
149233969|NCT01339273|538326345|FG001|Overall Study|Lost to Follow-up|8|||
149233970|NCT01422876|538326346|FG000|Week 24|Lost to Follow-up|1|||
149233971|NCT01422876|538326347|FG001|Week 24|Lost to Follow-up|1|||
149233972|NCT01422876|538326348|FG002|Week 24|Lost to Follow-up|2|||
149233973|NCT01422876|538326349|FG003|Week 24|Lost to Follow-up|4|||
149233974|NCT01422876|538326350|FG004|Week 24|Lost to Follow-up|2|||
149233975|NCT01422876|538326351|FG005|Week 24|Lost to Follow-up|0|||
149233976|NCT01422876|538326352|FG006|Week 24|Lost to Follow-up|1|||
149233977|NCT01422876|538326353|FG007|Week 24|Lost to Follow-up|3|||
149233978|NCT01422876|538326354|FG008|Week 24|Lost to Follow-up|3|||
149233979|NCT01422876|538326355|FG009|Week 24|Lost to Follow-up|4|||
149233980|NCT01422876|538326346|FG000|Week 24|Consent withdrawn|5|||
149233981|NCT01422876|538326347|FG001|Week 24|Consent withdrawn|1|||
149233982|NCT01422876|538326348|FG002|Week 24|Consent withdrawn|3|||
149233983|NCT01422876|538326349|FG003|Week 24|Consent withdrawn|4|||
149233984|NCT01422876|538326350|FG004|Week 24|Consent withdrawn|5|||
149233985|NCT01422876|538326351|FG005|Week 24|Consent withdrawn|6|||
149233986|NCT01422876|538326352|FG006|Week 24|Consent withdrawn|5|||
149233987|NCT01422876|538326353|FG007|Week 24|Consent withdrawn|4|||
149233988|NCT01422876|538326354|FG008|Week 24|Consent withdrawn|3|||
149233989|NCT01422876|538326355|FG009|Week 24|Consent withdrawn|6|||
149233990|NCT01422876|538326346|FG000|Week 24|Death|0|||
149233991|NCT01422876|538326347|FG001|Week 24|Death|1|||
149178315|NCT01330381|538127563|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
149178316|NCT01330381|538127564|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
149178317|NCT01330381|538127565|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
149178318|NCT01330381|538127563|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
149178319|NCT01330381|538127564|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
149178320|NCT01330381|538127565|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
149178321|NCT01330381|538127563|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
149178322|NCT01330381|538127564|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
148930439|NCT01907100|537230299|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
148930440|NCT01758289|537230300|FG000|Overall Study|Premature Study Termination|44|||
148930441|NCT01758289|537230300|FG000|Overall Study|Adverse Event|9|||
148930442|NCT00667602|537230303|FG000|Overall Study|Withdrawal by Subject|4|||
148930443|NCT00667602|537230304|FG001|Overall Study|Withdrawal by Subject|9|||
148930444|NCT00667602|537230305|FG002|Overall Study|Withdrawal by Subject|10|||
148930445|NCT00667602|537230303|FG000|Overall Study|Lost to Follow-up|4|||
148930446|NCT00667602|537230304|FG001|Overall Study|Lost to Follow-up|5|||
148930447|NCT00667602|537230305|FG002|Overall Study|Lost to Follow-up|6|||
148930448|NCT00667602|537230303|FG000|Overall Study|Administrative reason|0|||
148930449|NCT00667602|537230304|FG001|Overall Study|Administrative reason|0|||
148930450|NCT00667602|537230305|FG002|Overall Study|Administrative reason|2|||
148930451|NCT00667602|537230303|FG000|Overall Study|Protocol Violation|0|||
148930452|NCT00667602|537230304|FG001|Overall Study|Protocol Violation|1|||
148930453|NCT00667602|537230305|FG002|Overall Study|Protocol Violation|0|||
148930454|NCT03640559|537230310|FG000|Overall Study|Physician Decision|1|||
148930455|NCT03640559|537230311|FG001|Overall Study|Physician Decision|1|||
148930456|NCT03640559|537230310|FG000|Overall Study|Withdrawal by Subject|1|||
148930457|NCT03640559|537230311|FG001|Overall Study|Withdrawal by Subject|0|||
148930458|NCT01436162|537230312|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
148930459|NCT01436162|537230313|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
148930460|NCT01436162|537230314|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
148930461|NCT01436162|537230312|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
148930462|NCT01436162|537230313|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
148930463|NCT01436162|537230314|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
148930464|NCT01436162|537230312|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
148930465|NCT01436162|537230313|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
148930466|NCT01436162|537230314|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
148930467|NCT01436162|537230312|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
148930468|NCT01436162|537230313|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
148930469|NCT01436162|537230314|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
148930470|NCT01436162|537230312|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
148930471|NCT01436162|537230313|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148930472|NCT01436162|537230314|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
148930473|NCT01436162|537230312|FG000|Single-blind Lead-in Phase|Other|107|||
148930474|NCT01436162|537230313|FG001|Single-blind Lead-in Phase|Other|0|||
148930475|NCT01436162|537230314|FG002|Single-blind Lead-in Phase|Other|0|||
148930476|NCT01436162|537230312|FG000|Randomized Phase|Adverse Event|1|||
148930477|NCT01436162|537230313|FG001|Randomized Phase|Adverse Event|5|||
148930478|NCT01436162|537230314|FG002|Randomized Phase|Adverse Event|6|||
148930479|NCT01436162|537230312|FG000|Randomized Phase|Protocol Violation|4|||
148930480|NCT01436162|537230313|FG001|Randomized Phase|Protocol Violation|4|||
148930481|NCT01436162|537230314|FG002|Randomized Phase|Protocol Violation|2|||
148930482|NCT01436162|537230312|FG000|Randomized Phase|Withdrawal by Subject|16|||
148930483|NCT01436162|537230313|FG001|Randomized Phase|Withdrawal by Subject|9|||
148930484|NCT01436162|537230314|FG002|Randomized Phase|Withdrawal by Subject|8|||
148930485|NCT01436162|537230312|FG000|Randomized Phase|Lost to Follow-up|17|||
148930486|NCT01436162|537230313|FG001|Randomized Phase|Lost to Follow-up|5|||
148930487|NCT01436162|537230314|FG002|Randomized Phase|Lost to Follow-up|4|||
148930488|NCT01436162|537230312|FG000|Randomized Phase|Lack of Efficacy|0|||
148930489|NCT01436162|537230313|FG001|Randomized Phase|Lack of Efficacy|1|||
148930490|NCT01436162|537230314|FG002|Randomized Phase|Lack of Efficacy|1|||
148930491|NCT01436162|537230312|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
148930492|NCT01436162|537230313|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
148930493|NCT01436162|537230314|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
148930494|NCT01436162|537230312|FG000|Randomized Phase|Other|2|||
148930495|NCT01436162|537230313|FG001|Randomized Phase|Other|5|||
148930496|NCT01436162|537230314|FG002|Randomized Phase|Other|4|||
148930497|NCT00395538|537230315|FG000|Overall Study|Did not re-consent to revised protocol|1|||
148930498|NCT00395538|537230316|FG001|Overall Study|Did not re-consent to revised protocol|10|||
148930499|NCT00395538|537230317|FG002|Overall Study|Did not re-consent to revised protocol|0|||
148679337|NCT01619085|536299128|FG000|Overall Study|Lost to Follow-up|3|||
148679338|NCT01619085|536299128|FG000|Overall Study|Withdrawal by Subject|45|||
148679339|NCT01619085|536299128|FG000|Overall Study|Other than specified|96|||
148679340|NCT01619085|536299128|FG000|Overall Study|Not treated|1|||
148679341|NCT01619085|536299128|FG000|Overall Study|Death|145|||
148679342|NCT01345058|536299129|FG000|Overall Study|Withdrawal by Subject|1|||
148679343|NCT01345058|536299130|FG001|Overall Study|Withdrawal by Subject|0|||
148679344|NCT01345058|536299129|FG000|Overall Study|Participant Reported Increase in Events|1|||
148679345|NCT01345058|536299130|FG001|Overall Study|Participant Reported Increase in Events|0|||
148679346|NCT01345058|536299129|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
148679347|NCT01345058|536299130|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
148679348|NCT01345058|536299129|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
148679349|NCT01345058|536299130|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
148679350|NCT01345058|536299129|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
148679351|NCT01345058|536299130|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
148679352|NCT00000135|536299131|FG000|Overall Study|Death|27|||
148679353|NCT00000135|536299132|FG001|Overall Study|Death|14|||
148679354|NCT04816877|536299133|FG000|Overall Study|Withdrawal by Subject|1|||
148679355|NCT04816877|536299134|FG001|Overall Study|Withdrawal by Subject|0|||
148679356|NCT00759759|536299137|FG000|Overall Study|didn't return for period 2|1|||
148679357|NCT00759759|536299138|FG001|Overall Study|didn't return for period 2|0|||
148679358|NCT00759759|536299137|FG000|Overall Study|Didn't receive drug in period 2|1|||
148930500|NCT00395538|537230315|FG000|Overall Study|FDA partial hold on PTH|0|||
148930501|NCT00395538|537230316|FG001|Overall Study|FDA partial hold on PTH|0|||
148930502|NCT00395538|537230317|FG002|Overall Study|FDA partial hold on PTH|11|||
148930503|NCT00395538|537230315|FG000|Overall Study|Failed screening|0|||
148930504|NCT00395538|537230316|FG001|Overall Study|Failed screening|0|||
148930505|NCT00395538|537230317|FG002|Overall Study|Failed screening|4|||
148930506|NCT00395538|537230315|FG000|Overall Study|Switch to Natpara|0|||
148930507|NCT00395538|537230316|FG001|Overall Study|Switch to Natpara|0|||
149178323|NCT01330381|538127565|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
149178324|NCT01330381|538127563|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
149178325|NCT01330381|538127564|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
149178326|NCT01330381|538127565|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
149178327|NCT01330381|538127563|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
149178328|NCT01330381|538127564|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
149178329|NCT01330381|538127565|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
149178330|NCT01330381|538127563|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
149178331|NCT01330381|538127564|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
149178332|NCT01330381|538127565|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
149178333|NCT01330381|538127563|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
149178334|NCT01330381|538127564|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
149178335|NCT01330381|538127565|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
149178336|NCT01330381|538127563|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
149178337|NCT01330381|538127564|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
149178338|NCT01330381|538127565|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
148930508|NCT00395538|537230317|FG002|Overall Study|Switch to Natpara|3|||
149178339|NCT01330381|538127563|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
149178340|NCT01330381|538127564|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
149178341|NCT01330381|538127565|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
149178342|NCT01330381|538127563|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
149178343|NCT01330381|538127564|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
149178344|NCT01330381|538127565|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
148679359|NCT00759759|536299138|FG001|Overall Study|Didn't receive drug in period 2|0|||
148679360|NCT00759759|536299137|FG000|Overall Study|Withdrawal by Subject|2|||
148679361|NCT00759759|536299138|FG001|Overall Study|Withdrawal by Subject|1|||
148679362|NCT01861717|536299142|FG000|Overall Study|Lost to Follow-up|1|||
148679363|NCT01861717|536299142|FG000|Overall Study|Withdrawal by Subject|1|||
148679364|NCT00681824|536300751|FG000|Overall Study|withdrawn by investigator|0|||
148679365|NCT00681824|536300752|FG001|Overall Study|withdrawn by investigator|0|||
148679366|NCT00681824|536300753|FG002|Overall Study|withdrawn by investigator|1|||
148679367|NCT00681824|536300751|FG000|Overall Study|scheduling conflict|1|||
148679368|NCT00681824|536300752|FG001|Overall Study|scheduling conflict|0|||
148679369|NCT00681824|536300753|FG002|Overall Study|scheduling conflict|0|||
148679370|NCT00681824|536300751|FG000|Overall Study|Death|0|||
148679371|NCT00681824|536300752|FG001|Overall Study|Death|1|||
148679372|NCT00681824|536300753|FG002|Overall Study|Death|0|||
148679373|NCT03724916|536300754|FG000|Overall Study|Withdrawal by Subject|0|||
148679374|NCT03724916|536300755|FG001|Overall Study|Withdrawal by Subject|1|||
148930509|NCT00395538|537230315|FG000|Overall Study|Adverse Event|1|||
148679375|NCT03724916|536300756|FG002|Overall Study|Withdrawal by Subject|1|||
148930510|NCT00395538|537230316|FG001|Overall Study|Adverse Event|0|||
149178345|NCT01978912|538127567|FG000|Overall Study|Adverse Event|0|||
149178346|NCT01978912|538127568|FG001|Overall Study|Adverse Event|1|||
149178347|NCT01978912|538127569|FG002|Overall Study|Adverse Event|0|||
149178348|NCT01978912|538127570|FG003|Overall Study|Adverse Event|0|||
149178349|NCT01978912|538127567|FG000|Overall Study|Lost to Follow-up|1|||
149178350|NCT01978912|538127568|FG001|Overall Study|Lost to Follow-up|1|||
149178351|NCT01978912|538127569|FG002|Overall Study|Lost to Follow-up|0|||
149178352|NCT01978912|538127570|FG003|Overall Study|Lost to Follow-up|1|||
149178353|NCT01978912|538127567|FG000|Overall Study|Withdrawal by Subject|1|||
149178354|NCT01978912|538127568|FG001|Overall Study|Withdrawal by Subject|0|||
149178355|NCT01978912|538127569|FG002|Overall Study|Withdrawal by Subject|2|||
149178356|NCT01978912|538127570|FG003|Overall Study|Withdrawal by Subject|2|||
149178357|NCT01978912|538127567|FG000|Overall Study|Lumbar Surgery|1|||
149178358|NCT01978912|538127568|FG001|Overall Study|Lumbar Surgery|0|||
149178359|NCT01978912|538127569|FG002|Overall Study|Lumbar Surgery|1|||
149178360|NCT01978912|538127570|FG003|Overall Study|Lumbar Surgery|0|||
149178361|NCT01978912|538127567|FG000|Overall Study|Intradiscal Steroid Injection|0|||
149178362|NCT01978912|538127568|FG001|Overall Study|Intradiscal Steroid Injection|1|||
149178363|NCT01978912|538127569|FG002|Overall Study|Intradiscal Steroid Injection|0|||
149178364|NCT01978912|538127570|FG003|Overall Study|Intradiscal Steroid Injection|0|||
149178365|NCT00401973|538127571|FG000|Overall Study|Adverse Event|2|||
149178366|NCT00401973|538127572|FG001|Overall Study|Adverse Event|8|||
149178367|NCT00401973|538127573|FG002|Overall Study|Adverse Event|4|||
149178368|NCT00401973|538127571|FG000|Overall Study|Clinical Relapse|0|||
148679376|NCT03724916|536300757|FG003|Overall Study|Withdrawal by Subject|2|||
148679377|NCT03724916|536300754|FG000|Overall Study|Randomized but not Treated|1|||
148679378|NCT03724916|536300755|FG001|Overall Study|Randomized but not Treated|0|||
148679379|NCT03724916|536300756|FG002|Overall Study|Randomized but not Treated|0|||
148679380|NCT03724916|536300757|FG003|Overall Study|Randomized but not Treated|0|||
148679381|NCT02464059|536300764|FG000|Overall Study|Lost to Follow-up|6|||
148679382|NCT03591107|536300765|FG000|Overall Study|Same patient in both arms|1|||
148679383|NCT03591107|536300766|FG001|Overall Study|Same patient in both arms|1|||
148679384|NCT03591107|536300765|FG000|Overall Study|Sought care at other clinics|0|||
148679385|NCT03591107|536300766|FG001|Overall Study|Sought care at other clinics|2|||
148679386|NCT03591107|536300765|FG000|Overall Study|Discharged from clinic|0|||
148679387|NCT03591107|536300766|FG001|Overall Study|Discharged from clinic|1|||
148679388|NCT03591107|536300765|FG000|Overall Study|Withdrawal by Subject|0|||
148679389|NCT03591107|536300766|FG001|Overall Study|Withdrawal by Subject|1|||
148679390|NCT00736099|536300767|FG000|Overall Study|Adverse Event|61|||
148679391|NCT00736099|536300768|FG001|Overall Study|Adverse Event|18|||
148679392|NCT00736099|536300767|FG000|Overall Study|Protocol Violation|10|||
148679393|NCT00736099|536300768|FG001|Overall Study|Protocol Violation|4|||
148679394|NCT00736099|536300767|FG000|Overall Study|Lost to Follow-up|12|||
148679395|NCT00736099|536300768|FG001|Overall Study|Lost to Follow-up|5|||
148679396|NCT00736099|536300767|FG000|Overall Study|Withdrawal by Subject|42|||
148679397|NCT00736099|536300768|FG001|Overall Study|Withdrawal by Subject|13|||
148679398|NCT00736099|536300767|FG000|Overall Study|Lack of Efficacy|15|||
148679399|NCT00736099|536300768|FG001|Overall Study|Lack of Efficacy|8|||
148679400|NCT00736099|536300767|FG000|Overall Study|Other reason|43|||
148679401|NCT00736099|536300768|FG001|Overall Study|Other reason|10|||
148679402|NCT02773446|536300775|FG000|First Admission|Withdrawal by Subject|0|||
148679403|NCT02773446|536300776|FG001|First Admission|Withdrawal by Subject|0|||
148679404|NCT02773446|536300777|FG002|First Admission|Withdrawal by Subject|0|||
148679405|NCT02773446|536300778|FG003|First Admission|Withdrawal by Subject|1|||
149178369|NCT00401973|538127572|FG001|Overall Study|Clinical Relapse|1|||
149178370|NCT00401973|538127573|FG002|Overall Study|Clinical Relapse|1|||
148679406|NCT02773446|536300779|FG004|First Admission|Withdrawal by Subject|0|||
148679407|NCT02773446|536300780|FG005|First Admission|Withdrawal by Subject|0|||
148679408|NCT02773446|536300775|FG000|First Admission|Lost to Follow-up|1|||
148679409|NCT02773446|536300776|FG001|First Admission|Lost to Follow-up|0|||
148679410|NCT02773446|536300777|FG002|First Admission|Lost to Follow-up|0|||
149178371|NCT00401973|538127571|FG000|Overall Study|Lack of Efficacy|0|||
148679411|NCT02773446|536300778|FG003|First Admission|Lost to Follow-up|0|||
149178372|NCT00401973|538127572|FG001|Overall Study|Lack of Efficacy|0|||
149178373|NCT00401973|538127573|FG002|Overall Study|Lack of Efficacy|3|||
149178374|NCT00401973|538127571|FG000|Overall Study|Lost to Follow-up|2|||
149178375|NCT00401973|538127572|FG001|Overall Study|Lost to Follow-up|2|||
149178376|NCT00401973|538127573|FG002|Overall Study|Lost to Follow-up|2|||
149178377|NCT00401973|538127571|FG000|Overall Study|Physician Decision|2|||
149178378|NCT00401973|538127572|FG001|Overall Study|Physician Decision|0|||
149178379|NCT00401973|538127573|FG002|Overall Study|Physician Decision|1|||
149178380|NCT00401973|538127571|FG000|Overall Study|Protocol Violation|1|||
149178381|NCT00401973|538127572|FG001|Overall Study|Protocol Violation|2|||
149178382|NCT00401973|538127573|FG002|Overall Study|Protocol Violation|3|||
149178383|NCT00401973|538127571|FG000|Overall Study|Sponsor Decision|0|||
149178384|NCT00401973|538127572|FG001|Overall Study|Sponsor Decision|1|||
149178385|NCT00401973|538127573|FG002|Overall Study|Sponsor Decision|0|||
149178386|NCT00401973|538127571|FG000|Overall Study|Withdrawal by Subject|4|||
149178387|NCT00401973|538127572|FG001|Overall Study|Withdrawal by Subject|12|||
149178388|NCT00401973|538127573|FG002|Overall Study|Withdrawal by Subject|9|||
149178389|NCT01408537|538127574|FG000|Overall Study|Withdrawal by Subject|2|||
149178390|NCT01408537|538127574|FG000|Overall Study|Protocol Violation|3|||
149178391|NCT01408537|538127574|FG000|Overall Study|Lost to Follow-up|3|||
149178392|NCT04075604|538127583|FG000|Overall Study|Adverse Event|0|||
149178393|NCT04075604|538127584|FG001|Overall Study|Adverse Event|0|||
149178394|NCT04075604|538127585|FG002|Overall Study|Adverse Event|3|||
149178395|NCT04075604|538127583|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149178396|NCT04075604|538127584|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149178397|NCT04075604|538127585|FG002|Overall Study|Participant request to discontinue study treatment|1|||
149178398|NCT04075604|538127583|FG000|Overall Study|Participant withdrew consent|0|||
149178399|NCT04075604|538127584|FG001|Overall Study|Participant withdrew consent|0|||
149178400|NCT04075604|538127585|FG002|Overall Study|Participant withdrew consent|1|||
149178401|NCT04075604|538127583|FG000|Overall Study|Other reasons|1|||
149178402|NCT04075604|538127584|FG001|Overall Study|Other reasons|0|||
149178403|NCT04075604|538127585|FG002|Overall Study|Other reasons|0|||
149178404|NCT04075604|538127583|FG000|Overall Study|Disease progression|0|||
149178405|NCT04075604|538127584|FG001|Overall Study|Disease progression|1|||
149178406|NCT04075604|538127585|FG002|Overall Study|Disease progression|0|||
149178407|NCT04075604|538127583|FG000|Overall Study|Study drug toxicity|0|||
149178408|NCT04075604|538127584|FG001|Overall Study|Study drug toxicity|5|||
149178409|NCT04075604|538127585|FG002|Overall Study|Study drug toxicity|1|||
149178410|NCT02760602|538127586|FG000|Overall Study|Withdrawal by Subject|1|||
149178411|NCT02760602|538127587|FG001|Overall Study|Withdrawal by Subject|0|||
149178412|NCT02760602|538127586|FG000|Overall Study|Terminated by sponsor|12|||
149178413|NCT02760602|538127587|FG001|Overall Study|Terminated by sponsor|13|||
149178414|NCT04329923|538127592|FG000|Overall Study|Withdrawal by Subject|1|||
149178415|NCT04329923|538127593|FG001|Overall Study|Withdrawal by Subject|4|||
149178416|NCT04329923|538127594|FG002|Overall Study|Withdrawal by Subject|1|||
149178417|NCT04329923|538127595|FG003|Overall Study|Withdrawal by Subject|1|||
149178418|NCT04329923|538127596|FG004|Overall Study|Withdrawal by Subject|1|||
149178419|NCT04329923|538127597|FG005|Overall Study|Withdrawal by Subject|1|||
149178420|NCT04329923|538127592|FG000|Overall Study|early termination of study|0|||
149178421|NCT04329923|538127593|FG001|Overall Study|early termination of study|0|||
149178422|NCT04329923|538127594|FG002|Overall Study|early termination of study|0|||
149178423|NCT04329923|538127595|FG003|Overall Study|early termination of study|0|||
149178424|NCT04329923|538127596|FG004|Overall Study|early termination of study|1|||
149178425|NCT04329923|538127597|FG005|Overall Study|early termination of study|2|||
149178426|NCT04329923|538127592|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149178427|NCT04329923|538127593|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149178428|NCT04329923|538127594|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149178429|NCT04329923|538127595|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149178430|NCT04329923|538127596|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
149178431|NCT04329923|538127597|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
149178432|NCT01272180|538127598|FG000|Overall Study|Adverse Event|0|||
149178433|NCT01272180|538127599|FG001|Overall Study|Adverse Event|0|||
149178434|NCT01272180|538127600|FG002|Overall Study|Adverse Event|1|||
149178435|NCT01272180|538127601|FG003|Overall Study|Adverse Event|0|||
149178436|NCT01272180|538127598|FG000|Overall Study|Withdrawal by Subject|2|||
149178437|NCT01272180|538127599|FG001|Overall Study|Withdrawal by Subject|6|||
149178438|NCT01272180|538127600|FG002|Overall Study|Withdrawal by Subject|3|||
149178439|NCT01272180|538127601|FG003|Overall Study|Withdrawal by Subject|2|||
149178440|NCT01272180|538127598|FG000|Overall Study|Lost to Follow-up|15|||
149178441|NCT01272180|538127599|FG001|Overall Study|Lost to Follow-up|14|||
149178442|NCT01272180|538127600|FG002|Overall Study|Lost to Follow-up|8|||
149178443|NCT01272180|538127601|FG003|Overall Study|Lost to Follow-up|10|||
149178444|NCT01272180|538127598|FG000|Overall Study|Inappropriate enrollment|0|||
149178445|NCT01272180|538127599|FG001|Overall Study|Inappropriate enrollment|0|||
149178446|NCT01272180|538127600|FG002|Overall Study|Inappropriate enrollment|1|||
149178447|NCT01272180|538127601|FG003|Overall Study|Inappropriate enrollment|1|||
149178448|NCT01272180|538127598|FG000|Overall Study|Protocol Violation|0|||
149178449|NCT01272180|538127599|FG001|Overall Study|Protocol Violation|1|||
149178450|NCT01272180|538127600|FG002|Overall Study|Protocol Violation|0|||
149178451|NCT01272180|538127601|FG003|Overall Study|Protocol Violation|1|||
149178452|NCT03334214|538127602|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
149178453|NCT03334214|538127603|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
149178454|NCT03334214|538127602|FG000|Overall Study|Withdrawal by Subject|0|||
149178455|NCT03334214|538127603|FG001|Overall Study|Withdrawal by Subject|1|||
149178456|NCT03334214|538127602|FG000|Overall Study|Other|1|||
149178457|NCT03334214|538127603|FG001|Overall Study|Other|0|||
149178458|NCT01260181|538127605|FG000|Overall Study|Decision of Investigator|1|||
149178459|NCT01588197|538127608|FG000|Overall Study|Lack of Efficacy|0|||
149178460|NCT01588197|538127609|FG001|Overall Study|Lack of Efficacy|1|||
149178461|NCT01588197|538127608|FG000|Overall Study|No MRI|1|||
148679412|NCT02773446|536300779|FG004|First Admission|Lost to Follow-up|0|||
148679413|NCT02773446|536300780|FG005|First Admission|Lost to Follow-up|0|||
149178462|NCT01588197|538127609|FG001|Overall Study|No MRI|0|||
149178463|NCT03351244|538127610|FG000|Overall Study|Adverse Event|7|||
149178464|NCT03351244|538127611|FG001|Overall Study|Adverse Event|11|||
149178465|NCT03351244|538127612|FG002|Overall Study|Adverse Event|12|||
149013562|NCT00885352|537529207|FG000|Overall Study|Contradiction to study medication|0|||
149013563|NCT00885352|537529208|FG001|Overall Study|Contradiction to study medication|2|||
149013564|NCT00885352|537529207|FG000|Overall Study|Excluded medication|2|||
149013565|NCT00885352|537529208|FG001|Overall Study|Excluded medication|2|||
149013566|NCT00885352|537529207|FG000|Overall Study|Lab abnormalities|1|||
149013567|NCT00885352|537529208|FG001|Overall Study|Lab abnormalities|1|||
149013568|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
149013569|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
149013570|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149013571|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
149013572|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
149013573|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
149013574|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
149013575|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
149178466|NCT03351244|538127610|FG000|Overall Study|Investigator's decision|0|||
149178467|NCT03351244|538127611|FG001|Overall Study|Investigator's decision|0|||
149178468|NCT03351244|538127612|FG002|Overall Study|Investigator's decision|2|||
149178469|NCT03351244|538127610|FG000|Overall Study|System error|0|||
149178470|NCT03351244|538127611|FG001|Overall Study|System error|0|||
149178471|NCT03351244|538127612|FG002|Overall Study|System error|2|||
149178472|NCT03351244|538127610|FG000|Overall Study|COVID-19 restrictions|3|||
149178473|NCT03351244|538127611|FG001|Overall Study|COVID-19 restrictions|0|||
148679414|NCT04023994|536300781|FG000|Overall Study|Lost to Follow-up|0|||
149013576|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
149178474|NCT03351244|538127612|FG002|Overall Study|COVID-19 restrictions|1|||
149178475|NCT03351244|538127610|FG000|Overall Study|Non-compliance|2|||
149178476|NCT03351244|538127611|FG001|Overall Study|Non-compliance|5|||
149178477|NCT03351244|538127612|FG002|Overall Study|Non-compliance|0|||
149178478|NCT03351244|538127610|FG000|Overall Study|Withdrawal by Subject|11|||
149178479|NCT03351244|538127611|FG001|Overall Study|Withdrawal by Subject|16|||
149178480|NCT03351244|538127612|FG002|Overall Study|Withdrawal by Subject|13|||
149178481|NCT03351244|538127610|FG000|Overall Study|Lost to Follow-up|2|||
149178482|NCT03351244|538127611|FG001|Overall Study|Lost to Follow-up|6|||
149178483|NCT03351244|538127612|FG002|Overall Study|Lost to Follow-up|4|||
149178484|NCT03351244|538127610|FG000|Overall Study|Protocol Violation|2|||
149178485|NCT03351244|538127611|FG001|Overall Study|Protocol Violation|2|||
149178486|NCT03351244|538127612|FG002|Overall Study|Protocol Violation|0|||
149178487|NCT02088034|538127618|FG000|Overall Study|Lost to Follow-up|1|||
149178488|NCT02088034|538127619|FG001|Overall Study|Lost to Follow-up|1|||
149178489|NCT02088034|538127620|FG002|Overall Study|Lost to Follow-up|0|||
149178490|NCT02088034|538127618|FG000|Overall Study|Pregnancy|2|||
149178491|NCT02088034|538127619|FG001|Overall Study|Pregnancy|1|||
149178492|NCT02088034|538127620|FG002|Overall Study|Pregnancy|2|||
149178493|NCT00308620|538127621|FG000|Overall Study|Death|1|||
149178494|NCT00308620|538127622|FG001|Overall Study|Death|1|||
149178495|NCT00308620|538127623|FG002|Overall Study|Death|0|||
149178496|NCT00308620|538127621|FG000|Overall Study|Lost to Follow-up|0|||
149178497|NCT00308620|538127622|FG001|Overall Study|Lost to Follow-up|0|||
149178498|NCT00308620|538127623|FG002|Overall Study|Lost to Follow-up|1|||
149178499|NCT00091793|538127626|FG000|Overall Study|Adverse Event|1|||
149178500|NCT00091793|538127627|FG001|Overall Study|Adverse Event|2|||
149178501|NCT00091793|538127626|FG000|Overall Study|Withdrawal by Subject|10|||
149178502|NCT00091793|538127627|FG001|Overall Study|Withdrawal by Subject|15|||
149178503|NCT00091793|538127626|FG000|Overall Study|Ineligibility determined|2|||
149178504|NCT00091793|538127627|FG001|Overall Study|Ineligibility determined|0|||
149178505|NCT00091793|538127626|FG000|Overall Study|Lost to Follow-up|7|||
149178506|NCT00091793|538127627|FG001|Overall Study|Lost to Follow-up|5|||
149178507|NCT00091793|538127626|FG000|Overall Study|Noncompliance|2|||
149178508|NCT00091793|538127627|FG001|Overall Study|Noncompliance|0|||
149178509|NCT00091793|538127626|FG000|Overall Study|Other|2|||
149178510|NCT00091793|538127627|FG001|Overall Study|Other|0|||
149178511|NCT01025336|538127629|FG000|Overall Study|Protocol Violation|0|||
149178512|NCT01025336|538127630|FG001|Overall Study|Protocol Violation|0|||
149178513|NCT01025336|538127631|FG002|Overall Study|Protocol Violation|0|||
149178514|NCT01025336|538127632|FG003|Overall Study|Protocol Violation|2|||
149178515|NCT01025336|538127633|FG004|Overall Study|Protocol Violation|0|||
149178516|NCT00637728|538127637|FG000|Double-blind Phase|Adverse Event|1|||
149178517|NCT00637728|538127638|FG001|Double-blind Phase|Adverse Event|0|||
149178518|NCT00637728|538127639|FG002|Double-blind Phase|Adverse Event|0|||
149178519|NCT00637728|538127637|FG000|Double-blind Phase|Non-compliance|2|||
149178520|NCT00637728|538127638|FG001|Double-blind Phase|Non-compliance|0|||
149178521|NCT00637728|538127639|FG002|Double-blind Phase|Non-compliance|0|||
149178522|NCT00637728|538127637|FG000|Double-blind Phase|Study Discontinued|1|||
149178523|NCT00637728|538127638|FG001|Double-blind Phase|Study Discontinued|1|||
149178524|NCT00637728|538127639|FG002|Double-blind Phase|Study Discontinued|0|||
149178525|NCT01050062|538127642|FG000|Overall Study|Adverse Event|75|||
149178526|NCT01050062|538127643|FG001|Overall Study|Adverse Event|22|||
149178527|NCT01050062|538127642|FG000|Overall Study|Lost to Follow-up|83|||
149178528|NCT01050062|538127643|FG001|Overall Study|Lost to Follow-up|35|||
148679415|NCT04023994|536300782|FG001|Overall Study|Lost to Follow-up|1|||
148679416|NCT04023994|536300783|FG002|Overall Study|Lost to Follow-up|2|||
148807074|NCT03454555|536773168|FG001|Overall Study|Death|6|||
148930511|NCT00395538|537230317|FG002|Overall Study|Adverse Event|2|||
148930512|NCT00395538|537230315|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
148930513|NCT00395538|537230316|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
148930514|NCT00395538|537230317|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
148930515|NCT00395538|537230315|FG000|Overall Study|Non-compliance with study protocol|0|||
148930516|NCT00395538|537230316|FG001|Overall Study|Non-compliance with study protocol|1|||
148930517|NCT00395538|537230317|FG002|Overall Study|Non-compliance with study protocol|0|||
148930518|NCT00395538|537230315|FG000|Overall Study|PTH resistance|0|||
148930519|NCT00395538|537230316|FG001|Overall Study|PTH resistance|0|||
148930520|NCT00395538|537230317|FG002|Overall Study|PTH resistance|1|||
148930521|NCT00395538|537230315|FG000|Overall Study|Pregnancy|1|||
148930522|NCT00395538|537230316|FG001|Overall Study|Pregnancy|0|||
148930523|NCT00395538|537230317|FG002|Overall Study|Pregnancy|0|||
148930524|NCT00395538|537230315|FG000|Overall Study|Partial recovery of parathyroid function|0|||
148930525|NCT00395538|537230316|FG001|Overall Study|Partial recovery of parathyroid function|0|||
148930526|NCT00395538|537230317|FG002|Overall Study|Partial recovery of parathyroid function|1|||
148930527|NCT00395538|537230315|FG000|Overall Study|Participant elected to discontinue|0|||
148930528|NCT00395538|537230316|FG001|Overall Study|Participant elected to discontinue|0|||
149178529|NCT01050062|538127642|FG000|Overall Study|Lack of Efficacy|22|||
149178530|NCT01050062|538127643|FG001|Overall Study|Lack of Efficacy|35|||
149178531|NCT01050062|538127642|FG000|Overall Study|Physician Decision|74|||
149178532|NCT01050062|538127643|FG001|Overall Study|Physician Decision|9|||
149178533|NCT01050062|538127642|FG000|Overall Study|Others|17|||
149178534|NCT01050062|538127643|FG001|Overall Study|Others|11|||
149178535|NCT01873950|538127644|FG000|Period 5|Withdrawal by Subject|0|||
149178536|NCT01873950|538127645|FG001|Period 5|Withdrawal by Subject|0|||
149178537|NCT01873950|538127646|FG002|Period 5|Withdrawal by Subject|0|||
149178538|NCT01873950|538127647|FG003|Period 5|Withdrawal by Subject|1|||
149178539|NCT01873950|538127648|FG004|Period 5|Withdrawal by Subject|0|||
149178540|NCT03894540|538127649|FG000|Overall Study|Adverse Event|0|||
149178541|NCT03894540|538127650|FG001|Overall Study|Adverse Event|0|||
149178542|NCT03894540|538127651|FG002|Overall Study|Adverse Event|0|||
149178543|NCT03894540|538127652|FG003|Overall Study|Adverse Event|0|||
149178544|NCT03894540|538127653|FG004|Overall Study|Adverse Event|1|||
149178545|NCT03894540|538127654|FG005|Overall Study|Adverse Event|0|||
149178546|NCT03894540|538127649|FG000|Overall Study|Withdrawal by Subject|0|||
149178547|NCT03894540|538127650|FG001|Overall Study|Withdrawal by Subject|0|||
149178548|NCT03894540|538127651|FG002|Overall Study|Withdrawal by Subject|0|||
149178549|NCT03894540|538127652|FG003|Overall Study|Withdrawal by Subject|0|||
149178550|NCT03894540|538127653|FG004|Overall Study|Withdrawal by Subject|1|||
149178551|NCT03894540|538127654|FG005|Overall Study|Withdrawal by Subject|0|||
149178552|NCT03894540|538127649|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
149178553|NCT03894540|538127650|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
149178554|NCT03894540|538127651|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
149178555|NCT03894540|538127652|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
149178556|NCT03894540|538127653|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
149178557|NCT03894540|538127654|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
149178558|NCT03894540|538127649|FG000|Overall Study|Progressive Disease Clinical|1|||
149178559|NCT03894540|538127650|FG001|Overall Study|Progressive Disease Clinical|1|||
149178560|NCT03894540|538127651|FG002|Overall Study|Progressive Disease Clinical|0|||
149178561|NCT03894540|538127652|FG003|Overall Study|Progressive Disease Clinical|1|||
149178562|NCT03894540|538127653|FG004|Overall Study|Progressive Disease Clinical|5|||
149178563|NCT03894540|538127654|FG005|Overall Study|Progressive Disease Clinical|1|||
149178564|NCT03894540|538127649|FG000|Overall Study|Study termination by sponsor|0|||
149178565|NCT03894540|538127650|FG001|Overall Study|Study termination by sponsor|0|||
149178566|NCT03894540|538127651|FG002|Overall Study|Study termination by sponsor|0|||
149178567|NCT03894540|538127652|FG003|Overall Study|Study termination by sponsor|0|||
149178568|NCT03894540|538127653|FG004|Overall Study|Study termination by sponsor|2|||
149178569|NCT03894540|538127654|FG005|Overall Study|Study termination by sponsor|0|||
149178570|NCT03043365|538127655|FG000|Weeks 0 to Week 8|Adverse Event|1|||
149178571|NCT03043365|538127656|FG001|Weeks 0 to Week 8|Adverse Event|3|||
149178572|NCT03043365|538127655|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
149178573|NCT03043365|538127656|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
149178574|NCT03043365|538127655|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
149178575|NCT03043365|538127656|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
149178576|NCT00593112|538127657|FG000|Overall Study|Scan Anxiety|3|||
149178577|NCT00593112|538127658|FG001|Overall Study|Scan Anxiety|0|||
149178578|NCT00593112|538127657|FG000|Overall Study|Abnormal Scan|1|||
149178579|NCT00593112|538127658|FG001|Overall Study|Abnormal Scan|0|||
149178580|NCT00593112|538127657|FG000|Overall Study|Unreadable Scan|1|||
149178581|NCT00593112|538127658|FG001|Overall Study|Unreadable Scan|0|||
148930529|NCT00395538|537230317|FG002|Overall Study|Participant elected to discontinue|1|||
148930530|NCT01857583|537230318|FG000|Overall Study|Adverse Event|0|||
148930531|NCT01857583|537230319|FG001|Overall Study|Adverse Event|0|||
148930532|NCT01857583|537230320|FG002|Overall Study|Adverse Event|1|||
148930533|NCT01857583|537230321|FG003|Overall Study|Adverse Event|1|||
148930534|NCT01857583|537230318|FG000|Overall Study|Death|0|||
148930535|NCT01857583|537230319|FG001|Overall Study|Death|1|||
148930536|NCT01857583|537230320|FG002|Overall Study|Death|1|||
148930537|NCT01857583|537230321|FG003|Overall Study|Death|0|||
148930538|NCT01857583|537230318|FG000|Overall Study|Physician Decision|0|||
148930539|NCT01857583|537230319|FG001|Overall Study|Physician Decision|0|||
148930540|NCT01857583|537230320|FG002|Overall Study|Physician Decision|0|||
148930541|NCT01857583|537230321|FG003|Overall Study|Physician Decision|1|||
148930542|NCT01857583|537230318|FG000|Overall Study|Withdrawal by Subject|1|||
148930543|NCT01857583|537230319|FG001|Overall Study|Withdrawal by Subject|0|||
148930544|NCT01857583|537230320|FG002|Overall Study|Withdrawal by Subject|1|||
148930545|NCT01857583|537230321|FG003|Overall Study|Withdrawal by Subject|2|||
148930546|NCT03552965|537230323|FG000|Overall Study|Death|1|||
148930547|NCT03552965|537230324|FG001|Overall Study|Death|1|||
148930548|NCT03552965|537230323|FG000|Overall Study|Lost to Follow-up|1|||
148930549|NCT03552965|537230324|FG001|Overall Study|Lost to Follow-up|1|||
148930550|NCT03552965|537230323|FG000|Overall Study|Physician Decision|1|||
148930551|NCT03552965|537230324|FG001|Overall Study|Physician Decision|1|||
148930552|NCT03552965|537230323|FG000|Overall Study|Withdrawal by Subject|0|||
148930553|NCT03552965|537230324|FG001|Overall Study|Withdrawal by Subject|2|||
148930554|NCT03552965|537230323|FG000|Overall Study|Continuation not in patient best interest|1|||
148930555|NCT03552965|537230324|FG001|Overall Study|Continuation not in patient best interest|0|||
149178582|NCT00593112|538127657|FG000|Overall Study|Withdrawal by Subject|5|||
149178583|NCT00593112|538127658|FG001|Overall Study|Withdrawal by Subject|0|||
149178584|NCT02723630|538127659|FG000|Intervention Period 1|Adverse Event|1|||
149178585|NCT02723630|538127660|FG001|Intervention Period 1|Adverse Event|0|||
149178586|NCT02723630|538127661|FG002|Intervention Period 1|Adverse Event|0|||
149178587|NCT02723630|538127662|FG003|Intervention Period 1|Adverse Event|0|||
149178588|NCT02723630|538127663|FG004|Intervention Period 1|Adverse Event|0|||
149178589|NCT02723630|538127664|FG005|Intervention Period 1|Adverse Event|0|||
149178590|NCT02723630|538127659|FG000|Intervention Period 3|consumption of restricted item|0|||
149178591|NCT02723630|538127660|FG001|Intervention Period 3|consumption of restricted item|1|||
149178592|NCT02723630|538127661|FG002|Intervention Period 3|consumption of restricted item|0|||
149178593|NCT02723630|538127662|FG003|Intervention Period 3|consumption of restricted item|0|||
149178594|NCT02723630|538127663|FG004|Intervention Period 3|consumption of restricted item|0|||
149178595|NCT02723630|538127664|FG005|Intervention Period 3|consumption of restricted item|0|||
149178596|NCT02532543|538127665|FG000|Overall Study|Lost to Follow-up|0|||
149178597|NCT02532543|538127666|FG001|Overall Study|Lost to Follow-up|0|||
149178598|NCT02532543|538127667|FG002|Overall Study|Lost to Follow-up|1|||
149178599|NCT02532543|538127668|FG003|Overall Study|Lost to Follow-up|0|||
149178600|NCT00650585|538127669|FG000|Overall Study|Lost to Follow-up|505|||
149178601|NCT00650585|538127670|FG001|Overall Study|Lost to Follow-up|482|||
149178602|NCT00650585|538127669|FG000|Overall Study|No parental consent|935|||
149178603|NCT00650585|538127670|FG001|Overall Study|No parental consent|866|||
149178604|NCT00650585|538127669|FG000|Overall Study|Excluded/ruled ineligible|357|||
149178605|NCT00650585|538127670|FG001|Overall Study|Excluded/ruled ineligible|129|||
149178606|NCT02640612|538127671|FG000|Overall Study|Adverse Event|6|||
149178607|NCT02640612|538127672|FG001|Overall Study|Adverse Event|7|||
149178608|NCT02640612|538127673|FG002|Overall Study|Adverse Event|2|||
149178609|NCT02640612|538127671|FG000|Overall Study|Death|1|||
149178610|NCT02640612|538127672|FG001|Overall Study|Death|0|||
149178611|NCT02640612|538127673|FG002|Overall Study|Death|0|||
149178612|NCT02640612|538127671|FG000|Overall Study|Withdrawal by Subject|10|||
149178613|NCT02640612|538127672|FG001|Overall Study|Withdrawal by Subject|3|||
149013577|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
149013578|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
149178614|NCT02640612|538127673|FG002|Overall Study|Withdrawal by Subject|3|||
149178615|NCT02640612|538127671|FG000|Overall Study|Lost to Follow-up|4|||
149178616|NCT02640612|538127672|FG001|Overall Study|Lost to Follow-up|1|||
149178617|NCT02640612|538127673|FG002|Overall Study|Lost to Follow-up|1|||
149178618|NCT02640612|538127671|FG000|Overall Study|Protocol Violation|0|||
149178619|NCT02640612|538127672|FG001|Overall Study|Protocol Violation|2|||
149178620|NCT02640612|538127673|FG002|Overall Study|Protocol Violation|0|||
149178621|NCT02640612|538127671|FG000|Overall Study|Lack of Efficacy|1|||
149178622|NCT02640612|538127672|FG001|Overall Study|Lack of Efficacy|1|||
149178623|NCT02640612|538127673|FG002|Overall Study|Lack of Efficacy|0|||
149178624|NCT00923091|538127684|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
149178625|NCT00923091|538127685|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
149178626|NCT00923091|538127686|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
149178627|NCT00923091|538127687|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
149178628|NCT00923091|538127688|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
149178629|NCT00923091|538127689|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
148679417|NCT04023994|536300784|FG003|Overall Study|Lost to Follow-up|0|||
149013579|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
149013580|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
149013581|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
149013582|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
149013583|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
149013584|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
149013585|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
149013586|NCT00365378|537529209|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
149013587|NCT00365378|537529210|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
149178630|NCT00923091|538127690|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
149178631|NCT00923091|538127691|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
149178632|NCT00923091|538127692|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149178633|NCT00923091|538127693|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149178634|NCT00923091|538127694|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149178635|NCT00923091|538127695|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149178636|NCT00923091|538127696|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
149178637|NCT00923091|538127684|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
149178638|NCT00923091|538127685|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
149178639|NCT00923091|538127686|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
149178640|NCT00923091|538127687|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
149178641|NCT00923091|538127688|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
149178642|NCT00923091|538127689|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
149178643|NCT00923091|538127690|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
149178644|NCT00923091|538127691|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
149178645|NCT00923091|538127692|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149178646|NCT00923091|538127693|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149178647|NCT00923091|538127694|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149178648|NCT00923091|538127695|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
149178649|NCT00923091|538127696|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
148807075|NCT03454555|536773167|FG000|Overall Study|Lost to Follow-up|31|||
148807076|NCT03454555|536773168|FG001|Overall Study|Lost to Follow-up|12|||
148807077|NCT03454555|536773167|FG000|Overall Study|Physician Decision|2|||
148807078|NCT03454555|536773168|FG001|Overall Study|Physician Decision|6|||
148807079|NCT03454555|536773167|FG000|Overall Study|Withdrawal by Subject|34|||
148807080|NCT03454555|536773168|FG001|Overall Study|Withdrawal by Subject|5|||
148807081|NCT03454555|536773167|FG000|Overall Study|Ineligible|1|||
148807082|NCT03454555|536773168|FG001|Overall Study|Ineligible|5|||
148807083|NCT01288430|536773175|FG000|Part 1|Progressive disease|2|||
148807084|NCT01288430|536773176|FG001|Part 1|Progressive disease|1|||
148807085|NCT01288430|536773177|FG002|Part 1|Progressive disease|1|||
148807086|NCT01288430|536773178|FG003|Part 1|Progressive disease|6|||
148807087|NCT01288430|536773179|FG004|Part 1|Progressive disease|2|||
148807088|NCT01288430|536773180|FG005|Part 1|Progressive disease|4|||
148807089|NCT01288430|536773181|FG006|Part 1|Progressive disease|2|||
148807090|NCT01288430|536773182|FG007|Part 1|Progressive disease|0|||
148807091|NCT01288430|536773183|FG008|Part 1|Progressive disease|0|||
149013588|NCT00365378|537529211|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
149013589|NCT00365378|537529209|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
149013590|NCT00365378|537529210|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
149013591|NCT00365378|537529211|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
149013592|NCT00365378|537529209|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
149013593|NCT00365378|537529210|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
149013594|NCT00365378|537529211|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
149013595|NCT00365378|537529209|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
149013596|NCT00365378|537529210|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
149178650|NCT00923091|538127684|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
149178651|NCT00923091|538127685|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
149178652|NCT00923091|538127686|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
149178653|NCT00923091|538127687|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
148807092|NCT01288430|536773184|FG009|Part 1|Progressive disease|0|||
148807093|NCT01288430|536773175|FG000|Part 1|Clinical disease progression|0|||
148807094|NCT01288430|536773176|FG001|Part 1|Clinical disease progression|0|||
148807095|NCT01288430|536773177|FG002|Part 1|Clinical disease progression|1|||
148807096|NCT01288430|536773178|FG003|Part 1|Clinical disease progression|0|||
148807097|NCT01288430|536773179|FG004|Part 1|Clinical disease progression|0|||
148807098|NCT01288430|536773180|FG005|Part 1|Clinical disease progression|2|||
148807099|NCT01288430|536773181|FG006|Part 1|Clinical disease progression|2|||
148807100|NCT01288430|536773182|FG007|Part 1|Clinical disease progression|0|||
149013597|NCT00365378|537529211|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
149013598|NCT00365378|537529209|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
149178654|NCT00923091|538127688|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
149178655|NCT00923091|538127689|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
149178656|NCT00923091|538127690|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
149178657|NCT00923091|538127691|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
149178658|NCT00923091|538127692|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149178659|NCT00923091|538127693|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149178660|NCT00923091|538127694|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149178661|NCT00923091|538127695|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149178662|NCT00923091|538127696|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
149178663|NCT00923091|538127684|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178664|NCT00923091|538127685|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178665|NCT00923091|538127686|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178666|NCT00923091|538127687|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178667|NCT00923091|538127688|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178668|NCT00923091|538127689|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
149178669|NCT00923091|538127690|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178670|NCT00923091|538127691|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178671|NCT00923091|538127692|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178672|NCT00923091|538127693|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178673|NCT00923091|538127694|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178674|NCT00923091|538127695|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178675|NCT00923091|538127696|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
149178676|NCT00923091|538127684|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178677|NCT00923091|538127685|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
149178678|NCT00923091|538127686|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178679|NCT00923091|538127687|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
149178680|NCT00923091|538127688|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178681|NCT00923091|538127689|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
149178682|NCT00923091|538127690|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178683|NCT00923091|538127691|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178684|NCT00923091|538127692|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178685|NCT00923091|538127693|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178686|NCT00923091|538127694|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178687|NCT00923091|538127695|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178688|NCT00923091|538127696|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
149178689|NCT00923091|538127684|FG000|Period III (Single-Blind)|Adverse Event|5|||
149178690|NCT00923091|538127685|FG001|Period III (Single-Blind)|Adverse Event|0|||
149178691|NCT00923091|538127686|FG002|Period III (Single-Blind)|Adverse Event|0|||
149178692|NCT00923091|538127687|FG003|Period III (Single-Blind)|Adverse Event|0|||
149178693|NCT00923091|538127688|FG004|Period III (Single-Blind)|Adverse Event|0|||
149178694|NCT00923091|538127689|FG005|Period III (Single-Blind)|Adverse Event|0|||
148679418|NCT04023994|536300785|FG004|Overall Study|Lost to Follow-up|0|||
148679419|NCT04023994|536300786|FG005|Overall Study|Lost to Follow-up|0|||
148679420|NCT04023994|536300781|FG000|Overall Study|Withdrawal by Subject|0|||
148679421|NCT04023994|536300782|FG001|Overall Study|Withdrawal by Subject|0|||
148679422|NCT04023994|536300783|FG002|Overall Study|Withdrawal by Subject|0|||
148679423|NCT04023994|536300784|FG003|Overall Study|Withdrawal by Subject|1|||
148679424|NCT04023994|536300785|FG004|Overall Study|Withdrawal by Subject|0|||
148679425|NCT04023994|536300786|FG005|Overall Study|Withdrawal by Subject|0|||
149178695|NCT00923091|538127690|FG006|Period III (Single-Blind)|Adverse Event|0|||
149178696|NCT00923091|538127691|FG007|Period III (Single-Blind)|Adverse Event|0|||
149178697|NCT00923091|538127692|FG008|Period III (Single-Blind)|Adverse Event|0|||
149178698|NCT00923091|538127693|FG009|Period III (Single-Blind)|Adverse Event|0|||
149178699|NCT00923091|538127694|FG010|Period III (Single-Blind)|Adverse Event|0|||
149178700|NCT00923091|538127695|FG011|Period III (Single-Blind)|Adverse Event|0|||
149178701|NCT00923091|538127696|FG012|Period III (Single-Blind)|Adverse Event|0|||
149178702|NCT00923091|538127684|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
149178703|NCT00923091|538127685|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178704|NCT00923091|538127686|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178705|NCT00923091|538127687|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178706|NCT00923091|538127688|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178707|NCT00923091|538127689|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178708|NCT00923091|538127690|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178709|NCT00923091|538127691|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
148679426|NCT01613131|536300787|FG000|Overall Study|Withdrawal by Subject|3|||
149178710|NCT00923091|538127692|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178711|NCT00923091|538127693|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
148679427|NCT01613131|536300788|FG001|Overall Study|Withdrawal by Subject|5|||
148679428|NCT02454972|536300789|FG000|Overall Study|Progressive disease|17|||
149013599|NCT00365378|537529210|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
148930556|NCT03552965|537230323|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
148930557|NCT03552965|537230324|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
148930558|NCT03120624|537230325|FG000|Overall Study|Withdrawal by Subject|0|||
148930559|NCT03120624|537230326|FG001|Overall Study|Withdrawal by Subject|1|||
148930560|NCT03120624|537230327|FG002|Overall Study|Withdrawal by Subject|0|||
149178712|NCT00923091|538127694|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178713|NCT00923091|538127695|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178714|NCT00923091|538127696|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
149178715|NCT00923091|538127684|FG000|Period III (Single-Blind)|Protocol Violation|3|||
149178716|NCT00923091|538127685|FG001|Period III (Single-Blind)|Protocol Violation|0|||
149178717|NCT00923091|538127686|FG002|Period III (Single-Blind)|Protocol Violation|0|||
149178718|NCT00923091|538127687|FG003|Period III (Single-Blind)|Protocol Violation|0|||
149178719|NCT00923091|538127688|FG004|Period III (Single-Blind)|Protocol Violation|0|||
149178720|NCT00923091|538127689|FG005|Period III (Single-Blind)|Protocol Violation|0|||
149178721|NCT00923091|538127690|FG006|Period III (Single-Blind)|Protocol Violation|0|||
149178722|NCT00923091|538127691|FG007|Period III (Single-Blind)|Protocol Violation|0|||
148930561|NCT03120624|537230328|FG003|Overall Study|Withdrawal by Subject|0|||
148930562|NCT03120624|537230329|FG004|Overall Study|Withdrawal by Subject|0|||
149013600|NCT00365378|537529211|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
149013601|NCT00365378|537529209|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
149178723|NCT00923091|538127692|FG008|Period III (Single-Blind)|Protocol Violation|0|||
149178724|NCT00923091|538127693|FG009|Period III (Single-Blind)|Protocol Violation|0|||
149178725|NCT00923091|538127694|FG010|Period III (Single-Blind)|Protocol Violation|0|||
149178726|NCT00923091|538127695|FG011|Period III (Single-Blind)|Protocol Violation|0|||
149178727|NCT00923091|538127696|FG012|Period III (Single-Blind)|Protocol Violation|0|||
149178728|NCT00923091|538127684|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
149178729|NCT00923091|538127685|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
149013602|NCT00365378|537529210|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
149178730|NCT00923091|538127686|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
149178731|NCT00923091|538127687|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
149178732|NCT00923091|538127688|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
149178733|NCT00923091|538127689|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
149178734|NCT00923091|538127690|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
149178735|NCT00923091|538127691|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
149178736|NCT00923091|538127692|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
149178737|NCT00923091|538127693|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
149178738|NCT00923091|538127694|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
149178739|NCT00923091|538127695|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
149178740|NCT00923091|538127696|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
149178741|NCT00923091|538127684|FG000|Period IV (Double-Blind)|Adverse Event|2|||
149178742|NCT00923091|538127685|FG001|Period IV (Double-Blind)|Adverse Event|0|||
149178743|NCT00923091|538127686|FG002|Period IV (Double-Blind)|Adverse Event|0|||
149178744|NCT00923091|538127687|FG003|Period IV (Double-Blind)|Adverse Event|0|||
149178745|NCT00923091|538127688|FG004|Period IV (Double-Blind)|Adverse Event|0|||
149178746|NCT00923091|538127689|FG005|Period IV (Double-Blind)|Adverse Event|0|||
149178747|NCT00923091|538127690|FG006|Period IV (Double-Blind)|Adverse Event|0|||
149178748|NCT00923091|538127691|FG007|Period IV (Double-Blind)|Adverse Event|0|||
149178749|NCT00923091|538127692|FG008|Period IV (Double-Blind)|Adverse Event|0|||
149178750|NCT00923091|538127693|FG009|Period IV (Double-Blind)|Adverse Event|0|||
148807101|NCT01288430|536773183|FG008|Part 1|Clinical disease progression|0|||
148807102|NCT01288430|536773184|FG009|Part 1|Clinical disease progression|0|||
148807103|NCT01288430|536773175|FG000|Part 1|Death due to disease progression|0|||
148807104|NCT01288430|536773176|FG001|Part 1|Death due to disease progression|0|||
148807105|NCT01288430|536773177|FG002|Part 1|Death due to disease progression|0|||
148807106|NCT01288430|536773178|FG003|Part 1|Death due to disease progression|0|||
148930563|NCT03120624|537230330|FG005|Overall Study|Withdrawal by Subject|0|||
149178751|NCT00923091|538127694|FG010|Period IV (Double-Blind)|Adverse Event|0|||
149178752|NCT00923091|538127695|FG011|Period IV (Double-Blind)|Adverse Event|0|||
149178753|NCT00923091|538127696|FG012|Period IV (Double-Blind)|Adverse Event|0|||
149178754|NCT00923091|538127684|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178755|NCT00923091|538127685|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
148807107|NCT01288430|536773179|FG004|Part 1|Death due to disease progression|1|||
149178756|NCT00923091|538127686|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178757|NCT00923091|538127687|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178758|NCT00923091|538127688|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178759|NCT00923091|538127689|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178760|NCT00923091|538127690|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178761|NCT00923091|538127691|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178762|NCT00923091|538127692|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178763|NCT00923091|538127693|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178764|NCT00923091|538127694|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178765|NCT00923091|538127695|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178766|NCT00923091|538127696|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
149178767|NCT00923091|538127684|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
149178768|NCT00923091|538127685|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
149178769|NCT00923091|538127686|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
149178770|NCT00923091|538127687|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
149178771|NCT00923091|538127688|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
149178772|NCT00923091|538127689|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
149178773|NCT00923091|538127690|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
149178774|NCT00923091|538127691|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
149178775|NCT00923091|538127692|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
149178776|NCT00923091|538127693|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
149178777|NCT00923091|538127694|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
149178778|NCT00923091|538127695|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
149178779|NCT00923091|538127696|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
149178780|NCT00923091|538127684|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178781|NCT00923091|538127685|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178782|NCT00923091|538127686|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178783|NCT00923091|538127687|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178784|NCT00923091|538127688|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178785|NCT00923091|538127689|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178786|NCT00923091|538127690|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178787|NCT00923091|538127691|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178788|NCT00923091|538127692|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
149178789|NCT00923091|538127693|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178790|NCT00923091|538127694|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178791|NCT00923091|538127695|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
149178792|NCT00923091|538127696|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
149178793|NCT00923091|538127684|FG000|Period V (Double -Blind)|Protocol Violation|0|||
149178794|NCT00923091|538127685|FG001|Period V (Double -Blind)|Protocol Violation|0|||
148807108|NCT01288430|536773180|FG005|Part 1|Death due to disease progression|0|||
148807109|NCT01288430|536773181|FG006|Part 1|Death due to disease progression|0|||
148807110|NCT01288430|536773182|FG007|Part 1|Death due to disease progression|0|||
148807111|NCT01288430|536773183|FG008|Part 1|Death due to disease progression|0|||
148807112|NCT01288430|536773184|FG009|Part 1|Death due to disease progression|0|||
149178795|NCT00923091|538127686|FG002|Period V (Double -Blind)|Protocol Violation|0|||
149178796|NCT00923091|538127687|FG003|Period V (Double -Blind)|Protocol Violation|0|||
149178797|NCT00923091|538127688|FG004|Period V (Double -Blind)|Protocol Violation|0|||
149178798|NCT00923091|538127689|FG005|Period V (Double -Blind)|Protocol Violation|0|||
149178799|NCT00923091|538127690|FG006|Period V (Double -Blind)|Protocol Violation|0|||
149178800|NCT00923091|538127691|FG007|Period V (Double -Blind)|Protocol Violation|0|||
149178801|NCT00923091|538127692|FG008|Period V (Double -Blind)|Protocol Violation|0|||
149178802|NCT00923091|538127693|FG009|Period V (Double -Blind)|Protocol Violation|0|||
149178803|NCT00923091|538127694|FG010|Period V (Double -Blind)|Protocol Violation|0|||
149178804|NCT00923091|538127695|FG011|Period V (Double -Blind)|Protocol Violation|0|||
149178805|NCT00923091|538127696|FG012|Period V (Double -Blind)|Protocol Violation|1|||
149178806|NCT00923091|538127684|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
149178807|NCT00923091|538127685|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
148807113|NCT01288430|536773175|FG000|Part 1|Adverse Event|0|||
148807114|NCT01288430|536773176|FG001|Part 1|Adverse Event|0|||
148807115|NCT01288430|536773177|FG002|Part 1|Adverse Event|3|||
149178808|NCT00923091|538127686|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
149178809|NCT00923091|538127687|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
149178810|NCT00923091|538127688|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
149178811|NCT00923091|538127689|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
149178812|NCT00923091|538127690|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
149178813|NCT00923091|538127691|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
149178814|NCT00923091|538127692|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
149178815|NCT00923091|538127693|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
148679429|NCT02454972|536300790|FG001|Overall Study|Progressive disease|16|||
148679430|NCT02454972|536300791|FG002|Overall Study|Progressive disease|59|||
148807116|NCT01288430|536773178|FG003|Part 1|Adverse Event|1|||
148807117|NCT01288430|536773179|FG004|Part 1|Adverse Event|0|||
149178816|NCT00923091|538127694|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
149178817|NCT00923091|538127695|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
149178818|NCT00923091|538127696|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
149178819|NCT00923091|538127684|FG000|Period VI (Open-Label)|Adverse Event|17|||
149178820|NCT00923091|538127685|FG001|Period VI (Open-Label)|Adverse Event|0|||
149178821|NCT00923091|538127686|FG002|Period VI (Open-Label)|Adverse Event|4|||
149178822|NCT00923091|538127687|FG003|Period VI (Open-Label)|Adverse Event|1|||
149178823|NCT00923091|538127688|FG004|Period VI (Open-Label)|Adverse Event|1|||
149178824|NCT00923091|538127689|FG005|Period VI (Open-Label)|Adverse Event|0|||
149178825|NCT00923091|538127690|FG006|Period VI (Open-Label)|Adverse Event|0|||
149178826|NCT00923091|538127691|FG007|Period VI (Open-Label)|Adverse Event|0|||
149178827|NCT00923091|538127692|FG008|Period VI (Open-Label)|Adverse Event|0|||
149178828|NCT00923091|538127693|FG009|Period VI (Open-Label)|Adverse Event|0|||
149178829|NCT00923091|538127694|FG010|Period VI (Open-Label)|Adverse Event|0|||
149178830|NCT00923091|538127695|FG011|Period VI (Open-Label)|Adverse Event|0|||
149178831|NCT00923091|538127696|FG012|Period VI (Open-Label)|Adverse Event|0|||
149178832|NCT00923091|538127684|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
149178833|NCT00923091|538127685|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
149178834|NCT00923091|538127686|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
149178835|NCT00923091|538127687|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178836|NCT00923091|538127688|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
149178837|NCT00923091|538127689|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178838|NCT00923091|538127690|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178839|NCT00923091|538127691|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178840|NCT00923091|538127692|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178841|NCT00923091|538127693|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178842|NCT00923091|538127694|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178843|NCT00923091|538127695|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178844|NCT00923091|538127696|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
149178845|NCT00923091|538127684|FG000|Period VI (Open-Label)|Protocol Violation|6|||
149178846|NCT00923091|538127685|FG001|Period VI (Open-Label)|Protocol Violation|1|||
149178847|NCT00923091|538127686|FG002|Period VI (Open-Label)|Protocol Violation|3|||
149178848|NCT00923091|538127687|FG003|Period VI (Open-Label)|Protocol Violation|1|||
149178849|NCT00923091|538127688|FG004|Period VI (Open-Label)|Protocol Violation|4|||
149178850|NCT00923091|538127689|FG005|Period VI (Open-Label)|Protocol Violation|0|||
149178851|NCT00923091|538127690|FG006|Period VI (Open-Label)|Protocol Violation|0|||
149178852|NCT00923091|538127691|FG007|Period VI (Open-Label)|Protocol Violation|0|||
149178853|NCT00923091|538127692|FG008|Period VI (Open-Label)|Protocol Violation|0|||
149178854|NCT00923091|538127693|FG009|Period VI (Open-Label)|Protocol Violation|0|||
149178855|NCT00923091|538127694|FG010|Period VI (Open-Label)|Protocol Violation|0|||
149178856|NCT00923091|538127695|FG011|Period VI (Open-Label)|Protocol Violation|0|||
149178857|NCT00923091|538127696|FG012|Period VI (Open-Label)|Protocol Violation|0|||
149178858|NCT00923091|538127684|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
148930564|NCT03120624|537230331|FG006|Overall Study|Withdrawal by Subject|0|||
148930565|NCT03120624|537230332|FG007|Overall Study|Withdrawal by Subject|0|||
148930566|NCT04571515|537230333|FG000|Overall Study|Physician Decision|0|||
148930567|NCT04571515|537230334|FG001|Overall Study|Physician Decision|0|||
148930568|NCT04571515|537230335|FG002|Overall Study|Physician Decision|0|||
148930569|NCT04571515|537230336|FG003|Overall Study|Physician Decision|0|||
148930570|NCT04571515|537230337|FG004|Overall Study|Physician Decision|1|||
148930571|NCT04571515|537230333|FG000|Overall Study|Withdrawal by Subject|0|||
148930572|NCT04571515|537230334|FG001|Overall Study|Withdrawal by Subject|0|||
149178859|NCT00923091|538127685|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
149178860|NCT00923091|538127686|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
149178861|NCT00923091|538127687|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
149178862|NCT00923091|538127688|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
149178863|NCT00923091|538127689|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
149178864|NCT00923091|538127690|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
149178865|NCT00923091|538127691|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
149178866|NCT00923091|538127692|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
149178867|NCT00923091|538127693|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
149178868|NCT00923091|538127694|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
149178869|NCT00923091|538127695|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
149178870|NCT00923091|538127696|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
149178871|NCT00923091|538127684|FG000|Period VI (Open-Label)|Other Reason|0|||
148930573|NCT04571515|537230335|FG002|Overall Study|Withdrawal by Subject|0|||
149013603|NCT00365378|537529211|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
149178872|NCT00923091|538127685|FG001|Period VI (Open-Label)|Other Reason|0|||
149178873|NCT00923091|538127686|FG002|Period VI (Open-Label)|Other Reason|0|||
149178874|NCT00923091|538127687|FG003|Period VI (Open-Label)|Other Reason|1|||
149178875|NCT00923091|538127688|FG004|Period VI (Open-Label)|Other Reason|1|||
148930574|NCT04571515|537230336|FG003|Overall Study|Withdrawal by Subject|0|||
149178876|NCT00923091|538127689|FG005|Period VI (Open-Label)|Other Reason|0|||
149178877|NCT00923091|538127690|FG006|Period VI (Open-Label)|Other Reason|0|||
148807118|NCT01288430|536773180|FG005|Part 1|Adverse Event|0|||
148807119|NCT01288430|536773181|FG006|Part 1|Adverse Event|2|||
148807120|NCT01288430|536773182|FG007|Part 1|Adverse Event|0|||
148807121|NCT01288430|536773183|FG008|Part 1|Adverse Event|0|||
149178878|NCT00923091|538127691|FG007|Period VI (Open-Label)|Other Reason|0|||
149178879|NCT00923091|538127692|FG008|Period VI (Open-Label)|Other Reason|0|||
149178880|NCT00923091|538127693|FG009|Period VI (Open-Label)|Other Reason|0|||
148807122|NCT01288430|536773184|FG009|Part 1|Adverse Event|0|||
148807123|NCT01288430|536773175|FG000|Part 1|Other|0|||
148807124|NCT01288430|536773176|FG001|Part 1|Other|2|||
148807125|NCT01288430|536773177|FG002|Part 1|Other|0|||
148807126|NCT01288430|536773178|FG003|Part 1|Other|0|||
148807127|NCT01288430|536773179|FG004|Part 1|Other|0|||
148807128|NCT01288430|536773180|FG005|Part 1|Other|0|||
148807129|NCT01288430|536773181|FG006|Part 1|Other|1|||
148807130|NCT01288430|536773182|FG007|Part 1|Other|0|||
148807131|NCT01288430|536773183|FG008|Part 1|Other|0|||
148807132|NCT01288430|536773184|FG009|Part 1|Other|0|||
148807133|NCT01288430|536773175|FG000|Part 2|Progressive disease|0|||
148807134|NCT01288430|536773176|FG001|Part 2|Progressive disease|0|||
148807135|NCT01288430|536773177|FG002|Part 2|Progressive disease|0|||
148807136|NCT01288430|536773178|FG003|Part 2|Progressive disease|0|||
148930575|NCT04571515|537230337|FG004|Overall Study|Withdrawal by Subject|1|||
148930576|NCT04571515|537230333|FG000|Overall Study|insufficient pain|1|||
148930577|NCT04571515|537230334|FG001|Overall Study|insufficient pain|0|||
148930578|NCT04571515|537230335|FG002|Overall Study|insufficient pain|0|||
148930579|NCT04571515|537230336|FG003|Overall Study|insufficient pain|0|||
148930580|NCT04571515|537230337|FG004|Overall Study|insufficient pain|1|||
148930581|NCT05140382|537230338|FG000|Overall Study|Death|3|||
148930582|NCT05140382|537230339|FG001|Overall Study|Death|0|||
148930583|NCT05140382|537230340|FG002|Overall Study|Death|0|||
148930584|NCT05140382|537230338|FG000|Overall Study|Investigator decision|1|||
148930585|NCT05140382|537230339|FG001|Overall Study|Investigator decision|0|||
148930586|NCT05140382|537230340|FG002|Overall Study|Investigator decision|0|||
148930587|NCT05140382|537230338|FG000|Overall Study|Other|4|||
148930588|NCT05140382|537230339|FG001|Overall Study|Other|0|||
148930589|NCT05140382|537230340|FG002|Overall Study|Other|1|||
148930590|NCT05140382|537230338|FG000|Overall Study|Progressive disease|20|||
148930591|NCT05140382|537230339|FG001|Overall Study|Progressive disease|1|||
148930592|NCT05140382|537230340|FG002|Overall Study|Progressive disease|12|||
148930593|NCT05140382|537230338|FG000|Overall Study|Subjective disease progression|2|||
148930594|NCT05140382|537230339|FG001|Overall Study|Subjective disease progression|1|||
148930595|NCT05140382|537230340|FG002|Overall Study|Subjective disease progression|0|||
148930596|NCT05140382|537230338|FG000|Overall Study|Unknown at data cut-off|0|||
148930597|NCT05140382|537230339|FG001|Overall Study|Unknown at data cut-off|0|||
148930598|NCT05140382|537230340|FG002|Overall Study|Unknown at data cut-off|1|||
148930599|NCT05140382|537230338|FG000|Overall Study|Withdrawal by Subject|1|||
148930600|NCT05140382|537230339|FG001|Overall Study|Withdrawal by Subject|0|||
148930601|NCT05140382|537230340|FG002|Overall Study|Withdrawal by Subject|4|||
148930602|NCT05140382|537230338|FG000|Overall Study|Withdrawal of consent|0|||
148930603|NCT05140382|537230339|FG001|Overall Study|Withdrawal of consent|0|||
148930604|NCT05140382|537230340|FG002|Overall Study|Withdrawal of consent|1|||
148930605|NCT01104701|537231825|FG000|Overall Study|Withdrawal by Subject|0|||
148930606|NCT01104701|537231826|FG001|Overall Study|Withdrawal by Subject|1|||
148930607|NCT01104701|537231827|FG002|Overall Study|Withdrawal by Subject|2|||
148930608|NCT01104701|537231828|FG003|Overall Study|Withdrawal by Subject|1|||
148930609|NCT01104701|537231825|FG000|Overall Study|Adverse Event|0|||
148930610|NCT01104701|537231826|FG001|Overall Study|Adverse Event|0|||
148930611|NCT01104701|537231827|FG002|Overall Study|Adverse Event|0|||
149178881|NCT00923091|538127694|FG010|Period VI (Open-Label)|Other Reason|0|||
149178882|NCT00923091|538127695|FG011|Period VI (Open-Label)|Other Reason|0|||
149178883|NCT00923091|538127696|FG012|Period VI (Open-Label)|Other Reason|0|||
148930612|NCT01104701|537231828|FG003|Overall Study|Adverse Event|1|||
148930613|NCT01104701|537231825|FG000|Overall Study|Physician Decision|0|||
148930614|NCT01104701|537231826|FG001|Overall Study|Physician Decision|2|||
148930615|NCT01104701|537231827|FG002|Overall Study|Physician Decision|0|||
148930616|NCT01104701|537231828|FG003|Overall Study|Physician Decision|0|||
148930617|NCT00401531|537231831|FG000|Overall Study|Adverse Event|2|||
148930618|NCT00401531|537231832|FG001|Overall Study|Adverse Event|0|||
148930619|NCT00401531|537231831|FG000|Overall Study|Protocol Violation|3|||
149178884|NCT01645280|538127699|FG000|Overall Study|Death|0|||
148930620|NCT00401531|537231832|FG001|Overall Study|Protocol Violation|7|||
149178885|NCT01645280|538127700|FG001|Overall Study|Death|1|||
148807137|NCT01288430|536773179|FG004|Part 2|Progressive disease|0|||
148807138|NCT01288430|536773180|FG005|Part 2|Progressive disease|0|||
148807139|NCT01288430|536773181|FG006|Part 2|Progressive disease|0|||
148807140|NCT01288430|536773182|FG007|Part 2|Progressive disease|8|||
148807141|NCT01288430|536773183|FG008|Part 2|Progressive disease|7|||
148807142|NCT01288430|536773184|FG009|Part 2|Progressive disease|2|||
148930621|NCT00401531|537231831|FG000|Overall Study|Lost to Follow-up|1|||
148930622|NCT00401531|537231832|FG001|Overall Study|Lost to Follow-up|1|||
149178886|NCT01645280|538127701|FG002|Overall Study|Death|0|||
149178887|NCT01645280|538127702|FG003|Overall Study|Death|0|||
149178888|NCT01645280|538127703|FG004|Overall Study|Death|0|||
149178889|NCT01645280|538127699|FG000|Overall Study|Withdrawal by Subject|4|||
149178890|NCT01645280|538127700|FG001|Overall Study|Withdrawal by Subject|0|||
149178891|NCT01645280|538127701|FG002|Overall Study|Withdrawal by Subject|2|||
149178892|NCT01645280|538127702|FG003|Overall Study|Withdrawal by Subject|4|||
149178893|NCT01645280|538127703|FG004|Overall Study|Withdrawal by Subject|5|||
148930623|NCT00401531|537231831|FG000|Overall Study|Withdrawal by Subject|3|||
148930624|NCT00401531|537231832|FG001|Overall Study|Withdrawal by Subject|2|||
148930625|NCT02437513|537231833|FG000|Overall Study|Withdrawal by Subject|2|||
148930626|NCT03403374|537231836|FG000|Overall Study|Lost to Follow-up|1|||
148930627|NCT04879225|537231837|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
148930628|NCT04879225|537231837|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
148930629|NCT00736957|537231840|FG000|Overall Study|Adverse Event|43|||
148930630|NCT00736957|537231840|FG000|Overall Study|Withdrawal by Subject|49|||
148930631|NCT00736957|537231840|FG000|Overall Study|violation of eligibility criteria|2|||
148930632|NCT00736957|537231840|FG000|Overall Study|did not attend hospital appointments|1|||
148930633|NCT00736957|537231840|FG000|Overall Study|not eligible for Treatment Period I|22|||
148930634|NCT00736957|537231840|FG000|Overall Study|Physician Decision|5|||
148930635|NCT01409434|537231841|FG000|Overall Study|Protocol Violation|4|||
148930636|NCT02213042|537231842|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
148930637|NCT02213042|537231843|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
148930638|NCT02213042|537231844|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
148930639|NCT02213042|537231842|FG000|Overall Study|Adverse Event|2|||
148930640|NCT02213042|537231843|FG001|Overall Study|Adverse Event|1|||
148930641|NCT02213042|537231844|FG002|Overall Study|Adverse Event|0|||
148930642|NCT02213042|537231842|FG000|Overall Study|Withdrawal by Subject|0|||
148930643|NCT02213042|537231843|FG001|Overall Study|Withdrawal by Subject|1|||
148930644|NCT02213042|537231844|FG002|Overall Study|Withdrawal by Subject|1|||
148930645|NCT02213042|537231842|FG000|Overall Study|Protocol Violation|1|||
148930646|NCT02213042|537231843|FG001|Overall Study|Protocol Violation|0|||
148930647|NCT02213042|537231844|FG002|Overall Study|Protocol Violation|0|||
148930648|NCT02213042|537231842|FG000|Overall Study|Investigator discretion|0|||
148930649|NCT02213042|537231843|FG001|Overall Study|Investigator discretion|0|||
148930650|NCT02213042|537231844|FG002|Overall Study|Investigator discretion|1|||
148930651|NCT04622735|537231845|FG000|Overall Study|Lost to Follow-up|1|||
148930652|NCT04622735|537231846|FG001|Overall Study|Lost to Follow-up|2|||
148930653|NCT04622735|537231847|FG002|Overall Study|Lost to Follow-up|1|||
148930654|NCT04622735|537231845|FG000|Overall Study|Adverse Event|0|||
148930655|NCT04622735|537231846|FG001|Overall Study|Adverse Event|0|||
148930656|NCT04622735|537231847|FG002|Overall Study|Adverse Event|1|||
148930657|NCT04622735|537231845|FG000|Overall Study|Protocol Violation|1|||
148930658|NCT04622735|537231846|FG001|Overall Study|Protocol Violation|0|||
148930659|NCT04622735|537231847|FG002|Overall Study|Protocol Violation|0|||
148930660|NCT04087213|537231848|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
148930661|NCT04087213|537231848|FG000|In-Facility Introduction|Adverse Event|1|||
148930662|NCT04087213|537231848|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
148930663|NCT04087213|537231848|FG000|Assisted Evaluable Period|Personal reasons|3|||
148930664|NCT04087213|537231848|FG000|Transition Period B|Renal Transplantation|1|||
148930665|NCT01134315|537231850|FG000|Overall Study|Adverse Event|1|||
148930666|NCT01134315|537231851|FG001|Overall Study|Adverse Event|2|||
148930667|NCT01134315|537231850|FG000|Overall Study|Other Reason|8|||
148930668|NCT01134315|537231851|FG001|Overall Study|Other Reason|17|||
148930669|NCT02545075|537231854|FG000|Randomization|Lost to Follow-up|0|||
148930670|NCT02545075|537231855|FG001|Randomization|Lost to Follow-up|1|||
148930671|NCT02545075|537231854|FG000|Randomization|Withdrawal by Subject|0|||
148930672|NCT02545075|537231855|FG001|Randomization|Withdrawal by Subject|6|||
148930673|NCT02545075|537231854|FG000|Treatment|Disease progression|71|||
148930674|NCT02545075|537231855|FG001|Treatment|Disease progression|32|||
148930675|NCT02545075|537231854|FG000|Treatment|Participant dicontinued study treatment|7|||
148930676|NCT02545075|537231855|FG001|Treatment|Participant dicontinued study treatment|9|||
149013604|NCT00365378|537529209|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
149013605|NCT00365378|537529210|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
148679431|NCT02454972|536300792|FG003|Overall Study|Progressive disease|23|||
148679432|NCT02454972|536300793|FG004|Overall Study|Progressive disease|16|||
148930677|NCT02545075|537231854|FG000|Treatment|Withdrawal by Subject|1|||
149013606|NCT00365378|537529211|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
148679433|NCT02454972|536300794|FG005|Overall Study|Progressive disease|12|||
148930678|NCT02545075|537231855|FG001|Treatment|Withdrawal by Subject|0|||
148930679|NCT02545075|537231854|FG000|Treatment|Adverse event not related to study drug|1|||
148930680|NCT02545075|537231855|FG001|Treatment|Adverse event not related to study drug|0|||
148930681|NCT02545075|537231854|FG000|Treatment|Death|1|||
148930682|NCT02545075|537231855|FG001|Treatment|Death|0|||
148930683|NCT02545075|537231854|FG000|Treatment|Participant drug toxicity|1|||
149013607|NCT00365378|537529209|FG000|Extension|Adverse Event|0|||
149178894|NCT01645280|538127699|FG000|Overall Study|Lost to Follow-up|0|||
149178895|NCT01645280|538127700|FG001|Overall Study|Lost to Follow-up|0|||
149178896|NCT01645280|538127701|FG002|Overall Study|Lost to Follow-up|0|||
149178897|NCT01645280|538127702|FG003|Overall Study|Lost to Follow-up|2|||
149178898|NCT01645280|538127703|FG004|Overall Study|Lost to Follow-up|1|||
149178899|NCT01645280|538127699|FG000|Overall Study|Other|1|||
149178900|NCT01645280|538127700|FG001|Overall Study|Other|1|||
149178901|NCT01645280|538127701|FG002|Overall Study|Other|2|||
149178902|NCT01645280|538127702|FG003|Overall Study|Other|0|||
149178903|NCT01645280|538127703|FG004|Overall Study|Other|0|||
149178904|NCT01645280|538127699|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
148807143|NCT01288430|536773175|FG000|Part 2|Clinical disease progression|0|||
148807144|NCT01288430|536773176|FG001|Part 2|Clinical disease progression|0|||
148807145|NCT01288430|536773177|FG002|Part 2|Clinical disease progression|0|||
148807146|NCT01288430|536773178|FG003|Part 2|Clinical disease progression|0|||
149178905|NCT01645280|538127700|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
149178906|NCT01645280|538127701|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
149178907|NCT01645280|538127702|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
149178908|NCT01645280|538127703|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
149178909|NCT02460822|538127706|FG000|Overall Study|Withdrawal by Subject|1|||
149178910|NCT01254344|538127711|FG000|Overall Study|Adverse Event|2|||
149178911|NCT01254344|538127712|FG001|Overall Study|Adverse Event|5|||
149178912|NCT01254344|538127711|FG000|Overall Study|Physician Decision|7|||
148807147|NCT01288430|536773179|FG004|Part 2|Clinical disease progression|0|||
148807148|NCT01288430|536773180|FG005|Part 2|Clinical disease progression|0|||
148807149|NCT01288430|536773181|FG006|Part 2|Clinical disease progression|0|||
148807150|NCT01288430|536773182|FG007|Part 2|Clinical disease progression|2|||
149178913|NCT01254344|538127712|FG001|Overall Study|Physician Decision|4|||
149178914|NCT01254344|538127711|FG000|Overall Study|Protocol Violation|1|||
149178915|NCT01254344|538127712|FG001|Overall Study|Protocol Violation|4|||
149178916|NCT01254344|538127711|FG000|Overall Study|Withdrawal by Subject|3|||
149178917|NCT01254344|538127712|FG001|Overall Study|Withdrawal by Subject|6|||
149178918|NCT03249350|538127717|FG000|Overall Study|Participant did not initiate treatment|5|||
149178919|NCT03249350|538127718|FG001|Overall Study|Participant did not initiate treatment|8|||
149178920|NCT00624338|538127719|FG000|Overall Study|Adverse Event|14|||
149178921|NCT00624338|538127720|FG001|Overall Study|Adverse Event|14|||
149178922|NCT00624338|538127721|FG002|Overall Study|Adverse Event|18|||
149178923|NCT00624338|538127719|FG000|Overall Study|Lost to Follow-up|1|||
149178924|NCT00624338|538127720|FG001|Overall Study|Lost to Follow-up|0|||
149178925|NCT00624338|538127721|FG002|Overall Study|Lost to Follow-up|0|||
149178926|NCT00624338|538127719|FG000|Overall Study|Lack of Efficacy|11|||
149178927|NCT00624338|538127720|FG001|Overall Study|Lack of Efficacy|3|||
148930684|NCT02545075|537231855|FG001|Treatment|Participant drug toxicity|0|||
148930685|NCT02545075|537231854|FG000|Treatment|Completed treatment|40|||
148930686|NCT02545075|537231855|FG001|Treatment|Completed treatment|12|||
148930687|NCT05246397|537231859|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
148930688|NCT00147251|537231863|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
149178928|NCT00624338|538127721|FG002|Overall Study|Lack of Efficacy|14|||
149178929|NCT00624338|538127719|FG000|Overall Study|Protocol Violation|3|||
149178930|NCT00624338|538127720|FG001|Overall Study|Protocol Violation|3|||
149178931|NCT00624338|538127721|FG002|Overall Study|Protocol Violation|2|||
149178932|NCT00624338|538127719|FG000|Overall Study|Death|0|||
149178933|NCT00624338|538127720|FG001|Overall Study|Death|2|||
149178934|NCT00624338|538127721|FG002|Overall Study|Death|0|||
149178935|NCT00624338|538127719|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
149178936|NCT00624338|538127720|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
149178937|NCT00624338|538127721|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
148930689|NCT00147251|537231864|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
148930690|NCT02694523|537231869|FG000|Part A|Adverse Event|7|||
148930691|NCT02694523|537231870|FG001|Part A|Adverse Event|3|||
148930692|NCT02694523|537231871|FG002|Part A|Adverse Event|0|||
148930693|NCT02694523|537231872|FG003|Part A|Adverse Event|0|||
149013608|NCT00365378|537529210|FG001|Extension|Adverse Event|0|||
149178938|NCT00624338|538127719|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
148807151|NCT01288430|536773183|FG008|Part 2|Clinical disease progression|0|||
149013609|NCT00365378|537529211|FG002|Extension|Adverse Event|1|||
148807152|NCT01288430|536773184|FG009|Part 2|Clinical disease progression|0|||
149178939|NCT00624338|538127720|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
148930694|NCT02694523|537231873|FG004|Part A|Adverse Event|0|||
148930695|NCT02694523|537231874|FG005|Part A|Adverse Event|0|||
148930696|NCT02694523|537231875|FG006|Part A|Adverse Event|0|||
149178940|NCT00624338|538127721|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
149178941|NCT00624338|538127719|FG000|Overall Study|Other|15|||
149178942|NCT00624338|538127720|FG001|Overall Study|Other|5|||
149178943|NCT00624338|538127721|FG002|Overall Study|Other|9|||
148807153|NCT01288430|536773175|FG000|Part 2|Withdrawal by Subject|0|||
149013610|NCT00365378|537529209|FG000|Extension|Moved|0|||
149178944|NCT00624338|538127719|FG000|Overall Study|Randomized but not treated|2|||
149178945|NCT00624338|538127720|FG001|Overall Study|Randomized but not treated|1|||
149178946|NCT00624338|538127721|FG002|Overall Study|Randomized but not treated|3|||
149178947|NCT01476787|538127722|FG000|Treatment|Progression|64|||
149178948|NCT01476787|538127723|FG001|Treatment|Progression|71|||
149178949|NCT01476787|538127722|FG000|Treatment|Toxicity|44|||
149178950|NCT01476787|538127723|FG001|Treatment|Toxicity|16|||
148930697|NCT02694523|537231869|FG000|Part A|Protocol Violation|1|||
148930698|NCT02694523|537231870|FG001|Part A|Protocol Violation|0|||
148930699|NCT02694523|537231871|FG002|Part A|Protocol Violation|0|||
148930700|NCT02694523|537231872|FG003|Part A|Protocol Violation|0|||
148930701|NCT02694523|537231873|FG004|Part A|Protocol Violation|0|||
148930702|NCT02694523|537231874|FG005|Part A|Protocol Violation|0|||
148930703|NCT02694523|537231875|FG006|Part A|Protocol Violation|0|||
148930704|NCT02694523|537231869|FG000|Part A|Lost to Follow-up|1|||
148930705|NCT02694523|537231870|FG001|Part A|Lost to Follow-up|2|||
148930706|NCT02694523|537231871|FG002|Part A|Lost to Follow-up|0|||
148930707|NCT02694523|537231872|FG003|Part A|Lost to Follow-up|0|||
148930708|NCT02694523|537231873|FG004|Part A|Lost to Follow-up|0|||
148930709|NCT02694523|537231874|FG005|Part A|Lost to Follow-up|0|||
148930710|NCT02694523|537231875|FG006|Part A|Lost to Follow-up|0|||
148930711|NCT02694523|537231869|FG000|Part A|Withdrawal by Subject|3|||
148930712|NCT02694523|537231870|FG001|Part A|Withdrawal by Subject|1|||
148930713|NCT02694523|537231871|FG002|Part A|Withdrawal by Subject|0|||
148930714|NCT02694523|537231872|FG003|Part A|Withdrawal by Subject|0|||
148930715|NCT02694523|537231873|FG004|Part A|Withdrawal by Subject|0|||
148930716|NCT02694523|537231874|FG005|Part A|Withdrawal by Subject|0|||
148930717|NCT02694523|537231875|FG006|Part A|Withdrawal by Subject|0|||
148930718|NCT02694523|537231869|FG000|Part A|Other|1|||
148930719|NCT02694523|537231870|FG001|Part A|Other|1|||
148930720|NCT02694523|537231871|FG002|Part A|Other|0|||
148930721|NCT02694523|537231872|FG003|Part A|Other|0|||
148930722|NCT02694523|537231873|FG004|Part A|Other|0|||
148930723|NCT02694523|537231874|FG005|Part A|Other|0|||
148930724|NCT02694523|537231875|FG006|Part A|Other|0|||
148930725|NCT02694523|537231869|FG000|Part B|Adverse Event|0|||
148930726|NCT02694523|537231870|FG001|Part B|Adverse Event|0|||
148930727|NCT02694523|537231871|FG002|Part B|Adverse Event|7|||
148930728|NCT02694523|537231872|FG003|Part B|Adverse Event|1|||
148930729|NCT02694523|537231873|FG004|Part B|Adverse Event|1|||
148930730|NCT02694523|537231874|FG005|Part B|Adverse Event|2|||
148930731|NCT02694523|537231875|FG006|Part B|Adverse Event|0|||
148930732|NCT02694523|537231869|FG000|Part B|Protocol Violation|0|||
148930733|NCT02694523|537231870|FG001|Part B|Protocol Violation|0|||
148930734|NCT02694523|537231871|FG002|Part B|Protocol Violation|1|||
148930735|NCT02694523|537231872|FG003|Part B|Protocol Violation|0|||
148930736|NCT02694523|537231873|FG004|Part B|Protocol Violation|0|||
148930737|NCT02694523|537231874|FG005|Part B|Protocol Violation|0|||
148930738|NCT02694523|537231875|FG006|Part B|Protocol Violation|0|||
148930739|NCT02694523|537231869|FG000|Part B|Lost to Follow-up|0|||
148930740|NCT02694523|537231870|FG001|Part B|Lost to Follow-up|0|||
148930741|NCT02694523|537231871|FG002|Part B|Lost to Follow-up|2|||
148930742|NCT02694523|537231872|FG003|Part B|Lost to Follow-up|3|||
148930743|NCT02694523|537231873|FG004|Part B|Lost to Follow-up|2|||
148930744|NCT02694523|537231874|FG005|Part B|Lost to Follow-up|0|||
148930745|NCT02694523|537231875|FG006|Part B|Lost to Follow-up|1|||
148930746|NCT02694523|537231869|FG000|Part B|Withdrawal by Subject|0|||
148930747|NCT02694523|537231870|FG001|Part B|Withdrawal by Subject|0|||
148930748|NCT02694523|537231871|FG002|Part B|Withdrawal by Subject|9|||
148930749|NCT02694523|537231872|FG003|Part B|Withdrawal by Subject|0|||
148930750|NCT02694523|537231873|FG004|Part B|Withdrawal by Subject|1|||
148930751|NCT02694523|537231874|FG005|Part B|Withdrawal by Subject|3|||
148930752|NCT02694523|537231875|FG006|Part B|Withdrawal by Subject|0|||
149178951|NCT01476787|538127722|FG000|Treatment|Death|0|||
149178952|NCT01476787|538127723|FG001|Treatment|Death|1|||
149178953|NCT01476787|538127722|FG000|Treatment|Withdrawal by Subject|3|||
148679434|NCT02454972|536300795|FG006|Overall Study|Progressive disease|19|||
148930753|NCT02694523|537231869|FG000|Part B|Other|0|||
148930754|NCT02694523|537231870|FG001|Part B|Other|0|||
148930755|NCT02694523|537231871|FG002|Part B|Other|1|||
148930756|NCT02694523|537231872|FG003|Part B|Other|0|||
148930757|NCT02694523|537231873|FG004|Part B|Other|0|||
148930758|NCT02694523|537231874|FG005|Part B|Other|0|||
148930759|NCT02694523|537231875|FG006|Part B|Other|1|||
148930760|NCT01272661|537231876|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
148930761|NCT01272661|537231877|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
148930762|NCT01272661|537231878|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
148930763|NCT01086423|537231879|FG000|Overall Study|Protocol Violation|0|||
148930764|NCT01086423|537231880|FG001|Overall Study|Protocol Violation|0|||
148930765|NCT01086423|537231881|FG002|Overall Study|Protocol Violation|1|||
148930766|NCT01086423|537231879|FG000|Overall Study|Migrated/moved from study area|2|||
148930767|NCT01086423|537231880|FG001|Overall Study|Migrated/moved from study area|0|||
148930768|NCT01086423|537231881|FG002|Overall Study|Migrated/moved from study area|4|||
148930769|NCT01086423|537231879|FG000|Overall Study|Adverse event, fatal|1|||
148930770|NCT01086423|537231880|FG001|Overall Study|Adverse event, fatal|1|||
148930771|NCT01086423|537231881|FG002|Overall Study|Adverse event, fatal|0|||
148930772|NCT01086423|537231879|FG000|Overall Study|Adverse event, non-fatal|2|||
149178954|NCT01476787|538127723|FG001|Treatment|Withdrawal by Subject|14|||
149178955|NCT01476787|538127722|FG000|Treatment|Major protocol violation|1|||
149178956|NCT01476787|538127723|FG001|Treatment|Major protocol violation|6|||
149178957|NCT01476787|538127722|FG000|Treatment|Other reasons|10|||
149178958|NCT01476787|538127723|FG001|Treatment|Other reasons|22|||
149178959|NCT01476787|538127722|FG000|Treatment|Concurrent illness|12|||
149178960|NCT01476787|538127723|FG001|Treatment|Concurrent illness|9|||
149178961|NCT01476787|538127722|FG000|Treatment|Insufficient response|15|||
149178962|NCT01476787|538127723|FG001|Treatment|Insufficient response|3|||
149178963|NCT01476787|538127722|FG000|Treatment|Voluntary treatment discontinuation|8|||
149178964|NCT01476787|538127723|FG001|Treatment|Voluntary treatment discontinuation|4|||
149178965|NCT02986373|538127724|FG000|Overall Study|Adverse Event|4|||
149178966|NCT02986373|538127724|FG000|Overall Study|Lost to Follow-up|1|||
149178967|NCT02986373|538127724|FG000|Overall Study|Withdrawal by Subject|10|||
148930773|NCT01086423|537231880|FG001|Overall Study|Adverse event, non-fatal|1|||
148930774|NCT01086423|537231881|FG002|Overall Study|Adverse event, non-fatal|0|||
148930775|NCT01086423|537231879|FG000|Overall Study|Withdrawal by Subject|5|||
148930776|NCT01086423|537231880|FG001|Overall Study|Withdrawal by Subject|1|||
148930777|NCT01086423|537231881|FG002|Overall Study|Withdrawal by Subject|3|||
148930778|NCT01086423|537231879|FG000|Overall Study|Lost to Follow-up|0|||
148930779|NCT01086423|537231880|FG001|Overall Study|Lost to Follow-up|0|||
148930780|NCT01086423|537231881|FG002|Overall Study|Lost to Follow-up|1|||
148930781|NCT00984568|537231883|FG000|Overall Study|Withdrawal by Subject|1|||
148930782|NCT00984568|537231884|FG001|Overall Study|Withdrawal by Subject|2|||
148930783|NCT00984568|537231883|FG000|Overall Study|Lack of Efficacy|2|||
148930784|NCT00984568|537231884|FG001|Overall Study|Lack of Efficacy|0|||
148930785|NCT00984568|537231883|FG000|Overall Study|Adverse Event|2|||
148930786|NCT00984568|537231884|FG001|Overall Study|Adverse Event|0|||
148930787|NCT00984568|537231883|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
148930788|NCT00984568|537231884|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
148930789|NCT00984568|537231883|FG000|Overall Study|Lost to Follow-up|0|||
148930790|NCT00984568|537231884|FG001|Overall Study|Lost to Follow-up|1|||
148930791|NCT00984568|537231883|FG000|Overall Study|Opportunistic Infection|1|||
148930792|NCT00984568|537231884|FG001|Overall Study|Opportunistic Infection|0|||
148930793|NCT00984568|537231883|FG000|Overall Study|Unknown Reason|1|||
148930794|NCT00984568|537231884|FG001|Overall Study|Unknown Reason|3|||
148930795|NCT04505540|537231885|FG000|Baseline|Protocol Violation|10|||
148930796|NCT04505540|537231885|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
148930797|NCT04505540|537231885|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
148930798|NCT04505540|537231885|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
148930799|NCT04505540|537231885|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
148930800|NCT04505540|537231885|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
148930801|NCT04505540|537231885|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
149178968|NCT02986373|538127724|FG000|Overall Study|Other|24|||
149178969|NCT01151137|538127730|FG000|Overall Study|Death|15|||
148930802|NCT04505540|537231885|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
148930803|NCT04505540|537231885|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
148930804|NCT04505540|537231885|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
148930805|NCT04505540|537231885|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
148930806|NCT04505540|537231885|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
148930807|NCT04505540|537231885|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
148930808|NCT02791594|537231886|FG000|Overall Study|Physician Decision|2|||
148930809|NCT01367119|537231887|FG000|Overall Study|Adverse Event|1|||
148930810|NCT01367119|537231888|FG001|Overall Study|Adverse Event|0|||
148930811|NCT01367119|537231887|FG000|Overall Study|Withdrawal by Subject|1|||
148930812|NCT01367119|537231888|FG001|Overall Study|Withdrawal by Subject|1|||
148930813|NCT05342532|537231889|FG000|Overall Study|Adverse Event|5|||
148930814|NCT05342532|537231890|FG001|Overall Study|Adverse Event|20|||
148930815|NCT05342532|537231889|FG000|Overall Study|Lost to Follow-up|10|||
148930816|NCT05342532|537231890|FG001|Overall Study|Lost to Follow-up|15|||
148930817|NCT02057393|537231893|FG000|Overall Study|Withdrawal by Subject|1|||
148930818|NCT02057393|537231893|FG000|Overall Study|Patient did not meet criteria|1|||
148930819|NCT03180684|537231894|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
148930820|NCT03180684|537231895|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
148930821|NCT03180684|537231894|FG000|Overall Study|Physician Decision|1|||
148930822|NCT03180684|537231895|FG001|Overall Study|Physician Decision|0|||
148930823|NCT03180684|537231894|FG000|Overall Study|Lost to Follow-up|1|||
148930824|NCT03180684|537231895|FG001|Overall Study|Lost to Follow-up|0|||
148930825|NCT03180684|537231894|FG000|Overall Study|Progressive Disease|1|||
149178970|NCT01151137|538127731|FG001|Overall Study|Death|27|||
149178971|NCT01151137|538127730|FG000|Overall Study|Lost to Follow-up|1|||
149178972|NCT01151137|538127731|FG001|Overall Study|Lost to Follow-up|1|||
149178973|NCT01933672|538127732|FG000|Metformin Run-in Period|Adverse Event|1|||
149178974|NCT01933672|538127733|FG001|Metformin Run-in Period|Adverse Event|0|||
149178975|NCT01933672|538127734|FG002|Metformin Run-in Period|Adverse Event|0|||
149178976|NCT01933672|538127735|FG003|Metformin Run-in Period|Adverse Event|0|||
149178977|NCT01933672|538127736|FG004|Metformin Run-in Period|Adverse Event|0|||
149178978|NCT01933672|538127737|FG005|Metformin Run-in Period|Adverse Event|0|||
149178979|NCT01933672|538127738|FG006|Metformin Run-in Period|Adverse Event|0|||
149178980|NCT01933672|538127732|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
149178981|NCT01933672|538127733|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149178982|NCT01933672|538127734|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149178983|NCT01933672|538127735|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149178984|NCT01933672|538127736|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149178985|NCT01933672|538127737|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149178986|NCT01933672|538127738|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
149178987|NCT01933672|538127732|FG000|Metformin Run-in Period|Other|5|||
149178988|NCT01933672|538127733|FG001|Metformin Run-in Period|Other|0|||
149178989|NCT01933672|538127734|FG002|Metformin Run-in Period|Other|0|||
149178990|NCT01933672|538127735|FG003|Metformin Run-in Period|Other|0|||
149178991|NCT01933672|538127736|FG004|Metformin Run-in Period|Other|0|||
149178992|NCT01933672|538127737|FG005|Metformin Run-in Period|Other|0|||
148930826|NCT03180684|537231895|FG001|Overall Study|Progressive Disease|0|||
148930827|NCT02652767|537231897|FG000|Overall Study|Death|2|||
148930828|NCT02652767|537231897|FG000|Overall Study|Lost to Follow-up|1|||
148930829|NCT02652767|537231897|FG000|Overall Study|Withdrawal by Subject|1|||
148930830|NCT03953183|537231898|FG000|Overall Study|Physician Decision|0|||
148930831|NCT03953183|537231899|FG001|Overall Study|Physician Decision|1|||
148930832|NCT03953183|537231898|FG000|Overall Study|Withdrawal by Subject|0|||
148930833|NCT03953183|537231899|FG001|Overall Study|Withdrawal by Subject|1|||
148930834|NCT01130103|537231900|FG000|Randomized Treatment|Adverse Event|1|||
148930835|NCT01130103|537231901|FG001|Randomized Treatment|Adverse Event|1|||
149178993|NCT01933672|538127738|FG006|Metformin Run-in Period|Other|0|||
149178994|NCT01933672|538127732|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149178995|NCT01933672|538127733|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149178996|NCT01933672|538127734|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
148930836|NCT01130103|537231900|FG000|Randomized Treatment|Lost to Follow-up|1|||
148930837|NCT01130103|537231901|FG001|Randomized Treatment|Lost to Follow-up|0|||
148930838|NCT01130103|537231900|FG000|Randomized Treatment|Protocol Violation|3|||
148930839|NCT01130103|537231901|FG001|Randomized Treatment|Protocol Violation|2|||
148930840|NCT01130103|537231900|FG000|Randomized Treatment|Withdrawal by Subject|1|||
148930841|NCT01130103|537231901|FG001|Randomized Treatment|Withdrawal by Subject|2|||
148930842|NCT01130103|537231900|FG000|Maintenance Treatment|Lack of Efficacy|0|||
148930843|NCT01130103|537231901|FG001|Maintenance Treatment|Lack of Efficacy|1|||
148930844|NCT01130103|537231900|FG000|Maintenance Treatment|Lost to Follow-up|1|||
148930845|NCT01130103|537231901|FG001|Maintenance Treatment|Lost to Follow-up|1|||
148930846|NCT01130103|537231900|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
148930847|NCT01130103|537231901|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
148930848|NCT03091777|537231912|FG000|Overall Study|Pregnancy|2|||
148930849|NCT03091777|537231913|FG001|Overall Study|Pregnancy|1|||
148930850|NCT03091777|537231914|FG002|Overall Study|Pregnancy|0|||
148930851|NCT03091777|537231912|FG000|Overall Study|Adverse Event|2|||
148930852|NCT03091777|537231913|FG001|Overall Study|Adverse Event|1|||
148930853|NCT03091777|537231914|FG002|Overall Study|Adverse Event|4|||
148930854|NCT03091777|537231912|FG000|Overall Study|Withdrawal by Subject|4|||
148930855|NCT03091777|537231913|FG001|Overall Study|Withdrawal by Subject|2|||
148930856|NCT03091777|537231914|FG002|Overall Study|Withdrawal by Subject|6|||
148930857|NCT03091777|537231912|FG000|Overall Study|Protocol Violation|2|||
148930858|NCT03091777|537231913|FG001|Overall Study|Protocol Violation|1|||
148930859|NCT03091777|537231914|FG002|Overall Study|Protocol Violation|1|||
148930860|NCT03091777|537231912|FG000|Overall Study|Lost to Follow-up|12|||
148930861|NCT03091777|537231913|FG001|Overall Study|Lost to Follow-up|14|||
148930862|NCT03091777|537231914|FG002|Overall Study|Lost to Follow-up|7|||
148930863|NCT03091777|537231912|FG000|Overall Study|Lack of Efficacy|0|||
148930864|NCT03091777|537231913|FG001|Overall Study|Lack of Efficacy|0|||
148930865|NCT03091777|537231914|FG002|Overall Study|Lack of Efficacy|5|||
148930866|NCT03091777|537231912|FG000|Overall Study|Noncompliance with study drug|2|||
148930867|NCT03091777|537231913|FG001|Overall Study|Noncompliance with study drug|3|||
148930868|NCT03091777|537231914|FG002|Overall Study|Noncompliance with study drug|1|||
148930869|NCT03091777|537231912|FG000|Overall Study|Physician Decision|1|||
148930870|NCT03091777|537231913|FG001|Overall Study|Physician Decision|0|||
148930871|NCT03091777|537231914|FG002|Overall Study|Physician Decision|1|||
148930872|NCT03091777|537231912|FG000|Overall Study|Abnormal Laboratory Value|7|||
148930873|NCT03091777|537231913|FG001|Overall Study|Abnormal Laboratory Value|11|||
148930874|NCT03091777|537231914|FG002|Overall Study|Abnormal Laboratory Value|12|||
148930875|NCT02314143|537231915|FG000|Overall Study|Adverse Event|0|||
148930876|NCT02314143|537231916|FG001|Overall Study|Adverse Event|6|||
148930877|NCT02314143|537231917|FG002|Overall Study|Adverse Event|4|||
148930878|NCT02314143|537231915|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
148930879|NCT02314143|537231916|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
148930880|NCT02314143|537231917|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
148930881|NCT02314143|537231915|FG000|Overall Study|Physician Decision|2|||
148930882|NCT02314143|537231916|FG001|Overall Study|Physician Decision|1|||
148930883|NCT02314143|537231917|FG002|Overall Study|Physician Decision|0|||
148930884|NCT02314143|537231915|FG000|Overall Study|Withdrawal by Subject|1|||
148930885|NCT02314143|537231916|FG001|Overall Study|Withdrawal by Subject|0|||
148930886|NCT02314143|537231917|FG002|Overall Study|Withdrawal by Subject|1|||
148930887|NCT00089674|537231919|FG000|Overall Study|Physician Decision|4|||
148930888|NCT00089674|537231920|FG001|Overall Study|Physician Decision|2|||
148930889|NCT00089674|537231919|FG000|Overall Study|Adverse Event|23|||
148930890|NCT00089674|537231920|FG001|Overall Study|Adverse Event|29|||
148930891|NCT00089674|537231919|FG000|Overall Study|Withdrawal by Subject|143|||
149013611|NCT00365378|537529210|FG001|Extension|Moved|0|||
149013612|NCT00365378|537529211|FG002|Extension|Moved|8|||
148930892|NCT00089674|537231920|FG001|Overall Study|Withdrawal by Subject|127|||
148807154|NCT01288430|536773176|FG001|Part 2|Withdrawal by Subject|0|||
148930893|NCT00089674|537231919|FG000|Overall Study|Death|43|||
148930894|NCT00089674|537231920|FG001|Overall Study|Death|43|||
148930895|NCT00089674|537231919|FG000|Overall Study|Disease progression|21|||
148930896|NCT00089674|537231920|FG001|Overall Study|Disease progression|23|||
148930897|NCT00089674|537231919|FG000|Overall Study|Ineligibility determined|8|||
149013613|NCT00365378|537529209|FG000|Extension|Lost to Follow-up|0|||
149178997|NCT01933672|538127735|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149178998|NCT01933672|538127736|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
149178999|NCT01933672|538127737|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179000|NCT01933672|538127738|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179001|NCT01933672|538127732|FG000|First Intervention Period (12-16 Days)|Other|0|||
149179002|NCT01933672|538127733|FG001|First Intervention Period (12-16 Days)|Other|0|||
148930898|NCT00089674|537231920|FG001|Overall Study|Ineligibility determined|10|||
148930899|NCT00089674|537231919|FG000|Overall Study|Lost to Follow-up|21|||
148930900|NCT00089674|537231920|FG001|Overall Study|Lost to Follow-up|17|||
148930901|NCT00089674|537231919|FG000|Overall Study|Noncompliance|7|||
148930902|NCT00089674|537231920|FG001|Overall Study|Noncompliance|3|||
148930903|NCT00089674|537231919|FG000|Overall Study|Other|5|||
148930904|NCT00089674|537231920|FG001|Overall Study|Other|9|||
148930905|NCT00089674|537231919|FG000|Overall Study|Requirement for alternative therapy|14|||
148930906|NCT00089674|537231920|FG001|Overall Study|Requirement for alternative therapy|4|||
148930907|NCT03963401|537231921|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
148930908|NCT03963401|537231922|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
148930909|NCT03963401|537231923|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
148930910|NCT03963401|537231924|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
148930911|NCT03963401|537231925|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
148930912|NCT03963401|537231926|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
148930913|NCT03963401|537231921|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
148930914|NCT03963401|537231922|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
148930915|NCT03963401|537231923|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
148930916|NCT03963401|537231924|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
148930917|NCT03963401|537231925|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
148930918|NCT03963401|537231926|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
148930919|NCT03963401|537231921|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
148930920|NCT03963401|537231922|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
148930921|NCT03963401|537231923|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
148930922|NCT03963401|537231924|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
148930923|NCT03963401|537231925|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
148930924|NCT03963401|537231926|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
148930925|NCT03963401|537231921|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
148930926|NCT03963401|537231922|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
148930927|NCT03963401|537231923|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
148930928|NCT03963401|537231924|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
148930929|NCT03963401|537231925|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
148930930|NCT03963401|537231926|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
148930931|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
148930932|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
148930933|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
148930934|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
148930935|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
148930936|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
148930937|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
148930938|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
148930939|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
148930940|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
148930941|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
148930942|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
148930943|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
149179003|NCT01933672|538127734|FG002|First Intervention Period (12-16 Days)|Other|1|||
149179004|NCT01933672|538127735|FG003|First Intervention Period (12-16 Days)|Other|0|||
149179005|NCT01933672|538127736|FG004|First Intervention Period (12-16 Days)|Other|0|||
149179006|NCT01933672|538127737|FG005|First Intervention Period (12-16 Days)|Other|1|||
148930944|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
148930945|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
148930946|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
148930947|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
148930948|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
148930949|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
148930950|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
148930951|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
148930952|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
149179007|NCT01933672|538127738|FG006|First Intervention Period (12-16 Days)|Other|0|||
149179008|NCT01933672|538127732|FG000|Second Intervention Period (12-16 Days)|Other|0|||
149179009|NCT01933672|538127733|FG001|Second Intervention Period (12-16 Days)|Other|1|||
149179010|NCT01933672|538127734|FG002|Second Intervention Period (12-16 Days)|Other|1|||
149179011|NCT01933672|538127735|FG003|Second Intervention Period (12-16 Days)|Other|0|||
149179012|NCT01933672|538127736|FG004|Second Intervention Period (12-16 Days)|Other|0|||
149179013|NCT01933672|538127737|FG005|Second Intervention Period (12-16 Days)|Other|0|||
149179014|NCT01933672|538127738|FG006|Second Intervention Period (12-16 Days)|Other|0|||
149179015|NCT01933672|538127732|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179016|NCT01933672|538127733|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179017|NCT01933672|538127734|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179018|NCT01933672|538127735|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
149179019|NCT01933672|538127736|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
148930953|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
148930954|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
148930955|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
148930956|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
148930957|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
148930958|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
148930959|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
148930960|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
148930961|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
148930962|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
148930963|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
148930964|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
148930965|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
148930966|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
148930967|NCT03963401|537231921|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
148930968|NCT03963401|537231922|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
148930969|NCT03963401|537231923|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
149179020|NCT01933672|538127737|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179021|NCT01933672|538127738|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
149179022|NCT01933672|538127732|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149179023|NCT01933672|538127733|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
149179024|NCT01933672|538127734|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149179025|NCT01933672|538127735|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149179026|NCT01933672|538127736|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149179027|NCT01933672|538127737|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149179028|NCT01933672|538127738|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
149179029|NCT05635838|538129494|FG000|16-Week DBVC Period|Adverse Event|2|||
149179030|NCT05635838|538129495|FG001|16-Week DBVC Period|Adverse Event|0|||
149179031|NCT05635838|538129496|FG002|16-Week DBVC Period|Adverse Event|0|||
149179032|NCT05635838|538129497|FG003|16-Week DBVC Period|Adverse Event|0|||
149179033|NCT05635838|538129494|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
149179034|NCT05635838|538129495|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
149179035|NCT05635838|538129496|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
149179036|NCT05635838|538129497|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
149179037|NCT05635838|538129494|FG000|16-Week DBVC Period|Physician Decision|0|||
149179038|NCT05635838|538129495|FG001|16-Week DBVC Period|Physician Decision|1|||
149179039|NCT05635838|538129496|FG002|16-Week DBVC Period|Physician Decision|0|||
149179040|NCT05635838|538129497|FG003|16-Week DBVC Period|Physician Decision|0|||
149179041|NCT05635838|538129494|FG000|16-Week DBVC Period|Protocol Violation|1|||
149179042|NCT05635838|538129495|FG001|16-Week DBVC Period|Protocol Violation|0|||
149179043|NCT05635838|538129496|FG002|16-Week DBVC Period|Protocol Violation|0|||
149179044|NCT05635838|538129497|FG003|16-Week DBVC Period|Protocol Violation|0|||
149179045|NCT05635838|538129494|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
149179046|NCT05635838|538129495|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
149179047|NCT05635838|538129496|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
149179048|NCT05635838|538129497|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
149179049|NCT05635838|538129494|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
149179050|NCT05635838|538129495|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
149179051|NCT05635838|538129496|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
148930970|NCT03963401|537231924|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
148930971|NCT03963401|537231925|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
149013614|NCT00365378|537529210|FG001|Extension|Lost to Follow-up|0|||
149013615|NCT00365378|537529211|FG002|Extension|Lost to Follow-up|57|||
149179052|NCT05635838|538129497|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
149179053|NCT05635838|538129494|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
149179054|NCT05635838|538129495|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
149179055|NCT05635838|538129496|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
149179056|NCT05635838|538129497|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
149179057|NCT05635838|538129494|FG000|16-Week OLE Period|Adverse Event|0|||
149179058|NCT05635838|538129495|FG001|16-Week OLE Period|Adverse Event|0|||
149179059|NCT05635838|538129496|FG002|16-Week OLE Period|Adverse Event|0|||
149179060|NCT05635838|538129497|FG003|16-Week OLE Period|Adverse Event|2|||
149179061|NCT05635838|538129494|FG000|16-Week OLE Period|Lost to Follow-up|0|||
149179062|NCT05635838|538129495|FG001|16-Week OLE Period|Lost to Follow-up|0|||
149179063|NCT05635838|538129496|FG002|16-Week OLE Period|Lost to Follow-up|1|||
149179064|NCT05635838|538129497|FG003|16-Week OLE Period|Lost to Follow-up|3|||
149179065|NCT05635838|538129494|FG000|16-Week OLE Period|Physician Decision|0|||
149179066|NCT05635838|538129495|FG001|16-Week OLE Period|Physician Decision|0|||
149179067|NCT05635838|538129496|FG002|16-Week OLE Period|Physician Decision|0|||
149179068|NCT05635838|538129497|FG003|16-Week OLE Period|Physician Decision|1|||
149179069|NCT05635838|538129494|FG000|16-Week OLE Period|Protocol Violation|0|||
149179070|NCT05635838|538129495|FG001|16-Week OLE Period|Protocol Violation|0|||
149179071|NCT05635838|538129496|FG002|16-Week OLE Period|Protocol Violation|1|||
149179072|NCT05635838|538129497|FG003|16-Week OLE Period|Protocol Violation|1|||
149179073|NCT05635838|538129494|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
149179074|NCT05635838|538129495|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
149179075|NCT05635838|538129496|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
149179076|NCT05635838|538129497|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
149179077|NCT05635838|538129494|FG000|16-Week OLE Period|Pregnancy|0|||
149179078|NCT05635838|538129495|FG001|16-Week OLE Period|Pregnancy|0|||
149179079|NCT05635838|538129496|FG002|16-Week OLE Period|Pregnancy|1|||
149179080|NCT05635838|538129497|FG003|16-Week OLE Period|Pregnancy|0|||
149179081|NCT02031146|538129500|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
149179082|NCT02031146|538129501|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
149179083|NCT02031146|538129502|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
149179084|NCT02031146|538129503|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
149179085|NCT02031146|538129504|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
149179086|NCT02031146|538129505|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
149179087|NCT02031146|538129506|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
149179088|NCT05165394|538129507|FG000|Overall Study|Withdrawal by Subject|5|||
149179089|NCT05165394|538129508|FG001|Overall Study|Withdrawal by Subject|1|||
149179090|NCT05165394|538129507|FG000|Overall Study|Lost to Follow-up|1|||
149179091|NCT05165394|538129508|FG001|Overall Study|Lost to Follow-up|2|||
149179092|NCT05165394|538129507|FG000|Overall Study|Other Than Specified|0|||
149179093|NCT05165394|538129508|FG001|Overall Study|Other Than Specified|1|||
149179094|NCT00001259|538129511|FG000|Study 2|Adverse Event|0|||
149179095|NCT00001259|538129512|FG001|Study 2|Adverse Event|0|||
149179096|NCT00001259|538129513|FG002|Study 2|Adverse Event|0|||
149179097|NCT00001259|538129514|FG003|Study 2|Adverse Event|0|||
149179098|NCT00001259|538129515|FG004|Study 2|Adverse Event|2|||
149179099|NCT00001259|538129516|FG005|Study 2|Adverse Event|0|||
149179100|NCT00001259|538129517|FG006|Study 2|Adverse Event|0|||
149179101|NCT01582282|538129518|FG000|Overall Study|Adverse Event|1|||
149179102|NCT01582282|538129519|FG001|Overall Study|Adverse Event|1|||
149179103|NCT01582282|538129520|FG002|Overall Study|Adverse Event|0|||
149179104|NCT01582282|538129518|FG000|Overall Study|Lost to Follow-up|1|||
149179105|NCT01582282|538129519|FG001|Overall Study|Lost to Follow-up|0|||
149179106|NCT01582282|538129520|FG002|Overall Study|Lost to Follow-up|0|||
149179107|NCT01582282|538129518|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
149179108|NCT01582282|538129519|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
149179109|NCT01582282|538129520|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
149179110|NCT02629393|538129522|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
149179111|NCT02629393|538129522|FG000|Overall Study|Physician Decision|1|||
149179112|NCT03937986|538129523|FG000|Overall Study|COVID-19 Pandemic|1|||
149179113|NCT01853228|538129526|FG000|Phase 1|Lack of Efficacy|8|||
149179114|NCT01853228|538129527|FG001|Phase 1|Lack of Efficacy|0|||
148679435|NCT02454972|536300796|FG007|Overall Study|Progressive disease|27|||
148679436|NCT02454972|536300797|FG008|Overall Study|Progressive disease|0|||
148679437|NCT02454972|536300789|FG000|Overall Study|Death|0|||
149179115|NCT01853228|538129526|FG000|Phase 1|Other|1|||
149179116|NCT01853228|538129527|FG001|Phase 1|Other|0|||
149179117|NCT01853228|538129526|FG000|Phase 2|Physician Decision|0|||
149179118|NCT01853228|538129527|FG001|Phase 2|Physician Decision|1|||
149179119|NCT01853228|538129526|FG000|Phase 2|Proceed To Transplant|0|||
149179120|NCT01853228|538129527|FG001|Phase 2|Proceed To Transplant|3|||
149179121|NCT01853228|538129526|FG000|Phase 2|Lack of Efficacy|0|||
148679438|NCT02454972|536300790|FG001|Overall Study|Death|0|||
149179122|NCT01853228|538129527|FG001|Phase 2|Lack of Efficacy|4|||
149179123|NCT02839746|538129534|FG000|Overall Study|Not met selection criteria|12|||
149179124|NCT02089737|538129535|FG000|Overall Study|Survey form not completed|5|||
149179125|NCT02089737|538129535|FG000|Overall Study|Not treated|1|||
149179126|NCT00744055|538129536|FG000|Overall Study|Withdrawal by Subject|6|||
149179127|NCT00744055|538129537|FG001|Overall Study|Withdrawal by Subject|9|||
149179128|NCT00744055|538129536|FG000|Overall Study|Lack of Efficacy|0|||
148930972|NCT03963401|537231926|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
148930973|NCT01982331|537231931|FG000|Received Vaccination 2|Adverse Event|1|||
148930974|NCT01982331|537231932|FG001|Received Vaccination 2|Adverse Event|2|||
148930975|NCT01982331|537231931|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
148930976|NCT01982331|537231932|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
148930977|NCT01982331|537231931|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
148930978|NCT01982331|537231932|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
148930979|NCT01528215|537231933|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
148930980|NCT01528215|537231934|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
148930981|NCT01528215|537231933|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
148930982|NCT01528215|537231934|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
148930983|NCT01528215|537231933|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
148930984|NCT01528215|537231934|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
148930985|NCT01528215|537231933|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
148930986|NCT01528215|537231934|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
148930987|NCT01476644|537231935|FG000|Overall Study|Death|5|||
148930988|NCT01476644|537231935|FG000|Overall Study|moved to another state|2|||
148930989|NCT01476644|537231935|FG000|Overall Study|Lost to Follow-up|19|||
148930990|NCT01476644|537231935|FG000|Overall Study|Withdrawal by Subject|13|||
148930991|NCT01610271|537231936|FG000|Overall Study|Surgery not complete|0|||
148930992|NCT01610271|537231937|FG001|Overall Study|Surgery not complete|1|||
148930993|NCT01610271|537231936|FG000|Overall Study|Prosthesis not implanted|2|||
148930994|NCT01610271|537231937|FG001|Overall Study|Prosthesis not implanted|3|||
149013616|NCT00365378|537529209|FG000|Extension|Protocol Violation|0|||
149013617|NCT00365378|537529210|FG001|Extension|Protocol Violation|0|||
149013618|NCT00365378|537529211|FG002|Extension|Protocol Violation|2|||
149013619|NCT00365378|537529209|FG000|Extension|Withdrawal by Subject|0|||
149013620|NCT00365378|537529210|FG001|Extension|Withdrawal by Subject|0|||
149179129|NCT00744055|538129537|FG001|Overall Study|Lack of Efficacy|1|||
149179130|NCT00744055|538129536|FG000|Overall Study|Physician Decision|0|||
149179131|NCT00744055|538129537|FG001|Overall Study|Physician Decision|2|||
149179132|NCT00744055|538129536|FG000|Overall Study|Protocol Violation|1|||
149179133|NCT00744055|538129537|FG001|Overall Study|Protocol Violation|1|||
149179134|NCT00744055|538129536|FG000|Overall Study|Lost to Follow-up|0|||
149179135|NCT00744055|538129537|FG001|Overall Study|Lost to Follow-up|1|||
149179136|NCT02767570|538129538|FG000|Overall Study|Lost to Follow-up|3|||
149179137|NCT02767570|538129539|FG001|Overall Study|Lost to Follow-up|0|||
149179138|NCT02767570|538129538|FG000|Overall Study|COVID shutdown|2|||
149179139|NCT02767570|538129539|FG001|Overall Study|COVID shutdown|5|||
149179140|NCT02767570|538129538|FG000|Overall Study|Increased pain|2|||
149179141|NCT02767570|538129539|FG001|Overall Study|Increased pain|0|||
149179142|NCT02767570|538129538|FG000|Overall Study|Withdrawal by Subject|1|||
149179143|NCT02767570|538129539|FG001|Overall Study|Withdrawal by Subject|3|||
149179144|NCT02767570|538129538|FG000|Overall Study|Unrelated medical issue|1|||
149179145|NCT02767570|538129539|FG001|Overall Study|Unrelated medical issue|1|||
149179146|NCT02767570|538129538|FG000|Overall Study|Received intra-articular injection|0|||
149179147|NCT02767570|538129539|FG001|Overall Study|Received intra-articular injection|1|||
149179148|NCT04426630|538129540|FG000|Overall Study|Death|4|||
149179149|NCT04426630|538129540|FG000|Overall Study|Lost to Follow-up|2|||
149179150|NCT05523362|538129541|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
149179151|NCT05523362|538129541|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
149179152|NCT05523362|538129541|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
149179153|NCT05523362|538129541|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
148679439|NCT02454972|536300791|FG002|Overall Study|Death|5|||
148679440|NCT02454972|536300792|FG003|Overall Study|Death|1|||
148679441|NCT02454972|536300793|FG004|Overall Study|Death|0|||
148679442|NCT02454972|536300794|FG005|Overall Study|Death|0|||
148679443|NCT02454972|536300795|FG006|Overall Study|Death|0|||
148679444|NCT02454972|536300796|FG007|Overall Study|Death|0|||
148679445|NCT02454972|536300797|FG008|Overall Study|Death|95|||
148679446|NCT02454972|536300789|FG000|Overall Study|Physician Decision|0|||
148679447|NCT02454972|536300790|FG001|Overall Study|Physician Decision|1|||
148679448|NCT02454972|536300791|FG002|Overall Study|Physician Decision|2|||
148679449|NCT02454972|536300792|FG003|Overall Study|Physician Decision|1|||
148679450|NCT02454972|536300793|FG004|Overall Study|Physician Decision|2|||
148679451|NCT02454972|536300794|FG005|Overall Study|Physician Decision|0|||
148930995|NCT02393690|537231939|FG000|Overall Study|Ineligible|0|||
148930996|NCT02393690|537231940|FG001|Overall Study|Ineligible|1|||
148930997|NCT03488927|537231941|FG000|Overall Study|Withdrawal by Subject|44|||
148930998|NCT03488927|537231942|FG001|Overall Study|Withdrawal by Subject|118|||
149013621|NCT00365378|537529211|FG002|Extension|Withdrawal by Subject|98|||
149179154|NCT00467649|538129542|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
149179155|NCT00467649|538129543|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
149179156|NCT00467649|538129544|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
148679452|NCT02454972|536300795|FG006|Overall Study|Physician Decision|0|||
149179157|NCT00467649|538129545|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
148930999|NCT03488927|537231943|FG002|Overall Study|Withdrawal by Subject|217|||
148931000|NCT00237185|537231944|FG000|Core|Adverse Event|3|||
148931001|NCT00237185|537231945|FG001|Core|Adverse Event|4|||
149179158|NCT00467649|538129546|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
149179159|NCT00467649|538129547|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
149179160|NCT00467649|538129542|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
149179161|NCT00467649|538129543|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
149179162|NCT00467649|538129544|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
149179163|NCT00467649|538129545|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
149179164|NCT00467649|538129546|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
149179165|NCT00467649|538129547|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
149179166|NCT00467649|538129542|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
149179167|NCT00467649|538129543|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
149179168|NCT00467649|538129544|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149179169|NCT00467649|538129545|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149179170|NCT00467649|538129546|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149179171|NCT00467649|538129547|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
149179172|NCT00467649|538129542|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
148931002|NCT00237185|537231944|FG000|Core|Abnormal laboratory value|0|||
149179173|NCT00467649|538129543|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
149179174|NCT00467649|538129544|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149179175|NCT00467649|538129545|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149179176|NCT00467649|538129546|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149179177|NCT00467649|538129547|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
149179178|NCT00467649|538129542|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149179179|NCT00467649|538129543|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149179180|NCT00467649|538129544|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149179181|NCT00467649|538129545|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
149179182|NCT00467649|538129546|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149179183|NCT00467649|538129547|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
149179184|NCT00467649|538129542|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149179185|NCT00467649|538129543|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149179186|NCT00467649|538129544|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149179187|NCT00467649|538129545|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
149179188|NCT00467649|538129546|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149179189|NCT00467649|538129547|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
149179190|NCT00467649|538129542|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149179191|NCT00467649|538129543|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149179192|NCT00467649|538129544|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149179193|NCT00467649|538129545|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149179194|NCT00467649|538129546|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
149179195|NCT00467649|538129547|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
148931003|NCT00237185|537231945|FG001|Core|Abnormal laboratory value|4|||
148931004|NCT00237185|537231944|FG000|Core|Abnormal test procedure results|1|||
148931005|NCT00237185|537231945|FG001|Core|Abnormal test procedure results|0|||
148931006|NCT00237185|537231944|FG000|Core|Lack of Efficacy|30|||
148931007|NCT00237185|537231945|FG001|Core|Lack of Efficacy|23|||
148931008|NCT00237185|537231944|FG000|Core|Protocol Violation|1|||
148931009|NCT00237185|537231945|FG001|Core|Protocol Violation|1|||
148931010|NCT00237185|537231944|FG000|Core|Withdrawal by Subject|4|||
148931011|NCT00237185|537231945|FG001|Core|Withdrawal by Subject|4|||
148931012|NCT00237185|537231944|FG000|Core|Administrative problems|0|||
148931013|NCT00237185|537231945|FG001|Core|Administrative problems|1|||
148931014|NCT00237185|537231944|FG000|Core|Death|4|||
148931015|NCT00237185|537231945|FG001|Core|Death|0|||
148931016|NCT00237185|537231944|FG000|Core|Determined ineligible post randomization|1|||
148931017|NCT00237185|537231945|FG001|Core|Determined ineligible post randomization|0|||
149179196|NCT03240081|538129548|FG000|Overall Study|Withdrawal by Subject|0|||
149179197|NCT03240081|538129549|FG001|Overall Study|Withdrawal by Subject|2|||
148931018|NCT00237185|537231944|FG000|Extension|Adverse Event|1|||
148931019|NCT00237185|537231945|FG001|Extension|Adverse Event|0|||
148931020|NCT00237185|537231944|FG000|Extension|Abnormal laboratory value|0|||
148931021|NCT00237185|537231945|FG001|Extension|Abnormal laboratory value|1|||
149179198|NCT03240081|538129548|FG000|Overall Study|Lost to Follow-up|0|||
149179199|NCT03240081|538129549|FG001|Overall Study|Lost to Follow-up|1|||
149179200|NCT04925570|538129550|FG000|Overall Study|Protocol Violation|24|||
148679453|NCT02454972|536300796|FG007|Overall Study|Physician Decision|1|||
148931022|NCT00237185|537231944|FG000|Extension|Lack of Efficacy|9|||
148931023|NCT00237185|537231945|FG001|Extension|Lack of Efficacy|14|||
148931024|NCT00237185|537231944|FG000|Extension|Condition no longer required study drug|0|||
148931025|NCT00237185|537231945|FG001|Extension|Condition no longer required study drug|1|||
148931026|NCT00237185|537231944|FG000|Extension|Withdrawal by Subject|3|||
148931027|NCT00237185|537231945|FG001|Extension|Withdrawal by Subject|2|||
148931028|NCT00237185|537231944|FG000|Extension|Lost to Follow-up|1|||
148931029|NCT00237185|537231945|FG001|Extension|Lost to Follow-up|0|||
148931030|NCT00237185|537231944|FG000|Extension|Administrative problems|1|||
148931031|NCT00237185|537231945|FG001|Extension|Administrative problems|0|||
148931032|NCT00237185|537231944|FG000|Extension|Death|1|||
148931033|NCT00237185|537231945|FG001|Extension|Death|1|||
148931034|NCT02775903|537231949|FG000|Overall Study|Death|7|||
148931035|NCT02775903|537231950|FG001|Overall Study|Death|11|||
148931036|NCT02775903|537231951|FG002|Overall Study|Death|12|||
149179201|NCT04925570|538129551|FG001|Overall Study|Protocol Violation|30|||
149179202|NCT04925570|538129550|FG000|Overall Study|Withdrawal by Subject|0|||
149179203|NCT04925570|538129551|FG001|Overall Study|Withdrawal by Subject|2|||
149179204|NCT02111811|538129552|FG000|Treatment Phase|Lost to Follow-up|22|||
149179205|NCT02111811|538129553|FG001|Treatment Phase|Lost to Follow-up|18|||
149179206|NCT02111811|538129552|FG000|Treatment Phase|Death|2|||
149179207|NCT02111811|538129553|FG001|Treatment Phase|Death|0|||
149179208|NCT02111811|538129552|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
149179209|NCT02111811|538129553|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
149179210|NCT02111811|538129552|FG000|Follow up Period (Aim 2)|Death|2|||
149179211|NCT02111811|538129553|FG001|Follow up Period (Aim 2)|Death|0|||
149179212|NCT05593432|538129554|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
149179213|NCT05593432|538129555|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
149179214|NCT05593432|538129556|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
149179215|NCT05593432|538129557|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
149179216|NCT05593432|538129554|FG000|16-Week OLE Period|Lack of Efficacy|0|||
149179217|NCT05593432|538129555|FG001|16-Week OLE Period|Lack of Efficacy|0|||
149179218|NCT05593432|538129556|FG002|16-Week OLE Period|Lack of Efficacy|0|||
149179219|NCT05593432|538129557|FG003|16-Week OLE Period|Lack of Efficacy|1|||
149179220|NCT05593432|538129554|FG000|16-Week OLE Period|Lost to Follow-up|0|||
149179221|NCT05593432|538129555|FG001|16-Week OLE Period|Lost to Follow-up|0|||
149179222|NCT05593432|538129556|FG002|16-Week OLE Period|Lost to Follow-up|1|||
149179223|NCT05593432|538129557|FG003|16-Week OLE Period|Lost to Follow-up|2|||
149179224|NCT05593432|538129554|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
149179225|NCT05593432|538129555|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
149179226|NCT05593432|538129556|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
149179227|NCT05593432|538129557|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
149179228|NCT05897853|538129559|FG000|Overall Study|Lost to Follow-up|2|||
149179229|NCT05897853|538129560|FG001|Overall Study|Lost to Follow-up|0|||
149179230|NCT05897853|538129559|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
149179231|NCT05897853|538129560|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
149179232|NCT01450137|538129568|FG000|Up to Week 12|Adverse Event|2|||
149179233|NCT01450137|538129569|FG001|Up to Week 12|Adverse Event|1|||
149179234|NCT01450137|538129568|FG000|Up to Week 12|Withdrawal by Subject|0|||
149179235|NCT01450137|538129569|FG001|Up to Week 12|Withdrawal by Subject|2|||
148931037|NCT02775903|537231952|FG003|Overall Study|Death|11|||
148931038|NCT02775903|537231949|FG000|Overall Study|Adverse Event|0|||
149013622|NCT00365378|537529209|FG000|Extension|Other|0|||
149013623|NCT00365378|537529210|FG001|Extension|Other|0|||
149013624|NCT00365378|537529211|FG002|Extension|Other|31|||
149179236|NCT01450137|538129568|FG000|Week 12 to Study End|Death|0|||
149179237|NCT01450137|538129569|FG001|Week 12 to Study End|Death|1|||
149179238|NCT01450137|538129568|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
149179239|NCT01450137|538129569|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
149179240|NCT01926886|538129570|FG000|Overall Study|Administrative/other|1|||
149179241|NCT01926886|538129571|FG001|Overall Study|Administrative/other|0|||
149179242|NCT01926886|538129570|FG000|Overall Study|Adverse event/intercurrent illness|4|||
149179243|NCT01926886|538129571|FG001|Overall Study|Adverse event/intercurrent illness|0|||
149179244|NCT01926886|538129570|FG000|Overall Study|Disease progression/recurrence|4|||
148931039|NCT02775903|537231950|FG001|Overall Study|Adverse Event|1|||
148931040|NCT02775903|537231951|FG002|Overall Study|Adverse Event|12|||
149179245|NCT01926886|538129571|FG001|Overall Study|Disease progression/recurrence|0|||
148931041|NCT02775903|537231952|FG003|Overall Study|Adverse Event|3|||
149179246|NCT01926886|538129570|FG000|Overall Study|Withdrawal by Subject|15|||
148931042|NCT02775903|537231949|FG000|Overall Study|Progressive disease|15|||
149179247|NCT01926886|538129571|FG001|Overall Study|Withdrawal by Subject|0|||
149179248|NCT01926886|538129570|FG000|Overall Study|Failure to return|3|||
149179249|NCT01926886|538129571|FG001|Overall Study|Failure to return|0|||
149179250|NCT01926886|538129570|FG000|Overall Study|Recurrence of disease|1|||
149179251|NCT01926886|538129571|FG001|Overall Study|Recurrence of disease|0|||
149179252|NCT01926886|538129570|FG000|Overall Study|Progression of disease|2|||
149179253|NCT01926886|538129571|FG001|Overall Study|Progression of disease|0|||
149179254|NCT01926886|538129570|FG000|Overall Study|Death|1|||
149179255|NCT01926886|538129571|FG001|Overall Study|Death|0|||
149179256|NCT01926886|538129570|FG000|Overall Study|Did not cooperate|1|||
148931043|NCT02775903|537231950|FG001|Overall Study|Progressive disease|14|||
148931044|NCT02775903|537231951|FG002|Overall Study|Progressive disease|30|||
148931045|NCT02775903|537231952|FG003|Overall Study|Progressive disease|20|||
149013625|NCT04161807|537529214|FG000|Overall Study|Withdrawal by Subject|2|||
148931046|NCT02775903|537231949|FG000|Overall Study|Lack of Efficacy|2|||
148931047|NCT02775903|537231950|FG001|Overall Study|Lack of Efficacy|2|||
149179257|NCT01926886|538129571|FG001|Overall Study|Did not cooperate|0|||
149179258|NCT04458857|538129575|FG000|Overall Study|Adverse Event|0|||
149179259|NCT04458857|538129576|FG001|Overall Study|Adverse Event|1|||
149179260|NCT04458857|538129577|FG002|Overall Study|Adverse Event|0|||
149179261|NCT04458857|538129575|FG000|Overall Study|Withdrawal by Subject|2|||
149179262|NCT04458857|538129576|FG001|Overall Study|Withdrawal by Subject|0|||
149179263|NCT04458857|538129577|FG002|Overall Study|Withdrawal by Subject|0|||
149179264|NCT04458857|538129575|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149179265|NCT04458857|538129576|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149179266|NCT04458857|538129577|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149179267|NCT04458857|538129575|FG000|Overall Study|Non-compliance with study drug|0|||
149179268|NCT04458857|538129576|FG001|Overall Study|Non-compliance with study drug|1|||
149179269|NCT04458857|538129577|FG002|Overall Study|Non-compliance with study drug|0|||
149179270|NCT04458857|538129575|FG000|Overall Study|Lost to Follow-up|4|||
149179271|NCT04458857|538129576|FG001|Overall Study|Lost to Follow-up|1|||
149179272|NCT04458857|538129577|FG002|Overall Study|Lost to Follow-up|0|||
149179273|NCT04800315|538129578|FG000|Randomization|Did not receive study treatment|1|||
149179274|NCT04800315|538129579|FG001|Randomization|Did not receive study treatment|0|||
149179275|NCT04800315|538129580|FG002|Randomization|Did not receive study treatment|0|||
149179276|NCT04800315|538129581|FG003|Randomization|Did not receive study treatment|0|||
149179277|NCT04800315|538129578|FG000|Treatment Period|Adverse Event|4|||
149179278|NCT04800315|538129579|FG001|Treatment Period|Adverse Event|2|||
149179279|NCT04800315|538129580|FG002|Treatment Period|Adverse Event|1|||
149179280|NCT04800315|538129581|FG003|Treatment Period|Adverse Event|2|||
149179281|NCT04800315|538129578|FG000|Treatment Period|Lack of Efficacy|1|||
149179282|NCT04800315|538129579|FG001|Treatment Period|Lack of Efficacy|0|||
149179283|NCT04800315|538129580|FG002|Treatment Period|Lack of Efficacy|0|||
149179284|NCT04800315|538129581|FG003|Treatment Period|Lack of Efficacy|3|||
149179285|NCT04800315|538129578|FG000|Treatment Period|Lost to Follow-up|0|||
149179286|NCT04800315|538129579|FG001|Treatment Period|Lost to Follow-up|1|||
149179287|NCT04800315|538129580|FG002|Treatment Period|Lost to Follow-up|2|||
149179288|NCT04800315|538129581|FG003|Treatment Period|Lost to Follow-up|2|||
149179289|NCT04800315|538129578|FG000|Treatment Period|Withdrawal by participant|0|||
149179290|NCT04800315|538129579|FG001|Treatment Period|Withdrawal by participant|0|||
149179291|NCT04800315|538129580|FG002|Treatment Period|Withdrawal by participant|0|||
149179292|NCT04800315|538129581|FG003|Treatment Period|Withdrawal by participant|4|||
149179293|NCT04800315|538129578|FG000|Treatment Period|Other Reasons|0|||
149179294|NCT04800315|538129579|FG001|Treatment Period|Other Reasons|2|||
149179295|NCT04800315|538129580|FG002|Treatment Period|Other Reasons|0|||
149179296|NCT04800315|538129581|FG003|Treatment Period|Other Reasons|1|||
149179297|NCT00753922|538129584|FG000|Overall Study|Lost to Follow-up|155|||
149179298|NCT00753922|538129585|FG001|Overall Study|Lost to Follow-up|24|||
149179299|NCT00753922|538129586|FG002|Overall Study|Lost to Follow-up|28|||
149179300|NCT00753922|538129587|FG003|Overall Study|Lost to Follow-up|5|||
149179301|NCT00753922|538129584|FG000|Overall Study|Withdrawal by Subject|9|||
149179302|NCT00753922|538129585|FG001|Overall Study|Withdrawal by Subject|11|||
149179303|NCT00753922|538129586|FG002|Overall Study|Withdrawal by Subject|4|||
149179304|NCT00753922|538129587|FG003|Overall Study|Withdrawal by Subject|2|||
149179305|NCT00753922|538129584|FG000|Overall Study|Patient Non-compliance|55|||
149179306|NCT00753922|538129585|FG001|Overall Study|Patient Non-compliance|22|||
149179307|NCT00753922|538129586|FG002|Overall Study|Patient Non-compliance|14|||
149179308|NCT00753922|538129587|FG003|Overall Study|Patient Non-compliance|11|||
149179309|NCT00753922|538129584|FG000|Overall Study|Patients Not Completing Visit|11|||
148931048|NCT02775903|537231951|FG002|Overall Study|Lack of Efficacy|2|||
148931049|NCT02775903|537231952|FG003|Overall Study|Lack of Efficacy|6|||
148931050|NCT02775903|537231949|FG000|Overall Study|Withdrawal by Subject|7|||
148931051|NCT02775903|537231950|FG001|Overall Study|Withdrawal by Subject|5|||
148931052|NCT02775903|537231951|FG002|Overall Study|Withdrawal by Subject|5|||
149179310|NCT00753922|538129585|FG001|Overall Study|Patients Not Completing Visit|0|||
148931053|NCT02775903|537231952|FG003|Overall Study|Withdrawal by Subject|8|||
148807155|NCT01288430|536773177|FG002|Part 2|Withdrawal by Subject|0|||
149179311|NCT00753922|538129586|FG002|Overall Study|Patients Not Completing Visit|1|||
149179312|NCT00753922|538129587|FG003|Overall Study|Patients Not Completing Visit|0|||
149179313|NCT00753922|538129584|FG000|Overall Study|Death|2|||
148931054|NCT02775903|537231949|FG000|Overall Study|Other reasons|7|||
148931055|NCT02775903|537231950|FG001|Overall Study|Other reasons|8|||
149179314|NCT00753922|538129585|FG001|Overall Study|Death|23|||
149179315|NCT00753922|538129586|FG002|Overall Study|Death|2|||
149179316|NCT00753922|538129587|FG003|Overall Study|Death|1|||
149179317|NCT00753922|538129584|FG000|Overall Study|Discontinuation Due to Explantation|14|||
149179318|NCT00753922|538129585|FG001|Overall Study|Discontinuation Due to Explantation|14|||
149179319|NCT00753922|538129586|FG002|Overall Study|Discontinuation Due to Explantation|14|||
149233992|NCT01422876|538326348|FG002|Week 24|Death|0|||
148807156|NCT01288430|536773178|FG003|Part 2|Withdrawal by Subject|0|||
148931056|NCT02775903|537231951|FG002|Overall Study|Other reasons|2|||
148931057|NCT02775903|537231952|FG003|Overall Study|Other reasons|12|||
148931058|NCT04041700|537231953|FG000|Overall Study|Pregnancy|1|||
148931059|NCT04041700|537231953|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
148931060|NCT00285207|537231954|FG000|Overall Study|Lost to Follow-up|3|||
148931061|NCT00285207|537231955|FG001|Overall Study|Lost to Follow-up|2|||
148931062|NCT00285207|537231954|FG000|Overall Study|Withdrawal by Subject|5|||
148931063|NCT00285207|537231955|FG001|Overall Study|Withdrawal by Subject|2|||
148931064|NCT00285207|537231954|FG000|Overall Study|Pregnancy|1|||
148931065|NCT00285207|537231955|FG001|Overall Study|Pregnancy|1|||
148931066|NCT00285207|537231954|FG000|Overall Study|non-compliance|0|||
148931067|NCT00285207|537231955|FG001|Overall Study|non-compliance|1|||
148931068|NCT02171065|537233317|FG000|Overall Study|Withdrawal by Subject|1|||
148931069|NCT02171065|537233318|FG001|Overall Study|Withdrawal by Subject|0|||
148931070|NCT02171065|537233319|FG002|Overall Study|Withdrawal by Subject|0|||
148931071|NCT02171065|537233317|FG000|Overall Study|Lost to Follow-up|0|||
148931072|NCT02171065|537233318|FG001|Overall Study|Lost to Follow-up|0|||
148931073|NCT02171065|537233319|FG002|Overall Study|Lost to Follow-up|1|||
148931074|NCT00084838|537233320|FG000|Overall Study|Death|1|||
148931075|NCT00084838|537233320|FG000|Overall Study|Adverse Event|2|||
149179320|NCT00753922|538129587|FG003|Overall Study|Discontinuation Due to Explantation|4|||
149179321|NCT00196937|538129588|FG000|Overall Study|Serious Adverse Event|1|||
149179322|NCT00196937|538129589|FG001|Overall Study|Serious Adverse Event|0|||
149179323|NCT00196937|538129590|FG002|Overall Study|Serious Adverse Event|0|||
149179324|NCT00196937|538129588|FG000|Overall Study|Non-serious adverse event|1|||
149179325|NCT00196937|538129589|FG001|Overall Study|Non-serious adverse event|1|||
149179326|NCT00196937|538129590|FG002|Overall Study|Non-serious adverse event|1|||
149179327|NCT00196937|538129588|FG000|Overall Study|Withdrawal by Subject|0|||
149179328|NCT00196937|538129589|FG001|Overall Study|Withdrawal by Subject|0|||
149179329|NCT00196937|538129590|FG002|Overall Study|Withdrawal by Subject|2|||
149179330|NCT00196937|538129588|FG000|Overall Study|Lost to Follow-up|4|||
149179331|NCT00196937|538129589|FG001|Overall Study|Lost to Follow-up|3|||
149179332|NCT00196937|538129590|FG002|Overall Study|Lost to Follow-up|3|||
149179333|NCT00196937|538129588|FG000|Overall Study|Other|3|||
149179334|NCT00196937|538129589|FG001|Overall Study|Other|1|||
149179335|NCT00196937|538129590|FG002|Overall Study|Other|1|||
149179336|NCT03368404|538129600|FG000|Overall Study|Adverse Event|2|||
149179337|NCT03368404|538129601|FG001|Overall Study|Adverse Event|1|||
149179338|NCT03368404|538129600|FG000|Overall Study|Withdrawal by Subject|1|||
149179339|NCT03368404|538129601|FG001|Overall Study|Withdrawal by Subject|1|||
149179340|NCT02983292|538129602|FG000|Overall Study|Participant unwell & cannot travel|2|||
149179341|NCT02983292|538129602|FG000|Overall Study|Lost to Follow-up|3|||
149179342|NCT02983292|538129602|FG000|Overall Study|Participant withdrew consent|2|||
149179343|NCT02983292|538129602|FG000|Overall Study|Revision|7|||
149179344|NCT02983292|538129602|FG000|Overall Study|Death|1|||
149179345|NCT02983292|538129602|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
149179346|NCT02983292|538129602|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
149179347|NCT02983292|538129602|FG000|Overall Study|Participant relocation|1|||
149179348|NCT04725682|538129603|FG000|Overall Study|Withdrawal by Subject|7|||
149179349|NCT04725682|538129604|FG001|Overall Study|Withdrawal by Subject|5|||
149179350|NCT04725682|538129603|FG000|Overall Study|Failed to comply with the requirements|2|||
149179351|NCT04725682|538129604|FG001|Overall Study|Failed to comply with the requirements|1|||
148931076|NCT00084838|537233320|FG000|Overall Study|Withdrawal by Subject|1|||
148931077|NCT00084838|537233320|FG000|Overall Study|Progressive Disease|4|||
148931078|NCT00084838|537233320|FG000|Overall Study|Pt Non-Compliance|1|||
148931079|NCT00084838|537233320|FG000|Overall Study|Ineligible|4|||
149179352|NCT04725682|538129603|FG000|Overall Study|Adverse Event|1|||
149179353|NCT04725682|538129604|FG001|Overall Study|Adverse Event|1|||
149179354|NCT04725682|538129603|FG000|Overall Study|Death|0|||
149179355|NCT04725682|538129604|FG001|Overall Study|Death|1|||
149179356|NCT00964795|538129605|FG000|Overall Study|Withdrawal by Subject|79|||
148931080|NCT00518687|537233321|FG000|Overall Study|Adverse Event|201|||
148931081|NCT00518687|537233322|FG001|Overall Study|Adverse Event|177|||
148931082|NCT00518687|537233321|FG000|Overall Study|Lost to Follow-up|144|||
148931083|NCT00518687|537233322|FG001|Overall Study|Lost to Follow-up|155|||
148931084|NCT00518687|537233321|FG000|Overall Study|Physician Decision|42|||
148931085|NCT00518687|537233322|FG001|Overall Study|Physician Decision|48|||
149179357|NCT00964795|538129605|FG000|Overall Study|Adverse Event|12|||
149179358|NCT00964795|538129605|FG000|Overall Study|Death|14|||
149179359|NCT00964795|538129605|FG000|Overall Study|Lost to Follow-up|7|||
149179360|NCT00964795|538129605|FG000|Overall Study|Termination of Study by Sponsor|169|||
148807157|NCT01288430|536773179|FG004|Part 2|Withdrawal by Subject|0|||
148931086|NCT00518687|537233321|FG000|Overall Study|Progressive disease|2|||
148931087|NCT00518687|537233322|FG001|Overall Study|Progressive disease|2|||
148931088|NCT00518687|537233321|FG000|Overall Study|Protocol Violation|8|||
149179361|NCT00964795|538129605|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
149179362|NCT00964795|538129605|FG000|Overall Study|Other|23|||
149179363|NCT00586690|538129613|FG000|Overall Study|Death|2|||
149179364|NCT00586690|538129614|FG001|Overall Study|Death|0|||
149179365|NCT00586690|538129613|FG000|Overall Study|Disease Progression|10|||
149179366|NCT00586690|538129614|FG001|Overall Study|Disease Progression|0|||
149179367|NCT00586690|538129613|FG000|Overall Study|Adverse Event|1|||
149179368|NCT00586690|538129614|FG001|Overall Study|Adverse Event|0|||
149179369|NCT00586690|538129613|FG000|Overall Study|Lack of Efficacy|2|||
149179370|NCT00586690|538129614|FG001|Overall Study|Lack of Efficacy|0|||
149179371|NCT00586690|538129613|FG000|Overall Study|Lab can't accommodate|1|||
149179372|NCT00586690|538129614|FG001|Overall Study|Lab can't accommodate|0|||
149179373|NCT01751646|538129615|FG000|Overall Study|Lost to Follow-up|5|||
149179374|NCT01751646|538129616|FG001|Overall Study|Lost to Follow-up|1|||
149179375|NCT01751646|538129615|FG000|Overall Study|Withdrawal by Subject|0|||
149179376|NCT01751646|538129616|FG001|Overall Study|Withdrawal by Subject|4|||
149179377|NCT01751646|538129615|FG000|Overall Study|Starting hormone therapy|1|||
149179378|NCT01751646|538129616|FG001|Overall Study|Starting hormone therapy|0|||
149179379|NCT01751646|538129615|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
149179380|NCT01751646|538129616|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
149179381|NCT01751646|538129615|FG000|Overall Study|Inadvertent enrollment|1|||
149179382|NCT01751646|538129616|FG001|Overall Study|Inadvertent enrollment|1|||
149179383|NCT01751646|538129615|FG000|Overall Study|Moved out of the area|1|||
149179384|NCT01751646|538129616|FG001|Overall Study|Moved out of the area|5|||
149179385|NCT01751646|538129615|FG000|Overall Study|Inability to attend required visits|0|||
149179386|NCT01751646|538129616|FG001|Overall Study|Inability to attend required visits|1|||
149179387|NCT01751646|538129615|FG000|Overall Study|Off study due to multiple obligations|0|||
149179388|NCT01751646|538129616|FG001|Overall Study|Off study due to multiple obligations|1|||
149179389|NCT01751646|538129615|FG000|Overall Study|Fails to comply with study requirements|0|||
149179390|NCT01751646|538129616|FG001|Overall Study|Fails to comply with study requirements|1|||
149179391|NCT01751646|538129615|FG000|Overall Study|Childcare issues|1|||
149179392|NCT01751646|538129616|FG001|Overall Study|Childcare issues|1|||
149179393|NCT02190591|538129617|FG000|Overall Study|Withdrawal by Subject|1|||
149179394|NCT02190591|538129618|FG001|Overall Study|Withdrawal by Subject|8|||
149179395|NCT02190591|538129617|FG000|Overall Study|Protocol Violation|1|||
149179396|NCT02190591|538129618|FG001|Overall Study|Protocol Violation|0|||
149179397|NCT02190591|538129617|FG000|Overall Study|did not use peanut ball as instructed|0|||
149179398|NCT02190591|538129618|FG001|Overall Study|did not use peanut ball as instructed|2|||
149179399|NCT02190591|538129617|FG000|Overall Study|face presentation so she was ineligible|0|||
149179400|NCT02190591|538129618|FG001|Overall Study|face presentation so she was ineligible|1|||
149179401|NCT00857246|538129619|FG000|Induction Regimen|Adverse Event|1|||
149179402|NCT00857246|538129619|FG000|Induction Regimen|disease-related complications|1|||
149179403|NCT00857246|538129619|FG000|Induction Regimen|Withdrawal by Subject|1|||
148807158|NCT01288430|536773180|FG005|Part 2|Withdrawal by Subject|0|||
148807159|NCT01288430|536773181|FG006|Part 2|Withdrawal by Subject|0|||
148931089|NCT00518687|537233322|FG001|Overall Study|Protocol Violation|10|||
148931090|NCT00518687|537233321|FG000|Overall Study|Study terminated by sponsor|930|||
149179404|NCT00857246|538129619|FG000|Surgery (Curative)|disease progression|6|||
149179405|NCT00857246|538129619|FG000|ChemoRT|Withdrawal by Subject|1|||
149179406|NCT00857246|538129619|FG000|ChemoRT|Adverse Event|2|||
149179407|NCT00072189|538129620|FG000|Overall Study|Withdrawal by Subject|1|||
149179408|NCT02973815|538129621|FG000|Post Intervention|Death|1|||
149179409|NCT02973815|538129622|FG001|Post Intervention|Death|0|||
149179410|NCT02973815|538129621|FG000|Post Intervention|Lost to Follow-up|7|||
149179411|NCT02973815|538129622|FG001|Post Intervention|Lost to Follow-up|24|||
149179412|NCT02973815|538129621|FG000|Follow-up|Lost to Follow-up|2|||
149179413|NCT02973815|538129622|FG001|Follow-up|Lost to Follow-up|0|||
149179414|NCT04542291|538129623|FG000|Overall Study|Adverse Event|1|||
149179415|NCT04542291|538129623|FG000|Overall Study|Physician Decision|2|||
149179416|NCT01607892|538129631|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
149179417|NCT01607892|538129632|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
149179418|NCT01607892|538129633|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
149179419|NCT01607892|538129634|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
149179420|NCT01607892|538129635|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
149179421|NCT01607892|538129631|FG000|Overall Study|Death|4|||
149179422|NCT01607892|538129632|FG001|Overall Study|Death|2|||
149179423|NCT01607892|538129633|FG002|Overall Study|Death|8|||
149179424|NCT01607892|538129634|FG003|Overall Study|Death|10|||
149179425|NCT01607892|538129635|FG004|Overall Study|Death|3|||
149179426|NCT01607892|538129631|FG000|Overall Study|Investigator discretion|2|||
149179427|NCT01607892|538129632|FG001|Overall Study|Investigator discretion|4|||
149179428|NCT01607892|538129633|FG002|Overall Study|Investigator discretion|4|||
149179429|NCT01607892|538129634|FG003|Overall Study|Investigator discretion|8|||
148807160|NCT01288430|536773182|FG007|Part 2|Withdrawal by Subject|1|||
148931091|NCT00518687|537233322|FG001|Overall Study|Study terminated by sponsor|918|||
149179430|NCT01607892|538129635|FG004|Overall Study|Investigator discretion|0|||
149179431|NCT01607892|538129631|FG000|Overall Study|Other treatments became available|1|||
149179432|NCT01607892|538129632|FG001|Overall Study|Other treatments became available|1|||
149179433|NCT01607892|538129633|FG002|Overall Study|Other treatments became available|0|||
149179434|NCT01607892|538129634|FG003|Overall Study|Other treatments became available|0|||
149179435|NCT01607892|538129635|FG004|Overall Study|Other treatments became available|2|||
149179436|NCT01607892|538129631|FG000|Overall Study|Intercurrent illness|1|||
149179437|NCT01607892|538129632|FG001|Overall Study|Intercurrent illness|0|||
149179438|NCT01607892|538129633|FG002|Overall Study|Intercurrent illness|0|||
149179439|NCT01607892|538129634|FG003|Overall Study|Intercurrent illness|3|||
149179440|NCT01607892|538129635|FG004|Overall Study|Intercurrent illness|0|||
149179441|NCT01607892|538129631|FG000|Overall Study|Non-Compliance with study procedures|0|||
149179442|NCT01607892|538129632|FG001|Overall Study|Non-Compliance with study procedures|0|||
149179443|NCT01607892|538129633|FG002|Overall Study|Non-Compliance with study procedures|1|||
149179444|NCT01607892|538129634|FG003|Overall Study|Non-Compliance with study procedures|0|||
149179445|NCT01607892|538129635|FG004|Overall Study|Non-Compliance with study procedures|0|||
149179446|NCT01607892|538129631|FG000|Overall Study|Consent withdrawn by participant|9|||
149179447|NCT01607892|538129632|FG001|Overall Study|Consent withdrawn by participant|4|||
149179448|NCT01607892|538129633|FG002|Overall Study|Consent withdrawn by participant|24|||
149179449|NCT01607892|538129634|FG003|Overall Study|Consent withdrawn by participant|14|||
149179450|NCT01607892|538129635|FG004|Overall Study|Consent withdrawn by participant|4|||
149179451|NCT01607892|538129631|FG000|Overall Study|Disease progression|38|||
149179452|NCT01607892|538129632|FG001|Overall Study|Disease progression|13|||
149179453|NCT01607892|538129633|FG002|Overall Study|Disease progression|37|||
149179454|NCT01607892|538129634|FG003|Overall Study|Disease progression|57|||
149179455|NCT01607892|538129635|FG004|Overall Study|Disease progression|9|||
149179456|NCT01607892|538129631|FG000|Overall Study|Incidence or severity of Adverse events|3|||
149179457|NCT01607892|538129632|FG001|Overall Study|Incidence or severity of Adverse events|3|||
149179458|NCT01607892|538129633|FG002|Overall Study|Incidence or severity of Adverse events|7|||
149179459|NCT01607892|538129634|FG003|Overall Study|Incidence or severity of Adverse events|2|||
149179460|NCT01607892|538129635|FG004|Overall Study|Incidence or severity of Adverse events|6|||
149179461|NCT02273973|538129638|FG000|Overall Study|Adverse Event|4|||
149179462|NCT02273973|538129639|FG001|Overall Study|Adverse Event|0|||
149179463|NCT02273973|538129638|FG000|Overall Study|Withdrawal by Subject|2|||
148931092|NCT00518687|537233321|FG000|Overall Study|Withdrawal by Subject|110|||
149179464|NCT02273973|538129639|FG001|Overall Study|Withdrawal by Subject|3|||
149179465|NCT02273973|538129638|FG000|Overall Study|Death|1|||
149179466|NCT02273973|538129639|FG001|Overall Study|Death|0|||
149179467|NCT02273973|538129638|FG000|Overall Study|Non-compliance|1|||
149179468|NCT02273973|538129639|FG001|Overall Study|Non-compliance|0|||
149179469|NCT02273973|538129638|FG000|Overall Study|Protocol Violation|1|||
149179470|NCT02273973|538129639|FG001|Overall Study|Protocol Violation|0|||
149179471|NCT02273973|538129638|FG000|Overall Study|Progression of disease|0|||
149179472|NCT02273973|538129639|FG001|Overall Study|Progression of disease|2|||
149179473|NCT02273973|538129638|FG000|Overall Study|Lost to Follow-up|0|||
149179474|NCT02273973|538129639|FG001|Overall Study|Lost to Follow-up|1|||
149179475|NCT02273973|538129638|FG000|Overall Study|Physician Decision|0|||
149179476|NCT02273973|538129639|FG001|Overall Study|Physician Decision|1|||
149179477|NCT02273973|538129638|FG000|Overall Study|Reason not specified|0|||
149179478|NCT02273973|538129639|FG001|Overall Study|Reason not specified|1|||
149179479|NCT03022422|538129640|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
149179480|NCT03022422|538129641|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
149179481|NCT03022422|538129642|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
149179482|NCT03022422|538129643|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
149179483|NCT03022422|538129644|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
149179484|NCT03022422|538129645|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
149179485|NCT02403206|538129646|FG000|Overall Study|Lost to Follow-up|4|||
149179486|NCT02403206|538129647|FG001|Overall Study|Lost to Follow-up|3|||
149179487|NCT02403206|538129646|FG000|Overall Study|Physician Decision|2|||
149179488|NCT02403206|538129647|FG001|Overall Study|Physician Decision|0|||
149179489|NCT02403206|538129646|FG000|Overall Study|Withdrawal by Subject|3|||
149179490|NCT02403206|538129647|FG001|Overall Study|Withdrawal by Subject|3|||
149179491|NCT02403206|538129646|FG000|Overall Study|Reason not given|2|||
149179492|NCT02403206|538129647|FG001|Overall Study|Reason not given|4|||
149179493|NCT01287117|538129648|FG000|Overall Study|Adverse Event|2|||
149179494|NCT01287117|538129649|FG001|Overall Study|Adverse Event|1|||
149179495|NCT01287117|538129650|FG002|Overall Study|Adverse Event|1|||
149179496|NCT01287117|538129651|FG003|Overall Study|Adverse Event|1|||
149179497|NCT01287117|538129648|FG000|Overall Study|Lost to Follow-up|1|||
149179498|NCT01287117|538129649|FG001|Overall Study|Lost to Follow-up|1|||
149179499|NCT01287117|538129650|FG002|Overall Study|Lost to Follow-up|0|||
149179500|NCT01287117|538129651|FG003|Overall Study|Lost to Follow-up|0|||
149179501|NCT01287117|538129648|FG000|Overall Study|Physician Decision|0|||
149179502|NCT01287117|538129649|FG001|Overall Study|Physician Decision|1|||
149179503|NCT01287117|538129650|FG002|Overall Study|Physician Decision|1|||
149179504|NCT01287117|538129651|FG003|Overall Study|Physician Decision|1|||
149179505|NCT01287117|538129648|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
149179506|NCT01287117|538129649|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
149179507|NCT01287117|538129650|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
149179508|NCT01287117|538129651|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
149179509|NCT01287117|538129648|FG000|Overall Study|Disease Progression|10|||
149179510|NCT01287117|538129649|FG001|Overall Study|Disease Progression|5|||
149179511|NCT01287117|538129650|FG002|Overall Study|Disease Progression|6|||
149179512|NCT01287117|538129651|FG003|Overall Study|Disease Progression|5|||
149179513|NCT01676116|538129652|FG000|Overall Study|Withdrawal criteria|2|||
149179514|NCT01676116|538129653|FG001|Overall Study|Withdrawal criteria|14|||
149179515|NCT01676116|538129652|FG000|Overall Study|Adverse Event|1|||
149179516|NCT01676116|538129653|FG001|Overall Study|Adverse Event|2|||
149179517|NCT01676116|538129652|FG000|Overall Study|Unclassified|4|||
149179518|NCT01676116|538129653|FG001|Overall Study|Unclassified|10|||
149179519|NCT01676116|538129652|FG000|Overall Study|Protocol Violation|9|||
149179520|NCT01676116|538129653|FG001|Overall Study|Protocol Violation|3|||
149179521|NCT01821677|538129659|FG000|Overall Study|Adverse Event|4|||
149179522|NCT01821677|538129660|FG001|Overall Study|Adverse Event|6|||
149179523|NCT01821677|538129661|FG002|Overall Study|Adverse Event|5|||
149179524|NCT01821677|538129659|FG000|Overall Study|Physician Decision|1|||
148807161|NCT01288430|536773183|FG008|Part 2|Withdrawal by Subject|4|||
148807162|NCT01288430|536773184|FG009|Part 2|Withdrawal by Subject|0|||
148931093|NCT00518687|537233322|FG001|Overall Study|Withdrawal by Subject|110|||
148931094|NCT02598960|537233323|FG000|Treatment Period|Disease Progression|4|||
148931095|NCT02598960|537233324|FG001|Treatment Period|Disease Progression|4|||
148931096|NCT02598960|537233325|FG002|Treatment Period|Disease Progression|4|||
148931097|NCT02598960|537233326|FG003|Treatment Period|Disease Progression|6|||
148931098|NCT02598960|537233327|FG004|Treatment Period|Disease Progression|8|||
149179525|NCT01821677|538129660|FG001|Overall Study|Physician Decision|4|||
149179526|NCT01821677|538129661|FG002|Overall Study|Physician Decision|1|||
148931099|NCT02598960|537233328|FG005|Treatment Period|Disease Progression|2|||
149179527|NCT01821677|538129659|FG000|Overall Study|Non-compliance|0|||
149179528|NCT01821677|538129660|FG001|Overall Study|Non-compliance|1|||
149179529|NCT01821677|538129661|FG002|Overall Study|Non-compliance|2|||
149179530|NCT01821677|538129659|FG000|Overall Study|Lost to Follow-up|2|||
149179531|NCT01821677|538129660|FG001|Overall Study|Lost to Follow-up|1|||
149179532|NCT01821677|538129661|FG002|Overall Study|Lost to Follow-up|3|||
149179533|NCT01821677|538129659|FG000|Overall Study|Protocol Violation|0|||
149179534|NCT01821677|538129660|FG001|Overall Study|Protocol Violation|0|||
149179535|NCT01821677|538129661|FG002|Overall Study|Protocol Violation|2|||
149179536|NCT01821677|538129659|FG000|Overall Study|Withdrawal by Subject|7|||
149179537|NCT01821677|538129660|FG001|Overall Study|Withdrawal by Subject|3|||
148931100|NCT02598960|537233329|FG006|Treatment Period|Disease Progression|2|||
148931101|NCT02598960|537233330|FG007|Treatment Period|Disease Progression|3|||
148931102|NCT02598960|537233331|FG008|Treatment Period|Disease Progression|7|||
148931103|NCT02598960|537233332|FG009|Treatment Period|Disease Progression|9|||
148931104|NCT02598960|537233333|FG010|Treatment Period|Disease Progression|7|||
148931105|NCT02598960|537233334|FG011|Treatment Period|Disease Progression|143|||
148931106|NCT02598960|537233335|FG012|Treatment Period|Disease Progression|23|||
148931107|NCT02598960|537233323|FG000|Treatment Period|Study drug toxicity|0|||
148931108|NCT02598960|537233324|FG001|Treatment Period|Study drug toxicity|0|||
148931109|NCT02598960|537233325|FG002|Treatment Period|Study drug toxicity|0|||
148931110|NCT02598960|537233326|FG003|Treatment Period|Study drug toxicity|0|||
148931111|NCT02598960|537233327|FG004|Treatment Period|Study drug toxicity|0|||
148931112|NCT02598960|537233328|FG005|Treatment Period|Study drug toxicity|0|||
148931113|NCT02598960|537233329|FG006|Treatment Period|Study drug toxicity|0|||
148931114|NCT02598960|537233330|FG007|Treatment Period|Study drug toxicity|0|||
148931115|NCT02598960|537233331|FG008|Treatment Period|Study drug toxicity|0|||
148931116|NCT02598960|537233332|FG009|Treatment Period|Study drug toxicity|1|||
148931117|NCT02598960|537233333|FG010|Treatment Period|Study drug toxicity|0|||
148931118|NCT02598960|537233334|FG011|Treatment Period|Study drug toxicity|3|||
148931119|NCT02598960|537233335|FG012|Treatment Period|Study drug toxicity|0|||
148931120|NCT02598960|537233323|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
148931121|NCT02598960|537233324|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
148931122|NCT02598960|537233325|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
148931123|NCT02598960|537233326|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
148931124|NCT02598960|537233327|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
148931125|NCT02598960|537233328|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
148931126|NCT02598960|537233329|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
148931127|NCT02598960|537233330|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
148931128|NCT02598960|537233331|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
148931129|NCT02598960|537233332|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
149179538|NCT01821677|538129661|FG002|Overall Study|Withdrawal by Subject|2|||
149179539|NCT01821677|538129659|FG000|Overall Study|Other|9|||
149179540|NCT01821677|538129660|FG001|Overall Study|Other|0|||
149179541|NCT01821677|538129661|FG002|Overall Study|Other|0|||
149179542|NCT02606877|538129670|FG000|Overall Study|Adverse Event|3|||
149179543|NCT02606877|538129671|FG001|Overall Study|Adverse Event|0|||
149179544|NCT02606877|538129670|FG000|Overall Study|Non-compliance with protocol|0|||
149179545|NCT02606877|538129671|FG001|Overall Study|Non-compliance with protocol|1|||
149179546|NCT02606877|538129670|FG000|Overall Study|Other than listed above|1|||
149179547|NCT02606877|538129671|FG001|Overall Study|Other than listed above|0|||
149179548|NCT00778999|538129672|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
149179549|NCT00778999|538129673|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
149179550|NCT00778999|538129672|FG000|Overall Study|Did not receive recFSH|14|||
149179551|NCT00778999|538129673|FG001|Overall Study|Did not receive recFSH|20|||
149179552|NCT02032524|538129674|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
149179553|NCT02032524|538129675|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
149179554|NCT02032524|538129676|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
149179555|NCT02032524|538129677|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
149179556|NCT02032524|538129678|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
149179557|NCT02032524|538129679|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
149179558|NCT02032524|538129674|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149179559|NCT02032524|538129675|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149179560|NCT02032524|538129676|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149179561|NCT02032524|538129677|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
149179562|NCT02032524|538129678|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
149179563|NCT02032524|538129679|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
149179564|NCT02032524|538129674|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
148931130|NCT02598960|537233333|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
148931131|NCT02598960|537233334|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
149179565|NCT02032524|538129675|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
149179566|NCT02032524|538129676|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
149179567|NCT02032524|538129677|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
148931132|NCT02598960|537233335|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
148931133|NCT02598960|537233323|FG000|Treatment Period|participant request to discontinue|0|||
148931134|NCT02598960|537233324|FG001|Treatment Period|participant request to discontinue|1|||
149013626|NCT04161807|537529214|FG000|Overall Study|Performed only 1 treatment|2|||
149179568|NCT02032524|538129678|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
148931135|NCT02598960|537233325|FG002|Treatment Period|participant request to discontinue|0|||
148931136|NCT02598960|537233326|FG003|Treatment Period|participant request to discontinue|0|||
148931137|NCT02598960|537233327|FG004|Treatment Period|participant request to discontinue|1|||
149179569|NCT02032524|538129679|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
148807163|NCT01288430|536773175|FG000|Part 2|Adverse Event|0|||
148807164|NCT01288430|536773176|FG001|Part 2|Adverse Event|0|||
148807165|NCT01288430|536773177|FG002|Part 2|Adverse Event|0|||
148807166|NCT01288430|536773178|FG003|Part 2|Adverse Event|0|||
148807167|NCT01288430|536773179|FG004|Part 2|Adverse Event|0|||
148807168|NCT01288430|536773180|FG005|Part 2|Adverse Event|0|||
148807169|NCT01288430|536773181|FG006|Part 2|Adverse Event|0|||
148807170|NCT01288430|536773182|FG007|Part 2|Adverse Event|1|||
148807171|NCT01288430|536773183|FG008|Part 2|Adverse Event|1|||
148807172|NCT01288430|536773184|FG009|Part 2|Adverse Event|0|||
148807173|NCT01288430|536773175|FG000|Part 2|Other|0|||
148807174|NCT01288430|536773176|FG001|Part 2|Other|0|||
148807175|NCT01288430|536773177|FG002|Part 2|Other|0|||
148807176|NCT01288430|536773178|FG003|Part 2|Other|0|||
148807177|NCT01288430|536773179|FG004|Part 2|Other|0|||
148807178|NCT01288430|536773180|FG005|Part 2|Other|0|||
148807179|NCT01288430|536773181|FG006|Part 2|Other|0|||
148807180|NCT01288430|536773182|FG007|Part 2|Other|0|||
148807181|NCT01288430|536773183|FG008|Part 2|Other|0|||
148807182|NCT01288430|536773184|FG009|Part 2|Other|1|||
148807183|NCT03405870|536773187|FG000|Overall Study|Withdrawal|1|||
148807184|NCT03405870|536773188|FG001|Overall Study|Withdrawal|0|||
148807185|NCT03405870|536773189|FG002|Overall Study|Withdrawal|1|||
148807186|NCT03405870|536773190|FG003|Overall Study|Withdrawal|0|||
148807187|NCT03405870|536773191|FG004|Overall Study|Withdrawal|0|||
148807188|NCT03405870|536773192|FG005|Overall Study|Withdrawal|0|||
148807189|NCT03405870|536773193|FG006|Overall Study|Withdrawal|1|||
148807190|NCT03405870|536773194|FG007|Overall Study|Withdrawal|0|||
148807191|NCT02807259|536773199|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
148807192|NCT02807259|536773200|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
148807193|NCT02807259|536773199|FG000|Midline (3 Months)|migration, refusal, not available|30|||
148807194|NCT02807259|536773200|FG001|Midline (3 Months)|migration, refusal, not available|34|||
148807195|NCT02807259|536773199|FG000|Endline (3 Months)|migration, refusal, not available|35|||
148807196|NCT02807259|536773200|FG001|Endline (3 Months)|migration, refusal, not available|87|||
148807197|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
148807198|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
148807199|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
148807200|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
148807201|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
148807202|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
148807203|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
148807204|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
148807205|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
148807206|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
148807207|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
148807208|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
148807209|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
148807210|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
148807211|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
148807212|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
148807213|NCT00849056|536773201|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
148807214|NCT00849056|536773202|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
148807215|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
148807216|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
148931138|NCT02598960|537233328|FG005|Treatment Period|participant request to discontinue|0|||
148931139|NCT02598960|537233329|FG006|Treatment Period|participant request to discontinue|0|||
148931140|NCT02598960|537233330|FG007|Treatment Period|participant request to discontinue|0|||
148807217|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
148807218|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
148807219|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
148807220|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
148807221|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
148931141|NCT02598960|537233331|FG008|Treatment Period|participant request to discontinue|0|||
148807222|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
148807223|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
148807224|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
149179570|NCT02032524|538129674|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149179571|NCT02032524|538129675|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
149179572|NCT02032524|538129676|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149179573|NCT02032524|538129677|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149179574|NCT02032524|538129678|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
149179575|NCT02032524|538129679|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
149179576|NCT02032524|538129674|FG000|Period 2: LTS13769 Study|Other|0|||
149179577|NCT02032524|538129675|FG001|Period 2: LTS13769 Study|Other|0|||
149179578|NCT02032524|538129676|FG002|Period 2: LTS13769 Study|Other|0|||
149179579|NCT02032524|538129677|FG003|Period 2: LTS13769 Study|Other|0|||
149179580|NCT02032524|538129678|FG004|Period 2: LTS13769 Study|Other|0|||
149179581|NCT02032524|538129679|FG005|Period 2: LTS13769 Study|Other|1|||
149179582|NCT04513158|538129682|FG000|Overall Study|Screen Failure|1|||
149179583|NCT03705494|538131415|FG000|Overall Study|Lost to Follow-up|2|||
149179584|NCT03705494|538131416|FG001|Overall Study|Lost to Follow-up|1|||
149179585|NCT03705494|538131415|FG000|Overall Study|Withdrawal by Subject|5|||
149179586|NCT03705494|538131416|FG001|Overall Study|Withdrawal by Subject|2|||
149179587|NCT02786537|538131417|FG000|As Randomized|Adverse Event|0|||
149179588|NCT02786537|538131418|FG001|As Randomized|Adverse Event|11|||
149179589|NCT02786537|538131419|FG002|As Randomized|Adverse Event|0|||
149179590|NCT02786537|538131420|FG003|As Randomized|Adverse Event|4|||
149179591|NCT02786537|538131421|FG004|As Randomized|Adverse Event|6|||
149179592|NCT02786537|538131422|FG005|As Randomized|Adverse Event|2|||
149179593|NCT02786537|538131417|FG000|As Randomized|Lack of Efficacy|0|||
149179594|NCT02786537|538131418|FG001|As Randomized|Lack of Efficacy|0|||
149179595|NCT02786537|538131419|FG002|As Randomized|Lack of Efficacy|0|||
149179596|NCT02786537|538131420|FG003|As Randomized|Lack of Efficacy|1|||
149179597|NCT02786537|538131421|FG004|As Randomized|Lack of Efficacy|0|||
149179598|NCT02786537|538131422|FG005|As Randomized|Lack of Efficacy|0|||
149179599|NCT02786537|538131417|FG000|As Randomized|Withdrawal by Subject|1|||
149179600|NCT02786537|538131418|FG001|As Randomized|Withdrawal by Subject|2|||
149179601|NCT02786537|538131419|FG002|As Randomized|Withdrawal by Subject|0|||
149179602|NCT02786537|538131420|FG003|As Randomized|Withdrawal by Subject|1|||
149179603|NCT02786537|538131421|FG004|As Randomized|Withdrawal by Subject|1|||
149179604|NCT02786537|538131422|FG005|As Randomized|Withdrawal by Subject|0|||
149179605|NCT02786537|538131417|FG000|As Randomized|Death|0|||
149179606|NCT02786537|538131418|FG001|As Randomized|Death|2|||
149179607|NCT02786537|538131419|FG002|As Randomized|Death|0|||
149179608|NCT02786537|538131420|FG003|As Randomized|Death|3|||
149179609|NCT02786537|538131421|FG004|As Randomized|Death|1|||
149179610|NCT02786537|538131422|FG005|As Randomized|Death|0|||
149179611|NCT02786537|538131417|FG000|As Randomized|Non-compliance with study drug|1|||
149179612|NCT02786537|538131418|FG001|As Randomized|Non-compliance with study drug|11|||
149179613|NCT02786537|538131419|FG002|As Randomized|Non-compliance with study drug|0|||
149179614|NCT02786537|538131420|FG003|As Randomized|Non-compliance with study drug|1|||
149179615|NCT02786537|538131421|FG004|As Randomized|Non-compliance with study drug|0|||
149179616|NCT02786537|538131422|FG005|As Randomized|Non-compliance with study drug|1|||
149179617|NCT02786537|538131417|FG000|As Randomized|Lost to treatment follow-up|4|||
149179618|NCT02786537|538131418|FG001|As Randomized|Lost to treatment follow-up|32|||
149179619|NCT02786537|538131419|FG002|As Randomized|Lost to treatment follow-up|0|||
149179620|NCT02786537|538131420|FG003|As Randomized|Lost to treatment follow-up|24|||
149179621|NCT02786537|538131421|FG004|As Randomized|Lost to treatment follow-up|4|||
149179622|NCT02786537|538131422|FG005|As Randomized|Lost to treatment follow-up|4|||
149179623|NCT02786537|538131417|FG000|As Randomized|Incarceration|0|||
149179624|NCT02786537|538131418|FG001|As Randomized|Incarceration|1|||
149179625|NCT02786537|538131419|FG002|As Randomized|Incarceration|0|||
148931142|NCT02598960|537233332|FG009|Treatment Period|participant request to discontinue|0|||
148931143|NCT02598960|537233333|FG010|Treatment Period|participant request to discontinue|1|||
148931144|NCT02598960|537233334|FG011|Treatment Period|participant request to discontinue|4|||
148931145|NCT02598960|537233335|FG012|Treatment Period|participant request to discontinue|0|||
148931146|NCT02598960|537233323|FG000|Treatment Period|participant withdrew consent|0|||
148931147|NCT02598960|537233324|FG001|Treatment Period|participant withdrew consent|0|||
148931148|NCT02598960|537233325|FG002|Treatment Period|participant withdrew consent|0|||
149179626|NCT02786537|538131420|FG003|As Randomized|Incarceration|0|||
149179627|NCT02786537|538131421|FG004|As Randomized|Incarceration|0|||
149179628|NCT02786537|538131422|FG005|As Randomized|Incarceration|0|||
149179629|NCT02786537|538131417|FG000|As Randomized|Opiate Dependency Relapse|0|||
149179630|NCT02786537|538131418|FG001|As Randomized|Opiate Dependency Relapse|1|||
149179631|NCT02786537|538131419|FG002|As Randomized|Opiate Dependency Relapse|0|||
148931149|NCT02598960|537233326|FG003|Treatment Period|participant withdrew consent|0|||
149179632|NCT02786537|538131420|FG003|As Randomized|Opiate Dependency Relapse|0|||
149179633|NCT02786537|538131421|FG004|As Randomized|Opiate Dependency Relapse|0|||
149179634|NCT02786537|538131422|FG005|As Randomized|Opiate Dependency Relapse|0|||
149179635|NCT02786537|538131417|FG000|As Randomized|HCV drugs stolen from pt|0|||
149179636|NCT02786537|538131418|FG001|As Randomized|HCV drugs stolen from pt|1|||
149179637|NCT02786537|538131419|FG002|As Randomized|HCV drugs stolen from pt|0|||
148931150|NCT02598960|537233327|FG004|Treatment Period|participant withdrew consent|0|||
148931151|NCT02598960|537233328|FG005|Treatment Period|participant withdrew consent|0|||
148931152|NCT02598960|537233329|FG006|Treatment Period|participant withdrew consent|0|||
148931153|NCT02598960|537233330|FG007|Treatment Period|participant withdrew consent|0|||
148931154|NCT02598960|537233331|FG008|Treatment Period|participant withdrew consent|0|||
148931155|NCT02598960|537233332|FG009|Treatment Period|participant withdrew consent|0|||
148931156|NCT02598960|537233333|FG010|Treatment Period|participant withdrew consent|0|||
148931157|NCT02598960|537233334|FG011|Treatment Period|participant withdrew consent|3|||
148931158|NCT02598960|537233335|FG012|Treatment Period|participant withdrew consent|0|||
148931159|NCT02598960|537233323|FG000|Treatment Period|No longer meets study criteria|0|||
149179638|NCT02786537|538131420|FG003|As Randomized|HCV drugs stolen from pt|0|||
149179639|NCT02786537|538131421|FG004|As Randomized|HCV drugs stolen from pt|0|||
148931160|NCT02598960|537233324|FG001|Treatment Period|No longer meets study criteria|0|||
148931161|NCT02598960|537233325|FG002|Treatment Period|No longer meets study criteria|0|||
148931162|NCT02598960|537233326|FG003|Treatment Period|No longer meets study criteria|0|||
149179640|NCT02786537|538131422|FG005|As Randomized|HCV drugs stolen from pt|0|||
149179641|NCT02786537|538131417|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
149179642|NCT02786537|538131418|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
149179643|NCT02786537|538131419|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
149179644|NCT02786537|538131420|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
149179645|NCT02786537|538131421|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
149179646|NCT02786537|538131422|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
149179647|NCT02786537|538131417|FG000|As Randomized|Subject lost insurance|0|||
149179648|NCT02786537|538131418|FG001|As Randomized|Subject lost insurance|0|||
148807225|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
148807226|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
148807227|NCT00849056|536773201|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
148807228|NCT00849056|536773202|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
148807229|NCT00274456|536773207|FG000|Overall Study|Still on treatment|2|||
148807230|NCT00274456|536773208|FG001|Overall Study|Still on treatment|3|||
148807231|NCT00274456|536773209|FG002|Overall Study|Still on treatment|5|||
148807232|NCT00274456|536773210|FG003|Overall Study|Still on treatment|1|||
148807233|NCT00274456|536773207|FG000|Overall Study|Unacceptable toxicity|10|||
148807234|NCT00274456|536773208|FG001|Overall Study|Unacceptable toxicity|5|||
148807235|NCT00274456|536773209|FG002|Overall Study|Unacceptable toxicity|12|||
148807236|NCT00274456|536773210|FG003|Overall Study|Unacceptable toxicity|16|||
148807237|NCT00274456|536773207|FG000|Overall Study|Adverse Event|0|||
148807238|NCT00274456|536773208|FG001|Overall Study|Adverse Event|1|||
148807239|NCT00274456|536773209|FG002|Overall Study|Adverse Event|2|||
148807240|NCT00274456|536773210|FG003|Overall Study|Adverse Event|2|||
148807241|NCT00274456|536773207|FG000|Overall Study|Physician Decision|7|||
148807242|NCT00274456|536773208|FG001|Overall Study|Physician Decision|5|||
148807243|NCT00274456|536773209|FG002|Overall Study|Physician Decision|6|||
148807244|NCT00274456|536773210|FG003|Overall Study|Physician Decision|13|||
148807245|NCT00274456|536773207|FG000|Overall Study|Lost to Follow-up|0|||
148807246|NCT00274456|536773208|FG001|Overall Study|Lost to Follow-up|0|||
148807247|NCT00274456|536773209|FG002|Overall Study|Lost to Follow-up|1|||
148807248|NCT00274456|536773210|FG003|Overall Study|Lost to Follow-up|0|||
148807249|NCT00274456|536773207|FG000|Overall Study|Withdrawal by Subject|18|||
148807250|NCT00274456|536773208|FG001|Overall Study|Withdrawal by Subject|13|||
148807251|NCT00274456|536773209|FG002|Overall Study|Withdrawal by Subject|9|||
148807252|NCT00274456|536773210|FG003|Overall Study|Withdrawal by Subject|13|||
148807253|NCT00375752|536773214|FG000|Overall Study|Lack of Efficacy|4|||
148931163|NCT02598960|537233327|FG004|Treatment Period|No longer meets study criteria|0|||
148931164|NCT02598960|537233328|FG005|Treatment Period|No longer meets study criteria|0|||
149179649|NCT02786537|538131419|FG002|As Randomized|Subject lost insurance|0|||
149179650|NCT02786537|538131420|FG003|As Randomized|Subject lost insurance|1|||
149179651|NCT02786537|538131421|FG004|As Randomized|Subject lost insurance|0|||
149179652|NCT02786537|538131422|FG005|As Randomized|Subject lost insurance|0|||
148807254|NCT00375752|536773215|FG001|Overall Study|Lack of Efficacy|4|||
148807255|NCT00375752|536773214|FG000|Overall Study|Adverse Event|1|||
148931165|NCT02598960|537233329|FG006|Treatment Period|No longer meets study criteria|0|||
149179653|NCT02786537|538131417|FG000|As Treated|Adverse Event|0|||
148807256|NCT00375752|536773215|FG001|Overall Study|Adverse Event|6|||
148807257|NCT00375752|536773214|FG000|Overall Study|Withdrawal by Subject|6|||
148807258|NCT00375752|536773215|FG001|Overall Study|Withdrawal by Subject|1|||
148807259|NCT00375752|536773214|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
148931166|NCT02598960|537233330|FG007|Treatment Period|No longer meets study criteria|0|||
148931167|NCT02598960|537233331|FG008|Treatment Period|No longer meets study criteria|0|||
149179654|NCT02786537|538131418|FG001|As Treated|Adverse Event|11|||
149179655|NCT02786537|538131419|FG002|As Treated|Adverse Event|0|||
149179656|NCT02786537|538131420|FG003|As Treated|Adverse Event|4|||
148807260|NCT00375752|536773215|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
148807261|NCT00375752|536773214|FG000|Overall Study|Protocol Violation|0|||
149179657|NCT02786537|538131421|FG004|As Treated|Adverse Event|6|||
149179658|NCT02786537|538131422|FG005|As Treated|Adverse Event|2|||
149179659|NCT02786537|538131417|FG000|As Treated|Death|0|||
149179660|NCT02786537|538131418|FG001|As Treated|Death|2|||
149179661|NCT02786537|538131419|FG002|As Treated|Death|0|||
149179662|NCT02786537|538131420|FG003|As Treated|Death|3|||
149179663|NCT02786537|538131421|FG004|As Treated|Death|1|||
149179664|NCT02786537|538131422|FG005|As Treated|Death|0|||
149179665|NCT02786537|538131417|FG000|As Treated|Lack of Efficacy|0|||
149179666|NCT02786537|538131418|FG001|As Treated|Lack of Efficacy|0|||
149179667|NCT02786537|538131419|FG002|As Treated|Lack of Efficacy|0|||
149179668|NCT02786537|538131420|FG003|As Treated|Lack of Efficacy|1|||
149179669|NCT02786537|538131421|FG004|As Treated|Lack of Efficacy|0|||
149179670|NCT02786537|538131422|FG005|As Treated|Lack of Efficacy|0|||
149179671|NCT02786537|538131417|FG000|As Treated|Lost to Follow-up|4|||
149179672|NCT02786537|538131418|FG001|As Treated|Lost to Follow-up|32|||
149179673|NCT02786537|538131419|FG002|As Treated|Lost to Follow-up|0|||
149179674|NCT02786537|538131420|FG003|As Treated|Lost to Follow-up|25|||
149179675|NCT02786537|538131421|FG004|As Treated|Lost to Follow-up|4|||
149179676|NCT02786537|538131422|FG005|As Treated|Lost to Follow-up|4|||
149179677|NCT02786537|538131417|FG000|As Treated|Non-compliance with study drug|1|||
149179678|NCT02786537|538131418|FG001|As Treated|Non-compliance with study drug|11|||
149179679|NCT02786537|538131419|FG002|As Treated|Non-compliance with study drug|0|||
149179680|NCT02786537|538131420|FG003|As Treated|Non-compliance with study drug|1|||
149179681|NCT02786537|538131421|FG004|As Treated|Non-compliance with study drug|0|||
149179682|NCT02786537|538131422|FG005|As Treated|Non-compliance with study drug|1|||
149179683|NCT02786537|538131417|FG000|As Treated|Lost insurance|0|||
149179684|NCT02786537|538131418|FG001|As Treated|Lost insurance|0|||
149179685|NCT02786537|538131419|FG002|As Treated|Lost insurance|0|||
149179686|NCT02786537|538131420|FG003|As Treated|Lost insurance|1|||
149179687|NCT02786537|538131421|FG004|As Treated|Lost insurance|0|||
149179688|NCT02786537|538131422|FG005|As Treated|Lost insurance|0|||
149179689|NCT02786537|538131417|FG000|As Treated|Withdrawal by Subject|1|||
149179690|NCT02786537|538131418|FG001|As Treated|Withdrawal by Subject|2|||
149179691|NCT02786537|538131419|FG002|As Treated|Withdrawal by Subject|0|||
149179692|NCT02786537|538131420|FG003|As Treated|Withdrawal by Subject|0|||
149179693|NCT02786537|538131421|FG004|As Treated|Withdrawal by Subject|1|||
149179694|NCT02786537|538131422|FG005|As Treated|Withdrawal by Subject|0|||
149179695|NCT02786537|538131417|FG000|As Treated|Incarceration|0|||
149179696|NCT02786537|538131418|FG001|As Treated|Incarceration|1|||
149179697|NCT02786537|538131419|FG002|As Treated|Incarceration|0|||
149179698|NCT02786537|538131420|FG003|As Treated|Incarceration|0|||
149179699|NCT02786537|538131421|FG004|As Treated|Incarceration|0|||
149179700|NCT02786537|538131422|FG005|As Treated|Incarceration|0|||
149179701|NCT02786537|538131417|FG000|As Treated|Opiate dependency relapse|0|||
149179702|NCT02786537|538131418|FG001|As Treated|Opiate dependency relapse|1|||
149179703|NCT02786537|538131419|FG002|As Treated|Opiate dependency relapse|0|||
149179704|NCT02786537|538131420|FG003|As Treated|Opiate dependency relapse|0|||
149179705|NCT02786537|538131421|FG004|As Treated|Opiate dependency relapse|0|||
149179706|NCT02786537|538131422|FG005|As Treated|Opiate dependency relapse|0|||
149179707|NCT02786537|538131417|FG000|As Treated|Drugs stolen from patient|0|||
149179708|NCT02786537|538131418|FG001|As Treated|Drugs stolen from patient|1|||
149179709|NCT02786537|538131419|FG002|As Treated|Drugs stolen from patient|0|||
149179710|NCT02786537|538131420|FG003|As Treated|Drugs stolen from patient|0|||
149179711|NCT02786537|538131421|FG004|As Treated|Drugs stolen from patient|0|||
149179712|NCT02786537|538131422|FG005|As Treated|Drugs stolen from patient|0|||
149179713|NCT02786537|538131417|FG000|As Treated|Advised to stop tx after loss of meds|0|||
149179714|NCT02786537|538131418|FG001|As Treated|Advised to stop tx after loss of meds|1|||
149179715|NCT02786537|538131419|FG002|As Treated|Advised to stop tx after loss of meds|0|||
149179716|NCT02786537|538131420|FG003|As Treated|Advised to stop tx after loss of meds|0|||
149179717|NCT02786537|538131421|FG004|As Treated|Advised to stop tx after loss of meds|0|||
149179718|NCT02786537|538131422|FG005|As Treated|Advised to stop tx after loss of meds|0|||
148931168|NCT02598960|537233332|FG009|Treatment Period|No longer meets study criteria|0|||
149179719|NCT01357239|538131427|FG000|Stratum: All Patients|Adverse Event|0|||
149179720|NCT01357239|538131428|FG001|Stratum: All Patients|Adverse Event|0|||
149179721|NCT01357239|538131429|FG002|Stratum: All Patients|Adverse Event|1|||
149179722|NCT01357239|538131430|FG003|Stratum: All Patients|Adverse Event|1|||
149179723|NCT01357239|538131427|FG000|Stratum: All Patients|Subject withdrew consent|0|||
149179724|NCT01357239|538131428|FG001|Stratum: All Patients|Subject withdrew consent|0|||
149179725|NCT01357239|538131429|FG002|Stratum: All Patients|Subject withdrew consent|1|||
149179726|NCT01357239|538131430|FG003|Stratum: All Patients|Subject withdrew consent|1|||
149179727|NCT01357239|538131427|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
149179728|NCT01357239|538131428|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
149179729|NCT01357239|538131429|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
149179730|NCT01357239|538131430|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
149179731|NCT01357239|538131427|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
149179732|NCT01357239|538131428|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
149179733|NCT01357239|538131429|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
149179734|NCT01357239|538131430|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
148931169|NCT02598960|537233333|FG010|Treatment Period|No longer meets study criteria|0|||
149179735|NCT01357239|538131427|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
149179736|NCT01357239|538131428|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
149179737|NCT01357239|538131429|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
149179738|NCT01357239|538131430|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
149179739|NCT03455543|538131435|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
149179740|NCT03455543|538131436|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
149179741|NCT03455543|538131437|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
149179742|NCT03455543|538131435|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
149179743|NCT03455543|538131436|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
149179744|NCT03455543|538131437|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
149179745|NCT03455543|538131435|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
149179746|NCT03455543|538131436|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
149179747|NCT03455543|538131437|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
149179748|NCT03455543|538131435|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
149179749|NCT03455543|538131436|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
149179750|NCT03455543|538131437|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
149179751|NCT03455543|538131435|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
149179752|NCT03455543|538131436|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
149179753|NCT03455543|538131437|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
149179754|NCT03455543|538131435|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
149179755|NCT03455543|538131436|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
149179756|NCT03455543|538131437|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
149179757|NCT03455543|538131435|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
149179758|NCT03455543|538131436|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
149179759|NCT03455543|538131437|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
149179760|NCT03455543|538131435|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
149179761|NCT03455543|538131436|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
149179762|NCT03455543|538131437|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
149179763|NCT03455543|538131435|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
149179764|NCT03455543|538131436|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
149179765|NCT03455543|538131437|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
149179766|NCT00852930|538131438|FG000|Overall Study|Withdrawal by Subject|1|||
149179767|NCT00852930|538131439|FG001|Overall Study|Withdrawal by Subject|1|||
149179768|NCT00852930|538131440|FG002|Overall Study|Withdrawal by Subject|1|||
149179769|NCT00852930|538131438|FG000|Overall Study|Physician Decision|0|||
149179770|NCT00852930|538131439|FG001|Overall Study|Physician Decision|0|||
149179771|NCT00852930|538131440|FG002|Overall Study|Physician Decision|1|||
149179772|NCT00779038|538131441|FG000|Overall Study|Study Prematurely Terminated|13|||
149179773|NCT02614794|538131443|FG000|Overall Study|Death|258|||
149179774|NCT02614794|538131444|FG001|Overall Study|Death|151|||
149179775|NCT02614794|538131443|FG000|Overall Study|Study closure by Sponsor|119|||
149179776|NCT02614794|538131444|FG001|Overall Study|Study closure by Sponsor|45|||
149179777|NCT02614794|538131443|FG000|Overall Study|Withdrawal by Subject|24|||
149179778|NCT02614794|538131444|FG001|Overall Study|Withdrawal by Subject|5|||
149179779|NCT02614794|538131443|FG000|Overall Study|Lost to Follow-up|7|||
149179780|NCT02614794|538131444|FG001|Overall Study|Lost to Follow-up|0|||
149179781|NCT02614794|538131443|FG000|Overall Study|Physician Decision|1|||
149179782|NCT02614794|538131444|FG001|Overall Study|Physician Decision|1|||
149179783|NCT02614794|538131443|FG000|Overall Study|Hospital closure|1|||
149179784|NCT02614794|538131444|FG001|Overall Study|Hospital closure|0|||
149179785|NCT03396471|538131447|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
149179786|NCT03396471|538131447|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
149179787|NCT03396471|538131447|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
149179788|NCT03396471|538131447|FG000|Study Treatment - Up to 22 Months|Death|2|||
149179789|NCT03396471|538131447|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
149179790|NCT03396471|538131447|FG000|Follow up - Up to 2 Years|Death|9|||
149179791|NCT03396471|538131447|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
149179792|NCT03396471|538131447|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
148807262|NCT00375752|536773215|FG001|Overall Study|Protocol Violation|2|||
149179793|NCT03396471|538131447|FG000|Follow up - Up to 2 Years|study terminated|1|||
149179794|NCT03396471|538131447|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
149179795|NCT03396471|538131447|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
149179796|NCT01319929|538131451|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
149179797|NCT01319929|538131452|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
148807263|NCT00375752|536773214|FG000|Overall Study|Administrative Problems|0|||
148931170|NCT02598960|537233334|FG011|Treatment Period|No longer meets study criteria|1|||
149233993|NCT01422876|538326349|FG003|Week 24|Death|0|||
148931171|NCT02598960|537233335|FG012|Treatment Period|No longer meets study criteria|0|||
148931172|NCT02598960|537233323|FG000|Treatment Period|Other Reasons|0|||
148931173|NCT02598960|537233324|FG001|Treatment Period|Other Reasons|0|||
148931174|NCT02598960|537233325|FG002|Treatment Period|Other Reasons|0|||
148931175|NCT02598960|537233326|FG003|Treatment Period|Other Reasons|0|||
148931176|NCT02598960|537233327|FG004|Treatment Period|Other Reasons|0|||
148931177|NCT02598960|537233328|FG005|Treatment Period|Other Reasons|0|||
148931178|NCT02598960|537233329|FG006|Treatment Period|Other Reasons|0|||
148931179|NCT02598960|537233330|FG007|Treatment Period|Other Reasons|0|||
148931180|NCT02598960|537233331|FG008|Treatment Period|Other Reasons|0|||
148931181|NCT02598960|537233332|FG009|Treatment Period|Other Reasons|0|||
148931182|NCT02598960|537233333|FG010|Treatment Period|Other Reasons|0|||
149179798|NCT01319929|538131451|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
149179799|NCT01319929|538131452|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
149179800|NCT01319929|538131451|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
149179801|NCT01319929|538131452|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
149179802|NCT01319929|538131451|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
149179803|NCT01319929|538131452|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
149179804|NCT01319929|538131451|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
149179805|NCT01319929|538131452|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
149179806|NCT03237845|538131453|FG000|Overall Study|Adverse Event|0|||
149179807|NCT03237845|538131454|FG001|Overall Study|Adverse Event|1|||
149179808|NCT03237845|538131453|FG000|Overall Study|Lost to Follow-up|13|||
149179809|NCT03237845|538131454|FG001|Overall Study|Lost to Follow-up|10|||
149179810|NCT03237845|538131453|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
149179811|NCT03237845|538131454|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
149179812|NCT03237845|538131453|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
149179813|NCT03237845|538131454|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
149179814|NCT03237845|538131453|FG000|Overall Study|Physician Decision|1|||
149179815|NCT03237845|538131454|FG001|Overall Study|Physician Decision|2|||
149179816|NCT03237845|538131453|FG000|Overall Study|Pregnancy|1|||
149179817|NCT03237845|538131454|FG001|Overall Study|Pregnancy|0|||
149179818|NCT03237845|538131453|FG000|Overall Study|Protocol Deviation|0|||
149179819|NCT03237845|538131454|FG001|Overall Study|Protocol Deviation|1|||
149179820|NCT03237845|538131453|FG000|Overall Study|Technical Problems|8|||
149179821|NCT03237845|538131454|FG001|Overall Study|Technical Problems|1|||
149179822|NCT03237845|538131453|FG000|Overall Study|Withdrawal by Subject|3|||
149179823|NCT03237845|538131454|FG001|Overall Study|Withdrawal by Subject|3|||
149179824|NCT03237845|538131453|FG000|Overall Study|Other Reasons|4|||
149179825|NCT03237845|538131454|FG001|Overall Study|Other Reasons|0|||
149179826|NCT01221233|538131455|FG000|Overall Study|Withdrawal by Subject|3|||
149179827|NCT01221233|538131456|FG001|Overall Study|Withdrawal by Subject|1|||
149179828|NCT00234104|538131459|FG000|Overall Study|Adverse Event|4|||
149179829|NCT00234104|538131460|FG001|Overall Study|Adverse Event|0|||
149179830|NCT00234104|538131461|FG002|Overall Study|Adverse Event|3|||
149179831|NCT00234104|538131462|FG003|Overall Study|Adverse Event|5|||
149179832|NCT00234104|538131459|FG000|Overall Study|Protocol Violation|0|||
149179833|NCT00234104|538131460|FG001|Overall Study|Protocol Violation|0|||
149179834|NCT00234104|538131461|FG002|Overall Study|Protocol Violation|0|||
149179835|NCT00234104|538131462|FG003|Overall Study|Protocol Violation|1|||
149179836|NCT00234104|538131459|FG000|Overall Study|Physician Decision|0|||
149179837|NCT00234104|538131460|FG001|Overall Study|Physician Decision|1|||
149179838|NCT00234104|538131461|FG002|Overall Study|Physician Decision|2|||
149179839|NCT00234104|538131462|FG003|Overall Study|Physician Decision|2|||
149179840|NCT04045613|538131463|FG000|Overall Study|Adverse Event|2|||
149179841|NCT04045613|538131464|FG001|Overall Study|Adverse Event|2|||
149179842|NCT04045613|538131465|FG002|Overall Study|Adverse Event|1|||
149179843|NCT04045613|538131466|FG003|Overall Study|Adverse Event|1|||
149179844|NCT04045613|538131467|FG004|Overall Study|Adverse Event|0|||
149179845|NCT04045613|538131468|FG005|Overall Study|Adverse Event|0|||
149179846|NCT04045613|538131469|FG006|Overall Study|Adverse Event|1|||
148931183|NCT02598960|537233334|FG011|Treatment Period|Other Reasons|0|||
148931184|NCT02598960|537233335|FG012|Treatment Period|Other Reasons|1|||
148931185|NCT02598960|537233323|FG000|Participants Entering Follow Up Period|Death|1|||
148931186|NCT02598960|537233324|FG001|Participants Entering Follow Up Period|Death|0|||
149179847|NCT04045613|538131463|FG000|Overall Study|Withdrawal by Subject|0|||
149179848|NCT04045613|538131464|FG001|Overall Study|Withdrawal by Subject|5|||
149179849|NCT04045613|538131465|FG002|Overall Study|Withdrawal by Subject|0|||
149179850|NCT04045613|538131466|FG003|Overall Study|Withdrawal by Subject|0|||
149179851|NCT04045613|538131467|FG004|Overall Study|Withdrawal by Subject|0|||
149179852|NCT04045613|538131468|FG005|Overall Study|Withdrawal by Subject|1|||
149179853|NCT04045613|538131469|FG006|Overall Study|Withdrawal by Subject|0|||
149179854|NCT04045613|538131463|FG000|Overall Study|Physician Decision|2|||
149179855|NCT04045613|538131464|FG001|Overall Study|Physician Decision|0|||
149179856|NCT04045613|538131465|FG002|Overall Study|Physician Decision|0|||
149179857|NCT04045613|538131466|FG003|Overall Study|Physician Decision|0|||
148931187|NCT02598960|537233325|FG002|Participants Entering Follow Up Period|Death|0|||
149179858|NCT04045613|538131467|FG004|Overall Study|Physician Decision|1|||
149179859|NCT04045613|538131468|FG005|Overall Study|Physician Decision|0|||
148931188|NCT02598960|537233326|FG003|Participants Entering Follow Up Period|Death|0|||
148931189|NCT02598960|537233327|FG004|Participants Entering Follow Up Period|Death|0|||
148931190|NCT02598960|537233328|FG005|Participants Entering Follow Up Period|Death|0|||
148931191|NCT02598960|537233329|FG006|Participants Entering Follow Up Period|Death|0|||
148931192|NCT02598960|537233330|FG007|Participants Entering Follow Up Period|Death|0|||
148931193|NCT02598960|537233331|FG008|Participants Entering Follow Up Period|Death|0|||
148931194|NCT02598960|537233332|FG009|Participants Entering Follow Up Period|Death|1|||
149179860|NCT04045613|538131469|FG006|Overall Study|Physician Decision|0|||
149179861|NCT04045613|538131463|FG000|Overall Study|Death|3|||
149179862|NCT04045613|538131464|FG001|Overall Study|Death|0|||
149179863|NCT04045613|538131465|FG002|Overall Study|Death|0|||
149179864|NCT04045613|538131466|FG003|Overall Study|Death|0|||
149179865|NCT04045613|538131467|FG004|Overall Study|Death|0|||
149179866|NCT04045613|538131468|FG005|Overall Study|Death|0|||
149179867|NCT04045613|538131469|FG006|Overall Study|Death|1|||
149179868|NCT04045613|538131463|FG000|Overall Study|Other reasons|0|||
149179869|NCT04045613|538131464|FG001|Overall Study|Other reasons|1|||
149179870|NCT04045613|538131465|FG002|Overall Study|Other reasons|0|||
149179871|NCT04045613|538131466|FG003|Overall Study|Other reasons|0|||
149179872|NCT04045613|538131467|FG004|Overall Study|Other reasons|0|||
149179873|NCT04045613|538131468|FG005|Overall Study|Other reasons|0|||
149179874|NCT04045613|538131469|FG006|Overall Study|Other reasons|1|||
149179875|NCT04045613|538131463|FG000|Overall Study|Progressive disease: Clinical progression|1|||
149179876|NCT04045613|538131464|FG001|Overall Study|Progressive disease: Clinical progression|0|||
149179877|NCT04045613|538131465|FG002|Overall Study|Progressive disease: Clinical progression|3|||
149179878|NCT04045613|538131466|FG003|Overall Study|Progressive disease: Clinical progression|1|||
149179879|NCT04045613|538131467|FG004|Overall Study|Progressive disease: Clinical progression|1|||
149179880|NCT04045613|538131468|FG005|Overall Study|Progressive disease: Clinical progression|3|||
149179881|NCT04045613|538131469|FG006|Overall Study|Progressive disease: Clinical progression|3|||
149179882|NCT04045613|538131463|FG000|Overall Study|Progressive disease: Radiological progression|24|||
149179883|NCT04045613|538131464|FG001|Overall Study|Progressive disease: Radiological progression|6|||
149179884|NCT04045613|538131465|FG002|Overall Study|Progressive disease: Radiological progression|8|||
149179885|NCT04045613|538131466|FG003|Overall Study|Progressive disease: Radiological progression|0|||
149179886|NCT04045613|538131467|FG004|Overall Study|Progressive disease: Radiological progression|6|||
149179887|NCT04045613|538131468|FG005|Overall Study|Progressive disease: Radiological progression|6|||
149179888|NCT04045613|538131469|FG006|Overall Study|Progressive disease: Radiological progression|11|||
149179889|NCT01633060|538131472|FG000|Randomization Phase|Protocol deviation|1|||
149179890|NCT01633060|538131473|FG001|Randomization Phase|Protocol deviation|2|||
149179891|NCT01633060|538131472|FG000|Randomization Phase|Technical problem|0|||
149179892|NCT01633060|538131473|FG001|Randomization Phase|Technical problem|1|||
149179893|NCT01633060|538131472|FG000|Treatment Phase|Adverse Event|24|||
149179894|NCT01633060|538131473|FG001|Treatment Phase|Adverse Event|3|||
149179895|NCT01633060|538131472|FG000|Treatment Phase|Lost to Follow-up|1|||
148931195|NCT02598960|537233333|FG010|Participants Entering Follow Up Period|Death|0|||
148931196|NCT02598960|537233334|FG011|Participants Entering Follow Up Period|Death|11|||
148931197|NCT02598960|537233335|FG012|Participants Entering Follow Up Period|Death|2|||
148931198|NCT02598960|537233323|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
149179896|NCT01633060|538131473|FG001|Treatment Phase|Lost to Follow-up|0|||
149179897|NCT01633060|538131472|FG000|Treatment Phase|Physician Decision|16|||
149179898|NCT01633060|538131473|FG001|Treatment Phase|Physician Decision|7|||
149179899|NCT01633060|538131472|FG000|Treatment Phase|Progressive Disease|210|||
149179900|NCT01633060|538131473|FG001|Treatment Phase|Progressive Disease|120|||
149179901|NCT01633060|538131472|FG000|Treatment Phase|Protocol Deviation|1|||
149179902|NCT01633060|538131473|FG001|Treatment Phase|Protocol Deviation|0|||
149179903|NCT01633060|538131472|FG000|Treatment Phase|Study Terminated by sponsor|7|||
149179904|NCT01633060|538131473|FG001|Treatment Phase|Study Terminated by sponsor|3|||
149179905|NCT01633060|538131472|FG000|Treatment Phase|Subject/guardian decision|25|||
149179906|NCT01633060|538131473|FG001|Treatment Phase|Subject/guardian decision|4|||
149179907|NCT01633060|538131472|FG000|Treatment Phase|Death|4|||
148931199|NCT02598960|537233324|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
149179908|NCT01633060|538131473|FG001|Treatment Phase|Death|3|||
149179909|NCT01633060|538131472|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
149179910|NCT01633060|538131473|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
149179911|NCT01633060|538131472|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
149179912|NCT01633060|538131473|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
149179913|NCT01633060|538131472|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
149179914|NCT01633060|538131473|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
149179915|NCT01633060|538131472|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
148931200|NCT02598960|537233325|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
149233994|NCT01422876|538326350|FG004|Week 24|Death|0|||
149179916|NCT01633060|538131473|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
149179917|NCT01633060|538131472|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
149179918|NCT01633060|538131473|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
149179919|NCT01633060|538131472|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
149179920|NCT01633060|538131473|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
149179921|NCT01009294|538131481|FG000|Overall Study|Study discontinued by Sponsor|6|||
149179922|NCT01856673|538131482|FG000|Overall Study|Withdrawal by Subject|44|||
148931201|NCT02598960|537233326|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931202|NCT02598960|537233327|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931203|NCT02598960|537233328|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931204|NCT02598960|537233329|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931205|NCT02598960|537233330|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931206|NCT02598960|537233331|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931207|NCT02598960|537233332|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931208|NCT02598960|537233333|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931209|NCT02598960|537233334|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
148931210|NCT02598960|537233335|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
148931211|NCT02598960|537233323|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
148931212|NCT02598960|537233324|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
148931213|NCT02598960|537233325|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
148931214|NCT02598960|537233326|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
148931215|NCT02598960|537233327|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
148931216|NCT02598960|537233328|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
148931217|NCT02598960|537233329|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
148931218|NCT02598960|537233330|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
148931219|NCT02598960|537233331|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
148931220|NCT02598960|537233332|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
148931221|NCT02598960|537233333|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
148931222|NCT02598960|537233334|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
148931223|NCT02598960|537233335|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
148931224|NCT02598960|537233323|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931225|NCT02598960|537233324|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931226|NCT02598960|537233325|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
149179923|NCT01856673|538131483|FG001|Overall Study|Withdrawal by Subject|50|||
149179924|NCT01856673|538131484|FG002|Overall Study|Withdrawal by Subject|33|||
149179925|NCT01856673|538131482|FG000|Overall Study|Lost to Follow-up|31|||
149179926|NCT01856673|538131483|FG001|Overall Study|Lost to Follow-up|34|||
149179927|NCT01856673|538131484|FG002|Overall Study|Lost to Follow-up|0|||
149179928|NCT01856673|538131482|FG000|Overall Study|Unknown reasons|9|||
149179929|NCT01856673|538131483|FG001|Overall Study|Unknown reasons|0|||
149179930|NCT01856673|538131484|FG002|Overall Study|Unknown reasons|0|||
149179931|NCT01856673|538131482|FG000|Overall Study|Psychologist decision|1|||
149179932|NCT01856673|538131483|FG001|Overall Study|Psychologist decision|0|||
149179933|NCT01856673|538131484|FG002|Overall Study|Psychologist decision|0|||
149179934|NCT01856673|538131482|FG000|Overall Study|Paperwork errors|8|||
149179935|NCT01856673|538131483|FG001|Overall Study|Paperwork errors|0|||
149179936|NCT01856673|538131484|FG002|Overall Study|Paperwork errors|0|||
149179937|NCT01856673|538131482|FG000|Overall Study|Death|1|||
149179938|NCT01856673|538131483|FG001|Overall Study|Death|1|||
149179939|NCT01856673|538131484|FG002|Overall Study|Death|0|||
149179940|NCT01856673|538131482|FG000|Overall Study|Protocol Violation|1|||
149179941|NCT01856673|538131483|FG001|Overall Study|Protocol Violation|0|||
149179942|NCT01856673|538131484|FG002|Overall Study|Protocol Violation|1|||
149179943|NCT03114969|538131485|FG000|Overall Study|Lost to Follow-up|0|||
149179944|NCT03114969|538131486|FG001|Overall Study|Lost to Follow-up|0|||
148931227|NCT02598960|537233326|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931228|NCT02598960|537233327|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931229|NCT02598960|537233328|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931230|NCT02598960|537233329|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931231|NCT02598960|537233330|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
149179945|NCT03114969|538131487|FG002|Overall Study|Lost to Follow-up|3|||
149179946|NCT03114969|538131488|FG003|Overall Study|Lost to Follow-up|2|||
149179947|NCT03114969|538131489|FG004|Overall Study|Lost to Follow-up|0|||
149179948|NCT03114969|538131490|FG005|Overall Study|Lost to Follow-up|0|||
149179949|NCT03114969|538131491|FG006|Overall Study|Lost to Follow-up|0|||
149179950|NCT03114969|538131492|FG007|Overall Study|Lost to Follow-up|0|||
149179951|NCT03114969|538131493|FG008|Overall Study|Lost to Follow-up|0|||
149179952|NCT03114969|538131485|FG000|Overall Study|Adverse Event|0|||
148931232|NCT02598960|537233331|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931233|NCT02598960|537233332|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931234|NCT02598960|537233333|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
148931235|NCT02598960|537233334|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
148931236|NCT02598960|537233335|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
149179953|NCT03114969|538131486|FG001|Overall Study|Adverse Event|0|||
149179954|NCT03114969|538131487|FG002|Overall Study|Adverse Event|1|||
149179955|NCT03114969|538131488|FG003|Overall Study|Adverse Event|0|||
149179956|NCT03114969|538131489|FG004|Overall Study|Adverse Event|0|||
149179957|NCT03114969|538131490|FG005|Overall Study|Adverse Event|1|||
149179958|NCT03114969|538131491|FG006|Overall Study|Adverse Event|1|||
149179959|NCT03114969|538131492|FG007|Overall Study|Adverse Event|0|||
149179960|NCT03114969|538131493|FG008|Overall Study|Adverse Event|2|||
149179961|NCT02168946|538131494|FG000|Overall Study|Adverse Event|8|||
149179962|NCT02168946|538131495|FG001|Overall Study|Adverse Event|5|||
149179963|NCT02168946|538131494|FG000|Overall Study|Lost to Follow-up|3|||
149179964|NCT02168946|538131495|FG001|Overall Study|Lost to Follow-up|0|||
149179965|NCT02168946|538131494|FG000|Overall Study|Subject unable to come back for visits|1|||
149179966|NCT02168946|538131495|FG001|Overall Study|Subject unable to come back for visits|0|||
149179967|NCT00450866|538131505|FG000|Overall Study|Adverse Event|0|||
149179968|NCT00450866|538131506|FG001|Overall Study|Adverse Event|1|||
149179969|NCT00450866|538131505|FG000|Overall Study|Withdrawal by Subject|5|||
148807264|NCT00375752|536773215|FG001|Overall Study|Administrative Problems|1|||
148807265|NCT01140906|536773222|FG000|Overall Study|Adverse Event|7|||
148807266|NCT01140906|536773223|FG001|Overall Study|Adverse Event|10|||
149179970|NCT00450866|538131506|FG001|Overall Study|Withdrawal by Subject|2|||
149179971|NCT00450866|538131505|FG000|Overall Study|Death|1|||
149179972|NCT00450866|538131506|FG001|Overall Study|Death|0|||
149179973|NCT00450866|538131505|FG000|Overall Study|Physician Decision|1|||
149179974|NCT00450866|538131506|FG001|Overall Study|Physician Decision|0|||
149179975|NCT01743027|538131507|FG000|Overall Study|Adverse Event|2|||
149179976|NCT01743027|538131508|FG001|Overall Study|Adverse Event|0|||
149179977|NCT01743027|538131509|FG002|Overall Study|Adverse Event|0|||
149179978|NCT01743027|538131510|FG003|Overall Study|Adverse Event|0|||
149179979|NCT01743027|538131507|FG000|Overall Study|Lost to Follow-up|0|||
149179980|NCT01743027|538131508|FG001|Overall Study|Lost to Follow-up|0|||
149179981|NCT01743027|538131509|FG002|Overall Study|Lost to Follow-up|2|||
149179982|NCT01743027|538131510|FG003|Overall Study|Lost to Follow-up|0|||
149179983|NCT01743027|538131507|FG000|Overall Study|Progressive Disease|1|||
149179984|NCT01743027|538131508|FG001|Overall Study|Progressive Disease|4|||
149179985|NCT01743027|538131509|FG002|Overall Study|Progressive Disease|3|||
149179986|NCT01743027|538131510|FG003|Overall Study|Progressive Disease|0|||
149179987|NCT01743027|538131507|FG000|Overall Study|Protocol Violation|1|||
149179988|NCT01743027|538131508|FG001|Overall Study|Protocol Violation|1|||
149179989|NCT01743027|538131509|FG002|Overall Study|Protocol Violation|1|||
149179990|NCT01743027|538131510|FG003|Overall Study|Protocol Violation|0|||
149179991|NCT01743027|538131507|FG000|Overall Study|Withdrawal by Subject|1|||
149179992|NCT01743027|538131508|FG001|Overall Study|Withdrawal by Subject|0|||
149179993|NCT01743027|538131509|FG002|Overall Study|Withdrawal by Subject|3|||
149179994|NCT01743027|538131510|FG003|Overall Study|Withdrawal by Subject|1|||
149179995|NCT00138151|538131511|FG000|Overall Study|Withdrawal by Subject|3|||
149179996|NCT00138151|538131511|FG000|Overall Study|Physician Decision|1|||
149179997|NCT02675517|538131514|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
149179998|NCT02675517|538131514|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
149179999|NCT05121103|538131517|FG000|Overall Study|Progressive disease|2|||
149180000|NCT05121103|538131518|FG001|Overall Study|Progressive disease|1|||
149180001|NCT05121103|538131519|FG002|Overall Study|Progressive disease|6|||
149180002|NCT05121103|538131517|FG000|Overall Study|Physician Decision|2|||
149180003|NCT05121103|538131518|FG001|Overall Study|Physician Decision|1|||
149180004|NCT05121103|538131519|FG002|Overall Study|Physician Decision|0|||
149180005|NCT05121103|538131517|FG000|Overall Study|Withdrawal by Subject|0|||
148807267|NCT01140906|536773224|FG002|Overall Study|Adverse Event|17|||
148931237|NCT02598960|537233323|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
148931238|NCT02598960|537233324|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
149180006|NCT05121103|538131518|FG001|Overall Study|Withdrawal by Subject|1|||
149180007|NCT05121103|538131519|FG002|Overall Study|Withdrawal by Subject|0|||
149180008|NCT03443024|538131524|FG000|Overall Study|Adverse Event|2|||
149180009|NCT03443024|538131525|FG001|Overall Study|Adverse Event|4|||
149180010|NCT03443024|538131526|FG002|Overall Study|Adverse Event|3|||
149180011|NCT03443024|538131527|FG003|Overall Study|Adverse Event|1|||
149180012|NCT03443024|538131524|FG000|Overall Study|Lost to Follow-up|9|||
149180013|NCT03443024|538131525|FG001|Overall Study|Lost to Follow-up|9|||
149180014|NCT03443024|538131526|FG002|Overall Study|Lost to Follow-up|7|||
148807268|NCT01140906|536773225|FG003|Overall Study|Adverse Event|7|||
148807269|NCT01140906|536773222|FG000|Overall Study|Lack of Efficacy|6|||
149180015|NCT03443024|538131527|FG003|Overall Study|Lost to Follow-up|5|||
149180016|NCT03443024|538131524|FG000|Overall Study|Withdrawal by Subject|8|||
148931239|NCT02598960|537233325|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
148931240|NCT02598960|537233326|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
149180017|NCT03443024|538131525|FG001|Overall Study|Withdrawal by Subject|15|||
149180018|NCT03443024|538131526|FG002|Overall Study|Withdrawal by Subject|9|||
149180019|NCT03443024|538131527|FG003|Overall Study|Withdrawal by Subject|23|||
149180020|NCT03443024|538131524|FG000|Overall Study|Physician Decision|1|||
149180021|NCT03443024|538131525|FG001|Overall Study|Physician Decision|2|||
149180022|NCT03443024|538131526|FG002|Overall Study|Physician Decision|0|||
149180023|NCT03443024|538131527|FG003|Overall Study|Physician Decision|1|||
149180024|NCT03443024|538131524|FG000|Overall Study|Sponsor Decision|1|||
149180025|NCT03443024|538131525|FG001|Overall Study|Sponsor Decision|1|||
149180026|NCT03443024|538131526|FG002|Overall Study|Sponsor Decision|0|||
149180027|NCT03443024|538131527|FG003|Overall Study|Sponsor Decision|0|||
149180028|NCT03443024|538131524|FG000|Overall Study|Protocol Deviation|0|||
149180029|NCT03443024|538131525|FG001|Overall Study|Protocol Deviation|0|||
149180030|NCT03443024|538131526|FG002|Overall Study|Protocol Deviation|0|||
149180031|NCT03443024|538131527|FG003|Overall Study|Protocol Deviation|2|||
149180032|NCT00301067|538131528|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
149180033|NCT00301067|538131529|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
149180034|NCT00301067|538131530|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
149180035|NCT00301067|538131531|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
149180036|NCT00301067|538131528|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
149180037|NCT00301067|538131529|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
149180038|NCT00301067|538131530|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
149180039|NCT00301067|538131531|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
149180040|NCT00301067|538131528|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
149180041|NCT00301067|538131529|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
149180042|NCT00301067|538131530|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
149180043|NCT00301067|538131531|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
149180044|NCT00301067|538131528|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
149180045|NCT00301067|538131529|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
148931241|NCT02598960|537233327|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
148931242|NCT02598960|537233328|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
148931243|NCT02598960|537233329|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
148931244|NCT02598960|537233330|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
148931245|NCT02598960|537233331|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
148931246|NCT02598960|537233332|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
148931247|NCT02598960|537233333|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
148931248|NCT02598960|537233334|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
148931249|NCT02598960|537233335|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
148931250|NCT01846104|537233337|FG000|Overall Study|Withdrawal by Subject|1|||
148931251|NCT00851630|537233338|FG000|Overall Study|Death|2|||
148931252|NCT00851630|537233339|FG001|Overall Study|Death|1|||
148931253|NCT00851630|537233338|FG000|Overall Study|Clinical failure|0|||
148931254|NCT00851630|537233339|FG001|Overall Study|Clinical failure|1|||
148931255|NCT00398411|537233340|FG000|Overall Study|Death|0|||
148931256|NCT00398411|537233341|FG001|Overall Study|Death|1|||
148931257|NCT01397162|537233342|FG000|Overall Study|Adverse Event|4|||
148931258|NCT01397162|537233343|FG001|Overall Study|Adverse Event|0|||
148931259|NCT01397162|537233344|FG002|Overall Study|Adverse Event|0|||
149180046|NCT00301067|538131530|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
149180047|NCT00301067|538131531|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
149180048|NCT00301067|538131528|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
149180049|NCT00301067|538131529|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
149180050|NCT00301067|538131530|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
149180051|NCT00301067|538131531|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
149180052|NCT00301067|538131528|FG000|Follow up Until Death|Alive at last data cut point|1|||
149180053|NCT00301067|538131529|FG001|Follow up Until Death|Alive at last data cut point|0|||
149180054|NCT00301067|538131530|FG002|Follow up Until Death|Alive at last data cut point|0|||
149180055|NCT00301067|538131531|FG003|Follow up Until Death|Alive at last data cut point|1|||
149180056|NCT00149825|538131532|FG000|Overall Study|Intolerance to medication side effects|1|||
148807270|NCT01140906|536773223|FG001|Overall Study|Lack of Efficacy|8|||
148931260|NCT01397162|537233345|FG003|Overall Study|Adverse Event|0|||
148931261|NCT01397162|537233346|FG004|Overall Study|Adverse Event|0|||
149013627|NCT02761629|537529226|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
148931262|NCT01397162|537233342|FG000|Overall Study|Not yet defined|3|||
148931263|NCT01397162|537233343|FG001|Overall Study|Not yet defined|4|||
149180057|NCT00149825|538131533|FG001|Overall Study|Intolerance to medication side effects|2|||
148931264|NCT01397162|537233344|FG002|Overall Study|Not yet defined|3|||
149180058|NCT00149825|538131532|FG000|Overall Study|Time commitments|2|||
149180059|NCT00149825|538131533|FG001|Overall Study|Time commitments|1|||
149180060|NCT00149825|538131532|FG000|Overall Study|Not liking insomnia therapy|1|||
149180061|NCT00149825|538131533|FG001|Overall Study|Not liking insomnia therapy|0|||
149180062|NCT00149825|538131532|FG000|Overall Study|Other|1|||
149180063|NCT00149825|538131533|FG001|Overall Study|Other|0|||
149180064|NCT01359982|538131534|FG000|Overall Study|Adverse Event|2|||
149180065|NCT01359982|538131535|FG001|Overall Study|Adverse Event|0|||
149180066|NCT01359982|538131536|FG002|Overall Study|Adverse Event|0|||
149180067|NCT01359982|538131537|FG003|Overall Study|Adverse Event|1|||
149180068|NCT01359982|538131538|FG004|Overall Study|Adverse Event|0|||
149180069|NCT01359982|538131539|FG005|Overall Study|Adverse Event|0|||
149180070|NCT01359982|538131534|FG000|Overall Study|Death|1|||
149180071|NCT01359982|538131535|FG001|Overall Study|Death|0|||
149180072|NCT01359982|538131536|FG002|Overall Study|Death|0|||
149180073|NCT01359982|538131537|FG003|Overall Study|Death|0|||
149180074|NCT01359982|538131538|FG004|Overall Study|Death|0|||
149180075|NCT01359982|538131539|FG005|Overall Study|Death|0|||
149180076|NCT02609399|538131540|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
149180077|NCT02609399|538131541|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
149180078|NCT02609399|538131540|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
149180079|NCT02609399|538131541|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
149180080|NCT02609399|538131540|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
149180081|NCT02609399|538131541|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
149180082|NCT02453841|538131542|FG000|Overall Study|Protocol Violation|1|||
149180083|NCT02453841|538131542|FG000|Overall Study|Unable to obtain blood samples|2|||
149180084|NCT00970294|538131545|FG000|Overall Study|Physician Decision|4|||
149180085|NCT00970294|538131545|FG000|Overall Study|Withdrawal by Subject|1|||
149180086|NCT04579393|538131548|FG000|Overall Study|Withdrawal by Subject|2|||
149180087|NCT04579393|538131549|FG001|Overall Study|Withdrawal by Subject|2|||
149180088|NCT04579393|538131548|FG000|Overall Study|Death|1|||
149180089|NCT04579393|538131549|FG001|Overall Study|Death|3|||
149180090|NCT01333189|538131550|FG000|Overall Study|Time constraints|1|||
149180091|NCT01333189|538131551|FG001|Overall Study|Time constraints|0|||
149180092|NCT01333189|538131550|FG000|Overall Study|Adverse Event|1|||
149180093|NCT01333189|538131551|FG001|Overall Study|Adverse Event|0|||
149180094|NCT01333189|538131550|FG000|Overall Study|Transportation difficulties|0|||
149180095|NCT01333189|538131551|FG001|Overall Study|Transportation difficulties|1|||
149180096|NCT01333189|538131550|FG000|Overall Study|Moved from region|0|||
149180097|NCT01333189|538131551|FG001|Overall Study|Moved from region|1|||
149180098|NCT01739595|538131553|FG000|Overall Study|Adverse Event|3|||
149180099|NCT01739595|538131554|FG001|Overall Study|Adverse Event|0|||
149180100|NCT01739595|538131555|FG002|Overall Study|Adverse Event|0|||
149180101|NCT01739595|538131553|FG000|Overall Study|Lost to Follow-up|2|||
149180102|NCT01739595|538131554|FG001|Overall Study|Lost to Follow-up|0|||
149180103|NCT01739595|538131555|FG002|Overall Study|Lost to Follow-up|0|||
149180104|NCT01739595|538131553|FG000|Overall Study|Withdrawal by Subject|2|||
149180105|NCT01739595|538131554|FG001|Overall Study|Withdrawal by Subject|1|||
149180106|NCT01739595|538131555|FG002|Overall Study|Withdrawal by Subject|2|||
149180107|NCT01739595|538131553|FG000|Overall Study|Eligibility issue|3|||
149180108|NCT01739595|538131554|FG001|Overall Study|Eligibility issue|0|||
149180109|NCT01739595|538131555|FG002|Overall Study|Eligibility issue|0|||
149180110|NCT01739595|538131553|FG000|Overall Study|Protocol Violation|1|||
149180111|NCT01739595|538131554|FG001|Overall Study|Protocol Violation|0|||
149180112|NCT01739595|538131555|FG002|Overall Study|Protocol Violation|0|||
149180113|NCT01739595|538131553|FG000|Overall Study|Lab assessment|1|||
149180114|NCT01739595|538131554|FG001|Overall Study|Lab assessment|0|||
149180115|NCT01739595|538131555|FG002|Overall Study|Lab assessment|0|||
149180116|NCT01739595|538131553|FG000|Overall Study|Drug discrepancy|1|||
149180117|NCT01739595|538131554|FG001|Overall Study|Drug discrepancy|0|||
149180118|NCT01739595|538131555|FG002|Overall Study|Drug discrepancy|0|||
149180119|NCT00393458|538131556|FG000|Overall Study|Adverse Event|35|||
149180120|NCT00393458|538131557|FG001|Overall Study|Adverse Event|24|||
149180121|NCT00393458|538131558|FG002|Overall Study|Adverse Event|40|||
149180122|NCT00393458|538131559|FG003|Overall Study|Adverse Event|35|||
149180123|NCT00393458|538131556|FG000|Overall Study|Subject withdrew consent|27|||
149180124|NCT00393458|538131557|FG001|Overall Study|Subject withdrew consent|40|||
149180125|NCT00393458|538131558|FG002|Overall Study|Subject withdrew consent|33|||
148931265|NCT01397162|537233345|FG003|Overall Study|Not yet defined|5|||
149180126|NCT00393458|538131559|FG003|Overall Study|Subject withdrew consent|50|||
149180127|NCT00393458|538131556|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
149180128|NCT00393458|538131557|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
149180129|NCT00393458|538131558|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
149180130|NCT00393458|538131559|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
149180131|NCT00393458|538131556|FG000|Overall Study|Protocol deviation|11|||
149180132|NCT00393458|538131557|FG001|Overall Study|Protocol deviation|11|||
149180133|NCT00393458|538131558|FG002|Overall Study|Protocol deviation|11|||
149180134|NCT00393458|538131559|FG003|Overall Study|Protocol deviation|10|||
149180135|NCT00393458|538131556|FG000|Overall Study|Administrative problems|7|||
149180136|NCT00393458|538131557|FG001|Overall Study|Administrative problems|8|||
149180137|NCT00393458|538131558|FG002|Overall Study|Administrative problems|5|||
149180138|NCT00393458|538131559|FG003|Overall Study|Administrative problems|2|||
149180139|NCT00393458|538131556|FG000|Overall Study|Lost to Follow-up|5|||
149180140|NCT00393458|538131557|FG001|Overall Study|Lost to Follow-up|6|||
149180141|NCT00393458|538131558|FG002|Overall Study|Lost to Follow-up|5|||
149180142|NCT00393458|538131559|FG003|Overall Study|Lost to Follow-up|3|||
149180143|NCT00393458|538131556|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149180144|NCT00393458|538131557|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149180145|NCT00393458|538131558|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149180146|NCT00393458|538131559|FG003|Overall Study|Abnormal laboratory value(s)|0|||
148931266|NCT01397162|537233346|FG004|Overall Study|Not yet defined|3|||
148931267|NCT01614600|537233347|FG000|Overall Study|Unacceptable fit|1|||
148931268|NCT01614600|537233347|FG000|Overall Study|Discomfort|1|||
148931269|NCT01614600|537233347|FG000|Overall Study|Unable to remove lens at the end of day|1|||
148931270|NCT01614600|537233347|FG000|Overall Study|Protocol deviation|1|||
148931271|NCT02231918|537233348|FG000|Overall Study|Withdrawal by Subject|0|||
148931272|NCT02231918|537233349|FG001|Overall Study|Withdrawal by Subject|1|||
148931273|NCT02231918|537233350|FG002|Overall Study|Withdrawal by Subject|0|||
148931274|NCT02231918|537233348|FG000|Overall Study|Adverse Event|0|||
148931275|NCT02231918|537233349|FG001|Overall Study|Adverse Event|0|||
148931276|NCT02231918|537233350|FG002|Overall Study|Adverse Event|1|||
148931277|NCT00137631|537233358|FG000|Overall Study|Lost to Follow-up|37|||
148931278|NCT00137631|537233359|FG001|Overall Study|Lost to Follow-up|41|||
148931279|NCT00085709|537233360|FG000|Overall Study|Adverse Event|8|||
148931280|NCT00085709|537233361|FG001|Overall Study|Adverse Event|0|||
148931281|NCT00085709|537233360|FG000|Overall Study|Death|8|||
148931282|NCT00085709|537233361|FG001|Overall Study|Death|2|||
148931283|NCT00085709|537233360|FG000|Overall Study|Refusal unrelated to adverse events|1|||
148931284|NCT00085709|537233361|FG001|Overall Study|Refusal unrelated to adverse events|2|||
148931285|NCT00085709|537233360|FG000|Overall Study|Progression|3|||
148931286|NCT00085709|537233361|FG001|Overall Study|Progression|4|||
148931287|NCT00085709|537233360|FG000|Overall Study|Not protocol specified|12|||
148931288|NCT00085709|537233361|FG001|Overall Study|Not protocol specified|22|||
148931289|NCT00085709|537233360|FG000|Overall Study|Not eligible|19|||
148931290|NCT00085709|537233361|FG001|Overall Study|Not eligible|19|||
148931291|NCT00085709|537233360|FG000|Overall Study|Withdrawal by Subject|2|||
148931292|NCT00085709|537233361|FG001|Overall Study|Withdrawal by Subject|1|||
148931293|NCT00293215|537233362|FG000|Overall Study|Progressive disease|3|||
148931294|NCT00293215|537233363|FG001|Overall Study|Progressive disease|1|||
148931295|NCT00293215|537233362|FG000|Overall Study|Adverse Event|2|||
148931296|NCT00293215|537233363|FG001|Overall Study|Adverse Event|2|||
148931297|NCT03026088|537233364|FG000|Overall Study|Study termination|20|||
148931298|NCT03923738|537233365|FG000|Period 1|Adverse Event|1|||
148931299|NCT03923738|537233365|FG000|Period 1|Withdrawal by Subject|1|||
148931300|NCT03583164|537233369|FG000|Overall Study|Death in Main Phase|35|||
148931301|NCT03583164|537233369|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
148931302|NCT03583164|537233369|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
148931303|NCT03583164|537233369|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
148931304|NCT03583164|537233369|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
148931305|NCT03583164|537233369|FG000|Overall Study|Physician decision in Main Phase|1|||
148931306|NCT03583164|537233369|FG000|Overall Study|Physician decision in Extended Phase|2|||
148931307|NCT03583164|537233369|FG000|Overall Study|Death in Extended Phase|13|||
148931308|NCT03583164|537233369|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
148931309|NCT03583164|537233369|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
148931310|NCT03583164|537233369|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
148931311|NCT03583164|537233369|FG000|Overall Study|Treatment failure in Main Phase|2|||
148931312|NCT03583164|537233369|FG000|Overall Study|Treatment failure in Extended Phase|4|||
148931313|NCT03583164|537233369|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
148931314|NCT03583164|537233369|FG000|Overall Study|Other not specified reason in Main Phase|2|||
148931315|NCT00735254|537233370|FG000|Overall Study|Protocol Violation|1|||
148931316|NCT00735254|537233371|FG001|Overall Study|Protocol Violation|1|||
148931317|NCT00735254|537233372|FG002|Overall Study|Protocol Violation|1|||
148931318|NCT00735254|537233373|FG003|Overall Study|Protocol Violation|0|||
148931319|NCT00751621|537233378|FG000|Overall Study|Adverse Event|1|||
148931320|NCT00751621|537233378|FG000|Overall Study|Withdrawal by Subject|1|||
148931321|NCT00751621|537233378|FG000|Overall Study|Subject moved to another country|1|||
148931322|NCT00751621|537233378|FG000|Overall Study|Poor adherence to asthma treatment|1|||
149180147|NCT00393458|538131556|FG000|Overall Study|Death|1|||
149180148|NCT00393458|538131557|FG001|Overall Study|Death|1|||
149180149|NCT00393458|538131558|FG002|Overall Study|Death|5|||
149180150|NCT00393458|538131559|FG003|Overall Study|Death|5|||
148931323|NCT00573248|537233381|FG000|Overall Study|scheduling conflicts|15|||
148931324|NCT00573248|537233382|FG001|Overall Study|scheduling conflicts|11|||
148931325|NCT04508140|537233385|FG000|Overall Study|Adverse Event|2|||
148931326|NCT04508140|537233386|FG001|Overall Study|Adverse Event|2|||
148931327|NCT04508140|537233385|FG000|Overall Study|Withdrawal by Subject|0|||
149180151|NCT00393458|538131556|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149180152|NCT00393458|538131557|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148931328|NCT04508140|537233386|FG001|Overall Study|Withdrawal by Subject|2|||
148931329|NCT04508140|537233385|FG000|Overall Study|progressive disease|9|||
148931330|NCT04508140|537233386|FG001|Overall Study|progressive disease|3|||
148931331|NCT03059446|537233387|FG000|Overall Study|Adverse Event|11|||
148931332|NCT03059446|537233387|FG000|Overall Study|Withdrawal of Consent|16|||
149180153|NCT00393458|538131558|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149180154|NCT00393458|538131559|FG003|Overall Study|Abnormal test procedure result(s)|2|||
149180155|NCT00393458|538131556|FG000|Overall Study|Subject no longer requires study drug|0|||
149180156|NCT00393458|538131557|FG001|Overall Study|Subject no longer requires study drug|1|||
149180157|NCT00393458|538131558|FG002|Overall Study|Subject no longer requires study drug|0|||
149180158|NCT00393458|538131559|FG003|Overall Study|Subject no longer requires study drug|0|||
149180159|NCT01282814|538131566|FG000|First Intervention|Emesis During Dosing Interval|0|||
149180160|NCT01282814|538131567|FG001|First Intervention|Emesis During Dosing Interval|3|||
149180161|NCT01282814|538131566|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
149180162|NCT01282814|538131567|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149180163|NCT01524289|538131568|FG000|Overall Study|Lost to Follow-up|0|||
149180164|NCT01524289|538131569|FG001|Overall Study|Lost to Follow-up|1|||
149013628|NCT02761629|537529227|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
149180165|NCT01524289|538131568|FG000|Overall Study|Physician Decision|1|||
149180166|NCT01524289|538131569|FG001|Overall Study|Physician Decision|0|||
149180167|NCT01524289|538131568|FG000|Overall Study|Protocol Violation|5|||
149180168|NCT01524289|538131569|FG001|Overall Study|Protocol Violation|1|||
149180169|NCT01524289|538131568|FG000|Overall Study|Withdrawal by Subject|11|||
149180170|NCT01524289|538131569|FG001|Overall Study|Withdrawal by Subject|7|||
149180171|NCT01524289|538131568|FG000|Overall Study|Adverse Event|12|||
149180172|NCT01524289|538131569|FG001|Overall Study|Adverse Event|5|||
149180173|NCT01524289|538131568|FG000|Overall Study|Did not take study medication|1|||
149180174|NCT01524289|538131569|FG001|Overall Study|Did not take study medication|0|||
149180175|NCT02104180|538131570|FG000|Overall Study|Protocol Violation|1|||
149180176|NCT02104180|538131571|FG001|Overall Study|Protocol Violation|0|||
149180177|NCT01326962|538131574|FG000|Overall Study|Adverse Event|1|||
149180178|NCT01326962|538131574|FG000|Overall Study|Withdrawal by Subject|1|||
149180179|NCT01326962|538131574|FG000|Overall Study|Lost to Follow-up|3|||
149180180|NCT01326962|538131574|FG000|Overall Study|Other|2|||
149180181|NCT00793585|538131575|FG000|Overall Study|Adverse Event|1|||
149180182|NCT00793585|538131576|FG001|Overall Study|Adverse Event|1|||
149180183|NCT00793585|538131575|FG000|Overall Study|Protocol Violation|1|||
149180184|NCT00793585|538131576|FG001|Overall Study|Protocol Violation|2|||
149180185|NCT00035815|538131579|FG000|Overall Study|Withdrawal by Subject|17|||
149180186|NCT00035815|538131580|FG001|Overall Study|Withdrawal by Subject|11|||
149180187|NCT02209597|538131581|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
149180188|NCT02209597|538131581|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
149180189|NCT02209597|538131581|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
149180190|NCT02209597|538131581|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
149180191|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Adverse Event|37|||
149180192|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Adverse Event|0|||
149180193|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Adverse Event|0|||
148931333|NCT03059446|537233387|FG000|Overall Study|Lost to Follow-up|3|||
148931334|NCT03059446|537233387|FG000|Overall Study|Protocol Violation|1|||
148931335|NCT03059446|537233387|FG000|Overall Study|Study Terminated by Sponsor|131|||
148931336|NCT03059446|537233387|FG000|Overall Study|Reason not Specified|5|||
148931337|NCT00586066|537233388|FG000|Overall Study|Lost to Follow-up|6|||
149013629|NCT02761629|537529226|FG000|Overall Study|Insufficient Therapeutic Response|2|||
149013630|NCT02761629|537529227|FG001|Overall Study|Insufficient Therapeutic Response|7|||
149180194|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Adverse Event|0|||
149180195|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Death|2|||
149180196|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Death|0|||
149180197|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Death|0|||
149180198|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Death|0|||
149180199|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
149180200|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
149180201|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
149180202|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
149180203|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
149233995|NCT01422876|538326351|FG005|Week 24|Death|0|||
148931338|NCT00586066|537233389|FG001|Overall Study|Lost to Follow-up|3|||
148931339|NCT00586066|537233388|FG000|Overall Study|Lack of Efficacy|5|||
148931340|NCT00586066|537233389|FG001|Overall Study|Lack of Efficacy|3|||
148931341|NCT00586066|537233388|FG000|Overall Study|Adverse Event|2|||
149233996|NCT01422876|538326352|FG006|Week 24|Death|0|||
149233997|NCT01422876|538326353|FG007|Week 24|Death|0|||
149233998|NCT01422876|538326354|FG008|Week 24|Death|0|||
149233999|NCT01422876|538326355|FG009|Week 24|Death|0|||
149234000|NCT01422876|538326346|FG000|Week 52|Lost to Follow-up|3|||
149234001|NCT01422876|538326347|FG001|Week 52|Lost to Follow-up|5|||
149234002|NCT01422876|538326348|FG002|Week 52|Lost to Follow-up|7|||
149234003|NCT01422876|538326349|FG003|Week 52|Lost to Follow-up|5|||
148931342|NCT00586066|537233389|FG001|Overall Study|Adverse Event|2|||
148931343|NCT00586066|537233388|FG000|Overall Study|Physician Decision|1|||
148931344|NCT00586066|537233389|FG001|Overall Study|Physician Decision|0|||
148931345|NCT00586066|537233388|FG000|Overall Study|Withdrawal of consent|4|||
148931346|NCT00586066|537233389|FG001|Overall Study|Withdrawal of consent|2|||
148931347|NCT02676466|537233390|FG000|Overall Study|Death|0|||
148931348|NCT02676466|537233391|FG001|Overall Study|Death|2|||
148931349|NCT02676466|537233392|FG002|Overall Study|Death|1|||
148931350|NCT02676466|537233393|FG003|Overall Study|Death|0|||
148931351|NCT02676466|537233394|FG004|Overall Study|Death|0|||
148931352|NCT02676466|537233395|FG005|Overall Study|Death|0|||
148931353|NCT02676466|537233396|FG006|Overall Study|Death|0|||
148931354|NCT02676466|537233397|FG007|Overall Study|Death|0|||
148931355|NCT02676466|537233390|FG000|Overall Study|Withdrawal by Subject|4|||
149180204|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
149180205|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
149180206|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
149180207|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
149180208|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
149180209|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
149180210|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
149180211|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
149180212|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
149180213|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
149180214|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
149180215|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Physician Decision|4|||
149180216|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Physician Decision|0|||
149180217|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Physician Decision|0|||
149180218|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Physician Decision|0|||
149180219|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Pregnancy|1|||
149180220|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Pregnancy|0|||
149180221|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Pregnancy|0|||
149180222|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Pregnancy|0|||
149180223|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
149180224|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
149180225|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
149180226|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
149180227|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
149180228|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
149180229|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
149180230|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
149180231|NCT01855789|538131583|FG000|1) Baseline up to Week 24|Other|4|||
149180232|NCT01855789|538131584|FG001|1) Baseline up to Week 24|Other|0|||
149180233|NCT01855789|538131585|FG002|1) Baseline up to Week 24|Other|0|||
149180234|NCT01855789|538131586|FG003|1) Baseline up to Week 24|Other|0|||
149180235|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
149180236|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
149180237|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
149180238|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
149180239|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
149180240|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
149180241|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
149180242|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
148931356|NCT02676466|537233391|FG001|Overall Study|Withdrawal by Subject|3|||
148931357|NCT02676466|537233392|FG002|Overall Study|Withdrawal by Subject|1|||
148931358|NCT02676466|537233393|FG003|Overall Study|Withdrawal by Subject|0|||
148931359|NCT02676466|537233394|FG004|Overall Study|Withdrawal by Subject|3|||
148931360|NCT02676466|537233395|FG005|Overall Study|Withdrawal by Subject|1|||
148931361|NCT02676466|537233396|FG006|Overall Study|Withdrawal by Subject|1|||
148931362|NCT02676466|537233397|FG007|Overall Study|Withdrawal by Subject|1|||
148931363|NCT00908011|537233399|FG000|Overall Study|Withdrawal by Subject|2|||
148931364|NCT00908011|537233400|FG001|Overall Study|Withdrawal by Subject|2|||
148931365|NCT00760084|537233411|FG000|Overall Study|Physician Decision|5|||
148931366|NCT00760084|537233411|FG000|Overall Study|Withdrawal by Subject|2|||
149180243|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
148931367|NCT00760084|537233411|FG000|Overall Study|Progressive Disease|3|||
148931368|NCT02301988|537233412|FG000|Overall Study|Withdrawal by Subject|2|||
148931369|NCT02301988|537233413|FG001|Overall Study|Withdrawal by Subject|1|||
148931370|NCT02301988|537233412|FG000|Overall Study|Physician Decision|2|||
148931371|NCT02301988|537233413|FG001|Overall Study|Physician Decision|2|||
149180244|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
149180245|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
149180246|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
149180247|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
148931372|NCT02301988|537233412|FG000|Overall Study|Unknown Reason|1|||
148931373|NCT02301988|537233413|FG001|Overall Study|Unknown Reason|3|||
148931374|NCT02301988|537233412|FG000|Overall Study|Lack of Efficacy|3|||
148931375|NCT02301988|537233413|FG001|Overall Study|Lack of Efficacy|2|||
149180248|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
149180249|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
149180250|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
149180251|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
149180252|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
149180253|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
149180254|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
149180255|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
149180256|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
149180257|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
149180258|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
149180259|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
149180260|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
149180261|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
149180262|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
149180263|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
149180264|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
148931376|NCT02301988|537233412|FG000|Overall Study|Death|1|||
148931377|NCT02301988|537233413|FG001|Overall Study|Death|0|||
148931378|NCT02301988|537233412|FG000|Overall Study|Adverse Event|1|||
149180265|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
149180266|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
149180267|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
149180268|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
149180269|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
149180270|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
149180271|NCT01855789|538131583|FG000|2) Week 24 up to End of Study|Other|0|||
149180272|NCT01855789|538131584|FG001|2) Week 24 up to End of Study|Other|0|||
149180273|NCT01855789|538131585|FG002|2) Week 24 up to End of Study|Other|0|||
149180274|NCT01855789|538131586|FG003|2) Week 24 up to End of Study|Other|1|||
149180275|NCT01863758|538131587|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
149180276|NCT01863758|538131587|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
149180277|NCT04952389|538131588|FG000|Overall Study|Withdrawal by Subject|8|||
149180278|NCT04952389|538131589|FG001|Overall Study|Withdrawal by Subject|4|||
149180279|NCT01089725|538131590|FG000|Overall Study|Adverse Event|1|||
149180280|NCT01089725|538131591|FG001|Overall Study|Adverse Event|1|||
149180281|NCT01089725|538131592|FG002|Overall Study|Adverse Event|0|||
149180282|NCT01089725|538131593|FG003|Overall Study|Adverse Event|0|||
149180283|NCT01089725|538131594|FG004|Overall Study|Adverse Event|2|||
149180284|NCT01089725|538131590|FG000|Overall Study|Lack of Efficacy|4|||
149180285|NCT01089725|538131591|FG001|Overall Study|Lack of Efficacy|3|||
149180286|NCT01089725|538131592|FG002|Overall Study|Lack of Efficacy|1|||
149180287|NCT01089725|538131593|FG003|Overall Study|Lack of Efficacy|0|||
149180288|NCT01089725|538131594|FG004|Overall Study|Lack of Efficacy|4|||
149180289|NCT01089725|538131590|FG000|Overall Study|Lost to Follow-up|2|||
149180290|NCT01089725|538131591|FG001|Overall Study|Lost to Follow-up|2|||
149180291|NCT01089725|538131592|FG002|Overall Study|Lost to Follow-up|0|||
149180292|NCT01089725|538131593|FG003|Overall Study|Lost to Follow-up|3|||
149180293|NCT01089725|538131594|FG004|Overall Study|Lost to Follow-up|0|||
149180294|NCT01089725|538131590|FG000|Overall Study|Protocol Violation|0|||
149180295|NCT01089725|538131591|FG001|Overall Study|Protocol Violation|0|||
149180296|NCT01089725|538131592|FG002|Overall Study|Protocol Violation|1|||
148807271|NCT01140906|536773224|FG002|Overall Study|Lack of Efficacy|2|||
148807272|NCT01140906|536773225|FG003|Overall Study|Lack of Efficacy|1|||
148807273|NCT01140906|536773222|FG000|Overall Study|Non-compliance|0|||
148931379|NCT02301988|537233413|FG001|Overall Study|Adverse Event|1|||
148807274|NCT01140906|536773223|FG001|Overall Study|Non-compliance|1|||
148931380|NCT02567552|537233414|FG000|Overall Study|Adverse Event|0|||
148931381|NCT02567552|537233415|FG001|Overall Study|Adverse Event|1|||
148931382|NCT02891161|537233418|FG000|Study Treatment|Disease Progression|2|||
148931383|NCT02891161|537233419|FG001|Study Treatment|Disease Progression|4|||
149180297|NCT01089725|538131593|FG003|Overall Study|Protocol Violation|1|||
149180298|NCT01089725|538131594|FG004|Overall Study|Protocol Violation|0|||
149180299|NCT01089725|538131590|FG000|Overall Study|Withdrawal by Subject|5|||
149180300|NCT01089725|538131591|FG001|Overall Study|Withdrawal by Subject|5|||
149180301|NCT01089725|538131592|FG002|Overall Study|Withdrawal by Subject|4|||
149180302|NCT01089725|538131593|FG003|Overall Study|Withdrawal by Subject|5|||
149180303|NCT01089725|538131594|FG004|Overall Study|Withdrawal by Subject|4|||
149180304|NCT01089725|538131590|FG000|Overall Study|Study Terminated by Sponsor|51|||
149180305|NCT01089725|538131591|FG001|Overall Study|Study Terminated by Sponsor|56|||
149180306|NCT01089725|538131592|FG002|Overall Study|Study Terminated by Sponsor|53|||
149180307|NCT01089725|538131593|FG003|Overall Study|Study Terminated by Sponsor|68|||
149180308|NCT01089725|538131594|FG004|Overall Study|Study Terminated by Sponsor|68|||
149180309|NCT01089725|538131590|FG000|Overall Study|Randomized, but not treated|0|||
149180310|NCT01089725|538131591|FG001|Overall Study|Randomized, but not treated|1|||
149180311|NCT01089725|538131592|FG002|Overall Study|Randomized, but not treated|2|||
148931384|NCT02891161|537233418|FG000|Study Treatment|AE/Side Effects/Complications|1|||
149180312|NCT01089725|538131593|FG003|Overall Study|Randomized, but not treated|1|||
149180313|NCT01089725|538131594|FG004|Overall Study|Randomized, but not treated|2|||
149180314|NCT01089725|538131590|FG000|Overall Study|Other|3|||
149180315|NCT01089725|538131591|FG001|Overall Study|Other|0|||
149180316|NCT01089725|538131592|FG002|Overall Study|Other|0|||
149180317|NCT01089725|538131593|FG003|Overall Study|Other|1|||
149180318|NCT01089725|538131594|FG004|Overall Study|Other|0|||
149180319|NCT01266148|538132864|FG000|Overall Study|Adverse Event|2|||
149180320|NCT01266148|538132865|FG001|Overall Study|Adverse Event|0|||
149180321|NCT01266148|538132864|FG000|Overall Study|Ongoing rejection|1|||
149180322|NCT01266148|538132865|FG001|Overall Study|Ongoing rejection|0|||
148931385|NCT02891161|537233419|FG001|Study Treatment|AE/Side Effects/Complications|5|||
148931386|NCT02891161|537233418|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
149013631|NCT02761629|537529226|FG000|Overall Study|Failure to Return|2|||
149013632|NCT02761629|537529227|FG001|Overall Study|Failure to Return|4|||
149013633|NCT02761629|537529226|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
149013634|NCT02761629|537529227|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
149013635|NCT02761629|537529226|FG000|Overall Study|Protocol Violation|2|||
149013636|NCT02761629|537529227|FG001|Overall Study|Protocol Violation|2|||
149013637|NCT02761629|537529226|FG000|Overall Study|Withdrawal by Subject|0|||
149013638|NCT02761629|537529227|FG001|Overall Study|Withdrawal by Subject|3|||
149013639|NCT02761629|537529226|FG000|Overall Study|Other|0|||
149013640|NCT02761629|537529227|FG001|Overall Study|Other|2|||
149013641|NCT02761629|537529226|FG000|Overall Study|Lost to Follow-up|4|||
149013642|NCT02761629|537529227|FG001|Overall Study|Lost to Follow-up|1|||
149013643|NCT02761629|537529226|FG000|Overall Study|Randomized But Not Treated|8|||
149013644|NCT02761629|537529227|FG001|Overall Study|Randomized But Not Treated|4|||
148807275|NCT01140906|536773224|FG002|Overall Study|Non-compliance|0|||
148931387|NCT02891161|537233419|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
148931388|NCT02891161|537233418|FG000|Follow up|Death|4|||
148931389|NCT02891161|537233419|FG001|Follow up|Death|8|||
148931390|NCT02891161|537233418|FG000|Follow up|Refused to Follow up|0|||
148931391|NCT02891161|537233419|FG001|Follow up|Refused to Follow up|2|||
148931392|NCT02891161|537233418|FG000|Follow up|Symptomatic deterioration|0|||
148931393|NCT02891161|537233419|FG001|Follow up|Symptomatic deterioration|1|||
148931394|NCT02891161|537233418|FG000|Follow up|Study terminated|0|||
148931395|NCT02891161|537233419|FG001|Follow up|Study terminated|6|||
148931396|NCT02750943|537233420|FG000|Overall Study|Lost to Follow-up|1|||
148931397|NCT02750943|537233421|FG001|Overall Study|Lost to Follow-up|2|||
148931398|NCT02750943|537233420|FG000|Overall Study|Withdrawal by Subject|5|||
148931399|NCT02750943|537233421|FG001|Overall Study|Withdrawal by Subject|7|||
148931400|NCT01074047|537233428|FG000|Treatment Phase|Adverse Event|89|||
148931401|NCT01074047|537233429|FG001|Treatment Phase|Adverse Event|66|||
148931402|NCT01074047|537233428|FG000|Treatment Phase|Disease Progression|16|||
148931403|NCT01074047|537233429|FG001|Treatment Phase|Disease Progression|21|||
148931404|NCT01074047|537233428|FG000|Treatment Phase|Withdrawal by Subject|27|||
148931405|NCT01074047|537233429|FG001|Treatment Phase|Withdrawal by Subject|48|||
148931406|NCT01074047|537233428|FG000|Treatment Phase|Death|53|||
148931407|NCT01074047|537233429|FG001|Treatment Phase|Death|58|||
149013645|NCT00562978|537529228|FG000|Overall Study|Patient had imaging dose only|1|||
148931408|NCT01074047|537233428|FG000|Treatment Phase|Lost to Follow-up|0|||
149013646|NCT00562978|537529229|FG001|Overall Study|Patient had imaging dose only|11|||
149180323|NCT01266148|538132864|FG000|Overall Study|2 2R rejections|1|||
149180324|NCT01266148|538132865|FG001|Overall Study|2 2R rejections|0|||
149180325|NCT01266148|538132864|FG000|Overall Study|Death|2|||
149180326|NCT01266148|538132865|FG001|Overall Study|Death|3|||
149180327|NCT01266148|538132864|FG000|Overall Study|missing mGFR value + AE|1|||
148931409|NCT01074047|537233429|FG001|Treatment Phase|Lost to Follow-up|1|||
148931410|NCT01074047|537233428|FG000|Treatment Phase|Protocol Violation|0|||
148931411|NCT01074047|537233429|FG001|Treatment Phase|Protocol Violation|1|||
148931412|NCT01074047|537233428|FG000|Treatment Phase|Miscellaneous|32|||
148931413|NCT01074047|537233429|FG001|Treatment Phase|Miscellaneous|39|||
148931414|NCT01074047|537233428|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
149013647|NCT00936221|537529233|FG000|Overall Study|Withdrawal by Subject|1|||
149013648|NCT00936221|537529234|FG001|Overall Study|Withdrawal by Subject|1|||
149013649|NCT01348776|537529235|FG000|Overall Study|Lost to Follow-up|3|||
149013650|NCT04362137|537529239|FG000|Overall Study|Death|9|||
149013651|NCT04362137|537529240|FG001|Overall Study|Death|3|||
149013652|NCT04362137|537529239|FG000|Overall Study|Patient decision|6|||
149013653|NCT04362137|537529240|FG001|Overall Study|Patient decision|3|||
149013654|NCT04362137|537529239|FG000|Overall Study|Adverse Event|1|||
149013655|NCT04362137|537529240|FG001|Overall Study|Adverse Event|0|||
149013656|NCT04362137|537529239|FG000|Overall Study|Lost to Follow-up|1|||
149013657|NCT04362137|537529240|FG001|Overall Study|Lost to Follow-up|0|||
149013658|NCT04362137|537529239|FG000|Overall Study|Protocol deviation|1|||
149013659|NCT04362137|537529240|FG001|Overall Study|Protocol deviation|0|||
149013660|NCT01121484|537529244|FG000|Overall Study|Adverse Event|12|||
149013661|NCT01121484|537529245|FG001|Overall Study|Adverse Event|5|||
149013662|NCT01121484|537529244|FG000|Overall Study|Lack of Efficacy|3|||
149013663|NCT01121484|537529245|FG001|Overall Study|Lack of Efficacy|11|||
149013664|NCT01121484|537529244|FG000|Overall Study|Lost to Follow-up|5|||
149013665|NCT01121484|537529245|FG001|Overall Study|Lost to Follow-up|9|||
149013666|NCT01121484|537529244|FG000|Overall Study|Physician Decision|0|||
149013667|NCT01121484|537529245|FG001|Overall Study|Physician Decision|3|||
149013668|NCT01121484|537529244|FG000|Overall Study|Protocol Violation|1|||
149013669|NCT01121484|537529245|FG001|Overall Study|Protocol Violation|0|||
149013670|NCT01121484|537529244|FG000|Overall Study|Withdrawal by Subject|8|||
149013671|NCT01121484|537529245|FG001|Overall Study|Withdrawal by Subject|7|||
149013672|NCT01121484|537529244|FG000|Overall Study|Discontinuation of study by sponsor|0|||
149013673|NCT01121484|537529245|FG001|Overall Study|Discontinuation of study by sponsor|1|||
149013674|NCT01121484|537529244|FG000|Overall Study|Other|3|||
149013675|NCT01121484|537529245|FG001|Overall Study|Other|3|||
149013676|NCT01121484|537529244|FG000|Overall Study|Randomized, not treated|1|||
149013677|NCT01121484|537529245|FG001|Overall Study|Randomized, not treated|4|||
149013678|NCT02204579|537529249|FG000|Overall Study|Screen failures|2|||
149013679|NCT03176238|537529252|FG000|Overall Study|Unacceptable AEs|15|||
149013680|NCT03176238|537529253|FG001|Overall Study|Unacceptable AEs|8|||
149013681|NCT03176238|537529252|FG000|Overall Study|Abnormal lab value(s)|2|||
149013682|NCT03176238|537529253|FG001|Overall Study|Abnormal lab value(s)|0|||
149013683|NCT03176238|537529252|FG000|Overall Study|Inter-current illness|0|||
149013684|NCT03176238|537529253|FG001|Overall Study|Inter-current illness|1|||
149013685|NCT03176238|537529252|FG000|Overall Study|Consent withdrawal|14|||
149013686|NCT03176238|537529253|FG001|Overall Study|Consent withdrawal|2|||
149013687|NCT03176238|537529252|FG000|Overall Study|Lost to Follow-up|3|||
149013688|NCT03176238|537529253|FG001|Overall Study|Lost to Follow-up|0|||
149013689|NCT03176238|537529252|FG000|Overall Study|Administrative problems|1|||
149013690|NCT03176238|537529253|FG001|Overall Study|Administrative problems|0|||
149013691|NCT03176238|537529252|FG000|Overall Study|Death|3|||
149013692|NCT03176238|537529253|FG001|Overall Study|Death|0|||
149013693|NCT03176238|537529252|FG000|Overall Study|Disease Progression|133|||
149013694|NCT03176238|537529253|FG001|Overall Study|Disease Progression|22|||
149013695|NCT03176238|537529252|FG000|Overall Study|Tx duration completed per EAP|0|||
149013696|NCT03176238|537529253|FG001|Overall Study|Tx duration completed per EAP|1|||
149013697|NCT03176238|537529252|FG000|Overall Study|Patient is switched to commercial drug|16|||
149013698|NCT03176238|537529253|FG001|Overall Study|Patient is switched to commercial drug|1|||
149013699|NCT03176238|537529252|FG000|Overall Study|Protocol Violation|1|||
149013700|NCT03176238|537529253|FG001|Overall Study|Protocol Violation|0|||
149013701|NCT03176238|537529252|FG000|Overall Study|Changes in the patient's condition|2|||
149013702|NCT03176238|537529253|FG001|Overall Study|Changes in the patient's condition|1|||
149013703|NCT03176238|537529252|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
149013704|NCT03176238|537529253|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
149013705|NCT03556358|537529254|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
149013706|NCT03556358|537529255|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
149013707|NCT03556358|537529254|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
149013708|NCT03556358|537529255|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
149013709|NCT03556358|537529254|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
149013710|NCT03556358|537529255|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
149013711|NCT03556358|537529254|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
149013712|NCT03556358|537529255|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
149013713|NCT03556358|537529254|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
149013714|NCT03556358|537529255|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
149013715|NCT03556358|537529254|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
149013716|NCT03556358|537529255|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
149013717|NCT03556358|537529254|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
149013718|NCT03556358|537529255|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
149013719|NCT01065350|537529257|FG000|Overall Study|Received incorrect drug allocation|0|||
149013720|NCT01065350|537529258|FG001|Overall Study|Received incorrect drug allocation|1|||
149013721|NCT02875834|537529261|FG000|Open-label Phase|Withdrawal by Subject|3|||
149013722|NCT02875834|537529262|FG001|Open-label Phase|Withdrawal by Subject|0|||
149013723|NCT02875834|537529263|FG002|Open-label Phase|Withdrawal by Subject|0|||
149013724|NCT02875834|537529264|FG003|Open-label Phase|Withdrawal by Subject|0|||
149013725|NCT02875834|537529261|FG000|Open-label Phase|(Not collected)|4|||
149013726|NCT02875834|537529262|FG001|Open-label Phase|(Not collected)|0|||
149013727|NCT02875834|537529263|FG002|Open-label Phase|(Not collected)|0|||
149013728|NCT02875834|537529264|FG003|Open-label Phase|(Not collected)|0|||
149013729|NCT02875834|537529261|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
149013730|NCT02875834|537529262|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
149013731|NCT02875834|537529263|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
149013732|NCT02875834|537529264|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
149013733|NCT02875834|537529261|FG000|Randomized Treatment Phase|Protocol Violation|0|||
149013734|NCT02875834|537529262|FG001|Randomized Treatment Phase|Protocol Violation|2|||
149013735|NCT02875834|537529263|FG002|Randomized Treatment Phase|Protocol Violation|0|||
149013736|NCT02875834|537529264|FG003|Randomized Treatment Phase|Protocol Violation|0|||
149013737|NCT02875834|537529261|FG000|Randomized Treatment Phase|(Not collected)|0|||
149013738|NCT02875834|537529262|FG001|Randomized Treatment Phase|(Not collected)|9|||
149013739|NCT02875834|537529263|FG002|Randomized Treatment Phase|(Not collected)|10|||
149013740|NCT02875834|537529264|FG003|Randomized Treatment Phase|(Not collected)|9|||
149013741|NCT05200936|537529266|FG000|Overall Study|Withdrawal by Subject|2|||
149013742|NCT05200936|537529267|FG001|Overall Study|Withdrawal by Subject|2|||
149013743|NCT05200936|537529266|FG000|Overall Study|Lost to Follow-up|2|||
149013744|NCT05200936|537529267|FG001|Overall Study|Lost to Follow-up|0|||
149013745|NCT05200936|537529266|FG000|Overall Study|Pregnancy|0|||
149013746|NCT05200936|537529267|FG001|Overall Study|Pregnancy|1|||
149013747|NCT00539279|537529268|FG000|Treatment|Withdrawal by Subject|10|||
149013748|NCT00539279|537529269|FG001|Treatment|Withdrawal by Subject|8|||
149013749|NCT00539279|537529268|FG000|Treatment|Death|1|||
149013750|NCT00539279|537529269|FG001|Treatment|Death|0|||
149013751|NCT00539279|537529268|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
149013752|NCT00539279|537529269|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
149013753|NCT00539279|537529268|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
149013754|NCT00539279|537529269|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
149013755|NCT00251927|537530748|FG000|Overall Study|Adverse Event|3|||
149013756|NCT00251927|537530749|FG001|Overall Study|Adverse Event|15|||
149013757|NCT00251927|537530748|FG000|Overall Study|Lack of Efficacy|22|||
149013758|NCT00251927|537530749|FG001|Overall Study|Lack of Efficacy|16|||
149013759|NCT00251927|537530748|FG000|Overall Study|Lost to Follow-up|22|||
149013760|NCT00251927|537530749|FG001|Overall Study|Lost to Follow-up|8|||
149013761|NCT00251927|537530748|FG000|Overall Study|Protocol Violation|1|||
149013762|NCT00251927|537530749|FG001|Overall Study|Protocol Violation|2|||
149013763|NCT00251927|537530748|FG000|Overall Study|Pregnancy|2|||
149013764|NCT00251927|537530749|FG001|Overall Study|Pregnancy|0|||
149013765|NCT00251927|537530748|FG000|Overall Study|Withdrawal by Subject|40|||
149013766|NCT00251927|537530749|FG001|Overall Study|Withdrawal by Subject|25|||
149013767|NCT00251927|537530748|FG000|Overall Study|Study-specific discont. achieved|13|||
149013768|NCT00251927|537530749|FG001|Overall Study|Study-specific discont. achieved|2|||
149013769|NCT00251927|537530748|FG000|Overall Study|Study procedure non-compliance|5|||
149013770|NCT00251927|537530749|FG001|Overall Study|Study procedure non-compliance|6|||
149013771|NCT00452413|537530753|FG000|Overall Study|Progressive Disease|4|||
149013772|NCT00452413|537530754|FG001|Overall Study|Progressive Disease|11|||
149013773|NCT00452413|537530755|FG002|Overall Study|Progressive Disease|30|||
149013774|NCT00452413|537530753|FG000|Overall Study|Withdrawal by Subject|0|||
149013775|NCT00452413|537530754|FG001|Overall Study|Withdrawal by Subject|1|||
149013776|NCT00452413|537530755|FG002|Overall Study|Withdrawal by Subject|4|||
149013777|NCT00452413|537530753|FG000|Overall Study|Adverse Event|0|||
149013778|NCT00452413|537530754|FG001|Overall Study|Adverse Event|0|||
149013779|NCT00452413|537530755|FG002|Overall Study|Adverse Event|5|||
149013780|NCT00452413|537530753|FG000|Overall Study|Physician Decision|0|||
149013781|NCT00452413|537530754|FG001|Overall Study|Physician Decision|0|||
149013782|NCT00452413|537530755|FG002|Overall Study|Physician Decision|4|||
149013783|NCT00452413|537530753|FG000|Overall Study|Death due to study disease|0|||
149013784|NCT00452413|537530754|FG001|Overall Study|Death due to study disease|0|||
148807276|NCT01140906|536773225|FG003|Overall Study|Non-compliance|1|||
149013785|NCT00452413|537530755|FG002|Overall Study|Death due to study disease|2|||
149013786|NCT00452413|537530753|FG000|Overall Study|Death due to adverse event (AE)|0|||
149013787|NCT00452413|537530754|FG001|Overall Study|Death due to adverse event (AE)|0|||
149013788|NCT00452413|537530755|FG002|Overall Study|Death due to adverse event (AE)|1|||
149013789|NCT00452413|537530753|FG000|Overall Study|On treatment|0|||
149013790|NCT00452413|537530754|FG001|Overall Study|On treatment|0|||
149013791|NCT00452413|537530755|FG002|Overall Study|On treatment|3|||
149013792|NCT03119610|537530757|FG000|Overall Study|Adverse Event|1|||
149013793|NCT03119610|537530758|FG001|Overall Study|Adverse Event|0|||
149013794|NCT03119610|537530757|FG000|Overall Study|Lost to Follow-up|0|||
149013795|NCT03119610|537530758|FG001|Overall Study|Lost to Follow-up|1|||
149013796|NCT03283696|537530783|FG000|Overall Study|Physician Decision|5|||
149013797|NCT03283696|537530784|FG001|Overall Study|Physician Decision|6|||
148931415|NCT01074047|537233429|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
148931416|NCT01074047|537233428|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
148931417|NCT01074047|537233429|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
148931418|NCT01074047|537233428|FG000|Survival Follow-Up Phase|Death|116|||
148931419|NCT01074047|537233429|FG001|Survival Follow-Up Phase|Death|124|||
148931420|NCT01074047|537233428|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
148931421|NCT01074047|537233429|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
148931422|NCT01074047|537233428|FG000|Extension Phase|Physician Decision|1|||
148931423|NCT01074047|537233429|FG001|Extension Phase|Physician Decision|0|||
148931424|NCT01074047|537233428|FG000|Extension Phase|Adverse Event|5|||
148931425|NCT01074047|537233429|FG001|Extension Phase|Adverse Event|0|||
148931426|NCT01074047|537233428|FG000|Extension Phase|Disease Progression|9|||
148931427|NCT01074047|537233429|FG001|Extension Phase|Disease Progression|0|||
148931428|NCT01074047|537233428|FG000|Extension Phase|Withdrawal by Subject|2|||
148931429|NCT01074047|537233429|FG001|Extension Phase|Withdrawal by Subject|0|||
148931430|NCT01074047|537233428|FG000|Extension Phase|Death|5|||
148931431|NCT01074047|537233429|FG001|Extension Phase|Death|0|||
148931432|NCT04669535|537233430|FG000|Overall Study|Death|1|||
148931433|NCT04669535|537233431|FG001|Overall Study|Death|1|||
148931434|NCT04669535|537233432|FG002|Overall Study|Death|0|||
148931435|NCT04669535|537233433|FG003|Overall Study|Death|0|||
148931436|NCT05169567|537233435|FG000|Overall Study|On study treatment|116|||
148931437|NCT05169567|537233436|FG001|Overall Study|On study treatment|128|||
148931438|NCT05169567|537233435|FG000|Overall Study|Lost to Follow-up|1|||
148931439|NCT05169567|537233436|FG001|Overall Study|Lost to Follow-up|0|||
148931440|NCT05169567|537233435|FG000|Overall Study|Withdrawal by Subject|25|||
148931441|NCT05169567|537233436|FG001|Overall Study|Withdrawal by Subject|21|||
148931442|NCT02211638|537233437|FG000|Overall Study|Case Report Forms Uncollected|291|||
148931443|NCT02211638|537233437|FG000|Overall Study|Protocol Violation|692|||
148931444|NCT04382755|537233438|FG000|Overall Study|Withdrawal by Subject|1|||
148931445|NCT04382755|537233439|FG001|Overall Study|Withdrawal by Subject|0|||
148931446|NCT04382755|537233438|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
148931447|NCT04382755|537233439|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
148931448|NCT04382755|537233438|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
148931449|NCT04382755|537233439|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
148931450|NCT00458536|537233444|FG000|Overall Study|Disease progression prior to treatment|7|||
148931451|NCT00458536|537233444|FG000|Overall Study|Unable to make vaccine|3|||
148931452|NCT00458536|537233444|FG000|Overall Study|No measurable disease after surgery|2|||
148931453|NCT00458536|537233444|FG000|Overall Study|Did not have renal cell carcinoma|2|||
148931454|NCT00458536|537233444|FG000|Overall Study|Patient did not have surgery|1|||
148931455|NCT00458536|537233444|FG000|Overall Study|Ineligible due to toxicity|1|||
148931456|NCT00458536|537233444|FG000|Overall Study|Withdrawal by Subject|1|||
148931457|NCT00458536|537233444|FG000|Overall Study|Progressive disease during treatment|2|||
148931458|NCT05419908|537233449|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
148931459|NCT05419908|537233450|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
148931460|NCT05419908|537233449|FG000|Overall Study|Serious Adverse Event|0|||
148931461|NCT05419908|537233450|FG001|Overall Study|Serious Adverse Event|2|||
148931462|NCT05419908|537233449|FG000|Overall Study|Withdrawal by Subject|2|||
148931463|NCT05419908|537233450|FG001|Overall Study|Withdrawal by Subject|0|||
148931464|NCT05419908|537233449|FG000|Overall Study|Miscellaneous|1|||
148931465|NCT05419908|537233450|FG001|Overall Study|Miscellaneous|1|||
148931466|NCT05069259|537233454|FG000|Overall Study|Withdrawal by Subject|1|||
148931467|NCT05069259|537233454|FG000|Overall Study|Sponsor decision|1|||
148931468|NCT00674973|537235021|FG000|Overall Study|Insufficient Therapeutic Response|77|||
148931469|NCT00674973|537235022|FG001|Overall Study|Insufficient Therapeutic Response|72|||
148931470|NCT00674973|537235021|FG000|Overall Study|Refused Treatment|1|||
148931471|NCT00674973|537235022|FG001|Overall Study|Refused Treatment|5|||
148931472|NCT00674973|537235021|FG000|Overall Study|Failure to Return|1|||
148931473|NCT00674973|537235022|FG001|Overall Study|Failure to Return|0|||
148931474|NCT00674973|537235021|FG000|Overall Study|Adverse Event|2|||
148931475|NCT00674973|537235022|FG001|Overall Study|Adverse Event|9|||
148931476|NCT00674973|537235021|FG000|Overall Study|Death|19|||
149180328|NCT01266148|538132865|FG001|Overall Study|missing mGFR value + AE|0|||
148931477|NCT00674973|537235022|FG001|Overall Study|Death|15|||
148931478|NCT00674973|537235021|FG000|Overall Study|Protocol Violation|0|||
148931479|NCT00674973|537235022|FG001|Overall Study|Protocol Violation|1|||
148931480|NCT05036369|537235023|FG000|Overall Study|Run In non compliance|1|||
148931481|NCT05036369|537235024|FG001|Overall Study|Run In non compliance|2|||
149180329|NCT01269125|538132866|FG000|Overall Study|Adverse Event|3|||
148931482|NCT05036369|537235023|FG000|Overall Study|Change in eligibility criteria|0|||
148931483|NCT05036369|537235024|FG001|Overall Study|Change in eligibility criteria|1|||
148931484|NCT02349061|537235025|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
148931485|NCT02349061|537235026|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
149180330|NCT01269125|538132867|FG001|Overall Study|Adverse Event|5|||
148931486|NCT02349061|537235027|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
149180331|NCT01269125|538132868|FG002|Overall Study|Adverse Event|0|||
149180332|NCT01269125|538132866|FG000|Overall Study|Lost to Follow-up|4|||
149180333|NCT01269125|538132867|FG001|Overall Study|Lost to Follow-up|0|||
149180334|NCT01269125|538132868|FG002|Overall Study|Lost to Follow-up|0|||
149180335|NCT01300286|538132869|FG000|Overall Study|did not get dosed|1|||
149180336|NCT03635190|538132870|FG000|Overall Study|Lost to Follow-up|4|||
149180337|NCT03635190|538132870|FG000|Overall Study|Death|3|||
149180338|NCT03635190|538132870|FG000|Overall Study|Withdrawal by Subject|1|||
149180339|NCT03635190|538132870|FG000|Overall Study|Patient moved and did not return for follow up|1|||
149180340|NCT00417612|538132873|FG000|Overall Study|Errant diagnosis|0|||
149180341|NCT00417612|538132874|FG001|Overall Study|Errant diagnosis|1|||
149180342|NCT00417612|538132873|FG000|Overall Study|Adverse Event|2|||
149180343|NCT00417612|538132874|FG001|Overall Study|Adverse Event|0|||
149180344|NCT00417612|538132873|FG000|Overall Study|Protocol Violation|0|||
149180345|NCT00417612|538132874|FG001|Overall Study|Protocol Violation|2|||
149180346|NCT00417612|538132873|FG000|Overall Study|Lost to Follow-up|1|||
149180347|NCT00417612|538132874|FG001|Overall Study|Lost to Follow-up|0|||
149180348|NCT01712438|538132877|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
149180349|NCT01712438|538132877|FG000|Overall Study|Ongoing ITI treatment|6|||
149180350|NCT01712438|538132877|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
149180351|NCT01712438|538132877|FG000|Overall Study|Prematurely Discontinued|25|||
149180352|NCT03216265|538132878|FG000|Overall Study|Adverse Event|2|||
149180353|NCT03216265|538132879|FG001|Overall Study|Adverse Event|0|||
149180354|NCT03216265|538132880|FG002|Overall Study|Adverse Event|2|||
149180355|NCT03216265|538132878|FG000|Overall Study|Lost to Follow-up|0|||
149180356|NCT03216265|538132879|FG001|Overall Study|Lost to Follow-up|1|||
149180357|NCT03216265|538132880|FG002|Overall Study|Lost to Follow-up|0|||
149180358|NCT03216265|538132878|FG000|Overall Study|Withdrawal by Subject|0|||
149180359|NCT03216265|538132879|FG001|Overall Study|Withdrawal by Subject|0|||
149180360|NCT03216265|538132880|FG002|Overall Study|Withdrawal by Subject|1|||
149180361|NCT01306058|538132881|FG000|Overall Study|Death|1|||
149180362|NCT01306058|538132881|FG000|Overall Study|Enrolled but did not get treatment|1|||
149180363|NCT00849693|538132882|FG000|Acute Treatment Phase|Adverse Event|12|||
149180364|NCT00849693|538132883|FG001|Acute Treatment Phase|Adverse Event|7|||
149180365|NCT00849693|538132884|FG002|Acute Treatment Phase|Adverse Event|6|||
149180366|NCT00849693|538132885|FG003|Acute Treatment Phase|Adverse Event|4|||
149180367|NCT00849693|538132882|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
149180368|NCT00849693|538132883|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
149180369|NCT00849693|538132884|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
148931487|NCT02349061|537235025|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
148931488|NCT02349061|537235026|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
148931489|NCT02349061|537235027|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
148931490|NCT02349061|537235025|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
148931491|NCT02349061|537235026|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
148931492|NCT02349061|537235027|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
148931493|NCT02349061|537235025|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
148931494|NCT02349061|537235026|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
148931495|NCT02349061|537235027|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
148931496|NCT02349061|537235025|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
148931497|NCT02349061|537235026|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
148931498|NCT02349061|537235027|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
148931499|NCT02349061|537235025|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
148931500|NCT02349061|537235026|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
148931501|NCT02349061|537235027|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
148931502|NCT02349061|537235025|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
149180370|NCT00849693|538132885|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
149180371|NCT00849693|538132882|FG000|Acute Treatment Phase|Protocol Violation|1|||
149180372|NCT00849693|538132883|FG001|Acute Treatment Phase|Protocol Violation|5|||
149180373|NCT00849693|538132884|FG002|Acute Treatment Phase|Protocol Violation|2|||
149180374|NCT00849693|538132885|FG003|Acute Treatment Phase|Protocol Violation|6|||
148931503|NCT02349061|537235026|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
148931504|NCT02349061|537235027|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
148931505|NCT02349061|537235025|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
148931506|NCT02349061|537235026|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
148931507|NCT02349061|537235027|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
149013798|NCT03283696|537530783|FG000|Overall Study|Withdrawal by Subject|2|||
149180375|NCT00849693|538132882|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
149180376|NCT00849693|538132883|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
148931508|NCT02349061|537235025|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
148931509|NCT02349061|537235026|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
148931510|NCT02349061|537235027|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
148931511|NCT02349061|537235025|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
148931512|NCT02349061|537235026|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
148931513|NCT02349061|537235027|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
148931514|NCT02349061|537235025|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
148931515|NCT02349061|537235026|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
148931516|NCT02349061|537235027|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
148931517|NCT02349061|537235025|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
148931518|NCT02349061|537235026|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
148931519|NCT02349061|537235027|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
148931520|NCT02349061|537235025|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
148931521|NCT02349061|537235026|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
148931522|NCT02349061|537235027|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
148931523|NCT01507298|537235030|FG000|Overall Study|Protocol Violation|0|||
148931524|NCT01507298|537235031|FG001|Overall Study|Protocol Violation|6|||
148931525|NCT03906461|537235032|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
148931526|NCT03906461|537235032|FG000|Completed 12-month Follow-up|Missed Visit|6|||
148931527|NCT00426231|537235035|FG000|Overall Study|Withdrawal by Subject|9|||
148931528|NCT00426231|537235036|FG001|Overall Study|Withdrawal by Subject|12|||
148931529|NCT01795638|537235037|FG000|Overall Study|Death|0|||
148931530|NCT01795638|537235038|FG001|Overall Study|Death|3|||
148931531|NCT01795638|537235037|FG000|Overall Study|transferred to quaternary hospital|2|||
148931532|NCT01795638|537235038|FG001|Overall Study|transferred to quaternary hospital|3|||
148931533|NCT01795638|537235037|FG000|Overall Study|Protocol Violation|3|||
148931534|NCT01795638|537235038|FG001|Overall Study|Protocol Violation|0|||
148931535|NCT01795638|537235037|FG000|Overall Study|discharged from hospital|7|||
148931536|NCT01795638|537235038|FG001|Overall Study|discharged from hospital|5|||
148931537|NCT01795638|537235037|FG000|Overall Study|Withdrawal by Subject|1|||
149013799|NCT03283696|537530784|FG001|Overall Study|Withdrawal by Subject|0|||
149013800|NCT02765490|537530791|FG000|Overall Study|Lost to Follow-up|1|||
149180377|NCT00849693|538132884|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
149180378|NCT00849693|538132885|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
149180379|NCT00849693|538132882|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
149180380|NCT00849693|538132883|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
149180381|NCT00849693|538132884|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
149180382|NCT00849693|538132885|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
149180383|NCT00849693|538132882|FG000|Acute Treatment Phase|Physician Decision|2|||
149180384|NCT00849693|538132883|FG001|Acute Treatment Phase|Physician Decision|1|||
149180385|NCT00849693|538132884|FG002|Acute Treatment Phase|Physician Decision|2|||
149180386|NCT00849693|538132885|FG003|Acute Treatment Phase|Physician Decision|1|||
149180387|NCT00849693|538132882|FG000|Acute Treatment Phase|Sponsor decision|0|||
149180388|NCT00849693|538132883|FG001|Acute Treatment Phase|Sponsor decision|0|||
149180389|NCT00849693|538132884|FG002|Acute Treatment Phase|Sponsor decision|1|||
149180390|NCT00849693|538132885|FG003|Acute Treatment Phase|Sponsor decision|0|||
149013801|NCT02765490|537530792|FG001|Overall Study|Lost to Follow-up|1|||
149013802|NCT02765490|537530791|FG000|Overall Study|Other|0|||
149180391|NCT00849693|538132882|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
149180392|NCT00849693|538132883|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
149180393|NCT00849693|538132884|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
149180394|NCT00849693|538132885|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
149180395|NCT00849693|538132882|FG000|Extension Phase|Adverse Event|4|||
148931538|NCT01795638|537235038|FG001|Overall Study|Withdrawal by Subject|0|||
148931539|NCT03061097|537235039|FG000|Overall Study|Withdrawal by Subject|0|||
148931540|NCT03061097|537235040|FG001|Overall Study|Withdrawal by Subject|3|||
148931541|NCT00595465|537235047|FG000|Overall Study|Adverse Event|4|||
148931542|NCT00595465|537235048|FG001|Overall Study|Adverse Event|3|||
148931543|NCT00595465|537235049|FG002|Overall Study|Adverse Event|3|||
148931544|NCT00595465|537235047|FG000|Overall Study|Pregnancy|0|||
148931545|NCT00595465|537235048|FG001|Overall Study|Pregnancy|0|||
148931546|NCT00595465|537235049|FG002|Overall Study|Pregnancy|1|||
148931547|NCT00595465|537235047|FG000|Overall Study|Protocol Violation|2|||
148931548|NCT00595465|537235048|FG001|Overall Study|Protocol Violation|1|||
148931549|NCT00595465|537235049|FG002|Overall Study|Protocol Violation|0|||
148931550|NCT00595465|537235047|FG000|Overall Study|Lost to Follow-up|0|||
148931551|NCT00595465|537235048|FG001|Overall Study|Lost to Follow-up|0|||
148931552|NCT00595465|537235049|FG002|Overall Study|Lost to Follow-up|2|||
148679454|NCT02454972|536300797|FG008|Overall Study|Physician Decision|0|||
148931553|NCT00595465|537235047|FG000|Overall Study|administrative reason|0|||
148931554|NCT00595465|537235048|FG001|Overall Study|administrative reason|0|||
148931555|NCT00595465|537235049|FG002|Overall Study|administrative reason|1|||
148931556|NCT00107783|537235050|FG000|Overall Study|Adverse Event|0|||
148931557|NCT00107783|537235051|FG001|Overall Study|Adverse Event|2|||
149180396|NCT00849693|538132883|FG001|Extension Phase|Adverse Event|6|||
149180397|NCT00849693|538132884|FG002|Extension Phase|Adverse Event|3|||
149180398|NCT00849693|538132885|FG003|Extension Phase|Adverse Event|7|||
149180399|NCT00849693|538132882|FG000|Extension Phase|Lost to Follow-up|7|||
149180400|NCT00849693|538132883|FG001|Extension Phase|Lost to Follow-up|5|||
149180401|NCT00849693|538132884|FG002|Extension Phase|Lost to Follow-up|6|||
149180402|NCT00849693|538132885|FG003|Extension Phase|Lost to Follow-up|6|||
149180403|NCT00849693|538132882|FG000|Extension Phase|Protocol Violation|0|||
149180404|NCT00849693|538132883|FG001|Extension Phase|Protocol Violation|3|||
149180405|NCT00849693|538132884|FG002|Extension Phase|Protocol Violation|2|||
149180406|NCT00849693|538132885|FG003|Extension Phase|Protocol Violation|3|||
149180407|NCT00849693|538132882|FG000|Extension Phase|Withdrawal by Subject|6|||
149180408|NCT00849693|538132883|FG001|Extension Phase|Withdrawal by Subject|9|||
149180409|NCT00849693|538132884|FG002|Extension Phase|Withdrawal by Subject|10|||
149180410|NCT00849693|538132885|FG003|Extension Phase|Withdrawal by Subject|15|||
149180411|NCT00849693|538132882|FG000|Extension Phase|Parent or caregiver decision|9|||
149180412|NCT00849693|538132883|FG001|Extension Phase|Parent or caregiver decision|4|||
149180413|NCT00849693|538132884|FG002|Extension Phase|Parent or caregiver decision|10|||
149180414|NCT00849693|538132885|FG003|Extension Phase|Parent or caregiver decision|5|||
149180415|NCT00849693|538132882|FG000|Extension Phase|Physician Decision|1|||
149180416|NCT00849693|538132883|FG001|Extension Phase|Physician Decision|1|||
149180417|NCT00849693|538132884|FG002|Extension Phase|Physician Decision|2|||
149180418|NCT00849693|538132885|FG003|Extension Phase|Physician Decision|0|||
149180419|NCT00849693|538132882|FG000|Extension Phase|Sponsor decision|1|||
149180420|NCT00849693|538132883|FG001|Extension Phase|Sponsor decision|0|||
149180421|NCT00849693|538132884|FG002|Extension Phase|Sponsor decision|0|||
149180422|NCT00849693|538132885|FG003|Extension Phase|Sponsor decision|1|||
149180423|NCT00849693|538132882|FG000|Extension Phase|Lack of Efficacy|2|||
149180424|NCT00849693|538132883|FG001|Extension Phase|Lack of Efficacy|2|||
149180425|NCT00849693|538132884|FG002|Extension Phase|Lack of Efficacy|2|||
149180426|NCT00849693|538132885|FG003|Extension Phase|Lack of Efficacy|1|||
149180427|NCT00224107|538132886|FG000|Overall Study|Adverse Event|20|||
149180428|NCT00224107|538132887|FG001|Overall Study|Adverse Event|6|||
149180429|NCT00224107|538132886|FG000|Overall Study|Protocol Violation|2|||
149180430|NCT00224107|538132887|FG001|Overall Study|Protocol Violation|3|||
149180431|NCT00224107|538132886|FG000|Overall Study|Withdrawal by Subject|1|||
149180432|NCT00224107|538132887|FG001|Overall Study|Withdrawal by Subject|4|||
149180433|NCT00224107|538132886|FG000|Overall Study|Lack of Efficacy|2|||
148679455|NCT02454972|536300789|FG000|Overall Study|Non treatment-related adverse event|2|||
148807277|NCT01140906|536773222|FG000|Overall Study|Protocol Violation|5|||
149180434|NCT00224107|538132887|FG001|Overall Study|Lack of Efficacy|0|||
149180435|NCT00224107|538132886|FG000|Overall Study|Lost to Follow-up|4|||
149180436|NCT00224107|538132887|FG001|Overall Study|Lost to Follow-up|0|||
149180437|NCT00224107|538132886|FG000|Overall Study|Physician Decision|1|||
149180438|NCT00224107|538132887|FG001|Overall Study|Physician Decision|0|||
149180439|NCT00224107|538132886|FG000|Overall Study|Other|1|||
149180440|NCT00224107|538132887|FG001|Overall Study|Other|1|||
149180441|NCT01183858|538132888|FG000|Overall Study|Death not related to Progressive Disease|5|||
149180442|NCT01183858|538132889|FG001|Overall Study|Death not related to Progressive Disease|6|||
149180443|NCT01183858|538132888|FG000|Overall Study|Adverse Event|14|||
149180444|NCT01183858|538132889|FG001|Overall Study|Adverse Event|11|||
149180445|NCT01183858|538132888|FG000|Overall Study|Investigator's Decision|0|||
149180446|NCT01183858|538132889|FG001|Overall Study|Investigator's Decision|3|||
149180447|NCT01183858|538132888|FG000|Overall Study|Insufficient Therapeutic Response|2|||
149180448|NCT01183858|538132889|FG001|Overall Study|Insufficient Therapeutic Response|0|||
149180449|NCT01183858|538132888|FG000|Overall Study|Refused Treatment|1|||
149180450|NCT01183858|538132889|FG001|Overall Study|Refused Treatment|4|||
149180451|NCT01183858|538132888|FG000|Overall Study|Withdrew Consent|4|||
149180452|NCT01183858|538132889|FG001|Overall Study|Withdrew Consent|4|||
149180453|NCT01183858|538132888|FG000|Overall Study|Discontinued Smoking|3|||
149180454|NCT01183858|538132889|FG001|Overall Study|Discontinued Smoking|1|||
149180455|NCT01183858|538132888|FG000|Overall Study|Protocol Violation|1|||
149180456|NCT01183858|538132889|FG001|Overall Study|Protocol Violation|0|||
148807278|NCT01140906|536773223|FG001|Overall Study|Protocol Violation|3|||
148807279|NCT01140906|536773224|FG002|Overall Study|Protocol Violation|2|||
148807280|NCT01140906|536773225|FG003|Overall Study|Protocol Violation|1|||
149180457|NCT01183858|538132888|FG000|Overall Study|Administrative/Other|6|||
149180458|NCT01183858|538132889|FG001|Overall Study|Administrative/Other|6|||
149180459|NCT01183858|538132888|FG000|Overall Study|Progressive Disease|112|||
149180460|NCT01183858|538132889|FG001|Overall Study|Progressive Disease|115|||
148807281|NCT01140906|536773222|FG000|Overall Study|Withdrawal of consent|6|||
149180461|NCT01183858|538132888|FG000|Overall Study|Death related to Progressive Disease|4|||
149180462|NCT01183858|538132889|FG001|Overall Study|Death related to Progressive Disease|5|||
149180463|NCT01183858|538132888|FG000|Overall Study|Lost to Follow-up|1|||
149180464|NCT01183858|538132889|FG001|Overall Study|Lost to Follow-up|1|||
149180465|NCT00098345|538132890|FG000|Overall Study|Adverse Event|7|||
149180466|NCT00098345|538132890|FG000|Overall Study|Withdrawal by Subject|2|||
149180467|NCT00098345|538132890|FG000|Overall Study|progression|4|||
149180468|NCT02046564|538132893|FG000|Overall Study|Adverse Event|6|||
149180469|NCT02046564|538132894|FG001|Overall Study|Adverse Event|3|||
149180470|NCT02046564|538132893|FG000|Overall Study|Physician Decision|0|||
149180471|NCT02046564|538132894|FG001|Overall Study|Physician Decision|1|||
149180472|NCT02046564|538132893|FG000|Overall Study|Protocol Violation|3|||
149180473|NCT02046564|538132894|FG001|Overall Study|Protocol Violation|1|||
149180474|NCT02046564|538132893|FG000|Overall Study|Withdrawal by Subject|4|||
149180475|NCT02046564|538132894|FG001|Overall Study|Withdrawal by Subject|10|||
149180476|NCT02046564|538132893|FG000|Overall Study|Subject met withdrawal criteria|2|||
149180477|NCT02046564|538132894|FG001|Overall Study|Subject met withdrawal criteria|5|||
149180478|NCT01295905|538132897|FG000|Overall Study|Did not meet inclusion criteria|1|||
149180479|NCT01295905|538132898|FG001|Overall Study|Did not meet inclusion criteria|0|||
149180480|NCT01295905|538132897|FG000|Overall Study|Met exclusion criteria|1|||
149180481|NCT01295905|538132898|FG001|Overall Study|Met exclusion criteria|0|||
149180482|NCT03707977|538132899|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
149180483|NCT03707977|538132900|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
149180484|NCT03707977|538132901|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
149180485|NCT03707977|538132899|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
149180486|NCT03707977|538132900|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
149180487|NCT03707977|538132901|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
149180488|NCT03842709|538132902|FG000|Overall Study|Withdrawal by Subject|3|||
149180489|NCT03842709|538132903|FG001|Overall Study|Withdrawal by Subject|3|||
149180490|NCT03842709|538132902|FG000|Overall Study|Lost to Follow-up|1|||
149180491|NCT03842709|538132903|FG001|Overall Study|Lost to Follow-up|0|||
149180492|NCT00641147|538132904|FG000|Completed 4 Months.|Physician Decision|1|||
149180493|NCT00641147|538132905|FG001|Completed 4 Months.|Physician Decision|0|||
149180494|NCT00641147|538132904|FG000|Completed 4 Months.|Adverse Event|1|||
149180495|NCT00641147|538132905|FG001|Completed 4 Months.|Adverse Event|0|||
149180496|NCT00641147|538132904|FG000|Completed 8 Months.|Physician Decision|2|||
149180497|NCT00641147|538132905|FG001|Completed 8 Months.|Physician Decision|1|||
149180498|NCT00641147|538132904|FG000|Completed 8 Months.|non compliance|1|||
149180499|NCT00641147|538132905|FG001|Completed 8 Months.|non compliance|0|||
149180500|NCT00641147|538132904|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
149180501|NCT00641147|538132905|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
149180502|NCT00641147|538132904|FG000|Completed 12 Months.|Physician Decision|1|||
149180503|NCT00641147|538132905|FG001|Completed 12 Months.|Physician Decision|1|||
148931558|NCT00107783|537235050|FG000|Overall Study|Death|0|||
148931559|NCT00107783|537235051|FG001|Overall Study|Death|1|||
148931560|NCT00107783|537235050|FG000|Overall Study|Withdrawal by Subject|2|||
149180504|NCT00641147|538132904|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
149180505|NCT00641147|538132905|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
149180506|NCT00641147|538132904|FG000|Completed 16 Months.|Physician Decision|1|||
149180507|NCT00641147|538132905|FG001|Completed 16 Months.|Physician Decision|0|||
149180508|NCT00641147|538132904|FG000|Completed 16 Months.|Lost to Follow-up|1|||
149180509|NCT00641147|538132905|FG001|Completed 16 Months.|Lost to Follow-up|0|||
149180510|NCT00791128|538132906|FG000|Overall Study|Adverse Event|4|||
148931561|NCT00107783|537235051|FG001|Overall Study|Withdrawal by Subject|0|||
148931562|NCT00107783|537235050|FG000|Overall Study|Second hip replacement|1|||
148931563|NCT00107783|537235051|FG001|Overall Study|Second hip replacement|1|||
148931564|NCT00331864|537235052|FG000|Overall Study|Adverse Event|30|||
148931565|NCT00331864|537235053|FG001|Overall Study|Adverse Event|1|||
148931566|NCT00331864|537235052|FG000|Overall Study|Lack of Efficacy|4|||
148931567|NCT00331864|537235053|FG001|Overall Study|Lack of Efficacy|0|||
148931568|NCT00331864|537235052|FG000|Overall Study|Protocol Violation|3|||
148931569|NCT00331864|537235053|FG001|Overall Study|Protocol Violation|0|||
148931570|NCT00331864|537235052|FG000|Overall Study|Withdrawal by Subject|10|||
148931571|NCT00331864|537235053|FG001|Overall Study|Withdrawal by Subject|0|||
148931572|NCT00331864|537235052|FG000|Overall Study|Lost to Follow-up|4|||
148931573|NCT00331864|537235053|FG001|Overall Study|Lost to Follow-up|3|||
148931574|NCT00331864|537235052|FG000|Overall Study|Administrative Problems|1|||
148931575|NCT00331864|537235053|FG001|Overall Study|Administrative Problems|0|||
148931576|NCT00331864|537235052|FG000|Overall Study|Death|6|||
148931577|NCT00331864|537235053|FG001|Overall Study|Death|0|||
148931578|NCT02611960|537235054|FG000|Overall Study|Adverse Event|7|||
148931579|NCT02611960|537235055|FG001|Overall Study|Adverse Event|8|||
148931580|NCT02611960|537235054|FG000|Overall Study|Death|98|||
148931581|NCT02611960|537235055|FG001|Overall Study|Death|92|||
148931582|NCT02611960|537235054|FG000|Overall Study|Withdrawal by Subject|1|||
148931583|NCT02611960|537235055|FG001|Overall Study|Withdrawal by Subject|5|||
148931584|NCT02611960|537235054|FG000|Overall Study|Sponsor Decision|11|||
148931585|NCT02611960|537235055|FG001|Overall Study|Sponsor Decision|11|||
148931586|NCT04131556|537235057|FG000|Overall Study|Adverse Event|1|||
148931587|NCT04131556|537235057|FG000|Overall Study|Withdrawal by Subject|1|||
148931588|NCT00761579|537235061|FG000|Overall Study|Adverse Event|10|||
148931589|NCT00761579|537235061|FG000|Overall Study|Death|2|||
148931590|NCT00761579|537235061|FG000|Overall Study|Lack of Efficacy|21|||
148931591|NCT00761579|537235061|FG000|Overall Study|Lost to Follow-up|16|||
148931592|NCT00761579|537235061|FG000|Overall Study|Pregnancy|1|||
148931593|NCT00761579|537235061|FG000|Overall Study|Withdrawal by Subject|34|||
148931594|NCT00761579|537235061|FG000|Overall Study|Lack of compliance|2|||
148931595|NCT00761579|537235061|FG000|Overall Study|Protocol deviation|1|||
148931596|NCT00761579|537235061|FG000|Overall Study|Drug overdose|1|||
148931597|NCT00761579|537235061|FG000|Overall Study|Aggravation of depression|1|||
148931598|NCT00761579|537235061|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
148931599|NCT00761579|537235061|FG000|Overall Study|Lost survey form|1|||
148931600|NCT00761579|537235061|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
148931601|NCT03611010|537235062|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
148931602|NCT03611010|537235063|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
148931603|NCT03611010|537235064|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
148807282|NCT01140906|536773223|FG001|Overall Study|Withdrawal of consent|6|||
148807283|NCT01140906|536773224|FG002|Overall Study|Withdrawal of consent|2|||
148931604|NCT03611010|537235065|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
148931605|NCT00950911|537235067|FG000|Overall Study|Adverse Event|0|||
148931606|NCT00950911|537235068|FG001|Overall Study|Adverse Event|2|||
148931607|NCT00950911|537235067|FG000|Overall Study|Death|4|||
148931608|NCT00950911|537235068|FG001|Overall Study|Death|6|||
148931609|NCT00950911|537235067|FG000|Overall Study|Disease progression|2|||
148931610|NCT00950911|537235068|FG001|Overall Study|Disease progression|2|||
148931611|NCT00950911|537235067|FG000|Overall Study|Consent withdrawn|1|||
148931612|NCT00950911|537235068|FG001|Overall Study|Consent withdrawn|3|||
148931613|NCT00950911|537235067|FG000|Overall Study|Administrative decision|3|||
148931614|NCT00950911|537235068|FG001|Overall Study|Administrative decision|1|||
148931615|NCT00950911|537235067|FG000|Overall Study|Ineligibility determined|1|||
148931616|NCT00950911|537235068|FG001|Overall Study|Ineligibility determined|0|||
148931617|NCT00950911|537235067|FG000|Overall Study|Noncompliance|1|||
148931618|NCT00950911|537235068|FG001|Overall Study|Noncompliance|0|||
148931619|NCT00950911|537235067|FG000|Overall Study|Poor performance status|0|||
148931620|NCT00950911|537235068|FG001|Overall Study|Poor performance status|1|||
148931621|NCT02413372|537235073|FG000|Treatment|Lost to Follow-up|0|||
148931622|NCT02413372|537235074|FG001|Treatment|Lost to Follow-up|2|||
148931623|NCT02413372|537235075|FG002|Treatment|Lost to Follow-up|1|||
148679456|NCT02454972|536300790|FG001|Overall Study|Non treatment-related adverse event|0|||
148679457|NCT02454972|536300791|FG002|Overall Study|Non treatment-related adverse event|1|||
148931624|NCT02413372|537235073|FG000|Treatment|Withdrawal by Subject|1|||
148931625|NCT02413372|537235074|FG001|Treatment|Withdrawal by Subject|0|||
148931626|NCT02413372|537235075|FG002|Treatment|Withdrawal by Subject|0|||
148931627|NCT02413372|537235073|FG000|Follow-up|Lost to Follow-up|1|||
148931628|NCT02413372|537235074|FG001|Follow-up|Lost to Follow-up|1|||
148931629|NCT02413372|537235075|FG002|Follow-up|Lost to Follow-up|0|||
148931630|NCT02413372|537235073|FG000|Follow-up|Subject Withdrew Consent|1|||
148931631|NCT02413372|537235074|FG001|Follow-up|Subject Withdrew Consent|0|||
148679458|NCT02454972|536300792|FG003|Overall Study|Non treatment-related adverse event|0|||
148807284|NCT01140906|536773225|FG003|Overall Study|Withdrawal of consent|2|||
148931632|NCT02413372|537235075|FG002|Follow-up|Subject Withdrew Consent|1|||
148931633|NCT02413372|537235073|FG000|Follow-up|Subject unable to return for visit|0|||
148931634|NCT02413372|537235074|FG001|Follow-up|Subject unable to return for visit|0|||
148931635|NCT02413372|537235075|FG002|Follow-up|Subject unable to return for visit|1|||
149180511|NCT00791128|538132906|FG000|Overall Study|Device migration|2|||
149180512|NCT00791128|538132906|FG000|Overall Study|non-compliance by subject|2|||
149180513|NCT00791128|538132906|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
149180514|NCT00984659|538132907|FG000|2-week Run-in Period|Adverse Event|8|||
149180515|NCT00984659|538132908|FG001|2-week Run-in Period|Adverse Event|0|||
149180516|NCT00984659|538132909|FG002|2-week Run-in Period|Adverse Event|0|||
149180517|NCT00984659|538132910|FG003|2-week Run-in Period|Adverse Event|0|||
149180518|NCT00984659|538132907|FG000|2-week Run-in Period|Protocol Violation|5|||
149180519|NCT00984659|538132908|FG001|2-week Run-in Period|Protocol Violation|0|||
149180520|NCT00984659|538132909|FG002|2-week Run-in Period|Protocol Violation|0|||
149180521|NCT00984659|538132910|FG003|2-week Run-in Period|Protocol Violation|0|||
149180522|NCT00984659|538132907|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
149180523|NCT00984659|538132908|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
149180524|NCT00984659|538132909|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
149180525|NCT00984659|538132910|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
149180526|NCT00984659|538132907|FG000|2-week Run-in Period|Lost to Follow-up|3|||
149180527|NCT00984659|538132908|FG001|2-week Run-in Period|Lost to Follow-up|0|||
149180528|NCT00984659|538132909|FG002|2-week Run-in Period|Lost to Follow-up|0|||
149180529|NCT00984659|538132910|FG003|2-week Run-in Period|Lost to Follow-up|0|||
149180530|NCT00984659|538132907|FG000|2-week Run-in Period|Physician Decision|10|||
149180531|NCT00984659|538132908|FG001|2-week Run-in Period|Physician Decision|0|||
149180532|NCT00984659|538132909|FG002|2-week Run-in Period|Physician Decision|0|||
149180533|NCT00984659|538132910|FG003|2-week Run-in Period|Physician Decision|0|||
149180534|NCT00984659|538132907|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
149180535|NCT00984659|538132908|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149180536|NCT00984659|538132909|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
149180537|NCT00984659|538132910|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
149180538|NCT00984659|538132907|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
149180539|NCT00984659|538132908|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149180540|NCT00984659|538132909|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149180541|NCT00984659|538132910|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149180542|NCT00984659|538132907|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
149180543|NCT00984659|538132908|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
149180544|NCT00984659|538132909|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
149180545|NCT00984659|538132910|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
149180546|NCT00984659|538132907|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
149180547|NCT00984659|538132908|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
149180548|NCT00984659|538132909|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
149180549|NCT00984659|538132910|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
148807285|NCT01140906|536773222|FG000|Overall Study|Lost to Follow-up|1|||
148931636|NCT00760214|537235082|FG000|Overall Study|Adverse Event|8|||
148931637|NCT00760214|537235083|FG001|Overall Study|Adverse Event|9|||
148931638|NCT00760214|537235084|FG002|Overall Study|Adverse Event|12|||
148931639|NCT00760214|537235082|FG000|Overall Study|Protocol Violation|3|||
148931640|NCT00760214|537235083|FG001|Overall Study|Protocol Violation|0|||
148931641|NCT00760214|537235084|FG002|Overall Study|Protocol Violation|3|||
148931642|NCT00760214|537235082|FG000|Overall Study|Lost to Follow-up|0|||
148931643|NCT00760214|537235083|FG001|Overall Study|Lost to Follow-up|0|||
148931644|NCT00760214|537235084|FG002|Overall Study|Lost to Follow-up|1|||
148931645|NCT00760214|537235082|FG000|Overall Study|Withdrawal by Subject|12|||
149013803|NCT02765490|537530792|FG001|Overall Study|Other|1|||
149013804|NCT02765490|537530791|FG000|Overall Study|Death|0|||
149013805|NCT02765490|537530792|FG001|Overall Study|Death|1|||
149013806|NCT03237013|537530793|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
149013807|NCT03237013|537530794|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
149013808|NCT03237013|537530795|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
149013809|NCT00258440|537530800|FG000|Overall Study|Withdrawal by Subject|0|||
149013810|NCT00258440|537530801|FG001|Overall Study|Withdrawal by Subject|0|||
149180550|NCT00984659|538132907|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
149180551|NCT00984659|538132908|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
149180552|NCT00984659|538132909|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
149180553|NCT00984659|538132910|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
149180554|NCT00984659|538132907|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
149180555|NCT00984659|538132908|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
149180556|NCT00984659|538132909|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
149180557|NCT00984659|538132910|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
149180558|NCT00984659|538132907|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
149180559|NCT00984659|538132908|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
149180560|NCT00984659|538132909|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
149180561|NCT00984659|538132910|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
149180562|NCT02424149|538132912|FG000|Overall Study|surgery cancelled|2|||
149180563|NCT02424149|538132913|FG001|Overall Study|surgery cancelled|0|||
149180564|NCT02424149|538132912|FG000|Overall Study|Withdrawal by Subject|0|||
149180565|NCT02424149|538132913|FG001|Overall Study|Withdrawal by Subject|1|||
149180566|NCT00328198|538132920|FG000|Treatment|Adverse Event|21|||
149180567|NCT00328198|538132920|FG000|Treatment|Death|1|||
149180568|NCT00328198|538132920|FG000|Treatment|Physician Decision|5|||
149180569|NCT00328198|538132920|FG000|Treatment|Withdrawal by Subject|5|||
149180570|NCT00328198|538132920|FG000|Treatment|Evidence of disease progression|2|||
149180571|NCT00328198|538132920|FG000|Treatment|Non-compliance|1|||
149180572|NCT00328198|538132920|FG000|Treatment|Confirmed complete response, MRD -|3|||
149180573|NCT00328198|538132920|FG000|Follow-up|Lost to Follow-up|4|||
149180574|NCT00328198|538132920|FG000|Follow-up|Death|31|||
149180575|NCT01720667|538132925|FG000|Overall Study|Adverse Event|1|||
149180576|NCT01720667|538132926|FG001|Overall Study|Adverse Event|1|||
149180577|NCT01720667|538132925|FG000|Overall Study|Withdrawal by Subject|3|||
149180578|NCT01720667|538132926|FG001|Overall Study|Withdrawal by Subject|0|||
149180579|NCT03472534|538132927|FG000|Overall Study|Withdrawal by Subject|9|||
149180580|NCT03472534|538132927|FG000|Overall Study|Adverse Event|2|||
149180581|NCT02117050|538132934|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
149180582|NCT03865407|538132935|FG000|Overall Study|Adverse Event|1|||
149180583|NCT03865407|538132936|FG001|Overall Study|Adverse Event|0|||
149180584|NCT03865407|538132935|FG000|Overall Study|Withdrawal by Subject|1|||
149180585|NCT03865407|538132936|FG001|Overall Study|Withdrawal by Subject|0|||
149180586|NCT03865407|538132935|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
149180587|NCT03865407|538132936|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
149180588|NCT00546819|538132941|FG000|Overall Study|Adverse Event|2|||
149180589|NCT00546819|538132942|FG001|Overall Study|Adverse Event|3|||
149180590|NCT00546819|538132941|FG000|Overall Study|Lost to Follow-up|2|||
149180591|NCT00546819|538132942|FG001|Overall Study|Lost to Follow-up|1|||
149180592|NCT00546819|538132941|FG000|Overall Study|Withdrawal by Subject|4|||
149180593|NCT00546819|538132942|FG001|Overall Study|Withdrawal by Subject|2|||
149180594|NCT02052960|538132944|FG000|Overall Study|Adverse Event|19|||
149180595|NCT02052960|538132945|FG001|Overall Study|Adverse Event|17|||
149180596|NCT02052960|538132944|FG000|Overall Study|Protocol Violation|4|||
149180597|NCT02052960|538132945|FG001|Overall Study|Protocol Violation|3|||
149180598|NCT02052960|538132944|FG000|Overall Study|Withdrawal by Subject|6|||
149180599|NCT02052960|538132945|FG001|Overall Study|Withdrawal by Subject|11|||
149180600|NCT02052960|538132944|FG000|Overall Study|Other|25|||
149180601|NCT02052960|538132945|FG001|Overall Study|Other|15|||
149180602|NCT03633331|538132948|FG000|Overall Study|Withdrawal by Subject|1|||
149180603|NCT03233048|538132949|FG000|Overall Study|Withdrawal by Subject|1|||
149180604|NCT00491530|538132950|FG000|Overall Study|Adverse Event|6|||
149180605|NCT00491530|538132951|FG001|Overall Study|Adverse Event|1|||
149180606|NCT00491530|538132952|FG002|Overall Study|Adverse Event|2|||
149180607|NCT00491530|538132950|FG000|Overall Study|Withdrawal by Subject|3|||
148931646|NCT00760214|537235083|FG001|Overall Study|Withdrawal by Subject|14|||
149180608|NCT00491530|538132951|FG001|Overall Study|Withdrawal by Subject|0|||
149180609|NCT00491530|538132952|FG002|Overall Study|Withdrawal by Subject|0|||
149180610|NCT00491530|538132950|FG000|Overall Study|Lost to Follow-up|3|||
149180611|NCT00491530|538132951|FG001|Overall Study|Lost to Follow-up|2|||
149180612|NCT00491530|538132952|FG002|Overall Study|Lost to Follow-up|2|||
149180613|NCT00491530|538132950|FG000|Overall Study|Lack of Efficacy|0|||
149180614|NCT00491530|538132951|FG001|Overall Study|Lack of Efficacy|1|||
149180615|NCT00491530|538132952|FG002|Overall Study|Lack of Efficacy|0|||
149180616|NCT00491530|538132950|FG000|Overall Study|Investigator Discretion|0|||
149180617|NCT00491530|538132951|FG001|Overall Study|Investigator Discretion|1|||
149180618|NCT00491530|538132952|FG002|Overall Study|Investigator Discretion|0|||
149180619|NCT00491530|538132950|FG000|Overall Study|Patient Request|0|||
149180620|NCT00491530|538132951|FG001|Overall Study|Patient Request|1|||
149180621|NCT00491530|538132952|FG002|Overall Study|Patient Request|0|||
149180622|NCT00491530|538132950|FG000|Overall Study|Use of Prohibited Medication|0|||
149180623|NCT00491530|538132951|FG001|Overall Study|Use of Prohibited Medication|0|||
149180624|NCT00491530|538132952|FG002|Overall Study|Use of Prohibited Medication|1|||
149180625|NCT00883753|538132953|FG000|Overall Study|Adverse Event|37|||
148931647|NCT00760214|537235084|FG002|Overall Study|Withdrawal by Subject|13|||
149180626|NCT00883753|538132953|FG000|Overall Study|Death|2|||
149180627|NCT00883753|538132953|FG000|Overall Study|Insufficient therapeutic response|16|||
149180628|NCT00883753|538132953|FG000|Overall Study|Lost to Follow-up|4|||
149180629|NCT00883753|538132953|FG000|Overall Study|Violation of selection criteria at entry|7|||
149180630|NCT00883753|538132953|FG000|Overall Study|Protocol Violation|2|||
149180631|NCT00883753|538132953|FG000|Overall Study|Refused treatment|4|||
149180632|NCT00883753|538132953|FG000|Overall Study|Withdrew consent|10|||
149180633|NCT00883753|538132953|FG000|Overall Study|Investigator's decision|17|||
149180634|NCT00883753|538132953|FG000|Overall Study|Administrative/Other|8|||
149180635|NCT02859415|538132954|FG000|Overall Study|Physician Decision|1|||
149180636|NCT02859415|538132955|FG001|Overall Study|Physician Decision|0|||
149180637|NCT02859415|538132954|FG000|Overall Study|Off treatment due to cardiac event|0|||
149180638|NCT02859415|538132955|FG001|Overall Study|Off treatment due to cardiac event|1|||
149180639|NCT01396525|538132958|FG000|Overall Study|Withdrawal by Subject|8|||
149180640|NCT01396525|538132958|FG000|Overall Study|Death|14|||
149180641|NCT01396525|538132958|FG000|Overall Study|Lost to Follow-up|4|||
149180642|NCT00949650|538132959|FG000|Overall Study|Progressive disease|188|||
149180643|NCT00949650|538132960|FG001|Overall Study|Progressive disease|19|||
149180644|NCT00949650|538132959|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
149180645|NCT00949650|538132960|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
149180646|NCT00949650|538132959|FG000|Overall Study|Other Adverse Event (AE)|28|||
149180647|NCT00949650|538132960|FG001|Overall Study|Other Adverse Event (AE)|17|||
149180648|NCT00949650|538132959|FG000|Overall Study|Protocol Violation|1|||
149180649|NCT00949650|538132960|FG001|Overall Study|Protocol Violation|4|||
148931648|NCT00760214|537235082|FG000|Overall Study|Lack of Efficacy|3|||
148931649|NCT00760214|537235083|FG001|Overall Study|Lack of Efficacy|2|||
148931650|NCT00760214|537235084|FG002|Overall Study|Lack of Efficacy|4|||
148931651|NCT00760214|537235082|FG000|Overall Study|Pregnancy|0|||
148931652|NCT00760214|537235083|FG001|Overall Study|Pregnancy|0|||
148931653|NCT00760214|537235084|FG002|Overall Study|Pregnancy|1|||
148931654|NCT00760214|537235082|FG000|Overall Study|Physician Decision|1|||
148931655|NCT00760214|537235083|FG001|Overall Study|Physician Decision|1|||
149180650|NCT00949650|538132959|FG000|Overall Study|Refusal to continue medication|7|||
149180651|NCT00949650|538132960|FG001|Overall Study|Refusal to continue medication|11|||
149180652|NCT00949650|538132959|FG000|Overall Study|Not treated|1|||
149180653|NCT00949650|538132960|FG001|Overall Study|Not treated|4|||
149180654|NCT00949650|538132959|FG000|Overall Study|Other not specified above|5|||
149180655|NCT00949650|538132960|FG001|Overall Study|Other not specified above|0|||
149180656|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Adverse Event|12|||
149180657|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Adverse Event|3|||
149180658|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Adverse Event|4|||
149180659|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Adverse Event|2|||
149180660|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
149180661|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
149180662|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
149180663|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
149180664|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
149180665|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
149180666|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
149180667|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
149180668|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
149180669|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
149180670|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
149180671|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
149180672|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
149180673|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
149180674|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
149180675|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
149180676|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
149180677|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
149180678|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
149180679|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
149180680|NCT02436239|538132964|FG000|Open-Lable Treatment Period|Other Reason|1|||
149180681|NCT02436239|538132965|FG001|Open-Lable Treatment Period|Other Reason|1|||
149180682|NCT02436239|538132966|FG002|Open-Lable Treatment Period|Other Reason|0|||
149180683|NCT02436239|538132967|FG003|Open-Lable Treatment Period|Other Reason|0|||
149180684|NCT02436239|538132964|FG000|Down-Taper Period|Withdrawal by Subject|4|||
149180685|NCT02436239|538132965|FG001|Down-Taper Period|Withdrawal by Subject|4|||
148931656|NCT00760214|537235084|FG002|Overall Study|Physician Decision|1|||
149180686|NCT02436239|538132966|FG002|Down-Taper Period|Withdrawal by Subject|1|||
149180687|NCT02436239|538132967|FG003|Down-Taper Period|Withdrawal by Subject|2|||
149180688|NCT03671369|538132968|FG000|Overall Study|Other|1|||
149180689|NCT03671369|538132968|FG000|Overall Study|Withdrawal by Subject|289|||
149180690|NCT03671369|538132968|FG000|Overall Study|Not willing to be vaccinated|1|||
149180691|NCT00069121|538132970|FG000|Overall Study|Death|286|||
149180692|NCT00069121|538132971|FG001|Overall Study|Death|242|||
149180693|NCT00069121|538132970|FG000|Overall Study|Withdrawal by Subject|18|||
149180694|NCT00069121|538132971|FG001|Overall Study|Withdrawal by Subject|20|||
149180695|NCT00069121|538132970|FG000|Overall Study|Lost to Follow-up|63|||
149180696|NCT00069121|538132971|FG001|Overall Study|Lost to Follow-up|63|||
149180697|NCT00942708|538132972|FG000|Overall Study|Withdrawal by Subject|1|||
149180698|NCT03851510|538132973|FG000|Overall Study|Screen Fail|1|||
149180699|NCT03851510|538132973|FG000|Overall Study|Adverse Event|1|||
149180700|NCT03851510|538132973|FG000|Overall Study|Withdrawal by Subject|1|||
149180701|NCT02704429|538132977|FG000|Part A: 24 Weeks|Adverse Event|3|||
149180702|NCT02704429|538132978|FG001|Part A: 24 Weeks|Adverse Event|0|||
149180703|NCT02704429|538132977|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
149180704|NCT02704429|538132978|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
148679459|NCT02454972|536300793|FG004|Overall Study|Non treatment-related adverse event|0|||
148679460|NCT02454972|536300794|FG005|Overall Study|Non treatment-related adverse event|1|||
148679461|NCT02454972|536300795|FG006|Overall Study|Non treatment-related adverse event|0|||
148679462|NCT02454972|536300796|FG007|Overall Study|Non treatment-related adverse event|1|||
148679463|NCT02454972|536300797|FG008|Overall Study|Non treatment-related adverse event|0|||
148679464|NCT02454972|536300789|FG000|Overall Study|Treatment-related adverse events|0|||
148679465|NCT02454972|536300790|FG001|Overall Study|Treatment-related adverse events|1|||
148679466|NCT02454972|536300791|FG002|Overall Study|Treatment-related adverse events|1|||
148679467|NCT02454972|536300792|FG003|Overall Study|Treatment-related adverse events|0|||
148679468|NCT02454972|536300793|FG004|Overall Study|Treatment-related adverse events|2|||
148679469|NCT02454972|536300794|FG005|Overall Study|Treatment-related adverse events|0|||
148679470|NCT02454972|536300795|FG006|Overall Study|Treatment-related adverse events|0|||
148679471|NCT02454972|536300796|FG007|Overall Study|Treatment-related adverse events|2|||
148679472|NCT02454972|536300797|FG008|Overall Study|Treatment-related adverse events|0|||
148679473|NCT02454972|536300789|FG000|Overall Study|Patient moves to compassionate use|0|||
148679474|NCT02454972|536300790|FG001|Overall Study|Patient moves to compassionate use|0|||
148679475|NCT02454972|536300791|FG002|Overall Study|Patient moves to compassionate use|0|||
148679476|NCT02454972|536300792|FG003|Overall Study|Patient moves to compassionate use|0|||
148679477|NCT02454972|536300793|FG004|Overall Study|Patient moves to compassionate use|0|||
148679478|NCT02454972|536300794|FG005|Overall Study|Patient moves to compassionate use|0|||
148679479|NCT02454972|536300795|FG006|Overall Study|Patient moves to compassionate use|2|||
148679480|NCT02454972|536300796|FG007|Overall Study|Patient moves to compassionate use|0|||
148679481|NCT02454972|536300797|FG008|Overall Study|Patient moves to compassionate use|0|||
149013811|NCT00258440|537530802|FG002|Overall Study|Withdrawal by Subject|1|||
149013812|NCT00737061|537530803|FG000|Waiting Period|Lost to Follow-up|6|||
149013813|NCT00737061|537530803|FG000|Waiting Period|Withdrawal by Subject|1|||
149013814|NCT00737061|537530803|FG000|Waiting Period|Bilateral placement failure|34|||
149013815|NCT00737061|537530803|FG000|Waiting Period|Deemed patent following HSG|26|||
148679482|NCT02454972|536300789|FG000|Overall Study|Withdrawal by Subject|0|||
149180705|NCT00104104|538132980|FG000|Overall Study|Adverse Event|8|||
149180706|NCT00104104|538132981|FG001|Overall Study|Adverse Event|8|||
149180707|NCT00104104|538132980|FG000|Overall Study|Abnormal laboratory value(s)|20|||
149180708|NCT00104104|538132981|FG001|Overall Study|Abnormal laboratory value(s)|14|||
149180709|NCT00104104|538132980|FG000|Overall Study|Lack of Efficacy|0|||
149180710|NCT00104104|538132981|FG001|Overall Study|Lack of Efficacy|3|||
149180711|NCT00104104|538132980|FG000|Overall Study|Condition no longer requires study drug|7|||
149180712|NCT00104104|538132981|FG001|Overall Study|Condition no longer requires study drug|4|||
149180713|NCT00104104|538132980|FG000|Overall Study|Protocol Violation|5|||
149180714|NCT00104104|538132981|FG001|Overall Study|Protocol Violation|2|||
149180715|NCT00104104|538132980|FG000|Overall Study|Withdrawal by Subject|11|||
149180716|NCT00104104|538132981|FG001|Overall Study|Withdrawal by Subject|15|||
149180717|NCT00104104|538132980|FG000|Overall Study|Lost to Follow-up|3|||
149180718|NCT00104104|538132981|FG001|Overall Study|Lost to Follow-up|7|||
149180719|NCT00104104|538132980|FG000|Overall Study|Administrative problems|12|||
149180720|NCT00104104|538132981|FG001|Overall Study|Administrative problems|13|||
149180721|NCT00104104|538132980|FG000|Overall Study|Death|9|||
149180722|NCT00104104|538132981|FG001|Overall Study|Death|6|||
149180723|NCT02452970|538134059|FG000|Overall Study|Adverse Event|1|||
149180724|NCT01040832|538134061|FG000|Overall Study|Adverse Event|4|||
149180725|NCT01040832|538134062|FG001|Overall Study|Adverse Event|5|||
149180726|NCT01040832|538134061|FG000|Overall Study|Death|4|||
149180727|NCT01040832|538134062|FG001|Overall Study|Death|6|||
149180728|NCT01040832|538134061|FG000|Overall Study|Withdrawal by Subject|2|||
149180729|NCT01040832|538134062|FG001|Overall Study|Withdrawal by Subject|3|||
149180730|NCT01040832|538134061|FG000|Overall Study|Progressive disease|32|||
149180731|NCT01040832|538134062|FG001|Overall Study|Progressive disease|17|||
149180732|NCT01040832|538134061|FG000|Overall Study|Symptomatic deterioration|2|||
149180733|NCT01040832|538134062|FG001|Overall Study|Symptomatic deterioration|5|||
149180734|NCT01040832|538134061|FG000|Overall Study|Other|2|||
149180735|NCT01040832|538134062|FG001|Overall Study|Other|1|||
148931657|NCT00760214|537235082|FG000|Overall Study|Other|3|||
148931658|NCT00760214|537235083|FG001|Overall Study|Other|4|||
148931659|NCT00760214|537235084|FG002|Overall Study|Other|6|||
148931660|NCT03960554|537235090|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
148679483|NCT02454972|536300790|FG001|Overall Study|Withdrawal by Subject|1|||
148679484|NCT02454972|536300791|FG002|Overall Study|Withdrawal by Subject|5|||
148679485|NCT02454972|536300792|FG003|Overall Study|Withdrawal by Subject|2|||
148679486|NCT02454972|536300793|FG004|Overall Study|Withdrawal by Subject|3|||
148679487|NCT02454972|536300794|FG005|Overall Study|Withdrawal by Subject|2|||
148679488|NCT02454972|536300795|FG006|Overall Study|Withdrawal by Subject|0|||
148679489|NCT02454972|536300796|FG007|Overall Study|Withdrawal by Subject|1|||
148679490|NCT02454972|536300797|FG008|Overall Study|Withdrawal by Subject|2|||
148679491|NCT02454972|536300789|FG000|Overall Study|Multiple delay/holds on treatment|0|||
148931661|NCT03960554|537235091|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
148931662|NCT04587271|537235092|FG000|Overall Study|Lost to Follow-up|2|||
148679492|NCT02454972|536300790|FG001|Overall Study|Multiple delay/holds on treatment|0|||
148679493|NCT02454972|536300791|FG002|Overall Study|Multiple delay/holds on treatment|0|||
148679494|NCT02454972|536300792|FG003|Overall Study|Multiple delay/holds on treatment|1|||
148679495|NCT02454972|536300793|FG004|Overall Study|Multiple delay/holds on treatment|0|||
148679496|NCT02454972|536300794|FG005|Overall Study|Multiple delay/holds on treatment|0|||
148679497|NCT02454972|536300795|FG006|Overall Study|Multiple delay/holds on treatment|0|||
148679498|NCT02454972|536300796|FG007|Overall Study|Multiple delay/holds on treatment|0|||
148679499|NCT02454972|536300797|FG008|Overall Study|Multiple delay/holds on treatment|0|||
148679500|NCT02454972|536300789|FG000|Overall Study|Never treated|0|||
148679501|NCT02454972|536300790|FG001|Overall Study|Never treated|0|||
148679502|NCT02454972|536300791|FG002|Overall Study|Never treated|3|||
148679503|NCT02454972|536300792|FG003|Overall Study|Never treated|1|||
148679504|NCT02454972|536300793|FG004|Overall Study|Never treated|1|||
148679505|NCT02454972|536300794|FG005|Overall Study|Never treated|0|||
148679506|NCT02454972|536300795|FG006|Overall Study|Never treated|0|||
148679507|NCT02454972|536300796|FG007|Overall Study|Never treated|0|||
148679508|NCT02454972|536300797|FG008|Overall Study|Never treated|5|||
148679509|NCT02454972|536300789|FG000|Overall Study|Lost to Follow-up|0|||
148679510|NCT02454972|536300790|FG001|Overall Study|Lost to Follow-up|0|||
148679511|NCT02454972|536300791|FG002|Overall Study|Lost to Follow-up|0|||
148679512|NCT02454972|536300792|FG003|Overall Study|Lost to Follow-up|0|||
148679513|NCT02454972|536300793|FG004|Overall Study|Lost to Follow-up|0|||
148679514|NCT02454972|536300794|FG005|Overall Study|Lost to Follow-up|0|||
148679515|NCT02454972|536300795|FG006|Overall Study|Lost to Follow-up|0|||
148679516|NCT02454972|536300796|FG007|Overall Study|Lost to Follow-up|0|||
148679517|NCT02454972|536300797|FG008|Overall Study|Lost to Follow-up|2|||
148679518|NCT02454972|536300789|FG000|Overall Study|Study termination|0|||
148679519|NCT02454972|536300790|FG001|Overall Study|Study termination|0|||
148679520|NCT02454972|536300791|FG002|Overall Study|Study termination|0|||
148679521|NCT02454972|536300792|FG003|Overall Study|Study termination|0|||
148679522|NCT02454972|536300793|FG004|Overall Study|Study termination|0|||
148679523|NCT02454972|536300794|FG005|Overall Study|Study termination|0|||
148679524|NCT02454972|536300795|FG006|Overall Study|Study termination|0|||
148679525|NCT02454972|536300796|FG007|Overall Study|Study termination|0|||
148679526|NCT02454972|536300797|FG008|Overall Study|Study termination|6|||
148679527|NCT01020305|536300802|FG000|Overall Study|Adverse Event|2|||
148679528|NCT00467818|536300803|FG000|Overall Study|Adverse Event|1|||
148679529|NCT00467818|536300804|FG001|Overall Study|Adverse Event|0|||
148679530|NCT00467818|536300803|FG000|Overall Study|Lost to Follow-up|2|||
148679531|NCT00467818|536300804|FG001|Overall Study|Lost to Follow-up|2|||
148679532|NCT01070966|536300808|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
148931663|NCT04587271|537235093|FG001|Overall Study|Lost to Follow-up|2|||
148931664|NCT04587271|537235094|FG002|Overall Study|Lost to Follow-up|0|||
148931665|NCT04587271|537235095|FG003|Overall Study|Lost to Follow-up|2|||
148931666|NCT04587271|537235096|FG004|Overall Study|Lost to Follow-up|2|||
148931667|NCT04587271|537235097|FG005|Overall Study|Lost to Follow-up|0|||
148679533|NCT01070966|536300808|FG000|Participants for Safety Evaluation|Off-label use|9|||
148679534|NCT01070966|536300808|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
148679535|NCT01070966|536300808|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
148679536|NCT01070966|536300808|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
149013816|NCT00737061|537530803|FG000|Waiting Period|Alternative contraception failure|3|||
148679537|NCT01070966|536300808|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
148679538|NCT01070966|536300808|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
148679539|NCT01070966|536300808|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
148679540|NCT00618774|536300809|FG000|Overall Study|Adverse Event|5|||
148679541|NCT00618774|536300810|FG001|Overall Study|Adverse Event|3|||
148931668|NCT04587271|537235092|FG000|Overall Study|Caregiver brought child to visits|0|||
148931669|NCT04587271|537235093|FG001|Overall Study|Caregiver brought child to visits|0|||
148679542|NCT00618774|536300809|FG000|Overall Study|Withdrawal by Subject|1|||
148679543|NCT00618774|536300810|FG001|Overall Study|Withdrawal by Subject|0|||
148931670|NCT04587271|537235094|FG002|Overall Study|Caregiver brought child to visits|0|||
148931671|NCT04587271|537235095|FG003|Overall Study|Caregiver brought child to visits|1|||
148931672|NCT04587271|537235096|FG004|Overall Study|Caregiver brought child to visits|0|||
148679544|NCT01725113|536300811|FG000|Overall Study|Kidney Transplant|1|||
148679545|NCT01725113|536300812|FG001|Overall Study|Kidney Transplant|1|||
148679546|NCT01725113|536300811|FG000|Overall Study|Withdrawal by Subject|0|||
148679547|NCT01725113|536300812|FG001|Overall Study|Withdrawal by Subject|1|||
148679548|NCT01415921|536300814|FG000|Overall Study|Adverse Event|0|||
148679549|NCT01415921|536300815|FG001|Overall Study|Adverse Event|1|||
148679550|NCT01415921|536300814|FG000|Overall Study|Physician Decision|1|||
148679551|NCT01415921|536300815|FG001|Overall Study|Physician Decision|1|||
148679552|NCT01415921|536300814|FG000|Overall Study|Withdrawal by Subject|0|||
148679553|NCT01415921|536300815|FG001|Overall Study|Withdrawal by Subject|1|||
148679554|NCT01415921|536300814|FG000|Overall Study|Other|2|||
148679555|NCT01415921|536300815|FG001|Overall Study|Other|0|||
148679556|NCT01830920|536300818|FG000|Overall Study|Adverse Event|1|||
148679557|NCT01830920|536300819|FG001|Overall Study|Adverse Event|0|||
148679558|NCT01830920|536300820|FG002|Overall Study|Adverse Event|1|||
148679559|NCT01830920|536300821|FG003|Overall Study|Adverse Event|0|||
148679560|NCT01830920|536300822|FG004|Overall Study|Adverse Event|0|||
148679561|NCT01830920|536300818|FG000|Overall Study|Withdrawal by Subject|2|||
148679562|NCT01830920|536300819|FG001|Overall Study|Withdrawal by Subject|2|||
148679563|NCT01830920|536300820|FG002|Overall Study|Withdrawal by Subject|1|||
148679564|NCT01830920|536300821|FG003|Overall Study|Withdrawal by Subject|7|||
148679565|NCT01830920|536300822|FG004|Overall Study|Withdrawal by Subject|1|||
148679566|NCT01830920|536300818|FG000|Overall Study|Death|3|||
148679567|NCT01830920|536300819|FG001|Overall Study|Death|3|||
148679568|NCT01830920|536300820|FG002|Overall Study|Death|5|||
148679569|NCT01830920|536300821|FG003|Overall Study|Death|4|||
148679570|NCT01830920|536300822|FG004|Overall Study|Death|4|||
148679571|NCT01830920|536300818|FG000|Overall Study|Other|15|||
148679572|NCT01830920|536300819|FG001|Overall Study|Other|1|||
148679573|NCT01830920|536300820|FG002|Overall Study|Other|1|||
148679574|NCT01830920|536300821|FG003|Overall Study|Other|5|||
148679575|NCT01830920|536300822|FG004|Overall Study|Other|3|||
148679576|NCT01313728|536300823|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
148679577|NCT00736333|536300824|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
148679578|NCT00736333|536300824|FG000|Overall Study|Data Missing|2|||
148679579|NCT00736333|536300824|FG000|Overall Study|Tumor Progression|75|||
148679580|NCT00736333|536300824|FG000|Overall Study|Toxicity|6|||
148931673|NCT04587271|537235097|FG005|Overall Study|Caregiver brought child to visits|0|||
148679581|NCT00736333|536300824|FG000|Overall Study|Withdrawal by Subject|10|||
148679582|NCT00736333|536300824|FG000|Overall Study|Death|7|||
148679583|NCT00736333|536300824|FG000|Overall Study|Other|4|||
148679584|NCT02117479|536300828|FG000|Overall Study|Death|13|||
148931674|NCT00736879|537235098|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
148931675|NCT00736879|537235099|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
148679585|NCT02117479|536300829|FG001|Overall Study|Death|8|||
148679586|NCT02117479|536300828|FG000|Overall Study|Adverse Event|8|||
148679587|NCT02117479|536300829|FG001|Overall Study|Adverse Event|16|||
148679588|NCT02117479|536300828|FG000|Overall Study|Subject decision|8|||
148679589|NCT02117479|536300829|FG001|Overall Study|Subject decision|9|||
148679590|NCT02117479|536300828|FG000|Overall Study|Disease progression|104|||
148679591|NCT02117479|536300829|FG001|Overall Study|Disease progression|108|||
148679592|NCT02117479|536300828|FG000|Overall Study|Noncompliance with study treatment|1|||
148679593|NCT02117479|536300829|FG001|Overall Study|Noncompliance with study treatment|0|||
148679594|NCT02117479|536300828|FG000|Overall Study|Study terminated by the sponsor|4|||
148679595|NCT02117479|536300829|FG001|Overall Study|Study terminated by the sponsor|6|||
148679596|NCT02117479|536300828|FG000|Overall Study|Physician Decision|7|||
148679597|NCT02117479|536300829|FG001|Overall Study|Physician Decision|2|||
148931676|NCT00736879|537235100|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
148931677|NCT00736879|537235101|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
148679598|NCT02117479|536300828|FG000|Overall Study|Other unspecified|11|||
148679599|NCT02117479|536300829|FG001|Overall Study|Other unspecified|7|||
148679600|NCT02261974|536300830|FG000|Overall Study|Withdrawal by Subject|3|||
148679601|NCT02261974|536300831|FG001|Overall Study|Withdrawal by Subject|2|||
148679602|NCT02261974|536300830|FG000|Overall Study|Pregnancy|0|||
148679603|NCT02261974|536300831|FG001|Overall Study|Pregnancy|1|||
148679604|NCT02261974|536300830|FG000|Overall Study|Missed treatment cut-off date|6|||
148679605|NCT02261974|536300831|FG001|Overall Study|Missed treatment cut-off date|3|||
148679606|NCT02261974|536300830|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
148679607|NCT02261974|536300831|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
148679608|NCT02261974|536300830|FG000|Overall Study|Lost to Follow-up|2|||
148679609|NCT02261974|536300831|FG001|Overall Study|Lost to Follow-up|0|||
148679610|NCT02261974|536300830|FG000|Overall Study|Adverse Event|1|||
148679611|NCT02261974|536300831|FG001|Overall Study|Adverse Event|0|||
148931678|NCT00736879|537235098|FG000|Double Blind Treatment Period|Adverse Event|0|||
148679612|NCT03216954|536300832|FG000|Overall Study|Adverse Event|0|||
149180736|NCT01539837|538134063|FG000|Overall Study|reduce neutrophil level|0|||
149180737|NCT01539837|538134064|FG001|Overall Study|reduce neutrophil level|1|||
149180738|NCT01539837|538134065|FG002|Overall Study|reduce neutrophil level|1|||
149180739|NCT01539837|538134063|FG000|Overall Study|bad compliance|0|||
149180740|NCT01539837|538134064|FG001|Overall Study|bad compliance|0|||
149180741|NCT01539837|538134065|FG002|Overall Study|bad compliance|1|||
149180742|NCT01629667|538134068|FG000|Overall Study|Lost to Follow-up|0|||
149180743|NCT01629667|538134069|FG001|Overall Study|Lost to Follow-up|1|||
149180744|NCT01629667|538134070|FG002|Overall Study|Lost to Follow-up|1|||
149180745|NCT01629667|538134068|FG000|Overall Study|Withdrawal by Subject|31|||
149180746|NCT01629667|538134069|FG001|Overall Study|Withdrawal by Subject|20|||
149180747|NCT01629667|538134070|FG002|Overall Study|Withdrawal by Subject|28|||
149180748|NCT01629667|538134068|FG000|Overall Study|Death|1|||
149180749|NCT01629667|538134069|FG001|Overall Study|Death|5|||
149180750|NCT01629667|538134070|FG002|Overall Study|Death|3|||
149180751|NCT01629667|538134068|FG000|Overall Study|Randomized, not treated|2|||
149180752|NCT01629667|538134069|FG001|Overall Study|Randomized, not treated|1|||
149180753|NCT01629667|538134070|FG002|Overall Study|Randomized, not treated|0|||
149180754|NCT01629667|538134068|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
149180755|NCT01629667|538134069|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
149180756|NCT01629667|538134070|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
149180757|NCT01629667|538134068|FG000|Overall Study|Requiring lung transplant|2|||
149180758|NCT01629667|538134069|FG001|Overall Study|Requiring lung transplant|1|||
149180759|NCT01629667|538134070|FG002|Overall Study|Requiring lung transplant|3|||
149180760|NCT01629667|538134068|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
149180761|NCT01629667|538134069|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
149180762|NCT01629667|538134070|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
149180763|NCT01629667|538134068|FG000|Overall Study|Started other medicine|1|||
149180764|NCT01629667|538134069|FG001|Overall Study|Started other medicine|0|||
149180765|NCT01629667|538134070|FG002|Overall Study|Started other medicine|1|||
149180766|NCT01629667|538134068|FG000|Overall Study|Site error in safety follow-up|0|||
149180767|NCT01629667|538134069|FG001|Overall Study|Site error in safety follow-up|0|||
149180768|NCT01629667|538134070|FG002|Overall Study|Site error in safety follow-up|1|||
149180769|NCT01629667|538134068|FG000|Overall Study|Enrolled in another clinical study|0|||
149180770|NCT01629667|538134069|FG001|Overall Study|Enrolled in another clinical study|1|||
149180771|NCT01629667|538134070|FG002|Overall Study|Enrolled in another clinical study|0|||
148679613|NCT03216954|536300833|FG001|Overall Study|Adverse Event|0|||
148931679|NCT00736879|537235099|FG001|Double Blind Treatment Period|Adverse Event|1|||
149180772|NCT01629667|538134068|FG000|Overall Study|Code break|1|||
149180773|NCT01629667|538134069|FG001|Overall Study|Code break|0|||
149180774|NCT01629667|538134070|FG002|Overall Study|Code break|0|||
149180775|NCT02717546|538134072|FG000|Overall Study|Lost to Follow-up|12|||
149180776|NCT03849560|538134073|FG000|Overall Study|Withdrawal by Subject|1|||
149180777|NCT03849560|538134074|FG001|Overall Study|Withdrawal by Subject|0|||
149180778|NCT03849560|538134075|FG002|Overall Study|Withdrawal by Subject|0|||
149180779|NCT04382651|538134076|FG000|Overall Study|Death|26|||
149180780|NCT04382651|538134077|FG001|Overall Study|Death|23|||
149180781|NCT04382651|538134076|FG000|Overall Study|Lost to Follow-up|3|||
149180782|NCT04382651|538134077|FG001|Overall Study|Lost to Follow-up|4|||
149180783|NCT04382651|538134076|FG000|Overall Study|Withdrawal by Subject|2|||
149180784|NCT04382651|538134077|FG001|Overall Study|Withdrawal by Subject|0|||
149180785|NCT04382651|538134076|FG000|Overall Study|Physician Decision|0|||
149180786|NCT04382651|538134077|FG001|Overall Study|Physician Decision|1|||
149180787|NCT01507545|538134078|FG000|Overall Study|Withdrawal by Subject|6|||
149180788|NCT01507545|538134079|FG001|Overall Study|Withdrawal by Subject|2|||
149180789|NCT01507545|538134078|FG000|Overall Study|Lost to Follow-up|1|||
149180790|NCT01507545|538134079|FG001|Overall Study|Lost to Follow-up|0|||
149180791|NCT01507545|538134078|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
149180792|NCT01507545|538134079|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
149180793|NCT01507545|538134078|FG000|Overall Study|Progressive disease|60|||
149180794|NCT01507545|538134079|FG001|Overall Study|Progressive disease|27|||
149180795|NCT01507545|538134078|FG000|Overall Study|Other|6|||
149180796|NCT01507545|538134079|FG001|Overall Study|Other|4|||
149180797|NCT00790296|538134081|FG000|Overall Study|Did not meet study eligibility criteria|1|||
149180798|NCT00790296|538134082|FG001|Overall Study|Did not meet study eligibility criteria|1|||
149180799|NCT00790296|538134081|FG000|Overall Study|Adverse Event|0|||
149180800|NCT00790296|538134082|FG001|Overall Study|Adverse Event|1|||
149180801|NCT02612077|538134083|FG000|Overall Study|Adverse Event|3|||
149180802|NCT02612077|538134083|FG000|Overall Study|Withdrawal by Subject|9|||
149180803|NCT02612077|538134083|FG000|Overall Study|Protocol Violation|28|||
149180804|NCT02612077|538134083|FG000|Overall Study|Lost to Follow-up|20|||
149180805|NCT02612077|538134083|FG000|Overall Study|Death|377|||
149180806|NCT02612077|538134083|FG000|Overall Study|Moved or Changed Medical Team|23|||
149180807|NCT02612077|538134083|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
149180808|NCT02612077|538134083|FG000|Overall Study|Disease Progression|3|||
149180809|NCT02612077|538134083|FG000|Overall Study|Unknown reason|2|||
149180810|NCT01753518|538134084|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
149180811|NCT01753518|538134085|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
149180812|NCT01753518|538134084|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
149180813|NCT01753518|538134085|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
149180814|NCT01753518|538134084|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
149180815|NCT01753518|538134085|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
149180816|NCT01753518|538134084|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
149180817|NCT01753518|538134085|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
149180818|NCT01971476|538134086|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
149180819|NCT01971476|538134087|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
149180820|NCT01971476|538134088|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
149180821|NCT01971476|538134086|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
149180822|NCT01971476|538134087|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
148931680|NCT00736879|537235100|FG002|Double Blind Treatment Period|Adverse Event|1|||
149180823|NCT01971476|538134088|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
149180824|NCT01971476|538134086|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
149180825|NCT01971476|538134087|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
149180826|NCT01971476|538134088|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
149180827|NCT00940342|538134089|FG000|Overall Study|Adverse Event|0|||
149180828|NCT00940342|538134090|FG001|Overall Study|Adverse Event|2|||
149180829|NCT00940342|538134091|FG002|Overall Study|Adverse Event|1|||
149180830|NCT02498821|538134092|FG000|Overall Study|Screen failure|3|||
149180831|NCT02498821|538134093|FG001|Overall Study|Screen failure|5|||
149180832|NCT01716169|538134095|FG000|Overall Study|Adverse Event|1|||
149180833|NCT01716169|538134095|FG000|Overall Study|Lost to Follow-up|1|||
149180834|NCT01716169|538134095|FG000|Overall Study|Withdrawal by Subject|1|||
149180835|NCT01716169|538134095|FG000|Overall Study|inconsistent dressing application|1|||
148931681|NCT00736879|537235101|FG003|Double Blind Treatment Period|Adverse Event|0|||
148931682|NCT00736879|537235098|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
148931683|NCT00736879|537235099|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
148931684|NCT00736879|537235100|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
148931685|NCT00736879|537235101|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
148931686|NCT00736879|537235098|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
148931687|NCT00736879|537235099|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149180836|NCT00553787|538134096|FG000|Overall Study|Adverse Event|34|||
149180837|NCT00553787|538134097|FG001|Overall Study|Adverse Event|21|||
149180838|NCT00553787|538134098|FG002|Overall Study|Adverse Event|67|||
149180839|NCT00553787|538134096|FG000|Overall Study|Lost to Follow-up|132|||
149180840|NCT00553787|538134097|FG001|Overall Study|Lost to Follow-up|44|||
149180841|NCT00553787|538134098|FG002|Overall Study|Lost to Follow-up|78|||
149180842|NCT00553787|538134096|FG000|Overall Study|Withdrawal by Subject|151|||
149180843|NCT00553787|538134097|FG001|Overall Study|Withdrawal by Subject|40|||
149180844|NCT00553787|538134098|FG002|Overall Study|Withdrawal by Subject|83|||
149180845|NCT00553787|538134096|FG000|Overall Study|Lack of Efficacy|31|||
149180846|NCT00553787|538134097|FG001|Overall Study|Lack of Efficacy|1|||
149180847|NCT00553787|538134098|FG002|Overall Study|Lack of Efficacy|3|||
149180848|NCT00553787|538134096|FG000|Overall Study|Pregnancy|0|||
149180849|NCT00553787|538134097|FG001|Overall Study|Pregnancy|1|||
149180850|NCT00553787|538134098|FG002|Overall Study|Pregnancy|2|||
149180851|NCT00553787|538134096|FG000|Overall Study|non compliance|4|||
149180852|NCT00553787|538134097|FG001|Overall Study|non compliance|0|||
149180853|NCT00553787|538134098|FG002|Overall Study|non compliance|11|||
149180854|NCT00553787|538134096|FG000|Overall Study|Requirement for restricted medication|8|||
149180855|NCT00553787|538134097|FG001|Overall Study|Requirement for restricted medication|7|||
149180856|NCT00553787|538134098|FG002|Overall Study|Requirement for restricted medication|5|||
149180857|NCT00553787|538134096|FG000|Overall Study|Other|18|||
149180858|NCT00553787|538134097|FG001|Overall Study|Other|10|||
149180859|NCT00553787|538134098|FG002|Overall Study|Other|13|||
149180860|NCT01088412|538134099|FG000|Overall Study|Adverse Event|38|||
149180861|NCT01088412|538134100|FG001|Overall Study|Adverse Event|0|||
149180862|NCT01088412|538134101|FG002|Overall Study|Adverse Event|0|||
149180863|NCT01088412|538134099|FG000|Overall Study|Death|42|||
149180864|NCT01088412|538134100|FG001|Overall Study|Death|6|||
149180865|NCT01088412|538134101|FG002|Overall Study|Death|0|||
149180866|NCT01088412|538134099|FG000|Overall Study|Other Reason per Case Report Form|2089|||
149180867|NCT01088412|538134100|FG001|Overall Study|Other Reason per Case Report Form|103|||
149180868|NCT01088412|538134101|FG002|Overall Study|Other Reason per Case Report Form|9|||
149180869|NCT01088412|538134099|FG000|Overall Study|Withdrawal by Subject|1761|||
149180870|NCT01088412|538134100|FG001|Overall Study|Withdrawal by Subject|25|||
149180871|NCT01088412|538134101|FG002|Overall Study|Withdrawal by Subject|1|||
149180872|NCT01088412|538134099|FG000|Overall Study|Received Another GH Product|79|||
149180873|NCT01088412|538134100|FG001|Overall Study|Received Another GH Product|0|||
149180874|NCT01088412|538134101|FG002|Overall Study|Received Another GH Product|0|||
149180875|NCT01088412|538134099|FG000|Overall Study|Participant Moved|601|||
149180876|NCT01088412|538134100|FG001|Overall Study|Participant Moved|21|||
149180877|NCT01088412|538134101|FG002|Overall Study|Participant Moved|2|||
149180878|NCT01088412|538134099|FG000|Overall Study|Physician Decision|1041|||
149180879|NCT01088412|538134100|FG001|Overall Study|Physician Decision|8|||
149180880|NCT01088412|538134101|FG002|Overall Study|Physician Decision|4|||
149180881|NCT01088412|538134099|FG000|Overall Study|Sponsor Decision|4467|||
149180882|NCT01088412|538134100|FG001|Overall Study|Sponsor Decision|79|||
149180883|NCT01088412|538134101|FG002|Overall Study|Sponsor Decision|23|||
149180884|NCT01088412|538134099|FG000|Overall Study|Third Party Required to Change Brand|487|||
149180885|NCT01088412|538134100|FG001|Overall Study|Third Party Required to Change Brand|0|||
149180886|NCT01088412|538134101|FG002|Overall Study|Third Party Required to Change Brand|0|||
149180887|NCT01088412|538134099|FG000|Overall Study|Lost to Follow-up|3052|||
149180888|NCT01088412|538134100|FG001|Overall Study|Lost to Follow-up|130|||
149180889|NCT01088412|538134101|FG002|Overall Study|Lost to Follow-up|11|||
149180890|NCT01088412|538134099|FG000|Overall Study|Study Summary Not Completed|4360|||
149180891|NCT01088412|538134100|FG001|Overall Study|Study Summary Not Completed|64|||
149180892|NCT01088412|538134101|FG002|Overall Study|Study Summary Not Completed|22|||
149180893|NCT00793104|538134102|FG000|Overall Study|Lost to Follow-up|1|||
149180894|NCT03494725|538134107|FG000|Overall Study|Withdrawal by Subject|0|||
149180895|NCT03494725|538134108|FG001|Overall Study|Withdrawal by Subject|2|||
149180896|NCT03494725|538134107|FG000|Overall Study|Antibiotic use|1|||
149180897|NCT03494725|538134108|FG001|Overall Study|Antibiotic use|0|||
149180898|NCT02619253|538134109|FG000|Overall Study|Adverse Event|0|||
149180899|NCT02619253|538134110|FG001|Overall Study|Adverse Event|0|||
149180900|NCT02619253|538134111|FG002|Overall Study|Adverse Event|1|||
149180901|NCT02619253|538134112|FG003|Overall Study|Adverse Event|1|||
149180902|NCT02619253|538134113|FG004|Overall Study|Adverse Event|3|||
149180903|NCT02619253|538134109|FG000|Overall Study|Alternative Therapy|0|||
149180904|NCT02619253|538134110|FG001|Overall Study|Alternative Therapy|0|||
149180905|NCT02619253|538134111|FG002|Overall Study|Alternative Therapy|1|||
149180906|NCT02619253|538134112|FG003|Overall Study|Alternative Therapy|0|||
149180907|NCT02619253|538134113|FG004|Overall Study|Alternative Therapy|0|||
149180908|NCT02619253|538134109|FG000|Overall Study|Death|0|||
148931688|NCT00736879|537235100|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
148931689|NCT00736879|537235101|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
148931690|NCT00736879|537235098|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
148931691|NCT00736879|537235099|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
148931692|NCT00736879|537235100|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
149180909|NCT02619253|538134110|FG001|Overall Study|Death|0|||
149180910|NCT02619253|538134111|FG002|Overall Study|Death|0|||
149180911|NCT02619253|538134112|FG003|Overall Study|Death|1|||
149180912|NCT02619253|538134113|FG004|Overall Study|Death|0|||
149180913|NCT02619253|538134109|FG000|Overall Study|Disease Progression|4|||
149180914|NCT02619253|538134110|FG001|Overall Study|Disease Progression|2|||
149180915|NCT02619253|538134111|FG002|Overall Study|Disease Progression|8|||
149180916|NCT02619253|538134112|FG003|Overall Study|Disease Progression|9|||
149180917|NCT02619253|538134113|FG004|Overall Study|Disease Progression|10|||
149180918|NCT02619253|538134109|FG000|Overall Study|Needed a disqualifying therapy|0|||
149180919|NCT02619253|538134110|FG001|Overall Study|Needed a disqualifying therapy|0|||
149180920|NCT02619253|538134111|FG002|Overall Study|Needed a disqualifying therapy|1|||
149180921|NCT02619253|538134112|FG003|Overall Study|Needed a disqualifying therapy|0|||
149180922|NCT02619253|538134113|FG004|Overall Study|Needed a disqualifying therapy|0|||
149180923|NCT02619253|538134109|FG000|Overall Study|Transferred to hospice|0|||
149180924|NCT02619253|538134110|FG001|Overall Study|Transferred to hospice|0|||
149180925|NCT02619253|538134111|FG002|Overall Study|Transferred to hospice|1|||
149180926|NCT02619253|538134112|FG003|Overall Study|Transferred to hospice|0|||
149180927|NCT02619253|538134113|FG004|Overall Study|Transferred to hospice|0|||
149180928|NCT02619253|538134109|FG000|Overall Study|Physician Decision|0|||
149180929|NCT02619253|538134110|FG001|Overall Study|Physician Decision|1|||
149180930|NCT02619253|538134111|FG002|Overall Study|Physician Decision|2|||
149180931|NCT02619253|538134112|FG003|Overall Study|Physician Decision|3|||
149180932|NCT02619253|538134113|FG004|Overall Study|Physician Decision|0|||
149180933|NCT02619253|538134109|FG000|Overall Study|Withdrawal by Subject|0|||
149180934|NCT02619253|538134110|FG001|Overall Study|Withdrawal by Subject|1|||
149180935|NCT02619253|538134111|FG002|Overall Study|Withdrawal by Subject|0|||
149180936|NCT02619253|538134112|FG003|Overall Study|Withdrawal by Subject|0|||
149180937|NCT02619253|538134113|FG004|Overall Study|Withdrawal by Subject|2|||
149180938|NCT00514449|538134114|FG000|Overall Study|Withdrawal by Subject|1|||
149180939|NCT00514449|538134115|FG001|Overall Study|Withdrawal by Subject|2|||
149180940|NCT00514449|538134114|FG000|Overall Study|Protocol Violation|1|||
149180941|NCT00514449|538134115|FG001|Overall Study|Protocol Violation|2|||
149180942|NCT00514449|538134114|FG000|Overall Study|Lost to Follow-up|1|||
149180943|NCT00514449|538134115|FG001|Overall Study|Lost to Follow-up|0|||
149180944|NCT00995371|538134122|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
149180945|NCT00995371|538134123|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
149180946|NCT00306891|538134124|FG000|Part A|Withdrawal by Subject|1|||
149180947|NCT00306891|538134125|FG001|Part A|Withdrawal by Subject|1|||
149180948|NCT00306891|538134126|FG002|Part A|Withdrawal by Subject|0|||
149180949|NCT00306891|538134127|FG003|Part A|Withdrawal by Subject|0|||
149180950|NCT00306891|538134124|FG000|Part A|Condition under investigation worsened|2|||
149180951|NCT00306891|538134125|FG001|Part A|Condition under investigation worsened|2|||
149180952|NCT00306891|538134126|FG002|Part A|Condition under investigation worsened|0|||
149180953|NCT00306891|538134127|FG003|Part A|Condition under investigation worsened|0|||
149180954|NCT00306891|538134124|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
149180955|NCT00306891|538134125|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
149180956|NCT00306891|538134126|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
149180957|NCT00306891|538134127|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
149180958|NCT00306891|538134124|FG000|Part A|Partial bowel obstruction|1|||
149180959|NCT00306891|538134125|FG001|Part A|Partial bowel obstruction|0|||
149180960|NCT00306891|538134126|FG002|Part A|Partial bowel obstruction|0|||
149180961|NCT00306891|538134127|FG003|Part A|Partial bowel obstruction|0|||
149180962|NCT00306891|538134124|FG000|Part A|Reaccumul. of ascites following drainage|0|||
149180963|NCT00306891|538134125|FG001|Part A|Reaccumul. of ascites following drainage|1|||
149180964|NCT00306891|538134126|FG002|Part A|Reaccumul. of ascites following drainage|0|||
149180965|NCT00306891|538134127|FG003|Part A|Reaccumul. of ascites following drainage|0|||
149180966|NCT00306891|538134124|FG000|Part A|Suspicion of second malignancy|0|||
149180967|NCT00306891|538134125|FG001|Part A|Suspicion of second malignancy|1|||
149180968|NCT00306891|538134126|FG002|Part A|Suspicion of second malignancy|0|||
149180969|NCT00306891|538134127|FG003|Part A|Suspicion of second malignancy|0|||
149180970|NCT00306891|538134124|FG000|Part A|QTC interval outwith elig. criteria|1|||
149180971|NCT00306891|538134125|FG001|Part A|QTC interval outwith elig. criteria|0|||
149180972|NCT00306891|538134126|FG002|Part A|QTC interval outwith elig. criteria|0|||
149180973|NCT00306891|538134127|FG003|Part A|QTC interval outwith elig. criteria|0|||
149180974|NCT00306891|538134124|FG000|Part B|Death|0|||
149180975|NCT00306891|538134125|FG001|Part B|Death|0|||
149180976|NCT00306891|538134126|FG002|Part B|Death|1|||
149180977|NCT00306891|538134127|FG003|Part B|Death|2|||
149180978|NCT00306891|538134124|FG000|Part B|Adverse Event|0|||
149180979|NCT00306891|538134125|FG001|Part B|Adverse Event|0|||
149180980|NCT00306891|538134126|FG002|Part B|Adverse Event|5|||
149180981|NCT00306891|538134127|FG003|Part B|Adverse Event|5|||
149180982|NCT00306891|538134124|FG000|Part B|Withdrawal by Subject|0|||
149180983|NCT00306891|538134125|FG001|Part B|Withdrawal by Subject|0|||
149180984|NCT00306891|538134126|FG002|Part B|Withdrawal by Subject|3|||
149180985|NCT00306891|538134127|FG003|Part B|Withdrawal by Subject|1|||
149180986|NCT00306891|538134124|FG000|Part B|Condition under investigation worsened|0|||
149180987|NCT00306891|538134125|FG001|Part B|Condition under investigation worsened|0|||
149180988|NCT00306891|538134126|FG002|Part B|Condition under investigation worsened|2|||
149180989|NCT00306891|538134127|FG003|Part B|Condition under investigation worsened|8|||
149180990|NCT00306891|538134124|FG000|Part B|Development of study specific disc crit.|0|||
149180991|NCT00306891|538134125|FG001|Part B|Development of study specific disc crit.|0|||
149180992|NCT00306891|538134126|FG002|Part B|Development of study specific disc crit.|0|||
149180993|NCT00306891|538134127|FG003|Part B|Development of study specific disc crit.|1|||
149180994|NCT00673673|538134128|FG000|Overall Study|Progressive disease|27|||
149180995|NCT00673673|538134128|FG000|Overall Study|Adverse Event|4|||
149180996|NCT00673673|538134128|FG000|Overall Study|Withdrawal by Subject|3|||
149180997|NCT00673673|538134128|FG000|Overall Study|Investigators' discretion|2|||
149180998|NCT00206518|538134135|FG000|Overall Study|Lack of Efficacy|6|||
149180999|NCT00206518|538134136|FG001|Overall Study|Lack of Efficacy|4|||
149181000|NCT00206518|538134135|FG000|Overall Study|Adverse Event|2|||
149181001|NCT00206518|538134136|FG001|Overall Study|Adverse Event|1|||
149181002|NCT00206518|538134135|FG000|Overall Study|Physician Decision|1|||
149181003|NCT00206518|538134136|FG001|Overall Study|Physician Decision|0|||
149181004|NCT00206518|538134135|FG000|Overall Study|Protocol Violation|1|||
149181005|NCT00206518|538134136|FG001|Overall Study|Protocol Violation|1|||
149181006|NCT02335450|538134137|FG000|Overall Study|Pregnancy|1|||
149181007|NCT02613572|538134138|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
149181008|NCT02613572|538134139|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
149181009|NCT02613572|538134140|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
149181010|NCT02613572|538134138|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
149181011|NCT02613572|538134139|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
149181012|NCT02613572|538134140|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
149181013|NCT04538950|538134142|FG000|Overall Study|Pulmonary Issues|2|||
149181014|NCT04538950|538134142|FG000|Overall Study|illness|2|||
149181015|NCT00231478|538134143|FG000|Overall Study|Protocol Violation|3|||
149181016|NCT00231478|538134144|FG001|Overall Study|Protocol Violation|2|||
149181017|NCT00231478|538134143|FG000|Overall Study|Refused Treatment|1|||
149181018|NCT00231478|538134144|FG001|Overall Study|Refused Treatment|1|||
149181019|NCT00231478|538134143|FG000|Overall Study|Withdrawal by Subject|1|||
149181020|NCT00231478|538134144|FG001|Overall Study|Withdrawal by Subject|0|||
149181021|NCT00231478|538134143|FG000|Overall Study|Adverse Event|0|||
149181022|NCT00231478|538134144|FG001|Overall Study|Adverse Event|1|||
149181023|NCT00231478|538134143|FG000|Overall Study|Administrative|3|||
149181024|NCT00231478|538134144|FG001|Overall Study|Administrative|2|||
149181025|NCT00853905|538134145|FG000|Overall Study|Lost to Follow-up|1|||
149181026|NCT00853905|538134146|FG001|Overall Study|Lost to Follow-up|3|||
149181027|NCT00853905|538134145|FG000|Overall Study|Withdrawal by Subject|0|||
149181028|NCT00853905|538134146|FG001|Overall Study|Withdrawal by Subject|1|||
149181029|NCT00853905|538134145|FG000|Overall Study|never had surgery|1|||
149181030|NCT00853905|538134146|FG001|Overall Study|never had surgery|0|||
149181031|NCT00847561|538134151|FG000|Overall Study|Withdrawal by Subject|4|||
149181032|NCT00847561|538134152|FG001|Overall Study|Withdrawal by Subject|3|||
149181033|NCT00847561|538134151|FG000|Overall Study|Unable to schedule|9|||
149181034|NCT00847561|538134152|FG001|Overall Study|Unable to schedule|1|||
149181035|NCT02053246|538134154|FG000|Overall Study|Withdrawal by Subject|3|||
149181036|NCT02053246|538134154|FG000|Overall Study|Physician Decision|1|||
149181037|NCT02369510|538134157|FG000|Overall Study|Spilled Medication|1|||
149181038|NCT02369510|538134158|FG001|Overall Study|Spilled Medication|2|||
149181039|NCT02369510|538134159|FG002|Overall Study|Spilled Medication|1|||
149181040|NCT02369510|538134157|FG000|Overall Study|Epidural Activation|1|||
149181041|NCT02369510|538134158|FG001|Overall Study|Epidural Activation|1|||
149181042|NCT02369510|538134159|FG002|Overall Study|Epidural Activation|5|||
149181043|NCT04285723|538134166|FG000|Overall Study|Subject decision|1|||
149181044|NCT04285723|538134167|FG001|Overall Study|Subject decision|2|||
149181045|NCT04285723|538134166|FG000|Overall Study|Physician Decision|1|||
149181046|NCT04285723|538134167|FG001|Overall Study|Physician Decision|0|||
149181047|NCT04285723|538134166|FG000|Overall Study|No efficiency|1|||
149181048|NCT04285723|538134167|FG001|Overall Study|No efficiency|0|||
149181049|NCT03067311|538134168|FG000|Overall Study|Lost to Follow-up|1|||
149181050|NCT03067311|538134169|FG001|Overall Study|Lost to Follow-up|1|||
149181051|NCT03067311|538134168|FG000|Overall Study|Moved away|1|||
149181052|NCT03067311|538134169|FG001|Overall Study|Moved away|1|||
149181053|NCT02903511|538134170|FG000|Overall Study|Withdrawal by Subject|1|||
149181054|NCT02903511|538134171|FG001|Overall Study|Withdrawal by Subject|0|||
149181055|NCT02903511|538134170|FG000|Overall Study|Lost to Follow-up|3|||
149013817|NCT00737061|537530803|FG000|Waiting Period|Elected surgical tubal ligation|5|||
149181056|NCT02903511|538134171|FG001|Overall Study|Lost to Follow-up|2|||
149181057|NCT00907738|538134172|FG000|Overall Study|Adverse Event|2|||
149181058|NCT00907738|538134173|FG001|Overall Study|Adverse Event|0|||
149181059|NCT00907738|538134174|FG002|Overall Study|Adverse Event|1|||
149181060|NCT00907738|538134175|FG003|Overall Study|Adverse Event|0|||
149181061|NCT00907738|538134176|FG004|Overall Study|Adverse Event|0|||
149181062|NCT00907738|538134172|FG000|Overall Study|not specified or withdrew consent|3|||
149181063|NCT00907738|538134173|FG001|Overall Study|not specified or withdrew consent|0|||
149181064|NCT00907738|538134174|FG002|Overall Study|not specified or withdrew consent|0|||
149181065|NCT00907738|538134175|FG003|Overall Study|not specified or withdrew consent|0|||
149181066|NCT00907738|538134176|FG004|Overall Study|not specified or withdrew consent|0|||
149181067|NCT00907738|538134172|FG000|Overall Study|Disease progression|8|||
149181068|NCT00907738|538134173|FG001|Overall Study|Disease progression|1|||
149181069|NCT00907738|538134174|FG002|Overall Study|Disease progression|6|||
149181070|NCT00907738|538134175|FG003|Overall Study|Disease progression|4|||
149181071|NCT00907738|538134176|FG004|Overall Study|Disease progression|2|||
149181072|NCT05363293|538134177|FG000|Overall Study|Withdrawal by Subject|1|||
149181073|NCT05363293|538134178|FG001|Overall Study|Withdrawal by Subject|0|||
149181074|NCT05363293|538134179|FG002|Overall Study|Withdrawal by Subject|0|||
149181075|NCT05363293|538134180|FG003|Overall Study|Withdrawal by Subject|0|||
149181076|NCT05363293|538134181|FG004|Overall Study|Withdrawal by Subject|0|||
149181077|NCT05363293|538134182|FG005|Overall Study|Withdrawal by Subject|0|||
149181078|NCT05363293|538134183|FG006|Overall Study|Withdrawal by Subject|0|||
149181079|NCT05363293|538134184|FG007|Overall Study|Withdrawal by Subject|0|||
149181080|NCT05363293|538134185|FG008|Overall Study|Withdrawal by Subject|0|||
149181081|NCT05363293|538134186|FG009|Overall Study|Withdrawal by Subject|0|||
149181082|NCT01894516|538135697|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
149181083|NCT01894516|538135698|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
149181084|NCT01894516|538135699|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
149181085|NCT01894516|538135700|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
149181086|NCT01894516|538135697|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
149181087|NCT01894516|538135698|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149181088|NCT01894516|538135699|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149181089|NCT01894516|538135700|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149181090|NCT01894516|538135697|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
149181091|NCT01894516|538135698|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
149181092|NCT01894516|538135699|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
149181093|NCT01894516|538135700|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
149181094|NCT01894516|538135697|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
149181095|NCT01894516|538135698|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
149181096|NCT01894516|538135699|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
149181097|NCT01894516|538135700|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
149181098|NCT01894516|538135697|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
149181099|NCT01894516|538135698|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
149181100|NCT01894516|538135699|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
149181101|NCT01894516|538135700|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
149181102|NCT01894516|538135697|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
149181103|NCT01894516|538135698|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
149181104|NCT01894516|538135699|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
149181105|NCT01894516|538135700|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
149181106|NCT01894516|538135697|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
149181107|NCT01894516|538135698|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
149181108|NCT01894516|538135699|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
149181109|NCT01894516|538135700|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
149181110|NCT01894516|538135697|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149181111|NCT01894516|538135698|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149181112|NCT01894516|538135699|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
149181113|NCT01894516|538135700|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149181114|NCT00375934|538135713|FG000|Overall Study|Adverse Event|1|||
149181115|NCT00375934|538135714|FG001|Overall Study|Adverse Event|1|||
149181116|NCT00375934|538135713|FG000|Overall Study|Withdrawal by Subject|2|||
149181117|NCT00375934|538135714|FG001|Overall Study|Withdrawal by Subject|2|||
149181118|NCT00375934|538135713|FG000|Overall Study|Lack of Efficacy|0|||
149181119|NCT00375934|538135714|FG001|Overall Study|Lack of Efficacy|2|||
149181120|NCT00375934|538135713|FG000|Overall Study|Physician Decision|0|||
149181121|NCT00375934|538135714|FG001|Overall Study|Physician Decision|1|||
149181122|NCT03191396|538135715|FG000|Overall Study|Lost to Follow-up|0|||
149181123|NCT03191396|538135716|FG001|Overall Study|Lost to Follow-up|3|||
149181124|NCT03191396|538135715|FG000|Overall Study|Withdrawal by Subject|3|||
149181125|NCT03191396|538135716|FG001|Overall Study|Withdrawal by Subject|2|||
149181126|NCT05094154|538135719|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
149181127|NCT05094154|538135720|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
149181128|NCT05094154|538135719|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
149181129|NCT05094154|538135720|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
149181130|NCT00893113|538135727|FG000|Overall Study|Lost to Follow-up|4|||
149181131|NCT00893113|538135728|FG001|Overall Study|Lost to Follow-up|8|||
149181132|NCT00893113|538135727|FG000|Overall Study|Early Termination|1|||
149181133|NCT00893113|538135728|FG001|Overall Study|Early Termination|1|||
149181134|NCT00893113|538135727|FG000|Overall Study|Withdrew Consent|8|||
149181135|NCT00893113|538135728|FG001|Overall Study|Withdrew Consent|7|||
149181136|NCT02100657|538135729|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
149181137|NCT02100657|538135730|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
149181138|NCT02100657|538135731|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
149181139|NCT02100657|538135729|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
149181140|NCT02100657|538135730|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
149181141|NCT02100657|538135731|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
149181142|NCT02100657|538135729|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
149181143|NCT02100657|538135730|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
149181144|NCT02100657|538135731|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
149181145|NCT02100657|538135729|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
149181146|NCT02100657|538135730|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
149181147|NCT02100657|538135731|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
149181148|NCT02100657|538135729|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
149181149|NCT02100657|538135730|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
149181150|NCT02100657|538135731|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
149181151|NCT02100657|538135729|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
149181152|NCT02100657|538135730|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
149181153|NCT02100657|538135731|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
149181154|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
149181155|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
149181156|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
149181157|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Death|0|||
149181158|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Death|0|||
149181159|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Death|1|||
149181160|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
149181161|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
149181162|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
149181163|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
149181164|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
149181165|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
149181166|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
149181167|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
149181168|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
149181169|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
149181170|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
149181171|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
149181172|NCT02100657|538135729|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
149181173|NCT02100657|538135730|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
148931693|NCT00736879|537235101|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
149181174|NCT02100657|538135731|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
149181175|NCT02531035|538135734|FG000|Overall Study|Death|0|||
149181176|NCT02531035|538135735|FG001|Overall Study|Death|1|||
149181177|NCT02531035|538135734|FG000|Overall Study|Protocol Violation|1|||
149181178|NCT02531035|538135735|FG001|Overall Study|Protocol Violation|1|||
149181179|NCT02531035|538135734|FG000|Overall Study|Noncompliance with study drug|8|||
149181180|NCT02531035|538135735|FG001|Overall Study|Noncompliance with study drug|3|||
149181181|NCT02531035|538135734|FG000|Overall Study|Physician Decision|1|||
149181182|NCT02531035|538135735|FG001|Overall Study|Physician Decision|0|||
149181183|NCT02531035|538135734|FG000|Overall Study|Adverse Event|16|||
149181184|NCT02531035|538135735|FG001|Overall Study|Adverse Event|45|||
149181185|NCT02531035|538135734|FG000|Overall Study|Other|3|||
149181186|NCT02531035|538135735|FG001|Overall Study|Other|2|||
149181187|NCT02531035|538135734|FG000|Overall Study|Withdrawal by Subject|42|||
149181188|NCT02531035|538135735|FG001|Overall Study|Withdrawal by Subject|32|||
149181189|NCT02531035|538135734|FG000|Overall Study|Lost to Follow-up|8|||
149181190|NCT02531035|538135735|FG001|Overall Study|Lost to Follow-up|10|||
149181191|NCT02531035|538135734|FG000|Overall Study|Randomized, not treated|2|||
149181192|NCT02531035|538135735|FG001|Overall Study|Randomized, not treated|1|||
149181193|NCT03270085|538135744|FG000|Overall Study|Withdrawal by Subject|1|||
149181194|NCT03270085|538135745|FG001|Overall Study|Withdrawal by Subject|0|||
148931694|NCT00736879|537235098|FG000|Double Blind Treatment Period|No longer met criteria|0|||
149181195|NCT03692910|538135747|FG000|Overall Study|Lost to Follow-up|4|||
148931695|NCT00736879|537235099|FG001|Double Blind Treatment Period|No longer met criteria|1|||
149181196|NCT03692910|538135748|FG001|Overall Study|Lost to Follow-up|0|||
149181197|NCT03692910|538135749|FG002|Overall Study|Lost to Follow-up|0|||
149181198|NCT03692910|538135747|FG000|Overall Study|Withdrawal by Subject|2|||
149181199|NCT03692910|538135748|FG001|Overall Study|Withdrawal by Subject|0|||
148931696|NCT00736879|537235100|FG002|Double Blind Treatment Period|No longer met criteria|0|||
149181200|NCT03692910|538135749|FG002|Overall Study|Withdrawal by Subject|0|||
149181201|NCT00151411|538135752|FG000|Overall Study|Lost to Follow-up|15|||
149181202|NCT00151411|538135753|FG001|Overall Study|Lost to Follow-up|19|||
149181203|NCT00151411|538135752|FG000|Overall Study|Withdrawal by Subject|12|||
149181204|NCT00151411|538135753|FG001|Overall Study|Withdrawal by Subject|20|||
149181205|NCT00151411|538135752|FG000|Overall Study|Adverse Event|6|||
149181206|NCT00151411|538135753|FG001|Overall Study|Adverse Event|0|||
149181207|NCT00151411|538135752|FG000|Overall Study|Pregnancy|0|||
149181208|NCT00151411|538135753|FG001|Overall Study|Pregnancy|4|||
149181209|NCT01283581|538135754|FG000|Overall Study|Lost to Follow-up|8|||
149181210|NCT01283581|538135755|FG001|Overall Study|Lost to Follow-up|6|||
149181211|NCT01283581|538135756|FG002|Overall Study|Lost to Follow-up|8|||
149181212|NCT01283581|538135754|FG000|Overall Study|Withdrawal by Subject|2|||
149181213|NCT01283581|538135755|FG001|Overall Study|Withdrawal by Subject|5|||
149181214|NCT01283581|538135756|FG002|Overall Study|Withdrawal by Subject|2|||
149181215|NCT01283581|538135754|FG000|Overall Study|Adverse Event|1|||
149181216|NCT01283581|538135755|FG001|Overall Study|Adverse Event|1|||
149181217|NCT01283581|538135756|FG002|Overall Study|Adverse Event|4|||
149181218|NCT01283581|538135754|FG000|Overall Study|Physician Decision|0|||
149181219|NCT01283581|538135755|FG001|Overall Study|Physician Decision|1|||
149181220|NCT01283581|538135756|FG002|Overall Study|Physician Decision|2|||
149181221|NCT01283581|538135754|FG000|Overall Study|Protocol Violation|0|||
149181222|NCT01283581|538135755|FG001|Overall Study|Protocol Violation|1|||
149181223|NCT01283581|538135756|FG002|Overall Study|Protocol Violation|2|||
149181224|NCT01283581|538135754|FG000|Overall Study|Noncompliance|1|||
149181225|NCT01283581|538135755|FG001|Overall Study|Noncompliance|0|||
149181226|NCT01283581|538135756|FG002|Overall Study|Noncompliance|0|||
149181227|NCT01283581|538135754|FG000|Overall Study|Investigator unblinded|0|||
149181228|NCT01283581|538135755|FG001|Overall Study|Investigator unblinded|0|||
149181229|NCT01283581|538135756|FG002|Overall Study|Investigator unblinded|1|||
149181230|NCT01283581|538135754|FG000|Overall Study|"Early termination"|0|||
149181231|NCT01283581|538135755|FG001|Overall Study|"Early termination"|0|||
149181232|NCT01283581|538135756|FG002|Overall Study|"Early termination"|1|||
149181233|NCT00486226|538135757|FG000|Overall Study|Death|3|||
149181234|NCT00486226|538135757|FG000|Overall Study|Adverse Event|1|||
149181235|NCT00486226|538135757|FG000|Overall Study|Withdrawal by Subject|1|||
149181236|NCT00486226|538135757|FG000|Overall Study|Lost to Follow-up|8|||
149181237|NCT01259492|538135758|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
149181238|NCT01259492|538135759|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
149181239|NCT01259492|538135760|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
149181240|NCT01259492|538135761|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
149181241|NCT01259492|538135758|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
149181242|NCT01259492|538135759|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
149181243|NCT01259492|538135760|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
149181244|NCT01259492|538135761|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
149181245|NCT01259492|538135758|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
149181246|NCT01259492|538135759|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
149181247|NCT01259492|538135760|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
149181248|NCT01259492|538135761|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
149181249|NCT01259492|538135758|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
149181250|NCT01259492|538135759|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
149181251|NCT01259492|538135760|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
149181252|NCT01259492|538135761|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
149181253|NCT01259492|538135758|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
149181254|NCT01259492|538135759|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
149181255|NCT01259492|538135760|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
148679614|NCT03216954|536300834|FG002|Overall Study|Adverse Event|1|||
148931697|NCT00736879|537235101|FG003|Double Blind Treatment Period|No longer met criteria|0|||
148931698|NCT00736879|537235098|FG000|Double Blind Treatment Period|non-specified|0|||
148931699|NCT00736879|537235099|FG001|Double Blind Treatment Period|non-specified|1|||
148679615|NCT03216954|536300835|FG003|Overall Study|Adverse Event|0|||
148679616|NCT03216954|536300836|FG004|Overall Study|Adverse Event|1|||
148679617|NCT03216954|536300832|FG000|Overall Study|Withdrawal by Subject|2|||
148679618|NCT03216954|536300833|FG001|Overall Study|Withdrawal by Subject|0|||
148679619|NCT03216954|536300834|FG002|Overall Study|Withdrawal by Subject|0|||
148931700|NCT00736879|537235100|FG002|Double Blind Treatment Period|non-specified|0|||
148931701|NCT00736879|537235101|FG003|Double Blind Treatment Period|non-specified|0|||
148931702|NCT00736879|537235098|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
149181256|NCT01259492|538135761|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
149181257|NCT01259492|538135758|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
148679620|NCT03216954|536300835|FG003|Overall Study|Withdrawal by Subject|0|||
148679621|NCT03216954|536300836|FG004|Overall Study|Withdrawal by Subject|0|||
148691441|NCT01325207|536344179|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
148931703|NCT00736879|537235099|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
149181258|NCT01259492|538135759|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
149181259|NCT01259492|538135760|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
149181260|NCT01259492|538135761|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
149181261|NCT01259492|538135758|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
149181262|NCT01259492|538135759|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
149181263|NCT01259492|538135760|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
148931704|NCT00736879|537235100|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
148931705|NCT00736879|537235101|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
148931706|NCT00736879|537235098|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
148931707|NCT00736879|537235099|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
148931708|NCT00736879|537235100|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
148931709|NCT00736879|537235101|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
148931710|NCT02360111|537235102|FG000|Overall Study|Death|2|||
148931711|NCT01933217|537235107|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
148931712|NCT01933217|537235108|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
148931713|NCT01933217|537235107|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
148931714|NCT01933217|537235108|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
148931715|NCT01031381|537235111|FG000|Overall Study|Physician Decision|3|||
148931716|NCT01031381|537235111|FG000|Overall Study|Withdrawal by Subject|6|||
148931717|NCT00267189|537235112|FG000|Overall Study|Patient withdrew consent|1|||
148931718|NCT00267189|537235113|FG001|Overall Study|Patient withdrew consent|1|||
148931719|NCT00267189|537235112|FG000|Overall Study|Death|1|||
148931720|NCT00267189|537235113|FG001|Overall Study|Death|0|||
148931721|NCT00267189|537235112|FG000|Overall Study|Missing|3|||
148931722|NCT00267189|537235113|FG001|Overall Study|Missing|0|||
148931723|NCT04137224|537235114|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
148931724|NCT04137224|537235115|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
148931725|NCT04137224|537235114|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
148931726|NCT04137224|537235115|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
148931727|NCT04137224|537235114|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
148931728|NCT04137224|537235115|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
148931729|NCT01225887|537235116|FG000|Overall Study|Ineligible:required test not done|2|||
148931730|NCT01225887|537235116|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
148931731|NCT01225887|537235116|FG000|Overall Study|Ineligible:inadequate pathology|2|||
148931732|NCT00925990|537235117|FG000|Overall Study|Adverse Event|1|||
148931733|NCT00925990|537235118|FG001|Overall Study|Adverse Event|3|||
148931734|NCT00925990|537235117|FG000|Overall Study|Withdrawal by Subject|2|||
148931735|NCT00925990|537235118|FG001|Overall Study|Withdrawal by Subject|2|||
148931736|NCT00925990|537235117|FG000|Overall Study|Lost to Follow-up|1|||
148931737|NCT00925990|537235118|FG001|Overall Study|Lost to Follow-up|3|||
148931738|NCT00925990|537235117|FG000|Overall Study|Physician Decision|1|||
148931739|NCT00925990|537235118|FG001|Overall Study|Physician Decision|1|||
148931740|NCT00925990|537235117|FG000|Overall Study|moved out of state, missed medication|0|||
148931741|NCT00925990|537235118|FG001|Overall Study|moved out of state, missed medication|2|||
148931742|NCT01368432|537235119|FG000|Overall Study|Lost to Follow-up|0|||
148931743|NCT01368432|537235120|FG001|Overall Study|Lost to Follow-up|1|||
148931744|NCT04950166|537235126|FG000|Overall Study|Withdrawal by Subject|1|||
148931745|NCT05896748|537235127|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
148931746|NCT05896748|537235127|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
148931747|NCT05896748|537235127|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
148931748|NCT05896748|537235127|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
148931749|NCT05896748|537235127|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
149181264|NCT01259492|538135761|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
149181265|NCT01259492|538135758|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
149181266|NCT01259492|538135759|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
149181267|NCT01259492|538135760|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
149181268|NCT01259492|538135761|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
149181269|NCT01259492|538135758|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
149181270|NCT01259492|538135759|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
149181271|NCT01259492|538135760|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
149181272|NCT01259492|538135761|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
149181273|NCT01259492|538135758|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
149181274|NCT01259492|538135759|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
149181275|NCT01259492|538135760|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
149181276|NCT01259492|538135761|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
148931750|NCT01822678|537235135|FG000|Overall Study|Withdrawal by Subject|5|||
148931751|NCT01822678|537235136|FG001|Overall Study|Withdrawal by Subject|4|||
148931752|NCT01822678|537235137|FG002|Overall Study|Withdrawal by Subject|4|||
149181277|NCT01259492|538135758|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
148931753|NCT01822678|537235135|FG000|Overall Study|Adverse Event|4|||
149013818|NCT00737061|537530803|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
149181278|NCT01259492|538135759|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
149181279|NCT01259492|538135760|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
148807286|NCT01140906|536773223|FG001|Overall Study|Lost to Follow-up|1|||
148931754|NCT01822678|537235136|FG001|Overall Study|Adverse Event|3|||
148931755|NCT01822678|537235137|FG002|Overall Study|Adverse Event|1|||
148931756|NCT01822678|537235135|FG000|Overall Study|Lack of Efficacy|3|||
149234004|NCT01422876|538326350|FG004|Week 52|Lost to Follow-up|8|||
149181280|NCT01259492|538135761|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
149181281|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
148931757|NCT01822678|537235136|FG001|Overall Study|Lack of Efficacy|6|||
149181282|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
149181283|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
149181284|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
149181285|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
149181286|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
149181287|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
149181288|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
149181289|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
149181290|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
149181291|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
149181292|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
149181293|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
149181294|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
149181295|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
149181296|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
149181297|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
149181298|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
149181299|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
149181300|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
149181301|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
149181302|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
149181303|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
148931758|NCT01822678|537235137|FG002|Overall Study|Lack of Efficacy|5|||
148931759|NCT01822678|537235135|FG000|Overall Study|Lost to Follow-up|0|||
148931760|NCT01822678|537235136|FG001|Overall Study|Lost to Follow-up|2|||
149181304|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
149181305|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
149181306|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
149181307|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
149181308|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
149181309|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
149181310|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
149181311|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
149181312|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
149181313|NCT01259492|538135758|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
149181314|NCT01259492|538135759|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
149181315|NCT01259492|538135760|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
149181316|NCT01259492|538135761|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
149181317|NCT03846947|538135764|FG000|Overall Study|technical issues with imaging sequence|2|||
149181318|NCT00634543|538135770|FG000|Overall Study|Other|1|||
149181319|NCT00634543|538135771|FG001|Overall Study|Other|2|||
149181320|NCT00634543|538135770|FG000|Overall Study|Protocol Violation|3|||
148931761|NCT01822678|537235137|FG002|Overall Study|Lost to Follow-up|1|||
148931762|NCT00249288|537235143|FG000|Overall Study|Lost to Follow-up|3|||
148931763|NCT00249288|537235144|FG001|Overall Study|Lost to Follow-up|3|||
148931764|NCT00249288|537235143|FG000|Overall Study|Withdrawal by Subject|2|||
148931765|NCT00249288|537235144|FG001|Overall Study|Withdrawal by Subject|2|||
148931766|NCT04795622|537235145|FG000|Overall Study|Adverse Event|1|||
148931767|NCT04795622|537235146|FG001|Overall Study|Adverse Event|0|||
148931768|NCT04795622|537235145|FG000|Overall Study|Withdrawal by Subject|3|||
148931769|NCT04795622|537235146|FG001|Overall Study|Withdrawal by Subject|3|||
148931770|NCT04795622|537235145|FG000|Overall Study|Protocol Violation|0|||
148931771|NCT04795622|537235146|FG001|Overall Study|Protocol Violation|2|||
148931772|NCT04795622|537235145|FG000|Overall Study|Lost to Follow-up|2|||
148931773|NCT04795622|537235146|FG001|Overall Study|Lost to Follow-up|3|||
148931774|NCT04795622|537235145|FG000|Overall Study|Other|7|||
149013819|NCT00737061|537530803|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
148931775|NCT04795622|537235146|FG001|Overall Study|Other|8|||
149013820|NCT00737061|537530803|FG000|1 Year Wearing Period|Discontinued reilance|3|||
149013821|NCT00737061|537530803|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
148931776|NCT03309046|537235147|FG000|Overall Study|Withdrawal by Subject|4|||
148931777|NCT03309046|537235148|FG001|Overall Study|Withdrawal by Subject|17|||
148931778|NCT01437878|537235149|FG000|Overall Study|Withdrawal by Subject|1|||
148931779|NCT01437878|537235150|FG001|Overall Study|Withdrawal by Subject|0|||
148931780|NCT01070043|537235151|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
148931781|NCT01070043|537235152|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
148931782|NCT01070043|537235153|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
148931783|NCT01070043|537235151|FG000|Double-Blind Treatment|Adverse Event|0|||
148931784|NCT01070043|537235152|FG001|Double-Blind Treatment|Adverse Event|0|||
148931785|NCT01070043|537235153|FG002|Double-Blind Treatment|Adverse Event|2|||
148931786|NCT01721070|537235154|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
148931787|NCT02047227|537235155|FG000|Overall Study|Adverse Event|2|||
148931788|NCT02047227|537235156|FG001|Overall Study|Adverse Event|4|||
148931789|NCT02047227|537235155|FG000|Overall Study|Lost to Follow-up|0|||
148931790|NCT02047227|537235156|FG001|Overall Study|Lost to Follow-up|3|||
148931791|NCT02047227|537235155|FG000|Overall Study|Protocol Violation|1|||
148931792|NCT02047227|537235156|FG001|Overall Study|Protocol Violation|0|||
148931793|NCT02047227|537235155|FG000|Overall Study|Spontaneous pregnancy|1|||
148931794|NCT02047227|537235156|FG001|Overall Study|Spontaneous pregnancy|0|||
148931795|NCT02047227|537235155|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
148931796|NCT02047227|537235156|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
148931797|NCT02047227|537235155|FG000|Overall Study|No oocytes retrieved|21|||
148931798|NCT02047227|537235156|FG001|Overall Study|No oocytes retrieved|20|||
148931799|NCT02047227|537235155|FG000|Overall Study|No fertilization|61|||
148931800|NCT02047227|537235156|FG001|Overall Study|No fertilization|51|||
149181321|NCT00634543|538135771|FG001|Overall Study|Protocol Violation|3|||
149181322|NCT00634543|538135770|FG000|Overall Study|Adverse Event|11|||
149181323|NCT00634543|538135771|FG001|Overall Study|Adverse Event|11|||
149181324|NCT00634543|538135770|FG000|Overall Study|Withdrawal by Subject|4|||
149181325|NCT00634543|538135771|FG001|Overall Study|Withdrawal by Subject|4|||
149181326|NCT00634543|538135770|FG000|Overall Study|Lost to Follow-up|0|||
149181327|NCT00634543|538135771|FG001|Overall Study|Lost to Follow-up|1|||
149181328|NCT00474630|538135772|FG000|Overall Study|Adverse Event|98|||
149181329|NCT00474630|538135773|FG001|Overall Study|Adverse Event|26|||
149181330|NCT00474630|538135772|FG000|Overall Study|Lost to Follow-up|22|||
149181331|NCT00474630|538135773|FG001|Overall Study|Lost to Follow-up|15|||
149181332|NCT00474630|538135772|FG000|Overall Study|Withdrawal by Subject|21|||
149181333|NCT00474630|538135773|FG001|Overall Study|Withdrawal by Subject|15|||
149181334|NCT00474630|538135772|FG000|Overall Study|Protocol Violation|3|||
149181335|NCT00474630|538135773|FG001|Overall Study|Protocol Violation|4|||
149181336|NCT00474630|538135772|FG000|Overall Study|Lack of Efficacy|5|||
149181337|NCT00474630|538135773|FG001|Overall Study|Lack of Efficacy|6|||
149181338|NCT00474630|538135772|FG000|Overall Study|Drug noncompliance, other|11|||
149181339|NCT00474630|538135773|FG001|Overall Study|Drug noncompliance, other|4|||
149181340|NCT03515538|538135774|FG000|Overall Study|Lack of Efficacy|2|||
149181341|NCT03515538|538135775|FG001|Overall Study|Lack of Efficacy|0|||
149181342|NCT03515538|538135776|FG002|Overall Study|Lack of Efficacy|2|||
149181343|NCT03515538|538135777|FG003|Overall Study|Lack of Efficacy|0|||
149181344|NCT03515538|538135774|FG000|Overall Study|Death|0|||
149181345|NCT03515538|538135775|FG001|Overall Study|Death|0|||
149181346|NCT03515538|538135776|FG002|Overall Study|Death|1|||
149181347|NCT03515538|538135777|FG003|Overall Study|Death|0|||
149181348|NCT03515538|538135774|FG000|Overall Study|Protocol Violation|0|||
149181349|NCT03515538|538135775|FG001|Overall Study|Protocol Violation|0|||
149181350|NCT03515538|538135776|FG002|Overall Study|Protocol Violation|0|||
149181351|NCT03515538|538135777|FG003|Overall Study|Protocol Violation|1|||
148931801|NCT02047227|537235155|FG000|Overall Study|Intention to freeze all embryos|1|||
148931802|NCT02047227|537235156|FG001|Overall Study|Intention to freeze all embryos|0|||
148931803|NCT02047227|537235155|FG000|Overall Study|All embryos discarded|12|||
148931804|NCT02047227|537235156|FG001|Overall Study|All embryos discarded|11|||
148931805|NCT02047227|537235155|FG000|Overall Study|Other|10|||
148931806|NCT02047227|537235156|FG001|Overall Study|Other|9|||
148931807|NCT01090973|537235169|FG000|Overall Study|Disease progression|1|||
148931808|NCT00445978|537235170|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
148931809|NCT00445978|537235170|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
148931810|NCT00445978|537235170|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
148931811|NCT00445978|537235170|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
148931812|NCT00445978|537235170|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
148931813|NCT00445978|537235170|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
149181352|NCT03515538|538135774|FG000|Overall Study|Screen failure (baseline dropout)|0|||
149181353|NCT03515538|538135775|FG001|Overall Study|Screen failure (baseline dropout)|1|||
149181354|NCT03515538|538135776|FG002|Overall Study|Screen failure (baseline dropout)|0|||
148931814|NCT00445978|537235170|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
149181355|NCT03515538|538135777|FG003|Overall Study|Screen failure (baseline dropout)|0|||
149181356|NCT03515538|538135774|FG000|Overall Study|Withdrawal by Subject|2|||
149181357|NCT03515538|538135775|FG001|Overall Study|Withdrawal by Subject|2|||
148931815|NCT00445978|537235170|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
148931816|NCT00445978|537235170|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
148931817|NCT02766465|537235171|FG000|Overall Study|Withdrawal by Subject|0|||
148931818|NCT02766465|537235172|FG001|Overall Study|Withdrawal by Subject|10|||
148931819|NCT02435069|537235173|FG000|Dose Response - First Intervention|Adverse Event|0|||
148931820|NCT02435069|537235174|FG001|Dose Response - First Intervention|Adverse Event|1|||
148931821|NCT02435069|537235175|FG002|Dose Response - First Intervention|Adverse Event|1|||
148931822|NCT02435069|537235176|FG003|Dose Response - First Intervention|Adverse Event|0|||
148931823|NCT02435069|537235177|FG004|Dose Response - First Intervention|Adverse Event|0|||
148931824|NCT02435069|537235173|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
148931825|NCT02435069|537235174|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
148931826|NCT02435069|537235175|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
148931827|NCT02435069|537235176|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
148931828|NCT02435069|537235177|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
148931829|NCT03112590|537235178|FG000|Overall Study|Adverse Event|0|||
148931830|NCT03112590|537235179|FG001|Overall Study|Adverse Event|1|||
148931831|NCT03112590|537235180|FG002|Overall Study|Adverse Event|0|||
148931832|NCT02059005|537235183|FG000|Overall Study|Death|1|||
148931833|NCT02059005|537235184|FG001|Overall Study|Death|3|||
148931834|NCT02059005|537235183|FG000|Overall Study|Lost to Follow-up|19|||
148931835|NCT02059005|537235184|FG001|Overall Study|Lost to Follow-up|19|||
148931836|NCT02059005|537235183|FG000|Overall Study|Incarceration|0|||
148931837|NCT02059005|537235184|FG001|Overall Study|Incarceration|1|||
148931838|NCT02059005|537235183|FG000|Overall Study|Inpatient|0|||
148931839|NCT02059005|537235184|FG001|Overall Study|Inpatient|1|||
148931840|NCT00739596|537235185|FG000|Overall Study|Adverse Event|12|||
148931841|NCT00739596|537235186|FG001|Overall Study|Adverse Event|6|||
148931842|NCT00739596|537235185|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
148931843|NCT00739596|537235186|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
148931844|NCT00739596|537235185|FG000|Overall Study|Patient Withdrew Consent|8|||
148931845|NCT00739596|537235186|FG001|Overall Study|Patient Withdrew Consent|8|||
148931846|NCT00739596|537235185|FG000|Overall Study|Lost to Follow-up|0|||
148931847|NCT00739596|537235186|FG001|Overall Study|Lost to Follow-up|2|||
148931848|NCT00739596|537235185|FG000|Overall Study|Protocol Deviation|1|||
148931849|NCT00739596|537235186|FG001|Overall Study|Protocol Deviation|1|||
149013822|NCT06173570|537530808|FG000|Overall Study|Adverse Event|1|||
149013823|NCT06173570|537530809|FG001|Overall Study|Adverse Event|0|||
149181358|NCT03515538|538135776|FG002|Overall Study|Withdrawal by Subject|1|||
149181359|NCT03515538|538135777|FG003|Overall Study|Withdrawal by Subject|3|||
149181360|NCT03515538|538135774|FG000|Overall Study|Physician Decision|1|||
149181361|NCT03515538|538135775|FG001|Overall Study|Physician Decision|0|||
149181362|NCT03515538|538135776|FG002|Overall Study|Physician Decision|0|||
149181363|NCT03515538|538135777|FG003|Overall Study|Physician Decision|1|||
149181364|NCT01736683|538135785|FG000|Overall Study|Disease Relapse|0|||
149181365|NCT01736683|538135786|FG001|Overall Study|Disease Relapse|0|||
149181366|NCT01736683|538135787|FG002|Overall Study|Disease Relapse|2|||
149181367|NCT01736683|538135788|FG003|Overall Study|Disease Relapse|1|||
148931850|NCT00843726|537235187|FG000|Overall Study|Death|1|||
149181368|NCT01736683|538135789|FG004|Overall Study|Disease Relapse|0|||
149181369|NCT01736683|538135785|FG000|Overall Study|Adverse Event|0|||
149181370|NCT01736683|538135786|FG001|Overall Study|Adverse Event|2|||
149181371|NCT01736683|538135787|FG002|Overall Study|Adverse Event|2|||
148931851|NCT00843726|537235188|FG001|Overall Study|Death|0|||
148931852|NCT00843726|537235187|FG000|Overall Study|Withdrawal by Subject|0|||
148931853|NCT00843726|537235188|FG001|Overall Study|Withdrawal by Subject|1|||
148931854|NCT02520661|537235189|FG000|Overall Study|Lost to Follow-up|7|||
149013824|NCT06173570|537530810|FG002|Overall Study|Adverse Event|0|||
149181372|NCT01736683|538135788|FG003|Overall Study|Adverse Event|3|||
149181373|NCT01736683|538135789|FG004|Overall Study|Adverse Event|2|||
149181374|NCT01736683|538135785|FG000|Overall Study|Withdrawal by Subject|0|||
149181375|NCT01736683|538135786|FG001|Overall Study|Withdrawal by Subject|0|||
149181376|NCT01736683|538135787|FG002|Overall Study|Withdrawal by Subject|3|||
149181377|NCT01736683|538135788|FG003|Overall Study|Withdrawal by Subject|1|||
149181378|NCT01736683|538135789|FG004|Overall Study|Withdrawal by Subject|1|||
149181379|NCT01736683|538135785|FG000|Overall Study|Lack of Therapeutic Effect|7|||
149181380|NCT01736683|538135786|FG001|Overall Study|Lack of Therapeutic Effect|4|||
149181381|NCT01736683|538135787|FG002|Overall Study|Lack of Therapeutic Effect|13|||
149181382|NCT01736683|538135788|FG003|Overall Study|Lack of Therapeutic Effect|20|||
149181383|NCT01736683|538135789|FG004|Overall Study|Lack of Therapeutic Effect|1|||
148931855|NCT02520661|537235190|FG001|Overall Study|Lost to Follow-up|3|||
148931856|NCT02520661|537235189|FG000|Overall Study|Admitted from ED|49|||
148931857|NCT02520661|537235190|FG001|Overall Study|Admitted from ED|48|||
148931858|NCT02520661|537235189|FG000|Overall Study|ED greater than 24 hours|29|||
148931859|NCT02520661|537235190|FG001|Overall Study|ED greater than 24 hours|38|||
148931860|NCT02520661|537235189|FG000|Overall Study|other ineligibility|14|||
149181384|NCT01736683|538135785|FG000|Overall Study|Progressive Disease|0|||
148807287|NCT01140906|536773224|FG002|Overall Study|Lost to Follow-up|0|||
148807288|NCT01140906|536773225|FG003|Overall Study|Lost to Follow-up|2|||
148931861|NCT02520661|537235190|FG001|Overall Study|other ineligibility|22|||
148931862|NCT02520661|537235189|FG000|Overall Study|Withdrawal by Subject|7|||
149181385|NCT01736683|538135786|FG001|Overall Study|Progressive Disease|0|||
148807289|NCT01140906|536773222|FG000|Overall Study|Administrative or other reason|0|||
148931863|NCT02520661|537235190|FG001|Overall Study|Withdrawal by Subject|16|||
148931864|NCT00171054|537235196|FG000|Overall Study|Protocol Violation|1|||
149181386|NCT01736683|538135787|FG002|Overall Study|Progressive Disease|0|||
149181387|NCT01736683|538135788|FG003|Overall Study|Progressive Disease|1|||
149181388|NCT01736683|538135789|FG004|Overall Study|Progressive Disease|0|||
149181389|NCT01736683|538135785|FG000|Overall Study|Other|0|||
149181390|NCT01736683|538135786|FG001|Overall Study|Other|0|||
149181391|NCT01736683|538135787|FG002|Overall Study|Other|1|||
149181392|NCT01736683|538135788|FG003|Overall Study|Other|9|||
149181393|NCT01736683|538135789|FG004|Overall Study|Other|1|||
149181394|NCT03069690|538135791|FG000|Pregnancy Intervention|Pregnancy loss|9|||
149181395|NCT03069690|538135792|FG001|Pregnancy Intervention|Pregnancy loss|4|||
149181396|NCT03069690|538135793|FG002|Pregnancy Intervention|Pregnancy loss|0|||
149181397|NCT03069690|538135794|FG003|Pregnancy Intervention|Pregnancy loss|0|||
149181398|NCT03069690|538135795|FG004|Pregnancy Intervention|Pregnancy loss|0|||
149181399|NCT03069690|538135796|FG005|Pregnancy Intervention|Pregnancy loss|0|||
149181400|NCT03069690|538135791|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
149181401|NCT03069690|538135792|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
149181402|NCT03069690|538135793|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
149181403|NCT03069690|538135794|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
149181404|NCT03069690|538135795|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
149181405|NCT03069690|538135796|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
149181406|NCT03069690|538135791|FG000|Postpartum Intervention|Lost to Follow-up|0|||
149181407|NCT03069690|538135792|FG001|Postpartum Intervention|Lost to Follow-up|0|||
149181408|NCT03069690|538135793|FG002|Postpartum Intervention|Lost to Follow-up|5|||
149181409|NCT03069690|538135794|FG003|Postpartum Intervention|Lost to Follow-up|5|||
149181410|NCT03069690|538135795|FG004|Postpartum Intervention|Lost to Follow-up|2|||
149181411|NCT03069690|538135796|FG005|Postpartum Intervention|Lost to Follow-up|4|||
149181412|NCT02564120|538135797|FG000|Overall Study|Did not return release forms|160|||
149181413|NCT02564120|538135797|FG000|Overall Study|Death|58|||
149181414|NCT02564120|538135797|FG000|Overall Study|Withdrawal by Subject|204|||
149181415|NCT02564120|538135797|FG000|Overall Study|Other medical condition|24|||
149181416|NCT00891657|538135800|FG000|Overall Study|Withdrawal by Subject|1|||
149181417|NCT00891657|538135801|FG001|Overall Study|Withdrawal by Subject|1|||
149181418|NCT00670111|538135805|FG000|Enrollment to One Month|Testing Failure|0|||
149181419|NCT00670111|538135806|FG001|Enrollment to One Month|Testing Failure|0|||
149181420|NCT00670111|538135807|FG002|Enrollment to One Month|Testing Failure|13|||
149181421|NCT00670111|538135805|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
149181422|NCT00670111|538135806|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
149181423|NCT00670111|538135807|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
149181424|NCT00670111|538135805|FG000|Enrollment to One Month|Physician Decision|1|||
149181425|NCT00670111|538135806|FG001|Enrollment to One Month|Physician Decision|0|||
149181426|NCT00670111|538135807|FG002|Enrollment to One Month|Physician Decision|0|||
149181427|NCT02623361|538135808|FG000|Overall Study|Protocol Violation|0|||
149181428|NCT02623361|538135809|FG001|Overall Study|Protocol Violation|1|||
149181429|NCT02623361|538135808|FG000|Overall Study|Withdrawal by Subject|0|||
149181430|NCT02623361|538135809|FG001|Overall Study|Withdrawal by Subject|1|||
149181431|NCT00844883|538135810|FG000|Overall Study|Bridged to liver transplant|3|||
149181432|NCT00844883|538135810|FG000|Overall Study|Bridged to resection|1|||
149181433|NCT00537823|538135815|FG000|Overall Study|Adverse Event|2|||
149181434|NCT00537823|538135816|FG001|Overall Study|Adverse Event|0|||
149181435|NCT02873221|538135817|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
149181436|NCT02873221|538135818|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
149181437|NCT02873221|538135819|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
149181438|NCT02873221|538135817|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
149181439|NCT02873221|538135818|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
149181440|NCT02873221|538135819|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
149181441|NCT02873221|538135817|FG000|Treatment Period|Protocol Violation|2|||
149181442|NCT02873221|538135818|FG001|Treatment Period|Protocol Violation|5|||
149181443|NCT02873221|538135819|FG002|Treatment Period|Protocol Violation|8|||
149181444|NCT02873221|538135817|FG000|Treatment Period|Pregnancy|4|||
149181445|NCT02873221|538135818|FG001|Treatment Period|Pregnancy|6|||
149181446|NCT02873221|538135819|FG002|Treatment Period|Pregnancy|3|||
149181447|NCT02873221|538135817|FG000|Treatment Period|Lack of Qualifying Event|0|||
149181448|NCT02873221|538135818|FG001|Treatment Period|Lack of Qualifying Event|3|||
149181449|NCT02873221|538135819|FG002|Treatment Period|Lack of Qualifying Event|1|||
149181450|NCT02873221|538135817|FG000|Treatment Period|Withdrawal of Consent|52|||
149181451|NCT02873221|538135818|FG001|Treatment Period|Withdrawal of Consent|51|||
149181452|NCT02873221|538135819|FG002|Treatment Period|Withdrawal of Consent|41|||
149181453|NCT02873221|538135817|FG000|Treatment Period|Lack of Efficacy|0|||
149181454|NCT02873221|538135818|FG001|Treatment Period|Lack of Efficacy|17|||
149181455|NCT02873221|538135819|FG002|Treatment Period|Lack of Efficacy|12|||
149181456|NCT02873221|538135817|FG000|Treatment Period|Adverse Event|4|||
149181457|NCT02873221|538135818|FG001|Treatment Period|Adverse Event|9|||
149181458|NCT02873221|538135819|FG002|Treatment Period|Adverse Event|11|||
149181459|NCT02873221|538135817|FG000|Treatment Period|Lost to Follow-up|26|||
149181460|NCT02873221|538135818|FG001|Treatment Period|Lost to Follow-up|30|||
149181461|NCT02873221|538135819|FG002|Treatment Period|Lost to Follow-up|26|||
149181462|NCT02873221|538135817|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
148931865|NCT00171054|537235197|FG001|Overall Study|Protocol Violation|2|||
149181463|NCT02873221|538135818|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
149181464|NCT02873221|538135819|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
149181465|NCT02873221|538135817|FG000|Safety Follow-up Period|Protocol Violation|0|||
149181466|NCT02873221|538135818|FG001|Safety Follow-up Period|Protocol Violation|0|||
149181467|NCT02873221|538135819|FG002|Safety Follow-up Period|Protocol Violation|1|||
149181468|NCT02873221|538135817|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
149181469|NCT02873221|538135818|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
149181470|NCT02873221|538135819|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
149181471|NCT02873221|538135817|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
149181472|NCT02873221|538135818|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
149181473|NCT02873221|538135819|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
149181474|NCT00909090|538135822|FG000|Overall Study|Lost to Follow-up|17|||
149181475|NCT00909090|538135823|FG001|Overall Study|Lost to Follow-up|17|||
149181476|NCT01749735|538135825|FG000|Overall Study|Withdrawal by Subject|1|||
149181477|NCT01749735|538135826|FG001|Overall Study|Withdrawal by Subject|0|||
149181478|NCT02926573|538135827|FG000|Overall Study|Nausea|1|||
149181479|NCT02926573|538135828|FG001|Overall Study|Nausea|0|||
149181480|NCT02926573|538135827|FG000|Overall Study|Remain intubated|2|||
149181481|NCT02926573|538135828|FG001|Overall Study|Remain intubated|2|||
149181482|NCT02926573|538135827|FG000|Overall Study|Change in surgery plan|3|||
149181483|NCT02926573|538135828|FG001|Overall Study|Change in surgery plan|1|||
149181484|NCT02926573|538135827|FG000|Overall Study|Change to outpatient status|5|||
149181485|NCT02926573|538135828|FG001|Overall Study|Change to outpatient status|1|||
149181486|NCT02926573|538135827|FG000|Overall Study|Withdrawal by Subject|0|||
149181487|NCT02926573|538135828|FG001|Overall Study|Withdrawal by Subject|2|||
149181488|NCT02926573|538135827|FG000|Overall Study|Return to operating room|0|||
149181489|NCT02926573|538135828|FG001|Overall Study|Return to operating room|2|||
149181490|NCT02926573|538135827|FG000|Overall Study|Delirium|0|||
149181491|NCT02926573|538135828|FG001|Overall Study|Delirium|1|||
149181492|NCT00611455|538135831|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
149181493|NCT00611455|538135832|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
149181494|NCT00611455|538135833|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149181495|NCT00611455|538135831|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
149181496|NCT00611455|538135832|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149181497|NCT00611455|538135833|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149181498|NCT00611455|538135831|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
149181499|NCT00611455|538135832|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
149181500|NCT00611455|538135833|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149181501|NCT00611455|538135831|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
149181502|NCT00611455|538135832|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149181503|NCT00611455|538135833|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149181504|NCT00611455|538135831|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
149181505|NCT00611455|538135832|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
149181506|NCT00611455|538135833|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
149181507|NCT00611455|538135831|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
149181508|NCT00611455|538135832|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
149181509|NCT00611455|538135833|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
149181510|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
149181511|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
149181512|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
149181513|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
149181514|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
149181515|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
149181516|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
149181517|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
149181518|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
149181519|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
149181520|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
149181521|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
149181522|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
149181523|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
149181524|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
149181525|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
149181526|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
149181527|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
149181528|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
149181529|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
149181530|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
149181531|NCT00611455|538135831|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
149181532|NCT00611455|538135832|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
149181533|NCT00611455|538135833|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
149181534|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
149181535|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
149181536|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
149181537|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
149181538|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
149181539|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
149181540|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
149181541|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
149181542|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
149181543|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
149181544|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
149181545|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
149181546|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
149181547|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
149181548|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
149181549|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
149181550|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
149181551|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
149181552|NCT00611455|538135831|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
149181553|NCT00611455|538135832|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
149181554|NCT00611455|538135833|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
149181555|NCT04601272|538135836|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
149181556|NCT04601272|538135837|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
149181557|NCT04601272|538135838|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
149181558|NCT00414440|538135839|FG000|Core Period|Withdrawal by Subject|70|||
149181559|NCT00414440|538135840|FG001|Core Period|Withdrawal by Subject|32|||
149181560|NCT00414440|538135839|FG000|Extension Period|Lost to Follow-up|44|||
149181561|NCT00414440|538135840|FG001|Extension Period|Lost to Follow-up|52|||
149181562|NCT00414440|538135839|FG000|Extension Period|Did not consent to continue follow up|61|||
149181563|NCT00414440|538135840|FG001|Extension Period|Did not consent to continue follow up|54|||
149181564|NCT00414440|538135839|FG000|Extension Period|Other|1|||
149181565|NCT00414440|538135840|FG001|Extension Period|Other|1|||
149181566|NCT00414440|538135839|FG000|Extension Period|Administrative|16|||
149181567|NCT00414440|538135840|FG001|Extension Period|Administrative|16|||
149181568|NCT00414440|538135839|FG000|Extension Period|Death|1|||
149181569|NCT00414440|538135840|FG001|Extension Period|Death|2|||
149181570|NCT00414440|538135839|FG000|Extension Period|Withdrawal by Subject|9|||
149181571|NCT00414440|538135840|FG001|Extension Period|Withdrawal by Subject|7|||
149181572|NCT00414440|538135839|FG000|Extension Period|Not included in follow up period|18|||
149181573|NCT00414440|538135840|FG001|Extension Period|Not included in follow up period|8|||
149181574|NCT02732912|538135841|FG000|Overall Study|Discharged before night|2|||
149181575|NCT02732912|538135842|FG001|Overall Study|Discharged before night|6|||
149181576|NCT02732912|538135841|FG000|Overall Study|Incomplete completion of questionnaire|2|||
149181577|NCT02732912|538135842|FG001|Overall Study|Incomplete completion of questionnaire|3|||
149181578|NCT02732912|538135841|FG000|Overall Study|No outcome; discharged or refused|6|||
149181579|NCT02732912|538135842|FG001|Overall Study|No outcome; discharged or refused|9|||
149181580|NCT01873742|538135843|FG000|Overall Study|Lost to Follow-up|68|||
149181581|NCT01873742|538135844|FG001|Overall Study|Lost to Follow-up|76|||
149181582|NCT01707147|538135845|FG000|Overall Study|Administered Trajenta prior to contract|5|||
149181583|NCT01707147|538135845|FG000|Overall Study|Patients who have not taken Trajenta|1|||
149181584|NCT01707147|538135845|FG000|Overall Study|Follow-up failure|17|||
149181585|NCT01707147|538135845|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
149181586|NCT02489630|538135846|FG000|Overall Study|Oversedation|1|||
149181587|NCT02489630|538135847|FG001|Overall Study|Oversedation|1|||
149181588|NCT02489630|538135846|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
149181589|NCT02489630|538135847|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
149181590|NCT01056523|538135850|FG000|Overall Study|Death|1|||
149181591|NCT01056523|538135851|FG001|Overall Study|Death|0|||
149181592|NCT01056523|538135852|FG002|Overall Study|Death|2|||
149181593|NCT01056523|538135853|FG003|Overall Study|Death|3|||
149181594|NCT01056523|538135854|FG004|Overall Study|Death|0|||
149181595|NCT01056523|538135855|FG005|Overall Study|Death|0|||
149181596|NCT01056523|538135856|FG006|Overall Study|Death|1|||
148931866|NCT00171054|537235196|FG000|Overall Study|Patient withdrew consent|1|||
148931867|NCT00171054|537235197|FG001|Overall Study|Patient withdrew consent|0|||
148931868|NCT00171054|537235196|FG000|Overall Study|Lost to Follow-up|0|||
148931869|NCT00171054|537235197|FG001|Overall Study|Lost to Follow-up|1|||
148931870|NCT00171054|537235196|FG000|Overall Study|Adverse Event|8|||
148931871|NCT00171054|537235197|FG001|Overall Study|Adverse Event|8|||
148931872|NCT00171054|537235196|FG000|Overall Study|Condition no longer required study drug|0|||
148931873|NCT00171054|537235197|FG001|Overall Study|Condition no longer required study drug|1|||
148931874|NCT01828320|537235204|FG000|Overall Study|Lost to Follow-up|1|||
148931875|NCT01828320|537235205|FG001|Overall Study|Lost to Follow-up|3|||
148931876|NCT01828320|537235204|FG000|Overall Study|Withdrawal by Subject|7|||
148931877|NCT01828320|537235205|FG001|Overall Study|Withdrawal by Subject|2|||
148931878|NCT02160782|537236674|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
148931879|NCT02160782|537236675|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
148931880|NCT02160782|537236676|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
148931881|NCT02160782|537236677|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
148931882|NCT02160782|537236678|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
148931883|NCT02160782|537236674|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
148931884|NCT02160782|537236675|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
148931885|NCT02160782|537236676|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
148931886|NCT02160782|537236677|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
148931887|NCT02160782|537236678|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
148931888|NCT02160782|537236674|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
148931889|NCT02160782|537236675|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
148931890|NCT02160782|537236676|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
148931891|NCT02160782|537236677|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
148931892|NCT02160782|537236678|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
148931893|NCT02160782|537236674|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
148931894|NCT02160782|537236675|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
148931895|NCT02160782|537236676|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
148931896|NCT02160782|537236677|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
148931897|NCT02160782|537236678|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
148931898|NCT02160782|537236674|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
148931899|NCT02160782|537236675|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
148931900|NCT02160782|537236676|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
148931901|NCT02160782|537236677|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
148931902|NCT02160782|537236678|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
148931903|NCT02160782|537236674|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
148931904|NCT02160782|537236675|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
148931905|NCT02160782|537236676|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
148931906|NCT02160782|537236677|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
148931907|NCT02160782|537236678|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
148931908|NCT02160782|537236674|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
148931909|NCT02160782|537236675|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
148931910|NCT02160782|537236676|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
148931911|NCT02160782|537236677|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
148931912|NCT02160782|537236678|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
148931913|NCT00891462|537236681|FG000|Overall Study|Withdrawal by Subject|9|||
148931914|NCT00891462|537236682|FG001|Overall Study|Withdrawal by Subject|6|||
148931915|NCT00891462|537236683|FG002|Overall Study|Withdrawal by Subject|7|||
148931916|NCT00891462|537236681|FG000|Overall Study|Adverse Event|7|||
148931917|NCT00891462|537236682|FG001|Overall Study|Adverse Event|8|||
148931918|NCT00891462|537236683|FG002|Overall Study|Adverse Event|7|||
148931919|NCT00891462|537236681|FG000|Overall Study|Lack of Efficacy|10|||
148931920|NCT00891462|537236682|FG001|Overall Study|Lack of Efficacy|5|||
148931921|NCT00891462|537236683|FG002|Overall Study|Lack of Efficacy|1|||
148931922|NCT00891462|537236681|FG000|Overall Study|COPD exacerbation|7|||
148931923|NCT00891462|537236682|FG001|Overall Study|COPD exacerbation|4|||
148931924|NCT00891462|537236683|FG002|Overall Study|COPD exacerbation|1|||
148931925|NCT00891462|537236681|FG000|Overall Study|Other Reason|2|||
148931926|NCT00891462|537236682|FG001|Overall Study|Other Reason|5|||
148931927|NCT00891462|537236683|FG002|Overall Study|Other Reason|3|||
148931928|NCT00891462|537236681|FG000|Overall Study|Protocol Violation|2|||
148931929|NCT00891462|537236682|FG001|Overall Study|Protocol Violation|1|||
148931930|NCT00891462|537236683|FG002|Overall Study|Protocol Violation|3|||
148931931|NCT00891462|537236681|FG000|Overall Study|Inclusion/exclusion criteria|0|||
148931932|NCT00891462|537236682|FG001|Overall Study|Inclusion/exclusion criteria|2|||
148931933|NCT00891462|537236683|FG002|Overall Study|Inclusion/exclusion criteria|2|||
148931934|NCT00891462|537236681|FG000|Overall Study|Lost to Follow-up|0|||
148931935|NCT00891462|537236682|FG001|Overall Study|Lost to Follow-up|2|||
148931936|NCT00891462|537236683|FG002|Overall Study|Lost to Follow-up|0|||
148931937|NCT00423722|537236687|FG000|Overall Study|Death|4|||
148931938|NCT00423722|537236688|FG001|Overall Study|Death|4|||
148931939|NCT00423722|537236687|FG000|Overall Study|Declined to participate|2|||
148931940|NCT00423722|537236688|FG001|Overall Study|Declined to participate|3|||
148931941|NCT00423722|537236687|FG000|Overall Study|Unable to complete questionnaires|4|||
148931942|NCT00423722|537236688|FG001|Overall Study|Unable to complete questionnaires|4|||
148931943|NCT00423722|537236687|FG000|Overall Study|Withdrawal by Subject|4|||
148931944|NCT00423722|537236688|FG001|Overall Study|Withdrawal by Subject|2|||
148931945|NCT00215683|537236689|FG000|Overall Study|Adverse Event|15|||
148931946|NCT00215683|537236690|FG001|Overall Study|Adverse Event|16|||
148931947|NCT00215683|537236691|FG002|Overall Study|Adverse Event|15|||
148931948|NCT00215683|537236689|FG000|Overall Study|Lack of Efficacy|5|||
148931949|NCT00215683|537236690|FG001|Overall Study|Lack of Efficacy|1|||
148931950|NCT00215683|537236691|FG002|Overall Study|Lack of Efficacy|2|||
148931951|NCT00215683|537236689|FG000|Overall Study|Lost to Follow-up|0|||
148931952|NCT00215683|537236690|FG001|Overall Study|Lost to Follow-up|2|||
148931953|NCT00215683|537236691|FG002|Overall Study|Lost to Follow-up|1|||
148931954|NCT00215683|537236689|FG000|Overall Study|Withdrawal by Subject|9|||
148931955|NCT00215683|537236690|FG001|Overall Study|Withdrawal by Subject|4|||
148931956|NCT00215683|537236691|FG002|Overall Study|Withdrawal by Subject|13|||
148931957|NCT00215683|537236689|FG000|Overall Study|Physician Decision|0|||
148931958|NCT00215683|537236690|FG001|Overall Study|Physician Decision|0|||
148931959|NCT00215683|537236691|FG002|Overall Study|Physician Decision|1|||
148931960|NCT00215683|537236689|FG000|Overall Study|Difficult to attend visits|0|||
149181597|NCT03429556|538135857|FG000|Overall Study|Lost to Follow-up|0|||
149181598|NCT03429556|538135858|FG001|Overall Study|Lost to Follow-up|1|||
149181599|NCT03429556|538135859|FG002|Overall Study|Lost to Follow-up|0|||
149181600|NCT03429556|538135860|FG003|Overall Study|Lost to Follow-up|0|||
149181601|NCT02050048|538135867|FG000|Overall Study|Lost to Follow-up|0|||
149181602|NCT02050048|538135868|FG001|Overall Study|Lost to Follow-up|1|||
149181603|NCT02050048|538135867|FG000|Overall Study|Death|1|||
149181604|NCT02050048|538135868|FG001|Overall Study|Death|0|||
149181605|NCT02050048|538135867|FG000|Overall Study|Ineligible after ERCP|4|||
149181606|NCT02050048|538135868|FG001|Overall Study|Ineligible after ERCP|1|||
149181607|NCT01589094|538135872|FG000|Overall Study|Did not receive treatment|2|||
148807290|NCT01140906|536773223|FG001|Overall Study|Administrative or other reason|5|||
148807291|NCT01140906|536773224|FG002|Overall Study|Administrative or other reason|3|||
148807292|NCT01140906|536773225|FG003|Overall Study|Administrative or other reason|2|||
148807293|NCT00576758|536773226|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
149181608|NCT05243550|538137592|FG000|Overall Study|Ongoing in the Study|171|||
149181609|NCT05243550|538137592|FG000|Overall Study|Withdrawal by Subject|10|||
149181610|NCT05243550|538137592|FG000|Overall Study|Lost to Follow-up|7|||
149181611|NCT05243550|538137592|FG000|Overall Study|Adverse Event|3|||
149181612|NCT05243550|538137592|FG000|Overall Study|Noncompliance|1|||
149181613|NCT05243550|538137592|FG000|Overall Study|Physician Decision|1|||
149181614|NCT05243550|538137592|FG000|Overall Study|Other Reason|4|||
149181615|NCT01486316|538137593|FG000|Overall Study|Device explanted with/without re-implant|3|||
149181616|NCT01486316|538137594|FG001|Overall Study|Device explanted with/without re-implant|2|||
149181617|NCT01486316|538137595|FG002|Overall Study|Device explanted with/without re-implant|0|||
148807294|NCT00576758|536773227|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
148807295|NCT00576758|536773226|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
148807296|NCT00576758|536773227|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
148931961|NCT00215683|537236690|FG001|Overall Study|Difficult to attend visits|1|||
148931962|NCT00215683|537236691|FG002|Overall Study|Difficult to attend visits|0|||
148931963|NCT00215683|537236689|FG000|Overall Study|No study drug available|0|||
148931964|NCT00215683|537236690|FG001|Overall Study|No study drug available|1|||
148931965|NCT00215683|537236691|FG002|Overall Study|No study drug available|0|||
148931966|NCT00215683|537236689|FG000|Overall Study|Intermittent therapy required|0|||
148931967|NCT00215683|537236690|FG001|Overall Study|Intermittent therapy required|1|||
148931968|NCT00215683|537236691|FG002|Overall Study|Intermittent therapy required|0|||
148931969|NCT01083485|537236692|FG000|Overall Study|Adverse Event|0|||
148931970|NCT01083485|537236693|FG001|Overall Study|Adverse Event|1|||
148931971|NCT01083485|537236692|FG000|Overall Study|Protocol Violation|1|||
148931972|NCT01083485|537236693|FG001|Overall Study|Protocol Violation|0|||
148931973|NCT01083485|537236692|FG000|Overall Study|Withdrawal by Subject|5|||
148931974|NCT01083485|537236693|FG001|Overall Study|Withdrawal by Subject|2|||
148931975|NCT01083485|537236692|FG000|Overall Study|Other|1|||
148931976|NCT01083485|537236693|FG001|Overall Study|Other|0|||
149181618|NCT01486316|538137596|FG003|Overall Study|Device explanted with/without re-implant|2|||
149181619|NCT01486316|538137593|FG000|Overall Study|Not meeting eligibility criteria|0|||
148691442|NCT01325207|536344180|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
148931977|NCT04493333|537236694|FG000|Overall Study|Withdrawal by Subject|1|||
148931978|NCT04493333|537236695|FG001|Overall Study|Withdrawal by Subject|1|||
148931979|NCT04493333|537236694|FG000|Overall Study|Ineligible|0|||
148931980|NCT04493333|537236695|FG001|Overall Study|Ineligible|1|||
149181620|NCT01486316|538137594|FG001|Overall Study|Not meeting eligibility criteria|0|||
148931981|NCT04493333|537236694|FG000|Overall Study|Noncompliance|2|||
149181621|NCT01486316|538137595|FG002|Overall Study|Not meeting eligibility criteria|1|||
149181622|NCT01486316|538137596|FG003|Overall Study|Not meeting eligibility criteria|0|||
149181623|NCT01486316|538137593|FG000|Overall Study|Withdrawal by Subject|1|||
149181624|NCT01486316|538137594|FG001|Overall Study|Withdrawal by Subject|0|||
149181625|NCT01486316|538137595|FG002|Overall Study|Withdrawal by Subject|3|||
149181626|NCT01486316|538137596|FG003|Overall Study|Withdrawal by Subject|0|||
149181627|NCT01486316|538137593|FG000|Overall Study|Physician Decision|0|||
149181628|NCT01486316|538137594|FG001|Overall Study|Physician Decision|0|||
149181629|NCT01486316|538137595|FG002|Overall Study|Physician Decision|1|||
149181630|NCT01486316|538137596|FG003|Overall Study|Physician Decision|0|||
149181631|NCT01486316|538137593|FG000|Overall Study|Death|0|||
149181632|NCT01486316|538137594|FG001|Overall Study|Death|1|||
149181633|NCT01486316|538137595|FG002|Overall Study|Death|0|||
149181634|NCT01486316|538137596|FG003|Overall Study|Death|0|||
149181635|NCT01543490|538137599|FG000|Overall Study|Adverse Event|4|||
149181636|NCT01543490|538137600|FG001|Overall Study|Adverse Event|0|||
149181637|NCT01543490|538137599|FG000|Overall Study|Physician Decision|1|||
149181638|NCT01543490|538137600|FG001|Overall Study|Physician Decision|0|||
149181639|NCT01543490|538137599|FG000|Overall Study|Lack of Efficacy|3|||
149181640|NCT01543490|538137600|FG001|Overall Study|Lack of Efficacy|3|||
149181641|NCT01543490|538137599|FG000|Overall Study|Lost to Follow-up|5|||
149181642|NCT01543490|538137600|FG001|Overall Study|Lost to Follow-up|0|||
149181643|NCT01543490|538137599|FG000|Overall Study|Withdrawal by Subject|2|||
149181644|NCT01543490|538137600|FG001|Overall Study|Withdrawal by Subject|0|||
149181645|NCT01543490|538137599|FG000|Overall Study|Other-Various Administrative Reasons|1|||
149181646|NCT01543490|538137600|FG001|Overall Study|Other-Various Administrative Reasons|2|||
149181647|NCT04168645|538137606|FG000|Overall Study|Lost to Follow-up|23|||
149181648|NCT04168645|538137607|FG001|Overall Study|Lost to Follow-up|28|||
149181649|NCT04168645|538137608|FG002|Overall Study|Lost to Follow-up|15|||
149181650|NCT04168645|538137609|FG003|Overall Study|Lost to Follow-up|12|||
149181651|NCT04168645|538137606|FG000|Overall Study|Death|1|||
149181652|NCT04168645|538137607|FG001|Overall Study|Death|1|||
149181653|NCT04168645|538137608|FG002|Overall Study|Death|0|||
149181654|NCT04168645|538137609|FG003|Overall Study|Death|0|||
149181655|NCT04168645|538137606|FG000|Overall Study|Withdrawal by Subject|5|||
149181656|NCT04168645|538137607|FG001|Overall Study|Withdrawal by Subject|2|||
149181657|NCT04168645|538137608|FG002|Overall Study|Withdrawal by Subject|2|||
149181658|NCT04168645|538137609|FG003|Overall Study|Withdrawal by Subject|2|||
149181659|NCT04168645|538137606|FG000|Overall Study|Administrative Withdrawal|3|||
149181660|NCT04168645|538137607|FG001|Overall Study|Administrative Withdrawal|1|||
149181661|NCT04168645|538137608|FG002|Overall Study|Administrative Withdrawal|1|||
149181662|NCT04168645|538137609|FG003|Overall Study|Administrative Withdrawal|3|||
149181663|NCT02400346|538137610|FG000|Overall Study|Adverse Event|24|||
149181664|NCT02400346|538137610|FG000|Overall Study|Lack of Efficacy|9|||
149181665|NCT02400346|538137610|FG000|Overall Study|Non-compliance with IMP|1|||
149181666|NCT02400346|538137610|FG000|Overall Study|Withdrawal by Subject|7|||
149181667|NCT02400346|538137610|FG000|Overall Study|Administrative or other reason(s)|2|||
149181668|NCT02400346|538137610|FG000|Overall Study|Lost to Follow-up|1|||
149181669|NCT02114203|538137611|FG000|Overall Study|Adverse Event|0|||
149181670|NCT02114203|538137612|FG001|Overall Study|Adverse Event|1|||
149181671|NCT02114203|538137613|FG002|Overall Study|Adverse Event|0|||
149181672|NCT02114203|538137611|FG000|Overall Study|Withdrawal by Subject|0|||
149181673|NCT02114203|538137612|FG001|Overall Study|Withdrawal by Subject|1|||
149181674|NCT02114203|538137613|FG002|Overall Study|Withdrawal by Subject|0|||
149181675|NCT01518699|538137614|FG000|Period 2|Protocol Violation|1|||
149181676|NCT01518699|538137615|FG001|Period 2|Protocol Violation|1|||
149181677|NCT01518699|538137616|FG002|Period 2|Protocol Violation|0|||
149181678|NCT01518699|538137617|FG003|Period 2|Protocol Violation|0|||
149181679|NCT01518699|538137618|FG004|Period 2|Protocol Violation|0|||
149181680|NCT01518699|538137619|FG005|Period 2|Protocol Violation|0|||
149181681|NCT01518699|538137614|FG000|Period 2|Lost to Follow-up|0|||
149181682|NCT01518699|538137615|FG001|Period 2|Lost to Follow-up|1|||
149181683|NCT01518699|538137616|FG002|Period 2|Lost to Follow-up|0|||
149181684|NCT01518699|538137617|FG003|Period 2|Lost to Follow-up|0|||
149181685|NCT01518699|538137618|FG004|Period 2|Lost to Follow-up|0|||
149181686|NCT01518699|538137619|FG005|Period 2|Lost to Follow-up|0|||
149181687|NCT01518699|538137614|FG000|Period 2|Adverse Event|1|||
149181688|NCT01518699|538137615|FG001|Period 2|Adverse Event|0|||
148679622|NCT03216954|536300832|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149181689|NCT01518699|538137616|FG002|Period 2|Adverse Event|0|||
149181690|NCT01518699|538137617|FG003|Period 2|Adverse Event|0|||
149181691|NCT01518699|538137618|FG004|Period 2|Adverse Event|0|||
149181692|NCT01518699|538137619|FG005|Period 2|Adverse Event|0|||
149181693|NCT01981122|538137621|FG000|Overall Study|Withdrawal by Subject|0|||
149181694|NCT01981122|538137622|FG001|Overall Study|Withdrawal by Subject|2|||
149181695|NCT01981122|538137621|FG000|Overall Study|Protocol Violation|0|||
149181696|NCT01981122|538137622|FG001|Overall Study|Protocol Violation|1|||
149181697|NCT01981122|538137621|FG000|Overall Study|Lost to Follow-up|0|||
149181698|NCT01981122|538137622|FG001|Overall Study|Lost to Follow-up|1|||
149181699|NCT01981122|538137621|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
149181700|NCT01981122|538137622|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
149181701|NCT01981122|538137621|FG000|Overall Study|Death|14|||
149181702|NCT01981122|538137622|FG001|Overall Study|Death|15|||
149181703|NCT00500149|538137628|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
149181704|NCT00500149|538137629|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
149181705|NCT00500149|538137628|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
149181706|NCT00500149|538137629|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
149181707|NCT00500149|538137628|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
149181708|NCT00500149|538137629|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
149181709|NCT00500149|538137628|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
149181710|NCT00500149|538137629|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
149181711|NCT00500149|538137628|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
149181712|NCT00500149|538137629|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
149181713|NCT00500149|538137628|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
149181714|NCT00500149|538137629|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
149181715|NCT00500149|538137628|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
149181716|NCT00500149|538137629|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
149181717|NCT00521339|538137632|FG000|Treatment Phase|Adverse Event|2|||
149181718|NCT00521339|538137633|FG001|Treatment Phase|Adverse Event|0|||
149181719|NCT00521339|538137634|FG002|Treatment Phase|Adverse Event|0|||
149181720|NCT00521339|538137632|FG000|Treatment Phase|Intolerability to study drug|2|||
149181721|NCT00521339|538137633|FG001|Treatment Phase|Intolerability to study drug|0|||
149181722|NCT00521339|538137634|FG002|Treatment Phase|Intolerability to study drug|0|||
149181723|NCT00521339|538137632|FG000|Treatment Phase|Lack of Efficacy|3|||
149181724|NCT00521339|538137633|FG001|Treatment Phase|Lack of Efficacy|0|||
149181725|NCT00521339|538137634|FG002|Treatment Phase|Lack of Efficacy|0|||
149181726|NCT00521339|538137632|FG000|Treatment Phase|Withdrawal by Subject|3|||
149181727|NCT00521339|538137633|FG001|Treatment Phase|Withdrawal by Subject|0|||
149181728|NCT00521339|538137634|FG002|Treatment Phase|Withdrawal by Subject|0|||
149181729|NCT00521339|538137632|FG000|Treatment Phase|Lost to Follow-up|1|||
149181730|NCT00521339|538137633|FG001|Treatment Phase|Lost to Follow-up|0|||
149181731|NCT00521339|538137634|FG002|Treatment Phase|Lost to Follow-up|0|||
149181732|NCT00521339|538137632|FG000|Treatment Phase|Protocol Violation|1|||
149181733|NCT00521339|538137633|FG001|Treatment Phase|Protocol Violation|0|||
149181734|NCT00521339|538137634|FG002|Treatment Phase|Protocol Violation|0|||
149181735|NCT00521339|538137632|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
149181736|NCT00521339|538137633|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
149181737|NCT00521339|538137634|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
149181738|NCT00521339|538137632|FG000|Treatment Extension Phase|Death|0|||
149181739|NCT00521339|538137633|FG001|Treatment Extension Phase|Death|0|||
149181740|NCT00521339|538137634|FG002|Treatment Extension Phase|Death|1|||
149181741|NCT00089843|538137635|FG000|Overall Study|Withdrawal by Subject|1|||
149181742|NCT00089843|538137636|FG001|Overall Study|Withdrawal by Subject|4|||
149181743|NCT00089843|538137637|FG002|Overall Study|Withdrawal by Subject|5|||
149181744|NCT00089843|538137638|FG003|Overall Study|Withdrawal by Subject|6|||
149181745|NCT00089843|538137635|FG000|Overall Study|Physician Decision|1|||
149181746|NCT00089843|538137636|FG001|Overall Study|Physician Decision|0|||
149181747|NCT00089843|538137637|FG002|Overall Study|Physician Decision|0|||
149181748|NCT00089843|538137638|FG003|Overall Study|Physician Decision|1|||
149181749|NCT01157169|538137641|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
149181750|NCT01157169|538137642|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
149181751|NCT01157169|538137641|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
149181752|NCT01157169|538137642|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
149181753|NCT00663858|538137643|FG000|Overall Study|Adverse Event|9|||
149181754|NCT00663858|538137644|FG001|Overall Study|Adverse Event|1|||
149181755|NCT00663858|538137645|FG002|Overall Study|Adverse Event|6|||
149181756|NCT00663858|538137643|FG000|Overall Study|Lack of Efficacy|5|||
149181757|NCT00663858|538137644|FG001|Overall Study|Lack of Efficacy|1|||
149181758|NCT00663858|538137645|FG002|Overall Study|Lack of Efficacy|3|||
148931982|NCT04493333|537236695|FG001|Overall Study|Noncompliance|1|||
148931983|NCT05108922|537236701|FG000|Overall Study|Adverse Event|2|||
148931984|NCT05108922|537236702|FG001|Overall Study|Adverse Event|3|||
148931985|NCT05108922|537236701|FG000|Overall Study|Lost to Follow-up|2|||
148931986|NCT05108922|537236702|FG001|Overall Study|Lost to Follow-up|1|||
148931987|NCT05108922|537236701|FG000|Overall Study|Inadvertent enrollment|0|||
148931988|NCT05108922|537236702|FG001|Overall Study|Inadvertent enrollment|1|||
148931989|NCT05108922|537236701|FG000|Overall Study|Physician Decision|2|||
148931990|NCT05108922|537236702|FG001|Overall Study|Physician Decision|3|||
148931991|NCT05108922|537236701|FG000|Overall Study|Protocol deviation|1|||
148931992|NCT05108922|537236702|FG001|Overall Study|Protocol deviation|0|||
149181759|NCT00663858|538137643|FG000|Overall Study|Withdrawal by Subject|7|||
149181760|NCT00663858|538137644|FG001|Overall Study|Withdrawal by Subject|3|||
149181761|NCT00663858|538137645|FG002|Overall Study|Withdrawal by Subject|3|||
149181762|NCT00663858|538137643|FG000|Overall Study|Protocol Violation|5|||
149181763|NCT00663858|538137644|FG001|Overall Study|Protocol Violation|3|||
149181764|NCT00663858|538137645|FG002|Overall Study|Protocol Violation|4|||
149181765|NCT00663858|538137643|FG000|Overall Study|Other|8|||
149181766|NCT00663858|538137644|FG001|Overall Study|Other|2|||
149181767|NCT00663858|538137645|FG002|Overall Study|Other|4|||
149181768|NCT03060577|538137646|FG000|Overall Study|Withdrawal by Subject|25|||
149181769|NCT03060577|538137647|FG001|Overall Study|Withdrawal by Subject|5|||
149181770|NCT03060577|538137646|FG000|Overall Study|Physician Decision|4|||
149181771|NCT03060577|538137647|FG001|Overall Study|Physician Decision|3|||
149181772|NCT03060577|538137646|FG000|Overall Study|Lost to Follow-up|3|||
149181773|NCT03060577|538137647|FG001|Overall Study|Lost to Follow-up|0|||
149181774|NCT03060577|538137646|FG000|Overall Study|Death|7|||
149181775|NCT03060577|538137647|FG001|Overall Study|Death|1|||
149181776|NCT03060577|538137646|FG000|Overall Study|Adverse Event|9|||
149181777|NCT03060577|538137647|FG001|Overall Study|Adverse Event|1|||
149181778|NCT03060577|538137646|FG000|Overall Study|Inclusion/Exclusion|1|||
149181779|NCT03060577|538137647|FG001|Overall Study|Inclusion/Exclusion|0|||
149181780|NCT03060577|538137646|FG000|Overall Study|Other|8|||
149181781|NCT03060577|538137647|FG001|Overall Study|Other|2|||
149181782|NCT02940886|538137651|FG000|Overall Study|Adverse Event|7|||
149181783|NCT02940886|538137652|FG001|Overall Study|Adverse Event|3|||
149181784|NCT02940886|538137651|FG000|Overall Study|Protocol Violation|0|||
149181785|NCT02940886|538137652|FG001|Overall Study|Protocol Violation|2|||
149181786|NCT02940886|538137651|FG000|Overall Study|Withdrawal by Subject|28|||
149181787|NCT02940886|538137652|FG001|Overall Study|Withdrawal by Subject|20|||
149181788|NCT02940886|538137651|FG000|Overall Study|Death|1|||
149181789|NCT02940886|538137652|FG001|Overall Study|Death|0|||
149181790|NCT02940886|538137651|FG000|Overall Study|Lack of Efficacy|1|||
149181791|NCT02940886|538137652|FG001|Overall Study|Lack of Efficacy|0|||
149181792|NCT02940886|538137651|FG000|Overall Study|Lost to Follow-up|49|||
149181793|NCT02940886|538137652|FG001|Overall Study|Lost to Follow-up|21|||
149181794|NCT02940886|538137651|FG000|Overall Study|Physician Decision|9|||
149181795|NCT02940886|538137652|FG001|Overall Study|Physician Decision|4|||
149181796|NCT02940886|538137651|FG000|Overall Study|Sponsor decision|0|||
149181797|NCT02940886|538137652|FG001|Overall Study|Sponsor decision|1|||
149181798|NCT02940886|538137651|FG000|Overall Study|No treatment|7|||
149181799|NCT02940886|538137652|FG001|Overall Study|No treatment|2|||
149181800|NCT02940886|538137651|FG000|Overall Study|Enrolment error|0|||
149181801|NCT02940886|538137652|FG001|Overall Study|Enrolment error|1|||
149181802|NCT02584634|538137660|FG000|Overall Study|Adverse Event|3|||
149181803|NCT02584634|538137661|FG001|Overall Study|Adverse Event|5|||
149181804|NCT02584634|538137660|FG000|Overall Study|Death|0|||
149181805|NCT02584634|538137661|FG001|Overall Study|Death|1|||
149181806|NCT02584634|538137660|FG000|Overall Study|Lost to Follow-up|0|||
149181807|NCT02584634|538137661|FG001|Overall Study|Lost to Follow-up|1|||
149181808|NCT02584634|538137660|FG000|Overall Study|Physician Decision|1|||
149181809|NCT02584634|538137661|FG001|Overall Study|Physician Decision|2|||
149181810|NCT02584634|538137660|FG000|Overall Study|Progressive disease|7|||
149181811|NCT02584634|538137661|FG001|Overall Study|Progressive disease|15|||
149181812|NCT02584634|538137660|FG000|Overall Study|Withdrawal by Subject|1|||
149181813|NCT02584634|538137661|FG001|Overall Study|Withdrawal by Subject|1|||
149181814|NCT02584634|538137660|FG000|Overall Study|Other|0|||
149181815|NCT02584634|538137661|FG001|Overall Study|Other|6|||
149181816|NCT02225223|538137663|FG000|Overall Study|Death|10|||
149181817|NCT02225223|538137664|FG001|Overall Study|Death|1|||
149181818|NCT02225223|538137663|FG000|Overall Study|Lost to Follow-up|5|||
149181819|NCT02225223|538137664|FG001|Overall Study|Lost to Follow-up|0|||
149181820|NCT02225223|538137663|FG000|Overall Study|Other|1|||
149181821|NCT02225223|538137664|FG001|Overall Study|Other|2|||
149181822|NCT02225223|538137663|FG000|Overall Study|Physician Decision|1|||
149181823|NCT02225223|538137664|FG001|Overall Study|Physician Decision|0|||
149181824|NCT02225223|538137663|FG000|Overall Study|Withdrawal by Subject|2|||
149181825|NCT02225223|538137664|FG001|Overall Study|Withdrawal by Subject|2|||
148679623|NCT03216954|536300833|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
149181826|NCT01650779|538137665|FG000|Overall Study|Withdrawal by Subject|1|||
149181827|NCT03567291|538137666|FG000|Period I|Adverse Event|14|||
149181828|NCT03567291|538137667|FG001|Period I|Adverse Event|0|||
149181829|NCT03567291|538137668|FG002|Period I|Adverse Event|0|||
149181830|NCT03567291|538137669|FG003|Period I|Adverse Event|0|||
149181831|NCT03567291|538137666|FG000|Period I|Protocol Violation|1|||
149181832|NCT03567291|538137667|FG001|Period I|Protocol Violation|0|||
149181833|NCT03567291|538137668|FG002|Period I|Protocol Violation|0|||
149181834|NCT03567291|538137669|FG003|Period I|Protocol Violation|0|||
149181835|NCT03567291|538137666|FG000|Period I|Withdrawal by Subject|23|||
149181836|NCT03567291|538137667|FG001|Period I|Withdrawal by Subject|0|||
149181837|NCT03567291|538137668|FG002|Period I|Withdrawal by Subject|0|||
149181838|NCT03567291|538137669|FG003|Period I|Withdrawal by Subject|0|||
149181839|NCT03567291|538137666|FG000|Period I|Lost to Follow-up|2|||
149181840|NCT03567291|538137667|FG001|Period I|Lost to Follow-up|0|||
149181841|NCT03567291|538137668|FG002|Period I|Lost to Follow-up|0|||
149181842|NCT03567291|538137669|FG003|Period I|Lost to Follow-up|0|||
149181843|NCT03567291|538137666|FG000|Period I|Terminated by sponsor|44|||
149181844|NCT03567291|538137667|FG001|Period I|Terminated by sponsor|0|||
149181845|NCT03567291|538137668|FG002|Period I|Terminated by sponsor|0|||
149181846|NCT03567291|538137669|FG003|Period I|Terminated by sponsor|0|||
149181847|NCT03567291|538137666|FG000|Period I|Missing or unknown|7|||
149181848|NCT03567291|538137667|FG001|Period I|Missing or unknown|0|||
149181849|NCT03567291|538137668|FG002|Period I|Missing or unknown|0|||
149181850|NCT03567291|538137669|FG003|Period I|Missing or unknown|0|||
149181851|NCT03567291|538137666|FG000|Period II|Adverse Event|0|||
149181852|NCT03567291|538137667|FG001|Period II|Adverse Event|1|||
149181853|NCT03567291|538137668|FG002|Period II|Adverse Event|0|||
149181854|NCT03567291|538137669|FG003|Period II|Adverse Event|0|||
149181855|NCT03567291|538137666|FG000|Period II|Missing or unknown|0|||
149181856|NCT03567291|538137667|FG001|Period II|Missing or unknown|2|||
149181857|NCT03567291|538137668|FG002|Period II|Missing or unknown|1|||
149181858|NCT03567291|538137669|FG003|Period II|Missing or unknown|0|||
149181859|NCT03567291|538137666|FG000|Period III|Adverse Event|0|||
149181860|NCT03567291|538137667|FG001|Period III|Adverse Event|0|||
149181861|NCT03567291|538137668|FG002|Period III|Adverse Event|0|||
149181862|NCT03567291|538137669|FG003|Period III|Adverse Event|4|||
149181863|NCT03567291|538137666|FG000|Period III|Withdrawal by Subject|0|||
149181864|NCT03567291|538137667|FG001|Period III|Withdrawal by Subject|0|||
149181865|NCT03567291|538137668|FG002|Period III|Withdrawal by Subject|0|||
149181866|NCT03567291|538137669|FG003|Period III|Withdrawal by Subject|4|||
149181867|NCT03567291|538137666|FG000|Period III|Lost to Follow-up|0|||
149181868|NCT03567291|538137667|FG001|Period III|Lost to Follow-up|0|||
149181869|NCT03567291|538137668|FG002|Period III|Lost to Follow-up|0|||
149181870|NCT03567291|538137669|FG003|Period III|Lost to Follow-up|1|||
149181871|NCT03567291|538137666|FG000|Period III|Terminated by sponsor|0|||
149181872|NCT03567291|538137667|FG001|Period III|Terminated by sponsor|0|||
149181873|NCT03567291|538137668|FG002|Period III|Terminated by sponsor|0|||
149181874|NCT03567291|538137669|FG003|Period III|Terminated by sponsor|68|||
149181875|NCT03567291|538137666|FG000|Period III|Missing or unknown|0|||
149181876|NCT03567291|538137667|FG001|Period III|Missing or unknown|0|||
149181877|NCT03567291|538137668|FG002|Period III|Missing or unknown|0|||
149181878|NCT03567291|538137669|FG003|Period III|Missing or unknown|8|||
149181879|NCT03666143|538137670|FG000|Overall Study|Death|158|||
149181880|NCT03666143|538137670|FG000|Overall Study|Sponsor Decision|31|||
149181881|NCT03666143|538137670|FG000|Overall Study|Withdrawal by Subject|11|||
149181882|NCT03666143|538137670|FG000|Overall Study|Lost to Follow-up|5|||
149181883|NCT03666143|538137670|FG000|Overall Study|Physician Decision|1|||
149181884|NCT03666143|538137670|FG000|Overall Study|Rolled into extension study|9|||
149181885|NCT03666143|538137670|FG000|Overall Study|Progressive Disease|1|||
148931993|NCT05108922|537236701|FG000|Overall Study|Screen failure|1|||
148931994|NCT05108922|537236702|FG001|Overall Study|Screen failure|0|||
148931995|NCT05108922|537236701|FG000|Overall Study|Withdrawal by Subject|11|||
148931996|NCT05108922|537236702|FG001|Overall Study|Withdrawal by Subject|8|||
148931997|NCT02095223|537236707|FG000|Overall Study|Withdrawal by Subject|1|||
148931998|NCT02095223|537236708|FG001|Overall Study|Withdrawal by Subject|0|||
148931999|NCT01920555|537236713|FG000|Overall Study|Physician Decision|1|||
148932000|NCT01920555|537236714|FG001|Overall Study|Physician Decision|2|||
148932001|NCT01920555|537236715|FG002|Overall Study|Physician Decision|1|||
148932002|NCT01920555|537236716|FG003|Overall Study|Physician Decision|2|||
148932003|NCT01920555|537236717|FG004|Overall Study|Physician Decision|0|||
148932004|NCT01920555|537236713|FG000|Overall Study|Lack of Efficacy|2|||
148932005|NCT01920555|537236714|FG001|Overall Study|Lack of Efficacy|0|||
148932006|NCT01920555|537236715|FG002|Overall Study|Lack of Efficacy|0|||
148932007|NCT01920555|537236716|FG003|Overall Study|Lack of Efficacy|0|||
148932008|NCT01920555|537236717|FG004|Overall Study|Lack of Efficacy|0|||
148932009|NCT01920555|537236713|FG000|Overall Study|Travel Difficulties|1|||
148932010|NCT01920555|537236714|FG001|Overall Study|Travel Difficulties|1|||
148932011|NCT01920555|537236715|FG002|Overall Study|Travel Difficulties|0|||
148932012|NCT01920555|537236716|FG003|Overall Study|Travel Difficulties|0|||
148932013|NCT01920555|537236717|FG004|Overall Study|Travel Difficulties|1|||
148932014|NCT01920555|537236713|FG000|Overall Study|Lost to Follow-up|0|||
148932015|NCT01920555|537236714|FG001|Overall Study|Lost to Follow-up|1|||
148932016|NCT01920555|537236715|FG002|Overall Study|Lost to Follow-up|0|||
148932017|NCT01920555|537236716|FG003|Overall Study|Lost to Follow-up|1|||
148932018|NCT01920555|537236717|FG004|Overall Study|Lost to Follow-up|0|||
148932019|NCT00422097|537236718|FG000|Dose Level 2|Still on treatment|0|||
148932020|NCT00422097|537236719|FG001|Dose Level 2|Still on treatment|1|||
148932021|NCT00422097|537236720|FG002|Dose Level 2|Still on treatment|0|||
148932022|NCT00422097|537236721|FG003|Dose Level 2|Still on treatment|0|||
148932023|NCT00422097|537236722|FG004|Dose Level 2|Still on treatment|0|||
148932024|NCT00422097|537236723|FG005|Dose Level 2|Still on treatment|0|||
148932025|NCT00422097|537236724|FG006|Dose Level 2|Still on treatment|0|||
148932026|NCT00422097|537236725|FG007|Dose Level 2|Still on treatment|0|||
148932027|NCT02572388|537236726|FG000|Overall Study|Withdrawal by Subject|1|||
148932028|NCT02572388|537236727|FG001|Overall Study|Withdrawal by Subject|1|||
148932029|NCT02572388|537236728|FG002|Overall Study|Withdrawal by Subject|2|||
148932030|NCT02572388|537236729|FG003|Overall Study|Withdrawal by Subject|2|||
149181886|NCT01103349|538137671|FG000|Overall Study|Adverse Event|8|||
149181887|NCT01103349|538137672|FG001|Overall Study|Adverse Event|5|||
149181888|NCT01103349|538137673|FG002|Overall Study|Adverse Event|3|||
149181889|NCT01103349|538137671|FG000|Overall Study|Consent withdrawn|1|||
149181890|NCT01103349|538137672|FG001|Overall Study|Consent withdrawn|0|||
149181891|NCT01103349|538137673|FG002|Overall Study|Consent withdrawn|0|||
149181892|NCT01103349|538137671|FG000|Overall Study|Incorrectly included in the trial|1|||
149181893|NCT01103349|538137672|FG001|Overall Study|Incorrectly included in the trial|0|||
149181894|NCT01103349|538137673|FG002|Overall Study|Incorrectly included in the trial|0|||
149181895|NCT01103349|538137671|FG000|Overall Study|Withdrawal by Subject|1|||
149181896|NCT01103349|538137672|FG001|Overall Study|Withdrawal by Subject|1|||
149181897|NCT01103349|538137673|FG002|Overall Study|Withdrawal by Subject|0|||
149181898|NCT01103349|538137671|FG000|Overall Study|did not want to take trial medication|0|||
149181899|NCT01103349|538137672|FG001|Overall Study|did not want to take trial medication|1|||
149181900|NCT01103349|538137673|FG002|Overall Study|did not want to take trial medication|0|||
149181901|NCT01103349|538137671|FG000|Overall Study|forgot to take medication|0|||
149181902|NCT01103349|538137672|FG001|Overall Study|forgot to take medication|0|||
149181903|NCT01103349|538137673|FG002|Overall Study|forgot to take medication|1|||
149181904|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
149181905|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
149181906|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
149181907|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
149181908|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
149181909|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
149181910|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
149181911|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
149181912|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
149181913|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
149181914|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
149181915|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
149181916|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
149181917|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
149181918|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
149181919|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
149181920|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
149181921|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
149181922|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
149181923|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
149181924|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
149181925|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
149181926|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
149181927|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
149181928|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
148932031|NCT02360995|537236730|FG000|Overall Study|Lost to Follow-up|2|||
148932032|NCT02360995|537236731|FG001|Overall Study|Lost to Follow-up|0|||
148932033|NCT02360995|537236732|FG002|Overall Study|Lost to Follow-up|2|||
148932034|NCT02360995|537236730|FG000|Overall Study|Withdrawal by Subject|0|||
148932035|NCT02360995|537236731|FG001|Overall Study|Withdrawal by Subject|1|||
148932036|NCT02360995|537236732|FG002|Overall Study|Withdrawal by Subject|0|||
148932037|NCT00810108|537236733|FG000|Overall Study|Withdrawal by Subject|1|||
148932038|NCT00810108|537236734|FG001|Overall Study|Withdrawal by Subject|0|||
148932039|NCT01051466|537236735|FG000|Overall Study|Adverse Event|1|||
148932040|NCT01051466|537236736|FG001|Overall Study|Adverse Event|0|||
148932041|NCT01051466|537236735|FG000|Overall Study|Lost to Follow-up|1|||
148932042|NCT01051466|537236736|FG001|Overall Study|Lost to Follow-up|1|||
148932043|NCT01051466|537236735|FG000|Overall Study|Withdrawal by Subject|5|||
148932044|NCT01051466|537236736|FG001|Overall Study|Withdrawal by Subject|1|||
148932045|NCT01051466|537236735|FG000|Overall Study|Entry Criteria Not Met|0|||
148932046|NCT01051466|537236736|FG001|Overall Study|Entry Criteria Not Met|3|||
149181929|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
149181930|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
149181931|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
149181932|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
149181933|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
149181934|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
148807297|NCT00576758|536773226|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
148932047|NCT01051466|537236735|FG000|Overall Study|Physician Decision|1|||
149181935|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
148932048|NCT01051466|537236736|FG001|Overall Study|Physician Decision|0|||
148932049|NCT02395666|537236737|FG000|Overall Study|Physician Decision|3|||
149181936|NCT00958568|538137678|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
149181937|NCT00958568|538137679|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
149181938|NCT00958568|538137680|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
149181939|NCT00958568|538137681|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
149181940|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
149181941|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
149181942|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
149181943|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
149181944|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
149181945|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
149181946|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
149181947|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
148932050|NCT02395666|537236738|FG001|Overall Study|Physician Decision|0|||
148932051|NCT02395666|537236737|FG000|Overall Study|Lost to Follow-up|1|||
148932052|NCT02395666|537236738|FG001|Overall Study|Lost to Follow-up|0|||
148932053|NCT02395666|537236737|FG000|Overall Study|Withdrawal by Subject|2|||
148932054|NCT02395666|537236738|FG001|Overall Study|Withdrawal by Subject|1|||
148932055|NCT01229371|537236742|FG000|Overall Study|Withdrawal by Subject|0|||
148932056|NCT01229371|537236743|FG001|Overall Study|Withdrawal by Subject|1|||
148932057|NCT01229371|537236744|FG002|Overall Study|Withdrawal by Subject|0|||
148932058|NCT01229371|537236745|FG003|Overall Study|Withdrawal by Subject|0|||
148932059|NCT02600351|537236746|FG000|Overall Study|Lack of Efficacy|3|||
148932060|NCT02600351|537236747|FG001|Overall Study|Lack of Efficacy|0|||
148932061|NCT02600351|537236748|FG002|Overall Study|Lack of Efficacy|5|||
148932062|NCT02600351|537236749|FG003|Overall Study|Lack of Efficacy|2|||
148932063|NCT02600351|537236746|FG000|Overall Study|Lost to Follow-up|1|||
148932064|NCT02600351|537236747|FG001|Overall Study|Lost to Follow-up|0|||
148932065|NCT02600351|537236748|FG002|Overall Study|Lost to Follow-up|0|||
148932066|NCT02600351|537236749|FG003|Overall Study|Lost to Follow-up|0|||
148932067|NCT02600351|537236746|FG000|Overall Study|Randomized but Not Treated|1|||
148932068|NCT02600351|537236747|FG001|Overall Study|Randomized but Not Treated|0|||
149181948|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
149181949|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
149181950|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
149181951|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
149181952|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
149181953|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
149181954|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
149181955|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
149181956|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
149181957|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
149181958|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
149181959|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
149181960|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
149181961|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
149181962|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
149181963|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
149181964|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
149181965|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
149181966|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
149181967|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
149181968|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
149181969|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
149181970|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
149181971|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
148932069|NCT02600351|537236748|FG002|Overall Study|Randomized but Not Treated|1|||
148932070|NCT02600351|537236749|FG003|Overall Study|Randomized but Not Treated|3|||
148932071|NCT02106910|537236752|FG000|Overall Study|Lost to Follow-up|1|||
148932072|NCT02106910|537236753|FG001|Overall Study|Lost to Follow-up|1|||
148932073|NCT00567593|537236754|FG000|Overall Study|Adverse Event|1|||
149181972|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
148932074|NCT00567593|537236754|FG000|Overall Study|Physician Decision|1|||
148932075|NCT02476422|537236755|FG000|Overall Study|Subject/guardian decision|0|||
148932076|NCT02476422|537236756|FG001|Overall Study|Subject/guardian decision|1|||
148932077|NCT01859143|537236757|FG000|Overall Study|Lost to Follow-up|2|||
148932078|NCT01859143|537236758|FG001|Overall Study|Lost to Follow-up|0|||
148932079|NCT00700570|537236759|FG000|Overall Study|Adverse Event|2|||
149181973|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
149181974|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
149181975|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
149181976|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
149181977|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
149181978|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
148932080|NCT00700570|537236760|FG001|Overall Study|Adverse Event|6|||
148932081|NCT00700570|537236759|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
149181979|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
148932082|NCT00700570|537236760|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
148932083|NCT00700570|537236759|FG000|Overall Study|Disease Progression|8|||
148932084|NCT00700570|537236760|FG001|Overall Study|Disease Progression|11|||
148932085|NCT00700570|537236759|FG000|Overall Study|Withdrawal by Subject|1|||
148932086|NCT00700570|537236760|FG001|Overall Study|Withdrawal by Subject|6|||
148932087|NCT02180165|537236764|FG000|Overall Study|Not Treated|0|||
148932088|NCT02180165|537236765|FG001|Overall Study|Not Treated|0|||
148932089|NCT02180165|537236766|FG002|Overall Study|Not Treated|1|||
148932090|NCT02180165|537236767|FG003|Overall Study|Not Treated|0|||
148932091|NCT02180165|537236764|FG000|Overall Study|Adverse Event|7|||
149181980|NCT00958568|538137678|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
149181981|NCT00958568|538137679|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
149181982|NCT00958568|538137680|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
149181983|NCT00958568|538137681|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
149181984|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
149181985|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
149181986|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
149181987|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
149181988|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
149181989|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
149181990|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
149181991|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
149181992|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
149181993|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
149181994|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
149181995|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
148932092|NCT02180165|537236765|FG001|Overall Study|Adverse Event|0|||
148932093|NCT02180165|537236766|FG002|Overall Study|Adverse Event|18|||
149181996|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
149181997|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
148932094|NCT02180165|537236767|FG003|Overall Study|Adverse Event|3|||
148932095|NCT02180165|537236764|FG000|Overall Study|Lack of Efficacy|0|||
148932096|NCT02180165|537236765|FG001|Overall Study|Lack of Efficacy|1|||
148932097|NCT02180165|537236766|FG002|Overall Study|Lack of Efficacy|3|||
148932098|NCT02180165|537236767|FG003|Overall Study|Lack of Efficacy|2|||
148932099|NCT02180165|537236764|FG000|Overall Study|Physician Decision|1|||
148932100|NCT02180165|537236765|FG001|Overall Study|Physician Decision|0|||
148932101|NCT02180165|537236766|FG002|Overall Study|Physician Decision|5|||
148932102|NCT02180165|537236767|FG003|Overall Study|Physician Decision|0|||
148932103|NCT02180165|537236764|FG000|Overall Study|Withdrawal by Subject|3|||
148932104|NCT02180165|537236765|FG001|Overall Study|Withdrawal by Subject|0|||
148932105|NCT02180165|537236766|FG002|Overall Study|Withdrawal by Subject|2|||
148932106|NCT02180165|537236767|FG003|Overall Study|Withdrawal by Subject|1|||
148932107|NCT03875768|537236768|FG000|Overall Study|Lost to Follow-up|16|||
148932108|NCT03875768|537236769|FG001|Overall Study|Lost to Follow-up|13|||
148932109|NCT03875768|537236768|FG000|Overall Study|Withdrawal by Subject|10|||
148932110|NCT03875768|537236769|FG001|Overall Study|Withdrawal by Subject|21|||
148932111|NCT03875768|537236768|FG000|Overall Study|Did not complete assessment|21|||
148932112|NCT03875768|537236769|FG001|Overall Study|Did not complete assessment|12|||
148932113|NCT03875768|537236768|FG000|Overall Study|Became ineligible|1|||
148932114|NCT03875768|537236769|FG001|Overall Study|Became ineligible|0|||
148932115|NCT01925274|537236770|FG000|Overall Study|Death|1|||
148807298|NCT00576758|536773227|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
148807299|NCT00576758|536773226|FG000|Induction Treatment Period|Death|1|||
148932116|NCT01925274|537236771|FG001|Overall Study|Death|0|||
148932117|NCT01925274|537236772|FG002|Overall Study|Death|0|||
148932118|NCT01925274|537236770|FG000|Overall Study|Lost to Follow-up|0|||
148932119|NCT01925274|537236771|FG001|Overall Study|Lost to Follow-up|1|||
148932120|NCT01925274|537236772|FG002|Overall Study|Lost to Follow-up|0|||
148932121|NCT01925274|537236770|FG000|Overall Study|Withdrawal by Subject|1|||
148932122|NCT01925274|537236771|FG001|Overall Study|Withdrawal by Subject|2|||
148932123|NCT01925274|537236772|FG002|Overall Study|Withdrawal by Subject|0|||
148932124|NCT01925274|537236770|FG000|Overall Study|Study terminated by sponsor|4|||
149181998|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
149181999|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
149182000|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
149182001|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
149182002|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
149182003|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
149182004|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
149182005|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
149182006|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
149182007|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
149182008|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
149182009|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
149182010|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
149182011|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
149182012|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
149182013|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
149013825|NCT06173570|537530811|FG003|Overall Study|Adverse Event|2|||
149013826|NCT06173570|537530812|FG004|Overall Study|Adverse Event|0|||
149013827|NCT06173570|537530808|FG000|Overall Study|Lost to Follow-up|1|||
149013828|NCT06173570|537530809|FG001|Overall Study|Lost to Follow-up|0|||
149013829|NCT06173570|537530810|FG002|Overall Study|Lost to Follow-up|0|||
149013830|NCT06173570|537530811|FG003|Overall Study|Lost to Follow-up|0|||
149013831|NCT06173570|537530812|FG004|Overall Study|Lost to Follow-up|2|||
149013832|NCT06173570|537530808|FG000|Overall Study|Protocol Violation|0|||
149013833|NCT06173570|537530809|FG001|Overall Study|Protocol Violation|2|||
149013834|NCT06173570|537530810|FG002|Overall Study|Protocol Violation|0|||
149013835|NCT06173570|537530811|FG003|Overall Study|Protocol Violation|0|||
149013836|NCT06173570|537530812|FG004|Overall Study|Protocol Violation|1|||
149013837|NCT06173570|537530808|FG000|Overall Study|Withdrawal by Subject|0|||
149013838|NCT06173570|537530809|FG001|Overall Study|Withdrawal by Subject|1|||
149013839|NCT06173570|537530810|FG002|Overall Study|Withdrawal by Subject|1|||
149013840|NCT06173570|537530811|FG003|Overall Study|Withdrawal by Subject|1|||
149013841|NCT06173570|537530812|FG004|Overall Study|Withdrawal by Subject|1|||
149013842|NCT06173570|537530808|FG000|Overall Study|Non-compliance with Study Drug|1|||
149013843|NCT06173570|537530809|FG001|Overall Study|Non-compliance with Study Drug|0|||
149013844|NCT06173570|537530810|FG002|Overall Study|Non-compliance with Study Drug|0|||
149013845|NCT06173570|537530811|FG003|Overall Study|Non-compliance with Study Drug|0|||
149013846|NCT06173570|537530812|FG004|Overall Study|Non-compliance with Study Drug|0|||
149013847|NCT06173570|537530808|FG000|Overall Study|Screen Failure|0|||
149013848|NCT06173570|537530809|FG001|Overall Study|Screen Failure|0|||
149013849|NCT06173570|537530810|FG002|Overall Study|Screen Failure|0|||
149013850|NCT06173570|537530811|FG003|Overall Study|Screen Failure|0|||
149013851|NCT06173570|537530812|FG004|Overall Study|Screen Failure|1|||
149013852|NCT06173570|537530808|FG000|Overall Study|Other|2|||
149013853|NCT06173570|537530809|FG001|Overall Study|Other|1|||
149013854|NCT06173570|537530810|FG002|Overall Study|Other|0|||
149013855|NCT06173570|537530811|FG003|Overall Study|Other|2|||
149013856|NCT06173570|537530812|FG004|Overall Study|Other|0|||
149013857|NCT01844115|537530813|FG000|Overall Study|Adverse Event|4|||
149013858|NCT01844115|537530814|FG001|Overall Study|Adverse Event|22|||
149013859|NCT01844115|537530813|FG000|Overall Study|Lack of Efficacy|1|||
149013860|NCT01844115|537530814|FG001|Overall Study|Lack of Efficacy|4|||
149013861|NCT01844115|537530813|FG000|Overall Study|Protocol Violation|12|||
149013862|NCT01844115|537530814|FG001|Overall Study|Protocol Violation|10|||
149013863|NCT01844115|537530813|FG000|Overall Study|Withdrawal by Subject|11|||
149013864|NCT01844115|537530814|FG001|Overall Study|Withdrawal by Subject|11|||
149013865|NCT01844115|537530813|FG000|Overall Study|Lost to Follow-up|11|||
149013866|NCT01844115|537530814|FG001|Overall Study|Lost to Follow-up|10|||
149013867|NCT01844115|537530813|FG000|Overall Study|Pregnancy|0|||
149013868|NCT01844115|537530814|FG001|Overall Study|Pregnancy|1|||
149182014|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
149013869|NCT00366301|537530815|FG000|Overall Study|Lost to Follow-up|4|||
149013870|NCT00366301|537530816|FG001|Overall Study|Lost to Follow-up|4|||
149013871|NCT00366301|537530817|FG002|Overall Study|Lost to Follow-up|3|||
149013872|NCT00366301|537530818|FG003|Overall Study|Lost to Follow-up|7|||
149013873|NCT00366301|537530815|FG000|Overall Study|Withdrawal by Subject|4|||
149013874|NCT00366301|537530816|FG001|Overall Study|Withdrawal by Subject|2|||
149013875|NCT00366301|537530817|FG002|Overall Study|Withdrawal by Subject|1|||
149013876|NCT00366301|537530818|FG003|Overall Study|Withdrawal by Subject|1|||
149013877|NCT01372605|537530819|FG000|Overall Study|Death|1|||
149013878|NCT01372605|537530820|FG001|Overall Study|Death|2|||
149013879|NCT01372605|537530819|FG000|Overall Study|Lost to Follow-up|2|||
149013880|NCT01372605|537530820|FG001|Overall Study|Lost to Follow-up|1|||
149182015|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
149182016|NCT00958568|538137678|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
149013881|NCT01372605|537530819|FG000|Overall Study|Withdrawal by Subject|4|||
149013882|NCT01372605|537530820|FG001|Overall Study|Withdrawal by Subject|7|||
149013883|NCT01372605|537530819|FG000|Overall Study|Moved|3|||
149013884|NCT01372605|537530820|FG001|Overall Study|Moved|0|||
149013885|NCT01372605|537530819|FG000|Overall Study|Changed medical home|2|||
149013886|NCT01372605|537530820|FG001|Overall Study|Changed medical home|0|||
149013887|NCT01108510|537530821|FG000|Overall Study|Randomized but Not Treated|5|||
149013888|NCT01108510|537530822|FG001|Overall Study|Randomized but Not Treated|1|||
149013889|NCT01108510|537530821|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
149013890|NCT01108510|537530822|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
149013891|NCT01108510|537530821|FG000|Overall Study|Adverse Event|26|||
149013892|NCT01108510|537530822|FG001|Overall Study|Adverse Event|19|||
149013893|NCT01108510|537530821|FG000|Overall Study|Lost to Follow-up|20|||
149013894|NCT01108510|537530822|FG001|Overall Study|Lost to Follow-up|17|||
149013895|NCT01108510|537530821|FG000|Overall Study|Withdrew Consent|21|||
149013896|NCT01108510|537530822|FG001|Overall Study|Withdrew Consent|15|||
149013897|NCT01108510|537530821|FG000|Overall Study|Investigator's Discretion|12|||
149013898|NCT01108510|537530822|FG001|Overall Study|Investigator's Discretion|10|||
149013899|NCT01108510|537530821|FG000|Overall Study|Participant Noncompliance|5|||
149013900|NCT01108510|537530822|FG001|Overall Study|Participant Noncompliance|7|||
149013901|NCT01108510|537530821|FG000|Overall Study|Lack of Efficacy|3|||
149013902|NCT01108510|537530822|FG001|Overall Study|Lack of Efficacy|0|||
149013903|NCT01108510|537530821|FG000|Overall Study|Pregnancy|0|||
149013904|NCT01108510|537530822|FG001|Overall Study|Pregnancy|3|||
149013905|NCT01108510|537530821|FG000|Overall Study|Death|1|||
149013906|NCT01108510|537530822|FG001|Overall Study|Death|1|||
149013907|NCT00210119|537530823|FG000|Overall Study|Protocol Violation|1|||
149013908|NCT00210119|537530823|FG000|Overall Study|Withdrawal by Subject|1|||
149013909|NCT00951509|537530824|FG000|Overall Study|Withdrawal by Subject|2|||
149013910|NCT01830881|537530828|FG000|Overall Study|Changed decision to have an abortion|0|||
149013911|NCT01830881|537530829|FG001|Overall Study|Changed decision to have an abortion|1|||
149013912|NCT03125941|537530830|FG000|Overall Study|did not receive intervention|1|||
149013913|NCT03125941|537530831|FG001|Overall Study|did not receive intervention|2|||
149013914|NCT00734214|537530832|FG000|Overall Study|Withdrawal by Subject|3|||
149013915|NCT00734214|537530833|FG001|Overall Study|Withdrawal by Subject|4|||
149013916|NCT00734214|537530832|FG000|Overall Study|MD withdrawal|1|||
149013917|NCT00734214|537530833|FG001|Overall Study|MD withdrawal|0|||
149013918|NCT00582491|537530834|FG000|Overall Study|Withdrawal by Subject|1|||
149013919|NCT00582491|537530835|FG001|Overall Study|Withdrawal by Subject|0|||
149013920|NCT01425632|537530836|FG000|Overall Study|Adverse Event|0|||
149013921|NCT01425632|537530837|FG001|Overall Study|Adverse Event|1|||
149013922|NCT01425632|537530838|FG002|Overall Study|Adverse Event|1|||
149182017|NCT00958568|538137679|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
149182018|NCT00958568|538137680|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
149182019|NCT00958568|538137681|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
149182020|NCT00915005|538137682|FG000|Overall Study|Withdrawal by Subject|4|||
149182021|NCT00915005|538137683|FG001|Overall Study|Withdrawal by Subject|4|||
149182022|NCT00915005|538137682|FG000|Overall Study|Patient preferred protons therapy|6|||
149182023|NCT00915005|538137683|FG001|Overall Study|Patient preferred protons therapy|0|||
149182024|NCT00915005|538137682|FG000|Overall Study|Insurance denial|3|||
149182025|NCT00915005|538137683|FG001|Overall Study|Insurance denial|15|||
149182026|NCT00283712|538137690|FG000|Overall Study|Death|0|||
149182027|NCT00283712|538137691|FG001|Overall Study|Death|1|||
149182028|NCT03952650|538137693|FG000|Overall Study|TRAVEL|0|||
149182029|NCT03952650|538137694|FG001|Overall Study|TRAVEL|4|||
149182030|NCT03952650|538137695|FG002|Overall Study|TRAVEL|0|||
149182031|NCT03952650|538137696|FG003|Overall Study|TRAVEL|4|||
149182032|NCT03952650|538137697|FG004|Overall Study|TRAVEL|0|||
149182033|NCT03952650|538137698|FG005|Overall Study|TRAVEL|3|||
149182034|NCT03952650|538137699|FG006|Overall Study|TRAVEL|2|||
149182035|NCT03952650|538137693|FG000|Overall Study|Withdrawal by Subject|0|||
149182036|NCT03952650|538137694|FG001|Overall Study|Withdrawal by Subject|2|||
149182037|NCT03952650|538137695|FG002|Overall Study|Withdrawal by Subject|0|||
149182038|NCT03952650|538137696|FG003|Overall Study|Withdrawal by Subject|3|||
149013923|NCT01425632|537530836|FG000|Overall Study|Physician Decision|1|||
149182039|NCT03952650|538137697|FG004|Overall Study|Withdrawal by Subject|0|||
149013924|NCT01425632|537530837|FG001|Overall Study|Physician Decision|0|||
149013925|NCT01425632|537530838|FG002|Overall Study|Physician Decision|0|||
149013926|NCT01425632|537530836|FG000|Overall Study|Protocol Violation|0|||
149013927|NCT01425632|537530837|FG001|Overall Study|Protocol Violation|0|||
149013928|NCT01425632|537530838|FG002|Overall Study|Protocol Violation|2|||
149013929|NCT01425632|537530836|FG000|Overall Study|Withdrawal by Subject|0|||
149013930|NCT01425632|537530837|FG001|Overall Study|Withdrawal by Subject|0|||
149013931|NCT01425632|537530838|FG002|Overall Study|Withdrawal by Subject|1|||
149182040|NCT03952650|538137698|FG005|Overall Study|Withdrawal by Subject|1|||
149182041|NCT03952650|538137699|FG006|Overall Study|Withdrawal by Subject|1|||
149182042|NCT03952650|538137693|FG000|Overall Study|Lost to Follow-up|0|||
149182043|NCT03952650|538137694|FG001|Overall Study|Lost to Follow-up|1|||
148932125|NCT01925274|537236771|FG001|Overall Study|Study terminated by sponsor|0|||
148932126|NCT01925274|537236772|FG002|Overall Study|Study terminated by sponsor|0|||
148932127|NCT01925274|537236770|FG000|Overall Study|Protocol amendment|1|||
148932128|NCT01925274|537236771|FG001|Overall Study|Protocol amendment|3|||
148932129|NCT01925274|537236772|FG002|Overall Study|Protocol amendment|6|||
148932130|NCT04327674|537236773|FG000|Overall Study|Protocol Violation|19|||
148932131|NCT00723398|537236774|FG000|Overall Study|Withdrawal by Subject|2|||
148932132|NCT00723398|537236775|FG001|Overall Study|Withdrawal by Subject|6|||
148932133|NCT00723398|537236776|FG002|Overall Study|Withdrawal by Subject|4|||
148932134|NCT00723398|537236777|FG003|Overall Study|Withdrawal by Subject|4|||
148932135|NCT00723398|537236778|FG004|Overall Study|Withdrawal by Subject|4|||
148932136|NCT00723398|537236774|FG000|Overall Study|Protocol Violation|2|||
148932137|NCT00723398|537236775|FG001|Overall Study|Protocol Violation|1|||
148932138|NCT00723398|537236776|FG002|Overall Study|Protocol Violation|5|||
148932139|NCT00723398|537236777|FG003|Overall Study|Protocol Violation|0|||
148932140|NCT00723398|537236778|FG004|Overall Study|Protocol Violation|0|||
148932141|NCT00723398|537236774|FG000|Overall Study|Physician Decision|2|||
148932142|NCT00723398|537236775|FG001|Overall Study|Physician Decision|2|||
148932143|NCT00723398|537236776|FG002|Overall Study|Physician Decision|5|||
148932144|NCT00723398|537236777|FG003|Overall Study|Physician Decision|0|||
148932145|NCT00723398|537236778|FG004|Overall Study|Physician Decision|1|||
148932146|NCT00723398|537236774|FG000|Overall Study|Adverse Event|0|||
148932147|NCT00723398|537236775|FG001|Overall Study|Adverse Event|5|||
148932148|NCT00723398|537236776|FG002|Overall Study|Adverse Event|3|||
148932149|NCT00723398|537236777|FG003|Overall Study|Adverse Event|1|||
148932150|NCT00723398|537236778|FG004|Overall Study|Adverse Event|4|||
148932151|NCT00723398|537236774|FG000|Overall Study|Lost to Follow-up|0|||
148932152|NCT00723398|537236775|FG001|Overall Study|Lost to Follow-up|1|||
148932153|NCT00723398|537236776|FG002|Overall Study|Lost to Follow-up|0|||
148932154|NCT00723398|537236777|FG003|Overall Study|Lost to Follow-up|0|||
148932155|NCT00723398|537236778|FG004|Overall Study|Lost to Follow-up|0|||
148932156|NCT00566501|537236786|FG000|Overall Study|Adverse Event|68|||
148932157|NCT00566501|537236787|FG001|Overall Study|Adverse Event|59|||
149182044|NCT03952650|538137695|FG002|Overall Study|Lost to Follow-up|0|||
149182045|NCT03952650|538137696|FG003|Overall Study|Lost to Follow-up|0|||
149182046|NCT03952650|538137697|FG004|Overall Study|Lost to Follow-up|0|||
149182047|NCT03952650|538137698|FG005|Overall Study|Lost to Follow-up|1|||
149182048|NCT03952650|538137699|FG006|Overall Study|Lost to Follow-up|1|||
149182049|NCT03952650|538137693|FG000|Overall Study|Received wrong vaccine and travelled|0|||
149182050|NCT03952650|538137694|FG001|Overall Study|Received wrong vaccine and travelled|0|||
149182051|NCT03952650|538137695|FG002|Overall Study|Received wrong vaccine and travelled|0|||
149182052|NCT03952650|538137696|FG003|Overall Study|Received wrong vaccine and travelled|0|||
149182053|NCT03952650|538137697|FG004|Overall Study|Received wrong vaccine and travelled|0|||
149182054|NCT03952650|538137698|FG005|Overall Study|Received wrong vaccine and travelled|1|||
149182055|NCT03952650|538137699|FG006|Overall Study|Received wrong vaccine and travelled|0|||
149182056|NCT03952650|538137693|FG000|Overall Study|Unable to make study visit|0|||
149182057|NCT03952650|538137694|FG001|Overall Study|Unable to make study visit|0|||
149182058|NCT03952650|538137695|FG002|Overall Study|Unable to make study visit|0|||
149182059|NCT03952650|538137696|FG003|Overall Study|Unable to make study visit|0|||
149182060|NCT03952650|538137697|FG004|Overall Study|Unable to make study visit|0|||
149182061|NCT03952650|538137698|FG005|Overall Study|Unable to make study visit|1|||
149182062|NCT03952650|538137699|FG006|Overall Study|Unable to make study visit|0|||
149182063|NCT03988751|538137702|FG000|Overall Study|Withdrawal by Subject|1|||
149182064|NCT03988751|538137703|FG001|Overall Study|Withdrawal by Subject|0|||
149182065|NCT03988751|538137702|FG000|Overall Study|Protocol Violation|0|||
149182066|NCT03988751|538137703|FG001|Overall Study|Protocol Violation|1|||
149182067|NCT02441803|538137705|FG000|Overall Study|Physician Decision|0|||
149182068|NCT02441803|538137706|FG001|Overall Study|Physician Decision|2|||
149182069|NCT02441803|538137707|FG002|Overall Study|Physician Decision|2|||
149182070|NCT03065530|538137709|FG000|Overall Study|Lack of Efficacy|1|||
148807300|NCT00576758|536773227|FG001|Induction Treatment Period|Death|0|||
148932158|NCT00566501|537236786|FG000|Overall Study|Medication Non-compliance|5|||
148932159|NCT00566501|537236787|FG001|Overall Study|Medication Non-compliance|0|||
148932160|NCT00566501|537236786|FG000|Overall Study|Protocol Violation|2|||
148932161|NCT00566501|537236787|FG001|Overall Study|Protocol Violation|2|||
148932162|NCT00566501|537236786|FG000|Overall Study|Request of Investigator or Sponsor|6|||
148932163|NCT00566501|537236787|FG001|Overall Study|Request of Investigator or Sponsor|7|||
148932164|NCT00566501|537236786|FG000|Overall Study|Withdrawal by Subject|33|||
148932165|NCT00566501|537236787|FG001|Overall Study|Withdrawal by Subject|30|||
148932166|NCT00566501|537236786|FG000|Overall Study|Lack of Efficacy|8|||
148932167|NCT00566501|537236787|FG001|Overall Study|Lack of Efficacy|3|||
148932168|NCT00566501|537236786|FG000|Overall Study|Other|25|||
148932169|NCT00566501|537236787|FG001|Overall Study|Other|21|||
148932170|NCT02310321|537236795|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
148932171|NCT02310321|537236796|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
148932172|NCT02310321|537236797|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
149013932|NCT00406419|537530839|FG000|Overall Study|Death|3|||
149182071|NCT03065530|538137710|FG001|Overall Study|Lack of Efficacy|1|||
149182072|NCT03065530|538137711|FG002|Overall Study|Lack of Efficacy|0|||
149182073|NCT03065530|538137712|FG003|Overall Study|Lack of Efficacy|1|||
149182074|NCT03065530|538137709|FG000|Overall Study|Protocol Violation|1|||
149182075|NCT03065530|538137710|FG001|Overall Study|Protocol Violation|0|||
149182076|NCT03065530|538137711|FG002|Overall Study|Protocol Violation|1|||
149182077|NCT03065530|538137712|FG003|Overall Study|Protocol Violation|1|||
149182078|NCT01325493|538137713|FG000|Overall Study|Protocol Violation|0|||
148932173|NCT02310321|537236795|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
148932174|NCT02310321|537236796|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
148932175|NCT02310321|537236797|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
148932176|NCT02310321|537236795|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
148932177|NCT02310321|537236796|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
148932178|NCT02310321|537236797|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
148932179|NCT02310321|537236795|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
148932180|NCT02310321|537236796|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
148932181|NCT02310321|537236797|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
148932182|NCT02310321|537236795|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
148932183|NCT02310321|537236796|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
148932184|NCT02310321|537236797|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
148932185|NCT02310321|537236795|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
148932186|NCT02310321|537236796|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
148932187|NCT02310321|537236797|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
148932188|NCT02310321|537236795|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
148932189|NCT02310321|537236796|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
148932190|NCT02310321|537236797|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
148932191|NCT02310321|537236795|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
148932192|NCT02310321|537236796|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
148932193|NCT02310321|537236797|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
148932194|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
148932195|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
148932196|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
149182079|NCT01325493|538137714|FG001|Overall Study|Protocol Violation|1|||
149182080|NCT01325493|538137713|FG000|Overall Study|loss of neuromonitoring signals|0|||
149182081|NCT01325493|538137714|FG001|Overall Study|loss of neuromonitoring signals|2|||
149182082|NCT01325493|538137713|FG000|Overall Study|Allergy|1|||
149182083|NCT01325493|538137714|FG001|Overall Study|Allergy|0|||
149182084|NCT02240628|538137715|FG000|Overall Study|Physician Decision|6|||
149182085|NCT02240628|538137716|FG001|Overall Study|Physician Decision|5|||
149182086|NCT02285010|538137717|FG000|Overall Study|not abdominal hysterectomy|2|||
149182087|NCT02285010|538137718|FG001|Overall Study|not abdominal hysterectomy|0|||
149182088|NCT02285010|538137717|FG000|Overall Study|Not spinal anesthesia|3|||
149182089|NCT02285010|538137718|FG001|Overall Study|Not spinal anesthesia|1|||
149182090|NCT01457339|538137724|FG000|Period 3 (100 mg)|Adverse Event|0|||
149182091|NCT01457339|538137725|FG001|Period 3 (100 mg)|Adverse Event|1|||
149182092|NCT01457339|538137724|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
149182093|NCT01457339|538137725|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
149182094|NCT01457339|538137724|FG000|Period 6 (250 mg)|Family Emergency|1|||
149182095|NCT01457339|538137725|FG001|Period 6 (250 mg)|Family Emergency|0|||
149182096|NCT01457339|538137724|FG000|Period 6 (250 mg)|Personal appointment|0|||
149182097|NCT01457339|538137725|FG001|Period 6 (250 mg)|Personal appointment|1|||
149182098|NCT00394914|538137729|FG000|Treatment Period|Adverse Event|0|||
149182099|NCT00394914|538137730|FG001|Treatment Period|Adverse Event|3|||
149182100|NCT00394914|538137731|FG002|Treatment Period|Adverse Event|1|||
149182101|NCT00394914|538137729|FG000|Treatment Period|Lost to Follow-up|0|||
149182102|NCT00394914|538137730|FG001|Treatment Period|Lost to Follow-up|1|||
149182103|NCT00394914|538137731|FG002|Treatment Period|Lost to Follow-up|0|||
148932197|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
148932198|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
148932199|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
148932200|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
149182104|NCT00394914|538137729|FG000|Treatment Period|Withdrawal by Subject|0|||
149182105|NCT00394914|538137730|FG001|Treatment Period|Withdrawal by Subject|2|||
149182106|NCT00394914|538137731|FG002|Treatment Period|Withdrawal by Subject|2|||
149182107|NCT00394914|538137729|FG000|Treatment Period|Noncompliance with protocol|0|||
149182108|NCT00394914|538137730|FG001|Treatment Period|Noncompliance with protocol|3|||
149182109|NCT00394914|538137731|FG002|Treatment Period|Noncompliance with protocol|2|||
149182110|NCT00394914|538137729|FG000|Treatment Period|Did not meet protocol eligibility|0|||
149234005|NCT01422876|538326351|FG005|Week 52|Lost to Follow-up|5|||
149234006|NCT01422876|538326352|FG006|Week 52|Lost to Follow-up|5|||
149234007|NCT01422876|538326353|FG007|Week 52|Lost to Follow-up|8|||
149182111|NCT00394914|538137730|FG001|Treatment Period|Did not meet protocol eligibility|1|||
149182112|NCT00394914|538137731|FG002|Treatment Period|Did not meet protocol eligibility|1|||
149182113|NCT00312377|538137733|FG000|Overall Study|Death|403|||
149182114|NCT00312377|538137734|FG001|Overall Study|Death|418|||
149182115|NCT00312377|538137733|FG000|Overall Study|Withdrawal by Subject|23|||
149182116|NCT00312377|538137734|FG001|Overall Study|Withdrawal by Subject|30|||
149182117|NCT00312377|538137733|FG000|Overall Study|Lost to Follow-up|9|||
149182118|NCT00312377|538137734|FG001|Overall Study|Lost to Follow-up|12|||
149182119|NCT00312377|538137733|FG000|Overall Study|Non-compliance|0|||
149182120|NCT00312377|538137734|FG001|Overall Study|Non-compliance|2|||
149182121|NCT00312377|538137733|FG000|Overall Study|Randomised but never received treatment|6|||
149182122|NCT00312377|538137734|FG001|Overall Study|Randomised but never received treatment|6|||
149182123|NCT00312377|538137733|FG000|Overall Study|Discontinue treatment survival follow up|202|||
149182124|NCT00312377|538137734|FG001|Overall Study|Discontinue treatment survival follow up|200|||
149182125|NCT00312377|538137733|FG000|Overall Study|Site ended participation in study|1|||
149182126|NCT00312377|538137734|FG001|Overall Study|Site ended participation in study|0|||
149182127|NCT05258058|538137742|FG000|Overall Study|Withdrawal by Subject|2|||
149182128|NCT02179398|538137745|FG000|Overall Study|Lack of obligatory data|3|||
149182129|NCT02179398|538137746|FG001|Overall Study|Lack of obligatory data|3|||
149182130|NCT02179398|538137745|FG000|Overall Study|Lost to Follow-up|0|||
149182131|NCT02179398|538137746|FG001|Overall Study|Lost to Follow-up|1|||
149182132|NCT00408681|538137749|FG000|Overall Study|Lack of Efficacy|2|||
149182133|NCT00408681|538137749|FG000|Overall Study|Adverse Event|7|||
149182134|NCT02519231|538137759|FG000|Overall Study|Lost to Follow-up|2|||
149182135|NCT02519231|538137760|FG001|Overall Study|Lost to Follow-up|5|||
149182136|NCT02519231|538137759|FG000|Overall Study|Withdrawal by Subject|0|||
149182137|NCT02519231|538137760|FG001|Overall Study|Withdrawal by Subject|1|||
149182138|NCT00447421|538137761|FG000|Overall Study|Lack of Efficacy|1|||
149182139|NCT00447421|538137761|FG000|Overall Study|Adverse Event|3|||
149182140|NCT00447421|538137761|FG000|Overall Study|Sponsor Decision|2|||
149182141|NCT01787591|538137762|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
149182142|NCT01787591|538137763|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
149182143|NCT01787591|538137764|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
149182144|NCT01787591|538137765|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
149182145|NCT02725177|538137766|FG000|Overall Study|Physician Decision|4|||
149182146|NCT02725177|538137766|FG000|Overall Study|Adverse Event|1|||
149182147|NCT02707757|538137767|FG000|Overall Study|Protocol Violation|3|||
149182148|NCT02707757|538137768|FG001|Overall Study|Protocol Violation|2|||
149182149|NCT02707757|538137767|FG000|Overall Study|Withdrawal by Subject|2|||
149182150|NCT02707757|538137768|FG001|Overall Study|Withdrawal by Subject|0|||
149182151|NCT02707757|538137767|FG000|Overall Study|Death|0|||
149182152|NCT02707757|538137768|FG001|Overall Study|Death|1|||
149182153|NCT02707757|538137767|FG000|Overall Study|Adverse Event|6|||
149182154|NCT02707757|538137768|FG001|Overall Study|Adverse Event|4|||
149182155|NCT02707757|538137767|FG000|Overall Study|Renal transplant/elective operation|1|||
149182156|NCT02707757|538137768|FG001|Overall Study|Renal transplant/elective operation|5|||
149182157|NCT00815308|538137769|FG000|Overall Study|Adverse Event|4|||
149182158|NCT00815308|538137769|FG000|Overall Study|Withdrawal by Subject|0|||
149182159|NCT00815308|538137769|FG000|Overall Study|Protocol Violation|6|||
149182160|NCT00377299|538137770|FG000|Overall Study|Lost to Follow-up|14|||
149182161|NCT00377299|538137771|FG001|Overall Study|Lost to Follow-up|19|||
149182162|NCT00377299|538137770|FG000|Overall Study|Adverse Event|0|||
149182163|NCT00377299|538137771|FG001|Overall Study|Adverse Event|1|||
149182164|NCT00377299|538137770|FG000|Overall Study|Withdrawal by Subject|5|||
148807301|NCT00576758|536773226|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
148807302|NCT00576758|536773227|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
148807303|NCT00576758|536773226|FG000|Induction Treatment Period|Withdrew consent|1|||
148807304|NCT00576758|536773227|FG001|Induction Treatment Period|Withdrew consent|0|||
148807305|NCT00576758|536773226|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
148807306|NCT00576758|536773227|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
149182165|NCT00377299|538137771|FG001|Overall Study|Withdrawal by Subject|4|||
149182166|NCT04799782|538137772|FG000|Washout|Physician Decision|2|||
149182167|NCT04799782|538137773|FG001|Washout|Physician Decision|0|||
149182168|NCT04799782|538137772|FG000|Washout|Withdrawal by Subject|0|||
149182169|NCT04799782|538137773|FG001|Washout|Withdrawal by Subject|2|||
149182170|NCT04799782|538137772|FG000|Washout|Lost to Follow-up|0|||
149182171|NCT04799782|538137773|FG001|Washout|Lost to Follow-up|1|||
149182172|NCT00969618|538137774|FG000|Overall Study|Adverse Event|29|||
149182173|NCT00969618|538137774|FG000|Overall Study|Entry Criteria Not Met|3|||
149182174|NCT00969618|538137774|FG000|Overall Study|Lack of Efficacy|2|||
149182175|NCT00969618|538137774|FG000|Overall Study|Lost to Follow-up|7|||
149182176|NCT00969618|538137774|FG000|Overall Study|Physician Decision|1|||
149182177|NCT00969618|538137774|FG000|Overall Study|Protocol Violation|9|||
149182178|NCT00969618|538137774|FG000|Overall Study|Withdrawal by Subject|27|||
149182179|NCT01277289|538139835|FG000|Overall Study|fragile vein|1|||
148807307|NCT00576758|536773226|FG000|Extension Treatment Period|Death|1|||
148932201|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
148932202|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
148932203|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
148932204|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
149182180|NCT01277289|538139836|FG001|Overall Study|fragile vein|0|||
149182181|NCT01277289|538139835|FG000|Overall Study|Physician Decision|1|||
149182182|NCT01277289|538139836|FG001|Overall Study|Physician Decision|0|||
149182183|NCT01277289|538139835|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
149182184|NCT01277289|538139836|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
149182185|NCT01277289|538139835|FG000|Overall Study|Protocol Violation|1|||
149182186|NCT01277289|538139836|FG001|Overall Study|Protocol Violation|1|||
149182187|NCT01277289|538139835|FG000|Overall Study|Adverse Event|2|||
149182188|NCT01277289|538139836|FG001|Overall Study|Adverse Event|1|||
149182189|NCT01277289|538139835|FG000|Overall Study|consent withdrawn|1|||
149182190|NCT01277289|538139836|FG001|Overall Study|consent withdrawn|1|||
149182191|NCT01277289|538139835|FG000|Overall Study|premature closure of the study|4|||
149182192|NCT01277289|538139836|FG001|Overall Study|premature closure of the study|2|||
149182193|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
149182194|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
149182195|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
149182196|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
149182197|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
149182198|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
149182199|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
149182200|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
149182201|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
149182202|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
149182203|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
148932205|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
148932206|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
149182204|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
149182205|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
148932207|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
148932208|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
148932209|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
148932210|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
148932211|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
148932212|NCT02310321|537236795|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
148932213|NCT02310321|537236796|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
148932214|NCT02310321|537236797|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
148932215|NCT02310321|537236795|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
148932216|NCT02310321|537236796|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
148932217|NCT02310321|537236797|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
149182206|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
149182207|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
149182208|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
149182209|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
149182210|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
148807308|NCT00576758|536773227|FG001|Extension Treatment Period|Death|1|||
148807309|NCT00576758|536773226|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
148932218|NCT02310321|537236795|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
148932219|NCT02310321|537236796|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
148932220|NCT02310321|537236797|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
149182211|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
149182212|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
149182213|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
149182214|NCT00092547|538139837|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
149182215|NCT00092547|538139838|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
149182216|NCT00092547|538139839|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
149182217|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
149182218|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
149182219|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
149182220|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
149182221|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
149182222|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
149182223|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
149182224|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
149182225|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
149182226|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
149182227|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
149182228|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
149182229|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
148679624|NCT03216954|536300834|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149013933|NCT00406419|537530840|FG001|Overall Study|Death|1|||
149013934|NCT00406419|537530841|FG002|Overall Study|Death|4|||
149013935|NCT00406419|537530839|FG000|Overall Study|Protocol Violation|6|||
149013936|NCT00406419|537530840|FG001|Overall Study|Protocol Violation|2|||
149013937|NCT00406419|537530841|FG002|Overall Study|Protocol Violation|5|||
149013938|NCT00406419|537530839|FG000|Overall Study|Study Terminated by Sponsor|260|||
149013939|NCT00406419|537530840|FG001|Overall Study|Study Terminated by Sponsor|288|||
149013940|NCT00406419|537530841|FG002|Overall Study|Study Terminated by Sponsor|282|||
149013941|NCT00406419|537530839|FG000|Overall Study|Withdrawal by Subject|17|||
149013942|NCT00406419|537530840|FG001|Overall Study|Withdrawal by Subject|24|||
149013943|NCT00406419|537530841|FG002|Overall Study|Withdrawal by Subject|26|||
149013944|NCT00406419|537530839|FG000|Overall Study|Lack of Efficacy|12|||
149013945|NCT00406419|537530840|FG001|Overall Study|Lack of Efficacy|1|||
149013946|NCT00406419|537530841|FG002|Overall Study|Lack of Efficacy|6|||
149013947|NCT00406419|537530839|FG000|Overall Study|Non-Compliance with Study Drug|5|||
149013948|NCT00406419|537530840|FG001|Overall Study|Non-Compliance with Study Drug|6|||
149013949|NCT00406419|537530841|FG002|Overall Study|Non-Compliance with Study Drug|3|||
149013950|NCT00406419|537530839|FG000|Overall Study|Adverse Event|10|||
149013951|NCT00406419|537530840|FG001|Overall Study|Adverse Event|12|||
149013952|NCT00406419|537530841|FG002|Overall Study|Adverse Event|16|||
149013953|NCT00406419|537530839|FG000|Overall Study|Lost to Follow-up|11|||
149013954|NCT00406419|537530840|FG001|Overall Study|Lost to Follow-up|10|||
149013955|NCT00406419|537530841|FG002|Overall Study|Lost to Follow-up|5|||
149013956|NCT02340520|537530844|FG000|Overall Study|Lost to Follow-up|1|||
149013957|NCT02340520|537530844|FG000|Overall Study|Patient did not take drug as specified|1|||
149013958|NCT02340520|537530844|FG000|Overall Study|Withdrawal by Subject|1|||
149013959|NCT03915951|537530845|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
149013960|NCT03915951|537530846|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
149013961|NCT03915951|537530845|FG000|Overall Study|Adverse Event|12|||
149013962|NCT03915951|537530846|FG001|Overall Study|Adverse Event|6|||
149013963|NCT03915951|537530845|FG000|Overall Study|Disease progression (radiological)|17|||
149013964|NCT03915951|537530846|FG001|Overall Study|Disease progression (radiological)|15|||
149013965|NCT03915951|537530845|FG000|Overall Study|Disease progression (clinical)|4|||
149013966|NCT03915951|537530846|FG001|Overall Study|Disease progression (clinical)|1|||
149013967|NCT03915951|537530845|FG000|Overall Study|Patient decision|0|||
149013968|NCT03915951|537530846|FG001|Overall Study|Patient decision|4|||
149013969|NCT03915951|537530845|FG000|Overall Study|Investigator decision|0|||
149013970|NCT03915951|537530846|FG001|Overall Study|Investigator decision|1|||
149013971|NCT03915951|537530845|FG000|Overall Study|Consent withdrawn|1|||
149013972|NCT03915951|537530846|FG001|Overall Study|Consent withdrawn|1|||
149013973|NCT03915951|537530845|FG000|Overall Study|Death|0|||
149013974|NCT03915951|537530846|FG001|Overall Study|Death|3|||
149013975|NCT05064735|537530847|FG000|Overall Study|Withdrawal by Subject|7|||
149013976|NCT05064735|537530848|FG001|Overall Study|Withdrawal by Subject|8|||
149013977|NCT05064735|537530847|FG000|Overall Study|Lost to Follow-up|7|||
149013978|NCT05064735|537530848|FG001|Overall Study|Lost to Follow-up|2|||
149013979|NCT05064735|537530847|FG000|Overall Study|Physician Decision|2|||
149013980|NCT05064735|537530848|FG001|Overall Study|Physician Decision|1|||
149013981|NCT05064735|537530847|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
149013982|NCT05064735|537530848|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
149013983|NCT05064735|537530847|FG000|Overall Study|Site Closure|7|||
149013984|NCT05064735|537530848|FG001|Overall Study|Site Closure|2|||
149013985|NCT01396395|537530849|FG000|Overall Study|Withdrawal by Subject|10|||
149013986|NCT01396395|537530850|FG001|Overall Study|Withdrawal by Subject|12|||
149013987|NCT01396395|537530849|FG000|Overall Study|Protocol Violation|3|||
149182230|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
149182231|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
149234008|NCT01422876|538326354|FG008|Week 52|Lost to Follow-up|7|||
149013988|NCT01396395|537530850|FG001|Overall Study|Protocol Violation|1|||
149013989|NCT01396395|537530849|FG000|Overall Study|Adverse Event|10|||
149013990|NCT01396395|537530850|FG001|Overall Study|Adverse Event|2|||
149013991|NCT01396395|537530849|FG000|Overall Study|Lost to Follow-up|17|||
149013992|NCT01396395|537530850|FG001|Overall Study|Lost to Follow-up|11|||
149013993|NCT01396395|537530849|FG000|Overall Study|Other|0|||
149013994|NCT01396395|537530850|FG001|Overall Study|Other|1|||
149013995|NCT01370005|537530851|FG000|Overall Study|Not treated|1|||
149013996|NCT01370005|537530852|FG001|Overall Study|Not treated|0|||
149013997|NCT01370005|537530853|FG002|Overall Study|Not treated|0|||
149013998|NCT01370005|537530851|FG000|Overall Study|Adverse Event|5|||
149182232|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
149182233|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
149182234|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
149182235|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
149182236|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
149182237|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
149182238|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
148932221|NCT02310321|537236795|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
148932222|NCT02310321|537236796|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
148932223|NCT02310321|537236797|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
148932224|NCT02310321|537236795|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
148932225|NCT02310321|537236796|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
148932226|NCT02310321|537236797|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
148932227|NCT02310321|537236795|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
148932228|NCT02310321|537236796|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
148932229|NCT02310321|537236797|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
148932230|NCT02310321|537236795|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
148932231|NCT02310321|537236796|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
148932232|NCT02310321|537236797|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
148932233|NCT02310321|537236795|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
148932234|NCT02310321|537236796|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
148932235|NCT02310321|537236797|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
148932236|NCT02310321|537236795|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
148932237|NCT02310321|537236796|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
148932238|NCT02310321|537236797|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
148932239|NCT01698905|537236798|FG000|Overall Study|Adverse Event|4|||
148932240|NCT01698905|537236798|FG000|Overall Study|Physician Decision|2|||
148932241|NCT01698905|537236798|FG000|Overall Study|Pregnancy|1|||
148932242|NCT01698905|537236798|FG000|Overall Study|Protocol Violation|1|||
149182239|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
149182240|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
148932243|NCT01698905|537236798|FG000|Overall Study|Subject/guardian decision|2|||
148932244|NCT01698905|537236798|FG000|Overall Study|Death|1|||
148932245|NCT00857415|537236800|FG000|Overall Study|Image acquisition failure|2|||
148932246|NCT00857415|537236801|FG001|Overall Study|Image acquisition failure|0|||
148932247|NCT00857415|537236800|FG000|Overall Study|Invalid image or not imaged|3|||
148932248|NCT00857415|537236801|FG001|Overall Study|Invalid image or not imaged|0|||
148932249|NCT00857415|537236800|FG000|Overall Study|Subject still living at end of study|110|||
148932250|NCT00857415|537236801|FG001|Overall Study|Subject still living at end of study|0|||
148932251|NCT00857415|537236800|FG000|Overall Study|Deceased with no autopsy|2|||
148932252|NCT00857415|537236801|FG001|Overall Study|Deceased with no autopsy|0|||
149182241|NCT00092547|538139837|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
149182242|NCT00092547|538139838|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
149182243|NCT00092547|538139839|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
149182244|NCT00092547|538139837|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
149182245|NCT00092547|538139838|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
149182246|NCT00092547|538139839|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
149182247|NCT00092547|538139837|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
149182248|NCT00092547|538139838|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
149182249|NCT00092547|538139839|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
149182250|NCT00092547|538139837|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
149182251|NCT00092547|538139838|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
149182252|NCT00092547|538139839|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
149182253|NCT00092547|538139837|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
149182254|NCT00092547|538139838|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
149182255|NCT00092547|538139839|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
149182256|NCT00084682|538139840|FG000|Overall Study|Withdrawal by Subject|1|||
149182257|NCT01166659|538139841|FG000|Overall Study|Subject Decision|8|||
149182258|NCT01166659|538139841|FG000|Overall Study|Investigator Decision|2|||
149182259|NCT01166659|538139841|FG000|Overall Study|Death|1|||
149182260|NCT01166659|538139841|FG000|Overall Study|Lost to Follow-up|1|||
149182261|NCT01166659|538139841|FG000|Overall Study|Study Closed at Site|1|||
149182262|NCT03088605|538139844|FG000|Overall Study|Withdrawal by Subject|1|||
149182263|NCT03088605|538139845|FG001|Overall Study|Withdrawal by Subject|0|||
149182264|NCT02397655|538139846|FG000|Overall Study|data not completed|1301|||
148932253|NCT00764504|537236802|FG000|Overall Study|Death|12|||
148932254|NCT00764504|537236803|FG001|Overall Study|Death|6|||
148932255|NCT00764504|537236804|FG002|Overall Study|Death|13|||
148932256|NCT00764504|537236802|FG000|Overall Study|Revision of Device|12|||
149182265|NCT02747043|538139853|FG000|Overall Study|Other|1|||
148932257|NCT00764504|537236803|FG001|Overall Study|Revision of Device|23|||
148932258|NCT00764504|537236804|FG002|Overall Study|Revision of Device|14|||
148932259|NCT00764504|537236802|FG000|Overall Study|Physician Decision|1|||
148932260|NCT00764504|537236803|FG001|Overall Study|Physician Decision|0|||
148932261|NCT00764504|537236804|FG002|Overall Study|Physician Decision|0|||
148932262|NCT00764504|537236802|FG000|Overall Study|Withdrawal by Subject|1|||
148932263|NCT00764504|537236803|FG001|Overall Study|Withdrawal by Subject|7|||
148932264|NCT00764504|537236804|FG002|Overall Study|Withdrawal by Subject|4|||
148932265|NCT00764504|537236802|FG000|Overall Study|Lost to Follow-up|40|||
148932266|NCT00764504|537236803|FG001|Overall Study|Lost to Follow-up|34|||
148932267|NCT00764504|537236804|FG002|Overall Study|Lost to Follow-up|72|||
148932268|NCT00470847|537236807|FG000|Overall Study|Pt still receiving treatment|1|||
149182266|NCT02747043|538139854|FG001|Overall Study|Other|1|||
149182267|NCT02747043|538139853|FG000|Overall Study|Adverse Event|3|||
149182268|NCT02747043|538139854|FG001|Overall Study|Adverse Event|1|||
149182269|NCT02747043|538139853|FG000|Overall Study|Withdrawal by Subject|1|||
149182270|NCT02747043|538139854|FG001|Overall Study|Withdrawal by Subject|1|||
149182271|NCT02747043|538139853|FG000|Overall Study|Physician Decision|1|||
149182272|NCT02747043|538139854|FG001|Overall Study|Physician Decision|1|||
149182273|NCT02747043|538139853|FG000|Overall Study|Protocol Violation|0|||
149182274|NCT02747043|538139854|FG001|Overall Study|Protocol Violation|1|||
149182275|NCT02747043|538139853|FG000|Overall Study|Disease progression|4|||
149182276|NCT02747043|538139854|FG001|Overall Study|Disease progression|0|||
149182277|NCT04655586|538139863|FG000|Overall Study|Physician Decision|1|||
149182278|NCT04655586|538139864|FG001|Overall Study|Physician Decision|3|||
149182279|NCT04655586|538139865|FG002|Overall Study|Physician Decision|4|||
149182280|NCT04655586|538139863|FG000|Overall Study|Withdrawal by Subject|1|||
149182281|NCT04655586|538139864|FG001|Overall Study|Withdrawal by Subject|3|||
149182282|NCT04655586|538139865|FG002|Overall Study|Withdrawal by Subject|1|||
149182283|NCT00553059|538139870|FG000|Overall Study|Deemed ineligible|1|||
149182284|NCT00553059|538139871|FG001|Overall Study|Deemed ineligible|1|||
149182285|NCT00553059|538139870|FG000|Overall Study|Drug supply not available|0|||
149182286|NCT00553059|538139871|FG001|Overall Study|Drug supply not available|1|||
149182287|NCT01966731|538139872|FG000|Overall Study|Death|2|||
149182288|NCT01966731|538139872|FG000|Overall Study|Lost to Follow-up|1|||
149182289|NCT01966731|538139872|FG000|Overall Study|Physician Decision|2|||
149182290|NCT01966731|538139872|FG000|Overall Study|Follow up is not complete|600|||
149182291|NCT01966731|538139872|FG000|Overall Study|Screening Failure|29|||
149182292|NCT01966731|538139872|FG000|Overall Study|Found to be ineligible|1|||
149182293|NCT01380093|538139873|FG000|Naloxone Challenge Phase|Screen failures|21|||
149182294|NCT01380093|538139874|FG001|Naloxone Challenge Phase|Screen failures|0|||
149182295|NCT01380093|538139875|FG002|Naloxone Challenge Phase|Screen failures|0|||
149182296|NCT01380093|538139876|FG003|Naloxone Challenge Phase|Screen failures|0|||
149182297|NCT01380093|538139877|FG004|Naloxone Challenge Phase|Screen failures|0|||
149182298|NCT01380093|538139878|FG005|Naloxone Challenge Phase|Screen failures|0|||
149182299|NCT01380093|538139879|FG006|Naloxone Challenge Phase|Screen failures|0|||
149182300|NCT01380093|538139880|FG007|Naloxone Challenge Phase|Screen failures|0|||
149182301|NCT01380093|538139881|FG008|Naloxone Challenge Phase|Screen failures|0|||
149182302|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149182303|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
149182304|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
148932269|NCT01369615|537236814|FG000|Overall Study|Withdrawal by Subject|0|||
148932270|NCT01369615|537236815|FG001|Overall Study|Withdrawal by Subject|1|||
148932271|NCT01369615|537236814|FG000|Overall Study|Lost to Follow-up|0|||
148932272|NCT01369615|537236815|FG001|Overall Study|Lost to Follow-up|1|||
148932273|NCT04263454|537236816|FG000|Overall Study|Adverse Event|0|||
149182305|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149182306|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149182307|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
148932274|NCT04263454|537236817|FG001|Overall Study|Adverse Event|2|||
148932275|NCT04263454|537236816|FG000|Overall Study|Physician Decision|3|||
148932276|NCT04263454|537236817|FG001|Overall Study|Physician Decision|5|||
148932277|NCT04263454|537236816|FG000|Overall Study|Poor Data Quality|0|||
148932278|NCT04263454|537236817|FG001|Overall Study|Poor Data Quality|1|||
149182308|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149182309|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149182310|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
149182311|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
148932279|NCT00986479|537236818|FG000|Period 1|Improved mood|1|||
149013999|NCT01370005|537530852|FG001|Overall Study|Adverse Event|5|||
148932280|NCT00986479|537236819|FG001|Period 1|Improved mood|0|||
148932281|NCT00986479|537236818|FG000|Period 1|Administrative reasons|1|||
148932282|NCT00986479|537236819|FG001|Period 1|Administrative reasons|0|||
148932283|NCT02035475|537236820|FG000|Overall Study|Withdrawal by Subject|4|||
148932284|NCT02035475|537236820|FG000|Overall Study|Physician Decision|1|||
149182312|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
149182313|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
149182314|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149182315|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149182316|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149182317|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149182318|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
149182319|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
148932285|NCT02035475|537236820|FG000|Overall Study|Equipment Error|1|||
149182320|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182321|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
149182322|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182323|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182324|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182325|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182326|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182327|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182328|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
149182329|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149182330|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
149182331|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
148932286|NCT01460368|537236821|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
148932287|NCT01460368|537236822|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
148932288|NCT01460368|537236823|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
148932289|NCT01460368|537236824|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
148932290|NCT01460368|537236825|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
148932291|NCT01460368|537236826|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
148932292|NCT01460368|537236827|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
148932293|NCT01460368|537236821|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
148932294|NCT01460368|537236822|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
148932295|NCT01460368|537236823|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
148932296|NCT01460368|537236824|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
148932297|NCT01460368|537236825|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
148932298|NCT01460368|537236826|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
148932299|NCT01460368|537236827|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
148932300|NCT01460368|537236821|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
148932301|NCT01460368|537236822|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
148932302|NCT01460368|537236823|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
148932303|NCT01460368|537236824|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
148932304|NCT01460368|537236825|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
148932305|NCT01460368|537236826|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
148932306|NCT01460368|537236827|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
148932307|NCT01460368|537236821|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
148932308|NCT01460368|537236822|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
148932309|NCT01460368|537236823|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
148932310|NCT01460368|537236824|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
148932311|NCT01460368|537236825|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
148932312|NCT01460368|537236826|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
148932313|NCT01460368|537236827|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
148932314|NCT01460368|537236821|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
148932315|NCT01460368|537236822|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
148932316|NCT01460368|537236823|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
148932317|NCT01460368|537236824|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
148932318|NCT01460368|537236825|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
149014000|NCT01370005|537530853|FG002|Overall Study|Adverse Event|6|||
149182332|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
148679625|NCT03216954|536300835|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
149182333|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149182334|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149182335|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149182336|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149182337|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
149182338|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182339|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
149182340|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
149182341|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182342|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182343|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182344|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182345|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182346|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
149182347|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182348|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182349|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
149182350|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182351|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182352|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182353|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182354|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182355|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
149182356|NCT01380093|538139873|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182357|NCT01380093|538139874|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182358|NCT01380093|538139875|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
149182359|NCT01380093|538139876|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182360|NCT01380093|538139877|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182361|NCT01380093|538139878|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182362|NCT01380093|538139879|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
148932319|NCT01460368|537236826|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
148932320|NCT01460368|537236827|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
148932321|NCT02322021|537236828|FG000|Core Phase|Adverse Event|1|||
148932322|NCT02322021|537236829|FG001|Core Phase|Adverse Event|3|||
148932323|NCT02322021|537236830|FG002|Core Phase|Adverse Event|4|||
148932324|NCT02322021|537236831|FG003|Core Phase|Adverse Event|2|||
148932325|NCT02322021|537236832|FG004|Core Phase|Adverse Event|0|||
148932326|NCT02322021|537236828|FG000|Core Phase|Participant Choice|4|||
148932327|NCT02322021|537236829|FG001|Core Phase|Participant Choice|5|||
148932328|NCT02322021|537236830|FG002|Core Phase|Participant Choice|4|||
148932329|NCT02322021|537236831|FG003|Core Phase|Participant Choice|2|||
148932330|NCT02322021|537236832|FG004|Core Phase|Participant Choice|0|||
148932331|NCT02322021|537236828|FG000|Core Phase|Lost to Follow-up|0|||
148932332|NCT02322021|537236829|FG001|Core Phase|Lost to Follow-up|0|||
148932333|NCT02322021|537236830|FG002|Core Phase|Lost to Follow-up|0|||
148932334|NCT02322021|537236831|FG003|Core Phase|Lost to Follow-up|1|||
148932335|NCT02322021|537236832|FG004|Core Phase|Lost to Follow-up|0|||
148932336|NCT02322021|537236828|FG000|Core Phase|Other|0|||
148932337|NCT02322021|537236829|FG001|Core Phase|Other|0|||
148932338|NCT02322021|537236830|FG002|Core Phase|Other|1|||
148932339|NCT02322021|537236831|FG003|Core Phase|Other|0|||
148932340|NCT02322021|537236832|FG004|Core Phase|Other|0|||
149182363|NCT01380093|538139880|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182364|NCT01380093|538139881|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
149182365|NCT01380093|538139873|FG000|Treatment Phase: Second Intervention|Other|0|||
149182366|NCT01380093|538139874|FG001|Treatment Phase: Second Intervention|Other|0|||
149182367|NCT01380093|538139875|FG002|Treatment Phase: Second Intervention|Other|0|||
149182368|NCT01380093|538139876|FG003|Treatment Phase: Second Intervention|Other|1|||
149182369|NCT01380093|538139877|FG004|Treatment Phase: Second Intervention|Other|0|||
149182370|NCT01380093|538139878|FG005|Treatment Phase: Second Intervention|Other|0|||
149182371|NCT01380093|538139879|FG006|Treatment Phase: Second Intervention|Other|0|||
148932341|NCT02322021|537236828|FG000|Extension Phase|Adverse Event|0|||
148932342|NCT02322021|537236829|FG001|Extension Phase|Adverse Event|0|||
148932343|NCT02322021|537236830|FG002|Extension Phase|Adverse Event|0|||
148932344|NCT02322021|537236831|FG003|Extension Phase|Adverse Event|0|||
148932345|NCT02322021|537236832|FG004|Extension Phase|Adverse Event|3|||
148932346|NCT02322021|537236828|FG000|Extension Phase|Participant Choice|0|||
148932347|NCT02322021|537236829|FG001|Extension Phase|Participant Choice|0|||
148932348|NCT02322021|537236830|FG002|Extension Phase|Participant Choice|0|||
148932349|NCT02322021|537236831|FG003|Extension Phase|Participant Choice|0|||
148932350|NCT02322021|537236832|FG004|Extension Phase|Participant Choice|6|||
148932351|NCT02322021|537236828|FG000|Extension Phase|Other|0|||
149182372|NCT01380093|538139880|FG007|Treatment Phase: Second Intervention|Other|0|||
149182373|NCT01380093|538139881|FG008|Treatment Phase: Second Intervention|Other|0|||
149182374|NCT01380093|538139873|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
149182375|NCT01380093|538139874|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
149182376|NCT01380093|538139875|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
149182377|NCT01380093|538139876|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
149182378|NCT01380093|538139877|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
149182379|NCT01380093|538139878|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
149182380|NCT01380093|538139879|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
149182381|NCT01380093|538139880|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
149182382|NCT01380093|538139881|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
149182383|NCT01380093|538139873|FG000|Treatment Phase: Third Intervention|Other|0|||
149182384|NCT01380093|538139874|FG001|Treatment Phase: Third Intervention|Other|0|||
149182385|NCT01380093|538139875|FG002|Treatment Phase: Third Intervention|Other|0|||
149182386|NCT01380093|538139876|FG003|Treatment Phase: Third Intervention|Other|0|||
149182387|NCT01380093|538139877|FG004|Treatment Phase: Third Intervention|Other|0|||
149182388|NCT01380093|538139878|FG005|Treatment Phase: Third Intervention|Other|0|||
149182389|NCT01380093|538139879|FG006|Treatment Phase: Third Intervention|Other|0|||
149182390|NCT01380093|538139880|FG007|Treatment Phase: Third Intervention|Other|0|||
149182391|NCT01380093|538139881|FG008|Treatment Phase: Third Intervention|Other|1|||
149182392|NCT04734873|538139882|FG000|Overall Study|Lost to Follow-up|1|||
149182393|NCT04734873|538139883|FG001|Overall Study|Lost to Follow-up|3|||
149182394|NCT04734873|538139884|FG002|Overall Study|Lost to Follow-up|2|||
149182395|NCT04734873|538139882|FG000|Overall Study|Randomized but not dosed|1|||
149182396|NCT04734873|538139883|FG001|Overall Study|Randomized but not dosed|0|||
149182397|NCT04734873|538139884|FG002|Overall Study|Randomized but not dosed|1|||
149182398|NCT00592683|538139885|FG000|Overall Study|Found ineligible|0|||
149182399|NCT00592683|538139886|FG001|Overall Study|Found ineligible|1|||
149182400|NCT00592683|538139885|FG000|Overall Study|Withdrawal by Subject|1|||
149182401|NCT00592683|538139886|FG001|Overall Study|Withdrawal by Subject|0|||
149182402|NCT00592683|538139885|FG000|Overall Study|Adverse Event|0|||
149182403|NCT00592683|538139886|FG001|Overall Study|Adverse Event|2|||
149182404|NCT00592683|538139885|FG000|Overall Study|Protocol Violation|1|||
149182405|NCT00592683|538139886|FG001|Overall Study|Protocol Violation|0|||
149182406|NCT00592683|538139885|FG000|Overall Study|Study drug expired|1|||
149182407|NCT00592683|538139886|FG001|Overall Study|Study drug expired|0|||
149182408|NCT00592683|538139885|FG000|Overall Study|Other|1|||
149182409|NCT00592683|538139886|FG001|Overall Study|Other|0|||
149182410|NCT00592683|538139885|FG000|Overall Study|Lost to Follow-up|0|||
149182411|NCT00592683|538139886|FG001|Overall Study|Lost to Follow-up|1|||
149182412|NCT00201201|538139887|FG000|Overall Study|Death|0|||
149182413|NCT00201201|538139888|FG001|Overall Study|Death|2|||
149182414|NCT00201201|538139887|FG000|Overall Study|Withdrawal by Subject|5|||
149182415|NCT00201201|538139888|FG001|Overall Study|Withdrawal by Subject|5|||
149182416|NCT00545818|538139893|FG000|Overall Study|Protocol Violation|1|||
149182417|NCT00545818|538139894|FG001|Overall Study|Protocol Violation|0|||
149182418|NCT00545818|538139893|FG000|Overall Study|Adverse Event|1|||
149182419|NCT00545818|538139894|FG001|Overall Study|Adverse Event|1|||
149182420|NCT00545818|538139893|FG000|Overall Study|Lost to Follow-up|1|||
149182421|NCT00545818|538139894|FG001|Overall Study|Lost to Follow-up|6|||
149182422|NCT00609609|538139895|FG000|Overall Study|Withdrawal by Subject|2|||
149182423|NCT00609609|538139896|FG001|Overall Study|Withdrawal by Subject|0|||
149182424|NCT00609609|538139895|FG000|Overall Study|Progression|4|||
149182425|NCT00609609|538139896|FG001|Overall Study|Progression|2|||
149182426|NCT04530825|538139899|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
149182427|NCT04530825|538139900|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
149182428|NCT04530825|538139901|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
149182429|NCT04530825|538139902|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
149182430|NCT04530825|538139899|FG000|Overall Study|Did not complete follow-up|3|||
149182431|NCT04530825|538139900|FG001|Overall Study|Did not complete follow-up|0|||
149182432|NCT04530825|538139901|FG002|Overall Study|Did not complete follow-up|0|||
149182433|NCT04530825|538139902|FG003|Overall Study|Did not complete follow-up|0|||
149182434|NCT04101422|538139904|FG000|Overall Study|Ineligible|1|||
149182435|NCT04101422|538139905|FG001|Overall Study|Ineligible|0|||
149182436|NCT04101422|538139906|FG002|Overall Study|Ineligible|9|||
148932352|NCT02322021|537236829|FG001|Extension Phase|Other|0|||
149182437|NCT04101422|538139907|FG003|Overall Study|Ineligible|0|||
149182438|NCT04101422|538139904|FG000|Overall Study|Withdrawal by Subject|0|||
149182439|NCT04101422|538139905|FG001|Overall Study|Withdrawal by Subject|0|||
149182440|NCT04101422|538139906|FG002|Overall Study|Withdrawal by Subject|1|||
149182441|NCT04101422|538139907|FG003|Overall Study|Withdrawal by Subject|0|||
149182442|NCT04101422|538139904|FG000|Overall Study|Not attending to the stimuli|0|||
149182443|NCT04101422|538139905|FG001|Overall Study|Not attending to the stimuli|0|||
149182444|NCT04101422|538139906|FG002|Overall Study|Not attending to the stimuli|4|||
149182445|NCT04101422|538139907|FG003|Overall Study|Not attending to the stimuli|0|||
149182446|NCT04101422|538139904|FG000|Overall Study|Did not download app|0|||
149182447|NCT04101422|538139905|FG001|Overall Study|Did not download app|0|||
149182448|NCT04101422|538139906|FG002|Overall Study|Did not download app|0|||
149182449|NCT04101422|538139907|FG003|Overall Study|Did not download app|17|||
149182450|NCT04101422|538139904|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
149182451|NCT04101422|538139905|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
149182452|NCT04101422|538139906|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
149182453|NCT04101422|538139907|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
149182454|NCT00552305|538139908|FG000|Overall Study|Adverse Event|43|||
149182455|NCT00552305|538139908|FG000|Overall Study|Lack of Efficacy|120|||
149182456|NCT00552305|538139908|FG000|Overall Study|Lost to Follow-up|4|||
149182457|NCT00552305|538139908|FG000|Overall Study|Protocol Violation|3|||
149182458|NCT00552305|538139908|FG000|Overall Study|Withdrawal by Subject|44|||
149182459|NCT00552305|538139908|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
149182460|NCT00552305|538139908|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
148932353|NCT02322021|537236830|FG002|Extension Phase|Other|0|||
148932354|NCT02322021|537236831|FG003|Extension Phase|Other|0|||
148932355|NCT02322021|537236832|FG004|Extension Phase|Other|3|||
148932356|NCT02322021|537236828|FG000|Extension Phase|Lost to Follow-up|0|||
148932357|NCT02322021|537236829|FG001|Extension Phase|Lost to Follow-up|0|||
148932358|NCT02322021|537236830|FG002|Extension Phase|Lost to Follow-up|0|||
148932359|NCT02322021|537236831|FG003|Extension Phase|Lost to Follow-up|0|||
148932360|NCT02322021|537236832|FG004|Extension Phase|Lost to Follow-up|1|||
148932361|NCT02322021|537236828|FG000|Extension Phase|Study terminated by sponsor|0|||
148932362|NCT02322021|537236829|FG001|Extension Phase|Study terminated by sponsor|0|||
148932363|NCT02322021|537236830|FG002|Extension Phase|Study terminated by sponsor|0|||
148932364|NCT02322021|537236831|FG003|Extension Phase|Study terminated by sponsor|0|||
148932365|NCT02322021|537236832|FG004|Extension Phase|Study terminated by sponsor|28|||
148932366|NCT03803683|537236838|FG000|Overall Study|Lost to Follow-up|41|||
148932367|NCT03803683|537236839|FG001|Overall Study|Lost to Follow-up|18|||
148932368|NCT03803683|537236840|FG002|Overall Study|Lost to Follow-up|12|||
148932369|NCT03803683|537236838|FG000|Overall Study|Withdrawal by Subject|9|||
148932370|NCT03803683|537236839|FG001|Overall Study|Withdrawal by Subject|1|||
148932371|NCT03803683|537236840|FG002|Overall Study|Withdrawal by Subject|4|||
148932372|NCT02570074|537238632|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
148932373|NCT02570074|537238633|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
148932374|NCT01325623|537238634|FG000|Overall Study|Withdrawal by Subject|3|||
148932375|NCT01539642|537238639|FG000|Overall Study|Lack of Efficacy|20|||
148932376|NCT01539642|537238640|FG001|Overall Study|Lack of Efficacy|18|||
149182461|NCT00552305|538139908|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
149182462|NCT00552305|538139908|FG000|Overall Study|Unsatisfactory compliance|11|||
149182463|NCT00552305|538139908|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
149182464|NCT00552305|538139908|FG000|Overall Study|AE/Other: prohibited drug required|1|||
149182465|NCT00552305|538139908|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
149182466|NCT00552305|538139908|FG000|Overall Study|Other: Site closed|4|||
149182467|NCT00552305|538139908|FG000|Overall Study|Other: Personal problems|1|||
149182468|NCT00552305|538139908|FG000|Overall Study|Other: Unable to attend visits|1|||
149182469|NCT00552305|538139908|FG000|Overall Study|Other: Subject underwent surgery|4|||
149182470|NCT00552305|538139908|FG000|Overall Study|Other: Subject became pregnant|1|||
149182471|NCT00552305|538139908|FG000|Overall Study|Other: Health problems, not drug related|1|||
149182472|NCT00552305|538139908|FG000|Overall Study|Other: Subject moved from area|2|||
149182473|NCT00552305|538139908|FG000|Overall Study|Other: Subject incarcerated|1|||
149182474|NCT00552305|538139908|FG000|Overall Study|Other: Subject went to rehab|1|||
149182475|NCT01174784|538139911|FG000|Overall Study|Screen fails|4|||
149182476|NCT01671488|538139912|FG000|Overall Study|Withdrawal by Subject|1|||
149182477|NCT03503773|538139913|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
149182478|NCT03503773|538139914|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
149182479|NCT03503773|538139913|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
149182480|NCT03503773|538139914|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
149182481|NCT03503773|538139913|FG000|Overall Study|Not completing the primary ABPM|3|||
149182482|NCT03503773|538139914|FG001|Overall Study|Not completing the primary ABPM|1|||
149182483|NCT03503773|538139913|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
148932377|NCT01539642|537238639|FG000|Overall Study|Patient ready for early discharge|8|||
148932378|NCT01539642|537238640|FG001|Overall Study|Patient ready for early discharge|7|||
148932379|NCT01539642|537238639|FG000|Overall Study|Adverse Event|6|||
148932380|NCT01539642|537238640|FG001|Overall Study|Adverse Event|4|||
149182484|NCT03503773|538139914|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149182485|NCT00425438|538139918|FG000|Overall Study|Termination by Sponsor|25|||
149182486|NCT00425438|538139919|FG001|Overall Study|Termination by Sponsor|27|||
148932381|NCT01539642|537238639|FG000|Overall Study|Withdrawal by Subject|2|||
148932382|NCT01539642|537238640|FG001|Overall Study|Withdrawal by Subject|2|||
148932383|NCT00598702|537238641|FG000|Overall Study|Other|0|||
148932384|NCT00598702|537238642|FG001|Overall Study|Other|2|||
149182487|NCT02902809|538139922|FG000|Overall Study|Discontinuation of asthma program|28|||
149182488|NCT00532259|538139923|FG000|Overall Study|Withdrawal by Subject|2|||
149182489|NCT00532259|538139923|FG000|Overall Study|Adverse Event|1|||
149182490|NCT00532259|538139923|FG000|Overall Study|Death|1|||
148679626|NCT03216954|536300836|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
148679627|NCT04736576|536300841|FG000|Overall Study|Progressive disease|3|||
148679628|NCT04736576|536300842|FG001|Overall Study|Progressive disease|1|||
148679629|NCT04736576|536300841|FG000|Overall Study|Death|1|||
148932385|NCT00598702|537238643|FG002|Overall Study|Other|0|||
148932386|NCT00598702|537238644|FG003|Overall Study|Other|0|||
148932387|NCT00598702|537238645|FG004|Overall Study|Other|0|||
148932388|NCT00598702|537238646|FG005|Overall Study|Other|1|||
148932389|NCT00598702|537238647|FG006|Overall Study|Other|0|||
148932390|NCT00598702|537238648|FG007|Overall Study|Other|0|||
148932391|NCT00598702|537238641|FG000|Overall Study|Early discharge from hospital|0|||
148932392|NCT00598702|537238642|FG001|Overall Study|Early discharge from hospital|0|||
148932393|NCT00598702|537238643|FG002|Overall Study|Early discharge from hospital|2|||
148932394|NCT00598702|537238644|FG003|Overall Study|Early discharge from hospital|5|||
148932395|NCT00598702|537238645|FG004|Overall Study|Early discharge from hospital|0|||
148932396|NCT00598702|537238646|FG005|Overall Study|Early discharge from hospital|10|||
148932397|NCT00598702|537238647|FG006|Overall Study|Early discharge from hospital|1|||
148932398|NCT00598702|537238648|FG007|Overall Study|Early discharge from hospital|0|||
148932399|NCT00598702|537238641|FG000|Overall Study|Adverse Event|0|||
148932400|NCT00598702|537238642|FG001|Overall Study|Adverse Event|0|||
148932401|NCT00598702|537238643|FG002|Overall Study|Adverse Event|0|||
148932402|NCT00598702|537238644|FG003|Overall Study|Adverse Event|1|||
148932403|NCT00598702|537238645|FG004|Overall Study|Adverse Event|0|||
148932404|NCT00598702|537238646|FG005|Overall Study|Adverse Event|0|||
148932405|NCT00598702|537238647|FG006|Overall Study|Adverse Event|0|||
148932406|NCT00598702|537238648|FG007|Overall Study|Adverse Event|0|||
148932407|NCT00598702|537238641|FG000|Overall Study|Withdrawal by Subject|0|||
148932408|NCT00598702|537238642|FG001|Overall Study|Withdrawal by Subject|0|||
148932409|NCT00598702|537238643|FG002|Overall Study|Withdrawal by Subject|0|||
148932410|NCT00598702|537238644|FG003|Overall Study|Withdrawal by Subject|1|||
149182491|NCT00532259|538139923|FG000|Overall Study|Lack of Efficacy|21|||
149182492|NCT00532259|538139923|FG000|Overall Study|Lost to Follow-up|3|||
148679630|NCT04736576|536300842|FG001|Overall Study|Death|0|||
148679631|NCT02525562|536300849|FG000|Overall Study|Death|9|||
148679632|NCT02525562|536300850|FG001|Overall Study|Death|0|||
148679633|NCT02525562|536300851|FG002|Overall Study|Death|0|||
148679634|NCT02525562|536300849|FG000|Overall Study|Lost to Follow-up|19|||
148679635|NCT02525562|536300850|FG001|Overall Study|Lost to Follow-up|0|||
148679636|NCT02525562|536300851|FG002|Overall Study|Lost to Follow-up|0|||
148679637|NCT02525562|536300849|FG000|Overall Study|Withdrawal by Subject|37|||
148679638|NCT02525562|536300850|FG001|Overall Study|Withdrawal by Subject|0|||
148679639|NCT02525562|536300851|FG002|Overall Study|Withdrawal by Subject|0|||
148932411|NCT00598702|537238645|FG004|Overall Study|Withdrawal by Subject|1|||
148932412|NCT00598702|537238646|FG005|Overall Study|Withdrawal by Subject|0|||
148932413|NCT00598702|537238647|FG006|Overall Study|Withdrawal by Subject|0|||
148932414|NCT00598702|537238648|FG007|Overall Study|Withdrawal by Subject|0|||
148932415|NCT00598702|537238641|FG000|Overall Study|Physician Decision|0|||
148932416|NCT00598702|537238642|FG001|Overall Study|Physician Decision|0|||
149182493|NCT00532259|538139923|FG000|Overall Study|Physician Decision|3|||
149182494|NCT00532259|538139923|FG000|Overall Study|Protocol Violation|1|||
149182495|NCT01208181|538139926|FG000|Part 1|Withdrawal by Subject|11|||
148679640|NCT02525562|536300849|FG000|Overall Study|Revision/Removal of Study Device|4|||
148679641|NCT02525562|536300850|FG001|Overall Study|Revision/Removal of Study Device|0|||
148679642|NCT02525562|536300851|FG002|Overall Study|Revision/Removal of Study Device|0|||
148807310|NCT00576758|536773227|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
148932417|NCT00598702|537238643|FG002|Overall Study|Physician Decision|0|||
148932418|NCT00598702|537238644|FG003|Overall Study|Physician Decision|0|||
148932419|NCT00598702|537238645|FG004|Overall Study|Physician Decision|1|||
148932420|NCT00598702|537238646|FG005|Overall Study|Physician Decision|0|||
149182496|NCT01208181|538139927|FG001|Part 1|Withdrawal by Subject|10|||
149182497|NCT01208181|538139928|FG002|Part 1|Withdrawal by Subject|0|||
149182498|NCT01208181|538139929|FG003|Part 1|Withdrawal by Subject|0|||
149182499|NCT01208181|538139930|FG004|Part 1|Withdrawal by Subject|0|||
149182500|NCT01208181|538139926|FG000|Part 1|Technical problem|5|||
149182501|NCT01208181|538139927|FG001|Part 1|Technical problem|0|||
148932421|NCT00598702|537238647|FG006|Overall Study|Physician Decision|0|||
148932422|NCT00598702|537238648|FG007|Overall Study|Physician Decision|0|||
149182502|NCT01208181|538139928|FG002|Part 1|Technical problem|0|||
149182503|NCT01208181|538139929|FG003|Part 1|Technical problem|0|||
149182504|NCT01208181|538139930|FG004|Part 1|Technical problem|0|||
149182505|NCT01208181|538139926|FG000|Part 1|Protocol Violation|10|||
149182506|NCT01208181|538139927|FG001|Part 1|Protocol Violation|5|||
149182507|NCT01208181|538139928|FG002|Part 1|Protocol Violation|0|||
149182508|NCT01208181|538139929|FG003|Part 1|Protocol Violation|0|||
149182509|NCT01208181|538139930|FG004|Part 1|Protocol Violation|0|||
149182510|NCT01208181|538139926|FG000|Part 1|Physician Decision|4|||
149182511|NCT01208181|538139927|FG001|Part 1|Physician Decision|0|||
149182512|NCT01208181|538139928|FG002|Part 1|Physician Decision|0|||
149182513|NCT01208181|538139929|FG003|Part 1|Physician Decision|0|||
149182514|NCT01208181|538139930|FG004|Part 1|Physician Decision|0|||
149182515|NCT01208181|538139926|FG000|Part 1|Non-compliance with study drug|1|||
149182516|NCT01208181|538139927|FG001|Part 1|Non-compliance with study drug|1|||
148807311|NCT00576758|536773226|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
148807312|NCT00576758|536773227|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
148807313|NCT00576758|536773226|FG000|Extension Treatment Period|Administrative/Other|3|||
148807314|NCT00576758|536773227|FG001|Extension Treatment Period|Administrative/Other|1|||
148807315|NCT00576758|536773226|FG000|Follow-up Period|Administrative/Other|6|||
148807316|NCT00576758|536773227|FG001|Follow-up Period|Administrative/Other|8|||
148807317|NCT00576758|536773226|FG000|Follow-up Period|Death|3|||
148807318|NCT00576758|536773227|FG001|Follow-up Period|Death|3|||
148807319|NCT00576758|536773226|FG000|Follow-up Period|Insufficient therapeutic response|16|||
148807320|NCT00576758|536773227|FG001|Follow-up Period|Insufficient therapeutic response|5|||
148807321|NCT00576758|536773226|FG000|Follow-up Period|Withdrew consent|2|||
148807322|NCT00576758|536773227|FG001|Follow-up Period|Withdrew consent|1|||
148807323|NCT00903968|536773228|FG000|Overall Study|Adverse Event|0|||
148807324|NCT00903968|536773229|FG001|Overall Study|Adverse Event|0|||
148807325|NCT00903968|536773230|FG002|Overall Study|Adverse Event|0|||
148807326|NCT00903968|536773231|FG003|Overall Study|Adverse Event|0|||
148807327|NCT00903968|536773232|FG004|Overall Study|Adverse Event|0|||
148807328|NCT00903968|536773233|FG005|Overall Study|Adverse Event|0|||
148807329|NCT00903968|536773234|FG006|Overall Study|Adverse Event|1|||
148807330|NCT00903968|536773235|FG007|Overall Study|Adverse Event|8|||
148932423|NCT00598702|537238641|FG000|Overall Study|Dose limiting toxicity|0|||
148932424|NCT00598702|537238642|FG001|Overall Study|Dose limiting toxicity|0|||
148932425|NCT00598702|537238643|FG002|Overall Study|Dose limiting toxicity|0|||
148932426|NCT00598702|537238644|FG003|Overall Study|Dose limiting toxicity|1|||
149182517|NCT01208181|538139928|FG002|Part 1|Non-compliance with study drug|0|||
149182518|NCT01208181|538139929|FG003|Part 1|Non-compliance with study drug|0|||
149182519|NCT01208181|538139930|FG004|Part 1|Non-compliance with study drug|0|||
149182520|NCT01208181|538139926|FG000|Part 1|Lost to Follow-up|5|||
149182521|NCT01208181|538139927|FG001|Part 1|Lost to Follow-up|3|||
149182522|NCT01208181|538139928|FG002|Part 1|Lost to Follow-up|0|||
149182523|NCT01208181|538139929|FG003|Part 1|Lost to Follow-up|0|||
149182524|NCT01208181|538139930|FG004|Part 1|Lost to Follow-up|1|||
149182525|NCT01208181|538139926|FG000|Part 1|Lack of Efficacy|37|||
149182526|NCT01208181|538139927|FG001|Part 1|Lack of Efficacy|12|||
149182527|NCT01208181|538139928|FG002|Part 1|Lack of Efficacy|0|||
149182528|NCT01208181|538139929|FG003|Part 1|Lack of Efficacy|0|||
149182529|NCT01208181|538139930|FG004|Part 1|Lack of Efficacy|17|||
149182530|NCT01208181|538139926|FG000|Part 1|Adverse Event|26|||
148932427|NCT00598702|537238645|FG004|Overall Study|Dose limiting toxicity|1|||
149182531|NCT01208181|538139927|FG001|Part 1|Adverse Event|24|||
149182532|NCT01208181|538139928|FG002|Part 1|Adverse Event|0|||
149182533|NCT01208181|538139929|FG003|Part 1|Adverse Event|0|||
149182534|NCT01208181|538139930|FG004|Part 1|Adverse Event|4|||
148679643|NCT02525562|536300849|FG000|Overall Study|Study Closed by Sponsor|154|||
149182535|NCT01208181|538139926|FG000|Part 2|Adverse Event|0|||
149182536|NCT01208181|538139927|FG001|Part 2|Adverse Event|0|||
148807331|NCT00903968|536773228|FG000|Overall Study|DLT|0|||
148807332|NCT00903968|536773229|FG001|Overall Study|DLT|0|||
148807333|NCT00903968|536773230|FG002|Overall Study|DLT|0|||
148807334|NCT00903968|536773231|FG003|Overall Study|DLT|0|||
149182537|NCT01208181|538139928|FG002|Part 2|Adverse Event|6|||
149182538|NCT01208181|538139929|FG003|Part 2|Adverse Event|7|||
148807335|NCT00903968|536773232|FG004|Overall Study|DLT|0|||
148807336|NCT00903968|536773233|FG005|Overall Study|DLT|0|||
148932428|NCT00598702|537238646|FG005|Overall Study|Dose limiting toxicity|1|||
149182539|NCT01208181|538139930|FG004|Part 2|Adverse Event|0|||
149182540|NCT01208181|538139926|FG000|Part 2|Withdrawal by Subject|0|||
149182541|NCT01208181|538139927|FG001|Part 2|Withdrawal by Subject|0|||
149182542|NCT01208181|538139928|FG002|Part 2|Withdrawal by Subject|1|||
149182543|NCT01208181|538139929|FG003|Part 2|Withdrawal by Subject|1|||
149182544|NCT01208181|538139930|FG004|Part 2|Withdrawal by Subject|0|||
149182545|NCT01208181|538139926|FG000|Part 2|Protocol Violation|0|||
149182546|NCT01208181|538139927|FG001|Part 2|Protocol Violation|0|||
149182547|NCT01208181|538139928|FG002|Part 2|Protocol Violation|1|||
149182548|NCT01208181|538139929|FG003|Part 2|Protocol Violation|0|||
149182549|NCT01208181|538139930|FG004|Part 2|Protocol Violation|0|||
149182550|NCT01208181|538139926|FG000|Part 2|Physician Decision|0|||
149182551|NCT01208181|538139927|FG001|Part 2|Physician Decision|0|||
149182552|NCT01208181|538139928|FG002|Part 2|Physician Decision|1|||
149182553|NCT01208181|538139929|FG003|Part 2|Physician Decision|2|||
149182554|NCT01208181|538139930|FG004|Part 2|Physician Decision|0|||
149182555|NCT01208181|538139926|FG000|Part 2|Non-compliance with study drug|0|||
149182556|NCT01208181|538139927|FG001|Part 2|Non-compliance with study drug|0|||
149182557|NCT01208181|538139928|FG002|Part 2|Non-compliance with study drug|1|||
149182558|NCT01208181|538139929|FG003|Part 2|Non-compliance with study drug|1|||
149182559|NCT01208181|538139930|FG004|Part 2|Non-compliance with study drug|0|||
149182560|NCT01208181|538139926|FG000|Part 2|Lost to Follow-up|0|||
149182561|NCT01208181|538139927|FG001|Part 2|Lost to Follow-up|0|||
149182562|NCT01208181|538139928|FG002|Part 2|Lost to Follow-up|1|||
149182563|NCT01208181|538139929|FG003|Part 2|Lost to Follow-up|2|||
149182564|NCT01208181|538139930|FG004|Part 2|Lost to Follow-up|0|||
149182565|NCT01208181|538139926|FG000|Part 2|Lack of Efficacy|0|||
149182566|NCT01208181|538139927|FG001|Part 2|Lack of Efficacy|0|||
149182567|NCT01208181|538139928|FG002|Part 2|Lack of Efficacy|5|||
149182568|NCT01208181|538139929|FG003|Part 2|Lack of Efficacy|7|||
149182569|NCT01208181|538139930|FG004|Part 2|Lack of Efficacy|0|||
149182570|NCT01478347|538139935|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
149182571|NCT01478347|538139935|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
149182572|NCT01478347|538139935|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
149182573|NCT01645930|538139936|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
149182574|NCT01645930|538139936|FG000|Overall Study|Progressive Disease|12|||
149182575|NCT01645930|538139936|FG000|Overall Study|Adverse Event|4|||
149182576|NCT01645930|538139936|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
149182577|NCT01645930|538139936|FG000|Overall Study|Withdrawal by Participant|2|||
149182578|NCT01645930|538139936|FG000|Overall Study|Reason not Defined|1|||
149182579|NCT01164501|538139938|FG000|Overall Study|Not treated|2|||
149182580|NCT01164501|538139939|FG001|Overall Study|Not treated|0|||
149182581|NCT01164501|538139940|FG002|Overall Study|Not treated|1|||
149182582|NCT01164501|538139938|FG000|Overall Study|Adverse Event|18|||
149182583|NCT01164501|538139939|FG001|Overall Study|Adverse Event|4|||
149182584|NCT01164501|538139940|FG002|Overall Study|Adverse Event|21|||
149182585|NCT01164501|538139938|FG000|Overall Study|Lack of Efficacy|0|||
149182586|NCT01164501|538139939|FG001|Overall Study|Lack of Efficacy|0|||
149182587|NCT01164501|538139940|FG002|Overall Study|Lack of Efficacy|1|||
149182588|NCT01164501|538139938|FG000|Overall Study|Non compliant with protocol|1|||
149182589|NCT01164501|538139939|FG001|Overall Study|Non compliant with protocol|1|||
149182590|NCT01164501|538139940|FG002|Overall Study|Non compliant with protocol|4|||
149182591|NCT01164501|538139938|FG000|Overall Study|Lost to Follow-up|3|||
149182592|NCT01164501|538139939|FG001|Overall Study|Lost to Follow-up|0|||
149182593|NCT01164501|538139940|FG002|Overall Study|Lost to Follow-up|3|||
149182594|NCT01164501|538139938|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
149182595|NCT01164501|538139939|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
149182596|NCT01164501|538139940|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
149182597|NCT01164501|538139938|FG000|Overall Study|Other reason not defined above|9|||
149182598|NCT01164501|538139939|FG001|Overall Study|Other reason not defined above|1|||
149182599|NCT01164501|538139940|FG002|Overall Study|Other reason not defined above|4|||
149182600|NCT01096667|538139941|FG000|Overall Study|Lost to Follow-up|1|||
149182601|NCT01096667|538139942|FG001|Overall Study|Lost to Follow-up|1|||
149182602|NCT01096667|538139943|FG002|Overall Study|Lost to Follow-up|1|||
149182603|NCT01096667|538139944|FG003|Overall Study|Lost to Follow-up|0|||
149182604|NCT01096667|538139945|FG004|Overall Study|Lost to Follow-up|0|||
148932429|NCT00598702|537238647|FG006|Overall Study|Dose limiting toxicity|0|||
148932430|NCT00598702|537238648|FG007|Overall Study|Dose limiting toxicity|0|||
148932431|NCT02063880|537238649|FG000|Overall Study|Death|21|||
148932432|NCT02063880|537238650|FG001|Overall Study|Death|18|||
148932433|NCT02063880|537238649|FG000|Overall Study|Lost to Follow-up|7|||
148932434|NCT02063880|537238650|FG001|Overall Study|Lost to Follow-up|7|||
149182605|NCT01096667|538139941|FG000|Overall Study|Withdrawal by Subject|1|||
149182606|NCT01096667|538139942|FG001|Overall Study|Withdrawal by Subject|0|||
149182607|NCT01096667|538139943|FG002|Overall Study|Withdrawal by Subject|0|||
149182608|NCT01096667|538139944|FG003|Overall Study|Withdrawal by Subject|1|||
149182609|NCT01096667|538139945|FG004|Overall Study|Withdrawal by Subject|0|||
149182610|NCT01096667|538139941|FG000|Overall Study|Reason not available|0|||
148932435|NCT02063880|537238649|FG000|Overall Study|Ineligible|0|||
149182611|NCT01096667|538139942|FG001|Overall Study|Reason not available|1|||
148932436|NCT02063880|537238650|FG001|Overall Study|Ineligible|2|||
148932437|NCT02943460|537238656|FG000|Blinded Study Phase|Adverse Event|3|||
148932438|NCT02943460|537238657|FG001|Blinded Study Phase|Adverse Event|0|||
148932439|NCT02943460|537238658|FG002|Blinded Study Phase|Adverse Event|0|||
148932440|NCT02943460|537238656|FG000|Blinded Study Phase|Withdrew Consent|0|||
148932441|NCT02943460|537238657|FG001|Blinded Study Phase|Withdrew Consent|1|||
148932442|NCT02943460|537238658|FG002|Blinded Study Phase|Withdrew Consent|0|||
148932443|NCT02943460|537238656|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
148932444|NCT02943460|537238657|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
148932445|NCT02943460|537238658|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
148932446|NCT02943460|537238656|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
148932447|NCT02943460|537238657|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
148932448|NCT02943460|537238658|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
148932449|NCT02943460|537238656|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
148932450|NCT02943460|537238657|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
148932451|NCT02943460|537238658|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
148932452|NCT01461980|537238662|FG000|Overall Study|Other|9|||
148932453|NCT01461980|537238663|FG001|Overall Study|Other|8|||
148932454|NCT01461980|537238664|FG002|Overall Study|Other|6|||
148932455|NCT01461980|537238662|FG000|Overall Study|Medication error|7|||
148932456|NCT01461980|537238663|FG001|Overall Study|Medication error|5|||
148932457|NCT01461980|537238664|FG002|Overall Study|Medication error|6|||
148932458|NCT01461980|537238662|FG000|Overall Study|Adverse Event|12|||
148932459|NCT01461980|537238663|FG001|Overall Study|Adverse Event|5|||
148932460|NCT01461980|537238664|FG002|Overall Study|Adverse Event|6|||
148932461|NCT01461980|537238662|FG000|Overall Study|Protocol Violation|12|||
148932462|NCT01461980|537238663|FG001|Overall Study|Protocol Violation|19|||
148932463|NCT01461980|537238664|FG002|Overall Study|Protocol Violation|16|||
148932464|NCT01461980|537238662|FG000|Overall Study|No longer meets eligibility criteria|18|||
148932465|NCT01461980|537238663|FG001|Overall Study|No longer meets eligibility criteria|9|||
148932466|NCT01461980|537238664|FG002|Overall Study|No longer meets eligibility criteria|19|||
148932467|NCT01461980|537238662|FG000|Overall Study|Lost to Follow-up|52|||
148932468|NCT01461980|537238663|FG001|Overall Study|Lost to Follow-up|53|||
148932469|NCT01461980|537238664|FG002|Overall Study|Lost to Follow-up|51|||
148932470|NCT01461980|537238662|FG000|Overall Study|No longer willing to participate|52|||
149182612|NCT01096667|538139943|FG002|Overall Study|Reason not available|1|||
149182613|NCT01096667|538139944|FG003|Overall Study|Reason not available|1|||
149182614|NCT01096667|538139945|FG004|Overall Study|Reason not available|0|||
149182615|NCT01096667|538139941|FG000|Overall Study|Protocol Violation|0|||
149182616|NCT01096667|538139942|FG001|Overall Study|Protocol Violation|0|||
149182617|NCT01096667|538139943|FG002|Overall Study|Protocol Violation|0|||
149182618|NCT01096667|538139944|FG003|Overall Study|Protocol Violation|1|||
149182619|NCT01096667|538139945|FG004|Overall Study|Protocol Violation|0|||
149182620|NCT01096667|538139941|FG000|Overall Study|Not treated|1|||
149182621|NCT01096667|538139942|FG001|Overall Study|Not treated|0|||
149182622|NCT01096667|538139943|FG002|Overall Study|Not treated|0|||
149182623|NCT01096667|538139944|FG003|Overall Study|Not treated|0|||
149182624|NCT01096667|538139945|FG004|Overall Study|Not treated|0|||
149182625|NCT01845077|538139948|FG000|Washout Period|Lost to Follow-up|0|||
149182626|NCT01845077|538139949|FG001|Washout Period|Lost to Follow-up|1|||
149182627|NCT01845077|538139950|FG002|Washout Period|Lost to Follow-up|0|||
149182628|NCT01845077|538139951|FG003|Washout Period|Lost to Follow-up|1|||
149182629|NCT01845077|538139952|FG004|Washout Period|Lost to Follow-up|0|||
149182630|NCT01845077|538139953|FG005|Washout Period|Lost to Follow-up|1|||
149182631|NCT01845077|538139948|FG000|Washout Period|Adverse Event|1|||
149182632|NCT01845077|538139949|FG001|Washout Period|Adverse Event|0|||
149182633|NCT01845077|538139950|FG002|Washout Period|Adverse Event|0|||
149182634|NCT01845077|538139951|FG003|Washout Period|Adverse Event|0|||
149182635|NCT01845077|538139952|FG004|Washout Period|Adverse Event|0|||
149182636|NCT01845077|538139953|FG005|Washout Period|Adverse Event|0|||
149182637|NCT01845077|538139948|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
149182638|NCT01845077|538139949|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
149182639|NCT01845077|538139950|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
149182640|NCT01845077|538139951|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
149182641|NCT01845077|538139952|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
148679644|NCT02525562|536300850|FG001|Overall Study|Study Closed by Sponsor|0|||
148679645|NCT02525562|536300851|FG002|Overall Study|Study Closed by Sponsor|0|||
148679646|NCT02354976|536300852|FG000|Overall Study|Other - reason not specified|1|||
148932471|NCT01461980|537238663|FG001|Overall Study|No longer willing to participate|38|||
149182642|NCT01845077|538139953|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
149182643|NCT01845077|538139948|FG000|Washout Period|Protocol Violation|0|||
149182644|NCT01845077|538139949|FG001|Washout Period|Protocol Violation|0|||
149182645|NCT01845077|538139950|FG002|Washout Period|Protocol Violation|0|||
149182646|NCT01845077|538139951|FG003|Washout Period|Protocol Violation|1|||
148932472|NCT01461980|537238664|FG002|Overall Study|No longer willing to participate|54|||
148932473|NCT01461980|537238662|FG000|Overall Study|Randomized but not vaccinated|4|||
149182647|NCT01845077|538139952|FG004|Washout Period|Protocol Violation|1|||
149182648|NCT01845077|538139953|FG005|Washout Period|Protocol Violation|0|||
149182649|NCT00465738|538139956|FG000|Overall Study|Lost to Follow-up|2|||
149182650|NCT00465738|538139957|FG001|Overall Study|Lost to Follow-up|0|||
149182651|NCT00465738|538139956|FG000|Overall Study|Adverse Event|0|||
149182652|NCT00465738|538139957|FG001|Overall Study|Adverse Event|1|||
149182653|NCT00465738|538139956|FG000|Overall Study|Withdrawal by Subject|2|||
149182654|NCT00465738|538139957|FG001|Overall Study|Withdrawal by Subject|0|||
149182655|NCT00465738|538139956|FG000|Overall Study|Other|2|||
149182656|NCT00465738|538139957|FG001|Overall Study|Other|5|||
149182657|NCT01507246|538139964|FG000|Overall Study|Required different surgical procedures|2|||
149182658|NCT01507246|538139965|FG001|Overall Study|Required different surgical procedures|1|||
149182659|NCT02975349|538139968|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149182660|NCT02975349|538139969|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149182661|NCT02975349|538139970|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149182662|NCT02975349|538139971|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149182663|NCT02975349|538139972|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149182664|NCT02975349|538139973|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149182665|NCT02975349|538139974|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149182666|NCT02975349|538139968|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149182667|NCT02975349|538139969|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149182668|NCT02975349|538139970|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149182669|NCT02975349|538139971|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149182670|NCT02975349|538139972|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149182671|NCT02975349|538139973|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149182672|NCT02975349|538139974|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149182673|NCT02975349|538139968|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
149182674|NCT02975349|538139969|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
149182675|NCT02975349|538139970|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
149182676|NCT02975349|538139971|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
149182677|NCT02975349|538139972|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
149182678|NCT02975349|538139973|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
149182679|NCT02975349|538139974|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
149182680|NCT02975349|538139968|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
149182681|NCT02975349|538139969|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
149182682|NCT02975349|538139970|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
149182683|NCT02975349|538139971|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
149182684|NCT02975349|538139972|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
149182685|NCT02975349|538139973|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
149182686|NCT02975349|538139974|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
149182687|NCT02975349|538139968|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
149182688|NCT02975349|538139969|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
149182689|NCT02975349|538139970|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
149182690|NCT02975349|538139971|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
149182691|NCT02975349|538139972|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
149182692|NCT02975349|538139973|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
149182693|NCT02975349|538139974|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
149182694|NCT02975349|538139968|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149182695|NCT02975349|538139969|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149182696|NCT02975349|538139970|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149182697|NCT02975349|538139971|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
149182698|NCT02975349|538139972|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149182699|NCT02975349|538139973|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149182700|NCT02975349|538139974|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
149182701|NCT02975349|538139968|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149182702|NCT02975349|538139969|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
149182703|NCT02975349|538139970|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149182704|NCT02975349|538139971|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149182705|NCT02975349|538139972|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149182706|NCT02975349|538139973|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149182707|NCT02975349|538139974|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
149182708|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
149182709|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
149182710|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
149182711|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
149182712|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
149182713|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
149182714|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
149182715|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149182716|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149182717|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
148679647|NCT02354976|536300853|FG001|Overall Study|Other - reason not specified|0|||
148679648|NCT02354976|536300854|FG002|Overall Study|Other - reason not specified|1|||
148679649|NCT02354976|536300852|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
148679650|NCT02354976|536300853|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
148679651|NCT02354976|536300854|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
148679652|NCT02354976|536300852|FG000|Overall Study|Adverse Event|1|||
148679653|NCT02354976|536300853|FG001|Overall Study|Adverse Event|0|||
148679654|NCT02354976|536300854|FG002|Overall Study|Adverse Event|2|||
148679655|NCT02164539|536300855|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
148679656|NCT02164539|536300856|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
148679657|NCT02164539|536300857|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
148679658|NCT02164539|536300858|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
148679659|NCT02164539|536300859|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
148679660|NCT02164539|536300860|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
148679661|NCT02164539|536300861|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
148679662|NCT02164539|536300855|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
148679663|NCT02164539|536300856|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
148679664|NCT02164539|536300857|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
148679665|NCT02164539|536300858|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
148807337|NCT00903968|536773234|FG006|Overall Study|DLT|2|||
148807338|NCT00903968|536773235|FG007|Overall Study|DLT|0|||
148932474|NCT01461980|537238663|FG001|Overall Study|Randomized but not vaccinated|8|||
148932475|NCT01461980|537238664|FG002|Overall Study|Randomized but not vaccinated|7|||
149234009|NCT01422876|538326355|FG009|Week 52|Lost to Follow-up|8|||
149234010|NCT01422876|538326346|FG000|Week 52|Consent withdrawn|9|||
149234011|NCT01422876|538326347|FG001|Week 52|Consent withdrawn|4|||
149234012|NCT01422876|538326348|FG002|Week 52|Consent withdrawn|6|||
149234013|NCT01422876|538326349|FG003|Week 52|Consent withdrawn|12|||
148679666|NCT02164539|536300859|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
148807339|NCT00903968|536773228|FG000|Overall Study|Withdrawal by Subject|1|||
148932476|NCT04171765|537238665|FG000|Overall Study|Adverse Event|2|||
148932477|NCT04171765|537238666|FG001|Overall Study|Adverse Event|0|||
149234014|NCT01422876|538326350|FG004|Week 52|Consent withdrawn|7|||
149234015|NCT01422876|538326351|FG005|Week 52|Consent withdrawn|12|||
149234016|NCT01422876|538326352|FG006|Week 52|Consent withdrawn|10|||
149234017|NCT01422876|538326353|FG007|Week 52|Consent withdrawn|12|||
149234018|NCT01422876|538326354|FG008|Week 52|Consent withdrawn|13|||
149234019|NCT01422876|538326355|FG009|Week 52|Consent withdrawn|9|||
149234020|NCT01422876|538326346|FG000|Week 52|Death|0|||
149234021|NCT01422876|538326347|FG001|Week 52|Death|1|||
149234022|NCT01422876|538326348|FG002|Week 52|Death|0|||
149234023|NCT01422876|538326349|FG003|Week 52|Death|1|||
149234024|NCT01422876|538326350|FG004|Week 52|Death|0|||
149234025|NCT01422876|538326351|FG005|Week 52|Death|0|||
149234026|NCT01422876|538326352|FG006|Week 52|Death|1|||
149234027|NCT01422876|538326353|FG007|Week 52|Death|3|||
149234028|NCT01422876|538326354|FG008|Week 52|Death|1|||
149234029|NCT01422876|538326355|FG009|Week 52|Death|0|||
149234030|NCT00536991|538326356|FG000|Overall Study|Withdrawal by Subject|10|||
149234031|NCT00536991|538326356|FG000|Overall Study|Physician Decision|1|||
149234032|NCT00536991|538326356|FG000|Overall Study|patient ineligible|2|||
149234033|NCT00054639|538326357|FG000|Overall Study|Lack of Efficacy|1|||
149234034|NCT00054639|538326357|FG000|Overall Study|Physician Decision|1|||
149234035|NCT01366846|538326362|FG000|Overall Study|Withdrawal by Subject|2|||
149234036|NCT01366846|538326363|FG001|Overall Study|Withdrawal by Subject|0|||
149234037|NCT01366846|538326364|FG002|Overall Study|Withdrawal by Subject|0|||
149234038|NCT01366846|538326365|FG003|Overall Study|Withdrawal by Subject|0|||
149182718|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149182719|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
149182720|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149182721|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
149182722|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149182723|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149182724|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149182725|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149182726|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
149182727|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
149182728|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
149182729|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
149182730|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
148932478|NCT04171765|537238667|FG002|Overall Study|Adverse Event|1|||
148932479|NCT04171765|537238668|FG003|Overall Study|Adverse Event|0|||
148932480|NCT04171765|537238665|FG000|Overall Study|Lost to Follow-up|0|||
148932481|NCT04171765|537238666|FG001|Overall Study|Lost to Follow-up|2|||
149182731|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
149182732|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
149182733|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
149182734|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
149182735|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
149182736|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
149182737|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
149182738|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
149182739|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
149182740|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
148932482|NCT04171765|537238667|FG002|Overall Study|Lost to Follow-up|2|||
148932483|NCT04171765|537238668|FG003|Overall Study|Lost to Follow-up|2|||
148932484|NCT04171765|537238665|FG000|Overall Study|Week 58 visit missed|0|||
148932485|NCT04171765|537238666|FG001|Overall Study|Week 58 visit missed|0|||
148932486|NCT04171765|537238667|FG002|Overall Study|Week 58 visit missed|1|||
148932487|NCT04171765|537238668|FG003|Overall Study|Week 58 visit missed|0|||
149182741|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
149182742|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
148932488|NCT04171765|537238665|FG000|Overall Study|Study terminated by sponsor|2|||
148932489|NCT04171765|537238666|FG001|Overall Study|Study terminated by sponsor|0|||
148932490|NCT04171765|537238667|FG002|Overall Study|Study terminated by sponsor|0|||
148932491|NCT04171765|537238668|FG003|Overall Study|Study terminated by sponsor|0|||
148932492|NCT04171765|537238665|FG000|Overall Study|Withdrawal by Subject|1|||
148932493|NCT04171765|537238666|FG001|Overall Study|Withdrawal by Subject|0|||
148932494|NCT04171765|537238667|FG002|Overall Study|Withdrawal by Subject|0|||
148932495|NCT04171765|537238668|FG003|Overall Study|Withdrawal by Subject|3|||
148932496|NCT00122109|537238669|FG000|Overall Study|Did not meet criteria|6|||
148932497|NCT00122109|537238670|FG001|Overall Study|Did not meet criteria|7|||
148932498|NCT00809354|537238674|FG000|Overall Study|Adverse Event|32|||
148932499|NCT00809354|537238675|FG001|Overall Study|Adverse Event|45|||
148932500|NCT00809354|537238676|FG002|Overall Study|Adverse Event|37|||
148932501|NCT00809354|537238677|FG003|Overall Study|Adverse Event|53|||
148932502|NCT00809354|537238678|FG004|Overall Study|Adverse Event|26|||
148932503|NCT00809354|537238679|FG005|Overall Study|Adverse Event|33|||
148932504|NCT00809354|537238680|FG006|Overall Study|Adverse Event|44|||
148932505|NCT00809354|537238681|FG007|Overall Study|Adverse Event|40|||
148932506|NCT00809354|537238682|FG008|Overall Study|Adverse Event|46|||
148932507|NCT00809354|537238683|FG009|Overall Study|Adverse Event|26|||
148932508|NCT00809354|537238674|FG000|Overall Study|Lack of Efficacy|23|||
149182743|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149182744|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149182745|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
149182746|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149182747|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149182748|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
148679667|NCT02164539|536300860|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
148932509|NCT00809354|537238675|FG001|Overall Study|Lack of Efficacy|23|||
148932510|NCT00809354|537238676|FG002|Overall Study|Lack of Efficacy|22|||
148932511|NCT00809354|537238677|FG003|Overall Study|Lack of Efficacy|15|||
148932512|NCT00809354|537238678|FG004|Overall Study|Lack of Efficacy|40|||
148932513|NCT00809354|537238679|FG005|Overall Study|Lack of Efficacy|19|||
148932514|NCT00809354|537238680|FG006|Overall Study|Lack of Efficacy|21|||
148932515|NCT00809354|537238681|FG007|Overall Study|Lack of Efficacy|15|||
148932516|NCT00809354|537238682|FG008|Overall Study|Lack of Efficacy|18|||
148932517|NCT00809354|537238683|FG009|Overall Study|Lack of Efficacy|38|||
149182749|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
149182750|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
149182751|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
149182752|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
149182753|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
149182754|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
149182755|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
149182756|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
149182757|NCT02975349|538139968|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
149182758|NCT02975349|538139969|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
149182759|NCT02975349|538139970|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
149182760|NCT02975349|538139971|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
149182761|NCT02975349|538139972|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
149182762|NCT02975349|538139973|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
149182763|NCT02975349|538139974|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
149182764|NCT01318902|538139984|FG000|Overall Study|Symptomatic Deterioration|0|||
149182765|NCT01318902|538139985|FG001|Overall Study|Symptomatic Deterioration|1|||
149182766|NCT01318902|538139986|FG002|Overall Study|Symptomatic Deterioration|1|||
149182767|NCT01318902|538139987|FG003|Overall Study|Symptomatic Deterioration|2|||
149182768|NCT01318902|538139984|FG000|Overall Study|Withdrawal by Patient|0|||
149182769|NCT01318902|538139985|FG001|Overall Study|Withdrawal by Patient|1|||
149182770|NCT01318902|538139986|FG002|Overall Study|Withdrawal by Patient|0|||
149182771|NCT01318902|538139987|FG003|Overall Study|Withdrawal by Patient|3|||
149182772|NCT01318902|538139984|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
149182773|NCT01318902|538139985|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
149182774|NCT01318902|538139986|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
149182775|NCT01318902|538139987|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
149182776|NCT01318902|538139984|FG000|Overall Study|Adverse Event|0|||
149182777|NCT01318902|538139985|FG001|Overall Study|Adverse Event|1|||
149182778|NCT01318902|538139986|FG002|Overall Study|Adverse Event|0|||
149182779|NCT01318902|538139987|FG003|Overall Study|Adverse Event|0|||
149182780|NCT01318902|538139984|FG000|Overall Study|Terminated by Sponsor|0|||
149182781|NCT01318902|538139985|FG001|Overall Study|Terminated by Sponsor|0|||
149182782|NCT01318902|538139986|FG002|Overall Study|Terminated by Sponsor|1|||
149182783|NCT01318902|538139987|FG003|Overall Study|Terminated by Sponsor|0|||
149182784|NCT02699515|538141756|FG000|Overall Study|Death|3|||
149182785|NCT02699515|538141757|FG001|Overall Study|Death|3|||
149182786|NCT02699515|538141758|FG002|Overall Study|Death|3|||
149182787|NCT02699515|538141759|FG003|Overall Study|Death|23|||
149182788|NCT02699515|538141760|FG004|Overall Study|Death|22|||
149182789|NCT02699515|538141761|FG005|Overall Study|Death|23|||
149182790|NCT02699515|538141762|FG006|Overall Study|Death|3|||
149182791|NCT02699515|538141763|FG007|Overall Study|Death|5|||
149182792|NCT02699515|538141756|FG000|Overall Study|Withdrawal by Subject|0|||
149182793|NCT02699515|538141757|FG001|Overall Study|Withdrawal by Subject|0|||
149182794|NCT02699515|538141758|FG002|Overall Study|Withdrawal by Subject|3|||
149182795|NCT02699515|538141759|FG003|Overall Study|Withdrawal by Subject|1|||
149182796|NCT02699515|538141760|FG004|Overall Study|Withdrawal by Subject|5|||
149182797|NCT02699515|538141761|FG005|Overall Study|Withdrawal by Subject|3|||
149182798|NCT02699515|538141762|FG006|Overall Study|Withdrawal by Subject|0|||
149182799|NCT02699515|538141763|FG007|Overall Study|Withdrawal by Subject|1|||
149182800|NCT02699515|538141756|FG000|Overall Study|Other|1|||
149182801|NCT02699515|538141757|FG001|Overall Study|Other|0|||
149182802|NCT02699515|538141758|FG002|Overall Study|Other|1|||
149182803|NCT02699515|538141759|FG003|Overall Study|Other|6|||
149182804|NCT02699515|538141760|FG004|Overall Study|Other|4|||
149182805|NCT02699515|538141761|FG005|Overall Study|Other|3|||
149182806|NCT02699515|538141762|FG006|Overall Study|Other|0|||
149182807|NCT02699515|538141763|FG007|Overall Study|Other|0|||
149182808|NCT01240811|538141770|FG000|Overall Study|Physician Decision|0|||
149182809|NCT01240811|538141771|FG001|Overall Study|Physician Decision|1|||
149182810|NCT01240811|538141772|FG002|Overall Study|Physician Decision|0|||
149182811|NCT01240811|538141770|FG000|Overall Study|Withdrawal by Subject|0|||
149182812|NCT01240811|538141771|FG001|Overall Study|Withdrawal by Subject|0|||
149182813|NCT01240811|538141772|FG002|Overall Study|Withdrawal by Subject|1|||
149182814|NCT03825042|538141775|FG000|Overall Study|Adverse Event|1|||
149182815|NCT03825042|538141776|FG001|Overall Study|Adverse Event|0|||
149182816|NCT03825042|538141775|FG000|Overall Study|Withdrawal by Subject|1|||
149182817|NCT03825042|538141776|FG001|Overall Study|Withdrawal by Subject|0|||
149182818|NCT01158534|538141789|FG000|Overall Study|Withdrawal by Subject|1|||
149182819|NCT01158534|538141789|FG000|Overall Study|Death|1|||
149182820|NCT01158534|538141789|FG000|Overall Study|Other|1|||
149182821|NCT01988012|538141790|FG000|Overall Study|Adverse Event|5|||
149182822|NCT01988012|538141790|FG000|Overall Study|Insufficient Therapeutic Response|3|||
149182823|NCT01988012|538141790|FG000|Overall Study|Patient Withdrawal of Consent|4|||
149182824|NCT01988012|538141790|FG000|Overall Study|Lost to Follow-up|1|||
149182825|NCT01988012|538141790|FG000|Overall Study|Physician Decision|1|||
149182826|NCT01988012|538141790|FG000|Overall Study|Protocol Violation|1|||
149182827|NCT01058369|538141791|FG000|Overall Study|Adverse Event|1|||
149182828|NCT01058369|538141791|FG000|Overall Study|Early termination study|1|||
149182829|NCT04003155|538141792|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
149182830|NCT04003155|538141793|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
149182831|NCT04003155|538141794|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
149182832|NCT04003155|538141795|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
149182833|NCT04003155|538141796|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
149182834|NCT04003155|538141792|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
149182835|NCT04003155|538141793|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
149182836|NCT04003155|538141794|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
149182837|NCT04003155|538141795|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
149182838|NCT04003155|538141796|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
149182839|NCT04003155|538141792|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
149182840|NCT04003155|538141793|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
149182841|NCT04003155|538141794|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
149182842|NCT04003155|538141795|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
149182843|NCT04003155|538141796|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
149182844|NCT04003155|538141792|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
149182845|NCT04003155|538141793|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
149182846|NCT04003155|538141794|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
149182847|NCT04003155|538141795|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
149182848|NCT04003155|538141796|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
149182849|NCT04003155|538141792|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
149182850|NCT04003155|538141793|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
149182851|NCT04003155|538141794|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
149182852|NCT04003155|538141795|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
149182853|NCT04003155|538141796|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
149182854|NCT04003155|538141792|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
149182855|NCT04003155|538141793|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
149182856|NCT04003155|538141794|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
149182857|NCT04003155|538141795|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
149182858|NCT04003155|538141796|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
149182859|NCT04003155|538141792|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
149182860|NCT04003155|538141793|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
149182861|NCT04003155|538141794|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
149182862|NCT04003155|538141795|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
149182863|NCT04003155|538141796|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
149182864|NCT04003155|538141792|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
149182865|NCT04003155|538141793|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
149182866|NCT04003155|538141794|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
149182867|NCT04003155|538141795|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
149182868|NCT04003155|538141796|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
149182869|NCT04003155|538141792|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
149182870|NCT04003155|538141793|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
149182871|NCT04003155|538141794|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
149182872|NCT04003155|538141795|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
149182873|NCT04003155|538141796|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
149182874|NCT01666444|538141800|FG000|Overall Study|Did not initiate treatment|2|||
149182875|NCT01666444|538141801|FG001|Overall Study|Did not initiate treatment|1|||
149182876|NCT00950690|538141804|FG000|Overall Study|Death|4|||
149182877|NCT00950690|538141804|FG000|Overall Study|Adverse Event|15|||
149182878|NCT00950690|538141804|FG000|Overall Study|Lack of Efficacy|22|||
149182879|NCT00950690|538141804|FG000|Overall Study|Lost to Follow-up|40|||
149182880|NCT00950690|538141804|FG000|Overall Study|Other|163|||
149182881|NCT01713036|538141805|FG000|Overall Study|Death|1|||
149182882|NCT00592358|538141806|FG000|Overall Study|Withdrawal by Subject|2|||
149182883|NCT00592358|538141806|FG000|Overall Study|Adverse Event|1|||
149182884|NCT00592358|538141806|FG000|Overall Study|Lack of Efficacy|2|||
149182885|NCT00592358|538141806|FG000|Overall Study|Inability to swallow pills|1|||
149182886|NCT04760314|538141809|FG000|Induction Period|Withdrawal by Subject|0|||
149182887|NCT04760314|538141810|FG001|Induction Period|Withdrawal by Subject|1|||
149182888|NCT04760314|538141811|FG002|Induction Period|Withdrawal by Subject|1|||
149182889|NCT04760314|538141812|FG003|Induction Period|Withdrawal by Subject|0|||
149182890|NCT04760314|538141813|FG004|Induction Period|Withdrawal by Subject|0|||
149182891|NCT04760314|538141814|FG005|Induction Period|Withdrawal by Subject|0|||
149182892|NCT04760314|538141815|FG006|Induction Period|Withdrawal by Subject|0|||
149182893|NCT04760314|538141816|FG007|Induction Period|Withdrawal by Subject|0|||
149182894|NCT04760314|538141817|FG008|Induction Period|Withdrawal by Subject|0|||
149182895|NCT04760314|538141818|FG009|Induction Period|Withdrawal by Subject|0|||
149182896|NCT04760314|538141819|FG010|Induction Period|Withdrawal by Subject|0|||
149182897|NCT04760314|538141809|FG000|Induction Period|Adverse Event|0|||
149182898|NCT04760314|538141810|FG001|Induction Period|Adverse Event|0|||
149182899|NCT04760314|538141811|FG002|Induction Period|Adverse Event|2|||
149182900|NCT04760314|538141812|FG003|Induction Period|Adverse Event|0|||
149182901|NCT04760314|538141813|FG004|Induction Period|Adverse Event|0|||
149182902|NCT04760314|538141814|FG005|Induction Period|Adverse Event|0|||
149182903|NCT04760314|538141815|FG006|Induction Period|Adverse Event|0|||
149182904|NCT04760314|538141816|FG007|Induction Period|Adverse Event|0|||
149182905|NCT04760314|538141817|FG008|Induction Period|Adverse Event|0|||
149182906|NCT04760314|538141818|FG009|Induction Period|Adverse Event|0|||
149182907|NCT04760314|538141819|FG010|Induction Period|Adverse Event|0|||
149182908|NCT04760314|538141809|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182909|NCT04760314|538141810|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182910|NCT04760314|538141811|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182911|NCT04760314|538141812|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
149182912|NCT04760314|538141813|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
149182913|NCT04760314|538141814|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
149182914|NCT04760314|538141815|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
149182915|NCT04760314|538141816|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182916|NCT04760314|538141817|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182917|NCT04760314|538141818|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182918|NCT04760314|538141819|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
149182919|NCT04760314|538141809|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182920|NCT04760314|538141810|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182921|NCT04760314|538141811|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182922|NCT04760314|538141812|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
149182923|NCT04760314|538141813|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182924|NCT04760314|538141814|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
149182925|NCT04760314|538141815|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
149182926|NCT04760314|538141816|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182927|NCT04760314|538141817|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182928|NCT04760314|538141818|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182929|NCT04760314|538141819|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
149182930|NCT04760314|538141809|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182931|NCT04760314|538141810|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182932|NCT04760314|538141811|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182933|NCT04760314|538141812|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182934|NCT04760314|538141813|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
149182935|NCT04760314|538141814|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182936|NCT04760314|538141815|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182937|NCT04760314|538141816|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182938|NCT04760314|538141817|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182939|NCT04760314|538141818|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182940|NCT04760314|538141819|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
149182941|NCT04760314|538141809|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
149182942|NCT04760314|538141810|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
149182943|NCT04760314|538141811|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
149182944|NCT04760314|538141812|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
149182945|NCT04760314|538141813|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
149182946|NCT04760314|538141814|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
149182947|NCT04760314|538141815|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
149182948|NCT04760314|538141816|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
149182949|NCT04760314|538141817|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
149182950|NCT04760314|538141818|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
149182951|NCT04760314|538141819|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
149182952|NCT04760314|538141809|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182953|NCT04760314|538141810|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182954|NCT04760314|538141811|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182955|NCT04760314|538141812|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182956|NCT04760314|538141813|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182957|NCT04760314|538141814|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182958|NCT04760314|538141815|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182959|NCT04760314|538141816|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149182960|NCT04760314|538141817|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
149182961|NCT04760314|538141818|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149182962|NCT04760314|538141819|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
149182963|NCT04760314|538141809|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182964|NCT04760314|538141810|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182965|NCT04760314|538141811|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182966|NCT04760314|538141812|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182967|NCT04760314|538141813|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182968|NCT04760314|538141814|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182969|NCT04760314|538141815|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182970|NCT04760314|538141816|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
149182971|NCT04760314|538141817|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
149182972|NCT04760314|538141818|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
149182973|NCT04760314|538141819|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
149182974|NCT04760314|538141809|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182975|NCT04760314|538141810|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182976|NCT04760314|538141811|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182977|NCT04760314|538141812|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182978|NCT04760314|538141813|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182979|NCT04760314|538141814|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182980|NCT04760314|538141815|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182981|NCT04760314|538141816|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
149182982|NCT04760314|538141817|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182983|NCT04760314|538141818|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182984|NCT04760314|538141819|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
149182985|NCT04760314|538141809|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182986|NCT04760314|538141810|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182987|NCT04760314|538141811|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182988|NCT04760314|538141812|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182989|NCT04760314|538141813|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182990|NCT04760314|538141814|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182991|NCT04760314|538141815|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182992|NCT04760314|538141816|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182993|NCT04760314|538141817|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
149182994|NCT04760314|538141818|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
149182995|NCT04760314|538141819|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
149182996|NCT01013883|538141820|FG000|Overall Study|Lost to Follow-up|2|||
149182997|NCT01013883|538141821|FG001|Overall Study|Lost to Follow-up|2|||
149182998|NCT01371838|538141822|FG000|Overall Study|Withdrawal by Subject|27|||
149182999|NCT01371838|538141823|FG001|Overall Study|Withdrawal by Subject|33|||
149183000|NCT01371838|538141822|FG000|Overall Study|Lost to Follow-up|10|||
149183001|NCT01371838|538141823|FG001|Overall Study|Lost to Follow-up|20|||
149183002|NCT01371838|538141822|FG000|Overall Study|Death|3|||
149183003|NCT01371838|538141823|FG001|Overall Study|Death|4|||
149183004|NCT01371838|538141822|FG000|Overall Study|Protocol Violation|3|||
148932518|NCT00809354|537238674|FG000|Overall Study|Lost to Follow-up|10|||
148932519|NCT00809354|537238675|FG001|Overall Study|Lost to Follow-up|11|||
148932520|NCT00809354|537238676|FG002|Overall Study|Lost to Follow-up|8|||
148932521|NCT00809354|537238677|FG003|Overall Study|Lost to Follow-up|13|||
148932522|NCT00809354|537238678|FG004|Overall Study|Lost to Follow-up|6|||
148932523|NCT00809354|537238679|FG005|Overall Study|Lost to Follow-up|2|||
148932524|NCT00809354|537238680|FG006|Overall Study|Lost to Follow-up|0|||
148932525|NCT00809354|537238681|FG007|Overall Study|Lost to Follow-up|5|||
148932526|NCT00809354|537238682|FG008|Overall Study|Lost to Follow-up|4|||
148932527|NCT00809354|537238683|FG009|Overall Study|Lost to Follow-up|0|||
148932528|NCT00809354|537238674|FG000|Overall Study|Protocol Violation|7|||
148932529|NCT00809354|537238675|FG001|Overall Study|Protocol Violation|14|||
148932530|NCT00809354|537238676|FG002|Overall Study|Protocol Violation|14|||
148932531|NCT00809354|537238677|FG003|Overall Study|Protocol Violation|12|||
148932532|NCT00809354|537238678|FG004|Overall Study|Protocol Violation|14|||
148932533|NCT00809354|537238679|FG005|Overall Study|Protocol Violation|6|||
148932534|NCT00809354|537238680|FG006|Overall Study|Protocol Violation|4|||
148932535|NCT00809354|537238681|FG007|Overall Study|Protocol Violation|6|||
148932536|NCT00809354|537238682|FG008|Overall Study|Protocol Violation|9|||
148932537|NCT00809354|537238683|FG009|Overall Study|Protocol Violation|3|||
148932538|NCT00809354|537238674|FG000|Overall Study|Withdrawal by Subject|32|||
148932539|NCT00809354|537238675|FG001|Overall Study|Withdrawal by Subject|27|||
149183005|NCT01371838|538141823|FG001|Overall Study|Protocol Violation|0|||
149183006|NCT01371838|538141822|FG000|Overall Study|Investigator Decision|3|||
149183007|NCT01371838|538141823|FG001|Overall Study|Investigator Decision|8|||
149183008|NCT01371838|538141822|FG000|Overall Study|Last follow-up visit not conducted|2|||
149183009|NCT01371838|538141823|FG001|Overall Study|Last follow-up visit not conducted|0|||
149183010|NCT01371838|538141822|FG000|Overall Study|Lack of therapeutic response|0|||
148932540|NCT00809354|537238676|FG002|Overall Study|Withdrawal by Subject|31|||
148932541|NCT00809354|537238677|FG003|Overall Study|Withdrawal by Subject|33|||
148932542|NCT00809354|537238678|FG004|Overall Study|Withdrawal by Subject|34|||
148932543|NCT00809354|537238679|FG005|Overall Study|Withdrawal by Subject|29|||
148932544|NCT00809354|537238680|FG006|Overall Study|Withdrawal by Subject|27|||
149014001|NCT01370005|537530851|FG000|Overall Study|Lack of Efficacy|1|||
149014002|NCT01370005|537530852|FG001|Overall Study|Lack of Efficacy|0|||
149014003|NCT01370005|537530853|FG002|Overall Study|Lack of Efficacy|0|||
149014004|NCT01370005|537530851|FG000|Overall Study|Non compliant with protocol|0|||
149014005|NCT01370005|537530852|FG001|Overall Study|Non compliant with protocol|1|||
149014006|NCT01370005|537530853|FG002|Overall Study|Non compliant with protocol|2|||
149014007|NCT01370005|537530851|FG000|Overall Study|Lost to Follow-up|1|||
149014008|NCT01370005|537530852|FG001|Overall Study|Lost to Follow-up|1|||
149014009|NCT01370005|537530853|FG002|Overall Study|Lost to Follow-up|1|||
149014010|NCT01370005|537530851|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
149014011|NCT01370005|537530852|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
149014012|NCT01370005|537530853|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
149014013|NCT01370005|537530851|FG000|Overall Study|Other reason not defined above|3|||
149014014|NCT01370005|537530852|FG001|Overall Study|Other reason not defined above|0|||
149014015|NCT01370005|537530853|FG002|Overall Study|Other reason not defined above|2|||
149014016|NCT03691948|537530854|FG000|Overall Study|Lost to Follow-up|1|||
149014017|NCT03691948|537530855|FG001|Overall Study|Lost to Follow-up|3|||
149014018|NCT02009696|537530856|FG000|Overall Study|Withdrawal by Subject|2|||
149014019|NCT04844970|537530858|FG000|Overall Study|Adverse Event|0|||
149014020|NCT04844970|537530859|FG001|Overall Study|Adverse Event|1|||
149014021|NCT04844970|537530858|FG000|Overall Study|Withdrawal by Subject|2|||
149014022|NCT04844970|537530859|FG001|Overall Study|Withdrawal by Subject|0|||
149014023|NCT00447954|537530860|FG000|Overall Study|Adverse Event|0|||
149014024|NCT00447954|537530861|FG001|Overall Study|Adverse Event|2|||
149014025|NCT00447954|537530862|FG002|Overall Study|Adverse Event|0|||
149014026|NCT00447954|537530860|FG000|Overall Study|Withdrawal by Subject|0|||
149014027|NCT00447954|537530861|FG001|Overall Study|Withdrawal by Subject|1|||
149014028|NCT00447954|537530862|FG002|Overall Study|Withdrawal by Subject|1|||
149014029|NCT00447954|537530860|FG000|Overall Study|Lost to Follow-up|0|||
149014030|NCT00447954|537530861|FG001|Overall Study|Lost to Follow-up|1|||
149014031|NCT00447954|537530862|FG002|Overall Study|Lost to Follow-up|0|||
149014032|NCT00447954|537530860|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
149014033|NCT00447954|537530861|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
148932545|NCT00809354|537238681|FG007|Overall Study|Withdrawal by Subject|19|||
149183011|NCT01371838|538141823|FG001|Overall Study|Lack of therapeutic response|1|||
149183012|NCT01371838|538141822|FG000|Overall Study|Surgery|1|||
149183013|NCT01371838|538141823|FG001|Overall Study|Surgery|0|||
149183014|NCT00641043|538141830|FG000|Overall Study|Adverse Event|6|||
149183015|NCT00641043|538141831|FG001|Overall Study|Adverse Event|4|||
149183016|NCT00641043|538141830|FG000|Overall Study|Protocol Violation|2|||
149183017|NCT00641043|538141831|FG001|Overall Study|Protocol Violation|3|||
149183018|NCT00641043|538141830|FG000|Overall Study|Lost to Follow-up|3|||
149183019|NCT00641043|538141831|FG001|Overall Study|Lost to Follow-up|2|||
148807340|NCT00903968|536773229|FG001|Overall Study|Withdrawal by Subject|0|||
148932546|NCT00809354|537238682|FG008|Overall Study|Withdrawal by Subject|18|||
148932547|NCT00809354|537238683|FG009|Overall Study|Withdrawal by Subject|20|||
148932548|NCT00809354|537238674|FG000|Overall Study|Other|10|||
148932549|NCT00809354|537238675|FG001|Overall Study|Other|2|||
148932550|NCT00809354|537238676|FG002|Overall Study|Other|7|||
148932551|NCT00809354|537238677|FG003|Overall Study|Other|10|||
148932552|NCT00809354|537238678|FG004|Overall Study|Other|5|||
148932553|NCT00809354|537238679|FG005|Overall Study|Other|3|||
148932554|NCT00809354|537238680|FG006|Overall Study|Other|2|||
148932555|NCT00809354|537238681|FG007|Overall Study|Other|3|||
148932556|NCT00809354|537238682|FG008|Overall Study|Other|4|||
148932557|NCT00809354|537238683|FG009|Overall Study|Other|3|||
148932558|NCT00809354|537238674|FG000|Overall Study|Study terminated by sponsor|138|||
149014034|NCT00447954|537530862|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
149014035|NCT02120664|537530863|FG000|Overall Study|Withdrawal by Subject|0|||
149014036|NCT02120664|537530864|FG001|Overall Study|Withdrawal by Subject|0|||
149014037|NCT02120664|537530865|FG002|Overall Study|Withdrawal by Subject|0|||
149014038|NCT02120664|537530866|FG003|Overall Study|Withdrawal by Subject|1|||
149014039|NCT02120664|537530867|FG004|Overall Study|Withdrawal by Subject|0|||
149014040|NCT02460263|537530868|FG000|Transition Period|Withdrawal by Subject|1|||
149014041|NCT02460263|537530868|FG000|Transition Period|Death|1|||
149014042|NCT03916744|537530869|FG000|Overall Study|Withdrawal by Subject|0|||
149183020|NCT00641043|538141830|FG000|Overall Study|Withdrawal by Subject|4|||
148932559|NCT00809354|537238675|FG001|Overall Study|Study terminated by sponsor|134|||
148932560|NCT00809354|537238676|FG002|Overall Study|Study terminated by sponsor|129|||
148932561|NCT00809354|537238677|FG003|Overall Study|Study terminated by sponsor|120|||
149014043|NCT03916744|537530870|FG001|Overall Study|Withdrawal by Subject|1|||
149014044|NCT03916744|537530871|FG002|Overall Study|Withdrawal by Subject|2|||
149014045|NCT04524598|537530872|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
149014046|NCT04524598|537530873|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
149014047|NCT04524598|537530874|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
149014048|NCT04524598|537530875|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
149014049|NCT04524598|537530876|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
148932562|NCT00809354|537238678|FG004|Overall Study|Study terminated by sponsor|126|||
148932563|NCT00809354|537238679|FG005|Overall Study|Study terminated by sponsor|133|||
148932564|NCT00809354|537238680|FG006|Overall Study|Study terminated by sponsor|124|||
148932565|NCT00809354|537238681|FG007|Overall Study|Study terminated by sponsor|148|||
148932566|NCT00809354|537238682|FG008|Overall Study|Study terminated by sponsor|127|||
148932567|NCT00809354|537238683|FG009|Overall Study|Study terminated by sponsor|135|||
148932568|NCT00809354|537238674|FG000|Overall Study|Withdrawn due to pregnancy|0|||
148932569|NCT00809354|537238675|FG001|Overall Study|Withdrawn due to pregnancy|1|||
148932570|NCT00809354|537238676|FG002|Overall Study|Withdrawn due to pregnancy|0|||
148932571|NCT00809354|537238677|FG003|Overall Study|Withdrawn due to pregnancy|0|||
148932572|NCT00809354|537238678|FG004|Overall Study|Withdrawn due to pregnancy|0|||
148932573|NCT00809354|537238679|FG005|Overall Study|Withdrawn due to pregnancy|0|||
148932574|NCT00809354|537238680|FG006|Overall Study|Withdrawn due to pregnancy|0|||
148932575|NCT00809354|537238681|FG007|Overall Study|Withdrawn due to pregnancy|0|||
148932576|NCT00809354|537238682|FG008|Overall Study|Withdrawn due to pregnancy|0|||
148932577|NCT00809354|537238683|FG009|Overall Study|Withdrawn due to pregnancy|0|||
148932578|NCT00809354|537238674|FG000|Overall Study|Randomized but not Treated|3|||
148932579|NCT00809354|537238675|FG001|Overall Study|Randomized but not Treated|1|||
148932580|NCT00809354|537238676|FG002|Overall Study|Randomized but not Treated|6|||
148932581|NCT00809354|537238677|FG003|Overall Study|Randomized but not Treated|0|||
148932582|NCT00809354|537238678|FG004|Overall Study|Randomized but not Treated|5|||
148932583|NCT00809354|537238679|FG005|Overall Study|Randomized but not Treated|0|||
148932584|NCT00809354|537238680|FG006|Overall Study|Randomized but not Treated|1|||
148932585|NCT00809354|537238681|FG007|Overall Study|Randomized but not Treated|1|||
148932586|NCT00809354|537238682|FG008|Overall Study|Randomized but not Treated|2|||
148932587|NCT00809354|537238683|FG009|Overall Study|Randomized but not Treated|1|||
148932588|NCT00809354|537238674|FG000|Overall Study|Death|0|||
148932589|NCT00809354|537238675|FG001|Overall Study|Death|0|||
148932590|NCT00809354|537238676|FG002|Overall Study|Death|0|||
148932591|NCT00809354|537238677|FG003|Overall Study|Death|0|||
148932592|NCT00809354|537238678|FG004|Overall Study|Death|0|||
148932593|NCT00809354|537238679|FG005|Overall Study|Death|0|||
148932594|NCT00809354|537238680|FG006|Overall Study|Death|0|||
148932595|NCT00809354|537238681|FG007|Overall Study|Death|1|||
148932596|NCT00809354|537238682|FG008|Overall Study|Death|0|||
148932597|NCT00809354|537238683|FG009|Overall Study|Death|0|||
148932598|NCT00437320|537238686|FG000|Overall Study|Participant request|2|||
148932599|NCT00437320|537238687|FG001|Overall Study|Participant request|1|||
148932600|NCT00437320|537238688|FG002|Overall Study|Participant request|4|||
148932601|NCT01400815|537238698|FG000|Overall Study|Adverse Event|3|||
148932602|NCT01400815|537238699|FG001|Overall Study|Adverse Event|0|||
148932603|NCT01400815|537238698|FG000|Overall Study|Death|0|||
148932604|NCT01400815|537238699|FG001|Overall Study|Death|1|||
148932605|NCT01400815|537238698|FG000|Overall Study|Lost to Follow-up|18|||
148932606|NCT01400815|537238699|FG001|Overall Study|Lost to Follow-up|11|||
148932607|NCT01400815|537238698|FG000|Overall Study|Protocol Violation|0|||
148932608|NCT01400815|537238699|FG001|Overall Study|Protocol Violation|1|||
148932609|NCT01400815|537238698|FG000|Overall Study|Physician Decision|1|||
148932610|NCT01400815|537238699|FG001|Overall Study|Physician Decision|0|||
148932611|NCT01400815|537238698|FG000|Overall Study|Withdrawal by Subject|15|||
148932612|NCT01400815|537238699|FG001|Overall Study|Withdrawal by Subject|8|||
148932613|NCT01400815|537238698|FG000|Overall Study|Subject in jail|1|||
148932614|NCT01400815|537238699|FG001|Overall Study|Subject in jail|0|||
148932615|NCT01123850|537238700|FG000|Overall Study|Slow enrollment|45|||
149183021|NCT00641043|538141831|FG001|Overall Study|Withdrawal by Subject|4|||
149183022|NCT00641043|538141830|FG000|Overall Study|Other incl. lack of efficacy|4|||
149183023|NCT00641043|538141831|FG001|Overall Study|Other incl. lack of efficacy|2|||
149183024|NCT00907478|538141834|FG000|Overall Study|Ineligibility determined|0|||
149183025|NCT00907478|538141835|FG001|Overall Study|Ineligibility determined|0|||
148807341|NCT00903968|536773230|FG002|Overall Study|Withdrawal by Subject|1|||
148807342|NCT00903968|536773231|FG003|Overall Study|Withdrawal by Subject|0|||
148807343|NCT00903968|536773232|FG004|Overall Study|Withdrawal by Subject|1|||
148932616|NCT01199731|537238701|FG000|Overall Study|Adverse Event|0|||
148807344|NCT00903968|536773233|FG005|Overall Study|Withdrawal by Subject|1|||
148932617|NCT01199731|537238702|FG001|Overall Study|Adverse Event|1|||
148932618|NCT01199731|537238703|FG002|Overall Study|Adverse Event|0|||
148932619|NCT01199731|537238701|FG000|Overall Study|Study closed/terminated|7|||
148932620|NCT01199731|537238702|FG001|Overall Study|Study closed/terminated|9|||
148932621|NCT01199731|537238703|FG002|Overall Study|Study closed/terminated|7|||
148932622|NCT01199731|537238701|FG000|Overall Study|Lost to Follow-up|0|||
148932623|NCT01199731|537238702|FG001|Overall Study|Lost to Follow-up|0|||
148932624|NCT01199731|537238703|FG002|Overall Study|Lost to Follow-up|2|||
148932625|NCT01199731|537238701|FG000|Overall Study|Physician Decision|0|||
148932626|NCT01199731|537238702|FG001|Overall Study|Physician Decision|1|||
148932627|NCT01199731|537238703|FG002|Overall Study|Physician Decision|1|||
148932628|NCT01199731|537238701|FG000|Overall Study|Withdrawal by Subject|2|||
148932629|NCT01199731|537238702|FG001|Overall Study|Withdrawal by Subject|0|||
148932630|NCT01199731|537238703|FG002|Overall Study|Withdrawal by Subject|0|||
148932631|NCT02456103|537238704|FG000|Overall Study|Study Closure|207|||
149183026|NCT00907478|538141836|FG002|Overall Study|Ineligibility determined|1|||
149183027|NCT00907478|538141834|FG000|Overall Study|Noncompliance|0|||
149183028|NCT00907478|538141835|FG001|Overall Study|Noncompliance|0|||
149183029|NCT00907478|538141836|FG002|Overall Study|Noncompliance|1|||
149183030|NCT00907478|538141834|FG000|Overall Study|Adverse Event|3|||
149183031|NCT00907478|538141835|FG001|Overall Study|Adverse Event|1|||
149183032|NCT00907478|538141836|FG002|Overall Study|Adverse Event|2|||
149183033|NCT00907478|538141834|FG000|Overall Study|Withdrawal by Subject|8|||
149183034|NCT00907478|538141835|FG001|Overall Study|Withdrawal by Subject|9|||
149183035|NCT00907478|538141836|FG002|Overall Study|Withdrawal by Subject|6|||
149183036|NCT00907478|538141834|FG000|Overall Study|Requirement for alternative therapy|1|||
148932632|NCT02456103|537238704|FG000|Overall Study|Physician Decision|1|||
148932633|NCT02456103|537238704|FG000|Overall Study|Required prohibited medications|5|||
148932634|NCT02456103|537238704|FG000|Overall Study|Protocol Violation|1|||
148932635|NCT02456103|537238704|FG000|Overall Study|Adverse Event|5|||
149183037|NCT00907478|538141835|FG001|Overall Study|Requirement for alternative therapy|2|||
149183038|NCT00907478|538141836|FG002|Overall Study|Requirement for alternative therapy|3|||
149183039|NCT00907478|538141834|FG000|Overall Study|Physician Decision|2|||
149183040|NCT00907478|538141835|FG001|Overall Study|Physician Decision|0|||
149183041|NCT00907478|538141836|FG002|Overall Study|Physician Decision|3|||
149183042|NCT00907478|538141834|FG000|Overall Study|Death|4|||
149183043|NCT00907478|538141835|FG001|Overall Study|Death|2|||
149183044|NCT00907478|538141836|FG002|Overall Study|Death|1|||
149183045|NCT00907478|538141834|FG000|Overall Study|Protocol-specified criteria|5|||
149183046|NCT00907478|538141835|FG001|Overall Study|Protocol-specified criteria|2|||
149183047|NCT00907478|538141836|FG002|Overall Study|Protocol-specified criteria|3|||
149183048|NCT00907478|538141834|FG000|Overall Study|Pregnancy|0|||
149183049|NCT00907478|538141835|FG001|Overall Study|Pregnancy|1|||
149183050|NCT00907478|538141836|FG002|Overall Study|Pregnancy|1|||
149183051|NCT00907478|538141834|FG000|Overall Study|Lost to Follow-up|1|||
149183052|NCT00907478|538141835|FG001|Overall Study|Lost to Follow-up|0|||
149183053|NCT00907478|538141836|FG002|Overall Study|Lost to Follow-up|0|||
149183054|NCT00907478|538141834|FG000|Overall Study|Other|3|||
149183055|NCT00907478|538141835|FG001|Overall Study|Other|0|||
149183056|NCT00907478|538141836|FG002|Overall Study|Other|1|||
149183057|NCT01936649|538141837|FG000|Overall Study|Withdrawal by Subject|4|||
149183058|NCT01936649|538141837|FG000|Overall Study|Physician Decision|2|||
149183059|NCT01936649|538141837|FG000|Overall Study|Protocol Violation|2|||
149183060|NCT01936649|538141837|FG000|Overall Study|Other than specified above|5|||
149183061|NCT02546856|538141840|FG000|4 Months Evaluation|Death|2|||
149183062|NCT02546856|538141841|FG001|4 Months Evaluation|Death|3|||
149183063|NCT02546856|538141840|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
149183064|NCT02546856|538141841|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
149183065|NCT02546856|538141840|FG000|4 Months Evaluation|Lost to Follow-up|3|||
149183066|NCT02546856|538141841|FG001|4 Months Evaluation|Lost to Follow-up|3|||
149183067|NCT02546856|538141840|FG000|4 Months Evaluation|Physician Decision|3|||
148932636|NCT02456103|537238704|FG000|Overall Study|Abnormal Laboratory Value|2|||
148932637|NCT02456103|537238704|FG000|Overall Study|Lost to Follow-up|1|||
149183068|NCT02546856|538141841|FG001|4 Months Evaluation|Physician Decision|0|||
149183069|NCT02546856|538141840|FG000|4 Months Evaluation|Working or living abroad|5|||
149183070|NCT02546856|538141841|FG001|4 Months Evaluation|Working or living abroad|1|||
149183071|NCT02546856|538141840|FG000|4 Months Evaluation|reasons not due to titration|4|||
149183072|NCT02546856|538141841|FG001|4 Months Evaluation|reasons not due to titration|1|||
149183073|NCT02546856|538141840|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
149183074|NCT02546856|538141841|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
149183075|NCT02546856|538141840|FG000|6 Months Evaluation|Death|1|||
149183076|NCT02546856|538141841|FG001|6 Months Evaluation|Death|1|||
149183077|NCT02546856|538141840|FG000|6 Months Evaluation|Lost to Follow-up|1|||
149183078|NCT02546856|538141841|FG001|6 Months Evaluation|Lost to Follow-up|1|||
149183079|NCT02546856|538141840|FG000|6 Months Evaluation|Working or living abroad|6|||
149183080|NCT02546856|538141841|FG001|6 Months Evaluation|Working or living abroad|4|||
149183081|NCT02546856|538141840|FG000|6 Months Evaluation|reasons not due to titration|0|||
149183082|NCT02546856|538141841|FG001|6 Months Evaluation|reasons not due to titration|1|||
148932638|NCT02456103|537238704|FG000|Overall Study|Withdrawal by Subject|24|||
148932639|NCT04010539|537238705|FG000|Overall Study|Withdrawal by Subject|4|||
149183083|NCT03268746|538141843|FG000|Overall Study|Withdrawal by Subject|1|||
149183084|NCT00589472|538141844|FG000|Overall Study|Adverse Event|1|||
149183085|NCT00117338|538141845|FG000|Overall Study|Adverse Event|0|||
149183086|NCT00117338|538141846|FG001|Overall Study|Adverse Event|1|||
148932640|NCT04010539|537238706|FG001|Overall Study|Withdrawal by Subject|1|||
149183087|NCT00117338|538141845|FG000|Overall Study|Protocol Violation|3|||
149183088|NCT00117338|538141846|FG001|Overall Study|Protocol Violation|2|||
149183089|NCT00117338|538141845|FG000|Overall Study|Withdrawal by Subject|1|||
149183090|NCT00117338|538141846|FG001|Overall Study|Withdrawal by Subject|0|||
149183091|NCT00117338|538141845|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
149183092|NCT00117338|538141846|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
149183093|NCT00117338|538141845|FG000|Overall Study|Lack of Efficacy|0|||
149183094|NCT00117338|538141846|FG001|Overall Study|Lack of Efficacy|1|||
149183095|NCT00546351|538141847|FG000|Overall Study|Adverse Event|76|||
149183096|NCT00546351|538141847|FG000|Overall Study|Lack of Efficacy|15|||
149183097|NCT00546351|538141847|FG000|Overall Study|Withdrawal by Subject|109|||
149183098|NCT00546351|538141847|FG000|Overall Study|Lost to Follow-up|9|||
149183099|NCT00546351|538141847|FG000|Overall Study|Protocol Deviation|1|||
149183100|NCT00546351|538141847|FG000|Overall Study|Unsatisfactory compliance|9|||
149183101|NCT00546351|538141847|FG000|Overall Study|Other reasons for premature termination|17|||
149183102|NCT01342640|538141848|FG000|Overall Study|Adverse Event|3|||
149183103|NCT01342640|538141848|FG000|Overall Study|Protocol Violation|16|||
149014050|NCT04524598|537530872|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
149014051|NCT04524598|537530873|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
149014052|NCT04524598|537530874|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014053|NCT04524598|537530875|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014054|NCT04524598|537530876|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014055|NCT04524598|537530872|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
149014056|NCT04524598|537530873|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
149014057|NCT04524598|537530874|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
149014058|NCT04524598|537530875|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
149014059|NCT04524598|537530876|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
149014060|NCT04524598|537530872|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
149014061|NCT04524598|537530873|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
149014062|NCT04524598|537530874|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
149014063|NCT04524598|537530875|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
149014064|NCT04524598|537530876|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
149014065|NCT04524598|537530872|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014066|NCT04524598|537530873|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014067|NCT04524598|537530874|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
149014068|NCT04524598|537530875|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
149014069|NCT04524598|537530876|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
149183104|NCT01342640|538141848|FG000|Overall Study|Lost to Follow-up|21|||
149183105|NCT01342640|538141848|FG000|Overall Study|Other|1|||
149183106|NCT02616029|538141849|FG000|Overall Study|Adverse Event|1|||
149183107|NCT02616029|538141850|FG001|Overall Study|Adverse Event|0|||
149183108|NCT02616029|538141849|FG000|Overall Study|Death|0|||
149183109|NCT02616029|538141850|FG001|Overall Study|Death|1|||
149183110|NCT02616029|538141849|FG000|Overall Study|Protocol Violation|1|||
149183111|NCT02616029|538141850|FG001|Overall Study|Protocol Violation|0|||
149183112|NCT02616029|538141849|FG000|Overall Study|Withdrew Consent|1|||
149183113|NCT02616029|538141850|FG001|Overall Study|Withdrew Consent|0|||
149183114|NCT02616029|538141849|FG000|Overall Study|Enrolled and Never Treated|1|||
149183115|NCT02616029|538141850|FG001|Overall Study|Enrolled and Never Treated|1|||
149183116|NCT00479466|538141853|FG000|Overall Study|Adverse Event|5|||
149183117|NCT00479466|538141854|FG001|Overall Study|Adverse Event|1|||
149183118|NCT00479466|538141855|FG002|Overall Study|Adverse Event|0|||
149183119|NCT00479466|538141856|FG003|Overall Study|Adverse Event|1|||
149183120|NCT00479466|538141857|FG004|Overall Study|Adverse Event|2|||
149183121|NCT00479466|538141858|FG005|Overall Study|Adverse Event|0|||
149183122|NCT00479466|538141853|FG000|Overall Study|Hyperglycemia|0|||
149183123|NCT00479466|538141854|FG001|Overall Study|Hyperglycemia|0|||
149183124|NCT00479466|538141855|FG002|Overall Study|Hyperglycemia|0|||
149183125|NCT00479466|538141856|FG003|Overall Study|Hyperglycemia|0|||
149183126|NCT00479466|538141857|FG004|Overall Study|Hyperglycemia|0|||
149183127|NCT00479466|538141858|FG005|Overall Study|Hyperglycemia|1|||
149183128|NCT00479466|538141853|FG000|Overall Study|Lack of Efficacy|2|||
149183129|NCT00479466|538141854|FG001|Overall Study|Lack of Efficacy|0|||
149183130|NCT00479466|538141855|FG002|Overall Study|Lack of Efficacy|1|||
149183131|NCT00479466|538141856|FG003|Overall Study|Lack of Efficacy|0|||
149183132|NCT00479466|538141857|FG004|Overall Study|Lack of Efficacy|0|||
149183133|NCT00479466|538141858|FG005|Overall Study|Lack of Efficacy|0|||
149183134|NCT00479466|538141853|FG000|Overall Study|Lost to Follow-up|0|||
149183135|NCT00479466|538141854|FG001|Overall Study|Lost to Follow-up|1|||
149183136|NCT00479466|538141855|FG002|Overall Study|Lost to Follow-up|1|||
149183137|NCT00479466|538141856|FG003|Overall Study|Lost to Follow-up|0|||
149183138|NCT00479466|538141857|FG004|Overall Study|Lost to Follow-up|2|||
149183139|NCT00479466|538141858|FG005|Overall Study|Lost to Follow-up|2|||
149183140|NCT00479466|538141853|FG000|Overall Study|Physician Decision|2|||
149183141|NCT00479466|538141854|FG001|Overall Study|Physician Decision|1|||
149183142|NCT00479466|538141855|FG002|Overall Study|Physician Decision|1|||
149183143|NCT00479466|538141856|FG003|Overall Study|Physician Decision|0|||
149183144|NCT00479466|538141857|FG004|Overall Study|Physician Decision|0|||
149183145|NCT00479466|538141858|FG005|Overall Study|Physician Decision|0|||
149183146|NCT00479466|538141853|FG000|Overall Study|Pregnancy|0|||
148932641|NCT04010539|537238705|FG000|Overall Study|Physician Decision|0|||
148932642|NCT04010539|537238706|FG001|Overall Study|Physician Decision|2|||
148932643|NCT04010539|537238705|FG000|Overall Study|Lost to Follow-up|10|||
148932644|NCT04010539|537238706|FG001|Overall Study|Lost to Follow-up|14|||
148932645|NCT04010539|537238705|FG000|Overall Study|Adverse Event|3|||
148932646|NCT04010539|537238706|FG001|Overall Study|Adverse Event|0|||
148932647|NCT04010539|537238705|FG000|Overall Study|Participant Did Not Receive IP|0|||
148932648|NCT04010539|537238706|FG001|Overall Study|Participant Did Not Receive IP|1|||
148932649|NCT04010539|537238705|FG000|Overall Study|Protocol Deviation|0|||
148932650|NCT04010539|537238706|FG001|Overall Study|Protocol Deviation|1|||
148932651|NCT04010539|537238705|FG000|Overall Study|Randomized in Error/ Mistake|2|||
148932652|NCT04010539|537238706|FG001|Overall Study|Randomized in Error/ Mistake|0|||
148932653|NCT04010539|537238705|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
148932654|NCT04010539|537238706|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
148932655|NCT02448810|537238707|FG000|Overall Study|Adverse Event|0|||
148932656|NCT02448810|537238708|FG001|Overall Study|Adverse Event|0|||
148932657|NCT02448810|537238709|FG002|Overall Study|Adverse Event|1|||
148932658|NCT02448810|537238710|FG003|Overall Study|Adverse Event|0|||
148932659|NCT02448810|537238711|FG004|Overall Study|Adverse Event|0|||
148932660|NCT02448810|537238712|FG005|Overall Study|Adverse Event|0|||
148932661|NCT02448810|537238713|FG006|Overall Study|Adverse Event|0|||
148932662|NCT02448810|537238714|FG007|Overall Study|Adverse Event|0|||
148932663|NCT02448810|537238707|FG000|Overall Study|Withdrawal by Subject|0|||
148932664|NCT02448810|537238708|FG001|Overall Study|Withdrawal by Subject|0|||
148932665|NCT02448810|537238709|FG002|Overall Study|Withdrawal by Subject|1|||
149183147|NCT00479466|538141854|FG001|Overall Study|Pregnancy|0|||
149183148|NCT00479466|538141855|FG002|Overall Study|Pregnancy|0|||
149183149|NCT00479466|538141856|FG003|Overall Study|Pregnancy|0|||
149183150|NCT00479466|538141857|FG004|Overall Study|Pregnancy|1|||
149183151|NCT00479466|538141858|FG005|Overall Study|Pregnancy|0|||
149183152|NCT00479466|538141853|FG000|Overall Study|Protocol Violation|1|||
149183153|NCT00479466|538141854|FG001|Overall Study|Protocol Violation|0|||
149183154|NCT00479466|538141855|FG002|Overall Study|Protocol Violation|0|||
149183155|NCT00479466|538141856|FG003|Overall Study|Protocol Violation|0|||
149183156|NCT00479466|538141857|FG004|Overall Study|Protocol Violation|0|||
148932666|NCT02448810|537238710|FG003|Overall Study|Withdrawal by Subject|0|||
149183157|NCT00479466|538141858|FG005|Overall Study|Protocol Violation|0|||
149183158|NCT00479466|538141853|FG000|Overall Study|Withdrawal by Subject|3|||
149183159|NCT00479466|538141854|FG001|Overall Study|Withdrawal by Subject|5|||
149183160|NCT00479466|538141855|FG002|Overall Study|Withdrawal by Subject|0|||
149183161|NCT00479466|538141856|FG003|Overall Study|Withdrawal by Subject|2|||
149183162|NCT00479466|538141857|FG004|Overall Study|Withdrawal by Subject|3|||
149183163|NCT00479466|538141858|FG005|Overall Study|Withdrawal by Subject|1|||
149183164|NCT02927171|538141860|FG000|Overall Study|Lost to Follow-up|0|||
149183165|NCT02927171|538141861|FG001|Overall Study|Lost to Follow-up|1|||
149183166|NCT00850499|538141864|FG000|Overall Study|Adverse Event|3|||
149183167|NCT00850499|538141865|FG001|Overall Study|Adverse Event|1|||
149183168|NCT00850499|538141864|FG000|Overall Study|Lack of Efficacy|0|||
149183169|NCT00850499|538141865|FG001|Overall Study|Lack of Efficacy|1|||
149183170|NCT00718861|538141866|FG000|Overall Study|Withdrawal by Subject|15|||
149183171|NCT00718861|538141867|FG001|Overall Study|Withdrawal by Subject|10|||
148932667|NCT02448810|537238711|FG004|Overall Study|Withdrawal by Subject|3|||
148932668|NCT02448810|537238712|FG005|Overall Study|Withdrawal by Subject|5|||
148932669|NCT02448810|537238713|FG006|Overall Study|Withdrawal by Subject|0|||
148932670|NCT02448810|537238714|FG007|Overall Study|Withdrawal by Subject|2|||
148932671|NCT02448810|537238707|FG000|Overall Study|Other (study terminated by sponsor)|0|||
148932672|NCT02448810|537238708|FG001|Overall Study|Other (study terminated by sponsor)|0|||
148932673|NCT02448810|537238709|FG002|Overall Study|Other (study terminated by sponsor)|0|||
148932674|NCT02448810|537238710|FG003|Overall Study|Other (study terminated by sponsor)|0|||
148932675|NCT02448810|537238711|FG004|Overall Study|Other (study terminated by sponsor)|4|||
148932676|NCT02448810|537238712|FG005|Overall Study|Other (study terminated by sponsor)|2|||
148932677|NCT02448810|537238713|FG006|Overall Study|Other (study terminated by sponsor)|2|||
148932678|NCT02448810|537238714|FG007|Overall Study|Other (study terminated by sponsor)|1|||
149183172|NCT00718861|538141866|FG000|Overall Study|Adverse Event|2|||
149183173|NCT00718861|538141867|FG001|Overall Study|Adverse Event|1|||
148932679|NCT02448810|537238707|FG000|Overall Study|Death|1|||
148932680|NCT02448810|537238708|FG001|Overall Study|Death|0|||
148932681|NCT02448810|537238709|FG002|Overall Study|Death|1|||
148932682|NCT02448810|537238710|FG003|Overall Study|Death|0|||
149183174|NCT00718861|538141866|FG000|Overall Study|Lost to Follow-up|2|||
149183175|NCT00718861|538141867|FG001|Overall Study|Lost to Follow-up|1|||
149183176|NCT00718861|538141866|FG000|Overall Study|Administrative Problems|1|||
149183177|NCT00718861|538141867|FG001|Overall Study|Administrative Problems|1|||
148932683|NCT02448810|537238711|FG004|Overall Study|Death|1|||
148932684|NCT02448810|537238712|FG005|Overall Study|Death|0|||
148932685|NCT02448810|537238713|FG006|Overall Study|Death|0|||
149183178|NCT00718861|538141866|FG000|Overall Study|Death|1|||
149183179|NCT00718861|538141867|FG001|Overall Study|Death|5|||
149183180|NCT01703819|538141868|FG000|Overall Study|Adverse Event|0|||
149183181|NCT01703819|538141869|FG001|Overall Study|Adverse Event|1|||
149183182|NCT01703819|538141868|FG000|Overall Study|Withdrawal by Subject|0|||
148932686|NCT02448810|537238714|FG007|Overall Study|Death|0|||
148932687|NCT02448810|537238707|FG000|Overall Study|Other (Progressive disease)|2|||
148932688|NCT02448810|537238708|FG001|Overall Study|Other (Progressive disease)|2|||
149183183|NCT01703819|538141869|FG001|Overall Study|Withdrawal by Subject|1|||
149183184|NCT01302041|538141870|FG000|Overall Study|Death|5|||
149183185|NCT01302041|538141870|FG000|Overall Study|Withdrawal by Subject|4|||
149183186|NCT01302041|538141870|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
149183187|NCT01302041|538141870|FG000|Overall Study|Other-Miscellaneous Reason|2|||
149183188|NCT00858702|538141871|FG000|Overall Study|Lack of Efficacy|1|||
149183189|NCT00858702|538141872|FG001|Overall Study|Lack of Efficacy|0|||
148932689|NCT02448810|537238709|FG002|Overall Study|Other (Progressive disease)|0|||
148932690|NCT02448810|537238710|FG003|Overall Study|Other (Progressive disease)|3|||
148932691|NCT02448810|537238711|FG004|Overall Study|Other (Progressive disease)|23|||
148932692|NCT02448810|537238712|FG005|Overall Study|Other (Progressive disease)|9|||
148932693|NCT02448810|537238713|FG006|Overall Study|Other (Progressive disease)|14|||
149183190|NCT00858702|538141871|FG000|Overall Study|Protocol Violation|1|||
148932694|NCT02448810|537238714|FG007|Overall Study|Other (Progressive disease)|5|||
148932695|NCT02448810|537238707|FG000|Overall Study|Lost to Follow-up|0|||
148932696|NCT02448810|537238708|FG001|Overall Study|Lost to Follow-up|1|||
149183191|NCT00858702|538141872|FG001|Overall Study|Protocol Violation|1|||
149183192|NCT00858702|538141871|FG000|Overall Study|Other|2|||
149183193|NCT00858702|538141872|FG001|Overall Study|Other|1|||
149183194|NCT00858702|538141871|FG000|Overall Study|Withdrawal by Subject|1|||
149183195|NCT00858702|538141872|FG001|Overall Study|Withdrawal by Subject|0|||
149183196|NCT01849250|538141875|FG000|Overall Study|Withdrawal by Subject|1|||
149183197|NCT01849250|538141876|FG001|Overall Study|Withdrawal by Subject|0|||
149183198|NCT01849250|538141875|FG000|Overall Study|Not Evaluable|5|||
149183199|NCT01849250|538141876|FG001|Overall Study|Not Evaluable|3|||
149183200|NCT01849250|538141875|FG000|Overall Study|Screen Failure|1|||
149183201|NCT01849250|538141876|FG001|Overall Study|Screen Failure|0|||
149183202|NCT00367640|538141879|FG000|Overall Study|Adverse Event|3|||
149183203|NCT00367640|538141880|FG001|Overall Study|Adverse Event|6|||
149183204|NCT00367640|538141881|FG002|Overall Study|Adverse Event|8|||
149183205|NCT00367640|538141882|FG003|Overall Study|Adverse Event|0|||
149183206|NCT00367640|538141879|FG000|Overall Study|Withdrawal by Subject|8|||
149183207|NCT00367640|538141880|FG001|Overall Study|Withdrawal by Subject|11|||
149183208|NCT00367640|538141881|FG002|Overall Study|Withdrawal by Subject|8|||
148679668|NCT02164539|536300861|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
148679669|NCT02164539|536300855|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
148932697|NCT02448810|537238709|FG002|Overall Study|Lost to Follow-up|0|||
148932698|NCT02448810|537238710|FG003|Overall Study|Lost to Follow-up|0|||
148932699|NCT02448810|537238711|FG004|Overall Study|Lost to Follow-up|0|||
148932700|NCT02448810|537238712|FG005|Overall Study|Lost to Follow-up|0|||
148932701|NCT02448810|537238713|FG006|Overall Study|Lost to Follow-up|0|||
148932702|NCT02448810|537238714|FG007|Overall Study|Lost to Follow-up|0|||
148932703|NCT02448810|537238707|FG000|Overall Study|Other (unspecified)|0|||
148932704|NCT02448810|537238708|FG001|Overall Study|Other (unspecified)|0|||
148932705|NCT02448810|537238709|FG002|Overall Study|Other (unspecified)|0|||
148932706|NCT02448810|537238710|FG003|Overall Study|Other (unspecified)|0|||
148932707|NCT02448810|537238711|FG004|Overall Study|Other (unspecified)|0|||
148932708|NCT02448810|537238712|FG005|Overall Study|Other (unspecified)|0|||
148932709|NCT02448810|537238713|FG006|Overall Study|Other (unspecified)|2|||
149014070|NCT04524598|537530872|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
149014071|NCT04524598|537530873|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
149014072|NCT04524598|537530874|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
149183209|NCT00367640|538141882|FG003|Overall Study|Withdrawal by Subject|6|||
149183210|NCT00367640|538141879|FG000|Overall Study|Any other reason not above-mentioned|7|||
149183211|NCT00367640|538141880|FG001|Overall Study|Any other reason not above-mentioned|5|||
149183212|NCT00367640|538141881|FG002|Overall Study|Any other reason not above-mentioned|3|||
149183213|NCT00367640|538141882|FG003|Overall Study|Any other reason not above-mentioned|4|||
149183214|NCT04504032|538141883|FG000|Overall Study|Adverse Event|1|||
149183215|NCT04504032|538141884|FG001|Overall Study|Adverse Event|2|||
149183216|NCT04504032|538141883|FG000|Overall Study|Lost to Follow-up|6|||
149183217|NCT04504032|538141884|FG001|Overall Study|Lost to Follow-up|9|||
149183218|NCT04504032|538141883|FG000|Overall Study|Protocol Violation|2|||
149183219|NCT04504032|538141884|FG001|Overall Study|Protocol Violation|0|||
149183220|NCT04504032|538141883|FG000|Overall Study|Study terminated by sponsor|1|||
149183221|NCT04504032|538141884|FG001|Overall Study|Study terminated by sponsor|2|||
149183222|NCT04504032|538141883|FG000|Overall Study|Withdrawal by Subject|9|||
149183223|NCT04504032|538141884|FG001|Overall Study|Withdrawal by Subject|11|||
149183224|NCT04504032|538141883|FG000|Overall Study|Disease progression prior to dosing|15|||
149183225|NCT04504032|538141884|FG001|Overall Study|Disease progression prior to dosing|3|||
149183226|NCT04504032|538141883|FG000|Overall Study|Drug supply issues|1|||
149183227|NCT04504032|538141884|FG001|Overall Study|Drug supply issues|1|||
149014073|NCT04524598|537530875|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
148932710|NCT02448810|537238714|FG007|Overall Study|Other (unspecified)|0|||
148932711|NCT00568685|537238722|FG000|Overall Study|Adverse Event|2|||
148932712|NCT00568685|537238723|FG001|Overall Study|Adverse Event|3|||
148932713|NCT00568685|537238724|FG002|Overall Study|Adverse Event|3|||
148932714|NCT00568685|537238722|FG000|Overall Study|Withdrawal by Subject|7|||
148932715|NCT00568685|537238723|FG001|Overall Study|Withdrawal by Subject|2|||
148932716|NCT00568685|537238724|FG002|Overall Study|Withdrawal by Subject|2|||
148932717|NCT00568685|537238722|FG000|Overall Study|Protocol Violation|1|||
148932718|NCT00568685|537238723|FG001|Overall Study|Protocol Violation|0|||
148932719|NCT00568685|537238724|FG002|Overall Study|Protocol Violation|0|||
148932720|NCT01638819|537238727|FG000|Overall Study|Lost to Follow-up|1|||
148932721|NCT01638819|537238728|FG001|Overall Study|Lost to Follow-up|0|||
148932722|NCT00471146|537238731|FG000|Overall Study|Adverse Event|32|||
148932723|NCT00471146|537238732|FG001|Overall Study|Adverse Event|33|||
148932724|NCT00471146|537238731|FG000|Overall Study|Withdrawal by Subject|14|||
148932725|NCT00471146|537238732|FG001|Overall Study|Withdrawal by Subject|11|||
148932726|NCT00471146|537238731|FG000|Overall Study|Death|11|||
148932727|NCT00471146|537238732|FG001|Overall Study|Death|12|||
148932728|NCT00471146|537238731|FG000|Overall Study|Lost to Follow-up|4|||
148932729|NCT00471146|537238732|FG001|Overall Study|Lost to Follow-up|2|||
148932730|NCT00471146|537238731|FG000|Overall Study|Protocol Violation|2|||
148932731|NCT00471146|537238732|FG001|Overall Study|Protocol Violation|2|||
148932732|NCT00471146|537238731|FG000|Overall Study|Objective progression or relapse|84|||
148932733|NCT00471146|537238732|FG001|Overall Study|Objective progression or relapse|87|||
148932734|NCT00471146|537238731|FG000|Overall Study|Global deterioration of health status|12|||
148932735|NCT00471146|537238732|FG001|Overall Study|Global deterioration of health status|14|||
148932736|NCT00471146|537238731|FG000|Overall Study|Randomized but not treated|9|||
148932737|NCT00471146|537238732|FG001|Overall Study|Randomized but not treated|8|||
148932738|NCT00471146|537238731|FG000|Overall Study|Other|4|||
148932739|NCT00471146|537238732|FG001|Overall Study|Other|5|||
148932740|NCT03538431|537238733|FG000|Overall Study|Physician Decision|0|||
148932741|NCT03538431|537238734|FG001|Overall Study|Physician Decision|1|||
148932742|NCT03538431|537238733|FG000|Overall Study|Withdrawal by Subject|1|||
148932743|NCT03538431|537238734|FG001|Overall Study|Withdrawal by Subject|0|||
148932744|NCT00467610|537238737|FG000|Overall Study|Withdrawal by Subject|1|||
148932745|NCT02001181|537238740|FG000|Overall Study|Adverse Event|0|||
148932746|NCT02001181|537238741|FG001|Overall Study|Adverse Event|2|||
148932747|NCT02001181|537238740|FG000|Overall Study|Lost to Follow-up|1|||
148932748|NCT02001181|537238741|FG001|Overall Study|Lost to Follow-up|0|||
148932749|NCT02001181|537238740|FG000|Overall Study|Withdrawal by Subject|0|||
148932750|NCT02001181|537238741|FG001|Overall Study|Withdrawal by Subject|1|||
148932751|NCT03643159|537238750|FG000|Overall Study|Adverse Event|1|||
148932752|NCT03643159|537238750|FG000|Overall Study|Withdrawal by Subject|1|||
148932753|NCT03438383|537238751|FG000|Overall Study|Protocol Violation|9|||
148932754|NCT03438383|537238752|FG001|Overall Study|Protocol Violation|3|||
148932755|NCT01528033|537238753|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
148932756|NCT01528033|537238754|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
148932757|NCT01528033|537238753|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
148932758|NCT01528033|537238754|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
148932759|NCT01528033|537238753|FG000|Primary Endpoint Assessment ITT|Death|2|||
149014074|NCT04524598|537530876|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
149014075|NCT04524598|537530872|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014076|NCT04524598|537530873|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
149183228|NCT04504032|538141883|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
149183229|NCT04504032|538141884|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
149183230|NCT00771030|538141885|FG000|Overall Study|Adverse Event|0|||
149183231|NCT00771030|538141886|FG001|Overall Study|Adverse Event|1|||
149183232|NCT00771030|538141887|FG002|Overall Study|Adverse Event|0|||
149183233|NCT00771030|538141888|FG003|Overall Study|Adverse Event|0|||
149183234|NCT00771030|538141889|FG004|Overall Study|Adverse Event|0|||
149183235|NCT00771030|538141890|FG005|Overall Study|Adverse Event|0|||
149183236|NCT00771030|538141891|FG006|Overall Study|Adverse Event|0|||
149183237|NCT01839188|538141892|FG000|Overall Study|Withdrawal by Subject|1|||
149183238|NCT04983901|538141893|FG000|Overall Study|Death|1|||
149183239|NCT04983901|538141894|FG001|Overall Study|Death|4|||
148932760|NCT01528033|537238754|FG001|Primary Endpoint Assessment ITT|Death|2|||
148932761|NCT01528033|537238753|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
148932762|NCT01528033|537238754|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
149183240|NCT04983901|538141893|FG000|Overall Study|Lost to Follow-up|3|||
149183241|NCT04983901|538141894|FG001|Overall Study|Lost to Follow-up|0|||
149183242|NCT04983901|538141893|FG000|Overall Study|Protocol Violation|1|||
148932763|NCT01528033|537238753|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
148932764|NCT01528033|537238754|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
148932765|NCT01528033|537238753|FG000|Follow Up|No data available|46|||
148932766|NCT01528033|537238754|FG001|Follow Up|No data available|44|||
148932767|NCT02898116|537238759|FG000|Overall Study|Adverse Event|1|||
148932768|NCT02898116|537238759|FG000|Overall Study|Progressive disease|1|||
148932769|NCT03635788|537238760|FG000|Step 1|Death|1|||
148932770|NCT03635788|537238761|FG001|Step 1|Death|0|||
148932771|NCT03635788|537238762|FG002|Step 1|Death|0|||
148932772|NCT03635788|537238760|FG000|Step 1|Lost to Follow-up|31|||
148932773|NCT03635788|537238761|FG001|Step 1|Lost to Follow-up|0|||
148932774|NCT03635788|537238762|FG002|Step 1|Lost to Follow-up|0|||
148932775|NCT03635788|537238760|FG000|Step 1|Pregnancy|1|||
148932776|NCT03635788|537238761|FG001|Step 1|Pregnancy|0|||
148932777|NCT03635788|537238762|FG002|Step 1|Pregnancy|0|||
148932778|NCT03635788|537238760|FG000|Step 1|Protocol Violation|8|||
148932779|NCT03635788|537238761|FG001|Step 1|Protocol Violation|0|||
148932780|NCT03635788|537238762|FG002|Step 1|Protocol Violation|0|||
148932781|NCT03635788|537238760|FG000|Step 1|Withdrawal by Subject|13|||
148932782|NCT03635788|537238761|FG001|Step 1|Withdrawal by Subject|0|||
148932783|NCT03635788|537238762|FG002|Step 1|Withdrawal by Subject|0|||
148932784|NCT03635788|537238760|FG000|Step 1|Other reasons|12|||
148932785|NCT03635788|537238761|FG001|Step 1|Other reasons|0|||
149183243|NCT04983901|538141894|FG001|Overall Study|Protocol Violation|0|||
149183244|NCT04983901|538141893|FG000|Overall Study|Withdrawal by Subject|1|||
149183245|NCT04983901|538141894|FG001|Overall Study|Withdrawal by Subject|2|||
149183246|NCT02805907|538141895|FG000|Overall Study|Lost to Follow-up|3|||
149183247|NCT02805907|538141896|FG001|Overall Study|Lost to Follow-up|3|||
149183248|NCT02416908|538141903|FG000|Dose Escalation Phase|Adverse Event|0|||
149183249|NCT02416908|538141904|FG001|Dose Escalation Phase|Adverse Event|0|||
149183250|NCT02416908|538141905|FG002|Dose Escalation Phase|Adverse Event|3|||
149183251|NCT02416908|538141906|FG003|Dose Escalation Phase|Adverse Event|0|||
149183252|NCT02416908|538141903|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
149183253|NCT02416908|538141904|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
149183254|NCT02416908|538141905|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
149183255|NCT02416908|538141906|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149183256|NCT03792750|538141908|FG000|Overall Study|Death|3|||
149183257|NCT01651052|538141909|FG000|Overall Study|Death|21|||
149183258|NCT01651052|538141909|FG000|Overall Study|Explant|1|||
149183259|NCT01651052|538141909|FG000|Overall Study|Withdrawal by Subject|1|||
149183260|NCT01651052|538141909|FG000|Overall Study|Lost to Follow-up|3|||
149183261|NCT04983940|538141910|FG000|Overall Study|Lost to Follow-up|14|||
149183262|NCT04983940|538141910|FG000|Overall Study|Lack of Efficacy|2|||
149183263|NCT04156646|538141911|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
149183264|NCT04156646|538141912|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
149183265|NCT00638846|538141919|FG000|Overall Study|Adverse Event|0|||
149183266|NCT00638846|538141920|FG001|Overall Study|Adverse Event|1|||
149183267|NCT00638846|538141919|FG000|Overall Study|Lost to Follow-up|3|||
149183268|NCT00638846|538141920|FG001|Overall Study|Lost to Follow-up|2|||
149183269|NCT00638846|538141919|FG000|Overall Study|lens issue|1|||
149183270|NCT00638846|538141920|FG001|Overall Study|lens issue|3|||
149183271|NCT00734929|538141921|FG000|Overall Study|Lost to Follow-up|1|||
149183272|NCT00734929|538141922|FG001|Overall Study|Lost to Follow-up|2|||
149183273|NCT00734929|538141921|FG000|Overall Study|No intervention/ screen fail|5|||
149183274|NCT00734929|538141922|FG001|Overall Study|No intervention/ screen fail|3|||
149183275|NCT03176966|538141923|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
149183276|NCT03176966|538141924|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
149183277|NCT03176966|538141923|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
149183278|NCT03176966|538141924|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
149183279|NCT03176966|538141923|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
149183280|NCT03176966|538141924|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
149183281|NCT03176966|538141923|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
148932786|NCT03635788|537238762|FG002|Step 1|Other reasons|0|||
148932787|NCT03635788|537238760|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
149183282|NCT03176966|538141924|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
149183283|NCT03176966|538141923|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
149183284|NCT03176966|538141924|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
148932788|NCT03635788|537238761|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
149183285|NCT03176966|538141923|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
149183286|NCT03176966|538141924|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
149183287|NCT03176966|538141923|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
148932789|NCT03635788|537238762|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
148932790|NCT03635788|537238760|FG000|Step 2|Lost to Follow-up|0|||
148932791|NCT03635788|537238761|FG001|Step 2|Lost to Follow-up|8|||
148932792|NCT03635788|537238762|FG002|Step 2|Lost to Follow-up|15|||
148932793|NCT03635788|537238760|FG000|Step 2|Withdrawal by Subject|0|||
148932794|NCT03635788|537238761|FG001|Step 2|Withdrawal by Subject|6|||
149183288|NCT03176966|538141924|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
149183289|NCT01520922|538141928|FG000|Treatment Phase|Physician Decision|2|||
149183290|NCT01520922|538141929|FG001|Treatment Phase|Physician Decision|1|||
149183291|NCT01520922|538141928|FG000|Treatment Phase|Progression|0|||
149183292|NCT01520922|538141929|FG001|Treatment Phase|Progression|2|||
149183293|NCT01520922|538141928|FG000|Treatment Phase|Adverse Event|3|||
149183294|NCT01520922|538141929|FG001|Treatment Phase|Adverse Event|5|||
149183295|NCT01520922|538141928|FG000|Follow up|Lost to Follow-up|0|||
149183296|NCT01520922|538141929|FG001|Follow up|Lost to Follow-up|1|||
149183297|NCT01520922|538141928|FG000|Survival Follow-up|Withdrawal by Subject|1|||
149183298|NCT01520922|538141929|FG001|Survival Follow-up|Withdrawal by Subject|0|||
149183299|NCT02269319|538141932|FG000|Overall Study|Lost to Follow-up|4|||
149183300|NCT02269319|538141933|FG001|Overall Study|Lost to Follow-up|3|||
149183301|NCT02269319|538141932|FG000|Overall Study|Adverse Event|0|||
149183302|NCT02269319|538141933|FG001|Overall Study|Adverse Event|1|||
149183303|NCT02269319|538141932|FG000|Overall Study|Instructions not followed|1|||
149183304|NCT02269319|538141933|FG001|Overall Study|Instructions not followed|0|||
149183305|NCT03314519|538143388|FG000|Overall Study|Protocol Violation|3|||
149183306|NCT03314519|538143389|FG001|Overall Study|Protocol Violation|2|||
149183307|NCT01912872|538143390|FG000|Overall Study|Lost to Follow-up|2|||
149183308|NCT01912872|538143391|FG001|Overall Study|Lost to Follow-up|3|||
149183309|NCT01912872|538143392|FG002|Overall Study|Lost to Follow-up|5|||
149183310|NCT01912872|538143393|FG003|Overall Study|Lost to Follow-up|5|||
149183311|NCT01912872|538143390|FG000|Overall Study|Other unspecified|3|||
149183312|NCT01912872|538143391|FG001|Overall Study|Other unspecified|1|||
149183313|NCT01912872|538143392|FG002|Overall Study|Other unspecified|3|||
149183314|NCT01912872|538143393|FG003|Overall Study|Other unspecified|0|||
149183315|NCT01912872|538143390|FG000|Overall Study|Informed consent withdrawn|0|||
149183316|NCT01912872|538143391|FG001|Overall Study|Informed consent withdrawn|0|||
149183317|NCT01912872|538143392|FG002|Overall Study|Informed consent withdrawn|1|||
149183318|NCT01912872|538143393|FG003|Overall Study|Informed consent withdrawn|1|||
149183319|NCT01912872|538143390|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
149183320|NCT01912872|538143391|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
149183321|NCT01912872|538143392|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
149183322|NCT01912872|538143393|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
149183323|NCT01912872|538143390|FG000|Overall Study|Protocol Violation|0|||
149183324|NCT01912872|538143391|FG001|Overall Study|Protocol Violation|0|||
149183325|NCT01912872|538143392|FG002|Overall Study|Protocol Violation|1|||
149183326|NCT01912872|538143393|FG003|Overall Study|Protocol Violation|0|||
149183327|NCT01912872|538143390|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149183328|NCT01912872|538143391|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149183329|NCT01912872|538143392|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149183330|NCT01912872|538143393|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
149183331|NCT01912872|538143390|FG000|Overall Study|Withdrawal of study medication|0|||
149183332|NCT01912872|538143391|FG001|Overall Study|Withdrawal of study medication|0|||
149183333|NCT01912872|538143392|FG002|Overall Study|Withdrawal of study medication|0|||
149183334|NCT01912872|538143393|FG003|Overall Study|Withdrawal of study medication|2|||
149183335|NCT01912872|538143390|FG000|Overall Study|Missing|0|||
149183336|NCT01912872|538143391|FG001|Overall Study|Missing|0|||
149183337|NCT01912872|538143392|FG002|Overall Study|Missing|0|||
149014077|NCT04524598|537530874|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014078|NCT04524598|537530875|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
149014079|NCT04524598|537530876|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
149014080|NCT01351025|537530877|FG000|Week 0 - 20|Lost to Follow-up|2|||
149014081|NCT01351025|537530878|FG001|Week 0 - 20|Lost to Follow-up|1|||
149014082|NCT01351025|537530877|FG000|Week 0 - 20|Withdrawal by Subject|1|||
149014083|NCT01351025|537530878|FG001|Week 0 - 20|Withdrawal by Subject|0|||
149014084|NCT01351025|537530877|FG000|Week 24 - 44|Lost to Follow-up|0|||
149014085|NCT01351025|537530878|FG001|Week 24 - 44|Lost to Follow-up|2|||
149014086|NCT01351025|537530877|FG000|Week 24 - 44|Site closed|0|||
149014087|NCT01351025|537530878|FG001|Week 24 - 44|Site closed|1|||
149183338|NCT01912872|538143393|FG003|Overall Study|Missing|1|||
149183339|NCT03042611|538143394|FG000|Core Phase|Withdrawal by Subject|13|||
149183340|NCT03042611|538143395|FG001|Core Phase|Withdrawal by Subject|4|||
149183341|NCT03042611|538143396|FG002|Core Phase|Withdrawal by Subject|0|||
149183342|NCT03042611|538143397|FG003|Core Phase|Withdrawal by Subject|0|||
149014088|NCT01351025|537530877|FG000|Week 24 - 44|unable to get to clinic|1|||
149014089|NCT01351025|537530878|FG001|Week 24 - 44|unable to get to clinic|1|||
149183343|NCT03042611|538143394|FG000|Core Phase|Death|232|||
149183344|NCT03042611|538143395|FG001|Core Phase|Death|110|||
149183345|NCT03042611|538143396|FG002|Core Phase|Death|0|||
149183346|NCT03042611|538143397|FG003|Core Phase|Death|0|||
149183347|NCT03042611|538143394|FG000|Core Phase|Lost to Follow-up|4|||
149183348|NCT03042611|538143395|FG001|Core Phase|Lost to Follow-up|7|||
149183349|NCT03042611|538143396|FG002|Core Phase|Lost to Follow-up|0|||
149183350|NCT03042611|538143397|FG003|Core Phase|Lost to Follow-up|0|||
148932795|NCT03635788|537238762|FG002|Step 2|Withdrawal by Subject|6|||
149183351|NCT03042611|538143394|FG000|Core Phase|Physician Decision|7|||
149183352|NCT03042611|538143395|FG001|Core Phase|Physician Decision|2|||
149183353|NCT03042611|538143396|FG002|Core Phase|Physician Decision|0|||
149183354|NCT03042611|538143397|FG003|Core Phase|Physician Decision|0|||
149183355|NCT03042611|538143394|FG000|Core Phase|Study Closed|0|||
149183356|NCT03042611|538143395|FG001|Core Phase|Study Closed|1|||
149183357|NCT03042611|538143396|FG002|Core Phase|Study Closed|0|||
149183358|NCT03042611|538143397|FG003|Core Phase|Study Closed|0|||
149183359|NCT03042611|538143394|FG000|Extension Phase|Death|0|||
149183360|NCT03042611|538143395|FG001|Extension Phase|Death|0|||
149183361|NCT03042611|538143396|FG002|Extension Phase|Death|34|||
149183362|NCT03042611|538143397|FG003|Extension Phase|Death|16|||
149183363|NCT03042611|538143394|FG000|Extension Phase|Lost to Follow-up|0|||
149183364|NCT03042611|538143395|FG001|Extension Phase|Lost to Follow-up|0|||
149183365|NCT03042611|538143396|FG002|Extension Phase|Lost to Follow-up|1|||
149183366|NCT03042611|538143397|FG003|Extension Phase|Lost to Follow-up|1|||
149183367|NCT03042611|538143394|FG000|Extension Phase|Study Closed|0|||
149183368|NCT03042611|538143395|FG001|Extension Phase|Study Closed|0|||
149183369|NCT03042611|538143396|FG002|Extension Phase|Study Closed|17|||
149183370|NCT03042611|538143397|FG003|Extension Phase|Study Closed|11|||
149183371|NCT02241512|538143403|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
149183372|NCT02241512|538143404|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
149183373|NCT04275310|538143405|FG000|Overall Study|Non-randomized due to running out of funding|4|||
149183374|NCT04275310|538143406|FG001|Overall Study|Non-randomized due to running out of funding|0|||
149183375|NCT02345161|538143409|FG000|Overall Study|Withdrawal by Subject|25|||
149183376|NCT02345161|538143410|FG001|Overall Study|Withdrawal by Subject|33|||
149183377|NCT02345161|538143409|FG000|Overall Study|Adverse Event|16|||
149183378|NCT02345161|538143410|FG001|Overall Study|Adverse Event|19|||
149183379|NCT02345161|538143409|FG000|Overall Study|Physician Decision|4|||
149183380|NCT02345161|538143410|FG001|Overall Study|Physician Decision|4|||
149183381|NCT02345161|538143409|FG000|Overall Study|Lost to Follow-up|0|||
149183382|NCT02345161|538143410|FG001|Overall Study|Lost to Follow-up|1|||
149183383|NCT03554005|538143420|FG000|Overall Study|Not in participant's best interest|0|||
149183384|NCT03554005|538143421|FG001|Overall Study|Not in participant's best interest|0|||
149183385|NCT03554005|538143422|FG002|Overall Study|Not in participant's best interest|0|||
149183386|NCT03554005|538143423|FG003|Overall Study|Not in participant's best interest|0|||
149183387|NCT03554005|538143424|FG004|Overall Study|Not in participant's best interest|0|||
149183388|NCT03554005|538143425|FG005|Overall Study|Not in participant's best interest|1|||
149183389|NCT03554005|538143420|FG000|Overall Study|Disease Progression|1|||
149183390|NCT03554005|538143421|FG001|Overall Study|Disease Progression|1|||
149183391|NCT03554005|538143422|FG002|Overall Study|Disease Progression|1|||
149183392|NCT03554005|538143423|FG003|Overall Study|Disease Progression|1|||
149183393|NCT03554005|538143424|FG004|Overall Study|Disease Progression|5|||
149183394|NCT03554005|538143425|FG005|Overall Study|Disease Progression|6|||
149183395|NCT03554005|538143420|FG000|Overall Study|Adverse Event|0|||
149183396|NCT03554005|538143421|FG001|Overall Study|Adverse Event|0|||
149183397|NCT03554005|538143422|FG002|Overall Study|Adverse Event|0|||
149183398|NCT03554005|538143423|FG003|Overall Study|Adverse Event|0|||
149183399|NCT03554005|538143424|FG004|Overall Study|Adverse Event|0|||
149183400|NCT03554005|538143425|FG005|Overall Study|Adverse Event|3|||
149183401|NCT03554005|538143420|FG000|Overall Study|Physician Decision|0|||
149183402|NCT03554005|538143421|FG001|Overall Study|Physician Decision|0|||
149183403|NCT03554005|538143422|FG002|Overall Study|Physician Decision|0|||
149183404|NCT03554005|538143423|FG003|Overall Study|Physician Decision|0|||
149183405|NCT03554005|538143424|FG004|Overall Study|Physician Decision|1|||
149183406|NCT03554005|538143425|FG005|Overall Study|Physician Decision|0|||
149183407|NCT03554005|538143420|FG000|Overall Study|Other|0|||
149183408|NCT03554005|538143421|FG001|Overall Study|Other|0|||
149183409|NCT03554005|538143422|FG002|Overall Study|Other|0|||
149183410|NCT03554005|538143423|FG003|Overall Study|Other|0|||
149183411|NCT03554005|538143424|FG004|Overall Study|Other|0|||
149183412|NCT03554005|538143425|FG005|Overall Study|Other|1|||
149183413|NCT00631488|538143429|FG000|Overall Study|Adverse Event|1|||
149183414|NCT00631488|538143430|FG001|Overall Study|Adverse Event|0|||
149183415|NCT00631488|538143431|FG002|Overall Study|Adverse Event|0|||
149183416|NCT00631488|538143429|FG000|Overall Study|Lost to Follow-up|2|||
149183417|NCT00631488|538143430|FG001|Overall Study|Lost to Follow-up|2|||
149183418|NCT00631488|538143431|FG002|Overall Study|Lost to Follow-up|0|||
149183419|NCT00631488|538143429|FG000|Overall Study|Physician Decision|1|||
149183420|NCT00631488|538143430|FG001|Overall Study|Physician Decision|0|||
149183421|NCT00631488|538143431|FG002|Overall Study|Physician Decision|1|||
148932796|NCT03635788|537238760|FG000|Step 2|Death|0|||
149183422|NCT00631488|538143429|FG000|Overall Study|Protocol Violation|0|||
149183423|NCT00631488|538143430|FG001|Overall Study|Protocol Violation|0|||
149183424|NCT00631488|538143431|FG002|Overall Study|Protocol Violation|1|||
148679670|NCT02164539|536300856|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
148679671|NCT02164539|536300857|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
148679672|NCT02164539|536300858|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
148679673|NCT02164539|536300859|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
148679674|NCT02164539|536300860|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
148932797|NCT03635788|537238761|FG001|Step 2|Death|2|||
148932798|NCT03635788|537238762|FG002|Step 2|Death|0|||
148932799|NCT03635788|537238760|FG000|Step 2|Incarceration|0|||
148932800|NCT03635788|537238761|FG001|Step 2|Incarceration|2|||
148932801|NCT03635788|537238762|FG002|Step 2|Incarceration|0|||
148932802|NCT03635788|537238760|FG000|Step 2|Non-Compliance With Study Requirements|0|||
148932803|NCT03635788|537238761|FG001|Step 2|Non-Compliance With Study Requirements|1|||
148932804|NCT03635788|537238762|FG002|Step 2|Non-Compliance With Study Requirements|1|||
148932805|NCT03635788|537238760|FG000|Step 2|Confounding Medical Condition|0|||
148932806|NCT03635788|537238761|FG001|Step 2|Confounding Medical Condition|0|||
148932807|NCT03635788|537238762|FG002|Step 2|Confounding Medical Condition|1|||
148932808|NCT03635788|537238760|FG000|Step 2|Out Of State With No Plan To Return|0|||
148932809|NCT03635788|537238761|FG001|Step 2|Out Of State With No Plan To Return|1|||
148932810|NCT03635788|537238762|FG002|Step 2|Out Of State With No Plan To Return|0|||
148932811|NCT03635788|537238760|FG000|Step 2|Switched To Injectables|0|||
148932812|NCT03635788|537238761|FG001|Step 2|Switched To Injectables|0|||
148932813|NCT03635788|537238762|FG002|Step 2|Switched To Injectables|1|||
148932814|NCT03635788|537238760|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
148932815|NCT03635788|537238761|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
148932816|NCT03635788|537238762|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
148932817|NCT01015131|537238763|FG000|Overall Study|Physician Decision|1|||
148932818|NCT01015131|537238763|FG000|Overall Study|Protocol Violation|1|||
148932819|NCT01015131|537238763|FG000|Overall Study|Withdrawal by Subject|2|||
148932820|NCT01015131|537238763|FG000|Overall Study|Other Protocol Specified Criteria|4|||
148932821|NCT05521906|537238764|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
148932822|NCT05521906|537238765|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
148932823|NCT00492050|537238766|FG000|Overall Study|Adverse Event|1|||
148932824|NCT00492050|537238766|FG000|Overall Study|Lack of Efficacy|1|||
148932825|NCT00492050|537238766|FG000|Overall Study|Withdrawal by Subject|3|||
148932826|NCT00492050|537238766|FG000|Overall Study|Unable to collect SCT|2|||
148932827|NCT00492050|537238766|FG000|Overall Study|Progressive Disease|2|||
148932828|NCT00866788|537240112|FG000|Overall Study|Adverse Event|0|||
148932829|NCT00866788|537240113|FG001|Overall Study|Adverse Event|2|||
148932830|NCT00866788|537240114|FG002|Overall Study|Adverse Event|0|||
148932831|NCT00866788|537240115|FG003|Overall Study|Adverse Event|1|||
148932832|NCT00866788|537240112|FG000|Overall Study|Lost to Follow-up|1|||
148932833|NCT00866788|537240113|FG001|Overall Study|Lost to Follow-up|1|||
148932834|NCT00866788|537240114|FG002|Overall Study|Lost to Follow-up|0|||
148932835|NCT00866788|537240115|FG003|Overall Study|Lost to Follow-up|2|||
148932836|NCT00866788|537240112|FG000|Overall Study|Withdrawal by Subject|2|||
148932837|NCT00866788|537240113|FG001|Overall Study|Withdrawal by Subject|1|||
148932838|NCT00866788|537240114|FG002|Overall Study|Withdrawal by Subject|0|||
148932839|NCT00866788|537240115|FG003|Overall Study|Withdrawal by Subject|1|||
148932840|NCT00866788|537240112|FG000|Overall Study|Pregnancy|0|||
148932841|NCT00866788|537240113|FG001|Overall Study|Pregnancy|1|||
148932842|NCT00866788|537240114|FG002|Overall Study|Pregnancy|0|||
148932843|NCT00866788|537240115|FG003|Overall Study|Pregnancy|0|||
148932844|NCT00866788|537240112|FG000|Overall Study|Disease progression|3|||
148932845|NCT00866788|537240113|FG001|Overall Study|Disease progression|1|||
149014090|NCT05067933|537530882|FG000|Overall Study|Withdrawal by Subject|2|||
149014091|NCT05067933|537530883|FG001|Overall Study|Withdrawal by Subject|0|||
149014092|NCT05067933|537530884|FG002|Overall Study|Withdrawal by Subject|0|||
149014093|NCT05067933|537530885|FG003|Overall Study|Withdrawal by Subject|0|||
149014094|NCT05067933|537530886|FG004|Overall Study|Withdrawal by Subject|0|||
149014095|NCT05067933|537530887|FG005|Overall Study|Withdrawal by Subject|0|||
149014096|NCT05067933|537530882|FG000|Overall Study|Lost to Follow-up|1|||
149014097|NCT05067933|537530883|FG001|Overall Study|Lost to Follow-up|1|||
149014098|NCT05067933|537530884|FG002|Overall Study|Lost to Follow-up|1|||
149014099|NCT05067933|537530885|FG003|Overall Study|Lost to Follow-up|2|||
149014100|NCT05067933|537530886|FG004|Overall Study|Lost to Follow-up|1|||
149014101|NCT05067933|537530887|FG005|Overall Study|Lost to Follow-up|0|||
149014102|NCT05067933|537530882|FG000|Overall Study|Miscellaneous|1|||
149014103|NCT05067933|537530883|FG001|Overall Study|Miscellaneous|0|||
149014104|NCT05067933|537530884|FG002|Overall Study|Miscellaneous|0|||
149014105|NCT05067933|537530885|FG003|Overall Study|Miscellaneous|0|||
149014106|NCT05067933|537530886|FG004|Overall Study|Miscellaneous|0|||
149014107|NCT05067933|537530887|FG005|Overall Study|Miscellaneous|0|||
149014108|NCT05067933|537530882|FG000|Overall Study|Death|0|||
149014109|NCT05067933|537530883|FG001|Overall Study|Death|0|||
149014110|NCT05067933|537530884|FG002|Overall Study|Death|0|||
148932846|NCT00866788|537240114|FG002|Overall Study|Disease progression|1|||
148932847|NCT00866788|537240115|FG003|Overall Study|Disease progression|0|||
148932848|NCT00866788|537240112|FG000|Overall Study|Physician Decision|0|||
148932849|NCT00866788|537240113|FG001|Overall Study|Physician Decision|0|||
148932850|NCT00866788|537240114|FG002|Overall Study|Physician Decision|1|||
148932851|NCT00866788|537240115|FG003|Overall Study|Physician Decision|1|||
148932852|NCT02339285|537240116|FG000|Overall Study|Withdrawal by Subject|0|||
148932853|NCT02339285|537240117|FG001|Overall Study|Withdrawal by Subject|1|||
148932854|NCT02339285|537240118|FG002|Overall Study|Withdrawal by Subject|1|||
148932855|NCT02339285|537240116|FG000|Overall Study|Lost to Follow-up|1|||
148932856|NCT02339285|537240117|FG001|Overall Study|Lost to Follow-up|1|||
148932857|NCT02339285|537240118|FG002|Overall Study|Lost to Follow-up|1|||
148932858|NCT02339285|537240116|FG000|Overall Study|Protocol Deviation|0|||
148932859|NCT02339285|537240117|FG001|Overall Study|Protocol Deviation|1|||
148932860|NCT02339285|537240118|FG002|Overall Study|Protocol Deviation|0|||
148932861|NCT00282412|537240121|FG000|Overall Study|Death|2|||
148932862|NCT00537238|537240122|FG000|Overall Study|Death|1|||
148932863|NCT00537238|537240123|FG001|Overall Study|Death|2|||
148932864|NCT00537238|537240122|FG000|Overall Study|Adverse Event|31|||
148932865|NCT00537238|537240123|FG001|Overall Study|Adverse Event|22|||
148932866|NCT00537238|537240122|FG000|Overall Study|Lack of Efficacy|20|||
148932867|NCT00537238|537240123|FG001|Overall Study|Lack of Efficacy|21|||
148932868|NCT00537238|537240122|FG000|Overall Study|Lost to Follow-up|12|||
148932869|NCT00537238|537240123|FG001|Overall Study|Lost to Follow-up|8|||
149014111|NCT05067933|537530885|FG003|Overall Study|Death|1|||
149014112|NCT05067933|537530886|FG004|Overall Study|Death|0|||
149014113|NCT05067933|537530887|FG005|Overall Study|Death|0|||
149014114|NCT00621296|537530896|FG000|Overall Study|Adverse Event|2|||
149183425|NCT03648476|538143433|FG000|Overall Study|Withdrawal by Subject|2|||
149183426|NCT03648476|538143434|FG001|Overall Study|Withdrawal by Subject|1|||
148932870|NCT00537238|537240122|FG000|Overall Study|Withdrawal by Subject|51|||
148932871|NCT00537238|537240123|FG001|Overall Study|Withdrawal by Subject|47|||
148932872|NCT00537238|537240122|FG000|Overall Study|Protocol Violation|15|||
148932873|NCT00537238|537240123|FG001|Overall Study|Protocol Violation|19|||
148932874|NCT00537238|537240122|FG000|Overall Study|Does not meet entrance criteria|0|||
149183427|NCT02855411|538143435|FG000|Overall Study|Study terminated by sponsor|21|||
148932875|NCT00537238|537240123|FG001|Overall Study|Does not meet entrance criteria|2|||
148932876|NCT00537238|537240122|FG000|Overall Study|Other|44|||
148932877|NCT00537238|537240123|FG001|Overall Study|Other|52|||
148932878|NCT01854658|537240124|FG000|Overall Study|Protocol Violation|6|||
148932879|NCT01854658|537240125|FG001|Overall Study|Protocol Violation|2|||
148932880|NCT01854658|537240126|FG002|Overall Study|Protocol Violation|2|||
149014115|NCT00621296|537530896|FG000|Overall Study|Lack of Efficacy|1|||
149014116|NCT00621296|537530896|FG000|Overall Study|Physician Decision|7|||
149014117|NCT00621296|537530896|FG000|Overall Study|Unmatch Criteria|1|||
149014118|NCT00621296|537530896|FG000|Overall Study|Stopping Criteria|3|||
148932881|NCT01854658|537240127|FG003|Overall Study|Protocol Violation|1|||
148932882|NCT01854658|537240124|FG000|Overall Study|Physician Decision|7|||
148932883|NCT01854658|537240125|FG001|Overall Study|Physician Decision|5|||
148932884|NCT01854658|537240126|FG002|Overall Study|Physician Decision|2|||
148932885|NCT01854658|537240127|FG003|Overall Study|Physician Decision|4|||
149014119|NCT00384059|537530898|FG000|Infant Series|Not consented|2|||
149014120|NCT00384059|537530899|FG001|Infant Series|Not consented|6|||
149014121|NCT00384059|537530898|FG000|Infant Series|Withdrawal by Subject|2|||
149014122|NCT00384059|537530899|FG001|Infant Series|Withdrawal by Subject|2|||
149014123|NCT00384059|537530898|FG000|Infant Series|Adverse Event|1|||
149014124|NCT00384059|537530899|FG001|Infant Series|Adverse Event|2|||
149014125|NCT00384059|537530898|FG000|Infant Series|Protocol Violation|1|||
149014126|NCT00384059|537530899|FG001|Infant Series|Protocol Violation|2|||
149014127|NCT00384059|537530898|FG000|Infant Series|Lost to Follow-up|0|||
149014128|NCT00384059|537530899|FG001|Infant Series|Lost to Follow-up|1|||
149014129|NCT00384059|537530898|FG000|After Infant Series|Protocol Violation|2|||
149014130|NCT00384059|537530899|FG001|After Infant Series|Protocol Violation|3|||
149014131|NCT00384059|537530898|FG000|After Infant Series|Withdrawal by Subject|2|||
149014132|NCT00384059|537530899|FG001|After Infant Series|Withdrawal by Subject|2|||
149014133|NCT00384059|537530898|FG000|After Infant Series|Failed to Return|0|||
149014134|NCT00384059|537530899|FG001|After Infant Series|Failed to Return|2|||
149014135|NCT00384059|537530898|FG000|After Infant Series|Adverse Event|0|||
149014136|NCT00384059|537530899|FG001|After Infant Series|Adverse Event|1|||
149014137|NCT00384059|537530898|FG000|After Infant Series|Physician Decision|0|||
149014138|NCT00384059|537530899|FG001|After Infant Series|Physician Decision|1|||
149014139|NCT00384059|537530898|FG000|After Infant Series|Lost to Follow-up|0|||
149014140|NCT00384059|537530899|FG001|After Infant Series|Lost to Follow-up|1|||
149014141|NCT00384059|537530898|FG000|Toddler Dose|Lost to Follow-up|1|||
149014142|NCT00384059|537530899|FG001|Toddler Dose|Lost to Follow-up|1|||
149014143|NCT00384059|537530898|FG000|Toddler Dose|Failed to return|0|||
149014144|NCT00384059|537530899|FG001|Toddler Dose|Failed to return|1|||
149014145|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
149014146|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
149014147|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
149014148|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
149014149|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
149014150|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
149014151|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
149014152|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
149183428|NCT02855411|538143435|FG000|Overall Study|Does not meet entrance criteria|14|||
149183429|NCT02639182|538143436|FG000|Overall Study|Disease Progression|50|||
149183430|NCT02639182|538143437|FG001|Overall Study|Disease Progression|49|||
149183431|NCT02639182|538143436|FG000|Overall Study|Adverse Event|7|||
149183432|NCT02639182|538143437|FG001|Overall Study|Adverse Event|5|||
149183433|NCT02639182|538143436|FG000|Overall Study|Physician Decision|3|||
149183434|NCT02639182|538143437|FG001|Overall Study|Physician Decision|3|||
149183435|NCT02639182|538143436|FG000|Overall Study|Withdrew Consent|5|||
149183436|NCT02639182|538143437|FG001|Overall Study|Withdrew Consent|4|||
149183437|NCT02639182|538143436|FG000|Overall Study|Lost to Follow-up|0|||
149183438|NCT02639182|538143437|FG001|Overall Study|Lost to Follow-up|1|||
149183439|NCT02639182|538143436|FG000|Overall Study|Study Closure|1|||
149183440|NCT02639182|538143437|FG001|Overall Study|Study Closure|2|||
149183441|NCT02639182|538143436|FG000|Overall Study|Sponsor Ended Study|0|||
149183442|NCT02639182|538143437|FG001|Overall Study|Sponsor Ended Study|1|||
149183443|NCT02639182|538143436|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
149183444|NCT02639182|538143437|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
149183445|NCT00907881|538143438|FG000|Overall Study|Lost to Follow-up|59|||
149183446|NCT00907881|538143438|FG000|Overall Study|Noncompliance|5|||
149183447|NCT00907881|538143438|FG000|Overall Study|Withdrawal by Subject|5|||
149183448|NCT00907881|538143438|FG000|Overall Study|Protocol Violation|1|||
149183449|NCT00907881|538143438|FG000|Overall Study|Missing discontinuation information|15|||
149183450|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
149183451|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
149183452|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
149183453|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149183454|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149183455|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149183456|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149014153|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149014154|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149014155|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149014156|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149014157|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149183457|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
149183458|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
149183459|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
149183460|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
149183461|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149014158|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
149014159|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
149014160|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
149014161|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
149014162|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149014163|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149014164|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149014165|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149014166|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
149014167|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
149014168|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
149014169|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
149014170|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
149183462|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149183463|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149183464|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149183465|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
149183466|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
149183467|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
149014171|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
149014172|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
149014173|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149183468|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
149183469|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149183470|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149183471|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149183472|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149183473|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
149183474|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
149183475|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
149183476|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149183477|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149183478|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149183479|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149183480|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149183481|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
149183482|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
149183483|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
149183484|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
149183485|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149183486|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149183487|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149183488|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149183489|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
149183490|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
149183491|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
149183492|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149183493|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149183494|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149183495|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149183496|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149183497|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
149183498|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
149183499|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
149183500|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149014174|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149014175|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
149014176|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149014177|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149014178|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149014179|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
149014180|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
149014181|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
149183501|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149014182|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
149014183|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149183502|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149183503|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149183504|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
148807345|NCT00903968|536773234|FG006|Overall Study|Withdrawal by Subject|0|||
148932886|NCT01854658|537240124|FG000|Overall Study|Lost to Follow-up|8|||
148932887|NCT01854658|537240125|FG001|Overall Study|Lost to Follow-up|9|||
148932888|NCT01854658|537240126|FG002|Overall Study|Lost to Follow-up|8|||
148932889|NCT01854658|537240127|FG003|Overall Study|Lost to Follow-up|4|||
148932890|NCT01854658|537240124|FG000|Overall Study|Withdrawal by Subject|28|||
148932891|NCT01854658|537240125|FG001|Overall Study|Withdrawal by Subject|21|||
148932892|NCT01854658|537240126|FG002|Overall Study|Withdrawal by Subject|29|||
148932893|NCT01854658|537240127|FG003|Overall Study|Withdrawal by Subject|15|||
148932894|NCT01854658|537240124|FG000|Overall Study|Protocol-specified criteria|15|||
148932895|NCT01854658|537240125|FG001|Overall Study|Protocol-specified criteria|15|||
148932896|NCT01854658|537240126|FG002|Overall Study|Protocol-specified criteria|10|||
149183505|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
149183506|NCT01097616|538143443|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183507|NCT01097616|538143444|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183508|NCT01097616|538143445|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
149183509|NCT01097616|538143446|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183510|NCT01097616|538143447|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183511|NCT01097616|538143448|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183512|NCT01097616|538143449|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183513|NCT01097616|538143450|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
149183514|NCT01097616|538143443|FG000|Optional DB EXT Phase|Adverse Event|0|||
149183515|NCT01097616|538143444|FG001|Optional DB EXT Phase|Adverse Event|7|||
149183516|NCT01097616|538143445|FG002|Optional DB EXT Phase|Adverse Event|2|||
149183517|NCT01097616|538143446|FG003|Optional DB EXT Phase|Adverse Event|0|||
148932897|NCT01854658|537240127|FG003|Overall Study|Protocol-specified criteria|7|||
148932898|NCT01854658|537240124|FG000|Overall Study|Lack of Efficacy|3|||
149014184|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149014185|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149183518|NCT01097616|538143447|FG004|Optional DB EXT Phase|Adverse Event|0|||
149183519|NCT01097616|538143448|FG005|Optional DB EXT Phase|Adverse Event|0|||
149183520|NCT01097616|538143449|FG006|Optional DB EXT Phase|Adverse Event|0|||
149183521|NCT01097616|538143450|FG007|Optional DB EXT Phase|Adverse Event|0|||
149183522|NCT01097616|538143443|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
149183523|NCT01097616|538143444|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
149183524|NCT01097616|538143445|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
149183525|NCT01097616|538143446|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
149183526|NCT01097616|538143447|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
149183527|NCT01097616|538143448|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
149183528|NCT01097616|538143449|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
149183529|NCT01097616|538143450|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
149183530|NCT01097616|538143443|FG000|Optional DB EXT Phase|Protocol Violation|0|||
149183531|NCT01097616|538143444|FG001|Optional DB EXT Phase|Protocol Violation|2|||
149183532|NCT01097616|538143445|FG002|Optional DB EXT Phase|Protocol Violation|3|||
149183533|NCT01097616|538143446|FG003|Optional DB EXT Phase|Protocol Violation|0|||
149183534|NCT01097616|538143447|FG004|Optional DB EXT Phase|Protocol Violation|0|||
149183535|NCT01097616|538143448|FG005|Optional DB EXT Phase|Protocol Violation|0|||
149183536|NCT01097616|538143449|FG006|Optional DB EXT Phase|Protocol Violation|0|||
149183537|NCT01097616|538143450|FG007|Optional DB EXT Phase|Protocol Violation|0|||
149183538|NCT01097616|538143443|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
149183539|NCT01097616|538143444|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
149183540|NCT01097616|538143445|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
149183541|NCT01097616|538143446|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
149183542|NCT01097616|538143447|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
149183543|NCT01097616|538143448|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
149183544|NCT01097616|538143449|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
149183545|NCT01097616|538143450|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
149183546|NCT01097616|538143443|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
149183547|NCT01097616|538143444|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
149183548|NCT01097616|538143445|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
149183549|NCT01097616|538143446|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
149183550|NCT01097616|538143447|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
149183551|NCT01097616|538143448|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
149183552|NCT01097616|538143449|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
149183553|NCT01097616|538143450|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
149183554|NCT01097616|538143443|FG000|Optional DB EXT Phase|Physician Decision|1|||
149014186|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149014187|NCT04921969|537530902|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
149014188|NCT04921969|537530903|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
149183555|NCT01097616|538143444|FG001|Optional DB EXT Phase|Physician Decision|0|||
148932899|NCT01854658|537240125|FG001|Overall Study|Lack of Efficacy|8|||
149183556|NCT01097616|538143445|FG002|Optional DB EXT Phase|Physician Decision|0|||
149183557|NCT01097616|538143446|FG003|Optional DB EXT Phase|Physician Decision|0|||
149183558|NCT01097616|538143447|FG004|Optional DB EXT Phase|Physician Decision|0|||
149183559|NCT01097616|538143448|FG005|Optional DB EXT Phase|Physician Decision|0|||
149183560|NCT01097616|538143449|FG006|Optional DB EXT Phase|Physician Decision|0|||
149183561|NCT01097616|538143450|FG007|Optional DB EXT Phase|Physician Decision|0|||
149183562|NCT01097616|538143443|FG000|DB RO Phase|Adverse Event|0|||
149183563|NCT01097616|538143444|FG001|DB RO Phase|Adverse Event|0|||
149183564|NCT01097616|538143445|FG002|DB RO Phase|Adverse Event|0|||
149183565|NCT01097616|538143446|FG003|DB RO Phase|Adverse Event|0|||
149183566|NCT01097616|538143447|FG004|DB RO Phase|Adverse Event|0|||
149183567|NCT01097616|538143448|FG005|DB RO Phase|Adverse Event|0|||
149183568|NCT01097616|538143449|FG006|DB RO Phase|Adverse Event|1|||
149183569|NCT01097616|538143450|FG007|DB RO Phase|Adverse Event|0|||
149183570|NCT01097616|538143443|FG000|DB RO Phase|Withdrawal by Subject|0|||
149183571|NCT01097616|538143444|FG001|DB RO Phase|Withdrawal by Subject|0|||
149183572|NCT01097616|538143445|FG002|DB RO Phase|Withdrawal by Subject|0|||
149183573|NCT01097616|538143446|FG003|DB RO Phase|Withdrawal by Subject|0|||
149183574|NCT01097616|538143447|FG004|DB RO Phase|Withdrawal by Subject|0|||
149183575|NCT01097616|538143448|FG005|DB RO Phase|Withdrawal by Subject|1|||
149183576|NCT01097616|538143449|FG006|DB RO Phase|Withdrawal by Subject|0|||
149183577|NCT01097616|538143450|FG007|DB RO Phase|Withdrawal by Subject|0|||
149183578|NCT01097616|538143443|FG000|DB RO Phase|Lost to Follow-up|0|||
149183579|NCT01097616|538143444|FG001|DB RO Phase|Lost to Follow-up|0|||
149183580|NCT01097616|538143445|FG002|DB RO Phase|Lost to Follow-up|0|||
149183581|NCT01097616|538143446|FG003|DB RO Phase|Lost to Follow-up|1|||
149183582|NCT01097616|538143447|FG004|DB RO Phase|Lost to Follow-up|1|||
149183583|NCT01097616|538143448|FG005|DB RO Phase|Lost to Follow-up|0|||
149183584|NCT01097616|538143449|FG006|DB RO Phase|Lost to Follow-up|0|||
149183585|NCT01097616|538143450|FG007|DB RO Phase|Lost to Follow-up|1|||
149183586|NCT01097616|538143443|FG000|DB RO Phase|Not Treated in RO|0|||
149183587|NCT01097616|538143444|FG001|DB RO Phase|Not Treated in RO|0|||
149183588|NCT01097616|538143445|FG002|DB RO Phase|Not Treated in RO|0|||
149183589|NCT01097616|538143446|FG003|DB RO Phase|Not Treated in RO|0|||
149183590|NCT01097616|538143447|FG004|DB RO Phase|Not Treated in RO|0|||
149183591|NCT01097616|538143448|FG005|DB RO Phase|Not Treated in RO|1|||
149183592|NCT01097616|538143449|FG006|DB RO Phase|Not Treated in RO|0|||
149183593|NCT01097616|538143450|FG007|DB RO Phase|Not Treated in RO|0|||
149183594|NCT00130208|538143455|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
149183595|NCT00130208|538143456|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
149183596|NCT00130208|538143455|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
149183597|NCT00130208|538143456|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
149183598|NCT00130208|538143455|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
149183599|NCT00130208|538143456|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
149183600|NCT00130208|538143455|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
149183601|NCT00130208|538143456|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
149183602|NCT00130208|538143455|FG000|Maintenance Period (26 Weeks)|Other|1|||
149183603|NCT00130208|538143456|FG001|Maintenance Period (26 Weeks)|Other|1|||
149183604|NCT00130208|538143455|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
149183605|NCT00130208|538143456|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
149183606|NCT00130208|538143455|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
149183607|NCT00130208|538143456|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
149183608|NCT00130208|538143455|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
149183609|NCT00130208|538143456|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
149183610|NCT00130208|538143455|FG000|Washout Period (8 Weeks)|Other|1|||
149183611|NCT00130208|538143456|FG001|Washout Period (8 Weeks)|Other|1|||
148932900|NCT01854658|537240126|FG002|Overall Study|Lack of Efficacy|4|||
148932901|NCT01854658|537240127|FG003|Overall Study|Lack of Efficacy|7|||
148932902|NCT01854658|537240124|FG000|Overall Study|Adverse Event|21|||
148932903|NCT01854658|537240125|FG001|Overall Study|Adverse Event|14|||
148932904|NCT01854658|537240126|FG002|Overall Study|Adverse Event|23|||
148932905|NCT01854658|537240127|FG003|Overall Study|Adverse Event|19|||
148932906|NCT01854658|537240124|FG000|Overall Study|Administrative reasons|5|||
148932907|NCT01854658|537240125|FG001|Overall Study|Administrative reasons|1|||
149183612|NCT01372878|538143459|FG000|Overall Study|Withdrawal by Subject|63|||
149183613|NCT01372878|538143459|FG000|Overall Study|Protocol Violation|17|||
148932908|NCT01854658|537240126|FG002|Overall Study|Administrative reasons|2|||
148932909|NCT01854658|537240127|FG003|Overall Study|Administrative reasons|2|||
148932910|NCT03911713|537240128|FG000|Overall Study|Lost to Follow-up|0|||
149183614|NCT01372878|538143459|FG000|Overall Study|incomplete study procedure|104|||
149183615|NCT02064439|538143475|FG000|Overall Study|Adverse Event|51|||
149183616|NCT02064439|538143476|FG001|Overall Study|Adverse Event|47|||
148932911|NCT03911713|537240129|FG001|Overall Study|Lost to Follow-up|2|||
148932912|NCT03911713|537240130|FG002|Overall Study|Lost to Follow-up|0|||
148932913|NCT03911713|537240131|FG003|Overall Study|Lost to Follow-up|0|||
149183617|NCT02064439|538143477|FG002|Overall Study|Adverse Event|46|||
149183618|NCT02064439|538143475|FG000|Overall Study|Death|0|||
149183619|NCT02064439|538143476|FG001|Overall Study|Death|2|||
149183620|NCT02064439|538143477|FG002|Overall Study|Death|3|||
148932914|NCT03911713|537240132|FG004|Overall Study|Lost to Follow-up|0|||
148932915|NCT03911713|537240128|FG000|Overall Study|Other|0|||
148932916|NCT03911713|537240129|FG001|Overall Study|Other|0|||
148932917|NCT03911713|537240130|FG002|Overall Study|Other|0|||
148932918|NCT03911713|537240131|FG003|Overall Study|Other|1|||
148932919|NCT03911713|537240132|FG004|Overall Study|Other|0|||
148932920|NCT03911713|537240128|FG000|Overall Study|Randomized, Never Dosed|1|||
148932921|NCT03911713|537240129|FG001|Overall Study|Randomized, Never Dosed|0|||
148932922|NCT03911713|537240130|FG002|Overall Study|Randomized, Never Dosed|0|||
148932923|NCT03911713|537240131|FG003|Overall Study|Randomized, Never Dosed|1|||
148932924|NCT03911713|537240132|FG004|Overall Study|Randomized, Never Dosed|0|||
148932925|NCT02203071|537240135|FG000|Overall Study|Lost to Follow-up|3|||
148932926|NCT02203071|537240136|FG001|Overall Study|Lost to Follow-up|1|||
148932927|NCT01845818|537240137|FG000|Overall Study|Withdrawal by Subject|0|||
148932928|NCT01845818|537240138|FG001|Overall Study|Withdrawal by Subject|1|||
148932929|NCT01845818|537240137|FG000|Overall Study|Lost to Follow-up|7|||
148932930|NCT01845818|537240138|FG001|Overall Study|Lost to Follow-up|5|||
148932931|NCT01845818|537240137|FG000|Overall Study|Administrative Reasons|3|||
148932932|NCT01845818|537240138|FG001|Overall Study|Administrative Reasons|1|||
148932933|NCT01845818|537240137|FG000|Overall Study|Serious Adverse Event|1|||
148932934|NCT01845818|537240138|FG001|Overall Study|Serious Adverse Event|1|||
148932935|NCT01845818|537240137|FG000|Overall Study|Other|25|||
148932936|NCT01845818|537240138|FG001|Overall Study|Other|8|||
148932937|NCT01845818|537240137|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
148932938|NCT01845818|537240138|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
148932939|NCT01845818|537240137|FG000|Overall Study|No Follow-Up Data Available|4|||
148932940|NCT01845818|537240138|FG001|Overall Study|No Follow-Up Data Available|1|||
148932941|NCT01680965|537240139|FG000|Overall Study|Death|0|||
148932942|NCT01680965|537240140|FG001|Overall Study|Death|0|||
148932943|NCT01680965|537240141|FG002|Overall Study|Death|0|||
148932944|NCT01680965|537240142|FG003|Overall Study|Death|6|||
148932945|NCT00195273|537240143|FG000|Overall Study|Adverse Event|9|||
148932946|NCT00195273|537240144|FG001|Overall Study|Adverse Event|9|||
148932947|NCT00195273|537240143|FG000|Overall Study|Protocol deviation|0|||
149014189|NCT04921969|537530904|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
149183621|NCT02064439|538143475|FG000|Overall Study|Withdrawal by Subject|29|||
149183622|NCT02064439|538143476|FG001|Overall Study|Withdrawal by Subject|18|||
149183623|NCT02064439|538143477|FG002|Overall Study|Withdrawal by Subject|26|||
149183624|NCT02064439|538143475|FG000|Overall Study|Protocol Violation|3|||
149183625|NCT02064439|538143476|FG001|Overall Study|Protocol Violation|5|||
149183626|NCT02064439|538143477|FG002|Overall Study|Protocol Violation|3|||
149183627|NCT02064439|538143475|FG000|Overall Study|Lost to Follow-up|1|||
149183628|NCT02064439|538143476|FG001|Overall Study|Lost to Follow-up|3|||
149183629|NCT02064439|538143477|FG002|Overall Study|Lost to Follow-up|4|||
149183630|NCT02064439|538143475|FG000|Overall Study|Non-compliance with study medication|21|||
149183631|NCT02064439|538143476|FG001|Overall Study|Non-compliance with study medication|19|||
149183632|NCT02064439|538143477|FG002|Overall Study|Non-compliance with study medication|23|||
149183633|NCT02064439|538143475|FG000|Overall Study|Physician Decision|0|||
149183634|NCT02064439|538143476|FG001|Overall Study|Physician Decision|1|||
149183635|NCT02064439|538143477|FG002|Overall Study|Physician Decision|1|||
149183636|NCT02064439|538143475|FG000|Overall Study|Logistical difficulties|6|||
149183637|NCT02064439|538143476|FG001|Overall Study|Logistical difficulties|5|||
149183638|NCT02064439|538143477|FG002|Overall Study|Logistical difficulties|2|||
149183639|NCT02064439|538143475|FG000|Overall Study|Efficacy outcome reached|18|||
149183640|NCT02064439|538143476|FG001|Overall Study|Efficacy outcome reached|16|||
149183641|NCT02064439|538143477|FG002|Overall Study|Efficacy outcome reached|57|||
149183642|NCT02064439|538143475|FG000|Overall Study|Safety outcome reached|12|||
149183643|NCT02064439|538143476|FG001|Overall Study|Safety outcome reached|20|||
149183644|NCT02064439|538143477|FG002|Overall Study|Safety outcome reached|10|||
148932948|NCT00195273|537240144|FG001|Overall Study|Protocol deviation|1|||
148932949|NCT00195273|537240143|FG000|Overall Study|Lack of Efficacy|3|||
148932950|NCT00195273|537240144|FG001|Overall Study|Lack of Efficacy|1|||
148932951|NCT00195273|537240143|FG000|Overall Study|Procedural complications|9|||
148932952|NCT00195273|537240144|FG001|Overall Study|Procedural complications|3|||
148932953|NCT02595970|537240145|FG000|Overall Study|Withdrawal by Subject|2|||
148932954|NCT02595970|537240145|FG000|Overall Study|Physician Decision|2|||
148932955|NCT02595970|537240145|FG000|Overall Study|Protocol Violation|4|||
148932956|NCT02595970|537240145|FG000|Overall Study|Adverse Event|5|||
148932957|NCT02595970|537240145|FG000|Overall Study|Lack of Efficacy|7|||
148932958|NCT01886716|537240146|FG000|Week 1|Lost to Follow-up|0|||
149183645|NCT02064439|538143475|FG000|Overall Study|Other|2|||
149183646|NCT02064439|538143476|FG001|Overall Study|Other|2|||
149183647|NCT02064439|538143477|FG002|Overall Study|Other|7|||
149183648|NCT02433288|538143478|FG000|Overall Study|Severe non-compliance to protocol|13|||
149183649|NCT02433288|538143479|FG001|Overall Study|Severe non-compliance to protocol|7|||
149183650|NCT02433288|538143478|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
149183651|NCT02433288|538143479|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
149183652|NCT02433288|538143478|FG000|Overall Study|Withdrawal by Subject|101|||
149183653|NCT02433288|538143479|FG001|Overall Study|Withdrawal by Subject|99|||
149183654|NCT02433288|538143478|FG000|Overall Study|Lost to Follow-up|2|||
149183655|NCT02433288|538143479|FG001|Overall Study|Lost to Follow-up|14|||
149183656|NCT02433288|538143478|FG000|Overall Study|Death|0|||
149183657|NCT02433288|538143479|FG001|Overall Study|Death|3|||
149183658|NCT03350750|538143480|FG000|Overall Study|Death|1|||
149183659|NCT03350750|538143481|FG001|Overall Study|Death|1|||
149183660|NCT02234583|538143484|FG000|Overall Study|Adverse Event|172|||
149183661|NCT02234583|538143485|FG001|Overall Study|Adverse Event|156|||
149183662|NCT02234583|538143484|FG000|Overall Study|Withdrawal by Subject|109|||
149183663|NCT02234583|538143485|FG001|Overall Study|Withdrawal by Subject|157|||
149183664|NCT02234583|538143484|FG000|Overall Study|Lost to Follow-up|0|||
149183665|NCT02234583|538143485|FG001|Overall Study|Lost to Follow-up|1|||
149183666|NCT02234583|538143484|FG000|Overall Study|Lack of Efficacy|58|||
149183667|NCT02234583|538143485|FG001|Overall Study|Lack of Efficacy|103|||
149183668|NCT02234583|538143484|FG000|Overall Study|Protocol Violation|35|||
149183669|NCT02234583|538143485|FG001|Overall Study|Protocol Violation|42|||
149183670|NCT02234583|538143484|FG000|Overall Study|Other|39|||
149183671|NCT02234583|538143485|FG001|Overall Study|Other|97|||
149183672|NCT01214434|538143501|FG000|Overall Study|Withdrawal by Subject|1|||
149183673|NCT01214434|538143502|FG001|Overall Study|Withdrawal by Subject|0|||
149183674|NCT01214434|538143501|FG000|Overall Study|Lost to Follow-up|2|||
149183675|NCT01214434|538143502|FG001|Overall Study|Lost to Follow-up|2|||
149183676|NCT01214434|538143501|FG000|Overall Study|Site error|1|||
149183677|NCT01214434|538143502|FG001|Overall Study|Site error|0|||
149183678|NCT02075255|538143503|FG000|Overall Study|Study specific withdrawal criteria|0|||
149183679|NCT02075255|538143504|FG001|Overall Study|Study specific withdrawal criteria|1|||
149183680|NCT02075255|538143505|FG002|Overall Study|Study specific withdrawal criteria|1|||
149183681|NCT02075255|538143503|FG000|Overall Study|Withdrawal by Subject|4|||
149183682|NCT02075255|538143504|FG001|Overall Study|Withdrawal by Subject|1|||
149183683|NCT02075255|538143505|FG002|Overall Study|Withdrawal by Subject|0|||
149183684|NCT02075255|538143503|FG000|Overall Study|Lost to Follow-up|0|||
149183685|NCT02075255|538143504|FG001|Overall Study|Lost to Follow-up|0|||
149183686|NCT02075255|538143505|FG002|Overall Study|Lost to Follow-up|1|||
149183687|NCT02075255|538143503|FG000|Overall Study|Adverse Event|0|||
149183688|NCT02075255|538143504|FG001|Overall Study|Adverse Event|0|||
149183689|NCT02075255|538143505|FG002|Overall Study|Adverse Event|1|||
149183690|NCT02075255|538143503|FG000|Overall Study|Death|0|||
149183691|NCT02075255|538143504|FG001|Overall Study|Death|2|||
149183692|NCT02075255|538143505|FG002|Overall Study|Death|0|||
149183693|NCT01188798|538143506|FG000|Overall Study|Death|0|||
149183694|NCT01188798|538143507|FG001|Overall Study|Death|1|||
149183695|NCT01188798|538143506|FG000|Overall Study|Required additional transplant|1|||
149183696|NCT01188798|538143507|FG001|Overall Study|Required additional transplant|1|||
149183697|NCT01188798|538143506|FG000|Overall Study|Protocol closure|1|||
149183698|NCT01188798|538143507|FG001|Overall Study|Protocol closure|1|||
149183699|NCT01748760|538143508|FG000|Overall Study|Withdrawal by Subject|1|||
149183700|NCT01748760|538143509|FG001|Overall Study|Withdrawal by Subject|1|||
149183701|NCT01748760|538143508|FG000|Overall Study|Lost to Follow-up|5|||
149183702|NCT01748760|538143509|FG001|Overall Study|Lost to Follow-up|1|||
149183703|NCT00872898|538143510|FG000|Part Two - Double Blind|Adverse Event|4|||
149183704|NCT00872898|538143511|FG001|Part Two - Double Blind|Adverse Event|3|||
149183705|NCT00872898|538143510|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
149183706|NCT00872898|538143511|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
149183707|NCT00872898|538143510|FG000|Part Two - Double Blind|Protocol Violation|1|||
149183708|NCT00872898|538143511|FG001|Part Two - Double Blind|Protocol Violation|0|||
149183709|NCT00872898|538143510|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
149183710|NCT00872898|538143511|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
148807346|NCT00903968|536773235|FG007|Overall Study|Withdrawal by Subject|4|||
149183711|NCT00872898|538143510|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
149183712|NCT00872898|538143511|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
149183713|NCT00872898|538143510|FG000|Part Two - Double Blind|Other reasons|2|||
149183714|NCT00872898|538143511|FG001|Part Two - Double Blind|Other reasons|0|||
149183715|NCT00863928|538143512|FG000|Overall Study|Protocol Violation|26|||
149183716|NCT00863928|538143513|FG001|Overall Study|Protocol Violation|0|||
149183717|NCT00863928|538143512|FG000|Overall Study|Withdrawal by Subject|3|||
149183718|NCT00863928|538143513|FG001|Overall Study|Withdrawal by Subject|0|||
149183719|NCT00863928|538143512|FG000|Overall Study|surgery cancellation|4|||
149183720|NCT00863928|538143513|FG001|Overall Study|surgery cancellation|0|||
149183721|NCT00863928|538143512|FG000|Overall Study|medication allergy|3|||
149183722|NCT00863928|538143513|FG001|Overall Study|medication allergy|0|||
149183723|NCT02795156|538143518|FG000|Overall Study|Progressive Disease|22|||
149183724|NCT02795156|538143519|FG001|Overall Study|Progressive Disease|7|||
149183725|NCT02795156|538143520|FG002|Overall Study|Progressive Disease|34|||
149183726|NCT02795156|538143521|FG003|Overall Study|Progressive Disease|7|||
149183727|NCT02795156|538143518|FG000|Overall Study|Adverse Event|13|||
149183728|NCT02795156|538143519|FG001|Overall Study|Adverse Event|2|||
149183729|NCT02795156|538143520|FG002|Overall Study|Adverse Event|3|||
149183730|NCT02795156|538143521|FG003|Overall Study|Adverse Event|2|||
149183731|NCT02795156|538143518|FG000|Overall Study|Death|1|||
149183732|NCT02795156|538143519|FG001|Overall Study|Death|1|||
149183733|NCT02795156|538143520|FG002|Overall Study|Death|1|||
149183734|NCT02795156|538143521|FG003|Overall Study|Death|0|||
149183735|NCT02795156|538143518|FG000|Overall Study|Physician Decision|1|||
149183736|NCT02795156|538143519|FG001|Overall Study|Physician Decision|0|||
149183737|NCT02795156|538143520|FG002|Overall Study|Physician Decision|1|||
149183738|NCT02795156|538143521|FG003|Overall Study|Physician Decision|0|||
149183739|NCT02795156|538143518|FG000|Overall Study|Withdrawal by Subject|2|||
149183740|NCT02795156|538143519|FG001|Overall Study|Withdrawal by Subject|0|||
149183741|NCT02795156|538143520|FG002|Overall Study|Withdrawal by Subject|3|||
149183742|NCT02795156|538143521|FG003|Overall Study|Withdrawal by Subject|0|||
149183743|NCT02961764|538143528|FG000|Overall Study|Protocol Violation|0|||
149183744|NCT02961764|538143529|FG001|Overall Study|Protocol Violation|1|||
149183745|NCT02961764|538143528|FG000|Overall Study|Death|2|||
149183746|NCT02961764|538143529|FG001|Overall Study|Death|0|||
149183747|NCT02961764|538143528|FG000|Overall Study|Lost to Follow-up|35|||
149183748|NCT02961764|538143529|FG001|Overall Study|Lost to Follow-up|24|||
149183749|NCT02961764|538143528|FG000|Overall Study|Withdrawal by Subject|2|||
149183750|NCT02961764|538143529|FG001|Overall Study|Withdrawal by Subject|0|||
149183751|NCT01903434|538143533|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
149183752|NCT01903434|538143534|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
149183753|NCT01903434|538143533|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
149183754|NCT01903434|538143534|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
149183755|NCT01469052|538143535|FG000|Overall Study|Adverse Event|2|||
149183756|NCT01469052|538143536|FG001|Overall Study|Adverse Event|3|||
149183757|NCT01469052|538143537|FG002|Overall Study|Adverse Event|0|||
149183758|NCT01469052|538143538|FG003|Overall Study|Adverse Event|2|||
149183759|NCT01469052|538143539|FG004|Overall Study|Adverse Event|0|||
149183760|NCT01469052|538143540|FG005|Overall Study|Adverse Event|1|||
149183761|NCT01469052|538143535|FG000|Overall Study|Progressive disease|3|||
149183762|NCT01469052|538143536|FG001|Overall Study|Progressive disease|0|||
149183763|NCT01469052|538143537|FG002|Overall Study|Progressive disease|5|||
149183764|NCT01469052|538143538|FG003|Overall Study|Progressive disease|3|||
149183765|NCT01469052|538143539|FG004|Overall Study|Progressive disease|7|||
149183766|NCT01469052|538143540|FG005|Overall Study|Progressive disease|2|||
149183767|NCT01469052|538143535|FG000|Overall Study|Lack of Efficacy|0|||
149183768|NCT01469052|538143536|FG001|Overall Study|Lack of Efficacy|0|||
149183769|NCT01469052|538143537|FG002|Overall Study|Lack of Efficacy|0|||
149183770|NCT01469052|538143538|FG003|Overall Study|Lack of Efficacy|0|||
149183771|NCT01469052|538143539|FG004|Overall Study|Lack of Efficacy|0|||
149183772|NCT01469052|538143540|FG005|Overall Study|Lack of Efficacy|2|||
149183773|NCT01469052|538143535|FG000|Overall Study|Moved to rollover protocol|1|||
149183774|NCT01469052|538143536|FG001|Overall Study|Moved to rollover protocol|0|||
149183775|NCT01469052|538143537|FG002|Overall Study|Moved to rollover protocol|1|||
149183776|NCT01469052|538143538|FG003|Overall Study|Moved to rollover protocol|0|||
149183777|NCT01469052|538143539|FG004|Overall Study|Moved to rollover protocol|0|||
149183778|NCT01469052|538143540|FG005|Overall Study|Moved to rollover protocol|1|||
149183779|NCT01469052|538143535|FG000|Overall Study|Other|0|||
149183780|NCT01469052|538143536|FG001|Overall Study|Other|1|||
149183781|NCT01469052|538143537|FG002|Overall Study|Other|0|||
149183782|NCT01469052|538143538|FG003|Overall Study|Other|0|||
149183783|NCT01469052|538143539|FG004|Overall Study|Other|1|||
149183784|NCT01469052|538143540|FG005|Overall Study|Other|0|||
149183785|NCT00633139|538143541|FG000|Overall Study|Non compliance|0|||
149183786|NCT00633139|538143542|FG001|Overall Study|Non compliance|0|||
149183787|NCT00633139|538143543|FG002|Overall Study|Non compliance|1|||
148807347|NCT00903968|536773228|FG000|Overall Study|Non-Compliance|0|||
149183788|NCT00633139|538143541|FG000|Overall Study|Withdrawal by Subject|0|||
149183789|NCT00633139|538143542|FG001|Overall Study|Withdrawal by Subject|1|||
149183790|NCT00633139|538143543|FG002|Overall Study|Withdrawal by Subject|0|||
149183791|NCT02160977|538143544|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
149183792|NCT02160977|538143545|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
149183793|NCT02160977|538143544|FG000|Three Months After Surgery|Lost to Follow-up|0|||
149183794|NCT02160977|538143545|FG001|Three Months After Surgery|Lost to Follow-up|2|||
149183795|NCT02160977|538143544|FG000|Six Months After Surgery|Lost to Follow-up|2|||
149183796|NCT02160977|538143545|FG001|Six Months After Surgery|Lost to Follow-up|1|||
149183797|NCT04773041|538143548|FG000|Overall Study|Unable to data match|1|||
149183798|NCT04773041|538143549|FG001|Overall Study|Unable to data match|0|||
149183799|NCT04773041|538143550|FG002|Overall Study|Unable to data match|0|||
149183800|NCT05270694|538145092|FG000|Overall Study|Death|1|||
149183801|NCT05270694|538145092|FG000|Overall Study|Medical issues impacted ability to participate|2|||
149183802|NCT05270694|538145092|FG000|Overall Study|Lost to Follow-up|3|||
149183803|NCT05270694|538145092|FG000|Overall Study|Withdrawal by Subject|3|||
149183804|NCT00128206|538145095|FG000|Overall Study|Lost to Follow-up|137|||
149183805|NCT00128206|538145096|FG001|Overall Study|Lost to Follow-up|118|||
149183806|NCT00128206|538145095|FG000|Overall Study|Adverse Event|0|||
149183807|NCT00128206|538145096|FG001|Overall Study|Adverse Event|2|||
149183808|NCT03032068|538145099|FG000|Overall Study|Adverse Event|1|||
149183809|NCT03132805|538145102|FG000|Overall Study|Lost to Follow-up|142|||
149183810|NCT03132805|538145103|FG001|Overall Study|Lost to Follow-up|141|||
149183811|NCT03132805|538145104|FG002|Overall Study|Lost to Follow-up|113|||
149183812|NCT03009539|538145105|FG000|Overall Study|Lost to Follow-up|132|||
149183813|NCT03009539|538145106|FG001|Overall Study|Lost to Follow-up|113|||
149183814|NCT03009539|538145107|FG002|Overall Study|Lost to Follow-up|132|||
149183815|NCT03009539|538145108|FG003|Overall Study|Lost to Follow-up|113|||
149183816|NCT03151148|538145109|FG000|Overall Study|Lost to Follow-up|1|||
149183817|NCT03151148|538145110|FG001|Overall Study|Lost to Follow-up|0|||
149183818|NCT03151148|538145109|FG000|Overall Study|Withdrawal by Subject|1|||
149183819|NCT03151148|538145110|FG001|Overall Study|Withdrawal by Subject|0|||
149183820|NCT00710034|538145111|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
149183821|NCT00710034|538145112|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
149183822|NCT00710034|538145111|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
149183823|NCT00710034|538145112|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
149183824|NCT00710034|538145111|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
149183825|NCT00710034|538145112|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
149183826|NCT00710034|538145111|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
149183827|NCT00710034|538145112|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
149183828|NCT00710034|538145111|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
149183829|NCT00710034|538145112|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
149183830|NCT00710034|538145111|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
149183831|NCT00710034|538145112|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
149183832|NCT00710034|538145111|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
149183833|NCT00710034|538145112|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
149183834|NCT00710034|538145111|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
149183835|NCT00710034|538145112|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
149183836|NCT00710034|538145111|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
149183837|NCT00710034|538145112|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
149183838|NCT00710034|538145111|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
149183839|NCT00710034|538145112|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
149183840|NCT00710034|538145111|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
149183841|NCT00710034|538145112|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
149183842|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
149183843|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
149183844|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
149183845|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
149183846|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Death|8|||
148932959|NCT01886716|537240147|FG001|Week 1|Lost to Follow-up|0|||
148932960|NCT01886716|537240148|FG002|Week 1|Lost to Follow-up|2|||
148932961|NCT01886716|537240149|FG003|Week 1|Lost to Follow-up|2|||
148932962|NCT01886716|537240146|FG000|Week 2|Lost to Follow-up|3|||
149183847|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Death|3|||
149183848|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
149183849|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
149183850|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
149183851|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
149183852|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
149183853|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
149183854|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
149183855|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
148932963|NCT01886716|537240147|FG001|Week 2|Lost to Follow-up|2|||
148932964|NCT01886716|537240148|FG002|Week 2|Lost to Follow-up|1|||
148932965|NCT01886716|537240149|FG003|Week 2|Lost to Follow-up|3|||
148932966|NCT01886716|537240146|FG000|Week 3|Lost to Follow-up|1|||
148932967|NCT01886716|537240147|FG001|Week 3|Lost to Follow-up|1|||
149183856|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
149183857|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
149183858|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
149183859|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
149183860|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
149183861|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
149183862|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
149183863|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
149183864|NCT00494871|538145113|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
149183865|NCT00494871|538145114|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
149183866|NCT00494871|538145113|FG000|Follow-up (FU) Period|Adverse Event|1|||
149183867|NCT00494871|538145114|FG001|Follow-up (FU) Period|Adverse Event|1|||
149183868|NCT00494871|538145113|FG000|Follow-up (FU) Period|Death|13|||
149183869|NCT00494871|538145114|FG001|Follow-up (FU) Period|Death|12|||
149183870|NCT00494871|538145113|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
149183871|NCT00494871|538145114|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
149183872|NCT00494871|538145113|FG000|Follow-up (FU) Period|Physician Decision|0|||
149183873|NCT00494871|538145114|FG001|Follow-up (FU) Period|Physician Decision|1|||
149183874|NCT00494871|538145113|FG000|Follow-up (FU) Period|Protocol Violation|1|||
149183875|NCT00494871|538145114|FG001|Follow-up (FU) Period|Protocol Violation|0|||
149183876|NCT00494871|538145113|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
149183877|NCT00494871|538145114|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
149183878|NCT00494871|538145113|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
149183879|NCT00494871|538145114|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
149183880|NCT03918642|538145115|FG000|Overall Study|Lost to Follow-up|12|||
149183881|NCT03918642|538145116|FG001|Overall Study|Lost to Follow-up|10|||
149183882|NCT03238248|538145117|FG000|Overall Study|Death|5|||
149183883|NCT03238248|538145117|FG000|Overall Study|Withdrawal by Subject|7|||
149183884|NCT03238248|538145117|FG000|Overall Study|Participant proceeding to transplant|10|||
149183885|NCT03238248|538145117|FG000|Overall Study|Lack of Efficacy|4|||
149183886|NCT03238248|538145117|FG000|Overall Study|Physician Decision|3|||
149183887|NCT03238248|538145117|FG000|Overall Study|Transitioning to another study|1|||
149183888|NCT03238248|538145117|FG000|Overall Study|No longer benefiting|1|||
149183889|NCT03238248|538145117|FG000|Overall Study|Other complicating disease|1|||
149183890|NCT03238248|538145117|FG000|Overall Study|Adverse Event|5|||
149183891|NCT03238248|538145117|FG000|Overall Study|Disease progression|26|||
149183892|NCT03238248|538145117|FG000|Overall Study|N/A participant is still on treatment|1|||
149183893|NCT03238248|538145117|FG000|Overall Study|Decline in condition|1|||
149183894|NCT03238248|538145117|FG000|Overall Study|Alternative therapy|2|||
149183895|NCT00972244|538145118|FG000|Overall Study|Incorrect Enrolment|1|||
149183896|NCT00972244|538145119|FG001|Overall Study|Incorrect Enrolment|0|||
149183897|NCT00972244|538145120|FG002|Overall Study|Incorrect Enrolment|0|||
149183898|NCT00972244|538145121|FG003|Overall Study|Incorrect Enrolment|0|||
149183899|NCT00972244|538145122|FG004|Overall Study|Incorrect Enrolment|0|||
149183900|NCT00972244|538145118|FG000|Overall Study|Adverse Event|0|||
149183901|NCT00972244|538145119|FG001|Overall Study|Adverse Event|1|||
149183902|NCT00972244|538145120|FG002|Overall Study|Adverse Event|1|||
149183903|NCT00972244|538145121|FG003|Overall Study|Adverse Event|0|||
149183904|NCT00972244|538145122|FG004|Overall Study|Adverse Event|0|||
149183905|NCT00972244|538145118|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
149183906|NCT00972244|538145119|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
149183907|NCT00972244|538145120|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
149183908|NCT00972244|538145121|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
149183909|NCT00972244|538145122|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
149183910|NCT00972244|538145118|FG000|Overall Study|Withdrawal by Subject|1|||
149183911|NCT00972244|538145119|FG001|Overall Study|Withdrawal by Subject|2|||
148807348|NCT00903968|536773229|FG001|Overall Study|Non-Compliance|0|||
149183912|NCT00972244|538145120|FG002|Overall Study|Withdrawal by Subject|1|||
149183913|NCT00972244|538145121|FG003|Overall Study|Withdrawal by Subject|0|||
148807349|NCT00903968|536773230|FG002|Overall Study|Non-Compliance|0|||
148807350|NCT00903968|536773231|FG003|Overall Study|Non-Compliance|0|||
148807351|NCT00903968|536773232|FG004|Overall Study|Non-Compliance|0|||
149014190|NCT04921969|537530905|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
149183914|NCT00972244|538145122|FG004|Overall Study|Withdrawal by Subject|1|||
149183915|NCT00972244|538145118|FG000|Overall Study|Safety|0|||
149183916|NCT00972244|538145119|FG001|Overall Study|Safety|0|||
149183917|NCT00972244|538145120|FG002|Overall Study|Safety|0|||
149183918|NCT00972244|538145121|FG003|Overall Study|Safety|0|||
149183919|NCT00972244|538145122|FG004|Overall Study|Safety|1|||
149183920|NCT00972244|538145118|FG000|Overall Study|Death|1|||
149183921|NCT00972244|538145119|FG001|Overall Study|Death|0|||
149183922|NCT00972244|538145120|FG002|Overall Study|Death|0|||
149183923|NCT00972244|538145121|FG003|Overall Study|Death|0|||
148932968|NCT01886716|537240148|FG002|Week 3|Lost to Follow-up|0|||
148932969|NCT01886716|537240149|FG003|Week 3|Lost to Follow-up|1|||
149183924|NCT00972244|538145122|FG004|Overall Study|Death|0|||
149183925|NCT00972244|538145118|FG000|Overall Study|Various|0|||
149183926|NCT00972244|538145119|FG001|Overall Study|Various|0|||
149183927|NCT00972244|538145120|FG002|Overall Study|Various|0|||
149183928|NCT00972244|538145121|FG003|Overall Study|Various|0|||
149183929|NCT00972244|538145122|FG004|Overall Study|Various|2|||
149183930|NCT00090285|538145123|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
149183931|NCT00090285|538145124|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
148932970|NCT02367131|537240150|FG000|Overall Study|Adverse Event|64|||
148932971|NCT02367131|537240150|FG000|Overall Study|No visit since the first visit|3|||
148932972|NCT02367131|537240150|FG000|Overall Study|Request by patient|53|||
148932973|NCT02367131|537240150|FG000|Overall Study|Improvement/remission|2|||
149183932|NCT00090285|538145125|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149183933|NCT00090285|538145126|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149183934|NCT00090285|538145127|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149183935|NCT00090285|538145128|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
149183936|NCT00090285|538145123|FG000|Base Study Vaccination Period|Adverse Event|2|||
149183937|NCT00090285|538145124|FG001|Base Study Vaccination Period|Adverse Event|4|||
149183938|NCT00090285|538145125|FG002|Base Study Vaccination Period|Adverse Event|0|||
149183939|NCT00090285|538145126|FG003|Base Study Vaccination Period|Adverse Event|0|||
149183940|NCT00090285|538145127|FG004|Base Study Vaccination Period|Adverse Event|0|||
149183941|NCT00090285|538145128|FG005|Base Study Vaccination Period|Adverse Event|0|||
149183942|NCT00090285|538145123|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
149183943|NCT00090285|538145124|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
149183944|NCT00090285|538145125|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
149183945|NCT00090285|538145126|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
149183946|NCT00090285|538145127|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
149183947|NCT00090285|538145128|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
149183948|NCT00090285|538145123|FG000|Base Study Vaccination Period|Protocol Violation|2|||
149183949|NCT00090285|538145124|FG001|Base Study Vaccination Period|Protocol Violation|3|||
149183950|NCT00090285|538145125|FG002|Base Study Vaccination Period|Protocol Violation|0|||
149183951|NCT00090285|538145126|FG003|Base Study Vaccination Period|Protocol Violation|0|||
149183952|NCT00090285|538145127|FG004|Base Study Vaccination Period|Protocol Violation|0|||
149183953|NCT00090285|538145128|FG005|Base Study Vaccination Period|Protocol Violation|0|||
149183954|NCT00090285|538145123|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
149183955|NCT00090285|538145124|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
149183956|NCT00090285|538145125|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
149183957|NCT00090285|538145126|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
149183958|NCT00090285|538145127|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
148932974|NCT02367131|537240150|FG000|Overall Study|No change/progressive disease|78|||
148932975|NCT02367131|537240150|FG000|Overall Study|Other than stated above|20|||
148932976|NCT02367131|537240150|FG000|Overall Study|Not treated|2|||
149183959|NCT00090285|538145128|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
149183960|NCT00090285|538145123|FG000|Base Study Vaccination Period|Uncooperative|2|||
149183961|NCT00090285|538145124|FG001|Base Study Vaccination Period|Uncooperative|2|||
149183962|NCT00090285|538145125|FG002|Base Study Vaccination Period|Uncooperative|0|||
148932977|NCT05061966|537240152|FG000|Overall Study|Lost to Follow-up|13|||
148932978|NCT05061966|537240153|FG001|Overall Study|Lost to Follow-up|13|||
148932979|NCT03793556|537240154|FG000|Overall Study|Withdrawal by Subject|12|||
148932980|NCT03793556|537240155|FG001|Overall Study|Withdrawal by Subject|1|||
148932981|NCT03793556|537240154|FG000|Overall Study|Lost to Follow-up|1|||
148932982|NCT03793556|537240155|FG001|Overall Study|Lost to Follow-up|1|||
149183963|NCT00090285|538145126|FG003|Base Study Vaccination Period|Uncooperative|0|||
149183964|NCT00090285|538145127|FG004|Base Study Vaccination Period|Uncooperative|0|||
149183965|NCT00090285|538145128|FG005|Base Study Vaccination Period|Uncooperative|0|||
148932983|NCT04416633|537240156|FG000|Overall Study|Death|1|||
148932984|NCT04416633|537240156|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
149183966|NCT00090285|538145123|FG000|Base Study Vaccination Period|Moved|20|||
149183967|NCT00090285|538145124|FG001|Base Study Vaccination Period|Moved|21|||
149183968|NCT00090285|538145125|FG002|Base Study Vaccination Period|Moved|0|||
148807352|NCT00903968|536773233|FG005|Overall Study|Non-Compliance|1|||
148932985|NCT04416633|537240156|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
149183969|NCT00090285|538145126|FG003|Base Study Vaccination Period|Moved|0|||
149183970|NCT00090285|538145127|FG004|Base Study Vaccination Period|Moved|0|||
149183971|NCT00090285|538145128|FG005|Base Study Vaccination Period|Moved|0|||
149183972|NCT00090285|538145123|FG000|Base Study Vaccination Period|Site Terminated|1|||
149183973|NCT00090285|538145124|FG001|Base Study Vaccination Period|Site Terminated|0|||
149183974|NCT00090285|538145125|FG002|Base Study Vaccination Period|Site Terminated|0|||
149183975|NCT00090285|538145126|FG003|Base Study Vaccination Period|Site Terminated|0|||
149183976|NCT00090285|538145127|FG004|Base Study Vaccination Period|Site Terminated|0|||
149183977|NCT00090285|538145128|FG005|Base Study Vaccination Period|Site Terminated|0|||
149183978|NCT00090285|538145123|FG000|Base Study Vaccination Period|Other|2|||
149183979|NCT00090285|538145124|FG001|Base Study Vaccination Period|Other|2|||
149183980|NCT00090285|538145125|FG002|Base Study Vaccination Period|Other|0|||
149183981|NCT00090285|538145126|FG003|Base Study Vaccination Period|Other|0|||
149183982|NCT00090285|538145127|FG004|Base Study Vaccination Period|Other|0|||
149183983|NCT00090285|538145128|FG005|Base Study Vaccination Period|Other|0|||
149183984|NCT00090285|538145123|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
149183985|NCT00090285|538145124|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
149183986|NCT00090285|538145125|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
149183987|NCT00090285|538145126|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
149183988|NCT00090285|538145127|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
149183989|NCT00090285|538145128|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
149183990|NCT00090285|538145123|FG000|Base Study Vaccination Period|HIV positive|1|||
149183991|NCT00090285|538145124|FG001|Base Study Vaccination Period|HIV positive|1|||
149183992|NCT00090285|538145125|FG002|Base Study Vaccination Period|HIV positive|0|||
149183993|NCT00090285|538145126|FG003|Base Study Vaccination Period|HIV positive|0|||
149183994|NCT00090285|538145127|FG004|Base Study Vaccination Period|HIV positive|0|||
149183995|NCT00090285|538145128|FG005|Base Study Vaccination Period|HIV positive|0|||
149183996|NCT00090285|538145123|FG000|Base Study Follow-up Period|Adverse Event|3|||
149183997|NCT00090285|538145124|FG001|Base Study Follow-up Period|Adverse Event|10|||
149183998|NCT00090285|538145125|FG002|Base Study Follow-up Period|Adverse Event|0|||
149183999|NCT00090285|538145126|FG003|Base Study Follow-up Period|Adverse Event|0|||
149184000|NCT00090285|538145127|FG004|Base Study Follow-up Period|Adverse Event|0|||
149184001|NCT00090285|538145128|FG005|Base Study Follow-up Period|Adverse Event|0|||
149184002|NCT00090285|538145123|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
149184003|NCT00090285|538145124|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
149184004|NCT00090285|538145125|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
149184005|NCT00090285|538145126|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
149184006|NCT00090285|538145127|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
149184007|NCT00090285|538145128|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
149184008|NCT00090285|538145123|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
149184009|NCT00090285|538145124|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
149184010|NCT00090285|538145125|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
149184011|NCT00090285|538145126|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
149184012|NCT00090285|538145127|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
149184013|NCT00090285|538145128|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
149184014|NCT00090285|538145123|FG000|Base Study Follow-up Period|Moved|41|||
149184015|NCT00090285|538145124|FG001|Base Study Follow-up Period|Moved|36|||
149184016|NCT00090285|538145125|FG002|Base Study Follow-up Period|Moved|0|||
149184017|NCT00090285|538145126|FG003|Base Study Follow-up Period|Moved|0|||
149184018|NCT00090285|538145127|FG004|Base Study Follow-up Period|Moved|0|||
149184019|NCT00090285|538145128|FG005|Base Study Follow-up Period|Moved|0|||
149184020|NCT00090285|538145123|FG000|Base Study Follow-up Period|Other|2|||
149184021|NCT00090285|538145124|FG001|Base Study Follow-up Period|Other|0|||
149184022|NCT00090285|538145125|FG002|Base Study Follow-up Period|Other|0|||
149184023|NCT00090285|538145126|FG003|Base Study Follow-up Period|Other|0|||
148932986|NCT04416633|537240156|FG000|Overall Study|Adverse Event|6|||
148932987|NCT04416633|537240156|FG000|Overall Study|Withdrawal by Subject|6|||
148932988|NCT02923427|537240161|FG000|Overall Study|convert to laparatomy|2|||
148932989|NCT02923427|537240162|FG001|Overall Study|convert to laparatomy|2|||
148932990|NCT02923427|537240161|FG000|Overall Study|destaturation|1|||
148932991|NCT02923427|537240162|FG001|Overall Study|destaturation|0|||
149184024|NCT00090285|538145127|FG004|Base Study Follow-up Period|Other|0|||
149184025|NCT00090285|538145128|FG005|Base Study Follow-up Period|Other|0|||
149184026|NCT00090285|538145123|FG000|Base Study Follow-up Period|Protocol Violation|1|||
149184027|NCT00090285|538145124|FG001|Base Study Follow-up Period|Protocol Violation|0|||
149184028|NCT00090285|538145125|FG002|Base Study Follow-up Period|Protocol Violation|0|||
149184029|NCT00090285|538145126|FG003|Base Study Follow-up Period|Protocol Violation|0|||
149184030|NCT00090285|538145127|FG004|Base Study Follow-up Period|Protocol Violation|0|||
149184031|NCT00090285|538145128|FG005|Base Study Follow-up Period|Protocol Violation|0|||
149184032|NCT00090285|538145123|FG000|Base Study Follow-up Period|Uncooperative|3|||
149184033|NCT00090285|538145124|FG001|Base Study Follow-up Period|Uncooperative|4|||
148932992|NCT02923427|537240161|FG000|Overall Study|can not replace LMA|1|||
149184034|NCT00090285|538145125|FG002|Base Study Follow-up Period|Uncooperative|0|||
149184035|NCT00090285|538145126|FG003|Base Study Follow-up Period|Uncooperative|0|||
149184036|NCT00090285|538145127|FG004|Base Study Follow-up Period|Uncooperative|0|||
149184037|NCT00090285|538145128|FG005|Base Study Follow-up Period|Uncooperative|0|||
149184038|NCT00090285|538145123|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
149184039|NCT00090285|538145124|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
149184040|NCT00090285|538145125|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
149184041|NCT00090285|538145126|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
149184042|NCT00090285|538145127|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
149184043|NCT00090285|538145128|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
149184044|NCT00090285|538145123|FG000|Extension 1|Adverse Event|0|||
149184045|NCT00090285|538145124|FG001|Extension 1|Adverse Event|0|||
149184046|NCT00090285|538145125|FG002|Extension 1|Adverse Event|2|||
149184047|NCT00090285|538145126|FG003|Extension 1|Adverse Event|0|||
149184048|NCT00090285|538145127|FG004|Extension 1|Adverse Event|0|||
149184049|NCT00090285|538145128|FG005|Extension 1|Adverse Event|0|||
149184050|NCT00090285|538145123|FG000|Extension 1|Lost to Follow-up|0|||
149184051|NCT00090285|538145124|FG001|Extension 1|Lost to Follow-up|0|||
149184052|NCT00090285|538145125|FG002|Extension 1|Lost to Follow-up|35|||
149184053|NCT00090285|538145126|FG003|Extension 1|Lost to Follow-up|0|||
149184054|NCT00090285|538145127|FG004|Extension 1|Lost to Follow-up|0|||
149184055|NCT00090285|538145128|FG005|Extension 1|Lost to Follow-up|0|||
149184056|NCT00090285|538145123|FG000|Extension 1|Withdrawal by Subject|0|||
149184057|NCT00090285|538145124|FG001|Extension 1|Withdrawal by Subject|0|||
149184058|NCT00090285|538145125|FG002|Extension 1|Withdrawal by Subject|13|||
149184059|NCT00090285|538145126|FG003|Extension 1|Withdrawal by Subject|1|||
149184060|NCT00090285|538145127|FG004|Extension 1|Withdrawal by Subject|0|||
149184061|NCT00090285|538145128|FG005|Extension 1|Withdrawal by Subject|0|||
149184062|NCT00090285|538145123|FG000|Extension 1|Other|0|||
149184063|NCT00090285|538145124|FG001|Extension 1|Other|0|||
149184064|NCT00090285|538145125|FG002|Extension 1|Other|4|||
149184065|NCT00090285|538145126|FG003|Extension 1|Other|0|||
149184066|NCT00090285|538145127|FG004|Extension 1|Other|0|||
149184067|NCT00090285|538145128|FG005|Extension 1|Other|0|||
149184068|NCT00090285|538145123|FG000|Extension 1|Moved|0|||
149184069|NCT00090285|538145124|FG001|Extension 1|Moved|0|||
149184070|NCT00090285|538145125|FG002|Extension 1|Moved|3|||
149184071|NCT00090285|538145126|FG003|Extension 1|Moved|0|||
149184072|NCT00090285|538145127|FG004|Extension 1|Moved|0|||
149184073|NCT00090285|538145128|FG005|Extension 1|Moved|0|||
149184074|NCT00090285|538145123|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
149184075|NCT00090285|538145124|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
149184076|NCT00090285|538145125|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
149184077|NCT00090285|538145126|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
149184078|NCT00090285|538145127|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
149184079|NCT00090285|538145128|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
149184080|NCT00090285|538145123|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149184081|NCT00090285|538145124|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149184082|NCT00090285|538145125|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149184083|NCT00090285|538145126|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
149184084|NCT00090285|538145127|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
149184085|NCT00090285|538145128|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
149184086|NCT00090285|538145123|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149184087|NCT00090285|538145124|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149184088|NCT00090285|538145125|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149184089|NCT00090285|538145126|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
149184090|NCT00090285|538145127|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
149184091|NCT00090285|538145128|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
149184092|NCT00090285|538145123|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
149184093|NCT00090285|538145124|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
149184094|NCT00090285|538145125|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
149184095|NCT00090285|538145126|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
149184096|NCT00090285|538145127|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
149184097|NCT00090285|538145128|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
148932993|NCT02923427|537240162|FG001|Overall Study|can not replace LMA|0|||
149184098|NCT04498910|538145133|FG000|Overall Study|Lost to Follow-up|0|||
149184099|NCT04498910|538145134|FG001|Overall Study|Lost to Follow-up|1|||
149184100|NCT04498910|538145133|FG000|Overall Study|Withdrawal by Subject|2|||
149184101|NCT04498910|538145134|FG001|Overall Study|Withdrawal by Subject|1|||
149184102|NCT04498910|538145133|FG000|Overall Study|Adverse Event|1|||
149184103|NCT04498910|538145134|FG001|Overall Study|Adverse Event|0|||
149184104|NCT02345434|538145136|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
149184105|NCT02345434|538145137|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
149184106|NCT01022853|538145138|FG000|Overall Study|Progressive disease|2|||
149184107|NCT01022853|538145139|FG001|Overall Study|Progressive disease|3|||
149184108|NCT01022853|538145140|FG002|Overall Study|Progressive disease|11|||
148932994|NCT01675427|537240164|FG000|Overall Study|Withdrawal by Subject|7|||
149184109|NCT01022853|538145141|FG003|Overall Study|Progressive disease|7|||
149184110|NCT01022853|538145142|FG004|Overall Study|Progressive disease|1|||
149184111|NCT01022853|538145138|FG000|Overall Study|Dose-limiting toxicity|0|||
149184112|NCT01022853|538145139|FG001|Overall Study|Dose-limiting toxicity|0|||
149184113|NCT01022853|538145140|FG002|Overall Study|Dose-limiting toxicity|0|||
149184114|NCT01022853|538145141|FG003|Overall Study|Dose-limiting toxicity|0|||
149184115|NCT01022853|538145142|FG004|Overall Study|Dose-limiting toxicity|1|||
149184116|NCT01022853|538145138|FG000|Overall Study|Withdrawal by Subject|0|||
149184117|NCT01022853|538145139|FG001|Overall Study|Withdrawal by Subject|1|||
149184118|NCT01022853|538145140|FG002|Overall Study|Withdrawal by Subject|1|||
149184119|NCT01022853|538145141|FG003|Overall Study|Withdrawal by Subject|1|||
149184120|NCT01022853|538145142|FG004|Overall Study|Withdrawal by Subject|0|||
149184121|NCT01022853|538145138|FG000|Overall Study|Other not stated above|1|||
149184122|NCT01022853|538145139|FG001|Overall Study|Other not stated above|0|||
149184123|NCT01022853|538145140|FG002|Overall Study|Other not stated above|1|||
149184124|NCT01022853|538145141|FG003|Overall Study|Other not stated above|0|||
149184125|NCT01022853|538145142|FG004|Overall Study|Other not stated above|0|||
149184126|NCT00532883|538145143|FG000|Overall Study|Adverse Event|1|||
149184127|NCT00532883|538145144|FG001|Overall Study|Adverse Event|0|||
149184128|NCT00532883|538145145|FG002|Overall Study|Adverse Event|0|||
149184129|NCT00532883|538145146|FG003|Overall Study|Adverse Event|1|||
149184130|NCT00532883|538145143|FG000|Overall Study|Lost to Follow-up|1|||
149184131|NCT00532883|538145144|FG001|Overall Study|Lost to Follow-up|1|||
149184132|NCT00532883|538145145|FG002|Overall Study|Lost to Follow-up|1|||
149184133|NCT00532883|538145146|FG003|Overall Study|Lost to Follow-up|0|||
149184134|NCT00532883|538145143|FG000|Overall Study|Withdrawal by Subject|0|||
149184135|NCT00532883|538145144|FG001|Overall Study|Withdrawal by Subject|1|||
149184136|NCT00532883|538145145|FG002|Overall Study|Withdrawal by Subject|1|||
149184137|NCT00532883|538145146|FG003|Overall Study|Withdrawal by Subject|0|||
149184138|NCT00532883|538145143|FG000|Overall Study|Subject was Nonadherent|0|||
149184139|NCT00532883|538145144|FG001|Overall Study|Subject was Nonadherent|1|||
149184140|NCT00532883|538145145|FG002|Overall Study|Subject was Nonadherent|1|||
149184141|NCT00532883|538145146|FG003|Overall Study|Subject was Nonadherent|0|||
149184142|NCT00532883|538145143|FG000|Overall Study|Early Study Termination|4|||
149184143|NCT00532883|538145144|FG001|Overall Study|Early Study Termination|4|||
149184144|NCT00532883|538145145|FG002|Overall Study|Early Study Termination|1|||
149184145|NCT00532883|538145146|FG003|Overall Study|Early Study Termination|4|||
149184146|NCT01172288|538145147|FG000|Overall Study|Adverse Event|1|||
149184147|NCT01172288|538145148|FG001|Overall Study|Adverse Event|0|||
149184148|NCT01172288|538145147|FG000|Overall Study|Protocol Violation|0|||
149184149|NCT01172288|538145148|FG001|Overall Study|Protocol Violation|1|||
149184150|NCT01327339|538145149|FG000|Overall Study|Protocol Violation|8|||
149184151|NCT02795767|538145150|FG000|Overall Study|Received Commercial Emicizumab|1|||
149184152|NCT02795767|538145151|FG001|Overall Study|Received Commercial Emicizumab|0|||
149184153|NCT02795767|538145152|FG002|Overall Study|Received Commercial Emicizumab|0|||
149184154|NCT03964415|538145153|FG000|Overall Study|Sponsor's decision|1563|||
149184155|NCT03964415|538145154|FG001|Overall Study|Sponsor's decision|1528|||
149184156|NCT03964415|538145153|FG000|Overall Study|Lost to Follow-up|139|||
149184157|NCT03964415|538145154|FG001|Overall Study|Lost to Follow-up|146|||
149184158|NCT03964415|538145153|FG000|Overall Study|Withdrawal by Subject|68|||
149184159|NCT03964415|538145154|FG001|Overall Study|Withdrawal by Subject|72|||
149184160|NCT03964415|538145153|FG000|Overall Study|Physician Decision|34|||
149184161|NCT03964415|538145154|FG001|Overall Study|Physician Decision|48|||
149184162|NCT03964415|538145153|FG000|Overall Study|Adverse Event|3|||
149184163|NCT03964415|538145154|FG001|Overall Study|Adverse Event|0|||
149184164|NCT03964415|538145153|FG000|Overall Study|Death|4|||
149184165|NCT03964415|538145154|FG001|Overall Study|Death|6|||
149184166|NCT03964415|538145153|FG000|Overall Study|Protocol Violation|1|||
149184167|NCT03964415|538145154|FG001|Overall Study|Protocol Violation|4|||
149184168|NCT03964415|538145153|FG000|Overall Study|Other|35|||
149184169|NCT03964415|538145154|FG001|Overall Study|Other|38|||
149184170|NCT03964415|538145153|FG000|Overall Study|Randomized but not treated|6|||
149184171|NCT03964415|538145154|FG001|Overall Study|Randomized but not treated|7|||
148679675|NCT02164539|536300861|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
149184172|NCT01302769|538145159|FG000|Overall Study|Lost to Follow-up|1|||
149184173|NCT01302769|538145160|FG001|Overall Study|Lost to Follow-up|1|||
149184174|NCT01097330|538145161|FG000|Overall Study|Study terminated early|7|||
149184175|NCT01097330|538145162|FG001|Overall Study|Study terminated early|5|||
149184176|NCT03245814|538145173|FG000|Overall Study|Lost to Follow-up|5|||
149184177|NCT03245814|538145174|FG001|Overall Study|Lost to Follow-up|8|||
149184178|NCT03245814|538145173|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
149184179|NCT03245814|538145174|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
149184180|NCT02263365|538145178|FG000|Overall Study|Physician Decision|22|||
149184181|NCT02263365|538145179|FG001|Overall Study|Physician Decision|18|||
149184182|NCT00510692|538145180|FG000|Overall Study|Adverse Event|1|||
149184183|NCT00510692|538145181|FG001|Overall Study|Adverse Event|3|||
149184184|NCT00510692|538145180|FG000|Overall Study|Withdrawal by Subject|1|||
149184185|NCT00510692|538145181|FG001|Overall Study|Withdrawal by Subject|0|||
149184186|NCT00945191|538145182|FG000|Overall Study|Did not achieve a complete response|18|||
149184187|NCT00945191|538145182|FG000|Overall Study|Participant relocated to another state|1|||
149184188|NCT00945191|538145182|FG000|Overall Study|Disease progression|3|||
149184189|NCT00945191|538145182|FG000|Overall Study|Serious adverse event or adverse event|1|||
149184190|NCT00945191|538145182|FG000|Overall Study|Investigator's discretion|1|||
149184191|NCT00784784|538145183|FG000|Overall Study|Withdrawal by Subject|2|||
149184192|NCT00784784|538145184|FG001|Overall Study|Withdrawal by Subject|2|||
149184193|NCT01004146|538145185|FG000|Overall Study|Withdrawal by Subject|4|||
148932995|NCT01675427|537240164|FG000|Overall Study|Participant Refused Sample Collection|18|||
149184194|NCT01004146|538145186|FG001|Overall Study|Withdrawal by Subject|5|||
149184195|NCT03290300|538145189|FG000|Overall Study|Lost to Follow-up|3|||
149184196|NCT01001494|538145190|FG000|Overall Study|Adverse Event|8|||
149184197|NCT01001494|538145191|FG001|Overall Study|Adverse Event|4|||
149184198|NCT01001494|538145192|FG002|Overall Study|Adverse Event|6|||
148932996|NCT01675427|537240164|FG000|Overall Study|Sample not Collected by Mistake|2|||
148932997|NCT01675427|537240164|FG000|Overall Study|Lost to Follow-up|5|||
148932998|NCT01675427|537240164|FG000|Overall Study|Other|2|||
148932999|NCT02556203|537240165|FG000|Overall Study|Withdrawal by Subject|21|||
148933000|NCT02556203|537240166|FG001|Overall Study|Withdrawal by Subject|21|||
148933001|NCT02556203|537240165|FG000|Overall Study|Lost to Follow-up|5|||
148933002|NCT02556203|537240166|FG001|Overall Study|Lost to Follow-up|5|||
148933003|NCT02556203|537240165|FG000|Overall Study|Adverse Event|1|||
148933004|NCT02556203|537240166|FG001|Overall Study|Adverse Event|0|||
148933005|NCT00611533|537240167|FG000|First Intervention (6 Weeks)|Never started study|0|||
148933006|NCT00611533|537240168|FG001|First Intervention (6 Weeks)|Never started study|1|||
148933007|NCT00611533|537240167|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
148933008|NCT00611533|537240168|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
148933009|NCT00611533|537240167|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
148933010|NCT00611533|537240168|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
148933011|NCT05021081|537240171|FG000|Phase 2|Subject enrolled in error|1|||
148933012|NCT05021081|537240172|FG001|Phase 2|Subject enrolled in error|1|||
148933013|NCT05021081|537240173|FG002|Phase 2|Subject enrolled in error|0|||
148933014|NCT00100178|537240176|FG000|Overall Study|Lost to Follow-up|0|||
148933015|NCT00100178|537240177|FG001|Overall Study|Lost to Follow-up|6|||
148933016|NCT00100178|537240178|FG002|Overall Study|Lost to Follow-up|5|||
148933017|NCT00100178|537240176|FG000|Overall Study|Adverse Event|2|||
149184199|NCT01001494|538145190|FG000|Overall Study|Protocol Violation|0|||
149184200|NCT01001494|538145191|FG001|Overall Study|Protocol Violation|1|||
149184201|NCT01001494|538145192|FG002|Overall Study|Protocol Violation|1|||
149184202|NCT01001494|538145190|FG000|Overall Study|Lost to Follow-up|2|||
149184203|NCT01001494|538145191|FG001|Overall Study|Lost to Follow-up|0|||
149184204|NCT01001494|538145192|FG002|Overall Study|Lost to Follow-up|1|||
149184205|NCT01001494|538145190|FG000|Overall Study|Withdrawal by Subject|9|||
149184206|NCT01001494|538145191|FG001|Overall Study|Withdrawal by Subject|7|||
149184207|NCT01001494|538145192|FG002|Overall Study|Withdrawal by Subject|17|||
149184208|NCT01001494|538145190|FG000|Overall Study|COPD exacerbation|3|||
149184209|NCT01001494|538145191|FG001|Overall Study|COPD exacerbation|4|||
149184210|NCT01001494|538145192|FG002|Overall Study|COPD exacerbation|5|||
149184211|NCT01001494|538145190|FG000|Overall Study|Lack of Efficacy|2|||
149184212|NCT01001494|538145191|FG001|Overall Study|Lack of Efficacy|0|||
149184213|NCT01001494|538145192|FG002|Overall Study|Lack of Efficacy|8|||
149184214|NCT01001494|538145190|FG000|Overall Study|Other|0|||
149184215|NCT01001494|538145191|FG001|Overall Study|Other|1|||
149184216|NCT01001494|538145192|FG002|Overall Study|Other|3|||
149184217|NCT02124798|538145193|FG000|Overall Study|Adverse Event|3|||
149184218|NCT02124798|538145193|FG000|Overall Study|Lost to Follow-up|1|||
149184219|NCT01797432|538145194|FG000|Overall Study|Lost to Follow-up|1|||
149184220|NCT01797432|538145194|FG000|Overall Study|Adverse Event|1|||
148933018|NCT00100178|537240177|FG001|Overall Study|Adverse Event|2|||
148933019|NCT00100178|537240178|FG002|Overall Study|Adverse Event|1|||
148933020|NCT00100178|537240176|FG000|Overall Study|Withdrawal by Subject|1|||
148933021|NCT00100178|537240177|FG001|Overall Study|Withdrawal by Subject|1|||
148933022|NCT00100178|537240178|FG002|Overall Study|Withdrawal by Subject|1|||
148933023|NCT00100178|537240176|FG000|Overall Study|Physician Decision|6|||
149014191|NCT04921969|537530906|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
149184221|NCT01797432|538145194|FG000|Overall Study|Withdrawal by Subject|1|||
148933024|NCT00100178|537240177|FG001|Overall Study|Physician Decision|1|||
148933025|NCT00100178|537240178|FG002|Overall Study|Physician Decision|3|||
148933026|NCT00631696|537240185|FG000|Overall Study|Entered, not randomized to treatment|1|||
149184222|NCT01797432|538145194|FG000|Overall Study|lived too far from study site|1|||
149184223|NCT02792777|538145195|FG000|Overall Study|Withdrawal by Subject|2|||
149184224|NCT02792777|538145196|FG001|Overall Study|Withdrawal by Subject|0|||
149184225|NCT02792777|538145195|FG000|Overall Study|Recording malfunction|2|||
149184226|NCT02792777|538145196|FG001|Overall Study|Recording malfunction|0|||
149184227|NCT02792777|538145195|FG000|Overall Study|Later determined to be ineligible|2|||
149184228|NCT02792777|538145196|FG001|Overall Study|Later determined to be ineligible|0|||
149014192|NCT04921969|537530907|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
149014193|NCT04921969|537530908|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
149014194|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
149014195|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
149014196|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
149014197|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
149014198|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
149014199|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
149014200|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
149014201|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149014202|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149014203|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149014204|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
149014205|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149014206|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
149014207|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
149014208|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149014209|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149014210|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149014211|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
149014212|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
148933027|NCT00631696|537240186|FG001|Overall Study|Entered, not randomized to treatment|1|||
148933028|NCT00631696|537240185|FG000|Overall Study|Discontinued after database release date|1|||
148933029|NCT00631696|537240186|FG001|Overall Study|Discontinued after database release date|0|||
148933030|NCT00631696|537240185|FG000|Overall Study|Follow up after database release date|1|||
148933031|NCT00631696|537240186|FG001|Overall Study|Follow up after database release date|0|||
148933032|NCT00631696|537240185|FG000|Overall Study|Lost to Follow-up|7|||
148933033|NCT00631696|537240186|FG001|Overall Study|Lost to Follow-up|10|||
148933034|NCT00631696|537240185|FG000|Overall Study|Withdrawal by Subject|2|||
148933035|NCT00631696|537240186|FG001|Overall Study|Withdrawal by Subject|9|||
148933036|NCT00631696|537240185|FG000|Overall Study|Other|8|||
148933037|NCT00631696|537240186|FG001|Overall Study|Other|8|||
148933038|NCT00631696|537240185|FG000|Overall Study|Protocol Violation|9|||
148933039|NCT00631696|537240186|FG001|Overall Study|Protocol Violation|9|||
148933040|NCT00631696|537240185|FG000|Overall Study|Study terminated by sponsor|3|||
148933041|NCT00631696|537240186|FG001|Overall Study|Study terminated by sponsor|3|||
148933042|NCT00631696|537240185|FG000|Overall Study|Adverse Event|5|||
148933043|NCT00631696|537240186|FG001|Overall Study|Adverse Event|0|||
148933044|NCT01439568|537240188|FG000|Overall Study|Lost to Follow-up|1|||
148933045|NCT01439568|537240189|FG001|Overall Study|Lost to Follow-up|0|||
148933046|NCT01439568|537240188|FG000|Overall Study|Withdrawal by Subject|2|||
148933047|NCT01439568|537240189|FG001|Overall Study|Withdrawal by Subject|2|||
148933048|NCT01578330|537240190|FG000|Overall Study|Adverse Event|2|||
148933049|NCT01578330|537240190|FG000|Overall Study|Protocol Violation|5|||
148933050|NCT01134731|537240191|FG000|Overall Study|Adverse Event|3|||
148933051|NCT01134731|537240192|FG001|Overall Study|Adverse Event|2|||
148933052|NCT01134731|537240193|FG002|Overall Study|Adverse Event|1|||
148933053|NCT01134731|537240191|FG000|Overall Study|Physician Decision|2|||
148933054|NCT01134731|537240192|FG001|Overall Study|Physician Decision|2|||
148933055|NCT01134731|537240193|FG002|Overall Study|Physician Decision|2|||
148933056|NCT01134731|537240191|FG000|Overall Study|Lack of Efficacy|0|||
148933057|NCT01134731|537240192|FG001|Overall Study|Lack of Efficacy|0|||
148933058|NCT01134731|537240193|FG002|Overall Study|Lack of Efficacy|1|||
148933059|NCT01134731|537240191|FG000|Overall Study|Withdrawal by Subject|3|||
148933060|NCT01134731|537240192|FG001|Overall Study|Withdrawal by Subject|3|||
148933061|NCT01134731|537240193|FG002|Overall Study|Withdrawal by Subject|1|||
148933062|NCT01134731|537240191|FG000|Overall Study|Lost to Follow-up|5|||
149014213|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
149014214|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
148933063|NCT01134731|537240192|FG001|Overall Study|Lost to Follow-up|4|||
148933064|NCT01134731|537240193|FG002|Overall Study|Lost to Follow-up|3|||
148933065|NCT01669928|537240194|FG000|First Intervention|Withdrawal by Subject|3|||
148933066|NCT01669928|537240195|FG001|First Intervention|Withdrawal by Subject|5|||
148933067|NCT01954342|537240198|FG000|Overall Study|Missing data from 13-16week study visit|0|||
149014215|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
149184229|NCT02792777|538145195|FG000|Overall Study|Participant interviewed twice|1|||
149184230|NCT02792777|538145196|FG001|Overall Study|Participant interviewed twice|0|||
149184231|NCT02746679|538145198|FG000|Overall Study|Lost to Follow-up|4|||
149184232|NCT02746679|538145199|FG001|Overall Study|Lost to Follow-up|6|||
148933068|NCT01954342|537240199|FG001|Overall Study|Missing data from 13-16week study visit|0|||
148933069|NCT01954342|537240200|FG002|Overall Study|Missing data from 13-16week study visit|0|||
149184233|NCT00487279|538145200|FG000|Overall Study|Death|1|||
148933070|NCT01954342|537240201|FG003|Overall Study|Missing data from 13-16week study visit|1|||
148933071|NCT01954342|537240198|FG000|Overall Study|Miscarriage|0|||
149184234|NCT00487279|538145201|FG001|Overall Study|Death|0|||
149184235|NCT00487279|538145200|FG000|Overall Study|Withdrawal by Subject|0|||
149184236|NCT00487279|538145201|FG001|Overall Study|Withdrawal by Subject|2|||
149184237|NCT00515463|538145205|FG000|Overall Study|Physician Decision|4|||
149184238|NCT00515463|538145206|FG001|Overall Study|Physician Decision|2|||
149184239|NCT00515463|538145205|FG000|Overall Study|Adverse Event|1|||
149184240|NCT00515463|538145206|FG001|Overall Study|Adverse Event|2|||
149184241|NCT00515463|538145205|FG000|Overall Study|Withdrawal by Subject|3|||
149184242|NCT00515463|538145206|FG001|Overall Study|Withdrawal by Subject|4|||
149184243|NCT00515463|538145205|FG000|Overall Study|Lost to Follow-up|6|||
149184244|NCT00515463|538145206|FG001|Overall Study|Lost to Follow-up|5|||
149184245|NCT00515463|538145205|FG000|Overall Study|Other|0|||
149184246|NCT00515463|538145206|FG001|Overall Study|Other|1|||
149184247|NCT00916721|538145207|FG000|Overall Study|Lost to Follow-up|0|||
149184248|NCT00916721|538145208|FG001|Overall Study|Lost to Follow-up|1|||
149184249|NCT00916721|538145207|FG000|Overall Study|Adverse Event|6|||
149184250|NCT00916721|538145208|FG001|Overall Study|Adverse Event|3|||
149184251|NCT00916721|538145207|FG000|Overall Study|Withdrawal by Subject|2|||
149184252|NCT00916721|538145208|FG001|Overall Study|Withdrawal by Subject|2|||
149184253|NCT00916721|538145207|FG000|Overall Study|Protocol Violation|2|||
148933072|NCT01954342|537240199|FG001|Overall Study|Miscarriage|0|||
148933073|NCT01954342|537240200|FG002|Overall Study|Miscarriage|0|||
148933074|NCT01954342|537240201|FG003|Overall Study|Miscarriage|3|||
148933075|NCT01954342|537240198|FG000|Overall Study|Lost to Follow-up|0|||
148933076|NCT01954342|537240199|FG001|Overall Study|Lost to Follow-up|0|||
148933077|NCT01954342|537240200|FG002|Overall Study|Lost to Follow-up|0|||
148933078|NCT01954342|537240201|FG003|Overall Study|Lost to Follow-up|5|||
148933079|NCT01954342|537240198|FG000|Overall Study|Preterm delivery|0|||
148933080|NCT01954342|537240199|FG001|Overall Study|Preterm delivery|0|||
148933081|NCT01954342|537240200|FG002|Overall Study|Preterm delivery|0|||
148933082|NCT01954342|537240201|FG003|Overall Study|Preterm delivery|3|||
148933083|NCT01954342|537240198|FG000|Overall Study|Pre-eclampsia|0|||
148933084|NCT01954342|537240199|FG001|Overall Study|Pre-eclampsia|0|||
148933085|NCT01954342|537240200|FG002|Overall Study|Pre-eclampsia|0|||
148933086|NCT01954342|537240201|FG003|Overall Study|Pre-eclampsia|4|||
148933087|NCT01954342|537240198|FG000|Overall Study|Unreliable Data|0|||
148933088|NCT01954342|537240199|FG001|Overall Study|Unreliable Data|0|||
148933089|NCT01954342|537240200|FG002|Overall Study|Unreliable Data|0|||
148933090|NCT01954342|537240201|FG003|Overall Study|Unreliable Data|2|||
148933091|NCT00381381|537240206|FG000|Overall Study|Adverse Event|3|||
148933092|NCT00381381|537240206|FG000|Overall Study|Lost to Follow-up|52|||
148933093|NCT00381381|537240206|FG000|Overall Study|Withdrawal by Subject|9|||
148933094|NCT00292318|537240219|FG000|Overall Study|Study terminated by officials|2|||
148933095|NCT00292318|537240220|FG001|Overall Study|Study terminated by officials|1|||
148933096|NCT02027376|537240221|FG000|Overall Study|Death|1|||
148933097|NCT02027376|537240222|FG001|Overall Study|Death|0|||
148933098|NCT02027376|537240223|FG002|Overall Study|Death|0|||
148933099|NCT01414608|537240224|FG000|Overall Study|Ineligible|5|||
148933100|NCT01414608|537240225|FG001|Overall Study|Ineligible|2|||
148933101|NCT05156073|537240226|FG000|Overall Study|Patient canceled appointment with PCP|1|||
148933102|NCT00973349|537240227|FG000|Overall Study|Adverse Event|0|||
148933103|NCT00973349|537240228|FG001|Overall Study|Adverse Event|0|||
148933104|NCT00973349|537240229|FG002|Overall Study|Adverse Event|0|||
148933105|NCT00973349|537240230|FG003|Overall Study|Adverse Event|0|||
148933106|NCT00973349|537240231|FG004|Overall Study|Adverse Event|1|||
148933107|NCT00973349|537240232|FG005|Overall Study|Adverse Event|0|||
148933108|NCT00973349|537240233|FG006|Overall Study|Adverse Event|0|||
148933109|NCT00973349|537240234|FG007|Overall Study|Adverse Event|0|||
148933110|NCT00973349|537240235|FG008|Overall Study|Adverse Event|1|||
148933111|NCT00973349|537240236|FG009|Overall Study|Adverse Event|0|||
148933112|NCT00973349|537240237|FG010|Overall Study|Adverse Event|0|||
148933113|NCT00973349|537240238|FG011|Overall Study|Adverse Event|0|||
148933114|NCT00973349|537240239|FG012|Overall Study|Adverse Event|0|||
148933115|NCT00973349|537240240|FG013|Overall Study|Adverse Event|0|||
149184254|NCT00916721|538145208|FG001|Overall Study|Protocol Violation|4|||
149184255|NCT02399475|538145220|FG000|Overall Study|Physician Decision|1|||
148933116|NCT00973349|537240241|FG014|Overall Study|Adverse Event|1|||
148933117|NCT00973349|537240242|FG015|Overall Study|Adverse Event|0|||
148933118|NCT00973349|537240227|FG000|Overall Study|Withdrawal by Subject|1|||
148933119|NCT00973349|537240228|FG001|Overall Study|Withdrawal by Subject|2|||
149184256|NCT02399475|538145221|FG001|Overall Study|Physician Decision|0|||
149184257|NCT00404768|538145225|FG000|Part A and B|Withdrawn due to labor progression|1|||
149184258|NCT00404768|538145226|FG001|Part A and B|Withdrawn due to labor progression|0|||
149184259|NCT00404768|538145227|FG002|Part A and B|Withdrawn due to labor progression|0|||
149184260|NCT00404768|538145228|FG003|Part A and B|Withdrawn due to labor progression|0|||
149184261|NCT00404768|538145225|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
148807353|NCT00903968|536773234|FG006|Overall Study|Non-Compliance|0|||
148933120|NCT00973349|537240229|FG002|Overall Study|Withdrawal by Subject|2|||
148933121|NCT00973349|537240230|FG003|Overall Study|Withdrawal by Subject|3|||
149184262|NCT00404768|538145226|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
148933122|NCT00973349|537240231|FG004|Overall Study|Withdrawal by Subject|2|||
148933123|NCT00973349|537240232|FG005|Overall Study|Withdrawal by Subject|0|||
149184263|NCT00404768|538145227|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
149184264|NCT00404768|538145228|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
149184265|NCT00404768|538145225|FG000|Part C|Adverse Event|0|||
149184266|NCT00404768|538145226|FG001|Part C|Adverse Event|0|||
149184267|NCT00404768|538145227|FG002|Part C|Adverse Event|0|||
149184268|NCT00404768|538145228|FG003|Part C|Adverse Event|3|||
149184269|NCT00404768|538145225|FG000|Part C|Lost to Follow-up|0|||
149184270|NCT00404768|538145226|FG001|Part C|Lost to Follow-up|0|||
149184271|NCT00404768|538145227|FG002|Part C|Lost to Follow-up|3|||
149184272|NCT00404768|538145228|FG003|Part C|Lost to Follow-up|1|||
149184273|NCT00404768|538145225|FG000|Part C|Withdrawal by Subject|0|||
149184274|NCT00404768|538145226|FG001|Part C|Withdrawal by Subject|0|||
149184275|NCT00404768|538145227|FG002|Part C|Withdrawal by Subject|2|||
149184276|NCT00404768|538145228|FG003|Part C|Withdrawal by Subject|1|||
149184277|NCT00404768|538145225|FG000|Part C|Early withdrawal from study medication|0|||
149184278|NCT00404768|538145226|FG001|Part C|Early withdrawal from study medication|0|||
149184279|NCT00404768|538145227|FG002|Part C|Early withdrawal from study medication|1|||
149184280|NCT00404768|538145228|FG003|Part C|Early withdrawal from study medication|0|||
149184281|NCT00404768|538145225|FG000|Part C|Participant did not respond to therapy|0|||
149184282|NCT00404768|538145226|FG001|Part C|Participant did not respond to therapy|0|||
149184283|NCT00404768|538145227|FG002|Part C|Participant did not respond to therapy|1|||
149184284|NCT00404768|538145228|FG003|Part C|Participant did not respond to therapy|1|||
149184285|NCT00404768|538145225|FG000|Part C|Physician withdrew the study medication|0|||
149184286|NCT00404768|538145226|FG001|Part C|Physician withdrew the study medication|0|||
149184287|NCT00404768|538145227|FG002|Part C|Physician withdrew the study medication|1|||
149184288|NCT00404768|538145228|FG003|Part C|Physician withdrew the study medication|0|||
149184289|NCT00404768|538145225|FG000|Part C|Participant delivered baby|0|||
149184290|NCT00404768|538145226|FG001|Part C|Participant delivered baby|0|||
149184291|NCT00404768|538145227|FG002|Part C|Participant delivered baby|0|||
149184292|NCT00404768|538145228|FG003|Part C|Participant delivered baby|1|||
149184293|NCT00404768|538145225|FG000|Part C|Unsatisfactory uterine response to IP|0|||
149184294|NCT00404768|538145226|FG001|Part C|Unsatisfactory uterine response to IP|0|||
149184295|NCT00404768|538145227|FG002|Part C|Unsatisfactory uterine response to IP|0|||
149184296|NCT00404768|538145228|FG003|Part C|Unsatisfactory uterine response to IP|1|||
149184297|NCT00404768|538145225|FG000|Part C|Active labor|0|||
149184298|NCT00404768|538145226|FG001|Part C|Active labor|0|||
149184299|NCT00404768|538145227|FG002|Part C|Active labor|0|||
149184300|NCT00404768|538145228|FG003|Part C|Active labor|1|||
149184301|NCT00404768|538145225|FG000|Part C|Lack of Efficacy|0|||
149184302|NCT00404768|538145226|FG001|Part C|Lack of Efficacy|0|||
149184303|NCT00404768|538145227|FG002|Part C|Lack of Efficacy|0|||
149184304|NCT00404768|538145228|FG003|Part C|Lack of Efficacy|2|||
149184305|NCT00404768|538145225|FG000|Part C|Treatment failure|0|||
149184306|NCT00404768|538145226|FG001|Part C|Treatment failure|0|||
149184307|NCT00404768|538145227|FG002|Part C|Treatment failure|0|||
149184308|NCT00404768|538145228|FG003|Part C|Treatment failure|1|||
149184309|NCT00404768|538145225|FG000|Part C|Investigator discretion|0|||
149184310|NCT00404768|538145226|FG001|Part C|Investigator discretion|0|||
149184311|NCT00404768|538145227|FG002|Part C|Investigator discretion|0|||
149184312|NCT00404768|538145228|FG003|Part C|Investigator discretion|1|||
149184313|NCT00404768|538145225|FG000|Part C|Researcher suspended study medication|0|||
149184314|NCT00404768|538145226|FG001|Part C|Researcher suspended study medication|0|||
149184315|NCT00404768|538145227|FG002|Part C|Researcher suspended study medication|0|||
149184316|NCT00404768|538145228|FG003|Part C|Researcher suspended study medication|1|||
149184317|NCT03575468|538145229|FG000|Overall Study|Withdrawal by Subject|3|||
148933124|NCT00973349|537240233|FG006|Overall Study|Withdrawal by Subject|2|||
148933125|NCT00973349|537240234|FG007|Overall Study|Withdrawal by Subject|2|||
148933126|NCT00973349|537240235|FG008|Overall Study|Withdrawal by Subject|0|||
148933127|NCT00973349|537240236|FG009|Overall Study|Withdrawal by Subject|2|||
148933128|NCT00973349|537240237|FG010|Overall Study|Withdrawal by Subject|0|||
148933129|NCT00973349|537240238|FG011|Overall Study|Withdrawal by Subject|1|||
148933130|NCT00973349|537240239|FG012|Overall Study|Withdrawal by Subject|0|||
149184318|NCT03575468|538145230|FG001|Overall Study|Withdrawal by Subject|0|||
149184319|NCT03575468|538145229|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
149184320|NCT03575468|538145230|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
149184321|NCT03575468|538145229|FG000|Overall Study|Lost to Follow-up|13|||
149184322|NCT03575468|538145230|FG001|Overall Study|Lost to Follow-up|17|||
149184323|NCT01118143|538145231|FG000|Overall Study|Withdrawal by Subject|2|||
149184324|NCT01118143|538145232|FG001|Overall Study|Withdrawal by Subject|5|||
149184325|NCT02112448|538145233|FG000|Overall Study|lab values precluding use of ketorolac|2|||
149184326|NCT02112448|538145234|FG001|Overall Study|lab values precluding use of ketorolac|2|||
149184327|NCT02112448|538145233|FG000|Overall Study|Protocol Violation|1|||
149184328|NCT02112448|538145234|FG001|Overall Study|Protocol Violation|2|||
149184329|NCT02112448|538145233|FG000|Overall Study|Physician Decision|4|||
149184330|NCT02112448|538145234|FG001|Overall Study|Physician Decision|6|||
149184331|NCT02112448|538145233|FG000|Overall Study|required heparin so could not use ketoro|1|||
149184332|NCT02112448|538145234|FG001|Overall Study|required heparin so could not use ketoro|0|||
149184333|NCT01597622|538147021|FG000|Overall Study|Adverse Event|7|||
149184334|NCT01597622|538147021|FG000|Overall Study|Lack of Efficacy|3|||
149184335|NCT01597622|538147021|FG000|Overall Study|Protocol Violation|1|||
149184336|NCT01597622|538147021|FG000|Overall Study|Lost to Follow-up|1|||
149184337|NCT01597622|538147021|FG000|Overall Study|Investigator Discretion|5|||
149184338|NCT01597622|538147021|FG000|Overall Study|Withdrawal by Subject|20|||
149184339|NCT01597622|538147021|FG000|Overall Study|Death|1|||
149184340|NCT04543955|538147022|FG000|Overall Study|Company cancelled study|1|||
149184341|NCT04543955|538147023|FG001|Overall Study|Company cancelled study|0|||
149184342|NCT01228071|538147026|FG000|Overall Study|Protocol Violation|1|||
149184343|NCT01228071|538147026|FG000|Overall Study|Withdrawal by Subject|1|||
149184344|NCT02385123|538147034|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
149184345|NCT04230486|538147036|FG000|Overall Study|Screen Failure|1|||
149184346|NCT03215264|538147037|FG000|Dose Level 2|Adverse Event|0|||
149184347|NCT03215264|538147038|FG001|Dose Level 2|Adverse Event|1|||
149184348|NCT03215264|538147039|FG002|Dose Level 2|Adverse Event|0|||
149184349|NCT03215264|538147037|FG000|Dose Level 3|Withdrawal by Subject|0|||
149184350|NCT03215264|538147038|FG001|Dose Level 3|Withdrawal by Subject|0|||
149184351|NCT03215264|538147039|FG002|Dose Level 3|Withdrawal by Subject|1|||
149184352|NCT02145156|538147041|FG000|Overall Study|No match to vaccination records|60|||
149184353|NCT02145156|538147042|FG001|Overall Study|No match to vaccination records|52|||
149184354|NCT02145156|538147043|FG002|Overall Study|No match to vaccination records|41|||
149184355|NCT01740440|538147046|FG000|Overall Study|Lost to Follow-up|3|||
149184356|NCT02417233|538147047|FG000|Overall Study|Death|4|||
149184357|NCT02417233|538147048|FG001|Overall Study|Death|10|||
149184358|NCT02417233|538147049|FG002|Overall Study|Death|14|||
149184359|NCT02417233|538147047|FG000|Overall Study|Lost to Follow-up|27|||
149184360|NCT02417233|538147048|FG001|Overall Study|Lost to Follow-up|39|||
149184361|NCT02417233|538147049|FG002|Overall Study|Lost to Follow-up|34|||
149184362|NCT02417233|538147047|FG000|Overall Study|Protocol Violation|2|||
149184363|NCT02417233|538147048|FG001|Overall Study|Protocol Violation|0|||
149184364|NCT02417233|538147049|FG002|Overall Study|Protocol Violation|2|||
149184365|NCT02417233|538147047|FG000|Overall Study|Withdrawal by Subject|2|||
149184366|NCT02417233|538147048|FG001|Overall Study|Withdrawal by Subject|1|||
149184367|NCT02417233|538147049|FG002|Overall Study|Withdrawal by Subject|8|||
149184368|NCT02417233|538147047|FG000|Overall Study|Relocation out of study area|1|||
149184369|NCT02417233|538147048|FG001|Overall Study|Relocation out of study area|0|||
149184370|NCT02417233|538147049|FG002|Overall Study|Relocation out of study area|1|||
149184371|NCT02417233|538147047|FG000|Overall Study|Mentally unstable|0|||
149184372|NCT02417233|538147048|FG001|Overall Study|Mentally unstable|1|||
149184373|NCT02417233|538147049|FG002|Overall Study|Mentally unstable|0|||
149184374|NCT01063751|538147051|FG000|Overall Study|Censored from analyses|42|||
149184375|NCT01063751|538147051|FG000|Overall Study|Withdrawal by Subject|34|||
148933131|NCT00973349|537240240|FG013|Overall Study|Withdrawal by Subject|0|||
148933132|NCT00973349|537240241|FG014|Overall Study|Withdrawal by Subject|0|||
148933133|NCT00973349|537240242|FG015|Overall Study|Withdrawal by Subject|0|||
148933134|NCT00973349|537240227|FG000|Overall Study|Lost to Follow-up|3|||
148933135|NCT00973349|537240228|FG001|Overall Study|Lost to Follow-up|1|||
148933136|NCT00973349|537240229|FG002|Overall Study|Lost to Follow-up|2|||
148933137|NCT00973349|537240230|FG003|Overall Study|Lost to Follow-up|2|||
148933138|NCT00973349|537240231|FG004|Overall Study|Lost to Follow-up|1|||
148933139|NCT00973349|537240232|FG005|Overall Study|Lost to Follow-up|3|||
148933140|NCT00973349|537240233|FG006|Overall Study|Lost to Follow-up|0|||
148933141|NCT00973349|537240234|FG007|Overall Study|Lost to Follow-up|1|||
148933142|NCT00973349|537240235|FG008|Overall Study|Lost to Follow-up|2|||
148933143|NCT00973349|537240236|FG009|Overall Study|Lost to Follow-up|1|||
148933144|NCT00973349|537240237|FG010|Overall Study|Lost to Follow-up|0|||
148933145|NCT00973349|537240238|FG011|Overall Study|Lost to Follow-up|1|||
149184376|NCT01063751|538147051|FG000|Overall Study|Lost to Follow-up|30|||
149184377|NCT01063751|538147051|FG000|Overall Study|Death|13|||
149184378|NCT01063751|538147051|FG000|Overall Study|Sponsored Terminated Study|60|||
149184379|NCT01063751|538147051|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
149184380|NCT01063751|538147051|FG000|Overall Study|Investigator site closed|10|||
149184381|NCT01063751|538147051|FG000|Overall Study|Revision|6|||
148933146|NCT00973349|537240239|FG012|Overall Study|Lost to Follow-up|0|||
149184382|NCT01063751|538147051|FG000|Overall Study|Physician Decision|4|||
148933147|NCT00973349|537240240|FG013|Overall Study|Lost to Follow-up|0|||
148933148|NCT00973349|537240241|FG014|Overall Study|Lost to Follow-up|0|||
148933149|NCT00973349|537240242|FG015|Overall Study|Lost to Follow-up|1|||
149184383|NCT01264965|538147059|FG000|Overall Study|Withdrawal by Subject|10|||
149184384|NCT00406315|538147064|FG000|Overall Study|Death|1|||
149184385|NCT00406315|538147064|FG000|Overall Study|Adverse Event|39|||
149184386|NCT00406315|538147064|FG000|Overall Study|Laboratory Abnormality|4|||
149184387|NCT00406315|538147064|FG000|Overall Study|Lack of Efficacy|13|||
149184388|NCT00406315|538147064|FG000|Overall Study|Other|33|||
149184389|NCT00406315|538147064|FG000|Overall Study|Lost to Follow-up|21|||
149184390|NCT00406315|538147064|FG000|Overall Study|Withdrawal by Subject|30|||
149184391|NCT03799718|538147066|FG000|Overall Study|Adverse Event|2|||
149184392|NCT00321984|538147067|FG000|Overall Study|Adverse Event|9|||
149184393|NCT00321984|538147068|FG001|Overall Study|Adverse Event|6|||
149184394|NCT00321984|538147069|FG002|Overall Study|Adverse Event|8|||
149184395|NCT00321984|538147067|FG000|Overall Study|Protocol Violation|0|||
149184396|NCT00321984|538147068|FG001|Overall Study|Protocol Violation|1|||
149184397|NCT00321984|538147069|FG002|Overall Study|Protocol Violation|1|||
149184398|NCT00321984|538147067|FG000|Overall Study|Lost to Follow-up|2|||
149184399|NCT00321984|538147068|FG001|Overall Study|Lost to Follow-up|4|||
149184400|NCT00321984|538147069|FG002|Overall Study|Lost to Follow-up|2|||
149184401|NCT00321984|538147067|FG000|Overall Study|Withdrawal by Subject|8|||
149184402|NCT00321984|538147068|FG001|Overall Study|Withdrawal by Subject|6|||
149184403|NCT00321984|538147069|FG002|Overall Study|Withdrawal by Subject|5|||
149184404|NCT00321984|538147067|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
149184405|NCT00321984|538147068|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
149184406|NCT00321984|538147069|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
149184407|NCT00321984|538147067|FG000|Overall Study|Lack of Efficacy|3|||
149184408|NCT00321984|538147068|FG001|Overall Study|Lack of Efficacy|1|||
149184409|NCT00321984|538147069|FG002|Overall Study|Lack of Efficacy|3|||
149184410|NCT00321984|538147067|FG000|Overall Study|Noncompliant|0|||
149184411|NCT00321984|538147068|FG001|Overall Study|Noncompliant|0|||
149184412|NCT00321984|538147069|FG002|Overall Study|Noncompliant|2|||
149184413|NCT00321984|538147067|FG000|Overall Study|Pregnancy|0|||
149184414|NCT00321984|538147068|FG001|Overall Study|Pregnancy|1|||
149184415|NCT00321984|538147069|FG002|Overall Study|Pregnancy|0|||
149184416|NCT00321984|538147067|FG000|Overall Study|Per Subject Request|1|||
149184417|NCT00321984|538147068|FG001|Overall Study|Per Subject Request|0|||
149184418|NCT00321984|538147069|FG002|Overall Study|Per Subject Request|0|||
149184419|NCT00321984|538147067|FG000|Overall Study|Per Investigator Request|1|||
149184420|NCT00321984|538147068|FG001|Overall Study|Per Investigator Request|0|||
149184421|NCT00321984|538147069|FG002|Overall Study|Per Investigator Request|0|||
149184422|NCT00321984|538147067|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
149184423|NCT00321984|538147068|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
149184424|NCT00321984|538147069|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
149184425|NCT01469013|538147070|FG000|Part A (Treatment Period)|Adverse Event|1|||
149184426|NCT01469013|538147071|FG001|Part A (Treatment Period)|Adverse Event|0|||
149184427|NCT01469013|538147072|FG002|Part A (Treatment Period)|Adverse Event|0|||
149184428|NCT01469013|538147073|FG003|Part A (Treatment Period)|Adverse Event|0|||
149184429|NCT01469013|538147074|FG004|Part A (Treatment Period)|Adverse Event|1|||
149184430|NCT01469013|538147075|FG005|Part A (Treatment Period)|Adverse Event|0|||
149184431|NCT01469013|538147076|FG006|Part A (Treatment Period)|Adverse Event|0|||
149184432|NCT01469013|538147077|FG007|Part A (Treatment Period)|Adverse Event|0|||
149184433|NCT01469013|538147078|FG008|Part A (Treatment Period)|Adverse Event|0|||
149184434|NCT01469013|538147079|FG009|Part A (Treatment Period)|Adverse Event|0|||
149184435|NCT01469013|538147080|FG010|Part A (Treatment Period)|Adverse Event|0|||
149184436|NCT01469013|538147081|FG011|Part A (Treatment Period)|Adverse Event|0|||
149184437|NCT01469013|538147082|FG012|Part A (Treatment Period)|Adverse Event|0|||
149184438|NCT01469013|538147070|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184439|NCT01469013|538147071|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184440|NCT01469013|538147072|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
149184441|NCT01469013|538147073|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184442|NCT01469013|538147074|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184443|NCT01469013|538147075|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184444|NCT01469013|538147076|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184445|NCT01469013|538147077|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184446|NCT01469013|538147078|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184447|NCT01469013|538147079|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184448|NCT01469013|538147080|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184449|NCT01469013|538147081|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184450|NCT01469013|538147082|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
149184451|NCT01469013|538147070|FG000|Part B (Extension Period)|Adverse Event|0|||
149184452|NCT01469013|538147071|FG001|Part B (Extension Period)|Adverse Event|0|||
149184453|NCT01469013|538147072|FG002|Part B (Extension Period)|Adverse Event|0|||
149184454|NCT01469013|538147073|FG003|Part B (Extension Period)|Adverse Event|0|||
149184455|NCT01469013|538147074|FG004|Part B (Extension Period)|Adverse Event|0|||
149184456|NCT01469013|538147075|FG005|Part B (Extension Period)|Adverse Event|2|||
149184457|NCT01469013|538147076|FG006|Part B (Extension Period)|Adverse Event|5|||
149184458|NCT01469013|538147077|FG007|Part B (Extension Period)|Adverse Event|5|||
149184459|NCT01469013|538147078|FG008|Part B (Extension Period)|Adverse Event|3|||
149184460|NCT01469013|538147079|FG009|Part B (Extension Period)|Adverse Event|3|||
149184461|NCT01469013|538147080|FG010|Part B (Extension Period)|Adverse Event|1|||
149184462|NCT01469013|538147081|FG011|Part B (Extension Period)|Adverse Event|6|||
149184463|NCT01469013|538147082|FG012|Part B (Extension Period)|Adverse Event|3|||
149184464|NCT01469013|538147070|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
149184465|NCT01469013|538147071|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
149184466|NCT01469013|538147072|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
149184467|NCT01469013|538147073|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
149184468|NCT01469013|538147074|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
149184469|NCT01469013|538147075|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
149184470|NCT01469013|538147076|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
149184471|NCT01469013|538147077|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
149184472|NCT01469013|538147078|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
149184473|NCT01469013|538147079|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
149184474|NCT01469013|538147080|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
149184475|NCT01469013|538147081|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
149184476|NCT01469013|538147082|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
149184477|NCT05232097|538147085|FG000|Overall Study|Physician Decision|1|||
149184478|NCT00871858|538147086|FG000|Overall Study|Protocol Violation|3|||
149184479|NCT00871858|538147087|FG001|Overall Study|Protocol Violation|4|||
149184480|NCT00871858|538147086|FG000|Overall Study|Adverse Event|1|||
149184481|NCT00871858|538147087|FG001|Overall Study|Adverse Event|1|||
149184482|NCT00871858|538147086|FG000|Overall Study|Withdrawal by Subject|1|||
149184483|NCT00871858|538147087|FG001|Overall Study|Withdrawal by Subject|1|||
149184484|NCT00871858|538147086|FG000|Overall Study|Lost to Follow-up|0|||
149184485|NCT00871858|538147087|FG001|Overall Study|Lost to Follow-up|1|||
149184486|NCT00700752|538147092|FG000|First Intervention|Withdrawal by Subject|0|||
149184487|NCT00700752|538147093|FG001|First Intervention|Withdrawal by Subject|2|||
149184488|NCT03303339|538147094|FG000|Overall Study|Death|2|||
149184489|NCT03303339|538147095|FG001|Overall Study|Death|2|||
149184490|NCT03303339|538147096|FG002|Overall Study|Death|2|||
149184491|NCT03303339|538147097|FG003|Overall Study|Death|1|||
149184492|NCT03303339|538147098|FG004|Overall Study|Death|4|||
149184493|NCT03303339|538147099|FG005|Overall Study|Death|2|||
149184494|NCT03303339|538147100|FG006|Overall Study|Death|2|||
149184495|NCT03303339|538147101|FG007|Overall Study|Death|2|||
149184496|NCT03303339|538147102|FG008|Overall Study|Death|3|||
149184497|NCT03303339|538147103|FG009|Overall Study|Death|3|||
149184498|NCT03303339|538147104|FG010|Overall Study|Death|4|||
149184499|NCT03303339|538147105|FG011|Overall Study|Death|24|||
149184500|NCT03303339|538147094|FG000|Overall Study|Study Terminated by Sponsor|0|||
149184501|NCT03303339|538147095|FG001|Overall Study|Study Terminated by Sponsor|0|||
149184502|NCT03303339|538147096|FG002|Overall Study|Study Terminated by Sponsor|0|||
149184503|NCT03303339|538147097|FG003|Overall Study|Study Terminated by Sponsor|0|||
149184504|NCT03303339|538147098|FG004|Overall Study|Study Terminated by Sponsor|0|||
149184505|NCT03303339|538147099|FG005|Overall Study|Study Terminated by Sponsor|0|||
149184506|NCT03303339|538147100|FG006|Overall Study|Study Terminated by Sponsor|0|||
149184507|NCT03303339|538147101|FG007|Overall Study|Study Terminated by Sponsor|0|||
149184508|NCT03303339|538147102|FG008|Overall Study|Study Terminated by Sponsor|1|||
149184509|NCT03303339|538147103|FG009|Overall Study|Study Terminated by Sponsor|0|||
149184510|NCT03303339|538147104|FG010|Overall Study|Study Terminated by Sponsor|1|||
149184511|NCT03303339|538147105|FG011|Overall Study|Study Terminated by Sponsor|1|||
149184512|NCT03303339|538147094|FG000|Overall Study|Withdrawal by Subject|1|||
149184513|NCT03303339|538147095|FG001|Overall Study|Withdrawal by Subject|0|||
149184514|NCT03303339|538147096|FG002|Overall Study|Withdrawal by Subject|0|||
149184515|NCT03303339|538147097|FG003|Overall Study|Withdrawal by Subject|0|||
149184516|NCT03303339|538147098|FG004|Overall Study|Withdrawal by Subject|0|||
149184517|NCT03303339|538147099|FG005|Overall Study|Withdrawal by Subject|1|||
149184518|NCT03303339|538147100|FG006|Overall Study|Withdrawal by Subject|1|||
149184519|NCT03303339|538147101|FG007|Overall Study|Withdrawal by Subject|0|||
149184520|NCT03303339|538147102|FG008|Overall Study|Withdrawal by Subject|0|||
149184521|NCT03303339|538147103|FG009|Overall Study|Withdrawal by Subject|0|||
149184522|NCT03303339|538147104|FG010|Overall Study|Withdrawal by Subject|0|||
149184523|NCT03303339|538147105|FG011|Overall Study|Withdrawal by Subject|2|||
149184524|NCT03303339|538147094|FG000|Overall Study|Physician Decision|0|||
149184525|NCT03303339|538147095|FG001|Overall Study|Physician Decision|0|||
149184526|NCT03303339|538147096|FG002|Overall Study|Physician Decision|0|||
148807354|NCT00903968|536773235|FG007|Overall Study|Non-Compliance|0|||
148807355|NCT00903968|536773228|FG000|Overall Study|Physician Decision|0|||
149184527|NCT03303339|538147097|FG003|Overall Study|Physician Decision|0|||
149184528|NCT03303339|538147098|FG004|Overall Study|Physician Decision|1|||
149184529|NCT03303339|538147099|FG005|Overall Study|Physician Decision|0|||
149184530|NCT03303339|538147100|FG006|Overall Study|Physician Decision|0|||
149184531|NCT03303339|538147101|FG007|Overall Study|Physician Decision|0|||
149184532|NCT03303339|538147102|FG008|Overall Study|Physician Decision|0|||
148807356|NCT00903968|536773229|FG001|Overall Study|Physician Decision|0|||
149184533|NCT03303339|538147103|FG009|Overall Study|Physician Decision|0|||
149184534|NCT03303339|538147104|FG010|Overall Study|Physician Decision|0|||
149184535|NCT03303339|538147105|FG011|Overall Study|Physician Decision|0|||
149184536|NCT03303339|538147094|FG000|Overall Study|Safety/Non-compliance|0|||
149184537|NCT03303339|538147095|FG001|Overall Study|Safety/Non-compliance|0|||
149184538|NCT03303339|538147096|FG002|Overall Study|Safety/Non-compliance|0|||
149184539|NCT03303339|538147097|FG003|Overall Study|Safety/Non-compliance|0|||
149184540|NCT03303339|538147098|FG004|Overall Study|Safety/Non-compliance|0|||
149184541|NCT03303339|538147099|FG005|Overall Study|Safety/Non-compliance|0|||
149184542|NCT03303339|538147100|FG006|Overall Study|Safety/Non-compliance|0|||
149184543|NCT03303339|538147101|FG007|Overall Study|Safety/Non-compliance|0|||
149184544|NCT03303339|538147102|FG008|Overall Study|Safety/Non-compliance|0|||
149184545|NCT03303339|538147103|FG009|Overall Study|Safety/Non-compliance|0|||
149184546|NCT03303339|538147104|FG010|Overall Study|Safety/Non-compliance|0|||
149184547|NCT03303339|538147105|FG011|Overall Study|Safety/Non-compliance|1|||
149184548|NCT01426386|538147106|FG000|Overall Study|Adverse Event|0|||
149184549|NCT01426386|538147107|FG001|Overall Study|Adverse Event|1|||
149184550|NCT01426386|538147108|FG002|Overall Study|Adverse Event|0|||
149184551|NCT01426386|538147109|FG003|Overall Study|Adverse Event|0|||
149184552|NCT01426386|538147110|FG004|Overall Study|Adverse Event|0|||
149184553|NCT01426386|538147111|FG005|Overall Study|Adverse Event|0|||
149184554|NCT01426386|538147106|FG000|Overall Study|Did not attend scheduled visit|1|||
149184555|NCT01426386|538147107|FG001|Overall Study|Did not attend scheduled visit|4|||
149184556|NCT01426386|538147108|FG002|Overall Study|Did not attend scheduled visit|0|||
149184557|NCT01426386|538147109|FG003|Overall Study|Did not attend scheduled visit|0|||
149184558|NCT01426386|538147110|FG004|Overall Study|Did not attend scheduled visit|2|||
149184559|NCT01426386|538147111|FG005|Overall Study|Did not attend scheduled visit|1|||
149184560|NCT01426386|538147106|FG000|Overall Study|Poor response|2|||
149184561|NCT01426386|538147107|FG001|Overall Study|Poor response|1|||
149184562|NCT01426386|538147108|FG002|Overall Study|Poor response|2|||
149184563|NCT01426386|538147109|FG003|Overall Study|Poor response|0|||
149184564|NCT01426386|538147110|FG004|Overall Study|Poor response|1|||
149184565|NCT01426386|538147111|FG005|Overall Study|Poor response|0|||
149184566|NCT01426386|538147106|FG000|Overall Study|Personal reasons|0|||
149184567|NCT01426386|538147107|FG001|Overall Study|Personal reasons|0|||
149184568|NCT01426386|538147108|FG002|Overall Study|Personal reasons|0|||
149184569|NCT01426386|538147109|FG003|Overall Study|Personal reasons|0|||
148933150|NCT00973349|537240227|FG000|Overall Study|Inappropriate enrolment|0|||
148933151|NCT00973349|537240228|FG001|Overall Study|Inappropriate enrolment|0|||
148933152|NCT00973349|537240229|FG002|Overall Study|Inappropriate enrolment|1|||
148933153|NCT00973349|537240230|FG003|Overall Study|Inappropriate enrolment|0|||
148933154|NCT00973349|537240231|FG004|Overall Study|Inappropriate enrolment|0|||
148933155|NCT00973349|537240232|FG005|Overall Study|Inappropriate enrolment|0|||
148933156|NCT00973349|537240233|FG006|Overall Study|Inappropriate enrolment|0|||
148933157|NCT00973349|537240234|FG007|Overall Study|Inappropriate enrolment|0|||
148933158|NCT00973349|537240235|FG008|Overall Study|Inappropriate enrolment|0|||
148933159|NCT00973349|537240236|FG009|Overall Study|Inappropriate enrolment|2|||
148933160|NCT00973349|537240237|FG010|Overall Study|Inappropriate enrolment|0|||
148933161|NCT00973349|537240238|FG011|Overall Study|Inappropriate enrolment|0|||
148933162|NCT00973349|537240239|FG012|Overall Study|Inappropriate enrolment|1|||
148933163|NCT00973349|537240240|FG013|Overall Study|Inappropriate enrolment|0|||
148933164|NCT00973349|537240241|FG014|Overall Study|Inappropriate enrolment|1|||
148933165|NCT00973349|537240242|FG015|Overall Study|Inappropriate enrolment|1|||
148933166|NCT00973349|537240227|FG000|Overall Study|Protocol Violation|0|||
148933167|NCT00973349|537240228|FG001|Overall Study|Protocol Violation|0|||
148933168|NCT00973349|537240229|FG002|Overall Study|Protocol Violation|0|||
149184570|NCT01426386|538147110|FG004|Overall Study|Personal reasons|1|||
149184571|NCT01426386|538147111|FG005|Overall Study|Personal reasons|0|||
149184572|NCT02116972|538147116|FG000|Overall Study|Adverse Event|4|||
149184573|NCT02116972|538147117|FG001|Overall Study|Adverse Event|4|||
149184574|NCT02116972|538147118|FG002|Overall Study|Adverse Event|1|||
149184575|NCT02116972|538147116|FG000|Overall Study|Withdrawal by Subject|1|||
148679676|NCT02164539|536300855|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
148679677|NCT02164539|536300856|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
148679678|NCT02164539|536300857|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
148679679|NCT02164539|536300858|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
148679680|NCT02164539|536300859|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
148679681|NCT02164539|536300860|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
148679682|NCT02164539|536300861|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
148679683|NCT02164539|536300855|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
148679684|NCT02164539|536300856|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
148679685|NCT02164539|536300857|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
148679686|NCT02164539|536300858|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
149184576|NCT02116972|538147117|FG001|Overall Study|Withdrawal by Subject|1|||
149184577|NCT02116972|538147118|FG002|Overall Study|Withdrawal by Subject|5|||
149184578|NCT02116972|538147116|FG000|Overall Study|Protocol Violation|1|||
149184579|NCT02116972|538147117|FG001|Overall Study|Protocol Violation|0|||
149184580|NCT02116972|538147118|FG002|Overall Study|Protocol Violation|1|||
149184581|NCT02116972|538147116|FG000|Overall Study|Lost to Follow-up|4|||
149184582|NCT02116972|538147117|FG001|Overall Study|Lost to Follow-up|3|||
149184583|NCT02116972|538147118|FG002|Overall Study|Lost to Follow-up|1|||
149184584|NCT02116972|538147116|FG000|Overall Study|Lack of Efficacy|6|||
149184585|NCT02116972|538147117|FG001|Overall Study|Lack of Efficacy|6|||
149184586|NCT02116972|538147118|FG002|Overall Study|Lack of Efficacy|5|||
149184587|NCT02116972|538147116|FG000|Overall Study|scheduling conflicts and relocation|3|||
149184588|NCT02116972|538147117|FG001|Overall Study|scheduling conflicts and relocation|3|||
149184589|NCT02116972|538147118|FG002|Overall Study|scheduling conflicts and relocation|6|||
149184590|NCT01879618|538147119|FG000|Overall Study|Does not meet entrance criteria|1|||
149184591|NCT01879618|538147119|FG000|Overall Study|Withdrawal by Subject|1|||
149184592|NCT01879618|538147119|FG000|Overall Study|Surgery;changed schedule; not available|8|||
149184593|NCT01879618|538147119|FG000|Overall Study|Protocol Violation|6|||
149184594|NCT01879618|538147119|FG000|Overall Study|Adverse Event|5|||
149184595|NCT01137435|538147120|FG000|Overall Study|Lost to Follow-up|24|||
149184596|NCT01137435|538147120|FG000|Overall Study|Off label usage|4|||
149184597|NCT01416610|538147127|FG000|Overall Study|Adverse Event|4|||
149184598|NCT01416610|538147127|FG000|Overall Study|Adverse Event -Patient decision|3|||
149184599|NCT01416610|538147127|FG000|Overall Study|Lack of Efficacy|4|||
149184600|NCT01416610|538147127|FG000|Overall Study|No reason given|5|||
149184601|NCT01416610|538147127|FG000|Overall Study|Withdrawal by Subject|13|||
149184602|NCT01416610|538147127|FG000|Overall Study|Lost to Follow-up|7|||
149184603|NCT01416610|538147127|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
149184604|NCT00492921|538147128|FG000|Overall Study|Death|1|||
149184605|NCT00492921|538147129|FG001|Overall Study|Death|0|||
149184606|NCT00492921|538147130|FG002|Overall Study|Death|1|||
149184607|NCT01696877|538147131|FG000|Overall Study|Adverse Event|0|||
149184608|NCT01696877|538147132|FG001|Overall Study|Adverse Event|1|||
149184609|NCT00469014|538147135|FG000|Initial Phase Randomization|Disease Progression|0|||
149184610|NCT00469014|538147136|FG001|Initial Phase Randomization|Disease Progression|1|||
149184611|NCT00469014|538147137|FG002|Initial Phase Randomization|Disease Progression|1|||
149184612|NCT00469014|538147138|FG003|Initial Phase Randomization|Disease Progression|0|||
149184613|NCT00469014|538147135|FG000|Initial Phase Randomization|No Response|1|||
149184614|NCT00469014|538147136|FG001|Initial Phase Randomization|No Response|0|||
149184615|NCT00469014|538147137|FG002|Initial Phase Randomization|No Response|0|||
149184616|NCT00469014|538147138|FG003|Initial Phase Randomization|No Response|1|||
149184617|NCT00469014|538147135|FG000|Adaptive Randomization|Not Evaluable|1|||
149184618|NCT00469014|538147136|FG001|Adaptive Randomization|Not Evaluable|0|||
149184619|NCT00469014|538147137|FG002|Adaptive Randomization|Not Evaluable|0|||
149184620|NCT00469014|538147138|FG003|Adaptive Randomization|Not Evaluable|1|||
149184621|NCT00469014|538147135|FG000|Adaptive Randomization|No Response|0|||
149184622|NCT00469014|538147136|FG001|Adaptive Randomization|No Response|1|||
149184623|NCT00469014|538147137|FG002|Adaptive Randomization|No Response|0|||
149184624|NCT00469014|538147138|FG003|Adaptive Randomization|No Response|0|||
149184625|NCT00469014|538147135|FG000|Adaptive Randomization|Death|0|||
149184626|NCT00469014|538147136|FG001|Adaptive Randomization|Death|0|||
149184627|NCT00469014|538147137|FG002|Adaptive Randomization|Death|1|||
149184628|NCT00469014|538147138|FG003|Adaptive Randomization|Death|0|||
149184629|NCT00864227|538147141|FG000|Overall Study|Withdrawal by Subject|1|||
149184630|NCT00864227|538147141|FG000|Overall Study|Disease Relapse/Progression|3|||
148679687|NCT02164539|536300859|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
149184631|NCT03461289|538147142|FG000|Overall Study|Death|1|||
149184632|NCT03241173|538147143|FG000|Overall Study|Death|3|||
149184633|NCT03241173|538147144|FG001|Overall Study|Death|2|||
149184634|NCT03241173|538147145|FG002|Overall Study|Death|4|||
149184635|NCT03241173|538147146|FG003|Overall Study|Death|4|||
149184636|NCT03241173|538147147|FG004|Overall Study|Death|2|||
148679688|NCT02164539|536300860|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
148679689|NCT02164539|536300861|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
149184637|NCT03241173|538147148|FG005|Overall Study|Death|2|||
149184638|NCT03241173|538147149|FG006|Overall Study|Death|3|||
149184639|NCT03241173|538147150|FG007|Overall Study|Death|1|||
149184640|NCT03241173|538147151|FG008|Overall Study|Death|0|||
149184641|NCT03241173|538147152|FG009|Overall Study|Death|5|||
149184642|NCT03241173|538147153|FG010|Overall Study|Death|4|||
149184643|NCT03241173|538147154|FG011|Overall Study|Death|3|||
149184644|NCT03241173|538147155|FG012|Overall Study|Death|0|||
149184645|NCT03241173|538147156|FG013|Overall Study|Death|0|||
149184646|NCT03241173|538147157|FG014|Overall Study|Death|0|||
149184647|NCT03241173|538147143|FG000|Overall Study|Withdrawal by Subject|0|||
149184648|NCT03241173|538147144|FG001|Overall Study|Withdrawal by Subject|0|||
149184649|NCT03241173|538147145|FG002|Overall Study|Withdrawal by Subject|1|||
149184650|NCT03241173|538147146|FG003|Overall Study|Withdrawal by Subject|0|||
149184651|NCT03241173|538147147|FG004|Overall Study|Withdrawal by Subject|0|||
149184652|NCT03241173|538147148|FG005|Overall Study|Withdrawal by Subject|1|||
149184653|NCT03241173|538147149|FG006|Overall Study|Withdrawal by Subject|0|||
149184654|NCT03241173|538147150|FG007|Overall Study|Withdrawal by Subject|0|||
149184655|NCT03241173|538147151|FG008|Overall Study|Withdrawal by Subject|0|||
149184656|NCT03241173|538147152|FG009|Overall Study|Withdrawal by Subject|0|||
149184657|NCT03241173|538147153|FG010|Overall Study|Withdrawal by Subject|0|||
149184658|NCT03241173|538147154|FG011|Overall Study|Withdrawal by Subject|0|||
149184659|NCT03241173|538147155|FG012|Overall Study|Withdrawal by Subject|0|||
149184660|NCT03241173|538147156|FG013|Overall Study|Withdrawal by Subject|0|||
149184661|NCT03241173|538147157|FG014|Overall Study|Withdrawal by Subject|0|||
149184662|NCT03241173|538147143|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149184663|NCT03241173|538147144|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149184664|NCT03241173|538147145|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149184665|NCT03241173|538147146|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149184666|NCT03241173|538147147|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149184667|NCT03241173|538147148|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149184668|NCT03241173|538147149|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
149184669|NCT03241173|538147150|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149184670|NCT03241173|538147151|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149184671|NCT03241173|538147152|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149184672|NCT03241173|538147153|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
149184673|NCT03241173|538147154|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
149184674|NCT03241173|538147155|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149184675|NCT03241173|538147156|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149184676|NCT03241173|538147157|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
149184677|NCT03241173|538147143|FG000|Overall Study|Lost to Follow-up|0|||
149184678|NCT03241173|538147144|FG001|Overall Study|Lost to Follow-up|0|||
149184679|NCT03241173|538147145|FG002|Overall Study|Lost to Follow-up|0|||
149184680|NCT03241173|538147146|FG003|Overall Study|Lost to Follow-up|0|||
149184681|NCT03241173|538147147|FG004|Overall Study|Lost to Follow-up|1|||
149184682|NCT03241173|538147148|FG005|Overall Study|Lost to Follow-up|0|||
149184683|NCT03241173|538147149|FG006|Overall Study|Lost to Follow-up|0|||
149184684|NCT03241173|538147150|FG007|Overall Study|Lost to Follow-up|0|||
149184685|NCT03241173|538147151|FG008|Overall Study|Lost to Follow-up|0|||
149184686|NCT03241173|538147152|FG009|Overall Study|Lost to Follow-up|1|||
149184687|NCT03241173|538147153|FG010|Overall Study|Lost to Follow-up|0|||
149184688|NCT03241173|538147154|FG011|Overall Study|Lost to Follow-up|0|||
149184689|NCT03241173|538147155|FG012|Overall Study|Lost to Follow-up|0|||
149184690|NCT03241173|538147156|FG013|Overall Study|Lost to Follow-up|0|||
149184691|NCT03241173|538147157|FG014|Overall Study|Lost to Follow-up|0|||
149184692|NCT02698423|538147159|FG000|Overall Study|Lost to Follow-up|19|||
149184693|NCT02698423|538147160|FG001|Overall Study|Lost to Follow-up|24|||
149184694|NCT00081289|538147163|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
149184695|NCT00081289|538147164|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
148679690|NCT02164539|536300855|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
148933169|NCT00973349|537240230|FG003|Overall Study|Protocol Violation|0|||
148679691|NCT02164539|536300856|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
148679692|NCT02164539|536300857|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
148933170|NCT00973349|537240231|FG004|Overall Study|Protocol Violation|0|||
148679693|NCT02164539|536300858|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
148679694|NCT02164539|536300859|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
148933171|NCT00973349|537240232|FG005|Overall Study|Protocol Violation|0|||
148933172|NCT00973349|537240233|FG006|Overall Study|Protocol Violation|0|||
148933173|NCT00973349|537240234|FG007|Overall Study|Protocol Violation|0|||
148933174|NCT00973349|537240235|FG008|Overall Study|Protocol Violation|1|||
149184696|NCT00081289|538147163|FG000|Overall Study|Ineligible / no protocol treatment|3|||
149184697|NCT00081289|538147164|FG001|Overall Study|Ineligible / no protocol treatment|4|||
149184698|NCT00530712|538147166|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
149184699|NCT00530712|538147166|FG000|30 Day Follow-up Visit|Missed Visit|5|||
149184700|NCT00530712|538147166|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
149184701|NCT00530712|538147166|FG000|6 Month Follow-up Visit|Missed Visit|3|||
149184702|NCT00530712|538147166|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
149184703|NCT00530712|538147166|FG000|6 Month Follow-up Visit|Death|2|||
149184704|NCT00530712|538147166|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
149184705|NCT00530712|538147166|FG000|12 Month Follow-up Visit|Missed Visit|3|||
149184706|NCT00530712|538147166|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
149184707|NCT00530712|538147166|FG000|12 Month Follow-up Visit|Death|9|||
149184708|NCT02749370|538147167|FG000|Overall Study|Withdrawal by Subject|11|||
149184709|NCT02749370|538147167|FG000|Overall Study|Lost to Follow-up|3|||
149184710|NCT01519427|538147168|FG000|Overall Study|disease progression|2|||
149184711|NCT03894904|538147169|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
149184712|NCT03894904|538147170|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
149184713|NCT03894904|538147169|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
149184714|NCT03894904|538147170|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
149184715|NCT00651118|538147176|FG000|Overall Study|Adverse Event|4|||
149184716|NCT00651118|538147177|FG001|Overall Study|Adverse Event|0|||
149184717|NCT00651118|538147178|FG002|Overall Study|Adverse Event|1|||
149184718|NCT00651118|538147179|FG003|Overall Study|Adverse Event|1|||
149184719|NCT00651118|538147176|FG000|Overall Study|Protocol Violation|2|||
149184720|NCT00651118|538147177|FG001|Overall Study|Protocol Violation|2|||
149184721|NCT00651118|538147178|FG002|Overall Study|Protocol Violation|6|||
148933175|NCT00973349|537240236|FG009|Overall Study|Protocol Violation|0|||
148933176|NCT00973349|537240237|FG010|Overall Study|Protocol Violation|0|||
148933177|NCT00973349|537240238|FG011|Overall Study|Protocol Violation|0|||
148933178|NCT00973349|537240239|FG012|Overall Study|Protocol Violation|0|||
148933179|NCT00973349|537240240|FG013|Overall Study|Protocol Violation|0|||
148933180|NCT00973349|537240241|FG014|Overall Study|Protocol Violation|0|||
148933181|NCT00973349|537240242|FG015|Overall Study|Protocol Violation|0|||
148933182|NCT00973349|537240227|FG000|Overall Study|Unable to classify|0|||
148933183|NCT00973349|537240228|FG001|Overall Study|Unable to classify|0|||
148933184|NCT00973349|537240229|FG002|Overall Study|Unable to classify|0|||
148933185|NCT00973349|537240230|FG003|Overall Study|Unable to classify|0|||
148933186|NCT00973349|537240231|FG004|Overall Study|Unable to classify|1|||
148933187|NCT00973349|537240232|FG005|Overall Study|Unable to classify|1|||
148933188|NCT00973349|537240233|FG006|Overall Study|Unable to classify|0|||
148933189|NCT00973349|537240234|FG007|Overall Study|Unable to classify|0|||
148933190|NCT00973349|537240235|FG008|Overall Study|Unable to classify|0|||
148933191|NCT00973349|537240236|FG009|Overall Study|Unable to classify|1|||
148933192|NCT00973349|537240237|FG010|Overall Study|Unable to classify|0|||
148933193|NCT00973349|537240238|FG011|Overall Study|Unable to classify|0|||
148933194|NCT00973349|537240239|FG012|Overall Study|Unable to classify|0|||
148933195|NCT00973349|537240240|FG013|Overall Study|Unable to classify|0|||
148933196|NCT00973349|537240241|FG014|Overall Study|Unable to classify|0|||
148933197|NCT00973349|537240242|FG015|Overall Study|Unable to classify|0|||
148933198|NCT05430022|537240243|FG000|Overall Study|Withdrawal by Subject|4|||
148933199|NCT05430022|537240244|FG001|Overall Study|Withdrawal by Subject|4|||
148933200|NCT02452697|537240245|FG000|Overall Study|Physician Decision|4|||
148933201|NCT02452697|537240246|FG001|Overall Study|Physician Decision|4|||
148933202|NCT02452697|537240247|FG002|Overall Study|Physician Decision|3|||
148933203|NCT02452697|537240248|FG003|Overall Study|Physician Decision|2|||
148933204|NCT02452697|537240245|FG000|Overall Study|Withdrawal by Subject|1|||
148933205|NCT02452697|537240246|FG001|Overall Study|Withdrawal by Subject|0|||
148933206|NCT02452697|537240247|FG002|Overall Study|Withdrawal by Subject|0|||
148933207|NCT02452697|537240248|FG003|Overall Study|Withdrawal by Subject|0|||
148933208|NCT02452697|537240245|FG000|Overall Study|still in follow-up|2|||
148933209|NCT02452697|537240246|FG001|Overall Study|still in follow-up|2|||
148933210|NCT02452697|537240247|FG002|Overall Study|still in follow-up|1|||
148933211|NCT02452697|537240248|FG003|Overall Study|still in follow-up|3|||
148933212|NCT03148275|537240249|FG000|Overall Study|Death|6|||
148933213|NCT03148275|537240249|FG000|Overall Study|Adverse Event|3|||
148933214|NCT03148275|537240249|FG000|Overall Study|Liver transplant|2|||
148933215|NCT03148275|537240249|FG000|Overall Study|Patient decision|5|||
148933216|NCT03148275|537240249|FG000|Overall Study|transition to commercial drug|1|||
148933217|NCT03148275|537240249|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
148933218|NCT05098938|537240250|FG000|Overall Study|Adverse Event|4|||
148933219|NCT05098938|537240251|FG001|Overall Study|Adverse Event|3|||
149184722|NCT00651118|538147179|FG003|Overall Study|Protocol Violation|2|||
149184723|NCT00651118|538147176|FG000|Overall Study|Lost to Follow-up|2|||
149184724|NCT00651118|538147177|FG001|Overall Study|Lost to Follow-up|0|||
149184725|NCT00651118|538147178|FG002|Overall Study|Lost to Follow-up|1|||
149184726|NCT00651118|538147179|FG003|Overall Study|Lost to Follow-up|2|||
149184727|NCT00651118|538147176|FG000|Overall Study|administrative|1|||
149184728|NCT00651118|538147177|FG001|Overall Study|administrative|4|||
149184729|NCT00651118|538147178|FG002|Overall Study|administrative|2|||
149184730|NCT00651118|538147179|FG003|Overall Study|administrative|1|||
149184731|NCT00651118|538147176|FG000|Overall Study|Withdrawal by Subject|0|||
149184732|NCT00651118|538147177|FG001|Overall Study|Withdrawal by Subject|1|||
149184733|NCT00651118|538147178|FG002|Overall Study|Withdrawal by Subject|1|||
149184734|NCT00651118|538147179|FG003|Overall Study|Withdrawal by Subject|1|||
149184735|NCT02190435|538147182|FG000|Overall Study|First 12 patients were lead-ins|12|||
149184736|NCT02190435|538147183|FG001|Overall Study|First 12 patients were lead-ins|0|||
149184737|NCT02190435|538147182|FG000|Overall Study|3 consented screen fails|3|||
149184738|NCT02190435|538147183|FG001|Overall Study|3 consented screen fails|0|||
148933220|NCT05098938|537240250|FG000|Overall Study|inclusion/exclusion criteria change|11|||
148933221|NCT05098938|537240251|FG001|Overall Study|inclusion/exclusion criteria change|5|||
149184739|NCT02260193|538147184|FG000|Overall Study|Lack of Efficacy|0|||
148933222|NCT05098938|537240250|FG000|Overall Study|lack of compliance|26|||
148933223|NCT05098938|537240251|FG001|Overall Study|lack of compliance|19|||
149184740|NCT02260193|538147185|FG001|Overall Study|Lack of Efficacy|1|||
149184741|NCT02260193|538147186|FG002|Overall Study|Lack of Efficacy|6|||
149184742|NCT02260193|538147184|FG000|Overall Study|Adverse Event|3|||
149184743|NCT02260193|538147185|FG001|Overall Study|Adverse Event|4|||
149184744|NCT02260193|538147186|FG002|Overall Study|Adverse Event|1|||
149184745|NCT02260193|538147184|FG000|Overall Study|Protocol Violation|0|||
149184746|NCT02260193|538147185|FG001|Overall Study|Protocol Violation|4|||
149184747|NCT02260193|538147186|FG002|Overall Study|Protocol Violation|0|||
149184748|NCT02260193|538147184|FG000|Overall Study|Withdrawal by Subject|3|||
149184749|NCT02260193|538147185|FG001|Overall Study|Withdrawal by Subject|0|||
149184750|NCT02260193|538147186|FG002|Overall Study|Withdrawal by Subject|2|||
149184751|NCT02260193|538147184|FG000|Overall Study|Kidney Transplantation|0|||
149184752|NCT02260193|538147185|FG001|Overall Study|Kidney Transplantation|0|||
149184753|NCT02260193|538147186|FG002|Overall Study|Kidney Transplantation|1|||
149184754|NCT00935220|538147187|FG000|Overall Study|Adverse Event|1|||
149184755|NCT00935220|538147187|FG000|Overall Study|Other reason (not specified)|1|||
149184756|NCT00336492|538147190|FG000|Overall Study|Adverse Event|4|||
148933224|NCT05098938|537240250|FG000|Overall Study|Lost to Follow-up|37|||
148933225|NCT05098938|537240251|FG001|Overall Study|Lost to Follow-up|40|||
148933226|NCT05098938|537240250|FG000|Overall Study|Lost in treatment period|17|||
148933227|NCT05098938|537240251|FG001|Overall Study|Lost in treatment period|13|||
148933228|NCT05098938|537240250|FG000|Overall Study|Met an exclusion criterion|0|||
148933229|NCT05098938|537240251|FG001|Overall Study|Met an exclusion criterion|3|||
148933230|NCT05098938|537240250|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
148933231|NCT05098938|537240251|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
148933232|NCT05098938|537240250|FG000|Overall Study|Physician Decision|25|||
148933233|NCT05098938|537240251|FG001|Overall Study|Physician Decision|32|||
148933234|NCT05098938|537240250|FG000|Overall Study|Run in failure in treatment phase|1|||
148933235|NCT05098938|537240251|FG001|Overall Study|Run in failure in treatment phase|1|||
149184757|NCT00336492|538147191|FG001|Overall Study|Adverse Event|3|||
149184758|NCT00336492|538147192|FG002|Overall Study|Adverse Event|6|||
149184759|NCT00336492|538147190|FG000|Overall Study|Lack of Efficacy|6|||
149184760|NCT00336492|538147191|FG001|Overall Study|Lack of Efficacy|1|||
149184761|NCT00336492|538147192|FG002|Overall Study|Lack of Efficacy|4|||
149184762|NCT00336492|538147190|FG000|Overall Study|Other|5|||
149184763|NCT00336492|538147191|FG001|Overall Study|Other|0|||
149184764|NCT00336492|538147192|FG002|Overall Study|Other|1|||
149184765|NCT01415440|538147193|FG000|Overall Study|Lost to Follow-up|0|||
149184766|NCT01415440|538147194|FG001|Overall Study|Lost to Follow-up|1|||
149184767|NCT01415440|538147195|FG002|Overall Study|Lost to Follow-up|2|||
149184768|NCT01415440|538147193|FG000|Overall Study|Physician Decision|3|||
149184769|NCT01415440|538147194|FG001|Overall Study|Physician Decision|0|||
149184770|NCT01415440|538147195|FG002|Overall Study|Physician Decision|0|||
149184771|NCT01415440|538147193|FG000|Overall Study|Withdrawal by Subject|1|||
149184772|NCT01415440|538147194|FG001|Overall Study|Withdrawal by Subject|0|||
149184773|NCT01415440|538147195|FG002|Overall Study|Withdrawal by Subject|0|||
149184774|NCT01781026|538147196|FG000|Overall Study|Lack of Efficacy|2|||
149184775|NCT03103750|538147198|FG000|Overall Study|Adverse Event|1|||
149184776|NCT03103750|538147199|FG001|Overall Study|Adverse Event|0|||
149184777|NCT03103750|538147198|FG000|Overall Study|Lost to Follow-up|1|||
149184778|NCT03103750|538147199|FG001|Overall Study|Lost to Follow-up|0|||
149184779|NCT03103750|538147198|FG000|Overall Study|PET Equipment Related|2|||
149184780|NCT03103750|538147199|FG001|Overall Study|PET Equipment Related|2|||
149184781|NCT01663740|538147200|FG000|Overall Study|Lost to Follow-up|1|||
149184782|NCT01663740|538147201|FG001|Overall Study|Lost to Follow-up|4|||
149184783|NCT01663740|538147200|FG000|Overall Study|Other|9|||
149184784|NCT01663740|538147201|FG001|Overall Study|Other|2|||
149184785|NCT01663740|538147200|FG000|Overall Study|Inclusion/Exclusion not met|1|||
149184786|NCT01663740|538147201|FG001|Overall Study|Inclusion/Exclusion not met|0|||
149184787|NCT01663740|538147200|FG000|Overall Study|Death|0|||
149184788|NCT01663740|538147201|FG001|Overall Study|Death|1|||
149184789|NCT01663740|538147200|FG000|Overall Study|Withdrawal by Subject|2|||
149184790|NCT01663740|538147201|FG001|Overall Study|Withdrawal by Subject|1|||
149184791|NCT01663740|538147200|FG000|Overall Study|No end of study status|3|||
149184792|NCT01663740|538147201|FG001|Overall Study|No end of study status|0|||
149184793|NCT01522651|538147202|FG000|Overall Study|Adverse Event|3|||
149184794|NCT01522651|538147203|FG001|Overall Study|Adverse Event|4|||
149184795|NCT01522651|538147204|FG002|Overall Study|Adverse Event|4|||
149184796|NCT01522651|538147205|FG003|Overall Study|Adverse Event|5|||
149184797|NCT01522651|538147206|FG004|Overall Study|Adverse Event|4|||
149184798|NCT01522651|538147202|FG000|Overall Study|Cardioversion|1|||
149184799|NCT01522651|538147203|FG001|Overall Study|Cardioversion|0|||
149184800|NCT01522651|538147204|FG002|Overall Study|Cardioversion|0|||
149184801|NCT01522651|538147205|FG003|Overall Study|Cardioversion|0|||
149184802|NCT01522651|538147206|FG004|Overall Study|Cardioversion|0|||
149184803|NCT01522651|538147202|FG000|Overall Study|Device Malfunction|0|||
149184804|NCT01522651|538147203|FG001|Overall Study|Device Malfunction|1|||
149184805|NCT01522651|538147204|FG002|Overall Study|Device Malfunction|0|||
149184806|NCT01522651|538147205|FG003|Overall Study|Device Malfunction|0|||
149184807|NCT01522651|538147206|FG004|Overall Study|Device Malfunction|0|||
149184808|NCT01522651|538147202|FG000|Overall Study|Investigator's Discretion|0|||
149184809|NCT01522651|538147203|FG001|Overall Study|Investigator's Discretion|1|||
149184810|NCT01522651|538147204|FG002|Overall Study|Investigator's Discretion|0|||
149184811|NCT01522651|538147205|FG003|Overall Study|Investigator's Discretion|0|||
149184812|NCT01522651|538147206|FG004|Overall Study|Investigator's Discretion|0|||
149184813|NCT01522651|538147202|FG000|Overall Study|Protocol Violation|3|||
149184814|NCT01522651|538147203|FG001|Overall Study|Protocol Violation|0|||
149184815|NCT01522651|538147204|FG002|Overall Study|Protocol Violation|0|||
149184816|NCT01522651|538147205|FG003|Overall Study|Protocol Violation|0|||
149184817|NCT01522651|538147206|FG004|Overall Study|Protocol Violation|0|||
149184818|NCT01522651|538147202|FG000|Overall Study|Reason Not Specified|0|||
149184819|NCT01522651|538147203|FG001|Overall Study|Reason Not Specified|0|||
149184820|NCT01522651|538147204|FG002|Overall Study|Reason Not Specified|0|||
149184821|NCT01522651|538147205|FG003|Overall Study|Reason Not Specified|1|||
149184822|NCT01522651|538147206|FG004|Overall Study|Reason Not Specified|0|||
149184823|NCT01522651|538147202|FG000|Overall Study|Participant Non-Compliance|1|||
149184824|NCT01522651|538147203|FG001|Overall Study|Participant Non-Compliance|0|||
149184825|NCT01522651|538147204|FG002|Overall Study|Participant Non-Compliance|0|||
149184826|NCT01522651|538147205|FG003|Overall Study|Participant Non-Compliance|0|||
149184827|NCT01522651|538147206|FG004|Overall Study|Participant Non-Compliance|0|||
149184828|NCT01522651|538147202|FG000|Overall Study|Withdrew Consent|1|||
149184829|NCT01522651|538147203|FG001|Overall Study|Withdrew Consent|1|||
149184830|NCT01522651|538147204|FG002|Overall Study|Withdrew Consent|0|||
149184831|NCT01522651|538147205|FG003|Overall Study|Withdrew Consent|1|||
148933236|NCT05098938|537240250|FG000|Overall Study|Withdrawal by Subject|0|||
149184832|NCT01522651|538147206|FG004|Overall Study|Withdrew Consent|1|||
149184833|NCT01522651|538147202|FG000|Overall Study|Randomized but Never Treated|0|||
149184834|NCT01522651|538147203|FG001|Overall Study|Randomized but Never Treated|1|||
149184835|NCT01522651|538147204|FG002|Overall Study|Randomized but Never Treated|0|||
149184836|NCT01522651|538147205|FG003|Overall Study|Randomized but Never Treated|1|||
149184837|NCT01522651|538147206|FG004|Overall Study|Randomized but Never Treated|1|||
149184838|NCT02658656|538147207|FG000|Screening|Failed eligibility criteria|0|||
149184839|NCT02658656|538147208|FG001|Screening|Failed eligibility criteria|0|||
149184840|NCT02658656|538147209|FG002|Screening|Failed eligibility criteria|263|||
149184841|NCT02658656|538147207|FG000|Randomization|Withdrawal by Subject|8|||
149184842|NCT02658656|538147208|FG001|Randomization|Withdrawal by Subject|7|||
149184843|NCT02658656|538147209|FG002|Randomization|Withdrawal by Subject|0|||
149184844|NCT02658656|538147207|FG000|Randomization|Lost to Follow-up|1|||
149184845|NCT02658656|538147208|FG001|Randomization|Lost to Follow-up|3|||
149184846|NCT02658656|538147209|FG002|Randomization|Lost to Follow-up|0|||
149184847|NCT02658656|538147207|FG000|Randomization|Adverse Event|4|||
149184848|NCT02658656|538147208|FG001|Randomization|Adverse Event|0|||
149184849|NCT02658656|538147209|FG002|Randomization|Adverse Event|0|||
149184850|NCT02658656|538147207|FG000|Randomization|Administrative Termination|3|||
149184851|NCT02658656|538147208|FG001|Randomization|Administrative Termination|1|||
149184852|NCT02658656|538147209|FG002|Randomization|Administrative Termination|0|||
149184853|NCT02658656|538147207|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
149184854|NCT02658656|538147208|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
149184855|NCT02658656|538147209|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
149184856|NCT02658656|538147207|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
149184857|NCT02658656|538147208|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
149184858|NCT02658656|538147209|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
149184859|NCT02658656|538147207|FG000|Randomization|Not eligible for Randomization|1|||
149184860|NCT02658656|538147208|FG001|Randomization|Not eligible for Randomization|0|||
149184861|NCT02658656|538147209|FG002|Randomization|Not eligible for Randomization|0|||
149184862|NCT02658656|538147207|FG000|Randomization|Protocol Violation|1|||
149184863|NCT02658656|538147208|FG001|Randomization|Protocol Violation|0|||
149184864|NCT02658656|538147209|FG002|Randomization|Protocol Violation|0|||
149184865|NCT04267562|538148889|FG000|Assessed for Eligibility|Screen Failure|64|||
149184866|NCT04267562|538148889|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
149184867|NCT04267562|538148889|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
149184868|NCT04267562|538148889|FG000|Assessed for Eligibility|Site closure|6|||
148933237|NCT05098938|537240251|FG001|Overall Study|Withdrawal by Subject|3|||
148933238|NCT05098938|537240250|FG000|Overall Study|Run-in Failure in early study|505|||
148933239|NCT05098938|537240251|FG001|Overall Study|Run-in Failure in early study|514|||
148933240|NCT05098938|537240250|FG000|Overall Study|IMP delivery missed|1|||
148933241|NCT05098938|537240251|FG001|Overall Study|IMP delivery missed|5|||
148933242|NCT05098938|537240250|FG000|Overall Study|6 months visit was missed|2|||
148933243|NCT05098938|537240251|FG001|Overall Study|6 months visit was missed|0|||
148933244|NCT05098938|537240250|FG000|Overall Study|fit for use was not completed within window|3|||
148933245|NCT05098938|537240251|FG001|Overall Study|fit for use was not completed within window|0|||
148933246|NCT05098938|537240250|FG000|Overall Study|V2 visit was not completed within window|0|||
148933247|NCT05098938|537240251|FG001|Overall Study|V2 visit was not completed within window|1|||
148933248|NCT05098938|537240250|FG000|Overall Study|exclusionary medication use|1|||
148933249|NCT05098938|537240251|FG001|Overall Study|exclusionary medication use|2|||
148933250|NCT05098938|537240250|FG000|Overall Study|change in medication|1|||
148933251|NCT05098938|537240251|FG001|Overall Study|change in medication|0|||
148933252|NCT05098938|537240250|FG000|Overall Study|treatment failure|2|||
148933253|NCT05098938|537240251|FG001|Overall Study|treatment failure|1|||
148933254|NCT01193660|537242149|FG000|Overall Study|Withdrawal by Subject|2|||
148933255|NCT01193660|537242150|FG001|Overall Study|Withdrawal by Subject|3|||
148933256|NCT01193660|537242151|FG002|Overall Study|Withdrawal by Subject|1|||
148933257|NCT01193660|537242149|FG000|Overall Study|Death|1|||
148933258|NCT01193660|537242150|FG001|Overall Study|Death|0|||
148933259|NCT01193660|537242151|FG002|Overall Study|Death|0|||
148933260|NCT01193660|537242149|FG000|Overall Study|Physician Decision|1|||
148933261|NCT01193660|537242150|FG001|Overall Study|Physician Decision|0|||
148933262|NCT01193660|537242151|FG002|Overall Study|Physician Decision|1|||
148933263|NCT00639678|537242162|FG000|Overall Study|Withdrawal by Subject|3|||
148933264|NCT00639678|537242163|FG001|Overall Study|Withdrawal by Subject|0|||
148933265|NCT00639678|537242164|FG002|Overall Study|Withdrawal by Subject|4|||
148933266|NCT00639678|537242165|FG003|Overall Study|Withdrawal by Subject|0|||
148933267|NCT00639678|537242162|FG000|Overall Study|Lost to Follow-up|1|||
149184869|NCT04267562|538148889|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
149184870|NCT04267562|538148889|FG000|Assessed for Eligibility|Physician Decision|1|||
149184871|NCT04267562|538148889|FG000|Month 24|Elective hysterectomy|1|||
148933268|NCT00639678|537242163|FG001|Overall Study|Lost to Follow-up|0|||
148933269|NCT00639678|537242164|FG002|Overall Study|Lost to Follow-up|6|||
148933270|NCT00639678|537242165|FG003|Overall Study|Lost to Follow-up|0|||
148933271|NCT00639678|537242162|FG000|Overall Study|Adverse Event|0|||
149184872|NCT04267562|538148889|FG000|Month 24|Lost to Follow-up|1|||
149184873|NCT04267562|538148889|FG000|Month 36|Elective hysterectomy|2|||
149184874|NCT04267562|538148889|FG000|Month 36|Lost to Follow-up|3|||
149184875|NCT00408421|538148896|FG000|Treatment Initial Randomization|Adverse Event|5|||
149184876|NCT00408421|538148897|FG001|Treatment Initial Randomization|Adverse Event|9|||
148933272|NCT00639678|537242163|FG001|Overall Study|Adverse Event|1|||
149184877|NCT00408421|538148898|FG002|Treatment Initial Randomization|Adverse Event|0|||
149184878|NCT00408421|538148896|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
149184879|NCT00408421|538148897|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
149184880|NCT00408421|538148898|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
149184881|NCT00408421|538148896|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
149184882|NCT00408421|538148897|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
149184883|NCT00408421|538148898|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
149184884|NCT00408421|538148896|FG000|Treatment Initial Randomization|Physician Decision|1|||
149184885|NCT00408421|538148897|FG001|Treatment Initial Randomization|Physician Decision|0|||
149184886|NCT00408421|538148898|FG002|Treatment Initial Randomization|Physician Decision|0|||
149184887|NCT00408421|538148896|FG000|Treatment Initial Randomization|Protocol Violation|0|||
149184888|NCT00408421|538148897|FG001|Treatment Initial Randomization|Protocol Violation|1|||
149184889|NCT00408421|538148898|FG002|Treatment Initial Randomization|Protocol Violation|0|||
149184890|NCT00408421|538148896|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
149184891|NCT00408421|538148897|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
149184892|NCT00408421|538148898|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
149184893|NCT00408421|538148896|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
149184894|NCT00408421|538148897|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
149184895|NCT00408421|538148898|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
149184896|NCT00408421|538148896|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
149184897|NCT00408421|538148897|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
149184898|NCT00408421|538148898|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
149184899|NCT00408421|538148896|FG000|Treatment Re-Randomization|Adverse Event|2|||
149184900|NCT00408421|538148897|FG001|Treatment Re-Randomization|Adverse Event|2|||
149184901|NCT00408421|538148898|FG002|Treatment Re-Randomization|Adverse Event|4|||
149184902|NCT00408421|538148896|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
149184903|NCT00408421|538148897|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
149184904|NCT00408421|538148898|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
149184905|NCT00408421|538148896|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
149184906|NCT00408421|538148897|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
149184907|NCT00408421|538148898|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
149184908|NCT00408421|538148896|FG000|Treatment Re-Randomization|Physician Decision|1|||
149184909|NCT00408421|538148897|FG001|Treatment Re-Randomization|Physician Decision|3|||
149184910|NCT00408421|538148898|FG002|Treatment Re-Randomization|Physician Decision|0|||
149184911|NCT00408421|538148896|FG000|Treatment Re-Randomization|Protocol Violation|1|||
149184912|NCT00408421|538148897|FG001|Treatment Re-Randomization|Protocol Violation|1|||
149184913|NCT00408421|538148898|FG002|Treatment Re-Randomization|Protocol Violation|0|||
149184914|NCT00408421|538148896|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
149184915|NCT00408421|538148897|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
149184916|NCT00408421|538148898|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
149184917|NCT01614769|538148905|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
149184918|NCT01614769|538148906|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
149184919|NCT01614769|538148907|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
149184920|NCT01614769|538148908|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
149184921|NCT01614769|538148909|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
149184922|NCT01614769|538148910|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
149184923|NCT01614769|538148905|FG000|Period 1|Protocol Violation|0|||
149184924|NCT01614769|538148906|FG001|Period 1|Protocol Violation|0|||
149184925|NCT01614769|538148907|FG002|Period 1|Protocol Violation|0|||
149184926|NCT01614769|538148908|FG003|Period 1|Protocol Violation|1|||
149184927|NCT01614769|538148909|FG004|Period 1|Protocol Violation|0|||
149184928|NCT01614769|538148910|FG005|Period 1|Protocol Violation|0|||
149184929|NCT01614769|538148905|FG000|Period 1|Withdrawal by Subject|1|||
149184930|NCT01614769|538148906|FG001|Period 1|Withdrawal by Subject|0|||
149184931|NCT01614769|538148907|FG002|Period 1|Withdrawal by Subject|0|||
149184932|NCT01614769|538148908|FG003|Period 1|Withdrawal by Subject|0|||
149184933|NCT01614769|538148909|FG004|Period 1|Withdrawal by Subject|0|||
149184934|NCT01614769|538148910|FG005|Period 1|Withdrawal by Subject|0|||
149184935|NCT01614769|538148905|FG000|Period 3|Withdrawal by Subject|0|||
149184936|NCT01614769|538148906|FG001|Period 3|Withdrawal by Subject|0|||
149184937|NCT01614769|538148907|FG002|Period 3|Withdrawal by Subject|1|||
149184938|NCT01614769|538148908|FG003|Period 3|Withdrawal by Subject|0|||
149184939|NCT01614769|538148909|FG004|Period 3|Withdrawal by Subject|0|||
149184940|NCT01614769|538148910|FG005|Period 3|Withdrawal by Subject|0|||
149184941|NCT02115815|538148911|FG000|Overall Study|Withdrawal by Subject|2|||
149184942|NCT02115815|538148912|FG001|Overall Study|Withdrawal by Subject|0|||
149184943|NCT02115815|538148913|FG002|Overall Study|Withdrawal by Subject|0|||
149184944|NCT02115815|538148914|FG003|Overall Study|Withdrawal by Subject|0|||
149184945|NCT02115815|538148915|FG004|Overall Study|Withdrawal by Subject|0|||
149184946|NCT02115815|538148916|FG005|Overall Study|Withdrawal by Subject|0|||
149184947|NCT02115815|538148917|FG006|Overall Study|Withdrawal by Subject|0|||
149184948|NCT02115815|538148911|FG000|Overall Study|Not enough drug to dose participant|0|||
149184949|NCT02115815|538148912|FG001|Overall Study|Not enough drug to dose participant|0|||
149184950|NCT02115815|538148913|FG002|Overall Study|Not enough drug to dose participant|0|||
149184951|NCT02115815|538148914|FG003|Overall Study|Not enough drug to dose participant|0|||
149184952|NCT02115815|538148915|FG004|Overall Study|Not enough drug to dose participant|0|||
149184953|NCT02115815|538148916|FG005|Overall Study|Not enough drug to dose participant|1|||
149184954|NCT02115815|538148917|FG006|Overall Study|Not enough drug to dose participant|0|||
149184955|NCT02115815|538148911|FG000|Overall Study|Missed appointment, randomized in error|0|||
149184956|NCT02115815|538148912|FG001|Overall Study|Missed appointment, randomized in error|0|||
149184957|NCT02115815|538148913|FG002|Overall Study|Missed appointment, randomized in error|0|||
149184958|NCT02115815|538148914|FG003|Overall Study|Missed appointment, randomized in error|0|||
149184959|NCT02115815|538148915|FG004|Overall Study|Missed appointment, randomized in error|0|||
149184960|NCT02115815|538148916|FG005|Overall Study|Missed appointment, randomized in error|1|||
149184961|NCT02115815|538148917|FG006|Overall Study|Missed appointment, randomized in error|0|||
149184962|NCT01989546|538148918|FG000|Overall Study|Clinical Progression|1|||
149184963|NCT01989546|538148918|FG000|Overall Study|Disease progression on study|8|||
149184964|NCT04439838|538148923|FG000|Overall Study|Withdrawal by Subject|0|||
149184965|NCT04439838|538148924|FG001|Overall Study|Withdrawal by Subject|0|||
149184966|NCT04439838|538148925|FG002|Overall Study|Withdrawal by Subject|0|||
149184967|NCT04439838|538148926|FG003|Overall Study|Withdrawal by Subject|0|||
149184968|NCT04439838|538148927|FG004|Overall Study|Withdrawal by Subject|0|||
149184969|NCT04439838|538148928|FG005|Overall Study|Withdrawal by Subject|0|||
149184970|NCT04439838|538148929|FG006|Overall Study|Withdrawal by Subject|0|||
149184971|NCT04439838|538148930|FG007|Overall Study|Withdrawal by Subject|0|||
149184972|NCT04439838|538148931|FG008|Overall Study|Withdrawal by Subject|1|||
149184973|NCT01958671|538148934|FG000|Overall Study|Adverse Event|1|||
149184974|NCT01958671|538148935|FG001|Overall Study|Adverse Event|1|||
149184975|NCT01958671|538148936|FG002|Overall Study|Adverse Event|5|||
149184976|NCT01958671|538148934|FG000|Overall Study|Death|1|||
149184977|NCT01958671|538148935|FG001|Overall Study|Death|0|||
149184978|NCT01958671|538148936|FG002|Overall Study|Death|0|||
149184979|NCT01958671|538148934|FG000|Overall Study|Excluded medication|0|||
149184980|NCT01958671|538148935|FG001|Overall Study|Excluded medication|0|||
149184981|NCT01958671|538148936|FG002|Overall Study|Excluded medication|1|||
149184982|NCT01958671|538148934|FG000|Overall Study|Hyperglycemia|0|||
149184983|NCT01958671|538148935|FG001|Overall Study|Hyperglycemia|0|||
149184984|NCT01958671|538148936|FG002|Overall Study|Hyperglycemia|2|||
149184985|NCT01958671|538148934|FG000|Overall Study|Lost to Follow-up|7|||
149184986|NCT01958671|538148935|FG001|Overall Study|Lost to Follow-up|11|||
149184987|NCT01958671|538148936|FG002|Overall Study|Lost to Follow-up|7|||
149184988|NCT01958671|538148934|FG000|Overall Study|Non-compliance with study drug|1|||
149184989|NCT01958671|538148935|FG001|Overall Study|Non-compliance with study drug|1|||
149184990|NCT01958671|538148936|FG002|Overall Study|Non-compliance with study drug|1|||
149184991|NCT01958671|538148934|FG000|Overall Study|Pregnancy|0|||
149184992|NCT01958671|538148935|FG001|Overall Study|Pregnancy|0|||
149184993|NCT01958671|538148936|FG002|Overall Study|Pregnancy|1|||
149184994|NCT01958671|538148934|FG000|Overall Study|Protocol Violation|0|||
149184995|NCT01958671|538148935|FG001|Overall Study|Protocol Violation|1|||
149184996|NCT01958671|538148936|FG002|Overall Study|Protocol Violation|0|||
149184997|NCT01958671|538148934|FG000|Overall Study|Study site terminated by sponsor|1|||
149184998|NCT01958671|538148935|FG001|Overall Study|Study site terminated by sponsor|0|||
149184999|NCT01958671|538148936|FG002|Overall Study|Study site terminated by sponsor|1|||
149185000|NCT01958671|538148934|FG000|Overall Study|Participant moved|0|||
149185001|NCT01958671|538148935|FG001|Overall Study|Participant moved|0|||
149185002|NCT01958671|538148936|FG002|Overall Study|Participant moved|1|||
149185003|NCT01958671|538148934|FG000|Overall Study|Withdrawal by Subject|8|||
149185004|NCT01958671|538148935|FG001|Overall Study|Withdrawal by Subject|10|||
149185005|NCT01958671|538148936|FG002|Overall Study|Withdrawal by Subject|13|||
149185006|NCT02778867|538148937|FG000|Phase 1|Withdrawal by Subject|2|||
149185007|NCT02778867|538148938|FG001|Phase 1|Withdrawal by Subject|3|||
148933273|NCT00639678|537242164|FG002|Overall Study|Adverse Event|0|||
148933274|NCT00639678|537242165|FG003|Overall Study|Adverse Event|0|||
148933275|NCT00639678|537242162|FG000|Overall Study|Lack of Compliance|0|||
148933276|NCT00639678|537242163|FG001|Overall Study|Lack of Compliance|0|||
148933277|NCT00639678|537242164|FG002|Overall Study|Lack of Compliance|1|||
148933278|NCT00639678|537242165|FG003|Overall Study|Lack of Compliance|0|||
148933279|NCT01973569|537242166|FG000|Overall Study|Adverse Event|9|||
149185008|NCT02778867|538148939|FG002|Phase 1|Withdrawal by Subject|0|||
149185009|NCT02778867|538148940|FG003|Phase 1|Withdrawal by Subject|0|||
149185010|NCT02778867|538148937|FG000|Phase 2|Withdrawal by Subject|0|||
149185011|NCT02778867|538148938|FG001|Phase 2|Withdrawal by Subject|0|||
149185012|NCT02778867|538148939|FG002|Phase 2|Withdrawal by Subject|1|||
149185013|NCT02778867|538148940|FG003|Phase 2|Withdrawal by Subject|0|||
149185014|NCT02778867|538148937|FG000|Phase 2|Physician Decision|0|||
149185015|NCT02778867|538148938|FG001|Phase 2|Physician Decision|0|||
149185016|NCT02778867|538148939|FG002|Phase 2|Physician Decision|0|||
149185017|NCT02778867|538148940|FG003|Phase 2|Physician Decision|1|||
149185018|NCT02778867|538148937|FG000|Phase 2|Adverse Event|0|||
149185019|NCT02778867|538148938|FG001|Phase 2|Adverse Event|0|||
149185020|NCT02778867|538148939|FG002|Phase 2|Adverse Event|0|||
149185021|NCT02778867|538148940|FG003|Phase 2|Adverse Event|1|||
149185022|NCT00960440|538148942|FG000|Overall Study|Death|0|||
149185023|NCT00960440|538148943|FG001|Overall Study|Death|0|||
149185024|NCT00960440|538148944|FG002|Overall Study|Death|0|||
149185025|NCT00960440|538148945|FG003|Overall Study|Death|1|||
149185026|NCT00960440|538148942|FG000|Overall Study|Adverse Event|12|||
149185027|NCT00960440|538148943|FG001|Overall Study|Adverse Event|12|||
149185028|NCT00960440|538148944|FG002|Overall Study|Adverse Event|4|||
149185029|NCT00960440|538148945|FG003|Overall Study|Adverse Event|4|||
149185030|NCT00960440|538148942|FG000|Overall Study|Lack of Efficacy|2|||
149185031|NCT00960440|538148943|FG001|Overall Study|Lack of Efficacy|5|||
149185032|NCT00960440|538148944|FG002|Overall Study|Lack of Efficacy|3|||
149185033|NCT00960440|538148945|FG003|Overall Study|Lack of Efficacy|8|||
149185034|NCT00960440|538148942|FG000|Overall Study|Protocol Violation|2|||
149185035|NCT00960440|538148943|FG001|Overall Study|Protocol Violation|8|||
149185036|NCT00960440|538148944|FG002|Overall Study|Protocol Violation|3|||
149185037|NCT00960440|538148945|FG003|Overall Study|Protocol Violation|4|||
149185038|NCT00960440|538148942|FG000|Overall Study|Withdrawal by Subject|9|||
149185039|NCT00960440|538148943|FG001|Overall Study|Withdrawal by Subject|5|||
149185040|NCT00960440|538148944|FG002|Overall Study|Withdrawal by Subject|2|||
149185041|NCT00960440|538148945|FG003|Overall Study|Withdrawal by Subject|1|||
149185042|NCT00960440|538148942|FG000|Overall Study|Other|1|||
149185043|NCT00960440|538148943|FG001|Overall Study|Other|1|||
149185044|NCT00960440|538148944|FG002|Overall Study|Other|1|||
149185045|NCT00960440|538148945|FG003|Overall Study|Other|0|||
149185046|NCT01070303|538148946|FG000|Overall Study|Adverse Event|39|||
149185047|NCT01070303|538148946|FG000|Overall Study|Withdrawal by Subject|20|||
149185048|NCT01070303|538148946|FG000|Overall Study|Lost to Follow-up|9|||
149185049|NCT01070303|538148946|FG000|Overall Study|Protocol Violation|0|||
149185050|NCT01070303|538148946|FG000|Overall Study|Lack of Efficacy|2|||
149185051|NCT01070303|538148946|FG000|Overall Study|Administrative Reason|1|||
149185052|NCT01070303|538148946|FG000|Overall Study|Other|18|||
149185053|NCT00859898|538148948|FG000|Overall Study|Lack of Efficacy|0|||
149185054|NCT00859898|538148949|FG001|Overall Study|Lack of Efficacy|1|||
149185055|NCT00859898|538148950|FG002|Overall Study|Lack of Efficacy|1|||
149185056|NCT00859898|538148948|FG000|Overall Study|Adverse Event|4|||
149185057|NCT00859898|538148949|FG001|Overall Study|Adverse Event|9|||
149185058|NCT00859898|538148950|FG002|Overall Study|Adverse Event|8|||
149185059|NCT00859898|538148948|FG000|Overall Study|Withdrawal by Subject|11|||
149185060|NCT00859898|538148949|FG001|Overall Study|Withdrawal by Subject|8|||
149185061|NCT00859898|538148950|FG002|Overall Study|Withdrawal by Subject|11|||
149185062|NCT00859898|538148948|FG000|Overall Study|Death|0|||
149185063|NCT00859898|538148949|FG001|Overall Study|Death|0|||
149185064|NCT00859898|538148950|FG002|Overall Study|Death|1|||
149185065|NCT00859898|538148948|FG000|Overall Study|Lost to Follow-up|10|||
149185066|NCT00859898|538148949|FG001|Overall Study|Lost to Follow-up|11|||
149185067|NCT00859898|538148950|FG002|Overall Study|Lost to Follow-up|5|||
149185068|NCT00859898|538148948|FG000|Overall Study|poor/non-compliance|2|||
149185069|NCT00859898|538148949|FG001|Overall Study|poor/non-compliance|0|||
149185070|NCT00859898|538148950|FG002|Overall Study|poor/non-compliance|0|||
149185071|NCT00859898|538148948|FG000|Overall Study|No longer meets criteria|0|||
148679695|NCT02164539|536300860|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
148679696|NCT02164539|536300861|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
148679697|NCT01612702|536300862|FG000|Overall Study|Protocol Violation|11|||
148679698|NCT01612702|536300863|FG001|Overall Study|Protocol Violation|11|||
148679699|NCT00527397|536300864|FG000|Overall Study|Adverse Event|3|||
148679700|NCT00527397|536300864|FG000|Overall Study|Lack of Efficacy|1|||
148679701|NCT00527397|536300864|FG000|Overall Study|Protocol Violation|1|||
148679702|NCT00527397|536300864|FG000|Overall Study|Withdrawal by Subject|6|||
149185072|NCT00859898|538148949|FG001|Overall Study|No longer meets criteria|1|||
149185073|NCT00859898|538148950|FG002|Overall Study|No longer meets criteria|0|||
149185074|NCT00859898|538148948|FG000|Overall Study|non-specified|1|||
149185075|NCT00859898|538148949|FG001|Overall Study|non-specified|1|||
148679703|NCT00527397|536300864|FG000|Overall Study|Study terminated by sponsor|13|||
149014216|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
149185076|NCT00859898|538148950|FG002|Overall Study|non-specified|1|||
149185077|NCT03408873|538148952|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
149185078|NCT03408873|538148952|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
149185079|NCT03408873|538148952|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
149185080|NCT03408873|538148952|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
149185081|NCT03408873|538148952|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
149185082|NCT03408873|538148952|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
149185083|NCT01312428|538148953|FG000|Overall Study|Study Termination|3|||
149185084|NCT01312428|538148954|FG001|Overall Study|Study Termination|4|||
149185085|NCT01797783|538148957|FG000|Overall Study|Adverse Event|1|||
149185086|NCT01797783|538148958|FG001|Overall Study|Adverse Event|1|||
149185087|NCT01797783|538148957|FG000|Overall Study|Withdrawal by Subject|1|||
149185088|NCT01797783|538148958|FG001|Overall Study|Withdrawal by Subject|0|||
149185089|NCT02214186|538148963|FG000|Overall Study|Lost to Follow-up|1|||
149185090|NCT02214186|538148964|FG001|Overall Study|Lost to Follow-up|1|||
149185091|NCT02214186|538148963|FG000|Overall Study|Protocol Violation|1|||
149185092|NCT02214186|538148964|FG001|Overall Study|Protocol Violation|1|||
149185093|NCT01525849|538148965|FG000|Overall Study|Lost to Follow-up|3|||
149185094|NCT01525849|538148966|FG001|Overall Study|Lost to Follow-up|2|||
149185095|NCT01525849|538148965|FG000|Overall Study|Withdrawal by Subject|1|||
149185096|NCT01525849|538148966|FG001|Overall Study|Withdrawal by Subject|9|||
149185097|NCT01525849|538148965|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
149185098|NCT01525849|538148966|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
149185099|NCT01525849|538148965|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
148679704|NCT03012815|536300865|FG000|Overall Study|Lost to Follow-up|1|||
149185100|NCT01525849|538148966|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
149185101|NCT00793819|538148967|FG000|Overall Study|Adverse Event|8|||
149185102|NCT00793819|538148968|FG001|Overall Study|Adverse Event|4|||
149185103|NCT00793819|538148967|FG000|Overall Study|Lack of Efficacy|1|||
149185104|NCT00793819|538148968|FG001|Overall Study|Lack of Efficacy|1|||
149185105|NCT00793819|538148967|FG000|Overall Study|Withdrawal by Subject|4|||
149185106|NCT00793819|538148968|FG001|Overall Study|Withdrawal by Subject|3|||
149185107|NCT00793819|538148967|FG000|Overall Study|Lost to Follow-up|1|||
149185108|NCT00793819|538148968|FG001|Overall Study|Lost to Follow-up|1|||
149185109|NCT00611130|538148979|FG000|Overall Study|Lost to Follow-up|25|||
149185110|NCT00611130|538148980|FG001|Overall Study|Lost to Follow-up|29|||
149185111|NCT00611130|538148979|FG000|Overall Study|Protocol noncompliance|7|||
149185112|NCT00611130|538148980|FG001|Overall Study|Protocol noncompliance|6|||
149185113|NCT00611130|538148979|FG000|Overall Study|Withdrawal by Subject|6|||
149185114|NCT00611130|538148980|FG001|Overall Study|Withdrawal by Subject|5|||
149185115|NCT00611130|538148979|FG000|Overall Study|Other|5|||
149185116|NCT00611130|538148980|FG001|Overall Study|Other|4|||
149185117|NCT00611130|538148979|FG000|Overall Study|Incarceration|3|||
149185118|NCT00611130|538148980|FG001|Overall Study|Incarceration|2|||
149185119|NCT00611130|538148979|FG000|Overall Study|Administrative|1|||
149185120|NCT00611130|538148980|FG001|Overall Study|Administrative|1|||
149185121|NCT00611130|538148979|FG000|Overall Study|Adverse Event|1|||
149185122|NCT00611130|538148980|FG001|Overall Study|Adverse Event|0|||
149185123|NCT00611130|538148979|FG000|Overall Study|Death|1|||
149185124|NCT00611130|538148980|FG001|Overall Study|Death|0|||
149185125|NCT03662334|538148982|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
149185126|NCT03662334|538148983|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
149185127|NCT01734993|538148987|FG000|Overall Study|Adverse Event|1|||
149185128|NCT01734993|538148987|FG000|Overall Study|Lack of Efficacy|1|||
149185129|NCT03694522|538148988|FG000|Overall Study|Withdrawal by Subject|8|||
149185130|NCT03694522|538148989|FG001|Overall Study|Withdrawal by Subject|10|||
149185131|NCT03694522|538148988|FG000|Overall Study|Physician Decision|53|||
149185132|NCT03694522|538148989|FG001|Overall Study|Physician Decision|54|||
149185133|NCT03694522|538148988|FG000|Overall Study|Other|1|||
149185134|NCT03694522|538148989|FG001|Overall Study|Other|1|||
149185135|NCT03694522|538148988|FG000|Overall Study|Lost to Follow-up|0|||
149185136|NCT03694522|538148989|FG001|Overall Study|Lost to Follow-up|1|||
149185137|NCT02760407|538148990|FG000|Overall Study|Death|2|||
149185138|NCT02760407|538148991|FG001|Overall Study|Death|3|||
149185139|NCT02760407|538148992|FG002|Overall Study|Death|1|||
149185140|NCT02760407|538148993|FG003|Overall Study|Death|1|||
149185141|NCT02760407|538148990|FG000|Overall Study|Lost to Follow-up|1|||
149185142|NCT02760407|538148991|FG001|Overall Study|Lost to Follow-up|7|||
149185143|NCT02760407|538148992|FG002|Overall Study|Lost to Follow-up|4|||
149185144|NCT02760407|538148993|FG003|Overall Study|Lost to Follow-up|6|||
149185145|NCT02760407|538148990|FG000|Overall Study|Withdrawal by Subject|25|||
149185146|NCT02760407|538148991|FG001|Overall Study|Withdrawal by Subject|31|||
149185147|NCT02760407|538148992|FG002|Overall Study|Withdrawal by Subject|37|||
149185148|NCT02760407|538148993|FG003|Overall Study|Withdrawal by Subject|25|||
149185149|NCT02760407|538148990|FG000|Overall Study|Violation of Eligibility criteria|0|||
149185150|NCT02760407|538148991|FG001|Overall Study|Violation of Eligibility criteria|0|||
149185151|NCT02760407|538148992|FG002|Overall Study|Violation of Eligibility criteria|1|||
149185152|NCT02760407|538148993|FG003|Overall Study|Violation of Eligibility criteria|1|||
149185153|NCT02760407|538148990|FG000|Overall Study|Personal reasons|0|||
149185154|NCT02760407|538148991|FG001|Overall Study|Personal reasons|0|||
149185155|NCT02760407|538148992|FG002|Overall Study|Personal reasons|0|||
149185156|NCT02760407|538148993|FG003|Overall Study|Personal reasons|1|||
149185157|NCT02760407|538148990|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
149185158|NCT02760407|538148991|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
149185159|NCT02760407|538148992|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
149185160|NCT02760407|538148993|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
149185161|NCT02760407|538148990|FG000|Overall Study|Use of prohibited Medication|0|||
149185162|NCT02760407|538148991|FG001|Overall Study|Use of prohibited Medication|0|||
149185163|NCT02760407|538148992|FG002|Overall Study|Use of prohibited Medication|1|||
149185164|NCT02760407|538148993|FG003|Overall Study|Use of prohibited Medication|0|||
149185165|NCT02760407|538148990|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
149185166|NCT02760407|538148991|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
149185167|NCT02760407|538148992|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
148933280|NCT01973569|537242167|FG001|Overall Study|Adverse Event|2|||
148933281|NCT01973569|537242168|FG002|Overall Study|Adverse Event|4|||
148933282|NCT01973569|537242166|FG000|Overall Study|Protocol Violation|2|||
148933283|NCT01973569|537242167|FG001|Overall Study|Protocol Violation|1|||
149185168|NCT02760407|538148993|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
149185169|NCT02760407|538148990|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
149185170|NCT02760407|538148991|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
149185171|NCT02760407|538148992|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
149185172|NCT02760407|538148993|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
149185173|NCT02760407|538148990|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
149185174|NCT02760407|538148991|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
149185175|NCT02760407|538148992|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
149185176|NCT02760407|538148993|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
149185177|NCT02760407|538148990|FG000|Overall Study|Inadequately Enrolled|0|||
149185178|NCT02760407|538148991|FG001|Overall Study|Inadequately Enrolled|0|||
149185179|NCT02760407|538148992|FG002|Overall Study|Inadequately Enrolled|0|||
149185180|NCT02760407|538148993|FG003|Overall Study|Inadequately Enrolled|1|||
149185181|NCT02760407|538148990|FG000|Overall Study|Withdrawal By PI's Decision|0|||
149185182|NCT02760407|538148991|FG001|Overall Study|Withdrawal By PI's Decision|1|||
149185183|NCT02760407|538148992|FG002|Overall Study|Withdrawal By PI's Decision|0|||
149185184|NCT02760407|538148993|FG003|Overall Study|Withdrawal By PI's Decision|0|||
149185185|NCT02760407|538148990|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
149185186|NCT02760407|538148991|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
149185187|NCT02760407|538148992|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
149185188|NCT02760407|538148993|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
149185189|NCT02760407|538148990|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
149185190|NCT02760407|538148991|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
149185191|NCT02760407|538148992|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
149185192|NCT02760407|538148993|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
149185193|NCT02760407|538148990|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
149185194|NCT02760407|538148991|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
149185195|NCT02760407|538148992|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
149185196|NCT02760407|538148993|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
149185197|NCT02760407|538148990|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
149185198|NCT02760407|538148991|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
149185199|NCT02760407|538148992|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
149185200|NCT02760407|538148993|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
149185201|NCT02760407|538148990|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
149185202|NCT02760407|538148991|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
149185203|NCT02760407|538148992|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
149185204|NCT02760407|538148993|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
149185205|NCT02760407|538148990|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
149185206|NCT02760407|538148991|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
149185207|NCT02760407|538148992|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
149185208|NCT02760407|538148993|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
149185209|NCT02760407|538148990|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
149185210|NCT02760407|538148991|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
149185211|NCT02760407|538148992|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
149185212|NCT02760407|538148993|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
149185213|NCT02760407|538148990|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
148933284|NCT01973569|537242168|FG002|Overall Study|Protocol Violation|3|||
148933285|NCT01973569|537242166|FG000|Overall Study|Withdrawal by Subject|7|||
148679705|NCT03012815|536300866|FG001|Overall Study|Lost to Follow-up|0|||
149185214|NCT02760407|538148991|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
149185215|NCT02760407|538148992|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
149185216|NCT02760407|538148993|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
149185217|NCT02760407|538148990|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
149185218|NCT02760407|538148991|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
149185219|NCT02760407|538148992|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
149185220|NCT02760407|538148993|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
149185221|NCT02522377|538148994|FG000|Overall Study|Withdrawal by Subject|1|||
149185222|NCT02522377|538148995|FG001|Overall Study|Withdrawal by Subject|0|||
149185223|NCT02522377|538148994|FG000|Overall Study|Remission Achieved|3|||
149185224|NCT02522377|538148995|FG001|Overall Study|Remission Achieved|0|||
149185225|NCT01158950|538148996|FG000|1st Intervention (1 Day)|Physician Decision|1|||
149185226|NCT01158950|538148997|FG001|1st Intervention (1 Day)|Physician Decision|2|||
149185227|NCT02137772|538148998|FG000|Overall Study|Adverse Event|6|||
149185228|NCT02137772|538148999|FG001|Overall Study|Adverse Event|3|||
149185229|NCT02137772|538148998|FG000|Overall Study|Death|71|||
149185230|NCT02137772|538148999|FG001|Overall Study|Death|44|||
149185231|NCT02137772|538148998|FG000|Overall Study|Lost to Follow-up|8|||
149185232|NCT02137772|538148999|FG001|Overall Study|Lost to Follow-up|4|||
149185233|NCT02137772|538148998|FG000|Overall Study|Physician Decision|15|||
149185234|NCT02137772|538148999|FG001|Overall Study|Physician Decision|5|||
149185235|NCT02137772|538148998|FG000|Overall Study|Withdrawal by Subject|28|||
149185236|NCT02137772|538148999|FG001|Overall Study|Withdrawal by Subject|17|||
149185237|NCT02137772|538148998|FG000|Overall Study|Non-compliance with study drug|1|||
149185238|NCT02137772|538148999|FG001|Overall Study|Non-compliance with study drug|0|||
149185239|NCT02137772|538148998|FG000|Overall Study|Not treated|3|||
148933286|NCT01973569|537242167|FG001|Overall Study|Withdrawal by Subject|5|||
149185240|NCT02137772|538148999|FG001|Overall Study|Not treated|2|||
149185241|NCT01844700|538149000|FG000|Overall Study|Lack of Efficacy|1|||
149185242|NCT01844700|538149001|FG001|Overall Study|Lack of Efficacy|0|||
149185243|NCT01844700|538149000|FG000|Overall Study|refused medication switch|1|||
149185244|NCT01844700|538149001|FG001|Overall Study|refused medication switch|0|||
149185245|NCT01844700|538149000|FG000|Overall Study|Withdrawal by Subject|1|||
149185246|NCT01844700|538149001|FG001|Overall Study|Withdrawal by Subject|0|||
149185247|NCT01844700|538149000|FG000|Overall Study|stopped taking meds|0|||
149185248|NCT01844700|538149001|FG001|Overall Study|stopped taking meds|1|||
148933287|NCT01973569|537242168|FG002|Overall Study|Withdrawal by Subject|2|||
148933288|NCT01973569|537242166|FG000|Overall Study|Invasive dental treatment|3|||
148933289|NCT01973569|537242167|FG001|Overall Study|Invasive dental treatment|5|||
148933290|NCT01973569|537242168|FG002|Overall Study|Invasive dental treatment|6|||
148933291|NCT01973569|537242166|FG000|Overall Study|Prohibited concomitant d|1|||
148933292|NCT01973569|537242167|FG001|Overall Study|Prohibited concomitant d|5|||
148933293|NCT01973569|537242168|FG002|Overall Study|Prohibited concomitant d|0|||
148933294|NCT01973569|537242166|FG000|Overall Study|Disease progression|0|||
148933295|NCT01973569|537242167|FG001|Overall Study|Disease progression|3|||
148933296|NCT01973569|537242168|FG002|Overall Study|Disease progression|0|||
148933297|NCT01973569|537242166|FG000|Overall Study|Other|1|||
148933298|NCT01973569|537242167|FG001|Overall Study|Other|1|||
148933299|NCT01973569|537242168|FG002|Overall Study|Other|0|||
148933300|NCT01973569|537242166|FG000|Overall Study|Did not receive study drug|6|||
148933301|NCT01973569|537242167|FG001|Overall Study|Did not receive study drug|3|||
148933302|NCT01973569|537242168|FG002|Overall Study|Did not receive study drug|3|||
149185249|NCT00501852|538149005|FG000|Overall Study|Adverse Event|3|||
149185250|NCT00501852|538149005|FG000|Overall Study|Withdrawal by Subject|2|||
148933303|NCT02436304|537242169|FG000|Overall Study|Lost to Follow-up|0|||
148679706|NCT03012815|536300865|FG000|Overall Study|Physician Decision|3|||
148933304|NCT02436304|537242170|FG001|Overall Study|Lost to Follow-up|1|||
148933305|NCT02436304|537242171|FG002|Overall Study|Lost to Follow-up|0|||
148933306|NCT02436304|537242169|FG000|Overall Study|Withdrawal by Subject|0|||
148933307|NCT02436304|537242170|FG001|Overall Study|Withdrawal by Subject|1|||
149185251|NCT01171521|538149006|FG000|Overall Study|Lost to Follow-up|5|||
149185252|NCT01171521|538149006|FG000|Overall Study|screen failure|1|||
149185253|NCT01927562|538149007|FG000|Overall Study|Lost to Follow-up|30|||
149185254|NCT01927562|538149007|FG000|Overall Study|Withdrawal by Subject|3|||
149185255|NCT01927562|538149007|FG000|Overall Study|Physician Decision|5|||
149185256|NCT00652093|538149008|FG000|Overall Study|Withdrawal by Subject|0|||
149185257|NCT00652093|538149009|FG001|Overall Study|Withdrawal by Subject|0|||
148933308|NCT02436304|537242171|FG002|Overall Study|Withdrawal by Subject|0|||
148933309|NCT02436304|537242169|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
148933310|NCT02436304|537242170|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
148933311|NCT02436304|537242171|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
148933312|NCT00785928|537242174|FG000|Treatment Phase|Adverse Event|1|||
149185258|NCT00652093|538149010|FG002|Overall Study|Withdrawal by Subject|1|||
149185259|NCT00652093|538149011|FG003|Overall Study|Withdrawal by Subject|0|||
148933313|NCT00785928|537242175|FG001|Treatment Phase|Adverse Event|1|||
148933314|NCT00785928|537242176|FG002|Treatment Phase|Adverse Event|2|||
148933315|NCT00785928|537242177|FG003|Treatment Phase|Adverse Event|0|||
148933316|NCT00785928|537242178|FG004|Treatment Phase|Adverse Event|0|||
148933317|NCT00785928|537242179|FG005|Treatment Phase|Adverse Event|0|||
148933318|NCT00785928|537242180|FG006|Treatment Phase|Adverse Event|2|||
148933319|NCT00785928|537242174|FG000|Treatment Phase|Inadequate Response|0|||
148933320|NCT00785928|537242175|FG001|Treatment Phase|Inadequate Response|1|||
148933321|NCT00785928|537242176|FG002|Treatment Phase|Inadequate Response|0|||
148933322|NCT00785928|537242177|FG003|Treatment Phase|Inadequate Response|0|||
149185260|NCT00652093|538149012|FG004|Overall Study|Withdrawal by Subject|1|||
149185261|NCT00652093|538149013|FG005|Overall Study|Withdrawal by Subject|0|||
149185262|NCT00652093|538149008|FG000|Overall Study|Physician Decision|0|||
149185263|NCT00652093|538149009|FG001|Overall Study|Physician Decision|0|||
149185264|NCT00652093|538149010|FG002|Overall Study|Physician Decision|0|||
149185265|NCT00652093|538149011|FG003|Overall Study|Physician Decision|0|||
149185266|NCT00652093|538149012|FG004|Overall Study|Physician Decision|1|||
149185267|NCT00652093|538149013|FG005|Overall Study|Physician Decision|0|||
149185268|NCT01422304|538149016|FG000|Overall Study|Adverse Event|0|||
149185269|NCT01422304|538149017|FG001|Overall Study|Adverse Event|1|||
149185270|NCT01422304|538149016|FG000|Overall Study|Lost to Follow-up|14|||
149185271|NCT01422304|538149017|FG001|Overall Study|Lost to Follow-up|20|||
149185272|NCT01422304|538149016|FG000|Overall Study|Never Entered Follow-up|2|||
149185273|NCT01422304|538149017|FG001|Overall Study|Never Entered Follow-up|1|||
149185274|NCT01422304|538149016|FG000|Overall Study|Protocol Violation|1|||
149185275|NCT01422304|538149017|FG001|Overall Study|Protocol Violation|0|||
149185276|NCT01422304|538149016|FG000|Overall Study|Withdrawal by Subject|4|||
149185277|NCT01422304|538149017|FG001|Overall Study|Withdrawal by Subject|2|||
149185278|NCT01422304|538149016|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
149185279|NCT01422304|538149017|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
149185280|NCT01422304|538149016|FG000|Overall Study|Not Treated|3|||
149185281|NCT01422304|538149017|FG001|Overall Study|Not Treated|11|||
149185282|NCT00866294|538149021|FG000|Overall Study|Adverse Event|12|||
149185283|NCT00866294|538149022|FG001|Overall Study|Adverse Event|13|||
149185284|NCT00866294|538149023|FG002|Overall Study|Adverse Event|9|||
149014217|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
149014218|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
149014219|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
149185285|NCT00866294|538149021|FG000|Overall Study|Lack of Efficacy|7|||
149185286|NCT00866294|538149022|FG001|Overall Study|Lack of Efficacy|1|||
149185287|NCT00866294|538149023|FG002|Overall Study|Lack of Efficacy|0|||
149014220|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
149014221|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
149185288|NCT00866294|538149021|FG000|Overall Study|Protocol Violation|2|||
149185289|NCT00866294|538149022|FG001|Overall Study|Protocol Violation|0|||
149185290|NCT00866294|538149023|FG002|Overall Study|Protocol Violation|0|||
149185291|NCT00866294|538149021|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
149185292|NCT00866294|538149022|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149185293|NCT00866294|538149023|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149185294|NCT00866294|538149021|FG000|Overall Study|Lost to Follow-up|1|||
149185295|NCT00866294|538149022|FG001|Overall Study|Lost to Follow-up|3|||
149185296|NCT00866294|538149023|FG002|Overall Study|Lost to Follow-up|0|||
149185297|NCT00866294|538149021|FG000|Overall Study|Physician Decision|6|||
148679707|NCT03012815|536300866|FG001|Overall Study|Physician Decision|2|||
148933323|NCT00785928|537242178|FG004|Treatment Phase|Inadequate Response|0|||
148933324|NCT00785928|537242179|FG005|Treatment Phase|Inadequate Response|0|||
149014222|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149014223|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149185298|NCT00866294|538149022|FG001|Overall Study|Physician Decision|2|||
149185299|NCT00866294|538149023|FG002|Overall Study|Physician Decision|1|||
149185300|NCT02508701|538149024|FG000|Overall Study|Lost to Follow-up|9|||
149185301|NCT02508701|538149025|FG001|Overall Study|Lost to Follow-up|5|||
149185302|NCT02508701|538149026|FG002|Overall Study|Lost to Follow-up|5|||
149185303|NCT02508701|538149027|FG003|Overall Study|Lost to Follow-up|3|||
149185304|NCT03117049|538149034|FG000|Overall Study|Continued the follow-up period|109|||
149185305|NCT03117049|538149035|FG001|Overall Study|Continued the follow-up period|129|||
148933325|NCT00785928|537242180|FG006|Treatment Phase|Inadequate Response|0|||
149014224|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149185306|NCT03117049|538149034|FG000|Overall Study|Died|82|||
149185307|NCT03117049|538149035|FG001|Overall Study|Died|93|||
149185308|NCT03117049|538149034|FG000|Overall Study|Consent withdrawal|7|||
148933326|NCT00785928|537242174|FG000|Treatment Phase|Lack of Efficacy|0|||
149185309|NCT03117049|538149035|FG001|Overall Study|Consent withdrawal|6|||
149185310|NCT03117049|538149034|FG000|Overall Study|Missing contact|3|||
149185311|NCT03117049|538149035|FG001|Overall Study|Missing contact|3|||
149185312|NCT00839098|538149036|FG000|Overall Study|Withdrawal by Subject|2|||
149185313|NCT00839098|538149037|FG001|Overall Study|Withdrawal by Subject|1|||
149185314|NCT00839098|538149038|FG002|Overall Study|Withdrawal by Subject|7|||
149185315|NCT00798967|538149039|FG000|Overall Study|Adverse Event|2|||
149185316|NCT00798967|538149040|FG001|Overall Study|Adverse Event|3|||
149185317|NCT00798967|538149039|FG000|Overall Study|Withdrawal by Subject|0|||
149185318|NCT00798967|538149040|FG001|Overall Study|Withdrawal by Subject|1|||
149185319|NCT00798967|538149039|FG000|Overall Study|Physician Decision|1|||
149185320|NCT00798967|538149040|FG001|Overall Study|Physician Decision|0|||
149185321|NCT00798967|538149039|FG000|Overall Study|Randomized in error by site|1|||
149185322|NCT00798967|538149040|FG001|Overall Study|Randomized in error by site|0|||
149185323|NCT00227877|538149043|FG000|Pre-visit Assessment|Technical difficulties|7|||
149185324|NCT00227877|538149044|FG001|Pre-visit Assessment|Technical difficulties|3|||
149185325|NCT00227877|538149045|FG002|Pre-visit Assessment|Technical difficulties|0|||
149185326|NCT00227877|538149046|FG003|Pre-visit Assessment|Technical difficulties|0|||
149185327|NCT00227877|538149043|FG000|Post-visit Checklist|Lost to Follow-up|24|||
149185328|NCT00227877|538149044|FG001|Post-visit Checklist|Lost to Follow-up|13|||
149185329|NCT00227877|538149045|FG002|Post-visit Checklist|Lost to Follow-up|1|||
149185330|NCT00227877|538149046|FG003|Post-visit Checklist|Lost to Follow-up|0|||
149185331|NCT00227877|538149043|FG000|3-months Follow-up|Completed late|135|||
149185332|NCT00227877|538149044|FG001|3-months Follow-up|Completed late|128|||
148933327|NCT00785928|537242175|FG001|Treatment Phase|Lack of Efficacy|1|||
148933328|NCT00785928|537242176|FG002|Treatment Phase|Lack of Efficacy|1|||
148933329|NCT00785928|537242177|FG003|Treatment Phase|Lack of Efficacy|0|||
149185333|NCT00227877|538149045|FG002|3-months Follow-up|Completed late|34|||
149185334|NCT00227877|538149046|FG003|3-months Follow-up|Completed late|8|||
149185335|NCT00227877|538149043|FG000|3-months Follow-up|Lost to Follow-up|178|||
149185336|NCT00227877|538149044|FG001|3-months Follow-up|Lost to Follow-up|139|||
149185337|NCT00227877|538149045|FG002|3-months Follow-up|Lost to Follow-up|18|||
149185338|NCT00227877|538149046|FG003|3-months Follow-up|Lost to Follow-up|13|||
149185339|NCT00227877|538149043|FG000|12-months Follow-up|Completed late|78|||
149185340|NCT00227877|538149044|FG001|12-months Follow-up|Completed late|74|||
149185341|NCT00227877|538149045|FG002|12-months Follow-up|Completed late|1|||
149185342|NCT00227877|538149046|FG003|12-months Follow-up|Completed late|0|||
149185343|NCT00227877|538149043|FG000|12-months Follow-up|Lost to Follow-up|232|||
149185344|NCT00227877|538149044|FG001|12-months Follow-up|Lost to Follow-up|189|||
149185345|NCT00227877|538149045|FG002|12-months Follow-up|Lost to Follow-up|30|||
149185346|NCT00227877|538149046|FG003|12-months Follow-up|Lost to Follow-up|26|||
149185347|NCT03141307|538149047|FG000|In-Hospital|Withdrawal by Subject|0|||
149185348|NCT03141307|538149048|FG001|In-Hospital|Withdrawal by Subject|2|||
149185349|NCT03141307|538149047|FG000|In-Hospital|Protocol Violation|4|||
149185350|NCT03141307|538149048|FG001|In-Hospital|Protocol Violation|0|||
149185351|NCT03141307|538149047|FG000|Follow-Up|Lost to Follow-up|97|||
149185352|NCT03141307|538149048|FG001|Follow-Up|Lost to Follow-up|54|||
149185353|NCT03090737|538149049|FG000|Overall Study|Other reasons|1|||
149185354|NCT03090737|538149049|FG000|Overall Study|Completed treatment as per protocol|17|||
149185355|NCT03090737|538149049|FG000|Overall Study|Maximum clinical benefit|2|||
149185356|NCT03090737|538149049|FG000|Overall Study|Adverse event unrelated to study drug|7|||
149185357|NCT03090737|538149049|FG000|Overall Study|Study drug toxicity|4|||
149185358|NCT03090737|538149049|FG000|Overall Study|Disease progression|98|||
149185359|NCT02522481|538149055|FG000|Overall Study|discontinued|1|||
148933330|NCT00785928|537242178|FG004|Treatment Phase|Lack of Efficacy|0|||
149185360|NCT02522481|538149055|FG000|Overall Study|Not dosed|2|||
149185361|NCT03123939|538149056|FG000|Overall Study|Lack of Efficacy|6|||
149185362|NCT03123939|538149056|FG000|Overall Study|Death|5|||
149185363|NCT03123939|538149056|FG000|Overall Study|Physician Decision|2|||
149185364|NCT03123939|538149056|FG000|Overall Study|Subject/guardian decision|2|||
149185365|NCT03123939|538149056|FG000|Overall Study|Lost to Follow-up|1|||
149185366|NCT03123939|538149056|FG000|Overall Study|New therapy for study indication|1|||
149185367|NCT03123939|538149056|FG000|Overall Study|Protocol deviation|1|||
149185368|NCT03123939|538149056|FG000|Overall Study|Progressive disease|18|||
149185369|NCT03123939|538149056|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
149185370|NCT03123939|538149056|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
149185371|NCT01115569|538150367|FG000|Conversion/Titration Phase|Adverse Event|59|||
149185372|NCT01115569|538150368|FG001|Conversion/Titration Phase|Adverse Event|0|||
149185373|NCT01115569|538150367|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
149185374|NCT01115569|538150368|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
149185375|NCT01115569|538150367|FG000|Conversion/Titration Phase|Physician Decision|5|||
148933331|NCT00785928|537242179|FG005|Treatment Phase|Lack of Efficacy|0|||
148933332|NCT00785928|537242180|FG006|Treatment Phase|Lack of Efficacy|0|||
149185376|NCT01115569|538150368|FG001|Conversion/Titration Phase|Physician Decision|0|||
149185377|NCT01115569|538150367|FG000|Conversion/Titration Phase|Protocol Violation|68|||
149185378|NCT01115569|538150368|FG001|Conversion/Titration Phase|Protocol Violation|0|||
149185379|NCT01115569|538150367|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
149185380|NCT01115569|538150368|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
149185381|NCT01115569|538150367|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
149185382|NCT01115569|538150368|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
149185383|NCT01115569|538150367|FG000|Maintenance Phase|Adverse Event|0|||
149185384|NCT01115569|538150368|FG001|Maintenance Phase|Adverse Event|43|||
149185385|NCT01115569|538150367|FG000|Maintenance Phase|Lost to Follow-up|0|||
149185386|NCT01115569|538150368|FG001|Maintenance Phase|Lost to Follow-up|8|||
149185387|NCT01115569|538150367|FG000|Maintenance Phase|Physician Decision|0|||
149185388|NCT01115569|538150368|FG001|Maintenance Phase|Physician Decision|3|||
149185389|NCT01115569|538150367|FG000|Maintenance Phase|Protocol Violation|0|||
149185390|NCT01115569|538150368|FG001|Maintenance Phase|Protocol Violation|9|||
149185391|NCT01115569|538150367|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149185392|NCT01115569|538150368|FG001|Maintenance Phase|Withdrawal by Subject|27|||
149185393|NCT01115569|538150367|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
149185394|NCT01115569|538150368|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
149185395|NCT01115569|538150367|FG000|Maintenance Phase|Administrative|0|||
149185396|NCT01115569|538150368|FG001|Maintenance Phase|Administrative|1|||
149185397|NCT01254604|538150369|FG000|Overall Study|Lost to Follow-up|1|||
149185398|NCT01254604|538150370|FG001|Overall Study|Lost to Follow-up|1|||
149185399|NCT01254604|538150369|FG000|Overall Study|Protocol Violation|2|||
149185400|NCT01254604|538150370|FG001|Overall Study|Protocol Violation|2|||
149185401|NCT01254604|538150369|FG000|Overall Study|Withdrawal by Subject|2|||
149185402|NCT01254604|538150370|FG001|Overall Study|Withdrawal by Subject|4|||
149185403|NCT01254604|538150369|FG000|Overall Study|Adverse Event|3|||
149185404|NCT01254604|538150370|FG001|Overall Study|Adverse Event|2|||
149185405|NCT03504774|538150371|FG000|Overall Study|Adverse Event|2|||
149185406|NCT03504774|538150372|FG001|Overall Study|Adverse Event|0|||
149185407|NCT03504774|538150371|FG000|Overall Study|Lost to Follow-up|0|||
149185408|NCT03504774|538150372|FG001|Overall Study|Lost to Follow-up|1|||
149185409|NCT03504774|538150371|FG000|Overall Study|Protocol Violation|11|||
149185410|NCT03504774|538150372|FG001|Overall Study|Protocol Violation|3|||
149185411|NCT03504774|538150371|FG000|Overall Study|failed wk 52 DBPCFC|1|||
149185412|NCT03504774|538150372|FG001|Overall Study|failed wk 52 DBPCFC|0|||
149185413|NCT01781429|538150373|FG000|Overall Study|Death|0|||
149185414|NCT01781429|538150374|FG001|Overall Study|Death|0|||
149185415|NCT01781429|538150375|FG002|Overall Study|Death|0|||
149185416|NCT01781429|538150376|FG003|Overall Study|Death|0|||
149185417|NCT01781429|538150377|FG004|Overall Study|Death|0|||
149185418|NCT01781429|538150378|FG005|Overall Study|Death|0|||
149185419|NCT01781429|538150379|FG006|Overall Study|Death|0|||
149185420|NCT01781429|538150380|FG007|Overall Study|Death|0|||
149185421|NCT01781429|538150381|FG008|Overall Study|Death|0|||
149185422|NCT01781429|538150382|FG009|Overall Study|Death|1|||
149185423|NCT01781429|538150383|FG010|Overall Study|Death|0|||
149185424|NCT01781429|538150384|FG011|Overall Study|Death|0|||
149185425|NCT01781429|538150385|FG012|Overall Study|Death|1|||
149185426|NCT01781429|538150386|FG013|Overall Study|Death|0|||
149185427|NCT01781429|538150387|FG014|Overall Study|Death|1|||
149185428|NCT01781429|538150388|FG015|Overall Study|Death|0|||
149185429|NCT01781429|538150373|FG000|Overall Study|Withdrawal by Subject|0|||
149185430|NCT01781429|538150374|FG001|Overall Study|Withdrawal by Subject|0|||
149185431|NCT01781429|538150375|FG002|Overall Study|Withdrawal by Subject|0|||
149185432|NCT01781429|538150376|FG003|Overall Study|Withdrawal by Subject|0|||
149185433|NCT01781429|538150377|FG004|Overall Study|Withdrawal by Subject|0|||
148933333|NCT00785928|537242174|FG000|Treatment Phase|Physician Decision|0|||
148933334|NCT00785928|537242175|FG001|Treatment Phase|Physician Decision|0|||
148933335|NCT00785928|537242176|FG002|Treatment Phase|Physician Decision|0|||
148933336|NCT00785928|537242177|FG003|Treatment Phase|Physician Decision|0|||
149185434|NCT01781429|538150378|FG005|Overall Study|Withdrawal by Subject|0|||
149185435|NCT01781429|538150379|FG006|Overall Study|Withdrawal by Subject|0|||
149185436|NCT01781429|538150380|FG007|Overall Study|Withdrawal by Subject|0|||
149185437|NCT01781429|538150381|FG008|Overall Study|Withdrawal by Subject|1|||
149185438|NCT01781429|538150382|FG009|Overall Study|Withdrawal by Subject|3|||
149185439|NCT01781429|538150383|FG010|Overall Study|Withdrawal by Subject|1|||
149185440|NCT01781429|538150384|FG011|Overall Study|Withdrawal by Subject|1|||
149185441|NCT01781429|538150385|FG012|Overall Study|Withdrawal by Subject|5|||
149185442|NCT01781429|538150386|FG013|Overall Study|Withdrawal by Subject|2|||
148679708|NCT03012815|536300865|FG000|Overall Study|Adverse Event|1|||
148679709|NCT03012815|536300866|FG001|Overall Study|Adverse Event|0|||
148933337|NCT00785928|537242178|FG004|Treatment Phase|Physician Decision|1|||
149185443|NCT01781429|538150387|FG014|Overall Study|Withdrawal by Subject|3|||
149185444|NCT01781429|538150388|FG015|Overall Study|Withdrawal by Subject|0|||
149185445|NCT01781429|538150373|FG000|Overall Study|Disease Progression|1|||
149185446|NCT01781429|538150374|FG001|Overall Study|Disease Progression|0|||
149185447|NCT01781429|538150375|FG002|Overall Study|Disease Progression|1|||
149185448|NCT01781429|538150376|FG003|Overall Study|Disease Progression|1|||
149185449|NCT01781429|538150377|FG004|Overall Study|Disease Progression|1|||
149185450|NCT01781429|538150378|FG005|Overall Study|Disease Progression|4|||
149185451|NCT01781429|538150379|FG006|Overall Study|Disease Progression|7|||
149185452|NCT01781429|538150380|FG007|Overall Study|Disease Progression|4|||
149185453|NCT01781429|538150381|FG008|Overall Study|Disease Progression|6|||
149185454|NCT01781429|538150382|FG009|Overall Study|Disease Progression|15|||
149185455|NCT01781429|538150383|FG010|Overall Study|Disease Progression|15|||
149185456|NCT01781429|538150384|FG011|Overall Study|Disease Progression|15|||
149185457|NCT01781429|538150385|FG012|Overall Study|Disease Progression|15|||
149185458|NCT01781429|538150386|FG013|Overall Study|Disease Progression|4|||
149185459|NCT01781429|538150387|FG014|Overall Study|Disease Progression|11|||
149185460|NCT01781429|538150388|FG015|Overall Study|Disease Progression|0|||
149185461|NCT01781429|538150373|FG000|Overall Study|Unacceptable Toxicity|0|||
149185462|NCT01781429|538150374|FG001|Overall Study|Unacceptable Toxicity|0|||
149185463|NCT01781429|538150375|FG002|Overall Study|Unacceptable Toxicity|0|||
149185464|NCT01781429|538150376|FG003|Overall Study|Unacceptable Toxicity|0|||
149185465|NCT01781429|538150377|FG004|Overall Study|Unacceptable Toxicity|0|||
149185466|NCT01781429|538150378|FG005|Overall Study|Unacceptable Toxicity|0|||
149185467|NCT01781429|538150379|FG006|Overall Study|Unacceptable Toxicity|0|||
149185468|NCT01781429|538150380|FG007|Overall Study|Unacceptable Toxicity|0|||
149185469|NCT01781429|538150381|FG008|Overall Study|Unacceptable Toxicity|0|||
149185470|NCT01781429|538150382|FG009|Overall Study|Unacceptable Toxicity|0|||
149185471|NCT01781429|538150383|FG010|Overall Study|Unacceptable Toxicity|0|||
149185472|NCT01781429|538150384|FG011|Overall Study|Unacceptable Toxicity|2|||
149185473|NCT01781429|538150385|FG012|Overall Study|Unacceptable Toxicity|0|||
149185474|NCT01781429|538150386|FG013|Overall Study|Unacceptable Toxicity|0|||
149185475|NCT01781429|538150387|FG014|Overall Study|Unacceptable Toxicity|0|||
149185476|NCT01781429|538150388|FG015|Overall Study|Unacceptable Toxicity|0|||
149185477|NCT01781429|538150373|FG000|Overall Study|Patient Condition Changed|0|||
149185478|NCT01781429|538150374|FG001|Overall Study|Patient Condition Changed|0|||
149185479|NCT01781429|538150375|FG002|Overall Study|Patient Condition Changed|0|||
149185480|NCT01781429|538150376|FG003|Overall Study|Patient Condition Changed|0|||
149185481|NCT01781429|538150377|FG004|Overall Study|Patient Condition Changed|0|||
149185482|NCT01781429|538150378|FG005|Overall Study|Patient Condition Changed|0|||
149185483|NCT01781429|538150379|FG006|Overall Study|Patient Condition Changed|0|||
149185484|NCT01781429|538150380|FG007|Overall Study|Patient Condition Changed|0|||
149185485|NCT01781429|538150381|FG008|Overall Study|Patient Condition Changed|0|||
149185486|NCT01781429|538150382|FG009|Overall Study|Patient Condition Changed|4|||
149185487|NCT01781429|538150383|FG010|Overall Study|Patient Condition Changed|0|||
149185488|NCT01781429|538150384|FG011|Overall Study|Patient Condition Changed|1|||
149185489|NCT01781429|538150385|FG012|Overall Study|Patient Condition Changed|0|||
149185490|NCT01781429|538150386|FG013|Overall Study|Patient Condition Changed|1|||
148679710|NCT01462695|536300867|FG000|Overall Study|Adverse Event|1|||
148807357|NCT00903968|536773230|FG002|Overall Study|Physician Decision|0|||
148807358|NCT00903968|536773231|FG003|Overall Study|Physician Decision|0|||
148807359|NCT00903968|536773232|FG004|Overall Study|Physician Decision|0|||
148933338|NCT00785928|537242179|FG005|Treatment Phase|Physician Decision|0|||
148933339|NCT00785928|537242180|FG006|Treatment Phase|Physician Decision|0|||
148933340|NCT00785928|537242174|FG000|Treatment Phase|Sponsor Decision|1|||
148933341|NCT00785928|537242175|FG001|Treatment Phase|Sponsor Decision|0|||
148933342|NCT00785928|537242176|FG002|Treatment Phase|Sponsor Decision|0|||
148933343|NCT00785928|537242177|FG003|Treatment Phase|Sponsor Decision|0|||
148933344|NCT00785928|537242178|FG004|Treatment Phase|Sponsor Decision|0|||
148933345|NCT00785928|537242179|FG005|Treatment Phase|Sponsor Decision|0|||
148933346|NCT00785928|537242180|FG006|Treatment Phase|Sponsor Decision|1|||
148933347|NCT00785928|537242174|FG000|Treatment Phase|Withdrawal by Subject|1|||
148933348|NCT00785928|537242175|FG001|Treatment Phase|Withdrawal by Subject|2|||
148933349|NCT00785928|537242176|FG002|Treatment Phase|Withdrawal by Subject|0|||
148933350|NCT00785928|537242177|FG003|Treatment Phase|Withdrawal by Subject|0|||
148933351|NCT00785928|537242178|FG004|Treatment Phase|Withdrawal by Subject|1|||
148933352|NCT00785928|537242179|FG005|Treatment Phase|Withdrawal by Subject|0|||
148933353|NCT00785928|537242180|FG006|Treatment Phase|Withdrawal by Subject|0|||
148933354|NCT02477839|537242181|FG000|Overall Study|Adverse Event|0|||
148933355|NCT02477839|537242182|FG001|Overall Study|Adverse Event|1|||
148933356|NCT02477839|537242181|FG000|Overall Study|Protocol Violation|0|||
148933357|NCT02477839|537242182|FG001|Overall Study|Protocol Violation|2|||
148933358|NCT02477839|537242181|FG000|Overall Study|Withdrawal by Subject|3|||
148933359|NCT02477839|537242182|FG001|Overall Study|Withdrawal by Subject|3|||
148933360|NCT02477839|537242181|FG000|Overall Study|Participant had PGS during V6|0|||
148933361|NCT02477839|537242182|FG001|Overall Study|Participant had PGS during V6|1|||
148933362|NCT02477839|537242181|FG000|Overall Study|Parents decided to stop medication|0|||
148933363|NCT02477839|537242182|FG001|Overall Study|Parents decided to stop medication|1|||
148933364|NCT02477839|537242181|FG000|Overall Study|Lack of tolerability|0|||
149185491|NCT01781429|538150387|FG014|Overall Study|Patient Condition Changed|0|||
149185492|NCT01781429|538150388|FG015|Overall Study|Patient Condition Changed|0|||
149185493|NCT01781429|538150373|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
149185494|NCT01781429|538150374|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
149185495|NCT01781429|538150375|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
149185496|NCT01781429|538150376|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
149185497|NCT01781429|538150377|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
149185498|NCT01781429|538150378|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
149185499|NCT01781429|538150379|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
149185500|NCT01781429|538150380|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
149185501|NCT01781429|538150381|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
149185502|NCT01781429|538150382|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
149185503|NCT01781429|538150383|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
149185504|NCT01781429|538150384|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
149185505|NCT01781429|538150385|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
149185506|NCT01781429|538150386|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
149185507|NCT01781429|538150387|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
149185508|NCT01781429|538150388|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
149185509|NCT01781429|538150373|FG000|Overall Study|Enrolled, but not treated|0|||
149185510|NCT01781429|538150374|FG001|Overall Study|Enrolled, but not treated|0|||
149185511|NCT01781429|538150375|FG002|Overall Study|Enrolled, but not treated|0|||
149185512|NCT01781429|538150376|FG003|Overall Study|Enrolled, but not treated|0|||
149185513|NCT01781429|538150377|FG004|Overall Study|Enrolled, but not treated|0|||
149185514|NCT01781429|538150378|FG005|Overall Study|Enrolled, but not treated|0|||
149185515|NCT01781429|538150379|FG006|Overall Study|Enrolled, but not treated|0|||
149185516|NCT01781429|538150380|FG007|Overall Study|Enrolled, but not treated|0|||
149185517|NCT01781429|538150381|FG008|Overall Study|Enrolled, but not treated|0|||
149185518|NCT01781429|538150382|FG009|Overall Study|Enrolled, but not treated|0|||
149185519|NCT01781429|538150383|FG010|Overall Study|Enrolled, but not treated|1|||
149185520|NCT01781429|538150384|FG011|Overall Study|Enrolled, but not treated|0|||
149185521|NCT01781429|538150385|FG012|Overall Study|Enrolled, but not treated|0|||
149185522|NCT01781429|538150386|FG013|Overall Study|Enrolled, but not treated|0|||
149185523|NCT01781429|538150387|FG014|Overall Study|Enrolled, but not treated|0|||
149185524|NCT01781429|538150388|FG015|Overall Study|Enrolled, but not treated|0|||
149185525|NCT06094296|538150391|FG000|Overall Study|Progressive Disease|1|||
149185526|NCT06094296|538150392|FG001|Overall Study|Progressive Disease|0|||
149185527|NCT06094296|538150393|FG002|Overall Study|Progressive Disease|0|||
149185528|NCT06094296|538150394|FG003|Overall Study|Progressive Disease|0|||
149185529|NCT03332667|538150395|FG000|Overall Study|Adverse Event|0|||
149185530|NCT03332667|538150396|FG001|Overall Study|Adverse Event|0|||
149185531|NCT03332667|538150397|FG002|Overall Study|Adverse Event|2|||
149185532|NCT03332667|538150398|FG003|Overall Study|Adverse Event|1|||
149185533|NCT03332667|538150395|FG000|Overall Study|Withdrawal by Subject|2|||
149185534|NCT03332667|538150396|FG001|Overall Study|Withdrawal by Subject|1|||
149185535|NCT03332667|538150397|FG002|Overall Study|Withdrawal by Subject|5|||
149185536|NCT03332667|538150398|FG003|Overall Study|Withdrawal by Subject|1|||
149185537|NCT03332667|538150395|FG000|Overall Study|Disease Progression or Relapse|2|||
149185538|NCT03332667|538150396|FG001|Overall Study|Disease Progression or Relapse|1|||
149185539|NCT03332667|538150397|FG002|Overall Study|Disease Progression or Relapse|3|||
149185540|NCT03332667|538150398|FG003|Overall Study|Disease Progression or Relapse|0|||
149185541|NCT03332667|538150395|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
149185542|NCT03332667|538150396|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
148933365|NCT02477839|537242182|FG001|Overall Study|Lack of tolerability|1|||
149185543|NCT03332667|538150397|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
149185544|NCT03332667|538150398|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
149185545|NCT03332667|538150395|FG000|Overall Study|No Treatment Received|0|||
149185546|NCT03332667|538150396|FG001|Overall Study|No Treatment Received|0|||
149185547|NCT03332667|538150397|FG002|Overall Study|No Treatment Received|1|||
149185548|NCT03332667|538150398|FG003|Overall Study|No Treatment Received|0|||
149185549|NCT01035606|538150399|FG000|Overall Study|change in health, job demands,family|3|||
149185550|NCT01035606|538150400|FG001|Overall Study|change in health, job demands,family|3|||
149185551|NCT01035606|538150401|FG002|Overall Study|change in health, job demands,family|4|||
149185552|NCT01849848|538150402|FG000|Overall Study|Physician Decision|1|||
149185553|NCT01849848|538150402|FG000|Overall Study|Progression of the primary disease|3|||
148807360|NCT00903968|536773233|FG005|Overall Study|Physician Decision|1|||
148933366|NCT02477839|537242181|FG000|Overall Study|Exclusion criterion|0|||
148933367|NCT02477839|537242182|FG001|Overall Study|Exclusion criterion|1|||
148933368|NCT01050543|537242183|FG000|Overall Study|Withdrawal by Subject|0|||
149185554|NCT01809262|538150403|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185555|NCT01809262|538150404|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185556|NCT01809262|538150405|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185557|NCT01809262|538150406|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185558|NCT01809262|538150407|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
149185559|NCT01809262|538150408|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185560|NCT01809262|538150409|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
148933369|NCT01050543|537242184|FG001|Overall Study|Withdrawal by Subject|2|||
149185561|NCT01809262|538150410|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
148933370|NCT01050543|537242183|FG000|Overall Study|Protocol Violation|0|||
148933371|NCT01050543|537242184|FG001|Overall Study|Protocol Violation|1|||
148933372|NCT01050543|537242183|FG000|Overall Study|Administrative|4|||
148933373|NCT01050543|537242184|FG001|Overall Study|Administrative|1|||
148933374|NCT01465191|537242186|FG000|Overall Study|Protocol Violation|6|||
148933375|NCT01465191|537242187|FG001|Overall Study|Protocol Violation|3|||
148933376|NCT01465191|537242188|FG002|Overall Study|Protocol Violation|3|||
148933377|NCT01465191|537242186|FG000|Overall Study|Lost to Follow-up|3|||
148933378|NCT01465191|537242187|FG001|Overall Study|Lost to Follow-up|6|||
148933379|NCT01465191|537242188|FG002|Overall Study|Lost to Follow-up|4|||
148933380|NCT00943124|537242189|FG000|Period 1|Withdrawal by Subject|1|||
148933381|NCT00943124|537242190|FG001|Period 1|Withdrawal by Subject|1|||
148933382|NCT00943124|537242189|FG000|Period 1|Did Not Follow Study Procedures|1|||
148933383|NCT00943124|537242190|FG001|Period 1|Did Not Follow Study Procedures|0|||
148933384|NCT00943124|537242189|FG000|Period 1|Personal Reasons|0|||
148933385|NCT00943124|537242190|FG001|Period 1|Personal Reasons|1|||
148933386|NCT02992132|537242191|FG000|Overall Study|Adverse Event|4|||
149185562|NCT01809262|538150411|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185563|NCT01809262|538150412|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
149185564|NCT01809262|538150403|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185565|NCT01809262|538150404|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
149185566|NCT01809262|538150405|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185567|NCT01809262|538150406|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
148933387|NCT02992132|537242192|FG001|Overall Study|Adverse Event|1|||
149185568|NCT01809262|538150407|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185569|NCT01809262|538150408|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185570|NCT01809262|538150409|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185571|NCT01809262|538150410|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185572|NCT01809262|538150411|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185573|NCT01809262|538150412|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
149185574|NCT01505491|538150413|FG000|Overall Study|Other reason not listed|1|||
149185575|NCT01505491|538150414|FG001|Overall Study|Other reason not listed|0|||
149185576|NCT01505491|538150415|FG002|Overall Study|Other reason not listed|0|||
149185577|NCT01505491|538150413|FG000|Overall Study|Withdrawal by Subject|1|||
149185578|NCT01505491|538150414|FG001|Overall Study|Withdrawal by Subject|1|||
149185579|NCT01505491|538150415|FG002|Overall Study|Withdrawal by Subject|4|||
149185580|NCT01505491|538150413|FG000|Overall Study|Lost to Follow-up|0|||
149185581|NCT01505491|538150414|FG001|Overall Study|Lost to Follow-up|0|||
149185582|NCT01505491|538150415|FG002|Overall Study|Lost to Follow-up|1|||
149185583|NCT02202031|538150417|FG000|Overall Study|Lost to Follow-up|1|||
149185584|NCT02202031|538150418|FG001|Overall Study|Lost to Follow-up|0|||
149185585|NCT02202031|538150417|FG000|Overall Study|Too Busy|1|||
149185586|NCT02202031|538150418|FG001|Overall Study|Too Busy|3|||
149185587|NCT02202031|538150417|FG000|Overall Study|Illness/Medical Reason|0|||
149185588|NCT02202031|538150418|FG001|Overall Study|Illness/Medical Reason|2|||
149185589|NCT02202031|538150417|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
149185590|NCT02202031|538150418|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
149185591|NCT02184143|538150419|FG000|Overall Study|Withdrawal by Subject|4|||
149185592|NCT02184143|538150420|FG001|Overall Study|Withdrawal by Subject|4|||
149185593|NCT02184143|538150419|FG000|Overall Study|Lost to Follow-up|5|||
149185594|NCT02184143|538150420|FG001|Overall Study|Lost to Follow-up|3|||
149185595|NCT02184143|538150419|FG000|Overall Study|Death|1|||
149185596|NCT02184143|538150420|FG001|Overall Study|Death|0|||
149185597|NCT00431847|538150423|FG000|Overall Study|completion of less than two study visits|6|||
149185598|NCT00431847|538150424|FG001|Overall Study|completion of less than two study visits|3|||
148807361|NCT00903968|536773234|FG006|Overall Study|Physician Decision|0|||
148807362|NCT00903968|536773235|FG007|Overall Study|Physician Decision|0|||
148933388|NCT02992132|537242193|FG002|Overall Study|Adverse Event|3|||
148933389|NCT02992132|537242191|FG000|Overall Study|Lack of Efficacy|2|||
148933390|NCT02992132|537242192|FG001|Overall Study|Lack of Efficacy|0|||
148933391|NCT02992132|537242193|FG002|Overall Study|Lack of Efficacy|0|||
148933392|NCT02992132|537242191|FG000|Overall Study|Non-compliance with study drug|2|||
148933393|NCT02992132|537242192|FG001|Overall Study|Non-compliance with study drug|0|||
148933394|NCT02992132|537242193|FG002|Overall Study|Non-compliance with study drug|0|||
148933395|NCT02992132|537242191|FG000|Overall Study|Progressive disease|1|||
149185599|NCT00431847|538150425|FG002|Overall Study|completion of less than two study visits|4|||
149185600|NCT00431847|538150426|FG003|Overall Study|completion of less than two study visits|14|||
149185601|NCT00431847|538150427|FG004|Overall Study|completion of less than two study visits|0|||
149185602|NCT00431847|538150423|FG000|Overall Study|Protocol Violation|0|||
149185603|NCT00431847|538150424|FG001|Overall Study|Protocol Violation|0|||
149185604|NCT00431847|538150425|FG002|Overall Study|Protocol Violation|0|||
149185605|NCT00431847|538150426|FG003|Overall Study|Protocol Violation|0|||
148933396|NCT02992132|537242192|FG001|Overall Study|Progressive disease|0|||
148933397|NCT02992132|537242193|FG002|Overall Study|Progressive disease|0|||
148933398|NCT02992132|537242191|FG000|Overall Study|Protocol Violation|2|||
148933399|NCT02992132|537242192|FG001|Overall Study|Protocol Violation|2|||
148933400|NCT02992132|537242193|FG002|Overall Study|Protocol Violation|0|||
149185606|NCT00431847|538150427|FG004|Overall Study|Protocol Violation|1|||
149185607|NCT00339183|538150428|FG000|Overall Study|Adverse Event|5|||
149185608|NCT00339183|538150429|FG001|Overall Study|Adverse Event|3|||
149185609|NCT00339183|538150428|FG000|Overall Study|Withdrawal by Subject|16|||
149185610|NCT00339183|538150429|FG001|Overall Study|Withdrawal by Subject|19|||
149185611|NCT00339183|538150428|FG000|Overall Study|Physician Decision|2|||
149185612|NCT00339183|538150429|FG001|Overall Study|Physician Decision|4|||
149185613|NCT00339183|538150428|FG000|Overall Study|Lost to Follow-up|17|||
149185614|NCT00339183|538150429|FG001|Overall Study|Lost to Follow-up|17|||
149185615|NCT00339183|538150428|FG000|Overall Study|Protocol-specified criteria|12|||
149185616|NCT00339183|538150429|FG001|Overall Study|Protocol-specified criteria|8|||
149185617|NCT00339183|538150428|FG000|Overall Study|Missing reason|3|||
149185618|NCT00339183|538150429|FG001|Overall Study|Missing reason|1|||
149185619|NCT00339183|538150428|FG000|Overall Study|Other|46|||
149185620|NCT00339183|538150429|FG001|Overall Study|Other|40|||
149185621|NCT00339183|538150428|FG000|Overall Study|Ongoing|20|||
149185622|NCT00339183|538150429|FG001|Overall Study|Ongoing|13|||
149185623|NCT00446446|538150430|FG000|Overall Study|Death|10|||
149185624|NCT00446446|538150430|FG000|Overall Study|Withdrawal by Subject|6|||
149185625|NCT00446446|538150430|FG000|Overall Study|Other|4|||
149185626|NCT00446446|538150430|FG000|Overall Study|Disease Progession|2|||
149185627|NCT00446446|538150430|FG000|Overall Study|Adverse Event|1|||
149185628|NCT00446446|538150430|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
149185629|NCT02142894|538150431|FG000|Overall Study|Protocol Violation|8|||
149185630|NCT01024465|538150437|FG000|Overall Study|Adverse Event|2|||
149185631|NCT01024465|538150437|FG000|Overall Study|Physician Decision|1|||
149185632|NCT03078608|538150441|FG000|Overall Study|Death|1|||
149185633|NCT03078608|538150442|FG001|Overall Study|Death|2|||
149185634|NCT03078608|538150443|FG002|Overall Study|Death|0|||
149185635|NCT03078608|538150444|FG003|Overall Study|Death|0|||
149185636|NCT03078608|538150441|FG000|Overall Study|Withdrawal by Subject|8|||
149185637|NCT03078608|538150442|FG001|Overall Study|Withdrawal by Subject|1|||
149185638|NCT03078608|538150443|FG002|Overall Study|Withdrawal by Subject|0|||
149185639|NCT03078608|538150444|FG003|Overall Study|Withdrawal by Subject|0|||
149185640|NCT03078608|538150441|FG000|Overall Study|Lost to Follow-up|5|||
149185641|NCT03078608|538150442|FG001|Overall Study|Lost to Follow-up|8|||
149185642|NCT03078608|538150443|FG002|Overall Study|Lost to Follow-up|4|||
149185643|NCT03078608|538150444|FG003|Overall Study|Lost to Follow-up|1|||
149185644|NCT01455428|538150445|FG000|Overall Study|Protocol Violation|2|||
149185645|NCT01455428|538150446|FG001|Overall Study|Protocol Violation|1|||
149185646|NCT01455428|538150445|FG000|Overall Study|Adverse Event|6|||
149185647|NCT01455428|538150446|FG001|Overall Study|Adverse Event|2|||
149185648|NCT01455428|538150445|FG000|Overall Study|Lost to Follow-up|1|||
149185649|NCT01455428|538150446|FG001|Overall Study|Lost to Follow-up|1|||
149185650|NCT01455428|538150445|FG000|Overall Study|Withdrawal by Subject|2|||
149185651|NCT01455428|538150446|FG001|Overall Study|Withdrawal by Subject|5|||
149185652|NCT01455428|538150445|FG000|Overall Study|Did not meet entrance criteria|0|||
149185653|NCT01455428|538150446|FG001|Overall Study|Did not meet entrance criteria|2|||
149185654|NCT01455428|538150445|FG000|Overall Study|Insufficient clinical response|0|||
149185655|NCT01455428|538150446|FG001|Overall Study|Insufficient clinical response|2|||
149185656|NCT01455428|538150445|FG000|Overall Study|Did not receive treatment|1|||
149185657|NCT01455428|538150446|FG001|Overall Study|Did not receive treatment|1|||
149185658|NCT01455428|538150445|FG000|Overall Study|Other|2|||
149185659|NCT01455428|538150446|FG001|Overall Study|Other|4|||
149185660|NCT00789477|538150451|FG000|Overall Study|Withdrawal by Subject|2|||
148679711|NCT01462695|536300868|FG001|Overall Study|Adverse Event|1|||
148679712|NCT01462695|536300867|FG000|Overall Study|Death|2|||
149185661|NCT00789477|538150452|FG001|Overall Study|Withdrawal by Subject|1|||
149185662|NCT00789477|538150453|FG002|Overall Study|Withdrawal by Subject|3|||
149185663|NCT00789477|538150454|FG003|Overall Study|Withdrawal by Subject|2|||
148933401|NCT02992132|537242191|FG000|Overall Study|Caregiver withdrew consent|2|||
149185664|NCT00789477|538150455|FG004|Overall Study|Withdrawal by Subject|3|||
149185665|NCT00789477|538150451|FG000|Overall Study|Protocol Violation|1|||
149185666|NCT00789477|538150452|FG001|Overall Study|Protocol Violation|0|||
149185667|NCT00789477|538150453|FG002|Overall Study|Protocol Violation|0|||
149185668|NCT00789477|538150454|FG003|Overall Study|Protocol Violation|1|||
148933402|NCT02992132|537242192|FG001|Overall Study|Caregiver withdrew consent|3|||
148933403|NCT02992132|537242193|FG002|Overall Study|Caregiver withdrew consent|2|||
149185669|NCT00789477|538150455|FG004|Overall Study|Protocol Violation|0|||
149185670|NCT00789477|538150451|FG000|Overall Study|Adverse Event|3|||
148679713|NCT01462695|536300868|FG001|Overall Study|Death|0|||
149185671|NCT00789477|538150452|FG001|Overall Study|Adverse Event|3|||
149185672|NCT00789477|538150453|FG002|Overall Study|Adverse Event|1|||
149185673|NCT00789477|538150454|FG003|Overall Study|Adverse Event|0|||
149185674|NCT00789477|538150455|FG004|Overall Study|Adverse Event|0|||
149185675|NCT00789477|538150451|FG000|Overall Study|Death|1|||
149185676|NCT00789477|538150452|FG001|Overall Study|Death|1|||
149185677|NCT00789477|538150453|FG002|Overall Study|Death|2|||
149185678|NCT00789477|538150454|FG003|Overall Study|Death|2|||
149185679|NCT00789477|538150455|FG004|Overall Study|Death|0|||
149185680|NCT00789477|538150451|FG000|Overall Study|Lost to Follow-up|0|||
149185681|NCT00789477|538150452|FG001|Overall Study|Lost to Follow-up|1|||
149185682|NCT00789477|538150453|FG002|Overall Study|Lost to Follow-up|4|||
149185683|NCT00789477|538150454|FG003|Overall Study|Lost to Follow-up|2|||
149185684|NCT00789477|538150455|FG004|Overall Study|Lost to Follow-up|4|||
149185685|NCT00789477|538150451|FG000|Overall Study|Lack of Efficacy|2|||
149185686|NCT00789477|538150452|FG001|Overall Study|Lack of Efficacy|0|||
149185687|NCT00789477|538150453|FG002|Overall Study|Lack of Efficacy|0|||
149185688|NCT00789477|538150454|FG003|Overall Study|Lack of Efficacy|0|||
149185689|NCT00789477|538150455|FG004|Overall Study|Lack of Efficacy|0|||
149185690|NCT00789477|538150451|FG000|Overall Study|Other|2|||
149185691|NCT00789477|538150452|FG001|Overall Study|Other|0|||
149185692|NCT00789477|538150453|FG002|Overall Study|Other|1|||
149185693|NCT00789477|538150454|FG003|Overall Study|Other|3|||
149185694|NCT00789477|538150455|FG004|Overall Study|Other|0|||
149185695|NCT00455858|538150456|FG000|Overall Study|Lost to Follow-up|2|||
149185696|NCT00455858|538150456|FG000|Overall Study|Protocol Violation|1|||
149185697|NCT00455858|538150456|FG000|Overall Study|Lack of Efficacy|1|||
149185698|NCT00455858|538150456|FG000|Overall Study|Well controlled FPG without insulin|1|||
149185699|NCT00455858|538150456|FG000|Overall Study|Withdrawal|1|||
149185700|NCT02092389|538150457|FG000|Overall Study|Adverse Event|1|||
149185701|NCT02092389|538150457|FG000|Overall Study|Other|5|||
149185702|NCT00751881|538150463|FG000|Core Treatment Period|Not treated|1|||
149185703|NCT00751881|538150464|FG001|Core Treatment Period|Not treated|1|||
149185704|NCT00751881|538150465|FG002|Core Treatment Period|Not treated|2|||
149185705|NCT00751881|538150463|FG000|Core Treatment Period|Adverse Event|26|||
149185706|NCT00751881|538150464|FG001|Core Treatment Period|Adverse Event|54|||
149185707|NCT00751881|538150465|FG002|Core Treatment Period|Adverse Event|58|||
149185708|NCT00751881|538150463|FG000|Core Treatment Period|Lack of Efficacy|37|||
149185709|NCT00751881|538150464|FG001|Core Treatment Period|Lack of Efficacy|30|||
149185710|NCT00751881|538150465|FG002|Core Treatment Period|Lack of Efficacy|20|||
149185711|NCT00751881|538150463|FG000|Core Treatment Period|Poor compliance to protocol|15|||
149185712|NCT00751881|538150464|FG001|Core Treatment Period|Poor compliance to protocol|3|||
149185713|NCT00751881|538150465|FG002|Core Treatment Period|Poor compliance to protocol|4|||
149185714|NCT00751881|538150463|FG000|Core Treatment Period|Lost to Follow-up|6|||
149185715|NCT00751881|538150464|FG001|Core Treatment Period|Lost to Follow-up|4|||
149185716|NCT00751881|538150465|FG002|Core Treatment Period|Lost to Follow-up|3|||
149185717|NCT00751881|538150463|FG000|Core Treatment Period|Other: protocol deviation|3|||
149185718|NCT00751881|538150464|FG001|Core Treatment Period|Other: protocol deviation|3|||
149185719|NCT00751881|538150465|FG002|Core Treatment Period|Other: protocol deviation|7|||
149185720|NCT00751881|538150463|FG000|Core Treatment Period|Other: wish to parent|5|||
149185721|NCT00751881|538150464|FG001|Core Treatment Period|Other: wish to parent|7|||
149185722|NCT00751881|538150465|FG002|Core Treatment Period|Other: wish to parent|4|||
149185723|NCT00751881|538150463|FG000|Core Treatment Period|Other: personal/family constraints|6|||
149185724|NCT00751881|538150464|FG001|Core Treatment Period|Other: personal/family constraints|7|||
149185725|NCT00751881|538150465|FG002|Core Treatment Period|Other: personal/family constraints|10|||
149185726|NCT00751881|538150463|FG000|Core Treatment Period|Other: MS treatment change|6|||
149185727|NCT00751881|538150464|FG001|Core Treatment Period|Other: MS treatment change|4|||
149185728|NCT00751881|538150465|FG002|Core Treatment Period|Other: MS treatment change|4|||
149185729|NCT00751881|538150463|FG000|Core Treatment Period|Other: tolerability complaints|2|||
149185730|NCT00751881|538150464|FG001|Core Treatment Period|Other: tolerability complaints|0|||
149185731|NCT00751881|538150465|FG002|Core Treatment Period|Other: tolerability complaints|0|||
149185732|NCT00751881|538150463|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
148679714|NCT01462695|536300867|FG000|Overall Study|Lack of Efficacy|6|||
148933404|NCT02992132|537242191|FG000|Overall Study|Withdrawal by Subject|0|||
148933405|NCT02992132|537242192|FG001|Overall Study|Withdrawal by Subject|2|||
148933406|NCT02992132|537242193|FG002|Overall Study|Withdrawal by Subject|1|||
148933407|NCT02992132|537242191|FG000|Overall Study|Physician Decision|0|||
148933408|NCT02992132|537242192|FG001|Overall Study|Physician Decision|0|||
148933409|NCT02992132|537242193|FG002|Overall Study|Physician Decision|1|||
148933410|NCT01916967|537242199|FG000|Overall Study|Adverse Event|0|||
148933411|NCT01916967|537242200|FG001|Overall Study|Adverse Event|0|||
148933412|NCT01916967|537242201|FG002|Overall Study|Adverse Event|2|||
148933413|NCT01916967|537242199|FG000|Overall Study|Lack of Efficacy|0|||
149185733|NCT00751881|538150464|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
149185734|NCT00751881|538150465|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
149185735|NCT00751881|538150463|FG000|Extension Study Period|Adverse Event|18|||
149185736|NCT00751881|538150464|FG001|Extension Study Period|Adverse Event|20|||
149185737|NCT00751881|538150465|FG002|Extension Study Period|Adverse Event|21|||
149185738|NCT00751881|538150463|FG000|Extension Study Period|Lack of Efficacy|14|||
149185739|NCT00751881|538150464|FG001|Extension Study Period|Lack of Efficacy|10|||
149185740|NCT00751881|538150465|FG002|Extension Study Period|Lack of Efficacy|20|||
149185741|NCT00751881|538150463|FG000|Extension Study Period|Lost to Follow-up|4|||
148933414|NCT01916967|537242200|FG001|Overall Study|Lack of Efficacy|0|||
148933415|NCT01916967|537242201|FG002|Overall Study|Lack of Efficacy|6|||
148933416|NCT01916967|537242199|FG000|Overall Study|Physician Decision|0|||
149185742|NCT00751881|538150464|FG001|Extension Study Period|Lost to Follow-up|9|||
149185743|NCT00751881|538150465|FG002|Extension Study Period|Lost to Follow-up|6|||
149185744|NCT00751881|538150463|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
148933417|NCT01916967|537242200|FG001|Overall Study|Physician Decision|0|||
149185745|NCT00751881|538150464|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
149185746|NCT00751881|538150465|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
149185747|NCT00751881|538150463|FG000|Extension Study Period|Other than specified above|26|||
149185748|NCT00751881|538150464|FG001|Extension Study Period|Other than specified above|30|||
149185749|NCT00751881|538150465|FG002|Extension Study Period|Other than specified above|18|||
149185750|NCT00564629|538150466|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
149185751|NCT00564629|538150467|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
149185752|NCT01632878|538150468|FG000|Screening|Physician Decision|268|||
149185753|NCT01632878|538150468|FG000|Treatment|Lost to Follow-up|41|||
149185754|NCT01632878|538150468|FG000|Treatment|Withdrawal by Subject|36|||
149185755|NCT01632878|538150468|FG000|Treatment|Physician Decision|34|||
149185756|NCT01632878|538150468|FG000|Treatment|missing information|4|||
149185757|NCT01632878|538150468|FG000|Treatment|no information on study completion|43|||
149185758|NCT02119104|538150469|FG000|Overall Study|Protocol Violation|16|||
149185759|NCT01651260|538150471|FG000|Overall Study|unable to apply product|3|||
149185760|NCT01558089|538150474|FG000|Overall Study|Adverse Event|1|||
149185761|NCT01558089|538150474|FG000|Overall Study|Lack of Efficacy|1|||
149185762|NCT01558089|538150474|FG000|Overall Study|Lost to Follow-up|5|||
149185763|NCT01558089|538150474|FG000|Overall Study|Withdrawal by Subject|6|||
149185764|NCT02144220|538150475|FG000|Overall Study|technology incompatibility|9|||
149185765|NCT02144220|538150475|FG000|Overall Study|Lack of Efficacy|4|||
149185766|NCT02144220|538150475|FG000|Overall Study|Physician Decision|3|||
149185767|NCT02144220|538150475|FG000|Overall Study|Withdrawal by Subject|2|||
149185768|NCT02144220|538150475|FG000|Overall Study|Protocol Violation|1|||
149185769|NCT01952015|538150478|FG000|Induction|Protocol Violation|1|||
149185770|NCT01952015|538150478|FG000|Maintenance|Adverse Event|2|||
149185771|NCT01952015|538150478|FG000|Treatment Period 3|Physician Decision|9|||
149185772|NCT02239094|538150479|FG000|Overall Study|Withdrawal by Subject|1|||
149185773|NCT02239094|538150479|FG000|Overall Study|Remitted before started|1|||
149185774|NCT03648996|538150480|FG000|Overall Study|Withdrawal by Subject|0|||
149185775|NCT03648996|538150481|FG001|Overall Study|Withdrawal by Subject|2|||
149185776|NCT03648996|538150482|FG002|Overall Study|Withdrawal by Subject|2|||
149185777|NCT03648996|538150480|FG000|Overall Study|Physician Decision|2|||
149185778|NCT03648996|538150481|FG001|Overall Study|Physician Decision|0|||
149185779|NCT03648996|538150482|FG002|Overall Study|Physician Decision|0|||
149185780|NCT03242759|538150486|FG000|Overall Study|Adverse Event|5|||
149185781|NCT03242759|538150487|FG001|Overall Study|Adverse Event|1|||
149185782|NCT03242759|538150486|FG000|Overall Study|Withdrawal by Subject|4|||
149185783|NCT03242759|538150487|FG001|Overall Study|Withdrawal by Subject|3|||
149185784|NCT03242759|538150486|FG000|Overall Study|Lost to Follow-up|3|||
149185785|NCT03242759|538150487|FG001|Overall Study|Lost to Follow-up|1|||
149185786|NCT03242759|538150486|FG000|Overall Study|Administrative problems|1|||
149185787|NCT03242759|538150487|FG001|Overall Study|Administrative problems|1|||
149185788|NCT03242759|538150486|FG000|Overall Study|Death|22|||
149185789|NCT03242759|538150487|FG001|Overall Study|Death|0|||
148933418|NCT01916967|537242201|FG002|Overall Study|Physician Decision|1|||
148933419|NCT01916967|537242199|FG000|Overall Study|Protocol Violation|0|||
148933420|NCT01916967|537242200|FG001|Overall Study|Protocol Violation|1|||
148933421|NCT01916967|537242201|FG002|Overall Study|Protocol Violation|0|||
148933422|NCT01104155|537242206|FG000|Overall Study|Adverse Event|15|||
148933423|NCT01104155|537242207|FG001|Overall Study|Adverse Event|8|||
148933424|NCT01104155|537242206|FG000|Overall Study|Participant choice|6|||
148933425|NCT01104155|537242207|FG001|Overall Study|Participant choice|5|||
148933426|NCT01104155|537242206|FG000|Overall Study|Withdrawal of consent|1|||
148933427|NCT01104155|537242207|FG001|Overall Study|Withdrawal of consent|1|||
148933428|NCT01104155|537242206|FG000|Overall Study|Other|3|||
148933429|NCT01104155|537242207|FG001|Overall Study|Other|4|||
149185790|NCT03242759|538150486|FG000|Overall Study|Change visit schedule|0|||
149185791|NCT03242759|538150487|FG001|Overall Study|Change visit schedule|1|||
149185792|NCT00064662|538150488|FG000|Overall Study|Death|1|||
149185793|NCT00064662|538150489|FG001|Overall Study|Death|1|||
149185794|NCT00064662|538150488|FG000|Overall Study|Lost to Follow-up|57|||
148933430|NCT03799211|537242213|FG000|Overall Study|Lost to Follow-up|2|||
148933431|NCT03799211|537242214|FG001|Overall Study|Lost to Follow-up|13|||
148933432|NCT03799211|537242213|FG000|Overall Study|Withdrawal by Subject|2|||
149185795|NCT00064662|538150489|FG001|Overall Study|Lost to Follow-up|44|||
149185796|NCT00064662|538150488|FG000|Overall Study|Withdrawal by Subject|14|||
149185797|NCT00064662|538150489|FG001|Overall Study|Withdrawal by Subject|14|||
149185798|NCT00064662|538150488|FG000|Overall Study|Administratively withdrawn|2|||
149185799|NCT00064662|538150489|FG001|Overall Study|Administratively withdrawn|2|||
149185800|NCT00365976|538150498|FG000|Overall Study|Withdrawal by Subject|1|||
149185801|NCT00365976|538150499|FG001|Overall Study|Withdrawal by Subject|5|||
149185802|NCT01963117|538150502|FG000|Overall Study|Death|1|||
149185803|NCT01780389|538150503|FG000|Overall Study|Adverse Event|1|||
149185804|NCT01095250|538150504|FG000|Overall Study|administrative reasons|8|||
149185805|NCT01095250|538150505|FG001|Overall Study|administrative reasons|10|||
149185806|NCT01095250|538150506|FG002|Overall Study|administrative reasons|7|||
149185807|NCT01095250|538150507|FG003|Overall Study|administrative reasons|5|||
149185808|NCT01095250|538150504|FG000|Overall Study|Withdrawal by Subject|0|||
149185809|NCT01095250|538150505|FG001|Overall Study|Withdrawal by Subject|0|||
149185810|NCT01095250|538150506|FG002|Overall Study|Withdrawal by Subject|1|||
149185811|NCT01095250|538150507|FG003|Overall Study|Withdrawal by Subject|0|||
148807363|NCT00903968|536773228|FG000|Overall Study|Progressive Disease|2|||
149185812|NCT01000064|538150508|FG000|Overall Study|Withdrawal by Subject|1|||
149185813|NCT01000064|538150509|FG001|Overall Study|Withdrawal by Subject|1|||
149185814|NCT02518620|538150510|FG000|Overall Study|Adverse Event|23|||
149185815|NCT02518620|538150511|FG001|Overall Study|Adverse Event|11|||
149185816|NCT02518620|538150510|FG000|Overall Study|Lack of Efficacy|2|||
149185817|NCT02518620|538150511|FG001|Overall Study|Lack of Efficacy|0|||
149185818|NCT02518620|538150510|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149185819|NCT02518620|538150511|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149185820|NCT02518620|538150510|FG000|Overall Study|Physician Decision|1|||
149185821|NCT02518620|538150511|FG001|Overall Study|Physician Decision|1|||
149185822|NCT02518620|538150510|FG000|Overall Study|Sponsor's Decision|0|||
149185823|NCT02518620|538150511|FG001|Overall Study|Sponsor's Decision|3|||
149185824|NCT02518620|538150510|FG000|Overall Study|Lost to Follow-up|1|||
149185825|NCT02518620|538150511|FG001|Overall Study|Lost to Follow-up|1|||
149185826|NCT02518620|538150510|FG000|Overall Study|Withdrawal by Subject|17|||
149185827|NCT02518620|538150511|FG001|Overall Study|Withdrawal by Subject|9|||
149185828|NCT02518620|538150510|FG000|Overall Study|Death|1|||
149185829|NCT02518620|538150511|FG001|Overall Study|Death|0|||
149185830|NCT02518620|538150510|FG000|Overall Study|Pregnancy Wish|3|||
149185831|NCT02518620|538150511|FG001|Overall Study|Pregnancy Wish|0|||
149185832|NCT02518620|538150510|FG000|Overall Study|Pregnancy|1|||
149185833|NCT02518620|538150511|FG001|Overall Study|Pregnancy|0|||
149185834|NCT02518620|538150510|FG000|Overall Study|Relocation|2|||
149185835|NCT02518620|538150511|FG001|Overall Study|Relocation|1|||
149185836|NCT02078713|538152121|FG000|Overall Study|Lost to Follow-up|49|||
149185837|NCT02078713|538152122|FG001|Overall Study|Lost to Follow-up|55|||
149185838|NCT02078713|538152123|FG002|Overall Study|Lost to Follow-up|0|||
149185839|NCT02078713|538152124|FG003|Overall Study|Lost to Follow-up|0|||
149185840|NCT02078713|538152121|FG000|Overall Study|Pregnant at baseline|3|||
149185841|NCT02078713|538152122|FG001|Overall Study|Pregnant at baseline|5|||
149185842|NCT02078713|538152123|FG002|Overall Study|Pregnant at baseline|0|||
149185843|NCT02078713|538152124|FG003|Overall Study|Pregnant at baseline|0|||
149185844|NCT02078713|538152121|FG000|Overall Study|Enrolled twice|0|||
149185845|NCT02078713|538152122|FG001|Overall Study|Enrolled twice|1|||
149185846|NCT02078713|538152123|FG002|Overall Study|Enrolled twice|0|||
149185847|NCT02078713|538152124|FG003|Overall Study|Enrolled twice|0|||
149185848|NCT03123354|538152129|FG000|Overall Study|Physician Decision|6|||
149185849|NCT03074162|538152130|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149185850|NCT03074162|538152131|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149185851|NCT03074162|538152132|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
149185852|NCT03074162|538152133|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149185853|NCT03074162|538152134|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149185854|NCT03074162|538152135|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
149185855|NCT03074162|538152130|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149185856|NCT03074162|538152131|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149185857|NCT03074162|538152132|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
149185858|NCT03074162|538152133|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149185859|NCT03074162|538152134|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
149185860|NCT03074162|538152135|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
149185861|NCT03074162|538152130|FG000|Period 3|Withdrawal by Subject|1|||
149185862|NCT03074162|538152131|FG001|Period 3|Withdrawal by Subject|0|||
148807364|NCT00903968|536773229|FG001|Overall Study|Progressive Disease|3|||
149185863|NCT03074162|538152132|FG002|Period 3|Withdrawal by Subject|0|||
149185864|NCT03074162|538152133|FG003|Period 3|Withdrawal by Subject|0|||
149185865|NCT03074162|538152134|FG004|Period 3|Withdrawal by Subject|1|||
148807365|NCT00903968|536773230|FG002|Overall Study|Progressive Disease|2|||
149185866|NCT03074162|538152135|FG005|Period 3|Withdrawal by Subject|0|||
149185867|NCT02948777|538152141|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
149185868|NCT03242928|538152142|FG000|Overall Study|Adverse Event|2|||
149185869|NCT03242928|538152143|FG001|Overall Study|Adverse Event|1|||
149185870|NCT03242928|538152142|FG000|Overall Study|Lost to Follow-up|2|||
149185871|NCT03242928|538152143|FG001|Overall Study|Lost to Follow-up|0|||
148679715|NCT01462695|536300868|FG001|Overall Study|Lack of Efficacy|12|||
149185872|NCT03242928|538152142|FG000|Overall Study|Physician Decision|0|||
149185873|NCT03242928|538152143|FG001|Overall Study|Physician Decision|1|||
149185874|NCT03242928|538152142|FG000|Overall Study|Withdrawal by Subject|5|||
149185875|NCT03242928|538152143|FG001|Overall Study|Withdrawal by Subject|3|||
149185876|NCT00625365|538152147|FG000|Overall Study|Withdrawal by Subject|1|||
149185877|NCT00625365|538152147|FG000|Overall Study|No IV access|5|||
149185878|NCT00625365|538152147|FG000|Overall Study|VSD|1|||
149185879|NCT03650452|538152148|FG000|Overall Study|Physician Decision|1|||
149185880|NCT03650452|538152149|FG001|Overall Study|Physician Decision|0|||
149185881|NCT03650452|538152148|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
149185882|NCT03650452|538152149|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149185883|NCT03650452|538152148|FG000|Overall Study|Adverse Event|3|||
149185884|NCT03650452|538152149|FG001|Overall Study|Adverse Event|4|||
149185885|NCT03650452|538152148|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
149185886|NCT03650452|538152149|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
149185887|NCT01703286|538152158|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
149185888|NCT01703286|538152159|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
149185889|NCT01703286|538152160|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
149185890|NCT01703286|538152161|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
149185891|NCT01703286|538152162|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
149185892|NCT01703286|538152163|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
149185893|NCT01703286|538152158|FG000|Period 2 Including Washout|Adverse Event|0|||
149185894|NCT01703286|538152159|FG001|Period 2 Including Washout|Adverse Event|0|||
149185895|NCT01703286|538152160|FG002|Period 2 Including Washout|Adverse Event|0|||
149185896|NCT01703286|538152161|FG003|Period 2 Including Washout|Adverse Event|1|||
149185897|NCT01703286|538152162|FG004|Period 2 Including Washout|Adverse Event|0|||
149185898|NCT01703286|538152163|FG005|Period 2 Including Washout|Adverse Event|0|||
149185899|NCT02421120|538152164|FG000|Overall Study|Adverse Event|1|||
149185900|NCT00931892|538152165|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
149185901|NCT00931892|538152166|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
149185902|NCT01876732|538152167|FG000|Overall Study|MMA was not over 800mg/dL|75|||
149185903|NCT02207530|538152170|FG000|Overall Study|Worsening condition under investigation|78|||
149185904|NCT02207530|538152170|FG000|Overall Study|Patient decision to stop study treatment|5|||
149185905|NCT02207530|538152170|FG000|Overall Study|Adverse Event|8|||
149185906|NCT00305006|538152171|FG000|Overall Study|Withdrawal by Subject|1|||
149185907|NCT00305006|538152172|FG001|Overall Study|Withdrawal by Subject|0|||
149185908|NCT00305006|538152171|FG000|Overall Study|Failure to complete pretest|0|||
149185909|NCT00305006|538152172|FG001|Overall Study|Failure to complete pretest|1|||
149185910|NCT00986258|538152173|FG000|Observation Period|Not eligible to be dosed|11|||
149185911|NCT00986258|538152173|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
149185912|NCT00986258|538152173|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
149185913|NCT00986258|538152173|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
149185914|NCT00986258|538152173|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
149185915|NCT00986258|538152173|FG000|Titration and Optimal Dose Period|Other|1|||
149185916|NCT00986258|538152173|FG000|Maintenance Period|Adverse Event|5|||
149185917|NCT00986258|538152173|FG000|Maintenance Period|Lack of Efficacy|2|||
149185918|NCT00986258|538152173|FG000|Maintenance Period|Withdrawal by Subject|2|||
149185919|NCT04964063|538152174|FG000|Overall Study|Adverse Event|4|||
149185920|NCT04964063|538152174|FG000|Overall Study|Lost to Follow-up|47|||
149185921|NCT04964063|538152174|FG000|Overall Study|Withdrawal by Subject|5|||
149185922|NCT04964063|538152174|FG000|Overall Study|Baseline Tasks Expired|41|||
149185923|NCT04964063|538152174|FG000|Overall Study|Participant withdrawn in error|1|||
149185924|NCT01120093|538152177|FG000|Treatment Period 1|Adverse Event|0|||
149185925|NCT01120093|538152178|FG001|Treatment Period 1|Adverse Event|0|||
149185926|NCT01120093|538152179|FG002|Treatment Period 1|Adverse Event|1|||
149185927|NCT01120093|538152180|FG003|Treatment Period 1|Adverse Event|0|||
149185928|NCT01120093|538152181|FG004|Treatment Period 1|Adverse Event|1|||
149185929|NCT01120093|538152177|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149185930|NCT01120093|538152178|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149185931|NCT01120093|538152179|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149185932|NCT01120093|538152180|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149185933|NCT01120093|538152181|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149185934|NCT01120093|538152177|FG000|Treatment Period 2|Adverse Event|0|||
149185935|NCT01120093|538152178|FG001|Treatment Period 2|Adverse Event|0|||
149185936|NCT01120093|538152179|FG002|Treatment Period 2|Adverse Event|0|||
149185937|NCT01120093|538152180|FG003|Treatment Period 2|Adverse Event|1|||
149185938|NCT01120093|538152181|FG004|Treatment Period 2|Adverse Event|0|||
149185939|NCT01120093|538152177|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149185940|NCT01120093|538152178|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149185941|NCT01120093|538152179|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149185942|NCT01120093|538152180|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149185943|NCT01120093|538152181|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149185944|NCT01120093|538152177|FG000|Treatment Period 3|Lack of Efficacy|0|||
149185945|NCT01120093|538152178|FG001|Treatment Period 3|Lack of Efficacy|0|||
149185946|NCT01120093|538152179|FG002|Treatment Period 3|Lack of Efficacy|0|||
149185947|NCT01120093|538152180|FG003|Treatment Period 3|Lack of Efficacy|1|||
149185948|NCT01120093|538152181|FG004|Treatment Period 3|Lack of Efficacy|0|||
149185949|NCT01120093|538152177|FG000|Treatment Period 3|Adverse Event|0|||
149185950|NCT01120093|538152178|FG001|Treatment Period 3|Adverse Event|0|||
149185951|NCT01120093|538152179|FG002|Treatment Period 3|Adverse Event|0|||
149185952|NCT01120093|538152180|FG003|Treatment Period 3|Adverse Event|0|||
149185953|NCT01120093|538152181|FG004|Treatment Period 3|Adverse Event|1|||
149185954|NCT01120093|538152177|FG000|Treatment Period 3|Withdrawal by Subject|0|||
149185955|NCT01120093|538152178|FG001|Treatment Period 3|Withdrawal by Subject|0|||
149185956|NCT01120093|538152179|FG002|Treatment Period 3|Withdrawal by Subject|1|||
149185957|NCT01120093|538152180|FG003|Treatment Period 3|Withdrawal by Subject|0|||
149185958|NCT01120093|538152181|FG004|Treatment Period 3|Withdrawal by Subject|0|||
149185959|NCT01120093|538152177|FG000|Treatment Period 4|Adverse Event|1|||
149185960|NCT01120093|538152178|FG001|Treatment Period 4|Adverse Event|0|||
149185961|NCT01120093|538152179|FG002|Treatment Period 4|Adverse Event|0|||
149185962|NCT01120093|538152180|FG003|Treatment Period 4|Adverse Event|0|||
149185963|NCT01120093|538152181|FG004|Treatment Period 4|Adverse Event|0|||
149185964|NCT01120093|538152177|FG000|Treatment Period 5|Adverse Event|0|||
149185965|NCT01120093|538152178|FG001|Treatment Period 5|Adverse Event|1|||
149185966|NCT01120093|538152179|FG002|Treatment Period 5|Adverse Event|0|||
149185967|NCT01120093|538152180|FG003|Treatment Period 5|Adverse Event|1|||
149185968|NCT01120093|538152181|FG004|Treatment Period 5|Adverse Event|0|||
149185969|NCT03649321|538152182|FG000|Overall Study|Withdrawal by Subject|1|||
149185970|NCT03649321|538152183|FG001|Overall Study|Withdrawal by Subject|0|||
149185971|NCT03649321|538152182|FG000|Overall Study|Death|1|||
149185972|NCT03649321|538152183|FG001|Overall Study|Death|0|||
149185973|NCT00723840|538152190|FG000|Overall Study|Lost to Follow-up|2|||
149185974|NCT00723840|538152190|FG000|Overall Study|Failure to return|18|||
149185975|NCT00723840|538152190|FG000|Overall Study|Withdrawal by Subject|55|||
149185976|NCT00723840|538152190|FG000|Overall Study|Serious Adverse Events|3|||
149185977|NCT00723840|538152190|FG000|Overall Study|Other Medical Event|2|||
149185978|NCT00723840|538152190|FG000|Overall Study|Unspecified reason|2|||
149185979|NCT05100199|538152197|FG000|Overall Study|Lost to Follow-up|5|||
149185980|NCT05100199|538152198|FG001|Overall Study|Lost to Follow-up|8|||
149185981|NCT05100199|538152199|FG002|Overall Study|Lost to Follow-up|3|||
149185982|NCT05100199|538152200|FG003|Overall Study|Lost to Follow-up|6|||
149185983|NCT05100199|538152197|FG000|Overall Study|Withdrawal by Subject|3|||
149185984|NCT05100199|538152198|FG001|Overall Study|Withdrawal by Subject|3|||
149185985|NCT05100199|538152199|FG002|Overall Study|Withdrawal by Subject|9|||
149185986|NCT05100199|538152200|FG003|Overall Study|Withdrawal by Subject|7|||
149185987|NCT05100199|538152197|FG000|Overall Study|Other|0|||
149185988|NCT05100199|538152198|FG001|Overall Study|Other|0|||
149185989|NCT05100199|538152199|FG002|Overall Study|Other|1|||
149185990|NCT05100199|538152200|FG003|Overall Study|Other|1|||
149185991|NCT02853331|538152201|FG000|Overall Study|Death|59|||
149185992|NCT02853331|538152202|FG001|Overall Study|Death|95|||
149185993|NCT02853331|538152201|FG000|Overall Study|Withdrawal by Subject|5|||
149185994|NCT02853331|538152202|FG001|Overall Study|Withdrawal by Subject|9|||
149185995|NCT02853331|538152201|FG000|Overall Study|Ongoing in study|368|||
149185996|NCT02853331|538152202|FG001|Overall Study|Ongoing in study|325|||
149185997|NCT02062151|538152207|FG000|Overall Study|screen failure|1|||
149185998|NCT00257192|538152208|FG000|Overall Study|Adverse Event|21|||
149185999|NCT00257192|538152209|FG001|Overall Study|Adverse Event|10|||
149186000|NCT00257192|538152208|FG000|Overall Study|Laboratory abnormality|1|||
149186001|NCT00257192|538152209|FG001|Overall Study|Laboratory abnormality|1|||
149186002|NCT00257192|538152208|FG000|Overall Study|Lost to Follow-up|3|||
149186003|NCT00257192|538152209|FG001|Overall Study|Lost to Follow-up|3|||
149186004|NCT00257192|538152208|FG000|Overall Study|Insufficient clinical response|18|||
149186005|NCT00257192|538152209|FG001|Overall Study|Insufficient clinical response|18|||
149186006|NCT00257192|538152208|FG000|Overall Study|Withdrawal by Subject|14|||
149186007|NCT00257192|538152209|FG001|Overall Study|Withdrawal by Subject|2|||
149186008|NCT00257192|538152208|FG000|Overall Study|Randomized but not treated|0|||
149186009|NCT00257192|538152209|FG001|Overall Study|Randomized but not treated|1|||
149186010|NCT00257192|538152208|FG000|Overall Study|Study terminated by sponsor|1|||
149186011|NCT00257192|538152209|FG001|Overall Study|Study terminated by sponsor|0|||
149186012|NCT00257192|538152208|FG000|Overall Study|Miscellaneous|0|||
149186013|NCT00257192|538152209|FG001|Overall Study|Miscellaneous|4|||
149186014|NCT02086565|538152211|FG000|Overall Study|Lost to Follow-up|9|||
149186015|NCT02086565|538152212|FG001|Overall Study|Lost to Follow-up|7|||
149186016|NCT02086565|538152211|FG000|Overall Study|Withdrawal by Subject|2|||
149186017|NCT02086565|538152212|FG001|Overall Study|Withdrawal by Subject|1|||
149186018|NCT02086565|538152211|FG000|Overall Study|Death|3|||
149186019|NCT02086565|538152212|FG001|Overall Study|Death|2|||
149186020|NCT02086565|538152211|FG000|Overall Study|withdrawn by research team|2|||
149186021|NCT02086565|538152212|FG001|Overall Study|withdrawn by research team|2|||
149186022|NCT00751101|538152213|FG000|Overall Study|Withdrawal by Subject|1|||
149186023|NCT00751101|538152214|FG001|Overall Study|Withdrawal by Subject|0|||
149186024|NCT00751101|538152213|FG000|Overall Study|No HFS / Never Started Patch/|0|||
149186025|NCT00751101|538152214|FG001|Overall Study|No HFS / Never Started Patch/|4|||
149186026|NCT00751101|538152213|FG000|Overall Study|Never began capecitabine|1|||
149186027|NCT00751101|538152214|FG001|Overall Study|Never began capecitabine|0|||
149186028|NCT00751101|538152213|FG000|Overall Study|Physician Decision|0|||
149186029|NCT00751101|538152214|FG001|Overall Study|Physician Decision|1|||
149186030|NCT00739297|538152215|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
149186031|NCT00739297|538152216|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
149186032|NCT00739297|538152217|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
149186033|NCT00739297|538152218|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
149186034|NCT00739297|538152219|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
149186035|NCT00739297|538152220|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
149186036|NCT00739297|538152221|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
149186037|NCT00739297|538152215|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149186038|NCT00739297|538152216|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149186039|NCT00739297|538152217|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149186040|NCT00739297|538152218|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149186041|NCT00739297|538152219|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
149186042|NCT00739297|538152220|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
149186043|NCT00739297|538152221|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
149186044|NCT01400971|538152222|FG000|Overall Study|Death|82|||
149186045|NCT01400971|538152222|FG000|Overall Study|Lost to Follow-up|196|||
149186046|NCT01400971|538152222|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
149186047|NCT01400971|538152222|FG000|Overall Study|Physician Decision|57|||
149186048|NCT01400971|538152222|FG000|Overall Study|Withdrawal by Subject|158|||
149186049|NCT01400971|538152222|FG000|Overall Study|Other|422|||
149186050|NCT01242020|538152223|FG000|Overall Study|Withdrawal by Subject|2|||
149186051|NCT01242020|538152224|FG001|Overall Study|Withdrawal by Subject|0|||
149186052|NCT01242020|538152223|FG000|Overall Study|Failed screening|1|||
149186053|NCT01242020|538152224|FG001|Overall Study|Failed screening|0|||
149186054|NCT01595646|538152225|FG000|Overall Study|Withdrawal by Subject|1|||
149186055|NCT01595646|538152226|FG001|Overall Study|Withdrawal by Subject|0|||
149186056|NCT01595646|538152227|FG002|Overall Study|Withdrawal by Subject|0|||
149186057|NCT01161524|538152230|FG000|Core Study (23 Weeks)|Adverse Event|3|||
149186058|NCT01161524|538152231|FG001|Core Study (23 Weeks)|Adverse Event|0|||
149186059|NCT01161524|538152232|FG002|Core Study (23 Weeks)|Adverse Event|0|||
149186060|NCT01161524|538152230|FG000|Core Study (23 Weeks)|Other|1|||
149186061|NCT01161524|538152231|FG001|Core Study (23 Weeks)|Other|0|||
149186062|NCT01161524|538152232|FG002|Core Study (23 Weeks)|Other|0|||
149186063|NCT01161524|538152230|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
149186064|NCT01161524|538152231|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
149186065|NCT01161524|538152232|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
149186066|NCT01161524|538152230|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
149186067|NCT01161524|538152231|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
149186068|NCT01161524|538152232|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
149186069|NCT01161524|538152230|FG000|Core Study (23 Weeks)|Subject Choice|3|||
149186070|NCT01161524|538152231|FG001|Core Study (23 Weeks)|Subject Choice|2|||
149186071|NCT01161524|538152232|FG002|Core Study (23 Weeks)|Subject Choice|0|||
149186072|NCT01161524|538152230|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
149186073|NCT01161524|538152231|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
149186074|NCT01161524|538152232|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
149186075|NCT01161524|538152230|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
149186076|NCT01161524|538152231|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
149186077|NCT01161524|538152232|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
149186078|NCT01161524|538152230|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
149186079|NCT01161524|538152231|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
149186080|NCT01161524|538152232|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
149186081|NCT01161524|538152230|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
149186082|NCT01161524|538152231|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
149186083|NCT01161524|538152232|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
149186084|NCT01161524|538152230|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
149186085|NCT01161524|538152231|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
149186086|NCT01161524|538152232|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
149186087|NCT00642616|538152233|FG000|Overall Study|Adverse Event|2|||
149186088|NCT00642616|538152234|FG001|Overall Study|Adverse Event|0|||
149186089|NCT00642616|538152235|FG002|Overall Study|Adverse Event|1|||
149186090|NCT00642616|538152236|FG003|Overall Study|Adverse Event|0|||
148679716|NCT01462695|536300867|FG000|Overall Study|Physician Decision|5|||
149186091|NCT00642616|538152233|FG000|Overall Study|Study Terminated by Sponsor|7|||
149186092|NCT00642616|538152234|FG001|Overall Study|Study Terminated by Sponsor|6|||
149186093|NCT00642616|538152235|FG002|Overall Study|Study Terminated by Sponsor|4|||
149186094|NCT00642616|538152236|FG003|Overall Study|Study Terminated by Sponsor|5|||
149186095|NCT00642616|538152233|FG000|Overall Study|Withdrawal by Subject|0|||
148807366|NCT00903968|536773231|FG003|Overall Study|Progressive Disease|3|||
148807367|NCT00903968|536773232|FG004|Overall Study|Progressive Disease|3|||
149186096|NCT00642616|538152234|FG001|Overall Study|Withdrawal by Subject|1|||
149186097|NCT00642616|538152235|FG002|Overall Study|Withdrawal by Subject|1|||
149186098|NCT00642616|538152236|FG003|Overall Study|Withdrawal by Subject|1|||
149186099|NCT00642616|538152233|FG000|Overall Study|Protocol Violation|0|||
149186100|NCT00642616|538152234|FG001|Overall Study|Protocol Violation|0|||
149186101|NCT00642616|538152235|FG002|Overall Study|Protocol Violation|2|||
149186102|NCT00642616|538152236|FG003|Overall Study|Protocol Violation|0|||
149186103|NCT00642616|538152233|FG000|Overall Study|Physician Decision|0|||
149186104|NCT00642616|538152234|FG001|Overall Study|Physician Decision|0|||
149186105|NCT00642616|538152235|FG002|Overall Study|Physician Decision|1|||
149186106|NCT00642616|538152236|FG003|Overall Study|Physician Decision|1|||
149186107|NCT00399802|538152241|FG000|Overall Study|Adverse Event|0|||
149186108|NCT00399802|538152242|FG001|Overall Study|Adverse Event|2|||
149186109|NCT00399802|538152241|FG000|Overall Study|Participant discontinued by mistake|0|||
149186110|NCT00399802|538152242|FG001|Overall Study|Participant discontinued by mistake|1|||
149186111|NCT00542815|538152243|FG000|Overall Study|Adverse Event|19|||
149186112|NCT00542815|538152244|FG001|Overall Study|Adverse Event|6|||
149186113|NCT00542815|538152245|FG002|Overall Study|Adverse Event|9|||
149186114|NCT00542815|538152243|FG000|Overall Study|Death|10|||
149186115|NCT00542815|538152244|FG001|Overall Study|Death|7|||
149186116|NCT00542815|538152245|FG002|Overall Study|Death|3|||
149186117|NCT00542815|538152243|FG000|Overall Study|Lack of Efficacy|9|||
149186118|NCT00542815|538152244|FG001|Overall Study|Lack of Efficacy|2|||
149186119|NCT00542815|538152245|FG002|Overall Study|Lack of Efficacy|0|||
149186120|NCT00542815|538152243|FG000|Overall Study|Physician Decision|2|||
149186121|NCT00542815|538152244|FG001|Overall Study|Physician Decision|1|||
149186122|NCT00542815|538152245|FG002|Overall Study|Physician Decision|0|||
149186123|NCT00542815|538152243|FG000|Overall Study|Protocol Violation|1|||
149186124|NCT00542815|538152244|FG001|Overall Study|Protocol Violation|1|||
149186125|NCT00542815|538152245|FG002|Overall Study|Protocol Violation|2|||
149186126|NCT00542815|538152243|FG000|Overall Study|Withdrawal by Subject|41|||
149186127|NCT00542815|538152244|FG001|Overall Study|Withdrawal by Subject|5|||
149186128|NCT00542815|538152245|FG002|Overall Study|Withdrawal by Subject|8|||
149186129|NCT00542815|538152243|FG000|Overall Study|Other reasons|24|||
149186130|NCT00542815|538152244|FG001|Overall Study|Other reasons|10|||
149186131|NCT00542815|538152245|FG002|Overall Study|Other reasons|10|||
149186132|NCT01041573|538152248|FG000|Overall Study|Withdrawal by Subject|2|||
149186133|NCT01041573|538152249|FG001|Overall Study|Withdrawal by Subject|5|||
149186134|NCT01041573|538152250|FG002|Overall Study|Withdrawal by Subject|2|||
149186135|NCT01041573|538152251|FG003|Overall Study|Withdrawal by Subject|0|||
149186136|NCT01041573|538152248|FG000|Overall Study|Death|1|||
149186137|NCT01041573|538152249|FG001|Overall Study|Death|0|||
149186138|NCT01041573|538152250|FG002|Overall Study|Death|0|||
149186139|NCT01041573|538152251|FG003|Overall Study|Death|0|||
149186140|NCT01041573|538152248|FG000|Overall Study|Lost to Follow-up|0|||
149186141|NCT01041573|538152249|FG001|Overall Study|Lost to Follow-up|1|||
149186142|NCT01041573|538152250|FG002|Overall Study|Lost to Follow-up|2|||
149186143|NCT01041573|538152251|FG003|Overall Study|Lost to Follow-up|1|||
149186144|NCT01041573|538152248|FG000|Overall Study|Adverse Event|0|||
149186145|NCT01041573|538152249|FG001|Overall Study|Adverse Event|2|||
148807368|NCT00903968|536773233|FG005|Overall Study|Progressive Disease|3|||
148933433|NCT03799211|537242214|FG001|Overall Study|Withdrawal by Subject|0|||
148933434|NCT00764491|537242215|FG000|Overall Study|Lost to Follow-up|35|||
148933435|NCT00764491|537242216|FG001|Overall Study|Lost to Follow-up|17|||
149186146|NCT01041573|538152250|FG002|Overall Study|Adverse Event|0|||
149186147|NCT01041573|538152251|FG003|Overall Study|Adverse Event|0|||
149186148|NCT01041573|538152248|FG000|Overall Study|relocation|1|||
149186149|NCT01041573|538152249|FG001|Overall Study|relocation|4|||
149186150|NCT01041573|538152250|FG002|Overall Study|relocation|3|||
149186151|NCT01041573|538152251|FG003|Overall Study|relocation|1|||
149186152|NCT01041573|538152248|FG000|Overall Study|further blood extraction|0|||
149186153|NCT01041573|538152249|FG001|Overall Study|further blood extraction|1|||
149186154|NCT01041573|538152250|FG002|Overall Study|further blood extraction|0|||
149186155|NCT01041573|538152251|FG003|Overall Study|further blood extraction|0|||
149186156|NCT01041573|538152248|FG000|Overall Study|positive to anti-HCV|1|||
149186157|NCT01041573|538152249|FG001|Overall Study|positive to anti-HCV|0|||
149186158|NCT01041573|538152250|FG002|Overall Study|positive to anti-HCV|0|||
149186159|NCT01041573|538152251|FG003|Overall Study|positive to anti-HCV|0|||
149186160|NCT04172831|538152252|FG000|Overall Study|Adverse Event|21|||
149186161|NCT04172831|538152253|FG001|Overall Study|Adverse Event|9|||
149186162|NCT04172831|538152252|FG000|Overall Study|Lack of Efficacy|2|||
149186163|NCT04172831|538152253|FG001|Overall Study|Lack of Efficacy|8|||
149186164|NCT04172831|538152252|FG000|Overall Study|Physician Decision|0|||
149186165|NCT04172831|538152253|FG001|Overall Study|Physician Decision|1|||
149186166|NCT04172831|538152252|FG000|Overall Study|Withdrawal by Subject|12|||
149186167|NCT04172831|538152253|FG001|Overall Study|Withdrawal by Subject|11|||
149186168|NCT04172831|538152252|FG000|Overall Study|Lost to Follow-up|4|||
149186169|NCT04172831|538152253|FG001|Overall Study|Lost to Follow-up|9|||
149014225|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
149014226|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
149186170|NCT04172831|538152252|FG000|Overall Study|COVID-19 related crisis|3|||
149186171|NCT04172831|538152253|FG001|Overall Study|COVID-19 related crisis|3|||
149186172|NCT04172831|538152252|FG000|Overall Study|Subject non-compliance|1|||
149186173|NCT04172831|538152253|FG001|Overall Study|Subject non-compliance|1|||
149186174|NCT04172831|538152252|FG000|Overall Study|Family emergency|1|||
149186175|NCT04172831|538152253|FG001|Overall Study|Family emergency|0|||
149186176|NCT02955186|538152254|FG000|Overall Study|Withdrawal by Subject|6|||
149186177|NCT02955186|538152255|FG001|Overall Study|Withdrawal by Subject|2|||
149186178|NCT02955186|538152254|FG000|Overall Study|Protocol Violation|1|||
149186179|NCT02955186|538152255|FG001|Overall Study|Protocol Violation|0|||
149186180|NCT01276847|538152258|FG000|Overall Study|Withdrawal by Subject|1|||
149186181|NCT01276847|538152259|FG001|Overall Study|Withdrawal by Subject|0|||
149186182|NCT01276847|538152260|FG002|Overall Study|Withdrawal by Subject|0|||
149186183|NCT01618656|538152261|FG000|Overall Study|Withdrawal by Subject|7|||
149186184|NCT01618656|538152262|FG001|Overall Study|Withdrawal by Subject|3|||
149186185|NCT01618656|538152261|FG000|Overall Study|Physician Decision|1|||
149186186|NCT01618656|538152262|FG001|Overall Study|Physician Decision|1|||
149186187|NCT01899144|538152263|FG000|Treatment Period 2|Other|1|||
149186188|NCT01899144|538152263|FG000|Treatment Period 3|Other|2|||
149186189|NCT01899144|538152263|FG000|Treatment Period 5|Other|1|||
149186190|NCT04770155|538152264|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186191|NCT04770155|538152265|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186192|NCT04770155|538152266|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186193|NCT04770155|538152267|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186194|NCT04770155|538152268|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186195|NCT04770155|538152269|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186196|NCT04770155|538152270|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186197|NCT04770155|538152271|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
149186198|NCT02021812|538152272|FG000|Overall Study|Death|8|||
149186199|NCT02021812|538152272|FG000|Overall Study|Withdrawal by Subject|3|||
149186200|NCT02021812|538152272|FG000|Overall Study|Lost to Follow-up|2|||
149186201|NCT02021812|538152272|FG000|Overall Study|Refuse to return, COVD 19|2|||
149186202|NCT03634072|538152273|FG000|Overall Study|Early termination of overall study|1|||
149186203|NCT03634072|538152274|FG001|Overall Study|Early termination of overall study|0|||
149186204|NCT01765764|538152275|FG000|Treatment Period|Adverse Event|1|||
149186205|NCT01765764|538152276|FG001|Treatment Period|Adverse Event|2|||
149186206|NCT01765764|538152277|FG002|Treatment Period|Adverse Event|1|||
149186207|NCT01765764|538152275|FG000|Treatment Period|Lost to Follow-up|0|||
149186208|NCT01765764|538152276|FG001|Treatment Period|Lost to Follow-up|3|||
149186209|NCT01765764|538152277|FG002|Treatment Period|Lost to Follow-up|2|||
149186210|NCT01765764|538152275|FG000|Treatment Period|Personal Reasons|1|||
149186211|NCT01765764|538152276|FG001|Treatment Period|Personal Reasons|2|||
149186212|NCT01765764|538152277|FG002|Treatment Period|Personal Reasons|1|||
149186213|NCT01765764|538152275|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
149186214|NCT01765764|538152276|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
149186215|NCT01765764|538152277|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
149186216|NCT01597193|538152279|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
149186217|NCT01597193|538152280|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
149186218|NCT01597193|538152281|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149186219|NCT01597193|538152282|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149186220|NCT01597193|538152283|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149186221|NCT01597193|538152284|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
149186222|NCT01597193|538152285|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
148679717|NCT01462695|536300868|FG001|Overall Study|Physician Decision|0|||
148807369|NCT00903968|536773234|FG006|Overall Study|Progressive Disease|0|||
149014227|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
149014228|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
149014229|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
149014230|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
149014231|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
149014232|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
149014233|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
149014234|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
149014235|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
149014236|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149014237|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149014238|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149014239|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
149014240|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149014241|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
149014242|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
149014243|NCT04921969|537530902|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
149014244|NCT04921969|537530903|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
149014245|NCT04921969|537530904|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
149014246|NCT04921969|537530905|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
149014247|NCT04921969|537530906|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
149014248|NCT04921969|537530907|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
149014249|NCT04921969|537530908|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
149014250|NCT04287868|537530909|FG000|Overall Study|Screening fail|1|||
149014251|NCT04287868|537530910|FG001|Overall Study|Screening fail|0|||
149014252|NCT01282476|537532148|FG000|Overall Study|Death|11|||
149014253|NCT01811563|537532153|FG000|Overall Study|Lost to Follow-up|5|||
149014254|NCT01811563|537532154|FG001|Overall Study|Lost to Follow-up|2|||
149014255|NCT01811563|537532153|FG000|Overall Study|Incorrect Randomization procedure|0|||
149014256|NCT01811563|537532154|FG001|Overall Study|Incorrect Randomization procedure|1|||
149014257|NCT01267825|537532155|FG000|Overall Study|study terminated. no data collected.|1|||
149014258|NCT01267825|537532156|FG001|Overall Study|study terminated. no data collected.|0|||
149014259|NCT01087723|537532161|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
149014260|NCT01087723|537532162|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
149014261|NCT01087723|537532161|FG000|Overall Study|Withdrawal by Subject|10|||
149014262|NCT01087723|537532162|FG001|Overall Study|Withdrawal by Subject|13|||
149014263|NCT01087723|537532161|FG000|Overall Study|Physician Decision|2|||
149014264|NCT01087723|537532162|FG001|Overall Study|Physician Decision|0|||
149014265|NCT01087723|537532161|FG000|Overall Study|Lost to Follow-up|1|||
149014266|NCT01087723|537532162|FG001|Overall Study|Lost to Follow-up|4|||
149014267|NCT01087723|537532161|FG000|Overall Study|Reason Not Specified|1|||
149014268|NCT01087723|537532162|FG001|Overall Study|Reason Not Specified|2|||
149014269|NCT01868035|537532163|FG000|Overall Study|Lost to Follow-up|3|||
149014270|NCT01868035|537532163|FG000|Overall Study|Withdrawal by Subject|1|||
149014271|NCT01868035|537532163|FG000|Overall Study|Progressive Disease|2|||
149014272|NCT01868035|537532163|FG000|Overall Study|Non-compliance|1|||
149014273|NCT00806624|537532164|FG000|Overall Study|Adverse Event|2|||
149186223|NCT01597193|538152279|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149186224|NCT01597193|538152280|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149186225|NCT01597193|538152281|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149186226|NCT01597193|538152282|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
149186227|NCT01597193|538152283|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
149186228|NCT01597193|538152284|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
149186229|NCT01597193|538152285|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
149186230|NCT01597193|538152279|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
149186231|NCT01597193|538152280|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
149186232|NCT01597193|538152281|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
149186233|NCT01597193|538152282|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
149186234|NCT01597193|538152283|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
149014274|NCT00806624|537532165|FG001|Overall Study|Adverse Event|8|||
149014275|NCT00806624|537532166|FG002|Overall Study|Adverse Event|0|||
149186235|NCT01597193|538152284|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
149186236|NCT01597193|538152285|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
149186237|NCT01597193|538152279|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149186238|NCT01597193|538152280|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149186239|NCT01597193|538152281|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149186240|NCT01597193|538152282|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149186241|NCT01597193|538152283|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149186242|NCT01597193|538152284|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
149186243|NCT01597193|538152285|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
149186244|NCT01597193|538152279|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149186245|NCT01597193|538152280|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149186246|NCT01597193|538152281|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149186247|NCT01597193|538152282|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
148679718|NCT01462695|536300867|FG000|Overall Study|Withdrawal by Subject|2|||
148679719|NCT01462695|536300868|FG001|Overall Study|Withdrawal by Subject|0|||
148679720|NCT01462695|536300867|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
148679721|NCT01462695|536300868|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
148679722|NCT02400905|536300869|FG000|Overall Study|Death|24|||
148679723|NCT02400905|536300869|FG000|Overall Study|Lost to Follow-up|18|||
148679724|NCT02400905|536300869|FG000|Overall Study|Withdrawal by Subject|16|||
148679725|NCT02400905|536300869|FG000|Overall Study|Physician Decision|4|||
148679726|NCT02400905|536300869|FG000|Overall Study|Other|1|||
148679727|NCT00879970|536300870|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
148933436|NCT00923936|537242217|FG000|Overall Study|progressive disease on study|2|||
148933437|NCT00923936|537242218|FG001|Overall Study|progressive disease on study|1|||
149186248|NCT01597193|538152283|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149186249|NCT01597193|538152284|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
149186250|NCT01597193|538152285|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
149186251|NCT03184701|538152287|FG000|Overall Study|Death|3|||
149186252|NCT03184701|538152287|FG000|Overall Study|Physician Decision|3|||
149186253|NCT03184701|538152287|FG000|Overall Study|Withdrawal by Subject|6|||
149186254|NCT03184701|538152287|FG000|Overall Study|Lost to Follow-up|5|||
149186255|NCT03844633|538152290|FG000|1 Week FU|Lost to Follow-up|0|||
149186256|NCT03844633|538152291|FG001|1 Week FU|Lost to Follow-up|1|||
149186257|NCT03844633|538152292|FG002|1 Week FU|Lost to Follow-up|4|||
149186258|NCT03844633|538152290|FG000|12-month Follow-up|Lost to Follow-up|7|||
149186259|NCT03844633|538152291|FG001|12-month Follow-up|Lost to Follow-up|5|||
149186260|NCT03844633|538152292|FG002|12-month Follow-up|Lost to Follow-up|8|||
149186261|NCT03596177|538152296|FG000|Single Blind Period|Withdrawal by Subject|1|||
149186262|NCT03596177|538152297|FG001|Single Blind Period|Withdrawal by Subject|1|||
149186263|NCT03596177|538152296|FG000|Single Blind Period|Other|1|||
149186264|NCT03596177|538152297|FG001|Single Blind Period|Other|0|||
149186265|NCT03596177|538152296|FG000|Double Blind Period|Withdrawal by Subject|0|||
149186266|NCT03596177|538152297|FG001|Double Blind Period|Withdrawal by Subject|1|||
149186267|NCT03596177|538152296|FG000|Double Blind Period|Other|0|||
149186268|NCT03596177|538152297|FG001|Double Blind Period|Other|4|||
149186269|NCT03596177|538152296|FG000|Double Blind Period|Death during safety follow-up|0|||
149186270|NCT03596177|538152297|FG001|Double Blind Period|Death during safety follow-up|1|||
149186271|NCT04083222|538152300|FG000|Overall Study|Voluntary Withdrawal|0|||
149186272|NCT04083222|538152301|FG001|Overall Study|Voluntary Withdrawal|1|||
149186273|NCT04083222|538152300|FG000|Overall Study|Reason not Specified|0|||
149186274|NCT04083222|538152301|FG001|Overall Study|Reason not Specified|1|||
149186275|NCT03625986|538154259|FG000|Randomization Period|Lost to Follow-up|7|||
148679728|NCT00879970|536300871|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
148679729|NCT00879970|536300872|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
149186276|NCT03625986|538154260|FG001|Randomization Period|Lost to Follow-up|12|||
149186277|NCT03625986|538154259|FG000|Randomization Period|Withdrawal by Subject|10|||
149186278|NCT03625986|538154260|FG001|Randomization Period|Withdrawal by Subject|6|||
149186279|NCT01937130|538154261|FG000|Overall Study|Withdrawal by Subject|0|||
149186280|NCT01937130|538154262|FG001|Overall Study|Withdrawal by Subject|0|||
149186281|NCT01937130|538154263|FG002|Overall Study|Withdrawal by Subject|0|||
149186282|NCT01937130|538154264|FG003|Overall Study|Withdrawal by Subject|1|||
149186283|NCT01937130|538154261|FG000|Overall Study|Adverse Event|0|||
149186284|NCT01937130|538154262|FG001|Overall Study|Adverse Event|1|||
149186285|NCT01937130|538154263|FG002|Overall Study|Adverse Event|0|||
149186286|NCT01937130|538154264|FG003|Overall Study|Adverse Event|1|||
149186287|NCT01937130|538154261|FG000|Overall Study|Death|1|||
149186288|NCT01937130|538154262|FG001|Overall Study|Death|1|||
149186289|NCT01937130|538154263|FG002|Overall Study|Death|1|||
149186290|NCT01937130|538154264|FG003|Overall Study|Death|0|||
149186291|NCT01937130|538154261|FG000|Overall Study|Lost to Follow-up|2|||
149186292|NCT01937130|538154262|FG001|Overall Study|Lost to Follow-up|0|||
149186293|NCT01937130|538154263|FG002|Overall Study|Lost to Follow-up|2|||
149186294|NCT01937130|538154264|FG003|Overall Study|Lost to Follow-up|0|||
149186295|NCT01937130|538154261|FG000|Overall Study|Physician Decision|0|||
149186296|NCT01937130|538154262|FG001|Overall Study|Physician Decision|1|||
149186297|NCT01937130|538154263|FG002|Overall Study|Physician Decision|0|||
149186298|NCT01937130|538154264|FG003|Overall Study|Physician Decision|0|||
149186299|NCT01937130|538154261|FG000|Overall Study|Patients unable to swallow|0|||
149186300|NCT01937130|538154262|FG001|Overall Study|Patients unable to swallow|1|||
149186301|NCT01937130|538154263|FG002|Overall Study|Patients unable to swallow|0|||
149186302|NCT01937130|538154264|FG003|Overall Study|Patients unable to swallow|0|||
149186303|NCT01937130|538154261|FG000|Overall Study|Patient lost to FU due to death|2|||
149186304|NCT01937130|538154262|FG001|Overall Study|Patient lost to FU due to death|0|||
149186305|NCT01937130|538154263|FG002|Overall Study|Patient lost to FU due to death|0|||
149186306|NCT01937130|538154264|FG003|Overall Study|Patient lost to FU due to death|0|||
149186307|NCT01850563|538154265|FG000|Overall Study|Not eligible|3|||
149186308|NCT01850563|538154266|FG001|Overall Study|Not eligible|0|||
149186309|NCT04359823|538154267|FG000|Overall Study|Lost to Follow-up|0|||
149186310|NCT04359823|538154268|FG001|Overall Study|Lost to Follow-up|1|||
149186311|NCT04359823|538154267|FG000|Overall Study|Withdrawal by Subject|0|||
149186312|NCT04359823|538154268|FG001|Overall Study|Withdrawal by Subject|1|||
149186313|NCT04191967|538154269|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
149186314|NCT04191967|538154269|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
149186315|NCT01431144|538154270|FG000|Overall Study|Implant mobility and removal|2|||
149186316|NCT01431144|538154271|FG001|Overall Study|Implant mobility and removal|0|||
149186317|NCT02322892|538154272|FG000|Overall Study|Surgery cancelled|1|||
149186318|NCT02322892|538154273|FG001|Overall Study|Surgery cancelled|2|||
149186319|NCT02322892|538154272|FG000|Overall Study|Met exclusion criteria|0|||
149186320|NCT02322892|538154273|FG001|Overall Study|Met exclusion criteria|1|||
149186321|NCT02322892|538154272|FG000|Overall Study|Protocol Violation|1|||
149186322|NCT02322892|538154273|FG001|Overall Study|Protocol Violation|0|||
149186323|NCT02125331|538154274|FG000|Overall Study|Protocol Violation|1|||
149186324|NCT02125331|538154275|FG001|Overall Study|Protocol Violation|0|||
149186325|NCT02125331|538154274|FG000|Overall Study|technical problem|2|||
149186326|NCT02125331|538154275|FG001|Overall Study|technical problem|0|||
149186327|NCT02125331|538154274|FG000|Overall Study|screen failure|2|||
149186328|NCT02125331|538154275|FG001|Overall Study|screen failure|0|||
149186329|NCT01432262|538154276|FG000|Overall Study|Withdrawal by Subject|2|||
149186330|NCT01432262|538154277|FG001|Overall Study|Withdrawal by Subject|1|||
149186331|NCT00165646|538154278|FG000|Overall Study|Adverse Event|1|||
149186332|NCT00165646|538154279|FG001|Overall Study|Adverse Event|1|||
149186333|NCT00165646|538154280|FG002|Overall Study|Adverse Event|1|||
149186334|NCT00165646|538154278|FG000|Overall Study|Lack of Efficacy|1|||
149186335|NCT00165646|538154279|FG001|Overall Study|Lack of Efficacy|2|||
149186336|NCT00165646|538154280|FG002|Overall Study|Lack of Efficacy|0|||
149186337|NCT00165646|538154278|FG000|Overall Study|Withdrawal by Subject|0|||
149186338|NCT00165646|538154279|FG001|Overall Study|Withdrawal by Subject|2|||
149186339|NCT00165646|538154280|FG002|Overall Study|Withdrawal by Subject|1|||
149186340|NCT00165646|538154278|FG000|Overall Study|Physician Decision|2|||
149186341|NCT00165646|538154279|FG001|Overall Study|Physician Decision|0|||
149186342|NCT00165646|538154280|FG002|Overall Study|Physician Decision|2|||
149186343|NCT00165646|538154278|FG000|Overall Study|Protocol Violation|1|||
149186344|NCT00165646|538154279|FG001|Overall Study|Protocol Violation|0|||
149186345|NCT00165646|538154280|FG002|Overall Study|Protocol Violation|0|||
149186346|NCT01104558|538154281|FG000|Overall Study|Protocol Violation|6|||
149186347|NCT01104558|538154281|FG000|Overall Study|Missing of primary efficacy assessment|10|||
149186348|NCT01104558|538154281|FG000|Overall Study|Missing of genetic analysis results|1|||
149186349|NCT00696657|538154282|FG000|Overall Study|Protocol Violation|0|||
149186350|NCT00696657|538154283|FG001|Overall Study|Protocol Violation|0|||
149186351|NCT00696657|538154284|FG002|Overall Study|Protocol Violation|0|||
149186352|NCT00696657|538154285|FG003|Overall Study|Protocol Violation|0|||
149186353|NCT00696657|538154286|FG004|Overall Study|Protocol Violation|0|||
149186354|NCT00696657|538154287|FG005|Overall Study|Protocol Violation|1|||
149186355|NCT00696657|538154288|FG006|Overall Study|Protocol Violation|0|||
149186356|NCT00696657|538154289|FG007|Overall Study|Protocol Violation|0|||
149186357|NCT00696657|538154290|FG008|Overall Study|Protocol Violation|1|||
149186358|NCT00696657|538154282|FG000|Overall Study|Lack of Efficacy|0|||
148807370|NCT00903968|536773235|FG007|Overall Study|Progressive Disease|18|||
149186359|NCT00696657|538154283|FG001|Overall Study|Lack of Efficacy|1|||
149186360|NCT00696657|538154284|FG002|Overall Study|Lack of Efficacy|0|||
149186361|NCT00696657|538154285|FG003|Overall Study|Lack of Efficacy|0|||
149186362|NCT00696657|538154286|FG004|Overall Study|Lack of Efficacy|0|||
149186363|NCT00696657|538154287|FG005|Overall Study|Lack of Efficacy|0|||
149186364|NCT00696657|538154288|FG006|Overall Study|Lack of Efficacy|0|||
149186365|NCT00696657|538154289|FG007|Overall Study|Lack of Efficacy|0|||
149186366|NCT00696657|538154290|FG008|Overall Study|Lack of Efficacy|0|||
149186367|NCT00696657|538154282|FG000|Overall Study|Withdrawal criteria|1|||
149186368|NCT00696657|538154283|FG001|Overall Study|Withdrawal criteria|3|||
149186369|NCT00696657|538154284|FG002|Overall Study|Withdrawal criteria|2|||
149186370|NCT00696657|538154285|FG003|Overall Study|Withdrawal criteria|2|||
149186371|NCT00696657|538154286|FG004|Overall Study|Withdrawal criteria|0|||
149186372|NCT00696657|538154287|FG005|Overall Study|Withdrawal criteria|0|||
149186373|NCT00696657|538154288|FG006|Overall Study|Withdrawal criteria|1|||
149186374|NCT00696657|538154289|FG007|Overall Study|Withdrawal criteria|1|||
149186375|NCT00696657|538154290|FG008|Overall Study|Withdrawal criteria|2|||
149186376|NCT00696657|538154282|FG000|Overall Study|Unclassified|0|||
149186377|NCT00696657|538154283|FG001|Overall Study|Unclassified|1|||
149186378|NCT00696657|538154284|FG002|Overall Study|Unclassified|3|||
149186379|NCT00696657|538154285|FG003|Overall Study|Unclassified|2|||
149186380|NCT00696657|538154286|FG004|Overall Study|Unclassified|4|||
149186381|NCT00696657|538154287|FG005|Overall Study|Unclassified|2|||
149186382|NCT00696657|538154288|FG006|Overall Study|Unclassified|0|||
149186383|NCT00696657|538154289|FG007|Overall Study|Unclassified|0|||
149186384|NCT00696657|538154290|FG008|Overall Study|Unclassified|1|||
149186385|NCT00696657|538154282|FG000|Overall Study|Adverse Event|0|||
149186386|NCT00696657|538154283|FG001|Overall Study|Adverse Event|0|||
149186387|NCT00696657|538154284|FG002|Overall Study|Adverse Event|3|||
149186388|NCT00696657|538154285|FG003|Overall Study|Adverse Event|7|||
149186389|NCT00696657|538154286|FG004|Overall Study|Adverse Event|6|||
149186390|NCT00696657|538154287|FG005|Overall Study|Adverse Event|9|||
149186391|NCT00696657|538154288|FG006|Overall Study|Adverse Event|14|||
149186392|NCT00696657|538154289|FG007|Overall Study|Adverse Event|2|||
149186393|NCT00696657|538154290|FG008|Overall Study|Adverse Event|5|||
149186394|NCT02601001|538154293|FG000|Dosing Period 2|Adverse Event|0|||
149014276|NCT00806624|537532164|FG000|Overall Study|Death|0|||
149014277|NCT00806624|537532165|FG001|Overall Study|Death|1|||
149014278|NCT00806624|537532166|FG002|Overall Study|Death|1|||
149014279|NCT00806624|537532164|FG000|Overall Study|Lost to Follow-up|1|||
149014280|NCT00806624|537532165|FG001|Overall Study|Lost to Follow-up|0|||
149014281|NCT00806624|537532166|FG002|Overall Study|Lost to Follow-up|1|||
149014282|NCT00806624|537532164|FG000|Overall Study|Withdrawal by Subject|6|||
149014283|NCT00806624|537532165|FG001|Overall Study|Withdrawal by Subject|3|||
149014284|NCT00806624|537532166|FG002|Overall Study|Withdrawal by Subject|3|||
149014285|NCT00806624|537532164|FG000|Overall Study|discontinued before start of treatment|0|||
149014286|NCT00806624|537532165|FG001|Overall Study|discontinued before start of treatment|0|||
149014287|NCT00806624|537532166|FG002|Overall Study|discontinued before start of treatment|1|||
149014288|NCT01804673|537532171|FG000|Overall Study|Adverse Event|4|||
149014289|NCT01804673|537532171|FG000|Overall Study|Withdrawal by Subject|1|||
149014290|NCT01804673|537532171|FG000|Overall Study|Lack of Efficacy|9|||
149014291|NCT01804673|537532171|FG000|Overall Study|Change to Oral Therapy|37|||
149186395|NCT02601001|538154294|FG001|Dosing Period 2|Adverse Event|0|||
149186396|NCT02601001|538154295|FG002|Dosing Period 2|Adverse Event|0|||
149186397|NCT02601001|538154296|FG003|Dosing Period 2|Adverse Event|0|||
149186398|NCT02601001|538154297|FG004|Dosing Period 2|Adverse Event|0|||
149186399|NCT02601001|538154298|FG005|Dosing Period 2|Adverse Event|0|||
148807371|NCT00903968|536773228|FG000|Overall Study|Lack of Efficacy|0|||
149186400|NCT02601001|538154299|FG006|Dosing Period 2|Adverse Event|1|||
149186401|NCT01790438|538154300|FG000|Overall Study|Adverse Event|3|||
149186402|NCT01790438|538154301|FG001|Overall Study|Adverse Event|2|||
149186403|NCT01790438|538154300|FG000|Overall Study|Death|4|||
149186404|NCT01790438|538154301|FG001|Overall Study|Death|0|||
149186405|NCT01790438|538154300|FG000|Overall Study|Lost to Follow-up|5|||
148807372|NCT00903968|536773229|FG001|Overall Study|Lack of Efficacy|0|||
148807373|NCT00903968|536773230|FG002|Overall Study|Lack of Efficacy|0|||
148807374|NCT00903968|536773231|FG003|Overall Study|Lack of Efficacy|0|||
149014292|NCT01804673|537532171|FG000|Overall Study|No Further Therapy Required|84|||
149186406|NCT01790438|538154301|FG001|Overall Study|Lost to Follow-up|2|||
149186407|NCT01790438|538154300|FG000|Overall Study|Withdrawal by Subject|13|||
149186408|NCT01790438|538154301|FG001|Overall Study|Withdrawal by Subject|2|||
149186409|NCT01790438|538154300|FG000|Overall Study|Physician Decision|3|||
149186410|NCT01790438|538154301|FG001|Overall Study|Physician Decision|1|||
149186411|NCT01790438|538154300|FG000|Overall Study|Sponsor Decision|0|||
149186412|NCT01790438|538154301|FG001|Overall Study|Sponsor Decision|3|||
149014293|NCT01804673|537532171|FG000|Overall Study|Use of Prohibited Medication|1|||
149014294|NCT01804673|537532171|FG000|Overall Study|Other|4|||
148807375|NCT00903968|536773232|FG004|Overall Study|Lack of Efficacy|0|||
149186413|NCT01790438|538154300|FG000|Overall Study|Protocol Required Discontinuation|7|||
149186414|NCT01790438|538154301|FG001|Overall Study|Protocol Required Discontinuation|1|||
149186415|NCT02433210|538154309|FG000|Overall Study|Physician Decision|1|||
149186416|NCT02433210|538154310|FG001|Overall Study|Physician Decision|0|||
149186417|NCT02433210|538154311|FG002|Overall Study|Physician Decision|0|||
149186418|NCT02819310|538154312|FG000|Overall Study|Withdrawal by Subject|37|||
149186419|NCT02819310|538154312|FG000|Overall Study|Lost to Follow-up|16|||
149186420|NCT02819310|538154312|FG000|Overall Study|Adverse Event|13|||
149186421|NCT02819310|538154312|FG000|Overall Study|Lack of Efficacy|5|||
149186422|NCT02819310|538154312|FG000|Overall Study|Physician Decision|8|||
149186423|NCT02819310|538154312|FG000|Overall Study|Protocol Violation|30|||
149186424|NCT01793051|538154317|FG000|Overall Study|Withdrawal by Subject|6|||
149186425|NCT01793051|538154318|FG001|Overall Study|Withdrawal by Subject|4|||
149186426|NCT01793051|538154317|FG000|Overall Study|Adverse Event|0|||
149186427|NCT01793051|538154318|FG001|Overall Study|Adverse Event|2|||
149186428|NCT01793051|538154317|FG000|Overall Study|Too ill to continue|1|||
149186429|NCT01793051|538154318|FG001|Overall Study|Too ill to continue|0|||
149186430|NCT01793051|538154317|FG000|Overall Study|Switched chemo|1|||
149186431|NCT01793051|538154318|FG001|Overall Study|Switched chemo|1|||
149186432|NCT01793051|538154317|FG000|Overall Study|Lack of compliance|1|||
149186433|NCT01793051|538154318|FG001|Overall Study|Lack of compliance|0|||
149186434|NCT01793051|538154317|FG000|Overall Study|Requested to be removed from the study|1|||
149186435|NCT01793051|538154318|FG001|Overall Study|Requested to be removed from the study|1|||
149186436|NCT00059215|538154319|FG000|Overall Study|Adverse Event|5|||
149186437|NCT00059215|538154320|FG001|Overall Study|Adverse Event|5|||
149186438|NCT00059215|538154321|FG002|Overall Study|Adverse Event|9|||
149186439|NCT00059215|538154322|FG003|Overall Study|Adverse Event|9|||
149186440|NCT00059215|538154319|FG000|Overall Study|Death|0|||
149186441|NCT00059215|538154320|FG001|Overall Study|Death|0|||
149186442|NCT00059215|538154321|FG002|Overall Study|Death|3|||
149186443|NCT00059215|538154322|FG003|Overall Study|Death|0|||
149186444|NCT00059215|538154319|FG000|Overall Study|Lost to Follow-up|1|||
149186445|NCT00059215|538154320|FG001|Overall Study|Lost to Follow-up|2|||
149186446|NCT00059215|538154321|FG002|Overall Study|Lost to Follow-up|0|||
149186447|NCT00059215|538154322|FG003|Overall Study|Lost to Follow-up|0|||
149186448|NCT00059215|538154319|FG000|Overall Study|Withdrawal by Subject|4|||
149186449|NCT00059215|538154320|FG001|Overall Study|Withdrawal by Subject|4|||
149186450|NCT00059215|538154321|FG002|Overall Study|Withdrawal by Subject|1|||
149186451|NCT00059215|538154322|FG003|Overall Study|Withdrawal by Subject|3|||
149186452|NCT00059215|538154319|FG000|Overall Study|Protocol Violation|1|||
149186453|NCT00059215|538154320|FG001|Overall Study|Protocol Violation|0|||
149186454|NCT00059215|538154321|FG002|Overall Study|Protocol Violation|1|||
149186455|NCT00059215|538154322|FG003|Overall Study|Protocol Violation|0|||
149186456|NCT00059215|538154319|FG000|Overall Study|Protocol entry criteria not met|1|||
149186457|NCT00059215|538154320|FG001|Overall Study|Protocol entry criteria not met|1|||
149186458|NCT00059215|538154321|FG002|Overall Study|Protocol entry criteria not met|0|||
149186459|NCT00059215|538154322|FG003|Overall Study|Protocol entry criteria not met|2|||
149186460|NCT00059215|538154319|FG000|Overall Study|Physician Decision|1|||
149186461|NCT00059215|538154320|FG001|Overall Study|Physician Decision|2|||
149186462|NCT00059215|538154321|FG002|Overall Study|Physician Decision|1|||
149186463|NCT00059215|538154322|FG003|Overall Study|Physician Decision|1|||
149186464|NCT04494633|538154328|FG000|Overall Study|Lost to Follow-up|5|||
149186465|NCT04494633|538154329|FG001|Overall Study|Lost to Follow-up|3|||
149186466|NCT04494633|538154328|FG000|Overall Study|Protocol Violation|1|||
149186467|NCT04494633|538154329|FG001|Overall Study|Protocol Violation|1|||
149186468|NCT04907539|538154330|FG000|Overall Study|Consent withdrawn|1|||
149186469|NCT04907539|538154331|FG001|Overall Study|Consent withdrawn|0|||
149186470|NCT04907539|538154330|FG000|Overall Study|Death|14|||
149186471|NCT04907539|538154331|FG001|Overall Study|Death|3|||
149186472|NCT02311478|538154334|FG000|Overall Study|Withdrawal by Subject|1|||
149186473|NCT02311478|538154334|FG000|Overall Study|Lost to Follow-up|5|||
149186474|NCT02311478|538154334|FG000|Overall Study|Failed IUD Insertion|1|||
149186475|NCT03276936|538154335|FG000|Overall Study|Adverse Event|4|||
149186476|NCT03276936|538154336|FG001|Overall Study|Adverse Event|2|||
149186477|NCT03276936|538154335|FG000|Overall Study|Lost to Follow-up|16|||
149186478|NCT03276936|538154336|FG001|Overall Study|Lost to Follow-up|13|||
149186479|NCT03276936|538154335|FG000|Overall Study|Withdrawal by Subject|30|||
149186480|NCT03276936|538154336|FG001|Overall Study|Withdrawal by Subject|20|||
149186481|NCT03276936|538154335|FG000|Overall Study|Not mentioned|6|||
149186482|NCT03276936|538154336|FG001|Overall Study|Not mentioned|3|||
149186483|NCT03041116|538154337|FG000|Double-blind|Death|0|||
149186484|NCT03041116|538154338|FG001|Double-blind|Death|2|||
149186485|NCT03041116|538154337|FG000|Double-blind|Withdrawal by Subject|0|||
149186486|NCT03041116|538154338|FG001|Double-blind|Withdrawal by Subject|4|||
149186487|NCT03041116|538154337|FG000|Open-label|Death|1|||
149186488|NCT03041116|538154338|FG001|Open-label|Death|0|||
149186489|NCT03041116|538154337|FG000|Open-label|Termination of the study by Sponsor|39|||
149186490|NCT03041116|538154338|FG001|Open-label|Termination of the study by Sponsor|37|||
149186491|NCT03041116|538154337|FG000|Open-label|Withdrawal by Subject|1|||
149186492|NCT03041116|538154338|FG001|Open-label|Withdrawal by Subject|0|||
149186493|NCT00943319|538154339|FG000|Overall Study|Death|1|||
149186494|NCT02043301|538154340|FG000|Overall Study|Discontinued|0|||
149186495|NCT02043301|538154341|FG001|Overall Study|Discontinued|1|||
149186496|NCT02043301|538154342|FG002|Overall Study|Discontinued|0|||
149186497|NCT02023164|538154343|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
149186498|NCT02023164|538154344|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
149186499|NCT02653976|538154345|FG000|Overall Study|Withdrawal by Subject|5|||
149186500|NCT02653976|538154345|FG000|Overall Study|Death|4|||
149186501|NCT02436577|538154346|FG000|Overall Study|Protocol Deviation|0|||
149186502|NCT02436577|538154347|FG001|Overall Study|Protocol Deviation|1|||
149186503|NCT02436577|538154348|FG002|Overall Study|Protocol Deviation|0|||
149186504|NCT02436577|538154349|FG003|Overall Study|Protocol Deviation|0|||
149186505|NCT02436577|538154350|FG004|Overall Study|Protocol Deviation|0|||
149186506|NCT02436577|538154351|FG005|Overall Study|Protocol Deviation|0|||
149186507|NCT03703375|538154352|FG000|Randomization Period|Withdrawal by Subject|0|||
149186508|NCT03703375|538154353|FG001|Randomization Period|Withdrawal by Subject|0|||
149186509|NCT03703375|538154354|FG002|Randomization Period|Withdrawal by Subject|0|||
149186510|NCT03703375|538154355|FG003|Randomization Period|Withdrawal by Subject|1|||
149186511|NCT03703375|538154352|FG000|Randomization Period|Completed safety run-in treatment|7|||
149186512|NCT03703375|538154353|FG001|Randomization Period|Completed safety run-in treatment|0|||
149186513|NCT03703375|538154354|FG002|Randomization Period|Completed safety run-in treatment|0|||
149186514|NCT03703375|538154355|FG003|Randomization Period|Completed safety run-in treatment|0|||
149186515|NCT03703375|538154352|FG000|Treatment Period|Other Reasons|0|||
149186516|NCT03703375|538154353|FG001|Treatment Period|Other Reasons|1|||
149186517|NCT03703375|538154354|FG002|Treatment Period|Other Reasons|0|||
149186518|NCT03703375|538154355|FG003|Treatment Period|Other Reasons|3|||
149186519|NCT03703375|538154352|FG000|Treatment Period|Consent Withdrawal|0|||
149186520|NCT03703375|538154353|FG001|Treatment Period|Consent Withdrawal|0|||
149186521|NCT03703375|538154354|FG002|Treatment Period|Consent Withdrawal|0|||
149186522|NCT03703375|538154355|FG003|Treatment Period|Consent Withdrawal|1|||
149186523|NCT03703375|538154352|FG000|Treatment Period|Death|1|||
149186524|NCT03703375|538154353|FG001|Treatment Period|Death|0|||
149186525|NCT03703375|538154354|FG002|Treatment Period|Death|1|||
149186526|NCT03703375|538154355|FG003|Treatment Period|Death|2|||
149186527|NCT03703375|538154352|FG000|Treatment Period|Toxicity of Study Treatment|2|||
149186528|NCT03703375|538154353|FG001|Treatment Period|Toxicity of Study Treatment|0|||
149186529|NCT03703375|538154354|FG002|Treatment Period|Toxicity of Study Treatment|4|||
149186530|NCT03703375|538154355|FG003|Treatment Period|Toxicity of Study Treatment|1|||
149186531|NCT03703375|538154352|FG000|Treatment Period|Progression|32|||
149186532|NCT03703375|538154353|FG001|Treatment Period|Progression|1|||
149186533|NCT03703375|538154354|FG002|Treatment Period|Progression|7|||
149186534|NCT03703375|538154355|FG003|Treatment Period|Progression|11|||
149186535|NCT03703375|538154352|FG000|Treatment Period|Completed treatment|7|||
149186536|NCT03703375|538154353|FG001|Treatment Period|Completed treatment|2|||
149186537|NCT03703375|538154354|FG002|Treatment Period|Completed treatment|0|||
148807376|NCT00903968|536773233|FG005|Overall Study|Lack of Efficacy|0|||
149186538|NCT03703375|538154355|FG003|Treatment Period|Completed treatment|0|||
149186539|NCT01675011|538154356|FG000|Overall Study|Trial terminated by Sponsor|3|||
149186540|NCT01675011|538154357|FG001|Overall Study|Trial terminated by Sponsor|1|||
149186541|NCT00615290|538154358|FG000|Overall Study|Adverse Event|2|||
149186542|NCT00615290|538154358|FG000|Overall Study|Lost to Follow-up|3|||
149186543|NCT00615290|538154358|FG000|Overall Study|Withdrawal by Subject|1|||
149186544|NCT00615290|538154358|FG000|Overall Study|Other|2|||
149186545|NCT02849990|538154359|FG000|Overall Study|Adverse Event|1|||
149186546|NCT02849990|538154359|FG000|Overall Study|Withdrawal by Subject|1|||
149186547|NCT02531373|538154360|FG000|Overall Study|Lack of Efficacy|0|||
149186548|NCT02531373|538154361|FG001|Overall Study|Lack of Efficacy|0|||
149186549|NCT02531373|538154362|FG002|Overall Study|Lack of Efficacy|0|||
149186550|NCT02531373|538154363|FG003|Overall Study|Lack of Efficacy|0|||
149186551|NCT02531373|538154364|FG004|Overall Study|Lack of Efficacy|3|||
149186552|NCT02531373|538154365|FG005|Overall Study|Lack of Efficacy|2|||
149186553|NCT02531373|538154366|FG006|Overall Study|Lack of Efficacy|4|||
149186554|NCT02531373|538154367|FG007|Overall Study|Lack of Efficacy|8|||
149186555|NCT02531373|538154368|FG008|Overall Study|Lack of Efficacy|5|||
149186556|NCT02531373|538154360|FG000|Overall Study|Lost to Follow-up|0|||
149186557|NCT02531373|538154361|FG001|Overall Study|Lost to Follow-up|0|||
149186558|NCT02531373|538154362|FG002|Overall Study|Lost to Follow-up|0|||
149186559|NCT02531373|538154363|FG003|Overall Study|Lost to Follow-up|0|||
149186560|NCT02531373|538154364|FG004|Overall Study|Lost to Follow-up|0|||
149186561|NCT02531373|538154365|FG005|Overall Study|Lost to Follow-up|2|||
149186562|NCT02531373|538154366|FG006|Overall Study|Lost to Follow-up|2|||
148933438|NCT00923936|537242217|FG000|Overall Study|Adverse Event|2|||
148933439|NCT00923936|537242218|FG001|Overall Study|Adverse Event|1|||
148933440|NCT00923936|537242217|FG000|Overall Study|Lost to follow up|2|||
148933441|NCT00923936|537242218|FG001|Overall Study|Lost to follow up|0|||
148933442|NCT00923936|537242217|FG000|Overall Study|Continuing in follow up period|2|||
148933443|NCT00923936|537242218|FG001|Overall Study|Continuing in follow up period|1|||
149186563|NCT02531373|538154367|FG007|Overall Study|Lost to Follow-up|0|||
149186564|NCT02531373|538154368|FG008|Overall Study|Lost to Follow-up|0|||
149186565|NCT02531373|538154360|FG000|Overall Study|Physician Decision|0|||
149186566|NCT02531373|538154361|FG001|Overall Study|Physician Decision|0|||
149186567|NCT02531373|538154362|FG002|Overall Study|Physician Decision|0|||
149186568|NCT02531373|538154363|FG003|Overall Study|Physician Decision|0|||
149186569|NCT02531373|538154364|FG004|Overall Study|Physician Decision|2|||
149186570|NCT02531373|538154365|FG005|Overall Study|Physician Decision|1|||
149186571|NCT02531373|538154366|FG006|Overall Study|Physician Decision|0|||
149186572|NCT02531373|538154367|FG007|Overall Study|Physician Decision|0|||
149186573|NCT02531373|538154368|FG008|Overall Study|Physician Decision|0|||
149186574|NCT02531373|538154360|FG000|Overall Study|Protocol Violation|0|||
149186575|NCT02531373|538154361|FG001|Overall Study|Protocol Violation|0|||
149186576|NCT02531373|538154362|FG002|Overall Study|Protocol Violation|0|||
149186577|NCT02531373|538154363|FG003|Overall Study|Protocol Violation|0|||
149186578|NCT02531373|538154364|FG004|Overall Study|Protocol Violation|0|||
149186579|NCT02531373|538154365|FG005|Overall Study|Protocol Violation|1|||
149186580|NCT02531373|538154366|FG006|Overall Study|Protocol Violation|1|||
149186581|NCT02531373|538154367|FG007|Overall Study|Protocol Violation|0|||
149186582|NCT02531373|538154368|FG008|Overall Study|Protocol Violation|1|||
149186583|NCT02531373|538154360|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149186584|NCT02531373|538154361|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149186585|NCT02531373|538154362|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149186586|NCT02531373|538154363|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149186587|NCT02531373|538154364|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149186588|NCT02531373|538154365|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
149186589|NCT02531373|538154366|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
149186590|NCT02531373|538154367|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
149186591|NCT02531373|538154368|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
149186592|NCT02531373|538154360|FG000|Overall Study|Withdrawal by Subject|0|||
149186593|NCT02531373|538154361|FG001|Overall Study|Withdrawal by Subject|0|||
149186594|NCT02531373|538154362|FG002|Overall Study|Withdrawal by Subject|0|||
149186595|NCT02531373|538154363|FG003|Overall Study|Withdrawal by Subject|0|||
149186596|NCT02531373|538154364|FG004|Overall Study|Withdrawal by Subject|3|||
149186597|NCT02531373|538154365|FG005|Overall Study|Withdrawal by Subject|0|||
149186598|NCT02531373|538154366|FG006|Overall Study|Withdrawal by Subject|0|||
149186599|NCT02531373|538154367|FG007|Overall Study|Withdrawal by Subject|0|||
149186600|NCT02531373|538154368|FG008|Overall Study|Withdrawal by Subject|0|||
149186601|NCT01996319|538154370|FG000|Overall Study|Protocol Violation|1|||
149186602|NCT01996319|538154371|FG001|Overall Study|Protocol Violation|0|||
149186603|NCT01996319|538154370|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
149186604|NCT01996319|538154371|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
149186605|NCT01996319|538154370|FG000|Overall Study|Adverse Event|2|||
149186606|NCT01996319|538154371|FG001|Overall Study|Adverse Event|2|||
149186607|NCT00637273|538154372|FG000|Overall Study|Adverse Event|11|||
149186608|NCT00637273|538154373|FG001|Overall Study|Adverse Event|5|||
149186609|NCT00637273|538154374|FG002|Overall Study|Adverse Event|7|||
149186610|NCT00637273|538154372|FG000|Overall Study|Lost to Follow-up|8|||
149186611|NCT00637273|538154373|FG001|Overall Study|Lost to Follow-up|9|||
149186612|NCT00637273|538154374|FG002|Overall Study|Lost to Follow-up|13|||
149186613|NCT00637273|538154372|FG000|Overall Study|Protocol Violation|2|||
149186614|NCT00637273|538154373|FG001|Overall Study|Protocol Violation|4|||
149186615|NCT00637273|538154374|FG002|Overall Study|Protocol Violation|1|||
149186616|NCT00637273|538154372|FG000|Overall Study|Withdrawal of Consent|18|||
149186617|NCT00637273|538154373|FG001|Overall Study|Withdrawal of Consent|6|||
149186618|NCT00637273|538154374|FG002|Overall Study|Withdrawal of Consent|18|||
149186619|NCT00637273|538154372|FG000|Overall Study|Investigator Decision|1|||
149186620|NCT00637273|538154373|FG001|Overall Study|Investigator Decision|3|||
149186621|NCT00637273|538154374|FG002|Overall Study|Investigator Decision|1|||
149186622|NCT00637273|538154372|FG000|Overall Study|Administrative|2|||
149186623|NCT00637273|538154373|FG001|Overall Study|Administrative|0|||
149186624|NCT00637273|538154374|FG002|Overall Study|Administrative|0|||
149186625|NCT00637273|538154372|FG000|Overall Study|Loss of Glucose Control|1|||
149186626|NCT00637273|538154373|FG001|Overall Study|Loss of Glucose Control|1|||
149186627|NCT00637273|538154374|FG002|Overall Study|Loss of Glucose Control|1|||
149186628|NCT01702363|538154376|FG000|Overall Study|Adverse Event|14|||
149186629|NCT01702363|538154376|FG000|Overall Study|Lack of Efficacy|4|||
149186630|NCT01702363|538154376|FG000|Overall Study|Withdrawal by Subject|2|||
149186631|NCT00002663|538154377|FG000|Overall Study|Death|4|||
149186632|NCT00002663|538154378|FG001|Overall Study|Death|1|||
149186633|NCT00002663|538154379|FG002|Overall Study|Death|1|||
149186634|NCT00002663|538154380|FG003|Overall Study|Death|0|||
149186635|NCT00002663|538154381|FG004|Overall Study|Death|0|||
149186636|NCT00002663|538154382|FG005|Overall Study|Death|13|||
149186637|NCT00002663|538154383|FG006|Overall Study|Death|0|||
149186638|NCT00002663|538154384|FG007|Overall Study|Death|1|||
149186639|NCT00002663|538154385|FG008|Overall Study|Death|1|||
149186640|NCT00002663|538154386|FG009|Overall Study|Death|1|||
149186641|NCT00002663|538154377|FG000|Overall Study|Lost to Follow-up|3|||
149186642|NCT00002663|538154378|FG001|Overall Study|Lost to Follow-up|0|||
149186643|NCT00002663|538154379|FG002|Overall Study|Lost to Follow-up|0|||
149186644|NCT00002663|538154380|FG003|Overall Study|Lost to Follow-up|1|||
149186645|NCT00002663|538154381|FG004|Overall Study|Lost to Follow-up|0|||
149186646|NCT00002663|538154382|FG005|Overall Study|Lost to Follow-up|1|||
149186647|NCT00002663|538154383|FG006|Overall Study|Lost to Follow-up|0|||
149186648|NCT00002663|538154384|FG007|Overall Study|Lost to Follow-up|0|||
149186649|NCT00002663|538154385|FG008|Overall Study|Lost to Follow-up|0|||
149186650|NCT00002663|538154386|FG009|Overall Study|Lost to Follow-up|0|||
149186651|NCT00002663|538154377|FG000|Overall Study|Other|0|||
149186652|NCT00002663|538154378|FG001|Overall Study|Other|1|||
149186653|NCT00002663|538154379|FG002|Overall Study|Other|0|||
149186654|NCT00002663|538154380|FG003|Overall Study|Other|0|||
149186655|NCT00002663|538154381|FG004|Overall Study|Other|0|||
149186656|NCT00002663|538154382|FG005|Overall Study|Other|1|||
149186657|NCT00002663|538154383|FG006|Overall Study|Other|1|||
149186658|NCT00002663|538154384|FG007|Overall Study|Other|0|||
149186659|NCT00002663|538154385|FG008|Overall Study|Other|0|||
149186660|NCT00002663|538154386|FG009|Overall Study|Other|0|||
149186661|NCT00002663|538154377|FG000|Overall Study|Physician Decision|0|||
149186662|NCT00002663|538154378|FG001|Overall Study|Physician Decision|0|||
149186663|NCT00002663|538154379|FG002|Overall Study|Physician Decision|0|||
149186664|NCT00002663|538154380|FG003|Overall Study|Physician Decision|0|||
149186665|NCT00002663|538154381|FG004|Overall Study|Physician Decision|1|||
149186666|NCT00002663|538154382|FG005|Overall Study|Physician Decision|0|||
149186667|NCT00002663|538154383|FG006|Overall Study|Physician Decision|0|||
149186668|NCT00002663|538154384|FG007|Overall Study|Physician Decision|0|||
149186669|NCT00002663|538154385|FG008|Overall Study|Physician Decision|1|||
149186670|NCT00002663|538154386|FG009|Overall Study|Physician Decision|1|||
149186671|NCT00002663|538154377|FG000|Overall Study|Adverse Event|0|||
149186672|NCT00002663|538154378|FG001|Overall Study|Adverse Event|0|||
149186673|NCT00002663|538154379|FG002|Overall Study|Adverse Event|0|||
149186674|NCT00002663|538154380|FG003|Overall Study|Adverse Event|1|||
149186675|NCT00002663|538154381|FG004|Overall Study|Adverse Event|0|||
149186676|NCT00002663|538154382|FG005|Overall Study|Adverse Event|0|||
149186677|NCT00002663|538154383|FG006|Overall Study|Adverse Event|0|||
149186678|NCT00002663|538154384|FG007|Overall Study|Adverse Event|1|||
149186679|NCT00002663|538154385|FG008|Overall Study|Adverse Event|0|||
149186680|NCT00002663|538154386|FG009|Overall Study|Adverse Event|0|||
149186681|NCT00525148|538154390|FG000|Overall Study|Other Adverse Event|3|||
149186682|NCT00525148|538154391|FG001|Overall Study|Other Adverse Event|5|||
149186683|NCT00525148|538154392|FG002|Overall Study|Other Adverse Event|1|||
149186684|NCT00525148|538154393|FG003|Overall Study|Other Adverse Event|8|||
149186685|NCT00525148|538154390|FG000|Overall Study|Progressive disease|18|||
149186686|NCT00525148|538154391|FG001|Overall Study|Progressive disease|30|||
149186687|NCT00525148|538154392|FG002|Overall Study|Progressive disease|6|||
149186688|NCT00525148|538154393|FG003|Overall Study|Progressive disease|49|||
149186689|NCT00525148|538154390|FG000|Overall Study|Refused continuation of study medication|0|||
149186690|NCT00525148|538154391|FG001|Overall Study|Refused continuation of study medication|2|||
149186691|NCT00525148|538154392|FG002|Overall Study|Refused continuation of study medication|0|||
149186692|NCT00525148|538154393|FG003|Overall Study|Refused continuation of study medication|1|||
149186693|NCT00525148|538154390|FG000|Overall Study|Other than stated|2|||
149186694|NCT00525148|538154391|FG001|Overall Study|Other than stated|1|||
149186695|NCT00525148|538154392|FG002|Overall Study|Other than stated|0|||
149186696|NCT00525148|538154393|FG003|Overall Study|Other than stated|3|||
149186697|NCT03015610|538154394|FG000|Overall Study|Lost to Follow-up|1|||
148807377|NCT00903968|536773234|FG006|Overall Study|Lack of Efficacy|0|||
148807378|NCT00903968|536773235|FG007|Overall Study|Lack of Efficacy|3|||
149186698|NCT03015610|538154395|FG001|Overall Study|Lost to Follow-up|5|||
149186699|NCT01603641|538154396|FG000|Overall Study|Did not Receive Treatment|3|||
149186700|NCT01603641|538154396|FG000|Overall Study|Adverse Event|1|||
149186701|NCT01603641|538154396|FG000|Overall Study|Lack of Efficacy|1|||
149186702|NCT01603641|538154396|FG000|Overall Study|Lost to Follow-up|6|||
148807379|NCT00089648|536773236|FG000|Overall Study|Adverse Event|7|||
149186703|NCT01603641|538154396|FG000|Overall Study|Personal Reasons|18|||
149186704|NCT01603641|538154396|FG000|Overall Study|Other Miscellaneous Reasons|6|||
149186705|NCT00570739|538154397|FG000|Overall Study|Adverse Event|8|||
149186706|NCT00570739|538154398|FG001|Overall Study|Adverse Event|6|||
149186707|NCT00570739|538154399|FG002|Overall Study|Adverse Event|2|||
149186708|NCT00570739|538154400|FG003|Overall Study|Adverse Event|2|||
149186709|NCT00570739|538154397|FG000|Overall Study|Lost to Follow-up|4|||
149186710|NCT00570739|538154398|FG001|Overall Study|Lost to Follow-up|5|||
149186711|NCT00570739|538154399|FG002|Overall Study|Lost to Follow-up|4|||
149186712|NCT00570739|538154400|FG003|Overall Study|Lost to Follow-up|1|||
149186713|NCT00570739|538154397|FG000|Overall Study|Physician Decision|1|||
149186714|NCT00570739|538154398|FG001|Overall Study|Physician Decision|1|||
149186715|NCT00570739|538154399|FG002|Overall Study|Physician Decision|0|||
149186716|NCT00570739|538154400|FG003|Overall Study|Physician Decision|0|||
149186717|NCT00570739|538154397|FG000|Overall Study|Withdrawal by Subject|7|||
149186718|NCT00570739|538154398|FG001|Overall Study|Withdrawal by Subject|7|||
149186719|NCT00570739|538154399|FG002|Overall Study|Withdrawal by Subject|3|||
149186720|NCT00570739|538154400|FG003|Overall Study|Withdrawal by Subject|5|||
149186721|NCT00570739|538154397|FG000|Overall Study|Required restricted medication|0|||
149186722|NCT00570739|538154398|FG001|Overall Study|Required restricted medication|0|||
149186723|NCT00570739|538154399|FG002|Overall Study|Required restricted medication|1|||
149186724|NCT00570739|538154400|FG003|Overall Study|Required restricted medication|0|||
149186725|NCT00570739|538154397|FG000|Overall Study|Met discontinuation criteria|1|||
149186726|NCT00570739|538154398|FG001|Overall Study|Met discontinuation criteria|0|||
149186727|NCT00570739|538154399|FG002|Overall Study|Met discontinuation criteria|1|||
149186728|NCT00570739|538154400|FG003|Overall Study|Met discontinuation criteria|1|||
149186729|NCT00570739|538154397|FG000|Overall Study|Other|0|||
149186730|NCT00570739|538154398|FG001|Overall Study|Other|2|||
149186731|NCT00570739|538154399|FG002|Overall Study|Other|5|||
149186732|NCT00570739|538154400|FG003|Overall Study|Other|3|||
149186733|NCT01905397|538154405|FG000|Overall Study|Death|0|||
149186734|NCT01905397|538154406|FG001|Overall Study|Death|1|||
149186735|NCT01905397|538154405|FG000|Overall Study|Withdrawal by Subject|2|||
149186736|NCT01905397|538154406|FG001|Overall Study|Withdrawal by Subject|0|||
149186737|NCT01905397|538154405|FG000|Overall Study|Surgery canceled/aborted|9|||
149186738|NCT01905397|538154406|FG001|Overall Study|Surgery canceled/aborted|5|||
149186739|NCT01905397|538154405|FG000|Overall Study|Incision < 7 cm|2|||
149186740|NCT01905397|538154406|FG001|Overall Study|Incision < 7 cm|0|||
149186741|NCT01905397|538154405|FG000|Overall Study|Wrong treatment|1|||
149186742|NCT01905397|538154406|FG001|Overall Study|Wrong treatment|1|||
149186743|NCT01905397|538154405|FG000|Overall Study|Device not applied|3|||
149186744|NCT01905397|538154406|FG001|Overall Study|Device not applied|0|||
149186745|NCT01905397|538154405|FG000|Overall Study|Dressing not applied in operating room|1|||
149186746|NCT01905397|538154406|FG001|Overall Study|Dressing not applied in operating room|0|||
149186747|NCT01905397|538154405|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
149186748|NCT01905397|538154406|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
149186749|NCT01921270|538154407|FG000|Overall Study|Withdrawal by Subject|1|||
149186750|NCT00844428|538154408|FG000|Screening Period|Screen Failure|3|||
149186751|NCT00844428|538154408|FG000|Extension Treatment Period|Death|1|||
149186752|NCT00844428|538154408|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
149186753|NCT02680847|538154409|FG000|Overall Study|Other|2|||
149186754|NCT02680847|538154410|FG001|Overall Study|Other|0|||
149186755|NCT02680847|538154411|FG002|Overall Study|Other|0|||
149186756|NCT02680847|538154409|FG000|Overall Study|No longer met eligibility criteria|2|||
149186757|NCT02680847|538154410|FG001|Overall Study|No longer met eligibility criteria|2|||
149186758|NCT02680847|538154411|FG002|Overall Study|No longer met eligibility criteria|0|||
149186759|NCT02680847|538154409|FG000|Overall Study|Unwilling to participate in study|1|||
149186760|NCT02680847|538154410|FG001|Overall Study|Unwilling to participate in study|1|||
149186761|NCT02680847|538154411|FG002|Overall Study|Unwilling to participate in study|0|||
149186762|NCT02680847|538154409|FG000|Overall Study|Lack of Efficacy|0|||
149186763|NCT02680847|538154410|FG001|Overall Study|Lack of Efficacy|0|||
149186764|NCT02680847|538154411|FG002|Overall Study|Lack of Efficacy|2|||
149186765|NCT02680847|538154409|FG000|Overall Study|Adverse Event|0|||
149186766|NCT02680847|538154410|FG001|Overall Study|Adverse Event|0|||
149186767|NCT02680847|538154411|FG002|Overall Study|Adverse Event|1|||
149186768|NCT01096550|538154412|FG000|Overall Study|discontinued site|10|||
149186769|NCT01096550|538154413|FG001|Overall Study|discontinued site|11|||
149186770|NCT01096550|538154412|FG000|Overall Study|non-regular treatment track at clinic|1|||
149186771|NCT01096550|538154413|FG001|Overall Study|non-regular treatment track at clinic|1|||
149186772|NCT01096550|538154412|FG000|Overall Study|clinic readmission|1|||
149186773|NCT01096550|538154413|FG001|Overall Study|clinic readmission|1|||
149186774|NCT01096550|538154412|FG000|Overall Study|Withdrawal by Subject|0|||
149186775|NCT01096550|538154413|FG001|Overall Study|Withdrawal by Subject|1|||
149186776|NCT01096550|538154412|FG000|Overall Study|non-African American participant|13|||
149186777|NCT01096550|538154413|FG001|Overall Study|non-African American participant|6|||
149186778|NCT01096550|538154412|FG000|Overall Study|Lost to Follow-up|12|||
149186779|NCT01096550|538154413|FG001|Overall Study|Lost to Follow-up|9|||
149186780|NCT01345786|538154416|FG000|Overall Study|Adverse Event|0|||
148933444|NCT00620464|537242219|FG000|Overall Study|Adverse Event|15|||
148933445|NCT00620464|537242220|FG001|Overall Study|Adverse Event|17|||
149186781|NCT01345786|538154417|FG001|Overall Study|Adverse Event|1|||
149186782|NCT01345786|538154418|FG002|Overall Study|Adverse Event|3|||
149186783|NCT01345786|538154419|FG003|Overall Study|Adverse Event|1|||
149186784|NCT01345786|538154416|FG000|Overall Study|Subject withdrew consent|2|||
149186785|NCT01345786|538154417|FG001|Overall Study|Subject withdrew consent|2|||
149186786|NCT01345786|538154418|FG002|Overall Study|Subject withdrew consent|1|||
149186787|NCT01345786|538154419|FG003|Overall Study|Subject withdrew consent|0|||
149186788|NCT01345786|538154416|FG000|Overall Study|Noncompliance with protocol|1|||
149186789|NCT01345786|538154417|FG001|Overall Study|Noncompliance with protocol|0|||
149186790|NCT01345786|538154418|FG002|Overall Study|Noncompliance with protocol|1|||
149186791|NCT01345786|538154419|FG003|Overall Study|Noncompliance with protocol|0|||
149186792|NCT01345786|538154416|FG000|Overall Study|Administrative|3|||
149186793|NCT01345786|538154417|FG001|Overall Study|Administrative|5|||
149186794|NCT01345786|538154418|FG002|Overall Study|Administrative|0|||
149186795|NCT01345786|538154419|FG003|Overall Study|Administrative|0|||
149186796|NCT01345786|538154416|FG000|Overall Study|Lost to Follow-up|0|||
149186797|NCT01345786|538154417|FG001|Overall Study|Lost to Follow-up|0|||
149186798|NCT01345786|538154418|FG002|Overall Study|Lost to Follow-up|0|||
149186799|NCT01345786|538154419|FG003|Overall Study|Lost to Follow-up|2|||
149186800|NCT01605396|538154426|FG000|Overall Study|Adverse Event|5|||
149186801|NCT01605396|538154427|FG001|Overall Study|Adverse Event|3|||
149186802|NCT01605396|538154426|FG000|Overall Study|Lost to Follow-up|1|||
149186803|NCT01605396|538154427|FG001|Overall Study|Lost to Follow-up|0|||
149186804|NCT01605396|538154426|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149186805|NCT01605396|538154427|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149186806|NCT01605396|538154426|FG000|Overall Study|Physician Decision|2|||
149186807|NCT01605396|538154427|FG001|Overall Study|Physician Decision|2|||
149186808|NCT01605396|538154426|FG000|Overall Study|Progressive Disease|23|||
149186809|NCT01605396|538154427|FG001|Overall Study|Progressive Disease|27|||
148933446|NCT00620464|537242219|FG000|Overall Study|Lost to Follow-up|1|||
148933447|NCT00620464|537242220|FG001|Overall Study|Lost to Follow-up|1|||
148933448|NCT00620464|537242219|FG000|Overall Study|Planning Pregnancy|1|||
148933449|NCT00620464|537242220|FG001|Overall Study|Planning Pregnancy|4|||
148933450|NCT00620464|537242219|FG000|Overall Study|Personal|2|||
148933451|NCT00620464|537242220|FG001|Overall Study|Personal|2|||
148933452|NCT00620464|537242219|FG000|Overall Study|Used prohibited medication|1|||
148933453|NCT00620464|537242220|FG001|Overall Study|Used prohibited medication|0|||
148933454|NCT02038452|537242221|FG000|Overall Study|Withdrawal by Subject|7|||
148933455|NCT02038452|537242222|FG001|Overall Study|Withdrawal by Subject|9|||
148933456|NCT02038452|537242221|FG000|Overall Study|Lost to Follow-up|31|||
148933457|NCT02038452|537242222|FG001|Overall Study|Lost to Follow-up|28|||
148933458|NCT03139279|537242223|FG000|Overall Study|Physician Decision|2|||
148933459|NCT03139279|537242224|FG001|Overall Study|Physician Decision|0|||
148933460|NCT03139279|537242223|FG000|Overall Study|Protocol Violation|5|||
148933461|NCT03139279|537242224|FG001|Overall Study|Protocol Violation|4|||
148933462|NCT03139279|537242223|FG000|Overall Study|Withdrawal by Subject|0|||
148933463|NCT03139279|537242224|FG001|Overall Study|Withdrawal by Subject|2|||
148933464|NCT05394350|537242225|FG000|Overall Study|Death|2|||
148933465|NCT05394350|537242226|FG001|Overall Study|Death|2|||
148933466|NCT05394350|537242227|FG002|Overall Study|Death|4|||
148933467|NCT05394350|537242228|FG003|Overall Study|Death|0|||
148933468|NCT05394350|537242229|FG004|Overall Study|Death|1|||
149186810|NCT01605396|538154426|FG000|Overall Study|Withdrawal by Subject|4|||
148933469|NCT05394350|537242230|FG005|Overall Study|Death|0|||
148933470|NCT05394350|537242225|FG000|Overall Study|Study terminated by sponsor|1|||
148933471|NCT05394350|537242226|FG001|Overall Study|Study terminated by sponsor|1|||
148933472|NCT05394350|537242227|FG002|Overall Study|Study terminated by sponsor|7|||
149186811|NCT01605396|538154427|FG001|Overall Study|Withdrawal by Subject|2|||
149186812|NCT01605396|538154426|FG000|Overall Study|Transfer Off Study|4|||
149186813|NCT01605396|538154427|FG001|Overall Study|Transfer Off Study|5|||
149186814|NCT04598165|538154428|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
149186815|NCT04598165|538154429|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
149186816|NCT04598165|538154428|FG000|Completed 6-week Follow-up|Death|2|||
149186817|NCT04598165|538154429|FG001|Completed 6-week Follow-up|Death|1|||
149186818|NCT04598165|538154428|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
149186819|NCT04598165|538154429|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
149186820|NCT04598165|538154428|FG000|Completed 6-week Follow-up|Ineligible|4|||
149186821|NCT04598165|538154429|FG001|Completed 6-week Follow-up|Ineligible|3|||
149186822|NCT04598165|538154428|FG000|Completed 6-week Follow-up|Partner refusal|0|||
149186823|NCT04598165|538154429|FG001|Completed 6-week Follow-up|Partner refusal|1|||
149186824|NCT04598165|538154428|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
149186825|NCT04598165|538154429|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
149186826|NCT01323673|538154431|FG000|Overall Study|Adverse Event|0|||
149186827|NCT01323673|538154432|FG001|Overall Study|Adverse Event|1|||
149186828|NCT01323673|538154431|FG000|Overall Study|Lost to Follow-up|0|||
149186829|NCT01323673|538154432|FG001|Overall Study|Lost to Follow-up|1|||
149186830|NCT01323673|538154431|FG000|Overall Study|Protocol Violation|1|||
149186831|NCT01323673|538154432|FG001|Overall Study|Protocol Violation|0|||
149186832|NCT01323673|538154431|FG000|Overall Study|Withdrawal by Subject|2|||
149186833|NCT01323673|538154432|FG001|Overall Study|Withdrawal by Subject|3|||
149186834|NCT04400318|538156538|FG000|Overall Study|Adverse Event|1|||
149186835|NCT04400318|538156539|FG001|Overall Study|Adverse Event|0|||
149186836|NCT04400318|538156538|FG000|Overall Study|Withdrawal by Subject|1|||
149186837|NCT04400318|538156539|FG001|Overall Study|Withdrawal by Subject|1|||
149186838|NCT04400318|538156538|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
149186839|NCT04400318|538156539|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
149186840|NCT00953043|538156545|FG000|Overall Study|Withdrawal by Subject|4|||
149186841|NCT00953043|538156546|FG001|Overall Study|Withdrawal by Subject|0|||
149186842|NCT00953043|538156545|FG000|Overall Study|Physician Decision|0|||
149186843|NCT00953043|538156546|FG001|Overall Study|Physician Decision|2|||
149186844|NCT00747617|538156548|FG000|Overall Study|Lost to Follow-up|3|||
149186845|NCT00747617|538156549|FG001|Overall Study|Lost to Follow-up|1|||
149186846|NCT03509207|538156550|FG000|Overall Study|Death|2|||
149186847|NCT04657016|538156551|FG000|Overall Study|Adverse Event|2|||
149186848|NCT04657016|538156552|FG001|Overall Study|Adverse Event|4|||
149186849|NCT04657016|538156551|FG000|Overall Study|Death|1|||
149186850|NCT04657016|538156552|FG001|Overall Study|Death|1|||
149186851|NCT04657016|538156551|FG000|Overall Study|Lost to Follow-up|24|||
149186852|NCT04657016|538156552|FG001|Overall Study|Lost to Follow-up|12|||
149186853|NCT04657016|538156551|FG000|Overall Study|Physician Decision|1|||
149186854|NCT04657016|538156552|FG001|Overall Study|Physician Decision|2|||
149186855|NCT04657016|538156551|FG000|Overall Study|Pregnancy|2|||
149186856|NCT04657016|538156552|FG001|Overall Study|Pregnancy|2|||
149186857|NCT04657016|538156551|FG000|Overall Study|Protocol Deviation|1|||
149186858|NCT04657016|538156552|FG001|Overall Study|Protocol Deviation|0|||
149186859|NCT04657016|538156551|FG000|Overall Study|Withdrawal by Subject|28|||
149186860|NCT04657016|538156552|FG001|Overall Study|Withdrawal by Subject|14|||
149186861|NCT04657016|538156551|FG000|Overall Study|Other - as reported by the investigator|6|||
149186862|NCT04657016|538156552|FG001|Overall Study|Other - as reported by the investigator|0|||
149186863|NCT00523341|538156558|FG000|Overall Study|Withdrawal by Subject|399|||
149186864|NCT00523341|538156559|FG001|Overall Study|Withdrawal by Subject|427|||
149186865|NCT00523341|538156558|FG000|Overall Study|Other|181|||
149186866|NCT00523341|538156559|FG001|Overall Study|Other|198|||
149186867|NCT00523341|538156558|FG000|Overall Study|Adverse Event|122|||
149186868|NCT00523341|538156559|FG001|Overall Study|Adverse Event|155|||
149186869|NCT00523341|538156558|FG000|Overall Study|Death|101|||
149186870|NCT00523341|538156559|FG001|Overall Study|Death|110|||
149186871|NCT00523341|538156558|FG000|Overall Study|Lost to Follow-up|73|||
149186872|NCT00523341|538156559|FG001|Overall Study|Lost to Follow-up|61|||
149186873|NCT00523341|538156558|FG000|Overall Study|Non-compliance|20|||
149186874|NCT00523341|538156559|FG001|Overall Study|Non-compliance|13|||
149186875|NCT00523341|538156558|FG000|Overall Study|Physician Decision|14|||
149186876|NCT00523341|538156559|FG001|Overall Study|Physician Decision|13|||
149186877|NCT00523341|538156558|FG000|Overall Study|Requirement for Alternative Therapy|4|||
149186878|NCT00523341|538156559|FG001|Overall Study|Requirement for Alternative Therapy|14|||
149186879|NCT00523341|538156558|FG000|Overall Study|Protocol Deviation|6|||
149186880|NCT00523341|538156559|FG001|Overall Study|Protocol Deviation|5|||
149186881|NCT00523341|538156558|FG000|Overall Study|Ineligibility Determined|3|||
149186882|NCT00523341|538156559|FG001|Overall Study|Ineligibility Determined|4|||
149186883|NCT00523341|538156558|FG000|Overall Study|Disease Progression|1|||
149186884|NCT00523341|538156559|FG001|Overall Study|Disease Progression|0|||
149186885|NCT01356602|538156560|FG000|Overall Study|Protocol Deviation|0|||
149186886|NCT01356602|538156561|FG001|Overall Study|Protocol Deviation|1|||
149186887|NCT01356602|538156562|FG002|Overall Study|Protocol Deviation|1|||
149186888|NCT01356602|538156560|FG000|Overall Study|Administrative Problems|1|||
149186889|NCT01356602|538156561|FG001|Overall Study|Administrative Problems|4|||
149186890|NCT01356602|538156562|FG002|Overall Study|Administrative Problems|5|||
149186891|NCT01356602|538156560|FG000|Overall Study|Lost to Follow-up|4|||
149186892|NCT01356602|538156561|FG001|Overall Study|Lost to Follow-up|5|||
149186893|NCT01356602|538156562|FG002|Overall Study|Lost to Follow-up|6|||
149186894|NCT01356602|538156560|FG000|Overall Study|Withdrawal by Subject|4|||
149186895|NCT01356602|538156561|FG001|Overall Study|Withdrawal by Subject|3|||
149186896|NCT01356602|538156562|FG002|Overall Study|Withdrawal by Subject|7|||
149186897|NCT01356602|538156560|FG000|Overall Study|Lack of Efficacy|0|||
149186898|NCT01356602|538156561|FG001|Overall Study|Lack of Efficacy|1|||
149186899|NCT01356602|538156562|FG002|Overall Study|Lack of Efficacy|4|||
149186900|NCT01356602|538156560|FG000|Overall Study|Adverse Event|0|||
149186901|NCT01356602|538156561|FG001|Overall Study|Adverse Event|1|||
149186902|NCT01356602|538156562|FG002|Overall Study|Adverse Event|1|||
149186903|NCT01605071|538156563|FG000|Overall Study|Withdrawal by Subject|3|||
149186904|NCT01605071|538156564|FG001|Overall Study|Withdrawal by Subject|2|||
149186905|NCT01931462|538156565|FG000|Overall Study|Withdrawal by Subject|1|||
149186906|NCT00051558|538156566|FG000|Overall Study|Adverse Event|30|||
149186907|NCT00051558|538156567|FG001|Overall Study|Adverse Event|18|||
149186908|NCT00051558|538156566|FG000|Overall Study|Withdrawal by Subject|29|||
149186909|NCT00051558|538156567|FG001|Overall Study|Withdrawal by Subject|42|||
149186910|NCT00051558|538156566|FG000|Overall Study|Death|9|||
149186911|NCT00051558|538156567|FG001|Overall Study|Death|15|||
149186912|NCT00051558|538156566|FG000|Overall Study|Lost to Follow-up|4|||
149186913|NCT00051558|538156567|FG001|Overall Study|Lost to Follow-up|13|||
149186914|NCT00051558|538156566|FG000|Overall Study|Protocol Violation|3|||
149186915|NCT00051558|538156567|FG001|Overall Study|Protocol Violation|4|||
149186916|NCT00051558|538156566|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
149186917|NCT00051558|538156567|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
149186918|NCT00051558|538156566|FG000|Overall Study|Sponsor Decision|6|||
149186919|NCT00051558|538156567|FG001|Overall Study|Sponsor Decision|1|||
149186920|NCT00051558|538156566|FG000|Overall Study|Other|2|||
149186921|NCT00051558|538156567|FG001|Overall Study|Other|1|||
149186922|NCT00051558|538156566|FG000|Overall Study|Significant Lab Value|2|||
149186923|NCT00051558|538156567|FG001|Overall Study|Significant Lab Value|0|||
149186924|NCT00051558|538156566|FG000|Overall Study|Physician Decision|5|||
149186925|NCT00051558|538156567|FG001|Overall Study|Physician Decision|0|||
149186926|NCT01881620|538156570|FG000|Overall Study|Protocol Violation|4|||
149186927|NCT01808118|538156573|FG000|Period 1|Adverse Event|15|||
149186928|NCT01808118|538156574|FG001|Period 1|Adverse Event|0|||
149186929|NCT01808118|538156575|FG002|Period 1|Adverse Event|0|||
149186930|NCT01808118|538156573|FG000|Period 1|Withdrew consent|24|||
149186931|NCT01808118|538156574|FG001|Period 1|Withdrew consent|0|||
149186932|NCT01808118|538156575|FG002|Period 1|Withdrew consent|0|||
149186933|NCT01808118|538156573|FG000|Period 1|Lost to Follow-up|9|||
149186934|NCT01808118|538156574|FG001|Period 1|Lost to Follow-up|0|||
149186935|NCT01808118|538156575|FG002|Period 1|Lost to Follow-up|0|||
149186936|NCT01808118|538156573|FG000|Period 1|Did not meet criteria for remission|303|||
149186937|NCT01808118|538156574|FG001|Period 1|Did not meet criteria for remission|0|||
149186938|NCT01808118|538156575|FG002|Period 1|Did not meet criteria for remission|0|||
149186939|NCT01808118|538156573|FG000|Period 1|Enrolled in error|7|||
149186940|NCT01808118|538156574|FG001|Period 1|Enrolled in error|0|||
149186941|NCT01808118|538156575|FG002|Period 1|Enrolled in error|0|||
149186942|NCT01808118|538156573|FG000|Period 1|Did not meet inclusion criteria|3|||
149186943|NCT01808118|538156574|FG001|Period 1|Did not meet inclusion criteria|0|||
149186944|NCT01808118|538156575|FG002|Period 1|Did not meet inclusion criteria|0|||
149186945|NCT01808118|538156573|FG000|Period 1|Non-conformance with inclusion criteria|3|||
149186946|NCT01808118|538156574|FG001|Period 1|Non-conformance with inclusion criteria|0|||
149186947|NCT01808118|538156575|FG002|Period 1|Non-conformance with inclusion criteria|0|||
149186948|NCT01808118|538156573|FG000|Period 1|Investigator decision: site closure|2|||
149186949|NCT01808118|538156574|FG001|Period 1|Investigator decision: site closure|0|||
149186950|NCT01808118|538156575|FG002|Period 1|Investigator decision: site closure|0|||
149186951|NCT01808118|538156573|FG000|Period 1|Non-compliance per sponsor|1|||
149186952|NCT01808118|538156574|FG001|Period 1|Non-compliance per sponsor|0|||
149186953|NCT01808118|538156575|FG002|Period 1|Non-compliance per sponsor|0|||
149186954|NCT01808118|538156573|FG000|Period 1|Lack of Efficacy|1|||
149186955|NCT01808118|538156574|FG001|Period 1|Lack of Efficacy|0|||
148933473|NCT05394350|537242228|FG003|Overall Study|Study terminated by sponsor|3|||
149186956|NCT01808118|538156575|FG002|Period 1|Lack of Efficacy|0|||
148933474|NCT05394350|537242229|FG004|Overall Study|Study terminated by sponsor|2|||
149186957|NCT01808118|538156573|FG000|Period 2|Adverse Event|0|||
149186958|NCT01808118|538156574|FG001|Period 2|Adverse Event|4|||
149186959|NCT01808118|538156575|FG002|Period 2|Adverse Event|0|||
149186960|NCT01808118|538156573|FG000|Period 2|Withdrew consent|0|||
149186961|NCT01808118|538156574|FG001|Period 2|Withdrew consent|7|||
149186962|NCT01808118|538156575|FG002|Period 2|Withdrew consent|6|||
149186963|NCT01808118|538156573|FG000|Period 2|Lost to Follow-up|0|||
149186964|NCT01808118|538156574|FG001|Period 2|Lost to Follow-up|0|||
149186965|NCT01808118|538156575|FG002|Period 2|Lost to Follow-up|2|||
149186966|NCT01808118|538156573|FG000|Period 2|Investigator no longer conducting trials|0|||
149186967|NCT01808118|538156574|FG001|Period 2|Investigator no longer conducting trials|1|||
149186968|NCT01808118|538156575|FG002|Period 2|Investigator no longer conducting trials|0|||
149186969|NCT01808118|538156573|FG000|Period 2|Switched to other therapy|0|||
149186970|NCT01808118|538156574|FG001|Period 2|Switched to other therapy|1|||
149014295|NCT01857934|537532172|FG000|Overall Study|Relapse or progression|2|||
149014296|NCT01857934|537532172|FG000|Overall Study|Unacceptable toxicity|3|||
149014297|NCT01857934|537532172|FG000|Overall Study|Unwillingness or inability to comply|2|||
149014298|NCT01857934|537532172|FG000|Overall Study|Physician Decision|3|||
149014299|NCT01024959|537532173|FG000|Overall Study|ineligible|12|||
149014300|NCT01024959|537532173|FG000|Overall Study|results not evaluable|12|||
149014301|NCT01024959|537532173|FG000|Overall Study|missing results required for analysis|17|||
149014302|NCT00313911|537532174|FG000|Overall Study|Serious adverse event|6|||
149014303|NCT00313911|537532175|FG001|Overall Study|Serious adverse event|1|||
149014304|NCT00313911|537532174|FG000|Overall Study|Adverse Event|2|||
149014305|NCT00313911|537532175|FG001|Overall Study|Adverse Event|3|||
149014306|NCT00313911|537532174|FG000|Overall Study|Protocol Violation|19|||
149014307|NCT00313911|537532175|FG001|Overall Study|Protocol Violation|10|||
149014308|NCT00313911|537532174|FG000|Overall Study|Lost to Follow-up|27|||
149014309|NCT00313911|537532175|FG001|Overall Study|Lost to Follow-up|14|||
149186971|NCT01808118|538156575|FG002|Period 2|Switched to other therapy|0|||
149186972|NCT00414310|538156576|FG000|Overall Study|Not treated|1|||
149186973|NCT00414310|538156577|FG001|Overall Study|Not treated|0|||
149186974|NCT01701583|538156584|FG000|Overall Study|Withdrawal by Subject|2|||
149186975|NCT01701583|538156585|FG001|Overall Study|Withdrawal by Subject|0|||
149186976|NCT01441440|538156586|FG000|Overall Study|Death|1|||
149186977|NCT01441440|538156587|FG001|Overall Study|Death|0|||
149186978|NCT01441440|538156588|FG002|Overall Study|Death|1|||
149186979|NCT01441440|538156586|FG000|Overall Study|Adverse Event|2|||
149186980|NCT01441440|538156587|FG001|Overall Study|Adverse Event|9|||
149186981|NCT01441440|538156588|FG002|Overall Study|Adverse Event|9|||
149186982|NCT01441440|538156586|FG000|Overall Study|Lost to Follow-up|0|||
149186983|NCT01441440|538156587|FG001|Overall Study|Lost to Follow-up|2|||
149186984|NCT01441440|538156588|FG002|Overall Study|Lost to Follow-up|1|||
149186985|NCT01441440|538156586|FG000|Overall Study|Withdrawal by Subject|11|||
149186986|NCT01441440|538156587|FG001|Overall Study|Withdrawal by Subject|9|||
149186987|NCT01441440|538156588|FG002|Overall Study|Withdrawal by Subject|9|||
149186988|NCT01441440|538156586|FG000|Overall Study|Pregnancy|1|||
149186989|NCT01441440|538156587|FG001|Overall Study|Pregnancy|0|||
149186990|NCT01441440|538156588|FG002|Overall Study|Pregnancy|0|||
149186991|NCT01441440|538156586|FG000|Overall Study|Lack of Efficacy|1|||
149186992|NCT01441440|538156587|FG001|Overall Study|Lack of Efficacy|0|||
149186993|NCT01441440|538156588|FG002|Overall Study|Lack of Efficacy|1|||
149186994|NCT01441440|538156586|FG000|Overall Study|Moving|0|||
149186995|NCT01441440|538156587|FG001|Overall Study|Moving|1|||
149186996|NCT01441440|538156588|FG002|Overall Study|Moving|1|||
149186997|NCT01441440|538156586|FG000|Overall Study|Work-related matter|0|||
149014310|NCT00313911|537532174|FG000|Overall Study|Withdrawal by Subject|39|||
149014311|NCT00313911|537532175|FG001|Overall Study|Withdrawal by Subject|12|||
149186998|NCT01441440|538156587|FG001|Overall Study|Work-related matter|1|||
149186999|NCT01441440|538156588|FG002|Overall Study|Work-related matter|0|||
149187000|NCT01441440|538156586|FG000|Overall Study|Difficllty in keeping the schedule|1|||
149187001|NCT01441440|538156587|FG001|Overall Study|Difficllty in keeping the schedule|1|||
149187002|NCT01441440|538156588|FG002|Overall Study|Difficllty in keeping the schedule|0|||
149187003|NCT01993329|538156589|FG000|Period 2|Adverse Event|0|||
149187004|NCT01993329|538156590|FG001|Period 2|Adverse Event|0|||
149187005|NCT01993329|538156591|FG002|Period 2|Adverse Event|0|||
149187006|NCT01993329|538156592|FG003|Period 2|Adverse Event|0|||
149187007|NCT01993329|538156593|FG004|Period 2|Adverse Event|0|||
149187008|NCT01993329|538156594|FG005|Period 2|Adverse Event|1|||
148807380|NCT00089648|536773236|FG000|Overall Study|Withdrawal by Subject|1|||
149014312|NCT00313911|537532174|FG000|Overall Study|Did not meet age criteria|1|||
149014313|NCT00313911|537532175|FG001|Overall Study|Did not meet age criteria|1|||
149187009|NCT01993329|538156589|FG000|Wash-out|Personal reasons|0|||
149014314|NCT00636792|537532178|FG000|Overall Study|Adverse Event|16|||
149187010|NCT01993329|538156590|FG001|Wash-out|Personal reasons|1|||
149187011|NCT01993329|538156591|FG002|Wash-out|Personal reasons|0|||
149187012|NCT01993329|538156592|FG003|Wash-out|Personal reasons|0|||
149187013|NCT01993329|538156593|FG004|Wash-out|Personal reasons|0|||
149187014|NCT01993329|538156594|FG005|Wash-out|Personal reasons|0|||
149187015|NCT05070429|538156595|FG000|Overall Study|Death|0|||
149187016|NCT05070429|538156596|FG001|Overall Study|Death|4|||
149187017|NCT05070429|538156595|FG000|Overall Study|Withdrawal by Subject|2|||
149014315|NCT00636792|537532178|FG000|Overall Study|Physician Decision|7|||
149014316|NCT00636792|537532178|FG000|Overall Study|Progressive Disease|4|||
149014317|NCT00636792|537532178|FG000|Overall Study|Withdrawal by Subject|3|||
149014318|NCT00636792|537532178|FG000|Overall Study|Other|3|||
149187018|NCT05070429|538156596|FG001|Overall Study|Withdrawal by Subject|1|||
149187019|NCT05070429|538156595|FG000|Overall Study|Other|15|||
149187020|NCT05070429|538156596|FG001|Overall Study|Other|5|||
149187021|NCT03097328|538156597|FG000|Overall Study|Still on Therapy|2|||
149187022|NCT03097328|538156597|FG000|Overall Study|Progressive Disease|29|||
149187023|NCT03097328|538156597|FG000|Overall Study|Adverse Event|4|||
149187024|NCT03097328|538156597|FG000|Overall Study|Withdrawal by Subject|1|||
149187025|NCT03097328|538156597|FG000|Overall Study|Physician Decision|1|||
149187026|NCT03097328|538156597|FG000|Overall Study|Patient Decision|1|||
149187027|NCT03097328|538156597|FG000|Overall Study|Ineligible for Study Drug|1|||
149187028|NCT01798134|538156598|FG000|Overall Study|Lost to Follow-up|1|||
149187029|NCT01798134|538156598|FG000|Overall Study|Withdrawal by Subject|3|||
149187030|NCT01798134|538156598|FG000|Overall Study|Death|2|||
149187031|NCT01798134|538156598|FG000|Overall Study|Adverse Event|3|||
149187032|NCT01798134|538156598|FG000|Overall Study|Physician Decision|3|||
149187033|NCT01798134|538156598|FG000|Overall Study|Liver transplant/surgery|4|||
149187034|NCT02678741|538156599|FG000|Overall Study|Death|4|||
149187035|NCT02678741|538156599|FG000|Overall Study|Withdrawal by Subject|1|||
149187036|NCT02678741|538156599|FG000|Overall Study|ineligible|3|||
149187037|NCT02678741|538156599|FG000|Overall Study|Not RECIST Measurable|2|||
149187038|NCT02678741|538156599|FG000|Overall Study|Lack of Efficacy|10|||
149187039|NCT01795898|538156600|FG000|Overall Study|Adverse Event|27|||
149187040|NCT01795898|538156600|FG000|Overall Study|Lost to Follow-up|20|||
149187041|NCT01795898|538156600|FG000|Overall Study|Withdrawal of consent|6|||
149187042|NCT01795898|538156600|FG000|Overall Study|Diagnosed with metastasis|1|||
149187043|NCT01795898|538156600|FG000|Overall Study|No pain|1|||
148933475|NCT05394350|537242230|FG005|Overall Study|Study terminated by sponsor|4|||
148933476|NCT01336569|537242231|FG000|Overall Study|Lost to Follow-up|4|||
148933477|NCT02337738|537242234|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
148933478|NCT02337738|537242235|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
148933479|NCT02337738|537242236|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
148933480|NCT02337738|537242234|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
148933481|NCT02337738|537242235|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
148933482|NCT02337738|537242236|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
148933483|NCT02337738|537242234|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
148933484|NCT02337738|537242235|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
148933485|NCT02337738|537242236|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
148933486|NCT02337738|537242234|FG000|Overall Study|Voluntary Withdrawal|10|||
148933487|NCT02337738|537242235|FG001|Overall Study|Voluntary Withdrawal|5|||
148933488|NCT02337738|537242236|FG002|Overall Study|Voluntary Withdrawal|2|||
148933489|NCT02337738|537242234|FG000|Overall Study|Lack of Efficacy|2|||
148933490|NCT02337738|537242235|FG001|Overall Study|Lack of Efficacy|4|||
148933491|NCT02337738|537242236|FG002|Overall Study|Lack of Efficacy|0|||
148933492|NCT02337738|537242234|FG000|Overall Study|Investigator's Judgment|1|||
148933493|NCT02337738|537242235|FG001|Overall Study|Investigator's Judgment|1|||
148933494|NCT02337738|537242236|FG002|Overall Study|Investigator's Judgment|3|||
148933495|NCT03911154|537242237|FG000|Overall Study|Withdrawal by Subject|1|||
148933496|NCT00406354|537242238|FG000|All Randomized Patients|Protocol Violation|0|||
148933497|NCT00406354|537242239|FG001|All Randomized Patients|Protocol Violation|0|||
148933498|NCT00406354|537242240|FG002|All Randomized Patients|Protocol Violation|1|||
148933499|NCT00406354|537242238|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
148933500|NCT00406354|537242239|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
148933501|NCT00406354|537242240|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
148933502|NCT00406354|537242238|FG000|All Randomized and Treated Patients|Adverse Event|6|||
148933503|NCT00406354|537242239|FG001|All Randomized and Treated Patients|Adverse Event|2|||
148933504|NCT00406354|537242240|FG002|All Randomized and Treated Patients|Adverse Event|1|||
148933505|NCT00406354|537242238|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
149187044|NCT01795898|538156600|FG000|Overall Study|Death|1|||
149187045|NCT01795898|538156600|FG000|Overall Study|Withdrew consent & had adverse events|3|||
149187046|NCT01795898|538156600|FG000|Overall Study|Physician Decision|1|||
149187047|NCT00372190|538156612|FG000|Overall Study|Lost to Follow-up|3|||
149187048|NCT00372190|538156613|FG001|Overall Study|Lost to Follow-up|1|||
149187049|NCT01623531|538156614|FG000|Overall Study|Death|1|||
149187050|NCT01623531|538156615|FG001|Overall Study|Death|0|||
149187051|NCT01623531|538156614|FG000|Overall Study|Protocol Violation|2|||
149187052|NCT01623531|538156615|FG001|Overall Study|Protocol Violation|1|||
149187053|NCT01623531|538156614|FG000|Overall Study|Missing data at primary outcome time poi|1|||
148933506|NCT00406354|537242239|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
148933507|NCT00406354|537242240|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
149187054|NCT01623531|538156615|FG001|Overall Study|Missing data at primary outcome time poi|1|||
148933508|NCT00406354|537242238|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
148933509|NCT00406354|537242239|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
148933510|NCT00406354|537242240|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
148933511|NCT00406354|537242238|FG000|All Randomized and Treated Patients|Physician Decision|0|||
148933512|NCT00406354|537242239|FG001|All Randomized and Treated Patients|Physician Decision|0|||
148933513|NCT00406354|537242240|FG002|All Randomized and Treated Patients|Physician Decision|1|||
148933514|NCT01231347|537242241|FG000|Overall Study|Full Consent withdrawn|19|||
148933515|NCT01231347|537242242|FG001|Overall Study|Full Consent withdrawn|19|||
148933516|NCT01231347|537242243|FG002|Overall Study|Full Consent withdrawn|11|||
148933517|NCT01231347|537242241|FG000|Overall Study|Lost to Follow-up|4|||
148933518|NCT01231347|537242242|FG001|Overall Study|Lost to Follow-up|2|||
148933519|NCT01231347|537242243|FG002|Overall Study|Lost to Follow-up|2|||
148933520|NCT01231347|537242241|FG000|Overall Study|Death|202|||
148933521|NCT01231347|537242242|FG001|Overall Study|Death|210|||
148933522|NCT01231347|537242243|FG002|Overall Study|Death|101|||
148933523|NCT01231347|537242241|FG000|Overall Study|other event|7|||
148933524|NCT01231347|537242242|FG001|Overall Study|other event|9|||
148933525|NCT01231347|537242243|FG002|Overall Study|other event|3|||
148933526|NCT01385371|537242244|FG000|Overall Study|Adverse Event|54|||
148933527|NCT01385371|537242245|FG001|Overall Study|Adverse Event|19|||
148933528|NCT01385371|537242244|FG000|Overall Study|Lost to Follow-up|16|||
148933529|NCT01385371|537242245|FG001|Overall Study|Lost to Follow-up|16|||
148933530|NCT01385371|537242244|FG000|Overall Study|Withdrawal by Subject|52|||
148933531|NCT01385371|537242245|FG001|Overall Study|Withdrawal by Subject|39|||
148933532|NCT01385371|537242244|FG000|Overall Study|Protocol Violation|25|||
148933533|NCT01385371|537242245|FG001|Overall Study|Protocol Violation|21|||
148933534|NCT01385371|537242244|FG000|Overall Study|Administrative|2|||
148933535|NCT01385371|537242245|FG001|Overall Study|Administrative|2|||
148933536|NCT01626495|537242250|FG000|Overall Study|Adverse Event|3|||
148933537|NCT01626495|537242250|FG000|Overall Study|Disease progression|27|||
148933538|NCT01626495|537242250|FG000|Overall Study|Withdrawal by Subject|1|||
148933539|NCT01626495|537242250|FG000|Overall Study|Administrative problem|1|||
148933540|NCT01626495|537242250|FG000|Overall Study|Death|2|||
148933541|NCT01626495|537242250|FG000|Overall Study|Physician Decision|1|||
148933542|NCT01626495|537242250|FG000|Overall Study|New cancer therapy|16|||
148933543|NCT01626495|537242250|FG000|Overall Study|Manufacturing failure|1|||
148933544|NCT01565642|537242251|FG000|Overall Study|Withdrawal by Subject|2|||
148933545|NCT01565642|537242252|FG001|Overall Study|Withdrawal by Subject|1|||
148933546|NCT01934972|537242253|FG000|Overall Study|Withdrawal by Subject|9|||
148933547|NCT01934972|537242254|FG001|Overall Study|Withdrawal by Subject|6|||
148933548|NCT01278160|537242255|FG000|Overall Study|Adverse Event|1|||
148933549|NCT01278160|537242256|FG001|Overall Study|Adverse Event|1|||
148933550|NCT01278160|537242255|FG000|Overall Study|Lost to Follow-up|0|||
148933551|NCT01278160|537242256|FG001|Overall Study|Lost to Follow-up|1|||
148933552|NCT01278160|537242255|FG000|Overall Study|Withdrawal by Subject|3|||
148933553|NCT01278160|537242256|FG001|Overall Study|Withdrawal by Subject|2|||
148933554|NCT01278160|537242255|FG000|Overall Study|Unclassified|1|||
148933555|NCT01278160|537242256|FG001|Overall Study|Unclassified|2|||
148933556|NCT00304239|537242258|FG000|Overall Study|Protocol Deviations/Violations|15|||
148933557|NCT00304239|537242259|FG001|Overall Study|Protocol Deviations/Violations|0|||
148933558|NCT00304239|537242258|FG000|Overall Study|Adverse Event|2|||
148933559|NCT00304239|537242259|FG001|Overall Study|Adverse Event|0|||
148933560|NCT02979197|537242260|FG000|Overall Study|Adverse Event|4|||
148933561|NCT02979197|537242261|FG001|Overall Study|Adverse Event|2|||
148933562|NCT02979197|537242262|FG002|Overall Study|Adverse Event|0|||
148933563|NCT02979197|537242260|FG000|Overall Study|Protocol Violation|0|||
148933564|NCT02979197|537242261|FG001|Overall Study|Protocol Violation|1|||
148933565|NCT02979197|537242262|FG002|Overall Study|Protocol Violation|0|||
148933566|NCT02979197|537242260|FG000|Overall Study|Subject unable to commit to study dates|0|||
148933567|NCT02979197|537242261|FG001|Overall Study|Subject unable to commit to study dates|1|||
148933568|NCT02979197|537242262|FG002|Overall Study|Subject unable to commit to study dates|0|||
148933569|NCT01631812|537242263|FG000|Overall Study|Adverse Event|25|||
148933570|NCT01631812|537242263|FG000|Overall Study|Lack of Efficacy|5|||
148933571|NCT01631812|537242263|FG000|Overall Study|Withdrawal by Subject|4|||
148933572|NCT01631812|537242263|FG000|Overall Study|Physician Decision|3|||
149187055|NCT00623467|538156616|FG000|Overall Study|Lost to Follow-up|1|||
148933573|NCT02436681|537242264|FG000|Overall Study|Lost to Follow-up|10|||
149187056|NCT00623467|538156616|FG000|Overall Study|Protocol Violation|4|||
148933574|NCT02436681|537242264|FG000|Overall Study|Withdrawal by Subject|2|||
148933575|NCT02436681|537242264|FG000|Overall Study|Death|2|||
148933576|NCT02030938|537242265|FG000|Overall Study|Lost to Follow-up|4|||
148933577|NCT02030938|537242265|FG000|Overall Study|Withdrawal by Subject|1|||
148933578|NCT03954132|537242267|FG000|Overall Study|Adverse Event|2|||
148933579|NCT03954132|537242268|FG001|Overall Study|Adverse Event|0|||
148933580|NCT03954132|537242267|FG000|Overall Study|Patient's wish|5|||
148933581|NCT03954132|537242268|FG001|Overall Study|Patient's wish|0|||
148933582|NCT03954132|537242267|FG000|Overall Study|Lost to Follow-up|10|||
149187057|NCT00623467|538156616|FG000|Overall Study|Withdrawal by Subject|2|||
149187058|NCT02834403|538156625|FG000|Overall Study|Physician Decision|2|||
149187059|NCT02834403|538156626|FG001|Overall Study|Physician Decision|1|||
149187060|NCT02834403|538156627|FG002|Overall Study|Physician Decision|2|||
149187061|NCT02834403|538156628|FG003|Overall Study|Physician Decision|1|||
149187062|NCT02834403|538156629|FG004|Overall Study|Physician Decision|1|||
149187063|NCT02834403|538156630|FG005|Overall Study|Physician Decision|2|||
149187064|NCT02834403|538156631|FG006|Overall Study|Physician Decision|12|||
149187065|NCT02834403|538156625|FG000|Overall Study|Adverse Event|0|||
149187066|NCT02834403|538156626|FG001|Overall Study|Adverse Event|0|||
149187067|NCT02834403|538156627|FG002|Overall Study|Adverse Event|0|||
149187068|NCT02834403|538156628|FG003|Overall Study|Adverse Event|0|||
149187069|NCT02834403|538156629|FG004|Overall Study|Adverse Event|1|||
149187070|NCT02834403|538156630|FG005|Overall Study|Adverse Event|1|||
149187071|NCT02834403|538156631|FG006|Overall Study|Adverse Event|3|||
149187072|NCT02834403|538156625|FG000|Overall Study|Withdrawal by Subject|0|||
149187073|NCT02834403|538156626|FG001|Overall Study|Withdrawal by Subject|1|||
149187074|NCT02834403|538156627|FG002|Overall Study|Withdrawal by Subject|0|||
149187075|NCT02834403|538156628|FG003|Overall Study|Withdrawal by Subject|0|||
149187076|NCT02834403|538156629|FG004|Overall Study|Withdrawal by Subject|1|||
149187077|NCT02834403|538156630|FG005|Overall Study|Withdrawal by Subject|0|||
149187078|NCT02834403|538156631|FG006|Overall Study|Withdrawal by Subject|0|||
149187079|NCT02834403|538156625|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
149187080|NCT02834403|538156626|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
149187081|NCT02834403|538156627|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
149187082|NCT02834403|538156628|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
149187083|NCT02834403|538156629|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
149187084|NCT02834403|538156630|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
149187085|NCT02834403|538156631|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
149187086|NCT02341014|538156632|FG000|Overall Study|Adverse Event|0|||
149187087|NCT02341014|538156633|FG001|Overall Study|Adverse Event|1|||
149187088|NCT02341014|538156634|FG002|Overall Study|Adverse Event|0|||
149187089|NCT02341014|538156635|FG003|Overall Study|Adverse Event|0|||
149187090|NCT02341014|538156636|FG004|Overall Study|Adverse Event|2|||
149187091|NCT04705597|538156637|FG000|Overall Study|Death|16|||
149187092|NCT04705597|538156638|FG001|Overall Study|Death|9|||
149187093|NCT04705597|538156637|FG000|Overall Study|Lost to Follow-up|1|||
149187094|NCT04705597|538156638|FG001|Overall Study|Lost to Follow-up|0|||
149187095|NCT04705597|538156637|FG000|Overall Study|Withdrawal by Subject|1|||
149187096|NCT04705597|538156638|FG001|Overall Study|Withdrawal by Subject|2|||
149187097|NCT00390780|538156648|FG000|Overall Study|Not completed|10|||
149187098|NCT00390780|538156649|FG001|Overall Study|Not completed|4|||
149187099|NCT00390780|538156648|FG000|Overall Study|Protocol Violation|6|||
149187100|NCT00390780|538156649|FG001|Overall Study|Protocol Violation|4|||
149187101|NCT00390780|538156648|FG000|Overall Study|Lost to Follow-up|3|||
149187102|NCT00390780|538156649|FG001|Overall Study|Lost to Follow-up|6|||
149187103|NCT00390780|538156648|FG000|Overall Study|Adverse Event|2|||
149187104|NCT00390780|538156649|FG001|Overall Study|Adverse Event|3|||
149187105|NCT00390780|538156648|FG000|Overall Study|Death|1|||
149187106|NCT00390780|538156649|FG001|Overall Study|Death|3|||
149187107|NCT00390780|538156648|FG000|Overall Study|Withdrawal by Subject|1|||
149187108|NCT00390780|538156649|FG001|Overall Study|Withdrawal by Subject|2|||
149187109|NCT00390780|538156648|FG000|Overall Study|Inclusion criteria not satisfied|0|||
149187110|NCT00390780|538156649|FG001|Overall Study|Inclusion criteria not satisfied|2|||
149187111|NCT00390780|538156648|FG000|Overall Study|Lost to follow up and other reasons|0|||
149187112|NCT00390780|538156649|FG001|Overall Study|Lost to follow up and other reasons|1|||
149187113|NCT00390780|538156648|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
149187114|NCT00390780|538156649|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
149187115|NCT00390780|538156648|FG000|Overall Study|SAE, death|0|||
149187116|NCT00390780|538156649|FG001|Overall Study|SAE, death|1|||
149187117|NCT00273858|538156650|FG000|Overall Study|Not completed 24 month observation time|334|||
149187118|NCT00273858|538156650|FG000|Overall Study|Lost to Follow-up|101|||
149187119|NCT00273858|538156650|FG000|Overall Study|Withdrawal by Subject|21|||
148933583|NCT03954132|537242268|FG001|Overall Study|Lost to Follow-up|0|||
148933584|NCT03954132|537242267|FG000|Overall Study|Screening failure|0|||
148933585|NCT03954132|537242268|FG001|Overall Study|Screening failure|1|||
148933586|NCT03954132|537242267|FG000|Overall Study|No registration after Visit 1|5|||
148933587|NCT03954132|537242268|FG001|Overall Study|No registration after Visit 1|2|||
149187120|NCT00273858|538156650|FG000|Overall Study|Adverse Event|81|||
149187121|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
149187122|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
149187123|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
149187124|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
149187125|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
149187126|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
149187127|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
149187128|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
149187129|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
149187130|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
149187131|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
149187132|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
149187133|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
149187134|NCT02232516|538156655|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
149187135|NCT02232516|538156655|FG000|Survival Follow-up|Death|15|||
149187136|NCT02232516|538156655|FG000|Survival Follow-up|Withdrawal by Subject|3|||
149187137|NCT02232516|538156655|FG000|Survival Follow-up|Lost to Follow-up|1|||
149187138|NCT02232516|538156655|FG000|Survival Follow-up|Still in follow-up|5|||
149187139|NCT01070550|538156657|FG000|Overall Study|Adverse Event|43|||
149187140|NCT01070550|538156658|FG001|Overall Study|Adverse Event|1|||
149187141|NCT01070550|538156659|FG002|Overall Study|Adverse Event|3|||
149187142|NCT01070550|538156660|FG003|Overall Study|Adverse Event|0|||
149187143|NCT01070550|538156661|FG004|Overall Study|Adverse Event|0|||
149187144|NCT01070550|538156662|FG005|Overall Study|Adverse Event|0|||
149187145|NCT01070550|538156657|FG000|Overall Study|Death|20|||
149187146|NCT01070550|538156658|FG001|Overall Study|Death|4|||
149187147|NCT01070550|538156659|FG002|Overall Study|Death|3|||
149187148|NCT01070550|538156660|FG003|Overall Study|Death|0|||
149187149|NCT01070550|538156661|FG004|Overall Study|Death|0|||
149187150|NCT01070550|538156662|FG005|Overall Study|Death|0|||
149187151|NCT01070550|538156657|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
149187152|NCT01070550|538156658|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149187153|NCT01070550|538156659|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
149187154|NCT01070550|538156660|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149187155|NCT01070550|538156661|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149187156|NCT01070550|538156662|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
149187157|NCT01070550|538156657|FG000|Overall Study|Early termination|3|||
149187158|NCT01070550|538156658|FG001|Overall Study|Early termination|0|||
149187159|NCT01070550|538156659|FG002|Overall Study|Early termination|0|||
149187160|NCT01070550|538156660|FG003|Overall Study|Early termination|0|||
149187161|NCT01070550|538156661|FG004|Overall Study|Early termination|0|||
149187162|NCT01070550|538156662|FG005|Overall Study|Early termination|0|||
149187163|NCT01070550|538156657|FG000|Overall Study|Failed to return|450|||
149187164|NCT01070550|538156658|FG001|Overall Study|Failed to return|33|||
149187165|NCT01070550|538156659|FG002|Overall Study|Failed to return|144|||
149187166|NCT01070550|538156660|FG003|Overall Study|Failed to return|40|||
149187167|NCT01070550|538156661|FG004|Overall Study|Failed to return|1|||
149187168|NCT01070550|538156662|FG005|Overall Study|Failed to return|2|||
149187169|NCT01070550|538156657|FG000|Overall Study|Incomplete treatment|2|||
149187170|NCT01070550|538156658|FG001|Overall Study|Incomplete treatment|0|||
149187171|NCT01070550|538156659|FG002|Overall Study|Incomplete treatment|0|||
149187172|NCT01070550|538156660|FG003|Overall Study|Incomplete treatment|0|||
149187173|NCT01070550|538156661|FG004|Overall Study|Incomplete treatment|0|||
148933588|NCT03954132|537242267|FG000|Overall Study|Other reason than listed|2|||
149187174|NCT01070550|538156662|FG005|Overall Study|Incomplete treatment|0|||
149187175|NCT01070550|538156657|FG000|Overall Study|Lab test not done|22|||
149187176|NCT01070550|538156658|FG001|Overall Study|Lab test not done|3|||
149187177|NCT01070550|538156659|FG002|Overall Study|Lab test not done|4|||
149187178|NCT01070550|538156660|FG003|Overall Study|Lab test not done|1|||
149187179|NCT01070550|538156661|FG004|Overall Study|Lab test not done|0|||
149187180|NCT01070550|538156662|FG005|Overall Study|Lab test not done|1|||
148933589|NCT03954132|537242268|FG001|Overall Study|Other reason than listed|2|||
149187181|NCT01070550|538156657|FG000|Overall Study|Lack of Efficacy|65|||
149187182|NCT01070550|538156658|FG001|Overall Study|Lack of Efficacy|1|||
149187183|NCT01070550|538156659|FG002|Overall Study|Lack of Efficacy|5|||
149187184|NCT01070550|538156660|FG003|Overall Study|Lack of Efficacy|5|||
148933590|NCT03954132|537242267|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
148933591|NCT03954132|537242268|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
149187185|NCT01070550|538156661|FG004|Overall Study|Lack of Efficacy|0|||
149187186|NCT01070550|538156662|FG005|Overall Study|Lack of Efficacy|1|||
149187187|NCT01070550|538156657|FG000|Overall Study|Miscellaneous|12|||
149187188|NCT01070550|538156658|FG001|Overall Study|Miscellaneous|2|||
149187189|NCT01070550|538156659|FG002|Overall Study|Miscellaneous|3|||
149187190|NCT01070550|538156660|FG003|Overall Study|Miscellaneous|1|||
149187191|NCT01070550|538156661|FG004|Overall Study|Miscellaneous|0|||
149187192|NCT01070550|538156662|FG005|Overall Study|Miscellaneous|0|||
149187193|NCT01070550|538156657|FG000|Overall Study|New treatment started|3|||
149187194|NCT01070550|538156658|FG001|Overall Study|New treatment started|1|||
149187195|NCT01070550|538156659|FG002|Overall Study|New treatment started|0|||
149187196|NCT01070550|538156660|FG003|Overall Study|New treatment started|2|||
149187197|NCT01070550|538156661|FG004|Overall Study|New treatment started|0|||
149187198|NCT01070550|538156662|FG005|Overall Study|New treatment started|0|||
149187199|NCT01070550|538156657|FG000|Overall Study|Non-responders|493|||
149187200|NCT01070550|538156658|FG001|Overall Study|Non-responders|4|||
149187201|NCT01070550|538156659|FG002|Overall Study|Non-responders|21|||
149187202|NCT01070550|538156660|FG003|Overall Study|Non-responders|20|||
149187203|NCT01070550|538156661|FG004|Overall Study|Non-responders|0|||
149187204|NCT01070550|538156662|FG005|Overall Study|Non-responders|2|||
149187205|NCT01070550|538156657|FG000|Overall Study|Not categorized|33|||
149187206|NCT01070550|538156658|FG001|Overall Study|Not categorized|2|||
149187207|NCT01070550|538156659|FG002|Overall Study|Not categorized|6|||
149187208|NCT01070550|538156660|FG003|Overall Study|Not categorized|1|||
149187209|NCT01070550|538156661|FG004|Overall Study|Not categorized|0|||
149187210|NCT01070550|538156662|FG005|Overall Study|Not categorized|1|||
149187211|NCT01070550|538156657|FG000|Overall Study|Protocol Violation|15|||
149187212|NCT01070550|538156658|FG001|Overall Study|Protocol Violation|1|||
149187213|NCT01070550|538156659|FG002|Overall Study|Protocol Violation|1|||
149187214|NCT01070550|538156660|FG003|Overall Study|Protocol Violation|1|||
149187215|NCT01070550|538156661|FG004|Overall Study|Protocol Violation|0|||
149187216|NCT01070550|538156662|FG005|Overall Study|Protocol Violation|0|||
149187217|NCT01070550|538156657|FG000|Overall Study|Relapse|44|||
149187218|NCT01070550|538156658|FG001|Overall Study|Relapse|5|||
149187219|NCT01070550|538156659|FG002|Overall Study|Relapse|14|||
149187220|NCT01070550|538156660|FG003|Overall Study|Relapse|4|||
149187221|NCT01070550|538156661|FG004|Overall Study|Relapse|0|||
149187222|NCT01070550|538156662|FG005|Overall Study|Relapse|0|||
149187223|NCT01070550|538156657|FG000|Overall Study|Result not available|3|||
149187224|NCT01070550|538156658|FG001|Overall Study|Result not available|1|||
149187225|NCT01070550|538156659|FG002|Overall Study|Result not available|3|||
149187226|NCT01070550|538156660|FG003|Overall Study|Result not available|0|||
149187227|NCT01070550|538156661|FG004|Overall Study|Result not available|0|||
149187228|NCT01070550|538156662|FG005|Overall Study|Result not available|0|||
149187229|NCT01070550|538156657|FG000|Overall Study|Screen failure|1|||
149187230|NCT01070550|538156658|FG001|Overall Study|Screen failure|0|||
149187231|NCT01070550|538156659|FG002|Overall Study|Screen failure|0|||
148933592|NCT03954132|537242267|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
148933593|NCT03954132|537242268|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
149187232|NCT01070550|538156660|FG003|Overall Study|Screen failure|0|||
149187233|NCT01070550|538156661|FG004|Overall Study|Screen failure|0|||
149187234|NCT01070550|538156662|FG005|Overall Study|Screen failure|0|||
149187235|NCT01070550|538156657|FG000|Overall Study|Sponsor decision|1|||
149187236|NCT01070550|538156658|FG001|Overall Study|Sponsor decision|0|||
149187237|NCT01070550|538156659|FG002|Overall Study|Sponsor decision|0|||
149187238|NCT01070550|538156660|FG003|Overall Study|Sponsor decision|0|||
149187239|NCT01070550|538156661|FG004|Overall Study|Sponsor decision|0|||
149187240|NCT01070550|538156662|FG005|Overall Study|Sponsor decision|0|||
149187241|NCT01070550|538156657|FG000|Overall Study|Treatment duration shortened|1|||
149187242|NCT01070550|538156658|FG001|Overall Study|Treatment duration shortened|0|||
149187243|NCT01070550|538156659|FG002|Overall Study|Treatment duration shortened|0|||
149187244|NCT01070550|538156660|FG003|Overall Study|Treatment duration shortened|0|||
149187245|NCT01070550|538156661|FG004|Overall Study|Treatment duration shortened|0|||
149187246|NCT01070550|538156662|FG005|Overall Study|Treatment duration shortened|0|||
149187247|NCT01070550|538156657|FG000|Overall Study|Treatment interrupted|7|||
149187248|NCT01070550|538156658|FG001|Overall Study|Treatment interrupted|0|||
149187249|NCT01070550|538156659|FG002|Overall Study|Treatment interrupted|1|||
149187250|NCT01070550|538156660|FG003|Overall Study|Treatment interrupted|1|||
149187251|NCT01070550|538156661|FG004|Overall Study|Treatment interrupted|0|||
149187252|NCT01070550|538156662|FG005|Overall Study|Treatment interrupted|0|||
149187253|NCT01070550|538156657|FG000|Overall Study|Treatment not started|14|||
149187254|NCT01070550|538156658|FG001|Overall Study|Treatment not started|2|||
149187255|NCT01070550|538156659|FG002|Overall Study|Treatment not started|4|||
149187256|NCT01070550|538156660|FG003|Overall Study|Treatment not started|0|||
149187257|NCT01070550|538156661|FG004|Overall Study|Treatment not started|0|||
149187258|NCT01070550|538156662|FG005|Overall Study|Treatment not started|0|||
149187259|NCT01070550|538156657|FG000|Overall Study|Treatment restarted|0|||
149187260|NCT01070550|538156658|FG001|Overall Study|Treatment restarted|1|||
149187261|NCT01070550|538156659|FG002|Overall Study|Treatment restarted|0|||
149187262|NCT01070550|538156660|FG003|Overall Study|Treatment restarted|0|||
149187263|NCT01070550|538156661|FG004|Overall Study|Treatment restarted|0|||
149187264|NCT01070550|538156662|FG005|Overall Study|Treatment restarted|0|||
149187265|NCT01070550|538156657|FG000|Overall Study|Treatment stopped|3|||
149187266|NCT01070550|538156658|FG001|Overall Study|Treatment stopped|0|||
149187267|NCT01070550|538156659|FG002|Overall Study|Treatment stopped|0|||
149187268|NCT01070550|538156660|FG003|Overall Study|Treatment stopped|0|||
149187269|NCT01070550|538156661|FG004|Overall Study|Treatment stopped|0|||
149187270|NCT01070550|538156662|FG005|Overall Study|Treatment stopped|0|||
149187271|NCT01070550|538156657|FG000|Overall Study|Treatment unavailable|1|||
149187272|NCT01070550|538156658|FG001|Overall Study|Treatment unavailable|0|||
149187273|NCT01070550|538156659|FG002|Overall Study|Treatment unavailable|0|||
149187274|NCT01070550|538156660|FG003|Overall Study|Treatment unavailable|0|||
149187275|NCT01070550|538156661|FG004|Overall Study|Treatment unavailable|0|||
149187276|NCT01070550|538156662|FG005|Overall Study|Treatment unavailable|0|||
149187277|NCT01070550|538156657|FG000|Overall Study|Treatment was stopped early|7|||
149187278|NCT01070550|538156658|FG001|Overall Study|Treatment was stopped early|0|||
149187279|NCT01070550|538156659|FG002|Overall Study|Treatment was stopped early|0|||
149187280|NCT01070550|538156660|FG003|Overall Study|Treatment was stopped early|0|||
149187281|NCT01070550|538156661|FG004|Overall Study|Treatment was stopped early|0|||
149187282|NCT01070550|538156662|FG005|Overall Study|Treatment was stopped early|0|||
149187283|NCT01070550|538156657|FG000|Overall Study|Other|5|||
149187284|NCT01070550|538156658|FG001|Overall Study|Other|0|||
149187285|NCT01070550|538156659|FG002|Overall Study|Other|0|||
149187286|NCT01070550|538156660|FG003|Overall Study|Other|1|||
149187287|NCT01070550|538156661|FG004|Overall Study|Other|0|||
149187288|NCT01070550|538156662|FG005|Overall Study|Other|0|||
149187289|NCT01070550|538156657|FG000|Overall Study|Withdrawal by Subject|35|||
149187290|NCT01070550|538156658|FG001|Overall Study|Withdrawal by Subject|0|||
149187291|NCT01070550|538156659|FG002|Overall Study|Withdrawal by Subject|3|||
149187292|NCT01070550|538156660|FG003|Overall Study|Withdrawal by Subject|0|||
149187293|NCT01070550|538156661|FG004|Overall Study|Withdrawal by Subject|0|||
149187294|NCT01070550|538156662|FG005|Overall Study|Withdrawal by Subject|0|||
149187295|NCT05058664|538156664|FG000|Overall Study|No follow-up data provided|4|||
149187296|NCT05058664|538156665|FG001|Overall Study|No follow-up data provided|0|||
149187297|NCT05058664|538156666|FG002|Overall Study|No follow-up data provided|2|||
149187298|NCT05058664|538156664|FG000|Overall Study|Withdrawal by Subject|0|||
149187299|NCT05058664|538156665|FG001|Overall Study|Withdrawal by Subject|0|||
149187300|NCT05058664|538156666|FG002|Overall Study|Withdrawal by Subject|1|||
149187301|NCT01585961|538156667|FG000|Overall Study|Death|6|||
149187302|NCT01585961|538156667|FG000|Overall Study|Physician Decision|1|||
149187303|NCT01585961|538156667|FG000|Overall Study|Decision to use non-study catheter|1|||
149187304|NCT01585961|538156667|FG000|Overall Study|Withdrawal by Subject|1|||
149187305|NCT01585961|538156667|FG000|Overall Study|Lost to Follow-up|23|||
149187306|NCT01585961|538156667|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
149187307|NCT01258348|538156668|FG000|Overall Study|Adverse Event|1|||
149187308|NCT01258348|538156669|FG001|Overall Study|Adverse Event|1|||
149187309|NCT01258348|538156670|FG002|Overall Study|Adverse Event|3|||
149187310|NCT01258348|538156671|FG003|Overall Study|Adverse Event|2|||
149187311|NCT01258348|538156672|FG004|Overall Study|Adverse Event|4|||
149187312|NCT01258348|538156668|FG000|Overall Study|Progressive Disease|0|||
149187313|NCT01258348|538156669|FG001|Overall Study|Progressive Disease|3|||
149187314|NCT01258348|538156670|FG002|Overall Study|Progressive Disease|0|||
149187315|NCT01258348|538156671|FG003|Overall Study|Progressive Disease|2|||
149187316|NCT01258348|538156672|FG004|Overall Study|Progressive Disease|2|||
148933594|NCT00932737|537242271|FG000|Overall Study|Not treated in second episode|1|||
148933595|NCT00932737|537242272|FG001|Overall Study|Not treated in second episode|0|||
148933596|NCT00932737|537242271|FG000|Overall Study|Adverse Event|0|||
148933597|NCT00932737|537242272|FG001|Overall Study|Adverse Event|1|||
148933598|NCT02949700|537242275|FG000|Phase I|Withdrawal by Subject|1|||
148933599|NCT02949700|537242276|FG001|Phase I|Withdrawal by Subject|1|||
148933600|NCT02949700|537242277|FG002|Phase I|Withdrawal by Subject|0|||
149187317|NCT01258348|538156668|FG000|Overall Study|Physician Decision|0|||
149187318|NCT01258348|538156669|FG001|Overall Study|Physician Decision|0|||
149187319|NCT01258348|538156670|FG002|Overall Study|Physician Decision|0|||
149187320|NCT01258348|538156671|FG003|Overall Study|Physician Decision|2|||
149187321|NCT01258348|538156672|FG004|Overall Study|Physician Decision|0|||
149187322|NCT01258348|538156668|FG000|Overall Study|Withdrawal by Subject|0|||
149187323|NCT01258348|538156669|FG001|Overall Study|Withdrawal by Subject|1|||
149187324|NCT01258348|538156670|FG002|Overall Study|Withdrawal by Subject|0|||
149187325|NCT01258348|538156671|FG003|Overall Study|Withdrawal by Subject|0|||
148933601|NCT02949700|537242278|FG003|Phase I|Withdrawal by Subject|0|||
149187326|NCT01258348|538156672|FG004|Overall Study|Withdrawal by Subject|0|||
149187327|NCT00109733|538156676|FG000|Overall Study|Protocol Violation|0|||
149187328|NCT00109733|538156677|FG001|Overall Study|Protocol Violation|1|||
149187329|NCT00109733|538156676|FG000|Overall Study|Stopped taking study drug|1|||
149187330|NCT00109733|538156677|FG001|Overall Study|Stopped taking study drug|1|||
149187331|NCT00109733|538156676|FG000|Overall Study|Non-compliant|0|||
149187332|NCT00109733|538156677|FG001|Overall Study|Non-compliant|1|||
149187333|NCT00109733|538156676|FG000|Overall Study|Could not commit time for study|1|||
149187334|NCT00109733|538156677|FG001|Overall Study|Could not commit time for study|1|||
149187335|NCT02606045|538156680|FG000|Overall Study|Study closed before treament could begin|1|||
149187336|NCT02606045|538156681|FG001|Overall Study|Study closed before treament could begin|2|||
149187337|NCT03952468|538156682|FG000|Overall Study|Death|0|||
149187338|NCT03952468|538156683|FG001|Overall Study|Death|1|||
149187339|NCT03952468|538156682|FG000|Overall Study|Adverse Event|0|||
149187340|NCT03952468|538156683|FG001|Overall Study|Adverse Event|1|||
149187341|NCT03952468|538156682|FG000|Overall Study|Physician Decision|1|||
149187342|NCT03952468|538156683|FG001|Overall Study|Physician Decision|0|||
149187343|NCT03952468|538156682|FG000|Overall Study|Lost to Follow-up|3|||
149187344|NCT03952468|538156683|FG001|Overall Study|Lost to Follow-up|4|||
149187345|NCT03952468|538156682|FG000|Overall Study|Withdrawal by Subject|2|||
149187346|NCT03952468|538156683|FG001|Overall Study|Withdrawal by Subject|1|||
149187347|NCT01671085|538156685|FG000|Overall Study|Withdrawal by Subject|1|||
149187348|NCT01671085|538156686|FG001|Overall Study|Withdrawal by Subject|0|||
149187349|NCT00506077|538156694|FG000|Treatment Period 1|Adverse Event|2|||
149187350|NCT00506077|538156695|FG001|Treatment Period 1|Adverse Event|1|||
149187351|NCT00506077|538156694|FG000|Treatment Period 1|Lost to Follow-up|0|||
149187352|NCT00506077|538156695|FG001|Treatment Period 1|Lost to Follow-up|2|||
149187353|NCT00506077|538156694|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149187354|NCT00506077|538156695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149187355|NCT00506077|538156694|FG000|Treatment Period 2|Adverse Event|0|||
149187356|NCT00506077|538156695|FG001|Treatment Period 2|Adverse Event|1|||
149187357|NCT00506077|538156694|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149187358|NCT00506077|538156695|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149187359|NCT00316303|538156697|FG000|Overall Study|Lost to Follow-up|11|||
149187360|NCT00316303|538156698|FG001|Overall Study|Lost to Follow-up|16|||
149187361|NCT02375698|538156701|FG000|Overall Study|Withdrawal by Subject|0|||
149187362|NCT02375698|538156702|FG001|Overall Study|Withdrawal by Subject|2|||
149187363|NCT02375698|538156701|FG000|Overall Study|Physician Decision|2|||
149187364|NCT02375698|538156702|FG001|Overall Study|Physician Decision|0|||
149187365|NCT00772967|538156703|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
149187366|NCT00772967|538156704|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
149187367|NCT00772967|538156705|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
149187368|NCT00772967|538156706|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
149187369|NCT00772967|538156707|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
148933602|NCT02949700|537242275|FG000|Phase I|Protocol Violation|1|||
148933603|NCT02949700|537242276|FG001|Phase I|Protocol Violation|0|||
148933604|NCT02949700|537242277|FG002|Phase I|Protocol Violation|0|||
148933605|NCT02949700|537242278|FG003|Phase I|Protocol Violation|0|||
148933606|NCT02949700|537242275|FG000|Phase II|Withdrawal by Subject|0|||
148933607|NCT02949700|537242276|FG001|Phase II|Withdrawal by Subject|0|||
148933608|NCT02949700|537242277|FG002|Phase II|Withdrawal by Subject|0|||
148933609|NCT02949700|537242278|FG003|Phase II|Withdrawal by Subject|2|||
148933610|NCT02949700|537242275|FG000|Phase II|Protocol Violation|0|||
148933611|NCT02949700|537242276|FG001|Phase II|Protocol Violation|0|||
149187370|NCT00772967|538156708|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
149187371|NCT00772967|538156703|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149187372|NCT00772967|538156704|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
149187373|NCT00772967|538156705|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149187374|NCT00772967|538156706|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149187375|NCT00772967|538156707|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149187376|NCT00772967|538156708|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
149187377|NCT00772967|538156703|FG000|Crossover Treatment 3|Adverse Event|0|||
149187378|NCT00772967|538156704|FG001|Crossover Treatment 3|Adverse Event|0|||
149187379|NCT00772967|538156705|FG002|Crossover Treatment 3|Adverse Event|0|||
149187380|NCT00772967|538156706|FG003|Crossover Treatment 3|Adverse Event|0|||
148933612|NCT02949700|537242277|FG002|Phase II|Protocol Violation|1|||
148933613|NCT02949700|537242278|FG003|Phase II|Protocol Violation|3|||
149187381|NCT00772967|538156707|FG004|Crossover Treatment 3|Adverse Event|1|||
149187382|NCT00772967|538156708|FG005|Crossover Treatment 3|Adverse Event|0|||
149187383|NCT02229864|538156712|FG000|Overall Study|Death|2|||
149187384|NCT02229864|538156712|FG000|Overall Study|Lost to Follow-up|1|||
149187385|NCT02588248|538156719|FG000|Overall Study|Physician Decision|4|||
149187386|NCT02588248|538156720|FG001|Overall Study|Physician Decision|3|||
149187387|NCT04229446|538156721|FG000|Overall Study|Death|12|||
149187388|NCT04229446|538156722|FG001|Overall Study|Death|10|||
148807381|NCT00089648|536773236|FG000|Overall Study|Lack of Efficacy|33|||
148933614|NCT05597020|537242282|FG000|Washout|Forbidden medication|2|||
148933615|NCT05597020|537242283|FG001|Washout|Forbidden medication|0|||
148933616|NCT05597020|537242282|FG000|Treatment Period II|Advice from primary care physician|1|||
148933617|NCT05597020|537242283|FG001|Treatment Period II|Advice from primary care physician|0|||
148933618|NCT05597020|537242282|FG000|Treatment Period II|Subject lost investigational product|1|||
148933619|NCT05597020|537242283|FG001|Treatment Period II|Subject lost investigational product|0|||
148933620|NCT05597020|537242282|FG000|Treatment Period II|Private reasons|0|||
148933621|NCT05597020|537242283|FG001|Treatment Period II|Private reasons|1|||
148933622|NCT02718300|537242286|FG000|Overall Study|Death|4|||
148933623|NCT02718300|537242287|FG001|Overall Study|Death|5|||
148933624|NCT02718300|537242288|FG002|Overall Study|Death|17|||
148933625|NCT02718300|537242286|FG000|Overall Study|Lost to Follow-up|1|||
148933626|NCT02718300|537242287|FG001|Overall Study|Lost to Follow-up|0|||
148933627|NCT02718300|537242288|FG002|Overall Study|Lost to Follow-up|2|||
148933628|NCT02718300|537242286|FG000|Overall Study|Physician Decision|1|||
148933629|NCT02718300|537242287|FG001|Overall Study|Physician Decision|0|||
148933630|NCT02718300|537242288|FG002|Overall Study|Physician Decision|2|||
148933631|NCT02718300|537242286|FG000|Overall Study|Study Terminated by Sponsor|6|||
148933632|NCT02718300|537242287|FG001|Overall Study|Study Terminated by Sponsor|3|||
148933633|NCT02718300|537242288|FG002|Overall Study|Study Terminated by Sponsor|4|||
148933634|NCT02718300|537242286|FG000|Overall Study|Withdrawal by Subject|0|||
148933635|NCT02718300|537242287|FG001|Overall Study|Withdrawal by Subject|4|||
148933636|NCT02718300|537242288|FG002|Overall Study|Withdrawal by Subject|3|||
148933637|NCT02718300|537242286|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
148933638|NCT02718300|537242287|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
148933639|NCT02718300|537242288|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
148933640|NCT00560885|537242293|FG000|Overall Study|Death|7|||
149187389|NCT04229446|538156721|FG000|Overall Study|Lost to Follow-up|5|||
149187390|NCT04229446|538156722|FG001|Overall Study|Lost to Follow-up|8|||
149187391|NCT00705224|538156723|FG000|Overall Study|Adverse Event|1|||
149187392|NCT00705224|538156723|FG000|Overall Study|Lack of Efficacy|2|||
149187393|NCT00705224|538156723|FG000|Overall Study|Withdrawal by Subject|3|||
149187394|NCT00705224|538156723|FG000|Overall Study|Lost to Follow-up|5|||
149187395|NCT02566525|538156724|FG000|Overall Study|Protocol Violation|3|||
149187396|NCT02566525|538156725|FG001|Overall Study|Protocol Violation|5|||
149187397|NCT00337467|538156726|FG000|Overall Study|Adverse Event|3|||
149187398|NCT00337467|538156726|FG000|Overall Study|Subject Withdrew Consent|2|||
149187399|NCT00337467|538156726|FG000|Overall Study|Pregnancy|1|||
149187400|NCT00337467|538156726|FG000|Overall Study|Lost to Follow-up|2|||
149187401|NCT00337467|538156726|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
149187402|NCT03141086|538156727|FG000|Overall Study|Study Terminated By Sponsor|1|||
149187403|NCT03141086|538156728|FG001|Overall Study|Study Terminated By Sponsor|1|||
149187404|NCT03141086|538156727|FG000|Overall Study|Withdrawal by Subject|0|||
149187405|NCT03141086|538156728|FG001|Overall Study|Withdrawal by Subject|1|||
149187406|NCT03141086|538156727|FG000|Overall Study|Protocol Violation|0|||
149187407|NCT03141086|538156728|FG001|Overall Study|Protocol Violation|1|||
149187408|NCT03141086|538156727|FG000|Overall Study|Adverse Event|0|||
149187409|NCT03141086|538156728|FG001|Overall Study|Adverse Event|2|||
149187410|NCT04430582|538156730|FG000|Overall Study|Found to meet exclusionary criteria|1|||
149187411|NCT04430582|538156731|FG001|Overall Study|Found to meet exclusionary criteria|0|||
149187412|NCT04430582|538156730|FG000|Overall Study|Withdrawal by Subject|0|||
149187413|NCT04430582|538156731|FG001|Overall Study|Withdrawal by Subject|1|||
149187414|NCT03607682|538156732|FG000|Overall Study|Withdrawal by Subject|1|||
149187415|NCT03607682|538156732|FG000|Overall Study|Disease progression|1|||
149187416|NCT02410902|538158419|FG000|Overall Study|Adverse Event|2|||
149187417|NCT02410902|538158420|FG001|Overall Study|Adverse Event|3|||
149187418|NCT02410902|538158419|FG000|Overall Study|Lost to Follow-up|4|||
149187419|NCT02410902|538158420|FG001|Overall Study|Lost to Follow-up|1|||
149187420|NCT02410902|538158419|FG000|Overall Study|Protocol Violation|1|||
148933641|NCT00560885|537242293|FG000|Overall Study|Withdrawal by Subject|1|||
149187421|NCT02410902|538158420|FG001|Overall Study|Protocol Violation|4|||
148933642|NCT02887859|537242301|FG000|Overall Study|Ongoing|6|||
148933643|NCT02887859|537242301|FG000|Overall Study|Adverse Event|7|||
148933644|NCT02887859|537242301|FG000|Overall Study|Death|1|||
148933645|NCT02887859|537242301|FG000|Overall Study|Physician Decision|1|||
148933646|NCT01554397|537242304|FG000|Overall Study|Withdrawal by Subject|1|||
148933647|NCT01554397|537242305|FG001|Overall Study|Withdrawal by Subject|0|||
148933648|NCT01554397|537242304|FG000|Overall Study|Ineligible|7|||
148933649|NCT01554397|537242305|FG001|Overall Study|Ineligible|0|||
149187422|NCT02410902|538158419|FG000|Overall Study|Withdrawal by Subject|6|||
149187423|NCT02410902|538158420|FG001|Overall Study|Withdrawal by Subject|8|||
149187424|NCT02410902|538158419|FG000|Overall Study|Non-Compliance|8|||
149187425|NCT02410902|538158420|FG001|Overall Study|Non-Compliance|2|||
149187426|NCT01043185|538158421|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
149187427|NCT01043185|538158422|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
149187428|NCT01043185|538158423|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
149187429|NCT01043185|538158424|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
149187430|NCT01043185|538158425|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
149187431|NCT01043185|538158426|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
149187432|NCT01043185|538158427|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
149187433|NCT01043185|538158428|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
149187434|NCT01043185|538158429|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
149187435|NCT01043185|538158430|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
149187436|NCT00137436|538158431|FG000|Overall Study|Adverse Event|13|||
149187437|NCT00137436|538158431|FG000|Overall Study|Death|2|||
149187438|NCT00137436|538158431|FG000|Overall Study|Lack of Efficacy|17|||
149187439|NCT00137436|538158431|FG000|Overall Study|Withdrawal by Subject|6|||
149187440|NCT00137436|538158431|FG000|Overall Study|Other|5|||
149187441|NCT00701727|538158432|FG000|First Treatment Period|Adverse Event|0|||
149187442|NCT00701727|538158433|FG001|First Treatment Period|Adverse Event|0|||
149187443|NCT00701727|538158432|FG000|First Treatment Period|Withdrawal by Subject|1|||
149187444|NCT00701727|538158433|FG001|First Treatment Period|Withdrawal by Subject|0|||
149187445|NCT00701727|538158432|FG000|First Treatment Period|sponsor decision|0|||
149187446|NCT00701727|538158433|FG001|First Treatment Period|sponsor decision|1|||
149187447|NCT00701727|538158432|FG000|First Treatment Period|Lost to Follow-up|0|||
149187448|NCT00701727|538158433|FG001|First Treatment Period|Lost to Follow-up|1|||
149187449|NCT00701727|538158432|FG000|Second Treatment Period|Withdrawal by Subject|2|||
149187450|NCT00701727|538158433|FG001|Second Treatment Period|Withdrawal by Subject|0|||
149187451|NCT00912015|538158434|FG000|Overall Study|Lack of Efficacy|1|||
149187452|NCT00912015|538158435|FG001|Overall Study|Lack of Efficacy|0|||
149187453|NCT00912015|538158436|FG002|Overall Study|Lack of Efficacy|0|||
149187454|NCT00912015|538158437|FG003|Overall Study|Lack of Efficacy|0|||
149187455|NCT00912015|538158434|FG000|Overall Study|Withdrawal by Subject|8|||
149187456|NCT00912015|538158435|FG001|Overall Study|Withdrawal by Subject|8|||
149187457|NCT00912015|538158436|FG002|Overall Study|Withdrawal by Subject|3|||
149187458|NCT00912015|538158437|FG003|Overall Study|Withdrawal by Subject|0|||
149187459|NCT00912015|538158434|FG000|Overall Study|Protocol Violation|1|||
149187460|NCT00912015|538158435|FG001|Overall Study|Protocol Violation|0|||
149187461|NCT00912015|538158436|FG002|Overall Study|Protocol Violation|0|||
149187462|NCT00912015|538158437|FG003|Overall Study|Protocol Violation|1|||
149187463|NCT00912015|538158434|FG000|Overall Study|Adverse Event|6|||
149187464|NCT00912015|538158435|FG001|Overall Study|Adverse Event|0|||
149187465|NCT00912015|538158436|FG002|Overall Study|Adverse Event|0|||
149187466|NCT00912015|538158437|FG003|Overall Study|Adverse Event|1|||
149187467|NCT05137041|538158438|FG000|Overall Study|Lost to Follow-up|1|||
149187468|NCT05137041|538158439|FG001|Overall Study|Lost to Follow-up|1|||
149187469|NCT05137041|538158438|FG000|Overall Study|Withdrawal by Subject|0|||
149187470|NCT05137041|538158439|FG001|Overall Study|Withdrawal by Subject|2|||
149187471|NCT05137041|538158438|FG000|Overall Study|Reason not Specified|0|||
149187472|NCT05137041|538158439|FG001|Overall Study|Reason not Specified|1|||
149187473|NCT02090114|538158440|FG000|Overall Study|Withdrawal by Subject|3|||
149187474|NCT02090114|538158441|FG001|Overall Study|Withdrawal by Subject|6|||
149187475|NCT02090114|538158442|FG002|Overall Study|Withdrawal by Subject|2|||
149187476|NCT02090114|538158443|FG003|Overall Study|Withdrawal by Subject|1|||
149187477|NCT02090114|538158440|FG000|Overall Study|Physician Decision|5|||
149187478|NCT02090114|538158441|FG001|Overall Study|Physician Decision|0|||
149187479|NCT02090114|538158442|FG002|Overall Study|Physician Decision|1|||
149187480|NCT02090114|538158443|FG003|Overall Study|Physician Decision|1|||
149187481|NCT02090114|538158440|FG000|Overall Study|Adverse Event|1|||
149187482|NCT02090114|538158441|FG001|Overall Study|Adverse Event|2|||
148933650|NCT00257608|537244297|FG000|Chemotherapy Phase|Adverse Event|138|||
148933651|NCT00257608|537244298|FG001|Chemotherapy Phase|Adverse Event|0|||
148933652|NCT00257608|537244299|FG002|Chemotherapy Phase|Adverse Event|0|||
148933653|NCT00257608|537244297|FG000|Chemotherapy Phase|Disease progression|139|||
148933654|NCT00257608|537244298|FG001|Chemotherapy Phase|Disease progression|0|||
148933655|NCT00257608|537244299|FG002|Chemotherapy Phase|Disease progression|0|||
148933656|NCT00257608|537244297|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
149187483|NCT02090114|538158442|FG002|Overall Study|Adverse Event|2|||
149187484|NCT02090114|538158443|FG003|Overall Study|Adverse Event|0|||
148807382|NCT00423605|536773237|FG000|Overall Study|Adverse Event|129|||
148807383|NCT00423605|536773237|FG000|Overall Study|Withdrawal by Subject|36|||
149187485|NCT02090114|538158440|FG000|Overall Study|Progressive Disease|20|||
149187486|NCT02090114|538158441|FG001|Overall Study|Progressive Disease|21|||
149187487|NCT02090114|538158442|FG002|Overall Study|Progressive Disease|23|||
149187488|NCT02090114|538158443|FG003|Overall Study|Progressive Disease|6|||
149187489|NCT02090114|538158440|FG000|Overall Study|Death|1|||
149187490|NCT02090114|538158441|FG001|Overall Study|Death|0|||
149187491|NCT02090114|538158442|FG002|Overall Study|Death|1|||
149187492|NCT02090114|538158443|FG003|Overall Study|Death|0|||
149187493|NCT00392171|538158444|FG000|Overall Study|Did not meet inclusion criteria|4|||
149187494|NCT00392171|538158444|FG000|Overall Study|Disease progression|101|||
149187495|NCT03470922|538158446|FG000|Overall Study|Death|107|||
149187496|NCT03470922|538158447|FG001|Overall Study|Death|118|||
149187497|NCT03470922|538158446|FG000|Overall Study|Lost to Follow-up|5|||
149187498|NCT03470922|538158447|FG001|Overall Study|Lost to Follow-up|5|||
149187499|NCT03470922|538158446|FG000|Overall Study|Participant Withdrew Consent|4|||
149187500|NCT03470922|538158447|FG001|Overall Study|Participant Withdrew Consent|9|||
149187501|NCT03470922|538158446|FG000|Overall Study|Other reasons|1|||
149187502|NCT03470922|538158447|FG001|Overall Study|Other reasons|0|||
149187503|NCT03470922|538158446|FG000|Overall Study|Not reported|1|||
149187504|NCT03470922|538158447|FG001|Overall Study|Not reported|0|||
149187505|NCT02163993|538158450|FG000|Treatment Period|Adverse Event|0|||
149187506|NCT02163993|538158451|FG001|Treatment Period|Adverse Event|1|||
149187507|NCT02163993|538158452|FG002|Treatment Period|Adverse Event|0|||
149187508|NCT02163993|538158453|FG003|Treatment Period|Adverse Event|0|||
149187509|NCT02163993|538158454|FG004|Treatment Period|Adverse Event|1|||
149187510|NCT02163993|538158450|FG000|Treatment Period|Lost to Follow-up|2|||
149187511|NCT02163993|538158451|FG001|Treatment Period|Lost to Follow-up|3|||
149187512|NCT02163993|538158452|FG002|Treatment Period|Lost to Follow-up|1|||
149187513|NCT02163993|538158453|FG003|Treatment Period|Lost to Follow-up|3|||
149187514|NCT02163993|538158454|FG004|Treatment Period|Lost to Follow-up|1|||
149187515|NCT02163993|538158450|FG000|Treatment Period|Physician Decision|1|||
149187516|NCT02163993|538158451|FG001|Treatment Period|Physician Decision|0|||
149187517|NCT02163993|538158452|FG002|Treatment Period|Physician Decision|0|||
149187518|NCT02163993|538158453|FG003|Treatment Period|Physician Decision|0|||
149187519|NCT02163993|538158454|FG004|Treatment Period|Physician Decision|0|||
149187520|NCT02163993|538158450|FG000|Treatment Period|Protocol Violation|2|||
149187521|NCT02163993|538158451|FG001|Treatment Period|Protocol Violation|1|||
149187522|NCT02163993|538158452|FG002|Treatment Period|Protocol Violation|0|||
149187523|NCT02163993|538158453|FG003|Treatment Period|Protocol Violation|1|||
149187524|NCT02163993|538158454|FG004|Treatment Period|Protocol Violation|2|||
149187525|NCT02163993|538158450|FG000|Treatment Period|Withdrawal by Subject|6|||
149187526|NCT02163993|538158451|FG001|Treatment Period|Withdrawal by Subject|4|||
149187527|NCT02163993|538158452|FG002|Treatment Period|Withdrawal by Subject|1|||
149187528|NCT02163993|538158453|FG003|Treatment Period|Withdrawal by Subject|4|||
149187529|NCT02163993|538158454|FG004|Treatment Period|Withdrawal by Subject|1|||
149187530|NCT02163993|538158450|FG000|Treatment Period|Not treated|1|||
149187531|NCT02163993|538158451|FG001|Treatment Period|Not treated|0|||
149187532|NCT02163993|538158452|FG002|Treatment Period|Not treated|0|||
149187533|NCT02163993|538158453|FG003|Treatment Period|Not treated|1|||
149187534|NCT02163993|538158454|FG004|Treatment Period|Not treated|2|||
149187535|NCT02163993|538158450|FG000|Post-treatment Period|Adverse Event|0|||
149187536|NCT02163993|538158451|FG001|Post-treatment Period|Adverse Event|0|||
149187537|NCT02163993|538158452|FG002|Post-treatment Period|Adverse Event|1|||
149187538|NCT02163993|538158453|FG003|Post-treatment Period|Adverse Event|0|||
149187539|NCT02163993|538158454|FG004|Post-treatment Period|Adverse Event|0|||
149187540|NCT02163993|538158450|FG000|Post-treatment Period|Lost to Follow-up|2|||
149187541|NCT02163993|538158451|FG001|Post-treatment Period|Lost to Follow-up|2|||
149187542|NCT02163993|538158452|FG002|Post-treatment Period|Lost to Follow-up|3|||
149187543|NCT02163993|538158453|FG003|Post-treatment Period|Lost to Follow-up|1|||
149187544|NCT02163993|538158454|FG004|Post-treatment Period|Lost to Follow-up|0|||
149187545|NCT02163993|538158450|FG000|Post-treatment Period|Protocol Violation|0|||
149187546|NCT02163993|538158451|FG001|Post-treatment Period|Protocol Violation|0|||
149187547|NCT02163993|538158452|FG002|Post-treatment Period|Protocol Violation|0|||
149187548|NCT02163993|538158453|FG003|Post-treatment Period|Protocol Violation|0|||
149187549|NCT02163993|538158454|FG004|Post-treatment Period|Protocol Violation|1|||
149187550|NCT02163993|538158450|FG000|Post-treatment Period|Withdrawal by Subject|2|||
149187551|NCT02163993|538158451|FG001|Post-treatment Period|Withdrawal by Subject|4|||
148933657|NCT00257608|537244298|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
148933658|NCT00257608|537244299|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
149187552|NCT02163993|538158452|FG002|Post-treatment Period|Withdrawal by Subject|0|||
149187553|NCT02163993|538158453|FG003|Post-treatment Period|Withdrawal by Subject|1|||
148933659|NCT00257608|537244297|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
149187554|NCT02163993|538158454|FG004|Post-treatment Period|Withdrawal by Subject|2|||
149187555|NCT01345123|538158455|FG000|Overall Study|participants no longer with health plan|79|||
149187556|NCT01345123|538158456|FG001|Overall Study|participants no longer with health plan|85|||
149187557|NCT01345123|538158457|FG002|Overall Study|participants no longer with health plan|88|||
149187558|NCT00883558|538158458|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
149187559|NCT00883558|538158459|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
149187560|NCT00883558|538158460|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
148933660|NCT00257608|537244298|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
149187561|NCT00883558|538158458|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
149187562|NCT00883558|538158459|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
149187563|NCT00883558|538158460|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
149187564|NCT00883558|538158458|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
149187565|NCT00883558|538158459|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
149187566|NCT00883558|538158460|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
149187567|NCT00883558|538158458|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
149187568|NCT00883558|538158459|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
149187569|NCT00883558|538158460|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
149187570|NCT00883558|538158458|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
149187571|NCT00883558|538158459|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
149187572|NCT00883558|538158460|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
149187573|NCT00366548|538158462|FG000|Infant Series|Adverse Event|1|||
149187574|NCT00366548|538158463|FG001|Infant Series|Adverse Event|3|||
149187575|NCT00366548|538158462|FG000|Infant Series|Protocol Violation|0|||
149187576|NCT00366548|538158463|FG001|Infant Series|Protocol Violation|1|||
149187577|NCT00366548|538158462|FG000|Infant Series|Withdrawal by Subject|3|||
149187578|NCT00366548|538158463|FG001|Infant Series|Withdrawal by Subject|1|||
149187579|NCT00366548|538158462|FG000|After Infant Series|Withdrawal by Subject|3|||
149187580|NCT00366548|538158463|FG001|After Infant Series|Withdrawal by Subject|1|||
149187581|NCT00366548|538158462|FG000|After Infant Series|Adverse Event|2|||
149187582|NCT00366548|538158463|FG001|After Infant Series|Adverse Event|0|||
149187583|NCT00366548|538158462|FG000|After Infant Series|Lost to Follow-up|1|||
149187584|NCT00366548|538158463|FG001|After Infant Series|Lost to Follow-up|0|||
149187585|NCT01252134|538158464|FG000|Period 1, 8 Hours|Personal Reasons|0|||
149187586|NCT01252134|538158465|FG001|Period 1, 8 Hours|Personal Reasons|1|||
149187587|NCT01252134|538158466|FG002|Period 1, 8 Hours|Personal Reasons|1|||
149187588|NCT01252134|538158467|FG003|Period 1, 8 Hours|Personal Reasons|0|||
149187589|NCT01252134|538158468|FG004|Period 1, 8 Hours|Personal Reasons|0|||
149187590|NCT01252134|538158469|FG005|Period 1, 8 Hours|Personal Reasons|0|||
149187591|NCT01984346|538158470|FG000|Overall Study|Physician Decision|4|||
149187592|NCT01984346|538158471|FG001|Overall Study|Physician Decision|2|||
149187593|NCT01984346|538158470|FG000|Overall Study|Withdrawal by Subject|2|||
149187594|NCT01984346|538158471|FG001|Overall Study|Withdrawal by Subject|2|||
149187595|NCT01984346|538158470|FG000|Overall Study|Enrollment Closed|8|||
149187596|NCT01984346|538158471|FG001|Overall Study|Enrollment Closed|1|||
149187597|NCT01984346|538158470|FG000|Overall Study|Insurance Coverage|1|||
149187598|NCT01984346|538158471|FG001|Overall Study|Insurance Coverage|0|||
149187599|NCT01984346|538158470|FG000|Overall Study|Intra-operative Exclusion|2|||
149187600|NCT01984346|538158471|FG001|Overall Study|Intra-operative Exclusion|0|||
149187601|NCT00536731|538158472|FG000|Overall Study|Adverse Event|3|||
149187602|NCT00536731|538158473|FG001|Overall Study|Adverse Event|2|||
149187603|NCT00536731|538158474|FG002|Overall Study|Adverse Event|3|||
149187604|NCT00536731|538158472|FG000|Overall Study|Withdrawal by Subject|0|||
149187605|NCT00536731|538158473|FG001|Overall Study|Withdrawal by Subject|2|||
149187606|NCT00536731|538158474|FG002|Overall Study|Withdrawal by Subject|0|||
149187607|NCT00536731|538158472|FG000|Overall Study|Intake of prohibited conc. medication|0|||
149187608|NCT00536731|538158473|FG001|Overall Study|Intake of prohibited conc. medication|0|||
149187609|NCT00536731|538158474|FG002|Overall Study|Intake of prohibited conc. medication|1|||
149187610|NCT00536731|538158472|FG000|Overall Study|Safety reasons|0|||
149187611|NCT00536731|538158473|FG001|Overall Study|Safety reasons|0|||
149187612|NCT00536731|538158474|FG002|Overall Study|Safety reasons|1|||
149187613|NCT00536731|538158472|FG000|Overall Study|Other|1|||
149187614|NCT00536731|538158473|FG001|Overall Study|Other|1|||
149187615|NCT00536731|538158474|FG002|Overall Study|Other|0|||
149187616|NCT04184622|538158477|FG000|Primary Treatment Period|Adverse Event|6|||
149187617|NCT04184622|538158478|FG001|Primary Treatment Period|Adverse Event|4|||
149187618|NCT04184622|538158479|FG002|Primary Treatment Period|Adverse Event|8|||
149187619|NCT04184622|538158480|FG003|Primary Treatment Period|Adverse Event|6|||
149187620|NCT04184622|538158477|FG000|Primary Treatment Period|Death|4|||
149187621|NCT04184622|538158478|FG001|Primary Treatment Period|Death|4|||
149187622|NCT04184622|538158479|FG002|Primary Treatment Period|Death|2|||
149187623|NCT04184622|538158480|FG003|Primary Treatment Period|Death|1|||
149187624|NCT04184622|538158477|FG000|Primary Treatment Period|Lost to Follow-up|41|||
149187625|NCT04184622|538158478|FG001|Primary Treatment Period|Lost to Follow-up|17|||
149187626|NCT04184622|538158479|FG002|Primary Treatment Period|Lost to Follow-up|15|||
149187627|NCT04184622|538158480|FG003|Primary Treatment Period|Lost to Follow-up|13|||
149187628|NCT04184622|538158477|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
149187629|NCT04184622|538158478|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
149187630|NCT04184622|538158479|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
149187631|NCT04184622|538158480|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
149187632|NCT04184622|538158477|FG000|Primary Treatment Period|Physician Decision|0|||
149187633|NCT04184622|538158478|FG001|Primary Treatment Period|Physician Decision|0|||
149187634|NCT04184622|538158479|FG002|Primary Treatment Period|Physician Decision|3|||
149187635|NCT04184622|538158480|FG003|Primary Treatment Period|Physician Decision|1|||
149014319|NCT01912781|537532179|FG000|Overall Study|Withdrawal by Subject|2|||
149187636|NCT04184622|538158477|FG000|Primary Treatment Period|Pregnancy|4|||
149014320|NCT01912781|537532180|FG001|Overall Study|Withdrawal by Subject|0|||
149014321|NCT01235975|537532181|FG000|Overall Study|Serious Adverse Event|0|||
149014322|NCT01235975|537532182|FG001|Overall Study|Serious Adverse Event|1|||
149014323|NCT01235975|537532181|FG000|Overall Study|Withdrawal by Subject|8|||
149014324|NCT01235975|537532182|FG001|Overall Study|Withdrawal by Subject|2|||
149014325|NCT01235975|537532181|FG000|Overall Study|Migrated/moved from study area|2|||
149014326|NCT01235975|537532182|FG001|Overall Study|Migrated/moved from study area|1|||
149014327|NCT01235975|537532181|FG000|Overall Study|Lost to Follow-up|7|||
149187637|NCT04184622|538158478|FG001|Primary Treatment Period|Pregnancy|3|||
149187638|NCT04184622|538158479|FG002|Primary Treatment Period|Pregnancy|4|||
149187639|NCT04184622|538158480|FG003|Primary Treatment Period|Pregnancy|1|||
149014328|NCT01235975|537532182|FG001|Overall Study|Lost to Follow-up|3|||
149187640|NCT04184622|538158477|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
149187641|NCT04184622|538158478|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
149187642|NCT04184622|538158479|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
149187643|NCT04184622|538158480|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
149187644|NCT04184622|538158477|FG000|Additional Treatment Period|Adverse Event|1|||
149187645|NCT04184622|538158478|FG001|Additional Treatment Period|Adverse Event|2|||
149187646|NCT04184622|538158479|FG002|Additional Treatment Period|Adverse Event|1|||
149187647|NCT04184622|538158480|FG003|Additional Treatment Period|Adverse Event|0|||
149187648|NCT04184622|538158477|FG000|Additional Treatment Period|Death|0|||
149187649|NCT04184622|538158478|FG001|Additional Treatment Period|Death|0|||
149187650|NCT04184622|538158479|FG002|Additional Treatment Period|Death|1|||
149187651|NCT04184622|538158480|FG003|Additional Treatment Period|Death|1|||
149187652|NCT04184622|538158477|FG000|Additional Treatment Period|Lost to Follow-up|6|||
149187653|NCT04184622|538158478|FG001|Additional Treatment Period|Lost to Follow-up|4|||
149187654|NCT04184622|538158479|FG002|Additional Treatment Period|Lost to Follow-up|8|||
149187655|NCT04184622|538158480|FG003|Additional Treatment Period|Lost to Follow-up|6|||
149187656|NCT04184622|538158477|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
149187657|NCT04184622|538158478|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
149187658|NCT04184622|538158479|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
149187659|NCT04184622|538158480|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
149187660|NCT04184622|538158477|FG000|Additional Treatment Period|Physician Decision|0|||
149187661|NCT04184622|538158478|FG001|Additional Treatment Period|Physician Decision|0|||
149187662|NCT04184622|538158479|FG002|Additional Treatment Period|Physician Decision|1|||
149187663|NCT04184622|538158480|FG003|Additional Treatment Period|Physician Decision|0|||
149187664|NCT04184622|538158477|FG000|Additional Treatment Period|Pregnancy|0|||
149187665|NCT04184622|538158478|FG001|Additional Treatment Period|Pregnancy|0|||
149187666|NCT04184622|538158479|FG002|Additional Treatment Period|Pregnancy|0|||
149187667|NCT04184622|538158480|FG003|Additional Treatment Period|Pregnancy|1|||
149187668|NCT04184622|538158477|FG000|Additional Treatment Period|Protocol deviation|0|||
149187669|NCT04184622|538158478|FG001|Additional Treatment Period|Protocol deviation|0|||
149187670|NCT04184622|538158479|FG002|Additional Treatment Period|Protocol deviation|1|||
149187671|NCT04184622|538158480|FG003|Additional Treatment Period|Protocol deviation|0|||
149187672|NCT04184622|538158477|FG000|Additional Treatment Period|Site closed|1|||
149187673|NCT04184622|538158478|FG001|Additional Treatment Period|Site closed|0|||
149187674|NCT04184622|538158479|FG002|Additional Treatment Period|Site closed|1|||
149187675|NCT04184622|538158480|FG003|Additional Treatment Period|Site closed|0|||
149187676|NCT04184622|538158477|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
149187677|NCT04184622|538158478|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
149187678|NCT04184622|538158479|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
149187679|NCT04184622|538158480|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
149187680|NCT04184622|538158477|FG000|Safety Follow-up Period|Adverse Event|6|||
149187681|NCT04184622|538158478|FG001|Safety Follow-up Period|Adverse Event|8|||
149187682|NCT04184622|538158479|FG002|Safety Follow-up Period|Adverse Event|9|||
149187683|NCT04184622|538158480|FG003|Safety Follow-up Period|Adverse Event|16|||
149187684|NCT04184622|538158477|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
149187685|NCT04184622|538158478|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
149187686|NCT04184622|538158479|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
149187687|NCT04184622|538158480|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
149187688|NCT04184622|538158477|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
149187689|NCT04184622|538158478|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
149014329|NCT00708305|537532189|FG000|Period 1|Protocol Violation|1|||
149187690|NCT04184622|538158479|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
149187691|NCT04184622|538158480|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
149187692|NCT04184622|538158477|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
149187693|NCT04184622|538158478|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
149187694|NCT04184622|538158479|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
149014330|NCT00708305|537532190|FG001|Period 1|Protocol Violation|0|||
149014331|NCT00708305|537532191|FG002|Period 1|Protocol Violation|1|||
149014332|NCT00708305|537532192|FG003|Period 1|Protocol Violation|0|||
148807384|NCT00423605|536773237|FG000|Overall Study|Lost to Follow-up|15|||
148807385|NCT00423605|536773237|FG000|Overall Study|Lack of Efficacy|38|||
148933661|NCT00257608|537244299|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
148933662|NCT00257608|537244297|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
149187695|NCT04184622|538158480|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
149187696|NCT04184622|538158477|FG000|Safety Follow-up Period|Physician Decision|1|||
149187697|NCT04184622|538158478|FG001|Safety Follow-up Period|Physician Decision|0|||
149187698|NCT04184622|538158479|FG002|Safety Follow-up Period|Physician Decision|0|||
149187699|NCT04184622|538158480|FG003|Safety Follow-up Period|Physician Decision|1|||
149187700|NCT04184622|538158477|FG000|Safety Follow-up Period|Pregnancy|1|||
149187701|NCT04184622|538158478|FG001|Safety Follow-up Period|Pregnancy|3|||
149187702|NCT04184622|538158479|FG002|Safety Follow-up Period|Pregnancy|0|||
149187703|NCT04184622|538158480|FG003|Safety Follow-up Period|Pregnancy|6|||
149187704|NCT04184622|538158477|FG000|Safety Follow-up Period|Protocol deviation|1|||
149187705|NCT04184622|538158478|FG001|Safety Follow-up Period|Protocol deviation|0|||
149187706|NCT04184622|538158479|FG002|Safety Follow-up Period|Protocol deviation|0|||
149187707|NCT04184622|538158480|FG003|Safety Follow-up Period|Protocol deviation|0|||
149187708|NCT04184622|538158477|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
149187709|NCT04184622|538158478|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
149187710|NCT04184622|538158479|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
149187711|NCT04184622|538158480|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
149187712|NCT02795988|538158481|FG000|Phase 1b|Withdrawal by Subject|0|||
149187713|NCT02795988|538158482|FG001|Phase 1b|Withdrawal by Subject|1|||
149187714|NCT02795988|538158483|FG002|Phase 1b|Withdrawal by Subject|0|||
149187715|NCT02795988|538158484|FG003|Phase 1b|Withdrawal by Subject|0|||
149187716|NCT02795988|538158485|FG004|Phase 1b|Withdrawal by Subject|0|||
149187717|NCT02795988|538158486|FG005|Phase 1b|Withdrawal by Subject|0|||
149187718|NCT02795988|538158487|FG006|Phase 1b|Withdrawal by Subject|0|||
149187719|NCT02795988|538158481|FG000|Phase 1b|Death|1|||
149187720|NCT02795988|538158482|FG001|Phase 1b|Death|2|||
149187721|NCT02795988|538158483|FG002|Phase 1b|Death|1|||
149187722|NCT02795988|538158484|FG003|Phase 1b|Death|0|||
149187723|NCT02795988|538158485|FG004|Phase 1b|Death|0|||
149187724|NCT02795988|538158486|FG005|Phase 1b|Death|0|||
149187725|NCT02795988|538158487|FG006|Phase 1b|Death|0|||
149187726|NCT02795988|538158481|FG000|Phase 1b|Physician Decision|0|||
149187727|NCT02795988|538158482|FG001|Phase 1b|Physician Decision|0|||
149187728|NCT02795988|538158483|FG002|Phase 1b|Physician Decision|1|||
149187729|NCT02795988|538158484|FG003|Phase 1b|Physician Decision|0|||
149187730|NCT02795988|538158485|FG004|Phase 1b|Physician Decision|0|||
149187731|NCT02795988|538158486|FG005|Phase 1b|Physician Decision|0|||
149187732|NCT02795988|538158487|FG006|Phase 1b|Physician Decision|0|||
149187733|NCT02795988|538158481|FG000|Phase 1b|Progressive Disease|2|||
149187734|NCT02795988|538158482|FG001|Phase 1b|Progressive Disease|2|||
149187735|NCT02795988|538158483|FG002|Phase 1b|Progressive Disease|0|||
149187736|NCT02795988|538158484|FG003|Phase 1b|Progressive Disease|0|||
149187737|NCT02795988|538158485|FG004|Phase 1b|Progressive Disease|0|||
149187738|NCT02795988|538158486|FG005|Phase 1b|Progressive Disease|0|||
149187739|NCT02795988|538158487|FG006|Phase 1b|Progressive Disease|0|||
149187740|NCT02795988|538158481|FG000|Phase 2|Withdrawal by Subject|0|||
149187741|NCT02795988|538158482|FG001|Phase 2|Withdrawal by Subject|0|||
149187742|NCT02795988|538158483|FG002|Phase 2|Withdrawal by Subject|0|||
149187743|NCT02795988|538158484|FG003|Phase 2|Withdrawal by Subject|1|||
149187744|NCT02795988|538158485|FG004|Phase 2|Withdrawal by Subject|0|||
149187745|NCT02795988|538158486|FG005|Phase 2|Withdrawal by Subject|0|||
149187746|NCT02795988|538158487|FG006|Phase 2|Withdrawal by Subject|0|||
149187747|NCT02795988|538158481|FG000|Phase 2|Death|0|||
149187748|NCT02795988|538158482|FG001|Phase 2|Death|0|||
149187749|NCT02795988|538158483|FG002|Phase 2|Death|0|||
149187750|NCT02795988|538158484|FG003|Phase 2|Death|17|||
149187751|NCT02795988|538158485|FG004|Phase 2|Death|17|||
149187752|NCT02795988|538158486|FG005|Phase 2|Death|0|||
149187753|NCT02795988|538158487|FG006|Phase 2|Death|0|||
149187754|NCT02795988|538158481|FG000|Phase 2|Other|0|||
149187755|NCT02795988|538158482|FG001|Phase 2|Other|0|||
149187756|NCT02795988|538158483|FG002|Phase 2|Other|0|||
149187757|NCT02795988|538158484|FG003|Phase 2|Other|1|||
149187758|NCT02795988|538158485|FG004|Phase 2|Other|0|||
149014333|NCT00708305|537532189|FG000|Period 1|Other Reason|0|||
149187759|NCT02795988|538158486|FG005|Phase 2|Other|0|||
149187760|NCT02795988|538158487|FG006|Phase 2|Other|0|||
149187761|NCT02795988|538158481|FG000|Phase 2 Extension|Death|0|||
149187762|NCT02795988|538158482|FG001|Phase 2 Extension|Death|0|||
149187763|NCT02795988|538158483|FG002|Phase 2 Extension|Death|0|||
149187764|NCT02795988|538158484|FG003|Phase 2 Extension|Death|0|||
149187765|NCT02795988|538158485|FG004|Phase 2 Extension|Death|0|||
149187766|NCT02795988|538158486|FG005|Phase 2 Extension|Death|5|||
149187767|NCT02795988|538158487|FG006|Phase 2 Extension|Death|6|||
149187768|NCT02795988|538158481|FG000|Phase 2 Extension|Other reasons|0|||
149187769|NCT02795988|538158482|FG001|Phase 2 Extension|Other reasons|0|||
149187770|NCT02795988|538158483|FG002|Phase 2 Extension|Other reasons|0|||
149187771|NCT02795988|538158484|FG003|Phase 2 Extension|Other reasons|0|||
149187772|NCT02795988|538158485|FG004|Phase 2 Extension|Other reasons|0|||
149187773|NCT02795988|538158486|FG005|Phase 2 Extension|Other reasons|2|||
149187774|NCT02795988|538158487|FG006|Phase 2 Extension|Other reasons|1|||
149187775|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
149187776|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
149187777|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149187778|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149187779|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149187780|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149187781|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
149187782|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149187783|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
149187784|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149187785|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149187786|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
149187787|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149187788|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
149187789|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
149187790|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
149187791|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
149187792|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
149187793|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
149187794|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
149187795|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
149187796|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Other|0|||
149187797|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Other|1|||
149187798|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Other|0|||
149187799|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Other|0|||
149187800|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Other|0|||
149187801|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Other|0|||
149187802|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Other|0|||
149187803|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
149187804|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
149187805|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
149187806|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
149187807|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
149187808|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
149187809|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
149187810|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
149187811|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
149187812|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
149187813|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
149187814|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
149187815|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
149187816|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
149187817|NCT00365716|538158488|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
149187818|NCT00365716|538158489|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
149187819|NCT00365716|538158490|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
149187820|NCT00365716|538158491|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
149187821|NCT00365716|538158492|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
149187822|NCT00365716|538158493|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
149187823|NCT00365716|538158494|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
149187824|NCT00365716|538158488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
149187825|NCT00365716|538158489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149187826|NCT00365716|538158490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
148933663|NCT00257608|537244298|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
148933664|NCT00257608|537244299|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
148933665|NCT00257608|537244297|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
148933666|NCT00257608|537244298|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
148933667|NCT00257608|537244299|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
149187827|NCT00365716|538158491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
149187828|NCT00365716|538158492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
148807386|NCT00423605|536773237|FG000|Overall Study|Sponsor Decision|3|||
148933668|NCT00257608|537244297|FG000|Chemotherapy Phase|Physician Decision|28|||
149187829|NCT00365716|538158493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149187830|NCT00365716|538158494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
149187831|NCT00365716|538158488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
149187832|NCT00365716|538158489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
149187833|NCT00365716|538158490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
149187834|NCT00365716|538158491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
149187835|NCT00365716|538158492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
149187836|NCT00365716|538158493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
149187837|NCT00365716|538158494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
149187838|NCT00365716|538158488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
149187839|NCT00365716|538158489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
149187840|NCT00365716|538158490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
149187841|NCT00365716|538158491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
149187842|NCT00365716|538158492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
149187843|NCT00365716|538158493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
149187844|NCT00365716|538158494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
149187845|NCT00365716|538158488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
149187846|NCT00365716|538158489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149187847|NCT00365716|538158490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149187848|NCT00365716|538158491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149187849|NCT00365716|538158492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
149187850|NCT00365716|538158493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149187851|NCT00365716|538158494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
149187852|NCT00365716|538158488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149187853|NCT00365716|538158489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
149187854|NCT00365716|538158490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
149187855|NCT00365716|538158491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149187856|NCT00365716|538158492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149187857|NCT00365716|538158493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149187858|NCT00365716|538158494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
149187859|NCT00365716|538158488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
149187860|NCT00365716|538158489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
149187861|NCT00365716|538158490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
149187862|NCT00365716|538158491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
149187863|NCT00365716|538158492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
149187864|NCT00365716|538158493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
149187865|NCT00365716|538158494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
149187866|NCT00365716|538158488|FG000|Extension 1|Lost to Follow-up|0|||
149187867|NCT00365716|538158489|FG001|Extension 1|Lost to Follow-up|0|||
149187868|NCT00365716|538158490|FG002|Extension 1|Lost to Follow-up|0|||
149187869|NCT00365716|538158491|FG003|Extension 1|Lost to Follow-up|0|||
149187870|NCT00365716|538158492|FG004|Extension 1|Lost to Follow-up|0|||
149187871|NCT00365716|538158493|FG005|Extension 1|Lost to Follow-up|1|||
149187872|NCT00365716|538158494|FG006|Extension 1|Lost to Follow-up|0|||
149187873|NCT00365716|538158488|FG000|Extension 1|Other|0|||
149187874|NCT00365716|538158489|FG001|Extension 1|Other|0|||
149187875|NCT00365716|538158490|FG002|Extension 1|Other|0|||
149187876|NCT00365716|538158491|FG003|Extension 1|Other|0|||
149187877|NCT00365716|538158492|FG004|Extension 1|Other|0|||
149187878|NCT00365716|538158493|FG005|Extension 1|Other|9|||
149187879|NCT00365716|538158494|FG006|Extension 1|Other|0|||
149187880|NCT00365716|538158488|FG000|Extension 1|Moved|0|||
149187881|NCT00365716|538158489|FG001|Extension 1|Moved|0|||
149187882|NCT00365716|538158490|FG002|Extension 1|Moved|0|||
149187883|NCT00365716|538158491|FG003|Extension 1|Moved|0|||
149187884|NCT00365716|538158492|FG004|Extension 1|Moved|0|||
149187885|NCT00365716|538158493|FG005|Extension 1|Moved|4|||
149187886|NCT00365716|538158494|FG006|Extension 1|Moved|0|||
149187887|NCT00365716|538158488|FG000|Extension 1|Withdrawal by Subject|0|||
149187888|NCT00365716|538158489|FG001|Extension 1|Withdrawal by Subject|0|||
149187889|NCT00365716|538158490|FG002|Extension 1|Withdrawal by Subject|0|||
149187890|NCT00365716|538158491|FG003|Extension 1|Withdrawal by Subject|0|||
149187891|NCT00365716|538158492|FG004|Extension 1|Withdrawal by Subject|0|||
149187892|NCT00365716|538158493|FG005|Extension 1|Withdrawal by Subject|3|||
149187893|NCT00365716|538158494|FG006|Extension 1|Withdrawal by Subject|0|||
149187894|NCT00365716|538158488|FG000|Extension 1|Pregnancy|0|||
149187895|NCT00365716|538158489|FG001|Extension 1|Pregnancy|0|||
149187896|NCT00365716|538158490|FG002|Extension 1|Pregnancy|0|||
149187897|NCT00365716|538158491|FG003|Extension 1|Pregnancy|0|||
149187898|NCT00365716|538158492|FG004|Extension 1|Pregnancy|0|||
149187899|NCT00365716|538158493|FG005|Extension 1|Pregnancy|4|||
149187900|NCT00365716|538158494|FG006|Extension 1|Pregnancy|0|||
149187901|NCT00365716|538158488|FG000|Extension 1|Protocol Violation|0|||
149187902|NCT00365716|538158489|FG001|Extension 1|Protocol Violation|0|||
149187903|NCT00365716|538158490|FG002|Extension 1|Protocol Violation|0|||
149187904|NCT00365716|538158491|FG003|Extension 1|Protocol Violation|0|||
149187905|NCT00365716|538158492|FG004|Extension 1|Protocol Violation|0|||
149187906|NCT00365716|538158493|FG005|Extension 1|Protocol Violation|1|||
149187907|NCT00365716|538158494|FG006|Extension 1|Protocol Violation|0|||
149187908|NCT00365716|538158488|FG000|Extension 2|Lost to Follow-up|0|||
149187909|NCT00365716|538158489|FG001|Extension 2|Lost to Follow-up|0|||
149187910|NCT00365716|538158490|FG002|Extension 2|Lost to Follow-up|0|||
148933669|NCT00257608|537244298|FG001|Chemotherapy Phase|Physician Decision|0|||
148933670|NCT00257608|537244299|FG002|Chemotherapy Phase|Physician Decision|0|||
149187911|NCT00365716|538158491|FG003|Extension 2|Lost to Follow-up|0|||
149187912|NCT00365716|538158492|FG004|Extension 2|Lost to Follow-up|0|||
149187913|NCT00365716|538158493|FG005|Extension 2|Lost to Follow-up|0|||
149187914|NCT00365716|538158494|FG006|Extension 2|Lost to Follow-up|2|||
149187915|NCT00365716|538158488|FG000|Extension 2|Other|0|||
149187916|NCT00365716|538158489|FG001|Extension 2|Other|0|||
149187917|NCT00365716|538158490|FG002|Extension 2|Other|0|||
149187918|NCT00365716|538158491|FG003|Extension 2|Other|0|||
149187919|NCT00365716|538158492|FG004|Extension 2|Other|0|||
149187920|NCT00365716|538158493|FG005|Extension 2|Other|0|||
149187921|NCT00365716|538158494|FG006|Extension 2|Other|3|||
149187922|NCT00365716|538158488|FG000|Extension 2|Withdrawal by Subject|0|||
149187923|NCT00365716|538158489|FG001|Extension 2|Withdrawal by Subject|0|||
149187924|NCT00365716|538158490|FG002|Extension 2|Withdrawal by Subject|0|||
149187925|NCT00365716|538158491|FG003|Extension 2|Withdrawal by Subject|0|||
149187926|NCT00365716|538158492|FG004|Extension 2|Withdrawal by Subject|0|||
149187927|NCT00365716|538158493|FG005|Extension 2|Withdrawal by Subject|0|||
149187928|NCT00365716|538158494|FG006|Extension 2|Withdrawal by Subject|5|||
149187929|NCT02985450|538158495|FG000|Overall Study|Lost to Follow-up|7|||
149187930|NCT00069576|538158496|FG000|Original Trial|Lost to Follow-up|25|||
149187931|NCT00069576|538158497|FG001|Original Trial|Lost to Follow-up|33|||
149187932|NCT00069576|538158496|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
149187933|NCT00069576|538158497|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
149187934|NCT04060667|538158498|FG000|Overall Study|Lost to Follow-up|75|||
149187935|NCT04060667|538158499|FG001|Overall Study|Lost to Follow-up|10|||
149187936|NCT00114972|538158502|FG000|Overall Study|Withdrawal by Subject|40|||
149187937|NCT00114972|538158503|FG001|Overall Study|Withdrawal by Subject|7|||
149187938|NCT00114972|538158502|FG000|Overall Study|Lost to Follow-up|8|||
149187939|NCT00114972|538158503|FG001|Overall Study|Lost to Follow-up|5|||
149187940|NCT00358917|538158504|FG000|Overall Study|Adverse Event|14|||
149187941|NCT00358917|538158505|FG001|Overall Study|Adverse Event|21|||
149187942|NCT00358917|538158504|FG000|Overall Study|Withdrawal by Subject|5|||
149187943|NCT00358917|538158505|FG001|Overall Study|Withdrawal by Subject|7|||
149187944|NCT00358917|538158504|FG000|Overall Study|Lost to Follow-up|20|||
149187945|NCT00358917|538158505|FG001|Overall Study|Lost to Follow-up|17|||
149187946|NCT00358917|538158504|FG000|Overall Study|Noncompliance|12|||
149187947|NCT00358917|538158505|FG001|Overall Study|Noncompliance|11|||
149187948|NCT00358917|538158504|FG000|Overall Study|Death|2|||
149187949|NCT00358917|538158505|FG001|Overall Study|Death|3|||
149187950|NCT00358917|538158504|FG000|Overall Study|Virologic failure|11|||
149187951|NCT00358917|538158505|FG001|Overall Study|Virologic failure|8|||
149187952|NCT00358917|538158504|FG000|Overall Study|Unable to Continue Participation|2|||
149187953|NCT00358917|538158505|FG001|Overall Study|Unable to Continue Participation|2|||
149187954|NCT02890329|538158513|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149187955|NCT02890329|538158514|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
148933671|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Adverse Event|0|||
149187956|NCT02890329|538158515|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149187957|NCT02890329|538158516|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
148933672|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Adverse Event|34|||
149187958|NCT02890329|538158517|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149187959|NCT02890329|538158518|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
149187960|NCT02890329|538158513|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
149187961|NCT02890329|538158514|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
149187962|NCT02890329|538158515|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149187963|NCT02890329|538158516|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149187964|NCT02890329|538158517|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149234039|NCT01366846|538326362|FG000|Overall Study|Communication Difficulties|1|||
149234040|NCT01366846|538326363|FG001|Overall Study|Communication Difficulties|4|||
149234041|NCT01366846|538326364|FG002|Overall Study|Communication Difficulties|0|||
149234042|NCT01366846|538326365|FG003|Overall Study|Communication Difficulties|1|||
149234043|NCT01366846|538326362|FG000|Overall Study|Scheduling Conflicts|0|||
149234044|NCT01366846|538326363|FG001|Overall Study|Scheduling Conflicts|0|||
149234045|NCT01366846|538326364|FG002|Overall Study|Scheduling Conflicts|1|||
149234046|NCT01366846|538326365|FG003|Overall Study|Scheduling Conflicts|0|||
149234047|NCT02856282|538326368|FG000|Overall Study|Withdrawal by Subject|1|||
149234048|NCT05299359|538326372|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
149234049|NCT05299359|538326373|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
149234050|NCT05299359|538326372|FG000|Main Part: Day 1 up to Day 366|Other|2|||
149187965|NCT02890329|538158518|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
149187966|NCT02890329|538158513|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149187967|NCT02890329|538158514|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149187968|NCT02890329|538158515|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149187969|NCT02890329|538158516|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
149187970|NCT02890329|538158517|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149187971|NCT02890329|538158518|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
149187972|NCT02890329|538158513|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149187973|NCT02890329|538158514|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149187974|NCT02890329|538158515|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
149187975|NCT02890329|538158516|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149187976|NCT02890329|538158517|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149187977|NCT02890329|538158518|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
149187978|NCT00231062|538158524|FG000|Overall Study|Physician Decision|6|||
149187979|NCT00590681|538158528|FG000|Overall Study|Withdrawal by Subject|7|||
149187980|NCT00590681|538158528|FG000|Overall Study|Adverse Event|8|||
149187981|NCT00590681|538158528|FG000|Overall Study|Death|3|||
149187982|NCT00590681|538158528|FG000|Overall Study|Lost to Follow-up|1|||
149187983|NCT00590681|538158528|FG000|Overall Study|disease progression|1|||
149187984|NCT01259297|538158529|FG000|Double Blind Randomized Period|Death|1|||
149187985|NCT01259297|538158530|FG001|Double Blind Randomized Period|Death|1|||
149187986|NCT01259297|538158531|FG002|Double Blind Randomized Period|Death|1|||
149187987|NCT01259297|538158532|FG003|Double Blind Randomized Period|Death|2|||
149187988|NCT01259297|538158533|FG004|Double Blind Randomized Period|Death|1|||
149187989|NCT01259297|538158534|FG005|Double Blind Randomized Period|Death|5|||
149187990|NCT01259297|538158535|FG006|Double Blind Randomized Period|Death|2|||
149187991|NCT01259297|538158536|FG007|Double Blind Randomized Period|Death|1|||
149187992|NCT01259297|538158529|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149187993|NCT01259297|538158530|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149187994|NCT01259297|538158531|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
149187995|NCT01259297|538158532|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
149187996|NCT01259297|538158533|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
149187997|NCT01259297|538158534|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149187998|NCT01259297|538158535|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149187999|NCT01259297|538158536|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
149188000|NCT01259297|538158529|FG000|Double Blind Randomized Period|Other reasons|0|||
149188001|NCT01259297|538158530|FG001|Double Blind Randomized Period|Other reasons|1|||
149188002|NCT01259297|538158531|FG002|Double Blind Randomized Period|Other reasons|0|||
149188003|NCT01259297|538158532|FG003|Double Blind Randomized Period|Other reasons|0|||
149188004|NCT01259297|538158533|FG004|Double Blind Randomized Period|Other reasons|1|||
149188005|NCT01259297|538158534|FG005|Double Blind Randomized Period|Other reasons|2|||
149188006|NCT01259297|538158535|FG006|Double Blind Randomized Period|Other reasons|3|||
149188007|NCT01259297|538158536|FG007|Double Blind Randomized Period|Other reasons|1|||
149188008|NCT00443430|538158539|FG000|Overall Study|Lack of Efficacy|3|||
149188009|NCT00443430|538158540|FG001|Overall Study|Lack of Efficacy|3|||
149188010|NCT00443430|538158539|FG000|Overall Study|Adverse Event|1|||
149188011|NCT00443430|538158540|FG001|Overall Study|Adverse Event|1|||
149188012|NCT00053846|538158541|FG000|Overall Study|Changed mind|8|||
149188013|NCT00053846|538158542|FG001|Overall Study|Changed mind|13|||
149188014|NCT00053846|538158541|FG000|Overall Study|Became too ill|8|||
149188015|NCT00053846|538158542|FG001|Overall Study|Became too ill|7|||
149188016|NCT00053846|538158541|FG000|Overall Study|Expired|5|||
149188017|NCT00053846|538158542|FG001|Overall Study|Expired|0|||
149188018|NCT00053846|538158541|FG000|Overall Study|Became ineligible|3|||
149188019|NCT00053846|538158542|FG001|Overall Study|Became ineligible|1|||
149188020|NCT00053846|538158541|FG000|Overall Study|Did not return data|1|||
149188021|NCT00053846|538158542|FG001|Overall Study|Did not return data|2|||
149188022|NCT00053846|538158541|FG000|Overall Study|Quit due to side effects|1|||
149188023|NCT00053846|538158542|FG001|Overall Study|Quit due to side effects|3|||
149188024|NCT00053846|538158541|FG000|Overall Study|Pills too large|0|||
149188025|NCT00053846|538158542|FG001|Overall Study|Pills too large|1|||
149188026|NCT00592501|538158543|FG000|Overall Study|Withdrawal by Subject|1|||
149188027|NCT00592501|538158543|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
149188028|NCT03880227|538158545|FG000|First Visit|Withdrawal by Subject|1|||
149188029|NCT03880227|538158546|FG001|First Visit|Withdrawal by Subject|0|||
149188030|NCT03880227|538158547|FG002|First Visit|Withdrawal by Subject|0|||
148933673|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Adverse Event|38|||
148933674|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Disease progression|0|||
149188031|NCT03880227|538158548|FG003|First Visit|Withdrawal by Subject|0|||
149188032|NCT03880227|538158545|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
149188033|NCT03880227|538158546|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
149188034|NCT03880227|538158547|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
149188035|NCT03880227|538158548|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
149188036|NCT03880227|538158545|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
149188037|NCT03880227|538158546|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
149188038|NCT03880227|538158547|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
149188039|NCT03880227|538158548|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
149188040|NCT03880227|538158545|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
149188041|NCT03880227|538158546|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
149188042|NCT03880227|538158547|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
149188043|NCT03880227|538158548|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
149188044|NCT00504166|538158549|FG000|Overall Study|Adverse Event|1|||
149188045|NCT00504166|538158550|FG001|Overall Study|Adverse Event|4|||
149188046|NCT00504166|538158549|FG000|Overall Study|Withdrawal by Subject|3|||
149188047|NCT00504166|538158550|FG001|Overall Study|Withdrawal by Subject|6|||
149188048|NCT00504166|538158549|FG000|Overall Study|Physician Decision|1|||
149188049|NCT00504166|538158550|FG001|Overall Study|Physician Decision|1|||
149188050|NCT00504166|538158549|FG000|Overall Study|Lost to Follow-up|1|||
149188051|NCT00504166|538158550|FG001|Overall Study|Lost to Follow-up|3|||
149188052|NCT02650284|538158553|FG000|Overall Study|Lost to Follow-up|3|||
149188053|NCT02650284|538158554|FG001|Overall Study|Lost to Follow-up|3|||
149188054|NCT02650284|538158553|FG000|Overall Study|Consent incorrectly taken|0|||
149188055|NCT02650284|538158554|FG001|Overall Study|Consent incorrectly taken|1|||
149188056|NCT01929044|538158560|FG000|Overall Study|Adverse Event|1|||
149188057|NCT01929044|538158561|FG001|Overall Study|Adverse Event|0|||
149188058|NCT01929044|538158560|FG000|Overall Study|Protocol Violation|9|||
149188059|NCT01929044|538158561|FG001|Overall Study|Protocol Violation|14|||
149188060|NCT01929044|538158560|FG000|Overall Study|Not Treated|1|||
149188061|NCT01929044|538158561|FG001|Overall Study|Not Treated|3|||
149188062|NCT02084134|538158566|FG000|Overall Study|Protocol Violation|4|||
149188063|NCT02084134|538158567|FG001|Overall Study|Protocol Violation|2|||
149188064|NCT02084134|538158566|FG000|Overall Study|Death|0|||
149188065|NCT02084134|538158567|FG001|Overall Study|Death|1|||
149188066|NCT01555463|538158568|FG000|Treatment|Adverse Event|6|||
149188067|NCT01555463|538158569|FG001|Treatment|Adverse Event|12|||
149188068|NCT01555463|538158568|FG000|Treatment|Withdrawal by Subject|24|||
149188069|NCT01555463|538158569|FG001|Treatment|Withdrawal by Subject|36|||
149188070|NCT01555463|538158568|FG000|Treatment|Lost to Follow-up|28|||
149188071|NCT01555463|538158569|FG001|Treatment|Lost to Follow-up|23|||
149188072|NCT01555463|538158568|FG000|Treatment|Protocol Violation|4|||
149188073|NCT01555463|538158569|FG001|Treatment|Protocol Violation|5|||
149188074|NCT01555463|538158568|FG000|Treatment|Other reason|2|||
149188075|NCT01555463|538158569|FG001|Treatment|Other reason|3|||
149188076|NCT01555463|538158568|FG000|Follow up|Adverse Event|2|||
149188077|NCT01555463|538158569|FG001|Follow up|Adverse Event|5|||
149188078|NCT01555463|538158568|FG000|Follow up|Death|0|||
149188079|NCT01555463|538158569|FG001|Follow up|Death|1|||
149188080|NCT01555463|538158568|FG000|Follow up|Withdrawal by Subject|22|||
149188081|NCT01555463|538158569|FG001|Follow up|Withdrawal by Subject|22|||
149188082|NCT01555463|538158568|FG000|Follow up|Lost to Follow-up|9|||
149188083|NCT01555463|538158569|FG001|Follow up|Lost to Follow-up|10|||
149188084|NCT01555463|538158568|FG000|Follow up|Protocol Violation|2|||
149188085|NCT01555463|538158569|FG001|Follow up|Protocol Violation|4|||
149188086|NCT01555463|538158568|FG000|Follow up|Other reason|3|||
149188087|NCT01555463|538158569|FG001|Follow up|Other reason|3|||
149188088|NCT04333433|538158570|FG000|Overall Study|Withdrawal by Subject|6|||
149188089|NCT04333433|538158571|FG001|Overall Study|Withdrawal by Subject|3|||
149188090|NCT04333433|538158570|FG000|Overall Study|Death|3|||
148933675|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Disease progression|204|||
149188091|NCT04333433|538158571|FG001|Overall Study|Death|0|||
149188092|NCT04333433|538158570|FG000|Overall Study|Lost to Follow-up|6|||
149188093|NCT04333433|538158571|FG001|Overall Study|Lost to Follow-up|1|||
149188094|NCT04333433|538158570|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
149188095|NCT04333433|538158571|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
149188096|NCT02807454|538158572|FG000|Overall Study|Adverse Event|1|||
149188097|NCT02807454|538158573|FG001|Overall Study|Adverse Event|0|||
149188098|NCT02807454|538158572|FG000|Overall Study|Withdrawal by Subject|0|||
149188099|NCT02807454|538158573|FG001|Overall Study|Withdrawal by Subject|1|||
149188100|NCT02807454|538158572|FG000|Overall Study|Progressive Disease|30|||
149188101|NCT02807454|538158573|FG001|Overall Study|Progressive Disease|3|||
149188102|NCT02807454|538158572|FG000|Overall Study|Other Reasons|1|||
149188103|NCT02807454|538158573|FG001|Overall Study|Other Reasons|1|||
149188104|NCT05468086|538158574|FG000|Overall Study|Withdrawal by Subject|3|||
149188105|NCT05468086|538158574|FG000|Overall Study|Subject was found ineligible after consent|1|||
149188106|NCT01165203|538158575|FG000|Active Phase|Serious Adverse Event|1|||
149188107|NCT01165203|538158576|FG001|Active Phase|Serious Adverse Event|0|||
149188108|NCT01165203|538158575|FG000|Active Phase|Withdrawal by Subject|2|||
149188109|NCT01165203|538158576|FG001|Active Phase|Withdrawal by Subject|1|||
149188110|NCT01165203|538158575|FG000|Active Phase|Migrated/moved from study area|0|||
149188111|NCT01165203|538158576|FG001|Active Phase|Migrated/moved from study area|1|||
149188112|NCT01165203|538158575|FG000|Active Phase|Lost to Follow-up|2|||
149188113|NCT01165203|538158576|FG001|Active Phase|Lost to Follow-up|0|||
149188114|NCT01165203|538158575|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
149188115|NCT01165203|538158576|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
149188116|NCT01165203|538158575|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
149188117|NCT01165203|538158576|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
149188118|NCT01165203|538158575|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
149188119|NCT01165203|538158576|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
149188120|NCT01165203|538158575|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
149188121|NCT01165203|538158576|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
149188122|NCT01165203|538158575|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
149188123|NCT01165203|538158576|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
149188124|NCT01070784|538158577|FG000|Overall Study|Withdrawal by Subject|6|||
149188125|NCT01070784|538158578|FG001|Overall Study|Withdrawal by Subject|9|||
149188126|NCT01070784|538158577|FG000|Overall Study|Adverse Event|14|||
149188127|NCT01070784|538158578|FG001|Overall Study|Adverse Event|9|||
149188128|NCT02815397|538158580|FG000|Overall Study|Physician Decision|2|||
149188129|NCT01518192|538158581|FG000|Overall Study|Lost to Follow-up|29|||
149188130|NCT01518192|538158582|FG001|Overall Study|Lost to Follow-up|26|||
149188131|NCT01518192|538158583|FG002|Overall Study|Lost to Follow-up|35|||
149188132|NCT00085540|538158584|FG000|Overall Study|Withdrawal by Subject|0|||
149188133|NCT00085540|538158585|FG001|Overall Study|Withdrawal by Subject|1|||
149188134|NCT00085540|538158584|FG000|Overall Study|Protocol Violation|0|||
149188135|NCT00085540|538158585|FG001|Overall Study|Protocol Violation|1|||
149188136|NCT00783705|538158586|FG000|Overall Study|Adverse Event|2|||
149188137|NCT00783705|538158587|FG001|Overall Study|Adverse Event|0|||
149188138|NCT00783705|538158586|FG000|Overall Study|Withdrawal by Subject|3|||
149188139|NCT00783705|538158587|FG001|Overall Study|Withdrawal by Subject|2|||
149188140|NCT00783705|538158586|FG000|Overall Study|Lost to Follow-up|1|||
149188141|NCT00783705|538158587|FG001|Overall Study|Lost to Follow-up|3|||
149188142|NCT00426751|538158588|FG000|Overall Study|Adverse Event|8|||
149188143|NCT00426751|538158589|FG001|Overall Study|Adverse Event|1|||
149188144|NCT00426751|538158588|FG000|Overall Study|Lost to Follow-up|7|||
149188145|NCT00426751|538158589|FG001|Overall Study|Lost to Follow-up|6|||
149188146|NCT00426751|538158588|FG000|Overall Study|Consent Withdrawn|0|||
149188147|NCT00426751|538158589|FG001|Overall Study|Consent Withdrawn|1|||
149188148|NCT00426751|538158588|FG000|Overall Study|Other Reasons|7|||
149188149|NCT00426751|538158589|FG001|Overall Study|Other Reasons|12|||
149188150|NCT01200511|538158590|FG000|Overall Study|Lost to Follow-up|3|||
149188151|NCT01200511|538158590|FG000|Overall Study|Withdrawal by Subject|1|||
149188152|NCT01200511|538158590|FG000|Overall Study|Adverse Event|1|||
149188153|NCT03288779|538158595|FG000|Overall Study|Withdrawal by Subject|3|||
149188154|NCT01355068|538158599|FG000|First Intervention Period|Adverse Event|0|||
149188155|NCT01355068|538158600|FG001|First Intervention Period|Adverse Event|1|||
149188156|NCT01355068|538158599|FG000|First Intervention Period|Withdrawal by Subject|0|||
149188157|NCT01355068|538158600|FG001|First Intervention Period|Withdrawal by Subject|1|||
149188158|NCT00376688|538158601|FG000|Overall Study|Adverse Event|3|||
149188159|NCT00376688|538158601|FG000|Overall Study|Death|1|||
149188160|NCT01770353|538158602|FG000|Overall Study|Progressive disease|2|||
149188161|NCT01770353|538158603|FG001|Overall Study|Progressive disease|1|||
149188162|NCT01770353|538158602|FG000|Overall Study|Adverse Event|0|||
149188163|NCT01770353|538158603|FG001|Overall Study|Adverse Event|1|||
149188164|NCT01770353|538158602|FG000|Overall Study|Protocol Violation|1|||
148807387|NCT00423605|536773237|FG000|Overall Study|Physician Decision|8|||
148807388|NCT00423605|536773237|FG000|Overall Study|Protocol Violation|7|||
149188165|NCT01770353|538158603|FG001|Overall Study|Protocol Violation|0|||
149188166|NCT01770353|538158602|FG000|Overall Study|Physician Decision|0|||
149188167|NCT01770353|538158603|FG001|Overall Study|Physician Decision|3|||
149188168|NCT01770353|538158602|FG000|Overall Study|Clinical deterioration|3|||
149188169|NCT01770353|538158603|FG001|Overall Study|Clinical deterioration|6|||
149188170|NCT01770353|538158602|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
149188171|NCT01770353|538158603|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
149188172|NCT00620321|538159916|FG000|Overall Study|Adverse Event|1|||
149188173|NCT00620321|538159917|FG001|Overall Study|Adverse Event|1|||
149188174|NCT00620321|538159916|FG000|Overall Study|Death|1|||
149188175|NCT00620321|538159917|FG001|Overall Study|Death|1|||
149188176|NCT00620321|538159916|FG000|Overall Study|Physician Decision|0|||
149188177|NCT00620321|538159917|FG001|Overall Study|Physician Decision|7|||
149188178|NCT00620321|538159916|FG000|Overall Study|Progressive Disease|5|||
149188179|NCT00620321|538159917|FG001|Overall Study|Progressive Disease|5|||
149188180|NCT00620321|538159916|FG000|Overall Study|Sponsor Decision|0|||
149188181|NCT00620321|538159917|FG001|Overall Study|Sponsor Decision|1|||
149188182|NCT00620321|538159916|FG000|Overall Study|Withdrawal by Subject|1|||
149188183|NCT00620321|538159917|FG001|Overall Study|Withdrawal by Subject|1|||
149188184|NCT01746732|538159919|FG000|Lead-In Period|Withdrawal by Subject|1|||
149188185|NCT01746732|538159920|FG001|Lead-In Period|Withdrawal by Subject|0|||
149188186|NCT01746732|538159921|FG002|Lead-In Period|Withdrawal by Subject|0|||
149188187|NCT01746732|538159919|FG000|Period 1|Physician Decision|0|||
149188188|NCT01746732|538159920|FG001|Period 1|Physician Decision|1|||
149188189|NCT01746732|538159921|FG002|Period 1|Physician Decision|0|||
149188190|NCT01746732|538159919|FG000|Period 2|Withdrawal by Subject|0|||
149188191|NCT01746732|538159920|FG001|Period 2|Withdrawal by Subject|0|||
149188192|NCT01746732|538159921|FG002|Period 2|Withdrawal by Subject|2|||
149188193|NCT01746732|538159919|FG000|Period 2|Adverse Event|0|||
149188194|NCT01746732|538159920|FG001|Period 2|Adverse Event|0|||
149188195|NCT01746732|538159921|FG002|Period 2|Adverse Event|1|||
149188196|NCT01746732|538159919|FG000|Period 2|Lost to Follow-up|0|||
149188197|NCT01746732|538159920|FG001|Period 2|Lost to Follow-up|0|||
149188198|NCT01746732|538159921|FG002|Period 2|Lost to Follow-up|1|||
149188199|NCT02279524|538159922|FG000|Overall Study|Withdrawal by Subject|3|||
149188200|NCT02279524|538159923|FG001|Overall Study|Withdrawal by Subject|6|||
149188201|NCT02279524|538159924|FG002|Overall Study|Withdrawal by Subject|3|||
149188202|NCT02279524|538159922|FG000|Overall Study|Adverse Event|4|||
149188203|NCT02279524|538159923|FG001|Overall Study|Adverse Event|3|||
149188204|NCT02279524|538159924|FG002|Overall Study|Adverse Event|2|||
149188205|NCT02279524|538159922|FG000|Overall Study|Lost to Follow-up|1|||
149188206|NCT02279524|538159923|FG001|Overall Study|Lost to Follow-up|1|||
149188207|NCT02279524|538159924|FG002|Overall Study|Lost to Follow-up|0|||
149188208|NCT02279524|538159922|FG000|Overall Study|Disallowed medication|1|||
149188209|NCT02279524|538159923|FG001|Overall Study|Disallowed medication|1|||
149188210|NCT02279524|538159924|FG002|Overall Study|Disallowed medication|2|||
149188211|NCT02279524|538159922|FG000|Overall Study|Bariatric surgery|1|||
149188212|NCT02279524|538159923|FG001|Overall Study|Bariatric surgery|0|||
149188213|NCT02279524|538159924|FG002|Overall Study|Bariatric surgery|0|||
149188214|NCT02817555|538159925|FG000|Overall Study|Death|1|||
149188215|NCT02817555|538159926|FG001|Overall Study|Death|3|||
149188216|NCT02817555|538159925|FG000|Overall Study|moved away|1|||
149188217|NCT02817555|538159926|FG001|Overall Study|moved away|0|||
149188218|NCT02817555|538159925|FG000|Overall Study|transplant|1|||
149188219|NCT02817555|538159926|FG001|Overall Study|transplant|1|||
149188220|NCT02817555|538159925|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
149188221|NCT02817555|538159926|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
149188222|NCT01755195|538159927|FG000|Overall Study|Participant noncompliance|2|||
149188223|NCT01755195|538159927|FG000|Overall Study|Switched to alternative treatment|4|||
149188224|NCT01755195|538159927|FG000|Overall Study|Withdrawal by Subject|1|||
149188225|NCT01755195|538159927|FG000|Overall Study|Participant refused to start treatment|1|||
149188226|NCT01755195|538159927|FG000|Overall Study|Participant has been consented for another trial|1|||
149188227|NCT01755195|538159927|FG000|Overall Study|Refused further treatment|3|||
149188228|NCT01755195|538159927|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
149188229|NCT02340819|538159928|FG000|Overall Study|Adverse Event|1|||
149188230|NCT02340819|538159928|FG000|Overall Study|Withdrawal by Subject|2|||
149188231|NCT02340819|538159928|FG000|Overall Study|Discontinued with other reason|1|||
149188232|NCT02273050|538159930|FG000|Overall Study|Adverse Event|4|||
149188233|NCT02273050|538159931|FG001|Overall Study|Adverse Event|3|||
149188234|NCT02273050|538159932|FG002|Overall Study|Adverse Event|3|||
149188235|NCT02273050|538159930|FG000|Overall Study|Death|0|||
149188236|NCT02273050|538159931|FG001|Overall Study|Death|0|||
149188237|NCT02273050|538159932|FG002|Overall Study|Death|1|||
149188238|NCT02273050|538159930|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
149188239|NCT02273050|538159931|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
149188240|NCT02273050|538159932|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
149188241|NCT02273050|538159930|FG000|Overall Study|Lack of Efficacy|0|||
149188242|NCT02273050|538159931|FG001|Overall Study|Lack of Efficacy|1|||
149188243|NCT02273050|538159932|FG002|Overall Study|Lack of Efficacy|1|||
149014334|NCT00708305|537532190|FG001|Period 1|Other Reason|0|||
149188244|NCT02273050|538159930|FG000|Overall Study|Withdrawal by Subject|17|||
149188245|NCT02273050|538159931|FG001|Overall Study|Withdrawal by Subject|14|||
149188246|NCT02273050|538159932|FG002|Overall Study|Withdrawal by Subject|16|||
149188247|NCT02273050|538159930|FG000|Overall Study|Lost to Follow-up|0|||
149188248|NCT02273050|538159931|FG001|Overall Study|Lost to Follow-up|2|||
149188249|NCT02273050|538159932|FG002|Overall Study|Lost to Follow-up|3|||
149188250|NCT02273050|538159930|FG000|Overall Study|Protocol Violation|3|||
149188251|NCT02273050|538159931|FG001|Overall Study|Protocol Violation|1|||
149188252|NCT02273050|538159932|FG002|Overall Study|Protocol Violation|4|||
149188253|NCT03539458|538159934|FG000|Overall Study|Death|1|||
149188254|NCT02042404|538159937|FG000|Overall Study|Death|1|||
149188255|NCT02042404|538159938|FG001|Overall Study|Death|0|||
149188256|NCT02042404|538159937|FG000|Overall Study|Unrelated Adverse Event|3|||
148933676|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Disease progression|168|||
148933677|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
148933678|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
149014335|NCT00708305|537532191|FG002|Period 1|Other Reason|0|||
149188257|NCT02042404|538159938|FG001|Overall Study|Unrelated Adverse Event|0|||
149188258|NCT02042404|538159937|FG000|Overall Study|Inability to meet time requirements|1|||
149188259|NCT02042404|538159938|FG001|Overall Study|Inability to meet time requirements|0|||
149188260|NCT03100942|538159939|FG000|Randomized Treatment Period|Withdrew Consent|4|||
149188261|NCT03100942|538159940|FG001|Randomized Treatment Period|Withdrew Consent|5|||
149188262|NCT03100942|538159941|FG002|Randomized Treatment Period|Withdrew Consent|3|||
149188263|NCT03100942|538159942|FG003|Randomized Treatment Period|Withdrew Consent|3|||
149188264|NCT03100942|538159943|FG004|Randomized Treatment Period|Withdrew Consent|0|||
149188265|NCT03100942|538159944|FG005|Randomized Treatment Period|Withdrew Consent|0|||
149188266|NCT03100942|538159945|FG006|Randomized Treatment Period|Withdrew Consent|0|||
149188267|NCT03100942|538159939|FG000|Randomized Treatment Period|Adverse Event|5|||
149188268|NCT03100942|538159940|FG001|Randomized Treatment Period|Adverse Event|2|||
149188269|NCT03100942|538159941|FG002|Randomized Treatment Period|Adverse Event|1|||
149188270|NCT03100942|538159942|FG003|Randomized Treatment Period|Adverse Event|0|||
149188271|NCT03100942|538159943|FG004|Randomized Treatment Period|Adverse Event|0|||
149188272|NCT03100942|538159944|FG005|Randomized Treatment Period|Adverse Event|0|||
149188273|NCT03100942|538159945|FG006|Randomized Treatment Period|Adverse Event|0|||
149188274|NCT03100942|538159939|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
149188275|NCT03100942|538159940|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
149188276|NCT03100942|538159941|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
149188277|NCT03100942|538159942|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
149188278|NCT03100942|538159943|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
149188279|NCT03100942|538159944|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
149188280|NCT03100942|538159945|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
149188281|NCT03100942|538159939|FG000|Randomized Treatment Period|Protocol Violation|0|||
149188282|NCT03100942|538159940|FG001|Randomized Treatment Period|Protocol Violation|1|||
149188283|NCT03100942|538159941|FG002|Randomized Treatment Period|Protocol Violation|1|||
149188284|NCT03100942|538159942|FG003|Randomized Treatment Period|Protocol Violation|1|||
149188285|NCT03100942|538159943|FG004|Randomized Treatment Period|Protocol Violation|0|||
149188286|NCT03100942|538159944|FG005|Randomized Treatment Period|Protocol Violation|0|||
149188287|NCT03100942|538159945|FG006|Randomized Treatment Period|Protocol Violation|0|||
149188288|NCT03100942|538159939|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
149188289|NCT03100942|538159940|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
149188290|NCT03100942|538159941|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
149188291|NCT03100942|538159942|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
149188292|NCT03100942|538159943|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
149188293|NCT03100942|538159944|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
149188294|NCT03100942|538159945|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
149188295|NCT03100942|538159939|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
149188296|NCT03100942|538159940|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149188297|NCT03100942|538159941|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149188298|NCT03100942|538159942|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
149188299|NCT03100942|538159943|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149188300|NCT03100942|538159944|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149188301|NCT03100942|538159945|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
149188302|NCT03100942|538159939|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149188303|NCT03100942|538159940|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149188304|NCT03100942|538159941|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149188305|NCT03100942|538159942|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149188306|NCT03100942|538159943|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149188307|NCT03100942|538159944|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
149188308|NCT03100942|538159945|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
149188309|NCT00718419|538159946|FG000|Overall Study|Adverse Event|2|||
149188310|NCT00718419|538159947|FG001|Overall Study|Adverse Event|1|||
149188311|NCT00718419|538159946|FG000|Overall Study|Physician Decision|1|||
149188312|NCT00718419|538159947|FG001|Overall Study|Physician Decision|6|||
149188313|NCT00718419|538159946|FG000|Overall Study|Sponsor decision|0|||
149188314|NCT00718419|538159947|FG001|Overall Study|Sponsor decision|1|||
149188315|NCT00718419|538159946|FG000|Overall Study|Withdrawal by Subject|0|||
149188316|NCT00718419|538159947|FG001|Overall Study|Withdrawal by Subject|5|||
149188317|NCT00718419|538159946|FG000|Overall Study|Progressive Disease|7|||
149188318|NCT00718419|538159947|FG001|Overall Study|Progressive Disease|25|||
149188319|NCT00718419|538159946|FG000|Overall Study|Death Due to Progressive Disease|2|||
149188320|NCT00718419|538159947|FG001|Overall Study|Death Due to Progressive Disease|0|||
149188321|NCT00718419|538159946|FG000|Overall Study|Death Due to Study Drug Related|0|||
149188322|NCT00718419|538159947|FG001|Overall Study|Death Due to Study Drug Related|1|||
149188323|NCT00718419|538159946|FG000|Overall Study|Death Due to Adverse Events|1|||
149188324|NCT00718419|538159947|FG001|Overall Study|Death Due to Adverse Events|0|||
149188325|NCT01675531|538159948|FG000|Overall Study|Adverse Event|9|||
149188326|NCT01675531|538159948|FG000|Overall Study|Withdrawal by Subject|7|||
149188327|NCT01675531|538159948|FG000|Overall Study|Lack of Efficacy|1|||
149188328|NCT01675531|538159948|FG000|Overall Study|Protocol Violation|8|||
149188329|NCT01617681|538159949|FG000|Period 1 Double Blind|Adverse Event|2|||
149188330|NCT01617681|538159950|FG001|Period 1 Double Blind|Adverse Event|0|||
149188331|NCT01617681|538159951|FG002|Period 1 Double Blind|Adverse Event|0|||
149188332|NCT01617681|538159952|FG003|Period 1 Double Blind|Adverse Event|2|||
149188333|NCT01617681|538159953|FG004|Period 1 Double Blind|Adverse Event|0|||
149188334|NCT01617681|538159949|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
149188335|NCT01617681|538159950|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
149188336|NCT01617681|538159951|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
149188337|NCT01617681|538159952|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
149188338|NCT01617681|538159953|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
149188339|NCT01617681|538159949|FG000|Period 2 Open Label|Adverse Event|0|||
149188340|NCT01617681|538159950|FG001|Period 2 Open Label|Adverse Event|0|||
149188341|NCT01617681|538159951|FG002|Period 2 Open Label|Adverse Event|0|||
149188342|NCT01617681|538159952|FG003|Period 2 Open Label|Adverse Event|0|||
149188343|NCT01617681|538159953|FG004|Period 2 Open Label|Adverse Event|3|||
149188344|NCT01617681|538159949|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
149188345|NCT01617681|538159950|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
149188346|NCT01617681|538159951|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
149188347|NCT01617681|538159952|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
149188348|NCT01617681|538159953|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
149188349|NCT02280291|538159958|FG000|Overall Study|Lost to Follow-up|2|||
149188350|NCT02280291|538159959|FG001|Overall Study|Lost to Follow-up|1|||
149188351|NCT02280291|538159960|FG002|Overall Study|Lost to Follow-up|3|||
149188352|NCT02280291|538159961|FG003|Overall Study|Lost to Follow-up|8|||
149188353|NCT02280291|538159958|FG000|Overall Study|Protocol Violation|1|||
149188354|NCT02280291|538159959|FG001|Overall Study|Protocol Violation|0|||
149188355|NCT02280291|538159960|FG002|Overall Study|Protocol Violation|0|||
149188356|NCT02280291|538159961|FG003|Overall Study|Protocol Violation|0|||
149188357|NCT02280291|538159958|FG000|Overall Study|Other|1|||
149188358|NCT02280291|538159959|FG001|Overall Study|Other|1|||
149188359|NCT02280291|538159960|FG002|Overall Study|Other|0|||
149188360|NCT02280291|538159961|FG003|Overall Study|Other|0|||
149188361|NCT02918266|538159963|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
149188362|NCT02918266|538159964|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188363|NCT02918266|538159965|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188364|NCT02918266|538159966|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188365|NCT02918266|538159967|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188366|NCT02918266|538159968|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188367|NCT02918266|538159969|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
149188368|NCT02918266|538159970|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188369|NCT02918266|538159971|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
149188370|NCT02918266|538159972|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188371|NCT02918266|538159973|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
149188372|NCT01293032|538159974|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
149188373|NCT01293032|538159975|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
149188374|NCT01293032|538159976|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
149188375|NCT01293032|538159977|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
149188376|NCT01293032|538159974|FG000|Treatment|Adverse Event|0|||
149188377|NCT01293032|538159975|FG001|Treatment|Adverse Event|0|||
149188378|NCT01293032|538159976|FG002|Treatment|Adverse Event|1|||
149188379|NCT01293032|538159977|FG003|Treatment|Adverse Event|1|||
149188380|NCT01293032|538159974|FG000|Treatment|Withdrawal by Subject|2|||
149188381|NCT01293032|538159975|FG001|Treatment|Withdrawal by Subject|4|||
149188382|NCT01293032|538159976|FG002|Treatment|Withdrawal by Subject|0|||
149188383|NCT01293032|538159977|FG003|Treatment|Withdrawal by Subject|0|||
149188384|NCT01293032|538159974|FG000|Treatment|Disease Progression, relapse|0|||
149188385|NCT01293032|538159975|FG001|Treatment|Disease Progression, relapse|1|||
149188386|NCT01293032|538159976|FG002|Treatment|Disease Progression, relapse|0|||
149188387|NCT01293032|538159977|FG003|Treatment|Disease Progression, relapse|0|||
149188388|NCT01106534|538159980|FG000|Overall Study|Withdrawal by Subject|18|||
149188389|NCT01106534|538159980|FG000|Overall Study|Lost to Follow-up|2|||
149188390|NCT01106534|538159980|FG000|Overall Study|Death|16|||
149188391|NCT01106534|538159980|FG000|Overall Study|Physician Decision|1|||
149188392|NCT00905307|538159990|FG000|Overall Study|Switched to Open Label Rescue|7|||
149188393|NCT00905307|538159991|FG001|Overall Study|Switched to Open Label Rescue|17|||
149188394|NCT00905307|538159992|FG002|Overall Study|Switched to Open Label Rescue|11|||
149188395|NCT00905307|538159993|FG003|Overall Study|Switched to Open Label Rescue|11|||
149188396|NCT00905307|538159994|FG004|Overall Study|Switched to Open Label Rescue|4|||
149188397|NCT00905307|538159995|FG005|Overall Study|Switched to Open Label Rescue|15|||
149188398|NCT00905307|538159990|FG000|Overall Study|Lost to Follow-up|0|||
149188399|NCT00905307|538159991|FG001|Overall Study|Lost to Follow-up|0|||
149188400|NCT00905307|538159992|FG002|Overall Study|Lost to Follow-up|0|||
149188401|NCT00905307|538159993|FG003|Overall Study|Lost to Follow-up|0|||
149188402|NCT00905307|538159994|FG004|Overall Study|Lost to Follow-up|1|||
149188403|NCT00905307|538159995|FG005|Overall Study|Lost to Follow-up|1|||
149188404|NCT00905307|538159990|FG000|Overall Study|Adverse Event|3|||
149188405|NCT00905307|538159991|FG001|Overall Study|Adverse Event|4|||
149188406|NCT00905307|538159992|FG002|Overall Study|Adverse Event|5|||
149188407|NCT00905307|538159993|FG003|Overall Study|Adverse Event|11|||
149188408|NCT00905307|538159994|FG004|Overall Study|Adverse Event|3|||
149188409|NCT00905307|538159995|FG005|Overall Study|Adverse Event|5|||
149188410|NCT00905307|538159990|FG000|Overall Study|Withdrawal by Subject|5|||
149188411|NCT00905307|538159991|FG001|Overall Study|Withdrawal by Subject|13|||
149188412|NCT00905307|538159992|FG002|Overall Study|Withdrawal by Subject|15|||
149188413|NCT00905307|538159993|FG003|Overall Study|Withdrawal by Subject|11|||
149188414|NCT00905307|538159994|FG004|Overall Study|Withdrawal by Subject|4|||
149188415|NCT00905307|538159995|FG005|Overall Study|Withdrawal by Subject|13|||
149188416|NCT00905307|538159990|FG000|Overall Study|Protocol Violation|1|||
149188417|NCT00905307|538159991|FG001|Overall Study|Protocol Violation|0|||
149188418|NCT00905307|538159992|FG002|Overall Study|Protocol Violation|1|||
149188419|NCT00905307|538159993|FG003|Overall Study|Protocol Violation|0|||
149188420|NCT00905307|538159994|FG004|Overall Study|Protocol Violation|0|||
149188421|NCT00905307|538159995|FG005|Overall Study|Protocol Violation|0|||
149188422|NCT00905307|538159990|FG000|Overall Study|Lack of Efficacy|6|||
149188423|NCT00905307|538159991|FG001|Overall Study|Lack of Efficacy|3|||
149188424|NCT00905307|538159992|FG002|Overall Study|Lack of Efficacy|5|||
149188425|NCT00905307|538159993|FG003|Overall Study|Lack of Efficacy|4|||
149188426|NCT00905307|538159994|FG004|Overall Study|Lack of Efficacy|4|||
149188427|NCT00905307|538159995|FG005|Overall Study|Lack of Efficacy|8|||
149188428|NCT05590793|538159996|FG000|Overall Study|Withdrawal by Subject|6|||
149188429|NCT05590793|538159996|FG000|Overall Study|Physician Decision|1|||
149188430|NCT04488822|538159997|FG000|Overall Study|Adverse Event|8|||
149188431|NCT04488822|538159997|FG000|Overall Study|Withdrawal by Subject|1|||
149188432|NCT03838367|538159998|FG000|Overall Study|Early termination of study|3|||
149188433|NCT03838367|538159999|FG001|Overall Study|Early termination of study|4|||
149188434|NCT03838367|538160000|FG002|Overall Study|Early termination of study|3|||
149188435|NCT03838367|538160001|FG003|Overall Study|Early termination of study|0|||
149188436|NCT03406104|538160002|FG000|Overall Study|Lost to Follow-up|2|||
149188437|NCT03406104|538160002|FG000|Overall Study|Withdrawal by Subject|2|||
149188438|NCT03406104|538160002|FG000|Overall Study|due to Covid patient did not want to travel|1|||
149188439|NCT03406104|538160002|FG000|Overall Study|Death|2|||
149188440|NCT00803244|538160008|FG000|Overall Study|Adverse Event|1|||
149188441|NCT00803244|538160009|FG001|Overall Study|Adverse Event|2|||
149188442|NCT00803244|538160008|FG000|Overall Study|Withdrawal by Subject|2|||
149188443|NCT00803244|538160009|FG001|Overall Study|Withdrawal by Subject|3|||
149188444|NCT00803244|538160008|FG000|Overall Study|Any other reason not above-mentioned|4|||
149188445|NCT00803244|538160009|FG001|Overall Study|Any other reason not above-mentioned|10|||
149188446|NCT00616239|538160010|FG000|Overall Study|Withdrawal by Subject|2|||
149188447|NCT02873715|538160011|FG000|Overall Study|Lost to Follow-up|84|||
149188448|NCT02873715|538160012|FG001|Overall Study|Lost to Follow-up|94|||
149188449|NCT02873715|538160011|FG000|Overall Study|Withdrawal by Subject|7|||
149188450|NCT02873715|538160012|FG001|Overall Study|Withdrawal by Subject|26|||
149188451|NCT00933335|538160015|FG000|Overall Study|Lost to Follow-up|1|||
149188452|NCT00933335|538160016|FG001|Overall Study|Lost to Follow-up|3|||
149188453|NCT00933335|538160015|FG000|Overall Study|Withdrawal by Subject|0|||
149188454|NCT00933335|538160016|FG001|Overall Study|Withdrawal by Subject|1|||
149188455|NCT00933335|538160015|FG000|Overall Study|Progressive Disease|0|||
149188456|NCT00933335|538160016|FG001|Overall Study|Progressive Disease|11|||
149188457|NCT00933335|538160015|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
149188458|NCT00933335|538160016|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
149188459|NCT00933335|538160015|FG000|Overall Study|Co-morbid Illness|1|||
149188460|NCT00933335|538160016|FG001|Overall Study|Co-morbid Illness|0|||
149188461|NCT04590937|538160017|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
149188462|NCT02026271|538160018|FG000|Overall Study|Adverse Event|2|||
149188463|NCT02026271|538160019|FG001|Overall Study|Adverse Event|3|||
149188464|NCT02026271|538160020|FG002|Overall Study|Adverse Event|2|||
149188465|NCT02026271|538160021|FG003|Overall Study|Adverse Event|3|||
149188466|NCT02026271|538160022|FG004|Overall Study|Adverse Event|0|||
149188467|NCT02026271|538160018|FG000|Overall Study|Withdrawal by Subject|0|||
149188468|NCT02026271|538160019|FG001|Overall Study|Withdrawal by Subject|0|||
149188469|NCT02026271|538160020|FG002|Overall Study|Withdrawal by Subject|0|||
149188470|NCT02026271|538160021|FG003|Overall Study|Withdrawal by Subject|0|||
149188471|NCT02026271|538160022|FG004|Overall Study|Withdrawal by Subject|1|||
149188472|NCT02275026|538160023|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
149188473|NCT02275026|538160023|FG000|Overall Study|Withdrawal by Subject|4|||
149188474|NCT02275026|538160023|FG000|Overall Study|Ineligible due to medical history|13|||
149188475|NCT02275026|538160023|FG000|Overall Study|MRI malfunction precluded testing|1|||
149188476|NCT02275026|538160023|FG000|Overall Study|Ineligible after MRI findings|1|||
149188477|NCT02275026|538160023|FG000|Overall Study|Lost to Follow-up|2|||
149188478|NCT02275026|538160023|FG000|Overall Study|Scanner failure|1|||
149188479|NCT00374907|538160026|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
149188480|NCT00374907|538160027|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
149188481|NCT00374907|538160026|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
149188482|NCT00374907|538160027|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
149188483|NCT00374907|538160026|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
149188484|NCT00374907|538160027|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
149188485|NCT00374907|538160026|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
149188486|NCT00374907|538160027|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
149188487|NCT00374907|538160026|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
149188488|NCT00374907|538160027|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
149188489|NCT01108809|538160028|FG000|Overall Study|Adverse Event|3|||
149188490|NCT01108809|538160028|FG000|Overall Study|Lost to Follow-up|1|||
149188491|NCT02213198|538160033|FG000|Baseline|No show for intake|7|||
149188492|NCT02213198|538160034|FG001|Baseline|No show for intake|9|||
149188493|NCT02213198|538160033|FG000|Baseline|Withdrawal by Subject|34|||
149188494|NCT02213198|538160034|FG001|Baseline|Withdrawal by Subject|11|||
149188495|NCT02213198|538160033|FG000|Baseline|transferred out of clinic|7|||
149188496|NCT02213198|538160034|FG001|Baseline|transferred out of clinic|9|||
149188497|NCT02213198|538160033|FG000|Baseline|Lost to Follow-up|40|||
149188498|NCT02213198|538160034|FG001|Baseline|Lost to Follow-up|21|||
149188499|NCT02213198|538160033|FG000|Baseline|incarcerated,violent|0|||
149188500|NCT02213198|538160034|FG001|Baseline|incarcerated,violent|1|||
149188501|NCT02213198|538160033|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
149188502|NCT02213198|538160034|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
149188503|NCT02213198|538160033|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
149188504|NCT02213198|538160034|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
149188505|NCT02213198|538160033|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
149188506|NCT02213198|538160034|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
149188507|NCT02213198|538160033|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
149188508|NCT02213198|538160034|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
149188509|NCT02213198|538160033|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
149188510|NCT02213198|538160034|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
149188511|NCT02213198|538160033|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
149188512|NCT02213198|538160034|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
149188513|NCT00001262|538160035|FG000|Overall Study|Death|10|||
148933679|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
148933680|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
149188514|NCT00001262|538160036|FG001|Overall Study|Death|11|||
149188515|NCT00001262|538160037|FG002|Overall Study|Death|0|||
149188516|NCT00001262|538160035|FG000|Overall Study|Withdrawal by Subject|0|||
149188517|NCT00001262|538160036|FG001|Overall Study|Withdrawal by Subject|3|||
148933681|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
148933682|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
148933683|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
148933684|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
149188518|NCT00001262|538160037|FG002|Overall Study|Withdrawal by Subject|0|||
149188519|NCT00878072|538160038|FG000|Overall Study|Withdrew consent|2|||
149188520|NCT00524745|538160047|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
149188521|NCT00524745|538160048|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
149188522|NCT00524745|538160049|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
149188523|NCT00524745|538160050|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
149188524|NCT02504892|538160051|FG000|Overall Study|Adverse event-pneumonitis|2|||
149188525|NCT00576693|538160052|FG000|Overall Study|Lost to Follow-up|7|||
149188526|NCT00576693|538160053|FG001|Overall Study|Lost to Follow-up|11|||
149188527|NCT00576693|538160052|FG000|Overall Study|Withdrawal by Subject|3|||
149188528|NCT00576693|538160053|FG001|Overall Study|Withdrawal by Subject|13|||
149188529|NCT00540449|538160054|FG000|Overall Study|Adverse Event|12|||
149188530|NCT00540449|538160055|FG001|Overall Study|Adverse Event|32|||
149188531|NCT00540449|538160054|FG000|Overall Study|Sponsor's Decision|1|||
149188532|NCT00540449|538160055|FG001|Overall Study|Sponsor's Decision|1|||
149188533|NCT00540449|538160054|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
149188534|NCT00540449|538160055|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
149188535|NCT00540449|538160054|FG000|Overall Study|Lost to Follow-up|19|||
149188536|NCT00540449|538160055|FG001|Overall Study|Lost to Follow-up|17|||
149188537|NCT00540449|538160054|FG000|Overall Study|Subject Non-Compliant|7|||
149188538|NCT00540449|538160055|FG001|Overall Study|Subject Non-Compliant|5|||
149188539|NCT00540449|538160054|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
149188540|NCT00540449|538160055|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
149188541|NCT00540449|538160054|FG000|Overall Study|Withdrawal by Subject|10|||
149188542|NCT00540449|538160055|FG001|Overall Study|Withdrawal by Subject|10|||
149188543|NCT00540449|538160054|FG000|Overall Study|Other|1|||
149188544|NCT00540449|538160055|FG001|Overall Study|Other|4|||
149188545|NCT03643432|538160056|FG000|Overall Study|Lost to Follow-up|1|||
149188546|NCT03643432|538160057|FG001|Overall Study|Lost to Follow-up|0|||
149188547|NCT03283163|538160058|FG000|Overall Study|Lost to Follow-up|1|||
149188548|NCT03283163|538160058|FG000|Overall Study|other life commitments|6|||
149188549|NCT03283163|538160058|FG000|Overall Study|COVID-19 institution wide halting|1|||
149188550|NCT03283163|538160058|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
149188551|NCT03283163|538160058|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
149188552|NCT04238663|538160059|FG000|Overall Study|Lost to Follow-up|0|||
149188553|NCT04238663|538160060|FG001|Overall Study|Lost to Follow-up|1|||
149188554|NCT04238663|538160061|FG002|Overall Study|Lost to Follow-up|0|||
149188555|NCT05128162|538160064|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
149188556|NCT05128162|538160064|FG000|Overall Study|Physician Decision|1|||
149188557|NCT00370149|538160065|FG000|Overall Study|Physician Decision|16|||
149188558|NCT00370149|538160066|FG001|Overall Study|Physician Decision|16|||
149188559|NCT00370149|538160065|FG000|Overall Study|Protocol Violation|1|||
149188560|NCT00370149|538160066|FG001|Overall Study|Protocol Violation|0|||
149188561|NCT00370149|538160065|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
149188562|NCT00370149|538160066|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
149188563|NCT00370149|538160065|FG000|Overall Study|Pre-existing infection|0|||
149188564|NCT00370149|538160066|FG001|Overall Study|Pre-existing infection|1|||
149188565|NCT00370149|538160065|FG000|Overall Study|Antibiotic coated dressing placed|0|||
149188566|NCT00370149|538160066|FG001|Overall Study|Antibiotic coated dressing placed|1|||
149188567|NCT01429792|538161197|FG000|Overall Study|Other Reasons|67|||
149188568|NCT01429792|538161197|FG000|Overall Study|Unknown Disposition|94|||
149188569|NCT01429792|538161197|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
149188570|NCT01429792|538161197|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
149188571|NCT01429792|538161197|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
149188572|NCT01429792|538161197|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
148933685|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
148933686|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
148933687|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
149188573|NCT01429792|538161197|FG000|Overall Study|Withdrawal by Subject|70|||
149188574|NCT01429792|538161197|FG000|Overall Study|Lost to Follow-up|88|||
149188575|NCT00726323|538161198|FG000|Overall Study|Withdrawal by Subject|3|||
149188576|NCT00726323|538161199|FG001|Overall Study|Withdrawal by Subject|1|||
149188577|NCT00726323|538161198|FG000|Overall Study|Physician Decision|1|||
149188578|NCT00726323|538161199|FG001|Overall Study|Physician Decision|0|||
148807389|NCT00423605|536773237|FG000|Overall Study|Not one of the pre-specified options|5|||
149188579|NCT00726323|538161198|FG000|Overall Study|Progressive disease|23|||
149188580|NCT00726323|538161199|FG001|Overall Study|Progressive disease|16|||
149188581|NCT00726323|538161198|FG000|Overall Study|Clinical progression|0|||
149188582|NCT00726323|538161199|FG001|Overall Study|Clinical progression|3|||
149188583|NCT00726323|538161198|FG000|Overall Study|Adverse Event|9|||
149188584|NCT00726323|538161199|FG001|Overall Study|Adverse Event|9|||
149188585|NCT00726323|538161198|FG000|Overall Study|Death|1|||
149188586|NCT00726323|538161199|FG001|Overall Study|Death|0|||
149188587|NCT00726323|538161198|FG000|Overall Study|Participant wished to discontinue|0|||
149188588|NCT00726323|538161199|FG001|Overall Study|Participant wished to discontinue|1|||
149188589|NCT00726323|538161198|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
149188590|NCT00726323|538161199|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
149188591|NCT00879814|538161210|FG000|Overall Study|Adverse Event|0|||
149188592|NCT00879814|538161211|FG001|Overall Study|Adverse Event|1|||
149188593|NCT00879814|538161212|FG002|Overall Study|Adverse Event|0|||
149188594|NCT00879814|538161213|FG003|Overall Study|Adverse Event|0|||
149188595|NCT00879814|538161210|FG000|Overall Study|Lost to Follow-up|1|||
149188596|NCT00879814|538161211|FG001|Overall Study|Lost to Follow-up|0|||
149188597|NCT00879814|538161212|FG002|Overall Study|Lost to Follow-up|0|||
149188598|NCT00879814|538161213|FG003|Overall Study|Lost to Follow-up|2|||
149188599|NCT00879814|538161210|FG000|Overall Study|Participant Failed to Return|0|||
149188600|NCT00879814|538161211|FG001|Overall Study|Participant Failed to Return|0|||
149188601|NCT00879814|538161212|FG002|Overall Study|Participant Failed to Return|0|||
149188602|NCT00879814|538161213|FG003|Overall Study|Participant Failed to Return|1|||
149188603|NCT00879814|538161210|FG000|Overall Study|Withdrawal by Subject|3|||
149188604|NCT00879814|538161211|FG001|Overall Study|Withdrawal by Subject|1|||
149188605|NCT00879814|538161212|FG002|Overall Study|Withdrawal by Subject|1|||
149188606|NCT00879814|538161213|FG003|Overall Study|Withdrawal by Subject|2|||
149188607|NCT00879814|538161210|FG000|Overall Study|Physician Decision|0|||
149188608|NCT00879814|538161211|FG001|Overall Study|Physician Decision|0|||
149188609|NCT00879814|538161212|FG002|Overall Study|Physician Decision|1|||
149188610|NCT00879814|538161213|FG003|Overall Study|Physician Decision|0|||
149188611|NCT00879814|538161210|FG000|Overall Study|Other|0|||
149188612|NCT00879814|538161211|FG001|Overall Study|Other|0|||
149188613|NCT00879814|538161212|FG002|Overall Study|Other|1|||
149188614|NCT00879814|538161213|FG003|Overall Study|Other|0|||
149188615|NCT00972478|538161214|FG000|Overall Study|Adverse Event|3|||
149188616|NCT00972478|538161215|FG001|Overall Study|Adverse Event|16|||
149188617|NCT00972478|538161214|FG000|Overall Study|Withdrawal by Subject|1|||
149188618|NCT00972478|538161215|FG001|Overall Study|Withdrawal by Subject|8|||
149188619|NCT00972478|538161214|FG000|Overall Study|Progression/Relapse|0|||
149188620|NCT00972478|538161215|FG001|Overall Study|Progression/Relapse|2|||
149188621|NCT00972478|538161214|FG000|Overall Study|Death|0|||
149188622|NCT00972478|538161215|FG001|Overall Study|Death|2|||
149188623|NCT00972478|538161214|FG000|Overall Study|Not protocol specified|1|||
149188624|NCT00972478|538161215|FG001|Overall Study|Not protocol specified|1|||
149188625|NCT00972478|538161214|FG000|Overall Study|Ineligible|1|||
149188626|NCT00972478|538161215|FG001|Overall Study|Ineligible|7|||
149188627|NCT00972478|538161214|FG000|Overall Study|Not start protocol treatment|1|||
149188628|NCT00972478|538161215|FG001|Overall Study|Not start protocol treatment|2|||
149188629|NCT02561000|538161216|FG000|Overall Study|Withdrawal by Subject|2|||
149188630|NCT02561000|538161217|FG001|Overall Study|Withdrawal by Subject|3|||
149188631|NCT02561000|538161218|FG002|Overall Study|Withdrawal by Subject|0|||
149188632|NCT02561000|538161216|FG000|Overall Study|Adverse Event|0|||
149188633|NCT02561000|538161217|FG001|Overall Study|Adverse Event|1|||
149188634|NCT02561000|538161218|FG002|Overall Study|Adverse Event|0|||
149188635|NCT01234402|538161219|FG000|Overall Study|Lost to Follow-up|0|||
149188636|NCT01234402|538161220|FG001|Overall Study|Lost to Follow-up|1|||
149188637|NCT01234402|538161221|FG002|Overall Study|Lost to Follow-up|3|||
148933688|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
148933689|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
149188638|NCT01234402|538161219|FG000|Overall Study|Withdrawal by Subject|1|||
149188639|NCT01234402|538161220|FG001|Overall Study|Withdrawal by Subject|3|||
149188640|NCT01234402|538161221|FG002|Overall Study|Withdrawal by Subject|4|||
149188641|NCT01234402|538161219|FG000|Overall Study|Never treated: Death|0|||
149188642|NCT01234402|538161220|FG001|Overall Study|Never treated: Death|0|||
149188643|NCT01234402|538161221|FG002|Overall Study|Never treated: Death|1|||
149188644|NCT01234402|538161219|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
149188645|NCT01234402|538161220|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
149188646|NCT01234402|538161221|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
148933690|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
148933691|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
148933692|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Physician Decision|0|||
148933693|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Physician Decision|8|||
148933694|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Physician Decision|11|||
148933695|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
149188647|NCT01234402|538161219|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
149188648|NCT01234402|538161220|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
149188649|NCT01234402|538161221|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
149188650|NCT05761444|538161223|FG000|Overall Study|Protocol Violation|2|||
149188651|NCT05761444|538161224|FG001|Overall Study|Protocol Violation|1|||
149188652|NCT05761444|538161223|FG000|Overall Study|Adverse Event|2|||
149188653|NCT05761444|538161224|FG001|Overall Study|Adverse Event|2|||
149188654|NCT05761444|538161223|FG000|Overall Study|Withdrawal by Subject|3|||
149188655|NCT05761444|538161224|FG001|Overall Study|Withdrawal by Subject|2|||
149188656|NCT05761444|538161223|FG000|Overall Study|Other|1|||
149188657|NCT05761444|538161224|FG001|Overall Study|Other|0|||
149188658|NCT00752609|538161225|FG000|Overall Study|Adverse Event|2|||
149188659|NCT00752609|538161226|FG001|Overall Study|Adverse Event|2|||
149188660|NCT00752609|538161225|FG000|Overall Study|Withdrawal by Subject|3|||
149188661|NCT00752609|538161226|FG001|Overall Study|Withdrawal by Subject|0|||
149188662|NCT00752609|538161225|FG000|Overall Study|Physician Decision|1|||
149188663|NCT00752609|538161226|FG001|Overall Study|Physician Decision|0|||
149188664|NCT00752609|538161225|FG000|Overall Study|Death|1|||
149188665|NCT00752609|538161226|FG001|Overall Study|Death|0|||
149188666|NCT00752609|538161225|FG000|Overall Study|Met exclusion criteria|1|||
149188667|NCT00752609|538161226|FG001|Overall Study|Met exclusion criteria|0|||
149188668|NCT00752609|538161225|FG000|Overall Study|Received Aranesp in error|1|||
149188669|NCT00752609|538161226|FG001|Overall Study|Received Aranesp in error|0|||
149188670|NCT05114590|538161227|FG000|Overall Study|Adverse Event|1|||
149188671|NCT05114590|538161227|FG000|Overall Study|Investigator decision|1|||
149188672|NCT05114590|538161227|FG000|Overall Study|Lost to Follow-up|5|||
149188673|NCT05114590|538161227|FG000|Overall Study|Withdrawal by Subject|5|||
149188674|NCT05114590|538161227|FG000|Overall Study|Other|2|||
149188675|NCT01757704|538161228|FG000|Overall Study|Protocol Violation|1|||
149188676|NCT01757704|538161229|FG001|Overall Study|Protocol Violation|3|||
149188677|NCT00938327|538161230|FG000|Overall Study|Adverse Event|2|||
149188678|NCT00938327|538161230|FG000|Overall Study|Protocol Violation|1|||
149188679|NCT00938327|538161230|FG000|Overall Study|Withdrawal by Subject|4|||
149188680|NCT00938327|538161230|FG000|Overall Study|Lost to Follow-up|37|||
149188681|NCT00938327|538161230|FG000|Overall Study|2nd dose received outside of the study|7|||
149188682|NCT00938327|538161230|FG000|Overall Study|Vaccine not received as out of stock|9|||
149188683|NCT01425190|538161231|FG000|Overall Study|Full dose not consumed.|1|||
149188684|NCT01425190|538161232|FG001|Overall Study|Full dose not consumed.|0|||
149188685|NCT01425190|538161233|FG002|Overall Study|Full dose not consumed.|0|||
149188686|NCT01035255|538161235|FG000|Overall Study|Death|724|||
149188687|NCT01035255|538161236|FG001|Overall Study|Death|844|||
149188688|NCT01035255|538161235|FG000|Overall Study|Lost to Follow-up|2|||
149188689|NCT01035255|538161236|FG001|Overall Study|Lost to Follow-up|5|||
149188690|NCT01035255|538161235|FG000|Overall Study|patient's request|15|||
149188691|NCT01035255|538161236|FG001|Overall Study|patient's request|13|||
149188692|NCT00195260|538161239|FG000|Part 1: Dose Escalation|Adverse Event|0|||
149188693|NCT00195260|538161240|FG001|Part 1: Dose Escalation|Adverse Event|1|||
149188694|NCT00195260|538161241|FG002|Part 1: Dose Escalation|Adverse Event|0|||
149188695|NCT00195260|538161242|FG003|Part 1: Dose Escalation|Adverse Event|1|||
149188696|NCT00195260|538161243|FG004|Part 1: Dose Escalation|Adverse Event|1|||
149188697|NCT00195260|538161244|FG005|Part 1: Dose Escalation|Adverse Event|0|||
149188698|NCT00195260|538161245|FG006|Part 1: Dose Escalation|Adverse Event|3|||
149188699|NCT00195260|538161246|FG007|Part 1: Dose Escalation|Adverse Event|0|||
149188700|NCT00195260|538161247|FG008|Part 1: Dose Escalation|Adverse Event|0|||
149188701|NCT00195260|538161248|FG009|Part 1: Dose Escalation|Adverse Event|0|||
149188702|NCT00195260|538161249|FG010|Part 1: Dose Escalation|Adverse Event|0|||
149188703|NCT00195260|538161239|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148933696|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
148933697|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
149188704|NCT00195260|538161240|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188705|NCT00195260|538161241|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188706|NCT00195260|538161242|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188707|NCT00195260|538161243|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
149188708|NCT00195260|538161244|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188709|NCT00195260|538161245|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188710|NCT00195260|538161246|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
149188711|NCT00195260|538161247|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188712|NCT00195260|538161248|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188713|NCT00195260|538161249|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149188714|NCT00195260|538161239|FG000|Part 1: Dose Escalation|Death|0|||
149188715|NCT00195260|538161240|FG001|Part 1: Dose Escalation|Death|0|||
149188716|NCT00195260|538161241|FG002|Part 1: Dose Escalation|Death|0|||
149188717|NCT00195260|538161242|FG003|Part 1: Dose Escalation|Death|0|||
149188718|NCT00195260|538161243|FG004|Part 1: Dose Escalation|Death|0|||
149188719|NCT00195260|538161244|FG005|Part 1: Dose Escalation|Death|0|||
149188720|NCT00195260|538161245|FG006|Part 1: Dose Escalation|Death|0|||
149188721|NCT00195260|538161246|FG007|Part 1: Dose Escalation|Death|1|||
149188722|NCT00195260|538161247|FG008|Part 1: Dose Escalation|Death|0|||
149188723|NCT00195260|538161248|FG009|Part 1: Dose Escalation|Death|0|||
149188724|NCT00195260|538161249|FG010|Part 1: Dose Escalation|Death|0|||
149188725|NCT00195260|538161239|FG000|Part 1: Dose Escalation|Disease Progression|3|||
149188726|NCT00195260|538161240|FG001|Part 1: Dose Escalation|Disease Progression|2|||
149188727|NCT00195260|538161241|FG002|Part 1: Dose Escalation|Disease Progression|5|||
149188728|NCT00195260|538161242|FG003|Part 1: Dose Escalation|Disease Progression|6|||
149188729|NCT00195260|538161243|FG004|Part 1: Dose Escalation|Disease Progression|4|||
149188730|NCT00195260|538161244|FG005|Part 1: Dose Escalation|Disease Progression|6|||
149188731|NCT00195260|538161245|FG006|Part 1: Dose Escalation|Disease Progression|7|||
149188732|NCT00195260|538161246|FG007|Part 1: Dose Escalation|Disease Progression|4|||
149188733|NCT00195260|538161247|FG008|Part 1: Dose Escalation|Disease Progression|0|||
149188734|NCT00195260|538161248|FG009|Part 1: Dose Escalation|Disease Progression|0|||
149188735|NCT00195260|538161249|FG010|Part 1: Dose Escalation|Disease Progression|0|||
149188736|NCT00195260|538161239|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149188737|NCT00195260|538161240|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149188738|NCT00195260|538161241|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149188739|NCT00195260|538161242|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188740|NCT00195260|538161243|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188741|NCT00195260|538161244|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
149188742|NCT00195260|538161245|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188743|NCT00195260|538161246|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188744|NCT00195260|538161247|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188745|NCT00195260|538161248|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188746|NCT00195260|538161249|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
149188747|NCT00195260|538161239|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188748|NCT00195260|538161240|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188749|NCT00195260|538161241|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188750|NCT00195260|538161242|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188751|NCT00195260|538161243|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188752|NCT00195260|538161244|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188753|NCT00195260|538161245|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188754|NCT00195260|538161246|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
149188755|NCT00195260|538161247|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
149188756|NCT00195260|538161248|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
149188757|NCT00195260|538161249|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
149188758|NCT00195260|538161239|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188759|NCT00195260|538161240|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188760|NCT00195260|538161241|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188761|NCT00195260|538161242|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188762|NCT00195260|538161243|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188763|NCT00195260|538161244|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188764|NCT00195260|538161245|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188765|NCT00195260|538161246|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
149188766|NCT00195260|538161247|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
149188767|NCT00195260|538161248|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
149188768|NCT00195260|538161249|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
149188769|NCT00195260|538161239|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188770|NCT00195260|538161240|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188771|NCT00195260|538161241|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188772|NCT00195260|538161242|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188773|NCT00195260|538161243|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188774|NCT00195260|538161244|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188775|NCT00195260|538161245|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188776|NCT00195260|538161246|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
149188777|NCT00195260|538161247|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
149188778|NCT00195260|538161248|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
149188779|NCT00195260|538161249|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
149188780|NCT00195260|538161239|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188781|NCT00195260|538161240|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188782|NCT00195260|538161241|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188783|NCT00195260|538161242|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188784|NCT00195260|538161243|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188785|NCT00195260|538161244|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188786|NCT00195260|538161245|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188787|NCT00195260|538161246|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
149188788|NCT00195260|538161247|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
149188789|NCT00195260|538161248|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
149188790|NCT00195260|538161249|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
149188791|NCT02749721|538161250|FG000|Screening|Withdrawal by Subject|1|||
149188792|NCT02749721|538161250|FG000|Screening|Lost to Follow-up|2|||
149188793|NCT02749721|538161250|FG000|Screening|Protocol Violation|3|||
149188794|NCT02749721|538161250|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
149188795|NCT02749721|538161250|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
149188796|NCT01379534|538161251|FG000|Treatment Phase|Withdrawal by Subject|2|||
149188797|NCT01379534|538161252|FG001|Treatment Phase|Withdrawal by Subject|2|||
149188798|NCT01379534|538161251|FG000|Treatment Phase|Progressive disease|13|||
149188799|NCT01379534|538161252|FG001|Treatment Phase|Progressive disease|22|||
149188800|NCT01379534|538161251|FG000|Treatment Phase|Adverse Event|7|||
149188801|NCT01379534|538161252|FG001|Treatment Phase|Adverse Event|7|||
149188802|NCT01379534|538161251|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
149188803|NCT01379534|538161252|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
149188804|NCT01379534|538161251|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
149188805|NCT01379534|538161252|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
149188806|NCT01379534|538161251|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
149188807|NCT01379534|538161252|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
149188808|NCT01379534|538161251|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
149188809|NCT01379534|538161252|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
149188810|NCT02691247|538161253|FG000|Overall Study|Withdrawal by Subject|1|||
149188811|NCT02691247|538161254|FG001|Overall Study|Withdrawal by Subject|2|||
149188812|NCT02691247|538161255|FG002|Overall Study|Withdrawal by Subject|2|||
149188813|NCT02691247|538161253|FG000|Overall Study|Lost to Follow-up|2|||
149188814|NCT02691247|538161254|FG001|Overall Study|Lost to Follow-up|0|||
149188815|NCT02691247|538161255|FG002|Overall Study|Lost to Follow-up|1|||
149188816|NCT02552355|538161256|FG000|Overall Study|Adverse Event|0|||
149188817|NCT02552355|538161257|FG001|Overall Study|Adverse Event|2|||
149188818|NCT02552355|538161258|FG002|Overall Study|Adverse Event|2|||
149188819|NCT02552355|538161259|FG003|Overall Study|Adverse Event|0|||
149188820|NCT02552355|538161256|FG000|Overall Study|Withdrawal by Subject|0|||
149188821|NCT02552355|538161257|FG001|Overall Study|Withdrawal by Subject|0|||
149188822|NCT02552355|538161258|FG002|Overall Study|Withdrawal by Subject|0|||
149188823|NCT02552355|538161259|FG003|Overall Study|Withdrawal by Subject|1|||
149188824|NCT01519245|538161260|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
149188825|NCT01519245|538161261|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
149188826|NCT03321929|538161265|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
149188827|NCT01052012|538161266|FG000|Overall Study|Not treated|2|||
149188828|NCT01052012|538161267|FG001|Overall Study|Not treated|5|||
149188829|NCT01052012|538161268|FG002|Overall Study|Not treated|0|||
149188830|NCT01052012|538161269|FG003|Overall Study|Not treated|0|||
149188831|NCT01052012|538161270|FG004|Overall Study|Not treated|11|||
149188832|NCT01052012|538161271|FG005|Overall Study|Not treated|8|||
149188833|NCT01052012|538161266|FG000|Overall Study|Adverse Event|1|||
149188834|NCT01052012|538161267|FG001|Overall Study|Adverse Event|0|||
149188835|NCT01052012|538161268|FG002|Overall Study|Adverse Event|0|||
149188836|NCT01052012|538161269|FG003|Overall Study|Adverse Event|1|||
149188837|NCT01052012|538161270|FG004|Overall Study|Adverse Event|0|||
149188838|NCT01052012|538161271|FG005|Overall Study|Adverse Event|0|||
149188839|NCT01052012|538161266|FG000|Overall Study|Lost to Follow-up|0|||
149188840|NCT01052012|538161267|FG001|Overall Study|Lost to Follow-up|0|||
149188841|NCT01052012|538161268|FG002|Overall Study|Lost to Follow-up|0|||
149188842|NCT01052012|538161269|FG003|Overall Study|Lost to Follow-up|0|||
149188843|NCT01052012|538161270|FG004|Overall Study|Lost to Follow-up|1|||
148933698|NCT00257608|537244297|FG000|Post Chemotherapy Phase|Not treated|0|||
148933699|NCT00257608|537244298|FG001|Post Chemotherapy Phase|Not treated|4|||
148933700|NCT00257608|537244299|FG002|Post Chemotherapy Phase|Not treated|7|||
148933701|NCT01896050|537244300|FG000|Overall Study|Adverse Event|37|||
149188844|NCT01052012|538161271|FG005|Overall Study|Lost to Follow-up|0|||
149188845|NCT01052012|538161266|FG000|Overall Study|Withdrawal by Subject|1|||
149188846|NCT01052012|538161267|FG001|Overall Study|Withdrawal by Subject|1|||
149188847|NCT01052012|538161268|FG002|Overall Study|Withdrawal by Subject|0|||
149188848|NCT01052012|538161269|FG003|Overall Study|Withdrawal by Subject|0|||
149188849|NCT01052012|538161270|FG004|Overall Study|Withdrawal by Subject|3|||
148933702|NCT01896050|537244301|FG001|Overall Study|Adverse Event|2|||
148933703|NCT01896050|537244300|FG000|Overall Study|Death|1|||
149188850|NCT01052012|538161271|FG005|Overall Study|Withdrawal by Subject|1|||
149188851|NCT01052012|538161266|FG000|Overall Study|Physician Decision|0|||
149188852|NCT01052012|538161267|FG001|Overall Study|Physician Decision|0|||
149188853|NCT01052012|538161268|FG002|Overall Study|Physician Decision|0|||
149188854|NCT01052012|538161269|FG003|Overall Study|Physician Decision|0|||
149188855|NCT01052012|538161270|FG004|Overall Study|Physician Decision|0|||
149188856|NCT01052012|538161271|FG005|Overall Study|Physician Decision|1|||
149188857|NCT01052012|538161266|FG000|Overall Study|Other|0|||
149188858|NCT01052012|538161267|FG001|Overall Study|Other|0|||
149188859|NCT01052012|538161268|FG002|Overall Study|Other|0|||
149188860|NCT01052012|538161269|FG003|Overall Study|Other|0|||
149188861|NCT01052012|538161270|FG004|Overall Study|Other|1|||
149188862|NCT01052012|538161271|FG005|Overall Study|Other|0|||
149188863|NCT01413178|538161274|FG000|Overall Study|Toxicity|1|||
149188864|NCT01413178|538161275|FG001|Overall Study|Toxicity|0|||
148933704|NCT01896050|537244301|FG001|Overall Study|Death|0|||
148933705|NCT03693300|537244302|FG000|Overall Study|Withdrawal by Subject|6|||
148933706|NCT03693300|537244303|FG001|Overall Study|Withdrawal by Subject|0|||
149188865|NCT01413178|538161274|FG000|Overall Study|Ineligible|0|||
149188866|NCT01413178|538161275|FG001|Overall Study|Ineligible|2|||
149188867|NCT00872170|538161276|FG000|Overall Study|Adverse Event|1|||
149188868|NCT00872170|538161277|FG001|Overall Study|Adverse Event|0|||
149188869|NCT00804193|538161278|FG000|Overall Study|Lack of baseline fungus|32|||
149188870|NCT00804193|538161279|FG001|Overall Study|Lack of baseline fungus|31|||
149188871|NCT00804193|538161280|FG002|Overall Study|Lack of baseline fungus|19|||
149188872|NCT00804193|538161278|FG000|Overall Study|Adverse Event|0|||
149188873|NCT00804193|538161279|FG001|Overall Study|Adverse Event|0|||
149188874|NCT00804193|538161280|FG002|Overall Study|Adverse Event|2|||
149188875|NCT00804193|538161278|FG000|Overall Study|Lack of Efficacy|1|||
149188876|NCT00804193|538161279|FG001|Overall Study|Lack of Efficacy|1|||
149188877|NCT00804193|538161280|FG002|Overall Study|Lack of Efficacy|3|||
149188878|NCT00804193|538161278|FG000|Overall Study|Protocol Violation|0|||
149188879|NCT00804193|538161279|FG001|Overall Study|Protocol Violation|8|||
149188880|NCT00804193|538161280|FG002|Overall Study|Protocol Violation|2|||
149188881|NCT00804193|538161278|FG000|Overall Study|Lost to Follow-up|3|||
149188882|NCT00804193|538161279|FG001|Overall Study|Lost to Follow-up|3|||
149188883|NCT00804193|538161280|FG002|Overall Study|Lost to Follow-up|4|||
149188884|NCT00804193|538161278|FG000|Overall Study|Withdrawal by Subject|3|||
149188885|NCT00804193|538161279|FG001|Overall Study|Withdrawal by Subject|1|||
149188886|NCT00804193|538161280|FG002|Overall Study|Withdrawal by Subject|2|||
149188887|NCT00237796|538161283|FG000|Overall Study|Baseline and one other ILSS required|10|||
149188888|NCT00237796|538161284|FG001|Overall Study|Baseline and one other ILSS required|5|||
149188889|NCT01193348|538161285|FG000|Screening Period|Screen Failure|5|||
149188890|NCT01193348|538161285|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
148807390|NCT03183908|536773238|FG000|Overall Study|Missing Symptom Diary Data|0|||
148807391|NCT03183908|536773239|FG001|Overall Study|Missing Symptom Diary Data|2|||
148807392|NCT03738696|536773243|FG000|Overall Study|Withdrawal by Subject|0|||
148933707|NCT03693300|537244302|FG000|Overall Study|Death|50|||
148933708|NCT03693300|537244303|FG001|Overall Study|Death|2|||
148933709|NCT03693300|537244302|FG000|Overall Study|Lost to Follow-up|2|||
149188891|NCT01193348|538161285|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
149188892|NCT01193348|538161285|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
149188893|NCT01193348|538161285|FG000|Extension Treatment Period|Physician Decision|1|||
149188894|NCT01193348|538161285|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
149188895|NCT00968253|538161286|FG000|Overall Study|Death|0|||
149188896|NCT00968253|538161287|FG001|Overall Study|Death|0|||
149188897|NCT00968253|538161288|FG002|Overall Study|Death|2|||
149188898|NCT00968253|538161286|FG000|Overall Study|Withdrawal by Subject|0|||
149188899|NCT00968253|538161287|FG001|Overall Study|Withdrawal by Subject|0|||
149188900|NCT00968253|538161288|FG002|Overall Study|Withdrawal by Subject|1|||
149188901|NCT00968253|538161286|FG000|Overall Study|Disease Progression|0|||
148933710|NCT03693300|537244303|FG001|Overall Study|Lost to Follow-up|0|||
148933711|NCT02206048|537244304|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
148933712|NCT02925923|537244305|FG000|Overall Study|blood samples hemolyzed|0|||
148933713|NCT02925923|537244306|FG001|Overall Study|blood samples hemolyzed|2|||
149188902|NCT00968253|538161287|FG001|Overall Study|Disease Progression|3|||
149188903|NCT00968253|538161288|FG002|Overall Study|Disease Progression|3|||
149188904|NCT00968253|538161286|FG000|Overall Study|Adverse Event|0|||
149188905|NCT00968253|538161287|FG001|Overall Study|Adverse Event|0|||
149188906|NCT00968253|538161288|FG002|Overall Study|Adverse Event|1|||
149188907|NCT01721408|538161289|FG000|Overall Study|Adverse Event|6|||
149188908|NCT01721408|538161290|FG001|Overall Study|Adverse Event|1|||
149188909|NCT01721408|538161289|FG000|Overall Study|Death|1|||
149188910|NCT01721408|538161290|FG001|Overall Study|Death|0|||
149188911|NCT01721408|538161289|FG000|Overall Study|Insufficient clinical response|15|||
149188912|NCT01721408|538161290|FG001|Overall Study|Insufficient clinical response|6|||
148933714|NCT00697073|537244307|FG000|Overall Study|Withdrawal by Subject|2|||
148933715|NCT00697073|537244307|FG000|Overall Study|Pregnancy|1|||
149188913|NCT01721408|538161289|FG000|Overall Study|No longer willing to participate study|9|||
148933716|NCT00697073|537244307|FG000|Overall Study|non compliance and other|6|||
148933717|NCT03265665|537244308|FG000|24-week Data Collection|Withdrawal by Subject|2|||
148933718|NCT03265665|537244309|FG001|24-week Data Collection|Withdrawal by Subject|2|||
148933719|NCT03265665|537244308|FG000|24-week Data Collection|Lost to Follow-up|4|||
148933720|NCT03265665|537244309|FG001|24-week Data Collection|Lost to Follow-up|5|||
148933721|NCT03265665|537244308|FG000|36-week Data Collection|Lost to Follow-up|6|||
148933722|NCT03265665|537244309|FG001|36-week Data Collection|Lost to Follow-up|8|||
148933723|NCT01858376|537244310|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
148933724|NCT00108433|537244314|FG000|Overall Study|Lack of Efficacy|1|||
148933725|NCT00108433|537244315|FG001|Overall Study|Lack of Efficacy|2|||
148933726|NCT00108433|537244314|FG000|Overall Study|Death|3|||
148933727|NCT00108433|537244315|FG001|Overall Study|Death|0|||
149188914|NCT01721408|538161290|FG001|Overall Study|No longer willing to participate study|10|||
149188915|NCT01721408|538161289|FG000|Overall Study|Protocol Violation|0|||
149188916|NCT01721408|538161290|FG001|Overall Study|Protocol Violation|2|||
149188917|NCT01721408|538161289|FG000|Overall Study|Other|3|||
149188918|NCT01721408|538161290|FG001|Overall Study|Other|3|||
149188919|NCT01721408|538161289|FG000|Overall Study|Lost to Follow-up|1|||
149188920|NCT01721408|538161290|FG001|Overall Study|Lost to Follow-up|2|||
149188921|NCT01721408|538161289|FG000|Overall Study|Does not meet entrance criteria|1|||
149188922|NCT01721408|538161290|FG001|Overall Study|Does not meet entrance criteria|0|||
149188923|NCT01187901|538161291|FG000|Overall Study|Protocol Violation|1|||
148933728|NCT00108433|537244314|FG000|Overall Study|Adverse Event|3|||
148933729|NCT00108433|537244315|FG001|Overall Study|Adverse Event|1|||
148933730|NCT00108433|537244314|FG000|Overall Study|Other|14|||
148933731|NCT00108433|537244315|FG001|Overall Study|Other|14|||
149188924|NCT01187901|538161292|FG001|Overall Study|Protocol Violation|0|||
149188925|NCT01187901|538161291|FG000|Overall Study|Lost to Follow-up|1|||
149188926|NCT01187901|538161292|FG001|Overall Study|Lost to Follow-up|2|||
149188927|NCT01187901|538161291|FG000|Overall Study|Unrelated Health Reasons|1|||
149188928|NCT01187901|538161292|FG001|Overall Study|Unrelated Health Reasons|2|||
149188929|NCT01187901|538161291|FG000|Overall Study|Suspected Allergic Reaction|1|||
149188930|NCT01187901|538161292|FG001|Overall Study|Suspected Allergic Reaction|1|||
149188931|NCT01187901|538161291|FG000|Overall Study|Adverse Event|3|||
149188932|NCT01187901|538161292|FG001|Overall Study|Adverse Event|0|||
149188933|NCT01187901|538161291|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
149188934|NCT01187901|538161292|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
149188935|NCT01187901|538161291|FG000|Overall Study|Pregnancy|0|||
149188936|NCT01187901|538161292|FG001|Overall Study|Pregnancy|2|||
149188937|NCT04160468|538161293|FG000|Overall Study|Lost to Follow-up|19|||
149188938|NCT04160468|538161294|FG001|Overall Study|Lost to Follow-up|4|||
149188939|NCT04160468|538161293|FG000|Overall Study|Randomized but not dosed|6|||
149188940|NCT04160468|538161294|FG001|Overall Study|Randomized but not dosed|0|||
149188941|NCT04160468|538161293|FG000|Overall Study|Withdrawal by Subject|4|||
149188942|NCT04160468|538161294|FG001|Overall Study|Withdrawal by Subject|1|||
148933732|NCT03894046|537244318|FG000|Overall Study|Protocol Violation|1|||
148933733|NCT03894046|537244319|FG001|Overall Study|Protocol Violation|0|||
148933734|NCT03894046|537244320|FG002|Overall Study|Protocol Violation|0|||
148933735|NCT03894046|537244318|FG000|Overall Study|Adverse Event|0|||
148933736|NCT03894046|537244319|FG001|Overall Study|Adverse Event|1|||
148933737|NCT03894046|537244320|FG002|Overall Study|Adverse Event|0|||
148933738|NCT03894046|537244318|FG000|Overall Study|Withdrawal by Subject|2|||
148933739|NCT03894046|537244319|FG001|Overall Study|Withdrawal by Subject|3|||
148933740|NCT03894046|537244320|FG002|Overall Study|Withdrawal by Subject|1|||
148933741|NCT03894046|537244318|FG000|Overall Study|Death|15|||
149188943|NCT04160468|538161293|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
149188944|NCT04160468|538161294|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
148933742|NCT03894046|537244319|FG001|Overall Study|Death|21|||
149188945|NCT04160468|538161293|FG000|Overall Study|Participant incarcerated|1|||
149188946|NCT04160468|538161294|FG001|Overall Study|Participant incarcerated|0|||
149188947|NCT03987620|538161295|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
149188948|NCT03987620|538161296|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
148933743|NCT03894046|537244320|FG002|Overall Study|Death|4|||
148933744|NCT03894046|537244318|FG000|Overall Study|No growth of ABC|2|||
148933745|NCT03894046|537244319|FG001|Overall Study|No growth of ABC|1|||
148933746|NCT03894046|537244320|FG002|Overall Study|No growth of ABC|0|||
148933747|NCT03894046|537244318|FG000|Overall Study|Physician Decision|1|||
148933748|NCT03894046|537244319|FG001|Overall Study|Physician Decision|1|||
149188949|NCT03987620|538161295|FG000|Overall Study|Adverse Event|3|||
149188950|NCT03987620|538161296|FG001|Overall Study|Adverse Event|0|||
149188951|NCT03987620|538161295|FG000|Overall Study|Lost to Follow-up|1|||
149188952|NCT03987620|538161296|FG001|Overall Study|Lost to Follow-up|2|||
149188953|NCT03987620|538161295|FG000|Overall Study|Physician Decision|0|||
149188954|NCT03987620|538161296|FG001|Overall Study|Physician Decision|1|||
149188955|NCT03987620|538161295|FG000|Overall Study|Pregnancy|1|||
149188956|NCT03987620|538161296|FG001|Overall Study|Pregnancy|0|||
149188957|NCT03987620|538161295|FG000|Overall Study|Withdrawal by Subject|7|||
149188958|NCT03987620|538161296|FG001|Overall Study|Withdrawal by Subject|1|||
149188959|NCT03987620|538161295|FG000|Overall Study|Other|2|||
149188960|NCT03987620|538161296|FG001|Overall Study|Other|5|||
149188961|NCT02149836|538161297|FG000|Overall Study|Withdrawal by Subject|1|||
149188962|NCT03860844|538161298|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
149188963|NCT03860844|538161299|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
149188964|NCT03860844|538161300|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
149188965|NCT03860844|538161298|FG000|Overall Study|Progressive disease|5|||
149188966|NCT03860844|538161299|FG001|Overall Study|Progressive disease|3|||
149188967|NCT03860844|538161300|FG002|Overall Study|Progressive disease|4|||
149188968|NCT03860844|538161298|FG000|Overall Study|Other, Not related to COVID-19|0|||
149188969|NCT03860844|538161299|FG001|Overall Study|Other, Not related to COVID-19|1|||
149188970|NCT03860844|538161300|FG002|Overall Study|Other, Not related to COVID-19|0|||
149188971|NCT01678807|538161308|FG000|Overall Study|Adverse Event|4|||
148933749|NCT03894046|537244320|FG002|Overall Study|Physician Decision|1|||
148933750|NCT03894046|537244318|FG000|Overall Study|Prohibited concomitant medication|1|||
148933751|NCT03894046|537244319|FG001|Overall Study|Prohibited concomitant medication|0|||
148933752|NCT03894046|537244320|FG002|Overall Study|Prohibited concomitant medication|0|||
148933753|NCT03894046|537244318|FG000|Overall Study|Transferred to other arm/group|1|||
148933754|NCT03894046|537244319|FG001|Overall Study|Transferred to other arm/group|1|||
148933755|NCT03894046|537244320|FG002|Overall Study|Transferred to other arm/group|0|||
148933756|NCT04806503|537244321|FG000|Overall Study|Lost to Follow-up|0|||
148933757|NCT04806503|537244322|FG001|Overall Study|Lost to Follow-up|0|||
148933758|NCT04806503|537244323|FG002|Overall Study|Lost to Follow-up|1|||
148933759|NCT04806503|537244324|FG003|Overall Study|Lost to Follow-up|0|||
149188972|NCT01678807|538161309|FG001|Overall Study|Adverse Event|4|||
148933760|NCT04806503|537244325|FG004|Overall Study|Lost to Follow-up|0|||
148933761|NCT04806503|537244321|FG000|Overall Study|Withdrawal by Subject|1|||
148933762|NCT04806503|537244322|FG001|Overall Study|Withdrawal by Subject|0|||
148933763|NCT04806503|537244323|FG002|Overall Study|Withdrawal by Subject|1|||
148933764|NCT04806503|537244324|FG003|Overall Study|Withdrawal by Subject|1|||
148933765|NCT04806503|537244325|FG004|Overall Study|Withdrawal by Subject|1|||
148933766|NCT04806503|537244321|FG000|Overall Study|Adverse Event|1|||
148933767|NCT04806503|537244322|FG001|Overall Study|Adverse Event|1|||
148933768|NCT04806503|537244323|FG002|Overall Study|Adverse Event|0|||
148933769|NCT04806503|537244324|FG003|Overall Study|Adverse Event|1|||
148933770|NCT04806503|537244325|FG004|Overall Study|Adverse Event|0|||
148933771|NCT03589469|537244326|FG000|Overall Study|Withdrawal by Subject|8|||
148933772|NCT03589469|537244326|FG000|Overall Study|Physician Decision|20|||
148933773|NCT03589469|537244326|FG000|Overall Study|Death|97|||
148933774|NCT03589469|537244326|FG000|Overall Study|Lost to Follow-up|8|||
148933775|NCT03589469|537244326|FG000|Overall Study|Miscellaneous|1|||
149188973|NCT01678807|538161310|FG002|Overall Study|Adverse Event|0|||
149188974|NCT01678807|538161308|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
149188975|NCT01678807|538161309|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
149188976|NCT01678807|538161310|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
149188977|NCT02574312|538161311|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
149188978|NCT02574312|538161312|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
149188979|NCT05306873|538162824|FG000|Stage 2|Study stopped|1|||
149188980|NCT05306873|538162825|FG001|Stage 2|Study stopped|1|||
149188981|NCT05306873|538162826|FG002|Stage 2|Study stopped|0|||
149188982|NCT05306873|538162827|FG003|Stage 2|Study stopped|0|||
148933776|NCT01824342|537244335|FG000|Overall Study|Withdrawal by Subject|0|||
149188983|NCT05306873|538162824|FG000|Stage 2|Stage 2 Treatment Failure|2|||
149188984|NCT05306873|538162825|FG001|Stage 2|Stage 2 Treatment Failure|3|||
149188985|NCT05306873|538162826|FG002|Stage 2|Stage 2 Treatment Failure|0|||
149188986|NCT05306873|538162827|FG003|Stage 2|Stage 2 Treatment Failure|0|||
149188987|NCT05306873|538162824|FG000|Stage 2|Logistical issues due to participant moving|1|||
148933777|NCT01824342|537244336|FG001|Overall Study|Withdrawal by Subject|3|||
148933778|NCT01824342|537244335|FG000|Overall Study|Adverse Event|1|||
148933779|NCT01824342|537244336|FG001|Overall Study|Adverse Event|1|||
148933780|NCT01824342|537244335|FG000|Overall Study|Disease Progression|1|||
148933781|NCT01824342|537244336|FG001|Overall Study|Disease Progression|1|||
148933782|NCT01824342|537244335|FG000|Overall Study|Physician Decision|5|||
148933783|NCT01824342|537244336|FG001|Overall Study|Physician Decision|0|||
149188988|NCT05306873|538162825|FG001|Stage 2|Logistical issues due to participant moving|0|||
149188989|NCT05306873|538162826|FG002|Stage 2|Logistical issues due to participant moving|0|||
149188990|NCT05306873|538162827|FG003|Stage 2|Logistical issues due to participant moving|0|||
148933784|NCT01824342|537244335|FG000|Overall Study|Death|2|||
149188991|NCT05306873|538162824|FG000|Stage 3|Stage 3 Treatment Failure|0|||
149188992|NCT05306873|538162825|FG001|Stage 3|Stage 3 Treatment Failure|0|||
149188993|NCT05306873|538162826|FG002|Stage 3|Stage 3 Treatment Failure|0|||
149188994|NCT05306873|538162827|FG003|Stage 3|Stage 3 Treatment Failure|1|||
149188995|NCT05306873|538162824|FG000|Stage 3|Study Stopped|0|||
149188996|NCT05306873|538162825|FG001|Stage 3|Study Stopped|0|||
149188997|NCT05306873|538162826|FG002|Stage 3|Study Stopped|1|||
149188998|NCT05306873|538162827|FG003|Stage 3|Study Stopped|0|||
149188999|NCT04920084|538162829|FG000|Overall Study|Adverse Event|1|||
149189000|NCT04920084|538162829|FG000|Overall Study|Lost to Follow-up|2|||
149189001|NCT04920084|538162829|FG000|Overall Study|Withdrawal by Subject|2|||
149189002|NCT00074412|538162830|FG000|Overall Study|Death|30|||
149189003|NCT00074412|538162831|FG001|Overall Study|Death|26|||
149189004|NCT00074412|538162830|FG000|Overall Study|Lost to Follow-up|52|||
149189005|NCT00074412|538162831|FG001|Overall Study|Lost to Follow-up|58|||
149189006|NCT05113953|538162834|FG000|Overall Study|Adverse Event|5|||
149189007|NCT05113953|538162835|FG001|Overall Study|Adverse Event|0|||
149189008|NCT05113953|538162836|FG002|Overall Study|Adverse Event|3|||
149189009|NCT05113953|538162834|FG000|Overall Study|Lost to Follow-up|3|||
149189010|NCT05113953|538162835|FG001|Overall Study|Lost to Follow-up|4|||
149189011|NCT05113953|538162836|FG002|Overall Study|Lost to Follow-up|2|||
149189012|NCT05113953|538162834|FG000|Overall Study|Non-compliance with Study Drug|1|||
149189013|NCT05113953|538162835|FG001|Overall Study|Non-compliance with Study Drug|0|||
149189014|NCT05113953|538162836|FG002|Overall Study|Non-compliance with Study Drug|0|||
149189015|NCT05113953|538162834|FG000|Overall Study|Withdrawal by Subject|2|||
149189016|NCT05113953|538162835|FG001|Overall Study|Withdrawal by Subject|6|||
149189017|NCT05113953|538162836|FG002|Overall Study|Withdrawal by Subject|4|||
149189018|NCT05113953|538162834|FG000|Overall Study|Reason not Specified|2|||
149189019|NCT05113953|538162835|FG001|Overall Study|Reason not Specified|0|||
149189020|NCT05113953|538162836|FG002|Overall Study|Reason not Specified|0|||
149189021|NCT02626819|538162837|FG000|Overall Study|Lost to Follow-up|3|||
149189022|NCT02626819|538162838|FG001|Overall Study|Lost to Follow-up|2|||
149189023|NCT02626819|538162837|FG000|Overall Study|Withdrawal by Subject|1|||
149189024|NCT02626819|538162838|FG001|Overall Study|Withdrawal by Subject|0|||
149189025|NCT02626819|538162837|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
149189026|NCT02626819|538162838|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
149189027|NCT02361762|538162839|FG000|Overall Study|Withdrawal by Subject|0|||
149189028|NCT02361762|538162840|FG001|Overall Study|Withdrawal by Subject|1|||
149189029|NCT02361762|538162839|FG000|Overall Study|Lost to Follow-up|0|||
149189030|NCT02361762|538162840|FG001|Overall Study|Lost to Follow-up|1|||
149189031|NCT03488472|538162841|FG000|Overall Study|disease progression additional mets|1|||
149189032|NCT00028002|538162842|FG000|Overall Study|Withdrawal by Subject|3|||
149189033|NCT00028002|538162842|FG000|Overall Study|Ineligible|8|||
149189034|NCT00502307|538162845|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
149189035|NCT00502307|538162846|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
149189036|NCT00502307|538162847|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
149189037|NCT00502307|538162845|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
149189038|NCT00502307|538162846|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
149189039|NCT00502307|538162847|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
149189040|NCT00502307|538162845|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
149189041|NCT00502307|538162846|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
149189042|NCT00502307|538162847|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
149189043|NCT00502307|538162845|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
149189044|NCT00502307|538162846|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
149189045|NCT00502307|538162847|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
149189046|NCT00502307|538162845|FG000|Maintenance Period|Progressive disease|80|||
149189047|NCT00502307|538162846|FG001|Maintenance Period|Progressive disease|0|||
149189048|NCT00502307|538162847|FG002|Maintenance Period|Progressive disease|0|||
149189049|NCT00502307|538162845|FG000|Maintenance Period|Discontinued due to other reasons|68|||
149189050|NCT00502307|538162846|FG001|Maintenance Period|Discontinued due to other reasons|0|||
149189051|NCT00502307|538162847|FG002|Maintenance Period|Discontinued due to other reasons|0|||
149189052|NCT04467164|538162850|FG000|Washout (1 Week)|Lost to Follow-up|2|||
149189053|NCT04467164|538162851|FG001|Washout (1 Week)|Lost to Follow-up|0|||
149189054|NCT02750813|538162852|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
149189055|NCT02750813|538162853|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
149189056|NCT02750813|538162852|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
149189057|NCT02750813|538162853|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
149189058|NCT01998581|538162854|FG000|Overall Study|Refused repeat treatment|20|||
149189059|NCT01998581|538162855|FG001|Overall Study|Refused repeat treatment|4|||
149189060|NCT01998581|538162854|FG000|Overall Study|Protocol Violation|1|||
149189061|NCT01998581|538162855|FG001|Overall Study|Protocol Violation|0|||
149189062|NCT01998581|538162854|FG000|Overall Study|Withdrawal by Subject|8|||
149189063|NCT01998581|538162855|FG001|Overall Study|Withdrawal by Subject|1|||
149189064|NCT01998581|538162854|FG000|Overall Study|Lost to Follow-up|12|||
149189065|NCT01998581|538162855|FG001|Overall Study|Lost to Follow-up|4|||
149189066|NCT01998581|538162854|FG000|Overall Study|Adverse Event|1|||
149189067|NCT01998581|538162855|FG001|Overall Study|Adverse Event|1|||
149189068|NCT01998581|538162854|FG000|Overall Study|Other reasons|3|||
149189069|NCT01998581|538162855|FG001|Overall Study|Other reasons|2|||
149189070|NCT01998581|538162854|FG000|Overall Study|Randomized but withdrew before treatment|1|||
149189071|NCT01998581|538162855|FG001|Overall Study|Randomized but withdrew before treatment|0|||
149189072|NCT02273752|538162857|FG000|Overall Study|Trial was terminated early|2|||
149189073|NCT00903032|538162858|FG000|Overall Study|Withdrawal by Subject|5|||
149189074|NCT00903032|538162859|FG001|Overall Study|Withdrawal by Subject|3|||
149189075|NCT00903032|538162858|FG000|Overall Study|Lost to Follow-up|2|||
149189076|NCT00903032|538162859|FG001|Overall Study|Lost to Follow-up|2|||
149189077|NCT01763905|538162862|FG000|Overall Study|Withdrawal by Subject|1|||
149189078|NCT01763905|538162863|FG001|Overall Study|Withdrawal by Subject|1|||
149189079|NCT01763905|538162864|FG002|Overall Study|Withdrawal by Subject|0|||
149189080|NCT01763905|538162865|FG003|Overall Study|Withdrawal by Subject|1|||
149189081|NCT01763905|538162862|FG000|Overall Study|Decision by sponsor|5|||
149189082|NCT01763905|538162863|FG001|Overall Study|Decision by sponsor|0|||
149189083|NCT01763905|538162864|FG002|Overall Study|Decision by sponsor|8|||
149189084|NCT01763905|538162865|FG003|Overall Study|Decision by sponsor|0|||
149189085|NCT01763905|538162862|FG000|Overall Study|Lost to Follow-up|0|||
149189086|NCT01763905|538162863|FG001|Overall Study|Lost to Follow-up|0|||
149189087|NCT01763905|538162864|FG002|Overall Study|Lost to Follow-up|1|||
149189088|NCT01763905|538162865|FG003|Overall Study|Lost to Follow-up|0|||
149189089|NCT04346628|538162866|FG000|Overall Study|Lost to Follow-up|4|||
149189090|NCT04346628|538162867|FG001|Overall Study|Lost to Follow-up|4|||
149189091|NCT04346628|538162866|FG000|Overall Study|Withdrew (had personal reasons)|2|||
149189092|NCT04346628|538162867|FG001|Overall Study|Withdrew (had personal reasons)|5|||
149189093|NCT04346628|538162866|FG000|Overall Study|Withdrew (medication intolerant)|0|||
149189094|NCT04346628|538162867|FG001|Overall Study|Withdrew (medication intolerant)|3|||
149189095|NCT04346628|538162866|FG000|Overall Study|Withdrew (declined intervention)|0|||
149189096|NCT04346628|538162867|FG001|Overall Study|Withdrew (declined intervention)|1|||
149189097|NCT00630812|538162878|FG000|Randomisation to First Dose|Adverse Event|1|||
149189098|NCT00630812|538162879|FG001|Randomisation to First Dose|Adverse Event|1|||
149189099|NCT00630812|538162878|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
149189100|NCT00630812|538162879|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
149189101|NCT00630812|538162878|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
149189102|NCT00630812|538162879|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
149189103|NCT00630812|538162878|FG000|Randomisation to First Dose|Protocol Violation|4|||
149189104|NCT00630812|538162879|FG001|Randomisation to First Dose|Protocol Violation|1|||
149189105|NCT00630812|538162878|FG000|Double Blind Treatment Period|Adverse Event|13|||
149189106|NCT00630812|538162879|FG001|Double Blind Treatment Period|Adverse Event|5|||
149189107|NCT00630812|538162878|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
149189108|NCT00630812|538162879|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149189109|NCT00630812|538162878|FG000|Double Blind Treatment Period|Physician Decision|2|||
149189110|NCT00630812|538162879|FG001|Double Blind Treatment Period|Physician Decision|1|||
149189111|NCT00630812|538162878|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149189112|NCT00630812|538162879|FG001|Double Blind Treatment Period|Protocol Violation|0|||
149189113|NCT00630812|538162878|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
149189114|NCT00630812|538162879|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
149189115|NCT00630812|538162878|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
149189116|NCT00630812|538162879|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
149189117|NCT00630812|538162878|FG000|Double Blind Treatment Period|Non-compliance|0|||
149189118|NCT00630812|538162879|FG001|Double Blind Treatment Period|Non-compliance|1|||
148933785|NCT01824342|537244336|FG001|Overall Study|Death|0|||
149189119|NCT03430245|538162882|FG000|Overall Study|Withdrawal by Subject|6|||
149189120|NCT03430245|538162882|FG000|Overall Study|Lost to Follow-up|1|||
149189121|NCT05628181|538162883|FG000|Overall Study|Death|2|||
149189122|NCT05628181|538162884|FG001|Overall Study|Death|4|||
149189123|NCT05628181|538162885|FG002|Overall Study|Death|0|||
149189140|NCT04742907|538162894|FG000|Overall Study|Adverse Event|1|||
149189141|NCT04742907|538162895|FG001|Overall Study|Adverse Event|0|||
149189142|NCT04742907|538162896|FG002|Overall Study|Adverse Event|1|||
149189143|NCT04742907|538162894|FG000|Overall Study|Lost to Follow-up|3|||
149189144|NCT04742907|538162895|FG001|Overall Study|Lost to Follow-up|3|||
149189145|NCT04742907|538162896|FG002|Overall Study|Lost to Follow-up|2|||
149189146|NCT04742907|538162894|FG000|Overall Study|Physician Decision|0|||
149189147|NCT04742907|538162895|FG001|Overall Study|Physician Decision|1|||
149189148|NCT04742907|538162896|FG002|Overall Study|Physician Decision|0|||
149189149|NCT04742907|538162894|FG000|Overall Study|Protocol Violation|1|||
149189150|NCT04742907|538162895|FG001|Overall Study|Protocol Violation|1|||
149189151|NCT04742907|538162896|FG002|Overall Study|Protocol Violation|1|||
149189152|NCT04742907|538162894|FG000|Overall Study|Withdrawal by Subject|5|||
149189153|NCT04742907|538162895|FG001|Overall Study|Withdrawal by Subject|6|||
149189154|NCT04742907|538162896|FG002|Overall Study|Withdrawal by Subject|4|||
149189155|NCT04742907|538162894|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
149189156|NCT04742907|538162895|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
149189157|NCT04742907|538162896|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
149189158|NCT04742907|538162894|FG000|Overall Study|Did Not Receive the Study Drug|2|||
149189159|NCT04742907|538162895|FG001|Overall Study|Did Not Receive the Study Drug|4|||
149189160|NCT04742907|538162896|FG002|Overall Study|Did Not Receive the Study Drug|4|||
148933786|NCT02202837|537244337|FG000|Overall Study|Enbrel treatment discontinued|36|||
148933787|NCT02202837|537244338|FG001|Overall Study|Enbrel treatment discontinued|4|||
148933788|NCT02202837|537244337|FG000|Overall Study|Other|10|||
149189161|NCT01428063|538162897|FG000|Overall Study|Lack of Efficacy|8|||
149189162|NCT01428063|538162898|FG001|Overall Study|Lack of Efficacy|4|||
149189163|NCT01428063|538162899|FG002|Overall Study|Lack of Efficacy|1|||
149189164|NCT01428063|538162897|FG000|Overall Study|Adverse Event|2|||
148933789|NCT02202837|537244338|FG001|Overall Study|Other|0|||
149189165|NCT01428063|538162898|FG001|Overall Study|Adverse Event|3|||
149189166|NCT01428063|538162899|FG002|Overall Study|Adverse Event|0|||
149189167|NCT01428063|538162897|FG000|Overall Study|Lost to Follow-up|0|||
149189168|NCT01428063|538162898|FG001|Overall Study|Lost to Follow-up|2|||
148933790|NCT02202837|537244337|FG000|Overall Study|Lost to Follow-up|7|||
149189169|NCT01428063|538162899|FG002|Overall Study|Lost to Follow-up|0|||
149189170|NCT01428063|538162897|FG000|Overall Study|No longer meets study criteria|0|||
149189171|NCT01428063|538162898|FG001|Overall Study|No longer meets study criteria|1|||
149189172|NCT01428063|538162899|FG002|Overall Study|No longer meets study criteria|0|||
149189173|NCT03508622|538162900|FG000|Overall Study|Protocol Violation|1|||
149189174|NCT03508622|538162901|FG001|Overall Study|Protocol Violation|0|||
149189175|NCT03508622|538162900|FG000|Overall Study|Withdrawal by Subject|1|||
149189176|NCT03508622|538162901|FG001|Overall Study|Withdrawal by Subject|0|||
149189177|NCT03508622|538162900|FG000|Overall Study|Lost to Follow-up|16|||
149189178|NCT03508622|538162901|FG001|Overall Study|Lost to Follow-up|0|||
149189179|NCT03508622|538162900|FG000|Overall Study|Incomplete data|0|||
149189180|NCT03508622|538162901|FG001|Overall Study|Incomplete data|24|||
149189181|NCT01005719|538162902|FG000|Period 1|Adverse Event|0|||
149189182|NCT01005719|538162903|FG001|Period 1|Adverse Event|0|||
149189183|NCT01005719|538162904|FG002|Period 1|Adverse Event|0|||
149189184|NCT01005719|538162905|FG003|Period 1|Adverse Event|1|||
149189185|NCT01005719|538162906|FG004|Period 1|Adverse Event|0|||
149189186|NCT01005719|538162907|FG005|Period 1|Adverse Event|0|||
149189187|NCT01005719|538162902|FG000|Period 1|Delay in completing study procedures|0|||
149189188|NCT01005719|538162903|FG001|Period 1|Delay in completing study procedures|0|||
149189189|NCT01005719|538162904|FG002|Period 1|Delay in completing study procedures|0|||
149189190|NCT01005719|538162905|FG003|Period 1|Delay in completing study procedures|0|||
149189191|NCT01005719|538162906|FG004|Period 1|Delay in completing study procedures|0|||
149189192|NCT01005719|538162907|FG005|Period 1|Delay in completing study procedures|1|||
149189193|NCT01005719|538162902|FG000|Period 2|Adverse Event|0|||
149189194|NCT01005719|538162903|FG001|Period 2|Adverse Event|0|||
149189195|NCT01005719|538162904|FG002|Period 2|Adverse Event|0|||
149189196|NCT01005719|538162905|FG003|Period 2|Adverse Event|0|||
149189197|NCT01005719|538162906|FG004|Period 2|Adverse Event|1|||
149189198|NCT01005719|538162907|FG005|Period 2|Adverse Event|1|||
149189199|NCT02499146|538162908|FG000|Overall Study|Lost to Follow-up|1|||
149189200|NCT02499146|538162908|FG000|Overall Study|Withdrawal by Subject|1|||
149189201|NCT02499146|538162908|FG000|Overall Study|Other|2|||
149189202|NCT02499146|538162908|FG000|Overall Study|Ongoing at date of cut-off|9|||
149189203|NCT02499146|538162908|FG000|Overall Study|Began other treatment/therapy|13|||
149189204|NCT03161678|538162909|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149189205|NCT03161678|538162910|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149189206|NCT03161678|538162911|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149189207|NCT03161678|538162912|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
149189208|NCT03161678|538162913|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149189209|NCT03161678|538162914|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149189210|NCT03161678|538162909|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
149189211|NCT03161678|538162910|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
149189212|NCT03161678|538162911|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
149189213|NCT03161678|538162912|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
149189214|NCT03161678|538162913|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
149189215|NCT03161678|538162914|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
149189216|NCT03161678|538162909|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
149189217|NCT03161678|538162910|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
149189218|NCT03161678|538162911|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
149189219|NCT03161678|538162912|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
149189220|NCT03161678|538162913|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
149189221|NCT03161678|538162914|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
149189222|NCT03161678|538162909|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149189223|NCT03161678|538162910|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149189224|NCT03161678|538162911|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149189225|NCT03161678|538162912|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
149189226|NCT03161678|538162913|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149189227|NCT03161678|538162914|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
149189228|NCT03007953|538162918|FG000|Overall Study|Withdrawal by Subject|5|||
149189229|NCT03007953|538162919|FG001|Overall Study|Withdrawal by Subject|2|||
149189230|NCT03007953|538162918|FG000|Overall Study|Death|5|||
149189231|NCT03007953|538162919|FG001|Overall Study|Death|7|||
149189232|NCT03007953|538162918|FG000|Overall Study|Lost to Follow-up|3|||
149189233|NCT03007953|538162919|FG001|Overall Study|Lost to Follow-up|2|||
149189234|NCT03007953|538162918|FG000|Overall Study|Enrolled in Hospice|3|||
149189235|NCT03007953|538162919|FG001|Overall Study|Enrolled in Hospice|2|||
149189236|NCT00829166|538162922|FG000|Overall Study|Death|305|||
149189237|NCT00829166|538162923|FG001|Overall Study|Death|333|||
149189238|NCT00829166|538162922|FG000|Overall Study|Lost to Follow-up|5|||
149189239|NCT00829166|538162923|FG001|Overall Study|Lost to Follow-up|4|||
149189240|NCT00829166|538162922|FG000|Overall Study|Physician's Decision|4|||
149189241|NCT00829166|538162923|FG001|Overall Study|Physician's Decision|3|||
149189242|NCT00829166|538162922|FG000|Overall Study|Subject's Decision|41|||
149189243|NCT00829166|538162923|FG001|Overall Study|Subject's Decision|55|||
149189244|NCT00829166|538162922|FG000|Overall Study|Sponsor's Decision|137|||
149189245|NCT00829166|538162923|FG001|Overall Study|Sponsor's Decision|98|||
148679730|NCT00879970|536300873|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
148679731|NCT00879970|536300874|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
148679732|NCT00879970|536300870|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
148679733|NCT00879970|536300871|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
148679734|NCT00879970|536300872|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
148679735|NCT00879970|536300873|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
148679736|NCT00879970|536300874|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
148679737|NCT00879970|536300870|FG000|Period 1 TZD Randomization|Death|2|||
148679738|NCT00879970|536300871|FG001|Period 1 TZD Randomization|Death|1|||
148679739|NCT00879970|536300872|FG002|Period 1 TZD Randomization|Death|0|||
148679740|NCT00879970|536300873|FG003|Period 1 TZD Randomization|Death|0|||
148679741|NCT00879970|536300874|FG004|Period 1 TZD Randomization|Death|0|||
148679742|NCT00879970|536300870|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
148679743|NCT00879970|536300871|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
148679744|NCT00879970|536300872|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
148679745|NCT00879970|536300873|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
148679746|NCT00879970|536300874|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
148679747|NCT00879970|536300870|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
148679748|NCT00879970|536300871|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
148679749|NCT00879970|536300872|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
148679750|NCT00879970|536300873|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
148679751|NCT00879970|536300874|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
148679752|NCT00879970|536300870|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
148679753|NCT00879970|536300871|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
148679754|NCT00879970|536300872|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
148679755|NCT00879970|536300873|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
148679756|NCT00879970|536300874|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
149189246|NCT00829166|538162922|FG000|Overall Study|Reason Not Specified|3|||
149189247|NCT00829166|538162923|FG001|Overall Study|Reason Not Specified|3|||
149189248|NCT01635933|538162924|FG000|Overall Study|Adverse Event|1|||
149189249|NCT01635933|538162925|FG001|Overall Study|Adverse Event|0|||
149189250|NCT01635933|538162924|FG000|Overall Study|Lost to Follow-up|0|||
149189251|NCT01635933|538162925|FG001|Overall Study|Lost to Follow-up|5|||
149189252|NCT01635933|538162924|FG000|Overall Study|Subject decision|1|||
149189253|NCT01635933|538162925|FG001|Overall Study|Subject decision|1|||
149189254|NCT01635933|538162924|FG000|Overall Study|Noncompliance|0|||
149189255|NCT01635933|538162925|FG001|Overall Study|Noncompliance|1|||
149189256|NCT01635933|538162924|FG000|Overall Study|No longer had transportation|0|||
149189257|NCT01635933|538162925|FG001|Overall Study|No longer had transportation|1|||
149189258|NCT01544595|538162928|FG000|Status at Week 68|Adverse Event|3|||
149189259|NCT01544595|538162929|FG001|Status at Week 68|Adverse Event|2|||
149189260|NCT01544595|538162930|FG002|Status at Week 68|Adverse Event|1|||
149189261|NCT01544595|538162931|FG003|Status at Week 68|Adverse Event|0|||
149189262|NCT01544595|538162932|FG004|Status at Week 68|Adverse Event|0|||
149189263|NCT01544595|538162933|FG005|Status at Week 68|Adverse Event|0|||
149189264|NCT01544595|538162928|FG000|Status at Week 68|Lack of Efficacy|1|||
149189265|NCT01544595|538162929|FG001|Status at Week 68|Lack of Efficacy|0|||
149189266|NCT01544595|538162930|FG002|Status at Week 68|Lack of Efficacy|0|||
149189267|NCT01544595|538162931|FG003|Status at Week 68|Lack of Efficacy|0|||
149189268|NCT01544595|538162932|FG004|Status at Week 68|Lack of Efficacy|0|||
149189269|NCT01544595|538162933|FG005|Status at Week 68|Lack of Efficacy|0|||
149189270|NCT01544595|538162928|FG000|Status at Week 68|Lost to Follow-up|1|||
149189271|NCT01544595|538162929|FG001|Status at Week 68|Lost to Follow-up|1|||
149189272|NCT01544595|538162930|FG002|Status at Week 68|Lost to Follow-up|0|||
149189273|NCT01544595|538162931|FG003|Status at Week 68|Lost to Follow-up|0|||
149189274|NCT01544595|538162932|FG004|Status at Week 68|Lost to Follow-up|0|||
149189275|NCT01544595|538162933|FG005|Status at Week 68|Lost to Follow-up|0|||
149189276|NCT01544595|538162928|FG000|Status at Week 68|Non-compliance with study treatment|1|||
149189277|NCT01544595|538162929|FG001|Status at Week 68|Non-compliance with study treatment|0|||
149189278|NCT01544595|538162930|FG002|Status at Week 68|Non-compliance with study treatment|0|||
149189279|NCT01544595|538162931|FG003|Status at Week 68|Non-compliance with study treatment|1|||
149189280|NCT01544595|538162932|FG004|Status at Week 68|Non-compliance with study treatment|0|||
149189281|NCT01544595|538162933|FG005|Status at Week 68|Non-compliance with study treatment|0|||
149189282|NCT01544595|538162928|FG000|Status at Week 68|Protocol Violation|2|||
149189283|NCT01544595|538162929|FG001|Status at Week 68|Protocol Violation|0|||
149189284|NCT01544595|538162930|FG002|Status at Week 68|Protocol Violation|1|||
149189285|NCT01544595|538162931|FG003|Status at Week 68|Protocol Violation|1|||
149189286|NCT01544595|538162932|FG004|Status at Week 68|Protocol Violation|0|||
149189287|NCT01544595|538162933|FG005|Status at Week 68|Protocol Violation|0|||
149189288|NCT01544595|538162928|FG000|Status at Week 68|Technical problems|1|||
149189289|NCT01544595|538162929|FG001|Status at Week 68|Technical problems|0|||
149189290|NCT01544595|538162930|FG002|Status at Week 68|Technical problems|0|||
149189291|NCT01544595|538162931|FG003|Status at Week 68|Technical problems|1|||
149189292|NCT01544595|538162932|FG004|Status at Week 68|Technical problems|0|||
149189293|NCT01544595|538162933|FG005|Status at Week 68|Technical problems|0|||
149189294|NCT01544595|538162928|FG000|Status at Week 68|Withdrawal by Subject|0|||
149189295|NCT01544595|538162929|FG001|Status at Week 68|Withdrawal by Subject|1|||
149189296|NCT01544595|538162930|FG002|Status at Week 68|Withdrawal by Subject|1|||
149189297|NCT01544595|538162931|FG003|Status at Week 68|Withdrawal by Subject|2|||
149189298|NCT01544595|538162932|FG004|Status at Week 68|Withdrawal by Subject|0|||
149189299|NCT01544595|538162933|FG005|Status at Week 68|Withdrawal by Subject|0|||
149189300|NCT01544595|538162928|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
149189301|NCT01544595|538162929|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
149189302|NCT01544595|538162930|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
149189303|NCT01544595|538162931|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
149189304|NCT01544595|538162932|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
149189305|NCT01544595|538162933|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
149189306|NCT01544595|538162928|FG000|Status at Week 156|Withdrawal by Subject|9|||
149189307|NCT01544595|538162929|FG001|Status at Week 156|Withdrawal by Subject|10|||
149189308|NCT01544595|538162930|FG002|Status at Week 156|Withdrawal by Subject|4|||
149189309|NCT01544595|538162931|FG003|Status at Week 156|Withdrawal by Subject|9|||
149189310|NCT01544595|538162932|FG004|Status at Week 156|Withdrawal by Subject|20|||
149189311|NCT01544595|538162933|FG005|Status at Week 156|Withdrawal by Subject|6|||
149189312|NCT01544595|538162928|FG000|Status at Week 156|Adverse Event|9|||
149189313|NCT01544595|538162929|FG001|Status at Week 156|Adverse Event|11|||
149189314|NCT01544595|538162930|FG002|Status at Week 156|Adverse Event|1|||
149189315|NCT01544595|538162931|FG003|Status at Week 156|Adverse Event|3|||
149189316|NCT01544595|538162932|FG004|Status at Week 156|Adverse Event|4|||
148933791|NCT02202837|537244338|FG001|Overall Study|Lost to Follow-up|1|||
148933792|NCT04195906|537244341|FG000|Part 1|Adverse Event|3|||
148933793|NCT04195906|537244342|FG001|Part 1|Adverse Event|7|||
149189317|NCT01544595|538162933|FG005|Status at Week 156|Adverse Event|2|||
149189318|NCT01544595|538162928|FG000|Status at Week 156|Lost to Follow-up|4|||
149189319|NCT01544595|538162929|FG001|Status at Week 156|Lost to Follow-up|4|||
148807393|NCT03738696|536773244|FG001|Overall Study|Withdrawal by Subject|1|||
149189320|NCT01544595|538162930|FG002|Status at Week 156|Lost to Follow-up|0|||
149189321|NCT01544595|538162931|FG003|Status at Week 156|Lost to Follow-up|1|||
149189322|NCT01544595|538162932|FG004|Status at Week 156|Lost to Follow-up|4|||
149189323|NCT01544595|538162933|FG005|Status at Week 156|Lost to Follow-up|1|||
149189324|NCT01544595|538162928|FG000|Status at Week 156|Non-compliance with study treatement|0|||
149189325|NCT01544595|538162929|FG001|Status at Week 156|Non-compliance with study treatement|1|||
149189326|NCT01544595|538162930|FG002|Status at Week 156|Non-compliance with study treatement|0|||
149189327|NCT01544595|538162931|FG003|Status at Week 156|Non-compliance with study treatement|1|||
149189328|NCT01544595|538162932|FG004|Status at Week 156|Non-compliance with study treatement|0|||
149189329|NCT01544595|538162933|FG005|Status at Week 156|Non-compliance with study treatement|1|||
149189330|NCT01544595|538162928|FG000|Status at Week 156|Physician Decision|0|||
149189331|NCT01544595|538162929|FG001|Status at Week 156|Physician Decision|3|||
149189332|NCT01544595|538162930|FG002|Status at Week 156|Physician Decision|1|||
149189333|NCT01544595|538162931|FG003|Status at Week 156|Physician Decision|0|||
149189334|NCT01544595|538162932|FG004|Status at Week 156|Physician Decision|0|||
149189335|NCT01544595|538162933|FG005|Status at Week 156|Physician Decision|0|||
149189336|NCT01544595|538162928|FG000|Status at Week 156|Pregnancy|2|||
149189337|NCT01544595|538162929|FG001|Status at Week 156|Pregnancy|3|||
149189338|NCT01544595|538162930|FG002|Status at Week 156|Pregnancy|0|||
149189339|NCT01544595|538162931|FG003|Status at Week 156|Pregnancy|0|||
149189340|NCT01544595|538162932|FG004|Status at Week 156|Pregnancy|0|||
149189341|NCT01544595|538162933|FG005|Status at Week 156|Pregnancy|0|||
149189342|NCT01544595|538162928|FG000|Status at Week 156|Protocol Violation|3|||
149189343|NCT01544595|538162929|FG001|Status at Week 156|Protocol Violation|1|||
149189344|NCT01544595|538162930|FG002|Status at Week 156|Protocol Violation|2|||
149189345|NCT01544595|538162931|FG003|Status at Week 156|Protocol Violation|2|||
149189346|NCT01544595|538162932|FG004|Status at Week 156|Protocol Violation|0|||
149189347|NCT01544595|538162933|FG005|Status at Week 156|Protocol Violation|0|||
149189348|NCT01544595|538162928|FG000|Status at Week 156|Technical problems|3|||
149189349|NCT01544595|538162929|FG001|Status at Week 156|Technical problems|1|||
149189350|NCT01544595|538162930|FG002|Status at Week 156|Technical problems|0|||
149189351|NCT01544595|538162931|FG003|Status at Week 156|Technical problems|1|||
149189352|NCT01544595|538162932|FG004|Status at Week 156|Technical problems|0|||
149189353|NCT01544595|538162933|FG005|Status at Week 156|Technical problems|0|||
149189354|NCT01544595|538162928|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
149189355|NCT01544595|538162929|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
149189356|NCT01544595|538162930|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
149189357|NCT01544595|538162931|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
149189358|NCT01544595|538162932|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
149189359|NCT01544595|538162933|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
149189360|NCT01544595|538162928|FG000|Status at Week 156|Lack of Efficacy|1|||
149189361|NCT01544595|538162929|FG001|Status at Week 156|Lack of Efficacy|0|||
149189362|NCT01544595|538162930|FG002|Status at Week 156|Lack of Efficacy|1|||
149189363|NCT01544595|538162931|FG003|Status at Week 156|Lack of Efficacy|4|||
149189364|NCT01544595|538162932|FG004|Status at Week 156|Lack of Efficacy|10|||
149189365|NCT01544595|538162933|FG005|Status at Week 156|Lack of Efficacy|5|||
149189366|NCT02582749|538162936|FG000|Overall Study|Study terminated by funder|5|||
149189367|NCT02582749|538162937|FG001|Overall Study|Study terminated by funder|10|||
149189368|NCT02582749|538162936|FG000|Overall Study|Withdrawal by Subject|0|||
149189369|NCT02582749|538162937|FG001|Overall Study|Withdrawal by Subject|1|||
149189370|NCT02379923|538162938|FG000|Overall Study|Death|5|||
149189371|NCT03382899|538162939|FG000|Overall Study|Ineligibility Determined|0|||
149189372|NCT03382899|538162940|FG001|Overall Study|Ineligibility Determined|1|||
149189373|NCT03382899|538162939|FG000|Overall Study|Lost to Follow-up|0|||
149189374|NCT03382899|538162940|FG001|Overall Study|Lost to Follow-up|1|||
149189375|NCT03382899|538162939|FG000|Overall Study|Sponsor's decision|31|||
149189376|NCT03382899|538162940|FG001|Overall Study|Sponsor's decision|28|||
149189377|NCT03382899|538162939|FG000|Overall Study|Withdrawal by Subject|0|||
149189378|NCT03382899|538162940|FG001|Overall Study|Withdrawal by Subject|5|||
149189379|NCT01402284|538162943|FG000|Overall Study|Withdrawal consent|2|||
149189380|NCT01402284|538162943|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
149189381|NCT01402284|538162943|FG000|Overall Study|Physician Decision|1|||
149189382|NCT01402284|538162943|FG000|Overall Study|Disease progression on study|10|||
149189383|NCT02928406|538162944|FG000|Overall Study|Death|780|||
149189384|NCT02928406|538162944|FG000|Overall Study|Progressive disease|3|||
149189385|NCT02928406|538162944|FG000|Overall Study|Lost to Follow-up|49|||
149189386|NCT02928406|538162944|FG000|Overall Study|Non-compliance|2|||
149189387|NCT02928406|538162944|FG000|Overall Study|Withdrawal by Subject|40|||
149189388|NCT02928406|538162944|FG000|Overall Study|Study terminated by sponsor|57|||
149189389|NCT02928406|538162944|FG000|Overall Study|Physician Decision|1|||
149189390|NCT02928406|538162944|FG000|Overall Study|Various reasons|72|||
149189391|NCT01745393|538162946|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
149189392|NCT01745393|538162947|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
149189393|NCT01745393|538162946|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
148679757|NCT00879970|536300870|FG000|Period 2 Vitamin D Randomization|Death|0|||
148679758|NCT00879970|536300871|FG001|Period 2 Vitamin D Randomization|Death|0|||
148933794|NCT04195906|537244341|FG000|Part 1|Withdrawal by Subject|0|||
148933795|NCT04195906|537244342|FG001|Part 1|Withdrawal by Subject|1|||
148933796|NCT04195906|537244341|FG000|Part 2|Adverse Event|1|||
148933797|NCT04195906|537244342|FG001|Part 2|Adverse Event|1|||
148933798|NCT04195906|537244341|FG000|Part 2|Withdrawal by Subject|0|||
148933799|NCT04195906|537244342|FG001|Part 2|Withdrawal by Subject|3|||
148933800|NCT04195906|537244341|FG000|Part 2|Other|1|||
148933801|NCT04195906|537244342|FG001|Part 2|Other|3|||
148933802|NCT02486302|537244343|FG000|Overall Study|Discontinued prematurely|410|||
148933803|NCT02486302|537244343|FG000|Overall Study|Documentation not completed|255|||
148933804|NCT02486302|537244343|FG000|Overall Study|Excluded due to legal reasons|8|||
148933805|NCT02486302|537244343|FG000|Overall Study|Not treated|3|||
148933806|NCT01871142|537244344|FG000|Overall Study|Adverse Event|1|||
148933807|NCT00734474|537244354|FG000|Overall Study|Entry Criteria Not Met|0|||
148933808|NCT00734474|537244355|FG001|Overall Study|Entry Criteria Not Met|0|||
148933809|NCT00734474|537244356|FG002|Overall Study|Entry Criteria Not Met|5|||
148933810|NCT00734474|537244357|FG003|Overall Study|Entry Criteria Not Met|0|||
148933811|NCT00734474|537244358|FG004|Overall Study|Entry Criteria Not Met|3|||
148933812|NCT00734474|537244359|FG005|Overall Study|Entry Criteria Not Met|1|||
148933813|NCT00734474|537244360|FG006|Overall Study|Entry Criteria Not Met|0|||
148933814|NCT00734474|537244361|FG007|Overall Study|Entry Criteria Not Met|1|||
148933815|NCT00734474|537244362|FG008|Overall Study|Entry Criteria Not Met|1|||
148933816|NCT00734474|537244354|FG000|Overall Study|Lost to Follow-up|1|||
148933817|NCT00734474|537244355|FG001|Overall Study|Lost to Follow-up|0|||
148933818|NCT00734474|537244356|FG002|Overall Study|Lost to Follow-up|13|||
148933819|NCT00734474|537244357|FG003|Overall Study|Lost to Follow-up|0|||
148933820|NCT00734474|537244358|FG004|Overall Study|Lost to Follow-up|11|||
148933821|NCT00734474|537244359|FG005|Overall Study|Lost to Follow-up|1|||
148933822|NCT00734474|537244360|FG006|Overall Study|Lost to Follow-up|0|||
148933823|NCT00734474|537244361|FG007|Overall Study|Lost to Follow-up|9|||
148933824|NCT00734474|537244362|FG008|Overall Study|Lost to Follow-up|4|||
148933825|NCT00734474|537244354|FG000|Overall Study|Withdrawal by Subject|2|||
148933826|NCT00734474|537244355|FG001|Overall Study|Withdrawal by Subject|1|||
148933827|NCT00734474|537244356|FG002|Overall Study|Withdrawal by Subject|18|||
148933828|NCT00734474|537244357|FG003|Overall Study|Withdrawal by Subject|0|||
148933829|NCT00734474|537244358|FG004|Overall Study|Withdrawal by Subject|24|||
148933830|NCT00734474|537244359|FG005|Overall Study|Withdrawal by Subject|2|||
148933831|NCT00734474|537244360|FG006|Overall Study|Withdrawal by Subject|0|||
148933832|NCT00734474|537244361|FG007|Overall Study|Withdrawal by Subject|36|||
148933833|NCT00734474|537244362|FG008|Overall Study|Withdrawal by Subject|21|||
148933834|NCT00734474|537244354|FG000|Overall Study|Physician Decision|0|||
148933835|NCT00734474|537244355|FG001|Overall Study|Physician Decision|0|||
148933836|NCT00734474|537244356|FG002|Overall Study|Physician Decision|4|||
148933837|NCT00734474|537244357|FG003|Overall Study|Physician Decision|1|||
148933838|NCT00734474|537244358|FG004|Overall Study|Physician Decision|11|||
148933839|NCT00734474|537244359|FG005|Overall Study|Physician Decision|0|||
148933840|NCT00734474|537244360|FG006|Overall Study|Physician Decision|0|||
149189394|NCT01745393|538162947|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
149189395|NCT01745393|538162946|FG000|12-month Follow-up|Lost to Follow-up|6|||
149189396|NCT01745393|538162947|FG001|12-month Follow-up|Lost to Follow-up|5|||
149189397|NCT01064648|538162952|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
149189398|NCT01064648|538162953|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
149189399|NCT01064648|538162954|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
149189400|NCT01064648|538162955|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
148679759|NCT00879970|536300872|FG002|Period 2 Vitamin D Randomization|Death|0|||
148933841|NCT00734474|537244361|FG007|Overall Study|Physician Decision|9|||
148933842|NCT00734474|537244362|FG008|Overall Study|Physician Decision|9|||
148933843|NCT00734474|537244354|FG000|Overall Study|Adverse Event|4|||
148933844|NCT00734474|537244355|FG001|Overall Study|Adverse Event|4|||
148933845|NCT00734474|537244356|FG002|Overall Study|Adverse Event|63|||
148933846|NCT00734474|537244357|FG003|Overall Study|Adverse Event|1|||
149189401|NCT01064648|538162952|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
148679760|NCT00879970|536300873|FG003|Period 2 Vitamin D Randomization|Death|2|||
148679761|NCT00879970|536300874|FG004|Period 2 Vitamin D Randomization|Death|0|||
148933847|NCT00734474|537244358|FG004|Overall Study|Adverse Event|64|||
148933848|NCT00734474|537244359|FG005|Overall Study|Adverse Event|0|||
148933849|NCT00734474|537244360|FG006|Overall Study|Adverse Event|1|||
148933850|NCT00734474|537244361|FG007|Overall Study|Adverse Event|65|||
148933851|NCT00734474|537244362|FG008|Overall Study|Adverse Event|39|||
148933852|NCT00734474|537244354|FG000|Overall Study|Protocol Violation|0|||
148933853|NCT00734474|537244355|FG001|Overall Study|Protocol Violation|0|||
148933854|NCT00734474|537244356|FG002|Overall Study|Protocol Violation|4|||
148933855|NCT00734474|537244357|FG003|Overall Study|Protocol Violation|0|||
148933856|NCT00734474|537244358|FG004|Overall Study|Protocol Violation|3|||
148933857|NCT00734474|537244359|FG005|Overall Study|Protocol Violation|0|||
148933858|NCT00734474|537244360|FG006|Overall Study|Protocol Violation|0|||
148933859|NCT00734474|537244361|FG007|Overall Study|Protocol Violation|3|||
148933860|NCT00734474|537244362|FG008|Overall Study|Protocol Violation|1|||
148933861|NCT00734474|537244354|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
148933862|NCT00734474|537244355|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
148933863|NCT00734474|537244356|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
148933864|NCT00734474|537244357|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
148933865|NCT00734474|537244358|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
148933866|NCT00734474|537244359|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
148933867|NCT00734474|537244360|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
148933868|NCT00734474|537244361|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
148933869|NCT00734474|537244362|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
148933870|NCT00734474|537244354|FG000|Overall Study|Sponsor Decision|0|||
148933871|NCT00734474|537244355|FG001|Overall Study|Sponsor Decision|0|||
149189402|NCT01064648|538162953|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
149189403|NCT01064648|538162954|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
149189404|NCT01064648|538162955|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
149189405|NCT01064648|538162952|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
149189406|NCT01064648|538162953|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
149189407|NCT01064648|538162954|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
149189408|NCT01064648|538162955|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
149189409|NCT01064648|538162952|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
149189410|NCT01064648|538162953|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
149189411|NCT01064648|538162954|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
149189412|NCT01064648|538162955|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
148933872|NCT00734474|537244356|FG002|Overall Study|Sponsor Decision|0|||
148933873|NCT00734474|537244357|FG003|Overall Study|Sponsor Decision|0|||
148933874|NCT00734474|537244358|FG004|Overall Study|Sponsor Decision|2|||
149189413|NCT01064648|538162952|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
149189414|NCT01064648|538162953|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
149189415|NCT01064648|538162954|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
149189416|NCT01064648|538162955|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
149189417|NCT01064648|538162952|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
149189418|NCT01064648|538162953|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
149189419|NCT01064648|538162954|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
149189420|NCT01064648|538162955|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
149189421|NCT01064648|538162952|FG000|Phase II|Adverse Event|0|||
149189422|NCT01064648|538162953|FG001|Phase II|Adverse Event|0|||
149189423|NCT01064648|538162954|FG002|Phase II|Adverse Event|15|||
149189424|NCT01064648|538162955|FG003|Phase II|Adverse Event|8|||
149189425|NCT01064648|538162952|FG000|Phase II|Death|0|||
149189426|NCT01064648|538162953|FG001|Phase II|Death|0|||
149189427|NCT01064648|538162954|FG002|Phase II|Death|4|||
149189428|NCT01064648|538162955|FG003|Phase II|Death|5|||
149189429|NCT01064648|538162952|FG000|Phase II|Withdrawal by Subject|0|||
149189430|NCT01064648|538162953|FG001|Phase II|Withdrawal by Subject|0|||
149189431|NCT01064648|538162954|FG002|Phase II|Withdrawal by Subject|2|||
149189432|NCT01064648|538162955|FG003|Phase II|Withdrawal by Subject|5|||
149189433|NCT01064648|538162952|FG000|Phase II|Progression|0|||
149189434|NCT01064648|538162953|FG001|Phase II|Progression|0|||
149189435|NCT01064648|538162954|FG002|Phase II|Progression|21|||
149189436|NCT01064648|538162955|FG003|Phase II|Progression|27|||
148933875|NCT00734474|537244359|FG005|Overall Study|Sponsor Decision|0|||
149189437|NCT01064648|538162952|FG000|Phase II|Non-protocol specified|0|||
149189438|NCT01064648|538162953|FG001|Phase II|Non-protocol specified|0|||
149189439|NCT01064648|538162954|FG002|Phase II|Non-protocol specified|5|||
149189440|NCT01064648|538162955|FG003|Phase II|Non-protocol specified|3|||
149189441|NCT01064648|538162952|FG000|Phase II|Under Review|0|||
149189442|NCT01064648|538162953|FG001|Phase II|Under Review|0|||
149189443|NCT01064648|538162954|FG002|Phase II|Under Review|2|||
149189444|NCT01064648|538162955|FG003|Phase II|Under Review|0|||
149189445|NCT05513391|538162956|FG000|Overall Study|Adverse Event|1|||
149189446|NCT05513391|538162957|FG001|Overall Study|Adverse Event|0|||
149189447|NCT05513391|538162956|FG000|Overall Study|Protocol Deviation|0|||
149189448|NCT05513391|538162957|FG001|Overall Study|Protocol Deviation|1|||
149189449|NCT05513391|538162956|FG000|Overall Study|Withdrawal by Subject|3|||
149189450|NCT05513391|538162957|FG001|Overall Study|Withdrawal by Subject|1|||
149189451|NCT05513391|538162956|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149189452|NCT05513391|538162957|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
149189453|NCT05513391|538162956|FG000|Overall Study|Lost to Follow-up|0|||
149189454|NCT05513391|538162957|FG001|Overall Study|Lost to Follow-up|2|||
149189455|NCT02429427|538162958|FG000|Overall Study|Adverse Event|220|||
149189456|NCT02429427|538162959|FG001|Overall Study|Adverse Event|92|||
149189457|NCT02429427|538162958|FG000|Overall Study|Protocol Violation|10|||
149189458|NCT02429427|538162959|FG001|Overall Study|Protocol Violation|6|||
149189459|NCT02429427|538162958|FG000|Overall Study|Lost to Follow-up|15|||
149189460|NCT02429427|538162959|FG001|Overall Study|Lost to Follow-up|6|||
149189461|NCT02429427|538162958|FG000|Overall Study|Withdrawal by Subject|64|||
149189462|NCT02429427|538162959|FG001|Overall Study|Withdrawal by Subject|34|||
149189463|NCT02429427|538162958|FG000|Overall Study|Other|62|||
149189464|NCT02429427|538162959|FG001|Overall Study|Other|41|||
149189465|NCT00719732|538162960|FG000|Overall Study|Lost to Follow-up|20|||
149189466|NCT00719732|538162960|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
149189467|NCT00719732|538162960|FG000|Overall Study|Illness not associated with device|1|||
149189468|NCT04038255|538164310|FG000|Overall Study|Lost to Follow-up|0|||
149189469|NCT04038255|538164311|FG001|Overall Study|Lost to Follow-up|9|||
149189470|NCT04038255|538164312|FG002|Overall Study|Lost to Follow-up|5|||
149189471|NCT04038255|538164310|FG000|Overall Study|Withdrawal by Subject|0|||
149189472|NCT04038255|538164311|FG001|Overall Study|Withdrawal by Subject|0|||
149189473|NCT04038255|538164312|FG002|Overall Study|Withdrawal by Subject|1|||
148933876|NCT00734474|537244360|FG006|Overall Study|Sponsor Decision|0|||
149189474|NCT01597557|538164319|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
149189475|NCT01597557|538164320|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
149189476|NCT03165721|538164330|FG000|Overall Study|Refused further treatment|3|||
149189477|NCT03165721|538164331|FG001|Overall Study|Refused further treatment|0|||
149189478|NCT03165721|538164332|FG002|Overall Study|Refused further treatment|0|||
149189479|NCT03165721|538164330|FG000|Overall Study|Physician Decision|1|||
148933877|NCT00734474|537244361|FG007|Overall Study|Sponsor Decision|0|||
149189480|NCT03165721|538164331|FG001|Overall Study|Physician Decision|0|||
148933878|NCT00734474|537244362|FG008|Overall Study|Sponsor Decision|0|||
149189481|NCT03165721|538164332|FG002|Overall Study|Physician Decision|0|||
149189482|NCT01863849|538164333|FG000|Overall Study|Lost to Follow-up|1|||
149189483|NCT01863849|538164334|FG001|Overall Study|Lost to Follow-up|0|||
149189484|NCT01457118|538164335|FG000|Overall Study|Adverse Event|1|||
149189485|NCT01457118|538164336|FG001|Overall Study|Adverse Event|0|||
148933879|NCT00734474|537244354|FG000|Overall Study|Death|0|||
148933880|NCT00734474|537244355|FG001|Overall Study|Death|0|||
149189486|NCT01457118|538164337|FG002|Overall Study|Adverse Event|0|||
149189487|NCT01457118|538164338|FG003|Overall Study|Adverse Event|1|||
149189488|NCT01457118|538164335|FG000|Overall Study|Clinical Progression|0|||
149189489|NCT01457118|538164336|FG001|Overall Study|Clinical Progression|1|||
149189490|NCT01457118|538164337|FG002|Overall Study|Clinical Progression|0|||
149189491|NCT01457118|538164338|FG003|Overall Study|Clinical Progression|1|||
149189492|NCT01457118|538164335|FG000|Overall Study|Physician Decision|2|||
149189493|NCT01457118|538164336|FG001|Overall Study|Physician Decision|0|||
149189494|NCT01457118|538164337|FG002|Overall Study|Physician Decision|0|||
148679762|NCT00061945|536300877|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
148679763|NCT00061945|536300878|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
148679764|NCT00061945|536300877|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
148679765|NCT00061945|536300878|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
148679766|NCT00061945|536300877|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
148679767|NCT00061945|536300878|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
148679768|NCT00061945|536300877|FG000|Course IV: Alemtuzumab|Early exits|6|||
148679769|NCT00061945|536300878|FG001|Course IV: Alemtuzumab|Early exits|15|||
148679770|NCT01039584|536300879|FG000|Overall Study|Withdrawal by Subject|4|||
148679771|NCT01039584|536300880|FG001|Overall Study|Withdrawal by Subject|2|||
148679772|NCT01039584|536300881|FG002|Overall Study|Withdrawal by Subject|1|||
148679773|NCT01039584|536300879|FG000|Overall Study|Protocol Violation|10|||
148679774|NCT01039584|536300880|FG001|Overall Study|Protocol Violation|4|||
148679775|NCT01039584|536300881|FG002|Overall Study|Protocol Violation|6|||
148679776|NCT01039584|536300879|FG000|Overall Study|Lost to Follow-up|5|||
148679777|NCT01039584|536300880|FG001|Overall Study|Lost to Follow-up|3|||
148679778|NCT01039584|536300881|FG002|Overall Study|Lost to Follow-up|4|||
148679779|NCT01039584|536300879|FG000|Overall Study|Negative Baseline culture for Candida|59|||
148679780|NCT01039584|536300880|FG001|Overall Study|Negative Baseline culture for Candida|59|||
148807394|NCT03738696|536773243|FG000|Overall Study|Lost to Follow-up|8|||
148807395|NCT03738696|536773244|FG001|Overall Study|Lost to Follow-up|14|||
148807396|NCT00091819|536773246|FG000|Overall Study|Adverse Event|1|||
148933881|NCT00734474|537244356|FG002|Overall Study|Death|1|||
148933882|NCT00734474|537244357|FG003|Overall Study|Death|0|||
148933883|NCT00734474|537244358|FG004|Overall Study|Death|0|||
148933884|NCT00734474|537244359|FG005|Overall Study|Death|0|||
148933885|NCT00734474|537244360|FG006|Overall Study|Death|0|||
148933886|NCT00734474|537244361|FG007|Overall Study|Death|2|||
148933887|NCT00734474|537244362|FG008|Overall Study|Death|1|||
148933888|NCT00734474|537244354|FG000|Overall Study|Lack of Efficacy|0|||
148933889|NCT00734474|537244355|FG001|Overall Study|Lack of Efficacy|0|||
148933890|NCT00734474|537244356|FG002|Overall Study|Lack of Efficacy|4|||
148933891|NCT00734474|537244357|FG003|Overall Study|Lack of Efficacy|0|||
148933892|NCT00734474|537244358|FG004|Overall Study|Lack of Efficacy|0|||
148933893|NCT00734474|537244359|FG005|Overall Study|Lack of Efficacy|0|||
148933894|NCT00734474|537244360|FG006|Overall Study|Lack of Efficacy|0|||
148933895|NCT00734474|537244361|FG007|Overall Study|Lack of Efficacy|4|||
148933896|NCT00734474|537244362|FG008|Overall Study|Lack of Efficacy|6|||
148933897|NCT00231842|537244371|FG000|Overall Study|Withdrawal by Subject|3|||
148933898|NCT00231842|537244371|FG000|Overall Study|Did not complete the last 3 cycle|8|||
148933899|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
148933900|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
148933901|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
148933902|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
148933903|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
148933904|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
148933905|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
148933906|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
148933907|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
148933908|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
148933909|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
148933910|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
148933911|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
148933912|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
148933913|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
148933914|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
148933915|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
148933916|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
148933917|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
148933918|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
148933919|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
148933920|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
148933921|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
149189495|NCT01457118|538164338|FG003|Overall Study|Physician Decision|0|||
148679781|NCT01039584|536300881|FG002|Overall Study|Negative Baseline culture for Candida|24|||
148679782|NCT01039584|536300879|FG000|Overall Study|Lack of Efficacy|7|||
148679783|NCT01039584|536300880|FG001|Overall Study|Lack of Efficacy|6|||
148679784|NCT01039584|536300881|FG002|Overall Study|Lack of Efficacy|10|||
148679785|NCT01039584|536300879|FG000|Overall Study|other|1|||
148679786|NCT01039584|536300880|FG001|Overall Study|other|3|||
148679787|NCT01039584|536300881|FG002|Overall Study|other|1|||
148679788|NCT01039584|536300879|FG000|Overall Study|Pap smear with significant pathology|10|||
148679789|NCT01039584|536300880|FG001|Overall Study|Pap smear with significant pathology|10|||
148679790|NCT01039584|536300881|FG002|Overall Study|Pap smear with significant pathology|3|||
148679791|NCT01039584|536300879|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
148679792|NCT01039584|536300880|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
148679793|NCT01039584|536300881|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
148679794|NCT03672396|536300884|FG000|Overall Study|Withdrawal by Subject|4|||
148679795|NCT03672396|536300884|FG000|Overall Study|Physician Decision|1|||
148933922|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
148933923|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
148933924|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
148679796|NCT03672396|536300884|FG000|Overall Study|Adverse Event|1|||
148679797|NCT00558519|536300887|FG000|Overall Study|Ph+|20|||
148679798|NCT00558519|536300887|FG000|Overall Study|Ineligible|1|||
148679799|NCT00558519|536300887|FG000|Overall Study|Insufficient data|1|||
148679800|NCT00558519|536300887|FG000|Overall Study|Never received treatment|1|||
148679801|NCT03001011|536300888|FG000|Overall Study|Adverse Event|9|||
148679802|NCT03001011|536300889|FG001|Overall Study|Adverse Event|3|||
148933925|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
149014336|NCT00708305|537532192|FG003|Period 1|Other Reason|2|||
149014337|NCT00708305|537532189|FG000|Period 2|Lost to Follow-up|0|||
149014338|NCT00708305|537532190|FG001|Period 2|Lost to Follow-up|1|||
149014339|NCT00708305|537532191|FG002|Period 2|Lost to Follow-up|0|||
149014340|NCT00708305|537532192|FG003|Period 2|Lost to Follow-up|0|||
149014341|NCT00708305|537532189|FG000|Period 2|Protocol Violation|0|||
149014342|NCT00708305|537532190|FG001|Period 2|Protocol Violation|1|||
149014343|NCT00708305|537532191|FG002|Period 2|Protocol Violation|0|||
149014344|NCT00708305|537532192|FG003|Period 2|Protocol Violation|0|||
149014345|NCT00708305|537532189|FG000|Period 2|Other Reason|1|||
149014346|NCT00708305|537532190|FG001|Period 2|Other Reason|0|||
149014347|NCT00708305|537532191|FG002|Period 2|Other Reason|0|||
149014348|NCT00708305|537532192|FG003|Period 2|Other Reason|1|||
149014349|NCT00708305|537532189|FG000|Period 3|Protocol Violation|0|||
149014350|NCT00708305|537532190|FG001|Period 3|Protocol Violation|2|||
148807397|NCT00091819|536773247|FG001|Overall Study|Adverse Event|1|||
148807398|NCT00091819|536773246|FG000|Overall Study|Death|4|||
148807399|NCT00091819|536773247|FG001|Overall Study|Death|5|||
148807400|NCT00091819|536773246|FG000|Overall Study|Lost to Follow-up|26|||
148807401|NCT00091819|536773247|FG001|Overall Study|Lost to Follow-up|23|||
148807402|NCT00091819|536773246|FG000|Overall Study|Withdrawal by Subject|5|||
148807403|NCT00091819|536773247|FG001|Overall Study|Withdrawal by Subject|8|||
148807404|NCT00091819|536773246|FG000|Overall Study|Protocol Violation|1|||
148807405|NCT00091819|536773247|FG001|Overall Study|Protocol Violation|2|||
148807406|NCT00091819|536773246|FG000|Overall Study|Other|2|||
148807407|NCT00091819|536773247|FG001|Overall Study|Other|3|||
148807408|NCT00091819|536773246|FG000|Overall Study|Never received study treatment|3|||
148807409|NCT00091819|536773247|FG001|Overall Study|Never received study treatment|4|||
148807410|NCT00481676|536773248|FG000|Overall Study|Adverse Event|0|||
148807411|NCT00481676|536773249|FG001|Overall Study|Adverse Event|1|||
148807412|NCT00481676|536773248|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148807413|NCT00481676|536773249|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
148807414|NCT00481676|536773248|FG000|Overall Study|Administrative problem|1|||
148807415|NCT00481676|536773249|FG001|Overall Study|Administrative problem|0|||
148807416|NCT02911116|536773250|FG000|Overall Study|Insufficient Therapeutic Response|1|||
148807417|NCT02911116|536773251|FG001|Overall Study|Insufficient Therapeutic Response|0|||
148807418|NCT02911116|536773250|FG000|Overall Study|Lost to Follow-up|0|||
148807419|NCT02911116|536773251|FG001|Overall Study|Lost to Follow-up|1|||
148807420|NCT01513590|536773252|FG000|Overall Study|Adverse Event|2|||
148807421|NCT01513590|536773253|FG001|Overall Study|Adverse Event|3|||
148807422|NCT01513590|536773252|FG000|Overall Study|Withdrawal Criteria|3|||
148807423|NCT01513590|536773253|FG001|Overall Study|Withdrawal Criteria|0|||
148807424|NCT01513590|536773252|FG000|Overall Study|Unclassified|5|||
148807425|NCT01513590|536773253|FG001|Overall Study|Unclassified|10|||
148807426|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
148807427|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
148807428|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
148807429|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
148807430|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
148807431|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
148807432|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
148807433|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
148807434|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
148807435|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
148807436|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Death|3|||
148807437|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Death|1|||
148807438|NCT01056276|536773254|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
148807439|NCT01056276|536773255|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
148807440|NCT01056276|536773254|FG000|Maintenance Therapy|Toxicity|0|||
149189496|NCT01457118|538164335|FG000|Overall Study|Progressive Disease by RECIST|12|||
149189497|NCT01457118|538164336|FG001|Overall Study|Progressive Disease by RECIST|3|||
149189498|NCT01457118|538164337|FG002|Overall Study|Progressive Disease by RECIST|1|||
149189499|NCT01457118|538164338|FG003|Overall Study|Progressive Disease by RECIST|0|||
149189500|NCT01457118|538164335|FG000|Overall Study|Withdrawal by Subject|5|||
149189501|NCT01457118|538164336|FG001|Overall Study|Withdrawal by Subject|0|||
149189502|NCT01457118|538164337|FG002|Overall Study|Withdrawal by Subject|0|||
149189503|NCT01457118|538164338|FG003|Overall Study|Withdrawal by Subject|0|||
149189504|NCT02324842|538164339|FG000|Overall Study|Lost to Follow-up|1|||
149189505|NCT02324842|538164340|FG001|Overall Study|Lost to Follow-up|1|||
148807441|NCT01056276|536773255|FG001|Maintenance Therapy|Toxicity|2|||
148807442|NCT01056276|536773254|FG000|Maintenance Therapy|Progressive Disease|0|||
148807443|NCT01056276|536773255|FG001|Maintenance Therapy|Progressive Disease|9|||
148807444|NCT01056276|536773254|FG000|Maintenance Therapy|Physician Decision|0|||
148807445|NCT01056276|536773255|FG001|Maintenance Therapy|Physician Decision|1|||
148807446|NCT01056276|536773254|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
148807447|NCT01056276|536773255|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
148807448|NCT01056276|536773254|FG000|Maintenance Therapy|Intercurrent Illness|0|||
148933926|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
148933927|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
148933928|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
148933929|NCT00313300|537244372|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
148933930|NCT00313300|537244373|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
148933931|NCT00313300|537244374|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
148933932|NCT00313300|537244375|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
148933933|NCT00313300|537244376|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
148933934|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
149189506|NCT02324842|538164341|FG002|Overall Study|Lost to Follow-up|2|||
149189507|NCT02750800|538164345|FG000|Overall Study|Adverse Event|18|||
148807449|NCT01056276|536773255|FG001|Maintenance Therapy|Intercurrent Illness|1|||
148933935|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
148933936|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
148933937|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
148933938|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
149189508|NCT02750800|538164345|FG000|Overall Study|Lost to Follow-up|12|||
149189509|NCT02750800|538164345|FG000|Overall Study|Investigator decision|53|||
149189510|NCT02750800|538164345|FG000|Overall Study|Patient request|12|||
149189511|NCT02750800|538164345|FG000|Overall Study|Other, not specified|3|||
149189512|NCT03456713|538164348|FG000|Overall Study|Lost to Follow-up|1|||
149189513|NCT03456713|538164349|FG001|Overall Study|Lost to Follow-up|0|||
149189514|NCT03456713|538164350|FG002|Overall Study|Lost to Follow-up|0|||
149189515|NCT03456713|538164351|FG003|Overall Study|Lost to Follow-up|0|||
149189516|NCT01263691|538164355|FG000|Overall Study|Lost to Follow-up|1|||
149189517|NCT01263691|538164356|FG001|Overall Study|Lost to Follow-up|0|||
149189518|NCT01263691|538164357|FG002|Overall Study|Lost to Follow-up|1|||
149189519|NCT01263691|538164358|FG003|Overall Study|Lost to Follow-up|1|||
149189520|NCT01263691|538164359|FG004|Overall Study|Lost to Follow-up|0|||
149189521|NCT01263691|538164360|FG005|Overall Study|Lost to Follow-up|0|||
149189522|NCT01263691|538164355|FG000|Overall Study|Withdrawal by Subject|1|||
149189523|NCT01263691|538164356|FG001|Overall Study|Withdrawal by Subject|0|||
149189524|NCT01263691|538164357|FG002|Overall Study|Withdrawal by Subject|0|||
149189525|NCT01263691|538164358|FG003|Overall Study|Withdrawal by Subject|0|||
149189526|NCT01263691|538164359|FG004|Overall Study|Withdrawal by Subject|0|||
149189527|NCT01263691|538164360|FG005|Overall Study|Withdrawal by Subject|0|||
149189528|NCT01263691|538164355|FG000|Overall Study|Adverse Event|1|||
149189529|NCT01263691|538164356|FG001|Overall Study|Adverse Event|0|||
149189530|NCT01263691|538164357|FG002|Overall Study|Adverse Event|0|||
149189531|NCT01263691|538164358|FG003|Overall Study|Adverse Event|0|||
149189532|NCT01263691|538164359|FG004|Overall Study|Adverse Event|0|||
149189533|NCT01263691|538164360|FG005|Overall Study|Adverse Event|0|||
149189534|NCT01202227|538164363|FG000|Overall Study|Adverse Event|16|||
149189535|NCT01202227|538164363|FG000|Overall Study|Withdrawal by Subject|2|||
149189536|NCT01202227|538164363|FG000|Overall Study|Lack of Efficacy|1|||
149189537|NCT00643487|538164364|FG000|Overall Study|Technical difficulty|3|||
149189538|NCT01894477|538164365|FG000|Overall Study|Protocol Violation|0|||
149189539|NCT01894477|538164366|FG001|Overall Study|Protocol Violation|1|||
149189540|NCT01894477|538164365|FG000|Overall Study|protocol changed due SC changed to cord|0|||
149189541|NCT01894477|538164366|FG001|Overall Study|protocol changed due SC changed to cord|1|||
149189542|NCT00850759|538164373|FG000|Overall Study|Lost to Follow-up|7|||
149189543|NCT00850759|538164374|FG001|Overall Study|Lost to Follow-up|5|||
149189544|NCT00850759|538164375|FG002|Overall Study|Lost to Follow-up|5|||
149189545|NCT00850759|538164376|FG003|Overall Study|Lost to Follow-up|3|||
149189546|NCT03196505|538164377|FG000|Overall Study|Physician Decision|26|||
149189547|NCT03196505|538164378|FG001|Overall Study|Physician Decision|26|||
149189548|NCT01753076|538164379|FG000|Overall Study|Adverse Event|17|||
149189549|NCT01753076|538164380|FG001|Overall Study|Adverse Event|18|||
149189550|NCT01753076|538164379|FG000|Overall Study|Lack of Efficacy|3|||
149189551|NCT01753076|538164380|FG001|Overall Study|Lack of Efficacy|1|||
149189552|NCT01753076|538164379|FG000|Overall Study|Lost to Follow-up|2|||
149189553|NCT01753076|538164380|FG001|Overall Study|Lost to Follow-up|1|||
149189554|NCT01753076|538164379|FG000|Overall Study|Physician Decision|4|||
149189555|NCT01753076|538164380|FG001|Overall Study|Physician Decision|2|||
149189556|NCT01753076|538164379|FG000|Overall Study|Withdrawal by Subject|14|||
149189557|NCT01753076|538164380|FG001|Overall Study|Withdrawal by Subject|24|||
149189558|NCT01753076|538164379|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
149189559|NCT01753076|538164380|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
149189560|NCT02575079|538164381|FG000|Overall Study|Death|3|||
149189561|NCT02575079|538164382|FG001|Overall Study|Death|0|||
149189562|NCT02575079|538164381|FG000|Overall Study|Withdrawal by Subject|3|||
149189563|NCT02575079|538164382|FG001|Overall Study|Withdrawal by Subject|0|||
149189564|NCT02389816|538164383|FG000|Overall Study|Randomized but Not Treated|1|||
149189565|NCT02389816|538164384|FG001|Overall Study|Randomized but Not Treated|0|||
149189566|NCT02389816|538164385|FG002|Overall Study|Randomized but Not Treated|0|||
149189567|NCT02389816|538164383|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
149189568|NCT02389816|538164384|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
149189569|NCT02389816|538164385|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
149189570|NCT02389816|538164383|FG000|Overall Study|Major Protocol Deviation|1|||
149189571|NCT02389816|538164384|FG001|Overall Study|Major Protocol Deviation|0|||
149189572|NCT02389816|538164385|FG002|Overall Study|Major Protocol Deviation|0|||
149189573|NCT02389816|538164383|FG000|Overall Study|Lost to Follow-up|1|||
149189574|NCT02389816|538164384|FG001|Overall Study|Lost to Follow-up|0|||
149189575|NCT02389816|538164385|FG002|Overall Study|Lost to Follow-up|0|||
149189576|NCT02389816|538164383|FG000|Overall Study|Withdrawal of Consent|6|||
149189577|NCT02389816|538164384|FG001|Overall Study|Withdrawal of Consent|4|||
149189578|NCT02389816|538164385|FG002|Overall Study|Withdrawal of Consent|4|||
149189579|NCT02389816|538164383|FG000|Overall Study|Lack of Efficacy|1|||
149189580|NCT02389816|538164384|FG001|Overall Study|Lack of Efficacy|0|||
149189581|NCT02389816|538164385|FG002|Overall Study|Lack of Efficacy|0|||
149189582|NCT02389816|538164383|FG000|Overall Study|Non Compliance with Study Drug|1|||
149189583|NCT02389816|538164384|FG001|Overall Study|Non Compliance with Study Drug|1|||
149189584|NCT02389816|538164385|FG002|Overall Study|Non Compliance with Study Drug|1|||
149189585|NCT02389816|538164383|FG000|Overall Study|Reason not Specified|0|||
149189586|NCT02389816|538164384|FG001|Overall Study|Reason not Specified|2|||
149189587|NCT02389816|538164385|FG002|Overall Study|Reason not Specified|0|||
149189588|NCT01259856|538164392|FG000|Overall Study|Adverse Event|12|||
149189589|NCT01259856|538164393|FG001|Overall Study|Adverse Event|9|||
149189590|NCT01259856|538164392|FG000|Overall Study|Death|0|||
149189591|NCT01259856|538164393|FG001|Overall Study|Death|1|||
149189592|NCT01259856|538164392|FG000|Overall Study|Lack of Efficacy|3|||
149189593|NCT01259856|538164393|FG001|Overall Study|Lack of Efficacy|1|||
149189594|NCT01259856|538164392|FG000|Overall Study|Lost to Follow-up|1|||
149189595|NCT01259856|538164393|FG001|Overall Study|Lost to Follow-up|1|||
149189596|NCT01259856|538164392|FG000|Overall Study|Physician Decision|2|||
149189597|NCT01259856|538164393|FG001|Overall Study|Physician Decision|1|||
149189598|NCT01259856|538164392|FG000|Overall Study|Withdrawal by Subject|9|||
149189599|NCT01259856|538164393|FG001|Overall Study|Withdrawal by Subject|10|||
149189600|NCT01259856|538164392|FG000|Overall Study|Treatment never started|0|||
149189601|NCT01259856|538164393|FG001|Overall Study|Treatment never started|6|||
149189602|NCT01259856|538164392|FG000|Overall Study|Study closure by sponsor|40|||
149189603|NCT01259856|538164393|FG001|Overall Study|Study closure by sponsor|41|||
149189604|NCT01259856|538164392|FG000|Overall Study|Patient developed other disease|0|||
149189605|NCT01259856|538164393|FG001|Overall Study|Patient developed other disease|1|||
149189606|NCT01259856|538164392|FG000|Overall Study|Transfer to another study|0|||
149189607|NCT01259856|538164393|FG001|Overall Study|Transfer to another study|1|||
149189608|NCT01259856|538164392|FG000|Overall Study|Unknown/missing|2|||
149189609|NCT01259856|538164393|FG001|Overall Study|Unknown/missing|2|||
149189610|NCT00788775|538164394|FG000|Overall Study|Progressive Disease|8|||
149189611|NCT00788775|538164395|FG001|Overall Study|Progressive Disease|6|||
149189612|NCT00788775|538164394|FG000|Overall Study|Withdrawal by Subject|0|||
149189613|NCT00788775|538164395|FG001|Overall Study|Withdrawal by Subject|2|||
149189614|NCT00788775|538164394|FG000|Overall Study|Patient Non-Compliance|1|||
149189615|NCT00788775|538164395|FG001|Overall Study|Patient Non-Compliance|0|||
149189616|NCT00788775|538164394|FG000|Overall Study|Patient's measurable disease resected.|1|||
149189617|NCT00788775|538164395|FG001|Overall Study|Patient's measurable disease resected.|0|||
149189618|NCT00578864|538164396|FG000|Overall Study|Death|1|||
149189619|NCT00578864|538164397|FG001|Overall Study|Death|0|||
149189620|NCT01217190|538164401|FG000|Second Dosing|Withdrawal by Subject|0|||
149189621|NCT01217190|538164402|FG001|Second Dosing|Withdrawal by Subject|2|||
149189622|NCT01594476|538164403|FG000|Overall Study|Protocol Violation|1|||
149189623|NCT01594476|538164404|FG001|Overall Study|Protocol Violation|3|||
149189624|NCT01087528|538164405|FG000|Overall Study|Withdrawal by Subject|1|||
149189625|NCT01087528|538164405|FG000|Overall Study|Incomplete CE procedure|6|||
149189626|NCT03116399|538164408|FG000|Overall Study|Death|8|||
149189627|NCT03116399|538164409|FG001|Overall Study|Death|3|||
149189628|NCT03116399|538164408|FG000|Overall Study|Lost to Follow-up|7|||
149189629|NCT03116399|538164409|FG001|Overall Study|Lost to Follow-up|11|||
149189630|NCT03116399|538164408|FG000|Overall Study|Investigator Decision|1|||
149189631|NCT03116399|538164409|FG001|Overall Study|Investigator Decision|1|||
149189632|NCT03116399|538164408|FG000|Overall Study|Withdrawal by Subject|24|||
149189633|NCT03116399|538164409|FG001|Overall Study|Withdrawal by Subject|9|||
149189634|NCT00601523|538164412|FG000|Overall Study|Adverse Event|42|||
149189635|NCT00601523|538164413|FG001|Overall Study|Adverse Event|14|||
149189636|NCT00601523|538164412|FG000|Overall Study|Lack of Efficacy|3|||
149189637|NCT00601523|538164413|FG001|Overall Study|Lack of Efficacy|0|||
149189638|NCT00601523|538164412|FG000|Overall Study|Protocol Violation|5|||
149189639|NCT00601523|538164413|FG001|Overall Study|Protocol Violation|1|||
149189640|NCT00601523|538164412|FG000|Overall Study|Lost to Follow-up|0|||
149189641|NCT00601523|538164413|FG001|Overall Study|Lost to Follow-up|1|||
149189642|NCT00601523|538164412|FG000|Overall Study|Withdrawal by Subject|18|||
149189643|NCT00601523|538164413|FG001|Overall Study|Withdrawal by Subject|9|||
149189644|NCT00601523|538164412|FG000|Overall Study|Other|9|||
149189645|NCT00601523|538164413|FG001|Overall Study|Other|1|||
149189646|NCT04072146|538164414|FG000|Overall Study|Adverse Event|0|||
149189647|NCT04072146|538164415|FG001|Overall Study|Adverse Event|1|||
149189648|NCT01987986|538164416|FG000|Overall Study|Lost to Follow-up|1|||
149189649|NCT01987986|538164417|FG001|Overall Study|Lost to Follow-up|0|||
148679803|NCT03001011|536300888|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
148679804|NCT03001011|536300889|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
148679805|NCT03001011|536300888|FG000|Overall Study|Other than specified above|3|||
148679806|NCT03001011|536300889|FG001|Overall Study|Other than specified above|8|||
148679807|NCT04556838|536300894|FG000|Overall Study|Withdrawal by Subject|3|||
148679808|NCT04556838|536300895|FG001|Overall Study|Withdrawal by Subject|1|||
148679809|NCT04556838|536300896|FG002|Overall Study|Withdrawal by Subject|2|||
148679810|NCT04556838|536300894|FG000|Overall Study|Adverse Event|0|||
148679811|NCT04556838|536300895|FG001|Overall Study|Adverse Event|1|||
148679812|NCT04556838|536300896|FG002|Overall Study|Adverse Event|1|||
148679813|NCT04556838|536300894|FG000|Overall Study|Lost to Follow-up|0|||
148679814|NCT04556838|536300895|FG001|Overall Study|Lost to Follow-up|0|||
148679815|NCT04556838|536300896|FG002|Overall Study|Lost to Follow-up|2|||
148679816|NCT04556838|536300894|FG000|Overall Study|Subject travel|0|||
148679817|NCT04556838|536300895|FG001|Overall Study|Subject travel|1|||
148679818|NCT04556838|536300896|FG002|Overall Study|Subject travel|0|||
148679819|NCT04556838|536300894|FG000|Overall Study|Physician Decision|1|||
148679820|NCT04556838|536300895|FG001|Overall Study|Physician Decision|0|||
148679821|NCT04556838|536300896|FG002|Overall Study|Physician Decision|0|||
148679822|NCT04523831|536300897|FG000|Overall Study|Lost to Follow-up|15|||
148679823|NCT04523831|536300898|FG001|Overall Study|Lost to Follow-up|17|||
148679824|NCT04523831|536300897|FG000|Overall Study|Death|0|||
148679825|NCT04523831|536300898|FG001|Overall Study|Death|3|||
148679826|NCT04523831|536300897|FG000|Overall Study|Adverse Event|2|||
148679827|NCT04523831|536300898|FG001|Overall Study|Adverse Event|0|||
148679828|NCT00995930|536300899|FG000|Overall Study|Protocol deviation|2|||
148679829|NCT00995930|536300900|FG001|Overall Study|Protocol deviation|5|||
149189650|NCT01987986|538164418|FG002|Overall Study|Lost to Follow-up|0|||
149189651|NCT01987986|538164419|FG003|Overall Study|Lost to Follow-up|0|||
149189652|NCT01987986|538164416|FG000|Overall Study|Adverse Event|1|||
149189653|NCT01987986|538164417|FG001|Overall Study|Adverse Event|0|||
149189654|NCT01987986|538164418|FG002|Overall Study|Adverse Event|2|||
149189655|NCT01987986|538164419|FG003|Overall Study|Adverse Event|0|||
149189656|NCT01617434|538164420|FG000|Overall Study|Adverse Event|12|||
149189657|NCT01617434|538164421|FG001|Overall Study|Adverse Event|3|||
148679830|NCT00995930|536300899|FG000|Overall Study|Death|0|||
148679831|NCT00995930|536300900|FG001|Overall Study|Death|1|||
148679832|NCT00995930|536300899|FG000|Overall Study|Administrative problems|4|||
148679833|NCT00995930|536300900|FG001|Overall Study|Administrative problems|2|||
149189658|NCT01617434|538164420|FG000|Overall Study|Protocol Violation|8|||
149189659|NCT01617434|538164421|FG001|Overall Study|Protocol Violation|7|||
148679834|NCT00995930|536300899|FG000|Overall Study|Lost to Follow-up|1|||
148679835|NCT00995930|536300900|FG001|Overall Study|Lost to Follow-up|2|||
148679836|NCT00995930|536300899|FG000|Overall Study|Withdrawal by Subject|3|||
148679837|NCT00995930|536300900|FG001|Overall Study|Withdrawal by Subject|4|||
148679838|NCT00995930|536300899|FG000|Overall Study|Adverse Event|11|||
148679839|NCT00995930|536300900|FG001|Overall Study|Adverse Event|14|||
148679840|NCT01246973|536302206|FG000|Overall Study|Other|38|||
148679841|NCT01246973|536302207|FG001|Overall Study|Other|25|||
148679842|NCT01246973|536302206|FG000|Overall Study|Adverse Event|16|||
148679843|NCT01246973|536302207|FG001|Overall Study|Adverse Event|9|||
148679844|NCT01246973|536302206|FG000|Overall Study|Withdrawal by Subject|7|||
148679845|NCT01246973|536302207|FG001|Overall Study|Withdrawal by Subject|13|||
148679846|NCT03053622|536302209|FG000|Overall Study|Lost to Follow-up|0|||
148679847|NCT03053622|536302210|FG001|Overall Study|Lost to Follow-up|0|||
148679848|NCT03053622|536302211|FG002|Overall Study|Lost to Follow-up|0|||
148679849|NCT03053622|536302212|FG003|Overall Study|Lost to Follow-up|1|||
148679850|NCT02598622|536302213|FG000|Overall Study|Withdrawal by Subject|3|||
148679851|NCT02598622|536302214|FG001|Overall Study|Withdrawal by Subject|0|||
148679852|NCT02598622|536302213|FG000|Overall Study|Physician Decision|3|||
148679853|NCT02598622|536302214|FG001|Overall Study|Physician Decision|0|||
148679854|NCT01416142|536302218|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
148679855|NCT01416142|536302219|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
148679856|NCT01416142|536302220|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
148679857|NCT00678379|536302221|FG000|Overall Study|Injection performed after tonsillectomy|2|||
148679858|NCT00678379|536302222|FG001|Overall Study|Injection performed after tonsillectomy|0|||
148679859|NCT00678379|536302223|FG002|Overall Study|Injection performed after tonsillectomy|1|||
148679860|NCT00678379|536302221|FG000|Overall Study|Incomplete Data|4|||
148679861|NCT00678379|536302222|FG001|Overall Study|Incomplete Data|3|||
148679862|NCT00678379|536302223|FG002|Overall Study|Incomplete Data|3|||
148679863|NCT03333382|536302224|FG000|Overall Study|Lost to Follow-up|1|||
148679864|NCT03333382|536302225|FG001|Overall Study|Lost to Follow-up|0|||
148679865|NCT02513459|536302226|FG000|Overall Study|Adverse Event|7|||
148679866|NCT02513459|536302226|FG000|Overall Study|Withdrew consent|5|||
148679867|NCT02513459|536302226|FG000|Overall Study|Loss of efficacy|2|||
148679868|NCT02513459|536302226|FG000|Overall Study|Pregnancy|2|||
148679869|NCT02513459|536302226|FG000|Overall Study|Subject decision|2|||
148679870|NCT02513459|536302226|FG000|Overall Study|Lack of response|1|||
148933939|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
148933940|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
148679871|NCT02513459|536302226|FG000|Overall Study|Reproductive plans|1|||
148679872|NCT02513459|536302226|FG000|Overall Study|Surgery planned-- not done|1|||
148679873|NCT00787566|536302231|FG000|Overall Study|AE related to chemotherapy|0|||
148679874|NCT00787566|536302232|FG001|Overall Study|AE related to chemotherapy|1|||
148679875|NCT00787566|536302233|FG002|Overall Study|AE related to chemotherapy|0|||
148679876|NCT02629133|536302238|FG000|Overall Study|Lost to Follow-up|3|||
148679877|NCT02629133|536302239|FG001|Overall Study|Lost to Follow-up|1|||
148679878|NCT02629133|536302238|FG000|Overall Study|Withdrawal by Subject|1|||
148679879|NCT02629133|536302239|FG001|Overall Study|Withdrawal by Subject|1|||
148679880|NCT05180630|536302240|FG000|First Intervention|Physician Decision|0|||
148679881|NCT05180630|536302241|FG001|First Intervention|Physician Decision|0|||
148679882|NCT05180630|536302242|FG002|First Intervention|Physician Decision|3|||
148679883|NCT00709735|536302245|FG000|Overall Study|Lost to Follow-up|1|||
148679884|NCT00709735|536302246|FG001|Overall Study|Lost to Follow-up|1|||
148807450|NCT01056276|536773254|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
148807451|NCT01056276|536773255|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
148807452|NCT04154956|536773256|FG000|Overall Study|Death|109|||
148807453|NCT04154956|536773257|FG001|Overall Study|Death|110|||
148807454|NCT04154956|536773256|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
148807455|NCT04154956|536773257|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
148807456|NCT04154956|536773256|FG000|Overall Study|Withdrawal by Subject|1|||
148807457|NCT04154956|536773257|FG001|Overall Study|Withdrawal by Subject|7|||
148807458|NCT04154956|536773256|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
148807459|NCT04154956|536773257|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
148807460|NCT04424901|536773258|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
148807461|NCT04424901|536773259|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
148807462|NCT00147238|536773260|FG000|Overall Study|Inevaluable|8|||
148807463|NCT01348269|536773261|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
148807464|NCT01348269|536773262|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
148807465|NCT01348269|536773261|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
148807466|NCT01348269|536773262|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
148807467|NCT01348269|536773261|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
148807468|NCT01348269|536773262|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
148807469|NCT00805532|536773263|FG000|Overall Study|invalid data|0|||
148807470|NCT00805532|536773264|FG001|Overall Study|invalid data|1|||
148807471|NCT01859741|536773265|FG000|Overall Study|Death|3|||
148807472|NCT01859741|536773266|FG001|Overall Study|Death|2|||
148807473|NCT01859741|536773267|FG002|Overall Study|Death|4|||
148807474|NCT01859741|536773268|FG003|Overall Study|Death|3|||
148807475|NCT01859741|536773269|FG004|Overall Study|Death|5|||
148807476|NCT01859741|536773270|FG005|Overall Study|Death|4|||
148807477|NCT01859741|536773271|FG006|Overall Study|Death|51|||
148807478|NCT01859741|536773272|FG007|Overall Study|Death|51|||
148807479|NCT01859741|536773265|FG000|Overall Study|Lost to Follow-up|0|||
148807480|NCT01859741|536773266|FG001|Overall Study|Lost to Follow-up|0|||
148807481|NCT01859741|536773267|FG002|Overall Study|Lost to Follow-up|0|||
148807482|NCT01859741|536773268|FG003|Overall Study|Lost to Follow-up|0|||
148807483|NCT01859741|536773269|FG004|Overall Study|Lost to Follow-up|0|||
149189660|NCT01617434|538164420|FG000|Overall Study|Withdrawal Criteria|12|||
149189661|NCT01617434|538164421|FG001|Overall Study|Withdrawal Criteria|37|||
149189662|NCT01617434|538164420|FG000|Overall Study|Unclassified|3|||
149189663|NCT01617434|538164421|FG001|Overall Study|Unclassified|4|||
148679885|NCT00709735|536302245|FG000|Overall Study|Relapse into Opioid Abuse|0|||
148679886|NCT00709735|536302246|FG001|Overall Study|Relapse into Opioid Abuse|1|||
148679887|NCT00709735|536302245|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
148679888|NCT00709735|536302246|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
148679889|NCT00386100|536302247|FG000|Overall Study|Did not receive study medication|6|||
148679890|NCT00386100|536302248|FG001|Overall Study|Did not receive study medication|4|||
148679891|NCT00386100|536302247|FG000|Overall Study|Adverse Event|15|||
148679892|NCT00386100|536302248|FG001|Overall Study|Adverse Event|25|||
148679893|NCT00386100|536302247|FG000|Overall Study|Death|0|||
148679894|NCT00386100|536302248|FG001|Overall Study|Death|1|||
148679895|NCT00386100|536302247|FG000|Overall Study|Insufficient therapeutic effect|30|||
148679896|NCT00386100|536302248|FG001|Overall Study|Insufficient therapeutic effect|6|||
148679897|NCT00386100|536302247|FG000|Overall Study|Lost to Follow-up|29|||
148679898|NCT00386100|536302248|FG001|Overall Study|Lost to Follow-up|29|||
148807484|NCT01859741|536773270|FG005|Overall Study|Lost to Follow-up|1|||
149189664|NCT00540436|538164422|FG000|First 12-Week Treatment Period|Adverse Event|1|||
149189665|NCT00540436|538164422|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
148807485|NCT01859741|536773271|FG006|Overall Study|Lost to Follow-up|0|||
148807486|NCT01859741|536773272|FG007|Overall Study|Lost to Follow-up|4|||
148807487|NCT01859741|536773265|FG000|Overall Study|Withdrawal by Subject|0|||
148807488|NCT01859741|536773266|FG001|Overall Study|Withdrawal by Subject|1|||
148807489|NCT01859741|536773267|FG002|Overall Study|Withdrawal by Subject|2|||
148807490|NCT01859741|536773268|FG003|Overall Study|Withdrawal by Subject|0|||
149189666|NCT00540436|538164422|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
148807491|NCT01859741|536773269|FG004|Overall Study|Withdrawal by Subject|0|||
148807492|NCT01859741|536773270|FG005|Overall Study|Withdrawal by Subject|1|||
148679899|NCT00386100|536302247|FG000|Overall Study|Non-compliance|18|||
148679900|NCT00386100|536302248|FG001|Overall Study|Non-compliance|19|||
148679901|NCT00386100|536302247|FG000|Overall Study|Protocol Violation|5|||
148679902|NCT00386100|536302248|FG001|Overall Study|Protocol Violation|3|||
148679903|NCT00386100|536302247|FG000|Overall Study|Withdrawal by Subject|32|||
148679904|NCT00386100|536302248|FG001|Overall Study|Withdrawal by Subject|31|||
148933941|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
148933942|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
148933943|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
148933944|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
148933945|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
148933946|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
148933947|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
148933948|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
148933949|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
149189667|NCT00540436|538164422|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
149189668|NCT00905021|538164423|FG000|Overall Study|Adverse Event|2|||
149189669|NCT00786838|538164424|FG000|Overall Study|Physician Decision|4|||
149189670|NCT00786838|538164424|FG000|Overall Study|Death|4|||
149189671|NCT00786838|538164424|FG000|Overall Study|Adverse Event|6|||
148679905|NCT00386100|536302247|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
148679906|NCT00386100|536302248|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
148679907|NCT00386100|536302247|FG000|Overall Study|BMD <2.5|1|||
148679908|NCT00386100|536302248|FG001|Overall Study|BMD <2.5|0|||
148679909|NCT00386100|536302247|FG000|Overall Study|Consecutive elevated Hba1C|1|||
148679910|NCT00386100|536302248|FG001|Overall Study|Consecutive elevated Hba1C|0|||
148679911|NCT00386100|536302247|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
148679912|NCT00386100|536302248|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
148679913|NCT00386100|536302247|FG000|Overall Study|Laboratory findings|1|||
148679914|NCT00386100|536302248|FG001|Overall Study|Laboratory findings|0|||
148679915|NCT00386100|536302247|FG000|Overall Study|Participant's concern due to CPK levels|1|||
148679916|NCT00386100|536302248|FG001|Overall Study|Participant's concern due to CPK levels|0|||
148679917|NCT00386100|536302247|FG000|Overall Study|Participant moving out of state|2|||
148679918|NCT00386100|536302248|FG001|Overall Study|Participant moving out of state|0|||
148679919|NCT00386100|536302247|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
148679920|NCT00386100|536302248|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
148679921|NCT00386100|536302247|FG000|Overall Study|Didn't meet entry criteria|1|||
148679922|NCT00386100|536302248|FG001|Overall Study|Didn't meet entry criteria|1|||
148679923|NCT00386100|536302247|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
148679924|NCT00386100|536302248|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
148679925|NCT00386100|536302247|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
148679926|NCT00386100|536302248|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
148679927|NCT00386100|536302247|FG000|Overall Study|Bad metabolic control & patient security|1|||
148679928|NCT00386100|536302248|FG001|Overall Study|Bad metabolic control & patient security|0|||
148679929|NCT00386100|536302247|FG000|Overall Study|Bone loss by DXA bone scan|1|||
148679930|NCT00386100|536302248|FG001|Overall Study|Bone loss by DXA bone scan|0|||
148679931|NCT00386100|536302247|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
148679932|NCT00386100|536302248|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
148679933|NCT00386100|536302247|FG000|Overall Study|7.6% bone loss|1|||
148679934|NCT00386100|536302248|FG001|Overall Study|7.6% bone loss|0|||
148679935|NCT00386100|536302247|FG000|Overall Study|Osteoporosis|0|||
148679936|NCT00386100|536302248|FG001|Overall Study|Osteoporosis|1|||
148679937|NCT00386100|536302247|FG000|Overall Study|Positive pregnancy test|1|||
148679938|NCT00386100|536302248|FG001|Overall Study|Positive pregnancy test|3|||
148679939|NCT00386100|536302247|FG000|Overall Study|Out of country for 5 months|1|||
148679940|NCT00386100|536302248|FG001|Overall Study|Out of country for 5 months|0|||
148679941|NCT00386100|536302247|FG000|Overall Study|Hb1Ac >8%|0|||
148933950|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
148933951|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
149189672|NCT00786838|538164424|FG000|Overall Study|Progressive disease|31|||
148933952|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
148933953|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
148933954|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
148933955|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
148933956|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
148933957|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
148933958|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
148933959|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
148933960|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
148933961|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
148933962|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
148933963|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
148933964|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
148679942|NCT00386100|536302248|FG001|Overall Study|Hb1Ac >8%|1|||
148679943|NCT00386100|536302247|FG000|Overall Study|Participant randomized in error|1|||
148679944|NCT00386100|536302248|FG001|Overall Study|Participant randomized in error|0|||
148807493|NCT01859741|536773271|FG006|Overall Study|Withdrawal by Subject|1|||
148933965|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
148933966|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
148933967|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
148933968|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
148933969|NCT00313300|537244372|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
148933970|NCT00313300|537244373|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
148933971|NCT00313300|537244374|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
148933972|NCT00313300|537244375|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
148933973|NCT00313300|537244376|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
148933974|NCT00313300|537244372|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
148933975|NCT00313300|537244373|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
148933976|NCT00313300|537244374|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
148933977|NCT00313300|537244375|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
148933978|NCT00313300|537244376|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
148933979|NCT00313300|537244372|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
148933980|NCT00313300|537244373|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
148933981|NCT00313300|537244374|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
148933982|NCT00313300|537244375|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
149189673|NCT00786838|538164424|FG000|Overall Study|Withdrawal by Subject|4|||
149189674|NCT04937816|538164425|FG000|Overall Study|Study drug stopped, reason missing|5|||
149189675|NCT04937816|538164426|FG001|Overall Study|Study drug stopped, reason missing|3|||
149189676|NCT04937816|538164427|FG002|Overall Study|Study drug stopped, reason missing|4|||
149189677|NCT04937816|538164428|FG003|Overall Study|Study drug stopped, reason missing|6|||
149189678|NCT04937816|538164429|FG004|Overall Study|Study drug stopped, reason missing|1|||
149189679|NCT04937816|538164430|FG005|Overall Study|Study drug stopped, reason missing|0|||
149189680|NCT04937816|538164431|FG006|Overall Study|Study drug stopped, reason missing|0|||
149189681|NCT04937816|538164425|FG000|Overall Study|Other than stated below|173|||
149189682|NCT04937816|538164426|FG001|Overall Study|Other than stated below|143|||
149189683|NCT04937816|538164427|FG002|Overall Study|Other than stated below|125|||
149189684|NCT04937816|538164428|FG003|Overall Study|Other than stated below|44|||
149189685|NCT04937816|538164429|FG004|Overall Study|Other than stated below|45|||
149189686|NCT04937816|538164430|FG005|Overall Study|Other than stated below|28|||
149189687|NCT04937816|538164431|FG006|Overall Study|Other than stated below|31|||
149189688|NCT04937816|538164425|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
149189689|NCT04937816|538164426|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
149189690|NCT04937816|538164427|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
149189691|NCT04937816|538164428|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
149189692|NCT04937816|538164429|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
149189693|NCT04937816|538164430|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
149189694|NCT04937816|538164431|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
149189695|NCT04937816|538164425|FG000|Overall Study|Lost to Follow-up|15|||
149189696|NCT04937816|538164426|FG001|Overall Study|Lost to Follow-up|9|||
149189697|NCT04937816|538164427|FG002|Overall Study|Lost to Follow-up|6|||
149189698|NCT04937816|538164428|FG003|Overall Study|Lost to Follow-up|6|||
149189699|NCT04937816|538164429|FG004|Overall Study|Lost to Follow-up|16|||
149189700|NCT04937816|538164430|FG005|Overall Study|Lost to Follow-up|11|||
149189701|NCT04937816|538164431|FG006|Overall Study|Lost to Follow-up|17|||
149189702|NCT04937816|538164425|FG000|Overall Study|Protocol Violation|15|||
149189703|NCT04937816|538164426|FG001|Overall Study|Protocol Violation|15|||
149189704|NCT04937816|538164427|FG002|Overall Study|Protocol Violation|12|||
149189705|NCT04937816|538164428|FG003|Overall Study|Protocol Violation|30|||
149189706|NCT04937816|538164429|FG004|Overall Study|Protocol Violation|24|||
149189707|NCT04937816|538164430|FG005|Overall Study|Protocol Violation|5|||
149189708|NCT04937816|538164431|FG006|Overall Study|Protocol Violation|5|||
149189709|NCT04937816|538164425|FG000|Overall Study|Adverse Event|303|||
149189710|NCT04937816|538164426|FG001|Overall Study|Adverse Event|267|||
149189711|NCT04937816|538164427|FG002|Overall Study|Adverse Event|273|||
149189712|NCT04937816|538164428|FG003|Overall Study|Adverse Event|553|||
149189713|NCT04937816|538164429|FG004|Overall Study|Adverse Event|575|||
149189714|NCT04937816|538164430|FG005|Overall Study|Adverse Event|343|||
149189715|NCT04937816|538164431|FG006|Overall Study|Adverse Event|337|||
149189716|NCT04937816|538164425|FG000|Overall Study|Not treated|4|||
149189717|NCT04937816|538164426|FG001|Overall Study|Not treated|2|||
149189718|NCT04937816|538164427|FG002|Overall Study|Not treated|2|||
149189719|NCT04937816|538164428|FG003|Overall Study|Not treated|2|||
149189720|NCT04937816|538164429|FG004|Overall Study|Not treated|1|||
149189721|NCT04937816|538164430|FG005|Overall Study|Not treated|4|||
149189722|NCT04937816|538164431|FG006|Overall Study|Not treated|0|||
149189723|NCT02488759|538164433|FG000|Overall Study|Disease progression|73|||
149189724|NCT02488759|538164434|FG001|Overall Study|Disease progression|111|||
149189725|NCT02488759|538164435|FG002|Overall Study|Disease progression|62|||
149189726|NCT02488759|538164436|FG003|Overall Study|Disease progression|7|||
149189727|NCT02488759|538164437|FG004|Overall Study|Disease progression|4|||
149189728|NCT02488759|538164438|FG005|Overall Study|Disease progression|2|||
149189729|NCT02488759|538164433|FG000|Overall Study|Study drug toxicity|11|||
149189730|NCT02488759|538164434|FG001|Overall Study|Study drug toxicity|33|||
149189731|NCT02488759|538164435|FG002|Overall Study|Study drug toxicity|31|||
149189732|NCT02488759|538164436|FG003|Overall Study|Study drug toxicity|0|||
149189733|NCT02488759|538164437|FG004|Overall Study|Study drug toxicity|0|||
149189734|NCT02488759|538164438|FG005|Overall Study|Study drug toxicity|2|||
149189735|NCT02488759|538164433|FG000|Overall Study|Adverse event unrelated to study drug|9|||
149189736|NCT02488759|538164434|FG001|Overall Study|Adverse event unrelated to study drug|11|||
149189737|NCT02488759|538164435|FG002|Overall Study|Adverse event unrelated to study drug|7|||
149189738|NCT02488759|538164436|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149189739|NCT02488759|538164437|FG004|Overall Study|Adverse event unrelated to study drug|1|||
149189740|NCT02488759|538164438|FG005|Overall Study|Adverse event unrelated to study drug|0|||
149189741|NCT02488759|538164433|FG000|Overall Study|Participant request to discontinue study treatment|6|||
149189742|NCT02488759|538164434|FG001|Overall Study|Participant request to discontinue study treatment|8|||
149189743|NCT02488759|538164435|FG002|Overall Study|Participant request to discontinue study treatment|4|||
149189744|NCT02488759|538164436|FG003|Overall Study|Participant request to discontinue study treatment|0|||
149189745|NCT02488759|538164437|FG004|Overall Study|Participant request to discontinue study treatment|0|||
149189746|NCT02488759|538164438|FG005|Overall Study|Participant request to discontinue study treatment|0|||
149189747|NCT02488759|538164433|FG000|Overall Study|Withdrawal by Subject|4|||
149189748|NCT02488759|538164434|FG001|Overall Study|Withdrawal by Subject|0|||
149189749|NCT02488759|538164435|FG002|Overall Study|Withdrawal by Subject|3|||
149189750|NCT02488759|538164436|FG003|Overall Study|Withdrawal by Subject|0|||
149189751|NCT02488759|538164437|FG004|Overall Study|Withdrawal by Subject|0|||
149189752|NCT02488759|538164438|FG005|Overall Study|Withdrawal by Subject|2|||
149189753|NCT02488759|538164433|FG000|Overall Study|Lost to Follow-up|0|||
149189754|NCT02488759|538164434|FG001|Overall Study|Lost to Follow-up|0|||
149189755|NCT02488759|538164435|FG002|Overall Study|Lost to Follow-up|2|||
149189756|NCT02488759|538164436|FG003|Overall Study|Lost to Follow-up|0|||
149189757|NCT02488759|538164437|FG004|Overall Study|Lost to Follow-up|0|||
149189758|NCT02488759|538164438|FG005|Overall Study|Lost to Follow-up|0|||
149189759|NCT02488759|538164433|FG000|Overall Study|Maximum clinical benefit|3|||
149189760|NCT02488759|538164434|FG001|Overall Study|Maximum clinical benefit|0|||
149189761|NCT02488759|538164435|FG002|Overall Study|Maximum clinical benefit|1|||
149189762|NCT02488759|538164436|FG003|Overall Study|Maximum clinical benefit|0|||
149189763|NCT02488759|538164437|FG004|Overall Study|Maximum clinical benefit|0|||
149189764|NCT02488759|538164438|FG005|Overall Study|Maximum clinical benefit|0|||
149189765|NCT02488759|538164433|FG000|Overall Study|Other reasons|7|||
149189766|NCT02488759|538164434|FG001|Overall Study|Other reasons|32|||
149189767|NCT02488759|538164435|FG002|Overall Study|Other reasons|23|||
149189768|NCT02488759|538164436|FG003|Overall Study|Other reasons|1|||
149189769|NCT02488759|538164437|FG004|Overall Study|Other reasons|1|||
149189770|NCT02488759|538164438|FG005|Overall Study|Other reasons|1|||
149189771|NCT05281523|538164439|FG000|Overall Study|Adverse Event|1|||
149189772|NCT05281523|538164440|FG001|Overall Study|Adverse Event|1|||
149189773|NCT05281523|538164439|FG000|Overall Study|Physician Decision|1|||
149189774|NCT05281523|538164440|FG001|Overall Study|Physician Decision|1|||
149189775|NCT05281523|538164439|FG000|Overall Study|Withdrawal by Subject|5|||
149189776|NCT05281523|538164440|FG001|Overall Study|Withdrawal by Subject|15|||
149189777|NCT05281523|538164439|FG000|Overall Study|GCP violations|3|||
149189778|NCT05281523|538164440|FG001|Overall Study|GCP violations|4|||
149189779|NCT05513053|538164441|FG000|Overall Study|Lost to Follow-up|9|||
149189780|NCT05513053|538164442|FG001|Overall Study|Lost to Follow-up|11|||
149189781|NCT05513053|538164441|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149189782|NCT05513053|538164442|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149189783|NCT05513053|538164441|FG000|Overall Study|Withdrawal by Subject|2|||
149189784|NCT05513053|538164442|FG001|Overall Study|Withdrawal by Subject|9|||
149189785|NCT05513053|538164441|FG000|Overall Study|Protocol Violation|6|||
149189786|NCT05513053|538164442|FG001|Overall Study|Protocol Violation|3|||
149189787|NCT05513053|538164441|FG000|Overall Study|Adverse Event|0|||
149189788|NCT05513053|538164442|FG001|Overall Study|Adverse Event|2|||
149189789|NCT05183867|538166229|FG000|Overall Study|Withdrawal by Subject|3|||
149189790|NCT05183867|538166230|FG001|Overall Study|Withdrawal by Subject|2|||
148933983|NCT00313300|537244376|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
149189791|NCT05183867|538166231|FG002|Overall Study|Withdrawal by Subject|0|||
149189792|NCT04491877|538166232|FG000|Overall Study|Protocol Deviation|1|||
149189793|NCT04491877|538166233|FG001|Overall Study|Protocol Deviation|0|||
149189794|NCT04491877|538166234|FG002|Overall Study|Protocol Deviation|2|||
149189795|NCT04491877|538166235|FG003|Overall Study|Protocol Deviation|0|||
149189796|NCT04491877|538166236|FG004|Overall Study|Protocol Deviation|0|||
149189797|NCT04491877|538166237|FG005|Overall Study|Protocol Deviation|0|||
149189798|NCT04491877|538166238|FG006|Overall Study|Protocol Deviation|1|||
149189799|NCT04491877|538166239|FG007|Overall Study|Protocol Deviation|1|||
149189800|NCT04491877|538166240|FG008|Overall Study|Protocol Deviation|0|||
149189801|NCT04491877|538166232|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148933984|NCT00313300|537244372|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
148933985|NCT00313300|537244373|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
148679945|NCT00849524|536302258|FG000|Overall Study|Lack of Efficacy|3|||
148679946|NCT01493531|536302263|FG000|Overall Study|Adverse Event|4|||
148679947|NCT01493531|536302264|FG001|Overall Study|Adverse Event|12|||
148679948|NCT01493531|536302265|FG002|Overall Study|Adverse Event|9|||
148679949|NCT01493531|536302263|FG000|Overall Study|Gout flare|3|||
148679950|NCT01493531|536302264|FG001|Overall Study|Gout flare|0|||
148679951|NCT01493531|536302265|FG002|Overall Study|Gout flare|2|||
148679952|NCT01493531|536302263|FG000|Overall Study|Protocol Violation|8|||
148679953|NCT01493531|536302264|FG001|Overall Study|Protocol Violation|15|||
148679954|NCT01493531|536302265|FG002|Overall Study|Protocol Violation|12|||
148679955|NCT01493531|536302263|FG000|Overall Study|Sponsor terminated study|5|||
148679956|NCT01493531|536302264|FG001|Overall Study|Sponsor terminated study|2|||
148679957|NCT01493531|536302265|FG002|Overall Study|Sponsor terminated study|3|||
148679958|NCT01493531|536302263|FG000|Overall Study|Lost to Follow-up|5|||
148679959|NCT01493531|536302264|FG001|Overall Study|Lost to Follow-up|7|||
148679960|NCT01493531|536302265|FG002|Overall Study|Lost to Follow-up|11|||
148679961|NCT01493531|536302263|FG000|Overall Study|Withdrawal by Subject|16|||
148679962|NCT01493531|536302264|FG001|Overall Study|Withdrawal by Subject|13|||
148679963|NCT01493531|536302265|FG002|Overall Study|Withdrawal by Subject|11|||
148679964|NCT01493531|536302263|FG000|Overall Study|Death|0|||
148679965|NCT01493531|536302264|FG001|Overall Study|Death|1|||
148679966|NCT01493531|536302265|FG002|Overall Study|Death|0|||
148679967|NCT01946282|536302266|FG000|Year 1|Did not return FIT kit|4186|||
148679968|NCT01946282|536302267|FG001|Year 1|Did not return FIT kit|608|||
148679969|NCT01946282|536302268|FG002|Year 1|Did not return FIT kit|654|||
148679970|NCT01946282|536302266|FG000|Year 2|Did not return FIT kit|803|||
148679971|NCT01946282|536302267|FG001|Year 2|Did not return FIT kit|131|||
148679972|NCT01946282|536302268|FG002|Year 2|Did not return FIT kit|115|||
148679973|NCT01946282|536302266|FG000|Year 3|Did not return FIT kit|288|||
148679974|NCT01946282|536302267|FG001|Year 3|Did not return FIT kit|43|||
148679975|NCT01946282|536302268|FG002|Year 3|Did not return FIT kit|30|||
148679976|NCT03031431|536302269|FG000|Overall Study|Infant removed by maternal request|1|||
148679977|NCT01027884|536302273|FG000|Overall Study|Adverse Event|2|||
148679978|NCT01027884|536302274|FG001|Overall Study|Adverse Event|1|||
148679979|NCT01027884|536302273|FG000|Overall Study|Protocol Violation|1|||
148679980|NCT01027884|536302274|FG001|Overall Study|Protocol Violation|0|||
148679981|NCT01027884|536302273|FG000|Overall Study|Non-compliance|1|||
148679982|NCT01027884|536302274|FG001|Overall Study|Non-compliance|1|||
148679983|NCT01027884|536302273|FG000|Overall Study|Withdrawal by Subject|0|||
148679984|NCT01027884|536302274|FG001|Overall Study|Withdrawal by Subject|1|||
148679985|NCT01027884|536302273|FG000|Overall Study|Lost to Follow-up|0|||
148679986|NCT01027884|536302274|FG001|Overall Study|Lost to Follow-up|1|||
148679987|NCT01027884|536302273|FG000|Overall Study|Spinal fixation surgery|0|||
148679988|NCT01027884|536302274|FG001|Overall Study|Spinal fixation surgery|3|||
148679989|NCT03670537|536302276|FG000|Overall Study|Protocol Violation|1|||
148679990|NCT04380701|536302277|FG000|Overall Study|Pregnancy|0|||
148679991|NCT04380701|536302278|FG001|Overall Study|Pregnancy|0|||
148679992|NCT04380701|536302279|FG002|Overall Study|Pregnancy|0|||
148679993|NCT04380701|536302280|FG003|Overall Study|Pregnancy|0|||
148679994|NCT04380701|536302281|FG004|Overall Study|Pregnancy|0|||
148679995|NCT04380701|536302282|FG005|Overall Study|Pregnancy|0|||
148679996|NCT04380701|536302283|FG006|Overall Study|Pregnancy|0|||
148679997|NCT04380701|536302284|FG007|Overall Study|Pregnancy|0|||
148679998|NCT04380701|536302285|FG008|Overall Study|Pregnancy|0|||
148679999|NCT04380701|536302286|FG009|Overall Study|Pregnancy|0|||
148680000|NCT04380701|536302287|FG010|Overall Study|Pregnancy|0|||
148680001|NCT04380701|536302288|FG011|Overall Study|Pregnancy|0|||
148933986|NCT00313300|537244374|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
148933987|NCT00313300|537244375|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
148933988|NCT00313300|537244376|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
148933989|NCT00313300|537244372|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
148680002|NCT04380701|536302289|FG012|Overall Study|Pregnancy|0|||
148680003|NCT04380701|536302290|FG013|Overall Study|Pregnancy|0|||
148680004|NCT04380701|536302291|FG014|Overall Study|Pregnancy|0|||
148680005|NCT04380701|536302292|FG015|Overall Study|Pregnancy|0|||
148680006|NCT04380701|536302293|FG016|Overall Study|Pregnancy|0|||
148680007|NCT04380701|536302294|FG017|Overall Study|Pregnancy|0|||
148680008|NCT04380701|536302295|FG018|Overall Study|Pregnancy|0|||
148680009|NCT04380701|536302296|FG019|Overall Study|Pregnancy|0|||
148680010|NCT04380701|536302297|FG020|Overall Study|Pregnancy|0|||
148680011|NCT04380701|536302298|FG021|Overall Study|Pregnancy|0|||
148680012|NCT04380701|536302299|FG022|Overall Study|Pregnancy|0|||
148680013|NCT04380701|536302300|FG023|Overall Study|Pregnancy|0|||
148680014|NCT04380701|536302301|FG024|Overall Study|Pregnancy|0|||
148680015|NCT04380701|536302302|FG025|Overall Study|Pregnancy|0|||
148680016|NCT04380701|536302303|FG026|Overall Study|Pregnancy|0|||
148680017|NCT04380701|536302304|FG027|Overall Study|Pregnancy|0|||
148680018|NCT04380701|536302305|FG028|Overall Study|Pregnancy|0|||
148680019|NCT04380701|536302306|FG029|Overall Study|Pregnancy|0|||
148933990|NCT00313300|537244373|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
148933991|NCT00313300|537244374|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
148933992|NCT00313300|537244375|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
148933993|NCT00313300|537244376|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
148933994|NCT00313300|537244372|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
148933995|NCT00313300|537244373|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
148933996|NCT00313300|537244374|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
148933997|NCT00313300|537244375|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
148933998|NCT00313300|537244376|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
148933999|NCT00313300|537244372|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
148934000|NCT00313300|537244373|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
148934001|NCT00313300|537244374|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
148934002|NCT00313300|537244375|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
148934003|NCT00313300|537244376|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
148934004|NCT00369122|537244387|FG000|Overall Study|Ineligible|10|||
148934005|NCT00369122|537244387|FG000|Overall Study|No protocol treatment|1|||
148934006|NCT02651467|537244388|FG000|Overall Study|Withdrawal by Subject|0|||
148934007|NCT02651467|537244389|FG001|Overall Study|Withdrawal by Subject|0|||
148934008|NCT02651467|537244390|FG002|Overall Study|Withdrawal by Subject|2|||
148934009|NCT02651467|537244388|FG000|Overall Study|Other (Not specified)|1|||
148934010|NCT02651467|537244389|FG001|Overall Study|Other (Not specified)|0|||
148934011|NCT02651467|537244390|FG002|Overall Study|Other (Not specified)|2|||
148934012|NCT00573937|537244391|FG000|Overall Study|Study Terminated|0|||
148934013|NCT00573937|537244392|FG001|Overall Study|Study Terminated|1|||
148934014|NCT00333801|537244393|FG000|Overall Study|Moved to another state|5|||
148934015|NCT00333801|537244394|FG001|Overall Study|Moved to another state|3|||
148934016|NCT00333801|537244393|FG000|Overall Study|Lost to Follow-up|2|||
148934017|NCT00333801|537244394|FG001|Overall Study|Lost to Follow-up|0|||
148934018|NCT00333801|537244393|FG000|Overall Study|Incarcerated|1|||
148934019|NCT00333801|537244394|FG001|Overall Study|Incarcerated|2|||
148934020|NCT00333801|537244393|FG000|Overall Study|Withdrawal by Subject|0|||
148934021|NCT00333801|537244394|FG001|Overall Study|Withdrawal by Subject|1|||
148934022|NCT03633617|537244395|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
148934023|NCT03633617|537244396|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
148934024|NCT03633617|537244397|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934025|NCT03633617|537244398|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934026|NCT03633617|537244399|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934027|NCT03633617|537244400|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934028|NCT03633617|537244401|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934029|NCT03633617|537244402|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934030|NCT03633617|537244403|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934031|NCT03633617|537244404|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934032|NCT03633617|537244405|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
148934033|NCT03633617|537244395|FG000|Part A|Unconfirmed early termination visit|1|||
148934034|NCT03633617|537244396|FG001|Part A|Unconfirmed early termination visit|0|||
148934035|NCT03633617|537244397|FG002|Part A|Unconfirmed early termination visit|0|||
148934036|NCT03633617|537244398|FG003|Part A|Unconfirmed early termination visit|0|||
148934037|NCT03633617|537244399|FG004|Part A|Unconfirmed early termination visit|0|||
149189802|NCT04491877|538166233|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149189803|NCT04491877|538166234|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149189804|NCT04491877|538166235|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
149189805|NCT04491877|538166236|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
149189806|NCT04491877|538166237|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
149189807|NCT04491877|538166238|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
149189808|NCT04491877|538166239|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
149189809|NCT04491877|538166240|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
149189810|NCT04491877|538166232|FG000|Overall Study|Lost to Follow-up|0|||
149189811|NCT04491877|538166233|FG001|Overall Study|Lost to Follow-up|2|||
149189812|NCT04491877|538166234|FG002|Overall Study|Lost to Follow-up|0|||
149189813|NCT04491877|538166235|FG003|Overall Study|Lost to Follow-up|0|||
149189814|NCT04491877|538166236|FG004|Overall Study|Lost to Follow-up|0|||
149189815|NCT04491877|538166237|FG005|Overall Study|Lost to Follow-up|0|||
149189816|NCT04491877|538166238|FG006|Overall Study|Lost to Follow-up|2|||
149189817|NCT04491877|538166239|FG007|Overall Study|Lost to Follow-up|1|||
148934038|NCT03633617|537244400|FG005|Part A|Unconfirmed early termination visit|0|||
148934039|NCT03633617|537244401|FG006|Part A|Unconfirmed early termination visit|0|||
148934040|NCT03633617|537244402|FG007|Part A|Unconfirmed early termination visit|0|||
149189818|NCT04491877|538166240|FG008|Overall Study|Lost to Follow-up|1|||
149189819|NCT00418834|538166248|FG000|Overall Study|Adverse Event|16|||
149189820|NCT00418834|538166249|FG001|Overall Study|Adverse Event|9|||
148934041|NCT03633617|537244403|FG008|Part A|Unconfirmed early termination visit|0|||
148934042|NCT03633617|537244404|FG009|Part A|Unconfirmed early termination visit|0|||
148934043|NCT03633617|537244405|FG010|Part A|Unconfirmed early termination visit|0|||
148934044|NCT03633617|537244395|FG000|Part A|Adverse Event|0|||
148934045|NCT03633617|537244396|FG001|Part A|Adverse Event|1|||
148934046|NCT03633617|537244397|FG002|Part A|Adverse Event|0|||
148934047|NCT03633617|537244398|FG003|Part A|Adverse Event|0|||
148934048|NCT03633617|537244399|FG004|Part A|Adverse Event|0|||
148934049|NCT03633617|537244400|FG005|Part A|Adverse Event|0|||
148934050|NCT03633617|537244401|FG006|Part A|Adverse Event|0|||
148934051|NCT03633617|537244402|FG007|Part A|Adverse Event|0|||
148934052|NCT03633617|537244403|FG008|Part A|Adverse Event|0|||
148934053|NCT03633617|537244404|FG009|Part A|Adverse Event|0|||
148934054|NCT03633617|537244405|FG010|Part A|Adverse Event|0|||
148934055|NCT03633617|537244395|FG000|Part A|Pregnancy|1|||
148934056|NCT03633617|537244396|FG001|Part A|Pregnancy|0|||
148934057|NCT03633617|537244397|FG002|Part A|Pregnancy|0|||
148934058|NCT03633617|537244398|FG003|Part A|Pregnancy|0|||
148934059|NCT03633617|537244399|FG004|Part A|Pregnancy|0|||
148934060|NCT03633617|537244400|FG005|Part A|Pregnancy|0|||
148934061|NCT03633617|537244401|FG006|Part A|Pregnancy|0|||
148934062|NCT03633617|537244402|FG007|Part A|Pregnancy|0|||
148934063|NCT03633617|537244403|FG008|Part A|Pregnancy|0|||
148934064|NCT03633617|537244404|FG009|Part A|Pregnancy|0|||
148934065|NCT03633617|537244405|FG010|Part A|Pregnancy|0|||
148934066|NCT03633617|537244395|FG000|Part A|Withdrawal by Subject|0|||
148934067|NCT03633617|537244396|FG001|Part A|Withdrawal by Subject|1|||
148934068|NCT03633617|537244397|FG002|Part A|Withdrawal by Subject|0|||
148934069|NCT03633617|537244398|FG003|Part A|Withdrawal by Subject|0|||
148934070|NCT03633617|537244399|FG004|Part A|Withdrawal by Subject|0|||
148934071|NCT03633617|537244400|FG005|Part A|Withdrawal by Subject|0|||
148934072|NCT03633617|537244401|FG006|Part A|Withdrawal by Subject|0|||
148934073|NCT03633617|537244402|FG007|Part A|Withdrawal by Subject|0|||
148934074|NCT03633617|537244403|FG008|Part A|Withdrawal by Subject|0|||
148934075|NCT03633617|537244404|FG009|Part A|Withdrawal by Subject|0|||
148934076|NCT03633617|537244405|FG010|Part A|Withdrawal by Subject|0|||
148934077|NCT03633617|537244395|FG000|Part B|Adverse Event|0|||
148934078|NCT03633617|537244396|FG001|Part B|Adverse Event|0|||
148934079|NCT03633617|537244397|FG002|Part B|Adverse Event|2|||
148934080|NCT03633617|537244398|FG003|Part B|Adverse Event|2|||
148934081|NCT03633617|537244399|FG004|Part B|Adverse Event|1|||
148934082|NCT03633617|537244400|FG005|Part B|Adverse Event|0|||
148934083|NCT03633617|537244401|FG006|Part B|Adverse Event|0|||
148934084|NCT03633617|537244402|FG007|Part B|Adverse Event|0|||
148934085|NCT03633617|537244403|FG008|Part B|Adverse Event|0|||
148934086|NCT03633617|537244404|FG009|Part B|Adverse Event|0|||
148934087|NCT03633617|537244405|FG010|Part B|Adverse Event|0|||
148934088|NCT03633617|537244395|FG000|Part B|Withdrawal by Subject|0|||
148934089|NCT03633617|537244396|FG001|Part B|Withdrawal by Subject|0|||
148934090|NCT03633617|537244397|FG002|Part B|Withdrawal by Subject|1|||
148934091|NCT03633617|537244398|FG003|Part B|Withdrawal by Subject|0|||
148934092|NCT03633617|537244399|FG004|Part B|Withdrawal by Subject|2|||
148934093|NCT03633617|537244400|FG005|Part B|Withdrawal by Subject|0|||
148934094|NCT03633617|537244401|FG006|Part B|Withdrawal by Subject|0|||
148934095|NCT03633617|537244402|FG007|Part B|Withdrawal by Subject|0|||
148934096|NCT03633617|537244403|FG008|Part B|Withdrawal by Subject|0|||
148934097|NCT03633617|537244404|FG009|Part B|Withdrawal by Subject|0|||
148934098|NCT03633617|537244405|FG010|Part B|Withdrawal by Subject|0|||
148934099|NCT03633617|537244395|FG000|Part B|Lost to Follow-up|0|||
148934100|NCT03633617|537244396|FG001|Part B|Lost to Follow-up|0|||
148934101|NCT03633617|537244397|FG002|Part B|Lost to Follow-up|0|||
148934102|NCT03633617|537244398|FG003|Part B|Lost to Follow-up|0|||
149014351|NCT00708305|537532191|FG002|Period 3|Protocol Violation|0|||
148934103|NCT03633617|537244399|FG004|Part B|Lost to Follow-up|1|||
148934104|NCT03633617|537244400|FG005|Part B|Lost to Follow-up|0|||
148934105|NCT03633617|537244401|FG006|Part B|Lost to Follow-up|0|||
148934106|NCT03633617|537244402|FG007|Part B|Lost to Follow-up|0|||
148934107|NCT03633617|537244403|FG008|Part B|Lost to Follow-up|0|||
148934108|NCT03633617|537244404|FG009|Part B|Lost to Follow-up|0|||
148934109|NCT03633617|537244405|FG010|Part B|Lost to Follow-up|0|||
149014352|NCT00708305|537532192|FG003|Period 3|Protocol Violation|0|||
148934110|NCT03633617|537244395|FG000|Part B|Physician Decision|0|||
148934111|NCT03633617|537244396|FG001|Part B|Physician Decision|0|||
148934112|NCT03633617|537244397|FG002|Part B|Physician Decision|0|||
148934113|NCT03633617|537244398|FG003|Part B|Physician Decision|0|||
148934114|NCT03633617|537244399|FG004|Part B|Physician Decision|1|||
148934115|NCT03633617|537244400|FG005|Part B|Physician Decision|0|||
148934116|NCT03633617|537244401|FG006|Part B|Physician Decision|0|||
148934117|NCT03633617|537244402|FG007|Part B|Physician Decision|0|||
148934118|NCT03633617|537244403|FG008|Part B|Physician Decision|0|||
148934119|NCT03633617|537244404|FG009|Part B|Physician Decision|0|||
148934120|NCT03633617|537244405|FG010|Part B|Physician Decision|0|||
148934121|NCT03633617|537244395|FG000|Part B|COVID-19 Restrictions|0|||
148934122|NCT03633617|537244396|FG001|Part B|COVID-19 Restrictions|0|||
148934123|NCT03633617|537244397|FG002|Part B|COVID-19 Restrictions|1|||
149014353|NCT00708305|537532189|FG000|Period 3|Other Reason|1|||
148680020|NCT04380701|536302307|FG030|Overall Study|Pregnancy|0|||
148680021|NCT04380701|536302308|FG031|Overall Study|Pregnancy|0|||
148680022|NCT04380701|536302309|FG032|Overall Study|Pregnancy|1|||
148680023|NCT04380701|536302310|FG033|Overall Study|Pregnancy|0|||
148680024|NCT04380701|536302277|FG000|Overall Study|Lost to Follow-up|0|||
148680025|NCT04380701|536302278|FG001|Overall Study|Lost to Follow-up|0|||
148680026|NCT04380701|536302279|FG002|Overall Study|Lost to Follow-up|0|||
148680027|NCT04380701|536302280|FG003|Overall Study|Lost to Follow-up|0|||
148680028|NCT04380701|536302281|FG004|Overall Study|Lost to Follow-up|0|||
148680029|NCT04380701|536302282|FG005|Overall Study|Lost to Follow-up|0|||
148680030|NCT04380701|536302283|FG006|Overall Study|Lost to Follow-up|0|||
148680031|NCT04380701|536302284|FG007|Overall Study|Lost to Follow-up|0|||
148680032|NCT04380701|536302285|FG008|Overall Study|Lost to Follow-up|0|||
148680033|NCT04380701|536302286|FG009|Overall Study|Lost to Follow-up|0|||
148680034|NCT04380701|536302287|FG010|Overall Study|Lost to Follow-up|0|||
148680035|NCT04380701|536302288|FG011|Overall Study|Lost to Follow-up|0|||
148680036|NCT04380701|536302289|FG012|Overall Study|Lost to Follow-up|0|||
148680037|NCT04380701|536302290|FG013|Overall Study|Lost to Follow-up|0|||
148680038|NCT04380701|536302291|FG014|Overall Study|Lost to Follow-up|0|||
148680039|NCT04380701|536302292|FG015|Overall Study|Lost to Follow-up|0|||
148680040|NCT04380701|536302293|FG016|Overall Study|Lost to Follow-up|0|||
148680041|NCT04380701|536302294|FG017|Overall Study|Lost to Follow-up|0|||
148680042|NCT04380701|536302295|FG018|Overall Study|Lost to Follow-up|0|||
148680043|NCT04380701|536302296|FG019|Overall Study|Lost to Follow-up|0|||
148680044|NCT04380701|536302297|FG020|Overall Study|Lost to Follow-up|1|||
148680045|NCT04380701|536302298|FG021|Overall Study|Lost to Follow-up|0|||
148680046|NCT04380701|536302299|FG022|Overall Study|Lost to Follow-up|0|||
148680047|NCT04380701|536302300|FG023|Overall Study|Lost to Follow-up|1|||
148680048|NCT04380701|536302301|FG024|Overall Study|Lost to Follow-up|0|||
148680049|NCT04380701|536302302|FG025|Overall Study|Lost to Follow-up|0|||
148680050|NCT04380701|536302303|FG026|Overall Study|Lost to Follow-up|0|||
148680051|NCT04380701|536302304|FG027|Overall Study|Lost to Follow-up|0|||
148680052|NCT04380701|536302305|FG028|Overall Study|Lost to Follow-up|0|||
148680053|NCT04380701|536302306|FG029|Overall Study|Lost to Follow-up|1|||
148680054|NCT04380701|536302307|FG030|Overall Study|Lost to Follow-up|0|||
148680055|NCT04380701|536302308|FG031|Overall Study|Lost to Follow-up|0|||
148680056|NCT04380701|536302309|FG032|Overall Study|Lost to Follow-up|0|||
148680057|NCT04380701|536302310|FG033|Overall Study|Lost to Follow-up|1|||
148680058|NCT04380701|536302277|FG000|Overall Study|Private reason(s)|0|||
148680059|NCT04380701|536302278|FG001|Overall Study|Private reason(s)|0|||
148680060|NCT04380701|536302279|FG002|Overall Study|Private reason(s)|0|||
148680061|NCT04380701|536302280|FG003|Overall Study|Private reason(s)|0|||
148680062|NCT04380701|536302281|FG004|Overall Study|Private reason(s)|0|||
148680063|NCT04380701|536302282|FG005|Overall Study|Private reason(s)|0|||
148680064|NCT04380701|536302283|FG006|Overall Study|Private reason(s)|1|||
148680065|NCT04380701|536302284|FG007|Overall Study|Private reason(s)|0|||
148680066|NCT04380701|536302285|FG008|Overall Study|Private reason(s)|1|||
148680067|NCT04380701|536302286|FG009|Overall Study|Private reason(s)|1|||
148680068|NCT04380701|536302287|FG010|Overall Study|Private reason(s)|0|||
148680069|NCT04380701|536302288|FG011|Overall Study|Private reason(s)|0|||
148680070|NCT04380701|536302289|FG012|Overall Study|Private reason(s)|0|||
148680071|NCT04380701|536302290|FG013|Overall Study|Private reason(s)|0|||
148680072|NCT04380701|536302291|FG014|Overall Study|Private reason(s)|0|||
148680073|NCT04380701|536302292|FG015|Overall Study|Private reason(s)|0|||
148680074|NCT04380701|536302293|FG016|Overall Study|Private reason(s)|0|||
148680075|NCT04380701|536302294|FG017|Overall Study|Private reason(s)|0|||
148680076|NCT04380701|536302295|FG018|Overall Study|Private reason(s)|0|||
148680077|NCT04380701|536302296|FG019|Overall Study|Private reason(s)|0|||
148680078|NCT04380701|536302297|FG020|Overall Study|Private reason(s)|0|||
148680079|NCT04380701|536302298|FG021|Overall Study|Private reason(s)|0|||
148680080|NCT04380701|536302299|FG022|Overall Study|Private reason(s)|0|||
148680081|NCT04380701|536302300|FG023|Overall Study|Private reason(s)|1|||
148680082|NCT04380701|536302301|FG024|Overall Study|Private reason(s)|0|||
148680083|NCT04380701|536302302|FG025|Overall Study|Private reason(s)|0|||
148680084|NCT04380701|536302303|FG026|Overall Study|Private reason(s)|0|||
148807494|NCT01859741|536773272|FG007|Overall Study|Withdrawal by Subject|1|||
148680085|NCT04380701|536302304|FG027|Overall Study|Private reason(s)|0|||
148680086|NCT04380701|536302305|FG028|Overall Study|Private reason(s)|0|||
148680087|NCT04380701|536302306|FG029|Overall Study|Private reason(s)|1|||
148680088|NCT04380701|536302307|FG030|Overall Study|Private reason(s)|0|||
148680089|NCT04380701|536302308|FG031|Overall Study|Private reason(s)|0|||
148680090|NCT04380701|536302309|FG032|Overall Study|Private reason(s)|0|||
149189821|NCT00418834|538166248|FG000|Overall Study|Lost to Follow-up|0|||
148680091|NCT04380701|536302310|FG033|Overall Study|Private reason(s)|0|||
148680092|NCT04380701|536302277|FG000|Overall Study|Withdrawal by Subject|0|||
148680093|NCT04380701|536302278|FG001|Overall Study|Withdrawal by Subject|0|||
148680094|NCT04380701|536302279|FG002|Overall Study|Withdrawal by Subject|0|||
148680095|NCT04380701|536302280|FG003|Overall Study|Withdrawal by Subject|0|||
148680096|NCT04380701|536302281|FG004|Overall Study|Withdrawal by Subject|0|||
148680097|NCT04380701|536302282|FG005|Overall Study|Withdrawal by Subject|0|||
148680098|NCT04380701|536302283|FG006|Overall Study|Withdrawal by Subject|1|||
149189822|NCT00418834|538166249|FG001|Overall Study|Lost to Follow-up|1|||
149189823|NCT00418834|538166248|FG000|Overall Study|Protocol Violation|4|||
149189824|NCT00418834|538166249|FG001|Overall Study|Protocol Violation|3|||
149189825|NCT00418834|538166248|FG000|Overall Study|Withdrawal by Subject|3|||
149189826|NCT00418834|538166249|FG001|Overall Study|Withdrawal by Subject|7|||
149189827|NCT01953328|538166250|FG000|Overall Study|Withdrawal by Subject|0|||
148934124|NCT03633617|537244398|FG003|Part B|COVID-19 Restrictions|0|||
149189828|NCT01953328|538166251|FG001|Overall Study|Withdrawal by Subject|0|||
149189829|NCT01953328|538166252|FG002|Overall Study|Withdrawal by Subject|0|||
149189830|NCT01953328|538166253|FG003|Overall Study|Withdrawal by Subject|0|||
149189831|NCT01953328|538166254|FG004|Overall Study|Withdrawal by Subject|1|||
149189832|NCT01953328|538166255|FG005|Overall Study|Withdrawal by Subject|0|||
149189833|NCT01953328|538166256|FG006|Overall Study|Withdrawal by Subject|0|||
149189834|NCT01953328|538166257|FG007|Overall Study|Withdrawal by Subject|0|||
149189835|NCT01953328|538166250|FG000|Overall Study|Lost to Follow-up|0|||
149189836|NCT01953328|538166251|FG001|Overall Study|Lost to Follow-up|0|||
149189837|NCT01953328|538166252|FG002|Overall Study|Lost to Follow-up|0|||
149189838|NCT01953328|538166253|FG003|Overall Study|Lost to Follow-up|0|||
149189839|NCT01953328|538166254|FG004|Overall Study|Lost to Follow-up|1|||
149189840|NCT01953328|538166255|FG005|Overall Study|Lost to Follow-up|0|||
149189841|NCT01953328|538166256|FG006|Overall Study|Lost to Follow-up|0|||
149189842|NCT01953328|538166257|FG007|Overall Study|Lost to Follow-up|0|||
149189843|NCT00492856|538166261|FG000|Induction|Adverse Event|2|||
149189844|NCT00492856|538166262|FG001|Induction|Adverse Event|0|||
149189845|NCT00492856|538166263|FG002|Induction|Adverse Event|0|||
148680099|NCT04380701|536302284|FG007|Overall Study|Withdrawal by Subject|1|||
149189846|NCT00492856|538166264|FG003|Induction|Adverse Event|0|||
149189847|NCT00492856|538166261|FG000|Induction|Withdrawal by Subject|1|||
148680100|NCT04380701|536302285|FG008|Overall Study|Withdrawal by Subject|0|||
148680101|NCT04380701|536302286|FG009|Overall Study|Withdrawal by Subject|0|||
148680102|NCT04380701|536302287|FG010|Overall Study|Withdrawal by Subject|0|||
149189848|NCT00492856|538166262|FG001|Induction|Withdrawal by Subject|0|||
149189849|NCT00492856|538166263|FG002|Induction|Withdrawal by Subject|0|||
149189850|NCT00492856|538166264|FG003|Induction|Withdrawal by Subject|0|||
149189851|NCT00492856|538166261|FG000|Induction|Death|3|||
148934125|NCT03633617|537244399|FG004|Part B|COVID-19 Restrictions|0|||
148934126|NCT03633617|537244400|FG005|Part B|COVID-19 Restrictions|0|||
148934127|NCT03633617|537244401|FG006|Part B|COVID-19 Restrictions|0|||
148934128|NCT03633617|537244402|FG007|Part B|COVID-19 Restrictions|0|||
148934129|NCT03633617|537244403|FG008|Part B|COVID-19 Restrictions|0|||
148934130|NCT03633617|537244404|FG009|Part B|COVID-19 Restrictions|0|||
148934131|NCT03633617|537244405|FG010|Part B|COVID-19 Restrictions|0|||
148934132|NCT03633617|537244395|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934133|NCT03633617|537244396|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934134|NCT03633617|537244397|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
148934135|NCT03633617|537244398|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934136|NCT03633617|537244399|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934137|NCT03633617|537244400|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934138|NCT03633617|537244401|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934139|NCT03633617|537244402|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934140|NCT03633617|537244403|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934141|NCT03633617|537244404|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934142|NCT03633617|537244405|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
148934143|NCT03633617|537244395|FG000|Part C (& Follow-up)|Adverse Event|0|||
148934144|NCT03633617|537244396|FG001|Part C (& Follow-up)|Adverse Event|0|||
148934145|NCT03633617|537244397|FG002|Part C (& Follow-up)|Adverse Event|0|||
148934146|NCT03633617|537244398|FG003|Part C (& Follow-up)|Adverse Event|0|||
148934147|NCT03633617|537244399|FG004|Part C (& Follow-up)|Adverse Event|0|||
148934148|NCT03633617|537244400|FG005|Part C (& Follow-up)|Adverse Event|1|||
148934149|NCT03633617|537244401|FG006|Part C (& Follow-up)|Adverse Event|0|||
148934150|NCT03633617|537244402|FG007|Part C (& Follow-up)|Adverse Event|1|||
148934151|NCT03633617|537244403|FG008|Part C (& Follow-up)|Adverse Event|0|||
148934152|NCT03633617|537244404|FG009|Part C (& Follow-up)|Adverse Event|0|||
148934153|NCT03633617|537244405|FG010|Part C (& Follow-up)|Adverse Event|0|||
148934154|NCT03633617|537244395|FG000|Part C (& Follow-up)|Pregnancy|0|||
148934155|NCT03633617|537244396|FG001|Part C (& Follow-up)|Pregnancy|0|||
148934156|NCT03633617|537244397|FG002|Part C (& Follow-up)|Pregnancy|0|||
148934157|NCT03633617|537244398|FG003|Part C (& Follow-up)|Pregnancy|0|||
148934158|NCT03633617|537244399|FG004|Part C (& Follow-up)|Pregnancy|0|||
148934159|NCT03633617|537244400|FG005|Part C (& Follow-up)|Pregnancy|0|||
148934160|NCT03633617|537244401|FG006|Part C (& Follow-up)|Pregnancy|0|||
148934161|NCT03633617|537244402|FG007|Part C (& Follow-up)|Pregnancy|0|||
148934162|NCT03633617|537244403|FG008|Part C (& Follow-up)|Pregnancy|0|||
148934163|NCT03633617|537244404|FG009|Part C (& Follow-up)|Pregnancy|1|||
148934164|NCT03633617|537244405|FG010|Part C (& Follow-up)|Pregnancy|0|||
148934165|NCT03633617|537244395|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
148934166|NCT03633617|537244396|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
148934167|NCT03633617|537244397|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
148934168|NCT03633617|537244398|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
148934169|NCT03633617|537244399|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
148934170|NCT03633617|537244400|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
148934171|NCT03633617|537244401|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
148934172|NCT03633617|537244402|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
148934173|NCT03633617|537244403|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
148934174|NCT03633617|537244404|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
148934175|NCT03633617|537244405|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
148934176|NCT03633617|537244395|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
148934177|NCT03633617|537244396|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
148934178|NCT03633617|537244397|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
149014354|NCT00708305|537532190|FG001|Period 3|Other Reason|0|||
149014355|NCT00708305|537532191|FG002|Period 3|Other Reason|0|||
148680103|NCT04380701|536302288|FG011|Overall Study|Withdrawal by Subject|1|||
148934179|NCT03633617|537244398|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
148934180|NCT03633617|537244399|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
148934181|NCT03633617|537244400|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
148934182|NCT03633617|537244401|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
148934183|NCT03633617|537244402|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
148934184|NCT03633617|537244403|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
148934185|NCT03633617|537244404|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
148934186|NCT03633617|537244405|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
148934187|NCT03633617|537244395|FG000|Part C (& Follow-up)|Physician Decision|0|||
148934188|NCT03633617|537244396|FG001|Part C (& Follow-up)|Physician Decision|0|||
148934189|NCT03633617|537244397|FG002|Part C (& Follow-up)|Physician Decision|0|||
149014356|NCT00708305|537532192|FG003|Period 3|Other Reason|0|||
149014357|NCT00192023|537532199|FG000|Period III - Double-Blind|Adverse Event|3|||
149189852|NCT00492856|538166262|FG001|Induction|Death|0|||
149189853|NCT00492856|538166263|FG002|Induction|Death|0|||
149189854|NCT00492856|538166264|FG003|Induction|Death|0|||
149189855|NCT00492856|538166261|FG000|Consolidation|Adverse Event|6|||
149189856|NCT00492856|538166262|FG001|Consolidation|Adverse Event|0|||
149189857|NCT00492856|538166263|FG002|Consolidation|Adverse Event|0|||
149189858|NCT00492856|538166264|FG003|Consolidation|Adverse Event|0|||
149189859|NCT00492856|538166261|FG000|Consolidation|Not protocol specified|2|||
149189860|NCT00492856|538166262|FG001|Consolidation|Not protocol specified|0|||
149189861|NCT00492856|538166263|FG002|Consolidation|Not protocol specified|0|||
149189862|NCT00492856|538166264|FG003|Consolidation|Not protocol specified|0|||
149189863|NCT00492856|538166261|FG000|Consolidation|Lost to Follow-up|1|||
149189864|NCT00492856|538166262|FG001|Consolidation|Lost to Follow-up|0|||
149189865|NCT00492856|538166263|FG002|Consolidation|Lost to Follow-up|0|||
149189866|NCT00492856|538166264|FG003|Consolidation|Lost to Follow-up|0|||
149189867|NCT00492856|538166261|FG000|Post-consolidation|Adverse Event|0|||
149189868|NCT00492856|538166262|FG001|Post-consolidation|Adverse Event|4|||
149189869|NCT00492856|538166263|FG002|Post-consolidation|Adverse Event|0|||
149189870|NCT00492856|538166264|FG003|Post-consolidation|Adverse Event|1|||
149189871|NCT00492856|538166261|FG000|Post-consolidation|Withdrawal by Subject|0|||
149189872|NCT00492856|538166262|FG001|Post-consolidation|Withdrawal by Subject|4|||
149189873|NCT00492856|538166263|FG002|Post-consolidation|Withdrawal by Subject|0|||
149189874|NCT00492856|538166264|FG003|Post-consolidation|Withdrawal by Subject|0|||
149189875|NCT00492856|538166261|FG000|Post-consolidation|Death|0|||
149189876|NCT00492856|538166262|FG001|Post-consolidation|Death|1|||
149189877|NCT00492856|538166263|FG002|Post-consolidation|Death|0|||
149189878|NCT00492856|538166264|FG003|Post-consolidation|Death|0|||
149189879|NCT00492856|538166261|FG000|Post-consolidation|Not protocol specified|0|||
149189880|NCT00492856|538166262|FG001|Post-consolidation|Not protocol specified|1|||
149189881|NCT00492856|538166263|FG002|Post-consolidation|Not protocol specified|0|||
149189882|NCT00492856|538166264|FG003|Post-consolidation|Not protocol specified|0|||
149189883|NCT00492856|538166261|FG000|Post-consolidation|Lost to Follow-up|0|||
149189884|NCT00492856|538166262|FG001|Post-consolidation|Lost to Follow-up|2|||
148680104|NCT04380701|536302289|FG012|Overall Study|Withdrawal by Subject|0|||
148680105|NCT04380701|536302290|FG013|Overall Study|Withdrawal by Subject|1|||
148680106|NCT04380701|536302291|FG014|Overall Study|Withdrawal by Subject|0|||
148680107|NCT04380701|536302292|FG015|Overall Study|Withdrawal by Subject|0|||
148680108|NCT04380701|536302293|FG016|Overall Study|Withdrawal by Subject|1|||
148680109|NCT04380701|536302294|FG017|Overall Study|Withdrawal by Subject|0|||
148680110|NCT04380701|536302295|FG018|Overall Study|Withdrawal by Subject|0|||
148680111|NCT04380701|536302296|FG019|Overall Study|Withdrawal by Subject|0|||
148680112|NCT04380701|536302297|FG020|Overall Study|Withdrawal by Subject|0|||
148680113|NCT04380701|536302298|FG021|Overall Study|Withdrawal by Subject|0|||
148680114|NCT04380701|536302299|FG022|Overall Study|Withdrawal by Subject|2|||
148680115|NCT04380701|536302300|FG023|Overall Study|Withdrawal by Subject|2|||
148680116|NCT04380701|536302301|FG024|Overall Study|Withdrawal by Subject|1|||
148680117|NCT04380701|536302302|FG025|Overall Study|Withdrawal by Subject|1|||
148680118|NCT04380701|536302303|FG026|Overall Study|Withdrawal by Subject|0|||
148680119|NCT04380701|536302304|FG027|Overall Study|Withdrawal by Subject|0|||
148680120|NCT04380701|536302305|FG028|Overall Study|Withdrawal by Subject|0|||
148680121|NCT04380701|536302306|FG029|Overall Study|Withdrawal by Subject|0|||
148680122|NCT04380701|536302307|FG030|Overall Study|Withdrawal by Subject|0|||
148680123|NCT04380701|536302308|FG031|Overall Study|Withdrawal by Subject|0|||
149189885|NCT00492856|538166263|FG002|Post-consolidation|Lost to Follow-up|0|||
148680124|NCT04380701|536302309|FG032|Overall Study|Withdrawal by Subject|0|||
149189886|NCT00492856|538166264|FG003|Post-consolidation|Lost to Follow-up|0|||
148680125|NCT04380701|536302310|FG033|Overall Study|Withdrawal by Subject|0|||
148680126|NCT04380701|536302277|FG000|Overall Study|Adverse Event|0|||
148934190|NCT03633617|537244398|FG003|Part C (& Follow-up)|Physician Decision|0|||
148934191|NCT03633617|537244399|FG004|Part C (& Follow-up)|Physician Decision|0|||
148934192|NCT03633617|537244400|FG005|Part C (& Follow-up)|Physician Decision|0|||
149014358|NCT00192023|537532200|FG001|Period III - Double-Blind|Adverse Event|0|||
149189887|NCT00492856|538166261|FG000|Post-consolidation|Observation Arm|0|||
149189888|NCT00492856|538166262|FG001|Post-consolidation|Observation Arm|0|||
149189889|NCT00492856|538166263|FG002|Post-consolidation|Observation Arm|27|||
149189890|NCT00492856|538166264|FG003|Post-consolidation|Observation Arm|0|||
149189891|NCT02245568|538166267|FG000|Overall Study|Study terminated by Sponsor|346|||
149189892|NCT02245568|538166267|FG000|Overall Study|Adverse Event|144|||
149189893|NCT02245568|538166267|FG000|Overall Study|Lack of Efficacy|98|||
149189894|NCT02245568|538166267|FG000|Overall Study|Withdrawal by Caregiver|85|||
149189895|NCT02245568|538166267|FG000|Overall Study|Withdrawal by Subject|77|||
149189896|NCT02245568|538166267|FG000|Overall Study|Withdrawal by Legal Representative|31|||
149189897|NCT02245568|538166267|FG000|Overall Study|Missing (Site closure)|16|||
149189898|NCT02245568|538166267|FG000|Overall Study|Physician Decision|14|||
149189899|NCT02245568|538166267|FG000|Overall Study|Non-compliance with study drug|11|||
149189900|NCT02245568|538166267|FG000|Overall Study|Death|9|||
149189901|NCT02245568|538166267|FG000|Overall Study|Blue staining|6|||
149189902|NCT02245568|538166267|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
149189903|NCT02245568|538166267|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
149189904|NCT02245568|538166267|FG000|Overall Study|Lost to Follow-up|5|||
149189905|NCT02044159|538166268|FG000|Overall Study|Consent declined (deferred consent)|2|||
149189906|NCT02044159|538166269|FG001|Overall Study|Consent declined (deferred consent)|4|||
149189907|NCT02044159|538166268|FG000|Overall Study|No longer eligible, drug not given|1|||
149189908|NCT02044159|538166269|FG001|Overall Study|No longer eligible, drug not given|0|||
149189909|NCT02044159|538166268|FG000|Overall Study|Nurse declined to give study drug|1|||
149189910|NCT02044159|538166269|FG001|Overall Study|Nurse declined to give study drug|0|||
149189911|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
149189912|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149189913|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149189914|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149189915|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
149189916|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
149189917|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149189918|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149189919|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149189920|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
149189921|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
149189922|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149189923|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149189924|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149189925|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
149189926|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
149189927|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149189928|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149189929|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149189930|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
149189931|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
149189932|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149189933|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
148807495|NCT01859741|536773265|FG000|Overall Study|Study Terminated by Sponsor|0|||
148807496|NCT01859741|536773266|FG001|Overall Study|Study Terminated by Sponsor|0|||
148807497|NCT01859741|536773267|FG002|Overall Study|Study Terminated by Sponsor|0|||
148807498|NCT01859741|536773268|FG003|Overall Study|Study Terminated by Sponsor|0|||
148807499|NCT01859741|536773269|FG004|Overall Study|Study Terminated by Sponsor|1|||
148807500|NCT01859741|536773270|FG005|Overall Study|Study Terminated by Sponsor|0|||
148807501|NCT01859741|536773271|FG006|Overall Study|Study Terminated by Sponsor|16|||
148807502|NCT01859741|536773272|FG007|Overall Study|Study Terminated by Sponsor|14|||
148807503|NCT01859741|536773265|FG000|Overall Study|Other|0|||
148807504|NCT01859741|536773266|FG001|Overall Study|Other|0|||
148807505|NCT01859741|536773267|FG002|Overall Study|Other|0|||
148807506|NCT01859741|536773268|FG003|Overall Study|Other|0|||
148807507|NCT01859741|536773269|FG004|Overall Study|Other|0|||
148807508|NCT01859741|536773270|FG005|Overall Study|Other|0|||
148807509|NCT01859741|536773271|FG006|Overall Study|Other|2|||
148807510|NCT01859741|536773272|FG007|Overall Study|Other|0|||
148807511|NCT03834350|536773278|FG000|Overall Study|Withdrawal by Subject|1|||
148807512|NCT02701634|536773279|FG000|Overall Study|Adverse Event|2|||
148807513|NCT02701634|536773280|FG001|Overall Study|Adverse Event|3|||
148807514|NCT02701634|536773279|FG000|Overall Study|Death|1|||
148807515|NCT02701634|536773280|FG001|Overall Study|Death|0|||
148807516|NCT02701634|536773279|FG000|Overall Study|Investigator's Discretion|7|||
148807517|NCT02701634|536773280|FG001|Overall Study|Investigator's Discretion|4|||
148807518|NCT02701634|536773279|FG000|Overall Study|Study terminated by Sponsor|15|||
148807519|NCT02701634|536773280|FG001|Overall Study|Study terminated by Sponsor|17|||
148934193|NCT03633617|537244401|FG006|Part C (& Follow-up)|Physician Decision|0|||
148934194|NCT03633617|537244402|FG007|Part C (& Follow-up)|Physician Decision|1|||
149189934|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149189935|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
149189936|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
149189937|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149189938|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149189939|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149189940|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
149189941|NCT01111539|538166270|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
148934195|NCT03633617|537244403|FG008|Part C (& Follow-up)|Physician Decision|0|||
149189942|NCT01111539|538166271|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149189943|NCT01111539|538166272|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149189944|NCT01111539|538166273|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149189945|NCT01111539|538166274|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
149189946|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149189947|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149189948|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
149189949|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
149189950|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
149189951|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149189952|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149189953|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
149189954|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
149189955|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
149189956|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
149189957|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
149189958|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
149189959|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
149189960|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
149189961|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149189962|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149189963|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149189964|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
149189965|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
149189966|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149189967|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
148807520|NCT02701634|536773279|FG000|Overall Study|Withdrew Consent|6|||
148807521|NCT02701634|536773280|FG001|Overall Study|Withdrew Consent|7|||
148807522|NCT02701634|536773279|FG000|Overall Study|Randomized but not treated|1|||
148807523|NCT02701634|536773280|FG001|Overall Study|Randomized but not treated|0|||
148807524|NCT00537277|536773281|FG000|Overall Study|Adverse Event|1|||
148807525|NCT00537277|536773281|FG000|Overall Study|Lack of Efficacy|2|||
148934196|NCT03633617|537244404|FG009|Part C (& Follow-up)|Physician Decision|0|||
148934197|NCT03633617|537244405|FG010|Part C (& Follow-up)|Physician Decision|1|||
148680127|NCT04380701|536302278|FG001|Overall Study|Adverse Event|0|||
148680128|NCT04380701|536302279|FG002|Overall Study|Adverse Event|0|||
148934198|NCT03633617|537244395|FG000|Part C (& Follow-up)|COVID-19 related|0|||
149189968|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149189969|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
149189970|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
149189971|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149189972|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149189973|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149189974|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
149189975|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
149189976|NCT01111539|538166270|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149189977|NCT01111539|538166271|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149189978|NCT01111539|538166272|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149189979|NCT01111539|538166273|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
149189980|NCT01111539|538166274|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
149189981|NCT03628417|538166275|FG000|Overall Study|Death|1|||
149189982|NCT03628417|538166276|FG001|Overall Study|Death|1|||
149189983|NCT05619172|538166280|FG000|Safety Cohort 1|Death|7|||
149189984|NCT05619172|538166281|FG001|Safety Cohort 1|Death|0|||
149189985|NCT05619172|538166280|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
149189986|NCT05619172|538166281|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
149189987|NCT05619172|538166280|FG000|Safety Cohort 2|Death|0|||
149189988|NCT05619172|538166281|FG001|Safety Cohort 2|Death|1|||
149189989|NCT05619172|538166280|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
149189990|NCT05619172|538166281|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
149189991|NCT00450372|538166283|FG000|Overall Study|Physician Decision|1|||
149189992|NCT00769704|538166284|FG000|Overall Study|Lost to Follow-up|3|||
149189993|NCT00769704|538166285|FG001|Overall Study|Lost to Follow-up|2|||
149189994|NCT00769704|538166284|FG000|Overall Study|Death|95|||
149189995|NCT00769704|538166285|FG001|Overall Study|Death|190|||
149189996|NCT00769704|538166284|FG000|Overall Study|Withdrawal by Subject|12|||
148680129|NCT04380701|536302280|FG003|Overall Study|Adverse Event|0|||
148934199|NCT03633617|537244396|FG001|Part C (& Follow-up)|COVID-19 related|0|||
148934200|NCT03633617|537244397|FG002|Part C (& Follow-up)|COVID-19 related|0|||
148934201|NCT03633617|537244398|FG003|Part C (& Follow-up)|COVID-19 related|0|||
148934202|NCT03633617|537244399|FG004|Part C (& Follow-up)|COVID-19 related|0|||
148934203|NCT03633617|537244400|FG005|Part C (& Follow-up)|COVID-19 related|1|||
148934204|NCT03633617|537244401|FG006|Part C (& Follow-up)|COVID-19 related|0|||
148934205|NCT03633617|537244402|FG007|Part C (& Follow-up)|COVID-19 related|0|||
148934206|NCT03633617|537244403|FG008|Part C (& Follow-up)|COVID-19 related|0|||
148934207|NCT03633617|537244404|FG009|Part C (& Follow-up)|COVID-19 related|0|||
148934208|NCT03633617|537244405|FG010|Part C (& Follow-up)|COVID-19 related|0|||
148934209|NCT03633617|537244395|FG000|Part C (& Follow-up)|Protocol Violation|0|||
148934210|NCT03633617|537244396|FG001|Part C (& Follow-up)|Protocol Violation|0|||
148934211|NCT03633617|537244397|FG002|Part C (& Follow-up)|Protocol Violation|0|||
148934212|NCT03633617|537244398|FG003|Part C (& Follow-up)|Protocol Violation|0|||
148934213|NCT03633617|537244399|FG004|Part C (& Follow-up)|Protocol Violation|0|||
148934214|NCT03633617|537244400|FG005|Part C (& Follow-up)|Protocol Violation|0|||
148934215|NCT03633617|537244401|FG006|Part C (& Follow-up)|Protocol Violation|0|||
148934216|NCT03633617|537244402|FG007|Part C (& Follow-up)|Protocol Violation|0|||
148934217|NCT03633617|537244403|FG008|Part C (& Follow-up)|Protocol Violation|0|||
148934218|NCT03633617|537244404|FG009|Part C (& Follow-up)|Protocol Violation|3|||
148934219|NCT03633617|537244405|FG010|Part C (& Follow-up)|Protocol Violation|1|||
148934220|NCT03633617|537244395|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
148934221|NCT03633617|537244396|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
148934222|NCT03633617|537244397|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
148934223|NCT03633617|537244398|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
148934224|NCT03633617|537244399|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
148934225|NCT03633617|537244400|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
148934226|NCT03633617|537244401|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
148934227|NCT03633617|537244402|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
148934228|NCT03633617|537244403|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
148934229|NCT03633617|537244404|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
148934230|NCT03633617|537244405|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
148934231|NCT00580970|537244408|FG000|Pre-treatment|Non-compliance|1|||
148934232|NCT00580970|537244408|FG000|Treatment (Lovastatin)|Non-compliance|6|||
148934233|NCT00580970|537244408|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
148934234|NCT00580970|537244408|FG000|Treatment (Lovastatin)|Physician Decision|4|||
148934235|NCT00580970|537244408|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
149189997|NCT00769704|538166285|FG001|Overall Study|Withdrawal by Subject|5|||
149189998|NCT00769704|538166284|FG000|Overall Study|Other|1|||
149189999|NCT00769704|538166285|FG001|Overall Study|Other|2|||
149190000|NCT05131451|538166286|FG000|Overall Study|Protocol Violation|1|||
148934236|NCT00580970|537244408|FG000|Treatment (Lovastatin)|Death|1|||
148934237|NCT03161093|537244409|FG000|Overall Study|Protocol Violation|11|||
148934238|NCT03161093|537244410|FG001|Overall Study|Protocol Violation|14|||
148934239|NCT03161093|537244411|FG002|Overall Study|Protocol Violation|6|||
149190001|NCT05131451|538166287|FG001|Overall Study|Protocol Violation|0|||
149190002|NCT01856595|538166295|FG000|Overall Study|Withdrawal by Subject|0|||
149190003|NCT01856595|538166296|FG001|Overall Study|Withdrawal by Subject|1|||
149190004|NCT01856595|538166297|FG002|Overall Study|Withdrawal by Subject|0|||
149190005|NCT01856595|538166298|FG003|Overall Study|Withdrawal by Subject|0|||
149190006|NCT01856595|538166299|FG004|Overall Study|Withdrawal by Subject|0|||
149190007|NCT01856595|538166300|FG005|Overall Study|Withdrawal by Subject|0|||
149190008|NCT01856595|538166301|FG006|Overall Study|Withdrawal by Subject|1|||
149190009|NCT01856595|538166302|FG007|Overall Study|Withdrawal by Subject|0|||
149190010|NCT01856595|538166303|FG008|Overall Study|Withdrawal by Subject|0|||
149190011|NCT04426825|538166304|FG000|Overall Study|Death|17|||
149190012|NCT04426825|538166304|FG000|Overall Study|Lost to Follow-up|1|||
149190013|NCT04426825|538166304|FG000|Overall Study|Study terminated by sponsor|5|||
149190014|NCT06150573|538166308|FG000|Overall Study|Did not meet study criteria|1|||
149190015|NCT06150573|538166309|FG001|Overall Study|Did not meet study criteria|0|||
149190016|NCT06150573|538166308|FG000|Overall Study|Adverse Event|1|||
149190017|NCT06150573|538166309|FG001|Overall Study|Adverse Event|0|||
149190018|NCT06150573|538166308|FG000|Overall Study|Lost to Follow-up|0|||
149190019|NCT06150573|538166309|FG001|Overall Study|Lost to Follow-up|1|||
149190020|NCT06150573|538166308|FG000|Overall Study|Protocol Violation|0|||
149190021|NCT06150573|538166309|FG001|Overall Study|Protocol Violation|1|||
149190022|NCT06150573|538166308|FG000|Overall Study|Withdrawal by Subject|2|||
149190023|NCT06150573|538166309|FG001|Overall Study|Withdrawal by Subject|0|||
149190024|NCT02284906|538166312|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149190025|NCT02284906|538166313|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
149190026|NCT02284906|538166314|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
149190027|NCT02284906|538166312|FG000|Overall Study|Major Protocol Deviation|0|||
149190028|NCT02284906|538166313|FG001|Overall Study|Major Protocol Deviation|1|||
149190029|NCT02284906|538166314|FG002|Overall Study|Major Protocol Deviation|0|||
149190030|NCT02284906|538166312|FG000|Overall Study|Voluntary Withdrawal|2|||
149190031|NCT02284906|538166313|FG001|Overall Study|Voluntary Withdrawal|4|||
149190032|NCT02284906|538166314|FG002|Overall Study|Voluntary Withdrawal|5|||
149190033|NCT02284906|538166312|FG000|Overall Study|Study Termination|0|||
149190034|NCT02284906|538166313|FG001|Overall Study|Study Termination|11|||
149190035|NCT02284906|538166314|FG002|Overall Study|Study Termination|14|||
149190036|NCT02284906|538166312|FG000|Overall Study|Reason not Specified|1|||
149190037|NCT02284906|538166313|FG001|Overall Study|Reason not Specified|1|||
148680130|NCT04380701|536302281|FG004|Overall Study|Adverse Event|0|||
148680131|NCT04380701|536302282|FG005|Overall Study|Adverse Event|1|||
148680132|NCT04380701|536302283|FG006|Overall Study|Adverse Event|0|||
148680133|NCT04380701|536302284|FG007|Overall Study|Adverse Event|0|||
148680134|NCT04380701|536302285|FG008|Overall Study|Adverse Event|0|||
148680135|NCT04380701|536302286|FG009|Overall Study|Adverse Event|0|||
148680136|NCT04380701|536302287|FG010|Overall Study|Adverse Event|0|||
148680137|NCT04380701|536302288|FG011|Overall Study|Adverse Event|0|||
149190038|NCT02284906|538166314|FG002|Overall Study|Reason not Specified|0|||
149190039|NCT01727713|538166317|FG000|Overall Study|Lost to Follow-up|5|||
148934240|NCT03161093|537244412|FG003|Overall Study|Protocol Violation|13|||
148934241|NCT03161093|537244413|FG004|Overall Study|Protocol Violation|1|||
149190040|NCT01727713|538166317|FG000|Overall Study|Adverse Event|10|||
149190041|NCT01727713|538166317|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
149190042|NCT01727713|538166317|FG000|Overall Study|Withdrawal by Subject|13|||
149190043|NCT01727713|538166317|FG000|Overall Study|Protocol Deviation|2|||
149190044|NCT01253044|538166320|FG000|Overall Study|Lost to Follow-up|38|||
149190045|NCT01253044|538166321|FG001|Overall Study|Lost to Follow-up|29|||
148680138|NCT04380701|536302289|FG012|Overall Study|Adverse Event|0|||
148680139|NCT04380701|536302290|FG013|Overall Study|Adverse Event|0|||
149190046|NCT03885726|538166322|FG000|Overall Study|Staffing issues/lost interest|1|||
148680140|NCT04380701|536302291|FG014|Overall Study|Adverse Event|0|||
148680141|NCT04380701|536302292|FG015|Overall Study|Adverse Event|1|||
148680142|NCT04380701|536302293|FG016|Overall Study|Adverse Event|0|||
148934242|NCT03161093|537244414|FG005|Overall Study|Protocol Violation|0|||
148934243|NCT03161093|537244409|FG000|Overall Study|Adverse Event|5|||
149190047|NCT03885726|538166322|FG000|Overall Study|Early discharge from hospital|3|||
149190048|NCT02868216|538166325|FG000|Overall Study|Death|0|||
149190049|NCT02868216|538166326|FG001|Overall Study|Death|1|||
149190050|NCT02868216|538166325|FG000|Overall Study|coronary artery bypass|1|||
149190051|NCT02868216|538166326|FG001|Overall Study|coronary artery bypass|0|||
149190052|NCT02868216|538166325|FG000|Overall Study|Withdrawal by Subject|7|||
149190053|NCT02868216|538166326|FG001|Overall Study|Withdrawal by Subject|5|||
149190054|NCT00987623|538166327|FG000|Overall Study|Lost to Follow-up|2|||
149190055|NCT00987623|538166328|FG001|Overall Study|Lost to Follow-up|1|||
149190056|NCT00987623|538166327|FG000|Overall Study|Time/job conflict|2|||
149190057|NCT00987623|538166328|FG001|Overall Study|Time/job conflict|0|||
149190058|NCT00987623|538166327|FG000|Overall Study|Discomfort|1|||
149190059|NCT00987623|538166328|FG001|Overall Study|Discomfort|0|||
149190060|NCT00987623|538166327|FG000|Overall Study|Biomicroscopy|0|||
149190061|NCT00987623|538166328|FG001|Overall Study|Biomicroscopy|1|||
149190062|NCT00987623|538166327|FG000|Overall Study|Influenza|0|||
149190063|NCT00987623|538166328|FG001|Overall Study|Influenza|1|||
149190064|NCT00850460|538166332|FG000|Overall Study|Lost to Follow-up|4|||
149190065|NCT00850460|538166333|FG001|Overall Study|Lost to Follow-up|4|||
149190066|NCT00988559|538166336|FG000|Overall Study|Withdrawal by Subject|1|||
149190067|NCT00988559|538166337|FG001|Overall Study|Withdrawal by Subject|1|||
149190068|NCT00988559|538166338|FG002|Overall Study|Withdrawal by Subject|0|||
149190069|NCT00988559|538166339|FG003|Overall Study|Withdrawal by Subject|1|||
149190070|NCT00988559|538166336|FG000|Overall Study|Pregnancy|0|||
149190071|NCT00988559|538166337|FG001|Overall Study|Pregnancy|1|||
149190072|NCT00988559|538166338|FG002|Overall Study|Pregnancy|1|||
149190073|NCT00988559|538166339|FG003|Overall Study|Pregnancy|0|||
149190074|NCT00988559|538166336|FG000|Overall Study|Lost to Follow-up|0|||
149190075|NCT00988559|538166337|FG001|Overall Study|Lost to Follow-up|0|||
149190076|NCT00988559|538166338|FG002|Overall Study|Lost to Follow-up|1|||
149190077|NCT00988559|538166339|FG003|Overall Study|Lost to Follow-up|0|||
149190078|NCT02224846|538166340|FG000|Period 1 (Month 3)|Adverse Event|2|||
149190079|NCT02224846|538166341|FG001|Period 1 (Month 3)|Adverse Event|1|||
149190080|NCT02224846|538166340|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
149190081|NCT02224846|538166341|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
149190082|NCT02224846|538166340|FG000|Period 1 (Month 3)|Protocol Violation|4|||
149190083|NCT02224846|538166341|FG001|Period 1 (Month 3)|Protocol Violation|8|||
149190084|NCT02224846|538166340|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
149190085|NCT02224846|538166341|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
149190086|NCT02224846|538166340|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
149190087|NCT02224846|538166341|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
149190088|NCT02224846|538166340|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
149190089|NCT02224846|538166341|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
149190090|NCT02224846|538166340|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
149190091|NCT02224846|538166341|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
149190092|NCT02224846|538166340|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
149190093|NCT02224846|538166341|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
149190094|NCT02224846|538166340|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
149190095|NCT02224846|538166341|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
149190096|NCT02224846|538166340|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
149190097|NCT02224846|538166341|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
149190098|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
149190099|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
149190100|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
149190101|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
149190102|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
149190103|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
149190104|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
149190105|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
149190106|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
149190107|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
149190108|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
149190109|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
149190110|NCT02224846|538166340|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
149190111|NCT02224846|538166341|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
149190112|NCT05372575|538166342|FG000|Overall Study|Protocol Violation|7|||
149190113|NCT05372575|538166343|FG001|Overall Study|Protocol Violation|16|||
149190114|NCT03196297|538166344|FG000|Main Period|Withdrawal by Subject|4|||
149190115|NCT03196297|538166344|FG000|Extension Period|Withdrawal by Subject|1|||
149190116|NCT03196297|538166344|FG000|Extension Period|Lack of Efficacy|2|||
149190117|NCT02538666|538166345|FG000|Pre-Treatment|Disease progression|1|||
149190118|NCT02538666|538166346|FG001|Pre-Treatment|Disease progression|0|||
149190119|NCT02538666|538166347|FG002|Pre-Treatment|Disease progression|0|||
149190120|NCT02538666|538166345|FG000|Pre-Treatment|no longer meets study criteria|1|||
148680143|NCT04380701|536302294|FG017|Overall Study|Adverse Event|0|||
148680144|NCT04380701|536302295|FG018|Overall Study|Adverse Event|0|||
148680145|NCT04380701|536302296|FG019|Overall Study|Adverse Event|1|||
149190121|NCT02538666|538166346|FG001|Pre-Treatment|no longer meets study criteria|0|||
149190122|NCT02538666|538166347|FG002|Pre-Treatment|no longer meets study criteria|0|||
149190123|NCT02538666|538166345|FG000|Pre-Treatment|Withdrew Consent|0|||
148680146|NCT04380701|536302297|FG020|Overall Study|Adverse Event|0|||
148807526|NCT00537277|536773281|FG000|Overall Study|Lost to Follow-up|12|||
149014359|NCT00192023|537532199|FG000|Period III - Double-Blind|Physician Decision|2|||
149190124|NCT02538666|538166346|FG001|Pre-Treatment|Withdrew Consent|1|||
149190125|NCT02538666|538166347|FG002|Pre-Treatment|Withdrew Consent|1|||
149190126|NCT02538666|538166345|FG000|Treatment|Disease progression|270|||
149190127|NCT02538666|538166346|FG001|Treatment|Disease progression|227|||
149190128|NCT02538666|538166347|FG002|Treatment|Disease progression|165|||
149190129|NCT02538666|538166345|FG000|Treatment|Study drug toxicity|1|||
149190130|NCT02538666|538166346|FG001|Treatment|Study drug toxicity|29|||
149190131|NCT02538666|538166347|FG002|Treatment|Study drug toxicity|92|||
149190132|NCT02538666|538166345|FG000|Treatment|Death|0|||
149190133|NCT02538666|538166346|FG001|Treatment|Death|2|||
149190134|NCT02538666|538166347|FG002|Treatment|Death|3|||
149190135|NCT02538666|538166345|FG000|Treatment|Adverse event unrelated to study drug|8|||
149190136|NCT02538666|538166346|FG001|Treatment|Adverse event unrelated to study drug|10|||
149190137|NCT02538666|538166347|FG002|Treatment|Adverse event unrelated to study drug|15|||
149190138|NCT02538666|538166345|FG000|Treatment|Participant request to discontinue study treatment|3|||
149190139|NCT02538666|538166346|FG001|Treatment|Participant request to discontinue study treatment|6|||
149190140|NCT02538666|538166347|FG002|Treatment|Participant request to discontinue study treatment|11|||
149190141|NCT02538666|538166345|FG000|Treatment|Participant withdrew consent|2|||
149190142|NCT02538666|538166346|FG001|Treatment|Participant withdrew consent|5|||
149190143|NCT02538666|538166347|FG002|Treatment|Participant withdrew consent|3|||
149190144|NCT02538666|538166345|FG000|Treatment|Lost to Follow-up|0|||
149190145|NCT02538666|538166346|FG001|Treatment|Lost to Follow-up|1|||
149190146|NCT02538666|538166347|FG002|Treatment|Lost to Follow-up|1|||
149190147|NCT02538666|538166345|FG000|Treatment|Maximum clinical benefit|4|||
149190148|NCT02538666|538166346|FG001|Treatment|Maximum clinical benefit|3|||
149190149|NCT02538666|538166347|FG002|Treatment|Maximum clinical benefit|4|||
149190150|NCT02538666|538166345|FG000|Treatment|Poor/non-compliance|0|||
149190151|NCT02538666|538166346|FG001|Treatment|Poor/non-compliance|1|||
149190152|NCT02538666|538166347|FG002|Treatment|Poor/non-compliance|0|||
149190153|NCT02538666|538166345|FG000|Treatment|Participant no longer meets study criteria|0|||
149190154|NCT02538666|538166346|FG001|Treatment|Participant no longer meets study criteria|2|||
149190155|NCT02538666|538166347|FG002|Treatment|Participant no longer meets study criteria|0|||
149190156|NCT02538666|538166345|FG000|Treatment|Administrative reason by sponsor|0|||
149190157|NCT02538666|538166346|FG001|Treatment|Administrative reason by sponsor|0|||
149190158|NCT02538666|538166347|FG002|Treatment|Administrative reason by sponsor|1|||
149190159|NCT02538666|538166345|FG000|Treatment|Other reasons|8|||
149190160|NCT02538666|538166346|FG001|Treatment|Other reasons|15|||
149190161|NCT02538666|538166347|FG002|Treatment|Other reasons|5|||
149190162|NCT02538666|538166345|FG000|Treatment|Not reported|2|||
149190163|NCT02538666|538166346|FG001|Treatment|Not reported|2|||
149190164|NCT02538666|538166347|FG002|Treatment|Not reported|2|||
149190165|NCT03510663|538166348|FG000|Overall Study|Withdrawal by Subject|0|||
149190166|NCT03510663|538166349|FG001|Overall Study|Withdrawal by Subject|1|||
149190167|NCT03510663|538166350|FG002|Overall Study|Withdrawal by Subject|0|||
149190168|NCT03510663|538166351|FG003|Overall Study|Withdrawal by Subject|0|||
149190169|NCT03510663|538166352|FG004|Overall Study|Withdrawal by Subject|0|||
149190170|NCT03510663|538166353|FG005|Overall Study|Withdrawal by Subject|0|||
149190171|NCT03510663|538166354|FG006|Overall Study|Withdrawal by Subject|0|||
149190172|NCT03510663|538166355|FG007|Overall Study|Withdrawal by Subject|0|||
149190173|NCT00320385|538166364|FG000|Overall Study|Lost to Follow-up|7|||
149190174|NCT00320385|538166365|FG001|Overall Study|Lost to Follow-up|10|||
149190175|NCT00320385|538166364|FG000|Overall Study|Withdrawal by Subject|6|||
149190176|NCT00320385|538166365|FG001|Overall Study|Withdrawal by Subject|7|||
149190177|NCT00320385|538166364|FG000|Overall Study|Sponsor Terminated Study|2|||
149190178|NCT00320385|538166365|FG001|Overall Study|Sponsor Terminated Study|1|||
149190179|NCT00320385|538166364|FG000|Overall Study|Investigator Decision|0|||
149190180|NCT00320385|538166365|FG001|Overall Study|Investigator Decision|1|||
149190181|NCT00320385|538166364|FG000|Overall Study|Death|1|||
149190182|NCT00320385|538166365|FG001|Overall Study|Death|2|||
149190183|NCT00320385|538166364|FG000|Overall Study|Serious Adverse Event|1|||
149190184|NCT00320385|538166365|FG001|Overall Study|Serious Adverse Event|0|||
149190185|NCT00320385|538166364|FG000|Overall Study|Withdrew Consent|1|||
149190186|NCT00320385|538166365|FG001|Overall Study|Withdrew Consent|0|||
149190187|NCT00320385|538166364|FG000|Overall Study|Adverse Event|0|||
149190188|NCT00320385|538166365|FG001|Overall Study|Adverse Event|1|||
149190189|NCT04370028|538166366|FG000|Overall Study|Withdrawal by Subject|695|||
149190190|NCT04370028|538166366|FG000|Overall Study|Protocol Violation|9|||
149190191|NCT04370028|538166366|FG000|Overall Study|Adverse Event|3|||
149190192|NCT00748540|538166374|FG000|Overall Study|Physician Decision|1|||
149190193|NCT04743635|538166375|FG000|Overall Study|Lost to Follow-up|2|||
149190194|NCT04743635|538166376|FG001|Overall Study|Lost to Follow-up|0|||
149190195|NCT01954121|538166377|FG000|Overall Study|Lack of Efficacy|94|||
149190196|NCT01954121|538166378|FG001|Overall Study|Lack of Efficacy|41|||
149190197|NCT01954121|538166377|FG000|Overall Study|Protocol Violation|0|||
149190198|NCT01954121|538166378|FG001|Overall Study|Protocol Violation|2|||
149190199|NCT01954121|538166377|FG000|Overall Study|Lost to Follow-up|5|||
149190200|NCT01954121|538166378|FG001|Overall Study|Lost to Follow-up|6|||
149190201|NCT01954121|538166377|FG000|Overall Study|Withdrawal by Subject|18|||
149190202|NCT01954121|538166378|FG001|Overall Study|Withdrawal by Subject|12|||
149190203|NCT01954121|538166377|FG000|Overall Study|Pregnancy|1|||
149190204|NCT01954121|538166378|FG001|Overall Study|Pregnancy|1|||
149190205|NCT01954121|538166377|FG000|Overall Study|AE, serious fatal|1|||
148680147|NCT04380701|536302298|FG021|Overall Study|Adverse Event|0|||
148680148|NCT04380701|536302299|FG022|Overall Study|Adverse Event|0|||
148680149|NCT04380701|536302300|FG023|Overall Study|Adverse Event|0|||
148680150|NCT04380701|536302301|FG024|Overall Study|Adverse Event|0|||
148680151|NCT04380701|536302302|FG025|Overall Study|Adverse Event|0|||
148680152|NCT04380701|536302303|FG026|Overall Study|Adverse Event|0|||
148680153|NCT04380701|536302304|FG027|Overall Study|Adverse Event|0|||
148680154|NCT04380701|536302305|FG028|Overall Study|Adverse Event|0|||
148680155|NCT04380701|536302306|FG029|Overall Study|Adverse Event|0|||
148680156|NCT04380701|536302307|FG030|Overall Study|Adverse Event|0|||
148680157|NCT04380701|536302308|FG031|Overall Study|Adverse Event|0|||
148680158|NCT04380701|536302309|FG032|Overall Study|Adverse Event|0|||
148680159|NCT04380701|536302310|FG033|Overall Study|Adverse Event|0|||
148680160|NCT04380701|536302277|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
148680161|NCT04380701|536302278|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
148680162|NCT04380701|536302279|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
148680163|NCT04380701|536302280|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
148680164|NCT04380701|536302281|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
148680165|NCT04380701|536302282|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
148680166|NCT04380701|536302283|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
148680167|NCT04380701|536302284|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
148680168|NCT04380701|536302285|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
148680169|NCT04380701|536302286|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
148680170|NCT04380701|536302287|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
148680171|NCT04380701|536302288|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
148680172|NCT04380701|536302289|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
148680173|NCT04380701|536302290|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
148680174|NCT04380701|536302291|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
148680175|NCT04380701|536302292|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
148680176|NCT04380701|536302293|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
148934244|NCT03161093|537244410|FG001|Overall Study|Adverse Event|21|||
149190206|NCT01954121|538166378|FG001|Overall Study|AE, serious fatal|0|||
148934245|NCT03161093|537244411|FG002|Overall Study|Adverse Event|16|||
148934246|NCT03161093|537244412|FG003|Overall Study|Adverse Event|35|||
148934247|NCT03161093|537244413|FG004|Overall Study|Adverse Event|2|||
148934248|NCT03161093|537244414|FG005|Overall Study|Adverse Event|1|||
148934249|NCT03161093|537244409|FG000|Overall Study|Lack of Efficacy|9|||
148934250|NCT03161093|537244410|FG001|Overall Study|Lack of Efficacy|13|||
149190207|NCT01954121|538166377|FG000|Overall Study|AE, non-serious non-fatal|5|||
149190208|NCT01954121|538166378|FG001|Overall Study|AE, non-serious non-fatal|22|||
149190209|NCT01954121|538166377|FG000|Overall Study|SAE, non-fatal|1|||
149190210|NCT01954121|538166378|FG001|Overall Study|SAE, non-fatal|4|||
149190211|NCT01954121|538166377|FG000|Overall Study|Non-compliant with study procedures|1|||
149190212|NCT01954121|538166378|FG001|Overall Study|Non-compliant with study procedures|0|||
149190213|NCT01954121|538166377|FG000|Overall Study|Non-compliant patient|1|||
149190214|NCT01954121|538166378|FG001|Overall Study|Non-compliant patient|1|||
149190215|NCT01954121|538166377|FG000|Overall Study|Subject did not follow instructions|0|||
149190216|NCT01954121|538166378|FG001|Overall Study|Subject did not follow instructions|2|||
149190217|NCT01465178|538166381|FG000|Overall Study|Withdrawal by Subject|1|||
149190218|NCT01465178|538166382|FG001|Overall Study|Withdrawal by Subject|0|||
149190219|NCT01096446|538168029|FG000|Overall Study|Death|1|||
149190220|NCT01096446|538168030|FG001|Overall Study|Death|0|||
149190221|NCT01096446|538168029|FG000|Overall Study|Protocol Violation|2|||
149190222|NCT01096446|538168030|FG001|Overall Study|Protocol Violation|0|||
149190223|NCT01520324|538168033|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
149190224|NCT01328249|538168034|FG000|Overall Study|Adverse Event|3|||
149190225|NCT01328249|538168035|FG001|Overall Study|Adverse Event|0|||
149190226|NCT01328249|538168034|FG000|Overall Study|Disease progression|1|||
149190227|NCT01328249|538168035|FG001|Overall Study|Disease progression|0|||
149190228|NCT01328249|538168034|FG000|Overall Study|Withdrawal by Subject|1|||
148680177|NCT04380701|536302294|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
148934251|NCT03161093|537244411|FG002|Overall Study|Lack of Efficacy|9|||
148934252|NCT03161093|537244412|FG003|Overall Study|Lack of Efficacy|24|||
148934253|NCT03161093|537244413|FG004|Overall Study|Lack of Efficacy|4|||
149190229|NCT01328249|538168035|FG001|Overall Study|Withdrawal by Subject|1|||
149190230|NCT01328249|538168034|FG000|Overall Study|Moved before end of treatment visit|1|||
149190231|NCT01328249|538168035|FG001|Overall Study|Moved before end of treatment visit|0|||
149190232|NCT01328249|538168034|FG000|Overall Study|Subject choice|1|||
149190233|NCT01328249|538168035|FG001|Overall Study|Subject choice|1|||
148680178|NCT04380701|536302295|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
148680179|NCT04380701|536302296|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
148934254|NCT03161093|537244414|FG005|Overall Study|Lack of Efficacy|1|||
148934255|NCT03161093|537244409|FG000|Overall Study|Physician Decision|0|||
148934256|NCT03161093|537244410|FG001|Overall Study|Physician Decision|1|||
148934257|NCT03161093|537244411|FG002|Overall Study|Physician Decision|0|||
149190234|NCT01328249|538168034|FG000|Overall Study|Protocol Violation|0|||
149190235|NCT01328249|538168035|FG001|Overall Study|Protocol Violation|1|||
149190236|NCT00748553|538168036|FG000|Overall Study|Adverse Event|0|||
149190237|NCT00748553|538168037|FG001|Overall Study|Adverse Event|1|||
149190238|NCT00748553|538168036|FG000|Overall Study|disease progression|2|||
149190239|NCT00748553|538168037|FG001|Overall Study|disease progression|0|||
149190240|NCT00748553|538168036|FG000|Overall Study|noncompliance|1|||
148680180|NCT04380701|536302297|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
148680181|NCT04380701|536302298|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
148680182|NCT04380701|536302299|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
148680183|NCT04380701|536302300|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
148680184|NCT04380701|536302301|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
148680185|NCT04380701|536302302|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
148680186|NCT04380701|536302303|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
148680187|NCT04380701|536302304|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
148680188|NCT04380701|536302305|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
148680189|NCT04380701|536302306|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
148680190|NCT04380701|536302307|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
148680191|NCT04380701|536302308|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
148680192|NCT04380701|536302309|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
148680193|NCT04380701|536302310|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
148680194|NCT04380701|536302277|FG000|Overall Study|Physician Decision|0|||
148680195|NCT04380701|536302278|FG001|Overall Study|Physician Decision|0|||
148680196|NCT04380701|536302279|FG002|Overall Study|Physician Decision|0|||
148680197|NCT04380701|536302280|FG003|Overall Study|Physician Decision|0|||
148680198|NCT04380701|536302281|FG004|Overall Study|Physician Decision|0|||
148680199|NCT04380701|536302282|FG005|Overall Study|Physician Decision|0|||
148680200|NCT04380701|536302283|FG006|Overall Study|Physician Decision|0|||
148680201|NCT04380701|536302284|FG007|Overall Study|Physician Decision|0|||
148680202|NCT04380701|536302285|FG008|Overall Study|Physician Decision|0|||
148680203|NCT04380701|536302286|FG009|Overall Study|Physician Decision|0|||
148680204|NCT04380701|536302287|FG010|Overall Study|Physician Decision|0|||
148680205|NCT04380701|536302288|FG011|Overall Study|Physician Decision|0|||
148680206|NCT04380701|536302289|FG012|Overall Study|Physician Decision|0|||
148680207|NCT04380701|536302290|FG013|Overall Study|Physician Decision|0|||
148680208|NCT04380701|536302291|FG014|Overall Study|Physician Decision|0|||
148680209|NCT04380701|536302292|FG015|Overall Study|Physician Decision|0|||
148680210|NCT04380701|536302293|FG016|Overall Study|Physician Decision|0|||
148680211|NCT04380701|536302294|FG017|Overall Study|Physician Decision|0|||
148680212|NCT04380701|536302295|FG018|Overall Study|Physician Decision|0|||
148680213|NCT04380701|536302296|FG019|Overall Study|Physician Decision|0|||
148680214|NCT04380701|536302297|FG020|Overall Study|Physician Decision|0|||
148680215|NCT04380701|536302298|FG021|Overall Study|Physician Decision|0|||
148680216|NCT04380701|536302299|FG022|Overall Study|Physician Decision|0|||
148680217|NCT04380701|536302300|FG023|Overall Study|Physician Decision|0|||
148680218|NCT04380701|536302301|FG024|Overall Study|Physician Decision|2|||
148680219|NCT04380701|536302302|FG025|Overall Study|Physician Decision|0|||
148680220|NCT04380701|536302303|FG026|Overall Study|Physician Decision|0|||
148680221|NCT04380701|536302304|FG027|Overall Study|Physician Decision|0|||
148680222|NCT04380701|536302305|FG028|Overall Study|Physician Decision|0|||
148680223|NCT04380701|536302306|FG029|Overall Study|Physician Decision|0|||
148680224|NCT04380701|536302307|FG030|Overall Study|Physician Decision|0|||
148680225|NCT04380701|536302308|FG031|Overall Study|Physician Decision|0|||
148680226|NCT04380701|536302309|FG032|Overall Study|Physician Decision|0|||
148680227|NCT04380701|536302310|FG033|Overall Study|Physician Decision|0|||
148680228|NCT04380701|536302277|FG000|Overall Study|Death|0|||
148680229|NCT04380701|536302278|FG001|Overall Study|Death|0|||
148680230|NCT04380701|536302279|FG002|Overall Study|Death|0|||
148680231|NCT04380701|536302280|FG003|Overall Study|Death|0|||
148934258|NCT03161093|537244412|FG003|Overall Study|Physician Decision|2|||
148934259|NCT03161093|537244413|FG004|Overall Study|Physician Decision|17|||
148934260|NCT03161093|537244414|FG005|Overall Study|Physician Decision|15|||
148934261|NCT03161093|537244409|FG000|Overall Study|Withdrawal by Subject|24|||
148934262|NCT03161093|537244410|FG001|Overall Study|Withdrawal by Subject|73|||
148934263|NCT03161093|537244411|FG002|Overall Study|Withdrawal by Subject|44|||
148934264|NCT03161093|537244412|FG003|Overall Study|Withdrawal by Subject|97|||
149190241|NCT00748553|538168037|FG001|Overall Study|noncompliance|0|||
148680232|NCT04380701|536302281|FG004|Overall Study|Death|0|||
148807527|NCT00537277|536773281|FG000|Overall Study|Protocol Violation|11|||
148807528|NCT00537277|536773281|FG000|Overall Study|Unclassified|4|||
148934265|NCT03161093|537244413|FG004|Overall Study|Withdrawal by Subject|11|||
149190242|NCT00948818|538168038|FG000|Overall Study|Adverse Event|10|||
149190243|NCT00948818|538168039|FG001|Overall Study|Adverse Event|32|||
148934266|NCT03161093|537244414|FG005|Overall Study|Withdrawal by Subject|10|||
148680233|NCT04380701|536302282|FG005|Overall Study|Death|0|||
148680234|NCT04380701|536302283|FG006|Overall Study|Death|0|||
148680235|NCT04380701|536302284|FG007|Overall Study|Death|0|||
148680236|NCT04380701|536302285|FG008|Overall Study|Death|0|||
148680237|NCT04380701|536302286|FG009|Overall Study|Death|0|||
148680238|NCT04380701|536302287|FG010|Overall Study|Death|0|||
148680239|NCT04380701|536302288|FG011|Overall Study|Death|0|||
148680240|NCT04380701|536302289|FG012|Overall Study|Death|0|||
148680241|NCT04380701|536302290|FG013|Overall Study|Death|0|||
148680242|NCT04380701|536302291|FG014|Overall Study|Death|0|||
148680243|NCT04380701|536302292|FG015|Overall Study|Death|0|||
148680244|NCT04380701|536302293|FG016|Overall Study|Death|0|||
148680245|NCT04380701|536302294|FG017|Overall Study|Death|0|||
148680246|NCT04380701|536302295|FG018|Overall Study|Death|0|||
148680247|NCT04380701|536302296|FG019|Overall Study|Death|0|||
148680248|NCT04380701|536302297|FG020|Overall Study|Death|0|||
148680249|NCT04380701|536302298|FG021|Overall Study|Death|0|||
148680250|NCT04380701|536302299|FG022|Overall Study|Death|0|||
148680251|NCT04380701|536302300|FG023|Overall Study|Death|0|||
148680252|NCT04380701|536302301|FG024|Overall Study|Death|1|||
148680253|NCT04380701|536302302|FG025|Overall Study|Death|0|||
148680254|NCT04380701|536302303|FG026|Overall Study|Death|0|||
148680255|NCT04380701|536302304|FG027|Overall Study|Death|0|||
148680256|NCT04380701|536302305|FG028|Overall Study|Death|0|||
148680257|NCT04380701|536302306|FG029|Overall Study|Death|0|||
148680258|NCT04380701|536302307|FG030|Overall Study|Death|0|||
148680259|NCT04380701|536302308|FG031|Overall Study|Death|0|||
148680260|NCT04380701|536302309|FG032|Overall Study|Death|0|||
148680261|NCT04380701|536302310|FG033|Overall Study|Death|0|||
148680262|NCT04380701|536302277|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680263|NCT04380701|536302278|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680264|NCT04380701|536302279|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680265|NCT04380701|536302280|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680266|NCT04380701|536302281|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680267|NCT04380701|536302282|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680268|NCT04380701|536302283|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680269|NCT04380701|536302284|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680270|NCT04380701|536302285|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680271|NCT04380701|536302286|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680272|NCT04380701|536302287|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680273|NCT04380701|536302288|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148934267|NCT03161093|537244409|FG000|Overall Study|Lost to Follow-up|3|||
148934268|NCT03161093|537244410|FG001|Overall Study|Lost to Follow-up|12|||
148934269|NCT03161093|537244411|FG002|Overall Study|Lost to Follow-up|4|||
148934270|NCT03161093|537244412|FG003|Overall Study|Lost to Follow-up|7|||
148934271|NCT03161093|537244413|FG004|Overall Study|Lost to Follow-up|8|||
148934272|NCT03161093|537244414|FG005|Overall Study|Lost to Follow-up|13|||
148934273|NCT03161093|537244409|FG000|Overall Study|Death|3|||
148934274|NCT03161093|537244410|FG001|Overall Study|Death|9|||
148934275|NCT03161093|537244411|FG002|Overall Study|Death|7|||
148934276|NCT03161093|537244412|FG003|Overall Study|Death|9|||
148934277|NCT03161093|537244413|FG004|Overall Study|Death|0|||
148934278|NCT03161093|537244414|FG005|Overall Study|Death|0|||
148934279|NCT03161093|537244409|FG000|Overall Study|Unknown - Not reported|0|||
148934280|NCT03161093|537244410|FG001|Overall Study|Unknown - Not reported|1|||
148934281|NCT03161093|537244411|FG002|Overall Study|Unknown - Not reported|0|||
148934282|NCT03161093|537244412|FG003|Overall Study|Unknown - Not reported|0|||
148934283|NCT03161093|537244413|FG004|Overall Study|Unknown - Not reported|0|||
148934284|NCT03161093|537244414|FG005|Overall Study|Unknown - Not reported|1|||
148934285|NCT00570765|537244415|FG000|DB Phase|Withdrawal by Subject|1|||
148934286|NCT00570765|537244416|FG001|DB Phase|Withdrawal by Subject|0|||
148934287|NCT00570765|537244417|FG002|DB Phase|Withdrawal by Subject|0|||
148934288|NCT00570765|537244418|FG003|DB Phase|Withdrawal by Subject|0|||
148934289|NCT00570765|537244415|FG000|DB Phase|Protocol Violation|0|||
148934290|NCT00570765|537244416|FG001|DB Phase|Protocol Violation|1|||
148934291|NCT00570765|537244417|FG002|DB Phase|Protocol Violation|0|||
148934292|NCT00570765|537244418|FG003|DB Phase|Protocol Violation|0|||
148934293|NCT00570765|537244415|FG000|DB Phase|Adverse Event|3|||
148934294|NCT00570765|537244416|FG001|DB Phase|Adverse Event|6|||
148680274|NCT04380701|536302289|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680275|NCT04380701|536302290|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680276|NCT04380701|536302291|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680277|NCT04380701|536302292|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148934295|NCT00570765|537244417|FG002|DB Phase|Adverse Event|0|||
148934296|NCT00570765|537244418|FG003|DB Phase|Adverse Event|0|||
148934297|NCT00570765|537244415|FG000|DB Phase|Did Not Receive Study Drug|0|||
148934298|NCT00570765|537244416|FG001|DB Phase|Did Not Receive Study Drug|0|||
148934299|NCT00570765|537244417|FG002|DB Phase|Did Not Receive Study Drug|1|||
148934300|NCT00570765|537244418|FG003|DB Phase|Did Not Receive Study Drug|0|||
148680278|NCT04380701|536302293|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148934301|NCT00570765|537244415|FG000|LTSE Phase|Withdrawal by Subject|0|||
148934302|NCT00570765|537244416|FG001|LTSE Phase|Withdrawal by Subject|0|||
148934303|NCT00570765|537244417|FG002|LTSE Phase|Withdrawal by Subject|0|||
149014360|NCT00192023|537532200|FG001|Period III - Double-Blind|Physician Decision|0|||
149014361|NCT00192023|537532199|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
149014362|NCT00192023|537532200|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
149014363|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
149014364|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
149014365|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
149014366|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
149014367|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
149014368|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
149014369|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
149014370|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
149014371|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
149014372|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
149014373|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
149190244|NCT00948818|538168038|FG000|Overall Study|Protocol Violation|9|||
149190245|NCT00948818|538168039|FG001|Overall Study|Protocol Violation|10|||
149190246|NCT00948818|538168038|FG000|Overall Study|Withdrawal by Subject|25|||
149190247|NCT00948818|538168039|FG001|Overall Study|Withdrawal by Subject|25|||
149190248|NCT00948818|538168038|FG000|Overall Study|Lost to Follow-up|10|||
149190249|NCT00948818|538168039|FG001|Overall Study|Lost to Follow-up|17|||
149014374|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
149014375|NCT00192023|537532199|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
149014376|NCT00192023|537532200|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
149014377|NCT00114634|537532201|FG000|Overall Study|failure to return forms|3|||
149014378|NCT00758160|537532209|FG000|Overall Study|No Longer Requires Study Medication|4|||
149014379|NCT00758160|537532209|FG000|Overall Study|Administration Problems|3|||
149014380|NCT00758160|537532209|FG000|Overall Study|Adverse Event|15|||
149014381|NCT00758160|537532209|FG000|Overall Study|Lack of Efficacy|10|||
149014382|NCT00758160|537532209|FG000|Overall Study|Lost to Follow-up|14|||
149014383|NCT00758160|537532209|FG000|Overall Study|Protocol Violation|12|||
149014384|NCT00758160|537532209|FG000|Overall Study|Withdrawal by Subject|8|||
149014385|NCT00545363|537532210|FG000|Overall Study|Adverse Event|6|||
149014386|NCT00545363|537532211|FG001|Overall Study|Adverse Event|7|||
149014387|NCT00545363|537532210|FG000|Overall Study|Withdrawal by Subject|6|||
149014388|NCT00545363|537532211|FG001|Overall Study|Withdrawal by Subject|5|||
149014389|NCT00545363|537532210|FG000|Overall Study|Non-compliance|3|||
149014390|NCT00545363|537532211|FG001|Overall Study|Non-compliance|1|||
149014391|NCT00545363|537532210|FG000|Overall Study|Did not meet entry criteria|1|||
149014392|NCT00545363|537532211|FG001|Overall Study|Did not meet entry criteria|1|||
149014393|NCT00545363|537532210|FG000|Overall Study|Lost to Follow-up|2|||
149014394|NCT00545363|537532211|FG001|Overall Study|Lost to Follow-up|0|||
149014395|NCT00545363|537532210|FG000|Overall Study|Other|1|||
149014396|NCT00545363|537532211|FG001|Overall Study|Other|1|||
149014397|NCT01018563|537532216|FG000|Overall Study|Termination of the study by Sponsor|2|||
149014398|NCT01018563|537532217|FG001|Overall Study|Termination of the study by Sponsor|1|||
149014399|NCT02344537|537532218|FG000|Overall Study|Protocol Violation|1|||
149014400|NCT02344537|537532219|FG001|Overall Study|Protocol Violation|1|||
149014401|NCT02344537|537532218|FG000|Overall Study|Subject started another treatment after wk 6|1|||
149014402|NCT02344537|537532219|FG001|Overall Study|Subject started another treatment after wk 6|0|||
149014403|NCT02344537|537532218|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
149014404|NCT02344537|537532219|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
149014405|NCT00960752|537532227|FG000|Overall Study|Adverse Event|0|||
149014406|NCT00960752|537532228|FG001|Overall Study|Adverse Event|0|||
149014407|NCT00960752|537532229|FG002|Overall Study|Adverse Event|1|||
149014408|NCT00960752|537532227|FG000|Overall Study|Progression|0|||
149014409|NCT00960752|537532228|FG001|Overall Study|Progression|0|||
149014410|NCT00960752|537532229|FG002|Overall Study|Progression|1|||
149014411|NCT05490329|537532230|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
149014412|NCT05490329|537532231|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
149014413|NCT05490329|537532230|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
149014414|NCT05490329|537532231|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
149014415|NCT05490329|537532230|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
149014416|NCT05490329|537532231|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
149014417|NCT00856661|537532232|FG000|Overall Study|Death|15|||
149014418|NCT00856661|537532233|FG001|Overall Study|Death|18|||
149014419|NCT00856661|537532232|FG000|Overall Study|Protocol Violation|2|||
149190250|NCT00948818|538168038|FG000|Overall Study|Lack of Efficacy|4|||
149190251|NCT00948818|538168039|FG001|Overall Study|Lack of Efficacy|5|||
149014420|NCT00856661|537532233|FG001|Overall Study|Protocol Violation|1|||
149014421|NCT00856661|537532232|FG000|Overall Study|Withdrawal by Subject|1|||
149014422|NCT00856661|537532233|FG001|Overall Study|Withdrawal by Subject|2|||
149014423|NCT00856661|537532232|FG000|Overall Study|Lost to Follow-up|1|||
149014424|NCT00856661|537532233|FG001|Overall Study|Lost to Follow-up|3|||
149190252|NCT00948818|538168038|FG000|Overall Study|Other Reason|4|||
148680279|NCT04380701|536302294|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148934304|NCT00570765|537244418|FG003|LTSE Phase|Withdrawal by Subject|1|||
148934305|NCT00570765|537244415|FG000|LTSE Phase|Adverse Event|0|||
148934306|NCT00570765|537244416|FG001|LTSE Phase|Adverse Event|0|||
148934307|NCT00570765|537244417|FG002|LTSE Phase|Adverse Event|0|||
148934308|NCT00570765|537244418|FG003|LTSE Phase|Adverse Event|7|||
148934309|NCT00570765|537244415|FG000|LTSE Phase|Physician Decision|0|||
148934310|NCT00570765|537244416|FG001|LTSE Phase|Physician Decision|0|||
148934311|NCT00570765|537244417|FG002|LTSE Phase|Physician Decision|0|||
148934312|NCT00570765|537244418|FG003|LTSE Phase|Physician Decision|4|||
148934313|NCT01031706|537244419|FG000|Overall Study|Adverse Event|1|||
148934314|NCT01031706|537244420|FG001|Overall Study|Adverse Event|0|||
148934315|NCT01031706|537244419|FG000|Overall Study|Withdrawal by Subject|1|||
148934316|NCT01031706|537244420|FG001|Overall Study|Withdrawal by Subject|1|||
148934317|NCT03114488|537244421|FG000|Time Period 2|Withdrawal by Subject|1|||
148934318|NCT03114488|537244422|FG001|Time Period 2|Withdrawal by Subject|3|||
148934319|NCT03711266|537244423|FG000|Overall Study|Lost to Follow-up|10|||
148934320|NCT01646073|537244424|FG000|Period A (12 Weeks)|Adverse Event|0|||
148934321|NCT01646073|537244425|FG001|Period A (12 Weeks)|Adverse Event|2|||
148934322|NCT01646073|537244424|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
148934323|NCT01646073|537244425|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
148934324|NCT01646073|537244424|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
148934325|NCT01646073|537244425|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
148934326|NCT01646073|537244424|FG000|Period A (12 Weeks)|Protocol Violation|0|||
148934327|NCT01646073|537244425|FG001|Period A (12 Weeks)|Protocol Violation|1|||
148934328|NCT01646073|537244424|FG000|Period A (12 Weeks)|Other|0|||
148934329|NCT01646073|537244425|FG001|Period A (12 Weeks)|Other|1|||
148934330|NCT01646073|537244424|FG000|Period B (12 Weeks)|Adverse Event|0|||
148934331|NCT01646073|537244425|FG001|Period B (12 Weeks)|Adverse Event|7|||
148934332|NCT01646073|537244424|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
148934333|NCT01646073|537244425|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
148934334|NCT01646073|537244424|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
148934335|NCT01646073|537244425|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
148934336|NCT00057876|537244428|FG000|Overall Study|Adverse Event|8|||
148934337|NCT00057876|537244429|FG001|Overall Study|Adverse Event|8|||
148934338|NCT00057876|537244428|FG000|Overall Study|Death|2|||
148934339|NCT00057876|537244429|FG001|Overall Study|Death|1|||
148934340|NCT00057876|537244428|FG000|Overall Study|Withdrawal by Subject|5|||
148934341|NCT00057876|537244429|FG001|Overall Study|Withdrawal by Subject|6|||
148934342|NCT00057876|537244428|FG000|Overall Study|Lack of Efficacy|10|||
148934343|NCT00057876|537244429|FG001|Overall Study|Lack of Efficacy|8|||
148934344|NCT00057876|537244428|FG000|Overall Study|Ineligible|1|||
148934345|NCT00057876|537244429|FG001|Overall Study|Ineligible|2|||
148934346|NCT00057876|537244428|FG000|Overall Study|other reason|2|||
148934347|NCT00057876|537244429|FG001|Overall Study|other reason|2|||
148934348|NCT00057876|537244428|FG000|Overall Study|other complicating disease|1|||
148934349|NCT00057876|537244429|FG001|Overall Study|other complicating disease|0|||
148934350|NCT05095454|537244430|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
148934351|NCT05095454|537244431|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
148934352|NCT00679055|537244432|FG000|Overall Study|Adverse Event|0|||
148934353|NCT00679055|537244433|FG001|Overall Study|Adverse Event|1|||
148934354|NCT00679055|537244432|FG000|Overall Study|Other|0|||
148934355|NCT00679055|537244433|FG001|Overall Study|Other|3|||
148934356|NCT00679055|537244432|FG000|Overall Study|Study Terminated|2|||
148934357|NCT00679055|537244433|FG001|Overall Study|Study Terminated|1|||
148934358|NCT01393301|537244434|FG000|Overall Study|Lost to Follow-up|5|||
148934359|NCT01393301|537244435|FG001|Overall Study|Lost to Follow-up|3|||
148934360|NCT01393301|537244434|FG000|Overall Study|Withdrawal by Subject|2|||
148934361|NCT01393301|537244435|FG001|Overall Study|Withdrawal by Subject|0|||
149014425|NCT00856661|537532232|FG000|Overall Study|Physician Judgement|8|||
149190253|NCT00948818|538168039|FG001|Overall Study|Other Reason|5|||
149190254|NCT00745368|538168040|FG000|Overall Study|Unable to provide sample|3|||
149190255|NCT02364947|538168041|FG000|Overall Study|Withdrawal by Subject|10|||
149190256|NCT02364947|538168042|FG001|Overall Study|Withdrawal by Subject|8|||
149190257|NCT02364947|538168043|FG002|Overall Study|Withdrawal by Subject|9|||
149190258|NCT02364947|538168041|FG000|Overall Study|Adverse Event|45|||
149190259|NCT02364947|538168042|FG001|Overall Study|Adverse Event|33|||
149190260|NCT02364947|538168043|FG002|Overall Study|Adverse Event|11|||
149190261|NCT02364947|538168041|FG000|Overall Study|Protocol Violation|1|||
149190262|NCT02364947|538168042|FG001|Overall Study|Protocol Violation|1|||
149190263|NCT02364947|538168043|FG002|Overall Study|Protocol Violation|1|||
149190264|NCT02364947|538168041|FG000|Overall Study|Physician Decision|3|||
149190265|NCT02364947|538168042|FG001|Overall Study|Physician Decision|2|||
148934362|NCT01393301|537244434|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
148934363|NCT01393301|537244435|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
148934364|NCT02758171|537244436|FG000|Wash-out|Withdrawal by Subject|1|||
148934365|NCT02758171|537244437|FG001|Wash-out|Withdrawal by Subject|0|||
148934366|NCT02758171|537244436|FG000|Wash-out|Other reason|1|||
149014426|NCT00856661|537532233|FG001|Overall Study|Physician Judgement|5|||
149014427|NCT03936777|537532234|FG000|Overall Study|Adverse Event|3|||
149014428|NCT03936777|537532234|FG000|Overall Study|Death|3|||
149014429|NCT03936777|537532234|FG000|Overall Study|Lack of Efficacy|24|||
149014430|NCT03936777|537532234|FG000|Overall Study|Lost to Follow-up|3|||
149014431|NCT03936777|537532234|FG000|Overall Study|Physician Decision|1|||
149014432|NCT03936777|537532234|FG000|Overall Study|Withdrawal by Subject|11|||
149014433|NCT03936777|537532234|FG000|Overall Study|Subjected Weaned of ZX008|1|||
149014434|NCT03936777|537532234|FG000|Overall Study|Missing|6|||
149014435|NCT02301156|537532235|FG000|Overall Study|Adverse Event|13|||
149190266|NCT02364947|538168043|FG002|Overall Study|Physician Decision|5|||
149190267|NCT02364947|538168041|FG000|Overall Study|Death|0|||
149190268|NCT02364947|538168042|FG001|Overall Study|Death|1|||
149190269|NCT02364947|538168043|FG002|Overall Study|Death|0|||
149190270|NCT00423085|538168044|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
149190271|NCT00423085|538168045|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
149190272|NCT00423085|538168046|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
148680280|NCT04380701|536302295|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680281|NCT04380701|536302296|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680282|NCT04380701|536302297|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680283|NCT04380701|536302298|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
148680284|NCT04380701|536302299|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
148680285|NCT04380701|536302300|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
148680286|NCT04380701|536302301|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
148680287|NCT04380701|536302302|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680288|NCT04380701|536302303|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680289|NCT04380701|536302304|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680290|NCT04380701|536302305|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680291|NCT04380701|536302306|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
149014436|NCT02301156|537532236|FG001|Overall Study|Adverse Event|14|||
149014437|NCT02301156|537532235|FG000|Overall Study|Death|1|||
149014438|NCT02301156|537532236|FG001|Overall Study|Death|5|||
149014439|NCT02301156|537532235|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
149014440|NCT02301156|537532236|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
149014441|NCT02301156|537532235|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
149014442|NCT02301156|537532236|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
149014443|NCT02301156|537532235|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
149190273|NCT00423085|538168047|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
149014444|NCT02301156|537532236|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
149014445|NCT02301156|537532235|FG000|Overall Study|Reason not Specified|6|||
149014446|NCT02301156|537532236|FG001|Overall Study|Reason not Specified|3|||
149014447|NCT02306122|537532239|FG000|Initial Physician Randomization|Physician Decision|0|||
149014448|NCT02306122|537532240|FG001|Initial Physician Randomization|Physician Decision|0|||
149014449|NCT02306122|537532241|FG002|Initial Physician Randomization|Physician Decision|0|||
149014450|NCT02306122|537532242|FG003|Initial Physician Randomization|Physician Decision|0|||
149014451|NCT02306122|537532243|FG004|Initial Physician Randomization|Physician Decision|0|||
149190274|NCT00423085|538168044|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
149190275|NCT00423085|538168045|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
149190276|NCT00423085|538168046|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
149014452|NCT02306122|537532244|FG005|Initial Physician Randomization|Physician Decision|0|||
149014453|NCT02306122|537532245|FG006|Initial Physician Randomization|Physician Decision|0|||
149014454|NCT02306122|537532246|FG007|Initial Physician Randomization|Physician Decision|0|||
149014455|NCT02306122|537532247|FG008|Initial Physician Randomization|Physician Decision|1|||
149014456|NCT02306122|537532248|FG009|Initial Physician Randomization|Physician Decision|0|||
149014457|NCT02306122|537532249|FG010|Initial Physician Randomization|Physician Decision|0|||
149014458|NCT02638623|537532254|FG000|Overall Study|Surgery timing|5|||
149014459|NCT02638623|537532255|FG001|Overall Study|Surgery timing|6|||
149014460|NCT02638623|537532254|FG000|Overall Study|Not given intervention|2|||
149014461|NCT02638623|537532255|FG001|Overall Study|Not given intervention|0|||
149014462|NCT00180713|537532256|FG000|Overall Study|Withdrawal by Subject|2|||
149014463|NCT00180713|537532257|FG001|Overall Study|Withdrawal by Subject|0|||
149014464|NCT00180713|537532256|FG000|Overall Study|Adverse Event|3|||
149014465|NCT00180713|537532257|FG001|Overall Study|Adverse Event|3|||
149014466|NCT05295732|537532262|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
149014467|NCT05295732|537532263|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
149014468|NCT05295732|537532264|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
149190277|NCT00423085|538168047|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
148680292|NCT04380701|536302307|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148934367|NCT02758171|537244437|FG001|Wash-out|Other reason|0|||
148934368|NCT00853073|537244438|FG000|Overall Study|Withdrawal by Subject|3|||
149014469|NCT05295732|537532265|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
149014470|NCT05295732|537532266|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
149014471|NCT05295732|537532262|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
149014472|NCT05295732|537532263|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
149014473|NCT05295732|537532264|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
149014474|NCT05295732|537532265|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
149014475|NCT05295732|537532266|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
149014476|NCT04152343|537532267|FG000|Overall Study|Transplanted|5|||
149014477|NCT04152343|537532267|FG000|Overall Study|Death|20|||
149014478|NCT04152343|537532267|FG000|Overall Study|Lost to Follow-up|3|||
149190278|NCT00423085|538168044|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
149190279|NCT00423085|538168045|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
149190280|NCT00423085|538168046|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
149190281|NCT00423085|538168047|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
149190282|NCT00423085|538168044|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
149190283|NCT00423085|538168045|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
149190284|NCT00423085|538168046|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
149190285|NCT00423085|538168047|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
149190286|NCT00423085|538168044|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
149190287|NCT00423085|538168045|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
149190288|NCT00423085|538168046|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
149190289|NCT00423085|538168047|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
149190290|NCT00423085|538168044|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
149190291|NCT00423085|538168045|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
149190292|NCT00423085|538168046|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
149190293|NCT00423085|538168047|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
149190294|NCT00423085|538168044|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
149190295|NCT00423085|538168045|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
149190296|NCT00423085|538168046|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
149190297|NCT00423085|538168047|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
149190298|NCT00423085|538168044|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
149190299|NCT00423085|538168045|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
149190300|NCT00423085|538168046|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
148934369|NCT00853073|537244439|FG001|Overall Study|Withdrawal by Subject|2|||
148934370|NCT01999114|537244440|FG000|Overall Study|Adverse Event|8|||
148934371|NCT01999114|537244441|FG001|Overall Study|Adverse Event|7|||
148934372|NCT01999114|537244442|FG002|Overall Study|Adverse Event|2|||
148934373|NCT01999114|537244443|FG003|Overall Study|Adverse Event|2|||
148934374|NCT01999114|537244444|FG004|Overall Study|Adverse Event|1|||
148934375|NCT01999114|537244440|FG000|Overall Study|Withdrawal by Subject|0|||
148934376|NCT01999114|537244441|FG001|Overall Study|Withdrawal by Subject|0|||
148934377|NCT01999114|537244442|FG002|Overall Study|Withdrawal by Subject|1|||
148934378|NCT01999114|537244443|FG003|Overall Study|Withdrawal by Subject|0|||
148934379|NCT01999114|537244444|FG004|Overall Study|Withdrawal by Subject|1|||
148934380|NCT01999114|537244440|FG000|Overall Study|Lost to Follow-up|0|||
148934381|NCT01999114|537244441|FG001|Overall Study|Lost to Follow-up|0|||
148934382|NCT01999114|537244442|FG002|Overall Study|Lost to Follow-up|1|||
148934383|NCT01999114|537244443|FG003|Overall Study|Lost to Follow-up|0|||
148934384|NCT01999114|537244444|FG004|Overall Study|Lost to Follow-up|0|||
148934385|NCT01999114|537244440|FG000|Overall Study|Administrative|0|||
148934386|NCT01999114|537244441|FG001|Overall Study|Administrative|0|||
148934387|NCT01999114|537244442|FG002|Overall Study|Administrative|1|||
148934388|NCT01999114|537244443|FG003|Overall Study|Administrative|1|||
148934389|NCT01999114|537244444|FG004|Overall Study|Administrative|2|||
148934390|NCT03342963|537244447|FG000|Overall Study|Adverse Event|1|||
148934391|NCT03342963|537244448|FG001|Overall Study|Adverse Event|2|||
148934392|NCT03342963|537244449|FG002|Overall Study|Adverse Event|0|||
148934393|NCT03342963|537244450|FG003|Overall Study|Adverse Event|0|||
148934394|NCT03342963|537244447|FG000|Overall Study|Withdrawal by Subject|1|||
148934395|NCT03342963|537244448|FG001|Overall Study|Withdrawal by Subject|0|||
148934396|NCT03342963|537244449|FG002|Overall Study|Withdrawal by Subject|0|||
148934397|NCT03342963|537244450|FG003|Overall Study|Withdrawal by Subject|0|||
148934398|NCT01008150|537244451|FG000|Overall Study|did not receive study drug|1|||
148934399|NCT01008150|537244452|FG001|Overall Study|did not receive study drug|1|||
148934400|NCT01008150|537244453|FG002|Overall Study|did not receive study drug|1|||
148934401|NCT01008150|537244454|FG003|Overall Study|did not receive study drug|0|||
148934402|NCT01309165|537244455|FG000|Overall Study|Lost to Follow-up|4|||
148934403|NCT01309165|537244456|FG001|Overall Study|Lost to Follow-up|3|||
149014479|NCT00550550|537532268|FG000|Overall Study|Adverse Event|13|||
149014480|NCT00550550|537532269|FG001|Overall Study|Adverse Event|5|||
148934404|NCT01309165|537244455|FG000|Overall Study|Return to work|1|||
148934405|NCT01309165|537244456|FG001|Overall Study|Return to work|2|||
148934406|NCT01309165|537244455|FG000|Overall Study|Left country|0|||
148934407|NCT01309165|537244456|FG001|Overall Study|Left country|1|||
148934408|NCT01309165|537244455|FG000|Overall Study|No transportation|0|||
148934409|NCT01309165|537244456|FG001|Overall Study|No transportation|1|||
148934410|NCT01309165|537244455|FG000|Overall Study|Admitted to hospital for second stroke|1|||
148934411|NCT01309165|537244456|FG001|Overall Study|Admitted to hospital for second stroke|0|||
148934412|NCT01739309|537244459|FG000|Overall Study|Adverse Event|1|||
148934413|NCT01739309|537244459|FG000|Overall Study|Withdrawal by Subject|1|||
148934414|NCT02787551|537244463|FG000|Core Period: 26 Weeks|Adverse Event|10|||
148934415|NCT02787551|537244464|FG001|Core Period: 26 Weeks|Adverse Event|0|||
148934416|NCT02787551|537244463|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
149014481|NCT00550550|537532268|FG000|Overall Study|Treatment Failure|0|||
149014482|NCT00550550|537532269|FG001|Overall Study|Treatment Failure|1|||
149014483|NCT00550550|537532268|FG000|Overall Study|Lost to Follow-up|4|||
149014484|NCT00550550|537532269|FG001|Overall Study|Lost to Follow-up|0|||
149014485|NCT00550550|537532268|FG000|Overall Study|Withdrawal by Subject|10|||
149014486|NCT00550550|537532269|FG001|Overall Study|Withdrawal by Subject|8|||
149014487|NCT00550550|537532268|FG000|Overall Study|Protocol Violation|5|||
149014488|NCT00550550|537532269|FG001|Overall Study|Protocol Violation|14|||
149014489|NCT00550550|537532268|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
148934417|NCT02787551|537244464|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
148934418|NCT02787551|537244463|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
148934419|NCT02787551|537244464|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
148934420|NCT02787551|537244463|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
148934421|NCT02787551|537244464|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
148934422|NCT02787551|537244463|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
148934423|NCT02787551|537244464|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
149014490|NCT00550550|537532269|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
149014491|NCT00550550|537532268|FG000|Overall Study|Randomized But Not Treated|1|||
149014492|NCT00550550|537532269|FG001|Overall Study|Randomized But Not Treated|0|||
149014493|NCT00118092|537532270|FG000|Overall Study|Withdrawal by Subject|1|||
149014494|NCT00118092|537532270|FG000|Overall Study|Protocol Violation|1|||
149190301|NCT00423085|538168047|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
149190302|NCT00423085|538168044|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
149190303|NCT00423085|538168045|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
148934424|NCT02787551|537244463|FG000|Core Period: 26 Weeks|Other than specified|3|||
148934425|NCT02787551|537244464|FG001|Core Period: 26 Weeks|Other than specified|1|||
148934426|NCT02787551|537244463|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
148934427|NCT02787551|537244464|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
148934428|NCT02787551|537244463|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
148934429|NCT02787551|537244464|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
148934430|NCT02787551|537244463|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
148934431|NCT02787551|537244464|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
148934432|NCT02906332|537244469|FG000|Overall Study|Withdrawal by Subject|1|||
148934433|NCT04176705|537244473|FG000|Overall Study|Withdrawal by Subject|4|||
149014495|NCT02459093|537532275|FG000|Overall Study|Protocol Violation|6|||
149014496|NCT02459093|537532276|FG001|Overall Study|Protocol Violation|11|||
149190304|NCT00423085|538168046|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
149190305|NCT00423085|538168047|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
149190306|NCT00423085|538168044|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
149190307|NCT00423085|538168045|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
149190308|NCT00423085|538168046|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
149190309|NCT00423085|538168047|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
149190310|NCT00423085|538168044|FG000|52-Week Open-Label Extension Phase|Death|0|||
149190311|NCT00423085|538168045|FG001|52-Week Open-Label Extension Phase|Death|0|||
149190312|NCT00423085|538168046|FG002|52-Week Open-Label Extension Phase|Death|0|||
149190313|NCT00423085|538168047|FG003|52-Week Open-Label Extension Phase|Death|2|||
149190314|NCT00441441|538168049|FG000|Overall Study|Adverse Event|2|||
149190315|NCT00441441|538168050|FG001|Overall Study|Adverse Event|1|||
149190316|NCT00441441|538168049|FG000|Overall Study|Protocol Violation|4|||
149190317|NCT00441441|538168050|FG001|Overall Study|Protocol Violation|6|||
149190318|NCT00441441|538168049|FG000|Overall Study|Exacerbation of asthma|1|||
149190319|NCT00441441|538168050|FG001|Overall Study|Exacerbation of asthma|2|||
149190320|NCT00441441|538168049|FG000|Overall Study|Withdrawal by Subject|1|||
149190321|NCT00441441|538168050|FG001|Overall Study|Withdrawal by Subject|2|||
149190322|NCT00441441|538168049|FG000|Overall Study|Other|3|||
149190323|NCT00441441|538168050|FG001|Overall Study|Other|3|||
149190324|NCT01725152|538168051|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
149190325|NCT01725152|538168052|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
149014497|NCT02459093|537532275|FG000|Overall Study|Lost to Follow-up|6|||
149190326|NCT01725152|538168051|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
149190327|NCT01725152|538168052|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
149014498|NCT02459093|537532276|FG001|Overall Study|Lost to Follow-up|7|||
149014499|NCT00591864|537532277|FG000|Overall Study|Incomplete Imaging|5|||
149190328|NCT01725152|538168051|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
149190329|NCT01725152|538168052|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
149190330|NCT01725152|538168051|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
149190331|NCT01725152|538168052|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
149190332|NCT02808312|538168055|FG000|Overall Study|Enrolled but Never Treated|0|||
149190333|NCT02808312|538168056|FG001|Overall Study|Enrolled but Never Treated|0|||
149190334|NCT02808312|538168057|FG002|Overall Study|Enrolled but Never Treated|1|||
149014500|NCT02090634|537532278|FG000|Overall Study|Lost to Follow-up|0|||
149014501|NCT02090634|537532279|FG001|Overall Study|Lost to Follow-up|1|||
149014502|NCT02090634|537532278|FG000|Overall Study|Death|0|||
149014503|NCT02090634|537532279|FG001|Overall Study|Death|1|||
149190335|NCT02808312|538168058|FG003|Overall Study|Enrolled but Never Treated|0|||
149190336|NCT02808312|538168059|FG004|Overall Study|Enrolled but Never Treated|0|||
149190337|NCT01826422|538168060|FG000|Overall Study|Withdrawal by Subject|1|||
149190338|NCT01826422|538168061|FG001|Overall Study|Withdrawal by Subject|3|||
149190339|NCT05151471|538168062|FG000|Overall Study|Adverse Event|21|||
148934434|NCT04176705|537244474|FG001|Overall Study|Withdrawal by Subject|4|||
148934435|NCT04176705|537244473|FG000|Overall Study|Death|1|||
148934436|NCT04176705|537244474|FG001|Overall Study|Death|1|||
148934437|NCT04176705|537244473|FG000|Overall Study|Lost to Follow-up|3|||
148934438|NCT04176705|537244474|FG001|Overall Study|Lost to Follow-up|3|||
148934439|NCT03805646|537244475|FG000|Overall Study|Death|40|||
148934440|NCT03805646|537244476|FG001|Overall Study|Death|49|||
148934441|NCT03805646|537244475|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
148934442|NCT03805646|537244476|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
148934443|NCT03673046|537246053|FG000|Overall Study|Adverse Event|1|||
148934444|NCT03673046|537246054|FG001|Overall Study|Adverse Event|1|||
148934445|NCT03673046|537246053|FG000|Overall Study|Withdrawal by Subject|8|||
148934446|NCT03673046|537246054|FG001|Overall Study|Withdrawal by Subject|2|||
148934447|NCT03817879|537246055|FG000|Overall Study|Drop out|5|||
148934448|NCT03817879|537246056|FG001|Overall Study|Drop out|12|||
148934449|NCT03817879|537246055|FG000|Overall Study|Withdrawal by Subject|0|||
148934450|NCT03817879|537246056|FG001|Overall Study|Withdrawal by Subject|1|||
148934451|NCT00385762|537246057|FG000|Overall Study|Adverse Event|1|||
148934452|NCT00385762|537246057|FG000|Overall Study|Lost to Follow-up|1|||
148934453|NCT02422303|537246058|FG000|Overall Study|Lost to Follow-up|1|||
148934454|NCT02422303|537246059|FG001|Overall Study|Lost to Follow-up|1|||
148934455|NCT00428792|537246061|FG000|Overall Study|Lack of Efficacy|1|||
148934456|NCT00428792|537246062|FG001|Overall Study|Lack of Efficacy|3|||
148934457|NCT00428792|537246061|FG000|Overall Study|Lost to Follow-up|0|||
148934458|NCT00428792|537246062|FG001|Overall Study|Lost to Follow-up|1|||
148934459|NCT00850343|537246063|FG000|Overall Study|Withdrawal by Subject|11|||
148934460|NCT00850343|537246064|FG001|Overall Study|Withdrawal by Subject|0|||
148934461|NCT00850343|537246065|FG002|Overall Study|Withdrawal by Subject|3|||
148934462|NCT00850343|537246066|FG003|Overall Study|Withdrawal by Subject|2|||
148934463|NCT00850343|537246063|FG000|Overall Study|Adverse Event|15|||
148934464|NCT00850343|537246064|FG001|Overall Study|Adverse Event|2|||
148934465|NCT00850343|537246065|FG002|Overall Study|Adverse Event|6|||
148934466|NCT00850343|537246066|FG003|Overall Study|Adverse Event|6|||
148934467|NCT00850343|537246063|FG000|Overall Study|Pregnancy|0|||
148934468|NCT00850343|537246064|FG001|Overall Study|Pregnancy|0|||
148934469|NCT00850343|537246065|FG002|Overall Study|Pregnancy|0|||
148934470|NCT00850343|537246066|FG003|Overall Study|Pregnancy|1|||
148934471|NCT00850343|537246063|FG000|Overall Study|Lack of Efficacy|17|||
148934472|NCT00850343|537246064|FG001|Overall Study|Lack of Efficacy|0|||
148934473|NCT00850343|537246065|FG002|Overall Study|Lack of Efficacy|3|||
148934474|NCT00850343|537246066|FG003|Overall Study|Lack of Efficacy|2|||
149014504|NCT02090634|537532278|FG000|Overall Study|Protocol Violation|3|||
149190340|NCT05151471|538168063|FG001|Overall Study|Adverse Event|16|||
149190341|NCT05151471|538168062|FG000|Overall Study|Death|1|||
149190342|NCT05151471|538168063|FG001|Overall Study|Death|0|||
148934475|NCT00850343|537246063|FG000|Overall Study|Non-compliance with Study Procedures|1|||
148934476|NCT00850343|537246064|FG001|Overall Study|Non-compliance with Study Procedures|0|||
148934477|NCT00850343|537246065|FG002|Overall Study|Non-compliance with Study Procedures|1|||
148934478|NCT00850343|537246066|FG003|Overall Study|Non-compliance with Study Procedures|1|||
148934479|NCT00850343|537246063|FG000|Overall Study|Physician Decision|2|||
148934480|NCT00850343|537246064|FG001|Overall Study|Physician Decision|1|||
148934481|NCT00850343|537246065|FG002|Overall Study|Physician Decision|1|||
148934482|NCT00850343|537246066|FG003|Overall Study|Physician Decision|1|||
148934483|NCT00371826|537246067|FG000|Core Phase (12 Months)|Adverse Event|15|||
148934484|NCT00371826|537246068|FG001|Core Phase (12 Months)|Adverse Event|4|||
149014505|NCT02090634|537532279|FG001|Overall Study|Protocol Violation|1|||
149014506|NCT02090634|537532278|FG000|Overall Study|Adverse Event|2|||
149014507|NCT02090634|537532279|FG001|Overall Study|Adverse Event|0|||
148934485|NCT00371826|537246069|FG002|Core Phase (12 Months)|Adverse Event|9|||
148934486|NCT00371826|537246067|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
148934487|NCT00371826|537246068|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
148934488|NCT00371826|537246069|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
148934489|NCT00371826|537246067|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
148934490|NCT00371826|537246068|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
148934491|NCT00371826|537246069|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
148934492|NCT00371826|537246067|FG000|Core Phase (12 Months)|Protocol Violation|1|||
148934493|NCT00371826|537246068|FG001|Core Phase (12 Months)|Protocol Violation|0|||
148934494|NCT00371826|537246069|FG002|Core Phase (12 Months)|Protocol Violation|1|||
148934495|NCT00371826|537246067|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
148934496|NCT00371826|537246068|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
148934497|NCT00371826|537246069|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
148934498|NCT00371826|537246067|FG000|Core Phase (12 Months)|Administrative problems|1|||
148934499|NCT00371826|537246068|FG001|Core Phase (12 Months)|Administrative problems|0|||
148934500|NCT00371826|537246069|FG002|Core Phase (12 Months)|Administrative problems|8|||
148934501|NCT00371826|537246067|FG000|Core Phase (12 Months)|Graft Loss|0|||
148934502|NCT00371826|537246068|FG001|Core Phase (12 Months)|Graft Loss|1|||
148934503|NCT00371826|537246069|FG002|Core Phase (12 Months)|Graft Loss|0|||
148934504|NCT00371826|537246067|FG000|Extension Phase (24 Months)|Adverse Event|4|||
148934505|NCT00371826|537246068|FG001|Extension Phase (24 Months)|Adverse Event|5|||
148934506|NCT00371826|537246069|FG002|Extension Phase (24 Months)|Adverse Event|0|||
148934507|NCT00371826|537246067|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
148934508|NCT00371826|537246068|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
148934509|NCT00371826|537246069|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
148934510|NCT00371826|537246067|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
148934511|NCT00371826|537246068|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
148934512|NCT00371826|537246069|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
148934513|NCT00371826|537246067|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
148934514|NCT00371826|537246068|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
148934515|NCT00371826|537246069|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
148934516|NCT00371826|537246067|FG000|Extension Phase (24 Months)|Administrative problems|0|||
148934517|NCT00371826|537246068|FG001|Extension Phase (24 Months)|Administrative problems|0|||
148934518|NCT00371826|537246069|FG002|Extension Phase (24 Months)|Administrative problems|2|||
148934519|NCT04612790|537246073|FG000|DB Period (Up to 36 Weeks)|Death|1|||
148934520|NCT04612790|537246074|FG001|DB Period (Up to 36 Weeks)|Death|1|||
148934521|NCT04612790|537246075|FG002|DB Period (Up to 36 Weeks)|Death|0|||
148934522|NCT04612790|537246076|FG003|DB Period (Up to 36 Weeks)|Death|0|||
148934523|NCT04612790|537246073|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
148934524|NCT04612790|537246074|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
148934525|NCT04612790|537246075|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
148934526|NCT04612790|537246076|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
148934527|NCT04612790|537246073|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
148934528|NCT04612790|537246074|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
148934529|NCT04612790|537246075|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
148934530|NCT04612790|537246076|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
148934531|NCT04612790|537246073|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
148934532|NCT04612790|537246074|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
148934533|NCT04612790|537246075|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
148934534|NCT04612790|537246076|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
148934535|NCT04612790|537246073|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
148934536|NCT04612790|537246074|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
148934537|NCT04612790|537246075|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
148934538|NCT04612790|537246076|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
148934539|NCT04612790|537246073|FG000|DB Period (Up to 36 Weeks)|Other|1|||
148934540|NCT04612790|537246074|FG001|DB Period (Up to 36 Weeks)|Other|0|||
148934541|NCT04612790|537246075|FG002|DB Period (Up to 36 Weeks)|Other|0|||
148934542|NCT04612790|537246076|FG003|DB Period (Up to 36 Weeks)|Other|0|||
148934543|NCT04612790|537246073|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
148934544|NCT04612790|537246074|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
148934545|NCT04612790|537246075|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
148934546|NCT04612790|537246076|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
148934547|NCT04612790|537246073|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
149014508|NCT01965938|537532280|FG000|Overall Study|Withdrawal by Subject|1|||
149014509|NCT01965938|537532281|FG001|Overall Study|Withdrawal by Subject|0|||
148934548|NCT04612790|537246074|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
148934549|NCT04612790|537246075|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
148934550|NCT04612790|537246076|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
149014510|NCT02736968|537532282|FG000|Overall Study|Lost to Follow-up|0|||
149190343|NCT05151471|538168062|FG000|Overall Study|Lost to Follow-up|0|||
149190344|NCT05151471|538168063|FG001|Overall Study|Lost to Follow-up|1|||
148934551|NCT04612790|537246073|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
148934552|NCT04612790|537246074|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
148934553|NCT04612790|537246075|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
148934554|NCT04612790|537246076|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
148934555|NCT04612790|537246073|FG000|OLE Period (Up to 1 Year)|Other|0|||
148934556|NCT04612790|537246074|FG001|OLE Period (Up to 1 Year)|Other|0|||
148934557|NCT04612790|537246075|FG002|OLE Period (Up to 1 Year)|Other|0|||
149014511|NCT02736968|537532283|FG001|Overall Study|Lost to Follow-up|0|||
149014512|NCT02736968|537532284|FG002|Overall Study|Lost to Follow-up|0|||
149014513|NCT02736968|537532285|FG003|Overall Study|Lost to Follow-up|0|||
149014514|NCT02736968|537532286|FG004|Overall Study|Lost to Follow-up|0|||
149014515|NCT02736968|537532287|FG005|Overall Study|Lost to Follow-up|0|||
149014516|NCT02736968|537532288|FG006|Overall Study|Lost to Follow-up|5|||
149014517|NCT02736968|537532289|FG007|Overall Study|Lost to Follow-up|2|||
148934558|NCT04612790|537246076|FG003|OLE Period (Up to 1 Year)|Other|1|||
149014518|NCT02736968|537532282|FG000|Overall Study|COVID-19 Pandemic|0|||
149014519|NCT02736968|537532283|FG001|Overall Study|COVID-19 Pandemic|0|||
149014520|NCT02736968|537532284|FG002|Overall Study|COVID-19 Pandemic|0|||
148934559|NCT02497612|537246077|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
148934560|NCT02497612|537246078|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
148934561|NCT02497612|537246079|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
148934562|NCT02497612|537246080|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
149014521|NCT02736968|537532285|FG003|Overall Study|COVID-19 Pandemic|0|||
149190345|NCT05151471|538168062|FG000|Overall Study|Withdrawal by Subject|7|||
148680293|NCT04380701|536302308|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680294|NCT04380701|536302309|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680295|NCT04380701|536302310|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
148680296|NCT01021137|536302312|FG000|Overall Study|Lost to Follow-up|9|||
148680297|NCT01021137|536302313|FG001|Overall Study|Lost to Follow-up|4|||
148680298|NCT01021137|536302314|FG002|Overall Study|Lost to Follow-up|2|||
148680299|NCT01021137|536302315|FG003|Overall Study|Lost to Follow-up|6|||
148680300|NCT01021137|536302312|FG000|Overall Study|Withdrawal by Subject|1|||
148680301|NCT01021137|536302313|FG001|Overall Study|Withdrawal by Subject|0|||
148680302|NCT01021137|536302314|FG002|Overall Study|Withdrawal by Subject|0|||
148680303|NCT01021137|536302315|FG003|Overall Study|Withdrawal by Subject|3|||
148680304|NCT03125915|536302325|FG000|1 Month Follow up|Lost to Follow-up|3|||
148680305|NCT03125915|536302326|FG001|1 Month Follow up|Lost to Follow-up|3|||
148680306|NCT03125915|536302327|FG002|1 Month Follow up|Lost to Follow-up|2|||
148680307|NCT03125915|536302328|FG003|1 Month Follow up|Lost to Follow-up|3|||
148680308|NCT03125915|536302325|FG000|3 Month Follow-up|Lost to Follow-up|6|||
148680309|NCT03125915|536302326|FG001|3 Month Follow-up|Lost to Follow-up|4|||
148680310|NCT03125915|536302327|FG002|3 Month Follow-up|Lost to Follow-up|4|||
148680311|NCT03125915|536302328|FG003|3 Month Follow-up|Lost to Follow-up|2|||
148680312|NCT03125915|536302325|FG000|6 Month Follow-up|Lost to Follow-up|7|||
148680313|NCT03125915|536302326|FG001|6 Month Follow-up|Lost to Follow-up|3|||
148680314|NCT03125915|536302327|FG002|6 Month Follow-up|Lost to Follow-up|6|||
148680315|NCT03125915|536302328|FG003|6 Month Follow-up|Lost to Follow-up|3|||
148680316|NCT02176642|536302333|FG000|Overall Study|Withdrawal by Subject|0|||
148680317|NCT02176642|536302334|FG001|Overall Study|Withdrawal by Subject|1|||
148680318|NCT00295620|536302336|FG000|Overall Study|Lost to Follow-up|9|||
148680319|NCT00295620|536302337|FG001|Overall Study|Lost to Follow-up|5|||
148680320|NCT00295620|536302336|FG000|Overall Study|Withdrawal by Subject|37|||
148680321|NCT00295620|536302337|FG001|Overall Study|Withdrawal by Subject|50|||
148680322|NCT00295620|536302336|FG000|Overall Study|Death|206|||
148680323|NCT00295620|536302337|FG001|Overall Study|Death|207|||
148680324|NCT00295620|536302336|FG000|Overall Study|Other reasons|10|||
148680325|NCT00295620|536302337|FG001|Overall Study|Other reasons|9|||
148680326|NCT00295620|536302336|FG000|Overall Study|Discontinuation by sponsor|580|||
148680327|NCT00295620|536302337|FG001|Overall Study|Discontinuation by sponsor|593|||
148680328|NCT00295620|536302336|FG000|Overall Study|Protocol Violation|30|||
148680329|NCT00295620|536302337|FG001|Overall Study|Protocol Violation|32|||
148680330|NCT01309828|536302338|FG000|Overall Study|Adverse Event|10|||
148680331|NCT01309828|536302339|FG001|Overall Study|Adverse Event|11|||
148680332|NCT01309828|536302338|FG000|Overall Study|Voluntary Withdrawal|5|||
148680333|NCT01309828|536302339|FG001|Overall Study|Voluntary Withdrawal|4|||
148680334|NCT01309828|536302338|FG000|Overall Study|Major Protocol Deviation|0|||
148680335|NCT01309828|536302339|FG001|Overall Study|Major Protocol Deviation|1|||
148680336|NCT01309828|536302338|FG000|Overall Study|Other|1|||
148680337|NCT01309828|536302339|FG001|Overall Study|Other|0|||
148680338|NCT00217971|536302340|FG000|Overall Study|Adverse Event|1|||
148680339|NCT00217971|536302341|FG001|Overall Study|Adverse Event|1|||
148680340|NCT00217971|536302340|FG000|Overall Study|Lost to Follow-up|15|||
148807529|NCT00537277|536773281|FG000|Overall Study|Inability to tolerate trial medication|4|||
148934563|NCT02497612|537246077|FG000|Overall Study|Participant's request|2|||
148934564|NCT02497612|537246078|FG001|Overall Study|Participant's request|3|||
148934565|NCT02497612|537246079|FG002|Overall Study|Participant's request|4|||
148934566|NCT02497612|537246080|FG003|Overall Study|Participant's request|1|||
149190346|NCT05151471|538168063|FG001|Overall Study|Withdrawal by Subject|9|||
148680341|NCT00217971|536302341|FG001|Overall Study|Lost to Follow-up|19|||
148680342|NCT00217971|536302340|FG000|Overall Study|Physician Decision|0|||
148680343|NCT00217971|536302341|FG001|Overall Study|Physician Decision|1|||
148680344|NCT00217971|536302340|FG000|Overall Study|Withdrawal by Subject|7|||
148680345|NCT00217971|536302341|FG001|Overall Study|Withdrawal by Subject|12|||
148680346|NCT00217971|536302340|FG000|Overall Study|non compliant|1|||
148680347|NCT00217971|536302341|FG001|Overall Study|non compliant|0|||
148680348|NCT02556632|536302342|FG000|Overall Study|Lost to Follow-up|1|||
148680349|NCT02556632|536302343|FG001|Overall Study|Lost to Follow-up|0|||
148680350|NCT02556632|536302344|FG002|Overall Study|Lost to Follow-up|0|||
148680351|NCT02556632|536302342|FG000|Overall Study|Disliked Intervention|1|||
148680352|NCT02556632|536302343|FG001|Overall Study|Disliked Intervention|1|||
148934567|NCT02497612|537246077|FG000|Overall Study|Investigator's judgement|1|||
148680353|NCT02556632|536302344|FG002|Overall Study|Disliked Intervention|1|||
148680354|NCT02556632|536302342|FG000|Overall Study|No Reason|1|||
148680355|NCT02556632|536302343|FG001|Overall Study|No Reason|0|||
148680356|NCT02556632|536302344|FG002|Overall Study|No Reason|1|||
148680357|NCT02556632|536302342|FG000|Overall Study|Personal Issues|0|||
148680358|NCT02556632|536302343|FG001|Overall Study|Personal Issues|1|||
148680359|NCT02556632|536302344|FG002|Overall Study|Personal Issues|1|||
148680360|NCT02556632|536302342|FG000|Overall Study|Changed Mind|0|||
148680361|NCT02556632|536302343|FG001|Overall Study|Changed Mind|1|||
148680362|NCT02556632|536302344|FG002|Overall Study|Changed Mind|0|||
148807530|NCT00537277|536773281|FG000|Overall Study|Non-compliance with trial procedures|15|||
148807531|NCT03620162|536773282|FG000|Overall Study|Physician Decision|4|||
148807532|NCT03620162|536773283|FG001|Overall Study|Physician Decision|0|||
148807533|NCT03620162|536773284|FG002|Overall Study|Physician Decision|1|||
148807534|NCT03620162|536773285|FG003|Overall Study|Physician Decision|0|||
148807535|NCT03620162|536773286|FG004|Overall Study|Physician Decision|2|||
148807536|NCT03620162|536773282|FG000|Overall Study|Lost to Follow-up|2|||
148807537|NCT03620162|536773283|FG001|Overall Study|Lost to Follow-up|6|||
148807538|NCT03620162|536773284|FG002|Overall Study|Lost to Follow-up|7|||
148807539|NCT03620162|536773285|FG003|Overall Study|Lost to Follow-up|3|||
148807540|NCT03620162|536773286|FG004|Overall Study|Lost to Follow-up|2|||
148807541|NCT03620162|536773282|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
148807542|NCT03620162|536773283|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
148807543|NCT03620162|536773284|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
148807544|NCT03620162|536773285|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
148807545|NCT03620162|536773286|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
148934568|NCT02497612|537246078|FG001|Overall Study|Investigator's judgement|0|||
148934569|NCT02497612|537246079|FG002|Overall Study|Investigator's judgement|0|||
148934570|NCT02497612|537246080|FG003|Overall Study|Investigator's judgement|2|||
148934571|NCT02497612|537246077|FG000|Overall Study|Adverse Event|3|||
148934572|NCT02497612|537246078|FG001|Overall Study|Adverse Event|1|||
148934573|NCT02497612|537246079|FG002|Overall Study|Adverse Event|4|||
148934574|NCT02497612|537246080|FG003|Overall Study|Adverse Event|1|||
148934575|NCT02497612|537246077|FG000|Overall Study|Lost to Follow-up|1|||
148934576|NCT02497612|537246078|FG001|Overall Study|Lost to Follow-up|1|||
148934577|NCT02497612|537246079|FG002|Overall Study|Lost to Follow-up|0|||
148934578|NCT02497612|537246080|FG003|Overall Study|Lost to Follow-up|1|||
148934579|NCT02497612|537246077|FG000|Overall Study|Other unspecified|1|||
148934580|NCT02497612|537246078|FG001|Overall Study|Other unspecified|1|||
148934581|NCT02497612|537246079|FG002|Overall Study|Other unspecified|2|||
148934582|NCT02497612|537246080|FG003|Overall Study|Other unspecified|0|||
148934583|NCT02497612|537246077|FG000|Overall Study|Not eligible|1|||
148934584|NCT02497612|537246078|FG001|Overall Study|Not eligible|0|||
148934585|NCT02497612|537246079|FG002|Overall Study|Not eligible|0|||
148934586|NCT02497612|537246080|FG003|Overall Study|Not eligible|1|||
148934587|NCT00004635|537246081|FG000|Period One|refused|2|||
148934588|NCT00004635|537246082|FG001|Period One|refused|1|||
148934589|NCT00004635|537246081|FG000|Period One|Withdrawal by Subject|1|||
148934590|NCT00004635|537246082|FG001|Period One|Withdrawal by Subject|1|||
148934591|NCT00004635|537246081|FG000|Period One|Protocol Violation|1|||
148934592|NCT00004635|537246082|FG001|Period One|Protocol Violation|0|||
148934593|NCT00004635|537246081|FG000|Period One|PSA did not go <5 ng/mL|1|||
148934594|NCT00004635|537246082|FG001|Period One|PSA did not go <5 ng/mL|0|||
148934595|NCT00004635|537246081|FG000|Period One|second malignancy|1|||
148934596|NCT00004635|537246082|FG001|Period One|second malignancy|0|||
148934597|NCT00004635|537246081|FG000|Period One|progressed|0|||
148934598|NCT00004635|537246082|FG001|Period One|progressed|2|||
148934599|NCT00004635|537246081|FG000|Period One|health problem|0|||
148934600|NCT00004635|537246082|FG001|Period One|health problem|1|||
148934601|NCT00004635|537246081|FG000|Period One|discrepancy in data entry|0|||
148934602|NCT00004635|537246082|FG001|Period One|discrepancy in data entry|1|||
148934603|NCT00004635|537246081|FG000|Period Two|progression|2|||
148934604|NCT00004635|537246082|FG001|Period Two|progression|3|||
148934605|NCT00004635|537246081|FG000|Period Two|Adverse Event|1|||
148934606|NCT00004635|537246082|FG001|Period Two|Adverse Event|0|||
148934607|NCT00004635|537246081|FG000|Period Two|refused|0|||
148934608|NCT00004635|537246082|FG001|Period Two|refused|2|||
148934609|NCT00004635|537246081|FG000|Period Two|health problem|1|||
148934610|NCT00004635|537246082|FG001|Period Two|health problem|1|||
148934611|NCT00004635|537246081|FG000|Period Two|travel issues|0|||
148934612|NCT00004635|537246082|FG001|Period Two|travel issues|1|||
148934613|NCT00004635|537246081|FG000|Period Two|secondary malignancy|1|||
148934614|NCT00004635|537246082|FG001|Period Two|secondary malignancy|1|||
148934615|NCT00004635|537246081|FG000|Period Two|Lost to Follow-up|1|||
148680363|NCT02556632|536302342|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
148680364|NCT02556632|536302343|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
148680365|NCT02556632|536302344|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
148680366|NCT02556632|536302342|FG000|Overall Study|Unrelated Adverse Event|1|||
148680367|NCT02556632|536302343|FG001|Overall Study|Unrelated Adverse Event|0|||
148680368|NCT02556632|536302344|FG002|Overall Study|Unrelated Adverse Event|3|||
148807546|NCT04009837|536773290|FG000|Overall Study|Withdrawal by Subject|5|||
148934616|NCT00004635|537246082|FG001|Period Two|Lost to Follow-up|0|||
148934617|NCT00004635|537246081|FG000|Period Two|discrepancy in data entry|0|||
148934618|NCT00004635|537246082|FG001|Period Two|discrepancy in data entry|1|||
148934619|NCT00408629|537246083|FG000|Overall Study|Adverse Event|13|||
148934620|NCT00408629|537246084|FG001|Overall Study|Adverse Event|27|||
148934621|NCT00408629|537246083|FG000|Overall Study|Withdrawal by Subject|8|||
148934622|NCT00408629|537246084|FG001|Overall Study|Withdrawal by Subject|4|||
148934623|NCT00408629|537246083|FG000|Overall Study|Lost to Follow-up|1|||
148934624|NCT00408629|537246084|FG001|Overall Study|Lost to Follow-up|1|||
148934625|NCT00408629|537246083|FG000|Overall Study|Lack of Efficacy|63|||
148934626|NCT00408629|537246084|FG001|Overall Study|Lack of Efficacy|73|||
148934627|NCT00408629|537246083|FG000|Overall Study|Protocol Violation|1|||
148934628|NCT00408629|537246084|FG001|Overall Study|Protocol Violation|5|||
149014522|NCT02736968|537532286|FG004|Overall Study|COVID-19 Pandemic|0|||
149014523|NCT02736968|537532287|FG005|Overall Study|COVID-19 Pandemic|0|||
149014524|NCT02736968|537532288|FG006|Overall Study|COVID-19 Pandemic|2|||
149014525|NCT02736968|537532289|FG007|Overall Study|COVID-19 Pandemic|0|||
149014526|NCT02736968|537532282|FG000|Overall Study|Withdrawal by Subject|0|||
149014527|NCT02736968|537532283|FG001|Overall Study|Withdrawal by Subject|0|||
149014528|NCT02736968|537532284|FG002|Overall Study|Withdrawal by Subject|0|||
149014529|NCT02736968|537532285|FG003|Overall Study|Withdrawal by Subject|0|||
149014530|NCT02736968|537532286|FG004|Overall Study|Withdrawal by Subject|0|||
149014531|NCT02736968|537532287|FG005|Overall Study|Withdrawal by Subject|0|||
149014532|NCT02736968|537532288|FG006|Overall Study|Withdrawal by Subject|1|||
149014533|NCT02736968|537532289|FG007|Overall Study|Withdrawal by Subject|0|||
149014534|NCT03311230|537532293|FG000|Overall Study|Withdrawal by Subject|1|||
149014535|NCT03311230|537532294|FG001|Overall Study|Withdrawal by Subject|4|||
149014536|NCT03311230|537532295|FG002|Overall Study|Withdrawal by Subject|2|||
149014537|NCT03311230|537532296|FG003|Overall Study|Withdrawal by Subject|7|||
149014538|NCT03311230|537532293|FG000|Overall Study|Unrelated injury|0|||
149014539|NCT03311230|537532294|FG001|Overall Study|Unrelated injury|1|||
149014540|NCT03311230|537532295|FG002|Overall Study|Unrelated injury|0|||
149014541|NCT03311230|537532296|FG003|Overall Study|Unrelated injury|0|||
149014542|NCT01302938|537532297|FG000|Overall Study|Withdrawal by Subject|1|||
149014543|NCT01302938|537532298|FG001|Overall Study|Withdrawal by Subject|0|||
149014544|NCT01302938|537532297|FG000|Overall Study|Adverse Event|1|||
149014545|NCT01302938|537532298|FG001|Overall Study|Adverse Event|0|||
149014546|NCT03342053|537532299|FG000|Overall Study|Adverse Event|2|||
149014547|NCT03342053|537532300|FG001|Overall Study|Adverse Event|0|||
149014548|NCT03342053|537532299|FG000|Overall Study|Withdrawal by Subject|0|||
149014549|NCT03342053|537532300|FG001|Overall Study|Withdrawal by Subject|1|||
149014550|NCT00171873|537532303|FG000|Overall Study|Withdrawal by Subject|4|||
149014551|NCT00171873|537532304|FG001|Overall Study|Withdrawal by Subject|2|||
149014552|NCT00171873|537532303|FG000|Overall Study|Adverse Event|5|||
149014553|NCT00171873|537532304|FG001|Overall Study|Adverse Event|0|||
149014554|NCT00171873|537532303|FG000|Overall Study|Switched to Octreotide|0|||
149014555|NCT00171873|537532304|FG001|Overall Study|Switched to Octreotide|1|||
149014556|NCT02041923|537532305|FG000|Overall Study|Lost to Follow-up|26|||
148934629|NCT00408629|537246083|FG000|Overall Study|Miscellaneous|11|||
148934630|NCT00408629|537246084|FG001|Overall Study|Miscellaneous|15|||
149014557|NCT02041923|537532306|FG001|Overall Study|Lost to Follow-up|30|||
149014558|NCT00381641|537532307|FG000|Overall Study|Withdrawal by Subject|0|||
149014559|NCT00381641|537532308|FG001|Overall Study|Withdrawal by Subject|2|||
149014560|NCT04249336|537534268|FG000|Overall Study|Lost to Follow-up|3|||
149014561|NCT04249336|537534269|FG001|Overall Study|Lost to Follow-up|3|||
149014562|NCT04249336|537534270|FG002|Overall Study|Lost to Follow-up|3|||
149014563|NCT04249336|537534271|FG003|Overall Study|Lost to Follow-up|3|||
149014564|NCT01242176|537534272|FG000|Washout Period of 7 Days|Adverse Event|0|||
148680369|NCT02556632|536302342|FG000|Overall Study|Related Adverse Event|0|||
148680370|NCT02556632|536302343|FG001|Overall Study|Related Adverse Event|1|||
148680371|NCT02556632|536302344|FG002|Overall Study|Related Adverse Event|0|||
148680372|NCT02556632|536302342|FG000|Overall Study|Possibly Related Adverse Event|0|||
148680373|NCT02556632|536302343|FG001|Overall Study|Possibly Related Adverse Event|0|||
148680374|NCT02556632|536302344|FG002|Overall Study|Possibly Related Adverse Event|1|||
148680375|NCT02556632|536302342|FG000|Overall Study|Did Not Start RT|0|||
148680376|NCT02556632|536302343|FG001|Overall Study|Did Not Start RT|1|||
148680377|NCT02556632|536302344|FG002|Overall Study|Did Not Start RT|0|||
148680378|NCT02556632|536302342|FG000|Overall Study|Ineligible|0|||
148680379|NCT02556632|536302343|FG001|Overall Study|Ineligible|1|||
148680380|NCT02556632|536302344|FG002|Overall Study|Ineligible|0|||
148680381|NCT02556632|536302342|FG000|Overall Study|Disliked Study Procedures|0|||
148680382|NCT02556632|536302343|FG001|Overall Study|Disliked Study Procedures|0|||
148680383|NCT02556632|536302344|FG002|Overall Study|Disliked Study Procedures|1|||
148680384|NCT02556632|536302342|FG000|Overall Study|Treatment or Change Delay|0|||
148680385|NCT02556632|536302343|FG001|Overall Study|Treatment or Change Delay|0|||
148680386|NCT02556632|536302344|FG002|Overall Study|Treatment or Change Delay|1|||
148680387|NCT00808015|536302347|FG000|Overall Study|Death|1|||
148680388|NCT00808015|536302347|FG000|Overall Study|Lack of Efficacy|58|||
148680389|NCT00808015|536302347|FG000|Overall Study|Lost to Follow-up|76|||
148680390|NCT00808015|536302347|FG000|Overall Study|Participants not willing to participate|158|||
148680391|NCT00808015|536302347|FG000|Overall Study|Adverse Event|22|||
148680392|NCT00808015|536302347|FG000|Overall Study|Other|25|||
148680393|NCT00808015|536302347|FG000|Overall Study|Enrolled but not treated|4|||
148680394|NCT00084617|536302357|FG000|Overall Study|Withdrawal by Subject|7|||
148680395|NCT00084617|536302357|FG000|Overall Study|Lack of Efficacy|1|||
148680396|NCT00084617|536302357|FG000|Overall Study|Protocol Violation|1|||
148680397|NCT01625286|536302358|FG000|Overall Study|Adverse Event|0|||
148680398|NCT01625286|536302359|FG001|Overall Study|Adverse Event|0|||
148680399|NCT01625286|536302360|FG002|Overall Study|Adverse Event|0|||
148680400|NCT01625286|536302361|FG003|Overall Study|Adverse Event|0|||
148680401|NCT01625286|536302362|FG004|Overall Study|Adverse Event|1|||
148680402|NCT01625286|536302363|FG005|Overall Study|Adverse Event|2|||
148680403|NCT01625286|536302364|FG006|Overall Study|Adverse Event|1|||
148680404|NCT01625286|536302358|FG000|Overall Study|Death|0|||
148680405|NCT01625286|536302359|FG001|Overall Study|Death|0|||
148680406|NCT01625286|536302360|FG002|Overall Study|Death|1|||
148680407|NCT01625286|536302361|FG003|Overall Study|Death|1|||
148680408|NCT01625286|536302362|FG004|Overall Study|Death|0|||
148680409|NCT01625286|536302363|FG005|Overall Study|Death|11|||
148680410|NCT01625286|536302364|FG006|Overall Study|Death|16|||
148680411|NCT01625286|536302358|FG000|Overall Study|Withdrawal by Subject|0|||
148680412|NCT01625286|536302359|FG001|Overall Study|Withdrawal by Subject|1|||
148680413|NCT01625286|536302360|FG002|Overall Study|Withdrawal by Subject|0|||
148680414|NCT01625286|536302361|FG003|Overall Study|Withdrawal by Subject|1|||
148680415|NCT01625286|536302362|FG004|Overall Study|Withdrawal by Subject|0|||
148680416|NCT01625286|536302363|FG005|Overall Study|Withdrawal by Subject|0|||
148680417|NCT01625286|536302364|FG006|Overall Study|Withdrawal by Subject|1|||
148680418|NCT01625286|536302358|FG000|Overall Study|Any reason not specifically recorded|0|||
148680419|NCT01625286|536302359|FG001|Overall Study|Any reason not specifically recorded|0|||
148680420|NCT01625286|536302360|FG002|Overall Study|Any reason not specifically recorded|0|||
148680421|NCT01625286|536302361|FG003|Overall Study|Any reason not specifically recorded|0|||
148680422|NCT01625286|536302362|FG004|Overall Study|Any reason not specifically recorded|0|||
148680423|NCT01625286|536302363|FG005|Overall Study|Any reason not specifically recorded|1|||
148680424|NCT01625286|536302364|FG006|Overall Study|Any reason not specifically recorded|0|||
148680425|NCT01625286|536302358|FG000|Overall Study|Progressive disease|6|||
148680426|NCT01625286|536302359|FG001|Overall Study|Progressive disease|3|||
148680427|NCT01625286|536302360|FG002|Overall Study|Progressive disease|4|||
148934631|NCT00191906|537246085|FG000|Study Period II|Adverse Event|0|||
148934632|NCT00191906|537246086|FG001|Study Period II|Adverse Event|1|||
148934633|NCT00191906|537246087|FG002|Study Period II|Adverse Event|0|||
148934634|NCT00191906|537246088|FG003|Study Period II|Adverse Event|0|||
148934635|NCT00191906|537246085|FG000|Study Period II|Withdrawal by Subject|0|||
148934636|NCT00191906|537246086|FG001|Study Period II|Withdrawal by Subject|3|||
148934637|NCT00191906|537246087|FG002|Study Period II|Withdrawal by Subject|0|||
148680428|NCT01625286|536302361|FG003|Overall Study|Progressive disease|5|||
148680429|NCT01625286|536302362|FG004|Overall Study|Progressive disease|5|||
148680430|NCT01625286|536302363|FG005|Overall Study|Progressive disease|0|||
148680431|NCT01625286|536302364|FG006|Overall Study|Progressive disease|0|||
148680432|NCT01625286|536302358|FG000|Overall Study|Lost to Follow-up|0|||
148680433|NCT01625286|536302359|FG001|Overall Study|Lost to Follow-up|0|||
148680434|NCT01625286|536302360|FG002|Overall Study|Lost to Follow-up|0|||
148680435|NCT01625286|536302361|FG003|Overall Study|Lost to Follow-up|0|||
148680436|NCT01625286|536302362|FG004|Overall Study|Lost to Follow-up|0|||
148680437|NCT01625286|536302363|FG005|Overall Study|Lost to Follow-up|0|||
148680438|NCT01625286|536302364|FG006|Overall Study|Lost to Follow-up|1|||
148680439|NCT00928135|536302365|FG000|Overall Study|Withdrawal by Subject|1|||
148934638|NCT00191906|537246088|FG003|Study Period II|Withdrawal by Subject|0|||
148934639|NCT00191906|537246085|FG000|Study Period II|Parent/Caregiver Decision|0|||
149014565|NCT01242176|537534273|FG001|Washout Period of 7 Days|Adverse Event|2|||
149014566|NCT01242176|537534272|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
149014567|NCT01242176|537534273|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
148934640|NCT00191906|537246086|FG001|Study Period II|Parent/Caregiver Decision|1|||
148934641|NCT00191906|537246087|FG002|Study Period II|Parent/Caregiver Decision|0|||
148934642|NCT00191906|537246088|FG003|Study Period II|Parent/Caregiver Decision|0|||
148934643|NCT00191906|537246085|FG000|Study Period II|Entry Criteria Exclusion|0|||
148934644|NCT00191906|537246086|FG001|Study Period II|Entry Criteria Exclusion|0|||
148934645|NCT00191906|537246087|FG002|Study Period II|Entry Criteria Exclusion|1|||
148934646|NCT00191906|537246088|FG003|Study Period II|Entry Criteria Exclusion|0|||
148934647|NCT00191906|537246085|FG000|Study Period III|Adverse Event|1|||
148934648|NCT00191906|537246086|FG001|Study Period III|Adverse Event|0|||
148934649|NCT00191906|537246087|FG002|Study Period III|Adverse Event|0|||
148934650|NCT00191906|537246088|FG003|Study Period III|Adverse Event|0|||
148934651|NCT00191906|537246085|FG000|Study Period III|Lost to Follow-up|0|||
148934652|NCT00191906|537246086|FG001|Study Period III|Lost to Follow-up|1|||
148934653|NCT00191906|537246087|FG002|Study Period III|Lost to Follow-up|0|||
148934654|NCT00191906|537246088|FG003|Study Period III|Lost to Follow-up|0|||
148934655|NCT00191906|537246085|FG000|Study Period III|Parent/Caregiver Decision|1|||
148934656|NCT00191906|537246086|FG001|Study Period III|Parent/Caregiver Decision|0|||
148934657|NCT00191906|537246087|FG002|Study Period III|Parent/Caregiver Decision|0|||
148934658|NCT00191906|537246088|FG003|Study Period III|Parent/Caregiver Decision|0|||
148934659|NCT00191906|537246085|FG000|Study Period III|Lack of Efficacy|3|||
148934660|NCT00191906|537246086|FG001|Study Period III|Lack of Efficacy|3|||
148934661|NCT00191906|537246087|FG002|Study Period III|Lack of Efficacy|0|||
148934662|NCT00191906|537246088|FG003|Study Period III|Lack of Efficacy|0|||
148934663|NCT01890746|537246089|FG000|Overall Study|Death|39|||
148934664|NCT01890746|537246090|FG001|Overall Study|Death|30|||
149014568|NCT00871351|537534274|FG000|Overall Study|Withdrawal by Subject|1|||
149014569|NCT00871351|537534275|FG001|Overall Study|Withdrawal by Subject|0|||
149014570|NCT00871351|537534276|FG002|Overall Study|Withdrawal by Subject|0|||
149014571|NCT00871351|537534274|FG000|Overall Study|Adverse Event|3|||
148934665|NCT01890746|537246089|FG000|Overall Study|Adverse Event|1|||
148934666|NCT01890746|537246090|FG001|Overall Study|Adverse Event|0|||
148934667|NCT01890746|537246089|FG000|Overall Study|Lost to Follow-up|4|||
149014572|NCT00871351|537534275|FG001|Overall Study|Adverse Event|1|||
149014573|NCT00871351|537534276|FG002|Overall Study|Adverse Event|0|||
148807547|NCT04009837|536773291|FG001|Overall Study|Withdrawal by Subject|4|||
148934668|NCT01890746|537246090|FG001|Overall Study|Lost to Follow-up|1|||
148934669|NCT01890746|537246089|FG000|Overall Study|Physician Decision|3|||
148934670|NCT01890746|537246090|FG001|Overall Study|Physician Decision|2|||
148934671|NCT01890746|537246089|FG000|Overall Study|Withdrawal by Subject|5|||
148934672|NCT01890746|537246090|FG001|Overall Study|Withdrawal by Subject|8|||
148934673|NCT00777205|537246093|FG000|Overall Study|Lost to Follow-up|25|||
148934674|NCT00777205|537246094|FG001|Overall Study|Lost to Follow-up|9|||
148934675|NCT00777205|537246093|FG000|Overall Study|Withdrawal by Subject|6|||
148934676|NCT00777205|537246094|FG001|Overall Study|Withdrawal by Subject|4|||
148934677|NCT00777205|537246093|FG000|Overall Study|Death|0|||
148934678|NCT00777205|537246094|FG001|Overall Study|Death|2|||
148934679|NCT00777205|537246093|FG000|Overall Study|Protocol Violation|0|||
148934680|NCT00777205|537246094|FG001|Overall Study|Protocol Violation|56|||
148934681|NCT03257371|537246095|FG000|Overall Study|Lost to Follow-up|1|||
148934682|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
148934683|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
148934684|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
148934685|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
148934686|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
148934687|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
148934688|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
148934689|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
148934690|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
148934691|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
148934692|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
148934693|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
148934694|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
148934695|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
148934696|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
148934697|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
148934698|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
148934699|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
148934700|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
148934701|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
148934702|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
148934703|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
148934704|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
148934705|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
148934706|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Death|2|||
148934707|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Death|1|||
148934708|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Death|0|||
148934709|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Death|0|||
148934710|NCT02607930|537246101|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
148934711|NCT02607930|537246102|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
148934712|NCT02607930|537246103|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
148934713|NCT02607930|537246104|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
148934714|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
148934715|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
148934716|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
148934717|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
148934718|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
148934719|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
148934720|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
148934721|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
148934722|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
148934723|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
148934724|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
148934725|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
148934726|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
148934727|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
148934728|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
148934729|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
148934730|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
148934731|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
148934732|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
148934733|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
148934734|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
148807548|NCT04009837|536773290|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
148934735|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
148934736|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
148934737|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
149190347|NCT05151471|538168062|FG000|Overall Study|Study terminated by sponsor|49|||
148934738|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
149190348|NCT05151471|538168063|FG001|Overall Study|Study terminated by sponsor|47|||
149190349|NCT05151471|538168062|FG000|Overall Study|Other|2|||
149190350|NCT05151471|538168063|FG001|Overall Study|Other|1|||
149190351|NCT04263142|538168064|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149190352|NCT04263142|538168065|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149190353|NCT04263142|538168066|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149190354|NCT04263142|538168067|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
149190355|NCT04263142|538168068|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
149190356|NCT04263142|538168064|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149190357|NCT04263142|538168065|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149190358|NCT04263142|538168066|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149190359|NCT04263142|538168067|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
149190360|NCT04263142|538168068|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
149190361|NCT03010423|538168069|FG000|Overall Study|Study termination|8|||
149190362|NCT00115349|538168073|FG000|Overall Study|Study closed due to low enrollment.|11|||
149190363|NCT00115349|538168074|FG001|Overall Study|Study closed due to low enrollment.|9|||
149190364|NCT04402008|538168075|FG000|Overall Study|Adverse Event|0|||
149190365|NCT04402008|538168076|FG001|Overall Study|Adverse Event|0|||
149190366|NCT04402008|538168077|FG002|Overall Study|Adverse Event|0|||
149190367|NCT04402008|538168078|FG003|Overall Study|Adverse Event|1|||
149190368|NCT04402008|538168079|FG004|Overall Study|Adverse Event|0|||
148680440|NCT00928135|536302366|FG001|Overall Study|Withdrawal by Subject|0|||
148934739|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
148680441|NCT04355767|536302367|FG000|Overall Study|Withdrawal by Subject|2|||
148680442|NCT04355767|536302368|FG001|Overall Study|Withdrawal by Subject|2|||
148680443|NCT04355767|536302367|FG000|Overall Study|Death|5|||
148680444|NCT04355767|536302368|FG001|Overall Study|Death|1|||
148680445|NCT01999322|536302369|FG000|Overall Study|Adverse Event|1|||
148680446|NCT01999322|536302370|FG001|Overall Study|Adverse Event|0|||
148680447|NCT03338673|536302373|FG000|Overall Study|Lost to Follow-up|1|||
148680448|NCT03338673|536302374|FG001|Overall Study|Lost to Follow-up|1|||
148680449|NCT05788237|536302380|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
148680450|NCT05788237|536302381|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
148680451|NCT05788237|536302382|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
148934740|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
148934741|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
148934742|NCT02607930|537246101|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
148934743|NCT02607930|537246102|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
148934744|NCT02607930|537246103|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
148934745|NCT02607930|537246104|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
148934746|NCT01676727|537246105|FG000|Overall Study|Death|18|||
148680452|NCT05788237|536302383|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
148680453|NCT05788237|536302380|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
148680454|NCT05788237|536302381|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
148680455|NCT05788237|536302382|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
148680456|NCT05788237|536302383|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
148680457|NCT05788237|536302380|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
148680458|NCT05788237|536302381|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
148680459|NCT05788237|536302382|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
148680460|NCT05788237|536302383|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
148934747|NCT01676727|537246105|FG000|Overall Study|Withdrawal by Subject|6|||
148934748|NCT01676727|537246105|FG000|Overall Study|Screening failure|5|||
148934749|NCT01676727|537246105|FG000|Overall Study|Not willing to attend 1-year visit|2|||
148934750|NCT01676727|537246105|FG000|Overall Study|Valve explanted|1|||
148934751|NCT03053271|537246106|FG000|Overall Study|Did not meet randomization criteria|3|||
149190369|NCT04402008|538168080|FG005|Overall Study|Adverse Event|0|||
149190370|NCT04402008|538168081|FG006|Overall Study|Adverse Event|0|||
149190371|NCT04402008|538168075|FG000|Overall Study|Disease Progression|3|||
148680461|NCT05788237|536302380|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
149190372|NCT04402008|538168076|FG001|Overall Study|Disease Progression|2|||
149190373|NCT04402008|538168077|FG002|Overall Study|Disease Progression|3|||
149190374|NCT04402008|538168078|FG003|Overall Study|Disease Progression|3|||
149190375|NCT04402008|538168079|FG004|Overall Study|Disease Progression|4|||
149190376|NCT04402008|538168080|FG005|Overall Study|Disease Progression|3|||
149190377|NCT04402008|538168081|FG006|Overall Study|Disease Progression|10|||
148680462|NCT05788237|536302381|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
148680463|NCT05788237|536302382|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
149190378|NCT04402008|538168075|FG000|Overall Study|Withdrawal by Subject|0|||
148934752|NCT03053271|537246106|FG000|Overall Study|Withdrawal by Subject|1|||
148934753|NCT02124161|537246109|FG000|Overall Study|Other unspecified|0|||
148934754|NCT02124161|537246110|FG001|Overall Study|Other unspecified|1|||
148934755|NCT02124161|537246109|FG000|Overall Study|Death|1|||
149190379|NCT04402008|538168076|FG001|Overall Study|Withdrawal by Subject|1|||
149190380|NCT04402008|538168077|FG002|Overall Study|Withdrawal by Subject|0|||
149190381|NCT04402008|538168078|FG003|Overall Study|Withdrawal by Subject|0|||
149190382|NCT04402008|538168079|FG004|Overall Study|Withdrawal by Subject|1|||
149190383|NCT04402008|538168080|FG005|Overall Study|Withdrawal by Subject|0|||
149190384|NCT04402008|538168081|FG006|Overall Study|Withdrawal by Subject|0|||
149190385|NCT04402008|538168075|FG000|Overall Study|Sponsor Decision|0|||
149190386|NCT04402008|538168076|FG001|Overall Study|Sponsor Decision|0|||
148934756|NCT02124161|537246110|FG001|Overall Study|Death|0|||
148934757|NCT02124161|537246109|FG000|Overall Study|Protocol Violation|2|||
148934758|NCT02124161|537246110|FG001|Overall Study|Protocol Violation|1|||
148934759|NCT02124161|537246109|FG000|Overall Study|Withdrawal by Subject|1|||
148934760|NCT02124161|537246110|FG001|Overall Study|Withdrawal by Subject|2|||
148934761|NCT02124161|537246109|FG000|Overall Study|Adverse Event|2|||
148934762|NCT02124161|537246110|FG001|Overall Study|Adverse Event|0|||
148934763|NCT02124161|537246109|FG000|Overall Study|Does not meet entrance criteria|2|||
148934764|NCT02124161|537246110|FG001|Overall Study|Does not meet entrance criteria|3|||
148934765|NCT02124161|537246109|FG000|Overall Study|No longer meets eligibility criteria|5|||
148934766|NCT02124161|537246110|FG001|Overall Study|No longer meets eligibility criteria|4|||
148934767|NCT02124161|537246109|FG000|Overall Study|Lost to Follow-up|3|||
148934768|NCT02124161|537246110|FG001|Overall Study|Lost to Follow-up|4|||
148934769|NCT02517866|537246111|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
148934770|NCT02517866|537246112|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
148934771|NCT02517866|537246113|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
148934772|NCT02517866|537246111|FG000|Overall Study|Significant Protocol Deviation|4|||
148934773|NCT02517866|537246112|FG001|Overall Study|Significant Protocol Deviation|1|||
148934774|NCT02517866|537246113|FG002|Overall Study|Significant Protocol Deviation|0|||
148934775|NCT02517866|537246111|FG000|Overall Study|Lost to Follow-up|1|||
148934776|NCT02517866|537246112|FG001|Overall Study|Lost to Follow-up|0|||
149190387|NCT04402008|538168077|FG002|Overall Study|Sponsor Decision|0|||
149190388|NCT04402008|538168078|FG003|Overall Study|Sponsor Decision|0|||
149190389|NCT04402008|538168079|FG004|Overall Study|Sponsor Decision|0|||
148680464|NCT05788237|536302383|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
148680465|NCT05788237|536302380|FG000|SSA (Approximately 2 Months)|Death|0|||
148680466|NCT05788237|536302381|FG001|SSA (Approximately 2 Months)|Death|1|||
148680467|NCT05788237|536302382|FG002|SSA (Approximately 2 Months)|Death|0|||
148680468|NCT05788237|536302383|FG003|SSA (Approximately 2 Months)|Death|0|||
148680469|NCT05788237|536302380|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
148680470|NCT05788237|536302381|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
148680471|NCT05788237|536302382|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
148680472|NCT05788237|536302383|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
148680473|NCT05788237|536302380|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
148680474|NCT05788237|536302381|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
148680475|NCT05788237|536302382|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
148680476|NCT05788237|536302383|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
148680477|NCT05788237|536302380|FG000|SSB (Approximately 1 Month)|Other|0|||
148680478|NCT05788237|536302381|FG001|SSB (Approximately 1 Month)|Other|0|||
148680479|NCT05788237|536302382|FG002|SSB (Approximately 1 Month)|Other|0|||
148680480|NCT05788237|536302383|FG003|SSB (Approximately 1 Month)|Other|1|||
148680481|NCT01440647|536304706|FG000|Overall Study|Death|2|||
148680482|NCT01440647|536304707|FG001|Overall Study|Death|3|||
148680483|NCT04335110|536304719|FG000|Overall Study|Withdrawal by Subject|1|||
148680484|NCT04335110|536304720|FG001|Overall Study|Withdrawal by Subject|1|||
148680485|NCT04335110|536304719|FG000|Overall Study|Death|0|||
148680486|NCT04335110|536304720|FG001|Overall Study|Death|1|||
148680487|NCT04006847|536304724|FG000|Overall Study|Product issue|1|||
148680488|NCT01326702|536304731|FG000|Overall Study|Other|1|||
148680489|NCT01326702|536304732|FG001|Overall Study|Other|0|||
148680490|NCT01326702|536304733|FG002|Overall Study|Other|0|||
148680491|NCT01326702|536304734|FG003|Overall Study|Other|0|||
148680492|NCT01326702|536304735|FG004|Overall Study|Other|0|||
148680493|NCT01326702|536304736|FG005|Overall Study|Other|1|||
148680494|NCT01326702|536304737|FG006|Overall Study|Other|0|||
148680495|NCT01326702|536304731|FG000|Overall Study|progressive disease|1|||
148680496|NCT01326702|536304732|FG001|Overall Study|progressive disease|1|||
149190390|NCT04402008|538168080|FG005|Overall Study|Sponsor Decision|0|||
148680497|NCT01326702|536304733|FG002|Overall Study|progressive disease|3|||
148680498|NCT01326702|536304734|FG003|Overall Study|progressive disease|1|||
148680499|NCT01326702|536304735|FG004|Overall Study|progressive disease|3|||
148934777|NCT02517866|537246113|FG002|Overall Study|Lost to Follow-up|0|||
148934778|NCT02517866|537246111|FG000|Overall Study|Voluntary Withdrawal|2|||
148934779|NCT02517866|537246112|FG001|Overall Study|Voluntary Withdrawal|2|||
148680500|NCT01326702|536304736|FG005|Overall Study|progressive disease|2|||
148680501|NCT01326702|536304737|FG006|Overall Study|progressive disease|3|||
148680502|NCT01326702|536304731|FG000|Overall Study|Death|0|||
148680503|NCT01326702|536304732|FG001|Overall Study|Death|1|||
148680504|NCT01326702|536304733|FG002|Overall Study|Death|0|||
148680505|NCT01326702|536304734|FG003|Overall Study|Death|0|||
148680506|NCT01326702|536304735|FG004|Overall Study|Death|0|||
148680507|NCT01326702|536304736|FG005|Overall Study|Death|0|||
148680508|NCT01326702|536304737|FG006|Overall Study|Death|0|||
148680509|NCT01326702|536304731|FG000|Overall Study|Adverse Event|0|||
148680510|NCT01326702|536304732|FG001|Overall Study|Adverse Event|0|||
148680511|NCT01326702|536304733|FG002|Overall Study|Adverse Event|1|||
148680512|NCT01326702|536304734|FG003|Overall Study|Adverse Event|1|||
148680513|NCT01326702|536304735|FG004|Overall Study|Adverse Event|0|||
148680514|NCT01326702|536304736|FG005|Overall Study|Adverse Event|3|||
148680515|NCT01326702|536304737|FG006|Overall Study|Adverse Event|1|||
148680516|NCT01326702|536304731|FG000|Overall Study|Withdrawal by Subject|0|||
148680517|NCT01326702|536304732|FG001|Overall Study|Withdrawal by Subject|0|||
148680518|NCT01326702|536304733|FG002|Overall Study|Withdrawal by Subject|1|||
148680519|NCT01326702|536304734|FG003|Overall Study|Withdrawal by Subject|0|||
148680520|NCT01326702|536304735|FG004|Overall Study|Withdrawal by Subject|1|||
148680521|NCT01326702|536304736|FG005|Overall Study|Withdrawal by Subject|1|||
148680522|NCT01326702|536304737|FG006|Overall Study|Withdrawal by Subject|3|||
148680523|NCT01326702|536304731|FG000|Overall Study|Not Treated|0|||
148680524|NCT01326702|536304732|FG001|Overall Study|Not Treated|0|||
148680525|NCT01326702|536304733|FG002|Overall Study|Not Treated|0|||
148680526|NCT01326702|536304734|FG003|Overall Study|Not Treated|1|||
148680527|NCT01326702|536304735|FG004|Overall Study|Not Treated|0|||
148680528|NCT01326702|536304736|FG005|Overall Study|Not Treated|1|||
148680529|NCT01326702|536304737|FG006|Overall Study|Not Treated|0|||
148680530|NCT02082912|536304738|FG000|Overall Study|Physician Decision|0|||
148680531|NCT02082912|536304739|FG001|Overall Study|Physician Decision|1|||
148680532|NCT01835132|536304745|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
148680533|NCT00830063|536304753|FG000|Overall Study|Adverse Event|7|||
148680534|NCT00830063|536304754|FG001|Overall Study|Adverse Event|13|||
148680535|NCT00830063|536304755|FG002|Overall Study|Adverse Event|16|||
148680536|NCT00830063|536304756|FG003|Overall Study|Adverse Event|13|||
148680537|NCT00830063|536304753|FG000|Overall Study|Death|1|||
148680538|NCT00830063|536304754|FG001|Overall Study|Death|0|||
148680539|NCT00830063|536304755|FG002|Overall Study|Death|0|||
148680540|NCT00830063|536304756|FG003|Overall Study|Death|0|||
148680541|NCT00830063|536304753|FG000|Overall Study|Lost to Follow-up|0|||
148680542|NCT00830063|536304754|FG001|Overall Study|Lost to Follow-up|0|||
148680543|NCT00830063|536304755|FG002|Overall Study|Lost to Follow-up|3|||
148680544|NCT00830063|536304756|FG003|Overall Study|Lost to Follow-up|1|||
148680545|NCT00830063|536304753|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
148680546|NCT00830063|536304754|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
148680547|NCT00830063|536304755|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
148680548|NCT00830063|536304756|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
148680549|NCT00830063|536304753|FG000|Overall Study|Lack of Efficacy|51|||
148680550|NCT00830063|536304754|FG001|Overall Study|Lack of Efficacy|23|||
148680551|NCT00830063|536304755|FG002|Overall Study|Lack of Efficacy|25|||
148680552|NCT00830063|536304756|FG003|Overall Study|Lack of Efficacy|32|||
148680553|NCT00830063|536304753|FG000|Overall Study|Other|5|||
148680554|NCT00830063|536304754|FG001|Overall Study|Other|5|||
148680555|NCT00830063|536304755|FG002|Overall Study|Other|8|||
148680556|NCT00830063|536304756|FG003|Overall Study|Other|6|||
148680557|NCT00830063|536304753|FG000|Overall Study|Withdrawal by Subject|16|||
148680558|NCT00830063|536304754|FG001|Overall Study|Withdrawal by Subject|10|||
148680559|NCT00830063|536304755|FG002|Overall Study|Withdrawal by Subject|16|||
148680560|NCT00830063|536304756|FG003|Overall Study|Withdrawal by Subject|13|||
148680561|NCT00830063|536304753|FG000|Overall Study|Protocol Violation|1|||
148680562|NCT00830063|536304754|FG001|Overall Study|Protocol Violation|0|||
148680563|NCT00830063|536304755|FG002|Overall Study|Protocol Violation|3|||
148680564|NCT00830063|536304756|FG003|Overall Study|Protocol Violation|2|||
148680565|NCT00830063|536304753|FG000|Overall Study|Randomized But Not Treated|0|||
148680566|NCT00830063|536304754|FG001|Overall Study|Randomized But Not Treated|2|||
148807549|NCT04009837|536773291|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
148807550|NCT03692949|536773293|FG000|Overall Study|Lost to Follow-up|0|||
148807551|NCT03692949|536773294|FG001|Overall Study|Lost to Follow-up|0|||
148680567|NCT00830063|536304755|FG002|Overall Study|Randomized But Not Treated|0|||
148680568|NCT00830063|536304756|FG003|Overall Study|Randomized But Not Treated|2|||
148680569|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
148680570|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
148680571|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
148680572|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
148680573|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
148680574|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
148680575|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
149014574|NCT02291289|537534278|FG000|Induction Treatment|Withdrawal by Subject|0|||
149014575|NCT02291289|537534279|FG001|Induction Treatment|Withdrawal by Subject|0|||
149014576|NCT02291289|537534280|FG002|Induction Treatment|Withdrawal by Subject|0|||
149014577|NCT02291289|537534281|FG003|Induction Treatment|Withdrawal by Subject|24|||
149014578|NCT02291289|537534282|FG004|Induction Treatment|Withdrawal by Subject|0|||
149014579|NCT02291289|537534283|FG005|Induction Treatment|Withdrawal by Subject|0|||
149014580|NCT02291289|537534284|FG006|Induction Treatment|Withdrawal by Subject|0|||
149014581|NCT02291289|537534285|FG007|Induction Treatment|Withdrawal by Subject|0|||
149014582|NCT02291289|537534286|FG008|Induction Treatment|Withdrawal by Subject|0|||
149014583|NCT02291289|537534287|FG009|Induction Treatment|Withdrawal by Subject|18|||
149014584|NCT02291289|537534288|FG010|Induction Treatment|Withdrawal by Subject|0|||
149014585|NCT02291289|537534289|FG011|Induction Treatment|Withdrawal by Subject|0|||
149014586|NCT02291289|537534290|FG012|Induction Treatment|Withdrawal by Subject|0|||
149014587|NCT02291289|537534278|FG000|Induction Treatment|Adverse Event|0|||
149014588|NCT02291289|537534279|FG001|Induction Treatment|Adverse Event|0|||
149014589|NCT02291289|537534280|FG002|Induction Treatment|Adverse Event|0|||
149014590|NCT02291289|537534281|FG003|Induction Treatment|Adverse Event|3|||
149014591|NCT02291289|537534282|FG004|Induction Treatment|Adverse Event|0|||
149014592|NCT02291289|537534283|FG005|Induction Treatment|Adverse Event|0|||
149014593|NCT02291289|537534284|FG006|Induction Treatment|Adverse Event|0|||
149014594|NCT02291289|537534285|FG007|Induction Treatment|Adverse Event|0|||
149014595|NCT02291289|537534286|FG008|Induction Treatment|Adverse Event|0|||
149014596|NCT02291289|537534287|FG009|Induction Treatment|Adverse Event|1|||
149014597|NCT02291289|537534288|FG010|Induction Treatment|Adverse Event|0|||
148680576|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
148680577|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
148680578|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
148680579|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
148680580|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
148680581|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
148680582|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
148680583|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
148680584|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
148680585|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
148680586|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
148680587|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
148680588|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
148680589|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
148680590|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
148680591|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
148680592|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
148680593|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
148680594|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
148680595|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
148680596|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
148680597|NCT01872689|536304771|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
148680598|NCT01872689|536304772|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
148680599|NCT01872689|536304773|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
148680600|NCT01872689|536304774|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
148680601|NCT01872689|536304771|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
148680602|NCT01872689|536304772|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
148680603|NCT01872689|536304773|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
148680604|NCT01872689|536304774|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
148680605|NCT01872689|536304771|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
148680606|NCT01872689|536304772|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
148680607|NCT01872689|536304773|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
148680608|NCT01872689|536304774|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
148680609|NCT01872689|536304771|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
149014598|NCT02291289|537534289|FG011|Induction Treatment|Adverse Event|0|||
149014599|NCT02291289|537534290|FG012|Induction Treatment|Adverse Event|0|||
149014600|NCT02291289|537534278|FG000|Induction Treatment|Death|25|||
149014601|NCT02291289|537534279|FG001|Induction Treatment|Death|0|||
149014602|NCT02291289|537534280|FG002|Induction Treatment|Death|0|||
149014603|NCT02291289|537534281|FG003|Induction Treatment|Death|111|||
149014604|NCT02291289|537534282|FG004|Induction Treatment|Death|0|||
149014605|NCT02291289|537534283|FG005|Induction Treatment|Death|0|||
148680610|NCT01872689|536304772|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
149014606|NCT02291289|537534284|FG006|Induction Treatment|Death|1|||
149014607|NCT02291289|537534285|FG007|Induction Treatment|Death|0|||
149014608|NCT02291289|537534286|FG008|Induction Treatment|Death|0|||
149014609|NCT02291289|537534287|FG009|Induction Treatment|Death|82|||
149014610|NCT02291289|537534288|FG010|Induction Treatment|Death|0|||
149014611|NCT02291289|537534289|FG011|Induction Treatment|Death|0|||
149014612|NCT02291289|537534290|FG012|Induction Treatment|Death|0|||
149014613|NCT02291289|537534278|FG000|Induction Treatment|Lost to Follow-up|1|||
149014614|NCT02291289|537534279|FG001|Induction Treatment|Lost to Follow-up|0|||
149014615|NCT02291289|537534280|FG002|Induction Treatment|Lost to Follow-up|0|||
149014616|NCT02291289|537534281|FG003|Induction Treatment|Lost to Follow-up|12|||
149014617|NCT02291289|537534282|FG004|Induction Treatment|Lost to Follow-up|0|||
149014618|NCT02291289|537534283|FG005|Induction Treatment|Lost to Follow-up|0|||
149014619|NCT02291289|537534284|FG006|Induction Treatment|Lost to Follow-up|0|||
149014620|NCT02291289|537534285|FG007|Induction Treatment|Lost to Follow-up|0|||
149014621|NCT02291289|537534286|FG008|Induction Treatment|Lost to Follow-up|0|||
149014622|NCT02291289|537534287|FG009|Induction Treatment|Lost to Follow-up|9|||
149014623|NCT02291289|537534288|FG010|Induction Treatment|Lost to Follow-up|0|||
149014624|NCT02291289|537534289|FG011|Induction Treatment|Lost to Follow-up|0|||
149014625|NCT02291289|537534290|FG012|Induction Treatment|Lost to Follow-up|0|||
149014626|NCT02291289|537534278|FG000|Induction Treatment|Non-Compliance|0|||
149014627|NCT02291289|537534279|FG001|Induction Treatment|Non-Compliance|0|||
149014628|NCT02291289|537534280|FG002|Induction Treatment|Non-Compliance|0|||
149014629|NCT02291289|537534281|FG003|Induction Treatment|Non-Compliance|1|||
149014630|NCT02291289|537534282|FG004|Induction Treatment|Non-Compliance|0|||
149014631|NCT02291289|537534283|FG005|Induction Treatment|Non-Compliance|0|||
149014632|NCT02291289|537534284|FG006|Induction Treatment|Non-Compliance|0|||
149014633|NCT02291289|537534285|FG007|Induction Treatment|Non-Compliance|0|||
149014634|NCT02291289|537534286|FG008|Induction Treatment|Non-Compliance|0|||
149014635|NCT02291289|537534287|FG009|Induction Treatment|Non-Compliance|1|||
149014636|NCT02291289|537534288|FG010|Induction Treatment|Non-Compliance|0|||
149014637|NCT02291289|537534289|FG011|Induction Treatment|Non-Compliance|0|||
149014638|NCT02291289|537534290|FG012|Induction Treatment|Non-Compliance|0|||
149014639|NCT02291289|537534278|FG000|Induction Treatment|Reason Not Specified|0|||
149014640|NCT02291289|537534279|FG001|Induction Treatment|Reason Not Specified|0|||
149014641|NCT02291289|537534280|FG002|Induction Treatment|Reason Not Specified|0|||
149014642|NCT02291289|537534281|FG003|Induction Treatment|Reason Not Specified|4|||
149014643|NCT02291289|537534282|FG004|Induction Treatment|Reason Not Specified|0|||
149014644|NCT02291289|537534283|FG005|Induction Treatment|Reason Not Specified|0|||
149014645|NCT02291289|537534284|FG006|Induction Treatment|Reason Not Specified|0|||
149014646|NCT02291289|537534285|FG007|Induction Treatment|Reason Not Specified|0|||
149014647|NCT02291289|537534286|FG008|Induction Treatment|Reason Not Specified|0|||
149014648|NCT02291289|537534287|FG009|Induction Treatment|Reason Not Specified|7|||
149014649|NCT02291289|537534288|FG010|Induction Treatment|Reason Not Specified|0|||
149014650|NCT02291289|537534289|FG011|Induction Treatment|Reason Not Specified|0|||
149014651|NCT02291289|537534290|FG012|Induction Treatment|Reason Not Specified|0|||
149014652|NCT02291289|537534278|FG000|Induction Treatment|Physician Decision|0|||
149014653|NCT02291289|537534279|FG001|Induction Treatment|Physician Decision|0|||
149014654|NCT02291289|537534280|FG002|Induction Treatment|Physician Decision|0|||
149014655|NCT02291289|537534281|FG003|Induction Treatment|Physician Decision|3|||
149014656|NCT02291289|537534282|FG004|Induction Treatment|Physician Decision|0|||
149014657|NCT02291289|537534283|FG005|Induction Treatment|Physician Decision|0|||
149014658|NCT02291289|537534284|FG006|Induction Treatment|Physician Decision|0|||
149014659|NCT02291289|537534285|FG007|Induction Treatment|Physician Decision|0|||
149014660|NCT02291289|537534286|FG008|Induction Treatment|Physician Decision|0|||
149014661|NCT02291289|537534287|FG009|Induction Treatment|Physician Decision|1|||
149014662|NCT02291289|537534288|FG010|Induction Treatment|Physician Decision|0|||
149014663|NCT02291289|537534289|FG011|Induction Treatment|Physician Decision|0|||
149014664|NCT02291289|537534290|FG012|Induction Treatment|Physician Decision|0|||
149014665|NCT02291289|537534278|FG000|Induction Treatment|Protocol Violation|0|||
149014666|NCT02291289|537534279|FG001|Induction Treatment|Protocol Violation|0|||
149014667|NCT02291289|537534280|FG002|Induction Treatment|Protocol Violation|0|||
149014668|NCT02291289|537534281|FG003|Induction Treatment|Protocol Violation|3|||
149014669|NCT02291289|537534282|FG004|Induction Treatment|Protocol Violation|0|||
149014670|NCT02291289|537534283|FG005|Induction Treatment|Protocol Violation|0|||
149014671|NCT02291289|537534284|FG006|Induction Treatment|Protocol Violation|0|||
149014672|NCT02291289|537534285|FG007|Induction Treatment|Protocol Violation|0|||
149014673|NCT02291289|537534286|FG008|Induction Treatment|Protocol Violation|0|||
149014674|NCT02291289|537534287|FG009|Induction Treatment|Protocol Violation|2|||
149190391|NCT04402008|538168081|FG006|Overall Study|Sponsor Decision|3|||
149190392|NCT04402008|538168075|FG000|Overall Study|Death|0|||
149190393|NCT04402008|538168076|FG001|Overall Study|Death|0|||
149014675|NCT02291289|537534288|FG010|Induction Treatment|Protocol Violation|0|||
149014676|NCT02291289|537534289|FG011|Induction Treatment|Protocol Violation|0|||
149014677|NCT02291289|537534290|FG012|Induction Treatment|Protocol Violation|0|||
149014678|NCT02291289|537534278|FG000|Induction Treatment|Missing|4|||
149014679|NCT02291289|537534279|FG001|Induction Treatment|Missing|0|||
149190394|NCT04402008|538168077|FG002|Overall Study|Death|0|||
149014680|NCT02291289|537534280|FG002|Induction Treatment|Missing|0|||
149014681|NCT02291289|537534281|FG003|Induction Treatment|Missing|14|||
149014682|NCT02291289|537534282|FG004|Induction Treatment|Missing|0|||
149190395|NCT04402008|538168078|FG003|Overall Study|Death|0|||
149014683|NCT02291289|537534283|FG005|Induction Treatment|Missing|0|||
149014684|NCT02291289|537534284|FG006|Induction Treatment|Missing|0|||
149014685|NCT02291289|537534285|FG007|Induction Treatment|Missing|0|||
149014686|NCT02291289|537534286|FG008|Induction Treatment|Missing|0|||
149014687|NCT02291289|537534287|FG009|Induction Treatment|Missing|54|||
149014688|NCT02291289|537534288|FG010|Induction Treatment|Missing|0|||
149014689|NCT02291289|537534289|FG011|Induction Treatment|Missing|0|||
149014690|NCT02291289|537534290|FG012|Induction Treatment|Missing|0|||
149014691|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014692|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014693|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014694|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014695|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
149014696|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
149014697|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014698|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014699|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014700|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014701|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
149014702|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
149014703|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
149014704|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Death|0|||
149014705|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Death|29|||
149014706|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Death|16|||
149190396|NCT04402008|538168079|FG004|Overall Study|Death|1|||
149190397|NCT04402008|538168080|FG005|Overall Study|Death|0|||
148680611|NCT01872689|536304773|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
148680612|NCT01872689|536304774|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
148680613|NCT01872689|536304771|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
148680614|NCT01872689|536304772|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
148680615|NCT01872689|536304773|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
149014707|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Death|0|||
149014708|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Death|188|||
149014709|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Death|107|||
149014710|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Death|0|||
149014711|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Death|1|||
149190398|NCT04402008|538168081|FG006|Overall Study|Death|2|||
149190399|NCT04402008|538168075|FG000|Overall Study|Other|0|||
149190400|NCT04402008|538168076|FG001|Overall Study|Other|0|||
149190401|NCT04402008|538168077|FG002|Overall Study|Other|0|||
149190402|NCT04402008|538168078|FG003|Overall Study|Other|0|||
149190403|NCT04402008|538168079|FG004|Overall Study|Other|0|||
149190404|NCT04402008|538168080|FG005|Overall Study|Other|0|||
149190405|NCT04402008|538168081|FG006|Overall Study|Other|5|||
149190406|NCT05132569|538168082|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
149190407|NCT05132569|538168083|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
149190408|NCT05132569|538168082|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
149190409|NCT05132569|538168083|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
149190410|NCT05132569|538168082|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
149190411|NCT05132569|538168083|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
149190412|NCT03656926|538168084|FG000|Overall Study|Adverse Event|5|||
149190413|NCT03656926|538168085|FG001|Overall Study|Adverse Event|4|||
149190414|NCT03656926|538168084|FG000|Overall Study|Withdrawal by Subject|7|||
149190415|NCT03656926|538168085|FG001|Overall Study|Withdrawal by Subject|2|||
149190416|NCT03656926|538168084|FG000|Overall Study|Screen fail after randomization|1|||
148680616|NCT01872689|536304774|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
149014712|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Death|1|||
149014713|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Death|0|||
149190417|NCT03656926|538168085|FG001|Overall Study|Screen fail after randomization|0|||
149190418|NCT03656926|538168084|FG000|Overall Study|PI decision due to patient condition|1|||
148680617|NCT01872689|536304771|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
149014714|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Death|46|||
149014715|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Death|19|||
148680618|NCT01872689|536304772|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
148680619|NCT01872689|536304773|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
148680620|NCT01872689|536304774|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
148680621|NCT01872689|536304771|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
148680622|NCT01872689|536304772|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
148680623|NCT01872689|536304773|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
148680624|NCT01872689|536304774|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
148680625|NCT00660790|536304777|FG000|Baseline to 3 Months|Death|1|||
148680626|NCT00660790|536304777|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
148680627|NCT00660790|536304777|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
148680628|NCT00686374|536304782|FG000|Overall Study|Lack of Efficacy|10|||
148680629|NCT00686374|536304782|FG000|Overall Study|Adverse Event|8|||
148680630|NCT00686374|536304782|FG000|Overall Study|Withdrew consent|5|||
148680631|NCT00686374|536304782|FG000|Overall Study|Lost to Follow-up|1|||
148680632|NCT00686374|536304782|FG000|Overall Study|Missing reason|33|||
148680633|NCT00686374|536304782|FG000|Overall Study|Other, not specified|4|||
148680634|NCT02143947|536304783|FG000|Overall Study|Lost to Follow-up|4|||
148680635|NCT02143947|536304784|FG001|Overall Study|Lost to Follow-up|2|||
148680636|NCT01244815|536304787|FG000|Overall Study|Not Treated|0|||
148680637|NCT01244815|536304788|FG001|Overall Study|Not Treated|1|||
148680638|NCT01244815|536304789|FG002|Overall Study|Not Treated|0|||
148680639|NCT01244815|536304790|FG003|Overall Study|Not Treated|0|||
148680640|NCT01244815|536304787|FG000|Overall Study|Adverse Event|4|||
148680641|NCT01244815|536304788|FG001|Overall Study|Adverse Event|7|||
148680642|NCT01244815|536304789|FG002|Overall Study|Adverse Event|5|||
148680643|NCT01244815|536304790|FG003|Overall Study|Adverse Event|5|||
148680644|NCT01244815|536304787|FG000|Overall Study|Treatment Failure|0|||
148680645|NCT01244815|536304788|FG001|Overall Study|Treatment Failure|0|||
148680646|NCT01244815|536304789|FG002|Overall Study|Treatment Failure|0|||
148680647|NCT01244815|536304790|FG003|Overall Study|Treatment Failure|1|||
148680648|NCT01244815|536304787|FG000|Overall Study|Lost to Follow-up|3|||
148680649|NCT01244815|536304788|FG001|Overall Study|Lost to Follow-up|2|||
148680650|NCT01244815|536304789|FG002|Overall Study|Lost to Follow-up|3|||
148680651|NCT01244815|536304790|FG003|Overall Study|Lost to Follow-up|2|||
148680652|NCT01244815|536304787|FG000|Overall Study|Withdrawal by Subject|0|||
148680653|NCT01244815|536304788|FG001|Overall Study|Withdrawal by Subject|2|||
148680654|NCT01244815|536304789|FG002|Overall Study|Withdrawal by Subject|0|||
148680655|NCT01244815|536304790|FG003|Overall Study|Withdrawal by Subject|3|||
148680656|NCT01244815|536304787|FG000|Overall Study|Protocol Violation|7|||
148680657|NCT01244815|536304788|FG001|Overall Study|Protocol Violation|4|||
148680658|NCT01244815|536304789|FG002|Overall Study|Protocol Violation|3|||
148680659|NCT01244815|536304790|FG003|Overall Study|Protocol Violation|1|||
148680660|NCT01244815|536304787|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
148680661|NCT01244815|536304788|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
148680662|NCT01244815|536304789|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
148680663|NCT01244815|536304790|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
148680664|NCT01808209|536304792|FG000|Overall Study|Lost to Follow-up|0|||
148680665|NCT01808209|536304793|FG001|Overall Study|Lost to Follow-up|1|||
148680666|NCT00697112|536304794|FG000|Overall Study|Adverse Event|8|||
148680667|NCT00697112|536304794|FG000|Overall Study|Lost to Follow-up|1|||
148680668|NCT00697112|536304794|FG000|Overall Study|Did not meet inclusion criteria|1|||
148680669|NCT01427920|536304799|FG000|Overall Study|Adverse Event|1|||
148680670|NCT01427920|536304800|FG001|Overall Study|Adverse Event|2|||
148680671|NCT01427920|536304799|FG000|Overall Study|Lack of Efficacy|1|||
148680672|NCT01427920|536304800|FG001|Overall Study|Lack of Efficacy|0|||
148680673|NCT01427920|536304799|FG000|Overall Study|Protocol Violation|1|||
148680674|NCT01427920|536304800|FG001|Overall Study|Protocol Violation|3|||
148807552|NCT03692949|536773295|FG002|Overall Study|Lost to Follow-up|0|||
149190419|NCT03656926|538168085|FG001|Overall Study|PI decision due to patient condition|0|||
149190420|NCT03656926|538168084|FG000|Overall Study|Patient unresponsiveness|1|||
149190421|NCT03656926|538168085|FG001|Overall Study|Patient unresponsiveness|0|||
149190422|NCT00069095|538168086|FG000|Primary Treatment Phase|Ongoing|0|||
149190423|NCT00069095|538168087|FG001|Primary Treatment Phase|Ongoing|0|||
149190424|NCT00069095|538168088|FG002|Primary Treatment Phase|Ongoing|5|||
149190425|NCT00069095|538168089|FG003|Primary Treatment Phase|Ongoing|7|||
148680675|NCT01427920|536304799|FG000|Overall Study|Withdrawal Criteria|4|||
148680676|NCT01427920|536304800|FG001|Overall Study|Withdrawal Criteria|4|||
148680677|NCT01427920|536304799|FG000|Overall Study|Unclassified|2|||
148680678|NCT01427920|536304800|FG001|Overall Study|Unclassified|8|||
148680679|NCT04228302|536304801|FG000|Overall Study|Adverse Event|0|||
148680680|NCT04228302|536304802|FG001|Overall Study|Adverse Event|0|||
148680681|NCT04228302|536304803|FG002|Overall Study|Adverse Event|0|||
148680682|NCT04228302|536304804|FG003|Overall Study|Adverse Event|0|||
148680683|NCT04228302|536304805|FG004|Overall Study|Adverse Event|1|||
148680684|NCT04228302|536304806|FG005|Overall Study|Adverse Event|0|||
148680685|NCT03402126|536304809|FG000|Overall Study|Lost to Follow-up|6|||
148680686|NCT03402126|536304809|FG000|Overall Study|Protocol Violation|10|||
149190426|NCT00069095|538168090|FG004|Primary Treatment Phase|Ongoing|7|||
148680687|NCT03402126|536304809|FG000|Overall Study|Sponsor request/Study termination|29|||
148680688|NCT03402126|536304809|FG000|Overall Study|Study product no longer in use|1|||
148680689|NCT03402126|536304809|FG000|Overall Study|Technical problems|1|||
148680690|NCT03402126|536304809|FG000|Overall Study|Withdrawal by Subject|6|||
148680691|NCT03402126|536304809|FG000|Overall Study|Physician Decision|2|||
148680692|NCT03402126|536304809|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
148680693|NCT03402126|536304809|FG000|Overall Study|Death|4|||
148680694|NCT01959230|536304812|FG000|Overall Study|Failure to follow study procedures|0|||
148680695|NCT01959230|536304813|FG001|Overall Study|Failure to follow study procedures|1|||
148680696|NCT01959230|536304812|FG000|Overall Study|Administrative reasons|2|||
148680697|NCT01959230|536304813|FG001|Overall Study|Administrative reasons|0|||
148680698|NCT01959230|536304812|FG000|Overall Study|Withdrawal by Subject|2|||
148680699|NCT01959230|536304813|FG001|Overall Study|Withdrawal by Subject|0|||
148680700|NCT01453374|536304814|FG000|Overall Study|Adverse Event|7|||
148680701|NCT01453374|536304814|FG000|Overall Study|Lack of Efficacy|1|||
148680702|NCT01453374|536304814|FG000|Overall Study|Lost to Follow-up|3|||
148680703|NCT01453374|536304814|FG000|Overall Study|Withdrawal by Subject|5|||
148680704|NCT01453374|536304814|FG000|Overall Study|Incarcerated|2|||
148680705|NCT01223196|536304815|FG000|Overall Study|Lost to Follow-up|2|||
148680706|NCT01223196|536304816|FG001|Overall Study|Lost to Follow-up|0|||
148680707|NCT01223196|536304815|FG000|Overall Study|Physician Decision|1|||
148680708|NCT01223196|536304816|FG001|Overall Study|Physician Decision|0|||
148680709|NCT01223196|536304815|FG000|Overall Study|Withdrawal by Subject|1|||
148680710|NCT01223196|536304816|FG001|Overall Study|Withdrawal by Subject|0|||
148680711|NCT01238822|536304817|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
148680712|NCT02487979|536304818|FG000|Overall Study|Physician Decision|2|||
148680713|NCT02487979|536304818|FG000|Overall Study|Withdrawal by Subject|2|||
148680714|NCT02487979|536304818|FG000|Overall Study|Progressive Disease|17|||
148680715|NCT00447694|536304819|FG000|Overall Study|Adverse Event|2|||
148680716|NCT00447694|536304819|FG000|Overall Study|Abnormal laboratory value|1|||
148680717|NCT00447694|536304819|FG000|Overall Study|Abnormal test procedure result|1|||
148680718|NCT00447694|536304819|FG000|Overall Study|Withdrawal by Subject|2|||
148680719|NCT01965535|536304820|FG000|Overall Study|Lack of Efficacy|2|||
148680720|NCT01965535|536304821|FG001|Overall Study|Lack of Efficacy|1|||
148934780|NCT02517866|537246113|FG002|Overall Study|Voluntary Withdrawal|0|||
148934781|NCT02517866|537246111|FG000|Overall Study|Investigator Decision|2|||
148934782|NCT02517866|537246112|FG001|Overall Study|Investigator Decision|1|||
148934783|NCT02517866|537246113|FG002|Overall Study|Investigator Decision|0|||
148934784|NCT02517866|537246111|FG000|Overall Study|Reason not specified|2|||
148934785|NCT02517866|537246112|FG001|Overall Study|Reason not specified|0|||
148934786|NCT02517866|537246113|FG002|Overall Study|Reason not specified|0|||
148934787|NCT01497275|537246115|FG000|Overall Study|Death|1|||
148934788|NCT01497275|537246115|FG000|Overall Study|Adverse Event|1|||
148934789|NCT01950169|537246116|FG000|Overall Study|Withdrawal by Subject|2|||
148934790|NCT01950169|537246117|FG001|Overall Study|Withdrawal by Subject|8|||
148934791|NCT01950169|537246118|FG002|Overall Study|Withdrawal by Subject|1|||
148934792|NCT01950169|537246116|FG000|Overall Study|Death|1|||
148934793|NCT01950169|537246117|FG001|Overall Study|Death|0|||
148934794|NCT01950169|537246118|FG002|Overall Study|Death|0|||
148934795|NCT01938573|537246119|FG000|Overall Study|Lack of Efficacy|1|||
148934796|NCT01938573|537246120|FG001|Overall Study|Lack of Efficacy|0|||
148934797|NCT01938573|537246119|FG000|Overall Study|Operation at other hospital|1|||
148934798|NCT01938573|537246120|FG001|Overall Study|Operation at other hospital|0|||
148934799|NCT00737438|537246125|FG000|Overall Study|Withdrawal by Subject|2|||
148934800|NCT00737438|537246125|FG000|Overall Study|Patient ineligible|1|||
148934801|NCT02410551|537246126|FG000|Overall Study|Adverse Event|1|||
148934802|NCT02410551|537246126|FG000|Overall Study|Withdrawal by Subject|1|||
148934803|NCT02410551|537246126|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
148934804|NCT05085730|537246129|FG000|Overall Study|Withdrawal by Subject|4|||
148934805|NCT05085730|537246129|FG000|Overall Study|Physician Decision|1|||
149014716|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Death|0|||
149190427|NCT00069095|538168091|FG005|Primary Treatment Phase|Ongoing|4|||
149190428|NCT00069095|538168086|FG000|Primary Treatment Phase|Admin/Other|29|||
149190429|NCT00069095|538168087|FG001|Primary Treatment Phase|Admin/Other|38|||
149190430|NCT00069095|538168088|FG002|Primary Treatment Phase|Admin/Other|31|||
149190431|NCT00069095|538168089|FG003|Primary Treatment Phase|Admin/Other|45|||
149190432|NCT00069095|538168090|FG004|Primary Treatment Phase|Admin/Other|48|||
149190433|NCT00069095|538168091|FG005|Primary Treatment Phase|Admin/Other|42|||
149190434|NCT00069095|538168086|FG000|Primary Treatment Phase|Adverse Event|99|||
149190435|NCT00069095|538168087|FG001|Primary Treatment Phase|Adverse Event|92|||
149190436|NCT00069095|538168088|FG002|Primary Treatment Phase|Adverse Event|71|||
149190437|NCT00069095|538168089|FG003|Primary Treatment Phase|Adverse Event|72|||
148680721|NCT01169987|536304822|FG000|Overall Study|Withdrawal by Subject|3|||
148680722|NCT01169987|536304822|FG000|Overall Study|Lost to Follow-up|24|||
148680723|NCT01169987|536304822|FG000|Overall Study|Other|4|||
148680724|NCT00829439|536304823|FG000|Overall Study|Adverse Event|0|||
149190438|NCT00069095|538168090|FG004|Primary Treatment Phase|Adverse Event|109|||
149190439|NCT00069095|538168091|FG005|Primary Treatment Phase|Adverse Event|101|||
149190440|NCT00069095|538168086|FG000|Primary Treatment Phase|Death|14|||
149190441|NCT00069095|538168087|FG001|Primary Treatment Phase|Death|8|||
149190442|NCT00069095|538168088|FG002|Primary Treatment Phase|Death|2|||
149190443|NCT00069095|538168089|FG003|Primary Treatment Phase|Death|5|||
149190444|NCT00069095|538168090|FG004|Primary Treatment Phase|Death|8|||
149190445|NCT00069095|538168091|FG005|Primary Treatment Phase|Death|8|||
149190446|NCT00069095|538168086|FG000|Primary Treatment Phase|Failure to return|5|||
149190447|NCT00069095|538168087|FG001|Primary Treatment Phase|Failure to return|5|||
149190448|NCT00069095|538168088|FG002|Primary Treatment Phase|Failure to return|0|||
149190449|NCT00069095|538168089|FG003|Primary Treatment Phase|Failure to return|0|||
149190450|NCT00069095|538168090|FG004|Primary Treatment Phase|Failure to return|0|||
149190451|NCT00069095|538168091|FG005|Primary Treatment Phase|Failure to return|2|||
149190452|NCT00069095|538168086|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
149190453|NCT00069095|538168087|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
149190454|NCT00069095|538168088|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
149190455|NCT00069095|538168089|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
149014717|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Adverse Event|0|||
149014718|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Adverse Event|0|||
149014719|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Adverse Event|0|||
149014720|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Adverse Event|0|||
149014721|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Adverse Event|1|||
149014722|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Adverse Event|1|||
149014723|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Adverse Event|0|||
149014724|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Adverse Event|0|||
149014725|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Adverse Event|0|||
149014726|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Adverse Event|0|||
149014727|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Adverse Event|0|||
149014728|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Adverse Event|0|||
149014729|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Adverse Event|0|||
149014730|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014731|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
149014732|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014733|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014734|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
149014735|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
149014736|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014737|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
149014738|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014739|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014740|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
149014741|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
149014742|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
149014743|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
149014744|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
149014745|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
149014746|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
149014747|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
149014748|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
149014749|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
149014750|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
149014751|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
149014752|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
149014753|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
149014754|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
149014755|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
149014756|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Physician Decision|0|||
149190456|NCT00069095|538168090|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
148807553|NCT03692949|536773296|FG003|Overall Study|Lost to Follow-up|0|||
148807554|NCT03692949|536773297|FG004|Overall Study|Lost to Follow-up|0|||
149014757|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Physician Decision|2|||
149014758|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Physician Decision|0|||
149014759|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Physician Decision|0|||
149014760|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Physician Decision|3|||
149014761|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Physician Decision|0|||
149014762|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Physician Decision|0|||
149190457|NCT00069095|538168091|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
149190458|NCT00069095|538168086|FG000|Primary Treatment Phase|Refused treatment|15|||
149190459|NCT00069095|538168087|FG001|Primary Treatment Phase|Refused treatment|26|||
149190460|NCT00069095|538168088|FG002|Primary Treatment Phase|Refused treatment|17|||
149190461|NCT00069095|538168089|FG003|Primary Treatment Phase|Refused treatment|31|||
149190462|NCT00069095|538168090|FG004|Primary Treatment Phase|Refused treatment|24|||
149190463|NCT00069095|538168091|FG005|Primary Treatment Phase|Refused treatment|27|||
149190464|NCT00069095|538168086|FG000|Primary Treatment Phase|Withdrew|2|||
149190465|NCT00069095|538168087|FG001|Primary Treatment Phase|Withdrew|3|||
149190466|NCT00069095|538168088|FG002|Primary Treatment Phase|Withdrew|8|||
149190467|NCT00069095|538168089|FG003|Primary Treatment Phase|Withdrew|2|||
149190468|NCT00069095|538168090|FG004|Primary Treatment Phase|Withdrew|4|||
149190469|NCT00069095|538168091|FG005|Primary Treatment Phase|Withdrew|9|||
149190470|NCT00069095|538168086|FG000|Primary Treatment Phase|Other Violation|0|||
149190471|NCT00069095|538168087|FG001|Primary Treatment Phase|Other Violation|1|||
149190472|NCT00069095|538168088|FG002|Primary Treatment Phase|Other Violation|1|||
149190473|NCT00069095|538168089|FG003|Primary Treatment Phase|Other Violation|1|||
149190474|NCT00069095|538168090|FG004|Primary Treatment Phase|Other Violation|0|||
149190475|NCT00069095|538168091|FG005|Primary Treatment Phase|Other Violation|1|||
149190476|NCT00069095|538168086|FG000|Primary Treatment Phase|Violation criteria|0|||
148934806|NCT05447897|537246130|FG000|Overall Study|Did not participate in survey|2|||
148934807|NCT04553679|537246131|FG000|Overall Study|Withdrawal by Subject|2|||
148934808|NCT04553679|537246132|FG001|Overall Study|Withdrawal by Subject|0|||
148934809|NCT04553679|537246131|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
148934810|NCT04553679|537246132|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
148934811|NCT01649804|537246133|FG000|Overall Study|Administrative/Other|8|||
148934812|NCT03719586|537246134|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
148934813|NCT03719586|537246135|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
148934814|NCT03719586|537246136|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
148934815|NCT03719586|537246137|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
148934816|NCT00178633|537246138|FG000|Overall Study|Lost to Follow-up|6|||
148934817|NCT03845543|537246139|FG000|Overall Study|Death|25|||
148934818|NCT03845543|537246139|FG000|Overall Study|Withdrawal by Subject|2|||
148934819|NCT03845543|537246139|FG000|Overall Study|Lost to Follow-up|12|||
148934820|NCT03845543|537246139|FG000|Overall Study|Adverse Event|17|||
148934821|NCT02028871|537246144|FG000|Overall Study|Positive urine drug screen|1|||
148934822|NCT02028871|537246145|FG001|Overall Study|Positive urine drug screen|1|||
148934823|NCT02028871|537246144|FG000|Overall Study|Withdrawal by Subject|1|||
148934824|NCT02028871|537246145|FG001|Overall Study|Withdrawal by Subject|2|||
148934825|NCT02028871|537246144|FG000|Overall Study|IV placement difficulty|1|||
148934826|NCT02028871|537246145|FG001|Overall Study|IV placement difficulty|0|||
148934827|NCT02028871|537246144|FG000|Overall Study|Current Illness|1|||
148934828|NCT02028871|537246145|FG001|Overall Study|Current Illness|0|||
148934829|NCT02633501|537246148|FG000|Overall Study|Adverse Event|0|||
148934830|NCT02633501|537246149|FG001|Overall Study|Adverse Event|0|||
148934831|NCT02633501|537246150|FG002|Overall Study|Adverse Event|1|||
148934832|NCT02633501|537246151|FG003|Overall Study|Adverse Event|0|||
148934833|NCT02633501|537246152|FG004|Overall Study|Adverse Event|1|||
148934834|NCT02633501|537246153|FG005|Overall Study|Adverse Event|1|||
148934835|NCT02633501|537246148|FG000|Overall Study|Withdrawal by Subject|2|||
148934836|NCT02633501|537246149|FG001|Overall Study|Withdrawal by Subject|1|||
149190477|NCT00069095|538168087|FG001|Primary Treatment Phase|Violation criteria|2|||
149190478|NCT00069095|538168088|FG002|Primary Treatment Phase|Violation criteria|4|||
149190479|NCT00069095|538168089|FG003|Primary Treatment Phase|Violation criteria|3|||
149190480|NCT00069095|538168090|FG004|Primary Treatment Phase|Violation criteria|1|||
148680725|NCT00829439|536304824|FG001|Overall Study|Adverse Event|0|||
149190481|NCT00069095|538168091|FG005|Primary Treatment Phase|Violation criteria|5|||
149190482|NCT00069095|538168086|FG000|Post-study Treatment Phase|Missing reason|1|||
149190483|NCT00069095|538168087|FG001|Post-study Treatment Phase|Missing reason|3|||
149190484|NCT00069095|538168088|FG002|Post-study Treatment Phase|Missing reason|12|||
149190485|NCT00069095|538168089|FG003|Post-study Treatment Phase|Missing reason|8|||
149190486|NCT00069095|538168090|FG004|Post-study Treatment Phase|Missing reason|18|||
149190487|NCT00069095|538168091|FG005|Post-study Treatment Phase|Missing reason|17|||
149190488|NCT00069095|538168086|FG000|Post-study Treatment Phase|Adverse Event|2|||
149190489|NCT00069095|538168087|FG001|Post-study Treatment Phase|Adverse Event|3|||
148934837|NCT02633501|537246150|FG002|Overall Study|Withdrawal by Subject|2|||
148934838|NCT02633501|537246151|FG003|Overall Study|Withdrawal by Subject|2|||
148934839|NCT02633501|537246152|FG004|Overall Study|Withdrawal by Subject|1|||
148934840|NCT02633501|537246153|FG005|Overall Study|Withdrawal by Subject|3|||
148934841|NCT02633501|537246148|FG000|Overall Study|Various other reasons|0|||
148934842|NCT02633501|537246149|FG001|Overall Study|Various other reasons|2|||
148934843|NCT02633501|537246150|FG002|Overall Study|Various other reasons|4|||
148934844|NCT02633501|537246151|FG003|Overall Study|Various other reasons|1|||
148934845|NCT02633501|537246152|FG004|Overall Study|Various other reasons|7|||
148934846|NCT02633501|537246153|FG005|Overall Study|Various other reasons|11|||
148934847|NCT02633501|537246148|FG000|Overall Study|Lost to Follow-up|0|||
148934848|NCT02633501|537246149|FG001|Overall Study|Lost to Follow-up|0|||
148934849|NCT02633501|537246150|FG002|Overall Study|Lost to Follow-up|0|||
148934850|NCT02633501|537246151|FG003|Overall Study|Lost to Follow-up|1|||
148934851|NCT02633501|537246152|FG004|Overall Study|Lost to Follow-up|2|||
148934852|NCT02633501|537246153|FG005|Overall Study|Lost to Follow-up|0|||
148934853|NCT01069627|537246155|FG000|Overall Study|Disease progression|7|||
148934854|NCT01069627|537246155|FG000|Overall Study|Adverse Event|12|||
148934855|NCT01069627|537246155|FG000|Overall Study|Protocol Violation|1|||
148934856|NCT02963935|537246156|FG000|Overall Study|Adverse Event|12|||
148934857|NCT02963935|537246157|FG001|Overall Study|Adverse Event|6|||
148934858|NCT02963935|537246156|FG000|Overall Study|Protocol Violation|2|||
148934859|NCT02963935|537246157|FG001|Overall Study|Protocol Violation|1|||
148934860|NCT02963935|537246156|FG000|Overall Study|Lack of Efficacy|0|||
148934861|NCT02963935|537246157|FG001|Overall Study|Lack of Efficacy|2|||
148934862|NCT02963935|537246156|FG000|Overall Study|Lost to Follow-up|1|||
148934863|NCT02963935|537246157|FG001|Overall Study|Lost to Follow-up|6|||
148934864|NCT02963935|537246156|FG000|Overall Study|Unclassified|13|||
148934865|NCT02963935|537246157|FG001|Overall Study|Unclassified|22|||
148934866|NCT00464269|537246158|FG000|Overall Study|Lack of Efficacy|1|||
148934867|NCT00464269|537246159|FG001|Overall Study|Lack of Efficacy|0|||
148934868|NCT00464269|537246160|FG002|Overall Study|Lack of Efficacy|0|||
148934869|NCT00464269|537246161|FG003|Overall Study|Lack of Efficacy|0|||
148934870|NCT00464269|537246158|FG000|Overall Study|Lost to Follow-up|0|||
148934871|NCT00464269|537246159|FG001|Overall Study|Lost to Follow-up|4|||
148934872|NCT00464269|537246160|FG002|Overall Study|Lost to Follow-up|0|||
148680726|NCT00829439|536304825|FG002|Overall Study|Adverse Event|1|||
148680727|NCT00829439|536304826|FG003|Overall Study|Adverse Event|0|||
148680728|NCT01825876|536304827|FG000|Period 2|Withdrawal by Subject|0|||
148680729|NCT01825876|536304828|FG001|Period 2|Withdrawal by Subject|1|||
148680730|NCT03636542|536304829|FG000|Overall Study|Lost to Follow-up|1|||
148680731|NCT03636542|536304830|FG001|Overall Study|Lost to Follow-up|1|||
148680732|NCT03636542|536304829|FG000|Overall Study|Physician Decision|0|||
148680733|NCT03636542|536304830|FG001|Overall Study|Physician Decision|1|||
148680734|NCT03636542|536304829|FG000|Overall Study|Withdrawal by Subject|1|||
148680735|NCT03636542|536304830|FG001|Overall Study|Withdrawal by Subject|0|||
148680736|NCT02059187|536304833|FG000|Overall Study|Adverse Event|0|||
148680737|NCT02059187|536304834|FG001|Overall Study|Adverse Event|3|||
148680738|NCT02059187|536304833|FG000|Overall Study|Death|1|||
148680739|NCT02059187|536304834|FG001|Overall Study|Death|1|||
148680740|NCT02059187|536304833|FG000|Overall Study|Lost to Follow-up|9|||
148934873|NCT00464269|537246161|FG003|Overall Study|Lost to Follow-up|1|||
149190490|NCT00069095|538168088|FG002|Post-study Treatment Phase|Adverse Event|1|||
149190491|NCT00069095|538168089|FG003|Post-study Treatment Phase|Adverse Event|0|||
148680741|NCT02059187|536304834|FG001|Overall Study|Lost to Follow-up|8|||
148934874|NCT00464269|537246158|FG000|Overall Study|Withdrawal by Subject|0|||
148934875|NCT00464269|537246159|FG001|Overall Study|Withdrawal by Subject|2|||
148934876|NCT00464269|537246160|FG002|Overall Study|Withdrawal by Subject|1|||
148934877|NCT00464269|537246161|FG003|Overall Study|Withdrawal by Subject|1|||
148934878|NCT00464269|537246158|FG000|Overall Study|Other reason|3|||
148680742|NCT02059187|536304833|FG000|Overall Study|Non-compliance with study drug|1|||
148680743|NCT02059187|536304834|FG001|Overall Study|Non-compliance with study drug|0|||
148680744|NCT02059187|536304833|FG000|Overall Study|Physician Decision|1|||
148934879|NCT00464269|537246159|FG001|Overall Study|Other reason|3|||
148934880|NCT00464269|537246160|FG002|Overall Study|Other reason|1|||
148934881|NCT00464269|537246161|FG003|Overall Study|Other reason|1|||
148934882|NCT00464269|537246158|FG000|Overall Study|AE, serious fatal|0|||
148934883|NCT00464269|537246159|FG001|Overall Study|AE, serious fatal|0|||
149190492|NCT00069095|538168090|FG004|Post-study Treatment Phase|Adverse Event|5|||
149190493|NCT00069095|538168091|FG005|Post-study Treatment Phase|Adverse Event|1|||
149190494|NCT00069095|538168086|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
148680745|NCT02059187|536304834|FG001|Overall Study|Physician Decision|2|||
148680746|NCT02059187|536304833|FG000|Overall Study|Protocol Violation|1|||
148680747|NCT02059187|536304834|FG001|Overall Study|Protocol Violation|0|||
148680748|NCT02059187|536304833|FG000|Overall Study|Withdrawal by Subject|12|||
148680749|NCT02059187|536304834|FG001|Overall Study|Withdrawal by Subject|8|||
148680750|NCT03751020|536304835|FG000|Overall Study|Withdrawal by Subject|2|||
148680751|NCT03751020|536304836|FG001|Overall Study|Withdrawal by Subject|0|||
148680752|NCT03751020|536304837|FG002|Overall Study|Withdrawal by Subject|0|||
148680753|NCT03751020|536304835|FG000|Overall Study|Lost to Follow-up|7|||
148680754|NCT03751020|536304836|FG001|Overall Study|Lost to Follow-up|4|||
148680755|NCT03751020|536304837|FG002|Overall Study|Lost to Follow-up|10|||
148680756|NCT01889862|536304838|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
148680757|NCT01889862|536304839|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
148680758|NCT01889862|536304840|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
148680759|NCT01889862|536304841|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
148680760|NCT01889862|536304842|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
148680761|NCT01889862|536304838|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
148680762|NCT01889862|536304839|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
148680763|NCT01889862|536304840|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
148680764|NCT01889862|536304841|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
148680765|NCT01889862|536304842|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
148680766|NCT01889862|536304838|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
148680767|NCT01889862|536304839|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
148680768|NCT01889862|536304840|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
148680769|NCT01889862|536304841|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
148680770|NCT01889862|536304842|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
148680771|NCT01889862|536304838|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
148680772|NCT01889862|536304839|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
148680773|NCT01889862|536304840|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
148680774|NCT01889862|536304841|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
148680775|NCT01889862|536304842|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
148680776|NCT01889862|536304838|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
148680777|NCT01889862|536304839|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
148680778|NCT01889862|536304840|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
148680779|NCT01889862|536304841|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
148680780|NCT01889862|536304842|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
148680781|NCT01889862|536304838|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
148680782|NCT01889862|536304839|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
148680783|NCT01889862|536304840|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
148680784|NCT01889862|536304841|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
148680785|NCT01889862|536304842|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
148680786|NCT01889862|536304838|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
148680787|NCT01889862|536304839|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
148680788|NCT01889862|536304840|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
148680789|NCT01889862|536304841|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
148680790|NCT01889862|536304842|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
148680791|NCT01889862|536304838|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
148680792|NCT01889862|536304839|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
148680793|NCT01889862|536304840|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
148680794|NCT01889862|536304841|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
148680795|NCT01889862|536304842|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
148680796|NCT01889862|536304838|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
148680797|NCT01889862|536304839|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
148680798|NCT01889862|536304840|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
148680799|NCT01889862|536304841|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
148680800|NCT01889862|536304842|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
148680801|NCT01889862|536304838|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
148680802|NCT01889862|536304839|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
148680803|NCT01889862|536304840|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
148680804|NCT01889862|536304841|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
148680805|NCT01889862|536304842|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
148680806|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
148680807|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
148680808|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
148680809|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
148680810|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
148680811|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
148680812|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
148807555|NCT03692949|536773298|FG005|Overall Study|Lost to Follow-up|0|||
148680813|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
148680814|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
148680815|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
148680816|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
148680817|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
148680818|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
148680819|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
148680820|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
148680821|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
148680822|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
148680823|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
148934884|NCT00464269|537246160|FG002|Overall Study|AE, serious fatal|1|||
148934885|NCT00464269|537246161|FG003|Overall Study|AE, serious fatal|1|||
148934886|NCT00464269|537246158|FG000|Overall Study|SAE, non-fatal|0|||
148934887|NCT00464269|537246159|FG001|Overall Study|SAE, non-fatal|0|||
148680824|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
148680825|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
148680826|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
148680827|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
148680828|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
148680829|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
148680830|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
148680831|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
148680832|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
148680833|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
148680834|NCT00528879|536304843|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
148680835|NCT00528879|536304844|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
148680836|NCT00528879|536304845|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
148680837|NCT00528879|536304846|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
148680838|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
148680839|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
148680840|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
148680841|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
148680842|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
148680843|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
148680844|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
148680845|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
148680846|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
148680847|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
148680848|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
148680849|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
148680850|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
148680851|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
148680852|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
148680853|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
148680854|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
148680855|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
148680856|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
148680857|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
148680858|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
148680859|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
148680860|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
148680861|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
148680862|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
148934888|NCT00464269|537246160|FG002|Overall Study|SAE, non-fatal|0|||
148680863|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
148680864|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
148680865|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
148680866|NCT00528879|536304843|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
148680867|NCT00528879|536304844|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
148680868|NCT00528879|536304845|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
148680869|NCT00528879|536304846|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
148680870|NCT04133519|536304847|FG000|Overall Study|Withdrawal by Subject|5|||
148934889|NCT00464269|537246161|FG003|Overall Study|SAE, non-fatal|1|||
148934890|NCT00464269|537246158|FG000|Overall Study|AE, non-serious non-fatal|2|||
148934891|NCT00464269|537246159|FG001|Overall Study|AE, non-serious non-fatal|8|||
148934892|NCT00464269|537246160|FG002|Overall Study|AE, non-serious non-fatal|3|||
148934893|NCT00464269|537246161|FG003|Overall Study|AE, non-serious non-fatal|4|||
149014763|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Physician Decision|0|||
148680871|NCT04133519|536304848|FG001|Overall Study|Withdrawal by Subject|4|||
148680872|NCT04133519|536304847|FG000|Overall Study|Protocol Violation|0|||
148680873|NCT04133519|536304848|FG001|Overall Study|Protocol Violation|1|||
148680874|NCT04133519|536304847|FG000|Overall Study|Never started treatment|1|||
148680875|NCT04133519|536304848|FG001|Overall Study|Never started treatment|1|||
148680876|NCT02217345|536304849|FG000|Overall Study|Lost to Follow-up|2|||
148680877|NCT02217345|536304850|FG001|Overall Study|Lost to Follow-up|1|||
148680878|NCT02217345|536304849|FG000|Overall Study|Withdrawal by Subject|3|||
148680879|NCT02217345|536304850|FG001|Overall Study|Withdrawal by Subject|2|||
148680880|NCT02217345|536304849|FG000|Overall Study|Adverse Event|2|||
148680881|NCT02217345|536304850|FG001|Overall Study|Adverse Event|1|||
148680882|NCT02217345|536304849|FG000|Overall Study|Physician Decision|0|||
148680883|NCT02217345|536304850|FG001|Overall Study|Physician Decision|1|||
148680884|NCT00971204|536304851|FG000|Overall Study|Did not meet all criteria-not treated|14|||
148680885|NCT00971204|536304851|FG000|Overall Study|Lost to Follow-up|10|||
148680886|NCT04130919|536304852|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
148680887|NCT04130919|536304853|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
148680888|NCT04130919|536304854|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
148680889|NCT04130919|536304855|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
148680890|NCT04130919|536304856|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
148680891|NCT04130919|536304857|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
148680892|NCT04130919|536304852|FG000|Blinded Treatment Phase|Adverse Event|0|||
148680893|NCT04130919|536304853|FG001|Blinded Treatment Phase|Adverse Event|0|||
148680894|NCT04130919|536304854|FG002|Blinded Treatment Phase|Adverse Event|1|||
148934894|NCT00464269|537246158|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
148934895|NCT00464269|537246159|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
148934896|NCT00464269|537246160|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
148934897|NCT00464269|537246161|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
148680895|NCT04130919|536304855|FG003|Blinded Treatment Phase|Adverse Event|0|||
148680896|NCT04130919|536304856|FG004|Blinded Treatment Phase|Adverse Event|0|||
148680897|NCT04130919|536304857|FG005|Blinded Treatment Phase|Adverse Event|0|||
148680898|NCT04130919|536304852|FG000|Blinded Treatment Phase|Disease worsening|0|||
148680899|NCT04130919|536304853|FG001|Blinded Treatment Phase|Disease worsening|0|||
148680900|NCT04130919|536304854|FG002|Blinded Treatment Phase|Disease worsening|1|||
148680901|NCT04130919|536304855|FG003|Blinded Treatment Phase|Disease worsening|0|||
148680902|NCT04130919|536304856|FG004|Blinded Treatment Phase|Disease worsening|0|||
148680903|NCT04130919|536304857|FG005|Blinded Treatment Phase|Disease worsening|0|||
148680904|NCT04130919|536304852|FG000|Blinded Treatment Phase|Investigator's decision|0|||
148680905|NCT04130919|536304853|FG001|Blinded Treatment Phase|Investigator's decision|1|||
148680906|NCT04130919|536304854|FG002|Blinded Treatment Phase|Investigator's decision|0|||
148807556|NCT03692949|536773299|FG006|Overall Study|Lost to Follow-up|0|||
148680907|NCT04130919|536304855|FG003|Blinded Treatment Phase|Investigator's decision|0|||
148680908|NCT04130919|536304856|FG004|Blinded Treatment Phase|Investigator's decision|0|||
148680909|NCT04130919|536304857|FG005|Blinded Treatment Phase|Investigator's decision|0|||
148680910|NCT04130919|536304852|FG000|Blinded Treatment Phase|Withdrew consent|1|||
148680911|NCT04130919|536304853|FG001|Blinded Treatment Phase|Withdrew consent|0|||
148680912|NCT04130919|536304854|FG002|Blinded Treatment Phase|Withdrew consent|0|||
148680913|NCT04130919|536304855|FG003|Blinded Treatment Phase|Withdrew consent|0|||
148680914|NCT04130919|536304856|FG004|Blinded Treatment Phase|Withdrew consent|0|||
148680915|NCT04130919|536304857|FG005|Blinded Treatment Phase|Withdrew consent|0|||
148680916|NCT04130919|536304852|FG000|Open-label Treatment Phase|Withdrew consent|0|||
148680917|NCT04130919|536304853|FG001|Open-label Treatment Phase|Withdrew consent|0|||
148680918|NCT04130919|536304854|FG002|Open-label Treatment Phase|Withdrew consent|0|||
148680919|NCT04130919|536304855|FG003|Open-label Treatment Phase|Withdrew consent|1|||
148680920|NCT04130919|536304856|FG004|Open-label Treatment Phase|Withdrew consent|1|||
148680921|NCT04130919|536304857|FG005|Open-label Treatment Phase|Withdrew consent|1|||
148680922|NCT04130919|536304852|FG000|Open-label Treatment Phase|Disease worsening|0|||
148934898|NCT00747461|537246162|FG000|Overall Study|study terminated by sponsor|5|||
148680923|NCT04130919|536304853|FG001|Open-label Treatment Phase|Disease worsening|0|||
148680924|NCT04130919|536304854|FG002|Open-label Treatment Phase|Disease worsening|0|||
149190495|NCT00069095|538168087|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
149190496|NCT00069095|538168088|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
149190497|NCT00069095|538168089|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
149190498|NCT00069095|538168090|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
149190499|NCT00069095|538168091|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
149190500|NCT00069095|538168086|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
149190501|NCT00069095|538168087|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
149190502|NCT00069095|538168088|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
149190503|NCT00069095|538168089|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
149190504|NCT00069095|538168090|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
149190505|NCT00069095|538168091|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
149190506|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
148680925|NCT04130919|536304855|FG003|Open-label Treatment Phase|Disease worsening|1|||
148680926|NCT04130919|536304856|FG004|Open-label Treatment Phase|Disease worsening|0|||
148680927|NCT04130919|536304857|FG005|Open-label Treatment Phase|Disease worsening|1|||
148680928|NCT04130919|536304852|FG000|Open-label Treatment Phase|Investigator's decision|0|||
148680929|NCT04130919|536304853|FG001|Open-label Treatment Phase|Investigator's decision|0|||
148934899|NCT00299182|537246164|FG000|Overall Study|Withdrawal by Subject|0|||
148934900|NCT00299182|537246165|FG001|Overall Study|Withdrawal by Subject|0|||
148934901|NCT00299182|537246166|FG002|Overall Study|Withdrawal by Subject|1|||
148934902|NCT00299182|537246167|FG003|Overall Study|Withdrawal by Subject|0|||
148934903|NCT00299182|537246168|FG004|Overall Study|Withdrawal by Subject|1|||
148934904|NCT00299182|537246169|FG005|Overall Study|Withdrawal by Subject|2|||
148934905|NCT00299182|537246170|FG006|Overall Study|Withdrawal by Subject|0|||
148934906|NCT00299182|537246164|FG000|Overall Study|Chemotherapy Changed|0|||
148934907|NCT00299182|537246165|FG001|Overall Study|Chemotherapy Changed|0|||
148934908|NCT00299182|537246166|FG002|Overall Study|Chemotherapy Changed|1|||
148934909|NCT00299182|537246167|FG003|Overall Study|Chemotherapy Changed|0|||
148934910|NCT00299182|537246168|FG004|Overall Study|Chemotherapy Changed|1|||
148934911|NCT00299182|537246169|FG005|Overall Study|Chemotherapy Changed|0|||
148934912|NCT00299182|537246170|FG006|Overall Study|Chemotherapy Changed|1|||
148934913|NCT00299182|537246164|FG000|Overall Study|Adverse Event|0|||
148934914|NCT00299182|537246165|FG001|Overall Study|Adverse Event|0|||
148934915|NCT00299182|537246166|FG002|Overall Study|Adverse Event|0|||
148934916|NCT00299182|537246167|FG003|Overall Study|Adverse Event|0|||
148934917|NCT00299182|537246168|FG004|Overall Study|Adverse Event|0|||
148934918|NCT00299182|537246169|FG005|Overall Study|Adverse Event|1|||
148934919|NCT00299182|537246170|FG006|Overall Study|Adverse Event|0|||
148934920|NCT00299182|537246164|FG000|Overall Study|Not Eligible|0|||
148934921|NCT00299182|537246165|FG001|Overall Study|Not Eligible|0|||
148934922|NCT00299182|537246166|FG002|Overall Study|Not Eligible|0|||
148934923|NCT00299182|537246167|FG003|Overall Study|Not Eligible|0|||
148934924|NCT00299182|537246168|FG004|Overall Study|Not Eligible|1|||
148934925|NCT00299182|537246169|FG005|Overall Study|Not Eligible|0|||
148934926|NCT00299182|537246170|FG006|Overall Study|Not Eligible|0|||
148934927|NCT00771316|537246175|FG000|Overall Study|Adverse Event|0|||
148934928|NCT00771316|537246176|FG001|Overall Study|Adverse Event|1|||
148934929|NCT00771316|537246175|FG000|Overall Study|Patient withdrew consent|1|||
148934930|NCT00771316|537246176|FG001|Overall Study|Patient withdrew consent|0|||
148934931|NCT00771316|537246175|FG000|Overall Study|Discontinued due to early termination|1|||
148934932|NCT00771316|537246176|FG001|Overall Study|Discontinued due to early termination|0|||
148934933|NCT02955797|537246178|FG000|Overall Study|Protocol Violation|1|||
148934934|NCT02955797|537246179|FG001|Overall Study|Protocol Violation|0|||
148934935|NCT02955797|537246180|FG002|Overall Study|Protocol Violation|0|||
148934936|NCT02955797|537246181|FG003|Overall Study|Protocol Violation|1|||
148680930|NCT04130919|536304854|FG002|Open-label Treatment Phase|Investigator's decision|0|||
148680931|NCT04130919|536304855|FG003|Open-label Treatment Phase|Investigator's decision|1|||
148680932|NCT04130919|536304856|FG004|Open-label Treatment Phase|Investigator's decision|0|||
148680933|NCT04130919|536304857|FG005|Open-label Treatment Phase|Investigator's decision|0|||
148680934|NCT04130919|536304852|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
148934937|NCT02955797|537246178|FG000|Overall Study|Withdrawal by Subject|2|||
148934938|NCT02955797|537246179|FG001|Overall Study|Withdrawal by Subject|2|||
148934939|NCT02955797|537246180|FG002|Overall Study|Withdrawal by Subject|0|||
148934940|NCT02955797|537246181|FG003|Overall Study|Withdrawal by Subject|1|||
148934941|NCT02955797|537246178|FG000|Overall Study|Lost to Follow-up|0|||
148934942|NCT02955797|537246179|FG001|Overall Study|Lost to Follow-up|1|||
148680935|NCT04130919|536304853|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
148680936|NCT04130919|536304854|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
148680937|NCT04130919|536304855|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
148680938|NCT04130919|536304856|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
148680939|NCT04130919|536304857|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
148680940|NCT04130919|536304852|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
148680941|NCT04130919|536304853|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
148680942|NCT04130919|536304854|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
148680943|NCT04130919|536304855|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
148934943|NCT02955797|537246180|FG002|Overall Study|Lost to Follow-up|0|||
148680944|NCT04130919|536304856|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
148680945|NCT04130919|536304857|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
148680946|NCT02624518|536304858|FG000|Overall Study|Physician Decision|1|||
148680947|NCT02729194|536304859|FG000|Overall Study|Withdrawal by Subject|3|||
148680948|NCT00845026|536304860|FG000|Study Period III|Adverse Event|23|||
148680949|NCT00845026|536304861|FG001|Study Period III|Adverse Event|19|||
148680950|NCT00845026|536304860|FG000|Study Period III|Perceived lack of efficacy|27|||
148680951|NCT00845026|536304861|FG001|Study Period III|Perceived lack of efficacy|15|||
148680952|NCT00845026|536304860|FG000|Study Period III|Withdrawal by Subject|19|||
149190507|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149190508|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149190509|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149190510|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
149190511|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
149190512|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant had complete response|1|||
148934944|NCT02955797|537246181|FG003|Overall Study|Lost to Follow-up|0|||
148934945|NCT03131453|537246182|FG000|Overall Study|Study terminated by Sponsor|424|||
148934946|NCT03131453|537246183|FG001|Overall Study|Study terminated by Sponsor|222|||
148934947|NCT03131453|537246184|FG002|Overall Study|Study terminated by Sponsor|438|||
148934948|NCT03131453|537246182|FG000|Overall Study|Withdrawal by Subject|18|||
148934949|NCT03131453|537246183|FG001|Overall Study|Withdrawal by Subject|7|||
148934950|NCT03131453|537246184|FG002|Overall Study|Withdrawal by Subject|13|||
148934951|NCT03131453|537246182|FG000|Overall Study|Adverse Event|10|||
148934952|NCT03131453|537246183|FG001|Overall Study|Adverse Event|3|||
148934953|NCT03131453|537246184|FG002|Overall Study|Adverse Event|3|||
148934954|NCT03131453|537246182|FG000|Overall Study|Lost to Follow-up|1|||
148934955|NCT03131453|537246183|FG001|Overall Study|Lost to Follow-up|0|||
148934956|NCT03131453|537246184|FG002|Overall Study|Lost to Follow-up|1|||
148934957|NCT03131453|537246182|FG000|Overall Study|Physician Decision|1|||
148934958|NCT03131453|537246183|FG001|Overall Study|Physician Decision|0|||
148934959|NCT03131453|537246184|FG002|Overall Study|Physician Decision|1|||
148680953|NCT00845026|536304861|FG001|Study Period III|Withdrawal by Subject|15|||
148934960|NCT03131453|537246182|FG000|Overall Study|Non-compliance with study treatment|1|||
148934961|NCT03131453|537246183|FG001|Overall Study|Non-compliance with study treatment|0|||
148934962|NCT03131453|537246184|FG002|Overall Study|Non-compliance with study treatment|0|||
148680954|NCT00845026|536304860|FG000|Study Period III|Entry Criteria not met|8|||
148680955|NCT00845026|536304861|FG001|Study Period III|Entry Criteria not met|11|||
148680956|NCT00845026|536304860|FG000|Study Period III|Lost to Follow-up|4|||
148680957|NCT00845026|536304861|FG001|Study Period III|Lost to Follow-up|5|||
148934963|NCT03131453|537246182|FG000|Overall Study|Technical problems|1|||
148934964|NCT03131453|537246183|FG001|Overall Study|Technical problems|0|||
148934965|NCT03131453|537246184|FG002|Overall Study|Technical problems|0|||
148934966|NCT03131453|537246182|FG000|Overall Study|Protocol deviation|0|||
149190513|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant had complete response|1|||
148680958|NCT00845026|536304860|FG000|Study Period III|Protocol Violation|8|||
148680959|NCT00845026|536304861|FG001|Study Period III|Protocol Violation|1|||
148934967|NCT03131453|537246183|FG001|Overall Study|Protocol deviation|1|||
148934968|NCT03131453|537246184|FG002|Overall Study|Protocol deviation|0|||
148934969|NCT00392015|537247641|FG000|Overall Study|Lost to Follow-up|2|||
148934970|NCT00392015|537247642|FG001|Overall Study|Lost to Follow-up|0|||
148680960|NCT00845026|536304860|FG000|Study Period III|Scheduled conflict|3|||
148680961|NCT00845026|536304861|FG001|Study Period III|Scheduled conflict|1|||
148680962|NCT00845026|536304860|FG000|Study Period III|Subject is moving or has moved|2|||
148680963|NCT00845026|536304861|FG001|Study Period III|Subject is moving or has moved|4|||
148680964|NCT00845026|536304860|FG000|Study Period III|Transportation issues|1|||
148680965|NCT00845026|536304861|FG001|Study Period III|Transportation issues|1|||
148680966|NCT00845026|536304860|FG000|Study Period IV|Adverse Event|4|||
148680967|NCT00845026|536304861|FG001|Study Period IV|Adverse Event|0|||
148680968|NCT00845026|536304860|FG000|Study Period IV|Perceived lack of efficacy|2|||
148680969|NCT00845026|536304861|FG001|Study Period IV|Perceived lack of efficacy|1|||
148680970|NCT00845026|536304860|FG000|Study Period IV|Protocol Violation|3|||
148680971|NCT00845026|536304861|FG001|Study Period IV|Protocol Violation|1|||
148680972|NCT00845026|536304860|FG000|Study Period IV|Lost to Follow-up|1|||
148680973|NCT00845026|536304861|FG001|Study Period IV|Lost to Follow-up|0|||
148680974|NCT00845026|536304860|FG000|Study Period IV|Withdrawal by Subject|4|||
148680975|NCT00845026|536304861|FG001|Study Period IV|Withdrawal by Subject|1|||
148680976|NCT00845026|536304860|FG000|Study Period IV|Entry Criteria Not Met|1|||
148680977|NCT00845026|536304861|FG001|Study Period IV|Entry Criteria Not Met|0|||
148680978|NCT00845026|536304860|FG000|Study Period IV|Subject is moving or has moved|0|||
148680979|NCT00845026|536304861|FG001|Study Period IV|Subject is moving or has moved|1|||
148680980|NCT00845026|536304860|FG000|Study Period IV|Scheduling conflict|1|||
148680981|NCT00845026|536304861|FG001|Study Period IV|Scheduling conflict|0|||
148680982|NCT01256398|536304866|FG000|Overall Study|Withdrawal by Subject|1|||
148680983|NCT01364298|536304869|FG000|Overall Study|Adverse Event|3|||
148680984|NCT01364298|536304870|FG001|Overall Study|Adverse Event|4|||
148680985|NCT01364298|536304869|FG000|Overall Study|Lack of adherence to treatment|1|||
148680986|NCT01364298|536304870|FG001|Overall Study|Lack of adherence to treatment|3|||
148680987|NCT01364298|536304869|FG000|Overall Study|Lack of Efficacy|1|||
148680988|NCT01364298|536304870|FG001|Overall Study|Lack of Efficacy|0|||
148680989|NCT01364298|536304869|FG000|Overall Study|Lost to Follow-up|5|||
148680990|NCT01364298|536304870|FG001|Overall Study|Lost to Follow-up|10|||
148680991|NCT01364298|536304869|FG000|Overall Study|Withdrawal by Subject|3|||
148680992|NCT01364298|536304870|FG001|Overall Study|Withdrawal by Subject|3|||
148680993|NCT01364298|536304869|FG000|Overall Study|Other|1|||
148680994|NCT01364298|536304870|FG001|Overall Study|Other|3|||
148680995|NCT03550794|536304873|FG000|Overall Study|No longer met inclusion criteria|1|||
148680996|NCT03550794|536304874|FG001|Overall Study|No longer met inclusion criteria|2|||
148680997|NCT03550794|536304873|FG000|Overall Study|Goals of care changed|1|||
148680998|NCT03550794|536304874|FG001|Overall Study|Goals of care changed|0|||
148680999|NCT03550794|536304873|FG000|Overall Study|Withdrawal by Subject|2|||
148681000|NCT03550794|536304874|FG001|Overall Study|Withdrawal by Subject|0|||
148681001|NCT03550794|536304873|FG000|Overall Study|Death|0|||
148681002|NCT03550794|536304874|FG001|Overall Study|Death|1|||
148681003|NCT01864525|536304875|FG000|Overall Study|Adverse Event|1|||
148681004|NCT01864525|536304876|FG001|Overall Study|Adverse Event|0|||
148681005|NCT01890785|536304877|FG000|Third Intervention|Withdrawal by Subject|0|||
148681006|NCT01890785|536304878|FG001|Third Intervention|Withdrawal by Subject|1|||
148681007|NCT01890785|536304879|FG002|Third Intervention|Withdrawal by Subject|0|||
148681008|NCT01890785|536304880|FG003|Third Intervention|Withdrawal by Subject|0|||
148681009|NCT01890785|536304881|FG004|Third Intervention|Withdrawal by Subject|0|||
148681010|NCT01890785|536304882|FG005|Third Intervention|Withdrawal by Subject|0|||
148681011|NCT03296553|536304883|FG000|Overall Study|Withdrawal by Subject|1|||
148681012|NCT03296553|536304884|FG001|Overall Study|Withdrawal by Subject|1|||
148681013|NCT03296553|536304883|FG000|Overall Study|Death|1|||
148681014|NCT03296553|536304884|FG001|Overall Study|Death|0|||
148681015|NCT00065065|536304885|FG000|Overall Study|Adverse Event|3|||
148681016|NCT00065065|536304886|FG001|Overall Study|Adverse Event|2|||
148681017|NCT00065065|536304885|FG000|Overall Study|Withdrawal by Subject|1|||
148681018|NCT00065065|536304886|FG001|Overall Study|Withdrawal by Subject|5|||
148681019|NCT00065065|536304885|FG000|Overall Study|Lack of Efficacy|4|||
148681020|NCT00065065|536304886|FG001|Overall Study|Lack of Efficacy|11|||
148681021|NCT00065065|536304885|FG000|Overall Study|Other|2|||
148681022|NCT00065065|536304886|FG001|Overall Study|Other|2|||
148807557|NCT03692949|536773300|FG007|Overall Study|Lost to Follow-up|1|||
148681023|NCT04363736|536304887|FG000|Overall Study|Withdrawal by Subject|1|||
148681024|NCT04363736|536304888|FG001|Overall Study|Withdrawal by Subject|0|||
148681025|NCT04363736|536304887|FG000|Overall Study|Lost to Follow-up|10|||
148681026|NCT04363736|536304888|FG001|Overall Study|Lost to Follow-up|7|||
148681027|NCT04363736|536304887|FG000|Overall Study|Death|8|||
148807558|NCT03426878|536773308|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
148681028|NCT04363736|536304888|FG001|Overall Study|Death|6|||
148681029|NCT01050673|536304889|FG000|Overall Study|Physician Decision|4|||
148681030|NCT01050673|536304890|FG001|Overall Study|Physician Decision|5|||
148681031|NCT01458119|536304891|FG000|Overall Study|Physician Decision|4|||
148934971|NCT00392015|537247643|FG002|Overall Study|Lost to Follow-up|2|||
148681032|NCT01458119|536304891|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
148681033|NCT01458119|536304891|FG000|Overall Study|Pregnancy|1|||
148681034|NCT01458119|536304891|FG000|Overall Study|Death|2|||
149190514|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant had complete response|0|||
149190515|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant had complete response|0|||
148681035|NCT01458119|536304891|FG000|Overall Study|Adverse Event|1|||
148681036|NCT01458119|536304891|FG000|Overall Study|Consent Withdrawn by Participant|8|||
148681037|NCT01458119|536304891|FG000|Overall Study|Non-compliance With Study Drug|3|||
148681038|NCT03033069|536304892|FG000|Overall Study|Adverse Event|6|||
149014764|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Physician Decision|0|||
149014765|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Physician Decision|0|||
149014766|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Physician Decision|1|||
149014767|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Physician Decision|3|||
149014768|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Physician Decision|0|||
149014769|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Not Treated|0|||
149014770|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Not Treated|0|||
149014771|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Not Treated|2|||
149014772|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Not Treated|0|||
149014773|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Not Treated|0|||
149014774|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Not Treated|0|||
149014775|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Not Treated|0|||
149190516|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant had complete response|0|||
148681039|NCT03033069|536304893|FG001|Overall Study|Adverse Event|7|||
148681040|NCT03033069|536304894|FG002|Overall Study|Adverse Event|4|||
148681041|NCT03033069|536304895|FG003|Overall Study|Adverse Event|6|||
148681042|NCT03033069|536304892|FG000|Overall Study|Lack of Efficacy|0|||
148681043|NCT03033069|536304893|FG001|Overall Study|Lack of Efficacy|0|||
148681044|NCT03033069|536304894|FG002|Overall Study|Lack of Efficacy|1|||
148681045|NCT03033069|536304895|FG003|Overall Study|Lack of Efficacy|0|||
148681046|NCT03033069|536304892|FG000|Overall Study|Lost to Follow-up|6|||
148681047|NCT03033069|536304893|FG001|Overall Study|Lost to Follow-up|5|||
148681048|NCT03033069|536304894|FG002|Overall Study|Lost to Follow-up|5|||
148681049|NCT03033069|536304895|FG003|Overall Study|Lost to Follow-up|6|||
148681050|NCT03033069|536304892|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148681051|NCT03033069|536304893|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148681052|NCT03033069|536304894|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148681053|NCT03033069|536304895|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148681054|NCT03033069|536304892|FG000|Overall Study|Protocol Deviation|0|||
148681055|NCT03033069|536304893|FG001|Overall Study|Protocol Deviation|1|||
148681056|NCT03033069|536304894|FG002|Overall Study|Protocol Deviation|0|||
148681057|NCT03033069|536304895|FG003|Overall Study|Protocol Deviation|0|||
148681058|NCT03033069|536304892|FG000|Overall Study|Withdrawal by Subject|10|||
148681059|NCT03033069|536304893|FG001|Overall Study|Withdrawal by Subject|10|||
148681060|NCT03033069|536304894|FG002|Overall Study|Withdrawal by Subject|11|||
148681061|NCT03033069|536304895|FG003|Overall Study|Withdrawal by Subject|6|||
148681062|NCT03033069|536304892|FG000|Overall Study|Withdrawal By Caregiver|1|||
148681063|NCT03033069|536304893|FG001|Overall Study|Withdrawal By Caregiver|0|||
148681064|NCT03033069|536304894|FG002|Overall Study|Withdrawal By Caregiver|0|||
148681065|NCT03033069|536304895|FG003|Overall Study|Withdrawal By Caregiver|0|||
148681066|NCT03033069|536304892|FG000|Overall Study|Reason not Specified|0|||
148681067|NCT03033069|536304893|FG001|Overall Study|Reason not Specified|1|||
148681068|NCT03033069|536304894|FG002|Overall Study|Reason not Specified|0|||
148681069|NCT03033069|536304895|FG003|Overall Study|Reason not Specified|1|||
148807559|NCT03426878|536773308|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
148807560|NCT03426878|536773308|FG000|Overall Study|Declined to receive results|3|||
148934972|NCT00392015|537247644|FG003|Overall Study|Lost to Follow-up|1|||
148934973|NCT00392015|537247645|FG004|Overall Study|Lost to Follow-up|1|||
148934974|NCT00392015|537247646|FG005|Overall Study|Lost to Follow-up|0|||
148934975|NCT00392015|537247641|FG000|Overall Study|Withdrawal by Subject|0|||
148934976|NCT00392015|537247642|FG001|Overall Study|Withdrawal by Subject|0|||
148934977|NCT00392015|537247643|FG002|Overall Study|Withdrawal by Subject|2|||
148934978|NCT00392015|537247644|FG003|Overall Study|Withdrawal by Subject|0|||
148934979|NCT00392015|537247645|FG004|Overall Study|Withdrawal by Subject|0|||
148934980|NCT00392015|537247646|FG005|Overall Study|Withdrawal by Subject|0|||
148934981|NCT00392015|537247641|FG000|Overall Study|Adverse Event|0|||
148934982|NCT00392015|537247642|FG001|Overall Study|Adverse Event|0|||
148934983|NCT00392015|537247643|FG002|Overall Study|Adverse Event|0|||
148934984|NCT00392015|537247644|FG003|Overall Study|Adverse Event|0|||
148934985|NCT00392015|537247645|FG004|Overall Study|Adverse Event|1|||
148934986|NCT00392015|537247646|FG005|Overall Study|Adverse Event|0|||
148934987|NCT00392015|537247641|FG000|Overall Study|Previous trial recipient|0|||
148934988|NCT00392015|537247642|FG001|Overall Study|Previous trial recipient|0|||
148934989|NCT00392015|537247643|FG002|Overall Study|Previous trial recipient|0|||
148934990|NCT00392015|537247644|FG003|Overall Study|Previous trial recipient|0|||
148681070|NCT00789828|536304898|FG000|Core Period (48 Weeks)|Administrative problems|0|||
148681071|NCT00789828|536304899|FG001|Core Period (48 Weeks)|Administrative problems|1|||
148681072|NCT00789828|536304898|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
148934991|NCT00392015|537247645|FG004|Overall Study|Previous trial recipient|1|||
149190517|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant had complete response|0|||
149190518|NCT00069095|538168086|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149190519|NCT00069095|538168087|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
149190520|NCT00069095|538168088|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149190521|NCT00069095|538168089|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149190522|NCT00069095|538168090|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
149190523|NCT00069095|538168091|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
148681073|NCT00789828|536304899|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
148681074|NCT00789828|536304898|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
148681075|NCT00789828|536304899|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
148681076|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
148681077|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
148681078|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
148681079|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
148681080|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
148681081|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
148681082|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
148681083|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
148681084|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|Death|1|||
148681085|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|Death|0|||
148681086|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
148681087|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
148681088|NCT00789828|536304898|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
148681089|NCT00789828|536304899|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
148681090|NCT02623426|536304900|FG000|Overall Study|Lost to Follow-up|0|||
148681091|NCT02623426|536304901|FG001|Overall Study|Lost to Follow-up|0|||
148681092|NCT02623426|536304902|FG002|Overall Study|Lost to Follow-up|1|||
148681093|NCT02623426|536304900|FG000|Overall Study|Withdrawal by Subject|1|||
148681094|NCT02623426|536304901|FG001|Overall Study|Withdrawal by Subject|2|||
148681095|NCT02623426|536304902|FG002|Overall Study|Withdrawal by Subject|2|||
148681096|NCT02094937|536304903|FG000|8 Weeks in Period 1|Adverse Event|9|||
148681097|NCT02094937|536304904|FG001|8 Weeks in Period 1|Adverse Event|0|||
148681098|NCT02094937|536304905|FG002|8 Weeks in Period 1|Adverse Event|0|||
148681099|NCT02094937|536304906|FG003|8 Weeks in Period 1|Adverse Event|0|||
148681100|NCT02094937|536304903|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
148681101|NCT02094937|536304904|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
148681102|NCT02094937|536304905|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
148681103|NCT02094937|536304906|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
148681104|NCT02094937|536304903|FG000|8 Weeks in Period 1|Protocol Violation|2|||
148681105|NCT02094937|536304904|FG001|8 Weeks in Period 1|Protocol Violation|0|||
148681106|NCT02094937|536304905|FG002|8 Weeks in Period 1|Protocol Violation|0|||
148681107|NCT02094937|536304906|FG003|8 Weeks in Period 1|Protocol Violation|0|||
148681108|NCT02094937|536304903|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
148681109|NCT02094937|536304904|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
148681110|NCT02094937|536304905|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
148681111|NCT02094937|536304906|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
148681112|NCT02094937|536304903|FG000|8 Weeks in Period 1|Physician Decision|1|||
149190524|NCT00069095|538168086|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
148681113|NCT02094937|536304904|FG001|8 Weeks in Period 1|Physician Decision|0|||
148681114|NCT02094937|536304905|FG002|8 Weeks in Period 1|Physician Decision|0|||
148681115|NCT02094937|536304906|FG003|8 Weeks in Period 1|Physician Decision|0|||
148681116|NCT02094937|536304903|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
148681117|NCT02094937|536304904|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
148681118|NCT02094937|536304905|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
148681119|NCT02094937|536304906|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
148681120|NCT02094937|536304903|FG000|12 Weeks in Period 2|Adverse Event|0|||
148681121|NCT02094937|536304904|FG001|12 Weeks in Period 2|Adverse Event|2|||
148681122|NCT02094937|536304905|FG002|12 Weeks in Period 2|Adverse Event|4|||
148681123|NCT02094937|536304906|FG003|12 Weeks in Period 2|Adverse Event|1|||
148681124|NCT02094937|536304903|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
148681125|NCT02094937|536304904|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
148681126|NCT02094937|536304905|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
148681127|NCT02094937|536304906|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
148681128|NCT02094937|536304903|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
148681129|NCT02094937|536304904|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
148681130|NCT02094937|536304905|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
148681131|NCT02094937|536304906|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
148681132|NCT02094937|536304903|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
148681133|NCT02094937|536304904|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
148681134|NCT02094937|536304905|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
148681135|NCT02094937|536304906|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
148681136|NCT02094937|536304903|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
148681137|NCT02094937|536304904|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
148681138|NCT02094937|536304905|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
148681139|NCT02094937|536304906|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
148681140|NCT00555399|536304907|FG000|Overall Study|Withdrawal by Subject|0|||
148681141|NCT00555399|536304908|FG001|Overall Study|Withdrawal by Subject|0|||
148681142|NCT00555399|536304909|FG002|Overall Study|Withdrawal by Subject|1|||
148681143|NCT00555399|536304910|FG003|Overall Study|Withdrawal by Subject|0|||
148681144|NCT00555399|536304911|FG004|Overall Study|Withdrawal by Subject|0|||
148681145|NCT00555399|536304912|FG005|Overall Study|Withdrawal by Subject|0|||
148681146|NCT00555399|536304913|FG006|Overall Study|Withdrawal by Subject|0|||
148681147|NCT00555399|536304914|FG007|Overall Study|Withdrawal by Subject|0|||
148681148|NCT00555399|536304915|FG008|Overall Study|Withdrawal by Subject|0|||
148681149|NCT00555399|536304916|FG009|Overall Study|Withdrawal by Subject|0|||
148681150|NCT00555399|536304917|FG010|Overall Study|Withdrawal by Subject|0|||
148681151|NCT00555399|536304918|FG011|Overall Study|Withdrawal by Subject|1|||
148681152|NCT00555399|536304907|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
148681153|NCT00555399|536304908|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
148681154|NCT00555399|536304909|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
148681155|NCT00555399|536304910|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
148681156|NCT00555399|536304911|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
148681157|NCT00555399|536304912|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
148681158|NCT00555399|536304913|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
148681159|NCT00555399|536304914|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
148681160|NCT00555399|536304915|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
148681161|NCT00555399|536304916|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
148681162|NCT00555399|536304917|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
148681163|NCT00555399|536304918|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
148681164|NCT05458895|536304919|FG000|Overall Study|Withdrawal by Subject|8|||
148681165|NCT05458895|536304919|FG000|Overall Study|Lost to Follow-up|17|||
148681166|NCT05458895|536304919|FG000|Overall Study|Pregnancy|2|||
148681167|NCT05458895|536304919|FG000|Overall Study|Withdrawal by Study Team|1|||
148681168|NCT04639310|536304920|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
148681169|NCT04639310|536304921|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
148681170|NCT01011907|536306350|FG000|Overall Study|Withdrawal by Subject|13|||
148681171|NCT01011907|536306351|FG001|Overall Study|Withdrawal by Subject|11|||
148681172|NCT01011907|536306350|FG000|Overall Study|Adverse Event|1|||
149190525|NCT00069095|538168087|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
149190526|NCT00069095|538168088|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
149190527|NCT00069095|538168089|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
149190528|NCT00069095|538168090|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
149190529|NCT00069095|538168091|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
149190530|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
149190531|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
149190532|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
149190533|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
148681173|NCT01011907|536306351|FG001|Overall Study|Adverse Event|4|||
148681174|NCT00304954|536306352|FG000|Overall Study|Withdrawal by Subject|0|||
148681175|NCT00304954|536306353|FG001|Overall Study|Withdrawal by Subject|0|||
148681176|NCT00304954|536306354|FG002|Overall Study|Withdrawal by Subject|1|||
148681177|NCT00304954|536306355|FG003|Overall Study|Withdrawal by Subject|0|||
149014776|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Not Treated|0|||
149190534|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
149190535|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
149190536|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
149190537|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
149190538|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
149190539|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
149190540|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
149190541|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
149190542|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149190543|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149190544|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149190545|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
149190546|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149190547|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
149190548|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
149190549|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
149190550|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
149190551|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
149190552|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
149190553|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
149190554|NCT00069095|538168086|FG000|Post-study Treatment Phase|Surgery|0|||
149190555|NCT00069095|538168087|FG001|Post-study Treatment Phase|Surgery|0|||
149190556|NCT00069095|538168088|FG002|Post-study Treatment Phase|Surgery|0|||
149190557|NCT00069095|538168089|FG003|Post-study Treatment Phase|Surgery|1|||
149190558|NCT00069095|538168090|FG004|Post-study Treatment Phase|Surgery|1|||
149190559|NCT00069095|538168091|FG005|Post-study Treatment Phase|Surgery|0|||
149190560|NCT00069095|538168086|FG000|Post-study Treatment Phase|Death|0|||
149190561|NCT00069095|538168087|FG001|Post-study Treatment Phase|Death|0|||
149190562|NCT00069095|538168088|FG002|Post-study Treatment Phase|Death|0|||
149190563|NCT00069095|538168089|FG003|Post-study Treatment Phase|Death|0|||
149190564|NCT00069095|538168090|FG004|Post-study Treatment Phase|Death|1|||
149190565|NCT00069095|538168091|FG005|Post-study Treatment Phase|Death|0|||
149190566|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
149190567|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
149190568|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
149190569|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
149190570|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
149190571|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
149190572|NCT00069095|538168086|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149190573|NCT00069095|538168087|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149190574|NCT00069095|538168088|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149190575|NCT00069095|538168089|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149190576|NCT00069095|538168090|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
149190577|NCT00069095|538168091|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
149190578|NCT00069095|538168086|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149190579|NCT00069095|538168087|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149190580|NCT00069095|538168088|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149190581|NCT00069095|538168089|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149190582|NCT00069095|538168090|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
149190583|NCT00069095|538168091|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
149190584|NCT00069095|538168086|FG000|Post-study Treatment Phase|Investigator decision|0|||
149190585|NCT00069095|538168087|FG001|Post-study Treatment Phase|Investigator decision|0|||
149190586|NCT00069095|538168088|FG002|Post-study Treatment Phase|Investigator decision|0|||
149190587|NCT00069095|538168089|FG003|Post-study Treatment Phase|Investigator decision|0|||
149190588|NCT00069095|538168090|FG004|Post-study Treatment Phase|Investigator decision|0|||
149190589|NCT00069095|538168091|FG005|Post-study Treatment Phase|Investigator decision|1|||
149190590|NCT00069095|538168086|FG000|Follow-up Phase|Death|174|||
149190591|NCT00069095|538168087|FG001|Follow-up Phase|Death|206|||
149190592|NCT00069095|538168088|FG002|Follow-up Phase|Death|120|||
149190593|NCT00069095|538168089|FG003|Follow-up Phase|Death|112|||
149190594|NCT00069095|538168090|FG004|Follow-up Phase|Death|92|||
149190595|NCT00069095|538168091|FG005|Follow-up Phase|Death|101|||
149190596|NCT05610176|538168095|FG000|Overall Study|Death|6|||
149190597|NCT03249792|538168096|FG000|Arms 1, 2, and 4|Death|1|||
149190598|NCT03249792|538168097|FG001|Arms 1, 2, and 4|Death|1|||
149190599|NCT03249792|538168098|FG002|Arms 1, 2, and 4|Death|0|||
149190600|NCT03249792|538168099|FG003|Arms 1, 2, and 4|Death|2|||
149190601|NCT03249792|538168100|FG004|Arms 1, 2, and 4|Death|3|||
148681178|NCT00304954|536306352|FG000|Overall Study|Adverse Event|1|||
148681179|NCT00304954|536306353|FG001|Overall Study|Adverse Event|0|||
148681180|NCT00304954|536306354|FG002|Overall Study|Adverse Event|0|||
148681181|NCT00304954|536306355|FG003|Overall Study|Adverse Event|0|||
148681182|NCT00207714|536306356|FG000|Overall Study|Adverse Event|6|||
148681183|NCT00207714|536306357|FG001|Overall Study|Adverse Event|2|||
148681184|NCT00207714|536306358|FG002|Overall Study|Adverse Event|4|||
148681185|NCT00207714|536306359|FG003|Overall Study|Adverse Event|3|||
148681186|NCT00207714|536306360|FG004|Overall Study|Adverse Event|1|||
148681187|NCT00207714|536306356|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
148681188|NCT00207714|536306357|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
148681189|NCT00207714|536306358|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
148681190|NCT00207714|536306359|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
148681191|NCT00207714|536306360|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
148681192|NCT00207714|536306356|FG000|Overall Study|Other|3|||
148681193|NCT00207714|536306357|FG001|Overall Study|Other|2|||
148681194|NCT00207714|536306358|FG002|Overall Study|Other|5|||
148681195|NCT00207714|536306359|FG003|Overall Study|Other|1|||
148681196|NCT00207714|536306360|FG004|Overall Study|Other|0|||
148681197|NCT03627195|536306361|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
148681198|NCT03627195|536306362|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
148681199|NCT03627195|536306363|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
148681200|NCT03627195|536306364|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
148681201|NCT03627195|536306365|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
148681202|NCT03627195|536306366|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
148681203|NCT02290028|536306369|FG000|Overall Study|Death|217|||
149190602|NCT03249792|538168101|FG005|Arms 1, 2, and 4|Death|2|||
149190603|NCT03249792|538168102|FG006|Arms 1, 2, and 4|Death|2|||
149190604|NCT03249792|538168103|FG007|Arms 1, 2, and 4|Death|4|||
149190605|NCT03249792|538168104|FG008|Arms 1, 2, and 4|Death|2|||
149190606|NCT03249792|538168105|FG009|Arms 1, 2, and 4|Death|1|||
149190607|NCT03249792|538168106|FG010|Arms 1, 2, and 4|Death|7|||
149190608|NCT03249792|538168107|FG011|Arms 1, 2, and 4|Death|7|||
149190609|NCT03249792|538168108|FG012|Arms 1, 2, and 4|Death|12|||
149190610|NCT03249792|538168109|FG013|Arms 1, 2, and 4|Death|7|||
149190611|NCT03249792|538168110|FG014|Arms 1, 2, and 4|Death|0|||
149190612|NCT03249792|538168111|FG015|Arms 1, 2, and 4|Death|4|||
149190613|NCT03249792|538168112|FG016|Arms 1, 2, and 4|Death|4|||
149190614|NCT03249792|538168113|FG017|Arms 1, 2, and 4|Death|12|||
149190615|NCT03249792|538168114|FG018|Arms 1, 2, and 4|Death|6|||
149190616|NCT03249792|538168115|FG019|Arms 1, 2, and 4|Death|4|||
149190617|NCT03249792|538168116|FG020|Arms 1, 2, and 4|Death|2|||
149190618|NCT03249792|538168117|FG021|Arms 1, 2, and 4|Death|3|||
149190619|NCT03249792|538168118|FG022|Arms 1, 2, and 4|Death|1|||
149190620|NCT03249792|538168119|FG023|Arms 1, 2, and 4|Death|1|||
149190621|NCT03249792|538168120|FG024|Arms 1, 2, and 4|Death|4|||
149190622|NCT03249792|538168121|FG025|Arms 1, 2, and 4|Death|0|||
149190623|NCT03249792|538168122|FG026|Arms 1, 2, and 4|Death|0|||
149190624|NCT03249792|538168123|FG027|Arms 1, 2, and 4|Death|0|||
149190625|NCT03249792|538168124|FG028|Arms 1, 2, and 4|Death|0|||
149190626|NCT03249792|538168125|FG029|Arms 1, 2, and 4|Death|0|||
149190627|NCT03249792|538168126|FG030|Arms 1, 2, and 4|Death|0|||
149190628|NCT03249792|538168127|FG031|Arms 1, 2, and 4|Death|0|||
149190629|NCT03249792|538168128|FG032|Arms 1, 2, and 4|Death|0|||
149190630|NCT03249792|538168096|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190631|NCT03249792|538168097|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190632|NCT03249792|538168098|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149190633|NCT03249792|538168099|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190634|NCT03249792|538168100|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190635|NCT03249792|538168101|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149190636|NCT03249792|538168102|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
149190637|NCT03249792|538168103|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190638|NCT03249792|538168104|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
149190639|NCT03249792|538168105|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
148681204|NCT02290028|536306369|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
148681205|NCT02290028|536306369|FG000|Overall Study|No longer under care of study physician|76|||
148681206|NCT02290028|536306369|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
148934992|NCT00392015|537247646|FG005|Overall Study|Previous trial recipient|0|||
149190640|NCT03249792|538168106|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
149190641|NCT03249792|538168107|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
149190642|NCT03249792|538168108|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
149190643|NCT03249792|538168109|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
149190644|NCT03249792|538168110|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190645|NCT03249792|538168111|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
148681207|NCT02290028|536306369|FG000|Overall Study|Withdrawal by Subject|52|||
148681208|NCT02290028|536306369|FG000|Overall Study|Study site closure|44|||
148681209|NCT02290028|536306369|FG000|Overall Study|Lost to Follow-up|34|||
148681210|NCT02290028|536306369|FG000|Overall Study|Miscellaneous|10|||
148681211|NCT02290028|536306369|FG000|Overall Study|Transition to EP PASSION|1295|||
149190646|NCT03249792|538168112|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
149190647|NCT03249792|538168113|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190648|NCT03249792|538168114|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149190649|NCT03249792|538168115|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190650|NCT03249792|538168116|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190651|NCT03249792|538168117|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190652|NCT03249792|538168118|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149190653|NCT03249792|538168119|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
149190654|NCT03249792|538168120|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190655|NCT03249792|538168121|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190656|NCT03249792|538168122|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190657|NCT03249792|538168123|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190658|NCT03249792|538168124|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190659|NCT03249792|538168125|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190660|NCT03249792|538168126|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190661|NCT03249792|538168127|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190662|NCT03249792|538168128|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
149190663|NCT03249792|538168096|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
149190664|NCT03249792|538168097|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
149190665|NCT03249792|538168098|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
149190666|NCT03249792|538168099|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
149190667|NCT03249792|538168100|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
149190668|NCT03249792|538168101|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
149190669|NCT03249792|538168102|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
149190670|NCT03249792|538168103|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
149190671|NCT03249792|538168104|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
149190672|NCT03249792|538168105|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
149190673|NCT03249792|538168106|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
149190674|NCT03249792|538168107|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
149190675|NCT03249792|538168108|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
149190676|NCT03249792|538168109|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
149190677|NCT03249792|538168110|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
149190678|NCT03249792|538168111|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
149190679|NCT03249792|538168112|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
149190680|NCT03249792|538168113|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
149190681|NCT03249792|538168114|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
149190682|NCT03249792|538168115|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
149190683|NCT03249792|538168116|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
149190684|NCT03249792|538168117|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
149190685|NCT03249792|538168118|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
149190686|NCT03249792|538168119|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
149190687|NCT03249792|538168120|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
149190688|NCT03249792|538168121|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
149190689|NCT03249792|538168122|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
149190690|NCT03249792|538168123|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
149190691|NCT03249792|538168124|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
149190692|NCT03249792|538168125|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
149190693|NCT03249792|538168126|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
149190694|NCT03249792|538168127|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
149190695|NCT03249792|538168128|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
149190696|NCT03249792|538168096|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190697|NCT03249792|538168097|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190698|NCT03249792|538168098|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190699|NCT03249792|538168099|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190700|NCT03249792|538168100|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190701|NCT03249792|538168101|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190702|NCT03249792|538168102|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190703|NCT03249792|538168103|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190704|NCT03249792|538168104|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
149190705|NCT03249792|538168105|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190706|NCT03249792|538168106|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190707|NCT03249792|538168107|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190708|NCT03249792|538168108|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190709|NCT03249792|538168109|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190710|NCT03249792|538168110|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190711|NCT03249792|538168111|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190712|NCT03249792|538168112|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
148934993|NCT00717093|537247648|FG000|Overall Study|Adverse Event|19|||
149190713|NCT03249792|538168113|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
149190714|NCT03249792|538168114|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190715|NCT03249792|538168115|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
149190716|NCT03249792|538168116|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190717|NCT03249792|538168117|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190718|NCT03249792|538168118|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190719|NCT03249792|538168119|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190720|NCT03249792|538168120|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
148934994|NCT00717093|537247649|FG001|Overall Study|Adverse Event|9|||
149190721|NCT03249792|538168121|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190722|NCT03249792|538168122|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190723|NCT03249792|538168123|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190724|NCT03249792|538168124|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190725|NCT03249792|538168125|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190726|NCT03249792|538168126|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190727|NCT03249792|538168127|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190728|NCT03249792|538168128|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
149190729|NCT03249792|538168096|FG000|Switch Over Period|Withdrawal by Subject|0|||
149190730|NCT03249792|538168097|FG001|Switch Over Period|Withdrawal by Subject|0|||
149190731|NCT03249792|538168098|FG002|Switch Over Period|Withdrawal by Subject|0|||
149190732|NCT03249792|538168099|FG003|Switch Over Period|Withdrawal by Subject|0|||
149190733|NCT03249792|538168100|FG004|Switch Over Period|Withdrawal by Subject|0|||
149190734|NCT03249792|538168101|FG005|Switch Over Period|Withdrawal by Subject|0|||
149190735|NCT03249792|538168102|FG006|Switch Over Period|Withdrawal by Subject|0|||
149190736|NCT03249792|538168103|FG007|Switch Over Period|Withdrawal by Subject|0|||
149190737|NCT03249792|538168104|FG008|Switch Over Period|Withdrawal by Subject|0|||
149190738|NCT03249792|538168105|FG009|Switch Over Period|Withdrawal by Subject|0|||
149190739|NCT03249792|538168106|FG010|Switch Over Period|Withdrawal by Subject|0|||
149190740|NCT03249792|538168107|FG011|Switch Over Period|Withdrawal by Subject|0|||
149190741|NCT03249792|538168108|FG012|Switch Over Period|Withdrawal by Subject|0|||
149190742|NCT03249792|538168109|FG013|Switch Over Period|Withdrawal by Subject|0|||
149190743|NCT03249792|538168110|FG014|Switch Over Period|Withdrawal by Subject|0|||
149190744|NCT03249792|538168111|FG015|Switch Over Period|Withdrawal by Subject|0|||
149190745|NCT03249792|538168112|FG016|Switch Over Period|Withdrawal by Subject|0|||
149190746|NCT03249792|538168113|FG017|Switch Over Period|Withdrawal by Subject|0|||
149190747|NCT03249792|538168114|FG018|Switch Over Period|Withdrawal by Subject|0|||
149190748|NCT03249792|538168115|FG019|Switch Over Period|Withdrawal by Subject|0|||
149190749|NCT03249792|538168116|FG020|Switch Over Period|Withdrawal by Subject|0|||
149190750|NCT03249792|538168117|FG021|Switch Over Period|Withdrawal by Subject|0|||
149190751|NCT03249792|538168118|FG022|Switch Over Period|Withdrawal by Subject|0|||
149190752|NCT03249792|538168119|FG023|Switch Over Period|Withdrawal by Subject|0|||
149190753|NCT03249792|538168120|FG024|Switch Over Period|Withdrawal by Subject|0|||
149190754|NCT03249792|538168121|FG025|Switch Over Period|Withdrawal by Subject|0|||
149190755|NCT03249792|538168122|FG026|Switch Over Period|Withdrawal by Subject|0|||
149190756|NCT03249792|538168123|FG027|Switch Over Period|Withdrawal by Subject|0|||
149190757|NCT03249792|538168124|FG028|Switch Over Period|Withdrawal by Subject|0|||
149190758|NCT03249792|538168125|FG029|Switch Over Period|Withdrawal by Subject|0|||
149190759|NCT03249792|538168126|FG030|Switch Over Period|Withdrawal by Subject|0|||
149190760|NCT03249792|538168127|FG031|Switch Over Period|Withdrawal by Subject|1|||
149190761|NCT03249792|538168128|FG032|Switch Over Period|Withdrawal by Subject|0|||
149190762|NCT03249792|538168096|FG000|Switch Over Period|Progressive Disease|0|||
149190763|NCT03249792|538168097|FG001|Switch Over Period|Progressive Disease|0|||
149190764|NCT03249792|538168098|FG002|Switch Over Period|Progressive Disease|0|||
149190765|NCT03249792|538168099|FG003|Switch Over Period|Progressive Disease|0|||
149190766|NCT03249792|538168100|FG004|Switch Over Period|Progressive Disease|0|||
149190767|NCT03249792|538168101|FG005|Switch Over Period|Progressive Disease|0|||
149190768|NCT03249792|538168102|FG006|Switch Over Period|Progressive Disease|0|||
149190769|NCT03249792|538168103|FG007|Switch Over Period|Progressive Disease|0|||
149190770|NCT03249792|538168104|FG008|Switch Over Period|Progressive Disease|0|||
149190771|NCT03249792|538168105|FG009|Switch Over Period|Progressive Disease|0|||
149190772|NCT03249792|538168106|FG010|Switch Over Period|Progressive Disease|0|||
149190773|NCT03249792|538168107|FG011|Switch Over Period|Progressive Disease|0|||
149190774|NCT03249792|538168108|FG012|Switch Over Period|Progressive Disease|0|||
149190775|NCT03249792|538168109|FG013|Switch Over Period|Progressive Disease|0|||
149190776|NCT03249792|538168110|FG014|Switch Over Period|Progressive Disease|0|||
149190777|NCT03249792|538168111|FG015|Switch Over Period|Progressive Disease|0|||
149190778|NCT03249792|538168112|FG016|Switch Over Period|Progressive Disease|0|||
149190779|NCT03249792|538168113|FG017|Switch Over Period|Progressive Disease|0|||
149190780|NCT03249792|538168114|FG018|Switch Over Period|Progressive Disease|0|||
149190781|NCT03249792|538168115|FG019|Switch Over Period|Progressive Disease|0|||
149190782|NCT03249792|538168116|FG020|Switch Over Period|Progressive Disease|0|||
149190783|NCT03249792|538168117|FG021|Switch Over Period|Progressive Disease|0|||
149190784|NCT03249792|538168118|FG022|Switch Over Period|Progressive Disease|0|||
149190785|NCT03249792|538168119|FG023|Switch Over Period|Progressive Disease|0|||
149190786|NCT03249792|538168120|FG024|Switch Over Period|Progressive Disease|0|||
149190787|NCT03249792|538168121|FG025|Switch Over Period|Progressive Disease|0|||
149190788|NCT03249792|538168122|FG026|Switch Over Period|Progressive Disease|1|||
149190789|NCT03249792|538168123|FG027|Switch Over Period|Progressive Disease|0|||
149190790|NCT03249792|538168124|FG028|Switch Over Period|Progressive Disease|1|||
149190791|NCT03249792|538168125|FG029|Switch Over Period|Progressive Disease|2|||
149014777|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Not Treated|0|||
149014778|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Not Treated|0|||
149190792|NCT03249792|538168126|FG030|Switch Over Period|Progressive Disease|1|||
149190793|NCT03249792|538168127|FG031|Switch Over Period|Progressive Disease|0|||
149190794|NCT03249792|538168128|FG032|Switch Over Period|Progressive Disease|1|||
149190795|NCT03249792|538168096|FG000|Switch Over Period|Adverse Event|0|||
149190796|NCT03249792|538168097|FG001|Switch Over Period|Adverse Event|0|||
149190797|NCT03249792|538168098|FG002|Switch Over Period|Adverse Event|0|||
149190798|NCT03249792|538168099|FG003|Switch Over Period|Adverse Event|0|||
149190799|NCT03249792|538168100|FG004|Switch Over Period|Adverse Event|0|||
149190800|NCT03249792|538168101|FG005|Switch Over Period|Adverse Event|0|||
149190801|NCT03249792|538168102|FG006|Switch Over Period|Adverse Event|0|||
149190802|NCT03249792|538168103|FG007|Switch Over Period|Adverse Event|0|||
149190803|NCT03249792|538168104|FG008|Switch Over Period|Adverse Event|0|||
149190804|NCT03249792|538168105|FG009|Switch Over Period|Adverse Event|0|||
149190805|NCT03249792|538168106|FG010|Switch Over Period|Adverse Event|0|||
149190806|NCT03249792|538168107|FG011|Switch Over Period|Adverse Event|0|||
149190807|NCT03249792|538168108|FG012|Switch Over Period|Adverse Event|0|||
149190808|NCT03249792|538168109|FG013|Switch Over Period|Adverse Event|0|||
149190809|NCT03249792|538168110|FG014|Switch Over Period|Adverse Event|0|||
149190810|NCT03249792|538168111|FG015|Switch Over Period|Adverse Event|0|||
149190811|NCT03249792|538168112|FG016|Switch Over Period|Adverse Event|0|||
149190812|NCT03249792|538168113|FG017|Switch Over Period|Adverse Event|0|||
148681212|NCT02290028|536306369|FG000|Overall Study|Planned study completion at 12 months|257|||
148681213|NCT03862625|536306370|FG000|Overall Study|Lost to Follow-up|0|||
148681214|NCT03862625|536306371|FG001|Overall Study|Lost to Follow-up|1|||
149190813|NCT03249792|538168114|FG018|Switch Over Period|Adverse Event|0|||
149190814|NCT03249792|538168115|FG019|Switch Over Period|Adverse Event|0|||
149190815|NCT03249792|538168116|FG020|Switch Over Period|Adverse Event|0|||
149190816|NCT03249792|538168117|FG021|Switch Over Period|Adverse Event|0|||
149190817|NCT03249792|538168118|FG022|Switch Over Period|Adverse Event|0|||
149190818|NCT03249792|538168119|FG023|Switch Over Period|Adverse Event|0|||
149190819|NCT03249792|538168120|FG024|Switch Over Period|Adverse Event|0|||
149190820|NCT03249792|538168121|FG025|Switch Over Period|Adverse Event|1|||
148681215|NCT02614703|536306373|FG000|Overall Study|Withdrawal by Subject|7|||
148681216|NCT02614703|536306374|FG001|Overall Study|Withdrawal by Subject|1|||
148681217|NCT02402933|536306375|FG000|Overall Study|Withdrawal by Subject|4|||
148681218|NCT02402933|536306375|FG000|Overall Study|Discontinued; Site Termination|10|||
148681219|NCT00856778|536306384|FG000|Overall Study|Adverse Event|7|||
148681220|NCT00856778|536306384|FG000|Overall Study|Withdrawal by Subject|10|||
148681221|NCT00856778|536306384|FG000|Overall Study|Study deviation|2|||
148681222|NCT00856778|536306384|FG000|Overall Study|Lost to Follow-up|5|||
148681223|NCT01681771|536306385|FG000|Overall Study|Lost to Follow-up|4|||
148681224|NCT01681771|536306386|FG001|Overall Study|Lost to Follow-up|2|||
148681225|NCT00265083|536306387|FG000|Overall Study|Adverse Event|5|||
148681226|NCT00265083|536306388|FG001|Overall Study|Adverse Event|13|||
148681227|NCT00265083|536306389|FG002|Overall Study|Adverse Event|15|||
148681228|NCT00265083|536306387|FG000|Overall Study|Lost to Follow-up|3|||
148681229|NCT00265083|536306388|FG001|Overall Study|Lost to Follow-up|4|||
148681230|NCT00265083|536306389|FG002|Overall Study|Lost to Follow-up|4|||
148681231|NCT00265083|536306387|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
148681232|NCT00265083|536306388|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
148681233|NCT00265083|536306389|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
148681234|NCT00265083|536306387|FG000|Overall Study|Other|1|||
148681235|NCT00265083|536306388|FG001|Overall Study|Other|12|||
148681236|NCT00265083|536306389|FG002|Overall Study|Other|9|||
148681237|NCT03208933|536306390|FG000|Overall Study|Death|3|||
148681238|NCT03208933|536306390|FG000|Overall Study|Withdrawal by Subject|3|||
148681239|NCT03208933|536306390|FG000|Overall Study|Adverse Event|1|||
148681240|NCT03208933|536306390|FG000|Overall Study|Lost to Follow-up|2|||
148681241|NCT03208933|536306390|FG000|Overall Study|Physician Decision|3|||
148681242|NCT03208933|536306390|FG000|Overall Study|Protocol Violation|1|||
148681243|NCT04242186|536306393|FG000|Overall Study|Death|5|||
148681244|NCT00550420|536306394|FG000|Overall Study|Adverse Event|28|||
148681245|NCT00550420|536306394|FG000|Overall Study|Lost to Follow-up|8|||
148681246|NCT00550420|536306394|FG000|Overall Study|Protocol Violation|11|||
148681247|NCT00550420|536306394|FG000|Overall Study|Withdrawal by Subject|30|||
148681248|NCT00550420|536306394|FG000|Overall Study|Still in study at termination|206|||
148681249|NCT00550420|536306394|FG000|Overall Study|Missing|2|||
148681250|NCT00550420|536306394|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
148681251|NCT00550420|536306394|FG000|Overall Study|Investigators opinion|1|||
148681252|NCT00550420|536306394|FG000|Overall Study|Lack of curative effect|1|||
148681253|NCT00550420|536306394|FG000|Overall Study|Unethical stop of enrollment|2|||
148681254|NCT00550420|536306394|FG000|Overall Study|Caregiver's decision to withdraw|1|||
148681255|NCT00550420|536306394|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
148681256|NCT00550420|536306394|FG000|Overall Study|Exclusion criteria|1|||
148681257|NCT00550420|536306394|FG000|Overall Study|Prohibited medicine|1|||
148681258|NCT00782275|536306395|FG000|Overall Study|Adverse Event|11|||
148681259|NCT00782275|536306395|FG000|Overall Study|Withdrawal by Subject|1|||
149190821|NCT03249792|538168122|FG026|Switch Over Period|Adverse Event|0|||
149190822|NCT03249792|538168123|FG027|Switch Over Period|Adverse Event|1|||
149190823|NCT03249792|538168124|FG028|Switch Over Period|Adverse Event|0|||
149190824|NCT03249792|538168125|FG029|Switch Over Period|Adverse Event|0|||
149190825|NCT03249792|538168126|FG030|Switch Over Period|Adverse Event|0|||
149190826|NCT03249792|538168127|FG031|Switch Over Period|Adverse Event|0|||
149190827|NCT03249792|538168128|FG032|Switch Over Period|Adverse Event|0|||
149190828|NCT00532948|538168135|FG000|Overall Study|Protocol Violation|1|||
149190829|NCT00532948|538168136|FG001|Overall Study|Protocol Violation|0|||
149190830|NCT00532948|538168137|FG002|Overall Study|Protocol Violation|0|||
149190831|NCT00532948|538168135|FG000|Overall Study|Death|3|||
149190832|NCT00532948|538168136|FG001|Overall Study|Death|3|||
149190833|NCT00532948|538168137|FG002|Overall Study|Death|4|||
149190834|NCT00532948|538168135|FG000|Overall Study|Violation of selection criteria at entry|0|||
149190835|NCT00532948|538168136|FG001|Overall Study|Violation of selection criteria at entry|1|||
149190836|NCT00532948|538168137|FG002|Overall Study|Violation of selection criteria at entry|0|||
149190837|NCT00532948|538168135|FG000|Overall Study|Failure to return|0|||
149190838|NCT00532948|538168136|FG001|Overall Study|Failure to return|1|||
149190839|NCT00532948|538168137|FG002|Overall Study|Failure to return|0|||
149190840|NCT02702193|538168139|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
149190841|NCT02702193|538168140|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
149190842|NCT02702193|538168139|FG000|4 Month Follow up|Withdrawal by Subject|1|||
149190843|NCT02702193|538168140|FG001|4 Month Follow up|Withdrawal by Subject|0|||
148681260|NCT00782275|536306395|FG000|Overall Study|Progressive Disease|21|||
148681261|NCT00782275|536306395|FG000|Overall Study|Physician Decision|4|||
148681262|NCT00782275|536306395|FG000|Overall Study|Not started treatment|1|||
148681263|NCT00782275|536306395|FG000|Overall Study|Other|3|||
148681264|NCT00331773|536306396|FG000|Overall Study|Withdrawal by Subject|6|||
148681265|NCT00331773|536306397|FG001|Overall Study|Withdrawal by Subject|4|||
148681266|NCT00331773|536306396|FG000|Overall Study|Protocol Violation|10|||
148681267|NCT00331773|536306397|FG001|Overall Study|Protocol Violation|3|||
148681268|NCT04378010|536306398|FG000|Overall Study|Adverse Event|8|||
148681269|NCT04378010|536306399|FG001|Overall Study|Adverse Event|14|||
149190844|NCT02702193|538168139|FG000|4 Month Follow up|Lost to Follow-up|17|||
149190845|NCT02702193|538168140|FG001|4 Month Follow up|Lost to Follow-up|18|||
149190846|NCT02702193|538168139|FG000|8 Month Follow up|Withdrawal by Subject|1|||
149190847|NCT02702193|538168140|FG001|8 Month Follow up|Withdrawal by Subject|0|||
149190848|NCT02702193|538168139|FG000|8 Month Follow up|Lost to Follow-up|14|||
149190849|NCT02702193|538168140|FG001|8 Month Follow up|Lost to Follow-up|18|||
149190850|NCT02702193|538168139|FG000|12 Month Follow up|Withdrawal by Subject|1|||
149190851|NCT02702193|538168140|FG001|12 Month Follow up|Withdrawal by Subject|0|||
149190852|NCT02702193|538168139|FG000|12 Month Follow up|Lost to Follow-up|16|||
149190853|NCT02702193|538168140|FG001|12 Month Follow up|Lost to Follow-up|18|||
149190854|NCT01201798|538168145|FG000|Overall Study|Adverse Event|2|||
149190855|NCT01201798|538168146|FG001|Overall Study|Adverse Event|0|||
149190856|NCT01201798|538168145|FG000|Overall Study|Lost to Follow-up|3|||
149190857|NCT01201798|538168146|FG001|Overall Study|Lost to Follow-up|5|||
149190858|NCT01201798|538168145|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
149190859|NCT01201798|538168146|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
149190860|NCT01201798|538168145|FG000|Overall Study|Noncompliance|1|||
149190861|NCT01201798|538168146|FG001|Overall Study|Noncompliance|0|||
149190862|NCT01201798|538168145|FG000|Overall Study|Protocol Violation|1|||
149190863|NCT01201798|538168146|FG001|Overall Study|Protocol Violation|1|||
149190864|NCT01201798|538168145|FG000|Overall Study|Treatment Failure|1|||
149190865|NCT01201798|538168146|FG001|Overall Study|Treatment Failure|8|||
149190866|NCT05692154|538168149|FG000|Overall Study|Adverse Event|0|||
149190867|NCT05692154|538168150|FG001|Overall Study|Adverse Event|1|||
149190868|NCT01912729|538168153|FG000|Overall Study|Withdrawal by Subject|0|||
149190869|NCT01912729|538168154|FG001|Overall Study|Withdrawal by Subject|1|||
149190870|NCT04285346|538168162|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
149190871|NCT04285346|538168163|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
149190872|NCT04285346|538168162|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
149190873|NCT04285346|538168163|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
149190874|NCT04285346|538168162|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
149190875|NCT04285346|538168163|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
149190876|NCT01975272|538168166|FG000|Overall Study|Excluded after protocol amendment|1|||
149190877|NCT01975272|538168167|FG001|Overall Study|Excluded after protocol amendment|1|||
149190878|NCT01975272|538168168|FG002|Overall Study|Excluded after protocol amendment|2|||
149190879|NCT03259334|538168172|FG000|Overall Study|Adverse Event|3|||
149190880|NCT03259334|538168173|FG001|Overall Study|Adverse Event|8|||
149190881|NCT03259334|538168174|FG002|Overall Study|Adverse Event|5|||
149190882|NCT03259334|538168172|FG000|Overall Study|Withdrawal by Subject|4|||
149190883|NCT03259334|538168173|FG001|Overall Study|Withdrawal by Subject|2|||
149190884|NCT03259334|538168174|FG002|Overall Study|Withdrawal by Subject|4|||
149190885|NCT03259334|538168172|FG000|Overall Study|Physician Decision|1|||
149190886|NCT03259334|538168173|FG001|Overall Study|Physician Decision|0|||
149190887|NCT03259334|538168174|FG002|Overall Study|Physician Decision|0|||
149190888|NCT03259334|538168172|FG000|Overall Study|Lost to Follow-up|0|||
149190889|NCT03259334|538168173|FG001|Overall Study|Lost to Follow-up|2|||
149190890|NCT03259334|538168174|FG002|Overall Study|Lost to Follow-up|1|||
149190891|NCT03259334|538168172|FG000|Overall Study|Protocol Deviation|0|||
149190892|NCT03259334|538168173|FG001|Overall Study|Protocol Deviation|3|||
149190893|NCT03259334|538168174|FG002|Overall Study|Protocol Deviation|2|||
149190894|NCT03259334|538168172|FG000|Overall Study|Lack of Efficacy|2|||
149190895|NCT03259334|538168173|FG001|Overall Study|Lack of Efficacy|0|||
149190896|NCT03259334|538168174|FG002|Overall Study|Lack of Efficacy|1|||
149190897|NCT03259334|538168172|FG000|Overall Study|Randomized but never treated|0|||
149190898|NCT03259334|538168173|FG001|Overall Study|Randomized but never treated|2|||
149190899|NCT03259334|538168174|FG002|Overall Study|Randomized but never treated|0|||
149190900|NCT00436215|538168175|FG000|Overall Study|Refused further treatment|3|||
149190901|NCT00436215|538168175|FG000|Overall Study|Small bowel obstruction|1|||
149190902|NCT00309777|538168176|FG000|Overall Study|Adverse Event|13|||
148807561|NCT03426878|536773308|FG000|Overall Study|Received negative results by mailed letter|65|||
148807562|NCT03426878|536773308|FG000|Overall Study|Lost to Follow-up|177|||
149190903|NCT00309777|538168177|FG001|Overall Study|Adverse Event|2|||
149190904|NCT00309777|538168178|FG002|Overall Study|Adverse Event|8|||
149190905|NCT00309777|538168179|FG003|Overall Study|Adverse Event|1|||
149190906|NCT00309777|538168176|FG000|Overall Study|Protocol Violation|4|||
149190907|NCT00309777|538168177|FG001|Overall Study|Protocol Violation|1|||
149190908|NCT00309777|538168178|FG002|Overall Study|Protocol Violation|3|||
149190909|NCT00309777|538168179|FG003|Overall Study|Protocol Violation|1|||
148807563|NCT02855268|536773309|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
148807564|NCT02855268|536773310|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
148807565|NCT02855268|536773309|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
149190910|NCT00309777|538168176|FG000|Overall Study|Withdrawal by Subject|6|||
149190911|NCT00309777|538168177|FG001|Overall Study|Withdrawal by Subject|5|||
148807566|NCT02855268|536773310|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
148807567|NCT02855268|536773309|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
149190912|NCT00309777|538168178|FG002|Overall Study|Withdrawal by Subject|7|||
149190913|NCT00309777|538168179|FG003|Overall Study|Withdrawal by Subject|2|||
149190914|NCT00309777|538168176|FG000|Overall Study|Lost to Follow-up|0|||
149190915|NCT00309777|538168177|FG001|Overall Study|Lost to Follow-up|0|||
149190916|NCT00309777|538168178|FG002|Overall Study|Lost to Follow-up|1|||
149190917|NCT00309777|538168179|FG003|Overall Study|Lost to Follow-up|0|||
149190918|NCT00309777|538168176|FG000|Overall Study|Death|0|||
149190919|NCT00309777|538168177|FG001|Overall Study|Death|1|||
149190920|NCT00309777|538168178|FG002|Overall Study|Death|0|||
149190921|NCT00309777|538168179|FG003|Overall Study|Death|0|||
149190922|NCT00683475|538169755|FG000|Overall Study|Withdrawal by Subject|1|||
149190923|NCT00683475|538169756|FG001|Overall Study|Withdrawal by Subject|0|||
149190924|NCT00683475|538169755|FG000|Overall Study|Never Treated: Adverse Event|2|||
148934995|NCT00717093|537247648|FG000|Overall Study|Lack of Efficacy|3|||
148934996|NCT00717093|537247649|FG001|Overall Study|Lack of Efficacy|13|||
148934997|NCT00717093|537247648|FG000|Overall Study|Lost to Follow-up|9|||
148934998|NCT00717093|537247649|FG001|Overall Study|Lost to Follow-up|6|||
149190925|NCT00683475|538169756|FG001|Overall Study|Never Treated: Adverse Event|3|||
149190926|NCT00683475|538169755|FG000|Overall Study|Never Treated: Progressive Disease|1|||
149190927|NCT00683475|538169756|FG001|Overall Study|Never Treated: Progressive Disease|0|||
149190928|NCT02429258|538169760|FG000|Overall Study|Withdrawal by Subject|2|||
148934999|NCT00717093|537247648|FG000|Overall Study|Withdrawal by Subject|12|||
149190929|NCT02429258|538169761|FG001|Overall Study|Withdrawal by Subject|0|||
149190930|NCT02429258|538169760|FG000|Overall Study|Protocol Violation|0|||
149190931|NCT02429258|538169761|FG001|Overall Study|Protocol Violation|1|||
149190932|NCT03364335|538169763|FG000|Overall Study|Adverse Event|3|||
149190933|NCT03364335|538169764|FG001|Overall Study|Adverse Event|4|||
149190934|NCT03364335|538169765|FG002|Overall Study|Adverse Event|1|||
148681270|NCT04378010|536306400|FG002|Overall Study|Adverse Event|4|||
148681271|NCT04378010|536306398|FG000|Overall Study|Withdrawal by Subject|0|||
148681272|NCT04378010|536306399|FG001|Overall Study|Withdrawal by Subject|2|||
148681273|NCT04378010|536306400|FG002|Overall Study|Withdrawal by Subject|1|||
148681274|NCT04378010|536306398|FG000|Overall Study|Protocol Violation|2|||
148681275|NCT04378010|536306399|FG001|Overall Study|Protocol Violation|1|||
148681276|NCT04378010|536306400|FG002|Overall Study|Protocol Violation|4|||
148681277|NCT04378010|536306398|FG000|Overall Study|Study terminated by Sponsor|22|||
148681278|NCT04378010|536306399|FG001|Overall Study|Study terminated by Sponsor|16|||
148681279|NCT04378010|536306400|FG002|Overall Study|Study terminated by Sponsor|22|||
148681280|NCT04378010|536306398|FG000|Overall Study|Subject inability to complete study visit|0|||
148681281|NCT04378010|536306399|FG001|Overall Study|Subject inability to complete study visit|0|||
149190935|NCT03364335|538169766|FG003|Overall Study|Adverse Event|2|||
149190936|NCT03364335|538169767|FG004|Overall Study|Adverse Event|0|||
149190937|NCT03364335|538169763|FG000|Overall Study|Lost to Follow-up|7|||
149190938|NCT03364335|538169764|FG001|Overall Study|Lost to Follow-up|7|||
149190939|NCT03364335|538169765|FG002|Overall Study|Lost to Follow-up|10|||
149190940|NCT03364335|538169766|FG003|Overall Study|Lost to Follow-up|11|||
149190941|NCT03364335|538169767|FG004|Overall Study|Lost to Follow-up|11|||
149190942|NCT03987919|538169768|FG000|Overall Study|Adverse Event|1|||
149190943|NCT03987919|538169769|FG001|Overall Study|Adverse Event|4|||
149190944|NCT03987919|538169770|FG002|Overall Study|Adverse Event|1|||
149190945|NCT03987919|538169771|FG003|Overall Study|Adverse Event|3|||
149190946|NCT03987919|538169768|FG000|Overall Study|Death|4|||
149190947|NCT03987919|538169769|FG001|Overall Study|Death|4|||
149190948|NCT03987919|538169770|FG002|Overall Study|Death|4|||
149190949|NCT03987919|538169771|FG003|Overall Study|Death|1|||
149190950|NCT03987919|538169768|FG000|Overall Study|Lost to Follow-up|5|||
149190951|NCT03987919|538169769|FG001|Overall Study|Lost to Follow-up|6|||
149190952|NCT03987919|538169770|FG002|Overall Study|Lost to Follow-up|8|||
149190953|NCT03987919|538169771|FG003|Overall Study|Lost to Follow-up|12|||
149190954|NCT03987919|538169768|FG000|Overall Study|Physician Decision|0|||
149190955|NCT03987919|538169769|FG001|Overall Study|Physician Decision|2|||
149190956|NCT03987919|538169770|FG002|Overall Study|Physician Decision|0|||
149190957|NCT03987919|538169771|FG003|Overall Study|Physician Decision|4|||
149190958|NCT03987919|538169768|FG000|Overall Study|Pregnancy|1|||
149190959|NCT03987919|538169769|FG001|Overall Study|Pregnancy|0|||
149190960|NCT03987919|538169770|FG002|Overall Study|Pregnancy|1|||
149190961|NCT03987919|538169771|FG003|Overall Study|Pregnancy|1|||
149190962|NCT03987919|538169768|FG000|Overall Study|Protocol Violation|0|||
149190963|NCT03987919|538169769|FG001|Overall Study|Protocol Violation|1|||
149190964|NCT03987919|538169770|FG002|Overall Study|Protocol Violation|0|||
149190965|NCT03987919|538169771|FG003|Overall Study|Protocol Violation|0|||
149190966|NCT03987919|538169768|FG000|Overall Study|Site terminated by Sponsor|0|||
149190967|NCT03987919|538169769|FG001|Overall Study|Site terminated by Sponsor|0|||
149190968|NCT03987919|538169770|FG002|Overall Study|Site terminated by Sponsor|0|||
149190969|NCT03987919|538169771|FG003|Overall Study|Site terminated by Sponsor|1|||
149190970|NCT03987919|538169768|FG000|Overall Study|Withdrawal by Subject|7|||
149190971|NCT03987919|538169769|FG001|Overall Study|Withdrawal by Subject|7|||
149190972|NCT03987919|538169770|FG002|Overall Study|Withdrawal by Subject|8|||
149190973|NCT03987919|538169771|FG003|Overall Study|Withdrawal by Subject|4|||
149190974|NCT03987919|538169768|FG000|Overall Study|Other - as reported by the investigator|1|||
149190975|NCT03987919|538169769|FG001|Overall Study|Other - as reported by the investigator|3|||
149190976|NCT03987919|538169770|FG002|Overall Study|Other - as reported by the investigator|2|||
149190977|NCT03987919|538169771|FG003|Overall Study|Other - as reported by the investigator|0|||
149190978|NCT02330549|538169775|FG000|Overall Study|Adverse Event|1|||
149190979|NCT02330549|538169776|FG001|Overall Study|Adverse Event|0|||
149190980|NCT02330549|538169775|FG000|Overall Study|Subject withdrew consent|2|||
149190981|NCT02330549|538169776|FG001|Overall Study|Subject withdrew consent|1|||
149190982|NCT02330549|538169775|FG000|Overall Study|Failure to meet randomization criteria|1|||
149190983|NCT02330549|538169776|FG001|Overall Study|Failure to meet randomization criteria|0|||
149190984|NCT00853489|538169782|FG000|Overall Study|Lost to Follow-up|5|||
149190985|NCT00853489|538169783|FG001|Overall Study|Lost to Follow-up|2|||
149190986|NCT05525975|538169784|FG000|Overall Study|Surgery cancellation|4|||
149190987|NCT05525975|538169785|FG001|Overall Study|Surgery cancellation|5|||
149190988|NCT05525975|538169784|FG000|Overall Study|didn't fill prescription|1|||
149190989|NCT05525975|538169785|FG001|Overall Study|didn't fill prescription|0|||
148681282|NCT04378010|536306400|FG002|Overall Study|Subject inability to complete study visit|1|||
148681283|NCT04378010|536306398|FG000|Overall Study|Subject never dosed|0|||
149190990|NCT05525975|538169784|FG000|Overall Study|Withdrawal by Subject|0|||
149190991|NCT05525975|538169785|FG001|Overall Study|Withdrawal by Subject|3|||
149190992|NCT02326467|538169786|FG000|Overall Study|Withdrawal by Subject|1|||
149190993|NCT01251276|538169790|FG000|Overall Study|Protocol Violation|1|||
149190994|NCT01251276|538169791|FG001|Overall Study|Protocol Violation|0|||
149190995|NCT01251276|538169790|FG000|Overall Study|Lost to Follow-up|0|||
149190996|NCT01251276|538169791|FG001|Overall Study|Lost to Follow-up|1|||
149190997|NCT00262080|538169795|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
149190998|NCT00262080|538169796|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
149190999|NCT00262080|538169797|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
149191000|NCT00262080|538169795|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
149191001|NCT00262080|538169796|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
149191002|NCT00262080|538169797|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
149191003|NCT00262080|538169795|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
149191004|NCT00262080|538169796|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
149191005|NCT00262080|538169797|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
149191006|NCT00262080|538169795|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
149191007|NCT00262080|538169796|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
149191008|NCT00262080|538169797|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
149191009|NCT00262080|538169795|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
149191010|NCT00262080|538169796|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
149191011|NCT00262080|538169797|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
149191012|NCT00262080|538169795|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
149191013|NCT00262080|538169796|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
149191014|NCT00262080|538169797|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
149191015|NCT01051986|538169798|FG000|Overall Study|Death|1|||
149191016|NCT01051986|538169799|FG001|Overall Study|Death|0|||
149191017|NCT01051986|538169798|FG000|Overall Study|Withdrawal by Subject|2|||
149191018|NCT01051986|538169799|FG001|Overall Study|Withdrawal by Subject|1|||
149191019|NCT01051986|538169798|FG000|Overall Study|Protocol Violation|2|||
149191020|NCT01051986|538169799|FG001|Overall Study|Protocol Violation|3|||
149191021|NCT03580382|538169805|FG000|Overall Study|Early Termination of Study|0|||
149191022|NCT03580382|538169806|FG001|Overall Study|Early Termination of Study|3|||
149191023|NCT02420223|538169807|FG000|Overall Study|Adverse Event|1|||
149191024|NCT02420223|538169808|FG001|Overall Study|Adverse Event|0|||
149191025|NCT02420223|538169807|FG000|Overall Study|Physician Decision|0|||
149191026|NCT02420223|538169808|FG001|Overall Study|Physician Decision|2|||
149191027|NCT01361009|538169809|FG000|Overall Study|Protocol Violation|116|||
149191028|NCT04009096|538169813|FG000|Overall Study|Withdrawal by Subject|0|||
149191029|NCT04009096|538169814|FG001|Overall Study|Withdrawal by Subject|7|||
149191030|NCT04009096|538169815|FG002|Overall Study|Withdrawal by Subject|0|||
149191031|NCT04009096|538169813|FG000|Overall Study|Physician Decision|0|||
149191032|NCT04009096|538169814|FG001|Overall Study|Physician Decision|1|||
149191033|NCT04009096|538169815|FG002|Overall Study|Physician Decision|0|||
149191034|NCT00520676|538169818|FG000|Overall Study|Death|84|||
149191035|NCT00520676|538169819|FG001|Overall Study|Death|81|||
149191036|NCT00520676|538169818|FG000|Overall Study|Lost to Follow-up|6|||
149191037|NCT00520676|538169819|FG001|Overall Study|Lost to Follow-up|10|||
149191038|NCT00520676|538169818|FG000|Overall Study|Physician Decision|4|||
149191039|NCT00520676|538169819|FG001|Overall Study|Physician Decision|1|||
149191040|NCT00520676|538169818|FG000|Overall Study|Withdrawal by Subject|7|||
149191041|NCT00520676|538169819|FG001|Overall Study|Withdrawal by Subject|11|||
149191042|NCT03484923|538169822|FG000|Overall Study|Adverse Event|3|||
149191043|NCT03484923|538169823|FG001|Overall Study|Adverse Event|3|||
149191044|NCT03484923|538169824|FG002|Overall Study|Adverse Event|5|||
149191045|NCT03484923|538169825|FG003|Overall Study|Adverse Event|11|||
149191046|NCT03484923|538169826|FG004|Overall Study|Adverse Event|1|||
149191047|NCT03484923|538169822|FG000|Overall Study|Death|2|||
149191048|NCT03484923|538169823|FG001|Overall Study|Death|2|||
149191049|NCT03484923|538169824|FG002|Overall Study|Death|3|||
149191050|NCT03484923|538169825|FG003|Overall Study|Death|0|||
149191051|NCT03484923|538169826|FG004|Overall Study|Death|1|||
149191052|NCT03484923|538169822|FG000|Overall Study|Physician Decision|6|||
149191053|NCT03484923|538169823|FG001|Overall Study|Physician Decision|7|||
149191054|NCT03484923|538169824|FG002|Overall Study|Physician Decision|6|||
149191055|NCT03484923|538169825|FG003|Overall Study|Physician Decision|3|||
149191056|NCT03484923|538169826|FG004|Overall Study|Physician Decision|2|||
149191057|NCT03484923|538169822|FG000|Overall Study|Progressive disease|33|||
149191058|NCT03484923|538169823|FG001|Overall Study|Progressive disease|28|||
149191059|NCT03484923|538169824|FG002|Overall Study|Progressive disease|26|||
149191060|NCT03484923|538169825|FG003|Overall Study|Progressive disease|30|||
149191061|NCT03484923|538169826|FG004|Overall Study|Progressive disease|16|||
149191062|NCT03484923|538169822|FG000|Overall Study|Subject Decision|1|||
149191063|NCT03484923|538169823|FG001|Overall Study|Subject Decision|3|||
149191064|NCT03484923|538169824|FG002|Overall Study|Subject Decision|3|||
149191065|NCT03484923|538169825|FG003|Overall Study|Subject Decision|0|||
149191066|NCT03484923|538169826|FG004|Overall Study|Subject Decision|1|||
149191067|NCT03439748|538169827|FG000|Overall Study|Withdrawal by Subject|11|||
148807568|NCT02855268|536773310|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
148807569|NCT02855268|536773309|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
149191068|NCT03439748|538169828|FG001|Overall Study|Withdrawal by Subject|17|||
149191069|NCT03298412|538169831|FG000|Run-in Period|Other, Not Specified|1|||
149191070|NCT03298412|538169831|FG000|Run-in Period|Disease Progression|1|||
149191071|NCT03298412|538169831|FG000|Run-in Period|Ineligibility Determined|1|||
149191072|NCT03298412|538169831|FG000|Run-in Period|Decision by Sponsor|6|||
149191073|NCT01028651|538169836|FG000|Overall Study|Death|2|||
149191074|NCT01028651|538169836|FG000|Overall Study|Adverse Event|1|||
149191075|NCT01533935|538169837|FG000|Overall Study|Adverse Event|5|||
149191076|NCT01533935|538169838|FG001|Overall Study|Adverse Event|7|||
149191077|NCT01533935|538169839|FG002|Overall Study|Adverse Event|1|||
149191078|NCT01533935|538169840|FG003|Overall Study|Adverse Event|5|||
149191079|NCT01533935|538169841|FG004|Overall Study|Adverse Event|3|||
149191080|NCT01533935|538169837|FG000|Overall Study|Protocol Violation|0|||
149191081|NCT01533935|538169838|FG001|Overall Study|Protocol Violation|2|||
149191082|NCT01533935|538169839|FG002|Overall Study|Protocol Violation|0|||
149191083|NCT01533935|538169840|FG003|Overall Study|Protocol Violation|0|||
149191084|NCT01533935|538169841|FG004|Overall Study|Protocol Violation|0|||
149191085|NCT01533935|538169837|FG000|Overall Study|Lost to Follow-up|0|||
149191086|NCT01533935|538169838|FG001|Overall Study|Lost to Follow-up|0|||
149191087|NCT01533935|538169839|FG002|Overall Study|Lost to Follow-up|1|||
149191088|NCT01533935|538169840|FG003|Overall Study|Lost to Follow-up|0|||
149191089|NCT01533935|538169841|FG004|Overall Study|Lost to Follow-up|0|||
149191090|NCT01533935|538169837|FG000|Overall Study|Withdrawal by Subject|0|||
149191091|NCT01533935|538169838|FG001|Overall Study|Withdrawal by Subject|4|||
149191092|NCT01533935|538169839|FG002|Overall Study|Withdrawal by Subject|5|||
149191093|NCT01533935|538169840|FG003|Overall Study|Withdrawal by Subject|2|||
149191094|NCT01533935|538169841|FG004|Overall Study|Withdrawal by Subject|4|||
149191095|NCT01533935|538169837|FG000|Overall Study|Other reason not defined above|1|||
149191096|NCT01533935|538169838|FG001|Overall Study|Other reason not defined above|0|||
149191097|NCT01533935|538169839|FG002|Overall Study|Other reason not defined above|1|||
149191098|NCT01533935|538169840|FG003|Overall Study|Other reason not defined above|0|||
149191099|NCT01533935|538169841|FG004|Overall Study|Other reason not defined above|1|||
149191100|NCT05631548|538169842|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
149191101|NCT05631548|538169843|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
149191102|NCT02935634|538169844|FG000|Randomization|Participant withdrew consent|0|||
149191103|NCT02935634|538169845|FG001|Randomization|Participant withdrew consent|1|||
149191104|NCT02935634|538169846|FG002|Randomization|Participant withdrew consent|0|||
149191105|NCT02935634|538169847|FG003|Randomization|Participant withdrew consent|0|||
149191106|NCT02935634|538169848|FG004|Randomization|Participant withdrew consent|0|||
149191107|NCT02935634|538169849|FG005|Randomization|Participant withdrew consent|0|||
149191108|NCT02935634|538169844|FG000|Randomization|Death|2|||
149191109|NCT02935634|538169845|FG001|Randomization|Death|1|||
149191110|NCT02935634|538169846|FG002|Randomization|Death|1|||
149191111|NCT02935634|538169847|FG003|Randomization|Death|0|||
149191112|NCT02935634|538169848|FG004|Randomization|Death|0|||
149191113|NCT02935634|538169849|FG005|Randomization|Death|0|||
149191114|NCT02935634|538169844|FG000|Randomization|Other reasons|0|||
149191115|NCT02935634|538169845|FG001|Randomization|Other reasons|2|||
149191116|NCT02935634|538169846|FG002|Randomization|Other reasons|2|||
149191117|NCT02935634|538169847|FG003|Randomization|Other reasons|0|||
148681284|NCT04378010|536306399|FG001|Overall Study|Subject never dosed|1|||
149191118|NCT02935634|538169848|FG004|Randomization|Other reasons|0|||
149191119|NCT02935634|538169849|FG005|Randomization|Other reasons|0|||
149191120|NCT02935634|538169844|FG000|Treatment: Track 1|Disease progression|15|||
149191121|NCT02935634|538169845|FG001|Treatment: Track 1|Disease progression|17|||
149191122|NCT02935634|538169846|FG002|Treatment: Track 1|Disease progression|28|||
149191123|NCT02935634|538169847|FG003|Treatment: Track 1|Disease progression|4|||
148681285|NCT04378010|536306400|FG002|Overall Study|Subject never dosed|0|||
148681286|NCT01792284|536306401|FG000|Lead-in Period|Adverse Event|15|||
148681287|NCT01792284|536306402|FG001|Lead-in Period|Adverse Event|0|||
148681288|NCT01792284|536306403|FG002|Lead-in Period|Adverse Event|0|||
148681289|NCT01792284|536306401|FG000|Lead-in Period|Lost to Follow-up|2|||
148681290|NCT01792284|536306402|FG001|Lead-in Period|Lost to Follow-up|0|||
148681291|NCT01792284|536306403|FG002|Lead-in Period|Lost to Follow-up|0|||
148681292|NCT01792284|536306401|FG000|Lead-in Period|Protocol Violation|1|||
148681293|NCT01792284|536306402|FG001|Lead-in Period|Protocol Violation|0|||
148681294|NCT01792284|536306403|FG002|Lead-in Period|Protocol Violation|0|||
148681295|NCT01792284|536306401|FG000|Lead-in Period|Withdrawal by Subject|10|||
148681296|NCT01792284|536306402|FG001|Lead-in Period|Withdrawal by Subject|0|||
148681297|NCT01792284|536306403|FG002|Lead-in Period|Withdrawal by Subject|0|||
148681298|NCT01792284|536306401|FG000|Lead-in Period|Physician Decision|1|||
148681299|NCT01792284|536306402|FG001|Lead-in Period|Physician Decision|0|||
148681300|NCT01792284|536306403|FG002|Lead-in Period|Physician Decision|0|||
148681301|NCT01792284|536306401|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
148681302|NCT01792284|536306402|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
148935000|NCT00717093|537247649|FG001|Overall Study|Withdrawal by Subject|19|||
148935001|NCT00717093|537247648|FG000|Overall Study|Other|0|||
148935002|NCT00717093|537247649|FG001|Overall Study|Other|1|||
148935003|NCT00717093|537247648|FG000|Overall Study|Randomized but not treated|1|||
148935004|NCT00717093|537247649|FG001|Overall Study|Randomized but not treated|0|||
148935005|NCT02742441|537247650|FG000|Overall Study|Lost to Follow-up|4|||
149191124|NCT02935634|538169848|FG004|Treatment: Track 1|Disease progression|6|||
148681303|NCT01792284|536306403|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
148681304|NCT01792284|536306401|FG000|Randomization Period 1|Withdrawal by Subject|0|||
148681305|NCT01792284|536306402|FG001|Randomization Period 1|Withdrawal by Subject|1|||
148681306|NCT01792284|536306403|FG002|Randomization Period 1|Withdrawal by Subject|1|||
148681307|NCT01792284|536306401|FG000|Randomization Period 1|Physician Decision|0|||
148681308|NCT01792284|536306402|FG001|Randomization Period 1|Physician Decision|1|||
148681309|NCT01792284|536306403|FG002|Randomization Period 1|Physician Decision|1|||
148681310|NCT01792284|536306401|FG000|Randomization Period 1|Adverse Event|0|||
148681311|NCT01792284|536306402|FG001|Randomization Period 1|Adverse Event|0|||
148681312|NCT01792284|536306403|FG002|Randomization Period 1|Adverse Event|2|||
148681313|NCT01792284|536306401|FG000|Randomization Period 1|Lost to Follow-up|0|||
148681314|NCT01792284|536306402|FG001|Randomization Period 1|Lost to Follow-up|0|||
148681315|NCT01792284|536306403|FG002|Randomization Period 1|Lost to Follow-up|1|||
148681316|NCT01792284|536306401|FG000|Randomization Period 2|Protocol Violation|0|||
148681317|NCT01792284|536306402|FG001|Randomization Period 2|Protocol Violation|1|||
148681318|NCT01792284|536306403|FG002|Randomization Period 2|Protocol Violation|0|||
148681319|NCT01792284|536306401|FG000|Randomization Period 2|Withdrawal by Subject|0|||
148681320|NCT01792284|536306402|FG001|Randomization Period 2|Withdrawal by Subject|2|||
148681321|NCT01792284|536306403|FG002|Randomization Period 2|Withdrawal by Subject|0|||
148681322|NCT02019979|536306404|FG000|Overall Study|study terminated|14|||
149191125|NCT02935634|538169849|FG005|Treatment: Track 1|Disease progression|2|||
149191126|NCT02935634|538169844|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
149191127|NCT02935634|538169845|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
149191128|NCT02935634|538169846|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
149191129|NCT02935634|538169847|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
149191130|NCT02935634|538169848|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
149191131|NCT02935634|538169849|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
149191132|NCT02935634|538169844|FG000|Treatment: Track 1|Lost to Follow-up|1|||
149191133|NCT02935634|538169845|FG001|Treatment: Track 1|Lost to Follow-up|0|||
149191134|NCT02935634|538169846|FG002|Treatment: Track 1|Lost to Follow-up|0|||
149191135|NCT02935634|538169847|FG003|Treatment: Track 1|Lost to Follow-up|0|||
148681323|NCT00379587|536306410|FG000|Overall Study|Lost to Follow-up|2|||
148681324|NCT03237611|536306411|FG000|Overall Study|Withdrawal by Subject|1|||
148681325|NCT03237611|536306411|FG000|Overall Study|Ineligible|1|||
148935006|NCT02742441|537247651|FG001|Overall Study|Lost to Follow-up|4|||
149191136|NCT02935634|538169848|FG004|Treatment: Track 1|Lost to Follow-up|0|||
148681326|NCT00923195|536306412|FG000|Overall Study|Death|0|||
148681327|NCT00923195|536306413|FG001|Overall Study|Death|1|||
148681328|NCT00525031|536306414|FG000|Overall Study|Disease Progression|1|||
148681329|NCT00525031|536306415|FG001|Overall Study|Disease Progression|1|||
148681330|NCT02140164|536306418|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
148681331|NCT01814761|536306419|FG000|Overall Study|Other Reasons|1|||
148681332|NCT01814761|536306420|FG001|Overall Study|Other Reasons|10|||
148681333|NCT01814761|536306419|FG000|Overall Study|Ocular Adverse Event|6|||
148681334|NCT01814761|536306420|FG001|Overall Study|Ocular Adverse Event|15|||
148681335|NCT01814761|536306419|FG000|Overall Study|Lost to Follow-up|1|||
148681336|NCT01814761|536306420|FG001|Overall Study|Lost to Follow-up|5|||
148681337|NCT02962882|536306421|FG000|Overall Study|Adverse Event|2|||
148681338|NCT02962882|536306421|FG000|Overall Study|Withdrawal by Subject|2|||
148681339|NCT02962882|536306421|FG000|Overall Study|Transfer from ICU|32|||
148935007|NCT02742441|537247650|FG000|Overall Study|Withdrawal by Subject|2|||
149191137|NCT02935634|538169849|FG005|Treatment: Track 1|Lost to Follow-up|0|||
149191138|NCT02935634|538169844|FG000|Treatment: Track 1|Study drug toxicity|2|||
148681340|NCT01155063|536306422|FG000|Overall Study|Adverse Event|1|||
148681341|NCT01155063|536306422|FG000|Overall Study|Withdrawal by Subject|1|||
148681342|NCT01155063|536306422|FG000|Overall Study|Study terminated by sponsor|87|||
148681343|NCT01456052|536306423|FG000|Overall Study|Adverse Event|1|||
148681344|NCT01456052|536306424|FG001|Overall Study|Adverse Event|1|||
148681345|NCT01456052|536306425|FG002|Overall Study|Adverse Event|2|||
148681346|NCT01456052|536306423|FG000|Overall Study|Consent withdrawn|0|||
148681347|NCT01456052|536306424|FG001|Overall Study|Consent withdrawn|2|||
148681348|NCT01456052|536306425|FG002|Overall Study|Consent withdrawn|1|||
148681349|NCT01456052|536306423|FG000|Overall Study|Protocol Violation|0|||
148681350|NCT01456052|536306424|FG001|Overall Study|Protocol Violation|1|||
148681351|NCT01456052|536306425|FG002|Overall Study|Protocol Violation|0|||
148681352|NCT01456052|536306423|FG000|Overall Study|Physician Decision|1|||
148935008|NCT02742441|537247651|FG001|Overall Study|Withdrawal by Subject|2|||
148935009|NCT02742441|537247650|FG000|Overall Study|Adverse Event|0|||
148935010|NCT02742441|537247651|FG001|Overall Study|Adverse Event|2|||
148935011|NCT02281773|537247655|FG000|Overall Study|Adverse Event|6|||
148935012|NCT02281773|537247656|FG001|Overall Study|Adverse Event|1|||
148935013|NCT02281773|537247657|FG002|Overall Study|Adverse Event|4|||
148935014|NCT02281773|537247658|FG003|Overall Study|Adverse Event|8|||
148935015|NCT02281773|537247659|FG004|Overall Study|Adverse Event|9|||
148935016|NCT02281773|537247655|FG000|Overall Study|Protocol Violation|1|||
148935017|NCT02281773|537247656|FG001|Overall Study|Protocol Violation|0|||
148935018|NCT02281773|537247657|FG002|Overall Study|Protocol Violation|0|||
148935019|NCT02281773|537247658|FG003|Overall Study|Protocol Violation|2|||
148935020|NCT02281773|537247659|FG004|Overall Study|Protocol Violation|2|||
148935021|NCT02281773|537247655|FG000|Overall Study|Lost to Follow-up|2|||
148935022|NCT02281773|537247656|FG001|Overall Study|Lost to Follow-up|2|||
148935023|NCT02281773|537247657|FG002|Overall Study|Lost to Follow-up|6|||
148935024|NCT02281773|537247658|FG003|Overall Study|Lost to Follow-up|2|||
148935025|NCT02281773|537247659|FG004|Overall Study|Lost to Follow-up|10|||
148935026|NCT02281773|537247655|FG000|Overall Study|Withdrawal by Subject|2|||
148935027|NCT02281773|537247656|FG001|Overall Study|Withdrawal by Subject|8|||
148681353|NCT01456052|536306424|FG001|Overall Study|Physician Decision|0|||
148681354|NCT01456052|536306425|FG002|Overall Study|Physician Decision|1|||
148935028|NCT02281773|537247657|FG002|Overall Study|Withdrawal by Subject|6|||
148935029|NCT02281773|537247658|FG003|Overall Study|Withdrawal by Subject|6|||
148935030|NCT02281773|537247659|FG004|Overall Study|Withdrawal by Subject|8|||
148935031|NCT02281773|537247655|FG000|Overall Study|Other Reason|0|||
148935032|NCT02281773|537247656|FG001|Overall Study|Other Reason|4|||
148935033|NCT02281773|537247657|FG002|Overall Study|Other Reason|2|||
148681355|NCT01456052|536306423|FG000|Overall Study|Treatment Failure|0|||
149191139|NCT02935634|538169845|FG001|Treatment: Track 1|Study drug toxicity|1|||
148681356|NCT01456052|536306424|FG001|Overall Study|Treatment Failure|1|||
148681357|NCT01456052|536306425|FG002|Overall Study|Treatment Failure|1|||
148681358|NCT02424565|536306426|FG000|Period 1 (D0)|Protocol Violation|0|||
148935034|NCT02281773|537247658|FG003|Overall Study|Other Reason|3|||
148935035|NCT02281773|537247659|FG004|Overall Study|Other Reason|1|||
148935036|NCT02104752|537247661|FG000|Overall Study|Withdrawal by Subject|1|||
148935037|NCT02104752|537247662|FG001|Overall Study|Withdrawal by Subject|0|||
149191140|NCT02935634|538169846|FG002|Treatment: Track 1|Study drug toxicity|3|||
149191141|NCT02935634|538169847|FG003|Treatment: Track 1|Study drug toxicity|0|||
149191142|NCT02935634|538169848|FG004|Treatment: Track 1|Study drug toxicity|0|||
149191143|NCT02935634|538169849|FG005|Treatment: Track 1|Study drug toxicity|1|||
149191144|NCT02935634|538169844|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
149191145|NCT02935634|538169845|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
149191146|NCT02935634|538169846|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
149191147|NCT02935634|538169847|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
149191148|NCT02935634|538169848|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
149191149|NCT02935634|538169849|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
149191150|NCT02935634|538169844|FG000|Treatment: Track 1|Participant withdrew consent|2|||
149191151|NCT02935634|538169845|FG001|Treatment: Track 1|Participant withdrew consent|0|||
149191152|NCT02935634|538169846|FG002|Treatment: Track 1|Participant withdrew consent|1|||
149191153|NCT02935634|538169847|FG003|Treatment: Track 1|Participant withdrew consent|0|||
149191154|NCT02935634|538169848|FG004|Treatment: Track 1|Participant withdrew consent|1|||
149191155|NCT02935634|538169849|FG005|Treatment: Track 1|Participant withdrew consent|0|||
149191156|NCT02935634|538169844|FG000|Treatment: Track 1|Other reasons|0|||
149191157|NCT02935634|538169845|FG001|Treatment: Track 1|Other reasons|0|||
149191158|NCT02935634|538169846|FG002|Treatment: Track 1|Other reasons|2|||
149191159|NCT02935634|538169847|FG003|Treatment: Track 1|Other reasons|0|||
149191160|NCT02935634|538169848|FG004|Treatment: Track 1|Other reasons|0|||
149191161|NCT02935634|538169849|FG005|Treatment: Track 1|Other reasons|0|||
149191162|NCT02935634|538169844|FG000|Treatment: Track 2|Disease progression|13|||
148681359|NCT02424565|536306427|FG001|Period 1 (D0)|Protocol Violation|1|||
148935038|NCT02104752|537247661|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
148935039|NCT02104752|537247662|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
148935040|NCT02899299|537247665|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
148935041|NCT02899299|537247666|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
148935042|NCT02899299|537247665|FG000|Pre-treatment|Participant withdrew consent|1|||
148935043|NCT02899299|537247666|FG001|Pre-treatment|Participant withdrew consent|11|||
148935044|NCT02899299|537247665|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
149191163|NCT02935634|538169845|FG001|Treatment: Track 2|Disease progression|26|||
148681360|NCT01677910|536306428|FG000|Double-Blind Treatment Period|Adverse Event|6|||
148681361|NCT01677910|536306429|FG001|Double-Blind Treatment Period|Adverse Event|2|||
148681362|NCT01677910|536306430|FG002|Double-Blind Treatment Period|Adverse Event|3|||
148681363|NCT01677910|536306431|FG003|Double-Blind Treatment Period|Adverse Event|0|||
148681364|NCT01677910|536306428|FG000|Double-Blind Treatment Period|Physician Decision|0|||
148681365|NCT01677910|536306429|FG001|Double-Blind Treatment Period|Physician Decision|0|||
148681366|NCT01677910|536306430|FG002|Double-Blind Treatment Period|Physician Decision|1|||
148681367|NCT01677910|536306431|FG003|Double-Blind Treatment Period|Physician Decision|0|||
148681368|NCT01677910|536306428|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
148681369|NCT01677910|536306429|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
148681370|NCT01677910|536306430|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
148681371|NCT01677910|536306431|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
148681372|NCT01677910|536306428|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
148681373|NCT01677910|536306429|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
148681374|NCT01677910|536306430|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
148681375|NCT01677910|536306431|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
148681376|NCT01677910|536306428|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
148681377|NCT01677910|536306429|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
148681378|NCT01677910|536306430|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
148681379|NCT01677910|536306431|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
148681380|NCT01677910|536306428|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
148681381|NCT01677910|536306429|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
148681382|NCT01677910|536306430|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
148681383|NCT01677910|536306431|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
148681384|NCT01677910|536306428|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
148681385|NCT01677910|536306429|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
148681386|NCT01677910|536306430|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
148681387|NCT01677910|536306431|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
148681388|NCT01677910|536306428|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
148681389|NCT01677910|536306429|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
148681390|NCT01677910|536306430|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
148681391|NCT01677910|536306431|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
148681392|NCT01677910|536306428|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
148681393|NCT01677910|536306429|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
148681394|NCT01677910|536306430|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
148681395|NCT01677910|536306431|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
148681396|NCT01677910|536306428|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
148681397|NCT01677910|536306429|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
148681398|NCT01677910|536306430|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
148681399|NCT01677910|536306431|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
148681400|NCT03650400|536306432|FG000|Overall Study|Study terminated by sponsor|0|||
148681401|NCT03650400|536306433|FG001|Overall Study|Study terminated by sponsor|5|||
148681402|NCT03066440|536306434|FG000|Overall Study|Physician Decision|1|||
148681403|NCT03066440|536306435|FG001|Overall Study|Physician Decision|1|||
148681404|NCT03066440|536306434|FG000|Overall Study|Protocol Violation|0|||
148681405|NCT03066440|536306435|FG001|Overall Study|Protocol Violation|2|||
148681406|NCT04991311|536306437|FG000|Overall Study|Adverse Event|1|||
148681407|NCT00054275|536306438|FG000|Overall Study|Withdrawal by Subject|4|||
149191164|NCT02935634|538169846|FG002|Treatment: Track 2|Disease progression|20|||
149191165|NCT02935634|538169847|FG003|Treatment: Track 2|Disease progression|5|||
149191166|NCT02935634|538169848|FG004|Treatment: Track 2|Disease progression|1|||
149191167|NCT02935634|538169849|FG005|Treatment: Track 2|Disease progression|4|||
149191168|NCT02935634|538169844|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
148935045|NCT02899299|537247666|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
149191169|NCT02935634|538169845|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
149191170|NCT02935634|538169846|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
149191171|NCT02935634|538169847|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
148681408|NCT00054275|536306438|FG000|Overall Study|Adverse Event|5|||
148681409|NCT00054275|536306438|FG000|Overall Study|Progressive disease in cycle 1|1|||
148681410|NCT00054275|536306438|FG000|Overall Study|Physician Decision|1|||
148681411|NCT00755937|536306439|FG000|Recruitment|Unknown if infliximab received|164|||
148681412|NCT00755937|536306439|FG000|Observational Follow-up|Lost to Follow-up|148|||
148681413|NCT03876873|536306440|FG000|Overall Study|Physician Decision|0|||
148681414|NCT03876873|536306441|FG001|Overall Study|Physician Decision|1|||
148681415|NCT01106352|536306442|FG000|Overall Study|Subjects untreated|0|||
148681416|NCT01106352|536306443|FG001|Overall Study|Subjects untreated|0|||
148681417|NCT01106352|536306444|FG002|Overall Study|Subjects untreated|0|||
148681418|NCT01106352|536306445|FG003|Overall Study|Subjects untreated|3|||
148681419|NCT01106352|536306446|FG004|Overall Study|Subjects untreated|4|||
148681420|NCT01106352|536306442|FG000|Overall Study|Sponsor Decision|1|||
148681421|NCT01106352|536306443|FG001|Overall Study|Sponsor Decision|0|||
148935046|NCT02899299|537247665|FG000|Pre-treatment|Not reported|0|||
148935047|NCT02899299|537247666|FG001|Pre-treatment|Not reported|1|||
148935048|NCT02899299|537247665|FG000|Treatment|Disease Progression|182|||
148935049|NCT02899299|537247666|FG001|Treatment|Disease Progression|43|||
148935050|NCT02899299|537247665|FG000|Treatment|Study Drug Toxicity|60|||
148935051|NCT02899299|537247666|FG001|Treatment|Study Drug Toxicity|24|||
148935052|NCT02899299|537247665|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
148935053|NCT02899299|537247666|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
148681422|NCT01106352|536306444|FG002|Overall Study|Sponsor Decision|0|||
148681423|NCT01106352|536306445|FG003|Overall Study|Sponsor Decision|0|||
148681424|NCT01106352|536306446|FG004|Overall Study|Sponsor Decision|0|||
148681425|NCT01106352|536306442|FG000|Overall Study|Too ill to come in for the visit|0|||
148935054|NCT02899299|537247665|FG000|Treatment|Participant request to discontinue Study treatment|4|||
148935055|NCT02899299|537247666|FG001|Treatment|Participant request to discontinue Study treatment|10|||
148935056|NCT02899299|537247665|FG000|Treatment|Participant withdrew consent|6|||
148935057|NCT02899299|537247666|FG001|Treatment|Participant withdrew consent|3|||
149191172|NCT02935634|538169848|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
148681426|NCT01106352|536306443|FG001|Overall Study|Too ill to come in for the visit|0|||
148681427|NCT01106352|536306444|FG002|Overall Study|Too ill to come in for the visit|1|||
148681428|NCT01106352|536306445|FG003|Overall Study|Too ill to come in for the visit|0|||
148681429|NCT01106352|536306446|FG004|Overall Study|Too ill to come in for the visit|0|||
148681430|NCT01106352|536306442|FG000|Overall Study|Lost to Follow-up|0|||
148681431|NCT01106352|536306443|FG001|Overall Study|Lost to Follow-up|0|||
148807570|NCT02855268|536773310|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
148807571|NCT02855268|536773309|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
149191173|NCT02935634|538169849|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
149191174|NCT02935634|538169844|FG000|Treatment: Track 2|Study drug toxicity|7|||
148807572|NCT02855268|536773310|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
148807573|NCT02855268|536773309|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
149191175|NCT02935634|538169845|FG001|Treatment: Track 2|Study drug toxicity|3|||
149191176|NCT02935634|538169846|FG002|Treatment: Track 2|Study drug toxicity|0|||
149191177|NCT02935634|538169847|FG003|Treatment: Track 2|Study drug toxicity|0|||
149191178|NCT02935634|538169848|FG004|Treatment: Track 2|Study drug toxicity|0|||
149191179|NCT02935634|538169849|FG005|Treatment: Track 2|Study drug toxicity|0|||
149191180|NCT02935634|538169844|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
149191181|NCT02935634|538169845|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
149191182|NCT02935634|538169846|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
149191183|NCT02935634|538169847|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
149191184|NCT02935634|538169848|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
149191185|NCT02935634|538169849|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
149191186|NCT02935634|538169844|FG000|Treatment: Track 2|Participant withdrew consent|0|||
149191187|NCT02935634|538169845|FG001|Treatment: Track 2|Participant withdrew consent|1|||
149191188|NCT02935634|538169846|FG002|Treatment: Track 2|Participant withdrew consent|1|||
149191189|NCT02935634|538169847|FG003|Treatment: Track 2|Participant withdrew consent|0|||
149191190|NCT02935634|538169848|FG004|Treatment: Track 2|Participant withdrew consent|1|||
149191191|NCT02935634|538169849|FG005|Treatment: Track 2|Participant withdrew consent|0|||
149191192|NCT04075266|538169850|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
149191193|NCT04075266|538169851|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
149191194|NCT04075266|538169850|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
149191195|NCT04075266|538169851|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
148681432|NCT01106352|536306444|FG002|Overall Study|Lost to Follow-up|0|||
148681433|NCT01106352|536306445|FG003|Overall Study|Lost to Follow-up|0|||
148681434|NCT01106352|536306446|FG004|Overall Study|Lost to Follow-up|1|||
148681435|NCT01106352|536306442|FG000|Overall Study|Death|0|||
148807574|NCT02855268|536773310|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
149191196|NCT01554956|538169852|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
148681436|NCT01106352|536306443|FG001|Overall Study|Death|0|||
148681437|NCT01106352|536306444|FG002|Overall Study|Death|1|||
148681438|NCT01106352|536306445|FG003|Overall Study|Death|3|||
148681439|NCT01106352|536306446|FG004|Overall Study|Death|1|||
148935058|NCT02899299|537247665|FG000|Treatment|Lost to Follow-up|0|||
148935059|NCT02899299|537247666|FG001|Treatment|Lost to Follow-up|2|||
149191197|NCT01554956|538169853|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
148681440|NCT01106352|536306442|FG000|Overall Study|Disease progression|0|||
148681441|NCT01106352|536306443|FG001|Overall Study|Disease progression|0|||
148681442|NCT01106352|536306444|FG002|Overall Study|Disease progression|0|||
148681443|NCT01106352|536306445|FG003|Overall Study|Disease progression|1|||
148681444|NCT01106352|536306446|FG004|Overall Study|Disease progression|0|||
148681445|NCT01106352|536306442|FG000|Overall Study|Withdrawal by Subject|0|||
148681446|NCT01106352|536306443|FG001|Overall Study|Withdrawal by Subject|0|||
148681447|NCT01106352|536306444|FG002|Overall Study|Withdrawal by Subject|0|||
148681448|NCT01106352|536306445|FG003|Overall Study|Withdrawal by Subject|3|||
148681449|NCT01106352|536306446|FG004|Overall Study|Withdrawal by Subject|2|||
148681450|NCT01106352|536306442|FG000|Overall Study|Went on hospice|0|||
148681451|NCT01106352|536306443|FG001|Overall Study|Went on hospice|0|||
148681452|NCT01106352|536306444|FG002|Overall Study|Went on hospice|0|||
148681453|NCT01106352|536306445|FG003|Overall Study|Went on hospice|1|||
148681454|NCT01106352|536306446|FG004|Overall Study|Went on hospice|0|||
148681455|NCT01106352|536306442|FG000|Overall Study|Subject entered hospice|0|||
148681456|NCT01106352|536306443|FG001|Overall Study|Subject entered hospice|0|||
148681457|NCT01106352|536306444|FG002|Overall Study|Subject entered hospice|0|||
148681458|NCT01106352|536306445|FG003|Overall Study|Subject entered hospice|1|||
148681459|NCT01106352|536306446|FG004|Overall Study|Subject entered hospice|0|||
148681460|NCT01106352|536306442|FG000|Overall Study|Home hospice since July 2013|0|||
148681461|NCT01106352|536306443|FG001|Overall Study|Home hospice since July 2013|0|||
148681462|NCT01106352|536306444|FG002|Overall Study|Home hospice since July 2013|0|||
148681463|NCT01106352|536306445|FG003|Overall Study|Home hospice since July 2013|1|||
149191198|NCT01554956|538169854|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
149191199|NCT01554956|538169852|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
149191200|NCT01554956|538169853|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
148681464|NCT01106352|536306446|FG004|Overall Study|Home hospice since July 2013|0|||
148681465|NCT03547531|536306447|FG000|Overall Study|not coming in data collection : sick|2|||
148681466|NCT03547531|536306448|FG001|Overall Study|not coming in data collection : sick|2|||
148681467|NCT03547531|536306447|FG000|Overall Study|having family occasion|0|||
148681468|NCT03547531|536306448|FG001|Overall Study|having family occasion|2|||
148681469|NCT03944707|536306456|FG000|Overall Study|Adverse Event|0|||
149191201|NCT01554956|538169854|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
149191202|NCT01554956|538169852|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
149191203|NCT01554956|538169853|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
148681470|NCT03944707|536306457|FG001|Overall Study|Adverse Event|2|||
148681471|NCT03944707|536306456|FG000|Overall Study|Study terminated by sponsor|12|||
148681472|NCT03944707|536306457|FG001|Overall Study|Study terminated by sponsor|7|||
148681473|NCT03944707|536306456|FG000|Overall Study|Subject decision|0|||
148681474|NCT03944707|536306457|FG001|Overall Study|Subject decision|1|||
148681475|NCT02444182|536306458|FG000|Overall Study|non-compliance|2|||
148681476|NCT02444182|536306459|FG001|Overall Study|non-compliance|1|||
148681477|NCT02444182|536306458|FG000|Overall Study|Lost to Follow-up|0|||
148681478|NCT02444182|536306459|FG001|Overall Study|Lost to Follow-up|4|||
148681479|NCT00751998|536306464|FG000|Overall Study|Lost to Follow-up|7|||
148681480|NCT00751998|536306464|FG000|Overall Study|Death|11|||
148681481|NCT00751998|536306464|FG000|Overall Study|Withdrawal by Subject|2|||
148681482|NCT02598193|536306465|FG000|Overall Study|Adverse Event|13|||
148681483|NCT02598193|536306465|FG000|Overall Study|Withdrawal by Subject|1|||
148681484|NCT02598193|536306465|FG000|Overall Study|Listed in active lung transplant list|1|||
148807575|NCT00071981|536773316|FG000|Overall Study|Lack of Efficacy|37|||
148807576|NCT00071981|536773317|FG001|Overall Study|Lack of Efficacy|29|||
149191204|NCT01554956|538169854|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
149191205|NCT00913978|538169855|FG000|Overall Study|Surgeon choice|1|||
149191206|NCT00913978|538169856|FG001|Overall Study|Surgeon choice|3|||
149191207|NCT00210158|538169857|FG000|Overall Study|Protocol Violation|0|||
149191208|NCT00210158|538169858|FG001|Overall Study|Protocol Violation|2|||
149191209|NCT04716933|538169859|FG000|Overall Study|Sponsor Decision|36|||
149191210|NCT04716933|538169860|FG001|Overall Study|Sponsor Decision|33|||
149191211|NCT04716933|538169859|FG000|Overall Study|Death|65|||
149191212|NCT04716933|538169860|FG001|Overall Study|Death|67|||
148681485|NCT02598193|536306465|FG000|Overall Study|Does not want to take Nintedanib|1|||
148681486|NCT00078819|536306468|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
148681487|NCT00078819|536306469|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
148681488|NCT00078819|536306470|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
148681489|NCT00078819|536306471|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
148681490|NCT00078819|536306468|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
148807577|NCT00071981|536773318|FG002|Overall Study|Lack of Efficacy|30|||
149191213|NCT01327651|538169861|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
148681491|NCT00078819|536306469|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
148681492|NCT00078819|536306470|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
148681493|NCT00078819|536306471|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
148807578|NCT00071981|536773319|FG003|Overall Study|Lack of Efficacy|43|||
149191214|NCT01327651|538169862|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
149191215|NCT01327651|538169863|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
149191216|NCT01327651|538169864|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
149191217|NCT01327651|538169865|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
149191218|NCT01327651|538169866|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
149191219|NCT01327651|538169867|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
149191220|NCT01327651|538169868|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
149191221|NCT01327651|538169869|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
149191222|NCT01327651|538169861|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
149191223|NCT01327651|538169862|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191224|NCT01327651|538169863|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191225|NCT01327651|538169864|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191226|NCT01327651|538169865|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191227|NCT01327651|538169866|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191228|NCT01327651|538169867|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191229|NCT01327651|538169868|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191230|NCT01327651|538169869|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
149191231|NCT01327651|538169861|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
149191232|NCT01327651|538169862|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
149191233|NCT01327651|538169863|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
149191234|NCT01327651|538169864|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
149191235|NCT01327651|538169865|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
149191236|NCT01327651|538169866|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
149191237|NCT01327651|538169867|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
149191238|NCT01327651|538169868|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
149191239|NCT01327651|538169869|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
149191240|NCT01327651|538169861|FG000|Post Study Follow-up|Lost to Follow-up|0|||
149191241|NCT01327651|538169862|FG001|Post Study Follow-up|Lost to Follow-up|1|||
149191242|NCT01327651|538169863|FG002|Post Study Follow-up|Lost to Follow-up|1|||
149191243|NCT01327651|538169864|FG003|Post Study Follow-up|Lost to Follow-up|0|||
149191244|NCT01327651|538169865|FG004|Post Study Follow-up|Lost to Follow-up|0|||
149191245|NCT01327651|538169866|FG005|Post Study Follow-up|Lost to Follow-up|0|||
149191246|NCT01327651|538169867|FG006|Post Study Follow-up|Lost to Follow-up|4|||
149191247|NCT01327651|538169868|FG007|Post Study Follow-up|Lost to Follow-up|1|||
149191248|NCT01327651|538169869|FG008|Post Study Follow-up|Lost to Follow-up|2|||
149191249|NCT01842308|538169874|FG000|Overall Study|Withdrawal by Subject|0|||
149191250|NCT01842308|538169875|FG001|Overall Study|Withdrawal by Subject|0|||
149191251|NCT01842308|538169876|FG002|Overall Study|Withdrawal by Subject|0|||
149191252|NCT01842308|538169877|FG003|Overall Study|Withdrawal by Subject|0|||
149191253|NCT01842308|538169878|FG004|Overall Study|Withdrawal by Subject|1|||
149191254|NCT03521687|538169885|FG000|Overall Study|Adverse Event|4|||
149191255|NCT03521687|538169885|FG000|Overall Study|Physician Decision|1|||
149191256|NCT03609359|538169891|FG000|Overall Study|Progression of primary disease (PD)|25|||
149191257|NCT03609359|538169891|FG000|Overall Study|Patient's refusal|1|||
149191258|NCT03609359|538169891|FG000|Overall Study|Physician Decision|1|||
149191259|NCT03609359|538169891|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
149191260|NCT00610935|538169893|FG000|Overall Study|Lost to Follow-up|0|||
149191261|NCT00610935|538169894|FG001|Overall Study|Lost to Follow-up|1|||
149191262|NCT00610935|538169893|FG000|Overall Study|Withdrawal by Subject|0|||
149191263|NCT00610935|538169894|FG001|Overall Study|Withdrawal by Subject|2|||
149191264|NCT00610935|538169893|FG000|Overall Study|Sponsor Discontinuation|1|||
149191265|NCT00610935|538169894|FG001|Overall Study|Sponsor Discontinuation|0|||
149191266|NCT00740779|538169895|FG000|Overall Study|Adverse Event|4|||
149191267|NCT00740779|538169896|FG001|Overall Study|Adverse Event|6|||
149191268|NCT00740779|538169897|FG002|Overall Study|Adverse Event|3|||
149191269|NCT00740779|538169895|FG000|Overall Study|Protocol Violation|1|||
149191270|NCT00740779|538169896|FG001|Overall Study|Protocol Violation|1|||
149191271|NCT00740779|538169897|FG002|Overall Study|Protocol Violation|1|||
149191272|NCT00740779|538169895|FG000|Overall Study|Lack of Efficacy|0|||
149191273|NCT00740779|538169896|FG001|Overall Study|Lack of Efficacy|0|||
149191274|NCT00740779|538169897|FG002|Overall Study|Lack of Efficacy|2|||
148935060|NCT02899299|537247665|FG000|Treatment|Maximum Clinical Benefit|11|||
149191275|NCT00740779|538169895|FG000|Overall Study|Withdrawal by Subject|2|||
149191276|NCT00740779|538169896|FG001|Overall Study|Withdrawal by Subject|4|||
149191277|NCT00740779|538169897|FG002|Overall Study|Withdrawal by Subject|2|||
149191278|NCT00740779|538169895|FG000|Overall Study|Lost to Follow-up|2|||
149191279|NCT00740779|538169896|FG001|Overall Study|Lost to Follow-up|3|||
149191280|NCT00740779|538169897|FG002|Overall Study|Lost to Follow-up|5|||
149191281|NCT02399813|538169901|FG000|Overall Study|Progressive Disease-Radiographic|2|||
148807579|NCT00071981|536773316|FG000|Overall Study|Adverse Event|4|||
148681494|NCT00078819|536306468|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
148681495|NCT00078819|536306469|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
148681496|NCT00078819|536306470|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
148681497|NCT00078819|536306471|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
148681498|NCT00078819|536306468|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
148681499|NCT00078819|536306469|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
148681500|NCT00078819|536306470|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
148681501|NCT00078819|536306471|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
148681502|NCT00078819|536306468|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
148681503|NCT00078819|536306469|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
148681504|NCT00078819|536306470|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
148681505|NCT00078819|536306471|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
148681506|NCT00078819|536306468|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
148681507|NCT00078819|536306469|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
148681508|NCT00078819|536306470|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
148681509|NCT00078819|536306471|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
148681510|NCT00078819|536306468|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
148681511|NCT00078819|536306469|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
148681512|NCT00078819|536306470|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
148681513|NCT00078819|536306471|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
148681514|NCT00078819|536306468|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
148681515|NCT00078819|536306469|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
148681516|NCT00078819|536306470|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
148681517|NCT00078819|536306471|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
148681518|NCT02555618|536306472|FG000|Overall Study|Sponsor's Circumstances|1|||
148681519|NCT02555618|536306473|FG001|Overall Study|Sponsor's Circumstances|0|||
148681520|NCT01280981|536306478|FG000|Overall Study|Withdrawal by Subject|11|||
148681521|NCT01280981|536306478|FG000|Overall Study|Protocol Violation|2|||
148681522|NCT01280981|536306478|FG000|Overall Study|Lack of Efficacy|13|||
148681523|NCT01280981|536306478|FG000|Overall Study|Lost to Follow-up|3|||
148681524|NCT01280981|536306478|FG000|Overall Study|Adverse Event|6|||
148681525|NCT01280981|536306478|FG000|Overall Study|Irregular or discontinued menses|3|||
148681526|NCT01280981|536306478|FG000|Overall Study|Failed to return|45|||
148681527|NCT01280981|536306478|FG000|Overall Study|Non-compliance with protocol|3|||
148681528|NCT01280981|536306478|FG000|Overall Study|Withdrawal of consent|3|||
148681529|NCT01280981|536306478|FG000|Overall Study|Elective surgery|2|||
148681530|NCT01280981|536306478|FG000|Overall Study|Study site closure|1|||
148681531|NCT01749033|536306480|FG000|Overall Study|Did not receive allocated intervention|3|||
148681532|NCT01749033|536306481|FG001|Overall Study|Did not receive allocated intervention|3|||
148681533|NCT01749033|536306482|FG002|Overall Study|Did not receive allocated intervention|0|||
148681534|NCT01749033|536306480|FG000|Overall Study|Lost to Follow-up|0|||
148681535|NCT01749033|536306481|FG001|Overall Study|Lost to Follow-up|2|||
149191282|NCT02399813|538169901|FG000|Overall Study|Death|20|||
149191283|NCT02399813|538169901|FG000|Overall Study|Withdrawal by Subject|3|||
149191284|NCT02399813|538169901|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
149191285|NCT02399813|538169901|FG000|Overall Study|Lost to Follow-up|2|||
148807580|NCT00071981|536773317|FG001|Overall Study|Adverse Event|4|||
148807581|NCT00071981|536773318|FG002|Overall Study|Adverse Event|3|||
148807582|NCT00071981|536773319|FG003|Overall Study|Adverse Event|1|||
148807583|NCT00071981|536773316|FG000|Overall Study|Death|0|||
148807584|NCT00071981|536773317|FG001|Overall Study|Death|0|||
149191286|NCT02399813|538169901|FG000|Overall Study|Other than specified|5|||
149191287|NCT03345836|538169902|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
149191288|NCT03345836|538169903|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
149191289|NCT03345836|538169904|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
149191290|NCT03345836|538169905|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
148681536|NCT01749033|536306482|FG002|Overall Study|Lost to Follow-up|1|||
148681537|NCT01254045|536306483|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
148681538|NCT01254045|536306484|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
148807585|NCT00071981|536773318|FG002|Overall Study|Death|1|||
148807586|NCT00071981|536773319|FG003|Overall Study|Death|1|||
148807587|NCT00071981|536773316|FG000|Overall Study|Withdrawal by Subject|3|||
148807588|NCT00071981|536773317|FG001|Overall Study|Withdrawal by Subject|1|||
149191291|NCT03345836|538169906|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
148681539|NCT01254045|536306485|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
148681540|NCT01254045|536306486|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
148807589|NCT00071981|536773318|FG002|Overall Study|Withdrawal by Subject|0|||
148681541|NCT01254045|536306487|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
148681542|NCT01254045|536306488|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
148807590|NCT00071981|536773319|FG003|Overall Study|Withdrawal by Subject|0|||
148681543|NCT00520351|536306489|FG000|First Intervention|Withdrawal by Subject|1|||
148681544|NCT00520351|536306490|FG001|First Intervention|Withdrawal by Subject|1|||
148681545|NCT03797222|536306492|FG000|Overall Study|Withdrawal by Subject|1|||
149191292|NCT03345836|538169907|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
149191293|NCT03345836|538169902|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
149191294|NCT03345836|538169903|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
149191295|NCT03345836|538169904|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
149191296|NCT03345836|538169905|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
149191297|NCT03345836|538169906|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
149191298|NCT03345836|538169907|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
149191299|NCT03345836|538169902|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149191300|NCT03345836|538169903|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
149191301|NCT03345836|538169904|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149191302|NCT03345836|538169905|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149191303|NCT03345836|538169906|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149191304|NCT03345836|538169907|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
149191305|NCT03345836|538169902|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
149191306|NCT03345836|538169903|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
149191307|NCT03345836|538169904|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149191308|NCT03345836|538169905|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149191309|NCT03345836|538169906|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149191310|NCT03345836|538169907|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
149191311|NCT03345836|538169902|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
148681546|NCT04288115|536306497|FG000|Overall Study|Withdrawal by Subject|0|||
148807591|NCT00071981|536773316|FG000|Overall Study|No protocol therapy|2|||
148807592|NCT00071981|536773317|FG001|Overall Study|No protocol therapy|5|||
148807593|NCT00071981|536773318|FG002|Overall Study|No protocol therapy|1|||
149191312|NCT03345836|538169903|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
148681547|NCT04288115|536306498|FG001|Overall Study|Withdrawal by Subject|1|||
148935061|NCT02899299|537247666|FG001|Treatment|Maximum Clinical Benefit|2|||
148935062|NCT02899299|537247665|FG000|Treatment|Poor/Non-compliance|1|||
148935063|NCT02899299|537247666|FG001|Treatment|Poor/Non-compliance|0|||
148935064|NCT02899299|537247665|FG000|Treatment|Participant no longer meets Study criteria|4|||
148935065|NCT02899299|537247666|FG001|Treatment|Participant no longer meets Study criteria|0|||
148935066|NCT02899299|537247665|FG000|Treatment|Administrative reason by Sponsor|2|||
148935067|NCT02899299|537247666|FG001|Treatment|Administrative reason by Sponsor|0|||
148935068|NCT02899299|537247665|FG000|Treatment|Other reasons|12|||
149191313|NCT03345836|538169904|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
149191314|NCT03345836|538169905|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
149191315|NCT03345836|538169906|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
149191316|NCT03345836|538169907|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
149191317|NCT03345836|538169902|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149191318|NCT03345836|538169903|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149191319|NCT03345836|538169904|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149191320|NCT03345836|538169905|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
149191321|NCT03345836|538169906|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
149191322|NCT03345836|538169907|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
149191323|NCT03345836|538169902|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149191324|NCT03345836|538169903|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149191325|NCT03345836|538169904|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
149191326|NCT03345836|538169905|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
148807594|NCT00071981|536773319|FG003|Overall Study|No protocol therapy|0|||
149191327|NCT03345836|538169906|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
149191328|NCT03345836|538169907|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
149191329|NCT03345836|538169902|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149191330|NCT03345836|538169903|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149191331|NCT03345836|538169904|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149191332|NCT03345836|538169905|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149191333|NCT03345836|538169906|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
149191334|NCT03345836|538169907|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
149191335|NCT03345836|538169902|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
149191336|NCT03345836|538169903|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
149191337|NCT03345836|538169904|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
149191338|NCT03345836|538169905|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
149191339|NCT03345836|538169906|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
149191340|NCT03345836|538169907|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
149191341|NCT03345836|538169902|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149191342|NCT03345836|538169903|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149191343|NCT03345836|538169904|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149191344|NCT03345836|538169905|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149191345|NCT03345836|538169906|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
149191346|NCT03345836|538169907|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
149191347|NCT03345836|538169902|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
149191348|NCT03345836|538169903|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
149191349|NCT03345836|538169904|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
149191350|NCT03345836|538169905|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
149191351|NCT03345836|538169906|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
149191352|NCT03345836|538169907|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
149191353|NCT01915849|538169910|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
149191354|NCT01915849|538169911|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
149191355|NCT01915849|538169912|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
149191356|NCT01915849|538169913|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
149191357|NCT01915849|538169910|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
149191358|NCT01915849|538169911|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149191359|NCT01915849|538169912|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149191360|NCT01915849|538169913|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149191361|NCT02761993|538169915|FG000|Overall Study|Adverse Event|0|||
149191362|NCT02761993|538169916|FG001|Overall Study|Adverse Event|2|||
149191363|NCT02761993|538169917|FG002|Overall Study|Adverse Event|0|||
149191364|NCT02761993|538169915|FG000|Overall Study|Lost to Follow-up|1|||
149191365|NCT02761993|538169916|FG001|Overall Study|Lost to Follow-up|3|||
149191366|NCT02761993|538169917|FG002|Overall Study|Lost to Follow-up|2|||
149191367|NCT02761993|538169915|FG000|Overall Study|Withdrawal by Subject|1|||
149191368|NCT02761993|538169916|FG001|Overall Study|Withdrawal by Subject|1|||
149191369|NCT02761993|538169917|FG002|Overall Study|Withdrawal by Subject|2|||
149191370|NCT00488033|538169918|FG000|Overall Study|Withdrawal by Subject|1|||
149191371|NCT00488033|538169919|FG001|Overall Study|Withdrawal by Subject|0|||
149191372|NCT01515306|538169920|FG000|Overall Study|Adverse Event|3|||
149191373|NCT01515306|538169921|FG001|Overall Study|Adverse Event|2|||
149191374|NCT01515306|538169920|FG000|Overall Study|Progressive Disease|19|||
149191375|NCT01515306|538169921|FG001|Overall Study|Progressive Disease|9|||
149191376|NCT01515306|538169920|FG000|Overall Study|Withdrawal by Subject|1|||
149191377|NCT01515306|538169921|FG001|Overall Study|Withdrawal by Subject|2|||
149191378|NCT01515306|538169920|FG000|Overall Study|Physician Decision|1|||
149191379|NCT01515306|538169921|FG001|Overall Study|Physician Decision|1|||
149191380|NCT04973228|538169922|FG000|Overall Study|Adverse Event|2|||
149191381|NCT04973228|538169923|FG001|Overall Study|Adverse Event|3|||
149191382|NCT04973228|538169922|FG000|Overall Study|Lack of Efficacy|1|||
149191383|NCT04973228|538169923|FG001|Overall Study|Lack of Efficacy|3|||
149191384|NCT04973228|538169922|FG000|Overall Study|Lost to Follow-up|12|||
149191385|NCT04973228|538169923|FG001|Overall Study|Lost to Follow-up|4|||
149191386|NCT04973228|538169922|FG000|Overall Study|Withdrawal by Subject|11|||
149191387|NCT04973228|538169923|FG001|Overall Study|Withdrawal by Subject|4|||
149191388|NCT04973228|538169922|FG000|Overall Study|Did not tolerate application|1|||
148807595|NCT00071981|536773316|FG000|Overall Study|others (not specified in the study)|0|||
148807596|NCT00071981|536773317|FG001|Overall Study|others (not specified in the study)|2|||
149191389|NCT04973228|538169923|FG001|Overall Study|Did not tolerate application|0|||
149191390|NCT04973228|538169922|FG000|Overall Study|Wanted to early terminate and use own product|0|||
149191391|NCT04973228|538169923|FG001|Overall Study|Wanted to early terminate and use own product|1|||
149191392|NCT04973228|538169922|FG000|Overall Study|Missed visits due to new work schedule|1|||
149191393|NCT04973228|538169923|FG001|Overall Study|Missed visits due to new work schedule|0|||
148935069|NCT02899299|537247666|FG001|Treatment|Other reasons|2|||
148935070|NCT02899299|537247665|FG000|Treatment|Not reported|7|||
149191394|NCT02614287|538171483|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
149191395|NCT02614287|538171484|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
148935071|NCT02899299|537247666|FG001|Treatment|Not reported|0|||
148935072|NCT03198078|537247671|FG000|Overall Study|Adverse Event|0|||
148935073|NCT03198078|537247672|FG001|Overall Study|Adverse Event|1|||
148935074|NCT03198078|537247673|FG002|Overall Study|Adverse Event|2|||
148935075|NCT03198078|537247671|FG000|Overall Study|Lack of Efficacy|0|||
148935076|NCT03198078|537247672|FG001|Overall Study|Lack of Efficacy|0|||
148935077|NCT03198078|537247673|FG002|Overall Study|Lack of Efficacy|3|||
148935078|NCT03198078|537247671|FG000|Overall Study|Lost to Follow-up|1|||
148935079|NCT03198078|537247672|FG001|Overall Study|Lost to Follow-up|0|||
148935080|NCT03198078|537247673|FG002|Overall Study|Lost to Follow-up|0|||
148935081|NCT03198078|537247671|FG000|Overall Study|Pregnancy|0|||
149014779|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Not Treated|0|||
149014780|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Not Treated|0|||
149191396|NCT02614287|538171483|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
149191397|NCT02614287|538171484|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
149191398|NCT02614287|538171483|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
149191399|NCT02614287|538171484|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
149191400|NCT02614287|538171483|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
149191401|NCT02614287|538171484|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
149191402|NCT02614287|538171483|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
149191403|NCT02614287|538171484|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
149191404|NCT02614287|538171483|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
149191405|NCT02614287|538171484|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
149191406|NCT02614287|538171483|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
149191407|NCT02614287|538171484|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
149191408|NCT02614287|538171483|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
149191409|NCT02614287|538171484|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
149191410|NCT02294318|538171487|FG000|Overall Study|Worsening of drinking|3|||
149191411|NCT02294318|538171488|FG001|Overall Study|Worsening of drinking|0|||
149191412|NCT02294318|538171487|FG000|Overall Study|Not exposed to intervention|0|||
149191413|NCT02294318|538171488|FG001|Overall Study|Not exposed to intervention|2|||
149191414|NCT01694420|538171489|FG000|Overall Study|Lost to Follow-up|3|||
149191415|NCT03725202|538171490|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
149191416|NCT03725202|538171491|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
149191417|NCT03725202|538171492|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
149191418|NCT03725202|538171493|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149191419|NCT03725202|538171494|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149191420|NCT03725202|538171495|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149191421|NCT03725202|538171496|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149191422|NCT03725202|538171497|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
149191423|NCT03725202|538171490|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
149191424|NCT03725202|538171491|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
149191425|NCT03725202|538171492|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
149191426|NCT03725202|538171493|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149191427|NCT03725202|538171494|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149191428|NCT03725202|538171495|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149191429|NCT03725202|538171496|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149191430|NCT03725202|538171497|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
149191431|NCT03725202|538171490|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
149191432|NCT03725202|538171491|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
148935082|NCT03198078|537247672|FG001|Overall Study|Pregnancy|1|||
148935083|NCT03198078|537247673|FG002|Overall Study|Pregnancy|0|||
149191433|NCT03725202|538171492|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149191434|NCT03725202|538171493|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149191435|NCT03725202|538171494|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149191436|NCT03725202|538171495|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149191437|NCT03725202|538171496|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149191438|NCT03725202|538171497|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
149191439|NCT03725202|538171490|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
149191440|NCT03725202|538171491|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149191441|NCT03725202|538171492|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149191442|NCT03725202|538171493|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149191443|NCT03725202|538171494|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149191444|NCT03725202|538171495|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149191445|NCT03725202|538171496|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
149191446|NCT03725202|538171497|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
148807597|NCT00071981|536773318|FG002|Overall Study|others (not specified in the study)|2|||
148807598|NCT00071981|536773319|FG003|Overall Study|others (not specified in the study)|0|||
148807599|NCT00833755|536773321|FG000|Overall Study|Physician Decision|4|||
148807600|NCT00833755|536773322|FG001|Overall Study|Physician Decision|4|||
148807601|NCT00833755|536773323|FG002|Overall Study|Physician Decision|2|||
148807602|NCT00833755|536773324|FG003|Overall Study|Physician Decision|6|||
148807603|NCT00833755|536773321|FG000|Overall Study|Subject had scheduling issues|0|||
148807604|NCT00833755|536773322|FG001|Overall Study|Subject had scheduling issues|1|||
148807605|NCT00833755|536773323|FG002|Overall Study|Subject had scheduling issues|0|||
148807606|NCT00833755|536773324|FG003|Overall Study|Subject had scheduling issues|0|||
148807607|NCT00262925|536773325|FG000|Overall Study|Lack of Efficacy|3|||
148807608|NCT00262925|536773325|FG000|Overall Study|Adverse Event|4|||
148807609|NCT00262925|536773325|FG000|Overall Study|Death|2|||
148807610|NCT00262925|536773325|FG000|Overall Study|alternative therapy|1|||
148807611|NCT00262925|536773325|FG000|Overall Study|Other|1|||
148807612|NCT04682301|536773326|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
148807613|NCT04682301|536773326|FG000|Overall Study|Death|2|||
148807614|NCT00560404|536773327|FG000|Overall Study|Adverse Event|2|||
148807615|NCT00560404|536773328|FG001|Overall Study|Adverse Event|3|||
148807616|NCT00560404|536773327|FG000|Overall Study|Death|3|||
148807617|NCT00560404|536773328|FG001|Overall Study|Death|3|||
148807618|NCT00560404|536773327|FG000|Overall Study|Protocol Violation|12|||
148807619|NCT00560404|536773328|FG001|Overall Study|Protocol Violation|7|||
148935084|NCT03198078|537247671|FG000|Overall Study|Withdrawal by Subject|1|||
148935085|NCT03198078|537247672|FG001|Overall Study|Withdrawal by Subject|0|||
148935086|NCT03198078|537247673|FG002|Overall Study|Withdrawal by Subject|2|||
148935087|NCT03198078|537247671|FG000|Overall Study|Withdrawal by Caregiver|1|||
148935088|NCT03198078|537247672|FG001|Overall Study|Withdrawal by Caregiver|3|||
148681548|NCT04288115|536306497|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
148681549|NCT04288115|536306498|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
148681550|NCT00729365|536306499|FG000|Overall Study|Physician Decision|33|||
148681551|NCT00729365|536306500|FG001|Overall Study|Physician Decision|6|||
148681552|NCT00729365|536306501|FG002|Overall Study|Physician Decision|7|||
148681553|NCT02766400|536306505|FG000|Overall Study|Death|1|||
148681554|NCT02766400|536306506|FG001|Overall Study|Death|2|||
148681555|NCT02766400|536306505|FG000|Overall Study|Withdrawal by Subject|1|||
148681556|NCT02766400|536306506|FG001|Overall Study|Withdrawal by Subject|0|||
148681557|NCT01133392|536306507|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
148681558|NCT01133392|536306508|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
148681559|NCT01133392|536306507|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
148681560|NCT01133392|536306508|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
148681561|NCT03185949|536306509|FG000|ITT Analysis|Withdrawal by Subject|4|||
148681562|NCT03185949|536306510|FG001|ITT Analysis|Withdrawal by Subject|3|||
148681563|NCT03185949|536306509|FG000|PP Analysis|Protocol Violation|2|||
148681564|NCT03185949|536306510|FG001|PP Analysis|Protocol Violation|2|||
148681565|NCT03185949|536306509|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
148681566|NCT03185949|536306510|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
148681567|NCT03751124|536306516|FG000|Overall Study|Adverse Event|4|||
148681568|NCT03751124|536306517|FG001|Overall Study|Adverse Event|3|||
148681569|NCT03751124|536306516|FG000|Overall Study|Protocol Deviation|0|||
148681570|NCT03751124|536306517|FG001|Overall Study|Protocol Deviation|1|||
148681571|NCT03751124|536306516|FG000|Overall Study|Lost to Follow-up|6|||
148681572|NCT03751124|536306517|FG001|Overall Study|Lost to Follow-up|4|||
148681573|NCT03751124|536306516|FG000|Overall Study|Withdrawal by Subject|6|||
148681574|NCT03751124|536306517|FG001|Overall Study|Withdrawal by Subject|8|||
148807620|NCT00560404|536773327|FG000|Overall Study|Administrative Reasons|1|||
148807621|NCT00560404|536773328|FG001|Overall Study|Administrative Reasons|1|||
148807622|NCT00560404|536773327|FG000|Overall Study|Withdrew Consent|4|||
148807623|NCT00560404|536773328|FG001|Overall Study|Withdrew Consent|0|||
148807624|NCT00560404|536773327|FG000|Overall Study|Failure to return|1|||
148807625|NCT00560404|536773328|FG001|Overall Study|Failure to return|2|||
148807626|NCT00560404|536773327|FG000|Overall Study|Other withdrawal reason|13|||
148807627|NCT00560404|536773328|FG001|Overall Study|Other withdrawal reason|5|||
148807628|NCT02187783|536773335|FG000|Overall Study|Adverse Event|8|||
148807629|NCT02187783|536773335|FG000|Overall Study|Death|3|||
148807630|NCT02187783|536773335|FG000|Overall Study|Progressive disease|80|||
148935089|NCT03198078|537247673|FG002|Overall Study|Withdrawal by Caregiver|5|||
148681575|NCT03751124|536306516|FG000|Overall Study|Lack of Efficacy|1|||
148807631|NCT02187783|536773335|FG000|Overall Study|Protocol Violation|3|||
148807632|NCT02187783|536773335|FG000|Overall Study|Physician Decision|2|||
148807633|NCT02187783|536773335|FG000|Overall Study|Withdrawal by Subject|9|||
148807634|NCT02187783|536773335|FG000|Overall Study|Study terminated by sponsor|1|||
148807635|NCT03344757|536773336|FG000|Overall Study|Withdrawal by Subject|18|||
148807636|NCT03344757|536773337|FG001|Overall Study|Withdrawal by Subject|16|||
148935090|NCT03387683|537247674|FG000|Overall Study|In receipt of disallowed medication|1|||
148681576|NCT03751124|536306517|FG001|Overall Study|Lack of Efficacy|1|||
148681577|NCT03751124|536306516|FG000|Overall Study|Pregnancy|0|||
149014781|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Not Treated|0|||
149014782|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014783|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
149014784|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014785|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014786|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
148807637|NCT03344757|536773336|FG000|Overall Study|Lost to Follow-up|0|||
148807638|NCT03344757|536773337|FG001|Overall Study|Lost to Follow-up|2|||
149191447|NCT03725202|538171490|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
149191448|NCT03725202|538171491|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
149191449|NCT03725202|538171492|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
149191450|NCT03725202|538171493|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149191451|NCT03725202|538171494|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149191452|NCT03725202|538171495|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149191453|NCT03725202|538171496|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149191454|NCT03725202|538171497|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
149191455|NCT03725202|538171490|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191456|NCT03725202|538171491|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191457|NCT03725202|538171492|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
149191458|NCT03725202|538171493|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191459|NCT03725202|538171494|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191460|NCT03725202|538171495|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191461|NCT03725202|538171496|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191462|NCT03725202|538171497|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
149191463|NCT03725202|538171490|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
149191464|NCT03725202|538171491|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
149191465|NCT03725202|538171492|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
149191466|NCT03725202|538171493|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
149191467|NCT03725202|538171494|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
149191468|NCT03725202|538171495|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
149191469|NCT03725202|538171496|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
149191470|NCT03725202|538171497|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
149191471|NCT03725202|538171490|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
149191472|NCT03725202|538171491|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
149191473|NCT03725202|538171492|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
149191474|NCT03725202|538171493|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
149191475|NCT03725202|538171494|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
149191476|NCT03725202|538171495|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
149191477|NCT03725202|538171496|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
149191478|NCT03725202|538171497|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
149191479|NCT03725202|538171490|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149191480|NCT03725202|538171491|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149191481|NCT03725202|538171492|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149191482|NCT03725202|538171493|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
148807639|NCT00269152|536773338|FG000|Overall Study|Adverse Event|9|||
149014787|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014788|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014789|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014790|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149191483|NCT03725202|538171494|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149191484|NCT03725202|538171495|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
149191485|NCT03725202|538171496|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
149191486|NCT03725202|538171497|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
148807640|NCT00269152|536773339|FG001|Overall Study|Adverse Event|3|||
149191487|NCT03725202|538171490|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191488|NCT03725202|538171491|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191489|NCT03725202|538171492|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191490|NCT03725202|538171493|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191491|NCT03725202|538171494|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191492|NCT03725202|538171495|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191493|NCT03725202|538171496|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
149191494|NCT03725202|538171497|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
149191495|NCT03725202|538171490|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191496|NCT03725202|538171491|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191497|NCT03725202|538171492|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191498|NCT03725202|538171493|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191499|NCT03725202|538171494|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191500|NCT03725202|538171495|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
149191501|NCT03725202|538171496|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191502|NCT03725202|538171497|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
149191503|NCT03725202|538171490|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149191504|NCT03725202|538171491|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149191505|NCT03725202|538171492|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149191506|NCT03725202|538171493|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
149191507|NCT03725202|538171494|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149191508|NCT03725202|538171495|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
149191509|NCT03725202|538171496|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
148681578|NCT03751124|536306517|FG001|Overall Study|Pregnancy|1|||
148681579|NCT03751124|536306516|FG000|Overall Study|Other|9|||
148681580|NCT03751124|536306517|FG001|Overall Study|Other|9|||
148681581|NCT03751124|536306516|FG000|Overall Study|Participants who did not receive any study drug|0|||
148681582|NCT03751124|536306517|FG001|Overall Study|Participants who did not receive any study drug|1|||
148681583|NCT01835470|536307749|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
148681584|NCT01835470|536307749|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
148681585|NCT01406873|536307754|FG000|Overall Study|Withdrawal by Subject|1|||
148681586|NCT01406873|536307755|FG001|Overall Study|Withdrawal by Subject|1|||
148681587|NCT00854620|536307756|FG000|Overall Study|Adverse Event|1|||
148681588|NCT00534092|536307765|FG000|Overall Study|Lost to Follow-up|1|||
148681589|NCT00534092|536307766|FG001|Overall Study|Lost to Follow-up|0|||
148681590|NCT00534092|536307765|FG000|Overall Study|personal reasons/family concerns|1|||
148681591|NCT00534092|536307766|FG001|Overall Study|personal reasons/family concerns|0|||
148681592|NCT01169649|536307767|FG000|Overall Study|Patient Not Treated|3|||
148681593|NCT02919475|536307768|FG000|Overall Study|Adverse Event|3|||
148681594|NCT02919475|536307769|FG001|Overall Study|Adverse Event|3|||
148681595|NCT02919475|536307770|FG002|Overall Study|Adverse Event|3|||
148681596|NCT02919475|536307771|FG003|Overall Study|Adverse Event|9|||
149191510|NCT03725202|538171497|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
149191511|NCT00495495|538171498|FG000|Overall Study|Protocol Violation|99|||
149191512|NCT02702518|538171499|FG000|Overall Study|Lost to Follow-up|3|||
149191513|NCT02702518|538171500|FG001|Overall Study|Lost to Follow-up|4|||
149191514|NCT03331666|538171501|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
149191515|NCT03331666|538171502|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
149191516|NCT00434512|538171503|FG000|Overall Study|Migrated/moved from study area|0|||
149191517|NCT00434512|538171504|FG001|Overall Study|Migrated/moved from study area|0|||
149191518|NCT00434512|538171505|FG002|Overall Study|Migrated/moved from study area|0|||
149191519|NCT00434512|538171506|FG003|Overall Study|Migrated/moved from study area|1|||
149191520|NCT00434512|538171507|FG004|Overall Study|Migrated/moved from study area|1|||
149191521|NCT00434512|538171508|FG005|Overall Study|Migrated/moved from study area|1|||
149191522|NCT00434512|538171503|FG000|Overall Study|Other|0|||
149191523|NCT00434512|538171504|FG001|Overall Study|Other|1|||
149191524|NCT00434512|538171505|FG002|Overall Study|Other|0|||
149191525|NCT00434512|538171506|FG003|Overall Study|Other|0|||
149191526|NCT00434512|538171507|FG004|Overall Study|Other|0|||
149191527|NCT00434512|538171508|FG005|Overall Study|Other|0|||
149191528|NCT01575197|538171509|FG000|Overall Study|Migration out of study area|1|||
149191529|NCT01575197|538171510|FG001|Overall Study|Migration out of study area|5|||
149191530|NCT01575197|538171511|FG002|Overall Study|Migration out of study area|4|||
149191531|NCT01575197|538171509|FG000|Overall Study|SAE|0|||
149191532|NCT01575197|538171510|FG001|Overall Study|SAE|1|||
149191533|NCT01575197|538171511|FG002|Overall Study|SAE|0|||
149191534|NCT01575197|538171509|FG000|Overall Study|Lost to Follow-up|0|||
149191535|NCT01575197|538171510|FG001|Overall Study|Lost to Follow-up|1|||
149191536|NCT01575197|538171511|FG002|Overall Study|Lost to Follow-up|0|||
149191537|NCT01575197|538171509|FG000|Overall Study|Withdrawal by Subject|0|||
149191538|NCT01575197|538171510|FG001|Overall Study|Withdrawal by Subject|1|||
149191539|NCT01575197|538171511|FG002|Overall Study|Withdrawal by Subject|1|||
149191540|NCT01575197|538171509|FG000|Overall Study|Protocol Violation|2|||
149191541|NCT01575197|538171510|FG001|Overall Study|Protocol Violation|1|||
149191542|NCT01575197|538171511|FG002|Overall Study|Protocol Violation|1|||
149191543|NCT03303092|538171512|FG000|Overall Study|Adverse Event|1|||
149191544|NCT03303092|538171513|FG001|Overall Study|Adverse Event|0|||
149191545|NCT03303092|538171514|FG002|Overall Study|Adverse Event|1|||
149191546|NCT03303092|538171512|FG000|Overall Study|Protocol Violation|1|||
149191547|NCT03303092|538171513|FG001|Overall Study|Protocol Violation|5|||
148681597|NCT02919475|536307772|FG004|Overall Study|Adverse Event|2|||
148681598|NCT02919475|536307768|FG000|Overall Study|Death|0|||
148681599|NCT02919475|536307769|FG001|Overall Study|Death|1|||
148681600|NCT02919475|536307770|FG002|Overall Study|Death|0|||
148681601|NCT02919475|536307771|FG003|Overall Study|Death|0|||
148681602|NCT02919475|536307772|FG004|Overall Study|Death|0|||
149191548|NCT03303092|538171514|FG002|Overall Study|Protocol Violation|1|||
149191549|NCT03303092|538171512|FG000|Overall Study|Withdrawal by Subject|1|||
149191550|NCT03303092|538171513|FG001|Overall Study|Withdrawal by Subject|1|||
149191551|NCT03303092|538171514|FG002|Overall Study|Withdrawal by Subject|3|||
149191552|NCT00833248|538171519|FG000|Overall Study|Adverse Event|3|||
149191553|NCT00833248|538171520|FG001|Overall Study|Adverse Event|0|||
149191554|NCT00833248|538171519|FG000|Overall Study|Protocol Violation|1|||
149191555|NCT00833248|538171520|FG001|Overall Study|Protocol Violation|2|||
149191556|NCT00833248|538171519|FG000|Overall Study|Withdrawal by Subject|0|||
148681603|NCT02919475|536307768|FG000|Overall Study|Lost to Follow-up|0|||
148681604|NCT02919475|536307769|FG001|Overall Study|Lost to Follow-up|0|||
148681605|NCT02919475|536307770|FG002|Overall Study|Lost to Follow-up|0|||
148681606|NCT02919475|536307771|FG003|Overall Study|Lost to Follow-up|1|||
148681607|NCT02919475|536307772|FG004|Overall Study|Lost to Follow-up|0|||
148681608|NCT02919475|536307768|FG000|Overall Study|Withdrawal by Subject|2|||
148681609|NCT02919475|536307769|FG001|Overall Study|Withdrawal by Subject|3|||
148681610|NCT02919475|536307770|FG002|Overall Study|Withdrawal by Subject|1|||
148681611|NCT02919475|536307771|FG003|Overall Study|Withdrawal by Subject|2|||
148681612|NCT02919475|536307772|FG004|Overall Study|Withdrawal by Subject|2|||
148681613|NCT02919475|536307768|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
148681614|NCT02919475|536307769|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
148681615|NCT02919475|536307770|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
148681616|NCT02919475|536307771|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
148681617|NCT02919475|536307772|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
148681618|NCT02323295|536307780|FG000|Overall Study|Adverse Event|0|||
148681619|NCT02323295|536307781|FG001|Overall Study|Adverse Event|1|||
148681620|NCT02323295|536307780|FG000|Overall Study|Withdrawal by Subject|0|||
148681621|NCT02323295|536307781|FG001|Overall Study|Withdrawal by Subject|1|||
148681622|NCT02323295|536307780|FG000|Overall Study|Patient did not have surgery as planned.|0|||
148681623|NCT02323295|536307781|FG001|Overall Study|Patient did not have surgery as planned.|1|||
148681624|NCT02370784|536307782|FG000|Overall Study|Patient started prohibited medication|0|||
148681625|NCT02370784|536307783|FG001|Overall Study|Patient started prohibited medication|1|||
148681626|NCT00775983|536307785|FG000|Overall Study|Protocol Violation|1|||
148681627|NCT00775983|536307786|FG001|Overall Study|Protocol Violation|2|||
149191557|NCT00833248|538171520|FG001|Overall Study|Withdrawal by Subject|1|||
149191558|NCT01030458|538171521|FG000|Overall Study|Lost to Follow-up|9|||
149191559|NCT01030458|538171522|FG001|Overall Study|Lost to Follow-up|10|||
149191560|NCT01030458|538171521|FG000|Overall Study|Withdrawal by Subject|2|||
149191561|NCT01030458|538171522|FG001|Overall Study|Withdrawal by Subject|3|||
149191562|NCT01030458|538171521|FG000|Overall Study|Logistical reasons|9|||
149191563|NCT01030458|538171522|FG001|Overall Study|Logistical reasons|5|||
149191564|NCT01030458|538171521|FG000|Overall Study|Moved or changed job|6|||
149191565|NCT01030458|538171522|FG001|Overall Study|Moved or changed job|13|||
148681628|NCT01059071|536307787|FG000|Overall Study|Lack of Efficacy|1|||
148681629|NCT01059071|536307788|FG001|Overall Study|Lack of Efficacy|4|||
148681630|NCT01059071|536307789|FG002|Overall Study|Lack of Efficacy|2|||
148681631|NCT01059071|536307790|FG003|Overall Study|Lack of Efficacy|3|||
148681632|NCT01059071|536307787|FG000|Overall Study|Withdrawal by Subject|1|||
148681633|NCT01059071|536307788|FG001|Overall Study|Withdrawal by Subject|0|||
148681634|NCT01059071|536307789|FG002|Overall Study|Withdrawal by Subject|0|||
148681635|NCT01059071|536307790|FG003|Overall Study|Withdrawal by Subject|2|||
148681636|NCT01059071|536307787|FG000|Overall Study|Physician Decision|0|||
148681637|NCT01059071|536307788|FG001|Overall Study|Physician Decision|0|||
148681638|NCT01059071|536307789|FG002|Overall Study|Physician Decision|0|||
148681639|NCT01059071|536307790|FG003|Overall Study|Physician Decision|1|||
148681640|NCT03763331|536307795|FG000|Overall Study|Lost to Follow-up|1|||
148681641|NCT03763331|536307796|FG001|Overall Study|Lost to Follow-up|0|||
148681642|NCT03763331|536307795|FG000|Overall Study|Withdrawal by Subject|1|||
148681643|NCT03763331|536307796|FG001|Overall Study|Withdrawal by Subject|0|||
148681644|NCT03763331|536307795|FG000|Overall Study|Non-compliance|0|||
148681645|NCT03763331|536307796|FG001|Overall Study|Non-compliance|3|||
148681646|NCT00936884|536307797|FG000|Double-blind|Withdrawal by Subject|6|||
148681647|NCT00936884|536307798|FG001|Double-blind|Withdrawal by Subject|4|||
148681648|NCT00936884|536307799|FG002|Double-blind|Withdrawal by Subject|0|||
148681649|NCT00936884|536307797|FG000|Double-blind|Death|2|||
149191566|NCT01030458|538171521|FG000|Overall Study|Side effect of medication|1|||
149191567|NCT01030458|538171522|FG001|Overall Study|Side effect of medication|1|||
149191568|NCT00411788|538171525|FG000|Overall Study|Protocol Violation|1|||
148681650|NCT00936884|536307798|FG001|Double-blind|Death|1|||
149191569|NCT00411788|538171525|FG000|Overall Study|Adverse Event|1|||
149191570|NCT00995345|538171527|FG000|Overall Study|Withdrawal by Subject|4|||
149191571|NCT00995345|538171528|FG001|Overall Study|Withdrawal by Subject|2|||
149191572|NCT00995345|538171529|FG002|Overall Study|Withdrawal by Subject|1|||
149191573|NCT00995345|538171530|FG003|Overall Study|Withdrawal by Subject|3|||
149191574|NCT00995345|538171531|FG004|Overall Study|Withdrawal by Subject|1|||
149191575|NCT00995345|538171527|FG000|Overall Study|Adverse Event|3|||
149191576|NCT00995345|538171528|FG001|Overall Study|Adverse Event|1|||
148681651|NCT00936884|536307799|FG002|Double-blind|Death|0|||
148681652|NCT00936884|536307797|FG000|Double-blind|Lack of Efficacy|1|||
148681653|NCT00936884|536307798|FG001|Double-blind|Lack of Efficacy|1|||
148681654|NCT00936884|536307799|FG002|Double-blind|Lack of Efficacy|0|||
148681655|NCT00936884|536307797|FG000|Double-blind|Adverse Event|1|||
148681656|NCT00936884|536307798|FG001|Double-blind|Adverse Event|0|||
148681657|NCT00936884|536307799|FG002|Double-blind|Adverse Event|0|||
148681658|NCT00936884|536307797|FG000|Double-blind|Physician Decision|1|||
148681659|NCT00936884|536307798|FG001|Double-blind|Physician Decision|0|||
148681660|NCT00936884|536307799|FG002|Double-blind|Physician Decision|0|||
149191577|NCT00995345|538171529|FG002|Overall Study|Adverse Event|2|||
148681661|NCT00936884|536307797|FG000|Double-blind|No post baseline diary entry|1|||
149191578|NCT00995345|538171530|FG003|Overall Study|Adverse Event|0|||
149191579|NCT00995345|538171531|FG004|Overall Study|Adverse Event|1|||
149191580|NCT00995345|538171527|FG000|Overall Study|Lost to Follow-up|2|||
148681662|NCT00936884|536307798|FG001|Double-blind|No post baseline diary entry|0|||
148681663|NCT00936884|536307799|FG002|Double-blind|No post baseline diary entry|0|||
148681664|NCT00936884|536307797|FG000|Double-blind|Did not receive study drug|0|||
148681665|NCT00936884|536307798|FG001|Double-blind|Did not receive study drug|1|||
148681666|NCT00936884|536307799|FG002|Double-blind|Did not receive study drug|0|||
148681667|NCT04741503|536307800|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
148681668|NCT04741503|536307801|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
148681669|NCT04741503|536307802|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
148681670|NCT04741503|536307800|FG000|Initial Enrollment|Overquotas removed|0|||
148681671|NCT04741503|536307801|FG001|Initial Enrollment|Overquotas removed|0|||
148681672|NCT04741503|536307802|FG002|Initial Enrollment|Overquotas removed|186|||
148681673|NCT04741503|536307800|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
148681674|NCT04741503|536307801|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
148681675|NCT04741503|536307802|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
148681677|NCT01663714|536307804|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
148681678|NCT01663714|536307804|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
148681679|NCT01663714|536307804|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
148681680|NCT01663714|536307804|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
148681681|NCT01663714|536307804|FG000|Long-Term Follow-Up|Death|4|||
148681682|NCT01663714|536307804|FG000|Long-Term Follow-Up|Non-compliance|1|||
148681683|NCT00597584|536307807|FG000|Overall Study|Adverse Event|4|||
148681684|NCT00597584|536307808|FG001|Overall Study|Adverse Event|2|||
148681685|NCT00597584|536307807|FG000|Overall Study|Death|53|||
148681686|NCT00597584|536307808|FG001|Overall Study|Death|30|||
148681687|NCT00597584|536307807|FG000|Overall Study|Lack of Efficacy|1|||
148681688|NCT00597584|536307808|FG001|Overall Study|Lack of Efficacy|0|||
148681689|NCT00597584|536307807|FG000|Overall Study|Lost to Follow-up|2|||
148681690|NCT00597584|536307808|FG001|Overall Study|Lost to Follow-up|4|||
148681691|NCT00597584|536307807|FG000|Overall Study|Physician Decision|3|||
148681692|NCT00597584|536307808|FG001|Overall Study|Physician Decision|0|||
148681693|NCT00597584|536307807|FG000|Overall Study|Pregnancy|2|||
148681694|NCT00597584|536307808|FG001|Overall Study|Pregnancy|0|||
148681695|NCT00597584|536307807|FG000|Overall Study|Withdrawal by Subject|44|||
148681696|NCT00597584|536307808|FG001|Overall Study|Withdrawal by Subject|12|||
148681697|NCT00597584|536307807|FG000|Overall Study|Discontinued Dialysis|0|||
148681698|NCT00597584|536307808|FG001|Overall Study|Discontinued Dialysis|1|||
148681699|NCT00597584|536307807|FG000|Overall Study|Lost ability to consent|1|||
148681700|NCT00597584|536307808|FG001|Overall Study|Lost ability to consent|1|||
148681701|NCT00597584|536307807|FG000|Overall Study|Never dosed|1|||
148681702|NCT00597584|536307808|FG001|Overall Study|Never dosed|0|||
148681703|NCT00597584|536307807|FG000|Overall Study|Relocation|8|||
148681704|NCT00597584|536307808|FG001|Overall Study|Relocation|6|||
148681705|NCT00597584|536307807|FG000|Overall Study|Renal transplant|9|||
148681706|NCT00597584|536307808|FG001|Overall Study|Renal transplant|7|||
148681707|NCT02280421|536307809|FG000|Washout (2 Weeks)|Adverse Event|0|||
148681708|NCT02280421|536307810|FG001|Washout (2 Weeks)|Adverse Event|1|||
148681709|NCT02280421|536307809|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
148681710|NCT02280421|536307810|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
148681711|NCT01703741|536307817|FG000|Overall Study|Withdrawal by Subject|6|||
148681712|NCT01703741|536307817|FG000|Overall Study|Adverse Event|2|||
149191581|NCT00995345|538171528|FG001|Overall Study|Lost to Follow-up|2|||
149191582|NCT00995345|538171529|FG002|Overall Study|Lost to Follow-up|2|||
149191583|NCT00995345|538171530|FG003|Overall Study|Lost to Follow-up|1|||
149191584|NCT00995345|538171531|FG004|Overall Study|Lost to Follow-up|0|||
149191585|NCT00995345|538171527|FG000|Overall Study|all other reasons combined|2|||
149191586|NCT00995345|538171528|FG001|Overall Study|all other reasons combined|2|||
149191587|NCT00995345|538171529|FG002|Overall Study|all other reasons combined|2|||
149191588|NCT00995345|538171530|FG003|Overall Study|all other reasons combined|1|||
149191589|NCT00995345|538171531|FG004|Overall Study|all other reasons combined|3|||
149191590|NCT05122650|538171532|FG000|Overall Study|Adverse Event|4|||
149191591|NCT05122650|538171533|FG001|Overall Study|Adverse Event|16|||
148681713|NCT01703741|536307817|FG000|Overall Study|Physician Decision|2|||
148681714|NCT01703741|536307817|FG000|Overall Study|Protocol Violation|1|||
148681715|NCT01703741|536307817|FG000|Overall Study|Lost to Follow-up|3|||
148681716|NCT01703741|536307817|FG000|Overall Study|Subject did not want to continue|2|||
148681717|NCT01703741|536307817|FG000|Overall Study|Subject cannot comply with study visits|1|||
148681718|NCT01703741|536307817|FG000|Overall Study|Subject started testosterone injections|1|||
148681719|NCT04126733|536307823|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
148681720|NCT04126733|536307823|FG000|Treatment Period|Adverse Event|8|||
148807641|NCT00269152|536773338|FG000|Overall Study|Withdrawal by Subject|7|||
148807642|NCT00269152|536773339|FG001|Overall Study|Withdrawal by Subject|3|||
149191592|NCT05122650|538171534|FG002|Overall Study|Adverse Event|11|||
149191593|NCT05122650|538171535|FG003|Overall Study|Adverse Event|12|||
149191594|NCT05122650|538171532|FG000|Overall Study|Lack of Efficacy|0|||
149191595|NCT05122650|538171533|FG001|Overall Study|Lack of Efficacy|1|||
149191596|NCT05122650|538171534|FG002|Overall Study|Lack of Efficacy|1|||
149191597|NCT05122650|538171535|FG003|Overall Study|Lack of Efficacy|2|||
149191598|NCT05122650|538171532|FG000|Overall Study|Lost to Follow-up|1|||
149191599|NCT05122650|538171533|FG001|Overall Study|Lost to Follow-up|1|||
149191600|NCT05122650|538171534|FG002|Overall Study|Lost to Follow-up|3|||
149191601|NCT05122650|538171535|FG003|Overall Study|Lost to Follow-up|0|||
149191602|NCT05122650|538171532|FG000|Overall Study|Non-compliance with study intervention|0|||
149191603|NCT05122650|538171533|FG001|Overall Study|Non-compliance with study intervention|0|||
149191604|NCT05122650|538171534|FG002|Overall Study|Non-compliance with study intervention|0|||
149191605|NCT05122650|538171535|FG003|Overall Study|Non-compliance with study intervention|2|||
149191606|NCT05122650|538171532|FG000|Overall Study|Protocol Violation|0|||
149191607|NCT05122650|538171533|FG001|Overall Study|Protocol Violation|1|||
149191608|NCT05122650|538171534|FG002|Overall Study|Protocol Violation|0|||
149191609|NCT05122650|538171535|FG003|Overall Study|Protocol Violation|1|||
149191610|NCT05122650|538171532|FG000|Overall Study|Randomized by mistake|0|||
149191611|NCT05122650|538171533|FG001|Overall Study|Randomized by mistake|0|||
149191612|NCT05122650|538171534|FG002|Overall Study|Randomized by mistake|3|||
149191613|NCT05122650|538171535|FG003|Overall Study|Randomized by mistake|2|||
149191614|NCT05122650|538171532|FG000|Overall Study|Sponsor request|0|||
149191615|NCT05122650|538171533|FG001|Overall Study|Sponsor request|1|||
149191616|NCT05122650|538171534|FG002|Overall Study|Sponsor request|1|||
149191617|NCT05122650|538171535|FG003|Overall Study|Sponsor request|2|||
149191618|NCT05122650|538171532|FG000|Overall Study|Withdrawal by Subject|3|||
149191619|NCT05122650|538171533|FG001|Overall Study|Withdrawal by Subject|7|||
149191620|NCT05122650|538171534|FG002|Overall Study|Withdrawal by Subject|4|||
149191621|NCT05122650|538171535|FG003|Overall Study|Withdrawal by Subject|8|||
149191622|NCT05122650|538171532|FG000|Overall Study|Other|5|||
149191623|NCT05122650|538171533|FG001|Overall Study|Other|0|||
149191624|NCT05122650|538171534|FG002|Overall Study|Other|0|||
149191625|NCT05122650|538171535|FG003|Overall Study|Other|0|||
149191626|NCT00830037|538171539|FG000|Overall Study|Withdrawal by Subject|2|||
149191627|NCT00830037|538171540|FG001|Overall Study|Withdrawal by Subject|3|||
149191628|NCT00830037|538171539|FG000|Overall Study|Lost to Follow-up|1|||
149191629|NCT00830037|538171540|FG001|Overall Study|Lost to Follow-up|2|||
149191630|NCT00830037|538171539|FG000|Overall Study|Active when terminated by DSMB|15|||
149191631|NCT00830037|538171540|FG001|Overall Study|Active when terminated by DSMB|14|||
149191632|NCT03280550|538171547|FG000|Overall Study|Withdrawal by Subject|2|||
149191633|NCT03280550|538171548|FG001|Overall Study|Withdrawal by Subject|2|||
149191634|NCT03280550|538171547|FG000|Overall Study|Physician Decision|0|||
149191635|NCT03280550|538171548|FG001|Overall Study|Physician Decision|1|||
149191636|NCT00222729|538171553|FG000|Overall Study|Adverse Event|3|||
149191637|NCT02775864|538171554|FG000|Overall Study|Data ended end of 2010|1764|||
149191638|NCT02775864|538171555|FG001|Overall Study|Data ended end of 2010|2880|||
149191639|NCT02775864|538171556|FG002|Overall Study|Data ended end of 2010|1140|||
149191640|NCT02775864|538171557|FG003|Overall Study|Data ended end of 2010|1194|||
149191641|NCT02775864|538171554|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
149191642|NCT02775864|538171555|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
149191643|NCT02775864|538171556|FG002|Overall Study|Medicaid eligibility discontinued|720|||
149191644|NCT02775864|538171557|FG003|Overall Study|Medicaid eligibility discontinued|890|||
149191645|NCT02028338|538171558|FG000|Overall Study|Withdrawal by Subject|3|||
149191646|NCT02028338|538171559|FG001|Overall Study|Withdrawal by Subject|1|||
148681721|NCT04126733|536307823|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
148681722|NCT04126733|536307823|FG000|Treatment Period|Physician Decision|5|||
148681723|NCT04126733|536307823|FG000|Treatment Period|Death|1|||
149191647|NCT02028338|538171558|FG000|Overall Study|Unable to contact participant|1|||
149191648|NCT02028338|538171559|FG001|Overall Study|Unable to contact participant|0|||
149191649|NCT01842620|538171566|FG000|Period 1|Withdrawal by Subject|1|||
148681724|NCT04126733|536307823|FG000|Treatment Period|Other Reasons|2|||
148681725|NCT04126733|536307823|FG000|Active Follow-up Period|Death|13|||
149191650|NCT01842620|538171567|FG001|Period 1|Withdrawal by Subject|0|||
149191651|NCT00256867|538171568|FG000|Overall Study|Adverse Event|0|||
149191652|NCT00256867|538171569|FG001|Overall Study|Adverse Event|1|||
149014791|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149191653|NCT00256867|538171570|FG002|Overall Study|Adverse Event|1|||
149191654|NCT00256867|538171571|FG003|Overall Study|Adverse Event|1|||
149191655|NCT00256867|538171572|FG004|Overall Study|Adverse Event|2|||
149191656|NCT00256867|538171573|FG005|Overall Study|Adverse Event|2|||
148681726|NCT04126733|536307823|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
149191657|NCT00256867|538171574|FG006|Overall Study|Adverse Event|1|||
149191658|NCT00256867|538171575|FG007|Overall Study|Adverse Event|4|||
149191659|NCT00256867|538171568|FG000|Overall Study|Lost to Follow-up|2|||
149191660|NCT00256867|538171569|FG001|Overall Study|Lost to Follow-up|2|||
149191661|NCT00256867|538171570|FG002|Overall Study|Lost to Follow-up|2|||
149191662|NCT00256867|538171571|FG003|Overall Study|Lost to Follow-up|3|||
149191663|NCT00256867|538171572|FG004|Overall Study|Lost to Follow-up|2|||
148807643|NCT00269152|536773338|FG000|Overall Study|Physician Decision|2|||
148807644|NCT00269152|536773339|FG001|Overall Study|Physician Decision|3|||
148807645|NCT00269152|536773338|FG000|Overall Study|Protocol Violation|0|||
148807646|NCT00269152|536773339|FG001|Overall Study|Protocol Violation|1|||
149191664|NCT00256867|538171573|FG005|Overall Study|Lost to Follow-up|0|||
149191665|NCT00256867|538171574|FG006|Overall Study|Lost to Follow-up|1|||
149191666|NCT00256867|538171575|FG007|Overall Study|Lost to Follow-up|2|||
149191667|NCT00256867|538171568|FG000|Overall Study|Protocol Violation|0|||
149191668|NCT00256867|538171569|FG001|Overall Study|Protocol Violation|0|||
149191669|NCT00256867|538171570|FG002|Overall Study|Protocol Violation|0|||
149191670|NCT00256867|538171571|FG003|Overall Study|Protocol Violation|1|||
149191671|NCT00256867|538171572|FG004|Overall Study|Protocol Violation|0|||
149191672|NCT00256867|538171573|FG005|Overall Study|Protocol Violation|1|||
149191673|NCT00256867|538171574|FG006|Overall Study|Protocol Violation|0|||
149191674|NCT00256867|538171575|FG007|Overall Study|Protocol Violation|1|||
149191675|NCT00256867|538171568|FG000|Overall Study|Withdrawal by Subject|0|||
149191676|NCT00256867|538171569|FG001|Overall Study|Withdrawal by Subject|0|||
149191677|NCT00256867|538171570|FG002|Overall Study|Withdrawal by Subject|1|||
149191678|NCT00256867|538171571|FG003|Overall Study|Withdrawal by Subject|1|||
149191679|NCT00256867|538171572|FG004|Overall Study|Withdrawal by Subject|2|||
149191680|NCT00256867|538171573|FG005|Overall Study|Withdrawal by Subject|2|||
149191681|NCT00256867|538171574|FG006|Overall Study|Withdrawal by Subject|3|||
149191682|NCT00256867|538171575|FG007|Overall Study|Withdrawal by Subject|2|||
149191683|NCT00256867|538171568|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191684|NCT00256867|538171569|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
149191685|NCT00256867|538171570|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191686|NCT00256867|538171571|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191687|NCT00256867|538171572|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191688|NCT00256867|538171573|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191689|NCT00256867|538171574|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191690|NCT00256867|538171575|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
149191691|NCT00256867|538171568|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191692|NCT00256867|538171569|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191693|NCT00256867|538171570|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191694|NCT00256867|538171571|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191695|NCT00256867|538171572|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191696|NCT00256867|538171573|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191697|NCT00256867|538171574|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
149191698|NCT00256867|538171575|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
149191699|NCT00256867|538171568|FG000|Overall Study|Investigator's Decision|0|||
149191700|NCT00256867|538171569|FG001|Overall Study|Investigator's Decision|0|||
149191701|NCT00256867|538171570|FG002|Overall Study|Investigator's Decision|0|||
149191702|NCT00256867|538171571|FG003|Overall Study|Investigator's Decision|0|||
149191703|NCT00256867|538171572|FG004|Overall Study|Investigator's Decision|1|||
149191704|NCT00256867|538171573|FG005|Overall Study|Investigator's Decision|0|||
148807647|NCT00671788|536773342|FG000|Overall Study|Adverse Event|8|||
148807648|NCT00671788|536773342|FG000|Overall Study|Refused further treatment|3|||
148807649|NCT00671788|536773342|FG000|Overall Study|Ineligible|1|||
148807650|NCT00671788|536773342|FG000|Overall Study|MD Decision|1|||
148807651|NCT00671788|536773342|FG000|Overall Study|Other|1|||
148807652|NCT02792504|536773345|FG000|Overall Study|Lost to Follow-up|24|||
148807653|NCT02792504|536773345|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
148807654|NCT01035138|536773346|FG000|Overall Study|Adverse Event|4|||
149191705|NCT00256867|538171574|FG006|Overall Study|Investigator's Decision|0|||
149191706|NCT00256867|538171575|FG007|Overall Study|Investigator's Decision|0|||
149191707|NCT00256867|538171568|FG000|Overall Study|Non-compliance with study medication|0|||
149191708|NCT00256867|538171569|FG001|Overall Study|Non-compliance with study medication|0|||
149191709|NCT00256867|538171570|FG002|Overall Study|Non-compliance with study medication|0|||
149191710|NCT00256867|538171571|FG003|Overall Study|Non-compliance with study medication|0|||
149191711|NCT00256867|538171572|FG004|Overall Study|Non-compliance with study medication|0|||
149191712|NCT00256867|538171573|FG005|Overall Study|Non-compliance with study medication|0|||
149191713|NCT00256867|538171574|FG006|Overall Study|Non-compliance with study medication|0|||
149191714|NCT00256867|538171575|FG007|Overall Study|Non-compliance with study medication|1|||
149191715|NCT00256867|538171568|FG000|Overall Study|Participant travelled Overseas|0|||
148681727|NCT04126733|536307823|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
149191716|NCT00256867|538171569|FG001|Overall Study|Participant travelled Overseas|1|||
149191717|NCT00256867|538171570|FG002|Overall Study|Participant travelled Overseas|0|||
149191718|NCT00256867|538171571|FG003|Overall Study|Participant travelled Overseas|0|||
149191719|NCT00256867|538171572|FG004|Overall Study|Participant travelled Overseas|0|||
149191720|NCT00256867|538171573|FG005|Overall Study|Participant travelled Overseas|0|||
149191721|NCT00256867|538171574|FG006|Overall Study|Participant travelled Overseas|0|||
149191722|NCT00256867|538171575|FG007|Overall Study|Participant travelled Overseas|0|||
149191723|NCT00256867|538171568|FG000|Overall Study|Participant out of assessment window|0|||
149191724|NCT00256867|538171569|FG001|Overall Study|Participant out of assessment window|0|||
149191725|NCT00256867|538171570|FG002|Overall Study|Participant out of assessment window|1|||
149191726|NCT00256867|538171571|FG003|Overall Study|Participant out of assessment window|0|||
149191727|NCT00256867|538171572|FG004|Overall Study|Participant out of assessment window|0|||
149191728|NCT00256867|538171573|FG005|Overall Study|Participant out of assessment window|0|||
149191729|NCT00256867|538171574|FG006|Overall Study|Participant out of assessment window|0|||
149191730|NCT00256867|538171575|FG007|Overall Study|Participant out of assessment window|0|||
149191731|NCT00256867|538171568|FG000|Overall Study|Withdrawal by participant|0|||
149191732|NCT00256867|538171569|FG001|Overall Study|Withdrawal by participant|0|||
149191733|NCT00256867|538171570|FG002|Overall Study|Withdrawal by participant|0|||
149191734|NCT00256867|538171571|FG003|Overall Study|Withdrawal by participant|0|||
149191735|NCT00256867|538171572|FG004|Overall Study|Withdrawal by participant|0|||
149191736|NCT00256867|538171573|FG005|Overall Study|Withdrawal by participant|1|||
149191737|NCT00256867|538171574|FG006|Overall Study|Withdrawal by participant|0|||
149191738|NCT00256867|538171575|FG007|Overall Study|Withdrawal by participant|0|||
149191739|NCT01930799|538171578|FG000|Overall Study|Withdrawal by Subject|3|||
149191740|NCT01930799|538171578|FG000|Overall Study|Lost to Follow-up|5|||
149191741|NCT00875017|538171581|FG000|First Intervention|Withdrawal by Subject|1|||
149191742|NCT00875017|538171582|FG001|First Intervention|Withdrawal by Subject|0|||
149191743|NCT00875017|538171583|FG002|First Intervention|Withdrawal by Subject|1|||
149191744|NCT00875017|538171584|FG003|First Intervention|Withdrawal by Subject|0|||
149191745|NCT00875017|538171585|FG004|First Intervention|Withdrawal by Subject|0|||
149191746|NCT00875017|538171586|FG005|First Intervention|Withdrawal by Subject|0|||
149191747|NCT00875017|538171581|FG000|First Intervention|Adverse Event|0|||
149191748|NCT00875017|538171582|FG001|First Intervention|Adverse Event|0|||
149191749|NCT00875017|538171583|FG002|First Intervention|Adverse Event|0|||
149191750|NCT00875017|538171584|FG003|First Intervention|Adverse Event|1|||
149191751|NCT00875017|538171585|FG004|First Intervention|Adverse Event|0|||
149191752|NCT00875017|538171586|FG005|First Intervention|Adverse Event|0|||
149191753|NCT00875017|538171581|FG000|First Intervention|Problems collecting rectal effluent|1|||
149191754|NCT00875017|538171582|FG001|First Intervention|Problems collecting rectal effluent|0|||
149191755|NCT00875017|538171583|FG002|First Intervention|Problems collecting rectal effluent|0|||
149191756|NCT00875017|538171584|FG003|First Intervention|Problems collecting rectal effluent|0|||
149191757|NCT00875017|538171585|FG004|First Intervention|Problems collecting rectal effluent|0|||
149191758|NCT00875017|538171586|FG005|First Intervention|Problems collecting rectal effluent|0|||
149191759|NCT00875017|538171581|FG000|First Intervention|Intolerance to nasogastric tube|0|||
149191760|NCT00875017|538171582|FG001|First Intervention|Intolerance to nasogastric tube|0|||
149191761|NCT00875017|538171583|FG002|First Intervention|Intolerance to nasogastric tube|0|||
149191762|NCT00875017|538171584|FG003|First Intervention|Intolerance to nasogastric tube|0|||
149191763|NCT00875017|538171585|FG004|First Intervention|Intolerance to nasogastric tube|1|||
149191764|NCT00875017|538171586|FG005|First Intervention|Intolerance to nasogastric tube|0|||
149191765|NCT00875017|538171581|FG000|Washout|Problem collecting rectal effluent|0|||
149191766|NCT00875017|538171582|FG001|Washout|Problem collecting rectal effluent|0|||
149191767|NCT00875017|538171583|FG002|Washout|Problem collecting rectal effluent|1|||
149191768|NCT00875017|538171584|FG003|Washout|Problem collecting rectal effluent|0|||
149191769|NCT00875017|538171585|FG004|Washout|Problem collecting rectal effluent|0|||
149191770|NCT00875017|538171586|FG005|Washout|Problem collecting rectal effluent|0|||
149191771|NCT00875017|538171581|FG000|Second Intervention|Adverse Event|0|||
149191772|NCT00875017|538171582|FG001|Second Intervention|Adverse Event|0|||
149191773|NCT00875017|538171583|FG002|Second Intervention|Adverse Event|0|||
148681728|NCT04126733|536307823|FG000|Active Follow-up Period|Other Reasons|1|||
148681729|NCT04126733|536307823|FG000|Long-term Follow-up Period|Death|22|||
148681730|NCT04126733|536307823|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
148681731|NCT04126733|536307823|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
148681732|NCT02410837|536307824|FG000|Overall Study|Death|387|||
148681733|NCT02410837|536307824|FG000|Overall Study|Lost to Follow-up|50|||
148681734|NCT02410837|536307824|FG000|Overall Study|Withdrawal by Subject|44|||
149014792|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149191774|NCT00875017|538171584|FG003|Second Intervention|Adverse Event|1|||
149191775|NCT00875017|538171585|FG004|Second Intervention|Adverse Event|0|||
149191776|NCT00875017|538171586|FG005|Second Intervention|Adverse Event|0|||
149191777|NCT00875017|538171581|FG000|Washout|Problems collecting rectal effluent|0|||
149191778|NCT00875017|538171582|FG001|Washout|Problems collecting rectal effluent|1|||
148681735|NCT02410837|536307824|FG000|Overall Study|Physician Decision|6|||
148681736|NCT02410837|536307824|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
148681737|NCT00837577|536307825|FG000|Double-blind Period|Clinical Adverse Event|1|||
148681738|NCT00837577|536307826|FG001|Double-blind Period|Clinical Adverse Event|0|||
148681739|NCT00837577|536307825|FG000|Double-blind Period|Withdrawal by Subject|1|||
148681740|NCT00837577|536307826|FG001|Double-blind Period|Withdrawal by Subject|0|||
148681741|NCT00837577|536307825|FG000|Open-label Period|Clinical Adverse Event|2|||
148681742|NCT00837577|536307826|FG001|Open-label Period|Clinical Adverse Event|2|||
148681743|NCT00837577|536307825|FG000|Open-label Period|Laboratory Adverse Event|0|||
148681744|NCT00837577|536307826|FG001|Open-label Period|Laboratory Adverse Event|1|||
148681745|NCT00837577|536307825|FG000|Open-label Period|Lack of Efficacy|4|||
148681746|NCT00837577|536307826|FG001|Open-label Period|Lack of Efficacy|3|||
148681747|NCT00837577|536307825|FG000|Open-label Period|Withdrawal by Subject|1|||
148681748|NCT00837577|536307826|FG001|Open-label Period|Withdrawal by Subject|2|||
148681749|NCT00837577|536307825|FG000|Open-label Period|Other Reason|1|||
148681750|NCT00837577|536307826|FG001|Open-label Period|Other Reason|1|||
148681751|NCT01325532|536307831|FG000|Overall Study|Withdrawal by Subject|2|||
148681752|NCT01325532|536307832|FG001|Overall Study|Withdrawal by Subject|0|||
148681753|NCT03196791|536307835|FG000|Overall Study|Protocol Violation|7|||
148681754|NCT03196791|536307836|FG001|Overall Study|Protocol Violation|3|||
148681755|NCT03196791|536307835|FG000|Overall Study|Withdrawal by Subject|3|||
148681756|NCT03196791|536307836|FG001|Overall Study|Withdrawal by Subject|2|||
148681757|NCT03056001|536307838|FG000|Overall Study|Death|24|||
148681758|NCT02295280|536307840|FG000|Overall Study|Adverse Event|0|||
148681759|NCT02295280|536307841|FG001|Overall Study|Adverse Event|1|||
148681760|NCT02875067|536307842|FG000|Overall Study|Withdrawal by Subject|1|||
148681761|NCT02875067|536307842|FG000|Overall Study|Withdrawal by Termination of Study|5|||
148681762|NCT02713243|536307844|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
148681763|NCT02713243|536307845|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
148681764|NCT02713243|536307844|FG000|Overall Study|Administrative problems|0|||
148681765|NCT02713243|536307845|FG001|Overall Study|Administrative problems|1|||
149191779|NCT00875017|538171583|FG002|Washout|Problems collecting rectal effluent|0|||
149191780|NCT00875017|538171584|FG003|Washout|Problems collecting rectal effluent|0|||
149191781|NCT00875017|538171585|FG004|Washout|Problems collecting rectal effluent|0|||
149191782|NCT00875017|538171586|FG005|Washout|Problems collecting rectal effluent|0|||
149191783|NCT00875017|538171581|FG000|Third Intervention|Adverse Event|0|||
149191784|NCT00875017|538171582|FG001|Third Intervention|Adverse Event|1|||
149191785|NCT00875017|538171583|FG002|Third Intervention|Adverse Event|1|||
149191786|NCT00875017|538171584|FG003|Third Intervention|Adverse Event|0|||
149191787|NCT00875017|538171585|FG004|Third Intervention|Adverse Event|0|||
149191788|NCT00875017|538171586|FG005|Third Intervention|Adverse Event|0|||
149191789|NCT00875017|538171581|FG000|Washout|Withdrawal by Subject|0|||
149191790|NCT00875017|538171582|FG001|Washout|Withdrawal by Subject|0|||
149191791|NCT00875017|538171583|FG002|Washout|Withdrawal by Subject|0|||
149191792|NCT00875017|538171584|FG003|Washout|Withdrawal by Subject|0|||
149191793|NCT00875017|538171585|FG004|Washout|Withdrawal by Subject|1|||
149191794|NCT00875017|538171586|FG005|Washout|Withdrawal by Subject|0|||
149191795|NCT00875017|538171581|FG000|Fourth Intervention|Inability to comply with fasting|0|||
149191796|NCT00875017|538171582|FG001|Fourth Intervention|Inability to comply with fasting|0|||
149191797|NCT00875017|538171583|FG002|Fourth Intervention|Inability to comply with fasting|0|||
149191798|NCT00875017|538171584|FG003|Fourth Intervention|Inability to comply with fasting|0|||
149191799|NCT00875017|538171585|FG004|Fourth Intervention|Inability to comply with fasting|0|||
149191800|NCT00875017|538171586|FG005|Fourth Intervention|Inability to comply with fasting|1|||
149191801|NCT03342469|538171587|FG000|Overall Study|Withdrawal by Subject|0|||
149191802|NCT03342469|538171588|FG001|Overall Study|Withdrawal by Subject|1|||
148681766|NCT02713243|536307844|FG000|Overall Study|Protocol deviation|0|||
148681767|NCT02713243|536307845|FG001|Overall Study|Protocol deviation|1|||
148681768|NCT03056352|536307846|FG000|Overall Study|Lost to Follow-up|1|||
148681769|NCT02971605|536307847|FG000|Overall Study|Withdrawal by Subject|1|||
148681770|NCT00597207|536307848|FG000|Overall Study|Lost to Follow-up|5|||
148681771|NCT00597207|536307849|FG001|Overall Study|Lost to Follow-up|7|||
148681772|NCT03439293|536307852|FG000|Overall Study|Death|22|||
149191803|NCT03342469|538171589|FG002|Overall Study|Withdrawal by Subject|0|||
149191804|NCT03342469|538171590|FG003|Overall Study|Withdrawal by Subject|0|||
149191805|NCT02689219|538171591|FG000|Overall Study|Death|1|||
149191806|NCT02689219|538171592|FG001|Overall Study|Death|1|||
149191807|NCT02689219|538171591|FG000|Overall Study|Disease Progression|10|||
148681773|NCT03439293|536307852|FG000|Overall Study|Withdrawal by Subject|8|||
148681774|NCT03439293|536307852|FG000|Overall Study|Lost to Follow-up|2|||
148681775|NCT03439293|536307852|FG000|Overall Study|Reason Not Specified|28|||
148681776|NCT03439293|536307852|FG000|Overall Study|Missing|1|||
148681777|NCT03077828|536307855|FG000|Treatment Cycles|Death|1|||
148681778|NCT03077828|536307855|FG000|Treatment Cycles|Withdrawal by Subject|1|||
148681779|NCT03077828|536307855|FG000|Treatment Cycles|Screen Fail|2|||
148807655|NCT01035138|536773347|FG001|Overall Study|Adverse Event|0|||
149191808|NCT02689219|538171592|FG001|Overall Study|Disease Progression|6|||
149191809|NCT01477892|538171593|FG000|Overall Study|Withdrawal by Subject|0|||
149191810|NCT01477892|538171594|FG001|Overall Study|Withdrawal by Subject|2|||
149191811|NCT01921257|538171596|FG000|Overall Study|Adverse Event|1|||
148681780|NCT03077828|536307855|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
148681781|NCT03077828|536307855|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
148681782|NCT03077828|536307855|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
149191812|NCT01921257|538171596|FG000|Overall Study|Protocol Violation|1|||
149191813|NCT01921257|538171596|FG000|Overall Study|Withdrawal by Subject|1|||
149191814|NCT05515601|538171601|FG000|Overall Study|Withdrawal by Subject|1|||
149191815|NCT05515601|538171602|FG001|Overall Study|Withdrawal by Subject|3|||
149191816|NCT05515601|538171603|FG002|Overall Study|Withdrawal by Subject|2|||
149191817|NCT05515601|538171604|FG003|Overall Study|Withdrawal by Subject|1|||
149191818|NCT05515601|538171605|FG004|Overall Study|Withdrawal by Subject|1|||
149191819|NCT05515601|538171606|FG005|Overall Study|Withdrawal by Subject|1|||
149191820|NCT05515601|538171601|FG000|Overall Study|Lost to Follow-up|0|||
149191821|NCT05515601|538171602|FG001|Overall Study|Lost to Follow-up|0|||
149191822|NCT05515601|538171603|FG002|Overall Study|Lost to Follow-up|0|||
149191823|NCT05515601|538171604|FG003|Overall Study|Lost to Follow-up|0|||
149191824|NCT05515601|538171605|FG004|Overall Study|Lost to Follow-up|1|||
149191825|NCT05515601|538171606|FG005|Overall Study|Lost to Follow-up|0|||
149191826|NCT01689207|538171607|FG000|Overall Study|Adverse Event|0|||
149191827|NCT01689207|538171608|FG001|Overall Study|Adverse Event|1|||
149191828|NCT01689207|538171609|FG002|Overall Study|Adverse Event|0|||
149191829|NCT01689207|538171610|FG003|Overall Study|Adverse Event|0|||
149191830|NCT01689207|538171611|FG004|Overall Study|Adverse Event|2|||
148681783|NCT03077828|536307855|FG000|Follow-up|Patients still in follow-up|15|||
148681784|NCT00869089|536307857|FG000|Overall Study|Lost to Follow-up|1|||
148681785|NCT00869089|536307857|FG000|Overall Study|Withdrawal by Subject|1|||
148681786|NCT00869089|536307857|FG000|Overall Study|Screen Fail|1|||
148681787|NCT05037409|536307859|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
148681788|NCT05037409|536307860|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
148681789|NCT05037409|536307861|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
148681790|NCT03499249|536307862|FG000|Overall Study|Physician Decision|1|||
148681791|NCT01374906|536307865|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148681792|NCT01374906|536307866|FG001|Overall Study|Abnormal laboratory value(s)|3|||
148681793|NCT01374906|536307865|FG000|Overall Study|Administrative problems|2|||
148681794|NCT01374906|536307866|FG001|Overall Study|Administrative problems|2|||
148681795|NCT01374906|536307865|FG000|Overall Study|Adverse Event|10|||
149191831|NCT01689207|538171612|FG005|Overall Study|Adverse Event|1|||
149191832|NCT01689207|538171613|FG006|Overall Study|Adverse Event|0|||
149191833|NCT01689207|538171614|FG007|Overall Study|Adverse Event|0|||
149191834|NCT01689207|538171615|FG008|Overall Study|Adverse Event|1|||
149191835|NCT01689207|538171616|FG009|Overall Study|Adverse Event|0|||
149191836|NCT01689207|538171617|FG010|Overall Study|Adverse Event|0|||
149191837|NCT01912768|538171618|FG000|Overall Study|Adverse Event|2|||
149191838|NCT01912768|538171619|FG001|Overall Study|Adverse Event|0|||
149191839|NCT01912768|538171618|FG000|Overall Study|Lost to Follow-up|2|||
149191840|NCT01912768|538171619|FG001|Overall Study|Lost to Follow-up|1|||
149191841|NCT01912768|538171618|FG000|Overall Study|Withdrawal by Subject|5|||
149191842|NCT01912768|538171619|FG001|Overall Study|Withdrawal by Subject|3|||
149191843|NCT01912768|538171618|FG000|Overall Study|Randomized in error|1|||
149191844|NCT01912768|538171619|FG001|Overall Study|Randomized in error|0|||
149191845|NCT00524316|538171620|FG000|Overall Study|Withdrawal by Subject|2|||
149191846|NCT00524316|538171620|FG000|Overall Study|Adverse Event|7|||
149191847|NCT00524316|538171620|FG000|Overall Study|Disease Progression|7|||
149191848|NCT02426658|538171623|FG000|Overall Study|Withdrawal by Subject|1|||
149191849|NCT02426658|538171623|FG000|Overall Study|Patient expired before treatment|2|||
148681796|NCT01374906|536307866|FG001|Overall Study|Adverse Event|11|||
148681797|NCT01374906|536307865|FG000|Overall Study|Death|0|||
148681798|NCT01374906|536307866|FG001|Overall Study|Death|2|||
148681799|NCT01374906|536307865|FG000|Overall Study|Protocol Violation|2|||
148681800|NCT01374906|536307866|FG001|Overall Study|Protocol Violation|2|||
148681801|NCT01374906|536307865|FG000|Overall Study|Withdrawal by Subject|15|||
148681802|NCT01374906|536307866|FG001|Overall Study|Withdrawal by Subject|9|||
148681803|NCT01374906|536307865|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
149191850|NCT01199263|538171624|FG000|Overall Study|Ineligible|0|||
149191851|NCT01199263|538171625|FG001|Overall Study|Ineligible|2|||
149191852|NCT01199263|538171624|FG000|Overall Study|Never Treated|6|||
149191853|NCT01199263|538171625|FG001|Overall Study|Never Treated|0|||
149191854|NCT00634244|538171626|FG000|Overall Study|Never started treatment|0|||
149191855|NCT00634244|538171627|FG001|Overall Study|Never started treatment|1|||
149191856|NCT00634244|538171628|FG002|Overall Study|Never started treatment|0|||
149191857|NCT00634244|538171626|FG000|Overall Study|Death|1|||
149191858|NCT00634244|538171627|FG001|Overall Study|Death|6|||
149191859|NCT00634244|538171628|FG002|Overall Study|Death|0|||
149191860|NCT00634244|538171626|FG000|Overall Study|Adverse Event|0|||
149191861|NCT00634244|538171627|FG001|Overall Study|Adverse Event|2|||
149191862|NCT00634244|538171628|FG002|Overall Study|Adverse Event|0|||
148681804|NCT01374906|536307866|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
148681805|NCT00430638|536307871|FG000|Overall Study|Adverse Event|15|||
149191863|NCT00634244|538171626|FG000|Overall Study|Withdrawal by Subject|0|||
149191864|NCT00634244|538171627|FG001|Overall Study|Withdrawal by Subject|1|||
149191865|NCT00634244|538171628|FG002|Overall Study|Withdrawal by Subject|0|||
149191866|NCT00634244|538171626|FG000|Overall Study|Physician Decision|0|||
149191867|NCT00634244|538171627|FG001|Overall Study|Physician Decision|1|||
149191868|NCT00634244|538171628|FG002|Overall Study|Physician Decision|0|||
149191869|NCT00634244|538171626|FG000|Overall Study|Disease progression/relapse|0|||
149191870|NCT00634244|538171627|FG001|Overall Study|Disease progression/relapse|1|||
149191871|NCT00634244|538171628|FG002|Overall Study|Disease progression/relapse|0|||
149191872|NCT00634244|538171626|FG000|Overall Study|Other complicating disease|0|||
148681806|NCT00430638|536307872|FG001|Overall Study|Adverse Event|15|||
148681807|NCT00430638|536307871|FG000|Overall Study|Uncontrolled blood pressure|48|||
148681808|NCT00430638|536307872|FG001|Overall Study|Uncontrolled blood pressure|13|||
148681809|NCT00430638|536307871|FG000|Overall Study|Lost to Follow-up|1|||
148681810|NCT00430638|536307872|FG001|Overall Study|Lost to Follow-up|7|||
148681811|NCT00430638|536307871|FG000|Overall Study|Protocol Violation|6|||
148681812|NCT00430638|536307872|FG001|Overall Study|Protocol Violation|4|||
148681813|NCT00430638|536307871|FG000|Overall Study|Withdrawal by Subject|4|||
148681814|NCT00430638|536307872|FG001|Overall Study|Withdrawal by Subject|6|||
148681815|NCT00430638|536307871|FG000|Overall Study|Non-compliant|2|||
149191873|NCT00634244|538171627|FG001|Overall Study|Other complicating disease|1|||
149191874|NCT00634244|538171628|FG002|Overall Study|Other complicating disease|0|||
149191875|NCT03453151|538171633|FG000|Overall Study|Withdrawal by Subject|1|||
149191876|NCT03453151|538171633|FG000|Overall Study|Physician Decision|3|||
149191877|NCT01204658|538171639|FG000|Primary Phase|Adverse Event|0|||
149191878|NCT01204658|538171640|FG001|Primary Phase|Adverse Event|0|||
149191879|NCT01204658|538171641|FG002|Primary Phase|Adverse Event|1|||
149191880|NCT01204658|538171642|FG003|Primary Phase|Adverse Event|0|||
149191881|NCT04594239|538171643|FG000|Overall Study|Withdrawal by Subject|3|||
149191882|NCT04594239|538171644|FG001|Overall Study|Withdrawal by Subject|4|||
149191883|NCT04594239|538171645|FG002|Overall Study|Withdrawal by Subject|2|||
149191884|NCT04594239|538171646|FG003|Overall Study|Withdrawal by Subject|4|||
149191885|NCT04594239|538171643|FG000|Overall Study|Lost to Follow-up|8|||
149191886|NCT04594239|538171644|FG001|Overall Study|Lost to Follow-up|5|||
149191887|NCT04594239|538171645|FG002|Overall Study|Lost to Follow-up|4|||
149191888|NCT04594239|538171646|FG003|Overall Study|Lost to Follow-up|6|||
149191889|NCT04594239|538171643|FG000|Overall Study|Subject relocated|0|||
149191890|NCT04594239|538171644|FG001|Overall Study|Subject relocated|0|||
149191891|NCT04594239|538171645|FG002|Overall Study|Subject relocated|0|||
149191892|NCT04594239|538171646|FG003|Overall Study|Subject relocated|1|||
149191893|NCT02678780|538171649|FG000|Overall Study|Adverse Event|11|||
149191894|NCT02678780|538171650|FG001|Overall Study|Adverse Event|14|||
149191895|NCT02678780|538171649|FG000|Overall Study|Withdrawal by Subject|2|||
148681816|NCT00430638|536307872|FG001|Overall Study|Non-compliant|1|||
148681817|NCT00430638|536307871|FG000|Overall Study|Other|2|||
148681818|NCT00430638|536307872|FG001|Overall Study|Other|2|||
148681819|NCT02367781|536307873|FG000|Overall Study|Withdrawal by Subject|20|||
148681820|NCT02367781|536307874|FG001|Overall Study|Withdrawal by Subject|13|||
148681821|NCT02367781|536307873|FG000|Overall Study|Protocol Violation|0|||
148681822|NCT02367781|536307874|FG001|Overall Study|Protocol Violation|1|||
148681823|NCT02367781|536307873|FG000|Overall Study|Physician Decision|7|||
148681824|NCT02367781|536307874|FG001|Overall Study|Physician Decision|0|||
148681825|NCT02367781|536307873|FG000|Overall Study|Randomized in Error|5|||
148681826|NCT02367781|536307874|FG001|Overall Study|Randomized in Error|4|||
148681827|NCT02367781|536307873|FG000|Overall Study|Non-Compliance|1|||
148681828|NCT02367781|536307874|FG001|Overall Study|Non-Compliance|0|||
148681829|NCT02367781|536307873|FG000|Overall Study|Lost to Follow-up|1|||
148681830|NCT02367781|536307874|FG001|Overall Study|Lost to Follow-up|2|||
148681831|NCT02367781|536307873|FG000|Overall Study|Death|330|||
149191896|NCT02678780|538171650|FG001|Overall Study|Withdrawal by Subject|1|||
148681832|NCT02367781|536307874|FG001|Overall Study|Death|176|||
148681833|NCT02367781|536307873|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
148681834|NCT02367781|536307874|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
148681835|NCT02367781|536307873|FG000|Overall Study|Prolonged Hospitalization|1|||
148681836|NCT02367781|536307874|FG001|Overall Study|Prolonged Hospitalization|0|||
149191897|NCT02678780|538171649|FG000|Overall Study|Sponsor discontinuation|7|||
149191898|NCT02678780|538171650|FG001|Overall Study|Sponsor discontinuation|4|||
149191899|NCT02678780|538171649|FG000|Overall Study|Death|1|||
149191900|NCT02678780|538171650|FG001|Overall Study|Death|1|||
149191901|NCT02678780|538171649|FG000|Overall Study|Other|6|||
149191902|NCT02678780|538171650|FG001|Overall Study|Other|8|||
149191903|NCT00091390|538171664|FG000|Overall Study|Protocol Violation|1|||
149191904|NCT00091390|538171664|FG000|Overall Study|No protocol treatment|3|||
148681837|NCT02367781|536307873|FG000|Overall Study|Death Prior First Dose|1|||
148681838|NCT02367781|536307874|FG001|Overall Study|Death Prior First Dose|0|||
149191905|NCT00406640|538171669|FG000|Acute Phase|Adverse Event|18|||
148807656|NCT01035138|536773348|FG002|Overall Study|Adverse Event|2|||
149191906|NCT00406640|538171670|FG001|Acute Phase|Adverse Event|13|||
149191907|NCT00406640|538171669|FG000|Acute Phase|Failed to Return|5|||
149191908|NCT00406640|538171670|FG001|Acute Phase|Failed to Return|1|||
149191909|NCT00406640|538171669|FG000|Acute Phase|Physician Decision|0|||
149191910|NCT00406640|538171670|FG001|Acute Phase|Physician Decision|1|||
149191911|NCT00406640|538171669|FG000|Acute Phase|Lost to Follow-up|7|||
149191912|NCT00406640|538171670|FG001|Acute Phase|Lost to Follow-up|4|||
149191913|NCT00406640|538171669|FG000|Acute Phase|Protocol deviation|4|||
149191914|NCT00406640|538171670|FG001|Acute Phase|Protocol deviation|10|||
149191915|NCT00406640|538171669|FG000|Acute Phase|Protocol Violation|3|||
149191916|NCT00406640|538171670|FG001|Acute Phase|Protocol Violation|2|||
149191917|NCT00406640|538171669|FG000|Acute Phase|Withdrawal by Subject|11|||
149191918|NCT00406640|538171670|FG001|Acute Phase|Withdrawal by Subject|9|||
149191919|NCT00406640|538171669|FG000|Acute Phase|Lack of Efficacy|3|||
149191920|NCT00406640|538171670|FG001|Acute Phase|Lack of Efficacy|3|||
149191921|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
149191922|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
149191923|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Death|1|||
149191924|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Death|0|||
149191925|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
149191926|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
149191927|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
149191928|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
149191929|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
149191930|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
149191931|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|non-compliance|7|||
149191932|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|non-compliance|5|||
149191933|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
149191934|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
149191935|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
149191936|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
149191937|NCT00406640|538171669|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
149191938|NCT00406640|538171670|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
149191939|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
149191940|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
149191941|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
149191942|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
149191943|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
149191944|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
149191945|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
149191946|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
149191947|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
149191948|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
149191949|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
149191950|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
149191951|NCT00406640|538171669|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
149191952|NCT00406640|538171670|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
149191953|NCT03050359|538173109|FG000|Overall Study|Randomized But Not Treated|2|||
149191954|NCT03050359|538173110|FG001|Overall Study|Randomized But Not Treated|0|||
149191955|NCT03050359|538173109|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
149191956|NCT03050359|538173110|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
149191957|NCT03050359|538173109|FG000|Overall Study|Significant Protocol Deviation|2|||
149191958|NCT03050359|538173110|FG001|Overall Study|Significant Protocol Deviation|3|||
149191959|NCT03050359|538173109|FG000|Overall Study|Lost to Follow-up|2|||
149191960|NCT03050359|538173110|FG001|Overall Study|Lost to Follow-up|1|||
149191961|NCT03050359|538173109|FG000|Overall Study|Voluntary Withdrawal|4|||
149191962|NCT03050359|538173110|FG001|Overall Study|Voluntary Withdrawal|6|||
149191963|NCT03050359|538173109|FG000|Overall Study|Pregnancy|1|||
149191964|NCT03050359|538173110|FG001|Overall Study|Pregnancy|0|||
148681839|NCT02367781|536307873|FG000|Overall Study|Administrative-Change Facility|1|||
148681840|NCT02367781|536307874|FG001|Overall Study|Administrative-Change Facility|0|||
148681841|NCT02367781|536307873|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
149191965|NCT03050359|538173109|FG000|Overall Study|Reason Not Specified|1|||
149191966|NCT03050359|538173110|FG001|Overall Study|Reason Not Specified|0|||
149191967|NCT02020031|538173111|FG000|Overall Study|Physician Decision|1|||
149191968|NCT02020031|538173112|FG001|Overall Study|Physician Decision|1|||
149191969|NCT01592409|538173117|FG000|Overall Study|Withdrawal by Subject|0|||
148681842|NCT02367781|536307874|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
149191970|NCT01592409|538173118|FG001|Overall Study|Withdrawal by Subject|1|||
149191971|NCT01728584|538173119|FG000|Overall Study|Adverse Event|1|||
149191972|NCT01728584|538173120|FG001|Overall Study|Adverse Event|0|||
148681843|NCT02367781|536307873|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
148681844|NCT02367781|536307874|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
149014793|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014794|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
149014795|NCT02291289|537534278|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
149014796|NCT02291289|537534279|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
149014797|NCT02291289|537534280|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
149014798|NCT02291289|537534281|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
149014799|NCT02291289|537534282|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
149014800|NCT02291289|537534283|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
149014801|NCT02291289|537534284|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
149014802|NCT02291289|537534285|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
149014803|NCT02291289|537534286|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
149014804|NCT02291289|537534287|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
148681845|NCT02367781|536307873|FG000|Overall Study|Study Terminated by Sponsor|3|||
148681846|NCT02367781|536307874|FG001|Overall Study|Study Terminated by Sponsor|1|||
148681847|NCT02367781|536307873|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
149014805|NCT02291289|537534288|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
149014806|NCT02291289|537534289|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
149014807|NCT02291289|537534290|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
149014808|NCT02291289|537534278|FG000|Early Disease Progression|Death|0|||
149014809|NCT02291289|537534279|FG001|Early Disease Progression|Death|0|||
149014810|NCT02291289|537534280|FG002|Early Disease Progression|Death|0|||
149014811|NCT02291289|537534281|FG003|Early Disease Progression|Death|0|||
149191973|NCT01728584|538173121|FG002|Overall Study|Adverse Event|0|||
148681848|NCT02367781|536307874|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
148681849|NCT02367781|536307873|FG000|Overall Study|Sponsor Decision|2|||
148681850|NCT02367781|536307874|FG001|Overall Study|Sponsor Decision|0|||
148681851|NCT02367781|536307873|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
148681852|NCT02367781|536307874|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
148681853|NCT01529749|536307875|FG000|Overall Study|Lost to Follow-up|0|||
148935091|NCT03387683|537247675|FG001|Overall Study|In receipt of disallowed medication|0|||
148935092|NCT03387683|537247674|FG000|Overall Study|Did not receive treatment|1|||
148935093|NCT03387683|537247675|FG001|Overall Study|Did not receive treatment|0|||
148935094|NCT00629772|537247676|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
148935095|NCT00629772|537247677|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
148935096|NCT00629772|537247676|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
148935097|NCT00629772|537247677|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
148935098|NCT03840174|537247678|FG000|Overall Study|Withdrawal by Subject|1|||
148935099|NCT03840174|537247679|FG001|Overall Study|Withdrawal by Subject|0|||
148935100|NCT03840174|537247680|FG002|Overall Study|Withdrawal by Subject|0|||
148935101|NCT03840174|537247681|FG003|Overall Study|Withdrawal by Subject|0|||
148935102|NCT00722423|537247682|FG000|Overall Study|Protocol Violation|0|||
148935103|NCT00722423|537247683|FG001|Overall Study|Protocol Violation|1|||
148935104|NCT01986140|537247692|FG000|Overall Study|Withdrawal by Subject|31|||
148935105|NCT01986140|537247693|FG001|Overall Study|Withdrawal by Subject|25|||
148935106|NCT01986140|537247692|FG000|Overall Study|alternative treatment|1|||
148935107|NCT01986140|537247693|FG001|Overall Study|alternative treatment|1|||
148935108|NCT01986140|537247692|FG000|Overall Study|found not eligible|3|||
148935109|NCT01986140|537247693|FG001|Overall Study|found not eligible|0|||
148935110|NCT01986140|537247692|FG000|Overall Study|Adverse Event|0|||
148935111|NCT01986140|537247693|FG001|Overall Study|Adverse Event|1|||
148935112|NCT01986140|537247692|FG000|Overall Study|progression disease|0|||
148935113|NCT01986140|537247693|FG001|Overall Study|progression disease|1|||
148935114|NCT01484132|537247694|FG000|Overall Study|Lost to Follow-up|8|||
149191974|NCT01728584|538173122|FG003|Overall Study|Adverse Event|0|||
149191975|NCT01728584|538173119|FG000|Overall Study|Physician Decision|4|||
149191976|NCT01728584|538173120|FG001|Overall Study|Physician Decision|0|||
149191977|NCT01728584|538173121|FG002|Overall Study|Physician Decision|1|||
149191978|NCT01728584|538173122|FG003|Overall Study|Physician Decision|0|||
149191979|NCT01728584|538173119|FG000|Overall Study|Withdrawal by Subject|1|||
148935115|NCT01484132|537247694|FG000|Overall Study|Difficulty with time commitment|2|||
149014812|NCT02291289|537534282|FG004|Early Disease Progression|Death|0|||
149014813|NCT02291289|537534283|FG005|Early Disease Progression|Death|0|||
149014814|NCT02291289|537534284|FG006|Early Disease Progression|Death|0|||
149014815|NCT02291289|537534285|FG007|Early Disease Progression|Death|0|||
149191980|NCT01728584|538173120|FG001|Overall Study|Withdrawal by Subject|0|||
149191981|NCT01728584|538173121|FG002|Overall Study|Withdrawal by Subject|0|||
149191982|NCT01728584|538173122|FG003|Overall Study|Withdrawal by Subject|0|||
148935116|NCT01484132|537247694|FG000|Overall Study|Ineligible|1|||
148935117|NCT01484132|537247694|FG000|Overall Study|No pre-treatment urine sample collected|1|||
148935118|NCT01484132|537247694|FG000|Overall Study|No post-treatment urine sample collected|10|||
148935119|NCT01912963|537247695|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
149191983|NCT01728584|538173119|FG000|Overall Study|Screen failure|1|||
149191984|NCT01728584|538173120|FG001|Overall Study|Screen failure|0|||
149191985|NCT01728584|538173121|FG002|Overall Study|Screen failure|0|||
149191986|NCT01728584|538173122|FG003|Overall Study|Screen failure|0|||
149191987|NCT01728584|538173119|FG000|Overall Study|Other reason (not specified)|1|||
149191988|NCT01728584|538173120|FG001|Overall Study|Other reason (not specified)|0|||
149191989|NCT01728584|538173121|FG002|Overall Study|Other reason (not specified)|0|||
149191990|NCT01728584|538173122|FG003|Overall Study|Other reason (not specified)|1|||
149191991|NCT00471536|538173129|FG000|Overall Study|Withdrawal by Subject|1|||
149191992|NCT02651194|538173130|FG000|Overall Study|Lost to Follow-up|3|||
149191993|NCT02651194|538173130|FG000|Overall Study|Other|2|||
149191994|NCT01980706|538173133|FG000|Overall Study|Withdrawal by Subject|9|||
149191995|NCT01980706|538173134|FG001|Overall Study|Withdrawal by Subject|6|||
149191996|NCT01980706|538173135|FG002|Overall Study|Withdrawal by Subject|2|||
149191997|NCT01980706|538173133|FG000|Overall Study|Adverse Event|1|||
149191998|NCT01980706|538173134|FG001|Overall Study|Adverse Event|2|||
149191999|NCT01980706|538173135|FG002|Overall Study|Adverse Event|5|||
149192000|NCT01980706|538173133|FG000|Overall Study|Lost to Follow-up|3|||
149192001|NCT01980706|538173134|FG001|Overall Study|Lost to Follow-up|4|||
149192002|NCT01980706|538173135|FG002|Overall Study|Lost to Follow-up|3|||
149192003|NCT01980706|538173133|FG000|Overall Study|miscellaneous|4|||
149192004|NCT01980706|538173134|FG001|Overall Study|miscellaneous|5|||
149192005|NCT01980706|538173135|FG002|Overall Study|miscellaneous|3|||
149192006|NCT02546674|538173136|FG000|Overall Study|Adverse Event|19|||
149192007|NCT02546674|538173136|FG000|Overall Study|Death|1|||
149192008|NCT02546674|538173136|FG000|Overall Study|Lost to Follow-up|1|||
149192009|NCT02546674|538173136|FG000|Overall Study|Physician Decision|13|||
149192010|NCT02546674|538173136|FG000|Overall Study|Pregnancy|1|||
149192011|NCT02546674|538173136|FG000|Overall Study|Progressive Disease|2|||
149192012|NCT02546674|538173136|FG000|Overall Study|Protocol Deviation|2|||
149192013|NCT02546674|538173136|FG000|Overall Study|Subject/Guardian Decision|6|||
149192014|NCT02546674|538173136|FG000|Overall Study|Withdrawal of Informed Consent|3|||
149192015|NCT01864018|538173140|FG000|Overall Study|Ineligible|3|||
149192016|NCT01864018|538173141|FG001|Overall Study|Ineligible|1|||
149192017|NCT02509598|538173142|FG000|Overall Study|Withdrawal by Subject|1|||
149192018|NCT04056455|538173144|FG000|Overall Study|Adverse Event|1|||
149192019|NCT04056455|538173145|FG001|Overall Study|Adverse Event|0|||
149192020|NCT02512068|538173146|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
149192021|NCT02512068|538173147|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
149192022|NCT02512068|538173146|FG000|Overall Study|Major Protocol Deviation|1|||
149192023|NCT02512068|538173147|FG001|Overall Study|Major Protocol Deviation|0|||
149192024|NCT02512068|538173146|FG000|Overall Study|Voluntary Withdrawal|0|||
149192025|NCT02512068|538173147|FG001|Overall Study|Voluntary Withdrawal|1|||
149192026|NCT02512068|538173146|FG000|Overall Study|Lack of Efficacy|0|||
149192027|NCT02512068|538173147|FG001|Overall Study|Lack of Efficacy|1|||
149192028|NCT02512068|538173146|FG000|Overall Study|Reason Not Specified|3|||
149192029|NCT02512068|538173147|FG001|Overall Study|Reason Not Specified|5|||
149192030|NCT04891770|538173151|FG000|Overall Study|Withdrew consent|1|||
149192031|NCT04891770|538173152|FG001|Overall Study|Withdrew consent|3|||
149192032|NCT04891770|538173153|FG002|Overall Study|Withdrew consent|0|||
149192033|NCT04891770|538173151|FG000|Overall Study|Enrolled but never treated|0|||
149192034|NCT04891770|538173152|FG001|Overall Study|Enrolled but never treated|0|||
149192035|NCT04891770|538173153|FG002|Overall Study|Enrolled but never treated|1|||
149192036|NCT04891770|538173151|FG000|Overall Study|Investigator's discretion|0|||
149192037|NCT04891770|538173152|FG001|Overall Study|Investigator's discretion|1|||
149192038|NCT04891770|538173153|FG002|Overall Study|Investigator's discretion|0|||
148935120|NCT01912963|537247696|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
148935121|NCT01912963|537247697|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
148935122|NCT01912963|537247695|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
149192039|NCT01401010|538173154|FG000|Overall Study|Could not interpret assay results|1|||
149192040|NCT01401010|538173155|FG001|Overall Study|Could not interpret assay results|0|||
149192041|NCT01952834|538173156|FG000|Overall Study|Adverse Event|1|||
149192042|NCT04360187|538173159|FG000|Double-Blind Treatment|Adverse Event|9|||
149192043|NCT04360187|538173160|FG001|Double-Blind Treatment|Adverse Event|11|||
149192044|NCT04360187|538173159|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
148935123|NCT01912963|537247696|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
148935124|NCT01912963|537247697|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
149192045|NCT04360187|538173160|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
149192046|NCT04360187|538173159|FG000|Double-Blind Treatment|Physician Decision|1|||
149192047|NCT04360187|538173160|FG001|Double-Blind Treatment|Physician Decision|0|||
149192048|NCT04360187|538173159|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
149192049|NCT04360187|538173160|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
149192050|NCT04360187|538173159|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
149192051|NCT04360187|538173160|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
149192052|NCT04360187|538173159|FG000|Follow-Up|Lost to Follow-up|1|||
149192053|NCT04360187|538173160|FG001|Follow-Up|Lost to Follow-up|0|||
149192054|NCT02203838|538173166|FG000|Overall Study|Lack of Efficacy|7|||
149192055|NCT02203838|538173167|FG001|Overall Study|Lack of Efficacy|0|||
149192056|NCT02203838|538173168|FG002|Overall Study|Lack of Efficacy|1|||
149192057|NCT02203838|538173169|FG003|Overall Study|Lack of Efficacy|1|||
149192058|NCT02203838|538173166|FG000|Overall Study|Adverse Event|46|||
149192059|NCT02203838|538173167|FG001|Overall Study|Adverse Event|6|||
149192060|NCT02203838|538173168|FG002|Overall Study|Adverse Event|3|||
148935125|NCT01912963|537247695|FG000|Overall Study|Adverse Event|0|||
148935126|NCT01912963|537247696|FG001|Overall Study|Adverse Event|1|||
148935127|NCT01912963|537247697|FG002|Overall Study|Adverse Event|1|||
148935128|NCT01912963|537247695|FG000|Overall Study|Withdrawal by Subject|0|||
149192061|NCT02203838|538173169|FG003|Overall Study|Adverse Event|2|||
149192062|NCT02203838|538173166|FG000|Overall Study|Lost to Follow-up|39|||
149192063|NCT02203838|538173167|FG001|Overall Study|Lost to Follow-up|3|||
149192064|NCT02203838|538173168|FG002|Overall Study|Lost to Follow-up|2|||
149192065|NCT02203838|538173169|FG003|Overall Study|Lost to Follow-up|1|||
149192066|NCT02203838|538173166|FG000|Overall Study|Protocol Violation|7|||
148935129|NCT01912963|537247696|FG001|Overall Study|Withdrawal by Subject|1|||
148935130|NCT01912963|537247697|FG002|Overall Study|Withdrawal by Subject|0|||
148935131|NCT01912963|537247695|FG000|Overall Study|Sought treatment locally|0|||
148935132|NCT01912963|537247696|FG001|Overall Study|Sought treatment locally|1|||
148935133|NCT01912963|537247697|FG002|Overall Study|Sought treatment locally|0|||
148935134|NCT01147172|537247707|FG000|Overall Study|Withdrawal by Subject|2|||
148935135|NCT01147172|537247707|FG000|Overall Study|Lost to Follow-up|2|||
148935136|NCT02149875|537247714|FG000|Overall Study|Lost to Follow-up|3|||
148935137|NCT02149875|537247715|FG001|Overall Study|Lost to Follow-up|4|||
148935138|NCT02149875|537247716|FG002|Overall Study|Lost to Follow-up|5|||
148935139|NCT02149875|537247714|FG000|Overall Study|Withdrawal by Subject|3|||
149192067|NCT02203838|538173167|FG001|Overall Study|Protocol Violation|3|||
149192068|NCT02203838|538173168|FG002|Overall Study|Protocol Violation|0|||
149192069|NCT02203838|538173169|FG003|Overall Study|Protocol Violation|0|||
149192070|NCT02203838|538173166|FG000|Overall Study|Withdrawal by Subject|83|||
149192071|NCT02203838|538173167|FG001|Overall Study|Withdrawal by Subject|10|||
149192072|NCT02203838|538173168|FG002|Overall Study|Withdrawal by Subject|8|||
149192073|NCT02203838|538173169|FG003|Overall Study|Withdrawal by Subject|11|||
149192074|NCT02203838|538173166|FG000|Overall Study|Physician Decision|27|||
149192075|NCT02203838|538173167|FG001|Overall Study|Physician Decision|0|||
149192076|NCT02203838|538173168|FG002|Overall Study|Physician Decision|2|||
149192077|NCT02203838|538173169|FG003|Overall Study|Physician Decision|3|||
149192078|NCT02203838|538173166|FG000|Overall Study|Other|1|||
149192079|NCT02203838|538173167|FG001|Overall Study|Other|0|||
149192080|NCT02203838|538173168|FG002|Overall Study|Other|0|||
149192081|NCT02203838|538173169|FG003|Overall Study|Other|0|||
149192082|NCT05091060|538173170|FG000|Overall Study|Lost to Follow-up|1|||
149192083|NCT01798706|538173171|FG000|Overall Study|Adverse Event|15|||
149192084|NCT01798706|538173172|FG001|Overall Study|Adverse Event|10|||
148935140|NCT02149875|537247715|FG001|Overall Study|Withdrawal by Subject|2|||
148935141|NCT02149875|537247716|FG002|Overall Study|Withdrawal by Subject|2|||
148681854|NCT01529749|536307876|FG001|Overall Study|Lost to Follow-up|1|||
148681855|NCT01529749|536307877|FG002|Overall Study|Lost to Follow-up|1|||
148935142|NCT02149875|537247714|FG000|Overall Study|Physician Decision|1|||
148935143|NCT02149875|537247715|FG001|Overall Study|Physician Decision|2|||
148935144|NCT02149875|537247716|FG002|Overall Study|Physician Decision|2|||
148935145|NCT00936611|537247717|FG000|Overall Study|Progressive Disease|3|||
148935146|NCT00936611|537247717|FG000|Overall Study|New Systemic Therapy|22|||
148935147|NCT00936611|537247717|FG000|Overall Study|Lost to Follow-up|1|||
148935148|NCT00936611|537247717|FG000|Overall Study|Withdrawal by Subject|2|||
149192085|NCT01798706|538173171|FG000|Overall Study|Lack of Efficacy|0|||
149192086|NCT01798706|538173172|FG001|Overall Study|Lack of Efficacy|2|||
149192087|NCT01798706|538173171|FG000|Overall Study|Poor compliance to protocol|1|||
149192088|NCT01798706|538173172|FG001|Overall Study|Poor compliance to protocol|0|||
148681856|NCT01529749|536307878|FG003|Overall Study|Lost to Follow-up|0|||
148681857|NCT01529749|536307875|FG000|Overall Study|Physician Decision|0|||
148681858|NCT01529749|536307876|FG001|Overall Study|Physician Decision|0|||
148935149|NCT00936611|537247717|FG000|Overall Study|Still on Follow-up|1|||
148935150|NCT00936611|537247717|FG000|Overall Study|Still on Active Therapy|7|||
148935151|NCT00936611|537247717|FG000|Overall Study|Ineligible for Study Drug|3|||
148935152|NCT01822496|537247721|FG000|Overall Study|Protocol Violation|2|||
148935153|NCT01822496|537247722|FG001|Overall Study|Protocol Violation|2|||
148935154|NCT01822496|537247723|FG002|Overall Study|Protocol Violation|0|||
148935155|NCT01822496|537247724|FG003|Overall Study|Protocol Violation|1|||
148935156|NCT01822496|537247721|FG000|Overall Study|Withdrawal by Subject|0|||
148935157|NCT01822496|537247722|FG001|Overall Study|Withdrawal by Subject|0|||
148935158|NCT01822496|537247723|FG002|Overall Study|Withdrawal by Subject|0|||
148935159|NCT01822496|537247724|FG003|Overall Study|Withdrawal by Subject|3|||
149192089|NCT01798706|538173171|FG000|Overall Study|Other than specified above|5|||
149192090|NCT01798706|538173172|FG001|Overall Study|Other than specified above|9|||
149192091|NCT00496873|538173173|FG000|Overall Study|Ineligible|2|||
149192092|NCT00496873|538173173|FG000|Overall Study|Death|2|||
149192093|NCT00496873|538173173|FG000|Overall Study|Withdrawal by Subject|3|||
149192094|NCT01318083|538173174|FG000|Overall Study|Adverse Event|4|||
148681859|NCT01529749|536307877|FG002|Overall Study|Physician Decision|0|||
148681860|NCT01529749|536307878|FG003|Overall Study|Physician Decision|1|||
148681861|NCT01529749|536307875|FG000|Overall Study|Withdrawal by Subject|0|||
149192095|NCT01318083|538173175|FG001|Overall Study|Adverse Event|1|||
149192096|NCT01318083|538173176|FG002|Overall Study|Adverse Event|2|||
149192097|NCT01318083|538173174|FG000|Overall Study|Withdrawal by Subject|1|||
149192098|NCT01318083|538173175|FG001|Overall Study|Withdrawal by Subject|0|||
149192099|NCT01318083|538173176|FG002|Overall Study|Withdrawal by Subject|2|||
149192100|NCT01318083|538173174|FG000|Overall Study|Lack of Efficacy|0|||
149192101|NCT01318083|538173175|FG001|Overall Study|Lack of Efficacy|0|||
149192102|NCT01318083|538173176|FG002|Overall Study|Lack of Efficacy|1|||
149192103|NCT01318083|538173174|FG000|Overall Study|Treatment Complications|1|||
149192104|NCT01318083|538173175|FG001|Overall Study|Treatment Complications|0|||
149192105|NCT01318083|538173176|FG002|Overall Study|Treatment Complications|0|||
149192106|NCT01318083|538173174|FG000|Overall Study|Lack of Study Medication Compliance|0|||
149192107|NCT01318083|538173175|FG001|Overall Study|Lack of Study Medication Compliance|1|||
149192108|NCT01318083|538173176|FG002|Overall Study|Lack of Study Medication Compliance|0|||
149192109|NCT05896761|538173177|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
149192110|NCT05896761|538173178|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
149192111|NCT05896761|538173177|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
149192112|NCT05896761|538173178|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
149192113|NCT03552549|538173181|FG000|Overall Study|Disease progression|25|||
149192114|NCT03552549|538173182|FG001|Overall Study|Disease progression|17|||
149192115|NCT03552549|538173181|FG000|Overall Study|Adverse event in first 12 months|12|||
149192116|NCT03552549|538173182|FG001|Overall Study|Adverse event in first 12 months|8|||
149192117|NCT03552549|538173181|FG000|Overall Study|Withdrawal by Subject|7|||
149192118|NCT03552549|538173182|FG001|Overall Study|Withdrawal by Subject|7|||
149192119|NCT03552549|538173181|FG000|Overall Study|Unknown (no reason provided)|4|||
149192120|NCT03552549|538173182|FG001|Overall Study|Unknown (no reason provided)|2|||
149192121|NCT03552549|538173181|FG000|Overall Study|Not in participant's best interest|2|||
149192122|NCT03552549|538173182|FG001|Overall Study|Not in participant's best interest|1|||
149192123|NCT03552549|538173181|FG000|Overall Study|Did not complete study treatment|2|||
149192124|NCT03552549|538173182|FG001|Overall Study|Did not complete study treatment|3|||
149192125|NCT03552549|538173181|FG000|Overall Study|Did not meet eligibility criteria|1|||
149192126|NCT03552549|538173182|FG001|Overall Study|Did not meet eligibility criteria|0|||
149192127|NCT03552549|538173181|FG000|Overall Study|Administrative|0|||
149192128|NCT03552549|538173182|FG001|Overall Study|Administrative|14|||
149192129|NCT02739594|538173185|FG000|Overall Study|Undesired Event|3|||
149192130|NCT02739594|538173186|FG001|Overall Study|Undesired Event|4|||
149192131|NCT02739594|538173185|FG000|Overall Study|Violation of Eligibility Criteria|1|||
149192132|NCT02739594|538173186|FG001|Overall Study|Violation of Eligibility Criteria|2|||
149192133|NCT02739594|538173185|FG000|Overall Study|Protocol Violation|5|||
148681862|NCT01529749|536307876|FG001|Overall Study|Withdrawal by Subject|1|||
148681863|NCT01529749|536307877|FG002|Overall Study|Withdrawal by Subject|1|||
148681864|NCT01529749|536307878|FG003|Overall Study|Withdrawal by Subject|0|||
148681865|NCT01529749|536307875|FG000|Overall Study|Protocol Violation|0|||
148681866|NCT01529749|536307876|FG001|Overall Study|Protocol Violation|0|||
148681867|NCT01529749|536307877|FG002|Overall Study|Protocol Violation|0|||
148681868|NCT01529749|536307878|FG003|Overall Study|Protocol Violation|1|||
148681869|NCT00378482|536307879|FG000|Overall Study|Lost to Follow-up|1|||
148681870|NCT00378482|536307879|FG000|Overall Study|Lack of Efficacy|8|||
148681871|NCT00378482|536307879|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
148681872|NCT00378482|536307879|FG000|Overall Study|Withdrawal by Subject|4|||
148681873|NCT00378482|536307879|FG000|Overall Study|Adverse Event|9|||
148681874|NCT05166421|536307880|FG000|Overall Study|Other|3|||
148681875|NCT05166421|536307881|FG001|Overall Study|Other|1|||
148681876|NCT05166421|536307882|FG002|Overall Study|Other|1|||
148681877|NCT05166421|536307880|FG000|Overall Study|Withdrawal by Subject|5|||
148681878|NCT05166421|536307881|FG001|Overall Study|Withdrawal by Subject|3|||
148681879|NCT05166421|536307882|FG002|Overall Study|Withdrawal by Subject|6|||
148681880|NCT05166421|536307880|FG000|Overall Study|Lost to Follow-up|4|||
148681881|NCT05166421|536307881|FG001|Overall Study|Lost to Follow-up|1|||
148681882|NCT05166421|536307882|FG002|Overall Study|Lost to Follow-up|7|||
149192134|NCT02739594|538173186|FG001|Overall Study|Protocol Violation|6|||
149192135|NCT02739594|538173185|FG000|Overall Study|Death|4|||
149192136|NCT02739594|538173186|FG001|Overall Study|Death|2|||
149192137|NCT02739594|538173185|FG000|Overall Study|Renal Insufficiency|4|||
148681883|NCT01246986|536309368|FG000|Overall Study|Lost to Follow-up|0|||
148681884|NCT01246986|536309369|FG001|Overall Study|Lost to Follow-up|1|||
148681885|NCT01246986|536309370|FG002|Overall Study|Lost to Follow-up|3|||
148681886|NCT01246986|536309371|FG003|Overall Study|Lost to Follow-up|0|||
149192138|NCT02739594|538173186|FG001|Overall Study|Renal Insufficiency|6|||
149192139|NCT02739594|538173185|FG000|Overall Study|Administrative Reasons|1|||
149192140|NCT02739594|538173186|FG001|Overall Study|Administrative Reasons|3|||
149192141|NCT02739594|538173185|FG000|Overall Study|Withdrawal by Subject|1|||
149192142|NCT02739594|538173186|FG001|Overall Study|Withdrawal by Subject|1|||
149192143|NCT02739594|538173185|FG000|Overall Study|Lost to Follow-up|0|||
149192144|NCT02739594|538173186|FG001|Overall Study|Lost to Follow-up|1|||
148935160|NCT02081183|537247725|FG000|Overall Study|Lost to Follow-up|0|||
148935161|NCT02081183|537247726|FG001|Overall Study|Lost to Follow-up|1|||
148935162|NCT02081183|537247725|FG000|Overall Study|Protocol Violation|1|||
148935163|NCT02081183|537247726|FG001|Overall Study|Protocol Violation|0|||
149192145|NCT02739594|538173185|FG000|Overall Study|Elevated Serum Creatinine|0|||
149192146|NCT02739594|538173186|FG001|Overall Study|Elevated Serum Creatinine|1|||
149192147|NCT02739594|538173185|FG000|Overall Study|Other|6|||
149192148|NCT02739594|538173186|FG001|Overall Study|Other|2|||
149192149|NCT00527111|538173191|FG000|Overall Study|Adverse Event|14|||
149192150|NCT00527111|538173192|FG001|Overall Study|Adverse Event|13|||
149192151|NCT00527111|538173191|FG000|Overall Study|Death|0|||
149192152|NCT00527111|538173192|FG001|Overall Study|Death|1|||
149192153|NCT00527111|538173191|FG000|Overall Study|Investigator Request|2|||
149192154|NCT00527111|538173192|FG001|Overall Study|Investigator Request|1|||
149192155|NCT00527111|538173191|FG000|Overall Study|Patient Request|2|||
149192156|NCT00527111|538173192|FG001|Overall Study|Patient Request|5|||
149192157|NCT00527111|538173191|FG000|Overall Study|Other|2|||
149192158|NCT00527111|538173192|FG001|Overall Study|Other|2|||
149192159|NCT02993224|538173193|FG000|Core Phase - Period 1|Adverse Event|4|||
149192160|NCT02993224|538173193|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
149192161|NCT02993224|538173193|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
149192162|NCT02993224|538173193|FG000|Core Phase- Period 2|Adverse Event|1|||
149192163|NCT02993224|538173193|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
149192164|NCT02993224|538173193|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
149192165|NCT02993224|538173193|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
149192166|NCT02993224|538173193|FG000|Extension Phase|Adverse Event|3|||
149192167|NCT02993224|538173193|FG000|Extension Phase|Withdrawal by Subject|3|||
149192168|NCT02993224|538173193|FG000|Extension Phase|Lost to Follow-up|2|||
149192169|NCT02993224|538173193|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
149192170|NCT00952289|538173199|FG000|All Participants|Death|9|||
149192171|NCT00952289|538173200|FG001|All Participants|Death|9|||
149192172|NCT00952289|538173199|FG000|All Participants|Adverse Event|8|||
149192173|NCT00952289|538173200|FG001|All Participants|Adverse Event|8|||
149192174|NCT00952289|538173199|FG000|All Participants|Disease progression|3|||
148935164|NCT02081183|537247725|FG000|Overall Study|Other|3|||
148935165|NCT02081183|537247726|FG001|Overall Study|Other|3|||
149192175|NCT00952289|538173200|FG001|All Participants|Disease progression|12|||
149192176|NCT00952289|538173199|FG000|All Participants|Withdrawal by Subject|1|||
148935166|NCT00543543|537247727|FG000|Base Study|Adverse Event|1|||
148935167|NCT00543543|537247728|FG001|Base Study|Adverse Event|11|||
149192177|NCT00952289|538173200|FG001|All Participants|Withdrawal by Subject|10|||
149192178|NCT00952289|538173199|FG000|All Participants|Data lost during site relocation|0|||
149192179|NCT00952289|538173200|FG001|All Participants|Data lost during site relocation|1|||
149192180|NCT00952289|538173199|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
149192181|NCT00952289|538173200|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
149014816|NCT02291289|537534286|FG008|Early Disease Progression|Death|0|||
149014817|NCT02291289|537534287|FG009|Early Disease Progression|Death|0|||
149014818|NCT02291289|537534288|FG010|Early Disease Progression|Death|0|||
149014819|NCT02291289|537534289|FG011|Early Disease Progression|Death|0|||
149014820|NCT02291289|537534290|FG012|Early Disease Progression|Death|10|||
149014821|NCT02291289|537534278|FG000|Early Disease Progression|Lost to Follow-up|0|||
149014822|NCT02291289|537534279|FG001|Early Disease Progression|Lost to Follow-up|0|||
149014823|NCT02291289|537534280|FG002|Early Disease Progression|Lost to Follow-up|0|||
149014824|NCT02291289|537534281|FG003|Early Disease Progression|Lost to Follow-up|0|||
149014825|NCT02291289|537534282|FG004|Early Disease Progression|Lost to Follow-up|0|||
149014826|NCT02291289|537534283|FG005|Early Disease Progression|Lost to Follow-up|0|||
149014827|NCT02291289|537534284|FG006|Early Disease Progression|Lost to Follow-up|0|||
149192182|NCT00952289|538173199|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
149192183|NCT00952289|538173200|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
149192184|NCT00952289|538173199|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
149192185|NCT00952289|538173200|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
149192186|NCT00952289|538173199|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
148935168|NCT00543543|537247729|FG002|Base Study|Adverse Event|0|||
148935169|NCT00543543|537247730|FG003|Base Study|Adverse Event|5|||
148935170|NCT00543543|537247727|FG000|Base Study|Lost to Follow-up|12|||
148935171|NCT00543543|537247728|FG001|Base Study|Lost to Follow-up|749|||
148935172|NCT00543543|537247729|FG002|Base Study|Lost to Follow-up|9|||
148935173|NCT00543543|537247730|FG003|Base Study|Lost to Follow-up|701|||
148935174|NCT00543543|537247727|FG000|Base Study|Physician Decision|0|||
148935175|NCT00543543|537247728|FG001|Base Study|Physician Decision|4|||
148935176|NCT00543543|537247729|FG002|Base Study|Physician Decision|0|||
148935177|NCT00543543|537247730|FG003|Base Study|Physician Decision|7|||
148935178|NCT00543543|537247727|FG000|Base Study|Protocol Violation|0|||
148935179|NCT00543543|537247728|FG001|Base Study|Protocol Violation|6|||
148935180|NCT00543543|537247729|FG002|Base Study|Protocol Violation|0|||
148935181|NCT00543543|537247730|FG003|Base Study|Protocol Violation|6|||
148935182|NCT00543543|537247727|FG000|Base Study|Withdrawal by Subject|7|||
149192187|NCT00952289|538173200|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
149192188|NCT00952289|538173199|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
149192189|NCT00952289|538173200|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
149192190|NCT00777491|538173205|FG000|Overall Study|Protocol Violation|0|||
149192191|NCT00777491|538173206|FG001|Overall Study|Protocol Violation|2|||
149192192|NCT00777491|538173205|FG000|Overall Study|Did not receive any protocol treatment|2|||
149192193|NCT00777491|538173206|FG001|Overall Study|Did not receive any protocol treatment|0|||
149192194|NCT00364845|538173207|FG000|Overall Study|Adverse Event|1|||
149192195|NCT00364845|538173208|FG001|Overall Study|Adverse Event|0|||
149192196|NCT00364845|538173207|FG000|Overall Study|Withdrawal by Subject|2|||
149192197|NCT00364845|538173208|FG001|Overall Study|Withdrawal by Subject|1|||
149192198|NCT00364845|538173207|FG000|Overall Study|Physician Decision|8|||
149192199|NCT00364845|538173208|FG001|Overall Study|Physician Decision|8|||
149192200|NCT00364845|538173207|FG000|Overall Study|Lost to Follow-up|0|||
149192201|NCT00364845|538173208|FG001|Overall Study|Lost to Follow-up|1|||
149192202|NCT00364845|538173207|FG000|Overall Study|Death|0|||
149192203|NCT00364845|538173208|FG001|Overall Study|Death|1|||
149192204|NCT03255291|538173209|FG000|Overall Study|Determined to be ineligible|10|||
149192205|NCT03255291|538173210|FG001|Overall Study|Determined to be ineligible|12|||
149192206|NCT03255291|538173211|FG002|Overall Study|Determined to be ineligible|6|||
149192207|NCT03255291|538173212|FG003|Overall Study|Determined to be ineligible|6|||
149192208|NCT03255291|538173213|FG004|Overall Study|Determined to be ineligible|5|||
149192209|NCT03255291|538173214|FG005|Overall Study|Determined to be ineligible|10|||
149192210|NCT03255291|538173209|FG000|Overall Study|Baseline data collection issues|3|||
149192211|NCT03255291|538173210|FG001|Overall Study|Baseline data collection issues|0|||
149192212|NCT03255291|538173211|FG002|Overall Study|Baseline data collection issues|0|||
149192213|NCT03255291|538173212|FG003|Overall Study|Baseline data collection issues|0|||
149192214|NCT03255291|538173213|FG004|Overall Study|Baseline data collection issues|2|||
149192215|NCT03255291|538173214|FG005|Overall Study|Baseline data collection issues|0|||
149192216|NCT01423617|538173215|FG000|Overall Study|Lost to Follow-up|0|||
149192217|NCT01423617|538173216|FG001|Overall Study|Lost to Follow-up|1|||
149192218|NCT04369430|538173223|FG000|Overall Study|Adverse Event|2|||
149192219|NCT04369430|538173224|FG001|Overall Study|Adverse Event|3|||
149014828|NCT02291289|537534285|FG007|Early Disease Progression|Lost to Follow-up|0|||
149014829|NCT02291289|537534286|FG008|Early Disease Progression|Lost to Follow-up|0|||
149014830|NCT02291289|537534287|FG009|Early Disease Progression|Lost to Follow-up|0|||
149014831|NCT02291289|537534288|FG010|Early Disease Progression|Lost to Follow-up|0|||
149192220|NCT04369430|538173223|FG000|Overall Study|Death|1|||
149192221|NCT04369430|538173224|FG001|Overall Study|Death|0|||
148681887|NCT01246986|536309372|FG004|Overall Study|Lost to Follow-up|0|||
148681888|NCT01246986|536309373|FG005|Overall Study|Lost to Follow-up|1|||
148681889|NCT01246986|536309374|FG006|Overall Study|Lost to Follow-up|0|||
148681890|NCT01246986|536309368|FG000|Overall Study|Withdrawal by Subject|3|||
148681891|NCT01246986|536309369|FG001|Overall Study|Withdrawal by Subject|4|||
148681892|NCT01246986|536309370|FG002|Overall Study|Withdrawal by Subject|3|||
148681893|NCT01246986|536309371|FG003|Overall Study|Withdrawal by Subject|0|||
148681894|NCT01246986|536309372|FG004|Overall Study|Withdrawal by Subject|4|||
148681895|NCT01246986|536309373|FG005|Overall Study|Withdrawal by Subject|0|||
148681896|NCT01246986|536309374|FG006|Overall Study|Withdrawal by Subject|0|||
148681897|NCT01335399|536309375|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
148681898|NCT01335399|536309376|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
148681899|NCT01335399|536309375|FG000|Pre-treatment Period|Participant request to discontinue|0|||
148681900|NCT01335399|536309376|FG001|Pre-treatment Period|Participant request to discontinue|1|||
148681901|NCT01335399|536309375|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
148681902|NCT01335399|536309376|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
148681903|NCT01335399|536309375|FG000|Pre-treatment Period|Consent withdrawal|3|||
148681904|NCT01335399|536309376|FG001|Pre-treatment Period|Consent withdrawal|0|||
148681905|NCT01335399|536309375|FG000|Treatment Period|Disease progression|117|||
148681906|NCT01335399|536309376|FG001|Treatment Period|Disease progression|145|||
148681907|NCT01335399|536309375|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
148681908|NCT01335399|536309376|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
148681909|NCT01335399|536309375|FG000|Treatment Period|Study drug toxicity|52|||
148681910|NCT01335399|536309376|FG001|Treatment Period|Study drug toxicity|64|||
148681911|NCT01335399|536309375|FG000|Treatment Period|Participant request to discontinue|30|||
148681912|NCT01335399|536309376|FG001|Treatment Period|Participant request to discontinue|22|||
148681913|NCT01335399|536309375|FG000|Treatment Period|Other reasons|30|||
148681914|NCT01335399|536309376|FG001|Treatment Period|Other reasons|30|||
149014832|NCT02291289|537534289|FG011|Early Disease Progression|Lost to Follow-up|0|||
149014833|NCT02291289|537534290|FG012|Early Disease Progression|Lost to Follow-up|1|||
149014834|NCT00154063|537534293|FG000|Overall Study|Adverse Event|4|||
149192222|NCT04369430|538173223|FG000|Overall Study|Withdrawal by Subject|4|||
149192223|NCT04369430|538173224|FG001|Overall Study|Withdrawal by Subject|3|||
149192224|NCT04369430|538173223|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
149192225|NCT04369430|538173224|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
149192226|NCT04369430|538173223|FG000|Overall Study|Lost to Follow-up|0|||
149192227|NCT04369430|538173224|FG001|Overall Study|Lost to Follow-up|1|||
149192228|NCT00444626|538173225|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
149192229|NCT00444626|538173225|FG000|Initial Treatment Period|Adverse Event|1|||
149192230|NCT00444626|538173225|FG000|Initial Treatment Period|Lost to Follow-up|9|||
149192231|NCT00008138|538173226|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
149192232|NCT00008138|538173226|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
149192233|NCT00008138|538173226|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
149192234|NCT00008138|538173226|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
149192235|NCT00008138|538173226|FG000|Interval Debulking|Withdrawal by Subject|2|||
149192236|NCT00008138|538173226|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
149192237|NCT00008138|538173226|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
149192238|NCT00008138|538173226|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
149192239|NCT00142519|538173227|FG000|Overall Study|Not Treated|7|||
149192240|NCT00142519|538173228|FG001|Overall Study|Not Treated|9|||
149192241|NCT00142519|538173227|FG000|Overall Study|Protocol Violation|1|||
149192242|NCT00142519|538173228|FG001|Overall Study|Protocol Violation|0|||
149192243|NCT00142519|538173227|FG000|Overall Study|Withdrawal by Subject|10|||
149192244|NCT00142519|538173228|FG001|Overall Study|Withdrawal by Subject|7|||
149192245|NCT01687413|538173235|FG000|Overall Study|Withdrawal by Subject|0|||
149192246|NCT01687413|538173236|FG001|Overall Study|Withdrawal by Subject|2|||
149192247|NCT01687413|538173235|FG000|Overall Study|Not eligible|0|||
149192248|NCT01687413|538173236|FG001|Overall Study|Not eligible|2|||
149192249|NCT01687413|538173235|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
149192250|NCT01687413|538173236|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
149192251|NCT03229759|538173239|FG000|Overall Study|Screen Failure|30|||
149192252|NCT02669862|538175259|FG000|Overall Study|Lost to Follow-up|0|||
149192253|NCT02669862|538175260|FG001|Overall Study|Lost to Follow-up|2|||
149192254|NCT02669862|538175261|FG002|Overall Study|Lost to Follow-up|1|||
149192255|NCT02669862|538175259|FG000|Overall Study|Withdrawal by Subject|2|||
149192256|NCT02669862|538175260|FG001|Overall Study|Withdrawal by Subject|2|||
149192257|NCT02669862|538175261|FG002|Overall Study|Withdrawal by Subject|3|||
149192258|NCT02669862|538175259|FG000|Overall Study|moved|0|||
149192259|NCT02669862|538175260|FG001|Overall Study|moved|1|||
149192260|NCT02669862|538175261|FG002|Overall Study|moved|0|||
149192261|NCT02669862|538175259|FG000|Overall Study|Protocol Violation|0|||
149192262|NCT02669862|538175260|FG001|Overall Study|Protocol Violation|0|||
149192263|NCT02669862|538175261|FG002|Overall Study|Protocol Violation|1|||
149192264|NCT00762372|538175264|FG000|Overall Study|Adverse Event|1|||
149192265|NCT00762372|538175265|FG001|Overall Study|Adverse Event|0|||
149192266|NCT00762372|538175266|FG002|Overall Study|Adverse Event|0|||
149192267|NCT02670915|538175267|FG000|Overall Study|Withdrawal by Subject|0|||
149192268|NCT02670915|538175268|FG001|Overall Study|Withdrawal by Subject|1|||
149192269|NCT02670915|538175269|FG002|Overall Study|Withdrawal by Subject|4|||
149192270|NCT02670915|538175267|FG000|Overall Study|Withdrawal by parent/guardian|4|||
149192271|NCT02670915|538175268|FG001|Overall Study|Withdrawal by parent/guardian|4|||
149192272|NCT02670915|538175269|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148807657|NCT01035138|536773346|FG000|Overall Study|Caregiver Decision|2|||
148807658|NCT01035138|536773347|FG001|Overall Study|Caregiver Decision|0|||
149192273|NCT02670915|538175267|FG000|Overall Study|Unclassified|0|||
149192274|NCT02670915|538175268|FG001|Overall Study|Unclassified|3|||
149192275|NCT02670915|538175269|FG002|Overall Study|Unclassified|0|||
149192276|NCT00818207|538175270|FG000|Overall Study|Adverse Event|6|||
149192277|NCT00818207|538175271|FG001|Overall Study|Adverse Event|0|||
149192278|NCT00818207|538175270|FG000|Overall Study|Lost to Follow-up|160|||
149192279|NCT00818207|538175271|FG001|Overall Study|Lost to Follow-up|146|||
149192280|NCT00818207|538175270|FG000|Overall Study|Multiple reasons|11|||
149192281|NCT00818207|538175271|FG001|Overall Study|Multiple reasons|12|||
149192282|NCT00818207|538175270|FG000|Overall Study|Withdrawal by Subject|42|||
149192283|NCT00818207|538175271|FG001|Overall Study|Withdrawal by Subject|104|||
149192284|NCT00818207|538175270|FG000|Overall Study|Death|3|||
149192285|NCT00818207|538175271|FG001|Overall Study|Death|5|||
149192286|NCT02616185|538175272|FG000|Overall Study|Death|0|||
149192287|NCT02616185|538175273|FG001|Overall Study|Death|0|||
149192288|NCT02616185|538175274|FG002|Overall Study|Death|0|||
149192289|NCT02616185|538175275|FG003|Overall Study|Death|1|||
149192290|NCT02616185|538175276|FG004|Overall Study|Death|2|||
149192291|NCT02616185|538175277|FG005|Overall Study|Death|0|||
149192292|NCT02616185|538175278|FG006|Overall Study|Death|0|||
149192293|NCT02616185|538175279|FG007|Overall Study|Death|2|||
149192294|NCT02616185|538175280|FG008|Overall Study|Death|1|||
149192295|NCT02616185|538175272|FG000|Overall Study|Study terminated by sponsor|0|||
149192296|NCT02616185|538175273|FG001|Overall Study|Study terminated by sponsor|0|||
149192297|NCT02616185|538175274|FG002|Overall Study|Study terminated by sponsor|1|||
149192298|NCT02616185|538175275|FG003|Overall Study|Study terminated by sponsor|0|||
149192299|NCT02616185|538175276|FG004|Overall Study|Study terminated by sponsor|0|||
149192300|NCT02616185|538175277|FG005|Overall Study|Study terminated by sponsor|0|||
149192301|NCT02616185|538175278|FG006|Overall Study|Study terminated by sponsor|5|||
149192302|NCT02616185|538175279|FG007|Overall Study|Study terminated by sponsor|2|||
149192303|NCT02616185|538175280|FG008|Overall Study|Study terminated by sponsor|0|||
149192304|NCT02616185|538175272|FG000|Overall Study|Participant refused further follow-up|1|||
149192305|NCT02616185|538175273|FG001|Overall Study|Participant refused further follow-up|1|||
149192306|NCT02616185|538175274|FG002|Overall Study|Participant refused further follow-up|2|||
149192307|NCT02616185|538175275|FG003|Overall Study|Participant refused further follow-up|3|||
149192308|NCT02616185|538175276|FG004|Overall Study|Participant refused further follow-up|4|||
149192309|NCT02616185|538175277|FG005|Overall Study|Participant refused further follow-up|0|||
149192310|NCT02616185|538175278|FG006|Overall Study|Participant refused further follow-up|3|||
149192311|NCT02616185|538175279|FG007|Overall Study|Participant refused further follow-up|4|||
149192312|NCT02616185|538175280|FG008|Overall Study|Participant refused further follow-up|3|||
149192313|NCT02616185|538175272|FG000|Overall Study|Not reported|0|||
149192314|NCT02616185|538175273|FG001|Overall Study|Not reported|0|||
149192315|NCT02616185|538175274|FG002|Overall Study|Not reported|0|||
149192316|NCT02616185|538175275|FG003|Overall Study|Not reported|1|||
149192317|NCT02616185|538175276|FG004|Overall Study|Not reported|3|||
149192318|NCT02616185|538175277|FG005|Overall Study|Not reported|1|||
149192319|NCT02616185|538175278|FG006|Overall Study|Not reported|0|||
149192320|NCT02616185|538175279|FG007|Overall Study|Not reported|5|||
149192321|NCT02616185|538175280|FG008|Overall Study|Not reported|2|||
149192322|NCT01346371|538175281|FG000|Overall Study|Lost to Follow-up|2|||
149192323|NCT01346371|538175282|FG001|Overall Study|Lost to Follow-up|0|||
149192324|NCT01670656|538175286|FG000|Overall Study|Non-compliance with study drug|0|||
149192325|NCT01670656|538175287|FG001|Overall Study|Non-compliance with study drug|0|||
149192326|NCT01670656|538175288|FG002|Overall Study|Non-compliance with study drug|3|||
149192327|NCT01670656|538175289|FG003|Overall Study|Non-compliance with study drug|0|||
149192328|NCT01670656|538175290|FG004|Overall Study|Non-compliance with study drug|1|||
149192329|NCT01670656|538175286|FG000|Overall Study|Pregnancy|0|||
149192330|NCT01670656|538175287|FG001|Overall Study|Pregnancy|0|||
149192331|NCT01670656|538175288|FG002|Overall Study|Pregnancy|0|||
149192332|NCT01670656|538175289|FG003|Overall Study|Pregnancy|0|||
149192333|NCT01670656|538175290|FG004|Overall Study|Pregnancy|1|||
148807659|NCT01035138|536773348|FG002|Overall Study|Caregiver Decision|1|||
149014835|NCT00154063|537534294|FG001|Overall Study|Adverse Event|8|||
149192334|NCT01670656|538175286|FG000|Overall Study|Withdrawal by Subject|1|||
149192335|NCT01670656|538175287|FG001|Overall Study|Withdrawal by Subject|1|||
149192336|NCT01670656|538175288|FG002|Overall Study|Withdrawal by Subject|0|||
149192337|NCT01670656|538175289|FG003|Overall Study|Withdrawal by Subject|0|||
149192338|NCT01670656|538175290|FG004|Overall Study|Withdrawal by Subject|0|||
149192339|NCT01670656|538175286|FG000|Overall Study|Non-compliance with protocol|0|||
149192340|NCT01670656|538175287|FG001|Overall Study|Non-compliance with protocol|3|||
149192341|NCT01670656|538175288|FG002|Overall Study|Non-compliance with protocol|1|||
149192342|NCT01670656|538175289|FG003|Overall Study|Non-compliance with protocol|1|||
149192343|NCT01670656|538175290|FG004|Overall Study|Non-compliance with protocol|2|||
149192344|NCT01670656|538175286|FG000|Overall Study|Adverse Event|2|||
149192345|NCT01670656|538175287|FG001|Overall Study|Adverse Event|2|||
149192346|NCT01670656|538175288|FG002|Overall Study|Adverse Event|2|||
149192347|NCT01670656|538175289|FG003|Overall Study|Adverse Event|3|||
149192348|NCT01670656|538175290|FG004|Overall Study|Adverse Event|3|||
149192349|NCT01670656|538175286|FG000|Overall Study|Subject withdrew consent|0|||
149192350|NCT01670656|538175287|FG001|Overall Study|Subject withdrew consent|1|||
149192351|NCT01670656|538175288|FG002|Overall Study|Subject withdrew consent|2|||
149192352|NCT01670656|538175289|FG003|Overall Study|Subject withdrew consent|1|||
149192353|NCT01670656|538175290|FG004|Overall Study|Subject withdrew consent|1|||
149192354|NCT01670656|538175286|FG000|Overall Study|Lost to Follow-up|0|||
149192355|NCT01670656|538175287|FG001|Overall Study|Lost to Follow-up|0|||
149192356|NCT01670656|538175288|FG002|Overall Study|Lost to Follow-up|0|||
149192357|NCT01670656|538175289|FG003|Overall Study|Lost to Follow-up|0|||
149192358|NCT01670656|538175290|FG004|Overall Study|Lost to Follow-up|3|||
149192359|NCT01670656|538175286|FG000|Overall Study|Subject moved|0|||
149192360|NCT01670656|538175287|FG001|Overall Study|Subject moved|0|||
149192361|NCT01670656|538175288|FG002|Overall Study|Subject moved|0|||
149192362|NCT01670656|538175289|FG003|Overall Study|Subject moved|1|||
149192363|NCT01670656|538175290|FG004|Overall Study|Subject moved|0|||
149192364|NCT00111475|538175291|FG000|Overall Study|Lost to Follow-up|0|||
149192365|NCT00111475|538175292|FG001|Overall Study|Lost to Follow-up|0|||
149192366|NCT00111475|538175293|FG002|Overall Study|Lost to Follow-up|0|||
149192367|NCT00111475|538175294|FG003|Overall Study|Lost to Follow-up|0|||
149192368|NCT00111475|538175295|FG004|Overall Study|Lost to Follow-up|0|||
149192369|NCT00111475|538175296|FG005|Overall Study|Lost to Follow-up|1|||
149192370|NCT00111475|538175297|FG006|Overall Study|Lost to Follow-up|0|||
149192371|NCT00111475|538175298|FG007|Overall Study|Lost to Follow-up|0|||
149192372|NCT00111475|538175299|FG008|Overall Study|Lost to Follow-up|0|||
149192373|NCT00111475|538175300|FG009|Overall Study|Lost to Follow-up|0|||
149192374|NCT01026389|538175305|FG000|Overall Study|Withdrawal by Subject|1|||
149192375|NCT01026389|538175306|FG001|Overall Study|Withdrawal by Subject|3|||
149192376|NCT01026389|538175305|FG000|Overall Study|change of treatment, patient moved|4|||
149192377|NCT01026389|538175306|FG001|Overall Study|change of treatment, patient moved|2|||
149192378|NCT01995136|538175307|FG000|Overall Study|Change in residence|1|||
149192379|NCT03544268|538175308|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
149192380|NCT03544268|538175309|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
149192381|NCT01830543|538175313|FG000|Overall Study|Subject Decision|19|||
149192382|NCT01830543|538175314|FG001|Overall Study|Subject Decision|21|||
149192383|NCT01830543|538175315|FG002|Overall Study|Subject Decision|57|||
149192384|NCT01830543|538175313|FG000|Overall Study|Adverse Event|91|||
149192385|NCT01830543|538175314|FG001|Overall Study|Adverse Event|77|||
149192386|NCT01830543|538175315|FG002|Overall Study|Adverse Event|76|||
149192387|NCT01830543|538175313|FG000|Overall Study|Death|20|||
149192388|NCT01830543|538175314|FG001|Overall Study|Death|22|||
149192389|NCT01830543|538175315|FG002|Overall Study|Death|22|||
149192390|NCT01830543|538175313|FG000|Overall Study|Protocol Violation|3|||
149192391|NCT01830543|538175314|FG001|Overall Study|Protocol Violation|7|||
149192392|NCT01830543|538175315|FG002|Overall Study|Protocol Violation|7|||
149192393|NCT01830543|538175313|FG000|Overall Study|Physician Decision|11|||
149192394|NCT01830543|538175314|FG001|Overall Study|Physician Decision|5|||
149192395|NCT01830543|538175315|FG002|Overall Study|Physician Decision|12|||
149192396|NCT01830543|538175313|FG000|Overall Study|Withdrawal by consent|3|||
149192397|NCT01830543|538175314|FG001|Overall Study|Withdrawal by consent|3|||
149192398|NCT01830543|538175315|FG002|Overall Study|Withdrawal by consent|3|||
149192399|NCT01830543|538175313|FG000|Overall Study|Other|12|||
149192400|NCT01830543|538175314|FG001|Overall Study|Other|17|||
149192401|NCT01830543|538175315|FG002|Overall Study|Other|37|||
149192402|NCT02695524|538175320|FG000|Overall Study|Lost to Follow-up|3|||
149192403|NCT02695524|538175321|FG001|Overall Study|Lost to Follow-up|2|||
149192404|NCT02695524|538175320|FG000|Overall Study|Death|0|||
149192405|NCT02695524|538175321|FG001|Overall Study|Death|1|||
149192406|NCT03446651|538175330|FG000|Overall Study|Lost to Follow-up|4|||
149192407|NCT03446651|538175331|FG001|Overall Study|Lost to Follow-up|0|||
149192408|NCT03446651|538175330|FG000|Overall Study|Open Label Participants|5|||
149192409|NCT03446651|538175331|FG001|Overall Study|Open Label Participants|0|||
149192410|NCT00798655|538175332|FG000|Overall Study|Did not receive at least one dose of pan|2|||
149192411|NCT00343291|538175333|FG000|Overall Study|Adverse Event|13|||
149192412|NCT00343291|538175334|FG001|Overall Study|Adverse Event|13|||
148935183|NCT00543543|537247728|FG001|Base Study|Withdrawal by Subject|482|||
149192413|NCT00343291|538175333|FG000|Overall Study|Death|3|||
149192414|NCT00343291|538175334|FG001|Overall Study|Death|2|||
149192415|NCT00343291|538175333|FG000|Overall Study|Progressive disease|33|||
149192416|NCT00343291|538175334|FG001|Overall Study|Progressive disease|34|||
148935184|NCT00543543|537247729|FG002|Base Study|Withdrawal by Subject|5|||
148935185|NCT00543543|537247730|FG003|Base Study|Withdrawal by Subject|503|||
148935186|NCT00543543|537247727|FG000|Extension Study|Adverse Event|0|||
148935187|NCT00543543|537247728|FG001|Extension Study|Adverse Event|0|||
148935188|NCT00543543|537247729|FG002|Extension Study|Adverse Event|0|||
148935189|NCT00543543|537247730|FG003|Extension Study|Adverse Event|5|||
148935190|NCT00543543|537247727|FG000|Extension Study|Lost to Follow-up|0|||
148935191|NCT00543543|537247728|FG001|Extension Study|Lost to Follow-up|0|||
148935192|NCT00543543|537247729|FG002|Extension Study|Lost to Follow-up|0|||
148935193|NCT00543543|537247730|FG003|Extension Study|Lost to Follow-up|77|||
148935194|NCT00543543|537247727|FG000|Extension Study|Physician Decision|0|||
148935195|NCT00543543|537247728|FG001|Extension Study|Physician Decision|0|||
148935196|NCT00543543|537247729|FG002|Extension Study|Physician Decision|0|||
148935197|NCT00543543|537247730|FG003|Extension Study|Physician Decision|7|||
148935198|NCT00543543|537247727|FG000|Extension Study|Pregnancy|0|||
149192417|NCT00343291|538175333|FG000|Overall Study|Withdrawal by Subject|0|||
149192418|NCT00343291|538175334|FG001|Overall Study|Withdrawal by Subject|2|||
149192419|NCT00343291|538175333|FG000|Overall Study|Other|8|||
149192420|NCT00343291|538175334|FG001|Overall Study|Other|5|||
149192421|NCT00960934|538175335|FG000|Overall Study|Adverse Event|2|||
149192422|NCT00960934|538175336|FG001|Overall Study|Adverse Event|3|||
148935199|NCT00543543|537247728|FG001|Extension Study|Pregnancy|0|||
148935200|NCT00543543|537247729|FG002|Extension Study|Pregnancy|0|||
148935201|NCT00543543|537247730|FG003|Extension Study|Pregnancy|6|||
148935202|NCT00543543|537247727|FG000|Extension Study|Protocol Violation|0|||
148935203|NCT00543543|537247728|FG001|Extension Study|Protocol Violation|0|||
148935204|NCT00543543|537247729|FG002|Extension Study|Protocol Violation|0|||
149192423|NCT00960934|538175337|FG002|Overall Study|Adverse Event|3|||
149192424|NCT00960934|538175338|FG003|Overall Study|Adverse Event|2|||
149192425|NCT00960934|538175339|FG004|Overall Study|Adverse Event|4|||
149192426|NCT00960934|538175340|FG005|Overall Study|Adverse Event|3|||
149192427|NCT00960934|538175335|FG000|Overall Study|Lack of Efficacy|1|||
149192428|NCT00960934|538175336|FG001|Overall Study|Lack of Efficacy|0|||
149192429|NCT00960934|538175337|FG002|Overall Study|Lack of Efficacy|0|||
149192430|NCT00960934|538175338|FG003|Overall Study|Lack of Efficacy|0|||
149192431|NCT00960934|538175339|FG004|Overall Study|Lack of Efficacy|0|||
149192432|NCT00960934|538175340|FG005|Overall Study|Lack of Efficacy|0|||
149192433|NCT00960934|538175335|FG000|Overall Study|Lost to Follow-up|0|||
149192434|NCT00960934|538175336|FG001|Overall Study|Lost to Follow-up|1|||
149192435|NCT00960934|538175337|FG002|Overall Study|Lost to Follow-up|0|||
149192436|NCT00960934|538175338|FG003|Overall Study|Lost to Follow-up|0|||
149192437|NCT00960934|538175339|FG004|Overall Study|Lost to Follow-up|0|||
149192438|NCT00960934|538175340|FG005|Overall Study|Lost to Follow-up|0|||
149192439|NCT00960934|538175335|FG000|Overall Study|Other|2|||
149192440|NCT00960934|538175336|FG001|Overall Study|Other|1|||
149192441|NCT00960934|538175337|FG002|Overall Study|Other|5|||
149192442|NCT00960934|538175338|FG003|Overall Study|Other|4|||
149192443|NCT00960934|538175339|FG004|Overall Study|Other|2|||
149192444|NCT00960934|538175340|FG005|Overall Study|Other|2|||
149192445|NCT00960934|538175335|FG000|Overall Study|Physician Decision|0|||
149192446|NCT00960934|538175336|FG001|Overall Study|Physician Decision|1|||
149192447|NCT00960934|538175337|FG002|Overall Study|Physician Decision|0|||
149192448|NCT00960934|538175338|FG003|Overall Study|Physician Decision|0|||
149192449|NCT00960934|538175339|FG004|Overall Study|Physician Decision|0|||
149192450|NCT00960934|538175340|FG005|Overall Study|Physician Decision|0|||
149192451|NCT00960934|538175335|FG000|Overall Study|Progressive Disease|1|||
149192452|NCT00960934|538175336|FG001|Overall Study|Progressive Disease|1|||
149192453|NCT00960934|538175337|FG002|Overall Study|Progressive Disease|0|||
149192454|NCT00960934|538175338|FG003|Overall Study|Progressive Disease|0|||
149192455|NCT00960934|538175339|FG004|Overall Study|Progressive Disease|1|||
149192456|NCT00960934|538175340|FG005|Overall Study|Progressive Disease|1|||
149192457|NCT00960934|538175335|FG000|Overall Study|Protocol Violation|3|||
149192458|NCT00960934|538175336|FG001|Overall Study|Protocol Violation|4|||
149192459|NCT00960934|538175337|FG002|Overall Study|Protocol Violation|0|||
149192460|NCT00960934|538175338|FG003|Overall Study|Protocol Violation|3|||
149192461|NCT00960934|538175339|FG004|Overall Study|Protocol Violation|3|||
149192462|NCT00960934|538175340|FG005|Overall Study|Protocol Violation|2|||
149192463|NCT00960934|538175335|FG000|Overall Study|Withdrawal by Subject|5|||
149192464|NCT00960934|538175336|FG001|Overall Study|Withdrawal by Subject|6|||
148935205|NCT00543543|537247730|FG003|Extension Study|Protocol Violation|11|||
148935206|NCT00543543|537247727|FG000|Extension Study|Withdrawal by Subject|0|||
148935207|NCT00543543|537247728|FG001|Extension Study|Withdrawal by Subject|0|||
148935208|NCT00543543|537247729|FG002|Extension Study|Withdrawal by Subject|0|||
149192465|NCT00960934|538175337|FG002|Overall Study|Withdrawal by Subject|4|||
149192466|NCT00960934|538175338|FG003|Overall Study|Withdrawal by Subject|5|||
149192467|NCT00960934|538175339|FG004|Overall Study|Withdrawal by Subject|5|||
149192468|NCT00960934|538175340|FG005|Overall Study|Withdrawal by Subject|7|||
149192469|NCT00960934|538175335|FG000|Overall Study|Study Terminated by Sponsor|50|||
149192470|NCT00960934|538175336|FG001|Overall Study|Study Terminated by Sponsor|46|||
149192471|NCT00960934|538175337|FG002|Overall Study|Study Terminated by Sponsor|52|||
149192472|NCT00960934|538175338|FG003|Overall Study|Study Terminated by Sponsor|50|||
149192473|NCT00960934|538175339|FG004|Overall Study|Study Terminated by Sponsor|49|||
149192474|NCT00960934|538175340|FG005|Overall Study|Study Terminated by Sponsor|49|||
149192475|NCT04281030|538175345|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
149192476|NCT04281030|538175346|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
149192477|NCT04281030|538175345|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
149192478|NCT04281030|538175346|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
149192479|NCT01395368|538175347|FG000|Overall Study|Physician Decision|14|||
149192480|NCT01395368|538175347|FG000|Overall Study|Withdrawal by Subject|2|||
149192481|NCT00288860|538175352|FG000|Overall Study|Did not complete intake|4|||
149192482|NCT00288860|538175353|FG001|Overall Study|Did not complete intake|8|||
149192483|NCT00288860|538175352|FG000|Overall Study|Death|4|||
149192484|NCT00288860|538175353|FG001|Overall Study|Death|3|||
149192485|NCT00288860|538175352|FG000|Overall Study|Withdrawal by Subject|20|||
149192486|NCT00288860|538175353|FG001|Overall Study|Withdrawal by Subject|15|||
149192487|NCT00288860|538175352|FG000|Overall Study|Lost to Follow-up|74|||
149192488|NCT00288860|538175353|FG001|Overall Study|Lost to Follow-up|71|||
149192489|NCT05142332|538175354|FG000|Overall Study|Withdrawal by Subject|0|||
149192490|NCT05142332|538175355|FG001|Overall Study|Withdrawal by Subject|1|||
149192491|NCT05142332|538175356|FG002|Overall Study|Withdrawal by Subject|2|||
149192492|NCT05142332|538175357|FG003|Overall Study|Withdrawal by Subject|0|||
149192493|NCT05142332|538175358|FG004|Overall Study|Withdrawal by Subject|0|||
149192494|NCT05142332|538175359|FG005|Overall Study|Withdrawal by Subject|2|||
149192495|NCT05142332|538175360|FG006|Overall Study|Withdrawal by Subject|6|||
149192496|NCT05142332|538175354|FG000|Overall Study|Left ED|3|||
149192497|NCT05142332|538175355|FG001|Overall Study|Left ED|0|||
149192498|NCT05142332|538175356|FG002|Overall Study|Left ED|4|||
149192499|NCT05142332|538175357|FG003|Overall Study|Left ED|6|||
149192500|NCT05142332|538175358|FG004|Overall Study|Left ED|1|||
149192501|NCT05142332|538175359|FG005|Overall Study|Left ED|2|||
149192502|NCT05142332|538175360|FG006|Overall Study|Left ED|6|||
149192503|NCT05142332|538175354|FG000|Overall Study|Physician Decision|0|||
149192504|NCT05142332|538175355|FG001|Overall Study|Physician Decision|0|||
149192505|NCT05142332|538175356|FG002|Overall Study|Physician Decision|2|||
149192506|NCT05142332|538175357|FG003|Overall Study|Physician Decision|1|||
149192507|NCT05142332|538175358|FG004|Overall Study|Physician Decision|0|||
149192508|NCT05142332|538175359|FG005|Overall Study|Physician Decision|0|||
149192509|NCT05142332|538175360|FG006|Overall Study|Physician Decision|3|||
149192510|NCT05142332|538175354|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
149192511|NCT05142332|538175355|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
149192512|NCT05142332|538175356|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
149192513|NCT05142332|538175357|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
149192514|NCT05142332|538175358|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
149192515|NCT05142332|538175359|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
149192516|NCT05142332|538175360|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
149192517|NCT00390416|538175361|FG000|Overall Study|Withdrawal by Subject|1|||
148935209|NCT00543543|537247730|FG003|Extension Study|Withdrawal by Subject|120|||
148935210|NCT04308304|537247731|FG000|Overall Study|Withdrawal by Subject|4|||
148935211|NCT04308304|537247732|FG001|Overall Study|Withdrawal by Subject|0|||
148935212|NCT04308304|537247731|FG000|Overall Study|Protocol Violation|1|||
148935213|NCT04308304|537247732|FG001|Overall Study|Protocol Violation|0|||
148935214|NCT00945555|537247733|FG000|Overall Study|Referred to another hospital|5|||
148935215|NCT00945555|537247733|FG000|Overall Study|Worsening condition, intensive care unit|1|||
148935216|NCT00945555|537247733|FG000|Overall Study|Withdrawal by Subject|2|||
148935217|NCT00945555|537247733|FG000|Overall Study|Participant continued treatment at home|1|||
148935218|NCT00945555|537247733|FG000|Overall Study|Death|18|||
148935219|NCT00945555|537247733|FG000|Overall Study|Other|1|||
148935220|NCT01686828|537247738|FG000|Overall Study|Physician Decision|1|||
148935221|NCT01686828|537247739|FG001|Overall Study|Physician Decision|0|||
149192518|NCT00390416|538175361|FG000|Overall Study|Not treated|3|||
149192519|NCT01219959|538175362|FG000|Overall Study|Adverse Event|6|||
149192520|NCT01219959|538175363|FG001|Overall Study|Adverse Event|14|||
148935222|NCT01686828|537247740|FG002|Overall Study|Physician Decision|0|||
148935223|NCT01686828|537247741|FG003|Overall Study|Physician Decision|0|||
148935224|NCT01686828|537247738|FG000|Overall Study|New Job|0|||
148935225|NCT01686828|537247739|FG001|Overall Study|New Job|1|||
149192521|NCT01219959|538175362|FG000|Overall Study|Physician Decision|0|||
149192522|NCT01219959|538175363|FG001|Overall Study|Physician Decision|4|||
149192523|NCT01219959|538175362|FG000|Overall Study|Withdrawal by Subject|0|||
148935226|NCT01686828|537247740|FG002|Overall Study|New Job|0|||
148935227|NCT01686828|537247741|FG003|Overall Study|New Job|0|||
148935228|NCT01686828|537247738|FG000|Overall Study|Weight Loss|0|||
148935229|NCT01686828|537247739|FG001|Overall Study|Weight Loss|0|||
148935230|NCT01686828|537247740|FG002|Overall Study|Weight Loss|1|||
148935231|NCT01686828|537247741|FG003|Overall Study|Weight Loss|0|||
148935232|NCT01736124|537247744|FG000|Post-intervention Assessment|Death|2|||
148935233|NCT01736124|537247745|FG001|Post-intervention Assessment|Death|2|||
148935234|NCT01736124|537247744|FG000|Post-intervention Assessment|lost computer access|1|||
148935235|NCT01736124|537247745|FG001|Post-intervention Assessment|lost computer access|1|||
148935236|NCT01736124|537247744|FG000|Post-intervention Assessment|Moved away|3|||
148935237|NCT01736124|537247745|FG001|Post-intervention Assessment|Moved away|1|||
148935238|NCT01736124|537247744|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
148935239|NCT01736124|537247745|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
148935240|NCT01736124|537247744|FG000|Post-intervention Assessment|Illness|3|||
148935241|NCT01736124|537247745|FG001|Post-intervention Assessment|Illness|2|||
148935242|NCT01736124|537247744|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
148935243|NCT01736124|537247745|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
148935244|NCT01736124|537247744|FG000|Post-intervention Assessment|Temporarily away|3|||
148935245|NCT01736124|537247745|FG001|Post-intervention Assessment|Temporarily away|1|||
148935246|NCT01736124|537247744|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
148935247|NCT01736124|537247745|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
148935248|NCT01736124|537247744|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
148935249|NCT01736124|537247745|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
148935250|NCT01736124|537247744|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
148935251|NCT01736124|537247745|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
148935252|NCT01736124|537247744|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
148935253|NCT01736124|537247745|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
148935254|NCT01736124|537247744|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
148935255|NCT01736124|537247745|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
148935256|NCT01736124|537247744|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
148935257|NCT01736124|537247745|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
148935258|NCT01736124|537247744|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
148935259|NCT01736124|537247745|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
148935260|NCT01736124|537247744|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
148935261|NCT01736124|537247745|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
148935262|NCT01736124|537247744|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
148935263|NCT01736124|537247745|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
148935264|NCT02734433|537247756|FG000|Overall Study|Disease progression|1|||
148935265|NCT02734433|537247757|FG001|Overall Study|Disease progression|5|||
148935266|NCT02734433|537247756|FG000|Overall Study|Clinical progression|0|||
148935267|NCT02734433|537247757|FG001|Overall Study|Clinical progression|1|||
148935268|NCT02734433|537247756|FG000|Overall Study|Withdrawal by Subject|1|||
148935269|NCT02734433|537247757|FG001|Overall Study|Withdrawal by Subject|2|||
148935270|NCT02130024|537247759|FG000|Overall Study|Adverse Event|10|||
148935271|NCT02130024|537247760|FG001|Overall Study|Adverse Event|11|||
148935272|NCT02130024|537247759|FG000|Overall Study|Death|2|||
148935273|NCT02130024|537247760|FG001|Overall Study|Death|2|||
148935274|NCT02130024|537247759|FG000|Overall Study|Lost to Follow-up|1|||
148935275|NCT02130024|537247760|FG001|Overall Study|Lost to Follow-up|1|||
148935276|NCT02130024|537247759|FG000|Overall Study|Physician Decision|1|||
149192524|NCT01219959|538175363|FG001|Overall Study|Withdrawal by Subject|2|||
149192525|NCT01219959|538175362|FG000|Overall Study|Renal Transplantation|0|||
149192526|NCT01219959|538175363|FG001|Overall Study|Renal Transplantation|3|||
149192527|NCT01219959|538175362|FG000|Overall Study|Other|1|||
148935277|NCT02130024|537247760|FG001|Overall Study|Physician Decision|3|||
148935278|NCT02130024|537247759|FG000|Overall Study|Protocol Deviation|4|||
148935279|NCT02130024|537247760|FG001|Overall Study|Protocol Deviation|0|||
149192528|NCT01219959|538175363|FG001|Overall Study|Other|0|||
149192529|NCT01409031|538175365|FG000|Overall Study|transferred to other hosp|1|||
149192530|NCT01409031|538175366|FG001|Overall Study|transferred to other hosp|0|||
148935280|NCT02130024|537247759|FG000|Overall Study|Site Administration Problems|1|||
149192531|NCT02345252|538175367|FG000|Double-Blind Phase|Adverse Event|2|||
149192532|NCT02345252|538175368|FG001|Double-Blind Phase|Adverse Event|3|||
149192533|NCT02345252|538175367|FG000|Double-Blind Phase|Death|1|||
149192534|NCT02345252|538175368|FG001|Double-Blind Phase|Death|2|||
148935281|NCT02130024|537247760|FG001|Overall Study|Site Administration Problems|0|||
148935282|NCT02130024|537247759|FG000|Overall Study|Subject Withdrew Consent|6|||
149192535|NCT02345252|538175367|FG000|Double-Blind Phase|Lack of Efficacy|1|||
149192536|NCT02345252|538175368|FG001|Double-Blind Phase|Lack of Efficacy|0|||
148935283|NCT02130024|537247760|FG001|Overall Study|Subject Withdrew Consent|14|||
148935284|NCT05274165|537247761|FG000|Overall Study|Withdrawal by Subject|3|||
148935285|NCT05274165|537247762|FG001|Overall Study|Withdrawal by Subject|3|||
148935286|NCT02024555|537247768|FG000|Overall Study|Lost to Follow-up|1|||
149192537|NCT02345252|538175367|FG000|Double-Blind Phase|Investigator's Discretion|4|||
149192538|NCT02345252|538175368|FG001|Double-Blind Phase|Investigator's Discretion|6|||
149192539|NCT02345252|538175367|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
149192540|NCT02345252|538175368|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
149192541|NCT02345252|538175367|FG000|Double-Blind Phase|Protocol Violation|2|||
149192542|NCT02345252|538175368|FG001|Double-Blind Phase|Protocol Violation|1|||
149192543|NCT02345252|538175367|FG000|Double-Blind Phase|Withdrew Consent|21|||
149192544|NCT02345252|538175368|FG001|Double-Blind Phase|Withdrew Consent|23|||
149192545|NCT02345252|538175367|FG000|Double-Blind Phase|Lost to Follow-up|8|||
149192546|NCT02345252|538175368|FG001|Double-Blind Phase|Lost to Follow-up|10|||
149192547|NCT02345252|538175367|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
149192548|NCT02345252|538175368|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
149192549|NCT01094730|538175371|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
149192550|NCT01094730|538175372|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
149192551|NCT01094730|538175371|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
149192552|NCT01094730|538175372|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
149192553|NCT01094730|538175371|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
149192554|NCT01094730|538175372|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
149192555|NCT01094730|538175371|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
149192556|NCT01094730|538175372|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
149192557|NCT01094730|538175371|FG000|Period 2 (14 Days)|Protocol Violation|2|||
149192558|NCT01094730|538175372|FG001|Period 2 (14 Days)|Protocol Violation|0|||
149192559|NCT01094730|538175371|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
149192560|NCT01094730|538175372|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
149192561|NCT01094730|538175371|FG000|Period 2 (14 Days)|Adverse Event|0|||
149192562|NCT01094730|538175372|FG001|Period 2 (14 Days)|Adverse Event|1|||
149192563|NCT01094730|538175371|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
149192564|NCT01094730|538175372|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
149192565|NCT02232087|538175373|FG000|Overall Study|Withdrawal by Subject|2|||
149192566|NCT02232087|538175374|FG001|Overall Study|Withdrawal by Subject|0|||
149192567|NCT02232087|538175375|FG002|Overall Study|Withdrawal by Subject|0|||
149192568|NCT02232087|538175376|FG003|Overall Study|Withdrawal by Subject|0|||
149192569|NCT02232087|538175377|FG004|Overall Study|Withdrawal by Subject|0|||
149192570|NCT02232087|538175378|FG005|Overall Study|Withdrawal by Subject|1|||
149192571|NCT02232087|538175373|FG000|Overall Study|poor inhalation technique|0|||
149192572|NCT02232087|538175374|FG001|Overall Study|poor inhalation technique|1|||
149192573|NCT02232087|538175375|FG002|Overall Study|poor inhalation technique|0|||
149192574|NCT02232087|538175376|FG003|Overall Study|poor inhalation technique|0|||
149192575|NCT02232087|538175377|FG004|Overall Study|poor inhalation technique|0|||
149192576|NCT02232087|538175378|FG005|Overall Study|poor inhalation technique|2|||
149192577|NCT02232087|538175373|FG000|Overall Study|protocol stop criteria|0|||
149192578|NCT02232087|538175374|FG001|Overall Study|protocol stop criteria|1|||
149192579|NCT02232087|538175375|FG002|Overall Study|protocol stop criteria|0|||
149192580|NCT02232087|538175376|FG003|Overall Study|protocol stop criteria|1|||
149192581|NCT02232087|538175377|FG004|Overall Study|protocol stop criteria|0|||
149192582|NCT02232087|538175378|FG005|Overall Study|protocol stop criteria|0|||
148935287|NCT02024555|537247769|FG001|Overall Study|Lost to Follow-up|1|||
148935288|NCT02024555|537247768|FG000|Overall Study|Withdrawal by Subject|5|||
148935289|NCT02024555|537247769|FG001|Overall Study|Withdrawal by Subject|1|||
148935290|NCT04916769|537247770|FG000|Period 1|Physician Decision|0|||
148935291|NCT04916769|537247771|FG001|Period 1|Physician Decision|0|||
149192583|NCT02232087|538175373|FG000|Overall Study|Adverse Event|0|||
149192584|NCT02232087|538175374|FG001|Overall Study|Adverse Event|0|||
149192585|NCT02232087|538175375|FG002|Overall Study|Adverse Event|0|||
149192586|NCT02232087|538175376|FG003|Overall Study|Adverse Event|0|||
149192587|NCT02232087|538175377|FG004|Overall Study|Adverse Event|1|||
149192588|NCT02232087|538175378|FG005|Overall Study|Adverse Event|0|||
149192589|NCT01958125|538175379|FG000|Overall Study|Missing diary data|2|||
149192590|NCT01958125|538175380|FG001|Overall Study|Missing diary data|6|||
148935292|NCT04916769|537247772|FG002|Period 1|Physician Decision|0|||
149192591|NCT01958125|538175379|FG000|Overall Study|No headache attacks|0|||
149192592|NCT01958125|538175380|FG001|Overall Study|No headache attacks|2|||
149192593|NCT04096326|538175381|FG000|Overall Study|Withdrawal by Subject|0|||
149192594|NCT04096326|538175382|FG001|Overall Study|Withdrawal by Subject|0|||
148935293|NCT04916769|537247773|FG003|Period 1|Physician Decision|0|||
148935294|NCT04916769|537247774|FG004|Period 1|Physician Decision|0|||
148935295|NCT04916769|537247775|FG005|Period 1|Physician Decision|1|||
148935296|NCT04916769|537247770|FG000|Period 2|Physician Decision|0|||
149192595|NCT04096326|538175383|FG002|Overall Study|Withdrawal by Subject|0|||
149192596|NCT04096326|538175384|FG003|Overall Study|Withdrawal by Subject|0|||
149192597|NCT04096326|538175385|FG004|Overall Study|Withdrawal by Subject|0|||
149192598|NCT04096326|538175386|FG005|Overall Study|Withdrawal by Subject|0|||
149192599|NCT04096326|538175387|FG006|Overall Study|Withdrawal by Subject|1|||
149192600|NCT04096326|538175388|FG007|Overall Study|Withdrawal by Subject|0|||
149192601|NCT04096326|538175389|FG008|Overall Study|Withdrawal by Subject|0|||
149192602|NCT04096326|538175390|FG009|Overall Study|Withdrawal by Subject|0|||
149192603|NCT04096326|538175381|FG000|Overall Study|Lost to Follow-up|0|||
149192604|NCT04096326|538175382|FG001|Overall Study|Lost to Follow-up|1|||
149192605|NCT04096326|538175383|FG002|Overall Study|Lost to Follow-up|0|||
149192606|NCT04096326|538175384|FG003|Overall Study|Lost to Follow-up|0|||
149192607|NCT04096326|538175385|FG004|Overall Study|Lost to Follow-up|0|||
149192608|NCT04096326|538175386|FG005|Overall Study|Lost to Follow-up|0|||
149192609|NCT04096326|538175387|FG006|Overall Study|Lost to Follow-up|0|||
149192610|NCT04096326|538175388|FG007|Overall Study|Lost to Follow-up|0|||
149192611|NCT04096326|538175389|FG008|Overall Study|Lost to Follow-up|0|||
149192612|NCT04096326|538175390|FG009|Overall Study|Lost to Follow-up|0|||
149192613|NCT04096326|538175381|FG000|Overall Study|COVID-19-related reasons|0|||
149192614|NCT04096326|538175382|FG001|Overall Study|COVID-19-related reasons|0|||
149192615|NCT04096326|538175383|FG002|Overall Study|COVID-19-related reasons|0|||
149192616|NCT04096326|538175384|FG003|Overall Study|COVID-19-related reasons|0|||
149192617|NCT04096326|538175385|FG004|Overall Study|COVID-19-related reasons|1|||
149192618|NCT04096326|538175386|FG005|Overall Study|COVID-19-related reasons|5|||
149192619|NCT04096326|538175387|FG006|Overall Study|COVID-19-related reasons|0|||
149192620|NCT04096326|538175388|FG007|Overall Study|COVID-19-related reasons|0|||
149192621|NCT04096326|538175389|FG008|Overall Study|COVID-19-related reasons|0|||
149192622|NCT04096326|538175390|FG009|Overall Study|COVID-19-related reasons|0|||
149192623|NCT04804033|538175391|FG000|Period 1: DBT Phase|Adverse Event|1|||
149192624|NCT04804033|538175392|FG001|Period 1: DBT Phase|Adverse Event|5|||
149192625|NCT04804033|538175393|FG002|Period 1: DBT Phase|Adverse Event|3|||
149192626|NCT04804033|538175394|FG003|Period 1: DBT Phase|Adverse Event|4|||
149192627|NCT04804033|538175391|FG000|Period 1: DBT Phase|Death|1|||
149192628|NCT04804033|538175392|FG001|Period 1: DBT Phase|Death|0|||
149192629|NCT04804033|538175393|FG002|Period 1: DBT Phase|Death|0|||
149192630|NCT04804033|538175394|FG003|Period 1: DBT Phase|Death|0|||
149192631|NCT04804033|538175391|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
149192632|NCT04804033|538175392|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
149192633|NCT04804033|538175393|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
149192634|NCT04804033|538175394|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
149192635|NCT04804033|538175391|FG000|Period 1: DBT Phase|Non-compliance|1|||
149192636|NCT04804033|538175392|FG001|Period 1: DBT Phase|Non-compliance|0|||
149192637|NCT04804033|538175393|FG002|Period 1: DBT Phase|Non-compliance|1|||
149192638|NCT04804033|538175394|FG003|Period 1: DBT Phase|Non-compliance|2|||
149192639|NCT04804033|538175391|FG000|Period 1: DBT Phase|Other|0|||
149192640|NCT04804033|538175392|FG001|Period 1: DBT Phase|Other|1|||
149192641|NCT04804033|538175393|FG002|Period 1: DBT Phase|Other|0|||
149192642|NCT04804033|538175394|FG003|Period 1: DBT Phase|Other|0|||
149192643|NCT04804033|538175391|FG000|Period 1: DBT Phase|Pregnancy|2|||
149192644|NCT04804033|538175392|FG001|Period 1: DBT Phase|Pregnancy|0|||
148807660|NCT01035138|536773346|FG000|Overall Study|Withdrawal by Subject|1|||
148935297|NCT04916769|537247771|FG001|Period 2|Physician Decision|1|||
148935298|NCT04916769|537247772|FG002|Period 2|Physician Decision|0|||
149192645|NCT04804033|538175393|FG002|Period 1: DBT Phase|Pregnancy|0|||
149192646|NCT04804033|538175394|FG003|Period 1: DBT Phase|Pregnancy|0|||
149192647|NCT04804033|538175391|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
149192648|NCT04804033|538175392|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
149192649|NCT04804033|538175393|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
149192650|NCT04804033|538175394|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
149192651|NCT04804033|538175391|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
149192652|NCT04804033|538175392|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
148807661|NCT01035138|536773347|FG001|Overall Study|Withdrawal by Subject|0|||
148807662|NCT01035138|536773348|FG002|Overall Study|Withdrawal by Subject|0|||
148807663|NCT01035138|536773346|FG000|Overall Study|Physician Decision|0|||
149192653|NCT04804033|538175393|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
149192654|NCT04804033|538175394|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
149192655|NCT04804033|538175391|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
148807664|NCT01035138|536773347|FG001|Overall Study|Physician Decision|0|||
148935299|NCT04916769|537247773|FG003|Period 2|Physician Decision|0|||
149192656|NCT04804033|538175392|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
149192657|NCT04804033|538175393|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
149192658|NCT04804033|538175394|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
149192659|NCT04804033|538175391|FG000|Period 2: OLE Phase|Adverse Event|3|||
149192660|NCT04804033|538175392|FG001|Period 2: OLE Phase|Adverse Event|4|||
149014836|NCT00154063|537534293|FG000|Overall Study|Protocol Violation|1|||
149014837|NCT00154063|537534294|FG001|Overall Study|Protocol Violation|1|||
149014838|NCT00154063|537534293|FG000|Overall Study|Investigator or Sponsor Request|0|||
149014839|NCT00154063|537534294|FG001|Overall Study|Investigator or Sponsor Request|1|||
149014840|NCT00154063|537534293|FG000|Overall Study|Withdrawal by Subject|4|||
149014841|NCT00154063|537534294|FG001|Overall Study|Withdrawal by Subject|9|||
149014842|NCT00154063|537534293|FG000|Overall Study|Other|3|||
149014843|NCT00154063|537534294|FG001|Overall Study|Other|3|||
149014844|NCT04789577|537534303|FG000|Overall Study|Withdrawal by Subject|1|||
149014845|NCT04789577|537534304|FG001|Overall Study|Withdrawal by Subject|1|||
149014846|NCT04789577|537534305|FG002|Overall Study|Withdrawal by Subject|1|||
149014847|NCT04789577|537534306|FG003|Overall Study|Withdrawal by Subject|3|||
149014848|NCT04789577|537534307|FG004|Overall Study|Withdrawal by Subject|1|||
149014849|NCT04789577|537534308|FG005|Overall Study|Withdrawal by Subject|7|||
149014850|NCT04789577|537534309|FG006|Overall Study|Withdrawal by Subject|1|||
149014851|NCT04789577|537534303|FG000|Overall Study|Lost to Follow-up|7|||
149014852|NCT04789577|537534304|FG001|Overall Study|Lost to Follow-up|12|||
149014853|NCT04789577|537534305|FG002|Overall Study|Lost to Follow-up|7|||
149014854|NCT04789577|537534306|FG003|Overall Study|Lost to Follow-up|10|||
149192661|NCT04804033|538175393|FG002|Period 2: OLE Phase|Adverse Event|2|||
149192662|NCT04804033|538175394|FG003|Period 2: OLE Phase|Adverse Event|0|||
149192663|NCT04804033|538175391|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
149192664|NCT04804033|538175392|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
149192665|NCT04804033|538175393|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
149192666|NCT04804033|538175394|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
149192667|NCT04804033|538175391|FG000|Period 2: OLE Phase|Non-compliance|2|||
149192668|NCT04804033|538175392|FG001|Period 2: OLE Phase|Non-compliance|2|||
149192669|NCT04804033|538175393|FG002|Period 2: OLE Phase|Non-compliance|0|||
149192670|NCT04804033|538175394|FG003|Period 2: OLE Phase|Non-compliance|1|||
149192671|NCT04804033|538175391|FG000|Period 2: OLE Phase|Other|0|||
149192672|NCT04804033|538175392|FG001|Period 2: OLE Phase|Other|2|||
149192673|NCT04804033|538175393|FG002|Period 2: OLE Phase|Other|0|||
149192674|NCT04804033|538175394|FG003|Period 2: OLE Phase|Other|0|||
149192675|NCT04804033|538175391|FG000|Period 2: OLE Phase|Physician Decision|1|||
149192676|NCT04804033|538175392|FG001|Period 2: OLE Phase|Physician Decision|1|||
149192677|NCT04804033|538175393|FG002|Period 2: OLE Phase|Physician Decision|0|||
149192678|NCT04804033|538175394|FG003|Period 2: OLE Phase|Physician Decision|0|||
149192679|NCT04804033|538175391|FG000|Period 2: OLE Phase|Pregnancy|0|||
149192680|NCT04804033|538175392|FG001|Period 2: OLE Phase|Pregnancy|0|||
149192681|NCT04804033|538175393|FG002|Period 2: OLE Phase|Pregnancy|2|||
149192682|NCT04804033|538175394|FG003|Period 2: OLE Phase|Pregnancy|0|||
149192683|NCT04804033|538175391|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
149192684|NCT04804033|538175392|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
149192685|NCT04804033|538175393|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
149192686|NCT04804033|538175394|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
149192687|NCT04804033|538175391|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
149192688|NCT04804033|538175392|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
149192689|NCT04804033|538175393|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
149192690|NCT04804033|538175394|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
149192691|NCT04804033|538175391|FG000|Period 2: OLE Phase|Not reported|0|||
149192692|NCT04804033|538175392|FG001|Period 2: OLE Phase|Not reported|2|||
149192693|NCT04804033|538175393|FG002|Period 2: OLE Phase|Not reported|0|||
149192694|NCT04804033|538175394|FG003|Period 2: OLE Phase|Not reported|0|||
149014855|NCT04789577|537534307|FG004|Overall Study|Lost to Follow-up|8|||
149192695|NCT04804033|538175391|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
149192696|NCT04804033|538175392|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
149192697|NCT04804033|538175393|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
149192698|NCT04804033|538175394|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
149014856|NCT04789577|537534308|FG005|Overall Study|Lost to Follow-up|6|||
149014857|NCT04789577|537534309|FG006|Overall Study|Lost to Follow-up|10|||
149014858|NCT04789577|537534303|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
149014859|NCT04789577|537534304|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
149192699|NCT04804033|538175391|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
148935300|NCT04916769|537247774|FG004|Period 2|Physician Decision|0|||
148935301|NCT04916769|537247775|FG005|Period 2|Physician Decision|0|||
148935302|NCT05736224|537247776|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
148935303|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
148935304|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
148935305|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
148935306|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
148935307|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
148935308|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
148935309|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
148935310|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
148935311|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
148935312|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
148935313|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
148935314|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
148935315|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
148935316|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
148935317|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
148935318|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
148935319|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
148935320|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
148935321|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
148935322|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
148935323|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
148935324|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
148935325|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
148935326|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
148935327|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
148935328|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
148935329|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
148935330|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
148935331|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
148935332|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
148935333|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
148935334|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
148935335|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
148935336|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
148935337|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
148935338|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
148935339|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
148935340|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
148935341|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
149014860|NCT04789577|537534305|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
149014861|NCT04789577|537534306|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
149014862|NCT04789577|537534307|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
149014863|NCT04789577|537534308|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
149014864|NCT04789577|537534309|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
148807665|NCT01035138|536773348|FG002|Overall Study|Physician Decision|1|||
148935342|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
148935343|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
148935344|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
148935345|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
148935346|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
148935347|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
148935348|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
148935349|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
148935350|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
148935351|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
148935352|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
148935353|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
148935354|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
148935355|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
148935356|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
148935357|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
148935358|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
148935359|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
148935360|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
148935361|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
148935362|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
148935363|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
148935364|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
148935365|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
148935366|NCT04526509|537247777|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
148935367|NCT04526509|537247778|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
148935368|NCT04526509|537247779|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
148935369|NCT04526509|537247780|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
148935370|NCT04526509|537247781|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
148935371|NCT04526509|537247782|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
148935372|NCT04526509|537247783|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
148935373|NCT04526509|537247777|FG000|Enrolled|Study Terminated by Sponsor|0|||
148935374|NCT04526509|537247778|FG001|Enrolled|Study Terminated by Sponsor|0|||
148935375|NCT04526509|537247779|FG002|Enrolled|Study Terminated by Sponsor|0|||
148935376|NCT04526509|537247780|FG003|Enrolled|Study Terminated by Sponsor|0|||
148935377|NCT04526509|537247781|FG004|Enrolled|Study Terminated by Sponsor|0|||
148935378|NCT04526509|537247782|FG005|Enrolled|Study Terminated by Sponsor|0|||
148935379|NCT04526509|537247783|FG006|Enrolled|Study Terminated by Sponsor|1|||
148935380|NCT04526509|537247777|FG000|Enrolled|Death prior to lymphodepletion|0|||
148935381|NCT04526509|537247778|FG001|Enrolled|Death prior to lymphodepletion|0|||
148935382|NCT04526509|537247779|FG002|Enrolled|Death prior to lymphodepletion|0|||
148935383|NCT04526509|537247780|FG003|Enrolled|Death prior to lymphodepletion|1|||
148935384|NCT04526509|537247781|FG004|Enrolled|Death prior to lymphodepletion|0|||
148935385|NCT04526509|537247782|FG005|Enrolled|Death prior to lymphodepletion|0|||
148935386|NCT04526509|537247783|FG006|Enrolled|Death prior to lymphodepletion|0|||
148935387|NCT04526509|537247777|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
148935388|NCT04526509|537247778|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
149014865|NCT04789577|537534303|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
149192700|NCT04804033|538175392|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
149192701|NCT04804033|538175393|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
149192702|NCT04804033|538175394|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
149192703|NCT04804033|538175391|FG000|Period 3: Follow-up Phase|Other|0|||
148935389|NCT04526509|537247779|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
149192704|NCT04804033|538175392|FG001|Period 3: Follow-up Phase|Other|1|||
149192705|NCT04804033|538175393|FG002|Period 3: Follow-up Phase|Other|2|||
149192706|NCT04804033|538175394|FG003|Period 3: Follow-up Phase|Other|1|||
149192707|NCT04804033|538175391|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
149192708|NCT04804033|538175392|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
149192709|NCT04804033|538175393|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
149192710|NCT04804033|538175394|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
149192711|NCT04804033|538175391|FG000|Period 3: Follow-up Phase|Not reported|18|||
149192712|NCT04804033|538175392|FG001|Period 3: Follow-up Phase|Not reported|15|||
149192713|NCT04804033|538175393|FG002|Period 3: Follow-up Phase|Not reported|1|||
149192714|NCT04804033|538175394|FG003|Period 3: Follow-up Phase|Not reported|4|||
149192715|NCT03591146|538175401|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149192716|NCT03591146|538175402|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149192717|NCT03591146|538175403|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149192718|NCT03591146|538175404|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
149192719|NCT03591146|538175405|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
149192720|NCT03591146|538175401|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149192721|NCT03591146|538175402|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
149192722|NCT03591146|538175403|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149192723|NCT03591146|538175404|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149192724|NCT03591146|538175405|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
149192725|NCT03591146|538175401|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149192726|NCT03591146|538175402|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149192727|NCT03591146|538175403|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149192728|NCT03591146|538175404|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
149192729|NCT03591146|538175405|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
149192730|NCT03591146|538175401|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
149192731|NCT03591146|538175402|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
149192732|NCT03591146|538175403|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
149192733|NCT03591146|538175404|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
149192734|NCT03591146|538175405|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
149192735|NCT04737031|538175406|FG000|Overall Study|Patients who did not have a treatment visit|0|||
149192736|NCT04737031|538175407|FG001|Overall Study|Patients who did not have a treatment visit|31|||
149192737|NCT04737031|538175408|FG002|Overall Study|Patients who did not have a treatment visit|93|||
149192738|NCT04737031|538175409|FG003|Overall Study|Patients who did not have a treatment visit|227|||
149192739|NCT02435277|538175410|FG000|Overall Study|Adverse Event|1|||
149192740|NCT02435277|538175411|FG001|Overall Study|Adverse Event|1|||
149192741|NCT02435277|538175412|FG002|Overall Study|Adverse Event|0|||
149192742|NCT02435277|538175413|FG003|Overall Study|Adverse Event|0|||
149192743|NCT02435277|538175410|FG000|Overall Study|Withdrawal by Subject|1|||
149192744|NCT02435277|538175411|FG001|Overall Study|Withdrawal by Subject|0|||
149192745|NCT02435277|538175412|FG002|Overall Study|Withdrawal by Subject|0|||
149192746|NCT02435277|538175413|FG003|Overall Study|Withdrawal by Subject|0|||
149192747|NCT01067508|538175416|FG000|Overall Study|Physician Decision|0|||
149192748|NCT01067508|538175417|FG001|Overall Study|Physician Decision|1|||
149192749|NCT01067508|538175416|FG000|Overall Study|Withdrawal by Subject|0|||
149192750|NCT01067508|538175417|FG001|Overall Study|Withdrawal by Subject|1|||
149192751|NCT01468909|538175423|FG000|Overall Study|Never Treated|2|||
149192752|NCT01468909|538175424|FG001|Overall Study|Never Treated|2|||
149192753|NCT02635737|538175425|FG000|Overall Study|Protocol Violation|1|||
149192754|NCT01552928|538175426|FG000|Period 3|Adverse Event|0|||
149192755|NCT01552928|538175427|FG001|Period 3|Adverse Event|0|||
149192756|NCT01552928|538175428|FG002|Period 3|Adverse Event|1|||
149192757|NCT01552928|538175429|FG003|Period 3|Adverse Event|0|||
149192758|NCT01511419|538175430|FG000|Dose 2|Physician Decision|1|||
149192759|NCT01511419|538175431|FG001|Dose 2|Physician Decision|0|||
149192760|NCT00937768|538175432|FG000|Overall Study|Refused Further Treatment|3|||
149192761|NCT00937768|538175433|FG001|Overall Study|Refused Further Treatment|2|||
149192762|NCT00937768|538175432|FG000|Overall Study|Disease Progression|1|||
149192763|NCT00937768|538175433|FG001|Overall Study|Disease Progression|1|||
149192764|NCT00937768|538175432|FG000|Overall Study|Alternate Treatment|0|||
149192765|NCT00937768|538175433|FG001|Overall Study|Alternate Treatment|1|||
149192766|NCT00937768|538175432|FG000|Overall Study|No Further Funding|4|||
149192767|NCT00937768|538175433|FG001|Overall Study|No Further Funding|4|||
149192768|NCT00992446|538175439|FG000|Overall Study|Disease Progression|1|||
149192769|NCT00992446|538175439|FG000|Overall Study|Withdrawal by Subject|2|||
149192770|NCT00992446|538175439|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
149192771|NCT00755846|538177650|FG000|Overall Study|Adverse Event|0|||
149192772|NCT00755846|538177651|FG001|Overall Study|Adverse Event|0|||
149192773|NCT00755846|538177652|FG002|Overall Study|Adverse Event|0|||
149192774|NCT00755846|538177653|FG003|Overall Study|Adverse Event|1|||
149192775|NCT00755846|538177654|FG004|Overall Study|Adverse Event|3|||
148807666|NCT01035138|536773346|FG000|Overall Study|Sponsor Decision|66|||
149192776|NCT00755846|538177655|FG005|Overall Study|Adverse Event|2|||
149192777|NCT00755846|538177650|FG000|Overall Study|Protocol Violation|1|||
149192778|NCT00755846|538177651|FG001|Overall Study|Protocol Violation|1|||
149192779|NCT00755846|538177652|FG002|Overall Study|Protocol Violation|1|||
149192780|NCT00755846|538177653|FG003|Overall Study|Protocol Violation|1|||
149192781|NCT00755846|538177654|FG004|Overall Study|Protocol Violation|1|||
149192782|NCT00755846|538177655|FG005|Overall Study|Protocol Violation|1|||
149192783|NCT00755846|538177650|FG000|Overall Study|Lost to Follow-up|0|||
149192784|NCT00755846|538177651|FG001|Overall Study|Lost to Follow-up|2|||
149192785|NCT00755846|538177652|FG002|Overall Study|Lost to Follow-up|1|||
149192786|NCT00755846|538177653|FG003|Overall Study|Lost to Follow-up|0|||
149192787|NCT00755846|538177654|FG004|Overall Study|Lost to Follow-up|4|||
149192788|NCT00755846|538177655|FG005|Overall Study|Lost to Follow-up|2|||
149192789|NCT00755846|538177650|FG000|Overall Study|Withdrawal by Subject|2|||
149192790|NCT00755846|538177651|FG001|Overall Study|Withdrawal by Subject|3|||
149192791|NCT00755846|538177652|FG002|Overall Study|Withdrawal by Subject|5|||
149192792|NCT00755846|538177653|FG003|Overall Study|Withdrawal by Subject|2|||
149192793|NCT00755846|538177654|FG004|Overall Study|Withdrawal by Subject|0|||
149192794|NCT00755846|538177655|FG005|Overall Study|Withdrawal by Subject|1|||
149192795|NCT00755846|538177650|FG000|Overall Study|Hyperglycemic Rescue|21|||
149192796|NCT00755846|538177651|FG001|Overall Study|Hyperglycemic Rescue|7|||
149192797|NCT00755846|538177652|FG002|Overall Study|Hyperglycemic Rescue|5|||
149192798|NCT00755846|538177653|FG003|Overall Study|Hyperglycemic Rescue|8|||
149192799|NCT00755846|538177654|FG004|Overall Study|Hyperglycemic Rescue|8|||
149192800|NCT00755846|538177655|FG005|Overall Study|Hyperglycemic Rescue|7|||
149192801|NCT00755846|538177650|FG000|Overall Study|Physician Decision|1|||
149192802|NCT00755846|538177651|FG001|Overall Study|Physician Decision|3|||
149192803|NCT00755846|538177652|FG002|Overall Study|Physician Decision|0|||
149192804|NCT00755846|538177653|FG003|Overall Study|Physician Decision|1|||
149192805|NCT00755846|538177654|FG004|Overall Study|Physician Decision|0|||
149192806|NCT00755846|538177655|FG005|Overall Study|Physician Decision|1|||
149192807|NCT00755846|538177650|FG000|Overall Study|Administrative Error|0|||
149192808|NCT00755846|538177651|FG001|Overall Study|Administrative Error|1|||
149192809|NCT00755846|538177652|FG002|Overall Study|Administrative Error|0|||
149192810|NCT00755846|538177653|FG003|Overall Study|Administrative Error|0|||
149192811|NCT00755846|538177654|FG004|Overall Study|Administrative Error|0|||
149192812|NCT00755846|538177655|FG005|Overall Study|Administrative Error|0|||
149192813|NCT00755846|538177650|FG000|Overall Study|Participant Non-compliance|0|||
149192814|NCT00755846|538177651|FG001|Overall Study|Participant Non-compliance|0|||
149192815|NCT00755846|538177652|FG002|Overall Study|Participant Non-compliance|0|||
149192816|NCT00755846|538177653|FG003|Overall Study|Participant Non-compliance|0|||
149192817|NCT00755846|538177654|FG004|Overall Study|Participant Non-compliance|1|||
149192818|NCT00755846|538177655|FG005|Overall Study|Participant Non-compliance|0|||
149192819|NCT02922634|538177666|FG000|Overall Study|Withdrawal by Subject|5|||
149192820|NCT02922634|538177666|FG000|Overall Study|Did not have their surgery|5|||
149192821|NCT02723604|538177667|FG000|Overall Study|ineligible|1|||
149192822|NCT02723604|538177667|FG000|Overall Study|never received treatment|1|||
149192823|NCT00311181|538177668|FG000|Overall Study|Final DFTs were not obtained|96|||
149192824|NCT00506948|538177674|FG000|Overall Study|Death|4|||
149192825|NCT00506948|538177674|FG000|Overall Study|Adverse Event|5|||
149192826|NCT00506948|538177674|FG000|Overall Study|Physician Decision|1|||
149192827|NCT02395653|538177675|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
149192828|NCT02395653|538177675|FG000|Overall Study|Consent Withdrawn at Screening|1|||
149192829|NCT02395653|538177675|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
149192830|NCT02395653|538177675|FG000|Overall Study|Investigator Decision at Screening|1|||
149192831|NCT02395653|538177675|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
149192832|NCT02395653|538177675|FG000|Overall Study|Withdrawal by Subject|1|||
149192833|NCT02395653|538177675|FG000|Overall Study|Lost to Follow-up|1|||
149192834|NCT01194804|538177676|FG000|Overall Study|Withdrawal by Subject|1|||
149192835|NCT02494778|538177677|FG000|Overall Study|Death|3|||
148935390|NCT04526509|537247780|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
149192836|NCT02494778|538177677|FG000|Overall Study|Other|173|||
149192837|NCT02494778|538177677|FG000|Overall Study|Lack of Efficacy|4|||
149192838|NCT02494778|538177677|FG000|Overall Study|Adverse Event|18|||
149192839|NCT02494778|538177677|FG000|Overall Study|Withdrawal by Subject|20|||
149192840|NCT02494778|538177677|FG000|Overall Study|Lost to Follow-up|2|||
149192841|NCT02494778|538177677|FG000|Overall Study|Noncompliant with study drug admin.|1|||
149192842|NCT01303380|538177678|FG000|Overall Study|Lack of compliance to study procedures|1|||
149192843|NCT03621943|538177679|FG000|First Randomized Intervention|Lost to Follow-up|51|||
149192844|NCT03621943|538177680|FG001|First Randomized Intervention|Lost to Follow-up|54|||
148935391|NCT04526509|537247781|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
149192845|NCT03621943|538177679|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
149192846|NCT03621943|538177680|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
149192847|NCT03621943|538177679|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
149192848|NCT03621943|538177680|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
149192849|NCT03621943|538177679|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
149192850|NCT03621943|538177680|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
149192851|NCT02174861|538177681|FG000|Overall Study|Decision by sponsor|8|||
149192852|NCT02174861|538177681|FG000|Overall Study|Withdrawal by Subject|124|||
149192853|NCT02174861|538177681|FG000|Overall Study|Lost to Follow-up|26|||
149192854|NCT01215734|538177682|FG000|Overall Study|Death|0|||
149192855|NCT01215734|538177683|FG001|Overall Study|Death|1|||
149192856|NCT00315705|538177684|FG000|Phase 1|Refused further treatment|1|||
149192857|NCT00315705|538177684|FG000|Phase 1|Failure to achieve response|8|||
149192858|NCT00315705|538177684|FG000|Phase 1|Disease relapse|4|||
149192859|NCT00315705|538177684|FG000|Phase 1|Scheduled for transplant|9|||
149192860|NCT00315705|538177684|FG000|Phase 1|Death|3|||
149192861|NCT00315705|538177684|FG000|Phase 2|Physician Decision|4|||
149192862|NCT00315705|538177684|FG000|Phase 2|Adverse Event|1|||
149192863|NCT00315705|538177684|FG000|Phase 2|Failure to achieve response|3|||
149192864|NCT00315705|538177684|FG000|Phase 2|Disease relapse|1|||
149192865|NCT00315705|538177684|FG000|Phase 2|Scheduled for transplant|8|||
149192866|NCT00315705|538177684|FG000|Phase 2|Other|1|||
149192867|NCT00315705|538177684|FG000|Phase 2|Death|7|||
149192868|NCT01716533|538177685|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
149192869|NCT01716533|538177686|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
149192870|NCT01716533|538177687|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
149192871|NCT01716533|538177688|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
149192872|NCT01716533|538177685|FG000|Overall Study|Withdrawal by Subject|0|||
149192873|NCT01716533|538177686|FG001|Overall Study|Withdrawal by Subject|0|||
149192874|NCT01716533|538177687|FG002|Overall Study|Withdrawal by Subject|0|||
149192875|NCT01716533|538177688|FG003|Overall Study|Withdrawal by Subject|5|||
149192876|NCT01716533|538177685|FG000|Overall Study|Death|0|||
149192877|NCT01716533|538177686|FG001|Overall Study|Death|0|||
149192878|NCT01716533|538177687|FG002|Overall Study|Death|0|||
149192879|NCT01716533|538177688|FG003|Overall Study|Death|2|||
149192880|NCT01716533|538177685|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
149192881|NCT01716533|538177686|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
149192882|NCT01716533|538177687|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
149192883|NCT01716533|538177688|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
149192884|NCT00165841|538177696|FG000|Overall Study|Adverse Event|2|||
149192885|NCT00165841|538177697|FG001|Overall Study|Adverse Event|3|||
149192886|NCT00165841|538177696|FG000|Overall Study|Lack of Efficacy|6|||
149192887|NCT00165841|538177697|FG001|Overall Study|Lack of Efficacy|33|||
149192888|NCT00165841|538177696|FG000|Overall Study|Lost to Follow-up|4|||
149192889|NCT00165841|538177697|FG001|Overall Study|Lost to Follow-up|4|||
149192890|NCT00165841|538177696|FG000|Overall Study|Withdrawal by Subject|7|||
149192891|NCT00165841|538177697|FG001|Overall Study|Withdrawal by Subject|8|||
149192892|NCT00165841|538177696|FG000|Overall Study|Physician Decision|1|||
149192893|NCT00165841|538177697|FG001|Overall Study|Physician Decision|0|||
149192894|NCT00165841|538177696|FG000|Overall Study|Protocol Violation|6|||
149192895|NCT00165841|538177697|FG001|Overall Study|Protocol Violation|8|||
149192896|NCT00165841|538177696|FG000|Overall Study|Other|3|||
149192897|NCT00165841|538177697|FG001|Overall Study|Other|5|||
149192898|NCT00165841|538177696|FG000|Overall Study|Medication Noncompliance|1|||
149192899|NCT00165841|538177697|FG001|Overall Study|Medication Noncompliance|1|||
149192900|NCT00789958|538177698|FG000|Overall Study|Adverse Event|3|||
149192901|NCT00789958|538177698|FG000|Overall Study|Withdrawal by Subject|4|||
149192902|NCT00789958|538177698|FG000|Overall Study|Progression|3|||
149192903|NCT00789958|538177698|FG000|Overall Study|not protocol specified|1|||
149192904|NCT00789958|538177698|FG000|Overall Study|Not eligible/not analyzable|26|||
149192905|NCT02622724|538177701|FG000|Overall Study|Death|51|||
149192906|NCT02622724|538177702|FG001|Overall Study|Death|53|||
149192907|NCT02622724|538177701|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
149192908|NCT02622724|538177702|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
149192909|NCT02622724|538177701|FG000|Overall Study|Early termination of study|38|||
149192910|NCT02622724|538177702|FG001|Overall Study|Early termination of study|43|||
149192911|NCT00296725|538177703|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
149192912|NCT00296725|538177703|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
148935392|NCT04526509|537247782|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
148935393|NCT04526509|537247783|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
148935394|NCT04526509|537247777|FG000|Enrolled|Physician Decision|0|||
149192913|NCT00296725|538177703|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
149192914|NCT00487084|538177704|FG000|Overall Study|Did not receive intervention|4|||
149192915|NCT00487084|538177705|FG001|Overall Study|Did not receive intervention|3|||
148935395|NCT04526509|537247778|FG001|Enrolled|Physician Decision|1|||
149192916|NCT00487084|538177706|FG002|Overall Study|Did not receive intervention|5|||
149192917|NCT00254293|538177707|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149192918|NCT00254293|538177708|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
149192919|NCT00254293|538177709|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149192920|NCT00254293|538177710|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
149192921|NCT00254293|538177711|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149192922|NCT00254293|538177712|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149192923|NCT00254293|538177713|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
149192924|NCT00254293|538177707|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149192925|NCT00254293|538177708|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149192926|NCT00254293|538177709|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
149192927|NCT00254293|538177710|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149192928|NCT00254293|538177711|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149192929|NCT00254293|538177712|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149192930|NCT00254293|538177713|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
149192931|NCT00254293|538177707|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149192932|NCT00254293|538177708|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149192933|NCT00254293|538177709|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
149192934|NCT00254293|538177710|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149192935|NCT00254293|538177711|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149192936|NCT00254293|538177712|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149192937|NCT00254293|538177713|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
149192938|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Death|0|||
149192939|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Death|0|||
149192940|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Death|1|||
149192941|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Death|0|||
149192942|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Death|0|||
149192943|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Death|0|||
149192944|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Death|0|||
149192945|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
149192946|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149192947|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
149192948|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149192949|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
149192950|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149192951|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
149192952|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
149192953|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149192954|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
149192955|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149192956|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
149192957|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149192958|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
149192959|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149192960|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149192961|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
149192962|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149192963|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149192964|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149192965|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
149192966|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149192967|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149192968|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
149192969|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149192970|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149192971|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149192972|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
149192973|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149192974|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149192975|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
149192976|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149192977|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149192978|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
148935396|NCT04526509|537247779|FG002|Enrolled|Physician Decision|0|||
149192979|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
149192980|NCT00254293|538177707|FG000|LTE Open Label Variable SC Dosing|Other|0|||
149192981|NCT00254293|538177708|FG001|LTE Open Label Variable SC Dosing|Other|0|||
148935397|NCT04526509|537247780|FG003|Enrolled|Physician Decision|0|||
148935398|NCT04526509|537247781|FG004|Enrolled|Physician Decision|0|||
148935399|NCT04526509|537247782|FG005|Enrolled|Physician Decision|0|||
148935400|NCT04526509|537247783|FG006|Enrolled|Physician Decision|0|||
148935401|NCT02719327|537247788|FG000|Overall Study|Withdrawal by Subject|11|||
148935402|NCT02719327|537247789|FG001|Overall Study|Withdrawal by Subject|8|||
148935403|NCT04340193|537247790|FG000|Overall Study|Other reason|0|||
148935404|NCT04340193|537247791|FG001|Overall Study|Other reason|0|||
148935405|NCT04340193|537247792|FG002|Overall Study|Other reason|1|||
148935406|NCT04340193|537247790|FG000|Overall Study|Disease recurrence|0|||
148935407|NCT04340193|537247791|FG001|Overall Study|Disease recurrence|1|||
148935408|NCT04340193|537247792|FG002|Overall Study|Disease recurrence|0|||
148935409|NCT04340193|537247790|FG000|Overall Study|Study drug toxicity|1|||
148935410|NCT04340193|537247791|FG001|Overall Study|Study drug toxicity|0|||
148935411|NCT04340193|537247792|FG002|Overall Study|Study drug toxicity|0|||
148935412|NCT04340193|537247790|FG000|Overall Study|Disease progression|1|||
148935413|NCT04340193|537247791|FG001|Overall Study|Disease progression|2|||
148935414|NCT04340193|537247792|FG002|Overall Study|Disease progression|3|||
148935415|NCT04340193|537247790|FG000|Overall Study|Administrative reasons by sponsor|0|||
148935416|NCT04340193|537247791|FG001|Overall Study|Administrative reasons by sponsor|1|||
148935417|NCT04340193|537247792|FG002|Overall Study|Administrative reasons by sponsor|0|||
148935418|NCT04340193|537247790|FG000|Overall Study|Adverse Event|1|||
148935419|NCT04340193|537247791|FG001|Overall Study|Adverse Event|1|||
148935420|NCT04340193|537247792|FG002|Overall Study|Adverse Event|0|||
148935421|NCT03350620|537247793|FG000|Stage 2|Adverse Event|0|||
148935422|NCT03350620|537247794|FG001|Stage 2|Adverse Event|1|||
148935423|NCT03350620|537247795|FG002|Stage 2|Adverse Event|1|||
148935424|NCT03350620|537247793|FG000|Stage 2|Lack of Efficacy|0|||
148935425|NCT03350620|537247794|FG001|Stage 2|Lack of Efficacy|2|||
148935426|NCT03350620|537247795|FG002|Stage 2|Lack of Efficacy|0|||
148935427|NCT03350620|537247793|FG000|Stage 2|Lost to Follow-up|1|||
148935428|NCT03350620|537247794|FG001|Stage 2|Lost to Follow-up|2|||
148935429|NCT03350620|537247795|FG002|Stage 2|Lost to Follow-up|2|||
148935430|NCT03350620|537247793|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
148935431|NCT03350620|537247794|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
148935432|NCT03350620|537247795|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
148935433|NCT03507400|537247796|FG000|Overall Study|discontinued|5|||
148935434|NCT03507400|537247797|FG001|Overall Study|discontinued|1|||
148935435|NCT03507400|537247796|FG000|Overall Study|Lost to Follow-up|8|||
148935436|NCT03507400|537247797|FG001|Overall Study|Lost to Follow-up|6|||
148935437|NCT03507400|537247796|FG000|Overall Study|Protocol Violation|0|||
148935438|NCT03507400|537247797|FG001|Overall Study|Protocol Violation|1|||
148935439|NCT01543698|537249393|FG000|Phase 1b|Disease progression|2|||
148935440|NCT01543698|537249394|FG001|Phase 1b|Disease progression|4|||
148935441|NCT01543698|537249395|FG002|Phase 1b|Disease progression|3|||
148935442|NCT01543698|537249396|FG003|Phase 1b|Disease progression|2|||
148935443|NCT01543698|537249397|FG004|Phase 1b|Disease progression|10|||
148935444|NCT01543698|537249398|FG005|Phase 1b|Disease progression|6|||
148935445|NCT01543698|537249399|FG006|Phase 1b|Disease progression|5|||
148935446|NCT01543698|537249400|FG007|Phase 1b|Disease progression|3|||
148935447|NCT01543698|537249401|FG008|Phase 1b|Disease progression|4|||
148935448|NCT01543698|537249402|FG009|Phase 1b|Disease progression|5|||
148935449|NCT01543698|537249403|FG010|Phase 1b|Disease progression|1|||
148935450|NCT01543698|537249404|FG011|Phase 1b|Disease progression|0|||
148935451|NCT01543698|537249405|FG012|Phase 1b|Disease progression|0|||
148935452|NCT01543698|537249406|FG013|Phase 1b|Disease progression|0|||
148935453|NCT01543698|537249407|FG014|Phase 1b|Disease progression|0|||
148935454|NCT01543698|537249393|FG000|Phase 1b|Death|0|||
148935455|NCT01543698|537249394|FG001|Phase 1b|Death|0|||
149192982|NCT00254293|538177709|FG002|LTE Open Label Variable SC Dosing|Other|2|||
149192983|NCT00254293|538177710|FG003|LTE Open Label Variable SC Dosing|Other|0|||
148935456|NCT01543698|537249395|FG002|Phase 1b|Death|1|||
148935457|NCT01543698|537249396|FG003|Phase 1b|Death|1|||
148935458|NCT01543698|537249397|FG004|Phase 1b|Death|0|||
148935459|NCT01543698|537249398|FG005|Phase 1b|Death|0|||
148935460|NCT01543698|537249399|FG006|Phase 1b|Death|0|||
149014866|NCT04789577|537534304|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
148935461|NCT01543698|537249400|FG007|Phase 1b|Death|0|||
148935462|NCT01543698|537249401|FG008|Phase 1b|Death|0|||
148935463|NCT01543698|537249402|FG009|Phase 1b|Death|0|||
148935464|NCT01543698|537249403|FG010|Phase 1b|Death|1|||
148935465|NCT01543698|537249404|FG011|Phase 1b|Death|0|||
148935466|NCT01543698|537249405|FG012|Phase 1b|Death|0|||
148935467|NCT01543698|537249406|FG013|Phase 1b|Death|0|||
148935468|NCT01543698|537249407|FG014|Phase 1b|Death|0|||
148935469|NCT01543698|537249393|FG000|Phase 1b|Withdrawal by Subject|0|||
148935470|NCT01543698|537249394|FG001|Phase 1b|Withdrawal by Subject|1|||
148935471|NCT01543698|537249395|FG002|Phase 1b|Withdrawal by Subject|0|||
148935472|NCT01543698|537249396|FG003|Phase 1b|Withdrawal by Subject|1|||
149014867|NCT04789577|537534305|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
149014868|NCT04789577|537534306|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
149014869|NCT04789577|537534307|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
149014870|NCT04789577|537534308|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
149014871|NCT04789577|537534309|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
149014872|NCT01275196|537534310|FG000|Overall Study|Adverse Event|3|||
149014873|NCT01275196|537534311|FG001|Overall Study|Adverse Event|5|||
149014874|NCT01275196|537534310|FG000|Overall Study|Withdrawal by Subject|4|||
149014875|NCT01275196|537534311|FG001|Overall Study|Withdrawal by Subject|5|||
149014876|NCT01275196|537534310|FG000|Overall Study|Lost to Follow-up|1|||
149014877|NCT01275196|537534311|FG001|Overall Study|Lost to Follow-up|0|||
149014878|NCT01275196|537534310|FG000|Overall Study|Disease Progression|6|||
149192984|NCT00254293|538177711|FG004|LTE Open Label Variable SC Dosing|Other|0|||
149192985|NCT00254293|538177712|FG005|LTE Open Label Variable SC Dosing|Other|0|||
149192986|NCT00254293|538177713|FG006|LTE Open Label Variable SC Dosing|Other|0|||
149192987|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Death|0|||
149192988|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Death|0|||
149192989|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Death|0|||
149192990|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Death|0|||
149192991|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Death|0|||
149192992|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Death|0|||
149192993|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Death|3|||
149192994|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
149192995|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
149192996|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
149192997|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
149192998|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
149192999|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
149193000|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
149193001|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149193002|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
148935473|NCT01543698|537249397|FG004|Phase 1b|Withdrawal by Subject|0|||
148935474|NCT01543698|537249398|FG005|Phase 1b|Withdrawal by Subject|0|||
148935475|NCT01543698|537249399|FG006|Phase 1b|Withdrawal by Subject|1|||
148935476|NCT01543698|537249400|FG007|Phase 1b|Withdrawal by Subject|0|||
148935477|NCT01543698|537249401|FG008|Phase 1b|Withdrawal by Subject|0|||
148935478|NCT01543698|537249402|FG009|Phase 1b|Withdrawal by Subject|0|||
148935479|NCT01543698|537249403|FG010|Phase 1b|Withdrawal by Subject|0|||
148935480|NCT01543698|537249404|FG011|Phase 1b|Withdrawal by Subject|0|||
148935481|NCT01543698|537249405|FG012|Phase 1b|Withdrawal by Subject|0|||
148935482|NCT01543698|537249406|FG013|Phase 1b|Withdrawal by Subject|0|||
148935483|NCT01543698|537249407|FG014|Phase 1b|Withdrawal by Subject|0|||
148935484|NCT01543698|537249393|FG000|Phase 1b|Adverse Event|1|||
148935485|NCT01543698|537249394|FG001|Phase 1b|Adverse Event|0|||
148935486|NCT01543698|537249395|FG002|Phase 1b|Adverse Event|0|||
148935487|NCT01543698|537249396|FG003|Phase 1b|Adverse Event|1|||
148935488|NCT01543698|537249397|FG004|Phase 1b|Adverse Event|2|||
148935489|NCT01543698|537249398|FG005|Phase 1b|Adverse Event|2|||
149193003|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149193004|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149193005|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149193006|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
149193007|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
149193008|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149193009|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149193010|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149193011|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149193012|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149193013|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
149193014|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
149193015|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
148935490|NCT01543698|537249399|FG006|Phase 1b|Adverse Event|0|||
149014879|NCT01275196|537534311|FG001|Overall Study|Disease Progression|5|||
149014880|NCT01275196|537534310|FG000|Overall Study|Protocol Violation|1|||
149014881|NCT01275196|537534311|FG001|Overall Study|Protocol Violation|0|||
149193016|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
148935491|NCT01543698|537249400|FG007|Phase 1b|Adverse Event|0|||
148935492|NCT01543698|537249401|FG008|Phase 1b|Adverse Event|1|||
148935493|NCT01543698|537249402|FG009|Phase 1b|Adverse Event|1|||
149193017|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149193018|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149193019|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149193020|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
149193021|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
149193022|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149193023|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149193024|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149193025|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149193026|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149193027|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
149193028|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
149193029|NCT00254293|538177707|FG000|LTE Open Label Fixed Dosing|Other|0|||
149193030|NCT00254293|538177708|FG001|LTE Open Label Fixed Dosing|Other|0|||
149193031|NCT00254293|538177709|FG002|LTE Open Label Fixed Dosing|Other|0|||
149193032|NCT00254293|538177710|FG003|LTE Open Label Fixed Dosing|Other|0|||
149193033|NCT00254293|538177711|FG004|LTE Open Label Fixed Dosing|Other|0|||
149193034|NCT00254293|538177712|FG005|LTE Open Label Fixed Dosing|Other|0|||
149193035|NCT00254293|538177713|FG006|LTE Open Label Fixed Dosing|Other|1|||
149193036|NCT03712345|538177721|FG000|Overall Study|Failure to meet randomization criteria|0|||
149193037|NCT03712345|538177722|FG001|Overall Study|Failure to meet randomization criteria|0|||
149193038|NCT03712345|538177723|FG002|Overall Study|Failure to meet randomization criteria|1|||
149193039|NCT00839423|538177730|FG000|Overall Study|Adverse Event|4|||
149193040|NCT00839423|538177731|FG001|Overall Study|Adverse Event|3|||
149193041|NCT00839423|538177732|FG002|Overall Study|Adverse Event|7|||
149193042|NCT00839423|538177733|FG003|Overall Study|Adverse Event|16|||
149193043|NCT00839423|538177730|FG000|Overall Study|Lack of Efficacy|6|||
149193044|NCT00839423|538177731|FG001|Overall Study|Lack of Efficacy|6|||
149193045|NCT00839423|538177732|FG002|Overall Study|Lack of Efficacy|3|||
149193046|NCT00839423|538177733|FG003|Overall Study|Lack of Efficacy|2|||
149193047|NCT00839423|538177730|FG000|Overall Study|Non-compliance|0|||
149193048|NCT00839423|538177731|FG001|Overall Study|Non-compliance|0|||
149193049|NCT00839423|538177732|FG002|Overall Study|Non-compliance|0|||
149193050|NCT00839423|538177733|FG003|Overall Study|Non-compliance|1|||
149193051|NCT00839423|538177730|FG000|Overall Study|Protocol Violation|0|||
149193052|NCT00839423|538177731|FG001|Overall Study|Protocol Violation|1|||
149193053|NCT00839423|538177732|FG002|Overall Study|Protocol Violation|2|||
149193054|NCT00839423|538177733|FG003|Overall Study|Protocol Violation|0|||
149193055|NCT00839423|538177730|FG000|Overall Study|Withdrawal of consent|4|||
149193056|NCT00839423|538177731|FG001|Overall Study|Withdrawal of consent|0|||
148935494|NCT01543698|537249403|FG010|Phase 1b|Adverse Event|2|||
148935495|NCT01543698|537249404|FG011|Phase 1b|Adverse Event|0|||
148935496|NCT01543698|537249405|FG012|Phase 1b|Adverse Event|0|||
148935497|NCT01543698|537249406|FG013|Phase 1b|Adverse Event|0|||
148935498|NCT01543698|537249407|FG014|Phase 1b|Adverse Event|0|||
148935499|NCT01543698|537249393|FG000|Phase 1b|Administrative problems|1|||
148935500|NCT01543698|537249394|FG001|Phase 1b|Administrative problems|0|||
148935501|NCT01543698|537249395|FG002|Phase 1b|Administrative problems|0|||
148935502|NCT01543698|537249396|FG003|Phase 1b|Administrative problems|0|||
148935503|NCT01543698|537249397|FG004|Phase 1b|Administrative problems|1|||
148935504|NCT01543698|537249398|FG005|Phase 1b|Administrative problems|0|||
148935505|NCT01543698|537249399|FG006|Phase 1b|Administrative problems|0|||
148935506|NCT01543698|537249400|FG007|Phase 1b|Administrative problems|1|||
148935507|NCT01543698|537249401|FG008|Phase 1b|Administrative problems|0|||
148935508|NCT01543698|537249402|FG009|Phase 1b|Administrative problems|0|||
148935509|NCT01543698|537249403|FG010|Phase 1b|Administrative problems|2|||
148935510|NCT01543698|537249404|FG011|Phase 1b|Administrative problems|0|||
148935511|NCT01543698|537249405|FG012|Phase 1b|Administrative problems|0|||
148935512|NCT01543698|537249406|FG013|Phase 1b|Administrative problems|0|||
148935513|NCT01543698|537249407|FG014|Phase 1b|Administrative problems|0|||
148935514|NCT01543698|537249393|FG000|Phase 1b|Protocol Violation|2|||
148935515|NCT01543698|537249394|FG001|Phase 1b|Protocol Violation|0|||
148935516|NCT01543698|537249395|FG002|Phase 1b|Protocol Violation|0|||
148935517|NCT01543698|537249396|FG003|Phase 1b|Protocol Violation|0|||
149193057|NCT00839423|538177732|FG002|Overall Study|Withdrawal of consent|4|||
148935518|NCT01543698|537249397|FG004|Phase 1b|Protocol Violation|0|||
148935519|NCT01543698|537249398|FG005|Phase 1b|Protocol Violation|0|||
148935520|NCT01543698|537249399|FG006|Phase 1b|Protocol Violation|0|||
148935521|NCT01543698|537249400|FG007|Phase 1b|Protocol Violation|0|||
148935522|NCT01543698|537249401|FG008|Phase 1b|Protocol Violation|0|||
148935523|NCT01543698|537249402|FG009|Phase 1b|Protocol Violation|0|||
148935524|NCT01543698|537249403|FG010|Phase 1b|Protocol Violation|0|||
149193058|NCT00839423|538177733|FG003|Overall Study|Withdrawal of consent|1|||
149193059|NCT00839423|538177730|FG000|Overall Study|Lost to Follow-up|1|||
149193060|NCT00839423|538177731|FG001|Overall Study|Lost to Follow-up|0|||
149193061|NCT00839423|538177732|FG002|Overall Study|Lost to Follow-up|1|||
149193062|NCT00839423|538177733|FG003|Overall Study|Lost to Follow-up|0|||
149193063|NCT00839423|538177730|FG000|Overall Study|Administrative or other reasons|3|||
149193064|NCT00839423|538177731|FG001|Overall Study|Administrative or other reasons|0|||
149193065|NCT00839423|538177732|FG002|Overall Study|Administrative or other reasons|1|||
149193066|NCT00839423|538177733|FG003|Overall Study|Administrative or other reasons|0|||
149193067|NCT01071096|538177734|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
149193068|NCT01071096|538177735|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
149193069|NCT02585999|538177736|FG000|Overall Study|Lost to Follow-up|1|||
149193070|NCT02585999|538177736|FG000|Overall Study|Protocol Violation|1|||
149193071|NCT01332019|538177737|FG000|Overall Study|Was Not Dosed|1|||
149193072|NCT01332019|538177738|FG001|Overall Study|Was Not Dosed|0|||
149193073|NCT01332019|538177737|FG000|Overall Study|Other|16|||
149193074|NCT01332019|538177738|FG001|Overall Study|Other|18|||
149193075|NCT01332019|538177737|FG000|Overall Study|Death|2|||
149193076|NCT01332019|538177738|FG001|Overall Study|Death|1|||
149193077|NCT01332019|538177737|FG000|Overall Study|Physician Decision|4|||
149193078|NCT01332019|538177738|FG001|Overall Study|Physician Decision|3|||
149193079|NCT01332019|538177737|FG000|Overall Study|Withdrawal by Subject|73|||
149193080|NCT01332019|538177738|FG001|Overall Study|Withdrawal by Subject|71|||
149193081|NCT01332019|538177737|FG000|Overall Study|Lost to Follow-up|4|||
149193082|NCT01332019|538177738|FG001|Overall Study|Lost to Follow-up|7|||
149193083|NCT01332019|538177737|FG000|Overall Study|Adverse Event|13|||
149193084|NCT01332019|538177738|FG001|Overall Study|Adverse Event|22|||
149193085|NCT01369849|538177739|FG000|Overall Study|Ineligible prior to treatment|0|||
149193086|NCT01369849|538177740|FG001|Overall Study|Ineligible prior to treatment|0|||
149193087|NCT01369849|538177741|FG002|Overall Study|Ineligible prior to treatment|1|||
149193088|NCT01369849|538177739|FG000|Overall Study|Ineligible after receiving treatment|0|||
149193089|NCT01369849|538177740|FG001|Overall Study|Ineligible after receiving treatment|1|||
149193090|NCT01369849|538177741|FG002|Overall Study|Ineligible after receiving treatment|0|||
149193091|NCT00871377|538177742|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149193092|NCT00871377|538177743|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149193093|NCT00871377|538177744|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
149193094|NCT00871377|538177745|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149193095|NCT00871377|538177746|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149193096|NCT00871377|538177747|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
149193097|NCT00871377|538177742|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149193098|NCT00871377|538177743|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149193099|NCT00871377|538177744|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149193100|NCT00871377|538177745|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149193101|NCT00871377|538177746|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
149193102|NCT00871377|538177747|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
149193103|NCT00871377|538177742|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
149193104|NCT00871377|538177743|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193105|NCT00871377|538177744|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193106|NCT00871377|538177745|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193107|NCT00871377|538177746|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193108|NCT00871377|538177747|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193109|NCT00871377|538177742|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193110|NCT00871377|538177743|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193111|NCT00871377|538177744|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193112|NCT00871377|538177745|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193113|NCT00871377|538177746|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
149193114|NCT00871377|538177747|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
149193115|NCT00871377|538177742|FG000|Third Intervention (10 Weeks)|Death|0|||
149193116|NCT00871377|538177743|FG001|Third Intervention (10 Weeks)|Death|0|||
149193117|NCT00871377|538177744|FG002|Third Intervention (10 Weeks)|Death|0|||
149193118|NCT00871377|538177745|FG003|Third Intervention (10 Weeks)|Death|1|||
149193119|NCT00871377|538177746|FG004|Third Intervention (10 Weeks)|Death|0|||
149193120|NCT00871377|538177747|FG005|Third Intervention (10 Weeks)|Death|0|||
149193121|NCT02179515|538177752|FG000|Overall Study|switched to alternative treatment|0|||
149193122|NCT02179515|538177753|FG001|Overall Study|switched to alternative treatment|1|||
149193123|NCT02179515|538177754|FG002|Overall Study|switched to alternative treatment|1|||
149193124|NCT02179515|538177752|FG000|Overall Study|Death|0|||
149193125|NCT02179515|538177753|FG001|Overall Study|Death|1|||
149193126|NCT02179515|538177754|FG002|Overall Study|Death|1|||
149193127|NCT02179515|538177752|FG000|Overall Study|refused further treatment|0|||
149193128|NCT02179515|538177753|FG001|Overall Study|refused further treatment|3|||
149193129|NCT02179515|538177754|FG002|Overall Study|refused further treatment|4|||
149193130|NCT02179515|538177752|FG000|Overall Study|Disease progression on study|2|||
149193131|NCT02179515|538177753|FG001|Overall Study|Disease progression on study|11|||
149193132|NCT02179515|538177754|FG002|Overall Study|Disease progression on study|8|||
149193133|NCT02116660|538177755|FG000|Overall Study|Deteriorating renal function|0|||
149193134|NCT02116660|538177756|FG001|Overall Study|Deteriorating renal function|1|||
149193135|NCT02116660|538177755|FG000|Overall Study|Adverse Event|1|||
149193136|NCT02116660|538177756|FG001|Overall Study|Adverse Event|1|||
149193137|NCT02116660|538177755|FG000|Overall Study|Withdrawal by Subject|0|||
149193138|NCT02116660|538177756|FG001|Overall Study|Withdrawal by Subject|2|||
149193139|NCT02116660|538177755|FG000|Overall Study|Organization reason|1|||
149193140|NCT02116660|538177756|FG001|Overall Study|Organization reason|0|||
149193141|NCT01718509|538177757|FG000|Overall Study|Lost to Follow-up|18|||
149193142|NCT01718509|538177758|FG001|Overall Study|Lost to Follow-up|15|||
149193143|NCT01718509|538177757|FG000|Overall Study|Withdrawal by Subject|7|||
149193144|NCT01718509|538177758|FG001|Overall Study|Withdrawal by Subject|13|||
149193145|NCT01718509|538177757|FG000|Overall Study|Adverse Event|5|||
149193146|NCT01718509|538177758|FG001|Overall Study|Adverse Event|7|||
149193147|NCT01718509|538177757|FG000|Overall Study|Other|13|||
149193148|NCT01718509|538177758|FG001|Overall Study|Other|11|||
149193149|NCT01718509|538177757|FG000|Overall Study|Protocol Violation|4|||
149193150|NCT01718509|538177758|FG001|Overall Study|Protocol Violation|2|||
149193151|NCT01718509|538177757|FG000|Overall Study|Lack of Efficacy|1|||
149193152|NCT01718509|538177758|FG001|Overall Study|Lack of Efficacy|0|||
149193153|NCT02561299|538177759|FG000|Overall Study|Death|2|||
149193154|NCT02561299|538177760|FG001|Overall Study|Death|4|||
149193155|NCT02561299|538177759|FG000|Overall Study|Lost to Follow-up|1|||
149193156|NCT02561299|538177760|FG001|Overall Study|Lost to Follow-up|0|||
149193157|NCT02561299|538177759|FG000|Overall Study|Withdrawal by Subject|2|||
149193158|NCT02561299|538177760|FG001|Overall Study|Withdrawal by Subject|2|||
149193159|NCT05906732|538177761|FG000|Overall Study|Withdrawal by Subject|1|||
149193160|NCT05906732|538177762|FG001|Overall Study|Withdrawal by Subject|0|||
149193161|NCT05906732|538177763|FG002|Overall Study|Withdrawal by Subject|0|||
149193162|NCT05906732|538177764|FG003|Overall Study|Withdrawal by Subject|0|||
149193163|NCT05906732|538177761|FG000|Overall Study|Physician Decision|2|||
149193164|NCT05906732|538177762|FG001|Overall Study|Physician Decision|4|||
149193165|NCT05906732|538177763|FG002|Overall Study|Physician Decision|0|||
149193166|NCT05906732|538177764|FG003|Overall Study|Physician Decision|0|||
149193167|NCT02052778|538177765|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
149193168|NCT02052778|538177766|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
149193169|NCT02052778|538177767|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
149193170|NCT02052778|538177768|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
149193171|NCT02052778|538177769|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
149193172|NCT02052778|538177770|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
149193173|NCT02052778|538177771|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193174|NCT02052778|538177772|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
149193175|NCT02052778|538177773|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
149193176|NCT02052778|538177774|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
149193177|NCT02052778|538177775|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
149193178|NCT02052778|538177776|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
149193179|NCT02052778|538177777|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
149193180|NCT02052778|538177778|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
149193181|NCT02052778|538177779|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193182|NCT02052778|538177780|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193183|NCT02052778|538177781|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
148935525|NCT01543698|537249404|FG011|Phase 1b|Protocol Violation|0|||
148935526|NCT01543698|537249405|FG012|Phase 1b|Protocol Violation|0|||
148935527|NCT01543698|537249406|FG013|Phase 1b|Protocol Violation|0|||
149193184|NCT02052778|538177782|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193185|NCT02052778|538177783|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193186|NCT02052778|538177784|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193187|NCT02052778|538177785|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193188|NCT02052778|538177786|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193189|NCT02052778|538177787|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
149193190|NCT02052778|538177765|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
148935528|NCT01543698|537249407|FG014|Phase 1b|Protocol Violation|0|||
148935529|NCT01543698|537249393|FG000|Phase 2|Protocol Violation|0|||
149014882|NCT01275196|537534310|FG000|Overall Study|Suboptimal response/treatment failure|5|||
149014883|NCT01275196|537534311|FG001|Overall Study|Suboptimal response/treatment failure|6|||
149014884|NCT01027364|537534312|FG000|Overall Study|Adverse Event|1|||
149014885|NCT01027364|537534313|FG001|Overall Study|Adverse Event|0|||
149014886|NCT01027364|537534314|FG002|Overall Study|Adverse Event|1|||
149014887|NCT01027364|537534315|FG003|Overall Study|Adverse Event|0|||
149014888|NCT01027364|537534312|FG000|Overall Study|Lost to Follow-up|1|||
149014889|NCT01027364|537534313|FG001|Overall Study|Lost to Follow-up|0|||
149014890|NCT01027364|537534314|FG002|Overall Study|Lost to Follow-up|0|||
149014891|NCT01027364|537534315|FG003|Overall Study|Lost to Follow-up|0|||
149014892|NCT01027364|537534312|FG000|Overall Study|Protocol Violation|1|||
149014893|NCT01027364|537534313|FG001|Overall Study|Protocol Violation|0|||
149014894|NCT01027364|537534314|FG002|Overall Study|Protocol Violation|0|||
149014895|NCT01027364|537534315|FG003|Overall Study|Protocol Violation|1|||
149014896|NCT01027364|537534312|FG000|Overall Study|Withdrawal by Subject|1|||
149014897|NCT01027364|537534313|FG001|Overall Study|Withdrawal by Subject|2|||
149014898|NCT01027364|537534314|FG002|Overall Study|Withdrawal by Subject|0|||
149014899|NCT01027364|537534315|FG003|Overall Study|Withdrawal by Subject|0|||
149014900|NCT00684762|537534318|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
149014901|NCT00684762|537534319|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
149014902|NCT02572817|537534320|FG000|Overall Study|Death|6|||
149014903|NCT02572817|537534321|FG001|Overall Study|Death|3|||
149014904|NCT02572817|537534320|FG000|Overall Study|Lost to Follow-up|3|||
149014905|NCT02572817|537534321|FG001|Overall Study|Lost to Follow-up|3|||
149014906|NCT02310126|537534325|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
149014907|NCT02310126|537534326|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
149014908|NCT02310126|537534325|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
149014909|NCT02310126|537534326|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
149014910|NCT02441946|537534327|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
149014911|NCT02441946|537534328|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
149014912|NCT02441946|537534329|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
149014913|NCT02441946|537534327|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
149014914|NCT02441946|537534328|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
149014915|NCT02441946|537534329|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
149014916|NCT02441946|537534327|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
149014917|NCT02441946|537534328|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
149014918|NCT02441946|537534329|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
149014919|NCT02441946|537534327|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
149014920|NCT02441946|537534328|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
149014921|NCT02441946|537534329|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
149014922|NCT02441946|537534327|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
149014923|NCT02441946|537534328|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
149193191|NCT02052778|538177766|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149193192|NCT02052778|538177767|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149193193|NCT02052778|538177768|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149193194|NCT02052778|538177769|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149193195|NCT02052778|538177770|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149193196|NCT02052778|538177771|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
149193197|NCT02052778|538177772|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149193198|NCT02052778|538177773|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
149193199|NCT02052778|538177774|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193200|NCT02052778|538177775|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193201|NCT02052778|538177776|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149193202|NCT02052778|538177777|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
149193203|NCT02052778|538177778|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
149193204|NCT02052778|538177779|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193205|NCT02052778|538177780|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193206|NCT02052778|538177781|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193207|NCT02052778|538177782|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193208|NCT02052778|538177783|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193209|NCT02052778|538177784|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193210|NCT02052778|538177785|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193211|NCT02052778|538177786|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149193212|NCT02052778|538177787|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
149014924|NCT02441946|537534329|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
149014925|NCT02441946|537534327|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
149014926|NCT02441946|537534328|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
149014927|NCT02441946|537534329|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
148935530|NCT01543698|537249394|FG001|Phase 2|Protocol Violation|0|||
149193213|NCT02052778|538177765|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193214|NCT02052778|538177766|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193215|NCT02052778|538177767|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193216|NCT02052778|538177768|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193217|NCT02052778|538177769|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193218|NCT02052778|538177770|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193219|NCT02052778|538177771|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193220|NCT02052778|538177772|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193221|NCT02052778|538177773|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193222|NCT02052778|538177774|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193223|NCT02052778|538177775|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193224|NCT02052778|538177776|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193225|NCT02052778|538177777|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193226|NCT02052778|538177778|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
149193227|NCT02052778|538177779|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193228|NCT02052778|538177780|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193229|NCT02052778|538177781|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193230|NCT02052778|538177782|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193231|NCT02052778|538177783|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193232|NCT02052778|538177784|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193233|NCT02052778|538177785|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193234|NCT02052778|538177786|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193235|NCT02052778|538177787|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
149193236|NCT02052778|538177765|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
149193237|NCT02052778|538177766|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
149193238|NCT02052778|538177767|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
149193239|NCT02052778|538177768|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
149193240|NCT02052778|538177769|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
149193241|NCT02052778|538177770|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
149193242|NCT02052778|538177771|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
149193243|NCT02052778|538177772|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
149193244|NCT02052778|538177773|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
149193245|NCT02052778|538177774|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
149193246|NCT02052778|538177775|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
149193247|NCT02052778|538177776|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
149193248|NCT02052778|538177777|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
149193249|NCT02052778|538177778|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
149193250|NCT02052778|538177779|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
149193251|NCT02052778|538177780|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
149193252|NCT02052778|538177781|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
149193253|NCT02052778|538177782|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
149193254|NCT02052778|538177783|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
149193255|NCT02052778|538177784|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
149193256|NCT02052778|538177785|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
149193257|NCT02052778|538177786|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
149193258|NCT02052778|538177787|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
149193259|NCT02052778|538177765|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193260|NCT02052778|538177766|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193261|NCT02052778|538177767|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193262|NCT02052778|538177768|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193263|NCT02052778|538177769|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193264|NCT02052778|538177770|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
148935531|NCT01543698|537249395|FG002|Phase 2|Protocol Violation|0|||
149193265|NCT02052778|538177771|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193266|NCT02052778|538177772|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
148935532|NCT01543698|537249396|FG003|Phase 2|Protocol Violation|0|||
148935533|NCT01543698|537249397|FG004|Phase 2|Protocol Violation|0|||
148935534|NCT01543698|537249398|FG005|Phase 2|Protocol Violation|0|||
149193267|NCT02052778|538177773|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
149193268|NCT02052778|538177774|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193269|NCT02052778|538177775|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193270|NCT02052778|538177776|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
148935535|NCT01543698|537249399|FG006|Phase 2|Protocol Violation|0|||
148935536|NCT01543698|537249400|FG007|Phase 2|Protocol Violation|0|||
148807667|NCT01035138|536773347|FG001|Overall Study|Sponsor Decision|60|||
148935537|NCT01543698|537249401|FG008|Phase 2|Protocol Violation|0|||
148935538|NCT01543698|537249402|FG009|Phase 2|Protocol Violation|0|||
148935539|NCT01543698|537249403|FG010|Phase 2|Protocol Violation|0|||
148935540|NCT01543698|537249404|FG011|Phase 2|Protocol Violation|0|||
148935541|NCT01543698|537249405|FG012|Phase 2|Protocol Violation|1|||
148935542|NCT01543698|537249406|FG013|Phase 2|Protocol Violation|0|||
148935543|NCT01543698|537249407|FG014|Phase 2|Protocol Violation|0|||
148935544|NCT01543698|537249393|FG000|Phase 2|Disease progression|0|||
148935545|NCT01543698|537249394|FG001|Phase 2|Disease progression|0|||
148935546|NCT01543698|537249395|FG002|Phase 2|Disease progression|0|||
148935547|NCT01543698|537249396|FG003|Phase 2|Disease progression|0|||
148935548|NCT01543698|537249397|FG004|Phase 2|Disease progression|0|||
148935549|NCT01543698|537249398|FG005|Phase 2|Disease progression|0|||
148935550|NCT01543698|537249399|FG006|Phase 2|Disease progression|0|||
148935551|NCT01543698|537249400|FG007|Phase 2|Disease progression|0|||
148935552|NCT01543698|537249401|FG008|Phase 2|Disease progression|0|||
148935553|NCT01543698|537249402|FG009|Phase 2|Disease progression|0|||
148935554|NCT01543698|537249403|FG010|Phase 2|Disease progression|0|||
148935555|NCT01543698|537249404|FG011|Phase 2|Disease progression|10|||
148935556|NCT01543698|537249405|FG012|Phase 2|Disease progression|21|||
148935557|NCT01543698|537249406|FG013|Phase 2|Disease progression|30|||
148935558|NCT01543698|537249407|FG014|Phase 2|Disease progression|25|||
148935559|NCT01543698|537249393|FG000|Phase 2|Death|0|||
148935560|NCT01543698|537249394|FG001|Phase 2|Death|0|||
148935561|NCT01543698|537249395|FG002|Phase 2|Death|0|||
148935562|NCT01543698|537249396|FG003|Phase 2|Death|0|||
148935563|NCT01543698|537249397|FG004|Phase 2|Death|0|||
148935564|NCT01543698|537249398|FG005|Phase 2|Death|0|||
148935565|NCT01543698|537249399|FG006|Phase 2|Death|0|||
148935566|NCT01543698|537249400|FG007|Phase 2|Death|0|||
148935567|NCT01543698|537249401|FG008|Phase 2|Death|0|||
148935568|NCT01543698|537249402|FG009|Phase 2|Death|0|||
148935569|NCT01543698|537249403|FG010|Phase 2|Death|0|||
148935570|NCT01543698|537249404|FG011|Phase 2|Death|0|||
148935571|NCT01543698|537249405|FG012|Phase 2|Death|1|||
148935572|NCT01543698|537249406|FG013|Phase 2|Death|1|||
148935573|NCT01543698|537249407|FG014|Phase 2|Death|1|||
148935574|NCT01543698|537249393|FG000|Phase 2|Administrative problems|0|||
148935575|NCT01543698|537249394|FG001|Phase 2|Administrative problems|0|||
148935576|NCT01543698|537249395|FG002|Phase 2|Administrative problems|0|||
148935577|NCT01543698|537249396|FG003|Phase 2|Administrative problems|0|||
148935578|NCT01543698|537249397|FG004|Phase 2|Administrative problems|0|||
148935579|NCT01543698|537249398|FG005|Phase 2|Administrative problems|0|||
148935580|NCT01543698|537249399|FG006|Phase 2|Administrative problems|0|||
148935581|NCT01543698|537249400|FG007|Phase 2|Administrative problems|0|||
148935582|NCT01543698|537249401|FG008|Phase 2|Administrative problems|0|||
148935583|NCT01543698|537249402|FG009|Phase 2|Administrative problems|0|||
148935584|NCT01543698|537249403|FG010|Phase 2|Administrative problems|0|||
148935585|NCT01543698|537249404|FG011|Phase 2|Administrative problems|0|||
148935586|NCT01543698|537249405|FG012|Phase 2|Administrative problems|0|||
148935587|NCT01543698|537249406|FG013|Phase 2|Administrative problems|3|||
148935588|NCT01543698|537249407|FG014|Phase 2|Administrative problems|1|||
148935589|NCT01543698|537249393|FG000|Phase 2|Withdrawal by Subject|0|||
148935590|NCT01543698|537249394|FG001|Phase 2|Withdrawal by Subject|0|||
148935591|NCT01543698|537249395|FG002|Phase 2|Withdrawal by Subject|0|||
148935592|NCT01543698|537249396|FG003|Phase 2|Withdrawal by Subject|0|||
148935593|NCT01543698|537249397|FG004|Phase 2|Withdrawal by Subject|0|||
148935594|NCT01543698|537249398|FG005|Phase 2|Withdrawal by Subject|0|||
148935595|NCT01543698|537249399|FG006|Phase 2|Withdrawal by Subject|0|||
148935596|NCT01543698|537249400|FG007|Phase 2|Withdrawal by Subject|0|||
148935597|NCT01543698|537249401|FG008|Phase 2|Withdrawal by Subject|0|||
148935598|NCT01543698|537249402|FG009|Phase 2|Withdrawal by Subject|0|||
148935599|NCT01543698|537249403|FG010|Phase 2|Withdrawal by Subject|0|||
148935600|NCT01543698|537249404|FG011|Phase 2|Withdrawal by Subject|0|||
148935601|NCT01543698|537249405|FG012|Phase 2|Withdrawal by Subject|0|||
148935602|NCT01543698|537249406|FG013|Phase 2|Withdrawal by Subject|3|||
148935603|NCT01543698|537249407|FG014|Phase 2|Withdrawal by Subject|1|||
148935604|NCT01543698|537249393|FG000|Phase 2|Adverse Event|0|||
148935605|NCT01543698|537249394|FG001|Phase 2|Adverse Event|0|||
148935606|NCT01543698|537249395|FG002|Phase 2|Adverse Event|0|||
148935607|NCT01543698|537249396|FG003|Phase 2|Adverse Event|0|||
148935608|NCT01543698|537249397|FG004|Phase 2|Adverse Event|0|||
148935609|NCT01543698|537249398|FG005|Phase 2|Adverse Event|0|||
148935610|NCT01543698|537249399|FG006|Phase 2|Adverse Event|0|||
148935611|NCT01543698|537249400|FG007|Phase 2|Adverse Event|0|||
148935612|NCT01543698|537249401|FG008|Phase 2|Adverse Event|0|||
148935613|NCT01543698|537249402|FG009|Phase 2|Adverse Event|0|||
148935614|NCT01543698|537249403|FG010|Phase 2|Adverse Event|0|||
149193271|NCT02052778|538177777|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193272|NCT02052778|538177778|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
149193273|NCT02052778|538177779|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193274|NCT02052778|538177780|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193275|NCT02052778|538177781|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193276|NCT02052778|538177782|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193277|NCT02052778|538177783|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193278|NCT02052778|538177784|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193279|NCT02052778|538177785|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193280|NCT02052778|538177786|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193281|NCT02052778|538177787|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
149193282|NCT02052778|538177765|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193283|NCT02052778|538177766|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193284|NCT02052778|538177767|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193285|NCT02052778|538177768|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193286|NCT02052778|538177769|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193287|NCT02052778|538177770|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
149193288|NCT02052778|538177771|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193289|NCT02052778|538177772|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193290|NCT02052778|538177773|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193291|NCT02052778|538177774|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193292|NCT02052778|538177775|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193293|NCT02052778|538177776|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193294|NCT02052778|538177777|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
149193295|NCT02052778|538177778|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193296|NCT02052778|538177779|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193297|NCT02052778|538177780|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193298|NCT02052778|538177781|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193299|NCT02052778|538177782|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193300|NCT02052778|538177783|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193301|NCT02052778|538177784|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193302|NCT02052778|538177785|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193303|NCT02052778|538177786|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193304|NCT02052778|538177787|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
149193305|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193306|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193307|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193308|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193309|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193310|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
148935615|NCT01543698|537249404|FG011|Phase 2|Adverse Event|1|||
148681915|NCT01335399|536309375|FG000|Treatment Period|Consent withdrawal|10|||
148681916|NCT01335399|536309376|FG001|Treatment Period|Consent withdrawal|7|||
148681917|NCT01335399|536309375|FG000|Treatment Period|Death|7|||
148935616|NCT01543698|537249405|FG012|Phase 2|Adverse Event|3|||
148935617|NCT01543698|537249406|FG013|Phase 2|Adverse Event|5|||
148935618|NCT01543698|537249407|FG014|Phase 2|Adverse Event|14|||
149014928|NCT02441946|537534327|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
149014929|NCT02441946|537534328|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
148935619|NCT00217620|537249408|FG000|Overall Study|Adverse Event|2|||
148935620|NCT00217620|537249408|FG000|Overall Study|Progression|31|||
148935621|NCT00217620|537249408|FG000|Overall Study|Not Protocol Specified|4|||
149193311|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193312|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193313|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193314|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193315|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193316|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
148681918|NCT01335399|536309376|FG001|Treatment Period|Death|6|||
148681919|NCT01335399|536309375|FG000|Treatment Period|Poor/Non-compliance|3|||
148681920|NCT01335399|536309376|FG001|Treatment Period|Poor/Non-compliance|4|||
148681921|NCT01335399|536309375|FG000|Treatment Period|Lost to Follow-up|2|||
148681922|NCT01335399|536309376|FG001|Treatment Period|Lost to Follow-up|2|||
148681923|NCT01335399|536309375|FG000|Treatment Period|Maximum clinical benefit|1|||
148681924|NCT01335399|536309376|FG001|Treatment Period|Maximum clinical benefit|1|||
148935622|NCT00217620|537249408|FG000|Overall Study|Ineligible|13|||
148935623|NCT00217620|537249408|FG000|Overall Study|Never received treatment|1|||
149193317|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193318|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193319|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
149193320|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
149193321|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
149193322|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
149193323|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
149193324|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
149193325|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
149193326|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
149193327|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
149193328|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193329|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193330|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193331|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
148935624|NCT01863953|537249417|FG000|Overall Study|Adverse Event|0|||
148935625|NCT01863953|537249418|FG001|Overall Study|Adverse Event|0|||
148681925|NCT01335399|536309375|FG000|Treatment Period|No longer meet study criteria|1|||
148681926|NCT01335399|536309376|FG001|Treatment Period|No longer meet study criteria|1|||
148681927|NCT01335399|536309375|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
148681928|NCT01335399|536309376|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
148935626|NCT01863953|537249419|FG002|Overall Study|Adverse Event|1|||
148935627|NCT02008318|537249422|FG000|Overall Study|Adverse Event|4|||
148935628|NCT02008318|537249423|FG001|Overall Study|Adverse Event|0|||
149193332|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
148935629|NCT02008318|537249422|FG000|Overall Study|Physician Decision|2|||
148935630|NCT02008318|537249423|FG001|Overall Study|Physician Decision|0|||
148935631|NCT02008318|537249422|FG000|Overall Study|Progressive Disease|2|||
148935632|NCT02008318|537249423|FG001|Overall Study|Progressive Disease|0|||
148935633|NCT02008318|537249422|FG000|Overall Study|Protocol Violation|1|||
148935634|NCT02008318|537249423|FG001|Overall Study|Protocol Violation|1|||
148935635|NCT02008318|537249422|FG000|Overall Study|Withdrawal by Subject|3|||
148935636|NCT02008318|537249423|FG001|Overall Study|Withdrawal by Subject|0|||
148935637|NCT00573183|537249424|FG000|Overall Study|Lost to Follow-up|52|||
149193333|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193334|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193335|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193336|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193337|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193338|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193339|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193340|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193341|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193342|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
149193343|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
149193344|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193345|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
149193346|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
149193347|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
149193348|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
149193349|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
149193350|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
149193351|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193352|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193353|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193354|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193355|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193356|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193357|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193358|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193359|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193360|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193361|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193362|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193363|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193364|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193365|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
149193366|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
148935638|NCT00573183|537249425|FG001|Overall Study|Lost to Follow-up|50|||
148935639|NCT00573183|537249424|FG000|Overall Study|Withdrawal by Subject|8|||
148935640|NCT00573183|537249425|FG001|Overall Study|Withdrawal by Subject|2|||
148935641|NCT00573183|537249424|FG000|Overall Study|Death|0|||
148935642|NCT00573183|537249425|FG001|Overall Study|Death|1|||
148935643|NCT00573183|537249424|FG000|Overall Study|Adverse Event|2|||
148935644|NCT00573183|537249425|FG001|Overall Study|Adverse Event|0|||
148935645|NCT00573183|537249424|FG000|Overall Study|Incarceration|5|||
148935646|NCT00573183|537249425|FG001|Overall Study|Incarceration|8|||
148935647|NCT00573183|537249424|FG000|Overall Study|Other|5|||
148935648|NCT00573183|537249425|FG001|Overall Study|Other|2|||
148935649|NCT05439941|537249426|FG000|Overall Study|Lack of Efficacy|8|||
148935650|NCT05439941|537249427|FG001|Overall Study|Lack of Efficacy|5|||
148935651|NCT05439941|537249428|FG002|Overall Study|Lack of Efficacy|3|||
148935652|NCT05439941|537249426|FG000|Overall Study|Treatment Failure|0|||
148935653|NCT05439941|537249427|FG001|Overall Study|Treatment Failure|1|||
148935654|NCT05439941|537249428|FG002|Overall Study|Treatment Failure|0|||
148935655|NCT05439941|537249426|FG000|Overall Study|Adverse Event|1|||
148935656|NCT05439941|537249427|FG001|Overall Study|Adverse Event|3|||
148935657|NCT05439941|537249428|FG002|Overall Study|Adverse Event|0|||
148935658|NCT05439941|537249426|FG000|Overall Study|Adverse Event - Parent Study|1|||
148935659|NCT05439941|537249427|FG001|Overall Study|Adverse Event - Parent Study|0|||
148935660|NCT05439941|537249428|FG002|Overall Study|Adverse Event - Parent Study|0|||
148935661|NCT05439941|537249426|FG000|Overall Study|Pregnancy|1|||
148935662|NCT05439941|537249427|FG001|Overall Study|Pregnancy|0|||
148935663|NCT05439941|537249428|FG002|Overall Study|Pregnancy|0|||
148935664|NCT05439941|537249426|FG000|Overall Study|Withdrawal by Subject|9|||
148935665|NCT05439941|537249427|FG001|Overall Study|Withdrawal by Subject|6|||
149193367|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
148681929|NCT03990389|536309377|FG000|Overall Study|Lost to Follow-up|3|||
148681930|NCT03990389|536309378|FG001|Overall Study|Lost to Follow-up|0|||
148681931|NCT03770000|536309380|FG000|Overall Study|Premature discontinuation due to PD|0|||
148681932|NCT03770000|536309381|FG001|Overall Study|Premature discontinuation due to PD|0|||
148681933|NCT03770000|536309382|FG002|Overall Study|Premature discontinuation due to PD|1|||
148681934|NCT03770000|536309383|FG003|Overall Study|Premature discontinuation due to PD|3|||
148681935|NCT03770000|536309384|FG004|Overall Study|Premature discontinuation due to PD|2|||
148681936|NCT02595528|536309385|FG000|Overall Study|Withdrawal by Subject|1|||
148681937|NCT02595528|536309386|FG001|Overall Study|Withdrawal by Subject|2|||
148681938|NCT02595528|536309387|FG002|Overall Study|Withdrawal by Subject|1|||
148681939|NCT02595528|536309388|FG003|Overall Study|Withdrawal by Subject|3|||
149193368|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193369|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
149193370|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
149193371|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193372|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193373|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
149193374|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193375|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193376|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193377|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193378|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193379|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193380|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193381|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193382|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193383|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193384|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193385|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193386|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193387|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193388|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
149193389|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
149193390|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193391|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193392|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193393|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193394|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193395|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193396|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
149193397|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193398|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193399|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193400|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193401|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193402|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193403|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193404|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193405|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193406|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193407|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193408|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193409|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
148681940|NCT02595528|536309385|FG000|Overall Study|Lost to Follow-up|1|||
148681941|NCT02595528|536309386|FG001|Overall Study|Lost to Follow-up|1|||
148681942|NCT02595528|536309387|FG002|Overall Study|Lost to Follow-up|0|||
148681943|NCT02595528|536309388|FG003|Overall Study|Lost to Follow-up|1|||
148681944|NCT03202511|536309389|FG000|Overall Study|Withdrawal by Subject|1|||
148681945|NCT03202511|536309390|FG001|Overall Study|Withdrawal by Subject|0|||
148681946|NCT00686790|536309391|FG000|Overall Study|Adverse Event|2|||
148681947|NCT00686790|536309391|FG000|Overall Study|Withdrawal by Subject|1|||
148681948|NCT00686790|536309391|FG000|Overall Study|Death|1|||
148681949|NCT00686790|536309391|FG000|Overall Study|Lost to Follow-up|12|||
148681950|NCT00096382|536309392|FG000|Overall Study|Not treated|1|||
148681951|NCT00096382|536309393|FG001|Overall Study|Not treated|0|||
148935666|NCT05439941|537249428|FG002|Overall Study|Withdrawal by Subject|10|||
148935667|NCT05439941|537249426|FG000|Overall Study|Non-Compliance|1|||
148935668|NCT05439941|537249427|FG001|Overall Study|Non-Compliance|1|||
148935669|NCT05439941|537249428|FG002|Overall Study|Non-Compliance|1|||
148935670|NCT05439941|537249426|FG000|Overall Study|Lost to Follow-up|2|||
148935671|NCT05439941|537249427|FG001|Overall Study|Lost to Follow-up|2|||
148935672|NCT05439941|537249428|FG002|Overall Study|Lost to Follow-up|0|||
148935673|NCT05439941|537249426|FG000|Overall Study|Physician Decision|1|||
148935674|NCT05439941|537249427|FG001|Overall Study|Physician Decision|0|||
148935675|NCT05439941|537249428|FG002|Overall Study|Physician Decision|0|||
148935676|NCT05439941|537249426|FG000|Overall Study|Trial Termination by Sponsor|78|||
148935677|NCT05439941|537249427|FG001|Overall Study|Trial Termination by Sponsor|83|||
148935678|NCT05439941|537249428|FG002|Overall Study|Trial Termination by Sponsor|65|||
148935679|NCT05439941|537249426|FG000|Overall Study|Other than Reasons Listed|2|||
148935680|NCT05439941|537249427|FG001|Overall Study|Other than Reasons Listed|1|||
148935681|NCT05439941|537249428|FG002|Overall Study|Other than Reasons Listed|0|||
148935682|NCT02336373|537249429|FG000|Overall Study|Protocol closed early|4|||
148935683|NCT02336373|537249429|FG000|Overall Study|Physician Decision|14|||
148935684|NCT01364649|537249432|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
148935685|NCT01364649|537249433|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
148935686|NCT01364649|537249432|FG000|Overall Study|Lack of Efficacy|6|||
148935687|NCT01364649|537249433|FG001|Overall Study|Lack of Efficacy|0|||
148935688|NCT01364649|537249432|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
148935689|NCT01364649|537249433|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
148935690|NCT01364649|537249432|FG000|Overall Study|Protocol Deviations|4|||
148935691|NCT01364649|537249433|FG001|Overall Study|Protocol Deviations|8|||
148935692|NCT01364649|537249432|FG000|Overall Study|Withdrawal of Consent|9|||
148935693|NCT01364649|537249433|FG001|Overall Study|Withdrawal of Consent|7|||
148935694|NCT01364649|537249432|FG000|Overall Study|Lost to Follow-up|12|||
148935695|NCT01364649|537249433|FG001|Overall Study|Lost to Follow-up|13|||
148935696|NCT01364649|537249432|FG000|Overall Study|Other|4|||
148935697|NCT01364649|537249433|FG001|Overall Study|Other|1|||
148935698|NCT00902668|537249434|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
148935699|NCT01788046|537249435|FG000|Overall Study|Withdrawal by Subject|12|||
148935700|NCT01788046|537249436|FG001|Overall Study|Withdrawal by Subject|12|||
148935701|NCT01788046|537249435|FG000|Overall Study|Lost to Follow-up|12|||
148935702|NCT01788046|537249436|FG001|Overall Study|Lost to Follow-up|19|||
148935703|NCT01788046|537249435|FG000|Overall Study|Death|7|||
148935704|NCT01788046|537249436|FG001|Overall Study|Death|5|||
148935705|NCT01788046|537249435|FG000|Overall Study|Protocol Specified Criteria|25|||
148935706|NCT01788046|537249436|FG001|Overall Study|Protocol Specified Criteria|1|||
148935707|NCT01797731|537249437|FG000|Overall Study|Didn't have proper radiographs required|3|||
148935708|NCT01797731|537249438|FG001|Overall Study|Didn't have proper radiographs required|3|||
148935709|NCT00091442|537249440|FG000|Overall Study|Progressive Disease|220|||
148935710|NCT00091442|537249441|FG001|Overall Study|Progressive Disease|189|||
148935711|NCT00091442|537249440|FG000|Overall Study|Physician Decision|61|||
148935712|NCT00091442|537249441|FG001|Overall Study|Physician Decision|58|||
148935713|NCT00091442|537249440|FG000|Overall Study|Withdrawal by Subject|38|||
148935714|NCT00091442|537249441|FG001|Overall Study|Withdrawal by Subject|46|||
148935715|NCT00091442|537249440|FG000|Overall Study|Adverse Event|29|||
148935716|NCT00091442|537249441|FG001|Overall Study|Adverse Event|48|||
148935717|NCT00091442|537249440|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
148935718|NCT00091442|537249441|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
148935719|NCT00091442|537249440|FG000|Overall Study|Death|9|||
148935720|NCT00091442|537249441|FG001|Overall Study|Death|7|||
148935721|NCT00091442|537249440|FG000|Overall Study|Lost to Follow-up|1|||
148935722|NCT00091442|537249441|FG001|Overall Study|Lost to Follow-up|3|||
148935723|NCT00091442|537249440|FG000|Overall Study|Other|2|||
148935724|NCT00091442|537249441|FG001|Overall Study|Other|6|||
148935725|NCT00917501|537249442|FG000|Overall Study|Lost to Follow-up|4|||
148935726|NCT00917501|537249443|FG001|Overall Study|Lost to Follow-up|1|||
148935727|NCT00917501|537249442|FG000|Overall Study|Withdrawal by Subject|3|||
149193410|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193411|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
149193412|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
148935728|NCT00917501|537249443|FG001|Overall Study|Withdrawal by Subject|1|||
148935729|NCT00917501|537249442|FG000|Overall Study|Lack of Efficacy|1|||
148935730|NCT00917501|537249443|FG001|Overall Study|Lack of Efficacy|2|||
148935731|NCT00917501|537249442|FG000|Overall Study|trouble swollowing capsules|0|||
148935732|NCT00917501|537249443|FG001|Overall Study|trouble swollowing capsules|1|||
149014930|NCT02441946|537534329|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
148935733|NCT00986830|537249448|FG000|Overall Study|Death|1|||
148935734|NCT00986830|537249448|FG000|Overall Study|Lost to Follow-up|1|||
148935735|NCT00986830|537249448|FG000|Overall Study|Lack of Efficacy|1|||
148935736|NCT00986830|537249448|FG000|Overall Study|Unable to access sinus with device|5|||
148935737|NCT01495975|537249449|FG000|Overall Study|Lost to Follow-up|1|||
148935738|NCT01495975|537249450|FG001|Overall Study|Lost to Follow-up|0|||
149193413|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193414|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193415|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193416|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
149193417|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193418|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193419|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
149193420|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
149193421|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
149193422|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
149193423|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
149193424|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
149193425|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
149193426|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
149193427|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
149193428|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
149193429|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
149193430|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
149193431|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
149193432|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
149193433|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
149193434|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
149193435|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
149193436|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
149193437|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
149193438|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
149193439|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
149193440|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
149193441|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
149193442|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
149193443|NCT02052778|538177765|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193444|NCT02052778|538177766|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193445|NCT02052778|538177767|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193446|NCT02052778|538177768|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193447|NCT02052778|538177769|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193448|NCT02052778|538177770|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193449|NCT02052778|538177771|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193450|NCT02052778|538177772|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193451|NCT02052778|538177773|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193452|NCT02052778|538177774|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193453|NCT02052778|538177775|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193454|NCT02052778|538177776|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193455|NCT02052778|538177777|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193456|NCT02052778|538177778|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193457|NCT02052778|538177779|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149193458|NCT02052778|538177780|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
148807668|NCT01035138|536773348|FG002|Overall Study|Sponsor Decision|42|||
149193459|NCT02052778|538177781|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149193460|NCT02052778|538177782|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193461|NCT02052778|538177783|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
149193462|NCT02052778|538177784|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193463|NCT02052778|538177785|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193464|NCT02052778|538177786|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193465|NCT02052778|538177787|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
149193466|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193467|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193468|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193469|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193470|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193471|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193472|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193473|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193474|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193475|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193476|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193477|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193478|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193479|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193480|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193481|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193482|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193483|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193484|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193485|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193486|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193487|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
149193488|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
149193489|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193490|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193491|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193492|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193493|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193494|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193495|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193496|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193497|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193498|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193499|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193500|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193501|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193502|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193503|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193504|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193505|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193506|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193507|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193508|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193509|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193510|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
149193511|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
149193512|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193513|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193514|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193515|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193516|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193517|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193518|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193519|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193520|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193521|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193522|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149014931|NCT02441946|537534327|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
149193523|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193524|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193525|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193526|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193527|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193528|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193529|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193530|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193531|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193532|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193533|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
149193534|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
149193535|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193536|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193537|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193538|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193539|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193540|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193541|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193542|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193543|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193544|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193545|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193546|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193547|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
148681952|NCT00096382|536309392|FG000|Overall Study|Death during treatment|1|||
148681953|NCT00096382|536309393|FG001|Overall Study|Death during treatment|0|||
148681954|NCT00382291|536309394|FG000|Overall Study|Adverse Event|1|||
148681955|NCT00382291|536309395|FG001|Overall Study|Adverse Event|2|||
148681956|NCT00382291|536309396|FG002|Overall Study|Adverse Event|2|||
149193548|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193549|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193550|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193551|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193552|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193553|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193554|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193555|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193556|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
149193557|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
149193558|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193559|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193560|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193561|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193562|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193563|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193564|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193565|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193566|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193567|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193568|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193569|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193570|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193571|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193572|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193573|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193574|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193575|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193576|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193577|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
148681957|NCT00382291|536309394|FG000|Overall Study|Protocol Violation|1|||
148681958|NCT00382291|536309395|FG001|Overall Study|Protocol Violation|0|||
149193578|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
148681959|NCT00382291|536309396|FG002|Overall Study|Protocol Violation|0|||
148681960|NCT00382291|536309394|FG000|Overall Study|Temporary study suspension|2|||
149193579|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
149193580|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
149193581|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
149193582|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
149193583|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
149193584|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
149193585|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
149193586|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
149193587|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
149193588|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
149193589|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
149193590|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
149193591|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
149193592|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
149193593|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
149193594|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
149193595|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
149193596|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
149193597|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
149193598|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
149193599|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
149193600|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
149193601|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
149193602|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
149193603|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
149193604|NCT02052778|538177765|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193605|NCT02052778|538177766|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193606|NCT02052778|538177767|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193607|NCT02052778|538177768|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193608|NCT02052778|538177769|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193609|NCT02052778|538177770|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193610|NCT02052778|538177771|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193611|NCT02052778|538177772|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193612|NCT02052778|538177773|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193613|NCT02052778|538177774|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193614|NCT02052778|538177775|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193615|NCT02052778|538177776|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193616|NCT02052778|538177777|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193617|NCT02052778|538177778|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193618|NCT02052778|538177779|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193619|NCT02052778|538177780|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193620|NCT02052778|538177781|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193621|NCT02052778|538177782|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193622|NCT02052778|538177783|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193623|NCT02052778|538177784|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193624|NCT02052778|538177785|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193625|NCT02052778|538177786|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
149193626|NCT02052778|538177787|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
149193627|NCT02864940|538177794|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
149193628|NCT02864940|538177795|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
149193629|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
149193630|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
149193631|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
149193632|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
149193633|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
149193634|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
149193635|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
149193636|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
149193637|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
148935739|NCT00808483|537249453|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
148935740|NCT00808483|537249454|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
148935741|NCT00808483|537249453|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
149193638|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
149193639|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
149193640|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
149193641|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
149193642|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
149193643|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
149193644|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
148807669|NCT01035138|536773346|FG000|Overall Study|Lost to Follow-up|0|||
148807670|NCT01035138|536773347|FG001|Overall Study|Lost to Follow-up|0|||
149014932|NCT02441946|537534328|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
149014933|NCT02441946|537534329|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
149014934|NCT02441946|537534327|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
149014935|NCT02441946|537534328|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
149014936|NCT02441946|537534329|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
149014937|NCT02441946|537534327|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
149014938|NCT02441946|537534328|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
149014939|NCT02441946|537534329|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
149014940|NCT02441946|537534327|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
149014941|NCT02441946|537534328|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149014942|NCT02441946|537534329|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149014943|NCT00439179|537534330|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
149014944|NCT00439179|537534331|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
149014945|NCT00439179|537534332|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
149014946|NCT00439179|537534333|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
149014947|NCT01258660|537534336|FG000|Overall Study|Adverse Event|2|||
149014948|NCT01258660|537534337|FG001|Overall Study|Adverse Event|4|||
149014949|NCT01258660|537534336|FG000|Overall Study|Withdrawal by Subject|3|||
149014950|NCT01258660|537534337|FG001|Overall Study|Withdrawal by Subject|0|||
149014951|NCT01258660|537534336|FG000|Overall Study|due to relocation|2|||
149014952|NCT01258660|537534337|FG001|Overall Study|due to relocation|0|||
149014953|NCT01258660|537534336|FG000|Overall Study|Protocol Violation|0|||
149014954|NCT01258660|537534337|FG001|Overall Study|Protocol Violation|1|||
149014955|NCT01258660|537534336|FG000|Overall Study|Invalid for primary analysis data set|4|||
149014956|NCT01258660|537534337|FG001|Overall Study|Invalid for primary analysis data set|6|||
149014957|NCT04192630|537534340|FG000|Overall Study|Discontinued before surgery|2|||
148681961|NCT00382291|536309395|FG001|Overall Study|Temporary study suspension|2|||
148681962|NCT00382291|536309396|FG002|Overall Study|Temporary study suspension|5|||
149014958|NCT04192630|537534341|FG001|Overall Study|Discontinued before surgery|0|||
149014959|NCT04192630|537534340|FG000|Overall Study|Discontinued after surgery|5|||
149014960|NCT04192630|537534341|FG001|Overall Study|Discontinued after surgery|3|||
148681963|NCT00382291|536309394|FG000|Overall Study|Withdrawal by Subject|0|||
148681964|NCT00382291|536309395|FG001|Overall Study|Withdrawal by Subject|2|||
148681965|NCT00382291|536309396|FG002|Overall Study|Withdrawal by Subject|0|||
148681966|NCT00382291|536309394|FG000|Overall Study|Physician Decision|0|||
148681967|NCT00382291|536309395|FG001|Overall Study|Physician Decision|1|||
148681968|NCT00382291|536309396|FG002|Overall Study|Physician Decision|0|||
148681969|NCT00382291|536309394|FG000|Overall Study|Lack of Efficacy|0|||
148681970|NCT00382291|536309395|FG001|Overall Study|Lack of Efficacy|0|||
148807671|NCT01035138|536773348|FG002|Overall Study|Lost to Follow-up|1|||
148807672|NCT00848497|536773355|FG000|Overall Study|Screen failure|2|||
148807673|NCT00848497|536773356|FG001|Overall Study|Screen failure|0|||
148807674|NCT00848497|536773355|FG000|Overall Study|Withdrawal by Subject|0|||
148807675|NCT00848497|536773356|FG001|Overall Study|Withdrawal by Subject|1|||
149014961|NCT01193582|537534342|FG000|Vaccination Series|Withdrawal by Subject|11|||
149014962|NCT01193582|537534343|FG001|Vaccination Series|Withdrawal by Subject|13|||
149014963|NCT01193582|537534344|FG002|Vaccination Series|Withdrawal by Subject|8|||
149014964|NCT01193582|537534345|FG003|Vaccination Series|Withdrawal by Subject|3|||
149014965|NCT01193582|537534342|FG000|12 Month Follow-up|Death|0|||
149014966|NCT01193582|537534343|FG001|12 Month Follow-up|Death|0|||
149014967|NCT01193582|537534344|FG002|12 Month Follow-up|Death|1|||
149014968|NCT01193582|537534345|FG003|12 Month Follow-up|Death|0|||
149193645|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
149193646|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
149193647|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
149193648|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
149193649|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
149193650|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
149193651|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
149193652|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
149193653|NCT01106625|538177805|FG000|Core Period: Baseline to Week 26|Other|8|||
149193654|NCT01106625|538177806|FG001|Core Period: Baseline to Week 26|Other|7|||
149193655|NCT01106625|538177807|FG002|Core Period: Baseline to Week 26|Other|4|||
149193656|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
149193657|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
149193658|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
149193659|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
149193660|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
148681971|NCT00382291|536309396|FG002|Overall Study|Lack of Efficacy|1|||
148681972|NCT01270841|536309397|FG000|Overall Study|Adverse Event|0|||
148681973|NCT01270841|536309398|FG001|Overall Study|Adverse Event|1|||
149193661|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
149193662|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
149193663|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
149193664|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
149193665|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149193666|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
149193667|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
149193668|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
149193669|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149193670|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
149193671|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
149193672|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
149193673|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
149193674|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
149193675|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
149193676|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
149193677|NCT01106625|538177805|FG000|Extension Period: Week 26 to Week 52|Other|5|||
149193678|NCT01106625|538177806|FG001|Extension Period: Week 26 to Week 52|Other|5|||
149193679|NCT01106625|538177807|FG002|Extension Period: Week 26 to Week 52|Other|4|||
149193680|NCT02496585|538177808|FG000|Overall Study|Death|3|||
149193681|NCT02496585|538177809|FG001|Overall Study|Death|0|||
149193682|NCT02496585|538177808|FG000|Overall Study|Lost to Follow-up|2|||
149193683|NCT02496585|538177809|FG001|Overall Study|Lost to Follow-up|0|||
149193684|NCT02496585|538177808|FG000|Overall Study|Withdrawal by Subject|1|||
149193685|NCT02496585|538177809|FG001|Overall Study|Withdrawal by Subject|2|||
149193686|NCT02496585|538177808|FG000|Overall Study|Progression of Malignancy|4|||
149193687|NCT02496585|538177809|FG001|Overall Study|Progression of Malignancy|1|||
149193688|NCT01100307|538177810|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
149193689|NCT01100307|538177811|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
149193690|NCT01100307|538177810|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
149193691|NCT01100307|538177811|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
149193692|NCT01100307|538177810|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
149193693|NCT01100307|538177811|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
149193694|NCT01100307|538177810|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
149193695|NCT01100307|538177811|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
149193696|NCT01100307|538177810|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
149193697|NCT01100307|538177811|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
149193698|NCT01100307|538177810|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
149193699|NCT01100307|538177811|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
149193700|NCT00997321|538177812|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
149193701|NCT00997321|538177813|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
149193702|NCT01276457|538177816|FG000|Core Study|Adverse Event|6|||
149193703|NCT01276457|538177817|FG001|Core Study|Adverse Event|3|||
149193704|NCT01276457|538177816|FG000|Core Study|Lost to Follow-up|1|||
149193705|NCT01276457|538177817|FG001|Core Study|Lost to Follow-up|2|||
148935742|NCT00808483|537249454|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
148935743|NCT00808483|537249453|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
148935744|NCT00808483|537249454|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
148935745|NCT02038881|537249455|FG000|Overall Study|Withdrawal by Subject|0|||
148935746|NCT02038881|537249456|FG001|Overall Study|Withdrawal by Subject|0|||
148935747|NCT02038881|537249457|FG002|Overall Study|Withdrawal by Subject|1|||
149193706|NCT01276457|538177816|FG000|Core Study|Administrative problems|1|||
148681974|NCT01270841|536309399|FG002|Overall Study|Adverse Event|0|||
148935748|NCT02038881|537249455|FG000|Overall Study|Lost to Follow-up|2|||
148935749|NCT02038881|537249456|FG001|Overall Study|Lost to Follow-up|0|||
148935750|NCT02038881|537249457|FG002|Overall Study|Lost to Follow-up|0|||
148935751|NCT02038881|537249455|FG000|Overall Study|incarcerated|1|||
149014969|NCT01193582|537534342|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
149014970|NCT01193582|537534343|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
149193707|NCT01276457|538177817|FG001|Core Study|Administrative problems|1|||
149193708|NCT01276457|538177816|FG000|Core Study|Death|2|||
149193709|NCT01276457|538177817|FG001|Core Study|Death|2|||
149193710|NCT01276457|538177816|FG000|Core Study|Lack of Efficacy|3|||
148807676|NCT01832766|536773357|FG000|Washout|Lost to Follow-up|0|||
149193711|NCT01276457|538177817|FG001|Core Study|Lack of Efficacy|12|||
149193712|NCT01276457|538177816|FG000|Extension Study|Lost to Follow-up|3|||
149193713|NCT01276457|538177817|FG001|Extension Study|Lost to Follow-up|0|||
149193714|NCT01276457|538177816|FG000|Extension Study|Death|0|||
149193715|NCT01276457|538177817|FG001|Extension Study|Death|1|||
149193716|NCT01276457|538177816|FG000|Extension Study|Lack of Efficacy|3|||
148935752|NCT02038881|537249456|FG001|Overall Study|incarcerated|0|||
148935753|NCT02038881|537249457|FG002|Overall Study|incarcerated|0|||
148935754|NCT00333840|537249458|FG000|First-line Treatment Period|Adverse Event|38|||
148935755|NCT00333840|537249459|FG001|First-line Treatment Period|Adverse Event|37|||
149193717|NCT01276457|538177817|FG001|Extension Study|Lack of Efficacy|1|||
149193718|NCT02065869|538177818|FG000|Overall Study|Death|7|||
149193719|NCT02065869|538177818|FG000|Overall Study|Disease relapse|16|||
149193720|NCT02065869|538177818|FG000|Overall Study|Lost to Follow-up|4|||
149193721|NCT02065869|538177818|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
149193722|NCT02065869|538177818|FG000|Overall Study|Withdrawal by Subject|1|||
149193723|NCT03827473|538177819|FG000|Overall Study|Withdrawal by Subject|1|||
149193724|NCT03827473|538177820|FG001|Overall Study|Withdrawal by Subject|0|||
149193725|NCT00303108|538177823|FG000|Overall Study|Adverse Event|5|||
149193726|NCT00303108|538177824|FG001|Overall Study|Adverse Event|6|||
149193727|NCT00303108|538177825|FG002|Overall Study|Adverse Event|7|||
149193728|NCT00303108|538177823|FG000|Overall Study|Patient Request|4|||
148935756|NCT00333840|537249460|FG002|First-line Treatment Period|Adverse Event|0|||
148935757|NCT00333840|537249461|FG003|First-line Treatment Period|Adverse Event|0|||
148935758|NCT00333840|537249458|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
148935759|NCT00333840|537249459|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
148935760|NCT00333840|537249460|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
148935761|NCT00333840|537249461|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
148935762|NCT00333840|537249458|FG000|First-line Treatment Period|Abnormal procedure|2|||
148935763|NCT00333840|537249459|FG001|First-line Treatment Period|Abnormal procedure|0|||
148935764|NCT00333840|537249460|FG002|First-line Treatment Period|Abnormal procedure|0|||
148935765|NCT00333840|537249461|FG003|First-line Treatment Period|Abnormal procedure|0|||
148935766|NCT00333840|537249458|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
148935767|NCT00333840|537249459|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
148935768|NCT00333840|537249460|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
148935769|NCT00333840|537249461|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
149193729|NCT00303108|538177824|FG001|Overall Study|Patient Request|2|||
149193730|NCT00303108|538177825|FG002|Overall Study|Patient Request|8|||
149193731|NCT00303108|538177823|FG000|Overall Study|Failed Entry|1|||
149193732|NCT00303108|538177824|FG001|Overall Study|Failed Entry|0|||
149193733|NCT00303108|538177825|FG002|Overall Study|Failed Entry|1|||
148935770|NCT00333840|537249458|FG000|First-line Treatment Period|No longer required study drug|21|||
148935771|NCT00333840|537249459|FG001|First-line Treatment Period|No longer required study drug|8|||
148935772|NCT00333840|537249460|FG002|First-line Treatment Period|No longer required study drug|0|||
148935773|NCT00333840|537249461|FG003|First-line Treatment Period|No longer required study drug|0|||
148935774|NCT00333840|537249458|FG000|First-line Treatment Period|Protocol Violation|17|||
148935775|NCT00333840|537249459|FG001|First-line Treatment Period|Protocol Violation|17|||
148935776|NCT00333840|537249460|FG002|First-line Treatment Period|Protocol Violation|0|||
148935777|NCT00333840|537249461|FG003|First-line Treatment Period|Protocol Violation|0|||
148935778|NCT00333840|537249458|FG000|First-line Treatment Period|Subject withdrew consent|57|||
148935779|NCT00333840|537249459|FG001|First-line Treatment Period|Subject withdrew consent|77|||
148935780|NCT00333840|537249460|FG002|First-line Treatment Period|Subject withdrew consent|0|||
148935781|NCT00333840|537249461|FG003|First-line Treatment Period|Subject withdrew consent|0|||
148935782|NCT00333840|537249458|FG000|First-line Treatment Period|Lost to Follow-up|15|||
148935783|NCT00333840|537249459|FG001|First-line Treatment Period|Lost to Follow-up|6|||
148935784|NCT00333840|537249460|FG002|First-line Treatment Period|Lost to Follow-up|0|||
148935785|NCT00333840|537249461|FG003|First-line Treatment Period|Lost to Follow-up|0|||
148935786|NCT00333840|537249458|FG000|First-line Treatment Period|Administrative problems|12|||
149014971|NCT01193582|537534344|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
149193734|NCT00303108|538177823|FG000|Overall Study|ineligible|2|||
149193735|NCT00303108|538177824|FG001|Overall Study|ineligible|1|||
149193736|NCT00303108|538177825|FG002|Overall Study|ineligible|0|||
149193737|NCT00894413|538177828|FG000|Overall Study|Physician Decision|0|||
149193738|NCT00894413|538177829|FG001|Overall Study|Physician Decision|2|||
149193739|NCT00894413|538177828|FG000|Overall Study|Adverse Event|0|||
149193740|NCT00894413|538177829|FG001|Overall Study|Adverse Event|2|||
149193741|NCT00894413|538177828|FG000|Overall Study|Withdrawal by Subject|0|||
149193742|NCT00894413|538177829|FG001|Overall Study|Withdrawal by Subject|4|||
149193743|NCT03855137|538177831|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
148935787|NCT00333840|537249459|FG001|First-line Treatment Period|Administrative problems|6|||
148935788|NCT00333840|537249460|FG002|First-line Treatment Period|Administrative problems|0|||
148935789|NCT00333840|537249461|FG003|First-line Treatment Period|Administrative problems|0|||
148935790|NCT00333840|537249458|FG000|First-line Treatment Period|Death|19|||
148935791|NCT00333840|537249459|FG001|First-line Treatment Period|Death|2|||
148935792|NCT00333840|537249460|FG002|First-line Treatment Period|Death|0|||
148935793|NCT00333840|537249461|FG003|First-line Treatment Period|Death|0|||
148935794|NCT00333840|537249458|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
148935795|NCT00333840|537249459|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
148935796|NCT00333840|537249460|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
148935797|NCT00333840|537249461|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
149014972|NCT01193582|537534345|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
149014973|NCT01775930|537534349|FG000|Overall Study|Futility stopping boundary met|1|||
149193744|NCT03855137|538177832|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
149193745|NCT03855137|538177833|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
149193746|NCT03855137|538177831|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
149193747|NCT03855137|538177832|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
149193748|NCT03855137|538177833|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
149193749|NCT03855137|538177831|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
149193750|NCT03855137|538177832|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
149193751|NCT03855137|538177833|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
149193752|NCT03855137|538177831|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
149193753|NCT03855137|538177832|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
149193754|NCT03855137|538177833|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
149193755|NCT03855137|538177831|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
149193756|NCT03855137|538177832|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
149193757|NCT03855137|538177833|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
149193758|NCT03855137|538177831|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
149193759|NCT03855137|538177832|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
149193760|NCT03855137|538177833|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
149193761|NCT03855137|538177831|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
149193762|NCT03855137|538177832|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
149193763|NCT03855137|538177833|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
149193764|NCT03855137|538177831|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
149193765|NCT03855137|538177832|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
149193766|NCT03855137|538177833|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
149193767|NCT03855137|538177831|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
149193768|NCT03855137|538177832|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
149193769|NCT03855137|538177833|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
149193770|NCT03855137|538177831|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
149193771|NCT03855137|538177832|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
149193772|NCT03855137|538177833|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
149193773|NCT02427477|538177836|FG000|Period 1|Adverse Event|1|||
149193774|NCT02427477|538177837|FG001|Period 1|Adverse Event|0|||
149193775|NCT00471445|538177838|FG000|Overall Study|Withdrawal by Subject|1|||
149193776|NCT00471445|538177839|FG001|Overall Study|Withdrawal by Subject|1|||
149193777|NCT00471445|538177838|FG000|Overall Study|Ineligible|1|||
149193778|NCT00471445|538177839|FG001|Overall Study|Ineligible|0|||
149193779|NCT00471445|538177838|FG000|Overall Study|Protocol Violation|0|||
149193780|NCT00471445|538177839|FG001|Overall Study|Protocol Violation|1|||
149193781|NCT02065622|538177840|FG000|Induction Study|Adverse Event|13|||
149193782|NCT02065622|538177841|FG001|Induction Study|Adverse Event|19|||
149193783|NCT02065622|538177842|FG002|Induction Study|Adverse Event|0|||
149193784|NCT02065622|538177843|FG003|Induction Study|Adverse Event|0|||
149014974|NCT01208415|537534350|FG000|Overall Study|Death|1|||
149014975|NCT01208415|537534350|FG000|Overall Study|Lost to Follow-up|2|||
149014976|NCT01208415|537534350|FG000|Overall Study|Withdrawal by Subject|3|||
149014977|NCT01208415|537534350|FG000|Overall Study|Device not placed|1|||
149193785|NCT02065622|538177844|FG004|Induction Study|Adverse Event|0|||
149193786|NCT02065622|538177840|FG000|Induction Study|Withdrawal by Subject|3|||
149193787|NCT02065622|538177841|FG001|Induction Study|Withdrawal by Subject|5|||
149193788|NCT02065622|538177842|FG002|Induction Study|Withdrawal by Subject|0|||
149193789|NCT02065622|538177843|FG003|Induction Study|Withdrawal by Subject|0|||
149193790|NCT02065622|538177844|FG004|Induction Study|Withdrawal by Subject|0|||
149193791|NCT02065622|538177840|FG000|Induction Study|Lost to Follow-up|1|||
149193792|NCT02065622|538177841|FG001|Induction Study|Lost to Follow-up|0|||
149193793|NCT02065622|538177842|FG002|Induction Study|Lost to Follow-up|0|||
149193794|NCT02065622|538177843|FG003|Induction Study|Lost to Follow-up|0|||
149193795|NCT02065622|538177844|FG004|Induction Study|Lost to Follow-up|0|||
149193796|NCT02065622|538177840|FG000|Induction Study|Lack of Efficacy|22|||
149193797|NCT02065622|538177841|FG001|Induction Study|Lack of Efficacy|27|||
149193798|NCT02065622|538177842|FG002|Induction Study|Lack of Efficacy|0|||
149014978|NCT01208415|537534350|FG000|Overall Study|Still be eligible for follow-up|33|||
149193799|NCT02065622|538177843|FG003|Induction Study|Lack of Efficacy|0|||
149193800|NCT02065622|538177844|FG004|Induction Study|Lack of Efficacy|0|||
149193801|NCT02065622|538177840|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
149193802|NCT02065622|538177841|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
149193803|NCT02065622|538177842|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
149193804|NCT02065622|538177843|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
148935798|NCT00333840|537249458|FG000|Second-line Treatment Period|Adverse Event|0|||
148935799|NCT00333840|537249459|FG001|Second-line Treatment Period|Adverse Event|0|||
148935800|NCT00333840|537249460|FG002|Second-line Treatment Period|Adverse Event|3|||
148935801|NCT00333840|537249461|FG003|Second-line Treatment Period|Adverse Event|34|||
148935802|NCT00333840|537249458|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
148935803|NCT00333840|537249459|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
148935804|NCT00333840|537249460|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
148935805|NCT00333840|537249461|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
148935806|NCT00333840|537249458|FG000|Second-line Treatment Period|Abnormal procedure|0|||
148935807|NCT00333840|537249459|FG001|Second-line Treatment Period|Abnormal procedure|0|||
148935808|NCT00333840|537249460|FG002|Second-line Treatment Period|Abnormal procedure|0|||
148935809|NCT00333840|537249461|FG003|Second-line Treatment Period|Abnormal procedure|1|||
148935810|NCT00333840|537249458|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
148935811|NCT00333840|537249459|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
148935812|NCT00333840|537249460|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
148935813|NCT00333840|537249461|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
148935814|NCT00333840|537249458|FG000|Second-line Treatment Period|No longer required study drug|0|||
148935815|NCT00333840|537249459|FG001|Second-line Treatment Period|No longer required study drug|0|||
148935816|NCT00333840|537249460|FG002|Second-line Treatment Period|No longer required study drug|1|||
148935817|NCT00333840|537249461|FG003|Second-line Treatment Period|No longer required study drug|14|||
148935818|NCT00333840|537249458|FG000|Second-line Treatment Period|Protocol Violation|0|||
148935819|NCT00333840|537249459|FG001|Second-line Treatment Period|Protocol Violation|0|||
148935820|NCT00333840|537249460|FG002|Second-line Treatment Period|Protocol Violation|1|||
148935821|NCT00333840|537249461|FG003|Second-line Treatment Period|Protocol Violation|10|||
148935822|NCT00333840|537249458|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
148935823|NCT00333840|537249459|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
148935824|NCT00333840|537249460|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
148935825|NCT00333840|537249461|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
148935826|NCT00333840|537249458|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
148935827|NCT00333840|537249459|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
148935828|NCT00333840|537249460|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
148935829|NCT00333840|537249461|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
148935830|NCT00333840|537249458|FG000|Second-line Treatment Period|Administrative problems|0|||
148935831|NCT00333840|537249459|FG001|Second-line Treatment Period|Administrative problems|0|||
148935832|NCT00333840|537249460|FG002|Second-line Treatment Period|Administrative problems|0|||
148935833|NCT00333840|537249461|FG003|Second-line Treatment Period|Administrative problems|7|||
148935834|NCT00333840|537249458|FG000|Second-line Treatment Period|Death|0|||
148807677|NCT01832766|536773358|FG001|Washout|Lost to Follow-up|1|||
148807678|NCT01114724|536773361|FG000|Overall Study|Death|8|||
148807679|NCT01114724|536773361|FG000|Overall Study|Lost to Follow-up|1|||
148807680|NCT01114724|536773361|FG000|Overall Study|Withdrawal by Subject|1|||
148807681|NCT02966834|536773362|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
148807682|NCT02966834|536773363|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
148807683|NCT02966834|536773364|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
148807684|NCT02966834|536773365|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
148807685|NCT02966834|536773366|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
148807686|NCT02966834|536773367|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
148807687|NCT02966834|536773362|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
148807688|NCT02966834|536773363|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148807689|NCT02966834|536773364|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148807690|NCT02966834|536773365|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148807691|NCT02966834|536773366|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148807692|NCT02966834|536773367|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148807693|NCT02966834|536773362|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
148807694|NCT02966834|536773363|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
148807695|NCT02966834|536773364|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
148807696|NCT02966834|536773365|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
148807697|NCT02966834|536773366|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
148807698|NCT02966834|536773367|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
148807699|NCT02966834|536773362|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
148807700|NCT02966834|536773363|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
148807701|NCT02966834|536773364|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
148807702|NCT02966834|536773365|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
148807703|NCT02966834|536773366|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
148807704|NCT02966834|536773367|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
148807705|NCT02966834|536773362|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148807706|NCT02966834|536773363|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148807707|NCT02966834|536773364|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148807708|NCT02966834|536773365|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
148807709|NCT02966834|536773366|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148807710|NCT02966834|536773367|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148807711|NCT02966834|536773362|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
148935835|NCT00333840|537249459|FG001|Second-line Treatment Period|Death|0|||
148935836|NCT00333840|537249460|FG002|Second-line Treatment Period|Death|0|||
148807712|NCT02966834|536773363|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
148807713|NCT02966834|536773364|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
148807714|NCT02966834|536773365|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
149193805|NCT02065622|538177844|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
149193806|NCT02065622|538177840|FG000|Induction Study|Subject Noncompliance|1|||
149193807|NCT02065622|538177841|FG001|Induction Study|Subject Noncompliance|1|||
149193808|NCT02065622|538177842|FG002|Induction Study|Subject Noncompliance|0|||
149193809|NCT02065622|538177843|FG003|Induction Study|Subject Noncompliance|0|||
149193810|NCT02065622|538177844|FG004|Induction Study|Subject Noncompliance|0|||
149193811|NCT02065622|538177840|FG000|Induction Study|Other, Not Specified|3|||
149193812|NCT02065622|538177841|FG001|Induction Study|Other, Not Specified|2|||
149193813|NCT02065622|538177842|FG002|Induction Study|Other, Not Specified|0|||
149193814|NCT02065622|538177843|FG003|Induction Study|Other, Not Specified|0|||
149193815|NCT02065622|538177844|FG004|Induction Study|Other, Not Specified|0|||
149193816|NCT02065622|538177840|FG000|Maintenance Study|Adverse Event|0|||
149193817|NCT02065622|538177841|FG001|Maintenance Study|Adverse Event|0|||
149193818|NCT02065622|538177842|FG002|Maintenance Study|Adverse Event|25|||
149193819|NCT02065622|538177843|FG003|Maintenance Study|Adverse Event|22|||
149193820|NCT02065622|538177844|FG004|Maintenance Study|Adverse Event|11|||
148807715|NCT02966834|536773366|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
148807716|NCT02966834|536773367|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
148807717|NCT02469233|536774419|FG000|Overall Study|Death|1|||
148935837|NCT00333840|537249461|FG003|Second-line Treatment Period|Death|9|||
148935838|NCT01453725|537249462|FG000|Overall Study|Adverse Event|3|||
148935839|NCT01453725|537249463|FG001|Overall Study|Adverse Event|3|||
148935840|NCT01453725|537249462|FG000|Overall Study|Lost to Follow-up|4|||
148935841|NCT01453725|537249463|FG001|Overall Study|Lost to Follow-up|0|||
148935842|NCT01453725|537249462|FG000|Overall Study|Non-compliance With Protocol|1|||
149193821|NCT02065622|538177840|FG000|Maintenance Study|Withdrawal by Subject|0|||
148935843|NCT01453725|537249463|FG001|Overall Study|Non-compliance With Protocol|2|||
148935844|NCT01453725|537249462|FG000|Overall Study|Protocol Violation|1|||
148935845|NCT01453725|537249463|FG001|Overall Study|Protocol Violation|0|||
148935846|NCT01453725|537249462|FG000|Overall Study|Withdrawal by Subject|2|||
149193822|NCT02065622|538177841|FG001|Maintenance Study|Withdrawal by Subject|0|||
148935847|NCT01453725|537249463|FG001|Overall Study|Withdrawal by Subject|3|||
149193823|NCT02065622|538177842|FG002|Maintenance Study|Withdrawal by Subject|11|||
149193824|NCT02065622|538177843|FG003|Maintenance Study|Withdrawal by Subject|5|||
149193825|NCT02065622|538177844|FG004|Maintenance Study|Withdrawal by Subject|7|||
149193826|NCT02065622|538177840|FG000|Maintenance Study|Lost to Follow-up|0|||
149193827|NCT02065622|538177841|FG001|Maintenance Study|Lost to Follow-up|0|||
149193828|NCT02065622|538177842|FG002|Maintenance Study|Lost to Follow-up|4|||
149193829|NCT02065622|538177843|FG003|Maintenance Study|Lost to Follow-up|1|||
149193830|NCT02065622|538177844|FG004|Maintenance Study|Lost to Follow-up|1|||
149193831|NCT02065622|538177840|FG000|Maintenance Study|Lack of Efficacy|0|||
149193832|NCT02065622|538177841|FG001|Maintenance Study|Lack of Efficacy|0|||
149193833|NCT02065622|538177842|FG002|Maintenance Study|Lack of Efficacy|70|||
149193834|NCT02065622|538177843|FG003|Maintenance Study|Lack of Efficacy|55|||
149193835|NCT02065622|538177844|FG004|Maintenance Study|Lack of Efficacy|19|||
149193836|NCT02065622|538177840|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
149193837|NCT02065622|538177841|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
149193838|NCT02065622|538177842|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
149193839|NCT02065622|538177843|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
149193840|NCT02065622|538177844|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
149193841|NCT02065622|538177840|FG000|Maintenance Study|Subject Non-Compliance|0|||
149193842|NCT02065622|538177841|FG001|Maintenance Study|Subject Non-Compliance|0|||
149193843|NCT02065622|538177842|FG002|Maintenance Study|Subject Non-Compliance|1|||
149193844|NCT02065622|538177843|FG003|Maintenance Study|Subject Non-Compliance|3|||
149193845|NCT02065622|538177844|FG004|Maintenance Study|Subject Non-Compliance|2|||
149193846|NCT02065622|538177840|FG000|Maintenance Study|Other, Not Specified|0|||
149193847|NCT02065622|538177841|FG001|Maintenance Study|Other, Not Specified|0|||
149193848|NCT02065622|538177842|FG002|Maintenance Study|Other, Not Specified|6|||
149193849|NCT02065622|538177843|FG003|Maintenance Study|Other, Not Specified|14|||
149193850|NCT02065622|538177844|FG004|Maintenance Study|Other, Not Specified|2|||
149193851|NCT02065622|538177840|FG000|Maintenance Study|Unknown Reason|0|||
149193852|NCT02065622|538177841|FG001|Maintenance Study|Unknown Reason|0|||
149193853|NCT02065622|538177842|FG002|Maintenance Study|Unknown Reason|0|||
149193854|NCT02065622|538177843|FG003|Maintenance Study|Unknown Reason|1|||
148935848|NCT01453725|537249462|FG000|Overall Study|Pregnancy Wish|0|||
148935849|NCT01453725|537249463|FG001|Overall Study|Pregnancy Wish|2|||
148935850|NCT01453725|537249462|FG000|Overall Study|Pregnancy|1|||
149193855|NCT02065622|538177844|FG004|Maintenance Study|Unknown Reason|0|||
149193856|NCT00488618|538177851|FG000|Overall Study|Adverse Event|13|||
149193857|NCT00488618|538177852|FG001|Overall Study|Adverse Event|17|||
149193858|NCT00488618|538177851|FG000|Overall Study|Insufficient Therapeutic Response|18|||
149193859|NCT00488618|538177852|FG001|Overall Study|Insufficient Therapeutic Response|11|||
149193860|NCT00488618|538177851|FG000|Overall Study|Protocol Violation|0|||
149193861|NCT00488618|538177852|FG001|Overall Study|Protocol Violation|2|||
149193862|NCT00488618|538177851|FG000|Overall Study|Withdrawal of Consent|15|||
149193863|NCT00488618|538177852|FG001|Overall Study|Withdrawal of Consent|13|||
149193864|NCT00488618|538177851|FG000|Overall Study|Lost to Follow-up|1|||
149193865|NCT00488618|538177852|FG001|Overall Study|Lost to Follow-up|0|||
149193866|NCT00786032|538179201|FG000|Overall Study|Death|4|||
149193867|NCT00786032|538179201|FG000|Overall Study|Withdrawal by Subject|14|||
149193868|NCT00786032|538179201|FG000|Overall Study|Did not complete in the timeframe|6|||
149193869|NCT02625324|538179202|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
149193870|NCT02625324|538179202|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
149193871|NCT02625324|538179202|FG000|6-Month Follow-up Subject Accountability|Death|5|||
149193872|NCT02625324|538179202|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
149193873|NCT02625324|538179202|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
149193874|NCT02625324|538179202|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
149193875|NCT02625324|538179202|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
149193876|NCT02625324|538179202|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
148935851|NCT01453725|537249463|FG001|Overall Study|Pregnancy|0|||
149193877|NCT02625324|538179202|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
149193878|NCT02625324|538179202|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
149193879|NCT02625324|538179202|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
149193880|NCT02625324|538179202|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
149193881|NCT02625324|538179202|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
149193882|NCT02625324|538179202|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
149193883|NCT02625324|538179202|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
148935852|NCT01453725|537249462|FG000|Overall Study|Physician Decision|1|||
148935853|NCT01453725|537249463|FG001|Overall Study|Physician Decision|1|||
148935854|NCT03945214|537249464|FG000|Overall Study|Lost to Follow-up|3|||
148935855|NCT03945214|537249465|FG001|Overall Study|Lost to Follow-up|4|||
148935856|NCT03945214|537249466|FG002|Overall Study|Lost to Follow-up|7|||
148935857|NCT03945214|537249467|FG003|Overall Study|Lost to Follow-up|4|||
148935858|NCT01436396|537249478|FG000|Overall Study|Protocol Violation|7|||
148935859|NCT01436396|537249479|FG001|Overall Study|Protocol Violation|5|||
148935860|NCT01436396|537249478|FG000|Overall Study|Adverse Event|1|||
148935861|NCT01436396|537249479|FG001|Overall Study|Adverse Event|2|||
148935862|NCT01436396|537249478|FG000|Overall Study|Withdrawal by Subject|19|||
148935863|NCT01436396|537249479|FG001|Overall Study|Withdrawal by Subject|29|||
148935864|NCT01436396|537249478|FG000|Overall Study|Serious adverse event|2|||
148935865|NCT01436396|537249479|FG001|Overall Study|Serious adverse event|3|||
148935866|NCT01436396|537249478|FG000|Overall Study|Lost to Follow-up|3|||
148935867|NCT01436396|537249479|FG001|Overall Study|Lost to Follow-up|3|||
148935868|NCT00875979|537249480|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
148935869|NCT00875979|537249481|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
148935870|NCT00875979|537249480|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
148935871|NCT00875979|537249481|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
148935872|NCT00875979|537249480|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
148935873|NCT00875979|537249481|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
148935874|NCT00875979|537249480|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
148935875|NCT00875979|537249481|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
148935876|NCT00875979|537249480|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
148935877|NCT00875979|537249481|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
148935878|NCT00875979|537249480|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
148935879|NCT00875979|537249481|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
148935880|NCT00875979|537249480|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
148935881|NCT00875979|537249481|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
148935882|NCT00875979|537249480|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
148935883|NCT00875979|537249481|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
148935884|NCT00875979|537249480|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
148935885|NCT00875979|537249481|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
148935886|NCT00216476|537249482|FG000|Overall Study|Withdrawal by Subject|59|||
148935887|NCT00216476|537249483|FG001|Overall Study|Withdrawal by Subject|72|||
148935888|NCT00216476|537249484|FG002|Overall Study|Withdrawal by Subject|9|||
148935889|NCT00216476|537249482|FG000|Overall Study|Lost to Follow-up|10|||
148935890|NCT00216476|537249483|FG001|Overall Study|Lost to Follow-up|9|||
148935891|NCT00216476|537249484|FG002|Overall Study|Lost to Follow-up|1|||
148935892|NCT00216476|537249482|FG000|Overall Study|Adverse Event|6|||
149193884|NCT02625324|538179202|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
149193885|NCT02625324|538179202|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
149193886|NCT00967226|538179205|FG000|Overall Study|Adverse Event|0|||
149193887|NCT00967226|538179206|FG001|Overall Study|Adverse Event|5|||
149193888|NCT00967226|538179205|FG000|Overall Study|Protocol Violation|2|||
149193889|NCT00967226|538179206|FG001|Overall Study|Protocol Violation|0|||
149193890|NCT00967226|538179205|FG000|Overall Study|Physician Decision|0|||
148935893|NCT00216476|537249483|FG001|Overall Study|Adverse Event|10|||
148935894|NCT00216476|537249484|FG002|Overall Study|Adverse Event|1|||
148935895|NCT00216476|537249482|FG000|Overall Study|Lack of Efficacy|4|||
148935896|NCT00216476|537249483|FG001|Overall Study|Lack of Efficacy|3|||
148935897|NCT00216476|537249484|FG002|Overall Study|Lack of Efficacy|0|||
148935898|NCT00216476|537249482|FG000|Overall Study|Death|2|||
148935899|NCT00216476|537249483|FG001|Overall Study|Death|0|||
148935900|NCT00216476|537249484|FG002|Overall Study|Death|0|||
148935901|NCT00216476|537249482|FG000|Overall Study|Pregnancy|0|||
148935902|NCT00216476|537249483|FG001|Overall Study|Pregnancy|1|||
148935903|NCT00216476|537249484|FG002|Overall Study|Pregnancy|1|||
148935904|NCT00216476|537249482|FG000|Overall Study|Other|0|||
148935905|NCT00216476|537249483|FG001|Overall Study|Other|0|||
149193891|NCT00967226|538179206|FG001|Overall Study|Physician Decision|1|||
149193892|NCT01000727|538179211|FG000|Overall Study|Lost to Follow-up|41|||
149193893|NCT01000727|538179212|FG001|Overall Study|Lost to Follow-up|43|||
149193894|NCT01000727|538179211|FG000|Overall Study|Withdrawal by Subject|111|||
149193895|NCT01000727|538179212|FG001|Overall Study|Withdrawal by Subject|109|||
149193896|NCT01000727|538179211|FG000|Overall Study|Study closed/terminated|23|||
149193897|NCT01000727|538179212|FG001|Overall Study|Study closed/terminated|24|||
149193898|NCT03137121|538179213|FG000|Overall Study|Withdrawal by Subject|0|||
149193899|NCT03137121|538179214|FG001|Overall Study|Withdrawal by Subject|1|||
149193900|NCT03196193|538179215|FG000|Overall Study|Adverse Event|1|||
149193901|NCT03196193|538179216|FG001|Overall Study|Adverse Event|0|||
149193902|NCT03196193|538179215|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
149193903|NCT03196193|538179216|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
149193904|NCT02709083|538179222|FG000|Overall Study|Original PI left institution|7|||
149193905|NCT01697267|538179224|FG000|Overall Study|Death|3|||
149193906|NCT01697267|538179225|FG001|Overall Study|Death|1|||
149193907|NCT01697267|538179224|FG000|Overall Study|Withdrawal by Subject|5|||
149193908|NCT01697267|538179225|FG001|Overall Study|Withdrawal by Subject|5|||
149193909|NCT01697267|538179224|FG000|Overall Study|Adverse Event|2|||
149193910|NCT01697267|538179225|FG001|Overall Study|Adverse Event|1|||
149193911|NCT01697267|538179224|FG000|Overall Study|Lost to Follow-up|2|||
149193912|NCT01697267|538179225|FG001|Overall Study|Lost to Follow-up|4|||
149193913|NCT01697267|538179224|FG000|Overall Study|Physician Decision|2|||
149193914|NCT01697267|538179225|FG001|Overall Study|Physician Decision|4|||
149193915|NCT02006667|538179226|FG000|Overall Study|Adverse Event|3|||
149193916|NCT02006667|538179226|FG000|Overall Study|Death|2|||
149193917|NCT02006667|538179226|FG000|Overall Study|Withdrawal by Subject|1|||
149193918|NCT01626352|538179227|FG000|Overall Study|Disease Progression|3|||
149193919|NCT01626352|538179227|FG000|Overall Study|Intercurrent Illness|2|||
149193920|NCT01626352|538179227|FG000|Overall Study|Death|2|||
149193921|NCT01626352|538179227|FG000|Overall Study|Withdrawal by Subject|1|||
149193922|NCT01626352|538179227|FG000|Overall Study|Non-Compliance|1|||
149193923|NCT01626352|538179227|FG000|Overall Study|Never Treated|1|||
149193924|NCT02681055|538179231|FG000|Weeks 5-12|Adverse Event|1|||
149193925|NCT00310388|538179232|FG000|Primary Reporting Phase|Adverse Event|101|||
149193926|NCT00310388|538179233|FG001|Primary Reporting Phase|Adverse Event|0|||
149193927|NCT00310388|538179232|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
149193928|NCT00310388|538179233|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
149193929|NCT00310388|538179232|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
149193930|NCT00310388|538179233|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
149193931|NCT00310388|538179232|FG000|Primary Reporting Phase|Protocol Violation|10|||
149193932|NCT00310388|538179233|FG001|Primary Reporting Phase|Protocol Violation|0|||
149193933|NCT00310388|538179232|FG000|Primary Reporting Phase|Pregnancy|3|||
149193934|NCT00310388|538179233|FG001|Primary Reporting Phase|Pregnancy|0|||
149193935|NCT00310388|538179232|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
149193936|NCT00310388|538179233|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
149193937|NCT00310388|538179232|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
149193938|NCT00310388|538179233|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
149193939|NCT00310388|538179232|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
149193940|NCT00310388|538179233|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
149193941|NCT00310388|538179232|FG000|Primary Reporting Phase|Physician Decision|2|||
149193942|NCT00310388|538179233|FG001|Primary Reporting Phase|Physician Decision|0|||
148935906|NCT00216476|537249484|FG002|Overall Study|Other|1|||
148935907|NCT00216476|537249482|FG000|Overall Study|Refuses Injection|11|||
148935908|NCT00216476|537249483|FG001|Overall Study|Refuses Injection|0|||
149014979|NCT01115491|537534351|FG000|Overall Study|Death|22|||
149193943|NCT00310388|538179232|FG000|Primary Reporting Phase|Request of the sponsor|19|||
149193944|NCT00310388|538179233|FG001|Primary Reporting Phase|Request of the sponsor|0|||
149193945|NCT00310388|538179232|FG000|Primary Reporting Phase|Failed to return|8|||
149193946|NCT00310388|538179233|FG001|Primary Reporting Phase|Failed to return|0|||
148935909|NCT00216476|537249484|FG002|Overall Study|Refuses Injection|0|||
149193947|NCT00310388|538179232|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
149193948|NCT00310388|538179233|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
149193949|NCT00310388|538179232|FG000|Primary Reporting Phase|Participant request|2|||
149014980|NCT01115491|537534351|FG000|Overall Study|Adverse Event|3|||
149193950|NCT00310388|538179233|FG001|Primary Reporting Phase|Participant request|0|||
149193951|NCT00310388|538179232|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
149193952|NCT00310388|538179233|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
148935910|NCT00216476|537249482|FG000|Overall Study|No Further Need for Treatment|3|||
149014981|NCT01115491|537534351|FG000|Overall Study|Lost to Follow-up|3|||
148935911|NCT00216476|537249483|FG001|Overall Study|No Further Need for Treatment|4|||
148935912|NCT00216476|537249484|FG002|Overall Study|No Further Need for Treatment|1|||
148935913|NCT00216476|537249482|FG000|Overall Study|Non-compliance|0|||
148935914|NCT00216476|537249483|FG001|Overall Study|Non-compliance|4|||
148935915|NCT00216476|537249484|FG002|Overall Study|Non-compliance|1|||
148935916|NCT00216476|537249482|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
148935917|NCT00216476|537249483|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
148935918|NCT00216476|537249484|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
148935919|NCT00216476|537249482|FG000|Overall Study|Administrative Reasons|1|||
148935920|NCT00216476|537249483|FG001|Overall Study|Administrative Reasons|1|||
148935921|NCT00216476|537249484|FG002|Overall Study|Administrative Reasons|0|||
148935922|NCT00216476|537249482|FG000|Overall Study|Protocol Deviation|5|||
148935923|NCT00216476|537249483|FG001|Overall Study|Protocol Deviation|1|||
148935924|NCT00216476|537249484|FG002|Overall Study|Protocol Deviation|0|||
148935925|NCT00216476|537249482|FG000|Overall Study|Patient Moved|2|||
148935926|NCT00216476|537249483|FG001|Overall Study|Patient Moved|2|||
148935927|NCT00216476|537249484|FG002|Overall Study|Patient Moved|0|||
149193953|NCT00310388|538179232|FG000|Primary Reporting Phase|Discontinuation of study|1|||
149193954|NCT00310388|538179233|FG001|Primary Reporting Phase|Discontinuation of study|0|||
149193955|NCT00310388|538179232|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
149193956|NCT00310388|538179233|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
149193957|NCT00310388|538179232|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
149193958|NCT00310388|538179233|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
149193959|NCT00310388|538179232|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
149193960|NCT00310388|538179233|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
149193961|NCT00310388|538179232|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
149193962|NCT00310388|538179233|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
149193963|NCT00310388|538179232|FG000|Primary Reporting Phase|Participant passed away|1|||
149193964|NCT00310388|538179233|FG001|Primary Reporting Phase|Participant passed away|0|||
149193965|NCT00310388|538179232|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
149193966|NCT00310388|538179233|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
149193967|NCT00310388|538179232|FG000|Primary Reporting Phase|Missing|1|||
149193968|NCT00310388|538179233|FG001|Primary Reporting Phase|Missing|0|||
149193969|NCT00310388|538179232|FG000|Primary Reporting Phase|Other|1|||
149193970|NCT00310388|538179233|FG001|Primary Reporting Phase|Other|0|||
149193971|NCT00310388|538179232|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
149193972|NCT00310388|538179233|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
149193973|NCT00310388|538179232|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
149193974|NCT00310388|538179233|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
149193975|NCT00310388|538179232|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
149193976|NCT00310388|538179233|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
149193977|NCT00310388|538179232|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
149193978|NCT00310388|538179233|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
149193979|NCT00782418|538179238|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
149193980|NCT00782418|538179239|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149193981|NCT00782418|538179240|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149193982|NCT00782418|538179241|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
148935928|NCT00369707|537249488|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
148935929|NCT00369707|537249488|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
149193983|NCT00782418|538179242|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149193984|NCT00782418|538179243|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149193985|NCT00782418|538179244|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
149193986|NCT00782418|538179238|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
149193987|NCT00782418|538179239|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149193988|NCT00782418|538179240|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149193989|NCT00782418|538179241|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149193990|NCT00782418|538179242|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
149193991|NCT00782418|538179243|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
149193992|NCT00782418|538179244|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
149193993|NCT00882999|538179245|FG000|Overall Study|Adverse Event|0|||
149193994|NCT00882999|538179246|FG001|Overall Study|Adverse Event|0|||
149193995|NCT00882999|538179247|FG002|Overall Study|Adverse Event|0|||
149193996|NCT00882999|538179248|FG003|Overall Study|Adverse Event|0|||
149193997|NCT00882999|538179249|FG004|Overall Study|Adverse Event|1|||
149193998|NCT00882999|538179250|FG005|Overall Study|Adverse Event|0|||
149193999|NCT00882999|538179251|FG006|Overall Study|Adverse Event|0|||
149194000|NCT00882999|538179245|FG000|Overall Study|Death|0|||
149194001|NCT00882999|538179246|FG001|Overall Study|Death|1|||
149194002|NCT00882999|538179247|FG002|Overall Study|Death|0|||
149194003|NCT00882999|538179248|FG003|Overall Study|Death|0|||
149194004|NCT00882999|538179249|FG004|Overall Study|Death|0|||
149194005|NCT00882999|538179250|FG005|Overall Study|Death|0|||
149194006|NCT00882999|538179251|FG006|Overall Study|Death|0|||
149194007|NCT00882999|538179245|FG000|Overall Study|Withdrawal by Subject|7|||
149194008|NCT00882999|538179246|FG001|Overall Study|Withdrawal by Subject|6|||
149194009|NCT00882999|538179247|FG002|Overall Study|Withdrawal by Subject|3|||
149194010|NCT00882999|538179248|FG003|Overall Study|Withdrawal by Subject|3|||
149194011|NCT00882999|538179249|FG004|Overall Study|Withdrawal by Subject|6|||
149194012|NCT00882999|538179250|FG005|Overall Study|Withdrawal by Subject|5|||
149194013|NCT00882999|538179251|FG006|Overall Study|Withdrawal by Subject|5|||
149194014|NCT00882999|538179245|FG000|Overall Study|Lost to Follow-up|0|||
149194015|NCT00882999|538179246|FG001|Overall Study|Lost to Follow-up|1|||
149194016|NCT00882999|538179247|FG002|Overall Study|Lost to Follow-up|1|||
149194017|NCT00882999|538179248|FG003|Overall Study|Lost to Follow-up|2|||
149194018|NCT00882999|538179249|FG004|Overall Study|Lost to Follow-up|1|||
149194019|NCT00882999|538179250|FG005|Overall Study|Lost to Follow-up|1|||
149194020|NCT00882999|538179251|FG006|Overall Study|Lost to Follow-up|2|||
149194021|NCT00882999|538179245|FG000|Overall Study|Physician Decision|1|||
149194022|NCT00882999|538179246|FG001|Overall Study|Physician Decision|0|||
149194023|NCT00882999|538179247|FG002|Overall Study|Physician Decision|0|||
149194024|NCT00882999|538179248|FG003|Overall Study|Physician Decision|0|||
149194025|NCT00882999|538179249|FG004|Overall Study|Physician Decision|0|||
149194026|NCT00882999|538179250|FG005|Overall Study|Physician Decision|1|||
149194027|NCT00882999|538179251|FG006|Overall Study|Physician Decision|1|||
149194028|NCT01757405|538179254|FG000|Overall Study|Lost to Follow-up|1|||
149194029|NCT01757405|538179255|FG001|Overall Study|Lost to Follow-up|1|||
149194030|NCT01757405|538179254|FG000|Overall Study|Withdrawal by Subject|0|||
149194031|NCT01757405|538179255|FG001|Overall Study|Withdrawal by Subject|1|||
149194032|NCT00082758|538179257|FG000|Overall Study|Adverse Event|0|||
149194033|NCT00082758|538179258|FG001|Overall Study|Adverse Event|2|||
149194034|NCT00082758|538179259|FG002|Overall Study|Adverse Event|0|||
149194035|NCT00082758|538179257|FG000|Overall Study|Lack of Efficacy|12|||
149194036|NCT00082758|538179258|FG001|Overall Study|Lack of Efficacy|13|||
149194037|NCT00082758|538179259|FG002|Overall Study|Lack of Efficacy|0|||
149194038|NCT00082758|538179257|FG000|Overall Study|Physician Decision|0|||
149194039|NCT00082758|538179258|FG001|Overall Study|Physician Decision|1|||
149194040|NCT00082758|538179259|FG002|Overall Study|Physician Decision|0|||
149194041|NCT00082758|538179257|FG000|Overall Study|Withdrawal by Subject|3|||
149194042|NCT00082758|538179258|FG001|Overall Study|Withdrawal by Subject|0|||
149194043|NCT00082758|538179259|FG002|Overall Study|Withdrawal by Subject|0|||
149194044|NCT00082758|538179257|FG000|Overall Study|Protocol Violation|0|||
149194045|NCT00082758|538179258|FG001|Overall Study|Protocol Violation|1|||
149194046|NCT00082758|538179259|FG002|Overall Study|Protocol Violation|0|||
149194047|NCT00238303|538179260|FG000|Overall Study|Withdrawal by Subject|11|||
149194048|NCT00238303|538179261|FG001|Overall Study|Withdrawal by Subject|1|||
149194049|NCT00238303|538179262|FG002|Overall Study|Withdrawal by Subject|2|||
149194050|NCT00238303|538179260|FG000|Overall Study|Death|1|||
149194051|NCT00238303|538179261|FG001|Overall Study|Death|0|||
149194052|NCT00238303|538179262|FG002|Overall Study|Death|1|||
149194053|NCT00238303|538179260|FG000|Overall Study|Other Medical Problems|2|||
149194054|NCT00238303|538179261|FG001|Overall Study|Other Medical Problems|0|||
149194055|NCT00238303|538179262|FG002|Overall Study|Other Medical Problems|2|||
149194056|NCT00238303|538179260|FG000|Overall Study|Poor tolerance of study treatment|1|||
149194057|NCT00238303|538179261|FG001|Overall Study|Poor tolerance of study treatment|0|||
149194058|NCT00238303|538179262|FG002|Overall Study|Poor tolerance of study treatment|1|||
149194059|NCT00238303|538179260|FG000|Overall Study|Adverse Event|0|||
149014982|NCT01115491|537534351|FG000|Overall Study|Withdrawal by Subject|1|||
149014983|NCT01115491|537534351|FG000|Overall Study|Physician Decision|1|||
149014984|NCT03856996|537534352|FG000|Overall Study|Withdrawal by Subject|1|||
149014985|NCT03856996|537534353|FG001|Overall Study|Withdrawal by Subject|0|||
149014986|NCT03856996|537534352|FG000|Overall Study|Lost to Follow-up|0|||
149014987|NCT03856996|537534353|FG001|Overall Study|Lost to Follow-up|1|||
149014988|NCT03856996|537534352|FG000|Overall Study|Adverse Event|1|||
149014989|NCT03856996|537534353|FG001|Overall Study|Adverse Event|1|||
148935930|NCT00369707|537249488|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
148935931|NCT00369707|537249488|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
148935932|NCT00369707|537249488|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
148935933|NCT00369707|537249488|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
148935934|NCT00369707|537249488|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
148935935|NCT00369707|537249488|FG000|Follow up for 2 Years After Treatment|Death|1|||
149014990|NCT03856996|537534352|FG000|Overall Study|Other|1|||
149014991|NCT03856996|537534353|FG001|Overall Study|Other|0|||
149014992|NCT01586338|537534356|FG000|Overall Study|Adverse Event|3|||
149014993|NCT01586338|537534356|FG000|Overall Study|Lost to Follow-up|1|||
149014994|NCT01586338|537534356|FG000|Overall Study|Withdrawal by participant|3|||
149014995|NCT01586338|537534356|FG000|Overall Study|Other|1|||
149014996|NCT03306043|537534359|FG000|Overall Study|Adverse Event|1|||
149014997|NCT03306043|537534359|FG000|Overall Study|Lost to Follow-up|1|||
149014998|NCT03306043|537534359|FG000|Overall Study|Withdrawal by Subject|2|||
149014999|NCT01544491|537534360|FG000|Overall Study|Withdrawal by Subject|3|||
149015000|NCT01544491|537534361|FG001|Overall Study|Withdrawal by Subject|2|||
149015001|NCT01544491|537534360|FG000|Overall Study|Lost to Follow-up|0|||
149015002|NCT01544491|537534361|FG001|Overall Study|Lost to Follow-up|1|||
149015003|NCT01544491|537534360|FG000|Overall Study|administrative problems|2|||
149015004|NCT01544491|537534361|FG001|Overall Study|administrative problems|0|||
149015005|NCT01799720|537534362|FG000|Overall Study|Withdrawal by Subject|3|||
149015006|NCT01799720|537534363|FG001|Overall Study|Withdrawal by Subject|0|||
149015007|NCT01799720|537534364|FG002|Overall Study|Withdrawal by Subject|0|||
149015008|NCT01799720|537534362|FG000|Overall Study|Protocol Violation|0|||
149015009|NCT01799720|537534363|FG001|Overall Study|Protocol Violation|1|||
148681975|NCT01270841|536309400|FG003|Overall Study|Adverse Event|3|||
148935936|NCT00369707|537249488|FG000|Follow up for 2 Years After Treatment|Other|2|||
148935937|NCT03605212|537249493|FG000|Treatment Period|Adverse Event|1|||
148935938|NCT03605212|537249494|FG001|Treatment Period|Adverse Event|0|||
148935939|NCT03605212|537249495|FG002|Treatment Period|Adverse Event|0|||
148935940|NCT03605212|537249496|FG003|Treatment Period|Adverse Event|0|||
148935941|NCT03605212|537249497|FG004|Treatment Period|Adverse Event|0|||
148935942|NCT03605212|537249493|FG000|Treatment Period|Physician Decision|0|||
148935943|NCT03605212|537249494|FG001|Treatment Period|Physician Decision|0|||
148935944|NCT03605212|537249495|FG002|Treatment Period|Physician Decision|0|||
148935945|NCT03605212|537249496|FG003|Treatment Period|Physician Decision|0|||
148935946|NCT03605212|537249497|FG004|Treatment Period|Physician Decision|1|||
148935947|NCT01254292|537249498|FG000|Comparative Phase|Adverse Event|25|||
148935948|NCT01254292|537249499|FG001|Comparative Phase|Adverse Event|25|||
148935949|NCT01254292|537249498|FG000|Comparative Phase|Lost to Follow-up|3|||
148935950|NCT01254292|537249499|FG001|Comparative Phase|Lost to Follow-up|21|||
148935951|NCT01254292|537249498|FG000|Comparative Phase|Pregnancy|2|||
148935952|NCT01254292|537249499|FG001|Comparative Phase|Pregnancy|6|||
148935953|NCT01254292|537249498|FG000|Comparative Phase|Withdrawal by Subject|20|||
149015010|NCT01799720|537534364|FG002|Overall Study|Protocol Violation|0|||
149015011|NCT01799720|537534362|FG000|Overall Study|Pregnancy|0|||
148935954|NCT01254292|537249499|FG001|Comparative Phase|Withdrawal by Subject|21|||
149015012|NCT01799720|537534363|FG001|Overall Study|Pregnancy|0|||
149015013|NCT01799720|537534364|FG002|Overall Study|Pregnancy|1|||
149015014|NCT02733042|537534372|FG000|Overall Study|Adverse Event|1|||
149015015|NCT02733042|537534373|FG001|Overall Study|Adverse Event|0|||
149015016|NCT02733042|537534374|FG002|Overall Study|Adverse Event|1|||
149015017|NCT02733042|537534375|FG003|Overall Study|Adverse Event|1|||
149015018|NCT02733042|537534376|FG004|Overall Study|Adverse Event|0|||
149194060|NCT00238303|538179261|FG001|Overall Study|Adverse Event|1|||
149194061|NCT00238303|538179262|FG002|Overall Study|Adverse Event|3|||
149194062|NCT00937560|538179264|FG000|Initial Treatment|Death|6|||
149194063|NCT00937560|538179264|FG000|Initial Treatment|Withdraw consent|3|||
149194064|NCT00937560|538179264|FG000|Initial Treatment|Adverse Event|1|||
149194065|NCT00937560|538179264|FG000|Initial Treatment|Lost to Follow-up|1|||
149194066|NCT00937560|538179264|FG000|Initial Treatment|No end of study page|10|||
149194067|NCT00937560|538179264|FG000|Maintenance Treatment|Death|12|||
149194068|NCT00937560|538179264|FG000|Maintenance Treatment|Withdraw consent|5|||
149194069|NCT00937560|538179264|FG000|Maintenance Treatment|According to protocol|1|||
149194070|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
149194071|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
149194072|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
149194073|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
149194074|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
149194075|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
149194076|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
149194077|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
149194078|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
149194079|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
149194080|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
149194081|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
149194082|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
149194083|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
149194084|NCT00848549|538179265|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
149194085|NCT00848549|538179266|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
149194086|NCT00848549|538179265|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
149194087|NCT00848549|538179266|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
149194088|NCT00848549|538179265|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
149194089|NCT00848549|538179266|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
149194090|NCT00848549|538179265|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
149194091|NCT00848549|538179266|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
149194092|NCT00848549|538179265|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
149194093|NCT00848549|538179266|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
149194094|NCT00848549|538179265|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
149194095|NCT00848549|538179266|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
149194096|NCT00848549|538179265|FG000|E2090-E044-314 (Extension Study)|Other|5|||
149194097|NCT00848549|538179266|FG001|E2090-E044-314 (Extension Study)|Other|6|||
149194098|NCT01248130|538179269|FG000|Overall Study|Protocol Violation|1|||
149194099|NCT01248130|538179270|FG001|Overall Study|Protocol Violation|0|||
149194100|NCT01248130|538179269|FG000|Overall Study|Ineligible|1|||
149194101|NCT01248130|538179270|FG001|Overall Study|Ineligible|0|||
149194102|NCT01994226|538179273|FG000|Overall Study|Protocol Violation|13|||
149194103|NCT01994226|538179274|FG001|Overall Study|Protocol Violation|10|||
149194104|NCT01994226|538179273|FG000|Overall Study|Early Cessation of treatment|6|||
149194105|NCT01994226|538179274|FG001|Overall Study|Early Cessation of treatment|11|||
149194106|NCT02488551|538179280|FG000|Overall Study|Lost to Follow-up|4|||
149194107|NCT02488551|538179281|FG001|Overall Study|Lost to Follow-up|7|||
149194108|NCT02488551|538179282|FG002|Overall Study|Lost to Follow-up|0|||
149194109|NCT02488551|538179283|FG003|Overall Study|Lost to Follow-up|0|||
149194110|NCT02488551|538179280|FG000|Overall Study|Military Deployment|1|||
149194111|NCT02488551|538179281|FG001|Overall Study|Military Deployment|1|||
149194112|NCT02488551|538179282|FG002|Overall Study|Military Deployment|0|||
149194113|NCT02488551|538179283|FG003|Overall Study|Military Deployment|0|||
149194114|NCT04507867|538179291|FG000|Overall Study|Death|7|||
149194115|NCT04507867|538179292|FG001|Overall Study|Death|1|||
149194116|NCT01860534|538179295|FG000|ROP #1|Needed treatment for ROP|0|||
149194117|NCT01860534|538179296|FG001|ROP #1|Needed treatment for ROP|1|||
149194118|NCT01860534|538179295|FG000|ROP #2|discharged prior to ROP #2|1|||
149194119|NCT01860534|538179296|FG001|ROP #2|discharged prior to ROP #2|0|||
149194120|NCT01188564|538179297|FG000|Double-blind Phase|randomized not treated|1|||
149194121|NCT01188564|538179298|FG001|Double-blind Phase|randomized not treated|0|||
149194122|NCT04171037|538179299|FG000|Overall Study|Lost to Follow-up|1|||
149194123|NCT04171037|538179300|FG001|Overall Study|Lost to Follow-up|0|||
149194124|NCT04171037|538179299|FG000|Overall Study|Physician Decision|3|||
149194125|NCT04171037|538179300|FG001|Overall Study|Physician Decision|3|||
149194126|NCT01934894|538179301|FG000|Overall Study|Adverse Event|1|||
149194127|NCT01934894|538179302|FG001|Overall Study|Adverse Event|2|||
149194128|NCT01934894|538179301|FG000|Overall Study|Death|2|||
149194129|NCT01934894|538179302|FG001|Overall Study|Death|0|||
149194130|NCT01934894|538179301|FG000|Overall Study|Withdrawal by Subject|0|||
149194131|NCT01934894|538179302|FG001|Overall Study|Withdrawal by Subject|1|||
149194132|NCT01934894|538179301|FG000|Overall Study|Progressive Disease|3|||
149194133|NCT01934894|538179302|FG001|Overall Study|Progressive Disease|2|||
148935955|NCT01254292|537249498|FG000|Comparative Phase|Protocol Violation|1|||
148935956|NCT01254292|537249499|FG001|Comparative Phase|Protocol Violation|2|||
148935957|NCT01254292|537249498|FG000|Comparative Phase|Wish for pregnancy|4|||
148935958|NCT01254292|537249499|FG001|Comparative Phase|Wish for pregnancy|6|||
148935959|NCT01254292|537249498|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
148935960|NCT01254292|537249499|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
148935961|NCT01254292|537249498|FG000|LCS12 Extension Phase|Adverse Event|9|||
148935962|NCT01254292|537249499|FG001|LCS12 Extension Phase|Adverse Event|0|||
148935963|NCT01254292|537249498|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
148935964|NCT01254292|537249499|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
148935965|NCT01254292|537249498|FG000|LCS12 Extension Phase|Other unknown|4|||
148935966|NCT01254292|537249499|FG001|LCS12 Extension Phase|Other unknown|0|||
148935967|NCT01254292|537249498|FG000|LCS12 Extension Phase|Pregnancy|2|||
148935968|NCT01254292|537249499|FG001|LCS12 Extension Phase|Pregnancy|0|||
148935969|NCT01254292|537249498|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
148935970|NCT01254292|537249499|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
148935971|NCT02083081|537249500|FG000|Overall Study|Lost to Follow-up|31|||
148935972|NCT02083081|537249501|FG001|Overall Study|Lost to Follow-up|9|||
148935973|NCT01230710|537249504|FG000|Overall Study|Disease Progression|41|||
149194134|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
149194135|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194136|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194137|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194138|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194139|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194140|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194141|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194142|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149194143|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
149194144|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194145|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194146|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194147|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194148|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194149|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194150|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194151|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149194152|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
149194153|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149194154|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149194155|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149194156|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149194157|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149194158|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148935974|NCT01230710|537249504|FG000|Overall Study|Lost to Follow-up|3|||
148935975|NCT01230710|537249504|FG000|Overall Study|Death|4|||
148935976|NCT01230710|537249504|FG000|Overall Study|Withdrawal of Consent|1|||
148935977|NCT02905149|537249505|FG000|Overall Study|Lost to Follow-up|2|||
148935978|NCT02905149|537249506|FG001|Overall Study|Lost to Follow-up|0|||
148935979|NCT03277690|537249507|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
148935980|NCT03277690|537249508|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
148935981|NCT03277690|537249507|FG000|Dose Titration and Maintenance|Physician Decision|1|||
148935982|NCT03277690|537249508|FG001|Dose Titration and Maintenance|Physician Decision|0|||
149194159|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149194160|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148935983|NCT03277690|537249507|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
148935984|NCT03277690|537249508|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
148935985|NCT03277690|537249507|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
148935986|NCT03277690|537249508|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
149194161|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
149194162|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194163|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194164|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194165|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194166|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194167|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194168|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194169|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
149194170|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
149194171|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194172|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194173|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194174|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194175|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194176|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194177|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194178|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149194179|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
148935987|NCT03277690|537249507|FG000|Dose Titration and Maintenance|Adverse Event|15|||
148935988|NCT03277690|537249508|FG001|Dose Titration and Maintenance|Adverse Event|0|||
148935989|NCT03277690|537249507|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
148935990|NCT03277690|537249508|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
148935991|NCT03277690|537249507|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
148935992|NCT03277690|537249508|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
148935993|NCT00747812|537249509|FG000|Overall Study|Research Site Staff Relocation|5|||
148935994|NCT00747812|537249510|FG001|Overall Study|Research Site Staff Relocation|3|||
148935995|NCT01708161|537249511|FG000|Overall Study|Adverse Event|1|||
148935996|NCT01708161|537249512|FG001|Overall Study|Adverse Event|3|||
148935997|NCT01708161|537249513|FG002|Overall Study|Adverse Event|4|||
148935998|NCT01708161|537249514|FG003|Overall Study|Adverse Event|2|||
148935999|NCT01708161|537249515|FG004|Overall Study|Adverse Event|3|||
148936000|NCT01708161|537249516|FG005|Overall Study|Adverse Event|0|||
148936001|NCT01708161|537249511|FG000|Overall Study|Death|0|||
148936002|NCT01708161|537249512|FG001|Overall Study|Death|0|||
148936003|NCT01708161|537249513|FG002|Overall Study|Death|0|||
148936004|NCT01708161|537249514|FG003|Overall Study|Death|1|||
148936005|NCT01708161|537249515|FG004|Overall Study|Death|0|||
149194180|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194181|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
148807718|NCT02469233|536774420|FG001|Overall Study|Death|1|||
148936006|NCT01708161|537249516|FG005|Overall Study|Death|1|||
149194182|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194183|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194184|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194185|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194186|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194187|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149194188|NCT02175771|538179308|FG000|Run-In Period (Pre-assignment)|Other|8|||
149194189|NCT02175771|538179309|FG001|Run-In Period (Pre-assignment)|Other|0|||
149194190|NCT02175771|538179310|FG002|Run-In Period (Pre-assignment)|Other|0|||
149194191|NCT02175771|538179311|FG003|Run-In Period (Pre-assignment)|Other|0|||
149194192|NCT02175771|538179312|FG004|Run-In Period (Pre-assignment)|Other|0|||
149194193|NCT02175771|538179313|FG005|Run-In Period (Pre-assignment)|Other|0|||
149194194|NCT02175771|538179314|FG006|Run-In Period (Pre-assignment)|Other|0|||
149194195|NCT02175771|538179315|FG007|Run-In Period (Pre-assignment)|Other|0|||
149194196|NCT02175771|538179316|FG008|Run-In Period (Pre-assignment)|Other|0|||
149194197|NCT02175771|538179308|FG000|Treatment Period|Adverse Event|0|||
149194198|NCT02175771|538179309|FG001|Treatment Period|Adverse Event|2|||
149194199|NCT02175771|538179310|FG002|Treatment Period|Adverse Event|1|||
149194200|NCT02175771|538179311|FG003|Treatment Period|Adverse Event|1|||
149194201|NCT02175771|538179312|FG004|Treatment Period|Adverse Event|1|||
149194202|NCT02175771|538179313|FG005|Treatment Period|Adverse Event|3|||
149194203|NCT02175771|538179314|FG006|Treatment Period|Adverse Event|2|||
149194204|NCT02175771|538179315|FG007|Treatment Period|Adverse Event|0|||
149194205|NCT02175771|538179316|FG008|Treatment Period|Adverse Event|1|||
149194206|NCT02175771|538179308|FG000|Treatment Period|Withdrawal by Subject|0|||
149194207|NCT02175771|538179309|FG001|Treatment Period|Withdrawal by Subject|9|||
149194208|NCT02175771|538179310|FG002|Treatment Period|Withdrawal by Subject|3|||
149194209|NCT02175771|538179311|FG003|Treatment Period|Withdrawal by Subject|6|||
149194210|NCT02175771|538179312|FG004|Treatment Period|Withdrawal by Subject|2|||
149194211|NCT02175771|538179313|FG005|Treatment Period|Withdrawal by Subject|4|||
149194212|NCT02175771|538179314|FG006|Treatment Period|Withdrawal by Subject|2|||
149194213|NCT02175771|538179315|FG007|Treatment Period|Withdrawal by Subject|9|||
149194214|NCT02175771|538179316|FG008|Treatment Period|Withdrawal by Subject|2|||
149194215|NCT02175771|538179308|FG000|Treatment Period|Noncompliance|0|||
149194216|NCT02175771|538179309|FG001|Treatment Period|Noncompliance|1|||
149194217|NCT02175771|538179310|FG002|Treatment Period|Noncompliance|2|||
149194218|NCT02175771|538179311|FG003|Treatment Period|Noncompliance|0|||
149194219|NCT02175771|538179312|FG004|Treatment Period|Noncompliance|0|||
149194220|NCT02175771|538179313|FG005|Treatment Period|Noncompliance|0|||
149194221|NCT02175771|538179314|FG006|Treatment Period|Noncompliance|0|||
149194222|NCT02175771|538179315|FG007|Treatment Period|Noncompliance|0|||
149194223|NCT02175771|538179316|FG008|Treatment Period|Noncompliance|1|||
149194224|NCT02175771|538179308|FG000|Treatment Period|Protocol Violation|0|||
149194225|NCT02175771|538179309|FG001|Treatment Period|Protocol Violation|0|||
149194226|NCT02175771|538179310|FG002|Treatment Period|Protocol Violation|0|||
149194227|NCT02175771|538179311|FG003|Treatment Period|Protocol Violation|0|||
149194228|NCT02175771|538179312|FG004|Treatment Period|Protocol Violation|0|||
149194229|NCT02175771|538179313|FG005|Treatment Period|Protocol Violation|0|||
149194230|NCT02175771|538179314|FG006|Treatment Period|Protocol Violation|0|||
149194231|NCT02175771|538179315|FG007|Treatment Period|Protocol Violation|1|||
149194232|NCT02175771|538179316|FG008|Treatment Period|Protocol Violation|0|||
149194233|NCT02175771|538179308|FG000|Treatment Period|Disease progression|0|||
149194234|NCT02175771|538179309|FG001|Treatment Period|Disease progression|0|||
149194235|NCT02175771|538179310|FG002|Treatment Period|Disease progression|0|||
148936007|NCT01708161|537249511|FG000|Overall Study|Withdrawal by Subject|0|||
148936008|NCT01708161|537249512|FG001|Overall Study|Withdrawal by Subject|1|||
148936009|NCT01708161|537249513|FG002|Overall Study|Withdrawal by Subject|1|||
149194236|NCT02175771|538179311|FG003|Treatment Period|Disease progression|0|||
149194237|NCT02175771|538179312|FG004|Treatment Period|Disease progression|0|||
149194238|NCT02175771|538179313|FG005|Treatment Period|Disease progression|0|||
148936010|NCT01708161|537249514|FG003|Overall Study|Withdrawal by Subject|0|||
149194239|NCT02175771|538179314|FG006|Treatment Period|Disease progression|0|||
149194240|NCT02175771|538179315|FG007|Treatment Period|Disease progression|2|||
149194241|NCT02175771|538179316|FG008|Treatment Period|Disease progression|0|||
149194242|NCT02175771|538179308|FG000|Treatment Period|Lost to Follow-up|0|||
149194243|NCT02175771|538179309|FG001|Treatment Period|Lost to Follow-up|3|||
148807719|NCT02469233|536774419|FG000|Overall Study|Lost to post or 6 month follow up|7|||
149194244|NCT02175771|538179310|FG002|Treatment Period|Lost to Follow-up|1|||
149194245|NCT02175771|538179311|FG003|Treatment Period|Lost to Follow-up|3|||
149194246|NCT02175771|538179312|FG004|Treatment Period|Lost to Follow-up|1|||
149194247|NCT02175771|538179313|FG005|Treatment Period|Lost to Follow-up|2|||
149194248|NCT02175771|538179314|FG006|Treatment Period|Lost to Follow-up|1|||
149194249|NCT02175771|538179315|FG007|Treatment Period|Lost to Follow-up|2|||
148936011|NCT01708161|537249515|FG004|Overall Study|Withdrawal by Subject|0|||
148936012|NCT01708161|537249516|FG005|Overall Study|Withdrawal by Subject|0|||
148936013|NCT01708161|537249511|FG000|Overall Study|Administrative problems|0|||
148936014|NCT01708161|537249512|FG001|Overall Study|Administrative problems|1|||
148936015|NCT01708161|537249513|FG002|Overall Study|Administrative problems|0|||
148936016|NCT01708161|537249514|FG003|Overall Study|Administrative problems|0|||
148936017|NCT01708161|537249515|FG004|Overall Study|Administrative problems|0|||
148936018|NCT01708161|537249516|FG005|Overall Study|Administrative problems|0|||
149194250|NCT02175771|538179316|FG008|Treatment Period|Lost to Follow-up|2|||
149194251|NCT02175771|538179308|FG000|Treatment Period|Lack of Efficacy|0|||
149194252|NCT02175771|538179309|FG001|Treatment Period|Lack of Efficacy|0|||
149194253|NCT02175771|538179310|FG002|Treatment Period|Lack of Efficacy|0|||
149194254|NCT02175771|538179311|FG003|Treatment Period|Lack of Efficacy|0|||
149194255|NCT02175771|538179312|FG004|Treatment Period|Lack of Efficacy|0|||
149194256|NCT02175771|538179313|FG005|Treatment Period|Lack of Efficacy|1|||
149194257|NCT02175771|538179314|FG006|Treatment Period|Lack of Efficacy|0|||
149194258|NCT02175771|538179315|FG007|Treatment Period|Lack of Efficacy|1|||
149194259|NCT02175771|538179316|FG008|Treatment Period|Lack of Efficacy|0|||
149194260|NCT02175771|538179308|FG000|Treatment Period|Other|0|||
149194261|NCT02175771|538179309|FG001|Treatment Period|Other|1|||
149194262|NCT02175771|538179310|FG002|Treatment Period|Other|0|||
149194263|NCT02175771|538179311|FG003|Treatment Period|Other|3|||
149194264|NCT02175771|538179312|FG004|Treatment Period|Other|1|||
149194265|NCT02175771|538179313|FG005|Treatment Period|Other|0|||
149194266|NCT02175771|538179314|FG006|Treatment Period|Other|0|||
149194267|NCT02175771|538179315|FG007|Treatment Period|Other|2|||
149194268|NCT02175771|538179316|FG008|Treatment Period|Other|0|||
149194269|NCT03364673|538179317|FG000|Overall Study|Withdrawal by Subject|2|||
149194270|NCT03364673|538179317|FG000|Overall Study|Injury unrelated to study|3|||
149194271|NCT02208024|538179318|FG000|Overall Study|Withdrawal by Subject|1|||
149194272|NCT00779324|538179319|FG000|Overall Study|Lost to Follow-up|2|||
149194273|NCT00779324|538179320|FG001|Overall Study|Lost to Follow-up|1|||
149194274|NCT00779324|538179319|FG000|Overall Study|Withdrawal by Subject|4|||
149194275|NCT00779324|538179320|FG001|Overall Study|Withdrawal by Subject|2|||
149194276|NCT00779324|538179319|FG000|Overall Study|Missed visit|1|||
149194277|NCT00779324|538179320|FG001|Overall Study|Missed visit|1|||
149194278|NCT02207556|538179321|FG000|Overall Study|Physician Decision|1|||
149194279|NCT02207556|538179322|FG001|Overall Study|Physician Decision|0|||
149194280|NCT02207556|538179321|FG000|Overall Study|Withdrawal by Subject|1|||
149194281|NCT02207556|538179322|FG001|Overall Study|Withdrawal by Subject|0|||
149194282|NCT02207556|538179321|FG000|Overall Study|Death|0|||
149194283|NCT02207556|538179322|FG001|Overall Study|Death|5|||
148807720|NCT02469233|536774420|FG001|Overall Study|Lost to post or 6 month follow up|2|||
149015019|NCT02733042|537534377|FG005|Overall Study|Adverse Event|0|||
149015020|NCT02733042|537534378|FG006|Overall Study|Adverse Event|0|||
149015021|NCT02733042|537534379|FG007|Overall Study|Adverse Event|0|||
148936019|NCT01708161|537249511|FG000|Overall Study|Disease progression|3|||
148936020|NCT01708161|537249512|FG001|Overall Study|Disease progression|5|||
148936021|NCT01708161|537249513|FG002|Overall Study|Disease progression|5|||
149194284|NCT03558555|538179323|FG000|Overall Study|Lost to Follow-up|2|||
149194285|NCT03558555|538179324|FG001|Overall Study|Lost to Follow-up|1|||
149194286|NCT00194025|538179325|FG000|Overall Study|Adverse Event|1|||
149194287|NCT00194025|538179325|FG000|Overall Study|non-adherence with study medication|4|||
149194288|NCT01153763|538179328|FG000|Overall Study|Study Closed|16|||
149194289|NCT01153763|538179328|FG000|Overall Study|Lost to Follow-up|1|||
149194290|NCT01153763|538179328|FG000|Overall Study|Physician Decision|2|||
149194291|NCT01153763|538179328|FG000|Overall Study|Withdrawal by Subject|2|||
149194292|NCT04544709|538179329|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
149194293|NCT03238235|538179330|FG000|Overall Study|Adverse Event|2|||
149194294|NCT03238235|538179331|FG001|Overall Study|Adverse Event|0|||
149194295|NCT03238235|538179330|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
149194296|NCT03238235|538179331|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
149194297|NCT04436822|538179332|FG000|Overall Study|Physician Decision|2|||
149194298|NCT04436822|538179333|FG001|Overall Study|Physician Decision|0|||
149194299|NCT04436822|538179332|FG000|Overall Study|Sponsor request|1|||
149194300|NCT04436822|538179333|FG001|Overall Study|Sponsor request|0|||
149194301|NCT04436822|538179332|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149194302|NCT04436822|538179333|FG001|Overall Study|Withdrawal by parent/guardian|3|||
149194303|NCT04436822|538179332|FG000|Overall Study|Unsuccessful procedure|0|||
149194304|NCT04436822|538179333|FG001|Overall Study|Unsuccessful procedure|1|||
149194305|NCT04436822|538179332|FG000|Overall Study|Withdrawal due to Covid-19|8|||
149194306|NCT04436822|538179333|FG001|Overall Study|Withdrawal due to Covid-19|1|||
149194307|NCT04436822|538179332|FG000|Overall Study|Withdrawal by Subject|1|||
149194308|NCT04436822|538179333|FG001|Overall Study|Withdrawal by Subject|0|||
149194309|NCT04436822|538179332|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
149194310|NCT04436822|538179333|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
149194311|NCT04715230|538179334|FG000|Overall Study|Withdrawal by Subject|1|||
149194312|NCT04715230|538179335|FG001|Overall Study|Withdrawal by Subject|0|||
149194313|NCT04715230|538179336|FG002|Overall Study|Withdrawal by Subject|0|||
149194314|NCT04715230|538179334|FG000|Overall Study|Lost to Follow-up|0|||
149194315|NCT04715230|538179335|FG001|Overall Study|Lost to Follow-up|5|||
149194316|NCT04715230|538179336|FG002|Overall Study|Lost to Follow-up|1|||
149194317|NCT02457182|538180983|FG000|Overall Study|Lost to Follow-up|1|||
149194318|NCT02457182|538180984|FG001|Overall Study|Lost to Follow-up|0|||
149194319|NCT01009983|538180985|FG000|Overall Study|necessary scans not completed|1|||
149194320|NCT04410198|538180986|FG000|Overall Study|Death|10|||
149194321|NCT04410198|538180986|FG000|Overall Study|Withdrawal by Subject|7|||
149194322|NCT04410198|538180986|FG000|Overall Study|Transferred/Relocation|4|||
149194323|NCT04410198|538180986|FG000|Overall Study|Kidney Transplant|9|||
149194324|NCT04410198|538180986|FG000|Overall Study|Adverse Event|4|||
149194325|NCT04410198|538180986|FG000|Overall Study|Physician Decision|2|||
149194326|NCT04410198|538180986|FG000|Overall Study|Other than specified|1|||
149194327|NCT02338492|538180991|FG000|Overall Study|Death|32|||
149194328|NCT02338492|538180991|FG000|Overall Study|Adverse Event|3|||
149194329|NCT02338492|538180991|FG000|Overall Study|Lost to Follow-up|4|||
149194330|NCT02338492|538180991|FG000|Overall Study|Reason not captured above|6|||
149194331|NCT00756886|538180992|FG000|Overall Study|Lost to Follow-up|1|||
149194332|NCT00756886|538180993|FG001|Overall Study|Lost to Follow-up|0|||
149194333|NCT00756886|538180992|FG000|Overall Study|Adverse Event|0|||
149194334|NCT00756886|538180993|FG001|Overall Study|Adverse Event|3|||
149194335|NCT00756886|538180992|FG000|Overall Study|Lack of Efficacy|1|||
149194336|NCT00756886|538180993|FG001|Overall Study|Lack of Efficacy|0|||
149194337|NCT00756886|538180992|FG000|Overall Study|Ineligible|9|||
149194338|NCT00756886|538180993|FG001|Overall Study|Ineligible|4|||
149194339|NCT00120289|538180995|FG000|Overall Study|Death|96|||
149194340|NCT00120289|538180996|FG001|Overall Study|Death|82|||
149194341|NCT00120289|538180995|FG000|Overall Study|Lost to Follow-up|11|||
149194342|NCT00120289|538180996|FG001|Overall Study|Lost to Follow-up|14|||
149194343|NCT00120289|538180995|FG000|Overall Study|Withdrawal by Subject|14|||
149194344|NCT00120289|538180996|FG001|Overall Study|Withdrawal by Subject|13|||
149194345|NCT01911845|538181000|FG000|Overall Study|Adverse Event|2|||
149194346|NCT01911845|538181000|FG000|Overall Study|Lost to Follow-up|1|||
149194347|NCT01911845|538181000|FG000|Overall Study|Other (not specified)|3|||
149194348|NCT00501046|538181001|FG000|Overall Study|Adverse Event|21|||
149194349|NCT00501046|538181002|FG001|Overall Study|Adverse Event|25|||
149194350|NCT00501046|538181001|FG000|Overall Study|Death|23|||
149194351|NCT00501046|538181002|FG001|Overall Study|Death|30|||
149194352|NCT00501046|538181001|FG000|Overall Study|Lost to Follow-up|14|||
149194353|NCT00501046|538181002|FG001|Overall Study|Lost to Follow-up|13|||
149194354|NCT00501046|538181001|FG000|Overall Study|Physician Decision|7|||
149194355|NCT00501046|538181002|FG001|Overall Study|Physician Decision|2|||
149194356|NCT00501046|538181001|FG000|Overall Study|Pregnancy|0|||
149194357|NCT00501046|538181002|FG001|Overall Study|Pregnancy|3|||
149194358|NCT00501046|538181001|FG000|Overall Study|Protocol Violation|2|||
149194359|NCT00501046|538181002|FG001|Overall Study|Protocol Violation|1|||
149194360|NCT00501046|538181001|FG000|Overall Study|Withdrawal by Subject|84|||
149194361|NCT00501046|538181002|FG001|Overall Study|Withdrawal by Subject|83|||
149194362|NCT00501046|538181001|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
149194363|NCT00501046|538181002|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
149194364|NCT01576016|538181003|FG000|Lead Safety|Death|132|||
149194365|NCT01576016|538181004|FG001|Lead Safety|Death|0|||
149194366|NCT01576016|538181003|FG000|Lead Safety|Withdrawal by Subject|81|||
149194367|NCT01576016|538181004|FG001|Lead Safety|Withdrawal by Subject|0|||
149194368|NCT01576016|538181003|FG000|Lead Safety|System Explanted without Replacement|24|||
149194369|NCT01576016|538181004|FG001|Lead Safety|System Explanted without Replacement|0|||
149194370|NCT01576016|538181003|FG000|Lead Safety|Physician Decision|14|||
149194371|NCT01576016|538181004|FG001|Lead Safety|Physician Decision|0|||
149194372|NCT01576016|538181003|FG000|Lead Safety|Lost to Follow-up|13|||
149194373|NCT01576016|538181004|FG001|Lead Safety|Lost to Follow-up|0|||
149194374|NCT01576016|538181003|FG000|Lead Safety|Unsuccessful implant|2|||
149194375|NCT01576016|538181004|FG001|Lead Safety|Unsuccessful implant|0|||
149194376|NCT01576016|538181003|FG000|Lead Safety|Sponsor request|1|||
149194377|NCT01576016|538181004|FG001|Lead Safety|Sponsor request|0|||
149194378|NCT01576016|538181003|FG000|Lead Safety|Device replaced with CRT-D|1|||
149194379|NCT01576016|538181004|FG001|Lead Safety|Device replaced with CRT-D|0|||
149194380|NCT01576016|538181003|FG000|Lead Safety|Patient on Palliative Care|1|||
149194381|NCT01576016|538181004|FG001|Lead Safety|Patient on Palliative Care|0|||
149194382|NCT01576016|538181003|FG000|Lead Safety|Patient noncompliance|1|||
149194383|NCT01576016|538181004|FG001|Lead Safety|Patient noncompliance|0|||
149194384|NCT01576016|538181003|FG000|Lead Safety|Too far from study site|1|||
149194385|NCT01576016|538181004|FG001|Lead Safety|Too far from study site|0|||
149194386|NCT01576016|538181003|FG000|Lead Safety|System deactivated|1|||
149194387|NCT01576016|538181004|FG001|Lead Safety|System deactivated|0|||
149194388|NCT01576016|538181003|FG000|Lead Safety|Patient no longer followed by study PI|1|||
149194389|NCT01576016|538181004|FG001|Lead Safety|Patient no longer followed by study PI|0|||
149194390|NCT01576016|538181003|FG000|MRI Safety|Withdrawal by Subject|0|||
149194391|NCT01576016|538181004|FG001|MRI Safety|Withdrawal by Subject|10|||
149194392|NCT01576016|538181003|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
149194393|NCT01576016|538181004|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
149194394|NCT01576016|538181003|FG000|MRI Safety|Has not yet completed MRI scan|0|||
149194395|NCT01576016|538181004|FG001|MRI Safety|Has not yet completed MRI scan|56|||
149194396|NCT01576016|538181003|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
149194397|NCT01576016|538181004|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
149194398|NCT00543569|538181009|FG000|Overall Study|Death|2|||
149194399|NCT00543569|538181010|FG001|Overall Study|Death|2|||
149194400|NCT00543569|538181011|FG002|Overall Study|Death|3|||
149194401|NCT00543569|538181012|FG003|Overall Study|Death|1|||
149194402|NCT00543569|538181009|FG000|Overall Study|Lost to Follow-up|0|||
149194403|NCT00543569|538181010|FG001|Overall Study|Lost to Follow-up|0|||
149194404|NCT00543569|538181011|FG002|Overall Study|Lost to Follow-up|1|||
149194405|NCT00543569|538181012|FG003|Overall Study|Lost to Follow-up|1|||
149194406|NCT00543569|538181009|FG000|Overall Study|Miscellaneous Reasons|7|||
149194407|NCT00543569|538181010|FG001|Overall Study|Miscellaneous Reasons|3|||
149194408|NCT00543569|538181011|FG002|Overall Study|Miscellaneous Reasons|11|||
149194409|NCT00543569|538181012|FG003|Overall Study|Miscellaneous Reasons|4|||
149194410|NCT00543569|538181009|FG000|Overall Study|Randomized but never received study drug|3|||
149194411|NCT00543569|538181010|FG001|Overall Study|Randomized but never received study drug|3|||
149194412|NCT00543569|538181011|FG002|Overall Study|Randomized but never received study drug|5|||
149194413|NCT00543569|538181012|FG003|Overall Study|Randomized but never received study drug|3|||
149194414|NCT00862849|538181013|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149194415|NCT00862849|538181014|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
149194416|NCT00862849|538181015|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149194417|NCT00862849|538181016|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149194418|NCT00862849|538181017|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149194419|NCT00862849|538181018|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
149194420|NCT00862849|538181013|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149194421|NCT00862849|538181014|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
149194422|NCT00862849|538181015|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149194423|NCT00862849|538181016|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149194424|NCT00862849|538181017|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149194425|NCT00862849|538181018|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
149194426|NCT00511342|538181026|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
149194427|NCT00511342|538181027|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
149194428|NCT00511342|538181026|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
149194429|NCT00511342|538181027|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
148681976|NCT01270841|536309397|FG000|Overall Study|Withdrawal by Subject|3|||
148681977|NCT01270841|536309398|FG001|Overall Study|Withdrawal by Subject|2|||
148681978|NCT01270841|536309399|FG002|Overall Study|Withdrawal by Subject|3|||
148681979|NCT01270841|536309400|FG003|Overall Study|Withdrawal by Subject|3|||
148681980|NCT01270841|536309397|FG000|Overall Study|Lost to Follow-up|3|||
148681981|NCT01270841|536309398|FG001|Overall Study|Lost to Follow-up|1|||
149194430|NCT00511342|538181026|FG000|Overall Study|Pregnancy|0|||
149194431|NCT00511342|538181027|FG001|Overall Study|Pregnancy|1|||
149194432|NCT00511342|538181026|FG000|Overall Study|Pregnancy wish|0|||
149194433|NCT00511342|538181027|FG001|Overall Study|Pregnancy wish|1|||
149194434|NCT00511342|538181026|FG000|Overall Study|Lost to Follow-up|1|||
149194435|NCT00511342|538181027|FG001|Overall Study|Lost to Follow-up|5|||
148681982|NCT01270841|536309399|FG002|Overall Study|Lost to Follow-up|4|||
149194436|NCT00511342|538181026|FG000|Overall Study|Other Reason|2|||
149194437|NCT00511342|538181027|FG001|Overall Study|Other Reason|2|||
149194438|NCT02432040|538181028|FG000|Overall Study|Lack of Efficacy|3|||
149194439|NCT02432040|538181029|FG001|Overall Study|Lack of Efficacy|0|||
149194440|NCT02432040|538181028|FG000|Overall Study|Lost to Follow-up|4|||
149194441|NCT02432040|538181029|FG001|Overall Study|Lost to Follow-up|5|||
149194442|NCT02432040|538181028|FG000|Overall Study|Physician Decision|1|||
149194443|NCT02432040|538181029|FG001|Overall Study|Physician Decision|1|||
149194444|NCT03198754|538181031|FG000|Overall Study|Withdrawal by Subject|5|||
149194445|NCT03198754|538181032|FG001|Overall Study|Withdrawal by Subject|4|||
149194446|NCT03198754|538181031|FG000|Overall Study|Lost to Follow-up|4|||
149194447|NCT03198754|538181032|FG001|Overall Study|Lost to Follow-up|3|||
149194448|NCT03198754|538181031|FG000|Overall Study|Ineligible|2|||
149194449|NCT03198754|538181032|FG001|Overall Study|Ineligible|1|||
149194450|NCT00668200|538181038|FG000|Overall Study|Withdrawal by Subject|2|||
149194451|NCT00668200|538181038|FG000|Overall Study|Lost to Follow-up|1|||
149194452|NCT01474746|538181043|FG000|Overall Study|Lost to Follow-up|1|||
149194453|NCT01474746|538181044|FG001|Overall Study|Lost to Follow-up|1|||
149194454|NCT01474746|538181043|FG000|Overall Study|Withdrawal by Subject|2|||
149194455|NCT01474746|538181044|FG001|Overall Study|Withdrawal by Subject|1|||
149194456|NCT01606761|538181049|FG000|Prior to Week 24|Lost to Follow-up|0|||
149194457|NCT01606761|538181050|FG001|Prior to Week 24|Lost to Follow-up|3|||
149194458|NCT01606761|538181051|FG002|Prior to Week 24|Lost to Follow-up|2|||
149194459|NCT01606761|538181052|FG003|Prior to Week 24|Lost to Follow-up|0|||
149194460|NCT01606761|538181053|FG004|Prior to Week 24|Lost to Follow-up|0|||
149194461|NCT01606761|538181049|FG000|Prior to Week 24|Withdrawal by Subject|12|||
149194462|NCT01606761|538181050|FG001|Prior to Week 24|Withdrawal by Subject|10|||
149194463|NCT01606761|538181051|FG002|Prior to Week 24|Withdrawal by Subject|9|||
149194464|NCT01606761|538181052|FG003|Prior to Week 24|Withdrawal by Subject|0|||
149194465|NCT01606761|538181053|FG004|Prior to Week 24|Withdrawal by Subject|0|||
149194466|NCT01606761|538181049|FG000|Prior to Week 24|Adverse Event|11|||
149194467|NCT01606761|538181050|FG001|Prior to Week 24|Adverse Event|18|||
149194468|NCT01606761|538181051|FG002|Prior to Week 24|Adverse Event|22|||
149194469|NCT01606761|538181052|FG003|Prior to Week 24|Adverse Event|0|||
149194470|NCT01606761|538181053|FG004|Prior to Week 24|Adverse Event|0|||
149194471|NCT01606761|538181049|FG000|Prior to Week 24|Lack of Efficacy|15|||
149194472|NCT01606761|538181050|FG001|Prior to Week 24|Lack of Efficacy|14|||
149194473|NCT01606761|538181051|FG002|Prior to Week 24|Lack of Efficacy|8|||
149194474|NCT01606761|538181052|FG003|Prior to Week 24|Lack of Efficacy|0|||
149194475|NCT01606761|538181053|FG004|Prior to Week 24|Lack of Efficacy|0|||
149194476|NCT01606761|538181049|FG000|Prior to Week 24|Physician Decision|0|||
149194477|NCT01606761|538181050|FG001|Prior to Week 24|Physician Decision|3|||
149194478|NCT01606761|538181051|FG002|Prior to Week 24|Physician Decision|1|||
149194479|NCT01606761|538181052|FG003|Prior to Week 24|Physician Decision|0|||
149194480|NCT01606761|538181053|FG004|Prior to Week 24|Physician Decision|0|||
149194481|NCT01606761|538181049|FG000|Prior to Week 24|Other|4|||
149194482|NCT01606761|538181050|FG001|Prior to Week 24|Other|7|||
149194483|NCT01606761|538181051|FG002|Prior to Week 24|Other|5|||
149194484|NCT01606761|538181052|FG003|Prior to Week 24|Other|0|||
149194485|NCT01606761|538181053|FG004|Prior to Week 24|Other|0|||
149194486|NCT01606761|538181049|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
149194487|NCT01606761|538181050|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
149194488|NCT01606761|538181051|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
148681983|NCT01270841|536309400|FG003|Overall Study|Lost to Follow-up|2|||
148681984|NCT01270841|536309397|FG000|Overall Study|Physician Decision|0|||
148681985|NCT01270841|536309398|FG001|Overall Study|Physician Decision|1|||
148681986|NCT01270841|536309399|FG002|Overall Study|Physician Decision|0|||
148681987|NCT01270841|536309400|FG003|Overall Study|Physician Decision|0|||
148681988|NCT01270841|536309397|FG000|Overall Study|Did not qualify|6|||
149194489|NCT01606761|538181052|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
149194490|NCT01606761|538181053|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
149194491|NCT01606761|538181049|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
149194492|NCT01606761|538181050|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
149194493|NCT01606761|538181051|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
149194494|NCT01606761|538181052|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
149194495|NCT01606761|538181053|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
149194496|NCT01606761|538181049|FG000|Week 24 to Week 52|Adverse Event|0|||
149194497|NCT01606761|538181050|FG001|Week 24 to Week 52|Adverse Event|11|||
149194498|NCT01606761|538181051|FG002|Week 24 to Week 52|Adverse Event|14|||
149194499|NCT01606761|538181052|FG003|Week 24 to Week 52|Adverse Event|3|||
149194500|NCT01606761|538181053|FG004|Week 24 to Week 52|Adverse Event|15|||
149194501|NCT01606761|538181049|FG000|Week 24 to Week 52|Death|0|||
149194502|NCT01606761|538181050|FG001|Week 24 to Week 52|Death|0|||
149194503|NCT01606761|538181051|FG002|Week 24 to Week 52|Death|2|||
149194504|NCT01606761|538181052|FG003|Week 24 to Week 52|Death|1|||
148681989|NCT01270841|536309398|FG001|Overall Study|Did not qualify|3|||
149194505|NCT01606761|538181053|FG004|Week 24 to Week 52|Death|0|||
149194506|NCT01606761|538181049|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
149194507|NCT01606761|538181050|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
149194508|NCT01606761|538181051|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
148936022|NCT01708161|537249514|FG003|Overall Study|Disease progression|13|||
148936023|NCT01708161|537249515|FG004|Overall Study|Disease progression|3|||
149194509|NCT01606761|538181052|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
149194510|NCT01606761|538181053|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
149194511|NCT01606761|538181049|FG000|Week 24 to Week 52|Physician Decision|0|||
149194512|NCT01606761|538181050|FG001|Week 24 to Week 52|Physician Decision|1|||
149194513|NCT01606761|538181051|FG002|Week 24 to Week 52|Physician Decision|1|||
149194514|NCT01606761|538181052|FG003|Week 24 to Week 52|Physician Decision|0|||
149194515|NCT01606761|538181053|FG004|Week 24 to Week 52|Physician Decision|0|||
149194516|NCT01606761|538181049|FG000|Week 24 to Week 52|Other|0|||
149194517|NCT01606761|538181050|FG001|Week 24 to Week 52|Other|1|||
149194518|NCT01606761|538181051|FG002|Week 24 to Week 52|Other|5|||
149194519|NCT01606761|538181052|FG003|Week 24 to Week 52|Other|2|||
149194520|NCT01606761|538181053|FG004|Week 24 to Week 52|Other|2|||
149194521|NCT01606761|538181049|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
149194522|NCT01606761|538181050|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
149194523|NCT01606761|538181051|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
149194524|NCT01606761|538181052|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
149194525|NCT01606761|538181053|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
149194526|NCT01606761|538181049|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
149194527|NCT01606761|538181050|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
149194528|NCT01606761|538181051|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
149194529|NCT01606761|538181052|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
149194530|NCT01606761|538181053|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
149194531|NCT01606761|538181049|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
149194532|NCT01606761|538181050|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
149194533|NCT01606761|538181051|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
149194534|NCT01606761|538181052|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
149194535|NCT01606761|538181053|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
149194536|NCT01606761|538181049|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
149194537|NCT01606761|538181050|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
149194538|NCT01606761|538181051|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
149194539|NCT01606761|538181052|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
149194540|NCT01606761|538181053|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
149194541|NCT05086289|538181054|FG000|Overall Study|Adverse Event|4|||
149194542|NCT05086289|538181055|FG001|Overall Study|Adverse Event|2|||
149194543|NCT05086289|538181054|FG000|Overall Study|Lost to Follow-up|2|||
149194544|NCT05086289|538181055|FG001|Overall Study|Lost to Follow-up|0|||
149194545|NCT05086289|538181054|FG000|Overall Study|Non-compliance with study drug|2|||
149194546|NCT05086289|538181055|FG001|Overall Study|Non-compliance with study drug|1|||
149194547|NCT05086289|538181054|FG000|Overall Study|Physician Decision|2|||
149194548|NCT05086289|538181055|FG001|Overall Study|Physician Decision|0|||
149194549|NCT05086289|538181054|FG000|Overall Study|Withdrawal by Subject|5|||
149194550|NCT05086289|538181055|FG001|Overall Study|Withdrawal by Subject|2|||
149194551|NCT00515008|538181058|FG000|Overall Study|Lost to Follow-up|1|||
149194552|NCT00515008|538181059|FG001|Overall Study|Lost to Follow-up|0|||
149194553|NCT00515008|538181058|FG000|Overall Study|Declined|0|||
149194554|NCT00515008|538181059|FG001|Overall Study|Declined|3|||
149194555|NCT00515008|538181058|FG000|Overall Study|Left the Boston Area|1|||
149194556|NCT00515008|538181059|FG001|Overall Study|Left the Boston Area|1|||
149194557|NCT00515008|538181058|FG000|Overall Study|Scheduling conflict|1|||
149194558|NCT00515008|538181059|FG001|Overall Study|Scheduling conflict|0|||
149194559|NCT03135028|538181060|FG000|Overall Study|Death|6|||
149194560|NCT03135028|538181060|FG000|Overall Study|Study Terminated by Sponsor|2|||
149194561|NCT03135028|538181060|FG000|Overall Study|Withdrew Consent|1|||
149194562|NCT01814800|538181061|FG000|Overall Study|Adverse Event|2|||
149194563|NCT01814800|538181061|FG000|Overall Study|Pregnancy|1|||
148807721|NCT03979313|536774421|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
148807722|NCT03979313|536774422|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
149194564|NCT01814800|538181061|FG000|Overall Study|Sponsor decision|1|||
148807723|NCT03979313|536774421|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
148936024|NCT01708161|537249516|FG005|Overall Study|Disease progression|0|||
149194565|NCT01814800|538181061|FG000|Overall Study|Subject relocation|1|||
149194566|NCT02402218|538181062|FG000|Overall Study|Did not pickup study medication|12|||
149194567|NCT02402218|538181063|FG001|Overall Study|Did not pickup study medication|9|||
149194568|NCT02402218|538181064|FG002|Overall Study|Did not pickup study medication|13|||
149194569|NCT02402218|538181062|FG000|Overall Study|Lack of Efficacy|0|||
149194570|NCT02402218|538181063|FG001|Overall Study|Lack of Efficacy|1|||
149194571|NCT02402218|538181064|FG002|Overall Study|Lack of Efficacy|1|||
149194572|NCT02402218|538181062|FG000|Overall Study|Death|1|||
149194573|NCT02402218|538181063|FG001|Overall Study|Death|0|||
149194574|NCT02402218|538181064|FG002|Overall Study|Death|0|||
149194575|NCT02402218|538181062|FG000|Overall Study|Reinfection|0|||
149194576|NCT02402218|538181063|FG001|Overall Study|Reinfection|0|||
149194577|NCT02402218|538181064|FG002|Overall Study|Reinfection|1|||
149194578|NCT02402218|538181062|FG000|Overall Study|Adverse Event|0|||
149194579|NCT02402218|538181063|FG001|Overall Study|Adverse Event|2|||
149194580|NCT02402218|538181064|FG002|Overall Study|Adverse Event|1|||
149194581|NCT02402218|538181062|FG000|Overall Study|Withdrawal by Subject|1|||
149194582|NCT02402218|538181063|FG001|Overall Study|Withdrawal by Subject|1|||
149194583|NCT02402218|538181064|FG002|Overall Study|Withdrawal by Subject|1|||
149194584|NCT03807739|538181065|FG000|Overall Study|Adverse Event|1|||
149194585|NCT03807739|538181066|FG001|Overall Study|Adverse Event|0|||
149194586|NCT03807739|538181067|FG002|Overall Study|Adverse Event|0|||
149194587|NCT03807739|538181068|FG003|Overall Study|Adverse Event|0|||
149194588|NCT03807739|538181065|FG000|Overall Study|Withdrawal by Subject|1|||
149194589|NCT03807739|538181066|FG001|Overall Study|Withdrawal by Subject|0|||
149194590|NCT03807739|538181067|FG002|Overall Study|Withdrawal by Subject|0|||
149194591|NCT03807739|538181068|FG003|Overall Study|Withdrawal by Subject|0|||
149194592|NCT02371759|538181069|FG000|Overall Study|Protocol Violation|3|||
149194593|NCT02371759|538181070|FG001|Overall Study|Protocol Violation|1|||
149194594|NCT02371759|538181071|FG002|Overall Study|Protocol Violation|1|||
149194595|NCT02371759|538181072|FG003|Overall Study|Protocol Violation|0|||
149194596|NCT02371759|538181073|FG004|Overall Study|Protocol Violation|3|||
149194597|NCT02371759|538181074|FG005|Overall Study|Protocol Violation|1|||
149194598|NCT02371759|538181075|FG006|Overall Study|Protocol Violation|0|||
149194599|NCT02371759|538181076|FG007|Overall Study|Protocol Violation|3|||
149194600|NCT02371759|538181069|FG000|Overall Study|Withdrawal by Subject|0|||
149194601|NCT02371759|538181070|FG001|Overall Study|Withdrawal by Subject|0|||
149194602|NCT02371759|538181071|FG002|Overall Study|Withdrawal by Subject|0|||
149194603|NCT02371759|538181072|FG003|Overall Study|Withdrawal by Subject|0|||
149194604|NCT02371759|538181073|FG004|Overall Study|Withdrawal by Subject|0|||
149194605|NCT02371759|538181074|FG005|Overall Study|Withdrawal by Subject|0|||
149194606|NCT02371759|538181075|FG006|Overall Study|Withdrawal by Subject|0|||
149194607|NCT02371759|538181076|FG007|Overall Study|Withdrawal by Subject|1|||
149194608|NCT03375112|538181082|FG000|Overall Study|Withdrawal by Subject|3|||
149194609|NCT03375112|538181083|FG001|Overall Study|Withdrawal by Subject|0|||
149194610|NCT03599141|538181086|FG000|Overall Study|Lost to Follow-up|3|||
149194611|NCT03599141|538181087|FG001|Overall Study|Lost to Follow-up|1|||
149194612|NCT03136185|538181088|FG000|Overall Study|Adverse Event|0|||
149194613|NCT03136185|538181089|FG001|Overall Study|Adverse Event|1|||
149194614|NCT03136185|538181090|FG002|Overall Study|Adverse Event|3|||
149194615|NCT03136185|538181091|FG003|Overall Study|Adverse Event|1|||
149194616|NCT03136185|538181092|FG004|Overall Study|Adverse Event|2|||
149194617|NCT03136185|538181093|FG005|Overall Study|Adverse Event|2|||
149194618|NCT03136185|538181094|FG006|Overall Study|Adverse Event|5|||
149194619|NCT03136185|538181095|FG007|Overall Study|Adverse Event|1|||
149194620|NCT03136185|538181096|FG008|Overall Study|Adverse Event|1|||
149194621|NCT03136185|538181088|FG000|Overall Study|Death|0|||
149194622|NCT03136185|538181089|FG001|Overall Study|Death|0|||
149194623|NCT03136185|538181090|FG002|Overall Study|Death|0|||
149194624|NCT03136185|538181091|FG003|Overall Study|Death|1|||
149194625|NCT03136185|538181092|FG004|Overall Study|Death|1|||
149194626|NCT03136185|538181093|FG005|Overall Study|Death|0|||
149194627|NCT03136185|538181094|FG006|Overall Study|Death|1|||
149194628|NCT03136185|538181095|FG007|Overall Study|Death|0|||
149194629|NCT03136185|538181096|FG008|Overall Study|Death|0|||
149194630|NCT03136185|538181088|FG000|Overall Study|Physician Decision|3|||
149194631|NCT03136185|538181089|FG001|Overall Study|Physician Decision|1|||
149194632|NCT03136185|538181090|FG002|Overall Study|Physician Decision|1|||
149194633|NCT03136185|538181091|FG003|Overall Study|Physician Decision|2|||
149194634|NCT03136185|538181092|FG004|Overall Study|Physician Decision|1|||
149194635|NCT03136185|538181093|FG005|Overall Study|Physician Decision|2|||
149194636|NCT03136185|538181094|FG006|Overall Study|Physician Decision|1|||
149194637|NCT03136185|538181095|FG007|Overall Study|Physician Decision|0|||
149194638|NCT03136185|538181096|FG008|Overall Study|Physician Decision|1|||
149194639|NCT03136185|538181088|FG000|Overall Study|Protocol Defined Disease Progression|0|||
149194640|NCT03136185|538181089|FG001|Overall Study|Protocol Defined Disease Progression|0|||
149194641|NCT03136185|538181090|FG002|Overall Study|Protocol Defined Disease Progression|1|||
149194642|NCT03136185|538181091|FG003|Overall Study|Protocol Defined Disease Progression|0|||
149194643|NCT03136185|538181092|FG004|Overall Study|Protocol Defined Disease Progression|0|||
149194644|NCT03136185|538181093|FG005|Overall Study|Protocol Defined Disease Progression|1|||
149194645|NCT03136185|538181094|FG006|Overall Study|Protocol Defined Disease Progression|0|||
149194646|NCT03136185|538181095|FG007|Overall Study|Protocol Defined Disease Progression|1|||
149194647|NCT03136185|538181096|FG008|Overall Study|Protocol Defined Disease Progression|1|||
149194648|NCT03136185|538181088|FG000|Overall Study|Withdrawal by Subject|1|||
149194649|NCT03136185|538181089|FG001|Overall Study|Withdrawal by Subject|0|||
149194650|NCT03136185|538181090|FG002|Overall Study|Withdrawal by Subject|1|||
149194651|NCT03136185|538181091|FG003|Overall Study|Withdrawal by Subject|1|||
149194652|NCT03136185|538181092|FG004|Overall Study|Withdrawal by Subject|1|||
149194653|NCT03136185|538181093|FG005|Overall Study|Withdrawal by Subject|1|||
149194654|NCT03136185|538181094|FG006|Overall Study|Withdrawal by Subject|2|||
149194655|NCT03136185|538181095|FG007|Overall Study|Withdrawal by Subject|3|||
149194656|NCT03136185|538181096|FG008|Overall Study|Withdrawal by Subject|3|||
149194657|NCT03136185|538181088|FG000|Overall Study|Not Reported|4|||
149194658|NCT03136185|538181089|FG001|Overall Study|Not Reported|1|||
149194659|NCT03136185|538181090|FG002|Overall Study|Not Reported|0|||
149194660|NCT03136185|538181091|FG003|Overall Study|Not Reported|1|||
149194661|NCT03136185|538181092|FG004|Overall Study|Not Reported|0|||
149194662|NCT03136185|538181093|FG005|Overall Study|Not Reported|2|||
149194663|NCT03136185|538181094|FG006|Overall Study|Not Reported|1|||
149194664|NCT03136185|538181095|FG007|Overall Study|Not Reported|1|||
149194665|NCT03136185|538181096|FG008|Overall Study|Not Reported|0|||
149194666|NCT05118386|538181102|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149194667|NCT05118386|538181103|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149194668|NCT05118386|538181104|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149194669|NCT05118386|538181105|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
149194670|NCT05118386|538181106|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149194671|NCT05118386|538181107|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
149194672|NCT05118386|538181102|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149194673|NCT05118386|538181103|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149194674|NCT05118386|538181104|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149194675|NCT05118386|538181105|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149194676|NCT05118386|538181106|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
149194677|NCT05118386|538181107|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
149194678|NCT00369668|538181111|FG000|Overall Study|Lack of Efficacy|4|||
149194679|NCT00369668|538181112|FG001|Overall Study|Lack of Efficacy|5|||
149194680|NCT00369668|538181113|FG002|Overall Study|Lack of Efficacy|7|||
149194681|NCT03201198|538181116|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
149194682|NCT03201198|538181117|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
149194683|NCT03201198|538181116|FG000|Overall Study|Withdrawal by Subject|2|||
149194684|NCT03201198|538181117|FG001|Overall Study|Withdrawal by Subject|3|||
149194685|NCT03213626|538181125|FG000|Overall Study|Adverse Event|1|||
149194686|NCT03213626|538181125|FG000|Overall Study|Progressive Disease|6|||
149194687|NCT02596711|538181126|FG000|Overall Study|Lost to Follow-up|1|||
149194688|NCT02596711|538181127|FG001|Overall Study|Lost to Follow-up|2|||
149194689|NCT02596711|538181128|FG002|Overall Study|Lost to Follow-up|3|||
149194690|NCT00632463|538181130|FG000|Overall Study|Adverse Event|0|||
149194691|NCT00632463|538181131|FG001|Overall Study|Adverse Event|1|||
149194692|NCT00632463|538181132|FG002|Overall Study|Adverse Event|0|||
149194693|NCT01767194|538181135|FG000|Overall Study|Adverse Event|1|||
149194694|NCT01767194|538181136|FG001|Overall Study|Adverse Event|1|||
149194695|NCT01767194|538181135|FG000|Overall Study|Death|0|||
149194696|NCT01767194|538181136|FG001|Overall Study|Death|1|||
149194697|NCT01767194|538181135|FG000|Overall Study|Lack of Efficacy|12|||
149194698|NCT01767194|538181136|FG001|Overall Study|Lack of Efficacy|11|||
149194699|NCT01767194|538181135|FG000|Overall Study|Physician Decision|2|||
149194700|NCT01767194|538181136|FG001|Overall Study|Physician Decision|23|||
149194701|NCT01767194|538181135|FG000|Overall Study|Withdrawal by Subject|0|||
149194702|NCT01767194|538181136|FG001|Overall Study|Withdrawal by Subject|1|||
149194703|NCT01767194|538181135|FG000|Overall Study|Ineligible|1|||
149194704|NCT01767194|538181136|FG001|Overall Study|Ineligible|1|||
149194705|NCT01767194|538181135|FG000|Overall Study|Refusal by patient/parent|2|||
149194706|NCT01767194|538181136|FG001|Overall Study|Refusal by patient/parent|4|||
149194707|NCT01767194|538181135|FG000|Overall Study|Criteria not met on time for next cycle|0|||
149194708|NCT01767194|538181136|FG001|Overall Study|Criteria not met on time for next cycle|1|||
149194709|NCT02112994|538181137|FG000|Overall Study|Progressive Disease|0|||
149194710|NCT02112994|538181138|FG001|Overall Study|Progressive Disease|0|||
149194711|NCT02112994|538181139|FG002|Overall Study|Progressive Disease|1|||
149194712|NCT02112994|538181137|FG000|Overall Study|Pregnancy|0|||
149194713|NCT02112994|538181138|FG001|Overall Study|Pregnancy|1|||
149194714|NCT02112994|538181139|FG002|Overall Study|Pregnancy|1|||
149194715|NCT02112994|538181137|FG000|Overall Study|Liver Transplant|0|||
149194716|NCT02112994|538181138|FG001|Overall Study|Liver Transplant|1|||
149194717|NCT02112994|538181139|FG002|Overall Study|Liver Transplant|0|||
149194718|NCT02112994|538181137|FG000|Overall Study|Withdrawal by Subject|0|||
149194719|NCT02112994|538181138|FG001|Overall Study|Withdrawal by Subject|0|||
149194720|NCT02112994|538181139|FG002|Overall Study|Withdrawal by Subject|1|||
149194721|NCT01683071|538181143|FG000|Part 1|Lack of Efficacy|1|||
149194722|NCT01683071|538181144|FG001|Part 1|Lack of Efficacy|0|||
149194723|NCT01683071|538181145|FG002|Part 1|Lack of Efficacy|0|||
149194724|NCT01683071|538181146|FG003|Part 1|Lack of Efficacy|3|||
149194725|NCT01683071|538181147|FG004|Part 1|Lack of Efficacy|0|||
149194726|NCT01683071|538181148|FG005|Part 1|Lack of Efficacy|0|||
149194727|NCT01683071|538181143|FG000|Part 1|Withdrawal by Subject|1|||
149194728|NCT01683071|538181144|FG001|Part 1|Withdrawal by Subject|2|||
149194729|NCT01683071|538181145|FG002|Part 1|Withdrawal by Subject|2|||
149194730|NCT01683071|538181146|FG003|Part 1|Withdrawal by Subject|1|||
149194731|NCT01683071|538181147|FG004|Part 1|Withdrawal by Subject|0|||
149194732|NCT01683071|538181148|FG005|Part 1|Withdrawal by Subject|0|||
149194733|NCT01683071|538181143|FG000|Part 1|Surgery Cancelled|1|||
149194734|NCT01683071|538181144|FG001|Part 1|Surgery Cancelled|0|||
149194735|NCT01683071|538181145|FG002|Part 1|Surgery Cancelled|0|||
149194736|NCT01683071|538181146|FG003|Part 1|Surgery Cancelled|0|||
149194737|NCT01683071|538181147|FG004|Part 1|Surgery Cancelled|0|||
149194738|NCT01683071|538181148|FG005|Part 1|Surgery Cancelled|0|||
149194739|NCT01683071|538181143|FG000|Part 1|Did not receive study drug|1|||
149194740|NCT01683071|538181144|FG001|Part 1|Did not receive study drug|0|||
149194741|NCT01683071|538181145|FG002|Part 1|Did not receive study drug|0|||
149194742|NCT01683071|538181146|FG003|Part 1|Did not receive study drug|1|||
149194743|NCT01683071|538181147|FG004|Part 1|Did not receive study drug|0|||
149194744|NCT01683071|538181148|FG005|Part 1|Did not receive study drug|0|||
149194745|NCT01683071|538181143|FG000|Part 1|Early termination; met exclusion criteria|0|||
149194746|NCT01683071|538181144|FG001|Part 1|Early termination; met exclusion criteria|2|||
149194747|NCT01683071|538181145|FG002|Part 1|Early termination; met exclusion criteria|1|||
149194748|NCT01683071|538181146|FG003|Part 1|Early termination; met exclusion criteria|0|||
149194749|NCT01683071|538181147|FG004|Part 1|Early termination; met exclusion criteria|0|||
149194750|NCT01683071|538181148|FG005|Part 1|Early termination; met exclusion criteria|0|||
149194751|NCT01683071|538181143|FG000|Part 2|Lack of Efficacy|0|||
149194752|NCT01683071|538181144|FG001|Part 2|Lack of Efficacy|0|||
149194753|NCT01683071|538181145|FG002|Part 2|Lack of Efficacy|0|||
149194754|NCT01683071|538181146|FG003|Part 2|Lack of Efficacy|0|||
149194755|NCT01683071|538181147|FG004|Part 2|Lack of Efficacy|3|||
149194756|NCT01683071|538181148|FG005|Part 2|Lack of Efficacy|4|||
149194757|NCT01683071|538181143|FG000|Part 2|Lost to Follow-up|0|||
149194758|NCT01683071|538181144|FG001|Part 2|Lost to Follow-up|0|||
149194759|NCT01683071|538181145|FG002|Part 2|Lost to Follow-up|0|||
149194760|NCT01683071|538181146|FG003|Part 2|Lost to Follow-up|0|||
149194761|NCT01683071|538181147|FG004|Part 2|Lost to Follow-up|2|||
149194762|NCT01683071|538181148|FG005|Part 2|Lost to Follow-up|0|||
149194763|NCT01683071|538181143|FG000|Part 2|Withdrawal by Subject|0|||
149194764|NCT01683071|538181144|FG001|Part 2|Withdrawal by Subject|0|||
149194765|NCT01683071|538181145|FG002|Part 2|Withdrawal by Subject|0|||
149194766|NCT01683071|538181146|FG003|Part 2|Withdrawal by Subject|0|||
149194767|NCT01683071|538181147|FG004|Part 2|Withdrawal by Subject|3|||
149194768|NCT01683071|538181148|FG005|Part 2|Withdrawal by Subject|3|||
149194769|NCT01683071|538181143|FG000|Part 2|Surgery cancelled|0|||
149194770|NCT01683071|538181144|FG001|Part 2|Surgery cancelled|0|||
149194771|NCT01683071|538181145|FG002|Part 2|Surgery cancelled|0|||
149194772|NCT01683071|538181146|FG003|Part 2|Surgery cancelled|0|||
149194773|NCT01683071|538181147|FG004|Part 2|Surgery cancelled|4|||
149194774|NCT01683071|538181148|FG005|Part 2|Surgery cancelled|2|||
149194775|NCT01683071|538181143|FG000|Part 2|Did not receive study drug|0|||
149194776|NCT01683071|538181144|FG001|Part 2|Did not receive study drug|0|||
149194777|NCT01683071|538181145|FG002|Part 2|Did not receive study drug|0|||
149194778|NCT01683071|538181146|FG003|Part 2|Did not receive study drug|0|||
149194779|NCT01683071|538181147|FG004|Part 2|Did not receive study drug|2|||
149194780|NCT01683071|538181148|FG005|Part 2|Did not receive study drug|1|||
149194781|NCT01683071|538181143|FG000|Part 2|Met exclusion criterion|0|||
149194782|NCT01683071|538181144|FG001|Part 2|Met exclusion criterion|0|||
149194783|NCT01683071|538181145|FG002|Part 2|Met exclusion criterion|0|||
149194784|NCT01683071|538181146|FG003|Part 2|Met exclusion criterion|0|||
149194785|NCT01683071|538181147|FG004|Part 2|Met exclusion criterion|1|||
149194786|NCT01683071|538181148|FG005|Part 2|Met exclusion criterion|1|||
149194787|NCT01683071|538181143|FG000|Part 2|Protocol deviation|0|||
149194788|NCT01683071|538181144|FG001|Part 2|Protocol deviation|0|||
149194789|NCT01683071|538181145|FG002|Part 2|Protocol deviation|0|||
149194790|NCT01683071|538181146|FG003|Part 2|Protocol deviation|0|||
149194791|NCT01683071|538181147|FG004|Part 2|Protocol deviation|1|||
149194792|NCT01683071|538181148|FG005|Part 2|Protocol deviation|2|||
149194793|NCT01683071|538181143|FG000|Part 2|Withdrawal by investigator decision|0|||
149194794|NCT01683071|538181144|FG001|Part 2|Withdrawal by investigator decision|0|||
149194795|NCT01683071|538181145|FG002|Part 2|Withdrawal by investigator decision|0|||
149194796|NCT01683071|538181146|FG003|Part 2|Withdrawal by investigator decision|0|||
149194797|NCT01683071|538181147|FG004|Part 2|Withdrawal by investigator decision|1|||
149194798|NCT01683071|538181148|FG005|Part 2|Withdrawal by investigator decision|2|||
149194799|NCT00352755|538183285|FG000|Overall Study|Physician Decision|1|||
149194800|NCT00352755|538183285|FG000|Overall Study|Adverse Event|1|||
149194801|NCT02397694|538183286|FG000|Double-Blinded Phase|Adverse Event|1|||
149194802|NCT02397694|538183287|FG001|Double-Blinded Phase|Adverse Event|0|||
149194803|NCT02397694|538183286|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
149194804|NCT02397694|538183287|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
149194805|NCT02397694|538183286|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
149194806|NCT02397694|538183287|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
149194807|NCT02397694|538183286|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
149194808|NCT02397694|538183287|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
149194809|NCT02397694|538183286|FG000|Open Label Extension Phase|Protocol Violation|1|||
149194810|NCT02397694|538183287|FG001|Open Label Extension Phase|Protocol Violation|0|||
149194811|NCT02397694|538183286|FG000|Open Label Extension Phase|Withdrew Consent|3|||
149194812|NCT02397694|538183287|FG001|Open Label Extension Phase|Withdrew Consent|1|||
149194813|NCT02397694|538183286|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
149194814|NCT02397694|538183287|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
149194815|NCT01116687|538183288|FG000|Overall Study|Withdrawal by Subject|4|||
149194816|NCT00424528|538183289|FG000|Overall Study|Adverse Event|2|||
149194817|NCT00424528|538183290|FG001|Overall Study|Adverse Event|1|||
149194818|NCT00424528|538183291|FG002|Overall Study|Adverse Event|2|||
149194819|NCT00424528|538183289|FG000|Overall Study|Protocol Violation|1|||
149194820|NCT00424528|538183290|FG001|Overall Study|Protocol Violation|1|||
149194821|NCT00424528|538183291|FG002|Overall Study|Protocol Violation|0|||
149194822|NCT00424528|538183289|FG000|Overall Study|Lost to Follow-up|0|||
149194823|NCT00424528|538183290|FG001|Overall Study|Lost to Follow-up|1|||
149194824|NCT00424528|538183291|FG002|Overall Study|Lost to Follow-up|0|||
149194825|NCT00424528|538183289|FG000|Overall Study|noncompliance with study requirements|2|||
149194826|NCT00424528|538183290|FG001|Overall Study|noncompliance with study requirements|1|||
149194827|NCT00424528|538183291|FG002|Overall Study|noncompliance with study requirements|2|||
149194828|NCT02115113|538183292|FG000|Participants in Run-in Period|Death|0|||
149194829|NCT02115113|538183293|FG001|Participants in Run-in Period|Death|0|||
149194830|NCT02115113|538183294|FG002|Participants in Run-in Period|Death|1|||
149194831|NCT02115113|538183292|FG000|Participants in Run-in Period|Administrative problems|0|||
149194832|NCT02115113|538183293|FG001|Participants in Run-in Period|Administrative problems|0|||
149194833|NCT02115113|538183294|FG002|Participants in Run-in Period|Administrative problems|1|||
149194834|NCT02115113|538183292|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
149194835|NCT02115113|538183293|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
149194836|NCT02115113|538183294|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
149194837|NCT02115113|538183292|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
149194838|NCT02115113|538183293|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
149194839|NCT02115113|538183294|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
149194840|NCT02115113|538183292|FG000|Participants Randomized|Lost to Follow-up|1|||
149194841|NCT02115113|538183293|FG001|Participants Randomized|Lost to Follow-up|0|||
149194842|NCT02115113|538183294|FG002|Participants Randomized|Lost to Follow-up|0|||
149194843|NCT02115113|538183292|FG000|Participants Randomized|Death|1|||
148936025|NCT04209348|537249520|FG000|Overall Study|Lost to Follow-up|1|||
148936026|NCT04209348|537249521|FG001|Overall Study|Lost to Follow-up|0|||
148936027|NCT05055128|537249522|FG000|Overall Study|Adverse Event|0|||
149194844|NCT02115113|538183293|FG001|Participants Randomized|Death|0|||
149194845|NCT02115113|538183294|FG002|Participants Randomized|Death|0|||
149194846|NCT00789191|538183296|FG000|Overall Study|Adverse Event|2|||
148936028|NCT05055128|537249523|FG001|Overall Study|Adverse Event|0|||
148936029|NCT05055128|537249524|FG002|Overall Study|Adverse Event|0|||
148936030|NCT05055128|537249525|FG003|Overall Study|Adverse Event|1|||
148936031|NCT05055128|537249526|FG004|Overall Study|Adverse Event|1|||
148936032|NCT05055128|537249522|FG000|Overall Study|Protocol Violation|0|||
148936033|NCT05055128|537249523|FG001|Overall Study|Protocol Violation|0|||
148936034|NCT05055128|537249524|FG002|Overall Study|Protocol Violation|0|||
148936035|NCT05055128|537249525|FG003|Overall Study|Protocol Violation|1|||
148936036|NCT05055128|537249526|FG004|Overall Study|Protocol Violation|0|||
148936037|NCT05055128|537249522|FG000|Overall Study|Withdrawal by Subject|5|||
148936038|NCT05055128|537249523|FG001|Overall Study|Withdrawal by Subject|2|||
148936039|NCT05055128|537249524|FG002|Overall Study|Withdrawal by Subject|2|||
148936040|NCT05055128|537249525|FG003|Overall Study|Withdrawal by Subject|4|||
148936041|NCT05055128|537249526|FG004|Overall Study|Withdrawal by Subject|2|||
148936042|NCT05055128|537249522|FG000|Overall Study|Randomized By Mistake|0|||
148936043|NCT05055128|537249523|FG001|Overall Study|Randomized By Mistake|1|||
148936044|NCT05055128|537249524|FG002|Overall Study|Randomized By Mistake|0|||
148936045|NCT05055128|537249525|FG003|Overall Study|Randomized By Mistake|0|||
148936046|NCT05055128|537249526|FG004|Overall Study|Randomized By Mistake|0|||
148936047|NCT05055128|537249522|FG000|Overall Study|Other|1|||
148936048|NCT05055128|537249523|FG001|Overall Study|Other|0|||
148936049|NCT05055128|537249524|FG002|Overall Study|Other|0|||
148936050|NCT05055128|537249525|FG003|Overall Study|Other|0|||
148936051|NCT05055128|537249526|FG004|Overall Study|Other|0|||
148936052|NCT04502979|537249533|FG000|Overall Study|Lost to Follow-up|1|||
149194847|NCT00789191|538183297|FG001|Overall Study|Adverse Event|4|||
149194848|NCT00789191|538183296|FG000|Overall Study|Lack of Efficacy|0|||
148936053|NCT04502979|537249534|FG001|Overall Study|Lost to Follow-up|3|||
148936054|NCT04502979|537249533|FG000|Overall Study|Withdrawal by Subject|2|||
148936055|NCT04502979|537249534|FG001|Overall Study|Withdrawal by Subject|1|||
148936056|NCT00165984|537249536|FG000|Overall Study|Death|15|||
148936057|NCT03945266|537249537|FG000|Overall Study|Withdrawal by Subject|1|||
149194849|NCT00789191|538183297|FG001|Overall Study|Lack of Efficacy|5|||
148681990|NCT01270841|536309399|FG002|Overall Study|Did not qualify|4|||
148681991|NCT01270841|536309400|FG003|Overall Study|Did not qualify|5|||
148681992|NCT01270841|536309397|FG000|Overall Study|Protocol Violation|1|||
148681993|NCT01270841|536309398|FG001|Overall Study|Protocol Violation|5|||
148681994|NCT01270841|536309399|FG002|Overall Study|Protocol Violation|0|||
148681995|NCT01270841|536309400|FG003|Overall Study|Protocol Violation|0|||
148681996|NCT01270841|536309397|FG000|Overall Study|Enrolled in error|0|||
148681997|NCT01270841|536309398|FG001|Overall Study|Enrolled in error|1|||
148681998|NCT01270841|536309399|FG002|Overall Study|Enrolled in error|0|||
148681999|NCT01270841|536309400|FG003|Overall Study|Enrolled in error|0|||
148682000|NCT01375010|536309401|FG000|Overall Study|Lost to Follow-up|8|||
148682001|NCT01375010|536309402|FG001|Overall Study|Lost to Follow-up|2|||
148682002|NCT01375010|536309401|FG000|Overall Study|Withdrawal by Subject|4|||
148682003|NCT01375010|536309402|FG001|Overall Study|Withdrawal by Subject|2|||
148682004|NCT02266706|536309403|FG000|Overall Study|Withdrawal by Subject|0|||
148682005|NCT02266706|536309404|FG001|Overall Study|Withdrawal by Subject|1|||
148682006|NCT02266706|536309405|FG002|Overall Study|Withdrawal by Subject|1|||
148682007|NCT02266706|536309406|FG003|Overall Study|Withdrawal by Subject|0|||
148682008|NCT02266706|536309407|FG004|Overall Study|Withdrawal by Subject|0|||
148682009|NCT02266706|536309408|FG005|Overall Study|Withdrawal by Subject|1|||
148682010|NCT02266706|536309409|FG006|Overall Study|Withdrawal by Subject|0|||
148936058|NCT03945266|537249538|FG001|Overall Study|Withdrawal by Subject|0|||
148936059|NCT03945266|537249537|FG000|Overall Study|Miscarriage|0|||
148936060|NCT03945266|537249538|FG001|Overall Study|Miscarriage|2|||
148682011|NCT02266706|536309410|FG007|Overall Study|Withdrawal by Subject|0|||
148682012|NCT02266706|536309411|FG008|Overall Study|Withdrawal by Subject|0|||
148682013|NCT02266706|536309403|FG000|Overall Study|Screen failure|0|||
148682014|NCT02266706|536309404|FG001|Overall Study|Screen failure|0|||
148682015|NCT02266706|536309405|FG002|Overall Study|Screen failure|0|||
148682016|NCT02266706|536309406|FG003|Overall Study|Screen failure|0|||
148682017|NCT02266706|536309407|FG004|Overall Study|Screen failure|0|||
148682018|NCT02266706|536309408|FG005|Overall Study|Screen failure|1|||
148682019|NCT02266706|536309409|FG006|Overall Study|Screen failure|1|||
148682020|NCT02266706|536309410|FG007|Overall Study|Screen failure|0|||
148682021|NCT02266706|536309411|FG008|Overall Study|Screen failure|0|||
148682022|NCT02266706|536309403|FG000|Overall Study|Enrollment in another study|0|||
148682023|NCT02266706|536309404|FG001|Overall Study|Enrollment in another study|0|||
148682024|NCT02266706|536309405|FG002|Overall Study|Enrollment in another study|0|||
148682025|NCT02266706|536309406|FG003|Overall Study|Enrollment in another study|1|||
148682026|NCT02266706|536309407|FG004|Overall Study|Enrollment in another study|0|||
148682027|NCT02266706|536309408|FG005|Overall Study|Enrollment in another study|0|||
148682028|NCT02266706|536309409|FG006|Overall Study|Enrollment in another study|0|||
148682029|NCT02266706|536309410|FG007|Overall Study|Enrollment in another study|0|||
148682030|NCT02266706|536309411|FG008|Overall Study|Enrollment in another study|0|||
148682031|NCT01977352|536309412|FG000|Overall Study|Lost to Follow-up|1|||
148682032|NCT01977352|536309413|FG001|Overall Study|Lost to Follow-up|2|||
148682033|NCT00409188|536309414|FG000|Overall Study|Ongoing at data cut-off|383|||
148682034|NCT00409188|536309415|FG001|Overall Study|Ongoing at data cut-off|175|||
148682035|NCT00515073|536309419|FG000|Overall Study|Withdrawal by Subject|1|||
148682036|NCT00515073|536309419|FG000|Overall Study|Physician Decision|1|||
148682037|NCT02764489|536309420|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
148682038|NCT02764489|536309421|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
148682039|NCT02764489|536309420|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
148936061|NCT03945266|537249537|FG000|Overall Study|Lost to Follow-up|1|||
148936062|NCT03945266|537249538|FG001|Overall Study|Lost to Follow-up|0|||
148936063|NCT02628769|537249539|FG000|First Intervention|Adverse Event|1|||
148936064|NCT02628769|537249540|FG001|First Intervention|Adverse Event|0|||
148936065|NCT02628769|537249539|FG000|First Intervention|Withdrawal by Subject|0|||
148936066|NCT02628769|537249540|FG001|First Intervention|Withdrawal by Subject|1|||
148936067|NCT02628769|537249539|FG000|Second Intervention|Adverse Event|2|||
148936068|NCT02628769|537249540|FG001|Second Intervention|Adverse Event|0|||
148936069|NCT02628769|537249539|FG000|Second Intervention|Physician Decision|0|||
148936070|NCT02628769|537249540|FG001|Second Intervention|Physician Decision|1|||
148936071|NCT03698331|537249544|FG000|Overall Study|Adverse Event|2|||
148936072|NCT03698331|537249545|FG001|Overall Study|Adverse Event|3|||
148936073|NCT03698331|537249544|FG000|Overall Study|Withdrawal by Subject|1|||
148936074|NCT03698331|537249545|FG001|Overall Study|Withdrawal by Subject|1|||
148682040|NCT02764489|536309421|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
148936075|NCT03698331|537249544|FG000|Overall Study|Lost to Follow-up|0|||
148936076|NCT03698331|537249545|FG001|Overall Study|Lost to Follow-up|2|||
148936077|NCT03698331|537249544|FG000|Overall Study|Non-compliance with study drug|1|||
148936078|NCT03698331|537249545|FG001|Overall Study|Non-compliance with study drug|0|||
148936079|NCT01467583|537249546|FG000|Overall Study|Death|1|||
148682041|NCT02764489|536309420|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
148682042|NCT02764489|536309421|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
148682043|NCT02764489|536309420|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
148682044|NCT02764489|536309421|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
148682045|NCT00881959|536309422|FG000|Overall Study|Lost to Follow-up|2|||
148682046|NCT00881959|536309423|FG001|Overall Study|Lost to Follow-up|4|||
148682047|NCT02791659|536309424|FG000|Overall Study|Protocol Violation|0|||
148682048|NCT02791659|536309425|FG001|Overall Study|Protocol Violation|1|||
148682049|NCT03840811|536309426|FG000|Overall Study|Lost to Follow-up|0|||
148682050|NCT03840811|536309427|FG001|Overall Study|Lost to Follow-up|0|||
148682051|NCT03840811|536309428|FG002|Overall Study|Lost to Follow-up|1|||
148682052|NCT01294592|536309429|FG000|Overall Study|Adverse Event|28|||
149015022|NCT02733042|537534380|FG008|Overall Study|Adverse Event|0|||
149015023|NCT02733042|537534381|FG009|Overall Study|Adverse Event|0|||
149015024|NCT02733042|537534382|FG010|Overall Study|Adverse Event|2|||
149015025|NCT02733042|537534383|FG011|Overall Study|Adverse Event|2|||
149015026|NCT02733042|537534384|FG012|Overall Study|Adverse Event|0|||
149015027|NCT02733042|537534385|FG013|Overall Study|Adverse Event|2|||
149015028|NCT02733042|537534386|FG014|Overall Study|Adverse Event|0|||
149015029|NCT02733042|537534387|FG015|Overall Study|Adverse Event|0|||
149015030|NCT02733042|537534388|FG016|Overall Study|Adverse Event|0|||
149015031|NCT02733042|537534389|FG017|Overall Study|Adverse Event|1|||
149015032|NCT02733042|537534390|FG018|Overall Study|Adverse Event|0|||
149015033|NCT02733042|537534372|FG000|Overall Study|Progressive Disease|2|||
149015034|NCT02733042|537534373|FG001|Overall Study|Progressive Disease|1|||
149015035|NCT02733042|537534374|FG002|Overall Study|Progressive Disease|3|||
149015036|NCT02733042|537534375|FG003|Overall Study|Progressive Disease|1|||
149015037|NCT02733042|537534376|FG004|Overall Study|Progressive Disease|2|||
149015038|NCT02733042|537534377|FG005|Overall Study|Progressive Disease|3|||
149015039|NCT02733042|537534378|FG006|Overall Study|Progressive Disease|0|||
149015040|NCT02733042|537534379|FG007|Overall Study|Progressive Disease|3|||
149015041|NCT02733042|537534380|FG008|Overall Study|Progressive Disease|3|||
149015042|NCT02733042|537534381|FG009|Overall Study|Progressive Disease|2|||
149015043|NCT02733042|537534382|FG010|Overall Study|Progressive Disease|2|||
149015044|NCT02733042|537534383|FG011|Overall Study|Progressive Disease|2|||
149015045|NCT02733042|537534384|FG012|Overall Study|Progressive Disease|8|||
149015046|NCT02733042|537534385|FG013|Overall Study|Progressive Disease|1|||
149015047|NCT02733042|537534386|FG014|Overall Study|Progressive Disease|4|||
149015048|NCT02733042|537534387|FG015|Overall Study|Progressive Disease|7|||
149015049|NCT02733042|537534388|FG016|Overall Study|Progressive Disease|2|||
149015050|NCT02733042|537534389|FG017|Overall Study|Progressive Disease|3|||
149015051|NCT02733042|537534390|FG018|Overall Study|Progressive Disease|4|||
149015052|NCT02733042|537534372|FG000|Overall Study|Withdrawal by Subject|0|||
149015053|NCT02733042|537534373|FG001|Overall Study|Withdrawal by Subject|1|||
149015054|NCT02733042|537534374|FG002|Overall Study|Withdrawal by Subject|2|||
149015055|NCT02733042|537534375|FG003|Overall Study|Withdrawal by Subject|1|||
149015056|NCT02733042|537534376|FG004|Overall Study|Withdrawal by Subject|1|||
149015057|NCT02733042|537534377|FG005|Overall Study|Withdrawal by Subject|0|||
149015058|NCT02733042|537534378|FG006|Overall Study|Withdrawal by Subject|0|||
149015059|NCT02733042|537534379|FG007|Overall Study|Withdrawal by Subject|0|||
149015060|NCT02733042|537534380|FG008|Overall Study|Withdrawal by Subject|1|||
149015061|NCT02733042|537534381|FG009|Overall Study|Withdrawal by Subject|1|||
149015062|NCT02733042|537534382|FG010|Overall Study|Withdrawal by Subject|0|||
149015063|NCT02733042|537534383|FG011|Overall Study|Withdrawal by Subject|2|||
149015064|NCT02733042|537534384|FG012|Overall Study|Withdrawal by Subject|1|||
149015065|NCT02733042|537534385|FG013|Overall Study|Withdrawal by Subject|1|||
149015066|NCT02733042|537534386|FG014|Overall Study|Withdrawal by Subject|0|||
149015067|NCT02733042|537534387|FG015|Overall Study|Withdrawal by Subject|0|||
149015068|NCT02733042|537534388|FG016|Overall Study|Withdrawal by Subject|0|||
149015069|NCT02733042|537534389|FG017|Overall Study|Withdrawal by Subject|0|||
149015070|NCT02733042|537534390|FG018|Overall Study|Withdrawal by Subject|0|||
149015071|NCT02733042|537534372|FG000|Overall Study|Other Reasons|0|||
149015072|NCT02733042|537534373|FG001|Overall Study|Other Reasons|0|||
149015073|NCT02733042|537534374|FG002|Overall Study|Other Reasons|1|||
149015074|NCT02733042|537534375|FG003|Overall Study|Other Reasons|0|||
148682053|NCT01294592|536309430|FG001|Overall Study|Adverse Event|13|||
148807724|NCT03979313|536774422|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
149015075|NCT02733042|537534376|FG004|Overall Study|Other Reasons|0|||
149015076|NCT02733042|537534377|FG005|Overall Study|Other Reasons|0|||
148682054|NCT01294592|536309429|FG000|Overall Study|Lack of Efficacy|7|||
148682055|NCT01294592|536309430|FG001|Overall Study|Lack of Efficacy|5|||
148682056|NCT01294592|536309429|FG000|Overall Study|Protocol Violation|1|||
149015077|NCT02733042|537534378|FG006|Overall Study|Other Reasons|0|||
149015078|NCT02733042|537534379|FG007|Overall Study|Other Reasons|0|||
149015079|NCT02733042|537534380|FG008|Overall Study|Other Reasons|0|||
149015080|NCT02733042|537534381|FG009|Overall Study|Other Reasons|1|||
149015081|NCT02733042|537534382|FG010|Overall Study|Other Reasons|1|||
149015082|NCT02733042|537534383|FG011|Overall Study|Other Reasons|0|||
149015083|NCT02733042|537534384|FG012|Overall Study|Other Reasons|0|||
149015084|NCT02733042|537534385|FG013|Overall Study|Other Reasons|0|||
149015085|NCT02733042|537534386|FG014|Overall Study|Other Reasons|0|||
149015086|NCT02733042|537534387|FG015|Overall Study|Other Reasons|1|||
148682057|NCT01294592|536309430|FG001|Overall Study|Protocol Violation|7|||
149015087|NCT02733042|537534388|FG016|Overall Study|Other Reasons|0|||
149015088|NCT02733042|537534389|FG017|Overall Study|Other Reasons|1|||
149015089|NCT02733042|537534390|FG018|Overall Study|Other Reasons|0|||
149015090|NCT02733042|537534372|FG000|Overall Study|Death|0|||
149015091|NCT02733042|537534373|FG001|Overall Study|Death|0|||
149015092|NCT02733042|537534374|FG002|Overall Study|Death|0|||
149015093|NCT02733042|537534375|FG003|Overall Study|Death|0|||
149015094|NCT02733042|537534376|FG004|Overall Study|Death|0|||
149015095|NCT02733042|537534377|FG005|Overall Study|Death|0|||
149015096|NCT02733042|537534378|FG006|Overall Study|Death|1|||
149015097|NCT02733042|537534379|FG007|Overall Study|Death|0|||
149015098|NCT02733042|537534380|FG008|Overall Study|Death|1|||
149015099|NCT02733042|537534381|FG009|Overall Study|Death|0|||
149015100|NCT02733042|537534382|FG010|Overall Study|Death|1|||
149015101|NCT02733042|537534383|FG011|Overall Study|Death|0|||
149015102|NCT02733042|537534384|FG012|Overall Study|Death|0|||
149015103|NCT02733042|537534385|FG013|Overall Study|Death|0|||
149015104|NCT02733042|537534386|FG014|Overall Study|Death|1|||
149015105|NCT02733042|537534387|FG015|Overall Study|Death|2|||
149015106|NCT02733042|537534388|FG016|Overall Study|Death|0|||
149015107|NCT02733042|537534389|FG017|Overall Study|Death|0|||
149015108|NCT02733042|537534390|FG018|Overall Study|Death|0|||
149015109|NCT02838628|537534392|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
149015110|NCT02838628|537534393|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
149015111|NCT02838628|537534392|FG000|Recurrence Follow-up Period|Adverse Event|1|||
149015112|NCT02838628|537534393|FG001|Recurrence Follow-up Period|Adverse Event|0|||
149015113|NCT02838628|537534392|FG000|Recurrence Follow-up Period|Non-compliance|0|||
149015114|NCT02838628|537534393|FG001|Recurrence Follow-up Period|Non-compliance|1|||
149015115|NCT02838628|537534392|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
149015116|NCT02838628|537534393|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
149015117|NCT02838628|537534392|FG000|Recurrence Follow-up Period|Other un-specified|1|||
149194850|NCT00789191|538183296|FG000|Overall Study|Protocol Violation|5|||
149194851|NCT00789191|538183297|FG001|Overall Study|Protocol Violation|3|||
149194852|NCT00789191|538183296|FG000|Overall Study|Withdrawal Criteria|2|||
149194853|NCT00789191|538183297|FG001|Overall Study|Withdrawal Criteria|4|||
149194854|NCT00789191|538183296|FG000|Overall Study|Unclassified|5|||
149194855|NCT00789191|538183297|FG001|Overall Study|Unclassified|3|||
149194856|NCT03497429|538183299|FG000|Overall Study|Progressive disease|3|||
149194857|NCT03497429|538183300|FG001|Overall Study|Progressive disease|4|||
149194858|NCT03497429|538183299|FG000|Overall Study|Adverse Event|0|||
149194859|NCT03497429|538183300|FG001|Overall Study|Adverse Event|2|||
149194860|NCT00280150|538183304|FG000|Overall Study|Adverse Event|0|||
149194861|NCT00280150|538183305|FG001|Overall Study|Adverse Event|1|||
149194862|NCT00280150|538183306|FG002|Overall Study|Adverse Event|2|||
149194863|NCT00280150|538183307|FG003|Overall Study|Adverse Event|3|||
149194864|NCT00280150|538183304|FG000|Overall Study|Lack of Efficacy|0|||
149194865|NCT00280150|538183305|FG001|Overall Study|Lack of Efficacy|0|||
149194866|NCT00280150|538183306|FG002|Overall Study|Lack of Efficacy|0|||
149194867|NCT00280150|538183307|FG003|Overall Study|Lack of Efficacy|3|||
149194868|NCT00280150|538183304|FG000|Overall Study|Physician Decision|0|||
149194869|NCT00280150|538183305|FG001|Overall Study|Physician Decision|0|||
149194870|NCT00280150|538183306|FG002|Overall Study|Physician Decision|0|||
149194871|NCT00280150|538183307|FG003|Overall Study|Physician Decision|1|||
149194872|NCT00280150|538183304|FG000|Overall Study|Protocol Violation|0|||
149194873|NCT00280150|538183305|FG001|Overall Study|Protocol Violation|0|||
149194874|NCT00280150|538183306|FG002|Overall Study|Protocol Violation|0|||
149194875|NCT00280150|538183307|FG003|Overall Study|Protocol Violation|1|||
149194876|NCT00280150|538183304|FG000|Overall Study|Withdrawal by Subject|0|||
149194877|NCT00280150|538183305|FG001|Overall Study|Withdrawal by Subject|0|||
149194878|NCT00280150|538183306|FG002|Overall Study|Withdrawal by Subject|0|||
149194879|NCT00280150|538183307|FG003|Overall Study|Withdrawal by Subject|1|||
149194880|NCT00280150|538183304|FG000|Overall Study|Did not get consolidation therapy|3|||
149194881|NCT00280150|538183305|FG001|Overall Study|Did not get consolidation therapy|0|||
149194882|NCT00280150|538183306|FG002|Overall Study|Did not get consolidation therapy|3|||
149194883|NCT00280150|538183307|FG003|Overall Study|Did not get consolidation therapy|0|||
149015118|NCT02838628|537534393|FG001|Recurrence Follow-up Period|Other un-specified|1|||
149015119|NCT01821898|537534394|FG000|Overall Study|Withdrawal by Subject|2|||
149015120|NCT01821898|537534395|FG001|Overall Study|Withdrawal by Subject|1|||
149015121|NCT03904693|537534398|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
149015122|NCT03904693|537534399|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
149194884|NCT00280150|538183304|FG000|Overall Study|Declining Performance Status|0|||
149194885|NCT00280150|538183305|FG001|Overall Study|Declining Performance Status|0|||
149194886|NCT00280150|538183306|FG002|Overall Study|Declining Performance Status|0|||
149194887|NCT00280150|538183307|FG003|Overall Study|Declining Performance Status|1|||
148682058|NCT01294592|536309429|FG000|Overall Study|Lost to Follow-up|7|||
149015123|NCT03904693|537534400|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
149015124|NCT03904693|537534401|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
149015125|NCT03904693|537534402|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
149015126|NCT03904693|537534403|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
149194888|NCT02939937|538183308|FG000|Overall Study|Adverse Event|5|||
149194889|NCT02939937|538183309|FG001|Overall Study|Adverse Event|0|||
149194890|NCT02939937|538183308|FG000|Overall Study|Lost to Follow-up|1|||
149194891|NCT02939937|538183309|FG001|Overall Study|Lost to Follow-up|3|||
149194892|NCT00568958|538183310|FG000|Allocation|Withdrawal by Subject|7|||
149194893|NCT00568958|538183311|FG001|Allocation|Withdrawal by Subject|3|||
149194894|NCT00568958|538183310|FG000|Allocation|Physician Decision|2|||
149194895|NCT00568958|538183311|FG001|Allocation|Physician Decision|0|||
149194896|NCT00568958|538183310|FG000|Follow-Up|Withdrawal by Subject|6|||
149194897|NCT00568958|538183311|FG001|Follow-Up|Withdrawal by Subject|6|||
149194898|NCT00568958|538183310|FG000|Follow-Up|Physician Decision|1|||
149194899|NCT00568958|538183311|FG001|Follow-Up|Physician Decision|1|||
149194900|NCT00568958|538183310|FG000|Follow-Up|Family Emergency|1|||
149194901|NCT00568958|538183311|FG001|Follow-Up|Family Emergency|0|||
149194902|NCT00568958|538183310|FG000|Follow-Up|Adverse Event|1|||
149194903|NCT00568958|538183311|FG001|Follow-Up|Adverse Event|0|||
149194904|NCT03583372|538183315|FG000|Overall Study|Withdrawal by Subject|6|||
149194905|NCT03583372|538183316|FG001|Overall Study|Withdrawal by Subject|11|||
149194906|NCT03583372|538183317|FG002|Overall Study|Withdrawal by Subject|7|||
149194907|NCT03583372|538183318|FG003|Overall Study|Withdrawal by Subject|8|||
149194908|NCT03583372|538183315|FG000|Overall Study|Lost to Follow-up|4|||
149194909|NCT03583372|538183316|FG001|Overall Study|Lost to Follow-up|6|||
149194910|NCT03583372|538183317|FG002|Overall Study|Lost to Follow-up|3|||
149194911|NCT03583372|538183318|FG003|Overall Study|Lost to Follow-up|2|||
149194912|NCT03583372|538183315|FG000|Overall Study|Adverse Event|1|||
149194913|NCT03583372|538183316|FG001|Overall Study|Adverse Event|3|||
149194914|NCT03583372|538183317|FG002|Overall Study|Adverse Event|4|||
149194915|NCT03583372|538183318|FG003|Overall Study|Adverse Event|4|||
149194916|NCT03583372|538183315|FG000|Overall Study|Physician Decision|0|||
149194917|NCT03583372|538183316|FG001|Overall Study|Physician Decision|1|||
149194918|NCT03583372|538183317|FG002|Overall Study|Physician Decision|1|||
149194919|NCT03583372|538183318|FG003|Overall Study|Physician Decision|1|||
149194920|NCT03583372|538183315|FG000|Overall Study|Lack of Efficacy|0|||
149194921|NCT03583372|538183316|FG001|Overall Study|Lack of Efficacy|1|||
149194922|NCT03583372|538183317|FG002|Overall Study|Lack of Efficacy|0|||
149194923|NCT03583372|538183318|FG003|Overall Study|Lack of Efficacy|1|||
149194924|NCT03583372|538183315|FG000|Overall Study|Death|1|||
149194925|NCT03583372|538183316|FG001|Overall Study|Death|0|||
149194926|NCT03583372|538183317|FG002|Overall Study|Death|0|||
149194927|NCT03583372|538183318|FG003|Overall Study|Death|0|||
149194928|NCT03583372|538183315|FG000|Overall Study|Protocol Violation|0|||
149194929|NCT03583372|538183316|FG001|Overall Study|Protocol Violation|1|||
149194930|NCT03583372|538183317|FG002|Overall Study|Protocol Violation|0|||
149194931|NCT03583372|538183318|FG003|Overall Study|Protocol Violation|0|||
149194932|NCT03583372|538183315|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
149194933|NCT03583372|538183316|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
149194934|NCT03583372|538183317|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
149194935|NCT03583372|538183318|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
149194936|NCT03583372|538183315|FG000|Overall Study|Did Not Receive Study Drug|0|||
149194937|NCT03583372|538183316|FG001|Overall Study|Did Not Receive Study Drug|1|||
149194938|NCT03583372|538183317|FG002|Overall Study|Did Not Receive Study Drug|0|||
149194939|NCT03583372|538183318|FG003|Overall Study|Did Not Receive Study Drug|0|||
149194940|NCT03583372|538183315|FG000|Overall Study|Captured as Other in the Database|1|||
149194941|NCT03583372|538183316|FG001|Overall Study|Captured as Other in the Database|2|||
149194942|NCT03583372|538183317|FG002|Overall Study|Captured as Other in the Database|4|||
149194943|NCT03583372|538183318|FG003|Overall Study|Captured as Other in the Database|1|||
149194944|NCT02796391|538183319|FG000|Overall Study|Lost to Follow-up|2|||
149194945|NCT02796391|538183320|FG001|Overall Study|Lost to Follow-up|2|||
149194946|NCT02796391|538183321|FG002|Overall Study|Lost to Follow-up|13|||
149194947|NCT02796391|538183322|FG003|Overall Study|Lost to Follow-up|8|||
149194948|NCT02796391|538183323|FG004|Overall Study|Lost to Follow-up|14|||
149194949|NCT02796391|538183324|FG005|Overall Study|Lost to Follow-up|13|||
149194950|NCT02796391|538183319|FG000|Overall Study|COVID|0|||
149194951|NCT02796391|538183320|FG001|Overall Study|COVID|0|||
148682059|NCT01294592|536309430|FG001|Overall Study|Lost to Follow-up|9|||
149194952|NCT02796391|538183321|FG002|Overall Study|COVID|5|||
149194953|NCT02796391|538183322|FG003|Overall Study|COVID|5|||
149194954|NCT02796391|538183323|FG004|Overall Study|COVID|2|||
149194955|NCT02796391|538183324|FG005|Overall Study|COVID|4|||
149194956|NCT02796391|538183319|FG000|Overall Study|Participant did not like study cigarettes|0|||
149194957|NCT02796391|538183320|FG001|Overall Study|Participant did not like study cigarettes|0|||
149194958|NCT02796391|538183321|FG002|Overall Study|Participant did not like study cigarettes|3|||
149194959|NCT02796391|538183322|FG003|Overall Study|Participant did not like study cigarettes|0|||
149194960|NCT02796391|538183323|FG004|Overall Study|Participant did not like study cigarettes|0|||
149194961|NCT02796391|538183324|FG005|Overall Study|Participant did not like study cigarettes|0|||
149194962|NCT02796391|538183319|FG000|Overall Study|Withdrawal by Subject|1|||
149194963|NCT02796391|538183320|FG001|Overall Study|Withdrawal by Subject|1|||
149194964|NCT02796391|538183321|FG002|Overall Study|Withdrawal by Subject|4|||
149194965|NCT02796391|538183322|FG003|Overall Study|Withdrawal by Subject|3|||
149194966|NCT02796391|538183323|FG004|Overall Study|Withdrawal by Subject|4|||
149194967|NCT02796391|538183324|FG005|Overall Study|Withdrawal by Subject|3|||
149194968|NCT02796391|538183319|FG000|Overall Study|Adverse Event|0|||
149194969|NCT02796391|538183320|FG001|Overall Study|Adverse Event|0|||
149194970|NCT02796391|538183321|FG002|Overall Study|Adverse Event|0|||
149194971|NCT02796391|538183322|FG003|Overall Study|Adverse Event|1|||
149194972|NCT02796391|538183323|FG004|Overall Study|Adverse Event|0|||
149194973|NCT02796391|538183324|FG005|Overall Study|Adverse Event|0|||
149194974|NCT02796391|538183319|FG000|Overall Study|Protocol Violation|0|||
149194975|NCT02796391|538183320|FG001|Overall Study|Protocol Violation|0|||
149194976|NCT02796391|538183321|FG002|Overall Study|Protocol Violation|0|||
149194977|NCT02796391|538183322|FG003|Overall Study|Protocol Violation|1|||
149194978|NCT02796391|538183323|FG004|Overall Study|Protocol Violation|0|||
149194979|NCT02796391|538183324|FG005|Overall Study|Protocol Violation|0|||
149194980|NCT00377611|538183325|FG000|Overall Study|Adverse Event|2|||
149194981|NCT00377611|538183326|FG001|Overall Study|Adverse Event|9|||
149194982|NCT00377611|538183325|FG000|Overall Study|Protocol Violation|2|||
149194983|NCT00377611|538183326|FG001|Overall Study|Protocol Violation|0|||
149194984|NCT00377611|538183325|FG000|Overall Study|Withdrawal by Subject|0|||
149194985|NCT00377611|538183326|FG001|Overall Study|Withdrawal by Subject|5|||
149194986|NCT00377611|538183325|FG000|Overall Study|Lost to Follow-up|18|||
149194987|NCT00377611|538183326|FG001|Overall Study|Lost to Follow-up|16|||
149194988|NCT00377611|538183325|FG000|Overall Study|Other|0|||
149194989|NCT00377611|538183326|FG001|Overall Study|Other|3|||
149194990|NCT04831515|538183327|FG000|First Intervention|Adverse Event|0|||
149194991|NCT04831515|538183328|FG001|First Intervention|Adverse Event|1|||
149194992|NCT05254613|538183332|FG000|Overall Study|Lost to Follow-up|0|||
149194993|NCT05254613|538183333|FG001|Overall Study|Lost to Follow-up|0|||
149194994|NCT05254613|538183334|FG002|Overall Study|Lost to Follow-up|1|||
149194995|NCT00174785|538183338|FG000|Overall Study|Adverse Event|293|||
149194996|NCT00174785|538183339|FG001|Overall Study|Adverse Event|191|||
149194997|NCT00174785|538183338|FG000|Overall Study|Protocol Violation|14|||
149194998|NCT00174785|538183339|FG001|Overall Study|Protocol Violation|14|||
149194999|NCT00174785|538183338|FG000|Overall Study|Withdrawal by Subject|173|||
149195000|NCT00174785|538183339|FG001|Overall Study|Withdrawal by Subject|175|||
149195001|NCT00174785|538183338|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
149195002|NCT00174785|538183339|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
149195003|NCT00174785|538183338|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
149195004|NCT00174785|538183339|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
149195005|NCT00174785|538183338|FG000|Overall Study|Other prohibited medication|5|||
149195006|NCT00174785|538183339|FG001|Overall Study|Other prohibited medication|3|||
149195007|NCT00174785|538183338|FG000|Overall Study|Family request|6|||
149195008|NCT00174785|538183339|FG001|Overall Study|Family request|8|||
149195009|NCT00174785|538183338|FG000|Overall Study|Not pre-specified/Not coded|56|||
149195010|NCT00174785|538183339|FG001|Overall Study|Not pre-specified/Not coded|70|||
149195011|NCT04348656|538183340|FG000|Overall Study|Withdrawal by Subject|2|||
148936080|NCT01467583|537249547|FG001|Overall Study|Death|1|||
149195012|NCT04348656|538183341|FG001|Overall Study|Withdrawal by Subject|0|||
148936081|NCT01467583|537249548|FG002|Overall Study|Death|0|||
148936082|NCT01467583|537249546|FG000|Overall Study|Withdrawal by Subject|1|||
148936083|NCT01467583|537249547|FG001|Overall Study|Withdrawal by Subject|0|||
149195013|NCT04348656|538183340|FG000|Overall Study|Lost to Follow-up|11|||
148936084|NCT01467583|537249548|FG002|Overall Study|Withdrawal by Subject|0|||
149195014|NCT04348656|538183341|FG001|Overall Study|Lost to Follow-up|6|||
149195015|NCT02387372|538183342|FG000|Overall Study|Not Treated|1|||
149195016|NCT02387372|538183343|FG001|Overall Study|Not Treated|0|||
149195017|NCT00436566|538183347|FG000|Overall Study|Withdrawal by Subject|2|||
149195018|NCT00436566|538183347|FG000|Overall Study|Protocol Violation|1|||
149195019|NCT01954251|538183348|FG000|Overall Study|Adverse Event|5|||
149195020|NCT01954251|538183349|FG001|Overall Study|Adverse Event|7|||
149195021|NCT01954251|538183348|FG000|Overall Study|Lost to Follow-up|6|||
149195022|NCT01954251|538183349|FG001|Overall Study|Lost to Follow-up|6|||
149195023|NCT01954251|538183348|FG000|Overall Study|Withdrawal by Subject|2|||
149195024|NCT01954251|538183349|FG001|Overall Study|Withdrawal by Subject|6|||
149195025|NCT02504268|538183352|FG000|Overall Study|Adverse Event|18|||
149195026|NCT02504268|538183353|FG001|Overall Study|Adverse Event|8|||
149195027|NCT02504268|538183354|FG002|Overall Study|Adverse Event|14|||
149195028|NCT02504268|538183355|FG003|Overall Study|Adverse Event|0|||
149195029|NCT02504268|538183356|FG004|Overall Study|Adverse Event|0|||
149195030|NCT02504268|538183357|FG005|Overall Study|Adverse Event|0|||
149195031|NCT02504268|538183358|FG006|Overall Study|Adverse Event|0|||
149195032|NCT02504268|538183359|FG007|Overall Study|Adverse Event|0|||
149195033|NCT02504268|538183360|FG008|Overall Study|Adverse Event|0|||
149195034|NCT02504268|538183352|FG000|Overall Study|Withdrawal of Consent|11|||
149195035|NCT02504268|538183353|FG001|Overall Study|Withdrawal of Consent|10|||
149195036|NCT02504268|538183354|FG002|Overall Study|Withdrawal of Consent|3|||
149195037|NCT02504268|538183355|FG003|Overall Study|Withdrawal of Consent|0|||
149195038|NCT02504268|538183356|FG004|Overall Study|Withdrawal of Consent|0|||
149195039|NCT02504268|538183357|FG005|Overall Study|Withdrawal of Consent|0|||
149195040|NCT02504268|538183358|FG006|Overall Study|Withdrawal of Consent|0|||
149195041|NCT02504268|538183359|FG007|Overall Study|Withdrawal of Consent|0|||
149195042|NCT02504268|538183360|FG008|Overall Study|Withdrawal of Consent|0|||
149195043|NCT02504268|538183352|FG000|Overall Study|Pregnancy|2|||
149195044|NCT02504268|538183353|FG001|Overall Study|Pregnancy|0|||
149195045|NCT02504268|538183354|FG002|Overall Study|Pregnancy|0|||
149195046|NCT02504268|538183355|FG003|Overall Study|Pregnancy|0|||
149195047|NCT02504268|538183356|FG004|Overall Study|Pregnancy|0|||
149195048|NCT02504268|538183357|FG005|Overall Study|Pregnancy|0|||
149195049|NCT02504268|538183358|FG006|Overall Study|Pregnancy|0|||
149195050|NCT02504268|538183359|FG007|Overall Study|Pregnancy|0|||
149195051|NCT02504268|538183360|FG008|Overall Study|Pregnancy|0|||
149195052|NCT02504268|538183352|FG000|Overall Study|Lost to Follow-up|3|||
149195053|NCT02504268|538183353|FG001|Overall Study|Lost to Follow-up|6|||
149195054|NCT02504268|538183354|FG002|Overall Study|Lost to Follow-up|4|||
149195055|NCT02504268|538183355|FG003|Overall Study|Lost to Follow-up|0|||
149195056|NCT02504268|538183356|FG004|Overall Study|Lost to Follow-up|0|||
149195057|NCT02504268|538183357|FG005|Overall Study|Lost to Follow-up|0|||
149195058|NCT02504268|538183358|FG006|Overall Study|Lost to Follow-up|0|||
149195059|NCT02504268|538183359|FG007|Overall Study|Lost to Follow-up|0|||
149195060|NCT02504268|538183360|FG008|Overall Study|Lost to Follow-up|0|||
149195061|NCT02504268|538183352|FG000|Overall Study|Death|1|||
149195062|NCT02504268|538183353|FG001|Overall Study|Death|1|||
149195063|NCT02504268|538183354|FG002|Overall Study|Death|0|||
149195064|NCT02504268|538183355|FG003|Overall Study|Death|0|||
149195065|NCT02504268|538183356|FG004|Overall Study|Death|0|||
149195066|NCT02504268|538183357|FG005|Overall Study|Death|0|||
149195067|NCT02504268|538183358|FG006|Overall Study|Death|0|||
149195068|NCT02504268|538183359|FG007|Overall Study|Death|0|||
149195069|NCT02504268|538183360|FG008|Overall Study|Death|0|||
149195070|NCT02504268|538183352|FG000|Overall Study|Subject Request to Discontinue|11|||
149195071|NCT02504268|538183353|FG001|Overall Study|Subject Request to Discontinue|3|||
149195072|NCT02504268|538183354|FG002|Overall Study|Subject Request to Discontinue|6|||
149195073|NCT02504268|538183355|FG003|Overall Study|Subject Request to Discontinue|0|||
149195074|NCT02504268|538183356|FG004|Overall Study|Subject Request to Discontinue|0|||
149195075|NCT02504268|538183357|FG005|Overall Study|Subject Request to Discontinue|0|||
149195076|NCT02504268|538183358|FG006|Overall Study|Subject Request to Discontinue|0|||
149195077|NCT02504268|538183359|FG007|Overall Study|Subject Request to Discontinue|0|||
149195078|NCT02504268|538183360|FG008|Overall Study|Subject Request to Discontinue|0|||
149195079|NCT02504268|538183352|FG000|Overall Study|No Longer Meets Study Criteria|2|||
148936085|NCT01467583|537249546|FG000|Overall Study|Protocol Violation|0|||
149195080|NCT02504268|538183353|FG001|Overall Study|No Longer Meets Study Criteria|3|||
149195081|NCT02504268|538183354|FG002|Overall Study|No Longer Meets Study Criteria|0|||
149195082|NCT02504268|538183355|FG003|Overall Study|No Longer Meets Study Criteria|0|||
149195083|NCT02504268|538183356|FG004|Overall Study|No Longer Meets Study Criteria|0|||
149195084|NCT02504268|538183357|FG005|Overall Study|No Longer Meets Study Criteria|0|||
149195085|NCT02504268|538183358|FG006|Overall Study|No Longer Meets Study Criteria|0|||
149195086|NCT02504268|538183359|FG007|Overall Study|No Longer Meets Study Criteria|0|||
149195087|NCT02504268|538183360|FG008|Overall Study|No Longer Meets Study Criteria|0|||
149195088|NCT02504268|538183352|FG000|Overall Study|Lack of Efficacy|11|||
149195089|NCT02504268|538183353|FG001|Overall Study|Lack of Efficacy|35|||
149195090|NCT02504268|538183354|FG002|Overall Study|Lack of Efficacy|9|||
149195091|NCT02504268|538183355|FG003|Overall Study|Lack of Efficacy|0|||
149195092|NCT02504268|538183356|FG004|Overall Study|Lack of Efficacy|0|||
149195093|NCT02504268|538183357|FG005|Overall Study|Lack of Efficacy|0|||
149195094|NCT02504268|538183358|FG006|Overall Study|Lack of Efficacy|0|||
149195095|NCT02504268|538183359|FG007|Overall Study|Lack of Efficacy|0|||
148936086|NCT01467583|537249547|FG001|Overall Study|Protocol Violation|0|||
149195096|NCT02504268|538183360|FG008|Overall Study|Lack of Efficacy|0|||
149195097|NCT02504268|538183352|FG000|Overall Study|Poor/Non-Compliance|3|||
149195098|NCT02504268|538183353|FG001|Overall Study|Poor/Non-Compliance|2|||
149195099|NCT02504268|538183354|FG002|Overall Study|Poor/Non-Compliance|3|||
149195100|NCT02504268|538183355|FG003|Overall Study|Poor/Non-Compliance|0|||
149195101|NCT02504268|538183356|FG004|Overall Study|Poor/Non-Compliance|0|||
149195102|NCT02504268|538183357|FG005|Overall Study|Poor/Non-Compliance|0|||
149195103|NCT02504268|538183358|FG006|Overall Study|Poor/Non-Compliance|0|||
149195104|NCT02504268|538183359|FG007|Overall Study|Poor/Non-Compliance|0|||
149195105|NCT02504268|538183360|FG008|Overall Study|Poor/Non-Compliance|0|||
149195106|NCT02504268|538183352|FG000|Overall Study|Not Disclosed|1|||
149195107|NCT02504268|538183353|FG001|Overall Study|Not Disclosed|0|||
149195108|NCT02504268|538183354|FG002|Overall Study|Not Disclosed|2|||
149195109|NCT02504268|538183355|FG003|Overall Study|Not Disclosed|0|||
149195110|NCT02504268|538183356|FG004|Overall Study|Not Disclosed|0|||
149195111|NCT02504268|538183357|FG005|Overall Study|Not Disclosed|0|||
149195112|NCT02504268|538183358|FG006|Overall Study|Not Disclosed|0|||
149195113|NCT02504268|538183359|FG007|Overall Study|Not Disclosed|0|||
149195114|NCT02504268|538183360|FG008|Overall Study|Not Disclosed|0|||
149195115|NCT03025217|538183361|FG000|Overall Study|Pregnancy|1|||
149195116|NCT03025217|538183361|FG000|Overall Study|Lost to Follow-up|1|||
149195117|NCT03025217|538183361|FG000|Overall Study|Not eligible, poor English|2|||
149195118|NCT00617409|538183363|FG000|Overall Study|Withdrawal by Subject|4|||
149195119|NCT00617409|538183364|FG001|Overall Study|Withdrawal by Subject|1|||
149195120|NCT00617409|538183365|FG002|Overall Study|Withdrawal by Subject|2|||
149195121|NCT00617409|538183363|FG000|Overall Study|Adverse Event|0|||
149195122|NCT00617409|538183364|FG001|Overall Study|Adverse Event|2|||
149195123|NCT00617409|538183365|FG002|Overall Study|Adverse Event|3|||
149195124|NCT00617409|538183363|FG000|Overall Study|Disease Progression|8|||
149195125|NCT00617409|538183364|FG001|Overall Study|Disease Progression|8|||
149195126|NCT00617409|538183365|FG002|Overall Study|Disease Progression|18|||
149195127|NCT00617409|538183363|FG000|Overall Study|Death|3|||
149195128|NCT00617409|538183364|FG001|Overall Study|Death|5|||
149195129|NCT00617409|538183365|FG002|Overall Study|Death|4|||
149195130|NCT00617409|538183363|FG000|Overall Study|Alternative Therapy|1|||
149195131|NCT00617409|538183364|FG001|Overall Study|Alternative Therapy|2|||
149195132|NCT00617409|538183365|FG002|Overall Study|Alternative Therapy|0|||
149195133|NCT01496430|538183372|FG000|Overall Study|Adverse Event|0|||
149195134|NCT01496430|538183373|FG001|Overall Study|Adverse Event|0|||
149195135|NCT01496430|538183374|FG002|Overall Study|Adverse Event|1|||
149195136|NCT01496430|538183372|FG000|Overall Study|Major Protocol Deviation|0|||
149195137|NCT01496430|538183373|FG001|Overall Study|Major Protocol Deviation|0|||
149195138|NCT01496430|538183374|FG002|Overall Study|Major Protocol Deviation|1|||
149195139|NCT01496430|538183372|FG000|Overall Study|Lost to Follow-up|2|||
149195140|NCT01496430|538183373|FG001|Overall Study|Lost to Follow-up|3|||
149195141|NCT01496430|538183374|FG002|Overall Study|Lost to Follow-up|1|||
149195142|NCT01496430|538183372|FG000|Overall Study|Voluntary Withdrawal|2|||
149195143|NCT01496430|538183373|FG001|Overall Study|Voluntary Withdrawal|1|||
149195144|NCT01496430|538183374|FG002|Overall Study|Voluntary Withdrawal|6|||
149195145|NCT01496430|538183372|FG000|Overall Study|Principal Investigator Discretion|0|||
149195146|NCT01496430|538183373|FG001|Overall Study|Principal Investigator Discretion|1|||
149195147|NCT01496430|538183374|FG002|Overall Study|Principal Investigator Discretion|1|||
149195148|NCT01496430|538183372|FG000|Overall Study|Other|2|||
149195149|NCT01496430|538183373|FG001|Overall Study|Other|0|||
149195150|NCT01496430|538183374|FG002|Overall Study|Other|0|||
149195151|NCT02108951|538183375|FG000|Overall Study|Lost to Follow-up|1|||
149195152|NCT02108951|538183375|FG000|Overall Study|Patient's/guardian's decision|1|||
149195153|NCT02108951|538183375|FG000|Overall Study|Study Terminated by Sponsor|14|||
149195154|NCT00421343|538183379|FG000|Overall Study|Death|1|||
149195155|NCT00421343|538183379|FG000|Overall Study|Withdrawal by Subject|2|||
149195156|NCT00421343|538183379|FG000|Overall Study|Lost to Follow-up|3|||
149195157|NCT01151579|538183382|FG000|Overall Study|Physician Decision|3|||
149195158|NCT01151579|538183383|FG001|Overall Study|Physician Decision|1|||
149195159|NCT01151579|538183382|FG000|Overall Study|Withdrawal by Subject|3|||
149195160|NCT01151579|538183383|FG001|Overall Study|Withdrawal by Subject|2|||
149195161|NCT01151579|538183382|FG000|Overall Study|Not meet inclusion criteria|6|||
149195162|NCT01151579|538183383|FG001|Overall Study|Not meet inclusion criteria|4|||
149195163|NCT00608530|538183384|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
149195164|NCT00608530|538183385|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
149195165|NCT00608530|538183386|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
149195166|NCT00608530|538183387|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
149195167|NCT00608530|538183384|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
149195168|NCT00608530|538183385|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
149195169|NCT00608530|538183386|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
149195170|NCT00608530|538183387|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
149195171|NCT00608530|538183384|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
149195172|NCT00608530|538183385|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
149195173|NCT00608530|538183386|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
149195174|NCT00608530|538183387|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
149195175|NCT00608530|538183384|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
149195176|NCT00608530|538183385|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
149195177|NCT00608530|538183386|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
149195178|NCT00608530|538183387|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
149195179|NCT00608530|538183384|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
149195180|NCT00608530|538183385|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
149195181|NCT00608530|538183386|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
149195182|NCT00608530|538183387|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
149195183|NCT00608530|538183384|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
149195184|NCT00608530|538183385|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
149195185|NCT00608530|538183386|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
149195186|NCT00608530|538183387|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
149195187|NCT00077610|538183388|FG000|Overall Study|Adverse Event|9|||
149195188|NCT00077610|538183389|FG001|Overall Study|Adverse Event|7|||
149195189|NCT00077610|538183390|FG002|Overall Study|Adverse Event|1|||
149195190|NCT00077610|538183388|FG000|Overall Study|Lost to Follow-up|0|||
149195191|NCT00077610|538183389|FG001|Overall Study|Lost to Follow-up|1|||
149195192|NCT00077610|538183390|FG002|Overall Study|Lost to Follow-up|2|||
149195193|NCT00077610|538183388|FG000|Overall Study|Withdrawal by Subject|4|||
149195194|NCT00077610|538183389|FG001|Overall Study|Withdrawal by Subject|10|||
149195195|NCT00077610|538183390|FG002|Overall Study|Withdrawal by Subject|6|||
149195196|NCT00077610|538183388|FG000|Overall Study|Death|17|||
149195197|NCT00077610|538183389|FG001|Overall Study|Death|13|||
149195198|NCT00077610|538183390|FG002|Overall Study|Death|13|||
149195199|NCT00077610|538183388|FG000|Overall Study|Renal transplant|12|||
149195200|NCT00077610|538183389|FG001|Overall Study|Renal transplant|15|||
149195201|NCT00077610|538183390|FG002|Overall Study|Renal transplant|11|||
149195202|NCT00077610|538183388|FG000|Overall Study|Withdrew from dialysis care|5|||
149195203|NCT00077610|538183389|FG001|Overall Study|Withdrew from dialysis care|0|||
149195204|NCT00077610|538183390|FG002|Overall Study|Withdrew from dialysis care|3|||
149195205|NCT00077610|538183388|FG000|Overall Study|Insufficient Therapeutic Response|1|||
149195206|NCT00077610|538183389|FG001|Overall Study|Insufficient Therapeutic Response|0|||
149195207|NCT00077610|538183390|FG002|Overall Study|Insufficient Therapeutic Response|0|||
149195208|NCT00077610|538183388|FG000|Overall Study|Multiple blood transfusions|0|||
149195209|NCT00077610|538183389|FG001|Overall Study|Multiple blood transfusions|0|||
149195210|NCT00077610|538183390|FG002|Overall Study|Multiple blood transfusions|1|||
149195211|NCT00077610|538183388|FG000|Overall Study|Principal Investigator's decision|1|||
149195212|NCT00077610|538183389|FG001|Overall Study|Principal Investigator's decision|0|||
149195213|NCT00077610|538183390|FG002|Overall Study|Principal Investigator's decision|1|||
149195214|NCT00077610|538183388|FG000|Overall Study|Worsening of health condition|1|||
149195215|NCT00077610|538183389|FG001|Overall Study|Worsening of health condition|1|||
149195216|NCT00077610|538183390|FG002|Overall Study|Worsening of health condition|0|||
149195217|NCT00077610|538183388|FG000|Overall Study|Given Epogen in hospital|1|||
148936087|NCT01467583|537249548|FG002|Overall Study|Protocol Violation|2|||
149195218|NCT00077610|538183389|FG001|Overall Study|Given Epogen in hospital|0|||
149195219|NCT00077610|538183390|FG002|Overall Study|Given Epogen in hospital|0|||
149195220|NCT00077610|538183388|FG000|Overall Study|Transferred to other unit|0|||
149195221|NCT00077610|538183389|FG001|Overall Study|Transferred to other unit|0|||
149195222|NCT00077610|538183390|FG002|Overall Study|Transferred to other unit|1|||
149195223|NCT00077610|538183388|FG000|Overall Study|Transferred to nursing home|0|||
149195224|NCT00077610|538183389|FG001|Overall Study|Transferred to nursing home|0|||
149195225|NCT00077610|538183390|FG002|Overall Study|Transferred to nursing home|1|||
149195226|NCT00077610|538183388|FG000|Overall Study|Transfer to satellite unit|1|||
149195227|NCT00077610|538183389|FG001|Overall Study|Transfer to satellite unit|0|||
149195228|NCT00077610|538183390|FG002|Overall Study|Transfer to satellite unit|0|||
149195229|NCT00077610|538183388|FG000|Overall Study|Transfer to other center for surgery|1|||
149195230|NCT00077610|538183389|FG001|Overall Study|Transfer to other center for surgery|0|||
148936088|NCT01555983|537249550|FG000|Overall Study|Withdrawal by Subject|1|||
148936089|NCT01555983|537249551|FG001|Overall Study|Withdrawal by Subject|0|||
149195231|NCT00077610|538183390|FG002|Overall Study|Transfer to other center for surgery|0|||
149195232|NCT00077610|538183388|FG000|Overall Study|Change in dialysis modality|1|||
149195233|NCT00077610|538183389|FG001|Overall Study|Change in dialysis modality|0|||
149195234|NCT00077610|538183390|FG002|Overall Study|Change in dialysis modality|0|||
149195235|NCT00077610|538183388|FG000|Overall Study|Relocation|0|||
149195236|NCT00077610|538183389|FG001|Overall Study|Relocation|8|||
149195237|NCT00077610|538183390|FG002|Overall Study|Relocation|5|||
149195238|NCT00077610|538183388|FG000|Overall Study|Financial issues|0|||
149195239|NCT00077610|538183389|FG001|Overall Study|Financial issues|1|||
149195240|NCT00077610|538183390|FG002|Overall Study|Financial issues|0|||
149195241|NCT00077610|538183388|FG000|Overall Study|Sponsors decision to withdraw|0|||
149195242|NCT00077610|538183389|FG001|Overall Study|Sponsors decision to withdraw|0|||
149195243|NCT00077610|538183390|FG002|Overall Study|Sponsors decision to withdraw|1|||
149195244|NCT01357915|538183394|FG000|Overall Study|Lost to Follow-up|3|||
149195245|NCT01357915|538183395|FG001|Overall Study|Lost to Follow-up|0|||
149195246|NCT00305253|538183396|FG000|Overall Study|Withdrawal by Subject|0|||
149195247|NCT00305253|538183397|FG001|Overall Study|Withdrawal by Subject|1|||
149195248|NCT01098461|538183398|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
149195249|NCT01098461|538183399|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
149195250|NCT01098461|538183400|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
149195251|NCT01098461|538183401|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
149195252|NCT01098461|538183398|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
149195253|NCT01098461|538183399|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
149195254|NCT01098461|538183400|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
149195255|NCT01098461|538183401|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
149195256|NCT01098461|538183398|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
149195257|NCT01098461|538183399|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
149195258|NCT01098461|538183400|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
149195259|NCT01098461|538183401|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
149195260|NCT01098461|538183398|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
149195261|NCT01098461|538183399|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
149195262|NCT01098461|538183400|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
149195263|NCT01098461|538183401|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
149195264|NCT01098461|538183398|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
149195265|NCT01098461|538183399|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
149195266|NCT01098461|538183400|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
149195267|NCT01098461|538183401|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
149195268|NCT01098461|538183398|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
149195269|NCT01098461|538183399|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
149195270|NCT01098461|538183400|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
149195271|NCT01098461|538183401|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
149195272|NCT01098461|538183398|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
149195273|NCT01098461|538183399|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
149195274|NCT01098461|538183400|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
149195275|NCT01098461|538183401|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
149195276|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
149195277|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
149195278|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Death|2|||
149195279|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Death|1|||
149195280|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
149195281|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
149195282|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
149195283|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
149195284|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
149195285|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
149195286|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
149195287|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
149195288|NCT03633227|538183402|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
149195289|NCT03633227|538183403|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
149195290|NCT03633227|538183402|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
149195291|NCT03633227|538183403|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
149195292|NCT03633227|538183402|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
149195293|NCT03633227|538183403|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
148936090|NCT01555983|537249552|FG002|Overall Study|Withdrawal by Subject|0|||
149195294|NCT03633227|538183402|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
149195295|NCT03633227|538183403|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
148936091|NCT01555983|537249553|FG003|Overall Study|Withdrawal by Subject|0|||
148936092|NCT01555983|537249554|FG004|Overall Study|Withdrawal by Subject|1|||
148936093|NCT01555983|537249555|FG005|Overall Study|Withdrawal by Subject|1|||
149195296|NCT03633227|538183402|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
149195297|NCT03633227|538183403|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
149195298|NCT03633227|538183402|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
149195299|NCT03633227|538183403|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
149195300|NCT01766336|538183409|FG000|Overall Study|Adverse Event|11|||
149195301|NCT01766336|538183410|FG001|Overall Study|Adverse Event|8|||
149195302|NCT01766336|538183409|FG000|Overall Study|Death|4|||
149195303|NCT01766336|538183410|FG001|Overall Study|Death|3|||
149195304|NCT01766336|538183409|FG000|Overall Study|Lost to Follow-up|1|||
149195305|NCT01766336|538183410|FG001|Overall Study|Lost to Follow-up|3|||
149195306|NCT01766336|538183409|FG000|Overall Study|Physician Decision|4|||
149195307|NCT01766336|538183410|FG001|Overall Study|Physician Decision|2|||
149195308|NCT01766336|538183409|FG000|Overall Study|Protocol Violation|0|||
149195309|NCT01766336|538183410|FG001|Overall Study|Protocol Violation|1|||
149195310|NCT01766336|538183409|FG000|Overall Study|Sponsor Decision|52|||
149195311|NCT01766336|538183410|FG001|Overall Study|Sponsor Decision|43|||
149195312|NCT01766336|538183409|FG000|Overall Study|Withdrawal by Subject|18|||
149195313|NCT01766336|538183410|FG001|Overall Study|Withdrawal by Subject|15|||
149195314|NCT02605447|538183412|FG000|Overall Study|Death|66|||
149195315|NCT02605447|538183412|FG000|Overall Study|Physician Decision|1|||
149195316|NCT02605447|538183412|FG000|Overall Study|Lost to Follow-up|24|||
149195317|NCT02605447|538183412|FG000|Overall Study|Withdrawal by Subject|10|||
149195318|NCT02605447|538183412|FG000|Overall Study|Not disclosed|1|||
149195319|NCT01479374|538183413|FG000|Overall Study|Adverse Event|2|||
149195320|NCT01479374|538183414|FG001|Overall Study|Adverse Event|1|||
149195321|NCT01479374|538183415|FG002|Overall Study|Adverse Event|0|||
149195322|NCT01479374|538183413|FG000|Overall Study|Lost to Follow-up|1|||
149195323|NCT01479374|538183414|FG001|Overall Study|Lost to Follow-up|2|||
149195324|NCT01479374|538183415|FG002|Overall Study|Lost to Follow-up|0|||
149195325|NCT01479374|538183413|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
149195326|NCT01479374|538183414|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
149195327|NCT01479374|538183415|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
149195328|NCT01479374|538183413|FG000|Overall Study|Other|0|||
149195329|NCT01479374|538183414|FG001|Overall Study|Other|4|||
149195330|NCT01479374|538183415|FG002|Overall Study|Other|5|||
149195331|NCT02045212|538183417|FG000|Overall Study|Adverse Event|0|||
149195332|NCT02045212|538183418|FG001|Overall Study|Adverse Event|1|||
149195333|NCT02045212|538183417|FG000|Overall Study|Withdrawal by Subject|1|||
149195334|NCT02045212|538183418|FG001|Overall Study|Withdrawal by Subject|0|||
149195335|NCT02045212|538183417|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
149195336|NCT02045212|538183418|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
149195337|NCT00243230|538183427|FG000|Double-Blind Period|Adverse Event|0|||
149195338|NCT00243230|538183428|FG001|Double-Blind Period|Adverse Event|2|||
149195339|NCT00243230|538183429|FG002|Double-Blind Period|Adverse Event|2|||
149195340|NCT00243230|538183430|FG003|Double-Blind Period|Adverse Event|0|||
149195341|NCT00243230|538183427|FG000|Double-Blind Period|Withdrawal by Subject|1|||
149195342|NCT00243230|538183428|FG001|Double-Blind Period|Withdrawal by Subject|0|||
149195343|NCT00243230|538183429|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149195344|NCT00243230|538183430|FG003|Double-Blind Period|Withdrawal by Subject|0|||
149195345|NCT00243230|538183427|FG000|Double-Blind Period|Protocol Violation|0|||
149195346|NCT00243230|538183428|FG001|Double-Blind Period|Protocol Violation|0|||
149195347|NCT00243230|538183429|FG002|Double-Blind Period|Protocol Violation|1|||
149195348|NCT00243230|538183430|FG003|Double-Blind Period|Protocol Violation|0|||
149195349|NCT00243230|538183427|FG000|Double-Blind Period|Randomized but Not Treated|0|||
149195350|NCT00243230|538183428|FG001|Double-Blind Period|Randomized but Not Treated|0|||
149195351|NCT00243230|538183429|FG002|Double-Blind Period|Randomized but Not Treated|2|||
149195352|NCT00243230|538183430|FG003|Double-Blind Period|Randomized but Not Treated|0|||
149195353|NCT00243230|538183427|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
149195354|NCT00243230|538183428|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
149195355|NCT00243230|538183429|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
149195356|NCT00243230|538183430|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
149195357|NCT00243230|538183427|FG000|Open Label Period|Adverse Event|0|||
149195358|NCT00243230|538183428|FG001|Open Label Period|Adverse Event|0|||
149195359|NCT00243230|538183429|FG002|Open Label Period|Adverse Event|0|||
149195360|NCT00243230|538183430|FG003|Open Label Period|Adverse Event|2|||
149195361|NCT00243230|538183427|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
149195362|NCT00243230|538183428|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
149195363|NCT00243230|538183429|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
149195364|NCT00243230|538183430|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
149195365|NCT00243230|538183427|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
149195366|NCT00243230|538183428|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
149195367|NCT00243230|538183429|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
149195368|NCT00243230|538183430|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
149195369|NCT00243230|538183427|FG000|Open Label Period|Lost to Follow-up|0|||
149195370|NCT00243230|538183428|FG001|Open Label Period|Lost to Follow-up|0|||
149195371|NCT00243230|538183429|FG002|Open Label Period|Lost to Follow-up|0|||
149195372|NCT00243230|538183430|FG003|Open Label Period|Lost to Follow-up|2|||
149195373|NCT00243230|538183427|FG000|Open Label Period|Withdrawal by Subject|0|||
149195374|NCT00243230|538183428|FG001|Open Label Period|Withdrawal by Subject|0|||
149195375|NCT00243230|538183429|FG002|Open Label Period|Withdrawal by Subject|0|||
149195376|NCT00243230|538183430|FG003|Open Label Period|Withdrawal by Subject|2|||
149195377|NCT00243230|538183427|FG000|Open Label Period|Protocol Violation|0|||
149195378|NCT00243230|538183428|FG001|Open Label Period|Protocol Violation|0|||
149195379|NCT00243230|538183429|FG002|Open Label Period|Protocol Violation|0|||
149195380|NCT00243230|538183430|FG003|Open Label Period|Protocol Violation|2|||
149195381|NCT00243230|538183427|FG000|Open Label Period|Administrative Reason|0|||
149195382|NCT00243230|538183428|FG001|Open Label Period|Administrative Reason|0|||
149195383|NCT00243230|538183429|FG002|Open Label Period|Administrative Reason|0|||
149195384|NCT00243230|538183430|FG003|Open Label Period|Administrative Reason|63|||
149195385|NCT03126539|538183433|FG000|Overall Study|Lost to Follow-up|1|||
149195386|NCT03126539|538183434|FG001|Overall Study|Lost to Follow-up|1|||
149195387|NCT03126539|538183435|FG002|Overall Study|Lost to Follow-up|1|||
149195388|NCT03126539|538183436|FG003|Overall Study|Lost to Follow-up|0|||
149195389|NCT03126539|538183437|FG004|Overall Study|Lost to Follow-up|0|||
149195390|NCT01005732|538183438|FG000|Overall Study|Lost to Follow-up|10|||
149195391|NCT01005732|538183438|FG000|Overall Study|Death|1|||
149195392|NCT00586924|538183439|FG000|Overall Study|Adverse event/serious adverse event|0|||
149195393|NCT00586924|538183440|FG001|Overall Study|Adverse event/serious adverse event|0|||
149195394|NCT00586924|538183441|FG002|Overall Study|Adverse event/serious adverse event|0|||
149195395|NCT00586924|538183442|FG003|Overall Study|Adverse event/serious adverse event|1|||
149195396|NCT00586924|538183443|FG004|Overall Study|Adverse event/serious adverse event|0|||
149195397|NCT00586924|538183444|FG005|Overall Study|Adverse event/serious adverse event|2|||
149195398|NCT00586924|538183439|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
149195399|NCT00586924|538183440|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
149195400|NCT00586924|538183441|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
149195401|NCT00586924|538183442|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
149195402|NCT00586924|538183443|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
149195403|NCT00586924|538183444|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
149195404|NCT00586924|538183439|FG000|Overall Study|Disease progression|0|||
149195405|NCT00586924|538183440|FG001|Overall Study|Disease progression|0|||
149195406|NCT00586924|538183441|FG002|Overall Study|Disease progression|0|||
149195407|NCT00586924|538183442|FG003|Overall Study|Disease progression|1|||
149195408|NCT00586924|538183443|FG004|Overall Study|Disease progression|1|||
149195409|NCT00586924|538183444|FG005|Overall Study|Disease progression|0|||
149195410|NCT00586924|538183439|FG000|Overall Study|Development of neutralizing antibodies|2|||
149195411|NCT00586924|538183440|FG001|Overall Study|Development of neutralizing antibodies|2|||
149195412|NCT00586924|538183441|FG002|Overall Study|Development of neutralizing antibodies|2|||
149195413|NCT00586924|538183442|FG003|Overall Study|Development of neutralizing antibodies|0|||
149195414|NCT00586924|538183443|FG004|Overall Study|Development of neutralizing antibodies|0|||
149195415|NCT00586924|538183444|FG005|Overall Study|Development of neutralizing antibodies|22|||
149195416|NCT00586924|538183439|FG000|Overall Study|Complete response|0|||
149195417|NCT00586924|538183440|FG001|Overall Study|Complete response|1|||
149195418|NCT00586924|538183441|FG002|Overall Study|Complete response|0|||
149195419|NCT00586924|538183442|FG003|Overall Study|Complete response|0|||
149195420|NCT00586924|538183443|FG004|Overall Study|Complete response|2|||
149195421|NCT00586924|538183444|FG005|Overall Study|Complete response|2|||
149195422|NCT00586924|538183439|FG000|Overall Study|Other|1|||
149195423|NCT00586924|538183440|FG001|Overall Study|Other|0|||
149195424|NCT00586924|538183441|FG002|Overall Study|Other|1|||
149195425|NCT00586924|538183442|FG003|Overall Study|Other|1|||
149195426|NCT00586924|538183443|FG004|Overall Study|Other|1|||
149195427|NCT00586924|538183444|FG005|Overall Study|Other|6|||
148682060|NCT01294592|536309429|FG000|Overall Study|Physician Decision|6|||
148682061|NCT01294592|536309430|FG001|Overall Study|Physician Decision|11|||
148682062|NCT01294592|536309429|FG000|Overall Study|Withdrawal by Subject|28|||
148682063|NCT01294592|536309430|FG001|Overall Study|Withdrawal by Subject|28|||
148682064|NCT00623623|536309432|FG000|Overall Study|Previous enrolment into this study|1|||
148682065|NCT00623623|536309433|FG001|Overall Study|Previous enrolment into this study|1|||
148682066|NCT00693784|536309435|FG000|Overall Study|Lost to Follow-up|2|||
149195428|NCT04570657|538183450|FG000|Overall Study|Adverse Event|0|||
149195429|NCT04570657|538183451|FG001|Overall Study|Adverse Event|0|||
149195430|NCT04570657|538183452|FG002|Overall Study|Adverse Event|1|||
149195431|NCT04570657|538183450|FG000|Overall Study|Lost to Follow-up|0|||
149195432|NCT04570657|538183451|FG001|Overall Study|Lost to Follow-up|0|||
149195433|NCT04570657|538183452|FG002|Overall Study|Lost to Follow-up|1|||
149195434|NCT04570657|538183450|FG000|Overall Study|Physician Decision|0|||
149195435|NCT04570657|538183451|FG001|Overall Study|Physician Decision|1|||
149195436|NCT04570657|538183452|FG002|Overall Study|Physician Decision|0|||
149195437|NCT04570657|538183450|FG000|Overall Study|Withdrawal by Subject|1|||
149195438|NCT04570657|538183451|FG001|Overall Study|Withdrawal by Subject|2|||
149015127|NCT03904693|537534398|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149015128|NCT03904693|537534399|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149195439|NCT04570657|538183452|FG002|Overall Study|Withdrawal by Subject|2|||
149195440|NCT02998554|538183453|FG000|Overall Study|Adverse Event|8|||
149195441|NCT02998554|538183454|FG001|Overall Study|Adverse Event|3|||
149195442|NCT02998554|538183453|FG000|Overall Study|Protocol deviation|1|||
149195443|NCT02998554|538183454|FG001|Overall Study|Protocol deviation|0|||
149195444|NCT02998554|538183453|FG000|Overall Study|Withdrawal by Subject|2|||
149195445|NCT02998554|538183454|FG001|Overall Study|Withdrawal by Subject|6|||
149195446|NCT02998554|538183453|FG000|Overall Study|Lost to Follow-up|0|||
149195447|NCT02998554|538183454|FG001|Overall Study|Lost to Follow-up|1|||
149195448|NCT02998554|538183453|FG000|Overall Study|Lack of Efficacy|0|||
149195449|NCT02998554|538183454|FG001|Overall Study|Lack of Efficacy|1|||
149195450|NCT02349789|538184972|FG000|Overall Study|Withdrawal by Subject|2|||
149195451|NCT00836277|538184977|FG000|Overall Study|Not evaluable for response|6|||
149195452|NCT00831441|538184987|FG000|Randomized|Death|82|||
149195453|NCT00831441|538184988|FG001|Randomized|Death|81|||
149195454|NCT00831441|538184987|FG000|Randomized|Adverse Event|248|||
149195455|NCT00831441|538184988|FG001|Randomized|Adverse Event|321|||
149195456|NCT00831441|538184987|FG000|Randomized|Emergency procedure|2|||
149195457|NCT00831441|538184988|FG001|Randomized|Emergency procedure|2|||
149195458|NCT00831441|538184987|FG000|Randomized|Elective procedure|26|||
149195459|NCT00831441|538184988|FG001|Randomized|Elective procedure|25|||
149195460|NCT00831441|538184987|FG000|Randomized|Physician Decision|26|||
149195461|NCT00831441|538184988|FG001|Randomized|Physician Decision|35|||
149195462|NCT00831441|538184987|FG000|Randomized|No longer met criteria|13|||
149195463|NCT00831441|538184988|FG001|Randomized|No longer met criteria|19|||
149195464|NCT00831441|538184987|FG000|Randomized|Withdrawal by Subject|178|||
149195465|NCT00831441|538184988|FG001|Randomized|Withdrawal by Subject|212|||
149195466|NCT00831441|538184987|FG000|Randomized|Lost to Follow-up|26|||
149195467|NCT00831441|538184988|FG001|Randomized|Lost to Follow-up|35|||
149195468|NCT00831441|538184987|FG000|Randomized|Administrative reason by sponsor|2780|||
149195469|NCT00831441|538184988|FG001|Randomized|Administrative reason by sponsor|2671|||
149195470|NCT00831441|538184987|FG000|Randomized|poor/non-compliance|30|||
149195471|NCT00831441|538184988|FG001|Randomized|poor/non-compliance|38|||
149195472|NCT00831441|538184987|FG000|Randomized|non-specified|276|||
149195473|NCT00831441|538184988|FG001|Randomized|non-specified|266|||
149195474|NCT00831441|538184987|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
149195475|NCT00831441|538184988|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
149195476|NCT00831441|538184987|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
149195477|NCT00831441|538184988|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
149195478|NCT00831441|538184987|FG000|Follow Up (30 Days)|Death|63|||
149195479|NCT00831441|538184988|FG001|Follow Up (30 Days)|Death|86|||
149195480|NCT00831441|538184987|FG000|Follow Up (30 Days)|non-specified|16|||
149195481|NCT00831441|538184988|FG001|Follow Up (30 Days)|non-specified|26|||
149195482|NCT00831441|538184987|FG000|Follow Up (30 Days)|missing end of study status|0|||
149195483|NCT00831441|538184988|FG001|Follow Up (30 Days)|missing end of study status|1|||
149195484|NCT05674344|538184989|FG000|Overall Study|Screen Fail|21|||
149195485|NCT05674344|538184989|FG000|Overall Study|Incomplete study procedures|3|||
149195486|NCT00111917|538184990|FG000|Overall Study|Withdrawal by Subject|1|||
149195487|NCT00111917|538184991|FG001|Overall Study|Withdrawal by Subject|1|||
149195488|NCT01640925|538184992|FG000|Overall Study|Withdrawal by Subject|1|||
149195489|NCT01640925|538184993|FG001|Overall Study|Withdrawal by Subject|0|||
149195490|NCT01640925|538184992|FG000|Overall Study|Previously enrolled in this trial|13|||
149195491|NCT01640925|538184993|FG001|Overall Study|Previously enrolled in this trial|11|||
149195492|NCT02156492|538184994|FG000|Period 1|No Reason Given|0|||
149195493|NCT02156492|538184995|FG001|Period 1|No Reason Given|1|||
149195494|NCT02156492|538184996|FG002|Period 1|No Reason Given|0|||
149195495|NCT02156492|538184994|FG000|Period 3|Adverse Event|0|||
149195496|NCT02156492|538184995|FG001|Period 3|Adverse Event|1|||
148682067|NCT00693784|536309435|FG000|Overall Study|Withdrawal by Subject|2|||
149195497|NCT02156492|538184996|FG002|Period 3|Adverse Event|0|||
149195498|NCT00485589|538185013|FG000|Overall Study|Death|2|||
149195499|NCT00485589|538185014|FG001|Overall Study|Death|2|||
149195500|NCT00485589|538185015|FG002|Overall Study|Death|0|||
149195501|NCT00485589|538185013|FG000|Overall Study|Failure to return|6|||
149195502|NCT00485589|538185014|FG001|Overall Study|Failure to return|5|||
149195503|NCT00485589|538185015|FG002|Overall Study|Failure to return|1|||
149195504|NCT00485589|538185013|FG000|Overall Study|Protocol Violation|1|||
149195505|NCT00485589|538185014|FG001|Overall Study|Protocol Violation|0|||
149195506|NCT00485589|538185015|FG002|Overall Study|Protocol Violation|0|||
149195507|NCT00485589|538185013|FG000|Overall Study|Violation of selection criteria at entry|0|||
149195508|NCT00485589|538185014|FG001|Overall Study|Violation of selection criteria at entry|3|||
149195509|NCT00485589|538185015|FG002|Overall Study|Violation of selection criteria at entry|1|||
149195510|NCT00485589|538185013|FG000|Overall Study|Administrative/Other|1|||
149195511|NCT00485589|538185014|FG001|Overall Study|Administrative/Other|2|||
149195512|NCT00485589|538185015|FG002|Overall Study|Administrative/Other|1|||
149195513|NCT00485589|538185013|FG000|Overall Study|Insufficient therapeutic response|10|||
149195514|NCT00485589|538185014|FG001|Overall Study|Insufficient therapeutic response|3|||
149195515|NCT00485589|538185015|FG002|Overall Study|Insufficient therapeutic response|1|||
149195516|NCT00485589|538185013|FG000|Overall Study|Refused treatment/did not cooperate|1|||
149195517|NCT00485589|538185014|FG001|Overall Study|Refused treatment/did not cooperate|0|||
149195518|NCT00485589|538185015|FG002|Overall Study|Refused treatment/did not cooperate|2|||
149195519|NCT00485589|538185013|FG000|Overall Study|Withdrawal by Subject|3|||
149195520|NCT00485589|538185014|FG001|Overall Study|Withdrawal by Subject|2|||
149195521|NCT00485589|538185015|FG002|Overall Study|Withdrawal by Subject|2|||
149195522|NCT00485589|538185013|FG000|Overall Study|Adverse Event|3|||
149195523|NCT00485589|538185014|FG001|Overall Study|Adverse Event|3|||
149195524|NCT00485589|538185015|FG002|Overall Study|Adverse Event|10|||
149195525|NCT01944969|538185016|FG000|Overall Study|Adverse Event|1|||
149195526|NCT01944969|538185016|FG000|Overall Study|Lack of Efficacy|1|||
149195527|NCT01944969|538185016|FG000|Overall Study|Non-compliance with IMP|1|||
149195528|NCT01944969|538185016|FG000|Overall Study|Administrative or other reasons|23|||
149195529|NCT03072719|538185017|FG000|Overall Study|Adverse Event|1|||
149195530|NCT03072719|538185018|FG001|Overall Study|Adverse Event|1|||
149195531|NCT03421964|538185022|FG000|Overall Study|Lost to Follow-up|11|||
149195532|NCT03421964|538185023|FG001|Overall Study|Lost to Follow-up|21|||
149195533|NCT03421964|538185022|FG000|Overall Study|Withdrawal by Subject|9|||
148936094|NCT01926015|537250631|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148936095|NCT01926015|537250632|FG001|Overall Study|Withdrawal by parent/guardian|1|||
148936096|NCT01926015|537250631|FG000|Overall Study|Randomized not treated|2|||
148936097|NCT01926015|537250632|FG001|Overall Study|Randomized not treated|0|||
148936098|NCT00615108|537250633|FG000|Overall Study|Adverse Event|122|||
148936099|NCT00615108|537250633|FG000|Overall Study|Other|370|||
148936100|NCT00615108|537250633|FG000|Overall Study|Lost to Follow-up|15|||
148936101|NCT01914757|537250634|FG000|Overall Study|Severe non-compliance to protocol|3|||
148936102|NCT01914757|537250635|FG001|Overall Study|Severe non-compliance to protocol|1|||
148936103|NCT01914757|537250636|FG002|Overall Study|Severe non-compliance to protocol|2|||
148936104|NCT01914757|537250634|FG000|Overall Study|Lost to Follow-up|5|||
148936105|NCT01914757|537250635|FG001|Overall Study|Lost to Follow-up|8|||
148936106|NCT01914757|537250636|FG002|Overall Study|Lost to Follow-up|6|||
148936107|NCT01914757|537250634|FG000|Overall Study|Withdrawal by Subject|15|||
148936108|NCT01914757|537250635|FG001|Overall Study|Withdrawal by Subject|27|||
148936109|NCT01914757|537250636|FG002|Overall Study|Withdrawal by Subject|19|||
148936110|NCT01914757|537250634|FG000|Overall Study|Death|2|||
148936111|NCT01914757|537250635|FG001|Overall Study|Death|2|||
148936112|NCT01914757|537250636|FG002|Overall Study|Death|1|||
148936113|NCT01914757|537250634|FG000|Overall Study|Adverse Event|4|||
148936114|NCT01914757|537250635|FG001|Overall Study|Adverse Event|3|||
148936115|NCT01914757|537250636|FG002|Overall Study|Adverse Event|4|||
148936116|NCT01914757|537250634|FG000|Overall Study|Study specific withdrawal criteria|0|||
148936117|NCT01914757|537250635|FG001|Overall Study|Study specific withdrawal criteria|1|||
148936118|NCT01914757|537250636|FG002|Overall Study|Study specific withdrawal criteria|0|||
148936119|NCT01914757|537250634|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
148936120|NCT01914757|537250635|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148936121|NCT01914757|537250636|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
148936122|NCT01914757|537250634|FG000|Overall Study|Other reasons|5|||
148936123|NCT01914757|537250635|FG001|Overall Study|Other reasons|9|||
148936124|NCT01914757|537250636|FG002|Overall Study|Other reasons|4|||
148936125|NCT01147640|537250641|FG000|Overall Study|Adverse Event|2|||
148936126|NCT01147640|537250642|FG001|Overall Study|Adverse Event|0|||
148936127|NCT01147640|537250641|FG000|Overall Study|Physician Decision|1|||
148936128|NCT01147640|537250642|FG001|Overall Study|Physician Decision|0|||
148936129|NCT01147640|537250641|FG000|Overall Study|Withdrawal by Subject|1|||
148936130|NCT01147640|537250642|FG001|Overall Study|Withdrawal by Subject|0|||
148936131|NCT01147640|537250641|FG000|Overall Study|Lost to Follow-up|0|||
148936132|NCT01147640|537250642|FG001|Overall Study|Lost to Follow-up|1|||
148936133|NCT01147640|537250641|FG000|Overall Study|Didn't meet eligibility criteria|1|||
148936134|NCT01147640|537250642|FG001|Overall Study|Didn't meet eligibility criteria|0|||
149015129|NCT03904693|537534400|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
148936135|NCT01856907|537250643|FG000|Overall Study|Pregnancy|0|||
148936136|NCT01856907|537250644|FG001|Overall Study|Pregnancy|1|||
149195534|NCT03421964|538185023|FG001|Overall Study|Withdrawal by Subject|3|||
149195535|NCT03421964|538185022|FG000|Overall Study|Incarcerated|1|||
149195536|NCT03421964|538185023|FG001|Overall Study|Incarcerated|0|||
149195537|NCT03421964|538185022|FG000|Overall Study|Inpt Treatment Facility|1|||
149195538|NCT03421964|538185023|FG001|Overall Study|Inpt Treatment Facility|1|||
148936137|NCT01856907|537250645|FG002|Overall Study|Pregnancy|0|||
148936138|NCT01856907|537250643|FG000|Overall Study|Pregnancy|0|||
148936139|NCT01856907|537250644|FG001|Overall Study|Pregnancy|1|||
148936140|NCT01856907|537250645|FG002|Overall Study|Pregnancy|0|||
148936141|NCT01856907|537250643|FG000|Overall Study|Withdrawal by Subject|0|||
148936142|NCT01856907|537250644|FG001|Overall Study|Withdrawal by Subject|1|||
148936143|NCT01856907|537250645|FG002|Overall Study|Withdrawal by Subject|0|||
148936144|NCT02191137|537250650|FG000|Treatment|Death|4|||
148936145|NCT02191137|537250650|FG000|Treatment|Withdrawal by Subject|3|||
148936146|NCT02191137|537250650|FG000|Treatment|Adverse Event|2|||
148936147|NCT02191137|537250650|FG000|Treatment|Other|1|||
148936148|NCT02191137|537250650|FG000|Follow-up|Lost to Follow-up|2|||
148936149|NCT02191137|537250650|FG000|Follow-up|Ongoing/unknown|2|||
148936150|NCT02191137|537250650|FG000|Follow-up|Adverse Event|1|||
148936151|NCT01904058|537250651|FG000|Overall Study|Adverse Event|2|||
148936152|NCT01904058|537250652|FG001|Overall Study|Adverse Event|0|||
148936153|NCT01904058|537250653|FG002|Overall Study|Adverse Event|0|||
148936154|NCT01904058|537250654|FG003|Overall Study|Adverse Event|0|||
148936155|NCT01904058|537250651|FG000|Overall Study|Withdrawal by Subject|1|||
148936156|NCT01904058|537250652|FG001|Overall Study|Withdrawal by Subject|0|||
148936157|NCT01904058|537250653|FG002|Overall Study|Withdrawal by Subject|1|||
148936158|NCT01904058|537250654|FG003|Overall Study|Withdrawal by Subject|0|||
148936159|NCT01904058|537250651|FG000|Overall Study|Pregnancy|0|||
148936160|NCT01904058|537250652|FG001|Overall Study|Pregnancy|0|||
148936161|NCT01904058|537250653|FG002|Overall Study|Pregnancy|0|||
148936162|NCT01904058|537250654|FG003|Overall Study|Pregnancy|1|||
148936163|NCT03096483|537250655|FG000|Overall Study|Withdrawal by site|1|||
148936164|NCT04810481|537250656|FG000|Overall Study|Disqualified data sets|10|||
148936165|NCT04810481|537250657|FG001|Overall Study|Disqualified data sets|28|||
148936166|NCT02046733|537250665|FG000|Overall Study|never initiated 'treatment visits'|6|||
148936167|NCT02046733|537250666|FG001|Overall Study|never initiated 'treatment visits'|0|||
148936168|NCT04041375|537250670|FG000|Intervention Phase|Withdrawal by Subject|2|||
148936169|NCT04041375|537250671|FG001|Intervention Phase|Withdrawal by Subject|2|||
148936170|NCT04041375|537250670|FG000|Follow-up Phase|Death|2|||
148936171|NCT04041375|537250671|FG001|Follow-up Phase|Death|0|||
148936172|NCT04041375|537250670|FG000|Follow-up Phase|Lost to Follow-up|2|||
148936173|NCT04041375|537250671|FG001|Follow-up Phase|Lost to Follow-up|1|||
148936174|NCT04041375|537250670|FG000|Follow-up Phase|Too ill|3|||
148936175|NCT04041375|537250671|FG001|Follow-up Phase|Too ill|0|||
148936176|NCT04674644|537250677|FG000|Overall Study|with missing data|37|||
148936177|NCT01268150|537250678|FG000|Treatment Phase|Progression of disease|18|||
148936178|NCT01268150|537250678|FG000|Treatment Phase|Adverse Event|3|||
148936179|NCT01268150|537250678|FG000|Treatment Phase|Withdrawal by Subject|3|||
148936180|NCT01268150|537250678|FG000|Treatment Phase|Other|4|||
148936181|NCT01268150|537250678|FG000|Extension Phase|Adverse Event|3|||
148936182|NCT01268150|537250678|FG000|Extension Phase|Disease progression|18|||
148936183|NCT01268150|537250678|FG000|Extension Phase|Other|6|||
148936184|NCT00395733|537250679|FG000|Period 2|Withdrawal by Subject|1|||
148936185|NCT00395733|537250680|FG001|Period 2|Withdrawal by Subject|2|||
148936186|NCT00395733|537250679|FG000|Period 2|Protocol Violation|0|||
148936187|NCT00395733|537250680|FG001|Period 2|Protocol Violation|1|||
148936188|NCT00395733|537250679|FG000|Period 2|Adverse Event|0|||
148936189|NCT00395733|537250680|FG001|Period 2|Adverse Event|2|||
148936190|NCT00395733|537250679|FG000|Period 2|Technical problems|1|||
148936191|NCT00395733|537250680|FG001|Period 2|Technical problems|0|||
148936192|NCT03725852|537250681|FG000|Overall Study|Death|1|||
148936193|NCT03725852|537250682|FG001|Overall Study|Death|0|||
148936194|NCT03725852|537250681|FG000|Overall Study|Withdrawal by Subject|1|||
148936195|NCT03725852|537250682|FG001|Overall Study|Withdrawal by Subject|0|||
148936196|NCT03725852|537250681|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
148936197|NCT03725852|537250682|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
148682068|NCT02265952|536309436|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
148936198|NCT02808650|537250687|FG000|Overall Study|Death|0|||
148936199|NCT02808650|537250688|FG001|Overall Study|Death|0|||
148936200|NCT02808650|537250689|FG002|Overall Study|Death|0|||
148936201|NCT02808650|537250690|FG003|Overall Study|Death|0|||
148682069|NCT02265952|536309437|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
148936202|NCT02808650|537250691|FG004|Overall Study|Death|1|||
148936203|NCT02808650|537250687|FG000|Overall Study|Lack of Efficacy|5|||
148936204|NCT02808650|537250688|FG001|Overall Study|Lack of Efficacy|5|||
148936205|NCT02808650|537250689|FG002|Overall Study|Lack of Efficacy|6|||
148936206|NCT02808650|537250690|FG003|Overall Study|Lack of Efficacy|5|||
148682070|NCT02265952|536309436|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
148936207|NCT02808650|537250691|FG004|Overall Study|Lack of Efficacy|4|||
148936208|NCT02808650|537250687|FG000|Overall Study|Physician Decision|1|||
148936209|NCT02808650|537250688|FG001|Overall Study|Physician Decision|1|||
148936210|NCT02808650|537250689|FG002|Overall Study|Physician Decision|0|||
148936211|NCT02808650|537250690|FG003|Overall Study|Physician Decision|0|||
148936212|NCT02808650|537250691|FG004|Overall Study|Physician Decision|0|||
148936213|NCT02808650|537250687|FG000|Overall Study|Withdrawal by Subject|0|||
148936214|NCT02808650|537250688|FG001|Overall Study|Withdrawal by Subject|0|||
148936215|NCT02808650|537250689|FG002|Overall Study|Withdrawal by Subject|0|||
148936216|NCT02808650|537250690|FG003|Overall Study|Withdrawal by Subject|1|||
148936217|NCT02808650|537250691|FG004|Overall Study|Withdrawal by Subject|1|||
148936218|NCT01672736|537250695|FG000|Overall Study|Available drug expired on 31 May 16|3|||
148936219|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
148936220|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
148936221|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Death|1|||
148936222|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Death|0|||
148936223|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
148936224|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
148936225|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
148936226|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
148936227|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
148936228|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
148936229|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
148936230|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
148936231|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
148936232|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
148936233|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
148936234|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
148936235|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
148936236|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
148936237|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
148936238|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
148936239|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
148936240|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
148936241|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
148936242|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
148936243|NCT02927262|537250696|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
148936244|NCT02927262|537250697|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
148936245|NCT02927262|537250696|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
148936246|NCT02927262|537250697|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
148936247|NCT02927262|537250696|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
148936248|NCT02927262|537250697|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
148936249|NCT02927262|537250696|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
148936250|NCT02927262|537250697|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
148936251|NCT01697358|537250698|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
148936252|NCT01697358|537250699|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
148936253|NCT01697358|537250698|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
148936254|NCT01697358|537250699|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
148936255|NCT01697358|537250698|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
148936256|NCT01697358|537250699|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
148936257|NCT01697358|537250698|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
148936258|NCT01697358|537250699|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
148936259|NCT01697358|537250698|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
148936260|NCT01697358|537250699|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
148936261|NCT01697358|537250698|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
148936262|NCT01697358|537250699|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
148936263|NCT01697358|537250698|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
148936264|NCT01697358|537250699|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
148936265|NCT01697358|537250698|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
148936266|NCT01697358|537250699|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
148936267|NCT01697358|537250698|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
148936268|NCT01697358|537250699|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
149195539|NCT03421964|538185022|FG000|Overall Study|Virtual Platform Issues|1|||
149195540|NCT03421964|538185023|FG001|Overall Study|Virtual Platform Issues|1|||
149195541|NCT02938585|538185024|FG000|Overall Study|Withdrawal by parent or guardian|0|||
149195542|NCT02938585|538185025|FG001|Overall Study|Withdrawal by parent or guardian|1|||
149195543|NCT02938585|538185026|FG002|Overall Study|Withdrawal by parent or guardian|0|||
149195544|NCT02938585|538185027|FG003|Overall Study|Withdrawal by parent or guardian|0|||
149195545|NCT02938585|538185024|FG000|Overall Study|Withdrawal by Subject|0|||
149195546|NCT02938585|538185025|FG001|Overall Study|Withdrawal by Subject|0|||
148936269|NCT01697358|537250698|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
148936270|NCT01697358|537250699|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
148936271|NCT02853344|537250700|FG000|Overall Study|Lost to Follow-up|1|||
148936272|NCT02853344|537250701|FG001|Overall Study|Lost to Follow-up|1|||
148936273|NCT02853344|537250700|FG000|Overall Study|Withdrawal by Subject|2|||
148936274|NCT02853344|537250701|FG001|Overall Study|Withdrawal by Subject|4|||
148936275|NCT02853344|537250700|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
148936276|NCT02853344|537250701|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
148936277|NCT02853344|537250700|FG000|Overall Study|Death|70|||
148936278|NCT02853344|537250701|FG001|Overall Study|Death|112|||
148936279|NCT00669396|537250702|FG000|Overall Study|Lost to Follow-up|10|||
148936280|NCT00669396|537250703|FG001|Overall Study|Lost to Follow-up|12|||
148936281|NCT04043728|537250711|FG000|Overall Study|Lost to Follow-up|1|||
148936282|NCT04043728|537250712|FG001|Overall Study|Lost to Follow-up|2|||
148936283|NCT04043728|537250713|FG002|Overall Study|Lost to Follow-up|0|||
148936284|NCT03841448|537250714|FG000|Double-blind Treatment (DBT) Period|Death|1|||
148936285|NCT03841448|537250715|FG001|Double-blind Treatment (DBT) Period|Death|1|||
148936286|NCT03841448|537250716|FG002|Double-blind Treatment (DBT) Period|Death|0|||
148936287|NCT03841448|537250717|FG003|Double-blind Treatment (DBT) Period|Death|0|||
148936288|NCT03841448|537250714|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
148936289|NCT03841448|537250715|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
148936290|NCT03841448|537250716|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
148936291|NCT03841448|537250717|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
148936292|NCT03841448|537250714|FG000|Open-Label Extension (OLE) Period|Death|0|||
148936293|NCT03841448|537250715|FG001|Open-Label Extension (OLE) Period|Death|0|||
148936294|NCT03841448|537250716|FG002|Open-Label Extension (OLE) Period|Death|0|||
148936295|NCT03841448|537250717|FG003|Open-Label Extension (OLE) Period|Death|1|||
148936296|NCT03841448|537250714|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
148936297|NCT03841448|537250715|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
148936298|NCT03841448|537250716|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
148936299|NCT03841448|537250717|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
148936300|NCT03841448|537250714|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
148936301|NCT03841448|537250715|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
148936302|NCT03841448|537250716|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
148936303|NCT03841448|537250717|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
148936304|NCT03841448|537250714|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
148936305|NCT03841448|537250715|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
148936306|NCT03841448|537250716|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
148936307|NCT03841448|537250717|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
148936308|NCT00072176|537250718|FG000|Overall Study|Withdrawal by Subject|1|||
148807725|NCT03979313|536774421|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
148807726|NCT03979313|536774422|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
148807727|NCT03979313|536774421|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
148807728|NCT03979313|536774422|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
148807729|NCT03979313|536774421|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
148807730|NCT03979313|536774422|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
148807731|NCT03979313|536774421|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
148807732|NCT03979313|536774422|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
148807733|NCT03979313|536774421|FG000|All Subjects|Any Other Reason|16|||
148807734|NCT03979313|536774422|FG001|All Subjects|Any Other Reason|23|||
148807735|NCT03979313|536774421|FG000|All Subjects|Covid-19|1|||
148807736|NCT03979313|536774422|FG001|All Subjects|Covid-19|3|||
148807737|NCT03979313|536774421|FG000|All Subjects|Withdrawal by Subject|35|||
148807738|NCT03979313|536774422|FG001|All Subjects|Withdrawal by Subject|44|||
148807739|NCT03979313|536774421|FG000|All Subjects|Death|0|||
148936309|NCT00072176|537250719|FG001|Overall Study|Withdrawal by Subject|0|||
149195547|NCT02938585|538185026|FG002|Overall Study|Withdrawal by Subject|0|||
149195548|NCT02938585|538185027|FG003|Overall Study|Withdrawal by Subject|5|||
149195549|NCT03888391|538185032|FG000|Overall Study|Lost to Follow-up|15|||
149195550|NCT00502320|538185033|FG000|Overall Study|Lost to Follow-up|1|||
149195551|NCT00502320|538185034|FG001|Overall Study|Lost to Follow-up|1|||
149195552|NCT00502320|538185033|FG000|Overall Study|Withdrew Consent|1|||
149195553|NCT00502320|538185034|FG001|Overall Study|Withdrew Consent|0|||
148807740|NCT03979313|536774422|FG001|All Subjects|Death|5|||
148807741|NCT03979313|536774421|FG000|All Subjects|Lost to Follow-up|28|||
148936310|NCT00072176|537250718|FG000|Overall Study|Protocol Violation|0|||
148936311|NCT00072176|537250719|FG001|Overall Study|Protocol Violation|1|||
148936312|NCT04128371|537250720|FG000|Overall Study|Lack of Efficacy|1|||
148936313|NCT00968864|537250725|FG000|Overall Study|Protocol exception/ not evaluable|1|||
148936314|NCT00586625|537250726|FG000|Overall Study|Adverse Event|6|||
148936315|NCT00586625|537250727|FG001|Overall Study|Adverse Event|6|||
149195554|NCT00502320|538185033|FG000|Overall Study|No longer met criteria|1|||
148936316|NCT00586625|537250726|FG000|Overall Study|Protocol Violation|3|||
148936317|NCT00586625|537250727|FG001|Overall Study|Protocol Violation|0|||
148936318|NCT00586625|537250726|FG000|Overall Study|Withdrawal by Subject|32|||
148936319|NCT00586625|537250727|FG001|Overall Study|Withdrawal by Subject|10|||
148936320|NCT00586625|537250726|FG000|Overall Study|Subject non-compliance|0|||
148936321|NCT00586625|537250727|FG001|Overall Study|Subject non-compliance|1|||
148936322|NCT00586625|537250726|FG000|Overall Study|Subject unable to return for visit|2|||
148682071|NCT02265952|536309437|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
148682072|NCT00326885|536309441|FG000|Overall Study|Adverse Event|1|||
148682073|NCT00326885|536309441|FG000|Overall Study|Withdrawal by Subject|3|||
148682074|NCT00326885|536309441|FG000|Overall Study|Physician Decision|1|||
148682075|NCT00326885|536309441|FG000|Overall Study|Hospice withdrew consent|2|||
148682076|NCT01042977|536309442|FG000|Overall Study|Adverse Event|4|||
148682077|NCT01042977|536309443|FG001|Overall Study|Adverse Event|12|||
148682078|NCT01042977|536309442|FG000|Overall Study|Death|2|||
148682079|NCT01042977|536309443|FG001|Overall Study|Death|1|||
148682080|NCT01042977|536309442|FG000|Overall Study|Withdrawal by Subject|8|||
148682081|NCT01042977|536309443|FG001|Overall Study|Withdrawal by Subject|16|||
148682082|NCT01042977|536309442|FG000|Overall Study|Lost to Follow-up|0|||
148682083|NCT01042977|536309443|FG001|Overall Study|Lost to Follow-up|2|||
148682084|NCT01042977|536309442|FG000|Overall Study|Poor/non-compliance|3|||
148682085|NCT01042977|536309443|FG001|Overall Study|Poor/non-compliance|4|||
148682086|NCT01042977|536309442|FG000|Overall Study|Subject no longer meets study criteria|15|||
148682087|NCT01042977|536309443|FG001|Overall Study|Subject no longer meets study criteria|13|||
148682088|NCT01042977|536309442|FG000|Overall Study|Incorrect enrollment|6|||
148682089|NCT01042977|536309443|FG001|Overall Study|Incorrect enrollment|4|||
148682090|NCT01042977|536309442|FG000|Overall Study|Safety|0|||
148682091|NCT01042977|536309443|FG001|Overall Study|Safety|2|||
148682092|NCT01042977|536309442|FG000|Overall Study|Administrative reason by sponsor|0|||
148682093|NCT01042977|536309443|FG001|Overall Study|Administrative reason by sponsor|1|||
148682094|NCT01042977|536309442|FG000|Overall Study|Various|3|||
148682095|NCT01042977|536309443|FG001|Overall Study|Various|0|||
148682096|NCT02499354|536309444|FG000|Overall Study|Withdrawal by Subject|1|||
148682097|NCT02499354|536309445|FG001|Overall Study|Withdrawal by Subject|0|||
148682098|NCT04356573|536309447|FG000|Overall Study|Didn't Qualify|1|||
148682099|NCT04356573|536309448|FG001|Overall Study|Didn't Qualify|0|||
148682100|NCT01717456|536309452|FG000|End of Treatment|Physician Decision|0|||
148682101|NCT01717456|536309453|FG001|End of Treatment|Physician Decision|1|||
148682102|NCT01717456|536309452|FG000|End of Treatment|Lost to Follow-up|0|||
148682103|NCT01717456|536309453|FG001|End of Treatment|Lost to Follow-up|1|||
148682104|NCT01717456|536309452|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
148682105|NCT01717456|536309453|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
148682106|NCT00986154|536309454|FG000|Overall Study|Death|136|||
148682107|NCT00986154|536309455|FG001|Overall Study|Death|127|||
148682108|NCT00986154|536309454|FG000|Overall Study|Lost to Follow-up|7|||
148682109|NCT00986154|536309455|FG001|Overall Study|Lost to Follow-up|4|||
148682110|NCT00986154|536309454|FG000|Overall Study|Withdrawal by Subject|32|||
148682111|NCT00986154|536309455|FG001|Overall Study|Withdrawal by Subject|33|||
148682112|NCT00986154|536309454|FG000|Overall Study|investigator/subject decide not continue|6|||
148682113|NCT00986154|536309455|FG001|Overall Study|investigator/subject decide not continue|3|||
148682114|NCT00986154|536309454|FG000|Overall Study|never received study drug|25|||
148682115|NCT00986154|536309455|FG001|Overall Study|never received study drug|27|||
148682116|NCT03726437|536309456|FG000|Overall Study|Lost to Follow-up|85|||
148682117|NCT03726437|536309457|FG001|Overall Study|Lost to Follow-up|76|||
148682118|NCT00267007|536309458|FG000|Overall Study|Withdrawal by Subject|6|||
148682119|NCT00267007|536309459|FG001|Overall Study|Withdrawal by Subject|0|||
148936323|NCT00586625|537250727|FG001|Overall Study|Subject unable to return for visit|0|||
148936324|NCT04032652|537250729|FG000|Overall Study|The study was terminated and the PI has|1|||
148936325|NCT04032652|537250730|FG001|Overall Study|The study was terminated and the PI has|1|||
148936326|NCT02423772|537250731|FG000|Overall Study|Lost to Follow-up|3|||
148936327|NCT02423772|537250732|FG001|Overall Study|Lost to Follow-up|3|||
148936328|NCT02423772|537250731|FG000|Overall Study|Did not begin intervention|2|||
148936329|NCT02423772|537250732|FG001|Overall Study|Did not begin intervention|5|||
149195555|NCT00502320|538185034|FG001|Overall Study|No longer met criteria|0|||
149195556|NCT00502320|538185033|FG000|Overall Study|Screen Failure|0|||
149195557|NCT00502320|538185034|FG001|Overall Study|Screen Failure|1|||
148682120|NCT00267007|536309458|FG000|Overall Study|Lost to Follow-up|1|||
148682121|NCT00267007|536309459|FG001|Overall Study|Lost to Follow-up|0|||
148936330|NCT03672643|537250733|FG000|Overall Study|Adverse Event|3|||
149195558|NCT00502320|538185033|FG000|Overall Study|Adverse Event|3|||
148682122|NCT00267007|536309458|FG000|Overall Study|Non-compliance|0|||
148682123|NCT00267007|536309459|FG001|Overall Study|Non-compliance|1|||
148682124|NCT00267007|536309458|FG000|Overall Study|Adverse Event|1|||
148682125|NCT00267007|536309459|FG001|Overall Study|Adverse Event|0|||
148682126|NCT00033631|536309465|FG000|Overall Study|Protocol Violation|14|||
148682127|NCT00033631|536309466|FG001|Overall Study|Protocol Violation|11|||
148682128|NCT00033631|536309465|FG000|Overall Study|Withdrawal by Subject|4|||
148936331|NCT03672643|537250733|FG000|Overall Study|Death|2|||
149195559|NCT00502320|538185034|FG001|Overall Study|Adverse Event|5|||
148936332|NCT03672643|537250733|FG000|Overall Study|Withdrawal by Subject|1|||
148936333|NCT03672643|537250733|FG000|Overall Study|Progressive disease|11|||
148936334|NCT03672643|537250733|FG000|Overall Study|Global deterioration of health status|1|||
148936335|NCT03672643|537250733|FG000|Overall Study|Refused further treatment|7|||
148936336|NCT03672643|537250733|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
148936337|NCT01066000|537250736|FG000|Overall Study|Protocol Violation|4|||
148936338|NCT01066000|537250736|FG000|Overall Study|Death|3|||
148936339|NCT01066000|537250736|FG000|Overall Study|Withdrawal by Subject|1|||
148936340|NCT01066000|537250736|FG000|Overall Study|Adverse Event|1|||
148936341|NCT01386008|537250737|FG000|Overall Study|exited w/o incident /study discontinued|17|||
148936342|NCT01386008|537250737|FG000|Overall Study|Adverse Event|3|||
148936343|NCT03001882|537250738|FG000|Overall Study|Death|1|||
148936344|NCT03001882|537250739|FG001|Overall Study|Death|0|||
148936345|NCT03001882|537250740|FG002|Overall Study|Death|0|||
148936346|NCT03001882|537250741|FG003|Overall Study|Death|3|||
148936347|NCT03001882|537250738|FG000|Overall Study|Participant withdrew consent|0|||
148936348|NCT03001882|537250739|FG001|Overall Study|Participant withdrew consent|1|||
148936349|NCT03001882|537250740|FG002|Overall Study|Participant withdrew consent|0|||
148936350|NCT03001882|537250741|FG003|Overall Study|Participant withdrew consent|5|||
148936351|NCT03001882|537250738|FG000|Overall Study|Other reasons|1|||
148936352|NCT03001882|537250739|FG001|Overall Study|Other reasons|2|||
148936353|NCT03001882|537250740|FG002|Overall Study|Other reasons|0|||
148936354|NCT03001882|537250741|FG003|Overall Study|Other reasons|5|||
148936355|NCT03001882|537250738|FG000|Overall Study|Administrative reason by sponsor|0|||
148936356|NCT03001882|537250739|FG001|Overall Study|Administrative reason by sponsor|0|||
148936357|NCT03001882|537250740|FG002|Overall Study|Administrative reason by sponsor|0|||
148936358|NCT03001882|537250741|FG003|Overall Study|Administrative reason by sponsor|1|||
148936359|NCT03001882|537250738|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
148936360|NCT03001882|537250739|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
148936361|NCT03001882|537250740|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
148936362|NCT03001882|537250741|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
148936363|NCT03001882|537250738|FG000|Overall Study|Not reported|0|||
148936364|NCT03001882|537250739|FG001|Overall Study|Not reported|0|||
148682129|NCT00033631|536309466|FG001|Overall Study|Withdrawal by Subject|4|||
148682130|NCT01159769|536309467|FG000|Overall Study|Adverse Event|1|||
148682131|NCT00272961|536309468|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
148682132|NCT00272961|536309469|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
148682133|NCT00272961|536309470|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
148682134|NCT00272961|536309471|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
148807742|NCT03979313|536774422|FG001|All Subjects|Lost to Follow-up|61|||
148936365|NCT03001882|537250740|FG002|Overall Study|Not reported|0|||
148936366|NCT03001882|537250741|FG003|Overall Study|Not reported|6|||
148936367|NCT03001882|537250738|FG000|Overall Study|Maximum clinical benefit|2|||
148936368|NCT03001882|537250739|FG001|Overall Study|Maximum clinical benefit|3|||
148936369|NCT03001882|537250740|FG002|Overall Study|Maximum clinical benefit|0|||
148936370|NCT03001882|537250741|FG003|Overall Study|Maximum clinical benefit|10|||
148936371|NCT03001882|537250738|FG000|Overall Study|AE unrelated to study drug|3|||
148936372|NCT03001882|537250739|FG001|Overall Study|AE unrelated to study drug|3|||
148936373|NCT03001882|537250740|FG002|Overall Study|AE unrelated to study drug|0|||
148936374|NCT03001882|537250741|FG003|Overall Study|AE unrelated to study drug|11|||
148936375|NCT03001882|537250738|FG000|Overall Study|Study Drug Toxicity|8|||
148936376|NCT03001882|537250739|FG001|Overall Study|Study Drug Toxicity|5|||
148936377|NCT03001882|537250740|FG002|Overall Study|Study Drug Toxicity|0|||
148936378|NCT03001882|537250741|FG003|Overall Study|Study Drug Toxicity|37|||
148936379|NCT03001882|537250738|FG000|Overall Study|Disease progression|16|||
148936380|NCT03001882|537250739|FG001|Overall Study|Disease progression|14|||
148936381|NCT03001882|537250740|FG002|Overall Study|Disease progression|1|||
148936382|NCT03001882|537250741|FG003|Overall Study|Disease progression|90|||
148936383|NCT00566111|537250742|FG000|Overall Study|Adverse Event|0|||
148936384|NCT00566111|537250743|FG001|Overall Study|Adverse Event|2|||
148936385|NCT04449861|537250744|FG000|Overall Study|Withdrawal by Subject|4|||
148936386|NCT04449861|537250744|FG000|Overall Study|Lost to Follow-up|5|||
148936387|NCT04449861|537250744|FG000|Overall Study|Death|112|||
148936388|NCT05268055|537250745|FG000|Overall Study|Lost to Follow-up|68|||
148936389|NCT05268055|537250746|FG001|Overall Study|Lost to Follow-up|68|||
148936390|NCT05268055|537250745|FG000|Overall Study|Withdrawal by Subject|12|||
148936391|NCT05268055|537250746|FG001|Overall Study|Withdrawal by Subject|8|||
148936392|NCT02468232|537252530|FG000|Core Part of Study|Adverse Event|0|||
148936393|NCT02468232|537252531|FG001|Core Part of Study|Adverse Event|1|||
148936394|NCT02468232|537252532|FG002|Core Part of Study|Adverse Event|0|||
148936395|NCT02468232|537252533|FG003|Core Part of Study|Adverse Event|0|||
148936396|NCT02468232|537252530|FG000|Core Part of Study|Death|20|||
148936397|NCT02468232|537252531|FG001|Core Part of Study|Death|17|||
148936398|NCT02468232|537252532|FG002|Core Part of Study|Death|0|||
148936399|NCT02468232|537252533|FG003|Core Part of Study|Death|0|||
148936400|NCT02468232|537252530|FG000|Core Part of Study|Technical Problems|1|||
148936401|NCT02468232|537252531|FG001|Core Part of Study|Technical Problems|1|||
148936402|NCT02468232|537252532|FG002|Core Part of Study|Technical Problems|0|||
148936403|NCT02468232|537252533|FG003|Core Part of Study|Technical Problems|0|||
148936404|NCT02468232|537252530|FG000|OLE Part of Study|Adverse Event|0|||
148936405|NCT02468232|537252531|FG001|OLE Part of Study|Adverse Event|0|||
148936406|NCT02468232|537252532|FG002|OLE Part of Study|Adverse Event|4|||
148936407|NCT02468232|537252533|FG003|OLE Part of Study|Adverse Event|5|||
148936408|NCT02468232|537252530|FG000|OLE Part of Study|Death|0|||
148936409|NCT02468232|537252531|FG001|OLE Part of Study|Death|0|||
148936410|NCT02468232|537252532|FG002|OLE Part of Study|Death|4|||
148936411|NCT02468232|537252533|FG003|OLE Part of Study|Death|2|||
148936412|NCT02468232|537252530|FG000|OLE Part of Study|Physician Decision|0|||
148936413|NCT02468232|537252531|FG001|OLE Part of Study|Physician Decision|0|||
148936414|NCT02468232|537252532|FG002|OLE Part of Study|Physician Decision|4|||
148936415|NCT02468232|537252533|FG003|OLE Part of Study|Physician Decision|0|||
148936416|NCT02468232|537252530|FG000|OLE Part of Study|Subject/Guardian decision|0|||
148936417|NCT02468232|537252531|FG001|OLE Part of Study|Subject/Guardian decision|0|||
148936418|NCT02468232|537252532|FG002|OLE Part of Study|Subject/Guardian decision|2|||
148936419|NCT02468232|537252533|FG003|OLE Part of Study|Subject/Guardian decision|5|||
148936420|NCT01826604|537252534|FG000|Overall Study|Lost to Follow-up|8|||
149015130|NCT03904693|537534401|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149015131|NCT03904693|537534402|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149015132|NCT03904693|537534403|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
149015133|NCT03904693|537534398|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
149015134|NCT03904693|537534399|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
149015135|NCT03904693|537534400|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
149015136|NCT03904693|537534401|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
149015137|NCT03904693|537534402|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
149015138|NCT03904693|537534403|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
149015139|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
149015140|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
149015141|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
149195560|NCT03654755|538185035|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
149195561|NCT03654755|538185036|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
149195562|NCT03654755|538185037|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
149195563|NCT03654755|538185035|FG000|Overall Study|Withdrawal by Subject|2|||
149195564|NCT03654755|538185036|FG001|Overall Study|Withdrawal by Subject|4|||
149195565|NCT03654755|538185037|FG002|Overall Study|Withdrawal by Subject|8|||
149195566|NCT03654755|538185035|FG000|Overall Study|Lost to Follow-up|1|||
149195567|NCT03654755|538185036|FG001|Overall Study|Lost to Follow-up|3|||
149195568|NCT03654755|538185037|FG002|Overall Study|Lost to Follow-up|7|||
149195569|NCT03654755|538185035|FG000|Overall Study|Physician Decision|0|||
149195570|NCT03654755|538185036|FG001|Overall Study|Physician Decision|1|||
149195571|NCT03654755|538185037|FG002|Overall Study|Physician Decision|0|||
149195572|NCT03654755|538185035|FG000|Overall Study|Adverse Event|0|||
149195573|NCT03654755|538185036|FG001|Overall Study|Adverse Event|0|||
149195574|NCT03654755|538185037|FG002|Overall Study|Adverse Event|4|||
149195575|NCT03654755|538185035|FG000|Overall Study|Lack of Efficacy|0|||
149195576|NCT03654755|538185036|FG001|Overall Study|Lack of Efficacy|0|||
149195577|NCT03654755|538185037|FG002|Overall Study|Lack of Efficacy|1|||
149195578|NCT00781599|538185039|FG000|Overall Study|Lost to Follow-up|7|||
149195579|NCT00781599|538185040|FG001|Overall Study|Lost to Follow-up|4|||
149195580|NCT01088438|538185049|FG000|Overall Study|Withdrawal by Subject|11|||
149195581|NCT01088438|538185050|FG001|Overall Study|Withdrawal by Subject|6|||
149195582|NCT01088438|538185049|FG000|Overall Study|Lost to Follow-up|18|||
149195583|NCT01088438|538185050|FG001|Overall Study|Lost to Follow-up|30|||
149195584|NCT00718666|538185051|FG000|Booster Phase Year 5|No active participation request|0|||
149195585|NCT00718666|538185052|FG001|Booster Phase Year 5|No active participation request|0|||
149195586|NCT00718666|538185053|FG002|Booster Phase Year 5|No active participation request|1|||
149195587|NCT00718666|538185051|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
149195588|NCT00718666|538185052|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
149195589|NCT00718666|538185053|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
149195590|NCT00718666|538185051|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
149195591|NCT00718666|538185052|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
149195592|NCT00718666|538185053|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
149195593|NCT00718666|538185051|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
149195594|NCT00718666|538185052|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
149195595|NCT00718666|538185053|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
149195596|NCT02196038|538185056|FG000|Overall Study|Death|16|||
148936421|NCT01826604|537252535|FG001|Overall Study|Lost to Follow-up|9|||
148936422|NCT02024529|537252538|FG000|Overall Study|Withdrawal by Subject|11|||
148936423|NCT02024529|537252539|FG001|Overall Study|Withdrawal by Subject|21|||
148936424|NCT02024529|537252538|FG000|Overall Study|Lost to Follow-up|2|||
148936425|NCT02024529|537252539|FG001|Overall Study|Lost to Follow-up|4|||
149195597|NCT02196038|538185057|FG001|Overall Study|Death|21|||
148682135|NCT00272961|536309472|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
148682136|NCT00272961|536309468|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
148682137|NCT00272961|536309469|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
148682138|NCT00272961|536309470|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
148682139|NCT00272961|536309471|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
148682140|NCT00272961|536309472|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
148682141|NCT00272961|536309468|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
148682142|NCT00272961|536309469|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
148682143|NCT00272961|536309470|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
148682144|NCT00272961|536309471|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
148682145|NCT00272961|536309472|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
148936426|NCT00354614|537252540|FG000|Overall Study|Lack of Efficacy|28|||
148936427|NCT02476201|537252541|FG000|Overall Study|Unable to program MPP|9|||
148936428|NCT02476201|537252541|FG000|Overall Study|Study echo not performed|5|||
148936429|NCT02476201|537252541|FG000|Overall Study|Adverse Event|4|||
148936430|NCT02476201|537252541|FG000|Overall Study|Death|2|||
148936431|NCT02476201|537252541|FG000|Overall Study|Lost to Follow-up|2|||
148936432|NCT02476201|537252541|FG000|Overall Study|MPP programmed to OFF|2|||
148936433|NCT02476201|537252541|FG000|Overall Study|Withdrawal by Subject|1|||
148936434|NCT02476201|537252541|FG000|Overall Study|Unsuccessful implant|1|||
148936435|NCT03650556|537252542|FG000|Overall Study|Death|2|||
148936436|NCT03650556|537252542|FG000|Overall Study|Withdrawal by Subject|20|||
148936437|NCT03650556|537252542|FG000|Overall Study|Physician Decision|2|||
148936438|NCT03650556|537252542|FG000|Overall Study|Lost to Follow-up|8|||
148936439|NCT03650556|537252542|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
148936440|NCT03650556|537252542|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
148936441|NCT00694707|537252545|FG000|Overall Study|Did Not Receive Treatment|0|||
148936442|NCT00694707|537252546|FG001|Overall Study|Did Not Receive Treatment|0|||
148936443|NCT00694707|537252547|FG002|Overall Study|Did Not Receive Treatment|1|||
148936444|NCT00694707|537252548|FG003|Overall Study|Did Not Receive Treatment|1|||
148936445|NCT00694707|537252549|FG004|Overall Study|Did Not Receive Treatment|1|||
148936446|NCT00694707|537252545|FG000|Overall Study|Adverse Event|22|||
148936447|NCT00694707|537252546|FG001|Overall Study|Adverse Event|14|||
148936448|NCT00694707|537252547|FG002|Overall Study|Adverse Event|8|||
148936449|NCT00694707|537252548|FG003|Overall Study|Adverse Event|12|||
148936450|NCT00694707|537252549|FG004|Overall Study|Adverse Event|13|||
148936451|NCT00694707|537252545|FG000|Overall Study|Insufficient Therapeutic Response|33|||
148936452|NCT00694707|537252546|FG001|Overall Study|Insufficient Therapeutic Response|18|||
148936453|NCT00694707|537252547|FG002|Overall Study|Insufficient Therapeutic Response|17|||
148936454|NCT00694707|537252548|FG003|Overall Study|Insufficient Therapeutic Response|15|||
148936455|NCT00694707|537252549|FG004|Overall Study|Insufficient Therapeutic Response|10|||
148936456|NCT00694707|537252545|FG000|Overall Study|Protocol Violation|1|||
148936457|NCT00694707|537252546|FG001|Overall Study|Protocol Violation|2|||
148936458|NCT00694707|537252547|FG002|Overall Study|Protocol Violation|1|||
148936459|NCT00694707|537252548|FG003|Overall Study|Protocol Violation|3|||
148936460|NCT00694707|537252549|FG004|Overall Study|Protocol Violation|1|||
148936461|NCT00694707|537252545|FG000|Overall Study|Withdrawal of Consent|14|||
148936462|NCT00694707|537252546|FG001|Overall Study|Withdrawal of Consent|18|||
148936463|NCT00694707|537252547|FG002|Overall Study|Withdrawal of Consent|22|||
148936464|NCT00694707|537252548|FG003|Overall Study|Withdrawal of Consent|16|||
148936465|NCT00694707|537252549|FG004|Overall Study|Withdrawal of Consent|15|||
148936466|NCT00694707|537252545|FG000|Overall Study|Lost to Follow-up|0|||
148936467|NCT00694707|537252546|FG001|Overall Study|Lost to Follow-up|1|||
148936468|NCT00694707|537252547|FG002|Overall Study|Lost to Follow-up|2|||
148936469|NCT00694707|537252548|FG003|Overall Study|Lost to Follow-up|0|||
148936470|NCT00694707|537252549|FG004|Overall Study|Lost to Follow-up|0|||
148936471|NCT00694707|537252545|FG000|Overall Study|Jeopardizing Parole Status|1|||
148936472|NCT00694707|537252546|FG001|Overall Study|Jeopardizing Parole Status|0|||
149015142|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
148682146|NCT00272961|536309468|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
148682147|NCT00272961|536309469|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
148682148|NCT00272961|536309470|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
148682149|NCT00272961|536309471|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
148807743|NCT04889040|536774425|FG000|Overall Study|Withdrawal by Subject|3|||
148936473|NCT00694707|537252547|FG002|Overall Study|Jeopardizing Parole Status|0|||
148936474|NCT00694707|537252548|FG003|Overall Study|Jeopardizing Parole Status|0|||
148936475|NCT00694707|537252549|FG004|Overall Study|Jeopardizing Parole Status|0|||
148936476|NCT00694707|537252545|FG000|Overall Study|Death in the Family|1|||
148936477|NCT00694707|537252546|FG001|Overall Study|Death in the Family|0|||
148936478|NCT00694707|537252547|FG002|Overall Study|Death in the Family|0|||
148936479|NCT00694707|537252548|FG003|Overall Study|Death in the Family|0|||
148936480|NCT00694707|537252549|FG004|Overall Study|Death in the Family|0|||
148936481|NCT00694707|537252545|FG000|Overall Study|Arrest by Police|0|||
148936482|NCT00694707|537252546|FG001|Overall Study|Arrest by Police|1|||
148936483|NCT00694707|537252547|FG002|Overall Study|Arrest by Police|0|||
148936484|NCT00694707|537252548|FG003|Overall Study|Arrest by Police|0|||
148936485|NCT00694707|537252549|FG004|Overall Study|Arrest by Police|0|||
148936486|NCT00694707|537252545|FG000|Overall Study|Administrative Reasons|0|||
148936487|NCT00694707|537252546|FG001|Overall Study|Administrative Reasons|1|||
148936488|NCT00694707|537252547|FG002|Overall Study|Administrative Reasons|0|||
148936489|NCT00694707|537252548|FG003|Overall Study|Administrative Reasons|2|||
148936490|NCT00694707|537252549|FG004|Overall Study|Administrative Reasons|0|||
148936491|NCT00694707|537252545|FG000|Overall Study|Notification of Past Head Injury|0|||
148936492|NCT00694707|537252546|FG001|Overall Study|Notification of Past Head Injury|0|||
148936493|NCT00694707|537252547|FG002|Overall Study|Notification of Past Head Injury|0|||
148936494|NCT00694707|537252548|FG003|Overall Study|Notification of Past Head Injury|1|||
148936495|NCT00694707|537252549|FG004|Overall Study|Notification of Past Head Injury|0|||
148936496|NCT02913612|537252552|FG000|Overall Study|Lost to Follow-up|6|||
148936497|NCT02913612|537252553|FG001|Overall Study|Lost to Follow-up|5|||
148936498|NCT02913612|537252554|FG002|Overall Study|Lost to Follow-up|2|||
148936499|NCT02913612|537252555|FG003|Overall Study|Lost to Follow-up|0|||
148936500|NCT02913612|537252552|FG000|Overall Study|Physician Decision|1|||
148936501|NCT02913612|537252553|FG001|Overall Study|Physician Decision|4|||
148936502|NCT02913612|537252554|FG002|Overall Study|Physician Decision|1|||
148936503|NCT02913612|537252555|FG003|Overall Study|Physician Decision|0|||
148936504|NCT02913612|537252552|FG000|Overall Study|Withdrawal by Subject|2|||
148936505|NCT02913612|537252553|FG001|Overall Study|Withdrawal by Subject|4|||
148936506|NCT02913612|537252554|FG002|Overall Study|Withdrawal by Subject|0|||
148936507|NCT02913612|537252555|FG003|Overall Study|Withdrawal by Subject|0|||
148936508|NCT02913612|537252552|FG000|Overall Study|Hemangioma resolved|1|||
148936509|NCT02913612|537252553|FG001|Overall Study|Hemangioma resolved|0|||
148936510|NCT02913612|537252554|FG002|Overall Study|Hemangioma resolved|0|||
148936511|NCT02913612|537252555|FG003|Overall Study|Hemangioma resolved|0|||
148936512|NCT02913612|537252552|FG000|Overall Study|Local IRB decision|1|||
148936513|NCT02913612|537252553|FG001|Overall Study|Local IRB decision|0|||
148936514|NCT02913612|537252554|FG002|Overall Study|Local IRB decision|0|||
148936515|NCT02913612|537252555|FG003|Overall Study|Local IRB decision|0|||
148936516|NCT02913612|537252552|FG000|Overall Study|Study drug non-compliance|1|||
148936517|NCT02913612|537252553|FG001|Overall Study|Study drug non-compliance|1|||
148936518|NCT02913612|537252554|FG002|Overall Study|Study drug non-compliance|0|||
148936519|NCT02913612|537252555|FG003|Overall Study|Study drug non-compliance|0|||
148936520|NCT02913612|537252552|FG000|Overall Study|Insurance issues|0|||
148936521|NCT02913612|537252553|FG001|Overall Study|Insurance issues|1|||
148936522|NCT02913612|537252554|FG002|Overall Study|Insurance issues|0|||
148936523|NCT02913612|537252555|FG003|Overall Study|Insurance issues|0|||
148936524|NCT02913612|537252552|FG000|Overall Study|Needed to treat second hemangioma|0|||
148936525|NCT02913612|537252553|FG001|Overall Study|Needed to treat second hemangioma|1|||
148936526|NCT02913612|537252554|FG002|Overall Study|Needed to treat second hemangioma|0|||
148936527|NCT02913612|537252555|FG003|Overall Study|Needed to treat second hemangioma|0|||
148936528|NCT02913612|537252552|FG000|Overall Study|Study completion criteria not met|0|||
148936529|NCT02913612|537252553|FG001|Overall Study|Study completion criteria not met|1|||
148936530|NCT02913612|537252554|FG002|Overall Study|Study completion criteria not met|0|||
148936531|NCT02913612|537252555|FG003|Overall Study|Study completion criteria not met|0|||
148936532|NCT02913612|537252552|FG000|Overall Study|Ineligible|0|||
148936533|NCT02913612|537252553|FG001|Overall Study|Ineligible|1|||
148936534|NCT02913612|537252554|FG002|Overall Study|Ineligible|0|||
148936535|NCT02913612|537252555|FG003|Overall Study|Ineligible|0|||
148936536|NCT01262573|537252556|FG000|Overall Study|Withdrawal by Subject|0|||
148936537|NCT01262573|537252557|FG001|Overall Study|Withdrawal by Subject|1|||
148936538|NCT04251273|537252558|FG000|Overall Study|Lost to Follow-up|331|||
148936539|NCT04251273|537252559|FG001|Overall Study|Lost to Follow-up|290|||
148936540|NCT04402060|537252560|FG000|Overall Study|Death|1|||
148936541|NCT04402060|537252561|FG001|Overall Study|Death|12|||
148936542|NCT04402060|537252562|FG002|Overall Study|Death|7|||
148936543|NCT04402060|537252560|FG000|Overall Study|Adverse Event|0|||
148936544|NCT04402060|537252561|FG001|Overall Study|Adverse Event|0|||
148936545|NCT04402060|537252562|FG002|Overall Study|Adverse Event|1|||
148936546|NCT04402060|537252560|FG000|Overall Study|Withdrawal by Subject|0|||
148936547|NCT04402060|537252561|FG001|Overall Study|Withdrawal by Subject|1|||
148936548|NCT04402060|537252562|FG002|Overall Study|Withdrawal by Subject|2|||
148936549|NCT04402060|537252560|FG000|Overall Study|Sponsor Request|0|||
148936550|NCT04402060|537252561|FG001|Overall Study|Sponsor Request|2|||
148936551|NCT04402060|537252562|FG002|Overall Study|Sponsor Request|0|||
148936552|NCT04402060|537252560|FG000|Overall Study|Physician Decision|0|||
148936553|NCT04402060|537252561|FG001|Overall Study|Physician Decision|0|||
148936554|NCT04402060|537252562|FG002|Overall Study|Physician Decision|1|||
148936555|NCT04402060|537252560|FG000|Overall Study|Other|0|||
148936556|NCT04402060|537252561|FG001|Overall Study|Other|1|||
148936557|NCT04402060|537252562|FG002|Overall Study|Other|0|||
148936558|NCT00810693|537252563|FG000|Treatment Period|Adverse Event|8|||
148936559|NCT00810693|537252564|FG001|Treatment Period|Adverse Event|1|||
148936560|NCT00810693|537252565|FG002|Treatment Period|Adverse Event|7|||
148936561|NCT00810693|537252563|FG000|Treatment Period|Death|0|||
148936562|NCT00810693|537252564|FG001|Treatment Period|Death|1|||
148936563|NCT00810693|537252565|FG002|Treatment Period|Death|2|||
148936564|NCT00810693|537252563|FG000|Treatment Period|Lack of Efficacy|0|||
148936565|NCT00810693|537252564|FG001|Treatment Period|Lack of Efficacy|0|||
148936566|NCT00810693|537252565|FG002|Treatment Period|Lack of Efficacy|1|||
148936567|NCT00810693|537252563|FG000|Treatment Period|Lost to Follow-up|1|||
148936568|NCT00810693|537252564|FG001|Treatment Period|Lost to Follow-up|0|||
148936569|NCT00810693|537252565|FG002|Treatment Period|Lost to Follow-up|0|||
148936570|NCT00810693|537252563|FG000|Treatment Period|Non-compliance|1|||
148936571|NCT00810693|537252564|FG001|Treatment Period|Non-compliance|0|||
148936572|NCT00810693|537252565|FG002|Treatment Period|Non-compliance|0|||
148936573|NCT00810693|537252563|FG000|Treatment Period|Protocol Violation|1|||
148936574|NCT00810693|537252564|FG001|Treatment Period|Protocol Violation|2|||
148936575|NCT00810693|537252565|FG002|Treatment Period|Protocol Violation|2|||
148936576|NCT00810693|537252563|FG000|Treatment Period|Withdrawal by Subject|6|||
148936577|NCT00810693|537252564|FG001|Treatment Period|Withdrawal by Subject|2|||
148936578|NCT00810693|537252565|FG002|Treatment Period|Withdrawal by Subject|3|||
148936579|NCT00810693|537252563|FG000|Treatment Period|Not treated|0|||
148936580|NCT00810693|537252564|FG001|Treatment Period|Not treated|1|||
148936581|NCT00810693|537252565|FG002|Treatment Period|Not treated|1|||
148936582|NCT00810693|537252563|FG000|Follow-up Period (FUP)|Adverse Event|3|||
148936583|NCT00810693|537252564|FG001|Follow-up Period (FUP)|Adverse Event|1|||
148936584|NCT00810693|537252565|FG002|Follow-up Period (FUP)|Adverse Event|1|||
148936585|NCT00810693|537252563|FG000|Follow-up Period (FUP)|Death|2|||
148936586|NCT00810693|537252564|FG001|Follow-up Period (FUP)|Death|0|||
148936587|NCT00810693|537252565|FG002|Follow-up Period (FUP)|Death|1|||
148936588|NCT00810693|537252563|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
148936589|NCT00810693|537252564|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
148936590|NCT00810693|537252565|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
148936591|NCT00810693|537252563|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
148936592|NCT00810693|537252564|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
148936593|NCT00810693|537252565|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
148936594|NCT00810693|537252563|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
148936595|NCT00810693|537252564|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
148936596|NCT00810693|537252565|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
148936597|NCT02507973|537252572|FG000|Overall Study|Adverse Event|1|||
148936598|NCT00331422|537252573|FG000|Overall Study|Did not receive entire study regimen|5|||
148936599|NCT02345226|537252574|FG000|Double-Blind Phase|Adverse Event|5|||
148936600|NCT02345226|537252575|FG001|Double-Blind Phase|Adverse Event|6|||
148936601|NCT02345226|537252574|FG000|Double-Blind Phase|Death|3|||
148936602|NCT02345226|537252575|FG001|Double-Blind Phase|Death|0|||
148936603|NCT02345226|537252574|FG000|Double-Blind Phase|Pregnancy|0|||
148936604|NCT02345226|537252575|FG001|Double-Blind Phase|Pregnancy|1|||
148936605|NCT02345226|537252574|FG000|Double-Blind Phase|Lack of Efficacy|1|||
148936606|NCT02345226|537252575|FG001|Double-Blind Phase|Lack of Efficacy|0|||
148936607|NCT02345226|537252574|FG000|Double-Blind Phase|Investigator's Discretion|4|||
148936608|NCT02345226|537252575|FG001|Double-Blind Phase|Investigator's Discretion|3|||
148936609|NCT02345226|537252574|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
148936610|NCT02345226|537252575|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
148936611|NCT02345226|537252574|FG000|Double-Blind Phase|Withdrew Consent|41|||
148936612|NCT02345226|537252575|FG001|Double-Blind Phase|Withdrew Consent|39|||
148936613|NCT02345226|537252574|FG000|Double-Blind Phase|Lost to Follow-up|12|||
148936614|NCT02345226|537252575|FG001|Double-Blind Phase|Lost to Follow-up|16|||
148936615|NCT02345226|537252574|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
148936616|NCT02345226|537252575|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
148936617|NCT02345226|537252574|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
148936618|NCT02345226|537252575|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
149015143|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
148936619|NCT01710046|537252578|FG000|Overall Study|Lost to Follow-up|1|||
148936620|NCT01710046|537252579|FG001|Overall Study|Lost to Follow-up|0|||
148936621|NCT03386474|537252582|FG000|Overall Study|Death|1|||
148936622|NCT03386474|537252583|FG001|Overall Study|Death|0|||
148936623|NCT03386474|537252582|FG000|Overall Study|Adverse Event|0|||
148807744|NCT04889040|536774426|FG001|Overall Study|Withdrawal by Subject|3|||
148936624|NCT03386474|537252583|FG001|Overall Study|Adverse Event|1|||
148936625|NCT02282358|537252588|FG000|Overall Study|Nonevaluable|1|||
148936626|NCT01898208|537252589|FG000|Overall Study|Positive blood culture|17|||
148936627|NCT01898208|537252590|FG001|Overall Study|Positive blood culture|23|||
148936628|NCT01898208|537252591|FG002|Overall Study|Positive blood culture|15|||
148936629|NCT01898208|537252589|FG000|Overall Study|Death/comfort care within 24 hours|10|||
148936630|NCT01898208|537252590|FG001|Overall Study|Death/comfort care within 24 hours|9|||
148936631|NCT01898208|537252591|FG002|Overall Study|Death/comfort care within 24 hours|8|||
148936632|NCT01898208|537252589|FG000|Overall Study|Negative Gram Stain|6|||
148936633|NCT01898208|537252590|FG001|Overall Study|Negative Gram Stain|9|||
148936634|NCT01898208|537252591|FG002|Overall Study|Negative Gram Stain|6|||
148936635|NCT01898208|537252589|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
148936636|NCT01898208|537252590|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
148936637|NCT01898208|537252591|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
148936638|NCT01898208|537252589|FG000|Overall Study|System/Technical Error|1|||
148936639|NCT01898208|537252590|FG001|Overall Study|System/Technical Error|2|||
148936640|NCT01898208|537252591|FG002|Overall Study|System/Technical Error|3|||
148936641|NCT01898208|537252589|FG000|Overall Study|Lost to Follow-up|3|||
148936642|NCT01898208|537252590|FG001|Overall Study|Lost to Follow-up|1|||
148936643|NCT01898208|537252591|FG002|Overall Study|Lost to Follow-up|1|||
148936644|NCT00961649|537252593|FG000|Overall Study|Adverse Event|4|||
148936645|NCT00961649|537252594|FG001|Overall Study|Adverse Event|0|||
148936646|NCT00961649|537252595|FG002|Overall Study|Adverse Event|0|||
148936647|NCT00961649|537252596|FG003|Overall Study|Adverse Event|2|||
148936648|NCT00961649|537252593|FG000|Overall Study|Inadequate control of IOP|0|||
148936649|NCT00961649|537252594|FG001|Overall Study|Inadequate control of IOP|0|||
148936650|NCT00961649|537252595|FG002|Overall Study|Inadequate control of IOP|0|||
148936651|NCT00961649|537252596|FG003|Overall Study|Inadequate control of IOP|1|||
148936652|NCT00961649|537252593|FG000|Overall Study|Patient has travel plans during holidays|0|||
148936653|NCT00961649|537252594|FG001|Overall Study|Patient has travel plans during holidays|0|||
148936654|NCT00961649|537252595|FG002|Overall Study|Patient has travel plans during holidays|1|||
148936655|NCT00961649|537252596|FG003|Overall Study|Patient has travel plans during holidays|0|||
148936656|NCT00961649|537252593|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
148936657|NCT00961649|537252594|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
148936658|NCT00961649|537252595|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
148936659|NCT00961649|537252596|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
148936660|NCT00961649|537252593|FG000|Overall Study|Study terminated by sponsor|4|||
148936661|NCT00961649|537252594|FG001|Overall Study|Study terminated by sponsor|4|||
148936662|NCT00961649|537252595|FG002|Overall Study|Study terminated by sponsor|4|||
148936663|NCT00961649|537252596|FG003|Overall Study|Study terminated by sponsor|1|||
148936664|NCT02155881|537252597|FG000|Overall Study|Withdrawal by Subject|0|||
148936665|NCT02155881|537252598|FG001|Overall Study|Withdrawal by Subject|2|||
148936666|NCT02155881|537252597|FG000|Overall Study|Inappropriately randomized|2|||
148936667|NCT02155881|537252598|FG001|Overall Study|Inappropriately randomized|2|||
148936668|NCT02711345|537252599|FG000|Overall Study|Adverse Event|0|||
148936669|NCT02711345|537252600|FG001|Overall Study|Adverse Event|0|||
148936670|NCT02711345|537252601|FG002|Overall Study|Adverse Event|0|||
148936671|NCT02711345|537252602|FG003|Overall Study|Adverse Event|1|||
148936672|NCT02711345|537252603|FG004|Overall Study|Adverse Event|1|||
148936673|NCT02711345|537252604|FG005|Overall Study|Adverse Event|2|||
148936674|NCT02711345|537252605|FG006|Overall Study|Adverse Event|1|||
148936675|NCT02711345|537252606|FG007|Overall Study|Adverse Event|0|||
148936676|NCT02711345|537252607|FG008|Overall Study|Adverse Event|0|||
148936677|NCT02711345|537252608|FG009|Overall Study|Adverse Event|2|||
148936678|NCT02711345|537252599|FG000|Overall Study|Physician Decision|0|||
148936679|NCT02711345|537252600|FG001|Overall Study|Physician Decision|0|||
148936680|NCT02711345|537252601|FG002|Overall Study|Physician Decision|1|||
148936681|NCT02711345|537252602|FG003|Overall Study|Physician Decision|0|||
148936682|NCT02711345|537252603|FG004|Overall Study|Physician Decision|0|||
148936683|NCT02711345|537252604|FG005|Overall Study|Physician Decision|0|||
148936684|NCT02711345|537252605|FG006|Overall Study|Physician Decision|0|||
148936685|NCT02711345|537252606|FG007|Overall Study|Physician Decision|0|||
148936686|NCT02711345|537252607|FG008|Overall Study|Physician Decision|1|||
148936687|NCT02711345|537252608|FG009|Overall Study|Physician Decision|0|||
148936688|NCT02711345|537252599|FG000|Overall Study|Progressive disease|1|||
148936689|NCT02711345|537252600|FG001|Overall Study|Progressive disease|3|||
148936690|NCT02711345|537252601|FG002|Overall Study|Progressive disease|5|||
148936691|NCT02711345|537252602|FG003|Overall Study|Progressive disease|3|||
148936692|NCT02711345|537252603|FG004|Overall Study|Progressive disease|7|||
148936693|NCT02711345|537252604|FG005|Overall Study|Progressive disease|2|||
148936694|NCT02711345|537252605|FG006|Overall Study|Progressive disease|8|||
148936695|NCT02711345|537252606|FG007|Overall Study|Progressive disease|4|||
148936696|NCT02711345|537252607|FG008|Overall Study|Progressive disease|5|||
148936697|NCT02711345|537252608|FG009|Overall Study|Progressive disease|6|||
148936698|NCT02711345|537252599|FG000|Overall Study|Subject/guardian decision|0|||
148936699|NCT02711345|537252600|FG001|Overall Study|Subject/guardian decision|0|||
148936700|NCT02711345|537252601|FG002|Overall Study|Subject/guardian decision|0|||
148936701|NCT02711345|537252602|FG003|Overall Study|Subject/guardian decision|0|||
148936702|NCT02711345|537252603|FG004|Overall Study|Subject/guardian decision|0|||
148936703|NCT02711345|537252604|FG005|Overall Study|Subject/guardian decision|2|||
148936704|NCT02711345|537252605|FG006|Overall Study|Subject/guardian decision|3|||
148936705|NCT02711345|537252606|FG007|Overall Study|Subject/guardian decision|1|||
148936706|NCT02711345|537252607|FG008|Overall Study|Subject/guardian decision|0|||
148936707|NCT02711345|537252608|FG009|Overall Study|Subject/guardian decision|4|||
148936708|NCT02711345|537252599|FG000|Overall Study|Death|1|||
148936709|NCT02711345|537252600|FG001|Overall Study|Death|0|||
148936710|NCT02711345|537252601|FG002|Overall Study|Death|0|||
148936711|NCT02711345|537252602|FG003|Overall Study|Death|0|||
148936712|NCT02711345|537252603|FG004|Overall Study|Death|0|||
148936713|NCT02711345|537252604|FG005|Overall Study|Death|0|||
148936714|NCT02711345|537252605|FG006|Overall Study|Death|0|||
148936715|NCT02711345|537252606|FG007|Overall Study|Death|1|||
148936716|NCT02711345|537252607|FG008|Overall Study|Death|0|||
148936717|NCT02711345|537252608|FG009|Overall Study|Death|0|||
148936718|NCT04357782|537252609|FG000|Overall Study|Discharged from hospital|1|||
148936719|NCT04357782|537252610|FG001|Overall Study|Discharged from hospital|0|||
148936720|NCT04357782|537252609|FG000|Overall Study|Death|0|||
148936721|NCT04357782|537252610|FG001|Overall Study|Death|2|||
148936722|NCT01786148|537252611|FG000|Overall Study|Lost to Follow-up|21|||
148936723|NCT01786148|537252612|FG001|Overall Study|Lost to Follow-up|13|||
148936724|NCT01786148|537252611|FG000|Overall Study|Death|0|||
148936725|NCT01786148|537252612|FG001|Overall Study|Death|1|||
148936726|NCT01786148|537252611|FG000|Overall Study|Withdrawal by Subject|0|||
148936727|NCT01786148|537252612|FG001|Overall Study|Withdrawal by Subject|7|||
148936728|NCT01786148|537252611|FG000|Overall Study|Incarceration|1|||
148936729|NCT01786148|537252612|FG001|Overall Study|Incarceration|1|||
148936730|NCT03780543|537252614|FG000|Overall Study|Adverse Event|1|||
148936731|NCT03780543|537252615|FG001|Overall Study|Adverse Event|0|||
148936732|NCT03780543|537252616|FG002|Overall Study|Adverse Event|2|||
148936733|NCT03780543|537252614|FG000|Overall Study|Lost to Follow-up|2|||
148936734|NCT03780543|537252615|FG001|Overall Study|Lost to Follow-up|0|||
148936735|NCT03780543|537252616|FG002|Overall Study|Lost to Follow-up|1|||
148936736|NCT03780543|537252614|FG000|Overall Study|Study terminated by Sponsor|8|||
148936737|NCT03780543|537252615|FG001|Overall Study|Study terminated by Sponsor|7|||
148936738|NCT03780543|537252616|FG002|Overall Study|Study terminated by Sponsor|13|||
148936739|NCT03780543|537252614|FG000|Overall Study|Withdrawal by Subject|1|||
148936740|NCT03780543|537252615|FG001|Overall Study|Withdrawal by Subject|8|||
148936741|NCT03780543|537252616|FG002|Overall Study|Withdrawal by Subject|1|||
148936742|NCT03780543|537252614|FG000|Overall Study|Noncompliance with study drug|1|||
148936743|NCT03780543|537252615|FG001|Overall Study|Noncompliance with study drug|0|||
148936744|NCT03780543|537252616|FG002|Overall Study|Noncompliance with study drug|0|||
148936745|NCT01033851|537252617|FG000|Overall Study|Withdrawal by Subject|3|||
148936746|NCT01033851|537252618|FG001|Overall Study|Withdrawal by Subject|7|||
148936747|NCT00066729|537252619|FG000|Overall Study|Lost to Follow-up|1|||
148936748|NCT00066729|537252619|FG000|Overall Study|Disease progression|1|||
148936749|NCT02215096|537252620|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
148936750|NCT02215096|537252621|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
148936751|NCT02215096|537252622|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
148936752|NCT02215096|537252623|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
148936753|NCT02215096|537252624|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
148936754|NCT02215096|537252620|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
148936755|NCT02215096|537252621|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
148936756|NCT02215096|537252622|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
148936757|NCT02215096|537252623|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
148936758|NCT02215096|537252624|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
148936759|NCT02215096|537252620|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
148936760|NCT02215096|537252621|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
148936761|NCT02215096|537252622|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
148936762|NCT02215096|537252623|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
148936763|NCT02215096|537252624|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
148936764|NCT02215096|537252620|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
148936765|NCT02215096|537252621|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
148936766|NCT02215096|537252622|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
148936767|NCT02215096|537252623|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
148936768|NCT02215096|537252624|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
148936769|NCT02349542|537252625|FG000|Overall Study|Withdrawal by Subject|5|||
148936770|NCT01011738|537252626|FG000|Overall Study|Death|12|||
148936771|NCT01011738|537252627|FG001|Overall Study|Death|3|||
148936772|NCT01011738|537252628|FG002|Overall Study|Death|0|||
148936773|NCT01011738|537252626|FG000|Overall Study|Unknown reasons|312|||
148936774|NCT01011738|537252627|FG001|Overall Study|Unknown reasons|291|||
148936775|NCT01011738|537252628|FG002|Overall Study|Unknown reasons|17|||
148936776|NCT03896165|537252631|FG000|Overall Study|Withdrawal by Subject|2|||
148936777|NCT01163266|537252632|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
148936778|NCT01163266|537252633|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
148936779|NCT01163266|537252634|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
148936780|NCT01163266|537252632|FG000|Overall Study|Lack of Efficacy|1|||
148936781|NCT01163266|537252633|FG001|Overall Study|Lack of Efficacy|3|||
148936782|NCT01163266|537252634|FG002|Overall Study|Lack of Efficacy|1|||
148936783|NCT01163266|537252632|FG000|Overall Study|Noncompliance with Study Drug|0|||
148936784|NCT01163266|537252633|FG001|Overall Study|Noncompliance with Study Drug|2|||
148936785|NCT01163266|537252634|FG002|Overall Study|Noncompliance with Study Drug|0|||
148936786|NCT01163266|537252632|FG000|Overall Study|Protocol Deviations|2|||
148936787|NCT01163266|537252633|FG001|Overall Study|Protocol Deviations|2|||
148936788|NCT01163266|537252634|FG002|Overall Study|Protocol Deviations|5|||
148936789|NCT01163266|537252632|FG000|Overall Study|Withdrawal of Consent|5|||
148936790|NCT01163266|537252633|FG001|Overall Study|Withdrawal of Consent|7|||
148936791|NCT01163266|537252634|FG002|Overall Study|Withdrawal of Consent|3|||
148936792|NCT01163266|537252632|FG000|Overall Study|Lost to Follow-up|7|||
148936793|NCT01163266|537252633|FG001|Overall Study|Lost to Follow-up|7|||
148936794|NCT01163266|537252634|FG002|Overall Study|Lost to Follow-up|10|||
148936795|NCT01163266|537252632|FG000|Overall Study|Other|1|||
148936796|NCT01163266|537252633|FG001|Overall Study|Other|1|||
148936797|NCT01163266|537252634|FG002|Overall Study|Other|2|||
148936798|NCT02586064|537252635|FG000|Overall Study|Other Obligations|6|||
148936799|NCT02586064|537252636|FG001|Overall Study|Other Obligations|6|||
148936800|NCT02586064|537252635|FG000|Overall Study|Other|3|||
148936801|NCT02586064|537252636|FG001|Overall Study|Other|7|||
148936802|NCT02586064|537252635|FG000|Overall Study|Never Started|3|||
148936803|NCT02586064|537252636|FG001|Overall Study|Never Started|3|||
148936804|NCT02586064|537252635|FG000|Overall Study|Lost Interest|1|||
148936805|NCT02586064|537252636|FG001|Overall Study|Lost Interest|4|||
148936806|NCT02586064|537252635|FG000|Overall Study|Miscellaneous Life Issues|0|||
148936807|NCT02586064|537252636|FG001|Overall Study|Miscellaneous Life Issues|5|||
148936808|NCT02586064|537252635|FG000|Overall Study|Infrequent Attendance|2|||
148936809|NCT02586064|537252636|FG001|Overall Study|Infrequent Attendance|1|||
148936810|NCT02586064|537252635|FG000|Overall Study|Timed Out|2|||
148936811|NCT02586064|537252636|FG001|Overall Study|Timed Out|0|||
148936812|NCT02586064|537252635|FG000|Overall Study|AUD relapse|0|||
148936813|NCT02586064|537252636|FG001|Overall Study|AUD relapse|2|||
148936814|NCT02586064|537252635|FG000|Overall Study|Legal Issue|1|||
148936815|NCT02586064|537252636|FG001|Overall Study|Legal Issue|0|||
148936816|NCT02919696|537252637|FG000|Overall Study|Adverse Event|1|||
148936817|NCT02919696|537252638|FG001|Overall Study|Adverse Event|2|||
148936818|NCT02919696|537252637|FG000|Overall Study|Withdrawal by Subject|2|||
148936819|NCT02919696|537252638|FG001|Overall Study|Withdrawal by Subject|1|||
148936820|NCT02919696|537252637|FG000|Overall Study|Sponsor Decision|1|||
148936821|NCT02919696|537252638|FG001|Overall Study|Sponsor Decision|1|||
148936822|NCT02919696|537252637|FG000|Overall Study|Never Treated|0|||
148936823|NCT02919696|537252638|FG001|Overall Study|Never Treated|1|||
148936824|NCT02158975|537252639|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
148936825|NCT01346969|537252641|FG000|Overall Study|Withdrawal by Subject|0|||
148936826|NCT01346969|537252642|FG001|Overall Study|Withdrawal by Subject|0|||
148936827|NCT01346969|537252643|FG002|Overall Study|Withdrawal by Subject|1|||
148936828|NCT01346969|537252644|FG003|Overall Study|Withdrawal by Subject|0|||
148936829|NCT01346969|537252641|FG000|Overall Study|Lost to Follow-up|1|||
148936830|NCT01346969|537252642|FG001|Overall Study|Lost to Follow-up|0|||
148936831|NCT01346969|537252643|FG002|Overall Study|Lost to Follow-up|2|||
148936832|NCT01346969|537252644|FG003|Overall Study|Lost to Follow-up|0|||
148936833|NCT01346969|537252641|FG000|Overall Study|Physician Decision|0|||
148936834|NCT01346969|537252642|FG001|Overall Study|Physician Decision|0|||
148936835|NCT01346969|537252643|FG002|Overall Study|Physician Decision|0|||
148936836|NCT01346969|537252644|FG003|Overall Study|Physician Decision|1|||
148936837|NCT01346969|537252641|FG000|Overall Study|Randomized but not treated|1|||
148936838|NCT01346969|537252642|FG001|Overall Study|Randomized but not treated|0|||
148936839|NCT01346969|537252643|FG002|Overall Study|Randomized but not treated|0|||
148936840|NCT01346969|537252644|FG003|Overall Study|Randomized but not treated|0|||
148936841|NCT03540030|537252645|FG000|Overall Study|Withdrawal by Subject|2|||
148936842|NCT03540030|537252646|FG001|Overall Study|Withdrawal by Subject|1|||
148936843|NCT03540030|537252645|FG000|Overall Study|screen fail|7|||
148936844|NCT03540030|537252646|FG001|Overall Study|screen fail|1|||
148936845|NCT03540030|537252645|FG000|Overall Study|never had surgery after signing consent|9|||
148936846|NCT03540030|537252646|FG001|Overall Study|never had surgery after signing consent|1|||
148936847|NCT03666624|537252647|FG000|Overall Study|participant grieving over recent death of parent|1|||
148936848|NCT03666624|537252648|FG001|Overall Study|participant grieving over recent death of parent|0|||
148936849|NCT01558739|537252655|FG000|Overall Study|Adverse Event|7|||
148936850|NCT01558739|537252655|FG000|Overall Study|Withdrawal by Subject|2|||
148936851|NCT01558739|537252655|FG000|Overall Study|Death|3|||
148936852|NCT01558739|537252655|FG000|Overall Study|Disease Progression|4|||
148936853|NCT01558739|537252655|FG000|Overall Study|Protocol Violation|1|||
148936854|NCT01193842|537252659|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
148936855|NCT01193842|537252660|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
148936856|NCT01193842|537252661|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
148936857|NCT01193842|537252662|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
148936858|NCT01193842|537252663|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
148936859|NCT01193842|537252659|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
148936860|NCT01193842|537252660|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
148936861|NCT01193842|537252661|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
148936862|NCT01193842|537252662|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
148936863|NCT01193842|537252663|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
148936864|NCT01193842|537252659|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
148936865|NCT01193842|537252660|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
148936866|NCT01193842|537252661|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
148936867|NCT01193842|537252662|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
148936868|NCT01193842|537252663|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
148936869|NCT01193842|537252659|FG000|Phase II: Randomized Groups|Death|0|||
148936870|NCT01193842|537252660|FG001|Phase II: Randomized Groups|Death|0|||
148936871|NCT01193842|537252661|FG002|Phase II: Randomized Groups|Death|0|||
148936872|NCT01193842|537252662|FG003|Phase II: Randomized Groups|Death|1|||
148936873|NCT01193842|537252663|FG004|Phase II: Randomized Groups|Death|1|||
148936874|NCT01193842|537252659|FG000|Phase II: Randomized Groups|Adverse Event|0|||
148936875|NCT01193842|537252660|FG001|Phase II: Randomized Groups|Adverse Event|0|||
148936876|NCT01193842|537252661|FG002|Phase II: Randomized Groups|Adverse Event|0|||
148936877|NCT01193842|537252662|FG003|Phase II: Randomized Groups|Adverse Event|5|||
148936878|NCT01193842|537252663|FG004|Phase II: Randomized Groups|Adverse Event|3|||
148936879|NCT01193842|537252659|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
148936880|NCT01193842|537252660|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
148936881|NCT01193842|537252661|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
148936882|NCT01193842|537252662|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
148936883|NCT01193842|537252663|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
148936884|NCT01193842|537252659|FG000|Phase II: Randomized Groups|Ineligible|0|||
148936885|NCT01193842|537252660|FG001|Phase II: Randomized Groups|Ineligible|0|||
148936886|NCT01193842|537252661|FG002|Phase II: Randomized Groups|Ineligible|0|||
148936887|NCT01193842|537252662|FG003|Phase II: Randomized Groups|Ineligible|0|||
148936888|NCT01193842|537252663|FG004|Phase II: Randomized Groups|Ineligible|1|||
148936889|NCT01193842|537252659|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
148936890|NCT01193842|537252660|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
148936891|NCT01193842|537252661|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
148936892|NCT01193842|537252662|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
148936893|NCT01193842|537252663|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
148936894|NCT02484690|537252665|FG000|Overall Study|Adverse Event|1|||
148936895|NCT02484690|537252666|FG001|Overall Study|Adverse Event|3|||
148936896|NCT02484690|537252667|FG002|Overall Study|Adverse Event|0|||
148936897|NCT02484690|537252668|FG003|Overall Study|Adverse Event|0|||
148936898|NCT02484690|537252669|FG004|Overall Study|Adverse Event|5|||
148936899|NCT02484690|537252665|FG000|Overall Study|Death|0|||
148936900|NCT02484690|537252666|FG001|Overall Study|Death|0|||
148936901|NCT02484690|537252667|FG002|Overall Study|Death|0|||
148936902|NCT02484690|537252668|FG003|Overall Study|Death|0|||
148936903|NCT02484690|537252669|FG004|Overall Study|Death|1|||
148936904|NCT02484690|537252665|FG000|Overall Study|Withdrawal by Subject|1|||
148936905|NCT02484690|537252666|FG001|Overall Study|Withdrawal by Subject|3|||
148936906|NCT02484690|537252667|FG002|Overall Study|Withdrawal by Subject|1|||
148936907|NCT02484690|537252668|FG003|Overall Study|Withdrawal by Subject|2|||
148936908|NCT02484690|537252669|FG004|Overall Study|Withdrawal by Subject|0|||
148936909|NCT02484690|537252665|FG000|Overall Study|Physician Decision|2|||
148936910|NCT02484690|537252666|FG001|Overall Study|Physician Decision|0|||
148936911|NCT02484690|537252667|FG002|Overall Study|Physician Decision|1|||
148936912|NCT02484690|537252668|FG003|Overall Study|Physician Decision|0|||
148936913|NCT02484690|537252669|FG004|Overall Study|Physician Decision|0|||
148936914|NCT02484690|537252665|FG000|Overall Study|Lost to Follow-up|0|||
148936915|NCT02484690|537252666|FG001|Overall Study|Lost to Follow-up|0|||
148936916|NCT02484690|537252667|FG002|Overall Study|Lost to Follow-up|1|||
148936917|NCT02484690|537252668|FG003|Overall Study|Lost to Follow-up|0|||
148936918|NCT02484690|537252669|FG004|Overall Study|Lost to Follow-up|0|||
148936919|NCT02612129|537252670|FG000|Single Dose Treatment Period|Screening Failure|1|||
148936920|NCT02612129|537252671|FG001|Single Dose Treatment Period|Screening Failure|0|||
148807745|NCT04889040|536774425|FG000|Overall Study|Lost to Follow-up|0|||
148936921|NCT02612129|537252672|FG002|Single Dose Treatment Period|Screening Failure|0|||
148936922|NCT02612129|537252670|FG000|Continuous Treatment Period|Early Escape|0|||
148936923|NCT02612129|537252671|FG001|Continuous Treatment Period|Early Escape|2|||
148936924|NCT02612129|537252672|FG002|Continuous Treatment Period|Early Escape|0|||
148936925|NCT02612129|537252670|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
148807746|NCT04889040|536774426|FG001|Overall Study|Lost to Follow-up|1|||
148807747|NCT04889040|536774425|FG000|Overall Study|Adverse Event|2|||
148807748|NCT04889040|536774426|FG001|Overall Study|Adverse Event|1|||
148807749|NCT00726453|536774431|FG000|Primary Enrollment Group|Death|18|||
148807750|NCT00726453|536774432|FG001|Primary Enrollment Group|Death|0|||
148807751|NCT00726453|536774431|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
148807752|NCT00726453|536774432|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
148807753|NCT00726453|536774431|FG000|38 mm Length Group|Death|0|||
148807754|NCT00726453|536774432|FG001|38 mm Length Group|Death|3|||
148807755|NCT03801252|536774433|FG000|Overall Study|Protocol Violation|1|||
148807756|NCT03801252|536774434|FG001|Overall Study|Protocol Violation|2|||
148807757|NCT02690727|536774435|FG000|Overall Study|Adverse Event|2|||
148807758|NCT02690727|536774436|FG001|Overall Study|Adverse Event|2|||
148807759|NCT00656617|536774437|FG000|Overall Study|Adverse Event|1|||
148807760|NCT00656617|536774437|FG000|Overall Study|Death|2|||
148807761|NCT00656617|536774437|FG000|Overall Study|Insurance Issues|2|||
148807762|NCT00656617|536774437|FG000|Overall Study|Move to different clinical trial|2|||
148807763|NCT02030600|536774438|FG000|Treatment Period 1|Adverse Event|5|||
148807764|NCT02030600|536774439|FG001|Treatment Period 1|Adverse Event|7|||
148807765|NCT02030600|536774438|FG000|Treatment Period 1|Lack of Efficacy|0|||
148807766|NCT02030600|536774439|FG001|Treatment Period 1|Lack of Efficacy|1|||
148807767|NCT02030600|536774438|FG000|Treatment Period 1|Lost to Follow-up|11|||
148807768|NCT02030600|536774439|FG001|Treatment Period 1|Lost to Follow-up|3|||
148807769|NCT02030600|536774438|FG000|Treatment Period 1|Protocol Violation|22|||
148807770|NCT02030600|536774439|FG001|Treatment Period 1|Protocol Violation|17|||
148807771|NCT02030600|536774438|FG000|Treatment Period 1|Withdrawal by Subject|13|||
148807772|NCT02030600|536774439|FG001|Treatment Period 1|Withdrawal by Subject|17|||
148807773|NCT02030600|536774438|FG000|Treatment Period 1|Casebook Unsigned|1|||
148807774|NCT02030600|536774439|FG001|Treatment Period 1|Casebook Unsigned|0|||
148936926|NCT02612129|537252671|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
148936927|NCT02612129|537252672|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
148936928|NCT02612129|537252670|FG000|Continuous Treatment Period|Safety Reasons|0|||
148936929|NCT02612129|537252671|FG001|Continuous Treatment Period|Safety Reasons|3|||
148936930|NCT02612129|537252672|FG002|Continuous Treatment Period|Safety Reasons|0|||
148936931|NCT02612129|537252670|FG000|Continuous Treatment Period|Death|0|||
148936932|NCT02612129|537252671|FG001|Continuous Treatment Period|Death|1|||
148936933|NCT02612129|537252672|FG002|Continuous Treatment Period|Death|0|||
148936934|NCT02612129|537252670|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
148936935|NCT02612129|537252671|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
148936936|NCT02612129|537252672|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
148936937|NCT02557295|537252673|FG000|Overall Study|Withdrawal by Subject|9|||
148936938|NCT02557295|537252674|FG001|Overall Study|Withdrawal by Subject|2|||
148936939|NCT02557295|537252675|FG002|Overall Study|Withdrawal by Subject|4|||
148936940|NCT02557295|537252676|FG003|Overall Study|Withdrawal by Subject|0|||
148807775|NCT02030600|536774438|FG000|Treatment Period 1|Unclassified|1|||
148807776|NCT02030600|536774439|FG001|Treatment Period 1|Unclassified|0|||
148807777|NCT02030600|536774438|FG000|Treatment Period 2|Adverse Event|4|||
148807778|NCT02030600|536774439|FG001|Treatment Period 2|Adverse Event|4|||
148807779|NCT02030600|536774438|FG000|Treatment Period 2|Lack of Efficacy|2|||
148936941|NCT02557295|537252677|FG004|Overall Study|Withdrawal by Subject|0|||
148936942|NCT02557295|537252678|FG005|Overall Study|Withdrawal by Subject|0|||
148936943|NCT02557295|537252679|FG006|Overall Study|Withdrawal by Subject|15|||
148807780|NCT02030600|536774439|FG001|Treatment Period 2|Lack of Efficacy|1|||
148807781|NCT02030600|536774438|FG000|Treatment Period 2|Lost to Follow-up|4|||
148807782|NCT02030600|536774439|FG001|Treatment Period 2|Lost to Follow-up|2|||
148807783|NCT02030600|536774438|FG000|Treatment Period 2|Protocol Violation|1|||
148807784|NCT02030600|536774439|FG001|Treatment Period 2|Protocol Violation|2|||
148936944|NCT02557295|537252680|FG007|Overall Study|Withdrawal by Subject|1|||
148936945|NCT02557295|537252681|FG008|Overall Study|Withdrawal by Subject|3|||
148936946|NCT02557295|537252673|FG000|Overall Study|Disease Progression|0|||
148936947|NCT02557295|537252674|FG001|Overall Study|Disease Progression|0|||
148936948|NCT02557295|537252675|FG002|Overall Study|Disease Progression|0|||
148936949|NCT02557295|537252676|FG003|Overall Study|Disease Progression|0|||
148936950|NCT02557295|537252677|FG004|Overall Study|Disease Progression|0|||
148936951|NCT02557295|537252678|FG005|Overall Study|Disease Progression|0|||
148936952|NCT02557295|537252679|FG006|Overall Study|Disease Progression|1|||
148936953|NCT02557295|537252680|FG007|Overall Study|Disease Progression|0|||
148936954|NCT02557295|537252681|FG008|Overall Study|Disease Progression|0|||
148936955|NCT02557295|537252673|FG000|Overall Study|Lack of Efficacy|24|||
148936956|NCT02557295|537252674|FG001|Overall Study|Lack of Efficacy|1|||
148936957|NCT02557295|537252675|FG002|Overall Study|Lack of Efficacy|3|||
148936958|NCT02557295|537252676|FG003|Overall Study|Lack of Efficacy|0|||
148936959|NCT02557295|537252677|FG004|Overall Study|Lack of Efficacy|0|||
148936960|NCT02557295|537252678|FG005|Overall Study|Lack of Efficacy|0|||
148936961|NCT02557295|537252679|FG006|Overall Study|Lack of Efficacy|12|||
148936962|NCT02557295|537252680|FG007|Overall Study|Lack of Efficacy|1|||
148936963|NCT02557295|537252681|FG008|Overall Study|Lack of Efficacy|0|||
148936964|NCT02557295|537252673|FG000|Overall Study|Adverse Event|16|||
148936965|NCT02557295|537252674|FG001|Overall Study|Adverse Event|2|||
148936966|NCT02557295|537252675|FG002|Overall Study|Adverse Event|3|||
148936967|NCT02557295|537252676|FG003|Overall Study|Adverse Event|0|||
148936968|NCT02557295|537252677|FG004|Overall Study|Adverse Event|0|||
148936969|NCT02557295|537252678|FG005|Overall Study|Adverse Event|0|||
148936970|NCT02557295|537252679|FG006|Overall Study|Adverse Event|2|||
148936971|NCT02557295|537252680|FG007|Overall Study|Adverse Event|1|||
148936972|NCT02557295|537252681|FG008|Overall Study|Adverse Event|1|||
148936973|NCT02557295|537252673|FG000|Overall Study|Lost to Follow-up|4|||
148936974|NCT02557295|537252674|FG001|Overall Study|Lost to Follow-up|0|||
148936975|NCT02557295|537252675|FG002|Overall Study|Lost to Follow-up|0|||
148936976|NCT02557295|537252676|FG003|Overall Study|Lost to Follow-up|0|||
148936977|NCT02557295|537252677|FG004|Overall Study|Lost to Follow-up|0|||
148936978|NCT02557295|537252678|FG005|Overall Study|Lost to Follow-up|0|||
148936979|NCT02557295|537252679|FG006|Overall Study|Lost to Follow-up|9|||
148936980|NCT02557295|537252680|FG007|Overall Study|Lost to Follow-up|0|||
148936981|NCT02557295|537252681|FG008|Overall Study|Lost to Follow-up|0|||
148936982|NCT02557295|537252673|FG000|Overall Study|Study Close|54|||
148936983|NCT02557295|537252674|FG001|Overall Study|Study Close|3|||
148936984|NCT02557295|537252675|FG002|Overall Study|Study Close|5|||
148936985|NCT02557295|537252676|FG003|Overall Study|Study Close|3|||
148936986|NCT02557295|537252677|FG004|Overall Study|Study Close|0|||
148936987|NCT02557295|537252678|FG005|Overall Study|Study Close|0|||
148936988|NCT02557295|537252679|FG006|Overall Study|Study Close|37|||
148936989|NCT02557295|537252680|FG007|Overall Study|Study Close|3|||
148936990|NCT02557295|537252681|FG008|Overall Study|Study Close|19|||
148936991|NCT02557295|537252673|FG000|Overall Study|except for study close|4|||
148936992|NCT02557295|537252674|FG001|Overall Study|except for study close|0|||
148936993|NCT02557295|537252675|FG002|Overall Study|except for study close|0|||
148936994|NCT02557295|537252676|FG003|Overall Study|except for study close|0|||
148936995|NCT02557295|537252677|FG004|Overall Study|except for study close|0|||
148936996|NCT02557295|537252678|FG005|Overall Study|except for study close|0|||
148936997|NCT02557295|537252679|FG006|Overall Study|except for study close|5|||
148936998|NCT02557295|537252680|FG007|Overall Study|except for study close|1|||
148936999|NCT02557295|537252681|FG008|Overall Study|except for study close|0|||
148937000|NCT01067976|537252682|FG000|Overall Study|Study drug never administered|20|||
148937001|NCT01067976|537252682|FG000|Overall Study|Study prematurely discontinued|2|||
148937002|NCT00589290|537252683|FG000|Overall Study|Withdrawal by Subject|1|||
148937003|NCT00976677|537252684|FG000|Overall Study|Adverse Event|1|||
148937004|NCT00976677|537252685|FG001|Overall Study|Adverse Event|0|||
148937005|NCT00976677|537252684|FG000|Overall Study|Withdrawal by Subject|0|||
148937006|NCT00976677|537252685|FG001|Overall Study|Withdrawal by Subject|2|||
148937007|NCT00976677|537252684|FG000|Overall Study|Disease progression|1|||
148937008|NCT00976677|537252685|FG001|Overall Study|Disease progression|1|||
148937009|NCT00976677|537252684|FG000|Overall Study|Trial unblinded|2|||
148937010|NCT00976677|537252685|FG001|Overall Study|Trial unblinded|2|||
148937011|NCT00976677|537252684|FG000|Overall Study|Unknown/Missing|1|||
148937012|NCT00976677|537252685|FG001|Overall Study|Unknown/Missing|0|||
148937013|NCT03487549|537252690|FG000|Overall Study|Protocol Violation|0|||
148937014|NCT03487549|537252691|FG001|Overall Study|Protocol Violation|1|||
148937015|NCT03487549|537252690|FG000|Overall Study|Lost to Follow-up|2|||
148937016|NCT03487549|537252691|FG001|Overall Study|Lost to Follow-up|1|||
148937017|NCT03487549|537252690|FG000|Overall Study|Withdrawal by Subject|2|||
148937018|NCT03487549|537252691|FG001|Overall Study|Withdrawal by Subject|0|||
148937019|NCT02642029|537254350|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
148937020|NCT02642029|537254351|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
148937021|NCT02642029|537254352|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
148937022|NCT02642029|537254353|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
148937023|NCT02642029|537254354|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
148937024|NCT02642029|537254355|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
148937025|NCT02642029|537254350|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
148937026|NCT02642029|537254351|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
148937027|NCT02642029|537254352|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
148937028|NCT02642029|537254353|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
148937029|NCT02642029|537254354|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
148937030|NCT02642029|537254355|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
148937031|NCT02642029|537254350|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
148937032|NCT02642029|537254351|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
148937033|NCT02642029|537254352|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
148937034|NCT02642029|537254353|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
148937035|NCT02642029|537254354|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
148937036|NCT02642029|537254355|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
148937037|NCT02642029|537254350|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
148937038|NCT02642029|537254351|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
148937039|NCT02642029|537254352|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
148937040|NCT02642029|537254353|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
148937041|NCT02642029|537254354|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
148937042|NCT02642029|537254355|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
148937043|NCT02642029|537254350|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
148937044|NCT02642029|537254351|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
148937045|NCT02642029|537254352|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
148937046|NCT02642029|537254353|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
148937047|NCT02642029|537254354|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
148937048|NCT02642029|537254355|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
148937049|NCT02642029|537254350|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
148937050|NCT02642029|537254351|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
148937051|NCT02642029|537254352|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
148937052|NCT02642029|537254353|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
148937053|NCT02642029|537254354|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
148937054|NCT02642029|537254355|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
148937055|NCT00691301|537254356|FG000|Overall Study|Adverse Event|10|||
148937056|NCT00691301|537254356|FG000|Overall Study|Death|2|||
148937057|NCT00691301|537254356|FG000|Overall Study|Lack of Efficacy|32|||
148937058|NCT00691301|537254356|FG000|Overall Study|Withdrawal by Subject|4|||
148937059|NCT00691301|537254356|FG000|Overall Study|Concurrent illness|2|||
148937060|NCT00691301|537254356|FG000|Overall Study|other reason|3|||
148937061|NCT00691301|537254356|FG000|Overall Study|Did not initiate study treatment|1|||
148937062|NCT01823146|537254358|FG000|Overall Study|Withdrawal by Subject|0|||
148937063|NCT01823146|537254359|FG001|Overall Study|Withdrawal by Subject|1|||
148937064|NCT01823146|537254358|FG000|Overall Study|Lost to Follow-up|2|||
148937065|NCT01823146|537254359|FG001|Overall Study|Lost to Follow-up|1|||
148937066|NCT00463580|537254360|FG000|Overall Study|Lost to Follow-up|1|||
148937067|NCT00463580|537254361|FG001|Overall Study|Lost to Follow-up|0|||
148937068|NCT00463580|537254360|FG000|Overall Study|Schedule conflict|2|||
148937069|NCT00463580|537254361|FG001|Overall Study|Schedule conflict|0|||
148937070|NCT00463580|537254360|FG000|Overall Study|Medical/psychiatric complications|0|||
148937071|NCT00463580|537254361|FG001|Overall Study|Medical/psychiatric complications|2|||
148937072|NCT00676338|537254362|FG000|Overall Study|Adverse Event|6|||
148937073|NCT00676338|537254363|FG001|Overall Study|Adverse Event|6|||
148937074|NCT00676338|537254364|FG002|Overall Study|Adverse Event|5|||
148937075|NCT00676338|537254365|FG003|Overall Study|Adverse Event|1|||
148937076|NCT00676338|537254362|FG000|Overall Study|Lost to Follow-up|4|||
148937077|NCT00676338|537254363|FG001|Overall Study|Lost to Follow-up|1|||
148937078|NCT00676338|537254364|FG002|Overall Study|Lost to Follow-up|3|||
148937079|NCT00676338|537254365|FG003|Overall Study|Lost to Follow-up|4|||
148937080|NCT00676338|537254362|FG000|Overall Study|Physician Decision|3|||
148937081|NCT00676338|537254363|FG001|Overall Study|Physician Decision|3|||
148937082|NCT00676338|537254364|FG002|Overall Study|Physician Decision|2|||
148937083|NCT00676338|537254365|FG003|Overall Study|Physician Decision|3|||
148937084|NCT00676338|537254362|FG000|Overall Study|Protocol Violation|5|||
148937085|NCT00676338|537254363|FG001|Overall Study|Protocol Violation|9|||
148937086|NCT00676338|537254364|FG002|Overall Study|Protocol Violation|2|||
148937087|NCT00676338|537254365|FG003|Overall Study|Protocol Violation|5|||
148937088|NCT00676338|537254362|FG000|Overall Study|Withdrawal by Subject|17|||
148937089|NCT00676338|537254363|FG001|Overall Study|Withdrawal by Subject|9|||
148937090|NCT00676338|537254364|FG002|Overall Study|Withdrawal by Subject|12|||
148937091|NCT00676338|537254365|FG003|Overall Study|Withdrawal by Subject|6|||
148937092|NCT00676338|537254362|FG000|Overall Study|Entry Criteria Not Met|0|||
148937093|NCT00676338|537254363|FG001|Overall Study|Entry Criteria Not Met|2|||
148937094|NCT00676338|537254364|FG002|Overall Study|Entry Criteria Not Met|1|||
148691443|NCT01325207|536344181|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
148937095|NCT00676338|537254365|FG003|Overall Study|Entry Criteria Not Met|1|||
148937096|NCT00676338|537254362|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
148937097|NCT00676338|537254363|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
148937098|NCT00676338|537254364|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
148937099|NCT00676338|537254365|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
148937100|NCT02122458|537254366|FG000|Overall Study|Withdrawal by Subject|0|||
148937101|NCT02122458|537254367|FG001|Overall Study|Withdrawal by Subject|0|||
148937102|NCT02122458|537254368|FG002|Overall Study|Withdrawal by Subject|0|||
148937103|NCT02122458|537254369|FG003|Overall Study|Withdrawal by Subject|4|||
148937104|NCT02122458|537254370|FG004|Overall Study|Withdrawal by Subject|4|||
148937105|NCT02122458|537254371|FG005|Overall Study|Withdrawal by Subject|4|||
148937106|NCT02122458|537254372|FG006|Overall Study|Withdrawal by Subject|0|||
148937107|NCT02122458|537254366|FG000|Overall Study|Lost to Follow-up|1|||
148937108|NCT02122458|537254367|FG001|Overall Study|Lost to Follow-up|3|||
148937109|NCT02122458|537254368|FG002|Overall Study|Lost to Follow-up|0|||
148937110|NCT02122458|537254369|FG003|Overall Study|Lost to Follow-up|7|||
148937111|NCT02122458|537254370|FG004|Overall Study|Lost to Follow-up|5|||
148937112|NCT02122458|537254371|FG005|Overall Study|Lost to Follow-up|15|||
148937113|NCT02122458|537254372|FG006|Overall Study|Lost to Follow-up|1|||
148937114|NCT02122458|537254366|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
148937115|NCT02122458|537254367|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
148937116|NCT02122458|537254368|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
148937117|NCT02122458|537254369|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
148937118|NCT02122458|537254370|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
148937119|NCT02122458|537254371|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
148937120|NCT02122458|537254372|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
148937121|NCT02122458|537254366|FG000|Overall Study|Adverse Event|1|||
148937122|NCT02122458|537254367|FG001|Overall Study|Adverse Event|0|||
148937123|NCT02122458|537254368|FG002|Overall Study|Adverse Event|0|||
148937124|NCT02122458|537254369|FG003|Overall Study|Adverse Event|0|||
148937125|NCT02122458|537254370|FG004|Overall Study|Adverse Event|0|||
148937126|NCT02122458|537254371|FG005|Overall Study|Adverse Event|0|||
148937127|NCT02122458|537254372|FG006|Overall Study|Adverse Event|0|||
148937128|NCT02122458|537254366|FG000|Overall Study|Experimental Error|0|||
148937129|NCT02122458|537254367|FG001|Overall Study|Experimental Error|0|||
148937130|NCT02122458|537254368|FG002|Overall Study|Experimental Error|0|||
148937131|NCT02122458|537254369|FG003|Overall Study|Experimental Error|0|||
148937132|NCT02122458|537254370|FG004|Overall Study|Experimental Error|3|||
148937133|NCT02122458|537254371|FG005|Overall Study|Experimental Error|0|||
148937134|NCT02122458|537254372|FG006|Overall Study|Experimental Error|0|||
148937135|NCT02122458|537254366|FG000|Overall Study|Deployed or Moved|0|||
148937136|NCT02122458|537254367|FG001|Overall Study|Deployed or Moved|0|||
148937137|NCT02122458|537254368|FG002|Overall Study|Deployed or Moved|0|||
148937138|NCT02122458|537254369|FG003|Overall Study|Deployed or Moved|0|||
148937139|NCT02122458|537254370|FG004|Overall Study|Deployed or Moved|1|||
148937140|NCT02122458|537254371|FG005|Overall Study|Deployed or Moved|0|||
148937141|NCT02122458|537254372|FG006|Overall Study|Deployed or Moved|0|||
148937142|NCT02122458|537254366|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
148937143|NCT02122458|537254367|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
148937144|NCT02122458|537254368|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
148937145|NCT02122458|537254369|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
148937146|NCT02122458|537254370|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
148937147|NCT02122458|537254371|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
148937148|NCT02122458|537254372|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
148937149|NCT02122458|537254366|FG000|Overall Study|Noncompliance|0|||
148937150|NCT02122458|537254367|FG001|Overall Study|Noncompliance|1|||
148937151|NCT02122458|537254368|FG002|Overall Study|Noncompliance|0|||
148937152|NCT02122458|537254369|FG003|Overall Study|Noncompliance|0|||
148937153|NCT02122458|537254370|FG004|Overall Study|Noncompliance|0|||
148937154|NCT02122458|537254371|FG005|Overall Study|Noncompliance|0|||
148937155|NCT02122458|537254372|FG006|Overall Study|Noncompliance|0|||
148937156|NCT00412542|537254373|FG000|Overall Study|Withdrawal by Subject|0|||
148937157|NCT00412542|537254374|FG001|Overall Study|Withdrawal by Subject|2|||
148937158|NCT00412542|537254373|FG000|Overall Study|Not Eligible|0|||
148937159|NCT00412542|537254374|FG001|Overall Study|Not Eligible|1|||
148937160|NCT02833350|537254375|FG000|Overall Study|Adverse Event|0|||
148937161|NCT02833350|537254376|FG001|Overall Study|Adverse Event|3|||
148937162|NCT02833350|537254377|FG002|Overall Study|Adverse Event|4|||
148937163|NCT02833350|537254378|FG003|Overall Study|Adverse Event|4|||
148937164|NCT02833350|537254379|FG004|Overall Study|Adverse Event|1|||
148937165|NCT02833350|537254380|FG005|Overall Study|Adverse Event|0|||
148937166|NCT02833350|537254381|FG006|Overall Study|Adverse Event|1|||
148937167|NCT02833350|537254375|FG000|Overall Study|Death|0|||
148937168|NCT02833350|537254376|FG001|Overall Study|Death|0|||
148937169|NCT02833350|537254377|FG002|Overall Study|Death|1|||
148937170|NCT02833350|537254378|FG003|Overall Study|Death|0|||
148937171|NCT02833350|537254379|FG004|Overall Study|Death|0|||
148937172|NCT02833350|537254380|FG005|Overall Study|Death|0|||
148937173|NCT02833350|537254381|FG006|Overall Study|Death|0|||
148937174|NCT02833350|537254375|FG000|Overall Study|Lack of Efficacy|0|||
148937175|NCT02833350|537254376|FG001|Overall Study|Lack of Efficacy|2|||
148937176|NCT02833350|537254377|FG002|Overall Study|Lack of Efficacy|1|||
148937177|NCT02833350|537254378|FG003|Overall Study|Lack of Efficacy|4|||
148937178|NCT02833350|537254379|FG004|Overall Study|Lack of Efficacy|0|||
148937179|NCT02833350|537254380|FG005|Overall Study|Lack of Efficacy|1|||
148937180|NCT02833350|537254381|FG006|Overall Study|Lack of Efficacy|1|||
148937181|NCT02833350|537254375|FG000|Overall Study|Lost to Follow-up|0|||
148937182|NCT02833350|537254376|FG001|Overall Study|Lost to Follow-up|1|||
148937183|NCT02833350|537254377|FG002|Overall Study|Lost to Follow-up|0|||
148937184|NCT02833350|537254378|FG003|Overall Study|Lost to Follow-up|0|||
148937185|NCT02833350|537254379|FG004|Overall Study|Lost to Follow-up|0|||
148937186|NCT02833350|537254380|FG005|Overall Study|Lost to Follow-up|0|||
148937187|NCT02833350|537254381|FG006|Overall Study|Lost to Follow-up|1|||
149195598|NCT02196038|538185056|FG000|Overall Study|Withdrawal by Subject|0|||
149195599|NCT02196038|538185057|FG001|Overall Study|Withdrawal by Subject|1|||
148937188|NCT02833350|537254375|FG000|Overall Study|Withdrawal by Subject|3|||
149195600|NCT02196038|538185056|FG000|Overall Study|Lost to Follow-up|1|||
148937189|NCT02833350|537254376|FG001|Overall Study|Withdrawal by Subject|3|||
149195601|NCT02196038|538185057|FG001|Overall Study|Lost to Follow-up|0|||
149195602|NCT03471767|538185066|FG000|Overall Study|Withdrawal by Subject|3|||
149195603|NCT03471767|538185067|FG001|Overall Study|Withdrawal by Subject|1|||
149195604|NCT03471767|538185066|FG000|Overall Study|Adverse Event|1|||
149195605|NCT03471767|538185067|FG001|Overall Study|Adverse Event|0|||
149195606|NCT03471767|538185066|FG000|Overall Study|Lost to Follow-up|1|||
149195607|NCT03471767|538185067|FG001|Overall Study|Lost to Follow-up|0|||
149195608|NCT03471767|538185066|FG000|Overall Study|PI Withdrawal|1|||
149195609|NCT03471767|538185067|FG001|Overall Study|PI Withdrawal|3|||
149195610|NCT00678587|538185068|FG000|Overall Study|Adverse Event|3|||
149195611|NCT00678587|538185069|FG001|Overall Study|Adverse Event|3|||
149195612|NCT00678587|538185068|FG000|Overall Study|Lack of Efficacy|1|||
149195613|NCT00678587|538185069|FG001|Overall Study|Lack of Efficacy|0|||
149195614|NCT00678587|538185068|FG000|Overall Study|Protocol Violation|2|||
149195615|NCT00678587|538185069|FG001|Overall Study|Protocol Violation|1|||
149195616|NCT00678587|538185068|FG000|Overall Study|Study Closed/Terminated|1|||
149195617|NCT00678587|538185069|FG001|Overall Study|Study Closed/Terminated|0|||
149195618|NCT00678587|538185068|FG000|Overall Study|Lost to Follow-up|3|||
149195619|NCT00678587|538185069|FG001|Overall Study|Lost to Follow-up|5|||
149195620|NCT00678587|538185068|FG000|Overall Study|Investigator Discretion|2|||
149195621|NCT00678587|538185069|FG001|Overall Study|Investigator Discretion|6|||
149195622|NCT00678587|538185068|FG000|Overall Study|Withdrew Consent|8|||
149195623|NCT00678587|538185069|FG001|Overall Study|Withdrew Consent|3|||
149195624|NCT03806179|538185070|FG000|Overall Study|Progressive disease|0|||
149195625|NCT03806179|538185071|FG001|Overall Study|Progressive disease|2|||
149195626|NCT01952730|538185074|FG000|Overall Study|FDA shut down core lab used by study|1|||
149195627|NCT01514188|538185080|FG000|Overall Study|Adverse Event|3|||
149195628|NCT01514188|538185081|FG001|Overall Study|Adverse Event|5|||
149195629|NCT01514188|538185080|FG000|Overall Study|Withdrawal by Subject|2|||
149195630|NCT01514188|538185081|FG001|Overall Study|Withdrawal by Subject|4|||
149195631|NCT01514188|538185080|FG000|Overall Study|Protocol Violation|2|||
149195632|NCT01514188|538185081|FG001|Overall Study|Protocol Violation|4|||
149195633|NCT01514188|538185080|FG000|Overall Study|Physician Decision|0|||
149195634|NCT01514188|538185081|FG001|Overall Study|Physician Decision|2|||
149195635|NCT01514188|538185080|FG000|Overall Study|Disease Progression|13|||
149195636|NCT01514188|538185081|FG001|Overall Study|Disease Progression|14|||
149195637|NCT01514188|538185080|FG000|Overall Study|Death|1|||
148937190|NCT02833350|537254377|FG002|Overall Study|Withdrawal by Subject|2|||
148937191|NCT02833350|537254378|FG003|Overall Study|Withdrawal by Subject|0|||
148937192|NCT02833350|537254379|FG004|Overall Study|Withdrawal by Subject|2|||
148937193|NCT02833350|537254380|FG005|Overall Study|Withdrawal by Subject|0|||
149195638|NCT01514188|538185081|FG001|Overall Study|Death|3|||
149195639|NCT01514188|538185080|FG000|Overall Study|Other|2|||
149195640|NCT01514188|538185081|FG001|Overall Study|Other|1|||
149195641|NCT02662985|538185082|FG000|Treatment Period 1|Adverse Event|0|||
149195642|NCT02662985|538185083|FG001|Treatment Period 1|Adverse Event|2|||
149195643|NCT02662985|538185082|FG000|Treatment Period 1|Protocol Violation|0|||
149195644|NCT02662985|538185083|FG001|Treatment Period 1|Protocol Violation|1|||
149195645|NCT02662985|538185082|FG000|Treatment Period 1|Physician Decision|1|||
149195646|NCT02662985|538185083|FG001|Treatment Period 1|Physician Decision|0|||
149195647|NCT02662985|538185082|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149195648|NCT02662985|538185083|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149195649|NCT02662985|538185082|FG000|Treatment Period 2|Lack of Efficacy|0|||
149195650|NCT02662985|538185083|FG001|Treatment Period 2|Lack of Efficacy|1|||
148937194|NCT02833350|537254381|FG006|Overall Study|Withdrawal by Subject|2|||
148937195|NCT01604408|537254387|FG000|Treatment Period 1|Protocol Violation|0|||
148937196|NCT01604408|537254388|FG001|Treatment Period 1|Protocol Violation|1|||
148937197|NCT01604408|537254387|FG000|Treatment Period 2|Withdrawal by Subject|1|||
148937198|NCT01604408|537254388|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148937199|NCT01604408|537254387|FG000|Treatment Period 2|Protocol Violation|1|||
148937200|NCT01604408|537254388|FG001|Treatment Period 2|Protocol Violation|0|||
148937201|NCT01604408|537254387|FG000|Treatment Period 2|Adverse Event|0|||
148937202|NCT01604408|537254388|FG001|Treatment Period 2|Adverse Event|1|||
148937203|NCT01604408|537254387|FG000|Treatment Period 3|Protocol Violation|1|||
148937204|NCT01604408|537254388|FG001|Treatment Period 3|Protocol Violation|1|||
148937205|NCT01604408|537254387|FG000|Treatment Period 3|Adverse Event|0|||
148937206|NCT01604408|537254388|FG001|Treatment Period 3|Adverse Event|3|||
148937207|NCT01604408|537254387|FG000|Treatment Period 3|Withdrawal by Subject|3|||
148937208|NCT01604408|537254388|FG001|Treatment Period 3|Withdrawal by Subject|1|||
148937209|NCT01604408|537254387|FG000|Treatment Period 3|Sponsor Decision|1|||
148937210|NCT01604408|537254388|FG001|Treatment Period 3|Sponsor Decision|0|||
148937211|NCT01604408|537254387|FG000|Treatment Period 4|Death|1|||
148937212|NCT01604408|537254388|FG001|Treatment Period 4|Death|0|||
148937213|NCT01604408|537254387|FG000|Treatment Period 4|Withdrawal by Subject|2|||
148937214|NCT01604408|537254388|FG001|Treatment Period 4|Withdrawal by Subject|1|||
148937215|NCT01604408|537254387|FG000|Treatment Period 4|Adverse Event|0|||
148937216|NCT01604408|537254388|FG001|Treatment Period 4|Adverse Event|1|||
148937217|NCT01604408|537254387|FG000|Treatment Period 5|Adverse Event|4|||
148937218|NCT01604408|537254388|FG001|Treatment Period 5|Adverse Event|0|||
148937219|NCT01604408|537254387|FG000|Treatment Period 6|Lost to Follow-up|0|||
148937220|NCT01604408|537254388|FG001|Treatment Period 6|Lost to Follow-up|1|||
148937221|NCT01604408|537254387|FG000|Treatment Period 6|Adverse Event|2|||
148937222|NCT01604408|537254388|FG001|Treatment Period 6|Adverse Event|0|||
148937223|NCT01604408|537254387|FG000|Treatment Period 6|Sponsor decision|0|||
148937224|NCT01604408|537254388|FG001|Treatment Period 6|Sponsor decision|1|||
148937225|NCT01604408|537254387|FG000|Observation Period|Adverse Event|1|||
148937226|NCT01604408|537254388|FG001|Observation Period|Adverse Event|1|||
148937227|NCT01604408|537254387|FG000|Observation Period|Withdrawal by Subject|0|||
148937228|NCT01604408|537254388|FG001|Observation Period|Withdrawal by Subject|2|||
148937229|NCT00075218|537254389|FG000|Double-Blind Treatment|Adverse Event|23|||
148937230|NCT00075218|537254390|FG001|Double-Blind Treatment|Adverse Event|4|||
148937231|NCT00075218|537254391|FG002|Double-Blind Treatment|Adverse Event|0|||
148937232|NCT00075218|537254389|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
148937233|NCT00075218|537254390|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
148937234|NCT00075218|537254391|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
148937235|NCT00075218|537254389|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
148937236|NCT00075218|537254390|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
148937237|NCT00075218|537254391|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
148937238|NCT00075218|537254389|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
148937239|NCT00075218|537254390|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
148937240|NCT00075218|537254391|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
148937241|NCT00075218|537254389|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
148937242|NCT00075218|537254390|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
148937243|NCT00075218|537254391|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
148937244|NCT00075218|537254389|FG000|Double-Blind Treatment|No study medication taken|2|||
148937245|NCT00075218|537254390|FG001|Double-Blind Treatment|No study medication taken|0|||
148937246|NCT00075218|537254391|FG002|Double-Blind Treatment|No study medication taken|0|||
148937247|NCT00075218|537254389|FG000|Open-Label Treatment|Lack of Efficacy|0|||
148937248|NCT00075218|537254390|FG001|Open-Label Treatment|Lack of Efficacy|0|||
148937249|NCT00075218|537254391|FG002|Open-Label Treatment|Lack of Efficacy|174|||
148937250|NCT00075218|537254389|FG000|Open-Label Treatment|Adverse Event|0|||
148937251|NCT00075218|537254390|FG001|Open-Label Treatment|Adverse Event|0|||
148937252|NCT00075218|537254391|FG002|Open-Label Treatment|Adverse Event|51|||
148937253|NCT00075218|537254389|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
148937254|NCT00075218|537254390|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
148937255|NCT00075218|537254391|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
148937256|NCT00075218|537254389|FG000|Open-Label Treatment|Decision of Sponsor|0|||
148937257|NCT00075218|537254390|FG001|Open-Label Treatment|Decision of Sponsor|0|||
148937258|NCT00075218|537254391|FG002|Open-Label Treatment|Decision of Sponsor|8|||
149195651|NCT02662985|538185082|FG000|Treatment Period 2|Lost to Follow-up|1|||
148937259|NCT00075218|537254389|FG000|Open-Label Treatment|Protocol Violation|0|||
148937260|NCT00075218|537254390|FG001|Open-Label Treatment|Protocol Violation|0|||
148937261|NCT00075218|537254391|FG002|Open-Label Treatment|Protocol Violation|1|||
148937262|NCT00075218|537254389|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
148937263|NCT00075218|537254390|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
148937264|NCT00075218|537254391|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
148937265|NCT01189604|537254394|FG000|Overall Study|Impossible to visit|0|||
148937266|NCT01189604|537254395|FG001|Overall Study|Impossible to visit|0|||
148937267|NCT01189604|537254396|FG002|Overall Study|Impossible to visit|0|||
149195652|NCT02662985|538185083|FG001|Treatment Period 2|Lost to Follow-up|0|||
148937268|NCT01189604|537254397|FG003|Overall Study|Impossible to visit|0|||
148937269|NCT01189604|537254398|FG004|Overall Study|Impossible to visit|0|||
148937270|NCT01189604|537254399|FG005|Overall Study|Impossible to visit|1|||
148937271|NCT01189604|537254400|FG006|Overall Study|Impossible to visit|0|||
148937272|NCT01189604|537254394|FG000|Overall Study|Adverse Event|0|||
148937273|NCT01189604|537254395|FG001|Overall Study|Adverse Event|1|||
148937274|NCT01189604|537254396|FG002|Overall Study|Adverse Event|0|||
148937275|NCT01189604|537254397|FG003|Overall Study|Adverse Event|0|||
148937276|NCT01189604|537254398|FG004|Overall Study|Adverse Event|2|||
148937277|NCT01189604|537254399|FG005|Overall Study|Adverse Event|0|||
148937278|NCT01189604|537254400|FG006|Overall Study|Adverse Event|1|||
148937279|NCT01189604|537254394|FG000|Overall Study|Withdrawal by Subject|1|||
148937280|NCT01189604|537254395|FG001|Overall Study|Withdrawal by Subject|0|||
148937281|NCT01189604|537254396|FG002|Overall Study|Withdrawal by Subject|0|||
148937282|NCT01189604|537254397|FG003|Overall Study|Withdrawal by Subject|0|||
148937283|NCT01189604|537254398|FG004|Overall Study|Withdrawal by Subject|0|||
148937284|NCT01189604|537254399|FG005|Overall Study|Withdrawal by Subject|0|||
148937285|NCT01189604|537254400|FG006|Overall Study|Withdrawal by Subject|0|||
148937286|NCT03626168|537254401|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148937287|NCT03626168|537254402|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
148937288|NCT03626168|537254401|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
148937289|NCT03626168|537254402|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
148937290|NCT03626168|537254401|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
148937291|NCT03626168|537254402|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
148937292|NCT02357979|537254403|FG000|Overall Study|Lost to Follow-up|5|||
148937293|NCT02357979|537254404|FG001|Overall Study|Lost to Follow-up|5|||
148937294|NCT01772160|537254409|FG000|Overall Study|Death|3|||
148937295|NCT01772160|537254409|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
148937296|NCT01772160|537254409|FG000|Overall Study|Consent withdrawal|3|||
148937297|NCT01772160|537254409|FG000|Overall Study|Migrated / moved from the study area|4|||
148937298|NCT01772160|537254409|FG000|Overall Study|Lost to Follow-up|30|||
148937299|NCT01772160|537254409|FG000|Overall Study|Other|5|||
148937300|NCT01332331|537254412|FG000|Overall Study|Lost to Follow-up|0|||
148937301|NCT01332331|537254413|FG001|Overall Study|Lost to Follow-up|1|||
148937302|NCT01332331|537254412|FG000|Overall Study|Adverse Event|1|||
148937303|NCT01332331|537254413|FG001|Overall Study|Adverse Event|1|||
148937304|NCT01332331|537254412|FG000|Overall Study|Physician Decision|1|||
148937305|NCT01332331|537254413|FG001|Overall Study|Physician Decision|0|||
148937306|NCT00538291|537254414|FG000|Overall Study|Adverse Event|2|||
148937307|NCT00538291|537254414|FG000|Overall Study|Withdrawal by Subject|1|||
148937308|NCT01696695|537254415|FG000|Overall Study|Disease progression|373|||
148937309|NCT01696695|537254415|FG000|Overall Study|Death|29|||
148937310|NCT01696695|537254415|FG000|Overall Study|Adverse Event|74|||
148937311|NCT01696695|537254415|FG000|Overall Study|Withdrawal by Subject|92|||
148937312|NCT01696695|537254415|FG000|Overall Study|Lost to Follow-up|48|||
148937313|NCT01696695|537254415|FG000|Overall Study|Other|74|||
148937314|NCT01696695|537254415|FG000|Overall Study|Major Protocol Violation|192|||
148937315|NCT01756053|537254425|FG000|Period 1 (10 Days)|Protocol Violation|1|||
148937316|NCT01756053|537254426|FG001|Period 1 (10 Days)|Protocol Violation|1|||
148937317|NCT01756053|537254425|FG000|Period 2 (10 Days)|Protocol Violation|0|||
148937318|NCT01756053|537254426|FG001|Period 2 (10 Days)|Protocol Violation|2|||
148937319|NCT00285818|537254427|FG000|Overall Study|Withdrawal by Subject|3|||
148937320|NCT00285818|537254428|FG001|Overall Study|Withdrawal by Subject|2|||
148937321|NCT00285818|537254427|FG000|Overall Study|Lost to Follow-up|1|||
148937322|NCT00285818|537254428|FG001|Overall Study|Lost to Follow-up|0|||
148937323|NCT00199875|537254429|FG000|Overall Study|Withdrawal by Subject|0|||
148937324|NCT00199875|537254430|FG001|Overall Study|Withdrawal by Subject|0|||
148937325|NCT00199875|537254431|FG002|Overall Study|Withdrawal by Subject|0|||
148937326|NCT00199875|537254432|FG003|Overall Study|Withdrawal by Subject|0|||
148937327|NCT00199875|537254433|FG004|Overall Study|Withdrawal by Subject|1|||
148937328|NCT02404220|537254434|FG000|Overall Study|Adverse Event|0|||
148937329|NCT02404220|537254435|FG001|Overall Study|Adverse Event|0|||
148682150|NCT00272961|536309472|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
148937330|NCT02404220|537254436|FG002|Overall Study|Adverse Event|1|||
148937331|NCT02404220|537254437|FG003|Overall Study|Adverse Event|0|||
148937332|NCT02404220|537254434|FG000|Overall Study|Death|5|||
148937333|NCT02404220|537254435|FG001|Overall Study|Death|5|||
148937334|NCT02404220|537254436|FG002|Overall Study|Death|3|||
148937335|NCT02404220|537254437|FG003|Overall Study|Death|8|||
148937336|NCT02404220|537254434|FG000|Overall Study|Progressive Disease|0|||
148937337|NCT02404220|537254435|FG001|Overall Study|Progressive Disease|0|||
148937338|NCT02404220|537254436|FG002|Overall Study|Progressive Disease|1|||
148937339|NCT02404220|537254437|FG003|Overall Study|Progressive Disease|1|||
148937340|NCT02404220|537254434|FG000|Overall Study|Study Terminated by Sponsor|0|||
148937341|NCT02404220|537254435|FG001|Overall Study|Study Terminated by Sponsor|0|||
148937342|NCT02404220|537254436|FG002|Overall Study|Study Terminated by Sponsor|2|||
148937343|NCT02404220|537254437|FG003|Overall Study|Study Terminated by Sponsor|1|||
148937344|NCT02404220|537254434|FG000|Overall Study|Withdrawal by Subject|0|||
148937345|NCT02404220|537254435|FG001|Overall Study|Withdrawal by Subject|1|||
148937346|NCT02404220|537254436|FG002|Overall Study|Withdrawal by Subject|0|||
148937347|NCT02404220|537254437|FG003|Overall Study|Withdrawal by Subject|0|||
148937348|NCT02404220|537254434|FG000|Overall Study|Enrolled but Never Treated|0|||
148937349|NCT02404220|537254435|FG001|Overall Study|Enrolled but Never Treated|2|||
148937350|NCT02404220|537254436|FG002|Overall Study|Enrolled but Never Treated|0|||
148937351|NCT02404220|537254437|FG003|Overall Study|Enrolled but Never Treated|0|||
148937352|NCT01024231|537254441|FG000|Overall Study|Other Reasons|1|||
148937353|NCT01024231|537254442|FG001|Overall Study|Other Reasons|2|||
148937354|NCT01024231|537254443|FG002|Overall Study|Other Reasons|0|||
148937355|NCT01024231|537254444|FG003|Overall Study|Other Reasons|0|||
148937356|NCT01024231|537254445|FG004|Overall Study|Other Reasons|2|||
148937357|NCT01024231|537254446|FG005|Overall Study|Other Reasons|0|||
148937358|NCT01024231|537254447|FG006|Overall Study|Other Reasons|1|||
148937359|NCT01024231|537254441|FG000|Overall Study|Maximum Clinical Benefit|1|||
148937360|NCT01024231|537254442|FG001|Overall Study|Maximum Clinical Benefit|2|||
148937361|NCT01024231|537254443|FG002|Overall Study|Maximum Clinical Benefit|0|||
148937362|NCT01024231|537254444|FG003|Overall Study|Maximum Clinical Benefit|1|||
148937363|NCT01024231|537254445|FG004|Overall Study|Maximum Clinical Benefit|1|||
148937364|NCT01024231|537254446|FG005|Overall Study|Maximum Clinical Benefit|0|||
148937365|NCT01024231|537254447|FG006|Overall Study|Maximum Clinical Benefit|0|||
148937366|NCT01024231|537254441|FG000|Overall Study|Disease Progression|3|||
148937367|NCT01024231|537254442|FG001|Overall Study|Disease Progression|1|||
148937368|NCT01024231|537254443|FG002|Overall Study|Disease Progression|3|||
148937369|NCT01024231|537254444|FG003|Overall Study|Disease Progression|0|||
148937370|NCT01024231|537254445|FG004|Overall Study|Disease Progression|4|||
148937371|NCT01024231|537254446|FG005|Overall Study|Disease Progression|11|||
148937372|NCT01024231|537254447|FG006|Overall Study|Disease Progression|6|||
148937373|NCT01024231|537254441|FG000|Overall Study|AE unrelated to Study Drug|0|||
148937374|NCT01024231|537254442|FG001|Overall Study|AE unrelated to Study Drug|1|||
148937375|NCT01024231|537254443|FG002|Overall Study|AE unrelated to Study Drug|0|||
148937376|NCT01024231|537254444|FG003|Overall Study|AE unrelated to Study Drug|0|||
148937377|NCT01024231|537254445|FG004|Overall Study|AE unrelated to Study Drug|0|||
148937378|NCT01024231|537254446|FG005|Overall Study|AE unrelated to Study Drug|0|||
148937379|NCT01024231|537254447|FG006|Overall Study|AE unrelated to Study Drug|0|||
148937380|NCT01024231|537254441|FG000|Overall Study|No longer meets criteria|0|||
148937381|NCT01024231|537254442|FG001|Overall Study|No longer meets criteria|0|||
148937382|NCT01024231|537254443|FG002|Overall Study|No longer meets criteria|0|||
148937383|NCT01024231|537254444|FG003|Overall Study|No longer meets criteria|0|||
148937384|NCT01024231|537254445|FG004|Overall Study|No longer meets criteria|1|||
148937385|NCT01024231|537254446|FG005|Overall Study|No longer meets criteria|0|||
148937386|NCT01024231|537254447|FG006|Overall Study|No longer meets criteria|1|||
148937387|NCT01024231|537254441|FG000|Overall Study|Study Drug Toxicity|1|||
148937388|NCT01024231|537254442|FG001|Overall Study|Study Drug Toxicity|6|||
148937389|NCT01024231|537254443|FG002|Overall Study|Study Drug Toxicity|6|||
148937390|NCT01024231|537254444|FG003|Overall Study|Study Drug Toxicity|4|||
148937391|NCT01024231|537254445|FG004|Overall Study|Study Drug Toxicity|2|||
148937392|NCT01024231|537254446|FG005|Overall Study|Study Drug Toxicity|0|||
148937393|NCT01024231|537254447|FG006|Overall Study|Study Drug Toxicity|7|||
148937394|NCT01024231|537254441|FG000|Overall Study|Death|6|||
148937395|NCT01024231|537254442|FG001|Overall Study|Death|2|||
148937396|NCT01024231|537254443|FG002|Overall Study|Death|1|||
148937397|NCT01024231|537254444|FG003|Overall Study|Death|0|||
148937398|NCT01024231|537254445|FG004|Overall Study|Death|4|||
148937399|NCT01024231|537254446|FG005|Overall Study|Death|3|||
148937400|NCT01024231|537254447|FG006|Overall Study|Death|5|||
148937401|NCT01024231|537254441|FG000|Overall Study|Lost to Follow-up|0|||
148937402|NCT01024231|537254442|FG001|Overall Study|Lost to Follow-up|0|||
148937403|NCT01024231|537254443|FG002|Overall Study|Lost to Follow-up|0|||
148937404|NCT01024231|537254444|FG003|Overall Study|Lost to Follow-up|0|||
148937405|NCT01024231|537254445|FG004|Overall Study|Lost to Follow-up|0|||
148937406|NCT01024231|537254446|FG005|Overall Study|Lost to Follow-up|0|||
149195653|NCT02662985|538185082|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
149195654|NCT02662985|538185083|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
148937407|NCT01024231|537254447|FG006|Overall Study|Lost to Follow-up|1|||
148937408|NCT01024231|537254441|FG000|Overall Study|Withdrew Consent|0|||
148937409|NCT01024231|537254442|FG001|Overall Study|Withdrew Consent|1|||
148937410|NCT01024231|537254443|FG002|Overall Study|Withdrew Consent|0|||
148937411|NCT01024231|537254444|FG003|Overall Study|Withdrew Consent|0|||
148937412|NCT01024231|537254445|FG004|Overall Study|Withdrew Consent|0|||
148937413|NCT01024231|537254446|FG005|Overall Study|Withdrew Consent|0|||
148937414|NCT01024231|537254447|FG006|Overall Study|Withdrew Consent|0|||
148937415|NCT01024231|537254441|FG000|Overall Study|Continuing on Treatment|0|||
148937416|NCT01024231|537254442|FG001|Overall Study|Continuing on Treatment|0|||
148937417|NCT01024231|537254443|FG002|Overall Study|Continuing on Treatment|0|||
148937418|NCT01024231|537254444|FG003|Overall Study|Continuing on Treatment|0|||
148937419|NCT01024231|537254445|FG004|Overall Study|Continuing on Treatment|3|||
148937420|NCT01024231|537254446|FG005|Overall Study|Continuing on Treatment|2|||
148937421|NCT01024231|537254447|FG006|Overall Study|Continuing on Treatment|0|||
148937422|NCT03181893|537254448|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937423|NCT03181893|537254449|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
148937424|NCT03181893|537254450|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937425|NCT03181893|537254451|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937426|NCT03181893|537254452|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937427|NCT03181893|537254453|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937428|NCT03181893|537254454|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937429|NCT03181893|537254455|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937430|NCT03181893|537254456|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937431|NCT03181893|537254457|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937432|NCT03181893|537254458|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
148937433|NCT03181893|537254448|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
148937434|NCT03181893|537254449|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
148937435|NCT03181893|537254450|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937436|NCT03181893|537254451|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937437|NCT03181893|537254452|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937438|NCT03181893|537254453|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937439|NCT03181893|537254454|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937440|NCT03181893|537254455|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937441|NCT03181893|537254456|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937442|NCT03181893|537254457|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937443|NCT03181893|537254458|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
148937444|NCT03181893|537254448|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937445|NCT03181893|537254449|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937446|NCT03181893|537254450|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937447|NCT03181893|537254451|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937448|NCT03181893|537254452|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937449|NCT03181893|537254453|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937450|NCT03181893|537254454|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937451|NCT03181893|537254455|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
148937452|NCT03181893|537254456|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
148937453|NCT03181893|537254457|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937454|NCT03181893|537254458|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
148937455|NCT03181893|537254448|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937456|NCT03181893|537254449|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937457|NCT03181893|537254450|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937458|NCT03181893|537254451|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937459|NCT03181893|537254452|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937460|NCT03181893|537254453|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937461|NCT03181893|537254454|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937462|NCT03181893|537254455|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937463|NCT03181893|537254456|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937464|NCT03181893|537254457|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
148937465|NCT03181893|537254458|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
148937466|NCT03181893|537254448|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937467|NCT03181893|537254449|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937468|NCT03181893|537254450|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937469|NCT03181893|537254451|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937470|NCT03181893|537254452|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937471|NCT03181893|537254453|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148807785|NCT02030600|536774438|FG000|Treatment Period 2|Withdrawal by Subject|13|||
148937472|NCT03181893|537254454|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937473|NCT03181893|537254455|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937474|NCT03181893|537254456|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937475|NCT03181893|537254457|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
148937476|NCT03181893|537254458|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
148937477|NCT02840721|537254459|FG000|Treatment Period|Adverse Event|1|||
148937478|NCT02840721|537254459|FG000|Follow-Up|Lack of Efficacy|1|||
148937479|NCT02840721|537254459|FG000|Follow-Up|Withdrawal by Subject|4|||
148937480|NCT02840721|537254459|FG000|Follow-Up|Withdrawal of Consent|2|||
148937481|NCT01967173|537254460|FG000|Overall Study|Lost to Follow-up|5|||
148937482|NCT01967173|537254461|FG001|Overall Study|Lost to Follow-up|3|||
148937483|NCT01967173|537254462|FG002|Overall Study|Lost to Follow-up|2|||
149195655|NCT02662985|538185082|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
149195656|NCT02662985|538185083|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
148807786|NCT02030600|536774439|FG001|Treatment Period 2|Withdrawal by Subject|9|||
148937484|NCT01967173|537254463|FG003|Overall Study|Lost to Follow-up|4|||
148937485|NCT01967173|537254464|FG004|Overall Study|Lost to Follow-up|8|||
148937486|NCT01967173|537254465|FG005|Overall Study|Lost to Follow-up|12|||
148937487|NCT01967173|537254466|FG006|Overall Study|Lost to Follow-up|6|||
148937488|NCT01967173|537254467|FG007|Overall Study|Lost to Follow-up|8|||
148937489|NCT01967173|537254460|FG000|Overall Study|Physician Decision|2|||
148937490|NCT01967173|537254461|FG001|Overall Study|Physician Decision|0|||
148937491|NCT01967173|537254462|FG002|Overall Study|Physician Decision|2|||
148937492|NCT01967173|537254463|FG003|Overall Study|Physician Decision|1|||
148937493|NCT01967173|537254464|FG004|Overall Study|Physician Decision|1|||
148937494|NCT01967173|537254465|FG005|Overall Study|Physician Decision|1|||
148937495|NCT01967173|537254466|FG006|Overall Study|Physician Decision|1|||
148937496|NCT01967173|537254467|FG007|Overall Study|Physician Decision|0|||
148937497|NCT01967173|537254460|FG000|Overall Study|Lack of Efficacy|2|||
148937498|NCT01967173|537254461|FG001|Overall Study|Lack of Efficacy|0|||
148937499|NCT01967173|537254462|FG002|Overall Study|Lack of Efficacy|2|||
148937500|NCT01967173|537254463|FG003|Overall Study|Lack of Efficacy|2|||
148937501|NCT01967173|537254464|FG004|Overall Study|Lack of Efficacy|0|||
148937502|NCT01967173|537254465|FG005|Overall Study|Lack of Efficacy|1|||
148937503|NCT01967173|537254466|FG006|Overall Study|Lack of Efficacy|0|||
148937504|NCT01967173|537254467|FG007|Overall Study|Lack of Efficacy|2|||
148937505|NCT01967173|537254460|FG000|Overall Study|Pregnancy|0|||
148937506|NCT01967173|537254461|FG001|Overall Study|Pregnancy|0|||
148937507|NCT01967173|537254462|FG002|Overall Study|Pregnancy|0|||
148937508|NCT01967173|537254463|FG003|Overall Study|Pregnancy|0|||
148937509|NCT01967173|537254464|FG004|Overall Study|Pregnancy|0|||
148937510|NCT01967173|537254465|FG005|Overall Study|Pregnancy|0|||
148937511|NCT01967173|537254466|FG006|Overall Study|Pregnancy|1|||
148937512|NCT01967173|537254467|FG007|Overall Study|Pregnancy|1|||
148937513|NCT01967173|537254460|FG000|Overall Study|Adverse Event|0|||
148937514|NCT01967173|537254461|FG001|Overall Study|Adverse Event|0|||
148937515|NCT01967173|537254462|FG002|Overall Study|Adverse Event|0|||
148937516|NCT01967173|537254463|FG003|Overall Study|Adverse Event|0|||
148937517|NCT01967173|537254464|FG004|Overall Study|Adverse Event|0|||
148937518|NCT01967173|537254465|FG005|Overall Study|Adverse Event|0|||
148937519|NCT01967173|537254466|FG006|Overall Study|Adverse Event|0|||
148937520|NCT01967173|537254467|FG007|Overall Study|Adverse Event|1|||
148937521|NCT01967173|537254460|FG000|Overall Study|Withdrawal by Subject|15|||
148937522|NCT01967173|537254461|FG001|Overall Study|Withdrawal by Subject|14|||
148937523|NCT01967173|537254462|FG002|Overall Study|Withdrawal by Subject|10|||
148937524|NCT01967173|537254463|FG003|Overall Study|Withdrawal by Subject|7|||
148937525|NCT01967173|537254464|FG004|Overall Study|Withdrawal by Subject|8|||
148937526|NCT01967173|537254465|FG005|Overall Study|Withdrawal by Subject|9|||
148937527|NCT01967173|537254466|FG006|Overall Study|Withdrawal by Subject|10|||
148937528|NCT01967173|537254467|FG007|Overall Study|Withdrawal by Subject|12|||
148937529|NCT04815031|537254475|FG000|Overall Study|No adverse event information (missing information)|33|||
148937530|NCT03021304|537254476|FG000|Overall Study|Lack of Efficacy|1|||
148937531|NCT00397215|537254484|FG000|Month 0 (Day 0)|Adverse Event|0|||
148937532|NCT00397215|537254485|FG001|Month 0 (Day 0)|Adverse Event|1|||
148937533|NCT00397215|537254486|FG002|Month 0 (Day 0)|Adverse Event|0|||
149195657|NCT02662985|538185082|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
149195658|NCT02662985|538185083|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
149195659|NCT02662985|538185082|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
149195660|NCT02662985|538185083|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
149195661|NCT02662985|538185082|FG000|Treatment Period 3 (Extension Period)|Death|0|||
149195662|NCT02662985|538185083|FG001|Treatment Period 3 (Extension Period)|Death|1|||
149195663|NCT01019486|538185084|FG000|Overall Study|Withdrawal by Subject|1|||
149195664|NCT01019486|538185085|FG001|Overall Study|Withdrawal by Subject|1|||
149195665|NCT01019486|538185086|FG002|Overall Study|Withdrawal by Subject|1|||
149195666|NCT05373706|538185092|FG000|Overall Study|Lost to Follow-up|2|||
149195667|NCT05373706|538185093|FG001|Overall Study|Lost to Follow-up|2|||
149195668|NCT03442829|538185094|FG000|Overall Study|Scheduling clash|3|||
148937534|NCT00397215|537254487|FG003|Month 0 (Day 0)|Adverse Event|0|||
148937535|NCT00397215|537254484|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
148937536|NCT00397215|537254485|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
148937537|NCT00397215|537254486|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
148937538|NCT00397215|537254487|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
148937539|NCT00397215|537254484|FG000|Month 0 (Day 0)|Other|4|||
148937540|NCT00397215|537254485|FG001|Month 0 (Day 0)|Other|1|||
148937541|NCT00397215|537254486|FG002|Month 0 (Day 0)|Other|3|||
148937542|NCT00397215|537254487|FG003|Month 0 (Day 0)|Other|3|||
148937543|NCT00397215|537254484|FG000|Month 6 (Day 180)|Adverse Event|0|||
148937544|NCT00397215|537254485|FG001|Month 6 (Day 180)|Adverse Event|3|||
148937545|NCT00397215|537254486|FG002|Month 6 (Day 180)|Adverse Event|2|||
148937546|NCT00397215|537254487|FG003|Month 6 (Day 180)|Adverse Event|0|||
148937547|NCT00397215|537254484|FG000|Month 6 (Day 180)|Other|2|||
148937548|NCT00397215|537254485|FG001|Month 6 (Day 180)|Other|0|||
148937549|NCT00397215|537254486|FG002|Month 6 (Day 180)|Other|3|||
149195669|NCT03442829|538185095|FG001|Overall Study|Scheduling clash|1|||
148682151|NCT00272961|536309468|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
148682152|NCT00272961|536309469|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
148937550|NCT00397215|537254487|FG003|Month 6 (Day 180)|Other|0|||
148937551|NCT02959983|537254488|FG000|Overall Study|Protocol Violation|0|||
148937552|NCT02959983|537254489|FG001|Overall Study|Protocol Violation|1|||
148937553|NCT02959983|537254488|FG000|Overall Study|Lack of Efficacy|0|||
148937554|NCT02959983|537254489|FG001|Overall Study|Lack of Efficacy|1|||
148937555|NCT02959983|537254488|FG000|Overall Study|Lost to Follow-up|12|||
148937556|NCT02959983|537254489|FG001|Overall Study|Lost to Follow-up|9|||
148937557|NCT02959983|537254488|FG000|Overall Study|Other|1|||
148937558|NCT02959983|537254489|FG001|Overall Study|Other|1|||
148937559|NCT02959983|537254488|FG000|Overall Study|Physician Decision|1|||
148937560|NCT02959983|537254489|FG001|Overall Study|Physician Decision|0|||
148937561|NCT02959983|537254488|FG000|Overall Study|Adverse Event|5|||
148937562|NCT02959983|537254489|FG001|Overall Study|Adverse Event|1|||
148937563|NCT02959983|537254488|FG000|Overall Study|Withdrawal by Subject|7|||
148937564|NCT02959983|537254489|FG001|Overall Study|Withdrawal by Subject|12|||
148937565|NCT00484094|537254490|FG000|Overall Study|Discontinued|39|||
148937566|NCT00484094|537254490|FG000|Overall Study|Other|3|||
148937567|NCT02728596|537254491|FG000|Overall Study|Refusal unrelated to adverse event|3|||
148937568|NCT02728596|537254492|FG001|Overall Study|Refusal unrelated to adverse event|6|||
148937569|NCT02728596|537254493|FG002|Overall Study|Refusal unrelated to adverse event|7|||
148937570|NCT02728596|537254494|FG003|Overall Study|Refusal unrelated to adverse event|7|||
148937571|NCT02728596|537254491|FG000|Overall Study|Death|44|||
148937572|NCT02728596|537254492|FG001|Overall Study|Death|42|||
148937573|NCT02728596|537254493|FG002|Overall Study|Death|123|||
148937574|NCT02728596|537254494|FG003|Overall Study|Death|68|||
148937575|NCT03439657|537254499|FG000|Overall Study|Adverse Event|2|||
148937576|NCT03439657|537254500|FG001|Overall Study|Adverse Event|3|||
148937577|NCT03439657|537254499|FG000|Overall Study|Lost to Follow-up|1|||
148937578|NCT03439657|537254500|FG001|Overall Study|Lost to Follow-up|0|||
148937579|NCT03439657|537254499|FG000|Overall Study|Protocol Violation|1|||
148937580|NCT03439657|537254500|FG001|Overall Study|Protocol Violation|1|||
148937581|NCT03439657|537254499|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
148937582|NCT03439657|537254500|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
148937583|NCT00370071|537254502|FG000|Overall Study|Withdrawal by Subject|2|||
148937584|NCT00667875|537254505|FG000|Overall Study|Adverse Event|0|||
148937585|NCT00667875|537254506|FG001|Overall Study|Adverse Event|2|||
148937586|NCT00667875|537254507|FG002|Overall Study|Adverse Event|6|||
148937587|NCT00667875|537254505|FG000|Overall Study|Withdrawal by Subject|10|||
148937588|NCT00667875|537254506|FG001|Overall Study|Withdrawal by Subject|9|||
148937589|NCT00667875|537254507|FG002|Overall Study|Withdrawal by Subject|7|||
148937590|NCT00531934|537256719|FG000|Overall Study|Adverse Event|4|||
148937591|NCT00531934|537256720|FG001|Overall Study|Adverse Event|8|||
148937592|NCT00531934|537256719|FG000|Overall Study|Progression|52|||
148937593|NCT00531934|537256720|FG001|Overall Study|Progression|42|||
148937594|NCT00531934|537256719|FG000|Overall Study|Death|7|||
148937595|NCT00531934|537256720|FG001|Overall Study|Death|10|||
148937596|NCT00531934|537256719|FG000|Overall Study|Withdrawal by Subject|1|||
148937597|NCT00531934|537256720|FG001|Overall Study|Withdrawal by Subject|1|||
148937598|NCT00531934|537256719|FG000|Overall Study|Other|2|||
148937599|NCT00531934|537256720|FG001|Overall Study|Other|2|||
148682153|NCT00272961|536309470|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
148682154|NCT00272961|536309471|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
148682155|NCT00272961|536309472|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
148682156|NCT00272961|536309468|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
148682157|NCT00272961|536309469|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
148682158|NCT00272961|536309470|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
148682159|NCT00272961|536309471|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
148682160|NCT00272961|536309472|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
148682161|NCT00272961|536309468|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
148937600|NCT00150709|537256722|FG000|Overall Study|Protocol Violation|7|||
148937601|NCT00150709|537256723|FG001|Overall Study|Protocol Violation|8|||
148937602|NCT00150709|537256724|FG002|Overall Study|Protocol Violation|3|||
148937603|NCT00150709|537256725|FG003|Overall Study|Protocol Violation|1|||
148682162|NCT00272961|536309469|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
148682163|NCT00272961|536309470|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
148937604|NCT00150709|537256722|FG000|Overall Study|Adverse Event|8|||
148937605|NCT00150709|537256723|FG001|Overall Study|Adverse Event|2|||
148937606|NCT00150709|537256724|FG002|Overall Study|Adverse Event|2|||
148937607|NCT00150709|537256725|FG003|Overall Study|Adverse Event|3|||
148937608|NCT00150709|537256722|FG000|Overall Study|Lack of Efficacy|6|||
148682164|NCT00272961|536309471|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
148937609|NCT00150709|537256723|FG001|Overall Study|Lack of Efficacy|11|||
148937610|NCT00150709|537256724|FG002|Overall Study|Lack of Efficacy|9|||
148937611|NCT00150709|537256725|FG003|Overall Study|Lack of Efficacy|0|||
148937612|NCT00150709|537256722|FG000|Overall Study|Withdrawal by Subject|7|||
148807787|NCT02030600|536774438|FG000|Treatment Period 2|Unclassified|1|||
148807788|NCT02030600|536774439|FG001|Treatment Period 2|Unclassified|0|||
148807789|NCT02736617|536774440|FG000|Treatment|Adverse Event|1|||
148807790|NCT02736617|536774440|FG000|Treatment|Lack of Efficacy|1|||
148807791|NCT02736617|536774440|FG000|Treatment|Withdrawal by Subject|1|||
148807792|NCT02736617|536774440|FG000|Maintenance|Lack of Efficacy|4|||
148807793|NCT02736617|536774440|FG000|Maintenance|Physician Decision|1|||
148807794|NCT01240694|536774443|FG000|Overall Study|Adverse Event|9|||
148807795|NCT01240694|536774443|FG000|Overall Study|Lack of Efficacy|6|||
148807796|NCT01240694|536774443|FG000|Overall Study|Withdrawal by Subject|6|||
148807797|NCT01240694|536774443|FG000|Overall Study|Protocol Violation|2|||
148807798|NCT01240694|536774443|FG000|Overall Study|Lost to Follow-up|2|||
148807799|NCT01240694|536774443|FG000|Overall Study|Other than specified|3|||
148807800|NCT01240694|536774443|FG000|Overall Study|Withdrawn due to early study termination|107|||
148807801|NCT01881425|536774444|FG000|Overall Study|Death|5|||
148807802|NCT01881425|536774445|FG001|Overall Study|Death|1|||
148807803|NCT01881425|536774444|FG000|Overall Study|Withdrawal by Subject|8|||
148807804|NCT01881425|536774445|FG001|Overall Study|Withdrawal by Subject|3|||
148807805|NCT01881425|536774444|FG000|Overall Study|Physician Decision|2|||
148807806|NCT01881425|536774445|FG001|Overall Study|Physician Decision|1|||
148807807|NCT01881425|536774444|FG000|Overall Study|Adverse Event|3|||
148807808|NCT01881425|536774445|FG001|Overall Study|Adverse Event|0|||
148807809|NCT01881425|536774444|FG000|Overall Study|General Anesthesia panic attack|0|||
148807810|NCT01881425|536774445|FG001|Overall Study|General Anesthesia panic attack|1|||
148807811|NCT01881425|536774444|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
148807812|NCT01881425|536774445|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
148807813|NCT01881425|536774444|FG000|Overall Study|Lost to Follow-up|7|||
148807814|NCT01881425|536774445|FG001|Overall Study|Lost to Follow-up|2|||
148807815|NCT05352815|536774450|FG000|Overall Study|Withdrawal by Subject|28|||
148807816|NCT05352815|536774451|FG001|Overall Study|Withdrawal by Subject|24|||
148807817|NCT05352815|536774450|FG000|Overall Study|Lost to Follow-up|4|||
148807818|NCT05352815|536774451|FG001|Overall Study|Lost to Follow-up|7|||
148807819|NCT05352815|536774450|FG000|Overall Study|Death|2|||
148807820|NCT05352815|536774451|FG001|Overall Study|Death|3|||
148807821|NCT05352815|536774450|FG000|Overall Study|Site closure|1|||
148807822|NCT05352815|536774451|FG001|Overall Study|Site closure|0|||
148807823|NCT01933594|536774453|FG000|Overall Study|Lost to Follow-up|1|||
148807824|NCT01933594|536774454|FG001|Overall Study|Lost to Follow-up|0|||
148807825|NCT01933594|536774455|FG002|Overall Study|Lost to Follow-up|0|||
148807826|NCT01933594|536774456|FG003|Overall Study|Lost to Follow-up|0|||
148807827|NCT01933594|536774457|FG004|Overall Study|Lost to Follow-up|1|||
148807828|NCT01933594|536774458|FG005|Overall Study|Lost to Follow-up|0|||
148807829|NCT01933594|536774453|FG000|Overall Study|Ineligible for subsequent study step|0|||
148807830|NCT01933594|536774454|FG001|Overall Study|Ineligible for subsequent study step|0|||
148807831|NCT01933594|536774455|FG002|Overall Study|Ineligible for subsequent study step|0|||
148807832|NCT01933594|536774456|FG003|Overall Study|Ineligible for subsequent study step|0|||
148807833|NCT01933594|536774457|FG004|Overall Study|Ineligible for subsequent study step|1|||
148807834|NCT01933594|536774458|FG005|Overall Study|Ineligible for subsequent study step|0|||
148807835|NCT04513366|536774459|FG000|Treatment Phase|Withdrawal by Subject|6|||
148807836|NCT04513366|536774460|FG001|Treatment Phase|Withdrawal by Subject|8|||
148807837|NCT04513366|536774461|FG002|Treatment Phase|Withdrawal by Subject|3|||
148807838|NCT04513366|536774459|FG000|Treatment Phase|Lost to Follow-up|1|||
148807839|NCT04513366|536774460|FG001|Treatment Phase|Lost to Follow-up|2|||
148807840|NCT04513366|536774461|FG002|Treatment Phase|Lost to Follow-up|5|||
148807841|NCT04513366|536774459|FG000|Treatment Phase|Other than Specified|1|||
148807842|NCT04513366|536774460|FG001|Treatment Phase|Other than Specified|0|||
148807843|NCT04513366|536774461|FG002|Treatment Phase|Other than Specified|2|||
148807844|NCT04513366|536774459|FG000|Treatment Phase|Physician Decision|2|||
148807845|NCT04513366|536774460|FG001|Treatment Phase|Physician Decision|0|||
148807846|NCT04513366|536774461|FG002|Treatment Phase|Physician Decision|0|||
148807847|NCT04513366|536774459|FG000|Treatment Phase|Adverse Event|0|||
148807848|NCT04513366|536774460|FG001|Treatment Phase|Adverse Event|1|||
148807849|NCT04513366|536774461|FG002|Treatment Phase|Adverse Event|1|||
148807850|NCT04513366|536774459|FG000|Extension Phase|Withdrawal by Subject|3|||
148807851|NCT04513366|536774460|FG001|Extension Phase|Withdrawal by Subject|1|||
148807852|NCT04513366|536774461|FG002|Extension Phase|Withdrawal by Subject|1|||
148807853|NCT04513366|536774459|FG000|Extension Phase|Other than Specified|4|||
148807854|NCT04513366|536774460|FG001|Extension Phase|Other than Specified|0|||
148807855|NCT04513366|536774461|FG002|Extension Phase|Other than Specified|1|||
148807856|NCT04513366|536774459|FG000|Extension Phase|Lost to Follow-up|1|||
148807857|NCT04513366|536774460|FG001|Extension Phase|Lost to Follow-up|1|||
148807858|NCT04513366|536774461|FG002|Extension Phase|Lost to Follow-up|1|||
148807859|NCT04513366|536774459|FG000|Extension Phase|Sponsor Decision|0|||
148807860|NCT04513366|536774460|FG001|Extension Phase|Sponsor Decision|1|||
148807861|NCT04513366|536774461|FG002|Extension Phase|Sponsor Decision|0|||
148807862|NCT04513366|536774459|FG000|Extension Phase|Death|0|||
148807863|NCT04513366|536774460|FG001|Extension Phase|Death|1|||
148807864|NCT04513366|536774461|FG002|Extension Phase|Death|0|||
148937613|NCT00150709|537256723|FG001|Overall Study|Withdrawal by Subject|10|||
148937614|NCT00150709|537256724|FG002|Overall Study|Withdrawal by Subject|5|||
148937615|NCT00150709|537256725|FG003|Overall Study|Withdrawal by Subject|0|||
148937616|NCT00150709|537256722|FG000|Overall Study|Lost to Follow-up|3|||
148937617|NCT00150709|537256723|FG001|Overall Study|Lost to Follow-up|2|||
148937618|NCT00150709|537256724|FG002|Overall Study|Lost to Follow-up|0|||
148937619|NCT00150709|537256725|FG003|Overall Study|Lost to Follow-up|0|||
148937620|NCT00150709|537256722|FG000|Overall Study|Sponsor decision|0|||
148937621|NCT00150709|537256723|FG001|Overall Study|Sponsor decision|0|||
148937622|NCT00150709|537256724|FG002|Overall Study|Sponsor decision|0|||
148937623|NCT00150709|537256725|FG003|Overall Study|Sponsor decision|1|||
148937624|NCT00150709|537256722|FG000|Overall Study|Site/Investigator discontinued the study|5|||
148937625|NCT00150709|537256723|FG001|Overall Study|Site/Investigator discontinued the study|5|||
148937626|NCT00150709|537256724|FG002|Overall Study|Site/Investigator discontinued the study|2|||
148937627|NCT00150709|537256725|FG003|Overall Study|Site/Investigator discontinued the study|0|||
148937628|NCT00150709|537256722|FG000|Overall Study|Decision of parent(s)|1|||
148937629|NCT00150709|537256723|FG001|Overall Study|Decision of parent(s)|2|||
148937630|NCT00150709|537256724|FG002|Overall Study|Decision of parent(s)|0|||
148937631|NCT00150709|537256725|FG003|Overall Study|Decision of parent(s)|0|||
148937632|NCT00150709|537256722|FG000|Overall Study|Decision of parent(s) and investigator|3|||
148937633|NCT00150709|537256723|FG001|Overall Study|Decision of parent(s) and investigator|0|||
148937634|NCT00150709|537256724|FG002|Overall Study|Decision of parent(s) and investigator|0|||
148937635|NCT00150709|537256725|FG003|Overall Study|Decision of parent(s) and investigator|0|||
148937636|NCT00150709|537256722|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
148937637|NCT00150709|537256723|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
148937638|NCT00150709|537256724|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
148937639|NCT00150709|537256725|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
148937640|NCT00150709|537256722|FG000|Overall Study|Investigator decision|1|||
148937641|NCT00150709|537256723|FG001|Overall Study|Investigator decision|0|||
148937642|NCT00150709|537256724|FG002|Overall Study|Investigator decision|0|||
148937643|NCT00150709|537256725|FG003|Overall Study|Investigator decision|1|||
148937644|NCT00150709|537256722|FG000|Overall Study|Subject relocated|2|||
148937645|NCT00150709|537256723|FG001|Overall Study|Subject relocated|2|||
148937646|NCT00150709|537256724|FG002|Overall Study|Subject relocated|1|||
148937647|NCT00150709|537256725|FG003|Overall Study|Subject relocated|0|||
148937648|NCT00150709|537256722|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
148937649|NCT00150709|537256723|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
148937650|NCT00150709|537256724|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
148937651|NCT00150709|537256725|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
148937652|NCT00150709|537256722|FG000|Overall Study|Convenience|0|||
148937653|NCT00150709|537256723|FG001|Overall Study|Convenience|1|||
148937654|NCT00150709|537256724|FG002|Overall Study|Convenience|0|||
148937655|NCT00150709|537256725|FG003|Overall Study|Convenience|0|||
148937656|NCT00150709|537256722|FG000|Overall Study|Subject entered new drug study|0|||
148937657|NCT00150709|537256723|FG001|Overall Study|Subject entered new drug study|1|||
148937658|NCT00150709|537256724|FG002|Overall Study|Subject entered new drug study|0|||
148937659|NCT00150709|537256725|FG003|Overall Study|Subject entered new drug study|0|||
148937660|NCT00150709|537256722|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
148937661|NCT00150709|537256723|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
148937662|NCT00150709|537256724|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
148682165|NCT00272961|536309472|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
148682166|NCT00272961|536309468|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
148682167|NCT00272961|536309469|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
148682168|NCT00272961|536309470|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
148682169|NCT00272961|536309471|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
148682170|NCT00272961|536309472|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
148682171|NCT01507831|536309474|FG000|Overall Study|Randomized but not treated|0|||
148682172|NCT01507831|536309475|FG001|Overall Study|Randomized but not treated|3|||
148682173|NCT01507831|536309474|FG000|Overall Study|Adverse Event|48|||
148682174|NCT01507831|536309475|FG001|Overall Study|Adverse Event|113|||
148682175|NCT01507831|536309474|FG000|Overall Study|Death|6|||
148682176|NCT01507831|536309475|FG001|Overall Study|Death|2|||
148682177|NCT01507831|536309474|FG000|Overall Study|Poor compliance to protocol|38|||
148682178|NCT01507831|536309475|FG001|Overall Study|Poor compliance to protocol|60|||
148682179|NCT01507831|536309474|FG000|Overall Study|Physician Decision|0|||
148937663|NCT00150709|537256725|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
148937664|NCT00150709|537256722|FG000|Overall Study|Lack of ease of swallowing|0|||
148937665|NCT00150709|537256723|FG001|Overall Study|Lack of ease of swallowing|1|||
148937666|NCT00150709|537256724|FG002|Overall Study|Lack of ease of swallowing|0|||
148682180|NCT01507831|536309475|FG001|Overall Study|Physician Decision|4|||
148937667|NCT00150709|537256725|FG003|Overall Study|Lack of ease of swallowing|0|||
148937668|NCT04092582|537256726|FG000|Overall Study|Death|1|||
148937669|NCT04092582|537256727|FG001|Overall Study|Death|1|||
148937670|NCT04092582|537256726|FG000|Overall Study|Withdrawal by Subject|4|||
148937671|NCT04092582|537256727|FG001|Overall Study|Withdrawal by Subject|1|||
148937672|NCT04092582|537256726|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
148937673|NCT04092582|537256727|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
148937674|NCT01313858|537256738|FG000|Overall Study|Premature Treatment Termination|251|||
148937675|NCT01313858|537256739|FG001|Overall Study|Premature Treatment Termination|219|||
148937676|NCT01313858|537256740|FG002|Overall Study|Premature Treatment Termination|191|||
148937677|NCT01313858|537256738|FG000|Overall Study|Lost to Follow-up|35|||
148937678|NCT01313858|537256739|FG001|Overall Study|Lost to Follow-up|51|||
148937679|NCT01313858|537256740|FG002|Overall Study|Lost to Follow-up|47|||
148937680|NCT03689530|537256747|FG000|Overall Study|Withdrawal by Subject|53|||
148937681|NCT03689530|537256748|FG001|Overall Study|Withdrawal by Subject|16|||
148937682|NCT01392443|537256749|FG000|Overall Study|Disease progression|30|||
148937683|NCT01392443|537256749|FG000|Overall Study|Adverse Event|24|||
148937684|NCT01392443|537256749|FG000|Overall Study|Death|7|||
148937685|NCT01392443|537256749|FG000|Overall Study|Withdrawal by Subject|5|||
148937686|NCT01392443|537256749|FG000|Overall Study|Lost to Follow-up|1|||
148937687|NCT01392443|537256749|FG000|Overall Study|Protocol Violation|1|||
148937688|NCT01626456|537256764|FG000|Overall Study|Withdrawal by Subject|21|||
148937689|NCT01626456|537256765|FG001|Overall Study|Withdrawal by Subject|46|||
148937690|NCT01626456|537256764|FG000|Overall Study|Adverse Event|2|||
148937691|NCT01626456|537256765|FG001|Overall Study|Adverse Event|27|||
148937692|NCT01626456|537256764|FG000|Overall Study|Lost to Follow-up|2|||
148937693|NCT01626456|537256765|FG001|Overall Study|Lost to Follow-up|27|||
148937694|NCT01626456|537256764|FG000|Overall Study|Lack of Efficacy|6|||
148937695|NCT01626456|537256765|FG001|Overall Study|Lack of Efficacy|7|||
148937696|NCT01626456|537256764|FG000|Overall Study|Physician Decision|1|||
148937697|NCT01626456|537256765|FG001|Overall Study|Physician Decision|4|||
148937698|NCT01626456|537256764|FG000|Overall Study|Protocol Violation|1|||
148937699|NCT01626456|537256765|FG001|Overall Study|Protocol Violation|1|||
148937700|NCT01626456|537256764|FG000|Overall Study|Site Closure|2|||
148937701|NCT01626456|537256765|FG001|Overall Study|Site Closure|3|||
148937702|NCT01626456|537256764|FG000|Overall Study|Incarceration|0|||
148937703|NCT01626456|537256765|FG001|Overall Study|Incarceration|2|||
148937704|NCT01816074|537256766|FG000|Phase 1|Time commitment issues|0|||
148937705|NCT01816074|537256767|FG001|Phase 1|Time commitment issues|0|||
148937706|NCT01816074|537256768|FG002|Phase 1|Time commitment issues|1|||
148937707|NCT01816074|537256769|FG003|Phase 1|Time commitment issues|0|||
148937708|NCT01816074|537256766|FG000|Phase 2|Time commitment Issues|0|||
148937709|NCT01816074|537256767|FG001|Phase 2|Time commitment Issues|2|||
148937710|NCT01816074|537256768|FG002|Phase 2|Time commitment Issues|0|||
148937711|NCT01816074|537256769|FG003|Phase 2|Time commitment Issues|0|||
148937712|NCT01816074|537256766|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
148937713|NCT01816074|537256767|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
148937714|NCT01816074|537256768|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
148937715|NCT01816074|537256769|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
148937716|NCT01816074|537256766|FG000|Phase 2|Physician Decision|0|||
148937717|NCT01816074|537256767|FG001|Phase 2|Physician Decision|0|||
148937718|NCT01816074|537256768|FG002|Phase 2|Physician Decision|0|||
148937719|NCT01816074|537256769|FG003|Phase 2|Physician Decision|1|||
148937720|NCT01816074|537256766|FG000|Phase 2|Withdrawal by Subject|1|||
148937721|NCT01816074|537256767|FG001|Phase 2|Withdrawal by Subject|0|||
148937722|NCT01816074|537256768|FG002|Phase 2|Withdrawal by Subject|0|||
148937723|NCT01816074|537256769|FG003|Phase 2|Withdrawal by Subject|0|||
148937724|NCT01303861|537256783|FG000|Overall Study|Lost to Follow-up|34|||
148937725|NCT01303861|537256784|FG001|Overall Study|Lost to Follow-up|14|||
148937726|NCT01303861|537256785|FG002|Overall Study|Lost to Follow-up|27|||
148937727|NCT01303861|537256786|FG003|Overall Study|Lost to Follow-up|31|||
148937728|NCT01303861|537256783|FG000|Overall Study|Lack of Efficacy|3|||
148937729|NCT01303861|537256784|FG001|Overall Study|Lack of Efficacy|2|||
148937730|NCT01303861|537256785|FG002|Overall Study|Lack of Efficacy|1|||
148937731|NCT01303861|537256786|FG003|Overall Study|Lack of Efficacy|0|||
148937732|NCT01303861|537256783|FG000|Overall Study|Withdrawal by Subject|16|||
148937733|NCT01303861|537256784|FG001|Overall Study|Withdrawal by Subject|8|||
148807865|NCT04513366|536774459|FG000|Extension Phase|Adverse Event|0|||
148807866|NCT04513366|536774460|FG001|Extension Phase|Adverse Event|0|||
148807867|NCT04513366|536774461|FG002|Extension Phase|Adverse Event|1|||
148807868|NCT01316575|536774463|FG000|Overall Study|Withdrawal by Subject|2|||
148937734|NCT01303861|537256785|FG002|Overall Study|Withdrawal by Subject|8|||
148937735|NCT01303861|537256786|FG003|Overall Study|Withdrawal by Subject|23|||
148937736|NCT01303861|537256783|FG000|Overall Study|Adverse Event|4|||
148937737|NCT01303861|537256784|FG001|Overall Study|Adverse Event|1|||
148937738|NCT01303861|537256785|FG002|Overall Study|Adverse Event|0|||
148807869|NCT01316575|536774464|FG001|Overall Study|Withdrawal by Subject|0|||
148937739|NCT01303861|537256786|FG003|Overall Study|Adverse Event|5|||
148937740|NCT01303861|537256783|FG000|Overall Study|Pregnancy|1|||
148937741|NCT01303861|537256784|FG001|Overall Study|Pregnancy|0|||
148937742|NCT01303861|537256785|FG002|Overall Study|Pregnancy|0|||
148937743|NCT01303861|537256786|FG003|Overall Study|Pregnancy|0|||
148937744|NCT03270644|537256790|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
148937745|NCT03270644|537256790|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
148937746|NCT01868503|537256791|FG000|Overall Study|Withdrawal by Subject|1|||
148937747|NCT01868503|537256791|FG000|Overall Study|Protocol Violation|1|||
148937748|NCT03917459|537256796|FG000|Overall Study|Adverse Event|1|||
148937749|NCT03917459|537256797|FG001|Overall Study|Adverse Event|0|||
148937750|NCT03917459|537256796|FG000|Overall Study|Withdrawal by Subject|0|||
148937751|NCT03917459|537256797|FG001|Overall Study|Withdrawal by Subject|1|||
148937752|NCT00736944|537256798|FG000|Induction|Death|1|||
148937753|NCT00736944|537256798|FG000|Definitive Treatment|Physician Decision|1|||
148937754|NCT01426438|537256799|FG000|Overall Study|Lost to Follow-up|1|||
148937755|NCT01426438|537256800|FG001|Overall Study|Lost to Follow-up|3|||
148937756|NCT01426438|537256799|FG000|Overall Study|Off study Treatment|9|||
148937757|NCT01426438|537256800|FG001|Overall Study|Off study Treatment|3|||
148937758|NCT01426438|537256799|FG000|Overall Study|Poor scan quality|3|||
148937759|NCT01426438|537256800|FG001|Overall Study|Poor scan quality|2|||
148937760|NCT01426438|537256799|FG000|Overall Study|Missed Scan|2|||
148937761|NCT01426438|537256800|FG001|Overall Study|Missed Scan|2|||
148937762|NCT01500031|537256803|FG000|Overall Study|Death|1|||
148937763|NCT01500031|537256803|FG000|Overall Study|Withdrawal by Subject|4|||
148937764|NCT03643575|537256804|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
148937765|NCT03643575|537256805|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
148937766|NCT03643575|537256806|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
148937767|NCT03643575|537256807|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
148937768|NCT03643575|537256808|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
148937769|NCT03643575|537256809|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
148937770|NCT03643575|537256804|FG000|Washout: 7 Days|Adverse Event|1|||
148937771|NCT03643575|537256805|FG001|Washout: 7 Days|Adverse Event|0|||
148937772|NCT03643575|537256806|FG002|Washout: 7 Days|Adverse Event|0|||
148937773|NCT03643575|537256807|FG003|Washout: 7 Days|Adverse Event|0|||
148937774|NCT03643575|537256808|FG004|Washout: 7 Days|Adverse Event|0|||
148937775|NCT03643575|537256809|FG005|Washout: 7 Days|Adverse Event|0|||
148937776|NCT03643575|537256804|FG000|Washout: 7 Days|Non compliance check in|0|||
148937777|NCT03643575|537256805|FG001|Washout: 7 Days|Non compliance check in|1|||
148937778|NCT03643575|537256806|FG002|Washout: 7 Days|Non compliance check in|0|||
148937779|NCT03643575|537256807|FG003|Washout: 7 Days|Non compliance check in|0|||
148937780|NCT03643575|537256808|FG004|Washout: 7 Days|Non compliance check in|0|||
148937781|NCT03643575|537256809|FG005|Washout: 7 Days|Non compliance check in|0|||
148937782|NCT01330030|537256810|FG000|Overall Study|Lost to Follow-up|16|||
148937783|NCT01330030|537256811|FG001|Overall Study|Lost to Follow-up|17|||
148937784|NCT00845858|537256812|FG000|Overall Study|Withdrawal by Subject|5|||
148937785|NCT00845858|537256813|FG001|Overall Study|Withdrawal by Subject|1|||
148937786|NCT00845858|537256814|FG002|Overall Study|Withdrawal by Subject|1|||
148937787|NCT00845858|537256812|FG000|Overall Study|Adverse Event|3|||
148937788|NCT00845858|537256813|FG001|Overall Study|Adverse Event|8|||
148937789|NCT00845858|537256814|FG002|Overall Study|Adverse Event|4|||
148937790|NCT00845858|537256812|FG000|Overall Study|Protocol Violation|0|||
148937791|NCT00845858|537256813|FG001|Overall Study|Protocol Violation|0|||
148937792|NCT00845858|537256814|FG002|Overall Study|Protocol Violation|1|||
148937793|NCT00845858|537256812|FG000|Overall Study|not eligible|0|||
148937794|NCT00845858|537256813|FG001|Overall Study|not eligible|3|||
148937795|NCT00845858|537256814|FG002|Overall Study|not eligible|2|||
148937796|NCT02980783|537256815|FG000|Overall Study|Lost to Follow-up|1|||
148937797|NCT05047770|537256816|FG000|Overall Study|Withdrawal by Subject|15|||
148937798|NCT05047770|537256817|FG001|Overall Study|Withdrawal by Subject|10|||
148937799|NCT05047770|537256818|FG002|Overall Study|Withdrawal by Subject|6|||
148937800|NCT05047770|537256819|FG003|Overall Study|Withdrawal by Subject|12|||
148937801|NCT05047770|537256816|FG000|Overall Study|Lost to Follow-up|7|||
148937802|NCT05047770|537256817|FG001|Overall Study|Lost to Follow-up|5|||
148937803|NCT05047770|537256818|FG002|Overall Study|Lost to Follow-up|12|||
148937804|NCT05047770|537256819|FG003|Overall Study|Lost to Follow-up|13|||
148682181|NCT01507831|536309474|FG000|Overall Study|Participant moved|5|||
148682182|NCT01507831|536309475|FG001|Overall Study|Participant moved|19|||
148682183|NCT01507831|536309474|FG000|Overall Study|Consent withdrawn by participant|34|||
149195670|NCT03442829|538185094|FG000|Overall Study|Illness unrelated to study|1|||
149195671|NCT03442829|538185095|FG001|Overall Study|Illness unrelated to study|1|||
149195672|NCT01486784|538185096|FG000|Overall Study|Withdrawal by Subject|0|||
148682184|NCT01507831|536309475|FG001|Overall Study|Consent withdrawn by participant|72|||
148937805|NCT05047770|537256816|FG000|Overall Study|Other|1|||
148937806|NCT05047770|537256817|FG001|Overall Study|Other|0|||
148937807|NCT05047770|537256818|FG002|Overall Study|Other|1|||
148937808|NCT05047770|537256819|FG003|Overall Study|Other|0|||
148937809|NCT03758443|537256820|FG000|Induction Period|Adverse Event|2|||
148937810|NCT03758443|537256821|FG001|Induction Period|Adverse Event|4|||
148937811|NCT03758443|537256822|FG002|Induction Period|Adverse Event|2|||
148937812|NCT03758443|537256823|FG003|Induction Period|Adverse Event|3|||
148937813|NCT03758443|537256820|FG000|Induction Period|Physician Decision|1|||
148937814|NCT03758443|537256821|FG001|Induction Period|Physician Decision|1|||
148937815|NCT03758443|537256822|FG002|Induction Period|Physician Decision|3|||
148937816|NCT03758443|537256823|FG003|Induction Period|Physician Decision|0|||
148937817|NCT03758443|537256820|FG000|Induction Period|Protocol Violation|0|||
148937818|NCT03758443|537256821|FG001|Induction Period|Protocol Violation|0|||
148937819|NCT03758443|537256822|FG002|Induction Period|Protocol Violation|0|||
148937820|NCT03758443|537256823|FG003|Induction Period|Protocol Violation|1|||
148937821|NCT03758443|537256820|FG000|Induction Period|Withdrawal by Subject|3|||
148937822|NCT03758443|537256821|FG001|Induction Period|Withdrawal by Subject|2|||
148937823|NCT03758443|537256822|FG002|Induction Period|Withdrawal by Subject|2|||
148937824|NCT03758443|537256823|FG003|Induction Period|Withdrawal by Subject|4|||
148937825|NCT03758443|537256820|FG000|Extended Induction Period|Adverse Event|1|||
148937826|NCT03758443|537256821|FG001|Extended Induction Period|Adverse Event|1|||
148937827|NCT03758443|537256822|FG002|Extended Induction Period|Adverse Event|0|||
148937828|NCT03758443|537256823|FG003|Extended Induction Period|Adverse Event|1|||
148937829|NCT03758443|537256820|FG000|Extended Induction Period|Lost to Follow-up|1|||
148937830|NCT03758443|537256821|FG001|Extended Induction Period|Lost to Follow-up|0|||
148937831|NCT03758443|537256822|FG002|Extended Induction Period|Lost to Follow-up|0|||
148937832|NCT03758443|537256823|FG003|Extended Induction Period|Lost to Follow-up|0|||
148937833|NCT03758443|537256820|FG000|Extended Induction Period|Physician Decision|2|||
148937834|NCT03758443|537256821|FG001|Extended Induction Period|Physician Decision|1|||
148937835|NCT03758443|537256822|FG002|Extended Induction Period|Physician Decision|2|||
148937836|NCT03758443|537256823|FG003|Extended Induction Period|Physician Decision|2|||
148937837|NCT03758443|537256820|FG000|Extended Induction Period|Protocol Violation|0|||
148937838|NCT03758443|537256821|FG001|Extended Induction Period|Protocol Violation|0|||
148937839|NCT03758443|537256822|FG002|Extended Induction Period|Protocol Violation|0|||
148937840|NCT03758443|537256823|FG003|Extended Induction Period|Protocol Violation|1|||
148937841|NCT03758443|537256820|FG000|Extended Induction Period|Withdrawal by Subject|8|||
148937842|NCT03758443|537256821|FG001|Extended Induction Period|Withdrawal by Subject|1|||
148937843|NCT03758443|537256822|FG002|Extended Induction Period|Withdrawal by Subject|7|||
148937844|NCT03758443|537256823|FG003|Extended Induction Period|Withdrawal by Subject|3|||
148937845|NCT03758443|537256820|FG000|Extended Induction Period|Miscellaneous|1|||
148937846|NCT03758443|537256821|FG001|Extended Induction Period|Miscellaneous|0|||
148937847|NCT03758443|537256822|FG002|Extended Induction Period|Miscellaneous|0|||
148937848|NCT03758443|537256823|FG003|Extended Induction Period|Miscellaneous|0|||
148937849|NCT03758443|537256820|FG000|Maintenance Period|Adverse Event|1|||
148937850|NCT03758443|537256821|FG001|Maintenance Period|Adverse Event|2|||
148937851|NCT03758443|537256822|FG002|Maintenance Period|Adverse Event|0|||
148937852|NCT03758443|537256823|FG003|Maintenance Period|Adverse Event|0|||
148937853|NCT03758443|537256820|FG000|Maintenance Period|Lost to Follow-up|0|||
148937854|NCT03758443|537256821|FG001|Maintenance Period|Lost to Follow-up|0|||
148937855|NCT03758443|537256822|FG002|Maintenance Period|Lost to Follow-up|0|||
148937856|NCT03758443|537256823|FG003|Maintenance Period|Lost to Follow-up|1|||
148937857|NCT03758443|537256820|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
148937858|NCT03758443|537256821|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
148937859|NCT03758443|537256822|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
148937860|NCT03758443|537256823|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
148937861|NCT03758443|537256820|FG000|Maintenance Period|Protocol Violation|0|||
148937862|NCT03758443|537256821|FG001|Maintenance Period|Protocol Violation|1|||
148937863|NCT03758443|537256822|FG002|Maintenance Period|Protocol Violation|0|||
148937864|NCT03758443|537256823|FG003|Maintenance Period|Protocol Violation|0|||
148937865|NCT03758443|537256820|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
148937866|NCT03758443|537256821|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
148937867|NCT03758443|537256822|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
148937868|NCT03758443|537256823|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
148937869|NCT03758443|537256820|FG000|Maintenance Period|Withdrawal by Subject|1|||
148937870|NCT03758443|537256821|FG001|Maintenance Period|Withdrawal by Subject|0|||
148937871|NCT03758443|537256822|FG002|Maintenance Period|Withdrawal by Subject|1|||
149195673|NCT01486784|538185097|FG001|Overall Study|Withdrawal by Subject|0|||
148682185|NCT01507831|536309474|FG000|Overall Study|Related to study drug administration|5|||
148937872|NCT03758443|537256823|FG003|Maintenance Period|Withdrawal by Subject|1|||
148937873|NCT03758443|537256820|FG000|Maintenance Period|Miscellaneous|0|||
148937874|NCT03758443|537256821|FG001|Maintenance Period|Miscellaneous|0|||
148937875|NCT03758443|537256822|FG002|Maintenance Period|Miscellaneous|1|||
148937876|NCT03758443|537256823|FG003|Maintenance Period|Miscellaneous|0|||
148937877|NCT05224141|537256824|FG000|Overall Study|Ongoing|75|||
148937878|NCT05224141|537256825|FG001|Overall Study|Ongoing|88|||
148937879|NCT05224141|537256824|FG000|Overall Study|Withdrawal by Subject|2|||
148937880|NCT05224141|537256825|FG001|Overall Study|Withdrawal by Subject|4|||
148937881|NCT05224141|537256824|FG000|Overall Study|Death|153|||
148937882|NCT05224141|537256825|FG001|Overall Study|Death|138|||
148937883|NCT01691898|537256831|FG000|Overall Study|Death|34|||
148937884|NCT01691898|537256832|FG001|Overall Study|Death|32|||
148937885|NCT01691898|537256833|FG002|Overall Study|Death|6|||
148937886|NCT01691898|537256834|FG003|Overall Study|Death|3|||
148937887|NCT01691898|537256835|FG004|Overall Study|Death|8|||
148937888|NCT01691898|537256836|FG005|Overall Study|Death|31|||
148937889|NCT01691898|537256831|FG000|Overall Study|Adverse Event|0|||
148937890|NCT01691898|537256832|FG001|Overall Study|Adverse Event|1|||
148937891|NCT01691898|537256833|FG002|Overall Study|Adverse Event|0|||
148937892|NCT01691898|537256834|FG003|Overall Study|Adverse Event|1|||
148937893|NCT01691898|537256835|FG004|Overall Study|Adverse Event|1|||
148937894|NCT01691898|537256836|FG005|Overall Study|Adverse Event|0|||
148937895|NCT01691898|537256831|FG000|Overall Study|Progression of Disease|1|||
148937896|NCT01691898|537256832|FG001|Overall Study|Progression of Disease|2|||
148937897|NCT01691898|537256833|FG002|Overall Study|Progression of Disease|1|||
148937898|NCT01691898|537256834|FG003|Overall Study|Progression of Disease|0|||
148937899|NCT01691898|537256835|FG004|Overall Study|Progression of Disease|0|||
148937900|NCT01691898|537256836|FG005|Overall Study|Progression of Disease|1|||
148937901|NCT01691898|537256831|FG000|Overall Study|Lost to Follow-up|3|||
148937902|NCT01691898|537256832|FG001|Overall Study|Lost to Follow-up|1|||
148937903|NCT01691898|537256833|FG002|Overall Study|Lost to Follow-up|0|||
148937904|NCT01691898|537256834|FG003|Overall Study|Lost to Follow-up|0|||
148937905|NCT01691898|537256835|FG004|Overall Study|Lost to Follow-up|1|||
148937906|NCT01691898|537256836|FG005|Overall Study|Lost to Follow-up|0|||
148937907|NCT01691898|537256831|FG000|Overall Study|Withdrawal by Subject|9|||
148937908|NCT01691898|537256832|FG001|Overall Study|Withdrawal by Subject|8|||
148937909|NCT01691898|537256833|FG002|Overall Study|Withdrawal by Subject|2|||
148937910|NCT01691898|537256834|FG003|Overall Study|Withdrawal by Subject|1|||
148937911|NCT01691898|537256835|FG004|Overall Study|Withdrawal by Subject|3|||
148937912|NCT01691898|537256836|FG005|Overall Study|Withdrawal by Subject|3|||
148937913|NCT01691898|537256831|FG000|Overall Study|Non-Compliance|0|||
148937914|NCT01691898|537256832|FG001|Overall Study|Non-Compliance|0|||
148937915|NCT01691898|537256833|FG002|Overall Study|Non-Compliance|0|||
148937916|NCT01691898|537256834|FG003|Overall Study|Non-Compliance|0|||
148937917|NCT01691898|537256835|FG004|Overall Study|Non-Compliance|1|||
148937918|NCT01691898|537256836|FG005|Overall Study|Non-Compliance|0|||
148937919|NCT01013350|537256837|FG000|Overall Study|Lost to Follow-up|15|||
148937920|NCT01013350|537256838|FG001|Overall Study|Lost to Follow-up|95|||
148937921|NCT01013350|537256837|FG000|Overall Study|Adverse Event|0|||
148937922|NCT01013350|537256838|FG001|Overall Study|Adverse Event|1|||
148937923|NCT01013350|537256837|FG000|Overall Study|Physician Decision|4|||
148937924|NCT01013350|537256838|FG001|Overall Study|Physician Decision|20|||
148937925|NCT01013350|537256837|FG000|Overall Study|Withdrawal by Subject|15|||
148937926|NCT01013350|537256838|FG001|Overall Study|Withdrawal by Subject|38|||
148937927|NCT01013350|537256837|FG000|Overall Study|Death|3|||
148937928|NCT01013350|537256838|FG001|Overall Study|Death|5|||
148937929|NCT01013350|537256837|FG000|Overall Study|Participant entered interventional study|0|||
148937930|NCT01013350|537256838|FG001|Overall Study|Participant entered interventional study|8|||
148937931|NCT01013350|537256837|FG000|Overall Study|Other|1|||
148682186|NCT01507831|536309475|FG001|Overall Study|Related to study drug administration|14|||
148682187|NCT01507831|536309474|FG000|Overall Study|Last visit outside protocol visit window|51|||
148682188|NCT01507831|536309475|FG001|Overall Study|Last visit outside protocol visit window|143|||
148682189|NCT01507831|536309474|FG000|Overall Study|Selection criteria finally not met|0|||
148682190|NCT01507831|536309475|FG001|Overall Study|Selection criteria finally not met|1|||
148682191|NCT01507831|536309474|FG000|Overall Study|Site closure|0|||
148682192|NCT01507831|536309475|FG001|Overall Study|Site closure|3|||
148682193|NCT01507831|536309474|FG000|Overall Study|Potential lost to follow-up|3|||
148682194|NCT01507831|536309475|FG001|Overall Study|Potential lost to follow-up|0|||
148682195|NCT01507831|536309474|FG000|Overall Study|Other|3|||
148682196|NCT01507831|536309475|FG001|Overall Study|Other|6|||
148682197|NCT01252238|536309476|FG000|Overall Study|Sponsor terminated study|4|||
148682198|NCT01252238|536309477|FG001|Overall Study|Sponsor terminated study|4|||
148682199|NCT01252238|536309478|FG002|Overall Study|Sponsor terminated study|4|||
148682200|NCT00068237|536309479|FG000|Overall Study|Ineligible|3|||
148682201|NCT00068237|536309479|FG000|Overall Study|No protocol treatment received|2|||
148682202|NCT02475980|536309488|FG000|Overall Study|Lost to Follow-up|4|||
148937932|NCT01013350|537256838|FG001|Overall Study|Other|25|||
148937933|NCT02019277|537256839|FG000|Overall Study|Withdrawal by Subject|3|||
148682203|NCT02475980|536309488|FG000|Overall Study|Withdrawal by Subject|1|||
148682204|NCT00990093|536309489|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
148937934|NCT02019277|537256839|FG000|Overall Study|Death|7|||
148937935|NCT02019277|537256839|FG000|Overall Study|Did no Cooperate|1|||
148937936|NCT02019277|537256839|FG000|Overall Study|Adverse Event|1|||
148937937|NCT04738734|537256840|FG000|Overall Study|Withdrawal by Subject|2|||
148937938|NCT04738734|537256841|FG001|Overall Study|Withdrawal by Subject|4|||
148937939|NCT04738734|537256840|FG000|Overall Study|Lost to Follow-up|5|||
148937940|NCT04738734|537256841|FG001|Overall Study|Lost to Follow-up|2|||
148937941|NCT04738734|537256840|FG000|Overall Study|Physician Decision|0|||
148937942|NCT04738734|537256841|FG001|Overall Study|Physician Decision|1|||
148682205|NCT00990093|536309490|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
148937943|NCT04738734|537256840|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
148937944|NCT04738734|537256841|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
148807870|NCT01316575|536774463|FG000|Overall Study|Required alternate treatment|0|||
148807871|NCT01316575|536774464|FG001|Overall Study|Required alternate treatment|1|||
148807872|NCT00402831|536774465|FG000|Overall Study|Lost to Follow-up|1|||
148807873|NCT00402831|536774466|FG001|Overall Study|Lost to Follow-up|2|||
148807874|NCT00402831|536774465|FG000|Overall Study|Non-compliance with protocol|0|||
148807875|NCT00402831|536774466|FG001|Overall Study|Non-compliance with protocol|1|||
148807876|NCT04585893|536774469|FG000|Overall Study|Death|1|||
148937945|NCT03212690|537256844|FG000|Overall Study|Protocol Violation|1|||
148937946|NCT01297920|537256845|FG000|Overall Study|Adverse Event|42|||
148937947|NCT01297920|537256846|FG001|Overall Study|Adverse Event|10|||
148937948|NCT01297920|537256847|FG002|Overall Study|Adverse Event|38|||
148937949|NCT01297920|537256845|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
148937950|NCT01297920|537256846|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
148937951|NCT01297920|537256847|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
148937952|NCT01297920|537256845|FG000|Overall Study|Noncompliance|1|||
148937953|NCT01297920|537256846|FG001|Overall Study|Noncompliance|0|||
148937954|NCT01297920|537256847|FG002|Overall Study|Noncompliance|0|||
148937955|NCT01297920|537256845|FG000|Overall Study|Protocol Violation|1|||
148937956|NCT01297920|537256846|FG001|Overall Study|Protocol Violation|3|||
148937957|NCT01297920|537256847|FG002|Overall Study|Protocol Violation|0|||
148937958|NCT01297920|537256845|FG000|Overall Study|Inadequate Control of IOP|7|||
148937959|NCT01297920|537256846|FG001|Overall Study|Inadequate Control of IOP|9|||
148937960|NCT01297920|537256847|FG002|Overall Study|Inadequate Control of IOP|17|||
148937961|NCT01297920|537256845|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
148937962|NCT01297920|537256846|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
148937963|NCT01297920|537256847|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
148937964|NCT00474760|537256848|FG000|Overall Study|Death|0|||
148937965|NCT00474760|537256849|FG001|Overall Study|Death|0|||
148937966|NCT00474760|537256850|FG002|Overall Study|Death|0|||
148937967|NCT00474760|537256851|FG003|Overall Study|Death|0|||
148937968|NCT00474760|537256852|FG004|Overall Study|Death|2|||
148937969|NCT00474760|537256853|FG005|Overall Study|Death|0|||
148937970|NCT00474760|537256854|FG006|Overall Study|Death|0|||
148937971|NCT00474760|537256848|FG000|Overall Study|Adverse Event|0|||
148937972|NCT00474760|537256849|FG001|Overall Study|Adverse Event|0|||
148937973|NCT00474760|537256850|FG002|Overall Study|Adverse Event|0|||
148937974|NCT00474760|537256851|FG003|Overall Study|Adverse Event|0|||
148937975|NCT00474760|537256852|FG004|Overall Study|Adverse Event|1|||
148937976|NCT00474760|537256853|FG005|Overall Study|Adverse Event|7|||
148937977|NCT00474760|537256854|FG006|Overall Study|Adverse Event|0|||
148937978|NCT00474760|537256848|FG000|Overall Study|Laboratory abnormality|0|||
148937979|NCT00474760|537256849|FG001|Overall Study|Laboratory abnormality|0|||
148937980|NCT00474760|537256850|FG002|Overall Study|Laboratory abnormality|0|||
148937981|NCT00474760|537256851|FG003|Overall Study|Laboratory abnormality|0|||
148937982|NCT00474760|537256852|FG004|Overall Study|Laboratory abnormality|0|||
148937983|NCT00474760|537256853|FG005|Overall Study|Laboratory abnormality|1|||
148937984|NCT00474760|537256854|FG006|Overall Study|Laboratory abnormality|0|||
148937985|NCT00474760|537256848|FG000|Overall Study|Withdrawal by Subject|0|||
148937986|NCT00474760|537256849|FG001|Overall Study|Withdrawal by Subject|0|||
148937987|NCT00474760|537256850|FG002|Overall Study|Withdrawal by Subject|0|||
148937988|NCT00474760|537256851|FG003|Overall Study|Withdrawal by Subject|1|||
149015144|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
149015145|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
149015146|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
149015147|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
148682206|NCT00990093|536309489|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
148682207|NCT00990093|536309490|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
148682208|NCT00990093|536309489|FG000|Test Period 1 (1-14 Days)|Other|1|||
148682209|NCT00990093|536309490|FG001|Test Period 1 (1-14 Days)|Other|0|||
148682210|NCT00990093|536309489|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
148682211|NCT00990093|536309490|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
148682212|NCT00990093|536309489|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
148682213|NCT00990093|536309490|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
148682214|NCT00990093|536309489|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
148937989|NCT00474760|537256852|FG004|Overall Study|Withdrawal by Subject|0|||
148937990|NCT00474760|537256853|FG005|Overall Study|Withdrawal by Subject|1|||
148937991|NCT00474760|537256854|FG006|Overall Study|Withdrawal by Subject|1|||
148937992|NCT00474760|537256848|FG000|Overall Study|Other|0|||
148937993|NCT00474760|537256849|FG001|Overall Study|Other|1|||
148937994|NCT00474760|537256850|FG002|Overall Study|Other|0|||
148937995|NCT00474760|537256851|FG003|Overall Study|Other|0|||
148937996|NCT00474760|537256852|FG004|Overall Study|Other|1|||
148937997|NCT00474760|537256853|FG005|Overall Study|Other|0|||
148682215|NCT00990093|536309490|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
148682216|NCT00990093|536309489|FG000|Test Period 2 (15-28 Days)|Other|0|||
148682217|NCT00990093|536309490|FG001|Test Period 2 (15-28 Days)|Other|1|||
148807877|NCT04585893|536774470|FG001|Overall Study|Death|0|||
148937998|NCT00474760|537256854|FG006|Overall Study|Other|0|||
148937999|NCT00474760|537256848|FG000|Overall Study|Progressive disease|3|||
148938000|NCT00474760|537256849|FG001|Overall Study|Progressive disease|2|||
148938001|NCT00474760|537256850|FG002|Overall Study|Progressive disease|3|||
148938002|NCT00474760|537256851|FG003|Overall Study|Progressive disease|2|||
148938003|NCT00474760|537256852|FG004|Overall Study|Progressive disease|8|||
148938004|NCT00474760|537256853|FG005|Overall Study|Progressive disease|20|||
148938005|NCT00474760|537256854|FG006|Overall Study|Progressive disease|7|||
148938006|NCT00474760|537256848|FG000|Overall Study|Terminated by sponsor|0|||
148938007|NCT00474760|537256849|FG001|Overall Study|Terminated by sponsor|0|||
148938008|NCT00474760|537256850|FG002|Overall Study|Terminated by sponsor|0|||
148938009|NCT00474760|537256851|FG003|Overall Study|Terminated by sponsor|0|||
148938010|NCT00474760|537256852|FG004|Overall Study|Terminated by sponsor|0|||
148938011|NCT00474760|537256853|FG005|Overall Study|Terminated by sponsor|0|||
148938012|NCT00474760|537256854|FG006|Overall Study|Terminated by sponsor|2|||
148938013|NCT01927627|537256855|FG000|Overall Study|Adverse Event|3|||
148938014|NCT01927627|537256855|FG000|Overall Study|Lack of Efficacy|1|||
148938015|NCT01927627|537256855|FG000|Overall Study|Financial Concerns|1|||
148938016|NCT00910273|537256856|FG000|Overall Study|Lack of Efficacy|6|||
148938017|NCT00910273|537256857|FG001|Overall Study|Lack of Efficacy|9|||
148938018|NCT00910273|537256856|FG000|Overall Study|Adverse Event|1|||
148938019|NCT00910273|537256857|FG001|Overall Study|Adverse Event|1|||
148938020|NCT00910273|537256856|FG000|Overall Study|Withdrawal by Subject|1|||
148938021|NCT00910273|537256857|FG001|Overall Study|Withdrawal by Subject|0|||
148938022|NCT00910273|537256856|FG000|Overall Study|Discontinuation of study by sponsor|8|||
148938023|NCT00910273|537256857|FG001|Overall Study|Discontinuation of study by sponsor|2|||
148938024|NCT00910273|537256856|FG000|Overall Study|Protocol Violation|1|||
148938025|NCT00910273|537256857|FG001|Overall Study|Protocol Violation|0|||
148938026|NCT00910273|537256856|FG000|Overall Study|Lost to Follow-up|1|||
148938027|NCT00910273|537256857|FG001|Overall Study|Lost to Follow-up|1|||
148938028|NCT00338104|537256860|FG000|Overall Study|Protocol Violation|2|||
148938029|NCT00338104|537256861|FG001|Overall Study|Protocol Violation|1|||
148938030|NCT00338104|537256862|FG002|Overall Study|Protocol Violation|3|||
148938031|NCT00633750|537256863|FG000|Overall Study|Adverse Event|2|||
148938032|NCT00633750|537256863|FG000|Overall Study|Withdrawal by Subject|3|||
148938033|NCT02362269|537256866|FG000|Overall Study|Moved|1|||
148938034|NCT02362269|537256867|FG001|Overall Study|Moved|0|||
148938035|NCT02362269|537256866|FG000|Overall Study|Lost to Follow-up|0|||
148938036|NCT02362269|537256867|FG001|Overall Study|Lost to Follow-up|6|||
148938037|NCT00423514|537256868|FG000|Overall Study|Ineligible|1|||
148938038|NCT00423514|537256869|FG001|Overall Study|Ineligible|0|||
148938039|NCT01361568|537256874|FG000|Overall Study|Adverse Event|0|||
148938040|NCT01361568|537256875|FG001|Overall Study|Adverse Event|0|||
148938041|NCT01361568|537256876|FG002|Overall Study|Adverse Event|0|||
148938042|NCT01361568|537256877|FG003|Overall Study|Adverse Event|0|||
148938043|NCT01361568|537256878|FG004|Overall Study|Adverse Event|1|||
148938044|NCT01361568|537256879|FG005|Overall Study|Adverse Event|0|||
148938045|NCT01361568|537256874|FG000|Overall Study|Physician Decision|0|||
148938046|NCT01361568|537256875|FG001|Overall Study|Physician Decision|0|||
148938047|NCT01361568|537256876|FG002|Overall Study|Physician Decision|0|||
148938048|NCT01361568|537256877|FG003|Overall Study|Physician Decision|0|||
148938049|NCT01361568|537256878|FG004|Overall Study|Physician Decision|0|||
148938050|NCT01361568|537256879|FG005|Overall Study|Physician Decision|1|||
148938051|NCT01361568|537256874|FG000|Overall Study|Withdrawal by Subject|2|||
148938052|NCT01361568|537256875|FG001|Overall Study|Withdrawal by Subject|1|||
148938053|NCT01361568|537256876|FG002|Overall Study|Withdrawal by Subject|0|||
148938054|NCT01361568|537256877|FG003|Overall Study|Withdrawal by Subject|0|||
148938055|NCT01361568|537256878|FG004|Overall Study|Withdrawal by Subject|0|||
148938056|NCT01361568|537256879|FG005|Overall Study|Withdrawal by Subject|1|||
148938057|NCT01254630|537256880|FG000|Overall Study|Adverse Event|36|||
148938058|NCT01254630|537256881|FG001|Overall Study|Adverse Event|15|||
148938059|NCT01254630|537256882|FG002|Overall Study|Adverse Event|40|||
148938060|NCT01254630|537256883|FG003|Overall Study|Adverse Event|8|||
148938061|NCT01254630|537256880|FG000|Overall Study|Death|461|||
148938062|NCT01254630|537256881|FG001|Overall Study|Death|151|||
148938063|NCT01254630|537256882|FG002|Overall Study|Death|478|||
148938064|NCT01254630|537256883|FG003|Overall Study|Death|139|||
148938065|NCT01254630|537256880|FG000|Overall Study|Lost to Follow-up|80|||
148938066|NCT01254630|537256881|FG001|Overall Study|Lost to Follow-up|26|||
148938067|NCT01254630|537256882|FG002|Overall Study|Lost to Follow-up|89|||
148938068|NCT01254630|537256883|FG003|Overall Study|Lost to Follow-up|32|||
148938069|NCT01254630|537256880|FG000|Overall Study|Physician Decision|24|||
148938070|NCT01254630|537256881|FG001|Overall Study|Physician Decision|8|||
148938071|NCT01254630|537256882|FG002|Overall Study|Physician Decision|16|||
148938072|NCT01254630|537256883|FG003|Overall Study|Physician Decision|7|||
148807878|NCT03573297|536774477|FG000|Open Label Treatment Period|Adverse Event|67|||
148807879|NCT03573297|536774478|FG001|Open Label Treatment Period|Adverse Event|0|||
148807880|NCT03573297|536774479|FG002|Open Label Treatment Period|Adverse Event|0|||
148807881|NCT03573297|536774480|FG003|Open Label Treatment Period|Adverse Event|0|||
148807882|NCT03573297|536774477|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
148807883|NCT03573297|536774478|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
148807884|NCT03573297|536774479|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
148807885|NCT03573297|536774480|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
148807886|NCT03573297|536774477|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
148807887|NCT03573297|536774478|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
148807888|NCT03573297|536774479|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
148807889|NCT03573297|536774480|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
148807890|NCT03573297|536774477|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
148807891|NCT03573297|536774478|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
148807892|NCT03573297|536774479|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
148807893|NCT03573297|536774480|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
148807894|NCT03573297|536774477|FG000|Open Label Treatment Period|Pregnancy|1|||
148807895|NCT03573297|536774478|FG001|Open Label Treatment Period|Pregnancy|0|||
148807896|NCT03573297|536774479|FG002|Open Label Treatment Period|Pregnancy|0|||
148807897|NCT03573297|536774480|FG003|Open Label Treatment Period|Pregnancy|0|||
148807898|NCT03573297|536774477|FG000|Open Label Treatment Period|Protocol Violation|17|||
148807899|NCT03573297|536774478|FG001|Open Label Treatment Period|Protocol Violation|0|||
148807900|NCT03573297|536774479|FG002|Open Label Treatment Period|Protocol Violation|0|||
148807901|NCT03573297|536774480|FG003|Open Label Treatment Period|Protocol Violation|0|||
148807902|NCT03573297|536774477|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
148807903|NCT03573297|536774478|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
148807904|NCT03573297|536774479|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
148807905|NCT03573297|536774480|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
148807906|NCT03573297|536774477|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
148807907|NCT03573297|536774478|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
148807908|NCT03573297|536774479|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
148807909|NCT03573297|536774480|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
148807910|NCT03573297|536774477|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
148807911|NCT03573297|536774478|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
148807912|NCT03573297|536774479|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
148938073|NCT01254630|537256880|FG000|Overall Study|Withdrawal by Subject|201|||
148682218|NCT00435825|536309491|FG000|Overall Study|Abnormality of Laboratory Test|0|||
148682219|NCT00435825|536309492|FG001|Overall Study|Abnormality of Laboratory Test|1|||
148682220|NCT00435825|536309493|FG002|Overall Study|Abnormality of Laboratory Test|0|||
148682221|NCT00435825|536309494|FG003|Overall Study|Abnormality of Laboratory Test|0|||
148682222|NCT00435825|536309491|FG000|Overall Study|Insufficient Therapeutic Response|3|||
148682223|NCT00435825|536309492|FG001|Overall Study|Insufficient Therapeutic Response|1|||
148682224|NCT00435825|536309493|FG002|Overall Study|Insufficient Therapeutic Response|0|||
148682225|NCT00435825|536309494|FG003|Overall Study|Insufficient Therapeutic Response|3|||
148682226|NCT00435825|536309491|FG000|Overall Study|Other Protocol Violation|1|||
148682227|NCT00435825|536309492|FG001|Overall Study|Other Protocol Violation|0|||
148682228|NCT00435825|536309493|FG002|Overall Study|Other Protocol Violation|0|||
148682229|NCT00435825|536309494|FG003|Overall Study|Other Protocol Violation|0|||
148682230|NCT00435825|536309491|FG000|Overall Study|Refused treatment|2|||
148682231|NCT00435825|536309492|FG001|Overall Study|Refused treatment|0|||
148682232|NCT00435825|536309493|FG002|Overall Study|Refused treatment|0|||
148682233|NCT00435825|536309494|FG003|Overall Study|Refused treatment|5|||
148682234|NCT00435825|536309491|FG000|Overall Study|Failure to return|5|||
148682235|NCT00435825|536309492|FG001|Overall Study|Failure to return|0|||
148682236|NCT00435825|536309493|FG002|Overall Study|Failure to return|4|||
148938074|NCT01254630|537256881|FG001|Overall Study|Withdrawal by Subject|94|||
148938075|NCT01254630|537256882|FG002|Overall Study|Withdrawal by Subject|188|||
148938076|NCT01254630|537256883|FG003|Overall Study|Withdrawal by Subject|89|||
148938077|NCT01254630|537256880|FG000|Overall Study|Study terminated by sponsor|0|||
148938078|NCT01254630|537256881|FG001|Overall Study|Study terminated by sponsor|994|||
148938079|NCT01254630|537256882|FG002|Overall Study|Study terminated by sponsor|0|||
148938080|NCT01254630|537256883|FG003|Overall Study|Study terminated by sponsor|1010|||
148682237|NCT00435825|536309494|FG003|Overall Study|Failure to return|0|||
148682238|NCT00435825|536309491|FG000|Overall Study|Did not receive study drug|1|||
148938081|NCT01254630|537256880|FG000|Overall Study|Status not recorded|0|||
148682239|NCT00435825|536309492|FG001|Overall Study|Did not receive study drug|0|||
148938082|NCT01254630|537256881|FG001|Overall Study|Status not recorded|0|||
148682240|NCT00435825|536309493|FG002|Overall Study|Did not receive study drug|2|||
148682241|NCT00435825|536309494|FG003|Overall Study|Did not receive study drug|0|||
148807913|NCT03573297|536774480|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
148807914|NCT03573297|536774477|FG000|Open Label Treatment Period|Other, Not Specified|7|||
148938083|NCT01254630|537256882|FG002|Overall Study|Status not recorded|1|||
148938084|NCT01254630|537256883|FG003|Overall Study|Status not recorded|0|||
148938085|NCT02020577|537256884|FG000|Overall Study|Progressive disease|3|||
148938086|NCT02020577|537256885|FG001|Overall Study|Progressive disease|38|||
148938087|NCT02020577|537256884|FG000|Overall Study|Other AE or clinical progression|0|||
148938088|NCT02020577|537256885|FG001|Overall Study|Other AE or clinical progression|15|||
148938089|NCT02020577|537256884|FG000|Overall Study|Withdrawal by Subject|0|||
148938090|NCT02020577|537256885|FG001|Overall Study|Withdrawal by Subject|1|||
148938091|NCT02020577|537256884|FG000|Overall Study|Other than stated above|0|||
148938092|NCT02020577|537256885|FG001|Overall Study|Other than stated above|1|||
148938093|NCT01999868|537256886|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
148938094|NCT01999868|537256887|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
148938095|NCT01999868|537256888|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
148938096|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
148938097|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
148938098|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
148938099|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
148938100|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
148938101|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
148938102|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
148938103|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
148938104|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
148938105|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
148938106|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
148938107|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
148938108|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
148938109|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
148938110|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
148938111|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
148938112|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
148938113|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
148938114|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
148938115|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
148938116|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
148938117|NCT01999868|537256886|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
148938118|NCT01999868|537256887|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
148938119|NCT01999868|537256888|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
148938120|NCT01999868|537256886|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
148938121|NCT01999868|537256887|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
148938122|NCT01999868|537256888|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
148682242|NCT00435825|536309491|FG000|Overall Study|Did not enter follow-up|0|||
148682243|NCT00435825|536309492|FG001|Overall Study|Did not enter follow-up|4|||
148682244|NCT00435825|536309493|FG002|Overall Study|Did not enter follow-up|1|||
148682245|NCT00435825|536309494|FG003|Overall Study|Did not enter follow-up|3|||
148682246|NCT00435825|536309491|FG000|Overall Study|Did not complete full follow-up period|6|||
148682247|NCT00435825|536309492|FG001|Overall Study|Did not complete full follow-up period|6|||
148682248|NCT00435825|536309493|FG002|Overall Study|Did not complete full follow-up period|4|||
148682249|NCT00435825|536309494|FG003|Overall Study|Did not complete full follow-up period|5|||
148682250|NCT01123980|536309495|FG000|Overall Study|Adverse Event|1|||
148682251|NCT01123980|536309496|FG001|Overall Study|Adverse Event|1|||
148682252|NCT01123980|536309495|FG000|Overall Study|Lack of Efficacy|1|||
148682253|NCT01123980|536309496|FG001|Overall Study|Lack of Efficacy|0|||
148682254|NCT01123980|536309495|FG000|Overall Study|Physician Decision|0|||
148682255|NCT01123980|536309496|FG001|Overall Study|Physician Decision|1|||
148682256|NCT01123980|536309495|FG000|Overall Study|Lost to Follow-up|0|||
148682257|NCT01123980|536309496|FG001|Overall Study|Lost to Follow-up|6|||
148682258|NCT01123980|536309495|FG000|Overall Study|Protocol Violation|6|||
148682259|NCT01123980|536309496|FG001|Overall Study|Protocol Violation|6|||
148682260|NCT01123980|536309495|FG000|Overall Study|Withdrawal by Subject|5|||
148938123|NCT01999868|537256886|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
148682261|NCT01123980|536309496|FG001|Overall Study|Withdrawal by Subject|3|||
148938124|NCT01999868|537256887|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
148682262|NCT01123980|536309495|FG000|Overall Study|Unclassified|6|||
148682263|NCT01123980|536309496|FG001|Overall Study|Unclassified|7|||
148807915|NCT03573297|536774478|FG001|Open Label Treatment Period|Other, Not Specified|0|||
148938125|NCT01999868|537256888|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
149015148|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
148682264|NCT01225991|536309497|FG000|Overall Study|Withdrawal by Subject|6|||
148682265|NCT01963676|536310858|FG000|Overall Study|Withdrawal by Subject|1|||
148682266|NCT01963676|536310859|FG001|Overall Study|Withdrawal by Subject|0|||
148682267|NCT02496221|536310860|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
148682268|NCT02496221|536310861|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
148682269|NCT02496221|536310860|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
148682270|NCT02496221|536310861|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
148682271|NCT02496221|536310860|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
148682272|NCT02496221|536310861|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
148682273|NCT01120600|536310864|FG000|Overall Study|Adverse Event|7|||
148682274|NCT01120600|536310865|FG001|Overall Study|Adverse Event|7|||
148682275|NCT01120600|536310864|FG000|Overall Study|Excessive Bone Loss|0|||
148682276|NCT01120600|536310865|FG001|Overall Study|Excessive Bone Loss|4|||
148682277|NCT01120600|536310864|FG000|Overall Study|Lost to Follow-up|1|||
148682278|NCT01120600|536310865|FG001|Overall Study|Lost to Follow-up|3|||
148682279|NCT01120600|536310864|FG000|Overall Study|Physician Decision|1|||
148682280|NCT01120600|536310865|FG001|Overall Study|Physician Decision|3|||
148682281|NCT01120600|536310864|FG000|Overall Study|Protocol Violation|0|||
148682282|NCT01120600|536310865|FG001|Overall Study|Protocol Violation|4|||
148682283|NCT01120600|536310864|FG000|Overall Study|Withdrawal by Subject|10|||
148682284|NCT01120600|536310865|FG001|Overall Study|Withdrawal by Subject|11|||
148682285|NCT00833547|536310867|FG000|Overall Study|Withdrawal by Subject|2|||
148682286|NCT00833547|536310868|FG001|Overall Study|Withdrawal by Subject|2|||
148682287|NCT00566098|536310870|FG000|Collection of MILs|Withdrawal by Subject|1|||
148682288|NCT00566098|536310870|FG000|Collection of MILs|Relapsed|1|||
148682289|NCT00566098|536310870|FG000|Generation of MILs Product|Relapsed|1|||
148682290|NCT00566098|536310870|FG000|Administration of ASCT+MILs|Death|10|||
148682291|NCT00566098|536310870|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
148682292|NCT01690520|536310873|FG000|Overall Study|Death|25|||
148682293|NCT01690520|536310874|FG001|Overall Study|Death|21|||
148682294|NCT01690520|536310873|FG000|Overall Study|Lost to Follow-up|2|||
148682295|NCT01690520|536310874|FG001|Overall Study|Lost to Follow-up|3|||
148682296|NCT01690520|536310873|FG000|Overall Study|Withdrawal by Subject|2|||
148682297|NCT01690520|536310874|FG001|Overall Study|Withdrawal by Subject|0|||
148682298|NCT01690520|536310873|FG000|Overall Study|Relapse|0|||
148682299|NCT01690520|536310874|FG001|Overall Study|Relapse|1|||
148682300|NCT01690520|536310873|FG000|Overall Study|Other|0|||
148682301|NCT01690520|536310874|FG001|Overall Study|Other|1|||
148682302|NCT01690520|536310873|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
148682303|NCT01690520|536310874|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
148682304|NCT00275028|536310875|FG000|Overall Study|Withdrew consent before treatment began|1|||
148682305|NCT00275028|536310875|FG000|Overall Study|Withdrawal by Subject|5|||
148682306|NCT00275028|536310875|FG000|Overall Study|Adverse Event|9|||
148682307|NCT00275028|536310875|FG000|Overall Study|Progressive Disease|30|||
148682308|NCT00275028|536310875|FG000|Overall Study|Physician Decision|2|||
148682309|NCT01847313|536310878|FG000|Overall Study|Death|0|||
148682310|NCT01847313|536310879|FG001|Overall Study|Death|1|||
148682311|NCT01847313|536310878|FG000|Overall Study|Withdrawal by Subject|0|||
148682312|NCT01847313|536310879|FG001|Overall Study|Withdrawal by Subject|1|||
148682313|NCT00598559|536310881|FG000|Overall Study|Adverse Event|11|||
148682314|NCT00598559|536310882|FG001|Overall Study|Adverse Event|7|||
148682315|NCT00598559|536310883|FG002|Overall Study|Adverse Event|0|||
148682316|NCT00598559|536310881|FG000|Overall Study|Withdrawal by Subject|2|||
148682317|NCT00598559|536310882|FG001|Overall Study|Withdrawal by Subject|2|||
148682318|NCT00598559|536310883|FG002|Overall Study|Withdrawal by Subject|0|||
148682319|NCT00598559|536310881|FG000|Overall Study|Protocol Non-compliance|1|||
148682320|NCT00598559|536310882|FG001|Overall Study|Protocol Non-compliance|0|||
148682321|NCT00598559|536310883|FG002|Overall Study|Protocol Non-compliance|0|||
148682322|NCT00598559|536310881|FG000|Overall Study|Early discharge from hospital|9|||
148682323|NCT00598559|536310882|FG001|Overall Study|Early discharge from hospital|12|||
148682324|NCT00598559|536310883|FG002|Overall Study|Early discharge from hospital|3|||
148682325|NCT00598559|536310881|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
148938126|NCT01999868|537256886|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
148682326|NCT00598559|536310882|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
148682327|NCT00598559|536310883|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
148682328|NCT01904383|536310884|FG000|Overall Study|CRF not collected|117|||
148682329|NCT01904383|536310884|FG000|Overall Study|Reason not listed|147|||
148682330|NCT01904383|536310884|FG000|Overall Study|Lost to Follow-up|674|||
148682331|NCT01904383|536310884|FG000|Overall Study|Lack of Efficacy|370|||
148938127|NCT01999868|537256887|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
148682332|NCT01904383|536310884|FG000|Overall Study|Improvement|141|||
148682333|NCT01904383|536310884|FG000|Overall Study|Adverse Event|271|||
148682334|NCT01904383|536310884|FG000|Overall Study|No patient visit after entry|54|||
148682335|NCT01625845|536310885|FG000|Overall Study|Adverse Event|1|||
148682336|NCT01625845|536310886|FG001|Overall Study|Adverse Event|2|||
148682337|NCT01625845|536310885|FG000|Overall Study|Lost to Follow-up|2|||
148682338|NCT01625845|536310886|FG001|Overall Study|Lost to Follow-up|1|||
148682339|NCT01625845|536310885|FG000|Overall Study|Withdrawal by Subject|2|||
148682340|NCT01625845|536310886|FG001|Overall Study|Withdrawal by Subject|0|||
148938128|NCT01999868|537256888|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
148682341|NCT02853929|536310887|FG000|Overall Study|Lost to Follow-up|3|||
148682342|NCT02853929|536310888|FG001|Overall Study|Lost to Follow-up|0|||
148682343|NCT02853929|536310887|FG000|Overall Study|Withdrawal by Subject|1|||
148682344|NCT02853929|536310888|FG001|Overall Study|Withdrawal by Subject|0|||
148682345|NCT02853929|536310887|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
148682346|NCT02853929|536310888|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
148682347|NCT02762565|536310889|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
148682348|NCT01113710|536310890|FG000|Overall Study|Adverse Event|64|||
148682349|NCT01113710|536310890|FG000|Overall Study|Lack of Efficacy|41|||
148682350|NCT01113710|536310890|FG000|Overall Study|No Information Available|40|||
148682351|NCT01113710|536310890|FG000|Overall Study|Withdrawal by Subject|28|||
148682352|NCT01113710|536310890|FG000|Overall Study|Lost to Follow-up|20|||
148682353|NCT01113710|536310890|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
148682354|NCT01113710|536310890|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
148682355|NCT01113710|536310890|FG000|Overall Study|Lack of Patient's Compliance|8|||
148682356|NCT01113710|536310890|FG000|Overall Study|Other|7|||
148682357|NCT01113710|536310890|FG000|Overall Study|Adverse Event/Other|5|||
148682358|NCT01113710|536310890|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
148682359|NCT01113710|536310890|FG000|Overall Study|Lack of Efficacy/Other|4|||
148682360|NCT01113710|536310890|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
148682361|NCT01113710|536310890|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
148938129|NCT01999868|537256886|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
148938130|NCT01999868|537256887|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
148682362|NCT01113710|536310890|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
148682363|NCT01113710|536310890|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
148682364|NCT01113710|536310890|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
148682365|NCT01113710|536310890|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
148682366|NCT01113710|536310890|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
148682367|NCT01113710|536310890|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
148682368|NCT01113710|536310890|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
148682369|NCT01113710|536310890|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
148682370|NCT01113710|536310890|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
148682371|NCT01113710|536310890|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
148682372|NCT01113710|536310890|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
148682373|NCT01170364|536310891|FG000|Overall Study|Protocol Violation|4|||
148682374|NCT01170364|536310892|FG001|Overall Study|Protocol Violation|1|||
148682375|NCT04132232|536310893|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
148682376|NCT04132232|536310894|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
148682377|NCT04132232|536310893|FG000|Overall Study|Lost to Follow-up|6|||
148682378|NCT04132232|536310894|FG001|Overall Study|Lost to Follow-up|7|||
148682379|NCT00368537|536310896|FG000|Randomization|No study drug dosed|13|||
148682380|NCT00368537|536310897|FG001|Randomization|No study drug dosed|6|||
148682381|NCT00368537|536310896|FG000|Baseline Participants|Lost to Follow-up|16|||
148682382|NCT00368537|536310897|FG001|Baseline Participants|Lost to Follow-up|17|||
148682383|NCT00368537|536310896|FG000|Baseline Participants|Withdrawal by Subject|6|||
148682384|NCT00368537|536310897|FG001|Baseline Participants|Withdrawal by Subject|4|||
148682385|NCT00368537|536310896|FG000|Baseline Participants|Death|1|||
148682386|NCT00368537|536310897|FG001|Baseline Participants|Death|2|||
148682387|NCT00368537|536310896|FG000|Baseline Participants|No susceptibility|1|||
148682388|NCT00368537|536310897|FG001|Baseline Participants|No susceptibility|0|||
148682389|NCT00368537|536310896|FG000|Baseline Participants|Patient uncompliant|0|||
148682390|NCT00368537|536310897|FG001|Baseline Participants|Patient uncompliant|1|||
148682391|NCT01368276|536310907|FG000|Overall Study|Death|1|||
148682392|NCT01368276|536310908|FG001|Overall Study|Death|10|||
148682393|NCT03341273|536310911|FG000|Overall Study|Lost to Follow-up|7|||
148682394|NCT03341273|536310912|FG001|Overall Study|Lost to Follow-up|7|||
148682395|NCT03341273|536310911|FG000|Overall Study|Withdrawal by Subject|4|||
148807916|NCT03573297|536774479|FG002|Open Label Treatment Period|Other, Not Specified|0|||
148938131|NCT01999868|537256888|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
148938132|NCT01999868|537256886|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
148682396|NCT03341273|536310912|FG001|Overall Study|Withdrawal by Subject|2|||
148682397|NCT03341273|536310911|FG000|Overall Study|Physician Decision|1|||
148807917|NCT03573297|536774480|FG003|Open Label Treatment Period|Other, Not Specified|0|||
148682398|NCT03341273|536310912|FG001|Overall Study|Physician Decision|0|||
148682399|NCT03341273|536310911|FG000|Overall Study|Protocol Violation|0|||
148682400|NCT03341273|536310912|FG001|Overall Study|Protocol Violation|1|||
148682401|NCT03341273|536310911|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
148682402|NCT03341273|536310912|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
148682403|NCT03341273|536310911|FG000|Overall Study|Became ineligible after enrollment|1|||
148682404|NCT03341273|536310912|FG001|Overall Study|Became ineligible after enrollment|0|||
148682405|NCT03341273|536310911|FG000|Overall Study|Not Eligible at Enrollment|0|||
148938133|NCT01999868|537256887|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
148938134|NCT01999868|537256888|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
148938135|NCT01999868|537256886|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
148938136|NCT01999868|537256887|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
148938137|NCT01999868|537256888|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
148938138|NCT00761631|537256889|FG000|Overall Study|Parent/legal guardian request|8|||
148938139|NCT00761631|537256890|FG001|Overall Study|Parent/legal guardian request|3|||
148938140|NCT00761631|537256891|FG002|Overall Study|Parent/legal guardian request|8|||
148938141|NCT00761631|537256892|FG003|Overall Study|Parent/legal guardian request|0|||
148938142|NCT00761631|537256893|FG004|Overall Study|Parent/legal guardian request|5|||
148938143|NCT00761631|537256894|FG005|Overall Study|Parent/legal guardian request|0|||
148938144|NCT00761631|537256889|FG000|Overall Study|Lost to Follow-up|2|||
148938145|NCT00761631|537256890|FG001|Overall Study|Lost to Follow-up|4|||
148938146|NCT00761631|537256891|FG002|Overall Study|Lost to Follow-up|7|||
148938147|NCT00761631|537256892|FG003|Overall Study|Lost to Follow-up|1|||
148938148|NCT00761631|537256893|FG004|Overall Study|Lost to Follow-up|6|||
148938149|NCT00761631|537256894|FG005|Overall Study|Lost to Follow-up|1|||
148938150|NCT00761631|537256889|FG000|Overall Study|Protocol Violation|2|||
148938151|NCT00761631|537256890|FG001|Overall Study|Protocol Violation|0|||
148938152|NCT00761631|537256891|FG002|Overall Study|Protocol Violation|0|||
148938153|NCT00761631|537256892|FG003|Overall Study|Protocol Violation|1|||
148938154|NCT00761631|537256893|FG004|Overall Study|Protocol Violation|5|||
148938155|NCT00761631|537256894|FG005|Overall Study|Protocol Violation|1|||
148938156|NCT00761631|537256889|FG000|Overall Study|Randomized, not treated|1|||
148938157|NCT00761631|537256890|FG001|Overall Study|Randomized, not treated|0|||
148938158|NCT00761631|537256891|FG002|Overall Study|Randomized, not treated|0|||
148938159|NCT00761631|537256892|FG003|Overall Study|Randomized, not treated|0|||
148938160|NCT00761631|537256893|FG004|Overall Study|Randomized, not treated|0|||
148938161|NCT00761631|537256894|FG005|Overall Study|Randomized, not treated|0|||
148938162|NCT00761631|537256889|FG000|Overall Study|Failed to return|1|||
148938163|NCT00761631|537256890|FG001|Overall Study|Failed to return|0|||
148938164|NCT00761631|537256891|FG002|Overall Study|Failed to return|1|||
148938165|NCT00761631|537256892|FG003|Overall Study|Failed to return|1|||
148938166|NCT00761631|537256893|FG004|Overall Study|Failed to return|5|||
148938167|NCT00761631|537256894|FG005|Overall Study|Failed to return|2|||
148938168|NCT00761631|537256889|FG000|Overall Study|Physician Decision|1|||
148938169|NCT00761631|537256890|FG001|Overall Study|Physician Decision|0|||
148938170|NCT00761631|537256891|FG002|Overall Study|Physician Decision|0|||
148938171|NCT00761631|537256892|FG003|Overall Study|Physician Decision|0|||
148938172|NCT00761631|537256893|FG004|Overall Study|Physician Decision|0|||
148938173|NCT00761631|537256894|FG005|Overall Study|Physician Decision|0|||
148938174|NCT00761631|537256889|FG000|Overall Study|Other|0|||
148938175|NCT00761631|537256890|FG001|Overall Study|Other|0|||
148938176|NCT00761631|537256891|FG002|Overall Study|Other|0|||
148938177|NCT00761631|537256892|FG003|Overall Study|Other|0|||
148938178|NCT00761631|537256893|FG004|Overall Study|Other|1|||
148938179|NCT00761631|537256894|FG005|Overall Study|Other|1|||
148938180|NCT00289016|537256897|FG000|Overall Study|Disease Progression|29|||
148938181|NCT00289016|537256897|FG000|Overall Study|Death|2|||
148938182|NCT00289016|537256897|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
148938183|NCT00289016|537256897|FG000|Overall Study|Withdrawal by Subject|2|||
148938184|NCT00289016|537256897|FG000|Overall Study|Adverse Event|1|||
148938185|NCT00289016|537256897|FG000|Overall Study|Other|1|||
148938186|NCT00319501|537256898|FG000|Double-blind Period|Withdrawal by Subject|0|||
148938187|NCT00319501|537256899|FG001|Double-blind Period|Withdrawal by Subject|3|||
148938188|NCT00319501|537256898|FG000|Double-blind Period|Sponsor Request|1|||
148938189|NCT00319501|537256899|FG001|Double-blind Period|Sponsor Request|0|||
148938190|NCT00319501|537256898|FG000|Double-blind Period|Did not receive treatment|42|||
148938191|NCT00319501|537256899|FG001|Double-blind Period|Did not receive treatment|29|||
148938192|NCT00319501|537256898|FG000|Open-label Period|Adverse Event|5|||
149015149|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
149195674|NCT01486784|538185098|FG002|Overall Study|Withdrawal by Subject|1|||
149195675|NCT01486784|538185099|FG003|Overall Study|Withdrawal by Subject|0|||
148938193|NCT00319501|537256899|FG001|Open-label Period|Adverse Event|0|||
148938194|NCT00319501|537256898|FG000|Open-label Period|Protocol Violation|6|||
148938195|NCT00319501|537256899|FG001|Open-label Period|Protocol Violation|0|||
148938196|NCT00319501|537256898|FG000|Open-label Period|Withdrawal by Subject|38|||
148938197|NCT00319501|537256899|FG001|Open-label Period|Withdrawal by Subject|0|||
148938198|NCT00319501|537256898|FG000|Open-label Period|Principal Investigator decision|6|||
148938199|NCT00319501|537256899|FG001|Open-label Period|Principal Investigator decision|0|||
148938200|NCT00319501|537256898|FG000|Open-label Period|Sponsor request|12|||
148938201|NCT00319501|537256899|FG001|Open-label Period|Sponsor request|0|||
148938202|NCT00319501|537256898|FG000|Open-label Period|Lost to Follow-up|5|||
148938203|NCT00319501|537256899|FG001|Open-label Period|Lost to Follow-up|0|||
148938204|NCT00319501|537256898|FG000|Open-label Period|Did not receive treatment|33|||
149015150|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
149195676|NCT01486784|538185100|FG004|Overall Study|Withdrawal by Subject|1|||
149195677|NCT01486784|538185101|FG005|Overall Study|Withdrawal by Subject|2|||
149195678|NCT01486784|538185096|FG000|Overall Study|Subject did not meet entry criteria|0|||
149195679|NCT01486784|538185097|FG001|Overall Study|Subject did not meet entry criteria|0|||
149195680|NCT01486784|538185098|FG002|Overall Study|Subject did not meet entry criteria|0|||
149195681|NCT01486784|538185099|FG003|Overall Study|Subject did not meet entry criteria|0|||
148938205|NCT00319501|537256899|FG001|Open-label Period|Did not receive treatment|0|||
148938206|NCT00319501|537256898|FG000|Open-label Period|Other|11|||
148938207|NCT00319501|537256899|FG001|Open-label Period|Other|0|||
148938208|NCT00319501|537256898|FG000|Open-label Extension Period|Adverse Event|2|||
148938209|NCT00319501|537256899|FG001|Open-label Extension Period|Adverse Event|0|||
148938210|NCT00319501|537256898|FG000|Open-label Extension Period|Did not receive treatment|18|||
148938211|NCT00319501|537256899|FG001|Open-label Extension Period|Did not receive treatment|0|||
148938212|NCT00319501|537256898|FG000|Open-label Extension Period|Other|1|||
148938213|NCT00319501|537256899|FG001|Open-label Extension Period|Other|0|||
148938214|NCT00319501|537256898|FG000|Open-label Extension Period|Principal investigator decision|2|||
148938215|NCT00319501|537256899|FG001|Open-label Extension Period|Principal investigator decision|0|||
148938216|NCT00319501|537256898|FG000|Open-label Extension Period|Sponsor request|26|||
148938217|NCT00319501|537256899|FG001|Open-label Extension Period|Sponsor request|0|||
148938218|NCT00319501|537256898|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
148938219|NCT00319501|537256899|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
148938220|NCT00450255|537256901|FG000|Overall Study|Prior RFA ablation of liver|1|||
148938221|NCT03553927|537256902|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
148938222|NCT03553927|537256903|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
148938223|NCT03553927|537256902|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
148938224|NCT03553927|537256903|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
148938225|NCT01441180|537256904|FG000|Overall Study|Lost to Follow-up|1|||
148938226|NCT01441180|537256905|FG001|Overall Study|Lost to Follow-up|1|||
148938227|NCT01441180|537256906|FG002|Overall Study|Lost to Follow-up|1|||
148938228|NCT01441180|537256904|FG000|Overall Study|Discontinued|0|||
148938229|NCT01441180|537256905|FG001|Overall Study|Discontinued|0|||
148938230|NCT01441180|537256906|FG002|Overall Study|Discontinued|2|||
148938231|NCT01402011|537256907|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
148938232|NCT01402011|537256908|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
148938233|NCT01402011|537256909|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
148938234|NCT01402011|537256907|FG000|Active Treatment Period|Withdrawal by Subject|1|||
148938235|NCT01402011|537256908|FG001|Active Treatment Period|Withdrawal by Subject|3|||
148938236|NCT01402011|537256909|FG002|Active Treatment Period|Withdrawal by Subject|0|||
148938237|NCT01402011|537256907|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
148938238|NCT01402011|537256908|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
148938239|NCT01402011|537256909|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
148938240|NCT00142298|537256910|FG000|Overall Study|Adverse Event|10|||
148938241|NCT00142298|537256911|FG001|Overall Study|Adverse Event|10|||
148938242|NCT00142298|537256912|FG002|Overall Study|Adverse Event|1|||
148938243|NCT00142298|537256913|FG003|Overall Study|Adverse Event|5|||
148938244|NCT00142298|537256914|FG004|Overall Study|Adverse Event|2|||
148938245|NCT00142298|537256915|FG005|Overall Study|Adverse Event|2|||
148938246|NCT00142298|537256916|FG006|Overall Study|Adverse Event|0|||
148938247|NCT00142298|537256917|FG007|Overall Study|Adverse Event|0|||
148938248|NCT00142298|537256918|FG008|Overall Study|Adverse Event|0|||
148938249|NCT00142298|537256919|FG009|Overall Study|Adverse Event|0|||
148938250|NCT00142298|537256910|FG000|Overall Study|Clinical disease progression|1|||
148938251|NCT00142298|537256911|FG001|Overall Study|Clinical disease progression|0|||
148938252|NCT00142298|537256912|FG002|Overall Study|Clinical disease progression|0|||
148938253|NCT00142298|537256913|FG003|Overall Study|Clinical disease progression|0|||
148938254|NCT00142298|537256914|FG004|Overall Study|Clinical disease progression|0|||
148938255|NCT00142298|537256915|FG005|Overall Study|Clinical disease progression|0|||
148938256|NCT00142298|537256916|FG006|Overall Study|Clinical disease progression|0|||
148938257|NCT00142298|537256917|FG007|Overall Study|Clinical disease progression|0|||
148938258|NCT00142298|537256918|FG008|Overall Study|Clinical disease progression|0|||
148938259|NCT00142298|537256919|FG009|Overall Study|Clinical disease progression|0|||
148938260|NCT00142298|537256910|FG000|Overall Study|Death|1|||
148938261|NCT00142298|537256911|FG001|Overall Study|Death|1|||
148938262|NCT00142298|537256912|FG002|Overall Study|Death|1|||
148938263|NCT00142298|537256913|FG003|Overall Study|Death|0|||
149195682|NCT01486784|538185100|FG004|Overall Study|Subject did not meet entry criteria|1|||
148938264|NCT00142298|537256914|FG004|Overall Study|Death|0|||
148938265|NCT00142298|537256915|FG005|Overall Study|Death|6|||
148938266|NCT00142298|537256916|FG006|Overall Study|Death|0|||
148938267|NCT00142298|537256917|FG007|Overall Study|Death|0|||
148938268|NCT00142298|537256918|FG008|Overall Study|Death|0|||
148938269|NCT00142298|537256919|FG009|Overall Study|Death|0|||
148938270|NCT00142298|537256910|FG000|Overall Study|Lack of Efficacy|44|||
148807918|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
148807919|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
148807920|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
148807921|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
148807922|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148807923|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Adverse Event|1|||
148807924|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Adverse Event|5|||
148807925|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Adverse Event|1|||
148938271|NCT00142298|537256911|FG001|Overall Study|Lack of Efficacy|62|||
148938272|NCT00142298|537256912|FG002|Overall Study|Lack of Efficacy|9|||
148938273|NCT00142298|537256913|FG003|Overall Study|Lack of Efficacy|12|||
148938274|NCT00142298|537256914|FG004|Overall Study|Lack of Efficacy|1|||
148938275|NCT00142298|537256915|FG005|Overall Study|Lack of Efficacy|0|||
148938276|NCT00142298|537256916|FG006|Overall Study|Lack of Efficacy|0|||
148938277|NCT00142298|537256917|FG007|Overall Study|Lack of Efficacy|1|||
148938278|NCT00142298|537256918|FG008|Overall Study|Lack of Efficacy|0|||
148938279|NCT00142298|537256919|FG009|Overall Study|Lack of Efficacy|0|||
148938280|NCT00142298|537256910|FG000|Overall Study|Non-compliance|15|||
148938281|NCT00142298|537256911|FG001|Overall Study|Non-compliance|13|||
148938282|NCT00142298|537256912|FG002|Overall Study|Non-compliance|0|||
148938283|NCT00142298|537256913|FG003|Overall Study|Non-compliance|6|||
148938284|NCT00142298|537256914|FG004|Overall Study|Non-compliance|1|||
148938285|NCT00142298|537256915|FG005|Overall Study|Non-compliance|0|||
148938286|NCT00142298|537256916|FG006|Overall Study|Non-compliance|0|||
148938287|NCT00142298|537256917|FG007|Overall Study|Non-compliance|3|||
148938288|NCT00142298|537256918|FG008|Overall Study|Non-compliance|3|||
148938289|NCT00142298|537256919|FG009|Overall Study|Non-compliance|0|||
148938290|NCT00142298|537256910|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
148938291|NCT00142298|537256911|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
148938292|NCT00142298|537256912|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
148938293|NCT00142298|537256913|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
148938294|NCT00142298|537256914|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
148938295|NCT00142298|537256915|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
148938296|NCT00142298|537256916|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
148938297|NCT00142298|537256917|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
148938298|NCT00142298|537256918|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
148938299|NCT00142298|537256919|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
148938300|NCT00142298|537256910|FG000|Overall Study|Pregnancy|4|||
148938301|NCT00142298|537256911|FG001|Overall Study|Pregnancy|4|||
148938302|NCT00142298|537256912|FG002|Overall Study|Pregnancy|2|||
148938303|NCT00142298|537256913|FG003|Overall Study|Pregnancy|3|||
148938304|NCT00142298|537256914|FG004|Overall Study|Pregnancy|0|||
148938305|NCT00142298|537256915|FG005|Overall Study|Pregnancy|0|||
148938306|NCT00142298|537256916|FG006|Overall Study|Pregnancy|0|||
148938307|NCT00142298|537256917|FG007|Overall Study|Pregnancy|0|||
148938308|NCT00142298|537256918|FG008|Overall Study|Pregnancy|1|||
148938309|NCT00142298|537256919|FG009|Overall Study|Pregnancy|0|||
148938310|NCT00142298|537256910|FG000|Overall Study|Virologic breakthrough|19|||
148938311|NCT00142298|537256911|FG001|Overall Study|Virologic breakthrough|23|||
148938312|NCT00142298|537256912|FG002|Overall Study|Virologic breakthrough|9|||
148938313|NCT00142298|537256913|FG003|Overall Study|Virologic breakthrough|7|||
148938314|NCT00142298|537256914|FG004|Overall Study|Virologic breakthrough|2|||
148938315|NCT00142298|537256915|FG005|Overall Study|Virologic breakthrough|3|||
148938316|NCT00142298|537256916|FG006|Overall Study|Virologic breakthrough|3|||
148938317|NCT00142298|537256917|FG007|Overall Study|Virologic breakthrough|0|||
148938318|NCT00142298|537256918|FG008|Overall Study|Virologic breakthrough|0|||
149195683|NCT01486784|538185101|FG005|Overall Study|Subject did not meet entry criteria|0|||
149195684|NCT01486784|538185096|FG000|Overall Study|Death|0|||
148807926|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
148807927|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
148938319|NCT00142298|537256919|FG009|Overall Study|Virologic breakthrough|0|||
148938320|NCT00142298|537256910|FG000|Overall Study|Other- not specified|0|||
148938321|NCT00142298|537256911|FG001|Overall Study|Other- not specified|3|||
148938322|NCT00142298|537256912|FG002|Overall Study|Other- not specified|0|||
148938323|NCT00142298|537256913|FG003|Overall Study|Other- not specified|1|||
148938324|NCT00142298|537256914|FG004|Overall Study|Other- not specified|0|||
148938325|NCT00142298|537256915|FG005|Overall Study|Other- not specified|0|||
148938326|NCT00142298|537256916|FG006|Overall Study|Other- not specified|0|||
148938327|NCT00142298|537256917|FG007|Overall Study|Other- not specified|0|||
148938328|NCT00142298|537256918|FG008|Overall Study|Other- not specified|0|||
148938329|NCT00142298|537256919|FG009|Overall Study|Other- not specified|0|||
148938330|NCT00142298|537256910|FG000|Overall Study|Lost to Follow-up|0|||
148938331|NCT00142298|537256911|FG001|Overall Study|Lost to Follow-up|0|||
148938332|NCT00142298|537256912|FG002|Overall Study|Lost to Follow-up|0|||
148938333|NCT00142298|537256913|FG003|Overall Study|Lost to Follow-up|0|||
148807928|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
148807929|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
148807930|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148807931|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
148807932|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
148807933|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
148807934|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
148807935|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
148807936|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
148807937|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
148807938|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
148807939|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
148807940|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
148807941|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
148807942|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
148807943|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
148938334|NCT00142298|537256914|FG004|Overall Study|Lost to Follow-up|0|||
148938335|NCT00142298|537256915|FG005|Overall Study|Lost to Follow-up|0|||
148938336|NCT00142298|537256916|FG006|Overall Study|Lost to Follow-up|2|||
148938337|NCT00142298|537256917|FG007|Overall Study|Lost to Follow-up|0|||
148938338|NCT00142298|537256918|FG008|Overall Study|Lost to Follow-up|0|||
148938339|NCT00142298|537256919|FG009|Overall Study|Lost to Follow-up|0|||
148938340|NCT00142298|537256910|FG000|Overall Study|Treatment Failure|0|||
148938341|NCT00142298|537256911|FG001|Overall Study|Treatment Failure|0|||
148938342|NCT00142298|537256912|FG002|Overall Study|Treatment Failure|0|||
148938343|NCT00142298|537256913|FG003|Overall Study|Treatment Failure|0|||
148938344|NCT00142298|537256914|FG004|Overall Study|Treatment Failure|0|||
148938345|NCT00142298|537256915|FG005|Overall Study|Treatment Failure|2|||
148938346|NCT00142298|537256916|FG006|Overall Study|Treatment Failure|2|||
148938347|NCT00142298|537256917|FG007|Overall Study|Treatment Failure|0|||
148938348|NCT00142298|537256918|FG008|Overall Study|Treatment Failure|0|||
148938349|NCT00142298|537256919|FG009|Overall Study|Treatment Failure|0|||
148938350|NCT03360747|537256921|FG000|Overall Study|Voluntary Withdrawal|1|||
148938351|NCT01759511|537256922|FG000|Overall Study|Adverse Event|4|||
148938352|NCT01759511|537256922|FG000|Overall Study|Death|2|||
148938353|NCT01759511|537256922|FG000|Overall Study|Lack of Efficacy|2|||
148938354|NCT01759511|537256922|FG000|Overall Study|Physician Decision|1|||
148938355|NCT01759511|537256922|FG000|Overall Study|Progressive Disease|5|||
148938356|NCT01759511|537256922|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
148938357|NCT01759511|537256922|FG000|Overall Study|Study Terminated by Sponsor|13|||
148938358|NCT01759511|537256922|FG000|Overall Study|Withdrawal by Subject|3|||
148938359|NCT02569671|537256923|FG000|Overall Study|Lost to Follow-up|2|||
148938360|NCT02569671|537256924|FG001|Overall Study|Lost to Follow-up|1|||
148938361|NCT02569671|537256923|FG000|Overall Study|Withdrawal by Subject|1|||
148938362|NCT02569671|537256924|FG001|Overall Study|Withdrawal by Subject|3|||
148938363|NCT01757535|537256925|FG000|Overall Study|Disease Relapse|151|||
148938364|NCT01757535|537256926|FG001|Overall Study|Disease Relapse|181|||
148938365|NCT01757535|537256925|FG000|Overall Study|Other Reasons|28|||
148938366|NCT01757535|537256926|FG001|Overall Study|Other Reasons|27|||
148938367|NCT01757535|537256925|FG000|Overall Study|Adverse Event|31|||
148938368|NCT01757535|537256926|FG001|Overall Study|Adverse Event|11|||
148938369|NCT01757535|537256925|FG000|Overall Study|Withdrew Consent|19|||
148938370|NCT01757535|537256926|FG001|Overall Study|Withdrew Consent|13|||
148938371|NCT01757535|537256925|FG000|Overall Study|Physician Decision|7|||
148938372|NCT01757535|537256926|FG001|Overall Study|Physician Decision|0|||
148938373|NCT01757535|537256925|FG000|Overall Study|Death|2|||
148938374|NCT01757535|537256926|FG001|Overall Study|Death|2|||
148938375|NCT06238362|537256927|FG000|Overall Study|Insufficient total sleep time|1|||
148938376|NCT06238362|537256928|FG001|Overall Study|Insufficient total sleep time|0|||
148938377|NCT06238362|537256927|FG000|Overall Study|Inadequate signal quality|1|||
148938378|NCT06238362|537256928|FG001|Overall Study|Inadequate signal quality|0|||
148938379|NCT02323113|537258678|FG000|Overall Study|Adverse Event|3|||
149195685|NCT01486784|538185097|FG001|Overall Study|Death|0|||
149195686|NCT01486784|538185098|FG002|Overall Study|Death|0|||
149195687|NCT01486784|538185099|FG003|Overall Study|Death|0|||
148807944|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
148938380|NCT02323113|537258679|FG001|Overall Study|Adverse Event|3|||
148938381|NCT02323113|537258680|FG002|Overall Study|Adverse Event|2|||
148938382|NCT02323113|537258681|FG003|Overall Study|Adverse Event|5|||
148938383|NCT02323113|537258682|FG004|Overall Study|Adverse Event|8|||
148938384|NCT02323113|537258683|FG005|Overall Study|Adverse Event|3|||
149195688|NCT01486784|538185100|FG004|Overall Study|Death|0|||
148807945|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
148938385|NCT02323113|537258684|FG006|Overall Study|Adverse Event|6|||
148938386|NCT02323113|537258685|FG007|Overall Study|Adverse Event|0|||
148938387|NCT02323113|537258678|FG000|Overall Study|Progressive Disease|0|||
149195689|NCT01486784|538185101|FG005|Overall Study|Death|1|||
148938388|NCT02323113|537258679|FG001|Overall Study|Progressive Disease|1|||
148938389|NCT02323113|537258680|FG002|Overall Study|Progressive Disease|1|||
148938390|NCT02323113|537258681|FG003|Overall Study|Progressive Disease|0|||
148938391|NCT02323113|537258682|FG004|Overall Study|Progressive Disease|0|||
148938392|NCT02323113|537258683|FG005|Overall Study|Progressive Disease|3|||
148938393|NCT02323113|537258684|FG006|Overall Study|Progressive Disease|0|||
148938394|NCT02323113|537258685|FG007|Overall Study|Progressive Disease|0|||
148938395|NCT02323113|537258678|FG000|Overall Study|Symptomatic Deterioration|0|||
148938396|NCT02323113|537258679|FG001|Overall Study|Symptomatic Deterioration|0|||
148938397|NCT02323113|537258680|FG002|Overall Study|Symptomatic Deterioration|1|||
148938398|NCT02323113|537258681|FG003|Overall Study|Symptomatic Deterioration|0|||
148938399|NCT02323113|537258682|FG004|Overall Study|Symptomatic Deterioration|1|||
148938400|NCT02323113|537258683|FG005|Overall Study|Symptomatic Deterioration|0|||
148938401|NCT02323113|537258684|FG006|Overall Study|Symptomatic Deterioration|0|||
148938402|NCT02323113|537258685|FG007|Overall Study|Symptomatic Deterioration|0|||
148938403|NCT02323113|537258678|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
148938404|NCT02323113|537258679|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
148938405|NCT02323113|537258680|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
148938406|NCT02323113|537258681|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
148938407|NCT02323113|537258682|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
148938408|NCT02323113|537258683|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
148938409|NCT02323113|537258684|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
148938410|NCT02323113|537258685|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
148938411|NCT02323113|537258678|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
148938412|NCT02323113|537258679|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
148938413|NCT02323113|537258680|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
148938414|NCT02323113|537258681|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
148938415|NCT02323113|537258682|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
149195690|NCT02841787|538185102|FG000|Overall Study|Lost to Follow-up|1|||
149195691|NCT02841787|538185103|FG001|Overall Study|Lost to Follow-up|0|||
149195692|NCT02841787|538185104|FG002|Overall Study|Lost to Follow-up|0|||
149195693|NCT02841787|538185102|FG000|Overall Study|Symptoms dropped below threshold|1|||
149195694|NCT02841787|538185103|FG001|Overall Study|Symptoms dropped below threshold|0|||
149195695|NCT02841787|538185104|FG002|Overall Study|Symptoms dropped below threshold|0|||
149195696|NCT02841787|538185102|FG000|Overall Study|Withdrawal by Subject|1|||
149195697|NCT02841787|538185103|FG001|Overall Study|Withdrawal by Subject|4|||
149195698|NCT02841787|538185104|FG002|Overall Study|Withdrawal by Subject|0|||
149195699|NCT03491553|538185105|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
149195700|NCT03491553|538185106|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
149195701|NCT03491553|538185107|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
149195702|NCT03491553|538185108|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
149195703|NCT03491553|538185109|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
149195704|NCT03491553|538185110|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
149195705|NCT03491553|538185105|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
149195706|NCT03491553|538185106|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
149195707|NCT03491553|538185107|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
149195708|NCT03491553|538185108|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
149195709|NCT03491553|538185109|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
149195710|NCT03491553|538185110|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
149195711|NCT03029650|538185113|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
148938416|NCT02323113|537258683|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
148938417|NCT02323113|537258684|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
148938418|NCT02323113|537258685|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
148938419|NCT00316719|537258686|FG000|Overall Study|Adverse Event|0|||
148938420|NCT00316719|537258687|FG001|Overall Study|Adverse Event|6|||
148938421|NCT00316719|537258686|FG000|Overall Study|Consent withdrawn|2|||
148938422|NCT00316719|537258687|FG001|Overall Study|Consent withdrawn|0|||
148938423|NCT02280304|537258690|FG000|Overall Study|Lost to Follow-up|7|||
149195712|NCT03029650|538185114|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
149195713|NCT03029650|538185113|FG000|Washout (1 Week)|Physician Decision|0|||
149195714|NCT03029650|538185114|FG001|Washout (1 Week)|Physician Decision|1|||
148938424|NCT02280304|537258691|FG001|Overall Study|Lost to Follow-up|8|||
148938425|NCT02975336|537258692|FG000|DBPC (52 Weeks)|Adverse Event|16|||
149195715|NCT02237157|538185115|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
149195716|NCT02237157|538185116|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
148682406|NCT03341273|536310912|FG001|Overall Study|Not Eligible at Enrollment|1|||
148682407|NCT03341273|536310911|FG000|Overall Study|Participant incarcerated|1|||
148682408|NCT03341273|536310912|FG001|Overall Study|Participant incarcerated|0|||
148682409|NCT02041494|536310913|FG000|Overall Study|Death|1|||
148938426|NCT02975336|537258693|FG001|DBPC (52 Weeks)|Adverse Event|17|||
148938427|NCT02975336|537258694|FG002|DBPC (52 Weeks)|Adverse Event|13|||
148938428|NCT02975336|537258695|FG003|DBPC (52 Weeks)|Adverse Event|18|||
148938429|NCT02975336|537258696|FG004|DBPC (52 Weeks)|Adverse Event|0|||
148938430|NCT02975336|537258697|FG005|DBPC (52 Weeks)|Adverse Event|0|||
148938431|NCT02975336|537258698|FG006|DBPC (52 Weeks)|Adverse Event|0|||
148938432|NCT02975336|537258699|FG007|DBPC (52 Weeks)|Adverse Event|0|||
148938433|NCT02975336|537258692|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
148938434|NCT02975336|537258693|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
148938435|NCT02975336|537258694|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
148938436|NCT02975336|537258695|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
148938437|NCT02975336|537258696|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
148938438|NCT02975336|537258697|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
148938439|NCT02975336|537258698|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
148938440|NCT02975336|537258699|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
148938441|NCT02975336|537258692|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
148938442|NCT02975336|537258693|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
148938443|NCT02975336|537258694|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
148938444|NCT02975336|537258695|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
148938445|NCT02975336|537258696|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
148938446|NCT02975336|537258697|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
148938447|NCT02975336|537258698|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
148938448|NCT02975336|537258699|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
148938449|NCT02975336|537258692|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
148938450|NCT02975336|537258693|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
148938451|NCT02975336|537258694|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
148938452|NCT02975336|537258695|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
148938453|NCT02975336|537258696|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
148938454|NCT02975336|537258697|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
148938455|NCT02975336|537258698|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
148938456|NCT02975336|537258699|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
148938457|NCT02975336|537258692|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
148938458|NCT02975336|537258693|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
148938459|NCT02975336|537258694|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
148938460|NCT02975336|537258695|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
148938461|NCT02975336|537258696|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
148938462|NCT02975336|537258697|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
148938463|NCT02975336|537258698|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
148938464|NCT02975336|537258699|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
148938465|NCT02975336|537258692|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
148938466|NCT02975336|537258693|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
148938467|NCT02975336|537258694|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
148938468|NCT02975336|537258695|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
148938469|NCT02975336|537258696|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
148938470|NCT02975336|537258697|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
148938471|NCT02975336|537258698|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
148938472|NCT02975336|537258699|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
148938473|NCT02975336|537258692|FG000|LTE (104 Weeks)|Adverse Event|0|||
148938474|NCT02975336|537258693|FG001|LTE (104 Weeks)|Adverse Event|0|||
148938475|NCT02975336|537258694|FG002|LTE (104 Weeks)|Adverse Event|0|||
148938476|NCT02975336|537258695|FG003|LTE (104 Weeks)|Adverse Event|0|||
148938477|NCT02975336|537258696|FG004|LTE (104 Weeks)|Adverse Event|7|||
148938478|NCT02975336|537258697|FG005|LTE (104 Weeks)|Adverse Event|4|||
148938479|NCT02975336|537258698|FG006|LTE (104 Weeks)|Adverse Event|2|||
148938480|NCT02975336|537258699|FG007|LTE (104 Weeks)|Adverse Event|0|||
148938481|NCT02975336|537258692|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
148938482|NCT02975336|537258693|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
148938483|NCT02975336|537258694|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
148938484|NCT02975336|537258695|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
148938485|NCT02975336|537258696|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
148938486|NCT02975336|537258697|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
148938487|NCT02975336|537258698|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
148938488|NCT02975336|537258699|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
148938489|NCT02975336|537258692|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
148938490|NCT02975336|537258693|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
148938491|NCT02975336|537258694|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
148938492|NCT02975336|537258695|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
149195717|NCT02237157|538185117|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
148682410|NCT02041494|536310914|FG001|Overall Study|Death|3|||
148682411|NCT02041494|536310913|FG000|Overall Study|Lost to Follow-up|2|||
148682412|NCT02041494|536310914|FG001|Overall Study|Lost to Follow-up|6|||
148938493|NCT02975336|537258696|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
149015151|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
149015152|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
149015153|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
149015154|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
149015155|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
149015156|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
149015157|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
149015158|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
149015159|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
149015160|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
149015161|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
149015162|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
149015163|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
149195718|NCT02237157|538185118|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
149195719|NCT02237157|538185115|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
149195720|NCT02237157|538185116|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
149195721|NCT02237157|538185117|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
149195722|NCT02237157|538185118|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
149195723|NCT03628508|538185119|FG000|Overall Study|Lost to Follow-up|1|||
149195724|NCT01996748|538185120|FG000|Overall Study|Personal reason|1|||
149195725|NCT01996748|538185121|FG001|Overall Study|Personal reason|0|||
149195726|NCT01996748|538185120|FG000|Overall Study|Physician Decision|2|||
149195727|NCT01996748|538185121|FG001|Overall Study|Physician Decision|0|||
149195728|NCT01996748|538185120|FG000|Overall Study|Adverse Event|1|||
149195729|NCT01996748|538185121|FG001|Overall Study|Adverse Event|4|||
149195730|NCT01996748|538185120|FG000|Overall Study|Withdrawal by Subject|0|||
149195731|NCT01996748|538185121|FG001|Overall Study|Withdrawal by Subject|1|||
149195732|NCT01996748|538185120|FG000|Overall Study|Lost to Follow-up|4|||
149195733|NCT01996748|538185121|FG001|Overall Study|Lost to Follow-up|1|||
149195734|NCT03011840|538185122|FG000|Overall Study|Not received PIL in post PIL phase|0|||
149195735|NCT03011840|538185123|FG001|Overall Study|Not received PIL in post PIL phase|21|||
149195736|NCT03738566|538185124|FG000|Initial Study Phase|Withdrawal by Subject|1|||
149195737|NCT03738566|538185125|FG001|Initial Study Phase|Withdrawal by Subject|1|||
149195738|NCT03738566|538185126|FG002|Initial Study Phase|Withdrawal by Subject|2|||
149195739|NCT03738566|538185127|FG003|Initial Study Phase|Withdrawal by Subject|0|||
149195740|NCT03738566|538185124|FG000|Initial Study Phase|Death|0|||
149195741|NCT03738566|538185125|FG001|Initial Study Phase|Death|1|||
149195742|NCT03738566|538185126|FG002|Initial Study Phase|Death|0|||
149195743|NCT03738566|538185127|FG003|Initial Study Phase|Death|0|||
149195744|NCT03738566|538185124|FG000|Initial Study Phase|Treatment failure|5|||
149195745|NCT03738566|538185125|FG001|Initial Study Phase|Treatment failure|0|||
149195746|NCT03738566|538185126|FG002|Initial Study Phase|Treatment failure|0|||
149195747|NCT03738566|538185127|FG003|Initial Study Phase|Treatment failure|0|||
149195748|NCT03738566|538185124|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
149195749|NCT03738566|538185125|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
149195750|NCT03738566|538185126|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
149195751|NCT03738566|538185127|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
149195752|NCT00516269|538185130|FG000|Overall Study|Adverse Event|2|||
149195753|NCT00516269|538185131|FG001|Overall Study|Adverse Event|1|||
149195754|NCT00516269|538185130|FG000|Overall Study|Lost to Follow-up|0|||
149195755|NCT00516269|538185131|FG001|Overall Study|Lost to Follow-up|1|||
149195756|NCT00516269|538185130|FG000|Overall Study|Protocol Violation|0|||
149195757|NCT00516269|538185131|FG001|Overall Study|Protocol Violation|1|||
149195758|NCT01341652|538185135|FG000|Overall Study|Incorrect Random Assignment|0|||
149195759|NCT01341652|538185136|FG001|Overall Study|Incorrect Random Assignment|1|||
149195760|NCT01341652|538185135|FG000|Overall Study|ineligible; presence metastatic disease|0|||
149195761|NCT01341652|538185136|FG001|Overall Study|ineligible; presence metastatic disease|1|||
149195762|NCT01079962|538185138|FG000|Overall Study|Adverse Event|2|||
149195763|NCT01079962|538185139|FG001|Overall Study|Adverse Event|2|||
148682413|NCT02041494|536310913|FG000|Overall Study|study terminated|16|||
148682414|NCT02041494|536310914|FG001|Overall Study|study terminated|11|||
148682415|NCT00685919|536310916|FG000|Overall Study|Withdrawal by Subject|0|||
149015164|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
149195764|NCT01079962|538185138|FG000|Overall Study|Withdrawal by Subject|5|||
149195765|NCT01079962|538185139|FG001|Overall Study|Withdrawal by Subject|7|||
149195766|NCT01079962|538185138|FG000|Overall Study|Protocol Violation|2|||
149195767|NCT01079962|538185139|FG001|Overall Study|Protocol Violation|2|||
149195768|NCT01079962|538185138|FG000|Overall Study|No blood pressure (BP) control|3|||
149195769|NCT01079962|538185139|FG001|Overall Study|No blood pressure (BP) control|0|||
149195770|NCT01079962|538185138|FG000|Overall Study|Inclusion/exclusion criteria|1|||
149195771|NCT01079962|538185139|FG001|Overall Study|Inclusion/exclusion criteria|3|||
149195772|NCT01079962|538185138|FG000|Overall Study|Participant not returning for next visit|1|||
149195773|NCT01079962|538185139|FG001|Overall Study|Participant not returning for next visit|0|||
149195774|NCT01079962|538185138|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
149195775|NCT01079962|538185139|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
149195776|NCT01331239|538185140|FG000|Part II: Core Study|Adverse Event|0|||
149195777|NCT01331239|538185141|FG001|Part II: Core Study|Adverse Event|3|||
149195778|NCT01331239|538185142|FG002|Part II: Core Study|Adverse Event|0|||
149195779|NCT01331239|538185140|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
149195780|NCT01331239|538185141|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
149195781|NCT01331239|538185142|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
149195782|NCT01331239|538185140|FG000|Part II: Core Study|Withdrawal by Subject|0|||
149195783|NCT01331239|538185141|FG001|Part II: Core Study|Withdrawal by Subject|2|||
149195784|NCT01331239|538185142|FG002|Part II: Core Study|Withdrawal by Subject|0|||
149195785|NCT01331239|538185140|FG000|Part II: Core Study|Administrative problems|0|||
149195786|NCT01331239|538185141|FG001|Part II: Core Study|Administrative problems|1|||
149195787|NCT01331239|538185142|FG002|Part II: Core Study|Administrative problems|0|||
149195788|NCT01072539|538185143|FG000|Overall Study|Treated prior to the Site Initiation|1|||
149195789|NCT01072539|538185143|FG000|Overall Study|Protocol Violation|2|||
149195790|NCT00946530|538185145|FG000|Overall Study|Withdrawal by Subject|0|||
149195791|NCT00946530|538185146|FG001|Overall Study|Withdrawal by Subject|3|||
149195792|NCT00946530|538185147|FG002|Overall Study|Withdrawal by Subject|0|||
149195793|NCT00946530|538185148|FG003|Overall Study|Withdrawal by Subject|3|||
149195794|NCT00946530|538185145|FG000|Overall Study|Physician Decision|1|||
149195795|NCT00946530|538185146|FG001|Overall Study|Physician Decision|1|||
149195796|NCT00946530|538185147|FG002|Overall Study|Physician Decision|1|||
149195797|NCT00946530|538185148|FG003|Overall Study|Physician Decision|1|||
149195798|NCT01008995|538185149|FG000|Controlled Period|Adverse Event|1|||
149195799|NCT01008995|538185150|FG001|Controlled Period|Adverse Event|2|||
149195800|NCT01008995|538185151|FG002|Controlled Period|Adverse Event|0|||
149195801|NCT01008995|538185152|FG003|Controlled Period|Adverse Event|0|||
149195802|NCT01008995|538185149|FG000|Controlled Period|Other|2|||
149195803|NCT01008995|538185150|FG001|Controlled Period|Other|1|||
149195804|NCT01008995|538185151|FG002|Controlled Period|Other|0|||
149195805|NCT01008995|538185152|FG003|Controlled Period|Other|0|||
149195806|NCT01008995|538185149|FG000|After Controlled Period|Adverse Event|0|||
149195807|NCT01008995|538185150|FG001|After Controlled Period|Adverse Event|0|||
149195808|NCT01008995|538185151|FG002|After Controlled Period|Adverse Event|1|||
149195809|NCT01008995|538185152|FG003|After Controlled Period|Adverse Event|1|||
149195810|NCT01008995|538185149|FG000|After Controlled Period|Other|0|||
149195811|NCT01008995|538185150|FG001|After Controlled Period|Other|0|||
149195812|NCT01008995|538185151|FG002|After Controlled Period|Other|1|||
149195813|NCT01008995|538185152|FG003|After Controlled Period|Other|0|||
149195814|NCT00115804|538185155|FG000|Overall Study|Adverse Event|2|||
149195815|NCT00621855|538185156|FG000|Overall Study|Adverse Event|32|||
149195816|NCT00621855|538185157|FG001|Overall Study|Adverse Event|31|||
149195817|NCT00621855|538185158|FG002|Overall Study|Adverse Event|48|||
149195818|NCT00621855|538185159|FG003|Overall Study|Adverse Event|34|||
149195819|NCT00621855|538185160|FG004|Overall Study|Adverse Event|31|||
149195820|NCT00621855|538185156|FG000|Overall Study|Lost to Follow-up|0|||
149195821|NCT00621855|538185157|FG001|Overall Study|Lost to Follow-up|1|||
149195822|NCT00621855|538185158|FG002|Overall Study|Lost to Follow-up|3|||
149195823|NCT00621855|538185159|FG003|Overall Study|Lost to Follow-up|4|||
149195824|NCT00621855|538185160|FG004|Overall Study|Lost to Follow-up|1|||
149195825|NCT00621855|538185156|FG000|Overall Study|Protocol Violation|16|||
149195826|NCT00621855|538185157|FG001|Overall Study|Protocol Violation|8|||
149195827|NCT00621855|538185158|FG002|Overall Study|Protocol Violation|6|||
149195828|NCT00621855|538185159|FG003|Overall Study|Protocol Violation|7|||
149195829|NCT00621855|538185160|FG004|Overall Study|Protocol Violation|8|||
149195830|NCT00621855|538185156|FG000|Overall Study|Withdrawal by Subject|16|||
149195831|NCT00621855|538185157|FG001|Overall Study|Withdrawal by Subject|11|||
149195832|NCT00621855|538185158|FG002|Overall Study|Withdrawal by Subject|13|||
149195833|NCT00621855|538185159|FG003|Overall Study|Withdrawal by Subject|13|||
149195834|NCT00621855|538185160|FG004|Overall Study|Withdrawal by Subject|9|||
149195835|NCT00621855|538185156|FG000|Overall Study|Other|9|||
149195836|NCT00621855|538185157|FG001|Overall Study|Other|7|||
149195837|NCT00621855|538185158|FG002|Overall Study|Other|6|||
149195838|NCT00621855|538185159|FG003|Overall Study|Other|5|||
149195839|NCT00621855|538185160|FG004|Overall Study|Other|4|||
149195840|NCT00621855|538185156|FG000|Overall Study|Patients did not receive study drug|3|||
149195841|NCT00621855|538185157|FG001|Overall Study|Patients did not receive study drug|3|||
149195842|NCT00621855|538185158|FG002|Overall Study|Patients did not receive study drug|5|||
149195843|NCT00621855|538185159|FG003|Overall Study|Patients did not receive study drug|4|||
149195844|NCT00621855|538185160|FG004|Overall Study|Patients did not receive study drug|2|||
149195845|NCT03675737|538185161|FG000|Overall Study|Death|593|||
149195846|NCT03675737|538185162|FG001|Overall Study|Death|660|||
149195847|NCT03675737|538185161|FG000|Overall Study|Lost to Follow-up|1|||
149195848|NCT03675737|538185162|FG001|Overall Study|Lost to Follow-up|5|||
149195849|NCT03675737|538185161|FG000|Overall Study|Physician Decision|1|||
149195850|NCT03675737|538185162|FG001|Overall Study|Physician Decision|0|||
149195851|NCT03675737|538185161|FG000|Overall Study|Withdrawal by Subject|14|||
149195852|NCT03675737|538185162|FG001|Overall Study|Withdrawal by Subject|12|||
149195853|NCT03675737|538185161|FG000|Overall Study|Ongoing in Study|181|||
149195854|NCT03675737|538185162|FG001|Overall Study|Ongoing in Study|112|||
149195855|NCT00605722|538187191|FG000|Overall Study|Adverse Event|6|||
149195856|NCT00605722|538187191|FG000|Overall Study|Insufficient therapeutic response|44|||
149195857|NCT00605722|538187191|FG000|Overall Study|Failure to return|1|||
149195858|NCT00356863|538187194|FG000|Overall Study|Death|16|||
149195859|NCT00356863|538187195|FG001|Overall Study|Death|32|||
149195860|NCT00356863|538187194|FG000|Overall Study|Lost to Follow-up|76|||
149195861|NCT00356863|538187195|FG001|Overall Study|Lost to Follow-up|43|||
149195862|NCT02871401|538187197|FG000|Overall Study|Adverse Event|1|||
149195863|NCT02871401|538187198|FG001|Overall Study|Adverse Event|0|||
149195864|NCT01993615|538187202|FG000|Overall Study|Death|1|||
149195865|NCT01993615|538187203|FG001|Overall Study|Death|0|||
149195866|NCT01354353|538187206|FG000|Overall Study|Adverse Event|1|||
149195867|NCT01354353|538187207|FG001|Overall Study|Adverse Event|0|||
149195868|NCT01354353|538187208|FG002|Overall Study|Adverse Event|0|||
149195869|NCT01354353|538187209|FG003|Overall Study|Adverse Event|4|||
149195870|NCT01354353|538187210|FG004|Overall Study|Adverse Event|0|||
149195871|NCT01354353|538187211|FG005|Overall Study|Adverse Event|5|||
149195872|NCT01354353|538187206|FG000|Overall Study|Entry Criteria Not Met|0|||
149195873|NCT01354353|538187207|FG001|Overall Study|Entry Criteria Not Met|0|||
149195874|NCT01354353|538187208|FG002|Overall Study|Entry Criteria Not Met|0|||
149195875|NCT01354353|538187209|FG003|Overall Study|Entry Criteria Not Met|1|||
149195876|NCT01354353|538187210|FG004|Overall Study|Entry Criteria Not Met|1|||
149195877|NCT01354353|538187211|FG005|Overall Study|Entry Criteria Not Met|0|||
149195878|NCT01354353|538187206|FG000|Overall Study|Physician Decision|0|||
149195879|NCT01354353|538187207|FG001|Overall Study|Physician Decision|1|||
149195880|NCT01354353|538187208|FG002|Overall Study|Physician Decision|1|||
149195881|NCT01354353|538187209|FG003|Overall Study|Physician Decision|0|||
149195882|NCT01354353|538187210|FG004|Overall Study|Physician Decision|0|||
149195883|NCT01354353|538187211|FG005|Overall Study|Physician Decision|0|||
149195884|NCT01354353|538187206|FG000|Overall Study|Withdrawal by Subject|2|||
149195885|NCT01354353|538187207|FG001|Overall Study|Withdrawal by Subject|0|||
149195886|NCT01354353|538187208|FG002|Overall Study|Withdrawal by Subject|1|||
149195887|NCT01354353|538187209|FG003|Overall Study|Withdrawal by Subject|0|||
149195888|NCT01354353|538187210|FG004|Overall Study|Withdrawal by Subject|0|||
149195889|NCT01354353|538187211|FG005|Overall Study|Withdrawal by Subject|1|||
149195890|NCT02924688|538187214|FG000|Overall Study|Adverse Event|9|||
149195891|NCT02924688|538187215|FG001|Overall Study|Adverse Event|3|||
149195892|NCT02924688|538187216|FG002|Overall Study|Adverse Event|2|||
149195893|NCT02924688|538187217|FG003|Overall Study|Adverse Event|2|||
149195894|NCT02924688|538187218|FG004|Overall Study|Adverse Event|3|||
149195895|NCT02924688|538187219|FG005|Overall Study|Adverse Event|2|||
149195896|NCT02924688|538187214|FG000|Overall Study|Lack of Efficacy|2|||
149195897|NCT02924688|538187215|FG001|Overall Study|Lack of Efficacy|3|||
149195898|NCT02924688|538187216|FG002|Overall Study|Lack of Efficacy|4|||
149195899|NCT02924688|538187217|FG003|Overall Study|Lack of Efficacy|2|||
149195900|NCT02924688|538187218|FG004|Overall Study|Lack of Efficacy|1|||
149195901|NCT02924688|538187219|FG005|Overall Study|Lack of Efficacy|1|||
149195902|NCT02924688|538187214|FG000|Overall Study|Protocol Violation|3|||
149195903|NCT02924688|538187215|FG001|Overall Study|Protocol Violation|7|||
149195904|NCT02924688|538187216|FG002|Overall Study|Protocol Violation|5|||
149195905|NCT02924688|538187217|FG003|Overall Study|Protocol Violation|6|||
149195906|NCT02924688|538187218|FG004|Overall Study|Protocol Violation|2|||
149195907|NCT02924688|538187219|FG005|Overall Study|Protocol Violation|2|||
149195908|NCT02924688|538187214|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
149195909|NCT02924688|538187215|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
149195910|NCT02924688|538187216|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
149195911|NCT02924688|538187217|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
149195912|NCT02924688|538187218|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
149195913|NCT02924688|538187219|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
149195914|NCT02924688|538187214|FG000|Overall Study|Lost to Follow-up|2|||
149195915|NCT02924688|538187215|FG001|Overall Study|Lost to Follow-up|4|||
149195916|NCT02924688|538187216|FG002|Overall Study|Lost to Follow-up|2|||
149195917|NCT02924688|538187217|FG003|Overall Study|Lost to Follow-up|4|||
149195918|NCT02924688|538187218|FG004|Overall Study|Lost to Follow-up|2|||
149195919|NCT02924688|538187219|FG005|Overall Study|Lost to Follow-up|4|||
149195920|NCT02924688|538187214|FG000|Overall Study|Physician Decision|2|||
149195921|NCT02924688|538187215|FG001|Overall Study|Physician Decision|1|||
149195922|NCT02924688|538187216|FG002|Overall Study|Physician Decision|0|||
149195923|NCT02924688|538187217|FG003|Overall Study|Physician Decision|1|||
149195924|NCT02924688|538187218|FG004|Overall Study|Physician Decision|1|||
149195925|NCT02924688|538187219|FG005|Overall Study|Physician Decision|1|||
149195926|NCT02924688|538187214|FG000|Overall Study|Withdrawal by Subject|14|||
149195927|NCT02924688|538187215|FG001|Overall Study|Withdrawal by Subject|13|||
149195928|NCT02924688|538187216|FG002|Overall Study|Withdrawal by Subject|9|||
149195929|NCT02924688|538187217|FG003|Overall Study|Withdrawal by Subject|12|||
149195930|NCT02924688|538187218|FG004|Overall Study|Withdrawal by Subject|13|||
149195931|NCT02924688|538187219|FG005|Overall Study|Withdrawal by Subject|14|||
149195932|NCT01104584|538187224|FG000|Overall Study|Study drug never administered|21|||
149195933|NCT01104584|538187224|FG000|Overall Study|Study prematurely discontinued|2|||
149195934|NCT02370498|538187225|FG000|Overall Study|Adverse Event|10|||
149015165|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
149015166|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
149015167|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
149015168|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
149015169|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
149015170|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
149015171|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
149015172|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
149015173|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
149015174|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
149015175|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
149015176|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
149015177|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
149015178|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
149015179|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
149015180|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
149015181|NCT03904693|537534398|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
149015182|NCT03904693|537534399|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
149015183|NCT03904693|537534400|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
149015184|NCT03904693|537534401|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
149015185|NCT03904693|537534402|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
149015186|NCT03904693|537534403|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
149015187|NCT04654468|537534404|FG000|Overall Study|Death|1|||
149015188|NCT04654468|537534404|FG000|Overall Study|Ongoing in the Study|50|||
149015189|NCT06390826|537534405|FG000|Overall Study|Never Start Protocol Therapy|1|||
149015190|NCT06390826|537534405|FG000|Overall Study|Adverse Event|1|||
149015191|NCT06390826|537534405|FG000|Overall Study|Disease Progression|8|||
149015192|NCT01155661|537534406|FG000|Overall Study|Adverse Event|101|||
149015193|NCT01155661|537534406|FG000|Overall Study|Death|1|||
149015194|NCT01155661|537534406|FG000|Overall Study|Lack of Efficacy|32|||
149015195|NCT01155661|537534406|FG000|Overall Study|Lost to Follow-up|22|||
149015196|NCT01155661|537534406|FG000|Overall Study|Physician Decision|3|||
149195935|NCT02370498|538187226|FG001|Overall Study|Adverse Event|8|||
149195936|NCT02370498|538187225|FG000|Overall Study|Death|263|||
149195937|NCT02370498|538187226|FG001|Overall Study|Death|265|||
149195938|NCT02370498|538187225|FG000|Overall Study|Protocol Violation|1|||
149195939|NCT02370498|538187226|FG001|Overall Study|Protocol Violation|2|||
149195940|NCT02370498|538187225|FG000|Overall Study|Withdrawal by Subject|7|||
149195941|NCT02370498|538187226|FG001|Overall Study|Withdrawal by Subject|12|||
149195942|NCT02370498|538187225|FG000|Overall Study|Sponsor's decision|15|||
149195943|NCT02370498|538187226|FG001|Overall Study|Sponsor's decision|9|||
149015197|NCT01155661|537534406|FG000|Overall Study|Protocol Violation|35|||
149015198|NCT01155661|537534406|FG000|Overall Study|Withdrawal by Subject|73|||
149195944|NCT04017442|538187227|FG000|Overall Study|Withdrawal by Subject|0|||
149195945|NCT04017442|538187228|FG001|Overall Study|Withdrawal by Subject|3|||
149195946|NCT04017442|538187227|FG000|Overall Study|Lost to Follow-up|21|||
149195947|NCT04017442|538187228|FG001|Overall Study|Lost to Follow-up|19|||
149195948|NCT02586233|538187232|FG000|Overall Study|Randomized but did not receive treatment|0|||
149195949|NCT02586233|538187233|FG001|Overall Study|Randomized but did not receive treatment|1|||
149195950|NCT02586233|538187234|FG002|Overall Study|Randomized but did not receive treatment|0|||
149195951|NCT02586233|538187235|FG003|Overall Study|Randomized but did not receive treatment|0|||
149195952|NCT02586233|538187236|FG004|Overall Study|Randomized but did not receive treatment|0|||
149195953|NCT02586233|538187237|FG005|Overall Study|Randomized but did not receive treatment|2|||
148682416|NCT00685919|536310917|FG001|Overall Study|Withdrawal by Subject|0|||
149195954|NCT02586233|538187238|FG006|Overall Study|Randomized but did not receive treatment|2|||
149195955|NCT02586233|538187232|FG000|Overall Study|Death|0|||
149195956|NCT02586233|538187233|FG001|Overall Study|Death|1|||
149195957|NCT02586233|538187234|FG002|Overall Study|Death|0|||
149195958|NCT02586233|538187235|FG003|Overall Study|Death|0|||
149195959|NCT02586233|538187236|FG004|Overall Study|Death|2|||
149195960|NCT02586233|538187237|FG005|Overall Study|Death|0|||
149195961|NCT02586233|538187238|FG006|Overall Study|Death|0|||
149195962|NCT03225716|538187239|FG000|Overall Study|Withdrawal by Subject|2|||
149195963|NCT03225716|538187240|FG001|Overall Study|Withdrawal by Subject|2|||
149195964|NCT03225716|538187241|FG002|Overall Study|Withdrawal by Subject|0|||
149195965|NCT03225716|538187239|FG000|Overall Study|Lack of Efficacy|1|||
149195966|NCT03225716|538187240|FG001|Overall Study|Lack of Efficacy|0|||
149195967|NCT03225716|538187241|FG002|Overall Study|Lack of Efficacy|0|||
149195968|NCT03225716|538187239|FG000|Overall Study|Adverse Event|2|||
149195969|NCT03225716|538187240|FG001|Overall Study|Adverse Event|0|||
149195970|NCT03225716|538187241|FG002|Overall Study|Adverse Event|1|||
149195971|NCT03225716|538187239|FG000|Overall Study|Study early termination by Sponsor|0|||
149195972|NCT03225716|538187240|FG001|Overall Study|Study early termination by Sponsor|0|||
149195973|NCT03225716|538187241|FG002|Overall Study|Study early termination by Sponsor|2|||
149195974|NCT00848250|538187242|FG000|Overall Study|surgery was completed without cardiopulm|0|||
149195975|NCT00848250|538187243|FG001|Overall Study|surgery was completed without cardiopulm|1|||
149195976|NCT01205451|538187251|FG000|Overall Study|Lost to Follow-up|1|||
149195977|NCT01205451|538187252|FG001|Overall Study|Lost to Follow-up|1|||
149195978|NCT01205451|538187251|FG000|Overall Study|Withdrawal by Subject|5|||
149195979|NCT01205451|538187252|FG001|Overall Study|Withdrawal by Subject|9|||
148938494|NCT02975336|537258697|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
149195980|NCT02106455|538187264|FG000|Overall Study|Case Report Form Uncollected|6|||
149195981|NCT02106455|538187264|FG000|Overall Study|Protocol Deviation|2|||
149195982|NCT00213980|538187265|FG000|Overall Study|Withdrawal by Subject|3|||
149195983|NCT00213980|538187266|FG001|Overall Study|Withdrawal by Subject|1|||
149195984|NCT00213980|538187265|FG000|Overall Study|Adverse Event|1|||
149195985|NCT00213980|538187266|FG001|Overall Study|Adverse Event|1|||
149195986|NCT00213980|538187265|FG000|Overall Study|Disease progression|0|||
149195987|NCT00213980|538187266|FG001|Overall Study|Disease progression|2|||
149195988|NCT00213980|538187265|FG000|Overall Study|Developed ovarian cancer|1|||
149195989|NCT00213980|538187266|FG001|Overall Study|Developed ovarian cancer|0|||
149195990|NCT00213980|538187265|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
149195991|NCT00213980|538187266|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
149195992|NCT03607838|538187267|FG000|Overall Study|Lack of Efficacy|14|||
149195993|NCT03607838|538187268|FG001|Overall Study|Lack of Efficacy|20|||
149195994|NCT03607838|538187267|FG000|Overall Study|Withdrawal by Subject|13|||
149195995|NCT03607838|538187268|FG001|Overall Study|Withdrawal by Subject|8|||
149195996|NCT03607838|538187267|FG000|Overall Study|Lost to Follow-up|6|||
149195997|NCT03607838|538187268|FG001|Overall Study|Lost to Follow-up|11|||
149195998|NCT03607838|538187267|FG000|Overall Study|Adverse Event|2|||
149195999|NCT03607838|538187268|FG001|Overall Study|Adverse Event|2|||
149196000|NCT03607838|538187267|FG000|Overall Study|Physician Decision|2|||
149196001|NCT03607838|538187268|FG001|Overall Study|Physician Decision|0|||
149196002|NCT03607838|538187267|FG000|Overall Study|Failure to meet randomization criteria|1|||
149196003|NCT03607838|538187268|FG001|Overall Study|Failure to meet randomization criteria|2|||
149196004|NCT03607838|538187267|FG000|Overall Study|Pregnancy|1|||
149196005|NCT03607838|538187268|FG001|Overall Study|Pregnancy|0|||
149196006|NCT03607838|538187267|FG000|Overall Study|Protocol Violation|1|||
149196007|NCT03607838|538187268|FG001|Overall Study|Protocol Violation|0|||
149196008|NCT03607838|538187267|FG000|Overall Study|Due to work|1|||
149196009|NCT03607838|538187268|FG001|Overall Study|Due to work|0|||
149196010|NCT03607838|538187267|FG000|Overall Study|Litigation|0|||
149196011|NCT03607838|538187268|FG001|Overall Study|Litigation|1|||
149196012|NCT03607838|538187267|FG000|Overall Study|Temperature excursion for study drug|0|||
149196013|NCT03607838|538187268|FG001|Overall Study|Temperature excursion for study drug|1|||
149196014|NCT03607838|538187267|FG000|Overall Study|Change of mind|0|||
149196015|NCT03607838|538187268|FG001|Overall Study|Change of mind|1|||
149196016|NCT02411201|538187269|FG000|Overall Study|Adverse Event|2|||
149196017|NCT02411201|538187269|FG000|Overall Study|Withdrawal by Subject|2|||
149196018|NCT02411201|538187269|FG000|Overall Study|Age group completed|2|||
149196019|NCT01260467|538187270|FG000|Overall Study|Withdrawal by Subject|2|||
149196020|NCT00798694|538187271|FG000|Overall Study|Lost to Follow-up|1|||
149196021|NCT00798694|538187272|FG001|Overall Study|Lost to Follow-up|1|||
149196022|NCT00798694|538187271|FG000|Overall Study|Physician Decision|1|||
149196023|NCT00798694|538187272|FG001|Overall Study|Physician Decision|0|||
149196024|NCT01774344|538187274|FG000|Overall Study|Withdrawal by Subject|3|||
149196025|NCT01774344|538187275|FG001|Overall Study|Withdrawal by Subject|10|||
149196026|NCT01774344|538187274|FG000|Overall Study|Protocol Violation|0|||
149196027|NCT01774344|538187275|FG001|Overall Study|Protocol Violation|1|||
149196028|NCT01774344|538187274|FG000|Overall Study|Lost to Follow-up|4|||
149196029|NCT01774344|538187275|FG001|Overall Study|Lost to Follow-up|10|||
149196030|NCT01774344|538187274|FG000|Overall Study|End of survival follow-up not available|2|||
149196031|NCT01774344|538187275|FG001|Overall Study|End of survival follow-up not available|2|||
149196032|NCT01774344|538187274|FG000|Overall Study|Data collection finished|4|||
149196033|NCT01774344|538187275|FG001|Overall Study|Data collection finished|14|||
149196034|NCT01774344|538187274|FG000|Overall Study|Other|0|||
148682417|NCT00685919|536310918|FG002|Overall Study|Withdrawal by Subject|1|||
148938495|NCT02975336|537258698|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
149196035|NCT01774344|538187275|FG001|Overall Study|Other|1|||
149196036|NCT01774344|538187274|FG000|Overall Study|Did not enter Survival Follow up|49|||
148938496|NCT02975336|537258699|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
148938497|NCT02975336|537258692|FG000|LTE (104 Weeks)|Other|0|||
148938498|NCT02975336|537258693|FG001|LTE (104 Weeks)|Other|0|||
148938499|NCT02975336|537258694|FG002|LTE (104 Weeks)|Other|0|||
149196037|NCT01774344|538187275|FG001|Overall Study|Did not enter Survival Follow up|83|||
149196038|NCT03364608|538187284|FG000|Overall Study|Withdrawal by Subject|4|||
149196039|NCT03364608|538187284|FG000|Overall Study|Protocol Violation|2|||
149196040|NCT03364608|538187284|FG000|Overall Study|Lost to Follow-up|2|||
149196041|NCT02124707|538187290|FG000|Overall Study|Adverse Event|5|||
149196042|NCT02124707|538187290|FG000|Overall Study|Physician Decision|1|||
149196043|NCT02124707|538187290|FG000|Overall Study|Death|1|||
149196044|NCT01363713|538187291|FG000|Overall Study|Adverse Event|1|||
149196045|NCT01363713|538187291|FG000|Overall Study|Protocol Violation|3|||
149196046|NCT01363713|538187291|FG000|Overall Study|Withdrawal by Subject|2|||
149196047|NCT01199055|538187292|FG000|Overall Study|Death|0|||
149196048|NCT01199055|538187293|FG001|Overall Study|Death|1|||
149196049|NCT01199055|538187294|FG002|Overall Study|Death|0|||
149196050|NCT01199055|538187292|FG000|Overall Study|Physician Decision|0|||
149196051|NCT01199055|538187293|FG001|Overall Study|Physician Decision|1|||
149196052|NCT01199055|538187294|FG002|Overall Study|Physician Decision|1|||
149196053|NCT01199055|538187292|FG000|Overall Study|Progressive disease|2|||
149196054|NCT01199055|538187293|FG001|Overall Study|Progressive disease|1|||
149196055|NCT01199055|538187294|FG002|Overall Study|Progressive disease|2|||
149196056|NCT01199055|538187292|FG000|Overall Study|Withdrawal by Subject|0|||
149196057|NCT01199055|538187293|FG001|Overall Study|Withdrawal by Subject|0|||
149196058|NCT01199055|538187294|FG002|Overall Study|Withdrawal by Subject|1|||
149196059|NCT01875367|538187296|FG000|Overall Study|Not complete at least 2 questionaries|4|||
149196060|NCT01875367|538187297|FG001|Overall Study|Not complete at least 2 questionaries|2|||
149196061|NCT01875367|538187296|FG000|Overall Study|Not receive study treatment|1|||
149196062|NCT01875367|538187297|FG001|Overall Study|Not receive study treatment|0|||
149196063|NCT03977727|538187298|FG000|Second Treatment|Lost to Follow-up|0|||
149196064|NCT03977727|538187299|FG001|Second Treatment|Lost to Follow-up|3|||
149196065|NCT01419665|538187300|FG000|Combination Treatment|Adverse Event|7|||
149196066|NCT01419665|538187301|FG001|Combination Treatment|Adverse Event|10|||
149196067|NCT01419665|538187300|FG000|Combination Treatment|Physician Decision|5|||
149196068|NCT01419665|538187301|FG001|Combination Treatment|Physician Decision|8|||
149196069|NCT01419665|538187300|FG000|Combination Treatment|Protocol Violation|6|||
149196070|NCT01419665|538187301|FG001|Combination Treatment|Protocol Violation|2|||
149196071|NCT01419665|538187300|FG000|Combination Treatment|disease progression|10|||
149196072|NCT01419665|538187301|FG001|Combination Treatment|disease progression|9|||
149196073|NCT01419665|538187300|FG000|Combination Treatment|Death|5|||
149196074|NCT01419665|538187301|FG001|Combination Treatment|Death|7|||
149196075|NCT01419665|538187300|FG000|Combination Treatment|administrative problems|0|||
149196076|NCT01419665|538187301|FG001|Combination Treatment|administrative problems|1|||
149196077|NCT01419665|538187300|FG000|Combination Treatment|Withdrawal by Subject|5|||
149196078|NCT01419665|538187301|FG001|Combination Treatment|Withdrawal by Subject|4|||
149196079|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
149196080|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
149196081|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
149196082|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
149196083|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
149196084|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
149196085|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
149196086|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
149196087|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
149196088|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
149196089|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
149196090|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
149196091|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|Death|1|||
149196092|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|Death|2|||
149196093|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
149196094|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
149196095|NCT01419665|538187300|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
149196096|NCT01419665|538187301|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
149196097|NCT01419665|538187300|FG000|Open Label Phase|Death|1|||
149196098|NCT01419665|538187301|FG001|Open Label Phase|Death|0|||
148807946|NCT03573297|536774477|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
148938500|NCT02975336|537258695|FG003|LTE (104 Weeks)|Other|0|||
148938501|NCT02975336|537258696|FG004|LTE (104 Weeks)|Other|55|||
149196099|NCT01419665|538187300|FG000|Open Label Phase|disease progression|0|||
149196100|NCT01419665|538187301|FG001|Open Label Phase|disease progression|1|||
149196101|NCT00926796|538187303|FG000|Overall Study|Did not receive randomized treatment|4|||
149196102|NCT00926796|538187304|FG001|Overall Study|Did not receive randomized treatment|7|||
149196103|NCT00926796|538187303|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
149196104|NCT00926796|538187304|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
149196105|NCT00926796|538187303|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
149196106|NCT00926796|538187304|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
149196107|NCT00926796|538187303|FG000|Overall Study|Adverse Event|7|||
149196108|NCT00926796|538187304|FG001|Overall Study|Adverse Event|14|||
149196109|NCT00926796|538187303|FG000|Overall Study|Lost to Follow-up|22|||
149196110|NCT00926796|538187304|FG001|Overall Study|Lost to Follow-up|13|||
149196111|NCT00926796|538187303|FG000|Overall Study|Protocol Violation|15|||
149196112|NCT00926796|538187304|FG001|Overall Study|Protocol Violation|11|||
149196113|NCT00926796|538187303|FG000|Overall Study|Withdrawal by Subject|1|||
149196114|NCT00926796|538187304|FG001|Overall Study|Withdrawal by Subject|0|||
149196115|NCT03731364|538187305|FG000|Overall Study|Adverse Event|0|||
149196116|NCT03731364|538187306|FG001|Overall Study|Adverse Event|0|||
149196117|NCT03731364|538187307|FG002|Overall Study|Adverse Event|1|||
149196118|NCT03731364|538187308|FG003|Overall Study|Adverse Event|2|||
149196119|NCT03731364|538187309|FG004|Overall Study|Adverse Event|1|||
149196120|NCT02953782|538187310|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
149196121|NCT02953782|538187311|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
149196122|NCT02953782|538187312|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
149196123|NCT02953782|538187313|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
149196124|NCT02953782|538187314|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
149196125|NCT02953782|538187315|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
149196126|NCT02953782|538187316|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
149196127|NCT02953782|538187317|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
149196128|NCT02953782|538187310|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
149196129|NCT02953782|538187311|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149196130|NCT02953782|538187312|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
149196131|NCT02953782|538187313|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149196132|NCT02953782|538187314|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
149196133|NCT02953782|538187315|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149196134|NCT02953782|538187316|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149196135|NCT02953782|538187317|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
149196136|NCT02953782|538187310|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149196137|NCT02953782|538187311|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
149196138|NCT02953782|538187312|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149196139|NCT02953782|538187313|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
149196140|NCT02953782|538187314|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
149196141|NCT02953782|538187315|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149196142|NCT02953782|538187316|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149196143|NCT02953782|538187317|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
149196144|NCT02953782|538187310|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149196145|NCT02953782|538187311|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149196146|NCT02953782|538187312|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
148682418|NCT00685919|536310919|FG003|Overall Study|Withdrawal by Subject|0|||
148682419|NCT00685919|536310916|FG000|Overall Study|Physician Decision|1|||
148682420|NCT00685919|536310917|FG001|Overall Study|Physician Decision|0|||
148682421|NCT00685919|536310918|FG002|Overall Study|Physician Decision|0|||
148682422|NCT00685919|536310919|FG003|Overall Study|Physician Decision|0|||
148682423|NCT02732561|536310927|FG000|Overall Study|Lost to Follow-up|1|||
148682424|NCT02732561|536310928|FG001|Overall Study|Lost to Follow-up|1|||
148682425|NCT02732561|536310927|FG000|Overall Study|Withdrawal by Subject|1|||
148682426|NCT02732561|536310928|FG001|Overall Study|Withdrawal by Subject|0|||
148682427|NCT01886300|536310929|FG000|Overall Study|Trial terminated by sponsor|16|||
148682428|NCT01797120|536310932|FG000|Overall Study|Disesae progression|37|||
148682429|NCT01797120|536310933|FG001|Overall Study|Disesae progression|49|||
148682430|NCT01797120|536310932|FG000|Overall Study|Adverse Event|13|||
148682431|NCT01797120|536310933|FG001|Overall Study|Adverse Event|5|||
148938502|NCT02975336|537258697|FG005|LTE (104 Weeks)|Other|63|||
148938503|NCT02975336|537258698|FG006|LTE (104 Weeks)|Other|76|||
148938504|NCT02975336|537258699|FG007|LTE (104 Weeks)|Other|72|||
148938505|NCT01977794|537258701|FG000|Overall Study|Adverse Event|2|||
149196147|NCT02953782|538187313|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
149196148|NCT02953782|538187314|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149196149|NCT02953782|538187315|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
148682432|NCT01797120|536310932|FG000|Overall Study|Withdrawal by Subject|6|||
148938506|NCT01977794|537258702|FG001|Overall Study|Adverse Event|2|||
148682433|NCT01797120|536310933|FG001|Overall Study|Withdrawal by Subject|6|||
148682434|NCT01797120|536310932|FG000|Overall Study|Symptomatic progression|2|||
148682435|NCT01797120|536310933|FG001|Overall Study|Symptomatic progression|1|||
148682436|NCT01797120|536310932|FG000|Overall Study|Non-compliance|1|||
149196150|NCT02953782|538187316|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149196151|NCT02953782|538187317|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
149196152|NCT02953782|538187310|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149196153|NCT02953782|538187311|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149196154|NCT02953782|538187312|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149196155|NCT02953782|538187313|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149196156|NCT02953782|538187314|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
149196157|NCT02953782|538187315|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
149196158|NCT02953782|538187316|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
149196159|NCT02953782|538187317|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
149196160|NCT02953782|538187310|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149196161|NCT02953782|538187311|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149196162|NCT02953782|538187312|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149196163|NCT02953782|538187313|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149196164|NCT02953782|538187314|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
149196165|NCT02953782|538187315|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
149196166|NCT02953782|538187316|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
149196167|NCT02953782|538187317|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
149196168|NCT02953782|538187310|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149196169|NCT02953782|538187311|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149196170|NCT02953782|538187312|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149196171|NCT02953782|538187313|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149196172|NCT02953782|538187314|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
149196173|NCT02953782|538187315|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
149196174|NCT02953782|538187316|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
149196175|NCT02953782|538187317|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
149196176|NCT02953782|538187310|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196177|NCT02953782|538187311|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196178|NCT02953782|538187312|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196179|NCT02953782|538187313|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196180|NCT02953782|538187314|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196181|NCT02953782|538187315|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196182|NCT02953782|538187316|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
149196183|NCT02953782|538187317|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
149196184|NCT01934192|538187320|FG000|Overall Study|Protocol Violation|0|||
149196185|NCT01934192|538187321|FG001|Overall Study|Protocol Violation|0|||
149196186|NCT01934192|538187322|FG002|Overall Study|Protocol Violation|0|||
149196187|NCT01934192|538187323|FG003|Overall Study|Protocol Violation|1|||
149196188|NCT01934192|538187320|FG000|Overall Study|Other: reached stopping criteria|6|||
149196189|NCT01934192|538187321|FG001|Overall Study|Other: reached stopping criteria|5|||
149196190|NCT01934192|538187322|FG002|Overall Study|Other: reached stopping criteria|1|||
149196191|NCT01934192|538187323|FG003|Overall Study|Other: reached stopping criteria|0|||
149196192|NCT01934192|538187320|FG000|Overall Study|Physician Decision|3|||
149196193|NCT01934192|538187321|FG001|Overall Study|Physician Decision|2|||
149196194|NCT01934192|538187322|FG002|Overall Study|Physician Decision|0|||
149196195|NCT01934192|538187323|FG003|Overall Study|Physician Decision|0|||
149196196|NCT01737840|538187324|FG000|Overall Study|Diagnosed with an other pathology|2|||
149196197|NCT01737840|538187325|FG001|Overall Study|Diagnosed with an other pathology|2|||
149196198|NCT03105700|538187328|FG000|Overall Study|screen fail|3|||
149196199|NCT03105700|538187328|FG000|Overall Study|Lost to Follow-up|4|||
149196200|NCT02768194|538187329|FG000|Period 1|Adverse Event|0|||
149196201|NCT02768194|538187330|FG001|Period 1|Adverse Event|0|||
149196202|NCT02768194|538187331|FG002|Period 1|Adverse Event|0|||
149196203|NCT02768194|538187332|FG003|Period 1|Adverse Event|1|||
149196204|NCT02768194|538187333|FG004|Period 1|Adverse Event|0|||
149196205|NCT02768194|538187334|FG005|Period 1|Adverse Event|0|||
149196206|NCT02768194|538187329|FG000|Period 2|Other (Reason not specified)|1|||
149196207|NCT02768194|538187330|FG001|Period 2|Other (Reason not specified)|0|||
149196208|NCT02768194|538187331|FG002|Period 2|Other (Reason not specified)|0|||
149196209|NCT02768194|538187332|FG003|Period 2|Other (Reason not specified)|0|||
149196210|NCT02768194|538187333|FG004|Period 2|Other (Reason not specified)|0|||
149196211|NCT02768194|538187334|FG005|Period 2|Other (Reason not specified)|0|||
148682437|NCT01797120|536310933|FG001|Overall Study|Non-compliance|0|||
149196212|NCT02768194|538187329|FG000|Period 3|Other (Reason not specified)|0|||
149196213|NCT02768194|538187330|FG001|Period 3|Other (Reason not specified)|1|||
149196214|NCT02768194|538187331|FG002|Period 3|Other (Reason not specified)|0|||
149196215|NCT02768194|538187332|FG003|Period 3|Other (Reason not specified)|0|||
149196216|NCT02768194|538187333|FG004|Period 3|Other (Reason not specified)|0|||
149196217|NCT02768194|538187334|FG005|Period 3|Other (Reason not specified)|0|||
149196218|NCT03089216|538187337|FG000|Overall Study|Adverse Event|0|||
149196219|NCT03089216|538187338|FG001|Overall Study|Adverse Event|0|||
149196220|NCT03089216|538187339|FG002|Overall Study|Adverse Event|0|||
149196221|NCT03089216|538187340|FG003|Overall Study|Adverse Event|1|||
149196222|NCT03095521|538187341|FG000|Overall Study|Withdrawal by Subject|0|||
149196223|NCT03095521|538187342|FG001|Overall Study|Withdrawal by Subject|1|||
149196224|NCT03095521|538187341|FG000|Overall Study|Lost to Follow-up|0|||
149196225|NCT03095521|538187342|FG001|Overall Study|Lost to Follow-up|1|||
149196226|NCT01536119|538187343|FG000|Overall Study|Lost to Follow-up|17|||
149196227|NCT01536119|538187344|FG001|Overall Study|Lost to Follow-up|14|||
149196228|NCT03521193|538187345|FG000|Overall Study|Withdrawal by Subject|8|||
149196229|NCT03521193|538187346|FG001|Overall Study|Withdrawal by Subject|0|||
149196230|NCT03521193|538187345|FG000|Overall Study|non compliant to ASA treatment|8|||
149196231|NCT03521193|538187346|FG001|Overall Study|non compliant to ASA treatment|0|||
149196232|NCT01810042|538187347|FG000|Overall Study|Lost to Follow-up|10|||
149196233|NCT01208038|538187348|FG000|Overall Study|Withdrawal by Subject|1|||
149196234|NCT01454401|538187349|FG000|Overall Study|Death|1|||
149196235|NCT01454401|538187349|FG000|Overall Study|hospitalised|1|||
149196236|NCT01454401|538187349|FG000|Overall Study|osteomyelitis|2|||
149196237|NCT01454401|538187349|FG000|Overall Study|non-adherence|1|||
149196238|NCT00430521|538187354|FG000|Overall Study|Adverse Event|0|||
149196239|NCT00430521|538187355|FG001|Overall Study|Adverse Event|0|||
149196240|NCT00430521|538187356|FG002|Overall Study|Adverse Event|0|||
149196241|NCT00430521|538187357|FG003|Overall Study|Adverse Event|0|||
149196242|NCT00430521|538187358|FG004|Overall Study|Adverse Event|0|||
149196243|NCT00430521|538187359|FG005|Overall Study|Adverse Event|2|||
149196244|NCT00430521|538187360|FG006|Overall Study|Adverse Event|1|||
149196245|NCT00430521|538187361|FG007|Overall Study|Adverse Event|0|||
149196246|NCT00430521|538187354|FG000|Overall Study|Lost to Follow-up|7|||
149196247|NCT00430521|538187355|FG001|Overall Study|Lost to Follow-up|8|||
149196248|NCT00430521|538187356|FG002|Overall Study|Lost to Follow-up|3|||
149196249|NCT00430521|538187357|FG003|Overall Study|Lost to Follow-up|5|||
149196250|NCT00430521|538187358|FG004|Overall Study|Lost to Follow-up|5|||
149196251|NCT00430521|538187359|FG005|Overall Study|Lost to Follow-up|2|||
149196252|NCT00430521|538187360|FG006|Overall Study|Lost to Follow-up|8|||
149196253|NCT00430521|538187361|FG007|Overall Study|Lost to Follow-up|10|||
149196254|NCT00430521|538187354|FG000|Overall Study|Pregnancy|0|||
149196255|NCT00430521|538187355|FG001|Overall Study|Pregnancy|0|||
149196256|NCT00430521|538187356|FG002|Overall Study|Pregnancy|0|||
149196257|NCT00430521|538187357|FG003|Overall Study|Pregnancy|0|||
149196258|NCT00430521|538187358|FG004|Overall Study|Pregnancy|0|||
149196259|NCT00430521|538187359|FG005|Overall Study|Pregnancy|0|||
149196260|NCT00430521|538187360|FG006|Overall Study|Pregnancy|1|||
149196261|NCT00430521|538187361|FG007|Overall Study|Pregnancy|0|||
149196262|NCT00430521|538187354|FG000|Overall Study|Vaccine Expired|0|||
149196263|NCT00430521|538187355|FG001|Overall Study|Vaccine Expired|0|||
149196264|NCT00430521|538187356|FG002|Overall Study|Vaccine Expired|0|||
149196265|NCT00430521|538187357|FG003|Overall Study|Vaccine Expired|0|||
149196266|NCT00430521|538187358|FG004|Overall Study|Vaccine Expired|0|||
149196267|NCT00430521|538187359|FG005|Overall Study|Vaccine Expired|1|||
149196268|NCT00430521|538187360|FG006|Overall Study|Vaccine Expired|0|||
148682438|NCT01797120|536310932|FG000|Overall Study|Physician Decision|3|||
148938507|NCT01977794|537258701|FG000|Overall Study|Lost to Follow-up|2|||
148938508|NCT01977794|537258702|FG001|Overall Study|Lost to Follow-up|1|||
148938509|NCT01977794|537258701|FG000|Overall Study|Protocol Violation|1|||
148938510|NCT01977794|537258702|FG001|Overall Study|Protocol Violation|0|||
148938511|NCT01977794|537258701|FG000|Overall Study|Death|1|||
148938512|NCT01977794|537258702|FG001|Overall Study|Death|1|||
148938513|NCT01977794|537258701|FG000|Overall Study|Withdrew consent|2|||
148938514|NCT01977794|537258702|FG001|Overall Study|Withdrew consent|1|||
148938515|NCT01977794|537258701|FG000|Overall Study|Other|0|||
149015199|NCT01155661|537534406|FG000|Overall Study|Sponsor Decision|13|||
149196269|NCT00430521|538187361|FG007|Overall Study|Vaccine Expired|0|||
149196270|NCT00430521|538187354|FG000|Overall Study|Protocol Violation|1|||
149196271|NCT00430521|538187355|FG001|Overall Study|Protocol Violation|0|||
149196272|NCT00430521|538187356|FG002|Overall Study|Protocol Violation|0|||
149196273|NCT00430521|538187357|FG003|Overall Study|Protocol Violation|0|||
149196274|NCT00430521|538187358|FG004|Overall Study|Protocol Violation|0|||
149196275|NCT00430521|538187359|FG005|Overall Study|Protocol Violation|0|||
149196276|NCT00430521|538187360|FG006|Overall Study|Protocol Violation|0|||
149196277|NCT00430521|538187361|FG007|Overall Study|Protocol Violation|0|||
149196278|NCT00430521|538187354|FG000|Overall Study|Withdrawal by Subject|3|||
149196279|NCT00430521|538187355|FG001|Overall Study|Withdrawal by Subject|1|||
149196280|NCT00430521|538187356|FG002|Overall Study|Withdrawal by Subject|0|||
149196281|NCT00430521|538187357|FG003|Overall Study|Withdrawal by Subject|3|||
149196282|NCT00430521|538187358|FG004|Overall Study|Withdrawal by Subject|0|||
149196283|NCT00430521|538187359|FG005|Overall Study|Withdrawal by Subject|0|||
149196284|NCT00430521|538187360|FG006|Overall Study|Withdrawal by Subject|0|||
149196285|NCT00430521|538187361|FG007|Overall Study|Withdrawal by Subject|2|||
149196286|NCT05108805|538187362|FG000|Overall Study|T-cell expansion was not successful.|5|||
149196287|NCT00333619|538189241|FG000|Overall Study|Death|12|||
149196288|NCT00333619|538189242|FG001|Overall Study|Death|6|||
149196289|NCT00333619|538189241|FG000|Overall Study|Withdrawal by Subject|6|||
149196290|NCT00333619|538189242|FG001|Overall Study|Withdrawal by Subject|1|||
149196291|NCT00333619|538189241|FG000|Overall Study|Lost to Follow-up|3|||
149196292|NCT00333619|538189242|FG001|Overall Study|Lost to Follow-up|3|||
149196293|NCT01120379|538189251|FG000|One Year Timepoint|Withdrawal by Subject|41|||
149196294|NCT01120379|538189251|FG000|One Year Timepoint|Lost to Follow-up|115|||
149196295|NCT01120379|538189251|FG000|One Year Timepoint|Death|108|||
149196296|NCT01120379|538189251|FG000|One Year Timepoint|Physician Decision|9|||
149196297|NCT01120379|538189251|FG000|One Year Timepoint|Any other reason for early termination|5|||
149196298|NCT01120379|538189251|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
149196299|NCT01120379|538189251|FG000|Two Year Timepoint|Lost to Follow-up|87|||
149196300|NCT01120379|538189251|FG000|Two Year Timepoint|Death|123|||
149196301|NCT01120379|538189251|FG000|Two Year Timepoint|Physician Decision|12|||
149196302|NCT01120379|538189251|FG000|Two Year Timepoint|Any other reason for early termination|4|||
149196303|NCT01120379|538189251|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
149196304|NCT01120379|538189251|FG000|Three Year Timepoint|Lost to Follow-up|43|||
149196305|NCT01120379|538189251|FG000|Three Year Timepoint|Death|120|||
149196306|NCT01120379|538189251|FG000|Three Year Timepoint|Physician Decision|9|||
149196307|NCT01120379|538189251|FG000|Three Year Timepoint|Any other reason for early termination|17|||
149196308|NCT01120379|538189251|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
149196309|NCT01120379|538189251|FG000|Four Year Timepoint|Lost to Follow-up|10|||
149196310|NCT01120379|538189251|FG000|Four Year Timepoint|Death|131|||
149196311|NCT01120379|538189251|FG000|Four Year Timepoint|Physician Decision|5|||
149196312|NCT01120379|538189251|FG000|Four Year Timepoint|Any other reason for early termination|217|||
149196313|NCT03162055|538189252|FG000|Overall Study|Adverse Event|6|||
149196314|NCT03162055|538189253|FG001|Overall Study|Adverse Event|5|||
149196315|NCT03162055|538189252|FG000|Overall Study|Death|3|||
149196316|NCT03162055|538189253|FG001|Overall Study|Death|3|||
149196317|NCT03162055|538189252|FG000|Overall Study|Lost to Follow-up|0|||
149196318|NCT03162055|538189253|FG001|Overall Study|Lost to Follow-up|1|||
149196319|NCT03162055|538189252|FG000|Overall Study|Study-specific withdrawal criteria|22|||
149196320|NCT03162055|538189253|FG001|Overall Study|Study-specific withdrawal criteria|14|||
149196321|NCT03162055|538189252|FG000|Overall Study|Withdrawal by Subject|17|||
149196322|NCT03162055|538189253|FG001|Overall Study|Withdrawal by Subject|2|||
149196323|NCT03162055|538189252|FG000|Overall Study|Did not receive treatment|2|||
149196324|NCT03162055|538189253|FG001|Overall Study|Did not receive treatment|0|||
149196325|NCT03162055|538189252|FG000|Overall Study|Incorrect randomization|4|||
149196326|NCT03162055|538189253|FG001|Overall Study|Incorrect randomization|3|||
149196327|NCT03162055|538189252|FG000|Overall Study|Other|8|||
149196328|NCT03162055|538189253|FG001|Overall Study|Other|15|||
149196329|NCT04031404|538189254|FG000|Baseline|Lost to Follow-up|0|||
149196330|NCT04031404|538189255|FG001|Baseline|Lost to Follow-up|1|||
149196331|NCT04031404|538189254|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
149196332|NCT04031404|538189255|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
148938516|NCT01977794|537258702|FG001|Overall Study|Other|1|||
148938517|NCT00533897|537258703|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
148938518|NCT00533897|537258704|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
148938519|NCT00533897|537258705|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
148938520|NCT00533897|537258706|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
148938521|NCT00533897|537258707|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
148938522|NCT00533897|537258708|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
148938523|NCT00533897|537258709|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
148938524|NCT00533897|537258710|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
148938525|NCT00533897|537258703|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
148938526|NCT00533897|537258704|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
149196333|NCT04031404|538189254|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
148938527|NCT00533897|537258705|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
148938528|NCT00533897|537258706|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
148938529|NCT00533897|537258707|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
149196334|NCT04031404|538189255|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
149196335|NCT04031404|538189254|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
149196336|NCT04031404|538189255|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
149196337|NCT04031404|538189254|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
149196338|NCT04031404|538189255|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
149196339|NCT02282982|538189259|FG000|Overall Study|Lost to Follow-up|15|||
149196340|NCT02282982|538189259|FG000|Overall Study|Withdrew consent|2|||
149196341|NCT02282982|538189259|FG000|Overall Study|Death|4|||
149196342|NCT02282982|538189259|FG000|Overall Study|Lack of product|156|||
149196343|NCT02282982|538189259|FG000|Overall Study|Palivizumab is ended|11|||
149196344|NCT02282982|538189259|FG000|Overall Study|Other, not specified|18|||
149196345|NCT01295580|538189261|FG000|Overall Study|Protocol Violation|4|||
149196346|NCT01295580|538189262|FG001|Overall Study|Protocol Violation|2|||
149196347|NCT01295580|538189261|FG000|Overall Study|Withdrawal by Subject|1|||
149196348|NCT01295580|538189262|FG001|Overall Study|Withdrawal by Subject|4|||
149196349|NCT01295580|538189261|FG000|Overall Study|Adverse Event|2|||
149196350|NCT01295580|538189262|FG001|Overall Study|Adverse Event|1|||
149196351|NCT01295580|538189261|FG000|Overall Study|Lost to Follow-up|1|||
149196352|NCT01295580|538189262|FG001|Overall Study|Lost to Follow-up|0|||
149196353|NCT01295580|538189261|FG000|Overall Study|Lack of Efficacy|1|||
149196354|NCT01295580|538189262|FG001|Overall Study|Lack of Efficacy|0|||
149196355|NCT01295580|538189261|FG000|Overall Study|Other: inconvenience|1|||
149196356|NCT01295580|538189262|FG001|Overall Study|Other: inconvenience|0|||
149196357|NCT01295580|538189261|FG000|Overall Study|Other: family objection|0|||
149196358|NCT01295580|538189262|FG001|Overall Study|Other: family objection|1|||
149196359|NCT04032171|538189263|FG000|Overall Study|Study Termination|1|||
149196360|NCT04032171|538189264|FG001|Overall Study|Study Termination|0|||
149196361|NCT01742078|538189265|FG000|Overall Study|Withdrawal by Subject|0|||
149196362|NCT01742078|538189266|FG001|Overall Study|Withdrawal by Subject|0|||
149196363|NCT01742078|538189267|FG002|Overall Study|Withdrawal by Subject|0|||
149196364|NCT01742078|538189268|FG003|Overall Study|Withdrawal by Subject|1|||
149196365|NCT01742078|538189269|FG004|Overall Study|Withdrawal by Subject|0|||
149196366|NCT01742078|538189270|FG005|Overall Study|Withdrawal by Subject|0|||
149196367|NCT01742078|538189271|FG006|Overall Study|Withdrawal by Subject|0|||
149196368|NCT01742078|538189272|FG007|Overall Study|Withdrawal by Subject|0|||
149196369|NCT01742078|538189273|FG008|Overall Study|Withdrawal by Subject|0|||
149196370|NCT03247413|538189279|FG000|Overall Study|Lost to Follow-up|28|||
149196371|NCT00642746|538189280|FG000|Overall Study|Patient unevaluable|1|||
149196372|NCT00642746|538189281|FG001|Overall Study|Patient unevaluable|0|||
149196373|NCT00424294|538189282|FG000|Overall Study|Adverse Event|4|||
149196374|NCT00424294|538189283|FG001|Overall Study|Adverse Event|10|||
149196375|NCT00424294|538189282|FG000|Overall Study|Lack of Efficacy|2|||
149196376|NCT00424294|538189283|FG001|Overall Study|Lack of Efficacy|1|||
149196377|NCT00424294|538189282|FG000|Overall Study|Withdrawal by Subject|1|||
149196378|NCT00424294|538189283|FG001|Overall Study|Withdrawal by Subject|2|||
149196379|NCT00424294|538189282|FG000|Overall Study|Other|0|||
149196380|NCT00424294|538189283|FG001|Overall Study|Other|2|||
149196381|NCT00424294|538189282|FG000|Overall Study|Randomized but not Treated|1|||
149196382|NCT00424294|538189283|FG001|Overall Study|Randomized but not Treated|0|||
149196383|NCT03337152|538189286|FG000|Overall Study|Physician Decision|1|||
149196384|NCT03337152|538189287|FG001|Overall Study|Physician Decision|0|||
149196385|NCT03337152|538189286|FG000|Overall Study|Lost to Follow-up|1|||
149196386|NCT03337152|538189287|FG001|Overall Study|Lost to Follow-up|3|||
149196387|NCT03337152|538189286|FG000|Overall Study|Adverse Event|3|||
149196388|NCT03337152|538189287|FG001|Overall Study|Adverse Event|1|||
149196389|NCT03337152|538189286|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
149196390|NCT03337152|538189287|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
149196391|NCT00976950|538189289|FG000|Overall Study|Adverse Event|3|||
149196392|NCT00976950|538189289|FG000|Overall Study|Events with no relationship to Aptivus|3|||
149196393|NCT02932332|538189298|FG000|Overall Study|Withdrawal by Subject|1|||
149196394|NCT02932332|538189299|FG001|Overall Study|Withdrawal by Subject|1|||
149196395|NCT02932332|538189300|FG002|Overall Study|Withdrawal by Subject|0|||
149196396|NCT02932332|538189301|FG003|Overall Study|Withdrawal by Subject|1|||
149196397|NCT02932332|538189298|FG000|Overall Study|Chest pain|0|||
149196398|NCT02932332|538189299|FG001|Overall Study|Chest pain|0|||
149196399|NCT02932332|538189300|FG002|Overall Study|Chest pain|0|||
149196400|NCT02932332|538189301|FG003|Overall Study|Chest pain|1|||
149196401|NCT02932332|538189298|FG000|Overall Study|Not Dyspneic cough|1|||
149196402|NCT02932332|538189299|FG001|Overall Study|Not Dyspneic cough|2|||
149196403|NCT02932332|538189300|FG002|Overall Study|Not Dyspneic cough|1|||
149196404|NCT02932332|538189301|FG003|Overall Study|Not Dyspneic cough|0|||
149196405|NCT02493426|538189302|FG000|Overall Study|Withdrawal by Subject|0|||
149196406|NCT02493426|538189303|FG001|Overall Study|Withdrawal by Subject|1|||
149196407|NCT01069523|538189304|FG000|Overall Study|Withdrawal by Subject|4|||
149196408|NCT01069523|538189305|FG001|Overall Study|Withdrawal by Subject|7|||
148682439|NCT01797120|536310933|FG001|Overall Study|Physician Decision|0|||
149196409|NCT01025817|538189308|FG000|Completed Study Medication|Adverse Event|66|||
149196410|NCT01025817|538189309|FG001|Completed Study Medication|Adverse Event|39|||
149015200|NCT03757234|537534407|FG000|Overall Study|Adverse Event|0|||
149015201|NCT03757234|537534408|FG001|Overall Study|Adverse Event|0|||
149015202|NCT03757234|537534409|FG002|Overall Study|Adverse Event|0|||
149015203|NCT03757234|537534410|FG003|Overall Study|Adverse Event|0|||
149015204|NCT03757234|537534411|FG004|Overall Study|Adverse Event|1|||
149015205|NCT03757234|537534407|FG000|Overall Study|Lost to Follow-up|1|||
149015206|NCT03757234|537534408|FG001|Overall Study|Lost to Follow-up|0|||
149015207|NCT03757234|537534409|FG002|Overall Study|Lost to Follow-up|0|||
149015208|NCT03757234|537534410|FG003|Overall Study|Lost to Follow-up|0|||
149015209|NCT03757234|537534411|FG004|Overall Study|Lost to Follow-up|1|||
149015210|NCT03757234|537534407|FG000|Overall Study|Withdrawal by Subject|1|||
149015211|NCT03757234|537534408|FG001|Overall Study|Withdrawal by Subject|1|||
149015212|NCT03757234|537534409|FG002|Overall Study|Withdrawal by Subject|0|||
149015213|NCT03757234|537534410|FG003|Overall Study|Withdrawal by Subject|1|||
149015214|NCT03757234|537534411|FG004|Overall Study|Withdrawal by Subject|2|||
149015215|NCT03757234|537534407|FG000|Overall Study|Other|1|||
149015216|NCT03757234|537534408|FG001|Overall Study|Other|1|||
149015217|NCT03757234|537534409|FG002|Overall Study|Other|0|||
149015218|NCT03757234|537534410|FG003|Overall Study|Other|0|||
149015219|NCT03757234|537534411|FG004|Overall Study|Other|0|||
149015220|NCT01567865|537534419|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
149015221|NCT01567865|537534420|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
149015222|NCT01567865|537534421|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
149015223|NCT01567865|537534422|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
149015224|NCT01567865|537534419|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
149015225|NCT01567865|537534420|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
149015226|NCT01567865|537534421|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
149015227|NCT01567865|537534422|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
149015228|NCT02023879|537534430|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
149015229|NCT02023879|537534431|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
149015230|NCT02023879|537534432|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
149015231|NCT02023879|537534430|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
149015232|NCT02023879|537534431|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
149015233|NCT02023879|537534432|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
149015234|NCT02023879|537534430|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
149015235|NCT02023879|537534431|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
149015236|NCT02023879|537534432|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
149015237|NCT02023879|537534430|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
149015238|NCT02023879|537534431|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
149015239|NCT02023879|537534432|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
149015240|NCT02023879|537534430|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
149015241|NCT02023879|537534431|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
149015242|NCT02023879|537534432|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
149015243|NCT02023879|537534430|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
149015244|NCT02023879|537534431|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
149196411|NCT01025817|538189308|FG000|Completed Study Medication|Protocol Deviation|9|||
149196412|NCT01025817|538189309|FG001|Completed Study Medication|Protocol Deviation|8|||
149196413|NCT01025817|538189308|FG000|Completed Study Medication|Withdrawal by Subject|8|||
149196414|NCT01025817|538189309|FG001|Completed Study Medication|Withdrawal by Subject|9|||
149196415|NCT01025817|538189308|FG000|Completed Study Medication|Administrative problems|7|||
149196416|NCT01025817|538189309|FG001|Completed Study Medication|Administrative problems|5|||
149196417|NCT01025817|538189308|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
149196418|NCT01025817|538189309|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
149196419|NCT01025817|538189308|FG000|Completed Study Medication|Abnormal test procedure|4|||
149196420|NCT01025817|538189309|FG001|Completed Study Medication|Abnormal test procedure|0|||
149196421|NCT01025817|538189308|FG000|Completed Study Medication|Graft loss|2|||
149196422|NCT01025817|538189309|FG001|Completed Study Medication|Graft loss|5|||
149196423|NCT01025817|538189308|FG000|Completed Study Medication|Death|2|||
149196424|NCT01025817|538189309|FG001|Completed Study Medication|Death|2|||
149196425|NCT01025817|538189308|FG000|Completed Study Medication|Abnormal lab values|0|||
149015245|NCT02023879|537534432|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
149015246|NCT02023879|537534430|FG000|Extension Open Label Treatment|Adverse Event|1|||
149015247|NCT02023879|537534431|FG001|Extension Open Label Treatment|Adverse Event|7|||
148938530|NCT00533897|537258708|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
148938531|NCT00533897|537258709|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
148938532|NCT00533897|537258710|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
148938533|NCT00533897|537258703|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
148938534|NCT00533897|537258704|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938535|NCT00533897|537258705|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938536|NCT00533897|537258706|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938537|NCT00533897|537258707|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938538|NCT00533897|537258708|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938539|NCT00533897|537258709|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938540|NCT00533897|537258710|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
148938541|NCT00533897|537258703|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
148938542|NCT00533897|537258704|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938543|NCT00533897|537258705|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938544|NCT00533897|537258706|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938545|NCT00533897|537258707|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938546|NCT00533897|537258708|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938547|NCT00533897|537258709|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938548|NCT00533897|537258710|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
148938549|NCT00533897|537258703|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
148938550|NCT00533897|537258704|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938551|NCT00533897|537258705|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938552|NCT00533897|537258706|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938553|NCT00533897|537258707|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938554|NCT00533897|537258708|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938555|NCT00533897|537258709|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938556|NCT00533897|537258710|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
148938557|NCT00533897|537258703|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
148938558|NCT00533897|537258704|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
149196426|NCT01025817|538189309|FG001|Completed Study Medication|Abnormal lab values|2|||
149196427|NCT01025817|538189308|FG000|Completed Study Medication|Subject no longer required study drug|0|||
149196428|NCT01025817|538189309|FG001|Completed Study Medication|Subject no longer required study drug|1|||
149196429|NCT01025817|538189308|FG000|Completed Study Medication|Lost to Follow-up|0|||
149196430|NCT01025817|538189309|FG001|Completed Study Medication|Lost to Follow-up|1|||
149196431|NCT01025817|538189308|FG000|Completed Study|Withdrawal by Subject|8|||
149196432|NCT01025817|538189309|FG001|Completed Study|Withdrawal by Subject|16|||
149196433|NCT01025817|538189308|FG000|Completed Study|Death|6|||
149196434|NCT01025817|538189309|FG001|Completed Study|Death|5|||
149196435|NCT01025817|538189308|FG000|Completed Study|Missing|2|||
149196436|NCT01025817|538189309|FG001|Completed Study|Missing|0|||
149196437|NCT01025817|538189308|FG000|Completed Study|Lost to Follow-up|0|||
149196438|NCT01025817|538189309|FG001|Completed Study|Lost to Follow-up|1|||
149196439|NCT04533815|538189313|FG000|Overall Study|Adverse Event|2|||
149196440|NCT04533815|538189313|FG000|Overall Study|Site withdrew|5|||
149196441|NCT00488592|538189316|FG000|Overall Study|Withdrawal by Subject|1|||
149196442|NCT00488592|538189316|FG000|Overall Study|Disease progression|1|||
149196443|NCT00488592|538189316|FG000|Overall Study|Enrolled but not treated|1|||
149196444|NCT00441103|538189317|FG000|Overall Study|Adverse Event|2|||
149196445|NCT00441103|538189318|FG001|Overall Study|Adverse Event|1|||
149196446|NCT00441103|538189317|FG000|Overall Study|Death|1|||
149196447|NCT00441103|538189318|FG001|Overall Study|Death|0|||
149196448|NCT00441103|538189317|FG000|Overall Study|Disease Progression|2|||
149196449|NCT00441103|538189318|FG001|Overall Study|Disease Progression|0|||
149196450|NCT00441103|538189317|FG000|Overall Study|Lost to Follow-up|1|||
149196451|NCT00441103|538189318|FG001|Overall Study|Lost to Follow-up|0|||
149196452|NCT00441103|538189317|FG000|Overall Study|Protocol Violation|1|||
149196453|NCT00441103|538189318|FG001|Overall Study|Protocol Violation|0|||
149196454|NCT00441103|538189317|FG000|Overall Study|Participant unable to use Rebiject II|1|||
149196455|NCT00441103|538189318|FG001|Overall Study|Participant unable to use Rebiject II|0|||
149196456|NCT00441103|538189317|FG000|Overall Study|Participant refused MRI|1|||
149196457|NCT00441103|538189318|FG001|Overall Study|Participant refused MRI|0|||
149196458|NCT00441103|538189317|FG000|Overall Study|Inclusion criteria absent|1|||
149196459|NCT00441103|538189318|FG001|Overall Study|Inclusion criteria absent|0|||
149196460|NCT00441103|538189317|FG000|Overall Study|Non-compliant|0|||
149196461|NCT00441103|538189318|FG001|Overall Study|Non-compliant|1|||
149196462|NCT00441103|538189317|FG000|Overall Study|Participant decided to withdraw|1|||
149196463|NCT00441103|538189318|FG001|Overall Study|Participant decided to withdraw|0|||
149196464|NCT00441103|538189317|FG000|Overall Study|Participant's reason|0|||
149196465|NCT00441103|538189318|FG001|Overall Study|Participant's reason|1|||
149196466|NCT00441103|538189317|FG000|Overall Study|Participant decided to stop|0|||
149196467|NCT00441103|538189318|FG001|Overall Study|Participant decided to stop|1|||
149196468|NCT02951988|538189319|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
149196469|NCT02951988|538189320|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
149196470|NCT02951988|538189321|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
148938559|NCT00533897|537258705|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
148938560|NCT00533897|537258706|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
149196471|NCT02951988|538189322|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
149196472|NCT02951988|538189319|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
149196473|NCT02951988|538189320|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
149196474|NCT02951988|538189321|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
149196475|NCT02951988|538189322|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
149196476|NCT02951988|538189319|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
149196477|NCT02951988|538189320|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
149196478|NCT02951988|538189321|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
149196479|NCT02951988|538189322|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
149196480|NCT02951988|538189319|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
149196481|NCT02951988|538189320|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
149196482|NCT02951988|538189321|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
149196483|NCT02951988|538189322|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
149196484|NCT02951988|538189319|FG000|Open-Label Treatment Period|Protocol Violation|22|||
149196485|NCT02951988|538189320|FG001|Open-Label Treatment Period|Protocol Violation|0|||
149196486|NCT02951988|538189321|FG002|Open-Label Treatment Period|Protocol Violation|0|||
149196487|NCT02951988|538189322|FG003|Open-Label Treatment Period|Protocol Violation|0|||
149196488|NCT02951988|538189319|FG000|Open-Label Treatment Period|Pregnancy|2|||
149196489|NCT02951988|538189320|FG001|Open-Label Treatment Period|Pregnancy|0|||
149196490|NCT02951988|538189321|FG002|Open-Label Treatment Period|Pregnancy|0|||
149196491|NCT02951988|538189322|FG003|Open-Label Treatment Period|Pregnancy|0|||
149196492|NCT02951988|538189319|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
149196493|NCT02951988|538189320|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
149196494|NCT02951988|538189321|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
149196495|NCT02951988|538189322|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
149196496|NCT02951988|538189319|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
149196497|NCT02951988|538189320|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
149196498|NCT02951988|538189321|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
148938561|NCT00533897|537258707|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
148938562|NCT00533897|537258708|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
149196499|NCT02951988|538189322|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
149196500|NCT02951988|538189319|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
149196501|NCT02951988|538189320|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
149196502|NCT02951988|538189321|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
149196503|NCT02951988|538189322|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
149196504|NCT02951988|538189319|FG000|Open-Label Treatment Period|Adverse Event|45|||
149196505|NCT02951988|538189320|FG001|Open-Label Treatment Period|Adverse Event|0|||
149196506|NCT02951988|538189321|FG002|Open-Label Treatment Period|Adverse Event|0|||
149196507|NCT02951988|538189322|FG003|Open-Label Treatment Period|Adverse Event|0|||
149196508|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
149196509|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
149196510|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
149196511|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
149196512|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
149196513|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
149196514|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
149196515|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
149196516|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
149196517|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
149196518|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
149196519|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
148938563|NCT00533897|537258709|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
148938564|NCT00533897|537258710|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
148682440|NCT01797120|536310932|FG000|Overall Study|still on treatment|2|||
148938565|NCT00533897|537258703|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
149196520|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
148938566|NCT00533897|537258704|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
148938567|NCT00533897|537258705|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
148938568|NCT00533897|537258706|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
148938569|NCT00533897|537258707|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
148938570|NCT00533897|537258708|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
148938571|NCT00533897|537258709|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
148938572|NCT00533897|537258710|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
148938573|NCT00533897|537258703|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938574|NCT00533897|537258704|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938575|NCT00533897|537258705|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
148938576|NCT00533897|537258706|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938577|NCT00533897|537258707|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938578|NCT00533897|537258708|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938579|NCT00533897|537258709|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938580|NCT00533897|537258710|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
148938581|NCT00533897|537258703|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938582|NCT00533897|537258704|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938583|NCT00533897|537258705|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938584|NCT00533897|537258706|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938585|NCT00533897|537258707|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938586|NCT00533897|537258708|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
148938587|NCT00533897|537258709|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938588|NCT00533897|537258710|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
148938589|NCT00533897|537258703|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
148938590|NCT00533897|537258704|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
148938591|NCT00533897|537258705|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
148938592|NCT00533897|537258706|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
148938593|NCT00533897|537258707|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
148938594|NCT00533897|537258708|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
149196521|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
149196522|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
149196523|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
149196524|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Pregnancy|0|||
149196525|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Pregnancy|1|||
149196526|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Pregnancy|1|||
149196527|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Pregnancy|0|||
149196528|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149196529|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
149196530|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
149196531|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
149196532|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149196533|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
149196534|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
149196535|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
149196536|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Adverse Event|0|||
149196537|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Adverse Event|8|||
149196538|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Adverse Event|3|||
149196539|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Adverse Event|6|||
149196540|NCT02951988|538189319|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
149196541|NCT02951988|538189320|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
149196542|NCT02951988|538189321|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
149196543|NCT02951988|538189322|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
149196544|NCT05836818|538189323|FG000|Overall Study|Physician Decision|1|||
149196545|NCT05836818|538189324|FG001|Overall Study|Physician Decision|1|||
149196546|NCT05836818|538189325|FG002|Overall Study|Physician Decision|0|||
149196547|NCT05836818|538189323|FG000|Overall Study|Withdrawal by Subject|0|||
149196548|NCT05836818|538189324|FG001|Overall Study|Withdrawal by Subject|0|||
148938595|NCT00533897|537258709|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
149015248|NCT02023879|537534432|FG002|Extension Open Label Treatment|Adverse Event|3|||
149015249|NCT02023879|537534430|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
149015250|NCT02023879|537534431|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
149015251|NCT02023879|537534432|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
149196549|NCT05836818|538189325|FG002|Overall Study|Withdrawal by Subject|1|||
149196550|NCT05836818|538189323|FG000|Overall Study|Later found to be previously vaccinated|0|||
149196551|NCT05836818|538189324|FG001|Overall Study|Later found to be previously vaccinated|1|||
149196552|NCT05836818|538189325|FG002|Overall Study|Later found to be previously vaccinated|3|||
148938596|NCT00533897|537258710|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
149196553|NCT05836818|538189323|FG000|Overall Study|Pregnancy|0|||
149196554|NCT05836818|538189324|FG001|Overall Study|Pregnancy|1|||
149196555|NCT05836818|538189325|FG002|Overall Study|Pregnancy|0|||
149196556|NCT05836818|538189323|FG000|Overall Study|Allergic to vaccines|0|||
149196557|NCT05836818|538189324|FG001|Overall Study|Allergic to vaccines|1|||
149196558|NCT05836818|538189325|FG002|Overall Study|Allergic to vaccines|0|||
149196559|NCT00807846|538189326|FG000|Overall Study|Adverse Event|5|||
149196560|NCT00807846|538189327|FG001|Overall Study|Adverse Event|0|||
149196561|NCT00807846|538189326|FG000|Overall Study|Lack of Efficacy|2|||
149196562|NCT00807846|538189327|FG001|Overall Study|Lack of Efficacy|0|||
149196563|NCT00807846|538189326|FG000|Overall Study|Protocol Violation|2|||
149196564|NCT00807846|538189327|FG001|Overall Study|Protocol Violation|1|||
149196565|NCT00807846|538189326|FG000|Overall Study|Withdrawal by Subject|2|||
149196566|NCT00807846|538189327|FG001|Overall Study|Withdrawal by Subject|1|||
149196567|NCT00807846|538189326|FG000|Overall Study|Other|1|||
149196568|NCT00807846|538189327|FG001|Overall Study|Other|2|||
149196569|NCT01081873|538189328|FG000|Overall Study|Death|86|||
149196570|NCT01081873|538189328|FG000|Overall Study|Withdrawal by Subject|10|||
149196571|NCT01081873|538189328|FG000|Overall Study|Lost to Follow-up|142|||
149196572|NCT01081873|538189328|FG000|Overall Study|Progression of prostate cancer|13|||
149196573|NCT01081873|538189328|FG000|Overall Study|Other|47|||
149196574|NCT01165021|538189329|FG000|Overall Study|Death|1|||
149196575|NCT02491073|538189330|FG000|Overall Study|screen failure|1|||
149196576|NCT02491073|538189331|FG001|Overall Study|screen failure|0|||
149196577|NCT02683525|538189332|FG000|Overall Study|Lost to Follow-up|1|||
149196578|NCT02683525|538189332|FG000|Overall Study|Physician Decision|1|||
149196579|NCT02683525|538189332|FG000|Overall Study|Disease Progression|6|||
149196580|NCT01627067|538189333|FG000|Overall Study|Screen Failure|1|||
149196581|NCT03352414|538189337|FG000|Overall Study|Ineligible by operative criteria|12|||
148938597|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
148938598|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
148938599|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
148938600|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
148938601|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
148938602|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
148938603|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
148938604|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
148938605|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Death|0|||
148938606|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Death|0|||
148938607|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Death|0|||
149015252|NCT02023879|537534430|FG000|Extension Open Label Treatment|Participant moved|1|||
149015253|NCT02023879|537534431|FG001|Extension Open Label Treatment|Participant moved|2|||
149196582|NCT03352414|538189338|FG001|Overall Study|Ineligible by operative criteria|10|||
149196583|NCT04167306|538189343|FG000|Overall Study|Lost to Follow-up|2|||
149196584|NCT04167306|538189344|FG001|Overall Study|Lost to Follow-up|2|||
149196585|NCT04167306|538189345|FG002|Overall Study|Lost to Follow-up|5|||
149196586|NCT04167306|538189346|FG003|Overall Study|Lost to Follow-up|5|||
149196587|NCT04167306|538189343|FG000|Overall Study|Adverse Event|13|||
149196588|NCT04167306|538189344|FG001|Overall Study|Adverse Event|14|||
149196589|NCT04167306|538189345|FG002|Overall Study|Adverse Event|5|||
149196590|NCT04167306|538189346|FG003|Overall Study|Adverse Event|4|||
149196591|NCT04167306|538189343|FG000|Overall Study|Withdrawal by Subject|4|||
149196592|NCT04167306|538189344|FG001|Overall Study|Withdrawal by Subject|6|||
149196593|NCT04167306|538189345|FG002|Overall Study|Withdrawal by Subject|8|||
149196594|NCT04167306|538189346|FG003|Overall Study|Withdrawal by Subject|3|||
149196595|NCT04167306|538189343|FG000|Overall Study|covid|1|||
149196596|NCT04167306|538189344|FG001|Overall Study|covid|1|||
149196597|NCT04167306|538189345|FG002|Overall Study|covid|2|||
149196598|NCT04167306|538189346|FG003|Overall Study|covid|1|||
149196599|NCT04167306|538189343|FG000|Overall Study|concomitant medication|0|||
149196600|NCT04167306|538189344|FG001|Overall Study|concomitant medication|0|||
149196601|NCT04167306|538189345|FG002|Overall Study|concomitant medication|0|||
148938608|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Death|0|||
148938609|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Death|0|||
148938610|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Death|0|||
148938611|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Death|1|||
148938612|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Death|3|||
149196602|NCT04167306|538189346|FG003|Overall Study|concomitant medication|1|||
149196603|NCT04167306|538189343|FG000|Overall Study|Alcohol treatment|0|||
149196604|NCT04167306|538189344|FG001|Overall Study|Alcohol treatment|4|||
149196605|NCT04167306|538189345|FG002|Overall Study|Alcohol treatment|3|||
149196606|NCT04167306|538189346|FG003|Overall Study|Alcohol treatment|2|||
149196607|NCT04167306|538189343|FG000|Overall Study|non-compliance|0|||
149196608|NCT04167306|538189344|FG001|Overall Study|non-compliance|0|||
149196609|NCT04167306|538189345|FG002|Overall Study|non-compliance|1|||
149196610|NCT04167306|538189346|FG003|Overall Study|non-compliance|0|||
149196611|NCT04167306|538189343|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
148938613|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
148938614|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
148938615|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
148938616|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
148938617|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
148938618|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
148938619|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
148938620|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
148938621|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
148938622|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
148938623|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
148938624|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
148938625|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
149196612|NCT04167306|538189344|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
149196613|NCT04167306|538189345|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
148938626|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
148938627|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
148938628|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
148938629|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Adverse Event|0|||
148938630|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Adverse Event|0|||
148938631|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Adverse Event|0|||
148938632|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Adverse Event|0|||
149196614|NCT04167306|538189346|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
149196615|NCT02357849|538189347|FG000|Overall Study|Withdrawal by Subject|2|||
149196616|NCT02357849|538189348|FG001|Overall Study|Withdrawal by Subject|3|||
149196617|NCT00403559|538189349|FG000|Overall Study|Adverse Event|0|||
149196618|NCT00403559|538189350|FG001|Overall Study|Adverse Event|1|||
149196619|NCT00403559|538189349|FG000|Overall Study|Lost to Follow-up|3|||
149196620|NCT00403559|538189350|FG001|Overall Study|Lost to Follow-up|3|||
149196621|NCT00403559|538189349|FG000|Overall Study|Withdrawal by Subject|1|||
148938633|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Adverse Event|0|||
148938634|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Adverse Event|0|||
148938635|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Adverse Event|2|||
148938636|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Adverse Event|5|||
148938637|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Pregnancy|0|||
148938638|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Pregnancy|0|||
148938639|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Pregnancy|0|||
148938640|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Pregnancy|0|||
148938641|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Pregnancy|0|||
148938642|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Pregnancy|0|||
148938643|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Pregnancy|0|||
148938644|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Pregnancy|2|||
148938645|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
148938646|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
149196622|NCT00403559|538189350|FG001|Overall Study|Withdrawal by Subject|0|||
148938647|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
148938648|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
148938649|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
148938650|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
148938651|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
148938652|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
148938653|NCT00533897|537258703|FG000|Long Term Extension (LTE)|Other|0|||
148938654|NCT00533897|537258704|FG001|Long Term Extension (LTE)|Other|0|||
149015254|NCT02023879|537534432|FG002|Extension Open Label Treatment|Participant moved|0|||
149015255|NCT02023879|537534430|FG000|Extension Open Label Treatment|Other than specified above|2|||
149015256|NCT02023879|537534431|FG001|Extension Open Label Treatment|Other than specified above|7|||
149196623|NCT04105244|538189353|FG000|Overall Study|Withdrawal by Subject|10|||
149196624|NCT04105244|538189354|FG001|Overall Study|Withdrawal by Subject|12|||
149196625|NCT04105244|538189353|FG000|Overall Study|Lost to Follow-up|20|||
149196626|NCT04105244|538189354|FG001|Overall Study|Lost to Follow-up|15|||
149196627|NCT04105244|538189353|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
149196628|NCT04105244|538189354|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
149196629|NCT04105244|538189353|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
149196630|NCT04105244|538189354|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
149196631|NCT04387136|538189355|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
149196632|NCT04387136|538189356|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
149196633|NCT01029886|538189359|FG000|Overall Study|Adverse Event|12|||
149196634|NCT01029886|538189360|FG001|Overall Study|Adverse Event|25|||
149196635|NCT01029886|538189359|FG000|Overall Study|Lost to Follow-up|1|||
149196636|NCT01029886|538189360|FG001|Overall Study|Lost to Follow-up|0|||
149196637|NCT01029886|538189359|FG000|Overall Study|Physician Decision|2|||
149196638|NCT01029886|538189360|FG001|Overall Study|Physician Decision|6|||
149196639|NCT01029886|538189359|FG000|Overall Study|Protocol Violation|17|||
149196640|NCT01029886|538189360|FG001|Overall Study|Protocol Violation|5|||
149196641|NCT01029886|538189359|FG000|Overall Study|Withdrawal by Subject|8|||
149196642|NCT01029886|538189360|FG001|Overall Study|Withdrawal by Subject|18|||
149196643|NCT01029886|538189359|FG000|Overall Study|Entry Criteria Not Met|13|||
149196644|NCT01029886|538189360|FG001|Overall Study|Entry Criteria Not Met|5|||
149196645|NCT01029886|538189359|FG000|Overall Study|Sponsor Decision|1|||
149196646|NCT01029886|538189360|FG001|Overall Study|Sponsor Decision|0|||
149196647|NCT01029886|538189359|FG000|Overall Study|Loss Glucose Control|7|||
149196648|NCT01029886|538189360|FG001|Overall Study|Loss Glucose Control|1|||
149196649|NCT03294681|538189361|FG000|Overall Study|Withdrawal by Subject|1|||
149196650|NCT00417976|538189362|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
149196651|NCT00417976|538189362|FG000|Overall Study|Treatment -related toxicity|2|||
149196652|NCT02720016|538189363|FG000|Overall Study|Separation of couple|6|||
148938655|NCT00533897|537258705|FG002|Long Term Extension (LTE)|Other|0|||
148938656|NCT00533897|537258706|FG003|Long Term Extension (LTE)|Other|0|||
148938657|NCT00533897|537258707|FG004|Long Term Extension (LTE)|Other|0|||
148938658|NCT00533897|537258708|FG005|Long Term Extension (LTE)|Other|0|||
148938659|NCT00533897|537258709|FG006|Long Term Extension (LTE)|Other|1|||
148938660|NCT00533897|537258710|FG007|Long Term Extension (LTE)|Other|6|||
148938661|NCT01546207|537258713|FG000|Overall Study|Death|1|||
148938662|NCT00713323|537258714|FG000|Overall Study|Adverse Event|75|||
148938663|NCT00713323|537258714|FG000|Overall Study|Withdrawal by Subject|15|||
148938664|NCT00713323|537258714|FG000|Overall Study|Lost to Follow-up|11|||
148938665|NCT00713323|537258714|FG000|Overall Study|Lack of Efficacy|36|||
148938666|NCT00713323|537258714|FG000|Overall Study|Low creatine clearance at screening|1|||
149015257|NCT02023879|537534432|FG002|Extension Open Label Treatment|Other than specified above|2|||
149196653|NCT02720016|538189364|FG001|Overall Study|Separation of couple|8|||
149196654|NCT02720016|538189365|FG002|Overall Study|Separation of couple|2|||
149196655|NCT02720016|538189363|FG000|Overall Study|Withdrawal by Subject|6|||
148938667|NCT00713323|537258714|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
148938668|NCT00713323|537258714|FG000|Overall Study|Surgery cured allodynic pain|1|||
148938669|NCT00713323|537258714|FG000|Overall Study|Pain free|1|||
148938670|NCT00713323|537258714|FG000|Overall Study|Non-compliance|1|||
148938671|NCT00713323|537258714|FG000|Overall Study|Pain resolved|1|||
148938672|NCT00713323|537258714|FG000|Overall Study|Subject travelling to USA|1|||
148938673|NCT00713323|537258714|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
148938674|NCT00713323|537258714|FG000|Overall Study|Treatment that may interact with Sativex|1|||
148938675|NCT00506662|537258715|FG000|Overall Study|Adverse Event|0|||
148938676|NCT00506662|537258716|FG001|Overall Study|Adverse Event|2|||
148938677|NCT00506662|537258715|FG000|Overall Study|Lack of Efficacy|1|||
148938678|NCT00506662|537258716|FG001|Overall Study|Lack of Efficacy|0|||
148938679|NCT00506662|537258715|FG000|Overall Study|Protocol Violation|2|||
148938680|NCT00506662|537258716|FG001|Overall Study|Protocol Violation|4|||
148938681|NCT00506662|537258715|FG000|Overall Study|Trial terminated|10|||
148938682|NCT00506662|537258716|FG001|Overall Study|Trial terminated|16|||
148938683|NCT00506662|537258715|FG000|Overall Study|Not recorded|4|||
148938684|NCT00506662|537258716|FG001|Overall Study|Not recorded|6|||
148938685|NCT00491075|537258718|FG000|Overall Study|Withdrawal by Subject|1|||
148938686|NCT00491075|537258718|FG000|Overall Study|Physician Decision|1|||
148938687|NCT01603355|537258719|FG000|Overall Study|Lack of Efficacy|2|||
148938688|NCT00246753|537258723|FG000|Overall Study|Withdrawal by Subject|2|||
148938689|NCT00246753|537258723|FG000|Overall Study|Physician Decision|2|||
148938690|NCT00246753|537258723|FG000|Overall Study|Adverse Event|2|||
148938691|NCT00246753|537258723|FG000|Overall Study|Unacceptable toxicity|2|||
148938692|NCT00131508|537258731|FG000|Overall Study|Disease progression|0|||
148938693|NCT00131508|537258732|FG001|Overall Study|Disease progression|2|||
148938694|NCT00131508|537258731|FG000|Overall Study|Non-Compliance|2|||
148938695|NCT00131508|537258732|FG001|Overall Study|Non-Compliance|4|||
148938696|NCT00131508|537258731|FG000|Overall Study|Withdrawal by Subject|1|||
148938697|NCT00131508|537258732|FG001|Overall Study|Withdrawal by Subject|2|||
148938698|NCT00850070|537258733|FG000|Overall Study|Lack of Efficacy|1|||
149015258|NCT03713021|537534433|FG000|Overall Study|Did not have CT sim scan available|6|||
149196656|NCT02720016|538189364|FG001|Overall Study|Withdrawal by Subject|6|||
149196657|NCT02720016|538189365|FG002|Overall Study|Withdrawal by Subject|4|||
149196658|NCT02720016|538189363|FG000|Overall Study|Scheduling issues|2|||
149196659|NCT02720016|538189364|FG001|Overall Study|Scheduling issues|4|||
149196660|NCT02720016|538189365|FG002|Overall Study|Scheduling issues|7|||
149196661|NCT02720016|538189363|FG000|Overall Study|Childcare|2|||
149196662|NCT02720016|538189364|FG001|Overall Study|Childcare|0|||
149196663|NCT02720016|538189365|FG002|Overall Study|Childcare|2|||
149196664|NCT02720016|538189363|FG000|Overall Study|Withdrawal by PI|2|||
149196665|NCT02720016|538189364|FG001|Overall Study|Withdrawal by PI|2|||
149196666|NCT02720016|538189365|FG002|Overall Study|Withdrawal by PI|0|||
148682441|NCT01797120|536310933|FG001|Overall Study|still on treatment|4|||
148682442|NCT01797120|536310932|FG000|Overall Study|never start protocol therapy|2|||
149196667|NCT02720016|538189363|FG000|Overall Study|Moved away|2|||
149196668|NCT02720016|538189364|FG001|Overall Study|Moved away|0|||
149196669|NCT02720016|538189365|FG002|Overall Study|Moved away|0|||
149196670|NCT02720016|538189363|FG000|Overall Study|Not Primary Health Concern|0|||
149196671|NCT02720016|538189364|FG001|Overall Study|Not Primary Health Concern|0|||
149196672|NCT02720016|538189365|FG002|Overall Study|Not Primary Health Concern|2|||
148682443|NCT01797120|536310933|FG001|Overall Study|never start protocol therapy|0|||
148938699|NCT00850070|537258734|FG001|Overall Study|Lack of Efficacy|1|||
149196673|NCT02720016|538189363|FG000|Overall Study|Transportation issues|0|||
149196674|NCT02720016|538189364|FG001|Overall Study|Transportation issues|0|||
149196675|NCT02720016|538189365|FG002|Overall Study|Transportation issues|1|||
149196676|NCT02720016|538189363|FG000|Overall Study|Other|0|||
149196677|NCT02720016|538189364|FG001|Overall Study|Other|0|||
149196678|NCT02720016|538189365|FG002|Overall Study|Other|2|||
149196679|NCT01968954|538189368|FG000|Overall Study|Adverse Event|6|||
149196680|NCT01968954|538189369|FG001|Overall Study|Adverse Event|3|||
149196681|NCT01968954|538189368|FG000|Overall Study|Death|1|||
149196682|NCT01968954|538189369|FG001|Overall Study|Death|2|||
148682444|NCT00295854|536310934|FG000|Overall Study|Adverse Event|7|||
148938700|NCT00850070|537258733|FG000|Overall Study|Adverse Event|2|||
148938701|NCT00850070|537258734|FG001|Overall Study|Adverse Event|0|||
148938702|NCT01522248|537258735|FG000|Overall Study|Lost to Follow-up|1|||
148938703|NCT01522248|537258736|FG001|Overall Study|Lost to Follow-up|0|||
149015259|NCT03713021|537534433|FG000|Overall Study|Not eligible|4|||
149196683|NCT01968954|538189368|FG000|Overall Study|Lost to Follow-up|6|||
149196684|NCT01968954|538189369|FG001|Overall Study|Lost to Follow-up|4|||
148938704|NCT00696800|537258738|FG000|Overall Study|Adverse Event|16|||
148938705|NCT00696800|537258739|FG001|Overall Study|Adverse Event|3|||
149196685|NCT01968954|538189368|FG000|Overall Study|Withdrawal by Subject|20|||
149196686|NCT01968954|538189369|FG001|Overall Study|Withdrawal by Subject|23|||
149196687|NCT01968954|538189368|FG000|Overall Study|Other|7|||
149196688|NCT01968954|538189369|FG001|Overall Study|Other|8|||
149196689|NCT01968954|538189368|FG000|Overall Study|Protocol Violation|0|||
149196690|NCT01968954|538189369|FG001|Overall Study|Protocol Violation|1|||
148938706|NCT00696800|537258738|FG000|Overall Study|Insufficient compliance with medication|2|||
148938707|NCT00696800|537258739|FG001|Overall Study|Insufficient compliance with medication|1|||
148938708|NCT00696800|537258738|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
148938709|NCT00696800|537258739|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
148938710|NCT00696800|537258738|FG000|Overall Study|Insufficient ovarian response|4|||
148938711|NCT00696800|537258739|FG001|Overall Study|Insufficient ovarian response|1|||
148938712|NCT00696800|537258738|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
148938713|NCT00696800|537258739|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
148938714|NCT00696800|537258738|FG000|Overall Study|Too high ovarian response|6|||
148938715|NCT00696800|537258739|FG001|Overall Study|Too high ovarian response|1|||
148938716|NCT00696800|537258738|FG000|Overall Study|No/too few/bad quality oocytes|4|||
148938717|NCT00696800|537258739|FG001|Overall Study|No/too few/bad quality oocytes|3|||
148938718|NCT00696800|537258738|FG000|Overall Study|No/abnormal fertilization|11|||
148938719|NCT00696800|537258739|FG001|Overall Study|No/abnormal fertilization|13|||
148938720|NCT00696800|537258738|FG000|Overall Study|No/too few/bad quality embryos|24|||
148938721|NCT00696800|537258739|FG001|Overall Study|No/too few/bad quality embryos|18|||
148938722|NCT00696800|537258738|FG000|Overall Study|Other Reasons|5|||
148938723|NCT00696800|537258739|FG001|Overall Study|Other Reasons|3|||
148938724|NCT00696800|537258738|FG000|Overall Study|Not treated|1|||
148938725|NCT00696800|537258739|FG001|Overall Study|Not treated|2|||
148938726|NCT03469934|537258751|FG000|Overall Study|Withdrawal by Subject|0|||
148938727|NCT03469934|537258752|FG001|Overall Study|Withdrawal by Subject|1|||
148938728|NCT02435147|537258760|FG000|Overall Study|non-evaluable DXA scan|11|||
148938729|NCT02639546|537258761|FG000|Overall Study|Death|2|||
148938730|NCT02639546|537258762|FG001|Overall Study|Death|2|||
148938731|NCT02639546|537258763|FG002|Overall Study|Death|1|||
148938732|NCT02639546|537258764|FG003|Overall Study|Death|2|||
148938733|NCT02639546|537258765|FG004|Overall Study|Death|2|||
148938734|NCT02639546|537258766|FG005|Overall Study|Death|2|||
148938735|NCT02639546|537258767|FG006|Overall Study|Death|0|||
148938736|NCT02639546|537258768|FG007|Overall Study|Death|0|||
148938737|NCT02639546|537258761|FG000|Overall Study|Lost to Follow-up|0|||
148938738|NCT02639546|537258762|FG001|Overall Study|Lost to Follow-up|0|||
148938739|NCT02639546|537258763|FG002|Overall Study|Lost to Follow-up|1|||
148938740|NCT02639546|537258764|FG003|Overall Study|Lost to Follow-up|0|||
148938741|NCT02639546|537258765|FG004|Overall Study|Lost to Follow-up|1|||
148938742|NCT02639546|537258766|FG005|Overall Study|Lost to Follow-up|1|||
148938743|NCT02639546|537258767|FG006|Overall Study|Lost to Follow-up|0|||
148938744|NCT02639546|537258768|FG007|Overall Study|Lost to Follow-up|1|||
148938745|NCT02639546|537258761|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
148938746|NCT02639546|537258762|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
148938747|NCT02639546|537258763|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
148938748|NCT02639546|537258764|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
148938749|NCT02639546|537258765|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
148938750|NCT02639546|537258766|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
148938751|NCT02639546|537258767|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
148938752|NCT02639546|537258768|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
148938753|NCT02639546|537258761|FG000|Overall Study|Study Terminated By Sponsor|0|||
148938754|NCT02639546|537258762|FG001|Overall Study|Study Terminated By Sponsor|2|||
148938755|NCT02639546|537258763|FG002|Overall Study|Study Terminated By Sponsor|3|||
148938756|NCT02639546|537258764|FG003|Overall Study|Study Terminated By Sponsor|4|||
148938757|NCT02639546|537258765|FG004|Overall Study|Study Terminated By Sponsor|4|||
148938758|NCT02639546|537258766|FG005|Overall Study|Study Terminated By Sponsor|3|||
148938759|NCT02639546|537258767|FG006|Overall Study|Study Terminated By Sponsor|3|||
148938760|NCT02639546|537258768|FG007|Overall Study|Study Terminated By Sponsor|9|||
148938761|NCT02639546|537258761|FG000|Overall Study|Withdrawal by Subject|2|||
148938762|NCT02639546|537258762|FG001|Overall Study|Withdrawal by Subject|2|||
148938763|NCT02639546|537258763|FG002|Overall Study|Withdrawal by Subject|1|||
149196691|NCT01968954|538189368|FG000|Overall Study|Did not met inclusion criteria|0|||
148682445|NCT00295854|536310935|FG001|Overall Study|Adverse Event|7|||
148682446|NCT00295854|536310936|FG002|Overall Study|Adverse Event|6|||
148682447|NCT00295854|536310934|FG000|Overall Study|Protocol Violation|1|||
149196692|NCT01968954|538189369|FG001|Overall Study|Did not met inclusion criteria|2|||
148682448|NCT00295854|536310935|FG001|Overall Study|Protocol Violation|1|||
148938764|NCT02639546|537258764|FG003|Overall Study|Withdrawal by Subject|0|||
148938765|NCT02639546|537258765|FG004|Overall Study|Withdrawal by Subject|0|||
148938766|NCT02639546|537258766|FG005|Overall Study|Withdrawal by Subject|1|||
148938767|NCT02639546|537258767|FG006|Overall Study|Withdrawal by Subject|2|||
148938768|NCT02639546|537258768|FG007|Overall Study|Withdrawal by Subject|1|||
148938769|NCT02478372|537258769|FG000|Overall Study|Protocol Violation|12|||
148938770|NCT02478372|537258770|FG001|Overall Study|Protocol Violation|8|||
148938771|NCT02478372|537258769|FG000|Overall Study|Lost to Follow-up|1|||
148938772|NCT02478372|537258770|FG001|Overall Study|Lost to Follow-up|4|||
148938773|NCT02478372|537258769|FG000|Overall Study|Death|0|||
148938774|NCT02478372|537258770|FG001|Overall Study|Death|2|||
148938775|NCT00113087|537258771|FG000|Overall Study|Death or Transplant|14|||
148807947|NCT03573297|536774478|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
148807948|NCT03573297|536774479|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
148807949|NCT03573297|536774480|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
148807950|NCT03415178|536774481|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
148807951|NCT03415178|536774482|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
148807952|NCT03415178|536774481|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
148807953|NCT03415178|536774482|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
148807954|NCT01366092|536774483|FG000|Overall Study|Progressive cGVHD|2|||
148807955|NCT01366092|536774483|FG000|Overall Study|Physician Decision|1|||
148807956|NCT01366092|536774483|FG000|Overall Study|Withdrawal by Subject|1|||
148807957|NCT02273167|536774485|FG000|Overall Study|Adverse Event|1|||
149196693|NCT05319080|538189370|FG000|Overall Study|Withdrawal by Subject|2|||
149196694|NCT05319080|538189370|FG000|Overall Study|Physician Decision|4|||
149196695|NCT00751114|538189371|FG000|Overall Study|Adverse Event|2|||
149196696|NCT00751114|538189372|FG001|Overall Study|Adverse Event|4|||
149196697|NCT00751114|538189371|FG000|Overall Study|Protocol Violation|8|||
149196698|NCT00751114|538189372|FG001|Overall Study|Protocol Violation|9|||
149196699|NCT00751114|538189371|FG000|Overall Study|Withdrawal by Subject|9|||
149196700|NCT00751114|538189372|FG001|Overall Study|Withdrawal by Subject|4|||
149196701|NCT00751114|538189371|FG000|Overall Study|Lost to Follow-up|4|||
149196702|NCT00751114|538189372|FG001|Overall Study|Lost to Follow-up|7|||
149196703|NCT00751114|538189371|FG000|Overall Study|Lack of Efficacy|0|||
148807958|NCT02273167|536774486|FG001|Overall Study|Adverse Event|0|||
148807959|NCT02273167|536774487|FG002|Overall Study|Adverse Event|0|||
148807960|NCT02273167|536774485|FG000|Overall Study|Protocol Violation|3|||
148807961|NCT02273167|536774486|FG001|Overall Study|Protocol Violation|1|||
148807962|NCT02273167|536774487|FG002|Overall Study|Protocol Violation|1|||
148807963|NCT02273167|536774485|FG000|Overall Study|Lost to Follow-up|0|||
148807964|NCT02273167|536774486|FG001|Overall Study|Lost to Follow-up|1|||
148807965|NCT02273167|536774487|FG002|Overall Study|Lost to Follow-up|1|||
148938776|NCT00113087|537258772|FG001|Overall Study|Death or Transplant|16|||
148938777|NCT00113087|537258771|FG000|Overall Study|Family or MD withdrew subject|10|||
148938778|NCT00113087|537258772|FG001|Overall Study|Family or MD withdrew subject|5|||
148938779|NCT03452228|537258773|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
148938780|NCT03452228|537258774|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
148938781|NCT03452228|537258775|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
148938782|NCT03452228|537258773|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
148938783|NCT03452228|537258774|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
148938784|NCT03452228|537258775|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148938785|NCT03452228|537258773|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
148938786|NCT03452228|537258774|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
148938787|NCT03452228|537258775|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
148938788|NCT03452228|537258773|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148938789|NCT03452228|537258774|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148938790|NCT03452228|537258775|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
148938791|NCT00386607|537258776|FG000|Core|Adverse Event|40|||
148938792|NCT00386607|537258777|FG001|Core|Adverse Event|0|||
148938793|NCT00386607|537258776|FG000|Core|Abnormal laboratory value(s)|3|||
148938794|NCT00386607|537258777|FG001|Core|Abnormal laboratory value(s)|0|||
148938795|NCT00386607|537258776|FG000|Core|Unsatisfactory therapeutic effect|23|||
148938796|NCT00386607|537258777|FG001|Core|Unsatisfactory therapeutic effect|0|||
148938797|NCT00386607|537258776|FG000|Core|Condition no longer requires study drug|4|||
148938798|NCT00386607|537258777|FG001|Core|Condition no longer requires study drug|0|||
148938799|NCT00386607|537258776|FG000|Core|Patient withdrew consent|15|||
148807966|NCT02273167|536774485|FG000|Overall Study|Withdrawal by Subject|10|||
148807967|NCT02273167|536774486|FG001|Overall Study|Withdrawal by Subject|12|||
148938800|NCT00386607|537258777|FG001|Core|Patient withdrew consent|0|||
148938801|NCT00386607|537258776|FG000|Core|Lost to Follow-up|23|||
148938802|NCT00386607|537258777|FG001|Core|Lost to Follow-up|0|||
148938803|NCT00386607|537258776|FG000|Core|Administrative problems|1|||
148938804|NCT00386607|537258777|FG001|Core|Administrative problems|0|||
149196704|NCT00751114|538189372|FG001|Overall Study|Lack of Efficacy|7|||
149196705|NCT00751114|538189371|FG000|Overall Study|Not Treated|13|||
148807968|NCT02273167|536774487|FG002|Overall Study|Withdrawal by Subject|11|||
149196706|NCT00751114|538189372|FG001|Overall Study|Not Treated|1|||
148807969|NCT02273167|536774485|FG000|Overall Study|Various|10|||
148807970|NCT02273167|536774486|FG001|Overall Study|Various|9|||
149196707|NCT00751114|538189371|FG000|Overall Study|Out of country for 2 months|1|||
149196708|NCT00751114|538189372|FG001|Overall Study|Out of country for 2 months|0|||
149196709|NCT00751114|538189371|FG000|Overall Study|Move to another city|1|||
149196710|NCT00751114|538189372|FG001|Overall Study|Move to another city|0|||
149196711|NCT02358369|538189373|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
149196712|NCT02358369|538189374|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149196713|NCT02358369|538189375|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149196714|NCT02358369|538189376|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149196715|NCT02358369|538189377|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
149196716|NCT02358369|538189373|FG000|Treatment Period A/B|Adverse Event|0|||
149196717|NCT02358369|538189374|FG001|Treatment Period A/B|Adverse Event|0|||
149196718|NCT02358369|538189375|FG002|Treatment Period A/B|Adverse Event|1|||
149196719|NCT02358369|538189376|FG003|Treatment Period A/B|Adverse Event|2|||
149196720|NCT02358369|538189377|FG004|Treatment Period A/B|Adverse Event|0|||
149196721|NCT02358369|538189373|FG000|Treatment Period A/B|Death|0|||
149196722|NCT02358369|538189374|FG001|Treatment Period A/B|Death|0|||
149196723|NCT02358369|538189375|FG002|Treatment Period A/B|Death|1|||
149196724|NCT02358369|538189376|FG003|Treatment Period A/B|Death|0|||
149196725|NCT02358369|538189377|FG004|Treatment Period A/B|Death|0|||
149196726|NCT02358369|538189373|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
149196727|NCT02358369|538189374|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
149196728|NCT02358369|538189375|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
149196729|NCT02358369|538189376|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
149196730|NCT02358369|538189377|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
149196731|NCT02358369|538189373|FG000|Treatment Period C|Adverse Event|0|||
149196732|NCT02358369|538189374|FG001|Treatment Period C|Adverse Event|0|||
149196733|NCT02358369|538189375|FG002|Treatment Period C|Adverse Event|0|||
149196734|NCT02358369|538189376|FG003|Treatment Period C|Adverse Event|0|||
149196735|NCT02358369|538189377|FG004|Treatment Period C|Adverse Event|7|||
149196736|NCT00448916|538189380|FG000|Overall Study|Adverse Event|2|||
149196737|NCT00448916|538189381|FG001|Overall Study|Adverse Event|2|||
149196738|NCT00448916|538189382|FG002|Overall Study|Adverse Event|3|||
149196739|NCT00448916|538189383|FG003|Overall Study|Adverse Event|2|||
149196740|NCT00448916|538189380|FG000|Overall Study|Lack of Efficacy|1|||
149196741|NCT00448916|538189381|FG001|Overall Study|Lack of Efficacy|0|||
149196742|NCT00448916|538189382|FG002|Overall Study|Lack of Efficacy|2|||
149196743|NCT00448916|538189383|FG003|Overall Study|Lack of Efficacy|1|||
148682449|NCT00295854|536310936|FG002|Overall Study|Protocol Violation|1|||
148682450|NCT00295854|536310934|FG000|Overall Study|Lost to Follow-up|2|||
148682451|NCT00295854|536310935|FG001|Overall Study|Lost to Follow-up|0|||
148682452|NCT00295854|536310936|FG002|Overall Study|Lost to Follow-up|1|||
148682453|NCT00295854|536310934|FG000|Overall Study|Withdrawal by Subject|3|||
148938805|NCT00386607|537258776|FG000|Core|Protocol Deviation|6|||
148938806|NCT00386607|537258777|FG001|Core|Protocol Deviation|0|||
148938807|NCT00386607|537258776|FG000|Extension|Adverse Event|0|||
148938808|NCT00386607|537258777|FG001|Extension|Adverse Event|6|||
148938809|NCT00386607|537258776|FG000|Extension|Abnormal laboratory value(s)|0|||
148938810|NCT00386607|537258777|FG001|Extension|Abnormal laboratory value(s)|1|||
148938811|NCT00386607|537258776|FG000|Extension|Administrative problems|0|||
148938812|NCT00386607|537258777|FG001|Extension|Administrative problems|1|||
148938813|NCT00386607|537258776|FG000|Extension|Lost to Follow-up|0|||
148938814|NCT00386607|537258777|FG001|Extension|Lost to Follow-up|3|||
148938815|NCT00386607|537258776|FG000|Extension|Patient withdrew consent|0|||
148938816|NCT00386607|537258777|FG001|Extension|Patient withdrew consent|5|||
148938817|NCT00386607|537258776|FG000|Extension|Unsatisfactory therapeutic effect|0|||
148938818|NCT00386607|537258777|FG001|Extension|Unsatisfactory therapeutic effect|1|||
148938819|NCT03000569|537258779|FG000|Overall Study|Withdrawal by Subject|1|||
148938820|NCT03000569|537258780|FG001|Overall Study|Withdrawal by Subject|0|||
148938821|NCT02298023|537258781|FG000|Overall Study|Withdrawal by Subject|1|||
149196744|NCT00448916|538189380|FG000|Overall Study|Withdrawal by Subject|3|||
149196745|NCT00448916|538189381|FG001|Overall Study|Withdrawal by Subject|3|||
149196746|NCT00448916|538189382|FG002|Overall Study|Withdrawal by Subject|1|||
149196747|NCT00448916|538189383|FG003|Overall Study|Withdrawal by Subject|1|||
149196748|NCT00448916|538189380|FG000|Overall Study|Other|1|||
149196749|NCT00448916|538189381|FG001|Overall Study|Other|0|||
149196750|NCT00448916|538189382|FG002|Overall Study|Other|0|||
148682454|NCT00295854|536310935|FG001|Overall Study|Withdrawal by Subject|7|||
148938822|NCT02298023|537258782|FG001|Overall Study|Withdrawal by Subject|0|||
148938823|NCT02298023|537258783|FG002|Overall Study|Withdrawal by Subject|0|||
148938824|NCT04122534|537258784|FG000|Overall Study|Lost to Follow-up|4|||
148938825|NCT02128932|537258792|FG000|Overall Study|Withdrawal by Subject|11|||
148938826|NCT02128932|537258793|FG001|Overall Study|Withdrawal by Subject|7|||
148938827|NCT02128932|537258794|FG002|Overall Study|Withdrawal by Subject|8|||
149196751|NCT00448916|538189383|FG003|Overall Study|Other|0|||
149196752|NCT00448916|538189380|FG000|Overall Study|Lost to Follow-up|0|||
149196753|NCT00448916|538189381|FG001|Overall Study|Lost to Follow-up|1|||
149196754|NCT00448916|538189382|FG002|Overall Study|Lost to Follow-up|0|||
148682455|NCT00295854|536310936|FG002|Overall Study|Withdrawal by Subject|4|||
148682456|NCT00295854|536310934|FG000|Overall Study|did not continue to meet criteria|1|||
148682457|NCT00295854|536310935|FG001|Overall Study|did not continue to meet criteria|1|||
149015260|NCT03713021|537534433|FG000|Overall Study|Issues with TraceIT markers|5|||
149015261|NCT00874432|537534434|FG000|Overall Study|Withdrawal by Subject|1|||
149015262|NCT00874432|537534435|FG001|Overall Study|Withdrawal by Subject|0|||
149015263|NCT00874432|537534436|FG002|Overall Study|Withdrawal by Subject|0|||
149015264|NCT00874432|537534437|FG003|Overall Study|Withdrawal by Subject|0|||
149015265|NCT00874432|537534434|FG000|Overall Study|Physician Decision|1|||
149015266|NCT00874432|537534435|FG001|Overall Study|Physician Decision|0|||
149015267|NCT00874432|537534436|FG002|Overall Study|Physician Decision|0|||
149015268|NCT00874432|537534437|FG003|Overall Study|Physician Decision|0|||
149015269|NCT00874432|537534434|FG000|Overall Study|Other|1|||
149015270|NCT00874432|537534435|FG001|Overall Study|Other|2|||
149015271|NCT00874432|537534436|FG002|Overall Study|Other|8|||
149015272|NCT00874432|537534437|FG003|Overall Study|Other|3|||
149015273|NCT05256381|537534438|FG000|Overall Study|Withdrawal by Subject|4|||
149015274|NCT05256381|537534439|FG001|Overall Study|Withdrawal by Subject|0|||
149015275|NCT05256381|537534440|FG002|Overall Study|Withdrawal by Subject|2|||
149015276|NCT05256381|537534441|FG003|Overall Study|Withdrawal by Subject|2|||
149015277|NCT05256381|537534442|FG004|Overall Study|Withdrawal by Subject|8|||
149015278|NCT05256381|537534443|FG005|Overall Study|Withdrawal by Subject|6|||
149015279|NCT05256381|537534438|FG000|Overall Study|Physician Decision|0|||
149015280|NCT05256381|537534439|FG001|Overall Study|Physician Decision|0|||
149015281|NCT05256381|537534440|FG002|Overall Study|Physician Decision|1|||
149015282|NCT05256381|537534441|FG003|Overall Study|Physician Decision|0|||
149015283|NCT05256381|537534442|FG004|Overall Study|Physician Decision|2|||
149015284|NCT05256381|537534443|FG005|Overall Study|Physician Decision|0|||
149015285|NCT05256381|537534438|FG000|Overall Study|Death|17|||
149015286|NCT05256381|537534439|FG001|Overall Study|Death|3|||
149015287|NCT05256381|537534440|FG002|Overall Study|Death|4|||
149015288|NCT05256381|537534441|FG003|Overall Study|Death|5|||
149015289|NCT05256381|537534442|FG004|Overall Study|Death|24|||
149015290|NCT05256381|537534443|FG005|Overall Study|Death|21|||
149015291|NCT05256381|537534438|FG000|Overall Study|Other, not specified|0|||
149015292|NCT05256381|537534439|FG001|Overall Study|Other, not specified|0|||
149015293|NCT05256381|537534440|FG002|Overall Study|Other, not specified|0|||
149015294|NCT05256381|537534441|FG003|Overall Study|Other, not specified|0|||
149015295|NCT05256381|537534442|FG004|Overall Study|Other, not specified|2|||
149015296|NCT05256381|537534443|FG005|Overall Study|Other, not specified|1|||
149015297|NCT05256381|537534438|FG000|Overall Study|Study terminated by sponsor|18|||
149015298|NCT05256381|537534439|FG001|Overall Study|Study terminated by sponsor|5|||
149015299|NCT05256381|537534440|FG002|Overall Study|Study terminated by sponsor|5|||
149015300|NCT05256381|537534441|FG003|Overall Study|Study terminated by sponsor|5|||
149015301|NCT05256381|537534442|FG004|Overall Study|Study terminated by sponsor|18|||
149015302|NCT05256381|537534443|FG005|Overall Study|Study terminated by sponsor|11|||
148682458|NCT00295854|536310936|FG002|Overall Study|did not continue to meet criteria|2|||
148682459|NCT00295854|536310934|FG000|Overall Study|required a prohibited medication|1|||
148682460|NCT00295854|536310935|FG001|Overall Study|required a prohibited medication|0|||
148682461|NCT00295854|536310936|FG002|Overall Study|required a prohibited medication|0|||
149015303|NCT05256381|537534438|FG000|Overall Study|Lost to Follow-up|1|||
148682462|NCT00295854|536310934|FG000|Overall Study|Other|3|||
148682463|NCT00295854|536310935|FG001|Overall Study|Other|5|||
148682464|NCT00295854|536310936|FG002|Overall Study|Other|1|||
148682465|NCT00672620|536310937|FG000|Overall Study|Adverse Event|7|||
148682466|NCT00672620|536310938|FG001|Overall Study|Adverse Event|7|||
149015304|NCT05256381|537534439|FG001|Overall Study|Lost to Follow-up|0|||
149015305|NCT05256381|537534440|FG002|Overall Study|Lost to Follow-up|0|||
149015306|NCT05256381|537534441|FG003|Overall Study|Lost to Follow-up|0|||
149015307|NCT05256381|537534442|FG004|Overall Study|Lost to Follow-up|1|||
149015308|NCT05256381|537534443|FG005|Overall Study|Lost to Follow-up|0|||
149015309|NCT01518946|537534450|FG000|Open-label Phase|Other|4|||
149015310|NCT01518946|537534451|FG001|Open-label Phase|Other|0|||
148682467|NCT00672620|536310939|FG002|Overall Study|Adverse Event|12|||
149015311|NCT01518946|537534452|FG002|Open-label Phase|Other|0|||
149015312|NCT01518946|537534450|FG000|Randomized Phase (First Intervention)|Other|0|||
149015313|NCT01518946|537534451|FG001|Randomized Phase (First Intervention)|Other|1|||
149015314|NCT01518946|537534452|FG002|Randomized Phase (First Intervention)|Other|0|||
149196755|NCT00448916|538189383|FG003|Overall Study|Lost to Follow-up|1|||
149196756|NCT00448916|538189380|FG000|Overall Study|Protocol Violation|0|||
149196757|NCT00448916|538189381|FG001|Overall Study|Protocol Violation|0|||
149196758|NCT00448916|538189382|FG002|Overall Study|Protocol Violation|0|||
149196759|NCT00448916|538189383|FG003|Overall Study|Protocol Violation|1|||
149196760|NCT03655717|538189384|FG000|Overall Study|Withdrawal by Subject|4|||
149196761|NCT03655717|538189385|FG001|Overall Study|Withdrawal by Subject|8|||
149196762|NCT03655717|538189386|FG002|Overall Study|Withdrawal by Subject|1|||
149196763|NCT03655717|538189387|FG003|Overall Study|Withdrawal by Subject|0|||
149196764|NCT03655717|538189388|FG004|Overall Study|Withdrawal by Subject|0|||
149196765|NCT03655717|538189389|FG005|Overall Study|Withdrawal by Subject|1|||
149196766|NCT03655717|538189390|FG006|Overall Study|Withdrawal by Subject|3|||
149196767|NCT03655717|538189391|FG007|Overall Study|Withdrawal by Subject|1|||
149196768|NCT03655717|538189392|FG008|Overall Study|Withdrawal by Subject|2|||
149196769|NCT03655717|538189393|FG009|Overall Study|Withdrawal by Subject|0|||
149196770|NCT03655717|538189394|FG010|Overall Study|Withdrawal by Subject|0|||
149196771|NCT03655717|538189395|FG011|Overall Study|Withdrawal by Subject|1|||
149196772|NCT03655717|538189396|FG012|Overall Study|Withdrawal by Subject|0|||
149196773|NCT03655717|538189397|FG013|Overall Study|Withdrawal by Subject|3|||
149196774|NCT03655717|538189398|FG014|Overall Study|Withdrawal by Subject|0|||
149196775|NCT03655717|538189399|FG015|Overall Study|Withdrawal by Subject|1|||
149196776|NCT03655717|538189400|FG016|Overall Study|Withdrawal by Subject|0|||
149196777|NCT03655717|538189401|FG017|Overall Study|Withdrawal by Subject|0|||
149196778|NCT03655717|538189402|FG018|Overall Study|Withdrawal by Subject|1|||
149196779|NCT03655717|538189403|FG019|Overall Study|Withdrawal by Subject|0|||
149196780|NCT03655717|538189404|FG020|Overall Study|Withdrawal by Subject|0|||
149196781|NCT03655717|538189405|FG021|Overall Study|Withdrawal by Subject|1|||
149196782|NCT03655717|538189406|FG022|Overall Study|Withdrawal by Subject|2|||
149196783|NCT03655717|538189407|FG023|Overall Study|Withdrawal by Subject|1|||
149196784|NCT03655717|538189408|FG024|Overall Study|Withdrawal by Subject|1|||
149196785|NCT03655717|538189409|FG025|Overall Study|Withdrawal by Subject|0|||
149196786|NCT03655717|538189384|FG000|Overall Study|Physician Decision|3|||
149196787|NCT03655717|538189385|FG001|Overall Study|Physician Decision|3|||
149196788|NCT03655717|538189386|FG002|Overall Study|Physician Decision|0|||
149196789|NCT03655717|538189387|FG003|Overall Study|Physician Decision|0|||
149196790|NCT03655717|538189388|FG004|Overall Study|Physician Decision|0|||
149196791|NCT03655717|538189389|FG005|Overall Study|Physician Decision|0|||
149196792|NCT03655717|538189390|FG006|Overall Study|Physician Decision|0|||
149196793|NCT03655717|538189391|FG007|Overall Study|Physician Decision|0|||
149196794|NCT03655717|538189392|FG008|Overall Study|Physician Decision|0|||
149196795|NCT03655717|538189393|FG009|Overall Study|Physician Decision|1|||
149196796|NCT03655717|538189394|FG010|Overall Study|Physician Decision|0|||
149196797|NCT03655717|538189395|FG011|Overall Study|Physician Decision|0|||
149196798|NCT03655717|538189396|FG012|Overall Study|Physician Decision|0|||
149196799|NCT03655717|538189397|FG013|Overall Study|Physician Decision|0|||
149196800|NCT03655717|538189398|FG014|Overall Study|Physician Decision|0|||
149196801|NCT03655717|538189399|FG015|Overall Study|Physician Decision|0|||
149196802|NCT03655717|538189400|FG016|Overall Study|Physician Decision|0|||
149196803|NCT03655717|538189401|FG017|Overall Study|Physician Decision|0|||
149196804|NCT03655717|538189402|FG018|Overall Study|Physician Decision|0|||
149196805|NCT03655717|538189403|FG019|Overall Study|Physician Decision|1|||
149196806|NCT03655717|538189404|FG020|Overall Study|Physician Decision|0|||
149196807|NCT03655717|538189405|FG021|Overall Study|Physician Decision|0|||
149196808|NCT03655717|538189406|FG022|Overall Study|Physician Decision|0|||
149196809|NCT03655717|538189407|FG023|Overall Study|Physician Decision|1|||
149196810|NCT03655717|538189408|FG024|Overall Study|Physician Decision|0|||
149196811|NCT03655717|538189409|FG025|Overall Study|Physician Decision|0|||
149196812|NCT03655717|538189384|FG000|Overall Study|Lost to Follow-up|3|||
149196813|NCT03655717|538189385|FG001|Overall Study|Lost to Follow-up|1|||
149196814|NCT03655717|538189386|FG002|Overall Study|Lost to Follow-up|0|||
149196815|NCT03655717|538189387|FG003|Overall Study|Lost to Follow-up|1|||
149196816|NCT03655717|538189388|FG004|Overall Study|Lost to Follow-up|0|||
149196817|NCT03655717|538189389|FG005|Overall Study|Lost to Follow-up|1|||
149196818|NCT03655717|538189390|FG006|Overall Study|Lost to Follow-up|0|||
149196819|NCT03655717|538189391|FG007|Overall Study|Lost to Follow-up|0|||
149196820|NCT03655717|538189392|FG008|Overall Study|Lost to Follow-up|0|||
149196821|NCT03655717|538189393|FG009|Overall Study|Lost to Follow-up|0|||
149196822|NCT03655717|538189394|FG010|Overall Study|Lost to Follow-up|0|||
149196823|NCT03655717|538189395|FG011|Overall Study|Lost to Follow-up|1|||
149196824|NCT03655717|538189396|FG012|Overall Study|Lost to Follow-up|0|||
149196825|NCT03655717|538189397|FG013|Overall Study|Lost to Follow-up|0|||
149196826|NCT03655717|538189398|FG014|Overall Study|Lost to Follow-up|0|||
148938828|NCT02128932|537258792|FG000|Overall Study|Death|2|||
148938829|NCT02128932|537258793|FG001|Overall Study|Death|0|||
148938830|NCT02128932|537258794|FG002|Overall Study|Death|2|||
148938831|NCT02128932|537258792|FG000|Overall Study|Lost to Follow-up|2|||
148938832|NCT02128932|537258793|FG001|Overall Study|Lost to Follow-up|1|||
148938833|NCT02128932|537258794|FG002|Overall Study|Lost to Follow-up|1|||
148938834|NCT02128932|537258792|FG000|Overall Study|No reason for withdrawal|12|||
148938835|NCT02128932|537258793|FG001|Overall Study|No reason for withdrawal|11|||
148938836|NCT02128932|537258794|FG002|Overall Study|No reason for withdrawal|7|||
148938837|NCT03113916|537258795|FG000|Overall Study|Withdrawal by Subject|9|||
148938838|NCT03113916|537258796|FG001|Overall Study|Withdrawal by Subject|7|||
148938839|NCT03113916|537258795|FG000|Overall Study|Pregnancy|1|||
148938840|NCT03113916|537258796|FG001|Overall Study|Pregnancy|3|||
148938841|NCT03113916|537258795|FG000|Overall Study|Lost to Follow-up|1|||
148938842|NCT03113916|537258796|FG001|Overall Study|Lost to Follow-up|2|||
148938843|NCT04729621|537258797|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
148938844|NCT04729621|537258798|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
148938845|NCT04729621|537258799|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
148938846|NCT04729621|537258800|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
148938847|NCT04729621|537258801|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
148938848|NCT04729621|537258797|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
148938849|NCT04729621|537258798|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
148938850|NCT04729621|537258799|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
148938851|NCT04729621|537258800|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
148938852|NCT04729621|537258801|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
148938853|NCT04729621|537258797|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
148938854|NCT04729621|537258798|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
148938855|NCT04729621|537258799|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
148938856|NCT04729621|537258800|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
148938857|NCT04729621|537258801|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
148938858|NCT04729621|537258797|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
148938859|NCT04729621|537258798|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
148938860|NCT04729621|537258799|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
148938861|NCT04729621|537258800|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
148938862|NCT04729621|537258801|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
148938863|NCT04729621|537258797|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
148938864|NCT04729621|537258798|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
148938865|NCT04729621|537258799|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
148938866|NCT04729621|537258800|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
149196827|NCT03655717|538189399|FG015|Overall Study|Lost to Follow-up|0|||
149196828|NCT03655717|538189400|FG016|Overall Study|Lost to Follow-up|0|||
149196829|NCT03655717|538189401|FG017|Overall Study|Lost to Follow-up|0|||
149196830|NCT03655717|538189402|FG018|Overall Study|Lost to Follow-up|0|||
148938867|NCT04729621|537258801|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
149196831|NCT03655717|538189403|FG019|Overall Study|Lost to Follow-up|0|||
149196832|NCT03655717|538189404|FG020|Overall Study|Lost to Follow-up|0|||
149196833|NCT03655717|538189405|FG021|Overall Study|Lost to Follow-up|0|||
149196834|NCT03655717|538189406|FG022|Overall Study|Lost to Follow-up|0|||
149196835|NCT03655717|538189407|FG023|Overall Study|Lost to Follow-up|0|||
149196836|NCT03655717|538189408|FG024|Overall Study|Lost to Follow-up|0|||
149196837|NCT03655717|538189409|FG025|Overall Study|Lost to Follow-up|0|||
149196838|NCT01968187|538189413|FG000|Overall Study|Adverse Event|0|||
149196839|NCT01968187|538189414|FG001|Overall Study|Adverse Event|1|||
148938868|NCT04729621|537258797|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
148938869|NCT04729621|537258798|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
148938870|NCT04729621|537258799|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
148938871|NCT04729621|537258800|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
148938872|NCT04729621|537258801|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
148938873|NCT02663908|537258802|FG000|Overall Study|Withdrawal by Subject|8|||
148938874|NCT02663908|537258803|FG001|Overall Study|Withdrawal by Subject|5|||
148938875|NCT02663908|537258802|FG000|Overall Study|Lost to Follow-up|1|||
148938876|NCT02663908|537258803|FG001|Overall Study|Lost to Follow-up|5|||
148938877|NCT02663908|537258802|FG000|Overall Study|Adverse Event|13|||
148938878|NCT02663908|537258803|FG001|Overall Study|Adverse Event|11|||
148938879|NCT02663908|537258802|FG000|Overall Study|Protocol Violation|1|||
148938880|NCT02663908|537258803|FG001|Overall Study|Protocol Violation|2|||
148938881|NCT02663908|537258802|FG000|Overall Study|Lack of therapeutic response|2|||
148938882|NCT02663908|537258803|FG001|Overall Study|Lack of therapeutic response|0|||
148938883|NCT02663908|537258802|FG000|Overall Study|COVID-19|1|||
148938884|NCT02663908|537258803|FG001|Overall Study|COVID-19|0|||
148938885|NCT02663908|537258802|FG000|Overall Study|Site closed|1|||
148938886|NCT02663908|537258803|FG001|Overall Study|Site closed|0|||
148938887|NCT02663908|537258802|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
148938888|NCT02663908|537258803|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
148938889|NCT02663908|537258802|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
148938890|NCT02663908|537258803|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
148938891|NCT02663908|537258802|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
148938892|NCT02663908|537258803|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
148938893|NCT02663908|537258802|FG000|Overall Study|Death|1|||
148938894|NCT02663908|537258803|FG001|Overall Study|Death|0|||
148938895|NCT02663908|537258802|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
148938896|NCT02663908|537258803|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
148938897|NCT02663908|537258802|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
148938898|NCT02663908|537258803|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
148938899|NCT03308786|537258804|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
148938900|NCT02004522|537258805|FG000|Overall Study|Adverse Event|55|||
148938901|NCT02004522|537258806|FG001|Overall Study|Adverse Event|6|||
148938902|NCT02004522|537258805|FG000|Overall Study|Withdrawal by Subject|13|||
148938903|NCT02004522|537258806|FG001|Overall Study|Withdrawal by Subject|7|||
148938904|NCT02004522|537258805|FG000|Overall Study|Death|12|||
148938905|NCT02004522|537258806|FG001|Overall Study|Death|3|||
148938906|NCT02004522|537258805|FG000|Overall Study|Physician Decision|3|||
148938907|NCT02004522|537258806|FG001|Overall Study|Physician Decision|4|||
148938908|NCT02004522|537258805|FG000|Overall Study|Protocol Violation|1|||
148938909|NCT02004522|537258806|FG001|Overall Study|Protocol Violation|0|||
148938910|NCT02004522|537258805|FG000|Overall Study|Other is reason listed by PI|4|||
148938911|NCT02004522|537258806|FG001|Overall Study|Other is reason listed by PI|1|||
148938912|NCT02004522|537258805|FG000|Overall Study|Never Dosed|2|||
148938913|NCT02004522|537258806|FG001|Overall Study|Never Dosed|4|||
148938914|NCT02004522|537258805|FG000|Overall Study|Disease Progression|35|||
148938915|NCT02004522|537258806|FG001|Overall Study|Disease Progression|31|||
148938916|NCT02004522|537258805|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
148938917|NCT02004522|537258806|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
148938918|NCT01787331|537258807|FG000|Overall Study|Physician Decision|1|||
148938919|NCT01787331|537258807|FG000|Overall Study|Withdrawal by Subject|1|||
148938920|NCT03019185|537260232|FG000|Overall Study|Lost to Follow-up|3|||
148938921|NCT03019185|537260233|FG001|Overall Study|Lost to Follow-up|0|||
148938922|NCT03019185|537260234|FG002|Overall Study|Lost to Follow-up|2|||
148938923|NCT03019185|537260232|FG000|Overall Study|Withdrawal by Subject|1|||
148938924|NCT03019185|537260233|FG001|Overall Study|Withdrawal by Subject|1|||
148938925|NCT03019185|537260234|FG002|Overall Study|Withdrawal by Subject|0|||
148938926|NCT03019185|537260232|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
148682468|NCT00672620|536310940|FG003|Overall Study|Adverse Event|17|||
148938927|NCT03019185|537260233|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
148938928|NCT03019185|537260234|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
148938929|NCT03019185|537260232|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
148938930|NCT03019185|537260233|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
148938931|NCT03019185|537260234|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
148938932|NCT02764333|537260235|FG000|Overall Study|Ineligible|1|||
148938933|NCT03355365|537260236|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
148938934|NCT03355365|537260237|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
148938935|NCT03355365|537260236|FG000|Year 1, First Intervention|Protocol Violation|1|||
148938936|NCT03355365|537260237|FG001|Year 1, First Intervention|Protocol Violation|0|||
148938937|NCT03355365|537260236|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
148938938|NCT03355365|537260237|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
148938939|NCT03355365|537260236|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
148938940|NCT03355365|537260237|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
148938941|NCT03355365|537260236|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
148938942|NCT03355365|537260237|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
148938943|NCT03355365|537260236|FG000|Year 2, Crossover Intervention|severe COVID|0|||
148938944|NCT03355365|537260237|FG001|Year 2, Crossover Intervention|severe COVID|1|||
148938945|NCT03355365|537260236|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
148938946|NCT03355365|537260237|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
148938947|NCT04622306|537260238|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
148938948|NCT04622306|537260239|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
148938949|NCT04622306|537260240|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
148938950|NCT04622306|537260241|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
148938951|NCT04622306|537260242|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
148938952|NCT04622306|537260243|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
148938953|NCT04622306|537260238|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
148938954|NCT04622306|537260239|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
148938955|NCT04622306|537260240|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
148938956|NCT04622306|537260241|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
148938957|NCT04622306|537260242|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
148938958|NCT04622306|537260243|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
148938959|NCT00617851|537260244|FG000|Overall Study|Death|0|||
148938960|NCT00617851|537260245|FG001|Overall Study|Death|0|||
148938961|NCT00617851|537260246|FG002|Overall Study|Death|0|||
148938962|NCT00617851|537260247|FG003|Overall Study|Death|1|||
148938963|NCT00617851|537260244|FG000|Overall Study|Withdrawal by Subject|14|||
148938964|NCT00617851|537260245|FG001|Overall Study|Withdrawal by Subject|7|||
148938965|NCT00617851|537260246|FG002|Overall Study|Withdrawal by Subject|12|||
148938966|NCT00617851|537260247|FG003|Overall Study|Withdrawal by Subject|4|||
148938967|NCT00617851|537260244|FG000|Overall Study|Lost to Follow-up|27|||
148938968|NCT00617851|537260245|FG001|Overall Study|Lost to Follow-up|29|||
148938969|NCT00617851|537260246|FG002|Overall Study|Lost to Follow-up|31|||
148938970|NCT00617851|537260247|FG003|Overall Study|Lost to Follow-up|19|||
148938971|NCT00617851|537260244|FG000|Overall Study|Inappropriate Enrollment|5|||
148938972|NCT00617851|537260245|FG001|Overall Study|Inappropriate Enrollment|4|||
148938973|NCT00617851|537260246|FG002|Overall Study|Inappropriate Enrollment|1|||
148938974|NCT00617851|537260247|FG003|Overall Study|Inappropriate Enrollment|1|||
148938975|NCT00617851|537260244|FG000|Overall Study|Unable to classify|1|||
148938976|NCT00617851|537260245|FG001|Overall Study|Unable to classify|0|||
148938977|NCT00617851|537260246|FG002|Overall Study|Unable to classify|1|||
148938978|NCT00617851|537260247|FG003|Overall Study|Unable to classify|0|||
148938979|NCT01200524|537260248|FG000|Overall Study|Withdrawal by Subject|1|||
148938980|NCT01200524|537260249|FG001|Overall Study|Withdrawal by Subject|1|||
148938981|NCT01200524|537260250|FG002|Overall Study|Withdrawal by Subject|3|||
148938982|NCT01200524|537260248|FG000|Overall Study|Adverse Event|1|||
148938983|NCT01200524|537260249|FG001|Overall Study|Adverse Event|0|||
148938984|NCT01200524|537260250|FG002|Overall Study|Adverse Event|0|||
148938985|NCT01200524|537260248|FG000|Overall Study|Non availability of study nurse|0|||
148938986|NCT01200524|537260249|FG001|Overall Study|Non availability of study nurse|0|||
148938987|NCT01200524|537260250|FG002|Overall Study|Non availability of study nurse|1|||
148938988|NCT00697788|537260258|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
148938989|NCT00697788|537260259|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
148938990|NCT00697788|537260260|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
148938991|NCT00697788|537260261|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
148938992|NCT00697788|537260262|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
148938993|NCT00697788|537260263|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
149015315|NCT03857841|537534453|FG000|Overall Study|Death|1|||
149015316|NCT03857841|537534454|FG001|Overall Study|Death|0|||
149015317|NCT03857841|537534455|FG002|Overall Study|Death|0|||
149015318|NCT03857841|537534456|FG003|Overall Study|Death|0|||
149015319|NCT03857841|537534453|FG000|Overall Study|Study Terminated by Sponsor|1|||
149196840|NCT01968187|538189413|FG000|Overall Study|Randomized but not treated|1|||
149196841|NCT01968187|538189414|FG001|Overall Study|Randomized but not treated|0|||
149196842|NCT01877382|538189415|FG000|Dose Escalation|Progressive disease|2|||
149196843|NCT01877382|538189416|FG001|Dose Escalation|Progressive disease|0|||
149196844|NCT01877382|538189417|FG002|Dose Escalation|Progressive disease|1|||
149196845|NCT01877382|538189418|FG003|Dose Escalation|Progressive disease|6|||
149196846|NCT01877382|538189419|FG004|Dose Escalation|Progressive disease|1|||
149196847|NCT01877382|538189420|FG005|Dose Escalation|Progressive disease|0|||
149196848|NCT01877382|538189421|FG006|Dose Escalation|Progressive disease|3|||
149196849|NCT01877382|538189422|FG007|Dose Escalation|Progressive disease|10|||
149196850|NCT01877382|538189423|FG008|Dose Escalation|Progressive disease|4|||
149196851|NCT01877382|538189424|FG009|Dose Escalation|Progressive disease|2|||
149196852|NCT01877382|538189425|FG010|Dose Escalation|Progressive disease|3|||
149196853|NCT01877382|538189426|FG011|Dose Escalation|Progressive disease|3|||
149196854|NCT01877382|538189427|FG012|Dose Escalation|Progressive disease|13|||
149196855|NCT01877382|538189428|FG013|Dose Escalation|Progressive disease|1|||
149196856|NCT01877382|538189429|FG014|Dose Escalation|Progressive disease|0|||
149196857|NCT01877382|538189415|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149196858|NCT01877382|538189416|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196859|NCT01877382|538189417|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196860|NCT01877382|538189418|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149196861|NCT01877382|538189419|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196862|NCT01877382|538189420|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196863|NCT01877382|538189421|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149196864|NCT01877382|538189422|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196865|NCT01877382|538189423|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196866|NCT01877382|538189424|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196867|NCT01877382|538189425|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196868|NCT01877382|538189426|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196869|NCT01877382|538189427|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196870|NCT01877382|538189428|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196871|NCT01877382|538189429|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149196872|NCT01877382|538189415|FG000|Dose Escalation|Clinical progression|0|||
149196873|NCT01877382|538189416|FG001|Dose Escalation|Clinical progression|1|||
149196874|NCT01877382|538189417|FG002|Dose Escalation|Clinical progression|0|||
149196875|NCT01877382|538189418|FG003|Dose Escalation|Clinical progression|2|||
149196876|NCT01877382|538189419|FG004|Dose Escalation|Clinical progression|0|||
149196877|NCT01877382|538189420|FG005|Dose Escalation|Clinical progression|0|||
149196878|NCT01877382|538189421|FG006|Dose Escalation|Clinical progression|1|||
149196879|NCT01877382|538189422|FG007|Dose Escalation|Clinical progression|0|||
149196880|NCT01877382|538189423|FG008|Dose Escalation|Clinical progression|0|||
149196881|NCT01877382|538189424|FG009|Dose Escalation|Clinical progression|1|||
149196882|NCT01877382|538189425|FG010|Dose Escalation|Clinical progression|0|||
149196883|NCT01877382|538189426|FG011|Dose Escalation|Clinical progression|0|||
149196884|NCT01877382|538189427|FG012|Dose Escalation|Clinical progression|2|||
149196885|NCT01877382|538189428|FG013|Dose Escalation|Clinical progression|1|||
149196886|NCT01877382|538189429|FG014|Dose Escalation|Clinical progression|0|||
149196887|NCT01877382|538189415|FG000|Dose Escalation|Adverse Event|0|||
149196888|NCT01877382|538189416|FG001|Dose Escalation|Adverse Event|0|||
149196889|NCT01877382|538189417|FG002|Dose Escalation|Adverse Event|0|||
149196890|NCT01877382|538189418|FG003|Dose Escalation|Adverse Event|4|||
149196891|NCT01877382|538189419|FG004|Dose Escalation|Adverse Event|1|||
149196892|NCT01877382|538189420|FG005|Dose Escalation|Adverse Event|2|||
149196893|NCT01877382|538189421|FG006|Dose Escalation|Adverse Event|1|||
148682469|NCT00672620|536310937|FG000|Overall Study|Lack of Efficacy|1|||
148682470|NCT00672620|536310938|FG001|Overall Study|Lack of Efficacy|2|||
148682471|NCT00672620|536310939|FG002|Overall Study|Lack of Efficacy|2|||
148682472|NCT00672620|536310940|FG003|Overall Study|Lack of Efficacy|0|||
149196894|NCT01877382|538189422|FG007|Dose Escalation|Adverse Event|2|||
149196895|NCT01877382|538189423|FG008|Dose Escalation|Adverse Event|0|||
149196896|NCT01877382|538189424|FG009|Dose Escalation|Adverse Event|0|||
149196897|NCT01877382|538189425|FG010|Dose Escalation|Adverse Event|0|||
149196898|NCT01877382|538189426|FG011|Dose Escalation|Adverse Event|0|||
149196899|NCT01877382|538189427|FG012|Dose Escalation|Adverse Event|1|||
149196900|NCT01877382|538189428|FG013|Dose Escalation|Adverse Event|0|||
148682473|NCT00672620|536310937|FG000|Overall Study|Noncompliance with Study Drug|3|||
149015320|NCT03857841|537534454|FG001|Overall Study|Study Terminated by Sponsor|0|||
148938994|NCT00697788|537260264|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
148938995|NCT00697788|537260265|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
148938996|NCT00697788|537260258|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148938997|NCT00697788|537260259|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148938998|NCT00697788|537260260|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148938999|NCT00697788|537260261|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148939000|NCT00697788|537260262|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
148939001|NCT00697788|537260263|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148939002|NCT00697788|537260264|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148939003|NCT00697788|537260265|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
148939004|NCT03228433|537260266|FG000|Overall Study|Lost to Follow-up|1|||
148939005|NCT03228433|537260267|FG001|Overall Study|Lost to Follow-up|0|||
148939006|NCT03228433|537260268|FG002|Overall Study|Lost to Follow-up|0|||
148939007|NCT03228433|537260269|FG003|Overall Study|Lost to Follow-up|0|||
148939008|NCT03228433|537260270|FG004|Overall Study|Lost to Follow-up|0|||
148939009|NCT03228433|537260271|FG005|Overall Study|Lost to Follow-up|0|||
148939010|NCT03228433|537260266|FG000|Overall Study|Positive alcohol test|0|||
148939011|NCT03228433|537260267|FG001|Overall Study|Positive alcohol test|0|||
148939012|NCT03228433|537260268|FG002|Overall Study|Positive alcohol test|0|||
148939013|NCT03228433|537260269|FG003|Overall Study|Positive alcohol test|1|||
148939014|NCT03228433|537260270|FG004|Overall Study|Positive alcohol test|0|||
148939015|NCT03228433|537260271|FG005|Overall Study|Positive alcohol test|0|||
148939016|NCT01365052|537260279|FG000|Overall Study|Adverse Event|4|||
148939017|NCT01365052|537260280|FG001|Overall Study|Adverse Event|4|||
148939018|NCT00074984|537260281|FG000|Overall Study|Death|1|||
148939019|NCT00074984|537260282|FG001|Overall Study|Death|2|||
148939020|NCT00074984|537260281|FG000|Overall Study|Withdrawal by Subject|2|||
148939021|NCT00074984|537260282|FG001|Overall Study|Withdrawal by Subject|3|||
148939022|NCT00074984|537260281|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
149015321|NCT03857841|537534455|FG002|Overall Study|Study Terminated by Sponsor|0|||
148939023|NCT00074984|537260282|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
148939024|NCT03080454|537260283|FG000|Baseline|Adverse Event|2|||
149015322|NCT03857841|537534456|FG003|Overall Study|Study Terminated by Sponsor|0|||
149015323|NCT04213989|537536084|FG000|Overall Study|Withdrawal by Subject|3|||
149015324|NCT04213989|537536085|FG001|Overall Study|Withdrawal by Subject|2|||
149015325|NCT04213989|537536084|FG000|Overall Study|Physician Decision|1|||
149015326|NCT04213989|537536085|FG001|Overall Study|Physician Decision|0|||
149015327|NCT04213989|537536084|FG000|Overall Study|Lost to Follow-up|0|||
149015328|NCT04213989|537536085|FG001|Overall Study|Lost to Follow-up|4|||
149015329|NCT03918239|537536088|FG000|Overall Study|Lost to Follow-up|3|||
149015330|NCT03918239|537536089|FG001|Overall Study|Lost to Follow-up|1|||
149015331|NCT03918239|537536088|FG000|Overall Study|Pregnancy|0|||
149015332|NCT03918239|537536089|FG001|Overall Study|Pregnancy|2|||
149015333|NCT03918239|537536088|FG000|Overall Study|Withdrawal by Subject|3|||
149015334|NCT03918239|537536089|FG001|Overall Study|Withdrawal by Subject|3|||
149015335|NCT03918239|537536088|FG000|Overall Study|positive urine drug screening results|4|||
149015336|NCT03918239|537536089|FG001|Overall Study|positive urine drug screening results|1|||
149015337|NCT03390036|537536092|FG000|Overall Study|Lost to Follow-up|1|||
149015338|NCT03390036|537536093|FG001|Overall Study|Lost to Follow-up|0|||
149015339|NCT03390036|537536094|FG002|Overall Study|Lost to Follow-up|0|||
149015340|NCT03390036|537536092|FG000|Overall Study|Lack of Efficacy|1|||
149015341|NCT03390036|537536093|FG001|Overall Study|Lack of Efficacy|0|||
149015342|NCT03390036|537536094|FG002|Overall Study|Lack of Efficacy|0|||
149015343|NCT00358215|537536097|FG000|Overall Study|Ineligibility determined|4|||
149015344|NCT00358215|537536098|FG001|Overall Study|Ineligibility determined|3|||
149015345|NCT00358215|537536097|FG000|Overall Study|Adverse Event|83|||
149015346|NCT00358215|537536098|FG001|Overall Study|Adverse Event|65|||
149015347|NCT00358215|537536097|FG000|Overall Study|Withdrawal by Subject|111|||
149015348|NCT00358215|537536098|FG001|Overall Study|Withdrawal by Subject|102|||
149015349|NCT00358215|537536097|FG000|Overall Study|Participant request|65|||
149015350|NCT00358215|537536098|FG001|Overall Study|Participant request|64|||
149015351|NCT00358215|537536097|FG000|Overall Study|Physician Decision|47|||
149015352|NCT00358215|537536098|FG001|Overall Study|Physician Decision|39|||
149015353|NCT00358215|537536097|FG000|Overall Study|Lost to Follow-up|16|||
149015354|NCT00358215|537536098|FG001|Overall Study|Lost to Follow-up|22|||
149015355|NCT00358215|537536097|FG000|Overall Study|Death|265|||
149015356|NCT00358215|537536098|FG001|Overall Study|Death|281|||
149015357|NCT00358215|537536097|FG000|Overall Study|Protocol Violation|64|||
149015358|NCT00358215|537536098|FG001|Overall Study|Protocol Violation|59|||
149015359|NCT00358215|537536097|FG000|Overall Study|Pregnancy|1|||
149015360|NCT00358215|537536098|FG001|Overall Study|Pregnancy|0|||
149015361|NCT00358215|537536097|FG000|Overall Study|Other|21|||
149015362|NCT00358215|537536098|FG001|Overall Study|Other|14|||
149015363|NCT00358215|537536097|FG000|Overall Study|Did not receive investigational product|2|||
149015364|NCT00358215|537536098|FG001|Overall Study|Did not receive investigational product|3|||
149015365|NCT00744237|537536099|FG000|Overall Study|Lack of Efficacy|1|||
149015366|NCT00744237|537536100|FG001|Overall Study|Lack of Efficacy|1|||
149015367|NCT00744237|537536101|FG002|Overall Study|Lack of Efficacy|0|||
149015368|NCT00744237|537536099|FG000|Overall Study|Withdrawal by Subject|9|||
149015369|NCT00744237|537536100|FG001|Overall Study|Withdrawal by Subject|5|||
149015370|NCT00744237|537536101|FG002|Overall Study|Withdrawal by Subject|3|||
149015371|NCT00744237|537536099|FG000|Overall Study|Lost to Follow-up|1|||
149015372|NCT00744237|537536100|FG001|Overall Study|Lost to Follow-up|1|||
149015373|NCT00744237|537536101|FG002|Overall Study|Lost to Follow-up|1|||
149015374|NCT00744237|537536099|FG000|Overall Study|Protocol Violation|3|||
149015375|NCT00744237|537536100|FG001|Overall Study|Protocol Violation|4|||
149015376|NCT00744237|537536101|FG002|Overall Study|Protocol Violation|3|||
149015377|NCT00744237|537536099|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
149015378|NCT00744237|537536100|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
149196901|NCT01877382|538189429|FG014|Dose Escalation|Adverse Event|0|||
149196902|NCT01877382|538189415|FG000|Dose Escalation|Withdrawal by Subject|0|||
149196903|NCT01877382|538189416|FG001|Dose Escalation|Withdrawal by Subject|0|||
149196904|NCT01877382|538189417|FG002|Dose Escalation|Withdrawal by Subject|0|||
149196905|NCT01877382|538189418|FG003|Dose Escalation|Withdrawal by Subject|0|||
149196906|NCT01877382|538189419|FG004|Dose Escalation|Withdrawal by Subject|0|||
149196907|NCT01877382|538189420|FG005|Dose Escalation|Withdrawal by Subject|3|||
148682474|NCT00672620|536310938|FG001|Overall Study|Noncompliance with Study Drug|4|||
148682475|NCT00672620|536310939|FG002|Overall Study|Noncompliance with Study Drug|0|||
149015379|NCT00744237|537536101|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
149015380|NCT00744237|537536099|FG000|Overall Study|Dosing Error|1|||
149015381|NCT00744237|537536100|FG001|Overall Study|Dosing Error|0|||
149015382|NCT00744237|537536101|FG002|Overall Study|Dosing Error|1|||
149015383|NCT00744237|537536099|FG000|Overall Study|Study Drug Error|1|||
149196908|NCT01877382|538189421|FG006|Dose Escalation|Withdrawal by Subject|2|||
149196909|NCT01877382|538189422|FG007|Dose Escalation|Withdrawal by Subject|1|||
148682476|NCT00672620|536310940|FG003|Overall Study|Noncompliance with Study Drug|2|||
148682477|NCT00672620|536310937|FG000|Overall Study|Protocol Deviations|5|||
149015384|NCT00744237|537536100|FG001|Overall Study|Study Drug Error|0|||
149015385|NCT00744237|537536101|FG002|Overall Study|Study Drug Error|0|||
149196910|NCT01877382|538189423|FG008|Dose Escalation|Withdrawal by Subject|1|||
149196911|NCT01877382|538189424|FG009|Dose Escalation|Withdrawal by Subject|0|||
149196912|NCT01877382|538189425|FG010|Dose Escalation|Withdrawal by Subject|0|||
149015386|NCT00744237|537536099|FG000|Overall Study|Prohibited Concomitant Medication|0|||
149015387|NCT00744237|537536100|FG001|Overall Study|Prohibited Concomitant Medication|0|||
148939025|NCT03080454|537260283|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
148939026|NCT03080454|537260283|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
148939027|NCT02202980|537260284|FG000|Overall Study|Lack of Efficacy|1|||
148939028|NCT02202980|537260285|FG001|Overall Study|Lack of Efficacy|0|||
148939029|NCT02202980|537260286|FG002|Overall Study|Lack of Efficacy|7|||
148939030|NCT02202980|537260287|FG003|Overall Study|Lack of Efficacy|0|||
148939031|NCT02202980|537260288|FG004|Overall Study|Lack of Efficacy|3|||
148939032|NCT02202980|537260289|FG005|Overall Study|Lack of Efficacy|1|||
148939033|NCT02202980|537260290|FG006|Overall Study|Lack of Efficacy|11|||
148939034|NCT02202980|537260291|FG007|Overall Study|Lack of Efficacy|2|||
148939035|NCT02202980|537260292|FG008|Overall Study|Lack of Efficacy|2|||
148939036|NCT02202980|537260293|FG009|Overall Study|Lack of Efficacy|0|||
148939037|NCT02202980|537260294|FG010|Overall Study|Lack of Efficacy|0|||
148939038|NCT02202980|537260295|FG011|Overall Study|Lack of Efficacy|3|||
148939039|NCT02202980|537260296|FG012|Overall Study|Lack of Efficacy|10|||
148939040|NCT02202980|537260297|FG013|Overall Study|Lack of Efficacy|0|||
148939041|NCT02202980|537260284|FG000|Overall Study|Protocol Violation|0|||
148939042|NCT02202980|537260285|FG001|Overall Study|Protocol Violation|0|||
148939043|NCT02202980|537260286|FG002|Overall Study|Protocol Violation|0|||
148939044|NCT02202980|537260287|FG003|Overall Study|Protocol Violation|3|||
148939045|NCT02202980|537260288|FG004|Overall Study|Protocol Violation|3|||
148939046|NCT02202980|537260289|FG005|Overall Study|Protocol Violation|0|||
148939047|NCT02202980|537260290|FG006|Overall Study|Protocol Violation|0|||
148939048|NCT02202980|537260291|FG007|Overall Study|Protocol Violation|0|||
148939049|NCT02202980|537260292|FG008|Overall Study|Protocol Violation|0|||
148939050|NCT02202980|537260293|FG009|Overall Study|Protocol Violation|0|||
148939051|NCT02202980|537260294|FG010|Overall Study|Protocol Violation|0|||
148939052|NCT02202980|537260295|FG011|Overall Study|Protocol Violation|0|||
148939053|NCT02202980|537260296|FG012|Overall Study|Protocol Violation|0|||
148939054|NCT02202980|537260297|FG013|Overall Study|Protocol Violation|0|||
148939055|NCT02202980|537260284|FG000|Overall Study|Lost to Follow-up|0|||
148939056|NCT02202980|537260285|FG001|Overall Study|Lost to Follow-up|1|||
148939057|NCT02202980|537260286|FG002|Overall Study|Lost to Follow-up|1|||
148939058|NCT02202980|537260287|FG003|Overall Study|Lost to Follow-up|1|||
148939059|NCT02202980|537260288|FG004|Overall Study|Lost to Follow-up|0|||
148939060|NCT02202980|537260289|FG005|Overall Study|Lost to Follow-up|0|||
148939061|NCT02202980|537260290|FG006|Overall Study|Lost to Follow-up|0|||
148939062|NCT02202980|537260291|FG007|Overall Study|Lost to Follow-up|1|||
148939063|NCT02202980|537260292|FG008|Overall Study|Lost to Follow-up|1|||
148939064|NCT02202980|537260293|FG009|Overall Study|Lost to Follow-up|0|||
148939065|NCT02202980|537260294|FG010|Overall Study|Lost to Follow-up|0|||
148939066|NCT02202980|537260295|FG011|Overall Study|Lost to Follow-up|0|||
148939067|NCT02202980|537260296|FG012|Overall Study|Lost to Follow-up|1|||
148939068|NCT02202980|537260297|FG013|Overall Study|Lost to Follow-up|0|||
148939069|NCT02202980|537260284|FG000|Overall Study|Withdrew Consent|0|||
148939070|NCT02202980|537260285|FG001|Overall Study|Withdrew Consent|1|||
148939071|NCT02202980|537260286|FG002|Overall Study|Withdrew Consent|2|||
148939072|NCT02202980|537260287|FG003|Overall Study|Withdrew Consent|0|||
148939073|NCT02202980|537260288|FG004|Overall Study|Withdrew Consent|0|||
148939074|NCT02202980|537260289|FG005|Overall Study|Withdrew Consent|0|||
148939075|NCT02202980|537260290|FG006|Overall Study|Withdrew Consent|0|||
148939076|NCT02202980|537260291|FG007|Overall Study|Withdrew Consent|0|||
148939077|NCT02202980|537260292|FG008|Overall Study|Withdrew Consent|1|||
148939078|NCT02202980|537260293|FG009|Overall Study|Withdrew Consent|0|||
148939079|NCT02202980|537260294|FG010|Overall Study|Withdrew Consent|0|||
148939080|NCT02202980|537260295|FG011|Overall Study|Withdrew Consent|0|||
148939081|NCT02202980|537260296|FG012|Overall Study|Withdrew Consent|0|||
148939082|NCT02202980|537260297|FG013|Overall Study|Withdrew Consent|0|||
148939083|NCT04138810|537260304|FG000|Overall Study|Withdrawal by Subject|0|||
148939084|NCT04138810|537260305|FG001|Overall Study|Withdrawal by Subject|1|||
148939085|NCT04138810|537260304|FG000|Overall Study|Subject cancelled surgery|1|||
148939086|NCT04138810|537260305|FG001|Overall Study|Subject cancelled surgery|0|||
148939087|NCT04515394|537260315|FG000|Overall Study|Participant did not receive treatment|1|||
148939088|NCT01058655|537260316|FG000|Overall Study|Withdrawal by Subject|1|||
148682478|NCT00672620|536310938|FG001|Overall Study|Protocol Deviations|7|||
148682479|NCT00672620|536310939|FG002|Overall Study|Protocol Deviations|2|||
148939089|NCT01058655|537260317|FG001|Overall Study|Withdrawal by Subject|0|||
148939090|NCT01058655|537260318|FG002|Overall Study|Withdrawal by Subject|3|||
148939091|NCT01058655|537260319|FG003|Overall Study|Withdrawal by Subject|4|||
148939092|NCT01058655|537260316|FG000|Overall Study|Prolonged Treatment Delay|0|||
148939093|NCT01058655|537260317|FG001|Overall Study|Prolonged Treatment Delay|0|||
148939094|NCT01058655|537260318|FG002|Overall Study|Prolonged Treatment Delay|0|||
148939095|NCT01058655|537260319|FG003|Overall Study|Prolonged Treatment Delay|2|||
148939096|NCT01058655|537260316|FG000|Overall Study|Symptomatic Deterioration|0|||
148939097|NCT01058655|537260317|FG001|Overall Study|Symptomatic Deterioration|0|||
148939098|NCT01058655|537260318|FG002|Overall Study|Symptomatic Deterioration|0|||
148682480|NCT00672620|536310940|FG003|Overall Study|Protocol Deviations|5|||
148939099|NCT01058655|537260319|FG003|Overall Study|Symptomatic Deterioration|1|||
148939100|NCT01058655|537260316|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
148939101|NCT01058655|537260317|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
148939102|NCT01058655|537260318|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
148939103|NCT01058655|537260319|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
148939104|NCT01058655|537260316|FG000|Overall Study|Death|0|||
148939105|NCT01058655|537260317|FG001|Overall Study|Death|1|||
148939106|NCT01058655|537260318|FG002|Overall Study|Death|1|||
148939107|NCT01058655|537260319|FG003|Overall Study|Death|0|||
148939108|NCT01058655|537260316|FG000|Overall Study|Disease Progression|1|||
148939109|NCT01058655|537260317|FG001|Overall Study|Disease Progression|2|||
148939110|NCT01058655|537260318|FG002|Overall Study|Disease Progression|4|||
148939111|NCT01058655|537260319|FG003|Overall Study|Disease Progression|24|||
148939112|NCT01058655|537260316|FG000|Overall Study|Other|0|||
148807971|NCT02273167|536774487|FG002|Overall Study|Various|8|||
148939113|NCT01058655|537260317|FG001|Overall Study|Other|0|||
148939114|NCT01058655|537260318|FG002|Overall Study|Other|0|||
148939115|NCT01058655|537260319|FG003|Overall Study|Other|4|||
148939116|NCT02939079|537260322|FG000|Overall Study|Adverse Event|2|||
148939117|NCT02939079|537260323|FG001|Overall Study|Adverse Event|1|||
148939118|NCT02939079|537260322|FG000|Overall Study|Lost to Follow-up|0|||
148939119|NCT02939079|537260323|FG001|Overall Study|Lost to Follow-up|2|||
148939120|NCT02939079|537260322|FG000|Overall Study|Protocol Violation|1|||
148939121|NCT02939079|537260323|FG001|Overall Study|Protocol Violation|0|||
148939122|NCT02939079|537260322|FG000|Overall Study|Withdrawal by Subject|0|||
148939123|NCT02939079|537260323|FG001|Overall Study|Withdrawal by Subject|1|||
148939124|NCT02939079|537260322|FG000|Overall Study|relapse during the study|1|||
148939125|NCT02939079|537260323|FG001|Overall Study|relapse during the study|1|||
148939126|NCT04093414|537260324|FG000|3 Month Follow up|Physician Decision|0|||
148939127|NCT04093414|537260325|FG001|3 Month Follow up|Physician Decision|1|||
148939128|NCT04093414|537260324|FG000|6month Follow up|Physician Decision|1|||
148939129|NCT04093414|537260325|FG001|6month Follow up|Physician Decision|3|||
148939130|NCT04889222|537260326|FG000|Overall Study|Did not meet eligibility criteria|8|||
148939131|NCT04889222|537260326|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
148939132|NCT04889222|537260326|FG000|Overall Study|Did not proceed due to time constraints|5|||
148939133|NCT02761733|537260329|FG000|Overall Study|Death|3|||
148939134|NCT02761733|537260330|FG001|Overall Study|Death|5|||
148939135|NCT02761733|537260331|FG002|Overall Study|Death|1|||
148939136|NCT02761733|537260332|FG003|Overall Study|Death|1|||
148939137|NCT02761733|537260329|FG000|Overall Study|Lost to Follow-up|6|||
148939138|NCT02761733|537260330|FG001|Overall Study|Lost to Follow-up|7|||
148939139|NCT02761733|537260331|FG002|Overall Study|Lost to Follow-up|0|||
148939140|NCT02761733|537260332|FG003|Overall Study|Lost to Follow-up|3|||
148939141|NCT02761733|537260329|FG000|Overall Study|Physician Decision|4|||
148939142|NCT02761733|537260330|FG001|Overall Study|Physician Decision|0|||
148939143|NCT02761733|537260331|FG002|Overall Study|Physician Decision|0|||
148939144|NCT02761733|537260332|FG003|Overall Study|Physician Decision|0|||
148939145|NCT02761733|537260329|FG000|Overall Study|Withdrawal by Subject|2|||
148939146|NCT02761733|537260330|FG001|Overall Study|Withdrawal by Subject|0|||
148939147|NCT02761733|537260331|FG002|Overall Study|Withdrawal by Subject|0|||
148939148|NCT02761733|537260332|FG003|Overall Study|Withdrawal by Subject|0|||
148939149|NCT02761733|537260329|FG000|Overall Study|Discharged from Study Site|10|||
148939150|NCT02761733|537260330|FG001|Overall Study|Discharged from Study Site|9|||
148939151|NCT02761733|537260331|FG002|Overall Study|Discharged from Study Site|25|||
148939152|NCT02761733|537260332|FG003|Overall Study|Discharged from Study Site|11|||
148939153|NCT02761733|537260329|FG000|Overall Study|Cognitive Impairment|5|||
148939154|NCT02761733|537260330|FG001|Overall Study|Cognitive Impairment|0|||
148939155|NCT02761733|537260331|FG002|Overall Study|Cognitive Impairment|1|||
148939156|NCT02761733|537260332|FG003|Overall Study|Cognitive Impairment|0|||
148939157|NCT02713204|537260333|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
148939158|NCT02713204|537260334|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
148939159|NCT02713204|537260335|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
148682481|NCT00672620|536310937|FG000|Overall Study|Withdrawal of Consent|6|||
148939160|NCT02713204|537260336|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
148939161|NCT02713204|537260337|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
148939162|NCT02713204|537260338|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
148939163|NCT02713204|537260339|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
148939164|NCT02713204|537260340|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
148939165|NCT02713204|537260333|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148939166|NCT02713204|537260334|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148682482|NCT00672620|536310938|FG001|Overall Study|Withdrawal of Consent|12|||
148682483|NCT00672620|536310939|FG002|Overall Study|Withdrawal of Consent|5|||
148682484|NCT00672620|536310940|FG003|Overall Study|Withdrawal of Consent|6|||
148682485|NCT00672620|536310937|FG000|Overall Study|Lost to Follow-up|8|||
148682486|NCT00672620|536310938|FG001|Overall Study|Lost to Follow-up|19|||
148682487|NCT00672620|536310939|FG002|Overall Study|Lost to Follow-up|8|||
148682488|NCT00672620|536310940|FG003|Overall Study|Lost to Follow-up|11|||
148682489|NCT00672620|536310937|FG000|Overall Study|Reason not Specified|3|||
148682490|NCT00672620|536310938|FG001|Overall Study|Reason not Specified|3|||
148682491|NCT00672620|536310939|FG002|Overall Study|Reason not Specified|2|||
148682492|NCT00672620|536310940|FG003|Overall Study|Reason not Specified|1|||
148682493|NCT01205529|536310943|FG000|Overall Study|Procedure Cancelled|4|||
148682494|NCT01205529|536310943|FG000|Overall Study|Withdrawal by Subject|2|||
148682495|NCT01205529|536310943|FG000|Overall Study|Physician Decision|4|||
148682496|NCT01205529|536310943|FG000|Overall Study|Unstable post op|15|||
148682497|NCT01205529|536310943|FG000|Overall Study|No longer met criteria|30|||
148939167|NCT02713204|537260335|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
148939168|NCT02713204|537260336|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148939169|NCT02713204|537260337|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148939170|NCT02713204|537260338|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148939171|NCT02713204|537260339|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148939172|NCT02713204|537260340|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
148939173|NCT02713204|537260333|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939174|NCT02713204|537260334|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
148939175|NCT02713204|537260335|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939176|NCT02713204|537260336|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939177|NCT02713204|537260337|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939178|NCT02713204|537260338|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939179|NCT02713204|537260339|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939180|NCT02713204|537260340|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
148939181|NCT02713204|537260333|FG000|From Week 12 up to Week 36|Adverse Event|1|||
148939182|NCT02713204|537260334|FG001|From Week 12 up to Week 36|Adverse Event|0|||
148939183|NCT02713204|537260335|FG002|From Week 12 up to Week 36|Adverse Event|0|||
148939184|NCT02713204|537260336|FG003|From Week 12 up to Week 36|Adverse Event|1|||
148939185|NCT02713204|537260337|FG004|From Week 12 up to Week 36|Adverse Event|1|||
148939186|NCT02713204|537260338|FG005|From Week 12 up to Week 36|Adverse Event|0|||
148939187|NCT02713204|537260339|FG006|From Week 12 up to Week 36|Adverse Event|2|||
148939188|NCT02713204|537260340|FG007|From Week 12 up to Week 36|Adverse Event|1|||
148939189|NCT02713204|537260333|FG000|From Week 12 up to Week 36|Death|0|||
148939190|NCT02713204|537260334|FG001|From Week 12 up to Week 36|Death|0|||
148939191|NCT02713204|537260335|FG002|From Week 12 up to Week 36|Death|0|||
148939192|NCT02713204|537260336|FG003|From Week 12 up to Week 36|Death|1|||
148939193|NCT02713204|537260337|FG004|From Week 12 up to Week 36|Death|0|||
148939194|NCT02713204|537260338|FG005|From Week 12 up to Week 36|Death|1|||
148939195|NCT02713204|537260339|FG006|From Week 12 up to Week 36|Death|0|||
148939196|NCT02713204|537260340|FG007|From Week 12 up to Week 36|Death|3|||
148939197|NCT02713204|537260333|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
148939198|NCT02713204|537260334|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
148939199|NCT02713204|537260335|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
148939200|NCT02713204|537260336|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
148939201|NCT02713204|537260337|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
148939202|NCT02713204|537260338|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
148939203|NCT02713204|537260339|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
148939204|NCT02713204|537260340|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
148682498|NCT00667719|536310944|FG000|Overall Study|Adverse Event|39|||
148682499|NCT00667719|536310944|FG000|Overall Study|Abnormal Test Procedure|1|||
148682500|NCT00667719|536310944|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148939205|NCT02713204|537260333|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
148939206|NCT02713204|537260334|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
148939207|NCT02713204|537260335|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
148939208|NCT02713204|537260336|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
148939209|NCT02713204|537260337|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
148939210|NCT02713204|537260338|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
148939211|NCT02713204|537260339|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
148682501|NCT00667719|536310944|FG000|Overall Study|Protocol Violation|3|||
148939212|NCT02713204|537260340|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
148939213|NCT00788073|537260346|FG000|STX209 Then Placebo|Adverse Event|1|||
148939214|NCT00788073|537260347|FG001|STX209 Then Placebo|Adverse Event|0|||
148939215|NCT00788073|537260346|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
148939216|NCT00788073|537260347|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
148939217|NCT00788073|537260346|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
148939218|NCT00788073|537260347|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
148939219|NCT00788073|537260346|FG000|STX209 Then Placebo|unable to return due to travel|0|||
148939220|NCT00788073|537260347|FG001|STX209 Then Placebo|unable to return due to travel|1|||
148939221|NCT00788073|537260346|FG000|Placebo Then STX209|Adverse Event|2|||
148939222|NCT00788073|537260347|FG001|Placebo Then STX209|Adverse Event|0|||
148939223|NCT00788073|537260346|FG000|Placebo Then STX209|Protocol Violation|0|||
148939224|NCT00788073|537260347|FG001|Placebo Then STX209|Protocol Violation|1|||
148939225|NCT03608254|537260348|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
148939226|NCT03608254|537260348|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
148939227|NCT00660673|537260349|FG000|Overall Study|Adverse Event|84|||
148939228|NCT00660673|537260349|FG000|Overall Study|Lack of Efficacy|7|||
148939229|NCT00660673|537260349|FG000|Overall Study|Withdrawal by Subject|22|||
148939230|NCT00660673|537260349|FG000|Overall Study|Administrative|2|||
148939231|NCT00660673|537260349|FG000|Overall Study|Protocol Violation|2|||
148939232|NCT03208127|537260350|FG000|Overall Study|Death|1|||
148939233|NCT01903031|537260361|FG000|Overall Study|Not Able to Attend Clinic|1|||
148939234|NCT01903031|537260362|FG001|Overall Study|Not Able to Attend Clinic|1|||
148939235|NCT01903031|537260363|FG002|Overall Study|Not Able to Attend Clinic|0|||
148939236|NCT01903031|537260361|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
148939237|NCT01903031|537260362|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
148939238|NCT01903031|537260363|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
148939239|NCT01903031|537260361|FG000|Overall Study|Adverse Event|0|||
148939240|NCT01903031|537260362|FG001|Overall Study|Adverse Event|1|||
148939241|NCT01903031|537260363|FG002|Overall Study|Adverse Event|0|||
148939242|NCT01903031|537260361|FG000|Overall Study|Withdrawal by Subject|0|||
148939243|NCT01903031|537260362|FG001|Overall Study|Withdrawal by Subject|1|||
148939244|NCT01903031|537260363|FG002|Overall Study|Withdrawal by Subject|1|||
148939245|NCT01903031|537260361|FG000|Overall Study|Protocol Violation|0|||
148939246|NCT01903031|537260362|FG001|Overall Study|Protocol Violation|0|||
148939247|NCT01903031|537260363|FG002|Overall Study|Protocol Violation|2|||
148939248|NCT01903031|537260361|FG000|Overall Study|Lost to Follow-up|0|||
148939249|NCT01903031|537260362|FG001|Overall Study|Lost to Follow-up|0|||
148939250|NCT01903031|537260363|FG002|Overall Study|Lost to Follow-up|1|||
148939251|NCT01903031|537260361|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
148939252|NCT01903031|537260362|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
148939253|NCT01903031|537260363|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
148939254|NCT00569270|537260364|FG000|Period: First Intervention|Protocol Violation|0|||
148939255|NCT00569270|537260365|FG001|Period: First Intervention|Protocol Violation|1|||
148939256|NCT00447005|537260367|FG000|Overall Study|Adverse Event|1|||
148939257|NCT00447005|537260367|FG000|Overall Study|Lack of Efficacy|11|||
148939258|NCT00492531|537260368|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
148939259|NCT00492531|537260369|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
148939260|NCT03685123|537260373|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
148939261|NCT03685123|537260374|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
148939262|NCT03685123|537260375|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
148939263|NCT03685123|537260373|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
148939264|NCT03685123|537260374|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
148939265|NCT03685123|537260375|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
148939266|NCT03685123|537260373|FG000|Weight Loss Phase|Lost to Follow-up|1|||
148939267|NCT03685123|537260374|FG001|Weight Loss Phase|Lost to Follow-up|0|||
148939268|NCT03685123|537260375|FG002|Weight Loss Phase|Lost to Follow-up|0|||
148939269|NCT03685123|537260373|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
148939270|NCT03685123|537260374|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
148939271|NCT03685123|537260375|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
148939272|NCT03685123|537260373|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
148939273|NCT03685123|537260374|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
148939274|NCT03685123|537260375|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
148939275|NCT03685123|537260373|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
148939276|NCT03685123|537260374|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
148939277|NCT03685123|537260375|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
148939278|NCT01893203|537260379|FG000|Overall Study|Withdrawal by Subject|1|||
148939279|NCT01758523|537260380|FG000|Overall Study|Adverse Event|2|||
148939280|NCT01758523|537260381|FG001|Overall Study|Adverse Event|1|||
148939281|NCT01758523|537260380|FG000|Overall Study|Lack of Efficacy|4|||
148939282|NCT01758523|537260381|FG001|Overall Study|Lack of Efficacy|2|||
148939283|NCT01758523|537260380|FG000|Overall Study|Lost to Follow-up|3|||
148939284|NCT01758523|537260381|FG001|Overall Study|Lost to Follow-up|4|||
148939285|NCT01758523|537260380|FG000|Overall Study|Withdrawal by Subject|12|||
148939286|NCT01758523|537260381|FG001|Overall Study|Withdrawal by Subject|7|||
148939287|NCT02925117|537260382|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
148939288|NCT02925117|537260383|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
148939289|NCT02925117|537260384|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
148939290|NCT02925117|537260385|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
149196913|NCT01877382|538189426|FG011|Dose Escalation|Withdrawal by Subject|0|||
149196914|NCT01877382|538189427|FG012|Dose Escalation|Withdrawal by Subject|0|||
149196915|NCT01877382|538189428|FG013|Dose Escalation|Withdrawal by Subject|0|||
149196916|NCT01877382|538189429|FG014|Dose Escalation|Withdrawal by Subject|0|||
149196917|NCT01877382|538189415|FG000|Dose Escalation|Protocol Violation|0|||
149196918|NCT01877382|538189416|FG001|Dose Escalation|Protocol Violation|0|||
149196919|NCT01877382|538189417|FG002|Dose Escalation|Protocol Violation|0|||
149196920|NCT01877382|538189418|FG003|Dose Escalation|Protocol Violation|0|||
149196921|NCT01877382|538189419|FG004|Dose Escalation|Protocol Violation|0|||
149196922|NCT01877382|538189420|FG005|Dose Escalation|Protocol Violation|0|||
149196923|NCT01877382|538189421|FG006|Dose Escalation|Protocol Violation|1|||
149196924|NCT01877382|538189422|FG007|Dose Escalation|Protocol Violation|0|||
149196925|NCT01877382|538189423|FG008|Dose Escalation|Protocol Violation|0|||
149196926|NCT01877382|538189424|FG009|Dose Escalation|Protocol Violation|0|||
149196927|NCT01877382|538189425|FG010|Dose Escalation|Protocol Violation|0|||
149196928|NCT01877382|538189426|FG011|Dose Escalation|Protocol Violation|0|||
149196929|NCT01877382|538189427|FG012|Dose Escalation|Protocol Violation|0|||
149196930|NCT01877382|538189428|FG013|Dose Escalation|Protocol Violation|0|||
149196931|NCT01877382|538189429|FG014|Dose Escalation|Protocol Violation|0|||
149196932|NCT01877382|538189415|FG000|Dose Escalation|Study terminated by sponsor|0|||
149196933|NCT01877382|538189416|FG001|Dose Escalation|Study terminated by sponsor|0|||
149196934|NCT01877382|538189417|FG002|Dose Escalation|Study terminated by sponsor|0|||
149196935|NCT01877382|538189418|FG003|Dose Escalation|Study terminated by sponsor|0|||
149196936|NCT01877382|538189419|FG004|Dose Escalation|Study terminated by sponsor|0|||
149196937|NCT01877382|538189420|FG005|Dose Escalation|Study terminated by sponsor|0|||
149196938|NCT01877382|538189421|FG006|Dose Escalation|Study terminated by sponsor|0|||
148939291|NCT02925117|537260386|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939292|NCT02925117|537260387|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939293|NCT02925117|537260388|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939294|NCT02925117|537260389|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939295|NCT02925117|537260390|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939296|NCT02925117|537260391|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939297|NCT02925117|537260392|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
148939298|NCT02925117|537260393|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
149015388|NCT00744237|537536101|FG002|Overall Study|Prohibited Concomitant Medication|1|||
149196939|NCT01877382|538189422|FG007|Dose Escalation|Study terminated by sponsor|1|||
149196940|NCT01877382|538189423|FG008|Dose Escalation|Study terminated by sponsor|1|||
148939299|NCT02925117|537260382|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
148682502|NCT00667719|536310944|FG000|Overall Study|Withdrawal by Subject|17|||
148682503|NCT00667719|536310944|FG000|Overall Study|Lost to Follow-up|8|||
148682504|NCT03840135|536310945|FG000|Overall Study|Protocol Violation|6|||
148682505|NCT03840135|536310946|FG001|Overall Study|Protocol Violation|1|||
148939300|NCT02925117|537260383|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
148939301|NCT02925117|537260384|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
148939302|NCT02925117|537260385|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939303|NCT02925117|537260386|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939304|NCT02925117|537260387|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939305|NCT02925117|537260388|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939306|NCT02925117|537260389|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939307|NCT02925117|537260390|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939308|NCT02925117|537260391|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939309|NCT02925117|537260392|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939310|NCT02925117|537260393|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
148939311|NCT02925117|537260382|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
148939312|NCT02925117|537260383|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
148939313|NCT02925117|537260384|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939314|NCT02925117|537260385|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939315|NCT02925117|537260386|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939316|NCT02925117|537260387|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939317|NCT02925117|537260388|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939318|NCT02925117|537260389|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939319|NCT02925117|537260390|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939320|NCT02925117|537260391|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939321|NCT02925117|537260392|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939322|NCT02925117|537260393|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
148939323|NCT02925117|537260382|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
148939324|NCT02925117|537260383|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
148939325|NCT02925117|537260384|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
148939326|NCT02925117|537260385|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
148939327|NCT02925117|537260386|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
148939328|NCT02925117|537260387|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
148939329|NCT02925117|537260388|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
148939330|NCT02925117|537260389|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
148939331|NCT02925117|537260390|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
148939332|NCT02925117|537260391|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
148939333|NCT02925117|537260392|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
148939334|NCT02925117|537260393|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
148939335|NCT02925117|537260382|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939336|NCT02925117|537260383|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939337|NCT02925117|537260384|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939338|NCT02925117|537260385|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939339|NCT02925117|537260386|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939340|NCT02925117|537260387|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
148939341|NCT02925117|537260388|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939342|NCT02925117|537260389|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939343|NCT02925117|537260390|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939344|NCT02925117|537260391|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
148939345|NCT02925117|537260392|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
148939346|NCT02925117|537260393|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
148939347|NCT02925117|537260382|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
148939348|NCT02925117|537260383|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
149015389|NCT00744237|537536099|FG000|Overall Study|Poor Compliance|0|||
148682506|NCT03840135|536310945|FG000|Overall Study|Withdrawal by Subject|1|||
148939349|NCT02925117|537260384|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
148939350|NCT02925117|537260385|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
148939351|NCT02925117|537260386|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
148939352|NCT02925117|537260387|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
148939353|NCT02925117|537260388|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
148939354|NCT02925117|537260389|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
148939355|NCT02925117|537260390|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
148939356|NCT02925117|537260391|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
148939357|NCT02925117|537260392|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
148939358|NCT02925117|537260393|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
148939359|NCT02925117|537260382|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
148939360|NCT02925117|537260383|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
148939361|NCT02925117|537260384|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
148939362|NCT02925117|537260385|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
148939363|NCT02925117|537260386|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
148939364|NCT02925117|537260387|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
148939365|NCT02925117|537260388|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
148939366|NCT02925117|537260389|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
148939367|NCT02925117|537260390|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
148939368|NCT02925117|537260391|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
148939369|NCT02925117|537260392|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
148939370|NCT02925117|537260393|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
148939371|NCT02925117|537260382|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
148939372|NCT02925117|537260383|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
148939373|NCT02925117|537260384|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
148939374|NCT02925117|537260385|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
148939375|NCT02925117|537260386|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
148939376|NCT02925117|537260387|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
148939377|NCT02925117|537260388|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
148939378|NCT02925117|537260389|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
149196941|NCT01877382|538189424|FG009|Dose Escalation|Study terminated by sponsor|0|||
149196942|NCT01877382|538189425|FG010|Dose Escalation|Study terminated by sponsor|0|||
148939379|NCT02925117|537260390|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
148939380|NCT02925117|537260391|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
148939381|NCT02925117|537260392|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
148939382|NCT02925117|537260393|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
148939383|NCT03113071|537260395|FG000|Overall Study|Withdrawal by Subject|1|||
148939384|NCT03113071|537260396|FG001|Overall Study|Withdrawal by Subject|0|||
148939385|NCT00302107|537260400|FG000|Overall Study|Lost to Follow-up|6|||
148939386|NCT00302107|537260401|FG001|Overall Study|Lost to Follow-up|5|||
148939387|NCT00302107|537260400|FG000|Overall Study|Protocol Violation|1|||
148939388|NCT00302107|537260401|FG001|Overall Study|Protocol Violation|0|||
148939389|NCT00302107|537260400|FG000|Overall Study|Relocation|0|||
148939390|NCT00302107|537260401|FG001|Overall Study|Relocation|1|||
148939391|NCT00302107|537260400|FG000|Overall Study|Withdrawal by Subject|0|||
148939392|NCT00302107|537260401|FG001|Overall Study|Withdrawal by Subject|3|||
148939393|NCT00302107|537260400|FG000|Overall Study|Adverse Event|1|||
148939394|NCT00302107|537260401|FG001|Overall Study|Adverse Event|0|||
148939395|NCT00437983|537260402|FG000|Overall Study|Adverse Event|6|||
148939396|NCT00437983|537260403|FG001|Overall Study|Adverse Event|6|||
148939397|NCT00437983|537260402|FG000|Overall Study|Protocol Violation|2|||
148939398|NCT00437983|537260403|FG001|Overall Study|Protocol Violation|1|||
148939399|NCT00437983|537260402|FG000|Overall Study|Withdrawal by Subject|5|||
148939400|NCT00437983|537260403|FG001|Overall Study|Withdrawal by Subject|6|||
148939401|NCT00621959|537260404|FG000|Overall Study|Adverse Event|4|||
148939402|NCT00621959|537260405|FG001|Overall Study|Adverse Event|2|||
148939403|NCT00621959|537260404|FG000|Overall Study|Lack of Efficacy|1|||
148939404|NCT00621959|537260405|FG001|Overall Study|Lack of Efficacy|1|||
148939405|NCT00621959|537260404|FG000|Overall Study|Lost to Follow-up|0|||
148939406|NCT00621959|537260405|FG001|Overall Study|Lost to Follow-up|2|||
148939407|NCT00621959|537260404|FG000|Overall Study|Withdrawal by Subject|1|||
148939408|NCT00621959|537260405|FG001|Overall Study|Withdrawal by Subject|1|||
148939409|NCT00621959|537260404|FG000|Overall Study|Other|1|||
148939410|NCT00621959|537260405|FG001|Overall Study|Other|3|||
148939411|NCT00594659|537260408|FG000|Overall Study|Lost to Follow-up|13|||
148939412|NCT00594659|537260409|FG001|Overall Study|Lost to Follow-up|9|||
149196943|NCT01877382|538189426|FG011|Dose Escalation|Study terminated by sponsor|0|||
149196944|NCT01877382|538189427|FG012|Dose Escalation|Study terminated by sponsor|3|||
149196945|NCT01877382|538189428|FG013|Dose Escalation|Study terminated by sponsor|0|||
149196946|NCT01877382|538189429|FG014|Dose Escalation|Study terminated by sponsor|0|||
149196947|NCT01877382|538189415|FG000|Dose Escalation|Death|0|||
149196948|NCT01877382|538189416|FG001|Dose Escalation|Death|0|||
149196949|NCT01877382|538189417|FG002|Dose Escalation|Death|0|||
149196950|NCT01877382|538189418|FG003|Dose Escalation|Death|0|||
148939413|NCT00594659|537260410|FG002|Overall Study|Lost to Follow-up|7|||
149196951|NCT01877382|538189419|FG004|Dose Escalation|Death|0|||
149196952|NCT01877382|538189420|FG005|Dose Escalation|Death|0|||
148939414|NCT04439201|537260411|FG000|Overall Study|Ineligible|2|||
148939415|NCT04439201|537260411|FG000|Overall Study|Never start protocol therapy|1|||
148939416|NCT04439201|537260411|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
149196953|NCT01877382|538189421|FG006|Dose Escalation|Death|0|||
149196954|NCT01877382|538189422|FG007|Dose Escalation|Death|1|||
148939417|NCT04439201|537260411|FG000|Overall Study|Mutation status not confirmed|4|||
148939418|NCT04439201|537260411|FG000|Overall Study|Adverse Event|1|||
148939419|NCT04439201|537260411|FG000|Overall Study|Death|7|||
148807972|NCT01093846|536774488|FG000|Overall Study|Adverse Event|0|||
148939420|NCT04439201|537260411|FG000|Overall Study|Withdrawal by Subject|2|||
148939421|NCT04439201|537260411|FG000|Overall Study|Disease progression|20|||
148939422|NCT04439201|537260411|FG000|Overall Study|Alternative therapy|1|||
148939423|NCT04439201|537260411|FG000|Overall Study|Physician Decision|1|||
148939424|NCT03281577|537261816|FG000|Overall Study|Adverse Event|0|||
148939425|NCT03281577|537261817|FG001|Overall Study|Adverse Event|0|||
148939426|NCT03281577|537261818|FG002|Overall Study|Adverse Event|0|||
148939427|NCT03281577|537261819|FG003|Overall Study|Adverse Event|1|||
148939428|NCT03281577|537261816|FG000|Overall Study|Withdrawal by Subject|1|||
148939429|NCT03281577|537261817|FG001|Overall Study|Withdrawal by Subject|0|||
148939430|NCT03281577|537261818|FG002|Overall Study|Withdrawal by Subject|0|||
148939431|NCT03281577|537261819|FG003|Overall Study|Withdrawal by Subject|0|||
148939432|NCT01897454|537261820|FG000|Overall Study|Withdrawal by Subject|1|||
148939433|NCT04015336|537261821|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
148939434|NCT00491764|537261822|FG000|Overall Study|Adverse Event|1|||
148939435|NCT00491764|537261823|FG001|Overall Study|Adverse Event|2|||
148939436|NCT00491764|537261824|FG002|Overall Study|Adverse Event|4|||
148939437|NCT00491764|537261825|FG003|Overall Study|Adverse Event|4|||
148939438|NCT00491764|537261826|FG004|Overall Study|Adverse Event|0|||
148939439|NCT00491764|537261827|FG005|Overall Study|Adverse Event|1|||
148939440|NCT00491764|537261822|FG000|Overall Study|Lost to Follow-up|0|||
148939441|NCT00491764|537261823|FG001|Overall Study|Lost to Follow-up|1|||
148939442|NCT00491764|537261824|FG002|Overall Study|Lost to Follow-up|0|||
148939443|NCT00491764|537261825|FG003|Overall Study|Lost to Follow-up|1|||
148939444|NCT00491764|537261826|FG004|Overall Study|Lost to Follow-up|0|||
148939445|NCT00491764|537261827|FG005|Overall Study|Lost to Follow-up|3|||
148939446|NCT00491764|537261822|FG000|Overall Study|Withdrawal by Subject|2|||
148939447|NCT00491764|537261823|FG001|Overall Study|Withdrawal by Subject|3|||
148939448|NCT00491764|537261824|FG002|Overall Study|Withdrawal by Subject|1|||
148939449|NCT00491764|537261825|FG003|Overall Study|Withdrawal by Subject|2|||
148939450|NCT00491764|537261826|FG004|Overall Study|Withdrawal by Subject|2|||
148939451|NCT00491764|537261827|FG005|Overall Study|Withdrawal by Subject|4|||
148939452|NCT00491764|537261822|FG000|Overall Study|Non Compliance with the Protocol|1|||
148939453|NCT00491764|537261823|FG001|Overall Study|Non Compliance with the Protocol|0|||
148939454|NCT00491764|537261824|FG002|Overall Study|Non Compliance with the Protocol|0|||
148939455|NCT00491764|537261825|FG003|Overall Study|Non Compliance with the Protocol|0|||
148939456|NCT00491764|537261826|FG004|Overall Study|Non Compliance with the Protocol|0|||
148939457|NCT00491764|537261827|FG005|Overall Study|Non Compliance with the Protocol|0|||
148939458|NCT00491764|537261822|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
148939459|NCT00491764|537261823|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
148939460|NCT00491764|537261824|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
148939461|NCT00491764|537261825|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
148939462|NCT00491764|537261826|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
148939463|NCT00491764|537261827|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
148939464|NCT00491764|537261822|FG000|Overall Study|Administrative|1|||
148939465|NCT00491764|537261823|FG001|Overall Study|Administrative|0|||
148939466|NCT00491764|537261824|FG002|Overall Study|Administrative|2|||
148939467|NCT00491764|537261825|FG003|Overall Study|Administrative|1|||
148939468|NCT00491764|537261826|FG004|Overall Study|Administrative|0|||
148939469|NCT00491764|537261827|FG005|Overall Study|Administrative|0|||
148939470|NCT00894166|537261828|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
148939471|NCT00894166|537261829|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
149015390|NCT00744237|537536100|FG001|Overall Study|Poor Compliance|2|||
149196955|NCT01877382|538189423|FG008|Dose Escalation|Death|0|||
149196956|NCT01877382|538189424|FG009|Dose Escalation|Death|0|||
149196957|NCT01877382|538189425|FG010|Dose Escalation|Death|0|||
149196958|NCT01877382|538189426|FG011|Dose Escalation|Death|0|||
149196959|NCT01877382|538189427|FG012|Dose Escalation|Death|1|||
148939472|NCT00894166|537261830|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
148939473|NCT00894166|537261831|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
148939474|NCT00894166|537261832|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
148939475|NCT00894166|537261833|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
148939476|NCT00894166|537261834|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
148939477|NCT00894166|537261835|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
148939478|NCT00894166|537261828|FG000|Overall Study|Death|0|||
148939479|NCT00894166|537261829|FG001|Overall Study|Death|0|||
148939480|NCT00894166|537261830|FG002|Overall Study|Death|0|||
149196960|NCT01877382|538189428|FG013|Dose Escalation|Death|1|||
149196961|NCT01877382|538189429|FG014|Dose Escalation|Death|0|||
149196962|NCT01877382|538189415|FG000|Dose Expansion|Progressive disease|0|||
149196963|NCT01877382|538189416|FG001|Dose Expansion|Progressive disease|0|||
149196964|NCT01877382|538189417|FG002|Dose Expansion|Progressive disease|0|||
149196965|NCT01877382|538189418|FG003|Dose Expansion|Progressive disease|0|||
149196966|NCT01877382|538189419|FG004|Dose Expansion|Progressive disease|0|||
148939481|NCT00894166|537261831|FG003|Overall Study|Death|1|||
149196967|NCT01877382|538189420|FG005|Dose Expansion|Progressive disease|0|||
148939482|NCT00894166|537261832|FG004|Overall Study|Death|0|||
148939483|NCT00894166|537261833|FG005|Overall Study|Death|0|||
148939484|NCT00894166|537261834|FG006|Overall Study|Death|0|||
148939485|NCT00894166|537261835|FG007|Overall Study|Death|0|||
148939486|NCT05350410|537261836|FG000|Overall Study|Withdrawal by Subject|1|||
148939487|NCT01601132|537261837|FG000|Overall Study|Patient withdrew consent|1|||
148939488|NCT01601132|537261837|FG000|Overall Study|Protocol deviation|1|||
148939489|NCT02110238|537261839|FG000|12 Week Pivotal Phase|Adverse Event|3|||
148939490|NCT02110238|537261840|FG001|12 Week Pivotal Phase|Adverse Event|0|||
148939491|NCT02110238|537261839|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
148939492|NCT02110238|537261840|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
149015391|NCT00744237|537536101|FG002|Overall Study|Poor Compliance|0|||
149015392|NCT00744237|537536099|FG000|Overall Study|Administrative. Site Closed|1|||
149015393|NCT00744237|537536100|FG001|Overall Study|Administrative. Site Closed|1|||
149015394|NCT00744237|537536101|FG002|Overall Study|Administrative. Site Closed|1|||
149015395|NCT00744237|537536099|FG000|Overall Study|Adverse Event|9|||
149015396|NCT00744237|537536100|FG001|Overall Study|Adverse Event|13|||
149015397|NCT00744237|537536101|FG002|Overall Study|Adverse Event|5|||
149015398|NCT01984424|537536104|FG000|Overall Study|Withdrawal by Subject|3|||
149015399|NCT01984424|537536105|FG001|Overall Study|Withdrawal by Subject|5|||
149196968|NCT01877382|538189421|FG006|Dose Expansion|Progressive disease|0|||
149196969|NCT01877382|538189422|FG007|Dose Expansion|Progressive disease|0|||
149196970|NCT01877382|538189423|FG008|Dose Expansion|Progressive disease|0|||
149196971|NCT01877382|538189424|FG009|Dose Expansion|Progressive disease|0|||
149196972|NCT01877382|538189425|FG010|Dose Expansion|Progressive disease|0|||
149196973|NCT01877382|538189426|FG011|Dose Expansion|Progressive disease|0|||
149196974|NCT01877382|538189427|FG012|Dose Expansion|Progressive disease|0|||
149196975|NCT01877382|538189428|FG013|Dose Expansion|Progressive disease|0|||
149196976|NCT01877382|538189429|FG014|Dose Expansion|Progressive disease|11|||
149196977|NCT01877382|538189415|FG000|Dose Expansion|Clinical progression|0|||
149196978|NCT01877382|538189416|FG001|Dose Expansion|Clinical progression|0|||
149196979|NCT01877382|538189417|FG002|Dose Expansion|Clinical progression|0|||
149196980|NCT01877382|538189418|FG003|Dose Expansion|Clinical progression|0|||
149196981|NCT01877382|538189419|FG004|Dose Expansion|Clinical progression|0|||
149196982|NCT01877382|538189420|FG005|Dose Expansion|Clinical progression|0|||
149196983|NCT01877382|538189421|FG006|Dose Expansion|Clinical progression|0|||
149196984|NCT01877382|538189422|FG007|Dose Expansion|Clinical progression|0|||
149196985|NCT01877382|538189423|FG008|Dose Expansion|Clinical progression|0|||
149196986|NCT01877382|538189424|FG009|Dose Expansion|Clinical progression|0|||
149196987|NCT01877382|538189425|FG010|Dose Expansion|Clinical progression|0|||
149196988|NCT01877382|538189426|FG011|Dose Expansion|Clinical progression|0|||
149196989|NCT01877382|538189427|FG012|Dose Expansion|Clinical progression|0|||
149196990|NCT01877382|538189428|FG013|Dose Expansion|Clinical progression|0|||
149196991|NCT01877382|538189429|FG014|Dose Expansion|Clinical progression|6|||
149196992|NCT01877382|538189415|FG000|Dose Expansion|Adverse Event|0|||
149196993|NCT01877382|538189416|FG001|Dose Expansion|Adverse Event|0|||
148939493|NCT02110238|537261839|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
148939494|NCT02110238|537261840|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
149196994|NCT01877382|538189417|FG002|Dose Expansion|Adverse Event|0|||
149196995|NCT01877382|538189418|FG003|Dose Expansion|Adverse Event|0|||
149196996|NCT01877382|538189419|FG004|Dose Expansion|Adverse Event|0|||
149196997|NCT01877382|538189420|FG005|Dose Expansion|Adverse Event|0|||
148939495|NCT02110238|537261839|FG000|12 Week Pivotal Phase|Physician Decision|0|||
149196998|NCT01877382|538189421|FG006|Dose Expansion|Adverse Event|0|||
148939496|NCT02110238|537261840|FG001|12 Week Pivotal Phase|Physician Decision|2|||
148939497|NCT02110238|537261839|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
149015400|NCT01984424|537536104|FG000|Overall Study|Sponsor Decision|0|||
149015401|NCT01984424|537536105|FG001|Overall Study|Sponsor Decision|1|||
149015402|NCT01984424|537536104|FG000|Overall Study|Lost to Follow-up|0|||
149015403|NCT01984424|537536105|FG001|Overall Study|Lost to Follow-up|1|||
149015404|NCT01807221|537536106|FG000|Overall Study|Progressive disease|1|||
149015405|NCT01807221|537536107|FG001|Overall Study|Progressive disease|0|||
149015406|NCT01807221|537536108|FG002|Overall Study|Progressive disease|1|||
149015407|NCT01807221|537536109|FG003|Overall Study|Progressive disease|0|||
149015408|NCT01807221|537536110|FG004|Overall Study|Progressive disease|0|||
149015409|NCT01807221|537536111|FG005|Overall Study|Progressive disease|0|||
149015410|NCT01807221|537536106|FG000|Overall Study|Death|7|||
149015411|NCT01807221|537536107|FG001|Overall Study|Death|9|||
149015412|NCT01807221|537536108|FG002|Overall Study|Death|4|||
149015413|NCT01807221|537536109|FG003|Overall Study|Death|2|||
149015414|NCT01807221|537536110|FG004|Overall Study|Death|1|||
149015415|NCT01807221|537536111|FG005|Overall Study|Death|6|||
149015416|NCT01807221|537536106|FG000|Overall Study|Physician Decision|2|||
149015417|NCT01807221|537536107|FG001|Overall Study|Physician Decision|1|||
149015418|NCT01807221|537536108|FG002|Overall Study|Physician Decision|0|||
149015419|NCT01807221|537536109|FG003|Overall Study|Physician Decision|0|||
149015420|NCT01807221|537536110|FG004|Overall Study|Physician Decision|0|||
149015421|NCT01807221|537536111|FG005|Overall Study|Physician Decision|0|||
149015422|NCT01807221|537536106|FG000|Overall Study|Adverse Event|33|||
149015423|NCT01807221|537536107|FG001|Overall Study|Adverse Event|22|||
149015424|NCT01807221|537536108|FG002|Overall Study|Adverse Event|26|||
149015425|NCT01807221|537536109|FG003|Overall Study|Adverse Event|25|||
149015426|NCT01807221|537536110|FG004|Overall Study|Adverse Event|18|||
149015427|NCT01807221|537536111|FG005|Overall Study|Adverse Event|21|||
149015428|NCT01807221|537536106|FG000|Overall Study|Protocol Violation|0|||
149015429|NCT01807221|537536107|FG001|Overall Study|Protocol Violation|2|||
149015430|NCT01807221|537536108|FG002|Overall Study|Protocol Violation|1|||
149015431|NCT01807221|537536109|FG003|Overall Study|Protocol Violation|2|||
149015432|NCT01807221|537536110|FG004|Overall Study|Protocol Violation|0|||
149015433|NCT01807221|537536111|FG005|Overall Study|Protocol Violation|1|||
149015434|NCT01807221|537536106|FG000|Overall Study|Non-compliance|1|||
149015435|NCT01807221|537536107|FG001|Overall Study|Non-compliance|2|||
149015436|NCT01807221|537536108|FG002|Overall Study|Non-compliance|0|||
149015437|NCT01807221|537536109|FG003|Overall Study|Non-compliance|1|||
148682507|NCT03840135|536310946|FG001|Overall Study|Withdrawal by Subject|0|||
149015438|NCT01807221|537536110|FG004|Overall Study|Non-compliance|0|||
148682508|NCT01361607|536310949|FG000|Overall Study|Adverse Event|38|||
148682509|NCT01361607|536310950|FG001|Overall Study|Adverse Event|29|||
148682510|NCT01361607|536310949|FG000|Overall Study|Withdrawal by Subject|19|||
148682511|NCT01361607|536310950|FG001|Overall Study|Withdrawal by Subject|8|||
148682512|NCT01361607|536310949|FG000|Overall Study|Withdrawal by Investigator|5|||
148682513|NCT01361607|536310950|FG001|Overall Study|Withdrawal by Investigator|3|||
148682514|NCT01361607|536310949|FG000|Overall Study|Lost to Follow-up|1|||
148682515|NCT01361607|536310950|FG001|Overall Study|Lost to Follow-up|0|||
148682516|NCT01361607|536310949|FG000|Overall Study|Met Withdrawal Criteria|1|||
148682517|NCT01361607|536310950|FG001|Overall Study|Met Withdrawal Criteria|1|||
148682518|NCT00373685|536310951|FG000|Overall Study|Death|2|||
149015439|NCT01807221|537536111|FG005|Overall Study|Non-compliance|0|||
149015440|NCT01807221|537536106|FG000|Overall Study|Logistical difficulties|0|||
149015441|NCT01807221|537536107|FG001|Overall Study|Logistical difficulties|1|||
149015442|NCT01807221|537536108|FG002|Overall Study|Logistical difficulties|0|||
149015443|NCT01807221|537536109|FG003|Overall Study|Logistical difficulties|0|||
149015444|NCT01807221|537536110|FG004|Overall Study|Logistical difficulties|1|||
149015445|NCT01807221|537536111|FG005|Overall Study|Logistical difficulties|0|||
149015446|NCT01807221|537536106|FG000|Overall Study|Withdrawal by Subject|33|||
149015447|NCT01807221|537536107|FG001|Overall Study|Withdrawal by Subject|15|||
148682519|NCT00373685|536310952|FG001|Overall Study|Death|1|||
148682520|NCT00373685|536310951|FG000|Overall Study|Adverse Event|278|||
148682521|NCT00373685|536310952|FG001|Overall Study|Adverse Event|253|||
148682522|NCT00373685|536310951|FG000|Overall Study|Insufficient clinical response|169|||
148682523|NCT00373685|536310952|FG001|Overall Study|Insufficient clinical response|119|||
148682524|NCT00373685|536310951|FG000|Overall Study|Did not meet entrance criteria|167|||
148682525|NCT00373685|536310952|FG001|Overall Study|Did not meet entrance criteria|184|||
148682526|NCT00373685|536310951|FG000|Overall Study|Lost to follow up|83|||
149015448|NCT01807221|537536108|FG002|Overall Study|Withdrawal by Subject|8|||
149015449|NCT01807221|537536109|FG003|Overall Study|Withdrawal by Subject|14|||
149015450|NCT01807221|537536110|FG004|Overall Study|Withdrawal by Subject|16|||
149015451|NCT01807221|537536111|FG005|Overall Study|Withdrawal by Subject|13|||
149015452|NCT01807221|537536106|FG000|Overall Study|Sponsor decision|2|||
149015453|NCT01807221|537536107|FG001|Overall Study|Sponsor decision|0|||
148682527|NCT00373685|536310952|FG001|Overall Study|Lost to follow up|103|||
149015454|NCT01807221|537536108|FG002|Overall Study|Sponsor decision|1|||
149015455|NCT01807221|537536109|FG003|Overall Study|Sponsor decision|1|||
149015456|NCT01807221|537536110|FG004|Overall Study|Sponsor decision|0|||
149015457|NCT01807221|537536111|FG005|Overall Study|Sponsor decision|0|||
149015458|NCT01807221|537536106|FG000|Overall Study|Lost to Follow-up|1|||
148939498|NCT02110238|537261840|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
148939499|NCT02110238|537261839|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
148939500|NCT02110238|537261840|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
148939501|NCT02110238|537261839|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
148939502|NCT02110238|537261840|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
148939503|NCT02110238|537261839|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
148939504|NCT02110238|537261840|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
148939505|NCT02110238|537261839|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
148939506|NCT02110238|537261840|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
148939507|NCT02110238|537261839|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
148939508|NCT02110238|537261840|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
148939509|NCT02110238|537261839|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
148939510|NCT02110238|537261840|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
148939511|NCT00142935|537261843|FG000|Overall Study|Other reason|1|||
148939512|NCT00142935|537261844|FG001|Overall Study|Other reason|1|||
148939513|NCT00142935|537261845|FG002|Overall Study|Other reason|1|||
148939514|NCT00142935|537261843|FG000|Overall Study|Lost to Follow-up|2|||
148939515|NCT00142935|537261844|FG001|Overall Study|Lost to Follow-up|5|||
148939516|NCT00142935|537261845|FG002|Overall Study|Lost to Follow-up|5|||
148939517|NCT00142935|537261843|FG000|Overall Study|Death|0|||
148939518|NCT00142935|537261844|FG001|Overall Study|Death|2|||
148939519|NCT00142935|537261845|FG002|Overall Study|Death|1|||
148939520|NCT00129272|537261848|FG000|Overall Study|Lost to Follow-up|12|||
148939521|NCT00129272|537261849|FG001|Overall Study|Lost to Follow-up|11|||
148939522|NCT00129272|537261848|FG000|Overall Study|Withdrawal by Subject|5|||
148939523|NCT00129272|537261849|FG001|Overall Study|Withdrawal by Subject|11|||
148939524|NCT01146912|537261852|FG000|Overall Study|Already received influenza vaccination|817|||
148939525|NCT01146912|537261853|FG001|Overall Study|Already received influenza vaccination|822|||
148939526|NCT01146912|537261854|FG002|Overall Study|Already received influenza vaccination|13|||
148939527|NCT01146912|537261855|FG003|Overall Study|Already received influenza vaccination|15|||
148939528|NCT01146912|537261856|FG004|Overall Study|Already received influenza vaccination|41|||
148939529|NCT01146912|537261857|FG005|Overall Study|Already received influenza vaccination|61|||
148939530|NCT01146912|537261858|FG006|Overall Study|Already received influenza vaccination|56|||
148939531|NCT01146912|537261859|FG007|Overall Study|Already received influenza vaccination|0|||
148939532|NCT01146912|537261852|FG000|Overall Study|< 14 weeks gestational age|0|||
148939533|NCT01146912|537261853|FG001|Overall Study|< 14 weeks gestational age|0|||
148939534|NCT01146912|537261854|FG002|Overall Study|< 14 weeks gestational age|3|||
148939535|NCT01146912|537261855|FG003|Overall Study|< 14 weeks gestational age|2|||
148939536|NCT01146912|537261856|FG004|Overall Study|< 14 weeks gestational age|0|||
148939537|NCT01146912|537261857|FG005|Overall Study|< 14 weeks gestational age|0|||
148939538|NCT01146912|537261858|FG006|Overall Study|< 14 weeks gestational age|0|||
148939539|NCT01146912|537261859|FG007|Overall Study|< 14 weeks gestational age|0|||
148939540|NCT01146912|537261852|FG000|Overall Study|Duplicate patient|0|||
148939541|NCT01146912|537261853|FG001|Overall Study|Duplicate patient|0|||
149196999|NCT01877382|538189422|FG007|Dose Expansion|Adverse Event|0|||
148682528|NCT00373685|536310951|FG000|Overall Study|No longer willing to participate|337|||
148939542|NCT01146912|537261854|FG002|Overall Study|Duplicate patient|1|||
148939543|NCT01146912|537261855|FG003|Overall Study|Duplicate patient|0|||
148939544|NCT01146912|537261856|FG004|Overall Study|Duplicate patient|0|||
148939545|NCT01146912|537261857|FG005|Overall Study|Duplicate patient|0|||
148939546|NCT01146912|537261858|FG006|Overall Study|Duplicate patient|0|||
148939547|NCT01146912|537261859|FG007|Overall Study|Duplicate patient|0|||
148939548|NCT01952145|537261860|FG000|Overall Study|Protocol Violation|2|||
148939549|NCT01952145|537261861|FG001|Overall Study|Protocol Violation|1|||
148939550|NCT01952145|537261860|FG000|Overall Study|Death|0|||
148939551|NCT01952145|537261861|FG001|Overall Study|Death|1|||
148939552|NCT01952145|537261860|FG000|Overall Study|Adverse Event|9|||
148939553|NCT01952145|537261861|FG001|Overall Study|Adverse Event|0|||
148939554|NCT01952145|537261860|FG000|Overall Study|Withdrawal Criteria|16|||
148939555|NCT01952145|537261861|FG001|Overall Study|Withdrawal Criteria|11|||
148939556|NCT01952145|537261860|FG000|Overall Study|Unclassified|1|||
148939557|NCT01952145|537261861|FG001|Overall Study|Unclassified|1|||
148939558|NCT00591344|537261862|FG000|Overall Study|Transportation issues|1|||
148939559|NCT00591344|537261863|FG001|Overall Study|Transportation issues|0|||
148939560|NCT00591344|537261862|FG000|Overall Study|Moved out of state|1|||
148939561|NCT00591344|537261863|FG001|Overall Study|Moved out of state|0|||
148939562|NCT00591344|537261862|FG000|Overall Study|Medical complications|1|||
148939563|NCT00591344|537261863|FG001|Overall Study|Medical complications|3|||
149197000|NCT01877382|538189423|FG008|Dose Expansion|Adverse Event|0|||
149197001|NCT01877382|538189424|FG009|Dose Expansion|Adverse Event|0|||
148682529|NCT00373685|536310952|FG001|Overall Study|No longer willing to participate|352|||
148939564|NCT00591344|537261862|FG000|Overall Study|Underwent DBS|2|||
148939565|NCT00591344|537261863|FG001|Overall Study|Underwent DBS|2|||
148939566|NCT00591344|537261862|FG000|Overall Study|Death|0|||
148939567|NCT00591344|537261863|FG001|Overall Study|Death|1|||
148939568|NCT00591344|537261862|FG000|Overall Study|Lost to Follow-up|0|||
149197002|NCT01877382|538189425|FG010|Dose Expansion|Adverse Event|0|||
149197003|NCT01877382|538189426|FG011|Dose Expansion|Adverse Event|0|||
148807973|NCT01093846|536774489|FG001|Overall Study|Adverse Event|0|||
148807974|NCT01093846|536774490|FG002|Overall Study|Adverse Event|1|||
148807975|NCT01093846|536774488|FG000|Overall Study|Lack of Efficacy|0|||
148807976|NCT01093846|536774489|FG001|Overall Study|Lack of Efficacy|0|||
149197004|NCT01877382|538189427|FG012|Dose Expansion|Adverse Event|0|||
149197005|NCT01877382|538189428|FG013|Dose Expansion|Adverse Event|0|||
149197006|NCT01877382|538189429|FG014|Dose Expansion|Adverse Event|1|||
149197007|NCT01877382|538189415|FG000|Dose Expansion|Death|0|||
149197008|NCT01877382|538189416|FG001|Dose Expansion|Death|0|||
149197009|NCT01877382|538189417|FG002|Dose Expansion|Death|0|||
149197010|NCT01877382|538189418|FG003|Dose Expansion|Death|0|||
149197011|NCT01877382|538189419|FG004|Dose Expansion|Death|0|||
149197012|NCT01877382|538189420|FG005|Dose Expansion|Death|0|||
149197013|NCT01877382|538189421|FG006|Dose Expansion|Death|0|||
149197014|NCT01877382|538189422|FG007|Dose Expansion|Death|0|||
149197015|NCT01877382|538189423|FG008|Dose Expansion|Death|0|||
149197016|NCT01877382|538189424|FG009|Dose Expansion|Death|0|||
149197017|NCT01877382|538189425|FG010|Dose Expansion|Death|0|||
149197018|NCT01877382|538189426|FG011|Dose Expansion|Death|0|||
149197019|NCT01877382|538189427|FG012|Dose Expansion|Death|0|||
149197020|NCT01877382|538189428|FG013|Dose Expansion|Death|0|||
149197021|NCT01877382|538189429|FG014|Dose Expansion|Death|1|||
149197022|NCT01877382|538189415|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
148939569|NCT00591344|537261863|FG001|Overall Study|Lost to Follow-up|1|||
148939570|NCT00591344|537261862|FG000|Overall Study|Did not want to come off medication|0|||
148939571|NCT00591344|537261863|FG001|Overall Study|Did not want to come off medication|1|||
148939572|NCT00413244|537261867|FG000|Overall Study|Withdrawal by Subject|10|||
148939573|NCT00413244|537261868|FG001|Overall Study|Withdrawal by Subject|1|||
148939574|NCT00619177|537261870|FG000|Overall Study|Adverse Event|18|||
148939575|NCT00619177|537261870|FG000|Overall Study|Lost to Follow-up|2|||
148939576|NCT00619177|537261870|FG000|Overall Study|Lack of Efficacy|1|||
148939577|NCT00619177|537261870|FG000|Overall Study|Missing termination information|481|||
148939578|NCT00619177|537261870|FG000|Overall Study|Not specified reasons|6|||
148939579|NCT01609231|537261871|FG000|Overall Study|Adverse Event|1|||
148939580|NCT01609231|537261872|FG001|Overall Study|Adverse Event|3|||
148939581|NCT01609231|537261871|FG000|Overall Study|Physician Decision|1|||
148939582|NCT01609231|537261872|FG001|Overall Study|Physician Decision|0|||
148939583|NCT01609231|537261871|FG000|Overall Study|Withdrawal by Subject|1|||
148939584|NCT01609231|537261872|FG001|Overall Study|Withdrawal by Subject|0|||
148939585|NCT01180647|537261873|FG000|Overall Study|Lost to Follow-up|5|||
148939586|NCT01180647|537261874|FG001|Overall Study|Lost to Follow-up|6|||
148939587|NCT00071396|537261883|FG000|Overall Study|Withdrawal by Subject|1|||
148939588|NCT00071396|537261883|FG000|Overall Study|Physician Decision|2|||
148939589|NCT04545554|537261884|FG000|Overall Study|Withdrawal by Subject|0|||
148939590|NCT04545554|537261885|FG001|Overall Study|Withdrawal by Subject|0|||
148939591|NCT04545554|537261886|FG002|Overall Study|Withdrawal by Subject|0|||
148939592|NCT04545554|537261887|FG003|Overall Study|Withdrawal by Subject|1|||
149197023|NCT01877382|538189416|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197024|NCT01877382|538189417|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197025|NCT01877382|538189418|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197026|NCT01877382|538189419|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197027|NCT01877382|538189420|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197028|NCT01877382|538189421|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197029|NCT01877382|538189422|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197030|NCT01877382|538189423|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197031|NCT01877382|538189424|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197032|NCT01877382|538189425|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197033|NCT01877382|538189426|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197034|NCT01877382|538189427|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
149197035|NCT01877382|538189428|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
148939593|NCT04545554|537261888|FG004|Overall Study|Withdrawal by Subject|0|||
149197036|NCT01877382|538189429|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
149197037|NCT01274338|538191073|FG000|Overall Study|Lack of Efficacy|72|||
149197038|NCT01274338|538191074|FG001|Overall Study|Lack of Efficacy|108|||
149197039|NCT01274338|538191075|FG002|Overall Study|Lack of Efficacy|116|||
149197040|NCT01274338|538191076|FG003|Overall Study|Lack of Efficacy|0|||
149197041|NCT01274338|538191077|FG004|Overall Study|Lack of Efficacy|0|||
148939594|NCT04545554|537261889|FG005|Overall Study|Withdrawal by Subject|0|||
148939595|NCT00116428|537261890|FG000|Overall Study|Withdrawal by Subject|2|||
148939596|NCT00116428|537261891|FG001|Overall Study|Withdrawal by Subject|5|||
148807977|NCT01093846|536774490|FG002|Overall Study|Lack of Efficacy|4|||
148939597|NCT00116428|537261890|FG000|Overall Study|Did not meet inclusion criteria|1|||
148939598|NCT00116428|537261891|FG001|Overall Study|Did not meet inclusion criteria|0|||
148939599|NCT01032174|537261892|FG000|Overall Study|Adverse Event|0|||
148939600|NCT01032174|537261893|FG001|Overall Study|Adverse Event|1|||
148939601|NCT04295772|537261898|FG000|Overall Study|Protocol Violation|1|||
148939602|NCT04295772|537261899|FG001|Overall Study|Protocol Violation|0|||
148939603|NCT04295772|537261898|FG000|Overall Study|Ongoing for safety monitoring|14|||
148939604|NCT04295772|537261899|FG001|Overall Study|Ongoing for safety monitoring|1|||
148939605|NCT04295772|537261898|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
148939606|NCT04295772|537261899|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
148939607|NCT02635776|537261900|FG000|Overall Study|Physician Decision|1|||
148939608|NCT02635776|537261901|FG001|Overall Study|Physician Decision|0|||
148939609|NCT02635776|537261900|FG000|Overall Study|Adverse Event|51|||
148939610|NCT02635776|537261901|FG001|Overall Study|Adverse Event|3|||
148939611|NCT02635776|537261900|FG000|Overall Study|Withdrawal by Subject|41|||
148939612|NCT02635776|537261901|FG001|Overall Study|Withdrawal by Subject|7|||
148939613|NCT02635776|537261900|FG000|Overall Study|Lost to Follow-up|4|||
148939614|NCT02635776|537261901|FG001|Overall Study|Lost to Follow-up|0|||
148939615|NCT02635776|537261900|FG000|Overall Study|Other reasons|5|||
148939616|NCT02635776|537261901|FG001|Overall Study|Other reasons|1|||
148939617|NCT01811225|537261902|FG000|Treatment Period 1|Adverse Event|2|||
149197042|NCT01274338|538191078|FG005|Overall Study|Lack of Efficacy|0|||
149197043|NCT01274338|538191073|FG000|Overall Study|Adverse Event|272|||
149197044|NCT01274338|538191074|FG001|Overall Study|Adverse Event|105|||
149197045|NCT01274338|538191075|FG002|Overall Study|Adverse Event|180|||
149197046|NCT01274338|538191076|FG003|Overall Study|Adverse Event|1|||
149197047|NCT01274338|538191077|FG004|Overall Study|Adverse Event|0|||
149197048|NCT01274338|538191078|FG005|Overall Study|Adverse Event|0|||
149197049|NCT01274338|538191073|FG000|Overall Study|Death|8|||
149197050|NCT01274338|538191074|FG001|Overall Study|Death|1|||
149197051|NCT01274338|538191075|FG002|Overall Study|Death|0|||
149197052|NCT01274338|538191076|FG003|Overall Study|Death|0|||
149197053|NCT01274338|538191077|FG004|Overall Study|Death|0|||
149197054|NCT01274338|538191078|FG005|Overall Study|Death|0|||
149197055|NCT01274338|538191073|FG000|Overall Study|Withdrawal by Subject|27|||
149197056|NCT01274338|538191074|FG001|Overall Study|Withdrawal by Subject|99|||
149197057|NCT01274338|538191075|FG002|Overall Study|Withdrawal by Subject|17|||
149197058|NCT01274338|538191076|FG003|Overall Study|Withdrawal by Subject|0|||
149197059|NCT01274338|538191077|FG004|Overall Study|Withdrawal by Subject|0|||
148939618|NCT01811225|537261903|FG001|Treatment Period 1|Adverse Event|3|||
148939619|NCT01811225|537261902|FG000|Treatment Period 1|Lost to Follow-up|12|||
148939620|NCT01811225|537261903|FG001|Treatment Period 1|Lost to Follow-up|8|||
148939621|NCT01811225|537261902|FG000|Treatment Period 1|transporation|1|||
148939622|NCT01811225|537261903|FG001|Treatment Period 1|transporation|0|||
148939623|NCT01811225|537261902|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
148939624|NCT01811225|537261903|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
148939625|NCT01811225|537261902|FG000|Treatment Period 2|Lost to Follow-up|1|||
148939626|NCT01811225|537261903|FG001|Treatment Period 2|Lost to Follow-up|2|||
148939627|NCT01811225|537261902|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
148939628|NCT01811225|537261903|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
148939629|NCT00287365|537261904|FG000|Overall Study|sample not acquired|13|||
148939630|NCT00400764|537261905|FG000|Phase Ib|Adverse Event|1|||
148939631|NCT00400764|537261906|FG001|Phase Ib|Adverse Event|0|||
148939632|NCT00400764|537261907|FG002|Phase Ib|Adverse Event|0|||
148939633|NCT00400764|537261908|FG003|Phase Ib|Adverse Event|0|||
148939634|NCT00400764|537261909|FG004|Phase Ib|Adverse Event|0|||
148939635|NCT00400764|537261905|FG000|Phase Ib|Death|1|||
148939636|NCT00400764|537261906|FG001|Phase Ib|Death|0|||
149015459|NCT01807221|537536107|FG001|Overall Study|Lost to Follow-up|0|||
148939637|NCT00400764|537261907|FG002|Phase Ib|Death|0|||
148939638|NCT00400764|537261908|FG003|Phase Ib|Death|0|||
148939639|NCT00400764|537261909|FG004|Phase Ib|Death|0|||
148939640|NCT00400764|537261905|FG000|Phase Ib|Disease Progression|4|||
148939641|NCT00400764|537261906|FG001|Phase Ib|Disease Progression|4|||
148939642|NCT00400764|537261907|FG002|Phase Ib|Disease Progression|0|||
148939643|NCT00400764|537261908|FG003|Phase Ib|Disease Progression|0|||
148939644|NCT00400764|537261909|FG004|Phase Ib|Disease Progression|0|||
149197060|NCT01274338|538191078|FG005|Overall Study|Withdrawal by Subject|0|||
149197061|NCT01274338|538191073|FG000|Overall Study|Did not start treatment|8|||
148939645|NCT00400764|537261905|FG000|Phase II|Death|0|||
149197062|NCT01274338|538191074|FG001|Overall Study|Did not start treatment|116|||
149197063|NCT01274338|538191075|FG002|Overall Study|Did not start treatment|7|||
148939646|NCT00400764|537261906|FG001|Phase II|Death|0|||
148939647|NCT00400764|537261907|FG002|Phase II|Death|1|||
148939648|NCT00400764|537261908|FG003|Phase II|Death|2|||
148939649|NCT00400764|537261909|FG004|Phase II|Death|0|||
148939650|NCT00400764|537261905|FG000|Phase II|Lost to Follow-up|0|||
149197064|NCT01274338|538191076|FG003|Overall Study|Did not start treatment|0|||
148939651|NCT00400764|537261906|FG001|Phase II|Lost to Follow-up|0|||
148939652|NCT00400764|537261907|FG002|Phase II|Lost to Follow-up|1|||
148939653|NCT00400764|537261908|FG003|Phase II|Lost to Follow-up|0|||
148939654|NCT00400764|537261909|FG004|Phase II|Lost to Follow-up|0|||
148939655|NCT00400764|537261905|FG000|Phase II|Physician Decision|0|||
148939656|NCT00400764|537261906|FG001|Phase II|Physician Decision|0|||
148939657|NCT00400764|537261907|FG002|Phase II|Physician Decision|1|||
148939658|NCT00400764|537261908|FG003|Phase II|Physician Decision|1|||
148939659|NCT00400764|537261909|FG004|Phase II|Physician Decision|0|||
148939660|NCT00400764|537261905|FG000|Phase II|Sponsor's decision to terminate|0|||
148939661|NCT00400764|537261906|FG001|Phase II|Sponsor's decision to terminate|0|||
148939662|NCT00400764|537261907|FG002|Phase II|Sponsor's decision to terminate|18|||
148939663|NCT00400764|537261908|FG003|Phase II|Sponsor's decision to terminate|22|||
148939664|NCT00400764|537261909|FG004|Phase II|Sponsor's decision to terminate|11|||
148939665|NCT00400764|537261905|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
148939666|NCT00400764|537261906|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
148939667|NCT00400764|537261907|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
148939668|NCT00400764|537261908|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
148939669|NCT00400764|537261909|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
148939670|NCT00400764|537261905|FG000|Phase II|Withdrawal by Subject|0|||
148939671|NCT00400764|537261906|FG001|Phase II|Withdrawal by Subject|0|||
148939672|NCT00400764|537261907|FG002|Phase II|Withdrawal by Subject|1|||
148939673|NCT00400764|537261908|FG003|Phase II|Withdrawal by Subject|1|||
148939674|NCT00400764|537261909|FG004|Phase II|Withdrawal by Subject|0|||
148939675|NCT00722800|537261911|FG000|Overall Study|Withdrawal by Subject|1|||
148939676|NCT00722800|537261912|FG001|Overall Study|Withdrawal by Subject|0|||
148939677|NCT00722800|537261911|FG000|Overall Study|Physician Decision|1|||
148939678|NCT00722800|537261912|FG001|Overall Study|Physician Decision|0|||
148939679|NCT02130297|537261919|FG000|Overall Study|Lost to Follow-up|4|||
148939680|NCT01449539|537261920|FG000|Overall Study|Withdrawal by Subject|3|||
148939681|NCT01449539|537261920|FG000|Overall Study|Toxicity not study related|1|||
148939682|NCT00347360|537261921|FG000|Overall Study|Adverse Event|1|||
148939683|NCT00347360|537261922|FG001|Overall Study|Adverse Event|2|||
148939684|NCT00347360|537261923|FG002|Overall Study|Adverse Event|0|||
148939685|NCT00347360|537261924|FG003|Overall Study|Adverse Event|4|||
148939686|NCT00347360|537261925|FG004|Overall Study|Adverse Event|1|||
148939687|NCT00347360|537261926|FG005|Overall Study|Adverse Event|2|||
148939688|NCT00347360|537261927|FG006|Overall Study|Adverse Event|2|||
148939689|NCT00347360|537261928|FG007|Overall Study|Adverse Event|0|||
148939690|NCT00347360|537261929|FG008|Overall Study|Adverse Event|2|||
148939691|NCT00347360|537261930|FG009|Overall Study|Adverse Event|3|||
148939692|NCT00347360|537261931|FG010|Overall Study|Adverse Event|3|||
148939693|NCT00347360|537261932|FG011|Overall Study|Adverse Event|1|||
148939694|NCT00347360|537261933|FG012|Overall Study|Adverse Event|3|||
148939695|NCT00347360|537261934|FG013|Overall Study|Adverse Event|2|||
148939696|NCT00347360|537261935|FG014|Overall Study|Adverse Event|2|||
148939697|NCT00347360|537261921|FG000|Overall Study|Lost to Follow-up|0|||
148939698|NCT00347360|537261922|FG001|Overall Study|Lost to Follow-up|0|||
148939699|NCT00347360|537261923|FG002|Overall Study|Lost to Follow-up|0|||
148939700|NCT00347360|537261924|FG003|Overall Study|Lost to Follow-up|2|||
148939701|NCT00347360|537261925|FG004|Overall Study|Lost to Follow-up|1|||
148939702|NCT00347360|537261926|FG005|Overall Study|Lost to Follow-up|1|||
148682530|NCT00373685|536310951|FG000|Overall Study|Other|149|||
148939703|NCT00347360|537261927|FG006|Overall Study|Lost to Follow-up|0|||
148939704|NCT00347360|537261928|FG007|Overall Study|Lost to Follow-up|1|||
148939705|NCT00347360|537261929|FG008|Overall Study|Lost to Follow-up|1|||
148939706|NCT00347360|537261930|FG009|Overall Study|Lost to Follow-up|2|||
148939707|NCT00347360|537261931|FG010|Overall Study|Lost to Follow-up|0|||
148682531|NCT00373685|536310952|FG001|Overall Study|Other|146|||
148939708|NCT00347360|537261932|FG011|Overall Study|Lost to Follow-up|0|||
148939709|NCT00347360|537261933|FG012|Overall Study|Lost to Follow-up|1|||
148939710|NCT00347360|537261934|FG013|Overall Study|Lost to Follow-up|0|||
148939711|NCT00347360|537261935|FG014|Overall Study|Lost to Follow-up|0|||
148939712|NCT00347360|537261921|FG000|Overall Study|Protocol Violation|2|||
148939713|NCT00347360|537261922|FG001|Overall Study|Protocol Violation|3|||
148939714|NCT00347360|537261923|FG002|Overall Study|Protocol Violation|1|||
148939715|NCT00347360|537261924|FG003|Overall Study|Protocol Violation|2|||
148939716|NCT00347360|537261925|FG004|Overall Study|Protocol Violation|1|||
148939717|NCT00347360|537261926|FG005|Overall Study|Protocol Violation|2|||
148939718|NCT00347360|537261927|FG006|Overall Study|Protocol Violation|0|||
148939719|NCT00347360|537261928|FG007|Overall Study|Protocol Violation|0|||
148939720|NCT00347360|537261929|FG008|Overall Study|Protocol Violation|1|||
148939721|NCT00347360|537261930|FG009|Overall Study|Protocol Violation|2|||
148939722|NCT00347360|537261931|FG010|Overall Study|Protocol Violation|0|||
148939723|NCT00347360|537261932|FG011|Overall Study|Protocol Violation|0|||
148939724|NCT00347360|537261933|FG012|Overall Study|Protocol Violation|0|||
148939725|NCT00347360|537261934|FG013|Overall Study|Protocol Violation|1|||
148939726|NCT00347360|537261935|FG014|Overall Study|Protocol Violation|0|||
148939727|NCT00347360|537261921|FG000|Overall Study|Withdrawal by Subject|0|||
148939728|NCT00347360|537261922|FG001|Overall Study|Withdrawal by Subject|1|||
148939729|NCT00347360|537261923|FG002|Overall Study|Withdrawal by Subject|2|||
148939730|NCT00347360|537261924|FG003|Overall Study|Withdrawal by Subject|4|||
148939731|NCT00347360|537261925|FG004|Overall Study|Withdrawal by Subject|1|||
148939732|NCT00347360|537261926|FG005|Overall Study|Withdrawal by Subject|2|||
148939733|NCT00347360|537261927|FG006|Overall Study|Withdrawal by Subject|1|||
148939734|NCT00347360|537261928|FG007|Overall Study|Withdrawal by Subject|1|||
148939735|NCT00347360|537261929|FG008|Overall Study|Withdrawal by Subject|1|||
148939736|NCT00347360|537261930|FG009|Overall Study|Withdrawal by Subject|1|||
148939737|NCT00347360|537261931|FG010|Overall Study|Withdrawal by Subject|0|||
148939738|NCT00347360|537261932|FG011|Overall Study|Withdrawal by Subject|3|||
148939739|NCT00347360|537261933|FG012|Overall Study|Withdrawal by Subject|4|||
148939740|NCT00347360|537261934|FG013|Overall Study|Withdrawal by Subject|2|||
148939741|NCT00347360|537261935|FG014|Overall Study|Withdrawal by Subject|1|||
148939742|NCT00347360|537261921|FG000|Overall Study|Lack of Efficacy|1|||
148939743|NCT00347360|537261922|FG001|Overall Study|Lack of Efficacy|1|||
148939744|NCT00347360|537261923|FG002|Overall Study|Lack of Efficacy|3|||
148939745|NCT00347360|537261924|FG003|Overall Study|Lack of Efficacy|1|||
148939746|NCT00347360|537261925|FG004|Overall Study|Lack of Efficacy|0|||
148939747|NCT00347360|537261926|FG005|Overall Study|Lack of Efficacy|1|||
148939748|NCT00347360|537261927|FG006|Overall Study|Lack of Efficacy|0|||
148939749|NCT00347360|537261928|FG007|Overall Study|Lack of Efficacy|1|||
148939750|NCT00347360|537261929|FG008|Overall Study|Lack of Efficacy|1|||
148939751|NCT00347360|537261930|FG009|Overall Study|Lack of Efficacy|0|||
148939752|NCT00347360|537261931|FG010|Overall Study|Lack of Efficacy|0|||
148939753|NCT00347360|537261932|FG011|Overall Study|Lack of Efficacy|0|||
148939754|NCT00347360|537261933|FG012|Overall Study|Lack of Efficacy|0|||
148939755|NCT00347360|537261934|FG013|Overall Study|Lack of Efficacy|0|||
148939756|NCT00347360|537261935|FG014|Overall Study|Lack of Efficacy|0|||
148939757|NCT00347360|537261921|FG000|Overall Study|Reason not listed/blank|1|||
148939758|NCT00347360|537261922|FG001|Overall Study|Reason not listed/blank|0|||
148939759|NCT00347360|537261923|FG002|Overall Study|Reason not listed/blank|0|||
148939760|NCT00347360|537261924|FG003|Overall Study|Reason not listed/blank|0|||
148939761|NCT00347360|537261925|FG004|Overall Study|Reason not listed/blank|0|||
148939762|NCT00347360|537261926|FG005|Overall Study|Reason not listed/blank|0|||
148939763|NCT00347360|537261927|FG006|Overall Study|Reason not listed/blank|1|||
148939764|NCT00347360|537261928|FG007|Overall Study|Reason not listed/blank|0|||
148939765|NCT00347360|537261929|FG008|Overall Study|Reason not listed/blank|0|||
148939766|NCT00347360|537261930|FG009|Overall Study|Reason not listed/blank|0|||
148939767|NCT00347360|537261931|FG010|Overall Study|Reason not listed/blank|0|||
148939768|NCT00347360|537261932|FG011|Overall Study|Reason not listed/blank|0|||
148939769|NCT00347360|537261933|FG012|Overall Study|Reason not listed/blank|0|||
148939770|NCT00347360|537261934|FG013|Overall Study|Reason not listed/blank|1|||
148939771|NCT00347360|537261935|FG014|Overall Study|Reason not listed/blank|0|||
148939772|NCT00347360|537261921|FG000|Overall Study|Per sponsors instruction|0|||
148939773|NCT00347360|537261922|FG001|Overall Study|Per sponsors instruction|1|||
148939774|NCT00347360|537261923|FG002|Overall Study|Per sponsors instruction|0|||
148939775|NCT00347360|537261924|FG003|Overall Study|Per sponsors instruction|0|||
148939776|NCT00347360|537261925|FG004|Overall Study|Per sponsors instruction|0|||
148939777|NCT00347360|537261926|FG005|Overall Study|Per sponsors instruction|0|||
148939778|NCT00347360|537261927|FG006|Overall Study|Per sponsors instruction|0|||
148939779|NCT00347360|537261928|FG007|Overall Study|Per sponsors instruction|0|||
148939780|NCT00347360|537261929|FG008|Overall Study|Per sponsors instruction|0|||
148939781|NCT00347360|537261930|FG009|Overall Study|Per sponsors instruction|0|||
148939782|NCT00347360|537261931|FG010|Overall Study|Per sponsors instruction|0|||
148939783|NCT00347360|537261932|FG011|Overall Study|Per sponsors instruction|0|||
148939784|NCT00347360|537261933|FG012|Overall Study|Per sponsors instruction|0|||
148939785|NCT00347360|537261934|FG013|Overall Study|Per sponsors instruction|0|||
148939786|NCT00347360|537261935|FG014|Overall Study|Per sponsors instruction|0|||
149015460|NCT01807221|537536108|FG002|Overall Study|Lost to Follow-up|2|||
148939787|NCT00347360|537261921|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
148939788|NCT00347360|537261922|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
148939789|NCT00347360|537261923|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
149015461|NCT01807221|537536109|FG003|Overall Study|Lost to Follow-up|1|||
149015462|NCT01807221|537536110|FG004|Overall Study|Lost to Follow-up|0|||
149015463|NCT01807221|537536111|FG005|Overall Study|Lost to Follow-up|0|||
149015464|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
149015465|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
149015466|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
149015467|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
149015468|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
149015469|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
149015470|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
149015471|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
149015472|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
149015473|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
149015474|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
149015475|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
149015476|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
149015477|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
149015478|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
149015479|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
149015480|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
149015481|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
149015482|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
149015483|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
149015484|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
149015485|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
149015486|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
149015487|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
149015488|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
149015489|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
149015490|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
149015491|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
149015492|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
149015493|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
149015494|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
149015495|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
149015496|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
149015497|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
149015498|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
149015499|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
149015500|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
149015501|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
149015502|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
149015503|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
149015504|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
149015505|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
149015506|NCT01089556|537536112|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
149015507|NCT01089556|537536113|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
148939790|NCT00347360|537261924|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
148939791|NCT00347360|537261925|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
148939792|NCT00347360|537261926|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
148939793|NCT00347360|537261927|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
148939794|NCT00347360|537261928|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
148939795|NCT00347360|537261929|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
148939796|NCT00347360|537261930|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
148939797|NCT00347360|537261931|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
148939798|NCT00347360|537261932|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
148939799|NCT00347360|537261933|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
148939800|NCT00347360|537261934|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
148939801|NCT00347360|537261935|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
148939802|NCT00347360|537261921|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
149015508|NCT01089556|537536114|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
149015509|NCT01089556|537536115|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
149015510|NCT01089556|537536116|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
149015511|NCT01089556|537536117|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
149015512|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
149015513|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
148939803|NCT00347360|537261922|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
148939804|NCT00347360|537261923|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
148939805|NCT00347360|537261924|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
148939806|NCT00347360|537261925|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
148939807|NCT00347360|537261926|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
148939808|NCT00347360|537261927|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
148939809|NCT00347360|537261928|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
148939810|NCT00347360|537261929|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
148939811|NCT00347360|537261930|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
148939812|NCT00347360|537261931|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
148939813|NCT00347360|537261932|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
148939814|NCT00347360|537261933|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
148939815|NCT00347360|537261934|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
148939816|NCT00347360|537261935|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
148939817|NCT00347360|537261921|FG000|Overall Study|Abnormal lab values|0|||
148939818|NCT00347360|537261922|FG001|Overall Study|Abnormal lab values|0|||
148939819|NCT00347360|537261923|FG002|Overall Study|Abnormal lab values|0|||
148939820|NCT00347360|537261924|FG003|Overall Study|Abnormal lab values|0|||
148939821|NCT00347360|537261925|FG004|Overall Study|Abnormal lab values|0|||
148939822|NCT00347360|537261926|FG005|Overall Study|Abnormal lab values|0|||
148939823|NCT00347360|537261927|FG006|Overall Study|Abnormal lab values|1|||
148939824|NCT00347360|537261928|FG007|Overall Study|Abnormal lab values|0|||
148939825|NCT00347360|537261929|FG008|Overall Study|Abnormal lab values|0|||
148939826|NCT00347360|537261930|FG009|Overall Study|Abnormal lab values|0|||
148939827|NCT00347360|537261931|FG010|Overall Study|Abnormal lab values|0|||
148939828|NCT00347360|537261932|FG011|Overall Study|Abnormal lab values|0|||
148939829|NCT00347360|537261933|FG012|Overall Study|Abnormal lab values|0|||
148939830|NCT00347360|537261934|FG013|Overall Study|Abnormal lab values|0|||
148939831|NCT00347360|537261935|FG014|Overall Study|Abnormal lab values|0|||
148939832|NCT00347360|537261921|FG000|Overall Study|PI recommended early withdrawal|0|||
148939833|NCT00347360|537261922|FG001|Overall Study|PI recommended early withdrawal|0|||
148939834|NCT00347360|537261923|FG002|Overall Study|PI recommended early withdrawal|0|||
148939835|NCT00347360|537261924|FG003|Overall Study|PI recommended early withdrawal|0|||
148939836|NCT00347360|537261925|FG004|Overall Study|PI recommended early withdrawal|0|||
148939837|NCT00347360|537261926|FG005|Overall Study|PI recommended early withdrawal|0|||
148939838|NCT00347360|537261927|FG006|Overall Study|PI recommended early withdrawal|0|||
148939839|NCT00347360|537261928|FG007|Overall Study|PI recommended early withdrawal|0|||
148939840|NCT00347360|537261929|FG008|Overall Study|PI recommended early withdrawal|0|||
148939841|NCT00347360|537261930|FG009|Overall Study|PI recommended early withdrawal|1|||
148939842|NCT00347360|537261931|FG010|Overall Study|PI recommended early withdrawal|0|||
148939843|NCT00347360|537261932|FG011|Overall Study|PI recommended early withdrawal|0|||
148939844|NCT00347360|537261933|FG012|Overall Study|PI recommended early withdrawal|0|||
148939845|NCT00347360|537261934|FG013|Overall Study|PI recommended early withdrawal|0|||
148939846|NCT00347360|537261935|FG014|Overall Study|PI recommended early withdrawal|0|||
148939847|NCT00347360|537261921|FG000|Overall Study|Did not meet criteria before ABPM|0|||
148939848|NCT00347360|537261922|FG001|Overall Study|Did not meet criteria before ABPM|0|||
148939849|NCT00347360|537261923|FG002|Overall Study|Did not meet criteria before ABPM|0|||
148939850|NCT00347360|537261924|FG003|Overall Study|Did not meet criteria before ABPM|0|||
148939851|NCT00347360|537261925|FG004|Overall Study|Did not meet criteria before ABPM|0|||
148939852|NCT00347360|537261926|FG005|Overall Study|Did not meet criteria before ABPM|0|||
148939853|NCT00347360|537261927|FG006|Overall Study|Did not meet criteria before ABPM|0|||
148939854|NCT00347360|537261928|FG007|Overall Study|Did not meet criteria before ABPM|0|||
148939855|NCT00347360|537261929|FG008|Overall Study|Did not meet criteria before ABPM|0|||
148939856|NCT00347360|537261930|FG009|Overall Study|Did not meet criteria before ABPM|0|||
148939857|NCT00347360|537261931|FG010|Overall Study|Did not meet criteria before ABPM|1|||
148939858|NCT00347360|537261932|FG011|Overall Study|Did not meet criteria before ABPM|0|||
148939859|NCT00347360|537261933|FG012|Overall Study|Did not meet criteria before ABPM|0|||
148939860|NCT00347360|537261934|FG013|Overall Study|Did not meet criteria before ABPM|0|||
148682532|NCT00373685|536310951|FG000|Overall Study|Protocol Violation|191|||
148682533|NCT00373685|536310952|FG001|Overall Study|Protocol Violation|182|||
148682534|NCT00373685|536310951|FG000|Overall Study|Final Status Unknown|12|||
148682535|NCT00373685|536310952|FG001|Overall Study|Final Status Unknown|4|||
148682536|NCT00373685|536310951|FG000|Overall Study|Randomized, not treated|51|||
148682537|NCT00373685|536310952|FG001|Overall Study|Randomized, not treated|77|||
148682538|NCT02570165|536310953|FG000|Overall Study|Adverse Event|1|||
148682539|NCT02570165|536310954|FG001|Overall Study|Adverse Event|0|||
148682540|NCT02570165|536310955|FG002|Overall Study|Adverse Event|2|||
148682541|NCT02570165|536310956|FG003|Overall Study|Adverse Event|0|||
148682542|NCT02570165|536310957|FG004|Overall Study|Adverse Event|0|||
148682543|NCT02570165|536310958|FG005|Overall Study|Adverse Event|0|||
148682544|NCT02570165|536310959|FG006|Overall Study|Adverse Event|0|||
148682545|NCT02570165|536310953|FG000|Overall Study|Lack of Efficacy|0|||
148682546|NCT02570165|536310954|FG001|Overall Study|Lack of Efficacy|1|||
148682547|NCT02570165|536310955|FG002|Overall Study|Lack of Efficacy|0|||
148682548|NCT02570165|536310956|FG003|Overall Study|Lack of Efficacy|0|||
148682549|NCT02570165|536310957|FG004|Overall Study|Lack of Efficacy|4|||
148682550|NCT02570165|536310958|FG005|Overall Study|Lack of Efficacy|0|||
148682551|NCT02570165|536310959|FG006|Overall Study|Lack of Efficacy|0|||
148682552|NCT02570165|536310953|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
148682553|NCT02570165|536310954|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
148682554|NCT02570165|536310955|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
148682555|NCT02570165|536310956|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
148682556|NCT02570165|536310957|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
148939861|NCT00347360|537261935|FG014|Overall Study|Did not meet criteria before ABPM|0|||
148939862|NCT00347360|537261921|FG000|Overall Study|Randomized in error|0|||
148939863|NCT00347360|537261922|FG001|Overall Study|Randomized in error|0|||
148939864|NCT00347360|537261923|FG002|Overall Study|Randomized in error|0|||
148939865|NCT00347360|537261924|FG003|Overall Study|Randomized in error|0|||
148939866|NCT00347360|537261925|FG004|Overall Study|Randomized in error|0|||
148939867|NCT00347360|537261926|FG005|Overall Study|Randomized in error|0|||
148939868|NCT00347360|537261927|FG006|Overall Study|Randomized in error|0|||
148939869|NCT00347360|537261928|FG007|Overall Study|Randomized in error|0|||
148939870|NCT00347360|537261929|FG008|Overall Study|Randomized in error|0|||
148939871|NCT00347360|537261930|FG009|Overall Study|Randomized in error|0|||
148939872|NCT00347360|537261931|FG010|Overall Study|Randomized in error|0|||
148939873|NCT00347360|537261932|FG011|Overall Study|Randomized in error|1|||
148939874|NCT00347360|537261933|FG012|Overall Study|Randomized in error|0|||
148939875|NCT00347360|537261934|FG013|Overall Study|Randomized in error|0|||
148939876|NCT00347360|537261935|FG014|Overall Study|Randomized in error|0|||
148939877|NCT00347360|537261921|FG000|Overall Study|Failed inclusion criteria #4|0|||
148939878|NCT00347360|537261922|FG001|Overall Study|Failed inclusion criteria #4|0|||
148939879|NCT00347360|537261923|FG002|Overall Study|Failed inclusion criteria #4|0|||
148939880|NCT00347360|537261924|FG003|Overall Study|Failed inclusion criteria #4|0|||
148939881|NCT00347360|537261925|FG004|Overall Study|Failed inclusion criteria #4|0|||
148939882|NCT00347360|537261926|FG005|Overall Study|Failed inclusion criteria #4|0|||
148939883|NCT00347360|537261927|FG006|Overall Study|Failed inclusion criteria #4|0|||
148939884|NCT00347360|537261928|FG007|Overall Study|Failed inclusion criteria #4|0|||
148939885|NCT00347360|537261929|FG008|Overall Study|Failed inclusion criteria #4|0|||
148939886|NCT00347360|537261930|FG009|Overall Study|Failed inclusion criteria #4|0|||
148939887|NCT00347360|537261931|FG010|Overall Study|Failed inclusion criteria #4|0|||
148939888|NCT00347360|537261932|FG011|Overall Study|Failed inclusion criteria #4|1|||
148682557|NCT02570165|536310958|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
148682558|NCT02570165|536310959|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
148939889|NCT00347360|537261933|FG012|Overall Study|Failed inclusion criteria #4|0|||
148939890|NCT00347360|537261934|FG013|Overall Study|Failed inclusion criteria #4|0|||
148939891|NCT00347360|537261935|FG014|Overall Study|Failed inclusion criteria #4|0|||
148939892|NCT00347360|537261921|FG000|Overall Study|Prolonged duration between visits|0|||
148939893|NCT00347360|537261922|FG001|Overall Study|Prolonged duration between visits|0|||
148939894|NCT00347360|537261923|FG002|Overall Study|Prolonged duration between visits|0|||
148939895|NCT00347360|537261924|FG003|Overall Study|Prolonged duration between visits|0|||
148939896|NCT00347360|537261925|FG004|Overall Study|Prolonged duration between visits|0|||
148939897|NCT00347360|537261926|FG005|Overall Study|Prolonged duration between visits|0|||
148939898|NCT00347360|537261927|FG006|Overall Study|Prolonged duration between visits|0|||
148939899|NCT00347360|537261928|FG007|Overall Study|Prolonged duration between visits|0|||
148939900|NCT00347360|537261929|FG008|Overall Study|Prolonged duration between visits|0|||
148939901|NCT00347360|537261930|FG009|Overall Study|Prolonged duration between visits|0|||
148939902|NCT00347360|537261931|FG010|Overall Study|Prolonged duration between visits|0|||
148682559|NCT02570165|536310953|FG000|Overall Study|Lost to Follow-up|0|||
148682560|NCT02570165|536310954|FG001|Overall Study|Lost to Follow-up|0|||
148682561|NCT02570165|536310955|FG002|Overall Study|Lost to Follow-up|1|||
148682562|NCT02570165|536310956|FG003|Overall Study|Lost to Follow-up|1|||
148682563|NCT02570165|536310957|FG004|Overall Study|Lost to Follow-up|0|||
148682564|NCT02570165|536310958|FG005|Overall Study|Lost to Follow-up|0|||
148682565|NCT02570165|536310959|FG006|Overall Study|Lost to Follow-up|0|||
148682566|NCT02570165|536310953|FG000|Overall Study|Physician Decision|0|||
148682567|NCT02570165|536310954|FG001|Overall Study|Physician Decision|1|||
148682568|NCT02570165|536310955|FG002|Overall Study|Physician Decision|0|||
148682569|NCT02570165|536310956|FG003|Overall Study|Physician Decision|0|||
148682570|NCT02570165|536310957|FG004|Overall Study|Physician Decision|0|||
148682571|NCT02570165|536310958|FG005|Overall Study|Physician Decision|0|||
148682572|NCT02570165|536310959|FG006|Overall Study|Physician Decision|0|||
148682573|NCT02570165|536310953|FG000|Overall Study|Withdrawal by Subject|0|||
148682574|NCT02570165|536310954|FG001|Overall Study|Withdrawal by Subject|0|||
148939903|NCT00347360|537261932|FG011|Overall Study|Prolonged duration between visits|0|||
148939904|NCT00347360|537261933|FG012|Overall Study|Prolonged duration between visits|1|||
148939905|NCT00347360|537261934|FG013|Overall Study|Prolonged duration between visits|0|||
148939906|NCT00347360|537261935|FG014|Overall Study|Prolonged duration between visits|0|||
148939907|NCT00347360|537261921|FG000|Overall Study|Subject left town, ran out of study drug|0|||
148939908|NCT00347360|537261922|FG001|Overall Study|Subject left town, ran out of study drug|0|||
148939909|NCT00347360|537261923|FG002|Overall Study|Subject left town, ran out of study drug|0|||
148939910|NCT00347360|537261924|FG003|Overall Study|Subject left town, ran out of study drug|0|||
148939911|NCT00347360|537261925|FG004|Overall Study|Subject left town, ran out of study drug|0|||
148939912|NCT00347360|537261926|FG005|Overall Study|Subject left town, ran out of study drug|0|||
148939913|NCT00347360|537261927|FG006|Overall Study|Subject left town, ran out of study drug|0|||
148939914|NCT00347360|537261928|FG007|Overall Study|Subject left town, ran out of study drug|0|||
148939915|NCT00347360|537261929|FG008|Overall Study|Subject left town, ran out of study drug|0|||
148939916|NCT00347360|537261930|FG009|Overall Study|Subject left town, ran out of study drug|0|||
148939917|NCT00347360|537261931|FG010|Overall Study|Subject left town, ran out of study drug|0|||
148939918|NCT00347360|537261932|FG011|Overall Study|Subject left town, ran out of study drug|0|||
148939919|NCT00347360|537261933|FG012|Overall Study|Subject left town, ran out of study drug|0|||
148939920|NCT00347360|537261934|FG013|Overall Study|Subject left town, ran out of study drug|1|||
148939921|NCT00347360|537261935|FG014|Overall Study|Subject left town, ran out of study drug|0|||
148939922|NCT00347360|537261921|FG000|Overall Study|Subject refuse to sign updated consent|0|||
148939923|NCT00347360|537261922|FG001|Overall Study|Subject refuse to sign updated consent|0|||
148939924|NCT00347360|537261923|FG002|Overall Study|Subject refuse to sign updated consent|0|||
148939925|NCT00347360|537261924|FG003|Overall Study|Subject refuse to sign updated consent|0|||
148939926|NCT00347360|537261925|FG004|Overall Study|Subject refuse to sign updated consent|0|||
148939927|NCT00347360|537261926|FG005|Overall Study|Subject refuse to sign updated consent|0|||
148939928|NCT00347360|537261927|FG006|Overall Study|Subject refuse to sign updated consent|0|||
148939929|NCT00347360|537261928|FG007|Overall Study|Subject refuse to sign updated consent|0|||
148939930|NCT00347360|537261929|FG008|Overall Study|Subject refuse to sign updated consent|0|||
148939931|NCT00347360|537261930|FG009|Overall Study|Subject refuse to sign updated consent|0|||
148939932|NCT00347360|537261931|FG010|Overall Study|Subject refuse to sign updated consent|0|||
148939933|NCT00347360|537261932|FG011|Overall Study|Subject refuse to sign updated consent|0|||
148939934|NCT00347360|537261933|FG012|Overall Study|Subject refuse to sign updated consent|0|||
148939935|NCT00347360|537261934|FG013|Overall Study|Subject refuse to sign updated consent|0|||
148939936|NCT00347360|537261935|FG014|Overall Study|Subject refuse to sign updated consent|1|||
148939937|NCT00347360|537261921|FG000|Overall Study|Visits conflicted with new job|0|||
148939938|NCT00347360|537261922|FG001|Overall Study|Visits conflicted with new job|0|||
148939939|NCT00347360|537261923|FG002|Overall Study|Visits conflicted with new job|0|||
148939940|NCT00347360|537261924|FG003|Overall Study|Visits conflicted with new job|0|||
148939941|NCT00347360|537261925|FG004|Overall Study|Visits conflicted with new job|0|||
148939942|NCT00347360|537261926|FG005|Overall Study|Visits conflicted with new job|0|||
148939943|NCT00347360|537261927|FG006|Overall Study|Visits conflicted with new job|1|||
148939944|NCT00347360|537261928|FG007|Overall Study|Visits conflicted with new job|0|||
148939945|NCT00347360|537261929|FG008|Overall Study|Visits conflicted with new job|0|||
148939946|NCT00347360|537261930|FG009|Overall Study|Visits conflicted with new job|0|||
148939947|NCT00347360|537261931|FG010|Overall Study|Visits conflicted with new job|0|||
148939948|NCT00347360|537261932|FG011|Overall Study|Visits conflicted with new job|0|||
148939949|NCT00347360|537261933|FG012|Overall Study|Visits conflicted with new job|0|||
148939950|NCT00347360|537261934|FG013|Overall Study|Visits conflicted with new job|0|||
148939951|NCT00347360|537261935|FG014|Overall Study|Visits conflicted with new job|0|||
148939952|NCT01187433|537261938|FG000|Overall Study|Protocol Violation|6|||
148939953|NCT01187433|537261939|FG001|Overall Study|Protocol Violation|2|||
148939954|NCT01187433|537261938|FG000|Overall Study|Withdrawal by Subject|5|||
148939955|NCT01187433|537261939|FG001|Overall Study|Withdrawal by Subject|2|||
148939956|NCT01790932|537261942|FG000|Overall Study|Disease Progression|41|||
148939957|NCT01790932|537261942|FG000|Overall Study|Adverse Event|7|||
148939958|NCT01790932|537261942|FG000|Overall Study|Physician Decision|1|||
148939959|NCT01790932|537261942|FG000|Overall Study|Withdrawal by Subject|1|||
148682575|NCT02570165|536310955|FG002|Overall Study|Withdrawal by Subject|0|||
148682576|NCT02570165|536310956|FG003|Overall Study|Withdrawal by Subject|2|||
148939960|NCT04223973|537261943|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
148939961|NCT04223973|537261944|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
148939962|NCT04223973|537261943|FG000|Overall Study|Adverse Event|4|||
148939963|NCT04223973|537261944|FG001|Overall Study|Adverse Event|0|||
148939964|NCT04223973|537261943|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
148939965|NCT04223973|537261944|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
148939966|NCT04223973|537261943|FG000|Overall Study|Physician Decision|1|||
148939967|NCT04223973|537261944|FG001|Overall Study|Physician Decision|1|||
148939968|NCT04223973|537261943|FG000|Overall Study|Withdrawal by Subject|0|||
148939969|NCT04223973|537261944|FG001|Overall Study|Withdrawal by Subject|1|||
148939970|NCT00300274|537261950|FG000|Overall Study|Withdrawal by Subject|12|||
148939971|NCT00300274|537261951|FG001|Overall Study|Withdrawal by Subject|3|||
148939972|NCT00300274|537261952|FG002|Overall Study|Withdrawal by Subject|14|||
148939973|NCT00300274|537261950|FG000|Overall Study|Lost to Follow-up|3|||
148939974|NCT00300274|537261951|FG001|Overall Study|Lost to Follow-up|4|||
148939975|NCT00300274|537261952|FG002|Overall Study|Lost to Follow-up|5|||
148939976|NCT00300274|537261950|FG000|Overall Study|Death|31|||
148939977|NCT00300274|537261951|FG001|Overall Study|Death|20|||
148939978|NCT00300274|537261952|FG002|Overall Study|Death|25|||
148939979|NCT00300274|537261950|FG000|Overall Study|Re-transplant|0|||
148939980|NCT00300274|537261951|FG001|Overall Study|Re-transplant|0|||
148939981|NCT00300274|537261952|FG002|Overall Study|Re-transplant|1|||
148939982|NCT00242216|537261953|FG000|Overall Study|Lost to Follow-up|12|||
148939983|NCT00242216|537261954|FG001|Overall Study|Lost to Follow-up|17|||
148939984|NCT00242216|537261953|FG000|Overall Study|Death|4|||
148939985|NCT00242216|537261954|FG001|Overall Study|Death|2|||
148939986|NCT00242216|537261953|FG000|Overall Study|Lack of Efficacy|1|||
148939987|NCT00242216|537261954|FG001|Overall Study|Lack of Efficacy|2|||
148939988|NCT00242216|537261953|FG000|Overall Study|no medicaiton dispensed|1|||
148939989|NCT00242216|537261954|FG001|Overall Study|no medicaiton dispensed|1|||
148939990|NCT00678080|537261956|FG000|Overall Study|Physician Decision|2|||
148939991|NCT00678080|537261957|FG001|Overall Study|Physician Decision|0|||
148939992|NCT00678080|537261956|FG000|Overall Study|Lost to Follow-up|1|||
148939993|NCT00678080|537261957|FG001|Overall Study|Lost to Follow-up|0|||
148939994|NCT00678080|537261956|FG000|Overall Study|Withdrawal by Subject|0|||
148939995|NCT00678080|537261957|FG001|Overall Study|Withdrawal by Subject|1|||
148939996|NCT05136690|537261967|FG000|Period 1|Withdrawal by Subject|0|||
148939997|NCT05136690|537261968|FG001|Period 1|Withdrawal by Subject|1|||
148939998|NCT05136690|537261967|FG000|Period 2|Lost to Follow-up|0|||
148939999|NCT05136690|537261968|FG001|Period 2|Lost to Follow-up|3|||
148940000|NCT05136690|537261967|FG000|Period 2|Withdrawal by Subject|0|||
148940001|NCT05136690|537261968|FG001|Period 2|Withdrawal by Subject|1|||
148940002|NCT03730012|537261969|FG000|Overall Study|Adverse Event|0|||
148940003|NCT03730012|537261970|FG001|Overall Study|Adverse Event|1|||
148940004|NCT03730012|537261969|FG000|Overall Study|Lack of Efficacy|1|||
148940005|NCT03730012|537261970|FG001|Overall Study|Lack of Efficacy|5|||
148940006|NCT03730012|537261969|FG000|Overall Study|Withdrawal by Subject|0|||
148940007|NCT03730012|537261970|FG001|Overall Study|Withdrawal by Subject|1|||
148940008|NCT03730012|537261969|FG000|Overall Study|Miscellaneous|2|||
148940009|NCT03730012|537261970|FG001|Overall Study|Miscellaneous|1|||
148940010|NCT03320057|537263473|FG000|Overall Study|Lost to Follow-up|4|||
148940011|NCT03320057|537263474|FG001|Overall Study|Lost to Follow-up|17|||
148940012|NCT03320057|537263473|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
148940013|NCT03320057|537263474|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
148940014|NCT00403234|537263475|FG000|Overall Study|Withdrawal by Subject|0|||
148940015|NCT00403234|537263476|FG001|Overall Study|Withdrawal by Subject|1|||
148940016|NCT00403234|537263477|FG002|Overall Study|Withdrawal by Subject|0|||
148940017|NCT00403234|537263478|FG003|Overall Study|Withdrawal by Subject|0|||
148940018|NCT00403234|537263475|FG000|Overall Study|Adverse Event|1|||
148940019|NCT00403234|537263476|FG001|Overall Study|Adverse Event|0|||
148940020|NCT00403234|537263477|FG002|Overall Study|Adverse Event|1|||
148940021|NCT00403234|537263478|FG003|Overall Study|Adverse Event|0|||
148940022|NCT02468674|537263479|FG000|Overall Study|Adverse Event|0|||
148940023|NCT02468674|537263480|FG001|Overall Study|Adverse Event|0|||
148940024|NCT02468674|537263481|FG002|Overall Study|Adverse Event|0|||
148940025|NCT02468674|537263482|FG003|Overall Study|Adverse Event|1|||
148940026|NCT02468674|537263483|FG004|Overall Study|Adverse Event|0|||
148940027|NCT02468674|537263484|FG005|Overall Study|Adverse Event|1|||
148940028|NCT02468674|537263485|FG006|Overall Study|Adverse Event|0|||
148940029|NCT02468674|537263486|FG007|Overall Study|Adverse Event|0|||
148940030|NCT02468674|537263487|FG008|Overall Study|Adverse Event|0|||
148940031|NCT02468674|537263479|FG000|Overall Study|Lost to Follow-up|1|||
148940032|NCT02468674|537263480|FG001|Overall Study|Lost to Follow-up|0|||
148940033|NCT02468674|537263481|FG002|Overall Study|Lost to Follow-up|0|||
148940034|NCT02468674|537263482|FG003|Overall Study|Lost to Follow-up|0|||
148940035|NCT02468674|537263483|FG004|Overall Study|Lost to Follow-up|0|||
148940036|NCT02468674|537263484|FG005|Overall Study|Lost to Follow-up|0|||
148940037|NCT02468674|537263485|FG006|Overall Study|Lost to Follow-up|0|||
148940038|NCT02468674|537263486|FG007|Overall Study|Lost to Follow-up|1|||
148940039|NCT02468674|537263487|FG008|Overall Study|Lost to Follow-up|1|||
148940040|NCT02468674|537263479|FG000|Overall Study|Physician Decision|0|||
148940041|NCT02468674|537263480|FG001|Overall Study|Physician Decision|0|||
148940042|NCT02468674|537263481|FG002|Overall Study|Physician Decision|0|||
148940043|NCT02468674|537263482|FG003|Overall Study|Physician Decision|0|||
148940044|NCT02468674|537263483|FG004|Overall Study|Physician Decision|0|||
148940045|NCT02468674|537263484|FG005|Overall Study|Physician Decision|0|||
148940046|NCT02468674|537263485|FG006|Overall Study|Physician Decision|1|||
148940047|NCT02468674|537263486|FG007|Overall Study|Physician Decision|0|||
148940048|NCT02468674|537263487|FG008|Overall Study|Physician Decision|0|||
148940049|NCT02468674|537263479|FG000|Overall Study|Patient/Guardian Decision|0|||
148940050|NCT02468674|537263480|FG001|Overall Study|Patient/Guardian Decision|0|||
148940051|NCT02468674|537263481|FG002|Overall Study|Patient/Guardian Decision|0|||
148940052|NCT02468674|537263482|FG003|Overall Study|Patient/Guardian Decision|0|||
148940053|NCT02468674|537263483|FG004|Overall Study|Patient/Guardian Decision|1|||
148940054|NCT02468674|537263484|FG005|Overall Study|Patient/Guardian Decision|0|||
148940055|NCT02468674|537263485|FG006|Overall Study|Patient/Guardian Decision|0|||
148940056|NCT02468674|537263486|FG007|Overall Study|Patient/Guardian Decision|2|||
148940057|NCT02468674|537263487|FG008|Overall Study|Patient/Guardian Decision|1|||
148940058|NCT02468674|537263479|FG000|Overall Study|Protocol Deviation|0|||
148940059|NCT02468674|537263480|FG001|Overall Study|Protocol Deviation|0|||
148940060|NCT02468674|537263481|FG002|Overall Study|Protocol Deviation|0|||
148940061|NCT02468674|537263482|FG003|Overall Study|Protocol Deviation|0|||
148940062|NCT02468674|537263483|FG004|Overall Study|Protocol Deviation|0|||
148940063|NCT02468674|537263484|FG005|Overall Study|Protocol Deviation|0|||
148940064|NCT02468674|537263485|FG006|Overall Study|Protocol Deviation|0|||
148940065|NCT02468674|537263486|FG007|Overall Study|Protocol Deviation|1|||
148940066|NCT02468674|537263487|FG008|Overall Study|Protocol Deviation|1|||
148940067|NCT01644565|537263488|FG000|Overall Study|Undisclosed Medical History|1|||
148940068|NCT01644565|537263489|FG001|Overall Study|Undisclosed Medical History|0|||
148940069|NCT01644565|537263490|FG002|Overall Study|Undisclosed Medical History|0|||
148940070|NCT01644565|537263491|FG003|Overall Study|Undisclosed Medical History|0|||
148940071|NCT01644565|537263492|FG004|Overall Study|Undisclosed Medical History|0|||
148940072|NCT01644565|537263493|FG005|Overall Study|Undisclosed Medical History|0|||
148940073|NCT01644565|537263494|FG006|Overall Study|Undisclosed Medical History|0|||
148940074|NCT01644565|537263495|FG007|Overall Study|Undisclosed Medical History|0|||
148940075|NCT01644565|537263496|FG008|Overall Study|Undisclosed Medical History|0|||
148940076|NCT01644565|537263488|FG000|Overall Study|Lost to Follow-up|0|||
148940077|NCT01644565|537263489|FG001|Overall Study|Lost to Follow-up|0|||
148940078|NCT01644565|537263490|FG002|Overall Study|Lost to Follow-up|0|||
148940079|NCT01644565|537263491|FG003|Overall Study|Lost to Follow-up|1|||
148940080|NCT01644565|537263492|FG004|Overall Study|Lost to Follow-up|0|||
148940081|NCT01644565|537263493|FG005|Overall Study|Lost to Follow-up|0|||
148940082|NCT01644565|537263494|FG006|Overall Study|Lost to Follow-up|0|||
148940083|NCT01644565|537263495|FG007|Overall Study|Lost to Follow-up|2|||
148940084|NCT01644565|537263496|FG008|Overall Study|Lost to Follow-up|0|||
148940085|NCT01644565|537263488|FG000|Overall Study|Family emergency|0|||
148940086|NCT01644565|537263489|FG001|Overall Study|Family emergency|0|||
148940087|NCT01644565|537263490|FG002|Overall Study|Family emergency|0|||
148940088|NCT01644565|537263491|FG003|Overall Study|Family emergency|0|||
148940089|NCT01644565|537263492|FG004|Overall Study|Family emergency|1|||
148940090|NCT01644565|537263493|FG005|Overall Study|Family emergency|0|||
148940091|NCT01644565|537263494|FG006|Overall Study|Family emergency|0|||
148940092|NCT01644565|537263495|FG007|Overall Study|Family emergency|0|||
148940093|NCT01644565|537263496|FG008|Overall Study|Family emergency|0|||
148940094|NCT01644565|537263488|FG000|Overall Study|Relocation|0|||
148940095|NCT01644565|537263489|FG001|Overall Study|Relocation|0|||
148940096|NCT01644565|537263490|FG002|Overall Study|Relocation|0|||
148940097|NCT01644565|537263491|FG003|Overall Study|Relocation|0|||
148940098|NCT01644565|537263492|FG004|Overall Study|Relocation|0|||
148940099|NCT01644565|537263493|FG005|Overall Study|Relocation|0|||
148940100|NCT01644565|537263494|FG006|Overall Study|Relocation|0|||
148940101|NCT01644565|537263495|FG007|Overall Study|Relocation|0|||
148940102|NCT01644565|537263496|FG008|Overall Study|Relocation|1|||
148940103|NCT01550289|537263497|FG000|Overall Study|Protocol Violation|1|||
148940104|NCT01550289|537263498|FG001|Overall Study|Protocol Violation|0|||
148940105|NCT01550289|537263497|FG000|Overall Study|Lost to Follow-up|1|||
148940106|NCT01550289|537263498|FG001|Overall Study|Lost to Follow-up|1|||
148940107|NCT01550289|537263497|FG000|Overall Study|Withdrawal by Subject|11|||
148940108|NCT01550289|537263498|FG001|Overall Study|Withdrawal by Subject|3|||
148940109|NCT00541931|537263500|FG000|Overall Study|Adverse Event|1|||
148940110|NCT00541931|537263501|FG001|Overall Study|Adverse Event|0|||
148940111|NCT00541931|537263500|FG000|Overall Study|Lost to Follow-up|3|||
148940112|NCT00541931|537263501|FG001|Overall Study|Lost to Follow-up|3|||
148940113|NCT00541931|537263500|FG000|Overall Study|Withdrawal by Subject|1|||
148940114|NCT00541931|537263501|FG001|Overall Study|Withdrawal by Subject|0|||
148940115|NCT00541931|537263500|FG000|Overall Study|Transportation Issue|0|||
148940116|NCT00541931|537263501|FG001|Overall Study|Transportation Issue|1|||
148940117|NCT05154578|537263502|FG000|Overall Study|Withdrawal by Subject|2|||
148940118|NCT05154578|537263503|FG001|Overall Study|Withdrawal by Subject|3|||
148940119|NCT05154578|537263504|FG002|Overall Study|Withdrawal by Subject|2|||
148940120|NCT05154578|537263505|FG003|Overall Study|Withdrawal by Subject|4|||
148940121|NCT05154578|537263506|FG004|Overall Study|Withdrawal by Subject|0|||
148940122|NCT05154578|537263502|FG000|Overall Study|Lost to Follow-up|0|||
148940123|NCT05154578|537263503|FG001|Overall Study|Lost to Follow-up|1|||
148940124|NCT05154578|537263504|FG002|Overall Study|Lost to Follow-up|0|||
148940125|NCT05154578|537263505|FG003|Overall Study|Lost to Follow-up|3|||
148940126|NCT05154578|537263506|FG004|Overall Study|Lost to Follow-up|0|||
148940127|NCT05154578|537263502|FG000|Overall Study|Adverse Event|0|||
148940128|NCT05154578|537263503|FG001|Overall Study|Adverse Event|0|||
148940129|NCT05154578|537263504|FG002|Overall Study|Adverse Event|0|||
148940130|NCT05154578|537263505|FG003|Overall Study|Adverse Event|1|||
148940131|NCT05154578|537263506|FG004|Overall Study|Adverse Event|0|||
148940132|NCT05154578|537263502|FG000|Overall Study|Relocated to another province|0|||
148940133|NCT05154578|537263503|FG001|Overall Study|Relocated to another province|0|||
148940134|NCT05154578|537263504|FG002|Overall Study|Relocated to another province|1|||
148940135|NCT05154578|537263505|FG003|Overall Study|Relocated to another province|0|||
148940136|NCT05154578|537263506|FG004|Overall Study|Relocated to another province|1|||
148940137|NCT05154578|537263502|FG000|Overall Study|Baby loss|0|||
148940138|NCT05154578|537263503|FG001|Overall Study|Baby loss|1|||
148940139|NCT05154578|537263504|FG002|Overall Study|Baby loss|0|||
148940140|NCT05154578|537263505|FG003|Overall Study|Baby loss|0|||
148940141|NCT05154578|537263506|FG004|Overall Study|Baby loss|0|||
148940142|NCT01180985|537263518|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
148940143|NCT01180985|537263519|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
148940144|NCT00705289|537263520|FG000|Overall Study|Subject or treating physician's choice|131|||
148940145|NCT01030536|537263521|FG000|Overall Study|Withdrawal by Subject|0|||
148682577|NCT02570165|536310957|FG004|Overall Study|Withdrawal by Subject|1|||
148682578|NCT02570165|536310958|FG005|Overall Study|Withdrawal by Subject|0|||
148940146|NCT01030536|537263522|FG001|Overall Study|Withdrawal by Subject|0|||
148940147|NCT01030536|537263523|FG002|Overall Study|Withdrawal by Subject|1|||
148940148|NCT01030536|537263524|FG003|Overall Study|Withdrawal by Subject|0|||
148682579|NCT02570165|536310959|FG006|Overall Study|Withdrawal by Subject|0|||
148940149|NCT01030536|537263525|FG004|Overall Study|Withdrawal by Subject|0|||
148940150|NCT01030536|537263521|FG000|Overall Study|undefined|1|||
149015514|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
149015515|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
149015516|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
149015517|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
149015518|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
149015519|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
149015520|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
149015521|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
149015522|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
149015523|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
149015524|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
149015525|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
149015526|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
149015527|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
149015528|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
149015529|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
149015530|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
149015531|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
149015532|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
149015533|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
149015534|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
149015535|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
149015536|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
149015537|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
149015538|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
149015539|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
149015540|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
149015541|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
149015542|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
149015543|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
149015544|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
149015545|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
149015546|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
149015547|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
149015548|NCT01089556|537536112|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
149015549|NCT01089556|537536113|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
149015550|NCT01089556|537536114|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
149015551|NCT01089556|537536115|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
149015552|NCT01089556|537536116|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
149015553|NCT01089556|537536117|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
149015554|NCT01702428|537536118|FG000|Overall Study|Adverse Event|2|||
149015555|NCT01702428|537536119|FG001|Overall Study|Adverse Event|0|||
149015556|NCT01702428|537536120|FG002|Overall Study|Adverse Event|0|||
149015557|NCT01702428|537536121|FG003|Overall Study|Adverse Event|0|||
149015558|NCT01702428|537536118|FG000|Overall Study|Lost to Follow-up|33|||
149015559|NCT01702428|537536119|FG001|Overall Study|Lost to Follow-up|41|||
149015560|NCT01702428|537536120|FG002|Overall Study|Lost to Follow-up|37|||
149015561|NCT01702428|537536121|FG003|Overall Study|Lost to Follow-up|44|||
149015562|NCT01702428|537536118|FG000|Overall Study|Parents cannot assist to site|1|||
148940151|NCT01030536|537263522|FG001|Overall Study|undefined|0|||
148940152|NCT01030536|537263523|FG002|Overall Study|undefined|1|||
148940153|NCT01030536|537263524|FG003|Overall Study|undefined|1|||
148940154|NCT01030536|537263525|FG004|Overall Study|undefined|0|||
148940155|NCT01030536|537263521|FG000|Overall Study|Adverse Event|0|||
148940156|NCT01030536|537263522|FG001|Overall Study|Adverse Event|3|||
148940157|NCT01030536|537263523|FG002|Overall Study|Adverse Event|1|||
148940158|NCT01030536|537263524|FG003|Overall Study|Adverse Event|0|||
148940159|NCT01030536|537263525|FG004|Overall Study|Adverse Event|1|||
148940160|NCT01030536|537263521|FG000|Overall Study|Progressive disease|6|||
148940161|NCT01030536|537263522|FG001|Overall Study|Progressive disease|2|||
148940162|NCT01030536|537263523|FG002|Overall Study|Progressive disease|3|||
148940163|NCT01030536|537263524|FG003|Overall Study|Progressive disease|2|||
148940164|NCT01030536|537263525|FG004|Overall Study|Progressive disease|0|||
148940165|NCT01030536|537263521|FG000|Overall Study|Death|0|||
148940166|NCT01030536|537263522|FG001|Overall Study|Death|1|||
148940167|NCT01030536|537263523|FG002|Overall Study|Death|0|||
149015563|NCT01702428|537536119|FG001|Overall Study|Parents cannot assist to site|0|||
149015564|NCT01702428|537536120|FG002|Overall Study|Parents cannot assist to site|1|||
148940168|NCT01030536|537263524|FG003|Overall Study|Death|0|||
148940169|NCT01030536|537263525|FG004|Overall Study|Death|0|||
148940170|NCT02601027|537263527|FG000|Registration to Surgery|Withdrawal by Subject|20|||
148940171|NCT02601027|537263528|FG001|Registration to Surgery|Withdrawal by Subject|10|||
148940172|NCT01419626|537263529|FG000|Overall Study|Protocol Violation|3|||
148940173|NCT01419626|537263530|FG001|Overall Study|Protocol Violation|2|||
148940174|NCT01419626|537263531|FG002|Overall Study|Protocol Violation|2|||
148940175|NCT01419626|537263529|FG000|Overall Study|Withdrawal by Subject|1|||
148940176|NCT01419626|537263530|FG001|Overall Study|Withdrawal by Subject|0|||
148940177|NCT01419626|537263531|FG002|Overall Study|Withdrawal by Subject|0|||
148807978|NCT01093846|536774488|FG000|Overall Study|Condition no longer required study drug|1|||
148807979|NCT01093846|536774489|FG001|Overall Study|Condition no longer required study drug|1|||
148940178|NCT01419626|537263529|FG000|Overall Study|Lost to Follow-up|0|||
148940179|NCT01419626|537263530|FG001|Overall Study|Lost to Follow-up|1|||
148940180|NCT01419626|537263531|FG002|Overall Study|Lost to Follow-up|1|||
148940181|NCT02248701|537263534|FG000|Overall Study|Withdrawal by Subject|2|||
148940182|NCT02248701|537263535|FG001|Overall Study|Withdrawal by Subject|1|||
148940183|NCT02248701|537263534|FG000|Overall Study|Physician Decision|0|||
148940184|NCT02248701|537263535|FG001|Overall Study|Physician Decision|1|||
148940185|NCT02248701|537263534|FG000|Overall Study|Adverse Event|1|||
148940186|NCT02248701|537263535|FG001|Overall Study|Adverse Event|0|||
148940187|NCT02248701|537263534|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
148940188|NCT02248701|537263535|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
148940189|NCT01145625|537263536|FG000|Overall Study|Lost to Follow-up|8|||
148940190|NCT01145625|537263537|FG001|Overall Study|Lost to Follow-up|9|||
148940191|NCT01145625|537263536|FG000|Overall Study|Adverse Event|6|||
148940192|NCT01145625|537263537|FG001|Overall Study|Adverse Event|4|||
148807980|NCT01093846|536774490|FG002|Overall Study|Condition no longer required study drug|1|||
148807981|NCT01093846|536774488|FG000|Overall Study|Administrative Problems|18|||
148807982|NCT01093846|536774489|FG001|Overall Study|Administrative Problems|17|||
148807983|NCT01093846|536774490|FG002|Overall Study|Administrative Problems|15|||
148807984|NCT02781324|536774495|FG000|Overall Study|Withdrawal by Subject|1|||
148807985|NCT02781324|536774496|FG001|Overall Study|Withdrawal by Subject|0|||
148807986|NCT02781324|536774495|FG000|Overall Study|Physician Decision|1|||
148807987|NCT02781324|536774496|FG001|Overall Study|Physician Decision|2|||
148807988|NCT00834041|536774497|FG000|Overall Study|Withdrawal by Subject|1|||
148807989|NCT00834041|536774498|FG001|Overall Study|Withdrawal by Subject|0|||
148807990|NCT00834041|536774497|FG000|Overall Study|Lost to Follow-up|0|||
148807991|NCT00834041|536774498|FG001|Overall Study|Lost to Follow-up|1|||
148807992|NCT03074500|536774499|FG000|Overall Study|Lost to Follow-up|1|||
148807993|NCT03074500|536774500|FG001|Overall Study|Lost to Follow-up|0|||
148807994|NCT03074500|536774501|FG002|Overall Study|Lost to Follow-up|0|||
148807995|NCT03074500|536774499|FG000|Overall Study|Lack of Efficacy|0|||
148807996|NCT03074500|536774500|FG001|Overall Study|Lack of Efficacy|1|||
148807997|NCT03074500|536774501|FG002|Overall Study|Lack of Efficacy|0|||
148807998|NCT03074500|536774499|FG000|Overall Study|Adverse Event|0|||
148807999|NCT03074500|536774500|FG001|Overall Study|Adverse Event|0|||
148808000|NCT03074500|536774501|FG002|Overall Study|Adverse Event|1|||
148808001|NCT03321721|536774502|FG000|Overall Study|Lost to Follow-up|4|||
148808002|NCT03321721|536774503|FG001|Overall Study|Lost to Follow-up|8|||
148808003|NCT03321721|536774504|FG002|Overall Study|Lost to Follow-up|11|||
148808004|NCT01416571|536774507|FG000|Overall Study|Lost to Follow-up|2|||
148808005|NCT03608163|536774508|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
148808006|NCT03608163|536774509|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
148808007|NCT03353220|536774510|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
148808008|NCT03353220|536774511|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
148808009|NCT00661388|536774521|FG000|Overall Study|Adverse Event|14|||
148808010|NCT00661388|536774521|FG000|Overall Study|Protocol Violation|7|||
148808011|NCT00661388|536774521|FG000|Overall Study|Renal transplantation|1|||
148808012|NCT00661388|536774521|FG000|Overall Study|Dialysis initiation|1|||
148808013|NCT00661388|536774521|FG000|Overall Study|Administrative reasons|1|||
148808014|NCT04770753|536775095|FG000|Overall Study|Randomized, never treated|1|||
148940193|NCT01145625|537263536|FG000|Overall Study|Protocol Violation|3|||
148940194|NCT01145625|537263537|FG001|Overall Study|Protocol Violation|1|||
148940195|NCT01145625|537263536|FG000|Overall Study|Withdrawal by Subject|7|||
148808015|NCT04770753|536775096|FG001|Overall Study|Randomized, never treated|1|||
148808016|NCT04770753|536775095|FG000|Overall Study|Withdrawal by Subject|3|||
148808017|NCT04770753|536775096|FG001|Overall Study|Withdrawal by Subject|1|||
148808018|NCT04770753|536775095|FG000|Overall Study|Adverse Event|2|||
148940196|NCT01145625|537263537|FG001|Overall Study|Withdrawal by Subject|16|||
148940197|NCT01145625|537263536|FG000|Overall Study|Pregnancy|0|||
148940198|NCT01145625|537263537|FG001|Overall Study|Pregnancy|1|||
148940199|NCT04289623|537263538|FG000|Wave 1 Emails|Email was not delivered|268|||
148940200|NCT04289623|537263539|FG001|Wave 1 Emails|Email was not delivered|257|||
148940201|NCT04289623|537263540|FG002|Wave 1 Emails|Email was not delivered|0|||
148940202|NCT04289623|537263541|FG003|Wave 1 Emails|Email was not delivered|0|||
148940203|NCT04289623|537263542|FG004|Wave 1 Emails|Email was not delivered|0|||
148940204|NCT04289623|537263543|FG005|Wave 1 Emails|Email was not delivered|0|||
148808019|NCT04770753|536775096|FG001|Overall Study|Adverse Event|0|||
148808020|NCT04770753|536775095|FG000|Overall Study|Pregnancy|1|||
148808021|NCT04770753|536775096|FG001|Overall Study|Pregnancy|0|||
148682580|NCT02570165|536310953|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
148682581|NCT02570165|536310954|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
148682582|NCT02570165|536310955|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
148682583|NCT02570165|536310956|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
148682584|NCT02570165|536310957|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
148682585|NCT02570165|536310958|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
148682586|NCT02570165|536310959|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
148682587|NCT02570165|536310953|FG000|Overall Study|Withdrawal Request by GSK|0|||
148682588|NCT02570165|536310954|FG001|Overall Study|Withdrawal Request by GSK|0|||
148682589|NCT02570165|536310955|FG002|Overall Study|Withdrawal Request by GSK|2|||
148682590|NCT02570165|536310956|FG003|Overall Study|Withdrawal Request by GSK|0|||
148682591|NCT02570165|536310957|FG004|Overall Study|Withdrawal Request by GSK|0|||
148940205|NCT00762385|537263544|FG000|First Intervention|Lens Issue|1|||
148940206|NCT00762385|537263545|FG001|First Intervention|Lens Issue|1|||
148940207|NCT00762385|537263544|FG000|First Intervention|Lost to Follow-up|0|||
148940208|NCT00762385|537263545|FG001|First Intervention|Lost to Follow-up|2|||
148940209|NCT00762385|537263544|FG000|First Intervention|Ineligible|1|||
148940210|NCT00762385|537263545|FG001|First Intervention|Ineligible|0|||
148940211|NCT00762385|537263544|FG000|First Intervention|Protocol Violation|0|||
148940212|NCT00762385|537263545|FG001|First Intervention|Protocol Violation|1|||
148940213|NCT00762385|537263544|FG000|Second Intervention|Protocol Violation|3|||
148940214|NCT00762385|537263545|FG001|Second Intervention|Protocol Violation|3|||
148940215|NCT01540838|537263547|FG000|Overall Study|Open nasogastric tube|9|||
148940216|NCT01540838|537263548|FG001|Overall Study|Open nasogastric tube|7|||
148940217|NCT01540838|537263547|FG000|Overall Study|Treatment doses missing|8|||
148940218|NCT01540838|537263548|FG001|Overall Study|Treatment doses missing|12|||
148940219|NCT01540838|537263547|FG000|Overall Study|Additional antibiotic treatment|1|||
148940220|NCT01540838|537263548|FG001|Overall Study|Additional antibiotic treatment|2|||
148940221|NCT01540838|537263547|FG000|Overall Study|Died before treatment initiation|1|||
148940222|NCT01540838|537263548|FG001|Overall Study|Died before treatment initiation|1|||
148940223|NCT01540838|537263547|FG000|Overall Study|Not BM. Other treatment|3|||
148940224|NCT01540838|537263548|FG001|Overall Study|Not BM. Other treatment|1|||
148940225|NCT02130570|537263549|FG000|Overall Study|Death|3|||
148940226|NCT02130570|537263550|FG001|Overall Study|Death|5|||
148940227|NCT02130570|537263549|FG000|Overall Study|Withdrawal by Subject|6|||
148940228|NCT02130570|537263550|FG001|Overall Study|Withdrawal by Subject|3|||
148940229|NCT02130570|537263549|FG000|Overall Study|Part of practice that discontinued study|0|||
148940230|NCT02130570|537263550|FG001|Overall Study|Part of practice that discontinued study|5|||
148940231|NCT00493025|537263553|FG000|Overall Study|Physician Decision|19|||
148940232|NCT03863197|537263554|FG000|Overall Study|Lost to Follow-up|2|||
148940233|NCT03863197|537263555|FG001|Overall Study|Lost to Follow-up|3|||
148940234|NCT03863197|537263554|FG000|Overall Study|Withdrawal by Subject|4|||
148940235|NCT03863197|537263555|FG001|Overall Study|Withdrawal by Subject|0|||
148940236|NCT03863197|537263554|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
148940237|NCT03863197|537263555|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
148940238|NCT01065597|537263556|FG000|Overall Study|Adverse Event|1|||
148940239|NCT01781975|537263557|FG000|Overall Study|Death|1|||
148682592|NCT02570165|536310958|FG005|Overall Study|Withdrawal Request by GSK|0|||
148682593|NCT02570165|536310959|FG006|Overall Study|Withdrawal Request by GSK|0|||
148682594|NCT05266456|536310962|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
148682595|NCT05266456|536310963|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
148682596|NCT05266456|536310964|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
148682597|NCT05266456|536310965|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
148682598|NCT05266456|536310962|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
148682599|NCT05266456|536310963|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
148682600|NCT05266456|536310964|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
148682601|NCT05266456|536310965|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
148682602|NCT05266456|536310962|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
148682603|NCT05266456|536310963|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
148682604|NCT05266456|536310964|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
148682605|NCT05266456|536310965|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
148808022|NCT04770753|536775095|FG000|Overall Study|Other un-specified|1|||
148940240|NCT01781975|537263558|FG001|Overall Study|Death|0|||
148682606|NCT05266456|536310962|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
148682607|NCT05266456|536310963|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
148682608|NCT05266456|536310964|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
148940241|NCT01781975|537263557|FG000|Overall Study|Withdrawal by Subject|1|||
148940242|NCT01781975|537263558|FG001|Overall Study|Withdrawal by Subject|1|||
148940243|NCT01622231|537263559|FG000|Overall Study|Physician Decision|1|||
148940244|NCT01622231|537263559|FG000|Overall Study|Withdrawal by Subject|1|||
148940245|NCT04545060|537263560|FG000|Overall Study|Adverse Event|0|||
148940246|NCT04545060|537263561|FG001|Overall Study|Adverse Event|1|||
148808023|NCT04770753|536775096|FG001|Overall Study|Other un-specified|0|||
148808024|NCT04780659|536775097|FG000|Overall Study|Adverse event, serious fatal|3|||
148808025|NCT04780659|536775098|FG001|Overall Study|Adverse event, serious fatal|0|||
148808026|NCT04780659|536775097|FG000|Overall Study|Withdrawal by Subject|3|||
148808027|NCT04780659|536775098|FG001|Overall Study|Withdrawal by Subject|0|||
148808028|NCT04780659|536775097|FG000|Overall Study|Physician Decision|1|||
148808029|NCT04780659|536775098|FG001|Overall Study|Physician Decision|0|||
148808030|NCT04780659|536775097|FG000|Overall Study|Died in original disease|2|||
148808031|NCT04780659|536775098|FG001|Overall Study|Died in original disease|0|||
148808032|NCT04780659|536775097|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
148808033|NCT04780659|536775098|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
148808034|NCT05507437|536775099|FG000|Overall Study|Withdrawal by Subject|1|||
148808035|NCT05507437|536775100|FG001|Overall Study|Withdrawal by Subject|1|||
148808036|NCT05507437|536775099|FG000|Overall Study|Death|3|||
148808037|NCT05507437|536775100|FG001|Overall Study|Death|0|||
148808038|NCT06583096|536775101|FG000|Overall Study|Lost to Follow-up|4|||
148808039|NCT06583096|536775102|FG001|Overall Study|Lost to Follow-up|10|||
148808040|NCT06583096|536775101|FG000|Overall Study|Withdrawal by Subject|0|||
148808041|NCT06583096|536775102|FG001|Overall Study|Withdrawal by Subject|2|||
148808042|NCT04588259|536775103|FG000|Run-in period|Run-in failure|0|||
148808043|NCT04588259|536775104|FG001|Run-in period|Run-in failure|23|||
148808044|NCT04588259|536775103|FG000|Run-in period|Withdrawn before randomisation|0|||
148808045|NCT04588259|536775104|FG001|Run-in period|Withdrawn before randomisation|8|||
148808046|NCT04588259|536775103|FG000|Treatment period|Withdrawal by Subject|6|||
148808047|NCT04588259|536775104|FG001|Treatment period|Withdrawal by Subject|6|||
148808048|NCT04460885|536775105|FG000|Overall Study|Withdrawal by Subject|6|||
148808049|NCT04460885|536775106|FG001|Overall Study|Withdrawal by Subject|8|||
148808050|NCT04460885|536775105|FG000|Overall Study|Site closure|1|||
148808051|NCT04460885|536775106|FG001|Overall Study|Site closure|0|||
148808052|NCT04460885|536775105|FG000|Overall Study|Death|5|||
148808053|NCT04460885|536775106|FG001|Overall Study|Death|4|||
148808054|NCT04460885|536775105|FG000|Overall Study|Physician Decision|2|||
148808055|NCT04460885|536775106|FG001|Overall Study|Physician Decision|1|||
148808056|NCT04460885|536775105|FG000|Overall Study|Lost to Follow-up|4|||
148808057|NCT04460885|536775106|FG001|Overall Study|Lost to Follow-up|4|||
148808058|NCT05452239|536775113|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
148808059|NCT05452239|536775114|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
148808060|NCT05452239|536775113|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
148808061|NCT05452239|536775114|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
148808062|NCT05452239|536775113|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
148808063|NCT05452239|536775114|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
148808064|NCT05452239|536775113|FG000|Placebo-controlled Period|Randomized but not treated|2|||
148808065|NCT05452239|536775114|FG001|Placebo-controlled Period|Randomized but not treated|2|||
148808066|NCT05452239|536775113|FG000|Placebo-controlled Period|Other than specified|1|||
148808067|NCT05452239|536775114|FG001|Placebo-controlled Period|Other than specified|1|||
148808068|NCT05452239|536775113|FG000|Open-label Period|Withdrawal by Subject|2|||
148808069|NCT05452239|536775114|FG001|Open-label Period|Withdrawal by Subject|1|||
148808070|NCT05452239|536775113|FG000|Open-label Period|Lost to Follow-up|3|||
148808071|NCT05452239|536775114|FG001|Open-label Period|Lost to Follow-up|0|||
148808072|NCT05452239|536775113|FG000|Open-label Period|Other than specified|1|||
148808073|NCT05452239|536775114|FG001|Open-label Period|Other than specified|2|||
148808074|NCT01385176|536775118|FG000|Randomization Phase|Death|1|||
148940247|NCT04545060|537263560|FG000|Overall Study|Death|0|||
148940248|NCT04545060|537263561|FG001|Overall Study|Death|5|||
148940249|NCT04545060|537263560|FG000|Overall Study|Lost to Follow-up|10|||
148940250|NCT04545060|537263561|FG001|Overall Study|Lost to Follow-up|13|||
148940251|NCT04545060|537263560|FG000|Overall Study|Physician Decision|3|||
148940252|NCT04545060|537263561|FG001|Overall Study|Physician Decision|0|||
148940253|NCT04545060|537263560|FG000|Overall Study|Withdrawal by Subject|17|||
148940254|NCT04545060|537263561|FG001|Overall Study|Withdrawal by Subject|22|||
148940255|NCT00973674|537263564|FG000|Overall Study|Protocol Violation|2|||
148940256|NCT00973674|537263565|FG001|Overall Study|Protocol Violation|0|||
148940257|NCT00839852|537263572|FG000|Overall Study|Adverse Event|10|||
148940258|NCT00839852|537263572|FG000|Overall Study|Insufficient Therapeutic Response|3|||
148940259|NCT00839852|537263572|FG000|Overall Study|Protocol Violation|9|||
148940260|NCT00839852|537263572|FG000|Overall Study|Withdrawal of Consent|16|||
148940261|NCT00839852|537263572|FG000|Overall Study|Lost to Follow-up|7|||
148808075|NCT01385176|536775119|FG001|Randomization Phase|Death|2|||
148808076|NCT01385176|536775118|FG000|6-18 Month All VNS Active|Death|1|||
148808077|NCT01385176|536775119|FG001|6-18 Month All VNS Active|Death|2|||
148808078|NCT01385176|536775118|FG000|6-18 Month All VNS Active|Physician Decision|0|||
148808079|NCT01385176|536775119|FG001|6-18 Month All VNS Active|Physician Decision|1|||
148808080|NCT01385176|536775118|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
148940262|NCT00839852|537263572|FG000|Overall Study|Lack of Compliance While in Jail|1|||
148940263|NCT00839852|537263572|FG000|Overall Study|Pregnancy|1|||
148940264|NCT03082261|537263573|FG000|Overall Study|Death|4|||
148808081|NCT01385176|536775119|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
148940265|NCT03082261|537263573|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
148808082|NCT01385176|536775118|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
148940266|NCT03082261|537263573|FG000|Overall Study|Insurance denial|1|||
148940267|NCT03082261|537263573|FG000|Overall Study|Peripheral lead added|1|||
148940268|NCT03082261|537263573|FG000|Overall Study|Withdrawal by Subject|40|||
148940269|NCT03082261|537263573|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
148940270|NCT03082261|537263573|FG000|Overall Study|Subject implanted with device other than study device|1|||
148940271|NCT03082261|537263573|FG000|Overall Study|Lost to Follow-up|14|||
148940272|NCT03082261|537263573|FG000|Overall Study|Subject moved to a different state|1|||
148940273|NCT03082261|537263573|FG000|Overall Study|Subject non-compliance|2|||
148940274|NCT03082261|537263573|FG000|Overall Study|Subject participation terminated by investigator|9|||
148940275|NCT03082261|537263573|FG000|Overall Study|Subject participation terminated by sponsor|4|||
148940276|NCT03082261|537263573|FG000|Overall Study|System explant|19|||
148940277|NCT03082261|537263573|FG000|Overall Study|Unable to place lead(s)|2|||
148940278|NCT03082261|537263573|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
148940279|NCT00494299|537263576|FG000|Overall Study|Adverse Event|93|||
148940280|NCT00494299|537263577|FG001|Overall Study|Adverse Event|13|||
148940281|NCT00494299|537263576|FG000|Overall Study|Lost to Follow-up|1|||
148940282|NCT00494299|537263577|FG001|Overall Study|Lost to Follow-up|0|||
148940283|NCT00494299|537263576|FG000|Overall Study|Physician Decision|0|||
148940284|NCT00494299|537263577|FG001|Overall Study|Physician Decision|2|||
148940285|NCT00494299|537263576|FG000|Overall Study|Protocol Violation|1|||
148940286|NCT00494299|537263577|FG001|Overall Study|Protocol Violation|2|||
148940287|NCT00494299|537263576|FG000|Overall Study|Withdrawal by Subject|8|||
148940288|NCT00494299|537263577|FG001|Overall Study|Withdrawal by Subject|3|||
148940289|NCT00494299|537263576|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
148940290|NCT00494299|537263577|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
148940291|NCT00494299|537263576|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
148940292|NCT00494299|537263577|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
148940293|NCT00494299|537263576|FG000|Overall Study|Site Closed by Sponsor|6|||
148940294|NCT00494299|537263577|FG001|Overall Study|Site Closed by Sponsor|0|||
148940295|NCT00494299|537263576|FG000|Overall Study|Protocol Driven Decision Point|11|||
148940296|NCT00494299|537263577|FG001|Overall Study|Protocol Driven Decision Point|22|||
148940297|NCT01281137|537263578|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
148940298|NCT01281137|537263579|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
148940299|NCT01281137|537263578|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
148940300|NCT01281137|537263579|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
148940301|NCT01281137|537263578|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
148940302|NCT01281137|537263579|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
148940303|NCT01281137|537263578|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
148940304|NCT01281137|537263579|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
148940305|NCT01281137|537263578|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
148940306|NCT01281137|537263579|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
148940307|NCT01986907|537263582|FG000|Overall Study|Adverse Event|11|||
148940308|NCT01986907|537263582|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
148940309|NCT01986907|537263582|FG000|Overall Study|Protocol Violation|4|||
148940310|NCT01986907|537263582|FG000|Overall Study|Withdrawal by Subject|76|||
148940311|NCT01986907|537263582|FG000|Overall Study|Lost to Follow-up|38|||
148940312|NCT01986907|537263582|FG000|Overall Study|Death|9|||
148940313|NCT03800173|537263583|FG000|Overall Study|Lost to Follow-up|0|||
148940314|NCT03800173|537263584|FG001|Overall Study|Lost to Follow-up|0|||
148940315|NCT03800173|537263585|FG002|Overall Study|Lost to Follow-up|0|||
148940316|NCT03800173|537263586|FG003|Overall Study|Lost to Follow-up|0|||
148808083|NCT01385176|536775119|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
148808084|NCT05082025|536775120|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
148808085|NCT04458922|536775121|FG000|Overall Study|Withdrawal by Subject|1|||
148808086|NCT04458922|536775122|FG001|Overall Study|Withdrawal by Subject|0|||
148808087|NCT04458922|536775123|FG002|Overall Study|Withdrawal by Subject|2|||
148808088|NCT04458922|536775121|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
148808089|NCT04458922|536775122|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
148940317|NCT03800173|537263587|FG004|Overall Study|Lost to Follow-up|1|||
148940318|NCT02846324|537263588|FG000|Overall Study|Other|1|||
148940319|NCT02846324|537263589|FG001|Overall Study|Other|0|||
148940320|NCT02846324|537263590|FG002|Overall Study|Other|0|||
148808090|NCT04458922|536775123|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
148808091|NCT04458922|536775121|FG000|Overall Study|Adverse Event|1|||
148808092|NCT04458922|536775122|FG001|Overall Study|Adverse Event|0|||
148808093|NCT04458922|536775123|FG002|Overall Study|Adverse Event|0|||
148808094|NCT04458922|536775121|FG000|Overall Study|Started new study|0|||
148808095|NCT04458922|536775122|FG001|Overall Study|Started new study|0|||
148808096|NCT04458922|536775123|FG002|Overall Study|Started new study|1|||
148808097|NCT04458922|536775121|FG000|Overall Study|Progressive disease|6|||
148808098|NCT04458922|536775122|FG001|Overall Study|Progressive disease|8|||
148808099|NCT04458922|536775123|FG002|Overall Study|Progressive disease|2|||
148940321|NCT02846324|537263591|FG003|Overall Study|Other|0|||
148940322|NCT02846324|537263588|FG000|Overall Study|Withdrawal by Subject|1|||
148940323|NCT02846324|537263589|FG001|Overall Study|Withdrawal by Subject|0|||
148940324|NCT02846324|537263590|FG002|Overall Study|Withdrawal by Subject|4|||
148940325|NCT02846324|537263591|FG003|Overall Study|Withdrawal by Subject|0|||
148940326|NCT00579098|537263592|FG000|Overall Study|Lost to Follow-up|2|||
148940327|NCT00579098|537263593|FG001|Overall Study|Lost to Follow-up|0|||
148940328|NCT00579098|537263592|FG000|Overall Study|Adverse Event|2|||
148940329|NCT00579098|537263593|FG001|Overall Study|Adverse Event|3|||
148940330|NCT00579098|537263592|FG000|Overall Study|Withdrawal by Subject|2|||
148940331|NCT00579098|537263593|FG001|Overall Study|Withdrawal by Subject|3|||
148940332|NCT00579098|537263592|FG000|Overall Study|AF returned after ablation|3|||
148940333|NCT00579098|537263593|FG001|Overall Study|AF returned after ablation|2|||
148940334|NCT01254331|537263594|FG000|Initial Phase|Adverse Event|3|||
148940335|NCT01254331|537263594|FG000|Initial Phase|Withdrawal by Subject|1|||
148940336|NCT01254331|537263594|FG000|Initial Phase|Pregnancy|1|||
148940337|NCT01254331|537263594|FG000|Extension Phase|Lack of Efficacy|1|||
148940338|NCT01254331|537263594|FG000|Extension Phase|Lost to Follow-up|3|||
148940339|NCT05213481|537263595|FG000|Overall Study|Adverse Event|3|||
148940340|NCT05213481|537263595|FG000|Overall Study|Lost to Follow-up|1|||
148940341|NCT03822182|537263598|FG000|Overall Study|Protocol Violation|0|||
148940342|NCT03822182|537263599|FG001|Overall Study|Protocol Violation|1|||
148940343|NCT03822182|537263600|FG002|Overall Study|Protocol Violation|1|||
148940344|NCT01387789|537263604|FG000|Overall Study|Adverse Event|5|||
148940345|NCT01387789|537263604|FG000|Overall Study|Lack of Efficacy|2|||
148940346|NCT01387789|537263604|FG000|Overall Study|Lost to Follow-up|1|||
148940347|NCT00913380|537263605|FG000|Clinical Outcomes|Lost to Follow-up|6|||
148940348|NCT00913380|537263606|FG001|Clinical Outcomes|Lost to Follow-up|6|||
148940349|NCT01788228|537263611|FG000|Overall Study|Migrated/moved from study area|1|||
148940350|NCT01788228|537263612|FG001|Overall Study|Migrated/moved from study area|0|||
148940351|NCT02187744|537263613|FG000|Study|Participant refused further follow-up|1|||
148940352|NCT02187744|537263614|FG001|Study|Participant refused further follow-up|0|||
148940353|NCT02187744|537263613|FG000|Study|Other|2|||
148940354|NCT02187744|537263614|FG001|Study|Other|1|||
148940355|NCT02187744|537263613|FG000|Study|Lost to Follow-up|0|||
148940356|NCT02187744|537263614|FG001|Study|Lost to Follow-up|2|||
148940357|NCT02187744|537263613|FG000|Study|Related adverse event, not serious|0|||
148940358|NCT02187744|537263614|FG001|Study|Related adverse event, not serious|2|||
148940359|NCT02187744|537263613|FG000|Study|Death|1|||
148940360|NCT02187744|537263614|FG001|Study|Death|0|||
148940361|NCT02187744|537263613|FG000|Study|Related adverse event, serious non-fatal|0|||
148940362|NCT02187744|537263614|FG001|Study|Related adverse event, serious non-fatal|1|||
148940363|NCT02187744|537263613|FG000|Treatment|Death|1|||
148940364|NCT02187744|537263614|FG001|Treatment|Death|0|||
148940365|NCT02187744|537263613|FG000|Treatment|Related adverse event, serious non-fatal|0|||
148940366|NCT02187744|537263614|FG001|Treatment|Related adverse event, serious non-fatal|1|||
148940367|NCT02187744|537263613|FG000|Treatment|Related adverse event, not serious|0|||
148940368|NCT02187744|537263614|FG001|Treatment|Related adverse event, not serious|2|||
148940369|NCT02187744|537263613|FG000|Treatment|Lost to Follow-up|0|||
148940370|NCT02187744|537263614|FG001|Treatment|Lost to Follow-up|1|||
148940371|NCT02187744|537263613|FG000|Treatment|Other|2|||
148940372|NCT02187744|537263614|FG001|Treatment|Other|0|||
148940373|NCT02187744|537263613|FG000|Treatment|Participant refused continued treatment|1|||
148940374|NCT02187744|537263614|FG001|Treatment|Participant refused continued treatment|1|||
148940375|NCT00508755|537263619|FG000|Overall Study|Withdrawal by Subject|1|||
148940376|NCT00945893|537263620|FG000|Overall Study|Lost to Follow-up|2|||
148940377|NCT00945893|537263621|FG001|Overall Study|Lost to Follow-up|8|||
148940378|NCT00945893|537263620|FG000|Overall Study|Withdrawal of consent|1|||
148940379|NCT00945893|537263621|FG001|Overall Study|Withdrawal of consent|2|||
148940380|NCT01602120|537263624|FG000|Overall Study|Adverse Event|3|||
148940381|NCT01602120|537263625|FG001|Overall Study|Adverse Event|6|||
148940382|NCT01602120|537263626|FG002|Overall Study|Adverse Event|0|||
148940383|NCT01602120|537263627|FG003|Overall Study|Adverse Event|2|||
148940384|NCT01602120|537263624|FG000|Overall Study|Death|0|||
148808100|NCT04458922|536775121|FG000|Overall Study|Death|1|||
148940385|NCT01602120|537263625|FG001|Overall Study|Death|4|||
148940386|NCT01602120|537263626|FG002|Overall Study|Death|0|||
148940387|NCT01602120|537263627|FG003|Overall Study|Death|0|||
149015565|NCT01702428|537536121|FG003|Overall Study|Parents cannot assist to site|0|||
148808101|NCT04458922|536775122|FG001|Overall Study|Death|0|||
148808102|NCT04458922|536775123|FG002|Overall Study|Death|2|||
148940388|NCT01602120|537263624|FG000|Overall Study|Lost to Follow-up|0|||
148940389|NCT01602120|537263625|FG001|Overall Study|Lost to Follow-up|1|||
148808103|NCT04458922|536775121|FG000|Overall Study|Participant started chemotherapy|0|||
148940390|NCT01602120|537263626|FG002|Overall Study|Lost to Follow-up|0|||
148940391|NCT01602120|537263627|FG003|Overall Study|Lost to Follow-up|1|||
148940392|NCT01602120|537263624|FG000|Overall Study|Protocol Violation|1|||
148940393|NCT01602120|537263625|FG001|Overall Study|Protocol Violation|1|||
148940394|NCT01602120|537263626|FG002|Overall Study|Protocol Violation|0|||
148940395|NCT01602120|537263627|FG003|Overall Study|Protocol Violation|0|||
148940396|NCT01602120|537263624|FG000|Overall Study|Non-compliance|0|||
148940397|NCT01602120|537263625|FG001|Overall Study|Non-compliance|3|||
148940398|NCT01602120|537263626|FG002|Overall Study|Non-compliance|0|||
148940399|NCT01602120|537263627|FG003|Overall Study|Non-compliance|1|||
148940400|NCT01602120|537263624|FG000|Overall Study|Withdrawal by Subject|8|||
148940401|NCT01602120|537263625|FG001|Overall Study|Withdrawal by Subject|17|||
148940402|NCT01602120|537263626|FG002|Overall Study|Withdrawal by Subject|0|||
148940403|NCT01602120|537263627|FG003|Overall Study|Withdrawal by Subject|3|||
148940404|NCT01602120|537263624|FG000|Overall Study|Study Terminated by Sponsor|12|||
148808104|NCT04458922|536775122|FG001|Overall Study|Participant started chemotherapy|1|||
148808105|NCT04458922|536775123|FG002|Overall Study|Participant started chemotherapy|0|||
148808106|NCT02921256|536775124|FG000|Arm 1a v. Arm II|Adverse Event|6|||
148808107|NCT02921256|536775125|FG001|Arm 1a v. Arm II|Adverse Event|15|||
148808108|NCT02921256|536775126|FG002|Arm 1a v. Arm II|Adverse Event|0|||
148808109|NCT02921256|536775124|FG000|Arm 1a v. Arm II|Death|0|||
148808110|NCT02921256|536775125|FG001|Arm 1a v. Arm II|Death|2|||
148808111|NCT02921256|536775126|FG002|Arm 1a v. Arm II|Death|0|||
148808112|NCT02921256|536775124|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
148808113|NCT02921256|536775125|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
148808114|NCT02921256|536775126|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
148808115|NCT02921256|536775124|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
148808116|NCT02921256|536775125|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
148808117|NCT02921256|536775126|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
148808118|NCT02921256|536775124|FG000|Arm 1a v. Arm II|Physician Decision|1|||
148808119|NCT02921256|536775125|FG001|Arm 1a v. Arm II|Physician Decision|1|||
148808120|NCT02921256|536775126|FG002|Arm 1a v. Arm II|Physician Decision|0|||
148808121|NCT02921256|536775124|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
148808122|NCT02921256|536775125|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
148808123|NCT02921256|536775126|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
148808124|NCT02921256|536775124|FG000|Arm Ib v Arm III|Adverse Event|9|||
148808125|NCT02921256|536775125|FG001|Arm Ib v Arm III|Adverse Event|0|||
148808126|NCT02921256|536775126|FG002|Arm Ib v Arm III|Adverse Event|4|||
148808127|NCT02921256|536775124|FG000|Arm Ib v Arm III|Death|1|||
148808128|NCT02921256|536775125|FG001|Arm Ib v Arm III|Death|0|||
148808129|NCT02921256|536775126|FG002|Arm Ib v Arm III|Death|1|||
148808130|NCT02921256|536775124|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
148808131|NCT02921256|536775125|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
148808132|NCT02921256|536775126|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
148808133|NCT02921256|536775124|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
148808134|NCT02921256|536775125|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
148808135|NCT02921256|536775126|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
148808136|NCT02921256|536775124|FG000|Arm Ib v Arm III|Physician Decision|4|||
148808137|NCT02921256|536775125|FG001|Arm Ib v Arm III|Physician Decision|0|||
148808138|NCT02921256|536775126|FG002|Arm Ib v Arm III|Physician Decision|1|||
148808139|NCT02921256|536775124|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
148808140|NCT02921256|536775125|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
148808141|NCT02921256|536775126|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
148808142|NCT04848480|536775127|FG000|Main Phase (26 Weeks)|Death|1|||
148808143|NCT04848480|536775128|FG001|Main Phase (26 Weeks)|Death|0|||
148808144|NCT04848480|536775127|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
148808145|NCT04848480|536775128|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
148808146|NCT04848480|536775127|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
148940405|NCT01602120|537263625|FG001|Overall Study|Study Terminated by Sponsor|24|||
148940406|NCT01602120|537263626|FG002|Overall Study|Study Terminated by Sponsor|17|||
148940407|NCT01602120|537263627|FG003|Overall Study|Study Terminated by Sponsor|44|||
148940408|NCT01602120|537263624|FG000|Overall Study|Physician Decision|2|||
148940409|NCT01602120|537263625|FG001|Overall Study|Physician Decision|3|||
148940410|NCT01602120|537263626|FG002|Overall Study|Physician Decision|0|||
148940411|NCT01602120|537263627|FG003|Overall Study|Physician Decision|0|||
148940412|NCT01602120|537263624|FG000|Overall Study|Unspecified Reason|3|||
148808147|NCT04848480|536775128|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
148808148|NCT04848480|536775127|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
148808149|NCT04848480|536775128|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
148808150|NCT04848480|536775127|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
148808151|NCT04848480|536775128|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
148808152|NCT04848480|536775127|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
148808153|NCT04848480|536775128|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
148808154|NCT04428151|536775129|FG000|Overall Study|Death|100|||
148808155|NCT04428151|536775130|FG001|Overall Study|Death|86|||
148940413|NCT01602120|537263625|FG001|Overall Study|Unspecified Reason|1|||
148940414|NCT01602120|537263626|FG002|Overall Study|Unspecified Reason|0|||
148940415|NCT01602120|537263627|FG003|Overall Study|Unspecified Reason|2|||
148940416|NCT02764697|537263631|FG000|Overall Study|Lack of Efficacy|3|||
148940417|NCT03298867|537263640|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
148940418|NCT03298867|537263641|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
148940419|NCT03298867|537263640|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
148940420|NCT03298867|537263641|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
148940421|NCT03298867|537263640|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
148940422|NCT03298867|537263641|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
148940423|NCT03298867|537263640|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
148940424|NCT03298867|537263641|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
148940425|NCT03298867|537263640|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
148940426|NCT03298867|537263641|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
148940427|NCT03298867|537263640|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
148940428|NCT03298867|537263641|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
148940429|NCT03298867|537263640|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
148940430|NCT03298867|537263641|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
148940431|NCT03298867|537263640|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
148940432|NCT03298867|537263641|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
148940433|NCT03298867|537263640|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
148940434|NCT03298867|537263641|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
148940435|NCT00443261|537264970|FG000|Overall Study|Death|1|||
148940436|NCT02025621|537264971|FG000|Overall Study|Withdrawal by Subject|1|||
148940437|NCT02025621|537264972|FG001|Overall Study|Withdrawal by Subject|0|||
148940438|NCT02025621|537264971|FG000|Overall Study|Death|0|||
148940439|NCT02025621|537264972|FG001|Overall Study|Death|1|||
148940440|NCT02025621|537264971|FG000|Overall Study|No longer eligible|10|||
148940441|NCT02025621|537264972|FG001|Overall Study|No longer eligible|15|||
148940442|NCT02025621|537264971|FG000|Overall Study|Surgery initiated before infusion|3|||
148940443|NCT02025621|537264972|FG001|Overall Study|Surgery initiated before infusion|3|||
148940444|NCT00739674|537264973|FG000|Overall Study|Screening failures|19|||
148940445|NCT00739674|537264974|FG001|Overall Study|Screening failures|17|||
148940446|NCT00739674|537264973|FG000|Overall Study|Site 212 removal|19|||
148940447|NCT00739674|537264974|FG001|Overall Study|Site 212 removal|13|||
148940448|NCT00739674|537264973|FG000|Overall Study|No follow-up data|33|||
148940449|NCT00739674|537264974|FG001|Overall Study|No follow-up data|18|||
148940450|NCT00739674|537264973|FG000|Overall Study|Dietician consultation >30 days|1|||
148940451|NCT00739674|537264974|FG001|Overall Study|Dietician consultation >30 days|9|||
148940452|NCT00739674|537264973|FG000|Overall Study|Adverse Event|22|||
148940453|NCT00739674|537264974|FG001|Overall Study|Adverse Event|13|||
148940454|NCT00739674|537264973|FG000|Overall Study|Death|1|||
148940455|NCT00739674|537264974|FG001|Overall Study|Death|0|||
148940456|NCT00739674|537264973|FG000|Overall Study|Lack of Efficacy|1|||
148940457|NCT00739674|537264974|FG001|Overall Study|Lack of Efficacy|0|||
148940458|NCT00739674|537264973|FG000|Overall Study|Lost to Follow-up|52|||
148940459|NCT00739674|537264974|FG001|Overall Study|Lost to Follow-up|30|||
148940460|NCT00739674|537264973|FG000|Overall Study|Protocol Violation|5|||
148940461|NCT00739674|537264974|FG001|Overall Study|Protocol Violation|5|||
148940462|NCT00739674|537264973|FG000|Overall Study|Withdrawal by Subject|9|||
148940463|NCT00739674|537264974|FG001|Overall Study|Withdrawal by Subject|9|||
148940464|NCT00739674|537264973|FG000|Overall Study|Reason missing|2|||
148940465|NCT00739674|537264974|FG001|Overall Study|Reason missing|0|||
148940466|NCT00739674|537264973|FG000|Overall Study|Clinic closed|6|||
148940467|NCT00739674|537264974|FG001|Overall Study|Clinic closed|4|||
148940468|NCT00739674|537264973|FG000|Overall Study|Patient moved|3|||
148940469|NCT00739674|537264974|FG001|Overall Study|Patient moved|2|||
148940470|NCT00739674|537264973|FG000|Overall Study|Non compliant|4|||
148940471|NCT00739674|537264974|FG001|Overall Study|Non compliant|0|||
148940472|NCT00739674|537264973|FG000|Overall Study|Unable to attend visit|3|||
148940473|NCT00739674|537264974|FG001|Overall Study|Unable to attend visit|1|||
148940474|NCT00739674|537264973|FG000|Overall Study|Home monitoring off meds|1|||
148940475|NCT00739674|537264974|FG001|Overall Study|Home monitoring off meds|0|||
148940476|NCT00739674|537264973|FG000|Overall Study|Erectile dysfunction|0|||
148940477|NCT00739674|537264974|FG001|Overall Study|Erectile dysfunction|1|||
148940478|NCT01560403|537264978|FG000|Overall Study|Lost to Follow-up|0|||
148940479|NCT01560403|537264979|FG001|Overall Study|Lost to Follow-up|1|||
148940480|NCT01947582|537264985|FG000|Overall Study|Withdrawal by Subject|1|||
148940481|NCT00064337|537264986|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
148940482|NCT00064337|537264986|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
148940483|NCT00064337|537264986|FG000|PBSCC or Induction/PBSCC|Progression|3|||
148940484|NCT00064337|537264986|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
148940485|NCT00064337|537264986|FG000|PBSCC or Induction/PBSCC|Death|2|||
148940486|NCT00064337|537264986|FG000|Transplant|Adverse Event|9|||
148940487|NCT00064337|537264986|FG000|Transplant|Not protocol-specified|5|||
148940488|NCT00064337|537264986|FG000|Transplant|Death|3|||
148940489|NCT00064337|537264986|FG000|Transplant|Patient Refusal|2|||
148940490|NCT00064337|537264986|FG000|Transplant|Progression|2|||
148940491|NCT00064337|537264986|FG000|Maintenance|Adverse Event|3|||
148940492|NCT00064337|537264986|FG000|Maintenance|Progression|2|||
148940493|NCT00064337|537264986|FG000|Maintenance|On treatment at time of analysis|2|||
148940494|NCT00064337|537264986|FG000|Maintenance|Not protocol-specified|2|||
148940495|NCT00064337|537264986|FG000|Maintenance|Death|1|||
148940496|NCT01397890|537264991|FG000|Overall Study|Withdrawal by Subject|7|||
148940497|NCT01397890|537264992|FG001|Overall Study|Withdrawal by Subject|11|||
148940498|NCT01397890|537264991|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
148940499|NCT01397890|537264992|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
148940500|NCT01397890|537264991|FG000|Overall Study|Death|2|||
148940501|NCT01397890|537264992|FG001|Overall Study|Death|3|||
148940502|NCT01397890|537264991|FG000|Overall Study|Lost to Follow-up|1|||
148940503|NCT01397890|537264992|FG001|Overall Study|Lost to Follow-up|4|||
148940504|NCT01397890|537264991|FG000|Overall Study|Condition under Investigation Worsened|1|||
148940505|NCT01397890|537264992|FG001|Overall Study|Condition under Investigation Worsened|3|||
148940506|NCT01397890|537264991|FG000|Overall Study|Adverse Event|1|||
148940507|NCT01397890|537264992|FG001|Overall Study|Adverse Event|2|||
148940508|NCT01397890|537264991|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
148940509|NCT01397890|537264992|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
148940510|NCT01397890|537264991|FG000|Overall Study|Others|2|||
148940511|NCT01397890|537264992|FG001|Overall Study|Others|1|||
148940512|NCT00434954|537264993|FG000|Overall Study|Adverse Event|17|||
148940513|NCT00434954|537264994|FG001|Overall Study|Adverse Event|2|||
148940514|NCT00434954|537264993|FG000|Overall Study|Entry criteria not met|14|||
148940515|NCT00434954|537264994|FG001|Overall Study|Entry criteria not met|16|||
148940516|NCT00434954|537264993|FG000|Overall Study|Lost to Follow-up|0|||
148940517|NCT00434954|537264994|FG001|Overall Study|Lost to Follow-up|1|||
148940518|NCT00434954|537264993|FG000|Overall Study|Physician Decision|6|||
148940519|NCT00434954|537264994|FG001|Overall Study|Physician Decision|3|||
148940520|NCT00434954|537264993|FG000|Overall Study|Protocol Violation|36|||
148940521|NCT00434954|537264994|FG001|Overall Study|Protocol Violation|27|||
148940522|NCT00434954|537264993|FG000|Overall Study|Sponsor decision|1|||
148940523|NCT00434954|537264994|FG001|Overall Study|Sponsor decision|0|||
148940524|NCT00434954|537264993|FG000|Overall Study|Subject decision|8|||
148940525|NCT00434954|537264994|FG001|Overall Study|Subject decision|22|||
148940526|NCT02329080|537264995|FG000|Overall Study|Adverse Event|1|||
148940527|NCT02329080|537264995|FG000|Overall Study|Death|4|||
148940528|NCT02329080|537264995|FG000|Overall Study|Lack of Efficacy|22|||
148940529|NCT02329080|537264995|FG000|Overall Study|Lost to Follow-up|1|||
148940530|NCT02329080|537264995|FG000|Overall Study|Physician Decision|2|||
148940531|NCT02329080|537264995|FG000|Overall Study|Partial response|4|||
148940532|NCT02329080|537264995|FG000|Overall Study|Complete response|4|||
148940533|NCT01313312|537265001|FG000|Overall Study|Adverse Event|5|||
148940534|NCT01313312|537265001|FG000|Overall Study|Withdrawal by Subject|18|||
148940535|NCT01313312|537265001|FG000|Overall Study|Lack of Efficacy|3|||
148940536|NCT01313312|537265001|FG000|Overall Study|Investigator Decision|1|||
148940537|NCT01313312|537265001|FG000|Overall Study|Observational Phase|1|||
148940538|NCT01313312|537265001|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
148940539|NCT01313312|537265001|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
148940540|NCT01206166|537265009|FG000|Overall Study|No evaluable data|2|||
148940541|NCT01206166|537265010|FG001|Overall Study|No evaluable data|3|||
148940542|NCT02716805|537265011|FG000|Overall Study|Progressive disease|2|||
148940543|NCT02716805|537265012|FG001|Overall Study|Progressive disease|0|||
148940544|NCT02716805|537265013|FG002|Overall Study|Progressive disease|0|||
148940545|NCT02716805|537265014|FG003|Overall Study|Progressive disease|0|||
148940546|NCT00932126|537265015|FG000|Overall Study|Adverse Event|0|||
148940547|NCT00932126|537265016|FG001|Overall Study|Adverse Event|0|||
148940548|NCT00932126|537265017|FG002|Overall Study|Adverse Event|0|||
148940549|NCT00932126|537265018|FG003|Overall Study|Adverse Event|0|||
148940550|NCT00932126|537265019|FG004|Overall Study|Adverse Event|0|||
148940551|NCT00932126|537265020|FG005|Overall Study|Adverse Event|0|||
148940552|NCT00932126|537265021|FG006|Overall Study|Adverse Event|1|||
148940553|NCT00932126|537265022|FG007|Overall Study|Adverse Event|2|||
148940554|NCT00932126|537265015|FG000|Overall Study|Protocol Violation|0|||
148940555|NCT00932126|537265016|FG001|Overall Study|Protocol Violation|0|||
148940556|NCT00932126|537265017|FG002|Overall Study|Protocol Violation|0|||
148940557|NCT00932126|537265018|FG003|Overall Study|Protocol Violation|0|||
148940558|NCT00932126|537265019|FG004|Overall Study|Protocol Violation|1|||
148940559|NCT00932126|537265020|FG005|Overall Study|Protocol Violation|0|||
148940560|NCT00932126|537265021|FG006|Overall Study|Protocol Violation|0|||
149015566|NCT01702428|537536118|FG000|Overall Study|Lost Coverage|0|||
149015567|NCT01702428|537536119|FG001|Overall Study|Lost Coverage|0|||
149015568|NCT01702428|537536120|FG002|Overall Study|Lost Coverage|0|||
149015569|NCT01702428|537536121|FG003|Overall Study|Lost Coverage|1|||
149015570|NCT01702428|537536118|FG000|Overall Study|Lost Health Plan|3|||
149015571|NCT01702428|537536119|FG001|Overall Study|Lost Health Plan|5|||
149015572|NCT01702428|537536120|FG002|Overall Study|Lost Health Plan|0|||
149015573|NCT01702428|537536121|FG003|Overall Study|Lost Health Plan|2|||
149015574|NCT01702428|537536118|FG000|Overall Study|Mother transferred care|0|||
149015575|NCT01702428|537536119|FG001|Overall Study|Mother transferred care|1|||
149015576|NCT01702428|537536120|FG002|Overall Study|Mother transferred care|0|||
149015577|NCT01702428|537536121|FG003|Overall Study|Mother transferred care|0|||
149015578|NCT01702428|537536118|FG000|Overall Study|Parents too busy|1|||
149015579|NCT01702428|537536119|FG001|Overall Study|Parents too busy|0|||
149015580|NCT01702428|537536120|FG002|Overall Study|Parents too busy|0|||
149015581|NCT01702428|537536121|FG003|Overall Study|Parents too busy|0|||
149015582|NCT01702428|537536118|FG000|Overall Study|Protocol Violation|3|||
149015583|NCT01702428|537536119|FG001|Overall Study|Protocol Violation|0|||
149015584|NCT01702428|537536120|FG002|Overall Study|Protocol Violation|1|||
149015585|NCT01702428|537536121|FG003|Overall Study|Protocol Violation|0|||
148808156|NCT04428151|536775131|FG002|Overall Study|Death|57|||
148808157|NCT04428151|536775129|FG000|Overall Study|Lost to Follow-up|1|||
148808158|NCT04428151|536775130|FG001|Overall Study|Lost to Follow-up|1|||
149015586|NCT01702428|537536118|FG000|Overall Study|Withdrawal by Subject|21|||
149015587|NCT01702428|537536119|FG001|Overall Study|Withdrawal by Subject|23|||
149015588|NCT01702428|537536120|FG002|Overall Study|Withdrawal by Subject|14|||
149015589|NCT01702428|537536121|FG003|Overall Study|Withdrawal by Subject|10|||
149015590|NCT02091869|537536122|FG000|Overall Study|Withdrawal by Subject|0|||
149015591|NCT02091869|537536123|FG001|Overall Study|Withdrawal by Subject|3|||
149015592|NCT01533714|537536124|FG000|Overall Study|Adverse Event|0|||
149015593|NCT01533714|537536125|FG001|Overall Study|Adverse Event|1|||
149015594|NCT01533714|537536126|FG002|Overall Study|Adverse Event|2|||
149015595|NCT01533714|537536127|FG003|Overall Study|Adverse Event|2|||
149015596|NCT01533714|537536128|FG004|Overall Study|Adverse Event|2|||
148940561|NCT00932126|537265022|FG007|Overall Study|Protocol Violation|0|||
148940562|NCT00932126|537265015|FG000|Overall Study|Withdrawal by Subject|0|||
148940563|NCT00932126|537265016|FG001|Overall Study|Withdrawal by Subject|0|||
148940564|NCT00932126|537265017|FG002|Overall Study|Withdrawal by Subject|1|||
148940565|NCT00932126|537265018|FG003|Overall Study|Withdrawal by Subject|0|||
148940566|NCT00932126|537265019|FG004|Overall Study|Withdrawal by Subject|0|||
148940567|NCT00932126|537265020|FG005|Overall Study|Withdrawal by Subject|0|||
148940568|NCT00932126|537265021|FG006|Overall Study|Withdrawal by Subject|0|||
148940569|NCT00932126|537265022|FG007|Overall Study|Withdrawal by Subject|1|||
148940570|NCT00932126|537265015|FG000|Overall Study|Objective progression or relapse|3|||
148940571|NCT00932126|537265016|FG001|Overall Study|Objective progression or relapse|3|||
148940572|NCT00932126|537265017|FG002|Overall Study|Objective progression or relapse|2|||
148940573|NCT00932126|537265018|FG003|Overall Study|Objective progression or relapse|3|||
148940574|NCT00932126|537265019|FG004|Overall Study|Objective progression or relapse|3|||
148940575|NCT00932126|537265020|FG005|Overall Study|Objective progression or relapse|3|||
148940576|NCT00932126|537265021|FG006|Overall Study|Objective progression or relapse|3|||
148940577|NCT00932126|537265022|FG007|Overall Study|Objective progression or relapse|5|||
148940578|NCT00932126|537265015|FG000|Overall Study|Other|0|||
148940579|NCT00932126|537265016|FG001|Overall Study|Other|0|||
148940580|NCT00932126|537265017|FG002|Overall Study|Other|0|||
148940581|NCT00932126|537265018|FG003|Overall Study|Other|0|||
148940582|NCT00932126|537265019|FG004|Overall Study|Other|1|||
148940583|NCT00932126|537265020|FG005|Overall Study|Other|0|||
148940584|NCT00932126|537265021|FG006|Overall Study|Other|1|||
148940585|NCT00932126|537265022|FG007|Overall Study|Other|2|||
148940586|NCT00066365|537265023|FG000|Overall Study|Adverse Event|1|||
148940587|NCT00066365|537265024|FG001|Overall Study|Adverse Event|0|||
148940588|NCT00066365|537265023|FG000|Overall Study|Lack of Efficacy|15|||
148940589|NCT00066365|537265024|FG001|Overall Study|Lack of Efficacy|12|||
149015597|NCT01533714|537536129|FG005|Overall Study|Adverse Event|1|||
149015598|NCT01533714|537536124|FG000|Overall Study|Lack of Efficacy|0|||
148940590|NCT00066365|537265023|FG000|Overall Study|Physician Decision|1|||
149015599|NCT01533714|537536125|FG001|Overall Study|Lack of Efficacy|0|||
148682609|NCT05266456|536310965|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
148940591|NCT00066365|537265024|FG001|Overall Study|Physician Decision|0|||
148940592|NCT00066365|537265023|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
148940593|NCT00066365|537265024|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
148940594|NCT00066365|537265023|FG000|Overall Study|Ineligible|4|||
148940595|NCT00066365|537265024|FG001|Overall Study|Ineligible|2|||
149015600|NCT01533714|537536126|FG002|Overall Study|Lack of Efficacy|0|||
149015601|NCT01533714|537536127|FG003|Overall Study|Lack of Efficacy|0|||
149015602|NCT01533714|537536128|FG004|Overall Study|Lack of Efficacy|0|||
149015603|NCT01533714|537536129|FG005|Overall Study|Lack of Efficacy|1|||
148808159|NCT04428151|536775131|FG002|Overall Study|Lost to Follow-up|0|||
148940596|NCT00467857|537265027|FG000|Overall Study|Adverse Event|1|||
148940597|NCT00467857|537265028|FG001|Overall Study|Adverse Event|0|||
148940598|NCT00467857|537265027|FG000|Overall Study|Withdrew consent|2|||
148940599|NCT00467857|537265028|FG001|Overall Study|Withdrew consent|0|||
148940600|NCT00467857|537265027|FG000|Overall Study|Death|0|||
148940601|NCT00467857|537265028|FG001|Overall Study|Death|1|||
148940602|NCT00467857|537265027|FG000|Overall Study|Discharged from court service|0|||
148940603|NCT00467857|537265028|FG001|Overall Study|Discharged from court service|1|||
148940604|NCT00467857|537265027|FG000|Overall Study|Emergency care required|0|||
148940605|NCT00467857|537265028|FG001|Overall Study|Emergency care required|1|||
148940606|NCT00467857|537265027|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
148940607|NCT00467857|537265028|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
148940608|NCT00467857|537265027|FG000|Overall Study|Discontinuation reason missing|0|||
148940609|NCT00467857|537265028|FG001|Overall Study|Discontinuation reason missing|3|||
148940610|NCT03576495|537265032|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
148940611|NCT03576495|537265033|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
148940612|NCT00516074|537265037|FG000|Overall Study|Adverse Event|0|||
148940613|NCT00516074|537265038|FG001|Overall Study|Adverse Event|1|||
148940614|NCT00516074|537265037|FG000|Overall Study|Subject Decision|4|||
148940615|NCT00516074|537265038|FG001|Overall Study|Subject Decision|2|||
148940616|NCT00516074|537265037|FG000|Overall Study|Loss of Glucose Control|2|||
148940617|NCT00516074|537265038|FG001|Overall Study|Loss of Glucose Control|0|||
148940618|NCT00810355|537265045|FG000|Overall Study|Lost to Follow-up|13|||
148940619|NCT00810355|537265046|FG001|Overall Study|Lost to Follow-up|17|||
148940620|NCT00810355|537265047|FG002|Overall Study|Lost to Follow-up|11|||
148940621|NCT00810355|537265045|FG000|Overall Study|Withdrawal by Subject|1|||
148940622|NCT00810355|537265046|FG001|Overall Study|Withdrawal by Subject|0|||
148940623|NCT00810355|537265047|FG002|Overall Study|Withdrawal by Subject|0|||
148940624|NCT01612858|537265048|FG000|Overall Study|Withdrawal by Subject|5|||
148940625|NCT01612858|537265049|FG001|Overall Study|Withdrawal by Subject|1|||
148940626|NCT01484275|537265050|FG000|Overall Study|Study terminated by sponsor|28|||
148940627|NCT01484275|537265051|FG001|Overall Study|Study terminated by sponsor|32|||
148940628|NCT01484275|537265050|FG000|Overall Study|Other|10|||
148940629|NCT01484275|537265051|FG001|Overall Study|Other|0|||
148940630|NCT01484275|537265050|FG000|Overall Study|Death|3|||
148940631|NCT01484275|537265051|FG001|Overall Study|Death|4|||
148940632|NCT01484275|537265050|FG000|Overall Study|Withdrawal by Subject|1|||
148940633|NCT01484275|537265051|FG001|Overall Study|Withdrawal by Subject|5|||
148940634|NCT01484275|537265050|FG000|Overall Study|Lost to Follow-up|1|||
148940635|NCT01484275|537265051|FG001|Overall Study|Lost to Follow-up|1|||
148940636|NCT00003487|537265052|FG000|Overall Study|Not evaluable|2|||
148940637|NCT04154930|537265057|FG000|Overall Study|Withdrawal by Subject|15|||
148940638|NCT04154930|537265058|FG001|Overall Study|Withdrawal by Subject|6|||
148940639|NCT04154930|537265057|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
148940640|NCT04154930|537265058|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
148940641|NCT04154930|537265057|FG000|Overall Study|Lost to Follow-up|14|||
148940642|NCT04154930|537265058|FG001|Overall Study|Lost to Follow-up|6|||
148940643|NCT04154930|537265057|FG000|Overall Study|Other|6|||
148940644|NCT04154930|537265058|FG001|Overall Study|Other|0|||
148940645|NCT00657358|537265059|FG000|Overall Study|Lack of Efficacy|6|||
148940646|NCT02628938|537265063|FG000|Overall Study|Did not attend the follow up recall|2|||
148940647|NCT02628938|537265064|FG001|Overall Study|Did not attend the follow up recall|2|||
148940648|NCT02628938|537265065|FG002|Overall Study|Did not attend the follow up recall|1|||
148940649|NCT02628938|537265063|FG000|Overall Study|Failure to comply with the instructions|3|||
148940650|NCT02628938|537265064|FG001|Overall Study|Failure to comply with the instructions|0|||
148940651|NCT02628938|537265065|FG002|Overall Study|Failure to comply with the instructions|3|||
148940652|NCT02058693|537265066|FG000|Phase 1|Withdrawal by Subject|3|||
148940653|NCT02058693|537265067|FG001|Phase 1|Withdrawal by Subject|2|||
148940654|NCT02058693|537265066|FG000|Phase 1|Adverse Event|0|||
148940655|NCT02058693|537265067|FG001|Phase 1|Adverse Event|1|||
148940656|NCT02058693|537265066|FG000|Phase 1|Lack of Efficacy|1|||
148940657|NCT02058693|537265067|FG001|Phase 1|Lack of Efficacy|0|||
148940658|NCT02058693|537265066|FG000|Phase 1|Physician Decision|1|||
148940659|NCT02058693|537265067|FG001|Phase 1|Physician Decision|1|||
148940660|NCT02058693|537265066|FG000|Phase 2|Withdrawal by Subject|0|||
148940661|NCT02058693|537265067|FG001|Phase 2|Withdrawal by Subject|2|||
148940662|NCT00241358|537265068|FG000|Overall Study|Determined to be not ineligible|0|||
148940663|NCT00241358|537265069|FG001|Overall Study|Determined to be not ineligible|1|||
148940664|NCT00241358|537265070|FG002|Overall Study|Determined to be not ineligible|1|||
148940665|NCT03855228|537265071|FG000|Overall Study|Adverse Event|2|||
148940666|NCT03855228|537265072|FG001|Overall Study|Adverse Event|4|||
148940667|NCT03855228|537265073|FG002|Overall Study|Adverse Event|4|||
148940668|NCT03855228|537265074|FG003|Overall Study|Adverse Event|8|||
148940669|NCT03855228|537265071|FG000|Overall Study|Treatment Failure|1|||
148940670|NCT03855228|537265072|FG001|Overall Study|Treatment Failure|2|||
148940671|NCT03855228|537265073|FG002|Overall Study|Treatment Failure|1|||
148940672|NCT03855228|537265074|FG003|Overall Study|Treatment Failure|8|||
148940673|NCT03855228|537265071|FG000|Overall Study|Lost to Follow-up|0|||
148940674|NCT03855228|537265072|FG001|Overall Study|Lost to Follow-up|0|||
148940675|NCT03855228|537265073|FG002|Overall Study|Lost to Follow-up|0|||
148940676|NCT03855228|537265074|FG003|Overall Study|Lost to Follow-up|1|||
148940677|NCT03855228|537265071|FG000|Overall Study|Protocol Violation|0|||
148940678|NCT03855228|537265072|FG001|Overall Study|Protocol Violation|1|||
148940679|NCT03855228|537265073|FG002|Overall Study|Protocol Violation|2|||
148940680|NCT03855228|537265074|FG003|Overall Study|Protocol Violation|1|||
148940681|NCT03855228|537265071|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
148940682|NCT03855228|537265072|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
148940683|NCT03855228|537265073|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
148940684|NCT03855228|537265074|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
148940685|NCT00843856|537265075|FG000|Overall Study|Lost to Follow-up|1|||
148940686|NCT00843856|537265076|FG001|Overall Study|Lost to Follow-up|2|||
148940687|NCT00590135|537265077|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
148940688|NCT01972568|537265090|FG000|Overall Study|Other events|3|||
148940689|NCT01972568|537265091|FG001|Overall Study|Other events|0|||
148940690|NCT01972568|537265092|FG002|Overall Study|Other events|0|||
148940691|NCT01972568|537265090|FG000|Overall Study|Lack of Efficacy|0|||
148940692|NCT01972568|537265091|FG001|Overall Study|Lack of Efficacy|1|||
148940693|NCT01972568|537265092|FG002|Overall Study|Lack of Efficacy|2|||
148940694|NCT01972568|537265090|FG000|Overall Study|Protocol Violation|1|||
148940695|NCT01972568|537265091|FG001|Overall Study|Protocol Violation|2|||
148940696|NCT01972568|537265092|FG002|Overall Study|Protocol Violation|2|||
148940697|NCT01972568|537265090|FG000|Overall Study|Withdrawal by Subject|6|||
148940698|NCT01972568|537265091|FG001|Overall Study|Withdrawal by Subject|3|||
148940699|NCT01972568|537265092|FG002|Overall Study|Withdrawal by Subject|7|||
148940700|NCT01972568|537265090|FG000|Overall Study|Lost to Follow-up|1|||
148940701|NCT01972568|537265091|FG001|Overall Study|Lost to Follow-up|0|||
148940702|NCT01972568|537265092|FG002|Overall Study|Lost to Follow-up|0|||
148940703|NCT01972568|537265090|FG000|Overall Study|Adverse Event|5|||
148940704|NCT01972568|537265091|FG001|Overall Study|Adverse Event|6|||
148940705|NCT01972568|537265092|FG002|Overall Study|Adverse Event|5|||
148940706|NCT02059408|537265093|FG000|Overall Study|Did not get tested|0|||
149015604|NCT01533714|537536124|FG000|Overall Study|Withdrawal by Subject|0|||
149015605|NCT01533714|537536125|FG001|Overall Study|Withdrawal by Subject|1|||
149015606|NCT01533714|537536126|FG002|Overall Study|Withdrawal by Subject|0|||
149015607|NCT01533714|537536127|FG003|Overall Study|Withdrawal by Subject|1|||
149015608|NCT01533714|537536128|FG004|Overall Study|Withdrawal by Subject|1|||
149015609|NCT01533714|537536129|FG005|Overall Study|Withdrawal by Subject|0|||
149015610|NCT01533714|537536124|FG000|Overall Study|Exclusion criteria|0|||
149015611|NCT01533714|537536125|FG001|Overall Study|Exclusion criteria|1|||
149015612|NCT01533714|537536126|FG002|Overall Study|Exclusion criteria|0|||
149015613|NCT01533714|537536127|FG003|Overall Study|Exclusion criteria|0|||
149015614|NCT01533714|537536128|FG004|Overall Study|Exclusion criteria|0|||
149015615|NCT01533714|537536129|FG005|Overall Study|Exclusion criteria|0|||
149015616|NCT01533714|537536124|FG000|Overall Study|Positive for purified protein derivative|0|||
149015617|NCT01533714|537536125|FG001|Overall Study|Positive for purified protein derivative|0|||
149015618|NCT01533714|537536126|FG002|Overall Study|Positive for purified protein derivative|1|||
149015619|NCT01533714|537536127|FG003|Overall Study|Positive for purified protein derivative|0|||
149015620|NCT01533714|537536128|FG004|Overall Study|Positive for purified protein derivative|1|||
148682610|NCT05266456|536310962|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
149015621|NCT01533714|537536129|FG005|Overall Study|Positive for purified protein derivative|0|||
149015622|NCT01533714|537536124|FG000|Overall Study|Withdrawal criteria|0|||
148682611|NCT05266456|536310963|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
148940707|NCT02059408|537265094|FG001|Overall Study|Did not get tested|330|||
148940708|NCT02059408|537265095|FG002|Overall Study|Did not get tested|358|||
148940709|NCT00957580|537265096|FG000|Overall Study|Ongoing at data cut-off|0|||
148940710|NCT00957580|537265097|FG001|Overall Study|Ongoing at data cut-off|1|||
148940711|NCT00957580|537265098|FG002|Overall Study|Ongoing at data cut-off|0|||
148940712|NCT00957580|537265096|FG000|Overall Study|Enrolled but not treated|0|||
148940713|NCT00957580|537265097|FG001|Overall Study|Enrolled but not treated|1|||
148940714|NCT00957580|537265098|FG002|Overall Study|Enrolled but not treated|0|||
148808160|NCT04428151|536775129|FG000|Overall Study|Withdrawal by Subject|2|||
148940715|NCT02699593|537265105|FG000|Period 1|Unsatisfactory Visual Response|0|||
149015623|NCT01533714|537536125|FG001|Overall Study|Withdrawal criteria|0|||
148940716|NCT02699593|537265106|FG001|Period 1|Unsatisfactory Visual Response|1|||
149015624|NCT01533714|537536126|FG002|Overall Study|Withdrawal criteria|1|||
149015625|NCT01533714|537536127|FG003|Overall Study|Withdrawal criteria|0|||
149015626|NCT01533714|537536128|FG004|Overall Study|Withdrawal criteria|3|||
149015627|NCT01533714|537536129|FG005|Overall Study|Withdrawal criteria|1|||
149015628|NCT01533714|537536124|FG000|Overall Study|Ineligibility reason|0|||
149015629|NCT01533714|537536125|FG001|Overall Study|Ineligibility reason|0|||
149015630|NCT01533714|537536126|FG002|Overall Study|Ineligibility reason|0|||
149015631|NCT01533714|537536127|FG003|Overall Study|Ineligibility reason|1|||
149015632|NCT01533714|537536128|FG004|Overall Study|Ineligibility reason|0|||
149015633|NCT01533714|537536129|FG005|Overall Study|Ineligibility reason|0|||
149015634|NCT02111213|537536133|FG000|Overall Study|Withdrawal by Subject|3|||
149015635|NCT02111213|537536134|FG001|Overall Study|Withdrawal by Subject|2|||
149015636|NCT02111213|537536133|FG000|Overall Study|Lost to Follow-up|3|||
149015637|NCT02111213|537536134|FG001|Overall Study|Lost to Follow-up|4|||
149015638|NCT02153359|537536135|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
149015639|NCT02153359|537536136|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
149015640|NCT00779584|537536137|FG000|Overall Study|Protocol Violation|0|||
148940717|NCT02699593|537265105|FG000|Period 1|Torn Contact Len|4|||
148940718|NCT02699593|537265106|FG001|Period 1|Torn Contact Len|3|||
148940719|NCT02699593|537265105|FG000|Period 1|Protocol Violation|0|||
148940720|NCT02699593|537265106|FG001|Period 1|Protocol Violation|1|||
148940721|NCT02699593|537265105|FG000|Period 1|Withdrawal by Subject|0|||
148940722|NCT02699593|537265106|FG001|Period 1|Withdrawal by Subject|1|||
148940723|NCT02699593|537265105|FG000|Period 1|Adverse Event|1|||
148940724|NCT02699593|537265106|FG001|Period 1|Adverse Event|1|||
148940725|NCT02699593|537265105|FG000|Period 2|Adverse Event|1|||
148940726|NCT02699593|537265106|FG001|Period 2|Adverse Event|1|||
148940727|NCT02699593|537265105|FG000|Period 2|Lost Contact Lens|0|||
148940728|NCT02699593|537265106|FG001|Period 2|Lost Contact Lens|1|||
148940729|NCT02699593|537265105|FG000|Period 2|Torn Contact Lens|1|||
148940730|NCT02699593|537265106|FG001|Period 2|Torn Contact Lens|0|||
148940731|NCT01696071|537265119|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
149015641|NCT00779584|537536138|FG001|Overall Study|Protocol Violation|0|||
149015642|NCT00779584|537536139|FG002|Overall Study|Protocol Violation|0|||
149015643|NCT00779584|537536140|FG003|Overall Study|Protocol Violation|0|||
149015644|NCT00779584|537536141|FG004|Overall Study|Protocol Violation|0|||
149015645|NCT00779584|537536142|FG005|Overall Study|Protocol Violation|1|||
149015646|NCT00779584|537536143|FG006|Overall Study|Protocol Violation|0|||
149015647|NCT00779584|537536144|FG007|Overall Study|Protocol Violation|0|||
149015648|NCT00779584|537536145|FG008|Overall Study|Protocol Violation|0|||
149015649|NCT00779584|537536137|FG000|Overall Study|Withdrawal by Subject|1|||
149015650|NCT00779584|537536138|FG001|Overall Study|Withdrawal by Subject|1|||
149015651|NCT00779584|537536139|FG002|Overall Study|Withdrawal by Subject|2|||
149015652|NCT00779584|537536140|FG003|Overall Study|Withdrawal by Subject|0|||
149015653|NCT00779584|537536141|FG004|Overall Study|Withdrawal by Subject|0|||
149015654|NCT00779584|537536142|FG005|Overall Study|Withdrawal by Subject|2|||
149015655|NCT00779584|537536143|FG006|Overall Study|Withdrawal by Subject|1|||
148940732|NCT01696071|537265120|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
149015656|NCT00779584|537536144|FG007|Overall Study|Withdrawal by Subject|0|||
149015657|NCT00779584|537536145|FG008|Overall Study|Withdrawal by Subject|0|||
149015658|NCT00779584|537536137|FG000|Overall Study|Lost to Follow-up|0|||
149015659|NCT00779584|537536138|FG001|Overall Study|Lost to Follow-up|0|||
149015660|NCT00779584|537536139|FG002|Overall Study|Lost to Follow-up|0|||
149015661|NCT00779584|537536140|FG003|Overall Study|Lost to Follow-up|0|||
149015662|NCT00779584|537536141|FG004|Overall Study|Lost to Follow-up|1|||
148940733|NCT04203797|537265121|FG000|Overall Study|Adverse Event|1|||
148940734|NCT04203797|537265122|FG001|Overall Study|Adverse Event|0|||
148940735|NCT04203797|537265121|FG000|Overall Study|Did not complete End of Study follow-up|1|||
148940736|NCT04203797|537265122|FG001|Overall Study|Did not complete End of Study follow-up|0|||
149015663|NCT00779584|537536142|FG005|Overall Study|Lost to Follow-up|0|||
149015664|NCT00779584|537536143|FG006|Overall Study|Lost to Follow-up|0|||
149015665|NCT00779584|537536144|FG007|Overall Study|Lost to Follow-up|0|||
149015666|NCT00779584|537536145|FG008|Overall Study|Lost to Follow-up|0|||
148940737|NCT01999179|537265123|FG000|Overall Study|Adverse Event|1|||
149015667|NCT00779584|537536137|FG000|Overall Study|Progression of Disease|0|||
148808161|NCT04428151|536775130|FG001|Overall Study|Withdrawal by Subject|2|||
148808162|NCT04428151|536775131|FG002|Overall Study|Withdrawal by Subject|3|||
148808163|NCT04428151|536775129|FG000|Overall Study|Participant Ongoing in Study|41|||
148808164|NCT04428151|536775130|FG001|Overall Study|Participant Ongoing in Study|53|||
148808165|NCT04428151|536775131|FG002|Overall Study|Participant Ongoing in Study|28|||
148808166|NCT02783690|536775769|FG000|Overall Study|Withdrawal by Subject|3|||
148808167|NCT02783690|536775770|FG001|Overall Study|Withdrawal by Subject|3|||
148940738|NCT01999179|537265123|FG000|Overall Study|Lost to Follow-up|1|||
148940739|NCT01999179|537265123|FG000|Overall Study|Change in Therapy|3|||
148940740|NCT01999179|537265123|FG000|Overall Study|New catheter|2|||
148940741|NCT01995825|537267227|FG000|Overall Study|Withdrawal by Subject|1|||
148940742|NCT01995825|537267228|FG001|Overall Study|Withdrawal by Subject|0|||
148940743|NCT01798004|537267229|FG000|Overall Study|Death|2|||
148940744|NCT01798004|537267229|FG000|Overall Study|Lack of Efficacy|8|||
148940745|NCT01798004|537267229|FG000|Overall Study|Physician Decision|25|||
148940746|NCT01798004|537267229|FG000|Overall Study|Withdrawal by Subject|4|||
148940747|NCT01798004|537267229|FG000|Overall Study|Ineligible|4|||
148940748|NCT01798004|537267229|FG000|Overall Study|Patient/parent refusal|7|||
148940749|NCT01798004|537267229|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
148940750|NCT01798004|537267229|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
148940751|NCT04680052|537267230|FG000|Overall Study|Ongoing|244|||
148940752|NCT04680052|537267231|FG001|Overall Study|Ongoing|229|||
148940753|NCT04680052|537267232|FG002|Overall Study|Ongoing|39|||
148940754|NCT04680052|537267233|FG003|Overall Study|Ongoing|46|||
148940755|NCT04680052|537267230|FG000|Overall Study|Death|15|||
148940756|NCT04680052|537267231|FG001|Overall Study|Death|22|||
148808168|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
148808169|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
148808170|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
148808171|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
148808172|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Death|38|||
148808173|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Death|10|||
148808174|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
148808175|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
148808176|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
148808177|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
148808178|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
148808179|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
148808180|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
148808181|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
148808182|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
148808183|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
148808184|NCT02421939|536775771|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
148808185|NCT02421939|536775772|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
148808186|NCT02421939|536775771|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
148940757|NCT04680052|537267232|FG002|Overall Study|Death|7|||
148940758|NCT04680052|537267233|FG003|Overall Study|Death|1|||
148940759|NCT04680052|537267230|FG000|Overall Study|Lost to Follow-up|3|||
148940760|NCT04680052|537267231|FG001|Overall Study|Lost to Follow-up|2|||
148940761|NCT04680052|537267232|FG002|Overall Study|Lost to Follow-up|0|||
148940762|NCT04680052|537267233|FG003|Overall Study|Lost to Follow-up|1|||
148940763|NCT04680052|537267230|FG000|Overall Study|Withdrawal by Subject|11|||
148940764|NCT04680052|537267231|FG001|Overall Study|Withdrawal by Subject|19|||
148940765|NCT04680052|537267232|FG002|Overall Study|Withdrawal by Subject|7|||
148940766|NCT04680052|537267233|FG003|Overall Study|Withdrawal by Subject|5|||
148940767|NCT04680052|537267230|FG000|Overall Study|Missing|0|||
148940768|NCT04680052|537267231|FG001|Overall Study|Missing|1|||
148940769|NCT04680052|537267232|FG002|Overall Study|Missing|0|||
148940770|NCT04680052|537267233|FG003|Overall Study|Missing|0|||
148940771|NCT04680052|537267230|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
148940772|NCT04680052|537267231|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
148940773|NCT04680052|537267232|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
148940774|NCT04680052|537267233|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
148940775|NCT04680052|537267230|FG000|Overall Study|Physician Decision|0|||
148940776|NCT04680052|537267231|FG001|Overall Study|Physician Decision|1|||
148940777|NCT04680052|537267232|FG002|Overall Study|Physician Decision|0|||
148940778|NCT04680052|537267233|FG003|Overall Study|Physician Decision|0|||
148940779|NCT01367002|537267234|FG000|Overall Study|Withdrawal by Subject|1|||
148940780|NCT01367002|537267235|FG001|Overall Study|Withdrawal by Subject|0|||
148808187|NCT02421939|536775772|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
148940781|NCT01367002|537267234|FG000|Overall Study|Physician Decision|0|||
148940782|NCT01367002|537267235|FG001|Overall Study|Physician Decision|2|||
148940783|NCT06956170|537267236|FG000|Overall Study|Death|2|||
148940784|NCT06956170|537267237|FG001|Overall Study|Death|1|||
148940785|NCT06956170|537267236|FG000|Overall Study|Withdrawal by Subject|1|||
149015668|NCT00779584|537536138|FG001|Overall Study|Progression of Disease|1|||
149015669|NCT00779584|537536139|FG002|Overall Study|Progression of Disease|2|||
149015670|NCT00779584|537536140|FG003|Overall Study|Progression of Disease|6|||
149015671|NCT00779584|537536141|FG004|Overall Study|Progression of Disease|5|||
149015672|NCT00779584|537536142|FG005|Overall Study|Progression of Disease|1|||
148940786|NCT06956170|537267237|FG001|Overall Study|Withdrawal by Subject|0|||
148940787|NCT06956170|537267236|FG000|Overall Study|Ongoing|7|||
148940788|NCT06956170|537267237|FG001|Overall Study|Ongoing|10|||
148940789|NCT01516437|537267238|FG000|Overall Study|Reason not specified|0|||
148940790|NCT01516437|537267239|FG001|Overall Study|Reason not specified|0|||
148940791|NCT01516437|537267240|FG002|Overall Study|Reason not specified|1|||
148940792|NCT01516437|537267241|FG003|Overall Study|Reason not specified|1|||
148940793|NCT01385566|537267245|FG000|Overall Study|Lost to Follow-up|1|||
148940794|NCT01385566|537267246|FG001|Overall Study|Lost to Follow-up|0|||
148940795|NCT01385566|537267247|FG002|Overall Study|Lost to Follow-up|0|||
148940796|NCT01385566|537267248|FG003|Overall Study|Lost to Follow-up|0|||
148940797|NCT01385566|537267249|FG004|Overall Study|Lost to Follow-up|0|||
148940798|NCT01385566|537267250|FG005|Overall Study|Lost to Follow-up|0|||
148940799|NCT01385566|537267245|FG000|Overall Study|Withdrawal by Subject|0|||
148940800|NCT01385566|537267246|FG001|Overall Study|Withdrawal by Subject|0|||
148940801|NCT01385566|537267247|FG002|Overall Study|Withdrawal by Subject|0|||
148940802|NCT01385566|537267248|FG003|Overall Study|Withdrawal by Subject|1|||
148940803|NCT01385566|537267249|FG004|Overall Study|Withdrawal by Subject|0|||
148940804|NCT01385566|537267250|FG005|Overall Study|Withdrawal by Subject|0|||
148940805|NCT00825682|537267251|FG000|Overall Study|personal reasons/ inconvenience|13|||
148940806|NCT00825682|537267252|FG001|Overall Study|personal reasons/ inconvenience|5|||
148940807|NCT00560105|537267259|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
148940808|NCT00560105|537267260|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
148940809|NCT02400333|537267261|FG000|Overall Study|Withdrawal by Subject|0|||
148940810|NCT02400333|537267262|FG001|Overall Study|Withdrawal by Subject|1|||
148940811|NCT02400333|537267263|FG002|Overall Study|Withdrawal by Subject|0|||
148940812|NCT02400333|537267264|FG003|Overall Study|Withdrawal by Subject|1|||
148940813|NCT02400333|537267261|FG000|Overall Study|Protocol Violation|1|||
148940814|NCT02400333|537267262|FG001|Overall Study|Protocol Violation|0|||
148940815|NCT02400333|537267263|FG002|Overall Study|Protocol Violation|2|||
148940816|NCT02400333|537267264|FG003|Overall Study|Protocol Violation|1|||
148940817|NCT01687998|537267271|FG000|Overall Study|Withdrawal by Subject|49|||
148940818|NCT01687998|537267272|FG001|Overall Study|Withdrawal by Subject|51|||
148940819|NCT01687998|537267271|FG000|Overall Study|Known to be Alive at Study End|54|||
148940820|NCT01687998|537267272|FG001|Overall Study|Known to be Alive at Study End|62|||
148940821|NCT01687998|537267271|FG000|Overall Study|Lost to Follow-up|9|||
148940822|NCT01687998|537267272|FG001|Overall Study|Lost to Follow-up|7|||
148940823|NCT01663532|537267273|FG000|Overall Study|Lost to Follow-up|9|||
148940824|NCT01663532|537267274|FG001|Overall Study|Lost to Follow-up|10|||
148940825|NCT01663532|537267273|FG000|Overall Study|Adverse Event|7|||
148940826|NCT01663532|537267274|FG001|Overall Study|Adverse Event|13|||
148940827|NCT01663532|537267273|FG000|Overall Study|Met Withdrawal Criteria|7|||
148940828|NCT01663532|537267274|FG001|Overall Study|Met Withdrawal Criteria|6|||
148940829|NCT01663532|537267273|FG000|Overall Study|Physician Decision|1|||
148940830|NCT01663532|537267274|FG001|Overall Study|Physician Decision|1|||
148940831|NCT01663532|537267273|FG000|Overall Study|Withdrawal by Subject|35|||
148940832|NCT01663532|537267274|FG001|Overall Study|Withdrawal by Subject|17|||
148940833|NCT01663532|537267273|FG000|Overall Study|Lack of Efficacy|15|||
148940834|NCT01663532|537267274|FG001|Overall Study|Lack of Efficacy|60|||
148940835|NCT03539081|537267280|FG000|Overall Study|Withdrawal by Subject|2|||
148940836|NCT03539081|537267281|FG001|Overall Study|Withdrawal by Subject|3|||
148940837|NCT03539081|537267282|FG002|Overall Study|Withdrawal by Subject|0|||
148940838|NCT03539081|537267280|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
148940839|NCT03539081|537267281|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
148940840|NCT03539081|537267282|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
149015673|NCT00779584|537536143|FG006|Overall Study|Progression of Disease|4|||
149015674|NCT00779584|537536144|FG007|Overall Study|Progression of Disease|2|||
148940841|NCT04805541|537267283|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
149015675|NCT00779584|537536145|FG008|Overall Study|Progression of Disease|1|||
148940842|NCT00283400|537267287|FG000|Overall Study|Withdrawal by Subject|1|||
148940843|NCT00283400|537267288|FG001|Overall Study|Withdrawal by Subject|1|||
148940844|NCT00283400|537267289|FG002|Overall Study|Withdrawal by Subject|0|||
149015676|NCT00779584|537536137|FG000|Overall Study|Adverse Event|1|||
149015677|NCT00779584|537536138|FG001|Overall Study|Adverse Event|0|||
148940845|NCT00283400|537267290|FG003|Overall Study|Withdrawal by Subject|0|||
148940846|NCT00283400|537267287|FG000|Overall Study|Death|1|||
148940847|NCT00283400|537267288|FG001|Overall Study|Death|0|||
148940848|NCT00283400|537267289|FG002|Overall Study|Death|1|||
148940849|NCT00283400|537267290|FG003|Overall Study|Death|0|||
148940850|NCT02195583|537267293|FG000|Overall Study|Lost to Follow-up|1|||
148940851|NCT02195583|537267293|FG000|Overall Study|Withdrawal by Subject|4|||
148940852|NCT02195583|537267293|FG000|Overall Study|Adverse Event|2|||
148940853|NCT02195583|537267293|FG000|Overall Study|Other Reason|2|||
148940854|NCT00354744|537267294|FG000|Overall Study|Adverse Event|2|||
148940855|NCT00354744|537267294|FG000|Overall Study|Death|2|||
148940856|NCT00354744|537267294|FG000|Overall Study|Lack of Efficacy|11|||
148808188|NCT02421939|536775771|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
148808189|NCT02421939|536775772|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
148808190|NCT02421939|536775771|FG000|Long Term Follow up: up to 3 Years|Death|118|||
148808191|NCT02421939|536775772|FG001|Long Term Follow up: up to 3 Years|Death|65|||
148808192|NCT02421939|536775771|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
148808193|NCT02421939|536775772|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
148808194|NCT04770779|536775774|FG000|Overall Study|Randomized, never treated|0|||
148808195|NCT04770779|536775775|FG001|Overall Study|Randomized, never treated|1|||
148808196|NCT04770779|536775774|FG000|Overall Study|Adverse Event|9|||
148808197|NCT04770779|536775775|FG001|Overall Study|Adverse Event|1|||
148808198|NCT04770779|536775774|FG000|Overall Study|Withdrawal by Subject|7|||
148808199|NCT04770779|536775775|FG001|Overall Study|Withdrawal by Subject|1|||
148808200|NCT04770779|536775774|FG000|Overall Study|Pregnancy|0|||
148808201|NCT04770779|536775775|FG001|Overall Study|Pregnancy|1|||
148808202|NCT02799602|536775776|FG000|Overall Study|Protocol Violation|1|||
148808203|NCT02799602|536775777|FG001|Overall Study|Protocol Violation|0|||
148808204|NCT02799602|536775776|FG000|Overall Study|Physician Decision|5|||
148808205|NCT02799602|536775777|FG001|Overall Study|Physician Decision|6|||
148808206|NCT02799602|536775776|FG000|Overall Study|Lost to Follow-up|4|||
148808207|NCT02799602|536775777|FG001|Overall Study|Lost to Follow-up|2|||
148808208|NCT02799602|536775776|FG000|Overall Study|Additional primary malignancy|11|||
148808209|NCT02799602|536775777|FG001|Overall Study|Additional primary malignancy|6|||
148808210|NCT02799602|536775776|FG000|Overall Study|Non-compliance with study drug|14|||
148808211|NCT02799602|536775777|FG001|Overall Study|Non-compliance with study drug|12|||
148808212|NCT02799602|536775776|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
148808213|NCT02799602|536775777|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
148808214|NCT02799602|536775776|FG000|Overall Study|Withdrawal by Subject|26|||
148808215|NCT02799602|536775777|FG001|Overall Study|Withdrawal by Subject|40|||
148808216|NCT02799602|536775776|FG000|Overall Study|Progressive disease - clinical progression|131|||
148808217|NCT02799602|536775777|FG001|Overall Study|Progressive disease - clinical progression|276|||
148808218|NCT02799602|536775776|FG000|Overall Study|Progressive disease - radiological progression|90|||
148808219|NCT02799602|536775777|FG001|Overall Study|Progressive disease - radiological progression|133|||
148808220|NCT02799602|536775776|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
148808221|NCT02799602|536775777|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
148808222|NCT02799602|536775776|FG000|Overall Study|Death|9|||
148808223|NCT02799602|536775777|FG001|Overall Study|Death|5|||
148808224|NCT02799602|536775776|FG000|Overall Study|Other|287|||
148808225|NCT02799602|536775777|FG001|Overall Study|Other|118|||
148808226|NCT02799602|536775776|FG000|Overall Study|Study drug never administered|0|||
148808227|NCT02799602|536775777|FG001|Overall Study|Study drug never administered|3|||
148808228|NCT05516758|536775787|FG000|Overall Study|Adverse Event|5|||
148808229|NCT05516758|536775788|FG001|Overall Study|Adverse Event|1|||
148808230|NCT05516758|536775789|FG002|Overall Study|Adverse Event|3|||
148808231|NCT05516758|536775790|FG003|Overall Study|Adverse Event|0|||
148808232|NCT05516758|536775791|FG004|Overall Study|Adverse Event|1|||
148808233|NCT05516758|536775792|FG005|Overall Study|Adverse Event|3|||
148808234|NCT05516758|536775793|FG006|Overall Study|Adverse Event|5|||
148808235|NCT05516758|536775787|FG000|Overall Study|Assigned treatment by mistake|1|||
148808236|NCT05516758|536775788|FG001|Overall Study|Assigned treatment by mistake|0|||
148808237|NCT05516758|536775789|FG002|Overall Study|Assigned treatment by mistake|0|||
148808238|NCT05516758|536775790|FG003|Overall Study|Assigned treatment by mistake|0|||
148808239|NCT05516758|536775791|FG004|Overall Study|Assigned treatment by mistake|1|||
148808240|NCT05516758|536775792|FG005|Overall Study|Assigned treatment by mistake|0|||
148808241|NCT05516758|536775793|FG006|Overall Study|Assigned treatment by mistake|0|||
148808242|NCT05516758|536775787|FG000|Overall Study|Lack of Efficacy|6|||
148808243|NCT05516758|536775788|FG001|Overall Study|Lack of Efficacy|0|||
148808244|NCT05516758|536775789|FG002|Overall Study|Lack of Efficacy|2|||
148808245|NCT05516758|536775790|FG003|Overall Study|Lack of Efficacy|0|||
148940857|NCT00354744|537267294|FG000|Overall Study|Lost to Follow-up|2|||
148940858|NCT00354744|537267294|FG000|Overall Study|Physician Decision|11|||
148940859|NCT00354744|537267294|FG000|Overall Study|Withdrawal by Subject|14|||
148808246|NCT05516758|536775791|FG004|Overall Study|Lack of Efficacy|3|||
148808247|NCT05516758|536775792|FG005|Overall Study|Lack of Efficacy|6|||
148808248|NCT05516758|536775793|FG006|Overall Study|Lack of Efficacy|3|||
148808249|NCT05516758|536775787|FG000|Overall Study|Lost to Follow-up|2|||
148808250|NCT05516758|536775788|FG001|Overall Study|Lost to Follow-up|0|||
148808251|NCT05516758|536775789|FG002|Overall Study|Lost to Follow-up|2|||
148808252|NCT05516758|536775790|FG003|Overall Study|Lost to Follow-up|0|||
148808253|NCT05516758|536775791|FG004|Overall Study|Lost to Follow-up|3|||
149015678|NCT00779584|537536139|FG002|Overall Study|Adverse Event|2|||
149015679|NCT00779584|537536140|FG003|Overall Study|Adverse Event|0|||
149015680|NCT00779584|537536141|FG004|Overall Study|Adverse Event|0|||
149015681|NCT00779584|537536142|FG005|Overall Study|Adverse Event|0|||
149015682|NCT00779584|537536143|FG006|Overall Study|Adverse Event|2|||
149015683|NCT00779584|537536144|FG007|Overall Study|Adverse Event|1|||
149015684|NCT00779584|537536145|FG008|Overall Study|Adverse Event|1|||
149015685|NCT00779584|537536137|FG000|Overall Study|Symptomatic Deterioration|1|||
149015686|NCT00779584|537536138|FG001|Overall Study|Symptomatic Deterioration|1|||
149015687|NCT00779584|537536139|FG002|Overall Study|Symptomatic Deterioration|1|||
149015688|NCT00779584|537536140|FG003|Overall Study|Symptomatic Deterioration|0|||
149015689|NCT00779584|537536141|FG004|Overall Study|Symptomatic Deterioration|0|||
149015690|NCT00779584|537536142|FG005|Overall Study|Symptomatic Deterioration|1|||
149015691|NCT00779584|537536143|FG006|Overall Study|Symptomatic Deterioration|1|||
149015692|NCT00779584|537536144|FG007|Overall Study|Symptomatic Deterioration|0|||
149015693|NCT00779584|537536145|FG008|Overall Study|Symptomatic Deterioration|0|||
149015694|NCT00779584|537536137|FG000|Overall Study|Ongoing in Study|0|||
149015695|NCT00779584|537536138|FG001|Overall Study|Ongoing in Study|0|||
149015696|NCT00779584|537536139|FG002|Overall Study|Ongoing in Study|0|||
149015697|NCT00779584|537536140|FG003|Overall Study|Ongoing in Study|0|||
149015698|NCT00779584|537536141|FG004|Overall Study|Ongoing in Study|1|||
149015699|NCT00779584|537536142|FG005|Overall Study|Ongoing in Study|1|||
149015700|NCT00779584|537536143|FG006|Overall Study|Ongoing in Study|0|||
149015701|NCT00779584|537536144|FG007|Overall Study|Ongoing in Study|0|||
149015702|NCT00779584|537536145|FG008|Overall Study|Ongoing in Study|0|||
149015703|NCT00786474|537536148|FG000|Overall Study|Death|5|||
149015704|NCT00786474|537536149|FG001|Overall Study|Death|4|||
149015705|NCT00786474|537536148|FG000|Overall Study|Withdrawal by Subject|23|||
149015706|NCT00786474|537536149|FG001|Overall Study|Withdrawal by Subject|31|||
149015707|NCT00786474|537536148|FG000|Overall Study|Lost to Follow-up|3|||
149015708|NCT00786474|537536149|FG001|Overall Study|Lost to Follow-up|3|||
149015709|NCT00786474|537536148|FG000|Overall Study|Physician Decision|2|||
149015710|NCT00786474|537536149|FG001|Overall Study|Physician Decision|1|||
149015711|NCT00786474|537536148|FG000|Overall Study|Other|4|||
149015712|NCT00786474|537536149|FG001|Overall Study|Other|4|||
149015713|NCT01868074|537536150|FG000|Overall Study|Lost to Follow-up|3|||
149015714|NCT01868074|537536151|FG001|Overall Study|Lost to Follow-up|2|||
149015715|NCT01868074|537536150|FG000|Overall Study|Withdrawal by Subject|4|||
149015716|NCT01868074|537536151|FG001|Overall Study|Withdrawal by Subject|2|||
149015717|NCT01234649|537536152|FG000|Overall Study|Withdrawal by Subject|32|||
149015718|NCT01234649|537536153|FG001|Overall Study|Withdrawal by Subject|26|||
149015719|NCT01234649|537536152|FG000|Overall Study|Pregnancy|6|||
149015720|NCT01234649|537536153|FG001|Overall Study|Pregnancy|6|||
149015721|NCT01234649|537536152|FG000|Overall Study|intolerant to side effects|4|||
149015722|NCT01234649|537536153|FG001|Overall Study|intolerant to side effects|3|||
149015723|NCT01234649|537536152|FG000|Overall Study|Allergic reaction|1|||
149015724|NCT01234649|537536153|FG001|Overall Study|Allergic reaction|0|||
149015725|NCT01234649|537536152|FG000|Overall Study|Lack of Efficacy|0|||
149015726|NCT01234649|537536153|FG001|Overall Study|Lack of Efficacy|3|||
149015727|NCT00896454|537536154|FG000|Overall Study|Death|10|||
149015728|NCT00896454|537536154|FG000|Overall Study|Adverse Event|8|||
149015729|NCT00896454|537536154|FG000|Overall Study|Disease Progression|5|||
149015730|NCT00896454|537536154|FG000|Overall Study|Other|4|||
149015731|NCT00896454|537536154|FG000|Overall Study|Requirement for alternative therapy|3|||
149015732|NCT00896454|537536154|FG000|Overall Study|Ongoing in study|2|||
149015733|NCT00896454|537536154|FG000|Overall Study|Withdrawal by Subject|1|||
149015734|NCT01461993|537536158|FG000|Overall Study|Withdrawal by Subject|60|||
149015735|NCT01461993|537536159|FG001|Overall Study|Withdrawal by Subject|53|||
149015736|NCT01461993|537536160|FG002|Overall Study|Withdrawal by Subject|16|||
149015737|NCT01461993|537536158|FG000|Overall Study|Lost to Follow-up|44|||
149015738|NCT01461993|537536159|FG001|Overall Study|Lost to Follow-up|48|||
149015739|NCT01461993|537536160|FG002|Overall Study|Lost to Follow-up|22|||
149015740|NCT01461993|537536158|FG000|Overall Study|Protocol Violation|10|||
149015741|NCT01461993|537536159|FG001|Overall Study|Protocol Violation|9|||
149015742|NCT01461993|537536160|FG002|Overall Study|Protocol Violation|7|||
149015743|NCT01461993|537536158|FG000|Overall Study|Adverse Event|9|||
149015744|NCT01461993|537536159|FG001|Overall Study|Adverse Event|11|||
148940860|NCT00983437|537267295|FG000|Overall Study|Adverse Event|9|||
148940861|NCT00983437|537267295|FG000|Overall Study|Lack of Efficacy|1|||
148940862|NCT00983437|537267295|FG000|Overall Study|Withdrawal by Subject|8|||
148808254|NCT05516758|536775792|FG005|Overall Study|Lost to Follow-up|2|||
148808255|NCT05516758|536775793|FG006|Overall Study|Lost to Follow-up|1|||
148808256|NCT05516758|536775787|FG000|Overall Study|Other- As reported by the site|2|||
148808257|NCT05516758|536775788|FG001|Overall Study|Other- As reported by the site|1|||
148940863|NCT00983437|537267295|FG000|Overall Study|Noncompliance to Study Procedures|1|||
148940864|NCT00983437|537267295|FG000|Overall Study|Lost to Follow-up|2|||
148940865|NCT00983437|537267295|FG000|Overall Study|Other Reason|26|||
148940866|NCT00094172|537267296|FG000|Overall Study|Adverse Event|0|||
148940867|NCT00094172|537267297|FG001|Overall Study|Adverse Event|1|||
148940868|NCT00094172|537267296|FG000|Overall Study|Lost to Follow-up|2|||
148940869|NCT00094172|537267297|FG001|Overall Study|Lost to Follow-up|0|||
148940870|NCT00094172|537267296|FG000|Overall Study|Protocol Violation|0|||
148940871|NCT00094172|537267297|FG001|Overall Study|Protocol Violation|1|||
148940872|NCT00094172|537267296|FG000|Overall Study|Withdrawal by Subject|10|||
148940873|NCT00094172|537267297|FG001|Overall Study|Withdrawal by Subject|5|||
148940874|NCT00094172|537267296|FG000|Overall Study|Primary endpoint met.|1|||
148940875|NCT00094172|537267297|FG001|Overall Study|Primary endpoint met.|0|||
148940876|NCT00094172|537267296|FG000|Overall Study|Started other MS therapy due to disease|1|||
148940877|NCT00094172|537267297|FG001|Overall Study|Started other MS therapy due to disease|0|||
148940878|NCT01020981|537267298|FG000|Overall Study|Did not return mailed survey|74|||
148940879|NCT01020981|537267299|FG001|Overall Study|Did not return mailed survey|58|||
148940880|NCT01020981|537267298|FG000|Overall Study|Survey returned undeliverable|8|||
148940881|NCT01020981|537267299|FG001|Overall Study|Survey returned undeliverable|32|||
148940882|NCT01020981|537267298|FG000|Overall Study|Participant declined to complete survey|2|||
148940883|NCT01020981|537267299|FG001|Overall Study|Participant declined to complete survey|0|||
148940884|NCT00289133|537267302|FG000|Overall Study|Non-study device implanted|12|||
148940885|NCT00289133|537267303|FG001|Overall Study|Non-study device implanted|0|||
148940886|NCT00289133|537267302|FG000|Overall Study|Protocol Violation|32|||
148940887|NCT00289133|537267303|FG001|Overall Study|Protocol Violation|38|||
148940888|NCT00289133|537267302|FG000|Overall Study|Withdrawal by Subject|9|||
148940889|NCT00289133|537267303|FG001|Overall Study|Withdrawal by Subject|10|||
148940890|NCT00289133|537267302|FG000|Overall Study|Death|5|||
148940891|NCT00289133|537267303|FG001|Overall Study|Death|10|||
148940892|NCT00289133|537267302|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
148940893|NCT00289133|537267303|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
148940894|NCT00289133|537267302|FG000|Overall Study|Physician Decision|41|||
148940895|NCT00289133|537267303|FG001|Overall Study|Physician Decision|45|||
148940896|NCT00289133|537267302|FG000|Overall Study|Revision|8|||
148940897|NCT00289133|537267303|FG001|Overall Study|Revision|6|||
148940898|NCT00289133|537267302|FG000|Overall Study|Lost to Follow-up|92|||
148940899|NCT00289133|537267303|FG001|Overall Study|Lost to Follow-up|115|||
148940900|NCT00680017|537267308|FG000|Overall Study|Adverse Event|13|||
148940901|NCT00680017|537267309|FG001|Overall Study|Adverse Event|7|||
148940902|NCT00680017|537267308|FG000|Overall Study|Withdrawal by Subject|2|||
148940903|NCT00680017|537267309|FG001|Overall Study|Withdrawal by Subject|5|||
148940904|NCT00680017|537267308|FG000|Overall Study|Lost to Follow-up|2|||
148808258|NCT05516758|536775789|FG002|Overall Study|Other- As reported by the site|8|||
148808259|NCT05516758|536775790|FG003|Overall Study|Other- As reported by the site|1|||
148808260|NCT05516758|536775791|FG004|Overall Study|Other- As reported by the site|2|||
148808261|NCT05516758|536775792|FG005|Overall Study|Other- As reported by the site|3|||
148808262|NCT05516758|536775793|FG006|Overall Study|Other- As reported by the site|8|||
148808263|NCT05516758|536775787|FG000|Overall Study|Physician Decision|1|||
148808264|NCT05516758|536775788|FG001|Overall Study|Physician Decision|0|||
148808265|NCT05516758|536775789|FG002|Overall Study|Physician Decision|7|||
148808266|NCT05516758|536775790|FG003|Overall Study|Physician Decision|0|||
148808267|NCT05516758|536775791|FG004|Overall Study|Physician Decision|1|||
148808268|NCT05516758|536775792|FG005|Overall Study|Physician Decision|1|||
148808269|NCT05516758|536775793|FG006|Overall Study|Physician Decision|2|||
148808270|NCT05516758|536775787|FG000|Overall Study|Protocol Deviation|1|||
148940905|NCT00680017|537267309|FG001|Overall Study|Lost to Follow-up|0|||
148940906|NCT02555683|537267313|FG000|Overall Study|Physician Decision|1|||
148940907|NCT02555683|537267314|FG001|Overall Study|Physician Decision|0|||
148940908|NCT02555683|537267315|FG002|Overall Study|Physician Decision|2|||
148940909|NCT02555683|537267313|FG000|Overall Study|Lost to Follow-up|2|||
148808271|NCT05516758|536775788|FG001|Overall Study|Protocol Deviation|0|||
148808272|NCT05516758|536775789|FG002|Overall Study|Protocol Deviation|0|||
148940910|NCT02555683|537267314|FG001|Overall Study|Lost to Follow-up|1|||
148940911|NCT02555683|537267315|FG002|Overall Study|Lost to Follow-up|2|||
148940912|NCT02555683|537267313|FG000|Overall Study|Technical Problems|1|||
148940913|NCT02555683|537267314|FG001|Overall Study|Technical Problems|1|||
148940914|NCT02555683|537267315|FG002|Overall Study|Technical Problems|0|||
148808273|NCT05516758|536775790|FG003|Overall Study|Protocol Deviation|0|||
148808274|NCT05516758|536775791|FG004|Overall Study|Protocol Deviation|0|||
148940915|NCT02555683|537267313|FG000|Overall Study|Protocol deviation|0|||
148940916|NCT02555683|537267314|FG001|Overall Study|Protocol deviation|1|||
148940917|NCT02555683|537267315|FG002|Overall Study|Protocol deviation|0|||
148940918|NCT02555683|537267313|FG000|Overall Study|Lack of Efficacy|2|||
148940919|NCT02555683|537267314|FG001|Overall Study|Lack of Efficacy|0|||
148940920|NCT02555683|537267315|FG002|Overall Study|Lack of Efficacy|0|||
148940921|NCT02555683|537267313|FG000|Overall Study|Death|0|||
148940922|NCT02555683|537267314|FG001|Overall Study|Death|1|||
148940923|NCT02555683|537267315|FG002|Overall Study|Death|2|||
148940924|NCT02555683|537267313|FG000|Overall Study|Adverse Event|1|||
148940925|NCT02555683|537267314|FG001|Overall Study|Adverse Event|0|||
148940926|NCT02555683|537267315|FG002|Overall Study|Adverse Event|1|||
148940927|NCT02555683|537267313|FG000|Overall Study|Subject/guardian decision|12|||
148940928|NCT02555683|537267314|FG001|Overall Study|Subject/guardian decision|12|||
148940929|NCT02555683|537267315|FG002|Overall Study|Subject/guardian decision|22|||
148940930|NCT02555683|537267313|FG000|Overall Study|Death post Treatment/safety period|0|||
148940931|NCT02555683|537267314|FG001|Overall Study|Death post Treatment/safety period|1|||
148940932|NCT02555683|537267315|FG002|Overall Study|Death post Treatment/safety period|0|||
148940933|NCT00612040|537267320|FG000|Overall Study|Adverse Event|0|||
148940934|NCT00612040|537267321|FG001|Overall Study|Adverse Event|2|||
148940935|NCT00612040|537267322|FG002|Overall Study|Adverse Event|1|||
148940936|NCT00612040|537267320|FG000|Overall Study|Protocol Violation|1|||
148940937|NCT00612040|537267321|FG001|Overall Study|Protocol Violation|2|||
148940938|NCT00612040|537267322|FG002|Overall Study|Protocol Violation|1|||
148940939|NCT00612040|537267320|FG000|Overall Study|Lack of Efficacy|2|||
148940940|NCT00612040|537267321|FG001|Overall Study|Lack of Efficacy|1|||
148940941|NCT00612040|537267322|FG002|Overall Study|Lack of Efficacy|0|||
148940942|NCT00612040|537267320|FG000|Overall Study|Unclassified|2|||
148940943|NCT00612040|537267321|FG001|Overall Study|Unclassified|2|||
148940944|NCT00612040|537267322|FG002|Overall Study|Unclassified|5|||
148940945|NCT00827502|537267325|FG000|Overall Study|randomized but not treated|11|||
148940946|NCT00827502|537267325|FG000|Overall Study|Adverse Event|1|||
148940947|NCT00827502|537267325|FG000|Overall Study|Lost to Follow-up|4|||
148940948|NCT00827502|537267325|FG000|Overall Study|Withdrawal by Subject|5|||
148940949|NCT02478632|537267326|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
148940950|NCT02478632|537267327|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
148940951|NCT02478632|537267326|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
148940952|NCT02478632|537267327|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
148940953|NCT02478632|537267326|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
148940954|NCT02478632|537267327|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
148940955|NCT02924571|537267329|FG000|Overall Study|Lost to Follow-up|1|||
148940956|NCT02924571|537267330|FG001|Overall Study|Lost to Follow-up|1|||
148940957|NCT02924571|537267331|FG002|Overall Study|Lost to Follow-up|0|||
148940958|NCT00002651|537267335|FG000|Induction|Adverse Event|44|||
148940959|NCT00002651|537267336|FG001|Induction|Adverse Event|0|||
148940960|NCT00002651|537267337|FG002|Induction|Adverse Event|0|||
148940961|NCT00002651|537267335|FG000|Induction|Refusal unrelated to adverse event|50|||
148940962|NCT00002651|537267336|FG001|Induction|Refusal unrelated to adverse event|0|||
148940963|NCT00002651|537267337|FG002|Induction|Refusal unrelated to adverse event|0|||
148940964|NCT00002651|537267335|FG000|Induction|Progression/relapse|274|||
148940965|NCT00002651|537267336|FG001|Induction|Progression/relapse|0|||
148940966|NCT00002651|537267337|FG002|Induction|Progression/relapse|0|||
148940967|NCT00002651|537267335|FG000|Induction|Death|62|||
148940968|NCT00002651|537267336|FG001|Induction|Death|0|||
148940969|NCT00002651|537267337|FG002|Induction|Death|0|||
148940970|NCT00002651|537267335|FG000|Induction|Other|823|||
148940971|NCT00002651|537267336|FG001|Induction|Other|0|||
148940972|NCT00002651|537267337|FG002|Induction|Other|0|||
148940973|NCT00002651|537267335|FG000|Induction|not eligible|90|||
148940974|NCT00002651|537267336|FG001|Induction|not eligible|0|||
148940975|NCT00002651|537267337|FG002|Induction|not eligible|0|||
148940976|NCT00002651|537267335|FG000|Consolidation and Randomization|Adverse Event|0|||
148940977|NCT00002651|537267336|FG001|Consolidation and Randomization|Adverse Event|36|||
148940978|NCT00002651|537267337|FG002|Consolidation and Randomization|Adverse Event|14|||
148940979|NCT00002651|537267335|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
148940980|NCT00002651|537267336|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
148940981|NCT00002651|537267337|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
148940982|NCT00002651|537267335|FG000|Consolidation and Randomization|Progression/relapse|0|||
148940983|NCT00002651|537267336|FG001|Consolidation and Randomization|Progression/relapse|295|||
148940984|NCT00002651|537267337|FG002|Consolidation and Randomization|Progression/relapse|298|||
148940985|NCT00002651|537267335|FG000|Consolidation and Randomization|Death|0|||
148940986|NCT00002651|537267336|FG001|Consolidation and Randomization|Death|38|||
148940987|NCT00002651|537267337|FG002|Consolidation and Randomization|Death|48|||
148940988|NCT00002651|537267335|FG000|Consolidation and Randomization|Other|0|||
148940989|NCT00002651|537267336|FG001|Consolidation and Randomization|Other|314|||
148940990|NCT00002651|537267337|FG002|Consolidation and Randomization|Other|313|||
148940991|NCT00002651|537267335|FG000|Consolidation and Randomization|not eligible|0|||
148940992|NCT00002651|537267336|FG001|Consolidation and Randomization|not eligible|102|||
148940993|NCT00002651|537267337|FG002|Consolidation and Randomization|not eligible|112|||
148940994|NCT03750955|537267344|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
148940995|NCT03750955|537267345|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
148808275|NCT05516758|536775792|FG005|Overall Study|Protocol Deviation|1|||
148808276|NCT05516758|536775793|FG006|Overall Study|Protocol Deviation|5|||
148808277|NCT05516758|536775787|FG000|Overall Study|Withdrawal by Subject|11|||
148808278|NCT05516758|536775788|FG001|Overall Study|Withdrawal by Subject|1|||
148808279|NCT05516758|536775789|FG002|Overall Study|Withdrawal by Subject|15|||
148808280|NCT05516758|536775790|FG003|Overall Study|Withdrawal by Subject|2|||
148808281|NCT05516758|536775791|FG004|Overall Study|Withdrawal by Subject|7|||
148808282|NCT05516758|536775792|FG005|Overall Study|Withdrawal by Subject|7|||
148808283|NCT05516758|536775793|FG006|Overall Study|Withdrawal by Subject|6|||
148808284|NCT05516758|536775787|FG000|Overall Study|Death|1|||
148808285|NCT05516758|536775788|FG001|Overall Study|Death|0|||
148808286|NCT05516758|536775789|FG002|Overall Study|Death|0|||
148808287|NCT05516758|536775790|FG003|Overall Study|Death|0|||
148808288|NCT05516758|536775791|FG004|Overall Study|Death|0|||
148808289|NCT05516758|536775792|FG005|Overall Study|Death|0|||
148940996|NCT03750955|537267344|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
148940997|NCT03750955|537267345|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
148940998|NCT01705730|537267346|FG000|Overall Study|Lack of Efficacy|1|||
148808290|NCT05516758|536775793|FG006|Overall Study|Death|0|||
148808291|NCT05516758|536775787|FG000|Overall Study|Non-compliance With Study Drug|0|||
148808292|NCT05516758|536775788|FG001|Overall Study|Non-compliance With Study Drug|0|||
148808293|NCT05516758|536775789|FG002|Overall Study|Non-compliance With Study Drug|1|||
148808294|NCT05516758|536775790|FG003|Overall Study|Non-compliance With Study Drug|0|||
148808295|NCT05516758|536775791|FG004|Overall Study|Non-compliance With Study Drug|0|||
148808296|NCT05516758|536775792|FG005|Overall Study|Non-compliance With Study Drug|0|||
148808297|NCT05516758|536775793|FG006|Overall Study|Non-compliance With Study Drug|0|||
148808298|NCT05516758|536775787|FG000|Overall Study|Site Terminated by Sponsor|2|||
148808299|NCT05516758|536775788|FG001|Overall Study|Site Terminated by Sponsor|0|||
148808300|NCT05516758|536775789|FG002|Overall Study|Site Terminated by Sponsor|0|||
148808301|NCT05516758|536775790|FG003|Overall Study|Site Terminated by Sponsor|0|||
148808302|NCT05516758|536775791|FG004|Overall Study|Site Terminated by Sponsor|0|||
148808303|NCT05516758|536775792|FG005|Overall Study|Site Terminated by Sponsor|0|||
148808304|NCT05516758|536775793|FG006|Overall Study|Site Terminated by Sponsor|0|||
148808305|NCT05516758|536775787|FG000|Overall Study|Study Terminated by Sponsor|4|||
148808306|NCT05516758|536775788|FG001|Overall Study|Study Terminated by Sponsor|0|||
148808307|NCT05516758|536775789|FG002|Overall Study|Study Terminated by Sponsor|3|||
148808308|NCT05516758|536775790|FG003|Overall Study|Study Terminated by Sponsor|0|||
148808309|NCT05516758|536775791|FG004|Overall Study|Study Terminated by Sponsor|2|||
148808310|NCT05516758|536775792|FG005|Overall Study|Study Terminated by Sponsor|3|||
148808311|NCT05516758|536775793|FG006|Overall Study|Study Terminated by Sponsor|0|||
148808312|NCT05516758|536775787|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
148808313|NCT05516758|536775788|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
148808314|NCT05516758|536775789|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
148808315|NCT05516758|536775790|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
148808316|NCT05516758|536775791|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
148808317|NCT05516758|536775792|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
148808318|NCT05516758|536775793|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
148808319|NCT05516758|536775787|FG000|Overall Study|Other|0|||
148808320|NCT05516758|536775788|FG001|Overall Study|Other|0|||
148808321|NCT05516758|536775789|FG002|Overall Study|Other|0|||
148808322|NCT05516758|536775790|FG003|Overall Study|Other|0|||
148808323|NCT05516758|536775791|FG004|Overall Study|Other|0|||
148808324|NCT05516758|536775792|FG005|Overall Study|Other|0|||
148808325|NCT05516758|536775793|FG006|Overall Study|Other|1|||
148940999|NCT01705730|537267346|FG000|Overall Study|Adverse Event|3|||
148941000|NCT01705730|537267346|FG000|Overall Study|Lost to Follow-up|1|||
148941001|NCT01705730|537267346|FG000|Overall Study|Reason not Specified|4|||
148941002|NCT01773733|537267347|FG000|Overall Study|Adverse Event|3286|||
148941003|NCT01773733|537267348|FG001|Overall Study|Adverse Event|540|||
148941004|NCT01773733|537267347|FG000|Overall Study|Pregnancy|28|||
148808326|NCT06178991|536775797|FG000|Overall Study|Withdrawal by Subject|2|||
148808327|NCT06178991|536775798|FG001|Overall Study|Withdrawal by Subject|6|||
148808328|NCT06178991|536775799|FG002|Overall Study|Withdrawal by Subject|44|||
148808329|NCT06178991|536775800|FG003|Overall Study|Withdrawal by Subject|23|||
148808330|NCT06178991|536775801|FG004|Overall Study|Withdrawal by Subject|7|||
148808331|NCT06178991|536775802|FG005|Overall Study|Withdrawal by Subject|7|||
148808332|NCT06178991|536775803|FG006|Overall Study|Withdrawal by Subject|7|||
148808333|NCT06178991|536775804|FG007|Overall Study|Withdrawal by Subject|5|||
148808334|NCT06178991|536775797|FG000|Overall Study|Lost to Follow-up|2|||
149197065|NCT01274338|538191077|FG004|Overall Study|Did not start treatment|0|||
149197066|NCT01274338|538191078|FG005|Overall Study|Did not start treatment|0|||
149197067|NCT01274338|538191073|FG000|Overall Study|Alternative therapy|0|||
149197068|NCT01274338|538191074|FG001|Overall Study|Alternative therapy|1|||
149197069|NCT01274338|538191075|FG002|Overall Study|Alternative therapy|0|||
148941005|NCT01773733|537267348|FG001|Overall Study|Pregnancy|0|||
148941006|NCT01773733|537267347|FG000|Overall Study|Other different categories of not compl|55415|||
148941007|NCT01773733|537267348|FG001|Overall Study|Other different categories of not compl|7781|||
148941008|NCT03741062|537267349|FG000|Overall Study|Protocol Violation|1|||
148941009|NCT03741062|537267350|FG001|Overall Study|Protocol Violation|0|||
148941010|NCT02763462|537267358|FG000|Overall Study|Protocol Violation|6|||
148941011|NCT03417219|537267359|FG000|Overall Study|Lost to Follow-up|0|||
148808335|NCT06178991|536775798|FG001|Overall Study|Lost to Follow-up|4|||
148941012|NCT03417219|537267360|FG001|Overall Study|Lost to Follow-up|3|||
148941013|NCT02527161|537267361|FG000|Overall Study|Failed MRI|52|||
148941014|NCT02527161|537267361|FG000|Overall Study|Withdrawal by Subject|19|||
148941015|NCT02527161|537267361|FG000|Overall Study|Delay in or unfit for surgery|16|||
148941016|NCT02527161|537267361|FG000|Overall Study|MRI contraindication|6|||
148941017|NCT02527161|537267361|FG000|Overall Study|Consent violation|4|||
148941018|NCT02527161|537267361|FG000|Overall Study|Only Recruited to Part A|27|||
148941019|NCT02527161|537267361|FG000|Overall Study|Physician Decision|1|||
148941020|NCT02527161|537267361|FG000|Overall Study|Adverse Event|1|||
148941021|NCT02527161|537267361|FG000|Overall Study|Lost to Follow-up|6|||
148941022|NCT02100514|537267362|FG000|Treatment Period|Adverse Event|0|||
148941023|NCT02100514|537267363|FG001|Treatment Period|Adverse Event|5|||
148941024|NCT02100514|537267364|FG002|Treatment Period|Adverse Event|0|||
148941025|NCT02100514|537267365|FG003|Treatment Period|Adverse Event|0|||
148941026|NCT02100514|537267366|FG004|Treatment Period|Adverse Event|0|||
148941027|NCT02100514|537267362|FG000|Treatment Period|Death|2|||
148941028|NCT02100514|537267363|FG001|Treatment Period|Death|2|||
148941029|NCT02100514|537267364|FG002|Treatment Period|Death|0|||
148941030|NCT02100514|537267365|FG003|Treatment Period|Death|0|||
148941031|NCT02100514|537267366|FG004|Treatment Period|Death|0|||
148941032|NCT02100514|537267362|FG000|Treatment Period|Lost to Follow-up|5|||
148941033|NCT02100514|537267363|FG001|Treatment Period|Lost to Follow-up|17|||
148941034|NCT02100514|537267364|FG002|Treatment Period|Lost to Follow-up|0|||
148941035|NCT02100514|537267365|FG003|Treatment Period|Lost to Follow-up|0|||
148941036|NCT02100514|537267366|FG004|Treatment Period|Lost to Follow-up|0|||
148941037|NCT02100514|537267362|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
148941038|NCT02100514|537267363|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
148941039|NCT02100514|537267364|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
148941040|NCT02100514|537267365|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
148941041|NCT02100514|537267366|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
148941042|NCT02100514|537267362|FG000|Treatment Period|Protocol Violation|1|||
148941043|NCT02100514|537267363|FG001|Treatment Period|Protocol Violation|1|||
148941044|NCT02100514|537267364|FG002|Treatment Period|Protocol Violation|0|||
148941045|NCT02100514|537267365|FG003|Treatment Period|Protocol Violation|0|||
148941046|NCT02100514|537267366|FG004|Treatment Period|Protocol Violation|0|||
148941047|NCT02100514|537267362|FG000|Treatment Period|Withdrawal by Subject|12|||
148941048|NCT02100514|537267363|FG001|Treatment Period|Withdrawal by Subject|37|||
148941049|NCT02100514|537267364|FG002|Treatment Period|Withdrawal by Subject|0|||
148941050|NCT02100514|537267365|FG003|Treatment Period|Withdrawal by Subject|0|||
148941051|NCT02100514|537267366|FG004|Treatment Period|Withdrawal by Subject|0|||
148941052|NCT02100514|537267362|FG000|Treatment Period|Other|9|||
148941053|NCT02100514|537267363|FG001|Treatment Period|Other|11|||
148941054|NCT02100514|537267364|FG002|Treatment Period|Other|0|||
148941055|NCT02100514|537267365|FG003|Treatment Period|Other|0|||
148941056|NCT02100514|537267366|FG004|Treatment Period|Other|0|||
148941057|NCT02100514|537267362|FG000|Extension Period|Withdrew consent|0|||
148941058|NCT02100514|537267363|FG001|Extension Period|Withdrew consent|0|||
148941059|NCT02100514|537267364|FG002|Extension Period|Withdrew consent|2|||
148941060|NCT02100514|537267365|FG003|Extension Period|Withdrew consent|0|||
148941061|NCT02100514|537267366|FG004|Extension Period|Withdrew consent|0|||
148941062|NCT02609828|537267367|FG000|Overall Study|Adverse Event|8|||
148941063|NCT02609828|537267368|FG001|Overall Study|Adverse Event|1|||
148941064|NCT02609828|537267369|FG002|Overall Study|Adverse Event|0|||
148941065|NCT02609828|537267370|FG003|Overall Study|Adverse Event|6|||
148941066|NCT02609828|537267367|FG000|Overall Study|Death|15|||
148941067|NCT02609828|537267368|FG001|Overall Study|Death|1|||
148941068|NCT02609828|537267369|FG002|Overall Study|Death|1|||
148941069|NCT02609828|537267370|FG003|Overall Study|Death|19|||
148941070|NCT02609828|537267367|FG000|Overall Study|Insufficient clinical response|2|||
148941071|NCT02609828|537267368|FG001|Overall Study|Insufficient clinical response|1|||
148941072|NCT02609828|537267369|FG002|Overall Study|Insufficient clinical response|0|||
148941073|NCT02609828|537267370|FG003|Overall Study|Insufficient clinical response|0|||
148941074|NCT02609828|537267367|FG000|Overall Study|Lost to Follow-up|0|||
148941075|NCT02609828|537267368|FG001|Overall Study|Lost to Follow-up|0|||
148941076|NCT02609828|537267369|FG002|Overall Study|Lost to Follow-up|0|||
148941077|NCT02609828|537267370|FG003|Overall Study|Lost to Follow-up|1|||
148941078|NCT02609828|537267367|FG000|Overall Study|Protocol Violation|2|||
148941079|NCT02609828|537267368|FG001|Overall Study|Protocol Violation|0|||
148941080|NCT02609828|537267369|FG002|Overall Study|Protocol Violation|0|||
148941081|NCT02609828|537267370|FG003|Overall Study|Protocol Violation|1|||
148941082|NCT02609828|537267367|FG000|Overall Study|Withdrawal by Subject|12|||
148941083|NCT02609828|537267368|FG001|Overall Study|Withdrawal by Subject|1|||
148941084|NCT02609828|537267369|FG002|Overall Study|Withdrawal by Subject|0|||
148941085|NCT02609828|537267370|FG003|Overall Study|Withdrawal by Subject|10|||
148941086|NCT02609828|537267367|FG000|Overall Study|Other|3|||
148941087|NCT02609828|537267368|FG001|Overall Study|Other|0|||
148941088|NCT02609828|537267369|FG002|Overall Study|Other|0|||
148682612|NCT05266456|536310964|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
148941089|NCT02609828|537267370|FG003|Overall Study|Other|6|||
148941090|NCT02609828|537267367|FG000|Overall Study|Randomized but not treated|1|||
148941091|NCT02609828|537267368|FG001|Overall Study|Randomized but not treated|0|||
148941092|NCT02609828|537267369|FG002|Overall Study|Randomized but not treated|0|||
148941093|NCT02609828|537267370|FG003|Overall Study|Randomized but not treated|0|||
148941094|NCT00319553|537267371|FG000|Overall Study|Protocol Violation|1|||
148941095|NCT00319553|537267372|FG001|Overall Study|Protocol Violation|2|||
148941096|NCT00319553|537267371|FG000|Overall Study|Lost to Follow-up|2|||
148941097|NCT00319553|537267372|FG001|Overall Study|Lost to Follow-up|1|||
148941098|NCT00319553|537267371|FG000|Overall Study|Withdrawal by Subject|1|||
148941099|NCT00319553|537267372|FG001|Overall Study|Withdrawal by Subject|1|||
148941100|NCT01896102|537267373|FG000|Overall Study|Death|1|||
148941101|NCT01896102|537267373|FG000|Overall Study|Participant to receive allogenic transplant|2|||
148941102|NCT00885846|537267375|FG000|Overall Study|Withdrawal by Subject|2|||
148941103|NCT00885846|537267376|FG001|Overall Study|Withdrawal by Subject|5|||
148941104|NCT00885846|537267377|FG002|Overall Study|Withdrawal by Subject|2|||
148941105|NCT00880542|537267378|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
148941106|NCT00880542|537267378|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
148941107|NCT00880542|537267378|FG000|REP: Surgical Resection|progressive disease|1|||
148941108|NCT00190671|537267392|FG000|Overall Study|Satisfactory Response|4|||
148941109|NCT00190671|537267393|FG001|Overall Study|Satisfactory Response|7|||
148941110|NCT00190671|537267392|FG000|Overall Study|Lack of Efficacy|19|||
148941111|NCT00190671|537267393|FG001|Overall Study|Lack of Efficacy|24|||
148941112|NCT00190671|537267392|FG000|Overall Study|Death from Study Disease|1|||
148941113|NCT00190671|537267393|FG001|Overall Study|Death from Study Disease|1|||
148941114|NCT00190671|537267392|FG000|Overall Study|Adverse Event|3|||
148941115|NCT00190671|537267393|FG001|Overall Study|Adverse Event|2|||
148941116|NCT00190671|537267392|FG000|Overall Study|Clinical Relapse|0|||
148941117|NCT00190671|537267393|FG001|Overall Study|Clinical Relapse|1|||
148941118|NCT00190671|537267392|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
148941119|NCT00190671|537267393|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
148941120|NCT00190671|537267392|FG000|Overall Study|Death from Other Causes|0|||
148941121|NCT00190671|537267393|FG001|Overall Study|Death from Other Causes|2|||
148941122|NCT00190671|537267392|FG000|Overall Study|Protocol Violation|0|||
148941123|NCT00190671|537267393|FG001|Overall Study|Protocol Violation|1|||
148808336|NCT06178991|536775799|FG002|Overall Study|Lost to Follow-up|133|||
148808337|NCT06178991|536775800|FG003|Overall Study|Lost to Follow-up|65|||
148808338|NCT06178991|536775801|FG004|Overall Study|Lost to Follow-up|68|||
148808339|NCT06178991|536775802|FG005|Overall Study|Lost to Follow-up|57|||
148808340|NCT06178991|536775803|FG006|Overall Study|Lost to Follow-up|25|||
148808341|NCT06178991|536775804|FG007|Overall Study|Lost to Follow-up|18|||
148808342|NCT06178991|536775797|FG000|Overall Study|Death|1|||
148808343|NCT06178991|536775798|FG001|Overall Study|Death|0|||
148808344|NCT06178991|536775799|FG002|Overall Study|Death|2|||
148808345|NCT06178991|536775800|FG003|Overall Study|Death|1|||
148808346|NCT06178991|536775801|FG004|Overall Study|Death|1|||
148941124|NCT00190671|537267392|FG000|Overall Study|Withdrawal by Subject|0|||
148941125|NCT00190671|537267393|FG001|Overall Study|Withdrawal by Subject|2|||
148941126|NCT04502433|537267394|FG000|Overall Study|Death|2|||
148941127|NCT04502433|537267395|FG001|Overall Study|Death|4|||
148941128|NCT04502433|537267394|FG000|Overall Study|Lost to Follow-up|1|||
148941129|NCT04502433|537267395|FG001|Overall Study|Lost to Follow-up|0|||
148941130|NCT04502433|537267394|FG000|Overall Study|Physician Decision|0|||
148808347|NCT06178991|536775802|FG005|Overall Study|Death|0|||
148808348|NCT06178991|536775803|FG006|Overall Study|Death|1|||
148808349|NCT06178991|536775804|FG007|Overall Study|Death|1|||
148808350|NCT06178991|536775797|FG000|Overall Study|Randomized but not Vaccinated|4|||
148808351|NCT06178991|536775798|FG001|Overall Study|Randomized but not Vaccinated|1|||
148808352|NCT06178991|536775799|FG002|Overall Study|Randomized but not Vaccinated|15|||
148808353|NCT06178991|536775800|FG003|Overall Study|Randomized but not Vaccinated|9|||
148941131|NCT04502433|537267395|FG001|Overall Study|Physician Decision|1|||
148941132|NCT01681472|537267396|FG000|Overall Study|Adverse Event|0|||
148808354|NCT06178991|536775801|FG004|Overall Study|Randomized but not Vaccinated|8|||
148808355|NCT06178991|536775802|FG005|Overall Study|Randomized but not Vaccinated|4|||
148941133|NCT01681472|537267397|FG001|Overall Study|Adverse Event|1|||
148941134|NCT01681472|537267398|FG002|Overall Study|Adverse Event|0|||
148941135|NCT01681472|537267399|FG003|Overall Study|Adverse Event|0|||
148808356|NCT06178991|536775803|FG006|Overall Study|Randomized but not Vaccinated|2|||
148941136|NCT01752985|537267400|FG000|Treatment Period|Subject request to discontinue treatment|1|||
148941137|NCT01752985|537267401|FG001|Treatment Period|Subject request to discontinue treatment|0|||
148808357|NCT06178991|536775804|FG007|Overall Study|Randomized but not Vaccinated|2|||
148808358|NCT06178991|536775797|FG000|Overall Study|Other: Unspecified|0|||
148808359|NCT06178991|536775798|FG001|Overall Study|Other: Unspecified|1|||
148941138|NCT01752985|537267402|FG002|Treatment Period|Subject request to discontinue treatment|1|||
148941139|NCT01752985|537267400|FG000|Treatment Period|Subject no longer meets study criteria|0|||
148941140|NCT01752985|537267401|FG001|Treatment Period|Subject no longer meets study criteria|1|||
148941141|NCT01752985|537267402|FG002|Treatment Period|Subject no longer meets study criteria|1|||
148941142|NCT01752985|537267400|FG000|Treatment Period|Adverse Event|2|||
148941143|NCT01752985|537267401|FG001|Treatment Period|Adverse Event|1|||
148941144|NCT01752985|537267402|FG002|Treatment Period|Adverse Event|2|||
148941145|NCT01752985|537267400|FG000|Treatment Period|Withdrawal by Subject|1|||
148941146|NCT01752985|537267401|FG001|Treatment Period|Withdrawal by Subject|1|||
148941147|NCT01752985|537267402|FG002|Treatment Period|Withdrawal by Subject|0|||
148941148|NCT01752985|537267400|FG000|Treatment Period|Lost to Follow-up|0|||
148941149|NCT01752985|537267401|FG001|Treatment Period|Lost to Follow-up|0|||
148941150|NCT01752985|537267402|FG002|Treatment Period|Lost to Follow-up|1|||
148941151|NCT06934993|537267403|FG000|Overall Study|Withdrawal by Subject|29|||
148941152|NCT06934993|537267403|FG000|Overall Study|elevated postoperative creatinine level|11|||
148941153|NCT06934993|537267403|FG000|Overall Study|Death|3|||
148941154|NCT05147428|537267404|FG000|Overall Study|Removed prior to mailing|289|||
148941155|NCT05147428|537267405|FG001|Overall Study|Removed prior to mailing|306|||
148941156|NCT05147428|537267406|FG002|Overall Study|Removed prior to mailing|270|||
148941157|NCT05147428|537267404|FG000|Overall Study|Died or disenrolled during blackout period|239|||
148941158|NCT05147428|537267405|FG001|Overall Study|Died or disenrolled during blackout period|278|||
148941159|NCT05147428|537267406|FG002|Overall Study|Died or disenrolled during blackout period|273|||
148941160|NCT03372096|537269183|FG000|Overall Study|Study Closed|8|||
148941161|NCT00040365|537269184|FG000|Overall Study|Death|1|||
148941162|NCT00040365|537269184|FG000|Overall Study|Progressive disease|7|||
148941163|NCT00040365|537269184|FG000|Overall Study|Lost to Follow-up|3|||
148941164|NCT02279420|537269185|FG000|Overall Study|Lost to Follow-up|23|||
148941165|NCT01153347|537269186|FG000|Overall Study|Withdrawal by Subject|7|||
148941166|NCT01153347|537269187|FG001|Overall Study|Withdrawal by Subject|7|||
148941167|NCT01153347|537269188|FG002|Overall Study|Withdrawal by Subject|7|||
148941168|NCT01153347|537269189|FG003|Overall Study|Withdrawal by Subject|7|||
148941169|NCT01153347|537269186|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148941170|NCT01153347|537269187|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
148941171|NCT01153347|537269188|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
148941172|NCT01153347|537269189|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
148941173|NCT01153347|537269186|FG000|Overall Study|Adverse Event|3|||
148941174|NCT01153347|537269187|FG001|Overall Study|Adverse Event|9|||
148941175|NCT01153347|537269188|FG002|Overall Study|Adverse Event|21|||
148941176|NCT01153347|537269189|FG003|Overall Study|Adverse Event|7|||
148941177|NCT01153347|537269186|FG000|Overall Study|Severe non-compliance to protocol|6|||
148941178|NCT01153347|537269187|FG001|Overall Study|Severe non-compliance to protocol|7|||
148941179|NCT01153347|537269188|FG002|Overall Study|Severe non-compliance to protocol|4|||
148941180|NCT01153347|537269189|FG003|Overall Study|Severe non-compliance to protocol|3|||
148941181|NCT01153347|537269186|FG000|Overall Study|Condition under investigation worsened|1|||
148941182|NCT01153347|537269187|FG001|Overall Study|Condition under investigation worsened|1|||
148941183|NCT01153347|537269188|FG002|Overall Study|Condition under investigation worsened|0|||
148941184|NCT01153347|537269189|FG003|Overall Study|Condition under investigation worsened|0|||
148941185|NCT01153347|537269186|FG000|Overall Study|Lack of Efficacy|2|||
148941186|NCT01153347|537269187|FG001|Overall Study|Lack of Efficacy|2|||
148941187|NCT01153347|537269188|FG002|Overall Study|Lack of Efficacy|0|||
148941188|NCT01153347|537269189|FG003|Overall Study|Lack of Efficacy|4|||
148941189|NCT01153347|537269186|FG000|Overall Study|Study-specific withdrawal criteria|4|||
148941190|NCT01153347|537269187|FG001|Overall Study|Study-specific withdrawal criteria|3|||
148941191|NCT01153347|537269188|FG002|Overall Study|Study-specific withdrawal criteria|1|||
148941192|NCT01153347|537269189|FG003|Overall Study|Study-specific withdrawal criteria|2|||
148941193|NCT01153347|537269186|FG000|Overall Study|Lost to Follow-up|4|||
148941194|NCT01153347|537269187|FG001|Overall Study|Lost to Follow-up|9|||
148941195|NCT01153347|537269188|FG002|Overall Study|Lost to Follow-up|11|||
148941196|NCT01153347|537269189|FG003|Overall Study|Lost to Follow-up|8|||
148941197|NCT01153347|537269186|FG000|Overall Study|Other|5|||
148941198|NCT01153347|537269187|FG001|Overall Study|Other|5|||
148941199|NCT01153347|537269188|FG002|Overall Study|Other|4|||
148941200|NCT01153347|537269189|FG003|Overall Study|Other|0|||
148941201|NCT01153347|537269186|FG000|Overall Study|Death|1|||
148941202|NCT01153347|537269187|FG001|Overall Study|Death|0|||
148941203|NCT01153347|537269188|FG002|Overall Study|Death|0|||
148941204|NCT01153347|537269189|FG003|Overall Study|Death|0|||
148941205|NCT02835820|537269190|FG000|Overall Study|Baseline Screen Failure|0|||
148941206|NCT02835820|537269191|FG001|Overall Study|Baseline Screen Failure|3|||
148941207|NCT05096221|537269194|FG000|Part 2|Physician Decision|0|||
148941208|NCT05096221|537269195|FG001|Part 2|Physician Decision|1|||
148941209|NCT04678661|537269198|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
148941210|NCT04678661|537269199|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
148941211|NCT04678661|537269198|FG000|Overall Study|Protocol Violation|2|||
148941212|NCT04678661|537269199|FG001|Overall Study|Protocol Violation|0|||
148941213|NCT04678661|537269198|FG000|Overall Study|Withdrawal by Subject|1|||
148941214|NCT04678661|537269199|FG001|Overall Study|Withdrawal by Subject|0|||
148941215|NCT04678661|537269198|FG000|Overall Study|Lost to Follow-up|2|||
148941216|NCT04678661|537269199|FG001|Overall Study|Lost to Follow-up|0|||
148941217|NCT04678661|537269198|FG000|Overall Study|Death|2|||
148941218|NCT04678661|537269199|FG001|Overall Study|Death|0|||
148941219|NCT01086033|537269200|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
148941220|NCT01086033|537269200|FG000|Overall Study|Lost to Follow-up|86|||
148941221|NCT01086033|537269200|FG000|Overall Study|Adverse Event|42|||
148941222|NCT01086033|537269200|FG000|Overall Study|Withdrawal by Subject|41|||
148941223|NCT01086033|537269200|FG000|Overall Study|Other|14|||
148941224|NCT01086033|537269200|FG000|Overall Study|Other|13|||
148941225|NCT01086033|537269200|FG000|Overall Study|AE and Withdrew Consent|5|||
148941226|NCT01086033|537269200|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
148941227|NCT01086033|537269200|FG000|Overall Study|Withdrew consent and Other Reason|4|||
148941228|NCT01086033|537269200|FG000|Overall Study|AE and Lack of Efficacy|4|||
148941229|NCT01086033|537269200|FG000|Overall Study|Death|1|||
148941230|NCT01086033|537269200|FG000|Overall Study|AE and Lost to Follow-up|1|||
148941231|NCT01086033|537269200|FG000|Overall Study|AE and Other Reason|1|||
148941232|NCT01086033|537269200|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
148941233|NCT03094169|537269201|FG000|Overall Study|Lack of Efficacy|0|||
148941234|NCT03094169|537269202|FG001|Overall Study|Lack of Efficacy|0|||
148941235|NCT03094169|537269203|FG002|Overall Study|Lack of Efficacy|0|||
148941236|NCT03094169|537269204|FG003|Overall Study|Lack of Efficacy|0|||
148941237|NCT03094169|537269205|FG004|Overall Study|Lack of Efficacy|0|||
148941238|NCT03094169|537269206|FG005|Overall Study|Lack of Efficacy|0|||
148941239|NCT03094169|537269207|FG006|Overall Study|Lack of Efficacy|0|||
148941240|NCT03094169|537269208|FG007|Overall Study|Lack of Efficacy|21|||
148941241|NCT03094169|537269201|FG000|Overall Study|Adverse Event|0|||
148941242|NCT03094169|537269202|FG001|Overall Study|Adverse Event|0|||
148941243|NCT03094169|537269203|FG002|Overall Study|Adverse Event|0|||
148941244|NCT03094169|537269204|FG003|Overall Study|Adverse Event|0|||
148941245|NCT03094169|537269205|FG004|Overall Study|Adverse Event|0|||
148941246|NCT03094169|537269206|FG005|Overall Study|Adverse Event|0|||
148941247|NCT03094169|537269207|FG006|Overall Study|Adverse Event|0|||
148941248|NCT03094169|537269208|FG007|Overall Study|Adverse Event|2|||
148941249|NCT03094169|537269201|FG000|Overall Study|Withdrawal by Subject|0|||
148941250|NCT03094169|537269202|FG001|Overall Study|Withdrawal by Subject|0|||
148941251|NCT03094169|537269203|FG002|Overall Study|Withdrawal by Subject|0|||
148941252|NCT03094169|537269204|FG003|Overall Study|Withdrawal by Subject|0|||
148941253|NCT03094169|537269205|FG004|Overall Study|Withdrawal by Subject|0|||
148941254|NCT03094169|537269206|FG005|Overall Study|Withdrawal by Subject|0|||
148941255|NCT03094169|537269207|FG006|Overall Study|Withdrawal by Subject|1|||
148941256|NCT03094169|537269208|FG007|Overall Study|Withdrawal by Subject|1|||
148941257|NCT03094169|537269201|FG000|Overall Study|Trial Termination|0|||
148941258|NCT03094169|537269202|FG001|Overall Study|Trial Termination|0|||
148941259|NCT03094169|537269203|FG002|Overall Study|Trial Termination|0|||
148941260|NCT03094169|537269204|FG003|Overall Study|Trial Termination|0|||
148941261|NCT03094169|537269205|FG004|Overall Study|Trial Termination|0|||
148941262|NCT03094169|537269206|FG005|Overall Study|Trial Termination|0|||
148941263|NCT03094169|537269207|FG006|Overall Study|Trial Termination|0|||
148941264|NCT03094169|537269208|FG007|Overall Study|Trial Termination|1|||
148941265|NCT04645953|537269209|FG000|Overall Study|Lost to Follow-up|2|||
148941266|NCT04645953|537269210|FG001|Overall Study|Lost to Follow-up|1|||
148941267|NCT04645953|537269211|FG002|Overall Study|Lost to Follow-up|1|||
148941268|NCT04645953|537269209|FG000|Overall Study|Withdrawal by Subject|0|||
148941269|NCT04645953|537269210|FG001|Overall Study|Withdrawal by Subject|1|||
148941270|NCT04645953|537269211|FG002|Overall Study|Withdrawal by Subject|0|||
148941271|NCT04645953|537269209|FG000|Overall Study|Physician Decision|0|||
148941272|NCT04645953|537269210|FG001|Overall Study|Physician Decision|1|||
148941273|NCT04645953|537269211|FG002|Overall Study|Physician Decision|0|||
148941274|NCT04645953|537269209|FG000|Overall Study|Discontinued Prior to Dosing|0|||
148941275|NCT04645953|537269210|FG001|Overall Study|Discontinued Prior to Dosing|0|||
148941276|NCT04645953|537269211|FG002|Overall Study|Discontinued Prior to Dosing|2|||
148941277|NCT00864721|537269212|FG000|Overall Study|Patient request|11|||
148941278|NCT00864721|537269212|FG000|Overall Study|Hospitalized|1|||
148941279|NCT00864721|537269212|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
148941280|NCT00864721|537269212|FG000|Overall Study|Adverse Event|21|||
148941281|NCT03345914|537269215|FG000|Overall Study|Transition to another study at week 16|80|||
148941282|NCT03345914|537269216|FG001|Overall Study|Transition to another study at week 16|86|||
148941283|NCT03345914|537269217|FG002|Overall Study|Transition to another study at week 16|78|||
148941284|NCT03345914|537269215|FG000|Overall Study|Transition to OLE during follow-up|37|||
148941285|NCT03345914|537269216|FG001|Overall Study|Transition to OLE during follow-up|33|||
148941286|NCT03345914|537269217|FG002|Overall Study|Transition to OLE during follow-up|39|||
148941287|NCT03345914|537269215|FG000|Overall Study|Physician Decision|0|||
148941288|NCT03345914|537269216|FG001|Overall Study|Physician Decision|1|||
148941289|NCT03345914|537269217|FG002|Overall Study|Physician Decision|1|||
148941290|NCT03345914|537269215|FG000|Overall Study|Withdrawal by Subject|5|||
148941291|NCT03345914|537269216|FG001|Overall Study|Withdrawal by Subject|1|||
148941292|NCT03345914|537269217|FG002|Overall Study|Withdrawal by Subject|2|||
148941293|NCT03345914|537269215|FG000|Overall Study|Other|1|||
148941294|NCT03345914|537269216|FG001|Overall Study|Other|1|||
148941295|NCT03345914|537269217|FG002|Overall Study|Other|1|||
148941296|NCT03345914|537269215|FG000|Overall Study|Ongoing|0|||
148941297|NCT03345914|537269216|FG001|Overall Study|Ongoing|0|||
148941298|NCT03345914|537269217|FG002|Overall Study|Ongoing|1|||
148941299|NCT00261807|537269218|FG000|Overall Study|Lost to Follow-up|2|||
148941300|NCT00261807|537269218|FG000|Overall Study|Adverse Event|2|||
148941301|NCT00261807|537269218|FG000|Overall Study|Death|1|||
148941302|NCT00261807|537269218|FG000|Overall Study|Protocol Violation|2|||
148941303|NCT01706146|537269219|FG000|Overall Study|Withdrawal by Subject|1|||
148941304|NCT01706146|537269219|FG000|Overall Study|Adverse Event|3|||
148941305|NCT01706146|537269219|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
148941306|NCT00675948|537269221|FG000|Overall Study|Adverse Event|23|||
148941307|NCT00675948|537269222|FG001|Overall Study|Adverse Event|1|||
148808360|NCT06178991|536775799|FG002|Overall Study|Other: Unspecified|7|||
148808361|NCT06178991|536775800|FG003|Overall Study|Other: Unspecified|6|||
148808362|NCT06178991|536775801|FG004|Overall Study|Other: Unspecified|1|||
148808363|NCT06178991|536775802|FG005|Overall Study|Other: Unspecified|1|||
148808364|NCT06178991|536775803|FG006|Overall Study|Other: Unspecified|1|||
148808365|NCT06178991|536775804|FG007|Overall Study|Other: Unspecified|0|||
148808366|NCT06178991|536775797|FG000|Overall Study|Physician Decision|0|||
148808367|NCT06178991|536775798|FG001|Overall Study|Physician Decision|0|||
148808368|NCT06178991|536775799|FG002|Overall Study|Physician Decision|2|||
148808369|NCT06178991|536775800|FG003|Overall Study|Physician Decision|0|||
148808370|NCT06178991|536775801|FG004|Overall Study|Physician Decision|2|||
148808371|NCT06178991|536775802|FG005|Overall Study|Physician Decision|1|||
148808372|NCT06178991|536775803|FG006|Overall Study|Physician Decision|0|||
148808373|NCT06178991|536775804|FG007|Overall Study|Physician Decision|0|||
148808374|NCT06178991|536775797|FG000|Overall Study|Protocol Violation|0|||
148808375|NCT06178991|536775798|FG001|Overall Study|Protocol Violation|0|||
148808376|NCT06178991|536775799|FG002|Overall Study|Protocol Violation|1|||
148808377|NCT06178991|536775800|FG003|Overall Study|Protocol Violation|0|||
148808378|NCT06178991|536775801|FG004|Overall Study|Protocol Violation|0|||
148808379|NCT06178991|536775802|FG005|Overall Study|Protocol Violation|0|||
148808380|NCT06178991|536775803|FG006|Overall Study|Protocol Violation|0|||
148808381|NCT06178991|536775804|FG007|Overall Study|Protocol Violation|0|||
148808382|NCT04739800|536775805|FG000|Overall Study|Adverse Event|2|||
148808383|NCT04739800|536775806|FG001|Overall Study|Adverse Event|1|||
148808384|NCT04739800|536775807|FG002|Overall Study|Adverse Event|4|||
148808385|NCT04739800|536775808|FG003|Overall Study|Adverse Event|5|||
148808386|NCT04739800|536775805|FG000|Overall Study|Never Treated|2|||
148808387|NCT04739800|536775806|FG001|Overall Study|Never Treated|0|||
148808388|NCT04739800|536775807|FG002|Overall Study|Never Treated|1|||
148808389|NCT04739800|536775808|FG003|Overall Study|Never Treated|1|||
148808390|NCT04739800|536775805|FG000|Overall Study|On Treatment|5|||
148808391|NCT04739800|536775806|FG001|Overall Study|On Treatment|9|||
148808392|NCT04739800|536775807|FG002|Overall Study|On Treatment|9|||
148808393|NCT04739800|536775808|FG003|Overall Study|On Treatment|9|||
148808394|NCT04739800|536775805|FG000|Overall Study|Symptomatic Deterioration|1|||
148808395|NCT04739800|536775806|FG001|Overall Study|Symptomatic Deterioration|1|||
148808396|NCT04739800|536775807|FG002|Overall Study|Symptomatic Deterioration|3|||
148808397|NCT04739800|536775808|FG003|Overall Study|Symptomatic Deterioration|0|||
148808398|NCT04739800|536775805|FG000|Overall Study|Withdrawal by Subject|1|||
148808399|NCT04739800|536775806|FG001|Overall Study|Withdrawal by Subject|2|||
148808400|NCT04739800|536775807|FG002|Overall Study|Withdrawal by Subject|1|||
148808401|NCT04739800|536775808|FG003|Overall Study|Withdrawal by Subject|3|||
148808402|NCT04739800|536775805|FG000|Overall Study|Other Reason|1|||
148808403|NCT04739800|536775806|FG001|Overall Study|Other Reason|3|||
148808404|NCT04739800|536775807|FG002|Overall Study|Other Reason|5|||
148808405|NCT04739800|536775808|FG003|Overall Study|Other Reason|4|||
148808406|NCT04880850|536775811|FG000|Overall Study|Death|2|||
148808407|NCT04880850|536775812|FG001|Overall Study|Death|1|||
148808408|NCT04880850|536775811|FG000|Overall Study|Lost to Follow-up|3|||
148808409|NCT04880850|536775812|FG001|Overall Study|Lost to Follow-up|6|||
148808410|NCT04880850|536775811|FG000|Overall Study|Physician Decision|2|||
148808411|NCT04880850|536775812|FG001|Overall Study|Physician Decision|1|||
148808412|NCT04880850|536775811|FG000|Overall Study|Withdrawal by Subject|9|||
148808413|NCT04880850|536775812|FG001|Overall Study|Withdrawal by Subject|10|||
148808414|NCT04091451|536775813|FG000|Overall Study|Adverse Event|15|||
148808415|NCT04091451|536775814|FG001|Overall Study|Adverse Event|10|||
148808416|NCT04091451|536775813|FG000|Overall Study|Lost to Follow-up|8|||
148808417|NCT04091451|536775814|FG001|Overall Study|Lost to Follow-up|8|||
148808418|NCT04091451|536775813|FG000|Overall Study|Protocol Violation|5|||
148808419|NCT04091451|536775814|FG001|Overall Study|Protocol Violation|4|||
148941308|NCT00675948|537269221|FG000|Overall Study|Lack of Efficacy|3|||
148941309|NCT00675948|537269222|FG001|Overall Study|Lack of Efficacy|0|||
148941310|NCT00675948|537269221|FG000|Overall Study|Withdrawal by Subject|7|||
148941311|NCT00675948|537269222|FG001|Overall Study|Withdrawal by Subject|0|||
148941312|NCT00675948|537269221|FG000|Overall Study|Lost to Follow-up|2|||
148808420|NCT04091451|536775813|FG000|Overall Study|Withdrawal by Subject|21|||
148808421|NCT04091451|536775814|FG001|Overall Study|Withdrawal by Subject|27|||
148808422|NCT04091451|536775813|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
148941313|NCT00675948|537269222|FG001|Overall Study|Lost to Follow-up|0|||
148808423|NCT04091451|536775814|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
148808424|NCT04091451|536775813|FG000|Overall Study|Migrated/moved from the study area|3|||
148808425|NCT04091451|536775814|FG001|Overall Study|Migrated/moved from the study area|5|||
148808426|NCT04091451|536775813|FG000|Overall Study|Suspected HZ episode|1|||
148808427|NCT04091451|536775814|FG001|Overall Study|Suspected HZ episode|0|||
148808428|NCT03907488|536775815|FG000|Overall Study|Adverse Event|20|||
148808429|NCT03907488|536775816|FG001|Overall Study|Adverse Event|20|||
148808430|NCT03907488|536775815|FG000|Overall Study|Withdrawal by Subject|9|||
148808431|NCT03907488|536775816|FG001|Overall Study|Withdrawal by Subject|13|||
148941314|NCT00675948|537269221|FG000|Overall Study|Protocol Violation|1|||
148941315|NCT00675948|537269222|FG001|Overall Study|Protocol Violation|0|||
148941316|NCT00675948|537269221|FG000|Overall Study|Pain under control|1|||
148941317|NCT00675948|537269222|FG001|Overall Study|Pain under control|0|||
149015745|NCT01461993|537536160|FG002|Overall Study|Adverse Event|3|||
149015746|NCT01461993|537536158|FG000|Overall Study|No longer met eligibility criteria|13|||
149015747|NCT01461993|537536159|FG001|Overall Study|No longer met eligibility criteria|18|||
149015748|NCT01461993|537536160|FG002|Overall Study|No longer met eligibility criteria|10|||
149015749|NCT01461993|537536158|FG000|Overall Study|Did not meet entrance criteria|2|||
149015750|NCT01461993|537536159|FG001|Overall Study|Did not meet entrance criteria|3|||
149015751|NCT01461993|537536160|FG002|Overall Study|Did not meet entrance criteria|0|||
149015752|NCT01461993|537536158|FG000|Overall Study|Other|13|||
149015753|NCT01461993|537536159|FG001|Overall Study|Other|15|||
149015754|NCT01461993|537536160|FG002|Overall Study|Other|6|||
149015755|NCT00680056|537536162|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
149015756|NCT00680056|537536163|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
148941318|NCT00675948|537269221|FG000|Overall Study|Sponsor decision|0|||
148941319|NCT00675948|537269222|FG001|Overall Study|Sponsor decision|1|||
148941320|NCT00675948|537269221|FG000|Overall Study|Patient died|1|||
148941321|NCT00675948|537269222|FG001|Overall Study|Patient died|0|||
148941322|NCT00675948|537269221|FG000|Overall Study|Patient unable to comply with diaries|1|||
149015757|NCT00680056|537536162|FG000|Second Intervention|Protocol Violation|3|||
149015758|NCT00680056|537536163|FG001|Second Intervention|Protocol Violation|1|||
149015759|NCT03688711|537536164|FG000|Overall Study|Withdrawal by Subject|0|||
149015760|NCT03688711|537536165|FG001|Overall Study|Withdrawal by Subject|1|||
149015761|NCT04175912|537536169|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
149015762|NCT04175912|537536170|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
149015763|NCT04175912|537536169|FG000|Overall Study|Adverse Event|0|||
149015764|NCT04175912|537536170|FG001|Overall Study|Adverse Event|3|||
149015765|NCT04175912|537536169|FG000|Overall Study|Never started treatment|3|||
149015766|NCT04175912|537536170|FG001|Overall Study|Never started treatment|3|||
149015767|NCT04175912|537536169|FG000|Overall Study|Death|0|||
149015768|NCT04175912|537536170|FG001|Overall Study|Death|1|||
149015769|NCT05832437|537536182|FG000|Overall Study|time off work|1|||
149015770|NCT05832437|537536183|FG001|Overall Study|time off work|0|||
149015771|NCT05832437|537536184|FG002|Overall Study|time off work|0|||
149015772|NCT05832437|537536185|FG003|Overall Study|time off work|0|||
149015773|NCT03169881|537536189|FG000|Overall Study|Incomplete Follow-up|10|||
149015774|NCT03169881|537536190|FG001|Overall Study|Incomplete Follow-up|15|||
149015775|NCT03169881|537536189|FG000|Overall Study|Lost to Follow-up|18|||
149015776|NCT03169881|537536190|FG001|Overall Study|Lost to Follow-up|20|||
149015777|NCT03169881|537536189|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
149015778|NCT03169881|537536190|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
149015779|NCT03734991|537536191|FG000|Overall Study|Adverse Event|4|||
149015780|NCT03734991|537536192|FG001|Overall Study|Adverse Event|0|||
149015781|NCT03734991|537536191|FG000|Overall Study|Lost to Follow-up|4|||
149015782|NCT03734991|537536192|FG001|Overall Study|Lost to Follow-up|0|||
149015783|NCT03734991|537536191|FG000|Overall Study|Physician Decision|0|||
149015784|NCT03734991|537536192|FG001|Overall Study|Physician Decision|1|||
148941323|NCT00675948|537269222|FG001|Overall Study|Patient unable to comply with diaries|0|||
148941324|NCT00675948|537269221|FG000|Overall Study|Patient feels unable to take medication|0|||
148941325|NCT00675948|537269222|FG001|Overall Study|Patient feels unable to take medication|1|||
148941326|NCT00762229|537269223|FG000|Overall Study|Lost to Follow-up|1|||
148941327|NCT00762229|537269224|FG001|Overall Study|Lost to Follow-up|1|||
148941328|NCT00762229|537269223|FG000|Overall Study|did not recveive intervention|0|||
148941329|NCT00762229|537269224|FG001|Overall Study|did not recveive intervention|1|||
148941330|NCT01751178|537269229|FG000|Overall Study|Adverse Event|2|||
148941331|NCT01751178|537269230|FG001|Overall Study|Adverse Event|0|||
148941332|NCT01751178|537269231|FG002|Overall Study|Adverse Event|0|||
148941333|NCT01751178|537269229|FG000|Overall Study|Other Reason (unknown)|1|||
148941334|NCT01751178|537269230|FG001|Overall Study|Other Reason (unknown)|0|||
148941335|NCT01751178|537269231|FG002|Overall Study|Other Reason (unknown)|2|||
148941336|NCT02747875|537269232|FG000|Overall Study|Physician Decision|1|||
148941337|NCT02747875|537269233|FG001|Overall Study|Physician Decision|0|||
149015785|NCT03734991|537536191|FG000|Overall Study|Pregnancy|1|||
149015786|NCT03734991|537536192|FG001|Overall Study|Pregnancy|0|||
148941338|NCT02747875|537269232|FG000|Overall Study|Adverse Event|0|||
148941339|NCT02747875|537269233|FG001|Overall Study|Adverse Event|1|||
148941340|NCT02589405|537269234|FG000|Overall Study|Adverse Event|3|||
148941341|NCT02589405|537269234|FG000|Overall Study|Withdrawal by Subject|1|||
148941342|NCT02693119|537269238|FG000|Open-Label Period|Withdrawal by Subject|0|||
149015787|NCT03734991|537536191|FG000|Overall Study|Withdrawal by Subject|6|||
149015788|NCT03734991|537536192|FG001|Overall Study|Withdrawal by Subject|3|||
149015789|NCT03734991|537536191|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
149015790|NCT03734991|537536192|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
149015791|NCT03734991|537536191|FG000|Overall Study|Other|2|||
149015792|NCT03734991|537536192|FG001|Overall Study|Other|2|||
148941343|NCT02693119|537269239|FG001|Open-Label Period|Withdrawal by Subject|1|||
148941344|NCT01719783|537269240|FG000|Dose 2|Physician Decision|1|||
148941345|NCT01719783|537269241|FG001|Dose 2|Physician Decision|0|||
148941346|NCT01350492|537269242|FG000|Intervention|Lost to Follow-up|2|||
148941347|NCT01350492|537269243|FG001|Intervention|Lost to Follow-up|5|||
148941348|NCT01350492|537269242|FG000|Intervention|Withdrawal by Subject|3|||
148941349|NCT01350492|537269243|FG001|Intervention|Withdrawal by Subject|1|||
148941350|NCT01350492|537269242|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
148941351|NCT01350492|537269243|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
148941352|NCT01350492|537269242|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
148941353|NCT01350492|537269243|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
148941354|NCT02319837|537269244|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
148941355|NCT02319837|537269245|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
148941356|NCT02319837|537269246|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
148941357|NCT02319837|537269244|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
148941358|NCT02319837|537269245|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
148941359|NCT02319837|537269246|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
148941360|NCT02319837|537269244|FG000|Study Treatment Phase|Adverse Event|73|||
148941361|NCT02319837|537269245|FG001|Study Treatment Phase|Adverse Event|36|||
148941362|NCT02319837|537269246|FG002|Study Treatment Phase|Adverse Event|63|||
148941363|NCT02319837|537269244|FG000|Study Treatment Phase|Development of castration resistance|0|||
148941364|NCT02319837|537269245|FG001|Study Treatment Phase|Development of castration resistance|2|||
148941365|NCT02319837|537269246|FG002|Study Treatment Phase|Development of castration resistance|0|||
148941366|NCT02319837|537269244|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
148941367|NCT02319837|537269245|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
148941368|NCT02319837|537269246|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
148941369|NCT02319837|537269244|FG000|Study Treatment Phase|Protocol Violation|2|||
148941370|NCT02319837|537269245|FG001|Study Treatment Phase|Protocol Violation|2|||
148941371|NCT02319837|537269246|FG002|Study Treatment Phase|Protocol Violation|1|||
148941372|NCT02319837|537269244|FG000|Study Treatment Phase|Lost to Follow-up|0|||
148941373|NCT02319837|537269245|FG001|Study Treatment Phase|Lost to Follow-up|1|||
148941374|NCT02319837|537269246|FG002|Study Treatment Phase|Lost to Follow-up|0|||
148941375|NCT02319837|537269244|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
148941376|NCT02319837|537269245|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
148941377|NCT02319837|537269246|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
148941378|NCT02319837|537269244|FG000|Study Treatment Phase|Other|0|||
148941379|NCT02319837|537269245|FG001|Study Treatment Phase|Other|1|||
148941380|NCT02319837|537269246|FG002|Study Treatment Phase|Other|0|||
148941381|NCT02319837|537269244|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
148941382|NCT02319837|537269245|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
148941383|NCT02319837|537269246|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
148941384|NCT02319837|537269244|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
148941385|NCT02319837|537269245|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
148941386|NCT02319837|537269246|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
148941387|NCT02319837|537269244|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
148941388|NCT02319837|537269245|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
148941389|NCT02319837|537269246|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
148941390|NCT02319837|537269244|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
148941391|NCT02319837|537269245|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
148941392|NCT02319837|537269246|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
148941393|NCT02319837|537269244|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
148941394|NCT02319837|537269245|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
148941395|NCT02319837|537269246|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
148941396|NCT02319837|537269244|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
148941397|NCT02319837|537269245|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
148941398|NCT02319837|537269246|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
148941399|NCT02319837|537269244|FG000|Long-Term Follow-Up Phase|Death|33|||
148941400|NCT02319837|537269245|FG001|Long-Term Follow-Up Phase|Death|54|||
148941401|NCT02319837|537269246|FG002|Long-Term Follow-Up Phase|Death|42|||
148941402|NCT00753766|537269247|FG000|Overall Study|Physician Decision|1|||
148941403|NCT00753766|537269248|FG001|Overall Study|Physician Decision|0|||
148941404|NCT02805972|537269253|FG000|Washout Period|Lost to Follow-up|3|||
148941405|NCT02805972|537269254|FG001|Washout Period|Lost to Follow-up|0|||
149197070|NCT01274338|538191076|FG003|Overall Study|Alternative therapy|0|||
148941406|NCT00939640|537269255|FG000|Overall Study|Physician Decision|1|||
148941407|NCT00239590|537269256|FG000|Randomized|Lost to Follow-up|0|||
148941408|NCT00239590|537269257|FG001|Randomized|Lost to Follow-up|1|||
148941409|NCT00239590|537269256|FG000|Randomized|Withdrawal by Subject|0|||
148941410|NCT00239590|537269257|FG001|Randomized|Withdrawal by Subject|1|||
148941411|NCT00239590|537269256|FG000|Completed Study Protocol|Adverse Event|1|||
148941412|NCT00239590|537269257|FG001|Completed Study Protocol|Adverse Event|1|||
148941413|NCT00239590|537269256|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
148941414|NCT00239590|537269257|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
148941415|NCT02121522|537269259|FG000|Overall Study|Adverse Event|1|||
148941416|NCT00892047|537269265|FG000|Overall Study|Adverse Event|2|||
148941417|NCT00892047|537269266|FG001|Overall Study|Adverse Event|2|||
148941418|NCT00892047|537269265|FG000|Overall Study|subject burden|2|||
148941419|NCT00892047|537269266|FG001|Overall Study|subject burden|3|||
148941420|NCT00892047|537269265|FG000|Overall Study|Lack of Efficacy|0|||
148941421|NCT00892047|537269266|FG001|Overall Study|Lack of Efficacy|2|||
148682613|NCT05266456|536310965|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
148941422|NCT05306977|537269267|FG000|Overall Study|Withdrawal by Subject|1|||
148941423|NCT00369824|537269268|FG000|Overall Study|Adverse Event|0|||
148941424|NCT00369824|537269269|FG001|Overall Study|Adverse Event|2|||
148941425|NCT00369824|537269270|FG002|Overall Study|Adverse Event|0|||
149015793|NCT02322814|537536193|FG000|Overall Study|Death|7|||
149015794|NCT02322814|537536194|FG001|Overall Study|Death|29|||
149015795|NCT02322814|537536195|FG002|Overall Study|Death|32|||
149015796|NCT02322814|537536196|FG003|Overall Study|Death|23|||
149015797|NCT02322814|537536197|FG004|Overall Study|Death|14|||
149015798|NCT02322814|537536193|FG000|Overall Study|Lost to Follow-up|1|||
149015799|NCT02322814|537536194|FG001|Overall Study|Lost to Follow-up|3|||
149015800|NCT02322814|537536195|FG002|Overall Study|Lost to Follow-up|3|||
149015801|NCT02322814|537536196|FG003|Overall Study|Lost to Follow-up|1|||
149015802|NCT02322814|537536197|FG004|Overall Study|Lost to Follow-up|0|||
149015803|NCT02322814|537536193|FG000|Overall Study|Various Reasons|2|||
149015804|NCT02322814|537536194|FG001|Overall Study|Various Reasons|0|||
149015805|NCT02322814|537536195|FG002|Overall Study|Various Reasons|1|||
149015806|NCT02322814|537536196|FG003|Overall Study|Various Reasons|1|||
149015807|NCT02322814|537536197|FG004|Overall Study|Various Reasons|0|||
149015808|NCT02322814|537536193|FG000|Overall Study|Progressive Disease|0|||
149015809|NCT02322814|537536194|FG001|Overall Study|Progressive Disease|0|||
149015810|NCT02322814|537536195|FG002|Overall Study|Progressive Disease|0|||
149015811|NCT02322814|537536196|FG003|Overall Study|Progressive Disease|1|||
149015812|NCT02322814|537536197|FG004|Overall Study|Progressive Disease|1|||
149015813|NCT02322814|537536193|FG000|Overall Study|Protocol Violation|1|||
149015814|NCT02322814|537536194|FG001|Overall Study|Protocol Violation|0|||
149015815|NCT02322814|537536195|FG002|Overall Study|Protocol Violation|0|||
149015816|NCT02322814|537536196|FG003|Overall Study|Protocol Violation|0|||
149015817|NCT02322814|537536197|FG004|Overall Study|Protocol Violation|0|||
149015818|NCT02322814|537536193|FG000|Overall Study|Study Terminated by Sponsor|0|||
149015819|NCT02322814|537536194|FG001|Overall Study|Study Terminated by Sponsor|7|||
149015820|NCT02322814|537536195|FG002|Overall Study|Study Terminated by Sponsor|9|||
149015821|NCT02322814|537536196|FG003|Overall Study|Study Terminated by Sponsor|5|||
149015822|NCT02322814|537536197|FG004|Overall Study|Study Terminated by Sponsor|13|||
149015823|NCT02322814|537536193|FG000|Overall Study|Withdrawal by Subject|5|||
149015824|NCT02322814|537536194|FG001|Overall Study|Withdrawal by Subject|4|||
149015825|NCT02322814|537536195|FG002|Overall Study|Withdrawal by Subject|2|||
149015826|NCT02322814|537536196|FG003|Overall Study|Withdrawal by Subject|1|||
149015827|NCT02322814|537536197|FG004|Overall Study|Withdrawal by Subject|3|||
149015828|NCT03012061|537536198|FG000|Overall Study|Withdrawal by Subject|1|||
149015829|NCT03012061|537536199|FG001|Overall Study|Withdrawal by Subject|5|||
149015830|NCT03012061|537536200|FG002|Overall Study|Withdrawal by Subject|4|||
149015831|NCT03012061|537536198|FG000|Overall Study|Investigator Site Closed|1|||
149015832|NCT03012061|537536199|FG001|Overall Study|Investigator Site Closed|2|||
149015833|NCT03012061|537536200|FG002|Overall Study|Investigator Site Closed|0|||
149015834|NCT03012061|537536198|FG000|Overall Study|Lost to Follow-up|2|||
149015835|NCT03012061|537536199|FG001|Overall Study|Lost to Follow-up|1|||
149015836|NCT03012061|537536200|FG002|Overall Study|Lost to Follow-up|0|||
149015837|NCT03012061|537536198|FG000|Overall Study|Study closed/ Terminated|0|||
149015838|NCT03012061|537536199|FG001|Overall Study|Study closed/ Terminated|0|||
149015839|NCT03012061|537536200|FG002|Overall Study|Study closed/ Terminated|1|||
149015840|NCT03012061|537536198|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
149015841|NCT03012061|537536199|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
149015842|NCT03012061|537536200|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
149015843|NCT03012061|537536198|FG000|Overall Study|Protocol Violation|0|||
149015844|NCT03012061|537536199|FG001|Overall Study|Protocol Violation|0|||
149015845|NCT03012061|537536200|FG002|Overall Study|Protocol Violation|2|||
149015846|NCT03012061|537536198|FG000|Overall Study|Lack of Efficacy|0|||
149015847|NCT03012061|537536199|FG001|Overall Study|Lack of Efficacy|1|||
149015848|NCT03012061|537536200|FG002|Overall Study|Lack of Efficacy|0|||
149015849|NCT03012061|537536198|FG000|Overall Study|Adverse Event|2|||
149015850|NCT03012061|537536199|FG001|Overall Study|Adverse Event|0|||
149015851|NCT03012061|537536200|FG002|Overall Study|Adverse Event|0|||
149015852|NCT01164228|537536201|FG000|Overall Study|Progression|24|||
149015853|NCT01164228|537536202|FG001|Overall Study|Progression|25|||
149015854|NCT01164228|537536201|FG000|Overall Study|Adverse Event|13|||
149015855|NCT01164228|537536202|FG001|Overall Study|Adverse Event|7|||
149015856|NCT01164228|537536201|FG000|Overall Study|Death|1|||
149015857|NCT01164228|537536202|FG001|Overall Study|Death|1|||
149015858|NCT01164228|537536201|FG000|Overall Study|Withdrawal by Subject|2|||
149015859|NCT01164228|537536202|FG001|Overall Study|Withdrawal by Subject|0|||
149015860|NCT01164228|537536201|FG000|Overall Study|Physician Decision|1|||
149015861|NCT01164228|537536202|FG001|Overall Study|Physician Decision|2|||
149015862|NCT01164228|537536201|FG000|Overall Study|Symptomatic deterioration|1|||
149015863|NCT01164228|537536202|FG001|Overall Study|Symptomatic deterioration|0|||
149015864|NCT01164228|537536201|FG000|Overall Study|Never started treatment|1|||
149015865|NCT01164228|537536202|FG001|Overall Study|Never started treatment|3|||
149015866|NCT01164228|537536201|FG000|Overall Study|Ineligible|1|||
149015867|NCT01164228|537536202|FG001|Overall Study|Ineligible|0|||
149015868|NCT01233609|537536205|FG000|Overall Study|Death|1|||
149015869|NCT01233609|537536206|FG001|Overall Study|Death|0|||
149015870|NCT01233609|537536205|FG000|Overall Study|Lost to Follow-up|3|||
149015871|NCT01233609|537536206|FG001|Overall Study|Lost to Follow-up|1|||
149015872|NCT01233609|537536205|FG000|Overall Study|Adverse Event|2|||
149015873|NCT01233609|537536206|FG001|Overall Study|Adverse Event|1|||
149015874|NCT01233609|537536205|FG000|Overall Study|Withdrawal by Subject|3|||
149015875|NCT01233609|537536206|FG001|Overall Study|Withdrawal by Subject|0|||
149015876|NCT00735644|537536207|FG000|Overall Study|Did not receive study vaccine|0|||
149015877|NCT00735644|537536208|FG001|Overall Study|Did not receive study vaccine|1|||
149015878|NCT00735644|537536209|FG002|Overall Study|Did not receive study vaccine|0|||
149015879|NCT00735644|537536210|FG003|Overall Study|Did not receive study vaccine|0|||
149015880|NCT00735644|537536211|FG004|Overall Study|Did not receive study vaccine|0|||
149015881|NCT00735644|537536207|FG000|Overall Study|Withdrawal by Subject|0|||
149015882|NCT00735644|537536208|FG001|Overall Study|Withdrawal by Subject|1|||
149015883|NCT00735644|537536209|FG002|Overall Study|Withdrawal by Subject|1|||
149015884|NCT00735644|537536210|FG003|Overall Study|Withdrawal by Subject|1|||
149015885|NCT00735644|537536211|FG004|Overall Study|Withdrawal by Subject|0|||
148941426|NCT00369824|537269271|FG003|Overall Study|Adverse Event|0|||
148941427|NCT00369824|537269272|FG004|Overall Study|Adverse Event|1|||
148941428|NCT00369824|537269273|FG005|Overall Study|Adverse Event|0|||
148941429|NCT00369824|537269268|FG000|Overall Study|Protocol Violation|0|||
148941430|NCT00369824|537269269|FG001|Overall Study|Protocol Violation|1|||
148941431|NCT00369824|537269270|FG002|Overall Study|Protocol Violation|0|||
148682614|NCT01610167|536310966|FG000|Overall Study|Scheduling conflict.|0|||
148682615|NCT01610167|536310967|FG001|Overall Study|Scheduling conflict.|0|||
148682616|NCT01610167|536310968|FG002|Overall Study|Scheduling conflict.|2|||
148682617|NCT00411762|536310970|FG000|Overall Study|Withdrawal by Subject|5|||
148682618|NCT03276962|536310971|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
148682619|NCT03276962|536310972|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
148682620|NCT03276962|536310973|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
148682621|NCT03276962|536310974|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
148682622|NCT03276962|536310975|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
148682623|NCT03276962|536310971|FG000|Overall Study|Protocol Deviation|2|||
148941432|NCT00369824|537269271|FG003|Overall Study|Protocol Violation|1|||
148941433|NCT00369824|537269272|FG004|Overall Study|Protocol Violation|1|||
148941434|NCT00369824|537269273|FG005|Overall Study|Protocol Violation|0|||
148941435|NCT00369824|537269268|FG000|Overall Study|Withdrawal by Subject|9|||
148941436|NCT00369824|537269269|FG001|Overall Study|Withdrawal by Subject|5|||
148941437|NCT00369824|537269270|FG002|Overall Study|Withdrawal by Subject|5|||
148941438|NCT00369824|537269271|FG003|Overall Study|Withdrawal by Subject|4|||
148941439|NCT00369824|537269272|FG004|Overall Study|Withdrawal by Subject|6|||
148941440|NCT00369824|537269273|FG005|Overall Study|Withdrawal by Subject|2|||
148682624|NCT03276962|536310972|FG001|Overall Study|Protocol Deviation|0|||
148941441|NCT00369824|537269268|FG000|Overall Study|Lost to Follow-up|6|||
149015886|NCT02961374|537536212|FG000|Overall Study|Adverse Event|4|||
148682625|NCT03276962|536310973|FG002|Overall Study|Protocol Deviation|1|||
148682626|NCT03276962|536310974|FG003|Overall Study|Protocol Deviation|2|||
148682627|NCT03276962|536310975|FG004|Overall Study|Protocol Deviation|1|||
148682628|NCT03276962|536310971|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
148682629|NCT03276962|536310972|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
148682630|NCT03276962|536310973|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
148682631|NCT03276962|536310974|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
148682632|NCT03276962|536310975|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
148682633|NCT03276962|536310971|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
148682634|NCT03276962|536310972|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
148682635|NCT03276962|536310973|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
148682636|NCT03276962|536310974|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
148682637|NCT03276962|536310975|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
148941442|NCT00369824|537269269|FG001|Overall Study|Lost to Follow-up|11|||
148941443|NCT00369824|537269270|FG002|Overall Study|Lost to Follow-up|7|||
148941444|NCT00369824|537269271|FG003|Overall Study|Lost to Follow-up|8|||
149015887|NCT00309608|537536215|FG000|Overall Study|Adverse Event|1|||
149015888|NCT00309608|537536216|FG001|Overall Study|Adverse Event|5|||
148941445|NCT00369824|537269272|FG004|Overall Study|Lost to Follow-up|9|||
148941446|NCT00369824|537269273|FG005|Overall Study|Lost to Follow-up|6|||
148682638|NCT03276962|536310971|FG000|Overall Study|Lost to Follow-up|10|||
148941447|NCT00369824|537269268|FG000|Overall Study|Other|0|||
148941448|NCT00369824|537269269|FG001|Overall Study|Other|0|||
148941449|NCT00369824|537269270|FG002|Overall Study|Other|0|||
148941450|NCT00369824|537269271|FG003|Overall Study|Other|2|||
148941451|NCT00369824|537269272|FG004|Overall Study|Other|1|||
148941452|NCT00369824|537269273|FG005|Overall Study|Other|3|||
148941453|NCT00415168|537269274|FG000|Overall Study|Death|26|||
148941454|NCT00415168|537269274|FG000|Overall Study|Lost to Follow-up|3|||
148941455|NCT00415168|537269274|FG000|Overall Study|Physician Decision|13|||
148941456|NCT00415168|537269274|FG000|Overall Study|Sponsor Decision|4|||
148941457|NCT00415168|537269274|FG000|Overall Study|Withdrawal by Subject|6|||
148941458|NCT02106975|537269275|FG000|Overall Study|Death|25|||
148941459|NCT02106975|537269276|FG001|Overall Study|Death|39|||
148941460|NCT00806351|537269277|FG000|Overall Study|Death|5|||
148941461|NCT00806351|537269278|FG001|Overall Study|Death|4|||
148941462|NCT00306189|537269281|FG000|Overall Study|Physician Decision|0|||
148941463|NCT00306189|537269282|FG001|Overall Study|Physician Decision|0|||
148941464|NCT00306189|537269283|FG002|Overall Study|Physician Decision|0|||
148941465|NCT00306189|537269284|FG003|Overall Study|Physician Decision|1|||
148941466|NCT00306189|537269281|FG000|Overall Study|Adverse Event|3|||
148941467|NCT00306189|537269282|FG001|Overall Study|Adverse Event|3|||
148941468|NCT00306189|537269283|FG002|Overall Study|Adverse Event|2|||
148941469|NCT00306189|537269284|FG003|Overall Study|Adverse Event|2|||
148941470|NCT00306189|537269281|FG000|Overall Study|Withdrawal by Subject|4|||
148941471|NCT00306189|537269282|FG001|Overall Study|Withdrawal by Subject|2|||
148941472|NCT00306189|537269283|FG002|Overall Study|Withdrawal by Subject|8|||
148941473|NCT00306189|537269284|FG003|Overall Study|Withdrawal by Subject|1|||
148941474|NCT00306189|537269281|FG000|Overall Study|Ineligibility determined|1|||
148941475|NCT00306189|537269282|FG001|Overall Study|Ineligibility determined|1|||
148941476|NCT00306189|537269283|FG002|Overall Study|Ineligibility determined|1|||
148941477|NCT00306189|537269284|FG003|Overall Study|Ineligibility determined|1|||
148941478|NCT00306189|537269281|FG000|Overall Study|Other|1|||
148941479|NCT00306189|537269282|FG001|Overall Study|Other|0|||
148941480|NCT00306189|537269283|FG002|Overall Study|Other|0|||
148941481|NCT00306189|537269284|FG003|Overall Study|Other|0|||
148941482|NCT02993757|537269285|FG000|Overall Study|Non compliance with the protocol|155|||
148941483|NCT02993757|537269286|FG001|Overall Study|Non compliance with the protocol|170|||
148941484|NCT02993757|537269285|FG000|Overall Study|Lost to Follow-up|1|||
148941485|NCT02993757|537269286|FG001|Overall Study|Lost to Follow-up|0|||
148941486|NCT02993757|537269285|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
148941487|NCT02993757|537269286|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
148941488|NCT00087607|537269288|FG000|Overall Study|Adverse Event|14|||
148941489|NCT00087607|537269289|FG001|Overall Study|Adverse Event|24|||
148941490|NCT00087607|537269288|FG000|Overall Study|Death|0|||
148941491|NCT00087607|537269289|FG001|Overall Study|Death|1|||
148941492|NCT00087607|537269288|FG000|Overall Study|Insufficient Therapeutic Response|53|||
148941493|NCT00087607|537269289|FG001|Overall Study|Insufficient Therapeutic Response|42|||
148941494|NCT00087607|537269288|FG000|Overall Study|Failure to return|21|||
148941495|NCT00087607|537269289|FG001|Overall Study|Failure to return|17|||
148941496|NCT00087607|537269288|FG000|Overall Study|Withdrew Consent|12|||
148941497|NCT00087607|537269289|FG001|Overall Study|Withdrew Consent|16|||
148941498|NCT00087607|537269288|FG000|Overall Study|Administrative|12|||
148941499|NCT00087607|537269289|FG001|Overall Study|Administrative|12|||
148941500|NCT00087607|537269288|FG000|Overall Study|Refused Treatment|5|||
148941501|NCT00087607|537269289|FG001|Overall Study|Refused Treatment|7|||
148941502|NCT00087607|537269288|FG000|Overall Study|Other Protocol Violation|5|||
148941503|NCT00087607|537269289|FG001|Overall Study|Other Protocol Violation|2|||
148941504|NCT00087607|537269288|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
148941505|NCT00087607|537269289|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
148941506|NCT02015754|537269290|FG000|Overall Study|Disease progression|5|||
148682639|NCT03276962|536310972|FG001|Overall Study|Lost to Follow-up|10|||
148941507|NCT02015754|537269290|FG000|Overall Study|Change in treatment modality|5|||
148941508|NCT02015754|537269290|FG000|Overall Study|Lost to Follow-up|1|||
148941509|NCT00672646|537269296|FG000|Overall Study|Lost to Follow-up|0|||
148941510|NCT00672646|537269297|FG001|Overall Study|Lost to Follow-up|1|||
148941511|NCT00672646|537269298|FG002|Overall Study|Lost to Follow-up|2|||
148941512|NCT00672646|537269296|FG000|Overall Study|Withdrawal by Subject|0|||
148941513|NCT00672646|537269297|FG001|Overall Study|Withdrawal by Subject|0|||
148941514|NCT00672646|537269298|FG002|Overall Study|Withdrawal by Subject|1|||
148682640|NCT03276962|536310973|FG002|Overall Study|Lost to Follow-up|4|||
148941515|NCT00289783|537269299|FG000|Primary Phase|Adverse Event|10|||
148941516|NCT00289783|537269300|FG001|Primary Phase|Adverse Event|1|||
148941517|NCT00289783|537269299|FG000|Primary Phase|Protocol Violation|27|||
148941518|NCT00289783|537269300|FG001|Primary Phase|Protocol Violation|6|||
148941519|NCT00289783|537269299|FG000|Primary Phase|Withdrawal by Subject|93|||
148941520|NCT00289783|537269300|FG001|Primary Phase|Withdrawal by Subject|40|||
148941521|NCT00289783|537269299|FG000|Primary Phase|Lost to Follow-up|60|||
148941522|NCT00289783|537269300|FG001|Primary Phase|Lost to Follow-up|14|||
148682641|NCT03276962|536310974|FG003|Overall Study|Lost to Follow-up|6|||
148682642|NCT03276962|536310975|FG004|Overall Study|Lost to Follow-up|10|||
148682643|NCT03276962|536310971|FG000|Overall Study|Other|0|||
148682644|NCT03276962|536310972|FG001|Overall Study|Other|2|||
148682645|NCT03276962|536310973|FG002|Overall Study|Other|0|||
148682646|NCT03276962|536310974|FG003|Overall Study|Other|2|||
148682647|NCT03276962|536310975|FG004|Overall Study|Other|1|||
148682648|NCT01238211|536310976|FG000|Overall Study|Continues active treatment|31|||
148682649|NCT01238211|536310976|FG000|Overall Study|Adverse Event|7|||
148682650|NCT01238211|536310976|FG000|Overall Study|Death|4|||
148682651|NCT01238211|536310976|FG000|Overall Study|Relapse/Progression|2|||
148682652|NCT01238211|536310976|FG000|Overall Study|Withdrawal by Subject|7|||
148682653|NCT01238211|536310976|FG000|Overall Study|Non-protocol treatment|4|||
148682654|NCT01238211|536310976|FG000|Overall Study|Investigator/Patient Decision|3|||
148682655|NCT04428502|536310977|FG000|Overall Study|Did not meet entrance criteria|14|||
148682656|NCT01358708|536310978|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
148682657|NCT01358708|536310979|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148682658|NCT01358708|536310978|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
148682659|NCT01358708|536310979|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
148682660|NCT03712228|536310983|FG000|Treatment Period 1|Lack of Efficacy|0|||
148682661|NCT03712228|536310984|FG001|Treatment Period 1|Lack of Efficacy|0|||
148682662|NCT03712228|536310985|FG002|Treatment Period 1|Lack of Efficacy|0|||
148682663|NCT03712228|536310986|FG003|Treatment Period 1|Lack of Efficacy|0|||
148682664|NCT03712228|536310987|FG004|Treatment Period 1|Lack of Efficacy|0|||
148682665|NCT03712228|536310988|FG005|Treatment Period 1|Lack of Efficacy|1|||
148682666|NCT03712228|536310983|FG000|Treatment Period 2|Pregnancy|0|||
148682667|NCT03712228|536310984|FG001|Treatment Period 2|Pregnancy|0|||
148682668|NCT03712228|536310985|FG002|Treatment Period 2|Pregnancy|0|||
148682669|NCT03712228|536310986|FG003|Treatment Period 2|Pregnancy|1|||
148682670|NCT03712228|536310987|FG004|Treatment Period 2|Pregnancy|0|||
148682671|NCT03712228|536310988|FG005|Treatment Period 2|Pregnancy|0|||
148682672|NCT03712228|536310983|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148682673|NCT03712228|536310984|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148682674|NCT03712228|536310985|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148682675|NCT03712228|536310986|FG003|Treatment Period 2|Withdrawal by Subject|1|||
148682676|NCT03712228|536310987|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148682677|NCT03712228|536310988|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148682678|NCT01964105|536310989|FG000|Overall Study|Lost to Follow-up|2|||
148682679|NCT01964105|536310990|FG001|Overall Study|Lost to Follow-up|13|||
148682680|NCT01964105|536310991|FG002|Overall Study|Lost to Follow-up|0|||
148682681|NCT01430104|536310992|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
148941523|NCT00289783|537269299|FG000|Primary Phase|Migration from the study area|26|||
148941524|NCT00289783|537269300|FG001|Primary Phase|Migration from the study area|10|||
148941525|NCT00289783|537269299|FG000|Primary Phase|Other|32|||
148941526|NCT00289783|537269300|FG001|Primary Phase|Other|12|||
148941527|NCT00289783|537269299|FG000|Fourth Dose Phase|Adverse Event|1|||
148941528|NCT00289783|537269300|FG001|Fourth Dose Phase|Adverse Event|0|||
148941529|NCT00289783|537269299|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
148941530|NCT00289783|537269300|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
148941531|NCT00289783|537269299|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
148941532|NCT00289783|537269300|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
148941533|NCT00289783|537269299|FG000|Fourth Dose Phase|Migration from the study area|1|||
149015889|NCT00309608|537536217|FG002|Overall Study|Adverse Event|3|||
148682682|NCT05288673|536310993|FG000|Overall Study|Consent withdrawn by subject|0|||
148682683|NCT05288673|536310994|FG001|Overall Study|Consent withdrawn by subject|0|||
148682684|NCT05288673|536310995|FG002|Overall Study|Consent withdrawn by subject|1|||
148682685|NCT04147611|536311008|FG000|Overall Study|Physician Decision|0|||
148682686|NCT04147611|536311009|FG001|Overall Study|Physician Decision|1|||
148682687|NCT05003167|536311010|FG000|Overall Study|Withdrawal by Subject|1|||
148682688|NCT01010230|536311011|FG000|Overall Study|Withdrawal by Subject|6|||
148682689|NCT01010230|536311012|FG001|Overall Study|Withdrawal by Subject|5|||
148682690|NCT01010230|536311011|FG000|Overall Study|Lost to Follow-up|4|||
148682691|NCT01010230|536311012|FG001|Overall Study|Lost to Follow-up|2|||
148682692|NCT01585831|536311013|FG000|Overall Study|Physician Decision|0|||
148682693|NCT01585831|536311014|FG001|Overall Study|Physician Decision|1|||
148941534|NCT00289783|537269300|FG001|Fourth Dose Phase|Migration from the study area|1|||
148682694|NCT01585831|536311013|FG000|Overall Study|Withdrawal by Subject|2|||
148682695|NCT01585831|536311014|FG001|Overall Study|Withdrawal by Subject|1|||
148682696|NCT04444752|536311015|FG000|Overall Study|Adverse Event|1|||
148682697|NCT04444752|536311016|FG001|Overall Study|Adverse Event|0|||
148682698|NCT04444752|536311017|FG002|Overall Study|Adverse Event|0|||
148682699|NCT04444752|536311018|FG003|Overall Study|Adverse Event|2|||
148682700|NCT04444752|536311015|FG000|Overall Study|Lost to Follow-up|2|||
148682701|NCT04444752|536311016|FG001|Overall Study|Lost to Follow-up|6|||
148682702|NCT04444752|536311017|FG002|Overall Study|Lost to Follow-up|2|||
148682703|NCT04444752|536311018|FG003|Overall Study|Lost to Follow-up|5|||
148941535|NCT00289783|537269299|FG000|Fourth Dose Phase|Other|22|||
148941536|NCT00289783|537269300|FG001|Fourth Dose Phase|Other|10|||
148941537|NCT00660699|537269301|FG000|Overall Study|Withdrawal by Subject|2|||
148941538|NCT01453361|537269304|FG000|Overall Study|Disease Progression|6|||
148941539|NCT01453361|537269304|FG000|Overall Study|Screen-Failures|10|||
148941540|NCT03128047|537269305|FG000|Overall Study|Withdrawal by Subject|1|||
148941541|NCT01594281|537270560|FG000|Interventional Core Phase|Protocol Deviation|1|||
148941542|NCT01594281|537270561|FG001|Interventional Core Phase|Protocol Deviation|0|||
148941543|NCT01594281|537270562|FG002|Interventional Core Phase|Protocol Deviation|0|||
148941544|NCT01594281|537270560|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
148941545|NCT01594281|537270561|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
148941546|NCT01594281|537270562|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
148941547|NCT01594281|537270560|FG000|Interventional Core Phase|Death|1|||
148941548|NCT01594281|537270561|FG001|Interventional Core Phase|Death|1|||
148941549|NCT01594281|537270562|FG002|Interventional Core Phase|Death|2|||
148941550|NCT01594281|537270560|FG000|Interventional Core Phase|Lost to Follow-up|1|||
148941551|NCT01594281|537270561|FG001|Interventional Core Phase|Lost to Follow-up|4|||
148941552|NCT01594281|537270562|FG002|Interventional Core Phase|Lost to Follow-up|1|||
148941553|NCT01594281|537270560|FG000|Interventional Core Phase|Adverse Event|4|||
148941554|NCT01594281|537270561|FG001|Interventional Core Phase|Adverse Event|4|||
148941555|NCT01594281|537270562|FG002|Interventional Core Phase|Adverse Event|4|||
148941556|NCT01594281|537270560|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
148941557|NCT01594281|537270561|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
148941558|NCT01594281|537270562|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
148941559|NCT01594281|537270560|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
148941560|NCT01594281|537270561|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
148941561|NCT01594281|537270562|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
148941562|NCT01594281|537270560|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
148941563|NCT01594281|537270561|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
148941564|NCT01594281|537270562|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
148941565|NCT01871532|537270563|FG000|Overall Study|Withdrawal by Subject|1|||
148941566|NCT01871532|537270564|FG001|Overall Study|Withdrawal by Subject|2|||
148941567|NCT01673867|537270566|FG000|Randomization|Adverse event unrelated to study drug|1|||
148941568|NCT01673867|537270567|FG001|Randomization|Adverse event unrelated to study drug|0|||
148941569|NCT01673867|537270566|FG000|Randomization|Participant request to discontinue study treatment|0|||
148941570|NCT01673867|537270567|FG001|Randomization|Participant request to discontinue study treatment|4|||
148941571|NCT01673867|537270566|FG000|Randomization|Withdrawal by participant|0|||
148941572|NCT01673867|537270567|FG001|Randomization|Withdrawal by participant|12|||
148941573|NCT01673867|537270566|FG000|Randomization|Lost to Follow-up|0|||
148941574|NCT01673867|537270567|FG001|Randomization|Lost to Follow-up|1|||
148941575|NCT01673867|537270566|FG000|Randomization|Participant no longer meets study criteria|4|||
148682704|NCT04444752|536311015|FG000|Overall Study|Physician Decision|0|||
148682705|NCT04444752|536311016|FG001|Overall Study|Physician Decision|0|||
148808432|NCT03907488|536775815|FG000|Overall Study|Lack of Efficacy|0|||
148941576|NCT01673867|537270567|FG001|Randomization|Participant no longer meets study criteria|5|||
148941577|NCT01673867|537270566|FG000|Treatment|Disease Progression|208|||
148941578|NCT01673867|537270567|FG001|Treatment|Disease Progression|178|||
148941579|NCT01673867|537270566|FG000|Treatment|Study Drug Toxicity|23|||
148941580|NCT01673867|537270567|FG001|Treatment|Study Drug Toxicity|43|||
148941581|NCT01673867|537270566|FG000|Treatment|Death|2|||
148941582|NCT01673867|537270567|FG001|Treatment|Death|3|||
148941583|NCT01673867|537270566|FG000|Treatment|Adverse event unrelated to study drug|23|||
148941584|NCT01673867|537270567|FG001|Treatment|Adverse event unrelated to study drug|10|||
148941585|NCT01673867|537270566|FG000|Treatment|Participant request to discontinue study treatment|7|||
148941586|NCT01673867|537270567|FG001|Treatment|Participant request to discontinue study treatment|17|||
148941587|NCT01673867|537270566|FG000|Treatment|Withdrawal by participant|5|||
148941588|NCT01673867|537270567|FG001|Treatment|Withdrawal by participant|5|||
148941589|NCT01673867|537270566|FG000|Treatment|Maximum clinical benefit|1|||
148941590|NCT01673867|537270567|FG001|Treatment|Maximum clinical benefit|10|||
148941591|NCT01673867|537270566|FG000|Treatment|Participant no longer meets study criteria|2|||
148941592|NCT01673867|537270567|FG001|Treatment|Participant no longer meets study criteria|0|||
148941593|NCT01673867|537270566|FG000|Treatment|Administrative reason by sponsor|3|||
148941594|NCT01673867|537270567|FG001|Treatment|Administrative reason by sponsor|0|||
148941595|NCT01673867|537270566|FG000|Treatment|Other reason|11|||
148941596|NCT01673867|537270567|FG001|Treatment|Other reason|2|||
148941597|NCT02550106|537270570|FG000|Overall Study|Adverse Event|1|||
148941598|NCT02550106|537270570|FG000|Overall Study|Lack of Efficacy|3|||
148941599|NCT02550106|537270570|FG000|Overall Study|Protocol Violation|6|||
148941600|NCT02550106|537270570|FG000|Overall Study|Withdrawal by Subject|2|||
148941601|NCT01709513|537270571|FG000|Overall Study|Randomized but not treated|0|||
148941602|NCT01709513|537270572|FG001|Overall Study|Randomized but not treated|1|||
148941603|NCT01709513|537270573|FG002|Overall Study|Randomized but not treated|0|||
149015890|NCT00309608|537536218|FG003|Overall Study|Adverse Event|2|||
149015891|NCT00309608|537536219|FG004|Overall Study|Adverse Event|3|||
149015892|NCT00309608|537536215|FG000|Overall Study|Protocol Violation|2|||
148941604|NCT01709513|537270571|FG000|Overall Study|Adverse Event|16|||
148941605|NCT01709513|537270572|FG001|Overall Study|Adverse Event|31|||
148941606|NCT01709513|537270573|FG002|Overall Study|Adverse Event|23|||
148941607|NCT01709513|537270571|FG000|Overall Study|Poor compliance to protocol|2|||
148941608|NCT01709513|537270572|FG001|Overall Study|Poor compliance to protocol|0|||
148941609|NCT01709513|537270573|FG002|Overall Study|Poor compliance to protocol|0|||
149015893|NCT00309608|537536216|FG001|Overall Study|Protocol Violation|0|||
149015894|NCT00309608|537536217|FG002|Overall Study|Protocol Violation|0|||
149015895|NCT00309608|537536218|FG003|Overall Study|Protocol Violation|0|||
149015896|NCT00309608|537536219|FG004|Overall Study|Protocol Violation|0|||
149015897|NCT00309608|537536215|FG000|Overall Study|Lost to Follow-up|0|||
149015898|NCT00309608|537536216|FG001|Overall Study|Lost to Follow-up|0|||
149015899|NCT00309608|537536217|FG002|Overall Study|Lost to Follow-up|2|||
149015900|NCT00309608|537536218|FG003|Overall Study|Lost to Follow-up|0|||
149015901|NCT00309608|537536219|FG004|Overall Study|Lost to Follow-up|1|||
149015902|NCT00309608|537536215|FG000|Overall Study|Withdrawal by Subject|1|||
149015903|NCT00309608|537536216|FG001|Overall Study|Withdrawal by Subject|4|||
149015904|NCT00309608|537536217|FG002|Overall Study|Withdrawal by Subject|2|||
149015905|NCT00309608|537536218|FG003|Overall Study|Withdrawal by Subject|0|||
149015906|NCT00309608|537536219|FG004|Overall Study|Withdrawal by Subject|0|||
149015907|NCT00309608|537536215|FG000|Overall Study|Other incl. Lack of efficacy|10|||
149015908|NCT00309608|537536216|FG001|Overall Study|Other incl. Lack of efficacy|4|||
149015909|NCT00309608|537536217|FG002|Overall Study|Other incl. Lack of efficacy|3|||
149015910|NCT00309608|537536218|FG003|Overall Study|Other incl. Lack of efficacy|4|||
149015911|NCT00309608|537536219|FG004|Overall Study|Other incl. Lack of efficacy|0|||
148808433|NCT03907488|536775816|FG001|Overall Study|Lack of Efficacy|9|||
148808434|NCT03907488|536775815|FG000|Overall Study|Death|3|||
148808435|NCT03907488|536775816|FG001|Overall Study|Death|8|||
148808436|NCT03907488|536775815|FG000|Overall Study|not protocol specified|5|||
148808437|NCT03907488|536775816|FG001|Overall Study|not protocol specified|8|||
148808438|NCT03907488|536775815|FG000|Overall Study|Ineligible|9|||
148808439|NCT03907488|536775816|FG001|Overall Study|Ineligible|15|||
148808440|NCT03570892|536775820|FG000|Overall Study|Death|51|||
148941610|NCT01709513|537270571|FG000|Overall Study|Other|3|||
148941611|NCT01709513|537270572|FG001|Overall Study|Other|11|||
148941612|NCT01709513|537270573|FG002|Overall Study|Other|7|||
148941613|NCT01034631|537270574|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
149015912|NCT00127413|537536220|FG000|Overall Study|Lost to Follow-up|6|||
149015913|NCT00127413|537536221|FG001|Overall Study|Lost to Follow-up|4|||
149015914|NCT00127413|537536222|FG002|Overall Study|Lost to Follow-up|8|||
149015915|NCT00127413|537536223|FG003|Overall Study|Lost to Follow-up|2|||
149015916|NCT01051063|537536224|FG000|Overall Study|Death|2|||
149015917|NCT01051063|537536225|FG001|Overall Study|Death|2|||
149015918|NCT01051063|537536224|FG000|Overall Study|Withdrawal by Subject|1|||
149015919|NCT01051063|537536225|FG001|Overall Study|Withdrawal by Subject|1|||
149015920|NCT01051063|537536224|FG000|Overall Study|Termination of the study|5|||
149015921|NCT01051063|537536225|FG001|Overall Study|Termination of the study|0|||
149015922|NCT01051063|537536224|FG000|Overall Study|Moved from the study site area|1|||
148941614|NCT01034631|537270575|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
149015923|NCT01051063|537536225|FG001|Overall Study|Moved from the study site area|0|||
149015924|NCT01051063|537536224|FG000|Overall Study|Other|1|||
149015925|NCT01051063|537536225|FG001|Overall Study|Other|0|||
149015926|NCT01051063|537536224|FG000|Overall Study|Lost to Follow-up|0|||
149015927|NCT01051063|537536225|FG001|Overall Study|Lost to Follow-up|1|||
149015928|NCT03864926|537537793|FG000|Overall Study|Death|0|||
149015929|NCT03864926|537537794|FG001|Overall Study|Death|2|||
149015930|NCT00445601|537537795|FG000|Overall Study|Withdrawal by Subject|11|||
149015931|NCT00445601|537537796|FG001|Overall Study|Withdrawal by Subject|11|||
149015932|NCT00445601|537537795|FG000|Overall Study|TURBT Complication|12|||
148808441|NCT03570892|536775821|FG001|Overall Study|Death|45|||
148941615|NCT01034631|537270576|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
148941616|NCT01034631|537270574|FG000|Phase II|Not Evaluable per protocol|0|||
148808442|NCT03570892|536775820|FG000|Overall Study|Subject decision|5|||
148941617|NCT01034631|537270575|FG001|Phase II|Not Evaluable per protocol|0|||
148941618|NCT01034631|537270576|FG002|Phase II|Not Evaluable per protocol|2|||
148941619|NCT01034631|537270574|FG000|Phase II|Determined Ineligible per protocol|0|||
148941620|NCT01034631|537270575|FG001|Phase II|Determined Ineligible per protocol|1|||
149015933|NCT00445601|537537796|FG001|Overall Study|TURBT Complication|8|||
149015934|NCT00445601|537537795|FG000|Overall Study|Incorrect Disease Status|6|||
149015935|NCT00445601|537537796|FG001|Overall Study|Incorrect Disease Status|6|||
149015936|NCT00445601|537537795|FG000|Overall Study|Drug Delivery Issue|2|||
148808443|NCT03570892|536775821|FG001|Overall Study|Subject decision|3|||
149015937|NCT00445601|537537796|FG001|Overall Study|Drug Delivery Issue|2|||
149015938|NCT00445601|537537795|FG000|Overall Study|Adverse Event|2|||
148808444|NCT03570892|536775820|FG000|Overall Study|Protocol Violation|1|||
148941621|NCT01034631|537270576|FG002|Phase II|Determined Ineligible per protocol|0|||
148941622|NCT01193530|537270579|FG000|Overall Study|Withdrawal by Subject|2|||
148941623|NCT01193530|537270580|FG001|Overall Study|Withdrawal by Subject|2|||
148941624|NCT01193530|537270579|FG000|Overall Study|Began Contraindicated Therapy|1|||
148941625|NCT01193530|537270580|FG001|Overall Study|Began Contraindicated Therapy|0|||
148941626|NCT01193530|537270579|FG000|Overall Study|Lost Light Box|0|||
148941627|NCT01193530|537270580|FG001|Overall Study|Lost Light Box|1|||
148941628|NCT01193530|537270579|FG000|Overall Study|Returned home - out of state|0|||
148941629|NCT01193530|537270580|FG001|Overall Study|Returned home - out of state|1|||
148941630|NCT01193530|537270579|FG000|Overall Study|Non-Compliance|0|||
148941631|NCT01193530|537270580|FG001|Overall Study|Non-Compliance|1|||
148941632|NCT04218695|537270581|FG000|Overall Study|Adverse Event|1|||
148941633|NCT04218695|537270582|FG001|Overall Study|Adverse Event|0|||
148941634|NCT01890473|537270583|FG000|Overall Study|Lost to Follow-up|1|||
148941635|NCT01890473|537270584|FG001|Overall Study|Lost to Follow-up|0|||
148941636|NCT01890473|537270583|FG000|Overall Study|Poor/non-compliance|1|||
148941637|NCT01890473|537270584|FG001|Overall Study|Poor/non-compliance|0|||
148941638|NCT04019288|537270585|FG000|Overall Study|Death|1|||
148941639|NCT04019288|537270586|FG001|Overall Study|Death|0|||
148941640|NCT04019288|537270587|FG002|Overall Study|Death|0|||
148941641|NCT03166735|537270588|FG000|Overall Study|Not Treated|1|||
148941642|NCT03166735|537270589|FG001|Overall Study|Not Treated|0|||
148941643|NCT03166735|537270590|FG002|Overall Study|Not Treated|0|||
148941644|NCT03166735|537270591|FG003|Overall Study|Not Treated|0|||
148941645|NCT03166735|537270592|FG004|Overall Study|Not Treated|0|||
148941646|NCT03166735|537270588|FG000|Overall Study|follow-up not completed as planned|0|||
148941647|NCT03166735|537270589|FG001|Overall Study|follow-up not completed as planned|1|||
148941648|NCT03166735|537270590|FG002|Overall Study|follow-up not completed as planned|1|||
148941649|NCT03166735|537270591|FG003|Overall Study|follow-up not completed as planned|0|||
148941650|NCT03166735|537270592|FG004|Overall Study|follow-up not completed as planned|1|||
148941651|NCT03166735|537270588|FG000|Overall Study|Withdrawal by Subject|0|||
148941652|NCT03166735|537270589|FG001|Overall Study|Withdrawal by Subject|0|||
148941653|NCT03166735|537270590|FG002|Overall Study|Withdrawal by Subject|1|||
148941654|NCT03166735|537270591|FG003|Overall Study|Withdrawal by Subject|1|||
148941655|NCT03166735|537270592|FG004|Overall Study|Withdrawal by Subject|2|||
148941656|NCT03166735|537270588|FG000|Overall Study|Lost to Follow-up|0|||
148941657|NCT03166735|537270589|FG001|Overall Study|Lost to Follow-up|2|||
148941658|NCT03166735|537270590|FG002|Overall Study|Lost to Follow-up|1|||
148941659|NCT03166735|537270591|FG003|Overall Study|Lost to Follow-up|0|||
148941660|NCT03166735|537270592|FG004|Overall Study|Lost to Follow-up|1|||
148941661|NCT01543958|537270593|FG000|Overall Study|Loss to follow-up|3|||
148941662|NCT01543958|537270593|FG000|Overall Study|ART initiation|1|||
148941663|NCT00934089|537270594|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
148941664|NCT00934089|537270595|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
148941665|NCT00934089|537270594|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
148941666|NCT00934089|537270595|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
148941667|NCT01945281|537270596|FG000|Overall Study|Adverse Event|1|||
148941668|NCT01945281|537270597|FG001|Overall Study|Adverse Event|0|||
148941669|NCT01945281|537270596|FG000|Overall Study|Death|3|||
148941670|NCT01945281|537270597|FG001|Overall Study|Death|3|||
148941671|NCT01945281|537270596|FG000|Overall Study|Physician Decision|1|||
148941672|NCT01945281|537270597|FG001|Overall Study|Physician Decision|1|||
148941673|NCT01945281|537270596|FG000|Overall Study|Technical Problems|1|||
148941674|NCT01945281|537270597|FG001|Overall Study|Technical Problems|0|||
148941675|NCT00726986|537270601|FG000|Induction Phase|Adverse Event|4|||
148941676|NCT00726986|537270601|FG000|Induction Phase|Withdrawal by Subject|2|||
148941677|NCT00726986|537270601|FG000|Induction Phase|Death|2|||
148941678|NCT00726986|537270601|FG000|Induction Phase|Lack of Efficacy|5|||
148941679|NCT00726986|537270601|FG000|Induction Phase|Secondary Disease|2|||
148941680|NCT00726986|537270601|FG000|Maintenance Phase|Adverse Event|1|||
148941681|NCT00726986|537270601|FG000|Maintenance Phase|Lack of Efficacy|2|||
148941682|NCT05074667|537270611|FG000|Overall Study|Death|1|||
148941683|NCT05074667|537270611|FG000|Overall Study|Withdrawal by Subject|4|||
148941684|NCT05074667|537270611|FG000|Overall Study|Lost to Follow-up|10|||
148941685|NCT03535844|537270614|FG000|Overall Study|Withdrawal by Subject|0|||
148941686|NCT03535844|537270615|FG001|Overall Study|Withdrawal by Subject|1|||
148941687|NCT00297830|537270618|FG000|6 Month Visit|Death|1|||
148941688|NCT00297830|537270619|FG001|6 Month Visit|Death|0|||
148941689|NCT00297830|537270620|FG002|6 Month Visit|Death|2|||
148941690|NCT00297830|537270618|FG000|6 Month Visit|Withdrawal by Subject|2|||
148941691|NCT00297830|537270619|FG001|6 Month Visit|Withdrawal by Subject|1|||
148941692|NCT00297830|537270620|FG002|6 Month Visit|Withdrawal by Subject|1|||
148941693|NCT00297830|537270618|FG000|6 Month Visit|Adverse Event|0|||
149015939|NCT00445601|537537796|FG001|Overall Study|Adverse Event|0|||
149197071|NCT01274338|538191077|FG004|Overall Study|Alternative therapy|0|||
149197072|NCT01274338|538191078|FG005|Overall Study|Alternative therapy|0|||
148941694|NCT00297830|537270619|FG001|6 Month Visit|Adverse Event|1|||
148941695|NCT00297830|537270620|FG002|6 Month Visit|Adverse Event|0|||
148941696|NCT00297830|537270618|FG000|12 Month Visit|Lost to Follow-up|1|||
148941697|NCT00297830|537270619|FG001|12 Month Visit|Lost to Follow-up|0|||
148941698|NCT00297830|537270620|FG002|12 Month Visit|Lost to Follow-up|0|||
148941699|NCT00297830|537270618|FG000|12 Month Visit|Adverse Event|0|||
148941700|NCT00297830|537270619|FG001|12 Month Visit|Adverse Event|3|||
148941701|NCT00297830|537270620|FG002|12 Month Visit|Adverse Event|0|||
148941702|NCT00297830|537270618|FG000|12 Month Visit|Withdrawal by Subject|0|||
148941703|NCT00297830|537270619|FG001|12 Month Visit|Withdrawal by Subject|3|||
148941704|NCT00297830|537270620|FG002|12 Month Visit|Withdrawal by Subject|0|||
148941705|NCT04401423|537270621|FG000|Overall Study|Withdrawal by Subject|3|||
148941706|NCT04401423|537270622|FG001|Overall Study|Withdrawal by Subject|1|||
148941707|NCT04401423|537270621|FG000|Overall Study|Physician Decision|2|||
148941708|NCT04401423|537270622|FG001|Overall Study|Physician Decision|1|||
148941709|NCT00003473|537270623|FG000|Overall Study|Three patients were not evaluable.|3|||
148941710|NCT02193867|537270627|FG000|Overall Study|Death|2|||
148941711|NCT02193867|537270627|FG000|Overall Study|Sponsor Study Termination|2|||
148941712|NCT01867424|537270628|FG000|Overall Study|Patient noncompliance|2|||
148941713|NCT01867424|537270629|FG001|Overall Study|Patient noncompliance|1|||
148941714|NCT04613375|537270630|FG000|Overall Study|Death|198|||
148941715|NCT04613375|537270630|FG000|Overall Study|Withdrawal by Subject|3|||
148941716|NCT02582983|537270631|FG000|Overall Study|Death|3|||
148941717|NCT02582983|537270631|FG000|Overall Study|Withdrawal by Subject|2|||
148941718|NCT02582983|537270631|FG000|Overall Study|Adverse Event|1|||
148941719|NCT05209360|537270632|FG000|Overall Study|Withdrawal by Subject|0|||
148941720|NCT05209360|537270633|FG001|Overall Study|Withdrawal by Subject|0|||
148941721|NCT05209360|537270634|FG002|Overall Study|Withdrawal by Subject|1|||
148941722|NCT05209360|537270635|FG003|Overall Study|Withdrawal by Subject|0|||
148941723|NCT05209360|537270636|FG004|Overall Study|Withdrawal by Subject|0|||
148941724|NCT05209360|537270637|FG005|Overall Study|Withdrawal by Subject|0|||
148941725|NCT01776840|537270641|FG000|Overall Study|Lost to Follow-up|12|||
148941726|NCT01776840|537270642|FG001|Overall Study|Lost to Follow-up|7|||
148941727|NCT01776840|537270641|FG000|Overall Study|Withdrawal by Subject|32|||
148941728|NCT01776840|537270642|FG001|Overall Study|Withdrawal by Subject|48|||
148941729|NCT01776840|537270641|FG000|Overall Study|Sponsor decision|89|||
148941730|NCT01776840|537270642|FG001|Overall Study|Sponsor decision|87|||
148941731|NCT03641339|537270643|FG000|Overall Study|Physician Decision|1|||
148941732|NCT03641339|537270644|FG001|Overall Study|Physician Decision|0|||
148941733|NCT03641339|537270645|FG002|Overall Study|Physician Decision|0|||
148941734|NCT03641339|537270646|FG003|Overall Study|Physician Decision|0|||
148941735|NCT03641339|537270647|FG004|Overall Study|Physician Decision|0|||
148941736|NCT03641339|537270648|FG005|Overall Study|Physician Decision|0|||
148941737|NCT03641339|537270643|FG000|Overall Study|Withdrawal by Subject|0|||
148941738|NCT03641339|537270644|FG001|Overall Study|Withdrawal by Subject|2|||
148941739|NCT03641339|537270645|FG002|Overall Study|Withdrawal by Subject|0|||
148941740|NCT03641339|537270646|FG003|Overall Study|Withdrawal by Subject|2|||
148941741|NCT03641339|537270647|FG004|Overall Study|Withdrawal by Subject|0|||
148941742|NCT03641339|537270648|FG005|Overall Study|Withdrawal by Subject|1|||
148941743|NCT04457336|537270649|FG000|Period 2: Part A|Withdrawal by Subject|0|||
148941744|NCT04457336|537270650|FG001|Period 2: Part A|Withdrawal by Subject|1|||
148941745|NCT04457336|537270651|FG002|Period 2: Part A|Withdrawal by Subject|1|||
148941746|NCT04457336|537270652|FG003|Period 2: Part A|Withdrawal by Subject|1|||
148941747|NCT04457336|537270653|FG004|Period 2: Part A|Withdrawal by Subject|0|||
148941748|NCT04457336|537270654|FG005|Period 2: Part A|Withdrawal by Subject|0|||
148941749|NCT04457336|537270655|FG006|Period 2: Part A|Withdrawal by Subject|0|||
148941750|NCT04457336|537270656|FG007|Period 2: Part A|Withdrawal by Subject|0|||
148941751|NCT04457336|537270649|FG000|Period 2: Part A|Adverse Event|0|||
148941752|NCT04457336|537270650|FG001|Period 2: Part A|Adverse Event|0|||
148941753|NCT04457336|537270651|FG002|Period 2: Part A|Adverse Event|1|||
148941754|NCT04457336|537270652|FG003|Period 2: Part A|Adverse Event|1|||
148941755|NCT04457336|537270653|FG004|Period 2: Part A|Adverse Event|0|||
148941756|NCT04457336|537270654|FG005|Period 2: Part A|Adverse Event|0|||
148941757|NCT04457336|537270655|FG006|Period 2: Part A|Adverse Event|0|||
148808445|NCT03570892|536775821|FG001|Overall Study|Protocol Violation|4|||
148808446|NCT03570892|536775820|FG000|Overall Study|Physician Decision|0|||
148808447|NCT03570892|536775821|FG001|Overall Study|Physician Decision|2|||
148808448|NCT04284774|536775827|FG000|Overall Study|Progressive disease|5|||
148811247|NCT01995201|536787052|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
148811248|NCT01995201|536787053|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
148811249|NCT01995201|536787047|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
148811250|NCT01995201|536787048|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
148941758|NCT04457336|537270656|FG007|Period 2: Part A|Adverse Event|0|||
148941759|NCT04457336|537270649|FG000|Period 2: Part A|Study Terminated|0|||
148682706|NCT04444752|536311017|FG002|Overall Study|Physician Decision|0|||
148682707|NCT04444752|536311018|FG003|Overall Study|Physician Decision|2|||
148941760|NCT04457336|537270650|FG001|Period 2: Part A|Study Terminated|0|||
148941761|NCT04457336|537270651|FG002|Period 2: Part A|Study Terminated|1|||
148941762|NCT04457336|537270652|FG003|Period 2: Part A|Study Terminated|0|||
148682708|NCT04444752|536311015|FG000|Overall Study|Pregnancy|0|||
148682709|NCT04444752|536311016|FG001|Overall Study|Pregnancy|0|||
148682710|NCT04444752|536311017|FG002|Overall Study|Pregnancy|0|||
148941763|NCT04457336|537270653|FG004|Period 2: Part A|Study Terminated|0|||
148941764|NCT04457336|537270654|FG005|Period 2: Part A|Study Terminated|0|||
148941765|NCT04457336|537270655|FG006|Period 2: Part A|Study Terminated|0|||
148941766|NCT04457336|537270656|FG007|Period 2: Part A|Study Terminated|0|||
148941767|NCT04457336|537270649|FG000|Period 2: Part A|Protocol Violation|0|||
148941768|NCT04457336|537270650|FG001|Period 2: Part A|Protocol Violation|1|||
148941769|NCT04457336|537270651|FG002|Period 2: Part A|Protocol Violation|0|||
148941770|NCT04457336|537270652|FG003|Period 2: Part A|Protocol Violation|0|||
148941771|NCT04457336|537270653|FG004|Period 2: Part A|Protocol Violation|0|||
148941772|NCT04457336|537270654|FG005|Period 2: Part A|Protocol Violation|0|||
148941773|NCT04457336|537270655|FG006|Period 2: Part A|Protocol Violation|0|||
148941774|NCT04457336|537270656|FG007|Period 2: Part A|Protocol Violation|0|||
148941775|NCT04457336|537270649|FG000|Period 2: Part A|Lost to Follow-up|0|||
148941776|NCT04457336|537270650|FG001|Period 2: Part A|Lost to Follow-up|1|||
148941777|NCT04457336|537270651|FG002|Period 2: Part A|Lost to Follow-up|0|||
148941778|NCT04457336|537270652|FG003|Period 2: Part A|Lost to Follow-up|0|||
148941779|NCT04457336|537270653|FG004|Period 2: Part A|Lost to Follow-up|0|||
148941780|NCT04457336|537270654|FG005|Period 2: Part A|Lost to Follow-up|0|||
148941781|NCT04457336|537270655|FG006|Period 2: Part A|Lost to Follow-up|0|||
148941782|NCT04457336|537270656|FG007|Period 2: Part A|Lost to Follow-up|0|||
148941783|NCT04457336|537270649|FG000|Period 2: Part A|Other|0|||
148941784|NCT04457336|537270650|FG001|Period 2: Part A|Other|1|||
148941785|NCT04457336|537270651|FG002|Period 2: Part A|Other|0|||
148941786|NCT04457336|537270652|FG003|Period 2: Part A|Other|0|||
148941787|NCT04457336|537270653|FG004|Period 2: Part A|Other|0|||
148941788|NCT04457336|537270654|FG005|Period 2: Part A|Other|0|||
148941789|NCT04457336|537270655|FG006|Period 2: Part A|Other|0|||
148941790|NCT04457336|537270656|FG007|Period 2: Part A|Other|0|||
148941791|NCT04457336|537270649|FG000|Period 2: Part A|Physician Decision|0|||
148941792|NCT04457336|537270650|FG001|Period 2: Part A|Physician Decision|0|||
148941793|NCT04457336|537270651|FG002|Period 2: Part A|Physician Decision|0|||
148941794|NCT04457336|537270652|FG003|Period 2: Part A|Physician Decision|1|||
148941795|NCT04457336|537270653|FG004|Period 2: Part A|Physician Decision|0|||
148941796|NCT04457336|537270654|FG005|Period 2: Part A|Physician Decision|0|||
148941797|NCT04457336|537270655|FG006|Period 2: Part A|Physician Decision|0|||
148941798|NCT04457336|537270656|FG007|Period 2: Part A|Physician Decision|0|||
148941799|NCT04457336|537270649|FG000|Period 3: Part B|Study Terminated|0|||
148941800|NCT04457336|537270650|FG001|Period 3: Part B|Study Terminated|0|||
148941801|NCT04457336|537270651|FG002|Period 3: Part B|Study Terminated|0|||
148941802|NCT04457336|537270652|FG003|Period 3: Part B|Study Terminated|0|||
148941803|NCT04457336|537270653|FG004|Period 3: Part B|Study Terminated|1|||
148941804|NCT04457336|537270654|FG005|Period 3: Part B|Study Terminated|10|||
148941805|NCT04457336|537270655|FG006|Period 3: Part B|Study Terminated|13|||
148941806|NCT04457336|537270656|FG007|Period 3: Part B|Study Terminated|0|||
148941807|NCT04457336|537270649|FG000|Period 3: Part B|Withdrawal by Subject|0|||
148941808|NCT04457336|537270650|FG001|Period 3: Part B|Withdrawal by Subject|0|||
148941809|NCT04457336|537270651|FG002|Period 3: Part B|Withdrawal by Subject|0|||
148941810|NCT04457336|537270652|FG003|Period 3: Part B|Withdrawal by Subject|0|||
148941811|NCT04457336|537270653|FG004|Period 3: Part B|Withdrawal by Subject|0|||
148941812|NCT04457336|537270654|FG005|Period 3: Part B|Withdrawal by Subject|1|||
148941813|NCT04457336|537270655|FG006|Period 3: Part B|Withdrawal by Subject|2|||
148941814|NCT04457336|537270656|FG007|Period 3: Part B|Withdrawal by Subject|0|||
148941815|NCT04457336|537270649|FG000|Period 4: Part C|Study Terminated|0|||
148941816|NCT04457336|537270650|FG001|Period 4: Part C|Study Terminated|0|||
148941817|NCT04457336|537270651|FG002|Period 4: Part C|Study Terminated|0|||
148941818|NCT04457336|537270652|FG003|Period 4: Part C|Study Terminated|0|||
148941819|NCT04457336|537270653|FG004|Period 4: Part C|Study Terminated|0|||
148941820|NCT04457336|537270654|FG005|Period 4: Part C|Study Terminated|0|||
148941821|NCT04457336|537270655|FG006|Period 4: Part C|Study Terminated|0|||
148941822|NCT04457336|537270656|FG007|Period 4: Part C|Study Terminated|30|||
148941823|NCT04457336|537270649|FG000|Period 4: Part C|Adverse Event|0|||
148941824|NCT04457336|537270650|FG001|Period 4: Part C|Adverse Event|0|||
148941825|NCT04457336|537270651|FG002|Period 4: Part C|Adverse Event|0|||
148941826|NCT04457336|537270652|FG003|Period 4: Part C|Adverse Event|0|||
148941827|NCT04457336|537270653|FG004|Period 4: Part C|Adverse Event|0|||
148941828|NCT04457336|537270654|FG005|Period 4: Part C|Adverse Event|0|||
148941829|NCT04457336|537270655|FG006|Period 4: Part C|Adverse Event|0|||
148941830|NCT04457336|537270656|FG007|Period 4: Part C|Adverse Event|2|||
148941831|NCT04457336|537270649|FG000|Period 4: Part C|Site Terminated|0|||
148941832|NCT04457336|537270650|FG001|Period 4: Part C|Site Terminated|0|||
148941833|NCT04457336|537270651|FG002|Period 4: Part C|Site Terminated|0|||
148941834|NCT04457336|537270652|FG003|Period 4: Part C|Site Terminated|0|||
148941835|NCT04457336|537270653|FG004|Period 4: Part C|Site Terminated|0|||
148941836|NCT04457336|537270654|FG005|Period 4: Part C|Site Terminated|0|||
148941837|NCT04457336|537270655|FG006|Period 4: Part C|Site Terminated|0|||
148941838|NCT04457336|537270656|FG007|Period 4: Part C|Site Terminated|1|||
148941839|NCT04457336|537270649|FG000|Period 4: Part C|Other|0|||
148941840|NCT04457336|537270650|FG001|Period 4: Part C|Other|0|||
148941841|NCT04457336|537270651|FG002|Period 4: Part C|Other|0|||
148941842|NCT04457336|537270652|FG003|Period 4: Part C|Other|0|||
148941843|NCT04457336|537270653|FG004|Period 4: Part C|Other|0|||
148941844|NCT04457336|537270654|FG005|Period 4: Part C|Other|0|||
148941845|NCT04457336|537270655|FG006|Period 4: Part C|Other|0|||
148941846|NCT04457336|537270656|FG007|Period 4: Part C|Other|2|||
148941847|NCT04457336|537270649|FG000|Period 4: Part C|Withdrawal by Subject|0|||
148941848|NCT04457336|537270650|FG001|Period 4: Part C|Withdrawal by Subject|0|||
148941849|NCT04457336|537270651|FG002|Period 4: Part C|Withdrawal by Subject|0|||
148941850|NCT04457336|537270652|FG003|Period 4: Part C|Withdrawal by Subject|0|||
148941851|NCT04457336|537270653|FG004|Period 4: Part C|Withdrawal by Subject|0|||
148941852|NCT04457336|537270654|FG005|Period 4: Part C|Withdrawal by Subject|0|||
148941853|NCT04457336|537270655|FG006|Period 4: Part C|Withdrawal by Subject|0|||
148941854|NCT04457336|537270656|FG007|Period 4: Part C|Withdrawal by Subject|3|||
148941855|NCT00446251|537270657|FG000|Overall Study|On-study Transplants|2|||
148941856|NCT00446251|537270657|FG000|Overall Study|Rituximab Infusion Reaction|2|||
148941857|NCT00446251|537270657|FG000|Overall Study|Lost to Follow-up|1|||
148941858|NCT02264639|537270662|FG000|Overall Study|Death (after completing single-dose phase)|1|||
148941859|NCT02264639|537270663|FG001|Overall Study|Death (after completing single-dose phase)|0|||
148941860|NCT02264639|537270664|FG002|Overall Study|Death (after completing single-dose phase)|0|||
148941861|NCT02264639|537270665|FG003|Overall Study|Death (after completing single-dose phase)|0|||
148941862|NCT02264639|537270666|FG004|Overall Study|Death (after completing single-dose phase)|0|||
148941863|NCT02264639|537270662|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
148941864|NCT02264639|537270663|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
148941865|NCT02264639|537270664|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
148941866|NCT02264639|537270665|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
148941867|NCT02264639|537270666|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
148941868|NCT02264639|537270662|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
148941869|NCT02264639|537270663|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
148941870|NCT02264639|537270664|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
148941871|NCT02264639|537270665|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
148941872|NCT02264639|537270666|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
148941873|NCT02264639|537270662|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
148941874|NCT02264639|537270663|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
148941875|NCT02264639|537270664|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
148941876|NCT02264639|537270665|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
148941877|NCT02264639|537270666|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
148941878|NCT00702689|537270673|FG000|Overall Study|Withdrawal by Subject|4|||
148941879|NCT00702689|537270673|FG000|Overall Study|Recurrent malignancy|1|||
148941880|NCT00702689|537270673|FG000|Overall Study|Adverse Event|1|||
148941881|NCT01611155|537270677|FG000|Overall Study|Adverse Event|1|||
148941882|NCT01611155|537270678|FG001|Overall Study|Adverse Event|1|||
148941883|NCT01611155|537270677|FG000|Overall Study|Refused further treatment|6|||
148941884|NCT01611155|537270678|FG001|Overall Study|Refused further treatment|4|||
148941885|NCT01611155|537270677|FG000|Overall Study|Disease progression|1|||
148941886|NCT01611155|537270678|FG001|Overall Study|Disease progression|0|||
148941887|NCT01611155|537270677|FG000|Overall Study|Withdrawal by Subject|1|||
148941888|NCT01611155|537270678|FG001|Overall Study|Withdrawal by Subject|0|||
148941889|NCT01611155|537270677|FG000|Overall Study|Alternative treatment|0|||
148941890|NCT01611155|537270678|FG001|Overall Study|Alternative treatment|1|||
148941891|NCT01611155|537270677|FG000|Overall Study|Ineligible patient|0|||
148941892|NCT01611155|537270678|FG001|Overall Study|Ineligible patient|1|||
148941893|NCT02369016|537270679|FG000|Overall Study|AE associated with clinical disease progression|2|||
148941894|NCT02369016|537270680|FG001|Overall Study|AE associated with clinical disease progression|1|||
148941895|NCT02369016|537270679|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
148941896|NCT02369016|537270680|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
149015940|NCT00445601|537537795|FG000|Overall Study|Death prior to TURBT|0|||
149015941|NCT00445601|537537796|FG001|Overall Study|Death prior to TURBT|1|||
149015942|NCT01091428|537537797|FG000|Phase 1|Progressive Disease|24|||
149015943|NCT01091428|537537798|FG001|Phase 1|Progressive Disease|8|||
149015944|NCT01091428|537537799|FG002|Phase 1|Progressive Disease|0|||
149015945|NCT01091428|537537800|FG003|Phase 1|Progressive Disease|0|||
149015946|NCT01091428|537537797|FG000|Phase 1|Symptomatic Deterioration|3|||
149015947|NCT01091428|537537798|FG001|Phase 1|Symptomatic Deterioration|2|||
148941897|NCT02369016|537270679|FG000|Overall Study|Progressive disease - clinical progression|1|||
148941898|NCT02369016|537270680|FG001|Overall Study|Progressive disease - clinical progression|4|||
148941899|NCT02369016|537270679|FG000|Overall Study|withdrawal by patient|4|||
148941900|NCT02369016|537270680|FG001|Overall Study|withdrawal by patient|0|||
148941901|NCT02369016|537270679|FG000|Overall Study|Progressive disease - radiological progression|6|||
148941902|NCT02369016|537270680|FG001|Overall Study|Progressive disease - radiological progression|2|||
148941903|NCT02229383|537270683|FG000|Overall Study|Adverse Event|7|||
148941904|NCT02229383|537270684|FG001|Overall Study|Adverse Event|4|||
149015948|NCT01091428|537537799|FG002|Phase 1|Symptomatic Deterioration|0|||
149015949|NCT01091428|537537800|FG003|Phase 1|Symptomatic Deterioration|0|||
149015950|NCT01091428|537537797|FG000|Phase 1|Adverse Event|2|||
148941905|NCT02229383|537270683|FG000|Overall Study|Death|0|||
148941906|NCT02229383|537270684|FG001|Overall Study|Death|1|||
148941907|NCT02229383|537270683|FG000|Overall Study|Lost to Follow-up|5|||
148941908|NCT02229383|537270684|FG001|Overall Study|Lost to Follow-up|3|||
148941909|NCT02229383|537270683|FG000|Overall Study|Withdrawal by Subject|4|||
148941910|NCT02229383|537270684|FG001|Overall Study|Withdrawal by Subject|6|||
148808449|NCT05493111|536777499|FG000|Overall Study|Adverse Event|3|||
148808450|NCT05493111|536777500|FG001|Overall Study|Adverse Event|4|||
148941911|NCT02229383|537270683|FG000|Overall Study|Did not receive treatment|1|||
148941912|NCT02229383|537270684|FG001|Overall Study|Did not receive treatment|0|||
148941913|NCT02229383|537270683|FG000|Overall Study|Other|3|||
148941914|NCT02229383|537270684|FG001|Overall Study|Other|8|||
148941915|NCT05248867|537270687|FG000|Double-blind Period|Lost to Follow-up|0|||
148941916|NCT05248867|537270688|FG001|Double-blind Period|Lost to Follow-up|3|||
148941917|NCT05248867|537270689|FG002|Double-blind Period|Lost to Follow-up|0|||
148941918|NCT05248867|537270690|FG003|Double-blind Period|Lost to Follow-up|0|||
148941919|NCT05248867|537270691|FG004|Double-blind Period|Lost to Follow-up|0|||
148941920|NCT05248867|537270692|FG005|Double-blind Period|Lost to Follow-up|0|||
148941921|NCT05248867|537270687|FG000|Double-blind Period|Withdrawal by Subject|5|||
148941922|NCT05248867|537270688|FG001|Double-blind Period|Withdrawal by Subject|14|||
148941923|NCT05248867|537270689|FG002|Double-blind Period|Withdrawal by Subject|0|||
148941924|NCT05248867|537270690|FG003|Double-blind Period|Withdrawal by Subject|0|||
148941925|NCT05248867|537270691|FG004|Double-blind Period|Withdrawal by Subject|0|||
148941926|NCT05248867|537270692|FG005|Double-blind Period|Withdrawal by Subject|0|||
148941927|NCT05248867|537270687|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
148941928|NCT05248867|537270688|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
148941929|NCT05248867|537270689|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
148941930|NCT05248867|537270690|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
148941931|NCT05248867|537270691|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
148941932|NCT05248867|537270692|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
148941933|NCT05248867|537270687|FG000|Double-blind Period|Other, not specified|3|||
148941934|NCT05248867|537270688|FG001|Double-blind Period|Other, not specified|8|||
148941935|NCT05248867|537270689|FG002|Double-blind Period|Other, not specified|0|||
148941936|NCT05248867|537270690|FG003|Double-blind Period|Other, not specified|0|||
148941937|NCT05248867|537270691|FG004|Double-blind Period|Other, not specified|0|||
148941938|NCT05248867|537270692|FG005|Double-blind Period|Other, not specified|0|||
148941939|NCT05248867|537270687|FG000|Open-label Period|Withdrawal by Subject|0|||
148941940|NCT05248867|537270688|FG001|Open-label Period|Withdrawal by Subject|0|||
148941941|NCT05248867|537270689|FG002|Open-label Period|Withdrawal by Subject|3|||
148941942|NCT05248867|537270690|FG003|Open-label Period|Withdrawal by Subject|1|||
148941943|NCT05248867|537270691|FG004|Open-label Period|Withdrawal by Subject|7|||
148941944|NCT05248867|537270692|FG005|Open-label Period|Withdrawal by Subject|9|||
148941945|NCT05248867|537270687|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
148941946|NCT05248867|537270688|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
148808451|NCT05493111|536777499|FG000|Overall Study|Withdrawal of Consent|19|||
148941947|NCT05248867|537270689|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
148941948|NCT05248867|537270690|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
148941949|NCT05248867|537270691|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
148941950|NCT05248867|537270692|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
148941951|NCT05248867|537270687|FG000|Open-label Period|Lost to Follow-up|0|||
148941952|NCT05248867|537270688|FG001|Open-label Period|Lost to Follow-up|0|||
148941953|NCT05248867|537270689|FG002|Open-label Period|Lost to Follow-up|0|||
148808452|NCT05493111|536777500|FG001|Overall Study|Withdrawal of Consent|10|||
148941954|NCT05248867|537270690|FG003|Open-label Period|Lost to Follow-up|0|||
148941955|NCT05248867|537270691|FG004|Open-label Period|Lost to Follow-up|5|||
148941956|NCT05248867|537270692|FG005|Open-label Period|Lost to Follow-up|2|||
148941957|NCT05248867|537270687|FG000|Open-label Period|COVID-19 Infection|0|||
148941958|NCT05248867|537270688|FG001|Open-label Period|COVID-19 Infection|0|||
148941959|NCT05248867|537270689|FG002|Open-label Period|COVID-19 Infection|0|||
148941960|NCT05248867|537270690|FG003|Open-label Period|COVID-19 Infection|0|||
148941961|NCT05248867|537270691|FG004|Open-label Period|COVID-19 Infection|1|||
148941962|NCT05248867|537270692|FG005|Open-label Period|COVID-19 Infection|0|||
148941963|NCT05248867|537270687|FG000|Open-label Period|Other, not specified|0|||
148941964|NCT05248867|537270688|FG001|Open-label Period|Other, not specified|0|||
148941965|NCT05248867|537270689|FG002|Open-label Period|Other, not specified|0|||
148941966|NCT05248867|537270690|FG003|Open-label Period|Other, not specified|0|||
148941967|NCT05248867|537270691|FG004|Open-label Period|Other, not specified|4|||
148941968|NCT05248867|537270692|FG005|Open-label Period|Other, not specified|0|||
148941969|NCT00967668|537272046|FG000|Overall Study|Withdrawal by Subject|13|||
148941970|NCT00967668|537272047|FG001|Overall Study|Withdrawal by Subject|8|||
148941971|NCT00967668|537272048|FG002|Overall Study|Withdrawal by Subject|8|||
148941972|NCT00967668|537272046|FG000|Overall Study|Death|0|||
148941973|NCT00967668|537272047|FG001|Overall Study|Death|2|||
148941974|NCT00967668|537272048|FG002|Overall Study|Death|4|||
148941975|NCT00967668|537272046|FG000|Overall Study|Removed due to behavior|1|||
148941976|NCT00967668|537272047|FG001|Overall Study|Removed due to behavior|1|||
148941977|NCT00967668|537272048|FG002|Overall Study|Removed due to behavior|2|||
148941978|NCT00967668|537272046|FG000|Overall Study|Refused Year 2|11|||
148941979|NCT00967668|537272047|FG001|Overall Study|Refused Year 2|6|||
148941980|NCT00967668|537272048|FG002|Overall Study|Refused Year 2|4|||
148941981|NCT00967668|537272046|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
148941982|NCT00967668|537272047|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
148941983|NCT00967668|537272048|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
148941984|NCT00967668|537272046|FG000|Overall Study|Lost to Follow-up|15|||
148941985|NCT00967668|537272047|FG001|Overall Study|Lost to Follow-up|9|||
148941986|NCT00967668|537272048|FG002|Overall Study|Lost to Follow-up|16|||
148941987|NCT00967668|537272046|FG000|Overall Study|Refused 12-mo assessment|3|||
148941988|NCT00967668|537272047|FG001|Overall Study|Refused 12-mo assessment|1|||
148941989|NCT00967668|537272048|FG002|Overall Study|Refused 12-mo assessment|9|||
148941990|NCT00967668|537272046|FG000|Overall Study|Pregnancy|1|||
148941991|NCT00967668|537272047|FG001|Overall Study|Pregnancy|0|||
148941992|NCT00967668|537272048|FG002|Overall Study|Pregnancy|0|||
148941993|NCT00799383|537272052|FG000|Overall Study|Protocol Violation|1|||
148941994|NCT00799383|537272053|FG001|Overall Study|Protocol Violation|1|||
148941995|NCT00799383|537272052|FG000|Overall Study|Adverse Event|0|||
148941996|NCT00799383|537272053|FG001|Overall Study|Adverse Event|1|||
148941997|NCT00799383|537272052|FG000|Overall Study|Lost to Follow-up|1|||
148941998|NCT00799383|537272053|FG001|Overall Study|Lost to Follow-up|2|||
148941999|NCT00799383|537272052|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
148942000|NCT00799383|537272053|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
148942001|NCT00799383|537272052|FG000|Overall Study|Withdrawal by Subject|0|||
148942002|NCT00799383|537272053|FG001|Overall Study|Withdrawal by Subject|1|||
148942003|NCT00926328|537272054|FG000|Overall Study|Lost to Follow-up|12|||
148942004|NCT00926328|537272055|FG001|Overall Study|Lost to Follow-up|14|||
148942005|NCT03486223|537272061|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
148942006|NCT03486223|537272062|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
148942007|NCT01819831|537272063|FG000|Overall Study|Withdrawal by Subject|1|||
148942008|NCT01434667|537272064|FG000|Overall Study|Lost to Follow-up|5|||
148942009|NCT01434667|537272065|FG001|Overall Study|Lost to Follow-up|10|||
148942010|NCT02165215|537272066|FG000|Induction Phase|Adverse Event|1|||
148942011|NCT02165215|537272067|FG001|Induction Phase|Adverse Event|0|||
148942012|NCT02165215|537272068|FG002|Induction Phase|Adverse Event|0|||
148942013|NCT02165215|537272066|FG000|Induction Phase|Withdrawal by Subject|10|||
148942014|NCT02165215|537272067|FG001|Induction Phase|Withdrawal by Subject|0|||
148942015|NCT02165215|537272068|FG002|Induction Phase|Withdrawal by Subject|0|||
148942016|NCT02165215|537272066|FG000|Induction Phase|Protocol Violation|1|||
148942017|NCT02165215|537272067|FG001|Induction Phase|Protocol Violation|0|||
148942018|NCT02165215|537272068|FG002|Induction Phase|Protocol Violation|0|||
148942019|NCT02165215|537272066|FG000|Induction Phase|Physician Decision|1|||
148942020|NCT02165215|537272067|FG001|Induction Phase|Physician Decision|0|||
148942021|NCT02165215|537272068|FG002|Induction Phase|Physician Decision|0|||
148942022|NCT02165215|537272066|FG000|Induction Phase|Lack of Efficacy|2|||
148942023|NCT02165215|537272067|FG001|Induction Phase|Lack of Efficacy|0|||
148808453|NCT05493111|536777499|FG000|Overall Study|Non-compliance|1|||
148808454|NCT05493111|536777500|FG001|Overall Study|Non-compliance|1|||
148808455|NCT05493111|536777499|FG000|Overall Study|Lost to Follow-up|8|||
148808456|NCT05493111|536777500|FG001|Overall Study|Lost to Follow-up|1|||
148942024|NCT02165215|537272068|FG002|Induction Phase|Lack of Efficacy|0|||
148942025|NCT02165215|537272066|FG000|Induction Phase|Non-Compliance|2|||
148942026|NCT02165215|537272067|FG001|Induction Phase|Non-Compliance|0|||
148942027|NCT02165215|537272068|FG002|Induction Phase|Non-Compliance|0|||
148942028|NCT02165215|537272066|FG000|Induction Phase|Lost to Follow-up|6|||
148942029|NCT02165215|537272067|FG001|Induction Phase|Lost to Follow-up|0|||
148942030|NCT02165215|537272068|FG002|Induction Phase|Lost to Follow-up|0|||
148942031|NCT02165215|537272066|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148942032|NCT02165215|537272067|FG001|Maintenance Phase|Withdrawal by Subject|7|||
148942033|NCT02165215|537272068|FG002|Maintenance Phase|Withdrawal by Subject|3|||
148682711|NCT04444752|536311018|FG003|Overall Study|Pregnancy|1|||
148682712|NCT04444752|536311015|FG000|Overall Study|Withdrawal by Subject|6|||
148682713|NCT04444752|536311016|FG001|Overall Study|Withdrawal by Subject|5|||
148682714|NCT04444752|536311017|FG002|Overall Study|Withdrawal by Subject|3|||
148682715|NCT04444752|536311018|FG003|Overall Study|Withdrawal by Subject|4|||
148682716|NCT04444752|536311015|FG000|Overall Study|Protocol Violation|1|||
148942034|NCT02165215|537272066|FG000|Maintenance Phase|Multiple reasons|0|||
148942035|NCT02165215|537272067|FG001|Maintenance Phase|Multiple reasons|2|||
148942036|NCT02165215|537272068|FG002|Maintenance Phase|Multiple reasons|1|||
148942037|NCT02165215|537272066|FG000|Maintenance Phase|Lost to Follow-up|0|||
148942038|NCT02165215|537272067|FG001|Maintenance Phase|Lost to Follow-up|2|||
148942039|NCT02165215|537272068|FG002|Maintenance Phase|Lost to Follow-up|0|||
148942040|NCT02165215|537272066|FG000|Maintenance Phase|Adverse Event|0|||
148942041|NCT02165215|537272067|FG001|Maintenance Phase|Adverse Event|1|||
148942042|NCT02165215|537272068|FG002|Maintenance Phase|Adverse Event|1|||
148942043|NCT01877265|537272069|FG000|Treatment Period 1|Sponsor Decision|0|||
148942044|NCT01877265|537272070|FG001|Treatment Period 1|Sponsor Decision|0|||
148942045|NCT01877265|537272071|FG002|Treatment Period 1|Sponsor Decision|1|||
148942046|NCT01877265|537272072|FG003|Treatment Period 1|Sponsor Decision|0|||
148942047|NCT01877265|537272073|FG004|Treatment Period 1|Sponsor Decision|0|||
148942048|NCT01877265|537272074|FG005|Treatment Period 1|Sponsor Decision|0|||
148942049|NCT01877265|537272069|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
148942050|NCT01877265|537272070|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
148942051|NCT01877265|537272071|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
148942052|NCT01877265|537272072|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
148942053|NCT01877265|537272073|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
148942054|NCT01877265|537272074|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
148942055|NCT01877265|537272069|FG000|Treatment Period 3|Lost to Follow-up|1|||
148942056|NCT01877265|537272070|FG001|Treatment Period 3|Lost to Follow-up|0|||
148942057|NCT01877265|537272071|FG002|Treatment Period 3|Lost to Follow-up|0|||
148942058|NCT01877265|537272072|FG003|Treatment Period 3|Lost to Follow-up|0|||
148942059|NCT01877265|537272073|FG004|Treatment Period 3|Lost to Follow-up|0|||
148942060|NCT01877265|537272074|FG005|Treatment Period 3|Lost to Follow-up|0|||
148942061|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
148942062|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
148942063|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
148942064|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
148942065|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942066|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942067|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942068|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942069|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942070|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942071|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
148942072|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
148942073|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
148942074|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
148942075|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
148942076|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942077|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942078|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942079|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942080|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942081|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942082|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
148942083|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
148942084|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
148682717|NCT04444752|536311016|FG001|Overall Study|Protocol Violation|1|||
148682718|NCT04444752|536311017|FG002|Overall Study|Protocol Violation|0|||
148682719|NCT04444752|536311018|FG003|Overall Study|Protocol Violation|0|||
148682720|NCT04444752|536311015|FG000|Overall Study|Patient moving out of town|1|||
148942085|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
148942086|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
148942087|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148942088|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148682721|NCT04444752|536311016|FG001|Overall Study|Patient moving out of town|0|||
148682722|NCT04444752|536311017|FG002|Overall Study|Patient moving out of town|0|||
148682723|NCT04444752|536311018|FG003|Overall Study|Patient moving out of town|1|||
148942089|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148942090|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148942091|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148942092|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148942093|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
148942094|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942095|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942096|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942097|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
148942098|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942099|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942100|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942101|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942102|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942103|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942104|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
148942105|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
148942106|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
148942107|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
148942108|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
148942109|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942110|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942111|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942112|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942113|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942114|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942115|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
148942116|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
148942117|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
148942118|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
148942119|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
148942120|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942121|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942122|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942123|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942124|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942125|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942126|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
148942127|NCT01847274|537272080|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
148942128|NCT01847274|537272081|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
148942129|NCT01847274|537272082|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
148942130|NCT01847274|537272083|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
148942131|NCT01847274|537272084|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942132|NCT01847274|537272085|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942133|NCT01847274|537272086|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942134|NCT01847274|537272087|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942135|NCT01847274|537272088|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942136|NCT01847274|537272089|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942137|NCT01847274|537272090|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
148942138|NCT01847274|537272080|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942139|NCT01847274|537272081|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942140|NCT01847274|537272082|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942141|NCT01847274|537272083|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942142|NCT01847274|537272084|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942143|NCT01847274|537272085|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
148682724|NCT04444752|536311015|FG000|Overall Study|Lack of Efficacy|0|||
148942144|NCT01847274|537272086|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942145|NCT01847274|537272087|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942146|NCT01847274|537272088|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942147|NCT01847274|537272089|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942148|NCT01847274|537272090|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
148942149|NCT01847274|537272080|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942150|NCT01847274|537272081|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942151|NCT01847274|537272082|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942152|NCT01847274|537272083|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942153|NCT01847274|537272084|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
148942154|NCT01847274|537272085|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942155|NCT01847274|537272086|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942156|NCT01847274|537272087|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942157|NCT01847274|537272088|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942158|NCT01847274|537272089|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942159|NCT01847274|537272090|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
148942160|NCT01847274|537272080|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942161|NCT01847274|537272081|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942162|NCT01847274|537272082|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942163|NCT01847274|537272083|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942164|NCT01847274|537272084|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942165|NCT01847274|537272085|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942166|NCT01847274|537272086|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
148942167|NCT01847274|537272087|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942168|NCT01847274|537272088|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942169|NCT01847274|537272089|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942170|NCT01847274|537272090|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
148942171|NCT01847274|537272080|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942172|NCT01847274|537272081|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942173|NCT01847274|537272082|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942174|NCT01847274|537272083|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942175|NCT01847274|537272084|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942176|NCT01847274|537272085|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942177|NCT01847274|537272086|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
148942178|NCT01847274|537272087|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942179|NCT01847274|537272088|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942180|NCT01847274|537272089|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942181|NCT01847274|537272090|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
148942182|NCT01847274|537272080|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942183|NCT01847274|537272081|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942184|NCT01847274|537272082|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942185|NCT01847274|537272083|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942186|NCT01847274|537272084|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942187|NCT01847274|537272085|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942188|NCT01847274|537272086|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
148942189|NCT01847274|537272087|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942190|NCT01847274|537272088|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942191|NCT01847274|537272089|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942192|NCT01847274|537272090|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
148942193|NCT01847274|537272080|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
148942194|NCT01847274|537272081|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
149197073|NCT01274338|538191073|FG000|Overall Study|Other complicating diseases|0|||
149197074|NCT01274338|538191074|FG001|Overall Study|Other complicating diseases|3|||
149197075|NCT01274338|538191075|FG002|Overall Study|Other complicating diseases|1|||
149197076|NCT01274338|538191076|FG003|Overall Study|Other complicating diseases|0|||
149197077|NCT01274338|538191077|FG004|Overall Study|Other complicating diseases|0|||
149197078|NCT01274338|538191078|FG005|Overall Study|Other complicating diseases|0|||
149197079|NCT01274338|538191073|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
149197080|NCT01274338|538191074|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
149197081|NCT01274338|538191075|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
149197082|NCT01274338|538191076|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
149197083|NCT01274338|538191077|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
149197084|NCT01274338|538191078|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
149197085|NCT01274338|538191073|FG000|Overall Study|Pregnancy|0|||
149197086|NCT01274338|538191074|FG001|Overall Study|Pregnancy|0|||
149197087|NCT01274338|538191075|FG002|Overall Study|Pregnancy|1|||
148942195|NCT01847274|537272082|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
148942196|NCT01847274|537272083|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
148942197|NCT01847274|537272084|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
148942198|NCT01847274|537272085|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
148942199|NCT01847274|537272086|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
148942200|NCT01847274|537272087|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
148942201|NCT01847274|537272088|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
148942202|NCT01847274|537272089|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
148942203|NCT01847274|537272090|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
148942204|NCT01847274|537272080|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942205|NCT01847274|537272081|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942206|NCT01847274|537272082|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942207|NCT01847274|537272083|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942208|NCT01847274|537272084|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942209|NCT01847274|537272085|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942210|NCT01847274|537272086|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942211|NCT01847274|537272087|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
148942212|NCT01847274|537272088|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942213|NCT01847274|537272089|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
148942214|NCT01847274|537272090|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
148942215|NCT01847274|537272080|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942216|NCT01847274|537272081|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942217|NCT01847274|537272082|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942218|NCT01847274|537272083|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942219|NCT01847274|537272084|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942220|NCT01847274|537272085|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942221|NCT01847274|537272086|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942222|NCT01847274|537272087|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
148942223|NCT01847274|537272088|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
148942224|NCT01847274|537272089|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
148942225|NCT01847274|537272090|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
148942226|NCT01847274|537272080|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942227|NCT01847274|537272081|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942228|NCT01847274|537272082|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942229|NCT01847274|537272083|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942230|NCT01847274|537272084|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942231|NCT01847274|537272085|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942232|NCT01847274|537272086|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942233|NCT01847274|537272087|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942234|NCT01847274|537272088|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942235|NCT01847274|537272089|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
148942236|NCT01847274|537272090|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
148942237|NCT01921387|537272091|FG000|Overall Study|Adverse Event|1|||
148942238|NCT02021331|537272096|FG000|Overall Study|Adverse Event|0|||
148942239|NCT02021331|537272097|FG001|Overall Study|Adverse Event|2|||
148942240|NCT01081678|537272104|FG000|Overall Study|Ineligibility Determined|0|||
148942241|NCT01081678|537272105|FG001|Overall Study|Ineligibility Determined|0|||
148942242|NCT01081678|537272106|FG002|Overall Study|Ineligibility Determined|1|||
148942243|NCT01081678|537272107|FG003|Overall Study|Ineligibility Determined|1|||
148942244|NCT01081678|537272104|FG000|Overall Study|Noncompliance|3|||
148942245|NCT01081678|537272105|FG001|Overall Study|Noncompliance|4|||
148942246|NCT01081678|537272106|FG002|Overall Study|Noncompliance|5|||
148942247|NCT01081678|537272107|FG003|Overall Study|Noncompliance|2|||
148942248|NCT01081678|537272104|FG000|Overall Study|Adverse Event|2|||
148942249|NCT01081678|537272105|FG001|Overall Study|Adverse Event|1|||
148942250|NCT01081678|537272106|FG002|Overall Study|Adverse Event|2|||
148942251|NCT01081678|537272107|FG003|Overall Study|Adverse Event|2|||
148942252|NCT01081678|537272104|FG000|Overall Study|Withdrawal by Subject|15|||
148942253|NCT01081678|537272105|FG001|Overall Study|Withdrawal by Subject|7|||
148942254|NCT01081678|537272106|FG002|Overall Study|Withdrawal by Subject|17|||
148942255|NCT01081678|537272107|FG003|Overall Study|Withdrawal by Subject|14|||
148942256|NCT01081678|537272104|FG000|Overall Study|Administrative Decision|1|||
148942257|NCT01081678|537272105|FG001|Overall Study|Administrative Decision|0|||
148942258|NCT01081678|537272106|FG002|Overall Study|Administrative Decision|0|||
148942259|NCT01081678|537272107|FG003|Overall Study|Administrative Decision|1|||
148942260|NCT01081678|537272104|FG000|Overall Study|Lost to Follow-up|4|||
148942261|NCT01081678|537272105|FG001|Overall Study|Lost to Follow-up|1|||
148942262|NCT01081678|537272106|FG002|Overall Study|Lost to Follow-up|4|||
148942263|NCT01081678|537272107|FG003|Overall Study|Lost to Follow-up|3|||
148942264|NCT01081678|537272104|FG000|Overall Study|Death|2|||
148942265|NCT01081678|537272105|FG001|Overall Study|Death|2|||
148942266|NCT01081678|537272106|FG002|Overall Study|Death|2|||
148942267|NCT01081678|537272107|FG003|Overall Study|Death|6|||
148942268|NCT01081678|537272104|FG000|Overall Study|Other|0|||
148942269|NCT01081678|537272105|FG001|Overall Study|Other|1|||
148942270|NCT01081678|537272106|FG002|Overall Study|Other|0|||
148942271|NCT01081678|537272107|FG003|Overall Study|Other|0|||
148942272|NCT01619423|537272113|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
148942273|NCT01619423|537272114|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
148942274|NCT01619423|537272115|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
148942275|NCT01619423|537272116|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
148942276|NCT01786668|537272117|FG000|Overall Study|Adverse Event|0|||
148942277|NCT01786668|537272118|FG001|Overall Study|Adverse Event|1|||
148942278|NCT01786668|537272119|FG002|Overall Study|Adverse Event|1|||
148942279|NCT01786668|537272120|FG003|Overall Study|Adverse Event|2|||
148942280|NCT01786668|537272117|FG000|Overall Study|Withdrawal by Subject|0|||
148942281|NCT01786668|537272118|FG001|Overall Study|Withdrawal by Subject|0|||
148942282|NCT01786668|537272119|FG002|Overall Study|Withdrawal by Subject|3|||
148942283|NCT01786668|537272120|FG003|Overall Study|Withdrawal by Subject|1|||
148942284|NCT01786668|537272117|FG000|Overall Study|Pregnancy|0|||
148942285|NCT01786668|537272118|FG001|Overall Study|Pregnancy|0|||
148942286|NCT01786668|537272119|FG002|Overall Study|Pregnancy|0|||
148942287|NCT01786668|537272120|FG003|Overall Study|Pregnancy|1|||
148942288|NCT01786668|537272117|FG000|Overall Study|Lost to Follow-up|1|||
148942289|NCT01786668|537272118|FG001|Overall Study|Lost to Follow-up|0|||
148942290|NCT01786668|537272119|FG002|Overall Study|Lost to Follow-up|1|||
148942291|NCT01786668|537272120|FG003|Overall Study|Lost to Follow-up|0|||
148942292|NCT04891978|537272121|FG000|Baseline|Protocol Violation|2|||
148942293|NCT04891978|537272122|FG001|Baseline|Protocol Violation|1|||
148942294|NCT04891978|537272123|FG002|Baseline|Protocol Violation|0|||
148942295|NCT04891978|537272121|FG000|Baseline|Missing AIRQ|1|||
148942296|NCT04891978|537272122|FG001|Baseline|Missing AIRQ|0|||
148942297|NCT04891978|537272123|FG002|Baseline|Missing AIRQ|0|||
148942298|NCT04891978|537272121|FG000|Baseline|Did not attend a baseline visit|0|||
148942299|NCT04891978|537272122|FG001|Baseline|Did not attend a baseline visit|0|||
148942300|NCT04891978|537272123|FG002|Baseline|Did not attend a baseline visit|9|||
148942301|NCT03330288|537272135|FG000|Overall Study|Other reason|1|||
148942302|NCT03330288|537272136|FG001|Overall Study|Other reason|1|||
148942303|NCT03330288|537272135|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
148942304|NCT03330288|537272136|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
148942305|NCT03330288|537272135|FG000|Overall Study|Adverse Event|1|||
148942306|NCT03330288|537272136|FG001|Overall Study|Adverse Event|0|||
148942307|NCT03330288|537272135|FG000|Overall Study|Withdrawal by Subject|1|||
148942308|NCT03330288|537272136|FG001|Overall Study|Withdrawal by Subject|0|||
148942309|NCT03330288|537272135|FG000|Overall Study|Lost to Follow-up|26|||
148942310|NCT03330288|537272136|FG001|Overall Study|Lost to Follow-up|7|||
148942311|NCT01042678|537272137|FG000|Overall Study|Physician Decision|1|||
148942312|NCT01042678|537272138|FG001|Overall Study|Physician Decision|0|||
148942313|NCT01042678|537272139|FG002|Overall Study|Physician Decision|0|||
148942314|NCT01042678|537272140|FG003|Overall Study|Physician Decision|0|||
148942315|NCT01042678|537272141|FG004|Overall Study|Physician Decision|0|||
148942316|NCT01042678|537272142|FG005|Overall Study|Physician Decision|0|||
148942317|NCT01416272|537272144|FG000|Overall Study|Unacceptable distance visual acuity|2|||
148942318|NCT01416272|537272144|FG000|Overall Study|Lost to Follow-up|1|||
148942319|NCT01416272|537272144|FG000|Overall Study|Study related complaints|1|||
148942320|NCT00205881|537272147|FG000|Overall Study|Withdrawal by Subject|16|||
148942321|NCT01443078|537272148|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
148942322|NCT01443078|537272148|FG000|Overall Study|Withdrawal by Subject|1|||
148942323|NCT01443078|537272148|FG000|Overall Study|Patient had brain mets|1|||
148942324|NCT02217878|537272149|FG000|Overall Study|required morphine due to chest pain|1|||
148942325|NCT02217878|537272150|FG001|Overall Study|required morphine due to chest pain|2|||
148942326|NCT02217878|537272149|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
148942327|NCT02217878|537272150|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
148942328|NCT01201785|537272154|FG000|Overall Study|Lost to Follow-up|16|||
148942329|NCT02151110|537272155|FG000|Overall Study|Withdrawal by Subject|0|||
148942330|NCT02151110|537272156|FG001|Overall Study|Withdrawal by Subject|0|||
148942331|NCT02151110|537272157|FG002|Overall Study|Withdrawal by Subject|0|||
148942332|NCT02151110|537272158|FG003|Overall Study|Withdrawal by Subject|0|||
148942333|NCT02151110|537272159|FG004|Overall Study|Withdrawal by Subject|0|||
148942334|NCT02151110|537272160|FG005|Overall Study|Withdrawal by Subject|0|||
148942335|NCT02151110|537272161|FG006|Overall Study|Withdrawal by Subject|0|||
148942336|NCT02151110|537272162|FG007|Overall Study|Withdrawal by Subject|1|||
148942337|NCT02151110|537272155|FG000|Overall Study|Lost to Follow-up|0|||
148942338|NCT02151110|537272156|FG001|Overall Study|Lost to Follow-up|0|||
148942339|NCT02151110|537272157|FG002|Overall Study|Lost to Follow-up|0|||
148682725|NCT04444752|536311016|FG001|Overall Study|Lack of Efficacy|0|||
148682726|NCT04444752|536311017|FG002|Overall Study|Lack of Efficacy|0|||
148682727|NCT04444752|536311018|FG003|Overall Study|Lack of Efficacy|1|||
148682728|NCT04444752|536311015|FG000|Overall Study|Death|0|||
148682729|NCT04444752|536311016|FG001|Overall Study|Death|0|||
148682730|NCT04444752|536311017|FG002|Overall Study|Death|1|||
148682731|NCT04444752|536311018|FG003|Overall Study|Death|0|||
148682732|NCT00579254|536311019|FG000|Overall Study|Lost to Follow-up|39|||
148682733|NCT00579254|536311019|FG000|Overall Study|Discontinued when study terminated|73|||
148682734|NCT02557672|536311020|FG000|Overall Study|Withdrawal by Subject|4|||
148682735|NCT02557672|536311021|FG001|Overall Study|Withdrawal by Subject|2|||
148682736|NCT00343642|536312991|FG000|Overall Study|Lost to Follow-up|0|||
148682737|NCT00343642|536312992|FG001|Overall Study|Lost to Follow-up|1|||
148682738|NCT00343642|536312993|FG002|Overall Study|Lost to Follow-up|0|||
148682739|NCT00343642|536312991|FG000|Overall Study|Pregnancy|1|||
148682740|NCT00343642|536312992|FG001|Overall Study|Pregnancy|0|||
148682741|NCT00343642|536312993|FG002|Overall Study|Pregnancy|2|||
148682742|NCT00343642|536312991|FG000|Overall Study|Withdrawal by Subject|2|||
148682743|NCT00343642|536312992|FG001|Overall Study|Withdrawal by Subject|3|||
148682744|NCT00343642|536312993|FG002|Overall Study|Withdrawal by Subject|4|||
148682745|NCT00343642|536312991|FG000|Overall Study|Adverse Event|0|||
148682746|NCT00343642|536312992|FG001|Overall Study|Adverse Event|0|||
148682747|NCT00343642|536312993|FG002|Overall Study|Adverse Event|1|||
148682748|NCT00343642|536312991|FG000|Overall Study|Flare up|6|||
148682749|NCT00343642|536312992|FG001|Overall Study|Flare up|4|||
148682750|NCT00343642|536312993|FG002|Overall Study|Flare up|0|||
148682751|NCT00766506|536312996|FG000|Overall Study|Use rescue medication after 3 hours|3|||
148682752|NCT00766506|536312997|FG001|Overall Study|Use rescue medication after 3 hours|0|||
148682753|NCT00766506|536312996|FG000|Overall Study|Other|2|||
148682754|NCT00766506|536312997|FG001|Overall Study|Other|2|||
148682755|NCT03262233|536312999|FG000|Overall Study|Withdrawal by Subject|12|||
148682756|NCT03262233|536313000|FG001|Overall Study|Withdrawal by Subject|8|||
148682757|NCT03262233|536313001|FG002|Overall Study|Withdrawal by Subject|21|||
148682758|NCT03262233|536313002|FG003|Overall Study|Withdrawal by Subject|13|||
148682759|NCT03262233|536312999|FG000|Overall Study|Declined due to shock|1|||
148682760|NCT03262233|536313000|FG001|Overall Study|Declined due to shock|2|||
148682761|NCT03262233|536313001|FG002|Overall Study|Declined due to shock|2|||
148682762|NCT03262233|536313002|FG003|Overall Study|Declined due to shock|3|||
148682763|NCT03262233|536312999|FG000|Overall Study|Protocol Violation|5|||
148682764|NCT03262233|536313000|FG001|Overall Study|Protocol Violation|10|||
148682765|NCT03262233|536313001|FG002|Overall Study|Protocol Violation|2|||
148682766|NCT03262233|536313002|FG003|Overall Study|Protocol Violation|13|||
148682767|NCT03262233|536312999|FG000|Overall Study|data collection artifact|0|||
148942340|NCT02151110|537272158|FG003|Overall Study|Lost to Follow-up|0|||
148942341|NCT02151110|537272159|FG004|Overall Study|Lost to Follow-up|0|||
148942342|NCT02151110|537272160|FG005|Overall Study|Lost to Follow-up|0|||
148942343|NCT02151110|537272161|FG006|Overall Study|Lost to Follow-up|0|||
148942344|NCT02151110|537272162|FG007|Overall Study|Lost to Follow-up|2|||
148682768|NCT03262233|536313000|FG001|Overall Study|data collection artifact|1|||
148942345|NCT01064310|537272163|FG000|Period 1|Adverse Event|7|||
148942346|NCT01064310|537272164|FG001|Period 1|Adverse Event|10|||
148942347|NCT01064310|537272165|FG002|Period 1|Adverse Event|0|||
148942348|NCT01064310|537272163|FG000|Period 1|Physician Decision|1|||
148942349|NCT01064310|537272164|FG001|Period 1|Physician Decision|0|||
148942350|NCT01064310|537272165|FG002|Period 1|Physician Decision|0|||
148942351|NCT01064310|537272163|FG000|Period 1|Withdrawal by Subject|2|||
148942352|NCT01064310|537272164|FG001|Period 1|Withdrawal by Subject|2|||
148942353|NCT01064310|537272165|FG002|Period 1|Withdrawal by Subject|0|||
148942354|NCT01064310|537272163|FG000|Period 1|Lack of Efficacy|3|||
148942355|NCT01064310|537272164|FG001|Period 1|Lack of Efficacy|5|||
148942356|NCT01064310|537272165|FG002|Period 1|Lack of Efficacy|0|||
148942357|NCT01064310|537272163|FG000|Period 1|Entered Open-label Period|1|||
148942358|NCT01064310|537272164|FG001|Period 1|Entered Open-label Period|1|||
148942359|NCT01064310|537272165|FG002|Period 1|Entered Open-label Period|0|||
148942360|NCT01064310|537272163|FG000|Period 2|Adverse Event|2|||
148942361|NCT01064310|537272164|FG001|Period 2|Adverse Event|1|||
148682769|NCT03262233|536313001|FG002|Overall Study|data collection artifact|0|||
148682770|NCT03262233|536313002|FG003|Overall Study|data collection artifact|0|||
148682771|NCT03877237|536313003|FG000|Overall Study|Adverse Event|1|||
148682772|NCT03877237|536313004|FG001|Overall Study|Adverse Event|2|||
148682773|NCT03877237|536313003|FG000|Overall Study|Death|3|||
148682774|NCT03877237|536313004|FG001|Overall Study|Death|2|||
148682775|NCT03877237|536313003|FG000|Overall Study|Physician Decision|1|||
148682776|NCT03877237|536313004|FG001|Overall Study|Physician Decision|0|||
148682777|NCT03877237|536313003|FG000|Overall Study|Withdrawal by Subject|0|||
148682778|NCT03877237|536313004|FG001|Overall Study|Withdrawal by Subject|2|||
148682779|NCT03372083|536313005|FG000|Overall Study|Adverse Event|3|||
148682780|NCT03372083|536313005|FG000|Overall Study|Physician Decision|1|||
148682781|NCT03372083|536313005|FG000|Overall Study|Withdrawal by Subject|1|||
148682782|NCT02236754|536313006|FG000|Overall Study|Withdrawal by Subject|1|||
148682783|NCT02236754|536313007|FG001|Overall Study|Withdrawal by Subject|0|||
148682784|NCT02544633|536313008|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
148682785|NCT02544633|536313009|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
148942362|NCT01064310|537272165|FG002|Period 2|Adverse Event|0|||
148942363|NCT01064310|537272163|FG000|Period 2|Physician Decision|0|||
148942364|NCT01064310|537272164|FG001|Period 2|Physician Decision|1|||
148942365|NCT01064310|537272165|FG002|Period 2|Physician Decision|0|||
148942366|NCT01064310|537272163|FG000|Period 2|Entered Open-label Period|1|||
148942367|NCT01064310|537272164|FG001|Period 2|Entered Open-label Period|0|||
148682786|NCT02544633|536313010|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
148682787|NCT02544633|536313011|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
148942368|NCT01064310|537272165|FG002|Period 2|Entered Open-label Period|0|||
148942369|NCT01064310|537272163|FG000|Period 2|Lack of Efficacy|1|||
148942370|NCT01064310|537272164|FG001|Period 2|Lack of Efficacy|4|||
148942371|NCT01064310|537272165|FG002|Period 2|Lack of Efficacy|0|||
148942372|NCT01064310|537272163|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
148942373|NCT01064310|537272164|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
148942374|NCT01064310|537272165|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
148942375|NCT01064310|537272163|FG000|Open Label Pazopinib|Adverse Event|0|||
148942376|NCT01064310|537272164|FG001|Open Label Pazopinib|Adverse Event|0|||
148942377|NCT01064310|537272165|FG002|Open Label Pazopinib|Adverse Event|12|||
148942378|NCT01064310|537272163|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
149015951|NCT01091428|537537798|FG001|Phase 1|Adverse Event|0|||
148682788|NCT02544633|536313008|FG000|Treatment Period|Adverse Event|7|||
148682789|NCT02544633|536313009|FG001|Treatment Period|Adverse Event|4|||
148942379|NCT01064310|537272164|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
148942380|NCT01064310|537272165|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
148942381|NCT01064310|537272163|FG000|Open Label Pazopinib|Physician Decision|0|||
148942382|NCT01064310|537272164|FG001|Open Label Pazopinib|Physician Decision|0|||
148942383|NCT01064310|537272165|FG002|Open Label Pazopinib|Physician Decision|20|||
148682790|NCT02544633|536313010|FG002|Treatment Period|Adverse Event|0|||
148942384|NCT00001880|537272166|FG000|Overall Study|Death|14|||
148942385|NCT02639065|537272167|FG000|Study Treatment|Disease Progression|13|||
148942386|NCT02639065|537272167|FG000|Study Treatment|Adverse Event|9|||
148942387|NCT02639065|537272167|FG000|Study Treatment|Withdrawal by Subject|1|||
148942388|NCT02639065|537272167|FG000|Follow up|Subject refused to follow up|1|||
148942389|NCT02639065|537272167|FG000|Follow up|Symptomatic Deterioration|2|||
148942390|NCT02639065|537272167|FG000|Follow up|Death|2|||
149015952|NCT01091428|537537799|FG002|Phase 1|Adverse Event|0|||
148942391|NCT02639065|537272167|FG000|Follow up|Study Terminated|1|||
148942392|NCT02639065|537272167|FG000|Follow up|Disease Progression|3|||
148942393|NCT00481078|537272168|FG000|Overall Study|Progression of disease|11|||
148942394|NCT00481078|537272169|FG001|Overall Study|Progression of disease|11|||
148942395|NCT00481078|537272168|FG000|Overall Study|Adverse Event|15|||
148942396|NCT00481078|537272169|FG001|Overall Study|Adverse Event|3|||
148942397|NCT00481078|537272168|FG000|Overall Study|Death|5|||
148942398|NCT00481078|537272169|FG001|Overall Study|Death|3|||
148942399|NCT00481078|537272168|FG000|Overall Study|Intercurrent illness|1|||
148942400|NCT00481078|537272169|FG001|Overall Study|Intercurrent illness|0|||
148942401|NCT00481078|537272168|FG000|Overall Study|Withdrawal by Subject|7|||
148942402|NCT00481078|537272169|FG001|Overall Study|Withdrawal by Subject|1|||
148942403|NCT00481078|537272168|FG000|Overall Study|Information not available|1|||
148942404|NCT00481078|537272169|FG001|Overall Study|Information not available|0|||
148942405|NCT00481078|537272168|FG000|Overall Study|Received other treatment|2|||
148942406|NCT00481078|537272169|FG001|Overall Study|Received other treatment|1|||
148942407|NCT00481078|537272168|FG000|Overall Study|Brain metastasis|0|||
148942408|NCT00481078|537272169|FG001|Overall Study|Brain metastasis|1|||
148942409|NCT03128411|537272172|FG000|Treatment Phase|Adverse Event|21|||
148942410|NCT03128411|537272172|FG000|Treatment Phase|Physician Decision|1|||
148942411|NCT03128411|537272172|FG000|Treatment Phase|Other|2|||
148942412|NCT03128411|537272172|FG000|Long Term Follow-up Phase|Death|2|||
148942413|NCT00873015|537272173|FG000|Overall Study|Withdrawal by Subject|0|||
148942414|NCT00873015|537272174|FG001|Overall Study|Withdrawal by Subject|1|||
148942415|NCT00873015|537272175|FG002|Overall Study|Withdrawal by Subject|0|||
148942416|NCT00873015|537272176|FG003|Overall Study|Withdrawal by Subject|0|||
148942417|NCT00345839|537272177|FG000|Overall Study|Withdrawal by Subject|91|||
148942418|NCT00345839|537272178|FG001|Overall Study|Withdrawal by Subject|98|||
148942419|NCT00345839|537272177|FG000|Overall Study|Lost to Follow-up|58|||
148942420|NCT00345839|537272178|FG001|Overall Study|Lost to Follow-up|61|||
148942421|NCT03749447|537273842|FG000|Overall Study|Adverse Event|11|||
148942422|NCT03749447|537273843|FG001|Overall Study|Adverse Event|3|||
148942423|NCT03749447|537273842|FG000|Overall Study|Death|1|||
148942424|NCT03749447|537273843|FG001|Overall Study|Death|1|||
148942425|NCT03749447|537273842|FG000|Overall Study|Lost to Follow-up|2|||
148942426|NCT03749447|537273843|FG001|Overall Study|Lost to Follow-up|2|||
148942427|NCT03749447|537273842|FG000|Overall Study|Reason Not Specified|0|||
148942428|NCT03749447|537273843|FG001|Overall Study|Reason Not Specified|3|||
148942429|NCT03749447|537273842|FG000|Overall Study|Physician Decision|4|||
148942430|NCT03749447|537273843|FG001|Overall Study|Physician Decision|3|||
148942431|NCT03749447|537273842|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
148808457|NCT05493111|536777499|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
148808458|NCT05493111|536777500|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
148942432|NCT03749447|537273843|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
148942433|NCT03749447|537273842|FG000|Overall Study|Study Terminated By Sponsor|112|||
148942434|NCT03749447|537273843|FG001|Overall Study|Study Terminated By Sponsor|105|||
148942435|NCT03749447|537273842|FG000|Overall Study|Withdrawal by Subject|12|||
148942436|NCT03749447|537273843|FG001|Overall Study|Withdrawal by Subject|6|||
148942437|NCT03749447|537273842|FG000|Overall Study|Non-compliance With Study Drug|0|||
148942438|NCT03749447|537273843|FG001|Overall Study|Non-compliance With Study Drug|1|||
148942439|NCT00115739|537273844|FG000|Overall Study|Lost to Follow-up|3|||
148942440|NCT00259649|537273845|FG000|Overall Study|Lost to Follow-up|7|||
148942441|NCT00259649|537273845|FG000|Overall Study|irregular menses|3|||
148942442|NCT00745823|537273847|FG000|Overall Study|Adverse Event|5|||
148942443|NCT00745823|537273848|FG001|Overall Study|Adverse Event|3|||
148942444|NCT00745823|537273847|FG000|Overall Study|Lack of Efficacy|20|||
148942445|NCT00745823|537273848|FG001|Overall Study|Lack of Efficacy|6|||
148942446|NCT00745823|537273847|FG000|Overall Study|Lost to Follow-up|10|||
148942447|NCT00745823|537273848|FG001|Overall Study|Lost to Follow-up|11|||
148942448|NCT00745823|537273847|FG000|Overall Study|Physician Decision|10|||
148942449|NCT00745823|537273848|FG001|Overall Study|Physician Decision|5|||
148942450|NCT00745823|537273847|FG000|Overall Study|Pregnancy|0|||
148942451|NCT00745823|537273848|FG001|Overall Study|Pregnancy|4|||
148942452|NCT00745823|537273847|FG000|Overall Study|Withdrawal by Subject|14|||
148942453|NCT00745823|537273848|FG001|Overall Study|Withdrawal by Subject|8|||
148942454|NCT00745823|537273847|FG000|Overall Study|Study Terminated by Sponsor|326|||
148942455|NCT00745823|537273848|FG001|Overall Study|Study Terminated by Sponsor|349|||
148942456|NCT01433991|537273849|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
148942457|NCT01433991|537273850|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
148942458|NCT01433991|537273851|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
148942459|NCT01433991|537273852|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
148942460|NCT01433991|537273849|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
148942461|NCT01433991|537273850|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
148942462|NCT01433991|537273851|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
148942463|NCT01433991|537273852|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
148942464|NCT01433991|537273849|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
148942465|NCT01433991|537273850|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
148942466|NCT01433991|537273851|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
148942467|NCT01433991|537273852|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
148942468|NCT01433991|537273849|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
148942469|NCT01433991|537273850|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
148942470|NCT01433991|537273851|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
148942471|NCT01433991|537273852|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
148942472|NCT01433991|537273849|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
148942473|NCT01433991|537273850|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
148942474|NCT01433991|537273851|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
148942475|NCT01433991|537273852|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
148942476|NCT01433991|537273849|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
148942477|NCT01433991|537273850|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
148942478|NCT01433991|537273851|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
148942479|NCT01433991|537273852|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
148942480|NCT01433991|537273849|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
148942481|NCT01433991|537273850|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
148942482|NCT01433991|537273851|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
148942483|NCT01433991|537273852|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
148942484|NCT00787891|537273855|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
148942485|NCT00787891|537273856|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
148942486|NCT00787891|537273855|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
148942487|NCT00787891|537273856|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
148942488|NCT00787891|537273855|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
148942489|NCT00787891|537273856|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
148942490|NCT00787891|537273855|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
148942491|NCT00787891|537273856|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
148942492|NCT00787891|537273855|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
148942493|NCT00787891|537273856|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
148942494|NCT00787891|537273855|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
148942495|NCT00787891|537273856|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
148942496|NCT00787891|537273855|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
148942497|NCT00787891|537273856|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
148682791|NCT02544633|536313011|FG003|Treatment Period|Adverse Event|5|||
148942498|NCT00787891|537273855|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
148942499|NCT00787891|537273856|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
148942500|NCT00787891|537273855|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
148942501|NCT00787891|537273856|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
148942502|NCT00787891|537273855|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
148942503|NCT00787891|537273856|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
148682792|NCT02544633|536313008|FG000|Treatment Period|Lack of Efficacy|17|||
148682793|NCT02544633|536313009|FG001|Treatment Period|Lack of Efficacy|11|||
148942504|NCT00290888|537273859|FG000|Overall Study|Physician Decision|3|||
148942505|NCT00290888|537273860|FG001|Overall Study|Physician Decision|1|||
149015953|NCT01091428|537537800|FG003|Phase 1|Adverse Event|0|||
148682794|NCT02544633|536313010|FG002|Treatment Period|Lack of Efficacy|5|||
148942506|NCT01513343|537273861|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
148942507|NCT01513343|537273862|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
148942508|NCT01513343|537273861|FG000|Post Data Collection|Dropped/withdrew from study|7|||
148942509|NCT01513343|537273862|FG001|Post Data Collection|Dropped/withdrew from study|1|||
148942510|NCT01513343|537273861|FG000|Post Data Collection|Lost to Follow-up|10|||
148942511|NCT01513343|537273862|FG001|Post Data Collection|Lost to Follow-up|23|||
148942512|NCT01513343|537273861|FG000|6-month Follow-up|Lost to Follow-up|28|||
148942513|NCT01513343|537273862|FG001|6-month Follow-up|Lost to Follow-up|17|||
148942514|NCT01513343|537273861|FG000|12-month Follow-up|Lost to Follow-up|10|||
148942515|NCT01513343|537273862|FG001|12-month Follow-up|Lost to Follow-up|3|||
148942516|NCT02034110|537273865|FG000|Overall Study|Physician Decision|0|||
148942517|NCT02034110|537273866|FG001|Overall Study|Physician Decision|0|||
148942518|NCT02034110|537273867|FG002|Overall Study|Physician Decision|0|||
148942519|NCT02034110|537273868|FG003|Overall Study|Physician Decision|0|||
148942520|NCT02034110|537273869|FG004|Overall Study|Physician Decision|2|||
148942521|NCT02034110|537273870|FG005|Overall Study|Physician Decision|0|||
148942522|NCT02034110|537273871|FG006|Overall Study|Physician Decision|1|||
148942523|NCT02034110|537273872|FG007|Overall Study|Physician Decision|0|||
148942524|NCT02034110|537273865|FG000|Overall Study|Lost to Follow-up|1|||
148942525|NCT02034110|537273866|FG001|Overall Study|Lost to Follow-up|0|||
148942526|NCT02034110|537273867|FG002|Overall Study|Lost to Follow-up|0|||
148942527|NCT02034110|537273868|FG003|Overall Study|Lost to Follow-up|0|||
148942528|NCT02034110|537273869|FG004|Overall Study|Lost to Follow-up|1|||
148942529|NCT02034110|537273870|FG005|Overall Study|Lost to Follow-up|0|||
148942530|NCT02034110|537273871|FG006|Overall Study|Lost to Follow-up|1|||
148942531|NCT02034110|537273872|FG007|Overall Study|Lost to Follow-up|0|||
148942532|NCT02034110|537273865|FG000|Overall Study|Withdrawal by Subject|5|||
148942533|NCT02034110|537273866|FG001|Overall Study|Withdrawal by Subject|7|||
148942534|NCT02034110|537273867|FG002|Overall Study|Withdrawal by Subject|0|||
148942535|NCT02034110|537273868|FG003|Overall Study|Withdrawal by Subject|3|||
148942536|NCT02034110|537273869|FG004|Overall Study|Withdrawal by Subject|7|||
148942537|NCT02034110|537273870|FG005|Overall Study|Withdrawal by Subject|0|||
148942538|NCT02034110|537273871|FG006|Overall Study|Withdrawal by Subject|3|||
148942539|NCT02034110|537273872|FG007|Overall Study|Withdrawal by Subject|1|||
148942540|NCT02034110|537273865|FG000|Overall Study|Study closed by sponsor|6|||
148942541|NCT02034110|537273866|FG001|Overall Study|Study closed by sponsor|2|||
148942542|NCT02034110|537273867|FG002|Overall Study|Study closed by sponsor|0|||
148942543|NCT02034110|537273868|FG003|Overall Study|Study closed by sponsor|6|||
148942544|NCT02034110|537273869|FG004|Overall Study|Study closed by sponsor|7|||
148942545|NCT02034110|537273870|FG005|Overall Study|Study closed by sponsor|0|||
148942546|NCT02034110|537273871|FG006|Overall Study|Study closed by sponsor|42|||
148942547|NCT02034110|537273872|FG007|Overall Study|Study closed by sponsor|0|||
148942548|NCT02587234|537273873|FG000|Overall Study|Withdrawal by Subject|1|||
148942549|NCT02587234|537273874|FG001|Overall Study|Withdrawal by Subject|1|||
148942550|NCT02587234|537273873|FG000|Overall Study|Lost to Follow-up|0|||
148942551|NCT02587234|537273874|FG001|Overall Study|Lost to Follow-up|2|||
148942552|NCT00590720|537273875|FG000|Overall Study|Lost to Follow-up|1|||
148942553|NCT00590720|537273876|FG001|Overall Study|Lost to Follow-up|0|||
148942554|NCT00590720|537273875|FG000|Overall Study|Withdrawal by Subject|0|||
148942555|NCT00590720|537273876|FG001|Overall Study|Withdrawal by Subject|1|||
148942556|NCT01001377|537273878|FG000|Overall Study|Ineligibility determined|2|||
148942557|NCT01001377|537273879|FG001|Overall Study|Ineligibility determined|0|||
148942558|NCT01001377|537273878|FG000|Overall Study|Withdrawal by Subject|19|||
148942559|NCT01001377|537273879|FG001|Overall Study|Withdrawal by Subject|20|||
148942560|NCT01001377|537273878|FG000|Overall Study|Lost to Follow-up|14|||
148942561|NCT01001377|537273879|FG001|Overall Study|Lost to Follow-up|17|||
148942562|NCT01001377|537273878|FG000|Overall Study|Death|391|||
148682795|NCT02544633|536313011|FG003|Treatment Period|Lack of Efficacy|5|||
148682796|NCT02544633|536313008|FG000|Treatment Period|Global Deterioration of Health|3|||
148682797|NCT02544633|536313009|FG001|Treatment Period|Global Deterioration of Health|3|||
148942563|NCT01001377|537273879|FG001|Overall Study|Death|384|||
148942564|NCT03039283|537273881|FG000|Overall Study|Protocol Violation|2|||
148682798|NCT02544633|536313010|FG002|Treatment Period|Global Deterioration of Health|0|||
148682799|NCT02544633|536313011|FG003|Treatment Period|Global Deterioration of Health|1|||
148682800|NCT02544633|536313008|FG000|Treatment Period|Withdrawal by Subject|1|||
148942565|NCT01056653|537273882|FG000|Overall Study|Lost to Follow-up|0|||
148942566|NCT01056653|537273883|FG001|Overall Study|Lost to Follow-up|0|||
148942567|NCT01056653|537273884|FG002|Overall Study|Lost to Follow-up|2|||
148942568|NCT01281865|537273885|FG000|Overall Study|Adverse Event|1|||
148942569|NCT01281865|537273886|FG001|Overall Study|Adverse Event|1|||
148942570|NCT01281865|537273885|FG000|Overall Study|Withdrawal by Subject|1|||
148942571|NCT01281865|537273886|FG001|Overall Study|Withdrawal by Subject|0|||
148942572|NCT01281865|537273885|FG000|Overall Study|Lack of Efficacy|1|||
149015954|NCT01091428|537537797|FG000|Phase 1|Withdrawal by Subject|7|||
148808459|NCT05493111|536777499|FG000|Overall Study|Withdrawal by Subject|1|||
148942573|NCT01281865|537273886|FG001|Overall Study|Lack of Efficacy|0|||
148942574|NCT03478657|537273888|FG000|Overall Study|Withdrawal by Subject|0|||
148942575|NCT03478657|537273889|FG001|Overall Study|Withdrawal by Subject|1|||
148942576|NCT02590003|537273890|FG000|Overall Study|Death|1|||
148942577|NCT02590003|537273891|FG001|Overall Study|Death|2|||
148942578|NCT03733470|537273894|FG000|Overall Study|PI Decision|1|||
148942579|NCT03733470|537273895|FG001|Overall Study|PI Decision|1|||
148942580|NCT03570697|537273896|FG000|Overall Study|Lost to Follow-up|0|||
148942581|NCT03570697|537273897|FG001|Overall Study|Lost to Follow-up|1|||
148942582|NCT03570697|537273896|FG000|Overall Study|Death|2|||
148942583|NCT03570697|537273897|FG001|Overall Study|Death|0|||
148942584|NCT03570697|537273896|FG000|Overall Study|Withdrawal by Subject|4|||
148942585|NCT03570697|537273897|FG001|Overall Study|Withdrawal by Subject|2|||
148942586|NCT01849783|537273898|FG000|Overall Study|Adverse Event|5|||
148942587|NCT01849783|537273898|FG000|Overall Study|Death|2|||
148942588|NCT01849783|537273898|FG000|Overall Study|Physician Decision|1|||
148942589|NCT01849783|537273898|FG000|Overall Study|Withdrawal by Subject|1|||
148942590|NCT01849783|537273898|FG000|Overall Study|Unable to comply|2|||
148942591|NCT01849783|537273898|FG000|Overall Study|Disease progression|11|||
148942592|NCT03948581|537273899|FG000|Overall Study|Lost to Follow-up|0|||
148942593|NCT03948581|537273900|FG001|Overall Study|Lost to Follow-up|1|||
148942594|NCT03068455|537273901|FG000|Pre-treatment Period|Disease progression|0|||
148942595|NCT03068455|537273902|FG001|Pre-treatment Period|Disease progression|1|||
148942596|NCT03068455|537273901|FG000|Pre-treatment Period|Participant withdrew consent|1|||
148942597|NCT03068455|537273902|FG001|Pre-treatment Period|Participant withdrew consent|1|||
148942598|NCT03068455|537273901|FG000|Pre-treatment Period|Poor/non-compliance|0|||
148942599|NCT03068455|537273902|FG001|Pre-treatment Period|Poor/non-compliance|1|||
148942600|NCT03068455|537273901|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
148942601|NCT03068455|537273902|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
148942602|NCT03068455|537273901|FG000|Pre-treatment Period|Not reported|2|||
148942603|NCT03068455|537273902|FG001|Pre-treatment Period|Not reported|1|||
148942604|NCT03068455|537273901|FG000|Treatment Period|Disease progression|166|||
148942605|NCT03068455|537273902|FG001|Treatment Period|Disease progression|208|||
148942606|NCT03068455|537273901|FG000|Treatment Period|Study drug toxicity|317|||
148942607|NCT03068455|537273902|FG001|Treatment Period|Study drug toxicity|104|||
148942608|NCT03068455|537273901|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
148942609|NCT03068455|537273902|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
148942610|NCT03068455|537273901|FG000|Treatment Period|Participant request to stop therapy|33|||
148942611|NCT03068455|537273902|FG001|Treatment Period|Participant request to stop therapy|20|||
148942612|NCT03068455|537273901|FG000|Treatment Period|Participant withdrew consent|5|||
148942613|NCT03068455|537273902|FG001|Treatment Period|Participant withdrew consent|10|||
148942614|NCT03068455|537273901|FG000|Treatment Period|Poor/non-compliance|3|||
148942615|NCT03068455|537273902|FG001|Treatment Period|Poor/non-compliance|0|||
148942616|NCT03068455|537273901|FG000|Treatment Period|Participant no longer meets study criteria|1|||
148942617|NCT03068455|537273902|FG001|Treatment Period|Participant no longer meets study criteria|3|||
148942618|NCT03068455|537273901|FG000|Treatment Period|Other reasons|12|||
148942619|NCT03068455|537273902|FG001|Treatment Period|Other reasons|4|||
148942620|NCT01876420|537273903|FG000|Overall Study|Missed 30 day visit|1|||
148942621|NCT03173313|537273904|FG000|Overall Study|Lost to Follow-up|2|||
148942622|NCT03173313|537273905|FG001|Overall Study|Lost to Follow-up|3|||
148942623|NCT03173313|537273904|FG000|Overall Study|Withdrawal by Subject|0|||
148942624|NCT03173313|537273905|FG001|Overall Study|Withdrawal by Subject|1|||
148942625|NCT03173313|537273904|FG000|Overall Study|Death|5|||
148942626|NCT03173313|537273905|FG001|Overall Study|Death|0|||
148942627|NCT03173313|537273904|FG000|Overall Study|Physician Decision|1|||
148942628|NCT03173313|537273905|FG001|Overall Study|Physician Decision|0|||
148682801|NCT02544633|536313009|FG001|Treatment Period|Withdrawal by Subject|0|||
148682802|NCT02544633|536313010|FG002|Treatment Period|Withdrawal by Subject|0|||
148682803|NCT02544633|536313011|FG003|Treatment Period|Withdrawal by Subject|0|||
148942629|NCT03173313|537273904|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
148942630|NCT03173313|537273905|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
148942631|NCT03173313|537273904|FG000|Overall Study|Bone Fracture|1|||
148942632|NCT03173313|537273905|FG001|Overall Study|Bone Fracture|0|||
148942633|NCT05338216|537273906|FG000|Overall Study|Withdrawal by Subject|1|||
148942634|NCT05338216|537273907|FG001|Overall Study|Withdrawal by Subject|1|||
148942635|NCT04447794|537273916|FG000|Overall Study|Lost to Follow-up|2|||
148942636|NCT04447794|537273917|FG001|Overall Study|Lost to Follow-up|3|||
148942637|NCT04447794|537273918|FG002|Overall Study|Lost to Follow-up|8|||
148942638|NCT04447794|537273916|FG000|Overall Study|Withdrawal by Subject|1|||
148942639|NCT04447794|537273917|FG001|Overall Study|Withdrawal by Subject|1|||
148942640|NCT04447794|537273918|FG002|Overall Study|Withdrawal by Subject|0|||
148942641|NCT04203498|537273923|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
148942642|NCT04203498|537273924|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
148942643|NCT04203498|537273923|FG000|Overall Study|Withdrawal of patient consent|7|||
148942644|NCT04203498|537273924|FG001|Overall Study|Withdrawal of patient consent|2|||
148942645|NCT04203498|537273923|FG000|Overall Study|Adverse Event|4|||
148942646|NCT04203498|537273924|FG001|Overall Study|Adverse Event|1|||
148942647|NCT04203498|537273923|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
148942648|NCT04203498|537273924|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
148942649|NCT04203498|537273923|FG000|Overall Study|Did not receive IMP|2|||
148942650|NCT04203498|537273924|FG001|Overall Study|Did not receive IMP|0|||
148942651|NCT01235689|537273926|FG000|Overall Study|Adverse Event|12|||
148942652|NCT01235689|537273927|FG001|Overall Study|Adverse Event|16|||
148942653|NCT01235689|537273926|FG000|Overall Study|Lack of Efficacy|12|||
148942654|NCT01235689|537273927|FG001|Overall Study|Lack of Efficacy|5|||
148942655|NCT01235689|537273926|FG000|Overall Study|Withdrawal by Subject|3|||
148942656|NCT01235689|537273927|FG001|Overall Study|Withdrawal by Subject|4|||
149015955|NCT01091428|537537798|FG001|Phase 1|Withdrawal by Subject|0|||
149015956|NCT01091428|537537799|FG002|Phase 1|Withdrawal by Subject|0|||
149015957|NCT01091428|537537800|FG003|Phase 1|Withdrawal by Subject|0|||
148942657|NCT01235689|537273926|FG000|Overall Study|Lost to Follow-up|1|||
148942658|NCT01235689|537273927|FG001|Overall Study|Lost to Follow-up|2|||
148942659|NCT01235689|537273926|FG000|Overall Study|Miscellaneous|1|||
148942660|NCT01235689|537273927|FG001|Overall Study|Miscellaneous|5|||
148942661|NCT00005044|537273936|FG000|Overall Study|Protocol Violation|37|||
148942662|NCT00005044|537273937|FG001|Overall Study|Protocol Violation|46|||
148942663|NCT00005044|537273936|FG000|Overall Study|Withdrawal by Subject|1|||
148942664|NCT00005044|537273937|FG001|Overall Study|Withdrawal by Subject|5|||
148942665|NCT00005044|537273936|FG000|Overall Study|No protocol treatment|0|||
148942666|NCT00005044|537273937|FG001|Overall Study|No protocol treatment|1|||
148942667|NCT03546062|537273938|FG000|Overall Study|Adverse Event|6|||
148942668|NCT03546062|537273939|FG001|Overall Study|Adverse Event|5|||
148942669|NCT03546062|537273940|FG002|Overall Study|Adverse Event|8|||
148942670|NCT00181155|537273941|FG000|Overall Study|Physician Decision|1|||
148942671|NCT00181155|537273942|FG001|Overall Study|Physician Decision|0|||
148942672|NCT00181155|537273941|FG000|Overall Study|Withdrawal by Subject|1|||
148682804|NCT02544633|536313008|FG000|Treatment Period|Lost to Follow-up|0|||
148682805|NCT02544633|536313009|FG001|Treatment Period|Lost to Follow-up|1|||
148682806|NCT02544633|536313010|FG002|Treatment Period|Lost to Follow-up|0|||
148682807|NCT02544633|536313011|FG003|Treatment Period|Lost to Follow-up|0|||
148682808|NCT02544633|536313008|FG000|Treatment Period|Death|0|||
148682809|NCT02544633|536313009|FG001|Treatment Period|Death|0|||
148682810|NCT02544633|536313010|FG002|Treatment Period|Death|1|||
148682811|NCT02544633|536313011|FG003|Treatment Period|Death|0|||
148682812|NCT02544633|536313008|FG000|Treatment Period|Non-compliance|0|||
148682813|NCT02544633|536313009|FG001|Treatment Period|Non-compliance|0|||
148682814|NCT02544633|536313010|FG002|Treatment Period|Non-compliance|1|||
148682815|NCT02544633|536313011|FG003|Treatment Period|Non-compliance|0|||
148682816|NCT02544633|536313008|FG000|Treatment Period|Clinical Disease Progression|0|||
148682817|NCT02544633|536313009|FG001|Treatment Period|Clinical Disease Progression|0|||
148682818|NCT02544633|536313010|FG002|Treatment Period|Clinical Disease Progression|0|||
148682819|NCT02544633|536313011|FG003|Treatment Period|Clinical Disease Progression|1|||
148682820|NCT02544633|536313008|FG000|Survival Follow-up Period|Death|12|||
148682821|NCT02544633|536313009|FG001|Survival Follow-up Period|Death|14|||
148682822|NCT02544633|536313010|FG002|Survival Follow-up Period|Death|3|||
148682823|NCT02544633|536313011|FG003|Survival Follow-up Period|Death|9|||
148942673|NCT00181155|537273942|FG001|Overall Study|Withdrawal by Subject|0|||
148942674|NCT02572401|537273943|FG000|Overall Study|Lost to Follow-up|5|||
149015958|NCT01091428|537537797|FG000|Phase 1|Reason not specified|0|||
149015959|NCT01091428|537537798|FG001|Phase 1|Reason not specified|1|||
148942675|NCT02572401|537273944|FG001|Overall Study|Lost to Follow-up|8|||
148942676|NCT02572401|537273945|FG002|Overall Study|Lost to Follow-up|9|||
148942677|NCT02572401|537273946|FG003|Overall Study|Lost to Follow-up|9|||
148942678|NCT02572401|537273943|FG000|Overall Study|Death|0|||
148942679|NCT02572401|537273944|FG001|Overall Study|Death|0|||
148942680|NCT02572401|537273945|FG002|Overall Study|Death|0|||
148942681|NCT02572401|537273946|FG003|Overall Study|Death|1|||
149015960|NCT01091428|537537799|FG002|Phase 1|Reason not specified|0|||
148942682|NCT01548287|537273947|FG000|Screening|No reason provided|0|||
148942683|NCT01548287|537273948|FG001|Screening|No reason provided|0|||
148942684|NCT01548287|537273949|FG002|Screening|No reason provided|0|||
148942685|NCT01548287|537273950|FG003|Screening|No reason provided|0|||
148942686|NCT01548287|537273951|FG004|Screening|No reason provided|9|||
148942687|NCT01548287|537273947|FG000|Screening|Did not meet eligibility criteria|0|||
148942688|NCT01548287|537273948|FG001|Screening|Did not meet eligibility criteria|0|||
148682824|NCT02544633|536313008|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
148942689|NCT01548287|537273949|FG002|Screening|Did not meet eligibility criteria|0|||
148942690|NCT01548287|537273950|FG003|Screening|Did not meet eligibility criteria|0|||
149015961|NCT01091428|537537800|FG003|Phase 1|Reason not specified|0|||
148682825|NCT02544633|536313009|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
148682826|NCT02544633|536313010|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
148942691|NCT01548287|537273951|FG004|Screening|Did not meet eligibility criteria|74|||
148942692|NCT01548287|537273947|FG000|Randomized Period|Did not meet inclusion criteria|0|||
149015962|NCT01091428|537537797|FG000|Phase 1|Single-Patient IND|2|||
148942693|NCT01548287|537273948|FG001|Randomized Period|Did not meet inclusion criteria|0|||
148942694|NCT01548287|537273949|FG002|Randomized Period|Did not meet inclusion criteria|2|||
148942695|NCT01548287|537273950|FG003|Randomized Period|Did not meet inclusion criteria|0|||
148942696|NCT01548287|537273951|FG004|Randomized Period|Did not meet inclusion criteria|0|||
148942697|NCT01548287|537273947|FG000|Randomized Period|Adverse Event|0|||
148942698|NCT01548287|537273948|FG001|Randomized Period|Adverse Event|2|||
148942699|NCT01548287|537273949|FG002|Randomized Period|Adverse Event|5|||
148942700|NCT01548287|537273950|FG003|Randomized Period|Adverse Event|0|||
148942701|NCT01548287|537273951|FG004|Randomized Period|Adverse Event|0|||
148942702|NCT02762578|537273956|FG000|Overall Study|Adverse Event|1|||
148942703|NCT02762578|537273957|FG001|Overall Study|Adverse Event|6|||
148942704|NCT02762578|537273956|FG000|Overall Study|Protocol Violation|4|||
148942705|NCT02762578|537273957|FG001|Overall Study|Protocol Violation|2|||
148942706|NCT02762578|537273956|FG000|Overall Study|Withdrawal by Subject|4|||
148942707|NCT02762578|537273957|FG001|Overall Study|Withdrawal by Subject|2|||
148942708|NCT02762578|537273956|FG000|Overall Study|Unclassified|6|||
148942709|NCT02762578|537273957|FG001|Overall Study|Unclassified|0|||
148942710|NCT00259610|537273958|FG000|Overall Study|Withdrawal by Subject|33|||
148942711|NCT00259610|537273959|FG001|Overall Study|Withdrawal by Subject|25|||
148942712|NCT00259610|537273960|FG002|Overall Study|Withdrawal by Subject|29|||
148942713|NCT00259610|537273961|FG003|Overall Study|Withdrawal by Subject|19|||
148942714|NCT00259610|537273958|FG000|Overall Study|Lost to Follow-up|19|||
148942715|NCT00259610|537273959|FG001|Overall Study|Lost to Follow-up|8|||
148942716|NCT00259610|537273960|FG002|Overall Study|Lost to Follow-up|18|||
148942717|NCT00259610|537273961|FG003|Overall Study|Lost to Follow-up|15|||
148942718|NCT00259610|537273958|FG000|Overall Study|Physician Decision|6|||
148942719|NCT00259610|537273959|FG001|Overall Study|Physician Decision|4|||
148942720|NCT00259610|537273960|FG002|Overall Study|Physician Decision|7|||
148942721|NCT00259610|537273961|FG003|Overall Study|Physician Decision|2|||
148942722|NCT00259610|537273958|FG000|Overall Study|Death|1|||
148942723|NCT00259610|537273959|FG001|Overall Study|Death|1|||
148942724|NCT00259610|537273960|FG002|Overall Study|Death|2|||
148942725|NCT00259610|537273961|FG003|Overall Study|Death|0|||
148942726|NCT00259610|537273958|FG000|Overall Study|non medical reason|6|||
148942727|NCT00259610|537273959|FG001|Overall Study|non medical reason|2|||
148942728|NCT00259610|537273960|FG002|Overall Study|non medical reason|10|||
148942729|NCT00259610|537273961|FG003|Overall Study|non medical reason|3|||
148942730|NCT00259610|537273958|FG000|Overall Study|Adverse Event|3|||
148942731|NCT00259610|537273959|FG001|Overall Study|Adverse Event|4|||
148942732|NCT00259610|537273960|FG002|Overall Study|Adverse Event|5|||
148942733|NCT00259610|537273961|FG003|Overall Study|Adverse Event|2|||
148942734|NCT00259610|537273958|FG000|Overall Study|Serious Adverse Event|8|||
148942735|NCT00259610|537273959|FG001|Overall Study|Serious Adverse Event|2|||
148942736|NCT00259610|537273960|FG002|Overall Study|Serious Adverse Event|2|||
148942737|NCT00259610|537273961|FG003|Overall Study|Serious Adverse Event|2|||
148942738|NCT01090492|537273964|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
148942739|NCT01090492|537273965|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
148942740|NCT01090492|537273966|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
148942741|NCT01090492|537273967|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
148942742|NCT01090492|537273968|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
148942743|NCT01090492|537273969|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
148942744|NCT01090492|537273970|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
148942745|NCT01090492|537273971|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
148942746|NCT01090492|537273964|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
148942747|NCT01090492|537273965|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
148942748|NCT01090492|537273966|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
148942749|NCT01090492|537273967|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
148942750|NCT01090492|537273968|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
148942751|NCT01090492|537273969|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
148942752|NCT01090492|537273970|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
148942753|NCT01090492|537273971|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
148942754|NCT01090492|537273964|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942755|NCT01090492|537273965|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942756|NCT01090492|537273966|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
148942757|NCT01090492|537273967|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
149015963|NCT01091428|537537798|FG001|Phase 1|Single-Patient IND|0|||
148942758|NCT01090492|537273968|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942759|NCT01090492|537273969|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942760|NCT01090492|537273970|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942761|NCT01090492|537273971|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942762|NCT01090492|537273964|FG000|First Intervention Period (4 Weeks)|Other|0|||
148942763|NCT01090492|537273965|FG001|First Intervention Period (4 Weeks)|Other|0|||
148942764|NCT01090492|537273966|FG002|First Intervention Period (4 Weeks)|Other|1|||
148942765|NCT01090492|537273967|FG003|First Intervention Period (4 Weeks)|Other|1|||
148942766|NCT01090492|537273968|FG004|First Intervention Period (4 Weeks)|Other|2|||
148942767|NCT01090492|537273969|FG005|First Intervention Period (4 Weeks)|Other|0|||
148942768|NCT01090492|537273970|FG006|First Intervention Period (4 Weeks)|Other|0|||
148942769|NCT01090492|537273971|FG007|First Intervention Period (4 Weeks)|Other|0|||
148942770|NCT01090492|537273964|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942771|NCT01090492|537273965|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942772|NCT01090492|537273966|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942773|NCT01090492|537273967|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942774|NCT01090492|537273968|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
148942775|NCT01090492|537273969|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942776|NCT01090492|537273970|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942777|NCT01090492|537273971|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
148942778|NCT01090492|537273964|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
148942779|NCT01090492|537273965|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
148942780|NCT01090492|537273966|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
148942781|NCT01090492|537273967|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
148942782|NCT01090492|537273968|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
148942783|NCT01090492|537273969|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
148942784|NCT01090492|537273970|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
148942785|NCT01090492|537273971|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
148942786|NCT01090492|537273964|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
148942787|NCT01090492|537273965|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
148942788|NCT01090492|537273966|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
148942789|NCT01090492|537273967|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
148942790|NCT01090492|537273968|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
148942791|NCT01090492|537273969|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
148942792|NCT01090492|537273970|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
148942793|NCT01090492|537273971|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
148942794|NCT01090492|537273964|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942795|NCT01090492|537273965|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
148942796|NCT01090492|537273966|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942797|NCT01090492|537273967|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942798|NCT01090492|537273968|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942799|NCT01090492|537273969|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942800|NCT01090492|537273970|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942801|NCT01090492|537273971|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
148942802|NCT01090492|537273964|FG000|Second Intervention Period (4 Weeks)|Other|0|||
148942803|NCT01090492|537273965|FG001|Second Intervention Period (4 Weeks)|Other|1|||
148942804|NCT01090492|537273966|FG002|Second Intervention Period (4 Weeks)|Other|1|||
148942805|NCT01090492|537273967|FG003|Second Intervention Period (4 Weeks)|Other|0|||
148942806|NCT01090492|537273968|FG004|Second Intervention Period (4 Weeks)|Other|0|||
148942807|NCT01090492|537273969|FG005|Second Intervention Period (4 Weeks)|Other|0|||
148942808|NCT01090492|537273970|FG006|Second Intervention Period (4 Weeks)|Other|0|||
148942809|NCT01090492|537273971|FG007|Second Intervention Period (4 Weeks)|Other|0|||
148942810|NCT01090492|537273964|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
148942811|NCT01090492|537273965|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
148942812|NCT01090492|537273966|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
148942813|NCT01090492|537273967|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
148942814|NCT01090492|537273968|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
148942815|NCT01090492|537273969|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
148942816|NCT01090492|537273970|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
148942817|NCT01090492|537273971|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
148942818|NCT01090492|537273964|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942819|NCT01090492|537273965|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942820|NCT01090492|537273966|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942821|NCT01090492|537273967|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942822|NCT01090492|537273968|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942823|NCT01090492|537273969|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942824|NCT01090492|537273970|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
148942825|NCT01090492|537273971|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
148942826|NCT01768286|537273972|FG000|Overall Study|Randomized But Not Treated|0|||
148942827|NCT01768286|537273973|FG001|Overall Study|Randomized But Not Treated|0|||
148942828|NCT01768286|537273974|FG002|Overall Study|Randomized But Not Treated|1|||
148942829|NCT01768286|537273975|FG003|Overall Study|Randomized But Not Treated|0|||
148942830|NCT01768286|537273972|FG000|Overall Study|Lack of Efficacy|7|||
148942831|NCT01768286|537273973|FG001|Overall Study|Lack of Efficacy|4|||
148942832|NCT01768286|537273974|FG002|Overall Study|Lack of Efficacy|0|||
148942833|NCT01768286|537273975|FG003|Overall Study|Lack of Efficacy|1|||
148942834|NCT01768286|537273972|FG000|Overall Study|Withdrew Consent|0|||
148942835|NCT01768286|537273973|FG001|Overall Study|Withdrew Consent|0|||
148942836|NCT01768286|537273974|FG002|Overall Study|Withdrew Consent|1|||
148942837|NCT01768286|537273975|FG003|Overall Study|Withdrew Consent|0|||
148942838|NCT02083965|537273976|FG000|Treatment Period|Other|1|||
148942839|NCT02083965|537273977|FG001|Treatment Period|Other|0|||
148942840|NCT00868608|537273979|FG000|Overall Study|Withdrawal by Subject|3|||
148942841|NCT00868608|537273980|FG001|Overall Study|Withdrawal by Subject|1|||
148942842|NCT00868608|537273981|FG002|Overall Study|Withdrawal by Subject|0|||
148942843|NCT00868608|537273979|FG000|Overall Study|Lost to Follow-up|3|||
148942844|NCT00868608|537273980|FG001|Overall Study|Lost to Follow-up|0|||
148942845|NCT00868608|537273981|FG002|Overall Study|Lost to Follow-up|1|||
148942846|NCT00868608|537273979|FG000|Overall Study|Death|16|||
148942847|NCT00868608|537273980|FG001|Overall Study|Death|2|||
148942848|NCT00868608|537273981|FG002|Overall Study|Death|4|||
148942849|NCT00868608|537273979|FG000|Overall Study|Other - Unspecified|1|||
148942850|NCT00868608|537273980|FG001|Overall Study|Other - Unspecified|0|||
148942851|NCT00868608|537273981|FG002|Overall Study|Other - Unspecified|0|||
148942852|NCT02935842|537273982|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
148942853|NCT02935842|537273983|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
148942854|NCT02935842|537273984|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
148942855|NCT02935842|537273985|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
148942856|NCT02935842|537273982|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
148942857|NCT02935842|537273983|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
148942858|NCT02935842|537273984|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
148942859|NCT02935842|537273985|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
148942860|NCT02935842|537273982|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
148942861|NCT02935842|537273983|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
148942862|NCT02935842|537273984|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
148942863|NCT02935842|537273985|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
148942864|NCT02935842|537273982|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
148942865|NCT02935842|537273983|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
148942866|NCT02935842|537273984|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
148942867|NCT02935842|537273985|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
148942868|NCT02935842|537273982|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
148942869|NCT02935842|537273983|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
148942870|NCT02935842|537273984|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
148942871|NCT02935842|537273985|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
148942872|NCT00911547|537273986|FG000|Overall Study|Adverse Event|8|||
148942873|NCT00911547|537273987|FG001|Overall Study|Adverse Event|27|||
148942874|NCT00911547|537273988|FG002|Overall Study|Adverse Event|11|||
148942875|NCT00911547|537273989|FG003|Overall Study|Adverse Event|6|||
148942876|NCT00911547|537273986|FG000|Overall Study|Lost to Follow-up|0|||
148942877|NCT00911547|537273987|FG001|Overall Study|Lost to Follow-up|0|||
148942878|NCT00911547|537273988|FG002|Overall Study|Lost to Follow-up|2|||
148942879|NCT00911547|537273989|FG003|Overall Study|Lost to Follow-up|1|||
148942880|NCT00911547|537273986|FG000|Overall Study|Protocol Violation|0|||
148942881|NCT00911547|537273987|FG001|Overall Study|Protocol Violation|5|||
148942882|NCT00911547|537273988|FG002|Overall Study|Protocol Violation|5|||
148942883|NCT00911547|537273989|FG003|Overall Study|Protocol Violation|1|||
148942884|NCT00911547|537273986|FG000|Overall Study|Withdrawal by Subject|3|||
148942885|NCT00911547|537273987|FG001|Overall Study|Withdrawal by Subject|10|||
148942886|NCT00911547|537273988|FG002|Overall Study|Withdrawal by Subject|4|||
148942887|NCT00911547|537273989|FG003|Overall Study|Withdrawal by Subject|8|||
148942888|NCT03344796|537273990|FG000|Overall Study|Lost to Follow-up|0|||
148942889|NCT03344796|537273991|FG001|Overall Study|Lost to Follow-up|0|||
148942890|NCT03344796|537273992|FG002|Overall Study|Lost to Follow-up|0|||
148942891|NCT03344796|537273993|FG003|Overall Study|Lost to Follow-up|0|||
148942892|NCT03344796|537273994|FG004|Overall Study|Lost to Follow-up|0|||
148942893|NCT03344796|537273995|FG005|Overall Study|Lost to Follow-up|2|||
148942894|NCT00939770|537273998|FG000|Overall Study|Adverse Event|1|||
148942895|NCT00939770|537273999|FG001|Overall Study|Adverse Event|1|||
148942896|NCT00939770|537274000|FG002|Overall Study|Adverse Event|0|||
148942897|NCT00939770|537274001|FG003|Overall Study|Adverse Event|0|||
148942898|NCT00939770|537274002|FG004|Overall Study|Adverse Event|6|||
148942899|NCT00939770|537274003|FG005|Overall Study|Adverse Event|2|||
148942900|NCT00939770|537274004|FG006|Overall Study|Adverse Event|1|||
148942901|NCT00939770|537274005|FG007|Overall Study|Adverse Event|1|||
148942902|NCT00939770|537273998|FG000|Overall Study|Lack of Efficacy|4|||
148942903|NCT00939770|537273999|FG001|Overall Study|Lack of Efficacy|6|||
148942904|NCT00939770|537274000|FG002|Overall Study|Lack of Efficacy|13|||
148942905|NCT00939770|537274001|FG003|Overall Study|Lack of Efficacy|9|||
148942906|NCT00939770|537274002|FG004|Overall Study|Lack of Efficacy|16|||
148942907|NCT00939770|537274003|FG005|Overall Study|Lack of Efficacy|8|||
148942908|NCT00939770|537274004|FG006|Overall Study|Lack of Efficacy|11|||
148942909|NCT00939770|537274005|FG007|Overall Study|Lack of Efficacy|1|||
148942910|NCT00939770|537273998|FG000|Overall Study|Lost to Follow-up|0|||
148942911|NCT00939770|537273999|FG001|Overall Study|Lost to Follow-up|0|||
148942912|NCT00939770|537274000|FG002|Overall Study|Lost to Follow-up|0|||
148942913|NCT00939770|537274001|FG003|Overall Study|Lost to Follow-up|0|||
148942914|NCT00939770|537274002|FG004|Overall Study|Lost to Follow-up|1|||
148942915|NCT00939770|537274003|FG005|Overall Study|Lost to Follow-up|0|||
148942916|NCT00939770|537274004|FG006|Overall Study|Lost to Follow-up|0|||
148942917|NCT00939770|537274005|FG007|Overall Study|Lost to Follow-up|0|||
148942918|NCT00939770|537273998|FG000|Overall Study|Physician Decision|0|||
148942919|NCT00939770|537273999|FG001|Overall Study|Physician Decision|0|||
148942920|NCT00939770|537274000|FG002|Overall Study|Physician Decision|2|||
148942921|NCT00939770|537274001|FG003|Overall Study|Physician Decision|0|||
148942922|NCT00939770|537274002|FG004|Overall Study|Physician Decision|7|||
148942923|NCT00939770|537274003|FG005|Overall Study|Physician Decision|1|||
148942924|NCT00939770|537274004|FG006|Overall Study|Physician Decision|0|||
148942925|NCT00939770|537274005|FG007|Overall Study|Physician Decision|6|||
148942926|NCT00939770|537273998|FG000|Overall Study|Protocol Violation|0|||
148942927|NCT00939770|537273999|FG001|Overall Study|Protocol Violation|0|||
148942928|NCT00939770|537274000|FG002|Overall Study|Protocol Violation|0|||
148942929|NCT00939770|537274001|FG003|Overall Study|Protocol Violation|0|||
148942930|NCT00939770|537274002|FG004|Overall Study|Protocol Violation|1|||
148942931|NCT00939770|537274003|FG005|Overall Study|Protocol Violation|0|||
148942932|NCT00939770|537274004|FG006|Overall Study|Protocol Violation|0|||
148942933|NCT00939770|537274005|FG007|Overall Study|Protocol Violation|0|||
148942934|NCT00939770|537273998|FG000|Overall Study|Withdrawal by Subject|0|||
148942935|NCT00939770|537273999|FG001|Overall Study|Withdrawal by Subject|1|||
148942936|NCT00939770|537274000|FG002|Overall Study|Withdrawal by Subject|5|||
148942937|NCT00939770|537274001|FG003|Overall Study|Withdrawal by Subject|2|||
148942938|NCT00939770|537274002|FG004|Overall Study|Withdrawal by Subject|6|||
148942939|NCT00939770|537274003|FG005|Overall Study|Withdrawal by Subject|0|||
148942940|NCT00939770|537274004|FG006|Overall Study|Withdrawal by Subject|2|||
148942941|NCT00939770|537274005|FG007|Overall Study|Withdrawal by Subject|2|||
148942942|NCT01146665|537274006|FG000|Overall Study|Withdrawal by Subject|10|||
148942943|NCT01146665|537274007|FG001|Overall Study|Withdrawal by Subject|16|||
148942944|NCT00365508|537274012|FG000|Overall Study|Lost to Follow-up|139|||
148942945|NCT00365508|537274013|FG001|Overall Study|Lost to Follow-up|154|||
148942946|NCT02538029|537274015|FG000|Overall Study|unable to complete cognitive assessments|1|||
148942947|NCT02538029|537274016|FG001|Overall Study|unable to complete cognitive assessments|0|||
148942948|NCT02538029|537274017|FG002|Overall Study|unable to complete cognitive assessments|1|||
148942949|NCT00566995|537274020|FG000|Overall Study|Toxicity|4|||
148942950|NCT00566995|537274020|FG000|Overall Study|Withdrew consent|3|||
148942951|NCT00404235|537274021|FG000|Overall Study|Withdrawal by Subject|1|||
148942952|NCT00404235|537274022|FG001|Overall Study|Withdrawal by Subject|2|||
148942953|NCT04560998|537274023|FG000|Overall Study|Withdrawal by Subject|18|||
148942954|NCT04560998|537274024|FG001|Overall Study|Withdrawal by Subject|12|||
148942955|NCT04560998|537274023|FG000|Overall Study|Lost to Follow-up|8|||
149197088|NCT01274338|538191076|FG003|Overall Study|Pregnancy|0|||
149197089|NCT01274338|538191077|FG004|Overall Study|Pregnancy|0|||
149197090|NCT01274338|538191078|FG005|Overall Study|Pregnancy|0|||
149197091|NCT01274338|538191073|FG000|Overall Study|Reason not reported|12|||
149197092|NCT01274338|538191074|FG001|Overall Study|Reason not reported|21|||
149197093|NCT01274338|538191075|FG002|Overall Study|Reason not reported|3|||
149197094|NCT01274338|538191076|FG003|Overall Study|Reason not reported|0|||
149197095|NCT01274338|538191077|FG004|Overall Study|Reason not reported|1|||
149197096|NCT01274338|538191078|FG005|Overall Study|Reason not reported|0|||
149197097|NCT01927744|538191079|FG000|Overall Study|Death|2|||
149197098|NCT01927744|538191080|FG001|Overall Study|Death|9|||
149197099|NCT02198651|538191084|FG000|Lead-in Period|Withdrew consent|13|||
149197100|NCT02198651|538191085|FG001|Lead-in Period|Withdrew consent|0|||
149197101|NCT02198651|538191086|FG002|Lead-in Period|Withdrew consent|0|||
149197102|NCT02198651|538191087|FG003|Lead-in Period|Withdrew consent|0|||
149197103|NCT02198651|538191088|FG004|Lead-in Period|Withdrew consent|0|||
149197104|NCT02198651|538191084|FG000|Lead-in Period|Adverse Event|2|||
149197105|NCT02198651|538191085|FG001|Lead-in Period|Adverse Event|0|||
149197106|NCT02198651|538191086|FG002|Lead-in Period|Adverse Event|0|||
149197107|NCT02198651|538191087|FG003|Lead-in Period|Adverse Event|0|||
149197108|NCT02198651|538191088|FG004|Lead-in Period|Adverse Event|0|||
149197109|NCT02198651|538191084|FG000|Lead-in Period|Other, not specified|22|||
149197110|NCT02198651|538191085|FG001|Lead-in Period|Other, not specified|0|||
149197111|NCT02198651|538191086|FG002|Lead-in Period|Other, not specified|0|||
149197112|NCT02198651|538191087|FG003|Lead-in Period|Other, not specified|0|||
149197113|NCT02198651|538191088|FG004|Lead-in Period|Other, not specified|0|||
149197114|NCT02198651|538191084|FG000|Double-blind Period|Withdrew consent|0|||
149197115|NCT02198651|538191085|FG001|Double-blind Period|Withdrew consent|4|||
149197116|NCT02198651|538191086|FG002|Double-blind Period|Withdrew consent|0|||
149197117|NCT02198651|538191087|FG003|Double-blind Period|Withdrew consent|0|||
149197118|NCT02198651|538191088|FG004|Double-blind Period|Withdrew consent|0|||
149197119|NCT02198651|538191084|FG000|Double-blind Period|Adverse Event|0|||
149197120|NCT02198651|538191085|FG001|Double-blind Period|Adverse Event|1|||
149197121|NCT02198651|538191086|FG002|Double-blind Period|Adverse Event|0|||
149197122|NCT02198651|538191087|FG003|Double-blind Period|Adverse Event|0|||
149197123|NCT02198651|538191088|FG004|Double-blind Period|Adverse Event|0|||
149197124|NCT02198651|538191084|FG000|Double-blind Period|Other, not specified|0|||
148808460|NCT05493111|536777500|FG001|Overall Study|Withdrawal by Subject|1|||
148808461|NCT03836053|536777501|FG000|Overall Study|Protocol-specified criteria|0|||
149197125|NCT02198651|538191085|FG001|Double-blind Period|Other, not specified|4|||
149197126|NCT02198651|538191086|FG002|Double-blind Period|Other, not specified|1|||
148808462|NCT03836053|536777502|FG001|Overall Study|Protocol-specified criteria|2|||
149197127|NCT02198651|538191087|FG003|Double-blind Period|Other, not specified|0|||
149197128|NCT02198651|538191088|FG004|Double-blind Period|Other, not specified|0|||
149197129|NCT02198651|538191084|FG000|Open-label Rescue Period|Withdrew consent|0|||
149197130|NCT02198651|538191085|FG001|Open-label Rescue Period|Withdrew consent|0|||
149197131|NCT02198651|538191086|FG002|Open-label Rescue Period|Withdrew consent|0|||
149197132|NCT02198651|538191087|FG003|Open-label Rescue Period|Withdrew consent|2|||
149197133|NCT02198651|538191088|FG004|Open-label Rescue Period|Withdrew consent|0|||
149197134|NCT02198651|538191084|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149197135|NCT02198651|538191085|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149197136|NCT02198651|538191086|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149197137|NCT02198651|538191087|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
149197138|NCT02198651|538191088|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
149197139|NCT00369967|538191090|FG000|Overall Study|Lost to Follow-up|23|||
149197140|NCT00369967|538191091|FG001|Overall Study|Lost to Follow-up|12|||
149197141|NCT01617655|538191094|FG000|Overall Study|Adverse Event|2|||
149197142|NCT01617655|538191095|FG001|Overall Study|Adverse Event|3|||
149197143|NCT01617655|538191094|FG000|Overall Study|Poor compliance to protocol|1|||
149197144|NCT01617655|538191095|FG001|Overall Study|Poor compliance to protocol|4|||
149197145|NCT01617655|538191094|FG000|Overall Study|Participants moved|0|||
149197146|NCT01617655|538191095|FG001|Overall Study|Participants moved|4|||
149197147|NCT01617655|538191094|FG000|Overall Study|Consent withdrawn by participant|1|||
149197148|NCT01617655|538191095|FG001|Overall Study|Consent withdrawn by participant|1|||
149197149|NCT01617655|538191094|FG000|Overall Study|Last visit outside protocol visit window|1|||
149197150|NCT01617655|538191095|FG001|Overall Study|Last visit outside protocol visit window|10|||
149197151|NCT01617655|538191094|FG000|Overall Study|Site closure|3|||
149197152|NCT01617655|538191095|FG001|Overall Study|Site closure|5|||
149197153|NCT01617655|538191094|FG000|Overall Study|Other than specified above|1|||
149197154|NCT01617655|538191095|FG001|Overall Study|Other than specified above|2|||
149197155|NCT00423735|538191099|FG000|Overall Study|Ineligible / No protocol treatment|8|||
149197156|NCT00423735|538191100|FG001|Overall Study|Ineligible / No protocol treatment|6|||
149197157|NCT00423735|538191101|FG002|Overall Study|Ineligible / No protocol treatment|0|||
149197158|NCT01089582|538191102|FG000|Overall Study|Death|2|||
149197159|NCT01089582|538191102|FG000|Overall Study|Adverse Event|15|||
149197160|NCT01089582|538191102|FG000|Overall Study|Lost to Follow-up|8|||
149197161|NCT01089582|538191102|FG000|Overall Study|Other|4|||
149197162|NCT01089582|538191102|FG000|Overall Study|Withdrawal by Subject|1|||
149197163|NCT02394808|538191103|FG000|Period 1|Unsatisfactory lens fitting|0|||
149197164|NCT02394808|538191104|FG001|Period 1|Unsatisfactory lens fitting|1|||
149197165|NCT02394808|538191103|FG000|Period 2|Lost to Follow-up|1|||
149197166|NCT02394808|538191104|FG001|Period 2|Lost to Follow-up|0|||
149197167|NCT00209170|538191105|FG000|Overall Study|Adverse Event|0|||
149197168|NCT00209170|538191106|FG001|Overall Study|Adverse Event|1|||
149197169|NCT00209170|538191105|FG000|Overall Study|Withdrawal by Subject|2|||
149197170|NCT00209170|538191106|FG001|Overall Study|Withdrawal by Subject|1|||
149197171|NCT00209170|538191105|FG000|Overall Study|Lack of Efficacy|0|||
149197172|NCT00209170|538191106|FG001|Overall Study|Lack of Efficacy|1|||
149197173|NCT02130427|538191107|FG000|Overall Study|Imaging results not interpretable|30|||
149197174|NCT02108600|538191112|FG000|Overall Study|Withdrawal by Subject|2|||
149197175|NCT02108600|538191113|FG001|Overall Study|Withdrawal by Subject|0|||
149197176|NCT02108600|538191112|FG000|Overall Study|Lost to Follow-up|1|||
149197177|NCT02108600|538191113|FG001|Overall Study|Lost to Follow-up|1|||
149197178|NCT00992784|538191114|FG000|Overall Study|Adverse Event|2|||
149197179|NCT00992784|538191115|FG001|Overall Study|Adverse Event|1|||
149197180|NCT00992784|538191116|FG002|Overall Study|Adverse Event|0|||
149197181|NCT00992784|538191114|FG000|Overall Study|Withdrawal by Subject|1|||
149197182|NCT00992784|538191115|FG001|Overall Study|Withdrawal by Subject|1|||
149197183|NCT00992784|538191116|FG002|Overall Study|Withdrawal by Subject|1|||
149197184|NCT01124448|538191117|FG000|Overall Study|Lost to Follow-up|0|||
149197185|NCT01124448|538191118|FG001|Overall Study|Lost to Follow-up|3|||
149197186|NCT01124448|538191117|FG000|Overall Study|Protocol Violation|2|||
148942956|NCT04560998|537274024|FG001|Overall Study|Lost to Follow-up|5|||
148942957|NCT04560998|537274023|FG000|Overall Study|Physician Decision|4|||
148942958|NCT04560998|537274024|FG001|Overall Study|Physician Decision|0|||
149197187|NCT01124448|538191118|FG001|Overall Study|Protocol Violation|0|||
149197188|NCT01655823|538191119|FG000|Overall Study|Lost to Follow-up|0|||
149197189|NCT01655823|538191120|FG001|Overall Study|Lost to Follow-up|1|||
149197190|NCT01655823|538191121|FG002|Overall Study|Lost to Follow-up|0|||
149197191|NCT01655823|538191122|FG003|Overall Study|Lost to Follow-up|0|||
149197192|NCT01655823|538191123|FG004|Overall Study|Lost to Follow-up|1|||
149197193|NCT01655823|538191119|FG000|Overall Study|Withdrawal by Subject|0|||
149197194|NCT01655823|538191120|FG001|Overall Study|Withdrawal by Subject|1|||
149197195|NCT01655823|538191121|FG002|Overall Study|Withdrawal by Subject|0|||
148942959|NCT01218113|537275599|FG000|Overall Study|Withdrawal by Subject|1|||
148942960|NCT01218113|537275600|FG001|Overall Study|Withdrawal by Subject|0|||
149197196|NCT01655823|538191122|FG003|Overall Study|Withdrawal by Subject|1|||
149197197|NCT01655823|538191123|FG004|Overall Study|Withdrawal by Subject|0|||
149197198|NCT01029002|538191124|FG000|Overall Study|Lost to Follow-up|2|||
149197199|NCT01029002|538191125|FG001|Overall Study|Lost to Follow-up|4|||
149197200|NCT02632110|538191126|FG000|Overall Study|Withdrawal by Subject|1|||
149197201|NCT02632110|538191127|FG001|Overall Study|Withdrawal by Subject|1|||
149197202|NCT02632110|538191128|FG002|Overall Study|Withdrawal by Subject|0|||
149197203|NCT02632110|538191129|FG003|Overall Study|Withdrawal by Subject|0|||
149197204|NCT02632110|538191130|FG004|Overall Study|Withdrawal by Subject|1|||
149197205|NCT02632110|538191131|FG005|Overall Study|Withdrawal by Subject|1|||
149197206|NCT02632110|538191132|FG006|Overall Study|Withdrawal by Subject|3|||
149197207|NCT02632110|538191133|FG007|Overall Study|Withdrawal by Subject|3|||
149197208|NCT02632110|538191134|FG008|Overall Study|Withdrawal by Subject|1|||
149197209|NCT02632110|538191135|FG009|Overall Study|Withdrawal by Subject|1|||
149197210|NCT04146467|538191136|FG000|Overall Study|Adverse Event|0|||
149197211|NCT04146467|538191137|FG001|Overall Study|Adverse Event|1|||
149197212|NCT04146467|538191136|FG000|Overall Study|Lost to Follow-up|0|||
149197213|NCT04146467|538191137|FG001|Overall Study|Lost to Follow-up|2|||
149197214|NCT01189435|538191138|FG000|Overall Study|Withdrawal by Subject|1|||
149197215|NCT01189435|538191138|FG000|Overall Study|Physician Decision|1|||
149197216|NCT00547378|538191139|FG000|Randomized Cohort|Withdrawal by Subject|7|||
149197217|NCT00547378|538191140|FG001|Randomized Cohort|Withdrawal by Subject|5|||
149197218|NCT00547378|538191141|FG002|Randomized Cohort|Withdrawal by Subject|0|||
149197219|NCT00547378|538191139|FG000|Randomized Cohort|Death|0|||
149197220|NCT00547378|538191140|FG001|Randomized Cohort|Death|1|||
149197221|NCT00547378|538191141|FG002|Randomized Cohort|Death|0|||
149197222|NCT00547378|538191139|FG000|Randomized Cohort|Lost to Follow-up|1|||
149197223|NCT00547378|538191140|FG001|Randomized Cohort|Lost to Follow-up|0|||
149197224|NCT00547378|538191141|FG002|Randomized Cohort|Lost to Follow-up|0|||
149197225|NCT00547378|538191139|FG000|Randomized Cohort|Adverse Event|1|||
149197226|NCT00547378|538191140|FG001|Randomized Cohort|Adverse Event|0|||
149197227|NCT00547378|538191141|FG002|Randomized Cohort|Adverse Event|0|||
149197228|NCT00547378|538191139|FG000|Randomized Cohort|Other reasons|2|||
149197229|NCT00547378|538191140|FG001|Randomized Cohort|Other reasons|0|||
149197230|NCT00547378|538191141|FG002|Randomized Cohort|Other reasons|0|||
149197231|NCT00547378|538191139|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
149197232|NCT00547378|538191140|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
149197233|NCT00547378|538191141|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
149197234|NCT00547378|538191139|FG000|All Implanted Cohort|Adverse Event|4|||
149197235|NCT00547378|538191140|FG001|All Implanted Cohort|Adverse Event|10|||
149197236|NCT00547378|538191141|FG002|All Implanted Cohort|Adverse Event|17|||
149197237|NCT00547378|538191139|FG000|All Implanted Cohort|Lost to Follow-up|0|||
149197238|NCT00547378|538191140|FG001|All Implanted Cohort|Lost to Follow-up|1|||
149197239|NCT00547378|538191141|FG002|All Implanted Cohort|Lost to Follow-up|14|||
149197240|NCT00547378|538191139|FG000|All Implanted Cohort|Death|3|||
149197241|NCT00547378|538191140|FG001|All Implanted Cohort|Death|1|||
149197242|NCT00547378|538191141|FG002|All Implanted Cohort|Death|4|||
149197243|NCT00547378|538191139|FG000|All Implanted Cohort|Physician Decision|0|||
149197244|NCT00547378|538191140|FG001|All Implanted Cohort|Physician Decision|2|||
149197245|NCT00547378|538191141|FG002|All Implanted Cohort|Physician Decision|6|||
149197246|NCT00547378|538191139|FG000|All Implanted Cohort|Site closure|2|||
149197247|NCT00547378|538191140|FG001|All Implanted Cohort|Site closure|0|||
149197248|NCT00547378|538191141|FG002|All Implanted Cohort|Site closure|1|||
149197249|NCT00547378|538191139|FG000|All Implanted Cohort|Other reasons|1|||
149197250|NCT00547378|538191140|FG001|All Implanted Cohort|Other reasons|0|||
149197251|NCT00547378|538191141|FG002|All Implanted Cohort|Other reasons|1|||
149197252|NCT01449682|538191142|FG000|Overall Study|Death|0|||
149197253|NCT01449682|538191143|FG001|Overall Study|Death|1|||
149197254|NCT01449682|538191142|FG000|Overall Study|Adverse Event|1|||
149015964|NCT01091428|537537799|FG002|Phase 1|Single-Patient IND|0|||
149015965|NCT01091428|537537800|FG003|Phase 1|Single-Patient IND|0|||
149015966|NCT01091428|537537797|FG000|Phase 2|Progressive Disease|0|||
149015967|NCT01091428|537537798|FG001|Phase 2|Progressive Disease|0|||
149015968|NCT01091428|537537799|FG002|Phase 2|Progressive Disease|44|||
149015969|NCT01091428|537537800|FG003|Phase 2|Progressive Disease|46|||
149015970|NCT01091428|537537797|FG000|Phase 2|Symptomatic Deterioration|0|||
149015971|NCT01091428|537537798|FG001|Phase 2|Symptomatic Deterioration|0|||
149015972|NCT01091428|537537799|FG002|Phase 2|Symptomatic Deterioration|1|||
149015973|NCT01091428|537537800|FG003|Phase 2|Symptomatic Deterioration|6|||
149015974|NCT01091428|537537797|FG000|Phase 2|Adverse Event|0|||
149015975|NCT01091428|537537798|FG001|Phase 2|Adverse Event|0|||
149015976|NCT01091428|537537799|FG002|Phase 2|Adverse Event|12|||
149015977|NCT01091428|537537800|FG003|Phase 2|Adverse Event|5|||
149015978|NCT01091428|537537797|FG000|Phase 2|Withdrawal by Subject|0|||
149015979|NCT01091428|537537798|FG001|Phase 2|Withdrawal by Subject|0|||
149015980|NCT01091428|537537799|FG002|Phase 2|Withdrawal by Subject|9|||
149015981|NCT01091428|537537800|FG003|Phase 2|Withdrawal by Subject|8|||
149015982|NCT01091428|537537797|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
149015983|NCT01091428|537537798|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
149015984|NCT01091428|537537799|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
149197255|NCT01449682|538191143|FG001|Overall Study|Adverse Event|0|||
149197256|NCT04863014|538191144|FG000|Overall Study|Lost to Follow-up|3|||
149197257|NCT04863014|538191145|FG001|Overall Study|Lost to Follow-up|2|||
149197258|NCT04863014|538191144|FG000|Overall Study|Subject Decision|0|||
149197259|NCT04863014|538191145|FG001|Overall Study|Subject Decision|4|||
149197260|NCT04633473|538191150|FG000|Overall Study|Withdrawal by Subject|6|||
149197261|NCT01982773|538191151|FG000|Overall Study|Withdrawal by Subject|1|||
149197262|NCT01982773|538191152|FG001|Overall Study|Withdrawal by Subject|3|||
149197263|NCT01982773|538191151|FG000|Overall Study|Lost to Follow-up|7|||
149197264|NCT01982773|538191152|FG001|Overall Study|Lost to Follow-up|1|||
149197265|NCT01778127|538191157|FG000|Overall Study|Lost to Follow-up|5|||
149197266|NCT01778127|538191158|FG001|Overall Study|Lost to Follow-up|1|||
149197267|NCT01778127|538191159|FG002|Overall Study|Lost to Follow-up|2|||
149197268|NCT01778127|538191157|FG000|Overall Study|Withdrawal by Subject|3|||
149197269|NCT01778127|538191158|FG001|Overall Study|Withdrawal by Subject|1|||
149197270|NCT01778127|538191159|FG002|Overall Study|Withdrawal by Subject|4|||
149197271|NCT01348425|538191160|FG000|Overall Study|Imaging was not taken.|1|||
149197272|NCT01348425|538191161|FG001|Overall Study|Imaging was not taken.|1|||
149197273|NCT04191577|538191170|FG000|Overall Study|Withdrawal by Subject|2|||
149197274|NCT04191577|538191171|FG001|Overall Study|Withdrawal by Subject|2|||
149197275|NCT04191577|538191172|FG002|Overall Study|Withdrawal by Subject|1|||
149197276|NCT04191577|538191170|FG000|Overall Study|Physician Decision|1|||
149197277|NCT04191577|538191171|FG001|Overall Study|Physician Decision|1|||
149197278|NCT04191577|538191172|FG002|Overall Study|Physician Decision|0|||
149197279|NCT04191577|538191170|FG000|Overall Study|Adverse Event|0|||
149197280|NCT04191577|538191171|FG001|Overall Study|Adverse Event|0|||
149197281|NCT04191577|538191172|FG002|Overall Study|Adverse Event|1|||
149197282|NCT04191577|538191170|FG000|Overall Study|Death|0|||
149197283|NCT04191577|538191171|FG001|Overall Study|Death|0|||
149197284|NCT04191577|538191172|FG002|Overall Study|Death|1|||
149197285|NCT01185249|538191173|FG000|Overall Study|Patients discharged or change in status|42|||
149197286|NCT02365584|538191174|FG000|Overall Study|Adverse Event|2|||
149197287|NCT02365584|538191175|FG001|Overall Study|Adverse Event|2|||
149197288|NCT02365584|538191174|FG000|Overall Study|Withdrawal by Subject|1|||
149197289|NCT02365584|538191175|FG001|Overall Study|Withdrawal by Subject|0|||
149197290|NCT02365584|538191174|FG000|Overall Study|Disease Progression|9|||
149197291|NCT02365584|538191175|FG001|Overall Study|Disease Progression|12|||
149197292|NCT01973452|538191176|FG000|Overall Study|Lack of Efficacy|0|||
149197293|NCT01973452|538191177|FG001|Overall Study|Lack of Efficacy|1|||
149197294|NCT01973452|538191176|FG000|Overall Study|Lost to Follow-up|1|||
149197295|NCT01973452|538191177|FG001|Overall Study|Lost to Follow-up|0|||
149197296|NCT01973452|538191176|FG000|Overall Study|Withdrawal by Subject|10|||
149197297|NCT01973452|538191177|FG001|Overall Study|Withdrawal by Subject|9|||
148682827|NCT02544633|536313011|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
149197298|NCT01973452|538191176|FG000|Overall Study|Ineligible|1|||
149197299|NCT01973452|538191177|FG001|Overall Study|Ineligible|1|||
149197300|NCT01973452|538191176|FG000|Overall Study|Surgery canceled by participant|5|||
148682828|NCT02544633|536313008|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
149015985|NCT01091428|537537800|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
149015986|NCT01091428|537537797|FG000|Phase 2|Reason not specified|0|||
149015987|NCT01091428|537537798|FG001|Phase 2|Reason not specified|0|||
149015988|NCT01091428|537537799|FG002|Phase 2|Reason not specified|4|||
149015989|NCT01091428|537537800|FG003|Phase 2|Reason not specified|3|||
149197301|NCT01973452|538191177|FG001|Overall Study|Surgery canceled by participant|3|||
149197302|NCT00406783|538191181|FG000|Overall Study|Adverse Event|4|||
149197303|NCT00406783|538191182|FG001|Overall Study|Adverse Event|4|||
149197304|NCT00406783|538191181|FG000|Overall Study|Treatment Failure|2|||
149197305|NCT00406783|538191182|FG001|Overall Study|Treatment Failure|3|||
149197306|NCT00406783|538191181|FG000|Overall Study|Lost to Follow-up|3|||
149197307|NCT00406783|538191182|FG001|Overall Study|Lost to Follow-up|0|||
149197308|NCT00406783|538191181|FG000|Overall Study|Withdrawal by Subject|1|||
149197309|NCT00406783|538191182|FG001|Overall Study|Withdrawal by Subject|4|||
149197310|NCT00406783|538191181|FG000|Overall Study|Protocol Violation|4|||
149197311|NCT00406783|538191182|FG001|Overall Study|Protocol Violation|4|||
149197312|NCT05294211|538191183|FG000|Overall Study|Withdrawal by Subject|3|||
149197313|NCT05294211|538191183|FG000|Overall Study|Physician Decision|2|||
149197314|NCT05294211|538191183|FG000|Overall Study|Progressed to active labor|1|||
149197315|NCT05294211|538191183|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
149197316|NCT05294211|538191183|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
149197317|NCT00064350|538191184|FG000|Induction Treatment|Disease Progression|5|||
149197318|NCT00064350|538191185|FG001|Induction Treatment|Disease Progression|1|||
149197319|NCT00064350|538191186|FG002|Induction Treatment|Disease Progression|110|||
149197320|NCT00064350|538191184|FG000|Induction Treatment|Adverse Event|0|||
149197321|NCT00064350|538191185|FG001|Induction Treatment|Adverse Event|2|||
149197322|NCT00064350|538191186|FG002|Induction Treatment|Adverse Event|49|||
149197323|NCT00064350|538191184|FG000|Induction Treatment|Death|0|||
149197324|NCT00064350|538191185|FG001|Induction Treatment|Death|0|||
149197325|NCT00064350|538191186|FG002|Induction Treatment|Death|9|||
149197326|NCT00064350|538191184|FG000|Induction Treatment|Withdrawal by Subject|0|||
149197327|NCT00064350|538191185|FG001|Induction Treatment|Withdrawal by Subject|0|||
149197328|NCT00064350|538191186|FG002|Induction Treatment|Withdrawal by Subject|21|||
149197329|NCT00064350|538191184|FG000|Induction Treatment|Ineligible or never started treatment|3|||
149197330|NCT00064350|538191185|FG001|Induction Treatment|Ineligible or never started treatment|6|||
149197331|NCT00064350|538191186|FG002|Induction Treatment|Ineligible or never started treatment|34|||
149197332|NCT00064350|538191184|FG000|Induction Treatment|Other|0|||
149197333|NCT00064350|538191185|FG001|Induction Treatment|Other|0|||
149197334|NCT00064350|538191186|FG002|Induction Treatment|Other|13|||
149197335|NCT00064350|538191184|FG000|Randomization|Adverse Event|8|||
149197336|NCT00064350|538191185|FG001|Randomization|Adverse Event|3|||
149197337|NCT00064350|538191186|FG002|Randomization|Adverse Event|0|||
149197338|NCT00064350|538191184|FG000|Randomization|Death|3|||
149197339|NCT00064350|538191185|FG001|Randomization|Death|0|||
149197340|NCT00064350|538191186|FG002|Randomization|Death|0|||
149197341|NCT00064350|538191184|FG000|Randomization|Withdrawal by Subject|1|||
149197342|NCT00064350|538191185|FG001|Randomization|Withdrawal by Subject|0|||
149197343|NCT00064350|538191186|FG002|Randomization|Withdrawal by Subject|0|||
149197344|NCT00064350|538191184|FG000|Randomization|Ineligible or never started treatment|9|||
149197345|NCT00064350|538191185|FG001|Randomization|Ineligible or never started treatment|15|||
149197346|NCT00064350|538191186|FG002|Randomization|Ineligible or never started treatment|0|||
149197347|NCT00064350|538191184|FG000|Randomization|Other|5|||
149197348|NCT00064350|538191185|FG001|Randomization|Other|0|||
149197349|NCT00064350|538191186|FG002|Randomization|Other|0|||
149197350|NCT00064350|538191184|FG000|Cross-Over|Adverse Event|0|||
149197351|NCT00064350|538191185|FG001|Cross-Over|Adverse Event|1|||
149197352|NCT00064350|538191186|FG002|Cross-Over|Adverse Event|0|||
149197353|NCT00064350|538191184|FG000|Cross-Over|Death|1|||
149197354|NCT00064350|538191185|FG001|Cross-Over|Death|3|||
149197355|NCT00064350|538191186|FG002|Cross-Over|Death|0|||
149197356|NCT00064350|538191184|FG000|Cross-Over|Withdrawal by Subject|2|||
149197357|NCT00064350|538191185|FG001|Cross-Over|Withdrawal by Subject|2|||
149197358|NCT00064350|538191186|FG002|Cross-Over|Withdrawal by Subject|0|||
149197359|NCT00064350|538191184|FG000|Cross-Over|Ineligible or never started treatment|3|||
149197360|NCT00064350|538191185|FG001|Cross-Over|Ineligible or never started treatment|6|||
149197361|NCT00064350|538191186|FG002|Cross-Over|Ineligible or never started treatment|0|||
149197362|NCT00064350|538191184|FG000|Cross-Over|Other|0|||
149197363|NCT00064350|538191185|FG001|Cross-Over|Other|2|||
149197364|NCT00064350|538191186|FG002|Cross-Over|Other|0|||
149197365|NCT03600714|538191187|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
149197366|NCT01935336|538191190|FG000|Overall Study|Adverse Event|1|||
149197367|NCT01935336|538191191|FG001|Overall Study|Adverse Event|0|||
149197368|NCT01935336|538191192|FG002|Overall Study|Adverse Event|0|||
149197369|NCT01935336|538191193|FG003|Overall Study|Adverse Event|0|||
149197370|NCT01935336|538191190|FG000|Overall Study|Progressive disease|5|||
149197371|NCT01935336|538191191|FG001|Overall Study|Progressive disease|3|||
149197372|NCT01935336|538191192|FG002|Overall Study|Progressive disease|47|||
149197373|NCT01935336|538191193|FG003|Overall Study|Progressive disease|66|||
149197374|NCT00592553|538191194|FG000|Overall Study|Protocol Noncompliance|1|||
149197375|NCT00592553|538191195|FG001|Overall Study|Protocol Noncompliance|0|||
149197376|NCT00592553|538191196|FG002|Overall Study|Protocol Noncompliance|0|||
149197377|NCT03707158|538191197|FG000|Midtreatment|Lost to Follow-up|16|||
149197378|NCT03707158|538191198|FG001|Midtreatment|Lost to Follow-up|7|||
149197379|NCT03707158|538191197|FG000|Midtreatment|Withdrawal by Subject|28|||
149197380|NCT03707158|538191198|FG001|Midtreatment|Withdrawal by Subject|19|||
149197381|NCT03707158|538191197|FG000|Posttreatment|Lost to Follow-up|0|||
149197382|NCT03707158|538191198|FG001|Posttreatment|Lost to Follow-up|5|||
149197383|NCT03707158|538191197|FG000|Follow-up|Lost to Follow-up|19|||
149197384|NCT03707158|538191198|FG001|Follow-up|Lost to Follow-up|18|||
149197385|NCT03707158|538191197|FG000|Follow-up|Withdrawal by Subject|13|||
149197386|NCT03707158|538191198|FG001|Follow-up|Withdrawal by Subject|6|||
149197387|NCT04092816|538193015|FG000|Overall Study|Lost to Follow-up|1|||
149197388|NCT04092816|538193016|FG001|Overall Study|Lost to Follow-up|2|||
149197389|NCT01747811|538193017|FG000|Overall Study|Lack of Efficacy|2|||
149197390|NCT01747811|538193018|FG001|Overall Study|Lack of Efficacy|4|||
149197391|NCT03073213|538193019|FG000|Multiple Dose Period|Protocol Violation|0|||
149197392|NCT03073213|538193020|FG001|Multiple Dose Period|Protocol Violation|0|||
149197393|NCT03073213|538193021|FG002|Multiple Dose Period|Protocol Violation|1|||
149197394|NCT02680587|538193025|FG000|Overall Study|Withdrawal by Subject|1|||
149197395|NCT02680587|538193026|FG001|Overall Study|Withdrawal by Subject|0|||
149197396|NCT01194869|538193028|FG000|Overall Study|Disease Progression|2|||
149197397|NCT01194869|538193028|FG000|Overall Study|Toxicity|2|||
149197398|NCT01708941|538193029|FG000|Overall Study|Adverse Event|4|||
149197399|NCT01708941|538193030|FG001|Overall Study|Adverse Event|6|||
149197400|NCT01708941|538193031|FG002|Overall Study|Adverse Event|1|||
149197401|NCT01708941|538193032|FG003|Overall Study|Adverse Event|0|||
149197402|NCT01708941|538193029|FG000|Overall Study|Death|1|||
148682829|NCT02544633|536313009|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
148682830|NCT02544633|536313010|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
148682831|NCT02544633|536313011|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
149197403|NCT01708941|538193030|FG001|Overall Study|Death|1|||
149197404|NCT01708941|538193031|FG002|Overall Study|Death|2|||
149197405|NCT01708941|538193032|FG003|Overall Study|Death|14|||
149197406|NCT01708941|538193029|FG000|Overall Study|Withdrawal by Subject|1|||
149197407|NCT01708941|538193030|FG001|Overall Study|Withdrawal by Subject|0|||
149197408|NCT01708941|538193031|FG002|Overall Study|Withdrawal by Subject|3|||
149197409|NCT01708941|538193032|FG003|Overall Study|Withdrawal by Subject|4|||
149197410|NCT01708941|538193029|FG000|Overall Study|Disease progression|9|||
149197411|NCT01708941|538193030|FG001|Overall Study|Disease progression|10|||
149197412|NCT01708941|538193031|FG002|Overall Study|Disease progression|8|||
149197413|NCT01708941|538193032|FG003|Overall Study|Disease progression|0|||
149197414|NCT01708941|538193029|FG000|Overall Study|Alternative therapy|0|||
149197415|NCT01708941|538193030|FG001|Overall Study|Alternative therapy|0|||
149197416|NCT01708941|538193031|FG002|Overall Study|Alternative therapy|2|||
149197417|NCT01708941|538193032|FG003|Overall Study|Alternative therapy|0|||
149197418|NCT01708941|538193029|FG000|Overall Study|Ineligible and never started treatment|1|||
149197419|NCT01708941|538193030|FG001|Overall Study|Ineligible and never started treatment|0|||
149197420|NCT01708941|538193031|FG002|Overall Study|Ineligible and never started treatment|1|||
149197421|NCT01708941|538193032|FG003|Overall Study|Ineligible and never started treatment|0|||
149197422|NCT01708941|538193029|FG000|Overall Study|Never started treatment|2|||
149197423|NCT01708941|538193030|FG001|Overall Study|Never started treatment|1|||
149197424|NCT01708941|538193031|FG002|Overall Study|Never started treatment|0|||
149197425|NCT01708941|538193032|FG003|Overall Study|Never started treatment|0|||
149197426|NCT01708941|538193029|FG000|Overall Study|Ineligible|0|||
149197427|NCT01708941|538193030|FG001|Overall Study|Ineligible|0|||
149197428|NCT01708941|538193031|FG002|Overall Study|Ineligible|2|||
149197429|NCT01708941|538193032|FG003|Overall Study|Ineligible|0|||
149197430|NCT02226146|538193033|FG000|Overall Study|Received rescue therapy|1|||
149197431|NCT02226146|538193033|FG000|Overall Study|Withdrawal by Subject|2|||
149197432|NCT05464836|538193034|FG000|Overall Study|Progression of Disease|1|||
149197433|NCT05464836|538193034|FG000|Overall Study|Physician Decision|1|||
149197434|NCT01522976|538193035|FG000|Overall Study|Ineligible|4|||
149197435|NCT01522976|538193036|FG001|Overall Study|Ineligible|0|||
149197436|NCT01522976|538193037|FG002|Overall Study|Ineligible|1|||
149197437|NCT01522976|538193035|FG000|Overall Study|Death|7|||
149197438|NCT01522976|538193036|FG001|Overall Study|Death|6|||
149197439|NCT01522976|538193037|FG002|Overall Study|Death|2|||
149197440|NCT01522976|538193035|FG000|Overall Study|Still on treatment|9|||
149197441|NCT01522976|538193036|FG001|Overall Study|Still on treatment|9|||
149197442|NCT01522976|538193037|FG002|Overall Study|Still on treatment|6|||
149197443|NCT01522976|538193035|FG000|Overall Study|Disease progression|28|||
148682832|NCT02544633|536313008|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
148942961|NCT01218113|537275601|FG002|Overall Study|Withdrawal by Subject|1|||
148682833|NCT02544633|536313009|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
148942962|NCT01218113|537275599|FG000|Overall Study|Lost to Follow-up|4|||
149197444|NCT01522976|538193036|FG001|Overall Study|Disease progression|30|||
149197445|NCT01522976|538193037|FG002|Overall Study|Disease progression|25|||
149197446|NCT01522976|538193035|FG000|Overall Study|Adverse Event|17|||
149197447|NCT01522976|538193036|FG001|Overall Study|Adverse Event|7|||
149197448|NCT01522976|538193037|FG002|Overall Study|Adverse Event|18|||
149197449|NCT01522976|538193035|FG000|Overall Study|Refusal unrelated to adverse event|10|||
149197450|NCT01522976|538193036|FG001|Overall Study|Refusal unrelated to adverse event|13|||
149197451|NCT01522976|538193037|FG002|Overall Study|Refusal unrelated to adverse event|14|||
149197452|NCT01522976|538193035|FG000|Overall Study|Not protocol specified|22|||
149197453|NCT01522976|538193036|FG001|Overall Study|Not protocol specified|27|||
149197454|NCT01522976|538193037|FG002|Overall Study|Not protocol specified|27|||
149197455|NCT02883049|538193038|FG000|Induction|Adverse Event|52|||
149197456|NCT02883049|538193039|FG001|Induction|Adverse Event|2|||
148942963|NCT01218113|537275600|FG001|Overall Study|Lost to Follow-up|1|||
148942964|NCT01218113|537275601|FG002|Overall Study|Lost to Follow-up|4|||
148942965|NCT01218113|537275599|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
149197457|NCT02883049|538193040|FG002|Induction|Adverse Event|0|||
149197458|NCT02883049|538193041|FG003|Induction|Adverse Event|0|||
149197459|NCT02883049|538193042|FG004|Induction|Adverse Event|0|||
149197460|NCT02883049|538193043|FG005|Induction|Adverse Event|0|||
149197461|NCT02883049|538193044|FG006|Induction|Adverse Event|0|||
149197462|NCT02883049|538193045|FG007|Induction|Adverse Event|0|||
149197463|NCT02883049|538193046|FG008|Induction|Adverse Event|0|||
149197464|NCT02883049|538193047|FG009|Induction|Adverse Event|0|||
149197465|NCT02883049|538193048|FG010|Induction|Adverse Event|0|||
149197466|NCT02883049|538193049|FG011|Induction|Adverse Event|0|||
149197467|NCT02883049|538193050|FG012|Induction|Adverse Event|0|||
149197468|NCT02883049|538193051|FG013|Induction|Adverse Event|0|||
149197469|NCT02883049|538193052|FG014|Induction|Adverse Event|0|||
149197470|NCT02883049|538193053|FG015|Induction|Adverse Event|0|||
149197471|NCT02883049|538193038|FG000|Induction|Death|76|||
149197472|NCT02883049|538193039|FG001|Induction|Death|8|||
149197473|NCT02883049|538193040|FG002|Induction|Death|0|||
149197474|NCT02883049|538193041|FG003|Induction|Death|0|||
149197475|NCT02883049|538193042|FG004|Induction|Death|0|||
149197476|NCT02883049|538193043|FG005|Induction|Death|0|||
149197477|NCT02883049|538193044|FG006|Induction|Death|0|||
149197478|NCT02883049|538193045|FG007|Induction|Death|0|||
149197479|NCT02883049|538193046|FG008|Induction|Death|0|||
149197480|NCT02883049|538193047|FG009|Induction|Death|0|||
149197481|NCT02883049|538193048|FG010|Induction|Death|0|||
149197482|NCT02883049|538193049|FG011|Induction|Death|0|||
149197483|NCT02883049|538193050|FG012|Induction|Death|0|||
149197484|NCT02883049|538193051|FG013|Induction|Death|0|||
149197485|NCT02883049|538193052|FG014|Induction|Death|0|||
149197486|NCT02883049|538193053|FG015|Induction|Death|0|||
149197487|NCT02883049|538193038|FG000|Induction|Lost to Follow-up|2|||
149197488|NCT02883049|538193039|FG001|Induction|Lost to Follow-up|0|||
149197489|NCT02883049|538193040|FG002|Induction|Lost to Follow-up|0|||
149197490|NCT02883049|538193041|FG003|Induction|Lost to Follow-up|0|||
149197491|NCT02883049|538193042|FG004|Induction|Lost to Follow-up|0|||
149197492|NCT02883049|538193043|FG005|Induction|Lost to Follow-up|0|||
149197493|NCT02883049|538193044|FG006|Induction|Lost to Follow-up|0|||
149197494|NCT02883049|538193045|FG007|Induction|Lost to Follow-up|0|||
149197495|NCT02883049|538193046|FG008|Induction|Lost to Follow-up|0|||
149197496|NCT02883049|538193047|FG009|Induction|Lost to Follow-up|0|||
149197497|NCT02883049|538193048|FG010|Induction|Lost to Follow-up|0|||
149197498|NCT02883049|538193049|FG011|Induction|Lost to Follow-up|0|||
149197499|NCT02883049|538193050|FG012|Induction|Lost to Follow-up|0|||
149197500|NCT02883049|538193051|FG013|Induction|Lost to Follow-up|0|||
149197501|NCT02883049|538193052|FG014|Induction|Lost to Follow-up|0|||
149197502|NCT02883049|538193053|FG015|Induction|Lost to Follow-up|0|||
149197503|NCT02883049|538193038|FG000|Induction|Physician Decision|1407|||
149197504|NCT02883049|538193039|FG001|Induction|Physician Decision|8|||
149197505|NCT02883049|538193040|FG002|Induction|Physician Decision|0|||
149197506|NCT02883049|538193041|FG003|Induction|Physician Decision|0|||
149197507|NCT02883049|538193042|FG004|Induction|Physician Decision|0|||
149197508|NCT02883049|538193043|FG005|Induction|Physician Decision|0|||
149197509|NCT02883049|538193044|FG006|Induction|Physician Decision|0|||
149197510|NCT02883049|538193045|FG007|Induction|Physician Decision|0|||
149197511|NCT02883049|538193046|FG008|Induction|Physician Decision|0|||
149197512|NCT02883049|538193047|FG009|Induction|Physician Decision|0|||
149197513|NCT02883049|538193048|FG010|Induction|Physician Decision|0|||
149197514|NCT02883049|538193049|FG011|Induction|Physician Decision|0|||
149197515|NCT02883049|538193050|FG012|Induction|Physician Decision|0|||
149197516|NCT02883049|538193051|FG013|Induction|Physician Decision|0|||
149197517|NCT02883049|538193052|FG014|Induction|Physician Decision|0|||
149197518|NCT02883049|538193053|FG015|Induction|Physician Decision|0|||
149197519|NCT02883049|538193038|FG000|Induction|Protocol Violation|6|||
149197520|NCT02883049|538193039|FG001|Induction|Protocol Violation|0|||
149197521|NCT02883049|538193040|FG002|Induction|Protocol Violation|0|||
149197522|NCT02883049|538193041|FG003|Induction|Protocol Violation|0|||
149197523|NCT02883049|538193042|FG004|Induction|Protocol Violation|0|||
149197524|NCT02883049|538193043|FG005|Induction|Protocol Violation|0|||
149197525|NCT02883049|538193044|FG006|Induction|Protocol Violation|0|||
149197526|NCT02883049|538193045|FG007|Induction|Protocol Violation|0|||
149197527|NCT02883049|538193046|FG008|Induction|Protocol Violation|0|||
149197528|NCT02883049|538193047|FG009|Induction|Protocol Violation|0|||
149197529|NCT02883049|538193048|FG010|Induction|Protocol Violation|0|||
149197530|NCT02883049|538193049|FG011|Induction|Protocol Violation|0|||
149015990|NCT01091428|537537797|FG000|Phase 2|Physician Decision|0|||
149197531|NCT02883049|538193050|FG012|Induction|Protocol Violation|0|||
149197532|NCT02883049|538193051|FG013|Induction|Protocol Violation|0|||
149197533|NCT02883049|538193052|FG014|Induction|Protocol Violation|0|||
149197534|NCT02883049|538193053|FG015|Induction|Protocol Violation|0|||
149197535|NCT02883049|538193038|FG000|Induction|Withdrawal by Subject|6|||
149197536|NCT02883049|538193039|FG001|Induction|Withdrawal by Subject|0|||
149197537|NCT02883049|538193040|FG002|Induction|Withdrawal by Subject|0|||
149197538|NCT02883049|538193041|FG003|Induction|Withdrawal by Subject|0|||
149197539|NCT02883049|538193042|FG004|Induction|Withdrawal by Subject|0|||
149197540|NCT02883049|538193043|FG005|Induction|Withdrawal by Subject|0|||
149197541|NCT02883049|538193044|FG006|Induction|Withdrawal by Subject|0|||
149197542|NCT02883049|538193045|FG007|Induction|Withdrawal by Subject|0|||
149197543|NCT02883049|538193046|FG008|Induction|Withdrawal by Subject|0|||
149197544|NCT02883049|538193047|FG009|Induction|Withdrawal by Subject|0|||
149197545|NCT02883049|538193048|FG010|Induction|Withdrawal by Subject|0|||
149197546|NCT02883049|538193049|FG011|Induction|Withdrawal by Subject|0|||
149197547|NCT02883049|538193050|FG012|Induction|Withdrawal by Subject|0|||
149197548|NCT02883049|538193051|FG013|Induction|Withdrawal by Subject|0|||
149197549|NCT02883049|538193052|FG014|Induction|Withdrawal by Subject|0|||
149197550|NCT02883049|538193053|FG015|Induction|Withdrawal by Subject|0|||
149197551|NCT02883049|538193038|FG000|Induction|Ineligible|35|||
149197552|NCT02883049|538193039|FG001|Induction|Ineligible|1|||
149197553|NCT02883049|538193040|FG002|Induction|Ineligible|0|||
149197554|NCT02883049|538193041|FG003|Induction|Ineligible|0|||
149197555|NCT02883049|538193042|FG004|Induction|Ineligible|0|||
148942966|NCT01218113|537275600|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
148942967|NCT01218113|537275601|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
149197556|NCT02883049|538193043|FG005|Induction|Ineligible|0|||
149197557|NCT02883049|538193044|FG006|Induction|Ineligible|0|||
149197558|NCT02883049|538193045|FG007|Induction|Ineligible|0|||
149197559|NCT02883049|538193046|FG008|Induction|Ineligible|0|||
149197560|NCT02883049|538193047|FG009|Induction|Ineligible|0|||
149197561|NCT02883049|538193048|FG010|Induction|Ineligible|0|||
149197562|NCT02883049|538193049|FG011|Induction|Ineligible|0|||
149197563|NCT02883049|538193050|FG012|Induction|Ineligible|0|||
149197564|NCT02883049|538193051|FG013|Induction|Ineligible|0|||
149197565|NCT02883049|538193052|FG014|Induction|Ineligible|0|||
149197566|NCT02883049|538193053|FG015|Induction|Ineligible|0|||
149197567|NCT02883049|538193038|FG000|Induction|Refusal of further protocol therapy|466|||
149197568|NCT02883049|538193039|FG001|Induction|Refusal of further protocol therapy|2|||
149197569|NCT02883049|538193040|FG002|Induction|Refusal of further protocol therapy|0|||
149197570|NCT02883049|538193041|FG003|Induction|Refusal of further protocol therapy|0|||
149197571|NCT02883049|538193042|FG004|Induction|Refusal of further protocol therapy|0|||
149197572|NCT02883049|538193043|FG005|Induction|Refusal of further protocol therapy|0|||
149197573|NCT02883049|538193044|FG006|Induction|Refusal of further protocol therapy|0|||
149197574|NCT02883049|538193045|FG007|Induction|Refusal of further protocol therapy|0|||
149197575|NCT02883049|538193046|FG008|Induction|Refusal of further protocol therapy|0|||
149197576|NCT02883049|538193047|FG009|Induction|Refusal of further protocol therapy|0|||
149197577|NCT02883049|538193048|FG010|Induction|Refusal of further protocol therapy|0|||
149197578|NCT02883049|538193049|FG011|Induction|Refusal of further protocol therapy|0|||
149197579|NCT02883049|538193050|FG012|Induction|Refusal of further protocol therapy|0|||
149197580|NCT02883049|538193051|FG013|Induction|Refusal of further protocol therapy|0|||
149197581|NCT02883049|538193052|FG014|Induction|Refusal of further protocol therapy|0|||
149197582|NCT02883049|538193053|FG015|Induction|Refusal of further protocol therapy|0|||
149197583|NCT02883049|538193038|FG000|Induction|Identified as Ph+ patients|279|||
149197584|NCT02883049|538193039|FG001|Induction|Identified as Ph+ patients|1|||
149197585|NCT02883049|538193040|FG002|Induction|Identified as Ph+ patients|0|||
149197586|NCT02883049|538193041|FG003|Induction|Identified as Ph+ patients|0|||
148942968|NCT02732119|537275629|FG000|Phase I|Adverse Event|1|||
148942969|NCT02732119|537275630|FG001|Phase I|Adverse Event|3|||
148942970|NCT02732119|537275631|FG002|Phase I|Adverse Event|1|||
148942971|NCT02732119|537275632|FG003|Phase I|Adverse Event|0|||
148942972|NCT02732119|537275633|FG004|Phase I|Adverse Event|0|||
148942973|NCT02732119|537275629|FG000|Phase I|Progressive disease|7|||
148942974|NCT02732119|537275630|FG001|Phase I|Progressive disease|3|||
148942975|NCT02732119|537275631|FG002|Phase I|Progressive disease|2|||
148942976|NCT02732119|537275632|FG003|Phase I|Progressive disease|0|||
148942977|NCT02732119|537275633|FG004|Phase I|Progressive disease|0|||
148942978|NCT02732119|537275629|FG000|Phase I|Protocol deviation|0|||
149197587|NCT02883049|538193042|FG004|Induction|Identified as Ph+ patients|0|||
149197588|NCT02883049|538193043|FG005|Induction|Identified as Ph+ patients|0|||
149197589|NCT02883049|538193044|FG006|Induction|Identified as Ph+ patients|0|||
149197590|NCT02883049|538193045|FG007|Induction|Identified as Ph+ patients|0|||
149197591|NCT02883049|538193046|FG008|Induction|Identified as Ph+ patients|0|||
149197592|NCT02883049|538193047|FG009|Induction|Identified as Ph+ patients|0|||
149197593|NCT02883049|538193048|FG010|Induction|Identified as Ph+ patients|0|||
148942979|NCT02732119|537275630|FG001|Phase I|Protocol deviation|1|||
148942980|NCT02732119|537275631|FG002|Phase I|Protocol deviation|0|||
148942981|NCT02732119|537275632|FG003|Phase I|Protocol deviation|0|||
149197594|NCT02883049|538193049|FG011|Induction|Identified as Ph+ patients|0|||
149197595|NCT02883049|538193050|FG012|Induction|Identified as Ph+ patients|0|||
149197596|NCT02883049|538193051|FG013|Induction|Identified as Ph+ patients|0|||
149197597|NCT02883049|538193052|FG014|Induction|Identified as Ph+ patients|0|||
148682834|NCT02544633|536313010|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
148682835|NCT02544633|536313011|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
148682836|NCT02092961|536313012|FG000|Overall Study|Not reported|1|||
148682837|NCT02092961|536313013|FG001|Overall Study|Not reported|0|||
148682838|NCT02092961|536313014|FG002|Overall Study|Not reported|1|||
148682839|NCT02092961|536313012|FG000|Overall Study|Study stopped|13|||
148682840|NCT02092961|536313013|FG001|Overall Study|Study stopped|9|||
148682841|NCT02092961|536313014|FG002|Overall Study|Study stopped|12|||
148682842|NCT02092961|536313012|FG000|Overall Study|Lack of therapeutic response|2|||
149197598|NCT02883049|538193053|FG015|Induction|Identified as Ph+ patients|0|||
149197599|NCT02883049|538193038|FG000|Induction|M3 Marrow at Day29|8|||
149197600|NCT02883049|538193039|FG001|Induction|M3 Marrow at Day29|1|||
149197601|NCT02883049|538193040|FG002|Induction|M3 Marrow at Day29|0|||
149197602|NCT02883049|538193041|FG003|Induction|M3 Marrow at Day29|0|||
149197603|NCT02883049|538193042|FG004|Induction|M3 Marrow at Day29|0|||
149197604|NCT02883049|538193043|FG005|Induction|M3 Marrow at Day29|0|||
149197605|NCT02883049|538193044|FG006|Induction|M3 Marrow at Day29|0|||
149197606|NCT02883049|538193045|FG007|Induction|M3 Marrow at Day29|0|||
149197607|NCT02883049|538193046|FG008|Induction|M3 Marrow at Day29|0|||
149197608|NCT02883049|538193047|FG009|Induction|M3 Marrow at Day29|0|||
149197609|NCT02883049|538193048|FG010|Induction|M3 Marrow at Day29|0|||
149197610|NCT02883049|538193049|FG011|Induction|M3 Marrow at Day29|0|||
149197611|NCT02883049|538193050|FG012|Induction|M3 Marrow at Day29|0|||
149197612|NCT02883049|538193051|FG013|Induction|M3 Marrow at Day29|0|||
149197613|NCT02883049|538193052|FG014|Induction|M3 Marrow at Day29|0|||
149197614|NCT02883049|538193053|FG015|Induction|M3 Marrow at Day29|0|||
149197615|NCT02883049|538193038|FG000|Induction|Inevaluable|33|||
149197616|NCT02883049|538193039|FG001|Induction|Inevaluable|1|||
149197617|NCT02883049|538193040|FG002|Induction|Inevaluable|0|||
149197618|NCT02883049|538193041|FG003|Induction|Inevaluable|0|||
149197619|NCT02883049|538193042|FG004|Induction|Inevaluable|0|||
148682843|NCT02092961|536313013|FG001|Overall Study|Lack of therapeutic response|1|||
148682844|NCT02092961|536313014|FG002|Overall Study|Lack of therapeutic response|3|||
148682845|NCT02092961|536313012|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
148682846|NCT02092961|536313013|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
148682847|NCT02092961|536313014|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
148682848|NCT02092961|536313012|FG000|Overall Study|Adverse Event|2|||
148682849|NCT02092961|536313013|FG001|Overall Study|Adverse Event|4|||
148682850|NCT02092961|536313014|FG002|Overall Study|Adverse Event|0|||
148682851|NCT02270983|536313015|FG000|Overall Study|Adverse Event|3|||
148682852|NCT02270983|536313016|FG001|Overall Study|Adverse Event|2|||
148682853|NCT02270983|536313017|FG002|Overall Study|Adverse Event|6|||
148682854|NCT02270983|536313015|FG000|Overall Study|Lack of Efficacy|2|||
148682855|NCT02270983|536313016|FG001|Overall Study|Lack of Efficacy|1|||
148942982|NCT02732119|537275633|FG004|Phase I|Protocol deviation|0|||
148942983|NCT02732119|537275629|FG000|Phase I|Physician Decision|0|||
148942984|NCT02732119|537275630|FG001|Phase I|Physician Decision|3|||
148942985|NCT02732119|537275631|FG002|Phase I|Physician Decision|4|||
148942986|NCT02732119|537275632|FG003|Phase I|Physician Decision|0|||
149197620|NCT02883049|538193043|FG005|Induction|Inevaluable|0|||
149197621|NCT02883049|538193044|FG006|Induction|Inevaluable|0|||
148942987|NCT02732119|537275633|FG004|Phase I|Physician Decision|0|||
149197622|NCT02883049|538193045|FG007|Induction|Inevaluable|0|||
149197623|NCT02883049|538193046|FG008|Induction|Inevaluable|0|||
149197624|NCT02883049|538193047|FG009|Induction|Inevaluable|0|||
148682856|NCT02270983|536313017|FG002|Overall Study|Lack of Efficacy|1|||
148682857|NCT02270983|536313015|FG000|Overall Study|Withdrawal by Subject|1|||
148682858|NCT02270983|536313016|FG001|Overall Study|Withdrawal by Subject|0|||
148942988|NCT02732119|537275629|FG000|Phase II|Adverse Event|0|||
149197625|NCT02883049|538193048|FG010|Induction|Inevaluable|0|||
149197626|NCT02883049|538193049|FG011|Induction|Inevaluable|0|||
149197627|NCT02883049|538193050|FG012|Induction|Inevaluable|0|||
149197628|NCT02883049|538193051|FG013|Induction|Inevaluable|0|||
149197629|NCT02883049|538193052|FG014|Induction|Inevaluable|0|||
149197630|NCT02883049|538193053|FG015|Induction|Inevaluable|0|||
149197631|NCT02883049|538193038|FG000|Induction|Identified as VHR at end of Induction|244|||
148682859|NCT02270983|536313017|FG002|Overall Study|Withdrawal by Subject|2|||
148682860|NCT02270983|536313015|FG000|Overall Study|Lost to Follow-up|1|||
148682861|NCT02270983|536313016|FG001|Overall Study|Lost to Follow-up|1|||
148682862|NCT02270983|536313017|FG002|Overall Study|Lost to Follow-up|2|||
148682863|NCT02270983|536313015|FG000|Overall Study|Protocol Violation|1|||
148682864|NCT02270983|536313016|FG001|Overall Study|Protocol Violation|1|||
148682865|NCT02270983|536313017|FG002|Overall Study|Protocol Violation|1|||
148942989|NCT02732119|537275630|FG001|Phase II|Adverse Event|0|||
149197632|NCT02883049|538193039|FG001|Induction|Identified as VHR at end of Induction|0|||
149197633|NCT02883049|538193040|FG002|Induction|Identified as VHR at end of Induction|0|||
149197634|NCT02883049|538193041|FG003|Induction|Identified as VHR at end of Induction|0|||
149197635|NCT02883049|538193042|FG004|Induction|Identified as VHR at end of Induction|0|||
149197636|NCT02883049|538193043|FG005|Induction|Identified as VHR at end of Induction|0|||
149197637|NCT02883049|538193044|FG006|Induction|Identified as VHR at end of Induction|0|||
149197638|NCT02883049|538193045|FG007|Induction|Identified as VHR at end of Induction|0|||
149197639|NCT02883049|538193046|FG008|Induction|Identified as VHR at end of Induction|0|||
149197640|NCT02883049|538193047|FG009|Induction|Identified as VHR at end of Induction|0|||
149197641|NCT02883049|538193048|FG010|Induction|Identified as VHR at end of Induction|0|||
149197642|NCT02883049|538193049|FG011|Induction|Identified as VHR at end of Induction|0|||
149197643|NCT02883049|538193050|FG012|Induction|Identified as VHR at end of Induction|0|||
149197644|NCT02883049|538193051|FG013|Induction|Identified as VHR at end of Induction|0|||
149197645|NCT02883049|538193052|FG014|Induction|Identified as VHR at end of Induction|0|||
149197646|NCT02883049|538193053|FG015|Induction|Identified as VHR at end of Induction|0|||
149197647|NCT02883049|538193038|FG000|Induction|Moved to another non-COG institution|3|||
149197648|NCT02883049|538193039|FG001|Induction|Moved to another non-COG institution|0|||
149197649|NCT02883049|538193040|FG002|Induction|Moved to another non-COG institution|0|||
149197650|NCT02883049|538193041|FG003|Induction|Moved to another non-COG institution|0|||
149197651|NCT02883049|538193042|FG004|Induction|Moved to another non-COG institution|0|||
149197652|NCT02883049|538193043|FG005|Induction|Moved to another non-COG institution|0|||
149197653|NCT02883049|538193044|FG006|Induction|Moved to another non-COG institution|0|||
149197654|NCT02883049|538193045|FG007|Induction|Moved to another non-COG institution|0|||
149197655|NCT02883049|538193046|FG008|Induction|Moved to another non-COG institution|0|||
149197656|NCT02883049|538193047|FG009|Induction|Moved to another non-COG institution|0|||
149197657|NCT02883049|538193048|FG010|Induction|Moved to another non-COG institution|0|||
149197658|NCT02883049|538193049|FG011|Induction|Moved to another non-COG institution|0|||
149197659|NCT02883049|538193050|FG012|Induction|Moved to another non-COG institution|0|||
149197660|NCT02883049|538193051|FG013|Induction|Moved to another non-COG institution|0|||
149197661|NCT02883049|538193052|FG014|Induction|Moved to another non-COG institution|0|||
149197662|NCT02883049|538193053|FG015|Induction|Moved to another non-COG institution|0|||
149197663|NCT02883049|538193038|FG000|Induction|Randomization closed|41|||
149197664|NCT02883049|538193039|FG001|Induction|Randomization closed|0|||
149197665|NCT02883049|538193040|FG002|Induction|Randomization closed|0|||
149197666|NCT02883049|538193041|FG003|Induction|Randomization closed|0|||
149197667|NCT02883049|538193042|FG004|Induction|Randomization closed|0|||
149197668|NCT02883049|538193043|FG005|Induction|Randomization closed|0|||
149197669|NCT02883049|538193044|FG006|Induction|Randomization closed|0|||
149197670|NCT02883049|538193045|FG007|Induction|Randomization closed|0|||
149197671|NCT02883049|538193046|FG008|Induction|Randomization closed|0|||
149197672|NCT02883049|538193047|FG009|Induction|Randomization closed|0|||
149197673|NCT02883049|538193048|FG010|Induction|Randomization closed|0|||
149197674|NCT02883049|538193049|FG011|Induction|Randomization closed|0|||
149197675|NCT02883049|538193050|FG012|Induction|Randomization closed|0|||
149197676|NCT02883049|538193051|FG013|Induction|Randomization closed|0|||
149197677|NCT02883049|538193052|FG014|Induction|Randomization closed|0|||
149197678|NCT02883049|538193053|FG015|Induction|Randomization closed|0|||
149197679|NCT02883049|538193038|FG000|Induction|MRD negative|36|||
149197680|NCT02883049|538193039|FG001|Induction|MRD negative|0|||
149197681|NCT02883049|538193040|FG002|Induction|MRD negative|0|||
149197682|NCT02883049|538193041|FG003|Induction|MRD negative|0|||
149197683|NCT02883049|538193042|FG004|Induction|MRD negative|0|||
149197684|NCT02883049|538193043|FG005|Induction|MRD negative|0|||
149197685|NCT02883049|538193044|FG006|Induction|MRD negative|0|||
149197686|NCT02883049|538193045|FG007|Induction|MRD negative|0|||
149197687|NCT02883049|538193046|FG008|Induction|MRD negative|0|||
149197688|NCT02883049|538193047|FG009|Induction|MRD negative|0|||
149197689|NCT02883049|538193048|FG010|Induction|MRD negative|0|||
148682866|NCT02270983|536313015|FG000|Overall Study|family emergency|0|||
149197690|NCT02883049|538193049|FG011|Induction|MRD negative|0|||
149197691|NCT02883049|538193050|FG012|Induction|MRD negative|0|||
148682867|NCT02270983|536313016|FG001|Overall Study|family emergency|1|||
148682868|NCT02270983|536313017|FG002|Overall Study|family emergency|0|||
149197692|NCT02883049|538193051|FG013|Induction|MRD negative|0|||
149197693|NCT02883049|538193052|FG014|Induction|MRD negative|0|||
149197694|NCT02883049|538193053|FG015|Induction|MRD negative|0|||
149197695|NCT02883049|538193038|FG000|Induction|Identified as HR patients|165|||
149197696|NCT02883049|538193039|FG001|Induction|Identified as HR patients|0|||
149197697|NCT02883049|538193040|FG002|Induction|Identified as HR patients|0|||
148942990|NCT02732119|537275631|FG002|Phase II|Adverse Event|0|||
148942991|NCT02732119|537275632|FG003|Phase II|Adverse Event|3|||
148942992|NCT02732119|537275633|FG004|Phase II|Adverse Event|3|||
148942993|NCT02732119|537275629|FG000|Phase II|Death|0|||
148942994|NCT02732119|537275630|FG001|Phase II|Death|0|||
148942995|NCT02732119|537275631|FG002|Phase II|Death|0|||
149197698|NCT02883049|538193041|FG003|Induction|Identified as HR patients|0|||
149197699|NCT02883049|538193042|FG004|Induction|Identified as HR patients|0|||
149197700|NCT02883049|538193043|FG005|Induction|Identified as HR patients|0|||
149197701|NCT02883049|538193044|FG006|Induction|Identified as HR patients|0|||
149197702|NCT02883049|538193045|FG007|Induction|Identified as HR patients|0|||
149197703|NCT02883049|538193046|FG008|Induction|Identified as HR patients|0|||
149197704|NCT02883049|538193047|FG009|Induction|Identified as HR patients|0|||
149197705|NCT02883049|538193048|FG010|Induction|Identified as HR patients|0|||
149197706|NCT02883049|538193049|FG011|Induction|Identified as HR patients|0|||
149197707|NCT02883049|538193050|FG012|Induction|Identified as HR patients|0|||
149197708|NCT02883049|538193051|FG013|Induction|Identified as HR patients|0|||
149197709|NCT02883049|538193052|FG014|Induction|Identified as HR patients|0|||
149197710|NCT02883049|538193053|FG015|Induction|Identified as HR patients|0|||
149197711|NCT02883049|538193038|FG000|Induction|Developed SMN|0|||
149197712|NCT02883049|538193039|FG001|Induction|Developed SMN|1|||
149197713|NCT02883049|538193040|FG002|Induction|Developed SMN|0|||
149197714|NCT02883049|538193041|FG003|Induction|Developed SMN|0|||
149197715|NCT02883049|538193042|FG004|Induction|Developed SMN|0|||
149197716|NCT02883049|538193043|FG005|Induction|Developed SMN|0|||
149197717|NCT02883049|538193044|FG006|Induction|Developed SMN|0|||
149197718|NCT02883049|538193045|FG007|Induction|Developed SMN|0|||
148942996|NCT02732119|537275632|FG003|Phase II|Death|1|||
149197719|NCT02883049|538193046|FG008|Induction|Developed SMN|0|||
149197720|NCT02883049|538193047|FG009|Induction|Developed SMN|0|||
149197721|NCT02883049|538193048|FG010|Induction|Developed SMN|0|||
149197722|NCT02883049|538193049|FG011|Induction|Developed SMN|0|||
149197723|NCT02883049|538193050|FG012|Induction|Developed SMN|0|||
149197724|NCT02883049|538193051|FG013|Induction|Developed SMN|0|||
149197725|NCT02883049|538193052|FG014|Induction|Developed SMN|0|||
149197726|NCT02883049|538193053|FG015|Induction|Developed SMN|0|||
149197727|NCT02883049|538193038|FG000|Induction|Enrolled onto another COG study|72|||
149197728|NCT02883049|538193039|FG001|Induction|Enrolled onto another COG study|0|||
149197729|NCT02883049|538193040|FG002|Induction|Enrolled onto another COG study|0|||
149197730|NCT02883049|538193041|FG003|Induction|Enrolled onto another COG study|0|||
149197731|NCT02883049|538193042|FG004|Induction|Enrolled onto another COG study|0|||
149197732|NCT02883049|538193043|FG005|Induction|Enrolled onto another COG study|0|||
149197733|NCT02883049|538193044|FG006|Induction|Enrolled onto another COG study|0|||
149197734|NCT02883049|538193045|FG007|Induction|Enrolled onto another COG study|0|||
149197735|NCT02883049|538193046|FG008|Induction|Enrolled onto another COG study|0|||
149197736|NCT02883049|538193047|FG009|Induction|Enrolled onto another COG study|0|||
149197737|NCT02883049|538193048|FG010|Induction|Enrolled onto another COG study|0|||
149197738|NCT02883049|538193049|FG011|Induction|Enrolled onto another COG study|0|||
149197739|NCT02883049|538193050|FG012|Induction|Enrolled onto another COG study|0|||
149197740|NCT02883049|538193051|FG013|Induction|Enrolled onto another COG study|0|||
149197741|NCT02883049|538193052|FG014|Induction|Enrolled onto another COG study|0|||
149197742|NCT02883049|538193053|FG015|Induction|Enrolled onto another COG study|0|||
149197743|NCT02883049|538193038|FG000|Induction|Incomplete induction data|17|||
149197744|NCT02883049|538193039|FG001|Induction|Incomplete induction data|0|||
149197745|NCT02883049|538193040|FG002|Induction|Incomplete induction data|0|||
149197746|NCT02883049|538193041|FG003|Induction|Incomplete induction data|0|||
149197747|NCT02883049|538193042|FG004|Induction|Incomplete induction data|0|||
149197748|NCT02883049|538193043|FG005|Induction|Incomplete induction data|0|||
149197749|NCT02883049|538193044|FG006|Induction|Incomplete induction data|0|||
149197750|NCT02883049|538193045|FG007|Induction|Incomplete induction data|0|||
149197751|NCT02883049|538193046|FG008|Induction|Incomplete induction data|0|||
149197752|NCT02883049|538193047|FG009|Induction|Incomplete induction data|0|||
149197753|NCT02883049|538193048|FG010|Induction|Incomplete induction data|0|||
149197754|NCT02883049|538193049|FG011|Induction|Incomplete induction data|0|||
149197755|NCT02883049|538193050|FG012|Induction|Incomplete induction data|0|||
149197756|NCT02883049|538193051|FG013|Induction|Incomplete induction data|0|||
148808463|NCT03836053|536777503|FG002|Overall Study|Protocol-specified criteria|1|||
148808464|NCT03836053|536777501|FG000|Overall Study|Death|1|||
148808465|NCT03836053|536777502|FG001|Overall Study|Death|6|||
148808466|NCT03836053|536777503|FG002|Overall Study|Death|4|||
148942997|NCT02732119|537275633|FG004|Phase II|Death|0|||
148942998|NCT02732119|537275629|FG000|Phase II|Progressive dissease|0|||
149197757|NCT02883049|538193052|FG014|Induction|Incomplete induction data|0|||
149197758|NCT02883049|538193053|FG015|Induction|Incomplete induction data|0|||
149197759|NCT02883049|538193038|FG000|Post Induction|Adverse Event|0|||
149197760|NCT02883049|538193039|FG001|Post Induction|Adverse Event|0|||
149197761|NCT02883049|538193040|FG002|Post Induction|Adverse Event|0|||
149197762|NCT02883049|538193041|FG003|Post Induction|Adverse Event|7|||
149197763|NCT02883049|538193042|FG004|Post Induction|Adverse Event|8|||
149197764|NCT02883049|538193043|FG005|Post Induction|Adverse Event|3|||
148942999|NCT02732119|537275630|FG001|Phase II|Progressive dissease|0|||
148943000|NCT02732119|537275631|FG002|Phase II|Progressive dissease|0|||
149197765|NCT02883049|538193044|FG006|Post Induction|Adverse Event|4|||
149197766|NCT02883049|538193045|FG007|Post Induction|Adverse Event|5|||
149197767|NCT02883049|538193046|FG008|Post Induction|Adverse Event|6|||
149197768|NCT02883049|538193047|FG009|Post Induction|Adverse Event|7|||
149197769|NCT02883049|538193048|FG010|Post Induction|Adverse Event|2|||
149197770|NCT02883049|538193049|FG011|Post Induction|Adverse Event|2|||
149197771|NCT02883049|538193050|FG012|Post Induction|Adverse Event|0|||
149197772|NCT02883049|538193051|FG013|Post Induction|Adverse Event|0|||
149197773|NCT02883049|538193052|FG014|Post Induction|Adverse Event|5|||
149197774|NCT02883049|538193053|FG015|Post Induction|Adverse Event|2|||
149197775|NCT02883049|538193038|FG000|Post Induction|Death|0|||
149197776|NCT02883049|538193039|FG001|Post Induction|Death|0|||
149197777|NCT02883049|538193040|FG002|Post Induction|Death|0|||
149197778|NCT02883049|538193041|FG003|Post Induction|Death|9|||
149197779|NCT02883049|538193042|FG004|Post Induction|Death|9|||
149197780|NCT02883049|538193043|FG005|Post Induction|Death|0|||
149197781|NCT02883049|538193044|FG006|Post Induction|Death|1|||
149197782|NCT02883049|538193045|FG007|Post Induction|Death|6|||
149197783|NCT02883049|538193046|FG008|Post Induction|Death|5|||
149197784|NCT02883049|538193047|FG009|Post Induction|Death|3|||
149197785|NCT02883049|538193048|FG010|Post Induction|Death|1|||
149197786|NCT02883049|538193049|FG011|Post Induction|Death|0|||
149197787|NCT02883049|538193050|FG012|Post Induction|Death|1|||
149197788|NCT02883049|538193051|FG013|Post Induction|Death|1|||
149197789|NCT02883049|538193052|FG014|Post Induction|Death|10|||
149197790|NCT02883049|538193053|FG015|Post Induction|Death|2|||
149197791|NCT02883049|538193038|FG000|Post Induction|Lost to Follow-up|0|||
149197792|NCT02883049|538193039|FG001|Post Induction|Lost to Follow-up|0|||
148943001|NCT02732119|537275632|FG003|Phase II|Progressive dissease|30|||
148943002|NCT02732119|537275633|FG004|Phase II|Progressive dissease|23|||
149197793|NCT02883049|538193040|FG002|Post Induction|Lost to Follow-up|0|||
149197794|NCT02883049|538193041|FG003|Post Induction|Lost to Follow-up|0|||
149197795|NCT02883049|538193042|FG004|Post Induction|Lost to Follow-up|1|||
149197796|NCT02883049|538193043|FG005|Post Induction|Lost to Follow-up|1|||
149197797|NCT02883049|538193044|FG006|Post Induction|Lost to Follow-up|0|||
149197798|NCT02883049|538193045|FG007|Post Induction|Lost to Follow-up|0|||
149197799|NCT02883049|538193046|FG008|Post Induction|Lost to Follow-up|3|||
149197800|NCT02883049|538193047|FG009|Post Induction|Lost to Follow-up|0|||
149197801|NCT02883049|538193048|FG010|Post Induction|Lost to Follow-up|1|||
149197802|NCT02883049|538193049|FG011|Post Induction|Lost to Follow-up|0|||
149197803|NCT02883049|538193050|FG012|Post Induction|Lost to Follow-up|0|||
149197804|NCT02883049|538193051|FG013|Post Induction|Lost to Follow-up|0|||
149197805|NCT02883049|538193052|FG014|Post Induction|Lost to Follow-up|0|||
149197806|NCT02883049|538193053|FG015|Post Induction|Lost to Follow-up|0|||
149197807|NCT02883049|538193038|FG000|Post Induction|Physician Decision|0|||
149197808|NCT02883049|538193039|FG001|Post Induction|Physician Decision|0|||
149197809|NCT02883049|538193040|FG002|Post Induction|Physician Decision|0|||
149197810|NCT02883049|538193041|FG003|Post Induction|Physician Decision|27|||
148943003|NCT02732119|537275629|FG000|Phase II|Study terminated by sponsor|0|||
149197811|NCT02883049|538193042|FG004|Post Induction|Physician Decision|27|||
149197812|NCT02883049|538193043|FG005|Post Induction|Physician Decision|23|||
149197813|NCT02883049|538193044|FG006|Post Induction|Physician Decision|30|||
149197814|NCT02883049|538193045|FG007|Post Induction|Physician Decision|56|||
149197815|NCT02883049|538193046|FG008|Post Induction|Physician Decision|85|||
149197816|NCT02883049|538193047|FG009|Post Induction|Physician Decision|12|||
149197817|NCT02883049|538193048|FG010|Post Induction|Physician Decision|5|||
149197818|NCT02883049|538193049|FG011|Post Induction|Physician Decision|14|||
149197819|NCT02883049|538193050|FG012|Post Induction|Physician Decision|1|||
148943004|NCT02732119|537275630|FG001|Phase II|Study terminated by sponsor|0|||
149197820|NCT02883049|538193051|FG013|Post Induction|Physician Decision|11|||
149197821|NCT02883049|538193052|FG014|Post Induction|Physician Decision|19|||
149197822|NCT02883049|538193053|FG015|Post Induction|Physician Decision|5|||
148943005|NCT02732119|537275631|FG002|Phase II|Study terminated by sponsor|0|||
148943006|NCT02732119|537275632|FG003|Phase II|Study terminated by sponsor|2|||
149197823|NCT02883049|538193038|FG000|Post Induction|Protocol Violation|0|||
149197824|NCT02883049|538193039|FG001|Post Induction|Protocol Violation|0|||
149197825|NCT02883049|538193040|FG002|Post Induction|Protocol Violation|0|||
149197826|NCT02883049|538193041|FG003|Post Induction|Protocol Violation|0|||
149197827|NCT02883049|538193042|FG004|Post Induction|Protocol Violation|0|||
149197828|NCT02883049|538193043|FG005|Post Induction|Protocol Violation|0|||
149197829|NCT02883049|538193044|FG006|Post Induction|Protocol Violation|0|||
149197830|NCT02883049|538193045|FG007|Post Induction|Protocol Violation|1|||
149197831|NCT02883049|538193046|FG008|Post Induction|Protocol Violation|0|||
149197832|NCT02883049|538193047|FG009|Post Induction|Protocol Violation|0|||
149197833|NCT02883049|538193048|FG010|Post Induction|Protocol Violation|0|||
149197834|NCT02883049|538193049|FG011|Post Induction|Protocol Violation|0|||
149197835|NCT02883049|538193050|FG012|Post Induction|Protocol Violation|0|||
149197836|NCT02883049|538193051|FG013|Post Induction|Protocol Violation|0|||
149197837|NCT02883049|538193052|FG014|Post Induction|Protocol Violation|0|||
149197838|NCT02883049|538193053|FG015|Post Induction|Protocol Violation|0|||
149197839|NCT02883049|538193038|FG000|Post Induction|Withdrawal by Subject|0|||
149197840|NCT02883049|538193039|FG001|Post Induction|Withdrawal by Subject|0|||
149197841|NCT02883049|538193040|FG002|Post Induction|Withdrawal by Subject|0|||
149197842|NCT02883049|538193041|FG003|Post Induction|Withdrawal by Subject|5|||
149197843|NCT02883049|538193042|FG004|Post Induction|Withdrawal by Subject|2|||
149197844|NCT02883049|538193043|FG005|Post Induction|Withdrawal by Subject|1|||
149197845|NCT02883049|538193044|FG006|Post Induction|Withdrawal by Subject|0|||
149197846|NCT02883049|538193045|FG007|Post Induction|Withdrawal by Subject|0|||
149197847|NCT02883049|538193046|FG008|Post Induction|Withdrawal by Subject|2|||
149197848|NCT02883049|538193047|FG009|Post Induction|Withdrawal by Subject|0|||
149197849|NCT02883049|538193048|FG010|Post Induction|Withdrawal by Subject|1|||
149197850|NCT02883049|538193049|FG011|Post Induction|Withdrawal by Subject|1|||
149197851|NCT02883049|538193050|FG012|Post Induction|Withdrawal by Subject|0|||
149197852|NCT02883049|538193051|FG013|Post Induction|Withdrawal by Subject|0|||
149197853|NCT02883049|538193052|FG014|Post Induction|Withdrawal by Subject|1|||
149197854|NCT02883049|538193053|FG015|Post Induction|Withdrawal by Subject|0|||
149197855|NCT02883049|538193038|FG000|Post Induction|Ineligible|0|||
149197856|NCT02883049|538193039|FG001|Post Induction|Ineligible|0|||
149197857|NCT02883049|538193040|FG002|Post Induction|Ineligible|2|||
149197858|NCT02883049|538193041|FG003|Post Induction|Ineligible|0|||
149197859|NCT02883049|538193042|FG004|Post Induction|Ineligible|0|||
149197860|NCT02883049|538193043|FG005|Post Induction|Ineligible|0|||
149197861|NCT02883049|538193044|FG006|Post Induction|Ineligible|1|||
149197862|NCT02883049|538193045|FG007|Post Induction|Ineligible|0|||
149197863|NCT02883049|538193046|FG008|Post Induction|Ineligible|0|||
149197864|NCT02883049|538193047|FG009|Post Induction|Ineligible|0|||
149197865|NCT02883049|538193048|FG010|Post Induction|Ineligible|1|||
149197866|NCT02883049|538193049|FG011|Post Induction|Ineligible|0|||
149197867|NCT02883049|538193050|FG012|Post Induction|Ineligible|0|||
149197868|NCT02883049|538193051|FG013|Post Induction|Ineligible|0|||
149197869|NCT02883049|538193052|FG014|Post Induction|Ineligible|0|||
149197870|NCT02883049|538193053|FG015|Post Induction|Ineligible|1|||
149197871|NCT02883049|538193038|FG000|Post Induction|Refusal of further protocol therapy|0|||
149197872|NCT02883049|538193039|FG001|Post Induction|Refusal of further protocol therapy|0|||
149197873|NCT02883049|538193040|FG002|Post Induction|Refusal of further protocol therapy|0|||
149197874|NCT02883049|538193041|FG003|Post Induction|Refusal of further protocol therapy|11|||
149197875|NCT02883049|538193042|FG004|Post Induction|Refusal of further protocol therapy|15|||
149197876|NCT02883049|538193043|FG005|Post Induction|Refusal of further protocol therapy|9|||
149197877|NCT02883049|538193044|FG006|Post Induction|Refusal of further protocol therapy|13|||
149197878|NCT02883049|538193045|FG007|Post Induction|Refusal of further protocol therapy|5|||
149197879|NCT02883049|538193046|FG008|Post Induction|Refusal of further protocol therapy|21|||
149197880|NCT02883049|538193047|FG009|Post Induction|Refusal of further protocol therapy|7|||
149197881|NCT02883049|538193048|FG010|Post Induction|Refusal of further protocol therapy|0|||
149197882|NCT02883049|538193049|FG011|Post Induction|Refusal of further protocol therapy|7|||
149197883|NCT02883049|538193050|FG012|Post Induction|Refusal of further protocol therapy|3|||
149197884|NCT02883049|538193051|FG013|Post Induction|Refusal of further protocol therapy|0|||
149197885|NCT02883049|538193052|FG014|Post Induction|Refusal of further protocol therapy|4|||
149197886|NCT02883049|538193053|FG015|Post Induction|Refusal of further protocol therapy|1|||
149197887|NCT02883049|538193038|FG000|Post Induction|Inevaluable|0|||
149197888|NCT02883049|538193039|FG001|Post Induction|Inevaluable|0|||
149197889|NCT02883049|538193040|FG002|Post Induction|Inevaluable|0|||
149197890|NCT02883049|538193041|FG003|Post Induction|Inevaluable|1|||
149197891|NCT02883049|538193042|FG004|Post Induction|Inevaluable|1|||
149197892|NCT02883049|538193043|FG005|Post Induction|Inevaluable|2|||
149197893|NCT02883049|538193044|FG006|Post Induction|Inevaluable|7|||
149197894|NCT02883049|538193045|FG007|Post Induction|Inevaluable|6|||
149197895|NCT02883049|538193046|FG008|Post Induction|Inevaluable|4|||
149197896|NCT02883049|538193047|FG009|Post Induction|Inevaluable|4|||
148943007|NCT02732119|537275633|FG004|Phase II|Study terminated by sponsor|2|||
148943008|NCT02732119|537275629|FG000|Phase II|Other|0|||
148943009|NCT02732119|537275630|FG001|Phase II|Other|0|||
148943010|NCT02732119|537275631|FG002|Phase II|Other|0|||
149197897|NCT02883049|538193048|FG010|Post Induction|Inevaluable|1|||
149197898|NCT02883049|538193049|FG011|Post Induction|Inevaluable|1|||
149197899|NCT02883049|538193050|FG012|Post Induction|Inevaluable|2|||
149197900|NCT02883049|538193051|FG013|Post Induction|Inevaluable|0|||
149197901|NCT02883049|538193052|FG014|Post Induction|Inevaluable|0|||
149197902|NCT02883049|538193053|FG015|Post Induction|Inevaluable|1|||
148943011|NCT02732119|537275632|FG003|Phase II|Other|2|||
149197903|NCT02883049|538193038|FG000|Post Induction|Moved to another non-COG institution|0|||
149197904|NCT02883049|538193039|FG001|Post Induction|Moved to another non-COG institution|0|||
148943012|NCT02732119|537275633|FG004|Phase II|Other|0|||
149197905|NCT02883049|538193040|FG002|Post Induction|Moved to another non-COG institution|0|||
149197906|NCT02883049|538193041|FG003|Post Induction|Moved to another non-COG institution|0|||
149197907|NCT02883049|538193042|FG004|Post Induction|Moved to another non-COG institution|0|||
149197908|NCT02883049|538193043|FG005|Post Induction|Moved to another non-COG institution|0|||
149197909|NCT02883049|538193044|FG006|Post Induction|Moved to another non-COG institution|0|||
149197910|NCT02883049|538193045|FG007|Post Induction|Moved to another non-COG institution|2|||
149197911|NCT02883049|538193046|FG008|Post Induction|Moved to another non-COG institution|2|||
149197912|NCT02883049|538193047|FG009|Post Induction|Moved to another non-COG institution|0|||
149197913|NCT02883049|538193048|FG010|Post Induction|Moved to another non-COG institution|0|||
149197914|NCT02883049|538193049|FG011|Post Induction|Moved to another non-COG institution|1|||
149197915|NCT02883049|538193050|FG012|Post Induction|Moved to another non-COG institution|0|||
149197916|NCT02883049|538193051|FG013|Post Induction|Moved to another non-COG institution|0|||
149197917|NCT02883049|538193052|FG014|Post Induction|Moved to another non-COG institution|0|||
149197918|NCT02883049|538193053|FG015|Post Induction|Moved to another non-COG institution|0|||
149197919|NCT02883049|538193038|FG000|Post Induction|Randomization closed|0|||
149197920|NCT02883049|538193039|FG001|Post Induction|Randomization closed|0|||
149197921|NCT02883049|538193040|FG002|Post Induction|Randomization closed|0|||
149197922|NCT02883049|538193041|FG003|Post Induction|Randomization closed|0|||
149197923|NCT02883049|538193042|FG004|Post Induction|Randomization closed|0|||
149197924|NCT02883049|538193043|FG005|Post Induction|Randomization closed|0|||
149197925|NCT02883049|538193044|FG006|Post Induction|Randomization closed|0|||
149197926|NCT02883049|538193045|FG007|Post Induction|Randomization closed|20|||
149197927|NCT02883049|538193046|FG008|Post Induction|Randomization closed|0|||
149197928|NCT02883049|538193047|FG009|Post Induction|Randomization closed|0|||
149197929|NCT02883049|538193048|FG010|Post Induction|Randomization closed|0|||
149197930|NCT02883049|538193049|FG011|Post Induction|Randomization closed|0|||
149197931|NCT02883049|538193050|FG012|Post Induction|Randomization closed|0|||
149197932|NCT02883049|538193051|FG013|Post Induction|Randomization closed|0|||
149197933|NCT02883049|538193052|FG014|Post Induction|Randomization closed|0|||
149197934|NCT02883049|538193053|FG015|Post Induction|Randomization closed|0|||
149197935|NCT02883049|538193038|FG000|Post Induction|MRD negative|0|||
149197936|NCT02883049|538193039|FG001|Post Induction|MRD negative|0|||
149197937|NCT02883049|538193040|FG002|Post Induction|MRD negative|0|||
149197938|NCT02883049|538193041|FG003|Post Induction|MRD negative|0|||
149197939|NCT02883049|538193042|FG004|Post Induction|MRD negative|0|||
149197940|NCT02883049|538193043|FG005|Post Induction|MRD negative|0|||
149197941|NCT02883049|538193044|FG006|Post Induction|MRD negative|0|||
149197942|NCT02883049|538193045|FG007|Post Induction|MRD negative|11|||
149197943|NCT02883049|538193046|FG008|Post Induction|MRD negative|0|||
149197944|NCT02883049|538193047|FG009|Post Induction|MRD negative|0|||
149197945|NCT02883049|538193048|FG010|Post Induction|MRD negative|0|||
149197946|NCT02883049|538193049|FG011|Post Induction|MRD negative|0|||
149197947|NCT02883049|538193050|FG012|Post Induction|MRD negative|0|||
149197948|NCT02883049|538193051|FG013|Post Induction|MRD negative|0|||
149197949|NCT02883049|538193052|FG014|Post Induction|MRD negative|0|||
149197950|NCT02883049|538193053|FG015|Post Induction|MRD negative|0|||
149197951|NCT02883049|538193038|FG000|Post Induction|Developed SMN|0|||
149197952|NCT02883049|538193039|FG001|Post Induction|Developed SMN|0|||
149197953|NCT02883049|538193040|FG002|Post Induction|Developed SMN|0|||
149197954|NCT02883049|538193041|FG003|Post Induction|Developed SMN|0|||
149197955|NCT02883049|538193042|FG004|Post Induction|Developed SMN|1|||
149197956|NCT02883049|538193043|FG005|Post Induction|Developed SMN|0|||
149197957|NCT02883049|538193044|FG006|Post Induction|Developed SMN|1|||
149197958|NCT02883049|538193045|FG007|Post Induction|Developed SMN|0|||
149197959|NCT02883049|538193046|FG008|Post Induction|Developed SMN|0|||
149197960|NCT02883049|538193047|FG009|Post Induction|Developed SMN|0|||
149197961|NCT02883049|538193048|FG010|Post Induction|Developed SMN|1|||
149197962|NCT02883049|538193049|FG011|Post Induction|Developed SMN|1|||
149197963|NCT02883049|538193050|FG012|Post Induction|Developed SMN|0|||
149197964|NCT02883049|538193051|FG013|Post Induction|Developed SMN|0|||
149197965|NCT02883049|538193052|FG014|Post Induction|Developed SMN|1|||
149197966|NCT02883049|538193053|FG015|Post Induction|Developed SMN|0|||
149197967|NCT02883049|538193038|FG000|Post Induction|Enrolled onto another COG study|0|||
149197968|NCT02883049|538193039|FG001|Post Induction|Enrolled onto another COG study|0|||
149197969|NCT02883049|538193040|FG002|Post Induction|Enrolled onto another COG study|0|||
149197970|NCT02883049|538193041|FG003|Post Induction|Enrolled onto another COG study|1|||
149197971|NCT02883049|538193042|FG004|Post Induction|Enrolled onto another COG study|1|||
149197972|NCT02883049|538193043|FG005|Post Induction|Enrolled onto another COG study|0|||
149197973|NCT02883049|538193044|FG006|Post Induction|Enrolled onto another COG study|0|||
149197974|NCT02883049|538193045|FG007|Post Induction|Enrolled onto another COG study|4|||
149197975|NCT02883049|538193046|FG008|Post Induction|Enrolled onto another COG study|0|||
149197976|NCT02883049|538193047|FG009|Post Induction|Enrolled onto another COG study|0|||
149197977|NCT02883049|538193048|FG010|Post Induction|Enrolled onto another COG study|0|||
149197978|NCT02883049|538193049|FG011|Post Induction|Enrolled onto another COG study|2|||
149197979|NCT02883049|538193050|FG012|Post Induction|Enrolled onto another COG study|0|||
149197980|NCT02883049|538193051|FG013|Post Induction|Enrolled onto another COG study|1|||
149197981|NCT02883049|538193052|FG014|Post Induction|Enrolled onto another COG study|0|||
149197982|NCT02883049|538193053|FG015|Post Induction|Enrolled onto another COG study|0|||
149197983|NCT02883049|538193038|FG000|Post Induction|Recurrent leukemia|0|||
149197984|NCT02883049|538193039|FG001|Post Induction|Recurrent leukemia|0|||
149197985|NCT02883049|538193040|FG002|Post Induction|Recurrent leukemia|0|||
149197986|NCT02883049|538193041|FG003|Post Induction|Recurrent leukemia|17|||
149197987|NCT02883049|538193042|FG004|Post Induction|Recurrent leukemia|12|||
149197988|NCT02883049|538193043|FG005|Post Induction|Recurrent leukemia|4|||
149197989|NCT02883049|538193044|FG006|Post Induction|Recurrent leukemia|1|||
149197990|NCT02883049|538193045|FG007|Post Induction|Recurrent leukemia|13|||
149197991|NCT02883049|538193046|FG008|Post Induction|Recurrent leukemia|27|||
149197992|NCT02883049|538193047|FG009|Post Induction|Recurrent leukemia|5|||
149197993|NCT02883049|538193048|FG010|Post Induction|Recurrent leukemia|3|||
149197994|NCT02883049|538193049|FG011|Post Induction|Recurrent leukemia|12|||
149197995|NCT02883049|538193050|FG012|Post Induction|Recurrent leukemia|1|||
149197996|NCT02883049|538193051|FG013|Post Induction|Recurrent leukemia|1|||
149197997|NCT02883049|538193052|FG014|Post Induction|Recurrent leukemia|9|||
149197998|NCT02883049|538193053|FG015|Post Induction|Recurrent leukemia|3|||
149197999|NCT02883049|538193038|FG000|Post Induction|Induction Failure|0|||
149198000|NCT02883049|538193039|FG001|Post Induction|Induction Failure|0|||
149198001|NCT02883049|538193040|FG002|Post Induction|Induction Failure|0|||
149198002|NCT02883049|538193041|FG003|Post Induction|Induction Failure|0|||
149198003|NCT02883049|538193042|FG004|Post Induction|Induction Failure|0|||
149198004|NCT02883049|538193043|FG005|Post Induction|Induction Failure|0|||
149198005|NCT02883049|538193044|FG006|Post Induction|Induction Failure|0|||
149198006|NCT02883049|538193045|FG007|Post Induction|Induction Failure|2|||
149198007|NCT02883049|538193046|FG008|Post Induction|Induction Failure|2|||
149198008|NCT02883049|538193047|FG009|Post Induction|Induction Failure|0|||
149198009|NCT02883049|538193048|FG010|Post Induction|Induction Failure|0|||
149198010|NCT02883049|538193049|FG011|Post Induction|Induction Failure|0|||
149198011|NCT02883049|538193050|FG012|Post Induction|Induction Failure|0|||
149198012|NCT02883049|538193051|FG013|Post Induction|Induction Failure|2|||
149198013|NCT02883049|538193052|FG014|Post Induction|Induction Failure|0|||
149198014|NCT02883049|538193053|FG015|Post Induction|Induction Failure|0|||
149198015|NCT00229203|538193054|FG000|Overall Study|Progressive disease|18|||
149198016|NCT00229203|538193055|FG001|Overall Study|Progressive disease|9|||
149198017|NCT00229203|538193054|FG000|Overall Study|Toxicity|6|||
149198018|NCT00229203|538193055|FG001|Overall Study|Toxicity|1|||
149198019|NCT00229203|538193054|FG000|Overall Study|Death|4|||
149198020|NCT00229203|538193055|FG001|Overall Study|Death|2|||
149198021|NCT00229203|538193054|FG000|Overall Study|Other|3|||
149198022|NCT00229203|538193055|FG001|Overall Study|Other|3|||
149198023|NCT00229203|538193054|FG000|Overall Study|Withdrawal by Subject|1|||
149198024|NCT00229203|538193055|FG001|Overall Study|Withdrawal by Subject|4|||
149198025|NCT03457103|538193056|FG000|Overall Study|illness/hospitalization|4|||
149198026|NCT03457103|538193057|FG001|Overall Study|illness/hospitalization|2|||
149198027|NCT03457103|538193056|FG000|Overall Study|Lost to Follow-up|2|||
149198028|NCT03457103|538193057|FG001|Overall Study|Lost to Follow-up|1|||
149198029|NCT03457103|538193056|FG000|Overall Study|Withdrawal by Subject|1|||
149198030|NCT03457103|538193057|FG001|Overall Study|Withdrawal by Subject|2|||
149198031|NCT03457103|538193056|FG000|Overall Study|financial/ insurance issues|1|||
149198032|NCT03457103|538193057|FG001|Overall Study|financial/ insurance issues|1|||
149198033|NCT03004469|538193058|FG000|Overall Study|Adverse Event|6|||
149198034|NCT03004469|538193059|FG001|Overall Study|Adverse Event|4|||
149198035|NCT03004469|538193060|FG002|Overall Study|Adverse Event|6|||
149198036|NCT03004469|538193058|FG000|Overall Study|Lack of Efficacy|1|||
149198037|NCT03004469|538193059|FG001|Overall Study|Lack of Efficacy|0|||
149198038|NCT03004469|538193060|FG002|Overall Study|Lack of Efficacy|1|||
149198039|NCT03004469|538193058|FG000|Overall Study|Lost to Follow-up|23|||
149198040|NCT03004469|538193059|FG001|Overall Study|Lost to Follow-up|14|||
148943013|NCT02732119|537275629|FG000|Phase II|Physician Decision|0|||
149198041|NCT03004469|538193060|FG002|Overall Study|Lost to Follow-up|6|||
149198042|NCT03004469|538193058|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149198043|NCT03004469|538193059|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149198044|NCT03004469|538193060|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149198045|NCT03004469|538193058|FG000|Overall Study|Protocol Violation|0|||
149198046|NCT03004469|538193059|FG001|Overall Study|Protocol Violation|0|||
149198047|NCT03004469|538193060|FG002|Overall Study|Protocol Violation|1|||
149198048|NCT03004469|538193058|FG000|Overall Study|Withdrawal by Subject|29|||
149198049|NCT03004469|538193059|FG001|Overall Study|Withdrawal by Subject|27|||
149198050|NCT03004469|538193060|FG002|Overall Study|Withdrawal by Subject|10|||
149198051|NCT03004469|538193058|FG000|Overall Study|Other unspecified reason|0|||
149015991|NCT01091428|537537798|FG001|Phase 2|Physician Decision|0|||
149015992|NCT01091428|537537799|FG002|Phase 2|Physician Decision|2|||
149015993|NCT01091428|537537800|FG003|Phase 2|Physician Decision|0|||
149015994|NCT06017999|537537807|FG000|Overall Study|Withdrawal by Subject|0|||
149015995|NCT06017999|537537808|FG001|Overall Study|Withdrawal by Subject|4|||
149015996|NCT06017999|537537809|FG002|Overall Study|Withdrawal by Subject|3|||
149015997|NCT06017999|537537807|FG000|Overall Study|Adverse Event|2|||
149015998|NCT06017999|537537808|FG001|Overall Study|Adverse Event|1|||
149015999|NCT06017999|537537809|FG002|Overall Study|Adverse Event|1|||
149016000|NCT06017999|537537807|FG000|Overall Study|Lost to Follow-up|0|||
149016001|NCT06017999|537537808|FG001|Overall Study|Lost to Follow-up|0|||
149016002|NCT06017999|537537809|FG002|Overall Study|Lost to Follow-up|1|||
149016003|NCT06017999|537537807|FG000|Overall Study|Physician Decision|1|||
149016004|NCT06017999|537537808|FG001|Overall Study|Physician Decision|1|||
149016005|NCT06017999|537537809|FG002|Overall Study|Physician Decision|0|||
149016006|NCT06017999|537537807|FG000|Overall Study|Non-Compliance|0|||
149016007|NCT06017999|537537808|FG001|Overall Study|Non-Compliance|0|||
149016008|NCT06017999|537537809|FG002|Overall Study|Non-Compliance|1|||
149016009|NCT06017999|537537807|FG000|Overall Study|Lack of Efficacy|1|||
149016010|NCT06017999|537537808|FG001|Overall Study|Lack of Efficacy|0|||
149016011|NCT06017999|537537809|FG002|Overall Study|Lack of Efficacy|7|||
149016012|NCT06017999|537537807|FG000|Overall Study|COVID Positive|0|||
149198052|NCT03004469|538193059|FG001|Overall Study|Other unspecified reason|4|||
149198053|NCT03004469|538193060|FG002|Overall Study|Other unspecified reason|1|||
149198054|NCT01163253|538193061|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
149198055|NCT01163253|538193062|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
149198056|NCT01163253|538193061|FG000|Overall Study|Study Terminated by Sponsor|978|||
149198057|NCT01163253|538193062|FG001|Overall Study|Study Terminated by Sponsor|349|||
149198058|NCT01163253|538193061|FG000|Overall Study|Protocol Violation|43|||
149198059|NCT01163253|538193062|FG001|Overall Study|Protocol Violation|12|||
149198060|NCT01163253|538193061|FG000|Overall Study|Withdrawal by Subject|199|||
149198061|NCT01163253|538193062|FG001|Overall Study|Withdrawal by Subject|50|||
149198062|NCT01163253|538193061|FG000|Overall Study|Medication Error|1|||
149198063|NCT01163253|538193062|FG001|Overall Study|Medication Error|0|||
149198064|NCT01163253|538193061|FG000|Overall Study|Lost to Follow-up|125|||
149198065|NCT01163253|538193062|FG001|Overall Study|Lost to Follow-up|23|||
149198066|NCT01163253|538193061|FG000|Overall Study|Insufficient Clinical Response|423|||
149198067|NCT01163253|538193062|FG001|Overall Study|Insufficient Clinical Response|29|||
149198068|NCT01163253|538193061|FG000|Overall Study|Adverse Event|300|||
149198069|NCT01163253|538193062|FG001|Overall Study|Adverse Event|78|||
149198070|NCT01163253|538193061|FG000|Overall Study|Death|17|||
149198071|NCT01163253|538193062|FG001|Overall Study|Death|5|||
149198072|NCT01163253|538193061|FG000|Overall Study|Ongoing|13|||
149198073|NCT01163253|538193062|FG001|Overall Study|Ongoing|4|||
149016013|NCT06017999|537537808|FG001|Overall Study|COVID Positive|1|||
149198074|NCT01163253|538193061|FG000|Overall Study|Other Unspecified|170|||
149198075|NCT01163253|538193062|FG001|Overall Study|Other Unspecified|34|||
149198076|NCT02492997|538193063|FG000|Overall Study|Withdrawal by Subject|1|||
149016014|NCT06017999|537537809|FG002|Overall Study|COVID Positive|0|||
149016015|NCT06017999|537537807|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
149016016|NCT06017999|537537808|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
149016017|NCT06017999|537537809|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
149198077|NCT02492997|538193064|FG001|Overall Study|Withdrawal by Subject|0|||
148943014|NCT02732119|537275630|FG001|Phase II|Physician Decision|0|||
148943015|NCT02732119|537275631|FG002|Phase II|Physician Decision|0|||
148943016|NCT02732119|537275632|FG003|Phase II|Physician Decision|8|||
148943017|NCT02732119|537275633|FG004|Phase II|Physician Decision|5|||
148943018|NCT00964860|537275634|FG000|Overall Study|Withdrawal by Subject|0|||
148943019|NCT00964860|537275635|FG001|Overall Study|Withdrawal by Subject|1|||
148943020|NCT00867568|537275636|FG000|Overall Study|Lack of Efficacy|10|||
148943021|NCT00867568|537275636|FG000|Overall Study|Adverse Event|4|||
148943022|NCT00867568|537275636|FG000|Overall Study|Withdrawal by Subject|1|||
149198078|NCT02492997|538193063|FG000|Overall Study|Gained Weight|1|||
149198079|NCT02492997|538193064|FG001|Overall Study|Gained Weight|0|||
149198080|NCT02492997|538193063|FG000|Overall Study|Lost to Follow-up|0|||
149198081|NCT02492997|538193064|FG001|Overall Study|Lost to Follow-up|1|||
149198082|NCT01397552|538193065|FG000|Overall Study|Adverse Event|1|||
149198083|NCT01397552|538193066|FG001|Overall Study|Adverse Event|0|||
148943023|NCT03727230|537275638|FG000|Overall Study|Lost to Follow-up|12|||
149198084|NCT01397552|538193065|FG000|Overall Study|Withdrawal by Subject|2|||
149198085|NCT01397552|538193066|FG001|Overall Study|Withdrawal by Subject|1|||
149198086|NCT00579501|538193072|FG000|Overall Study|Death|1|||
149198087|NCT00579501|538193072|FG000|Overall Study|End of neoadjuvant therapy|25|||
149198088|NCT00579501|538193072|FG000|Overall Study|toxicity|1|||
149198089|NCT00579501|538193072|FG000|Overall Study|Secondary lesion|1|||
149198090|NCT00579501|538193072|FG000|Overall Study|Radiation therapy before surgery|1|||
149198091|NCT00190983|538193073|FG000|Overall Study|Inevaluable (never treated)|2|||
149198092|NCT02287402|538193074|FG000|Treatment Period|Adverse Event|17|||
149198093|NCT02287402|538193074|FG000|Treatment Period|Voluntary Withdrawal|10|||
149198094|NCT02287402|538193074|FG000|Follow-up|Lost to Follow-up|1|||
149198095|NCT02287402|538193074|FG000|Follow-up|Voluntary Withdrawal|2|||
149198096|NCT04069156|538193075|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
149198097|NCT04069156|538193076|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
148943024|NCT04377620|537275640|FG000|Overall Study|Death|42|||
148943025|NCT04377620|537275641|FG001|Overall Study|Death|48|||
148943026|NCT04377620|537275642|FG002|Overall Study|Death|36|||
148943027|NCT04377620|537275640|FG000|Overall Study|Withdrawal by Subject|0|||
148943028|NCT04377620|537275641|FG001|Overall Study|Withdrawal by Subject|2|||
148943029|NCT04377620|537275642|FG002|Overall Study|Withdrawal by Subject|0|||
148943030|NCT02059395|537275643|FG000|Overall Study|Lost to Follow-up|2|||
148943031|NCT02059395|537275644|FG001|Overall Study|Lost to Follow-up|4|||
148943032|NCT00134082|537275645|FG000|Overall Study|Adverse Event|2|||
148943033|NCT00134082|537275645|FG000|Overall Study|Death|1|||
148943034|NCT00724932|537275646|FG000|Overall Study|Lost to Follow-up|1|||
148943035|NCT00724932|537275647|FG001|Overall Study|Lost to Follow-up|0|||
148943036|NCT00724932|537275646|FG000|Overall Study|Not treated|4|||
148943037|NCT00724932|537275647|FG001|Overall Study|Not treated|3|||
148943038|NCT00289991|537275648|FG000|Overall Study|Death|35|||
148943039|NCT00289991|537275649|FG001|Overall Study|Death|38|||
148943040|NCT00289991|537275648|FG000|Overall Study|Adverse Event|15|||
148943041|NCT00289991|537275649|FG001|Overall Study|Adverse Event|13|||
148943042|NCT00289991|537275648|FG000|Overall Study|Failure of prophylaxis|1|||
148943043|NCT00289991|537275649|FG001|Overall Study|Failure of prophylaxis|1|||
148943044|NCT00289991|537275648|FG000|Overall Study|Fungal breakthrough infection|0|||
148943045|NCT00289991|537275649|FG001|Overall Study|Fungal breakthrough infection|1|||
148943046|NCT00289991|537275648|FG000|Overall Study|Lost to Follow-up|0|||
148943047|NCT00289991|537275649|FG001|Overall Study|Lost to Follow-up|1|||
148943048|NCT00289991|537275648|FG000|Overall Study|Withdrawal by Subject|2|||
148943049|NCT00289991|537275649|FG001|Overall Study|Withdrawal by Subject|12|||
148943050|NCT00289991|537275648|FG000|Overall Study|Other|5|||
148943051|NCT00289991|537275649|FG001|Overall Study|Other|14|||
148943052|NCT00444912|537275665|FG000|Overall Study|Death|1|||
148943053|NCT00444912|537275666|FG001|Overall Study|Death|2|||
148943054|NCT00444912|537275665|FG000|Overall Study|Lost to Follow-up|1|||
148943055|NCT00444912|537275666|FG001|Overall Study|Lost to Follow-up|0|||
148943056|NCT00444912|537275665|FG000|Overall Study|Participant Failed Mobilization|1|||
148943057|NCT00444912|537275666|FG001|Overall Study|Participant Failed Mobilization|0|||
149198098|NCT04069156|538193075|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
149198099|NCT04069156|538193076|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
149198100|NCT04069156|538193075|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
148943058|NCT01606007|537275667|FG000|Overall Study|Reason 'Other' in the protocol|0|||
148943059|NCT01606007|537275668|FG001|Overall Study|Reason 'Other' in the protocol|1|||
148943060|NCT01606007|537275669|FG002|Overall Study|Reason 'Other' in the protocol|1|||
148943061|NCT01606007|537275667|FG000|Overall Study|Pregnancy|0|||
148943062|NCT01606007|537275668|FG001|Overall Study|Pregnancy|1|||
148943063|NCT01606007|537275669|FG002|Overall Study|Pregnancy|1|||
148943064|NCT01606007|537275667|FG000|Overall Study|Withdrawal by Subject|8|||
148943065|NCT01606007|537275668|FG001|Overall Study|Withdrawal by Subject|6|||
148943066|NCT01606007|537275669|FG002|Overall Study|Withdrawal by Subject|1|||
149198101|NCT04069156|538193076|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
149198102|NCT04069156|538193075|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
149198103|NCT04069156|538193076|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
149198104|NCT04247815|538193077|FG000|Overall Study|Adverse Event|1|||
149198105|NCT04247815|538193078|FG001|Overall Study|Adverse Event|0|||
149198106|NCT04247815|538193077|FG000|Overall Study|Withdrawal by Subject|1|||
149198107|NCT04247815|538193078|FG001|Overall Study|Withdrawal by Subject|0|||
149198108|NCT04247815|538193077|FG000|Overall Study|Protocol Violation|0|||
149198109|NCT04247815|538193078|FG001|Overall Study|Protocol Violation|1|||
149198110|NCT00089479|538193087|FG000|Overall Study|Death|108|||
149198111|NCT00089479|538193088|FG001|Overall Study|Death|75|||
149198112|NCT00089479|538193087|FG000|Overall Study|Withdrawal by Subject|86|||
149198113|NCT00089479|538193088|FG001|Overall Study|Withdrawal by Subject|107|||
149198114|NCT00089479|538193087|FG000|Overall Study|Lost to Follow-up|137|||
149198115|NCT00089479|538193088|FG001|Overall Study|Lost to Follow-up|107|||
149198116|NCT03943953|538193089|FG000|Trial of ITG 1|Lost to Follow-up|19|||
149198117|NCT03943953|538193090|FG001|Trial of ITG 1|Lost to Follow-up|1|||
149198118|NCT03943953|538193089|FG000|Trial of ITG 2|Lost to Follow-up|8|||
149198119|NCT03943953|538193090|FG001|Trial of ITG 2|Lost to Follow-up|0|||
149198120|NCT03943953|538193089|FG000|Trial of ITG 3|Lost to Follow-up|2|||
149198121|NCT03943953|538193090|FG001|Trial of ITG 3|Lost to Follow-up|0|||
149198122|NCT03943953|538193089|FG000|Trial of ITG 4|Lost to Follow-up|2|||
149198123|NCT03943953|538193090|FG001|Trial of ITG 4|Lost to Follow-up|0|||
149198124|NCT00289185|538193093|FG000|Overall Study|Withdrawal by Subject|4|||
149198125|NCT00289185|538193094|FG001|Overall Study|Withdrawal by Subject|8|||
148943067|NCT01606007|537275667|FG000|Overall Study|Adverse Event|0|||
148943068|NCT01606007|537275668|FG001|Overall Study|Adverse Event|1|||
148943069|NCT01606007|537275669|FG002|Overall Study|Adverse Event|1|||
148943070|NCT01606007|537275667|FG000|Overall Study|discontinue study treatment|0|||
148943071|NCT01606007|537275668|FG001|Overall Study|discontinue study treatment|2|||
148943072|NCT01606007|537275669|FG002|Overall Study|discontinue study treatment|1|||
148943073|NCT01606007|537275667|FG000|Overall Study|Lost to Follow-up|6|||
148943074|NCT01606007|537275668|FG001|Overall Study|Lost to Follow-up|8|||
148943075|NCT01606007|537275669|FG002|Overall Study|Lost to Follow-up|5|||
148943076|NCT01606007|537275667|FG000|Overall Study|Poor/Non-compliance|1|||
148943077|NCT01606007|537275668|FG001|Overall Study|Poor/Non-compliance|0|||
148943078|NCT01606007|537275669|FG002|Overall Study|Poor/Non-compliance|0|||
148943079|NCT03758066|537275670|FG000|Overall Study|Lost to Follow-up|14|||
148943080|NCT02340975|537275673|FG000|Overall Study|Death|6|||
148943081|NCT02340975|537275674|FG001|Overall Study|Death|23|||
148943082|NCT02340975|537275675|FG002|Overall Study|Death|21|||
148943083|NCT02340975|537275676|FG003|Overall Study|Death|7|||
148943084|NCT02340975|537275677|FG004|Overall Study|Death|21|||
148943085|NCT02340975|537275678|FG005|Overall Study|Death|13|||
148943086|NCT02340975|537275673|FG000|Overall Study|Lost to Follow-up|0|||
148943087|NCT02340975|537275674|FG001|Overall Study|Lost to Follow-up|0|||
148943088|NCT02340975|537275675|FG002|Overall Study|Lost to Follow-up|0|||
148943089|NCT02340975|537275676|FG003|Overall Study|Lost to Follow-up|0|||
148943090|NCT02340975|537275677|FG004|Overall Study|Lost to Follow-up|2|||
148943091|NCT02340975|537275678|FG005|Overall Study|Lost to Follow-up|0|||
148943092|NCT02340975|537275673|FG000|Overall Study|Withdrawal by Subject|0|||
148943093|NCT02340975|537275674|FG001|Overall Study|Withdrawal by Subject|0|||
148943094|NCT02340975|537275675|FG002|Overall Study|Withdrawal by Subject|3|||
148943095|NCT02340975|537275676|FG003|Overall Study|Withdrawal by Subject|3|||
148943096|NCT02340975|537275677|FG004|Overall Study|Withdrawal by Subject|2|||
148943097|NCT02340975|537275678|FG005|Overall Study|Withdrawal by Subject|0|||
148943098|NCT02340975|537275673|FG000|Overall Study|Other|0|||
148943099|NCT02340975|537275674|FG001|Overall Study|Other|4|||
148943100|NCT02340975|537275675|FG002|Overall Study|Other|0|||
148943101|NCT02340975|537275676|FG003|Overall Study|Other|2|||
148943102|NCT02340975|537275677|FG004|Overall Study|Other|0|||
148943103|NCT02340975|537275678|FG005|Overall Study|Other|6|||
148943104|NCT01007812|537275679|FG000|Period 1, One Week|Lost to Follow-up|0|||
149198126|NCT00289185|538193093|FG000|Overall Study|Lost to Follow-up|23|||
149198127|NCT00289185|538193094|FG001|Overall Study|Lost to Follow-up|17|||
149198128|NCT00289185|538193093|FG000|Overall Study|Death|1|||
148943105|NCT01007812|537275680|FG001|Period 1, One Week|Lost to Follow-up|1|||
148943106|NCT01007812|537275679|FG000|Period 1, One Week|Discomfort|1|||
149198129|NCT00289185|538193094|FG001|Overall Study|Death|1|||
148943107|NCT01007812|537275680|FG001|Period 1, One Week|Discomfort|0|||
149198130|NCT01021852|538193097|FG000|Treatment Period 1|Adverse Event|3|||
149198131|NCT01021852|538193098|FG001|Treatment Period 1|Adverse Event|1|||
149198132|NCT01021852|538193099|FG002|Treatment Period 1|Adverse Event|1|||
149198133|NCT01021852|538193100|FG003|Treatment Period 1|Adverse Event|0|||
148943108|NCT01091974|537275683|FG000|Overall Study|Did not start intervention|3|||
148943109|NCT01091974|537275684|FG001|Overall Study|Did not start intervention|1|||
148943110|NCT01091974|537275685|FG002|Overall Study|Did not start intervention|3|||
148943111|NCT01091974|537275686|FG003|Overall Study|Did not start intervention|1|||
148943112|NCT01091974|537275683|FG000|Overall Study|resumed sleep medication|0|||
149198134|NCT01021852|538193101|FG004|Treatment Period 1|Adverse Event|2|||
149198135|NCT01021852|538193102|FG005|Treatment Period 1|Adverse Event|2|||
149198136|NCT01021852|538193103|FG006|Treatment Period 1|Adverse Event|0|||
149198137|NCT01021852|538193104|FG007|Treatment Period 1|Adverse Event|0|||
149198138|NCT01021852|538193097|FG000|Treatment Period 1|Pregnancy|0|||
149198139|NCT01021852|538193098|FG001|Treatment Period 1|Pregnancy|0|||
148943113|NCT01091974|537275684|FG001|Overall Study|resumed sleep medication|0|||
148943114|NCT01091974|537275685|FG002|Overall Study|resumed sleep medication|1|||
148943115|NCT01091974|537275686|FG003|Overall Study|resumed sleep medication|2|||
148943116|NCT01091974|537275683|FG000|Overall Study|Withdrawal by Subject|1|||
148943117|NCT01091974|537275684|FG001|Overall Study|Withdrawal by Subject|3|||
148943118|NCT01091974|537275685|FG002|Overall Study|Withdrawal by Subject|2|||
148943119|NCT01091974|537275686|FG003|Overall Study|Withdrawal by Subject|2|||
148943120|NCT01091974|537275683|FG000|Overall Study|side-effects|1|||
148943121|NCT01091974|537275684|FG001|Overall Study|side-effects|1|||
148943122|NCT01091974|537275685|FG002|Overall Study|side-effects|0|||
148943123|NCT01091974|537275686|FG003|Overall Study|side-effects|2|||
148943124|NCT05379231|537275691|FG000|Home Visit|Withdrawal by Subject|2|||
148943125|NCT05379231|537275691|FG000|In-lab Visit|Withdrawal by Subject|2|||
148943126|NCT01496807|537275695|FG000|Overall Study|Progressive Disease|21|||
148943127|NCT01496807|537275695|FG000|Overall Study|Participant preference/toxicity|8|||
148943128|NCT01496807|537275695|FG000|Overall Study|Change in diagnosis|1|||
148943129|NCT03095612|537275699|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
148943130|NCT03095612|537275700|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
148943131|NCT03095612|537275701|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
148943132|NCT03095612|537275702|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
148943133|NCT03095612|537275703|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
148943134|NCT03095612|537275704|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
148943135|NCT03095612|537275705|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
148943136|NCT01390649|537275706|FG000|Overall Study|Physician Decision|1|||
148943137|NCT00389597|537275707|FG000|Overall Study|Lost to Follow-up|8|||
148943138|NCT00389597|537275708|FG001|Overall Study|Lost to Follow-up|6|||
148943139|NCT00389597|537275709|FG002|Overall Study|Lost to Follow-up|4|||
148943140|NCT00389597|537275710|FG003|Overall Study|Lost to Follow-up|6|||
148943141|NCT03988088|537275711|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
148943142|NCT03988088|537275712|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
148943143|NCT03988088|537275713|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
148943144|NCT03988088|537275714|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
148943145|NCT03988088|537275711|FG000|Open-Label Addendum|Lost to Follow-up|0|||
148943146|NCT03988088|537275712|FG001|Open-Label Addendum|Lost to Follow-up|0|||
148943147|NCT03988088|537275713|FG002|Open-Label Addendum|Lost to Follow-up|1|||
148943148|NCT03988088|537275714|FG003|Open-Label Addendum|Lost to Follow-up|0|||
148943149|NCT00781274|537275715|FG000|Overall Study|Withdrawal by Subject|2|||
148943150|NCT03724032|537275720|FG000|Overall Study|Physician Decision|1|||
148943151|NCT03724032|537275721|FG001|Overall Study|Physician Decision|0|||
148943152|NCT03724032|537275722|FG002|Overall Study|Physician Decision|0|||
148943153|NCT03724032|537275720|FG000|Overall Study|Protocol Violation|2|||
148943154|NCT03724032|537275721|FG001|Overall Study|Protocol Violation|2|||
148943155|NCT03724032|537275722|FG002|Overall Study|Protocol Violation|1|||
148943156|NCT01817530|537275723|FG000|Overall Study|Exclusionary Medication Received|0|||
148943157|NCT01817530|537275724|FG001|Overall Study|Exclusionary Medication Received|0|||
148943158|NCT01817530|537275725|FG002|Overall Study|Exclusionary Medication Received|0|||
148943159|NCT01817530|537275726|FG003|Overall Study|Exclusionary Medication Received|0|||
148943160|NCT01817530|537275727|FG004|Overall Study|Exclusionary Medication Received|1|||
148943161|NCT01817530|537275728|FG005|Overall Study|Exclusionary Medication Received|0|||
148943162|NCT01817530|537275729|FG006|Overall Study|Exclusionary Medication Received|0|||
148943163|NCT01817530|537275730|FG007|Overall Study|Exclusionary Medication Received|0|||
148943164|NCT01817530|537275723|FG000|Overall Study|Adverse Event|6|||
148943165|NCT01817530|537275724|FG001|Overall Study|Adverse Event|3|||
148943166|NCT01817530|537275725|FG002|Overall Study|Adverse Event|2|||
148943167|NCT01817530|537275726|FG003|Overall Study|Adverse Event|5|||
148943168|NCT01817530|537275727|FG004|Overall Study|Adverse Event|0|||
148943169|NCT01817530|537275728|FG005|Overall Study|Adverse Event|10|||
148943170|NCT01817530|537275729|FG006|Overall Study|Adverse Event|5|||
148943171|NCT01817530|537275730|FG007|Overall Study|Adverse Event|8|||
149198140|NCT01021852|538193099|FG002|Treatment Period 1|Pregnancy|1|||
149198141|NCT01021852|538193100|FG003|Treatment Period 1|Pregnancy|0|||
148943172|NCT01817530|537275723|FG000|Overall Study|Subject Noncompliant|3|||
148943173|NCT01817530|537275724|FG001|Overall Study|Subject Noncompliant|1|||
149016018|NCT01757665|537537819|FG000|Overall Study|Still on Study - Visit Completed|240|||
149198142|NCT01021852|538193101|FG004|Treatment Period 1|Pregnancy|0|||
148943174|NCT01817530|537275725|FG002|Overall Study|Subject Noncompliant|0|||
148943175|NCT01817530|537275726|FG003|Overall Study|Subject Noncompliant|4|||
148943176|NCT01817530|537275727|FG004|Overall Study|Subject Noncompliant|0|||
149198143|NCT01021852|538193102|FG005|Treatment Period 1|Pregnancy|0|||
149198144|NCT01021852|538193103|FG006|Treatment Period 1|Pregnancy|0|||
149198145|NCT01021852|538193104|FG007|Treatment Period 1|Pregnancy|0|||
149198146|NCT01021852|538193097|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149198147|NCT01021852|538193098|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149198148|NCT01021852|538193099|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149198149|NCT01021852|538193100|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149198150|NCT01021852|538193101|FG004|Treatment Period 1|Withdrawal by Subject|1|||
149198151|NCT01021852|538193102|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149198152|NCT01021852|538193103|FG006|Treatment Period 1|Withdrawal by Subject|0|||
149198153|NCT01021852|538193104|FG007|Treatment Period 1|Withdrawal by Subject|1|||
149198154|NCT01021852|538193097|FG000|Treatment Period 1|Not Treated|0|||
149198155|NCT01021852|538193098|FG001|Treatment Period 1|Not Treated|0|||
149198156|NCT01021852|538193099|FG002|Treatment Period 1|Not Treated|0|||
149198157|NCT01021852|538193100|FG003|Treatment Period 1|Not Treated|2|||
149198158|NCT01021852|538193101|FG004|Treatment Period 1|Not Treated|0|||
149198159|NCT01021852|538193102|FG005|Treatment Period 1|Not Treated|0|||
149198160|NCT01021852|538193103|FG006|Treatment Period 1|Not Treated|0|||
149198161|NCT01021852|538193104|FG007|Treatment Period 1|Not Treated|0|||
149198162|NCT01021852|538193097|FG000|Washout Period-Placebo|Adverse Event|0|||
149198163|NCT01021852|538193098|FG001|Washout Period-Placebo|Adverse Event|0|||
149198164|NCT01021852|538193099|FG002|Washout Period-Placebo|Adverse Event|0|||
149198165|NCT01021852|538193100|FG003|Washout Period-Placebo|Adverse Event|1|||
149198166|NCT01021852|538193101|FG004|Washout Period-Placebo|Adverse Event|0|||
149198167|NCT01021852|538193102|FG005|Washout Period-Placebo|Adverse Event|1|||
149198168|NCT01021852|538193103|FG006|Washout Period-Placebo|Adverse Event|0|||
149198169|NCT01021852|538193104|FG007|Washout Period-Placebo|Adverse Event|0|||
149198170|NCT01021852|538193097|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
149198171|NCT01021852|538193098|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
149198172|NCT01021852|538193099|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
149198173|NCT01021852|538193100|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
149198174|NCT01021852|538193101|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
149198175|NCT01021852|538193102|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
148943177|NCT01817530|537275728|FG005|Overall Study|Subject Noncompliant|1|||
148943178|NCT01817530|537275729|FG006|Overall Study|Subject Noncompliant|1|||
148943179|NCT01817530|537275730|FG007|Overall Study|Subject Noncompliant|1|||
148943180|NCT01817530|537275723|FG000|Overall Study|Lack of Efficacy|1|||
148943181|NCT01817530|537275724|FG001|Overall Study|Lack of Efficacy|0|||
148943182|NCT01817530|537275725|FG002|Overall Study|Lack of Efficacy|0|||
148943183|NCT01817530|537275726|FG003|Overall Study|Lack of Efficacy|0|||
148943184|NCT01817530|537275727|FG004|Overall Study|Lack of Efficacy|0|||
148943185|NCT01817530|537275728|FG005|Overall Study|Lack of Efficacy|1|||
148943186|NCT01817530|537275729|FG006|Overall Study|Lack of Efficacy|0|||
148943187|NCT01817530|537275730|FG007|Overall Study|Lack of Efficacy|1|||
148943188|NCT01817530|537275723|FG000|Overall Study|Pregnancy|0|||
148943189|NCT01817530|537275724|FG001|Overall Study|Pregnancy|0|||
148943190|NCT01817530|537275725|FG002|Overall Study|Pregnancy|0|||
148943191|NCT01817530|537275726|FG003|Overall Study|Pregnancy|0|||
148943192|NCT01817530|537275727|FG004|Overall Study|Pregnancy|0|||
148943193|NCT01817530|537275728|FG005|Overall Study|Pregnancy|1|||
148943194|NCT01817530|537275729|FG006|Overall Study|Pregnancy|0|||
148943195|NCT01817530|537275730|FG007|Overall Study|Pregnancy|0|||
148943196|NCT01817530|537275723|FG000|Overall Study|Other|0|||
148943197|NCT01817530|537275724|FG001|Overall Study|Other|1|||
148943198|NCT01817530|537275725|FG002|Overall Study|Other|0|||
148943199|NCT01817530|537275726|FG003|Overall Study|Other|0|||
148943200|NCT01817530|537275727|FG004|Overall Study|Other|1|||
148943201|NCT01817530|537275728|FG005|Overall Study|Other|0|||
148943202|NCT01817530|537275729|FG006|Overall Study|Other|5|||
148943203|NCT01817530|537275730|FG007|Overall Study|Other|0|||
148943204|NCT01817530|537275723|FG000|Overall Study|Surgery or Invasive Intervention|1|||
149198176|NCT01021852|538193103|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
148943205|NCT01817530|537275724|FG001|Overall Study|Surgery or Invasive Intervention|0|||
148943206|NCT01817530|537275725|FG002|Overall Study|Surgery or Invasive Intervention|0|||
148943207|NCT01817530|537275726|FG003|Overall Study|Surgery or Invasive Intervention|0|||
148943208|NCT01817530|537275727|FG004|Overall Study|Surgery or Invasive Intervention|1|||
148943209|NCT01817530|537275728|FG005|Overall Study|Surgery or Invasive Intervention|1|||
149198177|NCT01021852|538193104|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
149198178|NCT01021852|538193097|FG000|Washout Period-Placebo|Protocol Violation|0|||
148943210|NCT01817530|537275729|FG006|Overall Study|Surgery or Invasive Intervention|1|||
149198179|NCT01021852|538193098|FG001|Washout Period-Placebo|Protocol Violation|0|||
149198180|NCT01021852|538193099|FG002|Washout Period-Placebo|Protocol Violation|0|||
149198181|NCT01021852|538193100|FG003|Washout Period-Placebo|Protocol Violation|0|||
149198182|NCT01021852|538193101|FG004|Washout Period-Placebo|Protocol Violation|0|||
149016019|NCT01757665|537537820|FG001|Overall Study|Still on Study - Visit Completed|30|||
149016020|NCT01757665|537537819|FG000|Overall Study|Still on Study - Visit Pending|398|||
149016021|NCT01757665|537537820|FG001|Overall Study|Still on Study - Visit Pending|40|||
149016022|NCT01757665|537537819|FG000|Overall Study|Still on Study - Missed Visit|14|||
149016023|NCT01757665|537537820|FG001|Overall Study|Still on Study - Missed Visit|1|||
149016024|NCT01757665|537537819|FG000|Overall Study|Death|25|||
149016025|NCT01757665|537537820|FG001|Overall Study|Death|8|||
149016026|NCT01757665|537537819|FG000|Overall Study|Explant|1|||
149016027|NCT01757665|537537820|FG001|Overall Study|Explant|2|||
149016028|NCT01757665|537537819|FG000|Overall Study|Withdrawal by Subject|10|||
149016029|NCT01757665|537537820|FG001|Overall Study|Withdrawal by Subject|0|||
149016030|NCT01757665|537537819|FG000|Overall Study|Lost to Follow-up|1|||
149016031|NCT01757665|537537820|FG001|Overall Study|Lost to Follow-up|1|||
149016032|NCT01757665|537537819|FG000|Overall Study|Not Implanted with Device|5|||
149016033|NCT01757665|537537820|FG001|Overall Study|Not Implanted with Device|1|||
149198183|NCT01021852|538193102|FG005|Washout Period-Placebo|Protocol Violation|0|||
149198184|NCT01021852|538193103|FG006|Washout Period-Placebo|Protocol Violation|1|||
149198185|NCT01021852|538193104|FG007|Washout Period-Placebo|Protocol Violation|0|||
149198186|NCT01021852|538193097|FG000|Washout Period-No Drug|Adverse Event|1|||
149198187|NCT01021852|538193098|FG001|Washout Period-No Drug|Adverse Event|0|||
149198188|NCT01021852|538193099|FG002|Washout Period-No Drug|Adverse Event|0|||
149198189|NCT01021852|538193100|FG003|Washout Period-No Drug|Adverse Event|0|||
149198190|NCT01021852|538193101|FG004|Washout Period-No Drug|Adverse Event|0|||
149198191|NCT01021852|538193102|FG005|Washout Period-No Drug|Adverse Event|1|||
149198192|NCT01021852|538193103|FG006|Washout Period-No Drug|Adverse Event|0|||
149198193|NCT01021852|538193104|FG007|Washout Period-No Drug|Adverse Event|0|||
149198194|NCT01021852|538193097|FG000|Treatment Period 2|Adverse Event|0|||
149198195|NCT01021852|538193098|FG001|Treatment Period 2|Adverse Event|1|||
149198196|NCT01021852|538193099|FG002|Treatment Period 2|Adverse Event|0|||
149198197|NCT01021852|538193100|FG003|Treatment Period 2|Adverse Event|0|||
149198198|NCT01021852|538193101|FG004|Treatment Period 2|Adverse Event|1|||
149198199|NCT01021852|538193102|FG005|Treatment Period 2|Adverse Event|0|||
149198200|NCT01021852|538193103|FG006|Treatment Period 2|Adverse Event|1|||
149198201|NCT01021852|538193104|FG007|Treatment Period 2|Adverse Event|0|||
149198202|NCT01021852|538193097|FG000|Treatment Period 2|Lack of Efficacy|0|||
149198203|NCT01021852|538193098|FG001|Treatment Period 2|Lack of Efficacy|0|||
149198204|NCT01021852|538193099|FG002|Treatment Period 2|Lack of Efficacy|0|||
149198205|NCT01021852|538193100|FG003|Treatment Period 2|Lack of Efficacy|0|||
149198206|NCT01021852|538193101|FG004|Treatment Period 2|Lack of Efficacy|0|||
149198207|NCT01021852|538193102|FG005|Treatment Period 2|Lack of Efficacy|1|||
149198208|NCT01021852|538193103|FG006|Treatment Period 2|Lack of Efficacy|0|||
149198209|NCT01021852|538193104|FG007|Treatment Period 2|Lack of Efficacy|0|||
149198210|NCT01021852|538193097|FG000|Treatment Period 2|Physician Decision|0|||
149198211|NCT01021852|538193098|FG001|Treatment Period 2|Physician Decision|0|||
149198212|NCT01021852|538193099|FG002|Treatment Period 2|Physician Decision|1|||
149198213|NCT01021852|538193100|FG003|Treatment Period 2|Physician Decision|0|||
149198214|NCT01021852|538193101|FG004|Treatment Period 2|Physician Decision|0|||
149198215|NCT01021852|538193102|FG005|Treatment Period 2|Physician Decision|0|||
149198216|NCT01021852|538193103|FG006|Treatment Period 2|Physician Decision|0|||
149198217|NCT01021852|538193104|FG007|Treatment Period 2|Physician Decision|0|||
149016034|NCT00594906|537537821|FG000|Overall Study|Physician Decision|1|||
149016035|NCT00594906|537537822|FG001|Overall Study|Physician Decision|0|||
149016036|NCT00594906|537537821|FG000|Overall Study|Physician Decision|0|||
149016037|NCT00594906|537537822|FG001|Overall Study|Physician Decision|1|||
149198218|NCT01021852|538193097|FG000|Treatment Period 2|Protocol Violation|0|||
149198219|NCT01021852|538193098|FG001|Treatment Period 2|Protocol Violation|0|||
149198220|NCT01021852|538193099|FG002|Treatment Period 2|Protocol Violation|0|||
149198221|NCT01021852|538193100|FG003|Treatment Period 2|Protocol Violation|0|||
149198222|NCT01021852|538193101|FG004|Treatment Period 2|Protocol Violation|1|||
148943211|NCT01817530|537275730|FG007|Overall Study|Surgery or Invasive Intervention|0|||
148943212|NCT01817530|537275723|FG000|Overall Study|Consent Withdrawn by Subject|3|||
148943213|NCT01817530|537275724|FG001|Overall Study|Consent Withdrawn by Subject|4|||
148943214|NCT01817530|537275725|FG002|Overall Study|Consent Withdrawn by Subject|7|||
148943215|NCT01817530|537275726|FG003|Overall Study|Consent Withdrawn by Subject|3|||
148943216|NCT01817530|537275727|FG004|Overall Study|Consent Withdrawn by Subject|5|||
148943217|NCT01817530|537275728|FG005|Overall Study|Consent Withdrawn by Subject|3|||
149198223|NCT01021852|538193102|FG005|Treatment Period 2|Protocol Violation|0|||
149198224|NCT01021852|538193103|FG006|Treatment Period 2|Protocol Violation|1|||
149198225|NCT01021852|538193104|FG007|Treatment Period 2|Protocol Violation|0|||
149198226|NCT01021852|538193097|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149198227|NCT01021852|538193098|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149198228|NCT01021852|538193099|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149198229|NCT01021852|538193100|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149198230|NCT01021852|538193101|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149198231|NCT01021852|538193102|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149198232|NCT01021852|538193103|FG006|Treatment Period 2|Withdrawal by Subject|1|||
149198233|NCT01021852|538193104|FG007|Treatment Period 2|Withdrawal by Subject|2|||
149198234|NCT04799405|538193107|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
149198235|NCT00603980|538193108|FG000|Study Qualification|Protocol Violation|3|||
149198236|NCT00603980|538193108|FG000|Study Qualification|Inconsistent data reporting|13|||
149198237|NCT00603980|538193108|FG000|Main Study|14th subject completed trial|1|||
149198238|NCT02618928|538193115|FG000|Overall Study|Failure to Return|28|||
149198239|NCT02618928|538193115|FG000|Overall Study|Insufficient Virological Response|1|||
149198240|NCT02618928|538193115|FG000|Overall Study|Withdrawal by Subject|2|||
149198241|NCT02618928|538193115|FG000|Overall Study|Death|3|||
149198242|NCT02618928|538193115|FG000|Overall Study|Other|11|||
149198243|NCT02618928|538193115|FG000|Overall Study|Missing|6|||
149198244|NCT02618928|538193115|FG000|Overall Study|Treatment Never Started|7|||
149198245|NCT01096849|538193116|FG000|Overall Study|Consent Withdrawn|1|||
148943218|NCT01817530|537275729|FG006|Overall Study|Consent Withdrawn by Subject|3|||
148943219|NCT01817530|537275730|FG007|Overall Study|Consent Withdrawn by Subject|10|||
148943220|NCT01817530|537275723|FG000|Overall Study|Lost to Follow-up|1|||
148943221|NCT01817530|537275724|FG001|Overall Study|Lost to Follow-up|4|||
148943222|NCT01817530|537275725|FG002|Overall Study|Lost to Follow-up|2|||
148943223|NCT01817530|537275726|FG003|Overall Study|Lost to Follow-up|1|||
148943224|NCT01817530|537275727|FG004|Overall Study|Lost to Follow-up|3|||
149198246|NCT01096849|538193117|FG001|Overall Study|Consent Withdrawn|4|||
149198247|NCT01096849|538193118|FG002|Overall Study|Consent Withdrawn|2|||
149198248|NCT01096849|538193116|FG000|Overall Study|Lack of Efficacy|0|||
149198249|NCT01096849|538193117|FG001|Overall Study|Lack of Efficacy|2|||
149198250|NCT01096849|538193118|FG002|Overall Study|Lack of Efficacy|0|||
149198251|NCT01096849|538193116|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
149198252|NCT01096849|538193117|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
149198253|NCT01096849|538193118|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
149198254|NCT01096849|538193116|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
149198255|NCT01096849|538193117|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
149198256|NCT01096849|538193118|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
149198257|NCT01096849|538193116|FG000|Overall Study|Administrative Reasons|0|||
149198258|NCT01096849|538193117|FG001|Overall Study|Administrative Reasons|1|||
149198259|NCT01096849|538193118|FG002|Overall Study|Administrative Reasons|2|||
149198260|NCT01096849|538193116|FG000|Overall Study|Lost to Follow-up|1|||
149198261|NCT01096849|538193117|FG001|Overall Study|Lost to Follow-up|3|||
149198262|NCT01096849|538193118|FG002|Overall Study|Lost to Follow-up|1|||
149198263|NCT01253421|538193126|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
149198264|NCT01253421|538193127|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
149198265|NCT01253421|538193128|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
149198266|NCT01253421|538193129|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
149198267|NCT01253421|538193130|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
149198268|NCT01253421|538193126|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
149198269|NCT01253421|538193127|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
149198270|NCT01253421|538193128|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
149198271|NCT01253421|538193129|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
149198272|NCT01253421|538193130|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
149198273|NCT01253421|538193126|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
149198274|NCT01253421|538193127|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
149198275|NCT01253421|538193128|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
149198276|NCT01253421|538193129|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
149198277|NCT01253421|538193130|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
149198278|NCT01253421|538193126|FG000|Assessment and Scheduling|Physician Decision|1|||
149198279|NCT01253421|538193127|FG001|Assessment and Scheduling|Physician Decision|0|||
149198280|NCT01253421|538193128|FG002|Assessment and Scheduling|Physician Decision|0|||
149198281|NCT01253421|538193129|FG003|Assessment and Scheduling|Physician Decision|0|||
149198282|NCT01253421|538193130|FG004|Assessment and Scheduling|Physician Decision|0|||
149198283|NCT01253421|538193126|FG000|Drug+Scanning Visit|Physician Decision|0|||
149198284|NCT01253421|538193127|FG001|Drug+Scanning Visit|Physician Decision|0|||
149198285|NCT01253421|538193128|FG002|Drug+Scanning Visit|Physician Decision|0|||
149198286|NCT01253421|538193129|FG003|Drug+Scanning Visit|Physician Decision|0|||
149198287|NCT01253421|538193130|FG004|Drug+Scanning Visit|Physician Decision|1|||
149198288|NCT00264849|538193131|FG000|Overall Study|Adverse Event|7|||
149198289|NCT00264849|538193132|FG001|Overall Study|Adverse Event|2|||
149198290|NCT00264849|538193131|FG000|Overall Study|Withdrawal by Subject|7|||
149198291|NCT00264849|538193132|FG001|Overall Study|Withdrawal by Subject|11|||
149198292|NCT00264849|538193131|FG000|Overall Study|Protocol Violation|5|||
149198293|NCT00264849|538193132|FG001|Overall Study|Protocol Violation|3|||
149198294|NCT00264849|538193131|FG000|Overall Study|Lack of Efficacy|1|||
149198295|NCT00264849|538193132|FG001|Overall Study|Lack of Efficacy|6|||
149198296|NCT00264849|538193131|FG000|Overall Study|Lost to Follow-up|0|||
149198297|NCT00264849|538193132|FG001|Overall Study|Lost to Follow-up|2|||
149198298|NCT00264849|538193131|FG000|Overall Study|Death|0|||
149198299|NCT00264849|538193132|FG001|Overall Study|Death|1|||
149198300|NCT00264849|538193131|FG000|Overall Study|Administrative Problems|2|||
149198301|NCT00264849|538193132|FG001|Overall Study|Administrative Problems|0|||
149198302|NCT00099359|538193133|FG000|Overall Study|Death|11|||
149198303|NCT00099359|538193134|FG001|Overall Study|Death|15|||
149198304|NCT00099359|538193135|FG002|Overall Study|Death|17|||
149198305|NCT00099359|538193133|FG000|Overall Study|Withdrawal by Subject|19|||
149198306|NCT00099359|538193134|FG001|Overall Study|Withdrawal by Subject|19|||
149198307|NCT00099359|538193135|FG002|Overall Study|Withdrawal by Subject|23|||
149198308|NCT00099359|538193133|FG000|Overall Study|Lost to Follow-up|15|||
149198309|NCT00099359|538193134|FG001|Overall Study|Lost to Follow-up|24|||
149198310|NCT00099359|538193135|FG002|Overall Study|Lost to Follow-up|24|||
149198311|NCT00099359|538193133|FG000|Overall Study|moved out of area|9|||
149198312|NCT00099359|538193134|FG001|Overall Study|moved out of area|7|||
149198313|NCT00099359|538193135|FG002|Overall Study|moved out of area|4|||
149198314|NCT04501679|538193136|FG000|Overall Study|Pregnancy|0|||
149198315|NCT04501679|538193137|FG001|Overall Study|Pregnancy|1|||
149198316|NCT04501679|538193136|FG000|Overall Study|Adverse Event|4|||
149198317|NCT04501679|538193137|FG001|Overall Study|Adverse Event|2|||
149198318|NCT04501679|538193136|FG000|Overall Study|Withdrawal by Subject|2|||
149198319|NCT04501679|538193137|FG001|Overall Study|Withdrawal by Subject|0|||
149198320|NCT04501679|538193136|FG000|Overall Study|Physician Decision|1|||
149198321|NCT04501679|538193137|FG001|Overall Study|Physician Decision|0|||
149198322|NCT04501679|538193136|FG000|Overall Study|Lost to Follow-up|2|||
149198323|NCT04501679|538193137|FG001|Overall Study|Lost to Follow-up|0|||
149198324|NCT02121756|538193139|FG000|Overall Study|Adverse Event|3|||
149198325|NCT02121756|538193140|FG001|Overall Study|Adverse Event|0|||
149198326|NCT02121756|538193139|FG000|Overall Study|Protocol Violation|1|||
149198327|NCT02121756|538193140|FG001|Overall Study|Protocol Violation|1|||
149198328|NCT02121756|538193139|FG000|Overall Study|Physician Decision|2|||
149198329|NCT02121756|538193140|FG001|Overall Study|Physician Decision|1|||
149198330|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
149198331|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
149198332|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
149198333|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
149198334|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
149016038|NCT00594906|537537821|FG000|Overall Study|Death|0|||
149016039|NCT00594906|537537822|FG001|Overall Study|Death|1|||
149016040|NCT02564055|537537828|FG000|Overall Study|Adverse Event|1|||
149016041|NCT02564055|537537829|FG001|Overall Study|Adverse Event|0|||
149016042|NCT02564055|537537830|FG002|Overall Study|Adverse Event|4|||
149016043|NCT02564055|537537831|FG003|Overall Study|Adverse Event|1|||
149016044|NCT02564055|537537832|FG004|Overall Study|Adverse Event|4|||
149016045|NCT02564055|537537833|FG005|Overall Study|Adverse Event|1|||
149016046|NCT02564055|537537828|FG000|Overall Study|Protocol Violation|1|||
149016047|NCT02564055|537537829|FG001|Overall Study|Protocol Violation|0|||
149016048|NCT02564055|537537830|FG002|Overall Study|Protocol Violation|0|||
149016049|NCT02564055|537537831|FG003|Overall Study|Protocol Violation|0|||
149016050|NCT02564055|537537832|FG004|Overall Study|Protocol Violation|0|||
149198335|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
149198336|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
149198337|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
149198338|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
149198339|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
149198340|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
149198341|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
149198342|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
149198343|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
149198344|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
149198345|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
149198346|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Missing|3|||
149198347|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Missing|1|||
149198348|NCT00838916|538193141|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
149198349|NCT00838916|538193142|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
149198350|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
149016051|NCT02564055|537537833|FG005|Overall Study|Protocol Violation|0|||
149016052|NCT02564055|537537828|FG000|Overall Study|Reached stopping criteria|0|||
149198351|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
149198352|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
149198353|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
149198354|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
149198355|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
149198356|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
149198357|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
149016053|NCT02564055|537537829|FG001|Overall Study|Reached stopping criteria|0|||
149016054|NCT02564055|537537830|FG002|Overall Study|Reached stopping criteria|0|||
149016055|NCT02564055|537537831|FG003|Overall Study|Reached stopping criteria|0|||
149198358|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
149198359|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
149198360|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
149198361|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
149198362|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
149198363|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
149198364|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
149198365|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
149198366|NCT00838916|538193141|FG000|Follow-up Period (8 Weeks)|Missing|3|||
149198367|NCT00838916|538193142|FG001|Follow-up Period (8 Weeks)|Missing|0|||
149198368|NCT01927419|538193143|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149198369|NCT01927419|538193144|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
149198370|NCT01927419|538193143|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
149198371|NCT01927419|538193144|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
149198372|NCT01927419|538193143|FG000|Treatment Period|Disease progression|17|||
149198373|NCT01927419|538193144|FG001|Treatment Period|Disease progression|20|||
149198374|NCT01927419|538193143|FG000|Treatment Period|Study drug toxicity|48|||
149198375|NCT01927419|538193144|FG001|Treatment Period|Study drug toxicity|10|||
149198376|NCT01927419|538193143|FG000|Treatment Period|Death|0|||
149198377|NCT01927419|538193144|FG001|Treatment Period|Death|1|||
149198378|NCT01927419|538193143|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
149198379|NCT01927419|538193144|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
149198380|NCT01927419|538193143|FG000|Treatment Period|Participant request to discontinue|12|||
148943225|NCT01817530|537275728|FG005|Overall Study|Lost to Follow-up|2|||
148943226|NCT01817530|537275729|FG006|Overall Study|Lost to Follow-up|8|||
148943227|NCT01817530|537275730|FG007|Overall Study|Lost to Follow-up|4|||
148943228|NCT00679432|537275731|FG000|Overall Study|Adverse Event|5|||
148943229|NCT00679432|537275732|FG001|Overall Study|Adverse Event|6|||
148943230|NCT00679432|537275733|FG002|Overall Study|Adverse Event|10|||
148943231|NCT00679432|537275734|FG003|Overall Study|Adverse Event|7|||
148943232|NCT00679432|537275731|FG000|Overall Study|Protocol Violation|1|||
148943233|NCT00679432|537275732|FG001|Overall Study|Protocol Violation|1|||
148943234|NCT00679432|537275733|FG002|Overall Study|Protocol Violation|2|||
149198381|NCT01927419|538193144|FG001|Treatment Period|Participant request to discontinue|4|||
149198382|NCT01927419|538193143|FG000|Treatment Period|Withdrawal by Subject|1|||
149198383|NCT01927419|538193144|FG001|Treatment Period|Withdrawal by Subject|1|||
149198384|NCT01927419|538193143|FG000|Treatment Period|Maximum Clinical Benefit|6|||
149198385|NCT01927419|538193144|FG001|Treatment Period|Maximum Clinical Benefit|2|||
149198386|NCT01927419|538193143|FG000|Treatment Period|Other reasons|3|||
149198387|NCT01927419|538193144|FG001|Treatment Period|Other reasons|4|||
149198388|NCT01927419|538193143|FG000|Treatment Period|Not Reported|1|||
149198389|NCT01927419|538193144|FG001|Treatment Period|Not Reported|1|||
149198390|NCT03488251|538193145|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
149198391|NCT03488251|538193146|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
149198392|NCT03488251|538193147|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
149198393|NCT03488251|538193148|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
149198394|NCT03488251|538193145|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
149198395|NCT03488251|538193146|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
149198396|NCT03488251|538193147|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
149198397|NCT03488251|538193148|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
149198398|NCT03488251|538193145|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
149198399|NCT03488251|538193146|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
149198400|NCT03488251|538193147|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
149198401|NCT03488251|538193148|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
149198402|NCT03488251|538193145|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
148943235|NCT00679432|537275734|FG003|Overall Study|Protocol Violation|1|||
148943236|NCT00679432|537275731|FG000|Overall Study|Withdrawal by Subject|8|||
148943237|NCT00679432|537275732|FG001|Overall Study|Withdrawal by Subject|11|||
148943238|NCT00679432|537275733|FG002|Overall Study|Withdrawal by Subject|10|||
149198403|NCT03488251|538193146|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
149198404|NCT03488251|538193147|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
149198405|NCT03488251|538193148|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
149198406|NCT03488251|538193145|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
149198407|NCT03488251|538193146|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
149198408|NCT03488251|538193147|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
149198409|NCT03488251|538193148|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
149198410|NCT00115765|538193149|FG000|Overall Study|Withdrawal by Subject|22|||
149198411|NCT00115765|538193150|FG001|Overall Study|Withdrawal by Subject|53|||
149198412|NCT00115765|538193151|FG002|Overall Study|Withdrawal by Subject|76|||
149198413|NCT00115765|538193152|FG003|Overall Study|Withdrawal by Subject|15|||
149198414|NCT00115765|538193149|FG000|Overall Study|Physician Decision|4|||
149198415|NCT00115765|538193150|FG001|Overall Study|Physician Decision|15|||
149198416|NCT00115765|538193151|FG002|Overall Study|Physician Decision|18|||
149198417|NCT00115765|538193152|FG003|Overall Study|Physician Decision|13|||
149198418|NCT00115765|538193149|FG000|Overall Study|Lost to Follow-up|3|||
149198419|NCT00115765|538193150|FG001|Overall Study|Lost to Follow-up|20|||
149198420|NCT00115765|538193151|FG002|Overall Study|Lost to Follow-up|18|||
149198421|NCT00115765|538193152|FG003|Overall Study|Lost to Follow-up|1|||
149198422|NCT00115765|538193149|FG000|Overall Study|Other|6|||
149198423|NCT00115765|538193150|FG001|Overall Study|Other|12|||
149198424|NCT00115765|538193151|FG002|Overall Study|Other|9|||
149198425|NCT00115765|538193152|FG003|Overall Study|Other|2|||
149198426|NCT00995670|538193155|FG000|Overall Study|Failed arterial cannulation|1|||
149198427|NCT00995670|538193156|FG001|Overall Study|Failed arterial cannulation|0|||
149198428|NCT00995670|538193157|FG002|Overall Study|Failed arterial cannulation|3|||
149198429|NCT00675103|538193158|FG000|Overall Study|Lack of Efficacy|2|||
149198430|NCT00675103|538193158|FG000|Overall Study|Adverse Event|1|||
149198431|NCT01244191|538193162|FG000|Overall Study|Progressive disease|295|||
149198432|NCT01244191|538193163|FG001|Overall Study|Progressive disease|350|||
149198433|NCT01244191|538193162|FG000|Overall Study|Clinical disease progression|54|||
149198434|NCT01244191|538193163|FG001|Overall Study|Clinical disease progression|36|||
149198435|NCT01244191|538193162|FG000|Overall Study|Adverse Event|65|||
149198436|NCT01244191|538193163|FG001|Overall Study|Adverse Event|48|||
149198437|NCT01244191|538193162|FG000|Overall Study|Death|22|||
149198438|NCT01244191|538193163|FG001|Overall Study|Death|29|||
149198439|NCT01244191|538193162|FG000|Overall Study|Lost to Follow-up|0|||
149198440|NCT01244191|538193163|FG001|Overall Study|Lost to Follow-up|2|||
149198441|NCT01244191|538193162|FG000|Overall Study|Protocol Violation|1|||
149198442|NCT01244191|538193163|FG001|Overall Study|Protocol Violation|2|||
149198443|NCT01244191|538193162|FG000|Overall Study|Withdrawal by Subject|31|||
149198444|NCT01244191|538193163|FG001|Overall Study|Withdrawal by Subject|23|||
149198445|NCT01244191|538193162|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
149198446|NCT01244191|538193163|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
149198447|NCT01752842|538193164|FG000|Overall Study|Adverse Event|3|||
149198448|NCT01752842|538193165|FG001|Overall Study|Adverse Event|0|||
149198449|NCT01752842|538193164|FG000|Overall Study|Withdrawal by Subject|0|||
149198450|NCT01752842|538193165|FG001|Overall Study|Withdrawal by Subject|2|||
149198451|NCT05584202|538193166|FG000|Overall Study|Withdrawal of Consent|3|||
149198452|NCT05584202|538193167|FG001|Overall Study|Withdrawal of Consent|2|||
149198453|NCT05584202|538193166|FG000|Overall Study|Lost to Follow-up|2|||
149198454|NCT05584202|538193167|FG001|Overall Study|Lost to Follow-up|1|||
149198455|NCT05584202|538193166|FG000|Overall Study|Death|0|||
149198456|NCT05584202|538193167|FG001|Overall Study|Death|1|||
149198457|NCT03260205|538193168|FG000|Overall Study|Adverse Event|2|||
149198458|NCT03260205|538193169|FG001|Overall Study|Adverse Event|0|||
149198459|NCT03260205|538193170|FG002|Overall Study|Adverse Event|2|||
149198460|NCT03260205|538193171|FG003|Overall Study|Adverse Event|2|||
149198461|NCT03260205|538193172|FG004|Overall Study|Adverse Event|4|||
149198462|NCT03260205|538193168|FG000|Overall Study|Lost to Follow-up|2|||
149198463|NCT03260205|538193169|FG001|Overall Study|Lost to Follow-up|2|||
149198464|NCT03260205|538193170|FG002|Overall Study|Lost to Follow-up|1|||
149198465|NCT03260205|538193171|FG003|Overall Study|Lost to Follow-up|1|||
149198466|NCT03260205|538193172|FG004|Overall Study|Lost to Follow-up|5|||
149198467|NCT03260205|538193168|FG000|Overall Study|Protocol Violation|0|||
149198468|NCT03260205|538193169|FG001|Overall Study|Protocol Violation|0|||
149198469|NCT03260205|538193170|FG002|Overall Study|Protocol Violation|2|||
149198470|NCT03260205|538193171|FG003|Overall Study|Protocol Violation|0|||
149198471|NCT03260205|538193172|FG004|Overall Study|Protocol Violation|1|||
149198472|NCT03260205|538193168|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
149198473|NCT03260205|538193169|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
149198474|NCT03260205|538193170|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
149198475|NCT03260205|538193171|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
149198476|NCT03260205|538193172|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
149198477|NCT03260205|538193168|FG000|Overall Study|Other: Unspecified|0|||
149198478|NCT03260205|538193169|FG001|Overall Study|Other: Unspecified|0|||
149198479|NCT03260205|538193170|FG002|Overall Study|Other: Unspecified|3|||
149198480|NCT03260205|538193171|FG003|Overall Study|Other: Unspecified|1|||
149198481|NCT03260205|538193172|FG004|Overall Study|Other: Unspecified|1|||
149198482|NCT03260205|538193168|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
149198483|NCT03260205|538193169|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
149198484|NCT03260205|538193170|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
149198485|NCT03260205|538193171|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
149198486|NCT03260205|538193172|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
149198487|NCT04095286|538193173|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198488|NCT04095286|538193174|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
149198489|NCT04095286|538193175|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198490|NCT04095286|538193176|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198491|NCT04095286|538193177|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198492|NCT04095286|538193178|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198493|NCT04095286|538193173|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
149198494|NCT04095286|538193174|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149198495|NCT04095286|538193175|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149198496|NCT04095286|538193176|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149198497|NCT04095286|538193177|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149198498|NCT04095286|538193178|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
149198499|NCT04095286|538193173|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149198500|NCT04095286|538193174|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149198501|NCT04095286|538193175|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
149198502|NCT04095286|538193176|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149198503|NCT04095286|538193177|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149198504|NCT04095286|538193178|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
149198505|NCT04095286|538193173|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198506|NCT04095286|538193174|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
148943239|NCT00679432|537275734|FG003|Overall Study|Withdrawal by Subject|9|||
148943240|NCT00679432|537275731|FG000|Overall Study|Lost to Follow-up|1|||
148943241|NCT00679432|537275732|FG001|Overall Study|Lost to Follow-up|5|||
148943242|NCT00679432|537275733|FG002|Overall Study|Lost to Follow-up|4|||
148943243|NCT00679432|537275734|FG003|Overall Study|Lost to Follow-up|2|||
148943244|NCT00679432|537275731|FG000|Overall Study|Physician Decision|3|||
148943245|NCT00679432|537275732|FG001|Overall Study|Physician Decision|2|||
148943246|NCT00679432|537275733|FG002|Overall Study|Physician Decision|2|||
148943247|NCT00679432|537275734|FG003|Overall Study|Physician Decision|2|||
148943248|NCT00679432|537275731|FG000|Overall Study|Sponsor decision|1|||
148943249|NCT00679432|537275732|FG001|Overall Study|Sponsor decision|0|||
148943250|NCT00679432|537275733|FG002|Overall Study|Sponsor decision|0|||
148943251|NCT00679432|537275734|FG003|Overall Study|Sponsor decision|0|||
148943252|NCT00679432|537275731|FG000|Overall Study|Lack of Efficacy|13|||
148943253|NCT00679432|537275732|FG001|Overall Study|Lack of Efficacy|9|||
148943254|NCT00679432|537275733|FG002|Overall Study|Lack of Efficacy|14|||
148943255|NCT00679432|537275734|FG003|Overall Study|Lack of Efficacy|8|||
148943256|NCT00679432|537275731|FG000|Overall Study|Infectious colitis, normal histology|5|||
148943257|NCT00679432|537275732|FG001|Overall Study|Infectious colitis, normal histology|4|||
148943258|NCT00679432|537275733|FG002|Overall Study|Infectious colitis, normal histology|8|||
148943259|NCT00679432|537275734|FG003|Overall Study|Infectious colitis, normal histology|3|||
148943260|NCT00679432|537275731|FG000|Overall Study|Randomization error, return to prior Rx|0|||
148943261|NCT00679432|537275732|FG001|Overall Study|Randomization error, return to prior Rx|0|||
148943262|NCT00679432|537275733|FG002|Overall Study|Randomization error, return to prior Rx|3|||
148943263|NCT00679432|537275734|FG003|Overall Study|Randomization error, return to prior Rx|0|||
148943264|NCT00228384|537275735|FG000|Overall Study|Death|9|||
148943265|NCT00228384|537275736|FG001|Overall Study|Death|3|||
148943266|NCT00228384|537275735|FG000|Overall Study|Lost to Follow-up|6|||
148943267|NCT00228384|537275736|FG001|Overall Study|Lost to Follow-up|10|||
148943268|NCT00228384|537275735|FG000|Overall Study|Surgical Intervention (bypass)|5|||
148943269|NCT00228384|537275736|FG001|Overall Study|Surgical Intervention (bypass)|5|||
148943270|NCT00228384|537275735|FG000|Overall Study|Withdrawal by Subject|9|||
148943271|NCT00228384|537275736|FG001|Overall Study|Withdrawal by Subject|10|||
148943272|NCT00228384|537275735|FG000|Overall Study|Physician Decision|0|||
148943273|NCT00228384|537275736|FG001|Overall Study|Physician Decision|1|||
148943274|NCT01084083|537275737|FG000|Overall Study|Adverse Event|5|||
148943275|NCT01084083|537275737|FG000|Overall Study|Death|1|||
148943276|NCT01084083|537275737|FG000|Overall Study|Withdrawal by Subject|2|||
148943277|NCT01084083|537275737|FG000|Overall Study|Complicating disease|1|||
148943278|NCT01084083|537275737|FG000|Overall Study|Other|2|||
149198507|NCT04095286|538193175|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
149234051|NCT05299359|538326373|FG001|Main Part: Day 1 up to Day 366|Other|0|||
148943279|NCT01084083|537275737|FG000|Overall Study|Never started assigned therapy|1|||
148943280|NCT00873912|537275738|FG000|Overall Study|Withdrawal by Subject|1|||
148943281|NCT00873912|537275739|FG001|Overall Study|Withdrawal by Subject|0|||
148943282|NCT00873912|537275738|FG000|Overall Study|Lost to Follow-up|2|||
148943283|NCT00873912|537275739|FG001|Overall Study|Lost to Follow-up|0|||
148943284|NCT01466153|537275740|FG000|Overall Study|Disease Progression|2|||
148943285|NCT01466153|537275741|FG001|Overall Study|Disease Progression|2|||
148943286|NCT01466153|537275742|FG002|Overall Study|Disease Progression|0|||
148943287|NCT01466153|537275740|FG000|Overall Study|Adverse Event|14|||
148943288|NCT01466153|537275741|FG001|Overall Study|Adverse Event|13|||
148943289|NCT01466153|537275742|FG002|Overall Study|Adverse Event|17|||
148943290|NCT01466153|537275740|FG000|Overall Study|Withdrawal of Consent|2|||
148943291|NCT01466153|537275741|FG001|Overall Study|Withdrawal of Consent|0|||
148943292|NCT01466153|537275742|FG002|Overall Study|Withdrawal of Consent|0|||
149198508|NCT04095286|538193176|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198509|NCT04095286|538193177|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198510|NCT04095286|538193178|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
149198511|NCT04095286|538193173|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149198512|NCT04095286|538193174|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149198513|NCT04095286|538193175|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149198514|NCT04095286|538193176|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149198515|NCT04095286|538193177|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
149198516|NCT04095286|538193178|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
149198517|NCT00479557|538193179|FG000|Overall Study|Death|0|||
149198518|NCT00479557|538193180|FG001|Overall Study|Death|0|||
149198519|NCT00479557|538193181|FG002|Overall Study|Death|0|||
149198520|NCT00479557|538193182|FG003|Overall Study|Death|0|||
149198521|NCT00479557|538193183|FG004|Overall Study|Death|0|||
149198522|NCT00479557|538193184|FG005|Overall Study|Death|1|||
149198523|NCT00479557|538193185|FG006|Overall Study|Death|0|||
149198524|NCT00479557|538193179|FG000|Overall Study|Lack of Efficacy|1|||
149198525|NCT00479557|538193180|FG001|Overall Study|Lack of Efficacy|0|||
149198526|NCT00479557|538193181|FG002|Overall Study|Lack of Efficacy|0|||
149198527|NCT00479557|538193182|FG003|Overall Study|Lack of Efficacy|0|||
149198528|NCT00479557|538193183|FG004|Overall Study|Lack of Efficacy|0|||
149198529|NCT00479557|538193184|FG005|Overall Study|Lack of Efficacy|0|||
149198530|NCT00479557|538193185|FG006|Overall Study|Lack of Efficacy|0|||
149198531|NCT00479557|538193179|FG000|Overall Study|Lost to Follow-up|0|||
149198532|NCT00479557|538193180|FG001|Overall Study|Lost to Follow-up|2|||
149198533|NCT00479557|538193181|FG002|Overall Study|Lost to Follow-up|0|||
149198534|NCT00479557|538193182|FG003|Overall Study|Lost to Follow-up|2|||
149198535|NCT00479557|538193183|FG004|Overall Study|Lost to Follow-up|0|||
149198536|NCT00479557|538193184|FG005|Overall Study|Lost to Follow-up|0|||
149198537|NCT00479557|538193185|FG006|Overall Study|Lost to Follow-up|0|||
149198538|NCT00479557|538193179|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
149198539|NCT00479557|538193180|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
149198540|NCT00479557|538193181|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
149198541|NCT00479557|538193182|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
149198542|NCT00479557|538193183|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
149198543|NCT00479557|538193184|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
149198544|NCT00479557|538193185|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
149198545|NCT00479557|538193179|FG000|Overall Study|AE not related to Study Drug|1|||
149198546|NCT00479557|538193180|FG001|Overall Study|AE not related to Study Drug|3|||
149198547|NCT00479557|538193181|FG002|Overall Study|AE not related to Study Drug|0|||
149198548|NCT00479557|538193182|FG003|Overall Study|AE not related to Study Drug|0|||
149198549|NCT00479557|538193183|FG004|Overall Study|AE not related to Study Drug|2|||
149198550|NCT00479557|538193184|FG005|Overall Study|AE not related to Study Drug|2|||
149198551|NCT00479557|538193185|FG006|Overall Study|AE not related to Study Drug|1|||
149198552|NCT00479557|538193179|FG000|Overall Study|Caregiver Request|2|||
149198553|NCT00479557|538193180|FG001|Overall Study|Caregiver Request|2|||
149198554|NCT00479557|538193181|FG002|Overall Study|Caregiver Request|2|||
149198555|NCT00479557|538193182|FG003|Overall Study|Caregiver Request|0|||
149198556|NCT00479557|538193183|FG004|Overall Study|Caregiver Request|1|||
149198557|NCT00479557|538193184|FG005|Overall Study|Caregiver Request|2|||
149198558|NCT00479557|538193185|FG006|Overall Study|Caregiver Request|0|||
149198559|NCT00479557|538193179|FG000|Overall Study|Investigator Request|0|||
149198560|NCT00479557|538193180|FG001|Overall Study|Investigator Request|0|||
149198561|NCT00479557|538193181|FG002|Overall Study|Investigator Request|1|||
149198562|NCT00479557|538193182|FG003|Overall Study|Investigator Request|0|||
148943293|NCT01466153|537275740|FG000|Overall Study|Investigator Discretion|3|||
148943294|NCT01466153|537275741|FG001|Overall Study|Investigator Discretion|2|||
148943295|NCT01466153|537275742|FG002|Overall Study|Investigator Discretion|2|||
149198563|NCT00479557|538193183|FG004|Overall Study|Investigator Request|0|||
149198564|NCT00479557|538193184|FG005|Overall Study|Investigator Request|0|||
149198565|NCT00479557|538193185|FG006|Overall Study|Investigator Request|0|||
148943296|NCT01466153|537275740|FG000|Overall Study|Randomized-Not Treated|2|||
148943297|NCT01466153|537275741|FG001|Overall Study|Randomized-Not Treated|3|||
148943298|NCT01466153|537275742|FG002|Overall Study|Randomized-Not Treated|4|||
148943299|NCT01466153|537275740|FG000|Overall Study|Other-Unspecified|6|||
148943300|NCT01466153|537275741|FG001|Overall Study|Other-Unspecified|4|||
148943301|NCT01466153|537275742|FG002|Overall Study|Other-Unspecified|2|||
148943302|NCT05695209|537275749|FG000|3-months|Withdrawal by Subject|2|||
149016056|NCT02564055|537537832|FG004|Overall Study|Reached stopping criteria|0|||
149016057|NCT02564055|537537833|FG005|Overall Study|Reached stopping criteria|1|||
149016058|NCT02564055|537537828|FG000|Overall Study|Lost to Follow-up|0|||
149016059|NCT02564055|537537829|FG001|Overall Study|Lost to Follow-up|1|||
149016060|NCT02564055|537537830|FG002|Overall Study|Lost to Follow-up|4|||
149016061|NCT02564055|537537831|FG003|Overall Study|Lost to Follow-up|2|||
149016062|NCT02564055|537537832|FG004|Overall Study|Lost to Follow-up|1|||
149016063|NCT02564055|537537833|FG005|Overall Study|Lost to Follow-up|0|||
149016064|NCT02564055|537537828|FG000|Overall Study|Physician Decision|0|||
149016065|NCT02564055|537537829|FG001|Overall Study|Physician Decision|0|||
149016066|NCT02564055|537537830|FG002|Overall Study|Physician Decision|1|||
149016067|NCT02564055|537537831|FG003|Overall Study|Physician Decision|0|||
149016068|NCT02564055|537537832|FG004|Overall Study|Physician Decision|0|||
149016069|NCT02564055|537537833|FG005|Overall Study|Physician Decision|0|||
149016070|NCT02564055|537537828|FG000|Overall Study|Withdrawal by Subject|4|||
149016071|NCT02564055|537537829|FG001|Overall Study|Withdrawal by Subject|4|||
149016072|NCT02564055|537537830|FG002|Overall Study|Withdrawal by Subject|3|||
149016073|NCT02564055|537537831|FG003|Overall Study|Withdrawal by Subject|3|||
149016074|NCT02564055|537537832|FG004|Overall Study|Withdrawal by Subject|10|||
149016075|NCT02564055|537537833|FG005|Overall Study|Withdrawal by Subject|10|||
149016076|NCT01375959|537537834|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
149016077|NCT01375959|537537835|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
149016078|NCT01375959|537537834|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
149016079|NCT01375959|537537835|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
149016080|NCT01375959|537537834|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
149016081|NCT01375959|537537835|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
149016082|NCT02226172|537537843|FG000|Overall Study|Participant refused further follow-up|4|||
149016083|NCT02226172|537537843|FG000|Overall Study|Other|5|||
149016084|NCT02226172|537537843|FG000|Overall Study|Death|1|||
149016085|NCT02226172|537537843|FG000|Overall Study|Study terminated by sponsor|1|||
149016086|NCT02226172|537537843|FG000|Overall Study|Adverse Event|6|||
149016087|NCT01865617|537537844|FG000|Overall Study|Death|27|||
149016088|NCT01865617|537537845|FG001|Overall Study|Death|3|||
149016089|NCT01865617|537537846|FG002|Overall Study|Death|1|||
149016090|NCT01865617|537537847|FG003|Overall Study|Death|1|||
149016091|NCT01865617|537537848|FG004|Overall Study|Death|5|||
149016092|NCT01865617|537537849|FG005|Overall Study|Death|1|||
149016093|NCT01865617|537537850|FG006|Overall Study|Death|11|||
149016094|NCT01865617|537537851|FG007|Overall Study|Death|1|||
149016095|NCT01865617|537537852|FG008|Overall Study|Death|11|||
149016096|NCT01865617|537537853|FG009|Overall Study|Death|3|||
149016097|NCT01865617|537537854|FG010|Overall Study|Death|32|||
149016098|NCT01865617|537537855|FG011|Overall Study|Death|6|||
149016099|NCT01865617|537537856|FG012|Overall Study|Death|13|||
149016100|NCT01865617|537537844|FG000|Overall Study|Lost to Follow-up|2|||
149016101|NCT01865617|537537845|FG001|Overall Study|Lost to Follow-up|0|||
149016102|NCT01865617|537537846|FG002|Overall Study|Lost to Follow-up|0|||
149016103|NCT01865617|537537847|FG003|Overall Study|Lost to Follow-up|0|||
149016104|NCT01865617|537537848|FG004|Overall Study|Lost to Follow-up|0|||
149016105|NCT01865617|537537849|FG005|Overall Study|Lost to Follow-up|0|||
149016106|NCT01865617|537537850|FG006|Overall Study|Lost to Follow-up|0|||
149016107|NCT01865617|537537851|FG007|Overall Study|Lost to Follow-up|0|||
149016108|NCT01865617|537537852|FG008|Overall Study|Lost to Follow-up|0|||
148943303|NCT05695209|537275750|FG001|3-months|Withdrawal by Subject|0|||
148943304|NCT05695209|537275749|FG000|3-months|Unable to contact for 3-month data collection|0|||
148943305|NCT05695209|537275750|FG001|3-months|Unable to contact for 3-month data collection|1|||
149016109|NCT01865617|537537853|FG009|Overall Study|Lost to Follow-up|0|||
149016110|NCT01865617|537537854|FG010|Overall Study|Lost to Follow-up|0|||
149016111|NCT01865617|537537855|FG011|Overall Study|Lost to Follow-up|0|||
149016112|NCT01865617|537537856|FG012|Overall Study|Lost to Follow-up|0|||
149016113|NCT01865617|537537844|FG000|Overall Study|Withdrawal by Subject|1|||
149016114|NCT01865617|537537845|FG001|Overall Study|Withdrawal by Subject|0|||
149016115|NCT01865617|537537846|FG002|Overall Study|Withdrawal by Subject|0|||
149016116|NCT01865617|537537847|FG003|Overall Study|Withdrawal by Subject|0|||
149016117|NCT01865617|537537848|FG004|Overall Study|Withdrawal by Subject|0|||
149016118|NCT01865617|537537849|FG005|Overall Study|Withdrawal by Subject|0|||
149016119|NCT01865617|537537850|FG006|Overall Study|Withdrawal by Subject|0|||
149016120|NCT01865617|537537851|FG007|Overall Study|Withdrawal by Subject|0|||
149016121|NCT01865617|537537852|FG008|Overall Study|Withdrawal by Subject|0|||
149198566|NCT00479557|538193179|FG000|Overall Study|Subject Request|3|||
149198567|NCT00479557|538193180|FG001|Overall Study|Subject Request|0|||
149016122|NCT01865617|537537853|FG009|Overall Study|Withdrawal by Subject|0|||
149016123|NCT01865617|537537854|FG010|Overall Study|Withdrawal by Subject|0|||
149016124|NCT01865617|537537855|FG011|Overall Study|Withdrawal by Subject|0|||
149016125|NCT01865617|537537856|FG012|Overall Study|Withdrawal by Subject|0|||
149016126|NCT01865617|537537844|FG000|Overall Study|Patient proceeded to new therapy|0|||
149016127|NCT01865617|537537845|FG001|Overall Study|Patient proceeded to new therapy|0|||
149016128|NCT01865617|537537846|FG002|Overall Study|Patient proceeded to new therapy|0|||
149198568|NCT00479557|538193181|FG002|Overall Study|Subject Request|1|||
149198569|NCT00479557|538193182|FG003|Overall Study|Subject Request|1|||
149198570|NCT00479557|538193183|FG004|Overall Study|Subject Request|1|||
149198571|NCT00479557|538193184|FG005|Overall Study|Subject Request|4|||
149198572|NCT00479557|538193185|FG006|Overall Study|Subject Request|1|||
149198573|NCT00479557|538193179|FG000|Overall Study|Other|2|||
149198574|NCT00479557|538193180|FG001|Overall Study|Other|3|||
149198575|NCT00479557|538193181|FG002|Overall Study|Other|1|||
149198576|NCT00479557|538193182|FG003|Overall Study|Other|0|||
149198577|NCT00479557|538193183|FG004|Overall Study|Other|0|||
149198578|NCT00479557|538193184|FG005|Overall Study|Other|3|||
149198579|NCT00479557|538193185|FG006|Overall Study|Other|0|||
149198580|NCT02509494|538193186|FG000|Overall Study|Lost to Follow-up|8|||
149198581|NCT02509494|538193187|FG001|Overall Study|Lost to Follow-up|47|||
149198582|NCT02509494|538193188|FG002|Overall Study|Lost to Follow-up|19|||
149198583|NCT02509494|538193189|FG003|Overall Study|Lost to Follow-up|6|||
149198584|NCT02509494|538193190|FG004|Overall Study|Lost to Follow-up|3|||
149198585|NCT02509494|538193191|FG005|Overall Study|Lost to Follow-up|3|||
149198586|NCT02509494|538193192|FG006|Overall Study|Lost to Follow-up|1|||
149198587|NCT02509494|538193193|FG007|Overall Study|Lost to Follow-up|3|||
149198588|NCT02509494|538193194|FG008|Overall Study|Lost to Follow-up|1|||
149016129|NCT01865617|537537847|FG003|Overall Study|Patient proceeded to new therapy|0|||
149016130|NCT01865617|537537848|FG004|Overall Study|Patient proceeded to new therapy|2|||
149016131|NCT01865617|537537849|FG005|Overall Study|Patient proceeded to new therapy|0|||
149016132|NCT01865617|537537850|FG006|Overall Study|Patient proceeded to new therapy|0|||
149016133|NCT01865617|537537851|FG007|Overall Study|Patient proceeded to new therapy|0|||
149016134|NCT01865617|537537852|FG008|Overall Study|Patient proceeded to new therapy|0|||
149016135|NCT01865617|537537853|FG009|Overall Study|Patient proceeded to new therapy|0|||
149016136|NCT01865617|537537854|FG010|Overall Study|Patient proceeded to new therapy|0|||
149016137|NCT01865617|537537855|FG011|Overall Study|Patient proceeded to new therapy|0|||
149016138|NCT01865617|537537856|FG012|Overall Study|Patient proceeded to new therapy|0|||
149016139|NCT01865617|537537844|FG000|Overall Study|Other|0|||
149016140|NCT01865617|537537845|FG001|Overall Study|Other|0|||
149016141|NCT01865617|537537846|FG002|Overall Study|Other|0|||
149016142|NCT01865617|537537847|FG003|Overall Study|Other|0|||
149016143|NCT01865617|537537848|FG004|Overall Study|Other|0|||
149016144|NCT01865617|537537849|FG005|Overall Study|Other|0|||
149016145|NCT01865617|537537850|FG006|Overall Study|Other|1|||
149016146|NCT01865617|537537851|FG007|Overall Study|Other|0|||
149016147|NCT01865617|537537852|FG008|Overall Study|Other|0|||
149016148|NCT01865617|537537853|FG009|Overall Study|Other|0|||
149016149|NCT01865617|537537854|FG010|Overall Study|Other|0|||
149016150|NCT01865617|537537855|FG011|Overall Study|Other|0|||
149016151|NCT01865617|537537856|FG012|Overall Study|Other|0|||
149016152|NCT00502996|537537859|FG000|Overall Study|Lost to Follow-up|9|||
149016153|NCT00502996|537537859|FG000|Overall Study|Protocol Violation|2|||
149016154|NCT00502996|537537859|FG000|Overall Study|Treatment failure|25|||
149016155|NCT00502996|537537859|FG000|Overall Study|Withdrawal Informed Consent|6|||
149198589|NCT02509494|538193186|FG000|Overall Study|Physician Decision|2|||
149198590|NCT02509494|538193187|FG001|Overall Study|Physician Decision|1|||
149198591|NCT02509494|538193188|FG002|Overall Study|Physician Decision|0|||
149198592|NCT02509494|538193189|FG003|Overall Study|Physician Decision|0|||
149198593|NCT02509494|538193190|FG004|Overall Study|Physician Decision|0|||
149198594|NCT02509494|538193191|FG005|Overall Study|Physician Decision|0|||
149198595|NCT02509494|538193192|FG006|Overall Study|Physician Decision|0|||
149198596|NCT02509494|538193193|FG007|Overall Study|Physician Decision|0|||
149198597|NCT02509494|538193194|FG008|Overall Study|Physician Decision|0|||
149198598|NCT02509494|538193186|FG000|Overall Study|Withdrawal by Subject|4|||
149198599|NCT02509494|538193187|FG001|Overall Study|Withdrawal by Subject|17|||
149198600|NCT02509494|538193188|FG002|Overall Study|Withdrawal by Subject|7|||
149198601|NCT02509494|538193189|FG003|Overall Study|Withdrawal by Subject|5|||
149198602|NCT02509494|538193190|FG004|Overall Study|Withdrawal by Subject|0|||
149016156|NCT00502996|537537859|FG000|Overall Study|Adverse Event|2|||
149016157|NCT02500979|537537860|FG000|Period 1|Hyperglycemia|1|||
149016158|NCT02500979|537537861|FG001|Period 1|Hyperglycemia|0|||
149016159|NCT02500979|537537860|FG000|Period 1|Severe non-compliance to protocol|0|||
149016160|NCT02500979|537537861|FG001|Period 1|Severe non-compliance to protocol|1|||
149016161|NCT02500979|537537860|FG000|Period 1|Adverse Event|1|||
149016162|NCT02500979|537537861|FG001|Period 1|Adverse Event|0|||
149016163|NCT02500979|537537860|FG000|Period 1|Subject decision|2|||
149016164|NCT02500979|537537861|FG001|Period 1|Subject decision|0|||
149016165|NCT02500979|537537860|FG000|Period 2|Change in risk|1|||
149016166|NCT02500979|537537861|FG001|Period 2|Change in risk|0|||
149198603|NCT02509494|538193191|FG005|Overall Study|Withdrawal by Subject|6|||
149198604|NCT02509494|538193192|FG006|Overall Study|Withdrawal by Subject|1|||
149198605|NCT02509494|538193193|FG007|Overall Study|Withdrawal by Subject|2|||
149198606|NCT02509494|538193194|FG008|Overall Study|Withdrawal by Subject|1|||
149198607|NCT02509494|538193186|FG000|Overall Study|Death|0|||
149198608|NCT02509494|538193187|FG001|Overall Study|Death|1|||
149198609|NCT02509494|538193188|FG002|Overall Study|Death|0|||
149198610|NCT02509494|538193189|FG003|Overall Study|Death|0|||
149198611|NCT02509494|538193190|FG004|Overall Study|Death|1|||
149198612|NCT02509494|538193191|FG005|Overall Study|Death|0|||
149198613|NCT02509494|538193192|FG006|Overall Study|Death|0|||
149198614|NCT02509494|538193193|FG007|Overall Study|Death|1|||
149198615|NCT02509494|538193194|FG008|Overall Study|Death|0|||
149198616|NCT02509494|538193186|FG000|Overall Study|Other|0|||
149198617|NCT02509494|538193187|FG001|Overall Study|Other|4|||
149198618|NCT02509494|538193188|FG002|Overall Study|Other|5|||
149198619|NCT02509494|538193189|FG003|Overall Study|Other|0|||
149198620|NCT02509494|538193190|FG004|Overall Study|Other|0|||
149198621|NCT02509494|538193191|FG005|Overall Study|Other|0|||
149198622|NCT02509494|538193192|FG006|Overall Study|Other|0|||
149198623|NCT02509494|538193193|FG007|Overall Study|Other|0|||
149198624|NCT02509494|538193194|FG008|Overall Study|Other|0|||
149198625|NCT02509494|538193186|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149198626|NCT02509494|538193187|FG001|Overall Study|Non-Compliance With Study Drug|11|||
149198627|NCT02509494|538193188|FG002|Overall Study|Non-Compliance With Study Drug|7|||
149198628|NCT02509494|538193189|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149198629|NCT02509494|538193190|FG004|Overall Study|Non-Compliance With Study Drug|1|||
149198630|NCT02509494|538193191|FG005|Overall Study|Non-Compliance With Study Drug|2|||
149198631|NCT02509494|538193192|FG006|Overall Study|Non-Compliance With Study Drug|1|||
149198632|NCT02509494|538193193|FG007|Overall Study|Non-Compliance With Study Drug|1|||
149198633|NCT02509494|538193194|FG008|Overall Study|Non-Compliance With Study Drug|0|||
149198634|NCT01511107|538193195|FG000|Overall Study|Ineligible|3|||
149198635|NCT01511107|538193196|FG001|Overall Study|Ineligible|2|||
148943306|NCT05695209|537275749|FG000|6-months|Lost to Follow-up|1|||
149198636|NCT01511107|538193195|FG000|Overall Study|Lost to Follow-up|10|||
149198637|NCT01511107|538193196|FG001|Overall Study|Lost to Follow-up|19|||
149198638|NCT01511107|538193195|FG000|Overall Study|Withdrawal by Subject|9|||
149198639|NCT01511107|538193196|FG001|Overall Study|Withdrawal by Subject|20|||
148943307|NCT05695209|537275750|FG001|6-months|Lost to Follow-up|1|||
148943308|NCT04362072|537275753|FG000|Treatment|Adverse Event|1|||
148943309|NCT04362072|537275753|FG000|Treatment|Death|9|||
148943310|NCT04362072|537275753|FG000|Treatment|Physician Decision|2|||
148943311|NCT04362072|537275753|FG000|Treatment|Progressive disease|27|||
148943312|NCT04362072|537275753|FG000|Treatment|Withdrawal by Subject|4|||
148943313|NCT04362072|537275753|FG000|Treatment|Global deterioration of health status|1|||
148943314|NCT04362072|537275753|FG000|Treatment|Switched to commercial Lorlatinib|13|||
148943315|NCT04362072|537275753|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
148943316|NCT04362072|537275753|FG000|Treatment|Other|3|||
148943317|NCT04362072|537275753|FG000|Follow up|Death|2|||
148943318|NCT04362072|537275753|FG000|Follow up|Other|2|||
148943319|NCT04731363|537275754|FG000|Overall Study|Could not obtain samples|0|||
148943320|NCT04731363|537275755|FG001|Overall Study|Could not obtain samples|1|||
148943321|NCT04731363|537275756|FG002|Overall Study|Could not obtain samples|0|||
148943322|NCT04731363|537275757|FG003|Overall Study|Could not obtain samples|0|||
148943323|NCT04731363|537275754|FG000|Overall Study|Physician Decision|0|||
148943324|NCT04731363|537275755|FG001|Overall Study|Physician Decision|1|||
148943325|NCT04731363|537275756|FG002|Overall Study|Physician Decision|0|||
148943326|NCT04731363|537275757|FG003|Overall Study|Physician Decision|0|||
148943327|NCT00688753|537277981|FG000|Overall Study|Disease progression|55|||
148943328|NCT00688753|537277981|FG000|Overall Study|Missing|1|||
149198640|NCT04752189|538193197|FG000|Overall Study|Withdrawal by Subject|0|||
149198641|NCT04752189|538193198|FG001|Overall Study|Withdrawal by Subject|150|||
149198642|NCT04752189|538193197|FG000|Overall Study|Lost to Follow-up|261|||
148943329|NCT00688753|537277981|FG000|Overall Study|Death|9|||
148943330|NCT00688753|537277981|FG000|Overall Study|Withdrawal by Subject|3|||
148943331|NCT00688753|537277981|FG000|Overall Study|Adverse Event|20|||
148943332|NCT00688753|537277981|FG000|Overall Study|Protocol Violation|1|||
148943333|NCT00688753|537277981|FG000|Overall Study|Lost to Follow-up|3|||
148943334|NCT05996718|537277982|FG000|Overall Study|Lost to Follow-up|3|||
148943335|NCT01713686|537277983|FG000|Overall Study|Lost to Follow-up|9|||
148943336|NCT01713686|537277983|FG000|Overall Study|Withdrawal by Subject|6|||
148943337|NCT03187197|537277987|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
148943338|NCT03187197|537277988|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
148943339|NCT03187197|537277989|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
148943340|NCT03187197|537277987|FG000|Overall Study|Withdrawal by Subject|8|||
148943341|NCT03187197|537277988|FG001|Overall Study|Withdrawal by Subject|63|||
148943342|NCT03187197|537277989|FG002|Overall Study|Withdrawal by Subject|4|||
148943343|NCT03187197|537277987|FG000|Overall Study|Lost to Follow-up|1|||
148943344|NCT03187197|537277988|FG001|Overall Study|Lost to Follow-up|60|||
148943345|NCT03187197|537277989|FG002|Overall Study|Lost to Follow-up|7|||
148943346|NCT03187197|537277987|FG000|Overall Study|Adverse Event|6|||
148943347|NCT03187197|537277988|FG001|Overall Study|Adverse Event|29|||
148943348|NCT03187197|537277989|FG002|Overall Study|Adverse Event|0|||
148943349|NCT03187197|537277987|FG000|Overall Study|Death|0|||
148943350|NCT03187197|537277988|FG001|Overall Study|Death|11|||
148943351|NCT03187197|537277989|FG002|Overall Study|Death|0|||
148943352|NCT03187197|537277987|FG000|Overall Study|Administrative problem|1|||
148943353|NCT03187197|537277988|FG001|Overall Study|Administrative problem|1|||
148943354|NCT03187197|537277989|FG002|Overall Study|Administrative problem|0|||
148943355|NCT03187197|537277987|FG000|Overall Study|Reason not listed|2|||
148943356|NCT03187197|537277988|FG001|Overall Study|Reason not listed|54|||
148943357|NCT03187197|537277989|FG002|Overall Study|Reason not listed|1|||
148943358|NCT03187197|537277987|FG000|Overall Study|Missing|1|||
148943359|NCT03187197|537277988|FG001|Overall Study|Missing|32|||
148943360|NCT03187197|537277989|FG002|Overall Study|Missing|3|||
148943361|NCT03187197|537277987|FG000|Overall Study|Status missing|2|||
148943362|NCT03187197|537277988|FG001|Overall Study|Status missing|33|||
148943363|NCT03187197|537277989|FG002|Overall Study|Status missing|3|||
148943364|NCT03187197|537277987|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
148943365|NCT03187197|537277988|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
148943366|NCT03187197|537277989|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
148943367|NCT02385045|537277990|FG000|Overall Study|Endoscopy could not be completed|4|||
148943368|NCT02200211|537277993|FG000|Overall Study|Lost to Follow-up|7|||
148943369|NCT02200211|537277994|FG001|Overall Study|Lost to Follow-up|7|||
148943370|NCT02200211|537277995|FG002|Overall Study|Lost to Follow-up|1|||
149198643|NCT04752189|538193198|FG001|Overall Study|Lost to Follow-up|126|||
148943371|NCT02200211|537277996|FG003|Overall Study|Lost to Follow-up|2|||
148943372|NCT02200211|537277993|FG000|Overall Study|Withdrawal by Subject|1|||
148943373|NCT02200211|537277994|FG001|Overall Study|Withdrawal by Subject|0|||
148943374|NCT02200211|537277995|FG002|Overall Study|Withdrawal by Subject|0|||
148943375|NCT02200211|537277996|FG003|Overall Study|Withdrawal by Subject|0|||
149016167|NCT01613027|537537864|FG000|Overall Study|Lost to Follow-up|5|||
148943376|NCT00381485|537277997|FG000|Open-Label Run-In Period|Adverse Event|9|||
148943377|NCT00381485|537277998|FG001|Open-Label Run-In Period|Adverse Event|0|||
148943378|NCT00381485|537277999|FG002|Open-Label Run-In Period|Adverse Event|0|||
148943379|NCT00381485|537278000|FG003|Open-Label Run-In Period|Adverse Event|0|||
148943380|NCT00381485|537277997|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
148943381|NCT00381485|537277998|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
148943382|NCT00381485|537277999|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
149016168|NCT01613027|537537864|FG000|Overall Study|Switched Physician|1|||
149016169|NCT01613027|537537864|FG000|Overall Study|Lack of Efficacy|1|||
149016170|NCT01613027|537537864|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
149016171|NCT04267614|537537867|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
149016172|NCT04267614|537537867|FG000|Overall Study|Lost to Follow-up|115|||
149016173|NCT03632434|537537873|FG000|Overall Study|Withdrawal by Subject|2|||
149016174|NCT02303626|537537875|FG000|Overall Study|Lack of Efficacy|1|||
149016175|NCT02303626|537537876|FG001|Overall Study|Lack of Efficacy|0|||
149016176|NCT02303626|537537877|FG002|Overall Study|Lack of Efficacy|1|||
149016177|NCT02303626|537537875|FG000|Overall Study|Adverse Event|0|||
149016178|NCT02303626|537537876|FG001|Overall Study|Adverse Event|2|||
149016179|NCT02303626|537537877|FG002|Overall Study|Adverse Event|0|||
149016180|NCT02303626|537537875|FG000|Overall Study|Protocol Violation|0|||
149016181|NCT02303626|537537876|FG001|Overall Study|Protocol Violation|1|||
149016182|NCT02303626|537537877|FG002|Overall Study|Protocol Violation|0|||
149016183|NCT02303626|537537875|FG000|Overall Study|Pregnancy|0|||
149016184|NCT02303626|537537876|FG001|Overall Study|Pregnancy|0|||
149016185|NCT02303626|537537877|FG002|Overall Study|Pregnancy|1|||
149016186|NCT02303626|537537875|FG000|Overall Study|Subject Non-Compliance|0|||
149016187|NCT02303626|537537876|FG001|Overall Study|Subject Non-Compliance|0|||
149016188|NCT02303626|537537877|FG002|Overall Study|Subject Non-Compliance|1|||
149016189|NCT05376371|537537878|FG000|Overall Study|change in release date|10|||
149016190|NCT04159415|537537879|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016191|NCT04159415|537537880|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016192|NCT04159415|537537881|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016193|NCT04159415|537537882|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016194|NCT04159415|537537883|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016195|NCT04159415|537537884|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016196|NCT04159415|537537885|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
149016197|NCT04159415|537537886|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
149016198|NCT04159415|537537887|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016199|NCT04159415|537537888|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
149016200|NCT04159415|537537879|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016201|NCT04159415|537537880|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016202|NCT04159415|537537881|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016203|NCT04159415|537537882|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016204|NCT04159415|537537883|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016205|NCT04159415|537537884|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016206|NCT04159415|537537885|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016207|NCT04159415|537537886|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
149016208|NCT04159415|537537887|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016209|NCT04159415|537537888|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
149016210|NCT04159415|537537879|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016211|NCT04159415|537537880|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016212|NCT04159415|537537881|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016213|NCT04159415|537537882|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016214|NCT04159415|537537883|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016215|NCT04159415|537537884|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016216|NCT04159415|537537885|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016217|NCT04159415|537537886|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
149016218|NCT04159415|537537887|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149016219|NCT04159415|537537888|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
149198644|NCT00975195|538193199|FG000|Overall Study|Adverse Event|108|||
149198645|NCT00975195|538193200|FG001|Overall Study|Adverse Event|101|||
149198646|NCT00975195|538193199|FG000|Overall Study|Lack of Efficacy|6|||
149198647|NCT00975195|538193200|FG001|Overall Study|Lack of Efficacy|6|||
149198648|NCT00975195|538193199|FG000|Overall Study|Protocol Violation|27|||
149198649|NCT00975195|538193200|FG001|Overall Study|Protocol Violation|23|||
149198650|NCT00975195|538193199|FG000|Overall Study|Lost to Follow-up|9|||
149198651|NCT00975195|538193200|FG001|Overall Study|Lost to Follow-up|7|||
149198652|NCT00975195|538193199|FG000|Overall Study|Withdrawal by Subject|48|||
149198653|NCT00975195|538193200|FG001|Overall Study|Withdrawal by Subject|61|||
148943383|NCT00381485|537278000|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
148943384|NCT00381485|537277997|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
149198654|NCT00975195|538193199|FG000|Overall Study|Other reason not defined above|29|||
149198655|NCT00975195|538193200|FG001|Overall Study|Other reason not defined above|33|||
149198656|NCT00975195|538193199|FG000|Overall Study|Not treated|1|||
149198657|NCT00975195|538193200|FG001|Overall Study|Not treated|2|||
149198658|NCT05195359|538194389|FG000|Overall Study|Lost to Follow-up|124|||
149198659|NCT05195359|538194390|FG001|Overall Study|Lost to Follow-up|34|||
149198660|NCT01146951|538194395|FG000|Overall Study|Adverse Event|4|||
149198661|NCT01146951|538194396|FG001|Overall Study|Adverse Event|1|||
149198662|NCT02690207|538194400|FG000|Overall Study|Lost to Follow-up|48|||
149198663|NCT02690207|538194400|FG000|Overall Study|Withdrawal by Subject|46|||
149198664|NCT02690207|538194400|FG000|Overall Study|Protocol Violation|2|||
149198665|NCT02690207|538194400|FG000|Overall Study|Serious adverse event|110|||
149198666|NCT02690207|538194400|FG000|Overall Study|Non-serious Adverse Event|18|||
149198667|NCT02690207|538194400|FG000|Overall Study|Migrated/moved from study area|5|||
149198668|NCT02690207|538194400|FG000|Overall Study|Suspected HZ Episode|1|||
149198669|NCT02690207|538194400|FG000|Overall Study|Other reasons for withdrawal|23|||
149198670|NCT01175213|538194405|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
149198671|NCT01175213|538194406|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
149198672|NCT01175213|538194405|FG000|IGSC, 10%/rHuPH20|Death|1|||
148808467|NCT03836053|536777501|FG000|Overall Study|Withdrawal of consent from study|0|||
148808468|NCT03836053|536777502|FG001|Overall Study|Withdrawal of consent from study|0|||
148808469|NCT03836053|536777503|FG002|Overall Study|Withdrawal of consent from study|1|||
148943385|NCT00381485|537277998|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
148943386|NCT00381485|537277999|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
148943387|NCT00381485|537278000|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
148943388|NCT00381485|537277997|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
148943389|NCT00381485|537277998|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
148943390|NCT00381485|537277999|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
148943391|NCT00381485|537278000|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
148943392|NCT00381485|537277997|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
148943393|NCT00381485|537277998|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
148943394|NCT00381485|537277999|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
148943395|NCT00381485|537278000|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
148943396|NCT00381485|537277997|FG000|Open-Label Run-In Period|Treatment failure|1|||
148943397|NCT00381485|537277998|FG001|Open-Label Run-In Period|Treatment failure|0|||
148943398|NCT00381485|537277999|FG002|Open-Label Run-In Period|Treatment failure|0|||
148943399|NCT00381485|537278000|FG003|Open-Label Run-In Period|Treatment failure|0|||
148943400|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148943401|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Adverse Event|2|||
148943402|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Adverse Event|2|||
148943403|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Adverse Event|5|||
148943404|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
148943405|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
148943406|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
148943407|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
148943408|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
148943409|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
148943410|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
148943411|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
148943412|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
148943413|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
148943414|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
148943415|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
148943416|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
148943417|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
148943418|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
148943419|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
148943420|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
149198673|NCT01175213|538194406|FG001|IGSC, 10%/rHuPH20|Death|0|||
148808470|NCT03836053|536777501|FG000|Overall Study|Decision by sponsor|0|||
148808471|NCT03836053|536777502|FG001|Overall Study|Decision by sponsor|2|||
148943421|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
148943422|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
148943423|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
149198674|NCT01175213|538194405|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
149198675|NCT01175213|538194406|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
149198676|NCT01175213|538194405|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
149198677|NCT01175213|538194406|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
149198678|NCT01175213|538194405|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
149198679|NCT01175213|538194406|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
149198680|NCT01175213|538194405|FG000|Safety Follow-up|Adverse Event|1|||
149198681|NCT01175213|538194406|FG001|Safety Follow-up|Adverse Event|0|||
149198682|NCT03057951|538194408|FG000|Overall Study|Adverse Event|553|||
149198683|NCT03057951|538194409|FG001|Overall Study|Adverse Event|575|||
149198684|NCT03057951|538194408|FG000|Overall Study|Protocol Violation|30|||
149198685|NCT03057951|538194409|FG001|Overall Study|Protocol Violation|24|||
149198686|NCT03057951|538194408|FG000|Overall Study|Lost to Follow-up|6|||
149198687|NCT03057951|538194409|FG001|Overall Study|Lost to Follow-up|16|||
149198688|NCT03057951|538194408|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
149198689|NCT03057951|538194409|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
149198690|NCT03057951|538194408|FG000|Overall Study|Study drug stopped, reason missing|6|||
149198691|NCT03057951|538194409|FG001|Overall Study|Study drug stopped, reason missing|1|||
149198692|NCT03057951|538194408|FG000|Overall Study|Medical advice|6|||
149198693|NCT03057951|538194409|FG001|Overall Study|Medical advice|2|||
149198694|NCT03057951|538194408|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
148943424|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
148943425|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
148943426|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
148943427|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
148943428|NCT00381485|537277997|FG000|Double-Blind Treatment Period|Administrative|0|||
148943429|NCT00381485|537277998|FG001|Double-Blind Treatment Period|Administrative|1|||
148943430|NCT00381485|537277999|FG002|Double-Blind Treatment Period|Administrative|0|||
148943431|NCT00381485|537278000|FG003|Double-Blind Treatment Period|Administrative|1|||
148943432|NCT01235351|537278001|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
148943433|NCT01235351|537278002|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
148943434|NCT01918774|537278003|FG000|Overall Study|Lost prior to first CBTw session|4|||
148943435|NCT01918774|537278003|FG000|Overall Study|Lost to Follow-up|1|||
148943436|NCT01606800|537278004|FG000|Overall Study|Adverse Event|3|||
148943437|NCT01606800|537278005|FG001|Overall Study|Adverse Event|1|||
148943438|NCT01606800|537278004|FG000|Overall Study|Participant withdrew consent|0|||
148943439|NCT01606800|537278005|FG001|Overall Study|Participant withdrew consent|1|||
148943440|NCT01606800|537278004|FG000|Overall Study|Missing completion status|2|||
148943441|NCT01606800|537278005|FG001|Overall Study|Missing completion status|0|||
148943442|NCT00126191|537278012|FG000|Overall Study|Physician Decision|0|||
148943443|NCT00126191|537278013|FG001|Overall Study|Physician Decision|1|||
148943444|NCT00126191|537278012|FG000|Overall Study|Death|0|||
148943445|NCT00126191|537278013|FG001|Overall Study|Death|1|||
148943446|NCT00307294|537278014|FG000|Overall Study|Withdrawal by Subject|1|||
148943447|NCT02955602|537278021|FG000|Overall Study|Adverse Event|0|||
148943448|NCT02955602|537278022|FG001|Overall Study|Adverse Event|3|||
148943449|NCT02955602|537278023|FG002|Overall Study|Adverse Event|0|||
148943450|NCT02955602|537278021|FG000|Overall Study|Withdrawal of informed consent|1|||
148943451|NCT02955602|537278022|FG001|Overall Study|Withdrawal of informed consent|3|||
148943452|NCT02955602|537278023|FG002|Overall Study|Withdrawal of informed consent|2|||
148943453|NCT02955602|537278021|FG000|Overall Study|Lost to Follow-up|0|||
148943454|NCT02955602|537278022|FG001|Overall Study|Lost to Follow-up|0|||
148943455|NCT02955602|537278023|FG002|Overall Study|Lost to Follow-up|1|||
148943456|NCT02955602|537278021|FG000|Overall Study|Other|0|||
148943457|NCT02955602|537278022|FG001|Overall Study|Other|1|||
148943458|NCT02955602|537278023|FG002|Overall Study|Other|3|||
148943459|NCT02980601|537278024|FG000|Overall Study|Lost to Follow-up|2|||
148943460|NCT02980601|537278025|FG001|Overall Study|Lost to Follow-up|2|||
148943461|NCT02980601|537278024|FG000|Overall Study|Death|0|||
148943462|NCT02980601|537278025|FG001|Overall Study|Death|1|||
149198695|NCT03057951|538194409|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
149198696|NCT03057951|538194408|FG000|Overall Study|Investigator decision|2|||
149198697|NCT03057951|538194409|FG001|Overall Study|Investigator decision|0|||
149198698|NCT03057951|538194408|FG000|Overall Study|Patient decision|5|||
149198699|NCT03057951|538194409|FG001|Overall Study|Patient decision|2|||
149198700|NCT03057951|538194408|FG000|Overall Study|Not attending study visits|3|||
149198701|NCT03057951|538194409|FG001|Overall Study|Not attending study visits|0|||
149198702|NCT03057951|538194408|FG000|Overall Study|Patient moved away|3|||
149198703|NCT03057951|538194409|FG001|Overall Study|Patient moved away|4|||
148943463|NCT02980601|537278024|FG000|Overall Study|Graft loss|1|||
148943464|NCT02980601|537278025|FG001|Overall Study|Graft loss|0|||
148943465|NCT02980601|537278024|FG000|Overall Study|Failed to sign consent|2|||
148943466|NCT02980601|537278025|FG001|Overall Study|Failed to sign consent|0|||
148943467|NCT01575769|537278026|FG000|Overall Study|Adverse Event|1|||
149198704|NCT03057951|538194408|FG000|Overall Study|Other reason than stated above|23|||
149198705|NCT03057951|538194409|FG001|Overall Study|Other reason than stated above|29|||
149198706|NCT03057951|538194408|FG000|Overall Study|Not treated|2|||
149198707|NCT03057951|538194409|FG001|Overall Study|Not treated|1|||
148943468|NCT01575769|537278026|FG000|Overall Study|Study terminated by sponsor|40|||
148943469|NCT02501473|537278029|FG000|Overall Study|Study Terminated|2|||
149198708|NCT02064205|538194410|FG000|Overall Study|Withdrawal by Subject|1|||
149198709|NCT02700919|538194411|FG000|Overall Study|Physician Decision|1|||
149198710|NCT02700919|538194412|FG001|Overall Study|Physician Decision|0|||
149198711|NCT02700919|538194413|FG002|Overall Study|Physician Decision|0|||
149198712|NCT02700919|538194411|FG000|Overall Study|Protocol Violation|1|||
149198713|NCT02700919|538194412|FG001|Overall Study|Protocol Violation|0|||
149198714|NCT02700919|538194413|FG002|Overall Study|Protocol Violation|0|||
149198715|NCT02700919|538194411|FG000|Overall Study|Adverse Event|1|||
149198716|NCT02700919|538194412|FG001|Overall Study|Adverse Event|3|||
149198717|NCT02700919|538194413|FG002|Overall Study|Adverse Event|1|||
149198718|NCT02700919|538194411|FG000|Overall Study|Withdrawal by Subject|5|||
149198719|NCT02700919|538194412|FG001|Overall Study|Withdrawal by Subject|8|||
149198720|NCT02700919|538194413|FG002|Overall Study|Withdrawal by Subject|2|||
149198721|NCT02700919|538194411|FG000|Overall Study|Lost to Follow-up|2|||
149198722|NCT02700919|538194412|FG001|Overall Study|Lost to Follow-up|0|||
149198723|NCT02700919|538194413|FG002|Overall Study|Lost to Follow-up|0|||
149198724|NCT02700919|538194411|FG000|Overall Study|Other|2|||
149198725|NCT02700919|538194412|FG001|Overall Study|Other|1|||
149198726|NCT02700919|538194413|FG002|Overall Study|Other|1|||
149198727|NCT05136170|538194414|FG000|Overall Study|Withdrawal by Subject|2|||
149198728|NCT05136170|538194415|FG001|Overall Study|Withdrawal by Subject|2|||
149198729|NCT05136170|538194414|FG000|Overall Study|Can no longer make office visits|1|||
149198730|NCT05136170|538194415|FG001|Overall Study|Can no longer make office visits|0|||
149198731|NCT00571688|538194422|FG000|Overall Study|Lost to Follow-up|3|||
149198732|NCT00571688|538194423|FG001|Overall Study|Lost to Follow-up|6|||
149198733|NCT00571688|538194422|FG000|Overall Study|subject did not tolerate Consta|1|||
149198734|NCT00571688|538194423|FG001|Overall Study|subject did not tolerate Consta|0|||
149198735|NCT00571688|538194422|FG000|Overall Study|subject moved out of the area|1|||
149198736|NCT00571688|538194423|FG001|Overall Study|subject moved out of the area|0|||
149198737|NCT01048853|538194424|FG000|Overall Study|Death|1|||
149198738|NCT01048853|538194425|FG001|Overall Study|Death|0|||
149198739|NCT01048853|538194426|FG002|Overall Study|Death|0|||
149198740|NCT01048853|538194424|FG000|Overall Study|Lost to Follow-up|1|||
149198741|NCT01048853|538194425|FG001|Overall Study|Lost to Follow-up|4|||
149198742|NCT01048853|538194426|FG002|Overall Study|Lost to Follow-up|0|||
149198743|NCT04999969|538194427|FG000|Overall Study|Death|76|||
149198744|NCT04999969|538194427|FG000|Overall Study|Progressive Disease|1|||
149198745|NCT04999969|538194427|FG000|Overall Study|Withdrawal by Subject|8|||
149198746|NCT04735393|538194437|FG000|Overall Study|Lost to Follow-up|46|||
149198747|NCT04735393|538194438|FG001|Overall Study|Lost to Follow-up|24|||
149198748|NCT04735393|538194437|FG000|Overall Study|Physician Decision|2|||
149198749|NCT04735393|538194438|FG001|Overall Study|Physician Decision|1|||
149198750|NCT04735393|538194437|FG000|Overall Study|Not Detailed|1|||
149198751|NCT04735393|538194438|FG001|Overall Study|Not Detailed|2|||
149198752|NCT04735393|538194437|FG000|Overall Study|Withdrawal by Subject|71|||
149198753|NCT04735393|538194438|FG001|Overall Study|Withdrawal by Subject|28|||
149198754|NCT04735393|538194437|FG000|Overall Study|Adverse Event|56|||
149198755|NCT04735393|538194438|FG001|Overall Study|Adverse Event|7|||
149198756|NCT04735393|538194437|FG000|Overall Study|Protocol Violation|6|||
149198757|NCT04735393|538194438|FG001|Overall Study|Protocol Violation|1|||
149198758|NCT04735393|538194437|FG000|Overall Study|Trial terminated by Sponsor|49|||
149198759|NCT04735393|538194438|FG001|Overall Study|Trial terminated by Sponsor|29|||
149198760|NCT03150095|538194441|FG000|Overall Study|Death|0|||
149198761|NCT03150095|538194442|FG001|Overall Study|Death|1|||
148943470|NCT02501473|537278030|FG001|Overall Study|Study Terminated|3|||
148943471|NCT02501473|537278031|FG002|Overall Study|Study Terminated|7|||
148943472|NCT02501473|537278032|FG003|Overall Study|Study Terminated|9|||
148943473|NCT02501473|537278033|FG004|Overall Study|Study Terminated|2|||
148943474|NCT02501473|537278034|FG005|Overall Study|Study Terminated|10|||
149198762|NCT03150095|538194441|FG000|Overall Study|Lost to Follow-up|1|||
149198763|NCT03150095|538194442|FG001|Overall Study|Lost to Follow-up|1|||
149198764|NCT03150095|538194441|FG000|Overall Study|Withdrawal by Subject|4|||
149198765|NCT03150095|538194442|FG001|Overall Study|Withdrawal by Subject|0|||
149198766|NCT03150095|538194441|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
149198767|NCT03150095|538194442|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
148943475|NCT02501473|537278035|FG006|Overall Study|Study Terminated|1|||
149198768|NCT03224104|538194446|FG000|Overall Study|Lack of Efficacy|2|||
148943476|NCT02501473|537278036|FG007|Overall Study|Study Terminated|0|||
148943477|NCT02501473|537278029|FG000|Overall Study|Withdrawal by Subject|0|||
149198769|NCT03224104|538194447|FG001|Overall Study|Lack of Efficacy|6|||
149198770|NCT03224104|538194448|FG002|Overall Study|Lack of Efficacy|3|||
149198771|NCT03224104|538194449|FG003|Overall Study|Lack of Efficacy|4|||
149198772|NCT03224104|538194450|FG004|Overall Study|Lack of Efficacy|42|||
149198773|NCT03224104|538194446|FG000|Overall Study|Withdrawal by Subject|0|||
149198774|NCT03224104|538194447|FG001|Overall Study|Withdrawal by Subject|2|||
149198775|NCT03224104|538194448|FG002|Overall Study|Withdrawal by Subject|0|||
149198776|NCT03224104|538194449|FG003|Overall Study|Withdrawal by Subject|1|||
149198777|NCT03224104|538194450|FG004|Overall Study|Withdrawal by Subject|3|||
149198778|NCT03224104|538194446|FG000|Overall Study|Death|0|||
149198779|NCT03224104|538194447|FG001|Overall Study|Death|1|||
149198780|NCT03224104|538194448|FG002|Overall Study|Death|0|||
149198781|NCT03224104|538194449|FG003|Overall Study|Death|0|||
149198782|NCT03224104|538194450|FG004|Overall Study|Death|0|||
149198783|NCT03224104|538194446|FG000|Overall Study|Adverse Event|1|||
149198784|NCT03224104|538194447|FG001|Overall Study|Adverse Event|0|||
149198785|NCT03224104|538194448|FG002|Overall Study|Adverse Event|0|||
149198786|NCT03224104|538194449|FG003|Overall Study|Adverse Event|1|||
149198787|NCT03224104|538194450|FG004|Overall Study|Adverse Event|3|||
149198788|NCT03224104|538194446|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
149198789|NCT03224104|538194447|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
149198790|NCT03224104|538194448|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
149198791|NCT03224104|538194449|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
149198792|NCT03224104|538194450|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
149198793|NCT03224104|538194446|FG000|Overall Study|Treatment ongoing|0|||
149198794|NCT03224104|538194447|FG001|Overall Study|Treatment ongoing|0|||
149198795|NCT03224104|538194448|FG002|Overall Study|Treatment ongoing|0|||
149198796|NCT03224104|538194449|FG003|Overall Study|Treatment ongoing|0|||
149198797|NCT03224104|538194450|FG004|Overall Study|Treatment ongoing|1|||
149198798|NCT05025787|538194451|FG000|Overall Study|Lack of Efficacy|0|||
149198799|NCT05025787|538194452|FG001|Overall Study|Lack of Efficacy|1|||
149198800|NCT05025787|538194451|FG000|Overall Study|Adverse Event|2|||
149198801|NCT05025787|538194452|FG001|Overall Study|Adverse Event|4|||
149198802|NCT05025787|538194451|FG000|Overall Study|Non compliance|0|||
149198803|NCT05025787|538194452|FG001|Overall Study|Non compliance|1|||
149198804|NCT05025787|538194451|FG000|Overall Study|Protocol Violation|3|||
149198805|NCT05025787|538194452|FG001|Overall Study|Protocol Violation|1|||
149198806|NCT05025787|538194451|FG000|Overall Study|Stopping criteria met|1|||
149198807|NCT05025787|538194452|FG001|Overall Study|Stopping criteria met|1|||
149198808|NCT05025787|538194451|FG000|Overall Study|Withdrawal by Subject|3|||
149198809|NCT05025787|538194452|FG001|Overall Study|Withdrawal by Subject|1|||
149198810|NCT05600309|538194453|FG000|Overall Study|Death|41|||
149198811|NCT05600309|538194454|FG001|Overall Study|Death|38|||
149198812|NCT05600309|538194453|FG000|Overall Study|Sponsor Decision|9|||
149198813|NCT05600309|538194454|FG001|Overall Study|Sponsor Decision|6|||
149198814|NCT06087328|538194455|FG000|28-Day Treatment|Lost to Follow-up|7|||
149198815|NCT06087328|538194456|FG001|28-Day Treatment|Lost to Follow-up|3|||
149198816|NCT06087328|538194457|FG002|28-Day Treatment|Lost to Follow-up|4|||
149198817|NCT06087328|538194455|FG000|1-month Follow-up|Lost to Follow-up|0|||
149198818|NCT06087328|538194456|FG001|1-month Follow-up|Lost to Follow-up|1|||
149198819|NCT06087328|538194457|FG002|1-month Follow-up|Lost to Follow-up|1|||
149198820|NCT05822830|538194458|FG000|Overall Study|Adverse Event|6|||
149198821|NCT05822830|538194459|FG001|Overall Study|Adverse Event|6|||
149198822|NCT05822830|538194458|FG000|Overall Study|Assigned Treatment by Mistake|5|||
149198823|NCT05822830|538194459|FG001|Overall Study|Assigned Treatment by Mistake|3|||
149198824|NCT05822830|538194458|FG000|Overall Study|Lost to Follow-up|16|||
149198825|NCT05822830|538194459|FG001|Overall Study|Lost to Follow-up|18|||
149198826|NCT05822830|538194458|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149198827|NCT05822830|538194459|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149198828|NCT05822830|538194458|FG000|Overall Study|Participant was Out of the Country|0|||
149198829|NCT05822830|538194459|FG001|Overall Study|Participant was Out of the Country|1|||
149198830|NCT05822830|538194458|FG000|Overall Study|Pregnancy|1|||
149198831|NCT05822830|538194459|FG001|Overall Study|Pregnancy|2|||
149198832|NCT05822830|538194458|FG000|Overall Study|Withdrawal by Subject|27|||
149198833|NCT05822830|538194459|FG001|Overall Study|Withdrawal by Subject|26|||
149198834|NCT03368664|538194461|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
149198835|NCT03368664|538194461|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
149198836|NCT03368664|538194461|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
149198837|NCT03368664|538194461|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
149198838|NCT03589326|538194469|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
149198839|NCT03589326|538194470|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
149198840|NCT03589326|538194469|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
149198841|NCT03589326|538194470|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
149198842|NCT03589326|538194469|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
149198843|NCT03589326|538194470|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
148682869|NCT02270983|536313015|FG000|Overall Study|study procedure non-compliance|1|||
149198844|NCT03589326|538194469|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
149198845|NCT03589326|538194470|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
149198846|NCT03589326|538194469|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
149198847|NCT03589326|538194470|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
149198848|NCT05441592|538194471|FG000|Overall Study|Lost to Follow-up|1|||
149198849|NCT05441592|538194472|FG001|Overall Study|Lost to Follow-up|5|||
149198850|NCT01371981|538194473|FG000|Overall Study|Adverse Event|12|||
149198851|NCT01371981|538194474|FG001|Overall Study|Adverse Event|17|||
148943478|NCT02501473|537278030|FG001|Overall Study|Withdrawal by Subject|0|||
148943479|NCT02501473|537278031|FG002|Overall Study|Withdrawal by Subject|3|||
148943480|NCT02501473|537278032|FG003|Overall Study|Withdrawal by Subject|3|||
148943481|NCT02501473|537278033|FG004|Overall Study|Withdrawal by Subject|2|||
148943482|NCT02501473|537278034|FG005|Overall Study|Withdrawal by Subject|2|||
148943483|NCT02501473|537278035|FG006|Overall Study|Withdrawal by Subject|0|||
148943484|NCT02501473|537278036|FG007|Overall Study|Withdrawal by Subject|0|||
149198852|NCT01371981|538194475|FG002|Overall Study|Adverse Event|0|||
149198853|NCT01371981|538194476|FG003|Overall Study|Adverse Event|4|||
149198854|NCT01371981|538194477|FG004|Overall Study|Adverse Event|1|||
149198855|NCT01371981|538194478|FG005|Overall Study|Adverse Event|0|||
149198856|NCT01371981|538194473|FG000|Overall Study|Death|22|||
149198857|NCT01371981|538194474|FG001|Overall Study|Death|16|||
149198858|NCT01371981|538194475|FG002|Overall Study|Death|0|||
149198859|NCT01371981|538194476|FG003|Overall Study|Death|0|||
149198860|NCT01371981|538194477|FG004|Overall Study|Death|2|||
149198861|NCT01371981|538194478|FG005|Overall Study|Death|2|||
149198862|NCT01371981|538194473|FG000|Overall Study|Lack of Efficacy|69|||
149198863|NCT01371981|538194474|FG001|Overall Study|Lack of Efficacy|61|||
149198864|NCT01371981|538194475|FG002|Overall Study|Lack of Efficacy|4|||
149198865|NCT01371981|538194476|FG003|Overall Study|Lack of Efficacy|8|||
149198866|NCT01371981|538194477|FG004|Overall Study|Lack of Efficacy|5|||
149198867|NCT01371981|538194478|FG005|Overall Study|Lack of Efficacy|0|||
149198868|NCT01371981|538194473|FG000|Overall Study|Physician Decision|48|||
149198869|NCT01371981|538194474|FG001|Overall Study|Physician Decision|63|||
149198870|NCT01371981|538194475|FG002|Overall Study|Physician Decision|1|||
149198871|NCT01371981|538194476|FG003|Overall Study|Physician Decision|7|||
149198872|NCT01371981|538194477|FG004|Overall Study|Physician Decision|14|||
149198873|NCT01371981|538194478|FG005|Overall Study|Physician Decision|3|||
149198874|NCT01371981|538194473|FG000|Overall Study|Withdrawal by Subject|12|||
149198875|NCT01371981|538194474|FG001|Overall Study|Withdrawal by Subject|19|||
149198876|NCT01371981|538194475|FG002|Overall Study|Withdrawal by Subject|1|||
149198877|NCT01371981|538194476|FG003|Overall Study|Withdrawal by Subject|2|||
149198878|NCT01371981|538194477|FG004|Overall Study|Withdrawal by Subject|10|||
149198879|NCT01371981|538194478|FG005|Overall Study|Withdrawal by Subject|3|||
149198880|NCT01371981|538194473|FG000|Overall Study|Ineligible|19|||
149198881|NCT01371981|538194474|FG001|Overall Study|Ineligible|13|||
149198882|NCT01371981|538194475|FG002|Overall Study|Ineligible|0|||
149198883|NCT01371981|538194476|FG003|Overall Study|Ineligible|0|||
149198884|NCT01371981|538194477|FG004|Overall Study|Ineligible|0|||
149198885|NCT01371981|538194478|FG005|Overall Study|Ineligible|4|||
149198886|NCT01371981|538194473|FG000|Overall Study|Did not start treatment|2|||
149198887|NCT01371981|538194474|FG001|Overall Study|Did not start treatment|3|||
149198888|NCT01371981|538194475|FG002|Overall Study|Did not start treatment|0|||
149198889|NCT01371981|538194476|FG003|Overall Study|Did not start treatment|0|||
149198890|NCT01371981|538194477|FG004|Overall Study|Did not start treatment|0|||
149198891|NCT01371981|538194478|FG005|Overall Study|Did not start treatment|2|||
149198892|NCT01586156|538194479|FG000|Overall Study|Pregnancy|0|||
148943485|NCT02501473|537278029|FG000|Overall Study|Death|0|||
148943486|NCT02501473|537278030|FG001|Overall Study|Death|0|||
149198893|NCT01586156|538194480|FG001|Overall Study|Pregnancy|1|||
149198894|NCT01586156|538194481|FG002|Overall Study|Pregnancy|0|||
149198895|NCT00414960|538194483|FG000|Overall Study|Adverse Event|4|||
149198896|NCT00414960|538194484|FG001|Overall Study|Adverse Event|0|||
149198897|NCT00414960|538194483|FG000|Overall Study|Withdrawal by Subject|3|||
149198898|NCT00414960|538194484|FG001|Overall Study|Withdrawal by Subject|0|||
148943487|NCT02501473|537278031|FG002|Overall Study|Death|1|||
148943488|NCT02501473|537278032|FG003|Overall Study|Death|1|||
149198899|NCT00414960|538194483|FG000|Overall Study|Physician Decision|0|||
149198900|NCT00414960|538194484|FG001|Overall Study|Physician Decision|1|||
149198901|NCT00717366|538194486|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
149198902|NCT00717366|538194487|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
149198903|NCT00717366|538194486|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
149198904|NCT00717366|538194487|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
149198905|NCT00717366|538194486|FG000|Core Study Period (20 Weeks)|Death|0|||
149198906|NCT00717366|538194487|FG001|Core Study Period (20 Weeks)|Death|1|||
149198907|NCT00717366|538194486|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
149198908|NCT00717366|538194487|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
149198909|NCT00717366|538194486|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
149198910|NCT00717366|538194487|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
149198911|NCT00717366|538194486|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
149198912|NCT00717366|538194487|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
149198913|NCT00717366|538194486|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
149198914|NCT00717366|538194487|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
149198915|NCT02104804|538194488|FG000|Overall Study|Did not take study medication|0|||
149198916|NCT02104804|538194489|FG001|Overall Study|Did not take study medication|1|||
149198917|NCT02104804|538194488|FG000|Overall Study|Study specific discontinuation criteria|6|||
149198918|NCT02104804|538194489|FG001|Overall Study|Study specific discontinuation criteria|1|||
149198919|NCT02104804|538194488|FG000|Overall Study|Other listed|2|||
149198920|NCT02104804|538194489|FG001|Overall Study|Other listed|1|||
149198921|NCT02104804|538194488|FG000|Overall Study|Protocol Violation|0|||
149198922|NCT02104804|538194489|FG001|Overall Study|Protocol Violation|1|||
149198923|NCT02104804|538194488|FG000|Overall Study|Adverse Event|4|||
149198924|NCT02104804|538194489|FG001|Overall Study|Adverse Event|3|||
149198925|NCT02104804|538194488|FG000|Overall Study|Withdrawal by Subject|4|||
149198926|NCT02104804|538194489|FG001|Overall Study|Withdrawal by Subject|12|||
149198927|NCT00434122|538194493|FG000|Overall Study|Non-compliance with protocol|0|||
149198928|NCT00434122|538194494|FG001|Overall Study|Non-compliance with protocol|1|||
149198929|NCT00434122|538194493|FG000|Overall Study|loss of subject contact|1|||
149198930|NCT00434122|538194494|FG001|Overall Study|loss of subject contact|1|||
149198931|NCT00434122|538194493|FG000|Overall Study|Personal reasons|1|||
149198932|NCT00434122|538194494|FG001|Overall Study|Personal reasons|1|||
149198933|NCT00434122|538194493|FG000|Overall Study|Large follicle size|2|||
149198934|NCT00434122|538194494|FG001|Overall Study|Large follicle size|2|||
149198935|NCT00434122|538194493|FG000|Overall Study|Low follicular response.|1|||
149198936|NCT00434122|538194494|FG001|Overall Study|Low follicular response.|2|||
149198937|NCT00434122|538194493|FG000|Overall Study|Travelling of subject.|1|||
149198938|NCT00434122|538194494|FG001|Overall Study|Travelling of subject.|0|||
149198939|NCT01391819|538194500|FG000|Overall Study|Withdrawal by Subject|56|||
149198940|NCT01391819|538194500|FG000|Overall Study|Migrated/moved from study area|82|||
149198941|NCT01391819|538194500|FG000|Overall Study|Lost to Follow-up|252|||
149198942|NCT01391819|538194500|FG000|Overall Study|Death|3|||
149198943|NCT01391819|538194500|FG000|Overall Study|Other|9|||
149198944|NCT02164513|538194501|FG000|Overall Study|Adverse Event|162|||
149198945|NCT02164513|538194502|FG001|Overall Study|Adverse Event|180|||
149198946|NCT02164513|538194503|FG002|Overall Study|Adverse Event|111|||
149198947|NCT02164513|538194501|FG000|Overall Study|Other: Study Closed or terminated|5|||
149198948|NCT02164513|538194502|FG001|Overall Study|Other: Study Closed or terminated|2|||
149198949|NCT02164513|538194503|FG002|Overall Study|Other: Study Closed or terminated|4|||
149198950|NCT02164513|538194501|FG000|Overall Study|Lost to Follow-up|30|||
149198951|NCT02164513|538194502|FG001|Overall Study|Lost to Follow-up|36|||
149198952|NCT02164513|538194503|FG002|Overall Study|Lost to Follow-up|22|||
149198953|NCT02164513|538194501|FG000|Overall Study|Physician Decision|47|||
149198954|NCT02164513|538194502|FG001|Overall Study|Physician Decision|57|||
149198955|NCT02164513|538194503|FG002|Overall Study|Physician Decision|28|||
149198956|NCT02164513|538194501|FG000|Overall Study|Withdrawal by Subject|192|||
149198957|NCT02164513|538194502|FG001|Overall Study|Withdrawal by Subject|261|||
149198958|NCT02164513|538194503|FG002|Overall Study|Withdrawal by Subject|130|||
149198959|NCT02164513|538194501|FG000|Overall Study|Other: Reason not provided by site|1|||
149198960|NCT02164513|538194502|FG001|Overall Study|Other: Reason not provided by site|0|||
149198961|NCT02164513|538194503|FG002|Overall Study|Other: Reason not provided by site|0|||
149198962|NCT02773238|538194505|FG000|Overall Study|Lack of Efficacy|4|||
149198963|NCT03423979|538194506|FG000|Overall Study|Death|5|||
149198964|NCT03423979|538194506|FG000|Overall Study|Adverse Event|4|||
149198965|NCT03423979|538194506|FG000|Overall Study|Withdrawal by Subject|3|||
149198966|NCT03423979|538194506|FG000|Overall Study|Lost to Follow-up|16|||
149198967|NCT02598661|538194507|FG000|Overall Study|Death|27|||
149198968|NCT02598661|538194508|FG001|Overall Study|Death|34|||
149198969|NCT02598661|538194509|FG002|Overall Study|Death|14|||
149198970|NCT02598661|538194510|FG003|Overall Study|Death|1|||
149198971|NCT02598661|538194511|FG004|Overall Study|Death|0|||
148682870|NCT02270983|536313016|FG001|Overall Study|study procedure non-compliance|0|||
148682871|NCT02270983|536313017|FG002|Overall Study|study procedure non-compliance|0|||
149198972|NCT02598661|538194507|FG000|Overall Study|Lost to Follow-up|2|||
149198973|NCT02598661|538194508|FG001|Overall Study|Lost to Follow-up|3|||
149198974|NCT02598661|538194509|FG002|Overall Study|Lost to Follow-up|2|||
149198975|NCT02598661|538194510|FG003|Overall Study|Lost to Follow-up|0|||
149198976|NCT02598661|538194511|FG004|Overall Study|Lost to Follow-up|0|||
149198977|NCT02598661|538194507|FG000|Overall Study|Withdrawal by Subject|13|||
149198978|NCT02598661|538194508|FG001|Overall Study|Withdrawal by Subject|24|||
148682872|NCT02270983|536313015|FG000|Overall Study|moved away from study site|0|||
148682873|NCT02270983|536313016|FG001|Overall Study|moved away from study site|1|||
148943489|NCT02501473|537278033|FG004|Overall Study|Death|0|||
148943490|NCT02501473|537278034|FG005|Overall Study|Death|1|||
148943491|NCT02501473|537278035|FG006|Overall Study|Death|0|||
148943492|NCT02501473|537278036|FG007|Overall Study|Death|0|||
148943493|NCT02501473|537278029|FG000|Overall Study|Lost to Follow-up|1|||
149198979|NCT02598661|538194509|FG002|Overall Study|Withdrawal by Subject|14|||
149198980|NCT02598661|538194510|FG003|Overall Study|Withdrawal by Subject|1|||
149198981|NCT02598661|538194511|FG004|Overall Study|Withdrawal by Subject|1|||
149198982|NCT02598661|538194507|FG000|Overall Study|Adverse Event|0|||
149198983|NCT02598661|538194508|FG001|Overall Study|Adverse Event|0|||
149198984|NCT02598661|538194509|FG002|Overall Study|Adverse Event|1|||
149198985|NCT02598661|538194510|FG003|Overall Study|Adverse Event|0|||
149198986|NCT02598661|538194511|FG004|Overall Study|Adverse Event|0|||
149198987|NCT02598661|538194507|FG000|Overall Study|Randomized, Never Treated|0|||
149198988|NCT02598661|538194508|FG001|Overall Study|Randomized, Never Treated|0|||
149198989|NCT02598661|538194509|FG002|Overall Study|Randomized, Never Treated|0|||
149198990|NCT02598661|538194510|FG003|Overall Study|Randomized, Never Treated|0|||
149198991|NCT02598661|538194511|FG004|Overall Study|Randomized, Never Treated|1|||
149198992|NCT03422133|538194512|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
149198993|NCT03422133|538194513|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
149198994|NCT03003403|538194514|FG000|Overall Study|Ineligible|8|||
149198995|NCT03003403|538194515|FG001|Overall Study|Ineligible|7|||
149198996|NCT03003403|538194514|FG000|Overall Study|Withdrawal by Subject|3|||
149198997|NCT03003403|538194515|FG001|Overall Study|Withdrawal by Subject|1|||
149198998|NCT05084053|538195853|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
149198999|NCT05084053|538195854|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
149199000|NCT05084053|538195855|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
149199001|NCT05084053|538195856|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
149199002|NCT05084053|538195853|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
149199003|NCT05084053|538195854|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
149199004|NCT05084053|538195855|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
149199005|NCT05084053|538195856|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
149199006|NCT05084053|538195853|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
149199007|NCT05084053|538195854|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
149199008|NCT05084053|538195855|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
149199009|NCT05084053|538195856|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
149199010|NCT02180724|538195857|FG000|Overall Study|Death|26|||
149199011|NCT02180724|538195858|FG001|Overall Study|Death|1|||
149199012|NCT02180724|538195857|FG000|Overall Study|Lost to Follow-up|3|||
149199013|NCT02180724|538195858|FG001|Overall Study|Lost to Follow-up|1|||
149199014|NCT02180724|538195857|FG000|Overall Study|Withdrawal by Subject|4|||
149199015|NCT02180724|538195858|FG001|Overall Study|Withdrawal by Subject|2|||
149199016|NCT02180724|538195857|FG000|Overall Study|PI Decision|5|||
149199017|NCT02180724|538195858|FG001|Overall Study|PI Decision|2|||
149199018|NCT02180724|538195857|FG000|Overall Study|Study terminated by sponsor|54|||
149199019|NCT02180724|538195858|FG001|Overall Study|Study terminated by sponsor|8|||
149199020|NCT05458011|538195860|FG000|DB Period (12 Weeks)|Adverse Event|2|||
149199021|NCT05458011|538195861|FG001|DB Period (12 Weeks)|Adverse Event|1|||
149199022|NCT05458011|538195862|FG002|DB Period (12 Weeks)|Adverse Event|1|||
149199023|NCT05458011|538195860|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
149199024|NCT05458011|538195861|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
149199025|NCT05458011|538195862|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
149199026|NCT05458011|538195860|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
149199027|NCT05458011|538195861|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
149199028|NCT05458011|538195862|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
149199029|NCT05458011|538195860|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
149199030|NCT05458011|538195861|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
149199031|NCT05458011|538195862|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
149199032|NCT05458011|538195860|FG000|OL Period (12 Weeks)|Adverse Event|1|||
149199033|NCT05458011|538195861|FG001|OL Period (12 Weeks)|Adverse Event|2|||
149199034|NCT05458011|538195862|FG002|OL Period (12 Weeks)|Adverse Event|1|||
149199035|NCT05458011|538195860|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
149199036|NCT05458011|538195861|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
148808472|NCT03836053|536777503|FG002|Overall Study|Decision by sponsor|4|||
149199037|NCT05458011|538195862|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
149199038|NCT03569449|538195865|FG000|Overall Study|Lost to Follow-up|0|||
149199039|NCT03569449|538195866|FG001|Overall Study|Lost to Follow-up|1|||
149199040|NCT03569449|538195867|FG002|Overall Study|Lost to Follow-up|0|||
149199041|NCT03569449|538195868|FG003|Overall Study|Lost to Follow-up|2|||
149199042|NCT03569449|538195869|FG004|Overall Study|Lost to Follow-up|0|||
149199043|NCT03569449|538195870|FG005|Overall Study|Lost to Follow-up|0|||
149199044|NCT03569449|538195871|FG006|Overall Study|Lost to Follow-up|0|||
149199045|NCT03569449|538195872|FG007|Overall Study|Lost to Follow-up|0|||
148943494|NCT02501473|537278030|FG001|Overall Study|Lost to Follow-up|0|||
149199046|NCT03569449|538195873|FG008|Overall Study|Lost to Follow-up|0|||
149199047|NCT03569449|538195874|FG009|Overall Study|Lost to Follow-up|0|||
149199048|NCT03569449|538195875|FG010|Overall Study|Lost to Follow-up|0|||
149199049|NCT03569449|538195876|FG011|Overall Study|Lost to Follow-up|0|||
149199050|NCT03569449|538195877|FG012|Overall Study|Lost to Follow-up|0|||
149199051|NCT03569449|538195878|FG013|Overall Study|Lost to Follow-up|0|||
149199052|NCT03569449|538195879|FG014|Overall Study|Lost to Follow-up|1|||
149199053|NCT03569449|538195880|FG015|Overall Study|Lost to Follow-up|0|||
149199054|NCT03569449|538195865|FG000|Overall Study|Withdrawal by Subject|0|||
149199055|NCT03569449|538195866|FG001|Overall Study|Withdrawal by Subject|1|||
149199056|NCT03569449|538195867|FG002|Overall Study|Withdrawal by Subject|0|||
149199057|NCT03569449|538195868|FG003|Overall Study|Withdrawal by Subject|0|||
149199058|NCT03569449|538195869|FG004|Overall Study|Withdrawal by Subject|1|||
149199059|NCT03569449|538195870|FG005|Overall Study|Withdrawal by Subject|0|||
149199060|NCT03569449|538195871|FG006|Overall Study|Withdrawal by Subject|0|||
149199061|NCT03569449|538195872|FG007|Overall Study|Withdrawal by Subject|0|||
149199062|NCT03569449|538195873|FG008|Overall Study|Withdrawal by Subject|0|||
149199063|NCT03569449|538195874|FG009|Overall Study|Withdrawal by Subject|0|||
149199064|NCT03569449|538195875|FG010|Overall Study|Withdrawal by Subject|0|||
149199065|NCT03569449|538195876|FG011|Overall Study|Withdrawal by Subject|0|||
149199066|NCT03569449|538195877|FG012|Overall Study|Withdrawal by Subject|0|||
149199067|NCT03569449|538195878|FG013|Overall Study|Withdrawal by Subject|0|||
149199068|NCT03569449|538195879|FG014|Overall Study|Withdrawal by Subject|0|||
149199069|NCT03569449|538195880|FG015|Overall Study|Withdrawal by Subject|0|||
149199070|NCT04124692|538195881|FG000|Overall Study|Medical reason|0|||
149199071|NCT04124692|538195882|FG001|Overall Study|Medical reason|1|||
149199072|NCT04124692|538195881|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
149016220|NCT04159415|537537879|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016221|NCT04159415|537537880|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016222|NCT04159415|537537881|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016223|NCT04159415|537537882|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016224|NCT04159415|537537883|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016225|NCT04159415|537537884|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016226|NCT04159415|537537885|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149199073|NCT04124692|538195882|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
149199074|NCT04124692|538195881|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
149199075|NCT04124692|538195882|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
149199076|NCT04124692|538195881|FG000|Overall Study|Lost to Follow-up|2|||
149199077|NCT04124692|538195882|FG001|Overall Study|Lost to Follow-up|4|||
149199078|NCT04124692|538195881|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
149199079|NCT04124692|538195882|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
149199080|NCT00205699|538195886|FG000|Overall Study|Lost to Follow-up|1|||
149199081|NCT00205699|538195887|FG001|Overall Study|Lost to Follow-up|3|||
149199082|NCT00205699|538195888|FG002|Overall Study|Lost to Follow-up|5|||
149199083|NCT00205699|538195886|FG000|Overall Study|Adverse Event|1|||
149199084|NCT00205699|538195887|FG001|Overall Study|Adverse Event|0|||
149199085|NCT00205699|538195888|FG002|Overall Study|Adverse Event|0|||
149199086|NCT00205699|538195886|FG000|Overall Study|Withdrawal by Subject|1|||
149199087|NCT00205699|538195887|FG001|Overall Study|Withdrawal by Subject|2|||
149199088|NCT00205699|538195888|FG002|Overall Study|Withdrawal by Subject|1|||
149199089|NCT00205699|538195886|FG000|Overall Study|Lack of Efficacy|0|||
149199090|NCT00205699|538195887|FG001|Overall Study|Lack of Efficacy|1|||
149199091|NCT00205699|538195888|FG002|Overall Study|Lack of Efficacy|0|||
149199092|NCT05279898|538195891|FG000|Overall Study|Withdrawal by Subject|1|||
149199093|NCT05279898|538195892|FG001|Overall Study|Withdrawal by Subject|0|||
149199094|NCT05279898|538195891|FG000|Overall Study|Physician Decision|1|||
149199095|NCT05279898|538195892|FG001|Overall Study|Physician Decision|1|||
149199096|NCT04393038|538195893|FG000|Overall Study|Adverse Event|11|||
149199097|NCT04393038|538195894|FG001|Overall Study|Adverse Event|2|||
149199098|NCT04393038|538195893|FG000|Overall Study|Protocol Violation|1|||
149199099|NCT04393038|538195894|FG001|Overall Study|Protocol Violation|0|||
149199100|NCT04393038|538195893|FG000|Overall Study|Death|6|||
149199101|NCT04393038|538195894|FG001|Overall Study|Death|4|||
149199102|NCT04393038|538195893|FG000|Overall Study|Withdrawal by Subject|24|||
149199103|NCT04393038|538195894|FG001|Overall Study|Withdrawal by Subject|8|||
149199104|NCT04393038|538195893|FG000|Overall Study|Lost to Follow-up|5|||
148943495|NCT02501473|537278031|FG002|Overall Study|Lost to Follow-up|1|||
149199105|NCT04393038|538195894|FG001|Overall Study|Lost to Follow-up|4|||
149199106|NCT04393038|538195893|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
149199107|NCT04393038|538195894|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
149199108|NCT04393038|538195893|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
149199109|NCT04393038|538195894|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
149199110|NCT05168813|538195895|FG000|Part A (Open-label)|Lost to Follow-up|21|||
149199111|NCT05168813|538195896|FG001|Part A (Open-label)|Lost to Follow-up|39|||
149199112|NCT05168813|538195897|FG002|Part A (Open-label)|Lost to Follow-up|8|||
149199113|NCT05168813|538195898|FG003|Part A (Open-label)|Lost to Follow-up|26|||
149199114|NCT05168813|538195899|FG004|Part A (Open-label)|Lost to Follow-up|0|||
149199115|NCT05168813|538195900|FG005|Part A (Open-label)|Lost to Follow-up|0|||
149199116|NCT05168813|538195895|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
149199117|NCT05168813|538195896|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
149199118|NCT05168813|538195897|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
149199119|NCT05168813|538195898|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
149199120|NCT05168813|538195899|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
149199121|NCT05168813|538195900|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
149199122|NCT05168813|538195895|FG000|Part A (Open-label)|Death|23|||
149199123|NCT05168813|538195896|FG001|Part A (Open-label)|Death|28|||
149199124|NCT05168813|538195897|FG002|Part A (Open-label)|Death|1|||
149199125|NCT05168813|538195898|FG003|Part A (Open-label)|Death|9|||
149199126|NCT05168813|538195899|FG004|Part A (Open-label)|Death|0|||
149199127|NCT05168813|538195900|FG005|Part A (Open-label)|Death|0|||
149199128|NCT05168813|538195895|FG000|Part A (Open-label)|Physician Decision|0|||
149199129|NCT05168813|538195896|FG001|Part A (Open-label)|Physician Decision|1|||
149199130|NCT05168813|538195897|FG002|Part A (Open-label)|Physician Decision|0|||
149199131|NCT05168813|538195898|FG003|Part A (Open-label)|Physician Decision|2|||
149199132|NCT05168813|538195899|FG004|Part A (Open-label)|Physician Decision|0|||
149199133|NCT05168813|538195900|FG005|Part A (Open-label)|Physician Decision|0|||
149199134|NCT05168813|538195895|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
149199135|NCT05168813|538195896|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
149199136|NCT05168813|538195897|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
149199137|NCT05168813|538195898|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
149199138|NCT05168813|538195899|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
149199139|NCT05168813|538195900|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
149199140|NCT05168813|538195895|FG000|Part A (Open-label)|Protocol Violation|0|||
149199141|NCT05168813|538195896|FG001|Part A (Open-label)|Protocol Violation|1|||
149199142|NCT05168813|538195897|FG002|Part A (Open-label)|Protocol Violation|0|||
149199143|NCT05168813|538195898|FG003|Part A (Open-label)|Protocol Violation|0|||
149199144|NCT05168813|538195899|FG004|Part A (Open-label)|Protocol Violation|0|||
149199145|NCT05168813|538195900|FG005|Part A (Open-label)|Protocol Violation|0|||
149199146|NCT05168813|538195895|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
149199147|NCT05168813|538195896|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
149199148|NCT05168813|538195897|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
149199149|NCT05168813|538195898|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
149199150|NCT05168813|538195899|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
149199151|NCT05168813|538195900|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
149199152|NCT05168813|538195895|FG000|Part A (Open-label)|Other|0|||
149199153|NCT05168813|538195896|FG001|Part A (Open-label)|Other|1|||
149199154|NCT05168813|538195897|FG002|Part A (Open-label)|Other|0|||
149199155|NCT05168813|538195898|FG003|Part A (Open-label)|Other|0|||
149199156|NCT05168813|538195899|FG004|Part A (Open-label)|Other|0|||
149199157|NCT05168813|538195900|FG005|Part A (Open-label)|Other|0|||
149199158|NCT05168813|538195895|FG000|Part B (Blinded)|Lost to Follow-up|0|||
149199159|NCT05168813|538195896|FG001|Part B (Blinded)|Lost to Follow-up|0|||
149199160|NCT05168813|538195897|FG002|Part B (Blinded)|Lost to Follow-up|0|||
149199161|NCT05168813|538195898|FG003|Part B (Blinded)|Lost to Follow-up|0|||
149199162|NCT05168813|538195899|FG004|Part B (Blinded)|Lost to Follow-up|219|||
149199163|NCT05168813|538195900|FG005|Part B (Blinded)|Lost to Follow-up|88|||
149199164|NCT05168813|538195895|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
149199165|NCT05168813|538195896|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
149199166|NCT05168813|538195897|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
149199167|NCT05168813|538195898|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
149199168|NCT05168813|538195899|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
149199169|NCT05168813|538195900|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
149199170|NCT05168813|538195895|FG000|Part B (Blinded)|Death|0|||
148943496|NCT02501473|537278032|FG003|Overall Study|Lost to Follow-up|0|||
148943497|NCT02501473|537278033|FG004|Overall Study|Lost to Follow-up|0|||
148943498|NCT02501473|537278034|FG005|Overall Study|Lost to Follow-up|1|||
149199171|NCT05168813|538195896|FG001|Part B (Blinded)|Death|0|||
149199172|NCT05168813|538195897|FG002|Part B (Blinded)|Death|0|||
149199173|NCT05168813|538195898|FG003|Part B (Blinded)|Death|0|||
149199174|NCT05168813|538195899|FG004|Part B (Blinded)|Death|63|||
149199175|NCT05168813|538195900|FG005|Part B (Blinded)|Death|19|||
149199176|NCT05168813|538195895|FG000|Part B (Blinded)|Physician Decision|0|||
149199177|NCT05168813|538195896|FG001|Part B (Blinded)|Physician Decision|0|||
149199178|NCT05168813|538195897|FG002|Part B (Blinded)|Physician Decision|0|||
149199179|NCT05168813|538195898|FG003|Part B (Blinded)|Physician Decision|0|||
149199180|NCT05168813|538195899|FG004|Part B (Blinded)|Physician Decision|6|||
149199181|NCT05168813|538195900|FG005|Part B (Blinded)|Physician Decision|1|||
149199182|NCT05168813|538195895|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149199183|NCT05168813|538195896|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149199184|NCT05168813|538195897|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149199185|NCT05168813|538195898|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
149199186|NCT05168813|538195899|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
149199187|NCT05168813|538195900|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
149199188|NCT05168813|538195895|FG000|Part B (Blinded)|Pregnancy|0|||
149199189|NCT05168813|538195896|FG001|Part B (Blinded)|Pregnancy|0|||
149199190|NCT05168813|538195897|FG002|Part B (Blinded)|Pregnancy|0|||
149199191|NCT05168813|538195898|FG003|Part B (Blinded)|Pregnancy|0|||
149199192|NCT05168813|538195899|FG004|Part B (Blinded)|Pregnancy|1|||
149199193|NCT05168813|538195900|FG005|Part B (Blinded)|Pregnancy|0|||
149199194|NCT05168813|538195895|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
149199195|NCT05168813|538195896|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
149199196|NCT05168813|538195897|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
149199197|NCT05168813|538195898|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
149199198|NCT05168813|538195899|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
149199199|NCT05168813|538195900|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
149199200|NCT05168813|538195895|FG000|Part B (Blinded)|Other|0|||
149199201|NCT05168813|538195896|FG001|Part B (Blinded)|Other|0|||
149199202|NCT05168813|538195897|FG002|Part B (Blinded)|Other|0|||
149199203|NCT05168813|538195898|FG003|Part B (Blinded)|Other|0|||
149199204|NCT05168813|538195899|FG004|Part B (Blinded)|Other|41|||
149199205|NCT05168813|538195900|FG005|Part B (Blinded)|Other|27|||
149199206|NCT06964165|538195901|FG000|Overall Study|Death|4|||
149199207|NCT06964165|538195902|FG001|Overall Study|Death|4|||
149199208|NCT06964165|538195901|FG000|Overall Study|Physician Decision|1|||
149199209|NCT06964165|538195902|FG001|Overall Study|Physician Decision|1|||
149199210|NCT06964165|538195901|FG000|Overall Study|Withdrawal by Subject|0|||
149199211|NCT06964165|538195902|FG001|Overall Study|Withdrawal by Subject|2|||
149199212|NCT06964165|538195901|FG000|Overall Study|Study terminated by sponsor|12|||
149199213|NCT06964165|538195902|FG001|Overall Study|Study terminated by sponsor|10|||
149199214|NCT06964165|538195901|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
149199215|NCT06964165|538195902|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
149199216|NCT06964165|538195901|FG000|Overall Study|Participant removed due to non-compliance|0|||
149199217|NCT06964165|538195902|FG001|Overall Study|Participant removed due to non-compliance|1|||
149199218|NCT04321252|538195903|FG000|Overall Study|Withdrawal by Subject|0|||
149199219|NCT04321252|538195904|FG001|Overall Study|Withdrawal by Subject|0|||
149199220|NCT04321252|538195905|FG002|Overall Study|Withdrawal by Subject|0|||
149199221|NCT04321252|538195906|FG003|Overall Study|Withdrawal by Subject|0|||
149199222|NCT04321252|538195907|FG004|Overall Study|Withdrawal by Subject|0|||
149199223|NCT04321252|538195908|FG005|Overall Study|Withdrawal by Subject|1|||
149199224|NCT04321252|538195909|FG006|Overall Study|Withdrawal by Subject|0|||
149199225|NCT04321252|538195910|FG007|Overall Study|Withdrawal by Subject|0|||
149199226|NCT04321252|538195911|FG008|Overall Study|Withdrawal by Subject|0|||
149199227|NCT06245044|538195912|FG000|No MI help|Technical issues|18|||
149199228|NCT00259740|538195915|FG000|Overall Study|Physician Decision|1|||
149199229|NCT00259740|538195916|FG001|Overall Study|Physician Decision|1|||
149199230|NCT00259740|538195915|FG000|Overall Study|Adverse Event|0|||
149199231|NCT00259740|538195916|FG001|Overall Study|Adverse Event|2|||
149199232|NCT00259740|538195915|FG000|Overall Study|Withdrawal by Subject|2|||
149199233|NCT00259740|538195916|FG001|Overall Study|Withdrawal by Subject|6|||
149199234|NCT00259740|538195915|FG000|Overall Study|Death|1|||
149199235|NCT00259740|538195916|FG001|Overall Study|Death|1|||
149199236|NCT00259740|538195915|FG000|Overall Study|Disease progression|19|||
149199237|NCT00259740|538195916|FG001|Overall Study|Disease progression|36|||
149199238|NCT00259740|538195915|FG000|Overall Study|Ongoing|17|||
149199239|NCT00259740|538195916|FG001|Overall Study|Ongoing|3|||
149199240|NCT00259740|538195915|FG000|Overall Study|Other|3|||
149199241|NCT00259740|538195916|FG001|Overall Study|Other|0|||
148808473|NCT00788671|536777504|FG000|Overall Study|Death|2|||
149199242|NCT00259740|538195915|FG000|Overall Study|Requirement for alternative therapy|0|||
149199243|NCT00259740|538195916|FG001|Overall Study|Requirement for alternative therapy|4|||
148943499|NCT02501473|537278035|FG006|Overall Study|Lost to Follow-up|0|||
148943500|NCT02501473|537278036|FG007|Overall Study|Lost to Follow-up|0|||
148943501|NCT02501473|537278029|FG000|Overall Study|Reason not specified|0|||
148943502|NCT02501473|537278030|FG001|Overall Study|Reason not specified|0|||
148943503|NCT02501473|537278031|FG002|Overall Study|Reason not specified|1|||
148943504|NCT02501473|537278032|FG003|Overall Study|Reason not specified|1|||
149199244|NCT01844830|538195921|FG000|Overall Study|Withdrawal by Subject|1|||
149199245|NCT01844830|538195922|FG001|Overall Study|Withdrawal by Subject|0|||
149199246|NCT01658579|538195923|FG000|Treatment Period A|Other|0|||
149199247|NCT01658579|538195924|FG001|Treatment Period A|Other|0|||
149199248|NCT01658579|538195925|FG002|Treatment Period A|Other|1|||
149199249|NCT01658579|538195926|FG003|Treatment Period A|Other|1|||
149199250|NCT01658579|538195923|FG000|Treatment Period A|Adverse Event|1|||
149199251|NCT01658579|538195924|FG001|Treatment Period A|Adverse Event|0|||
149199252|NCT01658579|538195925|FG002|Treatment Period A|Adverse Event|0|||
149199253|NCT01658579|538195926|FG003|Treatment Period A|Adverse Event|0|||
149199254|NCT01658579|538195923|FG000|Treatment Period B|Other|0|||
149199255|NCT01658579|538195924|FG001|Treatment Period B|Other|0|||
149199256|NCT01658579|538195925|FG002|Treatment Period B|Other|0|||
149199257|NCT01658579|538195926|FG003|Treatment Period B|Other|1|||
149199258|NCT04580394|538195927|FG000|First Intervention|Incorrectly Randomized|1|||
149199259|NCT04580394|538195927|FG000|First Intervention|Physician Decision|1|||
149199260|NCT04580394|538195927|FG000|First Intervention|Lost to Follow-up|1|||
149199261|NCT04580394|538195927|FG000|Washout (One Week)|Withdrawal by Subject|1|||
149199262|NCT04580394|538195927|FG000|Washout (One Week)|Adverse Event|1|||
149199263|NCT04580394|538195927|FG000|Washout (One Week)|Withdrawal by Subject|2|||
149199264|NCT04580394|538195927|FG000|Third Intervention|Adverse Event|1|||
149199265|NCT04580394|538195927|FG000|Third Intervention|Withdrawal by Subject|1|||
149199266|NCT04580394|538195927|FG000|Washout (One Week)|Withdrawal by Subject|2|||
149199267|NCT01464788|538195928|FG000|Overall Study|Lost to Follow-up|0|||
149199268|NCT01464788|538195929|FG001|Overall Study|Lost to Follow-up|1|||
149199269|NCT01464788|538195930|FG002|Overall Study|Lost to Follow-up|0|||
149199270|NCT01464788|538195928|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
149199271|NCT01464788|538195929|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
149199272|NCT01464788|538195930|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
149199273|NCT04397718|538195933|FG000|Overall Study|Death|7|||
149199274|NCT04397718|538195934|FG001|Overall Study|Death|11|||
149199275|NCT04397718|538195933|FG000|Overall Study|Lost to Follow-up|0|||
149199276|NCT04397718|538195934|FG001|Overall Study|Lost to Follow-up|4|||
149199277|NCT03201965|538195937|FG000|Overall Study|Death|5|||
149199278|NCT03201965|538195938|FG001|Overall Study|Death|65|||
149199279|NCT03201965|538195939|FG002|Overall Study|Death|47|||
149199280|NCT03201965|538195937|FG000|Overall Study|Lost to Follow-up|0|||
149199281|NCT03201965|538195938|FG001|Overall Study|Lost to Follow-up|6|||
149199282|NCT03201965|538195939|FG002|Overall Study|Lost to Follow-up|0|||
149199283|NCT03201965|538195937|FG000|Overall Study|Withdrawal by Subject|3|||
149199284|NCT03201965|538195938|FG001|Overall Study|Withdrawal by Subject|23|||
149199285|NCT03201965|538195939|FG002|Overall Study|Withdrawal by Subject|8|||
148943505|NCT02501473|537278033|FG004|Overall Study|Reason not specified|0|||
149199286|NCT03201965|538195937|FG000|Overall Study|Sponsor's Decision|20|||
149199287|NCT03201965|538195938|FG001|Overall Study|Sponsor's Decision|99|||
149199288|NCT03201965|538195939|FG002|Overall Study|Sponsor's Decision|140|||
149199289|NCT01153893|538195942|FG000|Overall Study|Adverse Event|1|||
149199290|NCT01153893|538195943|FG001|Overall Study|Adverse Event|0|||
149199291|NCT00118482|538195944|FG000|Overall Study|Lost to Follow-up|7|||
149199292|NCT00118482|538195945|FG001|Overall Study|Lost to Follow-up|7|||
149199293|NCT00118482|538195944|FG000|Overall Study|Withdrawal by Subject|23|||
149199294|NCT00118482|538195945|FG001|Overall Study|Withdrawal by Subject|22|||
149199295|NCT00125190|538195946|FG000|Overall Study|Subject/Parent Decision|7|||
149199296|NCT00125190|538195946|FG000|Overall Study|Non-compliance|2|||
149199297|NCT00125190|538195946|FG000|Overall Study|Adverse Event|1|||
149199298|NCT00125190|538195946|FG000|Overall Study|Other|1|||
149199299|NCT00125190|538195946|FG000|Overall Study|Lost to Follow-up|4|||
149199300|NCT02128763|538195947|FG000|Overall Study|Death|1|||
149199301|NCT02128763|538195948|FG001|Overall Study|Death|0|||
149199302|NCT02128763|538195947|FG000|Overall Study|Lost to Follow-up|19|||
149199303|NCT02128763|538195948|FG001|Overall Study|Lost to Follow-up|16|||
149199304|NCT03259490|538195949|FG000|Period 1|Withdrawal by Subject|0|||
149199305|NCT03259490|538195950|FG001|Period 1|Withdrawal by Subject|1|||
149199306|NCT03259490|538195949|FG000|Period 2|Protocol Violation|1|||
149199307|NCT03259490|538195950|FG001|Period 2|Protocol Violation|0|||
149199308|NCT00255086|538195951|FG000|Overall Study|Adverse Event|1|||
149199309|NCT00255086|538195952|FG001|Overall Study|Adverse Event|1|||
149199310|NCT00255086|538195951|FG000|Overall Study|Protocol Violation|1|||
149199311|NCT00255086|538195952|FG001|Overall Study|Protocol Violation|1|||
149199312|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
149199313|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
149199314|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
149199315|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
149199316|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
149199317|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
149199318|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
149199319|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
149199320|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
149199321|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
149199322|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
149199323|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
149199324|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149199325|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149199326|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
149199327|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149199328|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149199329|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
149199330|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149199331|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149199332|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
149199333|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
149199334|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
148682874|NCT02270983|536313017|FG002|Overall Study|moved away from study site|0|||
149016227|NCT04159415|537537886|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149199335|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
149199336|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
149199337|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
149199338|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
149199339|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
149199340|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
149199341|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
149199342|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149199343|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149199344|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149199345|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
149199346|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149199347|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
149199348|NCT01963208|538195954|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149199349|NCT01963208|538195955|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149199350|NCT01963208|538195956|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149199351|NCT01963208|538195957|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
149199352|NCT01963208|538195958|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149199353|NCT01963208|538195959|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
149199354|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149199355|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149199356|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149199357|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
149199358|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
149199359|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
149199360|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149199361|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149199362|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149199363|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
149199364|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
149199365|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
149199366|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149199367|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149199368|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149199369|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149199370|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
149199371|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
149199372|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149199373|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149199374|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149199375|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149199376|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
149199377|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
149199378|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
149199379|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
149199380|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
149199381|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
149199382|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
149199383|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
149199384|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149199385|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149199386|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149199387|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
149199388|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
149199389|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
149199390|NCT01963208|538195954|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
149199391|NCT01963208|538195955|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
149199392|NCT01963208|538195956|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
149199393|NCT01963208|538195957|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
149199394|NCT01963208|538195958|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
149199395|NCT01963208|538195959|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
149199396|NCT01842607|538195961|FG000|Overall Study|Adverse Event|11|||
149199397|NCT01842607|538195961|FG000|Overall Study|Lack of Efficacy|19|||
149199398|NCT01842607|538195961|FG000|Overall Study|Protocol Violation|8|||
149199399|NCT01842607|538195961|FG000|Overall Study|Protocol defined stopping criteria|2|||
149199400|NCT01842607|538195961|FG000|Overall Study|Lost to Follow-up|3|||
149199401|NCT01842607|538195961|FG000|Overall Study|Physician Decision|9|||
149199402|NCT01842607|538195961|FG000|Overall Study|Withdrawal by Subject|14|||
149199403|NCT00012012|538195962|FG000|Overall Study|Protocol Violation|1|||
149199404|NCT00012012|538195963|FG001|Overall Study|Protocol Violation|1|||
149199405|NCT00012012|538195962|FG000|Overall Study|Withdrawal by Subject|0|||
149199406|NCT00012012|538195963|FG001|Overall Study|Withdrawal by Subject|2|||
149199407|NCT02159469|538195964|FG000|Overall Study|Missing Completion status|1|||
149199408|NCT02159469|538195964|FG000|Overall Study|Adverse Event|5|||
149199409|NCT02159469|538195964|FG000|Overall Study|Non-compliance|2|||
149199410|NCT02159469|538195964|FG000|Overall Study|Withdrawal by Subject|9|||
149199411|NCT02159469|538195964|FG000|Overall Study|Lost to Follow-up|1|||
149199412|NCT02159469|538195964|FG000|Overall Study|Sponsor's request|2|||
149199413|NCT02159469|538195964|FG000|Overall Study|Met Stopping Criteria|3|||
149199414|NCT02159469|538195964|FG000|Overall Study|Other|1|||
149199415|NCT02159469|538195964|FG000|Overall Study|Multiple|29|||
149199416|NCT02034474|538195965|FG000|Overall Study|Adverse Event|3|||
149199417|NCT02034474|538195966|FG001|Overall Study|Adverse Event|2|||
149199418|NCT02034474|538195965|FG000|Overall Study|Withdrawal by Subject|1|||
149199419|NCT02034474|538195966|FG001|Overall Study|Withdrawal by Subject|2|||
149199420|NCT03629041|538195967|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
149199421|NCT03629041|538195968|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
149199422|NCT03629041|538195969|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
149199423|NCT03629041|538195970|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
149199424|NCT00808249|538195976|FG000|Overall Study|Adverse Event|4|||
149199425|NCT00808249|538195977|FG001|Overall Study|Adverse Event|7|||
149199426|NCT00808249|538195978|FG002|Overall Study|Adverse Event|10|||
149199427|NCT00808249|538195979|FG003|Overall Study|Adverse Event|6|||
149199428|NCT00808249|538195976|FG000|Overall Study|Lost to Follow-up|2|||
149199429|NCT00808249|538195977|FG001|Overall Study|Lost to Follow-up|3|||
149199430|NCT00808249|538195978|FG002|Overall Study|Lost to Follow-up|3|||
149199431|NCT00808249|538195979|FG003|Overall Study|Lost to Follow-up|5|||
149199432|NCT00808249|538195976|FG000|Overall Study|Withdrawal by Subject|4|||
149199433|NCT00808249|538195977|FG001|Overall Study|Withdrawal by Subject|0|||
149199434|NCT00808249|538195978|FG002|Overall Study|Withdrawal by Subject|2|||
149199435|NCT00808249|538195979|FG003|Overall Study|Withdrawal by Subject|4|||
149199436|NCT00808249|538195976|FG000|Overall Study|Protocol Violation|3|||
149199437|NCT00808249|538195977|FG001|Overall Study|Protocol Violation|3|||
149199438|NCT00808249|538195978|FG002|Overall Study|Protocol Violation|3|||
149199439|NCT00808249|538195979|FG003|Overall Study|Protocol Violation|0|||
149199440|NCT00808249|538195976|FG000|Overall Study|Lack of Efficacy|1|||
149199441|NCT00808249|538195977|FG001|Overall Study|Lack of Efficacy|1|||
149199442|NCT00808249|538195978|FG002|Overall Study|Lack of Efficacy|0|||
149199443|NCT00808249|538195979|FG003|Overall Study|Lack of Efficacy|0|||
149199444|NCT00808249|538195976|FG000|Overall Study|study specific discontinuation criteria|1|||
149199445|NCT00808249|538195977|FG001|Overall Study|study specific discontinuation criteria|0|||
149199446|NCT00808249|538195978|FG002|Overall Study|study specific discontinuation criteria|1|||
149199447|NCT00808249|538195979|FG003|Overall Study|study specific discontinuation criteria|0|||
149199448|NCT00808249|538195976|FG000|Overall Study|All other reasons|2|||
149199449|NCT00808249|538195977|FG001|Overall Study|All other reasons|1|||
149199450|NCT00808249|538195978|FG002|Overall Study|All other reasons|3|||
149199451|NCT00808249|538195979|FG003|Overall Study|All other reasons|1|||
149199452|NCT03829332|538195980|FG000|Overall Study|Death|225|||
149199453|NCT03829332|538195981|FG001|Overall Study|Death|230|||
148682875|NCT01623830|536313020|FG000|Overall Study|Withdrawal by Subject|6|||
148682876|NCT01623830|536313021|FG001|Overall Study|Withdrawal by Subject|7|||
148682877|NCT01623830|536313020|FG000|Overall Study|Exclusion from Study|1|||
148682878|NCT01623830|536313021|FG001|Overall Study|Exclusion from Study|2|||
148682879|NCT00928252|536313022|FG000|Overall Study|Physician Decision|3|||
148682880|NCT01605461|536313023|FG000|Overall Study|Lost to Follow-up|3|||
148682881|NCT01605461|536313023|FG000|Overall Study|Withdrawal by Subject|1|||
148682882|NCT02024698|536313024|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
148682883|NCT02024698|536313025|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
148682884|NCT03549130|536313026|FG000|Overall Study|Adverse Event|0|||
148682885|NCT03549130|536313027|FG001|Overall Study|Adverse Event|1|||
148682886|NCT03549130|536313026|FG000|Overall Study|Lost to Follow-up|0|||
148682887|NCT03549130|536313027|FG001|Overall Study|Lost to Follow-up|1|||
148682888|NCT01078623|536313028|FG000|Treatment Period 1|Adverse Event|1|||
148682889|NCT01078623|536313029|FG001|Treatment Period 1|Adverse Event|1|||
148682890|NCT01078623|536313030|FG002|Treatment Period 1|Adverse Event|1|||
148682891|NCT01078623|536313031|FG003|Treatment Period 1|Adverse Event|0|||
148682892|NCT01078623|536313032|FG004|Treatment Period 1|Adverse Event|0|||
148682893|NCT01078623|536313033|FG005|Treatment Period 1|Adverse Event|0|||
148682894|NCT01078623|536313034|FG006|Treatment Period 1|Adverse Event|1|||
148682895|NCT01078623|536313035|FG007|Treatment Period 1|Adverse Event|0|||
148682896|NCT01078623|536313036|FG008|Treatment Period 1|Adverse Event|1|||
148682897|NCT01078623|536313037|FG009|Treatment Period 1|Adverse Event|1|||
148682898|NCT01078623|536313038|FG010|Treatment Period 1|Adverse Event|0|||
148682899|NCT01078623|536313039|FG011|Treatment Period 1|Adverse Event|0|||
148682900|NCT01078623|536313040|FG012|Treatment Period 1|Adverse Event|0|||
148682901|NCT01078623|536313041|FG013|Treatment Period 1|Adverse Event|0|||
149199454|NCT03829332|538195980|FG000|Overall Study|Lost to Follow-up|1|||
149199455|NCT03829332|538195981|FG001|Overall Study|Lost to Follow-up|3|||
149199456|NCT03829332|538195980|FG000|Overall Study|Physician Decision|1|||
149199457|NCT03829332|538195981|FG001|Overall Study|Physician Decision|0|||
149199458|NCT03829332|538195980|FG000|Overall Study|Sponsor Decision|71|||
149199459|NCT03829332|538195981|FG001|Overall Study|Sponsor Decision|72|||
148682902|NCT01078623|536313042|FG014|Treatment Period 1|Adverse Event|0|||
148682903|NCT01078623|536313043|FG015|Treatment Period 1|Adverse Event|0|||
148682904|NCT01078623|536313044|FG016|Treatment Period 1|Adverse Event|0|||
148682905|NCT01078623|536313045|FG017|Treatment Period 1|Adverse Event|0|||
148682906|NCT01078623|536313046|FG018|Treatment Period 1|Adverse Event|0|||
148682907|NCT01078623|536313047|FG019|Treatment Period 1|Adverse Event|0|||
148682908|NCT01078623|536313028|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149199460|NCT03829332|538195980|FG000|Overall Study|Withdrawal by Subject|11|||
149199461|NCT03829332|538195981|FG001|Overall Study|Withdrawal by Subject|9|||
149199462|NCT05371912|538195982|FG000|Overall Study|Lost to Follow-up|3|||
149199463|NCT05371912|538195983|FG001|Overall Study|Lost to Follow-up|2|||
149199464|NCT01646398|538198420|FG000|Overall Study|Withdrawal by Subject|1|||
149199465|NCT01646398|538198421|FG001|Overall Study|Withdrawal by Subject|0|||
149199466|NCT00571519|538198422|FG000|Overall Study|Subject withdrew consent|0|||
149199467|NCT00571519|538198423|FG001|Overall Study|Subject withdrew consent|1|||
149199468|NCT00571519|538198424|FG002|Overall Study|Subject withdrew consent|0|||
149199469|NCT00571519|538198425|FG003|Overall Study|Subject withdrew consent|2|||
149199470|NCT00571519|538198426|FG004|Overall Study|Subject withdrew consent|1|||
149199471|NCT00571519|538198427|FG005|Overall Study|Subject withdrew consent|1|||
149199472|NCT00571519|538198428|FG006|Overall Study|Subject withdrew consent|2|||
149199473|NCT00571519|538198422|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
149199474|NCT00571519|538198423|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149199475|NCT00571519|538198424|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
149199476|NCT00571519|538198425|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
149199477|NCT00571519|538198426|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149199478|NCT00571519|538198427|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149199479|NCT00571519|538198428|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
149199480|NCT00571519|538198422|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
149199481|NCT00571519|538198423|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
149199482|NCT00571519|538198424|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
149199483|NCT00571519|538198425|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
149199484|NCT00571519|538198426|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
149199485|NCT00571519|538198427|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
149199486|NCT00571519|538198428|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
149199487|NCT00571519|538198422|FG000|Overall Study|Termination of study by Sponsor|2|||
149199488|NCT00571519|538198423|FG001|Overall Study|Termination of study by Sponsor|7|||
149199489|NCT00571519|538198424|FG002|Overall Study|Termination of study by Sponsor|10|||
149199490|NCT00571519|538198425|FG003|Overall Study|Termination of study by Sponsor|24|||
149199491|NCT00571519|538198426|FG004|Overall Study|Termination of study by Sponsor|8|||
149199492|NCT00571519|538198427|FG005|Overall Study|Termination of study by Sponsor|9|||
149199493|NCT00571519|538198428|FG006|Overall Study|Termination of study by Sponsor|22|||
149199494|NCT00571519|538198422|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149199495|NCT00571519|538198423|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149199496|NCT00571519|538198424|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
149199497|NCT00571519|538198425|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149199498|NCT00571519|538198426|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149199499|NCT00571519|538198427|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149199500|NCT00571519|538198428|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
149199501|NCT04656418|538198432|FG000|Overall Study|Withdrawal by Subject|1|||
149199502|NCT04656418|538198433|FG001|Overall Study|Withdrawal by Subject|3|||
149199503|NCT02475850|538198434|FG000|Overall Study|Death|155|||
149199504|NCT02475850|538198435|FG001|Overall Study|Death|141|||
149199505|NCT02475850|538198434|FG000|Overall Study|Lost to Follow-up|217|||
149199506|NCT02475850|538198435|FG001|Overall Study|Lost to Follow-up|188|||
149199507|NCT02475850|538198434|FG000|Overall Study|Withdrawal by Subject|221|||
149199508|NCT02475850|538198435|FG001|Overall Study|Withdrawal by Subject|155|||
149199509|NCT00781963|538198440|FG000|Overall Study|Death|3|||
149199510|NCT00781963|538198441|FG001|Overall Study|Death|0|||
149199511|NCT00781963|538198440|FG000|Overall Study|Lost to Follow-up|2|||
149199512|NCT00781963|538198441|FG001|Overall Study|Lost to Follow-up|1|||
149199513|NCT00781963|538198440|FG000|Overall Study|Withdrawal by Subject|3|||
149199514|NCT00781963|538198441|FG001|Overall Study|Withdrawal by Subject|1|||
149199515|NCT00781963|538198440|FG000|Overall Study|Refused follow-up|9|||
149199516|NCT00781963|538198441|FG001|Overall Study|Refused follow-up|0|||
149199517|NCT03297216|538198442|FG000|Overall Study|Death|0|||
149199518|NCT03297216|538198443|FG001|Overall Study|Death|1|||
149199519|NCT03297216|538198442|FG000|Overall Study|Miscarriage|0|||
149199520|NCT03297216|538198443|FG001|Overall Study|Miscarriage|2|||
149199521|NCT03297216|538198442|FG000|Overall Study|Lost to Follow-up|3|||
149199522|NCT03297216|538198443|FG001|Overall Study|Lost to Follow-up|2|||
149199523|NCT03434418|538198444|FG000|Overall Study|Disease Progression|11|||
149199524|NCT03434418|538198444|FG000|Overall Study|Adverse Event|2|||
149199525|NCT03434418|538198444|FG000|Overall Study|Physician Decision|1|||
149199526|NCT03434418|538198444|FG000|Overall Study|Decline in Performance Status (PS)|1|||
149199527|NCT00696436|538198445|FG000|Overall Study|Adverse Event|7|||
149199528|NCT00696436|538198446|FG001|Overall Study|Adverse Event|9|||
149199529|NCT00696436|538198447|FG002|Overall Study|Adverse Event|8|||
149199530|NCT00696436|538198448|FG003|Overall Study|Adverse Event|6|||
149199531|NCT00696436|538198449|FG004|Overall Study|Adverse Event|4|||
149199532|NCT00696436|538198445|FG000|Overall Study|Protocol Violation|3|||
149199533|NCT00696436|538198446|FG001|Overall Study|Protocol Violation|2|||
149199534|NCT00696436|538198447|FG002|Overall Study|Protocol Violation|2|||
149199535|NCT00696436|538198448|FG003|Overall Study|Protocol Violation|0|||
149199536|NCT00696436|538198449|FG004|Overall Study|Protocol Violation|1|||
149199537|NCT00696436|538198445|FG000|Overall Study|Lost to Follow-up|1|||
149199538|NCT00696436|538198446|FG001|Overall Study|Lost to Follow-up|6|||
149199539|NCT00696436|538198447|FG002|Overall Study|Lost to Follow-up|2|||
149199540|NCT00696436|538198448|FG003|Overall Study|Lost to Follow-up|4|||
149199541|NCT00696436|538198449|FG004|Overall Study|Lost to Follow-up|3|||
149199542|NCT00696436|538198445|FG000|Overall Study|Withdrawal by Subject|4|||
149199543|NCT00696436|538198446|FG001|Overall Study|Withdrawal by Subject|11|||
149199544|NCT00696436|538198447|FG002|Overall Study|Withdrawal by Subject|5|||
149199545|NCT00696436|538198448|FG003|Overall Study|Withdrawal by Subject|7|||
149199546|NCT00696436|538198449|FG004|Overall Study|Withdrawal by Subject|1|||
149199547|NCT00696436|538198445|FG000|Overall Study|Lack of Efficacy|3|||
149199548|NCT00696436|538198446|FG001|Overall Study|Lack of Efficacy|1|||
149199549|NCT00696436|538198447|FG002|Overall Study|Lack of Efficacy|5|||
149199550|NCT00696436|538198448|FG003|Overall Study|Lack of Efficacy|2|||
149199551|NCT00696436|538198449|FG004|Overall Study|Lack of Efficacy|4|||
149199552|NCT00696436|538198445|FG000|Overall Study|Participant Unavailability|2|||
149199553|NCT00696436|538198446|FG001|Overall Study|Participant Unavailability|0|||
149199554|NCT00696436|538198447|FG002|Overall Study|Participant Unavailability|2|||
149199555|NCT00696436|538198448|FG003|Overall Study|Participant Unavailability|1|||
149199556|NCT00696436|538198449|FG004|Overall Study|Participant Unavailability|0|||
149199557|NCT00696436|538198445|FG000|Overall Study|Administrative Error|2|||
149199558|NCT00696436|538198446|FG001|Overall Study|Administrative Error|0|||
149199559|NCT00696436|538198447|FG002|Overall Study|Administrative Error|2|||
149199560|NCT00696436|538198448|FG003|Overall Study|Administrative Error|0|||
149199561|NCT00696436|538198449|FG004|Overall Study|Administrative Error|0|||
149199562|NCT00696436|538198445|FG000|Overall Study|Participant Non-compliance|0|||
149199563|NCT00696436|538198446|FG001|Overall Study|Participant Non-compliance|0|||
149199564|NCT00696436|538198447|FG002|Overall Study|Participant Non-compliance|1|||
149199565|NCT00696436|538198448|FG003|Overall Study|Participant Non-compliance|2|||
149199566|NCT00696436|538198449|FG004|Overall Study|Participant Non-compliance|0|||
149199567|NCT00696436|538198445|FG000|Overall Study|Administrative Decision|1|||
149199568|NCT00696436|538198446|FG001|Overall Study|Administrative Decision|0|||
149199569|NCT00696436|538198447|FG002|Overall Study|Administrative Decision|0|||
149199570|NCT00696436|538198448|FG003|Overall Study|Administrative Decision|0|||
149199571|NCT00696436|538198449|FG004|Overall Study|Administrative Decision|0|||
149199572|NCT00696436|538198445|FG000|Overall Study|Missing|0|||
149199573|NCT00696436|538198446|FG001|Overall Study|Missing|1|||
149199574|NCT00696436|538198447|FG002|Overall Study|Missing|1|||
149199575|NCT00696436|538198448|FG003|Overall Study|Missing|0|||
149199576|NCT00696436|538198449|FG004|Overall Study|Missing|0|||
149199577|NCT01517412|538198452|FG000|Overall Study|Adverse Event|10|||
149199578|NCT01517412|538198453|FG001|Overall Study|Adverse Event|11|||
149199579|NCT01517412|538198452|FG000|Overall Study|Lack of Efficacy|10|||
149199580|NCT01517412|538198453|FG001|Overall Study|Lack of Efficacy|5|||
149199581|NCT01517412|538198452|FG000|Overall Study|Poor compliance to protocol|8|||
149199582|NCT01517412|538198453|FG001|Overall Study|Poor compliance to protocol|3|||
149199583|NCT01517412|538198452|FG000|Overall Study|Other than specified above|8|||
149199584|NCT01517412|538198453|FG001|Overall Study|Other than specified above|5|||
149199585|NCT01830816|538198459|FG000|Overall Study|Progressive Disease|12|||
149199586|NCT01830816|538198460|FG001|Overall Study|Progressive Disease|7|||
149199587|NCT01830816|538198461|FG002|Overall Study|Progressive Disease|7|||
149199588|NCT01830816|538198459|FG000|Overall Study|Adverse Event|3|||
149199589|NCT01830816|538198460|FG001|Overall Study|Adverse Event|4|||
149199590|NCT01830816|538198461|FG002|Overall Study|Adverse Event|0|||
149199591|NCT01830816|538198459|FG000|Overall Study|Study Terminated by Sponsor|1|||
149199592|NCT01830816|538198460|FG001|Overall Study|Study Terminated by Sponsor|1|||
149199593|NCT01830816|538198461|FG002|Overall Study|Study Terminated by Sponsor|0|||
149199594|NCT01830816|538198459|FG000|Overall Study|Withdrawal by Subject|1|||
149199595|NCT01830816|538198460|FG001|Overall Study|Withdrawal by Subject|1|||
149199596|NCT01830816|538198461|FG002|Overall Study|Withdrawal by Subject|0|||
149199597|NCT01830816|538198459|FG000|Overall Study|Lost to Follow-up|0|||
149199598|NCT01830816|538198460|FG001|Overall Study|Lost to Follow-up|1|||
149199599|NCT01830816|538198461|FG002|Overall Study|Lost to Follow-up|0|||
149199600|NCT01830816|538198459|FG000|Overall Study|Symptomatic Deterioration|1|||
149199601|NCT01830816|538198460|FG001|Overall Study|Symptomatic Deterioration|0|||
149199602|NCT01830816|538198461|FG002|Overall Study|Symptomatic Deterioration|0|||
149199603|NCT01830816|538198459|FG000|Overall Study|Reason not Specified|2|||
149199604|NCT01830816|538198460|FG001|Overall Study|Reason not Specified|0|||
149199605|NCT01830816|538198461|FG002|Overall Study|Reason not Specified|0|||
149199606|NCT02716194|538198462|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
149199607|NCT02716194|538198463|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
149199608|NCT02716194|538198464|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
149199609|NCT01754922|538198473|FG000|Overall Study|Adverse Event|0|||
149199610|NCT01754922|538198474|FG001|Overall Study|Adverse Event|1|||
149199611|NCT01207388|538198475|FG000|Overall Study|Death|67|||
149199612|NCT01207388|538198475|FG000|Overall Study|Withdrawal by Subject|1|||
149199613|NCT01885078|538198476|FG000|Treatment Period|Adverse Event|52|||
149199614|NCT01885078|538198477|FG001|Treatment Period|Adverse Event|136|||
149199615|NCT01885078|538198478|FG002|Treatment Period|Adverse Event|30|||
149199616|NCT01885078|538198479|FG003|Treatment Period|Adverse Event|73|||
149199617|NCT01885078|538198480|FG004|Treatment Period|Adverse Event|17|||
149199618|NCT01885078|538198481|FG005|Treatment Period|Adverse Event|72|||
149199619|NCT01885078|538198482|FG006|Treatment Period|Adverse Event|24|||
149199620|NCT01885078|538198483|FG007|Treatment Period|Adverse Event|5|||
149199621|NCT01885078|538198484|FG008|Treatment Period|Adverse Event|0|||
149199622|NCT01885078|538198485|FG009|Treatment Period|Adverse Event|0|||
149199623|NCT01885078|538198476|FG000|Treatment Period|Death|13|||
149199624|NCT01885078|538198477|FG001|Treatment Period|Death|33|||
149199625|NCT01885078|538198478|FG002|Treatment Period|Death|5|||
149199626|NCT01885078|538198479|FG003|Treatment Period|Death|9|||
149199627|NCT01885078|538198480|FG004|Treatment Period|Death|2|||
149199628|NCT01885078|538198481|FG005|Treatment Period|Death|10|||
149199629|NCT01885078|538198482|FG006|Treatment Period|Death|3|||
149199630|NCT01885078|538198483|FG007|Treatment Period|Death|2|||
148943506|NCT02501473|537278034|FG005|Overall Study|Reason not specified|0|||
148943507|NCT02501473|537278035|FG006|Overall Study|Reason not specified|0|||
148943508|NCT02501473|537278036|FG007|Overall Study|Reason not specified|0|||
148943509|NCT03068130|537278039|FG000|Overall Study|Adverse Event|19|||
148943510|NCT03068130|537278039|FG000|Overall Study|Death|14|||
148943511|NCT03068130|537278039|FG000|Overall Study|Lost to Follow-up|4|||
149199631|NCT01885078|538198484|FG008|Treatment Period|Death|0|||
149199632|NCT01885078|538198485|FG009|Treatment Period|Death|0|||
149199633|NCT01885078|538198476|FG000|Treatment Period|Lack of Efficacy|12|||
149199634|NCT01885078|538198477|FG001|Treatment Period|Lack of Efficacy|33|||
149199635|NCT01885078|538198478|FG002|Treatment Period|Lack of Efficacy|10|||
149199636|NCT01885078|538198479|FG003|Treatment Period|Lack of Efficacy|23|||
149199637|NCT01885078|538198480|FG004|Treatment Period|Lack of Efficacy|24|||
149199638|NCT01885078|538198481|FG005|Treatment Period|Lack of Efficacy|58|||
149199639|NCT01885078|538198482|FG006|Treatment Period|Lack of Efficacy|9|||
149199640|NCT01885078|538198483|FG007|Treatment Period|Lack of Efficacy|5|||
149199641|NCT01885078|538198484|FG008|Treatment Period|Lack of Efficacy|0|||
149199642|NCT01885078|538198485|FG009|Treatment Period|Lack of Efficacy|0|||
149199643|NCT01885078|538198476|FG000|Treatment Period|Lost to Follow-up|16|||
149199644|NCT01885078|538198477|FG001|Treatment Period|Lost to Follow-up|19|||
149199645|NCT01885078|538198478|FG002|Treatment Period|Lost to Follow-up|7|||
149199646|NCT01885078|538198479|FG003|Treatment Period|Lost to Follow-up|9|||
149199647|NCT01885078|538198480|FG004|Treatment Period|Lost to Follow-up|2|||
149199648|NCT01885078|538198481|FG005|Treatment Period|Lost to Follow-up|8|||
149199649|NCT01885078|538198482|FG006|Treatment Period|Lost to Follow-up|2|||
149199650|NCT01885078|538198483|FG007|Treatment Period|Lost to Follow-up|0|||
149199651|NCT01885078|538198484|FG008|Treatment Period|Lost to Follow-up|0|||
149199652|NCT01885078|538198485|FG009|Treatment Period|Lost to Follow-up|0|||
149199653|NCT01885078|538198476|FG000|Treatment Period|Physician Decision|19|||
149199654|NCT01885078|538198477|FG001|Treatment Period|Physician Decision|21|||
149199655|NCT01885078|538198478|FG002|Treatment Period|Physician Decision|5|||
149199656|NCT01885078|538198479|FG003|Treatment Period|Physician Decision|12|||
149199657|NCT01885078|538198480|FG004|Treatment Period|Physician Decision|9|||
149199658|NCT01885078|538198481|FG005|Treatment Period|Physician Decision|24|||
149199659|NCT01885078|538198482|FG006|Treatment Period|Physician Decision|4|||
149199660|NCT01885078|538198483|FG007|Treatment Period|Physician Decision|3|||
149199661|NCT01885078|538198484|FG008|Treatment Period|Physician Decision|0|||
149199662|NCT01885078|538198485|FG009|Treatment Period|Physician Decision|0|||
149199663|NCT01885078|538198476|FG000|Treatment Period|Protocol Violation|3|||
149199664|NCT01885078|538198477|FG001|Treatment Period|Protocol Violation|5|||
149199665|NCT01885078|538198478|FG002|Treatment Period|Protocol Violation|0|||
149199666|NCT01885078|538198479|FG003|Treatment Period|Protocol Violation|3|||
149199667|NCT01885078|538198480|FG004|Treatment Period|Protocol Violation|1|||
149199668|NCT01885078|538198481|FG005|Treatment Period|Protocol Violation|6|||
149199669|NCT01885078|538198482|FG006|Treatment Period|Protocol Violation|0|||
149199670|NCT01885078|538198483|FG007|Treatment Period|Protocol Violation|0|||
149199671|NCT01885078|538198484|FG008|Treatment Period|Protocol Violation|0|||
149199672|NCT01885078|538198485|FG009|Treatment Period|Protocol Violation|0|||
149199673|NCT01885078|538198476|FG000|Treatment Period|Sponsor Decision|245|||
149199674|NCT01885078|538198477|FG001|Treatment Period|Sponsor Decision|648|||
149199675|NCT01885078|538198478|FG002|Treatment Period|Sponsor Decision|49|||
149199676|NCT01885078|538198479|FG003|Treatment Period|Sponsor Decision|90|||
149199677|NCT01885078|538198480|FG004|Treatment Period|Sponsor Decision|20|||
149199678|NCT01885078|538198481|FG005|Treatment Period|Sponsor Decision|38|||
149199679|NCT01885078|538198482|FG006|Treatment Period|Sponsor Decision|162|||
149199680|NCT01885078|538198483|FG007|Treatment Period|Sponsor Decision|3|||
149199681|NCT01885078|538198484|FG008|Treatment Period|Sponsor Decision|0|||
149199682|NCT01885078|538198485|FG009|Treatment Period|Sponsor Decision|0|||
149199683|NCT01885078|538198476|FG000|Treatment Period|Withdrawal by Subject|72|||
149199684|NCT01885078|538198477|FG001|Treatment Period|Withdrawal by Subject|132|||
149199685|NCT01885078|538198478|FG002|Treatment Period|Withdrawal by Subject|25|||
149199686|NCT01885078|538198479|FG003|Treatment Period|Withdrawal by Subject|63|||
149199687|NCT01885078|538198480|FG004|Treatment Period|Withdrawal by Subject|15|||
149199688|NCT01885078|538198481|FG005|Treatment Period|Withdrawal by Subject|34|||
149199689|NCT01885078|538198482|FG006|Treatment Period|Withdrawal by Subject|17|||
149199690|NCT01885078|538198483|FG007|Treatment Period|Withdrawal by Subject|10|||
149199691|NCT01885078|538198484|FG008|Treatment Period|Withdrawal by Subject|0|||
149199692|NCT01885078|538198485|FG009|Treatment Period|Withdrawal by Subject|0|||
149199693|NCT01885078|538198476|FG000|Treatment Period|Other|0|||
149199694|NCT01885078|538198477|FG001|Treatment Period|Other|0|||
149199695|NCT01885078|538198478|FG002|Treatment Period|Other|0|||
149199696|NCT01885078|538198479|FG003|Treatment Period|Other|1|||
149199697|NCT01885078|538198480|FG004|Treatment Period|Other|0|||
148943512|NCT03068130|537278039|FG000|Overall Study|Withdrawal by Subject|26|||
148943513|NCT03068130|537278039|FG000|Overall Study|Administrative Reasons|3|||
149199698|NCT01885078|538198481|FG005|Treatment Period|Other|0|||
149199699|NCT01885078|538198482|FG006|Treatment Period|Other|0|||
149199700|NCT01885078|538198483|FG007|Treatment Period|Other|0|||
149016228|NCT04159415|537537887|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
149016229|NCT04159415|537537888|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
149199701|NCT01885078|538198484|FG008|Treatment Period|Other|0|||
149199702|NCT01885078|538198485|FG009|Treatment Period|Other|0|||
149199703|NCT01885078|538198476|FG000|Step-down Period|Sponsor Decision|0|||
149199704|NCT01885078|538198477|FG001|Step-down Period|Sponsor Decision|0|||
149199705|NCT01885078|538198478|FG002|Step-down Period|Sponsor Decision|0|||
149199706|NCT01885078|538198479|FG003|Step-down Period|Sponsor Decision|0|||
149199707|NCT01885078|538198480|FG004|Step-down Period|Sponsor Decision|0|||
149199708|NCT01885078|538198481|FG005|Step-down Period|Sponsor Decision|0|||
149199709|NCT01885078|538198482|FG006|Step-down Period|Sponsor Decision|0|||
149199710|NCT01885078|538198483|FG007|Step-down Period|Sponsor Decision|0|||
149199711|NCT01885078|538198484|FG008|Step-down Period|Sponsor Decision|1|||
149199712|NCT01885078|538198485|FG009|Step-down Period|Sponsor Decision|1|||
149199713|NCT01885078|538198476|FG000|Step-down Period|Adverse Event|0|||
149199714|NCT01885078|538198477|FG001|Step-down Period|Adverse Event|0|||
149199715|NCT01885078|538198478|FG002|Step-down Period|Adverse Event|0|||
149199716|NCT01885078|538198479|FG003|Step-down Period|Adverse Event|0|||
149199717|NCT01885078|538198480|FG004|Step-down Period|Adverse Event|0|||
149199718|NCT01885078|538198481|FG005|Step-down Period|Adverse Event|0|||
149199719|NCT01885078|538198482|FG006|Step-down Period|Adverse Event|0|||
149199720|NCT01885078|538198483|FG007|Step-down Period|Adverse Event|0|||
149199721|NCT01885078|538198484|FG008|Step-down Period|Adverse Event|29|||
149199722|NCT01885078|538198485|FG009|Step-down Period|Adverse Event|38|||
149199723|NCT01885078|538198476|FG000|Step-down Period|Withdrawal by Subject|0|||
149199724|NCT01885078|538198477|FG001|Step-down Period|Withdrawal by Subject|0|||
149199725|NCT01885078|538198478|FG002|Step-down Period|Withdrawal by Subject|0|||
149199726|NCT01885078|538198479|FG003|Step-down Period|Withdrawal by Subject|0|||
149199727|NCT01885078|538198480|FG004|Step-down Period|Withdrawal by Subject|0|||
149199728|NCT01885078|538198481|FG005|Step-down Period|Withdrawal by Subject|0|||
149199729|NCT01885078|538198482|FG006|Step-down Period|Withdrawal by Subject|0|||
149199730|NCT01885078|538198483|FG007|Step-down Period|Withdrawal by Subject|0|||
149199731|NCT01885078|538198484|FG008|Step-down Period|Withdrawal by Subject|25|||
149199732|NCT01885078|538198485|FG009|Step-down Period|Withdrawal by Subject|15|||
149199733|NCT01885078|538198476|FG000|Step-down Period|Physician Decision|0|||
149199734|NCT01885078|538198477|FG001|Step-down Period|Physician Decision|0|||
149199735|NCT01885078|538198478|FG002|Step-down Period|Physician Decision|0|||
149199736|NCT01885078|538198479|FG003|Step-down Period|Physician Decision|0|||
149199737|NCT01885078|538198480|FG004|Step-down Period|Physician Decision|0|||
149199738|NCT01885078|538198481|FG005|Step-down Period|Physician Decision|0|||
149199739|NCT01885078|538198482|FG006|Step-down Period|Physician Decision|0|||
149199740|NCT01885078|538198483|FG007|Step-down Period|Physician Decision|0|||
149199741|NCT01885078|538198484|FG008|Step-down Period|Physician Decision|7|||
149199742|NCT01885078|538198485|FG009|Step-down Period|Physician Decision|2|||
149199743|NCT01885078|538198476|FG000|Step-down Period|Death|0|||
149199744|NCT01885078|538198477|FG001|Step-down Period|Death|0|||
149199745|NCT01885078|538198478|FG002|Step-down Period|Death|0|||
149199746|NCT01885078|538198479|FG003|Step-down Period|Death|0|||
149199747|NCT01885078|538198480|FG004|Step-down Period|Death|0|||
149199748|NCT01885078|538198481|FG005|Step-down Period|Death|0|||
149199749|NCT01885078|538198482|FG006|Step-down Period|Death|0|||
149199750|NCT01885078|538198483|FG007|Step-down Period|Death|0|||
149199751|NCT01885078|538198484|FG008|Step-down Period|Death|4|||
149199752|NCT01885078|538198485|FG009|Step-down Period|Death|3|||
149199753|NCT01885078|538198476|FG000|Step-down Period|Lost to Follow-up|0|||
149199754|NCT01885078|538198477|FG001|Step-down Period|Lost to Follow-up|0|||
149199755|NCT01885078|538198478|FG002|Step-down Period|Lost to Follow-up|0|||
149199756|NCT01885078|538198479|FG003|Step-down Period|Lost to Follow-up|0|||
149199757|NCT01885078|538198480|FG004|Step-down Period|Lost to Follow-up|0|||
149016230|NCT05407311|537537889|FG000|Overall Study|Withdrawal by Subject|5|||
149016231|NCT05407311|537537889|FG000|Overall Study|Protocol Violation|3|||
149199758|NCT01885078|538198481|FG005|Step-down Period|Lost to Follow-up|0|||
149199759|NCT01885078|538198482|FG006|Step-down Period|Lost to Follow-up|0|||
149199760|NCT01885078|538198483|FG007|Step-down Period|Lost to Follow-up|0|||
149016232|NCT05407311|537537889|FG000|Overall Study|Physician Decision|1|||
149199761|NCT01885078|538198484|FG008|Step-down Period|Lost to Follow-up|1|||
149199762|NCT01885078|538198485|FG009|Step-down Period|Lost to Follow-up|1|||
149199763|NCT01885078|538198476|FG000|Step-down Period|Lack of Efficacy|0|||
149016233|NCT05407311|537537889|FG000|Overall Study|Non-compliance|1|||
149016234|NCT00337662|537537890|FG000|Study Period II|Lost to Follow-up|0|||
149199764|NCT01885078|538198477|FG001|Step-down Period|Lack of Efficacy|0|||
149199765|NCT01885078|538198478|FG002|Step-down Period|Lack of Efficacy|0|||
149199766|NCT01885078|538198479|FG003|Step-down Period|Lack of Efficacy|0|||
149199767|NCT01885078|538198480|FG004|Step-down Period|Lack of Efficacy|0|||
149199768|NCT01885078|538198481|FG005|Step-down Period|Lack of Efficacy|0|||
149199769|NCT01885078|538198482|FG006|Step-down Period|Lack of Efficacy|0|||
149199770|NCT01885078|538198483|FG007|Step-down Period|Lack of Efficacy|0|||
149199771|NCT01885078|538198484|FG008|Step-down Period|Lack of Efficacy|1|||
149199772|NCT01885078|538198485|FG009|Step-down Period|Lack of Efficacy|0|||
149199773|NCT01885078|538198476|FG000|Step-down Period|Protocol Violation|0|||
149199774|NCT01885078|538198477|FG001|Step-down Period|Protocol Violation|0|||
149199775|NCT01885078|538198478|FG002|Step-down Period|Protocol Violation|0|||
149199776|NCT01885078|538198479|FG003|Step-down Period|Protocol Violation|0|||
149199777|NCT01885078|538198480|FG004|Step-down Period|Protocol Violation|0|||
149199778|NCT01885078|538198481|FG005|Step-down Period|Protocol Violation|0|||
149199779|NCT01885078|538198482|FG006|Step-down Period|Protocol Violation|0|||
149199780|NCT01885078|538198483|FG007|Step-down Period|Protocol Violation|0|||
149199781|NCT01885078|538198484|FG008|Step-down Period|Protocol Violation|1|||
149199782|NCT01885078|538198485|FG009|Step-down Period|Protocol Violation|1|||
149199783|NCT01895452|538198489|FG000|Overall Study|Adverse Event|1|||
149199784|NCT01895452|538198490|FG001|Overall Study|Adverse Event|4|||
149199785|NCT01895452|538198489|FG000|Overall Study|Lost to Follow-up|1|||
149199786|NCT01895452|538198490|FG001|Overall Study|Lost to Follow-up|5|||
149199787|NCT01895452|538198489|FG000|Overall Study|Pregnancy|0|||
149199788|NCT01895452|538198490|FG001|Overall Study|Pregnancy|1|||
149199789|NCT01895452|538198489|FG000|Overall Study|Withdrawal by Subject|2|||
149199790|NCT01895452|538198490|FG001|Overall Study|Withdrawal by Subject|14|||
149199791|NCT01895452|538198489|FG000|Overall Study|Underlying disease|0|||
149199792|NCT01895452|538198490|FG001|Overall Study|Underlying disease|3|||
149199793|NCT01895452|538198489|FG000|Overall Study|Noncompliance with study drug|0|||
149199794|NCT01895452|538198490|FG001|Overall Study|Noncompliance with study drug|1|||
149199795|NCT00980343|538198491|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
149199796|NCT00980343|538198492|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
149199797|NCT02899377|538198499|FG000|Overall Study|Adverse Event|1|||
149199798|NCT02899377|538198500|FG001|Overall Study|Adverse Event|0|||
149199799|NCT01231607|538198501|FG000|Overall Study|Adverse Event|0|||
149199800|NCT01231607|538198502|FG001|Overall Study|Adverse Event|8|||
149199801|NCT01231607|538198503|FG002|Overall Study|Adverse Event|4|||
149199802|NCT01231607|538198504|FG003|Overall Study|Adverse Event|4|||
149199803|NCT01231607|538198505|FG004|Overall Study|Adverse Event|5|||
149199804|NCT01231607|538198501|FG000|Overall Study|Lost to Follow-up|13|||
149199805|NCT01231607|538198502|FG001|Overall Study|Lost to Follow-up|11|||
149199806|NCT01231607|538198503|FG002|Overall Study|Lost to Follow-up|10|||
149199807|NCT01231607|538198504|FG003|Overall Study|Lost to Follow-up|10|||
149199808|NCT01231607|538198505|FG004|Overall Study|Lost to Follow-up|4|||
149199809|NCT01231607|538198501|FG000|Overall Study|Physician Decision|4|||
149199810|NCT01231607|538198502|FG001|Overall Study|Physician Decision|4|||
149199811|NCT01231607|538198503|FG002|Overall Study|Physician Decision|3|||
149199812|NCT01231607|538198504|FG003|Overall Study|Physician Decision|5|||
149199813|NCT01231607|538198505|FG004|Overall Study|Physician Decision|4|||
149199814|NCT01231607|538198501|FG000|Overall Study|Protocol Violation|3|||
149199815|NCT01231607|538198502|FG001|Overall Study|Protocol Violation|2|||
149199816|NCT01231607|538198503|FG002|Overall Study|Protocol Violation|0|||
149199817|NCT01231607|538198504|FG003|Overall Study|Protocol Violation|2|||
149199818|NCT01231607|538198505|FG004|Overall Study|Protocol Violation|2|||
149199819|NCT01231607|538198501|FG000|Overall Study|Withdrawal by Subject|9|||
149199820|NCT01231607|538198502|FG001|Overall Study|Withdrawal by Subject|9|||
149199821|NCT01231607|538198503|FG002|Overall Study|Withdrawal by Subject|14|||
149199822|NCT01231607|538198504|FG003|Overall Study|Withdrawal by Subject|17|||
149199823|NCT01231607|538198505|FG004|Overall Study|Withdrawal by Subject|9|||
149199824|NCT01677507|538198508|FG000|Initial Assignment|Adverse Event|0|||
149199825|NCT01677507|538198509|FG001|Initial Assignment|Adverse Event|1|||
149199826|NCT01677507|538198508|FG000|Initial Assignment|Protocol Violation|0|||
149199827|NCT01677507|538198509|FG001|Initial Assignment|Protocol Violation|1|||
149199828|NCT01677507|538198508|FG000|Second Assigment|Withdrawal by Subject|2|||
149199829|NCT01677507|538198509|FG001|Second Assigment|Withdrawal by Subject|2|||
149199830|NCT01677507|538198508|FG000|Second Assigment|Adverse Event|1|||
149199831|NCT01677507|538198509|FG001|Second Assigment|Adverse Event|3|||
149199832|NCT03779334|538198510|FG000|Overall Study|Withdrawal by Subject|3|||
149199833|NCT03779334|538198511|FG001|Overall Study|Withdrawal by Subject|0|||
149199834|NCT03779334|538198512|FG002|Overall Study|Withdrawal by Subject|0|||
149199835|NCT03779334|538198510|FG000|Overall Study|Ongoing in Study|5|||
149199836|NCT03779334|538198511|FG001|Overall Study|Ongoing in Study|13|||
149199837|NCT03779334|538198512|FG002|Overall Study|Ongoing in Study|5|||
149199838|NCT00363246|538198525|FG000|Overall Study|Death|40|||
149199839|NCT00363246|538198525|FG000|Overall Study|Withdrawal by Subject|19|||
149199840|NCT00363246|538198525|FG000|Overall Study|Lost to Follow-up|14|||
149199841|NCT00363246|538198525|FG000|Overall Study|Bad health|6|||
149199842|NCT00363246|538198525|FG000|Overall Study|Stopped using wheelchair|11|||
149199843|NCT00363246|538198525|FG000|Overall Study|Subject expressed security concerns|2|||
149199844|NCT00363246|538198525|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
149199845|NCT01608724|538198526|FG000|Overall Study|Withdrawal by Subject|131|||
149199846|NCT01608724|538198526|FG000|Overall Study|Lost to Follow-up|41|||
149199847|NCT01608724|538198526|FG000|Overall Study|Study-specific discontinuation criteria|32|||
149199848|NCT01608724|538198526|FG000|Overall Study|Adverse Event|29|||
149199849|NCT01608724|538198526|FG000|Overall Study|Protocol Violation|6|||
149199850|NCT01608724|538198526|FG000|Overall Study|bood sugar too high, etc.|3|||
149199851|NCT01608724|538198526|FG000|Overall Study|Safety reasons|1|||
149199852|NCT00438399|538198529|FG000|Overall Study|Lost to Follow-up|2|||
149199853|NCT00438399|538198530|FG001|Overall Study|Lost to Follow-up|2|||
149199854|NCT00438399|538198531|FG002|Overall Study|Lost to Follow-up|1|||
149199855|NCT00438399|538198532|FG003|Overall Study|Lost to Follow-up|1|||
149199856|NCT00438399|538198533|FG004|Overall Study|Lost to Follow-up|1|||
149199857|NCT00438399|538198534|FG005|Overall Study|Lost to Follow-up|1|||
149199858|NCT00438399|538198529|FG000|Overall Study|Adverse Event|0|||
149199859|NCT00438399|538198530|FG001|Overall Study|Adverse Event|0|||
149199860|NCT00438399|538198531|FG002|Overall Study|Adverse Event|1|||
149199861|NCT00438399|538198532|FG003|Overall Study|Adverse Event|1|||
149199862|NCT00438399|538198533|FG004|Overall Study|Adverse Event|0|||
149199863|NCT00438399|538198534|FG005|Overall Study|Adverse Event|1|||
149199864|NCT00438399|538198529|FG000|Overall Study|Withdrawal by Subject|5|||
149199865|NCT00438399|538198530|FG001|Overall Study|Withdrawal by Subject|6|||
149199866|NCT00438399|538198531|FG002|Overall Study|Withdrawal by Subject|3|||
149199867|NCT00438399|538198532|FG003|Overall Study|Withdrawal by Subject|2|||
149199868|NCT00438399|538198533|FG004|Overall Study|Withdrawal by Subject|2|||
149199869|NCT00438399|538198534|FG005|Overall Study|Withdrawal by Subject|2|||
149199870|NCT00438399|538198529|FG000|Overall Study|Protocol Violation|0|||
149199871|NCT00438399|538198530|FG001|Overall Study|Protocol Violation|0|||
149199872|NCT00438399|538198531|FG002|Overall Study|Protocol Violation|1|||
149199873|NCT00438399|538198532|FG003|Overall Study|Protocol Violation|0|||
149199874|NCT00438399|538198533|FG004|Overall Study|Protocol Violation|0|||
149199875|NCT00438399|538198534|FG005|Overall Study|Protocol Violation|1|||
149199876|NCT00438399|538198529|FG000|Overall Study|Subje stopped study|0|||
149199877|NCT00438399|538198530|FG001|Overall Study|Subje stopped study|0|||
149199878|NCT00438399|538198531|FG002|Overall Study|Subje stopped study|1|||
149199879|NCT00438399|538198532|FG003|Overall Study|Subje stopped study|0|||
149199880|NCT00438399|538198533|FG004|Overall Study|Subje stopped study|0|||
149199881|NCT00438399|538198534|FG005|Overall Study|Subje stopped study|0|||
149199882|NCT00438399|538198529|FG000|Overall Study|Pregnancy|0|||
149199883|NCT00438399|538198530|FG001|Overall Study|Pregnancy|0|||
149199884|NCT00438399|538198531|FG002|Overall Study|Pregnancy|0|||
149199885|NCT00438399|538198532|FG003|Overall Study|Pregnancy|0|||
149199886|NCT00438399|538198533|FG004|Overall Study|Pregnancy|0|||
149199887|NCT00438399|538198534|FG005|Overall Study|Pregnancy|1|||
149199888|NCT00438399|538198529|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
149199889|NCT00438399|538198530|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
149199890|NCT00438399|538198531|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
149199891|NCT00438399|538198532|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
149199892|NCT00438399|538198533|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
149199893|NCT00438399|538198534|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
149199894|NCT00349752|538198538|FG000|Overall Study|Adverse Event|8|||
149199895|NCT00349752|538198539|FG001|Overall Study|Adverse Event|12|||
149199896|NCT00349752|538198538|FG000|Overall Study|Lack of Efficacy|37|||
149199897|NCT00349752|538198539|FG001|Overall Study|Lack of Efficacy|42|||
149199898|NCT00349752|538198538|FG000|Overall Study|Lost to Follow-up|4|||
149199899|NCT00349752|538198539|FG001|Overall Study|Lost to Follow-up|2|||
149199900|NCT00349752|538198538|FG000|Overall Study|Personal reasons|6|||
149199901|NCT00349752|538198539|FG001|Overall Study|Personal reasons|5|||
149199902|NCT00349752|538198538|FG000|Overall Study|Other: Required exclusionary medication|0|||
149199903|NCT00349752|538198539|FG001|Overall Study|Other: Required exclusionary medication|1|||
149199904|NCT00349752|538198538|FG000|Overall Study|Other: Non compliance|0|||
149199905|NCT00349752|538198539|FG001|Overall Study|Other: Non compliance|1|||
149199906|NCT00349752|538198538|FG000|Overall Study|Other: Patient stopped steroids|0|||
149199907|NCT00349752|538198539|FG001|Overall Study|Other: Patient stopped steroids|1|||
149199908|NCT00349752|538198538|FG000|Overall Study|Other: Patient's steroid use|1|||
149199909|NCT00349752|538198539|FG001|Overall Study|Other: Patient's steroid use|0|||
149199910|NCT00349752|538198538|FG000|Overall Study|Other: Ineligible|1|||
149199911|NCT00349752|538198539|FG001|Overall Study|Other: Ineligible|0|||
149016235|NCT00337662|537537891|FG001|Study Period II|Lost to Follow-up|0|||
149199912|NCT00349752|538198538|FG000|Overall Study|Other: Inadvertently unblinded|1|||
149199913|NCT00349752|538198539|FG001|Overall Study|Other: Inadvertently unblinded|0|||
149199914|NCT00349752|538198538|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
149199915|NCT00349752|538198539|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
149199916|NCT00819585|538198540|FG000|Core Study|Adverse Event|2|||
149199917|NCT00819585|538198541|FG001|Core Study|Adverse Event|1|||
149199918|NCT00819585|538198542|FG002|Core Study|Adverse Event|1|||
149199919|NCT00819585|538198543|FG003|Core Study|Adverse Event|4|||
149199920|NCT00819585|538198544|FG004|Core Study|Adverse Event|1|||
149199921|NCT00819585|538198545|FG005|Core Study|Adverse Event|0|||
149199922|NCT00819585|538198546|FG006|Core Study|Adverse Event|2|||
149199923|NCT00819585|538198547|FG007|Core Study|Adverse Event|0|||
149199924|NCT00819585|538198548|FG008|Core Study|Adverse Event|0|||
149199925|NCT00819585|538198549|FG009|Core Study|Adverse Event|0|||
149199926|NCT00819585|538198550|FG010|Core Study|Adverse Event|0|||
149199927|NCT00819585|538198540|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
149199928|NCT00819585|538198541|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
149199929|NCT00819585|538198542|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
149199930|NCT00819585|538198543|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
149199931|NCT00819585|538198544|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
149199932|NCT00819585|538198545|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
149199933|NCT00819585|538198546|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
149199934|NCT00819585|538198547|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
149199935|NCT00819585|538198548|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
149199936|NCT00819585|538198549|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
149199937|NCT00819585|538198550|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
149199938|NCT00819585|538198540|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199939|NCT00819585|538198541|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
149199940|NCT00819585|538198542|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199941|NCT00819585|538198543|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199942|NCT00819585|538198544|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199943|NCT00819585|538198545|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199944|NCT00819585|538198546|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
149199945|NCT00819585|538198547|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199946|NCT00819585|538198548|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199947|NCT00819585|538198549|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199948|NCT00819585|538198550|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
149199949|NCT00819585|538198540|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
149199950|NCT00819585|538198541|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
149199951|NCT00819585|538198542|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
149199952|NCT00819585|538198543|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
149199953|NCT00819585|538198544|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
149199954|NCT00819585|538198545|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
149199955|NCT00819585|538198546|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
149199956|NCT00819585|538198547|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
149199957|NCT00819585|538198548|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
149199958|NCT00819585|538198549|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
149199959|NCT00819585|538198550|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
149199960|NCT00819585|538198540|FG000|Core Study|Subject Withdrew Consent|0|||
149199961|NCT00819585|538198541|FG001|Core Study|Subject Withdrew Consent|3|||
149199962|NCT00819585|538198542|FG002|Core Study|Subject Withdrew Consent|2|||
149199963|NCT00819585|538198543|FG003|Core Study|Subject Withdrew Consent|1|||
149199964|NCT00819585|538198544|FG004|Core Study|Subject Withdrew Consent|0|||
149199965|NCT00819585|538198545|FG005|Core Study|Subject Withdrew Consent|0|||
149199966|NCT00819585|538198546|FG006|Core Study|Subject Withdrew Consent|3|||
149199967|NCT00819585|538198547|FG007|Core Study|Subject Withdrew Consent|0|||
149199968|NCT00819585|538198548|FG008|Core Study|Subject Withdrew Consent|0|||
149199969|NCT00819585|538198549|FG009|Core Study|Subject Withdrew Consent|0|||
149199970|NCT00819585|538198550|FG010|Core Study|Subject Withdrew Consent|0|||
149199971|NCT00819585|538198540|FG000|Core Study|Lost to Follow-up|2|||
149199972|NCT00819585|538198541|FG001|Core Study|Lost to Follow-up|1|||
149199973|NCT00819585|538198542|FG002|Core Study|Lost to Follow-up|2|||
149199974|NCT00819585|538198543|FG003|Core Study|Lost to Follow-up|0|||
149199975|NCT00819585|538198544|FG004|Core Study|Lost to Follow-up|1|||
149199976|NCT00819585|538198545|FG005|Core Study|Lost to Follow-up|1|||
149199977|NCT00819585|538198546|FG006|Core Study|Lost to Follow-up|1|||
149199978|NCT00819585|538198547|FG007|Core Study|Lost to Follow-up|0|||
149199979|NCT00819585|538198548|FG008|Core Study|Lost to Follow-up|0|||
149199980|NCT00819585|538198549|FG009|Core Study|Lost to Follow-up|0|||
149199981|NCT00819585|538198550|FG010|Core Study|Lost to Follow-up|0|||
149199982|NCT00819585|538198540|FG000|Core Study|Administrative Problems|0|||
149199983|NCT00819585|538198541|FG001|Core Study|Administrative Problems|0|||
149199984|NCT00819585|538198542|FG002|Core Study|Administrative Problems|0|||
149199985|NCT00819585|538198543|FG003|Core Study|Administrative Problems|0|||
149199986|NCT00819585|538198544|FG004|Core Study|Administrative Problems|0|||
149199987|NCT00819585|538198545|FG005|Core Study|Administrative Problems|0|||
149199988|NCT00819585|538198546|FG006|Core Study|Administrative Problems|2|||
149199989|NCT00819585|538198547|FG007|Core Study|Administrative Problems|0|||
149199990|NCT00819585|538198548|FG008|Core Study|Administrative Problems|0|||
149199991|NCT00819585|538198549|FG009|Core Study|Administrative Problems|0|||
149199992|NCT00819585|538198550|FG010|Core Study|Administrative Problems|0|||
149199993|NCT00819585|538198540|FG000|Core Study|Death|0|||
149199994|NCT00819585|538198541|FG001|Core Study|Death|0|||
149199995|NCT00819585|538198542|FG002|Core Study|Death|0|||
149199996|NCT00819585|538198543|FG003|Core Study|Death|0|||
149199997|NCT00819585|538198544|FG004|Core Study|Death|0|||
149199998|NCT00819585|538198545|FG005|Core Study|Death|0|||
149199999|NCT00819585|538198546|FG006|Core Study|Death|1|||
149200000|NCT00819585|538198547|FG007|Core Study|Death|0|||
149200001|NCT00819585|538198548|FG008|Core Study|Death|0|||
149200002|NCT00819585|538198549|FG009|Core Study|Death|0|||
149200003|NCT00819585|538198550|FG010|Core Study|Death|0|||
149200004|NCT00819585|538198540|FG000|Core Study|Protocol Violation|0|||
149200005|NCT00819585|538198541|FG001|Core Study|Protocol Violation|0|||
149200006|NCT00819585|538198542|FG002|Core Study|Protocol Violation|1|||
149200007|NCT00819585|538198543|FG003|Core Study|Protocol Violation|0|||
149200008|NCT00819585|538198544|FG004|Core Study|Protocol Violation|0|||
149200009|NCT00819585|538198545|FG005|Core Study|Protocol Violation|1|||
149200010|NCT00819585|538198546|FG006|Core Study|Protocol Violation|3|||
149200011|NCT00819585|538198547|FG007|Core Study|Protocol Violation|0|||
149200012|NCT00819585|538198548|FG008|Core Study|Protocol Violation|0|||
149200013|NCT00819585|538198549|FG009|Core Study|Protocol Violation|0|||
149200014|NCT00819585|538198550|FG010|Core Study|Protocol Violation|0|||
149200015|NCT00819585|538198540|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
149200016|NCT00819585|538198541|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
149200017|NCT00819585|538198542|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
149200018|NCT00819585|538198543|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
149200019|NCT00819585|538198544|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
149200020|NCT00819585|538198545|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
149200021|NCT00819585|538198546|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
149200022|NCT00819585|538198547|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
149200023|NCT00819585|538198548|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
149200024|NCT00819585|538198549|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
149200025|NCT00819585|538198550|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
149200026|NCT00819585|538198540|FG000|Extension Study|Subject Withdrew Consent|0|||
149200027|NCT00819585|538198541|FG001|Extension Study|Subject Withdrew Consent|0|||
149200028|NCT00819585|538198542|FG002|Extension Study|Subject Withdrew Consent|0|||
149200029|NCT00819585|538198543|FG003|Extension Study|Subject Withdrew Consent|0|||
149200030|NCT00819585|538198544|FG004|Extension Study|Subject Withdrew Consent|0|||
149200031|NCT00819585|538198545|FG005|Extension Study|Subject Withdrew Consent|0|||
149200032|NCT00819585|538198546|FG006|Extension Study|Subject Withdrew Consent|0|||
149200033|NCT00819585|538198547|FG007|Extension Study|Subject Withdrew Consent|0|||
149200034|NCT00819585|538198548|FG008|Extension Study|Subject Withdrew Consent|3|||
149200035|NCT00819585|538198549|FG009|Extension Study|Subject Withdrew Consent|0|||
149200036|NCT00819585|538198550|FG010|Extension Study|Subject Withdrew Consent|1|||
149200037|NCT00819585|538198540|FG000|Extension Study|Lost to Follow-up|0|||
149200038|NCT00819585|538198541|FG001|Extension Study|Lost to Follow-up|0|||
149200039|NCT00819585|538198542|FG002|Extension Study|Lost to Follow-up|0|||
149200040|NCT00819585|538198543|FG003|Extension Study|Lost to Follow-up|0|||
149200041|NCT00819585|538198544|FG004|Extension Study|Lost to Follow-up|0|||
149200042|NCT00819585|538198545|FG005|Extension Study|Lost to Follow-up|0|||
149200043|NCT00819585|538198546|FG006|Extension Study|Lost to Follow-up|0|||
149200044|NCT00819585|538198547|FG007|Extension Study|Lost to Follow-up|0|||
149200045|NCT00819585|538198548|FG008|Extension Study|Lost to Follow-up|2|||
149200046|NCT00819585|538198549|FG009|Extension Study|Lost to Follow-up|1|||
149200047|NCT00819585|538198550|FG010|Extension Study|Lost to Follow-up|1|||
149200048|NCT00819585|538198540|FG000|Extension Study|Death|0|||
149200049|NCT00819585|538198541|FG001|Extension Study|Death|0|||
149200050|NCT00819585|538198542|FG002|Extension Study|Death|0|||
149200051|NCT00819585|538198543|FG003|Extension Study|Death|0|||
149200052|NCT00819585|538198544|FG004|Extension Study|Death|0|||
149200053|NCT00819585|538198545|FG005|Extension Study|Death|0|||
149200054|NCT00819585|538198546|FG006|Extension Study|Death|0|||
149200055|NCT00819585|538198547|FG007|Extension Study|Death|0|||
149200056|NCT00819585|538198548|FG008|Extension Study|Death|2|||
149200057|NCT00819585|538198549|FG009|Extension Study|Death|0|||
149200058|NCT00819585|538198550|FG010|Extension Study|Death|0|||
149200059|NCT03334396|538198551|FG000|Overall Study|Adverse Event|1|||
149200060|NCT03334396|538198552|FG001|Overall Study|Adverse Event|0|||
149200061|NCT03334396|538198553|FG002|Overall Study|Adverse Event|1|||
149200062|NCT03334396|538198554|FG003|Overall Study|Adverse Event|0|||
149200063|NCT03334396|538198555|FG004|Overall Study|Adverse Event|0|||
149200064|NCT03334396|538198556|FG005|Overall Study|Adverse Event|0|||
148943514|NCT03068130|537278039|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
149200065|NCT03334396|538198557|FG006|Overall Study|Adverse Event|0|||
149016236|NCT00337662|537537892|FG002|Study Period II|Lost to Follow-up|0|||
149200066|NCT03334396|538198558|FG007|Overall Study|Adverse Event|0|||
149200067|NCT03334396|538198551|FG000|Overall Study|Lack of Efficacy|10|||
149200068|NCT03334396|538198552|FG001|Overall Study|Lack of Efficacy|4|||
149200069|NCT03334396|538198553|FG002|Overall Study|Lack of Efficacy|1|||
149200070|NCT03334396|538198554|FG003|Overall Study|Lack of Efficacy|3|||
149200071|NCT03334396|538198555|FG004|Overall Study|Lack of Efficacy|1|||
149200072|NCT03334396|538198556|FG005|Overall Study|Lack of Efficacy|0|||
149200073|NCT03334396|538198557|FG006|Overall Study|Lack of Efficacy|0|||
149200074|NCT03334396|538198558|FG007|Overall Study|Lack of Efficacy|1|||
149200075|NCT03334396|538198551|FG000|Overall Study|Lost to Follow-up|0|||
149200076|NCT03334396|538198552|FG001|Overall Study|Lost to Follow-up|0|||
149200077|NCT03334396|538198553|FG002|Overall Study|Lost to Follow-up|1|||
149200078|NCT03334396|538198554|FG003|Overall Study|Lost to Follow-up|0|||
149200079|NCT03334396|538198555|FG004|Overall Study|Lost to Follow-up|0|||
149200080|NCT03334396|538198556|FG005|Overall Study|Lost to Follow-up|0|||
149200081|NCT03334396|538198557|FG006|Overall Study|Lost to Follow-up|1|||
149200082|NCT03334396|538198558|FG007|Overall Study|Lost to Follow-up|0|||
149200083|NCT03334396|538198551|FG000|Overall Study|Physician Decision|1|||
149200084|NCT03334396|538198552|FG001|Overall Study|Physician Decision|0|||
149200085|NCT03334396|538198553|FG002|Overall Study|Physician Decision|0|||
149200086|NCT03334396|538198554|FG003|Overall Study|Physician Decision|0|||
149200087|NCT03334396|538198555|FG004|Overall Study|Physician Decision|0|||
149200088|NCT03334396|538198556|FG005|Overall Study|Physician Decision|0|||
149200089|NCT03334396|538198557|FG006|Overall Study|Physician Decision|0|||
149200090|NCT03334396|538198558|FG007|Overall Study|Physician Decision|0|||
149200091|NCT03334396|538198551|FG000|Overall Study|Withdrawal by Subject|10|||
149200092|NCT03334396|538198552|FG001|Overall Study|Withdrawal by Subject|5|||
149200093|NCT03334396|538198553|FG002|Overall Study|Withdrawal by Subject|7|||
149200094|NCT03334396|538198554|FG003|Overall Study|Withdrawal by Subject|2|||
149200095|NCT03334396|538198555|FG004|Overall Study|Withdrawal by Subject|2|||
149200096|NCT03334396|538198556|FG005|Overall Study|Withdrawal by Subject|1|||
149200097|NCT03334396|538198557|FG006|Overall Study|Withdrawal by Subject|2|||
149200098|NCT03334396|538198558|FG007|Overall Study|Withdrawal by Subject|0|||
149200099|NCT03334396|538198551|FG000|Overall Study|Pregnancy|0|||
149200100|NCT03334396|538198552|FG001|Overall Study|Pregnancy|1|||
149200101|NCT03334396|538198553|FG002|Overall Study|Pregnancy|0|||
149200102|NCT03334396|538198554|FG003|Overall Study|Pregnancy|0|||
149200103|NCT03334396|538198555|FG004|Overall Study|Pregnancy|0|||
149200104|NCT03334396|538198556|FG005|Overall Study|Pregnancy|0|||
149200105|NCT03334396|538198557|FG006|Overall Study|Pregnancy|0|||
149200106|NCT03334396|538198558|FG007|Overall Study|Pregnancy|0|||
149200107|NCT03334396|538198551|FG000|Overall Study|Ineligible|0|||
149200108|NCT03334396|538198552|FG001|Overall Study|Ineligible|1|||
149200109|NCT03334396|538198553|FG002|Overall Study|Ineligible|0|||
149200110|NCT03334396|538198554|FG003|Overall Study|Ineligible|0|||
149200111|NCT03334396|538198555|FG004|Overall Study|Ineligible|0|||
149200112|NCT03334396|538198556|FG005|Overall Study|Ineligible|0|||
149200113|NCT03334396|538198557|FG006|Overall Study|Ineligible|0|||
149200114|NCT03334396|538198558|FG007|Overall Study|Ineligible|0|||
149200115|NCT03334396|538198551|FG000|Overall Study|Started New Job|1|||
149200116|NCT03334396|538198552|FG001|Overall Study|Started New Job|0|||
149200117|NCT03334396|538198553|FG002|Overall Study|Started New Job|0|||
149200118|NCT03334396|538198554|FG003|Overall Study|Started New Job|0|||
149200119|NCT03334396|538198555|FG004|Overall Study|Started New Job|0|||
149200120|NCT03334396|538198556|FG005|Overall Study|Started New Job|0|||
149200121|NCT03334396|538198557|FG006|Overall Study|Started New Job|0|||
149200122|NCT03334396|538198558|FG007|Overall Study|Started New Job|0|||
149200123|NCT03730194|538198562|FG000|First Stage Treatment|Withdrawal by Subject|1|||
149200124|NCT03730194|538198563|FG001|First Stage Treatment|Withdrawal by Subject|1|||
149200125|NCT03730194|538198564|FG002|First Stage Treatment|Withdrawal by Subject|0|||
149200126|NCT03730194|538198565|FG003|First Stage Treatment|Withdrawal by Subject|0|||
149200127|NCT03730194|538198566|FG004|First Stage Treatment|Withdrawal by Subject|0|||
149200128|NCT03730194|538198567|FG005|First Stage Treatment|Withdrawal by Subject|0|||
149200129|NCT03730194|538198562|FG000|First Stage Treatment|Protocol Violation|3|||
149200130|NCT03730194|538198563|FG001|First Stage Treatment|Protocol Violation|3|||
149200131|NCT03730194|538198564|FG002|First Stage Treatment|Protocol Violation|0|||
149200132|NCT03730194|538198565|FG003|First Stage Treatment|Protocol Violation|0|||
149200133|NCT03730194|538198566|FG004|First Stage Treatment|Protocol Violation|0|||
149200134|NCT03730194|538198567|FG005|First Stage Treatment|Protocol Violation|0|||
149200135|NCT01766817|538198568|FG000|Overall Study|Drug-related adverse event|1|||
149200136|NCT01766817|538198569|FG001|Overall Study|Drug-related adverse event|2|||
149200137|NCT01766817|538198570|FG002|Overall Study|Drug-related adverse event|1|||
149200138|NCT01766817|538198568|FG000|Overall Study|Drug-unrelated adverse event|3|||
149200139|NCT01766817|538198569|FG001|Overall Study|Drug-unrelated adverse event|3|||
149200140|NCT01766817|538198570|FG002|Overall Study|Drug-unrelated adverse event|3|||
149200141|NCT01766817|538198568|FG000|Overall Study|Death|1|||
149200142|NCT01766817|538198569|FG001|Overall Study|Death|1|||
149200143|NCT01766817|538198570|FG002|Overall Study|Death|0|||
149200144|NCT01766817|538198568|FG000|Overall Study|Unable to take study drug|0|||
149200145|NCT01766817|538198569|FG001|Overall Study|Unable to take study drug|1|||
149200146|NCT01766817|538198570|FG002|Overall Study|Unable to take study drug|0|||
149200147|NCT01766817|538198568|FG000|Overall Study|Withdrawal by Subject|2|||
149200148|NCT01766817|538198569|FG001|Overall Study|Withdrawal by Subject|0|||
149200149|NCT01766817|538198570|FG002|Overall Study|Withdrawal by Subject|3|||
149200150|NCT01766817|538198568|FG000|Overall Study|Subject non-compliance|0|||
149200151|NCT01766817|538198569|FG001|Overall Study|Subject non-compliance|1|||
149200152|NCT01766817|538198570|FG002|Overall Study|Subject non-compliance|2|||
149200153|NCT01766817|538198568|FG000|Overall Study|Physician Decision|3|||
149200154|NCT01766817|538198569|FG001|Overall Study|Physician Decision|3|||
149200155|NCT01766817|538198570|FG002|Overall Study|Physician Decision|4|||
149200156|NCT01766817|538198568|FG000|Overall Study|Other|1|||
149200157|NCT01766817|538198569|FG001|Overall Study|Other|0|||
149200158|NCT01766817|538198570|FG002|Overall Study|Other|0|||
149200159|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
149200160|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
148682909|NCT01078623|536313029|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148682910|NCT01078623|536313030|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148943515|NCT03068130|537278039|FG000|Overall Study|Study terminated by sponsor|194|||
148943516|NCT05275400|537278048|FG000|Treatment Period|Adverse Event|7|||
148943517|NCT05275400|537278049|FG001|Treatment Period|Adverse Event|1|||
148943518|NCT05275400|537278048|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
148943519|NCT05275400|537278049|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
148943520|NCT05275400|537278048|FG000|Treatment Period|Death|5|||
149200161|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
149200162|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
149200163|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
149200164|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
149200165|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
149200166|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
149200167|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
149200168|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
149200169|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
149200170|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
149200171|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
149200172|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
149200173|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
149200174|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
149200175|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
149200176|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
149200177|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
149200178|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
149200179|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
149200180|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
149200181|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
149200182|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
149200183|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
149200184|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
149200185|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
149200186|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
149200187|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
149200188|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
149200189|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
149200190|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
149200191|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
149200192|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
149200193|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
149200194|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
149200195|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
149200196|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
149200197|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
149200198|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
149200199|NCT00383721|538198572|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
149200200|NCT00383721|538198573|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
149200201|NCT00383721|538198574|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
149200202|NCT00383721|538198575|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
149200203|NCT00383721|538198576|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
149200204|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
149200205|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
149200206|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
149200207|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
149200208|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
149200209|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
149200210|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
149200211|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
149200212|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
149200213|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
149200214|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
149200215|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
148808474|NCT00788671|536777504|FG000|Overall Study|Unable to biopsy|1|||
149200216|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
149200217|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
149200218|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
149200219|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
149200220|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
149200221|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
149200222|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
149200223|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
149200224|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149200225|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149200226|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149200227|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
149200228|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
149200229|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
149200230|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
149200231|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
149200232|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
149200233|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
149200234|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
149200235|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
149200236|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
149200237|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
149200238|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
149200239|NCT00383721|538198572|FG000|26-Week Treatment Safety Extension|Administrative|1|||
149200240|NCT00383721|538198573|FG001|26-Week Treatment Safety Extension|Administrative|2|||
149200241|NCT00383721|538198574|FG002|26-Week Treatment Safety Extension|Administrative|3|||
149200242|NCT00383721|538198575|FG003|26-Week Treatment Safety Extension|Administrative|1|||
149200243|NCT00383721|538198576|FG004|26-Week Treatment Safety Extension|Administrative|0|||
149200244|NCT03814590|538198580|FG000|Overall Study|Adverse Event|0|||
149200245|NCT03814590|538198581|FG001|Overall Study|Adverse Event|0|||
149200246|NCT03814590|538198582|FG002|Overall Study|Adverse Event|0|||
149200247|NCT03814590|538198583|FG003|Overall Study|Adverse Event|0|||
149200248|NCT03814590|538198584|FG004|Overall Study|Adverse Event|0|||
149200249|NCT03814590|538198585|FG005|Overall Study|Adverse Event|1|||
149200250|NCT03814590|538198586|FG006|Overall Study|Adverse Event|1|||
149200251|NCT03814590|538198587|FG007|Overall Study|Adverse Event|1|||
149200252|NCT03814590|538198588|FG008|Overall Study|Adverse Event|0|||
149200253|NCT03814590|538198589|FG009|Overall Study|Adverse Event|0|||
149200254|NCT03814590|538198590|FG010|Overall Study|Adverse Event|1|||
149200255|NCT03814590|538198591|FG011|Overall Study|Adverse Event|0|||
149016237|NCT00337662|537537893|FG003|Study Period II|Lost to Follow-up|35|||
149200256|NCT03814590|538198592|FG012|Overall Study|Adverse Event|3|||
149200257|NCT03814590|538198593|FG013|Overall Study|Adverse Event|0|||
149200258|NCT03814590|538198580|FG000|Overall Study|Lost to Follow-up|0|||
149200259|NCT03814590|538198581|FG001|Overall Study|Lost to Follow-up|2|||
149200260|NCT03814590|538198582|FG002|Overall Study|Lost to Follow-up|1|||
149200261|NCT03814590|538198583|FG003|Overall Study|Lost to Follow-up|0|||
149200262|NCT03814590|538198584|FG004|Overall Study|Lost to Follow-up|1|||
149200263|NCT03814590|538198585|FG005|Overall Study|Lost to Follow-up|1|||
149200264|NCT03814590|538198586|FG006|Overall Study|Lost to Follow-up|1|||
149200265|NCT03814590|538198587|FG007|Overall Study|Lost to Follow-up|1|||
149200266|NCT03814590|538198588|FG008|Overall Study|Lost to Follow-up|0|||
149200267|NCT03814590|538198589|FG009|Overall Study|Lost to Follow-up|0|||
149200268|NCT03814590|538198590|FG010|Overall Study|Lost to Follow-up|1|||
149200269|NCT03814590|538198591|FG011|Overall Study|Lost to Follow-up|0|||
149200270|NCT03814590|538198592|FG012|Overall Study|Lost to Follow-up|0|||
149200271|NCT03814590|538198593|FG013|Overall Study|Lost to Follow-up|1|||
149200272|NCT03814590|538198580|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200273|NCT03814590|538198581|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200274|NCT03814590|538198582|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200275|NCT03814590|538198583|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200276|NCT03814590|538198584|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200277|NCT03814590|538198585|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200278|NCT03814590|538198586|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200279|NCT03814590|538198587|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200280|NCT03814590|538198588|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200281|NCT03814590|538198589|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
149200282|NCT03814590|538198590|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200283|NCT03814590|538198591|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200284|NCT03814590|538198592|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200285|NCT03814590|538198593|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
149200286|NCT03814590|538198580|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200287|NCT03814590|538198581|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200288|NCT03814590|538198582|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200289|NCT03814590|538198583|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200290|NCT03814590|538198584|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200291|NCT03814590|538198585|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
149200292|NCT03814590|538198586|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
149200293|NCT03814590|538198587|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
149200294|NCT03814590|538198588|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200295|NCT03814590|538198589|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
149200296|NCT03814590|538198590|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
149200297|NCT03814590|538198591|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
149200298|NCT03814590|538198592|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
149200299|NCT03814590|538198593|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
149200300|NCT03814590|538198580|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200301|NCT03814590|538198581|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200302|NCT03814590|538198582|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200303|NCT03814590|538198583|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200304|NCT03814590|538198584|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200305|NCT03814590|538198585|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200306|NCT03814590|538198586|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200307|NCT03814590|538198587|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149200308|NCT03814590|538198588|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200309|NCT03814590|538198589|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149200310|NCT03814590|538198590|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200311|NCT03814590|538198591|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200312|NCT03814590|538198592|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200313|NCT03814590|538198593|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200314|NCT03814590|538198580|FG000|Overall Study|UNKNOWN REASON|0|||
149200315|NCT03814590|538198581|FG001|Overall Study|UNKNOWN REASON|0|||
149200316|NCT03814590|538198582|FG002|Overall Study|UNKNOWN REASON|0|||
149200317|NCT03814590|538198583|FG003|Overall Study|UNKNOWN REASON|0|||
149200318|NCT03814590|538198584|FG004|Overall Study|UNKNOWN REASON|0|||
149200319|NCT03814590|538198585|FG005|Overall Study|UNKNOWN REASON|0|||
149200320|NCT03814590|538198586|FG006|Overall Study|UNKNOWN REASON|0|||
149200321|NCT03814590|538198587|FG007|Overall Study|UNKNOWN REASON|1|||
149200322|NCT03814590|538198588|FG008|Overall Study|UNKNOWN REASON|0|||
149200323|NCT03814590|538198589|FG009|Overall Study|UNKNOWN REASON|0|||
149200324|NCT03814590|538198590|FG010|Overall Study|UNKNOWN REASON|0|||
149200325|NCT03814590|538198591|FG011|Overall Study|UNKNOWN REASON|0|||
149200326|NCT03814590|538198592|FG012|Overall Study|UNKNOWN REASON|0|||
149200327|NCT03814590|538198593|FG013|Overall Study|UNKNOWN REASON|0|||
149200328|NCT03519516|538198596|FG000|Overall Study|Adverse Event|0|||
149200329|NCT03519516|538198597|FG001|Overall Study|Adverse Event|1|||
149200330|NCT05301322|538198601|FG000|Overall Study|Adverse Event|7|||
149200331|NCT05301322|538198602|FG001|Overall Study|Adverse Event|3|||
149200332|NCT05301322|538198601|FG000|Overall Study|Death|0|||
149200333|NCT05301322|538198602|FG001|Overall Study|Death|1|||
149200334|NCT05301322|538198601|FG000|Overall Study|Lost to Follow-up|2|||
149200335|NCT05301322|538198602|FG001|Overall Study|Lost to Follow-up|1|||
149200336|NCT05301322|538198601|FG000|Overall Study|Protocol Violation|3|||
149200337|NCT05301322|538198602|FG001|Overall Study|Protocol Violation|1|||
149200338|NCT05301322|538198601|FG000|Overall Study|Withdrawal by Subject|3|||
149200339|NCT05301322|538198602|FG001|Overall Study|Withdrawal by Subject|0|||
149200340|NCT05301322|538198601|FG000|Overall Study|Other|4|||
149200341|NCT05301322|538198602|FG001|Overall Study|Other|0|||
149200342|NCT04971785|538198603|FG000|Overall Study|Withdrew Consent|5|||
149200343|NCT04971785|538198604|FG001|Overall Study|Withdrew Consent|5|||
149200344|NCT04971785|538198605|FG002|Overall Study|Withdrew Consent|17|||
149200345|NCT04971785|538198606|FG003|Overall Study|Withdrew Consent|7|||
148682911|NCT01078623|536313031|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149200346|NCT04971785|538198603|FG000|Overall Study|Adverse Event|7|||
149200347|NCT04971785|538198604|FG001|Overall Study|Adverse Event|8|||
148682912|NCT01078623|536313032|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149200348|NCT04971785|538198605|FG002|Overall Study|Adverse Event|6|||
149200349|NCT04971785|538198606|FG003|Overall Study|Adverse Event|3|||
149200350|NCT04971785|538198603|FG000|Overall Study|Lost to Follow-up|2|||
149200351|NCT04971785|538198604|FG001|Overall Study|Lost to Follow-up|1|||
149200352|NCT04971785|538198605|FG002|Overall Study|Lost to Follow-up|6|||
149200353|NCT04971785|538198606|FG003|Overall Study|Lost to Follow-up|7|||
149200354|NCT04971785|538198603|FG000|Overall Study|Protocol Violation|3|||
149200355|NCT04971785|538198604|FG001|Overall Study|Protocol Violation|1|||
149200356|NCT04971785|538198605|FG002|Overall Study|Protocol Violation|1|||
149200357|NCT04971785|538198606|FG003|Overall Study|Protocol Violation|2|||
149200358|NCT04971785|538198603|FG000|Overall Study|Investigator's Discretion|3|||
149200359|NCT04971785|538198604|FG001|Overall Study|Investigator's Discretion|1|||
149200360|NCT04971785|538198605|FG002|Overall Study|Investigator's Discretion|1|||
149200361|NCT04971785|538198606|FG003|Overall Study|Investigator's Discretion|0|||
149200362|NCT04971785|538198603|FG000|Overall Study|Randomized but Never Treated|1|||
149200363|NCT04971785|538198604|FG001|Overall Study|Randomized but Never Treated|2|||
149200364|NCT04971785|538198605|FG002|Overall Study|Randomized but Never Treated|0|||
149200365|NCT04971785|538198606|FG003|Overall Study|Randomized but Never Treated|1|||
149200366|NCT04971785|538198603|FG000|Overall Study|Death|0|||
149200367|NCT04971785|538198604|FG001|Overall Study|Death|1|||
149200368|NCT04971785|538198605|FG002|Overall Study|Death|1|||
149200369|NCT04971785|538198606|FG003|Overall Study|Death|0|||
149200370|NCT04971785|538198603|FG000|Overall Study|Site Terminated by Sponsor|1|||
149200371|NCT04971785|538198604|FG001|Overall Study|Site Terminated by Sponsor|1|||
149200372|NCT04971785|538198605|FG002|Overall Study|Site Terminated by Sponsor|0|||
149200373|NCT04971785|538198606|FG003|Overall Study|Site Terminated by Sponsor|0|||
149200374|NCT01255306|538200582|FG000|Overall Study|Physician Decision|1|||
149200375|NCT01255306|538200583|FG001|Overall Study|Physician Decision|1|||
149200376|NCT01179347|538200584|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
149200377|NCT01179347|538200585|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
149200378|NCT01179347|538200584|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
149200379|NCT01179347|538200585|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
149200380|NCT01179347|538200584|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
149200381|NCT01179347|538200585|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
149200382|NCT01179347|538200584|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
149200383|NCT01179347|538200585|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
149200384|NCT01179347|538200584|FG000|Double-blind Period (12 Weeks)|Other|2|||
149200385|NCT01179347|538200585|FG001|Double-blind Period (12 Weeks)|Other|4|||
149200386|NCT01179347|538200584|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
149200387|NCT01179347|538200585|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
149200388|NCT01179347|538200584|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
149200389|NCT01179347|538200585|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
149200390|NCT01179347|538200584|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
149200391|NCT01179347|538200585|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
149200392|NCT01179347|538200584|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
149200393|NCT01179347|538200585|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
149200394|NCT01179347|538200584|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
149200395|NCT01179347|538200585|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
149200396|NCT01179347|538200584|FG000|Open-label Period (12 Weeks)|Other|7|||
149200397|NCT01179347|538200585|FG001|Open-label Period (12 Weeks)|Other|4|||
149200398|NCT03363919|538200593|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
149200399|NCT03363919|538200594|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
149200400|NCT03363919|538200593|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
149200401|NCT03363919|538200594|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
149200402|NCT01827319|538200595|FG000|Overall Study|Lost to Follow-up|3|||
149200403|NCT00003476|538200596|FG000|Overall Study|Not evaluable|1|||
149200404|NCT00363051|538200599|FG000|Overall Study|Adminstrative problems|1|||
149200405|NCT00363051|538200600|FG001|Overall Study|Adminstrative problems|1|||
149200406|NCT00363051|538200599|FG000|Overall Study|Adverse Event|21|||
149200407|NCT00363051|538200600|FG001|Overall Study|Adverse Event|12|||
149200408|NCT00363051|538200599|FG000|Overall Study|New Cancer Therapy|2|||
149200409|NCT00363051|538200600|FG001|Overall Study|New Cancer Therapy|1|||
149200410|NCT00363051|538200599|FG000|Overall Study|Withdrawal by Subject|11|||
149200411|NCT00363051|538200600|FG001|Overall Study|Withdrawal by Subject|3|||
149200412|NCT00363051|538200599|FG000|Overall Study|Lost to Follow-up|0|||
148943521|NCT05275400|537278049|FG001|Treatment Period|Death|2|||
148943522|NCT05275400|537278048|FG000|Treatment Period|Protocol Violation|1|||
149200413|NCT00363051|538200600|FG001|Overall Study|Lost to Follow-up|1|||
148943523|NCT05275400|537278049|FG001|Treatment Period|Protocol Violation|0|||
149200414|NCT00363051|538200599|FG000|Overall Study|Protocol Violation|0|||
149200415|NCT00363051|538200600|FG001|Overall Study|Protocol Violation|2|||
149200416|NCT00363051|538200599|FG000|Overall Study|Death|3|||
149200417|NCT00363051|538200600|FG001|Overall Study|Death|2|||
149200418|NCT01610076|538200608|FG000|Overall Study|Technical issue with video|0|||
149200419|NCT01610076|538200609|FG001|Overall Study|Technical issue with video|1|||
149200420|NCT01610076|538200608|FG000|Overall Study|Lost to Follow-up|3|||
149200421|NCT01610076|538200609|FG001|Overall Study|Lost to Follow-up|4|||
149200422|NCT01653158|538200613|FG000|Overall Study|Death|0|||
149200423|NCT01653158|538200614|FG001|Overall Study|Death|0|||
149200424|NCT01653158|538200615|FG002|Overall Study|Death|0|||
149200425|NCT01653158|538200616|FG003|Overall Study|Death|1|||
149200426|NCT01653158|538200617|FG004|Overall Study|Death|0|||
149200427|NCT01653158|538200618|FG005|Overall Study|Death|0|||
149200428|NCT01653158|538200619|FG006|Overall Study|Death|0|||
149200429|NCT01653158|538200620|FG007|Overall Study|Death|2|||
149200430|NCT01653158|538200613|FG000|Overall Study|Adverse Event|0|||
149200431|NCT01653158|538200614|FG001|Overall Study|Adverse Event|0|||
149200432|NCT01653158|538200615|FG002|Overall Study|Adverse Event|0|||
149200433|NCT01653158|538200616|FG003|Overall Study|Adverse Event|1|||
149200434|NCT01653158|538200617|FG004|Overall Study|Adverse Event|0|||
149200435|NCT01653158|538200618|FG005|Overall Study|Adverse Event|0|||
149200436|NCT01653158|538200619|FG006|Overall Study|Adverse Event|0|||
149200437|NCT01653158|538200620|FG007|Overall Study|Adverse Event|3|||
149200438|NCT01653158|538200613|FG000|Overall Study|Other|0|||
149200439|NCT01653158|538200614|FG001|Overall Study|Other|0|||
149200440|NCT01653158|538200615|FG002|Overall Study|Other|0|||
149200441|NCT01653158|538200616|FG003|Overall Study|Other|0|||
149200442|NCT01653158|538200617|FG004|Overall Study|Other|0|||
149200443|NCT01653158|538200618|FG005|Overall Study|Other|0|||
149200444|NCT01653158|538200619|FG006|Overall Study|Other|0|||
149200445|NCT01653158|538200620|FG007|Overall Study|Other|1|||
149200446|NCT01653158|538200613|FG000|Overall Study|Progressive disease|0|||
149200447|NCT01653158|538200614|FG001|Overall Study|Progressive disease|0|||
149200448|NCT01653158|538200615|FG002|Overall Study|Progressive disease|0|||
149200449|NCT01653158|538200616|FG003|Overall Study|Progressive disease|0|||
149200450|NCT01653158|538200617|FG004|Overall Study|Progressive disease|1|||
149200451|NCT01653158|538200618|FG005|Overall Study|Progressive disease|1|||
149200452|NCT01653158|538200619|FG006|Overall Study|Progressive disease|2|||
149200453|NCT01653158|538200620|FG007|Overall Study|Progressive disease|9|||
149200454|NCT01653158|538200613|FG000|Overall Study|Withdrawal by Subject|1|||
149200455|NCT01653158|538200614|FG001|Overall Study|Withdrawal by Subject|0|||
149200456|NCT01653158|538200615|FG002|Overall Study|Withdrawal by Subject|0|||
149200457|NCT01653158|538200616|FG003|Overall Study|Withdrawal by Subject|0|||
149200458|NCT01653158|538200617|FG004|Overall Study|Withdrawal by Subject|0|||
149200459|NCT01653158|538200618|FG005|Overall Study|Withdrawal by Subject|0|||
149200460|NCT01653158|538200619|FG006|Overall Study|Withdrawal by Subject|0|||
149200461|NCT01653158|538200620|FG007|Overall Study|Withdrawal by Subject|0|||
149200462|NCT01840228|538200629|FG000|Overall Study|Lost to Follow-up|1|||
149200463|NCT01840228|538200630|FG001|Overall Study|Lost to Follow-up|1|||
149200464|NCT01103778|538200633|FG000|Overall Study|Lost to Follow-up|1|||
149200465|NCT01103778|538200633|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
149200466|NCT01103778|538200633|FG000|Overall Study|Screen failure|1|||
149200467|NCT05590767|538200634|FG000|Overall Study|Protocol Violation|1|||
149200468|NCT05590767|538200634|FG000|Overall Study|surgery canceled|1|||
149200469|NCT05590767|538200634|FG000|Overall Study|interscalene brachial block not performed|1|||
149200470|NCT00634114|538200635|FG000|Overall Study|Adverse Event|6|||
149200471|NCT00634114|538200636|FG001|Overall Study|Adverse Event|8|||
149200472|NCT00634114|538200637|FG002|Overall Study|Adverse Event|3|||
149200473|NCT00634114|538200635|FG000|Overall Study|Withdrawal by Subject|9|||
149200474|NCT00634114|538200636|FG001|Overall Study|Withdrawal by Subject|6|||
149200475|NCT00634114|538200637|FG002|Overall Study|Withdrawal by Subject|11|||
149200476|NCT00634114|538200635|FG000|Overall Study|Lost to Follow-up|0|||
149200477|NCT00634114|538200636|FG001|Overall Study|Lost to Follow-up|0|||
149200478|NCT00634114|538200637|FG002|Overall Study|Lost to Follow-up|1|||
149200479|NCT00634114|538200635|FG000|Overall Study|Protocol Violation|3|||
149200480|NCT00634114|538200636|FG001|Overall Study|Protocol Violation|3|||
149200481|NCT00634114|538200637|FG002|Overall Study|Protocol Violation|1|||
149200482|NCT00634114|538200635|FG000|Overall Study|Pregnancy|1|||
149200483|NCT00634114|538200636|FG001|Overall Study|Pregnancy|0|||
149200484|NCT00634114|538200637|FG002|Overall Study|Pregnancy|0|||
149200485|NCT00634114|538200635|FG000|Overall Study|Incorrect enrolment|0|||
149200486|NCT00634114|538200636|FG001|Overall Study|Incorrect enrolment|1|||
149200487|NCT00634114|538200637|FG002|Overall Study|Incorrect enrolment|0|||
149200488|NCT00634114|538200635|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
149200489|NCT00634114|538200636|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
149200490|NCT00634114|538200637|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
149200491|NCT00634114|538200635|FG000|Overall Study|Difficult to continue|3|||
149200492|NCT00634114|538200636|FG001|Overall Study|Difficult to continue|1|||
149200493|NCT00634114|538200637|FG002|Overall Study|Difficult to continue|1|||
149200494|NCT00634114|538200635|FG000|Overall Study|Other reason|1|||
149200495|NCT00634114|538200636|FG001|Overall Study|Other reason|1|||
149200496|NCT00634114|538200637|FG002|Overall Study|Other reason|1|||
149200497|NCT02802878|538200638|FG000|Overall Study|Withdrawal by Subject|3|||
149200498|NCT02802878|538200639|FG001|Overall Study|Withdrawal by Subject|3|||
149200499|NCT02802878|538200638|FG000|Overall Study|Protocol Violation|1|||
149200500|NCT02802878|538200639|FG001|Overall Study|Protocol Violation|0|||
149200501|NCT01599754|538200640|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
149200502|NCT01599754|538200641|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
149200503|NCT01599754|538200640|FG000|Overall Study|Participant noncompliance|4|||
149200504|NCT01599754|538200641|FG001|Overall Study|Participant noncompliance|4|||
149200505|NCT01599754|538200640|FG000|Overall Study|Lost to Follow-up|13|||
149200506|NCT01599754|538200641|FG001|Overall Study|Lost to Follow-up|6|||
149200507|NCT01599754|538200640|FG000|Overall Study|Death|31|||
149200508|NCT01599754|538200641|FG001|Overall Study|Death|33|||
149200509|NCT01599754|538200640|FG000|Overall Study|Adverse Event|3|||
149200510|NCT01599754|538200641|FG001|Overall Study|Adverse Event|2|||
149200511|NCT01599754|538200640|FG000|Overall Study|Investigator decision|1|||
149200512|NCT01599754|538200641|FG001|Overall Study|Investigator decision|3|||
149200513|NCT01599754|538200640|FG000|Overall Study|Withdrawal by Subject|24|||
149200514|NCT01599754|538200641|FG001|Overall Study|Withdrawal by Subject|25|||
149200515|NCT01599754|538200640|FG000|Overall Study|Study terminated by sponsor|282|||
149200516|NCT01599754|538200641|FG001|Overall Study|Study terminated by sponsor|285|||
149200517|NCT01577160|538200646|FG000|Overall Study|Adverse Event|9|||
149200518|NCT01577160|538200646|FG000|Overall Study|Lack of Efficacy|15|||
149200519|NCT01577160|538200646|FG000|Overall Study|Lost to Follow-up|40|||
149200520|NCT01577160|538200646|FG000|Overall Study|Withdrawal by Subject|18|||
149200521|NCT01577160|538200646|FG000|Overall Study|Subject Uncooperative|7|||
149200522|NCT01577160|538200646|FG000|Overall Study|Other|9|||
149200523|NCT01551758|538200647|FG000|Overall Study|Adverse Event|29|||
149200524|NCT01551758|538200648|FG001|Overall Study|Adverse Event|43|||
149200525|NCT01551758|538200647|FG000|Overall Study|Lack of Efficacy|0|||
149200526|NCT01551758|538200648|FG001|Overall Study|Lack of Efficacy|1|||
149200527|NCT01551758|538200647|FG000|Overall Study|Protocol Violation|5|||
149200528|NCT01551758|538200648|FG001|Overall Study|Protocol Violation|6|||
149200529|NCT01551758|538200647|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
149200530|NCT01551758|538200648|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
149200531|NCT01551758|538200647|FG000|Overall Study|Lost to Follow-up|29|||
149200532|NCT01551758|538200648|FG001|Overall Study|Lost to Follow-up|25|||
149200533|NCT01551758|538200647|FG000|Overall Study|Physician Decision|9|||
149200534|NCT01551758|538200648|FG001|Overall Study|Physician Decision|3|||
149200535|NCT01551758|538200647|FG000|Overall Study|Withdrawal by Subject|14|||
149200536|NCT01551758|538200648|FG001|Overall Study|Withdrawal by Subject|17|||
149200537|NCT00101192|538200649|FG000|Overall Study|Ineligible|6|||
149200538|NCT00101192|538200649|FG000|Overall Study|Inevaluable|1|||
149200539|NCT03670641|538200650|FG000|Overall Study|Lost to Follow-up|3|||
149200540|NCT03691610|538200651|FG000|Overall Study|Adverse Event|0|||
149200541|NCT03691610|538200652|FG001|Overall Study|Adverse Event|1|||
149200542|NCT03691610|538200653|FG002|Overall Study|Adverse Event|0|||
149200543|NCT03691610|538200654|FG003|Overall Study|Adverse Event|0|||
149200544|NCT03691610|538200651|FG000|Overall Study|Protocol Deviation|15|||
149200545|NCT03691610|538200652|FG001|Overall Study|Protocol Deviation|8|||
149200546|NCT03691610|538200653|FG002|Overall Study|Protocol Deviation|1|||
149200547|NCT03691610|538200654|FG003|Overall Study|Protocol Deviation|2|||
149200548|NCT03691610|538200651|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
149200549|NCT03691610|538200652|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
149200550|NCT03691610|538200653|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
149200551|NCT03691610|538200654|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
149200552|NCT03691610|538200651|FG000|Overall Study|Lost to Follow-up|20|||
149200553|NCT03691610|538200652|FG001|Overall Study|Lost to Follow-up|11|||
149200554|NCT03691610|538200653|FG002|Overall Study|Lost to Follow-up|5|||
149200555|NCT03691610|538200654|FG003|Overall Study|Lost to Follow-up|2|||
149200556|NCT00242580|538200657|FG000|Overall Study|Adverse Event|3|||
149200557|NCT00242580|538200658|FG001|Overall Study|Adverse Event|0|||
149200558|NCT00242580|538200659|FG002|Overall Study|Adverse Event|2|||
149200559|NCT00242580|538200657|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149200560|NCT00242580|538200658|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
149200561|NCT00242580|538200659|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
149200562|NCT00242580|538200657|FG000|Overall Study|Protocol Violation|0|||
149200563|NCT00242580|538200658|FG001|Overall Study|Protocol Violation|0|||
149200564|NCT00242580|538200659|FG002|Overall Study|Protocol Violation|1|||
149200565|NCT00242580|538200657|FG000|Overall Study|Subject withdrew consent|2|||
149200566|NCT00242580|538200658|FG001|Overall Study|Subject withdrew consent|2|||
149200567|NCT00242580|538200659|FG002|Overall Study|Subject withdrew consent|5|||
149200568|NCT00242580|538200657|FG000|Overall Study|Lost to Follow-up|0|||
149200569|NCT00242580|538200658|FG001|Overall Study|Lost to Follow-up|3|||
149200570|NCT00242580|538200659|FG002|Overall Study|Lost to Follow-up|0|||
149200571|NCT00242580|538200657|FG000|Overall Study|Death|1|||
149200572|NCT00242580|538200658|FG001|Overall Study|Death|2|||
149200573|NCT00242580|538200659|FG002|Overall Study|Death|1|||
149200574|NCT01232894|538200661|FG000|Overall Study|Lost to Follow-up|0|||
149200575|NCT01232894|538200662|FG001|Overall Study|Lost to Follow-up|1|||
149200576|NCT01232894|538200661|FG000|Overall Study|Death|1|||
149200577|NCT01232894|538200662|FG001|Overall Study|Death|0|||
149200578|NCT01232894|538200661|FG000|Overall Study|Protocol Violation|1|||
149200579|NCT01232894|538200662|FG001|Overall Study|Protocol Violation|1|||
149200580|NCT01232894|538200661|FG000|Overall Study|Withdrawal by Subject|8|||
149200581|NCT01232894|538200662|FG001|Overall Study|Withdrawal by Subject|5|||
149200582|NCT01232894|538200661|FG000|Overall Study|Physician Decision|2|||
149200583|NCT01232894|538200662|FG001|Overall Study|Physician Decision|1|||
149200584|NCT03970395|538200667|FG000|Overall Study|Withdrawal by Subject|3|||
149200585|NCT03970395|538200668|FG001|Overall Study|Withdrawal by Subject|4|||
149200586|NCT03970395|538200667|FG000|Overall Study|Lost to Follow-up|4|||
149200587|NCT03970395|538200668|FG001|Overall Study|Lost to Follow-up|8|||
149200588|NCT00916370|538200669|FG000|Overall Study|Death|3|||
149200589|NCT00916370|538200670|FG001|Overall Study|Death|1|||
149200590|NCT00916370|538200669|FG000|Overall Study|Withdrawal by Subject|2|||
149200591|NCT00916370|538200670|FG001|Overall Study|Withdrawal by Subject|0|||
149200592|NCT00916370|538200669|FG000|Overall Study|Physician Decision|0|||
149200593|NCT00916370|538200670|FG001|Overall Study|Physician Decision|1|||
149200594|NCT00929734|538200671|FG000|Overall Study|Lost to Follow-up|2|||
148682913|NCT01078623|536313033|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149200595|NCT00929734|538200672|FG001|Overall Study|Lost to Follow-up|1|||
149200596|NCT00929734|538200671|FG000|Overall Study|Withdrawal by Subject|0|||
149200597|NCT00929734|538200672|FG001|Overall Study|Withdrawal by Subject|2|||
149200598|NCT00121992|538200674|FG000|Overall Study|Treatment not received|2|||
149200599|NCT00121992|538200675|FG001|Overall Study|Treatment not received|11|||
149200600|NCT01318512|538200676|FG000|Maintenance Period (6 Months)|Death|2|||
149200601|NCT01318512|538200676|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
149200602|NCT01822691|538200679|FG000|Overall Study|Withdrawal by Subject|2|||
149200603|NCT02756650|538200680|FG000|Overall Study|Physician Decision|1|||
149200604|NCT02756650|538200680|FG000|Overall Study|Adverse Event|1|||
149200605|NCT01553916|538200681|FG000|Overall Study|Withdrawal by Subject|2|||
149200606|NCT01553916|538200681|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
149200607|NCT04348591|538200687|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
149200608|NCT04348591|538200688|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
149200609|NCT04348591|538200687|FG000|Imaging Session (120 Min)|Physician Decision|0|||
149200610|NCT04348591|538200688|FG001|Imaging Session (120 Min)|Physician Decision|1|||
149200611|NCT04348591|538200687|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
149200612|NCT04348591|538200688|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
149200613|NCT03722784|538200691|FG000|Overall Study|Withdrawal by Subject|1|||
149200614|NCT03722784|538200692|FG001|Overall Study|Withdrawal by Subject|0|||
149200615|NCT03722784|538200691|FG000|Overall Study|Physician Decision|1|||
149200616|NCT03722784|538200692|FG001|Overall Study|Physician Decision|1|||
149200617|NCT03722784|538200691|FG000|Overall Study|Protocol Violation|0|||
149200618|NCT03722784|538200692|FG001|Overall Study|Protocol Violation|1|||
149200619|NCT00910429|538200695|FG000|Overall Study|Death|18|||
149200620|NCT00910429|538200696|FG001|Overall Study|Death|12|||
149200621|NCT00910429|538200695|FG000|Overall Study|Withdrawal by Subject|3|||
149200622|NCT00910429|538200696|FG001|Overall Study|Withdrawal by Subject|2|||
149200623|NCT00910429|538200695|FG000|Overall Study|Protocol Violation|1|||
149200624|NCT00910429|538200696|FG001|Overall Study|Protocol Violation|0|||
149200625|NCT00910429|538200695|FG000|Overall Study|Lost to Follow-up|2|||
149200626|NCT00910429|538200696|FG001|Overall Study|Lost to Follow-up|1|||
149200627|NCT00910429|538200695|FG000|Overall Study|Adverse Event|10|||
149200628|NCT00910429|538200696|FG001|Overall Study|Adverse Event|5|||
149200629|NCT00910429|538200695|FG000|Overall Study|Drug non-compliance|1|||
149200630|NCT00910429|538200696|FG001|Overall Study|Drug non-compliance|0|||
149200631|NCT00910429|538200695|FG000|Overall Study|Lack of Efficacy|4|||
149200632|NCT00910429|538200696|FG001|Overall Study|Lack of Efficacy|1|||
149200633|NCT01317615|538200697|FG000|Overall Study|Disease progression|25|||
149200634|NCT01317615|538200697|FG000|Overall Study|New cancer therapy|5|||
149200635|NCT01317615|538200697|FG000|Overall Study|Death|6|||
149200636|NCT01317615|538200697|FG000|Overall Study|Withdrawal by Subject|5|||
149200637|NCT01317615|538200697|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149200638|NCT01317615|538200697|FG000|Overall Study|Adverse Event|7|||
149200639|NCT00645567|538200700|FG000|Overall Study|Adverse Event|1|||
149200640|NCT04465396|538200701|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
149200641|NCT04465396|538200702|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
149200642|NCT04465396|538200703|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
149200643|NCT04465396|538200704|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
149200644|NCT02648724|538200705|FG000|Overall Study|Withdrawal by Subject|0|||
149200645|NCT02648724|538200706|FG001|Overall Study|Withdrawal by Subject|1|||
149200646|NCT02648724|538200707|FG002|Overall Study|Withdrawal by Subject|1|||
149200647|NCT02648724|538200708|FG003|Overall Study|Withdrawal by Subject|0|||
149200648|NCT02648724|538200709|FG004|Overall Study|Withdrawal by Subject|1|||
149200649|NCT02648724|538200710|FG005|Overall Study|Withdrawal by Subject|0|||
149200650|NCT02648724|538200711|FG006|Overall Study|Withdrawal by Subject|0|||
149200651|NCT02648724|538200705|FG000|Overall Study|Progressive disease|2|||
149200652|NCT02648724|538200706|FG001|Overall Study|Progressive disease|2|||
149200653|NCT02648724|538200707|FG002|Overall Study|Progressive disease|2|||
149200654|NCT02648724|538200708|FG003|Overall Study|Progressive disease|3|||
149200655|NCT02648724|538200709|FG004|Overall Study|Progressive disease|22|||
149200656|NCT02648724|538200710|FG005|Overall Study|Progressive disease|7|||
149200657|NCT02648724|538200711|FG006|Overall Study|Progressive disease|8|||
149200658|NCT02648724|538200705|FG000|Overall Study|Other reason (unknown)|1|||
149200659|NCT02648724|538200706|FG001|Overall Study|Other reason (unknown)|0|||
149200660|NCT02648724|538200707|FG002|Overall Study|Other reason (unknown)|0|||
149200661|NCT02648724|538200708|FG003|Overall Study|Other reason (unknown)|0|||
149200662|NCT02648724|538200709|FG004|Overall Study|Other reason (unknown)|0|||
149200663|NCT02648724|538200710|FG005|Overall Study|Other reason (unknown)|0|||
149200664|NCT02648724|538200711|FG006|Overall Study|Other reason (unknown)|0|||
149200665|NCT02648724|538200705|FG000|Overall Study|Protocol Violation|0|||
149200666|NCT02648724|538200706|FG001|Overall Study|Protocol Violation|0|||
149200667|NCT02648724|538200707|FG002|Overall Study|Protocol Violation|0|||
149200668|NCT02648724|538200708|FG003|Overall Study|Protocol Violation|0|||
149200669|NCT02648724|538200709|FG004|Overall Study|Protocol Violation|1|||
149200670|NCT02648724|538200710|FG005|Overall Study|Protocol Violation|0|||
148682914|NCT01078623|536313034|FG006|Treatment Period 1|Withdrawal by Subject|0|||
148682915|NCT01078623|536313035|FG007|Treatment Period 1|Withdrawal by Subject|1|||
148682916|NCT01078623|536313036|FG008|Treatment Period 1|Withdrawal by Subject|0|||
148682917|NCT01078623|536313037|FG009|Treatment Period 1|Withdrawal by Subject|0|||
148682918|NCT01078623|536313038|FG010|Treatment Period 1|Withdrawal by Subject|1|||
148682919|NCT01078623|536313039|FG011|Treatment Period 1|Withdrawal by Subject|0|||
148682920|NCT01078623|536313040|FG012|Treatment Period 1|Withdrawal by Subject|0|||
148682921|NCT01078623|536313041|FG013|Treatment Period 1|Withdrawal by Subject|0|||
149200671|NCT02648724|538200711|FG006|Overall Study|Protocol Violation|0|||
149200672|NCT02648724|538200705|FG000|Overall Study|Death|0|||
149200673|NCT02648724|538200706|FG001|Overall Study|Death|0|||
149200674|NCT02648724|538200707|FG002|Overall Study|Death|0|||
149200675|NCT02648724|538200708|FG003|Overall Study|Death|0|||
149200676|NCT02648724|538200709|FG004|Overall Study|Death|0|||
149200677|NCT02648724|538200710|FG005|Overall Study|Death|0|||
149200678|NCT02648724|538200711|FG006|Overall Study|Death|3|||
149200679|NCT02648724|538200705|FG000|Overall Study|Physician Decision|0|||
149200680|NCT02648724|538200706|FG001|Overall Study|Physician Decision|0|||
149200681|NCT02648724|538200707|FG002|Overall Study|Physician Decision|0|||
149200682|NCT02648724|538200708|FG003|Overall Study|Physician Decision|0|||
149200683|NCT02648724|538200709|FG004|Overall Study|Physician Decision|1|||
149200684|NCT02648724|538200710|FG005|Overall Study|Physician Decision|0|||
149200685|NCT02648724|538200711|FG006|Overall Study|Physician Decision|1|||
149200686|NCT02648724|538200705|FG000|Overall Study|Transferred to named patient program|0|||
149200687|NCT02648724|538200706|FG001|Overall Study|Transferred to named patient program|0|||
149200688|NCT02648724|538200707|FG002|Overall Study|Transferred to named patient program|0|||
149200689|NCT02648724|538200708|FG003|Overall Study|Transferred to named patient program|0|||
149200690|NCT02648724|538200709|FG004|Overall Study|Transferred to named patient program|0|||
149200691|NCT02648724|538200710|FG005|Overall Study|Transferred to named patient program|1|||
149200692|NCT02648724|538200711|FG006|Overall Study|Transferred to named patient program|0|||
149200693|NCT01364233|538200712|FG000|Overall Study|Lost to Follow-up|1|||
149200694|NCT00302718|538200713|FG000|Overall Study|Participant left the hospital|1|||
149200695|NCT00302718|538200714|FG001|Overall Study|Participant left the hospital|0|||
149200696|NCT00302718|538200715|FG002|Overall Study|Participant left the hospital|0|||
149200697|NCT00302718|538200716|FG003|Overall Study|Participant left the hospital|1|||
149200698|NCT00302718|538200713|FG000|Overall Study|Withdrawal by Subject|0|||
149200699|NCT00302718|538200714|FG001|Overall Study|Withdrawal by Subject|1|||
149200700|NCT00302718|538200715|FG002|Overall Study|Withdrawal by Subject|0|||
149200701|NCT00302718|538200716|FG003|Overall Study|Withdrawal by Subject|0|||
149200702|NCT00302718|538200713|FG000|Overall Study|Participant left primary care setting|0|||
149200703|NCT00302718|538200714|FG001|Overall Study|Participant left primary care setting|0|||
149200704|NCT00302718|538200715|FG002|Overall Study|Participant left primary care setting|2|||
149200705|NCT00302718|538200716|FG003|Overall Study|Participant left primary care setting|1|||
149200706|NCT00738374|538200717|FG000|Induction Treatment Phase|Adverse Event|14|||
149200707|NCT00738374|538200718|FG001|Induction Treatment Phase|Adverse Event|0|||
149200708|NCT00738374|538200719|FG002|Induction Treatment Phase|Adverse Event|0|||
149200709|NCT00738374|538200720|FG003|Induction Treatment Phase|Adverse Event|0|||
149200710|NCT00738374|538200717|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
149200711|NCT00738374|538200718|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
149200712|NCT00738374|538200719|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
149200713|NCT00738374|538200720|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
149200714|NCT00738374|538200717|FG000|Induction Treatment Phase|Physician Decision|2|||
149200715|NCT00738374|538200718|FG001|Induction Treatment Phase|Physician Decision|0|||
149200716|NCT00738374|538200719|FG002|Induction Treatment Phase|Physician Decision|0|||
149200717|NCT00738374|538200720|FG003|Induction Treatment Phase|Physician Decision|0|||
149200718|NCT00738374|538200717|FG000|Induction Treatment Phase|Protocol Violation|2|||
149200719|NCT00738374|538200718|FG001|Induction Treatment Phase|Protocol Violation|0|||
149200720|NCT00738374|538200719|FG002|Induction Treatment Phase|Protocol Violation|0|||
149200721|NCT00738374|538200720|FG003|Induction Treatment Phase|Protocol Violation|0|||
149200722|NCT00738374|538200717|FG000|Induction Treatment Phase|Non-compliance|1|||
149200723|NCT00738374|538200718|FG001|Induction Treatment Phase|Non-compliance|0|||
149200724|NCT00738374|538200719|FG002|Induction Treatment Phase|Non-compliance|0|||
149200725|NCT00738374|538200720|FG003|Induction Treatment Phase|Non-compliance|0|||
149200726|NCT00738374|538200717|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
149200727|NCT00738374|538200718|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
149200728|NCT00738374|538200719|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
149200729|NCT00738374|538200720|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
149200730|NCT00738374|538200717|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
149200731|NCT00738374|538200718|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
149200732|NCT00738374|538200719|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
149200733|NCT00738374|538200720|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
148682922|NCT01078623|536313042|FG014|Treatment Period 1|Withdrawal by Subject|0|||
149200734|NCT00738374|538200717|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
149200735|NCT00738374|538200718|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
149200736|NCT00738374|538200719|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
149200737|NCT00738374|538200720|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
149200738|NCT00738374|538200717|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
149200739|NCT00738374|538200718|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
149200740|NCT00738374|538200719|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
149200741|NCT00738374|538200720|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
149200742|NCT00738374|538200717|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
149200743|NCT00738374|538200718|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
149200744|NCT00738374|538200719|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
149200745|NCT00738374|538200720|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
149200746|NCT00738374|538200717|FG000|Maintenance Treatment/Observation Phase|Other|0|||
149200747|NCT00738374|538200718|FG001|Maintenance Treatment/Observation Phase|Other|1|||
149200748|NCT00738374|538200719|FG002|Maintenance Treatment/Observation Phase|Other|0|||
149200749|NCT00738374|538200720|FG003|Maintenance Treatment/Observation Phase|Other|0|||
149200750|NCT00632541|538200721|FG000|Overall Study|Adverse Event|7|||
149200751|NCT02927873|538200722|FG000|Overall Study|Lost to Follow-up|0|||
149200752|NCT02927873|538200723|FG001|Overall Study|Lost to Follow-up|1|||
149200753|NCT02927873|538200724|FG002|Overall Study|Lost to Follow-up|0|||
149200754|NCT02927873|538200725|FG003|Overall Study|Lost to Follow-up|0|||
149200755|NCT02927873|538200726|FG004|Overall Study|Lost to Follow-up|0|||
149200756|NCT02927873|538200727|FG005|Overall Study|Lost to Follow-up|0|||
149200757|NCT02927873|538200722|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149200758|NCT02927873|538200723|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
149200759|NCT02927873|538200724|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149200760|NCT02927873|538200725|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149200761|NCT02927873|538200726|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149200762|NCT02927873|538200727|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
149200763|NCT02927873|538200722|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200764|NCT02927873|538200723|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200765|NCT02927873|538200724|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200766|NCT02927873|538200725|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200767|NCT02927873|538200726|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
149200768|NCT02927873|538200727|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
149200769|NCT02927873|538200722|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149200770|NCT02927873|538200723|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
149200771|NCT02927873|538200724|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149200772|NCT02927873|538200725|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149200773|NCT02927873|538200726|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149200774|NCT02927873|538200727|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
149200775|NCT02927873|538200722|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
149200776|NCT02927873|538200723|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149200777|NCT02927873|538200724|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149200778|NCT02927873|538200725|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149200779|NCT02927873|538200726|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149200780|NCT02927873|538200727|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
149200781|NCT02927873|538200722|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
149200782|NCT02927873|538200723|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149200783|NCT02927873|538200724|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149200784|NCT02927873|538200725|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149200785|NCT02927873|538200726|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149200786|NCT02927873|538200727|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
149200787|NCT05757427|538200730|FG000|Overall Study|Adverse Event|1|||
149200788|NCT05757427|538200730|FG000|Overall Study|Device deficiency|1|||
149200789|NCT05757427|538200730|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
149200790|NCT05757427|538200730|FG000|Overall Study|MWBI scan of only 1 breast|3|||
149200791|NCT05757427|538200730|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
149200812|NCT03833817|538202238|FG000|Overall Study|Withdrawal by Subject|3|||
149200813|NCT03833817|538202239|FG001|Overall Study|Withdrawal by Subject|3|||
149200814|NCT03833817|538202238|FG000|Overall Study|Lost to Follow-up|3|||
149200815|NCT03833817|538202239|FG001|Overall Study|Lost to Follow-up|3|||
149200816|NCT00884221|538202240|FG000|Overall Study|Withdrawal by Subject|0|||
149200817|NCT00884221|538202241|FG001|Overall Study|Withdrawal by Subject|3|||
149200818|NCT00884221|538202240|FG000|Overall Study|Adverse Event|6|||
149200819|NCT00884221|538202241|FG001|Overall Study|Adverse Event|3|||
149200820|NCT00884221|538202240|FG000|Overall Study|Protocol Violation|16|||
149200821|NCT00884221|538202241|FG001|Overall Study|Protocol Violation|13|||
149200822|NCT00884221|538202240|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
149200823|NCT00884221|538202241|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
149200824|NCT01975246|538202246|FG000|Overall Study|Adverse Event|2|||
149200825|NCT01975246|538202247|FG001|Overall Study|Adverse Event|1|||
149200826|NCT01975246|538202246|FG000|Overall Study|Lack of Efficacy|1|||
149200827|NCT01975246|538202247|FG001|Overall Study|Lack of Efficacy|0|||
149200828|NCT01975246|538202246|FG000|Overall Study|Protocol Violation|1|||
149200829|NCT01975246|538202247|FG001|Overall Study|Protocol Violation|0|||
149200830|NCT01975246|538202246|FG000|Overall Study|Other than stated|0|||
149200831|NCT01975246|538202247|FG001|Overall Study|Other than stated|1|||
149200832|NCT00255034|538202248|FG000|Overall Study|Withdrawal by Subject|15|||
149200833|NCT00255034|538202249|FG001|Overall Study|Withdrawal by Subject|38|||
149200834|NCT01263093|538202250|FG000|Washout|Physician Decision|1|||
149200835|NCT01263093|538202251|FG001|Washout|Physician Decision|0|||
149200836|NCT01263093|538202250|FG000|Period 2|Adverse Event|1|||
149200837|NCT01263093|538202251|FG001|Period 2|Adverse Event|0|||
149200838|NCT00424346|538202252|FG000|Core Study|Adverse Event|5|||
149200839|NCT00424346|538202253|FG001|Core Study|Adverse Event|3|||
149200840|NCT00424346|538202254|FG002|Core Study|Adverse Event|1|||
149200841|NCT00424346|538202255|FG003|Core Study|Adverse Event|1|||
149200842|NCT00424346|538202252|FG000|Core Study|Abnormal Laboratory Values|0|||
149200843|NCT00424346|538202253|FG001|Core Study|Abnormal Laboratory Values|1|||
149200844|NCT00424346|538202254|FG002|Core Study|Abnormal Laboratory Values|0|||
148808475|NCT00788671|536777504|FG000|Overall Study|Withdrawal by Subject|4|||
148808476|NCT00788671|536777504|FG000|Overall Study|IUD expulsed|1|||
149200845|NCT00424346|538202255|FG003|Core Study|Abnormal Laboratory Values|0|||
149200846|NCT00424346|538202252|FG000|Core Study|Lack of Efficacy|1|||
149200847|NCT00424346|538202253|FG001|Core Study|Lack of Efficacy|3|||
149200848|NCT00424346|538202254|FG002|Core Study|Lack of Efficacy|0|||
149200849|NCT00424346|538202255|FG003|Core Study|Lack of Efficacy|4|||
149200850|NCT00424346|538202252|FG000|Core Study|Withdrawal by Subject|1|||
149200851|NCT00424346|538202253|FG001|Core Study|Withdrawal by Subject|0|||
149200852|NCT00424346|538202254|FG002|Core Study|Withdrawal by Subject|0|||
149200853|NCT00424346|538202255|FG003|Core Study|Withdrawal by Subject|2|||
149200854|NCT00424346|538202252|FG000|Core Study|Lost to Follow-up|1|||
149200855|NCT00424346|538202253|FG001|Core Study|Lost to Follow-up|1|||
149200856|NCT00424346|538202254|FG002|Core Study|Lost to Follow-up|0|||
149200857|NCT00424346|538202255|FG003|Core Study|Lost to Follow-up|0|||
149200858|NCT00424346|538202252|FG000|Core Study|Administrative Problems|1|||
149200859|NCT00424346|538202253|FG001|Core Study|Administrative Problems|0|||
149200860|NCT00424346|538202254|FG002|Core Study|Administrative Problems|1|||
149200861|NCT00424346|538202255|FG003|Core Study|Administrative Problems|0|||
149200862|NCT00424346|538202252|FG000|Core Study|Protocol Violation|0|||
149200863|NCT00424346|538202253|FG001|Core Study|Protocol Violation|0|||
149200864|NCT00424346|538202254|FG002|Core Study|Protocol Violation|2|||
149200865|NCT00424346|538202255|FG003|Core Study|Protocol Violation|0|||
149200866|NCT00424346|538202252|FG000|Extension Phase|Adverse Event|0|||
149200867|NCT00424346|538202253|FG001|Extension Phase|Adverse Event|9|||
149200868|NCT00424346|538202254|FG002|Extension Phase|Adverse Event|5|||
149200869|NCT00424346|538202255|FG003|Extension Phase|Adverse Event|4|||
149200870|NCT00424346|538202252|FG000|Extension Phase|Lack of Efficacy|0|||
149200871|NCT00424346|538202253|FG001|Extension Phase|Lack of Efficacy|16|||
149200872|NCT00424346|538202254|FG002|Extension Phase|Lack of Efficacy|14|||
149200873|NCT00424346|538202255|FG003|Extension Phase|Lack of Efficacy|11|||
149200874|NCT00424346|538202252|FG000|Extension Phase|Withdrawal by Subject|0|||
149200875|NCT00424346|538202253|FG001|Extension Phase|Withdrawal by Subject|5|||
149200876|NCT00424346|538202254|FG002|Extension Phase|Withdrawal by Subject|3|||
149200877|NCT00424346|538202255|FG003|Extension Phase|Withdrawal by Subject|4|||
149200878|NCT00424346|538202252|FG000|Extension Phase|Lost to Follow-up|0|||
149200879|NCT00424346|538202253|FG001|Extension Phase|Lost to Follow-up|2|||
149200880|NCT00424346|538202254|FG002|Extension Phase|Lost to Follow-up|0|||
149200881|NCT00424346|538202255|FG003|Extension Phase|Lost to Follow-up|0|||
149200882|NCT00424346|538202252|FG000|Extension Phase|Administrative Problems|0|||
149200883|NCT00424346|538202253|FG001|Extension Phase|Administrative Problems|69|||
149200884|NCT00424346|538202254|FG002|Extension Phase|Administrative Problems|32|||
149200885|NCT00424346|538202255|FG003|Extension Phase|Administrative Problems|35|||
149200886|NCT00424346|538202252|FG000|Extension Phase|Death|0|||
149200887|NCT00424346|538202253|FG001|Extension Phase|Death|0|||
149200888|NCT00424346|538202254|FG002|Extension Phase|Death|0|||
149200889|NCT00424346|538202255|FG003|Extension Phase|Death|1|||
149200890|NCT00424346|538202252|FG000|Extension Phase|Protocol Violation|0|||
149200891|NCT00424346|538202253|FG001|Extension Phase|Protocol Violation|1|||
149200892|NCT00424346|538202254|FG002|Extension Phase|Protocol Violation|1|||
149200893|NCT00424346|538202255|FG003|Extension Phase|Protocol Violation|0|||
149200894|NCT03947255|538202257|FG000|Overall Study|Study Closure by Sponsor|2|||
149200895|NCT03947255|538202258|FG001|Overall Study|Study Closure by Sponsor|2|||
149200896|NCT03947255|538202257|FG000|Overall Study|Withdrawal by Subject|2|||
149200897|NCT03947255|538202258|FG001|Overall Study|Withdrawal by Subject|2|||
149200898|NCT03947255|538202257|FG000|Overall Study|Lost to Follow-up|2|||
149200899|NCT03947255|538202258|FG001|Overall Study|Lost to Follow-up|0|||
149200900|NCT03947255|538202257|FG000|Overall Study|Death|0|||
149200901|NCT03947255|538202258|FG001|Overall Study|Death|2|||
149200902|NCT02499575|538202259|FG000|Overall Study|Protocol Violation|0|||
148943524|NCT05275400|537278048|FG000|Treatment Period|Physician Decision|5|||
148943525|NCT05275400|537278049|FG001|Treatment Period|Physician Decision|4|||
148943526|NCT05275400|537278048|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
148943527|NCT05275400|537278049|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
148943528|NCT05275400|537278048|FG000|Treatment Period|Withdrawal by Subject|30|||
148943529|NCT05275400|537278049|FG001|Treatment Period|Withdrawal by Subject|12|||
148943530|NCT05275400|537278048|FG000|Treatment Period|Lost to Follow-up|1|||
148943531|NCT05275400|537278049|FG001|Treatment Period|Lost to Follow-up|5|||
148943532|NCT05275400|537278048|FG000|Treatment Period|Lack of Efficacy|1|||
148943533|NCT05275400|537278049|FG001|Treatment Period|Lack of Efficacy|0|||
148943534|NCT05275400|537278048|FG000|Treatment Period|Sponsor Decision|1|||
148943535|NCT05275400|537278049|FG001|Treatment Period|Sponsor Decision|0|||
148943536|NCT05275400|537278048|FG000|Follow-Up Period|Death|2|||
148943537|NCT05275400|537278049|FG001|Follow-Up Period|Death|0|||
148943538|NCT05275400|537278048|FG000|Follow-Up Period|Protocol Violation|1|||
149200903|NCT02499575|538202260|FG001|Overall Study|Protocol Violation|1|||
149200904|NCT00574119|538202261|FG000|Overall Study|Adverse Event|1|||
149200905|NCT00574119|538202261|FG000|Overall Study|Protocol Violation|1|||
149200906|NCT00574119|538202261|FG000|Overall Study|Withdrawal by Subject|1|||
149200907|NCT00574119|538202261|FG000|Overall Study|Physician Decision|1|||
148943539|NCT05275400|537278049|FG001|Follow-Up Period|Protocol Violation|0|||
148943540|NCT05275400|537278048|FG000|Follow-Up Period|Withdrawal by Subject|3|||
148943541|NCT05275400|537278049|FG001|Follow-Up Period|Withdrawal by Subject|0|||
148943542|NCT02585960|537278050|FG000|PK/Safety Assessment Period|Physician Decision|0|||
149200908|NCT03287245|538202264|FG000|Overall Study|Study terminated by sponsor|3|||
149200909|NCT03287245|538202265|FG001|Overall Study|Study terminated by sponsor|0|||
149200910|NCT03287245|538202266|FG002|Overall Study|Study terminated by sponsor|3|||
149200911|NCT03287245|538202267|FG003|Overall Study|Study terminated by sponsor|1|||
149200912|NCT03287245|538202264|FG000|Overall Study|Adverse Event|1|||
149200913|NCT03287245|538202265|FG001|Overall Study|Adverse Event|0|||
149200914|NCT03287245|538202266|FG002|Overall Study|Adverse Event|0|||
149200915|NCT03287245|538202267|FG003|Overall Study|Adverse Event|0|||
148943543|NCT02585960|537278051|FG001|PK/Safety Assessment Period|Physician Decision|1|||
148943544|NCT02585960|537278052|FG002|PK/Safety Assessment Period|Physician Decision|0|||
148943545|NCT02585960|537278050|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
149200916|NCT03287245|538202264|FG000|Overall Study|Withdrawal by Subject|8|||
149200917|NCT03287245|538202265|FG001|Overall Study|Withdrawal by Subject|3|||
149200918|NCT03287245|538202266|FG002|Overall Study|Withdrawal by Subject|3|||
149200919|NCT03287245|538202267|FG003|Overall Study|Withdrawal by Subject|0|||
149200920|NCT03287245|538202264|FG000|Overall Study|Physician Decision|3|||
149200921|NCT03287245|538202265|FG001|Overall Study|Physician Decision|2|||
149200922|NCT03287245|538202266|FG002|Overall Study|Physician Decision|0|||
149200923|NCT03287245|538202267|FG003|Overall Study|Physician Decision|0|||
149200924|NCT02586077|538202268|FG000|Overall Study|Withdrawal by Subject|1|||
149200925|NCT02586077|538202268|FG000|Overall Study|Physician Decision|4|||
149200926|NCT02586077|538202268|FG000|Overall Study|Lost to Follow-up|3|||
149200927|NCT02701192|538202269|FG000|Overall Study|Protocol Violation|2|||
149200928|NCT02701192|538202269|FG000|Overall Study|Lost to Follow-up|4|||
149200929|NCT02862548|538202270|FG000|Randomized Phase (Up to Week 48)|Death|0|||
149200930|NCT02862548|538202271|FG001|Randomized Phase (Up to Week 48)|Death|1|||
149200931|NCT02862548|538202270|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
149200932|NCT02862548|538202271|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
149200933|NCT02862548|538202270|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
149200934|NCT02862548|538202271|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
149200935|NCT02862548|538202270|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
149200936|NCT02862548|538202271|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
149200937|NCT00880763|538202272|FG000|Extension Period (Part 2)|Adverse Event|0|||
149200938|NCT00880763|538202273|FG001|Extension Period (Part 2)|Adverse Event|0|||
149200939|NCT00880763|538202274|FG002|Extension Period (Part 2)|Adverse Event|1|||
149200940|NCT00880763|538202275|FG003|Extension Period (Part 2)|Adverse Event|1|||
149200941|NCT00880763|538202272|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
149200942|NCT00880763|538202273|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
149200943|NCT00880763|538202274|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
149200944|NCT00880763|538202275|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
149200945|NCT00880763|538202272|FG000|Extension Period (Part 2)|Physician Decision|0|||
149200946|NCT00880763|538202273|FG001|Extension Period (Part 2)|Physician Decision|1|||
149200947|NCT00880763|538202274|FG002|Extension Period (Part 2)|Physician Decision|1|||
149200948|NCT00880763|538202275|FG003|Extension Period (Part 2)|Physician Decision|0|||
149200949|NCT00880763|538202272|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
149200950|NCT00880763|538202273|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
149200951|NCT00880763|538202274|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
149200952|NCT00880763|538202275|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
149200953|NCT01245764|538202277|FG000|Study Phase A|Other|3|||
149200954|NCT01245764|538202278|FG001|Study Phase A|Other|2|||
149200955|NCT01245764|538202279|FG002|Study Phase A|Other|3|||
149200956|NCT01245764|538202280|FG003|Study Phase A|Other|1|||
149200957|NCT01245764|538202277|FG000|Study Phase A|Protocol Violation|6|||
149200958|NCT01245764|538202278|FG001|Study Phase A|Protocol Violation|3|||
149200959|NCT01245764|538202279|FG002|Study Phase A|Protocol Violation|2|||
149200960|NCT01245764|538202280|FG003|Study Phase A|Protocol Violation|2|||
149200961|NCT01245764|538202277|FG000|Study Phase A|Lost to Follow-up|0|||
149200962|NCT01245764|538202278|FG001|Study Phase A|Lost to Follow-up|0|||
149200963|NCT01245764|538202279|FG002|Study Phase A|Lost to Follow-up|5|||
149200964|NCT01245764|538202280|FG003|Study Phase A|Lost to Follow-up|0|||
149200965|NCT02667457|538202281|FG000|Overall Study|Withdrawal by Subject|1|||
149200966|NCT02667457|538202282|FG001|Overall Study|Withdrawal by Subject|0|||
149200967|NCT02667457|538202281|FG000|Overall Study|Other Reason|0|||
149200968|NCT02667457|538202282|FG001|Overall Study|Other Reason|2|||
149200969|NCT00603733|538202285|FG000|Active Phase ITT|Adverse Event|8|||
149200970|NCT00603733|538202286|FG001|Active Phase ITT|Adverse Event|7|||
149200971|NCT00603733|538202285|FG000|Active Phase ITT|Withdrawal by Subject|0|||
148943546|NCT02585960|537278051|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
148943547|NCT02585960|537278052|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
148943548|NCT02585960|537278050|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
149200972|NCT00603733|538202286|FG001|Active Phase ITT|Withdrawal by Subject|3|||
149200973|NCT00603733|538202285|FG000|Active Phase ITT|Lost to Follow-up|0|||
149200974|NCT00603733|538202286|FG001|Active Phase ITT|Lost to Follow-up|1|||
149200975|NCT00603733|538202285|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
148943549|NCT02585960|537278051|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
149200976|NCT00603733|538202286|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
149200977|NCT00603733|538202285|FG000|Active Phase ITT|Lack of Efficacy|1|||
149200978|NCT00603733|538202286|FG001|Active Phase ITT|Lack of Efficacy|2|||
149200979|NCT00603733|538202285|FG000|Active Phase ITT|Subject moved, site closed|1|||
149200980|NCT00603733|538202286|FG001|Active Phase ITT|Subject moved, site closed|1|||
149200981|NCT00603733|538202285|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
149200982|NCT00603733|538202286|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
149200983|NCT00603733|538202285|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
149200984|NCT00603733|538202286|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
149200985|NCT00603733|538202285|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
149200986|NCT00603733|538202286|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
149200987|NCT00603733|538202285|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
149200988|NCT00603733|538202286|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
149200989|NCT00603733|538202285|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
149200990|NCT00603733|538202286|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
149200991|NCT00603733|538202285|FG000|Maintenance Phase ITT|Adverse Event|3|||
149200992|NCT00603733|538202286|FG001|Maintenance Phase ITT|Adverse Event|6|||
149200993|NCT00603733|538202285|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
149200994|NCT00603733|538202286|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
149200995|NCT00603733|538202285|FG000|Maintenance Phase ITT|Protocol Violation|1|||
149200996|NCT00603733|538202286|FG001|Maintenance Phase ITT|Protocol Violation|1|||
149200997|NCT00603733|538202285|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
149200998|NCT00603733|538202286|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
149200999|NCT00603733|538202285|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
149201000|NCT00603733|538202286|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
149201001|NCT00603733|538202285|FG000|Maintenance Phase ITT|Physician Decision|0|||
149201002|NCT00603733|538202286|FG001|Maintenance Phase ITT|Physician Decision|1|||
149201003|NCT00603733|538202285|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
149201004|NCT00603733|538202286|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
149201005|NCT03039738|538202299|FG000|Overall Study|Incomplete data sets|54|||
149201006|NCT03039738|538202300|FG001|Overall Study|Incomplete data sets|0|||
149201007|NCT00912340|538202301|FG000|Overall Study|Adverse Event|2|||
149201008|NCT00912340|538202302|FG001|Overall Study|Adverse Event|4|||
149201009|NCT00912340|538202303|FG002|Overall Study|Adverse Event|0|||
149201010|NCT00912340|538202301|FG000|Overall Study|Protocol revised to remove arm|0|||
149201011|NCT00912340|538202302|FG001|Overall Study|Protocol revised to remove arm|0|||
149201012|NCT00912340|538202303|FG002|Overall Study|Protocol revised to remove arm|4|||
149201013|NCT01253187|538202308|FG000|Period 2|Withdrawal by Subject|0|||
149201014|NCT01253187|538202309|FG001|Period 2|Withdrawal by Subject|0|||
149201015|NCT01253187|538202310|FG002|Period 2|Withdrawal by Subject|0|||
149201016|NCT01253187|538202311|FG003|Period 2|Withdrawal by Subject|0|||
149201017|NCT01253187|538202312|FG004|Period 2|Withdrawal by Subject|1|||
149201018|NCT01253187|538202313|FG005|Period 2|Withdrawal by Subject|0|||
149201019|NCT01253187|538202308|FG000|Period 3|Pregnancy|1|||
149201020|NCT01253187|538202309|FG001|Period 3|Pregnancy|0|||
149201021|NCT01253187|538202310|FG002|Period 3|Pregnancy|0|||
149201022|NCT01253187|538202311|FG003|Period 3|Pregnancy|0|||
149201023|NCT01253187|538202312|FG004|Period 3|Pregnancy|0|||
149201024|NCT01253187|538202313|FG005|Period 3|Pregnancy|0|||
149201025|NCT01253187|538202308|FG000|Period 3|difficulty with blood sampling|0|||
149201026|NCT01253187|538202309|FG001|Period 3|difficulty with blood sampling|1|||
149201027|NCT01253187|538202310|FG002|Period 3|difficulty with blood sampling|0|||
149201028|NCT01253187|538202311|FG003|Period 3|difficulty with blood sampling|0|||
149201029|NCT01253187|538202312|FG004|Period 3|difficulty with blood sampling|0|||
149201030|NCT01253187|538202313|FG005|Period 3|difficulty with blood sampling|0|||
149201031|NCT01253187|538202308|FG000|Period 3|non-compliance|0|||
149201032|NCT01253187|538202309|FG001|Period 3|non-compliance|0|||
149201033|NCT01253187|538202310|FG002|Period 3|non-compliance|0|||
149201034|NCT01253187|538202311|FG003|Period 3|non-compliance|0|||
149201035|NCT01253187|538202312|FG004|Period 3|non-compliance|1|||
149201036|NCT01253187|538202313|FG005|Period 3|non-compliance|0|||
149201037|NCT01293006|538202315|FG000|Period 2|Lost to Follow-up|1|||
149201038|NCT01293006|538202316|FG001|Period 2|Lost to Follow-up|0|||
149201039|NCT01293006|538202317|FG002|Period 2|Lost to Follow-up|0|||
149201040|NCT01293006|538202318|FG003|Period 2|Lost to Follow-up|0|||
149201041|NCT01494987|538202319|FG000|Overall Study|Adverse Event|6|||
149201042|NCT01494987|538202320|FG001|Overall Study|Adverse Event|5|||
149201043|NCT01494987|538202319|FG000|Overall Study|Hyperglycemia|6|||
149201044|NCT01494987|538202320|FG001|Overall Study|Hyperglycemia|4|||
149201045|NCT01494987|538202319|FG000|Overall Study|Investigator's Discretion|1|||
149201046|NCT01494987|538202320|FG001|Overall Study|Investigator's Discretion|2|||
149201047|NCT01494987|538202319|FG000|Overall Study|Lost to Follow-up|1|||
149201048|NCT01494987|538202320|FG001|Overall Study|Lost to Follow-up|1|||
149201049|NCT01494987|538202319|FG000|Overall Study|Protocol Violation|3|||
149201050|NCT01494987|538202320|FG001|Overall Study|Protocol Violation|3|||
149201051|NCT01494987|538202319|FG000|Overall Study|Subject Non-Compliance|9|||
149201052|NCT01494987|538202320|FG001|Overall Study|Subject Non-Compliance|10|||
149201053|NCT01494987|538202319|FG000|Overall Study|Subject Withdrew Consent|2|||
149201054|NCT01494987|538202320|FG001|Overall Study|Subject Withdrew Consent|3|||
149201055|NCT02254551|538202323|FG000|Dose Escalation|Physician Decision|1|||
149201056|NCT02254551|538202323|FG000|Dose Escalation|Dose-limiting toxicity|2|||
149201057|NCT02062463|538202324|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
149201058|NCT02062463|538202325|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
149201059|NCT02062463|538202326|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
149201060|NCT02062463|538202327|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
149201061|NCT02062463|538202324|FG000|Stage 2|Adverse Event|0|||
149201062|NCT02062463|538202325|FG001|Stage 2|Adverse Event|0|||
149201063|NCT02062463|538202326|FG002|Stage 2|Adverse Event|12|||
149201064|NCT02062463|538202327|FG003|Stage 2|Adverse Event|20|||
149201065|NCT02062463|538202324|FG000|Stage 2|Lack of Efficacy|0|||
149201066|NCT02062463|538202325|FG001|Stage 2|Lack of Efficacy|0|||
149201067|NCT02062463|538202326|FG002|Stage 2|Lack of Efficacy|3|||
149201068|NCT02062463|538202327|FG003|Stage 2|Lack of Efficacy|4|||
149201069|NCT02062463|538202324|FG000|Stage 2|Lost to Follow-up|0|||
149201070|NCT02062463|538202325|FG001|Stage 2|Lost to Follow-up|0|||
149201071|NCT02062463|538202326|FG002|Stage 2|Lost to Follow-up|20|||
149201072|NCT02062463|538202327|FG003|Stage 2|Lost to Follow-up|20|||
149201073|NCT02062463|538202324|FG000|Stage 2|Non-Compliance|0|||
149201074|NCT02062463|538202325|FG001|Stage 2|Non-Compliance|0|||
149201075|NCT02062463|538202326|FG002|Stage 2|Non-Compliance|0|||
149201076|NCT02062463|538202327|FG003|Stage 2|Non-Compliance|1|||
149201077|NCT02062463|538202324|FG000|Stage 2|Other than specified|0|||
149201078|NCT02062463|538202325|FG001|Stage 2|Other than specified|0|||
149201079|NCT02062463|538202326|FG002|Stage 2|Other than specified|3|||
149201080|NCT02062463|538202327|FG003|Stage 2|Other than specified|1|||
149201081|NCT02062463|538202324|FG000|Stage 2|Withdrawal by Subject|0|||
149201082|NCT02062463|538202325|FG001|Stage 2|Withdrawal by Subject|0|||
149201083|NCT02062463|538202326|FG002|Stage 2|Withdrawal by Subject|15|||
149201084|NCT02062463|538202327|FG003|Stage 2|Withdrawal by Subject|10|||
149201085|NCT00600028|538202338|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
149201086|NCT00600028|538202339|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
149201087|NCT00600028|538202338|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
149201088|NCT00600028|538202339|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
149201089|NCT00600028|538202338|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
149201090|NCT00600028|538202339|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
149201091|NCT03172481|538202340|FG000|Double-blind|Withdrawal by Subject|1|||
149201092|NCT03172481|538202341|FG001|Double-blind|Withdrawal by Subject|0|||
149201093|NCT00830115|538202342|FG000|Overall Study|Adverse Event|2|||
149201094|NCT00830115|538202342|FG000|Overall Study|Improvement/recovery|1|||
149201095|NCT01925612|538202343|FG000|Overall Study|Progressive Disease|1|||
149201096|NCT01925612|538202344|FG001|Overall Study|Progressive Disease|1|||
149201097|NCT01925612|538202345|FG002|Overall Study|Progressive Disease|1|||
149201098|NCT01925612|538202346|FG003|Overall Study|Progressive Disease|0|||
149201099|NCT01925612|538202347|FG004|Overall Study|Progressive Disease|0|||
149201100|NCT01925612|538202343|FG000|Overall Study|Adverse Event|3|||
149201101|NCT01925612|538202344|FG001|Overall Study|Adverse Event|3|||
149201102|NCT01925612|538202345|FG002|Overall Study|Adverse Event|0|||
149201103|NCT01925612|538202346|FG003|Overall Study|Adverse Event|1|||
149201104|NCT01925612|538202347|FG004|Overall Study|Adverse Event|2|||
149201105|NCT01107405|538202352|FG000|Overall Study|Adverse Event|1|||
149201106|NCT01107405|538202353|FG001|Overall Study|Adverse Event|1|||
149201107|NCT01107405|538202354|FG002|Overall Study|Adverse Event|0|||
149201108|NCT01107405|538202355|FG003|Overall Study|Adverse Event|0|||
149201109|NCT01107405|538202356|FG004|Overall Study|Adverse Event|2|||
149201110|NCT01107405|538202352|FG000|Overall Study|Withdrawal by Subject|1|||
149201111|NCT01107405|538202353|FG001|Overall Study|Withdrawal by Subject|0|||
149201112|NCT01107405|538202354|FG002|Overall Study|Withdrawal by Subject|1|||
149201113|NCT01107405|538202355|FG003|Overall Study|Withdrawal by Subject|2|||
149201114|NCT01107405|538202356|FG004|Overall Study|Withdrawal by Subject|1|||
149201115|NCT01107405|538202352|FG000|Overall Study|Protocol Violation|0|||
149201116|NCT01107405|538202353|FG001|Overall Study|Protocol Violation|0|||
149201117|NCT01107405|538202354|FG002|Overall Study|Protocol Violation|1|||
149201118|NCT01107405|538202355|FG003|Overall Study|Protocol Violation|1|||
149201119|NCT01107405|538202356|FG004|Overall Study|Protocol Violation|0|||
149201120|NCT01170702|538202358|FG000|Overall Study|Exclusion criteria met after consent|1|||
149201121|NCT01170702|538202359|FG001|Overall Study|Exclusion criteria met after consent|2|||
149201122|NCT01170702|538202360|FG002|Overall Study|Exclusion criteria met after consent|0|||
149201123|NCT01170702|538202361|FG003|Overall Study|Exclusion criteria met after consent|2|||
149201124|NCT00085917|538202362|FG000|Overall Study|Adverse Event|4|||
149201125|NCT00085917|538202363|FG001|Overall Study|Adverse Event|3|||
149201126|NCT01360762|538202366|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
149201127|NCT01360762|538202366|FG000|Main Study Period (12-month Treatment)|Death|5|||
149201128|NCT01360762|538202366|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
149201129|NCT01360762|538202366|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
149201130|NCT01360762|538202366|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
149201131|NCT01360762|538202366|FG000|Whole Study Period|Lost to Follow-up|10|||
149201132|NCT01360762|538202366|FG000|Whole Study Period|Death|7|||
149201133|NCT01360762|538202366|FG000|Whole Study Period|Patient relapsed|18|||
149201134|NCT01360762|538202366|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
149201135|NCT03084718|538202367|FG000|Overall Study|Withdrawal by Subject|4|||
149201136|NCT03084718|538202368|FG001|Overall Study|Withdrawal by Subject|3|||
149201137|NCT03084718|538202369|FG002|Overall Study|Withdrawal by Subject|4|||
149201138|NCT03084718|538202370|FG003|Overall Study|Withdrawal by Subject|0|||
149201139|NCT03084718|538202371|FG004|Overall Study|Withdrawal by Subject|0|||
149201140|NCT03084718|538202367|FG000|Overall Study|Physician Decision|1|||
149201141|NCT03084718|538202368|FG001|Overall Study|Physician Decision|0|||
149201142|NCT03084718|538202369|FG002|Overall Study|Physician Decision|0|||
149201143|NCT03084718|538202370|FG003|Overall Study|Physician Decision|0|||
149201144|NCT03084718|538202371|FG004|Overall Study|Physician Decision|0|||
149201145|NCT03084718|538202367|FG000|Overall Study|Adverse Event|3|||
149201146|NCT03084718|538202368|FG001|Overall Study|Adverse Event|5|||
149201147|NCT03084718|538202369|FG002|Overall Study|Adverse Event|5|||
149201148|NCT03084718|538202370|FG003|Overall Study|Adverse Event|8|||
149201149|NCT03084718|538202371|FG004|Overall Study|Adverse Event|2|||
149201150|NCT03084718|538202367|FG000|Overall Study|Lack of Efficacy|2|||
149201151|NCT03084718|538202368|FG001|Overall Study|Lack of Efficacy|0|||
149201152|NCT03084718|538202369|FG002|Overall Study|Lack of Efficacy|1|||
149201153|NCT03084718|538202370|FG003|Overall Study|Lack of Efficacy|4|||
149201154|NCT03084718|538202371|FG004|Overall Study|Lack of Efficacy|0|||
149201155|NCT03084718|538202367|FG000|Overall Study|Lost to Follow-up|0|||
149201156|NCT03084718|538202368|FG001|Overall Study|Lost to Follow-up|1|||
149201157|NCT03084718|538202369|FG002|Overall Study|Lost to Follow-up|0|||
149201158|NCT03084718|538202370|FG003|Overall Study|Lost to Follow-up|0|||
149201159|NCT03084718|538202371|FG004|Overall Study|Lost to Follow-up|2|||
149201160|NCT03084718|538202367|FG000|Overall Study|Protocol Violation|0|||
149201161|NCT03084718|538202368|FG001|Overall Study|Protocol Violation|0|||
149201162|NCT03084718|538202369|FG002|Overall Study|Protocol Violation|1|||
149201163|NCT03084718|538202370|FG003|Overall Study|Protocol Violation|0|||
149201164|NCT03084718|538202371|FG004|Overall Study|Protocol Violation|0|||
149201165|NCT03084718|538202367|FG000|Overall Study|Death|0|||
149201166|NCT03084718|538202368|FG001|Overall Study|Death|1|||
149201167|NCT03084718|538202369|FG002|Overall Study|Death|0|||
149201168|NCT03084718|538202370|FG003|Overall Study|Death|0|||
149201169|NCT03084718|538202371|FG004|Overall Study|Death|0|||
149201170|NCT03084718|538202367|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
149201171|NCT03084718|538202368|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
149201172|NCT03084718|538202369|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
149201173|NCT03084718|538202370|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
149201174|NCT03084718|538202371|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
149201175|NCT02806947|538202372|FG000|Overall Study|Withdrawal by Subject|5|||
149201176|NCT02806947|538202373|FG001|Overall Study|Withdrawal by Subject|1|||
149201177|NCT00865189|538202374|FG000|Overall Study|Other|1|||
149201178|NCT00865189|538202375|FG001|Overall Study|Other|2|||
149201179|NCT00865189|538202374|FG000|Overall Study|Death|4|||
149201180|NCT00865189|538202375|FG001|Overall Study|Death|11|||
149201181|NCT00865189|538202374|FG000|Overall Study|Lost to Follow-up|6|||
149201182|NCT00865189|538202375|FG001|Overall Study|Lost to Follow-up|6|||
149201183|NCT00865189|538202374|FG000|Overall Study|Withdrawal by Subject|1|||
149201184|NCT00865189|538202375|FG001|Overall Study|Withdrawal by Subject|0|||
149201185|NCT00084929|538202378|FG000|Overall Study|ineligible - medical contraindication|1|||
149201186|NCT00084929|538202378|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
148943550|NCT02585960|537278052|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
148943551|NCT02585960|537278050|FG000|PK/Safety Assessment Period|Other|4|||
148943552|NCT02585960|537278051|FG001|PK/Safety Assessment Period|Other|4|||
149201187|NCT00084929|538202378|FG000|Overall Study|Ineligible - Medical history|6|||
149201188|NCT00084929|538202378|FG000|Overall Study|Withdrawal by Subject|10|||
149201189|NCT00084929|538202378|FG000|Overall Study|Missing/incomplete CTC exam|9|||
149201190|NCT00084929|538202378|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
149201191|NCT00091026|538202379|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
149201192|NCT00091026|538202380|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
149201193|NCT00091026|538202379|FG000|Overall Study|Patient withdrew and never received trea|0|||
149201194|NCT00091026|538202380|FG001|Overall Study|Patient withdrew and never received trea|2|||
149201195|NCT00091026|538202379|FG000|Overall Study|Unknown-never received treatment|0|||
149201196|NCT00091026|538202380|FG001|Overall Study|Unknown-never received treatment|1|||
149201197|NCT03666858|538202381|FG000|Cohort 1|Adverse Event|1|||
149201198|NCT03666858|538202382|FG001|Cohort 1|Adverse Event|0|||
149201199|NCT03666858|538202381|FG000|Cohort 2|Adverse Event|0|||
149201200|NCT03666858|538202382|FG001|Cohort 2|Adverse Event|1|||
149201201|NCT02921919|538202383|FG000|Overall Study|Other|5|||
149201202|NCT02921919|538202384|FG001|Overall Study|Other|6|||
149201203|NCT02921919|538202383|FG000|Overall Study|Lost to Follow-up|0|||
149201204|NCT02921919|538202384|FG001|Overall Study|Lost to Follow-up|1|||
149201205|NCT02921919|538202383|FG000|Overall Study|Withdrawal by Subject|5|||
149201206|NCT02921919|538202384|FG001|Overall Study|Withdrawal by Subject|1|||
149201207|NCT02921919|538202383|FG000|Overall Study|Disease Progression|47|||
149201208|NCT02921919|538202384|FG001|Overall Study|Disease Progression|38|||
149201209|NCT02921919|538202383|FG000|Overall Study|Physician Decision|3|||
149201210|NCT02921919|538202384|FG001|Overall Study|Physician Decision|2|||
149201211|NCT02921919|538202383|FG000|Overall Study|Adverse Event|6|||
149201212|NCT02921919|538202384|FG001|Overall Study|Adverse Event|4|||
149201213|NCT00980980|538202385|FG000|Overall Study|Withdrawal by Hospital|0|||
149201214|NCT00980980|538202386|FG001|Overall Study|Withdrawal by Hospital|1|||
149201215|NCT00980980|538202387|FG002|Overall Study|Withdrawal by Hospital|0|||
149201216|NCT03550131|538202388|FG000|Overall Study|Lost to Follow-up|16|||
149201217|NCT03550131|538202389|FG001|Overall Study|Lost to Follow-up|24|||
149201218|NCT03550131|538202388|FG000|Overall Study|Withdrawal by Subject|36|||
149201219|NCT03550131|538202389|FG001|Overall Study|Withdrawal by Subject|28|||
149201220|NCT03550131|538202388|FG000|Overall Study|Illness of dyad member|10|||
149201221|NCT03550131|538202389|FG001|Overall Study|Illness of dyad member|2|||
149201222|NCT03550131|538202388|FG000|Overall Study|Death of person with dementia|4|||
149201223|NCT03550131|538202389|FG001|Overall Study|Death of person with dementia|8|||
149201224|NCT01283997|538203951|FG000|Overall Study|Physician Decision|8|||
149201225|NCT01283997|538203952|FG001|Overall Study|Physician Decision|10|||
149201226|NCT01283997|538203951|FG000|Overall Study|Withdrawal by Subject|3|||
149201227|NCT01283997|538203952|FG001|Overall Study|Withdrawal by Subject|2|||
149201228|NCT01283997|538203951|FG000|Overall Study|Physically unable to continue|0|||
149201229|NCT01283997|538203952|FG001|Overall Study|Physically unable to continue|1|||
149201230|NCT01283997|538203951|FG000|Overall Study|Progressive disease|1|||
149201231|NCT01283997|538203952|FG001|Overall Study|Progressive disease|0|||
149201232|NCT01283997|538203951|FG000|Overall Study|Other|4|||
149201233|NCT01283997|538203952|FG001|Overall Study|Other|4|||
149201234|NCT01337167|538203956|FG000|Infant Series|Adverse Event|1|||
149201235|NCT01337167|538203957|FG001|Infant Series|Adverse Event|1|||
149201236|NCT01337167|538203956|FG000|Infant Series|Death|1|||
149201237|NCT01337167|538203957|FG001|Infant Series|Death|1|||
149201238|NCT01337167|538203956|FG000|Infant Series|Lost to Follow-up|13|||
149201239|NCT01337167|538203957|FG001|Infant Series|Lost to Follow-up|7|||
149201240|NCT01337167|538203956|FG000|Infant Series|Non-compliance with study drug|2|||
149201241|NCT01337167|538203957|FG001|Infant Series|Non-compliance with study drug|1|||
149201242|NCT01337167|538203956|FG000|Infant Series|Physician Decision|3|||
149201243|NCT01337167|538203957|FG001|Infant Series|Physician Decision|1|||
149201244|NCT01337167|538203956|FG000|Infant Series|Protocol Violation|22|||
149201245|NCT01337167|538203957|FG001|Infant Series|Protocol Violation|9|||
149201246|NCT01337167|538203956|FG000|Infant Series|Withdrawal by Subject|15|||
149201247|NCT01337167|538203957|FG001|Infant Series|Withdrawal by Subject|4|||
149201248|NCT01337167|538203956|FG000|Infant Series|Randomized but not vaccinated|5|||
149201249|NCT01337167|538203957|FG001|Infant Series|Randomized but not vaccinated|3|||
149201250|NCT01337167|538203956|FG000|Interim Period|Lost to Follow-up|51|||
149201251|NCT01337167|538203957|FG001|Interim Period|Lost to Follow-up|23|||
149201252|NCT01337167|538203956|FG000|Interim Period|Non-compliance with study drug|1|||
148808477|NCT00788671|536777504|FG000|Overall Study|Lost to follow up|2|||
148808478|NCT04486716|536777505|FG000|Core Phase|Subject decision|6|||
149201253|NCT01337167|538203957|FG001|Interim Period|Non-compliance with study drug|0|||
149201254|NCT01337167|538203956|FG000|Interim Period|Physician Decision|6|||
149201255|NCT01337167|538203957|FG001|Interim Period|Physician Decision|3|||
149201256|NCT01337167|538203956|FG000|Interim Period|Protocol Violation|5|||
149201257|NCT01337167|538203957|FG001|Interim Period|Protocol Violation|3|||
149201258|NCT01337167|538203956|FG000|Interim Period|Withdrawal by Subject|18|||
149201259|NCT01337167|538203957|FG001|Interim Period|Withdrawal by Subject|10|||
149201260|NCT01337167|538203956|FG000|Interim Period|Other protocol criterion not met|0|||
149201261|NCT01337167|538203957|FG001|Interim Period|Other protocol criterion not met|1|||
149201262|NCT01337167|538203956|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
149201263|NCT01337167|538203957|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
149201264|NCT01337167|538203956|FG000|Toddler Vaccinations|Protocol Violation|0|||
149201265|NCT01337167|538203957|FG001|Toddler Vaccinations|Protocol Violation|1|||
149201266|NCT01337167|538203956|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
149201267|NCT01337167|538203957|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
149201268|NCT02126670|538203958|FG000|Overall Study|Withdrawal by Subject|1|||
149201269|NCT02126670|538203959|FG001|Overall Study|Withdrawal by Subject|0|||
149201270|NCT02126670|538203960|FG002|Overall Study|Withdrawal by Subject|0|||
149201271|NCT02126670|538203961|FG003|Overall Study|Withdrawal by Subject|1|||
149201272|NCT00436982|538203964|FG000|Overall Study|Withdrawal by Subject|3|||
149201273|NCT00436982|538203965|FG001|Overall Study|Withdrawal by Subject|1|||
149201274|NCT00436982|538203964|FG000|Overall Study|Did not receive allocated intervention|0|||
148943553|NCT02585960|537278052|FG002|PK/Safety Assessment Period|Other|0|||
148943554|NCT02585960|537278050|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
148943555|NCT02585960|537278051|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
148943556|NCT02585960|537278052|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
148943557|NCT02585960|537278050|FG000|PK/Safety Assessment Period|Screen Failure|0|||
148943558|NCT02585960|537278051|FG001|PK/Safety Assessment Period|Screen Failure|0|||
148943559|NCT02585960|537278052|FG002|PK/Safety Assessment Period|Screen Failure|1|||
148943560|NCT02585960|537278050|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
148943561|NCT02585960|537278051|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
148943562|NCT02585960|537278052|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
148943563|NCT02585960|537278050|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
148943564|NCT02585960|537278051|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
148943565|NCT02585960|537278052|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
148943566|NCT03639935|537278053|FG000|Overall Study|Death|3|||
148943567|NCT03639935|537278053|FG000|Overall Study|Adverse Event|1|||
148943568|NCT06333613|537278054|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
148943569|NCT04930965|537278057|FG000|Overall Study|Lost to Follow-up|7|||
148943570|NCT04930965|537278058|FG001|Overall Study|Lost to Follow-up|5|||
148943571|NCT02849678|537278059|FG000|Overall Study|Protocol Violation|3|||
148943572|NCT02849678|537278060|FG001|Overall Study|Protocol Violation|6|||
148943573|NCT00288054|537278061|FG000|Overall Study|Protocol Violation|2|||
148943574|NCT00288054|537278061|FG000|Overall Study|Lack of Efficacy|16|||
148943575|NCT00288054|537278061|FG000|Overall Study|Adverse Event|3|||
148943576|NCT00288054|537278061|FG000|Overall Study|Withdrawal by Subject|1|||
149201275|NCT00436982|538203965|FG001|Overall Study|Did not receive allocated intervention|1|||
149201276|NCT00436982|538203964|FG000|Overall Study|no RSA data|1|||
149201277|NCT00436982|538203965|FG001|Overall Study|no RSA data|2|||
149201278|NCT04058158|538203969|FG000|Period 1|Death|1|||
149201279|NCT04058158|538203970|FG001|Period 1|Death|0|||
149201280|NCT04058158|538203969|FG000|Period 1|Adverse Event|1|||
149201281|NCT04058158|538203970|FG001|Period 1|Adverse Event|1|||
149201282|NCT04058158|538203969|FG000|Period 1|Pregnancy|0|||
149201283|NCT04058158|538203970|FG001|Period 1|Pregnancy|1|||
149201284|NCT01634113|538203971|FG000|Overall Study|Not treated|0|||
149201285|NCT01634113|538203972|FG001|Overall Study|Not treated|0|||
149201286|NCT01634113|538203973|FG002|Overall Study|Not treated|1|||
149201287|NCT00520299|538203976|FG000|Overall Study|Withdrawal by Subject|0|||
149201288|NCT00520299|538203977|FG001|Overall Study|Withdrawal by Subject|0|||
149201289|NCT00520299|538203978|FG002|Overall Study|Withdrawal by Subject|2|||
149201290|NCT00520299|538203976|FG000|Overall Study|Progressive disease|0|||
149201291|NCT00520299|538203977|FG001|Overall Study|Progressive disease|3|||
149201292|NCT00520299|538203978|FG002|Overall Study|Progressive disease|4|||
149201293|NCT01352845|538203979|FG000|Overall Study|Lost to Follow-up|313|||
149201294|NCT01352845|538203980|FG001|Overall Study|Lost to Follow-up|92|||
149201295|NCT01352845|538203979|FG000|Overall Study|No Longer Willing to Participate|205|||
149201296|NCT01352845|538203980|FG001|Overall Study|No Longer Willing to Participate|58|||
149201297|NCT01352845|538203979|FG000|Overall Study|Withdrawal by Subject|48|||
149201298|NCT01352845|538203980|FG001|Overall Study|Withdrawal by Subject|16|||
149201299|NCT01352845|538203979|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
149201300|NCT01352845|538203980|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
149201301|NCT01352845|538203979|FG000|Overall Study|Pregnancy|27|||
149201302|NCT01352845|538203980|FG001|Overall Study|Pregnancy|7|||
149201303|NCT01352845|538203979|FG000|Overall Study|Adverse Event|22|||
149201304|NCT01352845|538203980|FG001|Overall Study|Adverse Event|6|||
148943577|NCT00288054|537278061|FG000|Overall Study|Not protocol specified|2|||
148943578|NCT00622401|537278065|FG000|Overall Study|Disease progression prior to treatment|3|||
148943579|NCT00622401|537278066|FG001|Overall Study|Disease progression prior to treatment|2|||
148943580|NCT00622401|537278067|FG002|Overall Study|Disease progression prior to treatment|0|||
148943581|NCT02021773|537278074|FG000|Overall Study|Adverse Event|1|||
148943582|NCT02021773|537278075|FG001|Overall Study|Adverse Event|4|||
148943583|NCT02021773|537278076|FG002|Overall Study|Adverse Event|3|||
149201305|NCT01352845|538203979|FG000|Overall Study|Other|17|||
149201306|NCT01352845|538203980|FG001|Overall Study|Other|7|||
149201307|NCT01352845|538203979|FG000|Overall Study|Protocol Violation|12|||
148943584|NCT02021773|537278074|FG000|Overall Study|Lack of Efficacy|2|||
148943585|NCT02021773|537278075|FG001|Overall Study|Lack of Efficacy|2|||
149016238|NCT00337662|537537890|FG000|Study Period II|Withdrawal by Subject|0|||
149201308|NCT01352845|538203980|FG001|Overall Study|Protocol Violation|6|||
149201309|NCT01352845|538203979|FG000|Overall Study|Death|3|||
149201310|NCT01352845|538203980|FG001|Overall Study|Death|0|||
149201311|NCT01956240|538203981|FG000|Overall Study|Lost to Follow-up|6|||
149201312|NCT01956240|538203982|FG001|Overall Study|Lost to Follow-up|20|||
149201313|NCT01956240|538203981|FG000|Overall Study|Adverse Event|17|||
149201314|NCT01956240|538203982|FG001|Overall Study|Adverse Event|4|||
149201315|NCT02759562|538203986|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
149201316|NCT02759562|538203987|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
148943586|NCT02021773|537278076|FG002|Overall Study|Lack of Efficacy|2|||
148943587|NCT02021773|537278074|FG000|Overall Study|Protocol Violation|2|||
148943588|NCT02021773|537278075|FG001|Overall Study|Protocol Violation|3|||
148943589|NCT02021773|537278076|FG002|Overall Study|Protocol Violation|1|||
148943590|NCT02021773|537278074|FG000|Overall Study|Withdrawal by Subject|3|||
148943591|NCT02021773|537278075|FG001|Overall Study|Withdrawal by Subject|4|||
148943592|NCT02021773|537278076|FG002|Overall Study|Withdrawal by Subject|5|||
149201317|NCT02759562|538203986|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
149201318|NCT02759562|538203987|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
149201319|NCT02293993|538203988|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
149201320|NCT02293993|538203989|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
149201321|NCT02293993|538203990|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
149201322|NCT02293993|538203991|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
149201323|NCT02293993|538203988|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
149201324|NCT02293993|538203989|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
149201325|NCT02293993|538203990|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
149201326|NCT02293993|538203991|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
149201327|NCT02293993|538203988|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
149201328|NCT02293993|538203989|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
149201329|NCT02293993|538203990|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
149201330|NCT02293993|538203991|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
149201331|NCT02293993|538203988|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
149201332|NCT02293993|538203989|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
148943593|NCT02021773|537278074|FG000|Overall Study|Lost to Follow-up|1|||
148943594|NCT02021773|537278075|FG001|Overall Study|Lost to Follow-up|3|||
149016239|NCT00337662|537537891|FG001|Study Period II|Withdrawal by Subject|0|||
149016240|NCT00337662|537537892|FG002|Study Period II|Withdrawal by Subject|0|||
149016241|NCT00337662|537537893|FG003|Study Period II|Withdrawal by Subject|20|||
149016242|NCT00337662|537537890|FG000|Study Period II|Adverse Event|0|||
149016243|NCT00337662|537537891|FG001|Study Period II|Adverse Event|0|||
149016244|NCT00337662|537537892|FG002|Study Period II|Adverse Event|0|||
149016245|NCT00337662|537537893|FG003|Study Period II|Adverse Event|16|||
149016246|NCT00337662|537537890|FG000|Study Period II|Physician Decision|0|||
149016247|NCT00337662|537537891|FG001|Study Period II|Physician Decision|0|||
149016248|NCT00337662|537537892|FG002|Study Period II|Physician Decision|0|||
149201333|NCT02293993|538203990|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
149201334|NCT02293993|538203991|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
149201335|NCT02293993|538203988|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
149201336|NCT02293993|538203989|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
149201337|NCT02293993|538203990|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
149201338|NCT02293993|538203991|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
149201339|NCT03587584|538203992|FG000|Overall Study|SOC deviations|4|||
149201340|NCT03587584|538203993|FG001|Overall Study|SOC deviations|6|||
149201341|NCT03587584|538203992|FG000|Overall Study|Incomplete data|0|||
149201342|NCT03587584|538203993|FG001|Overall Study|Incomplete data|3|||
149201343|NCT01061736|538203996|FG000|Overall Study|Dose regimen not selected|0|||
149201344|NCT01061736|538203997|FG001|Overall Study|Dose regimen not selected|0|||
149201345|NCT01061736|538203998|FG002|Overall Study|Dose regimen not selected|0|||
149201346|NCT01061736|538203999|FG003|Overall Study|Dose regimen not selected|0|||
149201347|NCT01061736|538204000|FG004|Overall Study|Dose regimen not selected|0|||
149201348|NCT01061736|538204001|FG005|Overall Study|Dose regimen not selected|0|||
149201349|NCT01061736|538204002|FG006|Overall Study|Dose regimen not selected|79|||
149016249|NCT00337662|537537893|FG003|Study Period II|Physician Decision|13|||
149016250|NCT00337662|537537890|FG000|Study Period II|Entry Criteria Not Met|0|||
149016251|NCT00337662|537537891|FG001|Study Period II|Entry Criteria Not Met|0|||
149016252|NCT00337662|537537892|FG002|Study Period II|Entry Criteria Not Met|0|||
149016253|NCT00337662|537537893|FG003|Study Period II|Entry Criteria Not Met|6|||
149016254|NCT00337662|537537890|FG000|Study Period II|Protocol Violation|0|||
148943595|NCT02021773|537278076|FG002|Overall Study|Lost to Follow-up|0|||
148943596|NCT02021773|537278074|FG000|Overall Study|Reason not specified|3|||
148943597|NCT02021773|537278075|FG001|Overall Study|Reason not specified|0|||
149016255|NCT00337662|537537891|FG001|Study Period II|Protocol Violation|0|||
148943598|NCT02021773|537278076|FG002|Overall Study|Reason not specified|0|||
148943599|NCT00282984|537278077|FG000|Overall Study|Death|2|||
148943600|NCT00282984|537278078|FG001|Overall Study|Death|5|||
148943601|NCT00282984|537278077|FG000|Overall Study|Adverse Event|8|||
148943602|NCT00282984|537278078|FG001|Overall Study|Adverse Event|5|||
148943603|NCT00282984|537278077|FG000|Overall Study|Lack of Efficacy|0|||
148943604|NCT00282984|537278078|FG001|Overall Study|Lack of Efficacy|2|||
148943605|NCT00282984|537278077|FG000|Overall Study|Lost to Follow-up|14|||
148943606|NCT00282984|537278078|FG001|Overall Study|Lost to Follow-up|10|||
148943607|NCT00282984|537278077|FG000|Overall Study|Withdrawal by Participant|22|||
148943608|NCT00282984|537278078|FG001|Overall Study|Withdrawal by Participant|34|||
148943609|NCT00282984|537278077|FG000|Overall Study|Participant stopped study medication|2|||
148943610|NCT00282984|537278078|FG001|Overall Study|Participant stopped study medication|2|||
148943611|NCT00282984|537278077|FG000|Overall Study|Participant only allowed phone follow-up|0|||
148943612|NCT00282984|537278078|FG001|Overall Study|Participant only allowed phone follow-up|1|||
148943613|NCT00282984|537278077|FG000|Overall Study|Participant used antipsychosis meds|0|||
148943614|NCT00282984|537278078|FG001|Overall Study|Participant used antipsychosis meds|1|||
149201350|NCT01061736|538204003|FG007|Overall Study|Dose regimen not selected|0|||
149201351|NCT01061736|538204004|FG008|Overall Study|Dose regimen not selected|0|||
149201352|NCT01061736|538204005|FG009|Overall Study|Dose regimen not selected|0|||
149201353|NCT01061736|538203996|FG000|Overall Study|Adverse Event|13|||
149201354|NCT01061736|538203997|FG001|Overall Study|Adverse Event|1|||
149201355|NCT01061736|538203998|FG002|Overall Study|Adverse Event|3|||
149201356|NCT01061736|538203999|FG003|Overall Study|Adverse Event|2|||
149201357|NCT01061736|538204000|FG004|Overall Study|Adverse Event|4|||
149201358|NCT01061736|538204001|FG005|Overall Study|Adverse Event|1|||
149201359|NCT01061736|538204002|FG006|Overall Study|Adverse Event|4|||
149201360|NCT01061736|538204003|FG007|Overall Study|Adverse Event|63|||
149201361|NCT01061736|538204004|FG008|Overall Study|Adverse Event|67|||
149201362|NCT01061736|538204005|FG009|Overall Study|Adverse Event|34|||
149201363|NCT01061736|538203996|FG000|Overall Study|Lack of Efficacy|0|||
149201364|NCT01061736|538203997|FG001|Overall Study|Lack of Efficacy|2|||
149201365|NCT01061736|538203998|FG002|Overall Study|Lack of Efficacy|1|||
149201366|NCT01061736|538203999|FG003|Overall Study|Lack of Efficacy|1|||
149201367|NCT01061736|538204000|FG004|Overall Study|Lack of Efficacy|1|||
149201368|NCT01061736|538204001|FG005|Overall Study|Lack of Efficacy|2|||
149201369|NCT01061736|538204002|FG006|Overall Study|Lack of Efficacy|1|||
149201370|NCT01061736|538204003|FG007|Overall Study|Lack of Efficacy|9|||
149201371|NCT01061736|538204004|FG008|Overall Study|Lack of Efficacy|9|||
149201372|NCT01061736|538204005|FG009|Overall Study|Lack of Efficacy|10|||
149201373|NCT01061736|538203996|FG000|Overall Study|Poor compliance to protocol|0|||
149201374|NCT01061736|538203997|FG001|Overall Study|Poor compliance to protocol|0|||
149201375|NCT01061736|538203998|FG002|Overall Study|Poor compliance to protocol|0|||
149201376|NCT01061736|538203999|FG003|Overall Study|Poor compliance to protocol|0|||
149201377|NCT01061736|538204000|FG004|Overall Study|Poor compliance to protocol|0|||
149201378|NCT01061736|538204001|FG005|Overall Study|Poor compliance to protocol|0|||
149201379|NCT01061736|538204002|FG006|Overall Study|Poor compliance to protocol|0|||
149201380|NCT01061736|538204003|FG007|Overall Study|Poor compliance to protocol|2|||
149201381|NCT01061736|538204004|FG008|Overall Study|Poor compliance to protocol|5|||
149201382|NCT01061736|538204005|FG009|Overall Study|Poor compliance to protocol|9|||
149201383|NCT01061736|538203996|FG000|Overall Study|Not treated|0|||
149201384|NCT01061736|538203997|FG001|Overall Study|Not treated|0|||
149201385|NCT01061736|538203998|FG002|Overall Study|Not treated|0|||
149201386|NCT01061736|538203999|FG003|Overall Study|Not treated|0|||
149201387|NCT01061736|538204000|FG004|Overall Study|Not treated|1|||
149201388|NCT01061736|538204001|FG005|Overall Study|Not treated|0|||
149201389|NCT01061736|538204002|FG006|Overall Study|Not treated|0|||
149201390|NCT01061736|538204003|FG007|Overall Study|Not treated|2|||
148943615|NCT00282984|537278077|FG000|Overall Study|lack of motivation|1|||
148943616|NCT00282984|537278078|FG001|Overall Study|lack of motivation|0|||
149201391|NCT01061736|538204004|FG008|Overall Study|Not treated|1|||
149201392|NCT01061736|538204005|FG009|Overall Study|Not treated|0|||
149201393|NCT01061736|538203996|FG000|Overall Study|Other than specified above|0|||
149201394|NCT01061736|538203997|FG001|Overall Study|Other than specified above|1|||
149016256|NCT00337662|537537892|FG002|Study Period II|Protocol Violation|0|||
149201395|NCT01061736|538203998|FG002|Overall Study|Other than specified above|2|||
149201396|NCT01061736|538203999|FG003|Overall Study|Other than specified above|0|||
149201397|NCT01061736|538204000|FG004|Overall Study|Other than specified above|1|||
148943617|NCT00282984|537278077|FG000|Overall Study|in prison|0|||
149016257|NCT00337662|537537893|FG003|Study Period II|Protocol Violation|6|||
148943618|NCT00282984|537278078|FG001|Overall Study|in prison|1|||
149201398|NCT01061736|538204001|FG005|Overall Study|Other than specified above|0|||
149201399|NCT01061736|538204002|FG006|Overall Study|Other than specified above|0|||
149201400|NCT01061736|538204003|FG007|Overall Study|Other than specified above|18|||
148943619|NCT00282984|537278077|FG000|Overall Study|Protocol Violation|2|||
149016258|NCT00337662|537537890|FG000|Study Period II|Lack of Efficacy|0|||
149201401|NCT01061736|538204004|FG008|Overall Study|Other than specified above|15|||
149201402|NCT01061736|538204005|FG009|Overall Study|Other than specified above|21|||
148943620|NCT00282984|537278078|FG001|Overall Study|Protocol Violation|0|||
148943621|NCT00191269|537278079|FG000|Overall Study|Protocol Violation|0|||
148943622|NCT00191269|537278080|FG001|Overall Study|Protocol Violation|2|||
148943623|NCT00191269|537278079|FG000|Overall Study|Adverse Event|1|||
148943624|NCT00191269|537278080|FG001|Overall Study|Adverse Event|4|||
148943625|NCT00191269|537278079|FG000|Overall Study|Progression of Disease|4|||
148943626|NCT00191269|537278080|FG001|Overall Study|Progression of Disease|42|||
148943627|NCT00191269|537278079|FG000|Overall Study|Lack of Efficacy|1|||
148943628|NCT00191269|537278080|FG001|Overall Study|Lack of Efficacy|5|||
148943629|NCT00191269|537278079|FG000|Overall Study|Withdrawal by Subject|0|||
148943630|NCT00191269|537278080|FG001|Overall Study|Withdrawal by Subject|1|||
148943631|NCT00191269|537278079|FG000|Overall Study|Pathologic Aggrevation|0|||
148943632|NCT00191269|537278080|FG001|Overall Study|Pathologic Aggrevation|1|||
148943633|NCT00191269|537278079|FG000|Overall Study|Physician Decision|0|||
148943634|NCT00191269|537278080|FG001|Overall Study|Physician Decision|3|||
148943635|NCT00915278|537278086|FG000|Overall Study|Death|1|||
148943636|NCT00915278|537278087|FG001|Overall Study|Death|0|||
148943637|NCT00915278|537278088|FG002|Overall Study|Death|0|||
148943638|NCT00915278|537278089|FG003|Overall Study|Death|0|||
148943639|NCT00915278|537278090|FG004|Overall Study|Death|0|||
148943640|NCT00915278|537278091|FG005|Overall Study|Death|0|||
148943641|NCT00915278|537278086|FG000|Overall Study|Lost to Follow-up|0|||
148943642|NCT00915278|537278087|FG001|Overall Study|Lost to Follow-up|1|||
148943643|NCT00915278|537278088|FG002|Overall Study|Lost to Follow-up|0|||
148943644|NCT00915278|537278089|FG003|Overall Study|Lost to Follow-up|0|||
148943645|NCT00915278|537278090|FG004|Overall Study|Lost to Follow-up|0|||
148943646|NCT00915278|537278091|FG005|Overall Study|Lost to Follow-up|0|||
148943647|NCT00915278|537278086|FG000|Overall Study|Withdrawal by Subject|0|||
148943648|NCT00915278|537278087|FG001|Overall Study|Withdrawal by Subject|1|||
148943649|NCT00915278|537278088|FG002|Overall Study|Withdrawal by Subject|0|||
148943650|NCT00915278|537278089|FG003|Overall Study|Withdrawal by Subject|0|||
148943651|NCT00915278|537278090|FG004|Overall Study|Withdrawal by Subject|1|||
148943652|NCT00915278|537278091|FG005|Overall Study|Withdrawal by Subject|4|||
148943653|NCT00915278|537278086|FG000|Overall Study|Adverse Event|4|||
148943654|NCT00915278|537278087|FG001|Overall Study|Adverse Event|1|||
148943655|NCT00915278|537278088|FG002|Overall Study|Adverse Event|0|||
148943656|NCT00915278|537278089|FG003|Overall Study|Adverse Event|0|||
148943657|NCT00915278|537278090|FG004|Overall Study|Adverse Event|0|||
148943658|NCT00915278|537278091|FG005|Overall Study|Adverse Event|0|||
148943659|NCT00915278|537278086|FG000|Overall Study|Progressive disease/clinical progression|0|||
148943660|NCT00915278|537278087|FG001|Overall Study|Progressive disease/clinical progression|0|||
148943661|NCT00915278|537278088|FG002|Overall Study|Progressive disease/clinical progression|0|||
148943662|NCT00915278|537278089|FG003|Overall Study|Progressive disease/clinical progression|3|||
148943663|NCT00915278|537278090|FG004|Overall Study|Progressive disease/clinical progression|1|||
148943664|NCT00915278|537278091|FG005|Overall Study|Progressive disease/clinical progression|2|||
148943665|NCT00915278|537278086|FG000|Overall Study|Infusion related AEs|0|||
148943666|NCT00915278|537278087|FG001|Overall Study|Infusion related AEs|0|||
148943667|NCT00915278|537278088|FG002|Overall Study|Infusion related AEs|0|||
149201403|NCT01093755|538204007|FG000|Overall Study|Withdrawal by Subject|3|||
149201404|NCT01093755|538204008|FG001|Overall Study|Withdrawal by Subject|4|||
149201405|NCT03115112|538204009|FG000|Overall Study|Adverse Event|5|||
149201406|NCT03115112|538204010|FG001|Overall Study|Adverse Event|1|||
149201407|NCT03115112|538204009|FG000|Overall Study|Withdrawal by Subject|4|||
149201408|NCT03115112|538204010|FG001|Overall Study|Withdrawal by Subject|2|||
149201409|NCT03115112|538204009|FG000|Overall Study|Lost to Follow-up|0|||
149201410|NCT03115112|538204010|FG001|Overall Study|Lost to Follow-up|1|||
149201411|NCT03115112|538204009|FG000|Overall Study|Death|1|||
149201412|NCT03115112|538204010|FG001|Overall Study|Death|0|||
149201413|NCT03115112|538204009|FG000|Overall Study|Pregnancy|1|||
149201414|NCT03115112|538204010|FG001|Overall Study|Pregnancy|0|||
149201415|NCT03115112|538204009|FG000|Overall Study|Site closure|1|||
148808479|NCT04486716|536777505|FG000|Core Phase|Adverse Event|5|||
148943668|NCT00915278|537278089|FG003|Overall Study|Infusion related AEs|0|||
149201416|NCT03115112|538204010|FG001|Overall Study|Site closure|1|||
149201417|NCT04019795|538204012|FG000|Overall Study|Withdrawal by Subject|1|||
148808480|NCT04486716|536777505|FG000|Core Phase|Lost to Follow-up|1|||
148808481|NCT04486716|536777505|FG000|Core Phase|Physician Decision|1|||
148943669|NCT00915278|537278090|FG004|Overall Study|Infusion related AEs|0|||
148943670|NCT00915278|537278091|FG005|Overall Study|Infusion related AEs|2|||
148943671|NCT00915278|537278086|FG000|Overall Study|Admission to hospice|0|||
148943672|NCT00915278|537278087|FG001|Overall Study|Admission to hospice|0|||
148943673|NCT00915278|537278088|FG002|Overall Study|Admission to hospice|1|||
148943674|NCT00915278|537278089|FG003|Overall Study|Admission to hospice|0|||
148943675|NCT00915278|537278090|FG004|Overall Study|Admission to hospice|0|||
148943676|NCT00915278|537278091|FG005|Overall Study|Admission to hospice|0|||
149201418|NCT04019795|538204013|FG001|Overall Study|Withdrawal by Subject|2|||
149201419|NCT04019795|538204014|FG002|Overall Study|Withdrawal by Subject|2|||
149201420|NCT04019795|538204015|FG003|Overall Study|Withdrawal by Subject|1|||
148943677|NCT00674362|537278095|FG000|Double Blind|Adverse Event|6|||
148943678|NCT00674362|537278096|FG001|Double Blind|Adverse Event|6|||
148943679|NCT00674362|537278095|FG000|Double Blind|Lack of Efficacy|2|||
148943680|NCT00674362|537278096|FG001|Double Blind|Lack of Efficacy|6|||
148943681|NCT00674362|537278095|FG000|Double Blind|Loss of efficacy|0|||
148943682|NCT00674362|537278096|FG001|Double Blind|Loss of efficacy|1|||
148943683|NCT00674362|537278095|FG000|Double Blind|Withdrawal by Subject|4|||
148943684|NCT00674362|537278096|FG001|Double Blind|Withdrawal by Subject|3|||
148943685|NCT00674362|537278095|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
148943686|NCT00674362|537278096|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
148943687|NCT00674362|537278095|FG000|Double Blind|Other: Surgery|0|||
148943688|NCT00674362|537278096|FG001|Double Blind|Other: Surgery|1|||
148943689|NCT00674362|537278095|FG000|Open Label|Adverse Event|1|||
148943690|NCT00674362|537278096|FG001|Open Label|Adverse Event|0|||
148943691|NCT00674362|537278095|FG000|Open Label|Other: Subject moved to extension study|1|||
148943692|NCT00674362|537278096|FG001|Open Label|Other: Subject moved to extension study|0|||
148943693|NCT00923156|537278099|FG000|Overall Study|Adverse Event|0|||
148943694|NCT00923156|537278100|FG001|Overall Study|Adverse Event|2|||
148943695|NCT00923156|537278101|FG002|Overall Study|Adverse Event|1|||
148943696|NCT00923156|537278099|FG000|Overall Study|Abnormal laboratory values|0|||
148943697|NCT00923156|537278100|FG001|Overall Study|Abnormal laboratory values|0|||
148943698|NCT00923156|537278101|FG002|Overall Study|Abnormal laboratory values|1|||
148943699|NCT00923156|537278099|FG000|Overall Study|Withdrawal by Subject|0|||
148943700|NCT00923156|537278100|FG001|Overall Study|Withdrawal by Subject|1|||
148943701|NCT00923156|537278101|FG002|Overall Study|Withdrawal by Subject|0|||
148943702|NCT00923156|537278099|FG000|Overall Study|Death|0|||
148943703|NCT00923156|537278100|FG001|Overall Study|Death|1|||
148943704|NCT00923156|537278101|FG002|Overall Study|Death|0|||
148943705|NCT00923156|537278099|FG000|Overall Study|Lack of Efficacy|0|||
148943706|NCT00923156|537278100|FG001|Overall Study|Lack of Efficacy|0|||
148943707|NCT00923156|537278101|FG002|Overall Study|Lack of Efficacy|1|||
148943708|NCT01201850|537278104|FG000|Overall Study|Tumor progression|4|||
148943709|NCT03137537|537278105|FG000|Overall Study|Adverse Event|0|||
148943710|NCT03137537|537278106|FG001|Overall Study|Adverse Event|1|||
148943711|NCT04066023|537278107|FG000|Overall Study|Adverse Event|0|||
148943712|NCT04066023|537278108|FG001|Overall Study|Adverse Event|0|||
148943713|NCT04066023|537278109|FG002|Overall Study|Adverse Event|1|||
148943714|NCT04066023|537278107|FG000|Overall Study|Sponsor decision|3|||
148943715|NCT04066023|537278108|FG001|Overall Study|Sponsor decision|6|||
148943716|NCT04066023|537278109|FG002|Overall Study|Sponsor decision|2|||
148943717|NCT04066023|537278107|FG000|Overall Study|Physician Decision|0|||
148943718|NCT04066023|537278108|FG001|Overall Study|Physician Decision|0|||
148943719|NCT04066023|537278109|FG002|Overall Study|Physician Decision|1|||
148943720|NCT04066023|537278107|FG000|Overall Study|Lost to Follow-up|0|||
148943721|NCT04066023|537278108|FG001|Overall Study|Lost to Follow-up|1|||
148943722|NCT04066023|537278109|FG002|Overall Study|Lost to Follow-up|1|||
149201421|NCT04019795|538204012|FG000|Overall Study|Lost to Follow-up|0|||
149201422|NCT04019795|538204013|FG001|Overall Study|Lost to Follow-up|1|||
149201423|NCT04019795|538204014|FG002|Overall Study|Lost to Follow-up|1|||
149201424|NCT04019795|538204015|FG003|Overall Study|Lost to Follow-up|2|||
149201425|NCT04019795|538204012|FG000|Overall Study|Treatment non-compliance|3|||
149201426|NCT04019795|538204013|FG001|Overall Study|Treatment non-compliance|1|||
149201427|NCT04019795|538204014|FG002|Overall Study|Treatment non-compliance|2|||
149201428|NCT04019795|538204015|FG003|Overall Study|Treatment non-compliance|0|||
149201429|NCT04019795|538204012|FG000|Overall Study|Physician Decision|0|||
149201430|NCT04019795|538204013|FG001|Overall Study|Physician Decision|0|||
149201431|NCT04019795|538204014|FG002|Overall Study|Physician Decision|1|||
149201432|NCT04019795|538204015|FG003|Overall Study|Physician Decision|0|||
149201433|NCT04019795|538204012|FG000|Overall Study|Adverse Event|1|||
149201434|NCT04019795|538204013|FG001|Overall Study|Adverse Event|0|||
149201435|NCT04019795|538204014|FG002|Overall Study|Adverse Event|0|||
149201436|NCT04019795|538204015|FG003|Overall Study|Adverse Event|0|||
149201437|NCT02310906|538204016|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
148943723|NCT04066023|537278107|FG000|Overall Study|Noncompliance|0|||
148943724|NCT04066023|537278108|FG001|Overall Study|Noncompliance|1|||
148943725|NCT04066023|537278109|FG002|Overall Study|Noncompliance|1|||
148943726|NCT04665856|537278110|FG000|Overall Study|Site Terminated by Sponsor|1|||
148943727|NCT04665856|537278111|FG001|Overall Study|Site Terminated by Sponsor|0|||
148943728|NCT04665856|537278110|FG000|Overall Study|Withdrawal by Subject|2|||
148943729|NCT04665856|537278111|FG001|Overall Study|Withdrawal by Subject|0|||
148943730|NCT04665856|537278110|FG000|Overall Study|Lost to Follow-up|3|||
148943731|NCT04665856|537278111|FG001|Overall Study|Lost to Follow-up|2|||
148943732|NCT04665856|537278110|FG000|Overall Study|Death|39|||
148943733|NCT04665856|537278111|FG001|Overall Study|Death|44|||
148943734|NCT04665856|537278110|FG000|Overall Study|Ongoing in study|17|||
148943735|NCT04665856|537278111|FG001|Overall Study|Ongoing in study|15|||
149201438|NCT02310906|538204017|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
149201439|NCT02310906|538204018|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
148943736|NCT01552694|537278112|FG000|Overall Study|Lost to Follow-up|0|||
148943737|NCT01552694|537278113|FG001|Overall Study|Lost to Follow-up|1|||
148943738|NCT01552694|537278112|FG000|Overall Study|Protocol Violation|0|||
148943739|NCT01552694|537278113|FG001|Overall Study|Protocol Violation|1|||
148943740|NCT00191139|537278114|FG000|Overall Study|Adverse Event|2|||
148943741|NCT00191139|537278115|FG001|Overall Study|Adverse Event|6|||
148943742|NCT00191139|537278114|FG000|Overall Study|Death|2|||
149201440|NCT02310906|538204019|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
149201441|NCT02310906|538204016|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
149201442|NCT02310906|538204017|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
149201443|NCT02310906|538204018|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
149201444|NCT02310906|538204019|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
149201445|NCT02310906|538204016|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
149201446|NCT02310906|538204017|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
149201447|NCT02310906|538204018|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
149201448|NCT02310906|538204019|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
149201449|NCT02310906|538204016|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
149201450|NCT02310906|538204017|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
149201451|NCT02310906|538204018|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
149201452|NCT02310906|538204019|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
149201453|NCT00433446|538204020|FG000|Overall Study|Adverse Event|4|||
149201454|NCT00433446|538204020|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
149201455|NCT00433446|538204020|FG000|Overall Study|Progression|44|||
149201456|NCT00433446|538204020|FG000|Overall Study|Other - Not Protocol specified|3|||
149201457|NCT00433446|538204020|FG000|Overall Study|Ineligible|9|||
149201458|NCT01188538|538204021|FG000|Overall Study|Lost to Follow-up|0|||
149201459|NCT01188538|538204022|FG001|Overall Study|Lost to Follow-up|1|||
149201460|NCT00098020|538204028|FG000|Overall Study|Adverse Event|2|||
149201461|NCT00098020|538204028|FG000|Overall Study|Lost to Follow-up|1|||
149201462|NCT00098020|538204028|FG000|Overall Study|elevated liver enzymes|1|||
149201463|NCT00098020|538204028|FG000|Overall Study|Low urine PCR|1|||
149201464|NCT00098020|538204028|FG000|Overall Study|Low epidermal growth factor receptor|1|||
149201465|NCT03495453|538204031|FG000|Overall Study|Withdrawal by Subject|0|||
149201466|NCT03495453|538204032|FG001|Overall Study|Withdrawal by Subject|1|||
149201467|NCT00712933|538204033|FG000|Overall Study|Adverse Event|69|||
149201468|NCT00712933|538204033|FG000|Overall Study|Lack of Efficacy|6|||
149201469|NCT00712933|538204033|FG000|Overall Study|Lost to Follow-up|22|||
149201470|NCT00712933|538204033|FG000|Overall Study|Non-compliance with study drug|13|||
149201471|NCT00712933|538204033|FG000|Overall Study|Other Pregnancy|37|||
149201472|NCT00712933|538204033|FG000|Overall Study|Sponsor decision|14|||
149201473|NCT00712933|538204033|FG000|Overall Study|Withdrew consent|4|||
149201474|NCT00712933|538204033|FG000|Overall Study|Hip replacement surgery|1|||
149201475|NCT00712933|538204033|FG000|Overall Study|Involved in Clinical research|3|||
149201476|NCT00712933|538204033|FG000|Overall Study|Participant hospitalized|1|||
149201477|NCT00712933|538204033|FG000|Overall Study|Participant travelled overseas|2|||
149201478|NCT00712933|538204033|FG000|Overall Study|Death of patient|1|||
149201479|NCT00712933|538204033|FG000|Overall Study|Other Physician decision|1|||
149201480|NCT00712933|538204033|FG000|Overall Study|Not committed to contraception|1|||
149201481|NCT00712933|538204033|FG000|Overall Study|Participant received medication|1|||
149201482|NCT00712933|538204033|FG000|Overall Study|Physician Decision|36|||
149201483|NCT00712933|538204033|FG000|Overall Study|Protocol Violation|4|||
149201484|NCT00712933|538204033|FG000|Overall Study|Withdrawal by Subject|151|||
149201485|NCT00065442|538204051|FG000|Overall Study|Lost to Follow-up|1|||
148943743|NCT00191139|537278115|FG001|Overall Study|Death|0|||
148943744|NCT00191139|537278114|FG000|Overall Study|Withdrawal by Subject|0|||
148943745|NCT00191139|537278115|FG001|Overall Study|Withdrawal by Subject|3|||
149201486|NCT00065442|538204052|FG001|Overall Study|Lost to Follow-up|1|||
149201487|NCT00065442|538204051|FG000|Overall Study|Death|121|||
148943746|NCT00191139|537278114|FG000|Overall Study|Disease Progression|0|||
148943747|NCT00191139|537278115|FG001|Overall Study|Disease Progression|1|||
148943748|NCT00191139|537278114|FG000|Overall Study|Other|1|||
148943749|NCT00191139|537278115|FG001|Overall Study|Other|2|||
148943750|NCT03386448|537278117|FG000|Overall Study|Adverse Event|0|||
148943751|NCT03386448|537278118|FG001|Overall Study|Adverse Event|2|||
148943752|NCT03338010|537278119|FG000|Overall Study|Withdrawal by Subject|14|||
149201488|NCT00065442|538204052|FG001|Overall Study|Death|210|||
149201489|NCT00065442|538204051|FG000|Overall Study|Withdrawal by Subject|3|||
149201490|NCT00065442|538204052|FG001|Overall Study|Withdrawal by Subject|9|||
149201491|NCT01797965|538204053|FG000|Overall Study|Adverse Event|104|||
148943753|NCT03338010|537278120|FG001|Overall Study|Withdrawal by Subject|8|||
148943754|NCT03338010|537278119|FG000|Overall Study|Lost to Follow-up|4|||
148943755|NCT03338010|537278120|FG001|Overall Study|Lost to Follow-up|2|||
148943756|NCT03338010|537278119|FG000|Overall Study|Adverse Event|3|||
148943757|NCT03338010|537278120|FG001|Overall Study|Adverse Event|2|||
148943758|NCT03338010|537278119|FG000|Overall Study|Physician Decision|2|||
148943759|NCT03338010|537278120|FG001|Overall Study|Physician Decision|2|||
148943760|NCT03338010|537278119|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148943761|NCT03338010|537278120|FG001|Overall Study|Non-Compliance with Study Drug|3|||
148943762|NCT03338010|537278119|FG000|Overall Study|Protocol Violation|0|||
148943763|NCT03338010|537278120|FG001|Overall Study|Protocol Violation|1|||
148943764|NCT02465515|537278123|FG000|Overall Study|Investigator site closed|4|||
148943765|NCT02465515|537278124|FG001|Overall Study|Investigator site closed|5|||
148943766|NCT02465515|537278123|FG000|Overall Study|Withdrawal by Subject|74|||
148943767|NCT02465515|537278124|FG001|Overall Study|Withdrawal by Subject|43|||
148943768|NCT02465515|537278123|FG000|Overall Study|Physician Decision|8|||
148943769|NCT02465515|537278124|FG001|Overall Study|Physician Decision|12|||
148943770|NCT02465515|537278123|FG000|Overall Study|Lost to Follow-up|68|||
148943771|NCT02465515|537278124|FG001|Overall Study|Lost to Follow-up|51|||
148943772|NCT02564796|537278125|FG000|Overall Study|Physician Decision|2|||
148943773|NCT02564796|537278126|FG001|Overall Study|Physician Decision|2|||
148943774|NCT00293033|537278127|FG000|Open-label Titration Period|Adverse Event|10|||
148943775|NCT00293033|537278127|FG000|Open-label Titration Period|Death|3|||
148943776|NCT00293033|537278127|FG000|Open-label Titration Period|Lack of Efficacy|5|||
148943777|NCT00293033|537278127|FG000|Open-label Titration Period|Protocol Violation|2|||
148943778|NCT00293033|537278127|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
148943779|NCT00293033|537278127|FG000|Open-label Titration Period|Noncompliance and other|27|||
148943780|NCT00293033|537278127|FG000|Double-blind Treatment Period|Adverse Event|3|||
148943781|NCT00293033|537278127|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
148943782|NCT00293033|537278127|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
148943783|NCT00293033|537278127|FG000|Double-blind Treatment Period|Noncompliance|4|||
148943784|NCT00816595|537278128|FG000|Overall Study|Withdrawal by Subject|2|||
148943785|NCT00816595|537278129|FG001|Overall Study|Withdrawal by Subject|0|||
148943786|NCT03583697|537278130|FG000|Overall Study|Withdrawal by Subject|0|||
148943787|NCT03583697|537278131|FG001|Overall Study|Withdrawal by Subject|0|||
148943788|NCT03583697|537278132|FG002|Overall Study|Withdrawal by Subject|1|||
148943789|NCT03583697|537278130|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
148943790|NCT03583697|537278131|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
148943791|NCT03583697|537278132|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
148943792|NCT00453063|537278133|FG000|Overall Study|Adverse Event|1|||
148943793|NCT00453063|537278134|FG001|Overall Study|Adverse Event|2|||
148943794|NCT00453063|537278133|FG000|Overall Study|Withdrawal by Subject|1|||
148943795|NCT00453063|537278134|FG001|Overall Study|Withdrawal by Subject|1|||
148943796|NCT00453063|537278133|FG000|Overall Study|Protocol Violation|1|||
148943797|NCT00453063|537278134|FG001|Overall Study|Protocol Violation|0|||
148943798|NCT00114530|537278135|FG000|Overall Study|Death|3|||
148943799|NCT00114530|537278136|FG001|Overall Study|Death|11|||
148943800|NCT00114530|537278135|FG000|Overall Study|Lost to Follow-up|1|||
148943801|NCT00114530|537278136|FG001|Overall Study|Lost to Follow-up|1|||
149201492|NCT01797965|538204054|FG001|Overall Study|Adverse Event|129|||
149201493|NCT01797965|538204055|FG002|Overall Study|Adverse Event|4|||
149201494|NCT01797965|538204056|FG003|Overall Study|Adverse Event|21|||
149201495|NCT01797965|538204053|FG000|Overall Study|Lost to Follow-up|9|||
149201496|NCT01797965|538204054|FG001|Overall Study|Lost to Follow-up|8|||
149201497|NCT01797965|538204055|FG002|Overall Study|Lost to Follow-up|1|||
149201498|NCT01797965|538204056|FG003|Overall Study|Lost to Follow-up|2|||
148943802|NCT00114530|537278135|FG000|Overall Study|Physician Decision|1|||
149201499|NCT01797965|538204053|FG000|Overall Study|Consent withdrawn|130|||
148943803|NCT00114530|537278136|FG001|Overall Study|Physician Decision|1|||
148943804|NCT00114530|537278135|FG000|Overall Study|Withdrawal by Subject|2|||
148943805|NCT00114530|537278136|FG001|Overall Study|Withdrawal by Subject|6|||
148943806|NCT00114530|537278135|FG000|Overall Study|Breast Cancer|1|||
148943807|NCT00114530|537278136|FG001|Overall Study|Breast Cancer|0|||
148943808|NCT00114530|537278135|FG000|Overall Study|Subject decision after endpoint failure|0|||
149201500|NCT01797965|538204054|FG001|Overall Study|Consent withdrawn|117|||
149201501|NCT01797965|538204055|FG002|Overall Study|Consent withdrawn|3|||
148943809|NCT00114530|537278136|FG001|Overall Study|Subject decision after endpoint failure|1|||
149201502|NCT01797965|538204056|FG003|Overall Study|Consent withdrawn|35|||
149201503|NCT01797965|538204053|FG000|Overall Study|Investigator decision|21|||
149201504|NCT01797965|538204054|FG001|Overall Study|Investigator decision|15|||
149201505|NCT01797965|538204055|FG002|Overall Study|Investigator decision|0|||
149201506|NCT01797965|538204056|FG003|Overall Study|Investigator decision|0|||
148943810|NCT00114530|537278135|FG000|Overall Study|Ineligible|1|||
148943811|NCT00114530|537278136|FG001|Overall Study|Ineligible|0|||
148943812|NCT00751933|537278140|FG000|Overall Study|Withdrawal by Subject|0|||
148943813|NCT00751933|537278141|FG001|Overall Study|Withdrawal by Subject|1|||
148943814|NCT00751933|537278142|FG002|Overall Study|Withdrawal by Subject|0|||
148943815|NCT00751933|537278143|FG003|Overall Study|Withdrawal by Subject|0|||
148943816|NCT00751933|537278140|FG000|Overall Study|Physician Decision|0|||
148943817|NCT00751933|537278141|FG001|Overall Study|Physician Decision|0|||
148943818|NCT00751933|537278142|FG002|Overall Study|Physician Decision|1|||
148943819|NCT00751933|537278143|FG003|Overall Study|Physician Decision|1|||
148943820|NCT01558271|537278146|FG000|Overall Study|Adverse Event|6|||
148943821|NCT01558271|537278147|FG001|Overall Study|Adverse Event|3|||
148943822|NCT01558271|537278148|FG002|Overall Study|Adverse Event|4|||
148943823|NCT01558271|537278146|FG000|Overall Study|Lost to Follow-up|1|||
148943824|NCT01558271|537278147|FG001|Overall Study|Lost to Follow-up|0|||
148943825|NCT01558271|537278148|FG002|Overall Study|Lost to Follow-up|0|||
148943826|NCT01558271|537278146|FG000|Overall Study|Protocol Violation|1|||
148943827|NCT01558271|537278147|FG001|Overall Study|Protocol Violation|0|||
148943828|NCT01558271|537278148|FG002|Overall Study|Protocol Violation|0|||
148943829|NCT01558271|537278146|FG000|Overall Study|Withdrawal by Subject|10|||
148943830|NCT01558271|537278147|FG001|Overall Study|Withdrawal by Subject|6|||
148943831|NCT01558271|537278148|FG002|Overall Study|Withdrawal by Subject|12|||
148943832|NCT01558271|537278146|FG000|Overall Study|Physician Decision|0|||
148943833|NCT01558271|537278147|FG001|Overall Study|Physician Decision|2|||
148943834|NCT01558271|537278148|FG002|Overall Study|Physician Decision|1|||
148943835|NCT01980940|537278151|FG000|Overall Study|Protocol Violation|0|||
148943836|NCT01980940|537278152|FG001|Overall Study|Protocol Violation|0|||
148943837|NCT01980940|537278153|FG002|Overall Study|Protocol Violation|0|||
148943838|NCT01980940|537278154|FG003|Overall Study|Protocol Violation|0|||
148943839|NCT01980940|537278155|FG004|Overall Study|Protocol Violation|0|||
148943840|NCT01980940|537278156|FG005|Overall Study|Protocol Violation|2|||
148943841|NCT01980940|537278157|FG006|Overall Study|Protocol Violation|0|||
148943842|NCT01980940|537278158|FG007|Overall Study|Protocol Violation|0|||
148943843|NCT05358444|537278160|FG000|Overall Study|Withdrawal by Subject|0|||
148943844|NCT05358444|537278161|FG001|Overall Study|Withdrawal by Subject|1|||
148943845|NCT05358444|537278160|FG000|Overall Study|Lost to Follow-up|0|||
148943846|NCT05358444|537278161|FG001|Overall Study|Lost to Follow-up|3|||
148943847|NCT05372419|537278165|FG000|Overall Study|Protocol Deviation|1|||
148943848|NCT05372419|537278165|FG000|Overall Study|Withdrawal by Subject|5|||
148943849|NCT05372419|537278165|FG000|Overall Study|Lost to Follow-up|7|||
148943850|NCT03000439|537280186|FG000|Open Label Part 1|Adverse Event|6|||
148943851|NCT03000439|537280187|FG001|Open Label Part 1|Adverse Event|0|||
148943852|NCT03000439|537280188|FG002|Open Label Part 1|Adverse Event|0|||
148943853|NCT03000439|537280189|FG003|Open Label Part 1|Adverse Event|0|||
148943854|NCT03000439|537280186|FG000|Open Label Part 1|Other|2|||
148943855|NCT03000439|537280187|FG001|Open Label Part 1|Other|0|||
148943856|NCT03000439|537280188|FG002|Open Label Part 1|Other|0|||
148943857|NCT03000439|537280189|FG003|Open Label Part 1|Other|0|||
148943858|NCT03000439|537280186|FG000|Open Label Part 1|Insufficient clinical response|16|||
148943859|NCT03000439|537280187|FG001|Open Label Part 1|Insufficient clinical response|0|||
148943860|NCT03000439|537280188|FG002|Open Label Part 1|Insufficient clinical response|0|||
148943861|NCT03000439|537280189|FG003|Open Label Part 1|Insufficient clinical response|0|||
148943862|NCT03000439|537280186|FG000|Open Label Part 2|Other|0|||
148943863|NCT03000439|537280187|FG001|Open Label Part 2|Other|5|||
148943864|NCT03000439|537280188|FG002|Open Label Part 2|Other|0|||
148943865|NCT03000439|537280189|FG003|Open Label Part 2|Other|0|||
148943866|NCT03000439|537280186|FG000|Open Label Part 2|Insufficient clinical response|0|||
148943867|NCT03000439|537280187|FG001|Open Label Part 2|Insufficient clinical response|12|||
148943868|NCT03000439|537280188|FG002|Open Label Part 2|Insufficient clinical response|0|||
148943869|NCT03000439|537280189|FG003|Open Label Part 2|Insufficient clinical response|0|||
148943870|NCT03000439|537280186|FG000|Double Blind Phase|Adverse Event|0|||
148943871|NCT03000439|537280187|FG001|Double Blind Phase|Adverse Event|0|||
148943872|NCT03000439|537280188|FG002|Double Blind Phase|Adverse Event|2|||
148943873|NCT03000439|537280189|FG003|Double Blind Phase|Adverse Event|1|||
148943874|NCT03000439|537280186|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
148943875|NCT03000439|537280187|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
148943876|NCT03000439|537280188|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
148943877|NCT03000439|537280189|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
148943878|NCT03000439|537280186|FG000|Double Blind Phase|Other|0|||
148943879|NCT03000439|537280187|FG001|Double Blind Phase|Other|0|||
149201507|NCT01797965|538204053|FG000|Overall Study|Death|2|||
149201508|NCT01797965|538204054|FG001|Overall Study|Death|4|||
149201509|NCT01797965|538204055|FG002|Overall Study|Death|0|||
148943880|NCT03000439|537280188|FG002|Double Blind Phase|Other|10|||
148943881|NCT03000439|537280189|FG003|Double Blind Phase|Other|11|||
148943882|NCT03000439|537280186|FG000|Double Blind Phase|Insufficient clinical response|0|||
148943883|NCT03000439|537280187|FG001|Double Blind Phase|Insufficient clinical response|0|||
148943884|NCT03000439|537280188|FG002|Double Blind Phase|Insufficient clinical response|0|||
148943885|NCT03000439|537280189|FG003|Double Blind Phase|Insufficient clinical response|2|||
148943886|NCT02370160|537280190|FG000|Overall Study|Death|3|||
148943887|NCT02370160|537280191|FG001|Overall Study|Death|4|||
148943888|NCT02370160|537280192|FG002|Overall Study|Death|1|||
148943889|NCT01581931|537280199|FG000|Washout|Adverse Event|0|||
148943890|NCT01581931|537280200|FG001|Washout|Adverse Event|1|||
148943891|NCT01473836|537280203|FG000|Overall Study|Adverse Event|4|||
148943892|NCT01473836|537280203|FG000|Overall Study|Lack of Efficacy|1|||
148943893|NCT01473836|537280203|FG000|Overall Study|Does not meet entrance criteria|1|||
148943894|NCT02954237|537280209|FG000|Overall Study|Withdrawal by Subject|25|||
148943895|NCT02954237|537280209|FG000|Overall Study|Missed visit|16|||
148943896|NCT02954237|537280209|FG000|Overall Study|Death|2|||
148943897|NCT00599924|537280211|FG000|Overall Study|Lack of Efficacy|3|||
148943898|NCT00599924|537280212|FG001|Overall Study|Lack of Efficacy|5|||
148943899|NCT00599924|537280213|FG002|Overall Study|Lack of Efficacy|1|||
148943900|NCT00599924|537280214|FG003|Overall Study|Lack of Efficacy|2|||
148943901|NCT00599924|537280215|FG004|Overall Study|Lack of Efficacy|3|||
148943902|NCT00599924|537280216|FG005|Overall Study|Lack of Efficacy|2|||
148943903|NCT00599924|537280217|FG006|Overall Study|Lack of Efficacy|0|||
148943904|NCT00599924|537280211|FG000|Overall Study|Adverse Event|0|||
148943905|NCT00599924|537280212|FG001|Overall Study|Adverse Event|0|||
148943906|NCT00599924|537280213|FG002|Overall Study|Adverse Event|0|||
148943907|NCT00599924|537280214|FG003|Overall Study|Adverse Event|2|||
148943908|NCT00599924|537280215|FG004|Overall Study|Adverse Event|0|||
148943909|NCT00599924|537280216|FG005|Overall Study|Adverse Event|0|||
148943910|NCT00599924|537280217|FG006|Overall Study|Adverse Event|2|||
148943911|NCT00599924|537280211|FG000|Overall Study|Death|0|||
148943912|NCT00599924|537280212|FG001|Overall Study|Death|0|||
148943913|NCT00599924|537280213|FG002|Overall Study|Death|0|||
148943914|NCT00599924|537280214|FG003|Overall Study|Death|2|||
148943915|NCT00599924|537280215|FG004|Overall Study|Death|0|||
148943916|NCT00599924|537280216|FG005|Overall Study|Death|2|||
148943917|NCT00599924|537280217|FG006|Overall Study|Death|1|||
148943918|NCT00599924|537280211|FG000|Overall Study|Protocol Violation|0|||
148943919|NCT00599924|537280212|FG001|Overall Study|Protocol Violation|0|||
148943920|NCT00599924|537280213|FG002|Overall Study|Protocol Violation|0|||
148943921|NCT00599924|537280214|FG003|Overall Study|Protocol Violation|1|||
148943922|NCT00599924|537280215|FG004|Overall Study|Protocol Violation|0|||
148943923|NCT00599924|537280216|FG005|Overall Study|Protocol Violation|0|||
148943924|NCT00599924|537280217|FG006|Overall Study|Protocol Violation|0|||
148943925|NCT00599924|537280211|FG000|Overall Study|Withdrawal by Subject|0|||
148943926|NCT00599924|537280212|FG001|Overall Study|Withdrawal by Subject|0|||
148943927|NCT00599924|537280213|FG002|Overall Study|Withdrawal by Subject|1|||
148943928|NCT00599924|537280214|FG003|Overall Study|Withdrawal by Subject|0|||
148943929|NCT00599924|537280215|FG004|Overall Study|Withdrawal by Subject|1|||
148943930|NCT00599924|537280216|FG005|Overall Study|Withdrawal by Subject|0|||
148943931|NCT00599924|537280217|FG006|Overall Study|Withdrawal by Subject|0|||
148943932|NCT00599924|537280211|FG000|Overall Study|Other|0|||
148943933|NCT00599924|537280212|FG001|Overall Study|Other|0|||
148943934|NCT00599924|537280213|FG002|Overall Study|Other|0|||
148943935|NCT00599924|537280214|FG003|Overall Study|Other|1|||
148943936|NCT00599924|537280215|FG004|Overall Study|Other|2|||
148943937|NCT00599924|537280216|FG005|Overall Study|Other|0|||
148943938|NCT00599924|537280217|FG006|Overall Study|Other|2|||
148943939|NCT01806298|537280218|FG000|Overall Study|Adverse Event|3|||
148943940|NCT01806298|537280218|FG000|Overall Study|Protocol Non-compliance|1|||
148943941|NCT01806298|537280218|FG000|Overall Study|Withdrawal by Subject|1|||
148943942|NCT01806298|537280218|FG000|Overall Study|Other|5|||
148943943|NCT00980057|537280223|FG000|Overall Study|Death|13|||
148943944|NCT00980057|537280224|FG001|Overall Study|Death|3|||
148943945|NCT00980057|537280223|FG000|Overall Study|Adverse Event|0|||
148943946|NCT00980057|537280224|FG001|Overall Study|Adverse Event|1|||
148943947|NCT00980057|537280223|FG000|Overall Study|Physician Decision|4|||
148943948|NCT00980057|537280224|FG001|Overall Study|Physician Decision|0|||
148943949|NCT00980057|537280223|FG000|Overall Study|Lost to Follow-up|1|||
148943950|NCT00980057|537280224|FG001|Overall Study|Lost to Follow-up|0|||
148943951|NCT00980057|537280223|FG000|Overall Study|Withdrawal by Subject|1|||
148943952|NCT00980057|537280224|FG001|Overall Study|Withdrawal by Subject|1|||
148943953|NCT04980040|537280225|FG000|Overall Study|Violated the Inclusion Criteria|260|||
148943954|NCT04980040|537280225|FG000|Overall Study|Violated the Administration & Dosage|225|||
148943955|NCT04980040|537280225|FG000|Overall Study|Lost to Safety-Follow-up|4|||
148943956|NCT04980040|537280225|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
148943957|NCT00691015|537280229|FG000|Overall Study|Refused further treatment|1|||
148956492|NCT01949051|537324447|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
148956493|NCT01949051|537324442|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
148943958|NCT04160195|537280232|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
148943959|NCT04160195|537280233|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
148943960|NCT00592384|537280236|FG000|Overall Study|Withdrawal by Subject|5|||
148943961|NCT00592384|537280237|FG001|Overall Study|Withdrawal by Subject|6|||
148943962|NCT02499783|537280238|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
148943963|NCT02499783|537280239|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
148943964|NCT02499783|537280240|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
148943965|NCT02499783|537280238|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
148943966|NCT02499783|537280239|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
148943967|NCT02499783|537280240|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
148943968|NCT02499783|537280238|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
148943969|NCT02499783|537280239|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
148943970|NCT02499783|537280240|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
148943971|NCT02499783|537280238|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
148943972|NCT02499783|537280239|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
148943973|NCT02499783|537280240|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
148943974|NCT02499783|537280238|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
148943975|NCT02499783|537280239|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
148943976|NCT02499783|537280240|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
148943977|NCT02499783|537280238|FG000|DB Period: Weeks 0-8|Other|1|||
148943978|NCT02499783|537280239|FG001|DB Period: Weeks 0-8|Other|1|||
148943979|NCT02499783|537280240|FG002|DB Period: Weeks 0-8|Other|0|||
148943980|NCT02499783|537280238|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
148943981|NCT02499783|537280239|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
148943982|NCT02499783|537280240|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
148943983|NCT02499783|537280238|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
148943984|NCT02499783|537280239|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
148943985|NCT02499783|537280240|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
148943986|NCT02499783|537280238|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
148943987|NCT02499783|537280239|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
148943988|NCT02499783|537280240|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
148943989|NCT02499783|537280238|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
148943990|NCT02499783|537280239|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
148943991|NCT02499783|537280240|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
148943992|NCT02228460|537280241|FG000|Overall Study|Adverse Event|1|||
148943993|NCT02228460|537280241|FG000|Overall Study|Lost to Follow-up|1|||
148943994|NCT01243892|537280242|FG000|Overall Study|Did not meet eligibility criteria|2|||
148943995|NCT01243892|537280243|FG001|Overall Study|Did not meet eligibility criteria|0|||
148943996|NCT01866293|537280248|FG000|Overall Study|Adverse Event|2|||
148943997|NCT03066804|537280249|FG000|Overall Study|Physician Decision|0|||
148943998|NCT03066804|537280250|FG001|Overall Study|Physician Decision|4|||
148943999|NCT03066804|537280249|FG000|Overall Study|Death|23|||
148944000|NCT03066804|537280250|FG001|Overall Study|Death|17|||
148944001|NCT03066804|537280249|FG000|Overall Study|Withdrawal by Subject|19|||
148944002|NCT03066804|537280250|FG001|Overall Study|Withdrawal by Subject|25|||
148944003|NCT03066804|537280249|FG000|Overall Study|Lost to Follow-up|2|||
148944004|NCT03066804|537280250|FG001|Overall Study|Lost to Follow-up|0|||
148944005|NCT03066804|537280249|FG000|Overall Study|Adverse Event|2|||
148944006|NCT03066804|537280250|FG001|Overall Study|Adverse Event|3|||
148944007|NCT03066804|537280249|FG000|Overall Study|Technical problems|5|||
148944008|NCT03066804|537280250|FG001|Overall Study|Technical problems|1|||
148944009|NCT00555971|537280252|FG000|Overall Study|Adverse Event|1|||
148944010|NCT00555971|537280253|FG001|Overall Study|Adverse Event|1|||
148944011|NCT03982368|537280254|FG000|Overall Study|Adverse Event|6|||
148944012|NCT03982368|537280255|FG001|Overall Study|Adverse Event|4|||
148944013|NCT03982368|537280256|FG002|Overall Study|Adverse Event|3|||
148944014|NCT03982368|537280254|FG000|Overall Study|Lost to Follow-up|2|||
148944015|NCT03982368|537280255|FG001|Overall Study|Lost to Follow-up|1|||
148944016|NCT03982368|537280256|FG002|Overall Study|Lost to Follow-up|0|||
148944017|NCT03982368|537280254|FG000|Overall Study|Withdrawal by Subject|1|||
148944018|NCT03982368|537280255|FG001|Overall Study|Withdrawal by Subject|2|||
148944019|NCT03982368|537280256|FG002|Overall Study|Withdrawal by Subject|0|||
148944020|NCT03982368|537280254|FG000|Overall Study|unknow|4|||
148944021|NCT03982368|537280255|FG001|Overall Study|unknow|0|||
148944022|NCT03982368|537280256|FG002|Overall Study|unknow|2|||
148944023|NCT00518284|537280257|FG000|Overall Study|Adverse Event|0|||
148944024|NCT00518284|537280258|FG001|Overall Study|Adverse Event|1|||
148944025|NCT00518284|537280259|FG002|Overall Study|Adverse Event|0|||
148944026|NCT00518284|537280260|FG003|Overall Study|Adverse Event|0|||
148944027|NCT00518284|537280257|FG000|Overall Study|Study Termination|0|||
148944028|NCT00518284|537280258|FG001|Overall Study|Study Termination|2|||
148944029|NCT00518284|537280259|FG002|Overall Study|Study Termination|1|||
148944030|NCT00518284|537280260|FG003|Overall Study|Study Termination|2|||
148944031|NCT03768414|537280261|FG000|Overall Study|Adverse Event or side effects|72|||
148944032|NCT03768414|537280262|FG001|Overall Study|Adverse Event or side effects|28|||
148944033|NCT03768414|537280261|FG000|Overall Study|Refusal unrelated to adverse event|33|||
148944034|NCT03768414|537280262|FG001|Overall Study|Refusal unrelated to adverse event|33|||
148944035|NCT03768414|537280261|FG000|Overall Study|Progression/relapse|132|||
148944036|NCT03768414|537280262|FG001|Overall Study|Progression/relapse|60|||
148944037|NCT03768414|537280261|FG000|Overall Study|Death|9|||
148944038|NCT03768414|537280262|FG001|Overall Study|Death|6|||
148944039|NCT03768414|537280261|FG000|Overall Study|Other - not protocol specified|45|||
148944040|NCT03768414|537280262|FG001|Overall Study|Other - not protocol specified|18|||
148944041|NCT03768414|537280261|FG000|Overall Study|Reason under review|3|||
148944042|NCT03768414|537280262|FG001|Overall Study|Reason under review|2|||
148944043|NCT02571777|537280264|FG000|Overall Study|Subject/guardian decision|34|||
148944044|NCT02571777|537280265|FG001|Overall Study|Subject/guardian decision|26|||
148944045|NCT02571777|537280266|FG002|Overall Study|Subject/guardian decision|26|||
148944046|NCT02571777|537280267|FG003|Overall Study|Subject/guardian decision|25|||
148944047|NCT02571777|537280268|FG004|Overall Study|Subject/guardian decision|27|||
148944048|NCT02571777|537280264|FG000|Overall Study|Protocol Deviation|2|||
148944049|NCT02571777|537280265|FG001|Overall Study|Protocol Deviation|3|||
148944050|NCT02571777|537280266|FG002|Overall Study|Protocol Deviation|4|||
148944051|NCT02571777|537280267|FG003|Overall Study|Protocol Deviation|8|||
148944052|NCT02571777|537280268|FG004|Overall Study|Protocol Deviation|4|||
148944053|NCT02571777|537280264|FG000|Overall Study|Death|1|||
148944054|NCT02571777|537280265|FG001|Overall Study|Death|1|||
148944055|NCT02571777|537280266|FG002|Overall Study|Death|4|||
148944056|NCT02571777|537280267|FG003|Overall Study|Death|0|||
148944057|NCT02571777|537280268|FG004|Overall Study|Death|0|||
148944058|NCT02571777|537280264|FG000|Overall Study|Lost to Follow-up|1|||
148944059|NCT02571777|537280265|FG001|Overall Study|Lost to Follow-up|1|||
148944060|NCT02571777|537280266|FG002|Overall Study|Lost to Follow-up|2|||
148944061|NCT02571777|537280267|FG003|Overall Study|Lost to Follow-up|0|||
148944062|NCT02571777|537280268|FG004|Overall Study|Lost to Follow-up|1|||
148944063|NCT02571777|537280264|FG000|Overall Study|Physician Decision|1|||
148944064|NCT02571777|537280265|FG001|Overall Study|Physician Decision|7|||
148944065|NCT02571777|537280266|FG002|Overall Study|Physician Decision|5|||
148944066|NCT02571777|537280267|FG003|Overall Study|Physician Decision|2|||
148944067|NCT02571777|537280268|FG004|Overall Study|Physician Decision|4|||
148944068|NCT02571777|537280264|FG000|Overall Study|Pregnancy|0|||
148944069|NCT02571777|537280265|FG001|Overall Study|Pregnancy|0|||
148944070|NCT02571777|537280266|FG002|Overall Study|Pregnancy|0|||
148944071|NCT02571777|537280267|FG003|Overall Study|Pregnancy|2|||
148944072|NCT02571777|537280268|FG004|Overall Study|Pregnancy|0|||
148944073|NCT03706079|537280269|FG000|Predecessor Study|Death|0|||
148944074|NCT03706079|537280270|FG001|Predecessor Study|Death|2|||
148944075|NCT03706079|537280271|FG002|Predecessor Study|Death|0|||
148944076|NCT03706079|537280272|FG003|Predecessor Study|Death|1|||
148944077|NCT03706079|537280273|FG004|Predecessor Study|Death|0|||
148944078|NCT03706079|537280274|FG005|Predecessor Study|Death|0|||
148944079|NCT03706079|537280269|FG000|Predecessor Study|Lost to Follow-up|5|||
148944080|NCT03706079|537280270|FG001|Predecessor Study|Lost to Follow-up|2|||
148944081|NCT03706079|537280271|FG002|Predecessor Study|Lost to Follow-up|0|||
148944082|NCT03706079|537280272|FG003|Predecessor Study|Lost to Follow-up|0|||
148944083|NCT03706079|537280273|FG004|Predecessor Study|Lost to Follow-up|1|||
148944084|NCT03706079|537280274|FG005|Predecessor Study|Lost to Follow-up|0|||
148944085|NCT03706079|537280269|FG000|Predecessor Study|Withdrawal by Subject|8|||
148944086|NCT03706079|537280270|FG001|Predecessor Study|Withdrawal by Subject|15|||
148944087|NCT03706079|537280271|FG002|Predecessor Study|Withdrawal by Subject|0|||
148944088|NCT03706079|537280272|FG003|Predecessor Study|Withdrawal by Subject|5|||
148944089|NCT03706079|537280273|FG004|Predecessor Study|Withdrawal by Subject|2|||
148944090|NCT03706079|537280274|FG005|Predecessor Study|Withdrawal by Subject|0|||
148944091|NCT03706079|537280269|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
148944092|NCT03706079|537280270|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
148944093|NCT03706079|537280271|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
148808482|NCT04486716|536777505|FG000|Core Phase|Enrolled subjects not treated|9|||
148944094|NCT03706079|537280272|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
148944095|NCT03706079|537280273|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
148944096|NCT03706079|537280274|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
148944097|NCT03706079|537280269|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
148944098|NCT03706079|537280270|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
148944099|NCT03706079|537280271|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
148944100|NCT03706079|537280272|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
148944101|NCT03706079|537280273|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
148944102|NCT03706079|537280274|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
148944103|NCT03706079|537280269|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
148944104|NCT03706079|537280270|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
148944105|NCT03706079|537280271|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
148944106|NCT03706079|537280272|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
148944107|NCT03706079|537280273|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
148944108|NCT03706079|537280274|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
148944109|NCT03706079|537280269|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
148944110|NCT03706079|537280270|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
148944111|NCT03706079|537280271|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
148944112|NCT03706079|537280272|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
148944113|NCT03706079|537280273|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
148944114|NCT03706079|537280274|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
148944115|NCT03706079|537280269|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
148944116|NCT03706079|537280270|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
148944117|NCT03706079|537280271|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
148944118|NCT03706079|537280272|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
148944119|NCT03706079|537280273|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
148944120|NCT03706079|537280274|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
148944121|NCT03706079|537280269|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
148944122|NCT03706079|537280270|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
148944123|NCT03706079|537280271|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
148944124|NCT03706079|537280272|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
148944125|NCT03706079|537280273|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
148944126|NCT03706079|537280274|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
148944127|NCT03706079|537280269|FG000|Long Term Extension (DESTINATION)|Death|8|||
148944128|NCT03706079|537280270|FG001|Long Term Extension (DESTINATION)|Death|2|||
148944129|NCT03706079|537280271|FG002|Long Term Extension (DESTINATION)|Death|2|||
148944130|NCT03706079|537280272|FG003|Long Term Extension (DESTINATION)|Death|1|||
148944131|NCT03706079|537280273|FG004|Long Term Extension (DESTINATION)|Death|0|||
148944132|NCT03706079|537280274|FG005|Long Term Extension (DESTINATION)|Death|0|||
148944133|NCT00329238|537280275|FG000|Overall Study|Adverse Event|147|||
148944134|NCT00329238|537280276|FG001|Overall Study|Adverse Event|129|||
148944135|NCT00329238|537280275|FG000|Overall Study|Protocol Violation|23|||
148944136|NCT00329238|537280276|FG001|Overall Study|Protocol Violation|34|||
148944137|NCT00329238|537280275|FG000|Overall Study|Lost to Follow-up|2|||
148944138|NCT00329238|537280276|FG001|Overall Study|Lost to Follow-up|6|||
148944139|NCT00329238|537280275|FG000|Overall Study|Withdrawal by Subject|64|||
148944140|NCT00329238|537280276|FG001|Overall Study|Withdrawal by Subject|58|||
148944141|NCT00329238|537280275|FG000|Overall Study|Other reason (not specified)|40|||
148944142|NCT00329238|537280276|FG001|Overall Study|Other reason (not specified)|54|||
148944143|NCT00801632|537280277|FG000|Overall Study|Re-transplant|1|||
148944144|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
148944145|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
148682923|NCT01078623|536313043|FG015|Treatment Period 1|Withdrawal by Subject|0|||
148682924|NCT01078623|536313044|FG016|Treatment Period 1|Withdrawal by Subject|0|||
148682925|NCT01078623|536313045|FG017|Treatment Period 1|Withdrawal by Subject|0|||
148682926|NCT01078623|536313046|FG018|Treatment Period 1|Withdrawal by Subject|0|||
148682927|NCT01078623|536313047|FG019|Treatment Period 1|Withdrawal by Subject|0|||
148682928|NCT01078623|536313028|FG000|Treatment Period 1|Protocol Violation|0|||
148682929|NCT01078623|536313029|FG001|Treatment Period 1|Protocol Violation|0|||
148682930|NCT01078623|536313030|FG002|Treatment Period 1|Protocol Violation|0|||
148682931|NCT01078623|536313031|FG003|Treatment Period 1|Protocol Violation|0|||
148682932|NCT01078623|536313032|FG004|Treatment Period 1|Protocol Violation|0|||
148682933|NCT01078623|536313033|FG005|Treatment Period 1|Protocol Violation|1|||
148682934|NCT01078623|536313034|FG006|Treatment Period 1|Protocol Violation|0|||
148682935|NCT01078623|536313035|FG007|Treatment Period 1|Protocol Violation|0|||
148682936|NCT01078623|536313036|FG008|Treatment Period 1|Protocol Violation|0|||
148682937|NCT01078623|536313037|FG009|Treatment Period 1|Protocol Violation|0|||
148682938|NCT01078623|536313038|FG010|Treatment Period 1|Protocol Violation|0|||
148808483|NCT03846479|536777506|FG000|Overall Study|Death|8|||
148944146|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
148944147|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
148944148|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
148944149|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
148944150|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
148944151|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
148944152|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
148944153|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
149016259|NCT00337662|537537891|FG001|Study Period II|Lack of Efficacy|0|||
148682939|NCT01078623|536313039|FG011|Treatment Period 1|Protocol Violation|0|||
148682940|NCT01078623|536313040|FG012|Treatment Period 1|Protocol Violation|0|||
148944154|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
148944155|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
148944156|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
148944157|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
148944158|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
148944159|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
148944160|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
148944161|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
148944162|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
148944163|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
148944164|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
148944165|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
148944166|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
148944167|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
148944168|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
148944169|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
148944170|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
148944171|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
148944172|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
148944173|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
148944174|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
148944175|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
148944176|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
148944177|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
148944178|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
148944179|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
148944180|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
148944181|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
148944182|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
148944183|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
148944184|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
148944185|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
148944186|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
148944187|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
148944188|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
148944189|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
148944190|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
148944191|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
148944192|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
148944193|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
148944194|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
148944195|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
148944196|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
148944197|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
148944198|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
148944199|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
148944200|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
148944201|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
148944202|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
148944203|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
148944204|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
148944205|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
148944206|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
148944207|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
148944208|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
148944209|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
148944210|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
148808484|NCT03846479|536777506|FG000|Overall Study|Lost to Follow-up|1|||
148944211|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
148944212|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
148944213|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
148944214|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Change of location|0|||
148944215|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Change of location|0|||
148808485|NCT02332707|536777507|FG000|Overall Study|Adverse Event|0|||
148944216|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Change of location|0|||
148944217|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Change of location|1|||
148944218|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Change of location|0|||
148944219|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
148944220|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
148944221|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
148944222|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
148944223|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
148944224|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
148944225|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
148944226|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
148944227|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
148944228|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
148944229|NCT00730405|537280284|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
148944230|NCT00730405|537280285|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
148944231|NCT00730405|537280286|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
148944232|NCT00730405|537280287|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
148944233|NCT00730405|537280288|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
148944234|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
148944235|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
148944236|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
148944237|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
148944238|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
148944239|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
148944240|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
148944241|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
148944242|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
148944243|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
148944244|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
148944245|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
148944246|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
148944247|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
148944248|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
148944249|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Death|0|||
148944250|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Death|1|||
148944251|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Death|0|||
148944252|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Death|1|||
148944253|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Death|0|||
148944254|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Change of location|1|||
148944255|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Change of location|1|||
148944256|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Change of location|0|||
148944257|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Change of location|1|||
148944258|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Change of location|0|||
148944259|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
148944260|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
148944261|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
148944262|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
148944263|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
148944264|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
148944265|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
148944266|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
149201510|NCT01797965|538204056|FG003|Overall Study|Death|0|||
149201511|NCT01797965|538204053|FG000|Overall Study|Disease progression, defined by protocol|3|||
149201512|NCT01797965|538204054|FG001|Overall Study|Disease progression, defined by protocol|1|||
149201513|NCT01797965|538204055|FG002|Overall Study|Disease progression, defined by protocol|0|||
149201514|NCT01797965|538204056|FG003|Overall Study|Disease progression, defined by protocol|0|||
149201515|NCT01797965|538204053|FG000|Overall Study|Reason Not Specified|280|||
149201516|NCT01797965|538204054|FG001|Overall Study|Reason Not Specified|295|||
149201517|NCT01797965|538204055|FG002|Overall Study|Reason Not Specified|0|||
149201518|NCT01797965|538204056|FG003|Overall Study|Reason Not Specified|15|||
149201519|NCT00712322|538204057|FG000|Overall Study|Protocol deviation|0|||
149201520|NCT00712322|538204058|FG001|Overall Study|Protocol deviation|1|||
149201521|NCT00712322|538204059|FG002|Overall Study|Protocol deviation|0|||
149201522|NCT00973921|538204062|FG000|Overall Study|IVUS results were not available|9|||
149201523|NCT02670330|538204073|FG000|Overall Study|Protocol Deviation|1|||
148944267|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
149016260|NCT00337662|537537892|FG002|Study Period II|Lack of Efficacy|0|||
149201524|NCT02670330|538204074|FG001|Overall Study|Protocol Deviation|0|||
148944268|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
148944269|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
148944270|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
148944271|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
148944272|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
148944273|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
148944274|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
148944275|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
148944276|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
148944277|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
148944278|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
148944279|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
148944280|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
148944281|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
148944282|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
149201525|NCT02670330|538204073|FG000|Overall Study|Study Terminated By Sponsor|36|||
149201526|NCT02670330|538204074|FG001|Overall Study|Study Terminated By Sponsor|43|||
149201527|NCT02670330|538204073|FG000|Overall Study|Adverse Event|1|||
149201528|NCT02670330|538204074|FG001|Overall Study|Adverse Event|3|||
149201529|NCT02670330|538204073|FG000|Overall Study|Withdrawal by Subject|34|||
149201530|NCT02670330|538204074|FG001|Overall Study|Withdrawal by Subject|29|||
149201531|NCT02670330|538204073|FG000|Overall Study|Lost to Follow-up|3|||
149201532|NCT02670330|538204074|FG001|Overall Study|Lost to Follow-up|2|||
149201533|NCT04404010|538204075|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
149201534|NCT04404010|538204076|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
149201535|NCT02120157|538204077|FG000|Overall Study|Death|8|||
149201536|NCT01354431|538204083|FG000|Pre-Treatment Period|Not reported|1|||
149201537|NCT01354431|538204084|FG001|Pre-Treatment Period|Not reported|0|||
149201538|NCT01354431|538204085|FG002|Pre-Treatment Period|Not reported|0|||
149201539|NCT01354431|538204083|FG000|Treatment Period|Disease Progression|50|||
149201540|NCT01354431|538204084|FG001|Treatment Period|Disease Progression|40|||
149201541|NCT01354431|538204085|FG002|Treatment Period|Disease Progression|44|||
149201542|NCT01354431|538204083|FG000|Treatment Period|Study Drug Toxicity|5|||
149201543|NCT01354431|538204084|FG001|Treatment Period|Study Drug Toxicity|8|||
149201544|NCT01354431|538204085|FG002|Treatment Period|Study Drug Toxicity|4|||
149201545|NCT01354431|538204083|FG000|Treatment Period|Death|0|||
148944283|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
148944284|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
148944285|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
148944286|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
148944287|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
148944288|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
148944289|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
148944290|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
148944291|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
148944292|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
148944293|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
148944294|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
148944295|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
148944296|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
148944297|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
148944298|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
148944299|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
148944300|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
148944301|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
148944302|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
148944303|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
149016261|NCT00337662|537537893|FG003|Study Period II|Lack of Efficacy|7|||
149016262|NCT00337662|537537890|FG000|Study Period II|Sponsor Decision|0|||
149201546|NCT01354431|538204084|FG001|Treatment Period|Death|1|||
149201547|NCT01354431|538204085|FG002|Treatment Period|Death|0|||
149201548|NCT01354431|538204083|FG000|Treatment Period|AE unrelated to study drug|1|||
149201549|NCT01354431|538204084|FG001|Treatment Period|AE unrelated to study drug|2|||
149201550|NCT01354431|538204085|FG002|Treatment Period|AE unrelated to study drug|5|||
149201551|NCT01354431|538204083|FG000|Treatment Period|Participant request to discontinue|2|||
149201552|NCT01354431|538204084|FG001|Treatment Period|Participant request to discontinue|2|||
148944304|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
148944305|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
148944306|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
148944307|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
148944308|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
148944309|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Missing|0|||
148944310|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Missing|0|||
148944311|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Missing|2|||
148944312|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Missing|0|||
148944313|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Missing|0|||
148944314|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
148944315|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
148944316|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
148944317|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
148944318|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
148944319|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
148944320|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
148944321|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
148944322|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
148944323|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
148944324|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
148944325|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
148944326|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
148944327|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
148944328|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
148944329|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
148944330|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
148944331|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
148944332|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
148944333|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
148944334|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
148944335|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
148944336|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
148944337|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
148944338|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
149201553|NCT01354431|538204085|FG002|Treatment Period|Participant request to discontinue|1|||
149201554|NCT01354431|538204083|FG000|Treatment Period|Participant withdrew consent|0|||
149201555|NCT01354431|538204084|FG001|Treatment Period|Participant withdrew consent|1|||
149201556|NCT01354431|538204085|FG002|Treatment Period|Participant withdrew consent|0|||
149201557|NCT01354431|538204083|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
149201558|NCT01354431|538204084|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
149201559|NCT01354431|538204085|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
148944339|NCT00730405|537280284|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
148944340|NCT00730405|537280285|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
148944341|NCT00730405|537280286|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
148944342|NCT00730405|537280287|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
148944343|NCT00730405|537280288|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
148944344|NCT00963937|537280291|FG000|Overall Study|Protocol Violation|1|||
148944345|NCT00963937|537280292|FG001|Overall Study|Protocol Violation|1|||
148944346|NCT00963937|537280293|FG002|Overall Study|Protocol Violation|0|||
148944347|NCT00963937|537280291|FG000|Overall Study|Physician Decision|18|||
148944348|NCT00963937|537280292|FG001|Overall Study|Physician Decision|10|||
149201560|NCT04685499|538204086|FG000|Overall Study|Study Terminated Early|1|||
148944349|NCT00963937|537280293|FG002|Overall Study|Physician Decision|4|||
148944350|NCT00334958|537280294|FG000|Overall Study|Medication Noncompliance|0|||
148944351|NCT00334958|537280295|FG001|Overall Study|Medication Noncompliance|3|||
148944352|NCT00334958|537280294|FG000|Overall Study|Protocol Violation|2|||
148944353|NCT00334958|537280295|FG001|Overall Study|Protocol Violation|2|||
148944354|NCT00334958|537280294|FG000|Overall Study|Request of the investigator or sponsor|0|||
148944355|NCT00334958|537280295|FG001|Overall Study|Request of the investigator or sponsor|1|||
148944356|NCT00334958|537280294|FG000|Overall Study|Withdrawal by Subject|7|||
148944357|NCT00334958|537280295|FG001|Overall Study|Withdrawal by Subject|4|||
149201561|NCT03176277|538204087|FG000|Part A Dose Escalation Study|Adverse Event|1|||
148944358|NCT00334958|537280294|FG000|Overall Study|Adverse Event|27|||
149016263|NCT00337662|537537891|FG001|Study Period II|Sponsor Decision|0|||
149201562|NCT03176277|538204088|FG001|Part A Dose Escalation Study|Adverse Event|0|||
148944359|NCT00334958|537280295|FG001|Overall Study|Adverse Event|12|||
148944360|NCT00334958|537280294|FG000|Overall Study|Other|1|||
148944361|NCT00334958|537280295|FG001|Overall Study|Other|2|||
148944362|NCT04431453|537280296|FG000|Overall Study|Withdrew Consent|0|||
148944363|NCT04431453|537280297|FG001|Overall Study|Withdrew Consent|1|||
148944364|NCT04431453|537280298|FG002|Overall Study|Withdrew Consent|0|||
148944365|NCT04431453|537280299|FG003|Overall Study|Withdrew Consent|2|||
148944366|NCT04431453|537280300|FG004|Overall Study|Withdrew Consent|0|||
148682941|NCT01078623|536313041|FG013|Treatment Period 1|Protocol Violation|0|||
148944367|NCT04431453|537280301|FG005|Overall Study|Withdrew Consent|0|||
148944368|NCT04431453|537280302|FG006|Overall Study|Withdrew Consent|0|||
148944369|NCT04431453|537280303|FG007|Overall Study|Withdrew Consent|0|||
148944370|NCT04431453|537280296|FG000|Overall Study|Death|1|||
148944371|NCT04431453|537280297|FG001|Overall Study|Death|0|||
148944372|NCT04431453|537280298|FG002|Overall Study|Death|0|||
149201563|NCT03176277|538204089|FG002|Part A Dose Escalation Study|Adverse Event|1|||
149201564|NCT03176277|538204090|FG003|Part A Dose Escalation Study|Adverse Event|0|||
149201565|NCT03176277|538204087|FG000|Part A Dose Escalation Study|Physician Decision|1|||
149201566|NCT03176277|538204088|FG001|Part A Dose Escalation Study|Physician Decision|1|||
149201567|NCT03176277|538204089|FG002|Part A Dose Escalation Study|Physician Decision|2|||
149201568|NCT03176277|538204090|FG003|Part A Dose Escalation Study|Physician Decision|0|||
149201569|NCT03176277|538204087|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
149201570|NCT03176277|538204088|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
149201571|NCT03176277|538204089|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
149201572|NCT03176277|538204090|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
149201573|NCT03176277|538204087|FG000|Part A Dose Escalation Study|Progressive disease|3|||
149201574|NCT03176277|538204088|FG001|Part A Dose Escalation Study|Progressive disease|1|||
149201575|NCT03176277|538204089|FG002|Part A Dose Escalation Study|Progressive disease|3|||
149201576|NCT03176277|538204090|FG003|Part A Dose Escalation Study|Progressive disease|0|||
149201577|NCT00702052|538204091|FG000|Overall Study|Adverse Event|23|||
149201578|NCT00702052|538204091|FG000|Overall Study|Disease Progression|30|||
149201579|NCT00702052|538204091|FG000|Overall Study|Withdrawal by Subject|5|||
149201580|NCT03282357|538204092|FG000|Overall Study|Lost to Follow-up|3|||
149201581|NCT03282357|538204092|FG000|Overall Study|Withdrawal by Subject|4|||
149201582|NCT03282357|538204092|FG000|Overall Study|Adverse Event|1|||
149201583|NCT03282357|538204092|FG000|Overall Study|Other|9|||
149201584|NCT00393913|538204094|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
149201585|NCT00393913|538204094|FG000|Initial Assessment|Withdrawal by Subject|16|||
149201586|NCT00393913|538204094|FG000|CPAP|Withdrawal by Subject|3|||
149201587|NCT00393913|538204094|FG000|CPAP|Physician Decision|1|||
149201588|NCT00393913|538204094|FG000|CPAP|TEchnical problem with CPAP|3|||
149201589|NCT01518244|538204095|FG000|Overall Study|Adverse Event|3|||
148682942|NCT01078623|536313042|FG014|Treatment Period 1|Protocol Violation|0|||
148682943|NCT01078623|536313043|FG015|Treatment Period 1|Protocol Violation|0|||
148682944|NCT01078623|536313044|FG016|Treatment Period 1|Protocol Violation|0|||
148682945|NCT01078623|536313045|FG017|Treatment Period 1|Protocol Violation|0|||
148682946|NCT01078623|536313046|FG018|Treatment Period 1|Protocol Violation|0|||
148682947|NCT01078623|536313047|FG019|Treatment Period 1|Protocol Violation|0|||
148682948|NCT01078623|536313028|FG000|Treatment Period 2|Adverse Event|0|||
148682949|NCT01078623|536313029|FG001|Treatment Period 2|Adverse Event|0|||
148682950|NCT01078623|536313030|FG002|Treatment Period 2|Adverse Event|0|||
148682951|NCT01078623|536313031|FG003|Treatment Period 2|Adverse Event|0|||
148682952|NCT01078623|536313032|FG004|Treatment Period 2|Adverse Event|0|||
148682953|NCT01078623|536313033|FG005|Treatment Period 2|Adverse Event|0|||
148682954|NCT01078623|536313034|FG006|Treatment Period 2|Adverse Event|1|||
148682955|NCT01078623|536313035|FG007|Treatment Period 2|Adverse Event|0|||
148682956|NCT01078623|536313036|FG008|Treatment Period 2|Adverse Event|0|||
148808486|NCT02332707|536777508|FG001|Overall Study|Adverse Event|0|||
148808487|NCT02332707|536777509|FG002|Overall Study|Adverse Event|0|||
148808488|NCT02332707|536777510|FG003|Overall Study|Adverse Event|0|||
148808489|NCT02332707|536777511|FG004|Overall Study|Adverse Event|0|||
148944373|NCT04431453|537280299|FG003|Overall Study|Death|0|||
148944374|NCT04431453|537280300|FG004|Overall Study|Death|0|||
148944375|NCT04431453|537280301|FG005|Overall Study|Death|0|||
148944376|NCT04431453|537280302|FG006|Overall Study|Death|0|||
149201590|NCT04900038|538204098|FG000|Overall Study|Adverse Event|1|||
149201591|NCT04900038|538204099|FG001|Overall Study|Adverse Event|0|||
149201592|NCT04900038|538204100|FG002|Overall Study|Adverse Event|1|||
148944377|NCT04431453|537280303|FG007|Overall Study|Death|1|||
149016264|NCT00337662|537537892|FG002|Study Period II|Sponsor Decision|0|||
149201593|NCT04900038|538204101|FG003|Overall Study|Adverse Event|1|||
148682957|NCT01078623|536313037|FG009|Treatment Period 2|Adverse Event|0|||
148682958|NCT01078623|536313038|FG010|Treatment Period 2|Adverse Event|0|||
148682959|NCT01078623|536313039|FG011|Treatment Period 2|Adverse Event|0|||
148944378|NCT04431453|537280296|FG000|Overall Study|Lost to Follow-up|0|||
148944379|NCT04431453|537280297|FG001|Overall Study|Lost to Follow-up|0|||
148944380|NCT04431453|537280298|FG002|Overall Study|Lost to Follow-up|1|||
149201594|NCT04900038|538204098|FG000|Overall Study|Withdrawal by Subject|0|||
148944381|NCT04431453|537280299|FG003|Overall Study|Lost to Follow-up|1|||
148944382|NCT04431453|537280300|FG004|Overall Study|Lost to Follow-up|0|||
149201595|NCT04900038|538204099|FG001|Overall Study|Withdrawal by Subject|1|||
149201596|NCT04900038|538204100|FG002|Overall Study|Withdrawal by Subject|0|||
149201597|NCT04900038|538204101|FG003|Overall Study|Withdrawal by Subject|0|||
149201598|NCT04900038|538204098|FG000|Overall Study|Study terminated by sponsor|18|||
149201599|NCT04900038|538204099|FG001|Overall Study|Study terminated by sponsor|15|||
149201600|NCT04900038|538204100|FG002|Overall Study|Study terminated by sponsor|17|||
149201601|NCT04900038|538204101|FG003|Overall Study|Study terminated by sponsor|14|||
149201602|NCT04900038|538204098|FG000|Overall Study|Protocol Deviation|1|||
149201603|NCT04900038|538204099|FG001|Overall Study|Protocol Deviation|1|||
149201604|NCT04900038|538204100|FG002|Overall Study|Protocol Deviation|0|||
149201605|NCT04900038|538204101|FG003|Overall Study|Protocol Deviation|0|||
149201606|NCT04900038|538204098|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
149201607|NCT04900038|538204099|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
149201608|NCT04900038|538204100|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
149201609|NCT04900038|538204101|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
149201610|NCT04900038|538204098|FG000|Overall Study|Lost to Follow-up|0|||
149201611|NCT04900038|538204099|FG001|Overall Study|Lost to Follow-up|0|||
149201612|NCT04900038|538204100|FG002|Overall Study|Lost to Follow-up|0|||
149201613|NCT04900038|538204101|FG003|Overall Study|Lost to Follow-up|1|||
149201614|NCT04093258|538204103|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
149201615|NCT04093258|538204104|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
149201616|NCT00986427|538204105|FG000|Overall Study|Lost to Follow-up|2|||
149201617|NCT00986427|538204106|FG001|Overall Study|Lost to Follow-up|0|||
149201618|NCT00986427|538204105|FG000|Overall Study|Lack of Efficacy|1|||
149201619|NCT00986427|538204106|FG001|Overall Study|Lack of Efficacy|0|||
149201620|NCT00986427|538204105|FG000|Overall Study|Withdrawal by Subject|1|||
149201621|NCT00986427|538204106|FG001|Overall Study|Withdrawal by Subject|0|||
149201622|NCT02379390|538204107|FG000|Overall Study|Adverse Event|1|||
149201623|NCT02379390|538204108|FG001|Overall Study|Adverse Event|1|||
149201624|NCT02379390|538204107|FG000|Overall Study|Investigator's decision|1|||
149201625|NCT02379390|538204108|FG001|Overall Study|Investigator's decision|0|||
149201626|NCT02379390|538204107|FG000|Overall Study|Study Termination|0|||
149201627|NCT02379390|538204108|FG001|Overall Study|Study Termination|1|||
149201628|NCT03245723|538204117|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
149201629|NCT03245723|538204118|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
149201630|NCT03245723|538204117|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
149201631|NCT03245723|538204118|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
149201632|NCT03245723|538204117|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
149201633|NCT03245723|538204118|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
149201634|NCT03245723|538204117|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
149201635|NCT03245723|538204118|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
149201636|NCT00077376|538204119|FG000|Overall Study|Adverse Event|8|||
149201637|NCT00077376|538204119|FG000|Overall Study|Withdrawal by Subject|2|||
149201638|NCT00077376|538204119|FG000|Overall Study|Death|1|||
149201639|NCT00077376|538204119|FG000|Overall Study|Physician Decision|1|||
149201640|NCT00077376|538204119|FG000|Overall Study|Alternative therapy|5|||
149201641|NCT00077376|538204119|FG000|Overall Study|Complicating disease|1|||
148944383|NCT04431453|537280301|FG005|Overall Study|Lost to Follow-up|0|||
148944384|NCT04431453|537280302|FG006|Overall Study|Lost to Follow-up|0|||
148944385|NCT04431453|537280303|FG007|Overall Study|Lost to Follow-up|0|||
148944386|NCT04431453|537280296|FG000|Overall Study|Enrolled but Never Treated|0|||
148944387|NCT04431453|537280297|FG001|Overall Study|Enrolled but Never Treated|0|||
148944388|NCT04431453|537280298|FG002|Overall Study|Enrolled but Never Treated|0|||
148944389|NCT04431453|537280299|FG003|Overall Study|Enrolled but Never Treated|0|||
148944390|NCT04431453|537280300|FG004|Overall Study|Enrolled but Never Treated|1|||
148944391|NCT04431453|537280301|FG005|Overall Study|Enrolled but Never Treated|0|||
148944392|NCT04431453|537280302|FG006|Overall Study|Enrolled but Never Treated|0|||
148944393|NCT04431453|537280303|FG007|Overall Study|Enrolled but Never Treated|0|||
148944394|NCT02243696|537280309|FG000|Overall Study|Death|282|||
149201642|NCT00077376|538204119|FG000|Overall Study|Still on treatment|1|||
149201643|NCT00077376|538204119|FG000|Overall Study|Symptomatic deterioration|1|||
149201644|NCT00077376|538204119|FG000|Overall Study|Surgery|1|||
148944395|NCT02243696|537280309|FG000|Overall Study|Withdrawal by Subject|79|||
149201645|NCT00077376|538204119|FG000|Overall Study|Insurance ran out|1|||
149201646|NCT02109744|538205396|FG000|Overall Study|Death|1|||
149201647|NCT02109744|538205397|FG001|Overall Study|Death|1|||
149201648|NCT02109744|538205396|FG000|Overall Study|no marrow exam|1|||
149201649|NCT02109744|538205397|FG001|Overall Study|no marrow exam|0|||
148944396|NCT02243696|537280309|FG000|Overall Study|Lost to Follow-up|57|||
149201650|NCT04095442|538205398|FG000|Overall Study|Lost to Follow-up|0|||
149201651|NCT04095442|538205399|FG001|Overall Study|Lost to Follow-up|1|||
148944397|NCT02243696|537280309|FG000|Overall Study|Subject No Longer has Study System|42|||
148944398|NCT02243696|537280309|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
148682960|NCT01078623|536313040|FG012|Treatment Period 2|Adverse Event|0|||
148682961|NCT01078623|536313041|FG013|Treatment Period 2|Adverse Event|0|||
148808490|NCT02332707|536777512|FG005|Overall Study|Adverse Event|0|||
148808491|NCT02332707|536777513|FG006|Overall Study|Adverse Event|0|||
148808492|NCT02332707|536777514|FG007|Overall Study|Adverse Event|0|||
148682962|NCT01078623|536313042|FG014|Treatment Period 2|Adverse Event|0|||
148944399|NCT02243696|537280309|FG000|Overall Study|Study Terminated for EP PASSION|961|||
148944400|NCT01534962|537280310|FG000|Overall Study|Randomized but did not start treatment|2|||
148944401|NCT01534962|537280311|FG001|Overall Study|Randomized but did not start treatment|0|||
148944402|NCT01534962|537280312|FG002|Overall Study|Randomized but did not start treatment|0|||
148944403|NCT01534962|537280313|FG003|Overall Study|Randomized but did not start treatment|1|||
148944404|NCT01534962|537280310|FG000|Overall Study|Discontinued at AF recurrence|35|||
148944405|NCT01534962|537280311|FG001|Overall Study|Discontinued at AF recurrence|26|||
148944406|NCT01534962|537280312|FG002|Overall Study|Discontinued at AF recurrence|24|||
148944407|NCT01534962|537280313|FG003|Overall Study|Discontinued at AF recurrence|31|||
148944408|NCT00622284|537280314|FG000|Overall Study|Lack of Efficacy|45|||
148944409|NCT00622284|537280315|FG001|Overall Study|Lack of Efficacy|15|||
148944410|NCT00622284|537280314|FG000|Overall Study|Adverse Event|61|||
148944411|NCT00622284|537280315|FG001|Overall Study|Adverse Event|90|||
148944412|NCT00622284|537280314|FG000|Overall Study|Protocol Violation|12|||
148944413|NCT00622284|537280315|FG001|Overall Study|Protocol Violation|5|||
148944414|NCT00622284|537280314|FG000|Overall Study|Lost to Follow-up|11|||
148944415|NCT00622284|537280315|FG001|Overall Study|Lost to Follow-up|13|||
148944416|NCT00622284|537280314|FG000|Overall Study|Withdrawal by Subject|27|||
148944417|NCT00622284|537280315|FG001|Overall Study|Withdrawal by Subject|24|||
148944418|NCT00622284|537280314|FG000|Overall Study|Other reason (not specified)|33|||
148944419|NCT00622284|537280315|FG001|Overall Study|Other reason (not specified)|24|||
148944420|NCT00457301|537280316|FG000|Overall Study|Withdrawal by Subject|3|||
148944421|NCT00457301|537280317|FG001|Overall Study|Withdrawal by Subject|3|||
148944422|NCT00457301|537280316|FG000|Overall Study|Censored out of the study|15|||
148944423|NCT00457301|537280317|FG001|Overall Study|Censored out of the study|14|||
148944424|NCT00457301|537280316|FG000|Overall Study|Death|5|||
148944425|NCT00457301|537280317|FG001|Overall Study|Death|7|||
148944426|NCT03408483|537280326|FG000|Overall Study|Physician Decision|3|||
148944427|NCT03408483|537280327|FG001|Overall Study|Physician Decision|3|||
148944428|NCT03408483|537280326|FG000|Overall Study|Lost to Follow-up|3|||
148944429|NCT03408483|537280327|FG001|Overall Study|Lost to Follow-up|0|||
148944430|NCT02094677|537280328|FG000|Overall Study|Screening|3|||
148944431|NCT02094677|537280329|FG001|Overall Study|Screening|1|||
148944432|NCT05399641|537280330|FG000|Overall Study|Adverse Event|0|||
148944433|NCT05399641|537280331|FG001|Overall Study|Adverse Event|1|||
148944434|NCT05399641|537280332|FG002|Overall Study|Adverse Event|1|||
148944435|NCT05399641|537280330|FG000|Overall Study|Lost to Follow-up|1|||
149201652|NCT04095442|538205398|FG000|Overall Study|Screen failure|1|||
149201653|NCT04095442|538205399|FG001|Overall Study|Screen failure|0|||
149201654|NCT01677624|538205400|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
149201655|NCT03097614|538205404|FG000|Overall Study|Adverse Event|3|||
149201656|NCT00953225|538205405|FG000|Overall Study|Withdrawal by Subject|2|||
149201657|NCT00953225|538205406|FG001|Overall Study|Withdrawal by Subject|0|||
149201658|NCT02215616|538205407|FG000|Overall Study|Sponsor requested to stop study drug|0|||
149201659|NCT02215616|538205408|FG001|Overall Study|Sponsor requested to stop study drug|0|||
149201660|NCT02215616|538205409|FG002|Overall Study|Sponsor requested to stop study drug|1|||
149201661|NCT02215616|538205410|FG003|Overall Study|Sponsor requested to stop study drug|4|||
149201662|NCT02215616|538205407|FG000|Overall Study|Death|1|||
149201663|NCT02215616|538205408|FG001|Overall Study|Death|0|||
149201664|NCT02215616|538205409|FG002|Overall Study|Death|0|||
149201665|NCT02215616|538205410|FG003|Overall Study|Death|0|||
149201666|NCT02215616|538205407|FG000|Overall Study|Adverse Event|7|||
149201667|NCT02215616|538205408|FG001|Overall Study|Adverse Event|4|||
149201668|NCT02215616|538205409|FG002|Overall Study|Adverse Event|9|||
149201669|NCT02215616|538205410|FG003|Overall Study|Adverse Event|2|||
149201670|NCT02215616|538205407|FG000|Overall Study|Withdrawal by Subject|1|||
149201671|NCT02215616|538205408|FG001|Overall Study|Withdrawal by Subject|8|||
149201672|NCT02215616|538205409|FG002|Overall Study|Withdrawal by Subject|2|||
149201673|NCT02215616|538205410|FG003|Overall Study|Withdrawal by Subject|5|||
149201674|NCT02215616|538205407|FG000|Overall Study|Non-compliance|0|||
149201675|NCT02215616|538205408|FG001|Overall Study|Non-compliance|2|||
149201676|NCT02215616|538205409|FG002|Overall Study|Non-compliance|1|||
149201677|NCT02215616|538205410|FG003|Overall Study|Non-compliance|0|||
148944436|NCT05399641|537280331|FG001|Overall Study|Lost to Follow-up|2|||
148944437|NCT05399641|537280332|FG002|Overall Study|Lost to Follow-up|2|||
148944438|NCT05399641|537280330|FG000|Overall Study|Physician Decision|1|||
148944439|NCT05399641|537280331|FG001|Overall Study|Physician Decision|3|||
148944440|NCT05399641|537280332|FG002|Overall Study|Physician Decision|3|||
148944441|NCT05399641|537280330|FG000|Overall Study|Withdrawal by Subject|4|||
148944442|NCT05399641|537280331|FG001|Overall Study|Withdrawal by Subject|11|||
149201678|NCT02215616|538205407|FG000|Overall Study|Protocol Violation|0|||
149201679|NCT02215616|538205408|FG001|Overall Study|Protocol Violation|2|||
149201680|NCT02215616|538205409|FG002|Overall Study|Protocol Violation|0|||
148944443|NCT05399641|537280332|FG002|Overall Study|Withdrawal by Subject|7|||
148944444|NCT05399641|537280330|FG000|Overall Study|Reason not defined|3|||
148944445|NCT05399641|537280331|FG001|Overall Study|Reason not defined|5|||
148944446|NCT05399641|537280332|FG002|Overall Study|Reason not defined|6|||
149201681|NCT02215616|538205410|FG003|Overall Study|Protocol Violation|0|||
149201682|NCT02215616|538205407|FG000|Overall Study|Lost to Follow-up|1|||
149201683|NCT02215616|538205408|FG001|Overall Study|Lost to Follow-up|1|||
149201684|NCT02215616|538205409|FG002|Overall Study|Lost to Follow-up|0|||
149201685|NCT02215616|538205410|FG003|Overall Study|Lost to Follow-up|1|||
149201686|NCT02215616|538205407|FG000|Overall Study|Other than specified|1|||
149201687|NCT02215616|538205408|FG001|Overall Study|Other than specified|0|||
149201688|NCT02215616|538205409|FG002|Overall Study|Other than specified|1|||
148944447|NCT00478231|537280333|FG000|Overall Study|Death|7|||
148944448|NCT00478231|537280333|FG000|Overall Study|Lack of Efficacy|47|||
148944449|NCT00478231|537280333|FG000|Overall Study|Lost to Follow-up|7|||
148944450|NCT00478231|537280333|FG000|Overall Study|Withdrawal by Subject|6|||
149201689|NCT02215616|538205410|FG003|Overall Study|Other than specified|1|||
149201690|NCT01957709|538205411|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
149201691|NCT04268004|538205414|FG000|Overall Study|Excluded from analyses|0|||
149201692|NCT04268004|538205415|FG001|Overall Study|Excluded from analyses|1|||
149201693|NCT01082367|538205416|FG000|Double-blind Period|Administrative problems|0|||
149201694|NCT01082367|538205417|FG001|Double-blind Period|Administrative problems|1|||
149201695|NCT01082367|538205416|FG000|Double-blind Period|Lack of Efficacy|5|||
149201696|NCT01082367|538205417|FG001|Double-blind Period|Lack of Efficacy|11|||
149201697|NCT01082367|538205416|FG000|Double-blind Period|Adverse Event|0|||
149201698|NCT01082367|538205417|FG001|Double-blind Period|Adverse Event|1|||
149201699|NCT01082367|538205416|FG000|Follow-up (F-U) Period|Administrative problems|1|||
149201700|NCT01082367|538205417|FG001|Follow-up (F-U) Period|Administrative problems|0|||
149201701|NCT01082367|538205416|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
149201702|NCT01082367|538205417|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
149201703|NCT01082367|538205416|FG000|Follow-up (F-U) Period|Adverse Event|0|||
149201704|NCT01082367|538205417|FG001|Follow-up (F-U) Period|Adverse Event|1|||
149201705|NCT01453998|538205418|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
149201706|NCT01453998|538205419|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
149201707|NCT01453998|538205420|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
149201708|NCT02022033|538205427|FG000|Overall Study|Physician Decision|1|||
148944451|NCT00478231|537280333|FG000|Overall Study|Other|9|||
148944452|NCT00478231|537280333|FG000|Overall Study|Adverse Event|5|||
148944453|NCT00478231|537280333|FG000|Overall Study|Randomized, not treated|3|||
148944454|NCT01300650|537280334|FG000|Overall Study|Adverse Event|1|||
148944455|NCT01702961|537280335|FG000|Overall Study|Additional treatment|3|||
148944456|NCT01702961|537280335|FG000|Overall Study|Progressive disease|5|||
148944457|NCT01702961|537280335|FG000|Overall Study|Relapse|20|||
148944458|NCT01702961|537280335|FG000|Overall Study|Death|6|||
148944459|NCT01702961|537280335|FG000|Overall Study|Lost to Follow-up|2|||
148944460|NCT01702961|537280335|FG000|Overall Study|Ongoing|11|||
148944461|NCT03846804|537280338|FG000|Overall Study|Refused blood draw|1|||
148944462|NCT03846804|537280338|FG000|Overall Study|Protocol Violation|1|||
148944463|NCT00824720|537280339|FG000|Overall Study|failed plug insertion|3|||
148944464|NCT00824720|537280340|FG001|Overall Study|failed plug insertion|1|||
148944465|NCT00824720|537280341|FG002|Overall Study|failed plug insertion|0|||
148944466|NCT00824720|537280339|FG000|Overall Study|Protocol Violation|0|||
148944467|NCT00824720|537280340|FG001|Overall Study|Protocol Violation|0|||
148944468|NCT00824720|537280341|FG002|Overall Study|Protocol Violation|1|||
148944469|NCT02339584|537280342|FG000|Overall Study|Adverse Event|11|||
148944470|NCT02339584|537280343|FG001|Overall Study|Adverse Event|7|||
148944471|NCT02339584|537280342|FG000|Overall Study|Lack of Efficacy|0|||
148944472|NCT02339584|537280343|FG001|Overall Study|Lack of Efficacy|1|||
148944473|NCT02339584|537280342|FG000|Overall Study|Physician Decision|1|||
148944474|NCT02339584|537280343|FG001|Overall Study|Physician Decision|2|||
148944475|NCT02339584|537280342|FG000|Overall Study|Protocol Violation|1|||
148944476|NCT02339584|537280343|FG001|Overall Study|Protocol Violation|1|||
148944477|NCT02339584|537280342|FG000|Overall Study|Withdrawal by Subject|2|||
148944478|NCT02339584|537280343|FG001|Overall Study|Withdrawal by Subject|4|||
149201709|NCT01429077|538205428|FG000|Overall Study|Lost to Follow-up|0|||
148944479|NCT02610725|537280344|FG000|Overall Study|Lost to Follow-up|197|||
148944480|NCT02610725|537280344|FG000|Overall Study|self-reported contraindication|9|||
148944481|NCT04094883|537280345|FG000|Overall Study|Withdrawal by Subject|1|||
148944482|NCT00743483|537280346|FG000|Baseline Period|Physician Decision|1|||
149201710|NCT01429077|538205429|FG001|Overall Study|Lost to Follow-up|3|||
149201711|NCT01413542|538205431|FG000|Overall Study|Physician Decision|1|||
148944483|NCT00743483|537280346|FG000|Treatment Period|Adverse Event|1|||
148944484|NCT01273597|537280347|FG000|Overall Study|Adverse Event|5|||
148944485|NCT01273597|537280347|FG000|Overall Study|Underwent Kidney Transplantation|2|||
148944486|NCT01273597|537280347|FG000|Overall Study|Reason Not Reported|1|||
148944487|NCT01785069|537280353|FG000|Overall Study|Implanted with nonstudy device|1|||
149201712|NCT01413542|538205432|FG001|Overall Study|Physician Decision|0|||
149201713|NCT01413542|538205433|FG002|Overall Study|Physician Decision|3|||
148944488|NCT01785069|537280354|FG001|Overall Study|Implanted with nonstudy device|2|||
148944489|NCT01785069|537280355|FG002|Overall Study|Implanted with nonstudy device|1|||
148944490|NCT01785069|537280356|FG003|Overall Study|Implanted with nonstudy device|0|||
148944491|NCT01785069|537280353|FG000|Overall Study|Death|0|||
148944492|NCT01785069|537280354|FG001|Overall Study|Death|0|||
149201714|NCT01413542|538205434|FG003|Overall Study|Physician Decision|0|||
149201715|NCT01413542|538205431|FG000|Overall Study|Adverse Event|0|||
149201716|NCT01413542|538205432|FG001|Overall Study|Adverse Event|0|||
149201717|NCT01413542|538205433|FG002|Overall Study|Adverse Event|0|||
149201718|NCT01413542|538205434|FG003|Overall Study|Adverse Event|1|||
149201719|NCT01879319|538205437|FG000|Overall Study|Withdrawal by Subject|1|||
149201720|NCT01879319|538205438|FG001|Overall Study|Withdrawal by Subject|0|||
149201721|NCT01879319|538205437|FG000|Overall Study|Lost to Follow-up|1|||
149201722|NCT01879319|538205438|FG001|Overall Study|Lost to Follow-up|5|||
149201723|NCT04724733|538205441|FG000|Overall Study|Lost to Follow-up|1|||
149201724|NCT04724733|538205442|FG001|Overall Study|Lost to Follow-up|1|||
149201725|NCT04724733|538205443|FG002|Overall Study|Lost to Follow-up|1|||
149201726|NCT03067129|538205444|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
149201727|NCT03067129|538205445|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
149201728|NCT03067129|538205446|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
149201729|NCT03067129|538205447|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
148944493|NCT01785069|537280355|FG002|Overall Study|Death|2|||
148944494|NCT01785069|537280356|FG003|Overall Study|Death|0|||
148944495|NCT01785069|537280353|FG000|Overall Study|Subject choice|2|||
148944496|NCT01785069|537280354|FG001|Overall Study|Subject choice|2|||
148944497|NCT01785069|537280355|FG002|Overall Study|Subject choice|0|||
148944498|NCT01785069|537280356|FG003|Overall Study|Subject choice|1|||
148944499|NCT01785069|537280353|FG000|Overall Study|Lost to Follow-up|1|||
148944500|NCT01785069|537280354|FG001|Overall Study|Lost to Follow-up|2|||
148944501|NCT01785069|537280355|FG002|Overall Study|Lost to Follow-up|4|||
148944502|NCT01785069|537280356|FG003|Overall Study|Lost to Follow-up|1|||
148944503|NCT01785069|537280353|FG000|Overall Study|Reason not Specified|1|||
148944504|NCT01785069|537280354|FG001|Overall Study|Reason not Specified|2|||
148944505|NCT01785069|537280355|FG002|Overall Study|Reason not Specified|1|||
148944506|NCT01785069|537280356|FG003|Overall Study|Reason not Specified|4|||
148944507|NCT01785069|537280353|FG000|Overall Study|Not evaluable|7|||
148944508|NCT01785069|537280354|FG001|Overall Study|Not evaluable|4|||
148944509|NCT01785069|537280355|FG002|Overall Study|Not evaluable|5|||
148944510|NCT01785069|537280356|FG003|Overall Study|Not evaluable|8|||
148944511|NCT01088997|537280357|FG000|Overall Study|Physician Decision|1|||
148944512|NCT01088997|537280358|FG001|Overall Study|Physician Decision|1|||
148944513|NCT01088997|537280357|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
148944514|NCT01088997|537280358|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
148944515|NCT01088997|537280357|FG000|Overall Study|Excluded prior to receiving drug|1|||
148944516|NCT01088997|537280358|FG001|Overall Study|Excluded prior to receiving drug|1|||
148944517|NCT05570500|537280363|FG000|Overall Study|Lost to Follow-up|7|||
148944518|NCT05570500|537280364|FG001|Overall Study|Lost to Follow-up|5|||
148944519|NCT02302807|537280367|FG000|Overall Study|Withdrawal by Subject|28|||
148944520|NCT02302807|537280368|FG001|Overall Study|Withdrawal by Subject|11|||
148944521|NCT02302807|537280367|FG000|Overall Study|Lost to Follow-up|4|||
148944522|NCT02302807|537280368|FG001|Overall Study|Lost to Follow-up|6|||
148944523|NCT02302807|537280367|FG000|Overall Study|Death|397|||
148944524|NCT02302807|537280368|FG001|Overall Study|Death|385|||
148944525|NCT02302807|537280367|FG000|Overall Study|Study Terminated By Sponsor|35|||
148944526|NCT02302807|537280368|FG001|Overall Study|Study Terminated By Sponsor|64|||
148944527|NCT02302807|537280367|FG000|Overall Study|Physician Decision|0|||
148944528|NCT02302807|537280368|FG001|Overall Study|Physician Decision|1|||
148944529|NCT01133522|537280372|FG000|Overall Study|Withdrawal by Subject|0|||
148944530|NCT01133522|537280373|FG001|Overall Study|Withdrawal by Subject|1|||
148944531|NCT01133522|537280374|FG002|Overall Study|Withdrawal by Subject|0|||
148944532|NCT01133522|537280375|FG003|Overall Study|Withdrawal by Subject|1|||
148944533|NCT01133522|537280376|FG004|Overall Study|Withdrawal by Subject|0|||
148944534|NCT01133522|537280377|FG005|Overall Study|Withdrawal by Subject|0|||
148944535|NCT01133522|537280378|FG006|Overall Study|Withdrawal by Subject|0|||
148944536|NCT01133522|537280379|FG007|Overall Study|Withdrawal by Subject|0|||
148944537|NCT01133522|537280380|FG008|Overall Study|Withdrawal by Subject|0|||
148944538|NCT01133522|537280381|FG009|Overall Study|Withdrawal by Subject|0|||
148944539|NCT01133522|537280372|FG000|Overall Study|Physician Decision|0|||
148944540|NCT01133522|537280373|FG001|Overall Study|Physician Decision|0|||
148944541|NCT01133522|537280374|FG002|Overall Study|Physician Decision|0|||
148944542|NCT01133522|537280375|FG003|Overall Study|Physician Decision|0|||
148944543|NCT01133522|537280376|FG004|Overall Study|Physician Decision|1|||
148944544|NCT01133522|537280377|FG005|Overall Study|Physician Decision|0|||
148682963|NCT01078623|536313043|FG015|Treatment Period 2|Adverse Event|0|||
148944545|NCT01133522|537280378|FG006|Overall Study|Physician Decision|0|||
148944546|NCT01133522|537280379|FG007|Overall Study|Physician Decision|0|||
148944547|NCT01133522|537280380|FG008|Overall Study|Physician Decision|0|||
148944548|NCT01133522|537280381|FG009|Overall Study|Physician Decision|0|||
148944549|NCT04997304|537280387|FG000|Overall Study|Lost to Follow-up|11|||
148944550|NCT04997304|537280387|FG000|Overall Study|Death|1|||
148944551|NCT04997304|537280387|FG000|Overall Study|Withdrawal by Subject|14|||
148944552|NCT03192462|537282260|FG000|Overall Study|Death|13|||
148944553|NCT03192462|537282261|FG001|Overall Study|Death|11|||
148944554|NCT03192462|537282262|FG002|Overall Study|Death|10|||
148944555|NCT03192462|537282260|FG000|Overall Study|Lost to Follow-up|0|||
148944556|NCT03192462|537282261|FG001|Overall Study|Lost to Follow-up|1|||
148944557|NCT03192462|537282262|FG002|Overall Study|Lost to Follow-up|0|||
148944558|NCT04840615|537282263|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
148944559|NCT04840615|537282264|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
148944560|NCT04840615|537282265|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
148944561|NCT00717197|537282266|FG000|Overall Study|Unable to purchase study drug|5|||
148944562|NCT00717197|537282266|FG000|Overall Study|Tumor Progression|1|||
148944563|NCT00717197|537282266|FG000|Overall Study|Physician Decision|1|||
148944564|NCT00982137|537282267|FG000|Overall Study|Lost to Follow-up|0|||
148944565|NCT00982137|537282268|FG001|Overall Study|Lost to Follow-up|0|||
148944566|NCT00982137|537282269|FG002|Overall Study|Lost to Follow-up|0|||
149201730|NCT03067129|538205444|FG000|Overall Study|Withdrawal by Subject|0|||
149201731|NCT03067129|538205445|FG001|Overall Study|Withdrawal by Subject|0|||
148944567|NCT00982137|537282270|FG003|Overall Study|Lost to Follow-up|1|||
148944568|NCT00982137|537282267|FG000|Overall Study|Withdrawal by Subject|0|||
148944569|NCT00982137|537282268|FG001|Overall Study|Withdrawal by Subject|1|||
148944570|NCT00982137|537282269|FG002|Overall Study|Withdrawal by Subject|0|||
148944571|NCT00982137|537282270|FG003|Overall Study|Withdrawal by Subject|0|||
148944572|NCT03003390|537282271|FG000|Overall Study|Physician Decision|2|||
148944573|NCT03003390|537282272|FG001|Overall Study|Physician Decision|0|||
148944574|NCT03003390|537282271|FG000|Overall Study|Parent refused intervention|2|||
148944575|NCT03003390|537282272|FG001|Overall Study|Parent refused intervention|0|||
148944576|NCT01648101|537282273|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
148944577|NCT01648101|537282274|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
148944578|NCT01648101|537282275|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
148944579|NCT01648101|537282273|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
148944580|NCT01648101|537282274|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
148944581|NCT01648101|537282275|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
148944582|NCT01648101|537282273|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
149201732|NCT03067129|538205446|FG002|Overall Study|Withdrawal by Subject|1|||
149201733|NCT03067129|538205447|FG003|Overall Study|Withdrawal by Subject|2|||
149201734|NCT03067129|538205444|FG000|Overall Study|Lost to Follow-up|5|||
149201735|NCT03067129|538205445|FG001|Overall Study|Lost to Follow-up|5|||
149201736|NCT03067129|538205446|FG002|Overall Study|Lost to Follow-up|4|||
149201737|NCT03067129|538205447|FG003|Overall Study|Lost to Follow-up|3|||
149201738|NCT03372603|538205448|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
149201739|NCT03372603|538205449|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
149201740|NCT03372603|538205448|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
149201741|NCT03372603|538205449|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
149201742|NCT03986190|538205450|FG000|Overall Study|Withdrawal by Subject|12|||
149201743|NCT03986190|538205451|FG001|Overall Study|Withdrawal by Subject|0|||
149201744|NCT04929613|538205452|FG000|Overall Study|Withdrawal by Subject|12|||
149201745|NCT00844649|538205458|FG000|Overall Study|Progressive Disease|196|||
149201746|NCT00844649|538205459|FG001|Overall Study|Progressive Disease|245|||
149201747|NCT00844649|538205458|FG000|Overall Study|Adverse Event|128|||
149201748|NCT00844649|538205459|FG001|Overall Study|Adverse Event|73|||
149201749|NCT00844649|538205458|FG000|Overall Study|Physician Decision|25|||
148944583|NCT01648101|537282274|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
148944584|NCT01648101|537282275|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
149201750|NCT00844649|538205459|FG001|Overall Study|Physician Decision|18|||
149201751|NCT00844649|538205458|FG000|Overall Study|Protocol Violation|10|||
149201752|NCT00844649|538205459|FG001|Overall Study|Protocol Violation|6|||
149201753|NCT00844649|538205458|FG000|Overall Study|Withdrawal by Subject|28|||
149201754|NCT00844649|538205459|FG001|Overall Study|Withdrawal by Subject|39|||
149201755|NCT00844649|538205458|FG000|Overall Study|Other|7|||
149201756|NCT00844649|538205459|FG001|Overall Study|Other|10|||
148682964|NCT01078623|536313044|FG016|Treatment Period 2|Adverse Event|0|||
148944585|NCT01648101|537282273|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
148944586|NCT01648101|537282274|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
148682965|NCT01078623|536313045|FG017|Treatment Period 2|Adverse Event|0|||
148944587|NCT01648101|537282275|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
149201757|NCT00844649|538205458|FG000|Overall Study|Withdrew prior to starting treatment|11|||
149201758|NCT00844649|538205459|FG001|Overall Study|Withdrew prior to starting treatment|27|||
149201759|NCT00664209|538205460|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
149201760|NCT00664209|538205460|FG000|Study Treatment Period|Physician Decision|4|||
149201761|NCT00664209|538205460|FG000|Study Treatment Period|Withdrawal by Subject|2|||
149201762|NCT02767856|538205461|FG000|Overall Study|Lost to Follow-up|9|||
149201763|NCT02767856|538205462|FG001|Overall Study|Lost to Follow-up|1|||
149201764|NCT02767856|538205461|FG000|Overall Study|Withdrawal by Subject|2|||
148944588|NCT01648101|537282273|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
148944589|NCT01648101|537282274|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
148682966|NCT01078623|536313046|FG018|Treatment Period 2|Adverse Event|1|||
149201765|NCT02767856|538205462|FG001|Overall Study|Withdrawal by Subject|1|||
149201766|NCT00418379|538205463|FG000|Year 1|Adverse Event|9|||
149201767|NCT00418379|538205464|FG001|Year 1|Adverse Event|15|||
149201768|NCT00418379|538205465|FG002|Year 1|Adverse Event|3|||
149201769|NCT00418379|538205463|FG000|Year 1|Withdrawal by Subject|7|||
149201770|NCT00418379|538205464|FG001|Year 1|Withdrawal by Subject|8|||
149201771|NCT00418379|538205465|FG002|Year 1|Withdrawal by Subject|5|||
149201772|NCT00418379|538205463|FG000|Year 1|Any other reason not above-mentioned|2|||
149201773|NCT00418379|538205464|FG001|Year 1|Any other reason not above-mentioned|5|||
149201774|NCT00418379|538205465|FG002|Year 1|Any other reason not above-mentioned|7|||
149201775|NCT00418379|538205463|FG000|Year 2|Adverse Event|5|||
149201776|NCT00418379|538205464|FG001|Year 2|Adverse Event|2|||
149201777|NCT00418379|538205465|FG002|Year 2|Adverse Event|1|||
149201778|NCT00418379|538205463|FG000|Year 2|Withdrawal by Subject|1|||
149201779|NCT00418379|538205464|FG001|Year 2|Withdrawal by Subject|1|||
149201780|NCT00418379|538205465|FG002|Year 2|Withdrawal by Subject|3|||
149201781|NCT00418379|538205463|FG000|Year 2|Any other reason not above-mentioned|2|||
149201782|NCT00418379|538205464|FG001|Year 2|Any other reason not above-mentioned|1|||
149201783|NCT00418379|538205465|FG002|Year 2|Any other reason not above-mentioned|6|||
149201784|NCT00418379|538205463|FG000|Year 3|Withdrawal by Subject|1|||
149201785|NCT00418379|538205464|FG001|Year 3|Withdrawal by Subject|1|||
149201786|NCT00418379|538205465|FG002|Year 3|Withdrawal by Subject|2|||
149201787|NCT00418379|538205463|FG000|Year 3|Any other reason not above-mentioned|2|||
149201788|NCT00418379|538205464|FG001|Year 3|Any other reason not above-mentioned|1|||
149201789|NCT00418379|538205465|FG002|Year 3|Any other reason not above-mentioned|1|||
149201790|NCT00418379|538205463|FG000|Year 4|Adverse Event|0|||
149201791|NCT00418379|538205464|FG001|Year 4|Adverse Event|1|||
149201792|NCT00418379|538205465|FG002|Year 4|Adverse Event|0|||
149201793|NCT00418379|538205463|FG000|Year 4|Withdrawal by Subject|2|||
149201794|NCT00418379|538205464|FG001|Year 4|Withdrawal by Subject|3|||
149201795|NCT00418379|538205465|FG002|Year 4|Withdrawal by Subject|2|||
149201796|NCT00418379|538205463|FG000|Year 4|Any other reason not above-mentioned|1|||
149201797|NCT00418379|538205464|FG001|Year 4|Any other reason not above-mentioned|1|||
149201798|NCT00418379|538205465|FG002|Year 4|Any other reason not above-mentioned|0|||
149201799|NCT00418379|538205463|FG000|Year 5|Adverse Event|0|||
149201800|NCT00418379|538205464|FG001|Year 5|Adverse Event|1|||
148808493|NCT02332707|536777515|FG008|Overall Study|Adverse Event|0|||
148808494|NCT02332707|536777516|FG009|Overall Study|Adverse Event|0|||
148808495|NCT02332707|536777517|FG010|Overall Study|Adverse Event|0|||
148808496|NCT02332707|536777518|FG011|Overall Study|Adverse Event|0|||
148808497|NCT02332707|536777519|FG012|Overall Study|Adverse Event|1|||
148808498|NCT02332707|536777520|FG013|Overall Study|Adverse Event|0|||
148808499|NCT02332707|536777521|FG014|Overall Study|Adverse Event|0|||
148808500|NCT02332707|536777522|FG015|Overall Study|Adverse Event|0|||
148808501|NCT02332707|536777523|FG016|Overall Study|Adverse Event|0|||
148808502|NCT02332707|536777524|FG017|Overall Study|Adverse Event|0|||
148808503|NCT02332707|536777507|FG000|Overall Study|Lost to Follow-up|0|||
148808504|NCT02332707|536777508|FG001|Overall Study|Lost to Follow-up|0|||
148808505|NCT02332707|536777509|FG002|Overall Study|Lost to Follow-up|0|||
148808506|NCT02332707|536777510|FG003|Overall Study|Lost to Follow-up|0|||
148808507|NCT02332707|536777511|FG004|Overall Study|Lost to Follow-up|0|||
148808508|NCT02332707|536777512|FG005|Overall Study|Lost to Follow-up|1|||
148808509|NCT02332707|536777513|FG006|Overall Study|Lost to Follow-up|0|||
148808510|NCT02332707|536777514|FG007|Overall Study|Lost to Follow-up|0|||
148808511|NCT02332707|536777515|FG008|Overall Study|Lost to Follow-up|0|||
148808512|NCT02332707|536777516|FG009|Overall Study|Lost to Follow-up|0|||
148808513|NCT02332707|536777517|FG010|Overall Study|Lost to Follow-up|2|||
148808514|NCT02332707|536777518|FG011|Overall Study|Lost to Follow-up|0|||
148808515|NCT02332707|536777519|FG012|Overall Study|Lost to Follow-up|3|||
148808516|NCT02332707|536777520|FG013|Overall Study|Lost to Follow-up|0|||
149201801|NCT00418379|538205465|FG002|Year 5|Adverse Event|0|||
149201802|NCT00418379|538205463|FG000|Year 5|Any other reason not above-mentioned|2|||
148808517|NCT02332707|536777521|FG014|Overall Study|Lost to Follow-up|0|||
148808518|NCT02332707|536777522|FG015|Overall Study|Lost to Follow-up|0|||
148808519|NCT02332707|536777523|FG016|Overall Study|Lost to Follow-up|0|||
148808520|NCT02332707|536777524|FG017|Overall Study|Lost to Follow-up|0|||
148808521|NCT02332707|536777507|FG000|Overall Study|Physician Decision|0|||
148808522|NCT02332707|536777508|FG001|Overall Study|Physician Decision|0|||
149201803|NCT00418379|538205464|FG001|Year 5|Any other reason not above-mentioned|4|||
149201804|NCT00418379|538205465|FG002|Year 5|Any other reason not above-mentioned|3|||
149201805|NCT00843843|538205466|FG000|Overall Study|Physician Decision|1|||
149201806|NCT00843843|538205467|FG001|Overall Study|Physician Decision|1|||
149201807|NCT00843843|538205466|FG000|Overall Study|Protocol Violation|1|||
148808523|NCT02332707|536777509|FG002|Overall Study|Physician Decision|0|||
148808524|NCT02332707|536777510|FG003|Overall Study|Physician Decision|1|||
148808525|NCT02332707|536777511|FG004|Overall Study|Physician Decision|0|||
148808526|NCT02332707|536777512|FG005|Overall Study|Physician Decision|0|||
148808527|NCT02332707|536777513|FG006|Overall Study|Physician Decision|0|||
148808528|NCT02332707|536777514|FG007|Overall Study|Physician Decision|0|||
148808529|NCT02332707|536777515|FG008|Overall Study|Physician Decision|0|||
148808530|NCT02332707|536777516|FG009|Overall Study|Physician Decision|0|||
148808531|NCT02332707|536777517|FG010|Overall Study|Physician Decision|0|||
148808532|NCT02332707|536777518|FG011|Overall Study|Physician Decision|0|||
148808533|NCT02332707|536777519|FG012|Overall Study|Physician Decision|1|||
148808534|NCT02332707|536777520|FG013|Overall Study|Physician Decision|0|||
148808535|NCT02332707|536777521|FG014|Overall Study|Physician Decision|0|||
148808536|NCT02332707|536777522|FG015|Overall Study|Physician Decision|0|||
148808537|NCT02332707|536777523|FG016|Overall Study|Physician Decision|0|||
148808538|NCT02332707|536777524|FG017|Overall Study|Physician Decision|0|||
148808539|NCT02332707|536777507|FG000|Overall Study|Withdrawal by Subject|0|||
148808540|NCT02332707|536777508|FG001|Overall Study|Withdrawal by Subject|0|||
148808541|NCT02332707|536777509|FG002|Overall Study|Withdrawal by Subject|1|||
148808542|NCT02332707|536777510|FG003|Overall Study|Withdrawal by Subject|0|||
148808543|NCT02332707|536777511|FG004|Overall Study|Withdrawal by Subject|0|||
148808544|NCT02332707|536777512|FG005|Overall Study|Withdrawal by Subject|0|||
148808545|NCT02332707|536777513|FG006|Overall Study|Withdrawal by Subject|0|||
148808546|NCT02332707|536777514|FG007|Overall Study|Withdrawal by Subject|0|||
148808547|NCT02332707|536777515|FG008|Overall Study|Withdrawal by Subject|0|||
148808548|NCT02332707|536777516|FG009|Overall Study|Withdrawal by Subject|3|||
148808549|NCT02332707|536777517|FG010|Overall Study|Withdrawal by Subject|0|||
148808550|NCT02332707|536777518|FG011|Overall Study|Withdrawal by Subject|0|||
148808551|NCT02332707|536777519|FG012|Overall Study|Withdrawal by Subject|0|||
148808552|NCT02332707|536777520|FG013|Overall Study|Withdrawal by Subject|0|||
148808553|NCT02332707|536777521|FG014|Overall Study|Withdrawal by Subject|0|||
148808554|NCT02332707|536777522|FG015|Overall Study|Withdrawal by Subject|0|||
148808555|NCT02332707|536777523|FG016|Overall Study|Withdrawal by Subject|0|||
148808556|NCT02332707|536777524|FG017|Overall Study|Withdrawal by Subject|0|||
148808557|NCT01473134|536777525|FG000|Overall Study|Lost to Follow-up|21|||
148808558|NCT01473134|536777526|FG001|Overall Study|Lost to Follow-up|13|||
148808559|NCT01473134|536777525|FG000|Overall Study|Protocol Violation|32|||
148808560|NCT01473134|536777526|FG001|Overall Study|Protocol Violation|19|||
148808561|NCT01473134|536777525|FG000|Overall Study|Withdrawal by Subject|1|||
148808562|NCT01473134|536777526|FG001|Overall Study|Withdrawal by Subject|2|||
148808563|NCT01473134|536777525|FG000|Overall Study|Death|0|||
148808564|NCT01473134|536777526|FG001|Overall Study|Death|1|||
148808565|NCT01473134|536777525|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
148808566|NCT01473134|536777526|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
148808567|NCT04761822|536777527|FG000|Overall Study|Adverse Event|3|||
148808568|NCT04761822|536777528|FG001|Overall Study|Adverse Event|1|||
148808569|NCT04761822|536777529|FG002|Overall Study|Adverse Event|1|||
148808570|NCT04761822|536777530|FG003|Overall Study|Adverse Event|3|||
148808571|NCT04761822|536777527|FG000|Overall Study|Lost to Follow-up|1|||
148808572|NCT04761822|536777528|FG001|Overall Study|Lost to Follow-up|0|||
148808573|NCT04761822|536777529|FG002|Overall Study|Lost to Follow-up|2|||
148808574|NCT04761822|536777530|FG003|Overall Study|Lost to Follow-up|3|||
148808575|NCT04761822|536777527|FG000|Overall Study|Physician Decision|0|||
148808576|NCT04761822|536777528|FG001|Overall Study|Physician Decision|1|||
148808577|NCT04761822|536777529|FG002|Overall Study|Physician Decision|0|||
148808578|NCT04761822|536777530|FG003|Overall Study|Physician Decision|0|||
148808579|NCT04761822|536777527|FG000|Overall Study|Withdrawal by Subject|3|||
148808580|NCT04761822|536777528|FG001|Overall Study|Withdrawal by Subject|8|||
148808581|NCT04761822|536777529|FG002|Overall Study|Withdrawal by Subject|1|||
148808582|NCT04761822|536777530|FG003|Overall Study|Withdrawal by Subject|11|||
148808583|NCT04761822|536777527|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
148808584|NCT04761822|536777528|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
148808585|NCT04761822|536777529|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
148808586|NCT04761822|536777530|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
148808587|NCT04761822|536777527|FG000|Overall Study|Participant requested unblinding|0|||
148808588|NCT04761822|536777528|FG001|Overall Study|Participant requested unblinding|0|||
148808589|NCT04761822|536777529|FG002|Overall Study|Participant requested unblinding|0|||
148808590|NCT04761822|536777530|FG003|Overall Study|Participant requested unblinding|1|||
148808591|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
148808592|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
148808593|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Death|1|||
148808594|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Death|3|||
148808595|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
148808596|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
148808597|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
148808598|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
148808599|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
148808600|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
148808601|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
148808602|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
148808603|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
148808604|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
148808605|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
148808606|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
148808607|NCT00362232|536777531|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
148808608|NCT00362232|536777532|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
148808609|NCT00362232|536777531|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
148808610|NCT00362232|536777532|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
148808611|NCT00362232|536777531|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
148808612|NCT00362232|536777532|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
148808613|NCT00362232|536777531|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
148808614|NCT00362232|536777532|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
148808615|NCT00362232|536777531|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
148808616|NCT00362232|536777532|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
148808617|NCT02233413|536777539|FG000|Overall Study|Lost to Follow-up|7|||
148808618|NCT02233413|536777540|FG001|Overall Study|Lost to Follow-up|9|||
148808619|NCT02233413|536777539|FG000|Overall Study|Withdrawal by Subject|4|||
148808620|NCT02233413|536777540|FG001|Overall Study|Withdrawal by Subject|5|||
148808621|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
148808622|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
148808623|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
148808624|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
148808625|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
148808626|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
148808627|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
148808628|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
148808629|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
148808630|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
148808631|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
148808632|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
148808633|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
148808634|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
148808635|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
148808636|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
148808637|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
148808638|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
148808639|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
148808640|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
148808641|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
148808642|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
148808643|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
148808644|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
148808645|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
148808646|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
148808647|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
149016265|NCT00337662|537537893|FG003|Study Period II|Sponsor Decision|2|||
149201808|NCT00843843|538205467|FG001|Overall Study|Protocol Violation|1|||
149201809|NCT01594333|538205468|FG000|Overall Study|Death|96|||
149201810|NCT01594333|538205469|FG001|Overall Study|Death|83|||
149201811|NCT01594333|538205468|FG000|Overall Study|Lost to Follow-up|5|||
149201812|NCT01594333|538205469|FG001|Overall Study|Lost to Follow-up|5|||
149201813|NCT01594333|538205468|FG000|Overall Study|Withdrawal by Subject|60|||
149201814|NCT01594333|538205469|FG001|Overall Study|Withdrawal by Subject|63|||
149201815|NCT01764256|538205470|FG000|Received All Vaccinations|Adverse Event|1|||
149201816|NCT01764256|538205471|FG001|Received All Vaccinations|Adverse Event|1|||
149201817|NCT01764256|538205472|FG002|Received All Vaccinations|Adverse Event|0|||
149201818|NCT01764256|538205473|FG003|Received All Vaccinations|Adverse Event|0|||
149201819|NCT01764256|538205470|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
149201820|NCT01764256|538205471|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
149201821|NCT01764256|538205472|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
149201822|NCT01764256|538205473|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
149201823|NCT01764256|538205470|FG000|Received All Vaccinations|Lost to Follow-up|1|||
149201824|NCT01764256|538205471|FG001|Received All Vaccinations|Lost to Follow-up|0|||
149201825|NCT01764256|538205472|FG002|Received All Vaccinations|Lost to Follow-up|0|||
149201826|NCT01764256|538205473|FG003|Received All Vaccinations|Lost to Follow-up|0|||
149201827|NCT01764256|538205470|FG000|Completed Study|Lost to Follow-up|0|||
149201828|NCT01764256|538205471|FG001|Completed Study|Lost to Follow-up|0|||
149201829|NCT01764256|538205472|FG002|Completed Study|Lost to Follow-up|0|||
149201830|NCT01764256|538205473|FG003|Completed Study|Lost to Follow-up|1|||
149201831|NCT00565058|538205474|FG000|Overall Study|Adverse Event|1|||
149201832|NCT00565058|538205475|FG001|Overall Study|Adverse Event|0|||
149201833|NCT00304915|538205476|FG000|Overall Study|Lost to Follow-up|11|||
149201834|NCT00304915|538205477|FG001|Overall Study|Lost to Follow-up|11|||
149201835|NCT00304915|538205476|FG000|Overall Study|Death|4|||
149201836|NCT00304915|538205477|FG001|Overall Study|Death|5|||
149201837|NCT00304915|538205476|FG000|Overall Study|Withdrawal by Subject|3|||
149201838|NCT00304915|538205477|FG001|Overall Study|Withdrawal by Subject|0|||
149201839|NCT02029638|538205478|FG000|Overall Study|Death|0|||
149201840|NCT02029638|538205479|FG001|Overall Study|Death|0|||
149201841|NCT02029638|538205480|FG002|Overall Study|Death|1|||
149201842|NCT02029638|538205478|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
149201843|NCT02029638|538205479|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
149201844|NCT02029638|538205480|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
149201845|NCT03428997|538205488|FG000|Overall Study|Sponsor decision.|1|||
149201846|NCT03428997|538205488|FG000|Overall Study|Withdrawal by Subject|3|||
149201847|NCT03428997|538205488|FG000|Overall Study|Lost to Follow-up|4|||
149201848|NCT01397448|538205492|FG000|Overall Study|Adverse Event|4|||
149201849|NCT01397448|538205493|FG001|Overall Study|Adverse Event|4|||
149201850|NCT01397448|538205494|FG002|Overall Study|Adverse Event|6|||
148682967|NCT01078623|536313047|FG019|Treatment Period 2|Adverse Event|0|||
148682968|NCT01078623|536313028|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148682969|NCT01078623|536313029|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148682970|NCT01078623|536313030|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148682971|NCT01078623|536313031|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148682972|NCT01078623|536313032|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148682973|NCT01078623|536313033|FG005|Treatment Period 2|Withdrawal by Subject|1|||
148682974|NCT01078623|536313034|FG006|Treatment Period 2|Withdrawal by Subject|0|||
148682975|NCT01078623|536313035|FG007|Treatment Period 2|Withdrawal by Subject|0|||
148682976|NCT01078623|536313036|FG008|Treatment Period 2|Withdrawal by Subject|0|||
148682977|NCT01078623|536313037|FG009|Treatment Period 2|Withdrawal by Subject|0|||
148682978|NCT01078623|536313038|FG010|Treatment Period 2|Withdrawal by Subject|0|||
148682979|NCT01078623|536313039|FG011|Treatment Period 2|Withdrawal by Subject|0|||
148682980|NCT01078623|536313040|FG012|Treatment Period 2|Withdrawal by Subject|0|||
148682981|NCT01078623|536313041|FG013|Treatment Period 2|Withdrawal by Subject|0|||
148682982|NCT01078623|536313042|FG014|Treatment Period 2|Withdrawal by Subject|0|||
148682983|NCT01078623|536313043|FG015|Treatment Period 2|Withdrawal by Subject|0|||
148682984|NCT01078623|536313044|FG016|Treatment Period 2|Withdrawal by Subject|0|||
148682985|NCT01078623|536313045|FG017|Treatment Period 2|Withdrawal by Subject|0|||
148682986|NCT01078623|536313046|FG018|Treatment Period 2|Withdrawal by Subject|0|||
149201851|NCT01397448|538205492|FG000|Overall Study|Withdrawal by Subject|4|||
149201852|NCT01397448|538205493|FG001|Overall Study|Withdrawal by Subject|4|||
148808648|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
149016266|NCT00337662|537537890|FG000|Study Period II|Parent/Caregiver Decision|0|||
149201853|NCT01397448|538205494|FG002|Overall Study|Withdrawal by Subject|3|||
149201854|NCT01397448|538205492|FG000|Overall Study|Lack of Efficacy|2|||
149201855|NCT01397448|538205493|FG001|Overall Study|Lack of Efficacy|0|||
149201856|NCT01397448|538205494|FG002|Overall Study|Lack of Efficacy|5|||
149201857|NCT01397448|538205492|FG000|Overall Study|Other|8|||
149201858|NCT01397448|538205493|FG001|Overall Study|Other|7|||
148682987|NCT01078623|536313047|FG019|Treatment Period 2|Withdrawal by Subject|0|||
148682988|NCT01078623|536313028|FG000|Treatment Period 3|Adverse Event|0|||
148682989|NCT01078623|536313029|FG001|Treatment Period 3|Adverse Event|0|||
149201859|NCT01397448|538205494|FG002|Overall Study|Other|4|||
148944590|NCT01648101|537282275|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
148944591|NCT01648101|537282273|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
148944592|NCT01648101|537282274|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
148944593|NCT01648101|537282275|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
148944594|NCT01648101|537282273|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
149201860|NCT02180217|538205499|FG000|Overall Study|Adverse Event|3|||
149201861|NCT02180217|538205500|FG001|Overall Study|Adverse Event|2|||
149201862|NCT02180217|538205501|FG002|Overall Study|Adverse Event|22|||
149201863|NCT02180217|538205499|FG000|Overall Study|Death|1|||
149201864|NCT02180217|538205500|FG001|Overall Study|Death|1|||
149201865|NCT02180217|538205501|FG002|Overall Study|Death|0|||
149201866|NCT02180217|538205499|FG000|Overall Study|Withdrawal by Subject|1|||
149201867|NCT02180217|538205500|FG001|Overall Study|Withdrawal by Subject|1|||
149201868|NCT02180217|538205501|FG002|Overall Study|Withdrawal by Subject|4|||
149201869|NCT02180217|538205499|FG000|Overall Study|Subject/Guardian decision|5|||
149201870|NCT02180217|538205500|FG001|Overall Study|Subject/Guardian decision|3|||
149201871|NCT02180217|538205501|FG002|Overall Study|Subject/Guardian decision|6|||
149201872|NCT02180217|538205499|FG000|Overall Study|Physician Decision|1|||
149201873|NCT02180217|538205500|FG001|Overall Study|Physician Decision|1|||
149201874|NCT02180217|538205501|FG002|Overall Study|Physician Decision|6|||
149201875|NCT02180217|538205499|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149201876|NCT02180217|538205500|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149201877|NCT02180217|538205501|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
149201878|NCT00239837|538205502|FG000|Overall Study|Lost to Follow-up|3|||
149201879|NCT00239837|538205503|FG001|Overall Study|Lost to Follow-up|7|||
149201880|NCT00536978|538205504|FG000|Overall Study|Not eligible for Adback Infusion|22|||
149201881|NCT00622869|538205510|FG000|Overall Study|Subject Withdrew Consent|13|||
149201882|NCT00622869|538205511|FG001|Overall Study|Subject Withdrew Consent|17|||
149201883|NCT00622869|538205512|FG002|Overall Study|Subject Withdrew Consent|11|||
149201884|NCT00622869|538205510|FG000|Overall Study|Administrative Problems|11|||
149201885|NCT00622869|538205511|FG001|Overall Study|Administrative Problems|17|||
149201886|NCT00622869|538205512|FG002|Overall Study|Administrative Problems|13|||
149201887|NCT00622869|538205510|FG000|Overall Study|Death|12|||
149201888|NCT00622869|538205511|FG001|Overall Study|Death|15|||
149201889|NCT00622869|538205512|FG002|Overall Study|Death|10|||
149201890|NCT00622869|538205510|FG000|Overall Study|Lost to Follow-up|2|||
149201891|NCT00622869|538205511|FG001|Overall Study|Lost to Follow-up|4|||
149201892|NCT00622869|538205512|FG002|Overall Study|Lost to Follow-up|2|||
149201893|NCT00622869|538205510|FG000|Overall Study|Graft Loss|5|||
149201894|NCT00622869|538205511|FG001|Overall Study|Graft Loss|3|||
148944595|NCT01648101|537282274|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
149201895|NCT00622869|538205512|FG002|Overall Study|Graft Loss|2|||
149201896|NCT00622869|538205510|FG000|Overall Study|Missing|0|||
149201897|NCT00622869|538205511|FG001|Overall Study|Missing|1|||
149201898|NCT00622869|538205512|FG002|Overall Study|Missing|1|||
148944596|NCT01648101|537282275|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
148944597|NCT01648101|537282273|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
148944598|NCT01648101|537282274|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
148944599|NCT01648101|537282275|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
148944600|NCT01648101|537282273|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
148944601|NCT01648101|537282274|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
148944602|NCT01648101|537282275|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
148944603|NCT01648101|537282273|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
148944604|NCT01648101|537282274|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
148944605|NCT01648101|537282275|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
148944606|NCT01648101|537282273|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
148944607|NCT01648101|537282274|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
148944608|NCT01648101|537282275|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
148944609|NCT02469298|537282292|FG000|Overall Study|Protocol Violation|0|||
148944610|NCT02469298|537282293|FG001|Overall Study|Protocol Violation|1|||
148944611|NCT02469298|537282294|FG002|Overall Study|Protocol Violation|1|||
148944612|NCT02469298|537282295|FG003|Overall Study|Protocol Violation|0|||
148944613|NCT02469298|537282292|FG000|Overall Study|Lost to Follow-up|1|||
148808649|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
148808650|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
148944614|NCT02469298|537282293|FG001|Overall Study|Lost to Follow-up|0|||
148944615|NCT02469298|537282294|FG002|Overall Study|Lost to Follow-up|1|||
148944616|NCT02469298|537282295|FG003|Overall Study|Lost to Follow-up|0|||
148944617|NCT02469298|537282292|FG000|Overall Study|Physician Decision|0|||
148944618|NCT02469298|537282293|FG001|Overall Study|Physician Decision|0|||
148944619|NCT02469298|537282294|FG002|Overall Study|Physician Decision|0|||
149201899|NCT03076190|538205514|FG000|Overall Study|Lost to Follow-up|9|||
149201900|NCT03076190|538205515|FG001|Overall Study|Lost to Follow-up|34|||
149201901|NCT03076190|538205514|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
148944620|NCT02469298|537282295|FG003|Overall Study|Physician Decision|1|||
148944621|NCT02469298|537282292|FG000|Overall Study|Withdrawal by Subject|0|||
148944622|NCT02469298|537282293|FG001|Overall Study|Withdrawal by Subject|0|||
148944623|NCT02469298|537282294|FG002|Overall Study|Withdrawal by Subject|0|||
148944624|NCT02469298|537282295|FG003|Overall Study|Withdrawal by Subject|1|||
148944625|NCT03311724|537282298|FG000|Overall Study|Physician Decision|0|||
148944626|NCT03311724|537282299|FG001|Overall Study|Physician Decision|0|||
148944627|NCT03311724|537282300|FG002|Overall Study|Physician Decision|0|||
148944628|NCT03311724|537282301|FG003|Overall Study|Physician Decision|1|||
148944629|NCT03311724|537282298|FG000|Overall Study|Protocol Violation|1|||
148944630|NCT03311724|537282299|FG001|Overall Study|Protocol Violation|0|||
148944631|NCT03311724|537282300|FG002|Overall Study|Protocol Violation|1|||
148944632|NCT03311724|537282301|FG003|Overall Study|Protocol Violation|0|||
148944633|NCT03311724|537282298|FG000|Overall Study|Withdrawal by Subject|1|||
148944634|NCT03311724|537282299|FG001|Overall Study|Withdrawal by Subject|1|||
148944635|NCT03311724|537282300|FG002|Overall Study|Withdrawal by Subject|0|||
148944636|NCT03311724|537282301|FG003|Overall Study|Withdrawal by Subject|0|||
148944637|NCT03311724|537282298|FG000|Overall Study|Lost to Follow-up|1|||
148944638|NCT03311724|537282299|FG001|Overall Study|Lost to Follow-up|0|||
148944639|NCT03311724|537282300|FG002|Overall Study|Lost to Follow-up|0|||
148944640|NCT03311724|537282301|FG003|Overall Study|Lost to Follow-up|0|||
148944641|NCT03311724|537282298|FG000|Overall Study|Sponsor Decision|0|||
148944642|NCT03311724|537282299|FG001|Overall Study|Sponsor Decision|0|||
148944643|NCT03311724|537282300|FG002|Overall Study|Sponsor Decision|1|||
148944644|NCT03311724|537282301|FG003|Overall Study|Sponsor Decision|0|||
148944645|NCT01408485|537282306|FG000|Overall Study|Withdrawal by Subject|21|||
148944646|NCT01397084|537282307|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
148944647|NCT01397084|537282307|FG000|Overall Study|Protocol Violation|2|||
148944648|NCT01397084|537282307|FG000|Overall Study|Adverse Event|2|||
148944649|NCT01397084|537282307|FG000|Overall Study|Withdrawal by Subject|1|||
148944650|NCT01397084|537282307|FG000|Overall Study|Lost to Follow-up|1|||
148944651|NCT01397084|537282307|FG000|Overall Study|Used other proton pump inhibitor|1|||
148944652|NCT01751867|537282308|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
149201902|NCT03076190|538205515|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
149201903|NCT00870818|538205516|FG000|Overall Study|Lost to Follow-up|3|||
149201904|NCT00870818|538205517|FG001|Overall Study|Lost to Follow-up|2|||
149201905|NCT00870818|538205518|FG002|Overall Study|Lost to Follow-up|1|||
149201906|NCT00870818|538205519|FG003|Overall Study|Lost to Follow-up|0|||
149201907|NCT00870818|538205520|FG004|Overall Study|Lost to Follow-up|0|||
149201908|NCT00870818|538205516|FG000|Overall Study|Withdrawal by Subject|0|||
149201909|NCT00870818|538205517|FG001|Overall Study|Withdrawal by Subject|0|||
149201910|NCT00870818|538205518|FG002|Overall Study|Withdrawal by Subject|1|||
149201911|NCT00870818|538205519|FG003|Overall Study|Withdrawal by Subject|2|||
149201912|NCT00870818|538205520|FG004|Overall Study|Withdrawal by Subject|0|||
149201913|NCT00870818|538205516|FG000|Overall Study|Terminated by sponsor|29|||
149201914|NCT00870818|538205517|FG001|Overall Study|Terminated by sponsor|70|||
149201915|NCT00870818|538205518|FG002|Overall Study|Terminated by sponsor|36|||
149201916|NCT00870818|538205519|FG003|Overall Study|Terminated by sponsor|36|||
149201917|NCT00870818|538205520|FG004|Overall Study|Terminated by sponsor|38|||
149201918|NCT00870818|538205516|FG000|Overall Study|Other|0|||
149201919|NCT00870818|538205517|FG001|Overall Study|Other|1|||
149201920|NCT00870818|538205518|FG002|Overall Study|Other|0|||
149201921|NCT00870818|538205519|FG003|Overall Study|Other|0|||
149201922|NCT00870818|538205520|FG004|Overall Study|Other|0|||
149201923|NCT06025396|538207326|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
149201924|NCT06025396|538207327|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
149201925|NCT06025396|538207328|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
149201926|NCT06025396|538207329|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
149201927|NCT06025396|538207330|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
149201928|NCT06025396|538207326|FG000|Overall Study|Withdrawal by Subject|0|||
149201929|NCT06025396|538207327|FG001|Overall Study|Withdrawal by Subject|1|||
149201930|NCT06025396|538207328|FG002|Overall Study|Withdrawal by Subject|1|||
149201931|NCT06025396|538207329|FG003|Overall Study|Withdrawal by Subject|0|||
149201932|NCT06025396|538207330|FG004|Overall Study|Withdrawal by Subject|0|||
149016267|NCT00337662|537537891|FG001|Study Period II|Parent/Caregiver Decision|0|||
149201933|NCT01512108|538207331|FG000|Overall Study|Adverse Event|9|||
148944653|NCT01751867|537282309|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
148944654|NCT01751867|537282308|FG000|Overall Study|Diease Progression|4|||
148944655|NCT01751867|537282309|FG001|Overall Study|Diease Progression|18|||
148944656|NCT01751867|537282308|FG000|Overall Study|Adverse Event|8|||
148944657|NCT01751867|537282309|FG001|Overall Study|Adverse Event|15|||
148944658|NCT01751867|537282308|FG000|Overall Study|Poor Compliance|0|||
148944659|NCT01751867|537282309|FG001|Overall Study|Poor Compliance|5|||
148944660|NCT01751867|537282308|FG000|Overall Study|Withdrawal by Subject|3|||
148944661|NCT01751867|537282309|FG001|Overall Study|Withdrawal by Subject|1|||
148944662|NCT01751867|537282308|FG000|Overall Study|Physician Decision|4|||
148944663|NCT01751867|537282309|FG001|Overall Study|Physician Decision|7|||
148944664|NCT01751867|537282308|FG000|Overall Study|Protocol Violation|0|||
148944665|NCT01751867|537282309|FG001|Overall Study|Protocol Violation|2|||
148944666|NCT01751867|537282308|FG000|Overall Study|Death|0|||
148944667|NCT01751867|537282309|FG001|Overall Study|Death|5|||
148944668|NCT01751867|537282308|FG000|Overall Study|Other|11|||
148944669|NCT01751867|537282309|FG001|Overall Study|Other|37|||
148944670|NCT01751867|537282308|FG000|Overall Study|Randomized but not treated.|2|||
148944671|NCT01751867|537282309|FG001|Overall Study|Randomized but not treated.|1|||
148944672|NCT04932096|537282310|FG000|Overall Study|Withdrawal by Subject|1|||
148944673|NCT04932096|537282311|FG001|Overall Study|Withdrawal by Subject|1|||
148944674|NCT04932096|537282310|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
148944675|NCT04932096|537282311|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
148944676|NCT01508650|537282312|FG000|Overall Study|Lost to Follow-up|0|||
148944677|NCT01508650|537282313|FG001|Overall Study|Lost to Follow-up|3|||
148944678|NCT02064894|537282314|FG000|Overall Study|Withdrawal by Subject|43|||
148944679|NCT02064894|537282315|FG001|Overall Study|Withdrawal by Subject|102|||
148944680|NCT02064894|537282316|FG002|Overall Study|Withdrawal by Subject|115|||
148944681|NCT00160693|537282317|FG000|Overall Study|Adverse Event|97|||
148944682|NCT00160693|537282317|FG000|Overall Study|Lack of Efficacy|30|||
148944683|NCT00160693|537282317|FG000|Overall Study|Protocol Violation|24|||
148944684|NCT00160693|537282317|FG000|Overall Study|Lost to Follow-up|15|||
148944685|NCT00160693|537282317|FG000|Overall Study|Withdrawal by Subject|54|||
148944686|NCT00160693|537282317|FG000|Overall Study|Study terminated by sponsor|15|||
148944687|NCT05988619|537282319|FG000|Overall Study|Lost to Follow-up|1|||
148944688|NCT05988619|537282320|FG001|Overall Study|Lost to Follow-up|4|||
148944689|NCT05988619|537282319|FG000|Overall Study|Withdrawal by Subject|2|||
148944690|NCT05988619|537282320|FG001|Overall Study|Withdrawal by Subject|9|||
148944691|NCT00587054|537282323|FG000|Overall Study|Patient not treated|9|||
148944692|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Death|0|||
148944693|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Death|0|||
148944694|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Death|0|||
148944695|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Death|0|||
148944696|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Death|1|||
148944697|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Death|0|||
148944698|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Death|0|||
148944699|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Death|0|||
148944700|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
148944701|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
148944702|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
148944703|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
148944704|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
148944705|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
148944706|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
148944707|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
148944708|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
148944709|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
148944710|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
148944711|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
148944712|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
148944713|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
148944714|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
148944715|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
148682990|NCT01078623|536313030|FG002|Treatment Period 3|Adverse Event|0|||
148682991|NCT01078623|536313031|FG003|Treatment Period 3|Adverse Event|0|||
148944716|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
148944717|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
148944718|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
148944719|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
148944720|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
148944721|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
148944722|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
148944723|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
148682992|NCT01078623|536313032|FG004|Treatment Period 3|Adverse Event|1|||
148944724|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
148944725|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
148944726|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
148944727|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
148944728|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
148944729|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
148944730|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
148944731|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
148944732|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
148944733|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
148944734|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
148944735|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
148944736|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
148944737|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
148944738|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
148944739|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
148944740|NCT00726232|537282325|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
148944741|NCT00726232|537282326|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944742|NCT00726232|537282327|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944743|NCT00726232|537282328|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944744|NCT00726232|537282329|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944745|NCT00726232|537282330|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944746|NCT00726232|537282331|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944747|NCT00726232|537282332|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
148944748|NCT00726232|537282325|FG000|Expansion Phase|Death|0|||
148944749|NCT00726232|537282326|FG001|Expansion Phase|Death|0|||
148944750|NCT00726232|537282327|FG002|Expansion Phase|Death|0|||
148944751|NCT00726232|537282328|FG003|Expansion Phase|Death|0|||
148944752|NCT00726232|537282329|FG004|Expansion Phase|Death|0|||
148944753|NCT00726232|537282330|FG005|Expansion Phase|Death|0|||
148944754|NCT00726232|537282331|FG006|Expansion Phase|Death|0|||
148944755|NCT00726232|537282332|FG007|Expansion Phase|Death|1|||
148944756|NCT00726232|537282325|FG000|Expansion Phase|Adverse Event|0|||
148944757|NCT00726232|537282326|FG001|Expansion Phase|Adverse Event|0|||
148944758|NCT00726232|537282327|FG002|Expansion Phase|Adverse Event|0|||
148944759|NCT00726232|537282328|FG003|Expansion Phase|Adverse Event|0|||
148944760|NCT00726232|537282329|FG004|Expansion Phase|Adverse Event|0|||
148944761|NCT00726232|537282330|FG005|Expansion Phase|Adverse Event|0|||
148944762|NCT00726232|537282331|FG006|Expansion Phase|Adverse Event|6|||
148944763|NCT00726232|537282332|FG007|Expansion Phase|Adverse Event|11|||
148944764|NCT00726232|537282325|FG000|Expansion Phase|Withdrawal by Subject|0|||
148944765|NCT00726232|537282326|FG001|Expansion Phase|Withdrawal by Subject|0|||
148944766|NCT00726232|537282327|FG002|Expansion Phase|Withdrawal by Subject|0|||
148944767|NCT00726232|537282328|FG003|Expansion Phase|Withdrawal by Subject|0|||
148944768|NCT00726232|537282329|FG004|Expansion Phase|Withdrawal by Subject|0|||
148944769|NCT00726232|537282330|FG005|Expansion Phase|Withdrawal by Subject|0|||
148944770|NCT00726232|537282331|FG006|Expansion Phase|Withdrawal by Subject|2|||
148944771|NCT00726232|537282332|FG007|Expansion Phase|Withdrawal by Subject|3|||
148944772|NCT00726232|537282325|FG000|Expansion Phase|Disease progression|0|||
148944773|NCT00726232|537282326|FG001|Expansion Phase|Disease progression|0|||
148944774|NCT00726232|537282327|FG002|Expansion Phase|Disease progression|0|||
148944775|NCT00726232|537282328|FG003|Expansion Phase|Disease progression|0|||
148944776|NCT00726232|537282329|FG004|Expansion Phase|Disease progression|0|||
148944777|NCT00726232|537282330|FG005|Expansion Phase|Disease progression|0|||
148944778|NCT00726232|537282331|FG006|Expansion Phase|Disease progression|4|||
148944779|NCT00726232|537282332|FG007|Expansion Phase|Disease progression|0|||
148944780|NCT00726232|537282325|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
148944781|NCT00726232|537282326|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
148944782|NCT00726232|537282327|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
148944783|NCT00726232|537282328|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
148944784|NCT00726232|537282329|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
148944785|NCT00726232|537282330|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
148944786|NCT00726232|537282331|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
148944787|NCT00726232|537282332|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
148944788|NCT00726232|537282325|FG000|Expansion Phase|Per Investigator: lack of response|0|||
148944789|NCT00726232|537282326|FG001|Expansion Phase|Per Investigator: lack of response|0|||
148944790|NCT00726232|537282327|FG002|Expansion Phase|Per Investigator: lack of response|0|||
148944791|NCT00726232|537282328|FG003|Expansion Phase|Per Investigator: lack of response|0|||
148944792|NCT00726232|537282329|FG004|Expansion Phase|Per Investigator: lack of response|0|||
148944793|NCT00726232|537282330|FG005|Expansion Phase|Per Investigator: lack of response|0|||
148944794|NCT00726232|537282331|FG006|Expansion Phase|Per Investigator: lack of response|1|||
148944795|NCT00726232|537282332|FG007|Expansion Phase|Per Investigator: lack of response|7|||
148944796|NCT00726232|537282325|FG000|Expansion Phase|Unspecified reason|0|||
148944797|NCT00726232|537282326|FG001|Expansion Phase|Unspecified reason|0|||
148944798|NCT00726232|537282327|FG002|Expansion Phase|Unspecified reason|0|||
148944799|NCT00726232|537282328|FG003|Expansion Phase|Unspecified reason|0|||
148944800|NCT00726232|537282329|FG004|Expansion Phase|Unspecified reason|0|||
148944801|NCT00726232|537282330|FG005|Expansion Phase|Unspecified reason|0|||
148944802|NCT00726232|537282331|FG006|Expansion Phase|Unspecified reason|1|||
148944803|NCT00726232|537282332|FG007|Expansion Phase|Unspecified reason|0|||
148944804|NCT01651039|537282333|FG000|Overall Study|Non-evaluables|5|||
148944805|NCT01651039|537282333|FG000|Overall Study|Physician Decision|2|||
148944806|NCT01651039|537282333|FG000|Overall Study|Withdrawal by Subject|1|||
148944807|NCT01651039|537282333|FG000|Overall Study|Progressive Disease|22|||
148944808|NCT00709761|537282334|FG000|Overall Study|Withdrawal by Subject|8|||
148944809|NCT00709761|537282334|FG000|Overall Study|study closed/terminated|17|||
148944810|NCT00709761|537282334|FG000|Overall Study|Lost to Follow-up|2|||
148944811|NCT03600818|537282335|FG000|Overall Study|Adverse Event|4|||
148944812|NCT03600818|537282336|FG001|Overall Study|Adverse Event|7|||
148944813|NCT03600818|537282335|FG000|Overall Study|Lack of Efficacy|9|||
148944814|NCT03600818|537282336|FG001|Overall Study|Lack of Efficacy|4|||
148944815|NCT03600818|537282335|FG000|Overall Study|Withdrawal by Subject|4|||
148944816|NCT03600818|537282336|FG001|Overall Study|Withdrawal by Subject|3|||
148944817|NCT03600818|537282335|FG000|Overall Study|Other-unspecified|5|||
148944818|NCT03600818|537282336|FG001|Overall Study|Other-unspecified|3|||
148944819|NCT03600818|537282335|FG000|Overall Study|Randomized and not treated|0|||
148944820|NCT03600818|537282336|FG001|Overall Study|Randomized and not treated|1|||
148944821|NCT01488370|537282339|FG000|Overall Study|Protocol Violation|0|||
148944822|NCT01488370|537282340|FG001|Overall Study|Protocol Violation|1|||
148944823|NCT01488370|537282341|FG002|Overall Study|Protocol Violation|1|||
148944824|NCT03478930|537282343|FG000|Overall Study|Adverse Event|0|||
148944825|NCT03478930|537282344|FG001|Overall Study|Adverse Event|1|||
148944826|NCT03478930|537282343|FG000|Overall Study|Lack of Efficacy|3|||
148944827|NCT03478930|537282344|FG001|Overall Study|Lack of Efficacy|3|||
148944828|NCT03478930|537282343|FG000|Overall Study|Withdrawal by Subject|6|||
148944829|NCT03478930|537282344|FG001|Overall Study|Withdrawal by Subject|5|||
148944830|NCT04189081|537282345|FG000|Overall Study|Lost to Follow-up|1|||
148944831|NCT04189081|537282346|FG001|Overall Study|Lost to Follow-up|0|||
148944832|NCT04189081|537282347|FG002|Overall Study|Lost to Follow-up|0|||
148944833|NCT04189081|537282345|FG000|Overall Study|Withdrawal by Subject|0|||
148944834|NCT04189081|537282346|FG001|Overall Study|Withdrawal by Subject|0|||
148944835|NCT04189081|537282347|FG002|Overall Study|Withdrawal by Subject|1|||
148944836|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
148944837|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
148944838|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
148944839|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
148944840|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
148944841|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
148944842|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
148944843|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
148944844|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
148944845|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
148944846|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
148944847|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
148944848|NCT00044083|537282348|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
148682993|NCT01078623|536313033|FG005|Treatment Period 3|Adverse Event|0|||
148944849|NCT00044083|537282349|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
148944850|NCT00044083|537282348|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
148944851|NCT00044083|537282349|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
148944852|NCT00044083|537282348|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
148944853|NCT00044083|537282349|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
148944854|NCT00044083|537282348|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
148944855|NCT00044083|537282349|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
148944856|NCT00553644|537282350|FG000|Overall Study|Adverse Event|17|||
148944857|NCT00553644|537282350|FG000|Overall Study|Withdrawal by Subject|4|||
148944858|NCT00553644|537282350|FG000|Overall Study|Physician Decision|1|||
148944859|NCT00553644|537282350|FG000|Overall Study|Alternative therapy|6|||
148944860|NCT00705484|537282351|FG000|Overall Study|Adverse Event|28|||
148944861|NCT00705484|537282352|FG001|Overall Study|Adverse Event|27|||
148944862|NCT00705484|537282351|FG000|Overall Study|Lost to Follow-up|169|||
148944863|NCT00705484|537282352|FG001|Overall Study|Lost to Follow-up|250|||
148944864|NCT00705484|537282351|FG000|Overall Study|Withdrawal by Subject|96|||
148944865|NCT00705484|537282352|FG001|Overall Study|Withdrawal by Subject|72|||
148944866|NCT00705484|537282351|FG000|Overall Study|Administrative|89|||
148944867|NCT00705484|537282352|FG001|Overall Study|Administrative|59|||
148944868|NCT00851747|537282354|FG000|Overall Study|Physician Decision|6|||
148944869|NCT00851747|537282355|FG001|Overall Study|Physician Decision|6|||
148944870|NCT00851747|537282356|FG002|Overall Study|Physician Decision|6|||
148944871|NCT00119106|537282361|FG000|Overall Study|HIV infected at baseline|179|||
148944872|NCT00119106|537282362|FG001|Overall Study|HIV infected at baseline|178|||
148944873|NCT01010061|537282363|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
148944874|NCT01010061|537282364|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
148944875|NCT01010061|537282363|FG000|Overall Study|Disease Progression|2|||
148944876|NCT01010061|537282364|FG001|Overall Study|Disease Progression|8|||
148944877|NCT01010061|537282363|FG000|Overall Study|Withdrew Consent|5|||
148944878|NCT01010061|537282364|FG001|Overall Study|Withdrew Consent|1|||
148944879|NCT01010061|537282363|FG000|Overall Study|Death|3|||
148944880|NCT01010061|537282364|FG001|Overall Study|Death|6|||
148944881|NCT01010061|537282363|FG000|Overall Study|Administrative/Other|0|||
148944882|NCT01010061|537282364|FG001|Overall Study|Administrative/Other|1|||
148944883|NCT01010061|537282363|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
148944884|NCT01010061|537282364|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
148944885|NCT01010061|537282363|FG000|Overall Study|Insufficient Therapeutic Response|1|||
148944886|NCT01010061|537282364|FG001|Overall Study|Insufficient Therapeutic Response|5|||
148944887|NCT01010061|537282363|FG000|Overall Study|Violation of Selection Criteria|0|||
148944888|NCT01010061|537282364|FG001|Overall Study|Violation of Selection Criteria|1|||
148944889|NCT01010061|537282363|FG000|Overall Study|Did Not Receive Treatment|2|||
148944890|NCT01010061|537282364|FG001|Overall Study|Did Not Receive Treatment|2|||
148944891|NCT03470441|537282368|FG000|Overall Study|Death|0|||
148944892|NCT03470441|537282369|FG001|Overall Study|Death|1|||
148944893|NCT03470441|537282370|FG002|Overall Study|Death|1|||
148944894|NCT03470441|537282371|FG003|Overall Study|Death|0|||
148944895|NCT03470441|537282368|FG000|Overall Study|Adverse Event|0|||
148944896|NCT03470441|537282369|FG001|Overall Study|Adverse Event|0|||
148944897|NCT03470441|537282370|FG002|Overall Study|Adverse Event|0|||
148944898|NCT03470441|537282371|FG003|Overall Study|Adverse Event|1|||
148944899|NCT03470441|537282368|FG000|Overall Study|Withdrawal by Subject|1|||
148944900|NCT03470441|537282369|FG001|Overall Study|Withdrawal by Subject|4|||
148944901|NCT03470441|537282370|FG002|Overall Study|Withdrawal by Subject|1|||
148944902|NCT03470441|537282371|FG003|Overall Study|Withdrawal by Subject|3|||
148944903|NCT01203098|537282375|FG000|Overall Study|Adverse Event|3|||
148944904|NCT01203098|537282376|FG001|Overall Study|Adverse Event|1|||
148944905|NCT01203098|537282377|FG002|Overall Study|Adverse Event|7|||
148944906|NCT01203098|537282375|FG000|Overall Study|Lost to Follow-up|0|||
148944907|NCT01203098|537282376|FG001|Overall Study|Lost to Follow-up|0|||
148944908|NCT01203098|537282377|FG002|Overall Study|Lost to Follow-up|1|||
148944909|NCT01203098|537282375|FG000|Overall Study|Physician Decision|2|||
148944910|NCT01203098|537282376|FG001|Overall Study|Physician Decision|2|||
148944911|NCT01203098|537282377|FG002|Overall Study|Physician Decision|0|||
148944912|NCT01203098|537282375|FG000|Overall Study|Withdrawal by Subject|1|||
148944913|NCT01203098|537282376|FG001|Overall Study|Withdrawal by Subject|1|||
148682994|NCT01078623|536313034|FG006|Treatment Period 3|Adverse Event|0|||
148682995|NCT01078623|536313035|FG007|Treatment Period 3|Adverse Event|0|||
148682996|NCT01078623|536313036|FG008|Treatment Period 3|Adverse Event|0|||
148682997|NCT01078623|536313037|FG009|Treatment Period 3|Adverse Event|0|||
148944914|NCT01203098|537282377|FG002|Overall Study|Withdrawal by Subject|3|||
148944915|NCT02197520|537282380|FG000|Period 1|Withdrawal by Subject|1|||
148944916|NCT02197520|537282381|FG001|Period 1|Withdrawal by Subject|0|||
148944917|NCT02197520|537282380|FG000|Period 2|Adverse Event|0|||
148944918|NCT02197520|537282381|FG001|Period 2|Adverse Event|2|||
148944919|NCT02197520|537282380|FG000|Period 2|Withdrawal by Subject|1|||
148944920|NCT02197520|537282381|FG001|Period 2|Withdrawal by Subject|0|||
148944921|NCT00913497|537282382|FG000|Overall Study|Adverse Event|1|||
148944922|NCT00913497|537282382|FG000|Overall Study|Withdrawal by Subject|2|||
148944923|NCT03385564|537282383|FG000|Overall Study|Adverse Event|0|||
148944924|NCT03385564|537282384|FG001|Overall Study|Adverse Event|0|||
148682998|NCT01078623|536313038|FG010|Treatment Period 3|Adverse Event|0|||
148944925|NCT03385564|537282385|FG002|Overall Study|Adverse Event|3|||
148682999|NCT01078623|536313039|FG011|Treatment Period 3|Adverse Event|0|||
148944926|NCT03385564|537282386|FG003|Overall Study|Adverse Event|3|||
148944927|NCT03385564|537282383|FG000|Overall Study|Other than listed|0|||
148944928|NCT03385564|537282384|FG001|Overall Study|Other than listed|0|||
148683000|NCT01078623|536313040|FG012|Treatment Period 3|Adverse Event|0|||
148683001|NCT01078623|536313041|FG013|Treatment Period 3|Adverse Event|1|||
148808651|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
148808652|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
148944929|NCT03385564|537282385|FG002|Overall Study|Other than listed|0|||
148944930|NCT03385564|537282386|FG003|Overall Study|Other than listed|5|||
148944931|NCT03385564|537282383|FG000|Overall Study|Withdrawal by Subject|0|||
148944932|NCT03385564|537282384|FG001|Overall Study|Withdrawal by Subject|1|||
148944933|NCT03385564|537282385|FG002|Overall Study|Withdrawal by Subject|1|||
148944934|NCT03385564|537282386|FG003|Overall Study|Withdrawal by Subject|0|||
148944935|NCT03385564|537282383|FG000|Overall Study|Lack of Efficacy|0|||
148944936|NCT03385564|537282384|FG001|Overall Study|Lack of Efficacy|0|||
148944937|NCT03385564|537282385|FG002|Overall Study|Lack of Efficacy|0|||
148944938|NCT03385564|537282386|FG003|Overall Study|Lack of Efficacy|1|||
148944939|NCT03385564|537282383|FG000|Overall Study|Death|0|||
148944940|NCT03385564|537282384|FG001|Overall Study|Death|0|||
148944941|NCT03385564|537282385|FG002|Overall Study|Death|1|||
148944942|NCT03385564|537282386|FG003|Overall Study|Death|0|||
148944943|NCT03087643|537282391|FG000|Overall Study|Withdrawal by Subject|2|||
148944944|NCT03087643|537282392|FG001|Overall Study|Withdrawal by Subject|4|||
148944945|NCT03087643|537282391|FG000|Overall Study|Death|2|||
148944946|NCT03087643|537282392|FG001|Overall Study|Death|2|||
148944947|NCT02256631|537282396|FG000|Overall Study|Lost to Follow-up|1|||
148944948|NCT02256631|537282397|FG001|Overall Study|Lost to Follow-up|1|||
148944949|NCT02256631|537282398|FG002|Overall Study|Lost to Follow-up|0|||
148944950|NCT02256631|537282399|FG003|Overall Study|Lost to Follow-up|2|||
148944951|NCT02256631|537282400|FG004|Overall Study|Lost to Follow-up|0|||
148944952|NCT02256631|537282401|FG005|Overall Study|Lost to Follow-up|4|||
148944953|NCT02256631|537282402|FG006|Overall Study|Lost to Follow-up|1|||
148944954|NCT02256631|537282396|FG000|Overall Study|Withdrawal by Subject|0|||
148944955|NCT02256631|537282397|FG001|Overall Study|Withdrawal by Subject|0|||
148944956|NCT02256631|537282398|FG002|Overall Study|Withdrawal by Subject|0|||
148944957|NCT02256631|537282399|FG003|Overall Study|Withdrawal by Subject|1|||
148944958|NCT02256631|537282400|FG004|Overall Study|Withdrawal by Subject|1|||
148944959|NCT02256631|537282401|FG005|Overall Study|Withdrawal by Subject|0|||
148944960|NCT02256631|537282402|FG006|Overall Study|Withdrawal by Subject|1|||
148944961|NCT02256631|537282396|FG000|Overall Study|Unable to get to clinic|0|||
148944962|NCT02256631|537282397|FG001|Overall Study|Unable to get to clinic|2|||
148944963|NCT02256631|537282398|FG002|Overall Study|Unable to get to clinic|0|||
148944964|NCT02256631|537282399|FG003|Overall Study|Unable to get to clinic|1|||
148944965|NCT02256631|537282400|FG004|Overall Study|Unable to get to clinic|0|||
149201934|NCT01512108|538207332|FG001|Overall Study|Adverse Event|4|||
149201935|NCT01512108|538207331|FG000|Overall Study|Protocol Violation|1|||
149201936|NCT01512108|538207332|FG001|Overall Study|Protocol Violation|2|||
149201937|NCT01512108|538207331|FG000|Overall Study|Withdrawal Criteria|1|||
149201938|NCT01512108|538207332|FG001|Overall Study|Withdrawal Criteria|0|||
149201939|NCT01512108|538207331|FG000|Overall Study|Unclassified|11|||
149201940|NCT01512108|538207332|FG001|Overall Study|Unclassified|3|||
149201941|NCT06422377|538207335|FG000|Overall Study|Study Terminated by Sponsor|1|||
149201942|NCT02017899|538207336|FG000|Overall Study|Withdrawal by Subject|0|||
149201943|NCT02017899|538207337|FG001|Overall Study|Withdrawal by Subject|0|||
149201944|NCT02017899|538207338|FG002|Overall Study|Withdrawal by Subject|0|||
149201945|NCT02017899|538207339|FG003|Overall Study|Withdrawal by Subject|1|||
149201946|NCT02017899|538207340|FG004|Overall Study|Withdrawal by Subject|1|||
149201947|NCT02017899|538207341|FG005|Overall Study|Withdrawal by Subject|0|||
149201948|NCT02843178|538207345|FG000|Overall Study|Lost to Follow-up|8|||
149201949|NCT02843178|538207346|FG001|Overall Study|Lost to Follow-up|8|||
149201950|NCT02843178|538207347|FG002|Overall Study|Lost to Follow-up|6|||
149201951|NCT02843178|538207348|FG003|Overall Study|Lost to Follow-up|3|||
149201952|NCT02843178|538207345|FG000|Overall Study|Withdrawal by Subject|0|||
149201953|NCT02843178|538207346|FG001|Overall Study|Withdrawal by Subject|0|||
149201954|NCT02843178|538207347|FG002|Overall Study|Withdrawal by Subject|1|||
149201955|NCT02843178|538207348|FG003|Overall Study|Withdrawal by Subject|1|||
149201956|NCT00646113|538207349|FG000|Overall Study|Lost to Follow-up|5|||
149201957|NCT00646113|538207349|FG000|Overall Study|Adverse Event|3|||
149201958|NCT02420795|538207358|FG000|Overall Study|Withdrawal by Subject|1|||
149201959|NCT02420795|538207359|FG001|Overall Study|Withdrawal by Subject|0|||
149201960|NCT02420795|538207360|FG002|Overall Study|Withdrawal by Subject|0|||
149201961|NCT02420795|538207358|FG000|Overall Study|Adverse Event|1|||
149201962|NCT02420795|538207359|FG001|Overall Study|Adverse Event|0|||
149201963|NCT02420795|538207360|FG002|Overall Study|Adverse Event|0|||
149201964|NCT02420795|538207358|FG000|Overall Study|Progressive disease|2|||
149201965|NCT02420795|538207359|FG001|Overall Study|Progressive disease|2|||
149201966|NCT02420795|538207360|FG002|Overall Study|Progressive disease|4|||
149201967|NCT02420795|538207358|FG000|Overall Study|Death|0|||
149201968|NCT02420795|538207359|FG001|Overall Study|Death|0|||
149201969|NCT02420795|538207360|FG002|Overall Study|Death|1|||
148944966|NCT02256631|537282401|FG005|Overall Study|Unable to get to clinic|1|||
148944967|NCT02256631|537282402|FG006|Overall Study|Unable to get to clinic|2|||
148944968|NCT01427972|537282403|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944969|NCT01427972|537282404|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944970|NCT01427972|537282405|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944971|NCT01427972|537282406|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944972|NCT01427972|537282407|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944973|NCT01427972|537282408|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944974|NCT01427972|537282409|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944975|NCT01427972|537282410|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
148944976|NCT01427972|537282411|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944977|NCT01427972|537282412|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944978|NCT01427972|537282413|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944979|NCT01427972|537282414|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
148944980|NCT01427972|537282403|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944981|NCT01427972|537282404|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944982|NCT01427972|537282405|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944983|NCT01427972|537282406|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944984|NCT01427972|537282407|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944985|NCT01427972|537282408|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
148944986|NCT01427972|537282409|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944987|NCT01427972|537282410|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944988|NCT01427972|537282411|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944989|NCT01427972|537282412|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
149016268|NCT00337662|537537892|FG002|Study Period II|Parent/Caregiver Decision|0|||
149016269|NCT00337662|537537893|FG003|Study Period II|Parent/Caregiver Decision|1|||
149016270|NCT00337662|537537890|FG000|Study Period III|Lost to Follow-up|14|||
149016271|NCT00337662|537537891|FG001|Study Period III|Lost to Follow-up|16|||
149201970|NCT02658968|538207361|FG000|Received Rituximab|Adverse Event|0|||
148944990|NCT01427972|537282413|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944991|NCT01427972|537282414|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
148944992|NCT01427972|537282403|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148944993|NCT01427972|537282404|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
148944994|NCT01427972|537282405|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148944995|NCT01427972|537282406|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148944996|NCT01427972|537282407|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
149201971|NCT02658968|538207362|FG001|Received Rituximab|Adverse Event|0|||
149201972|NCT02658968|538207363|FG002|Received Rituximab|Adverse Event|0|||
148944997|NCT01427972|537282408|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148944998|NCT01427972|537282409|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148944999|NCT01427972|537282410|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148945000|NCT01427972|537282411|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148945001|NCT01427972|537282412|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148945002|NCT01427972|537282413|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148945003|NCT01427972|537282414|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
148945004|NCT00668707|537282415|FG000|Overall Study|Cancer Recurrence|58|||
148945005|NCT00668707|537282416|FG001|Overall Study|Cancer Recurrence|58|||
148945006|NCT00668707|537282415|FG000|Overall Study|Withdrawal by Subject|117|||
148945007|NCT00668707|537282416|FG001|Overall Study|Withdrawal by Subject|100|||
148945008|NCT00668707|537282415|FG000|Overall Study|Lost to Follow-up|3|||
148945009|NCT00668707|537282416|FG001|Overall Study|Lost to Follow-up|6|||
148945010|NCT00668707|537282415|FG000|Overall Study|Protocol Violation|10|||
148945011|NCT00668707|537282416|FG001|Overall Study|Protocol Violation|12|||
148945012|NCT00668707|537282415|FG000|Overall Study|Death|11|||
148945013|NCT00668707|537282416|FG001|Overall Study|Death|4|||
148945014|NCT02605824|537282417|FG000|Overall Study|Physician Decision|1|||
148945015|NCT02605824|537282418|FG001|Overall Study|Physician Decision|0|||
148945016|NCT00074152|537282419|FG000|Overall Study|Death|21|||
148945017|NCT00074152|537282420|FG001|Overall Study|Death|9|||
148945018|NCT00074152|537282419|FG000|Overall Study|Lack of Efficacy|34|||
148945019|NCT00074152|537282420|FG001|Overall Study|Lack of Efficacy|24|||
149201973|NCT02658968|538207364|FG003|Received Rituximab|Adverse Event|0|||
149201974|NCT02658968|538207365|FG004|Received Rituximab|Adverse Event|1|||
148945020|NCT01382212|537282421|FG000|Overall Study|Kidney transplant|1|||
148945021|NCT01382212|537282421|FG000|Overall Study|Withdrew consent|1|||
149201975|NCT02658968|538207361|FG000|Received Rituximab|Progressive disease|0|||
149201976|NCT02658968|538207362|FG001|Received Rituximab|Progressive disease|0|||
148945022|NCT01095731|537282422|FG000|Overall Study|Protocol Violation|1|||
148945023|NCT01095731|537282423|FG001|Overall Study|Protocol Violation|1|||
148945024|NCT01095731|537282422|FG000|Overall Study|Withdrawal by Subject|0|||
149201977|NCT02658968|538207363|FG002|Received Rituximab|Progressive disease|0|||
149201978|NCT02658968|538207364|FG003|Received Rituximab|Progressive disease|0|||
149201979|NCT02658968|538207365|FG004|Received Rituximab|Progressive disease|1|||
148945025|NCT01095731|537282423|FG001|Overall Study|Withdrawal by Subject|1|||
148945026|NCT00837811|537282426|FG000|Overall Study|Adverse Event|4|||
148945027|NCT00837811|537282427|FG001|Overall Study|Adverse Event|6|||
148945028|NCT00837811|537282428|FG002|Overall Study|Adverse Event|0|||
148945029|NCT00837811|537282426|FG000|Overall Study|Death|1|||
148945030|NCT00837811|537282427|FG001|Overall Study|Death|1|||
148945031|NCT00837811|537282428|FG002|Overall Study|Death|0|||
149201980|NCT02658968|538207361|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
149201981|NCT02658968|538207362|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
149201982|NCT02658968|538207363|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
149201983|NCT02658968|538207364|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
148945032|NCT00837811|537282426|FG000|Overall Study|Lack of Efficacy|0|||
149201984|NCT02658968|538207365|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
149201985|NCT02658968|538207361|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
149201986|NCT02658968|538207362|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
149201987|NCT02658968|538207363|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
149201988|NCT02658968|538207364|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
149201989|NCT02658968|538207365|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
149201990|NCT02658968|538207361|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
149201991|NCT02658968|538207362|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
149201992|NCT02658968|538207363|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
149201993|NCT02658968|538207364|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
149201994|NCT02658968|538207365|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
149201995|NCT02658968|538207361|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149201996|NCT02658968|538207362|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
149201997|NCT02658968|538207363|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149201998|NCT02658968|538207364|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149201999|NCT02658968|538207365|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
149202000|NCT02658968|538207361|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
149202001|NCT02658968|538207362|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
149202002|NCT02658968|538207363|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
149202003|NCT02658968|538207364|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
149202004|NCT02658968|538207365|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
149202005|NCT00949910|538207366|FG000|Overall Study|Progressive Disease|3750|||
149202006|NCT00949910|538207366|FG000|Overall Study|Symptomatic Deterioration|1088|||
149202007|NCT00949910|538207366|FG000|Overall Study|Lost to Follow-up|100|||
149202008|NCT00949910|538207366|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
149202009|NCT00949910|538207366|FG000|Overall Study|Participant Refusal|390|||
149202010|NCT00949910|538207366|FG000|Overall Study|Death Due to Malignant Disease|456|||
149202011|NCT00949910|538207366|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
149202012|NCT00949910|538207366|FG000|Overall Study|Death Due to Adverse Event|115|||
149202013|NCT00949910|538207366|FG000|Overall Study|Death Due to Toxicity|3|||
149202014|NCT00949910|538207366|FG000|Overall Study|Death from Unknown Cause|5|||
149202015|NCT00949910|538207366|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
149202016|NCT00949910|538207366|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
149202017|NCT00949910|538207366|FG000|Overall Study|Switched to Commercial Treatment|4|||
149202018|NCT00949910|538207366|FG000|Overall Study|Violation of Eligibility|23|||
149202019|NCT00949910|538207366|FG000|Overall Study|Logistical Reasons|13|||
149202020|NCT00949910|538207366|FG000|Overall Study|Non-Compliance|10|||
149202021|NCT00949910|538207366|FG000|Overall Study|Prolonged Dosing Interruption|4|||
149202022|NCT00949910|538207366|FG000|Overall Study|Adverse Event|83|||
149202023|NCT00949910|538207366|FG000|Overall Study|Serious Adverse Event|6|||
149202024|NCT00949910|538207366|FG000|Overall Study|Physician/Participant Decision|7|||
149202025|NCT00949910|538207366|FG000|Overall Study|Other|4|||
149202026|NCT00949910|538207366|FG000|Overall Study|No Data|9|||
149202027|NCT03287869|538207367|FG000|Overall Study|Adverse Event|14|||
149202028|NCT03287869|538207368|FG001|Overall Study|Adverse Event|12|||
149202029|NCT03287869|538207367|FG000|Overall Study|Lack of Efficacy|1|||
149202030|NCT03287869|538207368|FG001|Overall Study|Lack of Efficacy|0|||
149202031|NCT03287869|538207367|FG000|Overall Study|Lost to Follow-up|13|||
149202032|NCT03287869|538207368|FG001|Overall Study|Lost to Follow-up|19|||
148945033|NCT00837811|537282427|FG001|Overall Study|Lack of Efficacy|11|||
148945034|NCT00837811|537282428|FG002|Overall Study|Lack of Efficacy|0|||
149202033|NCT03287869|538207367|FG000|Overall Study|Non-Compliance With Study Drug|5|||
149202034|NCT03287869|538207368|FG001|Overall Study|Non-Compliance With Study Drug|9|||
149202035|NCT03287869|538207367|FG000|Overall Study|Progressive Disease|1|||
149202036|NCT03287869|538207368|FG001|Overall Study|Progressive Disease|0|||
149202037|NCT03287869|538207367|FG000|Overall Study|Protocol Deviation|2|||
149202038|NCT03287869|538207368|FG001|Overall Study|Protocol Deviation|1|||
149202039|NCT03287869|538207367|FG000|Overall Study|Withdrawal by Subject|36|||
148945035|NCT00837811|537282426|FG000|Overall Study|Lost to Follow-up|1|||
148945036|NCT00837811|537282427|FG001|Overall Study|Lost to Follow-up|3|||
148945037|NCT00837811|537282428|FG002|Overall Study|Lost to Follow-up|0|||
148945038|NCT00837811|537282426|FG000|Overall Study|Physician Decision|0|||
148945039|NCT00837811|537282427|FG001|Overall Study|Physician Decision|2|||
148945040|NCT00837811|537282428|FG002|Overall Study|Physician Decision|1|||
148945041|NCT00837811|537282426|FG000|Overall Study|Withdrawal by Subject|1|||
148945042|NCT00837811|537282427|FG001|Overall Study|Withdrawal by Subject|9|||
148945043|NCT00837811|537282428|FG002|Overall Study|Withdrawal by Subject|0|||
148945044|NCT00837811|537282426|FG000|Overall Study|Sponsor Decision|0|||
148945045|NCT00837811|537282427|FG001|Overall Study|Sponsor Decision|2|||
148945046|NCT00837811|537282428|FG002|Overall Study|Sponsor Decision|0|||
148945047|NCT03307967|537282429|FG000|Overall Study|Lost to Follow-up|4|||
148945048|NCT02578316|537282430|FG000|Extension Phase|Progression of disease|6|||
148945049|NCT03268954|537282434|FG000|Overall Study|Withdrawal by Subject|27|||
148945050|NCT03268954|537282435|FG001|Overall Study|Withdrawal by Subject|17|||
148945051|NCT03268954|537282434|FG000|Overall Study|Lost to Follow-up|2|||
148945052|NCT03268954|537282435|FG001|Overall Study|Lost to Follow-up|3|||
148945053|NCT03268954|537282434|FG000|Overall Study|Reason Not Specified|3|||
149202040|NCT03287869|538207368|FG001|Overall Study|Withdrawal by Subject|43|||
149202041|NCT03287869|538207367|FG000|Overall Study|Early Closure of the Site|0|||
149202042|NCT03287869|538207368|FG001|Overall Study|Early Closure of the Site|1|||
149202043|NCT03287869|538207367|FG000|Overall Study|Physician Decision|5|||
149202044|NCT03287869|538207368|FG001|Overall Study|Physician Decision|5|||
149202045|NCT03287869|538207367|FG000|Overall Study|Reason not Specified|6|||
149202046|NCT03287869|538207368|FG001|Overall Study|Reason not Specified|3|||
149202047|NCT02455388|538207369|FG000|Overall Study|Protocol Violation|1|||
149202048|NCT02455388|538207370|FG001|Overall Study|Protocol Violation|0|||
149202049|NCT02455388|538207371|FG002|Overall Study|Protocol Violation|4|||
149202050|NCT02455388|538207369|FG000|Overall Study|Withdrawal by Subject|0|||
149202051|NCT02455388|538207370|FG001|Overall Study|Withdrawal by Subject|0|||
149202052|NCT02455388|538207371|FG002|Overall Study|Withdrawal by Subject|7|||
149202053|NCT04847141|538207372|FG000|Overall Study|Adverse Event|1|||
149202054|NCT04847141|538207373|FG001|Overall Study|Adverse Event|0|||
149202055|NCT04847141|538207374|FG002|Overall Study|Adverse Event|1|||
149202056|NCT04847141|538207372|FG000|Overall Study|Withdrawal by Subject|2|||
149202057|NCT04847141|538207373|FG001|Overall Study|Withdrawal by Subject|4|||
149202058|NCT04847141|538207374|FG002|Overall Study|Withdrawal by Subject|3|||
149202059|NCT04847141|538207372|FG000|Overall Study|Lost to Follow-up|7|||
149202060|NCT04847141|538207373|FG001|Overall Study|Lost to Follow-up|5|||
149202061|NCT04847141|538207374|FG002|Overall Study|Lost to Follow-up|7|||
149202062|NCT04847141|538207372|FG000|Overall Study|Reason not Specified|0|||
149202063|NCT04847141|538207373|FG001|Overall Study|Reason not Specified|1|||
149202064|NCT04847141|538207374|FG002|Overall Study|Reason not Specified|0|||
149202065|NCT00324740|538207375|FG000|Overall Study|Withdrawal by Subject|1|||
149202066|NCT00324740|538207376|FG001|Overall Study|Withdrawal by Subject|0|||
149202067|NCT00324740|538207377|FG002|Overall Study|Withdrawal by Subject|1|||
149202068|NCT00971425|538207380|FG000|Overall Study|Adverse Event|1|||
149202069|NCT00971425|538207381|FG001|Overall Study|Adverse Event|1|||
149202070|NCT00971425|538207380|FG000|Overall Study|Withdrawal by Subject|0|||
149202071|NCT00971425|538207381|FG001|Overall Study|Withdrawal by Subject|1|||
149202072|NCT02528253|538207382|FG000|Overall Study|Adverse Event|3|||
149202073|NCT02528253|538207383|FG001|Overall Study|Adverse Event|4|||
149202074|NCT02528253|538207384|FG002|Overall Study|Adverse Event|4|||
149202075|NCT02528253|538207385|FG003|Overall Study|Adverse Event|8|||
149202076|NCT02528253|538207386|FG004|Overall Study|Adverse Event|18|||
149202077|NCT02528253|538207382|FG000|Overall Study|Death|2|||
149202078|NCT02528253|538207383|FG001|Overall Study|Death|2|||
149202079|NCT02528253|538207384|FG002|Overall Study|Death|1|||
149202080|NCT02528253|538207385|FG003|Overall Study|Death|0|||
149202081|NCT02528253|538207386|FG004|Overall Study|Death|1|||
149202082|NCT02528253|538207382|FG000|Overall Study|Insufficient clinical response|7|||
149202083|NCT02528253|538207383|FG001|Overall Study|Insufficient clinical response|10|||
149202084|NCT02528253|538207384|FG002|Overall Study|Insufficient clinical response|13|||
149202085|NCT02528253|538207385|FG003|Overall Study|Insufficient clinical response|12|||
149202086|NCT02528253|538207386|FG004|Overall Study|Insufficient clinical response|16|||
149202087|NCT02528253|538207382|FG000|Overall Study|Lost to Follow-up|16|||
149202088|NCT02528253|538207383|FG001|Overall Study|Lost to Follow-up|9|||
149202089|NCT02528253|538207384|FG002|Overall Study|Lost to Follow-up|31|||
149202090|NCT02528253|538207385|FG003|Overall Study|Lost to Follow-up|16|||
149202091|NCT02528253|538207386|FG004|Overall Study|Lost to Follow-up|34|||
149202092|NCT02528253|538207382|FG000|Overall Study|Other|21|||
149202093|NCT02528253|538207383|FG001|Overall Study|Other|22|||
148945054|NCT03268954|537282435|FG001|Overall Study|Reason Not Specified|8|||
149202094|NCT02528253|538207384|FG002|Overall Study|Other|58|||
148945055|NCT04524689|537282438|FG000|Overall Study|Withdrawal by Subject|1|||
148945056|NCT04524689|537282439|FG001|Overall Study|Withdrawal by Subject|1|||
149202095|NCT02528253|538207385|FG003|Overall Study|Other|52|||
149202096|NCT02528253|538207386|FG004|Overall Study|Other|76|||
149202097|NCT02528253|538207382|FG000|Overall Study|Withdrawal by Subject|25|||
148945057|NCT04524689|537282440|FG002|Overall Study|Withdrawal by Subject|0|||
148945058|NCT04524689|537282441|FG003|Overall Study|Withdrawal by Subject|0|||
148945059|NCT04524689|537282442|FG004|Overall Study|Withdrawal by Subject|2|||
148945060|NCT04524689|537282443|FG005|Overall Study|Withdrawal by Subject|0|||
148945061|NCT04524689|537282438|FG000|Overall Study|Study terminated by Sponsor|6|||
148945062|NCT04524689|537282439|FG001|Overall Study|Study terminated by Sponsor|0|||
148945063|NCT04524689|537282440|FG002|Overall Study|Study terminated by Sponsor|1|||
148945064|NCT04524689|537282441|FG003|Overall Study|Study terminated by Sponsor|0|||
148945065|NCT04524689|537282442|FG004|Overall Study|Study terminated by Sponsor|4|||
148945066|NCT04524689|537282443|FG005|Overall Study|Study terminated by Sponsor|0|||
148945067|NCT04524689|537282438|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
148945068|NCT04524689|537282439|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
148945069|NCT04524689|537282440|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
148945070|NCT04524689|537282441|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
148945071|NCT04524689|537282442|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
148945072|NCT04524689|537282443|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
148945073|NCT00674700|537284132|FG000|Year 1|Adverse Event|17|||
148945074|NCT00674700|537284133|FG001|Year 1|Adverse Event|20|||
148945075|NCT00674700|537284134|FG002|Year 1|Adverse Event|5|||
148945076|NCT00674700|537284132|FG000|Year 1|Withdrawal by Subject|7|||
148945077|NCT00674700|537284133|FG001|Year 1|Withdrawal by Subject|7|||
148945078|NCT00674700|537284134|FG002|Year 1|Withdrawal by Subject|6|||
148945079|NCT00674700|537284132|FG000|Year 1|Any other reason not above-mentioned|7|||
148945080|NCT00674700|537284133|FG001|Year 1|Any other reason not above-mentioned|7|||
148945081|NCT00674700|537284134|FG002|Year 1|Any other reason not above-mentioned|6|||
148945082|NCT00674700|537284132|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
148945083|NCT00674700|537284133|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
148945084|NCT00674700|537284134|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
148945085|NCT00674700|537284132|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
148945086|NCT00674700|537284133|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
148945087|NCT00674700|537284134|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
148945088|NCT00674700|537284132|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
148945089|NCT00674700|537284133|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
148945090|NCT00674700|537284134|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
148945091|NCT00395304|537284135|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148945092|NCT00395304|537284136|FG001|Treatment Period 1|Withdrawal by Subject|3|||
148945093|NCT00395304|537284137|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148945094|NCT00395304|537284138|FG003|Treatment Period 1|Withdrawal by Subject|2|||
148945095|NCT00395304|537284139|FG004|Treatment Period 1|Withdrawal by Subject|1|||
148945096|NCT00395304|537284140|FG005|Treatment Period 1|Withdrawal by Subject|1|||
148945097|NCT00395304|537284135|FG000|Treatment Period 1|Lost to Follow-up|1|||
148945098|NCT00395304|537284136|FG001|Treatment Period 1|Lost to Follow-up|0|||
148945099|NCT00395304|537284137|FG002|Treatment Period 1|Lost to Follow-up|0|||
148945100|NCT00395304|537284138|FG003|Treatment Period 1|Lost to Follow-up|1|||
148945101|NCT00395304|537284139|FG004|Treatment Period 1|Lost to Follow-up|0|||
148945102|NCT00395304|537284140|FG005|Treatment Period 1|Lost to Follow-up|1|||
148945103|NCT00395304|537284135|FG000|Treatment Period 1|Physician Decision|0|||
148945104|NCT00395304|537284136|FG001|Treatment Period 1|Physician Decision|1|||
148945105|NCT00395304|537284137|FG002|Treatment Period 1|Physician Decision|0|||
148945106|NCT00395304|537284138|FG003|Treatment Period 1|Physician Decision|0|||
148945107|NCT00395304|537284139|FG004|Treatment Period 1|Physician Decision|0|||
148945108|NCT00395304|537284140|FG005|Treatment Period 1|Physician Decision|0|||
148945109|NCT00395304|537284135|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148945110|NCT00395304|537284136|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148945111|NCT00395304|537284137|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148945112|NCT00395304|537284138|FG003|Treatment Period 2|Withdrawal by Subject|1|||
149016272|NCT00337662|537537892|FG002|Study Period III|Lost to Follow-up|14|||
148945113|NCT00395304|537284139|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148945114|NCT00395304|537284140|FG005|Treatment Period 2|Withdrawal by Subject|2|||
148945115|NCT00395304|537284135|FG000|Treatment Period 2|Lost to Follow-up|0|||
148945116|NCT00395304|537284136|FG001|Treatment Period 2|Lost to Follow-up|3|||
148945117|NCT00395304|537284137|FG002|Treatment Period 2|Lost to Follow-up|0|||
148945118|NCT00395304|537284138|FG003|Treatment Period 2|Lost to Follow-up|0|||
148945119|NCT00395304|537284139|FG004|Treatment Period 2|Lost to Follow-up|0|||
148945120|NCT00395304|537284140|FG005|Treatment Period 2|Lost to Follow-up|0|||
148945121|NCT00395304|537284135|FG000|Treatment Period 2|Physician Decision|0|||
148945122|NCT00395304|537284136|FG001|Treatment Period 2|Physician Decision|0|||
148945123|NCT00395304|537284137|FG002|Treatment Period 2|Physician Decision|1|||
148945124|NCT00395304|537284138|FG003|Treatment Period 2|Physician Decision|0|||
148945125|NCT00395304|537284139|FG004|Treatment Period 2|Physician Decision|0|||
148945126|NCT00395304|537284140|FG005|Treatment Period 2|Physician Decision|0|||
148945127|NCT00395304|537284135|FG000|Treatment Period 2|Other|0|||
148945128|NCT00395304|537284136|FG001|Treatment Period 2|Other|1|||
148945129|NCT00395304|537284137|FG002|Treatment Period 2|Other|0|||
148945130|NCT00395304|537284138|FG003|Treatment Period 2|Other|0|||
148945131|NCT00395304|537284139|FG004|Treatment Period 2|Other|0|||
148945132|NCT00395304|537284140|FG005|Treatment Period 2|Other|0|||
148945133|NCT00395304|537284135|FG000|Treatment Period 3|Withdrawal by Subject|0|||
148945134|NCT00395304|537284136|FG001|Treatment Period 3|Withdrawal by Subject|0|||
148945135|NCT00395304|537284137|FG002|Treatment Period 3|Withdrawal by Subject|0|||
148945136|NCT00395304|537284138|FG003|Treatment Period 3|Withdrawal by Subject|1|||
148945137|NCT00395304|537284139|FG004|Treatment Period 3|Withdrawal by Subject|0|||
148945138|NCT00395304|537284140|FG005|Treatment Period 3|Withdrawal by Subject|1|||
148945139|NCT00395304|537284135|FG000|Treatment Period 3|Lost to Follow-up|1|||
148945140|NCT00395304|537284136|FG001|Treatment Period 3|Lost to Follow-up|1|||
148945141|NCT00395304|537284137|FG002|Treatment Period 3|Lost to Follow-up|0|||
148945142|NCT00395304|537284138|FG003|Treatment Period 3|Lost to Follow-up|0|||
148945143|NCT00395304|537284139|FG004|Treatment Period 3|Lost to Follow-up|0|||
148945144|NCT00395304|537284140|FG005|Treatment Period 3|Lost to Follow-up|0|||
148945145|NCT00395304|537284135|FG000|Treatment Period 3|Physician Decision|0|||
148945146|NCT00395304|537284136|FG001|Treatment Period 3|Physician Decision|1|||
148945147|NCT00395304|537284137|FG002|Treatment Period 3|Physician Decision|0|||
148945148|NCT00395304|537284138|FG003|Treatment Period 3|Physician Decision|0|||
148945149|NCT00395304|537284139|FG004|Treatment Period 3|Physician Decision|0|||
148945150|NCT00395304|537284140|FG005|Treatment Period 3|Physician Decision|0|||
149202098|NCT02528253|538207383|FG001|Overall Study|Withdrawal by Subject|20|||
149202099|NCT02528253|538207384|FG002|Overall Study|Withdrawal by Subject|29|||
149202100|NCT02528253|538207385|FG003|Overall Study|Withdrawal by Subject|48|||
149202101|NCT02528253|538207386|FG004|Overall Study|Withdrawal by Subject|73|||
149202102|NCT02528253|538207382|FG000|Overall Study|Protocol Violation|1|||
149202103|NCT02528253|538207383|FG001|Overall Study|Protocol Violation|2|||
149202104|NCT02528253|538207384|FG002|Overall Study|Protocol Violation|4|||
149202105|NCT02528253|538207385|FG003|Overall Study|Protocol Violation|0|||
149202106|NCT02528253|538207386|FG004|Overall Study|Protocol Violation|4|||
148945151|NCT00395304|537284135|FG000|Treatment Period 3|Other|0|||
148945152|NCT00395304|537284136|FG001|Treatment Period 3|Other|0|||
148945153|NCT00395304|537284137|FG002|Treatment Period 3|Other|0|||
148945154|NCT00395304|537284138|FG003|Treatment Period 3|Other|1|||
148945155|NCT00395304|537284139|FG004|Treatment Period 3|Other|0|||
148945156|NCT00395304|537284140|FG005|Treatment Period 3|Other|0|||
148945157|NCT01749137|537284141|FG000|Overall Study|Adverse Event|4|||
148945158|NCT01749137|537284142|FG001|Overall Study|Adverse Event|4|||
148945159|NCT01749137|537284141|FG000|Overall Study|Lost to Follow-up|2|||
148945160|NCT01749137|537284142|FG001|Overall Study|Lost to Follow-up|3|||
148945161|NCT01749137|537284141|FG000|Overall Study|Physician Decision|1|||
148945162|NCT01749137|537284142|FG001|Overall Study|Physician Decision|0|||
148945163|NCT01749137|537284141|FG000|Overall Study|Withdrawal by Subject|8|||
148945164|NCT01749137|537284142|FG001|Overall Study|Withdrawal by Subject|4|||
148945165|NCT00621985|537284143|FG000|Dexamethasone Admission|Adverse Event|1|||
148945166|NCT03130257|537284144|FG000|Overall Study|Withdrawal by Subject|1|||
148945167|NCT03130257|537284145|FG001|Overall Study|Withdrawal by Subject|0|||
148945168|NCT03130257|537284146|FG002|Overall Study|Withdrawal by Subject|2|||
148945169|NCT01396148|537284147|FG000|Overall Study|Patient Decision|1|||
148945170|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
148945171|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
148945172|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
148945173|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
148945174|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
148945175|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
148945176|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
148945177|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
148945178|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
149202107|NCT02528253|538207382|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
149202108|NCT02528253|538207383|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
148945179|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
148945180|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
148945181|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
148945182|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
148945183|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
148945184|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
148945185|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
149202109|NCT02528253|538207384|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
149202110|NCT02528253|538207385|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
149202111|NCT02528253|538207386|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
149202112|NCT00094835|538207389|FG000|Overall Study|Physician Decision|1|||
149202113|NCT00094835|538207390|FG001|Overall Study|Physician Decision|0|||
149202114|NCT00094835|538207391|FG002|Overall Study|Physician Decision|0|||
149202115|NCT00094835|538207392|FG003|Overall Study|Physician Decision|0|||
149202116|NCT00094835|538207393|FG004|Overall Study|Physician Decision|0|||
149202117|NCT00094835|538207394|FG005|Overall Study|Physician Decision|1|||
149202118|NCT00094835|538207395|FG006|Overall Study|Physician Decision|0|||
149202119|NCT00094835|538207389|FG000|Overall Study|Withdrawal by Subject|0|||
149202120|NCT00094835|538207390|FG001|Overall Study|Withdrawal by Subject|0|||
149202121|NCT00094835|538207391|FG002|Overall Study|Withdrawal by Subject|0|||
149202122|NCT00094835|538207392|FG003|Overall Study|Withdrawal by Subject|0|||
149202123|NCT00094835|538207393|FG004|Overall Study|Withdrawal by Subject|0|||
149202124|NCT00094835|538207394|FG005|Overall Study|Withdrawal by Subject|0|||
149202125|NCT00094835|538207395|FG006|Overall Study|Withdrawal by Subject|1|||
149202126|NCT00094835|538207389|FG000|Overall Study|Lost to Follow-up|0|||
149202127|NCT00094835|538207390|FG001|Overall Study|Lost to Follow-up|0|||
149202128|NCT00094835|538207391|FG002|Overall Study|Lost to Follow-up|0|||
149202129|NCT00094835|538207392|FG003|Overall Study|Lost to Follow-up|0|||
149202130|NCT00094835|538207393|FG004|Overall Study|Lost to Follow-up|1|||
149202131|NCT00094835|538207394|FG005|Overall Study|Lost to Follow-up|0|||
149202132|NCT00094835|538207395|FG006|Overall Study|Lost to Follow-up|0|||
149202133|NCT00094835|538207389|FG000|Overall Study|Death|1|||
149202134|NCT00094835|538207390|FG001|Overall Study|Death|0|||
149202135|NCT00094835|538207391|FG002|Overall Study|Death|0|||
149202136|NCT00094835|538207392|FG003|Overall Study|Death|0|||
149202137|NCT00094835|538207393|FG004|Overall Study|Death|1|||
149202138|NCT00094835|538207394|FG005|Overall Study|Death|0|||
149202139|NCT00094835|538207395|FG006|Overall Study|Death|0|||
149202140|NCT00094835|538207389|FG000|Overall Study|Non-compliance|1|||
149202141|NCT00094835|538207390|FG001|Overall Study|Non-compliance|2|||
149202142|NCT00094835|538207391|FG002|Overall Study|Non-compliance|2|||
149202143|NCT00094835|538207392|FG003|Overall Study|Non-compliance|0|||
149202144|NCT00094835|538207393|FG004|Overall Study|Non-compliance|2|||
149202145|NCT00094835|538207394|FG005|Overall Study|Non-compliance|2|||
149202146|NCT00094835|538207395|FG006|Overall Study|Non-compliance|1|||
149202147|NCT00094835|538207389|FG000|Overall Study|Other|1|||
149202148|NCT00094835|538207390|FG001|Overall Study|Other|1|||
149202149|NCT00094835|538207391|FG002|Overall Study|Other|1|||
149202150|NCT00094835|538207392|FG003|Overall Study|Other|1|||
149202151|NCT00094835|538207393|FG004|Overall Study|Other|0|||
149202152|NCT00094835|538207394|FG005|Overall Study|Other|0|||
149202153|NCT00094835|538207395|FG006|Overall Study|Other|0|||
149202154|NCT00505752|538207396|FG000|Overall Study|Adverse Event|1|||
149202155|NCT00505752|538207397|FG001|Overall Study|Adverse Event|0|||
149202156|NCT00505752|538207398|FG002|Overall Study|Adverse Event|1|||
149202157|NCT00505752|538207399|FG003|Overall Study|Adverse Event|0|||
149202158|NCT00505752|538207396|FG000|Overall Study|Lost to Follow-up|1|||
149202159|NCT00505752|538207397|FG001|Overall Study|Lost to Follow-up|0|||
149202160|NCT00505752|538207398|FG002|Overall Study|Lost to Follow-up|0|||
148945186|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
148945187|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
148945188|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
148945189|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
149202161|NCT00505752|538207399|FG003|Overall Study|Lost to Follow-up|0|||
149202162|NCT00505752|538207396|FG000|Overall Study|Lack of ovarian response|1|||
149202163|NCT00505752|538207397|FG001|Overall Study|Lack of ovarian response|3|||
149202164|NCT00505752|538207398|FG002|Overall Study|Lack of ovarian response|0|||
149202165|NCT00505752|538207399|FG003|Overall Study|Lack of ovarian response|0|||
149202166|NCT00505752|538207396|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149202167|NCT00505752|538207397|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149202168|NCT00505752|538207398|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
149202169|NCT00505752|538207399|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
149202170|NCT00505752|538207396|FG000|Overall Study|No oocytes retrieved|0|||
149202171|NCT00505752|538207397|FG001|Overall Study|No oocytes retrieved|2|||
149202172|NCT00505752|538207398|FG002|Overall Study|No oocytes retrieved|0|||
149202173|NCT00505752|538207399|FG003|Overall Study|No oocytes retrieved|1|||
149202174|NCT00505752|538207396|FG000|Overall Study|No Fertilization|1|||
149202175|NCT00505752|538207397|FG001|Overall Study|No Fertilization|1|||
149202176|NCT00505752|538207398|FG002|Overall Study|No Fertilization|2|||
149202177|NCT00505752|538207399|FG003|Overall Study|No Fertilization|1|||
149202178|NCT00505752|538207396|FG000|Overall Study|All embryos/blastocysts discarded|0|||
149202179|NCT00505752|538207397|FG001|Overall Study|All embryos/blastocysts discarded|0|||
149202180|NCT00505752|538207398|FG002|Overall Study|All embryos/blastocysts discarded|1|||
149202181|NCT00505752|538207399|FG003|Overall Study|All embryos/blastocysts discarded|1|||
149202182|NCT00505752|538207396|FG000|Overall Study|Other|1|||
149202183|NCT00505752|538207397|FG001|Overall Study|Other|2|||
149202184|NCT00505752|538207398|FG002|Overall Study|Other|1|||
149202185|NCT00505752|538207399|FG003|Overall Study|Other|2|||
149202186|NCT03819218|538207403|FG000|Overall Study|Protocol Violation|1|||
149202187|NCT02267278|538207404|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
149202188|NCT02267278|538207404|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
149202189|NCT02267278|538207404|FG000|Overall Study|Developed new cancer diagnoses|2|||
149202190|NCT02267278|538207404|FG000|Overall Study|prescribed prohibited medication|1|||
149202191|NCT02513771|538207405|FG000|Overall Study|Lost to Follow-up|1|||
149202192|NCT02513771|538207406|FG001|Overall Study|Lost to Follow-up|1|||
149202193|NCT02513771|538207405|FG000|Overall Study|Not being able to get to clinic|1|||
149202194|NCT02513771|538207406|FG001|Overall Study|Not being able to get to clinic|0|||
149202195|NCT01595438|538207407|FG000|Overall Study|Lost to Follow-up|20|||
149202196|NCT01595438|538207408|FG001|Overall Study|Lost to Follow-up|20|||
149202197|NCT01595438|538207407|FG000|Overall Study|Withdrawal by Subject|12|||
149202198|NCT01595438|538207408|FG001|Overall Study|Withdrawal by Subject|12|||
149202199|NCT01595438|538207407|FG000|Overall Study|Other Eligibility criteria|11|||
149202200|NCT01595438|538207408|FG001|Overall Study|Other Eligibility criteria|9|||
149202201|NCT00650091|538207410|FG000|Amended Study Design|Withdrawal by Subject|12|||
149202202|NCT00650091|538207411|FG001|Amended Study Design|Withdrawal by Subject|11|||
149202203|NCT00650091|538207412|FG002|Amended Study Design|Withdrawal by Subject|0|||
149202204|NCT00650091|538207410|FG000|Amended Study Design|Physician Decision|5|||
149202205|NCT00650091|538207411|FG001|Amended Study Design|Physician Decision|0|||
149202206|NCT00650091|538207412|FG002|Amended Study Design|Physician Decision|0|||
149202207|NCT00650091|538207410|FG000|Amended Study Design|Adverse Event|1|||
149202208|NCT00650091|538207411|FG001|Amended Study Design|Adverse Event|4|||
149202209|NCT00650091|538207412|FG002|Amended Study Design|Adverse Event|0|||
149202210|NCT00650091|538207410|FG000|Amended Study Design|Lung transplantation|4|||
149202211|NCT00650091|538207411|FG001|Amended Study Design|Lung transplantation|2|||
149202212|NCT00650091|538207412|FG002|Amended Study Design|Lung transplantation|0|||
149202213|NCT00650091|538207410|FG000|Amended Study Design|Other|1|||
149202214|NCT00650091|538207411|FG001|Amended Study Design|Other|3|||
149202215|NCT00650091|538207412|FG002|Amended Study Design|Other|0|||
149202216|NCT01204697|538207413|FG000|Overall Study|Death|26|||
149202217|NCT01204697|538207414|FG001|Overall Study|Death|27|||
149202218|NCT01204697|538207413|FG000|Overall Study|Lost to Follow-up|3|||
149202219|NCT01204697|538207414|FG001|Overall Study|Lost to Follow-up|4|||
149202220|NCT01204697|538207413|FG000|Overall Study|Withdrawal by Subject|2|||
149202221|NCT01204697|538207414|FG001|Overall Study|Withdrawal by Subject|4|||
149202222|NCT01204697|538207413|FG000|Overall Study|Randomized, but not treated|0|||
149202223|NCT01204697|538207414|FG001|Overall Study|Randomized, but not treated|1|||
149202224|NCT01280266|538207415|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
148945190|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
148945191|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
148945192|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
148945193|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
148945194|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
149202225|NCT01280266|538207416|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
149202226|NCT01280266|538207415|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
149202227|NCT01280266|538207416|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
149202228|NCT00469209|538207423|FG000|Overall Study|Adverse Event|1|||
149202229|NCT00469209|538207424|FG001|Overall Study|Adverse Event|0|||
149202230|NCT00469209|538207425|FG002|Overall Study|Adverse Event|1|||
149202231|NCT03341923|538207428|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
149202232|NCT03341923|538207429|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
149202233|NCT04511819|538207430|FG000|Overall Study|Non-compliance with study drug|5|||
149202234|NCT04511819|538207431|FG001|Overall Study|Non-compliance with study drug|1|||
149202235|NCT04511819|538207430|FG000|Overall Study|Withdrawal by Subject|0|||
149202236|NCT04511819|538207431|FG001|Overall Study|Withdrawal by Subject|3|||
149202237|NCT04511819|538207430|FG000|Overall Study|Adverse Event|0|||
149202238|NCT04511819|538207431|FG001|Overall Study|Adverse Event|1|||
149202239|NCT04511819|538207430|FG000|Overall Study|Protocol deviation|1|||
149202240|NCT04511819|538207431|FG001|Overall Study|Protocol deviation|0|||
149202241|NCT00589979|538207433|FG000|Run-In Period|Adverse Event|5|||
149202242|NCT00589979|538207434|FG001|Run-In Period|Adverse Event|0|||
149202243|NCT00589979|538207435|FG002|Run-In Period|Adverse Event|0|||
149202244|NCT00589979|538207433|FG000|Run-In Period|Protocol Violation|3|||
149202245|NCT00589979|538207434|FG001|Run-In Period|Protocol Violation|0|||
149202246|NCT00589979|538207435|FG002|Run-In Period|Protocol Violation|0|||
149202247|NCT00589979|538207433|FG000|Run-In Period|Did not qualify for randomization|54|||
148945195|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
148945196|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
148945197|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
148945198|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
148945199|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
148945200|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
148945201|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
148945202|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
148945203|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
148945204|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
148945205|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
148945206|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
148945207|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
148945208|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
148945209|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
148945210|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
148945211|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
149202248|NCT00589979|538207434|FG001|Run-In Period|Did not qualify for randomization|0|||
149202249|NCT00589979|538207435|FG002|Run-In Period|Did not qualify for randomization|0|||
149202250|NCT00589979|538207433|FG000|Run-In Period|Withdrawal by Subject|10|||
149202251|NCT00589979|538207434|FG001|Run-In Period|Withdrawal by Subject|0|||
149202252|NCT00589979|538207435|FG002|Run-In Period|Withdrawal by Subject|0|||
149202253|NCT00589979|538207433|FG000|Run-In Period|Informed Consent Withdrawn|4|||
149202254|NCT00589979|538207434|FG001|Run-In Period|Informed Consent Withdrawn|0|||
149202255|NCT00589979|538207435|FG002|Run-In Period|Informed Consent Withdrawn|0|||
149202256|NCT00589979|538207433|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
149202257|NCT00589979|538207434|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
149202258|NCT00589979|538207435|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
148945212|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
148945213|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
148945214|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
148945215|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
148945216|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
148945217|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
148945218|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
148945219|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
148945220|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
148945221|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
148945222|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
148945223|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
148945224|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
148945225|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
148945226|NCT03095066|537284158|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
148945227|NCT03095066|537284159|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
148945228|NCT03095066|537284160|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
148945229|NCT03095066|537284161|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
148945230|NCT03095066|537284162|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
148945231|NCT03095066|537284163|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
148945232|NCT03095066|537284164|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
148945233|NCT03095066|537284165|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
148945234|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
148945235|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
148945236|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
148945237|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
148945238|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
148945239|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
148945240|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
148945241|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
148945242|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
148945243|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
148945244|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
148945245|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
148945246|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
149202259|NCT00589979|538207433|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
149202260|NCT00589979|538207434|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
149202261|NCT00589979|538207435|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
148945247|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
148945248|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
148945249|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
148945250|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
148945251|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
148945252|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
148945253|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
148945254|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
148945255|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
148945256|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
148945257|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
148945258|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
148945259|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
148945260|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
148945261|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
148945262|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
148945263|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
148945264|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
148945265|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
148945266|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945267|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945268|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
148945269|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945270|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945271|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945272|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945273|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
148945274|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
148945275|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
148945276|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
148945277|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
148945278|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
148945279|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
148945280|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
148945281|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
148945282|NCT03095066|537284158|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945283|NCT03095066|537284159|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945284|NCT03095066|537284160|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945285|NCT03095066|537284161|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945286|NCT03095066|537284162|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945287|NCT03095066|537284163|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945288|NCT03095066|537284164|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
148945289|NCT03095066|537284165|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
148945290|NCT03095066|537284158|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945291|NCT03095066|537284159|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945292|NCT03095066|537284160|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945293|NCT03095066|537284161|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945294|NCT03095066|537284162|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945295|NCT03095066|537284163|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
148945296|NCT03095066|537284164|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945297|NCT03095066|537284165|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
148945298|NCT03095066|537284158|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
148945299|NCT03095066|537284159|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
148945300|NCT03095066|537284160|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
148945301|NCT03095066|537284161|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
148945302|NCT03095066|537284162|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
148945303|NCT03095066|537284163|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
148945304|NCT03095066|537284164|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
148945305|NCT03095066|537284165|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
148945306|NCT03095066|537284158|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
148945307|NCT03095066|537284159|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
148945308|NCT03095066|537284160|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
148945309|NCT03095066|537284161|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
148945310|NCT03095066|537284162|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
148945311|NCT03095066|537284163|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
148945312|NCT03095066|537284164|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
148945313|NCT03095066|537284165|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
148945314|NCT03095066|537284158|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
148945315|NCT03095066|537284159|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
148945316|NCT03095066|537284160|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
148945317|NCT03095066|537284161|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
148945318|NCT03095066|537284162|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
148945319|NCT03095066|537284163|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
148945320|NCT03095066|537284164|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
148945321|NCT03095066|537284165|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
148945322|NCT03095066|537284158|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
148945323|NCT03095066|537284159|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
148945324|NCT03095066|537284160|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
148945325|NCT03095066|537284161|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
148945326|NCT03095066|537284162|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
148945327|NCT03095066|537284163|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
149202262|NCT00589979|538207433|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
149202263|NCT00589979|538207434|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
149202264|NCT00589979|538207435|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
149202265|NCT00589979|538207433|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
149202266|NCT00589979|538207434|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
149202267|NCT00589979|538207435|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
149202268|NCT00589979|538207433|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
149202269|NCT00589979|538207434|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
148945328|NCT03095066|537284164|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
148945329|NCT03095066|537284165|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
148945330|NCT01976338|537284170|FG000|Overall Study|Physician Decision|0|||
148945331|NCT01976338|537284171|FG001|Overall Study|Physician Decision|1|||
148945332|NCT01976338|537284170|FG000|Overall Study|Lost to Follow-up|3|||
148945333|NCT01976338|537284171|FG001|Overall Study|Lost to Follow-up|0|||
148945334|NCT01976338|537284170|FG000|Overall Study|Withdrawal by Subject|5|||
148945335|NCT01976338|537284171|FG001|Overall Study|Withdrawal by Subject|2|||
148945336|NCT01976338|537284170|FG000|Overall Study|Adverse Event|5|||
148945337|NCT01976338|537284171|FG001|Overall Study|Adverse Event|1|||
148945338|NCT03766581|537284172|FG000|Randomization|Other reasons|2|||
148945339|NCT03766581|537284173|FG001|Randomization|Other reasons|1|||
148945340|NCT03766581|537284174|FG002|Randomization|Other reasons|0|||
148945341|NCT03766581|537284175|FG003|Randomization|Other reasons|1|||
148945342|NCT03766581|537284176|FG004|Randomization|Other reasons|0|||
149202270|NCT00589979|538207435|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
149202271|NCT00589979|538207433|FG000|Double-Blind Treatment Period 2|Other|0|||
148945343|NCT03766581|537284177|FG005|Randomization|Other reasons|0|||
148945344|NCT03766581|537284178|FG006|Randomization|Other reasons|0|||
148945345|NCT03766581|537284179|FG007|Randomization|Other reasons|0|||
148945346|NCT03766581|537284172|FG000|Randomization|Participant no longer meets study criteria|5|||
148945347|NCT03766581|537284173|FG001|Randomization|Participant no longer meets study criteria|3|||
148945348|NCT03766581|537284174|FG002|Randomization|Participant no longer meets study criteria|4|||
148945349|NCT03766581|537284175|FG003|Randomization|Participant no longer meets study criteria|0|||
148945350|NCT03766581|537284176|FG004|Randomization|Participant no longer meets study criteria|2|||
148945351|NCT03766581|537284177|FG005|Randomization|Participant no longer meets study criteria|3|||
148945352|NCT03766581|537284178|FG006|Randomization|Participant no longer meets study criteria|0|||
148945353|NCT03766581|537284179|FG007|Randomization|Participant no longer meets study criteria|1|||
148945354|NCT03766581|537284172|FG000|Randomization|Participant request to discontinue study treatment|1|||
148945355|NCT03766581|537284173|FG001|Randomization|Participant request to discontinue study treatment|0|||
148945356|NCT03766581|537284174|FG002|Randomization|Participant request to discontinue study treatment|0|||
149202272|NCT00589979|538207434|FG001|Double-Blind Treatment Period 2|Other|0|||
149202273|NCT00589979|538207435|FG002|Double-Blind Treatment Period 2|Other|1|||
149202274|NCT00589979|538207433|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
148945357|NCT03766581|537284175|FG003|Randomization|Participant request to discontinue study treatment|0|||
148945358|NCT03766581|537284176|FG004|Randomization|Participant request to discontinue study treatment|1|||
148945359|NCT03766581|537284177|FG005|Randomization|Participant request to discontinue study treatment|2|||
148945360|NCT03766581|537284178|FG006|Randomization|Participant request to discontinue study treatment|0|||
148945361|NCT03766581|537284179|FG007|Randomization|Participant request to discontinue study treatment|0|||
148945362|NCT03766581|537284172|FG000|Randomization|Participant withdrew consent|1|||
149016273|NCT00337662|537537893|FG003|Study Period III|Lost to Follow-up|0|||
149016274|NCT00337662|537537890|FG000|Study Period III|Withdrawal by Subject|18|||
149202275|NCT00589979|538207434|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
148945363|NCT03766581|537284173|FG001|Randomization|Participant withdrew consent|0|||
148945364|NCT03766581|537284174|FG002|Randomization|Participant withdrew consent|1|||
149016275|NCT00337662|537537891|FG001|Study Period III|Withdrawal by Subject|14|||
149202276|NCT00589979|538207435|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
149202277|NCT00589979|538207433|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
149016276|NCT00337662|537537892|FG002|Study Period III|Withdrawal by Subject|12|||
148945365|NCT03766581|537284175|FG003|Randomization|Participant withdrew consent|2|||
148945366|NCT03766581|537284176|FG004|Randomization|Participant withdrew consent|1|||
148945367|NCT03766581|537284177|FG005|Randomization|Participant withdrew consent|1|||
148945368|NCT03766581|537284178|FG006|Randomization|Participant withdrew consent|0|||
148945369|NCT03766581|537284179|FG007|Randomization|Participant withdrew consent|0|||
148945370|NCT03766581|537284172|FG000|Treatment|Adverse Event|82|||
148945371|NCT03766581|537284173|FG001|Treatment|Adverse Event|44|||
148945372|NCT03766581|537284174|FG002|Treatment|Adverse Event|47|||
148945373|NCT03766581|537284175|FG003|Treatment|Adverse Event|46|||
148945374|NCT03766581|537284176|FG004|Treatment|Adverse Event|50|||
148945375|NCT03766581|537284177|FG005|Treatment|Adverse Event|77|||
148945376|NCT03766581|537284178|FG006|Treatment|Adverse Event|5|||
148945377|NCT03766581|537284179|FG007|Treatment|Adverse Event|2|||
148945378|NCT03766581|537284172|FG000|Treatment|Participant request to discontinue treatment|34|||
148945379|NCT03766581|537284173|FG001|Treatment|Participant request to discontinue treatment|6|||
148945380|NCT03766581|537284174|FG002|Treatment|Participant request to discontinue treatment|10|||
148945381|NCT03766581|537284175|FG003|Treatment|Participant request to discontinue treatment|10|||
148945382|NCT03766581|537284176|FG004|Treatment|Participant request to discontinue treatment|14|||
148945383|NCT03766581|537284177|FG005|Treatment|Participant request to discontinue treatment|15|||
148945384|NCT03766581|537284178|FG006|Treatment|Participant request to discontinue treatment|0|||
148945385|NCT03766581|537284179|FG007|Treatment|Participant request to discontinue treatment|1|||
148945386|NCT03766581|537284172|FG000|Treatment|Participant withdrew consent|11|||
148945387|NCT03766581|537284173|FG001|Treatment|Participant withdrew consent|4|||
148945388|NCT03766581|537284174|FG002|Treatment|Participant withdrew consent|5|||
148945389|NCT03766581|537284175|FG003|Treatment|Participant withdrew consent|5|||
148945390|NCT03766581|537284176|FG004|Treatment|Participant withdrew consent|4|||
148945391|NCT03766581|537284177|FG005|Treatment|Participant withdrew consent|4|||
148945392|NCT03766581|537284178|FG006|Treatment|Participant withdrew consent|0|||
148945393|NCT03766581|537284179|FG007|Treatment|Participant withdrew consent|0|||
148945394|NCT03766581|537284172|FG000|Treatment|Death|1|||
148945395|NCT03766581|537284173|FG001|Treatment|Death|0|||
148945396|NCT03766581|537284174|FG002|Treatment|Death|0|||
148945397|NCT03766581|537284175|FG003|Treatment|Death|0|||
148945398|NCT03766581|537284176|FG004|Treatment|Death|0|||
148945399|NCT03766581|537284177|FG005|Treatment|Death|0|||
148945400|NCT03766581|537284178|FG006|Treatment|Death|0|||
148945401|NCT03766581|537284179|FG007|Treatment|Death|0|||
148945402|NCT03766581|537284172|FG000|Treatment|Lost to Follow-up|1|||
148945403|NCT03766581|537284173|FG001|Treatment|Lost to Follow-up|0|||
148945404|NCT03766581|537284174|FG002|Treatment|Lost to Follow-up|0|||
148945405|NCT03766581|537284175|FG003|Treatment|Lost to Follow-up|1|||
148945406|NCT03766581|537284176|FG004|Treatment|Lost to Follow-up|0|||
148945407|NCT03766581|537284177|FG005|Treatment|Lost to Follow-up|0|||
148945408|NCT03766581|537284178|FG006|Treatment|Lost to Follow-up|0|||
148945409|NCT03766581|537284179|FG007|Treatment|Lost to Follow-up|0|||
148945410|NCT03766581|537284172|FG000|Treatment|Poor/Non compliance|2|||
148945411|NCT03766581|537284173|FG001|Treatment|Poor/Non compliance|2|||
148945412|NCT03766581|537284174|FG002|Treatment|Poor/Non compliance|1|||
148945413|NCT03766581|537284175|FG003|Treatment|Poor/Non compliance|1|||
148945414|NCT03766581|537284176|FG004|Treatment|Poor/Non compliance|1|||
148945415|NCT03766581|537284177|FG005|Treatment|Poor/Non compliance|1|||
148945416|NCT03766581|537284178|FG006|Treatment|Poor/Non compliance|0|||
148945417|NCT03766581|537284179|FG007|Treatment|Poor/Non compliance|0|||
148945418|NCT03766581|537284172|FG000|Treatment|Participant no longer meets study criteria|9|||
148945419|NCT03766581|537284173|FG001|Treatment|Participant no longer meets study criteria|1|||
148945420|NCT03766581|537284174|FG002|Treatment|Participant no longer meets study criteria|5|||
148945421|NCT03766581|537284175|FG003|Treatment|Participant no longer meets study criteria|4|||
148945422|NCT03766581|537284176|FG004|Treatment|Participant no longer meets study criteria|4|||
148945423|NCT03766581|537284177|FG005|Treatment|Participant no longer meets study criteria|4|||
149202278|NCT00589979|538207434|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
149202279|NCT00589979|538207435|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
149202280|NCT01153841|538207436|FG000|Overall Study|Adverse Event|1|||
149202281|NCT01153841|538207437|FG001|Overall Study|Adverse Event|0|||
149202282|NCT01153841|538207436|FG000|Overall Study|Withdrawal by Subject|1|||
149202283|NCT01153841|538207437|FG001|Overall Study|Withdrawal by Subject|0|||
149202284|NCT01153841|538207436|FG000|Overall Study|Protocol Violation|2|||
149202285|NCT01153841|538207437|FG001|Overall Study|Protocol Violation|0|||
148945424|NCT03766581|537284178|FG006|Treatment|Participant no longer meets study criteria|2|||
148945425|NCT03766581|537284179|FG007|Treatment|Participant no longer meets study criteria|0|||
148945426|NCT03766581|537284172|FG000|Treatment|Other reasons|13|||
148945427|NCT03766581|537284173|FG001|Treatment|Other reasons|8|||
148945428|NCT03766581|537284174|FG002|Treatment|Other reasons|3|||
148945429|NCT03766581|537284175|FG003|Treatment|Other reasons|7|||
148945430|NCT03766581|537284176|FG004|Treatment|Other reasons|3|||
148945431|NCT03766581|537284177|FG005|Treatment|Other reasons|3|||
148945432|NCT03766581|537284178|FG006|Treatment|Other reasons|0|||
148945433|NCT03766581|537284179|FG007|Treatment|Other reasons|0|||
149202286|NCT01153841|538207436|FG000|Overall Study|Lost to Follow-up|2|||
148945434|NCT03716024|537284180|FG000|Overall Study|Randomized, not Treated|7|||
148945435|NCT03716024|537284181|FG001|Overall Study|Randomized, not Treated|8|||
148945436|NCT03716024|537284180|FG000|Overall Study|Adverse Event|1|||
148945437|NCT03716024|537284181|FG001|Overall Study|Adverse Event|2|||
148945438|NCT03716024|537284180|FG000|Overall Study|Treatment Failure|1|||
149202287|NCT01153841|538207437|FG001|Overall Study|Lost to Follow-up|0|||
148945439|NCT03716024|537284181|FG001|Overall Study|Treatment Failure|0|||
148945440|NCT03716024|537284180|FG000|Overall Study|Lost to Follow-up|2|||
148945441|NCT03716024|537284181|FG001|Overall Study|Lost to Follow-up|6|||
148945442|NCT03716024|537284180|FG000|Overall Study|Withdrawal by Subject|0|||
148945443|NCT03716024|537284181|FG001|Overall Study|Withdrawal by Subject|1|||
148945444|NCT03716024|537284180|FG000|Overall Study|Missing Reason|0|||
148945445|NCT03716024|537284181|FG001|Overall Study|Missing Reason|1|||
148945446|NCT04343261|537284182|FG000|Overall Study|Adverse Event|1|||
148945447|NCT04343261|537284182|FG000|Overall Study|received inadequate amount of antibodies|7|||
148945448|NCT02197247|537284188|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
148945449|NCT02197247|537284188|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
148945450|NCT02197247|537284188|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
148945451|NCT02197247|537284188|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
148945452|NCT02197247|537284188|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
148945453|NCT02197247|537284188|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
148945454|NCT02197247|537284188|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
148945455|NCT02197247|537284188|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
148945456|NCT03851705|537284193|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
149202288|NCT00830804|538207443|FG000|Overall Study|Lost to Follow-up|4|||
149202289|NCT00830804|538207443|FG000|Overall Study|Death|1|||
149202290|NCT00830804|538207443|FG000|Overall Study|Unable to get to clinic|7|||
149202291|NCT00830804|538207443|FG000|Overall Study|Consent withdrawn|2|||
149202292|NCT00830804|538207443|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
149202293|NCT05489081|538207448|FG000|Overall Study|student left classroom|0|||
149202294|NCT05489081|538207449|FG001|Overall Study|student left classroom|1|||
149202295|NCT05489081|538207448|FG000|Overall Study|teacher left school|0|||
149202296|NCT05489081|538207449|FG001|Overall Study|teacher left school|2|||
149202297|NCT00510068|538207450|FG000|Double-blind Period|Disease progression|98|||
149202298|NCT00510068|538207451|FG001|Double-blind Period|Disease progression|169|||
149202299|NCT00510068|538207450|FG000|Double-blind Period|Final primary analysis|52|||
149202300|NCT00510068|538207451|FG001|Double-blind Period|Final primary analysis|18|||
149202301|NCT00510068|538207450|FG000|Double-blind Period|Adverse Event|37|||
149202302|NCT00510068|538207451|FG001|Double-blind Period|Adverse Event|7|||
149202303|NCT00510068|538207450|FG000|Double-blind Period|Withdrawal by Subject|8|||
149202304|NCT00510068|538207451|FG001|Double-blind Period|Withdrawal by Subject|6|||
149202305|NCT00510068|538207450|FG000|Double-blind Period|Death|4|||
148945457|NCT03851705|537284194|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
149202306|NCT00510068|538207451|FG001|Double-blind Period|Death|3|||
148945458|NCT03851705|537284195|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
148945459|NCT03851705|537284196|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
148945460|NCT03851705|537284193|FG000|Part 1: Double-Blind Period|Other reason|1|||
149016277|NCT00337662|537537893|FG003|Study Period III|Withdrawal by Subject|0|||
149202307|NCT00510068|538207450|FG000|Double-blind Period|Abnormal test result (s)|1|||
149202308|NCT00510068|538207451|FG001|Double-blind Period|Abnormal test result (s)|0|||
149202309|NCT00510068|538207450|FG000|Double-blind Period|Lost to Follow-up|1|||
148945461|NCT03851705|537284194|FG001|Part 1: Double-Blind Period|Other reason|0|||
148945462|NCT03851705|537284195|FG002|Part 1: Double-Blind Period|Other reason|0|||
148945463|NCT03851705|537284196|FG003|Part 1: Double-Blind Period|Other reason|0|||
148945464|NCT03851705|537284193|FG000|Part 2: Open-Label Period|Other reason|0|||
148945465|NCT03851705|537284194|FG001|Part 2: Open-Label Period|Other reason|0|||
148945466|NCT03851705|537284195|FG002|Part 2: Open-Label Period|Other reason|0|||
148945467|NCT03851705|537284196|FG003|Part 2: Open-Label Period|Other reason|1|||
148945468|NCT03851705|537284193|FG000|Part 2: Open-Label Period|Death|0|||
148945469|NCT03851705|537284194|FG001|Part 2: Open-Label Period|Death|0|||
148945470|NCT03851705|537284195|FG002|Part 2: Open-Label Period|Death|3|||
148945471|NCT03851705|537284196|FG003|Part 2: Open-Label Period|Death|0|||
148945472|NCT03851705|537284193|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
148945473|NCT03851705|537284194|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
148945474|NCT03851705|537284195|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
149202310|NCT00510068|538207451|FG001|Double-blind Period|Lost to Follow-up|0|||
149202311|NCT00510068|538207450|FG000|Double-blind Period|Protocol Violation|6|||
149202312|NCT00510068|538207451|FG001|Double-blind Period|Protocol Violation|0|||
149202313|NCT00510068|538207450|FG000|Open-label Period|Disease Progression|124|||
149202314|NCT00510068|538207451|FG001|Open-label Period|Disease Progression|0|||
149202315|NCT00510068|538207450|FG000|Open-label Period|Adverse Event|46|||
149202316|NCT00510068|538207451|FG001|Open-label Period|Adverse Event|0|||
149202317|NCT00510068|538207450|FG000|Open-label Period|Withdrawal by Subject|21|||
149202318|NCT00510068|538207451|FG001|Open-label Period|Withdrawal by Subject|0|||
149202319|NCT00510068|538207450|FG000|Open-label Period|Administrative problems|17|||
149202320|NCT00510068|538207451|FG001|Open-label Period|Administrative problems|0|||
149202321|NCT00510068|538207450|FG000|Open-label Period|Death|7|||
149202322|NCT00510068|538207451|FG001|Open-label Period|Death|0|||
149202323|NCT00510068|538207450|FG000|Open-label Period|New cancer therapy|7|||
149202324|NCT00510068|538207451|FG001|Open-label Period|New cancer therapy|0|||
149202325|NCT00510068|538207450|FG000|Open-label Period|Protocol Violation|2|||
149202326|NCT00510068|538207451|FG001|Open-label Period|Protocol Violation|0|||
149202327|NCT00510068|538207450|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
149202328|NCT00510068|538207451|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
149202329|NCT00400712|538207452|FG000|Overall Study|Death|1|||
149202330|NCT00400712|538207453|FG001|Overall Study|Death|0|||
149202331|NCT00400712|538207452|FG000|Overall Study|Withdrawal by Subject|11|||
149202332|NCT00400712|538207453|FG001|Overall Study|Withdrawal by Subject|12|||
149202333|NCT00400712|538207452|FG000|Overall Study|Physician Decision|5|||
149202334|NCT00400712|538207453|FG001|Overall Study|Physician Decision|4|||
149202335|NCT00776555|538207456|FG000|Overall Study|Study terminated|3|||
149202336|NCT00776555|538207457|FG001|Overall Study|Study terminated|0|||
149202337|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
149202338|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
149202339|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
149202340|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
149202341|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
149202342|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
149202343|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Death|1|||
149202344|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Death|3|||
149202345|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
149202346|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
149202347|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
149202348|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
149202349|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
149202350|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
149202351|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
149202352|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
149202353|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
149202354|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
149202355|NCT02553317|538207458|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
149202356|NCT02553317|538207459|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
149202357|NCT03483116|538207461|FG000|Overall Study|Adverse Event|0|||
149202358|NCT03483116|538207462|FG001|Overall Study|Adverse Event|1|||
149202359|NCT03483116|538207463|FG002|Overall Study|Adverse Event|0|||
149202360|NCT03483116|538207464|FG003|Overall Study|Adverse Event|1|||
149202361|NCT03483116|538207461|FG000|Overall Study|Protocol Violation|1|||
149202362|NCT03483116|538207462|FG001|Overall Study|Protocol Violation|0|||
149202363|NCT03483116|538207463|FG002|Overall Study|Protocol Violation|0|||
149202364|NCT03483116|538207464|FG003|Overall Study|Protocol Violation|7|||
149202365|NCT03483116|538207461|FG000|Overall Study|Lost to Follow-up|9|||
149202366|NCT03483116|538207462|FG001|Overall Study|Lost to Follow-up|4|||
149202367|NCT03483116|538207463|FG002|Overall Study|Lost to Follow-up|9|||
149202368|NCT03483116|538207464|FG003|Overall Study|Lost to Follow-up|5|||
149202369|NCT03483116|538207461|FG000|Overall Study|Death|1|||
149202370|NCT03483116|538207462|FG001|Overall Study|Death|0|||
149202371|NCT03483116|538207463|FG002|Overall Study|Death|2|||
149202372|NCT03483116|538207464|FG003|Overall Study|Death|1|||
149202373|NCT03483116|538207461|FG000|Overall Study|Withdrawal by Subject|14|||
149202374|NCT03483116|538207462|FG001|Overall Study|Withdrawal by Subject|16|||
149202375|NCT03483116|538207463|FG002|Overall Study|Withdrawal by Subject|14|||
149202376|NCT03483116|538207464|FG003|Overall Study|Withdrawal by Subject|16|||
149202377|NCT03483116|538207461|FG000|Overall Study|Unknown other reason|3|||
149202378|NCT03483116|538207462|FG001|Overall Study|Unknown other reason|2|||
149202379|NCT03483116|538207463|FG002|Overall Study|Unknown other reason|1|||
149202380|NCT03483116|538207464|FG003|Overall Study|Unknown other reason|1|||
149202381|NCT01181102|538207465|FG000|Overall Study|Adverse Event|28|||
149202382|NCT01181102|538207466|FG001|Overall Study|Adverse Event|26|||
149202383|NCT01181102|538207465|FG000|Overall Study|Lack of Efficacy|3|||
149202384|NCT01181102|538207466|FG001|Overall Study|Lack of Efficacy|1|||
149202385|NCT01181102|538207465|FG000|Overall Study|Lost to Follow-up|2|||
149202386|NCT01181102|538207466|FG001|Overall Study|Lost to Follow-up|0|||
148945475|NCT03851705|537284196|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
148945476|NCT00621582|537284200|FG000|Overall Study|Adverse Event|7|||
148945477|NCT00621582|537284200|FG000|Overall Study|Protocol Violation|57|||
148945478|NCT00621582|537284200|FG000|Overall Study|Lost to Follow-up|24|||
148945479|NCT00621582|537284200|FG000|Overall Study|issues not identified by investigators|18|||
148945480|NCT01387932|537284202|FG000|Randomized and Treated|Physician Decision|3|||
148945481|NCT01387932|537284203|FG001|Randomized and Treated|Physician Decision|2|||
148945482|NCT01387932|537284202|FG000|Randomized and Treated|Withdrawal by Subject|4|||
148945483|NCT01387932|537284203|FG001|Randomized and Treated|Withdrawal by Subject|2|||
148945484|NCT01387932|537284202|FG000|Survival Follow-up|Liver Transplant|24|||
148945485|NCT01387932|537284203|FG001|Survival Follow-up|Liver Transplant|28|||
148945486|NCT01387932|537284202|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
148945487|NCT01387932|537284203|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
148945488|NCT01387932|537284202|FG000|Survival Follow-up|Withdrawal by Subject|2|||
148945489|NCT01387932|537284203|FG001|Survival Follow-up|Withdrawal by Subject|4|||
148945490|NCT01387932|537284202|FG000|Survival Follow-up|Lost to Follow-up|6|||
148945491|NCT01387932|537284203|FG001|Survival Follow-up|Lost to Follow-up|5|||
148945492|NCT01964430|537284204|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
148945493|NCT01964430|537284205|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
148945494|NCT01964430|537284204|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
148945495|NCT01964430|537284205|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
149202387|NCT01181102|538207465|FG000|Overall Study|Physician Decision|3|||
149202388|NCT01181102|538207466|FG001|Overall Study|Physician Decision|1|||
149202389|NCT01181102|538207465|FG000|Overall Study|Protocol Violation|5|||
149202390|NCT01181102|538207466|FG001|Overall Study|Protocol Violation|6|||
149202391|NCT01181102|538207465|FG000|Overall Study|Withdrawal by Subject|10|||
149202392|NCT01181102|538207466|FG001|Overall Study|Withdrawal by Subject|12|||
149202393|NCT01838590|538207472|FG000|Overall Study|Lack of Efficacy|12|||
149202394|NCT01838590|538207473|FG001|Overall Study|Lack of Efficacy|4|||
149202395|NCT01838590|538207472|FG000|Overall Study|Lost to Follow-up|0|||
149202396|NCT01838590|538207473|FG001|Overall Study|Lost to Follow-up|1|||
149202397|NCT04664855|538207474|FG000|Overall Study|Withdrawal by Subject|0|||
149202398|NCT04664855|538207475|FG001|Overall Study|Withdrawal by Subject|2|||
149202399|NCT00772382|538207478|FG000|Overall Study|Adverse Event|19|||
149202400|NCT00772382|538207478|FG000|Overall Study|Death|6|||
149202401|NCT00772382|538207478|FG000|Overall Study|Lack of Efficacy|4|||
149202402|NCT00772382|538207478|FG000|Overall Study|Physician Decision|5|||
148808653|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
148945496|NCT01964430|537284204|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
148945497|NCT01964430|537284205|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
148945498|NCT01964430|537284204|FG000|Treatment Period|Adverse Event|71|||
148945499|NCT01964430|537284205|FG001|Treatment Period|Adverse Event|37|||
148945500|NCT01964430|537284204|FG000|Treatment Period|Withdrawal by Subject|36|||
148945501|NCT01964430|537284205|FG001|Treatment Period|Withdrawal by Subject|27|||
148945502|NCT01964430|537284204|FG000|Treatment Period|Death|1|||
148945503|NCT01964430|537284205|FG001|Treatment Period|Death|3|||
148945504|NCT01964430|537284204|FG000|Treatment Period|Protocol Deviation|0|||
148945505|NCT01964430|537284205|FG001|Treatment Period|Protocol Deviation|1|||
148945506|NCT01964430|537284204|FG000|Treatment Period|Physician Decision|5|||
148945507|NCT01964430|537284205|FG001|Treatment Period|Physician Decision|4|||
148945508|NCT01964430|537284204|FG000|Treatment Period|Disease Relapse|28|||
148808654|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
148945509|NCT01964430|537284205|FG001|Treatment Period|Disease Relapse|38|||
148945510|NCT01964430|537284204|FG000|Treatment Period|Other reasons|1|||
148945511|NCT01964430|537284205|FG001|Treatment Period|Other reasons|3|||
148945512|NCT02591290|537284206|FG000|Overall Study|Withdrawal by Subject|2|||
148945513|NCT02571075|537284207|FG000|Overall Study|Lost to Follow-up|20|||
148945514|NCT02571075|537284208|FG001|Overall Study|Lost to Follow-up|24|||
148808655|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
148808656|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
148945515|NCT01306942|537284214|FG000|Phase I|Adverse Event|2|||
148945516|NCT01306942|537284215|FG001|Phase I|Adverse Event|2|||
148945517|NCT01306942|537284216|FG002|Phase I|Adverse Event|0|||
149016278|NCT00337662|537537890|FG000|Study Period III|Adverse Event|9|||
149016279|NCT00337662|537537891|FG001|Study Period III|Adverse Event|10|||
149016280|NCT00337662|537537892|FG002|Study Period III|Adverse Event|8|||
149016281|NCT00337662|537537893|FG003|Study Period III|Adverse Event|0|||
149016282|NCT00337662|537537890|FG000|Study Period III|Protocol Violation|3|||
149016283|NCT00337662|537537891|FG001|Study Period III|Protocol Violation|8|||
149016284|NCT00337662|537537892|FG002|Study Period III|Protocol Violation|2|||
148945518|NCT01306942|537284217|FG003|Phase I|Adverse Event|0|||
148945519|NCT01306942|537284214|FG000|Phase I|Physician Decision|3|||
148945520|NCT01306942|537284215|FG001|Phase I|Physician Decision|1|||
149016285|NCT00337662|537537893|FG003|Study Period III|Protocol Violation|0|||
149016286|NCT00337662|537537890|FG000|Study Period III|Physician Decision|6|||
149202403|NCT00772382|538207478|FG000|Overall Study|Protocol Violation|1|||
149202404|NCT00772382|538207478|FG000|Overall Study|Withdrawal by Subject|10|||
149202405|NCT00772382|538207478|FG000|Overall Study|Other Reasons|10|||
149202406|NCT00862121|538207483|FG000|Overall Study|Adverse Event|1|||
149202407|NCT00862121|538207484|FG001|Overall Study|Adverse Event|2|||
149202408|NCT00862121|538207483|FG000|Overall Study|Lack of Efficacy|0|||
149202409|NCT00862121|538207484|FG001|Overall Study|Lack of Efficacy|3|||
149202410|NCT00862121|538207483|FG000|Overall Study|Protocol Violation|0|||
149202411|NCT00862121|538207484|FG001|Overall Study|Protocol Violation|1|||
149202412|NCT00862121|538207483|FG000|Overall Study|Exclusion criterion violation|0|||
149202413|NCT00862121|538207484|FG001|Overall Study|Exclusion criterion violation|1|||
149202414|NCT00862121|538207483|FG000|Overall Study|Incorrect randomisation|0|||
149202415|NCT00862121|538207484|FG001|Overall Study|Incorrect randomisation|1|||
149202416|NCT01582971|538207485|FG000|Overall Study|Death|2|||
149202417|NCT01582971|538207486|FG001|Overall Study|Death|1|||
149202418|NCT01582971|538207485|FG000|Overall Study|Lost to Follow-up|18|||
149202419|NCT01582971|538207486|FG001|Overall Study|Lost to Follow-up|21|||
149202420|NCT01582971|538207485|FG000|Overall Study|Withdrawal by Subject|4|||
149202421|NCT01582971|538207486|FG001|Overall Study|Withdrawal by Subject|2|||
148945521|NCT01306942|537284216|FG002|Phase I|Physician Decision|0|||
148945522|NCT01306942|537284217|FG003|Phase I|Physician Decision|0|||
149016287|NCT00337662|537537891|FG001|Study Period III|Physician Decision|5|||
149202422|NCT01582971|538207485|FG000|Overall Study|Other|15|||
149202423|NCT01582971|538207486|FG001|Overall Study|Other|13|||
149202424|NCT02007954|538207487|FG000|Overall Study|Received liver transplant|3|||
149202425|NCT02007954|538207487|FG000|Overall Study|Switch in treatment modality|2|||
149202426|NCT02007954|538207487|FG000|Overall Study|Disease progression and unrelated AE|1|||
149202427|NCT02007954|538207487|FG000|Overall Study|Death|1|||
149202428|NCT03784027|538207488|FG000|Period 1|Withdrawal by Subject|0|||
149202429|NCT03784027|538207489|FG001|Period 1|Withdrawal by Subject|1|||
149202430|NCT01357980|538209819|FG000|Overall Study|Lack of Efficacy|0|||
149202431|NCT01357980|538209820|FG001|Overall Study|Lack of Efficacy|1|||
149202432|NCT01357980|538209821|FG002|Overall Study|Lack of Efficacy|0|||
149202433|NCT01357980|538209822|FG003|Overall Study|Lack of Efficacy|0|||
149202434|NCT01357980|538209819|FG000|Overall Study|Consent withdrawn|0|||
149202435|NCT01357980|538209820|FG001|Overall Study|Consent withdrawn|0|||
149202436|NCT01357980|538209821|FG002|Overall Study|Consent withdrawn|1|||
149202437|NCT01357980|538209822|FG003|Overall Study|Consent withdrawn|0|||
149202438|NCT00387348|538209823|FG000|Overall Study|Death|1|||
149202439|NCT00387348|538209824|FG001|Overall Study|Death|1|||
149202440|NCT00387348|538209825|FG002|Overall Study|Death|0|||
149202441|NCT00387348|538209823|FG000|Overall Study|Physician Decision|1|||
149202442|NCT00387348|538209824|FG001|Overall Study|Physician Decision|0|||
149202443|NCT00387348|538209825|FG002|Overall Study|Physician Decision|1|||
149202444|NCT00387348|538209823|FG000|Overall Study|Withdrawal by Subject|0|||
149202445|NCT00387348|538209824|FG001|Overall Study|Withdrawal by Subject|2|||
149202446|NCT00387348|538209825|FG002|Overall Study|Withdrawal by Subject|2|||
149202447|NCT00387348|538209823|FG000|Overall Study|Adverse Event|1|||
149202448|NCT00387348|538209824|FG001|Overall Study|Adverse Event|0|||
149202449|NCT00387348|538209825|FG002|Overall Study|Adverse Event|1|||
149202450|NCT03628599|538209826|FG000|Overall Study|Adverse Event|0|||
149202451|NCT03628599|538209827|FG001|Overall Study|Adverse Event|1|||
149202452|NCT01624506|538209830|FG000|Overall Study|Lost to Follow-up|29|||
149202453|NCT01624506|538209831|FG001|Overall Study|Lost to Follow-up|15|||
149202454|NCT01624506|538209830|FG000|Overall Study|Withdrawal by Subject|9|||
149202455|NCT01624506|538209831|FG001|Overall Study|Withdrawal by Subject|2|||
149202456|NCT01624506|538209830|FG000|Overall Study|Death|1|||
149202457|NCT01624506|538209831|FG001|Overall Study|Death|0|||
149202458|NCT01624506|538209830|FG000|Overall Study|LINX explants|23|||
149202459|NCT01624506|538209831|FG001|Overall Study|LINX explants|0|||
149202460|NCT01624506|538209830|FG000|Overall Study|Adverse Event|3|||
149202461|NCT01624506|538209831|FG001|Overall Study|Adverse Event|0|||
149202462|NCT01149343|538209832|FG000|Overall Study|Withdrawal by Subject|1|||
149202463|NCT01149343|538209833|FG001|Overall Study|Withdrawal by Subject|1|||
149202464|NCT01149343|538209834|FG002|Overall Study|Withdrawal by Subject|1|||
149202465|NCT01149343|538209835|FG003|Overall Study|Withdrawal by Subject|5|||
149202466|NCT01149343|538209832|FG000|Overall Study|Death|10|||
149202467|NCT01149343|538209833|FG001|Overall Study|Death|13|||
149202468|NCT01149343|538209834|FG002|Overall Study|Death|18|||
149202469|NCT01149343|538209835|FG003|Overall Study|Death|18|||
149202470|NCT01149343|538209832|FG000|Overall Study|Lost to Follow-up|1|||
148945523|NCT01306942|537284214|FG000|Phase II|Adverse Event|0|||
148945524|NCT01306942|537284215|FG001|Phase II|Adverse Event|0|||
148945525|NCT01306942|537284216|FG002|Phase II|Adverse Event|0|||
148945526|NCT01306942|537284217|FG003|Phase II|Adverse Event|6|||
148945527|NCT01306942|537284214|FG000|Phase II|Physician Decision|2|||
148945528|NCT01306942|537284215|FG001|Phase II|Physician Decision|0|||
148945529|NCT01306942|537284216|FG002|Phase II|Physician Decision|0|||
148945530|NCT01306942|537284217|FG003|Phase II|Physician Decision|5|||
148945531|NCT01306942|537284214|FG000|Phase II|Withdrawal by Subject|0|||
148945532|NCT01306942|537284215|FG001|Phase II|Withdrawal by Subject|0|||
148945533|NCT01306942|537284216|FG002|Phase II|Withdrawal by Subject|0|||
148945534|NCT01306942|537284217|FG003|Phase II|Withdrawal by Subject|2|||
148945535|NCT01306942|537284214|FG000|Phase II|Death|0|||
148945536|NCT01306942|537284215|FG001|Phase II|Death|0|||
149202471|NCT01149343|538209833|FG001|Overall Study|Lost to Follow-up|0|||
149202472|NCT01149343|538209834|FG002|Overall Study|Lost to Follow-up|0|||
149202473|NCT01149343|538209835|FG003|Overall Study|Lost to Follow-up|1|||
149202474|NCT01149343|538209832|FG000|Overall Study|Other|8|||
149202475|NCT01149343|538209833|FG001|Overall Study|Other|10|||
149202476|NCT01149343|538209834|FG002|Overall Study|Other|2|||
149202477|NCT01149343|538209835|FG003|Overall Study|Other|14|||
149202478|NCT01149343|538209832|FG000|Overall Study|Sponsor study termination|0|||
149202479|NCT01149343|538209833|FG001|Overall Study|Sponsor study termination|0|||
148945537|NCT01306942|537284216|FG002|Phase II|Death|0|||
148945538|NCT01306942|537284217|FG003|Phase II|Death|1|||
148945539|NCT01306942|537284214|FG000|Phase II|Not finished treatment|0|||
148945540|NCT01306942|537284215|FG001|Phase II|Not finished treatment|0|||
148945541|NCT01306942|537284216|FG002|Phase II|Not finished treatment|0|||
149202480|NCT01149343|538209834|FG002|Overall Study|Sponsor study termination|0|||
149202481|NCT01149343|538209835|FG003|Overall Study|Sponsor study termination|2|||
148945542|NCT01306942|537284217|FG003|Phase II|Not finished treatment|1|||
148945543|NCT01306942|537284214|FG000|Phase II|Protocol Violation|0|||
148945544|NCT01306942|537284215|FG001|Phase II|Protocol Violation|0|||
148945545|NCT01306942|537284216|FG002|Phase II|Protocol Violation|0|||
148945546|NCT01306942|537284217|FG003|Phase II|Protocol Violation|1|||
149202482|NCT01149343|538209832|FG000|Overall Study|Recurrence / Progressive disease|0|||
149202483|NCT01149343|538209833|FG001|Overall Study|Recurrence / Progressive disease|0|||
149202484|NCT01149343|538209834|FG002|Overall Study|Recurrence / Progressive disease|1|||
149202485|NCT01149343|538209835|FG003|Overall Study|Recurrence / Progressive disease|0|||
148945547|NCT03190915|537284218|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
148945548|NCT03190915|537284218|FG000|Overall Study|Progressive Disease|3|||
148945549|NCT02083783|537284219|FG000|Overall Study|Withdrawal by Subject|1|||
148945550|NCT02083783|537284220|FG001|Overall Study|Withdrawal by Subject|0|||
148945551|NCT01546883|537284221|FG000|Overall Study|Withdrawal by Subject|3|||
148945552|NCT01546883|537284221|FG000|Overall Study|Adverse Event|4|||
148945553|NCT01546883|537284221|FG000|Overall Study|Lost to Follow-up|2|||
148945554|NCT01546883|537284221|FG000|Overall Study|early closure of study|2|||
148945555|NCT01546883|537284221|FG000|Overall Study|other unrelated illness|1|||
148945556|NCT00530946|537284222|FG000|Overall Study|Adverse Event|1|||
148945557|NCT00530946|537284223|FG001|Overall Study|Adverse Event|2|||
148945558|NCT00530946|537284224|FG002|Overall Study|Adverse Event|1|||
148945559|NCT00530946|537284225|FG003|Overall Study|Adverse Event|1|||
148945560|NCT00530946|537284222|FG000|Overall Study|Protocol Violation|0|||
148945561|NCT00530946|537284223|FG001|Overall Study|Protocol Violation|0|||
148945562|NCT00530946|537284224|FG002|Overall Study|Protocol Violation|0|||
148945563|NCT00530946|537284225|FG003|Overall Study|Protocol Violation|1|||
148945564|NCT00530946|537284222|FG000|Overall Study|Noncompliance|1|||
148945565|NCT00530946|537284223|FG001|Overall Study|Noncompliance|0|||
148945566|NCT00530946|537284224|FG002|Overall Study|Noncompliance|0|||
148945567|NCT00530946|537284225|FG003|Overall Study|Noncompliance|0|||
148945568|NCT04545385|537284226|FG000|Overall Study|Withdrawal by Subject|2|||
148945569|NCT04545385|537284227|FG001|Overall Study|Withdrawal by Subject|0|||
148945570|NCT04545385|537284226|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
148945571|NCT04545385|537284227|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
148945572|NCT04545385|537284226|FG000|Overall Study|Study termination|10|||
148945573|NCT04545385|537284227|FG001|Overall Study|Study termination|10|||
148945574|NCT04545385|537284226|FG000|Overall Study|Sponsor decision|2|||
148945575|NCT04545385|537284227|FG001|Overall Study|Sponsor decision|2|||
148945576|NCT04545385|537284226|FG000|Overall Study|Other than specified|1|||
148945577|NCT04545385|537284227|FG001|Overall Study|Other than specified|0|||
148945578|NCT01128842|537284228|FG000|Overall Study|Adverse Event|1|||
148945579|NCT01128842|537284228|FG000|Overall Study|Disease Progression|6|||
148945580|NCT04528732|537284229|FG000|Overall Study|Death|1|||
148945581|NCT04528732|537284230|FG001|Overall Study|Death|0|||
148945582|NCT04528732|537284231|FG002|Overall Study|Death|1|||
148945583|NCT04528732|537284229|FG000|Overall Study|Lost to Follow-up|0|||
148945584|NCT04528732|537284230|FG001|Overall Study|Lost to Follow-up|1|||
148945585|NCT04528732|537284231|FG002|Overall Study|Lost to Follow-up|2|||
148945586|NCT03943147|537284236|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
148945587|NCT03943147|537284237|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
148945588|NCT03943147|537284236|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
148945589|NCT03943147|537284237|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
148945590|NCT03943147|537284236|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
148945591|NCT03943147|537284237|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
148945592|NCT03943147|537284236|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
148945593|NCT03943147|537284237|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
148945594|NCT03943147|537284236|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
148945595|NCT03943147|537284237|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
148945596|NCT03943147|537284236|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
148945597|NCT03943147|537284237|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
148945598|NCT00629707|537284238|FG000|Overall Study|Withdrawal by Subject|0|||
148945599|NCT00629707|537284239|FG001|Overall Study|Withdrawal by Subject|1|||
148945600|NCT00629707|537284238|FG000|Overall Study|Physician Decision|0|||
148945601|NCT00629707|537284239|FG001|Overall Study|Physician Decision|1|||
148945602|NCT00968201|537284243|FG000|Base Study - (Period II)|Adverse Event|8|||
148945603|NCT00968201|537284244|FG001|Base Study - (Period II)|Adverse Event|0|||
148945604|NCT00968201|537284245|FG002|Base Study - (Period II)|Adverse Event|16|||
148945605|NCT00968201|537284243|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
148945606|NCT00968201|537284244|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
148945607|NCT00968201|537284245|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
148945608|NCT00968201|537284243|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
148945609|NCT00968201|537284244|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
148945610|NCT00968201|537284245|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
148945611|NCT00968201|537284243|FG000|Base Study - (Period II)|Protocol Violation|12|||
148945612|NCT00968201|537284244|FG001|Base Study - (Period II)|Protocol Violation|0|||
148945613|NCT00968201|537284245|FG002|Base Study - (Period II)|Protocol Violation|12|||
148945614|NCT00968201|537284243|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
148945615|NCT00968201|537284244|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
148945616|NCT00968201|537284245|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
148945617|NCT00968201|537284243|FG000|Base Study - (Period II)|Site Error|0|||
148945618|NCT00968201|537284244|FG001|Base Study - (Period II)|Site Error|0|||
148945619|NCT00968201|537284245|FG002|Base Study - (Period II)|Site Error|1|||
148945620|NCT00968201|537284243|FG000|Extension Study - (Period III)|Adverse Event|0|||
148945621|NCT00968201|537284244|FG001|Extension Study - (Period III)|Adverse Event|5|||
148945622|NCT00968201|537284245|FG002|Extension Study - (Period III)|Adverse Event|22|||
148945623|NCT00968201|537284243|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
148945624|NCT00968201|537284244|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
148945625|NCT00968201|537284245|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
148945626|NCT00968201|537284243|FG000|Extension Study - (Period III)|Protocol Violation|0|||
148945627|NCT00968201|537284244|FG001|Extension Study - (Period III)|Protocol Violation|17|||
148945628|NCT00968201|537284245|FG002|Extension Study - (Period III)|Protocol Violation|14|||
148945629|NCT00968201|537284243|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
148945630|NCT00968201|537284244|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
148945631|NCT00968201|537284245|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
148945632|NCT00968201|537284243|FG000|Extension Study - (Period III)|Patient Relocated|0|||
148945633|NCT00968201|537284244|FG001|Extension Study - (Period III)|Patient Relocated|1|||
148945634|NCT00968201|537284245|FG002|Extension Study - (Period III)|Patient Relocated|1|||
148945635|NCT00968201|537284243|FG000|Extension Study - (Period III)|Noncompliance|0|||
148945636|NCT00968201|537284244|FG001|Extension Study - (Period III)|Noncompliance|0|||
148945637|NCT00968201|537284245|FG002|Extension Study - (Period III)|Noncompliance|3|||
148945638|NCT00968201|537284243|FG000|Extension Study - (Period III)|Other|0|||
148945639|NCT00968201|537284244|FG001|Extension Study - (Period III)|Other|0|||
148945640|NCT00968201|537284245|FG002|Extension Study - (Period III)|Other|2|||
148945641|NCT00968201|537284243|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
148945642|NCT00968201|537284244|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
148945643|NCT00968201|537284245|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
148945644|NCT02619175|537284246|FG000|Overall Study|Withdrawal by Subject|1|||
148945645|NCT02619175|537284247|FG001|Overall Study|Withdrawal by Subject|0|||
148945646|NCT02619175|537284246|FG000|Overall Study|foot pain|1|||
148945647|NCT02619175|537284247|FG001|Overall Study|foot pain|0|||
148945648|NCT02784431|537284248|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
148945649|NCT02784431|537284248|FG000|Overall Study|Early Study Termination|19|||
148945650|NCT02657369|537284249|FG000|Overall Study|Death|27|||
148945651|NCT02657369|537284249|FG000|Overall Study|Study terminated by sponsor|7|||
148945652|NCT00361569|537284250|FG000|Overall Study|Protocol Violation|3|||
148945653|NCT00361569|537284251|FG001|Overall Study|Protocol Violation|2|||
148945654|NCT00361569|537284252|FG002|Overall Study|Protocol Violation|4|||
148945655|NCT00361569|537284253|FG003|Overall Study|Protocol Violation|2|||
148945656|NCT00361569|537284250|FG000|Overall Study|Withdrawal by Subject|2|||
148945657|NCT00361569|537284251|FG001|Overall Study|Withdrawal by Subject|1|||
148945658|NCT00361569|537284252|FG002|Overall Study|Withdrawal by Subject|9|||
148945659|NCT00361569|537284253|FG003|Overall Study|Withdrawal by Subject|14|||
148945660|NCT00361569|537284250|FG000|Overall Study|Adverse Event|3|||
148945661|NCT00361569|537284251|FG001|Overall Study|Adverse Event|5|||
149202486|NCT00132314|538209844|FG000|Overall Study|Lost to Follow-up|70|||
149202487|NCT00132314|538209845|FG001|Overall Study|Lost to Follow-up|62|||
149202488|NCT00132314|538209844|FG000|Overall Study|Lacked SSN|1|||
149202489|NCT00132314|538209845|FG001|Overall Study|Lacked SSN|3|||
149202490|NCT00132314|538209844|FG000|Overall Study|Refused intervention at baseline|2|||
149202491|NCT00132314|538209845|FG001|Overall Study|Refused intervention at baseline|7|||
149202492|NCT04624672|538209856|FG000|Overall Study|Early Study Closure|2|||
149202493|NCT04624672|538209857|FG001|Overall Study|Early Study Closure|1|||
149202494|NCT03472040|538209858|FG000|Overall Study|Physician Decision|0|||
149202495|NCT03472040|538209859|FG001|Overall Study|Physician Decision|3|||
149202496|NCT03472040|538209858|FG000|Overall Study|Withdrawal by Subject|10|||
149202497|NCT03472040|538209859|FG001|Overall Study|Withdrawal by Subject|23|||
149202498|NCT03472040|538209858|FG000|Overall Study|Perceived Lack of Efficacy|29|||
149202499|NCT03472040|538209859|FG001|Overall Study|Perceived Lack of Efficacy|30|||
149202500|NCT03472040|538209858|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
149202501|NCT03472040|538209859|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
149202502|NCT03472040|538209858|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
149202503|NCT03472040|538209859|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
149202504|NCT03472040|538209858|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
149202505|NCT03472040|538209859|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
149202506|NCT03472040|538209858|FG000|Overall Study|Subject Non-compliance|2|||
149202507|NCT03472040|538209859|FG001|Overall Study|Subject Non-compliance|5|||
149202508|NCT03472040|538209858|FG000|Overall Study|Discontinuation due to Rash|0|||
149202509|NCT03472040|538209859|FG001|Overall Study|Discontinuation due to Rash|1|||
149202510|NCT03472040|538209858|FG000|Overall Study|Subsequent Ineligibility|0|||
149202511|NCT03472040|538209859|FG001|Overall Study|Subsequent Ineligibility|2|||
149202512|NCT03472040|538209858|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
149234052|NCT05299359|538326372|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
148945662|NCT00361569|537284252|FG002|Overall Study|Adverse Event|2|||
149016288|NCT00337662|537537892|FG002|Study Period III|Physician Decision|0|||
148945663|NCT00361569|537284253|FG003|Overall Study|Adverse Event|2|||
148945664|NCT00361569|537284250|FG000|Overall Study|Lost to Follow-up|2|||
148945665|NCT00361569|537284251|FG001|Overall Study|Lost to Follow-up|3|||
148945666|NCT00361569|537284252|FG002|Overall Study|Lost to Follow-up|3|||
148945667|NCT00361569|537284253|FG003|Overall Study|Lost to Follow-up|2|||
148945668|NCT00361569|537284250|FG000|Overall Study|Not specified by investigator|2|||
148945669|NCT00361569|537284251|FG001|Overall Study|Not specified by investigator|0|||
148945670|NCT00361569|537284252|FG002|Overall Study|Not specified by investigator|0|||
148945671|NCT00361569|537284253|FG003|Overall Study|Not specified by investigator|1|||
148945672|NCT04875195|537284254|FG000|Overall Study|Death|9|||
148945673|NCT04875195|537284255|FG001|Overall Study|Death|3|||
148945674|NCT04875195|537284254|FG000|Overall Study|Withdrawal by Subject|2|||
148945675|NCT04875195|537284255|FG001|Overall Study|Withdrawal by Subject|1|||
148945676|NCT04875195|537284254|FG000|Overall Study|Ongoing in study|49|||
148945677|NCT04875195|537284255|FG001|Overall Study|Ongoing in study|2|||
148945678|NCT00826943|537284256|FG000|Overall Study|Withdrawal by Subject|0|||
148945679|NCT00826943|537284257|FG001|Overall Study|Withdrawal by Subject|0|||
148945680|NCT00826943|537284258|FG002|Overall Study|Withdrawal by Subject|0|||
148945681|NCT00826943|537284259|FG003|Overall Study|Withdrawal by Subject|0|||
148945682|NCT00826943|537284260|FG004|Overall Study|Withdrawal by Subject|1|||
148945683|NCT00826943|537284261|FG005|Overall Study|Withdrawal by Subject|0|||
148945684|NCT03715530|537284262|FG000|Overall Study|Lost to Follow-up|3|||
148945685|NCT03715530|537284263|FG001|Overall Study|Lost to Follow-up|1|||
148945686|NCT03715530|537284264|FG002|Overall Study|Lost to Follow-up|2|||
148945687|NCT01594762|537284268|FG000|Overall Study|Withdrawal by Subject|1|||
148945688|NCT01594762|537284269|FG001|Overall Study|Withdrawal by Subject|0|||
148945689|NCT01594762|537284268|FG000|Overall Study|Lost to Follow-up|10|||
148945690|NCT01594762|537284269|FG001|Overall Study|Lost to Follow-up|10|||
148945691|NCT00382252|537284270|FG000|Overall Study|Death|4|||
148945692|NCT00382252|537284270|FG000|Overall Study|Protocol Violation|8|||
148945693|NCT00382252|537284270|FG000|Overall Study|Not treated by RFA|1|||
148945694|NCT03338998|537284272|FG000|Treatment Period|Withdrawal by Subject|1|||
148945695|NCT03338998|537284273|FG001|Treatment Period|Withdrawal by Subject|1|||
148945696|NCT03338998|537284272|FG000|Treatment Period|Adverse Event|0|||
148945697|NCT03338998|537284273|FG001|Treatment Period|Adverse Event|2|||
148945698|NCT03338998|537284272|FG000|Treatment Period|Protocol deviation|1|||
148945699|NCT03338998|537284273|FG001|Treatment Period|Protocol deviation|0|||
148945700|NCT03338998|537284272|FG000|Treatment Period|Physician Decision|2|||
148945701|NCT03338998|537284273|FG001|Treatment Period|Physician Decision|0|||
148945702|NCT03338998|537284272|FG000|Treatment Period|Subject failed swallow test|4|||
148945703|NCT03338998|537284273|FG001|Treatment Period|Subject failed swallow test|0|||
148945704|NCT03338998|537284272|FG000|Safety Follow-Up Period|Adverse Event|0|||
148945705|NCT03338998|537284273|FG001|Safety Follow-Up Period|Adverse Event|1|||
148945706|NCT03338998|537284272|FG000|Safety Follow-Up Period|Protocol deviation|1|||
149202513|NCT03472040|538209859|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
149202514|NCT02769832|538209860|FG000|Overall Study|Death|30|||
149202515|NCT00225147|538209869|FG000|Open-label Phase|Lost to Follow-up|0|||
149202516|NCT00225147|538209870|FG001|Open-label Phase|Lost to Follow-up|0|||
149202517|NCT00225147|538209871|FG002|Open-label Phase|Lost to Follow-up|0|||
149202518|NCT00225147|538209872|FG003|Open-label Phase|Lost to Follow-up|4|||
149202519|NCT00225147|538209869|FG000|Open-label Phase|Withdrawal by Subject|0|||
149202520|NCT00225147|538209870|FG001|Open-label Phase|Withdrawal by Subject|0|||
149202521|NCT00225147|538209871|FG002|Open-label Phase|Withdrawal by Subject|0|||
149202522|NCT00225147|538209872|FG003|Open-label Phase|Withdrawal by Subject|6|||
149202523|NCT03024255|538209873|FG000|Overall Study|Adverse Event|1|||
149202524|NCT03024255|538209874|FG001|Overall Study|Adverse Event|4|||
149202525|NCT03024255|538209875|FG002|Overall Study|Adverse Event|8|||
149202526|NCT03024255|538209876|FG003|Overall Study|Adverse Event|0|||
148945707|NCT03338998|537284273|FG001|Safety Follow-Up Period|Protocol deviation|0|||
148945708|NCT03338998|537284272|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
149202527|NCT03024255|538209873|FG000|Overall Study|Withdrawal by Subject|3|||
148945709|NCT03338998|537284273|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
148945710|NCT00039130|537284274|FG000|Overall Study|Adverse Event|11|||
148945711|NCT00039130|537284274|FG000|Overall Study|Death|9|||
148945712|NCT00039130|537284274|FG000|Overall Study|Withdrawal by Subject|3|||
148945713|NCT00039130|537284274|FG000|Overall Study|Progression|2|||
148945714|NCT00039130|537284274|FG000|Overall Study|Subsequent treatment|2|||
148945715|NCT00039130|537284274|FG000|Overall Study|Physician Decision|3|||
148945716|NCT03288129|537284275|FG000|Overall Study|Adverse Event|10|||
148945717|NCT03288129|537284275|FG000|Overall Study|Lost to Follow-up|3|||
148945718|NCT03288129|537284275|FG000|Overall Study|Withdrawal by Subject|3|||
148945719|NCT03288129|537284275|FG000|Overall Study|Withdrawal of consent/assent|1|||
148945720|NCT03288129|537284275|FG000|Overall Study|Other|5|||
148945721|NCT01446289|537284281|FG000|Overall Study|Withdrawal by Subject|1|||
148945722|NCT01446289|537284282|FG001|Overall Study|Withdrawal by Subject|0|||
148945723|NCT01446289|537284283|FG002|Overall Study|Withdrawal by Subject|1|||
148945724|NCT01446289|537284284|FG003|Overall Study|Withdrawal by Subject|0|||
148945725|NCT03329573|537284285|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
148945726|NCT03329573|537284286|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
148945727|NCT03329573|537284287|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
148945728|NCT03329573|537284288|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
148945729|NCT03329573|537284285|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
148945730|NCT03329573|537284286|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
148945731|NCT03329573|537284287|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
148945732|NCT03329573|537284288|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
148945733|NCT03329573|537284285|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
148945734|NCT03329573|537284286|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
148945735|NCT03329573|537284287|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
148945736|NCT03329573|537284288|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
148945737|NCT03329573|537284285|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
148945738|NCT03329573|537284286|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
148945739|NCT03329573|537284287|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
148945740|NCT03329573|537284288|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
148945741|NCT02777333|537284289|FG000|Overall Study|Withdrawal by Subject|0|||
148945742|NCT02777333|537284290|FG001|Overall Study|Withdrawal by Subject|1|||
148945743|NCT02777333|537284289|FG000|Overall Study|Lost to Follow-up|0|||
148945744|NCT02777333|537284290|FG001|Overall Study|Lost to Follow-up|1|||
148945745|NCT05243641|537284291|FG000|Overall Study|Adverse Event|3|||
148945746|NCT05243641|537284292|FG001|Overall Study|Adverse Event|0|||
148945747|NCT05243641|537284293|FG002|Overall Study|Adverse Event|0|||
148945748|NCT05243641|537284294|FG003|Overall Study|Adverse Event|1|||
148945749|NCT05243641|537284295|FG004|Overall Study|Adverse Event|0|||
148945750|NCT05243641|537284296|FG005|Overall Study|Adverse Event|0|||
148945751|NCT05243641|537284291|FG000|Overall Study|Disease progression|4|||
148945752|NCT05243641|537284292|FG001|Overall Study|Disease progression|0|||
148945753|NCT05243641|537284293|FG002|Overall Study|Disease progression|0|||
148945754|NCT05243641|537284294|FG003|Overall Study|Disease progression|2|||
148945755|NCT05243641|537284295|FG004|Overall Study|Disease progression|0|||
148945756|NCT05243641|537284296|FG005|Overall Study|Disease progression|0|||
148945757|NCT04698187|537284300|FG000|Overall Study|Withdrawal by Subject|7|||
148945758|NCT04698187|537284300|FG000|Overall Study|Death|21|||
148945759|NCT04698187|537284300|FG000|Overall Study|Sponsor Decision|15|||
148945760|NCT04698187|537284300|FG000|Overall Study|In-transit Disease|1|||
148945761|NCT03820986|537284301|FG000|Overall Study|Death|201|||
148945762|NCT03820986|537284302|FG001|Overall Study|Death|175|||
148945763|NCT03820986|537284301|FG000|Overall Study|Lost to Follow-up|1|||
148945764|NCT03820986|537284302|FG001|Overall Study|Lost to Follow-up|1|||
148945765|NCT03820986|537284301|FG000|Overall Study|Physician Decision|1|||
148945766|NCT03820986|537284302|FG001|Overall Study|Physician Decision|0|||
148945767|NCT03820986|537284301|FG000|Overall Study|Sponsor Decision|122|||
148945768|NCT03820986|537284302|FG001|Overall Study|Sponsor Decision|160|||
148945769|NCT03820986|537284301|FG000|Overall Study|Withdrawal by Subject|9|||
148945770|NCT03820986|537284302|FG001|Overall Study|Withdrawal by Subject|4|||
148945771|NCT02993146|537284303|FG000|Overall Study|Withdrawal by Subject|0|||
148945772|NCT02993146|537284304|FG001|Overall Study|Withdrawal by Subject|0|||
148945773|NCT02993146|537284305|FG002|Overall Study|Withdrawal by Subject|1|||
148945774|NCT02993146|537284306|FG003|Overall Study|Withdrawal by Subject|1|||
148945775|NCT02513394|537284311|FG000|Overall Study|Withdrawal by Subject|11|||
148945776|NCT02513394|537284312|FG001|Overall Study|Withdrawal by Subject|23|||
148945777|NCT02513394|537284311|FG000|Overall Study|Ineligible|1|||
148683002|NCT01078623|536313042|FG014|Treatment Period 3|Adverse Event|0|||
148683003|NCT01078623|536313043|FG015|Treatment Period 3|Adverse Event|0|||
148683004|NCT01078623|536313044|FG016|Treatment Period 3|Adverse Event|0|||
148683005|NCT01078623|536313045|FG017|Treatment Period 3|Adverse Event|0|||
148683006|NCT01078623|536313046|FG018|Treatment Period 3|Adverse Event|0|||
148683007|NCT01078623|536313047|FG019|Treatment Period 3|Adverse Event|0|||
148683008|NCT01078623|536313028|FG000|Treatment Period 4|Adverse Event|0|||
148945778|NCT02513394|537284312|FG001|Overall Study|Ineligible|0|||
148945779|NCT01898806|537286477|FG000|Overall Study|Withdrawal by Subject|2|||
148945780|NCT01898806|537286477|FG000|Overall Study|Physician Decision|1|||
148945781|NCT03156543|537286478|FG000|Overall Study|Withdrawal by Subject|1|||
148945782|NCT03156543|537286479|FG001|Overall Study|Withdrawal by Subject|0|||
148945783|NCT03364023|537286480|FG000|Overall Study|Lost to Follow-up|3|||
148945784|NCT03364023|537286480|FG000|Overall Study|Death|14|||
148683009|NCT01078623|536313029|FG001|Treatment Period 4|Adverse Event|0|||
148683010|NCT01078623|536313030|FG002|Treatment Period 4|Adverse Event|1|||
148945785|NCT01389817|537286487|FG000|Overall Study|Physician Decision|1|||
148945786|NCT01389817|537286488|FG001|Overall Study|Physician Decision|0|||
148945787|NCT01389817|537286487|FG000|Overall Study|Lost to Follow-up|1|||
148945788|NCT01389817|537286488|FG001|Overall Study|Lost to Follow-up|0|||
148945789|NCT01389817|537286487|FG000|Overall Study|Withdrawal by Subject|2|||
148945790|NCT01389817|537286488|FG001|Overall Study|Withdrawal by Subject|0|||
148945791|NCT02966028|537286496|FG000|Overall Study|Adverse Event|7|||
148945792|NCT02966028|537286497|FG001|Overall Study|Adverse Event|13|||
148945793|NCT02966028|537286498|FG002|Overall Study|Adverse Event|10|||
148945794|NCT02966028|537286496|FG000|Overall Study|Physician Decision|1|||
148945795|NCT02966028|537286497|FG001|Overall Study|Physician Decision|0|||
148945796|NCT02966028|537286498|FG002|Overall Study|Physician Decision|2|||
148945797|NCT02966028|537286496|FG000|Overall Study|Withdrawal by Subject|7|||
148945798|NCT02966028|537286497|FG001|Overall Study|Withdrawal by Subject|5|||
148945799|NCT02966028|537286498|FG002|Overall Study|Withdrawal by Subject|5|||
148945800|NCT02966028|537286496|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
148945801|NCT02966028|537286497|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
148945802|NCT02966028|537286498|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
148945803|NCT00573469|537286499|FG000|Overall Study|Adverse Event|1|||
148945804|NCT00573469|537286500|FG001|Overall Study|Adverse Event|1|||
148945805|NCT00573469|537286501|FG002|Overall Study|Adverse Event|1|||
148945806|NCT00573469|537286499|FG000|Overall Study|Withdrawal by Subject|0|||
148945807|NCT00573469|537286500|FG001|Overall Study|Withdrawal by Subject|2|||
148945808|NCT00573469|537286501|FG002|Overall Study|Withdrawal by Subject|0|||
148945809|NCT00573469|537286499|FG000|Overall Study|Other|5|||
148945810|NCT00573469|537286500|FG001|Overall Study|Other|1|||
148945811|NCT00573469|537286501|FG002|Overall Study|Other|3|||
148945812|NCT03052725|537286507|FG000|Overall Study|Adverse Event|2|||
148945813|NCT03052725|537286508|FG001|Overall Study|Adverse Event|0|||
148945814|NCT03052725|537286507|FG000|Overall Study|Withdrawal by Subject|3|||
149202528|NCT03024255|538209874|FG001|Overall Study|Withdrawal by Subject|1|||
149202529|NCT03024255|538209875|FG002|Overall Study|Withdrawal by Subject|0|||
148945815|NCT03052725|537286508|FG001|Overall Study|Withdrawal by Subject|4|||
148945816|NCT03052725|537286507|FG000|Overall Study|Pregnancy|0|||
148945817|NCT03052725|537286508|FG001|Overall Study|Pregnancy|1|||
148945818|NCT03052725|537286507|FG000|Overall Study|Site closure|0|||
148945819|NCT03052725|537286508|FG001|Overall Study|Site closure|1|||
148945820|NCT03052725|537286507|FG000|Overall Study|Study terminated by sponsor|143|||
148945821|NCT03052725|537286508|FG001|Overall Study|Study terminated by sponsor|144|||
148945822|NCT00520936|537286509|FG000|Overall Study|Physician Decision|0|||
148945823|NCT00520936|537286510|FG001|Overall Study|Physician Decision|2|||
148945824|NCT00520936|537286511|FG002|Overall Study|Physician Decision|1|||
149202530|NCT03024255|538209876|FG003|Overall Study|Withdrawal by Subject|3|||
149202531|NCT03024255|538209873|FG000|Overall Study|Protocol Violation|0|||
149202532|NCT03024255|538209874|FG001|Overall Study|Protocol Violation|0|||
148945825|NCT00520936|537286512|FG003|Overall Study|Physician Decision|0|||
148945826|NCT00520936|537286513|FG004|Overall Study|Physician Decision|0|||
148945827|NCT00520936|537286514|FG005|Overall Study|Physician Decision|0|||
148945828|NCT00520936|537286515|FG006|Overall Study|Physician Decision|0|||
148945829|NCT00520936|537286516|FG007|Overall Study|Physician Decision|0|||
148945830|NCT00520936|537286509|FG000|Overall Study|Withdrawal by Subject|0|||
148945831|NCT00520936|537286510|FG001|Overall Study|Withdrawal by Subject|0|||
148945832|NCT00520936|537286511|FG002|Overall Study|Withdrawal by Subject|0|||
148945833|NCT00520936|537286512|FG003|Overall Study|Withdrawal by Subject|0|||
148945834|NCT00520936|537286513|FG004|Overall Study|Withdrawal by Subject|0|||
148945835|NCT00520936|537286514|FG005|Overall Study|Withdrawal by Subject|0|||
148945836|NCT00520936|537286515|FG006|Overall Study|Withdrawal by Subject|0|||
148945837|NCT00520936|537286516|FG007|Overall Study|Withdrawal by Subject|1|||
148945838|NCT00520936|537286509|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
148945839|NCT00520936|537286510|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
148945840|NCT00520936|537286511|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
148945841|NCT00520936|537286512|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
148945842|NCT00520936|537286513|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
148945843|NCT00520936|537286514|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
148945844|NCT00520936|537286515|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
148945845|NCT00520936|537286516|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
148945846|NCT00520936|537286509|FG000|Overall Study|Death|0|||
148945847|NCT00520936|537286510|FG001|Overall Study|Death|0|||
148945848|NCT00520936|537286511|FG002|Overall Study|Death|0|||
148945849|NCT00520936|537286512|FG003|Overall Study|Death|0|||
148945850|NCT00520936|537286513|FG004|Overall Study|Death|0|||
148945851|NCT00520936|537286514|FG005|Overall Study|Death|0|||
148945852|NCT00520936|537286515|FG006|Overall Study|Death|1|||
148945853|NCT00520936|537286516|FG007|Overall Study|Death|0|||
149202533|NCT03024255|538209875|FG002|Overall Study|Protocol Violation|2|||
148945854|NCT00520936|537286509|FG000|Overall Study|Protocol Violation|0|||
148945855|NCT00520936|537286510|FG001|Overall Study|Protocol Violation|1|||
148945856|NCT00520936|537286511|FG002|Overall Study|Protocol Violation|1|||
148945857|NCT00520936|537286512|FG003|Overall Study|Protocol Violation|0|||
148945858|NCT00520936|537286513|FG004|Overall Study|Protocol Violation|1|||
148945859|NCT00520936|537286514|FG005|Overall Study|Protocol Violation|0|||
148945860|NCT00520936|537286515|FG006|Overall Study|Protocol Violation|1|||
148945861|NCT00520936|537286516|FG007|Overall Study|Protocol Violation|0|||
149202534|NCT03024255|538209876|FG003|Overall Study|Protocol Violation|0|||
149016289|NCT00337662|537537893|FG003|Study Period III|Physician Decision|0|||
149016290|NCT00337662|537537890|FG000|Study Period III|Entry Criteria Not Met|4|||
149016291|NCT00337662|537537891|FG001|Study Period III|Entry Criteria Not Met|1|||
148945862|NCT04182763|537286520|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
148945863|NCT04182763|537286521|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
148945864|NCT04182763|537286522|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
148945865|NCT04182763|537286523|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
148945866|NCT04182763|537286524|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
148945867|NCT04182763|537286520|FG000|Double-Blind Period, initial 6 months|Death|0|||
148945868|NCT04182763|537286521|FG001|Double-Blind Period, initial 6 months|Death|1|||
148945869|NCT04182763|537286522|FG002|Double-Blind Period, initial 6 months|Death|0|||
148945870|NCT04182763|537286523|FG003|Double-Blind Period, initial 6 months|Death|0|||
148945871|NCT04182763|537286524|FG004|Double-Blind Period, initial 6 months|Death|0|||
148945872|NCT04182763|537286520|FG000|Open-Label Period, subsequent 18 months|Death|3|||
148945873|NCT04182763|537286521|FG001|Open-Label Period, subsequent 18 months|Death|2|||
148945874|NCT04182763|537286522|FG002|Open-Label Period, subsequent 18 months|Death|2|||
148945875|NCT04182763|537286523|FG003|Open-Label Period, subsequent 18 months|Death|0|||
148945876|NCT04182763|537286524|FG004|Open-Label Period, subsequent 18 months|Death|1|||
148945877|NCT04182763|537286520|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
148945878|NCT04182763|537286521|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
148945879|NCT04182763|537286522|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
148945880|NCT04182763|537286523|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
148945881|NCT04182763|537286524|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
148945882|NCT04182763|537286520|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
148945883|NCT04182763|537286521|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
148945884|NCT04182763|537286522|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
148945885|NCT04182763|537286523|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
148945886|NCT04182763|537286524|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
148945887|NCT03616600|537286525|FG000|Overall Study|Withdrawal by Subject|1|||
148945888|NCT03616600|537286526|FG001|Overall Study|Withdrawal by Subject|0|||
148945889|NCT03984994|537286527|FG000|Overall Study|Withdrawal by Subject|2|||
148945890|NCT03984994|537286528|FG001|Overall Study|Withdrawal by Subject|1|||
148945891|NCT03010176|537286529|FG000|Overall Study|Death|21|||
148945892|NCT03010176|537286530|FG001|Overall Study|Death|35|||
148945893|NCT03010176|537286531|FG002|Overall Study|Death|19|||
148945894|NCT03010176|537286532|FG003|Overall Study|Death|19|||
148945895|NCT03010176|537286533|FG004|Overall Study|Death|14|||
148945896|NCT03010176|537286534|FG005|Overall Study|Death|0|||
148945897|NCT03010176|537286529|FG000|Overall Study|Lost to Follow-up|0|||
148945898|NCT03010176|537286530|FG001|Overall Study|Lost to Follow-up|0|||
148945899|NCT03010176|537286531|FG002|Overall Study|Lost to Follow-up|0|||
148945900|NCT03010176|537286532|FG003|Overall Study|Lost to Follow-up|0|||
148945901|NCT03010176|537286533|FG004|Overall Study|Lost to Follow-up|1|||
148945902|NCT03010176|537286534|FG005|Overall Study|Lost to Follow-up|0|||
148945903|NCT03010176|537286529|FG000|Overall Study|Physician Decision|0|||
148945904|NCT03010176|537286530|FG001|Overall Study|Physician Decision|4|||
148945905|NCT03010176|537286531|FG002|Overall Study|Physician Decision|0|||
148945906|NCT03010176|537286532|FG003|Overall Study|Physician Decision|1|||
148945907|NCT03010176|537286533|FG004|Overall Study|Physician Decision|0|||
148945908|NCT03010176|537286534|FG005|Overall Study|Physician Decision|0|||
149016292|NCT00337662|537537892|FG002|Study Period III|Entry Criteria Not Met|3|||
149016293|NCT00337662|537537893|FG003|Study Period III|Entry Criteria Not Met|0|||
149016294|NCT00337662|537537890|FG000|Study Period III|Lack of Efficacy|4|||
149016295|NCT00337662|537537891|FG001|Study Period III|Lack of Efficacy|4|||
149016296|NCT00337662|537537892|FG002|Study Period III|Lack of Efficacy|2|||
149016297|NCT00337662|537537893|FG003|Study Period III|Lack of Efficacy|0|||
149016298|NCT00337662|537537890|FG000|Study Period III|Parent/Caregiver Decision|0|||
149016299|NCT00337662|537537891|FG001|Study Period III|Parent/Caregiver Decision|0|||
149016300|NCT00337662|537537892|FG002|Study Period III|Parent/Caregiver Decision|2|||
149016301|NCT00337662|537537893|FG003|Study Period III|Parent/Caregiver Decision|0|||
149016302|NCT00337662|537537890|FG000|Study Period III|Sponsor Decision|1|||
148945909|NCT03010176|537286529|FG000|Overall Study|Sponsor Decision|0|||
148945910|NCT03010176|537286530|FG001|Overall Study|Sponsor Decision|4|||
148945911|NCT03010176|537286531|FG002|Overall Study|Sponsor Decision|4|||
148945912|NCT03010176|537286532|FG003|Overall Study|Sponsor Decision|1|||
148945913|NCT03010176|537286533|FG004|Overall Study|Sponsor Decision|6|||
148945914|NCT03010176|537286534|FG005|Overall Study|Sponsor Decision|0|||
149016303|NCT00337662|537537891|FG001|Study Period III|Sponsor Decision|0|||
148945915|NCT03010176|537286529|FG000|Overall Study|Withdrawal by Subject|11|||
148945916|NCT03010176|537286530|FG001|Overall Study|Withdrawal by Subject|9|||
148945917|NCT03010176|537286531|FG002|Overall Study|Withdrawal by Subject|3|||
148945918|NCT03010176|537286532|FG003|Overall Study|Withdrawal by Subject|0|||
148945919|NCT03010176|537286533|FG004|Overall Study|Withdrawal by Subject|4|||
148945920|NCT03010176|537286534|FG005|Overall Study|Withdrawal by Subject|0|||
148945921|NCT03897465|537286545|FG000|Overall Study|Lost to Follow-up|2|||
148945922|NCT03897465|537286546|FG001|Overall Study|Lost to Follow-up|1|||
148945923|NCT03897465|537286545|FG000|Overall Study|Adverse Event|2|||
148945924|NCT03897465|537286546|FG001|Overall Study|Adverse Event|0|||
148945925|NCT03897465|537286545|FG000|Overall Study|complete healing by V2|1|||
148945926|NCT03897465|537286546|FG001|Overall Study|complete healing by V2|0|||
148945927|NCT03897465|537286545|FG000|Overall Study|occurence of exclusion criterion|1|||
149202535|NCT03024255|538209873|FG000|Overall Study|Lost to Follow-up|1|||
149202536|NCT03024255|538209874|FG001|Overall Study|Lost to Follow-up|2|||
149202537|NCT03024255|538209875|FG002|Overall Study|Lost to Follow-up|1|||
149202538|NCT03024255|538209876|FG003|Overall Study|Lost to Follow-up|1|||
149202539|NCT03024255|538209873|FG000|Overall Study|Lack of Efficacy|1|||
149202540|NCT03024255|538209874|FG001|Overall Study|Lack of Efficacy|0|||
149202541|NCT03024255|538209875|FG002|Overall Study|Lack of Efficacy|0|||
149202542|NCT03024255|538209876|FG003|Overall Study|Lack of Efficacy|0|||
149202543|NCT03024255|538209873|FG000|Overall Study|Protocol Noncompliance|1|||
148945928|NCT03897465|537286546|FG001|Overall Study|occurence of exclusion criterion|1|||
148945929|NCT03897465|537286545|FG000|Overall Study|Other|1|||
148945930|NCT03897465|537286546|FG001|Overall Study|Other|0|||
148945931|NCT01471171|537286547|FG000|Treatment Period 1|Adverse Event|4|||
148945932|NCT01471171|537286548|FG001|Treatment Period 1|Adverse Event|1|||
148945933|NCT01471171|537286547|FG000|Treatment Period 2|Adverse Event|1|||
148945934|NCT01471171|537286548|FG001|Treatment Period 2|Adverse Event|0|||
148945935|NCT00601458|537286554|FG000|Overall Study|Dosing Error|1|||
148945936|NCT00601458|537286555|FG001|Overall Study|Dosing Error|0|||
148945937|NCT00601458|537286556|FG002|Overall Study|Dosing Error|0|||
148945938|NCT00601458|537286554|FG000|Overall Study|Incomplete Data|0|||
148945939|NCT00601458|537286555|FG001|Overall Study|Incomplete Data|2|||
148945940|NCT00601458|537286556|FG002|Overall Study|Incomplete Data|0|||
148945941|NCT00601458|537286554|FG000|Overall Study|Protocol Violation|3|||
148945942|NCT00601458|537286555|FG001|Overall Study|Protocol Violation|2|||
148945943|NCT00601458|537286556|FG002|Overall Study|Protocol Violation|1|||
148945944|NCT00601458|537286554|FG000|Overall Study|Early Termination|0|||
148945945|NCT00601458|537286555|FG001|Overall Study|Early Termination|1|||
148945946|NCT00601458|537286556|FG002|Overall Study|Early Termination|1|||
148945947|NCT00370032|537286557|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
148945948|NCT00370032|537286558|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
148945949|NCT00370032|537286557|FG000|Washout Period|Withdrawal by Subject|0|||
148945950|NCT00370032|537286558|FG001|Washout Period|Withdrawal by Subject|1|||
148945951|NCT00370032|537286557|FG000|Washout Period|Lost to Follow-up|0|||
148945952|NCT00370032|537286558|FG001|Washout Period|Lost to Follow-up|1|||
148945953|NCT00370032|537286557|FG000|Washout Period|Adverse Event|1|||
148945954|NCT00370032|537286558|FG001|Washout Period|Adverse Event|0|||
148945955|NCT00370032|537286557|FG000|Follow-up Period|Withdrawal by Subject|1|||
148945956|NCT00370032|537286558|FG001|Follow-up Period|Withdrawal by Subject|0|||
148945957|NCT05683249|537286559|FG000|Overall Study|Adverse Event|3|||
148945958|NCT05683249|537286560|FG001|Overall Study|Adverse Event|1|||
148945959|NCT05683249|537286559|FG000|Overall Study|Lack of Efficacy|0|||
148945960|NCT05683249|537286560|FG001|Overall Study|Lack of Efficacy|2|||
148945961|NCT05683249|537286559|FG000|Overall Study|Lost to Follow-up|6|||
148945962|NCT05683249|537286560|FG001|Overall Study|Lost to Follow-up|5|||
148945963|NCT05683249|537286559|FG000|Overall Study|Non-compliance with Study Drug|2|||
148945964|NCT05683249|537286560|FG001|Overall Study|Non-compliance with Study Drug|0|||
148945965|NCT05683249|537286559|FG000|Overall Study|Protocol Violation|6|||
148945966|NCT05683249|537286560|FG001|Overall Study|Protocol Violation|3|||
148945967|NCT05683249|537286559|FG000|Overall Study|Withdrawal by Subject|9|||
148945968|NCT05683249|537286560|FG001|Overall Study|Withdrawal by Subject|8|||
149202544|NCT03024255|538209874|FG001|Overall Study|Protocol Noncompliance|1|||
149202545|NCT03024255|538209875|FG002|Overall Study|Protocol Noncompliance|0|||
148945969|NCT05683249|537286559|FG000|Overall Study|Other|0|||
148945970|NCT05683249|537286560|FG001|Overall Study|Other|2|||
148945971|NCT05469178|537286561|FG000|Overall Study|Death|1|||
148945972|NCT05469178|537286562|FG001|Overall Study|Death|1|||
148945973|NCT05469178|537286563|FG002|Overall Study|Death|3|||
148945974|NCT05469178|537286564|FG003|Overall Study|Death|6|||
148945975|NCT05469178|537286561|FG000|Overall Study|Lack of Efficacy|2|||
148945976|NCT05469178|537286562|FG001|Overall Study|Lack of Efficacy|2|||
148945977|NCT05469178|537286563|FG002|Overall Study|Lack of Efficacy|1|||
148945978|NCT05469178|537286564|FG003|Overall Study|Lack of Efficacy|10|||
148945979|NCT05393895|537286565|FG000|Overall Study|Adverse Event|2|||
148945980|NCT05393895|537286566|FG001|Overall Study|Adverse Event|3|||
148945981|NCT05393895|537286565|FG000|Overall Study|Lost to Follow-up|4|||
148945982|NCT05393895|537286566|FG001|Overall Study|Lost to Follow-up|3|||
148945983|NCT05393895|537286565|FG000|Overall Study|Protocol Violation|1|||
148945984|NCT05393895|537286566|FG001|Overall Study|Protocol Violation|0|||
148945985|NCT05393895|537286565|FG000|Overall Study|Withdrawal by Subject|1|||
148945986|NCT05393895|537286566|FG001|Overall Study|Withdrawal by Subject|4|||
148945987|NCT00968513|537286567|FG000|Overall Study|Death|4|||
148945988|NCT00968513|537286568|FG001|Overall Study|Death|10|||
148945989|NCT00968513|537286569|FG002|Overall Study|Death|15|||
148945990|NCT03617185|537286572|FG000|Baseline|Lost to Follow-up|0|||
148945991|NCT03617185|537286573|FG001|Baseline|Lost to Follow-up|2|||
148945992|NCT03617185|537286574|FG002|Baseline|Lost to Follow-up|1|||
148945993|NCT03617185|537286575|FG003|Baseline|Lost to Follow-up|1|||
148945994|NCT03617185|537286572|FG000|Baseline|Withdrawal by Subject|0|||
148945995|NCT03617185|537286573|FG001|Baseline|Withdrawal by Subject|1|||
148945996|NCT03617185|537286574|FG002|Baseline|Withdrawal by Subject|0|||
148945997|NCT03617185|537286575|FG003|Baseline|Withdrawal by Subject|1|||
148945998|NCT03617185|537286572|FG000|Baseline|Driving Distance/Travel|0|||
148945999|NCT03617185|537286573|FG001|Baseline|Driving Distance/Travel|0|||
148946000|NCT03617185|537286574|FG002|Baseline|Driving Distance/Travel|2|||
148946001|NCT03617185|537286575|FG003|Baseline|Driving Distance/Travel|0|||
148946002|NCT03617185|537286572|FG000|Baseline|Family Obligations|0|||
148946003|NCT03617185|537286573|FG001|Baseline|Family Obligations|0|||
148946004|NCT03617185|537286574|FG002|Baseline|Family Obligations|0|||
148946005|NCT03617185|537286575|FG003|Baseline|Family Obligations|1|||
148946006|NCT03617185|537286572|FG000|3 Months|Lost to Follow-up|4|||
148946007|NCT03617185|537286573|FG001|3 Months|Lost to Follow-up|1|||
148946008|NCT03617185|537286574|FG002|3 Months|Lost to Follow-up|0|||
148946009|NCT03617185|537286575|FG003|3 Months|Lost to Follow-up|2|||
148946010|NCT03617185|537286572|FG000|3 Months|Withdrawal by Subject|1|||
148946011|NCT03617185|537286573|FG001|3 Months|Withdrawal by Subject|3|||
148946012|NCT03617185|537286574|FG002|3 Months|Withdrawal by Subject|0|||
148946013|NCT03617185|537286575|FG003|3 Months|Withdrawal by Subject|0|||
148946014|NCT03617185|537286572|FG000|3 Months|Driving Distance/Travel|1|||
148946015|NCT03617185|537286573|FG001|3 Months|Driving Distance/Travel|0|||
148946016|NCT03617185|537286574|FG002|3 Months|Driving Distance/Travel|0|||
148946017|NCT03617185|537286575|FG003|3 Months|Driving Distance/Travel|0|||
148946018|NCT03617185|537286572|FG000|3 Months|Family Obligations|0|||
148946019|NCT03617185|537286573|FG001|3 Months|Family Obligations|0|||
148946020|NCT03617185|537286574|FG002|3 Months|Family Obligations|0|||
148946021|NCT03617185|537286575|FG003|3 Months|Family Obligations|1|||
148946022|NCT03617185|537286572|FG000|12 Months|Lost to Follow-up|3|||
148946023|NCT03617185|537286573|FG001|12 Months|Lost to Follow-up|1|||
148946024|NCT03617185|537286574|FG002|12 Months|Lost to Follow-up|3|||
148946025|NCT03617185|537286575|FG003|12 Months|Lost to Follow-up|0|||
148946026|NCT03617185|537286572|FG000|12 Months|Withdrawal by Subject|0|||
148946027|NCT03617185|537286573|FG001|12 Months|Withdrawal by Subject|0|||
148946028|NCT03617185|537286574|FG002|12 Months|Withdrawal by Subject|0|||
148946029|NCT03617185|537286575|FG003|12 Months|Withdrawal by Subject|1|||
148946030|NCT03617185|537286572|FG000|12 Months|Driving Distance/Travel|0|||
148946031|NCT03617185|537286573|FG001|12 Months|Driving Distance/Travel|0|||
148946032|NCT03617185|537286574|FG002|12 Months|Driving Distance/Travel|1|||
148946033|NCT03617185|537286575|FG003|12 Months|Driving Distance/Travel|0|||
148946034|NCT02801396|537286576|FG000|Period 1|Withdrawal by Subject|0|||
148946035|NCT02801396|537286577|FG001|Period 1|Withdrawal by Subject|0|||
148946036|NCT02801396|537286578|FG002|Period 1|Withdrawal by Subject|0|||
148946037|NCT02801396|537286579|FG003|Period 1|Withdrawal by Subject|0|||
148946038|NCT02801396|537286580|FG004|Period 1|Withdrawal by Subject|1|||
148946039|NCT02801396|537286581|FG005|Period 1|Withdrawal by Subject|0|||
148946040|NCT03310021|537286586|FG000|Overall Study|Withdrawal by Subject|0|||
148946041|NCT03310021|537286587|FG001|Overall Study|Withdrawal by Subject|0|||
148946042|NCT03310021|537286588|FG002|Overall Study|Withdrawal by Subject|0|||
148946043|NCT03310021|537286589|FG003|Overall Study|Withdrawal by Subject|0|||
148946044|NCT03310021|537286590|FG004|Overall Study|Withdrawal by Subject|0|||
148946045|NCT03310021|537286591|FG005|Overall Study|Withdrawal by Subject|0|||
148946046|NCT03310021|537286592|FG006|Overall Study|Withdrawal by Subject|1|||
148946047|NCT03310021|537286593|FG007|Overall Study|Withdrawal by Subject|0|||
148946048|NCT03310021|537286594|FG008|Overall Study|Withdrawal by Subject|0|||
148946049|NCT03310021|537286595|FG009|Overall Study|Withdrawal by Subject|0|||
148946050|NCT03310021|537286596|FG010|Overall Study|Withdrawal by Subject|0|||
148946051|NCT03310021|537286597|FG011|Overall Study|Withdrawal by Subject|0|||
148946052|NCT03310021|537286598|FG012|Overall Study|Withdrawal by Subject|0|||
148946053|NCT03310021|537286599|FG013|Overall Study|Withdrawal by Subject|0|||
148946054|NCT03310021|537286600|FG014|Overall Study|Withdrawal by Subject|0|||
148946055|NCT03310021|537286601|FG015|Overall Study|Withdrawal by Subject|0|||
148946056|NCT03310021|537286602|FG016|Overall Study|Withdrawal by Subject|0|||
148946057|NCT03310021|537286603|FG017|Overall Study|Withdrawal by Subject|0|||
148946058|NCT03310021|537286604|FG018|Overall Study|Withdrawal by Subject|0|||
148946059|NCT03310021|537286605|FG019|Overall Study|Withdrawal by Subject|0|||
148946060|NCT03310021|537286586|FG000|Overall Study|Lost to Follow-up|0|||
148946061|NCT03310021|537286587|FG001|Overall Study|Lost to Follow-up|0|||
148946062|NCT03310021|537286588|FG002|Overall Study|Lost to Follow-up|0|||
148946063|NCT03310021|537286589|FG003|Overall Study|Lost to Follow-up|0|||
148946064|NCT03310021|537286590|FG004|Overall Study|Lost to Follow-up|0|||
148946065|NCT03310021|537286591|FG005|Overall Study|Lost to Follow-up|0|||
148946066|NCT03310021|537286592|FG006|Overall Study|Lost to Follow-up|0|||
148946067|NCT03310021|537286593|FG007|Overall Study|Lost to Follow-up|0|||
148946068|NCT03310021|537286594|FG008|Overall Study|Lost to Follow-up|0|||
148946069|NCT03310021|537286595|FG009|Overall Study|Lost to Follow-up|0|||
148946070|NCT03310021|537286596|FG010|Overall Study|Lost to Follow-up|1|||
148946071|NCT03310021|537286597|FG011|Overall Study|Lost to Follow-up|0|||
148946072|NCT03310021|537286598|FG012|Overall Study|Lost to Follow-up|0|||
148946073|NCT03310021|537286599|FG013|Overall Study|Lost to Follow-up|0|||
148946074|NCT03310021|537286600|FG014|Overall Study|Lost to Follow-up|0|||
148946075|NCT03310021|537286601|FG015|Overall Study|Lost to Follow-up|0|||
148946076|NCT03310021|537286602|FG016|Overall Study|Lost to Follow-up|0|||
148946077|NCT03310021|537286603|FG017|Overall Study|Lost to Follow-up|0|||
148946078|NCT03310021|537286604|FG018|Overall Study|Lost to Follow-up|0|||
148946079|NCT03310021|537286605|FG019|Overall Study|Lost to Follow-up|0|||
148946080|NCT00702923|537286608|FG000|Overall Study|Adverse Event|1|||
148946081|NCT02002091|537286613|FG000|Screening|Lost to Follow-up|10|||
148946082|NCT02002091|537286614|FG001|Screening|Lost to Follow-up|12|||
148946083|NCT02002091|537286613|FG000|Screening|Death|3|||
148946084|NCT02002091|537286614|FG001|Screening|Death|2|||
148946085|NCT03322631|537286632|FG000|Overall Study|Withdrawal by Subject|0|||
148946086|NCT03322631|537286633|FG001|Overall Study|Withdrawal by Subject|1|||
148946087|NCT03322631|537286634|FG002|Overall Study|Withdrawal by Subject|0|||
148946088|NCT03322631|537286635|FG003|Overall Study|Withdrawal by Subject|0|||
148946089|NCT03322631|537286632|FG000|Overall Study|Adverse Event|0|||
148946090|NCT03322631|537286633|FG001|Overall Study|Adverse Event|0|||
148946091|NCT03322631|537286634|FG002|Overall Study|Adverse Event|1|||
148946092|NCT03322631|537286635|FG003|Overall Study|Adverse Event|0|||
148946093|NCT02412618|537286637|FG000|Overall Study|Withdrawal by Subject|1|||
148946094|NCT02412618|537286638|FG001|Overall Study|Withdrawal by Subject|1|||
148946095|NCT02412618|537286637|FG000|Overall Study|Expulsion|1|||
148946096|NCT02412618|537286638|FG001|Overall Study|Expulsion|1|||
148946097|NCT02378961|537286639|FG000|Overall Study|Lack of Efficacy|4|||
148946098|NCT02378961|537286640|FG001|Overall Study|Lack of Efficacy|2|||
148946099|NCT02378961|537286641|FG002|Overall Study|Lack of Efficacy|0|||
148946100|NCT02378961|537286642|FG003|Overall Study|Lack of Efficacy|1|||
148946101|NCT02378961|537286639|FG000|Overall Study|Death|0|||
148946102|NCT02378961|537286640|FG001|Overall Study|Death|0|||
148946103|NCT02378961|537286641|FG002|Overall Study|Death|1|||
148946104|NCT02378961|537286642|FG003|Overall Study|Death|0|||
148946105|NCT01253408|537286643|FG000|Overall Study|Adverse Event|0|||
148946106|NCT01253408|537286644|FG001|Overall Study|Adverse Event|1|||
148946107|NCT01253408|537286645|FG002|Overall Study|Adverse Event|0|||
148946108|NCT04967443|537286652|FG000|Open Label Treatment|Death|1|||
148946109|NCT04967443|537286653|FG001|Open Label Treatment|Death|0|||
148946110|NCT04967443|537286654|FG002|Open Label Treatment|Death|0|||
148946111|NCT04967443|537286655|FG003|Open Label Treatment|Death|0|||
148946112|NCT04967443|537286656|FG004|Open Label Treatment|Death|0|||
148946113|NCT04967443|537286657|FG005|Open Label Treatment|Death|0|||
148946114|NCT04967443|537286658|FG006|Open Label Treatment|Death|0|||
148946115|NCT04967443|537286659|FG007|Open Label Treatment|Death|0|||
148946116|NCT04967443|537286652|FG000|Open Label Treatment|Lost to Follow-up|0|||
148946117|NCT04967443|537286653|FG001|Open Label Treatment|Lost to Follow-up|0|||
148946118|NCT04967443|537286654|FG002|Open Label Treatment|Lost to Follow-up|1|||
148946119|NCT04967443|537286655|FG003|Open Label Treatment|Lost to Follow-up|0|||
148946120|NCT04967443|537286656|FG004|Open Label Treatment|Lost to Follow-up|0|||
148946121|NCT04967443|537286657|FG005|Open Label Treatment|Lost to Follow-up|0|||
148946122|NCT04967443|537286658|FG006|Open Label Treatment|Lost to Follow-up|0|||
148946123|NCT04967443|537286659|FG007|Open Label Treatment|Lost to Follow-up|0|||
148946124|NCT04967443|537286652|FG000|Open Label Treatment|Withdrawal by Subject|0|||
148946125|NCT04967443|537286653|FG001|Open Label Treatment|Withdrawal by Subject|1|||
148946126|NCT04967443|537286654|FG002|Open Label Treatment|Withdrawal by Subject|0|||
148946127|NCT04967443|537286655|FG003|Open Label Treatment|Withdrawal by Subject|1|||
148946128|NCT04967443|537286656|FG004|Open Label Treatment|Withdrawal by Subject|0|||
148946129|NCT04967443|537286657|FG005|Open Label Treatment|Withdrawal by Subject|1|||
148946130|NCT04967443|537286658|FG006|Open Label Treatment|Withdrawal by Subject|2|||
148946131|NCT04967443|537286659|FG007|Open Label Treatment|Withdrawal by Subject|3|||
148946132|NCT04967443|537286652|FG000|Follow-Up|Death|1|||
148946133|NCT04967443|537286653|FG001|Follow-Up|Death|0|||
148946134|NCT04967443|537286654|FG002|Follow-Up|Death|0|||
148946135|NCT04967443|537286655|FG003|Follow-Up|Death|0|||
148946136|NCT04967443|537286656|FG004|Follow-Up|Death|0|||
148946137|NCT04967443|537286657|FG005|Follow-Up|Death|0|||
148946138|NCT04967443|537286658|FG006|Follow-Up|Death|0|||
148946139|NCT04967443|537286659|FG007|Follow-Up|Death|0|||
148946140|NCT04967443|537286652|FG000|Follow-Up|Lost to Follow-up|0|||
148946141|NCT04967443|537286653|FG001|Follow-Up|Lost to Follow-up|0|||
148946142|NCT04967443|537286654|FG002|Follow-Up|Lost to Follow-up|1|||
148946143|NCT04967443|537286655|FG003|Follow-Up|Lost to Follow-up|1|||
148946144|NCT04967443|537286656|FG004|Follow-Up|Lost to Follow-up|0|||
148946145|NCT04967443|537286657|FG005|Follow-Up|Lost to Follow-up|0|||
148946146|NCT04967443|537286658|FG006|Follow-Up|Lost to Follow-up|0|||
148946147|NCT04967443|537286659|FG007|Follow-Up|Lost to Follow-up|0|||
148946148|NCT04967443|537286652|FG000|Follow-Up|Withdrawal by Subject|0|||
148946149|NCT04967443|537286653|FG001|Follow-Up|Withdrawal by Subject|1|||
148946150|NCT04967443|537286654|FG002|Follow-Up|Withdrawal by Subject|0|||
148946151|NCT04967443|537286655|FG003|Follow-Up|Withdrawal by Subject|1|||
148946152|NCT04967443|537286656|FG004|Follow-Up|Withdrawal by Subject|0|||
148946153|NCT04967443|537286657|FG005|Follow-Up|Withdrawal by Subject|1|||
148946154|NCT04967443|537286658|FG006|Follow-Up|Withdrawal by Subject|2|||
148946155|NCT04967443|537286659|FG007|Follow-Up|Withdrawal by Subject|3|||
148946156|NCT02405780|537286660|FG000|Period I|Adverse Event|8|||
148946157|NCT02405780|537286661|FG001|Period I|Adverse Event|0|||
148946158|NCT02405780|537286662|FG002|Period I|Adverse Event|3|||
148946159|NCT02405780|537286663|FG003|Period I|Adverse Event|7|||
148946160|NCT02405780|537286660|FG000|Period I|Medical reasons|1|||
148946161|NCT02405780|537286661|FG001|Period I|Medical reasons|1|||
148946162|NCT02405780|537286662|FG002|Period I|Medical reasons|0|||
148946163|NCT02405780|537286663|FG003|Period I|Medical reasons|1|||
148946164|NCT02405780|537286660|FG000|Period I|Screening Failure|1|||
148946165|NCT02405780|537286661|FG001|Period I|Screening Failure|0|||
148946166|NCT02405780|537286662|FG002|Period I|Screening Failure|1|||
148946167|NCT02405780|537286663|FG003|Period I|Screening Failure|0|||
148946168|NCT02405780|537286660|FG000|Period I|Withdrawal by Subject|9|||
148946169|NCT02405780|537286661|FG001|Period I|Withdrawal by Subject|1|||
148946170|NCT02405780|537286662|FG002|Period I|Withdrawal by Subject|3|||
148946171|NCT02405780|537286663|FG003|Period I|Withdrawal by Subject|4|||
148946172|NCT02405780|537286660|FG000|Period I|Non-compliance with study procedures|8|||
148946173|NCT02405780|537286661|FG001|Period I|Non-compliance with study procedures|6|||
148946174|NCT02405780|537286662|FG002|Period I|Non-compliance with study procedures|8|||
148946175|NCT02405780|537286663|FG003|Period I|Non-compliance with study procedures|11|||
148946176|NCT02405780|537286660|FG000|Period II|Adverse Event|3|||
148946177|NCT02405780|537286661|FG001|Period II|Adverse Event|5|||
148946178|NCT02405780|537286662|FG002|Period II|Adverse Event|4|||
148946179|NCT02405780|537286663|FG003|Period II|Adverse Event|11|||
148946180|NCT02405780|537286660|FG000|Period II|Medical reason|0|||
148946181|NCT02405780|537286661|FG001|Period II|Medical reason|1|||
148946182|NCT02405780|537286662|FG002|Period II|Medical reason|0|||
148946183|NCT02405780|537286663|FG003|Period II|Medical reason|0|||
148946184|NCT02405780|537286660|FG000|Period II|Pregnancy|0|||
148946185|NCT02405780|537286661|FG001|Period II|Pregnancy|0|||
148946186|NCT02405780|537286662|FG002|Period II|Pregnancy|1|||
148946187|NCT02405780|537286663|FG003|Period II|Pregnancy|0|||
148946188|NCT02405780|537286660|FG000|Period II|Withdrawal by Subject|7|||
148946189|NCT02405780|537286661|FG001|Period II|Withdrawal by Subject|4|||
148946190|NCT02405780|537286662|FG002|Period II|Withdrawal by Subject|0|||
148946191|NCT02405780|537286663|FG003|Period II|Withdrawal by Subject|3|||
148946192|NCT02405780|537286660|FG000|Period II|Non-compliance with study procedures|5|||
148946193|NCT02405780|537286661|FG001|Period II|Non-compliance with study procedures|2|||
148946194|NCT02405780|537286662|FG002|Period II|Non-compliance with study procedures|7|||
148946195|NCT02405780|537286663|FG003|Period II|Non-compliance with study procedures|4|||
148946196|NCT01654536|537286664|FG000|Overall Study|Lost to Follow-up|5|||
148946197|NCT01654536|537286665|FG001|Overall Study|Lost to Follow-up|5|||
148946198|NCT01654536|537286664|FG000|Overall Study|Physician Decision|12|||
148946199|NCT01654536|537286665|FG001|Overall Study|Physician Decision|8|||
148946200|NCT01654536|537286664|FG000|Overall Study|Withdrawal by Subject|27|||
148683011|NCT01078623|536313031|FG003|Treatment Period 4|Adverse Event|0|||
148683012|NCT01078623|536313032|FG004|Treatment Period 4|Adverse Event|0|||
148683013|NCT01078623|536313033|FG005|Treatment Period 4|Adverse Event|0|||
148946201|NCT01654536|537286665|FG001|Overall Study|Withdrawal by Subject|25|||
148946202|NCT00602797|537286669|FG000|Overall Study|Adverse Event|1|||
148946203|NCT04502693|537286670|FG000|Overall Study|Adverse Event|7|||
148946204|NCT04502693|537286671|FG001|Overall Study|Adverse Event|6|||
148946205|NCT04502693|537286672|FG002|Overall Study|Adverse Event|11|||
148946206|NCT04502693|537286673|FG003|Overall Study|Adverse Event|1|||
148946207|NCT04502693|537286670|FG000|Overall Study|Lost to Follow-up|32|||
148946208|NCT04502693|537286671|FG001|Overall Study|Lost to Follow-up|36|||
148946209|NCT04502693|537286672|FG002|Overall Study|Lost to Follow-up|69|||
148946210|NCT04502693|537286673|FG003|Overall Study|Lost to Follow-up|4|||
148946211|NCT04502693|537286670|FG000|Overall Study|Protocol Violation|8|||
148946212|NCT04502693|537286671|FG001|Overall Study|Protocol Violation|8|||
148683014|NCT01078623|536313034|FG006|Treatment Period 4|Adverse Event|0|||
148946213|NCT04502693|537286672|FG002|Overall Study|Protocol Violation|16|||
148946214|NCT04502693|537286673|FG003|Overall Study|Protocol Violation|1|||
148946215|NCT04502693|537286670|FG000|Overall Study|Withdrawal by Subject|46|||
148946216|NCT04502693|537286671|FG001|Overall Study|Withdrawal by Subject|38|||
148946217|NCT04502693|537286672|FG002|Overall Study|Withdrawal by Subject|54|||
148946218|NCT04502693|537286673|FG003|Overall Study|Withdrawal by Subject|7|||
148946219|NCT04502693|537286670|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
148946220|NCT04502693|537286671|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
148946221|NCT04502693|537286672|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
148946222|NCT04502693|537286673|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148946223|NCT04502693|537286670|FG000|Overall Study|Other|1|||
148946224|NCT04502693|537286671|FG001|Overall Study|Other|0|||
148946225|NCT04502693|537286672|FG002|Overall Study|Other|1|||
148946226|NCT04502693|537286673|FG003|Overall Study|Other|1|||
148946227|NCT03736447|537286675|FG000|Overall Study|Adverse Event|5|||
148946228|NCT03736447|537286676|FG001|Overall Study|Adverse Event|1|||
148946229|NCT03736447|537286675|FG000|Overall Study|Withdrawal by Subject|5|||
148946230|NCT03736447|537286676|FG001|Overall Study|Withdrawal by Subject|1|||
148946231|NCT03736447|537286675|FG000|Overall Study|Lost to Follow-up|1|||
148946232|NCT03736447|537286676|FG001|Overall Study|Lost to Follow-up|0|||
148946233|NCT03736447|537286675|FG000|Overall Study|Physician Decision|1|||
148946234|NCT03736447|537286676|FG001|Overall Study|Physician Decision|0|||
148946235|NCT03736447|537286675|FG000|Overall Study|Continued commitment to study treatment|3|||
148946236|NCT03736447|537286676|FG001|Overall Study|Continued commitment to study treatment|0|||
148946237|NCT03736447|537286675|FG000|Overall Study|Taste aversion to study product|0|||
148946238|NCT03736447|537286676|FG001|Overall Study|Taste aversion to study product|1|||
148946239|NCT03547583|537286680|FG000|Overall Study|Adverse Event|16|||
148946240|NCT03547583|537286681|FG001|Overall Study|Adverse Event|11|||
149202546|NCT03024255|538209876|FG003|Overall Study|Protocol Noncompliance|1|||
149202547|NCT01415908|538209880|FG000|Overall Study|Withdrawal by Subject|1|||
149202548|NCT01415908|538209881|FG001|Overall Study|Withdrawal by Subject|0|||
149202549|NCT02685995|538209884|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
149202550|NCT02685995|538209885|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
149202551|NCT03625141|538209886|FG000|Overall Study|Adverse Event|0|||
149202552|NCT03625141|538209887|FG001|Overall Study|Adverse Event|2|||
149202553|NCT03625141|538209886|FG000|Overall Study|Study Terminated By Sponsor|1|||
149202554|NCT03625141|538209887|FG001|Overall Study|Study Terminated By Sponsor|13|||
149202555|NCT03625141|538209886|FG000|Overall Study|Withdrawal by Subject|3|||
149202556|NCT03625141|538209887|FG001|Overall Study|Withdrawal by Subject|0|||
149202557|NCT03625141|538209886|FG000|Overall Study|Withdrawal Of Consent|0|||
149202558|NCT03625141|538209887|FG001|Overall Study|Withdrawal Of Consent|1|||
149202559|NCT03625141|538209886|FG000|Overall Study|Death|11|||
149202560|NCT03625141|538209887|FG001|Overall Study|Death|47|||
149202561|NCT03625141|538209886|FG000|Overall Study|Progressive Disease|0|||
149202562|NCT03625141|538209887|FG001|Overall Study|Progressive Disease|2|||
149202563|NCT03250377|538209888|FG000|Overall Study|Adverse Event|2|||
149202564|NCT03250377|538209889|FG001|Overall Study|Adverse Event|4|||
149202565|NCT03250377|538209890|FG002|Overall Study|Adverse Event|0|||
149202566|NCT03250377|538209891|FG003|Overall Study|Adverse Event|4|||
149202567|NCT03250377|538209888|FG000|Overall Study|Lack of Efficacy|5|||
149202568|NCT03250377|538209889|FG001|Overall Study|Lack of Efficacy|14|||
149202569|NCT03250377|538209890|FG002|Overall Study|Lack of Efficacy|1|||
149202570|NCT03250377|538209891|FG003|Overall Study|Lack of Efficacy|3|||
149202571|NCT03250377|538209888|FG000|Overall Study|Protocol Violation|0|||
148946241|NCT03547583|537286682|FG002|Overall Study|Adverse Event|10|||
148946242|NCT03547583|537286680|FG000|Overall Study|Death|11|||
148946243|NCT03547583|537286681|FG001|Overall Study|Death|7|||
148946244|NCT03547583|537286682|FG002|Overall Study|Death|4|||
149202572|NCT03250377|538209889|FG001|Overall Study|Protocol Violation|2|||
149202573|NCT03250377|538209890|FG002|Overall Study|Protocol Violation|0|||
149202574|NCT03250377|538209891|FG003|Overall Study|Protocol Violation|1|||
149202575|NCT03250377|538209888|FG000|Overall Study|Lost to Follow-up|0|||
149202576|NCT03250377|538209889|FG001|Overall Study|Lost to Follow-up|1|||
149202577|NCT03250377|538209890|FG002|Overall Study|Lost to Follow-up|0|||
149202578|NCT03250377|538209891|FG003|Overall Study|Lost to Follow-up|0|||
149202579|NCT03250377|538209888|FG000|Overall Study|Withdrawal by Subject|7|||
149202580|NCT03250377|538209889|FG001|Overall Study|Withdrawal by Subject|7|||
149202581|NCT03250377|538209890|FG002|Overall Study|Withdrawal by Subject|0|||
149202582|NCT03250377|538209891|FG003|Overall Study|Withdrawal by Subject|4|||
148683015|NCT01078623|536313035|FG007|Treatment Period 4|Adverse Event|0|||
148683016|NCT01078623|536313036|FG008|Treatment Period 4|Adverse Event|0|||
148683017|NCT01078623|536313037|FG009|Treatment Period 4|Adverse Event|0|||
148808657|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
148946245|NCT03547583|537286680|FG000|Overall Study|Lost to Follow-up|1|||
148946246|NCT03547583|537286681|FG001|Overall Study|Lost to Follow-up|0|||
148946247|NCT03547583|537286682|FG002|Overall Study|Lost to Follow-up|0|||
148946248|NCT03547583|537286680|FG000|Overall Study|Non-compliance with study drug|0|||
148946249|NCT03547583|537286681|FG001|Overall Study|Non-compliance with study drug|0|||
148946250|NCT03547583|537286682|FG002|Overall Study|Non-compliance with study drug|1|||
148946251|NCT03547583|537286680|FG000|Overall Study|Physician Decision|1|||
148946252|NCT03547583|537286681|FG001|Overall Study|Physician Decision|0|||
148946253|NCT03547583|537286682|FG002|Overall Study|Physician Decision|3|||
148946254|NCT03547583|537286680|FG000|Overall Study|Protocol Violation|2|||
148683018|NCT01078623|536313038|FG010|Treatment Period 4|Adverse Event|0|||
148946255|NCT03547583|537286681|FG001|Overall Study|Protocol Violation|1|||
149202583|NCT03250377|538209888|FG000|Overall Study|Investigator's Judgment|1|||
149202584|NCT03250377|538209889|FG001|Overall Study|Investigator's Judgment|0|||
149202585|NCT03250377|538209890|FG002|Overall Study|Investigator's Judgment|0|||
149202586|NCT03250377|538209891|FG003|Overall Study|Investigator's Judgment|0|||
149202587|NCT03250377|538209888|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
149202588|NCT03250377|538209889|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
149202589|NCT03250377|538209890|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
149202590|NCT03250377|538209891|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
149202591|NCT03250377|538209888|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
149202592|NCT03250377|538209889|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
149202593|NCT03250377|538209890|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
149202594|NCT03250377|538209891|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
149202595|NCT03250377|538209888|FG000|Overall Study|Epilepsy Surgery|0|||
149202596|NCT03250377|538209889|FG001|Overall Study|Epilepsy Surgery|1|||
149202597|NCT03250377|538209890|FG002|Overall Study|Epilepsy Surgery|2|||
149202598|NCT03250377|538209891|FG003|Overall Study|Epilepsy Surgery|0|||
149202599|NCT03250377|538209888|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
149202600|NCT03250377|538209889|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
149202601|NCT03250377|538209890|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
149202602|NCT03250377|538209891|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
149202603|NCT03250377|538209888|FG000|Overall Study|Request From The Sponsor|0|||
148946256|NCT03547583|537286682|FG002|Overall Study|Protocol Violation|1|||
148946257|NCT03547583|537286680|FG000|Overall Study|Withdrawal by Subject|12|||
148946258|NCT03547583|537286681|FG001|Overall Study|Withdrawal by Subject|19|||
148946259|NCT03547583|537286682|FG002|Overall Study|Withdrawal by Subject|10|||
149202604|NCT03250377|538209889|FG001|Overall Study|Request From The Sponsor|1|||
149202605|NCT03250377|538209890|FG002|Overall Study|Request From The Sponsor|0|||
149202606|NCT03250377|538209891|FG003|Overall Study|Request From The Sponsor|0|||
149202607|NCT03250377|538209888|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
149202608|NCT03250377|538209889|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
149202609|NCT03250377|538209890|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
149202610|NCT03250377|538209891|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
149202611|NCT03250377|538209888|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
149202612|NCT03250377|538209889|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
149202613|NCT03250377|538209890|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
149202614|NCT03250377|538209891|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
149202615|NCT03250377|538209888|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
149202616|NCT03250377|538209889|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
149202617|NCT03250377|538209890|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
149202618|NCT03250377|538209891|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
149202619|NCT03250377|538209888|FG000|Overall Study|Pregnancy Event|0|||
149202620|NCT03250377|538209889|FG001|Overall Study|Pregnancy Event|1|||
149202621|NCT03250377|538209890|FG002|Overall Study|Pregnancy Event|0|||
149202622|NCT03250377|538209891|FG003|Overall Study|Pregnancy Event|0|||
149202623|NCT03250377|538209888|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
149202624|NCT03250377|538209889|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
149202625|NCT03250377|538209890|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
148946260|NCT03547583|537286680|FG000|Overall Study|Other|2|||
149202626|NCT03250377|538209891|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
149202627|NCT03250377|538209888|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
149202628|NCT03250377|538209889|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
149202629|NCT03250377|538209890|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
148946261|NCT03547583|537286681|FG001|Overall Study|Other|2|||
148946262|NCT03547583|537286682|FG002|Overall Study|Other|3|||
148946263|NCT01744197|537286685|FG000|Overall Study|Received 1 patch|2|||
148946264|NCT01744197|537286686|FG001|Overall Study|Received 1 patch|1|||
148946265|NCT01744197|537286685|FG000|Overall Study|No patch received|2|||
148946266|NCT01744197|537286686|FG001|Overall Study|No patch received|2|||
148946267|NCT04706091|537286687|FG000|Treatment 2|Withdrawal by Subject|1|||
148946268|NCT04706091|537286688|FG001|Treatment 2|Withdrawal by Subject|0|||
149202630|NCT03250377|538209891|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
149202631|NCT03250377|538209888|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
148946269|NCT01063868|537286689|FG000|Overall Study|Adverse Event|9|||
148946270|NCT01063868|537286690|FG001|Overall Study|Adverse Event|7|||
148946271|NCT01063868|537286689|FG000|Overall Study|Withdrawal by Subject|3|||
148946272|NCT01063868|537286690|FG001|Overall Study|Withdrawal by Subject|1|||
148946273|NCT01063868|537286689|FG000|Overall Study|Study Terminated By Sponsor|23|||
149202632|NCT03250377|538209889|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
149202633|NCT03250377|538209890|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
149202634|NCT03250377|538209891|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
149202635|NCT03250377|538209888|FG000|Overall Study|Patient requested to change hospital|0|||
149202636|NCT03250377|538209889|FG001|Overall Study|Patient requested to change hospital|0|||
149202637|NCT03250377|538209890|FG002|Overall Study|Patient requested to change hospital|0|||
149202638|NCT03250377|538209891|FG003|Overall Study|Patient requested to change hospital|1|||
148683019|NCT01078623|536313039|FG011|Treatment Period 4|Adverse Event|0|||
148683020|NCT01078623|536313040|FG012|Treatment Period 4|Adverse Event|0|||
148683021|NCT01078623|536313041|FG013|Treatment Period 4|Adverse Event|0|||
148683022|NCT01078623|536313042|FG014|Treatment Period 4|Adverse Event|0|||
148683023|NCT01078623|536313043|FG015|Treatment Period 4|Adverse Event|0|||
148683024|NCT01078623|536313044|FG016|Treatment Period 4|Adverse Event|0|||
148683025|NCT01078623|536313045|FG017|Treatment Period 4|Adverse Event|0|||
148683026|NCT01078623|536313046|FG018|Treatment Period 4|Adverse Event|0|||
148683027|NCT01078623|536313047|FG019|Treatment Period 4|Adverse Event|0|||
148683028|NCT01078623|536313028|FG000|Treatment Period 4|Withdrawal by Subject|0|||
148683029|NCT01078623|536313029|FG001|Treatment Period 4|Withdrawal by Subject|0|||
148683030|NCT01078623|536313030|FG002|Treatment Period 4|Withdrawal by Subject|0|||
148683031|NCT01078623|536313031|FG003|Treatment Period 4|Withdrawal by Subject|0|||
148808658|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
148808659|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
148808660|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
148946274|NCT01063868|537286690|FG001|Overall Study|Study Terminated By Sponsor|4|||
148946275|NCT01949506|537286691|FG000|Overall Study|Physician Decision|1|||
148946276|NCT02915016|537286692|FG000|Overall Study|Lost to Follow-up|4|||
148946277|NCT02915016|537286693|FG001|Overall Study|Lost to Follow-up|2|||
148946278|NCT02915016|537286694|FG002|Overall Study|Lost to Follow-up|5|||
148946279|NCT02915016|537286695|FG003|Overall Study|Lost to Follow-up|3|||
148946280|NCT02915016|537286696|FG004|Overall Study|Lost to Follow-up|5|||
148946281|NCT02915016|537286697|FG005|Overall Study|Lost to Follow-up|2|||
148946282|NCT02915016|537286698|FG006|Overall Study|Lost to Follow-up|8|||
148946283|NCT02915016|537286699|FG007|Overall Study|Lost to Follow-up|2|||
148946284|NCT02915016|537286692|FG000|Overall Study|Physician Decision|0|||
148946285|NCT02915016|537286693|FG001|Overall Study|Physician Decision|0|||
148946286|NCT02915016|537286694|FG002|Overall Study|Physician Decision|1|||
148946287|NCT02915016|537286695|FG003|Overall Study|Physician Decision|0|||
148946288|NCT02915016|537286696|FG004|Overall Study|Physician Decision|0|||
148946289|NCT02915016|537286697|FG005|Overall Study|Physician Decision|1|||
148946290|NCT02915016|537286698|FG006|Overall Study|Physician Decision|2|||
148946291|NCT02915016|537286699|FG007|Overall Study|Physician Decision|0|||
148946292|NCT02915016|537286692|FG000|Overall Study|Withdrawal by Subject|2|||
148946293|NCT02915016|537286693|FG001|Overall Study|Withdrawal by Subject|0|||
148946294|NCT02915016|537286694|FG002|Overall Study|Withdrawal by Subject|1|||
148946295|NCT02915016|537286695|FG003|Overall Study|Withdrawal by Subject|0|||
148946296|NCT02915016|537286696|FG004|Overall Study|Withdrawal by Subject|1|||
148946297|NCT02915016|537286697|FG005|Overall Study|Withdrawal by Subject|3|||
148946298|NCT02915016|537286698|FG006|Overall Study|Withdrawal by Subject|1|||
148946299|NCT02915016|537286699|FG007|Overall Study|Withdrawal by Subject|1|||
148946300|NCT02915016|537286692|FG000|Overall Study|Elected not to continue|0|||
148946301|NCT02915016|537286693|FG001|Overall Study|Elected not to continue|0|||
148946302|NCT02915016|537286694|FG002|Overall Study|Elected not to continue|0|||
148946303|NCT02915016|537286695|FG003|Overall Study|Elected not to continue|1|||
148946304|NCT02915016|537286696|FG004|Overall Study|Elected not to continue|0|||
148946305|NCT02915016|537286697|FG005|Overall Study|Elected not to continue|0|||
148946306|NCT02915016|537286698|FG006|Overall Study|Elected not to continue|1|||
148946307|NCT02915016|537286699|FG007|Overall Study|Elected not to continue|0|||
148946308|NCT02915016|537286692|FG000|Overall Study|HIV infection|1|||
148946309|NCT02915016|537286693|FG001|Overall Study|HIV infection|1|||
148946310|NCT02915016|537286694|FG002|Overall Study|HIV infection|1|||
148946311|NCT02915016|537286695|FG003|Overall Study|HIV infection|0|||
148946312|NCT02915016|537286696|FG004|Overall Study|HIV infection|1|||
148946313|NCT02915016|537286697|FG005|Overall Study|HIV infection|0|||
149202639|NCT03250377|538209888|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
149202640|NCT03250377|538209889|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
149202641|NCT03250377|538209890|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
148683032|NCT01078623|536313032|FG004|Treatment Period 4|Withdrawal by Subject|0|||
148946314|NCT02915016|537286698|FG006|Overall Study|HIV infection|0|||
148683033|NCT01078623|536313033|FG005|Treatment Period 4|Withdrawal by Subject|0|||
148683034|NCT01078623|536313034|FG006|Treatment Period 4|Withdrawal by Subject|0|||
148683035|NCT01078623|536313035|FG007|Treatment Period 4|Withdrawal by Subject|0|||
148946315|NCT02915016|537286699|FG007|Overall Study|HIV infection|0|||
148946316|NCT02915016|537286692|FG000|Overall Study|Participant unable to adhere|0|||
148946317|NCT02915016|537286693|FG001|Overall Study|Participant unable to adhere|0|||
148946318|NCT02915016|537286694|FG002|Overall Study|Participant unable to adhere|0|||
149202642|NCT03250377|538209891|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
149202643|NCT02168803|538209893|FG000|Overall Study|Lost to Follow-up|1|||
149202644|NCT02168803|538209894|FG001|Overall Study|Lost to Follow-up|0|||
149202645|NCT02168803|538209895|FG002|Overall Study|Lost to Follow-up|1|||
149202646|NCT02168803|538209893|FG000|Overall Study|Withdrawal by Subject|1|||
149202647|NCT02168803|538209894|FG001|Overall Study|Withdrawal by Subject|1|||
149202648|NCT02168803|538209895|FG002|Overall Study|Withdrawal by Subject|2|||
149202649|NCT02168803|538209893|FG000|Overall Study|Physician Decision|0|||
149202650|NCT02168803|538209894|FG001|Overall Study|Physician Decision|1|||
149202651|NCT02168803|538209895|FG002|Overall Study|Physician Decision|0|||
149202652|NCT02168803|538209893|FG000|Overall Study|Adverse Event|0|||
149202653|NCT02168803|538209894|FG001|Overall Study|Adverse Event|1|||
149202654|NCT02168803|538209895|FG002|Overall Study|Adverse Event|1|||
149202655|NCT02168803|538209893|FG000|Overall Study|Death|0|||
149202656|NCT02168803|538209894|FG001|Overall Study|Death|0|||
148946319|NCT02915016|537286695|FG003|Overall Study|Participant unable to adhere|0|||
148946320|NCT02915016|537286696|FG004|Overall Study|Participant unable to adhere|0|||
148946321|NCT02915016|537286697|FG005|Overall Study|Participant unable to adhere|0|||
148946322|NCT02915016|537286698|FG006|Overall Study|Participant unable to adhere|0|||
148946323|NCT02915016|537286699|FG007|Overall Study|Participant unable to adhere|1|||
148946324|NCT02166905|537286700|FG000|Overall Study|Withdrawal by Subject|1|||
148946325|NCT02166905|537286701|FG001|Overall Study|Withdrawal by Subject|0|||
148946326|NCT02166905|537286702|FG002|Overall Study|Withdrawal by Subject|0|||
148946327|NCT02166905|537286703|FG003|Overall Study|Withdrawal by Subject|0|||
149202657|NCT02168803|538209895|FG002|Overall Study|Death|1|||
149202658|NCT02168803|538209893|FG000|Overall Study|Sponsor Decision|0|||
149202659|NCT02168803|538209894|FG001|Overall Study|Sponsor Decision|0|||
149202660|NCT02168803|538209895|FG002|Overall Study|Sponsor Decision|1|||
149202661|NCT01114373|538209896|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
149202662|NCT01114373|538209897|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
149202663|NCT01114373|538209896|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
149202664|NCT01114373|538209897|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
149202665|NCT01114373|538209896|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
149202666|NCT01114373|538209897|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
149202667|NCT01114373|538209896|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
149202668|NCT01114373|538209897|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
149202669|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149202670|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149202671|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
149202672|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
149202673|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149202674|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
149202675|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
149202676|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
149202677|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
149202678|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
149202679|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
149202680|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
149202681|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
149202682|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
149202683|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
148946328|NCT02617628|537286704|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
148946329|NCT02617628|537286705|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
148946330|NCT04292743|537286715|FG000|Overall Study|Physician Decision|1|||
148946331|NCT04292743|537286716|FG001|Overall Study|Physician Decision|3|||
148946332|NCT04292743|537286717|FG002|Overall Study|Physician Decision|0|||
148946333|NCT04292743|537286718|FG003|Overall Study|Physician Decision|0|||
148946334|NCT04292743|537286715|FG000|Overall Study|Withdrawal by Subject|0|||
148946335|NCT04292743|537286716|FG001|Overall Study|Withdrawal by Subject|5|||
148946336|NCT04292743|537286717|FG002|Overall Study|Withdrawal by Subject|0|||
148946337|NCT04292743|537286718|FG003|Overall Study|Withdrawal by Subject|0|||
148946338|NCT04292743|537286715|FG000|Overall Study|Death|0|||
148946339|NCT04292743|537286716|FG001|Overall Study|Death|1|||
148946340|NCT04292743|537286717|FG002|Overall Study|Death|0|||
148946341|NCT04292743|537286718|FG003|Overall Study|Death|0|||
148946342|NCT04292743|537286715|FG000|Overall Study|Progression of Disease|2|||
148946343|NCT04292743|537286716|FG001|Overall Study|Progression of Disease|5|||
148946344|NCT04292743|537286717|FG002|Overall Study|Progression of Disease|0|||
149202684|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
148946345|NCT04292743|537286718|FG003|Overall Study|Progression of Disease|0|||
148946346|NCT04292743|537286715|FG000|Overall Study|No Treatment per protocol|0|||
148946347|NCT04292743|537286716|FG001|Overall Study|No Treatment per protocol|2|||
148946348|NCT04292743|537286717|FG002|Overall Study|No Treatment per protocol|0|||
149202685|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149202686|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149202687|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
149202688|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
149202689|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149202690|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149202691|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149202692|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
149202693|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
149202694|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
149202695|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149202696|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149202697|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
149202698|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
148946349|NCT04292743|537286718|FG003|Overall Study|No Treatment per protocol|0|||
148946350|NCT05766423|537286719|FG000|Overall Study|Withdrawal by Subject|1|||
148946351|NCT05766423|537286720|FG001|Overall Study|Withdrawal by Subject|0|||
148946352|NCT05766423|537286719|FG000|Overall Study|Consented, not scheduled|3|||
148946353|NCT05766423|537286720|FG001|Overall Study|Consented, not scheduled|5|||
148946354|NCT04487730|537288488|FG000|Overall Study|Withdrawal by Subject|3|||
149202699|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
149202700|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149202701|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149202702|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149202703|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
149202704|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
148946355|NCT04487730|537288489|FG001|Overall Study|Withdrawal by Subject|1|||
148946356|NCT04487730|537288488|FG000|Overall Study|Lost to Follow-up|0|||
148946357|NCT04487730|537288489|FG001|Overall Study|Lost to Follow-up|1|||
148946358|NCT04487730|537288488|FG000|Overall Study|Physician Decision|0|||
148946359|NCT04487730|537288489|FG001|Overall Study|Physician Decision|1|||
148946360|NCT00907777|537288490|FG000|Overall Study|Withdrawal by Subject|0|||
148946361|NCT00907777|537288491|FG001|Overall Study|Withdrawal by Subject|1|||
148946362|NCT02891850|537288494|FG000|Overall Study|Adverse Event|3|||
148946363|NCT02891850|537288495|FG001|Overall Study|Adverse Event|0|||
148946364|NCT02891850|537288494|FG000|Overall Study|Death|0|||
148946365|NCT02891850|537288495|FG001|Overall Study|Death|4|||
148946366|NCT02891850|537288494|FG000|Overall Study|Physician Decision|1|||
148946367|NCT02891850|537288495|FG001|Overall Study|Physician Decision|0|||
148946368|NCT02891850|537288494|FG000|Overall Study|Pregnancy|1|||
148946369|NCT02891850|537288495|FG001|Overall Study|Pregnancy|0|||
148946370|NCT02891850|537288494|FG000|Overall Study|Withdrawal by Subject|2|||
148946371|NCT02891850|537288495|FG001|Overall Study|Withdrawal by Subject|3|||
148946372|NCT02674529|537288496|FG000|Overall Study|Lost to Follow-up|1|||
148946373|NCT02674529|537288497|FG001|Overall Study|Lost to Follow-up|2|||
148946374|NCT02674529|537288496|FG000|Overall Study|Withdrawal by Subject|2|||
148946375|NCT02674529|537288497|FG001|Overall Study|Withdrawal by Subject|1|||
148946376|NCT02674529|537288496|FG000|Overall Study|Physician Decision|0|||
148946377|NCT02674529|537288497|FG001|Overall Study|Physician Decision|1|||
148946378|NCT02674529|537288496|FG000|Overall Study|Protocol Violation|0|||
148946379|NCT02674529|537288497|FG001|Overall Study|Protocol Violation|1|||
148946380|NCT03797014|537288503|FG000|Overall Study|Withdrawal by Subject|1|||
148946381|NCT03797014|537288503|FG000|Overall Study|Lost to Follow-up|1|||
148946382|NCT03797014|537288503|FG000|Overall Study|Protocol Violation|1|||
148946383|NCT01970397|537288504|FG000|Overall Study|Adverse Event|0|||
148946384|NCT01970397|537288505|FG001|Overall Study|Adverse Event|1|||
148946385|NCT01970397|537288504|FG000|Overall Study|Lost to Follow-up|0|||
148946386|NCT01970397|537288505|FG001|Overall Study|Lost to Follow-up|1|||
148946387|NCT01970397|537288504|FG000|Overall Study|Personal Reasons|1|||
148946388|NCT01970397|537288505|FG001|Overall Study|Personal Reasons|2|||
149202705|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
148946389|NCT01970397|537288504|FG000|Overall Study|Protocol Violation|1|||
148946390|NCT01970397|537288505|FG001|Overall Study|Protocol Violation|1|||
148946391|NCT03305575|537288508|FG000|Overall Study|Physician Decision|1|||
148946392|NCT03305575|537288509|FG001|Overall Study|Physician Decision|0|||
148946393|NCT00105469|537288510|FG000|Overall Study|Adverse Event|9|||
148946394|NCT00105469|537288511|FG001|Overall Study|Adverse Event|8|||
148946395|NCT00105469|537288510|FG000|Overall Study|Protocol Violation|4|||
148946396|NCT00105469|537288511|FG001|Overall Study|Protocol Violation|0|||
148946397|NCT00105469|537288510|FG000|Overall Study|Withdrawal by Subject|2|||
148946398|NCT00105469|537288511|FG001|Overall Study|Withdrawal by Subject|3|||
148946399|NCT00105469|537288510|FG000|Overall Study|Lost to Follow-up|1|||
148946400|NCT00105469|537288511|FG001|Overall Study|Lost to Follow-up|0|||
148946401|NCT00105469|537288510|FG000|Overall Study|Lack of Efficacy|2|||
148946402|NCT00105469|537288511|FG001|Overall Study|Lack of Efficacy|0|||
149202706|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
149202707|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
149202708|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
149202709|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
149202710|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
149202711|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
149202712|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
149202713|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149202714|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149202715|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149202716|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
149202717|NCT03444870|538209898|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
149202718|NCT03444870|538209899|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149202719|NCT03444870|538209900|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149202720|NCT03444870|538209901|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149202721|NCT03444870|538209902|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149202722|NCT03444870|538209903|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
149202723|NCT03444870|538209898|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149202724|NCT03444870|538209899|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149202725|NCT03444870|538209900|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149202726|NCT03444870|538209901|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149202727|NCT03444870|538209902|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
149202728|NCT03444870|538209903|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
149202729|NCT03444870|538209898|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
149202730|NCT03444870|538209899|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
149202731|NCT03444870|538209900|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
149202732|NCT03444870|538209901|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
149202733|NCT03444870|538209902|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
149202734|NCT03444870|538209903|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
149202735|NCT03444870|538209898|FG000|Open-Label Extension (OLE) Period|Death|0|||
149202736|NCT03444870|538209899|FG001|Open-Label Extension (OLE) Period|Death|0|||
149202737|NCT03444870|538209900|FG002|Open-Label Extension (OLE) Period|Death|0|||
149202738|NCT03444870|538209901|FG003|Open-Label Extension (OLE) Period|Death|0|||
149202739|NCT03444870|538209902|FG004|Open-Label Extension (OLE) Period|Death|1|||
149202740|NCT03444870|538209903|FG005|Open-Label Extension (OLE) Period|Death|0|||
149202741|NCT00868166|538209904|FG000|Overall Study|Death|58|||
149202742|NCT00868166|538209905|FG001|Overall Study|Death|65|||
149202743|NCT00868166|538209904|FG000|Overall Study|Withdrawal by Subject|33|||
149202744|NCT00868166|538209905|FG001|Overall Study|Withdrawal by Subject|25|||
149202745|NCT00868166|538209904|FG000|Overall Study|Protocol Violation|1|||
149202746|NCT00868166|538209905|FG001|Overall Study|Protocol Violation|0|||
149202747|NCT00868166|538209904|FG000|Overall Study|Lost to Follow-up|1|||
149202748|NCT00868166|538209905|FG001|Overall Study|Lost to Follow-up|3|||
149202749|NCT00868166|538209904|FG000|Overall Study|Adverse Event|9|||
149202750|NCT00868166|538209905|FG001|Overall Study|Adverse Event|10|||
149202751|NCT00868166|538209904|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
149202752|NCT00868166|538209905|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
149202753|NCT00868166|538209904|FG000|Overall Study|Non-compliance with IMP|1|||
149202754|NCT00868166|538209905|FG001|Overall Study|Non-compliance with IMP|1|||
149202755|NCT02034552|538209912|FG000|Overall Study|Never treated|3|||
149202756|NCT02034552|538209913|FG001|Overall Study|Never treated|2|||
149202757|NCT02034552|538209914|FG002|Overall Study|Never treated|0|||
149202758|NCT02034552|538209912|FG000|Overall Study|Radiological progression|3|||
149202759|NCT02034552|538209913|FG001|Overall Study|Radiological progression|5|||
148946403|NCT00105469|537288510|FG000|Overall Study|Other Reason|4|||
148946404|NCT00105469|537288511|FG001|Overall Study|Other Reason|0|||
148946405|NCT02871297|537288513|FG000|Overall Study|Adverse Event|34|||
148946406|NCT02871297|537288513|FG000|Overall Study|Lack of Efficacy|10|||
148946407|NCT02871297|537288513|FG000|Overall Study|Non-compliance with study drug|15|||
148946408|NCT02871297|537288513|FG000|Overall Study|Protocol Violation|3|||
148946409|NCT02871297|537288513|FG000|Overall Study|Withdrawal by Subject|20|||
149202760|NCT02034552|538209914|FG002|Overall Study|Radiological progression|4|||
148946410|NCT02871297|537288513|FG000|Overall Study|Lost to Follow-up|13|||
148946411|NCT02871297|537288513|FG000|Overall Study|Rolled over to 13546A|2|||
149202761|NCT02034552|538209912|FG000|Overall Study|AE not assoc. with disease progression|1|||
148683036|NCT01078623|536313036|FG008|Treatment Period 4|Withdrawal by Subject|0|||
148683037|NCT01078623|536313037|FG009|Treatment Period 4|Withdrawal by Subject|0|||
148946412|NCT02871297|537288513|FG000|Overall Study|Other than specified|39|||
149202762|NCT02034552|538209913|FG001|Overall Study|AE not assoc. with disease progression|4|||
149202763|NCT02034552|538209914|FG002|Overall Study|AE not assoc. with disease progression|2|||
149202764|NCT02034552|538209912|FG000|Overall Study|AE associated with disease progression|0|||
148946413|NCT04115839|537288517|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
149202765|NCT02034552|538209913|FG001|Overall Study|AE associated with disease progression|1|||
149202766|NCT02034552|538209914|FG002|Overall Study|AE associated with disease progression|0|||
149202767|NCT02034552|538209912|FG000|Overall Study|Withdrawal by Subject|2|||
149202768|NCT02034552|538209913|FG001|Overall Study|Withdrawal by Subject|1|||
149202769|NCT02034552|538209914|FG002|Overall Study|Withdrawal by Subject|1|||
149202770|NCT02034552|538209912|FG000|Overall Study|Non-compliance with study drug|0|||
149202771|NCT02034552|538209913|FG001|Overall Study|Non-compliance with study drug|0|||
149202772|NCT02034552|538209914|FG002|Overall Study|Non-compliance with study drug|1|||
149202773|NCT02034552|538209912|FG000|Overall Study|Clinical progression|5|||
149202774|NCT02034552|538209913|FG001|Overall Study|Clinical progression|7|||
149202775|NCT02034552|538209914|FG002|Overall Study|Clinical progression|9|||
149202776|NCT02197897|538209920|FG000|Overall Study|not eligible|1|||
149202777|NCT02501902|538209921|FG000|Overall Study|Subject Refused Further Follow-up|0|||
149202778|NCT02501902|538209922|FG001|Overall Study|Subject Refused Further Follow-up|0|||
149202779|NCT02501902|538209923|FG002|Overall Study|Subject Refused Further Follow-up|0|||
149202780|NCT02501902|538209924|FG003|Overall Study|Subject Refused Further Follow-up|0|||
149202781|NCT02501902|538209925|FG004|Overall Study|Subject Refused Further Follow-up|0|||
149202782|NCT02501902|538209926|FG005|Overall Study|Subject Refused Further Follow-up|0|||
149202783|NCT02501902|538209927|FG006|Overall Study|Subject Refused Further Follow-up|0|||
149202784|NCT02501902|538209928|FG007|Overall Study|Subject Refused Further Follow-up|1|||
149202785|NCT02501902|538209921|FG000|Overall Study|Study Terminated by Sponsor|0|||
149202786|NCT02501902|538209922|FG001|Overall Study|Study Terminated by Sponsor|3|||
149202787|NCT02501902|538209923|FG002|Overall Study|Study Terminated by Sponsor|0|||
149202788|NCT02501902|538209924|FG003|Overall Study|Study Terminated by Sponsor|1|||
149202789|NCT02501902|538209925|FG004|Overall Study|Study Terminated by Sponsor|1|||
149202790|NCT02501902|538209926|FG005|Overall Study|Study Terminated by Sponsor|0|||
149202791|NCT02501902|538209927|FG006|Overall Study|Study Terminated by Sponsor|2|||
149202792|NCT02501902|538209928|FG007|Overall Study|Study Terminated by Sponsor|4|||
149202793|NCT02501902|538209921|FG000|Overall Study|Death|3|||
149202794|NCT02501902|538209922|FG001|Overall Study|Death|4|||
149202795|NCT02501902|538209923|FG002|Overall Study|Death|4|||
149202796|NCT02501902|538209924|FG003|Overall Study|Death|10|||
149202797|NCT02501902|538209925|FG004|Overall Study|Death|10|||
149202798|NCT02501902|538209926|FG005|Overall Study|Death|11|||
149202799|NCT02501902|538209927|FG006|Overall Study|Death|7|||
149202800|NCT02501902|538209928|FG007|Overall Study|Death|15|||
149202801|NCT01797445|538209931|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
149202802|NCT01797445|538209932|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
149202803|NCT01797445|538209931|FG000|Double-Blind Phase|Adverse Event|3|||
149202804|NCT01797445|538209932|FG001|Double-Blind Phase|Adverse Event|0|||
149202805|NCT01797445|538209931|FG000|Double-Blind Phase|Death|5|||
149202806|NCT01797445|538209932|FG001|Double-Blind Phase|Death|4|||
149202807|NCT01797445|538209931|FG000|Double-Blind Phase|Pregnancy|0|||
149202808|NCT01797445|538209932|FG001|Double-Blind Phase|Pregnancy|1|||
149202809|NCT01797445|538209931|FG000|Double-Blind Phase|Lack of Efficacy|1|||
149202810|NCT01797445|538209932|FG001|Double-Blind Phase|Lack of Efficacy|2|||
149202811|NCT01797445|538209931|FG000|Double-Blind Phase|Investigator's Discretion|15|||
149202812|NCT01797445|538209932|FG001|Double-Blind Phase|Investigator's Discretion|17|||
149202813|NCT01797445|538209931|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
149202814|NCT01797445|538209932|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
149202815|NCT01797445|538209931|FG000|Double-Blind Phase|Protocol Violation|0|||
149202816|NCT01797445|538209932|FG001|Double-Blind Phase|Protocol Violation|1|||
149202817|NCT01797445|538209931|FG000|Double-Blind Phase|Withdrew Consent|20|||
149202818|NCT01797445|538209932|FG001|Double-Blind Phase|Withdrew Consent|35|||
149202819|NCT01797445|538209931|FG000|Double-Blind Phase|Lost to Follow-up|34|||
149202820|NCT01797445|538209932|FG001|Double-Blind Phase|Lost to Follow-up|26|||
149202821|NCT01797445|538209931|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
149202822|NCT01797445|538209932|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
149202823|NCT00688545|538209933|FG000|Overall Study|Lost to Follow-up|1|||
149202824|NCT00688545|538209934|FG001|Overall Study|Lost to Follow-up|4|||
149202825|NCT00688545|538209933|FG000|Overall Study|Insurance/cost of drug|0|||
149202826|NCT00688545|538209934|FG001|Overall Study|Insurance/cost of drug|1|||
149202827|NCT00688545|538209933|FG000|Overall Study|Withdrawal by Subject|2|||
149202828|NCT00688545|538209934|FG001|Overall Study|Withdrawal by Subject|3|||
149202829|NCT00688545|538209933|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
149202830|NCT00688545|538209934|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
149202831|NCT01878097|538209937|FG000|Baseline|Surveys not fully completed|2497|||
149202832|NCT01878097|538209938|FG001|Baseline|Surveys not fully completed|1800|||
149202833|NCT01878097|538209937|FG000|Implementation Year 1|Surveys not fully completed|3202|||
149202834|NCT01878097|538209938|FG001|Implementation Year 1|Surveys not fully completed|2549|||
149202835|NCT01878097|538209937|FG000|Implementation Year 2|Surveys not fully completed|3281|||
149202836|NCT01878097|538209938|FG001|Implementation Year 2|Surveys not fully completed|2841|||
149202837|NCT01878097|538209937|FG000|Implementation Year 3|Surveys not fully completed|3494|||
149202838|NCT01878097|538209938|FG001|Implementation Year 3|Surveys not fully completed|2980|||
148946414|NCT04115839|537288518|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
148946415|NCT04115839|537288519|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
149202839|NCT01878097|538209937|FG000|Implementation Year 4|Surveys not fully completed|3604|||
149202840|NCT01878097|538209938|FG001|Implementation Year 4|Surveys not fully completed|3007|||
149202841|NCT04295356|538209945|FG000|Overall Study|Physician Decision|1|||
149202842|NCT04295356|538209946|FG001|Overall Study|Physician Decision|0|||
149202843|NCT04295356|538209945|FG000|Overall Study|Lost to Follow-up|0|||
149202844|NCT04295356|538209946|FG001|Overall Study|Lost to Follow-up|3|||
149202845|NCT04295356|538209945|FG000|Overall Study|Protocol Violation|0|||
149202846|NCT04295356|538209946|FG001|Overall Study|Protocol Violation|1|||
149202847|NCT04116073|538209952|FG000|Overall Study|Withdrawal by Subject|2|||
149202848|NCT04116073|538209952|FG000|Overall Study|failed to maintained eligibility|1|||
149202849|NCT03939637|538209956|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
149202850|NCT03939637|538209957|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
149202851|NCT03939637|538209956|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
149202852|NCT03939637|538209957|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
149202853|NCT03783442|538209960|FG000|Overall Study|Death|252|||
149202854|NCT03783442|538209961|FG001|Overall Study|Death|268|||
149202855|NCT03783442|538209960|FG000|Overall Study|Withdrawal by Subject|19|||
148946416|NCT04115839|537288520|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
149202856|NCT03783442|538209961|FG001|Overall Study|Withdrawal by Subject|21|||
148946417|NCT04115839|537288521|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
148946418|NCT04115839|537288522|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
148946419|NCT04115839|537288523|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
148946420|NCT04115839|537288517|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
148946421|NCT04115839|537288518|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
148946422|NCT04115839|537288519|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
148946423|NCT04115839|537288520|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
148946424|NCT04115839|537288521|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
148946425|NCT04115839|537288522|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
148946426|NCT04115839|537288523|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
148808661|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
148946427|NCT04115839|537288517|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
148946428|NCT04115839|537288518|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
148946429|NCT04115839|537288519|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
149202857|NCT03783442|538209960|FG000|Overall Study|Lost to Follow-up|7|||
149202858|NCT03783442|538209961|FG001|Overall Study|Lost to Follow-up|6|||
149202859|NCT03783442|538209960|FG000|Overall Study|Sponsor Ended Study|48|||
149202860|NCT03783442|538209961|FG001|Overall Study|Sponsor Ended Study|28|||
149202861|NCT00168064|538209962|FG000|Overall Study|Adverse Event|26|||
149202862|NCT00168064|538209963|FG001|Overall Study|Adverse Event|22|||
148946430|NCT04115839|537288520|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
148946431|NCT04115839|537288521|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
149202863|NCT00168064|538209962|FG000|Overall Study|Withdrawal by Subject|3|||
149202864|NCT00168064|538209963|FG001|Overall Study|Withdrawal by Subject|4|||
149202865|NCT00168064|538209962|FG000|Overall Study|Lack of Efficacy|4|||
149202866|NCT00168064|538209963|FG001|Overall Study|Lack of Efficacy|4|||
149202867|NCT00168064|538209962|FG000|Overall Study|Lost to Follow-up|4|||
148946432|NCT04115839|537288522|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
148946433|NCT04115839|537288523|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
148946434|NCT04115839|537288517|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
148946435|NCT04115839|537288518|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
149202868|NCT00168064|538209963|FG001|Overall Study|Lost to Follow-up|3|||
149202869|NCT00168064|538209962|FG000|Overall Study|Non-compliance|2|||
149202870|NCT00168064|538209963|FG001|Overall Study|Non-compliance|3|||
149202871|NCT00168064|538209962|FG000|Overall Study|Concurrent Illness|4|||
149202872|NCT00168064|538209963|FG001|Overall Study|Concurrent Illness|3|||
149202873|NCT00168064|538209962|FG000|Overall Study|Subject's Best interest|2|||
149202874|NCT00168064|538209963|FG001|Overall Study|Subject's Best interest|2|||
149202875|NCT00168064|538209962|FG000|Overall Study|Various|4|||
149202876|NCT00168064|538209963|FG001|Overall Study|Various|3|||
149202877|NCT01309841|538209965|FG000|Overall Study|Other|0|||
149202878|NCT01309841|538209966|FG001|Overall Study|Other|1|||
149202879|NCT01309841|538209967|FG002|Overall Study|Other|1|||
149202880|NCT01309841|538209965|FG000|Overall Study|Lost to Follow-up|7|||
149202881|NCT01309841|538209966|FG001|Overall Study|Lost to Follow-up|6|||
149202882|NCT01309841|538209967|FG002|Overall Study|Lost to Follow-up|4|||
149202883|NCT01309841|538209965|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
149202884|NCT01309841|538209966|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
149202885|NCT01309841|538209967|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
149202886|NCT01309841|538209965|FG000|Overall Study|Lack of Efficacy|0|||
149202887|NCT01309841|538209966|FG001|Overall Study|Lack of Efficacy|0|||
149202888|NCT01309841|538209967|FG002|Overall Study|Lack of Efficacy|2|||
149202889|NCT01309841|538209965|FG000|Overall Study|Adverse Event|9|||
149202890|NCT01309841|538209966|FG001|Overall Study|Adverse Event|22|||
149202891|NCT01309841|538209967|FG002|Overall Study|Adverse Event|11|||
149202892|NCT01309841|538209965|FG000|Overall Study|Death|1|||
149202893|NCT01309841|538209966|FG001|Overall Study|Death|0|||
149202894|NCT01309841|538209967|FG002|Overall Study|Death|0|||
149202895|NCT01309841|538209965|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149202896|NCT01309841|538209966|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149202897|NCT01309841|538209967|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
149202898|NCT01309841|538209965|FG000|Overall Study|Withdrawal by Subject|17|||
149202899|NCT01309841|538209966|FG001|Overall Study|Withdrawal by Subject|6|||
149202900|NCT01309841|538209967|FG002|Overall Study|Withdrawal by Subject|13|||
149202901|NCT01309841|538209965|FG000|Overall Study|Did Not Receive Treatment|2|||
149202902|NCT01309841|538209966|FG001|Overall Study|Did Not Receive Treatment|0|||
149202903|NCT01309841|538209967|FG002|Overall Study|Did Not Receive Treatment|1|||
149202904|NCT01309841|538209965|FG000|Overall Study|Severe non-compliance with protocol|0|||
149202905|NCT01309841|538209966|FG001|Overall Study|Severe non-compliance with protocol|5|||
149202906|NCT01309841|538209967|FG002|Overall Study|Severe non-compliance with protocol|2|||
149202907|NCT01441115|538209968|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
149202908|NCT02475395|538209971|FG000|Overall Study|Protocol Violation|30|||
149202909|NCT02475395|538209972|FG001|Overall Study|Protocol Violation|3|||
149202910|NCT02227108|538209973|FG000|Overall Study|Did not receive treatment|2|||
149202911|NCT02227108|538209973|FG000|Overall Study|Other|3|||
149202912|NCT02227108|538209973|FG000|Overall Study|Progressive disease|17|||
149202913|NCT02227108|538209973|FG000|Overall Study|Initiation of alternative therapy|2|||
149202914|NCT02227108|538209973|FG000|Overall Study|Investigator discretion|1|||
149202915|NCT02227108|538209973|FG000|Overall Study|Adverse Event|6|||
149202916|NCT02486952|538209974|FG000|Overall Study|Not Started Induction Therapy|3|||
149202917|NCT02486952|538209974|FG000|Overall Study|Adverse Event|1|||
149202918|NCT02486952|538209974|FG000|Overall Study|Death|15|||
149202919|NCT02486952|538209974|FG000|Overall Study|Lack of Efficacy|3|||
148946436|NCT04115839|537288519|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
148946437|NCT04115839|537288520|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
148946438|NCT04115839|537288521|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
148946439|NCT04115839|537288522|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
149202920|NCT02486952|538209974|FG000|Overall Study|Lost to Follow-up|26|||
149202921|NCT02486952|538209974|FG000|Overall Study|Other|2|||
149202922|NCT00594204|538209975|FG000|Overall Study|Adverse Event|15|||
149202923|NCT00594204|538209976|FG001|Overall Study|Adverse Event|3|||
148946440|NCT04115839|537288523|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
149202924|NCT00594204|538209975|FG000|Overall Study|Lost to Follow-up|9|||
149202925|NCT00594204|538209976|FG001|Overall Study|Lost to Follow-up|5|||
149202926|NCT00594204|538209975|FG000|Overall Study|Withdrawal by Subject|23|||
149202927|NCT00594204|538209976|FG001|Overall Study|Withdrawal by Subject|29|||
148946441|NCT04115839|537288517|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
149202928|NCT00594204|538209975|FG000|Overall Study|Other|4|||
149202929|NCT00594204|538209976|FG001|Overall Study|Other|3|||
149202930|NCT00594204|538209975|FG000|Overall Study|Lack of Efficacy|3|||
149202931|NCT00594204|538209976|FG001|Overall Study|Lack of Efficacy|4|||
149202932|NCT00594204|538209975|FG000|Overall Study|Randomized but not treated|4|||
149202933|NCT00594204|538209976|FG001|Overall Study|Randomized but not treated|1|||
149202934|NCT00567541|538209979|FG000|Overall Study|Adverse Event|0|||
149202935|NCT00567541|538209980|FG001|Overall Study|Adverse Event|1|||
149202936|NCT01890512|538209981|FG000|Overall Study|Physician Decision|1|||
149202937|NCT01890512|538209981|FG000|Overall Study|Withdrawal by Subject|1|||
149202938|NCT01890512|538209981|FG000|Overall Study|Protocol Violation|1|||
149202939|NCT01529385|538209982|FG000|Overall Study|Lost to Follow-up|2|||
149202940|NCT01529385|538209983|FG001|Overall Study|Lost to Follow-up|1|||
149202941|NCT01401465|538209984|FG000|Treatment Period 1|Adverse Event|4|||
149202942|NCT01401465|538209985|FG001|Treatment Period 1|Adverse Event|1|||
149202943|NCT01401465|538209984|FG000|Treatment Period 1|Pregnancy|0|||
149202944|NCT01401465|538209985|FG001|Treatment Period 1|Pregnancy|1|||
149202945|NCT01401465|538209984|FG000|Treatment Period 1|Protocol Violation|5|||
149202946|NCT01401465|538209985|FG001|Treatment Period 1|Protocol Violation|0|||
149202947|NCT01401465|538209984|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149202948|NCT01401465|538209985|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149202949|NCT01401465|538209984|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
149202950|NCT01401465|538209985|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
149202951|NCT01401465|538209984|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
149202952|NCT01401465|538209985|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
149202953|NCT01401465|538209984|FG000|Treatment Period 1|Scheduling Difficulties|1|||
149202954|NCT01401465|538209985|FG001|Treatment Period 1|Scheduling Difficulties|1|||
149202955|NCT01401465|538209984|FG000|Treatment Period 2|Lost to Follow-up|0|||
149202956|NCT01401465|538209985|FG001|Treatment Period 2|Lost to Follow-up|1|||
149202957|NCT01401465|538209984|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149202958|NCT01401465|538209985|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149202959|NCT01115738|538209986|FG000|Overall Study|Death|1|||
149202960|NCT01115738|538209987|FG001|Overall Study|Death|0|||
149202961|NCT01115738|538209988|FG002|Overall Study|Death|0|||
149202962|NCT01115738|538209986|FG000|Overall Study|Lost to Follow-up|0|||
149202963|NCT01115738|538209987|FG001|Overall Study|Lost to Follow-up|0|||
149202964|NCT01115738|538209988|FG002|Overall Study|Lost to Follow-up|1|||
149202965|NCT01115738|538209986|FG000|Overall Study|Physician Decision|18|||
149202966|NCT01115738|538209987|FG001|Overall Study|Physician Decision|15|||
149202967|NCT01115738|538209988|FG002|Overall Study|Physician Decision|17|||
149202968|NCT01115738|538209986|FG000|Overall Study|Withdrawal by Subject|6|||
149202969|NCT01115738|538209987|FG001|Overall Study|Withdrawal by Subject|6|||
149202970|NCT01115738|538209988|FG002|Overall Study|Withdrawal by Subject|9|||
149202971|NCT00575094|538209989|FG000|Overall Study|Adverse Event|2|||
149202972|NCT00575094|538209989|FG000|Overall Study|Withdrawal by Subject|1|||
149202973|NCT02721251|538209990|FG000|Overall Study|Withdrawal by Subject|8|||
149202974|NCT02721251|538209991|FG001|Overall Study|Withdrawal by Subject|7|||
149202975|NCT02721251|538209992|FG002|Overall Study|Withdrawal by Subject|9|||
149202976|NCT02721251|538209990|FG000|Overall Study|poor adherence|2|||
149202977|NCT02721251|538209991|FG001|Overall Study|poor adherence|2|||
149202978|NCT02721251|538209992|FG002|Overall Study|poor adherence|2|||
149202979|NCT02921763|538209993|FG000|Overall Study|Adverse Event|4|||
149202980|NCT02921763|538209993|FG000|Overall Study|Lost to Follow-up|4|||
149202981|NCT02921763|538209993|FG000|Overall Study|Lack of Efficacy|3|||
149202982|NCT02921763|538209993|FG000|Overall Study|Protocol Violation|2|||
149202983|NCT02921763|538209993|FG000|Overall Study|Withdrawal by Subject|2|||
149202984|NCT02921763|538209993|FG000|Overall Study|Physician Decision|1|||
149202985|NCT02921763|538209993|FG000|Overall Study|No data obtained|2|||
149202986|NCT01195363|538209997|FG000|Overall Study|Lost to Follow-up|7|||
149202987|NCT01195363|538209998|FG001|Overall Study|Lost to Follow-up|4|||
149202988|NCT01195363|538209997|FG000|Overall Study|Adverse Event|3|||
148946442|NCT04115839|537288518|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
148946443|NCT04115839|537288519|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
149202989|NCT01195363|538209998|FG001|Overall Study|Adverse Event|1|||
149202990|NCT01195363|538209997|FG000|Overall Study|Lack of Efficacy|0|||
148946444|NCT04115839|537288520|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
149202991|NCT01195363|538209998|FG001|Overall Study|Lack of Efficacy|4|||
149202992|NCT01195363|538209997|FG000|Overall Study|incarceration|1|||
148946445|NCT04115839|537288521|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
149202993|NCT01195363|538209998|FG001|Overall Study|incarceration|0|||
149202994|NCT01763866|538210000|FG000|Overall Study|Withdrawal by Subject|2|||
149202995|NCT01763866|538210001|FG001|Overall Study|Withdrawal by Subject|1|||
149202996|NCT01763866|538210002|FG002|Overall Study|Withdrawal by Subject|4|||
149202997|NCT01763866|538210003|FG003|Overall Study|Withdrawal by Subject|0|||
149202998|NCT01763866|538210004|FG004|Overall Study|Withdrawal by Subject|0|||
149202999|NCT01763866|538210005|FG005|Overall Study|Withdrawal by Subject|3|||
149203000|NCT01763866|538210006|FG006|Overall Study|Withdrawal by Subject|4|||
149203001|NCT01763866|538210007|FG007|Overall Study|Withdrawal by Subject|0|||
148808662|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
148808663|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
148808664|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
148946446|NCT04115839|537288522|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
148946447|NCT04115839|537288523|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
148946448|NCT04115839|537288517|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
148946449|NCT04115839|537288518|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
148946450|NCT04115839|537288519|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
149203002|NCT01763866|538210008|FG008|Overall Study|Withdrawal by Subject|1|||
149203003|NCT01763866|538210009|FG009|Overall Study|Withdrawal by Subject|1|||
149203004|NCT01763866|538210010|FG010|Overall Study|Withdrawal by Subject|2|||
149203005|NCT01763866|538210011|FG011|Overall Study|Withdrawal by Subject|2|||
149203006|NCT01763866|538210012|FG012|Overall Study|Withdrawal by Subject|2|||
149203007|NCT01763866|538210013|FG013|Overall Study|Withdrawal by Subject|0|||
149203008|NCT01763866|538210014|FG014|Overall Study|Withdrawal by Subject|6|||
149203009|NCT01763866|538210015|FG015|Overall Study|Withdrawal by Subject|3|||
149203010|NCT01763866|538210016|FG016|Overall Study|Withdrawal by Subject|0|||
149203011|NCT01763866|538210017|FG017|Overall Study|Withdrawal by Subject|1|||
149203012|NCT01763866|538210018|FG018|Overall Study|Withdrawal by Subject|1|||
149203013|NCT01763866|538210019|FG019|Overall Study|Withdrawal by Subject|1|||
149203014|NCT01763866|538210020|FG020|Overall Study|Withdrawal by Subject|2|||
149203015|NCT01763866|538210021|FG021|Overall Study|Withdrawal by Subject|1|||
149203016|NCT01763866|538210022|FG022|Overall Study|Withdrawal by Subject|2|||
149203017|NCT01763866|538210023|FG023|Overall Study|Withdrawal by Subject|1|||
149203018|NCT01763866|538210000|FG000|Overall Study|Decision by sponsor|0|||
149203019|NCT01763866|538210001|FG001|Overall Study|Decision by sponsor|0|||
149203020|NCT01763866|538210002|FG002|Overall Study|Decision by sponsor|1|||
149203021|NCT01763866|538210003|FG003|Overall Study|Decision by sponsor|0|||
149203022|NCT01763866|538210004|FG004|Overall Study|Decision by sponsor|2|||
149203023|NCT01763866|538210005|FG005|Overall Study|Decision by sponsor|0|||
149203024|NCT01763866|538210006|FG006|Overall Study|Decision by sponsor|2|||
149203025|NCT01763866|538210007|FG007|Overall Study|Decision by sponsor|0|||
149203026|NCT01763866|538210008|FG008|Overall Study|Decision by sponsor|2|||
149203027|NCT01763866|538210009|FG009|Overall Study|Decision by sponsor|0|||
149203028|NCT01763866|538210010|FG010|Overall Study|Decision by sponsor|6|||
149203029|NCT01763866|538210011|FG011|Overall Study|Decision by sponsor|0|||
149203030|NCT01763866|538210012|FG012|Overall Study|Decision by sponsor|1|||
149203031|NCT01763866|538210013|FG013|Overall Study|Decision by sponsor|0|||
149203032|NCT01763866|538210014|FG014|Overall Study|Decision by sponsor|5|||
149203033|NCT01763866|538210015|FG015|Overall Study|Decision by sponsor|0|||
149203034|NCT01763866|538210016|FG016|Overall Study|Decision by sponsor|0|||
149203035|NCT01763866|538210017|FG017|Overall Study|Decision by sponsor|0|||
149203036|NCT01763866|538210018|FG018|Overall Study|Decision by sponsor|4|||
149203037|NCT01763866|538210019|FG019|Overall Study|Decision by sponsor|0|||
149203038|NCT01763866|538210020|FG020|Overall Study|Decision by sponsor|2|||
149203039|NCT01763866|538210021|FG021|Overall Study|Decision by sponsor|0|||
149203040|NCT01763866|538210022|FG022|Overall Study|Decision by sponsor|1|||
149203041|NCT01763866|538210023|FG023|Overall Study|Decision by sponsor|0|||
149203042|NCT01763866|538210000|FG000|Overall Study|Lost to Follow-up|0|||
149203043|NCT01763866|538210001|FG001|Overall Study|Lost to Follow-up|0|||
149203044|NCT01763866|538210002|FG002|Overall Study|Lost to Follow-up|0|||
149203045|NCT01763866|538210003|FG003|Overall Study|Lost to Follow-up|0|||
149203046|NCT01763866|538210004|FG004|Overall Study|Lost to Follow-up|0|||
149203047|NCT01763866|538210005|FG005|Overall Study|Lost to Follow-up|0|||
149203048|NCT01763866|538210006|FG006|Overall Study|Lost to Follow-up|1|||
149203049|NCT01763866|538210007|FG007|Overall Study|Lost to Follow-up|0|||
149203050|NCT01763866|538210008|FG008|Overall Study|Lost to Follow-up|0|||
149203051|NCT01763866|538210009|FG009|Overall Study|Lost to Follow-up|0|||
149203052|NCT01763866|538210010|FG010|Overall Study|Lost to Follow-up|0|||
149203053|NCT01763866|538210011|FG011|Overall Study|Lost to Follow-up|0|||
149203054|NCT01763866|538210012|FG012|Overall Study|Lost to Follow-up|1|||
149203055|NCT01763866|538210013|FG013|Overall Study|Lost to Follow-up|0|||
149203056|NCT01763866|538210014|FG014|Overall Study|Lost to Follow-up|1|||
149203057|NCT01763866|538210015|FG015|Overall Study|Lost to Follow-up|0|||
149203058|NCT01763866|538210016|FG016|Overall Study|Lost to Follow-up|0|||
149203059|NCT01763866|538210017|FG017|Overall Study|Lost to Follow-up|0|||
149203060|NCT01763866|538210018|FG018|Overall Study|Lost to Follow-up|1|||
149203061|NCT01763866|538210019|FG019|Overall Study|Lost to Follow-up|1|||
149203062|NCT01763866|538210020|FG020|Overall Study|Lost to Follow-up|0|||
149203063|NCT01763866|538210021|FG021|Overall Study|Lost to Follow-up|0|||
149203064|NCT01763866|538210022|FG022|Overall Study|Lost to Follow-up|0|||
149203065|NCT01763866|538210023|FG023|Overall Study|Lost to Follow-up|1|||
149203066|NCT01763866|538210000|FG000|Overall Study|Death|0|||
149203067|NCT01763866|538210001|FG001|Overall Study|Death|0|||
149203068|NCT01763866|538210002|FG002|Overall Study|Death|0|||
149203069|NCT01763866|538210003|FG003|Overall Study|Death|0|||
149203070|NCT01763866|538210004|FG004|Overall Study|Death|0|||
149203071|NCT01763866|538210005|FG005|Overall Study|Death|0|||
149203072|NCT01763866|538210006|FG006|Overall Study|Death|0|||
149203073|NCT01763866|538210007|FG007|Overall Study|Death|0|||
149203074|NCT01763866|538210008|FG008|Overall Study|Death|0|||
149203075|NCT01763866|538210009|FG009|Overall Study|Death|0|||
149203076|NCT01763866|538210010|FG010|Overall Study|Death|0|||
149203077|NCT01763866|538210011|FG011|Overall Study|Death|0|||
149203078|NCT01763866|538210012|FG012|Overall Study|Death|0|||
149203079|NCT01763866|538210013|FG013|Overall Study|Death|0|||
149203080|NCT01763866|538210014|FG014|Overall Study|Death|0|||
148946451|NCT04115839|537288520|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
149203081|NCT01763866|538210015|FG015|Overall Study|Death|0|||
149203082|NCT01763866|538210016|FG016|Overall Study|Death|1|||
149203083|NCT01763866|538210017|FG017|Overall Study|Death|0|||
149203084|NCT01763866|538210018|FG018|Overall Study|Death|0|||
149203085|NCT01763866|538210019|FG019|Overall Study|Death|0|||
149203086|NCT01763866|538210020|FG020|Overall Study|Death|0|||
149203087|NCT01763866|538210021|FG021|Overall Study|Death|0|||
149203088|NCT01763866|538210022|FG022|Overall Study|Death|0|||
149203089|NCT01763866|538210023|FG023|Overall Study|Death|0|||
149203090|NCT05691829|538211227|FG000|Overall Study|Physician Decision|2|||
149203091|NCT05691829|538211227|FG000|Overall Study|Eligibility criteria not met|3|||
149203092|NCT00804843|538211228|FG000|Overall Study|Protocol Violation|1|||
149203093|NCT00804843|538211229|FG001|Overall Study|Protocol Violation|0|||
149203094|NCT00804843|538211228|FG000|Overall Study|Adverse Event|8|||
149203095|NCT00804843|538211229|FG001|Overall Study|Adverse Event|5|||
149203096|NCT00804843|538211228|FG000|Overall Study|Withdrawal by Subject|1|||
149203097|NCT00804843|538211229|FG001|Overall Study|Withdrawal by Subject|2|||
149203098|NCT03927911|538211230|FG000|Overall Study|problems with eDiary|0|||
149203099|NCT03927911|538211231|FG001|Overall Study|problems with eDiary|1|||
149203100|NCT03927911|538211232|FG002|Overall Study|problems with eDiary|0|||
149203101|NCT03927911|538211233|FG003|Overall Study|problems with eDiary|1|||
149203102|NCT03927911|538211234|FG004|Overall Study|problems with eDiary|0|||
149203103|NCT03927911|538211235|FG005|Overall Study|problems with eDiary|4|||
149203104|NCT03927911|538211230|FG000|Overall Study|Adverse Event|0|||
149203105|NCT03927911|538211231|FG001|Overall Study|Adverse Event|0|||
149203106|NCT03927911|538211232|FG002|Overall Study|Adverse Event|0|||
149203107|NCT03927911|538211233|FG003|Overall Study|Adverse Event|0|||
149203108|NCT03927911|538211234|FG004|Overall Study|Adverse Event|0|||
149203109|NCT03927911|538211235|FG005|Overall Study|Adverse Event|1|||
149203110|NCT03927911|538211230|FG000|Overall Study|not treated -study terminated by sponsor|0|||
149203111|NCT03927911|538211231|FG001|Overall Study|not treated -study terminated by sponsor|1|||
149203112|NCT03927911|538211232|FG002|Overall Study|not treated -study terminated by sponsor|0|||
148683038|NCT01078623|536313038|FG010|Treatment Period 4|Withdrawal by Subject|0|||
148683039|NCT01078623|536313039|FG011|Treatment Period 4|Withdrawal by Subject|0|||
148683040|NCT01078623|536313040|FG012|Treatment Period 4|Withdrawal by Subject|0|||
148683041|NCT01078623|536313041|FG013|Treatment Period 4|Withdrawal by Subject|0|||
148683042|NCT01078623|536313042|FG014|Treatment Period 4|Withdrawal by Subject|0|||
148683043|NCT01078623|536313043|FG015|Treatment Period 4|Withdrawal by Subject|1|||
148683044|NCT01078623|536313044|FG016|Treatment Period 4|Withdrawal by Subject|0|||
148808665|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
148808666|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
148946452|NCT04115839|537288521|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
148946453|NCT04115839|537288522|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
149203113|NCT03927911|538211233|FG003|Overall Study|not treated -study terminated by sponsor|0|||
149203114|NCT03927911|538211234|FG004|Overall Study|not treated -study terminated by sponsor|0|||
149203115|NCT03927911|538211235|FG005|Overall Study|not treated -study terminated by sponsor|0|||
149203116|NCT03927911|538211230|FG000|Overall Study|Surgery cancelled|0|||
149203117|NCT03927911|538211231|FG001|Overall Study|Surgery cancelled|0|||
149203118|NCT03927911|538211232|FG002|Overall Study|Surgery cancelled|0|||
149203119|NCT03927911|538211233|FG003|Overall Study|Surgery cancelled|1|||
149203120|NCT03927911|538211234|FG004|Overall Study|Surgery cancelled|0|||
149203121|NCT03927911|538211235|FG005|Overall Study|Surgery cancelled|1|||
149203122|NCT03927911|538211230|FG000|Overall Study|Protocol Violation|0|||
149203123|NCT03927911|538211231|FG001|Overall Study|Protocol Violation|0|||
148683045|NCT01078623|536313045|FG017|Treatment Period 4|Withdrawal by Subject|0|||
148683046|NCT01078623|536313046|FG018|Treatment Period 4|Withdrawal by Subject|0|||
149203124|NCT03927911|538211232|FG002|Overall Study|Protocol Violation|0|||
149203125|NCT03927911|538211233|FG003|Overall Study|Protocol Violation|0|||
149203126|NCT03927911|538211234|FG004|Overall Study|Protocol Violation|0|||
149203127|NCT03927911|538211235|FG005|Overall Study|Protocol Violation|1|||
149203128|NCT01297309|538211240|FG000|Overall Study|Eligibility failure|2|||
149203129|NCT01297309|538211240|FG000|Overall Study|Screen failure|2|||
149203130|NCT01297309|538211240|FG000|Overall Study|Withdrawal by Subject|5|||
149203131|NCT01297309|538211240|FG000|Overall Study|Adverse Event|1|||
149203132|NCT01297309|538211240|FG000|Overall Study|Investigator Decision|2|||
149203133|NCT01297309|538211240|FG000|Overall Study|Death|1|||
149203134|NCT01297309|538211240|FG000|Overall Study|Participant not entering extensionperiod|1|||
149203135|NCT02591238|538211241|FG000|Overall Study|Pregnancy|1|||
149203136|NCT02591238|538211242|FG001|Overall Study|Pregnancy|0|||
149203137|NCT02591238|538211243|FG002|Overall Study|Pregnancy|0|||
149203138|NCT02591238|538211244|FG003|Overall Study|Pregnancy|0|||
149203139|NCT02591238|538211241|FG000|Overall Study|Withdrawal by Subject|0|||
149203140|NCT02591238|538211242|FG001|Overall Study|Withdrawal by Subject|0|||
149203141|NCT02591238|538211243|FG002|Overall Study|Withdrawal by Subject|0|||
149203142|NCT02591238|538211244|FG003|Overall Study|Withdrawal by Subject|1|||
149203143|NCT02591238|538211241|FG000|Overall Study|influenza|0|||
149203144|NCT02591238|538211242|FG001|Overall Study|influenza|0|||
149203145|NCT02591238|538211243|FG002|Overall Study|influenza|0|||
149203146|NCT02591238|538211244|FG003|Overall Study|influenza|1|||
149203147|NCT02591238|538211241|FG000|Overall Study|personal circumstances|0|||
149203148|NCT02591238|538211242|FG001|Overall Study|personal circumstances|0|||
149203149|NCT02591238|538211243|FG002|Overall Study|personal circumstances|0|||
149203150|NCT02591238|538211244|FG003|Overall Study|personal circumstances|1|||
149203151|NCT02591238|538211241|FG000|Overall Study|personal circumstances|0|||
149203152|NCT02591238|538211242|FG001|Overall Study|personal circumstances|1|||
149203153|NCT02591238|538211243|FG002|Overall Study|personal circumstances|0|||
149203154|NCT02591238|538211244|FG003|Overall Study|personal circumstances|0|||
149203155|NCT00640146|538211246|FG000|Overall Study|Adverse Event|2|||
149203156|NCT00640146|538211247|FG001|Overall Study|Adverse Event|0|||
149203157|NCT00640146|538211246|FG000|Overall Study|Lost to Follow-up|0|||
149203158|NCT00640146|538211247|FG001|Overall Study|Lost to Follow-up|1|||
149203159|NCT00640146|538211246|FG000|Overall Study|Lack of Efficacy|0|||
149203160|NCT00640146|538211247|FG001|Overall Study|Lack of Efficacy|1|||
149203161|NCT00640146|538211246|FG000|Overall Study|Withdrawal by Subject|1|||
149203162|NCT00640146|538211247|FG001|Overall Study|Withdrawal by Subject|1|||
149203163|NCT00640146|538211246|FG000|Overall Study|Randomized but not treated|1|||
149203164|NCT00640146|538211247|FG001|Overall Study|Randomized but not treated|3|||
149203165|NCT02016898|538211253|FG000|Overall Study|Death|1|||
149203166|NCT02016898|538211254|FG001|Overall Study|Death|1|||
149203167|NCT02016898|538211253|FG000|Overall Study|Lost to Follow-up|4|||
149203168|NCT02016898|538211254|FG001|Overall Study|Lost to Follow-up|4|||
149203169|NCT01381718|538211255|FG000|Overall Study|Withdrawal by Subject|2|||
149203170|NCT01381718|538211256|FG001|Overall Study|Withdrawal by Subject|5|||
149203171|NCT01381718|538211255|FG000|Overall Study|Lost to Follow-up|3|||
149203172|NCT01381718|538211256|FG001|Overall Study|Lost to Follow-up|5|||
149203173|NCT01381718|538211255|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
149203174|NCT01381718|538211256|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
149203175|NCT02505542|538211261|FG000|Part A: Open-Label Period|Adverse Event|31|||
149203176|NCT02505542|538211262|FG001|Part A: Open-Label Period|Adverse Event|0|||
149203177|NCT02505542|538211263|FG002|Part A: Open-Label Period|Adverse Event|0|||
149203178|NCT02505542|538211264|FG003|Part A: Open-Label Period|Adverse Event|0|||
149203179|NCT02505542|538211261|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
149203180|NCT02505542|538211262|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
149203181|NCT02505542|538211263|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
149203182|NCT02505542|538211264|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
149203183|NCT02505542|538211261|FG000|Part A: Open-Label Period|Protocol Violation|1|||
149203184|NCT02505542|538211262|FG001|Part A: Open-Label Period|Protocol Violation|0|||
149203185|NCT02505542|538211263|FG002|Part A: Open-Label Period|Protocol Violation|0|||
149203186|NCT02505542|538211264|FG003|Part A: Open-Label Period|Protocol Violation|0|||
149203187|NCT02505542|538211261|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
149203188|NCT02505542|538211262|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
149203189|NCT02505542|538211263|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
149203190|NCT02505542|538211264|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
149203191|NCT02505542|538211261|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
149203192|NCT02505542|538211262|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
149203193|NCT02505542|538211263|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
149203194|NCT02505542|538211264|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
149203195|NCT02505542|538211261|FG000|Part A: Open-Label Period|New medical history available|1|||
149203196|NCT02505542|538211262|FG001|Part A: Open-Label Period|New medical history available|0|||
149203197|NCT02505542|538211263|FG002|Part A: Open-Label Period|New medical history available|0|||
149203198|NCT02505542|538211264|FG003|Part A: Open-Label Period|New medical history available|0|||
149203199|NCT02505542|538211261|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
149203200|NCT02505542|538211262|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
149203201|NCT02505542|538211263|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
149203202|NCT02505542|538211264|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
149203203|NCT02505542|538211261|FG000|Part A: Open-Label Period|Pregnancy|2|||
149203204|NCT02505542|538211262|FG001|Part A: Open-Label Period|Pregnancy|0|||
149203205|NCT02505542|538211263|FG002|Part A: Open-Label Period|Pregnancy|0|||
149203206|NCT02505542|538211264|FG003|Part A: Open-Label Period|Pregnancy|0|||
149203207|NCT02505542|538211261|FG000|Part A: Open-Label Period|Sponsor directive|1|||
149203208|NCT02505542|538211262|FG001|Part A: Open-Label Period|Sponsor directive|0|||
149203209|NCT02505542|538211263|FG002|Part A: Open-Label Period|Sponsor directive|0|||
149203210|NCT02505542|538211264|FG003|Part A: Open-Label Period|Sponsor directive|0|||
149203211|NCT02505542|538211261|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
149203212|NCT02505542|538211262|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
149203213|NCT02505542|538211263|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
149203214|NCT02505542|538211264|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
149203215|NCT02505542|538211261|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
149203216|NCT02505542|538211262|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
149203217|NCT02505542|538211263|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
149203218|NCT02505542|538211264|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
149203219|NCT02505542|538211261|FG000|Part A: Open-Label Period|Non-compliance|1|||
149203220|NCT02505542|538211262|FG001|Part A: Open-Label Period|Non-compliance|0|||
149203221|NCT02505542|538211263|FG002|Part A: Open-Label Period|Non-compliance|0|||
149203222|NCT02505542|538211264|FG003|Part A: Open-Label Period|Non-compliance|0|||
149203223|NCT02505542|538211261|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
149203224|NCT02505542|538211262|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
149203225|NCT02505542|538211263|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
149203226|NCT02505542|538211264|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
149203227|NCT02505542|538211261|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
149203228|NCT02505542|538211262|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
149203229|NCT02505542|538211263|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
149203230|NCT02505542|538211264|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
149203231|NCT02505542|538211261|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
149203232|NCT02505542|538211262|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
149203233|NCT02505542|538211263|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
149203234|NCT02505542|538211264|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
149203235|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Adverse Event|0|||
149203236|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Adverse Event|0|||
149203237|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Adverse Event|1|||
148946454|NCT04115839|537288523|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
148946455|NCT03808545|537288524|FG000|Overall Study|Withdrawal by Subject|1|||
148946456|NCT03808545|537288525|FG001|Overall Study|Withdrawal by Subject|1|||
149203238|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Adverse Event|3|||
149203239|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
149203240|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
149203241|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
149203242|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
149203243|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
149203244|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
149203245|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
149203246|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
149203247|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
149203248|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
148683047|NCT01078623|536313047|FG019|Treatment Period 4|Withdrawal by Subject|0|||
148683048|NCT00463866|536313048|FG000|Overall Study|Adverse Event|70|||
148683049|NCT00463866|536313049|FG001|Overall Study|Adverse Event|93|||
148683050|NCT00463866|536313048|FG000|Overall Study|Withdrawal by Subject|81|||
148683051|NCT00463866|536313049|FG001|Overall Study|Withdrawal by Subject|79|||
148683052|NCT00463866|536313048|FG000|Overall Study|Lost to Follow-up|46|||
148683053|NCT00463866|536313049|FG001|Overall Study|Lost to Follow-up|55|||
148683054|NCT00463866|536313048|FG000|Overall Study|Incorrect Enrolment|64|||
148683055|NCT00463866|536313049|FG001|Overall Study|Incorrect Enrolment|66|||
148683056|NCT00463866|536313048|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
148683057|NCT00463866|536313049|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
148683058|NCT00463866|536313048|FG000|Overall Study|Safety Reason|1|||
148683059|NCT00463866|536313049|FG001|Overall Study|Safety Reason|3|||
148683060|NCT00463866|536313048|FG000|Overall Study|Mis-Randomization of subject|0|||
148683061|NCT00463866|536313049|FG001|Overall Study|Mis-Randomization of subject|1|||
148683062|NCT00463866|536313048|FG000|Overall Study|Other|22|||
148683063|NCT00463866|536313049|FG001|Overall Study|Other|22|||
148683064|NCT04313283|536313051|FG000|Overall Study|did not complete intervention|4|||
148683065|NCT03568500|536313056|FG000|Overall Study|Lost to Follow-up|1|||
148683066|NCT03568500|536313057|FG001|Overall Study|Lost to Follow-up|1|||
148683067|NCT03568500|536313058|FG002|Overall Study|Lost to Follow-up|2|||
148683068|NCT03568500|536313056|FG000|Overall Study|Adverse Event|1|||
148683069|NCT03568500|536313057|FG001|Overall Study|Adverse Event|1|||
148683070|NCT03568500|536313058|FG002|Overall Study|Adverse Event|2|||
148683071|NCT03568500|536313056|FG000|Overall Study|Physician Decision|1|||
148683072|NCT03568500|536313057|FG001|Overall Study|Physician Decision|0|||
148683073|NCT03568500|536313058|FG002|Overall Study|Physician Decision|0|||
148683074|NCT03568500|536313056|FG000|Overall Study|Withdrawal by Subject|4|||
148946457|NCT02820753|537288526|FG000|2 Month|Withdrawal by Subject|3|||
148946458|NCT02820753|537288527|FG001|2 Month|Withdrawal by Subject|3|||
148946459|NCT02820753|537288526|FG000|2 Month|Lost to Follow-up|24|||
148946460|NCT02820753|537288527|FG001|2 Month|Lost to Follow-up|26|||
148946461|NCT02820753|537288526|FG000|2 Month|Stopped per NIH Hold|51|||
148946462|NCT02820753|537288527|FG001|2 Month|Stopped per NIH Hold|13|||
148946463|NCT02820753|537288526|FG000|6 Month|Withdrawal by Subject|2|||
148946464|NCT02820753|537288527|FG001|6 Month|Withdrawal by Subject|2|||
148946465|NCT02820753|537288526|FG000|6 Month|Lost to Follow-up|20|||
148946466|NCT02820753|537288527|FG001|6 Month|Lost to Follow-up|27|||
148946467|NCT02820753|537288526|FG000|6 Month|Stopped per NIH Hold|81|||
148946468|NCT02820753|537288527|FG001|6 Month|Stopped per NIH Hold|81|||
148946469|NCT02820753|537288526|FG000|6 Month|Death|0|||
148946470|NCT02820753|537288527|FG001|6 Month|Death|1|||
148946471|NCT00331682|537288532|FG000|Overall Study|Adverse Event|1|||
148946472|NCT00790023|537288533|FG000|Overall Study|Adverse Event|2|||
148946473|NCT00790023|537288534|FG001|Overall Study|Adverse Event|1|||
148946474|NCT00790023|537288535|FG002|Overall Study|Adverse Event|4|||
148946475|NCT00790023|537288533|FG000|Overall Study|Protocol Violation|2|||
149203249|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
149203250|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
149203251|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
149203252|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
149203253|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
149203254|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
148683075|NCT03568500|536313057|FG001|Overall Study|Withdrawal by Subject|2|||
148683076|NCT03568500|536313058|FG002|Overall Study|Withdrawal by Subject|0|||
148683077|NCT03568500|536313056|FG000|Overall Study|Technical Problems|2|||
148683078|NCT03568500|536313057|FG001|Overall Study|Technical Problems|1|||
148683079|NCT03568500|536313058|FG002|Overall Study|Technical Problems|0|||
148683080|NCT03568500|536313056|FG000|Overall Study|Participant Noncompliance|1|||
148683081|NCT03568500|536313057|FG001|Overall Study|Participant Noncompliance|1|||
148683082|NCT03568500|536313058|FG002|Overall Study|Participant Noncompliance|0|||
148683083|NCT02736227|536313074|FG000|Overall Study|Withdrawal by Subject|0|||
148946476|NCT00790023|537288534|FG001|Overall Study|Protocol Violation|4|||
148946477|NCT00790023|537288535|FG002|Overall Study|Protocol Violation|2|||
148946478|NCT00790023|537288533|FG000|Overall Study|Withdrawal by Subject|2|||
148946479|NCT00790023|537288534|FG001|Overall Study|Withdrawal by Subject|0|||
149203255|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
149203256|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
149203257|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
149203258|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
149203259|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
149203260|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
149203261|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
149203262|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
149203263|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Miscalculation|0|||
149203264|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Miscalculation|1|||
149203265|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Miscalculation|0|||
149203266|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Miscalculation|0|||
149203267|NCT02505542|538211261|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
149203268|NCT02505542|538211262|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
149203269|NCT02505542|538211263|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
149203270|NCT02505542|538211264|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
149203271|NCT00992186|538211265|FG000|Overall Study|Withdrawal by Subject|2|||
149203272|NCT00992186|538211265|FG000|Overall Study|Protocol Violation|1|||
149203273|NCT00992186|538211265|FG000|Overall Study|Physician Decision|1|||
149203274|NCT00992186|538211265|FG000|Overall Study|Adverse Event|9|||
149203275|NCT00992186|538211265|FG000|Overall Study|Progressive Disease|30|||
149203276|NCT00992186|538211265|FG000|Overall Study|Refusal To Receive Study Agent|3|||
149203277|NCT00973622|538211266|FG000|Overall Study|did not attend MRI|14|||
149203278|NCT00973622|538211267|FG001|Overall Study|did not attend MRI|3|||
149203279|NCT00973622|538211266|FG000|Overall Study|did not pass MRI screen|6|||
149203280|NCT00973622|538211267|FG001|Overall Study|did not pass MRI screen|0|||
149203281|NCT00973622|538211266|FG000|Overall Study|did not complete rTMS sessions|11|||
149203282|NCT00973622|538211267|FG001|Overall Study|did not complete rTMS sessions|2|||
149203283|NCT03074149|538211270|FG000|Overall Study|Reason unknown|22|||
149203284|NCT03074149|538211271|FG001|Overall Study|Reason unknown|35|||
149203285|NCT03074149|538211270|FG000|Overall Study|Death|10|||
149203286|NCT03074149|538211271|FG001|Overall Study|Death|45|||
149203287|NCT00830960|538211272|FG000|Overall Study|Death|5|||
149203288|NCT00830960|538211273|FG001|Overall Study|Death|4|||
149203289|NCT00830960|538211274|FG002|Overall Study|Death|3|||
149203290|NCT00830960|538211275|FG003|Overall Study|Death|2|||
149203291|NCT00830960|538211276|FG004|Overall Study|Death|6|||
149203292|NCT00830960|538211277|FG005|Overall Study|Death|1|||
149203293|NCT00830960|538211272|FG000|Overall Study|Lost to Follow-up|1|||
149203294|NCT00830960|538211273|FG001|Overall Study|Lost to Follow-up|1|||
148683084|NCT02736227|536313075|FG001|Overall Study|Withdrawal by Subject|0|||
148683085|NCT02736227|536313076|FG002|Overall Study|Withdrawal by Subject|1|||
148683086|NCT02736227|536313074|FG000|Overall Study|Physician Decision|0|||
148683087|NCT02736227|536313075|FG001|Overall Study|Physician Decision|0|||
148683088|NCT02736227|536313076|FG002|Overall Study|Physician Decision|5|||
148683089|NCT02736227|536313074|FG000|Overall Study|Non Compliant|0|||
148683090|NCT02736227|536313075|FG001|Overall Study|Non Compliant|0|||
148683091|NCT02736227|536313076|FG002|Overall Study|Non Compliant|2|||
148683092|NCT04120194|536313081|FG000|Overall Study|Lost to Follow-up|11|||
148683093|NCT04120194|536313082|FG001|Overall Study|Lost to Follow-up|8|||
148683094|NCT04120194|536313081|FG000|Overall Study|Adverse Event|4|||
148683095|NCT04120194|536313082|FG001|Overall Study|Adverse Event|5|||
148683096|NCT04120194|536313081|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
149203295|NCT00830960|538211274|FG002|Overall Study|Lost to Follow-up|1|||
149203296|NCT00830960|538211275|FG003|Overall Study|Lost to Follow-up|0|||
149203297|NCT00830960|538211276|FG004|Overall Study|Lost to Follow-up|0|||
149203298|NCT00830960|538211277|FG005|Overall Study|Lost to Follow-up|1|||
149203299|NCT00830960|538211272|FG000|Overall Study|Withdrawal by Subject|19|||
149203300|NCT00830960|538211273|FG001|Overall Study|Withdrawal by Subject|19|||
149203301|NCT00830960|538211274|FG002|Overall Study|Withdrawal by Subject|18|||
149203302|NCT00830960|538211275|FG003|Overall Study|Withdrawal by Subject|23|||
149203303|NCT00830960|538211276|FG004|Overall Study|Withdrawal by Subject|16|||
148683097|NCT04120194|536313082|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
148683098|NCT04120194|536313081|FG000|Overall Study|Miscellaneous|4|||
148683099|NCT04120194|536313082|FG001|Overall Study|Miscellaneous|5|||
148683100|NCT02622074|536313092|FG000|Overall Study|Death|4|||
148683101|NCT02622074|536313093|FG001|Overall Study|Death|0|||
148683102|NCT02622074|536313094|FG002|Overall Study|Death|0|||
148683103|NCT02622074|536313095|FG003|Overall Study|Death|1|||
148946480|NCT00790023|537288535|FG002|Overall Study|Withdrawal by Subject|6|||
148946481|NCT00790023|537288533|FG000|Overall Study|Lost to Follow-up|0|||
148946482|NCT00790023|537288534|FG001|Overall Study|Lost to Follow-up|0|||
148946483|NCT00790023|537288535|FG002|Overall Study|Lost to Follow-up|1|||
148946484|NCT00790023|537288533|FG000|Overall Study|Other|5|||
148946485|NCT00790023|537288534|FG001|Overall Study|Other|5|||
148946486|NCT00790023|537288535|FG002|Overall Study|Other|8|||
148946487|NCT01338792|537288536|FG000|Overall Study|Adverse Event|2|||
148946488|NCT01338792|537288536|FG000|Overall Study|Death|1|||
148946489|NCT01338792|537288536|FG000|Overall Study|Withdrawal by Subject|1|||
148946490|NCT00618072|537288537|FG000|Overall Study|Lost to Follow-up|2|||
148946491|NCT00618072|537288538|FG001|Overall Study|Lost to Follow-up|0|||
148946492|NCT00618072|537288539|FG002|Overall Study|Lost to Follow-up|3|||
148946493|NCT00618072|537288537|FG000|Overall Study|Physician Decision|0|||
148946494|NCT00618072|537288538|FG001|Overall Study|Physician Decision|1|||
148946495|NCT00618072|537288539|FG002|Overall Study|Physician Decision|1|||
148946496|NCT02151591|537288540|FG000|Overall Study|Lost to Follow-up|6|||
148946497|NCT02151591|537288541|FG001|Overall Study|Lost to Follow-up|3|||
148946498|NCT03555591|537288544|FG000|Overall Study|Protocol Violation|77|||
148946499|NCT01532414|537288545|FG000|Overall Study|Lost to Follow-up|3|||
148946500|NCT01532414|537288546|FG001|Overall Study|Lost to Follow-up|0|||
148946501|NCT01532414|537288547|FG002|Overall Study|Lost to Follow-up|1|||
148946502|NCT01532414|537288545|FG000|Overall Study|Withdrawal by Subject|3|||
148946503|NCT01532414|537288546|FG001|Overall Study|Withdrawal by Subject|0|||
148946504|NCT01532414|537288547|FG002|Overall Study|Withdrawal by Subject|0|||
148946505|NCT01532414|537288545|FG000|Overall Study|No V6 semen sample|0|||
148946506|NCT01532414|537288546|FG001|Overall Study|No V6 semen sample|1|||
148946507|NCT01532414|537288547|FG002|Overall Study|No V6 semen sample|0|||
148946508|NCT01532414|537288545|FG000|Overall Study|Adverse Event|0|||
148946509|NCT01532414|537288546|FG001|Overall Study|Adverse Event|1|||
148946510|NCT01532414|537288547|FG002|Overall Study|Adverse Event|1|||
148946511|NCT01532414|537288545|FG000|Overall Study|Unable to complete 24 hour PK|0|||
148946512|NCT01532414|537288546|FG001|Overall Study|Unable to complete 24 hour PK|0|||
148946513|NCT01532414|537288547|FG002|Overall Study|Unable to complete 24 hour PK|1|||
148946514|NCT01532414|537288545|FG000|Overall Study|Withdrawn by sponsor|1|||
148946515|NCT01532414|537288546|FG001|Overall Study|Withdrawn by sponsor|0|||
149203304|NCT00830960|538211277|FG005|Overall Study|Withdrawal by Subject|21|||
149203305|NCT00830960|538211272|FG000|Overall Study|Sponsor Decision|1|||
149203306|NCT00830960|538211273|FG001|Overall Study|Sponsor Decision|2|||
149203307|NCT00830960|538211274|FG002|Overall Study|Sponsor Decision|3|||
149203308|NCT00830960|538211275|FG003|Overall Study|Sponsor Decision|4|||
148683104|NCT02622074|536313096|FG004|Overall Study|Death|1|||
148683105|NCT02622074|536313097|FG005|Overall Study|Death|0|||
148683106|NCT02622074|536313092|FG000|Overall Study|Withdrawal by Subject|0|||
148683107|NCT02622074|536313093|FG001|Overall Study|Withdrawal by Subject|1|||
148683108|NCT02622074|536313094|FG002|Overall Study|Withdrawal by Subject|0|||
148683109|NCT02622074|536313095|FG003|Overall Study|Withdrawal by Subject|0|||
148683110|NCT02622074|536313096|FG004|Overall Study|Withdrawal by Subject|0|||
148683111|NCT02622074|536313097|FG005|Overall Study|Withdrawal by Subject|0|||
148683112|NCT02114931|536313098|FG000|Overall Study|Withdrawal by Subject|15|||
148683113|NCT02114931|536313099|FG001|Overall Study|Withdrawal by Subject|18|||
148683114|NCT02114931|536313098|FG000|Overall Study|Adverse Event|4|||
148683115|NCT02114931|536313099|FG001|Overall Study|Adverse Event|6|||
148808667|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
148808668|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
149203309|NCT00830960|538211276|FG004|Overall Study|Sponsor Decision|5|||
148683116|NCT02114931|536313098|FG000|Overall Study|Lost to Follow-up|3|||
148683117|NCT02114931|536313099|FG001|Overall Study|Lost to Follow-up|3|||
148808669|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
148683118|NCT02114931|536313098|FG000|Overall Study|Physician Decision|1|||
148683119|NCT02114931|536313099|FG001|Overall Study|Physician Decision|2|||
148683120|NCT02114931|536313098|FG000|Overall Study|Other|2|||
148683121|NCT02114931|536313099|FG001|Overall Study|Other|1|||
148946516|NCT01532414|537288547|FG002|Overall Study|Withdrawn by sponsor|0|||
148946517|NCT00187486|537288548|FG000|Overall Study|Protocol Violation|1|||
148946518|NCT00684593|537288549|FG000|Overall Study|Adverse Event|0|||
148946519|NCT00684593|537288550|FG001|Overall Study|Adverse Event|2|||
148946520|NCT02380677|537288558|FG000|Overall Study|Adverse Event|0|||
148946521|NCT02380677|537288559|FG001|Overall Study|Adverse Event|0|||
148946522|NCT02380677|537288560|FG002|Overall Study|Adverse Event|0|||
149203310|NCT00830960|538211277|FG005|Overall Study|Sponsor Decision|7|||
148946523|NCT02380677|537288561|FG003|Overall Study|Adverse Event|1|||
149203311|NCT00830960|538211272|FG000|Overall Study|No study drug received|7|||
149203312|NCT00830960|538211273|FG001|Overall Study|No study drug received|2|||
149203313|NCT00830960|538211274|FG002|Overall Study|No study drug received|4|||
149203314|NCT00830960|538211275|FG003|Overall Study|No study drug received|3|||
149203315|NCT00830960|538211276|FG004|Overall Study|No study drug received|5|||
149203316|NCT00830960|538211277|FG005|Overall Study|No study drug received|7|||
149203317|NCT05127421|538211287|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
149203318|NCT05127421|538211288|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
149203319|NCT05127421|538211289|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
149203320|NCT05127421|538211290|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
149203321|NCT05127421|538211287|FG000|4-Week Double-Blind Period|Physician Decision|1|||
149203322|NCT05127421|538211288|FG001|4-Week Double-Blind Period|Physician Decision|0|||
149203323|NCT05127421|538211289|FG002|4-Week Double-Blind Period|Physician Decision|0|||
149203324|NCT05127421|538211290|FG003|4-Week Double-Blind Period|Physician Decision|0|||
149203325|NCT05127421|538211287|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
149203326|NCT05127421|538211288|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
149203327|NCT05127421|538211289|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
149203328|NCT05127421|538211290|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
149203329|NCT05127421|538211287|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
149203330|NCT05127421|538211288|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
149203331|NCT05127421|538211289|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
149203332|NCT05127421|538211290|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
149203333|NCT05127421|538211287|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
149203334|NCT05127421|538211288|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
149203335|NCT05127421|538211289|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
149203336|NCT05127421|538211290|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
149203337|NCT05127421|538211287|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
149203338|NCT05127421|538211288|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
149203339|NCT05127421|538211289|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
149203340|NCT05127421|538211290|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
149203341|NCT05127421|538211287|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
149203342|NCT05127421|538211288|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
149203343|NCT05127421|538211289|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
149203344|NCT05127421|538211290|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
149203345|NCT05127421|538211287|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
149203346|NCT05127421|538211288|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
149203347|NCT05127421|538211289|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
149203348|NCT05127421|538211290|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
149203349|NCT00878215|538211292|FG000|Overall Study|Determined to be ineligible|0|||
149203350|NCT00878215|538211293|FG001|Overall Study|Determined to be ineligible|10|||
149203351|NCT00878215|538211294|FG002|Overall Study|Determined to be ineligible|0|||
149203352|NCT00878215|538211295|FG003|Overall Study|Determined to be ineligible|0|||
149203353|NCT00574496|538211300|FG000|Overall Study|Withdrawal by Subject|1|||
149203354|NCT01969799|538211303|FG000|Overall Study|Adverse Event|0|||
149203355|NCT01969799|538211304|FG001|Overall Study|Adverse Event|1|||
149203356|NCT01969799|538211303|FG000|Overall Study|Death|16|||
149203357|NCT01969799|538211304|FG001|Overall Study|Death|11|||
149203358|NCT01969799|538211303|FG000|Overall Study|Lost to Follow-up|0|||
149203359|NCT01969799|538211304|FG001|Overall Study|Lost to Follow-up|2|||
149203360|NCT01969799|538211303|FG000|Overall Study|Physician Decision|1|||
149203361|NCT01969799|538211304|FG001|Overall Study|Physician Decision|0|||
149203362|NCT02815293|538211305|FG000|Overall Study|Study termination by sponsor|10|||
149203363|NCT02815293|538211306|FG001|Overall Study|Study termination by sponsor|7|||
149203364|NCT02815293|538211307|FG002|Overall Study|Study termination by sponsor|0|||
149203365|NCT02815293|538211305|FG000|Overall Study|Participants not randomized|0|||
149203366|NCT02815293|538211306|FG001|Overall Study|Participants not randomized|0|||
149203367|NCT02815293|538211307|FG002|Overall Study|Participants not randomized|18|||
149203368|NCT02815293|538211305|FG000|Overall Study|Adverse Event|0|||
149203369|NCT02815293|538211306|FG001|Overall Study|Adverse Event|1|||
149203370|NCT02815293|538211307|FG002|Overall Study|Adverse Event|0|||
149203371|NCT01361919|538211310|FG000|Overall Study|technical issues|10|||
149203372|NCT01361919|538211311|FG001|Overall Study|technical issues|12|||
149203373|NCT01361919|538211312|FG002|Overall Study|technical issues|10|||
149203374|NCT01056341|538211313|FG000|Overall Study|Treatment Intolerance|0|||
149203375|NCT01056341|538211314|FG001|Overall Study|Treatment Intolerance|2|||
149203376|NCT01056341|538211315|FG002|Overall Study|Treatment Intolerance|0|||
149203377|NCT01056341|538211316|FG003|Overall Study|Treatment Intolerance|2|||
149203378|NCT01056341|538211317|FG004|Overall Study|Treatment Intolerance|0|||
149203379|NCT01056341|538211313|FG000|Overall Study|Lack of Efficacy|32|||
149203380|NCT01056341|538211314|FG001|Overall Study|Lack of Efficacy|30|||
149203381|NCT01056341|538211315|FG002|Overall Study|Lack of Efficacy|7|||
149203382|NCT01056341|538211316|FG003|Overall Study|Lack of Efficacy|25|||
149203383|NCT01056341|538211317|FG004|Overall Study|Lack of Efficacy|9|||
149203384|NCT01056341|538211313|FG000|Overall Study|Other reasons|4|||
148946524|NCT02380677|537288562|FG004|Overall Study|Adverse Event|1|||
148946525|NCT02380677|537288563|FG005|Overall Study|Adverse Event|4|||
148946526|NCT02380677|537288564|FG006|Overall Study|Adverse Event|2|||
148946527|NCT02380677|537288565|FG007|Overall Study|Adverse Event|2|||
148946528|NCT02380677|537288566|FG008|Overall Study|Adverse Event|2|||
148946529|NCT02380677|537288567|FG009|Overall Study|Adverse Event|1|||
148946530|NCT02380677|537288568|FG010|Overall Study|Adverse Event|2|||
148946531|NCT02380677|537288569|FG011|Overall Study|Adverse Event|1|||
148946532|NCT02380677|537288558|FG000|Overall Study|Physician Decision|1|||
148946533|NCT02380677|537288559|FG001|Overall Study|Physician Decision|0|||
148946534|NCT02380677|537288560|FG002|Overall Study|Physician Decision|1|||
148946535|NCT02380677|537288561|FG003|Overall Study|Physician Decision|1|||
148946536|NCT02380677|537288562|FG004|Overall Study|Physician Decision|0|||
148946537|NCT02380677|537288563|FG005|Overall Study|Physician Decision|0|||
148946538|NCT02380677|537288564|FG006|Overall Study|Physician Decision|0|||
148946539|NCT02380677|537288565|FG007|Overall Study|Physician Decision|0|||
148946540|NCT02380677|537288566|FG008|Overall Study|Physician Decision|0|||
148946541|NCT02380677|537288567|FG009|Overall Study|Physician Decision|0|||
148946542|NCT02380677|537288568|FG010|Overall Study|Physician Decision|0|||
148946543|NCT02380677|537288569|FG011|Overall Study|Physician Decision|0|||
148946544|NCT02380677|537288558|FG000|Overall Study|Lack of Efficacy|0|||
148946545|NCT02380677|537288559|FG001|Overall Study|Lack of Efficacy|1|||
148946546|NCT02380677|537288560|FG002|Overall Study|Lack of Efficacy|2|||
148946547|NCT02380677|537288561|FG003|Overall Study|Lack of Efficacy|0|||
148946548|NCT02380677|537288562|FG004|Overall Study|Lack of Efficacy|4|||
148946549|NCT02380677|537288563|FG005|Overall Study|Lack of Efficacy|1|||
148808670|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
148808671|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
148808672|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
148808673|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
149203385|NCT01056341|538211314|FG001|Overall Study|Other reasons|4|||
149203386|NCT01056341|538211315|FG002|Overall Study|Other reasons|8|||
149203387|NCT01056341|538211316|FG003|Overall Study|Other reasons|9|||
149203388|NCT01056341|538211317|FG004|Overall Study|Other reasons|5|||
149203389|NCT01086150|538211318|FG000|Overall Study|Withdrawal by Subject|0|||
148808674|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
148808675|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
148946550|NCT02380677|537288564|FG006|Overall Study|Lack of Efficacy|1|||
148946551|NCT02380677|537288565|FG007|Overall Study|Lack of Efficacy|2|||
148946552|NCT02380677|537288566|FG008|Overall Study|Lack of Efficacy|2|||
148946553|NCT02380677|537288567|FG009|Overall Study|Lack of Efficacy|0|||
148946554|NCT02380677|537288568|FG010|Overall Study|Lack of Efficacy|2|||
148946555|NCT02380677|537288569|FG011|Overall Study|Lack of Efficacy|1|||
148946556|NCT02380677|537288558|FG000|Overall Study|Withdrawal by Subject|0|||
148946557|NCT02380677|537288559|FG001|Overall Study|Withdrawal by Subject|0|||
148946558|NCT02380677|537288560|FG002|Overall Study|Withdrawal by Subject|0|||
148946559|NCT02380677|537288561|FG003|Overall Study|Withdrawal by Subject|0|||
148946560|NCT02380677|537288562|FG004|Overall Study|Withdrawal by Subject|0|||
148946561|NCT02380677|537288563|FG005|Overall Study|Withdrawal by Subject|0|||
149016304|NCT00337662|537537892|FG002|Study Period III|Sponsor Decision|1|||
149203390|NCT01086150|538211319|FG001|Overall Study|Withdrawal by Subject|4|||
149203391|NCT01086150|538211320|FG002|Overall Study|Withdrawal by Subject|1|||
149203392|NCT01086150|538211318|FG000|Overall Study|Lost to Follow-up|0|||
149203393|NCT01086150|538211319|FG001|Overall Study|Lost to Follow-up|1|||
149203394|NCT01086150|538211320|FG002|Overall Study|Lost to Follow-up|0|||
149203395|NCT01086150|538211318|FG000|Overall Study|Screen Failure|0|||
149203396|NCT01086150|538211319|FG001|Overall Study|Screen Failure|1|||
149203397|NCT01086150|538211320|FG002|Overall Study|Screen Failure|0|||
149203398|NCT01681576|538211323|FG000|Period 1|Adverse Event|1|||
149203399|NCT01681576|538211324|FG001|Period 1|Adverse Event|0|||
149203400|NCT01681576|538211323|FG000|Period 1|Protocol Deviation|1|||
148946562|NCT02380677|537288564|FG006|Overall Study|Withdrawal by Subject|0|||
148946563|NCT02380677|537288565|FG007|Overall Study|Withdrawal by Subject|0|||
148946564|NCT02380677|537288566|FG008|Overall Study|Withdrawal by Subject|0|||
148946565|NCT02380677|537288567|FG009|Overall Study|Withdrawal by Subject|1|||
148946566|NCT02380677|537288568|FG010|Overall Study|Withdrawal by Subject|0|||
148946567|NCT02380677|537288569|FG011|Overall Study|Withdrawal by Subject|3|||
148946568|NCT02380677|537288558|FG000|Overall Study|Other|0|||
148946569|NCT02380677|537288559|FG001|Overall Study|Other|0|||
148946570|NCT02380677|537288560|FG002|Overall Study|Other|0|||
148946571|NCT02380677|537288561|FG003|Overall Study|Other|1|||
148946572|NCT02380677|537288562|FG004|Overall Study|Other|1|||
148946573|NCT02380677|537288563|FG005|Overall Study|Other|1|||
148946574|NCT02380677|537288564|FG006|Overall Study|Other|0|||
149203401|NCT01681576|538211324|FG001|Period 1|Protocol Deviation|0|||
149203402|NCT01681576|538211323|FG000|Period 2|subject/guardian decision|3|||
149203403|NCT01681576|538211324|FG001|Period 2|subject/guardian decision|1|||
148808676|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
148808677|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
148808678|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
148808679|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
148808680|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
149203404|NCT01681576|538211323|FG000|Period 2|Non-compliance with study treatment|1|||
149203405|NCT01681576|538211324|FG001|Period 2|Non-compliance with study treatment|0|||
149203406|NCT03543358|538211326|FG000|Overall Study|Death|1|||
149203407|NCT03543358|538211327|FG001|Overall Study|Death|0|||
149203408|NCT03543358|538211326|FG000|Overall Study|Disease Progression|1|||
149203409|NCT03543358|538211327|FG001|Overall Study|Disease Progression|0|||
149203410|NCT03543358|538211326|FG000|Overall Study|Parent Study Closure|1|||
149203411|NCT03543358|538211327|FG001|Overall Study|Parent Study Closure|0|||
149203412|NCT00178464|538211328|FG000|Overall Study|Withdrawal by Subject|1|||
149203413|NCT00178464|538211328|FG000|Overall Study|Physician Decision|1|||
149203414|NCT04111107|538211329|FG000|Overall Study|Withdrawal by Subject|6|||
149203415|NCT04111107|538211329|FG000|Overall Study|Declining Health|5|||
149203416|NCT03956225|538211330|FG000|Overall Study|Lack of Efficacy|1|||
149203417|NCT03956225|538211331|FG001|Overall Study|Lack of Efficacy|1|||
149203418|NCT03956225|538211330|FG000|Overall Study|Lost to Follow-up|0|||
149203419|NCT03956225|538211331|FG001|Overall Study|Lost to Follow-up|1|||
148683122|NCT03870997|536313100|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
148683123|NCT03870997|536313101|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
148683124|NCT03870997|536313102|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
148683125|NCT03870997|536313103|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
148683126|NCT03870997|536313104|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
148683127|NCT03870997|536313105|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
148683128|NCT01827371|536313109|FG000|Overall Study|Adverse Event|0|||
148683129|NCT01827371|536313110|FG001|Overall Study|Adverse Event|0|||
148683130|NCT01827371|536313111|FG002|Overall Study|Adverse Event|4|||
148683131|NCT01827371|536313112|FG003|Overall Study|Adverse Event|2|||
148683132|NCT01827371|536313109|FG000|Overall Study|Lost to Follow-up|0|||
148683133|NCT01827371|536313110|FG001|Overall Study|Lost to Follow-up|2|||
148683134|NCT01827371|536313111|FG002|Overall Study|Lost to Follow-up|0|||
148683135|NCT01827371|536313112|FG003|Overall Study|Lost to Follow-up|4|||
148683136|NCT01827371|536313109|FG000|Overall Study|Protocol Violation|1|||
148683137|NCT01827371|536313110|FG001|Overall Study|Protocol Violation|0|||
148683138|NCT01827371|536313111|FG002|Overall Study|Protocol Violation|0|||
148683139|NCT01827371|536313112|FG003|Overall Study|Protocol Violation|0|||
148683140|NCT01827371|536313109|FG000|Overall Study|Withdrawal by Subject|1|||
148683141|NCT01827371|536313110|FG001|Overall Study|Withdrawal by Subject|2|||
148683142|NCT01827371|536313111|FG002|Overall Study|Withdrawal by Subject|2|||
148946575|NCT02380677|537288565|FG007|Overall Study|Other|0|||
148683143|NCT01827371|536313112|FG003|Overall Study|Withdrawal by Subject|3|||
148683144|NCT01827371|536313109|FG000|Overall Study|Physician Decision|0|||
148683145|NCT01827371|536313110|FG001|Overall Study|Physician Decision|1|||
148683146|NCT01827371|536313111|FG002|Overall Study|Physician Decision|0|||
148808681|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
149203420|NCT03956225|538211330|FG000|Overall Study|Withdrawal by Subject|2|||
149203421|NCT03956225|538211331|FG001|Overall Study|Withdrawal by Subject|1|||
149203422|NCT03956225|538211330|FG000|Overall Study|Other Reasons|2|||
149203423|NCT03956225|538211331|FG001|Overall Study|Other Reasons|1|||
149203424|NCT02260648|538211332|FG000|Overall Study|Adverse Event|3|||
149203425|NCT02260648|538211333|FG001|Overall Study|Adverse Event|0|||
149203426|NCT02260648|538211334|FG002|Overall Study|Adverse Event|1|||
149203427|NCT02260648|538211332|FG000|Overall Study|Withdrawal by Subject|1|||
148808682|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
148808683|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
148808684|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
148808685|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
148808686|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
148808687|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
148808688|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
148808689|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
148808690|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
148808691|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
148808692|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
148808693|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
148808694|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
148808695|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
148808696|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
148808697|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
148808698|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
148808699|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
148808700|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
148808701|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
148808702|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
148808703|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
148808704|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
148808705|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
148808706|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
148808707|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
149016305|NCT00337662|537537893|FG003|Study Period III|Sponsor Decision|0|||
149016306|NCT00337662|537537890|FG000|Study Period III|Clinical Relapse|1|||
149016307|NCT00337662|537537891|FG001|Study Period III|Clinical Relapse|0|||
149203428|NCT02260648|538211333|FG001|Overall Study|Withdrawal by Subject|1|||
149203429|NCT02260648|538211334|FG002|Overall Study|Withdrawal by Subject|0|||
149203430|NCT02260648|538211332|FG000|Overall Study|Protocol Violation|1|||
149203431|NCT02260648|538211333|FG001|Overall Study|Protocol Violation|0|||
149203432|NCT02260648|538211334|FG002|Overall Study|Protocol Violation|0|||
149203433|NCT02260648|538211332|FG000|Overall Study|Discontinue Due to Study Termination|13|||
149203434|NCT02260648|538211333|FG001|Overall Study|Discontinue Due to Study Termination|12|||
149203435|NCT02260648|538211334|FG002|Overall Study|Discontinue Due to Study Termination|7|||
149203436|NCT00805545|538211337|FG000|Overall Study|Protocol Violation|3|||
149203437|NCT00805545|538211338|FG001|Overall Study|Protocol Violation|2|||
149203438|NCT00805545|538211337|FG000|Overall Study|Protocol Violation|3|||
149203439|NCT00805545|538211338|FG001|Overall Study|Protocol Violation|1|||
149203440|NCT00171314|538211351|FG000|Overall Study|Adverse Event|44|||
149203441|NCT00171314|538211352|FG001|Overall Study|Adverse Event|41|||
149203442|NCT00171314|538211351|FG000|Overall Study|Lack of Efficacy|19|||
149203443|NCT00171314|538211352|FG001|Overall Study|Lack of Efficacy|14|||
149203444|NCT00171314|538211351|FG000|Overall Study|Withdrawal by Subject|9|||
149203445|NCT00171314|538211352|FG001|Overall Study|Withdrawal by Subject|6|||
149203446|NCT00171314|538211351|FG000|Overall Study|Abnormal Test Procedure Results|9|||
149203447|NCT00171314|538211352|FG001|Overall Study|Abnormal Test Procedure Results|3|||
149203448|NCT00171314|538211351|FG000|Overall Study|Protocol Violation|3|||
149203449|NCT00171314|538211352|FG001|Overall Study|Protocol Violation|7|||
149203450|NCT00171314|538211351|FG000|Overall Study|Administrative Problems|4|||
149203451|NCT00171314|538211352|FG001|Overall Study|Administrative Problems|3|||
149203452|NCT00171314|538211351|FG000|Overall Study|Lost to Follow-up|1|||
149203453|NCT00171314|538211352|FG001|Overall Study|Lost to Follow-up|3|||
149203454|NCT00171314|538211351|FG000|Overall Study|Death|2|||
149203455|NCT00171314|538211352|FG001|Overall Study|Death|1|||
149203456|NCT00377429|538211353|FG000|Overall Study|Withdrawal by Subject|5|||
149203457|NCT00377429|538211353|FG000|Overall Study|Adverse Event|8|||
149203458|NCT00377429|538211353|FG000|Overall Study|Physician Decision|1|||
149203459|NCT00377429|538211353|FG000|Overall Study|Patient non-compliance|1|||
149203460|NCT02394795|538211356|FG000|Overall Study|Adverse Event|92|||
149203461|NCT02394795|538211357|FG001|Overall Study|Adverse Event|70|||
149203462|NCT02394795|538211356|FG000|Overall Study|Lost to Follow-up|0|||
149203463|NCT02394795|538211357|FG001|Overall Study|Lost to Follow-up|1|||
149203464|NCT02394795|538211356|FG000|Overall Study|Withdrawal by Subject|17|||
149203465|NCT02394795|538211357|FG001|Overall Study|Withdrawal by Subject|26|||
149203466|NCT02394795|538211356|FG000|Overall Study|Lack of Efficacy|181|||
149203467|NCT02394795|538211357|FG001|Overall Study|Lack of Efficacy|211|||
149203468|NCT02394795|538211356|FG000|Overall Study|Death|4|||
149203469|NCT02394795|538211357|FG001|Overall Study|Death|5|||
149203470|NCT02394795|538211356|FG000|Overall Study|Physician Decision|109|||
148808708|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
148946576|NCT02380677|537288566|FG008|Overall Study|Other|0|||
148946577|NCT02380677|537288567|FG009|Overall Study|Other|0|||
148946578|NCT02380677|537288568|FG010|Overall Study|Other|0|||
148946579|NCT02380677|537288569|FG011|Overall Study|Other|0|||
148946580|NCT02599129|537288570|FG000|Overall Study|Lack of Efficacy|2|||
149203471|NCT02394795|538211357|FG001|Overall Study|Physician Decision|93|||
149203472|NCT02939599|538211359|FG000|Overall Study|Adverse Event|1|||
149203473|NCT02939599|538211360|FG001|Overall Study|Adverse Event|0|||
149203474|NCT02939599|538211359|FG000|Overall Study|Study Terminated By Sponsor|2|||
149203475|NCT02939599|538211360|FG001|Overall Study|Study Terminated By Sponsor|2|||
149203476|NCT01669811|538211361|FG000|Overall Study|Investigator decision|0|||
149203477|NCT01669811|538211362|FG001|Overall Study|Investigator decision|1|||
149203478|NCT01669811|538211361|FG000|Overall Study|Withdrawal by Subject|1|||
149203479|NCT01669811|538211362|FG001|Overall Study|Withdrawal by Subject|2|||
149203480|NCT01669811|538211361|FG000|Overall Study|Adverse Event|2|||
149203481|NCT01669811|538211362|FG001|Overall Study|Adverse Event|6|||
149203482|NCT01669811|538211361|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149203483|NCT01669811|538211362|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
149203484|NCT03337139|538211363|FG000|Phase I|Withdrawal by Subject|10|||
149203485|NCT03337139|538211364|FG001|Phase I|Withdrawal by Subject|0|||
149203486|NCT03288493|538211365|FG000|Overall Study|Withdrawal by Subject|4|||
149203487|NCT03288493|538211366|FG001|Overall Study|Withdrawal by Subject|0|||
149203488|NCT03288493|538211367|FG002|Overall Study|Withdrawal by Subject|0|||
149203489|NCT03288493|538211368|FG003|Overall Study|Withdrawal by Subject|0|||
149203490|NCT03288493|538211369|FG004|Overall Study|Withdrawal by Subject|0|||
149203491|NCT03288493|538211370|FG005|Overall Study|Withdrawal by Subject|2|||
149203492|NCT03288493|538211371|FG006|Overall Study|Withdrawal by Subject|0|||
149203493|NCT03288493|538211365|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
149203494|NCT03288493|538211366|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
149203495|NCT03288493|538211367|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
149203496|NCT03288493|538211368|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
149203497|NCT03288493|538211369|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
149203498|NCT03288493|538211370|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
149203499|NCT03288493|538211371|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
148946581|NCT02599129|537288571|FG001|Overall Study|Lack of Efficacy|2|||
148946582|NCT02599129|537288570|FG000|Overall Study|Lost to Follow-up|1|||
148946583|NCT02599129|537288571|FG001|Overall Study|Lost to Follow-up|0|||
148946584|NCT02599129|537288570|FG000|Overall Study|Withdrawal by Subject|2|||
149203500|NCT03288493|538211365|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
149203501|NCT03288493|538211366|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149203502|NCT03288493|538211367|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149203503|NCT03288493|538211368|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
149203504|NCT03288493|538211369|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149203505|NCT03288493|538211370|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
148946585|NCT02599129|537288571|FG001|Overall Study|Withdrawal by Subject|1|||
148946586|NCT00617773|537288572|FG000|Overall Study|Physician Decision|1|||
148946587|NCT00617773|537288572|FG000|Overall Study|Lack of compliance with the protocol|1|||
148946588|NCT00617773|537288572|FG000|Overall Study|Withdrawal by Subject|1|||
148946589|NCT00617773|537288572|FG000|Overall Study|Death|1|||
148946590|NCT00617773|537288572|FG000|Overall Study|Progressive disease|19|||
148946591|NCT00617773|537288572|FG000|Overall Study|Protocol Violation|1|||
148946592|NCT05526716|537288575|FG000|Overall Study|Death|1|||
148946593|NCT05526716|537288576|FG001|Overall Study|Death|2|||
148946594|NCT05526716|537288575|FG000|Overall Study|Lost to Follow-up|17|||
148946595|NCT05526716|537288576|FG001|Overall Study|Lost to Follow-up|15|||
148946596|NCT05526716|537288575|FG000|Overall Study|Physician Decision|0|||
148946597|NCT05526716|537288576|FG001|Overall Study|Physician Decision|1|||
148946598|NCT05526716|537288575|FG000|Overall Study|Randomized by mistake without study treatment|0|||
148946599|NCT05526716|537288576|FG001|Overall Study|Randomized by mistake without study treatment|1|||
148946600|NCT05526716|537288575|FG000|Overall Study|Withdrawal by Subject|12|||
148946601|NCT05526716|537288576|FG001|Overall Study|Withdrawal by Subject|12|||
148946602|NCT05526716|537288575|FG000|Overall Study|Not reported|0|||
148946603|NCT05526716|537288576|FG001|Overall Study|Not reported|2|||
148946604|NCT05035550|537288584|FG000|Overall Study|Withdrawal by Subject|3|||
148946605|NCT05035550|537288585|FG001|Overall Study|Withdrawal by Subject|0|||
148946606|NCT01438957|537288586|FG000|Overall Study|Physician Decision|1|||
149203506|NCT03288493|538211371|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
149203507|NCT03288493|538211365|FG000|Overall Study|Death|2|||
149203508|NCT03288493|538211366|FG001|Overall Study|Death|0|||
149203509|NCT03288493|538211367|FG002|Overall Study|Death|0|||
149203510|NCT03288493|538211368|FG003|Overall Study|Death|0|||
149203511|NCT03288493|538211369|FG004|Overall Study|Death|0|||
149203512|NCT03288493|538211370|FG005|Overall Study|Death|0|||
149203513|NCT03288493|538211371|FG006|Overall Study|Death|0|||
149203514|NCT03288493|538211365|FG000|Overall Study|other reason not listed above|2|||
149203515|NCT03288493|538211366|FG001|Overall Study|other reason not listed above|0|||
149203516|NCT03288493|538211367|FG002|Overall Study|other reason not listed above|0|||
149203517|NCT03288493|538211368|FG003|Overall Study|other reason not listed above|0|||
149203518|NCT03288493|538211369|FG004|Overall Study|other reason not listed above|0|||
149203519|NCT03288493|538211370|FG005|Overall Study|other reason not listed above|0|||
149203520|NCT03288493|538211371|FG006|Overall Study|other reason not listed above|0|||
149203521|NCT01871896|538211372|FG000|Overall Study|Lost to Follow-up|1|||
149203522|NCT00562640|538212848|FG000|Overall Study|Death|0|||
149203523|NCT00562640|538212849|FG001|Overall Study|Death|1|||
149203524|NCT00562640|538212850|FG002|Overall Study|Death|1|||
149203525|NCT00562640|538212851|FG003|Overall Study|Death|0|||
149203526|NCT01412151|538212852|FG000|Week 0 - 306 - Treatment Period|Death|1|||
149203527|NCT01412151|538212852|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
149203528|NCT01412151|538212852|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
149203529|NCT01412151|538212852|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
149203530|NCT03127852|538212853|FG000|Overall Study|Withdrawal by Subject|4|||
149203531|NCT03127852|538212854|FG001|Overall Study|Withdrawal by Subject|1|||
149203532|NCT03127852|538212853|FG000|Overall Study|Death|1|||
149203533|NCT03127852|538212854|FG001|Overall Study|Death|1|||
149203534|NCT01824693|538212855|FG000|Overall Study|Death|0|||
149203535|NCT01824693|538212856|FG001|Overall Study|Death|1|||
149203536|NCT01824693|538212857|FG002|Overall Study|Death|0|||
149203537|NCT01824693|538212855|FG000|Overall Study|Physician Decision|1|||
149203538|NCT01824693|538212856|FG001|Overall Study|Physician Decision|1|||
149203539|NCT01824693|538212857|FG002|Overall Study|Physician Decision|1|||
149203540|NCT01824693|538212855|FG000|Overall Study|Withdrawal by Subject|0|||
149203541|NCT01824693|538212856|FG001|Overall Study|Withdrawal by Subject|0|||
149203542|NCT01824693|538212857|FG002|Overall Study|Withdrawal by Subject|1|||
148946607|NCT01438957|537288587|FG001|Overall Study|Physician Decision|1|||
148946608|NCT01438957|537288588|FG002|Overall Study|Physician Decision|0|||
148946609|NCT01438957|537288589|FG003|Overall Study|Physician Decision|1|||
148946610|NCT01438957|537288590|FG004|Overall Study|Physician Decision|0|||
148946611|NCT00224042|537288591|FG000|Overall Study|Adverse Event|2|||
148946612|NCT00224042|537288592|FG001|Overall Study|Adverse Event|1|||
148946613|NCT00224042|537288591|FG000|Overall Study|Protocol Violation|0|||
148946614|NCT00224042|537288592|FG001|Overall Study|Protocol Violation|1|||
148946615|NCT00224042|537288591|FG000|Overall Study|Physician Decision|0|||
148808709|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
148808710|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
148808711|NCT00090103|536777541|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
148808712|NCT00090103|536777542|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
148808713|NCT00090103|536777543|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
148808714|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
148808715|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
148808716|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
148808717|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
148808718|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
148808719|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
148808720|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
148808721|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
148808722|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
148808723|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
148808724|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
148808725|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
148808726|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
148808727|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
148808728|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
148808729|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
148808730|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
148808731|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
148808732|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
148808733|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
148808734|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
148808735|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
149203543|NCT01824693|538212855|FG000|Overall Study|Progressive Disease|0|||
149203544|NCT01824693|538212856|FG001|Overall Study|Progressive Disease|5|||
149203545|NCT01824693|538212857|FG002|Overall Study|Progressive Disease|0|||
149203546|NCT01824693|538212855|FG000|Overall Study|Ineligible|0|||
149203547|NCT01824693|538212856|FG001|Overall Study|Ineligible|0|||
149203548|NCT01824693|538212857|FG002|Overall Study|Ineligible|3|||
149203549|NCT01824693|538212855|FG000|Overall Study|No Transplant Planned|0|||
149203550|NCT01824693|538212856|FG001|Overall Study|No Transplant Planned|0|||
149203551|NCT01824693|538212857|FG002|Overall Study|No Transplant Planned|10|||
149203552|NCT02150213|538212858|FG000|Overall Study|Lost to Follow-up|1|||
149203553|NCT02150213|538212858|FG000|Overall Study|Withdrawal by Subject|1|||
149203554|NCT00656084|538212859|FG000|Overall Study|Adverse Event|4|||
149203555|NCT00656084|538212859|FG000|Overall Study|Withdrawal by Subject|1|||
149203556|NCT00656084|538212859|FG000|Overall Study|Patient Request|1|||
149203557|NCT00656084|538212859|FG000|Overall Study|Investigator Request|1|||
149203558|NCT00525785|538212862|FG000|Overall Study|Withdrawal by Subject|1|||
149203559|NCT00525785|538212862|FG000|Overall Study|Lack of Efficacy|1|||
149203560|NCT00525785|538212862|FG000|Overall Study|Physician Decision|1|||
149203561|NCT02855450|538212867|FG000|Overall Study|Adverse Event|1|||
149203562|NCT02855450|538212868|FG001|Overall Study|Adverse Event|0|||
149203563|NCT02855450|538212867|FG000|Overall Study|Lost to Follow-up|4|||
149203564|NCT02855450|538212868|FG001|Overall Study|Lost to Follow-up|0|||
149203565|NCT01376245|538212869|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
149203566|NCT01376245|538212870|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149203567|NCT01376245|538212871|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149203568|NCT01376245|538212872|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149203569|NCT01376245|538212873|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
149203570|NCT01376245|538212869|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
149203571|NCT01376245|538212870|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
148808736|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
148808737|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
148808738|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
148808739|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
148808740|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
148808741|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
148808742|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
148946616|NCT00224042|537288592|FG001|Overall Study|Physician Decision|1|||
149203572|NCT01376245|538212871|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
149203573|NCT01376245|538212872|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
149203574|NCT01376245|538212873|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
148946617|NCT00224042|537288591|FG000|Overall Study|Did not meet lab incusion criteria|2|||
148946618|NCT00224042|537288592|FG001|Overall Study|Did not meet lab incusion criteria|3|||
148946619|NCT00224042|537288591|FG000|Overall Study|Other|2|||
148946620|NCT00224042|537288592|FG001|Overall Study|Other|0|||
148946621|NCT00840450|537288593|FG000|Overall Study|Adverse Event|1|||
148946622|NCT00840450|537288593|FG000|Overall Study|Lack of Efficacy|2|||
148946623|NCT02170298|537288594|FG000|Overall Study|Withdrawal by Subject|0|||
148946624|NCT02170298|537288595|FG001|Overall Study|Withdrawal by Subject|1|||
149203575|NCT01376245|538212869|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
149203576|NCT01376245|538212870|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149203577|NCT01376245|538212871|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149203578|NCT01376245|538212872|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149203579|NCT01376245|538212873|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
149203580|NCT01376245|538212869|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
149203581|NCT01376245|538212870|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149203582|NCT01376245|538212871|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149203583|NCT01376245|538212872|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
149203584|NCT01376245|538212873|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
148946625|NCT02170298|537288594|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
148946626|NCT02170298|537288595|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
149203585|NCT01376245|538212869|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
149203586|NCT01376245|538212870|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149203587|NCT01376245|538212871|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149203588|NCT01376245|538212872|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149203589|NCT01376245|538212873|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
149203590|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
149203591|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
149203592|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
149203593|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
149203594|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
149203595|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
149203596|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
149203597|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
149203598|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
149203599|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
149203600|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
149203601|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
149203602|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
149203603|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
149203604|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
149203605|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149203606|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
149203607|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
149203608|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
149203609|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
149203610|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148946627|NCT00777608|537288597|FG000|Overall Study|Lost to Follow-up|1|||
148946628|NCT00777608|537288598|FG001|Overall Study|Lost to Follow-up|1|||
148946629|NCT00777608|537288597|FG000|Overall Study|Withdrawal by Subject|1|||
148946630|NCT00777608|537288598|FG001|Overall Study|Withdrawal by Subject|3|||
148946631|NCT00777608|537288597|FG000|Overall Study|Protocol Violation|1|||
148946632|NCT00777608|537288598|FG001|Overall Study|Protocol Violation|0|||
149203611|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
149203612|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
149203613|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
149203614|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
149203615|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
149203616|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
149203617|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
149203618|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
149203619|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
149203620|NCT01376245|538212869|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
149203621|NCT01376245|538212870|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
149203622|NCT01376245|538212871|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
149203623|NCT01376245|538212872|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
149203624|NCT01376245|538212873|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
149203625|NCT05159362|538212874|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
149203626|NCT05159362|538212875|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
149203627|NCT05159362|538212876|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
149203628|NCT00050960|538212877|FG000|Overall Study|Progressive Disease|137|||
149203629|NCT00050960|538212878|FG001|Overall Study|Progressive Disease|93|||
149203630|NCT00050960|538212877|FG000|Overall Study|Stable Disease|19|||
149203631|NCT00050960|538212878|FG001|Overall Study|Stable Disease|48|||
149203632|NCT00050960|538212877|FG000|Overall Study|Partial Response|14|||
149203633|NCT00050960|538212878|FG001|Overall Study|Partial Response|19|||
149203634|NCT00050960|538212877|FG000|Overall Study|Complete Response|0|||
149203635|NCT00050960|538212878|FG001|Overall Study|Complete Response|2|||
149203636|NCT00050960|538212877|FG000|Overall Study|Adverse Event|62|||
149203637|NCT00050960|538212878|FG001|Overall Study|Adverse Event|61|||
149203638|NCT00050960|538212877|FG000|Overall Study|Lost to Follow-up|0|||
149203639|NCT00050960|538212878|FG001|Overall Study|Lost to Follow-up|1|||
149203640|NCT00050960|538212877|FG000|Overall Study|Withdrawal by Subject|23|||
149203641|NCT00050960|538212878|FG001|Overall Study|Withdrawal by Subject|18|||
149203642|NCT00050960|538212877|FG000|Overall Study|Administrative|31|||
149203643|NCT00050960|538212878|FG001|Overall Study|Administrative|46|||
149203644|NCT00050960|538212877|FG000|Overall Study|Non-compliance|3|||
149203645|NCT00050960|538212878|FG001|Overall Study|Non-compliance|1|||
148946633|NCT00777608|537288597|FG000|Overall Study|Investigator Decision|1|||
148946634|NCT00777608|537288598|FG001|Overall Study|Investigator Decision|2|||
149203646|NCT00050960|538212877|FG000|Overall Study|Death|13|||
149203647|NCT00050960|538212878|FG001|Overall Study|Death|15|||
149203648|NCT00764946|538212882|FG000|Overall Study|Lack of Efficacy|1|||
149203649|NCT00764946|538212883|FG001|Overall Study|Lack of Efficacy|0|||
149203650|NCT00764946|538212884|FG002|Overall Study|Lack of Efficacy|0|||
149203651|NCT00764946|538212882|FG000|Overall Study|Lost to Follow-up|3|||
149203652|NCT00764946|538212883|FG001|Overall Study|Lost to Follow-up|4|||
149203653|NCT00764946|538212884|FG002|Overall Study|Lost to Follow-up|0|||
149203654|NCT00764946|538212882|FG000|Overall Study|Physician Decision|2|||
149203655|NCT00764946|538212883|FG001|Overall Study|Physician Decision|4|||
149203656|NCT00764946|538212884|FG002|Overall Study|Physician Decision|0|||
149203657|NCT00764946|538212882|FG000|Overall Study|Adverse Event|3|||
149203658|NCT00764946|538212883|FG001|Overall Study|Adverse Event|2|||
149203659|NCT00764946|538212884|FG002|Overall Study|Adverse Event|1|||
149203660|NCT00764946|538212882|FG000|Overall Study|Withdrawal by Subject|3|||
149203661|NCT00764946|538212883|FG001|Overall Study|Withdrawal by Subject|6|||
149203662|NCT00764946|538212884|FG002|Overall Study|Withdrawal by Subject|2|||
149203663|NCT00764946|538212882|FG000|Overall Study|Never Treated|1|||
149203664|NCT00764946|538212883|FG001|Overall Study|Never Treated|1|||
149203665|NCT00764946|538212884|FG002|Overall Study|Never Treated|1|||
149203666|NCT01162304|538212885|FG000|Overall Study|Beck scale to high|11|||
149203667|NCT01996904|538212886|FG000|Overall Study|Lost to Follow-up|38|||
149203668|NCT01996904|538212887|FG001|Overall Study|Lost to Follow-up|27|||
149203669|NCT00585923|538212888|FG000|Overall Study|Physician decided not to continue|31|||
149203670|NCT00585923|538212889|FG001|Overall Study|Physician decided not to continue|33|||
149203671|NCT01324622|538212890|FG000|Overall Study|Lost to Follow-up|7|||
149203672|NCT01324622|538212891|FG001|Overall Study|Lost to Follow-up|7|||
149203673|NCT01324622|538212890|FG000|Overall Study|Death|1|||
149203674|NCT01324622|538212891|FG001|Overall Study|Death|0|||
149203675|NCT01324622|538212890|FG000|Overall Study|Lack of Efficacy|1|||
149203676|NCT01324622|538212891|FG001|Overall Study|Lack of Efficacy|0|||
149203677|NCT00618449|538212892|FG000|Overall Study|Lost to Follow-up|98|||
149203678|NCT00618449|538212893|FG001|Overall Study|Lost to Follow-up|110|||
149203679|NCT02219087|538212894|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
149203680|NCT02219087|538212895|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
149203681|NCT00138424|538212896|FG000|Overall Study|Physician Decision|0|||
149203682|NCT00138424|538212897|FG001|Overall Study|Physician Decision|1|||
149203683|NCT00138424|538212898|FG002|Overall Study|Physician Decision|0|||
149203684|NCT00138424|538212899|FG003|Overall Study|Physician Decision|0|||
149203685|NCT04311177|538212900|FG000|Overall Study|Adverse Event|3|||
149203686|NCT04311177|538212901|FG001|Overall Study|Adverse Event|1|||
149203687|NCT04311177|538212900|FG000|Overall Study|Physician Decision|4|||
149203688|NCT04311177|538212901|FG001|Overall Study|Physician Decision|3|||
149203689|NCT04311177|538212900|FG000|Overall Study|Withdrawal by Subject|1|||
149203690|NCT04311177|538212901|FG001|Overall Study|Withdrawal by Subject|0|||
149203691|NCT00413062|538212906|FG000|Overall Study|Adverse event/serious adverse event|289|||
149203692|NCT00413062|538212907|FG001|Overall Study|Adverse event/serious adverse event|56|||
149203693|NCT00413062|538212906|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
149203694|NCT00413062|538212907|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
149203695|NCT00413062|538212906|FG000|Overall Study|Withdrawal of informed consent|111|||
149203696|NCT00413062|538212907|FG001|Overall Study|Withdrawal of informed consent|36|||
149203697|NCT00413062|538212906|FG000|Overall Study|Pregnancy|15|||
149203698|NCT00413062|538212907|FG001|Overall Study|Pregnancy|5|||
149203699|NCT00413062|538212906|FG000|Overall Study|Pregnancy wish|17|||
149203700|NCT00413062|538212907|FG001|Overall Study|Pregnancy wish|6|||
149203701|NCT00413062|538212906|FG000|Overall Study|Lost to Follow-up|175|||
149203702|NCT00413062|538212907|FG001|Overall Study|Lost to Follow-up|73|||
149203703|NCT00413062|538212906|FG000|Overall Study|Other reason|70|||
149203704|NCT00413062|538212907|FG001|Overall Study|Other reason|34|||
149203705|NCT02176291|538212908|FG000|Overall Study|Death|1|||
149203706|NCT02176291|538212909|FG001|Overall Study|Death|0|||
149203707|NCT02176291|538212908|FG000|Overall Study|non compliance with protocol|2|||
149203708|NCT02176291|538212909|FG001|Overall Study|non compliance with protocol|0|||
149203709|NCT02176291|538212908|FG000|Overall Study|Withdrawal by Subject|2|||
149203710|NCT02176291|538212909|FG001|Overall Study|Withdrawal by Subject|0|||
149203711|NCT02431468|538212910|FG000|Overall Study|Adverse Event|2|||
149203712|NCT02431468|538212911|FG001|Overall Study|Adverse Event|4|||
149203713|NCT02431468|538212912|FG002|Overall Study|Adverse Event|5|||
149203714|NCT02431468|538212910|FG000|Overall Study|Withdrawal by Subject|4|||
148683147|NCT01827371|536313112|FG003|Overall Study|Physician Decision|1|||
148683148|NCT01827371|536313109|FG000|Overall Study|Temporary study halt to vaccinations|11|||
148683149|NCT01827371|536313110|FG001|Overall Study|Temporary study halt to vaccinations|2|||
148683150|NCT01827371|536313111|FG002|Overall Study|Temporary study halt to vaccinations|5|||
148683151|NCT01827371|536313112|FG003|Overall Study|Temporary study halt to vaccinations|13|||
148683152|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683153|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683154|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683155|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
148683156|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683157|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683158|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683159|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683160|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683161|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
148683162|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148683163|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Adverse Event|1|||
148683164|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Adverse Event|1|||
148683165|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Adverse Event|1|||
148683166|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Adverse Event|1|||
148683167|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Adverse Event|1|||
148683168|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Adverse Event|0|||
148683169|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Adverse Event|0|||
148683170|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Adverse Event|0|||
148683171|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Adverse Event|0|||
148683172|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
148683173|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
148683174|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
148683175|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
148683176|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
148683177|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
148683178|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
148946635|NCT02853604|537288601|FG000|Overall Study|Withdrawal by Subject|12|||
149203715|NCT02431468|538212911|FG001|Overall Study|Withdrawal by Subject|12|||
149203716|NCT02431468|538212912|FG002|Overall Study|Withdrawal by Subject|2|||
148683179|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
148683180|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
148683181|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
149203717|NCT02431468|538212910|FG000|Overall Study|noncompliance, investigator termination,|2|||
149203718|NCT02431468|538212911|FG001|Overall Study|noncompliance, investigator termination,|2|||
149203719|NCT02431468|538212912|FG002|Overall Study|noncompliance, investigator termination,|2|||
149203720|NCT00006604|538212913|FG000|Overall Study|Met study objective - no further FU|1|||
149203721|NCT00006604|538212914|FG001|Overall Study|Met study objective - no further FU|0|||
149203722|NCT00006604|538212915|FG002|Overall Study|Met study objective - no further FU|0|||
149203723|NCT00006604|538212916|FG003|Overall Study|Met study objective - no further FU|0|||
149203724|NCT00006604|538212917|FG004|Overall Study|Met study objective - no further FU|0|||
148808743|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
148808744|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
148808745|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
148808746|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
148808747|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
148808748|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
148946636|NCT02853604|537288602|FG001|Overall Study|Withdrawal by Subject|35|||
148946637|NCT02853604|537288601|FG000|Overall Study|Lost to Follow-up|4|||
148946638|NCT02853604|537288602|FG001|Overall Study|Lost to Follow-up|8|||
148946639|NCT02853604|537288601|FG000|Overall Study|Death|1|||
148946640|NCT02853604|537288602|FG001|Overall Study|Death|5|||
148946641|NCT02853604|537288601|FG000|Overall Study|Miscellaneous|11|||
148946642|NCT02853604|537288602|FG001|Overall Study|Miscellaneous|2|||
148946643|NCT02853604|537288601|FG000|Overall Study|Progressive Disease|0|||
149203725|NCT00006604|538212918|FG005|Overall Study|Met study objective - no further FU|0|||
149203726|NCT00006604|538212919|FG006|Overall Study|Met study objective - no further FU|0|||
149203727|NCT00006604|538212920|FG007|Overall Study|Met study objective - no further FU|0|||
149203728|NCT00006604|538212921|FG008|Overall Study|Met study objective - no further FU|0|||
149203729|NCT00006604|538212922|FG009|Overall Study|Met study objective - no further FU|0|||
149203730|NCT00006604|538212923|FG010|Overall Study|Met study objective - no further FU|0|||
149203731|NCT00006604|538212924|FG011|Overall Study|Met study objective - no further FU|0|||
149203732|NCT00006604|538212925|FG012|Overall Study|Met study objective - no further FU|0|||
149203733|NCT00006604|538212926|FG013|Overall Study|Met study objective - no further FU|0|||
149203734|NCT00006604|538212927|FG014|Overall Study|Met study objective - no further FU|1|||
149203735|NCT00006604|538212928|FG015|Overall Study|Met study objective - no further FU|1|||
149203736|NCT00006604|538212929|FG016|Overall Study|Met study objective - no further FU|0|||
149203737|NCT00006604|538212913|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
149203738|NCT00006604|538212914|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
149203739|NCT00006604|538212915|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
149203740|NCT00006604|538212916|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
149203741|NCT00006604|538212917|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
149203742|NCT00006604|538212918|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
149203743|NCT00006604|538212919|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
149203744|NCT00006604|538212920|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
149203745|NCT00006604|538212921|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
149203746|NCT00006604|538212922|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
149203747|NCT00006604|538212923|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
149203748|NCT00006604|538212924|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
149203749|NCT00006604|538212925|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
149203750|NCT00006604|538212926|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
149203751|NCT00006604|538212927|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
149203752|NCT00006604|538212928|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
149203753|NCT00006604|538212929|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
149203754|NCT00006604|538212913|FG000|Overall Study|Death|0|||
149203755|NCT00006604|538212914|FG001|Overall Study|Death|0|||
149203756|NCT00006604|538212915|FG002|Overall Study|Death|0|||
149203757|NCT00006604|538212916|FG003|Overall Study|Death|0|||
149203758|NCT00006604|538212917|FG004|Overall Study|Death|0|||
149203759|NCT00006604|538212918|FG005|Overall Study|Death|0|||
149203760|NCT00006604|538212919|FG006|Overall Study|Death|0|||
149203761|NCT00006604|538212920|FG007|Overall Study|Death|0|||
149203762|NCT00006604|538212921|FG008|Overall Study|Death|0|||
149203763|NCT00006604|538212922|FG009|Overall Study|Death|1|||
149203764|NCT00006604|538212923|FG010|Overall Study|Death|1|||
149203765|NCT00006604|538212924|FG011|Overall Study|Death|1|||
149203766|NCT00006604|538212925|FG012|Overall Study|Death|0|||
149203767|NCT00006604|538212926|FG013|Overall Study|Death|0|||
149203768|NCT00006604|538212927|FG014|Overall Study|Death|0|||
149203769|NCT00006604|538212928|FG015|Overall Study|Death|0|||
149203770|NCT00006604|538212929|FG016|Overall Study|Death|0|||
149203771|NCT00006604|538212913|FG000|Overall Study|Severe debilitation, unable to continue|0|||
148946644|NCT02853604|537288602|FG001|Overall Study|Progressive Disease|2|||
148946645|NCT04213079|537288603|FG000|Overall Study|Lost to Follow-up|0|||
149203772|NCT00006604|538212914|FG001|Overall Study|Severe debilitation, unable to continue|0|||
149203773|NCT00006604|538212915|FG002|Overall Study|Severe debilitation, unable to continue|0|||
149203774|NCT00006604|538212916|FG003|Overall Study|Severe debilitation, unable to continue|0|||
149203775|NCT00006604|538212917|FG004|Overall Study|Severe debilitation, unable to continue|0|||
149203776|NCT00006604|538212918|FG005|Overall Study|Severe debilitation, unable to continue|0|||
149203777|NCT00006604|538212919|FG006|Overall Study|Severe debilitation, unable to continue|3|||
149203778|NCT00006604|538212920|FG007|Overall Study|Severe debilitation, unable to continue|0|||
149016308|NCT00337662|537537892|FG002|Study Period III|Clinical Relapse|0|||
149016309|NCT00337662|537537893|FG003|Study Period III|Clinical Relapse|0|||
149016310|NCT00882921|537537897|FG000|Overall Study|Death|2|||
149016311|NCT00882921|537537897|FG000|Overall Study|Other|3|||
149016312|NCT00882921|537537897|FG000|Overall Study|Lost to Follow-up|2|||
149016313|NCT00882921|537537897|FG000|Overall Study|Termination By Investigator|3|||
149016314|NCT00882921|537537897|FG000|Overall Study|Withdrawal Of Consent|1|||
149016315|NCT05027074|537537902|FG000|Overall Study|Death|47|||
148683182|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149016316|NCT05027074|537537903|FG001|Overall Study|Death|42|||
148683183|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
149016317|NCT05027074|537537904|FG002|Overall Study|Death|39|||
149203779|NCT00006604|538212921|FG008|Overall Study|Severe debilitation, unable to continue|0|||
149203780|NCT00006604|538212922|FG009|Overall Study|Severe debilitation, unable to continue|5|||
149203781|NCT00006604|538212923|FG010|Overall Study|Severe debilitation, unable to continue|0|||
149203782|NCT00006604|538212924|FG011|Overall Study|Severe debilitation, unable to continue|2|||
149203783|NCT00006604|538212925|FG012|Overall Study|Severe debilitation, unable to continue|1|||
149203784|NCT00006604|538212926|FG013|Overall Study|Severe debilitation, unable to continue|0|||
149203785|NCT00006604|538212927|FG014|Overall Study|Severe debilitation, unable to continue|2|||
149203786|NCT00006604|538212928|FG015|Overall Study|Severe debilitation, unable to continue|0|||
149203787|NCT00006604|538212929|FG016|Overall Study|Severe debilitation, unable to continue|0|||
149203788|NCT00006604|538212913|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
149203789|NCT00006604|538212914|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
149203790|NCT00006604|538212915|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
149203791|NCT00006604|538212916|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
149203792|NCT00006604|538212917|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
149203793|NCT00006604|538212918|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
149203794|NCT00006604|538212919|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
149203795|NCT00006604|538212920|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
149203796|NCT00006604|538212921|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
149203797|NCT00006604|538212922|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
148946646|NCT04213079|537288604|FG001|Overall Study|Lost to Follow-up|2|||
149203798|NCT00006604|538212923|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
149203799|NCT00006604|538212924|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
149203800|NCT00006604|538212925|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
149203801|NCT00006604|538212926|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
149203802|NCT00006604|538212927|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
149203803|NCT00006604|538212928|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
149203804|NCT00006604|538212929|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
149203805|NCT00006604|538212913|FG000|Overall Study|Site closing|0|||
149203806|NCT00006604|538212914|FG001|Overall Study|Site closing|0|||
149203807|NCT00006604|538212915|FG002|Overall Study|Site closing|1|||
149203808|NCT00006604|538212916|FG003|Overall Study|Site closing|1|||
149203809|NCT00006604|538212917|FG004|Overall Study|Site closing|0|||
149203810|NCT00006604|538212918|FG005|Overall Study|Site closing|0|||
149203811|NCT00006604|538212919|FG006|Overall Study|Site closing|0|||
149203812|NCT00006604|538212920|FG007|Overall Study|Site closing|1|||
149203813|NCT00006604|538212921|FG008|Overall Study|Site closing|0|||
149203814|NCT00006604|538212922|FG009|Overall Study|Site closing|0|||
149203815|NCT00006604|538212923|FG010|Overall Study|Site closing|0|||
149203816|NCT00006604|538212924|FG011|Overall Study|Site closing|1|||
149203817|NCT00006604|538212925|FG012|Overall Study|Site closing|1|||
149203818|NCT00006604|538212926|FG013|Overall Study|Site closing|1|||
149203819|NCT00006604|538212927|FG014|Overall Study|Site closing|0|||
149203820|NCT00006604|538212928|FG015|Overall Study|Site closing|0|||
149203821|NCT00006604|538212929|FG016|Overall Study|Site closing|1|||
149203822|NCT00006604|538212913|FG000|Overall Study|Withdrawal by Subject|1|||
149203823|NCT00006604|538212914|FG001|Overall Study|Withdrawal by Subject|0|||
149203824|NCT00006604|538212915|FG002|Overall Study|Withdrawal by Subject|2|||
149203825|NCT00006604|538212916|FG003|Overall Study|Withdrawal by Subject|0|||
149203826|NCT00006604|538212917|FG004|Overall Study|Withdrawal by Subject|1|||
149203827|NCT00006604|538212918|FG005|Overall Study|Withdrawal by Subject|2|||
149203828|NCT00006604|538212919|FG006|Overall Study|Withdrawal by Subject|2|||
149203829|NCT00006604|538212920|FG007|Overall Study|Withdrawal by Subject|0|||
149203830|NCT00006604|538212921|FG008|Overall Study|Withdrawal by Subject|1|||
149203831|NCT00006604|538212922|FG009|Overall Study|Withdrawal by Subject|3|||
149203832|NCT00006604|538212923|FG010|Overall Study|Withdrawal by Subject|2|||
149203833|NCT00006604|538212924|FG011|Overall Study|Withdrawal by Subject|0|||
149203834|NCT00006604|538212925|FG012|Overall Study|Withdrawal by Subject|1|||
149203835|NCT00006604|538212926|FG013|Overall Study|Withdrawal by Subject|2|||
149203836|NCT00006604|538212927|FG014|Overall Study|Withdrawal by Subject|1|||
149203837|NCT00006604|538212928|FG015|Overall Study|Withdrawal by Subject|0|||
149203838|NCT00006604|538212929|FG016|Overall Study|Withdrawal by Subject|1|||
149203839|NCT00006604|538212913|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
149203840|NCT00006604|538212914|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
148808749|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
148808750|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
148946647|NCT01061177|537288610|FG000|Overall Study|Adverse Event|117|||
148946648|NCT01061177|537288610|FG000|Overall Study|Withdrawal by Subject|27|||
149203841|NCT00006604|538212915|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
149203842|NCT00006604|538212916|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
149203843|NCT00006604|538212917|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
149203844|NCT00006604|538212918|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
149203845|NCT00006604|538212919|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
149203846|NCT00006604|538212920|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
149203847|NCT00006604|538212921|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
149203848|NCT00006604|538212922|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
149203849|NCT00006604|538212923|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
149203850|NCT00006604|538212924|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
149203851|NCT00006604|538212925|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
149203852|NCT00006604|538212926|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
149203853|NCT00006604|538212927|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
148946649|NCT01061177|537288610|FG000|Overall Study|Disease progression|17|||
148946650|NCT01061177|537288610|FG000|Overall Study|Protocol Violation|11|||
149203854|NCT00006604|538212928|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
149203855|NCT00006604|538212929|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
149203856|NCT00006604|538212913|FG000|Overall Study|Lost to Follow-up|0|||
149203857|NCT00006604|538212914|FG001|Overall Study|Lost to Follow-up|0|||
149203858|NCT00006604|538212915|FG002|Overall Study|Lost to Follow-up|0|||
149203859|NCT00006604|538212916|FG003|Overall Study|Lost to Follow-up|0|||
149203860|NCT00006604|538212917|FG004|Overall Study|Lost to Follow-up|0|||
149203861|NCT00006604|538212918|FG005|Overall Study|Lost to Follow-up|0|||
149203862|NCT00006604|538212919|FG006|Overall Study|Lost to Follow-up|0|||
149203863|NCT00006604|538212920|FG007|Overall Study|Lost to Follow-up|1|||
149203864|NCT00006604|538212921|FG008|Overall Study|Lost to Follow-up|0|||
148946651|NCT01061177|537288610|FG000|Overall Study|Lost to Follow-up|9|||
148946652|NCT01061177|537288610|FG000|Overall Study|New cancer therapy|9|||
148946653|NCT01061177|537288610|FG000|Overall Study|Abnormal laboratory values|6|||
148946654|NCT01061177|537288610|FG000|Overall Study|Abnormal test procedure results|4|||
148946655|NCT01061177|537288610|FG000|Overall Study|Administratie problems|4|||
148946656|NCT01061177|537288610|FG000|Overall Study|Death|4|||
148946657|NCT04220866|537288611|FG000|Overall Study|Death|4|||
148946658|NCT04220866|537288612|FG001|Overall Study|Death|5|||
148946659|NCT04220866|537288611|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
148946660|NCT04220866|537288612|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
148946661|NCT04220866|537288611|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
148946662|NCT04220866|537288612|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
148946663|NCT04220866|537288611|FG000|Overall Study|Withdrawal by Subject|0|||
149203865|NCT00006604|538212922|FG009|Overall Study|Lost to Follow-up|2|||
148946664|NCT04220866|537288612|FG001|Overall Study|Withdrawal by Subject|1|||
148946665|NCT03858309|537288613|FG000|Overall Study|Withdrawal by Subject|2|||
148946666|NCT03858309|537288614|FG001|Overall Study|Withdrawal by Subject|3|||
149203866|NCT00006604|538212923|FG010|Overall Study|Lost to Follow-up|0|||
148946667|NCT00847379|537288615|FG000|Overall Study|Study terminated by Sponsor|59|||
149203867|NCT00006604|538212924|FG011|Overall Study|Lost to Follow-up|0|||
149203868|NCT00006604|538212925|FG012|Overall Study|Lost to Follow-up|0|||
149203869|NCT00006604|538212926|FG013|Overall Study|Lost to Follow-up|0|||
149203870|NCT00006604|538212927|FG014|Overall Study|Lost to Follow-up|0|||
149203871|NCT00006604|538212928|FG015|Overall Study|Lost to Follow-up|1|||
149203872|NCT00006604|538212929|FG016|Overall Study|Lost to Follow-up|3|||
149203873|NCT00006604|538212913|FG000|Overall Study|Other Reason|0|||
148946668|NCT00847379|537288616|FG001|Overall Study|Study terminated by Sponsor|57|||
149203874|NCT00006604|538212914|FG001|Overall Study|Other Reason|0|||
148946669|NCT00847379|537288617|FG002|Overall Study|Study terminated by Sponsor|57|||
148946670|NCT00378378|537288620|FG000|Overall Study|Withdrawal by Subject|0|||
149203875|NCT00006604|538212915|FG002|Overall Study|Other Reason|0|||
149203876|NCT00006604|538212916|FG003|Overall Study|Other Reason|0|||
149203877|NCT00006604|538212917|FG004|Overall Study|Other Reason|0|||
148946671|NCT00378378|537288621|FG001|Overall Study|Withdrawal by Subject|1|||
148946672|NCT00378378|537288622|FG002|Overall Study|Withdrawal by Subject|0|||
148946673|NCT00378378|537288620|FG000|Overall Study|Treatment Failure|0|||
148946674|NCT00378378|537288621|FG001|Overall Study|Treatment Failure|0|||
148946675|NCT00378378|537288622|FG002|Overall Study|Treatment Failure|1|||
148946676|NCT00378378|537288620|FG000|Overall Study|Non-compliance with protocol|0|||
148946677|NCT00378378|537288621|FG001|Overall Study|Non-compliance with protocol|0|||
148946678|NCT00378378|537288622|FG002|Overall Study|Non-compliance with protocol|1|||
148946679|NCT00407797|537288623|FG000|Overall Study|Lost to Follow-up|2|||
148946680|NCT00407797|537288623|FG000|Overall Study|Adverse Event|6|||
148946681|NCT00407797|537288623|FG000|Overall Study|Other|7|||
148946682|NCT00407797|537288623|FG000|Overall Study|Withdrawal by Subject|3|||
148946683|NCT01812174|537288624|FG000|Overall Study|Death|1|||
148946684|NCT01812174|537288625|FG001|Overall Study|Death|0|||
148946685|NCT01812174|537288624|FG000|Overall Study|Protocol Violation|2|||
148946686|NCT01812174|537288625|FG001|Overall Study|Protocol Violation|0|||
148946687|NCT03132220|537288628|FG000|Overall Study|Lost to Follow-up|17|||
148946688|NCT03132220|537288629|FG001|Overall Study|Lost to Follow-up|8|||
148946689|NCT03132220|537288628|FG000|Overall Study|Withdrawal by Subject|1|||
148946690|NCT03132220|537288629|FG001|Overall Study|Withdrawal by Subject|4|||
148946691|NCT00518986|537288630|FG000|Overall Study|Adverse Event|12|||
148946692|NCT00518986|537288631|FG001|Overall Study|Adverse Event|7|||
148946693|NCT00518986|537288630|FG000|Overall Study|Lack of Efficacy|0|||
148946694|NCT00518986|537288631|FG001|Overall Study|Lack of Efficacy|2|||
148946695|NCT00518986|537288630|FG000|Overall Study|Lost to Follow-up|3|||
148946696|NCT00518986|537288631|FG001|Overall Study|Lost to Follow-up|2|||
148946697|NCT00518986|537288630|FG000|Overall Study|Physician Decision|0|||
148946698|NCT00518986|537288631|FG001|Overall Study|Physician Decision|3|||
148946699|NCT00518986|537288630|FG000|Overall Study|Protocol Violation|5|||
148946700|NCT00518986|537288631|FG001|Overall Study|Protocol Violation|7|||
148946701|NCT00518986|537288630|FG000|Overall Study|Withdrawal by Subject|4|||
148946702|NCT00518986|537288631|FG001|Overall Study|Withdrawal by Subject|4|||
148946703|NCT00518986|537288630|FG000|Overall Study|Non-Specific|2|||
148946704|NCT00518986|537288631|FG001|Overall Study|Non-Specific|1|||
148946705|NCT01328431|537288632|FG000|Baseline|Protocol Violation|0|||
148946706|NCT01328431|537288633|FG001|Baseline|Protocol Violation|2|||
148946707|NCT01328431|537288632|FG000|1 Month (1M)|Lost to Follow-up|55|||
148946708|NCT01328431|537288633|FG001|1 Month (1M)|Lost to Follow-up|58|||
148946709|NCT01328431|537288632|FG000|3 Month (3M)|Death|2|||
148946710|NCT01328431|537288633|FG001|3 Month (3M)|Death|2|||
148946711|NCT01328431|537288632|FG000|3 Month (3M)|Lost to Follow-up|75|||
148946712|NCT01328431|537288633|FG001|3 Month (3M)|Lost to Follow-up|70|||
148946713|NCT01328431|537288632|FG000|12 Month (12M)|Death|2|||
148946714|NCT01328431|537288633|FG001|12 Month (12M)|Death|6|||
148946715|NCT01328431|537288632|FG000|12 Month (12M)|Lost to Follow-up|82|||
148946716|NCT01328431|537288633|FG001|12 Month (12M)|Lost to Follow-up|91|||
148946717|NCT00393029|537288638|FG000|Overall Study|Not treated|0|||
148946718|NCT00393029|537288639|FG001|Overall Study|Not treated|1|||
148946719|NCT02612727|537288640|FG000|Overall Study|Parent request|4|||
148946720|NCT02612727|537288641|FG001|Overall Study|Parent request|1|||
148946721|NCT02612727|537288640|FG000|Overall Study|Needed treatment incompatible with PT|1|||
148946722|NCT02612727|537288641|FG001|Overall Study|Needed treatment incompatible with PT|1|||
148946723|NCT02612727|537288640|FG000|Overall Study|Direct hyperbilirubinemia|0|||
148946724|NCT02612727|537288641|FG001|Overall Study|Direct hyperbilirubinemia|2|||
148946725|NCT00612690|537290142|FG000|Overall Study|Lost to Follow-up|72|||
148946726|NCT00612690|537290143|FG001|Overall Study|Lost to Follow-up|98|||
148946727|NCT00612690|537290142|FG000|Overall Study|Withdrawal by Subject|32|||
148946728|NCT00612690|537290143|FG001|Overall Study|Withdrawal by Subject|20|||
148946729|NCT00612690|537290142|FG000|Overall Study|Withdrawal by Site|11|||
148946730|NCT00612690|537290143|FG001|Overall Study|Withdrawal by Site|0|||
148946731|NCT01664533|537290144|FG000|Overall Study|Death|42|||
148946732|NCT01664533|537290144|FG000|Overall Study|Lost to Follow-up|3|||
148946733|NCT01664533|537290144|FG000|Overall Study|Study termination|9|||
148946734|NCT01664533|537290144|FG000|Overall Study|Protocol Violation|3|||
149016318|NCT05027074|537537902|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148946735|NCT05255068|537290146|FG000|Overall Study|Lost to Follow-up|0|||
148946736|NCT05255068|537290147|FG001|Overall Study|Lost to Follow-up|1|||
148946737|NCT00540514|537290149|FG000|Overall Study|Still on treatment|3|||
148946738|NCT00540514|537290150|FG001|Overall Study|Still on treatment|0|||
148946739|NCT00540514|537290149|FG000|Overall Study|Unacceptable Toxicity|61|||
148946740|NCT00540514|537290150|FG001|Overall Study|Unacceptable Toxicity|62|||
148946741|NCT00540514|537290149|FG000|Overall Study|Adverse Event|20|||
148946742|NCT00540514|537290150|FG001|Overall Study|Adverse Event|24|||
148946743|NCT00540514|537290149|FG000|Overall Study|Physician Decision|86|||
148946744|NCT00540514|537290150|FG001|Overall Study|Physician Decision|99|||
148946745|NCT00540514|537290149|FG000|Overall Study|Protocol Deviation|3|||
148946746|NCT00540514|537290150|FG001|Overall Study|Protocol Deviation|4|||
148946747|NCT00540514|537290149|FG000|Overall Study|Lost to Follow-up|1|||
148946748|NCT00540514|537290150|FG001|Overall Study|Lost to Follow-up|1|||
148946749|NCT00540514|537290149|FG000|Overall Study|Withdrawal by Subject|65|||
148946750|NCT00540514|537290150|FG001|Overall Study|Withdrawal by Subject|67|||
148946751|NCT00540514|537290149|FG000|Overall Study|Excluded prior to treatment|7|||
148946752|NCT00540514|537290150|FG001|Overall Study|Excluded prior to treatment|7|||
148946753|NCT00540514|537290149|FG000|Overall Study|Paclitaxel not available|0|||
148946754|NCT00540514|537290150|FG001|Overall Study|Paclitaxel not available|2|||
148946755|NCT03291808|537290151|FG000|Overall Study|Lost to Follow-up|6|||
148946756|NCT03291808|537290151|FG000|Overall Study|Research burden|4|||
148946757|NCT02397278|537290158|FG000|Overall Study|Withdrawal by Subject|0|||
148946758|NCT02397278|537290159|FG001|Overall Study|Withdrawal by Subject|2|||
148946759|NCT02397278|537290158|FG000|Overall Study|Deemed ineligible following surgery|1|||
148946760|NCT02397278|537290159|FG001|Overall Study|Deemed ineligible following surgery|1|||
148946761|NCT02161731|537290161|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
148946762|NCT02161731|537290162|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
148946763|NCT02161731|537290161|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
148946764|NCT02161731|537290162|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
148946765|NCT02468414|537290163|FG000|Overall Study|Early Study Termination by Sponsor|1|||
148946766|NCT02468414|537290164|FG001|Overall Study|Early Study Termination by Sponsor|0|||
148946767|NCT02468414|537290163|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
148946768|NCT02468414|537290164|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
148946769|NCT02468414|537290163|FG000|Overall Study|Screen Failure|1|||
148946770|NCT02468414|537290164|FG001|Overall Study|Screen Failure|0|||
148946771|NCT00004978|537290165|FG000|Overall Study|Death|107|||
148946772|NCT00004978|537290166|FG001|Overall Study|Death|116|||
148946773|NCT00004978|537290165|FG000|Overall Study|Lost to Follow-up|101|||
148946774|NCT00004978|537290166|FG001|Overall Study|Lost to Follow-up|108|||
148946775|NCT00004978|537290165|FG000|Overall Study|Withdrawal by Subject|17|||
148683184|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
148683185|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
148946776|NCT00004978|537290166|FG001|Overall Study|Withdrawal by Subject|26|||
148946777|NCT00004978|537290165|FG000|Overall Study|site closure - not in analysis cohort|19|||
148946778|NCT00004978|537290166|FG001|Overall Study|site closure - not in analysis cohort|20|||
148946779|NCT01652703|537290167|FG000|Overall Study|Withdrawal by Subject|0|||
148946780|NCT01652703|537290168|FG001|Overall Study|Withdrawal by Subject|1|||
148946781|NCT01652703|537290169|FG002|Overall Study|Withdrawal by Subject|3|||
148946782|NCT01652703|537290170|FG003|Overall Study|Withdrawal by Subject|1|||
148946783|NCT01652703|537290171|FG004|Overall Study|Withdrawal by Subject|0|||
148946784|NCT01652703|537290172|FG005|Overall Study|Withdrawal by Subject|1|||
148946785|NCT01652703|537290167|FG000|Overall Study|Other|0|||
148946786|NCT01652703|537290168|FG001|Overall Study|Other|0|||
148946787|NCT01652703|537290169|FG002|Overall Study|Other|0|||
148946788|NCT01652703|537290170|FG003|Overall Study|Other|1|||
148946789|NCT01652703|537290171|FG004|Overall Study|Other|1|||
148946790|NCT01652703|537290172|FG005|Overall Study|Other|1|||
148946791|NCT00062374|537290176|FG000|Overall Study|Not treated|12|||
148946792|NCT02155608|537290177|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
148946793|NCT02155608|537290178|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
148946794|NCT02155608|537290177|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
148946795|NCT02155608|537290178|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
148946796|NCT03217175|537290184|FG000|Overall Study|Physician Decision|4|||
148946797|NCT03217175|537290185|FG001|Overall Study|Physician Decision|1|||
148946798|NCT01539538|537290186|FG000|Overall Study|Adverse Event|13|||
148946799|NCT01539538|537290187|FG001|Overall Study|Adverse Event|18|||
148946800|NCT01539538|537290186|FG000|Overall Study|Lack of Efficacy|13|||
148946801|NCT01539538|537290187|FG001|Overall Study|Lack of Efficacy|16|||
148946802|NCT01539538|537290186|FG000|Overall Study|Withdrawal by Subject|2|||
148946803|NCT01539538|537290187|FG001|Overall Study|Withdrawal by Subject|3|||
148946804|NCT01539538|537290186|FG000|Overall Study|PCA no longer required or PCA problem|3|||
148946805|NCT01539538|537290187|FG001|Overall Study|PCA no longer required or PCA problem|7|||
148946806|NCT04390191|537290188|FG000|Overall Study|Withdrawal by Subject|1|||
148946807|NCT04390191|537290189|FG001|Overall Study|Withdrawal by Subject|0|||
148946808|NCT03978832|537290190|FG000|Overall Study|Adverse Event|1|||
148946809|NCT03978832|537290190|FG000|Overall Study|Lost to Follow-up|1|||
148946810|NCT03978832|537290190|FG000|Overall Study|Withdrawal by Subject|6|||
149203878|NCT00006604|538212918|FG005|Overall Study|Other Reason|1|||
149203879|NCT00006604|538212919|FG006|Overall Study|Other Reason|0|||
149203880|NCT00006604|538212920|FG007|Overall Study|Other Reason|0|||
149203881|NCT00006604|538212921|FG008|Overall Study|Other Reason|0|||
149203882|NCT00006604|538212922|FG009|Overall Study|Other Reason|1|||
149203883|NCT00006604|538212923|FG010|Overall Study|Other Reason|0|||
149203884|NCT00006604|538212924|FG011|Overall Study|Other Reason|0|||
149203885|NCT00006604|538212925|FG012|Overall Study|Other Reason|0|||
149203886|NCT00006604|538212926|FG013|Overall Study|Other Reason|0|||
149203887|NCT00006604|538212927|FG014|Overall Study|Other Reason|0|||
149203888|NCT00006604|538212928|FG015|Overall Study|Other Reason|0|||
149203889|NCT00006604|538212929|FG016|Overall Study|Other Reason|0|||
149203890|NCT02157506|538212934|FG000|Overall Study|Adverse Event|0|||
148683186|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
148683187|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
148683188|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
148683189|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
148683190|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
148683191|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
148683192|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
148683193|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
148683194|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683195|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683196|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683197|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683198|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683199|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
148683200|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683201|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683202|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
148683203|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
148683204|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
148683205|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
148683206|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
148683207|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
148946811|NCT03978832|537290190|FG000|Overall Study|Physician Decision|2|||
148946812|NCT03978832|537290190|FG000|Overall Study|did not pass screening criteria|44|||
148946813|NCT00003499|537290191|FG000|Overall Study|Not evaluable|8|||
149203891|NCT02157506|538212935|FG001|Overall Study|Adverse Event|1|||
149203892|NCT02157506|538212936|FG002|Overall Study|Adverse Event|0|||
149203893|NCT02157506|538212937|FG003|Overall Study|Adverse Event|0|||
149203894|NCT02157506|538212938|FG004|Overall Study|Adverse Event|0|||
148946814|NCT02864498|537290196|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
148946815|NCT02864498|537290197|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
148946816|NCT02864498|537290198|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
148946817|NCT02864498|537290196|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
149203895|NCT02157506|538212934|FG000|Overall Study|Lost to Follow-up|0|||
149203896|NCT02157506|538212935|FG001|Overall Study|Lost to Follow-up|0|||
149203897|NCT02157506|538212936|FG002|Overall Study|Lost to Follow-up|1|||
148946818|NCT02864498|537290197|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
148946819|NCT02864498|537290198|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
148946820|NCT02864498|537290196|FG000|Overall Study|Investigator Discretion|0|||
148946821|NCT02864498|537290197|FG001|Overall Study|Investigator Discretion|2|||
148946822|NCT02864498|537290198|FG002|Overall Study|Investigator Discretion|1|||
148946823|NCT02864498|537290196|FG000|Overall Study|Lost to Follow-up|8|||
148946824|NCT02864498|537290197|FG001|Overall Study|Lost to Follow-up|6|||
148946825|NCT02864498|537290198|FG002|Overall Study|Lost to Follow-up|3|||
148946826|NCT02864498|537290196|FG000|Overall Study|Lack of Efficacy|5|||
148946827|NCT02864498|537290197|FG001|Overall Study|Lack of Efficacy|3|||
148946828|NCT02864498|537290198|FG002|Overall Study|Lack of Efficacy|3|||
148946829|NCT02864498|537290196|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
148946830|NCT02864498|537290197|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
148946831|NCT02864498|537290198|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
148946832|NCT02864498|537290196|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
148946833|NCT02864498|537290197|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
148946834|NCT02864498|537290198|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
148946835|NCT02864498|537290196|FG000|Overall Study|Subject moved out of the country.|0|||
148946836|NCT02864498|537290197|FG001|Overall Study|Subject moved out of the country.|0|||
148946837|NCT02864498|537290198|FG002|Overall Study|Subject moved out of the country.|1|||
148946838|NCT01256008|537290199|FG000|Overall Study|Lost to Follow-up|6|||
148946839|NCT01256008|537290200|FG001|Overall Study|Lost to Follow-up|4|||
148946840|NCT01256008|537290201|FG002|Overall Study|Lost to Follow-up|11|||
148946841|NCT01256008|537290199|FG000|Overall Study|Withdrawal by Subject|2|||
148946842|NCT01256008|537290200|FG001|Overall Study|Withdrawal by Subject|3|||
148946843|NCT01256008|537290201|FG002|Overall Study|Withdrawal by Subject|10|||
148946844|NCT01854710|537290212|FG000|Overall Study|Withdrawal by Subject|2|||
148946845|NCT01854710|537290213|FG001|Overall Study|Withdrawal by Subject|1|||
148946846|NCT01854710|537290214|FG002|Overall Study|Withdrawal by Subject|0|||
148946847|NCT01854710|537290215|FG003|Overall Study|Withdrawal by Subject|0|||
149203898|NCT02157506|538212937|FG003|Overall Study|Lost to Follow-up|0|||
149203899|NCT02157506|538212938|FG004|Overall Study|Lost to Follow-up|0|||
149203900|NCT03448224|538212939|FG000|Overall Study|Provided same answer to every question|1|||
149203901|NCT03448224|538212940|FG001|Overall Study|Provided same answer to every question|0|||
149203902|NCT03103906|538212941|FG000|Overall Study|Adverse Event|2|||
149203903|NCT03103906|538212942|FG001|Overall Study|Adverse Event|3|||
149203904|NCT03103906|538212941|FG000|Overall Study|Other|2|||
149203905|NCT03103906|538212942|FG001|Overall Study|Other|0|||
149203906|NCT00764478|538212943|FG000|Overall Study|Adverse Event|1|||
149203907|NCT00764478|538212944|FG001|Overall Study|Adverse Event|1|||
149203908|NCT00764478|538212945|FG002|Overall Study|Adverse Event|1|||
149203909|NCT00764478|538212943|FG000|Overall Study|Withdrawal by Subject|7|||
149203910|NCT00764478|538212944|FG001|Overall Study|Withdrawal by Subject|12|||
149203911|NCT00764478|538212945|FG002|Overall Study|Withdrawal by Subject|1|||
149203912|NCT00764478|538212943|FG000|Overall Study|Lost to Follow-up|7|||
149203913|NCT00764478|538212944|FG001|Overall Study|Lost to Follow-up|8|||
149203914|NCT00764478|538212945|FG002|Overall Study|Lost to Follow-up|5|||
149203915|NCT00764478|538212943|FG000|Overall Study|Protocol Violation|0|||
149203916|NCT00764478|538212944|FG001|Overall Study|Protocol Violation|1|||
149203917|NCT00764478|538212945|FG002|Overall Study|Protocol Violation|1|||
149203918|NCT00643604|538212948|FG000|Overall Study|Death|1|||
149203919|NCT02702011|538212949|FG000|Overall Study|Withdrawal by Subject|0|||
149203920|NCT02702011|538212950|FG001|Overall Study|Withdrawal by Subject|1|||
149203921|NCT02702011|538212951|FG002|Overall Study|Withdrawal by Subject|0|||
149203922|NCT02702011|538212952|FG003|Overall Study|Withdrawal by Subject|0|||
149203923|NCT03498287|538212956|FG000|Overall Study|Withdrawal by Subject|3|||
148946848|NCT01854710|537290216|FG004|Overall Study|Withdrawal by Subject|0|||
148946849|NCT01854710|537290217|FG005|Overall Study|Withdrawal by Subject|0|||
148946850|NCT01854710|537290212|FG000|Overall Study|CRI procedural error|2|||
148946851|NCT01854710|537290213|FG001|Overall Study|CRI procedural error|2|||
148946852|NCT01854710|537290214|FG002|Overall Study|CRI procedural error|2|||
148946853|NCT01854710|537290215|FG003|Overall Study|CRI procedural error|2|||
148946854|NCT01854710|537290216|FG004|Overall Study|CRI procedural error|2|||
148946855|NCT01854710|537290217|FG005|Overall Study|CRI procedural error|2|||
148946856|NCT00730132|537290218|FG000|Overall Study|Protocol Violation|154|||
148946857|NCT00730132|537290218|FG000|Overall Study|Death|1|||
148946858|NCT02296320|537290220|FG000|Overall Study|Withdrawal by Subject|4|||
149203924|NCT03498287|538212957|FG001|Overall Study|Withdrawal by Subject|0|||
149203925|NCT03498287|538212956|FG000|Overall Study|Protocol Violation|0|||
149203926|NCT03498287|538212957|FG001|Overall Study|Protocol Violation|4|||
149203927|NCT03498287|538212956|FG000|Overall Study|Adverse Event|0|||
149203928|NCT03498287|538212957|FG001|Overall Study|Adverse Event|1|||
149203929|NCT01740388|538212960|FG000|Overall Study|Withdrawal by Subject|1|||
149203930|NCT01740388|538212961|FG001|Overall Study|Withdrawal by Subject|2|||
149203931|NCT01740388|538212960|FG000|Overall Study|Lost to Follow-up|2|||
149203932|NCT01740388|538212961|FG001|Overall Study|Lost to Follow-up|0|||
149203933|NCT01740388|538212960|FG000|Overall Study|Physician Decision|2|||
149203934|NCT01740388|538212961|FG001|Overall Study|Physician Decision|6|||
149203935|NCT01740388|538212960|FG000|Overall Study|Subjects missing data, completed|41|||
149203936|NCT01740388|538212961|FG001|Overall Study|Subjects missing data, completed|36|||
149203937|NCT04142216|538212962|FG000|Overall Study|Hospitalization|0|||
149203938|NCT04142216|538212963|FG001|Overall Study|Hospitalization|2|||
149203939|NCT04142216|538212962|FG000|Overall Study|Death|3|||
149203940|NCT04142216|538212963|FG001|Overall Study|Death|1|||
149203941|NCT04142216|538212962|FG000|Overall Study|Referral to another hemodialysis unit|3|||
149203942|NCT04142216|538212963|FG001|Overall Study|Referral to another hemodialysis unit|2|||
149203943|NCT04142216|538212962|FG000|Overall Study|Use of clove|0|||
149203944|NCT04142216|538212963|FG001|Overall Study|Use of clove|1|||
149203945|NCT01054976|538212966|FG000|Overall Study|Adverse Event|16|||
149203946|NCT01054976|538212966|FG000|Overall Study|Uncooperative participations to study|7|||
149203947|NCT01054976|538212966|FG000|Overall Study|Withdrawal by Subject|4|||
149203948|NCT01054976|538212966|FG000|Overall Study|Other|8|||
149203949|NCT01641991|538212967|FG000|Overall Study|Physician Decision|0|||
149203950|NCT01641991|538212968|FG001|Overall Study|Physician Decision|1|||
149203951|NCT01641991|538212969|FG002|Overall Study|Physician Decision|7|||
149203952|NCT01641991|538212970|FG003|Overall Study|Physician Decision|5|||
149203953|NCT01641991|538212967|FG000|Overall Study|Withdrawal by Subject|4|||
149203954|NCT01641991|538212968|FG001|Overall Study|Withdrawal by Subject|2|||
149203955|NCT01641991|538212969|FG002|Overall Study|Withdrawal by Subject|1|||
149203956|NCT01641991|538212970|FG003|Overall Study|Withdrawal by Subject|5|||
149203957|NCT01641991|538212967|FG000|Overall Study|Adverse Event|2|||
148683208|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149203958|NCT01641991|538212968|FG001|Overall Study|Adverse Event|1|||
149203959|NCT01641991|538212969|FG002|Overall Study|Adverse Event|2|||
148683209|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
148683210|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
149203960|NCT01641991|538212970|FG003|Overall Study|Adverse Event|1|||
149203961|NCT01641991|538212967|FG000|Overall Study|Lost to Follow-up|0|||
149203962|NCT01641991|538212968|FG001|Overall Study|Lost to Follow-up|2|||
149203963|NCT01641991|538212969|FG002|Overall Study|Lost to Follow-up|3|||
149203964|NCT01641991|538212970|FG003|Overall Study|Lost to Follow-up|1|||
149203965|NCT01641991|538212967|FG000|Overall Study|Protocol Violation|1|||
149203966|NCT01641991|538212968|FG001|Overall Study|Protocol Violation|1|||
149203967|NCT01641991|538212969|FG002|Overall Study|Protocol Violation|3|||
149203968|NCT01641991|538212970|FG003|Overall Study|Protocol Violation|0|||
149203969|NCT01641991|538212967|FG000|Overall Study|Pregnancy|0|||
148683211|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
148683212|NCT00950599|536313114|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
148683213|NCT00950599|536313115|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
148683214|NCT00950599|536313116|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
148683215|NCT00950599|536313117|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
148683216|NCT00950599|536313118|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
148683217|NCT00950599|536313119|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
148683218|NCT00950599|536313120|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
148683219|NCT00950599|536313121|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
148683220|NCT00950599|536313122|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
149016319|NCT05027074|537537903|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149016320|NCT05027074|537537904|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149203970|NCT01641991|538212968|FG001|Overall Study|Pregnancy|0|||
149203971|NCT01641991|538212969|FG002|Overall Study|Pregnancy|1|||
149203972|NCT01641991|538212970|FG003|Overall Study|Pregnancy|0|||
149203973|NCT01641991|538212967|FG000|Overall Study|no longer eligible|2|||
149203974|NCT01641991|538212968|FG001|Overall Study|no longer eligible|1|||
149203975|NCT01641991|538212969|FG002|Overall Study|no longer eligible|0|||
149203976|NCT01641991|538212970|FG003|Overall Study|no longer eligible|4|||
149203977|NCT02555657|538212971|FG000|Overall Study|Death|274|||
149203978|NCT02555657|538212972|FG001|Overall Study|Death|262|||
149203979|NCT02555657|538212971|FG000|Overall Study|Physician Decision|0|||
149203980|NCT02555657|538212972|FG001|Overall Study|Physician Decision|1|||
149203981|NCT02555657|538212971|FG000|Overall Study|Sponsor Decision|27|||
149203982|NCT02555657|538212972|FG001|Overall Study|Sponsor Decision|15|||
149203983|NCT02555657|538212971|FG000|Overall Study|Withdrawal by Subject|11|||
149203984|NCT02555657|538212972|FG001|Overall Study|Withdrawal by Subject|32|||
149203985|NCT01578785|538212980|FG000|Overall Study|Withdrawal by Subject|0|||
149203986|NCT01578785|538212981|FG001|Overall Study|Withdrawal by Subject|1|||
149203987|NCT01578785|538212980|FG000|Overall Study|Study terminated by sponsor|59|||
149203988|NCT01578785|538212981|FG001|Overall Study|Study terminated by sponsor|118|||
149203989|NCT01164865|538212982|FG000|Overall Study|Lost to Follow-up|2|||
149203990|NCT01164865|538212983|FG001|Overall Study|Lost to Follow-up|1|||
149203991|NCT00599027|538212984|FG000|Overall Study|Withdrawal by Subject|1|||
149203992|NCT00599027|538212985|FG001|Overall Study|Withdrawal by Subject|1|||
149203993|NCT00599027|538212984|FG000|Overall Study|Adverse Event|0|||
149203994|NCT00599027|538212985|FG001|Overall Study|Adverse Event|1|||
149203995|NCT00599027|538212984|FG000|Overall Study|Treatment Failure|0|||
149203996|NCT00599027|538212985|FG001|Overall Study|Treatment Failure|1|||
149203997|NCT00475540|538212986|FG000|36 Months|Lost to Follow-up|4|||
149203998|NCT00475540|538212987|FG001|36 Months|Lost to Follow-up|4|||
149203999|NCT00475540|538212986|FG000|36 Months|Death|1|||
149204000|NCT00475540|538212987|FG001|36 Months|Death|2|||
149204001|NCT00475540|538212986|FG000|36 Months|Censored due to reoperation|3|||
149204002|NCT00475540|538212987|FG001|36 Months|Censored due to reoperation|0|||
149204003|NCT02133742|538213008|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
149204004|NCT02133742|538213008|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
149204005|NCT02133742|538213008|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
149204006|NCT02133742|538213008|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
149204007|NCT02133742|538213008|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
149204008|NCT03479216|538213009|FG000|Overall Study|Withdrawal by Subject|3|||
149204009|NCT03479216|538213010|FG001|Overall Study|Withdrawal by Subject|2|||
149204010|NCT03479216|538213009|FG000|Overall Study|Physician Decision|2|||
149204011|NCT03479216|538213010|FG001|Overall Study|Physician Decision|3|||
149204012|NCT01265420|538213011|FG000|Overall Study|Lost to Follow-up|1|||
149204013|NCT02554253|538213012|FG000|Overall Study|ineligible after enrollment|1|||
149204014|NCT02554253|538213013|FG001|Overall Study|ineligible after enrollment|0|||
149204015|NCT02554253|538213012|FG000|Overall Study|converted to transcatheter procedure|0|||
149204016|NCT02554253|538213013|FG001|Overall Study|converted to transcatheter procedure|1|||
149204017|NCT02554253|538213012|FG000|Overall Study|received both drugs|0|||
149204018|NCT02554253|538213013|FG001|Overall Study|received both drugs|1|||
148683221|NCT00950599|536313123|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
148683222|NCT00950599|536313114|FG000|Follow-Up Period|Adverse Event|0|||
148683223|NCT00950599|536313115|FG001|Follow-Up Period|Adverse Event|0|||
149204019|NCT01736254|538213015|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
149204020|NCT01736254|538213015|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
149204021|NCT02559206|538213016|FG000|Overall Study|Adverse Event|0|||
149204022|NCT02559206|538213017|FG001|Overall Study|Adverse Event|4|||
149204023|NCT02559206|538213018|FG002|Overall Study|Adverse Event|1|||
149204024|NCT02559206|538213019|FG003|Overall Study|Adverse Event|5|||
148683224|NCT00950599|536313116|FG002|Follow-Up Period|Adverse Event|0|||
148683225|NCT00950599|536313117|FG003|Follow-Up Period|Adverse Event|0|||
148683226|NCT00950599|536313118|FG004|Follow-Up Period|Adverse Event|0|||
148683227|NCT00950599|536313119|FG005|Follow-Up Period|Adverse Event|0|||
149204025|NCT02559206|538213020|FG004|Overall Study|Adverse Event|3|||
149204026|NCT02559206|538213021|FG005|Overall Study|Adverse Event|0|||
149204027|NCT02559206|538213022|FG006|Overall Study|Adverse Event|1|||
149204028|NCT02559206|538213023|FG007|Overall Study|Adverse Event|0|||
149204029|NCT02559206|538213016|FG000|Overall Study|Protocol Violation|1|||
149204030|NCT02559206|538213017|FG001|Overall Study|Protocol Violation|0|||
149204031|NCT02559206|538213018|FG002|Overall Study|Protocol Violation|1|||
149204032|NCT02559206|538213019|FG003|Overall Study|Protocol Violation|0|||
149204033|NCT02559206|538213020|FG004|Overall Study|Protocol Violation|0|||
149204034|NCT02559206|538213021|FG005|Overall Study|Protocol Violation|2|||
149204035|NCT02559206|538213022|FG006|Overall Study|Protocol Violation|0|||
149204036|NCT02559206|538213023|FG007|Overall Study|Protocol Violation|0|||
149204037|NCT02559206|538213016|FG000|Overall Study|Withdrawal by Subject|3|||
149204038|NCT02559206|538213017|FG001|Overall Study|Withdrawal by Subject|3|||
149204039|NCT02559206|538213018|FG002|Overall Study|Withdrawal by Subject|1|||
149204040|NCT02559206|538213019|FG003|Overall Study|Withdrawal by Subject|3|||
149204041|NCT02559206|538213020|FG004|Overall Study|Withdrawal by Subject|5|||
149204042|NCT02559206|538213021|FG005|Overall Study|Withdrawal by Subject|4|||
149204043|NCT02559206|538213022|FG006|Overall Study|Withdrawal by Subject|1|||
149204044|NCT02559206|538213023|FG007|Overall Study|Withdrawal by Subject|2|||
149204045|NCT02559206|538213016|FG000|Overall Study|Lost to Follow-up|3|||
149204046|NCT02559206|538213017|FG001|Overall Study|Lost to Follow-up|5|||
149204047|NCT02559206|538213018|FG002|Overall Study|Lost to Follow-up|3|||
149204048|NCT02559206|538213019|FG003|Overall Study|Lost to Follow-up|3|||
149204049|NCT02559206|538213020|FG004|Overall Study|Lost to Follow-up|2|||
149204050|NCT02559206|538213021|FG005|Overall Study|Lost to Follow-up|5|||
149204051|NCT02559206|538213022|FG006|Overall Study|Lost to Follow-up|1|||
149204052|NCT02559206|538213023|FG007|Overall Study|Lost to Follow-up|4|||
149204053|NCT02559206|538213016|FG000|Overall Study|Lack of Efficacy|1|||
149204054|NCT02559206|538213017|FG001|Overall Study|Lack of Efficacy|0|||
149204055|NCT02559206|538213018|FG002|Overall Study|Lack of Efficacy|3|||
149204056|NCT02559206|538213019|FG003|Overall Study|Lack of Efficacy|2|||
149204057|NCT02559206|538213020|FG004|Overall Study|Lack of Efficacy|2|||
149204058|NCT02559206|538213021|FG005|Overall Study|Lack of Efficacy|3|||
149204059|NCT02559206|538213022|FG006|Overall Study|Lack of Efficacy|3|||
149204060|NCT02559206|538213023|FG007|Overall Study|Lack of Efficacy|3|||
149204061|NCT02559206|538213016|FG000|Overall Study|Other Not Specified|0|||
149204062|NCT02559206|538213017|FG001|Overall Study|Other Not Specified|0|||
149204063|NCT02559206|538213018|FG002|Overall Study|Other Not Specified|0|||
148946859|NCT02296320|537290221|FG001|Overall Study|Withdrawal by Subject|0|||
148946860|NCT02296320|537290222|FG002|Overall Study|Withdrawal by Subject|2|||
149204064|NCT02559206|538213019|FG003|Overall Study|Other Not Specified|1|||
149204065|NCT02559206|538213020|FG004|Overall Study|Other Not Specified|0|||
149204066|NCT02559206|538213021|FG005|Overall Study|Other Not Specified|0|||
149204067|NCT02559206|538213022|FG006|Overall Study|Other Not Specified|0|||
149204068|NCT02559206|538213023|FG007|Overall Study|Other Not Specified|0|||
149204069|NCT03862131|538213024|FG000|Overall Study|Lost to Follow-up|1|||
149204070|NCT03862131|538213025|FG001|Overall Study|Lost to Follow-up|0|||
149204071|NCT03862131|538213026|FG002|Overall Study|Lost to Follow-up|1|||
149204072|NCT03862131|538213024|FG000|Overall Study|Determined to be ineligible|0|||
149204073|NCT03862131|538213025|FG001|Overall Study|Determined to be ineligible|0|||
149204074|NCT03862131|538213026|FG002|Overall Study|Determined to be ineligible|5|||
149204075|NCT03862131|538213024|FG000|Overall Study|Death|4|||
149204076|NCT03862131|538213025|FG001|Overall Study|Death|4|||
149204077|NCT03862131|538213026|FG002|Overall Study|Death|0|||
149204078|NCT03862131|538213024|FG000|Overall Study|Withdrawal by Subject|5|||
149204079|NCT03862131|538213025|FG001|Overall Study|Withdrawal by Subject|3|||
149204080|NCT03862131|538213026|FG002|Overall Study|Withdrawal by Subject|0|||
149204081|NCT03862131|538213024|FG000|Overall Study|Physician Decision|0|||
148946861|NCT02296320|537290220|FG000|Overall Study|Death|24|||
148946862|NCT02296320|537290221|FG001|Overall Study|Death|3|||
148946863|NCT02296320|537290222|FG002|Overall Study|Death|27|||
148946864|NCT02296320|537290220|FG000|Overall Study|Lost to Follow-up|5|||
148946865|NCT02296320|537290221|FG001|Overall Study|Lost to Follow-up|2|||
148946866|NCT02296320|537290222|FG002|Overall Study|Lost to Follow-up|7|||
149204082|NCT03862131|538213025|FG001|Overall Study|Physician Decision|1|||
149204083|NCT03862131|538213026|FG002|Overall Study|Physician Decision|0|||
149204084|NCT00453180|538214916|FG000|Overall Study|Lost to Follow-up|2|||
149204085|NCT00453180|538214917|FG001|Overall Study|Lost to Follow-up|1|||
149204086|NCT00453180|538214916|FG000|Overall Study|Adverse Event|1|||
149204087|NCT00453180|538214917|FG001|Overall Study|Adverse Event|2|||
149204088|NCT03326869|538214923|FG000|Overall Study|Study data has been lost to natural disa|1|||
149204089|NCT03326869|538214924|FG001|Overall Study|Study data has been lost to natural disa|1|||
148946867|NCT02296320|537290220|FG000|Overall Study|Not treated|2|||
148946868|NCT02296320|537290221|FG001|Overall Study|Not treated|0|||
148946869|NCT02296320|537290222|FG002|Overall Study|Not treated|0|||
148946870|NCT02296320|537290220|FG000|Overall Study|Not - specified|0|||
149204090|NCT01002742|538214927|FG000|Overall Study|Determined to be ineligible|0|||
149204091|NCT01002742|538214928|FG001|Overall Study|Determined to be ineligible|1|||
149204092|NCT05263921|538214929|FG000|Overall Study|Other: family emergency.|0|||
149204093|NCT05263921|538214930|FG001|Overall Study|Other: family emergency.|0|||
149204094|NCT05263921|538214931|FG002|Overall Study|Other: family emergency.|1|||
149204095|NCT05263921|538214932|FG003|Overall Study|Other: family emergency.|0|||
149204096|NCT02670928|538214933|FG000|Overall Study|Adverse Event|3|||
149204097|NCT02670928|538214934|FG001|Overall Study|Adverse Event|1|||
149204098|NCT02670928|538214933|FG000|Overall Study|Withdrawal by Subject|4|||
149204099|NCT02670928|538214934|FG001|Overall Study|Withdrawal by Subject|0|||
149204100|NCT02670928|538214933|FG000|Overall Study|Lost to Follow-up|1|||
149204101|NCT02670928|538214934|FG001|Overall Study|Lost to Follow-up|0|||
149204102|NCT02670928|538214933|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
149204103|NCT02670928|538214934|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
149204104|NCT02678312|538214935|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
149204105|NCT02678312|538214936|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149204106|NCT02678312|538214937|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149204107|NCT02678312|538214938|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149204108|NCT02678312|538214939|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
149204109|NCT02678312|538214935|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
149204110|NCT02678312|538214936|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149204111|NCT02678312|538214937|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149204112|NCT02678312|538214938|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149204113|NCT02678312|538214939|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
149204114|NCT02678312|538214935|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
149204115|NCT02678312|538214936|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149204116|NCT02678312|538214937|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149204117|NCT02678312|538214938|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149204118|NCT02678312|538214939|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
149204119|NCT02678312|538214935|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
149204120|NCT02678312|538214936|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
149204121|NCT02678312|538214937|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
149204122|NCT02678312|538214938|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
149204123|NCT02678312|538214939|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
149204124|NCT02678312|538214935|FG000|Part 2 Double Blind Epoch|Death|0|||
149204125|NCT02678312|538214936|FG001|Part 2 Double Blind Epoch|Death|0|||
149204126|NCT02678312|538214937|FG002|Part 2 Double Blind Epoch|Death|0|||
149204127|NCT02678312|538214938|FG003|Part 2 Double Blind Epoch|Death|8|||
149204128|NCT02678312|538214939|FG004|Part 2 Double Blind Epoch|Death|12|||
149204129|NCT02678312|538214935|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
149204130|NCT02678312|538214936|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
149204131|NCT02678312|538214937|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
149204132|NCT02678312|538214938|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
149204133|NCT02678312|538214939|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
149204134|NCT02678312|538214935|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149204135|NCT02678312|538214936|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149204136|NCT02678312|538214937|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149204137|NCT02678312|538214938|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
149204138|NCT02678312|538214939|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
149204139|NCT02678312|538214935|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
149204140|NCT02678312|538214936|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
149204141|NCT02678312|538214937|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
149204142|NCT02678312|538214938|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
149204143|NCT02678312|538214939|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
149204144|NCT04507776|538214940|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
149204145|NCT01136746|538214942|FG000|Overall Study|Lost to Follow-up|0|||
149204146|NCT01136746|538214943|FG001|Overall Study|Lost to Follow-up|2|||
149204147|NCT01136746|538214942|FG000|Overall Study|Protocol Violation|2|||
148946871|NCT02296320|537290221|FG001|Overall Study|Not - specified|0|||
148946872|NCT02296320|537290222|FG002|Overall Study|Not - specified|1|||
148946873|NCT05466682|537290226|FG000|Overall Study|Withdrawal by Subject|0|||
148946874|NCT05466682|537290227|FG001|Overall Study|Withdrawal by Subject|2|||
148946875|NCT05466682|537290226|FG000|Overall Study|Lost to Follow-up|2|||
148946876|NCT05466682|537290227|FG001|Overall Study|Lost to Follow-up|1|||
148946877|NCT01930123|537290228|FG000|Overall Study|Adverse Event|1|||
148946878|NCT01930123|537290229|FG001|Overall Study|Adverse Event|0|||
148946879|NCT01930123|537290228|FG000|Overall Study|Physician Decision|21|||
148946880|NCT01930123|537290229|FG001|Overall Study|Physician Decision|8|||
148946881|NCT01930123|537290228|FG000|Overall Study|Withdrawal by Subject|1|||
149204148|NCT01136746|538214943|FG001|Overall Study|Protocol Violation|1|||
149204149|NCT01136746|538214942|FG000|Overall Study|Death|1|||
148946882|NCT01930123|537290229|FG001|Overall Study|Withdrawal by Subject|0|||
149204150|NCT01136746|538214943|FG001|Overall Study|Death|0|||
149204151|NCT00092677|538214959|FG000|Overall Study|Lost to Follow-up|0|||
149204152|NCT00092677|538214960|FG001|Overall Study|Lost to Follow-up|2|||
149204153|NCT00092677|538214959|FG000|Overall Study|Adminstrative|5|||
148946883|NCT02695329|537290230|FG000|Overall Study|Adverse Event|1|||
149204154|NCT00092677|538214960|FG001|Overall Study|Adminstrative|9|||
149204155|NCT02966353|538214961|FG000|Overall Study|Withdrawal by Subject|7|||
149204156|NCT02966353|538214961|FG000|Overall Study|Adverse Event|4|||
149204157|NCT02966353|538214961|FG000|Overall Study|Death|4|||
149204158|NCT02966353|538214961|FG000|Overall Study|Physician Decision|3|||
149204159|NCT02966353|538214961|FG000|Overall Study|Progressive disease|2|||
149204160|NCT02966353|538214961|FG000|Overall Study|Protocol deviation|2|||
149204161|NCT00093470|538214969|FG000|Overall Study|Disease progression|39|||
149204162|NCT00093470|538214970|FG001|Overall Study|Disease progression|0|||
149204163|NCT00093470|538214969|FG000|Overall Study|Adverse Event|15|||
148946884|NCT02695329|537290231|FG001|Overall Study|Adverse Event|0|||
149204164|NCT00093470|538214970|FG001|Overall Study|Adverse Event|0|||
149204165|NCT00093470|538214969|FG000|Overall Study|Death|2|||
149204166|NCT00093470|538214970|FG001|Overall Study|Death|0|||
149204167|NCT00093470|538214969|FG000|Overall Study|Withdrawal by Subject|8|||
149204168|NCT00093470|538214970|FG001|Overall Study|Withdrawal by Subject|0|||
149204169|NCT00093470|538214969|FG000|Overall Study|Alternative therapy|2|||
149204170|NCT00093470|538214970|FG001|Overall Study|Alternative therapy|0|||
149204171|NCT00093470|538214969|FG000|Overall Study|Other complicating disease|3|||
149204172|NCT00093470|538214970|FG001|Overall Study|Other complicating disease|0|||
149204173|NCT00093470|538214969|FG000|Overall Study|Physician Decision|2|||
149204174|NCT00093470|538214970|FG001|Overall Study|Physician Decision|0|||
149204175|NCT00093470|538214969|FG000|Overall Study|Never started treatment|1|||
149204176|NCT00093470|538214970|FG001|Overall Study|Never started treatment|0|||
148683228|NCT00950599|536313120|FG006|Follow-Up Period|Adverse Event|0|||
148946885|NCT02695329|537290230|FG000|Overall Study|Poor X-ray quality for measurement|4|||
148946886|NCT02695329|537290231|FG001|Overall Study|Poor X-ray quality for measurement|5|||
148946887|NCT01348165|537290232|FG000|Overall Study|Adverse Event|0|||
149204177|NCT00093470|538214969|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
149204178|NCT00093470|538214970|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
149204179|NCT00010803|538214976|FG000|Overall Study|Withdrawal by Subject|97|||
149204180|NCT00010803|538214977|FG001|Overall Study|Withdrawal by Subject|98|||
149204181|NCT05905601|538214978|FG000|Overall Study|Lost to Follow-up|1|||
148946888|NCT01348165|537290233|FG001|Overall Study|Adverse Event|0|||
148946889|NCT01348165|537290234|FG002|Overall Study|Adverse Event|0|||
148946890|NCT01348165|537290235|FG003|Overall Study|Adverse Event|0|||
148946891|NCT01348165|537290236|FG004|Overall Study|Adverse Event|0|||
149204182|NCT05905601|538214979|FG001|Overall Study|Lost to Follow-up|3|||
149204183|NCT02514772|538214980|FG000|Overall Study|Adverse Event|1|||
149204184|NCT02514772|538214981|FG001|Overall Study|Adverse Event|0|||
149204185|NCT02514772|538214980|FG000|Overall Study|Death|0|||
149204186|NCT02514772|538214981|FG001|Overall Study|Death|1|||
149204187|NCT02514772|538214980|FG000|Overall Study|Withdrawal by Subject|2|||
149204188|NCT02514772|538214981|FG001|Overall Study|Withdrawal by Subject|1|||
149204189|NCT00877006|538214982|FG000|Treatment Period|Death|2|||
149204190|NCT00877006|538214983|FG001|Treatment Period|Death|1|||
149204191|NCT00877006|538214982|FG000|Treatment Period|Adverse Event|10|||
149204192|NCT00877006|538214983|FG001|Treatment Period|Adverse Event|3|||
149204193|NCT00877006|538214982|FG000|Treatment Period|Withdrawal by Subject|2|||
149204194|NCT00877006|538214983|FG001|Treatment Period|Withdrawal by Subject|3|||
149204195|NCT00877006|538214982|FG000|Treatment Period|Protocol Violation|1|||
149204196|NCT00877006|538214983|FG001|Treatment Period|Protocol Violation|0|||
149204197|NCT00877006|538214982|FG000|Treatment Period|Lost to Follow-up|0|||
149204198|NCT00877006|538214983|FG001|Treatment Period|Lost to Follow-up|1|||
149204199|NCT00877006|538214982|FG000|Treatment Period|Disease Progression|1|||
149204200|NCT00877006|538214983|FG001|Treatment Period|Disease Progression|2|||
149204201|NCT00877006|538214982|FG000|Treatment Period|Started New Treatment Regimen|2|||
149204202|NCT00877006|538214983|FG001|Treatment Period|Started New Treatment Regimen|5|||
149204203|NCT00877006|538214982|FG000|Treatment Period|Other|4|||
149204204|NCT00877006|538214983|FG001|Treatment Period|Other|4|||
149204205|NCT00877006|538214982|FG000|Treatment Period|Randomized but Not Treated|3|||
149204206|NCT00877006|538214983|FG001|Treatment Period|Randomized but Not Treated|8|||
149204207|NCT00877006|538214982|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
149204208|NCT00877006|538214983|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
149204209|NCT00877006|538214982|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
149204210|NCT00877006|538214983|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
149204211|NCT00877006|538214982|FG000|Long-Term Follow-up Period|Death|26|||
149204212|NCT00877006|538214983|FG001|Long-Term Follow-up Period|Death|18|||
149204213|NCT00877006|538214982|FG000|Long-Term Follow-up Period|Other|7|||
149204214|NCT00877006|538214983|FG001|Long-Term Follow-up Period|Other|9|||
149204215|NCT04671342|538214984|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
149204216|NCT04671342|538214984|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
149204217|NCT04671342|538214984|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
149204218|NCT04671342|538214984|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
149204219|NCT04671342|538214984|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
149204220|NCT04671342|538214984|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
149204221|NCT03583606|538214985|FG000|Overall Study|Lost to Follow-up|0|||
149204222|NCT03583606|538214986|FG001|Overall Study|Lost to Follow-up|1|||
149204223|NCT03583606|538214987|FG002|Overall Study|Lost to Follow-up|0|||
149204224|NCT03583606|538214985|FG000|Overall Study|Ineligible at baseline|1|||
149204225|NCT03583606|538214986|FG001|Overall Study|Ineligible at baseline|0|||
149204226|NCT03583606|538214987|FG002|Overall Study|Ineligible at baseline|0|||
149204227|NCT00817206|538214992|FG000|Overall Study|Adverse Event|10|||
149204228|NCT00817206|538214993|FG001|Overall Study|Adverse Event|3|||
149204229|NCT00817206|538214992|FG000|Overall Study|Protocol Violation|0|||
149204230|NCT00817206|538214993|FG001|Overall Study|Protocol Violation|2|||
149204231|NCT00817206|538214992|FG000|Overall Study|Lost to Follow-up|0|||
149204232|NCT00817206|538214993|FG001|Overall Study|Lost to Follow-up|1|||
149204233|NCT00817206|538214992|FG000|Overall Study|Death|2|||
149204234|NCT00817206|538214993|FG001|Overall Study|Death|0|||
149204235|NCT00817206|538214992|FG000|Overall Study|Withdrawal by Subject|7|||
149204236|NCT00817206|538214993|FG001|Overall Study|Withdrawal by Subject|3|||
149204237|NCT00817206|538214992|FG000|Overall Study|Physician Decision|2|||
148946892|NCT01348165|537290237|FG005|Overall Study|Adverse Event|0|||
148946893|NCT01348165|537290238|FG006|Overall Study|Adverse Event|1|||
149204238|NCT00817206|538214993|FG001|Overall Study|Physician Decision|0|||
149204239|NCT00126581|538214994|FG000|Overall Study|Adverse Event|3|||
149204240|NCT00126581|538214995|FG001|Overall Study|Adverse Event|7|||
149204241|NCT00126581|538214994|FG000|Overall Study|Death|3|||
149204242|NCT00126581|538214995|FG001|Overall Study|Death|2|||
149204243|NCT00126581|538214994|FG000|Overall Study|Withdrawal by Subject|1|||
149204244|NCT00126581|538214995|FG001|Overall Study|Withdrawal by Subject|4|||
149204245|NCT00126581|538214994|FG000|Overall Study|Alternative therapy|3|||
149204246|NCT00126581|538214995|FG001|Overall Study|Alternative therapy|3|||
149204247|NCT00126581|538214994|FG000|Overall Study|Other illness/MD discretion|3|||
149204248|NCT00126581|538214995|FG001|Overall Study|Other illness/MD discretion|4|||
149204249|NCT00793182|538214996|FG000|Overall Study|Adverse Event|0|||
149204250|NCT00793182|538214997|FG001|Overall Study|Adverse Event|1|||
148946894|NCT01929343|537290239|FG000|Overall Study|Physician Decision|0|||
148946895|NCT01929343|537290240|FG001|Overall Study|Physician Decision|2|||
148946896|NCT01929343|537290241|FG002|Overall Study|Physician Decision|0|||
148946897|NCT01929343|537290239|FG000|Overall Study|Withdrawal by Subject|1|||
148946898|NCT01929343|537290240|FG001|Overall Study|Withdrawal by Subject|0|||
149204251|NCT03728140|538214999|FG000|Overall Study|Abnormal embryo transfer operation|10|||
149204252|NCT03728140|538215000|FG001|Overall Study|Abnormal embryo transfer operation|7|||
149204253|NCT01188096|538215001|FG000|Overall Study|progression of disease|4|||
149204254|NCT01188096|538215001|FG000|Overall Study|Withdrawal by Subject|2|||
149204255|NCT00851253|538215002|FG000|Overall Study|Disease Progression|1|||
149204256|NCT00851253|538215003|FG001|Overall Study|Disease Progression|0|||
149204257|NCT03004976|538215013|FG000|Overall Study|Lost to Follow-up|7|||
149204258|NCT03004976|538215014|FG001|Overall Study|Lost to Follow-up|5|||
149204259|NCT03004976|538215013|FG000|Overall Study|Physician Decision|1|||
149204260|NCT03004976|538215014|FG001|Overall Study|Physician Decision|0|||
149204261|NCT03004976|538215013|FG000|Overall Study|Withdrawal by Subject|1|||
149204262|NCT03004976|538215014|FG001|Overall Study|Withdrawal by Subject|0|||
149204263|NCT03004976|538215013|FG000|Overall Study|Death|4|||
149204264|NCT03004976|538215014|FG001|Overall Study|Death|1|||
149204265|NCT02786836|538215015|FG000|Overall Study|Death|1|||
148946899|NCT01929343|537290241|FG002|Overall Study|Withdrawal by Subject|0|||
149204266|NCT02786836|538215015|FG000|Overall Study|Lack of Efficacy|2|||
149204267|NCT02786836|538215015|FG000|Overall Study|Protocol Violation|3|||
149204268|NCT02786836|538215015|FG000|Overall Study|Withdrawal by Subject|3|||
149204269|NCT02786836|538215015|FG000|Overall Study|Liver Transplantation|2|||
149204270|NCT02786836|538215015|FG000|Overall Study|Device or Pharmacy Issues|3|||
148946900|NCT01269463|537290242|FG000|First Intervention|Withdrawal by Subject|1|||
148946901|NCT01269463|537290243|FG001|First Intervention|Withdrawal by Subject|0|||
148946902|NCT01269463|537290242|FG000|First Intervention|Adverse Event|1|||
148946903|NCT01269463|537290243|FG001|First Intervention|Adverse Event|0|||
148946904|NCT01269463|537290242|FG000|First Intervention|Lack of Efficacy|0|||
148946905|NCT01269463|537290243|FG001|First Intervention|Lack of Efficacy|1|||
148946906|NCT01269463|537290242|FG000|First Intervention|Physician Decision|0|||
148946907|NCT01269463|537290243|FG001|First Intervention|Physician Decision|1|||
148946908|NCT02549937|537290245|FG000|Overall Study|Death|0|||
148946909|NCT02549937|537290246|FG001|Overall Study|Death|1|||
148946910|NCT02549937|537290247|FG002|Overall Study|Death|0|||
148946911|NCT02549937|537290248|FG003|Overall Study|Death|1|||
148946912|NCT02549937|537290249|FG004|Overall Study|Death|0|||
148946913|NCT02549937|537290250|FG005|Overall Study|Death|8|||
148946914|NCT02549937|537290251|FG006|Overall Study|Death|0|||
148946915|NCT02549937|537290252|FG007|Overall Study|Death|0|||
148946916|NCT02549937|537290253|FG008|Overall Study|Death|19|||
148946917|NCT02549937|537290245|FG000|Overall Study|No follow up required|3|||
148946918|NCT02549937|537290246|FG001|Overall Study|No follow up required|6|||
148946919|NCT02549937|537290247|FG002|Overall Study|No follow up required|3|||
148946920|NCT02549937|537290248|FG003|Overall Study|No follow up required|8|||
148946921|NCT02549937|537290249|FG004|Overall Study|No follow up required|12|||
148946922|NCT02549937|537290250|FG005|Overall Study|No follow up required|21|||
149204271|NCT01143714|538215016|FG000|Overall Study|Adverse Event|4|||
149204272|NCT01143714|538215017|FG001|Overall Study|Adverse Event|2|||
149204273|NCT01143714|538215016|FG000|Overall Study|Withdrawal by Subject|1|||
149204274|NCT01143714|538215017|FG001|Overall Study|Withdrawal by Subject|0|||
149204275|NCT01143714|538215016|FG000|Overall Study|Subject non-compliance|0|||
149204276|NCT01143714|538215017|FG001|Overall Study|Subject non-compliance|1|||
149204277|NCT01143714|538215016|FG000|Overall Study|wound closed = deemed healed|1|||
149204278|NCT01143714|538215017|FG001|Overall Study|wound closed = deemed healed|0|||
149204279|NCT01143714|538215016|FG000|Overall Study|wound size increased|1|||
149204280|NCT01143714|538215017|FG001|Overall Study|wound size increased|0|||
149204281|NCT01106391|538215018|FG000|Overall Study|Death|12|||
149204282|NCT01106391|538215018|FG000|Overall Study|Withdrawal by Subject|7|||
149204283|NCT00150345|538215019|FG000|Overall Study|Death|5|||
149204284|NCT00150345|538215020|FG001|Overall Study|Death|2|||
148683229|NCT00950599|536313121|FG007|Follow-Up Period|Adverse Event|0|||
148683230|NCT00950599|536313122|FG008|Follow-Up Period|Adverse Event|1|||
148683231|NCT00950599|536313123|FG009|Follow-Up Period|Adverse Event|0|||
148683232|NCT00950599|536313114|FG000|Follow-Up Period|Lack of Efficacy|0|||
148683233|NCT00950599|536313115|FG001|Follow-Up Period|Lack of Efficacy|0|||
148683234|NCT00950599|536313116|FG002|Follow-Up Period|Lack of Efficacy|0|||
148683235|NCT00950599|536313117|FG003|Follow-Up Period|Lack of Efficacy|0|||
148683236|NCT00950599|536313118|FG004|Follow-Up Period|Lack of Efficacy|0|||
148683237|NCT00950599|536313119|FG005|Follow-Up Period|Lack of Efficacy|0|||
148683238|NCT00950599|536313120|FG006|Follow-Up Period|Lack of Efficacy|0|||
148683239|NCT00950599|536313121|FG007|Follow-Up Period|Lack of Efficacy|0|||
148683240|NCT00950599|536313122|FG008|Follow-Up Period|Lack of Efficacy|3|||
148683241|NCT00950599|536313123|FG009|Follow-Up Period|Lack of Efficacy|0|||
148683242|NCT00950599|536313114|FG000|Follow-Up Period|Lost to Follow-up|0|||
148683243|NCT00950599|536313115|FG001|Follow-Up Period|Lost to Follow-up|0|||
148683244|NCT00950599|536313116|FG002|Follow-Up Period|Lost to Follow-up|0|||
148683245|NCT00950599|536313117|FG003|Follow-Up Period|Lost to Follow-up|0|||
148683246|NCT00950599|536313118|FG004|Follow-Up Period|Lost to Follow-up|0|||
148683247|NCT00950599|536313119|FG005|Follow-Up Period|Lost to Follow-up|0|||
148683248|NCT00950599|536313120|FG006|Follow-Up Period|Lost to Follow-up|0|||
148683249|NCT00950599|536313121|FG007|Follow-Up Period|Lost to Follow-up|0|||
148683250|NCT00950599|536313122|FG008|Follow-Up Period|Lost to Follow-up|5|||
148683251|NCT00950599|536313123|FG009|Follow-Up Period|Lost to Follow-up|1|||
148683252|NCT00950599|536313114|FG000|Follow-Up Period|Physician Decision|0|||
148946923|NCT02549937|537290251|FG006|Overall Study|No follow up required|9|||
148946924|NCT02549937|537290252|FG007|Overall Study|No follow up required|11|||
148946925|NCT02549937|537290253|FG008|Overall Study|No follow up required|0|||
148946926|NCT02549937|537290245|FG000|Overall Study|Other|0|||
148946927|NCT02549937|537290246|FG001|Overall Study|Other|0|||
149204285|NCT00150345|538215019|FG000|Overall Study|Adverse Event|8|||
149204286|NCT00150345|538215020|FG001|Overall Study|Adverse Event|6|||
148683253|NCT00950599|536313115|FG001|Follow-Up Period|Physician Decision|0|||
148946928|NCT02549937|537290247|FG002|Overall Study|Other|0|||
148946929|NCT02549937|537290248|FG003|Overall Study|Other|0|||
148946930|NCT02549937|537290249|FG004|Overall Study|Other|1|||
148946931|NCT02549937|537290250|FG005|Overall Study|Other|0|||
148946932|NCT02549937|537290251|FG006|Overall Study|Other|3|||
148946933|NCT02549937|537290252|FG007|Overall Study|Other|2|||
148946934|NCT02549937|537290253|FG008|Overall Study|Other|3|||
149204287|NCT00150345|538215019|FG000|Overall Study|Lack of Efficacy|5|||
148683254|NCT00950599|536313116|FG002|Follow-Up Period|Physician Decision|0|||
148683255|NCT00950599|536313117|FG003|Follow-Up Period|Physician Decision|0|||
148946935|NCT02549937|537290245|FG000|Overall Study|Lost to Follow-up|0|||
148808751|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
148808752|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
148808753|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
148808754|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
148808755|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
148808756|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
148808757|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
148808758|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
148808759|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
148808760|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
148808761|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
148808762|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Death|1|||
148808763|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Death|0|||
148808764|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Death|1|||
148808765|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
148808766|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
148808767|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
148808768|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
148808769|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
148808770|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
148808771|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
148808772|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
148808773|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
148808774|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
148808775|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
148808776|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
148808777|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
148808778|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
148808779|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
148808780|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
148808781|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
148808782|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
148808783|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
148808784|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
148808785|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
148808786|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Depression|0|||
148808787|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Depression|1|||
148808788|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Depression|0|||
148808789|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
148808790|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
148808791|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
148808792|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Jailed|0|||
148808793|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Jailed|1|||
148808794|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Jailed|0|||
148808795|NCT00090103|536777541|FG000|16-Week Safety Follow-up Period|Other|0|||
148808796|NCT00090103|536777542|FG001|16-Week Safety Follow-up Period|Other|1|||
148808797|NCT00090103|536777543|FG002|16-Week Safety Follow-up Period|Other|0|||
148808798|NCT01799889|536777544|FG000|Overall Study|Adverse Event|4|||
148808799|NCT01799889|536777545|FG001|Overall Study|Adverse Event|4|||
148808800|NCT01799889|536777546|FG002|Overall Study|Adverse Event|5|||
148808801|NCT01799889|536777547|FG003|Overall Study|Adverse Event|1|||
148808802|NCT01799889|536777548|FG004|Overall Study|Adverse Event|11|||
148808803|NCT01799889|536777549|FG005|Overall Study|Adverse Event|1|||
148808804|NCT01799889|536777550|FG006|Overall Study|Adverse Event|5|||
148808805|NCT01799889|536777551|FG007|Overall Study|Adverse Event|2|||
148808806|NCT01799889|536777552|FG008|Overall Study|Adverse Event|3|||
149204288|NCT00150345|538215020|FG001|Overall Study|Lack of Efficacy|4|||
149204289|NCT00150345|538215019|FG000|Overall Study|Withdrawal by Subject|3|||
149204290|NCT00150345|538215020|FG001|Overall Study|Withdrawal by Subject|4|||
149204291|NCT00150345|538215019|FG000|Overall Study|Laboratory abnormality|1|||
149204292|NCT00150345|538215020|FG001|Overall Study|Laboratory abnormality|2|||
149204293|NCT00150345|538215019|FG000|Overall Study|Other|12|||
149204294|NCT00150345|538215020|FG001|Overall Study|Other|14|||
149204295|NCT05224076|538215026|FG000|Overall Study|Lost to Follow-up|24|||
149204296|NCT01807949|538215027|FG000|Overall Study|Adverse Event|1|||
149204297|NCT01807949|538215028|FG001|Overall Study|Adverse Event|2|||
149204298|NCT01807949|538215029|FG002|Overall Study|Adverse Event|2|||
149204299|NCT01807949|538215027|FG000|Overall Study|Withdrawal by Subject|1|||
149204300|NCT01807949|538215028|FG001|Overall Study|Withdrawal by Subject|2|||
149204301|NCT01807949|538215029|FG002|Overall Study|Withdrawal by Subject|2|||
149204302|NCT01807949|538215027|FG000|Overall Study|Non-Compliance|0|||
149204303|NCT01807949|538215028|FG001|Overall Study|Non-Compliance|0|||
149204304|NCT01807949|538215029|FG002|Overall Study|Non-Compliance|1|||
149204305|NCT01807949|538215027|FG000|Overall Study|Undefined|0|||
149204306|NCT01807949|538215028|FG001|Overall Study|Undefined|1|||
149204307|NCT01807949|538215029|FG002|Overall Study|Undefined|2|||
149204308|NCT01807949|538215027|FG000|Overall Study|Randomized But Not Treated|0|||
149204309|NCT01807949|538215028|FG001|Overall Study|Randomized But Not Treated|2|||
149204310|NCT01807949|538215029|FG002|Overall Study|Randomized But Not Treated|2|||
149204311|NCT04325906|538215030|FG000|Overall Study|Withdrawal by Subject|2|||
149204312|NCT04325906|538215031|FG001|Overall Study|Withdrawal by Subject|0|||
148683256|NCT00950599|536313118|FG004|Follow-Up Period|Physician Decision|0|||
148683257|NCT00950599|536313119|FG005|Follow-Up Period|Physician Decision|0|||
148683258|NCT00950599|536313120|FG006|Follow-Up Period|Physician Decision|0|||
148683259|NCT00950599|536313121|FG007|Follow-Up Period|Physician Decision|0|||
148683260|NCT00950599|536313122|FG008|Follow-Up Period|Physician Decision|1|||
148683261|NCT00950599|536313123|FG009|Follow-Up Period|Physician Decision|0|||
148683262|NCT00950599|536313114|FG000|Follow-Up Period|Poor/Noncompliance|0|||
148683263|NCT00950599|536313115|FG001|Follow-Up Period|Poor/Noncompliance|0|||
148683264|NCT00950599|536313116|FG002|Follow-Up Period|Poor/Noncompliance|0|||
148683265|NCT00950599|536313117|FG003|Follow-Up Period|Poor/Noncompliance|0|||
148683266|NCT00950599|536313118|FG004|Follow-Up Period|Poor/Noncompliance|0|||
148683267|NCT00950599|536313119|FG005|Follow-Up Period|Poor/Noncompliance|0|||
148683268|NCT00950599|536313120|FG006|Follow-Up Period|Poor/Noncompliance|0|||
148683269|NCT00950599|536313121|FG007|Follow-Up Period|Poor/Noncompliance|0|||
148683270|NCT00950599|536313122|FG008|Follow-Up Period|Poor/Noncompliance|1|||
148683271|NCT00950599|536313123|FG009|Follow-Up Period|Poor/Noncompliance|0|||
148683272|NCT00950599|536313114|FG000|Follow-Up Period|Subject withdrew Consent|0|||
148683273|NCT00950599|536313115|FG001|Follow-Up Period|Subject withdrew Consent|0|||
148683274|NCT00950599|536313116|FG002|Follow-Up Period|Subject withdrew Consent|0|||
148683275|NCT00950599|536313117|FG003|Follow-Up Period|Subject withdrew Consent|0|||
148683276|NCT00950599|536313118|FG004|Follow-Up Period|Subject withdrew Consent|0|||
148683277|NCT00950599|536313119|FG005|Follow-Up Period|Subject withdrew Consent|0|||
148683278|NCT00950599|536313120|FG006|Follow-Up Period|Subject withdrew Consent|0|||
148683279|NCT00950599|536313121|FG007|Follow-Up Period|Subject withdrew Consent|0|||
148683280|NCT00950599|536313122|FG008|Follow-Up Period|Subject withdrew Consent|2|||
148683281|NCT00950599|536313123|FG009|Follow-Up Period|Subject withdrew Consent|1|||
148683282|NCT01684722|536313124|FG000|Overall Study|Lost to Follow-up|78|||
148683283|NCT01684722|536313125|FG001|Overall Study|Lost to Follow-up|56|||
148683284|NCT01684722|536313126|FG002|Overall Study|Lost to Follow-up|75|||
148683285|NCT01684722|536313127|FG003|Overall Study|Lost to Follow-up|89|||
149204313|NCT01306032|538215034|FG000|First Intervention|Adverse Event|1|||
149204314|NCT01306032|538215035|FG001|First Intervention|Adverse Event|0|||
149204315|NCT01306032|538215036|FG002|First Intervention|Adverse Event|1|||
149204316|NCT01306032|538215037|FG003|First Intervention|Adverse Event|0|||
149204317|NCT01306032|538215038|FG004|First Intervention|Adverse Event|0|||
149204318|NCT01306032|538215039|FG005|First Intervention|Adverse Event|1|||
148683286|NCT01684722|536313124|FG000|Overall Study|Death|19|||
148683287|NCT01684722|536313125|FG001|Overall Study|Death|21|||
148683288|NCT01684722|536313126|FG002|Overall Study|Death|19|||
149204319|NCT01306032|538215034|FG000|First Intervention|Withdrawal by Subject|0|||
148946936|NCT02549937|537290246|FG001|Overall Study|Lost to Follow-up|0|||
148946937|NCT02549937|537290247|FG002|Overall Study|Lost to Follow-up|0|||
148946938|NCT02549937|537290248|FG003|Overall Study|Lost to Follow-up|0|||
148946939|NCT02549937|537290249|FG004|Overall Study|Lost to Follow-up|0|||
149204320|NCT01306032|538215035|FG001|First Intervention|Withdrawal by Subject|2|||
149204321|NCT01306032|538215036|FG002|First Intervention|Withdrawal by Subject|0|||
149204322|NCT01306032|538215037|FG003|First Intervention|Withdrawal by Subject|1|||
149204323|NCT01306032|538215038|FG004|First Intervention|Withdrawal by Subject|0|||
149204324|NCT01306032|538215039|FG005|First Intervention|Withdrawal by Subject|0|||
148946940|NCT02549937|537290250|FG005|Overall Study|Lost to Follow-up|0|||
148946941|NCT02549937|537290251|FG006|Overall Study|Lost to Follow-up|0|||
148946942|NCT02549937|537290252|FG007|Overall Study|Lost to Follow-up|0|||
148946943|NCT02549937|537290253|FG008|Overall Study|Lost to Follow-up|3|||
148946944|NCT02549937|537290245|FG000|Overall Study|Withdrawal by Subject|0|||
148946945|NCT02549937|537290246|FG001|Overall Study|Withdrawal by Subject|0|||
148946946|NCT02549937|537290247|FG002|Overall Study|Withdrawal by Subject|0|||
148946947|NCT02549937|537290248|FG003|Overall Study|Withdrawal by Subject|0|||
148946948|NCT02549937|537290249|FG004|Overall Study|Withdrawal by Subject|0|||
148946949|NCT02549937|537290250|FG005|Overall Study|Withdrawal by Subject|1|||
148946950|NCT02549937|537290251|FG006|Overall Study|Withdrawal by Subject|4|||
148946951|NCT02549937|537290252|FG007|Overall Study|Withdrawal by Subject|3|||
148946952|NCT02549937|537290253|FG008|Overall Study|Withdrawal by Subject|2|||
148946953|NCT02549937|537290245|FG000|Overall Study|Sponsor Decision|0|||
149204325|NCT01306032|538215034|FG000|First Intervention|Death|0|||
149204326|NCT01306032|538215035|FG001|First Intervention|Death|0|||
149204327|NCT01306032|538215036|FG002|First Intervention|Death|1|||
149204328|NCT01306032|538215037|FG003|First Intervention|Death|0|||
149204329|NCT01306032|538215038|FG004|First Intervention|Death|0|||
149204330|NCT01306032|538215039|FG005|First Intervention|Death|0|||
149204331|NCT01306032|538215034|FG000|First Intervention|Ineligible|0|||
149204332|NCT01306032|538215035|FG001|First Intervention|Ineligible|0|||
149204333|NCT01306032|538215036|FG002|First Intervention|Ineligible|0|||
149204334|NCT01306032|538215037|FG003|First Intervention|Ineligible|0|||
149204335|NCT01306032|538215038|FG004|First Intervention|Ineligible|0|||
149204336|NCT01306032|538215039|FG005|First Intervention|Ineligible|1|||
149204337|NCT01306032|538215034|FG000|First Intervention|Progressive disease|0|||
149204338|NCT01306032|538215035|FG001|First Intervention|Progressive disease|0|||
149204339|NCT01306032|538215036|FG002|First Intervention|Progressive disease|0|||
149204340|NCT01306032|538215037|FG003|First Intervention|Progressive disease|0|||
149204341|NCT01306032|538215038|FG004|First Intervention|Progressive disease|2|||
149204342|NCT01306032|538215039|FG005|First Intervention|Progressive disease|0|||
149204343|NCT01306032|538215034|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
149204344|NCT01306032|538215035|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
149204345|NCT01306032|538215036|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
149204346|NCT01306032|538215037|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
149204347|NCT01306032|538215038|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
149204348|NCT01306032|538215039|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
149204349|NCT01306032|538215034|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
149204350|NCT01306032|538215035|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
149204351|NCT01306032|538215036|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
149204352|NCT01306032|538215037|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
149204353|NCT01306032|538215038|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
149204354|NCT01306032|538215039|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
149204355|NCT00555568|538215042|FG000|Overall Study|Lost to Follow-up|26|||
149204356|NCT00555568|538215043|FG001|Overall Study|Lost to Follow-up|16|||
149204357|NCT00555568|538215044|FG002|Overall Study|Lost to Follow-up|16|||
149204358|NCT01588353|538215045|FG000|Step2|Withdrawal by Subject|0|||
149204359|NCT01588353|538215046|FG001|Step2|Withdrawal by Subject|1|||
149016321|NCT05027074|537537902|FG000|Overall Study|Site Terminated By Sponsor|3|||
149016322|NCT05027074|537537903|FG001|Overall Study|Site Terminated By Sponsor|0|||
149204360|NCT01588353|538215047|FG002|Step2|Withdrawal by Subject|0|||
149204361|NCT01588353|538215045|FG000|Step3|Adverse Event|0|||
149204362|NCT01588353|538215046|FG001|Step3|Adverse Event|0|||
149204363|NCT01588353|538215047|FG002|Step3|Adverse Event|2|||
148946954|NCT02549937|537290246|FG001|Overall Study|Sponsor Decision|0|||
149204364|NCT01409993|538215048|FG000|Overall Study|Adverse Event|4|||
149204365|NCT01409993|538215049|FG001|Overall Study|Adverse Event|4|||
149204366|NCT01409993|538215050|FG002|Overall Study|Adverse Event|3|||
149204367|NCT01409993|538215051|FG003|Overall Study|Adverse Event|1|||
149204368|NCT01409993|538215048|FG000|Overall Study|Withdrawal by Subject|0|||
148683289|NCT01684722|536313127|FG003|Overall Study|Death|21|||
148946955|NCT02549937|537290247|FG002|Overall Study|Sponsor Decision|0|||
148946956|NCT02549937|537290248|FG003|Overall Study|Sponsor Decision|0|||
149016323|NCT05027074|537537904|FG002|Overall Study|Site Terminated By Sponsor|2|||
148946957|NCT02549937|537290249|FG004|Overall Study|Sponsor Decision|0|||
148946958|NCT02549937|537290250|FG005|Overall Study|Sponsor Decision|0|||
148946959|NCT02549937|537290251|FG006|Overall Study|Sponsor Decision|0|||
148946960|NCT02549937|537290252|FG007|Overall Study|Sponsor Decision|0|||
148946961|NCT02549937|537290253|FG008|Overall Study|Sponsor Decision|6|||
148946962|NCT03199274|537290254|FG000|Overall Study|Withdrawal by Subject|4|||
148946963|NCT03199274|537290255|FG001|Overall Study|Withdrawal by Subject|0|||
148946964|NCT03199274|537290254|FG000|Overall Study|Lost to Follow-up|0|||
148946965|NCT03199274|537290255|FG001|Overall Study|Lost to Follow-up|1|||
148946966|NCT03199274|537290254|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
148946967|NCT03199274|537290255|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
148946968|NCT03278873|537290256|FG000|Overall Study|Withdrawal by Subject|0|||
148946969|NCT03278873|537290257|FG001|Overall Study|Withdrawal by Subject|1|||
148946970|NCT03278873|537290258|FG002|Overall Study|Withdrawal by Subject|0|||
148946971|NCT03278873|537290259|FG003|Overall Study|Withdrawal by Subject|0|||
148946972|NCT03278873|537290256|FG000|Overall Study|Sponsor's decision|0|||
148946973|NCT03278873|537290257|FG001|Overall Study|Sponsor's decision|1|||
148946974|NCT03278873|537290258|FG002|Overall Study|Sponsor's decision|0|||
148946975|NCT03278873|537290259|FG003|Overall Study|Sponsor's decision|0|||
148946976|NCT03278873|537290256|FG000|Overall Study|Early Termination|2|||
148946977|NCT03278873|537290257|FG001|Overall Study|Early Termination|6|||
148946978|NCT03278873|537290258|FG002|Overall Study|Early Termination|0|||
148946979|NCT03278873|537290259|FG003|Overall Study|Early Termination|4|||
148946980|NCT03278873|537290256|FG000|Overall Study|Lost to Follow-up|0|||
148946981|NCT03278873|537290257|FG001|Overall Study|Lost to Follow-up|0|||
149204369|NCT01409993|538215049|FG001|Overall Study|Withdrawal by Subject|0|||
149204370|NCT01409993|538215050|FG002|Overall Study|Withdrawal by Subject|0|||
149204371|NCT01409993|538215051|FG003|Overall Study|Withdrawal by Subject|4|||
148946982|NCT03278873|537290258|FG002|Overall Study|Lost to Follow-up|2|||
148946983|NCT03278873|537290259|FG003|Overall Study|Lost to Follow-up|0|||
148946984|NCT03278873|537290256|FG000|Overall Study|The patient decided to withdraw via email|1|||
148946985|NCT03278873|537290257|FG001|Overall Study|The patient decided to withdraw via email|0|||
148946986|NCT03278873|537290258|FG002|Overall Study|The patient decided to withdraw via email|0|||
148946987|NCT03278873|537290259|FG003|Overall Study|The patient decided to withdraw via email|0|||
148946988|NCT03278873|537290256|FG000|Overall Study|The patient was unresponsive to contact|0|||
148946989|NCT03278873|537290257|FG001|Overall Study|The patient was unresponsive to contact|0|||
148946990|NCT03278873|537290258|FG002|Overall Study|The patient was unresponsive to contact|0|||
148946991|NCT03278873|537290259|FG003|Overall Study|The patient was unresponsive to contact|4|||
148946992|NCT03278873|537290256|FG000|Overall Study|The patient wished to participate no longer|0|||
148946993|NCT03278873|537290257|FG001|Overall Study|The patient wished to participate no longer|1|||
148946994|NCT03278873|537290258|FG002|Overall Study|The patient wished to participate no longer|0|||
148946995|NCT03278873|537290259|FG003|Overall Study|The patient wished to participate no longer|0|||
148946996|NCT03278873|537290256|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
149204372|NCT01409993|538215048|FG000|Overall Study|Lost to Follow-up|0|||
149204373|NCT01409993|538215049|FG001|Overall Study|Lost to Follow-up|1|||
149204374|NCT01409993|538215050|FG002|Overall Study|Lost to Follow-up|0|||
149204375|NCT01409993|538215051|FG003|Overall Study|Lost to Follow-up|0|||
149204376|NCT02677220|538215052|FG000|Overall Study|Adverse Event|1|||
149204377|NCT00965146|538215053|FG000|Overall Study|Death|7|||
149204378|NCT00965146|538215053|FG000|Overall Study|Lost to Follow-up|22|||
149204379|NCT00965146|538215053|FG000|Overall Study|Withdrawal by Subject|17|||
149204380|NCT00965146|538215053|FG000|Overall Study|Unable to return|1|||
149204381|NCT00965146|538215053|FG000|Overall Study|Unwilling to return|11|||
149204382|NCT00965146|538215053|FG000|Overall Study|Intercurrent illness|1|||
148946997|NCT03278873|537290257|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
148946998|NCT03278873|537290258|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
148946999|NCT03278873|537290259|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
148947000|NCT04518306|537290265|FG000|Double-Blind Period|Run in failure|0|||
148947001|NCT04518306|537290266|FG001|Double-Blind Period|Run in failure|0|||
148947002|NCT04518306|537290267|FG002|Double-Blind Period|Run in failure|1|||
148947003|NCT04518306|537290265|FG000|Double-Blind Period|Adverse Event|0|||
148947004|NCT04518306|537290266|FG001|Double-Blind Period|Adverse Event|2|||
148947005|NCT04518306|537290267|FG002|Double-Blind Period|Adverse Event|2|||
149204383|NCT00965146|538215053|FG000|Overall Study|Revision / Removal of Study Implant|6|||
149204384|NCT00965146|538215053|FG000|Overall Study|Overall Study Termination|145|||
149204385|NCT01148693|538215054|FG000|Overall Study|Attempts for cannulation were failed|13|||
149204386|NCT01148693|538215055|FG001|Overall Study|Attempts for cannulation were failed|10|||
148947006|NCT04518306|537290265|FG000|Double-Blind Period|Lost to Follow-up|1|||
148947007|NCT04518306|537290266|FG001|Double-Blind Period|Lost to Follow-up|2|||
148947008|NCT04518306|537290267|FG002|Double-Blind Period|Lost to Follow-up|2|||
148947009|NCT04518306|537290265|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
148947010|NCT04518306|537290266|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
148947011|NCT04518306|537290267|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
148947012|NCT04518306|537290265|FG000|Double-Blind Period|Other|0|||
148947013|NCT04518306|537290266|FG001|Double-Blind Period|Other|2|||
148947014|NCT04518306|537290267|FG002|Double-Blind Period|Other|0|||
148947015|NCT04518306|537290265|FG000|Double-Blind Period|Missing|0|||
148947016|NCT04518306|537290266|FG001|Double-Blind Period|Missing|1|||
149204387|NCT01504971|538215056|FG000|Overall Study|Physician Decision|13|||
149204388|NCT04581863|538215057|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
149204389|NCT04581863|538215058|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
149204390|NCT00225212|538215059|FG000|Overall Study|Disease progression|2|||
149204391|NCT00225212|538215059|FG000|Overall Study|Death|1|||
149204392|NCT00225212|538215059|FG000|Overall Study|Adverse Event|2|||
149204393|NCT00225212|538215059|FG000|Overall Study|Intercurrent illness|1|||
149204394|NCT01335698|538215062|FG000|Treatment Stage 1|Lack of Efficacy|3|||
149204395|NCT01335698|538215063|FG001|Treatment Stage 1|Lack of Efficacy|1|||
149204396|NCT01335698|538215064|FG002|Treatment Stage 1|Lack of Efficacy|3|||
149204397|NCT01335698|538215065|FG003|Treatment Stage 1|Lack of Efficacy|3|||
149204398|NCT01335698|538215066|FG004|Treatment Stage 1|Lack of Efficacy|1|||
149204399|NCT01335698|538215062|FG000|Treatment Stage 1|Adverse Event|1|||
149204400|NCT01335698|538215063|FG001|Treatment Stage 1|Adverse Event|2|||
149204401|NCT01335698|538215064|FG002|Treatment Stage 1|Adverse Event|2|||
149204402|NCT01335698|538215065|FG003|Treatment Stage 1|Adverse Event|1|||
149204403|NCT01335698|538215066|FG004|Treatment Stage 1|Adverse Event|1|||
149204404|NCT01335698|538215062|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
149204405|NCT01335698|538215063|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
149204406|NCT01335698|538215064|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
149204407|NCT01335698|538215065|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
149204408|NCT01335698|538215066|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
149204409|NCT01335698|538215062|FG000|Treatment Stage 1|Lost to Follow-up|1|||
149204410|NCT01335698|538215063|FG001|Treatment Stage 1|Lost to Follow-up|1|||
149204411|NCT01335698|538215064|FG002|Treatment Stage 1|Lost to Follow-up|0|||
148947017|NCT04518306|537290267|FG002|Double-Blind Period|Missing|0|||
148947018|NCT02801331|537290268|FG000|Overall Study|Transferred to another hospital|8|||
148947019|NCT02801331|537290269|FG001|Overall Study|Transferred to another hospital|7|||
148947020|NCT02801331|537290268|FG000|Overall Study|Withdrawal by Subject|0|||
149204412|NCT01335698|538215065|FG003|Treatment Stage 1|Lost to Follow-up|0|||
148947021|NCT02801331|537290269|FG001|Overall Study|Withdrawal by Subject|4|||
149204413|NCT01335698|538215066|FG004|Treatment Stage 1|Lost to Follow-up|0|||
149204414|NCT01335698|538215062|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
149204415|NCT01335698|538215063|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
149204416|NCT01335698|538215064|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
149204417|NCT01335698|538215065|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
149204418|NCT01335698|538215066|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
149204419|NCT01335698|538215062|FG000|Treatment Stage 1|No longer meets study criteria|1|||
149204420|NCT01335698|538215063|FG001|Treatment Stage 1|No longer meets study criteria|1|||
149204421|NCT01335698|538215064|FG002|Treatment Stage 1|No longer meets study criteria|0|||
149204422|NCT01335698|538215065|FG003|Treatment Stage 1|No longer meets study criteria|1|||
149204423|NCT01335698|538215066|FG004|Treatment Stage 1|No longer meets study criteria|0|||
149204424|NCT01335698|538215062|FG000|Treatment Stage 1|Other|1|||
149204425|NCT01335698|538215063|FG001|Treatment Stage 1|Other|0|||
149204426|NCT01335698|538215064|FG002|Treatment Stage 1|Other|0|||
149204427|NCT01335698|538215065|FG003|Treatment Stage 1|Other|1|||
149204428|NCT01335698|538215066|FG004|Treatment Stage 1|Other|0|||
149204429|NCT01335698|538215062|FG000|Treatment Stage 2|Lack of Efficacy|2|||
149204430|NCT01335698|538215063|FG001|Treatment Stage 2|Lack of Efficacy|1|||
149204431|NCT01335698|538215064|FG002|Treatment Stage 2|Lack of Efficacy|3|||
149204432|NCT01335698|538215065|FG003|Treatment Stage 2|Lack of Efficacy|1|||
149204433|NCT01335698|538215066|FG004|Treatment Stage 2|Lack of Efficacy|0|||
149204434|NCT01335698|538215062|FG000|Treatment Stage 2|Adverse Event|2|||
149204435|NCT01335698|538215063|FG001|Treatment Stage 2|Adverse Event|0|||
149204436|NCT01335698|538215064|FG002|Treatment Stage 2|Adverse Event|0|||
149204437|NCT01335698|538215065|FG003|Treatment Stage 2|Adverse Event|3|||
149204438|NCT01335698|538215066|FG004|Treatment Stage 2|Adverse Event|0|||
149204439|NCT01335698|538215062|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
149204440|NCT01335698|538215063|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
149204441|NCT01335698|538215064|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
149204442|NCT01335698|538215065|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
149204443|NCT01335698|538215066|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
149204444|NCT01335698|538215062|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
149204445|NCT01335698|538215063|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
149204446|NCT01335698|538215064|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
149204447|NCT01335698|538215065|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
149204448|NCT01335698|538215066|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
149204449|NCT01335698|538215062|FG000|Treatment Stage 2|Lost to Follow-up|1|||
149204450|NCT01335698|538215063|FG001|Treatment Stage 2|Lost to Follow-up|0|||
148808807|NCT01799889|536777553|FG009|Overall Study|Adverse Event|1|||
148808808|NCT01799889|536777554|FG010|Overall Study|Adverse Event|1|||
148808809|NCT01799889|536777555|FG011|Overall Study|Adverse Event|0|||
148808810|NCT01799889|536777544|FG000|Overall Study|Death|1|||
149204451|NCT01335698|538215064|FG002|Treatment Stage 2|Lost to Follow-up|0|||
149204452|NCT01335698|538215065|FG003|Treatment Stage 2|Lost to Follow-up|0|||
149204453|NCT01335698|538215066|FG004|Treatment Stage 2|Lost to Follow-up|0|||
149204454|NCT01335698|538215062|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
149204455|NCT01335698|538215063|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
149204456|NCT01335698|538215064|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
149204457|NCT01335698|538215065|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
149204458|NCT01335698|538215066|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
149204459|NCT01335698|538215062|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
148947022|NCT02801331|537290268|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
148947023|NCT02801331|537290269|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
148947024|NCT02443987|537290270|FG000|Overall Study|Bladder injury|1|||
149204460|NCT01335698|538215063|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
149204461|NCT01335698|538215064|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
149204462|NCT01335698|538215065|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
149204463|NCT01335698|538215066|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
149204464|NCT01335698|538215062|FG000|Treatment Stage 2|Switched to another formulation|1|||
149204465|NCT01335698|538215063|FG001|Treatment Stage 2|Switched to another formulation|1|||
149204466|NCT01335698|538215064|FG002|Treatment Stage 2|Switched to another formulation|0|||
149204467|NCT01335698|538215065|FG003|Treatment Stage 2|Switched to another formulation|0|||
149204468|NCT01335698|538215066|FG004|Treatment Stage 2|Switched to another formulation|0|||
149204469|NCT01357889|538215067|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
149204470|NCT01357889|538215068|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
149204471|NCT01357889|538215067|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
149204472|NCT01357889|538215068|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
149204473|NCT01357889|538215067|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
149204474|NCT01357889|538215068|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
149204475|NCT01357889|538215067|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
149204476|NCT01357889|538215068|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
149204477|NCT01357889|538215067|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
149204478|NCT01357889|538215068|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
149204479|NCT01357889|538215067|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
149204480|NCT01357889|538215068|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
149204481|NCT01357889|538215067|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
149204482|NCT01357889|538215068|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
149204483|NCT01357889|538215067|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
149204484|NCT01357889|538215068|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
149204485|NCT01357889|538215067|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
148683290|NCT00219557|536313128|FG000|Phase 1|Lack of Efficacy|3|||
148683291|NCT00219557|536313129|FG001|Phase 1|Lack of Efficacy|0|||
148683292|NCT00219557|536313130|FG002|Phase 1|Lack of Efficacy|0|||
148683293|NCT00219557|536313128|FG000|Phase 1|Adverse Event|2|||
148683294|NCT00219557|536313129|FG001|Phase 1|Adverse Event|0|||
148683295|NCT00219557|536313130|FG002|Phase 1|Adverse Event|0|||
148947025|NCT02443987|537290271|FG001|Overall Study|Bladder injury|1|||
148947026|NCT02443987|537290270|FG000|Overall Study|Other|0|||
148947027|NCT02443987|537290271|FG001|Overall Study|Other|1|||
148947028|NCT03069378|537290276|FG000|Overall Study|Withdrawal by Subject|1|||
148947029|NCT01397708|537290277|FG000|Overall Study|Withdrawal by Subject|0|||
148947030|NCT01397708|537290278|FG001|Overall Study|Withdrawal by Subject|0|||
148947031|NCT01397708|537290279|FG002|Overall Study|Withdrawal by Subject|1|||
148947032|NCT01397708|537290280|FG003|Overall Study|Withdrawal by Subject|0|||
148947033|NCT01397708|537290281|FG004|Overall Study|Withdrawal by Subject|0|||
148947034|NCT01397708|537290282|FG005|Overall Study|Withdrawal by Subject|0|||
148683296|NCT00219557|536313128|FG000|Phase 1|Withdrawal by Subject|1|||
148947035|NCT01397708|537290283|FG006|Overall Study|Withdrawal by Subject|0|||
148947036|NCT01397708|537290284|FG007|Overall Study|Withdrawal by Subject|1|||
148947037|NCT01397708|537290277|FG000|Overall Study|Death|0|||
148683297|NCT00219557|536313129|FG001|Phase 1|Withdrawal by Subject|0|||
148683298|NCT00219557|536313130|FG002|Phase 1|Withdrawal by Subject|0|||
148683299|NCT00219557|536313128|FG000|Phase 1|Started chemotherapy at other institute|1|||
148683300|NCT00219557|536313129|FG001|Phase 1|Started chemotherapy at other institute|0|||
148683301|NCT00219557|536313130|FG002|Phase 1|Started chemotherapy at other institute|0|||
148683302|NCT00219557|536313128|FG000|Phase 2|Lack of Efficacy|0|||
148683303|NCT00219557|536313129|FG001|Phase 2|Lack of Efficacy|21|||
148683304|NCT00219557|536313130|FG002|Phase 2|Lack of Efficacy|15|||
148683305|NCT00219557|536313128|FG000|Phase 2|Adverse Event|0|||
148683306|NCT00219557|536313129|FG001|Phase 2|Adverse Event|22|||
148683307|NCT00219557|536313130|FG002|Phase 2|Adverse Event|2|||
148683308|NCT00219557|536313128|FG000|Phase 2|Death|0|||
148683309|NCT00219557|536313129|FG001|Phase 2|Death|8|||
148683310|NCT00219557|536313130|FG002|Phase 2|Death|2|||
148683311|NCT00219557|536313128|FG000|Phase 2|Other|0|||
148683312|NCT00219557|536313129|FG001|Phase 2|Other|8|||
148683313|NCT00219557|536313130|FG002|Phase 2|Other|6|||
148683314|NCT00219557|536313128|FG000|Phase 2|Withdrawal by Subject|0|||
148683315|NCT00219557|536313129|FG001|Phase 2|Withdrawal by Subject|9|||
148683316|NCT00219557|536313130|FG002|Phase 2|Withdrawal by Subject|5|||
148683317|NCT00219557|536313128|FG000|Phase 2|Treatment not received|0|||
148683318|NCT00219557|536313129|FG001|Phase 2|Treatment not received|1|||
148683319|NCT00219557|536313130|FG002|Phase 2|Treatment not received|3|||
148683320|NCT03063632|536313137|FG000|Overall Study|Death|4|||
148683321|NCT03063632|536313138|FG001|Overall Study|Death|6|||
148683322|NCT03063632|536313137|FG000|Overall Study|Lost to Follow-up|0|||
148683323|NCT03063632|536313138|FG001|Overall Study|Lost to Follow-up|1|||
148683324|NCT03063632|536313137|FG000|Overall Study|Withdrawal by Subject|0|||
148947038|NCT01397708|537290278|FG001|Overall Study|Death|0|||
148947039|NCT01397708|537290279|FG002|Overall Study|Death|1|||
148947040|NCT01397708|537290280|FG003|Overall Study|Death|1|||
148947041|NCT01397708|537290281|FG004|Overall Study|Death|0|||
148947042|NCT01397708|537290282|FG005|Overall Study|Death|0|||
148683325|NCT03063632|536313138|FG001|Overall Study|Withdrawal by Subject|2|||
148808811|NCT01799889|536777545|FG001|Overall Study|Death|0|||
148947043|NCT01397708|537290283|FG006|Overall Study|Death|0|||
148947044|NCT01397708|537290284|FG007|Overall Study|Death|0|||
148683326|NCT03063632|536313137|FG000|Overall Study|Physician Decision|2|||
148683327|NCT03063632|536313138|FG001|Overall Study|Physician Decision|0|||
148947045|NCT01397708|537290277|FG000|Overall Study|Lost to Follow-up|0|||
148947046|NCT01397708|537290278|FG001|Overall Study|Lost to Follow-up|0|||
148947047|NCT01397708|537290279|FG002|Overall Study|Lost to Follow-up|0|||
148947048|NCT01397708|537290280|FG003|Overall Study|Lost to Follow-up|0|||
148947049|NCT01397708|537290281|FG004|Overall Study|Lost to Follow-up|1|||
149204486|NCT01357889|538215068|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
148683328|NCT03063632|536313137|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
148683329|NCT03063632|536313138|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
148683330|NCT03652961|536313141|FG000|Overall Study|Lost to Follow-up|3|||
148683331|NCT03652961|536313141|FG000|Overall Study|Screen Failure|1|||
148683332|NCT02741271|536313142|FG000|Overall Study|Lost to Follow-up|2|||
148683333|NCT02741271|536313143|FG001|Overall Study|Lost to Follow-up|0|||
148808812|NCT01799889|536777546|FG002|Overall Study|Death|5|||
148947050|NCT01397708|537290282|FG005|Overall Study|Lost to Follow-up|0|||
148683334|NCT02741271|536313142|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148683335|NCT02741271|536313143|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
148808813|NCT01799889|536777547|FG003|Overall Study|Death|3|||
148808814|NCT01799889|536777548|FG004|Overall Study|Death|1|||
148808815|NCT01799889|536777549|FG005|Overall Study|Death|0|||
148947051|NCT01397708|537290283|FG006|Overall Study|Lost to Follow-up|0|||
148947052|NCT01397708|537290284|FG007|Overall Study|Lost to Follow-up|0|||
148947053|NCT01397708|537290277|FG000|Overall Study|Other|0|||
148947054|NCT01397708|537290278|FG001|Overall Study|Other|0|||
148947055|NCT01397708|537290279|FG002|Overall Study|Other|0|||
148947056|NCT01397708|537290280|FG003|Overall Study|Other|0|||
148947057|NCT01397708|537290281|FG004|Overall Study|Other|0|||
148947058|NCT01397708|537290282|FG005|Overall Study|Other|0|||
148683336|NCT00410410|536313144|FG000|Induction Period (IP)|Death|1|||
148683337|NCT00410410|536313145|FG001|Induction Period (IP)|Death|0|||
148683338|NCT00410410|536313146|FG002|Induction Period (IP)|Death|0|||
148683339|NCT00410410|536313147|FG003|Induction Period (IP)|Death|0|||
148683340|NCT00410410|536313148|FG004|Induction Period (IP)|Death|0|||
148683341|NCT00410410|536313149|FG005|Induction Period (IP)|Death|0|||
148683342|NCT00410410|536313150|FG006|Induction Period (IP)|Death|0|||
148683343|NCT00410410|536313151|FG007|Induction Period (IP)|Death|0|||
148683344|NCT00410410|536313152|FG008|Induction Period (IP)|Death|0|||
148683345|NCT00410410|536313144|FG000|Induction Period (IP)|Adverse Event|3|||
148683346|NCT00410410|536313145|FG001|Induction Period (IP)|Adverse Event|4|||
148683347|NCT00410410|536313146|FG002|Induction Period (IP)|Adverse Event|2|||
148683348|NCT00410410|536313147|FG003|Induction Period (IP)|Adverse Event|4|||
148683349|NCT00410410|536313148|FG004|Induction Period (IP)|Adverse Event|1|||
148683350|NCT00410410|536313149|FG005|Induction Period (IP)|Adverse Event|0|||
148683351|NCT00410410|536313150|FG006|Induction Period (IP)|Adverse Event|0|||
148683352|NCT00410410|536313151|FG007|Induction Period (IP)|Adverse Event|0|||
148683353|NCT00410410|536313152|FG008|Induction Period (IP)|Adverse Event|0|||
148683354|NCT00410410|536313144|FG000|Induction Period (IP)|Lack of Efficacy|26|||
148683355|NCT00410410|536313145|FG001|Induction Period (IP)|Lack of Efficacy|24|||
148683356|NCT00410410|536313146|FG002|Induction Period (IP)|Lack of Efficacy|8|||
148683357|NCT00410410|536313147|FG003|Induction Period (IP)|Lack of Efficacy|8|||
148683358|NCT00410410|536313148|FG004|Induction Period (IP)|Lack of Efficacy|7|||
148947059|NCT01397708|537290283|FG006|Overall Study|Other|1|||
148947060|NCT01397708|537290284|FG007|Overall Study|Other|0|||
148947061|NCT01638546|537290295|FG000|Overall Study|Adverse Event|1|||
148947062|NCT01638546|537290296|FG001|Overall Study|Adverse Event|3|||
148947063|NCT05330702|537290297|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
148947064|NCT05330702|537290298|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
148947065|NCT05330702|537290299|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
148947066|NCT02881554|537290300|FG000|Overall Study|Withdrawal by Subject|2|||
148947067|NCT02881554|537290301|FG001|Overall Study|Withdrawal by Subject|0|||
148947068|NCT00844831|537291812|FG000|Overall Study|Withdrawal by Subject|4|||
148947069|NCT00844831|537291812|FG000|Overall Study|Adverse Event|1|||
148947070|NCT00844831|537291812|FG000|Overall Study|Physician Decision|1|||
148947071|NCT01315678|537291813|FG000|Overall Study|Withdrawal by Subject|7|||
148947072|NCT01315678|537291814|FG001|Overall Study|Withdrawal by Subject|3|||
148947073|NCT01315678|537291813|FG000|Overall Study|Adverse Event|3|||
148947074|NCT01315678|537291814|FG001|Overall Study|Adverse Event|1|||
148947075|NCT01315678|537291813|FG000|Overall Study|Lost to Follow-up|1|||
148947076|NCT01315678|537291814|FG001|Overall Study|Lost to Follow-up|0|||
149204487|NCT01357889|538215067|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
148683359|NCT00410410|536313149|FG005|Induction Period (IP)|Lack of Efficacy|7|||
148683360|NCT00410410|536313150|FG006|Induction Period (IP)|Lack of Efficacy|0|||
148683361|NCT00410410|536313151|FG007|Induction Period (IP)|Lack of Efficacy|0|||
148683362|NCT00410410|536313152|FG008|Induction Period (IP)|Lack of Efficacy|0|||
148808816|NCT01799889|536777550|FG006|Overall Study|Death|0|||
148683363|NCT00410410|536313144|FG000|Induction Period (IP)|Lost to Follow-up|2|||
148683364|NCT00410410|536313145|FG001|Induction Period (IP)|Lost to Follow-up|2|||
148683365|NCT00410410|536313146|FG002|Induction Period (IP)|Lost to Follow-up|2|||
148683366|NCT00410410|536313147|FG003|Induction Period (IP)|Lost to Follow-up|3|||
148683367|NCT00410410|536313148|FG004|Induction Period (IP)|Lost to Follow-up|0|||
148808817|NCT01799889|536777551|FG007|Overall Study|Death|0|||
148947077|NCT01315678|537291813|FG000|Overall Study|similar reason to those listed above|3|||
148947078|NCT01315678|537291814|FG001|Overall Study|similar reason to those listed above|2|||
148947079|NCT03633695|537291820|FG000|Overall Study|Lost to Follow-up|4|||
149204488|NCT01357889|538215068|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
148683368|NCT00410410|536313149|FG005|Induction Period (IP)|Lost to Follow-up|1|||
148683369|NCT00410410|536313150|FG006|Induction Period (IP)|Lost to Follow-up|0|||
148683370|NCT00410410|536313151|FG007|Induction Period (IP)|Lost to Follow-up|0|||
148947080|NCT03633695|537291821|FG001|Overall Study|Lost to Follow-up|5|||
148947081|NCT03633695|537291820|FG000|Overall Study|Discontinued|8|||
148808818|NCT01799889|536777552|FG008|Overall Study|Death|1|||
148947082|NCT03633695|537291821|FG001|Overall Study|Discontinued|4|||
148947083|NCT00429273|537291822|FG000|Overall Study|Lost to Follow-up|1|||
148947084|NCT00429273|537291823|FG001|Overall Study|Lost to Follow-up|2|||
149204489|NCT01357889|538215067|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
149204490|NCT01357889|538215068|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
149204491|NCT01357889|538215067|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
149204492|NCT01357889|538215068|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
149204493|NCT01357889|538215067|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
149204494|NCT01357889|538215068|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
149204495|NCT01170221|538215069|FG000|Overall Study|Lost to Follow-up|22|||
149204496|NCT01170221|538215070|FG001|Overall Study|Lost to Follow-up|21|||
149204497|NCT01170221|538215069|FG000|Overall Study|Withdrawal by Subject|9|||
149204498|NCT01170221|538215070|FG001|Overall Study|Withdrawal by Subject|7|||
149204499|NCT01170221|538215069|FG000|Overall Study|Subject completed only screening and LFU|1|||
149204500|NCT01170221|538215070|FG001|Overall Study|Subject completed only screening and LFU|0|||
149204501|NCT01170221|538215069|FG000|Overall Study|Randomized but not treated|1|||
149204502|NCT01170221|538215070|FG001|Overall Study|Randomized but not treated|0|||
149204503|NCT03589885|538215072|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
149204504|NCT03589885|538215073|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
149204505|NCT03589885|538215074|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
149204506|NCT03589885|538215075|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
149204507|NCT03589885|538215076|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
149204508|NCT03589885|538215072|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149204509|NCT03589885|538215073|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149204510|NCT03589885|538215074|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
149204511|NCT03589885|538215075|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149204512|NCT03589885|538215076|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
149204513|NCT03589885|538215072|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149204514|NCT03589885|538215073|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
149204515|NCT03589885|538215074|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149204516|NCT03589885|538215075|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149204517|NCT03589885|538215076|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
149204518|NCT03589885|538215072|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149204519|NCT03589885|538215073|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149204520|NCT03589885|538215074|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
149204521|NCT03589885|538215075|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149204522|NCT03589885|538215076|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
149204523|NCT03589885|538215072|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
149204524|NCT03589885|538215073|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
149204525|NCT03589885|538215074|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
149204526|NCT03589885|538215075|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
149204527|NCT03589885|538215076|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
148683371|NCT00410410|536313152|FG008|Induction Period (IP)|Lost to Follow-up|0|||
148683372|NCT00410410|536313144|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
148683373|NCT00410410|536313145|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
148683374|NCT00410410|536313146|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
148683375|NCT00410410|536313147|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
148683376|NCT00410410|536313148|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
148683377|NCT00410410|536313149|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
148683378|NCT00410410|536313150|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
148683379|NCT00410410|536313151|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
148683380|NCT00410410|536313152|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
148947085|NCT00429273|537291824|FG002|Overall Study|Lost to Follow-up|2|||
148947086|NCT00429273|537291822|FG000|Overall Study|Physician Decision|6|||
148947087|NCT00429273|537291823|FG001|Overall Study|Physician Decision|5|||
148947088|NCT00429273|537291824|FG002|Overall Study|Physician Decision|5|||
148947089|NCT00429273|537291822|FG000|Overall Study|Adverse Event|1|||
148947090|NCT00429273|537291823|FG001|Overall Study|Adverse Event|1|||
148947091|NCT00429273|537291824|FG002|Overall Study|Adverse Event|2|||
149204528|NCT03589885|538215072|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
149204529|NCT03589885|538215073|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
149204530|NCT03589885|538215074|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
149204531|NCT03589885|538215075|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
149204532|NCT03589885|538215076|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
149204533|NCT03589885|538215072|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
149204534|NCT03589885|538215073|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
149204535|NCT03589885|538215074|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
149204536|NCT03589885|538215075|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
149204537|NCT03589885|538215076|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
149204538|NCT03589885|538215072|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149204539|NCT03589885|538215073|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
148947092|NCT00884312|537291826|FG000|Overall Study|Non-fatal Progressive Disease|0|||
148947093|NCT00884312|537291827|FG001|Overall Study|Non-fatal Progressive Disease|8|||
148947094|NCT00884312|537291826|FG000|Overall Study|Fatal Progressive Disease|0|||
148947095|NCT00884312|537291827|FG001|Overall Study|Fatal Progressive Disease|1|||
149204540|NCT03589885|538215074|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149204541|NCT03589885|538215075|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149204542|NCT03589885|538215076|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
149204543|NCT02031432|538215079|FG000|Overall Study|Protocol Violation|1|||
149204544|NCT02031432|538215079|FG000|Overall Study|Lack of Efficacy|5|||
149204545|NCT02031432|538215079|FG000|Overall Study|Cancer Progression|2|||
149204546|NCT02031432|538215079|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
149204547|NCT02031432|538215079|FG000|Overall Study|Adverse Event|8|||
149204548|NCT02031432|538215079|FG000|Overall Study|Withdrawal by Subject|5|||
149204549|NCT02031432|538215079|FG000|Overall Study|Lost to Follow-up|1|||
149204550|NCT02031432|538215079|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
149204551|NCT02031432|538215079|FG000|Overall Study|Death|10|||
149204552|NCT01617187|538215080|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
149204553|NCT01617187|538215081|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
149204554|NCT01617187|538215082|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
149204555|NCT01617187|538215083|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
149204556|NCT01617187|538215080|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
149204557|NCT01617187|538215081|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
149204558|NCT01617187|538215082|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
149204559|NCT01617187|538215083|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
149204560|NCT01617187|538215080|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
149204561|NCT01617187|538215081|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
149204562|NCT01617187|538215082|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
149204563|NCT01617187|538215083|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
149204564|NCT01617187|538215080|FG000|Treatment Through Study Completion|Adverse Event|1|||
149204565|NCT01617187|538215081|FG001|Treatment Through Study Completion|Adverse Event|1|||
148683381|NCT00410410|536313144|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683382|NCT00410410|536313145|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683383|NCT00410410|536313146|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
148683384|NCT00410410|536313147|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683385|NCT00410410|536313148|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683386|NCT00410410|536313149|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683387|NCT00410410|536313150|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683388|NCT00410410|536313151|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683389|NCT00410410|536313152|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
148683390|NCT00410410|536313144|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683391|NCT00410410|536313145|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683392|NCT00410410|536313146|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683393|NCT00410410|536313147|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683394|NCT00410410|536313148|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
148683395|NCT00410410|536313149|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
148683396|NCT00410410|536313150|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683397|NCT00410410|536313151|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683398|NCT00410410|536313152|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
148683399|NCT00410410|536313144|FG000|Induction Period (IP)|Other|0|||
148683400|NCT00410410|536313145|FG001|Induction Period (IP)|Other|0|||
148683401|NCT00410410|536313146|FG002|Induction Period (IP)|Other|1|||
148683402|NCT00410410|536313147|FG003|Induction Period (IP)|Other|0|||
148683403|NCT00410410|536313148|FG004|Induction Period (IP)|Other|0|||
148683404|NCT00410410|536313149|FG005|Induction Period (IP)|Other|0|||
148683405|NCT00410410|536313150|FG006|Induction Period (IP)|Other|0|||
148683406|NCT00410410|536313151|FG007|Induction Period (IP)|Other|0|||
148683407|NCT00410410|536313152|FG008|Induction Period (IP)|Other|0|||
148683408|NCT00410410|536313144|FG000|Maintenance Period (MP)|Death|0|||
148683409|NCT00410410|536313145|FG001|Maintenance Period (MP)|Death|0|||
148683410|NCT00410410|536313146|FG002|Maintenance Period (MP)|Death|0|||
148808819|NCT01799889|536777553|FG009|Overall Study|Death|0|||
148808820|NCT01799889|536777554|FG010|Overall Study|Death|1|||
148947096|NCT00884312|537291826|FG000|Overall Study|Non-fatal Adverse Event|1|||
149204566|NCT01617187|538215082|FG002|Treatment Through Study Completion|Adverse Event|0|||
148808821|NCT01799889|536777555|FG011|Overall Study|Death|0|||
148808822|NCT01799889|536777544|FG000|Overall Study|Lack of Efficacy|1|||
148683411|NCT00410410|536313147|FG003|Maintenance Period (MP)|Death|0|||
148683412|NCT00410410|536313148|FG004|Maintenance Period (MP)|Death|0|||
148808823|NCT01799889|536777545|FG001|Overall Study|Lack of Efficacy|1|||
148683413|NCT00410410|536313149|FG005|Maintenance Period (MP)|Death|0|||
148683414|NCT00410410|536313150|FG006|Maintenance Period (MP)|Death|1|||
148683415|NCT00410410|536313151|FG007|Maintenance Period (MP)|Death|0|||
148683416|NCT00410410|536313152|FG008|Maintenance Period (MP)|Death|0|||
148683417|NCT00410410|536313144|FG000|Maintenance Period (MP)|Adverse Event|0|||
148683418|NCT00410410|536313145|FG001|Maintenance Period (MP)|Adverse Event|0|||
148683419|NCT00410410|536313146|FG002|Maintenance Period (MP)|Adverse Event|0|||
148683420|NCT00410410|536313147|FG003|Maintenance Period (MP)|Adverse Event|0|||
148683421|NCT00410410|536313148|FG004|Maintenance Period (MP)|Adverse Event|0|||
148683422|NCT00410410|536313149|FG005|Maintenance Period (MP)|Adverse Event|0|||
148683423|NCT00410410|536313150|FG006|Maintenance Period (MP)|Adverse Event|1|||
148683424|NCT00410410|536313151|FG007|Maintenance Period (MP)|Adverse Event|3|||
148683425|NCT00410410|536313152|FG008|Maintenance Period (MP)|Adverse Event|0|||
148683426|NCT00410410|536313144|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
148683427|NCT00410410|536313145|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
148683428|NCT00410410|536313146|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
148683429|NCT00410410|536313147|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
148683430|NCT00410410|536313148|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
148683431|NCT00410410|536313149|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
148683432|NCT00410410|536313150|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
148683433|NCT00410410|536313151|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
149204567|NCT01617187|538215083|FG003|Treatment Through Study Completion|Adverse Event|1|||
149204568|NCT01617187|538215080|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
149204569|NCT01617187|538215081|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
149204570|NCT01617187|538215082|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
149204571|NCT01617187|538215083|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
149204572|NCT01617187|538215080|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
149204573|NCT01617187|538215081|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
149204574|NCT01617187|538215082|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
149204575|NCT01617187|538215083|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
149204576|NCT01617187|538215080|FG000|Treatment Through Study Completion|Protocol Violation|1|||
149204577|NCT01617187|538215081|FG001|Treatment Through Study Completion|Protocol Violation|0|||
149204578|NCT01617187|538215082|FG002|Treatment Through Study Completion|Protocol Violation|0|||
149204579|NCT01617187|538215083|FG003|Treatment Through Study Completion|Protocol Violation|1|||
149204580|NCT01561560|538215093|FG000|First Two Weeks of Wear|Time/job conflict|0|||
149204581|NCT01561560|538215094|FG001|First Two Weeks of Wear|Time/job conflict|1|||
149204582|NCT01561560|538215093|FG000|First Two Weeks of Wear|Adverse Event|0|||
149204583|NCT01561560|538215094|FG001|First Two Weeks of Wear|Adverse Event|1|||
149204584|NCT01561560|538215093|FG000|Second Two Weeks of Wear|Adverse Event|0|||
149204585|NCT01561560|538215094|FG001|Second Two Weeks of Wear|Adverse Event|1|||
149204586|NCT05406440|538217457|FG000|Overall Study|Lost to Follow-up|0|||
149204587|NCT05406440|538217458|FG001|Overall Study|Lost to Follow-up|0|||
149204588|NCT05406440|538217459|FG002|Overall Study|Lost to Follow-up|0|||
149204589|NCT05406440|538217460|FG003|Overall Study|Lost to Follow-up|0|||
149204590|NCT05406440|538217461|FG004|Overall Study|Lost to Follow-up|2|||
149204591|NCT05406440|538217462|FG005|Overall Study|Lost to Follow-up|0|||
149204592|NCT05406440|538217463|FG006|Overall Study|Lost to Follow-up|0|||
149204593|NCT05406440|538217457|FG000|Overall Study|Physician Decision|0|||
149204594|NCT05406440|538217458|FG001|Overall Study|Physician Decision|0|||
149204595|NCT05406440|538217459|FG002|Overall Study|Physician Decision|0|||
149204596|NCT05406440|538217460|FG003|Overall Study|Physician Decision|0|||
148683434|NCT00410410|536313152|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
148683435|NCT00410410|536313144|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
148683436|NCT00410410|536313145|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
148683437|NCT00410410|536313146|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
148683438|NCT00410410|536313147|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
148683439|NCT00410410|536313148|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
148683440|NCT00410410|536313149|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
148683441|NCT00410410|536313150|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
148683442|NCT00410410|536313151|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
148683443|NCT00410410|536313152|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
149204597|NCT05406440|538217461|FG004|Overall Study|Physician Decision|1|||
149204598|NCT05406440|538217462|FG005|Overall Study|Physician Decision|0|||
148683444|NCT00410410|536313144|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
148683445|NCT00410410|536313145|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
149204599|NCT05406440|538217463|FG006|Overall Study|Physician Decision|0|||
149204600|NCT05406440|538217457|FG000|Overall Study|Withdrawal by Subject|0|||
149204601|NCT05406440|538217458|FG001|Overall Study|Withdrawal by Subject|0|||
149204602|NCT05406440|538217459|FG002|Overall Study|Withdrawal by Subject|0|||
149204603|NCT05406440|538217460|FG003|Overall Study|Withdrawal by Subject|0|||
149204604|NCT05406440|538217461|FG004|Overall Study|Withdrawal by Subject|0|||
149204605|NCT05406440|538217462|FG005|Overall Study|Withdrawal by Subject|2|||
149204606|NCT05406440|538217463|FG006|Overall Study|Withdrawal by Subject|0|||
148683446|NCT00410410|536313146|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
149204607|NCT00859573|538217464|FG000|Overall Study|Withdrawal by Subject|4|||
149204608|NCT00859573|538217465|FG001|Overall Study|Withdrawal by Subject|1|||
148947097|NCT00884312|537291827|FG001|Overall Study|Non-fatal Adverse Event|0|||
148947098|NCT00884312|537291826|FG000|Overall Study|Fatal Adverse Event|1|||
148947099|NCT00884312|537291827|FG001|Overall Study|Fatal Adverse Event|4|||
148947100|NCT00884312|537291826|FG000|Overall Study|Withdrawal by Subject|0|||
148947101|NCT00884312|537291827|FG001|Overall Study|Withdrawal by Subject|6|||
148947102|NCT00884312|537291826|FG000|Overall Study|Physician Decision|0|||
148947103|NCT00884312|537291827|FG001|Overall Study|Physician Decision|1|||
148947104|NCT00884312|537291826|FG000|Overall Study|Other|0|||
149204609|NCT00859573|538217464|FG000|Overall Study|Physician Decision|1|||
149204610|NCT00859573|538217465|FG001|Overall Study|Physician Decision|1|||
149204611|NCT03488238|538217466|FG000|Overall Study|Equipment malfunction|1|||
149204612|NCT03488238|538217466|FG000|Overall Study|Adverse Event|1|||
149204613|NCT01316939|538217467|FG000|Overall Study|Study closed/terminated|26|||
149204614|NCT01316939|538217468|FG001|Overall Study|Study closed/terminated|25|||
149204615|NCT01316939|538217469|FG002|Overall Study|Study closed/terminated|23|||
149204616|NCT01316939|538217467|FG000|Overall Study|Lack of Efficacy|24|||
149204617|NCT01316939|538217468|FG001|Overall Study|Lack of Efficacy|25|||
149204618|NCT01316939|538217469|FG002|Overall Study|Lack of Efficacy|25|||
149204619|NCT01316939|538217467|FG000|Overall Study|Adverse Event|9|||
149204620|NCT01316939|538217468|FG001|Overall Study|Adverse Event|12|||
149204621|NCT01316939|538217469|FG002|Overall Study|Adverse Event|11|||
149204622|NCT01316939|538217467|FG000|Overall Study|Withdrawal by Subject|1|||
149204623|NCT01316939|538217468|FG001|Overall Study|Withdrawal by Subject|3|||
149204624|NCT01316939|538217469|FG002|Overall Study|Withdrawal by Subject|6|||
149204625|NCT01316939|538217467|FG000|Overall Study|Physician Decision|2|||
149204626|NCT01316939|538217468|FG001|Overall Study|Physician Decision|2|||
149204627|NCT01316939|538217469|FG002|Overall Study|Physician Decision|1|||
149204628|NCT01316939|538217467|FG000|Overall Study|Lost to Follow-up|0|||
149204629|NCT01316939|538217468|FG001|Overall Study|Lost to Follow-up|0|||
149204630|NCT01316939|538217469|FG002|Overall Study|Lost to Follow-up|2|||
149204631|NCT01316939|538217467|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
149204632|NCT01316939|538217468|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
149204633|NCT01316939|538217469|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
149204634|NCT01316939|538217467|FG000|Overall Study|Protocol Violation|0|||
149204635|NCT01316939|538217468|FG001|Overall Study|Protocol Violation|1|||
148947105|NCT00884312|537291827|FG001|Overall Study|Other|4|||
148947106|NCT00884312|537291826|FG000|Overall Study|Did Not Receive Study Drug|0|||
149204636|NCT01316939|538217469|FG002|Overall Study|Protocol Violation|0|||
149204637|NCT01432457|538217470|FG000|Overall Study|Adverse Event|7|||
149204638|NCT01432457|538217471|FG001|Overall Study|Adverse Event|10|||
149204639|NCT01432457|538217472|FG002|Overall Study|Adverse Event|16|||
149204640|NCT01432457|538217470|FG000|Overall Study|Lack of Efficacy|2|||
149204641|NCT01432457|538217471|FG001|Overall Study|Lack of Efficacy|1|||
149204642|NCT01432457|538217472|FG002|Overall Study|Lack of Efficacy|1|||
149204643|NCT01432457|538217470|FG000|Overall Study|Lost to Follow-up|11|||
149204644|NCT01432457|538217471|FG001|Overall Study|Lost to Follow-up|15|||
149204645|NCT01432457|538217472|FG002|Overall Study|Lost to Follow-up|20|||
149204646|NCT01432457|538217470|FG000|Overall Study|Protocol Violation|3|||
149204647|NCT01432457|538217471|FG001|Overall Study|Protocol Violation|2|||
149204648|NCT01432457|538217472|FG002|Overall Study|Protocol Violation|6|||
149204649|NCT01432457|538217470|FG000|Overall Study|Withdrawal by Subject|6|||
149204650|NCT01432457|538217471|FG001|Overall Study|Withdrawal by Subject|11|||
149204651|NCT01432457|538217472|FG002|Overall Study|Withdrawal by Subject|9|||
149204652|NCT01432457|538217470|FG000|Overall Study|Reasons not defined|2|||
148947107|NCT00884312|537291827|FG001|Overall Study|Did Not Receive Study Drug|1|||
148947108|NCT02548650|537291831|FG000|Triple Therapy|Adverse Event|1|||
148947109|NCT02548650|537291832|FG001|Triple Therapy|Adverse Event|0|||
149204653|NCT01432457|538217471|FG001|Overall Study|Reasons not defined|3|||
149204654|NCT01432457|538217472|FG002|Overall Study|Reasons not defined|4|||
149204655|NCT01432457|538217470|FG000|Overall Study|Did not take study drug|6|||
149204656|NCT01432457|538217471|FG001|Overall Study|Did not take study drug|6|||
149204657|NCT01432457|538217472|FG002|Overall Study|Did not take study drug|3|||
149204658|NCT04134728|538217473|FG000|Overall Study|Adverse Event|3|||
149204659|NCT04134728|538217474|FG001|Overall Study|Adverse Event|2|||
149204660|NCT04134728|538217475|FG002|Overall Study|Adverse Event|9|||
149204661|NCT04134728|538217476|FG003|Overall Study|Adverse Event|0|||
149204662|NCT04134728|538217477|FG004|Overall Study|Adverse Event|0|||
149204663|NCT04134728|538217478|FG005|Overall Study|Adverse Event|0|||
149204664|NCT04134728|538217473|FG000|Overall Study|Lack of Efficacy|3|||
149204665|NCT04134728|538217474|FG001|Overall Study|Lack of Efficacy|3|||
149204666|NCT04134728|538217475|FG002|Overall Study|Lack of Efficacy|1|||
149204667|NCT04134728|538217476|FG003|Overall Study|Lack of Efficacy|2|||
149204668|NCT04134728|538217477|FG004|Overall Study|Lack of Efficacy|0|||
148947110|NCT02548650|537291831|FG000|Triple Therapy|Withdrawal by Subject|0|||
149204669|NCT04134728|538217478|FG005|Overall Study|Lack of Efficacy|0|||
149204670|NCT04134728|538217473|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
148947111|NCT02548650|537291832|FG001|Triple Therapy|Withdrawal by Subject|4|||
148947112|NCT02548650|537291831|FG000|Double Therapy|Adverse Event|1|||
148947113|NCT02548650|537291832|FG001|Double Therapy|Adverse Event|1|||
148947114|NCT02548650|537291831|FG000|Double Therapy|Withdrawal by Subject|0|||
148947115|NCT02548650|537291832|FG001|Double Therapy|Withdrawal by Subject|1|||
149204671|NCT04134728|538217474|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149204672|NCT04134728|538217475|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
149204673|NCT04134728|538217476|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149204674|NCT04134728|538217477|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149204675|NCT04134728|538217478|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149204676|NCT04134728|538217473|FG000|Overall Study|Protocol Deviation|0|||
149204677|NCT04134728|538217474|FG001|Overall Study|Protocol Deviation|0|||
149204678|NCT04134728|538217475|FG002|Overall Study|Protocol Deviation|1|||
149204679|NCT04134728|538217476|FG003|Overall Study|Protocol Deviation|0|||
149204680|NCT04134728|538217477|FG004|Overall Study|Protocol Deviation|0|||
149204681|NCT04134728|538217478|FG005|Overall Study|Protocol Deviation|0|||
149204682|NCT04134728|538217473|FG000|Overall Study|Informed Consent Withdrawn|3|||
149204683|NCT04134728|538217474|FG001|Overall Study|Informed Consent Withdrawn|6|||
149204684|NCT04134728|538217475|FG002|Overall Study|Informed Consent Withdrawn|8|||
149204685|NCT04134728|538217476|FG003|Overall Study|Informed Consent Withdrawn|1|||
149204686|NCT04134728|538217477|FG004|Overall Study|Informed Consent Withdrawn|1|||
149204687|NCT04134728|538217478|FG005|Overall Study|Informed Consent Withdrawn|0|||
149204688|NCT04134728|538217473|FG000|Overall Study|Physician Decision|2|||
149204689|NCT04134728|538217474|FG001|Overall Study|Physician Decision|0|||
149204690|NCT04134728|538217475|FG002|Overall Study|Physician Decision|0|||
149204691|NCT04134728|538217476|FG003|Overall Study|Physician Decision|0|||
149204692|NCT04134728|538217477|FG004|Overall Study|Physician Decision|0|||
149204693|NCT04134728|538217478|FG005|Overall Study|Physician Decision|0|||
149204694|NCT04134728|538217473|FG000|Overall Study|Lost to Follow-up|1|||
149204695|NCT04134728|538217474|FG001|Overall Study|Lost to Follow-up|2|||
149204696|NCT04134728|538217475|FG002|Overall Study|Lost to Follow-up|1|||
149204697|NCT04134728|538217476|FG003|Overall Study|Lost to Follow-up|0|||
149204698|NCT04134728|538217477|FG004|Overall Study|Lost to Follow-up|0|||
149204699|NCT04134728|538217478|FG005|Overall Study|Lost to Follow-up|1|||
149204700|NCT04134728|538217473|FG000|Overall Study|Investigator Site Closed|0|||
149204701|NCT04134728|538217474|FG001|Overall Study|Investigator Site Closed|1|||
149204702|NCT04134728|538217475|FG002|Overall Study|Investigator Site Closed|1|||
149204703|NCT04134728|538217476|FG003|Overall Study|Investigator Site Closed|0|||
148808824|NCT01799889|536777546|FG002|Overall Study|Lack of Efficacy|0|||
148808825|NCT01799889|536777547|FG003|Overall Study|Lack of Efficacy|1|||
148808826|NCT01799889|536777548|FG004|Overall Study|Lack of Efficacy|2|||
148808827|NCT01799889|536777549|FG005|Overall Study|Lack of Efficacy|2|||
148947116|NCT02128113|537291834|FG000|Overall Study|Withdrawal by Subject|3|||
148808828|NCT01799889|536777550|FG006|Overall Study|Lack of Efficacy|0|||
148947117|NCT02128113|537291835|FG001|Overall Study|Withdrawal by Subject|1|||
148947118|NCT02128113|537291836|FG002|Overall Study|Withdrawal by Subject|0|||
148808829|NCT01799889|536777551|FG007|Overall Study|Lack of Efficacy|0|||
148947119|NCT02128113|537291834|FG000|Overall Study|Protocol Violation|0|||
149204704|NCT04134728|538217477|FG004|Overall Study|Investigator Site Closed|0|||
149204705|NCT04134728|538217478|FG005|Overall Study|Investigator Site Closed|0|||
149204706|NCT01175590|538217484|FG000|Overall Study|Lost to Follow-up|1|||
149204707|NCT01175590|538217485|FG001|Overall Study|Lost to Follow-up|0|||
149204708|NCT01175590|538217484|FG000|Overall Study|Withdrawal by Subject|0|||
149204709|NCT01175590|538217485|FG001|Overall Study|Withdrawal by Subject|2|||
149204710|NCT01175590|538217484|FG000|Overall Study|Adverse Event|4|||
149204711|NCT01175590|538217485|FG001|Overall Study|Adverse Event|0|||
149204712|NCT01175590|538217484|FG000|Overall Study|Physician Decision|1|||
149204713|NCT01175590|538217485|FG001|Overall Study|Physician Decision|4|||
149204714|NCT01175590|538217484|FG000|Overall Study|Lack of Efficacy|1|||
149204715|NCT01175590|538217485|FG001|Overall Study|Lack of Efficacy|1|||
149204716|NCT01175590|538217484|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
149204717|NCT01175590|538217485|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
149204718|NCT01175590|538217484|FG000|Overall Study|Treated not as randomized|3|||
149204719|NCT01175590|538217485|FG001|Overall Study|Treated not as randomized|2|||
149204720|NCT01175590|538217484|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
149204721|NCT01175590|538217485|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
149204722|NCT01175590|538217484|FG000|Overall Study|Protocol Violation|0|||
149204723|NCT01175590|538217485|FG001|Overall Study|Protocol Violation|1|||
149204724|NCT01019252|538217486|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
149204725|NCT01019252|538217487|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
149204726|NCT01019252|538217486|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
149204727|NCT01019252|538217487|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
149204728|NCT01019252|538217486|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
149204729|NCT01019252|538217487|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
149204730|NCT01019252|538217486|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
149204731|NCT01019252|538217487|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
149204732|NCT01779648|538217488|FG000|Overall Study|Protocol Violation|1|||
149204733|NCT01779648|538217489|FG001|Overall Study|Protocol Violation|0|||
149204734|NCT02384395|538217490|FG000|Overall Study|Physician Decision|4|||
149204735|NCT02384395|538217490|FG000|Overall Study|Withdrawal by Subject|3|||
149204736|NCT02384395|538217490|FG000|Overall Study|Lost to Follow-up|3|||
149204737|NCT03351478|538217495|FG000|Overall Study|At the subject's own request|11|||
149204738|NCT03351478|538217496|FG001|Overall Study|At the subject's own request|12|||
149204739|NCT03351478|538217497|FG002|Overall Study|At the subject's own request|5|||
149204740|NCT03351478|538217495|FG000|Overall Study|Adverse Event|1|||
149204741|NCT03351478|538217496|FG001|Overall Study|Adverse Event|2|||
149016324|NCT05027074|537537902|FG000|Overall Study|Withdrawal by Subject|13|||
148683447|NCT00410410|536313147|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
148683448|NCT00410410|536313148|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
148683449|NCT00410410|536313149|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
148683450|NCT00410410|536313150|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
149204742|NCT03351478|538217497|FG002|Overall Study|Adverse Event|1|||
149204743|NCT03351478|538217495|FG000|Overall Study|Poor compliance to protocol|1|||
149204744|NCT03351478|538217496|FG001|Overall Study|Poor compliance to protocol|0|||
149204745|NCT03351478|538217497|FG002|Overall Study|Poor compliance to protocol|0|||
149204746|NCT03351478|538217495|FG000|Overall Study|Reason not Specified|1|||
149204747|NCT03351478|538217496|FG001|Overall Study|Reason not Specified|3|||
149204748|NCT03351478|538217497|FG002|Overall Study|Reason not Specified|0|||
148947120|NCT02128113|537291835|FG001|Overall Study|Protocol Violation|1|||
148947121|NCT02128113|537291836|FG002|Overall Study|Protocol Violation|0|||
148947122|NCT02128113|537291834|FG000|Overall Study|Surgery cancelled|0|||
148947123|NCT02128113|537291835|FG001|Overall Study|Surgery cancelled|1|||
148947124|NCT02128113|537291836|FG002|Overall Study|Surgery cancelled|0|||
148947125|NCT02128113|537291834|FG000|Overall Study|Adverse Event|0|||
148947126|NCT02128113|537291835|FG001|Overall Study|Adverse Event|0|||
148947127|NCT02128113|537291836|FG002|Overall Study|Adverse Event|1|||
148947128|NCT00299104|537291837|FG000|Treatment Period|Adverse Event|14|||
148947129|NCT00299104|537291838|FG001|Treatment Period|Adverse Event|9|||
149204749|NCT03351478|538217495|FG000|Overall Study|Lost to Follow-up|0|||
149204750|NCT03351478|538217496|FG001|Overall Study|Lost to Follow-up|0|||
149204751|NCT03351478|538217497|FG002|Overall Study|Lost to Follow-up|1|||
149204752|NCT03485222|538217498|FG000|Overall Study|Death|0|||
149204753|NCT03485222|538217499|FG001|Overall Study|Death|1|||
149204754|NCT03485222|538217498|FG000|Overall Study|Lost to Follow-up|2|||
149204755|NCT03485222|538217499|FG001|Overall Study|Lost to Follow-up|1|||
149204756|NCT03657810|538217502|FG000|Overall Study|Adverse Event|0|||
149204757|NCT03657810|538217503|FG001|Overall Study|Adverse Event|1|||
149204758|NCT03657810|538217504|FG002|Overall Study|Adverse Event|0|||
149204759|NCT03657810|538217502|FG000|Overall Study|Lack of Efficacy|4|||
149204760|NCT03657810|538217503|FG001|Overall Study|Lack of Efficacy|1|||
149204761|NCT03657810|538217504|FG002|Overall Study|Lack of Efficacy|3|||
149204762|NCT03657810|538217502|FG000|Overall Study|Protocol Violation|1|||
149204763|NCT03657810|538217503|FG001|Overall Study|Protocol Violation|0|||
149204764|NCT03657810|538217504|FG002|Overall Study|Protocol Violation|0|||
149204765|NCT03657810|538217502|FG000|Overall Study|Lost to Follow-up|0|||
149204766|NCT03657810|538217503|FG001|Overall Study|Lost to Follow-up|1|||
149204767|NCT03657810|538217504|FG002|Overall Study|Lost to Follow-up|0|||
149204768|NCT03657810|538217502|FG000|Overall Study|Not provided|0|||
149204769|NCT03657810|538217503|FG001|Overall Study|Not provided|1|||
149204770|NCT03657810|538217504|FG002|Overall Study|Not provided|0|||
149204771|NCT03911869|538217505|FG000|Safety Lead-in Phase|Death|7|||
149204772|NCT03911869|538217506|FG001|Safety Lead-in Phase|Death|0|||
149204773|NCT03911869|538217507|FG002|Safety Lead-in Phase|Death|0|||
149204774|NCT03911869|538217505|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
149204775|NCT03911869|538217506|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
148947130|NCT00299104|537291839|FG002|Treatment Period|Adverse Event|7|||
148947131|NCT00299104|537291837|FG000|Treatment Period|Death|1|||
148947132|NCT00299104|537291838|FG001|Treatment Period|Death|1|||
148947133|NCT00299104|537291839|FG002|Treatment Period|Death|1|||
148947134|NCT00299104|537291837|FG000|Treatment Period|Insufficient therapeutic response|34|||
148947135|NCT00299104|537291838|FG001|Treatment Period|Insufficient therapeutic response|13|||
148947136|NCT00299104|537291839|FG002|Treatment Period|Insufficient therapeutic response|8|||
148947137|NCT00299104|537291837|FG000|Treatment Period|Failure to return|9|||
148947138|NCT00299104|537291838|FG001|Treatment Period|Failure to return|8|||
148947139|NCT00299104|537291839|FG002|Treatment Period|Failure to return|8|||
148947140|NCT00299104|537291837|FG000|Treatment Period|Violation of selection criteria|1|||
148947141|NCT00299104|537291838|FG001|Treatment Period|Violation of selection criteria|2|||
148947142|NCT00299104|537291839|FG002|Treatment Period|Violation of selection criteria|0|||
148947143|NCT00299104|537291837|FG000|Treatment Period|Protocol Violation|1|||
149204776|NCT03911869|538217507|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
149204777|NCT03911869|538217505|FG000|Safety Lead-in Phase|Other|1|||
149204778|NCT03911869|538217506|FG001|Safety Lead-in Phase|Other|0|||
149204779|NCT03911869|538217507|FG002|Safety Lead-in Phase|Other|0|||
149204780|NCT03911869|538217505|FG000|Phase 2|Death|0|||
149204781|NCT03911869|538217506|FG001|Phase 2|Death|3|||
148947144|NCT00299104|537291838|FG001|Treatment Period|Protocol Violation|1|||
148947145|NCT00299104|537291839|FG002|Treatment Period|Protocol Violation|0|||
149204782|NCT03911869|538217507|FG002|Phase 2|Death|0|||
149204783|NCT00985738|538217510|FG000|Overall Study|Study closed prematurely|8|||
149204784|NCT00985738|538217511|FG001|Overall Study|Study closed prematurely|8|||
149204785|NCT00367341|538217512|FG000|Overall Study|Physician Decision|1|||
149204786|NCT00367341|538217513|FG001|Overall Study|Physician Decision|0|||
149204787|NCT00367341|538217512|FG000|Overall Study|Protocol Violation|1|||
148683451|NCT00410410|536313151|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
149204788|NCT00367341|538217513|FG001|Overall Study|Protocol Violation|0|||
148947146|NCT00299104|537291837|FG000|Treatment Period|Refused treatment|9|||
148947147|NCT00299104|537291838|FG001|Treatment Period|Refused treatment|2|||
148947148|NCT00299104|537291839|FG002|Treatment Period|Refused treatment|2|||
148947149|NCT00299104|537291837|FG000|Treatment Period|Withdrew consent|14|||
149204789|NCT03325556|538217514|FG000|Open-label Period|Lack of Response in OL period|70|||
148947150|NCT00299104|537291838|FG001|Treatment Period|Withdrew consent|19|||
149204790|NCT03325556|538217515|FG001|Open-label Period|Lack of Response in OL period|0|||
149204791|NCT03325556|538217516|FG002|Open-label Period|Lack of Response in OL period|0|||
149204792|NCT03325556|538217514|FG000|Open-label Period|Adverse Event|27|||
149204793|NCT03325556|538217515|FG001|Open-label Period|Adverse Event|0|||
149204794|NCT03325556|538217516|FG002|Open-label Period|Adverse Event|0|||
149204795|NCT03325556|538217514|FG000|Open-label Period|Death|1|||
149204796|NCT03325556|538217515|FG001|Open-label Period|Death|0|||
149204797|NCT03325556|538217516|FG002|Open-label Period|Death|0|||
149204798|NCT03325556|538217514|FG000|Open-label Period|Lost to Follow-up|1|||
149204799|NCT03325556|538217515|FG001|Open-label Period|Lost to Follow-up|0|||
149204800|NCT03325556|538217516|FG002|Open-label Period|Lost to Follow-up|0|||
149204801|NCT03325556|538217514|FG000|Open-label Period|Non-compliance with study drug|5|||
149204802|NCT03325556|538217515|FG001|Open-label Period|Non-compliance with study drug|0|||
149204803|NCT03325556|538217516|FG002|Open-label Period|Non-compliance with study drug|0|||
149204804|NCT03325556|538217514|FG000|Open-label Period|Use of prohibited medication|1|||
149204805|NCT03325556|538217515|FG001|Open-label Period|Use of prohibited medication|0|||
149204806|NCT03325556|538217516|FG002|Open-label Period|Use of prohibited medication|0|||
149204807|NCT03325556|538217514|FG000|Open-label Period|Protocol Violation|4|||
149204808|NCT03325556|538217515|FG001|Open-label Period|Protocol Violation|0|||
149204809|NCT03325556|538217516|FG002|Open-label Period|Protocol Violation|0|||
149204810|NCT03325556|538217514|FG000|Open-label Period|Withdrawal by Subject|17|||
149204811|NCT03325556|538217515|FG001|Open-label Period|Withdrawal by Subject|0|||
149204812|NCT03325556|538217516|FG002|Open-label Period|Withdrawal by Subject|0|||
149204813|NCT03325556|538217514|FG000|Open-label Period|Not otherwise specified|8|||
149204814|NCT03325556|538217515|FG001|Open-label Period|Not otherwise specified|0|||
149204815|NCT03325556|538217516|FG002|Open-label Period|Not otherwise specified|0|||
149204816|NCT03325556|538217514|FG000|Open-label Period|Administrative discont. at study termination|41|||
149204817|NCT03325556|538217515|FG001|Open-label Period|Administrative discont. at study termination|0|||
149204818|NCT03325556|538217516|FG002|Open-label Period|Administrative discont. at study termination|0|||
149204819|NCT03325556|538217514|FG000|Double-blind Period|Relapse|0|||
149204820|NCT03325556|538217515|FG001|Double-blind Period|Relapse|15|||
149204821|NCT03325556|538217516|FG002|Double-blind Period|Relapse|34|||
149204822|NCT03325556|538217514|FG000|Double-blind Period|Adverse Event|0|||
149204823|NCT03325556|538217515|FG001|Double-blind Period|Adverse Event|3|||
149204824|NCT03325556|538217516|FG002|Double-blind Period|Adverse Event|1|||
149204825|NCT03325556|538217514|FG000|Double-blind Period|Noncompliance with study drug|0|||
149204826|NCT03325556|538217515|FG001|Double-blind Period|Noncompliance with study drug|0|||
149204827|NCT03325556|538217516|FG002|Double-blind Period|Noncompliance with study drug|1|||
149204828|NCT03325556|538217514|FG000|Double-blind Period|Use of prohibited medication|0|||
149204829|NCT03325556|538217515|FG001|Double-blind Period|Use of prohibited medication|1|||
149204830|NCT03325556|538217516|FG002|Double-blind Period|Use of prohibited medication|0|||
149204831|NCT03325556|538217514|FG000|Double-blind Period|Physician Decision|0|||
149204832|NCT03325556|538217515|FG001|Double-blind Period|Physician Decision|0|||
149204833|NCT03325556|538217516|FG002|Double-blind Period|Physician Decision|1|||
149204834|NCT03325556|538217514|FG000|Double-blind Period|Withdrawal by Subject|0|||
149204835|NCT03325556|538217515|FG001|Double-blind Period|Withdrawal by Subject|6|||
149204836|NCT03325556|538217516|FG002|Double-blind Period|Withdrawal by Subject|4|||
149204837|NCT03325556|538217514|FG000|Double-blind Period|Not otherwise specified|0|||
149204838|NCT03325556|538217515|FG001|Double-blind Period|Not otherwise specified|1|||
149204839|NCT03325556|538217516|FG002|Double-blind Period|Not otherwise specified|5|||
149204840|NCT03325556|538217514|FG000|Double-blind Period|Administrative discont. at study termination|0|||
149204841|NCT03325556|538217515|FG001|Double-blind Period|Administrative discont. at study termination|35|||
149204842|NCT03325556|538217516|FG002|Double-blind Period|Administrative discont. at study termination|31|||
149204843|NCT01705587|538217517|FG000|Overall Study|Withdrawal by Subject|0|||
149204844|NCT01705587|538217518|FG001|Overall Study|Withdrawal by Subject|1|||
149204845|NCT02227849|538217519|FG000|Overall Study|Adverse Event|4|||
149204846|NCT02227849|538217519|FG000|Overall Study|Physician Decision|1|||
148947151|NCT00299104|537291839|FG002|Treatment Period|Withdrew consent|9|||
149204847|NCT02227849|538217519|FG000|Overall Study|Withdrawal by Subject|3|||
149204848|NCT02119026|538217520|FG000|1st-line Treatment|Adverse Event|9|||
149204849|NCT02119026|538217521|FG001|1st-line Treatment|Adverse Event|14|||
149204850|NCT02119026|538217520|FG000|1st-line Treatment|Physician Decision|3|||
149204851|NCT02119026|538217521|FG001|1st-line Treatment|Physician Decision|8|||
149204852|NCT02119026|538217520|FG000|1st-line Treatment|Withdrawal by Subject|4|||
149204853|NCT02119026|538217521|FG001|1st-line Treatment|Withdrawal by Subject|10|||
149204854|NCT02119026|538217520|FG000|1st-line Treatment|Patient condition or compliance|6|||
149204855|NCT02119026|538217521|FG001|1st-line Treatment|Patient condition or compliance|4|||
149204856|NCT02119026|538217520|FG000|1st-line Treatment|Surgery of metastases|2|||
149204857|NCT02119026|538217521|FG001|1st-line Treatment|Surgery of metastases|1|||
149204858|NCT02119026|538217520|FG000|1st-line Treatment|Death|2|||
149204859|NCT02119026|538217521|FG001|1st-line Treatment|Death|1|||
149204860|NCT02119026|538217520|FG000|2nd-line Treatment|Lost to Follow-up|2|||
149204861|NCT02119026|538217521|FG001|2nd-line Treatment|Lost to Follow-up|0|||
149204862|NCT02119026|538217520|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
149204863|NCT02119026|538217521|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
149204864|NCT02119026|538217520|FG000|2nd-line Treatment|Adverse Event|4|||
149204865|NCT02119026|538217521|FG001|2nd-line Treatment|Adverse Event|1|||
149204866|NCT01373918|538217524|FG000|Overall Study|Physician Decision|0|||
149204867|NCT01373918|538217525|FG001|Overall Study|Physician Decision|1|||
149204868|NCT00340834|538217526|FG000|Core Phase of Study|Adverse Event|26|||
149204869|NCT00340834|538217527|FG001|Core Phase of Study|Adverse Event|9|||
149204870|NCT00340834|538217528|FG002|Core Phase of Study|Adverse Event|9|||
149204871|NCT00340834|538217529|FG003|Core Phase of Study|Adverse Event|0|||
149204872|NCT00340834|538217530|FG004|Core Phase of Study|Adverse Event|0|||
149204873|NCT00340834|538217526|FG000|Core Phase of Study|Withdrawal by Subject|11|||
149204874|NCT00340834|538217527|FG001|Core Phase of Study|Withdrawal by Subject|9|||
149204875|NCT00340834|538217528|FG002|Core Phase of Study|Withdrawal by Subject|16|||
149204876|NCT00340834|538217529|FG003|Core Phase of Study|Withdrawal by Subject|0|||
149204877|NCT00340834|538217530|FG004|Core Phase of Study|Withdrawal by Subject|0|||
149204878|NCT00340834|538217526|FG000|Core Phase of Study|Administrative Problems|6|||
149204879|NCT00340834|538217527|FG001|Core Phase of Study|Administrative Problems|2|||
149204880|NCT00340834|538217528|FG002|Core Phase of Study|Administrative Problems|7|||
149204881|NCT00340834|538217529|FG003|Core Phase of Study|Administrative Problems|0|||
149204882|NCT00340834|538217530|FG004|Core Phase of Study|Administrative Problems|0|||
149204883|NCT00340834|538217526|FG000|Core Phase of Study|Lack of Efficacy|3|||
149204884|NCT00340834|538217527|FG001|Core Phase of Study|Lack of Efficacy|3|||
149204885|NCT00340834|538217528|FG002|Core Phase of Study|Lack of Efficacy|7|||
148683452|NCT00410410|536313152|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
148683453|NCT00410410|536313144|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148683454|NCT00410410|536313145|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148683455|NCT00410410|536313146|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148683456|NCT00410410|536313147|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148683457|NCT00410410|536313148|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148808830|NCT01799889|536777552|FG008|Overall Study|Lack of Efficacy|2|||
148808831|NCT01799889|536777553|FG009|Overall Study|Lack of Efficacy|0|||
148808832|NCT01799889|536777554|FG010|Overall Study|Lack of Efficacy|1|||
148947152|NCT00299104|537291837|FG000|Treatment Period|Administrative reasons|106|||
148947153|NCT00299104|537291838|FG001|Treatment Period|Administrative reasons|120|||
148947154|NCT00299104|537291839|FG002|Treatment Period|Administrative reasons|137|||
148947155|NCT00299104|537291837|FG000|Safety Follow-Up (SFU) Period|Death|3|||
148947156|NCT00299104|537291838|FG001|Safety Follow-Up (SFU) Period|Death|2|||
148947157|NCT00299104|537291839|FG002|Safety Follow-Up (SFU) Period|Death|1|||
148947158|NCT00299104|537291837|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
149204886|NCT00340834|538217529|FG003|Core Phase of Study|Lack of Efficacy|0|||
149204887|NCT00340834|538217530|FG004|Core Phase of Study|Lack of Efficacy|0|||
149204888|NCT00340834|538217526|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
149204889|NCT00340834|538217527|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
149204890|NCT00340834|538217528|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
149204891|NCT00340834|538217529|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
149204892|NCT00340834|538217530|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
149204893|NCT00340834|538217526|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
149204894|NCT00340834|538217527|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
149204895|NCT00340834|538217528|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
149204896|NCT00340834|538217529|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
149204897|NCT00340834|538217530|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
149204898|NCT00340834|538217526|FG000|Core Phase of Study|Lost to Follow-up|1|||
149204899|NCT00340834|538217527|FG001|Core Phase of Study|Lost to Follow-up|1|||
149204900|NCT00340834|538217528|FG002|Core Phase of Study|Lost to Follow-up|4|||
149204901|NCT00340834|538217529|FG003|Core Phase of Study|Lost to Follow-up|0|||
149204902|NCT00340834|538217530|FG004|Core Phase of Study|Lost to Follow-up|0|||
149204903|NCT00340834|538217526|FG000|Core Phase of Study|Death|2|||
148947159|NCT00299104|537291838|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
148947160|NCT00299104|537291839|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
148947161|NCT00299104|537291837|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
148947162|NCT00299104|537291838|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
148947163|NCT00299104|537291839|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
148947164|NCT00299104|537291837|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
148947165|NCT00299104|537291838|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
148947166|NCT00299104|537291839|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
149204904|NCT00340834|538217527|FG001|Core Phase of Study|Death|0|||
149204905|NCT00340834|538217528|FG002|Core Phase of Study|Death|0|||
149204906|NCT00340834|538217529|FG003|Core Phase of Study|Death|0|||
149204907|NCT00340834|538217530|FG004|Core Phase of Study|Death|0|||
149204908|NCT00340834|538217526|FG000|Core Phase of Study|Protocol Violation|0|||
149204909|NCT00340834|538217527|FG001|Core Phase of Study|Protocol Violation|0|||
149204910|NCT00340834|538217528|FG002|Core Phase of Study|Protocol Violation|2|||
149204911|NCT00340834|538217529|FG003|Core Phase of Study|Protocol Violation|0|||
149204912|NCT00340834|538217530|FG004|Core Phase of Study|Protocol Violation|0|||
149204913|NCT00340834|538217526|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
149204914|NCT00340834|538217527|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
149204915|NCT00340834|538217528|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
149204916|NCT00340834|538217529|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
149204917|NCT00340834|538217530|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
149204918|NCT00340834|538217526|FG000|Extension Phase of Study|Subject withdrew consent|26|||
149204919|NCT00340834|538217527|FG001|Extension Phase of Study|Subject withdrew consent|31|||
149204920|NCT00340834|538217528|FG002|Extension Phase of Study|Subject withdrew consent|0|||
149204921|NCT00340834|538217529|FG003|Extension Phase of Study|Subject withdrew consent|12|||
149204922|NCT00340834|538217530|FG004|Extension Phase of Study|Subject withdrew consent|15|||
149204923|NCT00340834|538217526|FG000|Extension Phase of Study|Adverse Event|21|||
149204924|NCT00340834|538217527|FG001|Extension Phase of Study|Adverse Event|22|||
149204925|NCT00340834|538217528|FG002|Extension Phase of Study|Adverse Event|0|||
149204926|NCT00340834|538217529|FG003|Extension Phase of Study|Adverse Event|19|||
149204927|NCT00340834|538217530|FG004|Extension Phase of Study|Adverse Event|7|||
149204928|NCT00340834|538217526|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
149204929|NCT00340834|538217527|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
149204930|NCT00340834|538217528|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
149204931|NCT00340834|538217529|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
149204932|NCT00340834|538217530|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
149204933|NCT00340834|538217526|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
148683458|NCT00410410|536313149|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148683459|NCT00410410|536313150|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
148683460|NCT00410410|536313151|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
148683461|NCT00410410|536313152|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
148683462|NCT00410410|536313144|FG000|Open-Label Period (OL)|Death|0|||
148683463|NCT00410410|536313145|FG001|Open-Label Period (OL)|Death|0|||
148683464|NCT00410410|536313146|FG002|Open-Label Period (OL)|Death|0|||
148683465|NCT00410410|536313147|FG003|Open-Label Period (OL)|Death|0|||
148683466|NCT00410410|536313148|FG004|Open-Label Period (OL)|Death|0|||
148683467|NCT00410410|536313149|FG005|Open-Label Period (OL)|Death|0|||
148683468|NCT00410410|536313150|FG006|Open-Label Period (OL)|Death|0|||
148683469|NCT00410410|536313151|FG007|Open-Label Period (OL)|Death|0|||
148683470|NCT00410410|536313152|FG008|Open-Label Period (OL)|Death|1|||
148683471|NCT00410410|536313144|FG000|Open-Label Period (OL)|Adverse Event|0|||
148683472|NCT00410410|536313145|FG001|Open-Label Period (OL)|Adverse Event|0|||
148683473|NCT00410410|536313146|FG002|Open-Label Period (OL)|Adverse Event|0|||
148683474|NCT00410410|536313147|FG003|Open-Label Period (OL)|Adverse Event|0|||
148683475|NCT00410410|536313148|FG004|Open-Label Period (OL)|Adverse Event|0|||
148683476|NCT00410410|536313149|FG005|Open-Label Period (OL)|Adverse Event|0|||
148683477|NCT00410410|536313150|FG006|Open-Label Period (OL)|Adverse Event|0|||
148808833|NCT01799889|536777555|FG011|Overall Study|Lack of Efficacy|0|||
148947167|NCT00299104|537291837|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
149204934|NCT00340834|538217527|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
149204935|NCT00340834|538217528|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
149204936|NCT00340834|538217529|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
149204937|NCT00340834|538217530|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
149204938|NCT00340834|538217526|FG000|Extension Phase of Study|Lost to Follow-up|1|||
149204939|NCT00340834|538217527|FG001|Extension Phase of Study|Lost to Follow-up|1|||
148683478|NCT00410410|536313151|FG007|Open-Label Period (OL)|Adverse Event|0|||
148947168|NCT00299104|537291838|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
148947169|NCT00299104|537291839|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
149204940|NCT00340834|538217528|FG002|Extension Phase of Study|Lost to Follow-up|0|||
148683479|NCT00410410|536313152|FG008|Open-Label Period (OL)|Adverse Event|10|||
148947170|NCT00299104|537291837|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
148947171|NCT00299104|537291838|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
148947172|NCT00299104|537291839|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
148947173|NCT00299104|537291837|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
148947174|NCT00299104|537291838|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
148947175|NCT00299104|537291839|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
148947176|NCT00299104|537291837|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
148947177|NCT00299104|537291838|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
148947178|NCT00299104|537291839|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
148947179|NCT00521014|537291852|FG000|Overall Study|Inevaluable, not treated|1|||
148947180|NCT02244606|537291853|FG000|Overall Study|Adverse Event|0|||
148947181|NCT02244606|537291854|FG001|Overall Study|Adverse Event|1|||
148947182|NCT02244606|537291855|FG002|Overall Study|Adverse Event|1|||
148947183|NCT02244606|537291856|FG003|Overall Study|Adverse Event|0|||
148947184|NCT02244606|537291853|FG000|Overall Study|Lost to Follow-up|2|||
148947185|NCT02244606|537291854|FG001|Overall Study|Lost to Follow-up|2|||
148947186|NCT02244606|537291855|FG002|Overall Study|Lost to Follow-up|1|||
148947187|NCT02244606|537291856|FG003|Overall Study|Lost to Follow-up|0|||
148947188|NCT02244606|537291853|FG000|Overall Study|Protocol Violation|0|||
148947189|NCT02244606|537291854|FG001|Overall Study|Protocol Violation|0|||
148947190|NCT02244606|537291855|FG002|Overall Study|Protocol Violation|0|||
148947191|NCT02244606|537291856|FG003|Overall Study|Protocol Violation|1|||
148947192|NCT02244606|537291853|FG000|Overall Study|Withdrawal by Subject|1|||
148947193|NCT02244606|537291854|FG001|Overall Study|Withdrawal by Subject|1|||
148947194|NCT02244606|537291855|FG002|Overall Study|Withdrawal by Subject|0|||
148947195|NCT02244606|537291856|FG003|Overall Study|Withdrawal by Subject|0|||
148947196|NCT02244606|537291853|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
148947197|NCT02244606|537291854|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
148947198|NCT02244606|537291855|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
148947199|NCT02244606|537291856|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
148947200|NCT01402492|537291857|FG000|Overall Study|Withdrawal by Subject|17|||
148947201|NCT01402492|537291858|FG001|Overall Study|Withdrawal by Subject|11|||
148947202|NCT01402492|537291859|FG002|Overall Study|Withdrawal by Subject|11|||
148947203|NCT01402492|537291857|FG000|Overall Study|Adverse Event|2|||
148947204|NCT01402492|537291858|FG001|Overall Study|Adverse Event|3|||
148947205|NCT01402492|537291859|FG002|Overall Study|Adverse Event|4|||
148947206|NCT01402492|537291857|FG000|Overall Study|Physician Decision|0|||
148947207|NCT01402492|537291858|FG001|Overall Study|Physician Decision|3|||
148947208|NCT01402492|537291859|FG002|Overall Study|Physician Decision|0|||
148947209|NCT01402492|537291857|FG000|Overall Study|Incarcerated (N=3)|2|||
148947210|NCT01402492|537291858|FG001|Overall Study|Incarcerated (N=3)|0|||
148947211|NCT01402492|537291859|FG002|Overall Study|Incarcerated (N=3)|1|||
148947212|NCT01336764|537291860|FG000|Overall Study|Withdrawal by Subject|5|||
148947213|NCT01336764|537291861|FG001|Overall Study|Withdrawal by Subject|5|||
148947214|NCT02573311|537291862|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
148947215|NCT02573311|537291863|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
148947216|NCT02573311|537291862|FG000|Disposition for Part 2|Physician Decision|25|||
148947217|NCT02573311|537291863|FG001|Disposition for Part 2|Physician Decision|7|||
148947218|NCT02573311|537291862|FG000|Disposition for Part 2|Adverse Event|36|||
149204941|NCT00340834|538217529|FG003|Extension Phase of Study|Lost to Follow-up|2|||
149204942|NCT00340834|538217530|FG004|Extension Phase of Study|Lost to Follow-up|3|||
149204943|NCT00340834|538217526|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
149204944|NCT00340834|538217527|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
149204945|NCT00340834|538217528|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
149204946|NCT00340834|538217529|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
149204947|NCT00340834|538217530|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
149204948|NCT00340834|538217526|FG000|Extension Phase of Study|Administrative problems|3|||
149204949|NCT00340834|538217527|FG001|Extension Phase of Study|Administrative problems|0|||
148947219|NCT02573311|537291863|FG001|Disposition for Part 2|Adverse Event|5|||
148947220|NCT02573311|537291862|FG000|Disposition for Part 2|Lost to Follow-up|76|||
149204950|NCT00340834|538217528|FG002|Extension Phase of Study|Administrative problems|0|||
149204951|NCT00340834|538217529|FG003|Extension Phase of Study|Administrative problems|1|||
148947221|NCT02573311|537291863|FG001|Disposition for Part 2|Lost to Follow-up|7|||
148947222|NCT02573311|537291862|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
148947223|NCT02573311|537291863|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
148947224|NCT02573311|537291862|FG000|Disposition for Part 2|Investigator decision|0|||
148947225|NCT02573311|537291863|FG001|Disposition for Part 2|Investigator decision|1|||
148947226|NCT02573311|537291862|FG000|Disposition for Part 2|Other than specified above|13|||
148947227|NCT02573311|537291863|FG001|Disposition for Part 2|Other than specified above|3|||
148947228|NCT05537883|537291865|FG000|Overall Study|revisional surgery|4|||
149204952|NCT00340834|538217530|FG004|Extension Phase of Study|Administrative problems|1|||
148947229|NCT05537883|537291866|FG001|Overall Study|revisional surgery|2|||
148947230|NCT05537883|537291865|FG000|Overall Study|surgeries were cancelled|0|||
149204953|NCT00340834|538217526|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
148947231|NCT05537883|537291866|FG001|Overall Study|surgeries were cancelled|2|||
148947232|NCT05537883|537291865|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
148947233|NCT05537883|537291866|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
148947234|NCT02099708|537291867|FG000|Overall Study|Data Not Available|30|||
148947235|NCT02099708|537291867|FG000|Overall Study|Lost to Follow-up|141|||
148947236|NCT02099708|537291867|FG000|Overall Study|Other|29|||
148947237|NCT05229406|537291868|FG000|Overall Study|Withdrawal by Subject|1|||
148947238|NCT05229406|537291869|FG001|Overall Study|Withdrawal by Subject|2|||
148947239|NCT01658072|537291870|FG000|Overall Study|Protocol Violation|4|||
148947240|NCT01658072|537291871|FG001|Overall Study|Protocol Violation|2|||
148947241|NCT03208244|537291872|FG000|Overall Study|Death|1|||
148947242|NCT00040664|537291873|FG000|Overall Study|Adverse Event|12|||
148947243|NCT00040664|537291874|FG001|Overall Study|Adverse Event|3|||
148947244|NCT00040664|537291875|FG002|Overall Study|Adverse Event|2|||
148947245|NCT00040664|537291876|FG003|Overall Study|Adverse Event|7|||
148947246|NCT00040664|537291873|FG000|Overall Study|Lack of Efficacy|9|||
148947247|NCT00040664|537291874|FG001|Overall Study|Lack of Efficacy|2|||
148947248|NCT00040664|537291875|FG002|Overall Study|Lack of Efficacy|3|||
148947249|NCT00040664|537291876|FG003|Overall Study|Lack of Efficacy|4|||
148947250|NCT00040664|537291873|FG000|Overall Study|Insufficient CD4 response|1|||
149204954|NCT00340834|538217527|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
149204955|NCT00340834|538217528|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
149204956|NCT00340834|538217529|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
149204957|NCT00340834|538217530|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
149204958|NCT00340834|538217526|FG000|Extension Phase of Study|Protocol Violation|3|||
149204959|NCT00340834|538217527|FG001|Extension Phase of Study|Protocol Violation|0|||
149204960|NCT00340834|538217528|FG002|Extension Phase of Study|Protocol Violation|0|||
149204961|NCT00340834|538217529|FG003|Extension Phase of Study|Protocol Violation|0|||
149204962|NCT00340834|538217530|FG004|Extension Phase of Study|Protocol Violation|0|||
149204963|NCT00340834|538217526|FG000|Extension Phase of Study|Death|0|||
149204964|NCT00340834|538217527|FG001|Extension Phase of Study|Death|0|||
149204965|NCT00340834|538217528|FG002|Extension Phase of Study|Death|0|||
149204966|NCT00340834|538217529|FG003|Extension Phase of Study|Death|0|||
149204967|NCT00340834|538217530|FG004|Extension Phase of Study|Death|1|||
149204968|NCT00762268|538217531|FG000|Overall Study|Withdrawal by Subject|3|||
149204969|NCT00762268|538217532|FG001|Overall Study|Withdrawal by Subject|3|||
149204970|NCT00291499|538217533|FG000|Overall Study|Adverse Event|3|||
149204971|NCT00291499|538217534|FG001|Overall Study|Adverse Event|8|||
149204972|NCT00291499|538217533|FG000|Overall Study|Change to other therapy|2|||
149204973|NCT00291499|538217534|FG001|Overall Study|Change to other therapy|1|||
149204974|NCT00291499|538217533|FG000|Overall Study|Intercurrent illness|1|||
149204975|NCT00291499|538217534|FG001|Overall Study|Intercurrent illness|0|||
149204976|NCT00291499|538217533|FG000|Overall Study|Protocol Violation|2|||
149204977|NCT00291499|538217534|FG001|Overall Study|Protocol Violation|2|||
149204978|NCT00291499|538217533|FG000|Overall Study|Other reasons|1|||
149204979|NCT00291499|538217534|FG001|Overall Study|Other reasons|4|||
149204980|NCT04897594|538217539|FG000|Overall Study|Lost to Follow-up|0|||
149204981|NCT04897594|538217540|FG001|Overall Study|Lost to Follow-up|1|||
149204982|NCT04897594|538217541|FG002|Overall Study|Lost to Follow-up|1|||
149204983|NCT04897594|538217539|FG000|Overall Study|Sponsor Decision|0|||
149204984|NCT04897594|538217540|FG001|Overall Study|Sponsor Decision|0|||
148947251|NCT00040664|537291874|FG001|Overall Study|Insufficient CD4 response|0|||
148947252|NCT00040664|537291875|FG002|Overall Study|Insufficient CD4 response|1|||
148947253|NCT00040664|537291876|FG003|Overall Study|Insufficient CD4 response|0|||
148947254|NCT00040664|537291873|FG000|Overall Study|Lost to Follow-up|4|||
148947255|NCT00040664|537291874|FG001|Overall Study|Lost to Follow-up|2|||
148947256|NCT00040664|537291875|FG002|Overall Study|Lost to Follow-up|0|||
149204985|NCT04897594|538217541|FG002|Overall Study|Sponsor Decision|1|||
149204986|NCT04897594|538217539|FG000|Overall Study|Withdrawal by Subject|1|||
149204987|NCT04897594|538217540|FG001|Overall Study|Withdrawal by Subject|0|||
148947257|NCT00040664|537291876|FG003|Overall Study|Lost to Follow-up|2|||
148947258|NCT00040664|537291873|FG000|Overall Study|Protocol Violation|2|||
148947259|NCT00040664|537291874|FG001|Overall Study|Protocol Violation|1|||
149204988|NCT04897594|538217541|FG002|Overall Study|Withdrawal by Subject|1|||
149204989|NCT01387074|538217542|FG000|Overall Study|Lost to Follow-up|7|||
149204990|NCT01387074|538217542|FG000|Overall Study|Lack of Efficacy|1|||
149204991|NCT01532570|538217556|FG000|Overall Study|Lack of Efficacy|1|||
149204992|NCT01532570|538217557|FG001|Overall Study|Lack of Efficacy|0|||
149204993|NCT01532570|538217558|FG002|Overall Study|Lack of Efficacy|0|||
149204994|NCT01532570|538217559|FG003|Overall Study|Lack of Efficacy|0|||
149204995|NCT01532570|538217556|FG000|Overall Study|Withdrawal by Subject|0|||
149204996|NCT01532570|538217557|FG001|Overall Study|Withdrawal by Subject|1|||
149204997|NCT01532570|538217558|FG002|Overall Study|Withdrawal by Subject|0|||
149204998|NCT01532570|538217559|FG003|Overall Study|Withdrawal by Subject|0|||
149204999|NCT03892707|538217560|FG000|Overall Study|Screen failure|6|||
149205000|NCT03892707|538217561|FG001|Overall Study|Screen failure|0|||
149205001|NCT03892707|538217560|FG000|Overall Study|Pain resolution|0|||
149205002|NCT03892707|538217561|FG001|Overall Study|Pain resolution|4|||
149205003|NCT03892707|538217560|FG000|Overall Study|Withdrawal by Subject|0|||
149205004|NCT03892707|538217561|FG001|Overall Study|Withdrawal by Subject|1|||
149205005|NCT03892707|538217560|FG000|Overall Study|Other (long business trip)|0|||
149205006|NCT03892707|538217561|FG001|Overall Study|Other (long business trip)|1|||
149205007|NCT04190186|538217563|FG000|Overall Study|ILR is no longer functioning|0|||
149205008|NCT04190186|538217564|FG001|Overall Study|ILR is no longer functioning|1|||
149205009|NCT04190186|538217563|FG000|Overall Study|Lost to Follow-up|0|||
149205010|NCT04190186|538217564|FG001|Overall Study|Lost to Follow-up|1|||
149205011|NCT04190186|538217563|FG000|Overall Study|Withdrawal by Subject|2|||
149205012|NCT04190186|538217564|FG001|Overall Study|Withdrawal by Subject|0|||
149205013|NCT04190186|538217563|FG000|Overall Study|Subject choice to explant|1|||
149205014|NCT04190186|538217564|FG001|Overall Study|Subject choice to explant|0|||
149205015|NCT04190186|538217563|FG000|Overall Study|Physician Decision|0|||
149205016|NCT04190186|538217564|FG001|Overall Study|Physician Decision|1|||
149205017|NCT04190186|538217563|FG000|Overall Study|Study was stopped|4|||
149205018|NCT04190186|538217564|FG001|Overall Study|Study was stopped|5|||
149205019|NCT02141217|538217565|FG000|Overall Study|Adverse Event|1|||
149205020|NCT02141217|538217566|FG001|Overall Study|Adverse Event|2|||
149205021|NCT02141217|538217565|FG000|Overall Study|Protocol Violation|1|||
149205022|NCT02141217|538217566|FG001|Overall Study|Protocol Violation|4|||
149205023|NCT02141217|538217565|FG000|Overall Study|Withdrawal by Subject|6|||
149205024|NCT02141217|538217566|FG001|Overall Study|Withdrawal by Subject|0|||
149205025|NCT02141217|538217565|FG000|Overall Study|Lost to Follow-up|1|||
149205026|NCT02141217|538217566|FG001|Overall Study|Lost to Follow-up|1|||
149205027|NCT02141217|538217565|FG000|Overall Study|Physician Decision|1|||
149205028|NCT02141217|538217566|FG001|Overall Study|Physician Decision|0|||
149205029|NCT02141217|538217565|FG000|Overall Study|Surgical Intervention|1|||
148947260|NCT00040664|537291875|FG002|Overall Study|Protocol Violation|0|||
148947261|NCT00040664|537291876|FG003|Overall Study|Protocol Violation|1|||
148947262|NCT00040664|537291873|FG000|Overall Study|Withdrawal by Subject|7|||
148947263|NCT00040664|537291874|FG001|Overall Study|Withdrawal by Subject|0|||
148947264|NCT00040664|537291875|FG002|Overall Study|Withdrawal by Subject|3|||
148947265|NCT00040664|537291876|FG003|Overall Study|Withdrawal by Subject|4|||
148947266|NCT00040664|537291873|FG000|Overall Study|Pregnancy|3|||
148947267|NCT00040664|537291874|FG001|Overall Study|Pregnancy|0|||
148947268|NCT00040664|537291875|FG002|Overall Study|Pregnancy|0|||
148947269|NCT00040664|537291876|FG003|Overall Study|Pregnancy|3|||
148947270|NCT00040664|537291873|FG000|Overall Study|Medication adherence/compliance problems|8|||
148947271|NCT00040664|537291874|FG001|Overall Study|Medication adherence/compliance problems|2|||
148947272|NCT00040664|537291875|FG002|Overall Study|Medication adherence/compliance problems|1|||
148947273|NCT00040664|537291876|FG003|Overall Study|Medication adherence/compliance problems|5|||
148947274|NCT00040664|537291873|FG000|Overall Study|Poor taste|2|||
148947275|NCT00040664|537291874|FG001|Overall Study|Poor taste|0|||
148947276|NCT00040664|537291875|FG002|Overall Study|Poor taste|2|||
148947277|NCT00040664|537291876|FG003|Overall Study|Poor taste|0|||
148947278|NCT00040664|537291873|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
148947279|NCT00040664|537291874|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
148947280|NCT00040664|537291875|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
148947281|NCT00040664|537291876|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
148947282|NCT00040664|537291873|FG000|Overall Study|Change of formulation|2|||
149205030|NCT02141217|538217566|FG001|Overall Study|Surgical Intervention|1|||
149205031|NCT01457924|538217569|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
149205032|NCT01457924|538217570|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
149205033|NCT01457924|538217571|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
149205034|NCT01457924|538217572|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
149205035|NCT01457924|538217573|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
149205036|NCT01457924|538217569|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149205037|NCT01457924|538217570|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149205038|NCT01457924|538217571|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149205039|NCT01457924|538217572|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
149205040|NCT01457924|538217573|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
149205041|NCT01457924|538217569|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
149205042|NCT01457924|538217570|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149205043|NCT01457924|538217571|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149205044|NCT01457924|538217572|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149205045|NCT01457924|538217573|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
149205046|NCT01457924|538217569|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
149205047|NCT01457924|538217570|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
149205048|NCT01457924|538217571|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
149205049|NCT01457924|538217572|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
149205050|NCT01457924|538217573|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
149205051|NCT01457924|538217569|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
149205052|NCT01457924|538217570|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
149205053|NCT01457924|538217571|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
149205054|NCT01457924|538217572|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
149205055|NCT01457924|538217573|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
149205056|NCT01457924|538217569|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
149205057|NCT01457924|538217570|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
149205058|NCT01457924|538217571|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
149205059|NCT01457924|538217572|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
149205060|NCT01457924|538217573|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
149205061|NCT01457924|538217569|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
149205062|NCT01457924|538217570|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
149205063|NCT01457924|538217571|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
149205064|NCT01457924|538217572|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
149205065|NCT01457924|538217573|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
149205066|NCT01457924|538217569|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
149205067|NCT01457924|538217570|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
149205068|NCT01457924|538217571|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
149205069|NCT01457924|538217572|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
149205070|NCT01457924|538217573|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
149205071|NCT01457924|538217569|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149205072|NCT01457924|538217570|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149205073|NCT01457924|538217571|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149205074|NCT01457924|538217572|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
149205075|NCT01457924|538217573|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
149205076|NCT01457924|538217569|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
149205077|NCT01457924|538217570|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
149205078|NCT01457924|538217571|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
148947283|NCT00040664|537291874|FG001|Overall Study|Change of formulation|2|||
148947284|NCT00040664|537291875|FG002|Overall Study|Change of formulation|0|||
148947285|NCT00040664|537291876|FG003|Overall Study|Change of formulation|0|||
148947286|NCT00040664|537291873|FG000|Overall Study|Non-viability of oral suspension|1|||
149205079|NCT01457924|538217572|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
149205080|NCT01457924|538217573|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
148947287|NCT00040664|537291874|FG001|Overall Study|Non-viability of oral suspension|0|||
148947288|NCT00040664|537291875|FG002|Overall Study|Non-viability of oral suspension|1|||
149205081|NCT01457924|538217569|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
149205082|NCT01457924|538217570|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
149205083|NCT01457924|538217571|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
149205084|NCT01457924|538217572|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
149205085|NCT01457924|538217573|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
149205086|NCT01457924|538217569|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
149205087|NCT01457924|538217570|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
149205088|NCT01457924|538217571|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
149205089|NCT01457924|538217572|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
149205090|NCT01457924|538217573|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
149205091|NCT01457924|538217569|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
149205092|NCT01457924|538217570|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
149205093|NCT01457924|538217571|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
149205094|NCT01457924|538217572|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
149205095|NCT01457924|538217573|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
149205096|NCT01665768|538217574|FG000|Overall Study|Adverse Event|3|||
149205097|NCT01665768|538217574|FG000|Overall Study|Lack of Efficacy|19|||
148947289|NCT00040664|537291876|FG003|Overall Study|Non-viability of oral suspension|0|||
148947290|NCT03953820|537291878|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
149205098|NCT01665768|538217574|FG000|Overall Study|Withdrawal by Subject|1|||
149205099|NCT01329341|538217575|FG000|Overall Study|Withdrawal by Subject|44|||
148947291|NCT03953820|537291879|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
149205100|NCT00448760|538217576|FG000|Overall Study|Death|3|||
149205101|NCT04603391|538217579|FG000|First Intervention (4 Days)|Adverse Event|1|||
149205102|NCT04603391|538217580|FG001|First Intervention (4 Days)|Adverse Event|0|||
149205103|NCT04603391|538217579|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
149205104|NCT04603391|538217580|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
149205105|NCT05067452|538217584|FG000|Overall Study|Lost to Follow-up|0|||
148947292|NCT03953820|537291880|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
148947293|NCT03953820|537291878|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
148947294|NCT03953820|537291879|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
148947295|NCT03953820|537291880|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
148947296|NCT01233258|537291883|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
148947297|NCT01233258|537291884|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
148683480|NCT00410410|536313144|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
148683481|NCT00410410|536313145|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
148683482|NCT00410410|536313146|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
148683483|NCT00410410|536313147|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
148683484|NCT00410410|536313148|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
148683485|NCT00410410|536313149|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
148683486|NCT00410410|536313150|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
148683487|NCT00410410|536313151|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
148683488|NCT00410410|536313152|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
148947298|NCT01233258|537291885|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
148947299|NCT01233258|537291886|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
148947300|NCT01233258|537291887|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
148947301|NCT01233258|537291888|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
148947302|NCT01233258|537291883|FG000|First Intervention (6 Months)|Protocol Violation|0|||
148947303|NCT01233258|537291884|FG001|First Intervention (6 Months)|Protocol Violation|0|||
148947304|NCT01233258|537291885|FG002|First Intervention (6 Months)|Protocol Violation|1|||
148947305|NCT01233258|537291886|FG003|First Intervention (6 Months)|Protocol Violation|0|||
149205106|NCT05067452|538217585|FG001|Overall Study|Lost to Follow-up|4|||
149205107|NCT00067470|538217586|FG000|Overall Study|Withdrawal by Subject|0|||
149205108|NCT00067470|538217587|FG001|Overall Study|Withdrawal by Subject|1|||
149205109|NCT01135017|538217588|FG000|Overall Study|Adverse Event|3|||
149205110|NCT01135017|538217589|FG001|Overall Study|Adverse Event|8|||
149205111|NCT01135017|538217588|FG000|Overall Study|Other than above|3|||
149205112|NCT01135017|538217589|FG001|Overall Study|Other than above|4|||
149205113|NCT00050622|538217591|FG000|Overall Study|Adverse Event|1|||
149205114|NCT00936117|538217594|FG000|Overall Study|Adverse Event|7|||
149205115|NCT00936117|538217594|FG000|Overall Study|Unable to continue oral medication|3|||
149205116|NCT01803711|538217595|FG000|Overall Study|Adverse Event|1|||
148683489|NCT00410410|536313144|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
148683490|NCT00410410|536313145|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
148683491|NCT00410410|536313146|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
148683492|NCT00410410|536313147|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
148683493|NCT00410410|536313148|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
148947306|NCT01233258|537291887|FG004|First Intervention (6 Months)|Protocol Violation|0|||
148947307|NCT01233258|537291888|FG005|First Intervention (6 Months)|Protocol Violation|0|||
148947308|NCT01233258|537291883|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
148947309|NCT01233258|537291884|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
148947310|NCT01233258|537291885|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
148947311|NCT01233258|537291886|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
148947312|NCT01233258|537291887|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
148947313|NCT01233258|537291888|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
148683494|NCT00410410|536313149|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
148683495|NCT00410410|536313150|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
148947314|NCT00390468|537291890|FG000|Overall Study|Protocol Violation|2|||
148947315|NCT00390468|537291890|FG000|Overall Study|Lack of Efficacy|1|||
148947316|NCT01049308|537291891|FG000|Pill Counts|Withdrawal by Subject|83|||
148947317|NCT03845985|537291894|FG000|Overall Study|Lost to Follow-up|2|||
148947318|NCT03845985|537291895|FG001|Overall Study|Lost to Follow-up|1|||
148947319|NCT03845985|537291894|FG000|Overall Study|Physician Decision|1|||
148947320|NCT03845985|537291895|FG001|Overall Study|Physician Decision|0|||
148947321|NCT03845985|537291894|FG000|Overall Study|Withdrawal by Subject|4|||
148947322|NCT03845985|537291895|FG001|Overall Study|Withdrawal by Subject|1|||
148947323|NCT01318993|537291896|FG000|Overall Study|Adverse Event|53|||
148947324|NCT01318993|537291896|FG000|Overall Study|Lack of Efficacy|121|||
148947325|NCT01318993|537291896|FG000|Overall Study|Protocol Violation|3|||
148947326|NCT01318993|537291896|FG000|Overall Study|Protocol based stopping criteria|6|||
148947327|NCT01318993|537291896|FG000|Overall Study|Study closed or terminated|174|||
149205117|NCT01803711|538217596|FG001|Overall Study|Adverse Event|1|||
149205118|NCT02693691|538217597|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
149205119|NCT02693691|538217597|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
148683496|NCT00410410|536313151|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
148683497|NCT00410410|536313152|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
148947328|NCT01318993|537291896|FG000|Overall Study|Lost to Follow-up|4|||
148947329|NCT01318993|537291896|FG000|Overall Study|Physician Decision|13|||
149205120|NCT02693691|538217597|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
149205121|NCT02693691|538217597|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
148947330|NCT01318993|537291896|FG000|Overall Study|Withdrawal by Subject|24|||
148947331|NCT03334539|537291897|FG000|Overall Study|Adverse Event|3|||
149205122|NCT02693691|538217597|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
149205123|NCT02693691|538217597|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
149205124|NCT02693691|538217597|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
149205125|NCT02727660|538217598|FG000|Overall Study|Lack of Efficacy|40|||
149205126|NCT02727660|538217599|FG001|Overall Study|Lack of Efficacy|40|||
149205127|NCT02727660|538217600|FG002|Overall Study|Lack of Efficacy|70|||
149205128|NCT02727660|538217598|FG000|Overall Study|Adverse Event|28|||
149205129|NCT02727660|538217599|FG001|Overall Study|Adverse Event|21|||
149205130|NCT02727660|538217600|FG002|Overall Study|Adverse Event|32|||
149205131|NCT02727660|538217598|FG000|Overall Study|Withdrawal by Subject|26|||
149205132|NCT02727660|538217599|FG001|Overall Study|Withdrawal by Subject|25|||
149205133|NCT02727660|538217600|FG002|Overall Study|Withdrawal by Subject|30|||
149205134|NCT02727660|538217598|FG000|Overall Study|Physician Decision|3|||
149205135|NCT02727660|538217599|FG001|Overall Study|Physician Decision|8|||
149205136|NCT02727660|538217600|FG002|Overall Study|Physician Decision|14|||
149205137|NCT02727660|538217598|FG000|Overall Study|Lost to Follow-up|5|||
149205138|NCT02727660|538217599|FG001|Overall Study|Lost to Follow-up|9|||
149205139|NCT02727660|538217600|FG002|Overall Study|Lost to Follow-up|8|||
149205140|NCT02727660|538217598|FG000|Overall Study|Protocol Violation|7|||
149205141|NCT02727660|538217599|FG001|Overall Study|Protocol Violation|5|||
149205142|NCT02727660|538217600|FG002|Overall Study|Protocol Violation|5|||
149205143|NCT02727660|538217598|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
149205144|NCT02727660|538217599|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
149205145|NCT02727660|538217600|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
149205146|NCT02727660|538217598|FG000|Overall Study|Administrative Reasons|2|||
149205147|NCT02727660|538217599|FG001|Overall Study|Administrative Reasons|3|||
149205148|NCT02727660|538217600|FG002|Overall Study|Administrative Reasons|4|||
149205149|NCT03454412|538217603|FG000|Baseline Assesment|Physician Decision|12|||
149205150|NCT01167582|538217604|FG000|Overall Study|Lost to Follow-up|0|||
149205151|NCT01167582|538217605|FG001|Overall Study|Lost to Follow-up|1|||
149205152|NCT01928485|538217606|FG000|Overall Study|Physician Decision|0|||
149205153|NCT01928485|538217607|FG001|Overall Study|Physician Decision|1|||
149205154|NCT00039741|538217608|FG000|Overall Study|Death|0|||
149205155|NCT00039741|538217609|FG001|Overall Study|Death|1|||
149205156|NCT00039741|538217610|FG002|Overall Study|Death|0|||
149205157|NCT00039741|538217611|FG003|Overall Study|Death|0|||
149205158|NCT00039741|538217608|FG000|Overall Study|Lost to Follow-up|3|||
149205159|NCT00039741|538217609|FG001|Overall Study|Lost to Follow-up|1|||
149205160|NCT00039741|538217610|FG002|Overall Study|Lost to Follow-up|5|||
149205161|NCT00039741|538217611|FG003|Overall Study|Lost to Follow-up|2|||
148808834|NCT01799889|536777544|FG000|Overall Study|Lost to Follow-up|0|||
148808835|NCT01799889|536777545|FG001|Overall Study|Lost to Follow-up|1|||
148947332|NCT03334539|537291898|FG001|Overall Study|Adverse Event|5|||
149205162|NCT00039741|538217608|FG000|Overall Study|Confounding medical condition|1|||
149205163|NCT00039741|538217609|FG001|Overall Study|Confounding medical condition|0|||
149205164|NCT00039741|538217610|FG002|Overall Study|Confounding medical condition|0|||
149205165|NCT00039741|538217611|FG003|Overall Study|Confounding medical condition|0|||
149205166|NCT00039741|538217608|FG000|Overall Study|Not able to get to clinic|5|||
149205167|NCT00039741|538217609|FG001|Overall Study|Not able to get to clinic|2|||
149205168|NCT00039741|538217610|FG002|Overall Study|Not able to get to clinic|0|||
149205169|NCT00039741|538217611|FG003|Overall Study|Not able to get to clinic|3|||
149205170|NCT00039741|538217608|FG000|Overall Study|Moved|3|||
149205171|NCT00039741|538217609|FG001|Overall Study|Moved|2|||
149205172|NCT00039741|538217610|FG002|Overall Study|Moved|3|||
149205173|NCT00039741|538217611|FG003|Overall Study|Moved|6|||
149205174|NCT00039741|538217608|FG000|Overall Study|Non-compliance with protocol|1|||
149205175|NCT00039741|538217609|FG001|Overall Study|Non-compliance with protocol|0|||
149205176|NCT00039741|538217610|FG002|Overall Study|Non-compliance with protocol|1|||
149205177|NCT00039741|538217611|FG003|Overall Study|Non-compliance with protocol|0|||
149205178|NCT00039741|538217608|FG000|Overall Study|Withdrew consent|0|||
149205179|NCT00039741|538217609|FG001|Overall Study|Withdrew consent|5|||
149205180|NCT00039741|538217610|FG002|Overall Study|Withdrew consent|0|||
149205181|NCT00039741|538217611|FG003|Overall Study|Withdrew consent|1|||
149205182|NCT00039741|538217608|FG000|Overall Study|Missed final visit|2|||
149205183|NCT00039741|538217609|FG001|Overall Study|Missed final visit|1|||
149205184|NCT00039741|538217610|FG002|Overall Study|Missed final visit|2|||
149205185|NCT00039741|538217611|FG003|Overall Study|Missed final visit|2|||
149205186|NCT00946881|538217612|FG000|First Treatment|Withdrawal by Subject|1|||
149205187|NCT00946881|538217612|FG000|First Treatment|Patient relocated to another state|1|||
149205188|NCT00946881|538217612|FG000|Retreatment|Withdrawal by Subject|1|||
149205189|NCT01714817|538217614|FG000|Year 1 Period|Lack of Efficacy|11|||
149205190|NCT01714817|538217615|FG001|Year 1 Period|Lack of Efficacy|9|||
149205191|NCT01714817|538217614|FG000|Year 1 Period|Adverse Event|20|||
149205192|NCT01714817|538217615|FG001|Year 1 Period|Adverse Event|17|||
149205193|NCT01714817|538217614|FG000|Year 1 Period|Withdrawal by Subject|6|||
149205194|NCT01714817|538217615|FG001|Year 1 Period|Withdrawal by Subject|7|||
148947333|NCT03334539|537291899|FG002|Overall Study|Adverse Event|0|||
148947334|NCT03334539|537291897|FG000|Overall Study|Withdrawal by Subject|0|||
148947335|NCT03334539|537291898|FG001|Overall Study|Withdrawal by Subject|1|||
148947336|NCT03334539|537291899|FG002|Overall Study|Withdrawal by Subject|1|||
148947337|NCT03334539|537291897|FG000|Overall Study|Administrative Reasons|1|||
149205195|NCT01714817|538217614|FG000|Year 1 Period|Death|1|||
149205196|NCT01714817|538217615|FG001|Year 1 Period|Death|1|||
149205197|NCT01714817|538217614|FG000|Year 1 Period|Lost to Follow-up|0|||
149205198|NCT01714817|538217615|FG001|Year 1 Period|Lost to Follow-up|2|||
149205199|NCT01714817|538217614|FG000|Year 1 Period|Poor / non-compliance|0|||
149205200|NCT01714817|538217615|FG001|Year 1 Period|Poor / non-compliance|1|||
149205201|NCT01714817|538217614|FG000|Year 1 Period|Pregnancy|2|||
149205202|NCT01714817|538217615|FG001|Year 1 Period|Pregnancy|0|||
149205203|NCT01714817|538217614|FG000|Year 1 Period|Participant no longer meets criteria|6|||
149205204|NCT01714817|538217615|FG001|Year 1 Period|Participant no longer meets criteria|2|||
149205205|NCT01714817|538217614|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
149205206|NCT01714817|538217615|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
149205207|NCT01714817|538217614|FG000|Year 1 Period|Change in Concomitant Medication|0|||
149205208|NCT01714817|538217615|FG001|Year 1 Period|Change in Concomitant Medication|1|||
149205209|NCT01714817|538217614|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
149205210|NCT01714817|538217615|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
149205211|NCT01714817|538217614|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
149205212|NCT01714817|538217615|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
149205213|NCT01714817|538217614|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
149205214|NCT01714817|538217615|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
149205215|NCT01714817|538217614|FG000|Year 2 Period|Lack of Efficacy|4|||
149205216|NCT01714817|538217615|FG001|Year 2 Period|Lack of Efficacy|12|||
149205217|NCT01714817|538217614|FG000|Year 2 Period|Adverse Event|7|||
149205218|NCT01714817|538217615|FG001|Year 2 Period|Adverse Event|6|||
149205219|NCT01714817|538217614|FG000|Year 2 Period|Participant request to stop treatment|4|||
149205220|NCT01714817|538217615|FG001|Year 2 Period|Participant request to stop treatment|4|||
149205221|NCT01714817|538217614|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
149205222|NCT01714817|538217615|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
149205223|NCT01714817|538217614|FG000|Year 2 Period|Participant withdrew consent|1|||
149205224|NCT01714817|538217615|FG001|Year 2 Period|Participant withdrew consent|5|||
149205225|NCT01714817|538217614|FG000|Year 2 Period|Participant no longer meets criteria|1|||
149205226|NCT01714817|538217615|FG001|Year 2 Period|Participant no longer meets criteria|4|||
149205227|NCT01714817|538217614|FG000|Year 2 Period|Lost to Follow-up|2|||
149205228|NCT01714817|538217615|FG001|Year 2 Period|Lost to Follow-up|0|||
149205229|NCT01714817|538217614|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
149205230|NCT01714817|538217615|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
149205231|NCT01714817|538217614|FG000|Year 2 Period|Pregnancy|1|||
149205232|NCT01714817|538217615|FG001|Year 2 Period|Pregnancy|1|||
149205233|NCT01714817|538217614|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
149205234|NCT01714817|538217615|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
149205235|NCT01714817|538217614|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
149205236|NCT01714817|538217615|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
149205237|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
149205238|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
149205239|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
149205240|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
148947338|NCT03334539|537291898|FG001|Overall Study|Administrative Reasons|0|||
148947339|NCT03334539|537291899|FG002|Overall Study|Administrative Reasons|0|||
148808836|NCT01799889|536777546|FG002|Overall Study|Lost to Follow-up|0|||
148947340|NCT03334539|537291897|FG000|Overall Study|Hypertension Not Controlled|0|||
148947341|NCT03334539|537291898|FG001|Overall Study|Hypertension Not Controlled|1|||
148947342|NCT03334539|537291899|FG002|Overall Study|Hypertension Not Controlled|0|||
148947343|NCT04974697|537291903|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
149205241|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
149205242|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
149205243|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
149205244|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
149205245|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
149205246|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
149205247|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
149205248|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
149205249|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
148947344|NCT04974697|537291903|FG000|Overall Study|Lens discomfort|1|||
148808837|NCT01799889|536777547|FG003|Overall Study|Lost to Follow-up|0|||
149016325|NCT05027074|537537903|FG001|Overall Study|Withdrawal by Subject|8|||
149205250|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
149205251|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
149205252|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
149205253|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
149205254|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
149205255|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
149205256|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
149205257|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
149205258|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
149205259|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
149205260|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
149205261|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
149205262|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
149205263|NCT01714817|538217614|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
149205264|NCT01714817|538217615|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
149205265|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
149205266|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
149205267|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
149205268|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
149205269|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
149205270|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
149205271|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
149205272|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
149205273|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
149205274|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
149205275|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
149205276|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
149205277|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
149205278|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
149205279|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
149205280|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
149205281|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
149205282|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
149205283|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
149205284|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
149205285|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
149205286|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
149205287|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
149205288|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
149205289|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
149205290|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
149205291|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
149205292|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
149205293|NCT00476996|538217618|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
149205294|NCT00476996|538217619|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
149016326|NCT05027074|537537904|FG002|Overall Study|Withdrawal by Subject|10|||
149205295|NCT00476996|538217620|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
149205296|NCT00476996|538217621|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
149205297|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
149205298|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
149205299|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
149205300|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
149205301|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
149205302|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
149205303|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
149205304|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
149205305|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Death|0|||
149205306|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Death|0|||
149205307|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Death|0|||
149205308|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Death|7|||
149205309|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
149205310|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
149205311|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
149205312|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
149205313|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
149205314|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
149205315|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
149205316|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
149205317|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
149205318|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
149205319|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
149205320|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
149205321|NCT00476996|538217618|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
149205322|NCT00476996|538217619|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
148947345|NCT03706456|537291904|FG000|Overall Study|Adverse Event|1|||
149205323|NCT00476996|538217620|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
149205324|NCT00476996|538217621|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
149205325|NCT01769469|538217626|FG000|Overall Study|Consent Withdrawn|5|||
149205326|NCT01769469|538217626|FG000|Overall Study|Moved Out Of Area|3|||
149205327|NCT01769469|538217626|FG000|Overall Study|Lost to Follow-up|17|||
149205328|NCT01769469|538217626|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
149205329|NCT01769469|538217626|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
149205330|NCT02726113|538217634|FG000|Total Enrollment|Physician Decision|0|||
149205331|NCT02726113|538217635|FG001|Total Enrollment|Physician Decision|1|||
149205332|NCT02726113|538217634|FG000|Total Enrollment|Protocol Violation|1|||
149205333|NCT02726113|538217635|FG001|Total Enrollment|Protocol Violation|0|||
149205334|NCT02726113|538217634|FG000|Total Enrollment|Withdrawal by Subject|2|||
149205335|NCT02726113|538217635|FG001|Total Enrollment|Withdrawal by Subject|1|||
149205336|NCT02726113|538217634|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
149205337|NCT02726113|538217635|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
149205338|NCT02726113|538217634|FG000|Genomic Analysis|Protocol Violation|1|||
149205339|NCT02726113|538217635|FG001|Genomic Analysis|Protocol Violation|0|||
149205340|NCT02726113|538217634|FG000|Genomic Analysis|Withdrawal by Subject|2|||
149205341|NCT02726113|538217635|FG001|Genomic Analysis|Withdrawal by Subject|1|||
149205342|NCT02726113|538217634|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
149205343|NCT02726113|538217635|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
149205344|NCT03017846|538219537|FG000|Overall Study|Lost to Follow-up|3|||
149205345|NCT03017846|538219537|FG000|Overall Study|Adverse Event|2|||
149205346|NCT02759861|538219539|FG000|Overall Study|Death|1|||
149205347|NCT02151682|538219540|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149205348|NCT02151682|538219541|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
149205349|NCT02151682|538219542|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149205350|NCT02151682|538219543|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149205351|NCT02151682|538219544|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149205352|NCT02151682|538219545|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
149205353|NCT02151682|538219540|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
148947346|NCT03706456|537291904|FG000|Overall Study|Lack of Efficacy|2|||
149205354|NCT02151682|538219541|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
149205355|NCT02151682|538219542|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
148947347|NCT03302234|537291906|FG000|Overall Study|Death|191|||
149205356|NCT02151682|538219543|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149205357|NCT02151682|538219544|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149205358|NCT02151682|538219545|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
149205359|NCT02151682|538219540|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149205360|NCT02151682|538219541|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
149205361|NCT02151682|538219542|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149205362|NCT02151682|538219543|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149205363|NCT02151682|538219544|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149205364|NCT02151682|538219545|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
149205365|NCT02151682|538219540|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
149205366|NCT02151682|538219541|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
149205367|NCT02151682|538219542|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149205368|NCT02151682|538219543|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149205369|NCT02151682|538219544|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149205370|NCT02151682|538219545|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
149205371|NCT02151682|538219540|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
149205372|NCT02151682|538219541|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149205373|NCT02151682|538219542|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149205374|NCT02151682|538219543|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149205375|NCT02151682|538219544|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149205376|NCT02151682|538219545|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
149205377|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149205378|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149205379|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
149205380|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149205381|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149205382|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
149205383|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
149205384|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
149205385|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
149205386|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
149205387|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
149205388|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
149205389|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149205390|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149205391|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
149205392|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
149205393|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149205394|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
149205395|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149205396|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149205397|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
149205398|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149205399|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149205400|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
149205401|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149205402|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149205403|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
149205404|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
148683498|NCT00410410|536313144|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683499|NCT00410410|536313145|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683500|NCT00410410|536313146|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683501|NCT00410410|536313147|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683502|NCT00410410|536313148|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683503|NCT00410410|536313149|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683504|NCT00410410|536313150|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683505|NCT00410410|536313151|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
148683506|NCT00410410|536313152|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
148683507|NCT00410410|536313144|FG000|Open-Label Period (OL)|Pregnancy|0|||
148683508|NCT00410410|536313145|FG001|Open-Label Period (OL)|Pregnancy|0|||
148683509|NCT00410410|536313146|FG002|Open-Label Period (OL)|Pregnancy|0|||
148683510|NCT00410410|536313147|FG003|Open-Label Period (OL)|Pregnancy|0|||
148683511|NCT00410410|536313148|FG004|Open-Label Period (OL)|Pregnancy|0|||
148683512|NCT00410410|536313149|FG005|Open-Label Period (OL)|Pregnancy|0|||
148683513|NCT00410410|536313150|FG006|Open-Label Period (OL)|Pregnancy|0|||
148683514|NCT00410410|536313151|FG007|Open-Label Period (OL)|Pregnancy|0|||
148683515|NCT00410410|536313152|FG008|Open-Label Period (OL)|Pregnancy|1|||
148683516|NCT00410410|536313144|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683517|NCT00410410|536313145|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683518|NCT00410410|536313146|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683519|NCT00410410|536313147|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683520|NCT00410410|536313148|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683521|NCT00410410|536313149|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683522|NCT00410410|536313150|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683523|NCT00410410|536313151|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
148683524|NCT00410410|536313152|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
148683525|NCT00410410|536313144|FG000|Open-Label Period (OL)|Other|0|||
148683526|NCT00410410|536313145|FG001|Open-Label Period (OL)|Other|0|||
148683527|NCT00410410|536313146|FG002|Open-Label Period (OL)|Other|0|||
148683528|NCT00410410|536313147|FG003|Open-Label Period (OL)|Other|0|||
148683529|NCT00410410|536313148|FG004|Open-Label Period (OL)|Other|0|||
148683530|NCT00410410|536313149|FG005|Open-Label Period (OL)|Other|0|||
148683531|NCT00410410|536313150|FG006|Open-Label Period (OL)|Other|0|||
148683532|NCT00410410|536313151|FG007|Open-Label Period (OL)|Other|0|||
148683533|NCT00410410|536313152|FG008|Open-Label Period (OL)|Other|7|||
148683534|NCT01783496|536313153|FG000|Overall Study|Lost to Follow-up|0|||
148683535|NCT01783496|536313154|FG001|Overall Study|Lost to Follow-up|0|||
148683536|NCT01783496|536313155|FG002|Overall Study|Lost to Follow-up|0|||
148683537|NCT01783496|536313156|FG003|Overall Study|Lost to Follow-up|2|||
148683538|NCT01783496|536313157|FG004|Overall Study|Lost to Follow-up|0|||
148683539|NCT01783496|536313158|FG005|Overall Study|Lost to Follow-up|1|||
148683540|NCT01783496|536313153|FG000|Overall Study|Withdrawal by Subject|1|||
148683541|NCT01783496|536313154|FG001|Overall Study|Withdrawal by Subject|0|||
148683542|NCT01783496|536313155|FG002|Overall Study|Withdrawal by Subject|0|||
148683543|NCT01783496|536313156|FG003|Overall Study|Withdrawal by Subject|0|||
148683544|NCT01783496|536313157|FG004|Overall Study|Withdrawal by Subject|0|||
148683545|NCT01783496|536313158|FG005|Overall Study|Withdrawal by Subject|0|||
148683546|NCT00106028|536313159|FG000|Overall Study|Adverse Event|3|||
148683547|NCT00106028|536313160|FG001|Overall Study|Adverse Event|2|||
148683548|NCT00106028|536313159|FG000|Overall Study|Protocol Violation|1|||
148808838|NCT01799889|536777548|FG004|Overall Study|Lost to Follow-up|0|||
148683549|NCT00106028|536313160|FG001|Overall Study|Protocol Violation|1|||
148683550|NCT00106028|536313159|FG000|Overall Study|Withdrawal by Subject|2|||
148683551|NCT00106028|536313160|FG001|Overall Study|Withdrawal by Subject|8|||
148683552|NCT00106028|536313159|FG000|Overall Study|Lost to Follow-up|0|||
148683553|NCT00106028|536313160|FG001|Overall Study|Lost to Follow-up|1|||
149016327|NCT05027074|537537902|FG000|Overall Study|Lost to Follow-up|2|||
149205405|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149205406|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
149205407|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149205408|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149205409|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
149205410|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149205411|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149205412|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
149205413|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
149205414|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
149205415|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
149205416|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
149205417|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
149205418|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
149205419|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
149205420|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
149205421|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
149205422|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
149205423|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
149205424|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
149205425|NCT02151682|538219540|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149205426|NCT02151682|538219541|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149205427|NCT02151682|538219542|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
149205428|NCT02151682|538219543|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149205429|NCT02151682|538219544|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149205430|NCT02151682|538219545|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
149205431|NCT02151682|538219540|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149205432|NCT02151682|538219541|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149205433|NCT02151682|538219542|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149205434|NCT02151682|538219543|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149205435|NCT02151682|538219544|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
149205436|NCT02151682|538219545|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
149205437|NCT02151682|538219540|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149205438|NCT02151682|538219541|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149205439|NCT02151682|538219542|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149205440|NCT02151682|538219543|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149205441|NCT02151682|538219544|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
149205442|NCT02151682|538219545|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
149205443|NCT02151682|538219540|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149205444|NCT02151682|538219541|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149205445|NCT02151682|538219542|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149205446|NCT02151682|538219543|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149205447|NCT02151682|538219544|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
149205448|NCT02151682|538219545|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
149205449|NCT02151682|538219540|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149205450|NCT02151682|538219541|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149205451|NCT02151682|538219542|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149205452|NCT02151682|538219543|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149205453|NCT02151682|538219544|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
149205454|NCT02151682|538219545|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
149205455|NCT00618995|538219546|FG000|Period 1|Adverse Event|0|||
149205456|NCT00618995|538219547|FG001|Period 1|Adverse Event|0|||
149205457|NCT00618995|538219548|FG002|Period 1|Adverse Event|1|||
149205458|NCT00618995|538219549|FG003|Period 1|Adverse Event|0|||
149205459|NCT00618995|538219546|FG000|Period 1|Protocol Violation|0|||
149205460|NCT00618995|538219547|FG001|Period 1|Protocol Violation|1|||
148947348|NCT03302234|537291907|FG001|Overall Study|Death|192|||
148947349|NCT03302234|537291906|FG000|Overall Study|Withdrawal by Subject|2|||
148947350|NCT03302234|537291907|FG001|Overall Study|Withdrawal by Subject|2|||
148947351|NCT03302234|537291906|FG000|Overall Study|Sponsor Decision|90|||
148947352|NCT03302234|537291907|FG001|Overall Study|Sponsor Decision|89|||
148947353|NCT03302234|537291906|FG000|Overall Study|Laryngeal carcinoma|0|||
148947354|NCT03302234|537291907|FG001|Overall Study|Laryngeal carcinoma|1|||
148947355|NCT03302234|537291906|FG000|Overall Study|Not Reported|1|||
148947356|NCT03302234|537291907|FG001|Overall Study|Not Reported|0|||
148947357|NCT02795832|537291910|FG000|Overall Study|Adverse Event|0|||
148947358|NCT02795832|537291911|FG001|Overall Study|Adverse Event|0|||
148947359|NCT02795832|537291912|FG002|Overall Study|Adverse Event|0|||
148947360|NCT02795832|537291913|FG003|Overall Study|Adverse Event|0|||
148947361|NCT02795832|537291914|FG004|Overall Study|Adverse Event|0|||
148947362|NCT02795832|537291915|FG005|Overall Study|Adverse Event|3|||
148947363|NCT04112784|537291916|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
148947364|NCT04112784|537291916|FG000|Overall Study|Screen Failures|4|||
148947365|NCT01845831|537291917|FG000|Inpatient Phase|Withdrawal by Subject|1|||
148947366|NCT01845831|537291918|FG001|Inpatient Phase|Withdrawal by Subject|1|||
148947367|NCT01845831|537291919|FG002|Inpatient Phase|Withdrawal by Subject|0|||
148947368|NCT01845831|537291920|FG003|Inpatient Phase|Withdrawal by Subject|0|||
148947369|NCT01845831|537291921|FG004|Inpatient Phase|Withdrawal by Subject|0|||
148947370|NCT00221403|537291923|FG000|Overall Study|Protocol Violation|1|||
148947371|NCT00221403|537291924|FG001|Overall Study|Protocol Violation|0|||
148947372|NCT00221403|537291925|FG002|Overall Study|Protocol Violation|0|||
148947373|NCT00221403|537291923|FG000|Overall Study|Physician Decision|1|||
148947374|NCT00221403|537291924|FG001|Overall Study|Physician Decision|0|||
148947375|NCT00221403|537291925|FG002|Overall Study|Physician Decision|0|||
148947376|NCT00221403|537291923|FG000|Overall Study|Withdrawal by Subject|0|||
148947377|NCT00221403|537291924|FG001|Overall Study|Withdrawal by Subject|3|||
148947378|NCT00221403|537291925|FG002|Overall Study|Withdrawal by Subject|0|||
148947379|NCT00221403|537291923|FG000|Overall Study|Lack of Efficacy|0|||
148947380|NCT00221403|537291924|FG001|Overall Study|Lack of Efficacy|1|||
149205461|NCT00618995|538219548|FG002|Period 1|Protocol Violation|1|||
149205462|NCT00618995|538219549|FG003|Period 1|Protocol Violation|0|||
149205463|NCT00618995|538219546|FG000|Period 2|Protocol Violation|0|||
149205464|NCT00618995|538219547|FG001|Period 2|Protocol Violation|0|||
149205465|NCT00618995|538219548|FG002|Period 2|Protocol Violation|1|||
149205466|NCT00618995|538219549|FG003|Period 2|Protocol Violation|0|||
149205467|NCT00618995|538219546|FG000|Period 4|Adverse Event|1|||
149205468|NCT00618995|538219547|FG001|Period 4|Adverse Event|0|||
149205469|NCT00618995|538219548|FG002|Period 4|Adverse Event|0|||
149205470|NCT00618995|538219549|FG003|Period 4|Adverse Event|0|||
149205471|NCT02988219|538219550|FG000|Overall Study|Lack of Efficacy|1|||
149205472|NCT02988219|538219551|FG001|Overall Study|Lack of Efficacy|1|||
149205473|NCT02988219|538219550|FG000|Overall Study|Withdrawal by Subject|0|||
149205474|NCT02988219|538219551|FG001|Overall Study|Withdrawal by Subject|2|||
149205475|NCT01213264|538219552|FG000|Overall Study|Adverse Event|1|||
149205476|NCT01213264|538219553|FG001|Overall Study|Adverse Event|0|||
149205477|NCT01213264|538219554|FG002|Overall Study|Adverse Event|0|||
149205478|NCT01213264|538219552|FG000|Overall Study|Lost to Follow-up|1|||
149205479|NCT01213264|538219553|FG001|Overall Study|Lost to Follow-up|2|||
149205480|NCT01213264|538219554|FG002|Overall Study|Lost to Follow-up|6|||
149205481|NCT01522443|538219556|FG000|Overall Study|No longer receiving clinical benefit|36|||
149205482|NCT01522443|538219557|FG001|Overall Study|No longer receiving clinical benefit|28|||
149205483|NCT01522443|538219556|FG000|Overall Study|Adverse Event|10|||
149205484|NCT01522443|538219557|FG001|Overall Study|Adverse Event|15|||
149205485|NCT01522443|538219556|FG000|Overall Study|Withdrawal by Subject|5|||
149205486|NCT01522443|538219557|FG001|Overall Study|Withdrawal by Subject|8|||
149205487|NCT01522443|538219556|FG000|Overall Study|No study treatment given|1|||
149205488|NCT01522443|538219557|FG001|Overall Study|No study treatment given|1|||
149205489|NCT01522443|538219556|FG000|Overall Study|Other|1|||
149205490|NCT01522443|538219557|FG001|Overall Study|Other|3|||
149205491|NCT03260894|538219558|FG000|Overall Study|Death|6|||
149205492|NCT03260894|538219559|FG001|Overall Study|Death|8|||
149205493|NCT03260894|538219558|FG000|Overall Study|Withdrawal by Subject|4|||
149205494|NCT03260894|538219559|FG001|Overall Study|Withdrawal by Subject|11|||
148947381|NCT00221403|537291925|FG002|Overall Study|Lack of Efficacy|0|||
148947382|NCT00221403|537291923|FG000|Overall Study|Adverse Event|0|||
148947383|NCT00221403|537291924|FG001|Overall Study|Adverse Event|1|||
149205495|NCT03260894|538219558|FG000|Overall Study|On-going at clinical cut off date|36|||
148947384|NCT00221403|537291925|FG002|Overall Study|Adverse Event|0|||
148947385|NCT00256750|537291927|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
148947386|NCT00256750|537291928|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
148947387|NCT00256750|537291929|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
149205496|NCT03260894|538219559|FG001|Overall Study|On-going at clinical cut off date|31|||
149205497|NCT00290589|538219561|FG000|Overall Study|Lost to Follow-up|2|||
149205498|NCT00290589|538219562|FG001|Overall Study|Lost to Follow-up|2|||
149205499|NCT05014542|538219563|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
149205500|NCT05014542|538219564|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
149205501|NCT05014542|538219563|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
149205502|NCT05014542|538219564|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
149205503|NCT05014542|538219563|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
149205504|NCT05014542|538219564|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
149205505|NCT05014542|538219563|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
149205506|NCT05014542|538219564|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
149205507|NCT01438307|538219565|FG000|Overall Study|Death|1|||
149205508|NCT01438307|538219566|FG001|Overall Study|Death|1|||
149205509|NCT02378883|538219567|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
149205510|NCT02378883|538219567|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
149205511|NCT02378883|538219567|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
149205512|NCT02378883|538219567|FG000|30 Day Follow-Up|Physician Decision|2|||
149205513|NCT02378883|538219567|FG000|30 Day Follow-Up|Missed Visit|2|||
149205514|NCT02378883|538219567|FG000|30 Day Follow-Up|Death|1|||
149205515|NCT02378883|538219567|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
149205516|NCT02378883|538219567|FG000|12 Months Follow-Up|Death|2|||
149205517|NCT00318565|538219568|FG000|Overall Study|Excluded per protocol|24|||
149205518|NCT00691093|538219569|FG000|Overall Study|Adverse Event|1|||
149205519|NCT00691093|538219569|FG000|Overall Study|Lost to Follow-up|1|||
149205520|NCT00691093|538219569|FG000|Overall Study|Lack of Efficacy|1|||
149205521|NCT00691093|538219569|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
149205522|NCT00493467|538219570|FG000|Overall Study|Death|1|||
149205523|NCT03814005|538219572|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
149205524|NCT03814005|538219573|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
149205525|NCT03814005|538219574|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
149205526|NCT03814005|538219572|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
149205527|NCT03814005|538219573|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
149205528|NCT03814005|538219574|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
149205529|NCT03814005|538219572|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
149205530|NCT03814005|538219573|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
149205531|NCT03814005|538219574|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
149205532|NCT03814005|538219572|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
149205533|NCT03814005|538219573|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
149205534|NCT03814005|538219574|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
149205535|NCT03814005|538219572|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
149205536|NCT03814005|538219573|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
149205537|NCT03814005|538219574|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
149205538|NCT03814005|538219572|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
149205539|NCT03814005|538219573|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
149205540|NCT03814005|538219574|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
149205541|NCT00810810|538219575|FG000|Overall Study|Withdrawal by Subject|0|||
149205542|NCT00810810|538219576|FG001|Overall Study|Withdrawal by Subject|8|||
149205543|NCT00810810|538219577|FG002|Overall Study|Withdrawal by Subject|10|||
149205544|NCT00810810|538219578|FG003|Overall Study|Withdrawal by Subject|8|||
149205545|NCT00810810|538219575|FG000|Overall Study|Physician Decision|0|||
149205546|NCT00810810|538219576|FG001|Overall Study|Physician Decision|3|||
149205547|NCT00810810|538219577|FG002|Overall Study|Physician Decision|1|||
149205548|NCT00810810|538219578|FG003|Overall Study|Physician Decision|5|||
149205549|NCT01896856|538219579|FG000|Overall Study|Transportation issues / Non-compliance|0|||
149205550|NCT01896856|538219580|FG001|Overall Study|Transportation issues / Non-compliance|0|||
149205551|NCT01896856|538219581|FG002|Overall Study|Transportation issues / Non-compliance|1|||
149205552|NCT01896856|538219582|FG003|Overall Study|Transportation issues / Non-compliance|0|||
149205553|NCT01896856|538219583|FG004|Overall Study|Transportation issues / Non-compliance|0|||
149205554|NCT01896856|538219584|FG005|Overall Study|Transportation issues / Non-compliance|0|||
149205555|NCT02563925|538219587|FG000|Overall Study|Withdrawal by Subject|2|||
149205556|NCT01700985|538219588|FG000|Overall Study|Incarcerated|0|||
149205557|NCT01700985|538219589|FG001|Overall Study|Incarcerated|1|||
149205558|NCT01342952|538219591|FG000|Overall Study|Adverse Event|0|||
149205559|NCT01342952|538219592|FG001|Overall Study|Adverse Event|5|||
149205560|NCT01342952|538219593|FG002|Overall Study|Adverse Event|1|||
149205561|NCT01342952|538219594|FG003|Overall Study|Adverse Event|0|||
149205562|NCT01342952|538219591|FG000|Overall Study|Lost to Follow-up|0|||
149205563|NCT01342952|538219592|FG001|Overall Study|Lost to Follow-up|2|||
149205564|NCT01342952|538219593|FG002|Overall Study|Lost to Follow-up|0|||
149205565|NCT01342952|538219594|FG003|Overall Study|Lost to Follow-up|0|||
149205566|NCT01342952|538219591|FG000|Overall Study|Withdrawal by Subject|1|||
149205567|NCT01342952|538219592|FG001|Overall Study|Withdrawal by Subject|1|||
149205568|NCT01342952|538219593|FG002|Overall Study|Withdrawal by Subject|0|||
149205569|NCT01342952|538219594|FG003|Overall Study|Withdrawal by Subject|0|||
149205570|NCT01342952|538219591|FG000|Overall Study|Physician Decision|3|||
149205571|NCT01342952|538219592|FG001|Overall Study|Physician Decision|3|||
149205572|NCT01342952|538219593|FG002|Overall Study|Physician Decision|1|||
149205573|NCT01342952|538219594|FG003|Overall Study|Physician Decision|0|||
149205574|NCT00426556|538219597|FG000|Phase I - Core Phase|Disease Progression|0|||
149205575|NCT00426556|538219598|FG001|Phase I - Core Phase|Disease Progression|6|||
149205576|NCT00426556|538219599|FG002|Phase I - Core Phase|Disease Progression|2|||
149205577|NCT00426556|538219600|FG003|Phase I - Core Phase|Disease Progression|0|||
149205578|NCT00426556|538219597|FG000|Phase I - Core Phase|Adverse Event|1|||
149205579|NCT00426556|538219598|FG001|Phase I - Core Phase|Adverse Event|3|||
149205580|NCT00426556|538219599|FG002|Phase I - Core Phase|Adverse Event|1|||
149205581|NCT00426556|538219600|FG003|Phase I - Core Phase|Adverse Event|0|||
149205582|NCT00426556|538219597|FG000|Phase I - Core Phase|Death|0|||
149205583|NCT00426556|538219598|FG001|Phase I - Core Phase|Death|1|||
149205584|NCT00426556|538219599|FG002|Phase I - Core Phase|Death|0|||
149205585|NCT00426556|538219600|FG003|Phase I - Core Phase|Death|0|||
149205586|NCT00426556|538219597|FG000|Phase I - Extension Phase|Adverse Event|0|||
149205587|NCT00426556|538219598|FG001|Phase I - Extension Phase|Adverse Event|1|||
149205588|NCT00426556|538219599|FG002|Phase I - Extension Phase|Adverse Event|1|||
149205589|NCT00426556|538219600|FG003|Phase I - Extension Phase|Adverse Event|0|||
149205590|NCT00426556|538219597|FG000|Phase I - Extension Phase|Disease Progression|5|||
149205591|NCT00426556|538219598|FG001|Phase I - Extension Phase|Disease Progression|5|||
149205592|NCT00426556|538219599|FG002|Phase I - Extension Phase|Disease Progression|6|||
149205593|NCT00426556|538219600|FG003|Phase I - Extension Phase|Disease Progression|0|||
149205594|NCT00426556|538219597|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
149205595|NCT00426556|538219598|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
149205596|NCT00426556|538219599|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
149205597|NCT00426556|538219600|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
149205598|NCT00426556|538219597|FG000|Phase II - Core Phase|Disease Progression|0|||
149205599|NCT00426556|538219598|FG001|Phase II - Core Phase|Disease Progression|0|||
149205600|NCT00426556|538219599|FG002|Phase II - Core Phase|Disease Progression|0|||
149205601|NCT00426556|538219600|FG003|Phase II - Core Phase|Disease Progression|16|||
149205602|NCT00426556|538219597|FG000|Phase II - Core Phase|Adverse Event|0|||
149205603|NCT00426556|538219598|FG001|Phase II - Core Phase|Adverse Event|0|||
149205604|NCT00426556|538219599|FG002|Phase II - Core Phase|Adverse Event|0|||
149205605|NCT00426556|538219600|FG003|Phase II - Core Phase|Adverse Event|8|||
149205606|NCT00426556|538219597|FG000|Phase II - Extension Phase|Disease Progression|0|||
148683554|NCT00947011|536313162|FG000|Overall Study|Study was terminated,PI left institution|12|||
148683555|NCT00860574|536314936|FG000|Overall Study|Death|2|||
148683556|NCT00860574|536314936|FG000|Overall Study|Relapse|1|||
148683557|NCT01165242|536314939|FG000|Overall Study|Unreachable Subjects|1|||
148683558|NCT01165242|536314940|FG001|Overall Study|Unreachable Subjects|0|||
148683559|NCT01165242|536314941|FG002|Overall Study|Unreachable Subjects|0|||
148683560|NCT01165242|536314939|FG000|Overall Study|Incarcerated Subjects|0|||
148683561|NCT01165242|536314940|FG001|Overall Study|Incarcerated Subjects|1|||
148683562|NCT01165242|536314941|FG002|Overall Study|Incarcerated Subjects|0|||
148808839|NCT01799889|536777549|FG005|Overall Study|Lost to Follow-up|0|||
148808840|NCT01799889|536777550|FG006|Overall Study|Lost to Follow-up|0|||
148808841|NCT01799889|536777551|FG007|Overall Study|Lost to Follow-up|0|||
148808842|NCT01799889|536777552|FG008|Overall Study|Lost to Follow-up|0|||
148808843|NCT01799889|536777553|FG009|Overall Study|Lost to Follow-up|0|||
148808844|NCT01799889|536777554|FG010|Overall Study|Lost to Follow-up|0|||
148808845|NCT01799889|536777555|FG011|Overall Study|Lost to Follow-up|0|||
148808846|NCT01799889|536777544|FG000|Overall Study|Physician Decision|3|||
148808847|NCT01799889|536777545|FG001|Overall Study|Physician Decision|2|||
148808848|NCT01799889|536777546|FG002|Overall Study|Physician Decision|4|||
148947388|NCT00256750|537291927|FG000|Transplanted Pre-Treatment|Other|2|||
149205607|NCT00426556|538219598|FG001|Phase II - Extension Phase|Disease Progression|0|||
149205608|NCT00426556|538219599|FG002|Phase II - Extension Phase|Disease Progression|0|||
149205609|NCT00426556|538219600|FG003|Phase II - Extension Phase|Disease Progression|21|||
149205610|NCT00426556|538219597|FG000|Phase II - Extension Phase|Adverse Event|0|||
148947389|NCT00256750|537291928|FG001|Transplanted Pre-Treatment|Other|0|||
149205611|NCT00426556|538219598|FG001|Phase II - Extension Phase|Adverse Event|0|||
149205612|NCT00426556|538219599|FG002|Phase II - Extension Phase|Adverse Event|0|||
149205613|NCT00426556|538219600|FG003|Phase II - Extension Phase|Adverse Event|2|||
149205614|NCT03970824|538219604|FG000|Overall Study|Withdrawal by Subject|1|||
148947390|NCT00256750|537291929|FG002|Transplanted Pre-Treatment|Other|0|||
149205615|NCT03970824|538219605|FG001|Overall Study|Withdrawal by Subject|1|||
148683563|NCT01165242|536314939|FG000|Overall Study|Visit 2 Declined by Subject|0|||
148683564|NCT01165242|536314940|FG001|Overall Study|Visit 2 Declined by Subject|0|||
148808849|NCT01799889|536777547|FG003|Overall Study|Physician Decision|4|||
149205616|NCT03970824|538219606|FG002|Overall Study|Withdrawal by Subject|3|||
149205617|NCT03970824|538219604|FG000|Overall Study|Lost to Follow-up|0|||
149205618|NCT03970824|538219605|FG001|Overall Study|Lost to Follow-up|2|||
149205619|NCT03970824|538219606|FG002|Overall Study|Lost to Follow-up|1|||
149205620|NCT03970824|538219604|FG000|Overall Study|Adverse Event|1|||
149205621|NCT03970824|538219605|FG001|Overall Study|Adverse Event|0|||
149205622|NCT03970824|538219606|FG002|Overall Study|Adverse Event|0|||
149205623|NCT00416312|538219607|FG000|Overall Study|tumors not visible on imaging|2|||
149205624|NCT00105560|538219610|FG000|Overall Study|Lost to Follow-up|1|||
149205625|NCT01192204|538219612|FG000|Overall Study|could not keep recall appointments|1|||
149205626|NCT01192204|538219613|FG001|Overall Study|could not keep recall appointments|0|||
149205627|NCT00425100|538219614|FG000|Overall Study|Adverse Event|36|||
149205628|NCT00425100|538219614|FG000|Overall Study|Lack of Efficacy|4|||
149205629|NCT00425100|538219614|FG000|Overall Study|Lost to Follow-up|2|||
149205630|NCT00425100|538219614|FG000|Overall Study|Protocol Violation|4|||
149205631|NCT00425100|538219614|FG000|Overall Study|Withdrawal by Subject|7|||
149205632|NCT01315847|538219615|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
149205633|NCT01315847|538219616|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
149205634|NCT01315847|538219615|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
149205635|NCT01315847|538219616|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
149205636|NCT03699631|538219620|FG000|Overall Study|Adverse Event|3|||
149205637|NCT02940626|538219621|FG000|Overall Study|Death|40|||
149205638|NCT02940626|538219622|FG001|Overall Study|Death|32|||
149205639|NCT02940626|538219621|FG000|Overall Study|Lost to Follow-up|5|||
149205640|NCT02940626|538219622|FG001|Overall Study|Lost to Follow-up|2|||
149205641|NCT02940626|538219621|FG000|Overall Study|Withdrawal by Subject|1|||
149205642|NCT02940626|538219622|FG001|Overall Study|Withdrawal by Subject|0|||
149205643|NCT02940626|538219621|FG000|Overall Study|Transfer to Hospice Care|1|||
149205644|NCT02940626|538219622|FG001|Overall Study|Transfer to Hospice Care|0|||
149205645|NCT02940626|538219621|FG000|Overall Study|Prohibited Concomitant Medication|0|||
149205646|NCT02940626|538219622|FG001|Overall Study|Prohibited Concomitant Medication|1|||
149205647|NCT02559713|538219625|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
149205648|NCT01767519|538219626|FG000|Overall Study|Other Reasons|4|||
149205649|NCT01767519|538219627|FG001|Overall Study|Other Reasons|4|||
149205650|NCT01767519|538219628|FG002|Overall Study|Other Reasons|2|||
149205651|NCT01767519|538219626|FG000|Overall Study|Protocol Violation|0|||
149205652|NCT01767519|538219627|FG001|Overall Study|Protocol Violation|3|||
149205653|NCT01767519|538219628|FG002|Overall Study|Protocol Violation|0|||
149205654|NCT01767519|538219626|FG000|Overall Study|Personal Reasons|1|||
149205655|NCT01767519|538219627|FG001|Overall Study|Personal Reasons|0|||
149205656|NCT01767519|538219628|FG002|Overall Study|Personal Reasons|0|||
149205657|NCT01767519|538219626|FG000|Overall Study|Lost to Follow-up|3|||
149205658|NCT01767519|538219627|FG001|Overall Study|Lost to Follow-up|1|||
149205659|NCT01767519|538219628|FG002|Overall Study|Lost to Follow-up|2|||
149205660|NCT01767519|538219626|FG000|Overall Study|Lack of Efficacy|1|||
149205661|NCT01767519|538219627|FG001|Overall Study|Lack of Efficacy|0|||
148947391|NCT00256750|537291927|FG000|Transplanted Pre-Treatment|Death|1|||
148947392|NCT00256750|537291928|FG001|Transplanted Pre-Treatment|Death|0|||
148947393|NCT00256750|537291929|FG002|Transplanted Pre-Treatment|Death|0|||
148947394|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
148947395|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
148947396|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
148947397|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Death|3|||
148947398|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Death|2|||
148947399|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Death|4|||
148947400|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
148947401|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
148947402|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
148947403|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
148947404|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
148947405|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
148947406|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Other|5|||
148947407|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Other|4|||
148947408|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Other|2|||
148947409|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
148947410|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
148947411|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
148947412|NCT00256750|537291927|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
148947413|NCT00256750|537291928|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
148947414|NCT00256750|537291929|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
148947415|NCT00256750|537291927|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
148947416|NCT00256750|537291928|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
148947417|NCT00256750|537291929|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
148947418|NCT00256750|537291927|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
148947419|NCT00256750|537291928|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
148947420|NCT00256750|537291929|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
148947421|NCT00256750|537291927|FG000|Post-Transplant Treated (24 Months)|Death|3|||
148947422|NCT00256750|537291928|FG001|Post-Transplant Treated (24 Months)|Death|0|||
148947423|NCT00256750|537291929|FG002|Post-Transplant Treated (24 Months)|Death|0|||
148947424|NCT00256750|537291927|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
148947425|NCT00256750|537291928|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
148947426|NCT00256750|537291929|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
148947427|NCT00256750|537291927|FG000|Post-Transplant Treated (24 Months)|Other|2|||
148947428|NCT00256750|537291928|FG001|Post-Transplant Treated (24 Months)|Other|0|||
148947429|NCT00256750|537291929|FG002|Post-Transplant Treated (24 Months)|Other|1|||
148947430|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
148947431|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
148947432|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
148947433|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
148947434|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
148947435|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
148947436|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Death|0|||
148947437|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Death|2|||
148947438|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Death|1|||
148947439|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
149205662|NCT01767519|538219628|FG002|Overall Study|Lack of Efficacy|0|||
149205663|NCT01767519|538219626|FG000|Overall Study|Adverse Event|5|||
149205664|NCT01767519|538219627|FG001|Overall Study|Adverse Event|5|||
149205665|NCT01767519|538219628|FG002|Overall Study|Adverse Event|1|||
149205666|NCT00293423|538219629|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
149205667|NCT00293423|538219630|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
149205668|NCT00293423|538219629|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
149205669|NCT00293423|538219630|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
148947440|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
149205670|NCT00293423|538219629|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
149205671|NCT00293423|538219630|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
149205672|NCT00293423|538219629|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
148947441|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
148947442|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
148947443|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
148947444|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
148947445|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
148947446|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
148947447|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
148947448|NCT00256750|537291927|FG000|Post-Transplant Treated (36 Months)|Other|0|||
148947449|NCT00256750|537291928|FG001|Post-Transplant Treated (36 Months)|Other|1|||
148947450|NCT00256750|537291929|FG002|Post-Transplant Treated (36 Months)|Other|1|||
148947451|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
149205673|NCT00293423|538219630|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
149205674|NCT00293423|538219629|FG000|Surgical Resection|processing error during surgical resection|1|||
149205675|NCT00293423|538219630|FG001|Surgical Resection|processing error during surgical resection|0|||
149205676|NCT00293423|538219629|FG000|Surgical Resection|Withdrawal by Subject|4|||
149205677|NCT00293423|538219630|FG001|Surgical Resection|Withdrawal by Subject|0|||
149205678|NCT00293423|538219629|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
149205679|NCT00293423|538219630|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
149205680|NCT00964158|538219631|FG000|Overall Study|Lost to Follow-up|0|||
149205681|NCT00964158|538219632|FG001|Overall Study|Lost to Follow-up|1|||
149205682|NCT00964158|538219633|FG002|Overall Study|Lost to Follow-up|2|||
149205683|NCT00964158|538219631|FG000|Overall Study|Withdrawal by Subject|0|||
149205684|NCT00964158|538219632|FG001|Overall Study|Withdrawal by Subject|0|||
149205685|NCT00964158|538219633|FG002|Overall Study|Withdrawal by Subject|6|||
149205686|NCT00507416|538219634|FG000|Overall Study|Adverse Event|58|||
148683565|NCT01165242|536314941|FG002|Overall Study|Visit 2 Declined by Subject|1|||
148683566|NCT01165242|536314939|FG000|Overall Study|Withdrawal by Subject|0|||
149016328|NCT05027074|537537903|FG001|Overall Study|Lost to Follow-up|4|||
149205687|NCT00507416|538219635|FG001|Overall Study|Adverse Event|67|||
149205688|NCT00507416|538219636|FG002|Overall Study|Adverse Event|65|||
149205689|NCT00507416|538219634|FG000|Overall Study|Protocol Violation|1|||
149016329|NCT05027074|537537904|FG002|Overall Study|Lost to Follow-up|3|||
149205690|NCT00507416|538219635|FG001|Overall Study|Protocol Violation|2|||
149205691|NCT00507416|538219636|FG002|Overall Study|Protocol Violation|0|||
149205692|NCT00507416|538219634|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
149205693|NCT00507416|538219635|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
149205694|NCT00507416|538219636|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
149205695|NCT00507416|538219634|FG000|Overall Study|Progressive Disease|20|||
148683567|NCT01165242|536314940|FG001|Overall Study|Withdrawal by Subject|2|||
148683568|NCT01165242|536314941|FG002|Overall Study|Withdrawal by Subject|2|||
148683569|NCT01165242|536314939|FG000|Overall Study|Extended Holiday|0|||
148683570|NCT01165242|536314940|FG001|Overall Study|Extended Holiday|0|||
148683571|NCT01165242|536314941|FG002|Overall Study|Extended Holiday|1|||
148683572|NCT01165242|536314939|FG000|Overall Study|Lost to Follow-up|9|||
148683573|NCT01165242|536314940|FG001|Overall Study|Lost to Follow-up|7|||
148683574|NCT01165242|536314941|FG002|Overall Study|Lost to Follow-up|10|||
148683575|NCT01859390|536314946|FG000|Overall Study|Insufficient Sputum Collected|1|||
148683576|NCT01859390|536314947|FG001|Overall Study|Insufficient Sputum Collected|3|||
148683577|NCT01859390|536314946|FG000|Overall Study|Sample Missing Collection Date|0|||
148683578|NCT01859390|536314947|FG001|Overall Study|Sample Missing Collection Date|1|||
148683579|NCT01859390|536314946|FG000|Overall Study|Tube Cracked|0|||
148683580|NCT01859390|536314947|FG001|Overall Study|Tube Cracked|2|||
148683581|NCT01859390|536314946|FG000|Overall Study|Shipment Error|0|||
148683582|NCT01859390|536314947|FG001|Overall Study|Shipment Error|1|||
148683583|NCT01706198|536314949|FG000|Overall Study|Adverse Event|12|||
148683584|NCT01706198|536314950|FG001|Overall Study|Adverse Event|15|||
148683585|NCT01706198|536314949|FG000|Overall Study|Protocol Violation|7|||
148683586|NCT01706198|536314950|FG001|Overall Study|Protocol Violation|5|||
148683587|NCT01706198|536314949|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
148683588|NCT01706198|536314950|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
148683589|NCT01706198|536314949|FG000|Overall Study|Lost to Follow-up|97|||
148683590|NCT01706198|536314950|FG001|Overall Study|Lost to Follow-up|93|||
148683591|NCT01706198|536314949|FG000|Overall Study|Physician Decision|23|||
148683592|NCT01706198|536314950|FG001|Overall Study|Physician Decision|37|||
148683593|NCT01706198|536314949|FG000|Overall Study|Withdrawal by Subject|23|||
148683594|NCT01706198|536314950|FG001|Overall Study|Withdrawal by Subject|31|||
148683595|NCT01084005|536314951|FG000|Overall Study|Adverse Event|1|||
148683596|NCT01084005|536314952|FG001|Overall Study|Adverse Event|8|||
148683597|NCT01084005|536314951|FG000|Overall Study|Protocol Violation|3|||
148683598|NCT01084005|536314952|FG001|Overall Study|Protocol Violation|7|||
148683599|NCT01084005|536314951|FG000|Overall Study|Withdrawal by Subject|1|||
148683600|NCT01084005|536314952|FG001|Overall Study|Withdrawal by Subject|1|||
148683601|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
148683602|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
149205696|NCT00507416|538219635|FG001|Overall Study|Progressive Disease|10|||
149205697|NCT00507416|538219636|FG002|Overall Study|Progressive Disease|13|||
149205698|NCT00507416|538219634|FG000|Overall Study|Patient declined further treatment|18|||
148683603|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
148683604|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
148683605|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
148683606|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
148683607|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
148683608|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
148683609|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
148683610|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
148683611|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
148683612|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
148683613|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
148683614|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
148683615|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
148683616|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
148683617|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
148683618|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
148683619|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
148683620|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
148683621|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
148808850|NCT01799889|536777548|FG004|Overall Study|Physician Decision|5|||
148947452|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
148947453|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
148947454|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
148947455|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
149205699|NCT00507416|538219635|FG001|Overall Study|Patient declined further treatment|14|||
149205700|NCT00507416|538219636|FG002|Overall Study|Patient declined further treatment|11|||
148808851|NCT01799889|536777549|FG005|Overall Study|Physician Decision|5|||
148808852|NCT01799889|536777550|FG006|Overall Study|Physician Decision|5|||
148808853|NCT01799889|536777551|FG007|Overall Study|Physician Decision|2|||
148808854|NCT01799889|536777552|FG008|Overall Study|Physician Decision|6|||
148808855|NCT01799889|536777553|FG009|Overall Study|Physician Decision|0|||
148808856|NCT01799889|536777554|FG010|Overall Study|Physician Decision|0|||
148808857|NCT01799889|536777555|FG011|Overall Study|Physician Decision|1|||
148808858|NCT01799889|536777544|FG000|Overall Study|Progressive Disease|30|||
148808859|NCT01799889|536777545|FG001|Overall Study|Progressive Disease|26|||
148808860|NCT01799889|536777546|FG002|Overall Study|Progressive Disease|25|||
148808861|NCT01799889|536777547|FG003|Overall Study|Progressive Disease|30|||
148808862|NCT01799889|536777548|FG004|Overall Study|Progressive Disease|23|||
148808863|NCT01799889|536777549|FG005|Overall Study|Progressive Disease|9|||
148808864|NCT01799889|536777550|FG006|Overall Study|Progressive Disease|8|||
148808865|NCT01799889|536777551|FG007|Overall Study|Progressive Disease|13|||
148808866|NCT01799889|536777552|FG008|Overall Study|Progressive Disease|18|||
148808867|NCT01799889|536777553|FG009|Overall Study|Progressive Disease|5|||
148808868|NCT01799889|536777554|FG010|Overall Study|Progressive Disease|3|||
148808869|NCT01799889|536777555|FG011|Overall Study|Progressive Disease|1|||
148808870|NCT01799889|536777544|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
148808871|NCT01799889|536777545|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
148808872|NCT01799889|536777546|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
148808873|NCT01799889|536777547|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
148808874|NCT01799889|536777548|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
148808875|NCT01799889|536777549|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
148808876|NCT01799889|536777550|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
148808877|NCT01799889|536777551|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
148808878|NCT01799889|536777552|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
148808879|NCT01799889|536777553|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
148808880|NCT01799889|536777554|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
148808881|NCT01799889|536777555|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
148808882|NCT01799889|536777544|FG000|Overall Study|Study Terminated By Sponsor|1|||
148808883|NCT01799889|536777545|FG001|Overall Study|Study Terminated By Sponsor|0|||
148808884|NCT01799889|536777546|FG002|Overall Study|Study Terminated By Sponsor|0|||
148808885|NCT01799889|536777547|FG003|Overall Study|Study Terminated By Sponsor|0|||
148808886|NCT01799889|536777548|FG004|Overall Study|Study Terminated By Sponsor|2|||
148808887|NCT01799889|536777549|FG005|Overall Study|Study Terminated By Sponsor|1|||
148808888|NCT01799889|536777550|FG006|Overall Study|Study Terminated By Sponsor|0|||
148808889|NCT01799889|536777551|FG007|Overall Study|Study Terminated By Sponsor|2|||
148808890|NCT01799889|536777552|FG008|Overall Study|Study Terminated By Sponsor|1|||
148808891|NCT01799889|536777553|FG009|Overall Study|Study Terminated By Sponsor|1|||
148808892|NCT01799889|536777554|FG010|Overall Study|Study Terminated By Sponsor|0|||
148808893|NCT01799889|536777555|FG011|Overall Study|Study Terminated By Sponsor|0|||
148808894|NCT01799889|536777544|FG000|Overall Study|Withdrawal by Subject|1|||
148808895|NCT01799889|536777545|FG001|Overall Study|Withdrawal by Subject|6|||
148808896|NCT01799889|536777546|FG002|Overall Study|Withdrawal by Subject|4|||
148808897|NCT01799889|536777547|FG003|Overall Study|Withdrawal by Subject|0|||
148808898|NCT01799889|536777548|FG004|Overall Study|Withdrawal by Subject|5|||
148808899|NCT01799889|536777549|FG005|Overall Study|Withdrawal by Subject|1|||
148808900|NCT01799889|536777550|FG006|Overall Study|Withdrawal by Subject|3|||
148808901|NCT01799889|536777551|FG007|Overall Study|Withdrawal by Subject|1|||
148808902|NCT01799889|536777552|FG008|Overall Study|Withdrawal by Subject|2|||
148808903|NCT01799889|536777553|FG009|Overall Study|Withdrawal by Subject|1|||
148808904|NCT01799889|536777554|FG010|Overall Study|Withdrawal by Subject|1|||
148808905|NCT01799889|536777555|FG011|Overall Study|Withdrawal by Subject|1|||
148808906|NCT01799889|536777544|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148808907|NCT01799889|536777545|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149205701|NCT00507416|538219634|FG000|Overall Study|Other|11|||
149205702|NCT00507416|538219635|FG001|Overall Study|Other|16|||
149205703|NCT00507416|538219636|FG002|Overall Study|Other|13|||
149205704|NCT00507416|538219634|FG000|Overall Study|Did not Receive Study Treatment|3|||
148808908|NCT01799889|536777546|FG002|Overall Study|Non-Compliance With Study Drug|0|||
148808909|NCT01799889|536777547|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148808910|NCT01799889|536777548|FG004|Overall Study|Non-Compliance With Study Drug|0|||
148808911|NCT01799889|536777549|FG005|Overall Study|Non-Compliance With Study Drug|1|||
148808912|NCT01799889|536777550|FG006|Overall Study|Non-Compliance With Study Drug|0|||
148808913|NCT01799889|536777551|FG007|Overall Study|Non-Compliance With Study Drug|0|||
149205705|NCT00507416|538219635|FG001|Overall Study|Did not Receive Study Treatment|9|||
149205706|NCT00507416|538219636|FG002|Overall Study|Did not Receive Study Treatment|4|||
148808914|NCT01799889|536777552|FG008|Overall Study|Non-Compliance With Study Drug|0|||
148808915|NCT01799889|536777553|FG009|Overall Study|Non-Compliance With Study Drug|0|||
148808916|NCT01799889|536777554|FG010|Overall Study|Non-Compliance With Study Drug|0|||
148808917|NCT01799889|536777555|FG011|Overall Study|Non-Compliance With Study Drug|0|||
148808918|NCT04476043|536777558|FG000|Overall Study|Withdrawal by Subject|1|||
148808919|NCT04476043|536777559|FG001|Overall Study|Withdrawal by Subject|3|||
148947456|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
148947457|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
148947458|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
148947459|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
148947460|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
148947461|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
148947462|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
148947463|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
148947464|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
148947465|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
148947466|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
148947467|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
148947468|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
148947469|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
148947470|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
148947471|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
148947472|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
148947473|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
148947474|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
148947475|NCT00256750|537291927|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
148947476|NCT00256750|537291928|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
148947477|NCT00256750|537291929|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
148947478|NCT04659161|537291930|FG000|Overall Study|Adverse Event|10|||
148947479|NCT04659161|537291931|FG001|Overall Study|Adverse Event|6|||
148947480|NCT04659161|537291930|FG000|Overall Study|Withdrawal by Subject|13|||
148947481|NCT04659161|537291931|FG001|Overall Study|Withdrawal by Subject|12|||
148947482|NCT04659161|537291930|FG000|Overall Study|Other|9|||
148947483|NCT04659161|537291931|FG001|Overall Study|Other|8|||
148947484|NCT02197130|537291935|FG000|Overall Study|Adverse Event|13|||
148947485|NCT02197130|537291936|FG001|Overall Study|Adverse Event|4|||
148947486|NCT02197130|537291937|FG002|Overall Study|Adverse Event|23|||
148947487|NCT02197130|537291935|FG000|Overall Study|Death|0|||
148947488|NCT02197130|537291936|FG001|Overall Study|Death|1|||
148947489|NCT02197130|537291937|FG002|Overall Study|Death|0|||
148947490|NCT02197130|537291935|FG000|Overall Study|Lost to Follow-up|2|||
148947491|NCT02197130|537291936|FG001|Overall Study|Lost to Follow-up|0|||
148947492|NCT02197130|537291937|FG002|Overall Study|Lost to Follow-up|1|||
148947493|NCT02197130|537291935|FG000|Overall Study|Does not meet entrance criteria|0|||
148947494|NCT02197130|537291936|FG001|Overall Study|Does not meet entrance criteria|0|||
148947495|NCT02197130|537291937|FG002|Overall Study|Does not meet entrance criteria|1|||
148947496|NCT02197130|537291935|FG000|Overall Study|Withdrawal by Subject|0|||
148947497|NCT02197130|537291936|FG001|Overall Study|Withdrawal by Subject|3|||
148947498|NCT02197130|537291937|FG002|Overall Study|Withdrawal by Subject|4|||
148947499|NCT02197130|537291935|FG000|Overall Study|Other|1|||
148947500|NCT02197130|537291936|FG001|Overall Study|Other|0|||
148947501|NCT02197130|537291937|FG002|Overall Study|Other|3|||
148947502|NCT02615145|537291938|FG000|Overall Study|Did Not Start Treatment|0|||
148947503|NCT02615145|537291939|FG001|Overall Study|Did Not Start Treatment|0|||
149205707|NCT01182337|538219639|FG000|Overall Study|Withdrawal by Subject|3|||
149205708|NCT01182337|538219640|FG001|Overall Study|Withdrawal by Subject|1|||
149205709|NCT01182337|538219639|FG000|Overall Study|Lost to Follow-up|0|||
149205710|NCT01182337|538219640|FG001|Overall Study|Lost to Follow-up|1|||
149205711|NCT03101514|538219641|FG000|Overall Study|Withdrawal by Subject|4|||
149205712|NCT03101514|538219641|FG000|Overall Study|Protocol Violation|2|||
149205713|NCT03101514|538219641|FG000|Overall Study|patient's information was incomplete|1|||
149205714|NCT01021813|538219642|FG000|DB Treatment Phase|Adverse Event|60|||
149205715|NCT01021813|538219643|FG001|DB Treatment Phase|Adverse Event|22|||
149205716|NCT01021813|538219644|FG002|DB Treatment Phase|Adverse Event|0|||
149205717|NCT01021813|538219645|FG003|DB Treatment Phase|Adverse Event|0|||
149205718|NCT01021813|538219646|FG004|DB Treatment Phase|Adverse Event|0|||
149205719|NCT01021813|538219642|FG000|DB Treatment Phase|Lack of Efficacy|44|||
149205720|NCT01021813|538219643|FG001|DB Treatment Phase|Lack of Efficacy|28|||
149205721|NCT01021813|538219644|FG002|DB Treatment Phase|Lack of Efficacy|0|||
149205722|NCT01021813|538219645|FG003|DB Treatment Phase|Lack of Efficacy|0|||
149205723|NCT01021813|538219646|FG004|DB Treatment Phase|Lack of Efficacy|0|||
149205724|NCT01021813|538219642|FG000|DB Treatment Phase|Lost to Follow-up|14|||
149205725|NCT01021813|538219643|FG001|DB Treatment Phase|Lost to Follow-up|12|||
149205726|NCT01021813|538219644|FG002|DB Treatment Phase|Lost to Follow-up|0|||
149205727|NCT01021813|538219645|FG003|DB Treatment Phase|Lost to Follow-up|0|||
149205728|NCT01021813|538219646|FG004|DB Treatment Phase|Lost to Follow-up|0|||
148947504|NCT02615145|537291940|FG002|Overall Study|Did Not Start Treatment|1|||
148947505|NCT02615145|537291941|FG003|Overall Study|Did Not Start Treatment|1|||
148947506|NCT02615145|537291938|FG000|Overall Study|Failure to Return|20|||
149205729|NCT01021813|538219642|FG000|DB Treatment Phase|Physician Decision|17|||
149205730|NCT01021813|538219643|FG001|DB Treatment Phase|Physician Decision|8|||
149205731|NCT01021813|538219644|FG002|DB Treatment Phase|Physician Decision|0|||
149205732|NCT01021813|538219645|FG003|DB Treatment Phase|Physician Decision|0|||
149205733|NCT01021813|538219646|FG004|DB Treatment Phase|Physician Decision|0|||
149205734|NCT01021813|538219642|FG000|DB Treatment Phase|Pregnancy|1|||
149205735|NCT01021813|538219643|FG001|DB Treatment Phase|Pregnancy|0|||
149205736|NCT01021813|538219644|FG002|DB Treatment Phase|Pregnancy|0|||
149205737|NCT01021813|538219645|FG003|DB Treatment Phase|Pregnancy|0|||
149205738|NCT01021813|538219646|FG004|DB Treatment Phase|Pregnancy|0|||
149205739|NCT01021813|538219642|FG000|DB Treatment Phase|Protocol Violation|4|||
149205740|NCT01021813|538219643|FG001|DB Treatment Phase|Protocol Violation|3|||
149205741|NCT01021813|538219644|FG002|DB Treatment Phase|Protocol Violation|0|||
149205742|NCT01021813|538219645|FG003|DB Treatment Phase|Protocol Violation|0|||
149205743|NCT01021813|538219646|FG004|DB Treatment Phase|Protocol Violation|0|||
149205744|NCT01021813|538219642|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
149205745|NCT01021813|538219643|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
149205746|NCT01021813|538219644|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
148683622|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
149205747|NCT01021813|538219645|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
149205748|NCT01021813|538219646|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
149205749|NCT01021813|538219642|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
149205750|NCT01021813|538219643|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
149205751|NCT01021813|538219644|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
149205752|NCT01021813|538219645|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
149205753|NCT01021813|538219646|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
149205754|NCT01021813|538219642|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149205755|NCT01021813|538219643|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149205756|NCT01021813|538219644|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149205757|NCT01021813|538219645|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
149205758|NCT01021813|538219646|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
149205759|NCT01021813|538219642|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149205760|NCT01021813|538219643|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149205761|NCT01021813|538219644|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149205762|NCT01021813|538219645|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
149205763|NCT01021813|538219646|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
149205764|NCT01021813|538219642|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149205765|NCT01021813|538219643|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149205766|NCT01021813|538219644|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
149205767|NCT01021813|538219645|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149205768|NCT01021813|538219646|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
149205769|NCT01021813|538219642|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
149205770|NCT01021813|538219643|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
149205771|NCT01021813|538219644|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
149205772|NCT01021813|538219645|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
149205773|NCT01021813|538219646|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
149205774|NCT03571256|538219647|FG000|Overall Study|Adverse Event|3|||
149205775|NCT03571256|538219648|FG001|Overall Study|Adverse Event|0|||
149205776|NCT03571256|538219649|FG002|Overall Study|Adverse Event|1|||
149205777|NCT03571256|538219647|FG000|Overall Study|Withdrawal by Subject|3|||
149205778|NCT03571256|538219648|FG001|Overall Study|Withdrawal by Subject|1|||
149205779|NCT03571256|538219649|FG002|Overall Study|Withdrawal by Subject|1|||
149205780|NCT03571256|538219647|FG000|Overall Study|Other than specified|0|||
149205781|NCT03571256|538219648|FG001|Overall Study|Other than specified|1|||
149205782|NCT03571256|538219649|FG002|Overall Study|Other than specified|1|||
149205783|NCT03571256|538219647|FG000|Overall Study|Protocol Violation|0|||
149205784|NCT03571256|538219648|FG001|Overall Study|Protocol Violation|1|||
149205785|NCT03571256|538219649|FG002|Overall Study|Protocol Violation|1|||
149205786|NCT02270684|538219652|FG000|Overall Study|Lost to Follow-up|0|||
149205787|NCT02270684|538219653|FG001|Overall Study|Lost to Follow-up|3|||
149205788|NCT02270684|538219652|FG000|Overall Study|Study terminated|1|||
149205789|NCT02270684|538219653|FG001|Overall Study|Study terminated|0|||
149205790|NCT02247401|538219658|FG000|Overall Study|Adverse Event|1|||
149205791|NCT02247401|538219659|FG001|Overall Study|Adverse Event|0|||
149205792|NCT02247401|538219660|FG002|Overall Study|Adverse Event|0|||
149205793|NCT02247401|538219658|FG000|Overall Study|Withdrawal by Subject|4|||
149205794|NCT02247401|538219659|FG001|Overall Study|Withdrawal by Subject|1|||
149205795|NCT02247401|538219660|FG002|Overall Study|Withdrawal by Subject|1|||
149205796|NCT02247401|538219658|FG000|Overall Study|Lost to Follow-up|1|||
149205797|NCT02247401|538219659|FG001|Overall Study|Lost to Follow-up|1|||
149205798|NCT02247401|538219660|FG002|Overall Study|Lost to Follow-up|1|||
149205799|NCT03695393|538219666|FG000|Overall Study|Death|3|||
149205800|NCT03695393|538219667|FG001|Overall Study|Death|1|||
149205801|NCT03695393|538219666|FG000|Overall Study|Lost to Follow-up|0|||
149205802|NCT03695393|538219667|FG001|Overall Study|Lost to Follow-up|1|||
149205803|NCT04169061|538219668|FG000|Overall Study|Adverse Event|2|||
149205804|NCT04169061|538219668|FG000|Overall Study|Death|1|||
149205805|NCT04169061|538219668|FG000|Overall Study|Withdrawal by Subject|1|||
149205806|NCT04169061|538219668|FG000|Overall Study|Protocol Violation|1|||
149205807|NCT04585451|538219669|FG000|Overall Study|Withdrawal by Subject|26|||
149205808|NCT04585451|538219670|FG001|Overall Study|Withdrawal by Subject|0|||
149205809|NCT00493974|538219671|FG000|Overall Study|Death|1|||
149205810|NCT00493974|538219672|FG001|Overall Study|Death|2|||
149205811|NCT00493974|538219671|FG000|Overall Study|Withdrawal by Subject|8|||
149205812|NCT00493974|538219672|FG001|Overall Study|Withdrawal by Subject|6|||
149205813|NCT00493974|538219671|FG000|Overall Study|Lost to Follow-up|4|||
149205814|NCT00493974|538219672|FG001|Overall Study|Lost to Follow-up|6|||
149205815|NCT02807363|538219673|FG000|Dosing Period|Adverse Event|0|||
149205816|NCT02807363|538219674|FG001|Dosing Period|Adverse Event|1|||
149205817|NCT02807363|538219675|FG002|Dosing Period|Adverse Event|0|||
149205818|NCT02807363|538219676|FG003|Dosing Period|Adverse Event|0|||
149205819|NCT02188719|538219677|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
149205820|NCT02188719|538219678|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
149205821|NCT02188719|538219679|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
149205822|NCT02188719|538219680|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
149205823|NCT00966693|538219681|FG000|Overall Study|Adverse Event|0|||
149205824|NCT00966693|538219682|FG001|Overall Study|Adverse Event|0|||
149205825|NCT00966693|538219683|FG002|Overall Study|Adverse Event|1|||
149205826|NCT00966693|538219684|FG003|Overall Study|Adverse Event|2|||
149205827|NCT00966693|538219681|FG000|Overall Study|Death|0|||
149205828|NCT00966693|538219682|FG001|Overall Study|Death|0|||
149205829|NCT00966693|538219683|FG002|Overall Study|Death|1|||
148808920|NCT04476043|536777560|FG002|Overall Study|Withdrawal by Subject|4|||
148808921|NCT04476043|536777561|FG003|Overall Study|Withdrawal by Subject|1|||
148808922|NCT04476043|536777558|FG000|Overall Study|Lost to Follow-up|1|||
148808923|NCT04476043|536777559|FG001|Overall Study|Lost to Follow-up|1|||
148808924|NCT04476043|536777560|FG002|Overall Study|Lost to Follow-up|2|||
148808925|NCT04476043|536777561|FG003|Overall Study|Lost to Follow-up|1|||
148808926|NCT04476043|536777558|FG000|Overall Study|Adverse Event|2|||
148808927|NCT04476043|536777559|FG001|Overall Study|Adverse Event|0|||
148808928|NCT04476043|536777560|FG002|Overall Study|Adverse Event|1|||
148808929|NCT04476043|536777561|FG003|Overall Study|Adverse Event|0|||
148808930|NCT04476043|536777558|FG000|Overall Study|Protocol Violation|0|||
148808931|NCT04476043|536777559|FG001|Overall Study|Protocol Violation|1|||
148808932|NCT04476043|536777560|FG002|Overall Study|Protocol Violation|0|||
148808933|NCT04476043|536777561|FG003|Overall Study|Protocol Violation|0|||
148808934|NCT06217380|536777562|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
148808935|NCT06217380|536777562|FG000|Overall Study|Physician Decision|1|||
148808936|NCT06217380|536777562|FG000|Overall Study|Withdrawal by Subject|2|||
148808937|NCT06633965|536777563|FG000|Overall Study|Withdrawal by Subject|0|||
148808938|NCT06633965|536777564|FG001|Overall Study|Withdrawal by Subject|1|||
148808939|NCT02328105|536777565|FG000|Overall Study|Death|6|||
148808940|NCT02328105|536777565|FG000|Overall Study|Withdrawal by Subject|1|||
148808941|NCT02328105|536777565|FG000|Overall Study|Still On Study in Follow-Up|4|||
148808942|NCT00614393|536777566|FG000|Overall Study|Adverse Event|20|||
148808943|NCT00614393|536777567|FG001|Overall Study|Adverse Event|2|||
148808944|NCT00614393|536777568|FG002|Overall Study|Adverse Event|3|||
148808945|NCT00614393|536777569|FG003|Overall Study|Adverse Event|13|||
148808946|NCT00614393|536777570|FG004|Overall Study|Adverse Event|21|||
148808947|NCT00614393|536777566|FG000|Overall Study|Lost to Follow-up|0|||
148808948|NCT00614393|536777567|FG001|Overall Study|Lost to Follow-up|0|||
148808949|NCT00614393|536777568|FG002|Overall Study|Lost to Follow-up|0|||
148808950|NCT00614393|536777569|FG003|Overall Study|Lost to Follow-up|1|||
148808951|NCT00614393|536777570|FG004|Overall Study|Lost to Follow-up|2|||
148808952|NCT00614393|536777566|FG000|Overall Study|Physician Decision|17|||
148808953|NCT00614393|536777567|FG001|Overall Study|Physician Decision|0|||
148808954|NCT00614393|536777568|FG002|Overall Study|Physician Decision|1|||
148808955|NCT00614393|536777569|FG003|Overall Study|Physician Decision|8|||
148808956|NCT00614393|536777570|FG004|Overall Study|Physician Decision|9|||
148808957|NCT00614393|536777566|FG000|Overall Study|Progressive Disease|118|||
148808958|NCT00614393|536777567|FG001|Overall Study|Progressive Disease|5|||
148947507|NCT02615145|537291939|FG001|Overall Study|Failure to Return|10|||
148947508|NCT02615145|537291940|FG002|Overall Study|Failure to Return|7|||
148947509|NCT02615145|537291941|FG003|Overall Study|Failure to Return|0|||
148947510|NCT02615145|537291938|FG000|Overall Study|Death|2|||
148947511|NCT02615145|537291939|FG001|Overall Study|Death|3|||
148947512|NCT02615145|537291940|FG002|Overall Study|Death|0|||
148947513|NCT02615145|537291941|FG003|Overall Study|Death|0|||
148947514|NCT02615145|537291938|FG000|Overall Study|Other, Not Specified|5|||
148947515|NCT02615145|537291939|FG001|Overall Study|Other, Not Specified|2|||
148947516|NCT02615145|537291940|FG002|Overall Study|Other, Not Specified|0|||
148808959|NCT00614393|536777568|FG002|Overall Study|Progressive Disease|5|||
148808960|NCT00614393|536777569|FG003|Overall Study|Progressive Disease|138|||
148808961|NCT00614393|536777570|FG004|Overall Study|Progressive Disease|130|||
148808962|NCT00614393|536777566|FG000|Overall Study|Protocol Violation|1|||
148808963|NCT00614393|536777567|FG001|Overall Study|Protocol Violation|0|||
148808964|NCT00614393|536777568|FG002|Overall Study|Protocol Violation|0|||
148808965|NCT00614393|536777569|FG003|Overall Study|Protocol Violation|0|||
148808966|NCT00614393|536777570|FG004|Overall Study|Protocol Violation|0|||
148947517|NCT02615145|537291941|FG003|Overall Study|Other, Not Specified|0|||
148947518|NCT03648983|537291946|FG000|Overall Study|Study was terminated due to PI departure|95|||
148947519|NCT04404361|537291950|FG000|Overall Study|Death|12|||
148947520|NCT04404361|537291951|FG001|Overall Study|Death|12|||
148947521|NCT04404361|537291950|FG000|Overall Study|Withdrawal by Subject|13|||
148947522|NCT04404361|537291951|FG001|Overall Study|Withdrawal by Subject|5|||
148947523|NCT04404361|537291950|FG000|Overall Study|Lost to Follow-up|6|||
148947524|NCT04404361|537291951|FG001|Overall Study|Lost to Follow-up|3|||
148947525|NCT04404361|537291950|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
148947526|NCT04404361|537291951|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
148947527|NCT00638378|537293390|FG000|Overall Study|Death|2|||
148947528|NCT00638378|537293390|FG000|Overall Study|Adverse Event|1|||
148947529|NCT00638378|537293390|FG000|Overall Study|Disease progression|15|||
148947530|NCT00638378|537293390|FG000|Overall Study|Physician Decision|4|||
148947531|NCT01892293|537293393|FG000|Overall Study|Apheresed but not treated|4|||
148947532|NCT03602482|537293394|FG000|Overall Study|Withdrawal by Subject|6|||
148947533|NCT03602482|537293395|FG001|Overall Study|Withdrawal by Subject|7|||
148947534|NCT03602482|537293396|FG002|Overall Study|Withdrawal by Subject|0|||
148947535|NCT03602482|537293397|FG003|Overall Study|Withdrawal by Subject|0|||
148947536|NCT02601469|537293400|FG000|Overall Study|Enrolled in Error|1|||
148947537|NCT02601469|537293401|FG001|Overall Study|Enrolled in Error|0|||
148947538|NCT01411774|537293406|FG000|Overall Study|Withdrawal by Subject|0|||
148947539|NCT01411774|537293407|FG001|Overall Study|Withdrawal by Subject|3|||
148947540|NCT00056316|537293408|FG000|Overall Study|Withdrawal by Subject|2|||
148947541|NCT00056316|537293409|FG001|Overall Study|Withdrawal by Subject|2|||
148947542|NCT00056316|537293408|FG000|Overall Study|Death/NH placement of pt|1|||
148947543|NCT00056316|537293409|FG001|Overall Study|Death/NH placement of pt|1|||
148947544|NCT00684307|537293413|FG000|Overall Study|Adverse Event|11|||
148947545|NCT00684307|537293414|FG001|Overall Study|Adverse Event|6|||
148947546|NCT00684307|537293415|FG002|Overall Study|Adverse Event|15|||
148947547|NCT00684307|537293416|FG003|Overall Study|Adverse Event|16|||
148947548|NCT00684307|537293417|FG004|Overall Study|Adverse Event|8|||
148947549|NCT00684307|537293413|FG000|Overall Study|Development of increasing Liver Function|0|||
148947550|NCT00684307|537293414|FG001|Overall Study|Development of increasing Liver Function|2|||
148947551|NCT00684307|537293415|FG002|Overall Study|Development of increasing Liver Function|0|||
148947552|NCT00684307|537293416|FG003|Overall Study|Development of increasing Liver Function|1|||
148947553|NCT00684307|537293417|FG004|Overall Study|Development of increasing Liver Function|0|||
148947554|NCT00684307|537293413|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
148947555|NCT00684307|537293414|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
148947556|NCT00684307|537293415|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
148947557|NCT00684307|537293416|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
148947558|NCT00684307|537293417|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
148947559|NCT00684307|537293413|FG000|Overall Study|Incorrect enrolment or randomization|4|||
148947560|NCT00684307|537293414|FG001|Overall Study|Incorrect enrolment or randomization|0|||
148947561|NCT00684307|537293415|FG002|Overall Study|Incorrect enrolment or randomization|0|||
148947562|NCT00684307|537293416|FG003|Overall Study|Incorrect enrolment or randomization|0|||
148947563|NCT00684307|537293417|FG004|Overall Study|Incorrect enrolment or randomization|0|||
148947564|NCT00684307|537293413|FG000|Overall Study|Interupted IP for more than 7 days|0|||
148947565|NCT00684307|537293414|FG001|Overall Study|Interupted IP for more than 7 days|4|||
148947566|NCT00684307|537293415|FG002|Overall Study|Interupted IP for more than 7 days|1|||
148947567|NCT00684307|537293416|FG003|Overall Study|Interupted IP for more than 7 days|3|||
148947568|NCT00684307|537293417|FG004|Overall Study|Interupted IP for more than 7 days|3|||
148947569|NCT00684307|537293413|FG000|Overall Study|Severe non compliance to protocol|1|||
148947570|NCT00684307|537293414|FG001|Overall Study|Severe non compliance to protocol|0|||
148947571|NCT00684307|537293415|FG002|Overall Study|Severe non compliance to protocol|0|||
148947572|NCT00684307|537293416|FG003|Overall Study|Severe non compliance to protocol|1|||
148947573|NCT00684307|537293417|FG004|Overall Study|Severe non compliance to protocol|2|||
148947574|NCT00684307|537293413|FG000|Overall Study|Participant not willing to continue|7|||
148947575|NCT00684307|537293414|FG001|Overall Study|Participant not willing to continue|10|||
148947576|NCT00684307|537293415|FG002|Overall Study|Participant not willing to continue|11|||
149205830|NCT00966693|538219684|FG003|Overall Study|Death|0|||
149205831|NCT00966693|538219681|FG000|Overall Study|Withdrawal by Subject|1|||
149205832|NCT00966693|538219682|FG001|Overall Study|Withdrawal by Subject|0|||
149205833|NCT00966693|538219683|FG002|Overall Study|Withdrawal by Subject|0|||
149205834|NCT00966693|538219684|FG003|Overall Study|Withdrawal by Subject|5|||
149205835|NCT00966693|538219681|FG000|Overall Study|Disease Progression|0|||
148947577|NCT00684307|537293416|FG003|Overall Study|Participant not willing to continue|5|||
149016330|NCT05027074|537537902|FG000|Overall Study|Status Not Recorded|0|||
149205836|NCT00966693|538219682|FG001|Overall Study|Disease Progression|0|||
148683623|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
148683624|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
148947578|NCT00684307|537293417|FG004|Overall Study|Participant not willing to continue|8|||
148947579|NCT00684307|537293413|FG000|Overall Study|Criteria from the CSR|0|||
148947580|NCT00684307|537293414|FG001|Overall Study|Criteria from the CSR|0|||
148947581|NCT00684307|537293415|FG002|Overall Study|Criteria from the CSR|1|||
149205837|NCT00966693|538219683|FG002|Overall Study|Disease Progression|1|||
149205838|NCT00966693|538219684|FG003|Overall Study|Disease Progression|16|||
149205839|NCT00192036|538219685|FG000|Overall Study|Protocol Violation|3|||
149205840|NCT00192036|538219685|FG000|Overall Study|Adverse Event|6|||
149205841|NCT00192036|538219685|FG000|Overall Study|Patient/Physician Perception|1|||
149205842|NCT00192036|538219685|FG000|Overall Study|Objective Tumor Progression|4|||
149205843|NCT00192036|538219685|FG000|Overall Study|Clinical Disease Progression|1|||
149205844|NCT00192036|538219685|FG000|Overall Study|Death|1|||
149205845|NCT00192036|538219685|FG000|Overall Study|Unknown or Not Specified|5|||
149205846|NCT03371732|538219686|FG000|Overall Study|Withdrawal by Subject|9|||
149205847|NCT03371732|538219687|FG001|Overall Study|Withdrawal by Subject|3|||
149205848|NCT03371732|538219686|FG000|Overall Study|Refusal to continue|3|||
149205849|NCT03371732|538219687|FG001|Overall Study|Refusal to continue|4|||
149205850|NCT02581982|538219690|FG000|Overall Study|Lack of Efficacy|12|||
149205851|NCT02581982|538219690|FG000|Overall Study|Adverse Event|3|||
149205852|NCT02581982|538219690|FG000|Overall Study|Physician Decision|1|||
149205853|NCT00405821|538219691|FG000|Overall Study|Death|5|||
148683625|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
149205854|NCT00405821|538219692|FG001|Overall Study|Death|7|||
149205855|NCT00405821|538219691|FG000|Overall Study|Lost to Follow-up|7|||
149205856|NCT00405821|538219692|FG001|Overall Study|Lost to Follow-up|7|||
149205857|NCT00405821|538219691|FG000|Overall Study|Protocol Violation|1|||
149205858|NCT00405821|538219692|FG001|Overall Study|Protocol Violation|0|||
149016331|NCT05027074|537537903|FG001|Overall Study|Status Not Recorded|0|||
149205859|NCT00405821|538219691|FG000|Overall Study|initiated ART|9|||
149205860|NCT00405821|538219692|FG001|Overall Study|initiated ART|8|||
149205861|NCT02148211|538219698|FG000|Overall Study|Lost to Follow-up|352|||
149205862|NCT03148756|538219700|FG000|Overall Study|Study Terminated|0|||
149205863|NCT03148756|538219701|FG001|Overall Study|Study Terminated|1|||
149205864|NCT01770145|538221383|FG000|Baseline|Adverse Event|20|||
149205865|NCT01770145|538221383|FG000|Baseline|Withdrawal by Subject|1|||
149205866|NCT01770145|538221383|FG000|Baseline|Lost to Follow-up|1|||
149205867|NCT01770145|538221383|FG000|Baseline|Unable to define optimal dose|4|||
149205868|NCT01770145|538221383|FG000|Treatment|Adverse Event|3|||
149205869|NCT01770145|538221383|FG000|Treatment|Withdrawal by Subject|1|||
149205870|NCT03788967|538221384|FG000|Overall Study|Lost to Follow-up|14|||
149205871|NCT03788967|538221385|FG001|Overall Study|Lost to Follow-up|10|||
149205872|NCT03788967|538221384|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
149205873|NCT03788967|538221385|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
149205874|NCT03788967|538221384|FG000|Overall Study|Participant Withdrawal of Consent|13|||
149205875|NCT03788967|538221385|FG001|Overall Study|Participant Withdrawal of Consent|5|||
149205876|NCT03788967|538221384|FG000|Overall Study|Adverse Event|1|||
149205877|NCT03788967|538221385|FG001|Overall Study|Adverse Event|1|||
149205878|NCT03788967|538221384|FG000|Overall Study|COVID-19|1|||
149205879|NCT03788967|538221385|FG001|Overall Study|COVID-19|2|||
149205880|NCT04268303|538221386|FG000|Overall Study|Lost to Follow-up|1|||
149205881|NCT04268303|538221387|FG001|Overall Study|Lost to Follow-up|1|||
148683626|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
148683627|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
148683628|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
148683629|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
148683630|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
148683631|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
148683632|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
148683633|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
148683634|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
148683635|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
148683636|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
148683637|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
148683638|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
148683639|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
148683640|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
148683641|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
148683642|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
148683643|NCT00606684|536314957|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
148683644|NCT00606684|536314958|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
148683645|NCT00606684|536314959|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
148683646|NCT00606684|536314960|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
148683647|NCT00606684|536314961|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
148683648|NCT00606684|536314962|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
148683649|NCT00606684|536314963|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
148683650|NCT00606684|536314957|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148683651|NCT00606684|536314958|FG001|Double-Blind Treatment Period|Adverse Event|3|||
148683652|NCT00606684|536314959|FG002|Double-Blind Treatment Period|Adverse Event|2|||
148683653|NCT00606684|536314960|FG003|Double-Blind Treatment Period|Adverse Event|4|||
148683654|NCT00606684|536314961|FG004|Double-Blind Treatment Period|Adverse Event|2|||
148683655|NCT00606684|536314962|FG005|Double-Blind Treatment Period|Adverse Event|0|||
148683656|NCT00606684|536314963|FG006|Double-Blind Treatment Period|Adverse Event|1|||
148683657|NCT00606684|536314957|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
148683658|NCT00606684|536314958|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
148683659|NCT00606684|536314959|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
148683660|NCT00606684|536314960|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
148683661|NCT00606684|536314961|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
148683662|NCT00606684|536314962|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
148683663|NCT00606684|536314963|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
148683664|NCT00606684|536314957|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
149205882|NCT04268303|538221388|FG002|Overall Study|Lost to Follow-up|2|||
149205883|NCT04268303|538221386|FG000|Overall Study|Withdrawal by Subject|0|||
149205884|NCT04268303|538221387|FG001|Overall Study|Withdrawal by Subject|1|||
148683665|NCT00606684|536314958|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
149016332|NCT05027074|537537904|FG002|Overall Study|Status Not Recorded|1|||
149205885|NCT04268303|538221388|FG002|Overall Study|Withdrawal by Subject|1|||
149205886|NCT04268303|538221386|FG000|Overall Study|Adverse Event|2|||
149205887|NCT04268303|538221387|FG001|Overall Study|Adverse Event|0|||
149205888|NCT04268303|538221388|FG002|Overall Study|Adverse Event|0|||
148808967|NCT00614393|536777566|FG000|Overall Study|Terminated by Sponsor|0|||
149205889|NCT00355134|538221389|FG000|Core Phase|Withdrawal by Subject|35|||
149205890|NCT00355134|538221390|FG001|Core Phase|Withdrawal by Subject|24|||
149205891|NCT00355134|538221391|FG002|Core Phase|Withdrawal by Subject|35|||
149205892|NCT00355134|538221392|FG003|Core Phase|Withdrawal by Subject|0|||
149205893|NCT00355134|538221393|FG004|Core Phase|Withdrawal by Subject|0|||
149205894|NCT00355134|538221389|FG000|Core Phase|Adverse Event|28|||
149205895|NCT00355134|538221390|FG001|Core Phase|Adverse Event|22|||
149205896|NCT00355134|538221391|FG002|Core Phase|Adverse Event|16|||
149205897|NCT00355134|538221392|FG003|Core Phase|Adverse Event|0|||
149205898|NCT00355134|538221393|FG004|Core Phase|Adverse Event|0|||
149205899|NCT00355134|538221389|FG000|Core Phase|Lost to Follow-up|17|||
149205900|NCT00355134|538221390|FG001|Core Phase|Lost to Follow-up|13|||
149205901|NCT00355134|538221391|FG002|Core Phase|Lost to Follow-up|21|||
149205902|NCT00355134|538221392|FG003|Core Phase|Lost to Follow-up|0|||
149205903|NCT00355134|538221393|FG004|Core Phase|Lost to Follow-up|0|||
149205904|NCT00355134|538221389|FG000|Core Phase|Abnormal laboratory value(s)|19|||
149205905|NCT00355134|538221390|FG001|Core Phase|Abnormal laboratory value(s)|14|||
149205906|NCT00355134|538221391|FG002|Core Phase|Abnormal laboratory value(s)|2|||
149205907|NCT00355134|538221392|FG003|Core Phase|Abnormal laboratory value(s)|0|||
149205908|NCT00355134|538221393|FG004|Core Phase|Abnormal laboratory value(s)|0|||
149205909|NCT00355134|538221389|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
149205910|NCT00355134|538221390|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
149205911|NCT00355134|538221391|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
149205912|NCT00355134|538221392|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
149205913|NCT00355134|538221393|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
149205914|NCT00355134|538221389|FG000|Core Phase|Administrative problems|5|||
149205915|NCT00355134|538221390|FG001|Core Phase|Administrative problems|3|||
149205916|NCT00355134|538221391|FG002|Core Phase|Administrative problems|5|||
149205917|NCT00355134|538221392|FG003|Core Phase|Administrative problems|0|||
149205918|NCT00355134|538221393|FG004|Core Phase|Administrative problems|0|||
149205919|NCT00355134|538221389|FG000|Core Phase|Protocol Violation|3|||
148808968|NCT00614393|536777567|FG001|Overall Study|Terminated by Sponsor|0|||
148808969|NCT00614393|536777568|FG002|Overall Study|Terminated by Sponsor|0|||
148808970|NCT00614393|536777569|FG003|Overall Study|Terminated by Sponsor|0|||
148808971|NCT00614393|536777570|FG004|Overall Study|Terminated by Sponsor|1|||
148808972|NCT00614393|536777566|FG000|Overall Study|Withdrawal by Subject|20|||
148808973|NCT00614393|536777567|FG001|Overall Study|Withdrawal by Subject|1|||
149205920|NCT00355134|538221390|FG001|Core Phase|Protocol Violation|2|||
149205921|NCT00355134|538221391|FG002|Core Phase|Protocol Violation|2|||
149205922|NCT00355134|538221392|FG003|Core Phase|Protocol Violation|0|||
149205923|NCT00355134|538221393|FG004|Core Phase|Protocol Violation|0|||
149205924|NCT00355134|538221389|FG000|Core Phase|Abnormal test procedure result(s)|1|||
148808974|NCT00614393|536777568|FG002|Overall Study|Withdrawal by Subject|1|||
148808975|NCT00614393|536777569|FG003|Overall Study|Withdrawal by Subject|16|||
148808976|NCT00614393|536777570|FG004|Overall Study|Withdrawal by Subject|13|||
148808977|NCT00614393|536777566|FG000|Overall Study|Other|4|||
148808978|NCT00614393|536777567|FG001|Overall Study|Other|0|||
148808979|NCT00614393|536777568|FG002|Overall Study|Other|0|||
148808980|NCT00614393|536777569|FG003|Overall Study|Other|4|||
148947582|NCT00684307|537293416|FG003|Overall Study|Criteria from the CSR|3|||
149205925|NCT00355134|538221390|FG001|Core Phase|Abnormal test procedure result(s)|2|||
149205926|NCT00355134|538221391|FG002|Core Phase|Abnormal test procedure result(s)|1|||
149205927|NCT00355134|538221392|FG003|Core Phase|Abnormal test procedure result(s)|0|||
149205928|NCT00355134|538221393|FG004|Core Phase|Abnormal test procedure result(s)|0|||
149205929|NCT00355134|538221389|FG000|Core Phase|Condition no longer requires study drug|1|||
148808981|NCT00614393|536777570|FG004|Overall Study|Other|2|||
148808982|NCT00614393|536777566|FG000|Overall Study|Not Treated|0|||
148808983|NCT00614393|536777567|FG001|Overall Study|Not Treated|0|||
148947583|NCT00684307|537293417|FG004|Overall Study|Criteria from the CSR|3|||
148808984|NCT00614393|536777568|FG002|Overall Study|Not Treated|0|||
148947584|NCT01029795|537293424|FG000|Overall Study|Entry Criteria Not Met|2|||
149205930|NCT00355134|538221390|FG001|Core Phase|Condition no longer requires study drug|0|||
148808985|NCT00614393|536777569|FG003|Overall Study|Not Treated|0|||
148808986|NCT00614393|536777570|FG004|Overall Study|Not Treated|2|||
149205931|NCT00355134|538221391|FG002|Core Phase|Condition no longer requires study drug|1|||
149205932|NCT00355134|538221392|FG003|Core Phase|Condition no longer requires study drug|0|||
149205933|NCT00355134|538221393|FG004|Core Phase|Condition no longer requires study drug|0|||
149205934|NCT00355134|538221389|FG000|Extension Phase|Withdrawal by Subject|7|||
149205935|NCT00355134|538221390|FG001|Extension Phase|Withdrawal by Subject|11|||
149205936|NCT00355134|538221391|FG002|Extension Phase|Withdrawal by Subject|0|||
149205937|NCT00355134|538221392|FG003|Extension Phase|Withdrawal by Subject|7|||
149205938|NCT00355134|538221393|FG004|Extension Phase|Withdrawal by Subject|5|||
148947585|NCT01029795|537293425|FG001|Overall Study|Entry Criteria Not Met|1|||
148947586|NCT01029795|537293424|FG000|Overall Study|Physician Decision|2|||
148947587|NCT01029795|537293425|FG001|Overall Study|Physician Decision|1|||
149205939|NCT00355134|538221389|FG000|Extension Phase|Adverse Event|13|||
148808987|NCT00855582|536777571|FG000|Overall Study|Adverse Event|2|||
148808988|NCT00855582|536777572|FG001|Overall Study|Adverse Event|6|||
148808989|NCT00855582|536777573|FG002|Overall Study|Adverse Event|3|||
148808990|NCT00855582|536777571|FG000|Overall Study|Death|1|||
148808991|NCT00855582|536777572|FG001|Overall Study|Death|0|||
148808992|NCT00855582|536777573|FG002|Overall Study|Death|0|||
148808993|NCT00855582|536777571|FG000|Overall Study|Lack of Efficacy|1|||
148808994|NCT00855582|536777572|FG001|Overall Study|Lack of Efficacy|3|||
148808995|NCT00855582|536777573|FG002|Overall Study|Lack of Efficacy|8|||
148808996|NCT00855582|536777571|FG000|Overall Study|Lost to Follow-up|1|||
148808997|NCT00855582|536777572|FG001|Overall Study|Lost to Follow-up|3|||
148808998|NCT00855582|536777573|FG002|Overall Study|Lost to Follow-up|1|||
148808999|NCT00855582|536777571|FG000|Overall Study|Physician Decision|0|||
148809000|NCT00855582|536777572|FG001|Overall Study|Physician Decision|0|||
148809001|NCT00855582|536777573|FG002|Overall Study|Physician Decision|1|||
148809002|NCT00855582|536777571|FG000|Overall Study|Protocol Violation|6|||
148809003|NCT00855582|536777572|FG001|Overall Study|Protocol Violation|2|||
148809004|NCT00855582|536777573|FG002|Overall Study|Protocol Violation|6|||
148809005|NCT00855582|536777571|FG000|Overall Study|Entry Criteria Not Met|8|||
148809006|NCT00855582|536777572|FG001|Overall Study|Entry Criteria Not Met|6|||
148809007|NCT00855582|536777573|FG002|Overall Study|Entry Criteria Not Met|3|||
148809008|NCT00855582|536777571|FG000|Overall Study|Withdrawal by Subject|7|||
148809009|NCT00855582|536777572|FG001|Overall Study|Withdrawal by Subject|4|||
148809010|NCT00855582|536777573|FG002|Overall Study|Withdrawal by Subject|8|||
148809011|NCT03345004|536777577|FG000|Overall Study|Physician Decision|1|||
148809012|NCT03345004|536777578|FG001|Overall Study|Physician Decision|0|||
148809013|NCT03345004|536777577|FG000|Overall Study|Withdrawal by Subject|0|||
148809014|NCT03345004|536777578|FG001|Overall Study|Withdrawal by Subject|1|||
148809015|NCT01013753|536777581|FG000|Overall Study|Adverse Event|8|||
148809016|NCT01013753|536777581|FG000|Overall Study|Protocol Violation|3|||
148809017|NCT01013753|536777581|FG000|Overall Study|Lost to Follow-up|1|||
148809018|NCT01013753|536777581|FG000|Overall Study|Withdrawal by Subject|2|||
148809019|NCT01013753|536777581|FG000|Overall Study|Other|2|||
148809020|NCT04757636|536777585|FG000|Overall Study|Adverse Event|25|||
148809021|NCT04757636|536777586|FG001|Overall Study|Adverse Event|8|||
148809022|NCT04757636|536777587|FG002|Overall Study|Adverse Event|11|||
148809023|NCT04757636|536777585|FG000|Overall Study|Death|9|||
148809024|NCT04757636|536777586|FG001|Overall Study|Death|12|||
148809025|NCT04757636|536777587|FG002|Overall Study|Death|6|||
148809026|NCT04757636|536777585|FG000|Overall Study|Lack of Efficacy|2|||
148809027|NCT04757636|536777586|FG001|Overall Study|Lack of Efficacy|0|||
148809028|NCT04757636|536777587|FG002|Overall Study|Lack of Efficacy|0|||
148809029|NCT04757636|536777585|FG000|Overall Study|Lost to Follow-up|1|||
148809030|NCT04757636|536777586|FG001|Overall Study|Lost to Follow-up|6|||
148809031|NCT04757636|536777587|FG002|Overall Study|Lost to Follow-up|7|||
148809032|NCT04757636|536777585|FG000|Overall Study|Physician Decision|1|||
148809033|NCT04757636|536777586|FG001|Overall Study|Physician Decision|3|||
148809034|NCT04757636|536777587|FG002|Overall Study|Physician Decision|4|||
148809035|NCT04757636|536777585|FG000|Overall Study|Withdrawal by Subject|20|||
148809036|NCT04757636|536777586|FG001|Overall Study|Withdrawal by Subject|23|||
148809037|NCT04757636|536777587|FG002|Overall Study|Withdrawal by Subject|18|||
148809038|NCT04757636|536777585|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
148809039|NCT04757636|536777586|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
148809040|NCT04757636|536777587|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
148809041|NCT04757636|536777585|FG000|Overall Study|Study Terminated by Sponsor|103|||
148809042|NCT04757636|536777586|FG001|Overall Study|Study Terminated by Sponsor|104|||
148809043|NCT04757636|536777587|FG002|Overall Study|Study Terminated by Sponsor|114|||
148809044|NCT04757636|536777585|FG000|Overall Study|Sponsor Decision|0|||
148809045|NCT04757636|536777586|FG001|Overall Study|Sponsor Decision|0|||
148809046|NCT04757636|536777587|FG002|Overall Study|Sponsor Decision|1|||
148809047|NCT04757636|536777585|FG000|Overall Study|Randomized in Error|0|||
148809048|NCT04757636|536777586|FG001|Overall Study|Randomized in Error|0|||
148809049|NCT04757636|536777587|FG002|Overall Study|Randomized in Error|2|||
148809050|NCT03286504|536777588|FG000|Overall Study|Lost to Follow-up|19|||
148809051|NCT03286504|536777589|FG001|Overall Study|Lost to Follow-up|16|||
148809052|NCT00141921|536777591|FG000|Overall Study|Remain on Study|28|||
148809053|NCT00141921|536777591|FG000|Overall Study|Withdrawal by Subject|42|||
148809054|NCT00141921|536777591|FG000|Overall Study|Lost to Follow-up|19|||
148809055|NCT00141921|536777591|FG000|Overall Study|Noncompliance|17|||
148809056|NCT00141921|536777591|FG000|Overall Study|Disease Progression|7|||
148809057|NCT00141921|536777591|FG000|Overall Study|Protocol Deviation|7|||
148809058|NCT00141921|536777591|FG000|Overall Study|Adverse Event|5|||
148809059|NCT00141921|536777591|FG000|Overall Study|Administrative Decision|2|||
148809060|NCT00141921|536777591|FG000|Overall Study|Pregnancy|4|||
148809061|NCT00141921|536777591|FG000|Overall Study|Ineligibility Determined|2|||
148809062|NCT00141921|536777591|FG000|Overall Study|Other|8|||
148809063|NCT03813654|536777594|FG000|Overall Study|Protocol Violation|0|||
148809064|NCT03813654|536777595|FG001|Overall Study|Protocol Violation|1|||
148809065|NCT03813654|536777596|FG002|Overall Study|Protocol Violation|2|||
148947588|NCT01029795|537293424|FG000|Overall Study|Sponsor Decision|11|||
149205940|NCT00355134|538221390|FG001|Extension Phase|Adverse Event|9|||
149205941|NCT00355134|538221391|FG002|Extension Phase|Adverse Event|0|||
149205942|NCT00355134|538221392|FG003|Extension Phase|Adverse Event|3|||
149205943|NCT00355134|538221393|FG004|Extension Phase|Adverse Event|5|||
149205944|NCT00355134|538221389|FG000|Extension Phase|Lost to Follow-up|2|||
149205945|NCT00355134|538221390|FG001|Extension Phase|Lost to Follow-up|6|||
149205946|NCT00355134|538221391|FG002|Extension Phase|Lost to Follow-up|0|||
149205947|NCT00355134|538221392|FG003|Extension Phase|Lost to Follow-up|2|||
149205948|NCT00355134|538221393|FG004|Extension Phase|Lost to Follow-up|4|||
149205949|NCT00355134|538221389|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
149205950|NCT00355134|538221390|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
148683666|NCT00606684|536314959|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
149205951|NCT00355134|538221391|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
149205952|NCT00355134|538221392|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
149205953|NCT00355134|538221393|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
149205954|NCT00355134|538221389|FG000|Extension Phase|Administrative problems|2|||
149205955|NCT00355134|538221390|FG001|Extension Phase|Administrative problems|4|||
149205956|NCT00355134|538221391|FG002|Extension Phase|Administrative problems|0|||
149205957|NCT00355134|538221392|FG003|Extension Phase|Administrative problems|1|||
149205958|NCT00355134|538221393|FG004|Extension Phase|Administrative problems|1|||
149205959|NCT00355134|538221389|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
149205960|NCT00355134|538221390|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
149205961|NCT00355134|538221391|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
149205962|NCT00355134|538221392|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
149205963|NCT00355134|538221393|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
149205964|NCT00355134|538221389|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
149205965|NCT00355134|538221390|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
149205966|NCT00355134|538221391|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
149205967|NCT00355134|538221392|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
149205968|NCT00355134|538221393|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
149205969|NCT00355134|538221389|FG000|Extension Phase|Protocol Violation|0|||
149205970|NCT00355134|538221390|FG001|Extension Phase|Protocol Violation|0|||
149205971|NCT00355134|538221391|FG002|Extension Phase|Protocol Violation|0|||
149205972|NCT00355134|538221392|FG003|Extension Phase|Protocol Violation|1|||
149205973|NCT00355134|538221393|FG004|Extension Phase|Protocol Violation|0|||
149205974|NCT03621189|538221409|FG000|Overall Study|Withdrawal by Subject|0|||
149205975|NCT03621189|538221410|FG001|Overall Study|Withdrawal by Subject|3|||
149205976|NCT03621189|538221409|FG000|Overall Study|Physician Decision|0|||
149205977|NCT03621189|538221410|FG001|Overall Study|Physician Decision|2|||
148947589|NCT01029795|537293425|FG001|Overall Study|Sponsor Decision|17|||
148947590|NCT01029795|537293424|FG000|Overall Study|Withdrawal by Subject|1|||
148947591|NCT01029795|537293425|FG001|Overall Study|Withdrawal by Subject|3|||
148947592|NCT01806545|537293426|FG000|Overall Study|Adverse Event|2|||
148947593|NCT01806545|537293427|FG001|Overall Study|Adverse Event|3|||
148947594|NCT01806545|537293426|FG000|Overall Study|Lost to Follow-up|1|||
148947595|NCT01806545|537293427|FG001|Overall Study|Lost to Follow-up|0|||
148947596|NCT01806545|537293426|FG000|Overall Study|Withdrawal by Subject|3|||
148947597|NCT01806545|537293427|FG001|Overall Study|Withdrawal by Subject|2|||
148947598|NCT00617123|537293428|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
149205978|NCT01135394|538221411|FG000|Screening|Lost to Follow-up|2|||
149205979|NCT01135394|538221411|FG000|Screening|Withdrawal by Subject|10|||
149205980|NCT01135394|538221411|FG000|Screening|Screening failure|16|||
149205981|NCT01135394|538221411|FG000|Screening|Physician Decision|5|||
149205982|NCT01135394|538221411|FG000|Baseline Assessment|Withdrawal by Subject|9|||
149205983|NCT01135394|538221411|FG000|Baseline Assessment|Physician Decision|3|||
149205984|NCT01135394|538221411|FG000|Baseline Assessment|Lost to Follow-up|2|||
149205985|NCT01135394|538221411|FG000|Baseline Assessment|Adverse Event|1|||
149205986|NCT01135394|538221411|FG000|Study Treatment|Withdrawal by Subject|1|||
149205987|NCT01135394|538221411|FG000|Study Treatment|Physician Decision|1|||
149205988|NCT01135394|538221411|FG000|Study Treatment|Adverse Event|2|||
149205989|NCT04432376|538221412|FG000|Double-blind Treatment Period|Adverse Event|2|||
149205990|NCT04432376|538221413|FG001|Double-blind Treatment Period|Adverse Event|6|||
149205991|NCT04432376|538221414|FG002|Double-blind Treatment Period|Adverse Event|0|||
149205992|NCT04432376|538221412|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
149205993|NCT04432376|538221413|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
149205994|NCT04432376|538221414|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
149205995|NCT04432376|538221412|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149205996|NCT04432376|538221413|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149205997|NCT04432376|538221414|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149205998|NCT04432376|538221412|FG000|Double-blind Treatment Period|Protocol Violation|0|||
149205999|NCT04432376|538221413|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149206000|NCT04432376|538221414|FG002|Double-blind Treatment Period|Protocol Violation|0|||
149206001|NCT04432376|538221412|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
149206002|NCT04432376|538221413|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
149206003|NCT04432376|538221414|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
149206004|NCT05742841|538221415|FG000|Overall Study|Withdrawal by Subject|1|||
149206005|NCT05742841|538221415|FG000|Overall Study|Lost to Follow-up|1|||
149206006|NCT02088541|538221416|FG000|Overall Study|Adverse Event|3|||
149206007|NCT02088541|538221417|FG001|Overall Study|Adverse Event|0|||
149206008|NCT02088541|538221418|FG002|Overall Study|Adverse Event|3|||
149206009|NCT02088541|538221419|FG003|Overall Study|Adverse Event|3|||
149206010|NCT02088541|538221420|FG004|Overall Study|Adverse Event|0|||
149206011|NCT02088541|538221416|FG000|Overall Study|Death|51|||
149206012|NCT02088541|538221417|FG001|Overall Study|Death|21|||
149206013|NCT02088541|538221418|FG002|Overall Study|Death|85|||
149206014|NCT02088541|538221419|FG003|Overall Study|Death|28|||
149206015|NCT02088541|538221420|FG004|Overall Study|Death|38|||
149206016|NCT02088541|538221416|FG000|Overall Study|Lost to Follow-up|2|||
149206017|NCT02088541|538221417|FG001|Overall Study|Lost to Follow-up|0|||
149206018|NCT02088541|538221418|FG002|Overall Study|Lost to Follow-up|1|||
149206019|NCT02088541|538221419|FG003|Overall Study|Lost to Follow-up|0|||
149206020|NCT02088541|538221420|FG004|Overall Study|Lost to Follow-up|0|||
149206021|NCT02088541|538221416|FG000|Overall Study|Physician Decision|2|||
149206022|NCT02088541|538221417|FG001|Overall Study|Physician Decision|1|||
149206023|NCT02088541|538221418|FG002|Overall Study|Physician Decision|2|||
149206024|NCT02088541|538221419|FG003|Overall Study|Physician Decision|0|||
149206025|NCT02088541|538221420|FG004|Overall Study|Physician Decision|2|||
149206026|NCT02088541|538221416|FG000|Overall Study|Disease progression|7|||
149206027|NCT02088541|538221417|FG001|Overall Study|Disease progression|1|||
149206028|NCT02088541|538221418|FG002|Overall Study|Disease progression|2|||
149206029|NCT02088541|538221419|FG003|Overall Study|Disease progression|3|||
149206030|NCT02088541|538221420|FG004|Overall Study|Disease progression|1|||
149206031|NCT02088541|538221416|FG000|Overall Study|Study terminated by sponsor|1|||
149206032|NCT02088541|538221417|FG001|Overall Study|Study terminated by sponsor|1|||
149206033|NCT02088541|538221418|FG002|Overall Study|Study terminated by sponsor|12|||
149206034|NCT02088541|538221419|FG003|Overall Study|Study terminated by sponsor|2|||
149206035|NCT02088541|538221420|FG004|Overall Study|Study terminated by sponsor|6|||
149206036|NCT02088541|538221416|FG000|Overall Study|Withdrawal by Subject|3|||
149206037|NCT02088541|538221417|FG001|Overall Study|Withdrawal by Subject|2|||
149206038|NCT02088541|538221418|FG002|Overall Study|Withdrawal by Subject|9|||
149206039|NCT02088541|538221419|FG003|Overall Study|Withdrawal by Subject|7|||
149206040|NCT02088541|538221420|FG004|Overall Study|Withdrawal by Subject|10|||
149206041|NCT02088541|538221416|FG000|Overall Study|Other|2|||
149206042|NCT02088541|538221417|FG001|Overall Study|Other|1|||
149206043|NCT02088541|538221418|FG002|Overall Study|Other|3|||
149206044|NCT02088541|538221419|FG003|Overall Study|Other|1|||
149206045|NCT02088541|538221420|FG004|Overall Study|Other|1|||
149206046|NCT00379236|538221421|FG000|Double-blind|Adverse Event|11|||
149206047|NCT00379236|538221422|FG001|Double-blind|Adverse Event|6|||
149206048|NCT00379236|538221423|FG002|Double-blind|Adverse Event|0|||
149206049|NCT00379236|538221421|FG000|Double-blind|Protocol Violation|3|||
149206050|NCT00379236|538221422|FG001|Double-blind|Protocol Violation|3|||
149206051|NCT00379236|538221423|FG002|Double-blind|Protocol Violation|0|||
149206052|NCT00379236|538221421|FG000|Double-blind|Withdrawal by Subject|12|||
149206053|NCT00379236|538221422|FG001|Double-blind|Withdrawal by Subject|13|||
148947599|NCT00617123|537293429|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
148947600|NCT00617123|537293428|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
149206054|NCT00379236|538221423|FG002|Double-blind|Withdrawal by Subject|0|||
149206055|NCT00379236|538221421|FG000|Double-blind|Lost to Follow-up|4|||
149206056|NCT00379236|538221422|FG001|Double-blind|Lost to Follow-up|3|||
149206057|NCT00379236|538221423|FG002|Double-blind|Lost to Follow-up|0|||
149206058|NCT00379236|538221421|FG000|Double-blind|Use of exclusionary medication|1|||
149206059|NCT00379236|538221422|FG001|Double-blind|Use of exclusionary medication|2|||
149206060|NCT00379236|538221423|FG002|Double-blind|Use of exclusionary medication|0|||
149206061|NCT00379236|538221421|FG000|Double-blind|Other|3|||
149206062|NCT00379236|538221422|FG001|Double-blind|Other|7|||
149206063|NCT00379236|538221423|FG002|Double-blind|Other|0|||
149206064|NCT00379236|538221421|FG000|Double-blind|Data could not be retrieved|2|||
148947601|NCT00617123|537293429|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
148947602|NCT00617123|537293428|FG000|Referral Screening Period|Adverse Event|0|||
149206065|NCT00379236|538221422|FG001|Double-blind|Data could not be retrieved|2|||
149206066|NCT00379236|538221423|FG002|Double-blind|Data could not be retrieved|0|||
149206067|NCT00379236|538221421|FG000|Open-label Extension|Adverse Event|0|||
149206068|NCT00379236|538221422|FG001|Open-label Extension|Adverse Event|0|||
148947603|NCT00617123|537293429|FG001|Referral Screening Period|Adverse Event|1|||
148947604|NCT00617123|537293428|FG000|Study Treatment Period|Withdrawal by Subject|8|||
148947605|NCT00617123|537293429|FG001|Study Treatment Period|Withdrawal by Subject|12|||
148947606|NCT00617123|537293428|FG000|Study Treatment Period|Adverse Event|7|||
148947607|NCT00617123|537293429|FG001|Study Treatment Period|Adverse Event|3|||
148947608|NCT00617123|537293428|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
148947609|NCT00617123|537293429|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
148947610|NCT00617123|537293428|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
148947611|NCT00617123|537293429|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
148947612|NCT00133952|537293430|FG000|Overall Study|Adverse Event|1|||
148947613|NCT00133952|537293431|FG001|Overall Study|Adverse Event|2|||
148947614|NCT00133952|537293430|FG000|Overall Study|Death|3|||
148947615|NCT00133952|537293431|FG001|Overall Study|Death|2|||
148947616|NCT00133952|537293430|FG000|Overall Study|Lost to Follow-up|9|||
148947617|NCT00133952|537293431|FG001|Overall Study|Lost to Follow-up|14|||
148947618|NCT00133952|537293430|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
148947619|NCT00133952|537293431|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
148947620|NCT00133952|537293430|FG000|Overall Study|Protocol Violation|1|||
148947621|NCT00133952|537293431|FG001|Overall Study|Protocol Violation|1|||
148947622|NCT00133952|537293430|FG000|Overall Study|Withdrawal by Subject|20|||
148947623|NCT00133952|537293431|FG001|Overall Study|Withdrawal by Subject|4|||
149206069|NCT00379236|538221423|FG002|Open-label Extension|Adverse Event|13|||
149206070|NCT00379236|538221421|FG000|Open-label Extension|Protocol Violation|0|||
149206071|NCT00379236|538221422|FG001|Open-label Extension|Protocol Violation|0|||
149206072|NCT00379236|538221423|FG002|Open-label Extension|Protocol Violation|7|||
149206073|NCT00379236|538221421|FG000|Open-label Extension|Withdrawal by Subject|0|||
149206074|NCT00379236|538221422|FG001|Open-label Extension|Withdrawal by Subject|0|||
149206075|NCT00379236|538221423|FG002|Open-label Extension|Withdrawal by Subject|13|||
149206076|NCT00379236|538221421|FG000|Open-label Extension|Lost to Follow-up|0|||
149206077|NCT00379236|538221422|FG001|Open-label Extension|Lost to Follow-up|0|||
149206078|NCT00379236|538221423|FG002|Open-label Extension|Lost to Follow-up|12|||
149206079|NCT00379236|538221421|FG000|Open-label Extension|Use of exclusionary medication|0|||
149206080|NCT00379236|538221422|FG001|Open-label Extension|Use of exclusionary medication|0|||
149206081|NCT00379236|538221423|FG002|Open-label Extension|Use of exclusionary medication|3|||
149206082|NCT00379236|538221421|FG000|Open-label Extension|Other|0|||
149206083|NCT00379236|538221422|FG001|Open-label Extension|Other|0|||
149206084|NCT00379236|538221423|FG002|Open-label Extension|Other|7|||
149206085|NCT00801892|538221429|FG000|Main Study Period|Withdrawal by Subject|0|||
149206086|NCT00801892|538221430|FG001|Main Study Period|Withdrawal by Subject|1|||
148947624|NCT00133952|537293430|FG000|Overall Study|Physician Decision|4|||
148947625|NCT00133952|537293431|FG001|Overall Study|Physician Decision|3|||
149206087|NCT00801892|538221429|FG000|Sham Crossover Period|Lost to Follow-up|0|||
149206088|NCT00801892|538221430|FG001|Sham Crossover Period|Lost to Follow-up|2|||
149206089|NCT01711541|538221433|FG000|Overall Study|Cancel prior to treatment|0|||
149206090|NCT01711541|538221434|FG001|Overall Study|Cancel prior to treatment|0|||
149206091|NCT01711541|538221435|FG002|Overall Study|Cancel prior to treatment|0|||
149206092|NCT01711541|538221436|FG003|Overall Study|Cancel prior to treatment|1|||
149206093|NCT01711541|538221437|FG004|Overall Study|Cancel prior to treatment|0|||
149206094|NCT01711541|538221433|FG000|Overall Study|Ineligible|0|||
149206095|NCT01711541|538221434|FG001|Overall Study|Ineligible|1|||
149206096|NCT01711541|538221435|FG002|Overall Study|Ineligible|0|||
149206097|NCT01711541|538221436|FG003|Overall Study|Ineligible|0|||
149206098|NCT01711541|538221437|FG004|Overall Study|Ineligible|0|||
149206099|NCT00728936|538221438|FG000|Overall Study|Withdrawal by Subject|0|||
148947626|NCT00133952|537293430|FG000|Overall Study|Sponsor Decision|0|||
149206100|NCT00728936|538221439|FG001|Overall Study|Withdrawal by Subject|0|||
148947627|NCT00133952|537293431|FG001|Overall Study|Sponsor Decision|1|||
148947628|NCT05048784|537293435|FG000|Period 1|Adverse Event|3|||
148947629|NCT05048784|537293436|FG001|Period 1|Adverse Event|1|||
148947630|NCT05048784|537293437|FG002|Period 1|Adverse Event|0|||
148947631|NCT05048784|537293438|FG003|Period 1|Adverse Event|0|||
148947632|NCT05048784|537293435|FG000|Period 2|Lost to Follow-up|0|||
148947633|NCT05048784|537293436|FG001|Period 2|Lost to Follow-up|1|||
148683667|NCT00606684|536314960|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
148683668|NCT00606684|536314961|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
148683669|NCT00606684|536314962|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
148683670|NCT00606684|536314963|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
148683671|NCT00606684|536314957|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
148683672|NCT00606684|536314958|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
148809066|NCT03813654|536777594|FG000|Overall Study|Withdrawal by Subject|1|||
148809067|NCT03813654|536777595|FG001|Overall Study|Withdrawal by Subject|0|||
148809068|NCT03813654|536777596|FG002|Overall Study|Withdrawal by Subject|0|||
148947634|NCT05048784|537293437|FG002|Period 2|Lost to Follow-up|0|||
148947635|NCT05048784|537293438|FG003|Period 2|Lost to Follow-up|0|||
148947636|NCT02270957|537293441|FG000|Overall Study|Lack of Efficacy|2|||
148947637|NCT02270957|537293442|FG001|Overall Study|Lack of Efficacy|4|||
148947638|NCT02270957|537293441|FG000|Overall Study|Adverse Event|2|||
148947639|NCT02270957|537293442|FG001|Overall Study|Adverse Event|0|||
148947640|NCT03462082|537293446|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
148947641|NCT03462082|537293447|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
148947642|NCT03462082|537293448|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
148947643|NCT03462082|537293449|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
148809069|NCT01732692|536777597|FG000|Overall Study|Adverse Event|0|||
148947644|NCT03462082|537293450|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
148947645|NCT03462082|537293451|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
148947646|NCT03462082|537293452|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
148947647|NCT03462082|537293453|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
148947648|NCT00166114|537293458|FG000|Overall Study|Protocol Violation|2|||
148947649|NCT00166114|537293459|FG001|Overall Study|Protocol Violation|1|||
148947650|NCT00166114|537293458|FG000|Overall Study|Withdrawal by Subject|10|||
148947651|NCT00166114|537293459|FG001|Overall Study|Withdrawal by Subject|4|||
148947652|NCT00166114|537293458|FG000|Overall Study|Adverse Event|2|||
148947653|NCT00166114|537293459|FG001|Overall Study|Adverse Event|1|||
148947654|NCT00545168|537293466|FG000|Overall Study|Lost to Follow-up|5|||
148947655|NCT00545168|537293467|FG001|Overall Study|Lost to Follow-up|5|||
148947656|NCT00545168|537293468|FG002|Overall Study|Lost to Follow-up|5|||
148947657|NCT00545168|537293466|FG000|Overall Study|Withdrawal by Subject|9|||
148947658|NCT00545168|537293467|FG001|Overall Study|Withdrawal by Subject|0|||
148947659|NCT00545168|537293468|FG002|Overall Study|Withdrawal by Subject|13|||
148947660|NCT00545168|537293466|FG000|Overall Study|Protocol Violation|1|||
148947661|NCT00545168|537293467|FG001|Overall Study|Protocol Violation|0|||
148947662|NCT00545168|537293468|FG002|Overall Study|Protocol Violation|1|||
148947663|NCT00545168|537293466|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
148947664|NCT00545168|537293467|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
148947665|NCT00545168|537293468|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
148947666|NCT00743340|537293471|FG000|Overall Study|Study medication non-compliance|1|||
148947667|NCT00743340|537293471|FG000|Overall Study|Lost to Follow-up|1|||
148947668|NCT00743340|537293471|FG000|Overall Study|Withdrawal from the Study|5|||
148947669|NCT00743340|537293471|FG000|Overall Study|Protocol Violation|1|||
148947670|NCT00743340|537293471|FG000|Overall Study|Virologic failure|8|||
148947671|NCT00743340|537293471|FG000|Overall Study|Pregnancy|1|||
148947672|NCT00743340|537293471|FG000|Overall Study|Rolled over to other Gilead Study|23|||
148947673|NCT00743340|537293471|FG000|Overall Study|Participant Relocated|1|||
148809070|NCT01732692|536777598|FG001|Overall Study|Adverse Event|1|||
148809071|NCT01155323|536777605|FG000|First Intervention|exclusion criteria|1|||
148809072|NCT01155323|536777606|FG001|First Intervention|exclusion criteria|1|||
148809073|NCT01155323|536777605|FG000|Second Intervention|Lost to Follow-up|1|||
148947674|NCT03266107|537293480|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
148947675|NCT03266107|537293480|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
148809074|NCT01155323|536777606|FG001|Second Intervention|Lost to Follow-up|1|||
148809075|NCT02606253|536777610|FG000|Overall Study|Adverse Event|2|||
148809076|NCT02606253|536777611|FG001|Overall Study|Adverse Event|0|||
148809077|NCT02606253|536777612|FG002|Overall Study|Adverse Event|0|||
148809078|NCT02606253|536777610|FG000|Overall Study|Protocol Violation|2|||
148809079|NCT02606253|536777611|FG001|Overall Study|Protocol Violation|1|||
148809080|NCT02606253|536777612|FG002|Overall Study|Protocol Violation|0|||
148809081|NCT02606253|536777610|FG000|Overall Study|Physician Decision|1|||
148809082|NCT02606253|536777611|FG001|Overall Study|Physician Decision|1|||
148809083|NCT02606253|536777612|FG002|Overall Study|Physician Decision|0|||
148809084|NCT02765165|536777613|FG000|Treatment Period|Progressive disease|3|||
148809085|NCT02765165|536777614|FG001|Treatment Period|Progressive disease|2|||
148809086|NCT02765165|536777615|FG002|Treatment Period|Progressive disease|3|||
148809087|NCT02765165|536777616|FG003|Treatment Period|Progressive disease|3|||
148809088|NCT02765165|536777617|FG004|Treatment Period|Progressive disease|4|||
148809089|NCT02765165|536777618|FG005|Treatment Period|Progressive disease|2|||
148809090|NCT02765165|536777619|FG006|Treatment Period|Progressive disease|2|||
148809091|NCT02765165|536777613|FG000|Treatment Period|Physician Decision|0|||
148809092|NCT02765165|536777614|FG001|Treatment Period|Physician Decision|1|||
148809093|NCT02765165|536777615|FG002|Treatment Period|Physician Decision|0|||
148809094|NCT02765165|536777616|FG003|Treatment Period|Physician Decision|0|||
148809095|NCT02765165|536777617|FG004|Treatment Period|Physician Decision|0|||
148809096|NCT02765165|536777618|FG005|Treatment Period|Physician Decision|0|||
148809097|NCT02765165|536777619|FG006|Treatment Period|Physician Decision|0|||
148809098|NCT02765165|536777613|FG000|Treatment Period|Adverse Event|0|||
148809099|NCT02765165|536777614|FG001|Treatment Period|Adverse Event|1|||
148809100|NCT02765165|536777615|FG002|Treatment Period|Adverse Event|0|||
148947676|NCT03266107|537293480|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
148947677|NCT03266107|537293480|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
148947678|NCT00982878|537293485|FG000|Overall Study|Physician Decision|1|||
148947679|NCT01626391|537293490|FG000|Overall Study|Physician Decision|1|||
148947680|NCT01626391|537293491|FG001|Overall Study|Physician Decision|0|||
148947681|NCT01626391|537293490|FG000|Overall Study|Withdrawal by Subject|1|||
148947682|NCT01626391|537293491|FG001|Overall Study|Withdrawal by Subject|0|||
148947683|NCT01370356|537293496|FG000|Overall Study|Death|1|||
148809101|NCT02765165|536777616|FG003|Treatment Period|Adverse Event|0|||
148809102|NCT02765165|536777617|FG004|Treatment Period|Adverse Event|0|||
148809103|NCT02765165|536777618|FG005|Treatment Period|Adverse Event|0|||
148809104|NCT02765165|536777619|FG006|Treatment Period|Adverse Event|0|||
148809105|NCT02765165|536777613|FG000|Treatment Period|Withdrawal by Subject|0|||
148947684|NCT01370356|537293497|FG001|Overall Study|Death|0|||
148947685|NCT01370356|537293496|FG000|Overall Study|Lack of Efficacy|6|||
148947686|NCT01370356|537293497|FG001|Overall Study|Lack of Efficacy|28|||
148947687|NCT01370356|537293496|FG000|Overall Study|Lost to Follow-up|76|||
148947688|NCT01370356|537293497|FG001|Overall Study|Lost to Follow-up|81|||
148947689|NCT01370356|537293496|FG000|Overall Study|Withdrawal by Subject|54|||
148947690|NCT01370356|537293497|FG001|Overall Study|Withdrawal by Subject|59|||
148947691|NCT01370356|537293496|FG000|Overall Study|Reason not specified|39|||
148947692|NCT01370356|537293497|FG001|Overall Study|Reason not specified|43|||
148947693|NCT01370356|537293496|FG000|Overall Study|Protocol Violation|3|||
148947694|NCT01370356|537293497|FG001|Overall Study|Protocol Violation|3|||
148947695|NCT01370356|537293496|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
148947696|NCT01370356|537293497|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
148947697|NCT01370356|537293496|FG000|Overall Study|AE Not Related to Study Drug|1|||
148947698|NCT01370356|537293497|FG001|Overall Study|AE Not Related to Study Drug|4|||
148947699|NCT00799422|537293501|FG000|First Week of Wear|Lost to Follow-up|0|||
148947700|NCT00799422|537293502|FG001|First Week of Wear|Lost to Follow-up|0|||
148947701|NCT00799422|537293503|FG002|First Week of Wear|Lost to Follow-up|1|||
148947702|NCT00799422|537293504|FG003|First Week of Wear|Lost to Follow-up|0|||
148947703|NCT00799422|537293505|FG004|First Week of Wear|Lost to Follow-up|0|||
148947704|NCT00799422|537293506|FG005|First Week of Wear|Lost to Follow-up|0|||
148947705|NCT00799422|537293501|FG000|First Week of Wear|Adverse Event|0|||
148947706|NCT00799422|537293502|FG001|First Week of Wear|Adverse Event|0|||
148947707|NCT00799422|537293503|FG002|First Week of Wear|Adverse Event|0|||
148947708|NCT00799422|537293504|FG003|First Week of Wear|Adverse Event|1|||
148947709|NCT00799422|537293505|FG004|First Week of Wear|Adverse Event|0|||
148947710|NCT00799422|537293506|FG005|First Week of Wear|Adverse Event|0|||
148947711|NCT00880009|537293507|FG000|Overall Study|Study terminated by sponsor|14|||
148947712|NCT00880009|537293507|FG000|Overall Study|Withdrawal by Subject|1|||
148947713|NCT00880009|537293507|FG000|Overall Study|Protocol Violation|1|||
148947714|NCT01217801|537293508|FG000|Period 1|Protocol Violation|1|||
148947715|NCT01217801|537293509|FG001|Period 1|Protocol Violation|1|||
148947716|NCT01217801|537293508|FG000|Period 1|Withdrawal by Subject|0|||
148947717|NCT01217801|537293509|FG001|Period 1|Withdrawal by Subject|1|||
148683673|NCT00606684|536314959|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
148683674|NCT00606684|536314960|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
148683675|NCT00606684|536314961|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
148683676|NCT00606684|536314962|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
148683677|NCT00606684|536314963|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
148683678|NCT00606684|536314957|FG000|Double-Blind Treatment Period|Physician Decision|0|||
148683679|NCT00606684|536314958|FG001|Double-Blind Treatment Period|Physician Decision|5|||
148683680|NCT00606684|536314959|FG002|Double-Blind Treatment Period|Physician Decision|1|||
148683681|NCT00606684|536314960|FG003|Double-Blind Treatment Period|Physician Decision|0|||
148683682|NCT00606684|536314961|FG004|Double-Blind Treatment Period|Physician Decision|3|||
148683683|NCT00606684|536314962|FG005|Double-Blind Treatment Period|Physician Decision|1|||
148683684|NCT00606684|536314963|FG006|Double-Blind Treatment Period|Physician Decision|2|||
148683685|NCT00606684|536314957|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148683686|NCT00606684|536314958|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148683687|NCT00606684|536314959|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148683688|NCT00606684|536314960|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
148683689|NCT00606684|536314961|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148683690|NCT00606684|536314962|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
148683691|NCT00606684|536314963|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148683692|NCT00772577|536314966|FG000|Overall Study|Adverse Event|6|||
148683693|NCT00772577|536314967|FG001|Overall Study|Adverse Event|3|||
148683694|NCT00772577|536314966|FG000|Overall Study|Abnormal laboratory values|0|||
148683695|NCT00772577|536314967|FG001|Overall Study|Abnormal laboratory values|1|||
148683696|NCT00772577|536314966|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148683697|NCT00772577|536314967|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
148683698|NCT00772577|536314966|FG000|Overall Study|Patient withdrew consent|8|||
148683699|NCT00772577|536314967|FG001|Overall Study|Patient withdrew consent|5|||
148683700|NCT00772577|536314966|FG000|Overall Study|Lost to Follow-up|4|||
148683701|NCT00772577|536314967|FG001|Overall Study|Lost to Follow-up|3|||
148683702|NCT00772577|536314966|FG000|Overall Study|Administrative problems|2|||
148683703|NCT00772577|536314967|FG001|Overall Study|Administrative problems|1|||
148683704|NCT00772577|536314966|FG000|Overall Study|Protocol Deviation|3|||
148947718|NCT04584645|537293510|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
148683705|NCT00772577|536314967|FG001|Overall Study|Protocol Deviation|2|||
148683706|NCT03211156|536314968|FG000|Overall Study|Withdrawal by Subject|0|||
148947719|NCT04584645|537293511|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
148683707|NCT03211156|536314969|FG001|Overall Study|Withdrawal by Subject|2|||
148683708|NCT03211156|536314968|FG000|Overall Study|Lost to Follow-up|1|||
148947720|NCT03926169|537293516|FG000|Period A|Adverse Event|2|||
148947721|NCT03926169|537293517|FG001|Period A|Adverse Event|2|||
148947722|NCT03926169|537293518|FG002|Period A|Adverse Event|1|||
148947723|NCT03926169|537293516|FG000|Period A|Withdrawal by Subject|2|||
148947724|NCT03926169|537293517|FG001|Period A|Withdrawal by Subject|2|||
149206101|NCT00728936|538221440|FG002|Overall Study|Withdrawal by Subject|0|||
149206102|NCT00728936|538221441|FG003|Overall Study|Withdrawal by Subject|0|||
149206103|NCT00728936|538221442|FG004|Overall Study|Withdrawal by Subject|0|||
149206104|NCT00728936|538221443|FG005|Overall Study|Withdrawal by Subject|1|||
149206105|NCT00728936|538221444|FG006|Overall Study|Withdrawal by Subject|0|||
149206106|NCT00438464|538221445|FG000|Overall Study|Terminated Early|14|||
149206107|NCT00438464|538221446|FG001|Overall Study|Terminated Early|5|||
149206108|NCT00438464|538221445|FG000|Overall Study|Incomplete data submission|0|||
149206109|NCT00438464|538221446|FG001|Overall Study|Incomplete data submission|2|||
149206110|NCT03943446|538221447|FG000|Overall Study|Lost to Follow-up|0|||
149206111|NCT03943446|538221448|FG001|Overall Study|Lost to Follow-up|0|||
148809106|NCT02765165|536777614|FG001|Treatment Period|Withdrawal by Subject|0|||
148809107|NCT02765165|536777615|FG002|Treatment Period|Withdrawal by Subject|0|||
148947725|NCT03926169|537293518|FG002|Period A|Withdrawal by Subject|2|||
148947726|NCT03926169|537293516|FG000|Period A|Lost to Follow-up|3|||
148947727|NCT03926169|537293517|FG001|Period A|Lost to Follow-up|1|||
148947728|NCT03926169|537293518|FG002|Period A|Lost to Follow-up|0|||
148947729|NCT03926169|537293516|FG000|Period A|Lack of Efficacy|0|||
148947730|NCT03926169|537293517|FG001|Period A|Lack of Efficacy|2|||
148947731|NCT03926169|537293518|FG002|Period A|Lack of Efficacy|2|||
148947732|NCT03926169|537293516|FG000|Period A|COVID-19 Infection|0|||
148947733|NCT03926169|537293517|FG001|Period A|COVID-19 Infection|1|||
148947734|NCT03926169|537293518|FG002|Period A|COVID-19 Infection|0|||
148947735|NCT03926169|537293516|FG000|Period A|COVID-19 Logistical Restrictions|0|||
148947736|NCT03926169|537293517|FG001|Period A|COVID-19 Logistical Restrictions|2|||
148947737|NCT03926169|537293518|FG002|Period A|COVID-19 Logistical Restrictions|1|||
148947738|NCT03926169|537293516|FG000|Period A|Other, Not Specified|1|||
148947739|NCT03926169|537293517|FG001|Period A|Other, Not Specified|0|||
148947740|NCT03926169|537293518|FG002|Period A|Other, Not Specified|0|||
148947741|NCT03926169|537293516|FG000|Period B|Adverse Event|3|||
148947742|NCT03926169|537293517|FG001|Period B|Adverse Event|1|||
148947743|NCT03926169|537293518|FG002|Period B|Adverse Event|1|||
148947744|NCT03926169|537293516|FG000|Period B|Withdrawal by Subject|1|||
148947745|NCT03926169|537293517|FG001|Period B|Withdrawal by Subject|3|||
148809108|NCT02765165|536777616|FG003|Treatment Period|Withdrawal by Subject|0|||
148947746|NCT03926169|537293518|FG002|Period B|Withdrawal by Subject|0|||
148947747|NCT03926169|537293516|FG000|Period B|Lack of Efficacy|3|||
149206112|NCT03943446|538221449|FG002|Overall Study|Lost to Follow-up|1|||
148947748|NCT03926169|537293517|FG001|Period B|Lack of Efficacy|1|||
149206113|NCT03943446|538221447|FG000|Overall Study|Withdrawal by Subject|1|||
149206114|NCT03943446|538221448|FG001|Overall Study|Withdrawal by Subject|1|||
149206115|NCT03943446|538221449|FG002|Overall Study|Withdrawal by Subject|2|||
148809109|NCT02765165|536777617|FG004|Treatment Period|Withdrawal by Subject|2|||
148947749|NCT03926169|537293518|FG002|Period B|Lack of Efficacy|1|||
148947750|NCT03926169|537293516|FG000|Period B|Lost to Follow-up|1|||
148947751|NCT03926169|537293517|FG001|Period B|Lost to Follow-up|1|||
148947752|NCT03926169|537293518|FG002|Period B|Lost to Follow-up|4|||
148947753|NCT03926169|537293516|FG000|Period B|Other, Not Specified|62|||
148947754|NCT03926169|537293517|FG001|Period B|Other, Not Specified|57|||
148947755|NCT03926169|537293518|FG002|Period B|Other, Not Specified|65|||
148947756|NCT03708328|537293521|FG000|Overall Study|Death|3|||
148947757|NCT03708328|537293522|FG001|Overall Study|Death|3|||
148947758|NCT03708328|537293523|FG002|Overall Study|Death|4|||
148947759|NCT03708328|537293524|FG003|Overall Study|Death|2|||
148947760|NCT03708328|537293525|FG004|Overall Study|Death|2|||
148947761|NCT03708328|537293526|FG005|Overall Study|Death|13|||
148947762|NCT03708328|537293527|FG006|Overall Study|Death|26|||
148947763|NCT03708328|537293528|FG007|Overall Study|Death|18|||
148947764|NCT03708328|537293529|FG008|Overall Study|Death|13|||
148947765|NCT03708328|537293530|FG009|Overall Study|Death|8|||
148947766|NCT03708328|537293521|FG000|Overall Study|Lost to Follow-up|0|||
148947767|NCT03708328|537293522|FG001|Overall Study|Lost to Follow-up|1|||
148947768|NCT03708328|537293523|FG002|Overall Study|Lost to Follow-up|0|||
148947769|NCT03708328|537293524|FG003|Overall Study|Lost to Follow-up|1|||
148947770|NCT03708328|537293525|FG004|Overall Study|Lost to Follow-up|0|||
148947771|NCT03708328|537293526|FG005|Overall Study|Lost to Follow-up|3|||
148947772|NCT03708328|537293527|FG006|Overall Study|Lost to Follow-up|3|||
148947773|NCT03708328|537293528|FG007|Overall Study|Lost to Follow-up|0|||
148947774|NCT03708328|537293529|FG008|Overall Study|Lost to Follow-up|0|||
148947775|NCT03708328|537293530|FG009|Overall Study|Lost to Follow-up|1|||
148947776|NCT03708328|537293521|FG000|Overall Study|Physician Decision|0|||
148947777|NCT03708328|537293522|FG001|Overall Study|Physician Decision|0|||
148947778|NCT03708328|537293523|FG002|Overall Study|Physician Decision|0|||
148947779|NCT03708328|537293524|FG003|Overall Study|Physician Decision|0|||
148947780|NCT03708328|537293525|FG004|Overall Study|Physician Decision|0|||
148947781|NCT03708328|537293526|FG005|Overall Study|Physician Decision|1|||
148947782|NCT03708328|537293527|FG006|Overall Study|Physician Decision|0|||
149206116|NCT03943446|538221447|FG000|Overall Study|Study Terminated by Sponsor|1|||
149206117|NCT03943446|538221448|FG001|Overall Study|Study Terminated by Sponsor|2|||
149206118|NCT03943446|538221449|FG002|Overall Study|Study Terminated by Sponsor|1|||
149206119|NCT03943446|538221447|FG000|Overall Study|Reason not Specified|5|||
149206120|NCT03943446|538221448|FG001|Overall Study|Reason not Specified|1|||
149206121|NCT03943446|538221449|FG002|Overall Study|Reason not Specified|3|||
149206122|NCT01281189|538221454|FG000|Overall Study|Adverse Event|7|||
149206123|NCT01281189|538221455|FG001|Overall Study|Adverse Event|9|||
149206124|NCT01281189|538221454|FG000|Overall Study|Lost to Follow-up|6|||
149206125|NCT01281189|538221455|FG001|Overall Study|Lost to Follow-up|4|||
149206126|NCT01281189|538221454|FG000|Overall Study|Withdrawal by Subject|21|||
149206127|NCT01281189|538221455|FG001|Overall Study|Withdrawal by Subject|24|||
149206128|NCT01281189|538221454|FG000|Overall Study|Physician Decision|2|||
149206129|NCT01281189|538221455|FG001|Overall Study|Physician Decision|3|||
149206130|NCT01281189|538221454|FG000|Overall Study|Death|103|||
149206131|NCT01281189|538221455|FG001|Overall Study|Death|91|||
149206132|NCT01281189|538221454|FG000|Overall Study|Other|8|||
149206133|NCT01281189|538221455|FG001|Overall Study|Other|12|||
149206134|NCT05355818|538221456|FG000|Overall Study|Adverse Event|1|||
149206135|NCT05355818|538221457|FG001|Overall Study|Adverse Event|1|||
149206136|NCT05355818|538221456|FG000|Overall Study|Lack of Efficacy|2|||
149206137|NCT05355818|538221457|FG001|Overall Study|Lack of Efficacy|1|||
149206138|NCT05355818|538221456|FG000|Overall Study|Lost to Follow-up|0|||
149206139|NCT05355818|538221457|FG001|Overall Study|Lost to Follow-up|1|||
149206140|NCT01601704|538221458|FG000|Overall Study|Randomized but not dispensed study med|1|||
148947783|NCT03708328|537293528|FG007|Overall Study|Physician Decision|0|||
148947784|NCT03708328|537293529|FG008|Overall Study|Physician Decision|0|||
148947785|NCT03708328|537293530|FG009|Overall Study|Physician Decision|0|||
148947786|NCT03708328|537293521|FG000|Overall Study|Withdrawal by Subject|0|||
148947787|NCT03708328|537293522|FG001|Overall Study|Withdrawal by Subject|0|||
149206141|NCT01601704|538221459|FG001|Overall Study|Randomized but not dispensed study med|4|||
149206142|NCT01090102|538221460|FG000|First 12 Weeks|Withdrawal by Subject|1|||
149206143|NCT01090102|538221461|FG001|First 12 Weeks|Withdrawal by Subject|1|||
149206144|NCT01090102|538221460|FG000|First 12 Weeks|Adverse Event|2|||
148947788|NCT03708328|537293523|FG002|Overall Study|Withdrawal by Subject|0|||
148947789|NCT03708328|537293524|FG003|Overall Study|Withdrawal by Subject|0|||
149206145|NCT01090102|538221461|FG001|First 12 Weeks|Adverse Event|0|||
149206146|NCT01090102|538221460|FG000|First 12 Weeks|Death|1|||
149206147|NCT01090102|538221461|FG001|First 12 Weeks|Death|1|||
148947790|NCT03708328|537293525|FG004|Overall Study|Withdrawal by Subject|1|||
148947791|NCT03708328|537293526|FG005|Overall Study|Withdrawal by Subject|0|||
148947792|NCT03708328|537293527|FG006|Overall Study|Withdrawal by Subject|2|||
148947793|NCT03708328|537293528|FG007|Overall Study|Withdrawal by Subject|4|||
149206148|NCT01090102|538221460|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
148947794|NCT03708328|537293529|FG008|Overall Study|Withdrawal by Subject|1|||
149206149|NCT01090102|538221461|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
149206150|NCT03518034|538221462|FG000|Overall Study|Not Treated|5|||
148947795|NCT03708328|537293530|FG009|Overall Study|Withdrawal by Subject|5|||
148947796|NCT03708328|537293521|FG000|Overall Study|Study Closed Locally|0|||
149206151|NCT03518034|538221463|FG001|Overall Study|Not Treated|1|||
149206152|NCT03518034|538221462|FG000|Overall Study|Withdrawal by Subject|309|||
149206153|NCT03518034|538221463|FG001|Overall Study|Withdrawal by Subject|351|||
149206154|NCT03518034|538221462|FG000|Overall Study|Lost to Follow-up|446|||
149206155|NCT03518034|538221463|FG001|Overall Study|Lost to Follow-up|458|||
149206156|NCT03518034|538221462|FG000|Overall Study|Adverse Event|138|||
149206157|NCT03518034|538221463|FG001|Overall Study|Adverse Event|130|||
149206158|NCT03518034|538221462|FG000|Overall Study|Lack of Efficacy|11|||
149206159|NCT03518034|538221463|FG001|Overall Study|Lack of Efficacy|23|||
149206160|NCT03518034|538221462|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
149206161|NCT03518034|538221463|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
149206162|NCT03518034|538221462|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
149206163|NCT03518034|538221463|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
149206164|NCT03518034|538221462|FG000|Overall Study|Other, Not Specified|84|||
149206165|NCT03518034|538221463|FG001|Overall Study|Other, Not Specified|53|||
149206166|NCT03518034|538221462|FG000|Overall Study|Reason Missing|2|||
149206167|NCT03518034|538221463|FG001|Overall Study|Reason Missing|3|||
149206168|NCT02273037|538221465|FG000|Overall Study|Lost to Follow-up|1|||
149206169|NCT02273037|538221466|FG001|Overall Study|Lost to Follow-up|0|||
149206170|NCT02273037|538221465|FG000|Overall Study|Delivered before monitoring initiated|1|||
149206171|NCT02273037|538221466|FG001|Overall Study|Delivered before monitoring initiated|3|||
149206172|NCT02273037|538221465|FG000|Overall Study|Breech delivery|2|||
149206173|NCT02273037|538221466|FG001|Overall Study|Breech delivery|3|||
149206174|NCT02273037|538221465|FG000|Overall Study|Multiple delivery|2|||
149206175|NCT02273037|538221466|FG001|Overall Study|Multiple delivery|2|||
149206176|NCT02273037|538221465|FG000|Overall Study|Other complication|2|||
149206177|NCT02273037|538221466|FG001|Overall Study|Other complication|0|||
149206178|NCT02062398|538221467|FG000|Overall Study|Implant removal|1|||
149206179|NCT00415519|538221469|FG000|Overall Study|Adverse Event|1|||
149206180|NCT00415519|538221470|FG001|Overall Study|Adverse Event|0|||
149206181|NCT00415519|538221469|FG000|Overall Study|Withdrawal by Subject|2|||
149206182|NCT00415519|538221470|FG001|Overall Study|Withdrawal by Subject|0|||
149206183|NCT00415519|538221469|FG000|Overall Study|Patient's convenience|1|||
149206184|NCT00415519|538221470|FG001|Overall Study|Patient's convenience|0|||
149206185|NCT00510484|538221472|FG000|Wash-out Period|Adverse Event|0|||
149206186|NCT00510484|538221473|FG001|Wash-out Period|Adverse Event|1|||
149206187|NCT01590212|538221474|FG000|Overall Study|Withdrawal by Subject|2|||
149206188|NCT01590212|538221475|FG001|Overall Study|Withdrawal by Subject|2|||
149206189|NCT01590212|538221476|FG002|Overall Study|Withdrawal by Subject|2|||
149206190|NCT01590212|538221474|FG000|Overall Study|Lost to Follow-up|1|||
149206191|NCT01590212|538221475|FG001|Overall Study|Lost to Follow-up|2|||
149206192|NCT01590212|538221476|FG002|Overall Study|Lost to Follow-up|3|||
149206193|NCT02533401|538221477|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
149206194|NCT02533401|538221477|FG000|Overall Study|Death|5|||
149206195|NCT02533401|538221477|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
149206196|NCT02533401|538221477|FG000|Overall Study|Lost to Follow-up|1|||
149206197|NCT02533401|538221477|FG000|Overall Study|Violation of Selection Criteria|1|||
149206198|NCT00881361|538221484|FG000|Overall Study|Terminated prior to surgery|27|||
149206199|NCT00881361|538221485|FG001|Overall Study|Terminated prior to surgery|7|||
149206200|NCT00881361|538221486|FG002|Overall Study|Terminated prior to surgery|0|||
149206201|NCT00881361|538221484|FG000|Overall Study|Ineligible|17|||
149206202|NCT00881361|538221485|FG001|Overall Study|Ineligible|2|||
149206203|NCT00881361|538221486|FG002|Overall Study|Ineligible|2|||
149206204|NCT06000501|538221490|FG000|Overall Study|Screen failure|3|||
149206205|NCT06000501|538221490|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
149206206|NCT06000501|538221490|FG000|Overall Study|Physician Decision|4|||
149206207|NCT06000501|538221490|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
149206208|NCT06000501|538221490|FG000|Overall Study|Scheduling issues|2|||
149206209|NCT03496662|538221491|FG000|Overall Study|Adverse Event|0|||
149206210|NCT03496662|538221492|FG001|Overall Study|Adverse Event|0|||
149206211|NCT03496662|538221493|FG002|Overall Study|Adverse Event|4|||
149206212|NCT03496662|538221491|FG000|Overall Study|Withdrawal by Subject|1|||
149206213|NCT03496662|538221492|FG001|Overall Study|Withdrawal by Subject|0|||
149206214|NCT03496662|538221493|FG002|Overall Study|Withdrawal by Subject|2|||
149206215|NCT03496662|538221491|FG000|Overall Study|Death|0|||
149206216|NCT03496662|538221492|FG001|Overall Study|Death|0|||
149206217|NCT03496662|538221493|FG002|Overall Study|Death|2|||
149206218|NCT03496662|538221491|FG000|Overall Study|Noncompliance|0|||
149206219|NCT03496662|538221492|FG001|Overall Study|Noncompliance|0|||
149206220|NCT03496662|538221493|FG002|Overall Study|Noncompliance|1|||
149206221|NCT00282867|538221498|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
149206222|NCT00282867|538221499|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
149206223|NCT00282867|538221500|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
149206224|NCT01074658|538221501|FG000|Overall Study|No implant attempted|19|||
149206225|NCT00432562|538221505|FG000|Overall Study|Death|3|||
149206226|NCT00432562|538221506|FG001|Overall Study|Death|0|||
148947797|NCT03708328|537293522|FG001|Overall Study|Study Closed Locally|0|||
148947798|NCT03708328|537293523|FG002|Overall Study|Study Closed Locally|0|||
148947799|NCT03708328|537293524|FG003|Overall Study|Study Closed Locally|0|||
148947800|NCT03708328|537293525|FG004|Overall Study|Study Closed Locally|0|||
148947801|NCT03708328|537293526|FG005|Overall Study|Study Closed Locally|0|||
148947802|NCT03708328|537293527|FG006|Overall Study|Study Closed Locally|0|||
148947803|NCT03708328|537293528|FG007|Overall Study|Study Closed Locally|1|||
148947804|NCT03708328|537293529|FG008|Overall Study|Study Closed Locally|0|||
148947805|NCT03708328|537293530|FG009|Overall Study|Study Closed Locally|0|||
148947806|NCT03708328|537293521|FG000|Overall Study|Study Ended By Sponsor|0|||
148947807|NCT03708328|537293522|FG001|Overall Study|Study Ended By Sponsor|0|||
148947808|NCT03708328|537293523|FG002|Overall Study|Study Ended By Sponsor|0|||
148947809|NCT03708328|537293524|FG003|Overall Study|Study Ended By Sponsor|0|||
148947810|NCT03708328|537293525|FG004|Overall Study|Study Ended By Sponsor|0|||
148947811|NCT03708328|537293526|FG005|Overall Study|Study Ended By Sponsor|1|||
148947812|NCT03708328|537293527|FG006|Overall Study|Study Ended By Sponsor|0|||
148947813|NCT03708328|537293528|FG007|Overall Study|Study Ended By Sponsor|1|||
148947814|NCT03708328|537293529|FG008|Overall Study|Study Ended By Sponsor|0|||
148947815|NCT03708328|537293530|FG009|Overall Study|Study Ended By Sponsor|0|||
148947816|NCT03708328|537293521|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947817|NCT03708328|537293522|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947818|NCT03708328|537293523|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947819|NCT03708328|537293524|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947820|NCT03708328|537293525|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947821|NCT03708328|537293526|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947822|NCT03708328|537293527|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947823|NCT03708328|537293528|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947824|NCT03708328|537293529|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
148947825|NCT03708328|537293530|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
148947826|NCT04523220|537293531|FG000|Main Treatment Period|Physician Decision|1|||
148947827|NCT04523220|537293532|FG001|Main Treatment Period|Physician Decision|1|||
148947828|NCT04523220|537293533|FG002|Main Treatment Period|Physician Decision|0|||
148947829|NCT04523220|537293531|FG000|Main Treatment Period|Other|5|||
148947830|NCT04523220|537293532|FG001|Main Treatment Period|Other|2|||
148947831|NCT04523220|537293533|FG002|Main Treatment Period|Other|4|||
148947832|NCT04523220|537293531|FG000|Main Treatment Period|Subject Decision|5|||
148947833|NCT04523220|537293532|FG001|Main Treatment Period|Subject Decision|7|||
148947834|NCT04523220|537293533|FG002|Main Treatment Period|Subject Decision|3|||
148947835|NCT04523220|537293531|FG000|Main Treatment Period|Death|5|||
148947836|NCT04523220|537293532|FG001|Main Treatment Period|Death|11|||
148947837|NCT04523220|537293533|FG002|Main Treatment Period|Death|4|||
149206227|NCT02146248|538221507|FG000|Overall Study|Withdrawal by Subject|2|||
149206228|NCT01374217|538221511|FG000|Overall Study|Lack of Efficacy|13|||
149206229|NCT00555906|538221512|FG000|Phase 1|Objective Progression or Relapse|3|||
149206230|NCT00555906|538221513|FG001|Phase 1|Objective Progression or Relapse|5|||
149206231|NCT00555906|538221514|FG002|Phase 1|Objective Progression or Relapse|3|||
149206232|NCT00555906|538221515|FG003|Phase 1|Objective Progression or Relapse|1|||
149206233|NCT00555906|538221516|FG004|Phase 1|Objective Progression or Relapse|0|||
149206234|NCT00555906|538221512|FG000|Phase 1|Global Deterioration of Health Status|0|||
148947838|NCT04523220|537293531|FG000|Main Treatment Period|Adverse Event|11|||
149206235|NCT00555906|538221513|FG001|Phase 1|Global Deterioration of Health Status|1|||
149206236|NCT00555906|538221514|FG002|Phase 1|Global Deterioration of Health Status|1|||
149206237|NCT00555906|538221515|FG003|Phase 1|Global Deterioration of Health Status|1|||
149206238|NCT00555906|538221516|FG004|Phase 1|Global Deterioration of Health Status|0|||
149206239|NCT00555906|538221512|FG000|Phase 1|Adverse Event|0|||
149206240|NCT00555906|538221513|FG001|Phase 1|Adverse Event|0|||
149206241|NCT00555906|538221514|FG002|Phase 1|Adverse Event|3|||
149206242|NCT00555906|538221515|FG003|Phase 1|Adverse Event|2|||
149206243|NCT00555906|538221516|FG004|Phase 1|Adverse Event|0|||
149206244|NCT00555906|538221512|FG000|Phase 1|Withdrawal by Subject|0|||
149206245|NCT00555906|538221513|FG001|Phase 1|Withdrawal by Subject|0|||
149206246|NCT00555906|538221514|FG002|Phase 1|Withdrawal by Subject|0|||
149206247|NCT00555906|538221515|FG003|Phase 1|Withdrawal by Subject|1|||
148809110|NCT02765165|536777618|FG005|Treatment Period|Withdrawal by Subject|0|||
148947839|NCT04523220|537293532|FG001|Main Treatment Period|Adverse Event|9|||
148947840|NCT04523220|537293533|FG002|Main Treatment Period|Adverse Event|9|||
148947841|NCT04523220|537293531|FG000|Main Treatment Period|Withdrawal by Subject|3|||
148947842|NCT04523220|537293532|FG001|Main Treatment Period|Withdrawal by Subject|3|||
148947843|NCT04523220|537293533|FG002|Main Treatment Period|Withdrawal by Subject|4|||
148947844|NCT04523220|537293531|FG000|Main Treatment Period|Study drug never adminstered|10|||
149206248|NCT00555906|538221516|FG004|Phase 1|Withdrawal by Subject|0|||
149206249|NCT00555906|538221512|FG000|Phase 2|Adverse Event|0|||
149206250|NCT00555906|538221513|FG001|Phase 2|Adverse Event|0|||
148947845|NCT04523220|537293532|FG001|Main Treatment Period|Study drug never adminstered|3|||
148947846|NCT04523220|537293533|FG002|Main Treatment Period|Study drug never adminstered|5|||
148947847|NCT04523220|537293531|FG000|Extension Treatment Period|Physician Decision|1|||
148947848|NCT04523220|537293532|FG001|Extension Treatment Period|Physician Decision|0|||
148947849|NCT04523220|537293533|FG002|Extension Treatment Period|Physician Decision|3|||
148947850|NCT04523220|537293531|FG000|Extension Treatment Period|Other|2|||
148947851|NCT04523220|537293532|FG001|Extension Treatment Period|Other|6|||
148947852|NCT04523220|537293533|FG002|Extension Treatment Period|Other|6|||
148947853|NCT04523220|537293531|FG000|Extension Treatment Period|Subject Decision|5|||
148947854|NCT04523220|537293532|FG001|Extension Treatment Period|Subject Decision|2|||
148947855|NCT04523220|537293533|FG002|Extension Treatment Period|Subject Decision|4|||
148947856|NCT04523220|537293531|FG000|Extension Treatment Period|Death|6|||
148947857|NCT04523220|537293532|FG001|Extension Treatment Period|Death|4|||
148947858|NCT04523220|537293533|FG002|Extension Treatment Period|Death|7|||
148947859|NCT04523220|537293531|FG000|Extension Treatment Period|Adverse Event|6|||
148947860|NCT04523220|537293532|FG001|Extension Treatment Period|Adverse Event|7|||
148947861|NCT04523220|537293533|FG002|Extension Treatment Period|Adverse Event|9|||
148947862|NCT04523220|537293531|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
148947863|NCT04523220|537293532|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
148947864|NCT04523220|537293533|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
148947865|NCT04523220|537293531|FG000|Extension Treatment Period|Study drug never administered|0|||
148947866|NCT04523220|537293532|FG001|Extension Treatment Period|Study drug never administered|1|||
148947867|NCT04523220|537293533|FG002|Extension Treatment Period|Study drug never administered|0|||
148947868|NCT00571948|537293534|FG000|Overall Study|Lost to Follow-up|2|||
148947869|NCT00571948|537293535|FG001|Overall Study|Lost to Follow-up|0|||
148947870|NCT00571948|537293534|FG000|Overall Study|Withdrawal by Subject|1|||
148947871|NCT00571948|537293535|FG001|Overall Study|Withdrawal by Subject|2|||
148947872|NCT00571948|537293534|FG000|Overall Study|Protocol Violation|3|||
148947873|NCT00571948|537293535|FG001|Overall Study|Protocol Violation|3|||
148947874|NCT00571948|537293534|FG000|Overall Study|infant refused study meal|3|||
148947875|NCT00571948|537293535|FG001|Overall Study|infant refused study meal|4|||
148947876|NCT00571948|537293534|FG000|Overall Study|Parent were afraid of blood colection|2|||
148947877|NCT00571948|537293535|FG001|Overall Study|Parent were afraid of blood colection|5|||
148947878|NCT02006719|537293536|FG000|Overall Study|Withdrawal by Subject|10|||
148947879|NCT02006719|537293537|FG001|Overall Study|Withdrawal by Subject|2|||
148947880|NCT02006719|537293536|FG000|Overall Study|Lost to Follow-up|5|||
148947881|NCT02006719|537293537|FG001|Overall Study|Lost to Follow-up|1|||
148947882|NCT02006719|537293536|FG000|Overall Study|Protocol Violation|2|||
148947883|NCT02006719|537293537|FG001|Overall Study|Protocol Violation|0|||
148947884|NCT02006719|537293536|FG000|Overall Study|Adverse Event|1|||
148947885|NCT02006719|537293537|FG001|Overall Study|Adverse Event|1|||
148947886|NCT02006719|537293536|FG000|Overall Study|Other/Unknown|0|||
148947887|NCT02006719|537293537|FG001|Overall Study|Other/Unknown|1|||
148947888|NCT02439138|537293539|FG000|Overall Study|Adverse Event|1|||
148947889|NCT02439138|537293539|FG000|Overall Study|PI decision to terminate the study|2|||
148947890|NCT03727347|537293546|FG000|Overall Study|Withdrawal by Subject|2|||
148947891|NCT03727347|537293546|FG000|Overall Study|Lost to Follow-up|1|||
148947892|NCT00006237|537293547|FG000|Overall Study|Adverse Event|39|||
148947893|NCT00006237|537293548|FG001|Overall Study|Adverse Event|29|||
148947894|NCT00006237|537293547|FG000|Overall Study|Death|1|||
148947895|NCT00006237|537293548|FG001|Overall Study|Death|0|||
148947896|NCT00006237|537293547|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
148947897|NCT00006237|537293548|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
148947898|NCT00006237|537293547|FG000|Overall Study|Progression/relapse|54|||
148947899|NCT00006237|537293548|FG001|Overall Study|Progression/relapse|2|||
148947900|NCT00006237|537293547|FG000|Overall Study|Not eligible|9|||
148947901|NCT00006237|537293548|FG001|Overall Study|Not eligible|20|||
148947902|NCT00006237|537293547|FG000|Overall Study|Withdrawal by Subject|0|||
148947903|NCT00006237|537293548|FG001|Overall Study|Withdrawal by Subject|1|||
148947904|NCT00006237|537293547|FG000|Overall Study|Not protocol specified|14|||
148947905|NCT00006237|537293548|FG001|Overall Study|Not protocol specified|5|||
148947906|NCT01846416|537293551|FG000|Treatment Phase|Death|2|||
148947907|NCT01846416|537293552|FG001|Treatment Phase|Death|9|||
149016333|NCT04150029|537537905|FG000|Overall Study|Disease Relapse|0|||
148947908|NCT01846416|537293553|FG002|Treatment Phase|Death|1|||
148947909|NCT01846416|537293551|FG000|Treatment Phase|Withdrawal by Subject|2|||
148947910|NCT01846416|537293552|FG001|Treatment Phase|Withdrawal by Subject|4|||
148947911|NCT01846416|537293553|FG002|Treatment Phase|Withdrawal by Subject|2|||
148947912|NCT01846416|537293551|FG000|Treatment Phase|Other|1|||
148947913|NCT01846416|537293552|FG001|Treatment Phase|Other|5|||
148947914|NCT01846416|537293553|FG002|Treatment Phase|Other|1|||
148947915|NCT01846416|537293551|FG000|Treatment Phase|Physician Decision|1|||
148947916|NCT01846416|537293552|FG001|Treatment Phase|Physician Decision|2|||
148947917|NCT01846416|537293553|FG002|Treatment Phase|Physician Decision|0|||
148947918|NCT01846416|537293551|FG000|Treatment Phase|Adverse Event|3|||
148947919|NCT01846416|537293552|FG001|Treatment Phase|Adverse Event|4|||
148947920|NCT01846416|537293553|FG002|Treatment Phase|Adverse Event|0|||
148947921|NCT01846416|537293551|FG000|Treatment Phase|Non-compliance|0|||
148947922|NCT01846416|537293552|FG001|Treatment Phase|Non-compliance|2|||
148947923|NCT01846416|537293553|FG002|Treatment Phase|Non-compliance|0|||
148947924|NCT01846416|537293551|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
148947925|NCT01846416|537293552|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
148947926|NCT01846416|537293553|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
148947927|NCT01846416|537293551|FG000|Treatment Phase|Progressive Disease|21|||
148947928|NCT01846416|537293552|FG001|Treatment Phase|Progressive Disease|63|||
148947929|NCT01846416|537293553|FG002|Treatment Phase|Progressive Disease|9|||
148947930|NCT01846416|537293551|FG000|Survival Follow-up|Death|21|||
148947931|NCT01846416|537293552|FG001|Survival Follow-up|Death|62|||
148947932|NCT01846416|537293553|FG002|Survival Follow-up|Death|9|||
148947933|NCT01846416|537293551|FG000|Survival Follow-up|Lost to Follow-up|0|||
148947934|NCT01846416|537293552|FG001|Survival Follow-up|Lost to Follow-up|2|||
148947935|NCT01846416|537293553|FG002|Survival Follow-up|Lost to Follow-up|2|||
148947936|NCT01846416|537293551|FG000|Survival Follow-up|Withdrawal by Subject|2|||
148947937|NCT01846416|537293552|FG001|Survival Follow-up|Withdrawal by Subject|7|||
148947938|NCT01846416|537293553|FG002|Survival Follow-up|Withdrawal by Subject|0|||
148947939|NCT01846416|537293551|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
148947940|NCT01846416|537293552|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
148947941|NCT01846416|537293553|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
148947942|NCT01846416|537293551|FG000|Survival Follow-up|Other|3|||
148947943|NCT01846416|537293552|FG001|Survival Follow-up|Other|1|||
148947944|NCT01846416|537293553|FG002|Survival Follow-up|Other|1|||
148947945|NCT00558558|537293556|FG000|Overall Study|Unable to swallow|1|||
148947946|NCT00558558|537293556|FG000|Overall Study|Withdrawal by Subject|1|||
148947947|NCT00558558|537293556|FG000|Overall Study|Lack of Efficacy|4|||
148947948|NCT00317356|537293558|FG000|Overall Study|Adverse Event|0|||
148947949|NCT00317356|537293559|FG001|Overall Study|Adverse Event|0|||
148947950|NCT00317356|537293560|FG002|Overall Study|Adverse Event|1|||
148947951|NCT00317356|537293561|FG003|Overall Study|Adverse Event|0|||
148947952|NCT00317356|537293558|FG000|Overall Study|Lack of Efficacy|1|||
148947953|NCT00317356|537293559|FG001|Overall Study|Lack of Efficacy|1|||
148947954|NCT00317356|537293560|FG002|Overall Study|Lack of Efficacy|0|||
148947955|NCT00317356|537293561|FG003|Overall Study|Lack of Efficacy|3|||
148947956|NCT00317356|537293558|FG000|Overall Study|Physician Decision|0|||
148947957|NCT00317356|537293559|FG001|Overall Study|Physician Decision|1|||
148947958|NCT00317356|537293560|FG002|Overall Study|Physician Decision|0|||
149206251|NCT00555906|538221514|FG002|Phase 2|Adverse Event|0|||
149206252|NCT00555906|538221515|FG003|Phase 2|Adverse Event|0|||
149206253|NCT00555906|538221516|FG004|Phase 2|Adverse Event|4|||
149206254|NCT00555906|538221512|FG000|Phase 2|Global Deterioration of Health Status|0|||
149206255|NCT00555906|538221513|FG001|Phase 2|Global Deterioration of Health Status|0|||
148947959|NCT00317356|537293561|FG003|Overall Study|Physician Decision|0|||
148947960|NCT05980182|537293564|FG000|Overall Study|Lost to Follow-up|10|||
148947961|NCT03292588|537295603|FG000|Overall Study|Death|1|||
148947962|NCT03292588|537295604|FG001|Overall Study|Death|0|||
148947963|NCT03292588|537295603|FG000|Overall Study|Lost to Follow-up|12|||
148947964|NCT03292588|537295604|FG001|Overall Study|Lost to Follow-up|16|||
148947965|NCT03292588|537295603|FG000|Overall Study|Physician Decision|0|||
148947966|NCT03292588|537295604|FG001|Overall Study|Physician Decision|1|||
148947967|NCT03292588|537295603|FG000|Overall Study|Withdrawal by Subject|4|||
148947968|NCT03292588|537295604|FG001|Overall Study|Withdrawal by Subject|4|||
148947969|NCT03292588|537295603|FG000|Overall Study|Move out of town|1|||
148947970|NCT03292588|537295604|FG001|Overall Study|Move out of town|0|||
148947971|NCT03292588|537295603|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
148947972|NCT03292588|537295604|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
148947973|NCT03761277|537295605|FG000|Enrollment to Implant|Screen Failure|17|||
148947974|NCT03761277|537295605|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
149206256|NCT00555906|538221514|FG002|Phase 2|Global Deterioration of Health Status|0|||
149206257|NCT00555906|538221515|FG003|Phase 2|Global Deterioration of Health Status|0|||
149206258|NCT00555906|538221516|FG004|Phase 2|Global Deterioration of Health Status|2|||
149206259|NCT00555906|538221512|FG000|Phase 2|Objective Progression or Relapse|0|||
149206260|NCT00555906|538221513|FG001|Phase 2|Objective Progression or Relapse|0|||
149206261|NCT00555906|538221514|FG002|Phase 2|Objective Progression or Relapse|0|||
148947975|NCT03761277|537295605|FG000|Enrollment to Implant|Physician Decision|2|||
148947976|NCT03761277|537295605|FG000|Enrollment to Implant|Site Closure|3|||
148947977|NCT03761277|537295605|FG000|Enrollment to Implant|Sponsor Request|2|||
148947978|NCT03761277|537295605|FG000|Post-Implant to 6 Months|Adverse Event|2|||
148947979|NCT03761277|537295605|FG000|Post-Implant to 6 Months|Death|1|||
148947980|NCT03761277|537295605|FG000|Post-Implant to 6 Months|Site Closure|2|||
148947981|NCT03761277|537295605|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
148947982|NCT03761277|537295605|FG000|6 Months to 12 Months|Physician Decision|2|||
148947983|NCT03761277|537295605|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
148947984|NCT00759031|537295606|FG000|First Intervention (1 Day)|Physician Decision|1|||
148947985|NCT00759031|537295607|FG001|First Intervention (1 Day)|Physician Decision|0|||
148947986|NCT00759031|537295606|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
149206262|NCT00555906|538221515|FG003|Phase 2|Objective Progression or Relapse|0|||
149206263|NCT00555906|538221516|FG004|Phase 2|Objective Progression or Relapse|16|||
149206264|NCT00555906|538221512|FG000|Phase 2|Withdrawal by Subject|0|||
149206265|NCT00555906|538221513|FG001|Phase 2|Withdrawal by Subject|0|||
149206266|NCT00555906|538221514|FG002|Phase 2|Withdrawal by Subject|0|||
149206267|NCT00555906|538221515|FG003|Phase 2|Withdrawal by Subject|0|||
149206268|NCT00555906|538221516|FG004|Phase 2|Withdrawal by Subject|2|||
149206269|NCT00555906|538221512|FG000|Phase 2|Other|0|||
149206270|NCT00555906|538221513|FG001|Phase 2|Other|0|||
149206271|NCT00555906|538221514|FG002|Phase 2|Other|0|||
149206272|NCT00555906|538221515|FG003|Phase 2|Other|0|||
149206273|NCT00555906|538221516|FG004|Phase 2|Other|6|||
149206274|NCT00555906|538221512|FG000|Phase 2|Randomized but not Treated|0|||
149206275|NCT00555906|538221513|FG001|Phase 2|Randomized but not Treated|0|||
149206276|NCT00555906|538221514|FG002|Phase 2|Randomized but not Treated|0|||
149206277|NCT00555906|538221515|FG003|Phase 2|Randomized but not Treated|0|||
148947987|NCT00759031|537295607|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
149206278|NCT00555906|538221516|FG004|Phase 2|Randomized but not Treated|2|||
149206279|NCT01033487|538221517|FG000|Fourth Intervention Period|Adverse Event|0|||
148683709|NCT03211156|536314969|FG001|Overall Study|Lost to Follow-up|1|||
148947988|NCT00759031|537295606|FG000|First Intervention (1 Day)|Screening failure|1|||
148947989|NCT00759031|537295607|FG001|First Intervention (1 Day)|Screening failure|0|||
149206280|NCT01033487|538221518|FG001|Fourth Intervention Period|Adverse Event|0|||
149206281|NCT01033487|538221519|FG002|Fourth Intervention Period|Adverse Event|0|||
148683710|NCT03211156|536314968|FG000|Overall Study|Adverse Event|1|||
149206282|NCT01033487|538221520|FG003|Fourth Intervention Period|Adverse Event|0|||
149206283|NCT01033487|538221521|FG004|Fourth Intervention Period|Adverse Event|0|||
149206284|NCT01033487|538221522|FG005|Fourth Intervention Period|Adverse Event|0|||
148947990|NCT00543140|537295608|FG000|Overall Study|Lost to Follow-up|33|||
148947991|NCT00543140|537295608|FG000|Overall Study|Withdrawal by Subject|13|||
148947992|NCT00543140|537295608|FG000|Overall Study|Protocol Violation|10|||
148947993|NCT00543140|537295608|FG000|Overall Study|Insufficient weight loss|10|||
148947994|NCT00543140|537295608|FG000|Overall Study|SAE leading to explant of SAGB|3|||
148947995|NCT00543140|537295608|FG000|Overall Study|Death|1|||
149206285|NCT01033487|538221523|FG006|Fourth Intervention Period|Adverse Event|0|||
149206286|NCT01033487|538221524|FG007|Fourth Intervention Period|Adverse Event|0|||
149206287|NCT01033487|538221525|FG008|Fourth Intervention Period|Adverse Event|1|||
149206288|NCT01033487|538221526|FG009|Fourth Intervention Period|Adverse Event|0|||
149206289|NCT00862654|538221527|FG000|Overall Study|Lack of Efficacy|1|||
149206290|NCT00862654|538221528|FG001|Overall Study|Lack of Efficacy|0|||
149206291|NCT00862654|538221529|FG002|Overall Study|Lack of Efficacy|1|||
149206292|NCT00862654|538221530|FG003|Overall Study|Lack of Efficacy|0|||
149206293|NCT00862654|538221527|FG000|Overall Study|Lost to Follow-up|1|||
149206294|NCT00862654|538221528|FG001|Overall Study|Lost to Follow-up|2|||
149206295|NCT00862654|538221529|FG002|Overall Study|Lost to Follow-up|1|||
149206296|NCT00862654|538221530|FG003|Overall Study|Lost to Follow-up|3|||
149206297|NCT00862654|538221527|FG000|Overall Study|Adverse Event|0|||
149206298|NCT00862654|538221528|FG001|Overall Study|Adverse Event|1|||
149206299|NCT00862654|538221529|FG002|Overall Study|Adverse Event|1|||
148947996|NCT00543140|537295608|FG000|Overall Study|Subject moved|1|||
148947997|NCT00543140|537295608|FG000|Overall Study|Conversion to different procedure|1|||
148947998|NCT00578812|537295609|FG000|Overall Study|Not treated|6|||
148947999|NCT00578812|537295610|FG001|Overall Study|Not treated|7|||
148948000|NCT00309387|537295612|FG000|Overall Study|Death|72|||
148948001|NCT00309387|537295613|FG001|Overall Study|Death|73|||
149206300|NCT00862654|538221530|FG003|Overall Study|Adverse Event|0|||
149206301|NCT00862654|538221527|FG000|Overall Study|Pregnancy|1|||
148683711|NCT03211156|536314969|FG001|Overall Study|Adverse Event|0|||
148809111|NCT02765165|536777619|FG006|Treatment Period|Withdrawal by Subject|0|||
148809112|NCT02765165|536777613|FG000|Treatment Period|Study terminated|0|||
148948002|NCT00309387|537295612|FG000|Overall Study|Lost to Follow-up|70|||
149016334|NCT04150029|537537906|FG001|Overall Study|Disease Relapse|18|||
149016335|NCT04150029|537537905|FG000|Overall Study|Progressive Disease|2|||
149016336|NCT04150029|537537906|FG001|Overall Study|Progressive Disease|16|||
149206302|NCT00862654|538221528|FG001|Overall Study|Pregnancy|1|||
149206303|NCT00862654|538221529|FG002|Overall Study|Pregnancy|0|||
149206304|NCT00862654|538221530|FG003|Overall Study|Pregnancy|0|||
149206305|NCT00862654|538221527|FG000|Overall Study|Withdrawal by Subject|2|||
149206306|NCT00862654|538221528|FG001|Overall Study|Withdrawal by Subject|2|||
148948003|NCT00309387|537295613|FG001|Overall Study|Lost to Follow-up|86|||
148948004|NCT04532164|537295614|FG000|Overall Study|Adverse Event|1|||
148948005|NCT04532164|537295614|FG000|Overall Study|Protocol Violation|5|||
148948006|NCT04532164|537295614|FG000|Overall Study|Lost to Follow-up|1|||
148948007|NCT04532164|537295614|FG000|Overall Study|Found to be Ineligible|3|||
148948008|NCT04532164|537295614|FG000|Overall Study|Withdrawal by Subject|14|||
148948009|NCT02483520|537295615|FG000|Overall Study|Lost to Follow-up|3|||
148948010|NCT02483520|537295616|FG001|Overall Study|Lost to Follow-up|4|||
148948011|NCT02483520|537295615|FG000|Overall Study|Withdrawal by Subject|4|||
149206307|NCT00862654|538221529|FG002|Overall Study|Withdrawal by Subject|2|||
149206308|NCT00862654|538221530|FG003|Overall Study|Withdrawal by Subject|3|||
149206309|NCT00862654|538221527|FG000|Overall Study|Subject mistake|0|||
149206310|NCT00862654|538221528|FG001|Overall Study|Subject mistake|1|||
149206311|NCT00862654|538221529|FG002|Overall Study|Subject mistake|0|||
149206312|NCT00862654|538221530|FG003|Overall Study|Subject mistake|0|||
149206313|NCT00862654|538221527|FG000|Overall Study|Familly constraint|0|||
149206314|NCT00862654|538221528|FG001|Overall Study|Familly constraint|1|||
149206315|NCT00862654|538221529|FG002|Overall Study|Familly constraint|0|||
149206316|NCT00862654|538221530|FG003|Overall Study|Familly constraint|0|||
149206317|NCT00862654|538221527|FG000|Overall Study|Never used study drugs|1|||
149206318|NCT00862654|538221528|FG001|Overall Study|Never used study drugs|0|||
149206319|NCT00862654|538221529|FG002|Overall Study|Never used study drugs|0|||
149206320|NCT00862654|538221530|FG003|Overall Study|Never used study drugs|0|||
149206321|NCT00862654|538221527|FG000|Overall Study|Included after end of inclusions|0|||
149206322|NCT00862654|538221528|FG001|Overall Study|Included after end of inclusions|0|||
149206323|NCT00862654|538221529|FG002|Overall Study|Included after end of inclusions|1|||
149206324|NCT00862654|538221530|FG003|Overall Study|Included after end of inclusions|0|||
149206325|NCT03219567|538221531|FG000|Overall Study|Withdrawal by Subject|0|||
149206326|NCT03219567|538221532|FG001|Overall Study|Withdrawal by Subject|1|||
149206327|NCT00889681|538221533|FG000|Overall Study|Not meeting qualification Criteria|2|||
149206328|NCT00889681|538221533|FG000|Overall Study|Insurance disapproval|1|||
149206329|NCT04176445|538221534|FG000|Overall Study|Adverse Event|0|||
149206330|NCT04176445|538221535|FG001|Overall Study|Adverse Event|1|||
149206331|NCT04176445|538221534|FG000|Overall Study|change plans weaning after first intervention|0|||
149206332|NCT04176445|538221535|FG001|Overall Study|change plans weaning after first intervention|1|||
149206333|NCT04377672|538221537|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
149206334|NCT03954444|538221538|FG000|Overall Study|Withdrawal by Subject|5|||
149206335|NCT03954444|538221539|FG001|Overall Study|Withdrawal by Subject|5|||
149206336|NCT03954444|538221540|FG002|Overall Study|Withdrawal by Subject|5|||
149206337|NCT03954444|538221538|FG000|Overall Study|Adverse Event|1|||
149206338|NCT03954444|538221539|FG001|Overall Study|Adverse Event|3|||
149206339|NCT03954444|538221540|FG002|Overall Study|Adverse Event|2|||
149206340|NCT03954444|538221538|FG000|Overall Study|Protocol Violation|0|||
149206341|NCT03954444|538221539|FG001|Overall Study|Protocol Violation|3|||
149206342|NCT03954444|538221540|FG002|Overall Study|Protocol Violation|5|||
149206343|NCT03954444|538221538|FG000|Overall Study|Use of prohibited therapy|1|||
149206344|NCT03954444|538221539|FG001|Overall Study|Use of prohibited therapy|1|||
149206345|NCT03954444|538221540|FG002|Overall Study|Use of prohibited therapy|2|||
149206346|NCT03954444|538221538|FG000|Overall Study|Lost to Follow-up|1|||
149206347|NCT03954444|538221539|FG001|Overall Study|Lost to Follow-up|0|||
149206348|NCT03954444|538221540|FG002|Overall Study|Lost to Follow-up|1|||
148683712|NCT00553540|536314976|FG000|Overall Study|discharged after first visit|2|||
148948012|NCT02483520|537295616|FG001|Overall Study|Withdrawal by Subject|14|||
149016337|NCT04150029|537537905|FG000|Overall Study|Adverse Event|1|||
149206349|NCT03954444|538221538|FG000|Overall Study|Non-compliant with study drug application|2|||
149206350|NCT03954444|538221539|FG001|Overall Study|Non-compliant with study drug application|2|||
149206351|NCT03954444|538221540|FG002|Overall Study|Non-compliant with study drug application|0|||
149206352|NCT03954444|538221538|FG000|Overall Study|Administrative reasons|0|||
148683713|NCT00553540|536314977|FG001|Overall Study|discharged after first visit|5|||
148683714|NCT03565211|536314978|FG000|Overall Study|Withdrawal by Subject|2|||
148809113|NCT02765165|536777614|FG001|Treatment Period|Study terminated|0|||
148948013|NCT02483520|537295615|FG000|Overall Study|Hospitalized|2|||
148948014|NCT02483520|537295616|FG001|Overall Study|Hospitalized|3|||
149206353|NCT03954444|538221539|FG001|Overall Study|Administrative reasons|0|||
149206354|NCT03954444|538221540|FG002|Overall Study|Administrative reasons|1|||
148948015|NCT02483520|537295615|FG000|Overall Study|Moved to LTC|2|||
148948016|NCT02483520|537295616|FG001|Overall Study|Moved to LTC|3|||
148948017|NCT01104493|537295617|FG000|Overall Study|Lost to Follow-up|0|||
148948018|NCT01104493|537295618|FG001|Overall Study|Lost to Follow-up|2|||
148948019|NCT01342796|537295620|FG000|Overall Study|Withdrawal by Subject|2|||
148948020|NCT01342796|537295621|FG001|Overall Study|Withdrawal by Subject|0|||
148948021|NCT01342796|537295620|FG000|Overall Study|Lost to Follow-up|0|||
148948022|NCT01342796|537295621|FG001|Overall Study|Lost to Follow-up|3|||
148948023|NCT01342796|537295620|FG000|Overall Study|Inappropriate enrollment|1|||
148948024|NCT01342796|537295621|FG001|Overall Study|Inappropriate enrollment|0|||
148948025|NCT01599234|537295631|FG000|Overall Study|Adverse Event|9|||
148948026|NCT01599234|537295632|FG001|Overall Study|Adverse Event|5|||
148948027|NCT01599234|537295631|FG000|Overall Study|Withdrawal by Subject|2|||
148948028|NCT01599234|537295632|FG001|Overall Study|Withdrawal by Subject|1|||
148948029|NCT01599234|537295631|FG000|Overall Study|Lost to Follow-up|1|||
148948030|NCT01599234|537295632|FG001|Overall Study|Lost to Follow-up|2|||
148948031|NCT01599234|537295631|FG000|Overall Study|Lack of Efficacy|2|||
148948032|NCT01599234|537295632|FG001|Overall Study|Lack of Efficacy|4|||
148948033|NCT01599234|537295631|FG000|Overall Study|Unable to operate spray|1|||
148948034|NCT01599234|537295632|FG001|Overall Study|Unable to operate spray|0|||
148948035|NCT01599234|537295631|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
148948036|NCT01599234|537295632|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
148948037|NCT01599234|537295631|FG000|Overall Study|Death|1|||
148948038|NCT01599234|537295632|FG001|Overall Study|Death|0|||
148948039|NCT01599234|537295631|FG000|Overall Study|Patient would not stop driving|1|||
148948040|NCT01599234|537295632|FG001|Overall Study|Patient would not stop driving|0|||
148948041|NCT01599234|537295631|FG000|Overall Study|Contra-indication discovered|0|||
148948042|NCT01599234|537295632|FG001|Overall Study|Contra-indication discovered|1|||
148948043|NCT01599234|537295631|FG000|Overall Study|Pregnancy|0|||
148948044|NCT01599234|537295632|FG001|Overall Study|Pregnancy|1|||
148948045|NCT03489720|537295635|FG000|Overall Study|Withdrawal by Subject|2|||
148948046|NCT03489720|537295636|FG001|Overall Study|Withdrawal by Subject|0|||
148948047|NCT02269241|537295649|FG000|Overall Study|Lost to Follow-up|269|||
148948048|NCT02269241|537295649|FG000|Overall Study|Withdrawal by Subject|155|||
148948049|NCT02269241|537295649|FG000|Overall Study|Protocol Violation|1|||
148948050|NCT02269241|537295649|FG000|Overall Study|Physician Decision|7|||
148809114|NCT02765165|536777615|FG002|Treatment Period|Study terminated|0|||
148948051|NCT02269241|537295649|FG000|Overall Study|Pregnancy|15|||
148948052|NCT02269241|537295649|FG000|Overall Study|Wish for pregnancy|5|||
148948053|NCT02269241|537295649|FG000|Overall Study|Development of an exclusion criteria|16|||
148948054|NCT02269241|537295649|FG000|Overall Study|Adverse Event|113|||
148948055|NCT02269241|537295649|FG000|Overall Study|At the specific request of the sponsor|20|||
148948056|NCT02269241|537295649|FG000|Overall Study|Several reasons not classified|53|||
148948057|NCT02269241|537295649|FG000|Overall Study|Screening failures|546|||
148948058|NCT03020160|537295650|FG000|Overall Study|Withdrawal by Subject|1|||
148948059|NCT03020160|537295651|FG001|Overall Study|Withdrawal by Subject|0|||
148948060|NCT01513473|537295652|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
148948061|NCT01513473|537295653|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
148948062|NCT01513473|537295652|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
148948063|NCT01513473|537295653|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
148948064|NCT01513473|537295652|FG000|Main Trial (26 Weeks)|Unclassified|0|||
148948065|NCT01513473|537295653|FG001|Main Trial (26 Weeks)|Unclassified|2|||
148948066|NCT01513473|537295652|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
148948067|NCT01513473|537295653|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
148948068|NCT01513473|537295652|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
148948069|NCT01513473|537295653|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
148948070|NCT04166435|537295654|FG000|Overall Study|2 patients ineligible for response|2|||
148809115|NCT02765165|536777616|FG003|Treatment Period|Study terminated|0|||
148948071|NCT01218204|537295655|FG000|Part B Washout|Adverse Event|0|||
148948072|NCT01218204|537295656|FG001|Part B Washout|Adverse Event|1|||
149016338|NCT04150029|537537906|FG001|Overall Study|Adverse Event|11|||
148809116|NCT02765165|536777617|FG004|Treatment Period|Study terminated|0|||
148809117|NCT02765165|536777618|FG005|Treatment Period|Study terminated|1|||
148809118|NCT02765165|536777619|FG006|Treatment Period|Study terminated|2|||
148948073|NCT01218204|537295657|FG002|Part B Washout|Adverse Event|0|||
148948074|NCT01218204|537295658|FG003|Part B Washout|Adverse Event|0|||
148948075|NCT01218204|537295655|FG000|Part B Washout|Lost to Follow-up|0|||
148809119|NCT02765165|536777613|FG000|Post-treatment Follow-up|Death|1|||
148809120|NCT02765165|536777614|FG001|Post-treatment Follow-up|Death|2|||
148809121|NCT02765165|536777615|FG002|Post-treatment Follow-up|Death|1|||
148809122|NCT02765165|536777616|FG003|Post-treatment Follow-up|Death|1|||
148809123|NCT02765165|536777617|FG004|Post-treatment Follow-up|Death|1|||
148809124|NCT02765165|536777618|FG005|Post-treatment Follow-up|Death|1|||
148809125|NCT02765165|536777619|FG006|Post-treatment Follow-up|Death|0|||
148809126|NCT02765165|536777613|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
148809127|NCT02765165|536777614|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
148809128|NCT02765165|536777615|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
148809129|NCT02765165|536777616|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
148809130|NCT02765165|536777617|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
148809131|NCT02765165|536777618|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
148809132|NCT02765165|536777619|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
148809133|NCT02765165|536777613|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
148809134|NCT02765165|536777614|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
148809135|NCT02765165|536777615|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
148809136|NCT02765165|536777616|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
148809137|NCT02765165|536777617|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
148809138|NCT02765165|536777618|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
148809139|NCT02765165|536777619|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
148809140|NCT02765165|536777613|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
148809141|NCT02765165|536777614|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
148809142|NCT02765165|536777615|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
148809143|NCT02765165|536777616|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
148809144|NCT02765165|536777617|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
148809145|NCT02765165|536777618|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
148809146|NCT02765165|536777619|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
148809147|NCT02765165|536777613|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
148809148|NCT02765165|536777614|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
148809149|NCT02765165|536777615|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
148809150|NCT02765165|536777616|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
148809151|NCT02765165|536777617|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
148809152|NCT02765165|536777618|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
148809153|NCT02765165|536777619|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
148809154|NCT02765165|536777613|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
148809155|NCT02765165|536777614|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
148809156|NCT02765165|536777615|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
148809157|NCT02765165|536777616|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
148809158|NCT02765165|536777617|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
148809159|NCT02765165|536777618|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
148809160|NCT02765165|536777619|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
148809161|NCT02567188|536777620|FG000|Overall Study|Death|10|||
148809162|NCT02567188|536777620|FG000|Overall Study|Terminated Mircera Treatment|9|||
148809163|NCT02567188|536777620|FG000|Overall Study|Lost to Follow-up|5|||
148809164|NCT02567188|536777620|FG000|Overall Study|Adverse Event|1|||
148809165|NCT02567188|536777620|FG000|Overall Study|Withdrawal by Subject|1|||
148809166|NCT02567188|536777620|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
148809167|NCT02567188|536777620|FG000|Overall Study|Moved and Changed Clinic|1|||
148809168|NCT02567188|536777620|FG000|Overall Study|Started Hemodialysis|2|||
148809169|NCT02567188|536777620|FG000|Overall Study|Protocol Violation|5|||
148809170|NCT01189266|536777625|FG000|Overall Study|Adverse Event|1|||
148809171|NCT01189266|536777626|FG001|Overall Study|Adverse Event|0|||
148809172|NCT01189266|536777627|FG002|Overall Study|Adverse Event|5|||
148809173|NCT01189266|536777625|FG000|Overall Study|Death|0|||
148683715|NCT03565211|536314978|FG000|Overall Study|Lost to Follow-up|1|||
148948076|NCT01218204|537295656|FG001|Part B Washout|Lost to Follow-up|2|||
148948077|NCT01218204|537295657|FG002|Part B Washout|Lost to Follow-up|0|||
148948078|NCT01218204|537295658|FG003|Part B Washout|Lost to Follow-up|0|||
148948079|NCT01218204|537295655|FG000|Part B Washout|Physician Decision|0|||
148948080|NCT01218204|537295656|FG001|Part B Washout|Physician Decision|14|||
148948081|NCT01218204|537295657|FG002|Part B Washout|Physician Decision|0|||
148948082|NCT01218204|537295658|FG003|Part B Washout|Physician Decision|0|||
148948083|NCT01218204|537295655|FG000|Part B Washout|Withdrawal by Subject|0|||
148948084|NCT01218204|537295656|FG001|Part B Washout|Withdrawal by Subject|14|||
148948085|NCT01218204|537295657|FG002|Part B Washout|Withdrawal by Subject|0|||
149206355|NCT03954444|538221538|FG000|Overall Study|Miscellaneous|3|||
149206356|NCT03954444|538221539|FG001|Overall Study|Miscellaneous|2|||
149206357|NCT03954444|538221540|FG002|Overall Study|Miscellaneous|1|||
149206358|NCT02447458|538221543|FG000|Overall Study|Other|0|||
149206359|NCT02447458|538221544|FG001|Overall Study|Other|0|||
149206360|NCT02447458|538221545|FG002|Overall Study|Other|1|||
149206361|NCT02447458|538221546|FG003|Overall Study|Other|0|||
148948086|NCT01218204|537295658|FG003|Part B Washout|Withdrawal by Subject|0|||
148948087|NCT01218204|537295655|FG000|Part B Washout|Reached defined stopping criteria|0|||
148948088|NCT01218204|537295656|FG001|Part B Washout|Reached defined stopping criteria|2|||
148948089|NCT01218204|537295657|FG002|Part B Washout|Reached defined stopping criteria|0|||
148948090|NCT01218204|537295658|FG003|Part B Washout|Reached defined stopping criteria|0|||
148948091|NCT01218204|537295655|FG000|Part B Washout|Did not meet continuation criteria|0|||
148948092|NCT01218204|537295656|FG001|Part B Washout|Did not meet continuation criteria|112|||
148948093|NCT01218204|537295657|FG002|Part B Washout|Did not meet continuation criteria|0|||
148948094|NCT01218204|537295658|FG003|Part B Washout|Did not meet continuation criteria|0|||
148948095|NCT01218204|537295655|FG000|Part B Run-in|Adverse Event|0|||
149206362|NCT02447458|538221547|FG004|Overall Study|Other|0|||
149206363|NCT02447458|538221548|FG005|Overall Study|Other|0|||
148948096|NCT01218204|537295656|FG001|Part B Run-in|Adverse Event|0|||
148948097|NCT01218204|537295657|FG002|Part B Run-in|Adverse Event|1|||
148948098|NCT01218204|537295658|FG003|Part B Run-in|Adverse Event|0|||
148948099|NCT01218204|537295655|FG000|Part B Run-in|Protocol Violation|0|||
148948100|NCT01218204|537295656|FG001|Part B Run-in|Protocol Violation|0|||
148948101|NCT01218204|537295657|FG002|Part B Run-in|Protocol Violation|2|||
148948102|NCT01218204|537295658|FG003|Part B Run-in|Protocol Violation|0|||
148948103|NCT01218204|537295655|FG000|Part B Run-in|Withdrawal by Subject|0|||
148948104|NCT01218204|537295656|FG001|Part B Run-in|Withdrawal by Subject|0|||
148948105|NCT01218204|537295657|FG002|Part B Run-in|Withdrawal by Subject|3|||
148948106|NCT01218204|537295658|FG003|Part B Run-in|Withdrawal by Subject|0|||
148948107|NCT01218204|537295655|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
148948108|NCT01218204|537295656|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
148948109|NCT01218204|537295657|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
148948110|NCT01218204|537295658|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
148948111|NCT01218204|537295655|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
149206364|NCT03094832|538221549|FG000|Overall Study|Lost to Follow-up|0|||
149206365|NCT03094832|538221550|FG001|Overall Study|Lost to Follow-up|0|||
149206366|NCT03094832|538221551|FG002|Overall Study|Lost to Follow-up|0|||
149206367|NCT03094832|538221552|FG003|Overall Study|Lost to Follow-up|1|||
149206368|NCT03094832|538221553|FG004|Overall Study|Lost to Follow-up|1|||
149206369|NCT03094832|538221549|FG000|Overall Study|Death|1|||
149206370|NCT03094832|538221550|FG001|Overall Study|Death|0|||
149206371|NCT03094832|538221551|FG002|Overall Study|Death|0|||
149206372|NCT03094832|538221552|FG003|Overall Study|Death|0|||
149206373|NCT03094832|538221553|FG004|Overall Study|Death|0|||
149206374|NCT03094832|538221549|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149206375|NCT03094832|538221550|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149206376|NCT03094832|538221551|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149206377|NCT03094832|538221552|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
148948112|NCT01218204|537295656|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
148948113|NCT01218204|537295657|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
148948114|NCT01218204|537295658|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
148948115|NCT00127660|537295659|FG000|Overall Study|Protocol Violation|3|||
149206378|NCT03094832|538221553|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
148809174|NCT01189266|536777626|FG001|Overall Study|Death|0|||
148809175|NCT01189266|536777627|FG002|Overall Study|Death|5|||
148809176|NCT01189266|536777625|FG000|Overall Study|Lack of Efficacy|4|||
149206379|NCT03094832|538221549|FG000|Overall Study|Other|13|||
148809177|NCT01189266|536777626|FG001|Overall Study|Lack of Efficacy|5|||
148809178|NCT01189266|536777627|FG002|Overall Study|Lack of Efficacy|44|||
148948116|NCT00127660|537295660|FG001|Overall Study|Protocol Violation|3|||
148948117|NCT00127660|537295661|FG002|Overall Study|Protocol Violation|5|||
148948118|NCT00127660|537295662|FG003|Overall Study|Protocol Violation|0|||
148948119|NCT01833520|537295663|FG000|Overall Study|Lack of Efficacy|3|||
148948120|NCT01833520|537295664|FG001|Overall Study|Lack of Efficacy|3|||
148948121|NCT01833520|537295665|FG002|Overall Study|Lack of Efficacy|8|||
149206380|NCT03094832|538221550|FG001|Overall Study|Other|20|||
149206381|NCT03094832|538221551|FG002|Overall Study|Other|1|||
149206382|NCT03094832|538221552|FG003|Overall Study|Other|7|||
148948122|NCT01833520|537295666|FG003|Overall Study|Lack of Efficacy|3|||
148948123|NCT00489541|537295667|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
148948124|NCT00489541|537295668|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
148948125|NCT00489541|537295667|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
148948126|NCT00489541|537295668|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
148948127|NCT00489541|537295667|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
148948128|NCT00489541|537295668|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
148948129|NCT00489541|537295667|FG000|12-Month Clinical Follow-up|Death|3|||
148948130|NCT00489541|537295668|FG001|12-Month Clinical Follow-up|Death|2|||
148948131|NCT00489541|537295667|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
148948132|NCT00489541|537295668|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
148948133|NCT00489541|537295667|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
148948134|NCT00489541|537295668|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
148948135|NCT05131646|537295669|FG000|Overall Study|Withdrawal by Subject|1|||
148948136|NCT05131646|537295670|FG001|Overall Study|Withdrawal by Subject|0|||
148948137|NCT05131646|537295671|FG002|Overall Study|Withdrawal by Subject|0|||
148948138|NCT01191801|537295674|FG000|Overall Study|Death|36|||
148948139|NCT01191801|537295675|FG001|Overall Study|Death|12|||
148948140|NCT01191801|537295674|FG000|Overall Study|Lack of Efficacy|176|||
148948141|NCT01191801|537295675|FG001|Overall Study|Lack of Efficacy|258|||
148948142|NCT01191801|537295674|FG000|Overall Study|Adverse Event|9|||
148948143|NCT01191801|537295675|FG001|Overall Study|Adverse Event|8|||
149206383|NCT03094832|538221553|FG004|Overall Study|Other|1|||
149206384|NCT02674685|538221559|FG000|Overall Study|Withdrawal by Subject|4|||
149206385|NCT01181778|538221560|FG000|Overall Study|Physician Decision|48|||
149234053|NCT05299359|538326373|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
149234054|NCT05299359|538326372|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
148948144|NCT01191801|537295674|FG000|Overall Study|Protocol Violation|2|||
148948145|NCT01191801|537295675|FG001|Overall Study|Protocol Violation|4|||
149234055|NCT05299359|538326373|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
149234056|NCT05299359|538326372|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
149234057|NCT05299359|538326373|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
149234058|NCT05299359|538326372|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
149234059|NCT05299359|538326373|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
148948146|NCT01191801|537295674|FG000|Overall Study|Physician Decision|47|||
148948147|NCT01191801|537295675|FG001|Overall Study|Physician Decision|24|||
148948148|NCT01191801|537295674|FG000|Overall Study|Withdrawal by Subject|1|||
148948149|NCT01191801|537295675|FG001|Overall Study|Withdrawal by Subject|4|||
148948150|NCT01191801|537295674|FG000|Overall Study|Not Provided|45|||
148948151|NCT01191801|537295675|FG001|Overall Study|Not Provided|27|||
148948152|NCT00003479|537295676|FG000|Overall Study|Not evaluable|3|||
148948153|NCT02042183|537295678|FG000|Overall Study|Physician Decision|7|||
149234060|NCT05299359|538326372|FG000|Extension Part: Day 1 to Day 366|Other|0|||
149234061|NCT05299359|538326373|FG001|Extension Part: Day 1 to Day 366|Other|1|||
149234062|NCT04780776|538326378|FG000|Titration Week 1-5|Lost to Follow-up|2|||
149234063|NCT04780776|538326379|FG001|Titration Week 1-5|Lost to Follow-up|8|||
149234064|NCT04780776|538326378|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
149234065|NCT04780776|538326379|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
149234066|NCT04780776|538326378|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
149234067|NCT04780776|538326379|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
149234068|NCT03113760|538326380|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
149234069|NCT03113760|538326381|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
149234070|NCT03113760|538326382|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
149234071|NCT03113760|538326383|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
149234072|NCT03113760|538326380|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
149234073|NCT03113760|538326381|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
149234074|NCT03113760|538326382|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
149234075|NCT03113760|538326383|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
149234076|NCT03113760|538326380|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
149234077|NCT03113760|538326381|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
149234078|NCT03113760|538326382|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
149234079|NCT03113760|538326383|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
149234080|NCT00423137|538326384|FG000|Overall Study|Lost to Follow-up|0|||
149234081|NCT00423137|538326385|FG001|Overall Study|Lost to Follow-up|0|||
149234082|NCT00423137|538326386|FG002|Overall Study|Lost to Follow-up|1|||
149234083|NCT00423137|538326387|FG003|Overall Study|Lost to Follow-up|0|||
149234084|NCT00423137|538326384|FG000|Overall Study|Protocol Violation|0|||
149234085|NCT00423137|538326385|FG001|Overall Study|Protocol Violation|0|||
148683716|NCT03565211|536314978|FG000|Overall Study|Adverse Event|44|||
148948154|NCT02042183|537295679|FG001|Overall Study|Physician Decision|2|||
148948155|NCT02042183|537295678|FG000|Overall Study|Lack of Efficacy|4|||
148948156|NCT02042183|537295679|FG001|Overall Study|Lack of Efficacy|3|||
149234086|NCT00423137|538326386|FG002|Overall Study|Protocol Violation|0|||
149234087|NCT00423137|538326387|FG003|Overall Study|Protocol Violation|1|||
148948157|NCT02042183|537295678|FG000|Overall Study|Non-compliance with Study Drug|2|||
148948158|NCT02042183|537295679|FG001|Overall Study|Non-compliance with Study Drug|3|||
148948159|NCT02042183|537295678|FG000|Overall Study|Adverse Event|17|||
148948160|NCT02042183|537295679|FG001|Overall Study|Adverse Event|6|||
148948161|NCT02042183|537295678|FG000|Overall Study|Other|3|||
148948162|NCT02042183|537295679|FG001|Overall Study|Other|3|||
148948163|NCT02042183|537295678|FG000|Overall Study|Withdrawal by Subject|21|||
148948164|NCT02042183|537295679|FG001|Overall Study|Withdrawal by Subject|16|||
148948165|NCT02042183|537295678|FG000|Overall Study|Site Terminated by Sponsor|2|||
148948166|NCT02042183|537295679|FG001|Overall Study|Site Terminated by Sponsor|1|||
148948167|NCT02042183|537295678|FG000|Overall Study|Lost to Follow-up|9|||
148948168|NCT02042183|537295679|FG001|Overall Study|Lost to Follow-up|2|||
148948169|NCT01192516|537295682|FG000|Overall Study|Lost to Follow-up|7|||
148948170|NCT01192516|537295683|FG001|Overall Study|Lost to Follow-up|10|||
148948171|NCT01192516|537295684|FG002|Overall Study|Lost to Follow-up|7|||
148948172|NCT01192516|537295682|FG000|Overall Study|Withdrawal by Subject|4|||
148948173|NCT01192516|537295683|FG001|Overall Study|Withdrawal by Subject|4|||
148948174|NCT01192516|537295684|FG002|Overall Study|Withdrawal by Subject|1|||
148948175|NCT01192516|537295682|FG000|Overall Study|started new treatment|5|||
148948176|NCT01192516|537295683|FG001|Overall Study|started new treatment|1|||
148948177|NCT01192516|537295684|FG002|Overall Study|started new treatment|0|||
148948178|NCT01192516|537295682|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
148948179|NCT01192516|537295683|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
148948180|NCT01192516|537295684|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
148948181|NCT02321800|537295685|FG000|Overall Study|Withdrawal by Subject|3|||
148948182|NCT02321800|537295686|FG001|Overall Study|Withdrawal by Subject|3|||
148948183|NCT02321800|537295685|FG000|Overall Study|Death|1|||
148948184|NCT02321800|537295686|FG001|Overall Study|Death|0|||
148948185|NCT02321800|537295685|FG000|Overall Study|Protocol Violation|1|||
148948186|NCT02321800|537295686|FG001|Overall Study|Protocol Violation|0|||
148948187|NCT02321800|537295685|FG000|Overall Study|Lost to Follow-up|10|||
148948188|NCT02321800|537295686|FG001|Overall Study|Lost to Follow-up|4|||
148948189|NCT02321800|537295685|FG000|Overall Study|Adverse Event|2|||
148948190|NCT02321800|537295686|FG001|Overall Study|Adverse Event|3|||
148948191|NCT02321800|537295685|FG000|Overall Study|Other, Miscellaneous|3|||
148948192|NCT02321800|537295686|FG001|Overall Study|Other, Miscellaneous|1|||
148948193|NCT01051323|537295687|FG000|Overall Study|Discontinuation of treatment|103|||
148948194|NCT01051323|537295687|FG000|Overall Study|Transplantation|28|||
148948195|NCT01051323|537295687|FG000|Overall Study|Dialysis dependency|22|||
148948196|NCT01051323|537295687|FG000|Overall Study|Withdrawal by Subject|13|||
149206386|NCT00462488|538223257|FG000|Overall Study|Protocol Violation|1|||
149206387|NCT00462488|538223258|FG001|Overall Study|Protocol Violation|0|||
149206388|NCT00462488|538223257|FG000|Overall Study|Lack of Efficacy|19|||
149206389|NCT00462488|538223258|FG001|Overall Study|Lack of Efficacy|17|||
149206390|NCT02848313|538223261|FG000|Overall Study|Adverse Event|1|||
149206391|NCT02848313|538223262|FG001|Overall Study|Adverse Event|2|||
149206392|NCT02848313|538223261|FG000|Overall Study|Lack of Efficacy|0|||
149206393|NCT02848313|538223262|FG001|Overall Study|Lack of Efficacy|1|||
149206394|NCT02848313|538223261|FG000|Overall Study|Withdrawal by Subject|1|||
149206395|NCT02848313|538223262|FG001|Overall Study|Withdrawal by Subject|1|||
149206396|NCT02848313|538223261|FG000|Overall Study|Lost to follow up|1|||
149206397|NCT02848313|538223262|FG001|Overall Study|Lost to follow up|0|||
149206398|NCT03510910|538223263|FG000|Overall Study|Incomplete Survey|2|||
149206399|NCT03510910|538223264|FG001|Overall Study|Incomplete Survey|3|||
149206400|NCT01673490|538223265|FG000|Overall Study|Lost to Follow-up|1|||
149206401|NCT01673490|538223265|FG000|Overall Study|Adverse Event|3|||
149206402|NCT01673490|538223265|FG000|Overall Study|Withdrawal by Subject|3|||
149206403|NCT03382262|538223266|FG000|Overall Study|Physician Decision|0|||
149206404|NCT03382262|538223267|FG001|Overall Study|Physician Decision|0|||
149206405|NCT03382262|538223268|FG002|Overall Study|Physician Decision|1|||
149206406|NCT03382262|538223269|FG003|Overall Study|Physician Decision|0|||
149206407|NCT03382262|538223266|FG000|Overall Study|Withdrawal by Subject|0|||
149206408|NCT03382262|538223267|FG001|Overall Study|Withdrawal by Subject|0|||
149206409|NCT03382262|538223268|FG002|Overall Study|Withdrawal by Subject|0|||
149206410|NCT03382262|538223269|FG003|Overall Study|Withdrawal by Subject|1|||
149206411|NCT04914819|538223270|FG000|Overall Study|Pregnancy|3|||
149206412|NCT04914819|538223271|FG001|Overall Study|Pregnancy|1|||
149206413|NCT04914819|538223270|FG000|Overall Study|Discontinued study|4|||
149206414|NCT04914819|538223271|FG001|Overall Study|Discontinued study|1|||
149206415|NCT04914819|538223270|FG000|Overall Study|Lost to Follow-up|7|||
149206416|NCT04914819|538223271|FG001|Overall Study|Lost to Follow-up|0|||
149206417|NCT02715804|538223272|FG000|Overall Study|Death|222|||
149206418|NCT02715804|538223273|FG001|Overall Study|Death|106|||
149206419|NCT02715804|538223272|FG000|Overall Study|Withdrawal by Subject|5|||
149206420|NCT02715804|538223273|FG001|Overall Study|Withdrawal by Subject|4|||
149206421|NCT02715804|538223272|FG000|Overall Study|Other than specified|2|||
149206422|NCT02715804|538223273|FG001|Overall Study|Other than specified|3|||
149206423|NCT01625611|538223276|FG000|Overall Study|No adlib drinks Lab 1|3|||
149206424|NCT01625611|538223277|FG001|Overall Study|No adlib drinks Lab 1|0|||
149206425|NCT01625611|538223276|FG000|Overall Study|Technical issues with PET|1|||
149206426|NCT01625611|538223277|FG001|Overall Study|Technical issues with PET|0|||
149206427|NCT01625611|538223276|FG000|Overall Study|Unable to complete study procedures|1|||
149206428|NCT01625611|538223277|FG001|Overall Study|Unable to complete study procedures|0|||
149206429|NCT01625611|538223276|FG000|Overall Study|Withdrawal by Subject|3|||
149206430|NCT01625611|538223277|FG001|Overall Study|Withdrawal by Subject|0|||
149206431|NCT00948194|538223278|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
149206432|NCT00948194|538223279|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
149206433|NCT00233324|538223280|FG000|Main Study|Death|68|||
149206434|NCT00233324|538223281|FG001|Main Study|Death|60|||
149206435|NCT00233324|538223282|FG002|Main Study|Death|62|||
149206436|NCT00233324|538223283|FG003|Main Study|Death|47|||
149206437|NCT00233324|538223280|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
148948197|NCT01051323|537295687|FG000|Overall Study|Lost to Follow-up|31|||
148948198|NCT01051323|537295687|FG000|Overall Study|Death|129|||
148948199|NCT01051323|537295687|FG000|Overall Study|Hospitalization|28|||
148948200|NCT01051323|537295687|FG000|Overall Study|Other|148|||
148948201|NCT01051323|537295687|FG000|Overall Study|Missing|37|||
149206438|NCT00233324|538223281|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
149206439|NCT00233324|538223282|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
149206440|NCT00233324|538223283|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
149206441|NCT00233324|538223280|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
148948202|NCT04605484|537295691|FG000|Overall Study|Lost to Follow-up|0|||
148948203|NCT04605484|537295692|FG001|Overall Study|Lost to Follow-up|1|||
148948204|NCT04605484|537295693|FG002|Overall Study|Lost to Follow-up|1|||
148948205|NCT04605484|537295691|FG000|Overall Study|Other|0|||
148948206|NCT04605484|537295692|FG001|Overall Study|Other|1|||
148948207|NCT04605484|537295693|FG002|Overall Study|Other|0|||
148948208|NCT04171531|537295694|FG000|Overall Study|Lost to Follow-up|4|||
148948209|NCT04171531|537295695|FG001|Overall Study|Lost to Follow-up|5|||
148948210|NCT04171531|537295694|FG000|Overall Study|Consent only through 6 months|1|||
148948211|NCT04171531|537295695|FG001|Overall Study|Consent only through 6 months|1|||
148948212|NCT04171531|537295694|FG000|Overall Study|Insurance did not cover procedure|0|||
148948213|NCT04171531|537295695|FG001|Overall Study|Insurance did not cover procedure|1|||
148948214|NCT04171531|537295694|FG000|Overall Study|Physician Decision|0|||
148948215|NCT04171531|537295695|FG001|Overall Study|Physician Decision|3|||
148948216|NCT04171531|537295694|FG000|Overall Study|Withdrawal by Subject|1|||
148948217|NCT04171531|537295695|FG001|Overall Study|Withdrawal by Subject|5|||
148948218|NCT04862585|537295699|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
148948219|NCT04862585|537295700|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
148948220|NCT04862585|537295699|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
148948221|NCT04862585|537295700|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
148948222|NCT04862585|537295699|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
148948223|NCT04862585|537295700|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
148948224|NCT04862585|537295699|FG000|Overall Study|one withdrew without providing a reason|0|||
148948225|NCT04862585|537295700|FG001|Overall Study|one withdrew without providing a reason|1|||
148948226|NCT03366337|537295703|FG000|Overall Study|Lost to Follow-up|1|||
148948227|NCT03366337|537295704|FG001|Overall Study|Lost to Follow-up|0|||
148948228|NCT03366337|537295705|FG002|Overall Study|Lost to Follow-up|1|||
148948229|NCT03366337|537295706|FG003|Overall Study|Lost to Follow-up|0|||
148948230|NCT03366337|537295703|FG000|Overall Study|Withdrawal by Subject|2|||
148948231|NCT03366337|537295704|FG001|Overall Study|Withdrawal by Subject|0|||
148948232|NCT03366337|537295705|FG002|Overall Study|Withdrawal by Subject|1|||
148948233|NCT03366337|537295706|FG003|Overall Study|Withdrawal by Subject|1|||
148948234|NCT05288062|537295707|FG000|Overall Study|Ineligible|0|||
148948235|NCT05288062|537295708|FG001|Overall Study|Ineligible|0|||
148948236|NCT05288062|537295709|FG002|Overall Study|Ineligible|1|||
148948237|NCT05288062|537295710|FG003|Overall Study|Ineligible|0|||
148948238|NCT05288062|537295707|FG000|Overall Study|Withdrawal by Subject|0|||
148948239|NCT05288062|537295708|FG001|Overall Study|Withdrawal by Subject|0|||
148948240|NCT05288062|537295709|FG002|Overall Study|Withdrawal by Subject|1|||
148948241|NCT05288062|537295710|FG003|Overall Study|Withdrawal by Subject|0|||
148948242|NCT01025752|537295714|FG000|Overall Study|Lost to Follow-up|7|||
148948243|NCT01025752|537295715|FG001|Overall Study|Lost to Follow-up|10|||
148948244|NCT01025752|537295714|FG000|Overall Study|Physician Decision|1|||
148948245|NCT01025752|537295715|FG001|Overall Study|Physician Decision|3|||
148948246|NCT01537393|537295716|FG000|Overall Study|Exclude prior to study|32|||
148948247|NCT01537393|537295717|FG001|Overall Study|Exclude prior to study|44|||
148948248|NCT01537393|537295716|FG000|Overall Study|Death|20|||
148948249|NCT01537393|537295717|FG001|Overall Study|Death|32|||
148948250|NCT01537393|537295716|FG000|Overall Study|Withdrawal by Subject|18|||
148948251|NCT01537393|537295717|FG001|Overall Study|Withdrawal by Subject|17|||
148948252|NCT01537393|537295716|FG000|Overall Study|Lost to Follow-up|53|||
148948253|NCT01537393|537295717|FG001|Overall Study|Lost to Follow-up|48|||
148948254|NCT01537393|537295716|FG000|Overall Study|Failure - Regrafted|28|||
148948255|NCT01537393|537295717|FG001|Overall Study|Failure - Regrafted|43|||
148948256|NCT01537393|537295716|FG000|Overall Study|Failure - Not regrafted|2|||
148948257|NCT01537393|537295717|FG001|Overall Study|Failure - Not regrafted|6|||
149206442|NCT00233324|538223281|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
149206443|NCT00233324|538223282|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
149206444|NCT00233324|538223283|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
149206445|NCT02905825|538223286|FG000|Overall Study|Protocol Violation|11|||
149206446|NCT02905825|538223286|FG000|Overall Study|Device Malfunction|1|||
149206447|NCT01709708|538223288|FG000|Overall Study|Protocol Violation|1|||
149206448|NCT01709708|538223289|FG001|Overall Study|Protocol Violation|2|||
148809179|NCT01189266|536777625|FG000|Overall Study|Physician Decision|0|||
148948258|NCT01537393|537295716|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
148948259|NCT01537393|537295717|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
148948260|NCT01697566|537295718|FG000|Overall Study|Withdrawal by Subject|0|||
148948261|NCT01697566|537295719|FG001|Overall Study|Withdrawal by Subject|0|||
148948262|NCT01697566|537295720|FG002|Overall Study|Withdrawal by Subject|1|||
148948263|NCT01697566|537295721|FG003|Overall Study|Withdrawal by Subject|1|||
148948264|NCT01697566|537295718|FG000|Overall Study|Final biopsy not obtained|0|||
148948265|NCT01697566|537295719|FG001|Overall Study|Final biopsy not obtained|0|||
148948266|NCT01697566|537295720|FG002|Overall Study|Final biopsy not obtained|1|||
149016339|NCT04150029|537537905|FG000|Overall Study|Physician Decision|0|||
148809180|NCT01189266|536777626|FG001|Overall Study|Physician Decision|0|||
148809181|NCT01189266|536777627|FG002|Overall Study|Physician Decision|1|||
148809182|NCT01189266|536777625|FG000|Overall Study|Protocol Violation|0|||
148809183|NCT01189266|536777626|FG001|Overall Study|Protocol Violation|1|||
148809184|NCT01189266|536777627|FG002|Overall Study|Protocol Violation|1|||
148809185|NCT01189266|536777625|FG000|Overall Study|Withdrawal by Subject|0|||
148948267|NCT01697566|537295721|FG003|Overall Study|Final biopsy not obtained|0|||
148948268|NCT00459953|537295722|FG000|Overall Study|not analyzed-household member in study|1|||
148948269|NCT00459953|537295723|FG001|Overall Study|not analyzed-household member in study|1|||
148948270|NCT01447433|537295724|FG000|Overall Study|Lost to Follow-up|0|||
148948271|NCT01447433|537295725|FG001|Overall Study|Lost to Follow-up|2|||
148948272|NCT01447433|537295724|FG000|Overall Study|Withdrawal by Subject|3|||
148948273|NCT01447433|537295725|FG001|Overall Study|Withdrawal by Subject|3|||
148948274|NCT01447433|537295724|FG000|Overall Study|Protocol Violation|1|||
148948275|NCT01447433|537295725|FG001|Overall Study|Protocol Violation|1|||
148948276|NCT00036270|537295726|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
148948277|NCT00036270|537295727|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
148948278|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
148948279|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
148948280|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
148948281|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
148948282|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
148948283|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
148948284|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Other|277|||
148948285|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Other|288|||
148948286|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
148948287|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
148948288|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
148948289|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
148948290|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
148948291|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
148948292|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
148948293|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
148948294|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
148948295|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
148948296|NCT00036270|537295726|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
148948297|NCT00036270|537295727|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
148948298|NCT01578187|537295728|FG000|Usability Phase|Withdrawal by Subject|1|||
148948299|NCT02516163|537295733|FG000|Overall Study|Withdrawal by Subject|1|||
148948300|NCT02516163|537295733|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
148948301|NCT02516163|537295733|FG000|Overall Study|Unfit/delay in surgery|3|||
148948302|NCT02516163|537295733|FG000|Overall Study|Use of incorrect measurement technique|5|||
148948303|NCT02516163|537295733|FG000|Overall Study|Data not recorded|2|||
148948304|NCT02516163|537295733|FG000|Overall Study|MRI contraindication exclusion|6|||
148948305|NCT01709162|537295736|FG000|Overall Study|Disease progression|3|||
148948306|NCT01709162|537295737|FG001|Overall Study|Disease progression|3|||
148948307|NCT01709162|537295736|FG000|Overall Study|Study drug toxicity|2|||
148948308|NCT01709162|537295737|FG001|Overall Study|Study drug toxicity|0|||
148948309|NCT01709162|537295736|FG000|Overall Study|Administrative reason by sponsor|0|||
148948310|NCT01709162|537295737|FG001|Overall Study|Administrative reason by sponsor|1|||
148948311|NCT01709162|537295736|FG000|Overall Study|Other|1|||
148948312|NCT01709162|537295737|FG001|Overall Study|Other|0|||
148948313|NCT01709162|537295736|FG000|Overall Study|Withdrawal by Subject|0|||
148948314|NCT01709162|537295737|FG001|Overall Study|Withdrawal by Subject|1|||
148948315|NCT01874054|537295738|FG000|Overall Study|Withdrawal by Subject|3|||
148948316|NCT01874054|537295738|FG000|Overall Study|Study Termination by Sponsor|42|||
148948317|NCT01874054|537295738|FG000|Overall Study|Lost to Follow-up|5|||
148948318|NCT01874054|537295738|FG000|Overall Study|Death|5|||
148948319|NCT02010775|537295739|FG000|Overall Study|Adverse Event|0|||
148948320|NCT02010775|537295740|FG001|Overall Study|Adverse Event|0|||
148948321|NCT02010775|537295741|FG002|Overall Study|Adverse Event|0|||
148948322|NCT02010775|537295742|FG003|Overall Study|Adverse Event|0|||
148948323|NCT02010775|537295743|FG004|Overall Study|Adverse Event|1|||
148948324|NCT02010775|537295739|FG000|Overall Study|Pregnancy|0|||
148948325|NCT02010775|537295740|FG001|Overall Study|Pregnancy|0|||
148948326|NCT02010775|537295741|FG002|Overall Study|Pregnancy|2|||
148948327|NCT02010775|537295742|FG003|Overall Study|Pregnancy|0|||
148948328|NCT02010775|537295743|FG004|Overall Study|Pregnancy|0|||
148948329|NCT02010775|537295739|FG000|Overall Study|Lost to Follow-up|2|||
148948330|NCT02010775|537295740|FG001|Overall Study|Lost to Follow-up|0|||
148948331|NCT02010775|537295741|FG002|Overall Study|Lost to Follow-up|0|||
149016340|NCT04150029|537537906|FG001|Overall Study|Physician Decision|10|||
149016341|NCT04150029|537537905|FG000|Overall Study|Study Terminated by Sponsor|1|||
148809186|NCT01189266|536777626|FG001|Overall Study|Withdrawal by Subject|0|||
148683717|NCT03565211|536314978|FG000|Overall Study|Personal issues|1|||
148683718|NCT00323609|536314979|FG000|Overall Study|Death|16|||
148683719|NCT00323609|536314980|FG001|Overall Study|Death|21|||
148683720|NCT00323609|536314981|FG002|Overall Study|Death|0|||
148683721|NCT00323609|536314982|FG003|Overall Study|Death|0|||
148683722|NCT00323609|536314979|FG000|Overall Study|Lost to Follow-up|9|||
148683723|NCT00323609|536314980|FG001|Overall Study|Lost to Follow-up|10|||
148683724|NCT00323609|536314981|FG002|Overall Study|Lost to Follow-up|0|||
148683725|NCT00323609|536314982|FG003|Overall Study|Lost to Follow-up|0|||
148683726|NCT00323609|536314979|FG000|Overall Study|Physician Decision|2|||
148683727|NCT00323609|536314980|FG001|Overall Study|Physician Decision|0|||
148683728|NCT00323609|536314981|FG002|Overall Study|Physician Decision|0|||
148683729|NCT00323609|536314982|FG003|Overall Study|Physician Decision|1|||
148683730|NCT00323609|536314979|FG000|Overall Study|Withdrawal by Subject|11|||
148683731|NCT00323609|536314980|FG001|Overall Study|Withdrawal by Subject|23|||
148683732|NCT00323609|536314981|FG002|Overall Study|Withdrawal by Subject|4|||
148683733|NCT00323609|536314982|FG003|Overall Study|Withdrawal by Subject|4|||
148683734|NCT00323609|536314979|FG000|Overall Study|Other non-VCF-related medical condition|3|||
148683735|NCT00323609|536314980|FG001|Overall Study|Other non-VCF-related medical condition|2|||
148683736|NCT00323609|536314981|FG002|Overall Study|Other non-VCF-related medical condition|0|||
148683737|NCT00323609|536314982|FG003|Overall Study|Other non-VCF-related medical condition|0|||
148683738|NCT00323609|536314979|FG000|Overall Study|Sponsor discontinued trial|29|||
148683739|NCT00323609|536314980|FG001|Overall Study|Sponsor discontinued trial|29|||
148683740|NCT00323609|536314981|FG002|Overall Study|Sponsor discontinued trial|0|||
148683741|NCT00323609|536314982|FG003|Overall Study|Sponsor discontinued trial|0|||
148683742|NCT00323609|536314979|FG000|Overall Study|Unrelenting or severe back pain|1|||
148683743|NCT00323609|536314980|FG001|Overall Study|Unrelenting or severe back pain|1|||
148683744|NCT00323609|536314981|FG002|Overall Study|Unrelenting or severe back pain|0|||
148683745|NCT00323609|536314982|FG003|Overall Study|Unrelenting or severe back pain|0|||
148683746|NCT00323609|536314979|FG000|Overall Study|Logistical withdrawal|9|||
148683747|NCT00323609|536314980|FG001|Overall Study|Logistical withdrawal|5|||
148683748|NCT00323609|536314981|FG002|Overall Study|Logistical withdrawal|0|||
148683749|NCT00323609|536314982|FG003|Overall Study|Logistical withdrawal|1|||
148683750|NCT00323609|536314979|FG000|Overall Study|Other reason|11|||
148948332|NCT02010775|537295742|FG003|Overall Study|Lost to Follow-up|1|||
148948333|NCT02010775|537295743|FG004|Overall Study|Lost to Follow-up|1|||
148948334|NCT02010775|537295739|FG000|Overall Study|Personal Reasons|3|||
148948335|NCT02010775|537295740|FG001|Overall Study|Personal Reasons|3|||
149206449|NCT01527110|538223290|FG000|Overall Study|Adverse Event|1|||
149206450|NCT02657434|538223291|FG000|Overall Study|Study Terminated By Sponsor|64|||
149206451|NCT02657434|538223292|FG001|Overall Study|Study Terminated By Sponsor|82|||
149206452|NCT02657434|538223291|FG000|Overall Study|Death|189|||
149206453|NCT02657434|538223292|FG001|Overall Study|Death|190|||
149206454|NCT02657434|538223291|FG000|Overall Study|Lost to Follow-up|2|||
149206455|NCT02657434|538223292|FG001|Overall Study|Lost to Follow-up|2|||
149206456|NCT02657434|538223291|FG000|Overall Study|Randomization by Error|2|||
149206457|NCT02657434|538223292|FG001|Overall Study|Randomization by Error|0|||
149206458|NCT02657434|538223291|FG000|Overall Study|Withdrawal by Subject|28|||
149206459|NCT02657434|538223292|FG001|Overall Study|Withdrawal by Subject|17|||
149206460|NCT02657434|538223291|FG000|Overall Study|Protocol Violation|1|||
149206461|NCT02657434|538223292|FG001|Overall Study|Protocol Violation|0|||
149206462|NCT02657434|538223291|FG000|Overall Study|Physician Decision|0|||
149206463|NCT02657434|538223292|FG001|Overall Study|Physician Decision|1|||
149206476|NCT00511108|538223297|FG000|Overall Study|Adverse Event|2|||
148683751|NCT00323609|536314980|FG001|Overall Study|Other reason|8|||
148683752|NCT00323609|536314981|FG002|Overall Study|Other reason|4|||
148683753|NCT00323609|536314982|FG003|Overall Study|Other reason|9|||
148683754|NCT01023269|536314986|FG000|Overall Study|early termination of the study|2|||
148683755|NCT01023269|536314987|FG001|Overall Study|early termination of the study|0|||
148948336|NCT02010775|537295741|FG002|Overall Study|Personal Reasons|1|||
149206477|NCT00511108|538223298|FG001|Overall Study|Adverse Event|0|||
149206478|NCT00511108|538223299|FG002|Overall Study|Adverse Event|1|||
149206479|NCT00511108|538223300|FG003|Overall Study|Adverse Event|2|||
148683756|NCT01953783|536314988|FG000|Overall Study|Progressive disease|2|||
148683757|NCT01789281|536314989|FG000|Overall Study|Disease progression|15|||
148683758|NCT01789281|536314990|FG001|Overall Study|Disease progression|4|||
148683759|NCT01789281|536314989|FG000|Overall Study|Adverse Event|5|||
148683760|NCT01789281|536314990|FG001|Overall Study|Adverse Event|5|||
148683761|NCT01789281|536314989|FG000|Overall Study|Withdrawal by Subject|1|||
148683762|NCT01789281|536314990|FG001|Overall Study|Withdrawal by Subject|0|||
148683763|NCT01789281|536314989|FG000|Overall Study|Lost to Follow-up|1|||
148683764|NCT01789281|536314990|FG001|Overall Study|Lost to Follow-up|0|||
148683765|NCT01789281|536314989|FG000|Overall Study|Administrative problems|0|||
148683766|NCT01789281|536314990|FG001|Overall Study|Administrative problems|1|||
148683767|NCT00814658|536314991|FG000|Overall Study|Lost to Follow-up|0|||
148683768|NCT00814658|536314992|FG001|Overall Study|Lost to Follow-up|1|||
148683769|NCT00814658|536314991|FG000|Overall Study|Physician Decision|1|||
148683770|NCT00814658|536314992|FG001|Overall Study|Physician Decision|0|||
148683771|NCT00814658|536314991|FG000|Overall Study|Adverse Event|3|||
148683772|NCT00814658|536314992|FG001|Overall Study|Adverse Event|3|||
148683773|NCT01141283|536314994|FG000|Overall Study|Adverse Event|56|||
148683774|NCT01141283|536314994|FG000|Overall Study|Lost to Follow-up|4|||
148683775|NCT01141283|536314994|FG000|Overall Study|Withdrawal by Subject|14|||
148683776|NCT01141283|536314994|FG000|Overall Study|Administrative|4|||
148683777|NCT01141283|536314994|FG000|Overall Study|Lack of Efficacy|10|||
148683778|NCT06371079|536314997|FG000|Overall Study|Missing data|88|||
148683779|NCT06371079|536314998|FG001|Overall Study|Missing data|247|||
148683780|NCT00449930|536314999|FG000|Overall Study|Adverse Event|9|||
148683781|NCT00449930|536315000|FG001|Overall Study|Adverse Event|19|||
148683782|NCT00449930|536314999|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
148683783|NCT00449930|536315000|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
148683784|NCT00449930|536314999|FG000|Overall Study|Lack of Efficacy|10|||
148683785|NCT00449930|536315000|FG001|Overall Study|Lack of Efficacy|1|||
148683786|NCT00449930|536314999|FG000|Overall Study|Lost to Follow-up|9|||
148683787|NCT00449930|536315000|FG001|Overall Study|Lost to Follow-up|14|||
148683788|NCT00449930|536314999|FG000|Overall Study|Physician Decision|1|||
148683789|NCT00449930|536315000|FG001|Overall Study|Physician Decision|2|||
148683790|NCT00449930|536314999|FG000|Overall Study|Protocol Violation|14|||
148683791|NCT00449930|536315000|FG001|Overall Study|Protocol Violation|15|||
148683792|NCT00449930|536314999|FG000|Overall Study|Withdrawal by Subject|16|||
148683793|NCT00449930|536315000|FG001|Overall Study|Withdrawal by Subject|23|||
148683794|NCT00449930|536314999|FG000|Overall Study|Glycemic discontinuation criteria|1|||
148683795|NCT00449930|536315000|FG001|Overall Study|Glycemic discontinuation criteria|1|||
148683796|NCT02746705|536315001|FG000|Overall Study|Physician Decision|1|||
148683797|NCT02746705|536315002|FG001|Overall Study|Physician Decision|1|||
148683798|NCT02746705|536315001|FG000|Overall Study|Lost to Follow-up|1|||
148683799|NCT02746705|536315002|FG001|Overall Study|Lost to Follow-up|0|||
148683800|NCT02746705|536315001|FG000|Overall Study|outlier scores deemed not valid|0|||
148683801|NCT02746705|536315002|FG001|Overall Study|outlier scores deemed not valid|1|||
148683802|NCT00575328|536315003|FG000|Overall Study|Adverse Event|1|||
148683803|NCT00575328|536315004|FG001|Overall Study|Adverse Event|1|||
148683804|NCT00575328|536315003|FG000|Overall Study|Lost to Follow-up|2|||
148683805|NCT00575328|536315004|FG001|Overall Study|Lost to Follow-up|1|||
148683806|NCT00124449|536315009|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
148683807|NCT00124449|536315010|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
148683808|NCT00124449|536315009|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
148683809|NCT00124449|536315010|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
148683810|NCT00124449|536315009|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
148948337|NCT02010775|537295742|FG003|Overall Study|Personal Reasons|2|||
148948338|NCT02010775|537295743|FG004|Overall Study|Personal Reasons|4|||
148948339|NCT02030041|537295744|FG000|Overall Study|Withdrawal by Subject|2|||
148948340|NCT02030041|537295745|FG001|Overall Study|Withdrawal by Subject|2|||
149206480|NCT00511108|538223297|FG000|Overall Study|Lost to Follow-up|0|||
149206481|NCT00511108|538223298|FG001|Overall Study|Lost to Follow-up|2|||
149206482|NCT00511108|538223299|FG002|Overall Study|Lost to Follow-up|1|||
149206483|NCT00511108|538223300|FG003|Overall Study|Lost to Follow-up|0|||
149206484|NCT00511108|538223297|FG000|Overall Study|Physician Decision|0|||
149206485|NCT00511108|538223298|FG001|Overall Study|Physician Decision|0|||
149206486|NCT00511108|538223299|FG002|Overall Study|Physician Decision|0|||
149206487|NCT00511108|538223300|FG003|Overall Study|Physician Decision|1|||
149206488|NCT00511108|538223297|FG000|Overall Study|Withdrawal by Subject|4|||
149206489|NCT00511108|538223298|FG001|Overall Study|Withdrawal by Subject|0|||
148683811|NCT00124449|536315010|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
148683812|NCT00124449|536315009|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
148683813|NCT00124449|536315010|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
148683814|NCT00124449|536315009|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
148683815|NCT00124449|536315010|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
148683816|NCT00124449|536315009|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
148683817|NCT00124449|536315010|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
148683818|NCT00124449|536315009|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
148683819|NCT00124449|536315010|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
148683820|NCT00124449|536315009|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
148683821|NCT00124449|536315010|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
148683822|NCT00124449|536315009|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
148683823|NCT00124449|536315010|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
148683824|NCT00124449|536315009|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
148683825|NCT00124449|536315010|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
148683826|NCT00124449|536315009|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
148683827|NCT00124449|536315010|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
148683828|NCT00124449|536315009|FG000|18-Month Untreated Observation Period|Relocated|1|||
148683829|NCT00124449|536315010|FG001|18-Month Untreated Observation Period|Relocated|0|||
148683830|NCT03124381|536315016|FG000|Overall Study|Lost to Follow-up|1|||
148683831|NCT03124381|536315017|FG001|Overall Study|Lost to Follow-up|1|||
148683832|NCT03124381|536315016|FG000|Overall Study|Withdrawal by Subject|6|||
148683833|NCT03124381|536315017|FG001|Overall Study|Withdrawal by Subject|3|||
148683834|NCT03124381|536315016|FG000|Overall Study|Protocol Violation|0|||
148683835|NCT03124381|536315017|FG001|Overall Study|Protocol Violation|1|||
148683836|NCT03124381|536315016|FG000|Overall Study|Adverse Event|1|||
148683837|NCT03124381|536315017|FG001|Overall Study|Adverse Event|1|||
148683838|NCT03124381|536315016|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
148683839|NCT03124381|536315017|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
148683840|NCT02533999|536315023|FG000|Overall Study|Lost to Follow-up|3|||
148683841|NCT02533999|536315024|FG001|Overall Study|Lost to Follow-up|5|||
148683842|NCT02533999|536315023|FG000|Overall Study|Protocol Violation|3|||
148683843|NCT02533999|536315024|FG001|Overall Study|Protocol Violation|0|||
148683844|NCT02533999|536315023|FG000|Overall Study|Adverse Event|0|||
148683845|NCT02533999|536315024|FG001|Overall Study|Adverse Event|1|||
148683846|NCT02533999|536315023|FG000|Overall Study|Randomized but intervention not received|0|||
148683847|NCT02533999|536315024|FG001|Overall Study|Randomized but intervention not received|1|||
148683848|NCT03210259|536315025|FG000|12-Week Run-in Period|Adverse Event|1|||
148683849|NCT03210259|536315026|FG001|12-Week Run-in Period|Adverse Event|0|||
148683850|NCT03210259|536315027|FG002|12-Week Run-in Period|Adverse Event|0|||
148683851|NCT03210259|536315025|FG000|12-Week Run-in Period|Death|1|||
148683852|NCT03210259|536315026|FG001|12-Week Run-in Period|Death|0|||
148683853|NCT03210259|536315027|FG002|12-Week Run-in Period|Death|0|||
148683854|NCT03210259|536315025|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
148683855|NCT03210259|536315026|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
148683856|NCT03210259|536315027|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
148683857|NCT03210259|536315025|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
148683858|NCT03210259|536315026|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
148683859|NCT03210259|536315027|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
148683860|NCT03210259|536315025|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
148683861|NCT03210259|536315026|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
148683862|NCT03210259|536315027|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
148683863|NCT03210259|536315025|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
148683864|NCT03210259|536315026|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
148683865|NCT03210259|536315027|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
148683866|NCT03210259|536315025|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
149206490|NCT00511108|538223299|FG002|Overall Study|Withdrawal by Subject|3|||
149206491|NCT00511108|538223300|FG003|Overall Study|Withdrawal by Subject|2|||
148683867|NCT03210259|536315026|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
148948341|NCT02030041|537295746|FG002|Overall Study|Withdrawal by Subject|1|||
148948342|NCT01032837|537295748|FG000|Overall Study|Adverse event/internal illness|0|||
148948343|NCT01032837|537295749|FG001|Overall Study|Adverse event/internal illness|1|||
148948344|NCT01032837|537295750|FG002|Overall Study|Adverse event/internal illness|0|||
148948345|NCT01032837|537295751|FG003|Overall Study|Adverse event/internal illness|1|||
148948346|NCT01032837|537295748|FG000|Overall Study|Withdrew consent|0|||
148948347|NCT01032837|537295749|FG001|Overall Study|Withdrew consent|2|||
148948348|NCT01032837|537295750|FG002|Overall Study|Withdrew consent|0|||
148948349|NCT01032837|537295751|FG003|Overall Study|Withdrew consent|1|||
148948350|NCT01032837|537295748|FG000|Overall Study|Failed to return|0|||
148948351|NCT01032837|537295749|FG001|Overall Study|Failed to return|0|||
148948352|NCT01032837|537295750|FG002|Overall Study|Failed to return|1|||
148948353|NCT01032837|537295751|FG003|Overall Study|Failed to return|0|||
148948354|NCT01032837|537295748|FG000|Overall Study|Refused treatment|0|||
148948355|NCT01032837|537295749|FG001|Overall Study|Refused treatment|0|||
148948356|NCT01032837|537295750|FG002|Overall Study|Refused treatment|0|||
148948357|NCT01032837|537295751|FG003|Overall Study|Refused treatment|1|||
148948358|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
148948359|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
148948360|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
148948361|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
148948362|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
148948363|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
148948364|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
148948365|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
148948366|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
148948367|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
148948368|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
148948369|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
148948370|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
148948371|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
148948372|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
148948373|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
148948374|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
148948375|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
148948376|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
148948377|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
148948378|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
148948379|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
148948380|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
148948381|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
148948382|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
149206492|NCT02147691|538223303|FG000|Overall Study|Withdrawal by Subject|2|||
149206493|NCT02147691|538223304|FG001|Overall Study|Withdrawal by Subject|0|||
149206494|NCT02147691|538223303|FG000|Overall Study|Adverse Event|2|||
149206495|NCT02147691|538223304|FG001|Overall Study|Adverse Event|0|||
149206496|NCT02147691|538223303|FG000|Overall Study|Lost to Follow-up|0|||
149206497|NCT02147691|538223304|FG001|Overall Study|Lost to Follow-up|1|||
149206498|NCT01392742|538223307|FG000|Overall Study|Premature study termination|42|||
148948383|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
148948384|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
148948385|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
149206499|NCT01392742|538223307|FG000|Overall Study|Failure to return|35|||
149206500|NCT01392742|538223307|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
149206501|NCT01392742|538223307|FG000|Overall Study|Lost to Follow-up|34|||
149206502|NCT01392742|538223307|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
149206503|NCT01392742|538223307|FG000|Overall Study|ITR and Protocol deviation|1|||
149206504|NCT01392742|538223307|FG000|Overall Study|Adverse event/intercurrent illness|17|||
149206505|NCT01392742|538223307|FG000|Overall Study|Protocol Violation|14|||
149206506|NCT01392742|538223307|FG000|Overall Study|Other|3|||
149206507|NCT01392742|538223307|FG000|Overall Study|Missing information|13|||
149206508|NCT01998958|538223308|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206509|NCT01998958|538223309|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
149206510|NCT01998958|538223310|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206511|NCT01998958|538223311|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206512|NCT01998958|538223312|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206513|NCT01998958|538223313|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206514|NCT01998958|538223314|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206515|NCT01998958|538223315|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206516|NCT01998958|538223316|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
148948386|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
148948387|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
148948388|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
148948389|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
149206517|NCT01998958|538223317|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206518|NCT01998958|538223318|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206519|NCT01998958|538223319|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206520|NCT01998958|538223320|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206521|NCT01998958|538223321|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206522|NCT01998958|538223322|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206523|NCT01998958|538223323|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206524|NCT01998958|538223324|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206525|NCT01998958|538223325|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206526|NCT01998958|538223326|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206527|NCT01998958|538223327|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206528|NCT01998958|538223328|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206529|NCT01998958|538223329|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
148948390|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
148948391|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
148948392|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
148948393|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
148948394|NCT00843024|537295752|FG000|Single-blind Placebo Run-In Phase|Other|0|||
148948395|NCT00843024|537295753|FG001|Single-blind Placebo Run-In Phase|Other|1|||
148948396|NCT00843024|537295754|FG002|Single-blind Placebo Run-In Phase|Other|0|||
148948397|NCT00843024|537295755|FG003|Single-blind Placebo Run-In Phase|Other|0|||
148948398|NCT00843024|537295756|FG004|Single-blind Placebo Run-In Phase|Other|0|||
148948399|NCT00843024|537295757|FG005|Single-blind Placebo Run-In Phase|Other|0|||
148948400|NCT00843024|537295752|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
149206530|NCT01998958|538223330|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206531|NCT01998958|538223331|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206532|NCT01998958|538223332|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206533|NCT01998958|538223333|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206534|NCT01998958|538223334|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206535|NCT01998958|538223335|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206536|NCT01998958|538223336|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206537|NCT01998958|538223337|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206538|NCT01998958|538223338|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206539|NCT01998958|538223339|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
149206540|NCT01998958|538223308|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206541|NCT01998958|538223309|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
149206542|NCT01998958|538223310|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206543|NCT01998958|538223311|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206544|NCT01998958|538223312|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206545|NCT01998958|538223313|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206546|NCT01998958|538223314|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206547|NCT01998958|538223315|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206548|NCT01998958|538223316|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206549|NCT01998958|538223317|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206550|NCT01998958|538223318|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206551|NCT01998958|538223319|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206552|NCT01998958|538223320|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206553|NCT01998958|538223321|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206554|NCT01998958|538223322|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206555|NCT01998958|538223323|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206556|NCT01998958|538223324|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206557|NCT01998958|538223325|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206558|NCT01998958|538223326|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206559|NCT01998958|538223327|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206560|NCT01998958|538223328|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206561|NCT01998958|538223329|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206562|NCT01998958|538223330|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206563|NCT01998958|538223331|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206564|NCT01998958|538223332|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206565|NCT01998958|538223333|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206566|NCT01998958|538223334|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206567|NCT01998958|538223335|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206568|NCT01998958|538223336|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206569|NCT01998958|538223337|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206570|NCT01998958|538223338|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206571|NCT01998958|538223339|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
149206572|NCT01998958|538223308|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
149206573|NCT01998958|538223309|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
148948401|NCT00843024|537295753|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
148948402|NCT00843024|537295754|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
148948403|NCT00843024|537295755|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
148948404|NCT00843024|537295756|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
148948405|NCT00843024|537295757|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
149206574|NCT01998958|538223310|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
149206575|NCT01998958|538223311|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
149206576|NCT01998958|538223312|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
149206577|NCT01998958|538223313|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
149206578|NCT01998958|538223314|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
149206579|NCT01998958|538223315|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
149206580|NCT01998958|538223316|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
149206581|NCT01998958|538223317|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
149206582|NCT01998958|538223318|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
149206583|NCT01998958|538223319|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
149206584|NCT01998958|538223320|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
149206585|NCT01998958|538223321|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
149206586|NCT01998958|538223322|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
149206587|NCT01998958|538223323|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
149206588|NCT01998958|538223324|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
149206589|NCT01998958|538223325|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
149206590|NCT01998958|538223326|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
149206591|NCT01998958|538223327|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
149206592|NCT01998958|538223328|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
149206593|NCT01998958|538223329|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
149206594|NCT01998958|538223330|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
149206595|NCT01998958|538223331|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
149206596|NCT01998958|538223332|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
149206597|NCT01998958|538223333|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
149206598|NCT01998958|538223334|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
149206599|NCT01998958|538223335|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
149206600|NCT01998958|538223336|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
149206601|NCT01998958|538223337|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
149206602|NCT01998958|538223338|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
149206603|NCT01998958|538223339|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
149206604|NCT01998958|538223308|FG000|Period 1 (Panel A and B)|Other|1|||
149206605|NCT01998958|538223309|FG001|Period 1 (Panel A and B)|Other|0|||
149206606|NCT01998958|538223310|FG002|Period 1 (Panel A and B)|Other|0|||
149206607|NCT01998958|538223311|FG003|Period 1 (Panel A and B)|Other|0|||
149206608|NCT01998958|538223312|FG004|Period 1 (Panel A and B)|Other|0|||
149206609|NCT01998958|538223313|FG005|Period 1 (Panel A and B)|Other|0|||
149206610|NCT01998958|538223314|FG006|Period 1 (Panel A and B)|Other|0|||
149206611|NCT01998958|538223315|FG007|Period 1 (Panel A and B)|Other|0|||
149206612|NCT01998958|538223316|FG008|Period 1 (Panel A and B)|Other|0|||
149206613|NCT01998958|538223317|FG009|Period 1 (Panel A and B)|Other|0|||
149206614|NCT01998958|538223318|FG010|Period 1 (Panel A and B)|Other|0|||
149206615|NCT01998958|538223319|FG011|Period 1 (Panel A and B)|Other|0|||
149206616|NCT01998958|538223320|FG012|Period 1 (Panel A and B)|Other|0|||
149206617|NCT01998958|538223321|FG013|Period 1 (Panel A and B)|Other|0|||
149206618|NCT01998958|538223322|FG014|Period 1 (Panel A and B)|Other|0|||
149206619|NCT01998958|538223323|FG015|Period 1 (Panel A and B)|Other|0|||
149206620|NCT01998958|538223324|FG016|Period 1 (Panel A and B)|Other|0|||
149206621|NCT01998958|538223325|FG017|Period 1 (Panel A and B)|Other|0|||
149206622|NCT01998958|538223326|FG018|Period 1 (Panel A and B)|Other|0|||
149206623|NCT01998958|538223327|FG019|Period 1 (Panel A and B)|Other|0|||
149206624|NCT01998958|538223328|FG020|Period 1 (Panel A and B)|Other|0|||
149206625|NCT01998958|538223329|FG021|Period 1 (Panel A and B)|Other|0|||
149206626|NCT01998958|538223330|FG022|Period 1 (Panel A and B)|Other|0|||
149206627|NCT01998958|538223331|FG023|Period 1 (Panel A and B)|Other|0|||
149206628|NCT01998958|538223332|FG024|Period 1 (Panel A and B)|Other|0|||
148948406|NCT00843024|537295752|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
149206629|NCT01998958|538223333|FG025|Period 1 (Panel A and B)|Other|0|||
149206630|NCT01998958|538223334|FG026|Period 1 (Panel A and B)|Other|0|||
149206631|NCT01998958|538223335|FG027|Period 1 (Panel A and B)|Other|0|||
149206632|NCT01998958|538223336|FG028|Period 1 (Panel A and B)|Other|0|||
149206633|NCT01998958|538223337|FG029|Period 1 (Panel A and B)|Other|0|||
149206634|NCT01998958|538223338|FG030|Period 1 (Panel A and B)|Other|0|||
149206635|NCT01998958|538223339|FG031|Period 1 (Panel A and B)|Other|0|||
149206636|NCT01998958|538223308|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
149206637|NCT01998958|538223309|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
149206638|NCT01998958|538223310|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
149206639|NCT01998958|538223311|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
149206640|NCT01998958|538223312|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
149206641|NCT01998958|538223313|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
149206642|NCT01998958|538223314|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
149206643|NCT01998958|538223315|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
149206644|NCT01998958|538223316|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
149206645|NCT01998958|538223317|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
148948407|NCT00843024|537295753|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
148948408|NCT00843024|537295754|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
148948409|NCT00843024|537295755|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
148948410|NCT00843024|537295756|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
148948411|NCT00843024|537295757|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
148948412|NCT00843024|537295752|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
149206646|NCT01998958|538223318|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
149206647|NCT01998958|538223319|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
149206648|NCT01998958|538223320|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
149206649|NCT01998958|538223321|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
149206650|NCT01998958|538223322|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
149206651|NCT01998958|538223323|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
149206652|NCT01998958|538223324|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
149206653|NCT01998958|538223325|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
149206654|NCT01998958|538223326|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
149206655|NCT01998958|538223327|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
149206656|NCT01998958|538223328|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
149206657|NCT01998958|538223329|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
149206658|NCT01998958|538223330|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
149206659|NCT01998958|538223331|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
148948413|NCT00843024|537295753|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
149206660|NCT01998958|538223332|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
148948414|NCT00843024|537295754|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148948415|NCT00843024|537295755|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
149206661|NCT01998958|538223333|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
149206662|NCT01998958|538223334|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
149206663|NCT01998958|538223335|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
149206664|NCT01998958|538223336|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
149206665|NCT01998958|538223337|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
149206666|NCT01998958|538223338|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
149206667|NCT01998958|538223339|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
149206668|NCT01998958|538223308|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206669|NCT01998958|538223309|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206670|NCT01998958|538223310|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206671|NCT01998958|538223311|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206672|NCT01998958|538223312|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206673|NCT01998958|538223313|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206674|NCT01998958|538223314|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206675|NCT01998958|538223315|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206676|NCT01998958|538223316|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206677|NCT01998958|538223317|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206678|NCT01998958|538223318|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206679|NCT01998958|538223319|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206680|NCT01998958|538223320|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206681|NCT01998958|538223321|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206682|NCT01998958|538223322|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
149206683|NCT01998958|538223323|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206684|NCT01998958|538223324|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206685|NCT01998958|538223325|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206686|NCT01998958|538223326|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
149206687|NCT01998958|538223327|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206688|NCT01998958|538223328|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206689|NCT01998958|538223329|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206690|NCT01998958|538223330|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206691|NCT01998958|538223331|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206692|NCT01998958|538223332|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206693|NCT01998958|538223333|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206694|NCT01998958|538223334|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206695|NCT01998958|538223335|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206696|NCT01998958|538223336|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206697|NCT01998958|538223337|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206698|NCT01998958|538223338|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
149206699|NCT01998958|538223339|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
148948416|NCT00843024|537295756|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148948417|NCT00843024|537295757|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
148948418|NCT00843024|537295752|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
148948419|NCT00843024|537295753|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
148948420|NCT00843024|537295754|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
148948421|NCT00843024|537295755|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
148948422|NCT00843024|537295756|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
148948423|NCT00843024|537295757|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
148948424|NCT00843024|537295752|FG000|Double-blind Treatment Phase|Physician Decision|0|||
148948425|NCT00843024|537295753|FG001|Double-blind Treatment Phase|Physician Decision|0|||
148948426|NCT00843024|537295754|FG002|Double-blind Treatment Phase|Physician Decision|0|||
148948427|NCT00843024|537295755|FG003|Double-blind Treatment Phase|Physician Decision|3|||
148948428|NCT00843024|537295756|FG004|Double-blind Treatment Phase|Physician Decision|1|||
148948429|NCT00843024|537295757|FG005|Double-blind Treatment Phase|Physician Decision|1|||
148948430|NCT00843024|537295752|FG000|Double-blind Treatment Phase|Adverse Event|0|||
148948431|NCT00843024|537295753|FG001|Double-blind Treatment Phase|Adverse Event|0|||
148948432|NCT00843024|537295754|FG002|Double-blind Treatment Phase|Adverse Event|0|||
148948433|NCT00843024|537295755|FG003|Double-blind Treatment Phase|Adverse Event|0|||
148948434|NCT00843024|537295756|FG004|Double-blind Treatment Phase|Adverse Event|1|||
148948435|NCT00843024|537295757|FG005|Double-blind Treatment Phase|Adverse Event|1|||
148948436|NCT00843024|537295752|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
148948437|NCT00843024|537295753|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
148948438|NCT00843024|537295754|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
148948439|NCT00843024|537295755|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
149206700|NCT01998958|538223308|FG000|Open Label Phase (Optional)|Adverse Event|0|||
149206701|NCT01998958|538223309|FG001|Open Label Phase (Optional)|Adverse Event|0|||
148948440|NCT00843024|537295756|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
148948441|NCT00843024|537295757|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
148948442|NCT05201703|537295758|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
148948443|NCT05201703|537295759|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
148948444|NCT05201703|537295758|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
148948445|NCT05201703|537295759|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
148948446|NCT01737697|537295762|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
149206702|NCT01998958|538223310|FG002|Open Label Phase (Optional)|Adverse Event|0|||
149206703|NCT01998958|538223311|FG003|Open Label Phase (Optional)|Adverse Event|0|||
149206704|NCT01998958|538223312|FG004|Open Label Phase (Optional)|Adverse Event|0|||
149206705|NCT01998958|538223313|FG005|Open Label Phase (Optional)|Adverse Event|0|||
149206706|NCT01998958|538223314|FG006|Open Label Phase (Optional)|Adverse Event|0|||
149206707|NCT01998958|538223315|FG007|Open Label Phase (Optional)|Adverse Event|0|||
149206708|NCT01998958|538223316|FG008|Open Label Phase (Optional)|Adverse Event|0|||
148948447|NCT01737697|537295763|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
148948448|NCT01737697|537295764|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948449|NCT01737697|537295765|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
148948450|NCT01737697|537295766|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
148948451|NCT01737697|537295767|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948452|NCT01737697|537295768|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948453|NCT01737697|537295769|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948454|NCT01737697|537295770|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948455|NCT01737697|537295771|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948456|NCT01737697|537295772|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948457|NCT01737697|537295773|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948458|NCT01737697|537295774|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948459|NCT01737697|537295775|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948460|NCT01737697|537295776|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
148948461|NCT01737697|537295762|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
148948462|NCT01737697|537295763|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
148948463|NCT01737697|537295764|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
148948464|NCT01737697|537295765|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948465|NCT01737697|537295766|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948466|NCT01737697|537295767|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948467|NCT01737697|537295768|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948468|NCT01737697|537295769|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948469|NCT01737697|537295770|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948470|NCT01737697|537295771|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948471|NCT01737697|537295772|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948472|NCT01737697|537295773|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
149206709|NCT01998958|538223317|FG009|Open Label Phase (Optional)|Adverse Event|0|||
148948473|NCT01737697|537295774|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948474|NCT01737697|537295775|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948475|NCT01737697|537295776|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
148948476|NCT01737697|537295762|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948477|NCT01737697|537295763|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948478|NCT01737697|537295764|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948479|NCT01737697|537295765|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
149206710|NCT01998958|538223318|FG010|Open Label Phase (Optional)|Adverse Event|0|||
149206711|NCT01998958|538223319|FG011|Open Label Phase (Optional)|Adverse Event|0|||
148809187|NCT01189266|536777627|FG002|Overall Study|Withdrawal by Subject|1|||
148948480|NCT01737697|537295766|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948481|NCT01737697|537295767|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948482|NCT01737697|537295768|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948483|NCT01737697|537295769|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948484|NCT01737697|537295770|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948485|NCT01737697|537295771|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
149206712|NCT01998958|538223320|FG012|Open Label Phase (Optional)|Adverse Event|0|||
149206713|NCT01998958|538223321|FG013|Open Label Phase (Optional)|Adverse Event|0|||
149206714|NCT01998958|538223322|FG014|Open Label Phase (Optional)|Adverse Event|0|||
149206715|NCT01998958|538223323|FG015|Open Label Phase (Optional)|Adverse Event|0|||
149206716|NCT01998958|538223324|FG016|Open Label Phase (Optional)|Adverse Event|0|||
149206717|NCT01998958|538223325|FG017|Open Label Phase (Optional)|Adverse Event|0|||
149206718|NCT01998958|538223326|FG018|Open Label Phase (Optional)|Adverse Event|0|||
149206719|NCT01998958|538223327|FG019|Open Label Phase (Optional)|Adverse Event|0|||
149206720|NCT01998958|538223328|FG020|Open Label Phase (Optional)|Adverse Event|0|||
149206721|NCT01998958|538223329|FG021|Open Label Phase (Optional)|Adverse Event|0|||
149206722|NCT01998958|538223330|FG022|Open Label Phase (Optional)|Adverse Event|0|||
149206723|NCT01998958|538223331|FG023|Open Label Phase (Optional)|Adverse Event|1|||
149206724|NCT01998958|538223332|FG024|Open Label Phase (Optional)|Adverse Event|0|||
149206725|NCT01998958|538223333|FG025|Open Label Phase (Optional)|Adverse Event|0|||
149206726|NCT01998958|538223334|FG026|Open Label Phase (Optional)|Adverse Event|0|||
148683868|NCT03210259|536315027|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
148683869|NCT03210259|536315025|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
148683870|NCT03210259|536315026|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
148683871|NCT03210259|536315027|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
148683872|NCT03210259|536315025|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
148683873|NCT03210259|536315026|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
148683874|NCT03210259|536315027|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
148683875|NCT03210259|536315025|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
148683876|NCT03210259|536315026|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
148683877|NCT03210259|536315027|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
149206727|NCT01998958|538223335|FG027|Open Label Phase (Optional)|Adverse Event|0|||
149206728|NCT01998958|538223336|FG028|Open Label Phase (Optional)|Adverse Event|0|||
149206729|NCT01998958|538223337|FG029|Open Label Phase (Optional)|Adverse Event|0|||
149206730|NCT01998958|538223338|FG030|Open Label Phase (Optional)|Adverse Event|0|||
149206731|NCT01998958|538223339|FG031|Open Label Phase (Optional)|Adverse Event|0|||
149206732|NCT01998958|538223308|FG000|Open Label Phase (Optional)|Other|0|||
149206733|NCT01998958|538223309|FG001|Open Label Phase (Optional)|Other|0|||
149206734|NCT01998958|538223310|FG002|Open Label Phase (Optional)|Other|0|||
149206735|NCT01998958|538223311|FG003|Open Label Phase (Optional)|Other|0|||
149206736|NCT01998958|538223312|FG004|Open Label Phase (Optional)|Other|0|||
149206737|NCT01998958|538223313|FG005|Open Label Phase (Optional)|Other|0|||
149206738|NCT01998958|538223314|FG006|Open Label Phase (Optional)|Other|0|||
149206739|NCT01998958|538223315|FG007|Open Label Phase (Optional)|Other|0|||
149206740|NCT01998958|538223316|FG008|Open Label Phase (Optional)|Other|0|||
149206741|NCT01998958|538223317|FG009|Open Label Phase (Optional)|Other|0|||
149206742|NCT01998958|538223318|FG010|Open Label Phase (Optional)|Other|0|||
149206743|NCT01998958|538223319|FG011|Open Label Phase (Optional)|Other|0|||
149206744|NCT01998958|538223320|FG012|Open Label Phase (Optional)|Other|0|||
149206745|NCT01998958|538223321|FG013|Open Label Phase (Optional)|Other|0|||
149206746|NCT01998958|538223322|FG014|Open Label Phase (Optional)|Other|0|||
149206747|NCT01998958|538223323|FG015|Open Label Phase (Optional)|Other|0|||
149206748|NCT01998958|538223324|FG016|Open Label Phase (Optional)|Other|0|||
149206749|NCT01998958|538223325|FG017|Open Label Phase (Optional)|Other|0|||
149206750|NCT01998958|538223326|FG018|Open Label Phase (Optional)|Other|0|||
149206751|NCT01998958|538223327|FG019|Open Label Phase (Optional)|Other|0|||
149206752|NCT01998958|538223328|FG020|Open Label Phase (Optional)|Other|0|||
149206753|NCT01998958|538223329|FG021|Open Label Phase (Optional)|Other|0|||
149206754|NCT01998958|538223330|FG022|Open Label Phase (Optional)|Other|5|||
148683878|NCT03210259|536315025|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
148683879|NCT03210259|536315026|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
148683880|NCT03210259|536315027|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
148948486|NCT01737697|537295772|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948487|NCT01737697|537295773|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948488|NCT01737697|537295774|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948489|NCT01737697|537295775|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
149206755|NCT01998958|538223331|FG023|Open Label Phase (Optional)|Other|1|||
149206756|NCT01998958|538223332|FG024|Open Label Phase (Optional)|Other|0|||
149206757|NCT01998958|538223333|FG025|Open Label Phase (Optional)|Other|0|||
149206758|NCT01998958|538223334|FG026|Open Label Phase (Optional)|Other|0|||
149206759|NCT01998958|538223335|FG027|Open Label Phase (Optional)|Other|0|||
149206760|NCT01998958|538223336|FG028|Open Label Phase (Optional)|Other|0|||
149206761|NCT01998958|538223337|FG029|Open Label Phase (Optional)|Other|0|||
149206762|NCT01998958|538223338|FG030|Open Label Phase (Optional)|Other|0|||
149206763|NCT01998958|538223339|FG031|Open Label Phase (Optional)|Other|0|||
149206764|NCT01998958|538223308|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206765|NCT01998958|538223309|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206766|NCT01998958|538223310|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206767|NCT01998958|538223311|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206768|NCT01998958|538223312|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206769|NCT01998958|538223313|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
148948490|NCT01737697|537295776|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
148948491|NCT01737697|537295762|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948492|NCT01737697|537295763|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
148948493|NCT01737697|537295764|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948494|NCT01737697|537295765|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948495|NCT01737697|537295766|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
149206770|NCT01998958|538223314|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
148948496|NCT01737697|537295767|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948497|NCT01737697|537295768|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948498|NCT01737697|537295769|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948499|NCT01737697|537295770|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948500|NCT01737697|537295771|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948501|NCT01737697|537295772|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948502|NCT01737697|537295773|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948503|NCT01737697|537295774|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948504|NCT01737697|537295775|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948505|NCT01737697|537295776|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
148948506|NCT01737697|537295762|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948507|NCT01737697|537295763|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948508|NCT01737697|537295764|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948509|NCT01737697|537295765|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948510|NCT01737697|537295766|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
148948511|NCT01737697|537295767|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948512|NCT01737697|537295768|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948513|NCT01737697|537295769|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948514|NCT01737697|537295770|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948515|NCT01737697|537295771|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948516|NCT01737697|537295772|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948517|NCT01737697|537295773|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948518|NCT01737697|537295774|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948519|NCT01737697|537295775|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948520|NCT01737697|537295776|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
148948521|NCT01737697|537295762|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948522|NCT01737697|537295763|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
148948523|NCT01737697|537295764|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
148948524|NCT01737697|537295765|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
148948525|NCT01737697|537295766|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
148948526|NCT01737697|537295767|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948527|NCT01737697|537295768|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948528|NCT01737697|537295769|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948529|NCT01737697|537295770|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948530|NCT01737697|537295771|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948531|NCT01737697|537295772|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948532|NCT01737697|537295773|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948533|NCT01737697|537295774|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948534|NCT01737697|537295775|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948535|NCT01737697|537295776|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
148948536|NCT01737697|537295762|FG000|Subacute Phase|Adverse Event|0|||
148948537|NCT01737697|537295763|FG001|Subacute Phase|Adverse Event|0|||
148948538|NCT01737697|537295764|FG002|Subacute Phase|Adverse Event|0|||
148948539|NCT01737697|537295765|FG003|Subacute Phase|Adverse Event|0|||
148948540|NCT01737697|537295766|FG004|Subacute Phase|Adverse Event|0|||
148948541|NCT01737697|537295767|FG005|Subacute Phase|Adverse Event|1|||
148948542|NCT01737697|537295768|FG006|Subacute Phase|Adverse Event|1|||
148948543|NCT01737697|537295769|FG007|Subacute Phase|Adverse Event|1|||
148948544|NCT01737697|537295770|FG008|Subacute Phase|Adverse Event|1|||
148948545|NCT01737697|537295771|FG009|Subacute Phase|Adverse Event|1|||
148948546|NCT01737697|537295772|FG010|Subacute Phase|Adverse Event|4|||
148948547|NCT01737697|537295773|FG011|Subacute Phase|Adverse Event|1|||
148948548|NCT01737697|537295774|FG012|Subacute Phase|Adverse Event|1|||
148948549|NCT01737697|537295775|FG013|Subacute Phase|Adverse Event|0|||
148948550|NCT01737697|537295776|FG014|Subacute Phase|Adverse Event|0|||
148948551|NCT01737697|537295762|FG000|Subacute Phase|Withdrawal by Subject|0|||
148948552|NCT01737697|537295763|FG001|Subacute Phase|Withdrawal by Subject|0|||
149206771|NCT01998958|538223315|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
148948553|NCT01737697|537295764|FG002|Subacute Phase|Withdrawal by Subject|0|||
148948554|NCT01737697|537295765|FG003|Subacute Phase|Withdrawal by Subject|0|||
148948555|NCT01737697|537295766|FG004|Subacute Phase|Withdrawal by Subject|0|||
148948556|NCT01737697|537295767|FG005|Subacute Phase|Withdrawal by Subject|1|||
148948557|NCT01737697|537295768|FG006|Subacute Phase|Withdrawal by Subject|0|||
148948558|NCT01737697|537295769|FG007|Subacute Phase|Withdrawal by Subject|2|||
148948559|NCT01737697|537295770|FG008|Subacute Phase|Withdrawal by Subject|0|||
148948560|NCT01737697|537295771|FG009|Subacute Phase|Withdrawal by Subject|1|||
148948561|NCT01737697|537295772|FG010|Subacute Phase|Withdrawal by Subject|0|||
148948562|NCT01737697|537295773|FG011|Subacute Phase|Withdrawal by Subject|1|||
148948563|NCT01737697|537295774|FG012|Subacute Phase|Withdrawal by Subject|1|||
148948564|NCT01737697|537295775|FG013|Subacute Phase|Withdrawal by Subject|1|||
148948565|NCT01737697|537295776|FG014|Subacute Phase|Withdrawal by Subject|0|||
148948566|NCT01737697|537295762|FG000|Subacute Phase|Lost to Follow-up|0|||
148948567|NCT01737697|537295763|FG001|Subacute Phase|Lost to Follow-up|0|||
148948568|NCT01737697|537295764|FG002|Subacute Phase|Lost to Follow-up|0|||
148948569|NCT01737697|537295765|FG003|Subacute Phase|Lost to Follow-up|0|||
149016342|NCT04150029|537537906|FG001|Overall Study|Study Terminated by Sponsor|10|||
149016343|NCT04150029|537537905|FG000|Overall Study|Death|0|||
149016344|NCT04150029|537537906|FG001|Overall Study|Death|8|||
149016345|NCT04150029|537537905|FG000|Overall Study|Participant Decision|0|||
149016346|NCT04150029|537537906|FG001|Overall Study|Participant Decision|7|||
149016347|NCT04150029|537537905|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
149016348|NCT04150029|537537906|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
149206772|NCT01998958|538223316|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206773|NCT01998958|538223317|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
148683881|NCT05017493|536315030|FG000|Overall Study|Withdrawal by Subject|26|||
149016351|NCT03797326|537537912|FG000|Overall Study|Lost to Follow-up|1|||
149016352|NCT03797326|537537913|FG001|Overall Study|Lost to Follow-up|0|||
149016353|NCT03797326|537537914|FG002|Overall Study|Lost to Follow-up|0|||
149016354|NCT03797326|537537915|FG003|Overall Study|Lost to Follow-up|1|||
149016355|NCT03797326|537537916|FG004|Overall Study|Lost to Follow-up|0|||
149016356|NCT03797326|537537917|FG005|Overall Study|Lost to Follow-up|0|||
149016357|NCT03797326|537537918|FG006|Overall Study|Lost to Follow-up|0|||
149016358|NCT03797326|537537919|FG007|Overall Study|Lost to Follow-up|0|||
149016359|NCT03797326|537537912|FG000|Overall Study|Withdrawal by Subject|0|||
149016360|NCT03797326|537537913|FG001|Overall Study|Withdrawal by Subject|0|||
149016361|NCT03797326|537537914|FG002|Overall Study|Withdrawal by Subject|1|||
149016362|NCT03797326|537537915|FG003|Overall Study|Withdrawal by Subject|3|||
149016363|NCT03797326|537537916|FG004|Overall Study|Withdrawal by Subject|0|||
149016364|NCT03797326|537537917|FG005|Overall Study|Withdrawal by Subject|2|||
149016365|NCT03797326|537537918|FG006|Overall Study|Withdrawal by Subject|2|||
149016366|NCT03797326|537537919|FG007|Overall Study|Withdrawal by Subject|3|||
149016367|NCT03797326|537537912|FG000|Overall Study|Sponsor Decision|3|||
149016368|NCT03797326|537537913|FG001|Overall Study|Sponsor Decision|3|||
149016369|NCT03797326|537537914|FG002|Overall Study|Sponsor Decision|3|||
149206774|NCT01998958|538223318|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206775|NCT01998958|538223319|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206776|NCT01998958|538223320|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206777|NCT01998958|538223321|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
148683882|NCT05017493|536315031|FG001|Overall Study|Withdrawal by Subject|0|||
148683883|NCT05017493|536315030|FG000|Overall Study|Physician Decision|15|||
148683884|NCT05017493|536315031|FG001|Overall Study|Physician Decision|0|||
148948570|NCT01737697|537295766|FG004|Subacute Phase|Lost to Follow-up|0|||
148948571|NCT01737697|537295767|FG005|Subacute Phase|Lost to Follow-up|0|||
148948572|NCT01737697|537295768|FG006|Subacute Phase|Lost to Follow-up|0|||
148948573|NCT01737697|537295769|FG007|Subacute Phase|Lost to Follow-up|0|||
148948574|NCT01737697|537295770|FG008|Subacute Phase|Lost to Follow-up|0|||
148948575|NCT01737697|537295771|FG009|Subacute Phase|Lost to Follow-up|0|||
149016370|NCT03797326|537537915|FG003|Overall Study|Sponsor Decision|6|||
149016371|NCT03797326|537537916|FG004|Overall Study|Sponsor Decision|0|||
149206778|NCT01998958|538223322|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
148948576|NCT01737697|537295772|FG010|Subacute Phase|Lost to Follow-up|0|||
148948577|NCT01737697|537295773|FG011|Subacute Phase|Lost to Follow-up|0|||
148948578|NCT01737697|537295774|FG012|Subacute Phase|Lost to Follow-up|0|||
148948579|NCT01737697|537295775|FG013|Subacute Phase|Lost to Follow-up|0|||
149016372|NCT03797326|537537917|FG005|Overall Study|Sponsor Decision|3|||
149016373|NCT03797326|537537918|FG006|Overall Study|Sponsor Decision|3|||
149206779|NCT01998958|538223323|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
149016374|NCT03797326|537537919|FG007|Overall Study|Sponsor Decision|2|||
149016375|NCT03797326|537537912|FG000|Overall Study|Death|27|||
149016376|NCT03797326|537537913|FG001|Overall Study|Death|28|||
149016377|NCT03797326|537537914|FG002|Overall Study|Death|95|||
149016378|NCT03797326|537537915|FG003|Overall Study|Death|95|||
149016379|NCT03797326|537537916|FG004|Overall Study|Death|30|||
148948580|NCT01737697|537295776|FG014|Subacute Phase|Lost to Follow-up|1|||
149206780|NCT01998958|538223324|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206781|NCT01998958|538223325|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206782|NCT01998958|538223326|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206783|NCT01998958|538223327|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206784|NCT01998958|538223328|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206785|NCT01998958|538223329|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206786|NCT01998958|538223330|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
149206787|NCT01998958|538223331|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206788|NCT01998958|538223332|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206789|NCT01998958|538223333|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206790|NCT01998958|538223334|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206791|NCT01998958|538223335|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206792|NCT01998958|538223336|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206793|NCT01998958|538223337|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206794|NCT01998958|538223338|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206795|NCT01998958|538223339|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
149206796|NCT01998958|538223308|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206797|NCT01998958|538223309|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206798|NCT01998958|538223310|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206799|NCT01998958|538223311|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206800|NCT01998958|538223312|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206801|NCT01998958|538223313|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206802|NCT01998958|538223314|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206803|NCT01998958|538223315|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206804|NCT01998958|538223316|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206805|NCT01998958|538223317|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206806|NCT01998958|538223318|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206807|NCT01998958|538223319|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206808|NCT01998958|538223320|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
148683885|NCT05017493|536315030|FG000|Overall Study|Protocol Violation|81|||
148683886|NCT05017493|536315031|FG001|Overall Study|Protocol Violation|0|||
148683887|NCT03940586|536315032|FG000|Overall Study|Death|3|||
148683888|NCT03940586|536315033|FG001|Overall Study|Death|2|||
148683889|NCT03940586|536315034|FG002|Overall Study|Death|0|||
148683890|NCT03940586|536315032|FG000|Overall Study|Physician Decision|1|||
148683891|NCT03940586|536315033|FG001|Overall Study|Physician Decision|0|||
149206809|NCT01998958|538223321|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206810|NCT01998958|538223322|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206811|NCT01998958|538223323|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206812|NCT01998958|538223324|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206813|NCT01998958|538223325|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206814|NCT01998958|538223326|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206815|NCT01998958|538223327|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206816|NCT01998958|538223328|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206817|NCT01998958|538223329|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
149206818|NCT01998958|538223330|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
149206819|NCT01998958|538223331|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206820|NCT01998958|538223332|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206821|NCT01998958|538223333|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
149016380|NCT03797326|537537917|FG005|Overall Study|Death|96|||
149016381|NCT03797326|537537918|FG006|Overall Study|Death|97|||
149016382|NCT03797326|537537919|FG007|Overall Study|Death|98|||
149016383|NCT03797326|537537912|FG000|Overall Study|Enrolled in error|0|||
149016384|NCT03797326|537537913|FG001|Overall Study|Enrolled in error|0|||
149016385|NCT03797326|537537914|FG002|Overall Study|Enrolled in error|3|||
149016386|NCT03797326|537537915|FG003|Overall Study|Enrolled in error|2|||
149016387|NCT03797326|537537916|FG004|Overall Study|Enrolled in error|2|||
149016388|NCT03797326|537537917|FG005|Overall Study|Enrolled in error|1|||
149016389|NCT03797326|537537918|FG006|Overall Study|Enrolled in error|1|||
149016390|NCT03797326|537537919|FG007|Overall Study|Enrolled in error|0|||
149016391|NCT04908449|537537920|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
149016392|NCT04908449|537537921|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
149016393|NCT04908449|537537920|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
149016394|NCT04908449|537537921|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
149016395|NCT00147225|537537922|FG000|Overall Study|Withdrawal by Subject|1|||
149016396|NCT00147225|537537923|FG001|Overall Study|Withdrawal by Subject|0|||
149016397|NCT00147225|537537924|FG002|Overall Study|Withdrawal by Subject|1|||
149016398|NCT00147225|537537925|FG003|Overall Study|Withdrawal by Subject|0|||
149016399|NCT00147225|537537926|FG004|Overall Study|Withdrawal by Subject|0|||
149016400|NCT00147225|537537927|FG005|Overall Study|Withdrawal by Subject|1|||
149016401|NCT00147225|537537922|FG000|Overall Study|Adverse Event|0|||
149206822|NCT01998958|538223334|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
148948581|NCT01737697|537295762|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
149206823|NCT01998958|538223335|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206824|NCT01998958|538223336|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206825|NCT01998958|538223337|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206826|NCT01998958|538223338|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206827|NCT01998958|538223339|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
149206828|NCT01998958|538223308|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206829|NCT01998958|538223309|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206830|NCT01998958|538223310|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206831|NCT01998958|538223311|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206832|NCT01998958|538223312|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206833|NCT01998958|538223313|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206834|NCT01998958|538223314|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206835|NCT01998958|538223315|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206836|NCT01998958|538223316|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206837|NCT01998958|538223317|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206838|NCT01998958|538223318|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206839|NCT01998958|538223319|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
148948582|NCT01737697|537295763|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
148948583|NCT01737697|537295764|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
148948584|NCT01737697|537295765|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
148948585|NCT01737697|537295766|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
148948586|NCT01737697|537295767|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
148948587|NCT01737697|537295768|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
148948588|NCT01737697|537295769|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
148948589|NCT01737697|537295770|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
148948590|NCT01737697|537295771|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
149206840|NCT01998958|538223320|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206841|NCT01998958|538223321|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206842|NCT01998958|538223322|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206843|NCT01998958|538223323|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
148948591|NCT01737697|537295772|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
149016402|NCT00147225|537537923|FG001|Overall Study|Adverse Event|0|||
149016403|NCT00147225|537537924|FG002|Overall Study|Adverse Event|1|||
149016404|NCT00147225|537537925|FG003|Overall Study|Adverse Event|1|||
149016405|NCT00147225|537537926|FG004|Overall Study|Adverse Event|0|||
149016406|NCT00147225|537537927|FG005|Overall Study|Adverse Event|0|||
149016407|NCT00147225|537537922|FG000|Overall Study|Screen Failure|0|||
149206844|NCT01998958|538223324|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206845|NCT01998958|538223325|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206846|NCT01998958|538223326|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206847|NCT01998958|538223327|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206848|NCT01998958|538223328|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206849|NCT01998958|538223329|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
149206850|NCT01998958|538223330|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
149206851|NCT01998958|538223331|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
149206852|NCT01998958|538223332|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206853|NCT01998958|538223333|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206854|NCT01998958|538223334|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206855|NCT01998958|538223335|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206856|NCT01998958|538223336|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206857|NCT01998958|538223337|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206858|NCT01998958|538223338|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206859|NCT01998958|538223339|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
149206860|NCT02432703|538223340|FG000|Overall Study|Adverse Event|1|||
149206861|NCT02432703|538223341|FG001|Overall Study|Adverse Event|4|||
149206862|NCT02432703|538223340|FG000|Overall Study|Lack of Efficacy|1|||
149206863|NCT02432703|538223341|FG001|Overall Study|Lack of Efficacy|0|||
149206864|NCT02432703|538223340|FG000|Overall Study|Lost to Follow-up|5|||
149206865|NCT02432703|538223341|FG001|Overall Study|Lost to Follow-up|3|||
149206866|NCT02432703|538223340|FG000|Overall Study|Withdrawal by Subject|9|||
149206867|NCT02432703|538223341|FG001|Overall Study|Withdrawal by Subject|6|||
149206868|NCT02432703|538223340|FG000|Overall Study|Other|6|||
149206869|NCT02432703|538223341|FG001|Overall Study|Other|5|||
149206870|NCT00673894|538223344|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
149206871|NCT00673894|538223345|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
149206872|NCT00673894|538223344|FG000|First Intervention 4 Weeks|Adverse Event|1|||
148683892|NCT03940586|536315034|FG002|Overall Study|Physician Decision|1|||
148683893|NCT03940586|536315032|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
148683894|NCT03940586|536315033|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
148683895|NCT03940586|536315034|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
148683896|NCT03940586|536315032|FG000|Overall Study|Not Treated|0|||
148683897|NCT03940586|536315033|FG001|Overall Study|Not Treated|2|||
148683898|NCT03940586|536315034|FG002|Overall Study|Not Treated|0|||
148683899|NCT02006147|536315035|FG000|Overall Study|Protocol Violation|1|||
148683900|NCT02006147|536315036|FG001|Overall Study|Protocol Violation|1|||
148683901|NCT02006147|536315037|FG002|Overall Study|Protocol Violation|0|||
148683902|NCT02006147|536315038|FG003|Overall Study|Protocol Violation|0|||
148683903|NCT02006147|536315035|FG000|Overall Study|Withdrawal by Subject|0|||
148683904|NCT02006147|536315036|FG001|Overall Study|Withdrawal by Subject|1|||
148683905|NCT02006147|536315037|FG002|Overall Study|Withdrawal by Subject|0|||
148683906|NCT02006147|536315038|FG003|Overall Study|Withdrawal by Subject|0|||
148683907|NCT02006147|536315035|FG000|Overall Study|Withdrawal by Sponsor|1|||
148683908|NCT02006147|536315036|FG001|Overall Study|Withdrawal by Sponsor|0|||
148683909|NCT02006147|536315037|FG002|Overall Study|Withdrawal by Sponsor|0|||
149206873|NCT00673894|538223345|FG001|First Intervention 4 Weeks|Adverse Event|0|||
149206874|NCT02193828|538223346|FG000|Overall Study|Withdrawal by Subject|0|||
149206875|NCT02193828|538223347|FG001|Overall Study|Withdrawal by Subject|0|||
149206876|NCT02193828|538223348|FG002|Overall Study|Withdrawal by Subject|1|||
148683910|NCT02006147|536315038|FG003|Overall Study|Withdrawal by Sponsor|0|||
148683911|NCT00345683|536315039|FG000|Overall Study|Lost to Follow-up|19|||
148948592|NCT01737697|537295773|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
148948593|NCT01737697|537295774|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
148948594|NCT01737697|537295775|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
148948595|NCT01737697|537295776|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
148948596|NCT01737697|537295762|FG000|Subacute Phase|Protocol Violation|0|||
148948597|NCT01737697|537295763|FG001|Subacute Phase|Protocol Violation|0|||
148948598|NCT01737697|537295764|FG002|Subacute Phase|Protocol Violation|0|||
148948599|NCT01737697|537295765|FG003|Subacute Phase|Protocol Violation|0|||
148948600|NCT01737697|537295766|FG004|Subacute Phase|Protocol Violation|0|||
148948601|NCT01737697|537295767|FG005|Subacute Phase|Protocol Violation|1|||
148948602|NCT01737697|537295768|FG006|Subacute Phase|Protocol Violation|0|||
148948603|NCT01737697|537295769|FG007|Subacute Phase|Protocol Violation|0|||
148948604|NCT01737697|537295770|FG008|Subacute Phase|Protocol Violation|0|||
148948605|NCT01737697|537295771|FG009|Subacute Phase|Protocol Violation|0|||
148948606|NCT01737697|537295772|FG010|Subacute Phase|Protocol Violation|1|||
148948607|NCT01737697|537295773|FG011|Subacute Phase|Protocol Violation|0|||
148948608|NCT01737697|537295774|FG012|Subacute Phase|Protocol Violation|0|||
148948609|NCT01737697|537295775|FG013|Subacute Phase|Protocol Violation|0|||
148948610|NCT01737697|537295776|FG014|Subacute Phase|Protocol Violation|0|||
148948611|NCT01737697|537295762|FG000|Subacute Phase|Physician Decision|0|||
148948612|NCT01737697|537295763|FG001|Subacute Phase|Physician Decision|0|||
148948613|NCT01737697|537295764|FG002|Subacute Phase|Physician Decision|0|||
148948614|NCT01737697|537295765|FG003|Subacute Phase|Physician Decision|0|||
148948615|NCT01737697|537295766|FG004|Subacute Phase|Physician Decision|0|||
148948616|NCT01737697|537295767|FG005|Subacute Phase|Physician Decision|0|||
148948617|NCT01737697|537295768|FG006|Subacute Phase|Physician Decision|0|||
149206877|NCT02193828|538223349|FG003|Overall Study|Withdrawal by Subject|1|||
149206878|NCT04046341|538223350|FG000|Overall Study|Lost to Follow-up|2|||
149206879|NCT04046341|538223350|FG000|Overall Study|Withdrawal by Subject|1|||
149206880|NCT00405652|538223351|FG000|Overall Study|Adverse Event|4|||
149206881|NCT05109702|538223353|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
149206882|NCT05109702|538223354|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
149206883|NCT05109702|538223355|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
149206884|NCT05109702|538223353|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
149206885|NCT05109702|538223354|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
149206886|NCT05109702|538223355|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
149206887|NCT05109702|538223353|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
149206888|NCT05109702|538223354|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
149206889|NCT05109702|538223355|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
149206890|NCT05109702|538223353|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
149206891|NCT05109702|538223354|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
149206892|NCT05109702|538223355|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
149206893|NCT05109702|538223353|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
149206894|NCT05109702|538223354|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
149206895|NCT05109702|538223355|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
149206896|NCT01392378|538223358|FG000|Infant Series|Adverse Event|0|||
149206897|NCT01392378|538223359|FG001|Infant Series|Adverse Event|0|||
149206898|NCT01392378|538223360|FG002|Infant Series|Adverse Event|0|||
149206899|NCT01392378|538223361|FG003|Infant Series|Adverse Event|1|||
149206900|NCT01392378|538223362|FG004|Infant Series|Adverse Event|0|||
149206901|NCT01392378|538223358|FG000|Infant Series|Lost to Follow-up|0|||
149206902|NCT01392378|538223359|FG001|Infant Series|Lost to Follow-up|0|||
148948618|NCT01737697|537295769|FG007|Subacute Phase|Physician Decision|0|||
148948619|NCT01737697|537295770|FG008|Subacute Phase|Physician Decision|1|||
148948620|NCT01737697|537295771|FG009|Subacute Phase|Physician Decision|0|||
148948621|NCT01737697|537295772|FG010|Subacute Phase|Physician Decision|0|||
148948622|NCT01737697|537295773|FG011|Subacute Phase|Physician Decision|0|||
148948623|NCT01737697|537295774|FG012|Subacute Phase|Physician Decision|0|||
148948624|NCT01737697|537295775|FG013|Subacute Phase|Physician Decision|0|||
148948625|NCT01737697|537295776|FG014|Subacute Phase|Physician Decision|0|||
148948626|NCT01737697|537295762|FG000|Subacute Phase|Death|0|||
148948627|NCT01737697|537295763|FG001|Subacute Phase|Death|0|||
149206903|NCT01392378|538223360|FG002|Infant Series|Lost to Follow-up|0|||
149206904|NCT01392378|538223361|FG003|Infant Series|Lost to Follow-up|1|||
149206905|NCT01392378|538223362|FG004|Infant Series|Lost to Follow-up|0|||
149206906|NCT01392378|538223358|FG000|Infant Series|Protocol Violation|0|||
148948628|NCT01737697|537295764|FG002|Subacute Phase|Death|0|||
149206907|NCT01392378|538223359|FG001|Infant Series|Protocol Violation|1|||
149206908|NCT01392378|538223360|FG002|Infant Series|Protocol Violation|0|||
148948629|NCT01737697|537295765|FG003|Subacute Phase|Death|0|||
149206909|NCT01392378|538223361|FG003|Infant Series|Protocol Violation|0|||
149206910|NCT01392378|538223362|FG004|Infant Series|Protocol Violation|0|||
148683912|NCT00345683|536315040|FG001|Overall Study|Lost to Follow-up|7|||
148683913|NCT00345683|536315039|FG000|Overall Study|Other|6|||
148683914|NCT00345683|536315040|FG001|Overall Study|Other|2|||
148948630|NCT01737697|537295766|FG004|Subacute Phase|Death|0|||
148948631|NCT01737697|537295767|FG005|Subacute Phase|Death|0|||
148948632|NCT01737697|537295768|FG006|Subacute Phase|Death|0|||
148948633|NCT01737697|537295769|FG007|Subacute Phase|Death|0|||
148683915|NCT01154127|536315047|FG000|Period 1 (21 Days)|Adverse Event|3|||
148683916|NCT01154127|536315048|FG001|Period 1 (21 Days)|Adverse Event|4|||
148683917|NCT01154127|536315047|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
148683918|NCT01154127|536315048|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
148683919|NCT01154127|536315047|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
148683920|NCT01154127|536315048|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
148683921|NCT01154127|536315047|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
148683922|NCT01154127|536315048|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
148683923|NCT01154127|536315047|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
148683924|NCT01154127|536315048|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
148683925|NCT01697449|536315049|FG000|Overall Study|Disease progression|47|||
148683926|NCT01697449|536315049|FG000|Overall Study|Adverse Event|7|||
148683927|NCT01697449|536315049|FG000|Overall Study|Lost to Follow-up|5|||
148683928|NCT01697449|536315049|FG000|Overall Study|Withdrawal by Subject|2|||
148683929|NCT01697449|536315049|FG000|Overall Study|Physician Decision|1|||
148683930|NCT01697449|536315049|FG000|Overall Study|Death|2|||
148683931|NCT01697449|536315049|FG000|Overall Study|Other|1|||
148683932|NCT01697449|536315049|FG000|Overall Study|Missing|25|||
148683933|NCT01169844|536315050|FG000|Overall Study|Adverse Event|0|||
148683934|NCT01169844|536315051|FG001|Overall Study|Adverse Event|1|||
148683935|NCT01169844|536315050|FG000|Overall Study|Patient withdrew consent|4|||
148683936|NCT01169844|536315051|FG001|Overall Study|Patient withdrew consent|0|||
148683937|NCT01169844|536315050|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148683938|NCT01169844|536315051|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148683939|NCT01337050|536315055|FG000|Overall Study|Death|0|||
148683940|NCT01337050|536315056|FG001|Overall Study|Death|0|||
148683941|NCT01337050|536315057|FG002|Overall Study|Death|4|||
148683942|NCT01337050|536315055|FG000|Overall Study|Other|4|||
148683943|NCT01337050|536315056|FG001|Overall Study|Other|6|||
148683944|NCT01337050|536315057|FG002|Overall Study|Other|8|||
148683945|NCT01337050|536315055|FG000|Overall Study|Participants refused further follow-up|0|||
148683946|NCT01337050|536315056|FG001|Overall Study|Participants refused further follow-up|7|||
148683947|NCT01337050|536315057|FG002|Overall Study|Participants refused further follow-up|7|||
148683948|NCT00003102|536315058|FG000|Overall Study|Physician Decision|1|||
148683949|NCT00003102|536315059|FG001|Overall Study|Physician Decision|1|||
148683950|NCT00003102|536315060|FG002|Overall Study|Physician Decision|0|||
148683951|NCT00003102|536315058|FG000|Overall Study|Progressive Disease|0|||
148683952|NCT00003102|536315059|FG001|Overall Study|Progressive Disease|1|||
148683953|NCT00003102|536315060|FG002|Overall Study|Progressive Disease|0|||
148683954|NCT00003102|536315058|FG000|Overall Study|Adverse Event|0|||
148683955|NCT00003102|536315059|FG001|Overall Study|Adverse Event|1|||
148683956|NCT00003102|536315060|FG002|Overall Study|Adverse Event|1|||
148683957|NCT00003102|536315058|FG000|Overall Study|Death|0|||
148683958|NCT00003102|536315059|FG001|Overall Study|Death|0|||
148683959|NCT00003102|536315060|FG002|Overall Study|Death|1|||
148683960|NCT01559818|536315063|FG000|Overall Study|Physician Decision|1|||
148683961|NCT01559818|536315063|FG000|Overall Study|Pregnancy|1|||
148683962|NCT01559818|536315063|FG000|Overall Study|Study terminated by Sponsor|4|||
148683963|NCT01559818|536315063|FG000|Overall Study|Withdrawal by Subject|1|||
148683964|NCT00096486|536315064|FG000|Overall Study|Withdrawal by Subject|0|||
148683965|NCT00096486|536315065|FG001|Overall Study|Withdrawal by Subject|0|||
148683966|NCT00096486|536315066|FG002|Overall Study|Withdrawal by Subject|1|||
148683967|NCT00096486|536315067|FG003|Overall Study|Withdrawal by Subject|1|||
148683968|NCT00096486|536315064|FG000|Overall Study|Not Treated|0|||
148683969|NCT00096486|536315065|FG001|Overall Study|Not Treated|0|||
148683970|NCT00096486|536315066|FG002|Overall Study|Not Treated|1|||
148683971|NCT00096486|536315067|FG003|Overall Study|Not Treated|1|||
148683972|NCT04071626|536315068|FG000|Overall Study|Withdrawal by Subject|1|||
148683973|NCT04071626|536315069|FG001|Overall Study|Withdrawal by Subject|1|||
148683974|NCT04071626|536315068|FG000|Overall Study|Protocol Violation|0|||
148683975|NCT04071626|536315069|FG001|Overall Study|Protocol Violation|1|||
148683976|NCT00529568|536315070|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
148683977|NCT00529568|536315071|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
148683978|NCT00529568|536315072|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
148683979|NCT00529568|536315070|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
148683980|NCT00529568|536315071|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
148683981|NCT00529568|536315072|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
148683982|NCT00529568|536315070|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
148683983|NCT00529568|536315071|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
148683984|NCT00529568|536315072|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
148683985|NCT00529568|536315070|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
148683986|NCT00529568|536315071|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
148683987|NCT00529568|536315072|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
148683988|NCT00529568|536315070|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
148948634|NCT01737697|537295770|FG008|Subacute Phase|Death|0|||
148948635|NCT01737697|537295771|FG009|Subacute Phase|Death|0|||
149206911|NCT01392378|538223358|FG000|Infant Series|Withdrawal by Parent|4|||
149206912|NCT01392378|538223359|FG001|Infant Series|Withdrawal by Parent|1|||
149206913|NCT01392378|538223360|FG002|Infant Series|Withdrawal by Parent|0|||
149206914|NCT01392378|538223361|FG003|Infant Series|Withdrawal by Parent|0|||
149206915|NCT01392378|538223362|FG004|Infant Series|Withdrawal by Parent|0|||
149206916|NCT01392378|538223358|FG000|After Infant Series|Lost to Follow-up|0|||
149206917|NCT01392378|538223359|FG001|After Infant Series|Lost to Follow-up|0|||
149206918|NCT01392378|538223360|FG002|After Infant Series|Lost to Follow-up|1|||
149206919|NCT01392378|538223361|FG003|After Infant Series|Lost to Follow-up|0|||
149206920|NCT01392378|538223362|FG004|After Infant Series|Lost to Follow-up|0|||
149206921|NCT01392378|538223358|FG000|After Infant Series|Withdrawal by Parent|0|||
149206922|NCT01392378|538223359|FG001|After Infant Series|Withdrawal by Parent|1|||
149206923|NCT01392378|538223360|FG002|After Infant Series|Withdrawal by Parent|1|||
149206924|NCT01392378|538223361|FG003|After Infant Series|Withdrawal by Parent|0|||
149206925|NCT01392378|538223362|FG004|After Infant Series|Withdrawal by Parent|1|||
149206926|NCT01392378|538223358|FG000|Toddler Dose|Lost to Follow-up|0|||
149206927|NCT01392378|538223359|FG001|Toddler Dose|Lost to Follow-up|0|||
149206928|NCT01392378|538223360|FG002|Toddler Dose|Lost to Follow-up|0|||
149206929|NCT01392378|538223361|FG003|Toddler Dose|Lost to Follow-up|1|||
149206930|NCT01392378|538223362|FG004|Toddler Dose|Lost to Follow-up|0|||
149206931|NCT01392378|538223358|FG000|Toddler Dose|Withdrawal by Parent|0|||
149206932|NCT01392378|538223359|FG001|Toddler Dose|Withdrawal by Parent|1|||
149206933|NCT01392378|538223360|FG002|Toddler Dose|Withdrawal by Parent|0|||
149206934|NCT01392378|538223361|FG003|Toddler Dose|Withdrawal by Parent|1|||
149016408|NCT00147225|537537923|FG001|Overall Study|Screen Failure|0|||
149016409|NCT00147225|537537924|FG002|Overall Study|Screen Failure|0|||
149016410|NCT00147225|537537925|FG003|Overall Study|Screen Failure|0|||
149016411|NCT00147225|537537926|FG004|Overall Study|Screen Failure|1|||
149016412|NCT00147225|537537927|FG005|Overall Study|Screen Failure|0|||
149016413|NCT00147225|537537922|FG000|Overall Study|Chemotherapy Changed|0|||
149016414|NCT00147225|537537923|FG001|Overall Study|Chemotherapy Changed|0|||
149016415|NCT00147225|537537924|FG002|Overall Study|Chemotherapy Changed|0|||
149016416|NCT00147225|537537925|FG003|Overall Study|Chemotherapy Changed|0|||
149016417|NCT00147225|537537926|FG004|Overall Study|Chemotherapy Changed|0|||
149016418|NCT00147225|537537927|FG005|Overall Study|Chemotherapy Changed|1|||
149016419|NCT01032044|537537928|FG000|Overall Study|Protocol Violation|14|||
149206935|NCT01392378|538223362|FG004|Toddler Dose|Withdrawal by Parent|1|||
149206936|NCT02322411|538223363|FG000|Overall Study|Lost to Follow-up|4|||
149206937|NCT02322411|538223364|FG001|Overall Study|Lost to Follow-up|7|||
149206938|NCT02322411|538223363|FG000|Overall Study|Withdrawal by Subject|1|||
149206939|NCT02322411|538223364|FG001|Overall Study|Withdrawal by Subject|0|||
149206940|NCT02671461|538223369|FG000|Treatment|Adverse Event|0|||
149206941|NCT02671461|538223370|FG001|Treatment|Adverse Event|0|||
149206942|NCT02671461|538223371|FG002|Treatment|Adverse Event|1|||
149206943|NCT02671461|538223369|FG000|Treatment|Administrative Reason by Sponsor|1|||
149206944|NCT02671461|538223370|FG001|Treatment|Administrative Reason by Sponsor|3|||
149206945|NCT02671461|538223371|FG002|Treatment|Administrative Reason by Sponsor|4|||
149206946|NCT02671461|538223369|FG000|Treatment|Randomized, not treated|1|||
149206947|NCT02671461|538223370|FG001|Treatment|Randomized, not treated|0|||
149206948|NCT02671461|538223371|FG002|Treatment|Randomized, not treated|0|||
149206949|NCT02671461|538223369|FG000|Follow-up|Withdrawal by Subject|1|||
149206950|NCT02671461|538223370|FG001|Follow-up|Withdrawal by Subject|0|||
149206951|NCT02671461|538223371|FG002|Follow-up|Withdrawal by Subject|0|||
149206952|NCT02671461|538223369|FG000|Follow-up|Lost to Follow-up|0|||
149206953|NCT02671461|538223370|FG001|Follow-up|Lost to Follow-up|0|||
149206954|NCT02671461|538223371|FG002|Follow-up|Lost to Follow-up|1|||
149206955|NCT02671461|538223369|FG000|Follow-up|Administrative Reason by Sponsor|0|||
149206956|NCT02671461|538223370|FG001|Follow-up|Administrative Reason by Sponsor|1|||
149206957|NCT02671461|538223371|FG002|Follow-up|Administrative Reason by Sponsor|0|||
149206958|NCT01412060|538223372|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
149206959|NCT01412060|538223373|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
149206960|NCT01412060|538223374|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
149206961|NCT01412060|538223372|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
149206962|NCT01412060|538223373|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
149206963|NCT01412060|538223374|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
148809188|NCT01189266|536777625|FG000|Overall Study|Patient refuses further therapy|1|||
148809189|NCT01189266|536777626|FG001|Overall Study|Patient refuses further therapy|0|||
148809190|NCT01189266|536777627|FG002|Overall Study|Patient refuses further therapy|7|||
148809191|NCT01189266|536777625|FG000|Overall Study|No treatment|0|||
149206964|NCT01412060|538223372|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
149206965|NCT01412060|538223373|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
149206966|NCT01412060|538223374|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
149206967|NCT01412060|538223372|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
149016420|NCT01032044|537537929|FG001|Overall Study|Protocol Violation|8|||
149016421|NCT01032044|537537928|FG000|Overall Study|Adverse Event|0|||
149206968|NCT01412060|538223373|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
149206969|NCT01412060|538223374|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
149206970|NCT01412060|538223372|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
149206971|NCT01412060|538223373|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
149206972|NCT01412060|538223374|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
149206973|NCT01412060|538223372|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
149206974|NCT01412060|538223373|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
149206975|NCT01412060|538223374|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
149206976|NCT01412060|538223372|FG000|Period Between RIP and SP|Adverse Event|4|||
149206977|NCT01412060|538223373|FG001|Period Between RIP and SP|Adverse Event|0|||
149206978|NCT01412060|538223374|FG002|Period Between RIP and SP|Adverse Event|0|||
149206979|NCT01412060|538223372|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
149206980|NCT01412060|538223373|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
149206981|NCT01412060|538223374|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
149206982|NCT01412060|538223372|FG000|Period Between RIP and SP|Protocol Violation|2|||
149206983|NCT01412060|538223373|FG001|Period Between RIP and SP|Protocol Violation|0|||
149206984|NCT01412060|538223374|FG002|Period Between RIP and SP|Protocol Violation|0|||
149206985|NCT01412060|538223372|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
149206986|NCT01412060|538223373|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
149206987|NCT01412060|538223374|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
149206988|NCT01412060|538223372|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
149206989|NCT01412060|538223373|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
149206990|NCT01412060|538223374|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
149206991|NCT01412060|538223372|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
149206992|NCT01412060|538223373|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
149206993|NCT01412060|538223374|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
149206994|NCT01412060|538223372|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
149206995|NCT01412060|538223373|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
149206996|NCT01412060|538223374|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
149206997|NCT01412060|538223372|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
149206998|NCT01412060|538223373|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
149206999|NCT01412060|538223374|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
149207000|NCT01412060|538223372|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
149207001|NCT01412060|538223373|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
149207002|NCT01412060|538223374|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
149207003|NCT01412060|538223372|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
149207004|NCT01412060|538223373|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
149207005|NCT01412060|538223374|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
149207006|NCT01412060|538223372|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
149207007|NCT01412060|538223373|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
149207008|NCT01412060|538223374|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
149207009|NCT01412060|538223372|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
149207010|NCT01412060|538223373|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
149207011|NCT01412060|538223374|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
149207012|NCT01412060|538223372|FG000|Period Between SP and DBP|Protocol Violation|2|||
149207013|NCT01412060|538223373|FG001|Period Between SP and DBP|Protocol Violation|0|||
149207014|NCT01412060|538223374|FG002|Period Between SP and DBP|Protocol Violation|0|||
149207015|NCT01412060|538223372|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
149207016|NCT01412060|538223373|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
149207017|NCT01412060|538223374|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
149207018|NCT01412060|538223372|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
149207019|NCT01412060|538223373|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
149207020|NCT01412060|538223374|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
149207021|NCT01412060|538223372|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
149207022|NCT01412060|538223373|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
149207023|NCT01412060|538223374|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
149207024|NCT01412060|538223372|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
149207025|NCT01412060|538223373|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
149207026|NCT01412060|538223374|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
149207027|NCT01412060|538223372|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
149207028|NCT01412060|538223373|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
149207029|NCT01412060|538223374|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
149207030|NCT01412060|538223372|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
148809192|NCT01189266|536777626|FG001|Overall Study|No treatment|0|||
148948636|NCT01737697|537295772|FG010|Subacute Phase|Death|1|||
148948637|NCT01737697|537295773|FG011|Subacute Phase|Death|0|||
148948638|NCT01737697|537295774|FG012|Subacute Phase|Death|0|||
148948639|NCT01737697|537295775|FG013|Subacute Phase|Death|0|||
148948640|NCT01737697|537295776|FG014|Subacute Phase|Death|0|||
148948641|NCT01866930|537295778|FG000|Treatment Period|Other|1|||
148948642|NCT01866930|537295779|FG001|Treatment Period|Other|0|||
148948643|NCT01866930|537295778|FG000|Treatment Period|Death|0|||
148948644|NCT01866930|537295779|FG001|Treatment Period|Death|2|||
148948645|NCT01866930|537295778|FG000|Treatment Period|Poor/non compliance|0|||
148948646|NCT01866930|537295779|FG001|Treatment Period|Poor/non compliance|2|||
148948647|NCT01866930|537295778|FG000|Treatment Period|No longer meets study criteria|0|||
148948648|NCT01866930|537295779|FG001|Treatment Period|No longer meets study criteria|1|||
148948649|NCT01866930|537295778|FG000|Treatment Period|Withdrawal by Subject|2|||
148948650|NCT01866930|537295779|FG001|Treatment Period|Withdrawal by Subject|8|||
148948651|NCT01866930|537295778|FG000|Treatment Period|Lack of Efficacy|1|||
148948652|NCT01866930|537295779|FG001|Treatment Period|Lack of Efficacy|9|||
149207031|NCT01412060|538223373|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
149207032|NCT01412060|538223374|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
149207033|NCT01412060|538223372|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
149207034|NCT01412060|538223373|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
149207035|NCT01412060|538223374|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
149207036|NCT01412060|538223372|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
148809193|NCT01189266|536777627|FG002|Overall Study|No treatment|1|||
148809194|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
148809195|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
148809196|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
148809197|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
148948653|NCT01866930|537295778|FG000|Treatment Period|Adverse Event|4|||
148948654|NCT01866930|537295779|FG001|Treatment Period|Adverse Event|12|||
148948655|NCT01866930|537295778|FG000|Treatment Period|Lost to Follow-up|1|||
148948656|NCT01866930|537295779|FG001|Treatment Period|Lost to Follow-up|1|||
148948657|NCT01866930|537295778|FG000|Follow-up Period|Lost to Follow-up|1|||
148948658|NCT01866930|537295779|FG001|Follow-up Period|Lost to Follow-up|1|||
148948659|NCT01866930|537295778|FG000|Follow-up Period|Other|1|||
149016422|NCT01032044|537537929|FG001|Overall Study|Adverse Event|1|||
149207037|NCT01412060|538223373|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
149207038|NCT01412060|538223374|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
149207039|NCT01412060|538223372|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
149207040|NCT01412060|538223373|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
149207041|NCT01412060|538223374|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
149207042|NCT01412060|538223372|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
149207043|NCT01412060|538223373|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
149207044|NCT01412060|538223374|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
149207045|NCT00004732|538223376|FG000|Overall Study|Withdrawal by Subject|36|||
149207046|NCT00004732|538223377|FG001|Overall Study|Withdrawal by Subject|64|||
149207047|NCT00004732|538223376|FG000|Overall Study|Lost to Follow-up|33|||
149207048|NCT00004732|538223377|FG001|Overall Study|Lost to Follow-up|47|||
149207049|NCT01688635|538223380|FG000|Washout 1|Withdrawal by Subject|1|||
149207050|NCT01688635|538223381|FG001|Washout 1|Withdrawal by Subject|0|||
149207051|NCT01688635|538223380|FG000|Washout 1|Adverse Event|0|||
149207052|NCT01688635|538223381|FG001|Washout 1|Adverse Event|1|||
149207053|NCT01688635|538223380|FG000|Washout 1|Physician Decision|0|||
149207054|NCT01688635|538223381|FG001|Washout 1|Physician Decision|1|||
149207055|NCT01688635|538223380|FG000|Washout 2|Physician Decision|1|||
149207056|NCT01688635|538223381|FG001|Washout 2|Physician Decision|0|||
149207057|NCT01688635|538223380|FG000|Washout 2|Withdrawal by Subject|1|||
149207058|NCT01688635|538223381|FG001|Washout 2|Withdrawal by Subject|0|||
149207059|NCT01688635|538223380|FG000|Washout 2|Sponsor Decision|1|||
149207060|NCT01688635|538223381|FG001|Washout 2|Sponsor Decision|2|||
149207061|NCT01688635|538223380|FG000|Washout 3|Withdrawal by Subject|1|||
149207062|NCT01688635|538223381|FG001|Washout 3|Withdrawal by Subject|0|||
149207063|NCT02713789|538223382|FG000|Overall Study|Lost to Follow-up|0|||
149207064|NCT02713789|538223383|FG001|Overall Study|Lost to Follow-up|1|||
149207065|NCT02713789|538223384|FG002|Overall Study|Lost to Follow-up|1|||
149207066|NCT02661464|538223390|FG000|Overall Study|Lost to Follow-up|28|||
149207067|NCT02661464|538223391|FG001|Overall Study|Lost to Follow-up|0|||
149207068|NCT02661464|538223392|FG002|Overall Study|Lost to Follow-up|0|||
149207069|NCT02661464|538223393|FG003|Overall Study|Lost to Follow-up|0|||
149207070|NCT02661464|538223390|FG000|Overall Study|Withdrawal by Subject|3|||
149207071|NCT02661464|538223391|FG001|Overall Study|Withdrawal by Subject|1|||
149207072|NCT02661464|538223392|FG002|Overall Study|Withdrawal by Subject|0|||
149207073|NCT02661464|538223393|FG003|Overall Study|Withdrawal by Subject|0|||
149207074|NCT02661464|538223390|FG000|Overall Study|Participants terminated prematurely|288|||
149207075|NCT02661464|538223391|FG001|Overall Study|Participants terminated prematurely|52|||
149207076|NCT02661464|538223392|FG002|Overall Study|Participants terminated prematurely|1|||
149207077|NCT02661464|538223393|FG003|Overall Study|Participants terminated prematurely|1|||
149207078|NCT02661464|538223390|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
148948660|NCT01866930|537295779|FG001|Follow-up Period|Other|5|||
148948661|NCT01866930|537295778|FG000|Follow-up Period|No longer required per protocol|1|||
148948662|NCT01866930|537295779|FG001|Follow-up Period|No longer required per protocol|0|||
148948663|NCT01866930|537295778|FG000|Follow-up Period|Withdrawal by Subject|3|||
148948664|NCT01866930|537295779|FG001|Follow-up Period|Withdrawal by Subject|3|||
148948665|NCT04023526|537297208|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
148948666|NCT04023526|537297209|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
148948667|NCT04023526|537297208|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
148948668|NCT04023526|537297209|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
148948669|NCT02324569|537297219|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
148948670|NCT02324569|537297220|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
148948671|NCT02324569|537297219|FG000|Overall Study|Voluntary Withdrawal|3|||
148948672|NCT02324569|537297220|FG001|Overall Study|Voluntary Withdrawal|6|||
148948673|NCT02324569|537297219|FG000|Overall Study|Lack of Efficacy|2|||
149016423|NCT01032044|537537928|FG000|Overall Study|Lost to Follow-up|11|||
149207079|NCT02661464|538223391|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
149207080|NCT02661464|538223392|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
149207081|NCT02661464|538223393|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
149207082|NCT00903370|538223394|FG000|Overall Study|Death|13|||
149207083|NCT00903370|538223395|FG001|Overall Study|Death|10|||
149207084|NCT00903370|538223394|FG000|Overall Study|Withdrawal by Subject|9|||
149207085|NCT00903370|538223395|FG001|Overall Study|Withdrawal by Subject|6|||
149207086|NCT00903370|538223394|FG000|Overall Study|Lost to Follow-up|6|||
149207087|NCT00903370|538223395|FG001|Overall Study|Lost to Follow-up|8|||
149016424|NCT01032044|537537929|FG001|Overall Study|Lost to Follow-up|11|||
149016425|NCT06385483|537537930|FG000|Overall Study|Withdrawal by Subject|2|||
149207088|NCT00367432|538223396|FG000|First Period (16 Weeks)|Adverse Event|6|||
149207089|NCT00367432|538223397|FG001|First Period (16 Weeks)|Adverse Event|0|||
149207090|NCT00367432|538223396|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
149207091|NCT00367432|538223397|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
149207092|NCT00367432|538223396|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
149207093|NCT00367432|538223397|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
149016426|NCT06385483|537537930|FG000|Overall Study|Never start protocol therapy|2|||
149016427|NCT06385483|537537930|FG000|Overall Study|Disease progression|15|||
149016428|NCT05569954|537537931|FG000|Overall Study|Lost to Follow-up|3|||
149207094|NCT00367432|538223396|FG000|First Period (16 Weeks)|Other Reason|2|||
149207095|NCT00367432|538223397|FG001|First Period (16 Weeks)|Other Reason|0|||
149207096|NCT00367432|538223396|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
149207097|NCT00367432|538223397|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
148809198|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
149016429|NCT05569954|537537932|FG001|Overall Study|Lost to Follow-up|4|||
149016430|NCT05569954|537537931|FG000|Overall Study|Protocol Violation|1|||
149016431|NCT05569954|537537932|FG001|Overall Study|Protocol Violation|2|||
149016432|NCT05569954|537537931|FG000|Overall Study|Withdrawal by Subject|4|||
149016433|NCT05569954|537537932|FG001|Overall Study|Withdrawal by Subject|2|||
149016434|NCT00329719|537538794|FG000|Overall Study|Lost to Follow-up|0|||
149016435|NCT00329719|537538795|FG001|Overall Study|Lost to Follow-up|0|||
149016436|NCT00329719|537538796|FG002|Overall Study|Lost to Follow-up|0|||
149016437|NCT00329719|537538797|FG003|Overall Study|Lost to Follow-up|1|||
149016438|NCT00373295|537538798|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149016439|NCT00373295|537538799|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
149016440|NCT00373295|537538800|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149016441|NCT00373295|537538801|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
149016442|NCT00373295|537538802|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
149016443|NCT00373295|537538803|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
148948674|NCT02324569|537297220|FG001|Overall Study|Lack of Efficacy|3|||
148948675|NCT02324569|537297219|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
148948676|NCT02324569|537297220|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
148948677|NCT02324569|537297219|FG000|Overall Study|Inconvenient Schedule|2|||
148948678|NCT02324569|537297220|FG001|Overall Study|Inconvenient Schedule|0|||
148948679|NCT01943292|537297227|FG000|Overall Study|Withdrawal by Subject|1|||
148948680|NCT01943292|537297228|FG001|Overall Study|Withdrawal by Subject|0|||
148948681|NCT01943292|537297229|FG002|Overall Study|Withdrawal by Subject|0|||
148948682|NCT00911820|537297230|FG000|Overall Study|RECIST progression|12|||
149207098|NCT00367432|538223396|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
149207099|NCT00367432|538223397|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
148948683|NCT00911820|537297231|FG001|Overall Study|RECIST progression|8|||
149016444|NCT04012814|537538804|FG000|Overall Study|Lost to Follow-up|4|||
149016445|NCT04012814|537538804|FG000|Overall Study|Withdrawal by Subject|2|||
149207100|NCT00367432|538223396|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
149207101|NCT00367432|538223397|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
149207102|NCT00367432|538223396|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
149207103|NCT00367432|538223397|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
149207104|NCT00367432|538223396|FG000|Second Period (up to 54 Months)|Other Reason|6|||
149207105|NCT00367432|538223397|FG001|Second Period (up to 54 Months)|Other Reason|2|||
149207106|NCT05567393|538223401|FG000|Overall Study|Voluntary Withdrawal|0|||
149207107|NCT05567393|538223402|FG001|Overall Study|Voluntary Withdrawal|0|||
149207108|NCT05567393|538223403|FG002|Overall Study|Voluntary Withdrawal|0|||
149207109|NCT05567393|538223404|FG003|Overall Study|Voluntary Withdrawal|0|||
149207110|NCT05567393|538223405|FG004|Overall Study|Voluntary Withdrawal|0|||
149207111|NCT05567393|538223406|FG005|Overall Study|Voluntary Withdrawal|0|||
149207112|NCT05567393|538223407|FG006|Overall Study|Voluntary Withdrawal|0|||
149207113|NCT05567393|538223408|FG007|Overall Study|Voluntary Withdrawal|0|||
149207114|NCT05567393|538223409|FG008|Overall Study|Voluntary Withdrawal|0|||
149207115|NCT05567393|538223410|FG009|Overall Study|Voluntary Withdrawal|0|||
149207116|NCT05567393|538223411|FG010|Overall Study|Voluntary Withdrawal|0|||
149207117|NCT05567393|538223412|FG011|Overall Study|Voluntary Withdrawal|0|||
149207118|NCT05567393|538223413|FG012|Overall Study|Voluntary Withdrawal|0|||
149207119|NCT05567393|538223414|FG013|Overall Study|Voluntary Withdrawal|1|||
149207120|NCT05567393|538223415|FG014|Overall Study|Voluntary Withdrawal|0|||
149207121|NCT05567393|538223416|FG015|Overall Study|Voluntary Withdrawal|0|||
149207122|NCT05567393|538223417|FG016|Overall Study|Voluntary Withdrawal|0|||
149207123|NCT05567393|538223418|FG017|Overall Study|Voluntary Withdrawal|0|||
149207124|NCT02177175|538223423|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
149207125|NCT02177175|538223424|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
149207126|NCT01924299|538223425|FG000|Period 2|Withdrawal by Subject|1|||
149207127|NCT01924299|538223426|FG001|Period 2|Withdrawal by Subject|0|||
149207128|NCT01924299|538223425|FG000|Period 2|Adverse Event|0|||
149207129|NCT01924299|538223426|FG001|Period 2|Adverse Event|1|||
149207130|NCT00141037|538223431|FG000|Overall Study|Physician Decision|1|||
149207131|NCT00141037|538223432|FG001|Overall Study|Physician Decision|2|||
149207132|NCT00141037|538223431|FG000|Overall Study|Lost to Follow-up|3|||
149207133|NCT00141037|538223432|FG001|Overall Study|Lost to Follow-up|1|||
149207134|NCT00141037|538223431|FG000|Overall Study|Protocol Violation|0|||
149207135|NCT00141037|538223432|FG001|Overall Study|Protocol Violation|2|||
149207136|NCT00141037|538223431|FG000|Overall Study|Withdrawal by Subject|2|||
149207137|NCT00141037|538223432|FG001|Overall Study|Withdrawal by Subject|1|||
149207138|NCT00141037|538223431|FG000|Overall Study|Other|0|||
149207139|NCT00141037|538223432|FG001|Overall Study|Other|1|||
149207140|NCT00141037|538223431|FG000|Overall Study|Moved from area|1|||
149207141|NCT00141037|538223432|FG001|Overall Study|Moved from area|7|||
149207142|NCT00141037|538223431|FG000|Overall Study|Graft Failure|3|||
149207143|NCT00141037|538223432|FG001|Overall Study|Graft Failure|4|||
149207144|NCT00888615|538223433|FG000|Overall Study|No treatment|2|||
149207145|NCT00637377|538223434|FG000|Overall Study|Adverse Event|2|||
149207146|NCT00637377|538223435|FG001|Overall Study|Adverse Event|6|||
149207147|NCT00637377|538223436|FG002|Overall Study|Adverse Event|8|||
149207148|NCT00637377|538223437|FG003|Overall Study|Adverse Event|9|||
149207149|NCT00637377|538223434|FG000|Overall Study|Death|1|||
149207150|NCT00637377|538223435|FG001|Overall Study|Death|3|||
149207151|NCT00637377|538223436|FG002|Overall Study|Death|2|||
149207152|NCT00637377|538223437|FG003|Overall Study|Death|1|||
149207153|NCT00637377|538223434|FG000|Overall Study|Lack of Efficacy|0|||
149207154|NCT00637377|538223435|FG001|Overall Study|Lack of Efficacy|0|||
149207155|NCT00637377|538223436|FG002|Overall Study|Lack of Efficacy|1|||
149207156|NCT00637377|538223437|FG003|Overall Study|Lack of Efficacy|1|||
149207157|NCT00637377|538223434|FG000|Overall Study|Lost to Follow-up|4|||
149207158|NCT00637377|538223435|FG001|Overall Study|Lost to Follow-up|1|||
149207159|NCT00637377|538223436|FG002|Overall Study|Lost to Follow-up|2|||
148948684|NCT00911820|537297230|FG000|Overall Study|Adverse Event|8|||
148948685|NCT00911820|537297231|FG001|Overall Study|Adverse Event|8|||
149207160|NCT00637377|538223437|FG003|Overall Study|Lost to Follow-up|2|||
149207161|NCT00637377|538223434|FG000|Overall Study|Protocol Violation|2|||
149207162|NCT00637377|538223435|FG001|Overall Study|Protocol Violation|1|||
149207163|NCT00637377|538223436|FG002|Overall Study|Protocol Violation|1|||
149207164|NCT00637377|538223437|FG003|Overall Study|Protocol Violation|0|||
149207165|NCT00637377|538223434|FG000|Overall Study|Withdrawal by Subject|11|||
149207166|NCT00637377|538223435|FG001|Overall Study|Withdrawal by Subject|15|||
149207167|NCT00637377|538223436|FG002|Overall Study|Withdrawal by Subject|13|||
149207168|NCT00637377|538223437|FG003|Overall Study|Withdrawal by Subject|11|||
149207169|NCT00637377|538223434|FG000|Overall Study|Other (no further information available)|7|||
149207170|NCT00637377|538223435|FG001|Overall Study|Other (no further information available)|6|||
149207171|NCT00637377|538223436|FG002|Overall Study|Other (no further information available)|10|||
149207172|NCT00637377|538223437|FG003|Overall Study|Other (no further information available)|5|||
148809199|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
148809200|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
148809201|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
148809202|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
148809203|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
148809204|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
148809205|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
148809206|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
148809207|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
148809208|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
148809209|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
148809210|NCT00410163|536777628|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
148809211|NCT00410163|536777629|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
148809212|NCT00410163|536777628|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
148809213|NCT00410163|536777629|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
148948686|NCT00911820|537297230|FG000|Overall Study|Clinical Progression|7|||
149207173|NCT01293084|538223438|FG000|Overall Study|Physician Decision|3|||
149207174|NCT01293084|538223438|FG000|Overall Study|Withdrawal by Subject|2|||
149207175|NCT04186663|538223439|FG000|Overall Study|Lost to Follow-up|1|||
149207176|NCT04186663|538223439|FG000|Overall Study|Unable to complete blood draw|3|||
149207177|NCT00719862|538223440|FG000|Overall Study|Adverse Event|1|||
149207178|NCT00719862|538223441|FG001|Overall Study|Adverse Event|2|||
149207179|NCT00719862|538223440|FG000|Overall Study|Lack of Efficacy|3|||
149207180|NCT00719862|538223441|FG001|Overall Study|Lack of Efficacy|0|||
149207181|NCT00719862|538223440|FG000|Overall Study|Non-Compliance|1|||
149207182|NCT00719862|538223441|FG001|Overall Study|Non-Compliance|0|||
149207183|NCT00719862|538223440|FG000|Overall Study|Withdrawal by Subject|1|||
149207184|NCT00719862|538223441|FG001|Overall Study|Withdrawal by Subject|0|||
149207185|NCT00719862|538223440|FG000|Overall Study|Lost to Follow-up|0|||
148948687|NCT00911820|537297231|FG001|Overall Study|Clinical Progression|5|||
148948688|NCT00911820|537297230|FG000|Overall Study|Physician Decision|5|||
148948689|NCT00911820|537297231|FG001|Overall Study|Physician Decision|9|||
148948690|NCT00911820|537297230|FG000|Overall Study|Decline in Performance Status|4|||
148948691|NCT00911820|537297231|FG001|Overall Study|Decline in Performance Status|2|||
148948692|NCT00911820|537297230|FG000|Overall Study|Withdrawal by Subject|3|||
148948693|NCT00911820|537297231|FG001|Overall Study|Withdrawal by Subject|4|||
148948694|NCT00911820|537297230|FG000|Overall Study|Death|1|||
148948695|NCT00911820|537297231|FG001|Overall Study|Death|2|||
148948696|NCT00911820|537297230|FG000|Overall Study|Pursue surgery|1|||
148948697|NCT00911820|537297231|FG001|Overall Study|Pursue surgery|1|||
148948698|NCT00911820|537297230|FG000|Overall Study|Pursue Radiation|1|||
148948699|NCT00911820|537297231|FG001|Overall Study|Pursue Radiation|0|||
148948700|NCT00911820|537297230|FG000|Overall Study|Still on Therapy|2|||
148948701|NCT00911820|537297231|FG001|Overall Study|Still on Therapy|2|||
148948702|NCT00911820|537297230|FG000|Overall Study|Pathology Not Confirmed|1|||
148948703|NCT00911820|537297231|FG001|Overall Study|Pathology Not Confirmed|0|||
148948704|NCT00911820|537297230|FG000|Overall Study|Withdraw before Receive Treatment|0|||
148948705|NCT00911820|537297231|FG001|Overall Study|Withdraw before Receive Treatment|2|||
148948706|NCT00996216|537297232|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
148948707|NCT00996216|537297232|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
148948708|NCT00996216|537297232|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
148948709|NCT00963547|537297243|FG000|Overall Study|Adverse Event|0|||
148948710|NCT00963547|537297244|FG001|Overall Study|Adverse Event|1|||
148948711|NCT00963547|537297245|FG002|Overall Study|Adverse Event|0|||
148948712|NCT00963547|537297246|FG003|Overall Study|Adverse Event|1|||
148948713|NCT00963547|537297247|FG004|Overall Study|Adverse Event|0|||
148948714|NCT00963547|537297248|FG005|Overall Study|Adverse Event|0|||
148948715|NCT00963547|537297249|FG006|Overall Study|Adverse Event|0|||
148948716|NCT00963547|537297243|FG000|Overall Study|Physician Decision|1|||
148948717|NCT00963547|537297244|FG001|Overall Study|Physician Decision|1|||
148948718|NCT00963547|537297245|FG002|Overall Study|Physician Decision|0|||
149207186|NCT00719862|538223441|FG001|Overall Study|Lost to Follow-up|1|||
149207187|NCT00719862|538223440|FG000|Overall Study|Other|2|||
148948719|NCT00963547|537297246|FG003|Overall Study|Physician Decision|0|||
148948720|NCT00963547|537297247|FG004|Overall Study|Physician Decision|0|||
148948721|NCT00963547|537297248|FG005|Overall Study|Physician Decision|0|||
148948722|NCT00963547|537297249|FG006|Overall Study|Physician Decision|0|||
148948723|NCT00963547|537297243|FG000|Overall Study|Progressive Disease|3|||
148948724|NCT00963547|537297244|FG001|Overall Study|Progressive Disease|8|||
149207188|NCT00719862|538223441|FG001|Overall Study|Other|3|||
149207189|NCT01184846|538223442|FG000|Overall Study|Adverse Event|2|||
149207190|NCT01184846|538223442|FG000|Overall Study|Insufficient response|1|||
148948725|NCT00963547|537297245|FG002|Overall Study|Progressive Disease|9|||
148948726|NCT00963547|537297246|FG003|Overall Study|Progressive Disease|5|||
148948727|NCT00963547|537297247|FG004|Overall Study|Progressive Disease|0|||
148948728|NCT00963547|537297248|FG005|Overall Study|Progressive Disease|0|||
148948729|NCT00963547|537297249|FG006|Overall Study|Progressive Disease|0|||
148948730|NCT00963547|537297243|FG000|Overall Study|Withdrawal by Subject|0|||
148948731|NCT00963547|537297244|FG001|Overall Study|Withdrawal by Subject|0|||
148948732|NCT00963547|537297245|FG002|Overall Study|Withdrawal by Subject|3|||
148948733|NCT00963547|537297246|FG003|Overall Study|Withdrawal by Subject|0|||
148948734|NCT00963547|537297247|FG004|Overall Study|Withdrawal by Subject|0|||
148948735|NCT00963547|537297248|FG005|Overall Study|Withdrawal by Subject|0|||
148948736|NCT00963547|537297249|FG006|Overall Study|Withdrawal by Subject|0|||
148948737|NCT00963547|537297243|FG000|Overall Study|Reason Unknown|0|||
148948738|NCT00963547|537297244|FG001|Overall Study|Reason Unknown|1|||
148948739|NCT00963547|537297245|FG002|Overall Study|Reason Unknown|0|||
148948740|NCT00963547|537297246|FG003|Overall Study|Reason Unknown|0|||
148948741|NCT00963547|537297247|FG004|Overall Study|Reason Unknown|0|||
148948742|NCT00963547|537297248|FG005|Overall Study|Reason Unknown|0|||
148948743|NCT00963547|537297249|FG006|Overall Study|Reason Unknown|0|||
148948744|NCT00903695|537297253|FG000|Overall Study|medical exclusion after 1st testing|1|||
148948745|NCT00903695|537297254|FG001|Overall Study|medical exclusion after 1st testing|0|||
148948746|NCT00903695|537297253|FG000|Overall Study|lung cancer|1|||
148948747|NCT00903695|537297254|FG001|Overall Study|lung cancer|0|||
148948748|NCT02430311|537297256|FG000|Part A|Adverse Event|0|||
148948749|NCT02430311|537297257|FG001|Part A|Adverse Event|1|||
148948750|NCT02430311|537297256|FG000|Part A|Withdrawal by Subject|1|||
148948751|NCT02430311|537297257|FG001|Part A|Withdrawal by Subject|0|||
148948752|NCT02430311|537297256|FG000|Part B|Meet study-specific withdrawal criteria|6|||
148948753|NCT02430311|537297257|FG001|Part B|Meet study-specific withdrawal criteria|6|||
148948754|NCT02430311|537297256|FG000|Part B|Withdrawal by Subject|2|||
148948755|NCT02430311|537297257|FG001|Part B|Withdrawal by Subject|2|||
148948756|NCT02430311|537297256|FG000|Part B|Adverse Event|1|||
148948757|NCT02430311|537297257|FG001|Part B|Adverse Event|0|||
148948758|NCT02430311|537297256|FG000|Part B|Death|1|||
148948759|NCT02430311|537297257|FG001|Part B|Death|0|||
148948760|NCT04492618|537297260|FG000|Overall Study|Withdrawal by Subject|1|||
148948761|NCT02511184|537297261|FG000|Overall Study|Death|1|||
148948762|NCT02511184|537297262|FG001|Overall Study|Death|0|||
148948763|NCT02511184|537297261|FG000|Overall Study|Lost to Follow-up|0|||
148948764|NCT02511184|537297262|FG001|Overall Study|Lost to Follow-up|1|||
148948765|NCT02511184|537297261|FG000|Overall Study|Study terminated by sponsor|1|||
148948766|NCT02511184|537297262|FG001|Overall Study|Study terminated by sponsor|5|||
148948767|NCT02511184|537297261|FG000|Overall Study|Withdrawal by Subject|0|||
148948768|NCT02511184|537297262|FG001|Overall Study|Withdrawal by Subject|1|||
148948769|NCT00085631|537297273|FG000|Overall Study|Missing Data|4|||
148948770|NCT00085631|537297274|FG001|Overall Study|Missing Data|11|||
148948771|NCT00085631|537297275|FG002|Overall Study|Missing Data|7|||
148948772|NCT01349790|537297276|FG000|Overall Study|Investigator Judgement|3|||
148948773|NCT01349790|537297276|FG000|Overall Study|Death|2|||
148948774|NCT01349790|537297276|FG000|Overall Study|Withdrawal by Patient|2|||
148948775|NCT01349790|537297276|FG000|Overall Study|Adverse Event|1|||
148948776|NCT01349790|537297276|FG000|Overall Study|Lost to Follow-up|1|||
149016446|NCT04012814|537538804|FG000|Overall Study|Protocol Violation|1|||
149016447|NCT04012814|537538804|FG000|Overall Study|Adverse Event|1|||
149016448|NCT04397523|537538805|FG000|Overall Study|Lost to Follow-up|3|||
149016449|NCT04397523|537538805|FG000|Overall Study|Transfer from/to other hospital|8|||
149016450|NCT01394250|537538809|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
149016451|NCT01394250|537538810|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
149016452|NCT01394250|537538809|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
148948777|NCT03902574|537297277|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
148948778|NCT03902574|537297278|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
148948779|NCT03902574|537297279|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
148948780|NCT03521934|537297280|FG000|Overall Study|Death|65|||
148948781|NCT03521934|537297281|FG001|Overall Study|Death|73|||
148948782|NCT03521934|537297280|FG000|Overall Study|Withdrawal by Subject|18|||
148948783|NCT03521934|537297281|FG001|Overall Study|Withdrawal by Subject|23|||
148948784|NCT03521934|537297280|FG000|Overall Study|Site Terminated by Sponsor|39|||
148948785|NCT03521934|537297281|FG001|Overall Study|Site Terminated by Sponsor|35|||
148948786|NCT03521934|537297280|FG000|Overall Study|Study Terminated by Sponsor|483|||
148948787|NCT03521934|537297281|FG001|Overall Study|Study Terminated by Sponsor|477|||
149016453|NCT01394250|537538810|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
148948788|NCT03521934|537297280|FG000|Overall Study|Reason not Specified|3|||
148948789|NCT03521934|537297281|FG001|Overall Study|Reason not Specified|6|||
148948790|NCT00727025|537297282|FG000|Overall Study|Physician Decision|23|||
148948791|NCT02101060|537297283|FG000|Overall Study|Adverse Event|1|||
148948792|NCT02101060|537297284|FG001|Overall Study|Adverse Event|0|||
148948793|NCT02101060|537297283|FG000|Overall Study|Withdrawal by Subject|1|||
149207191|NCT01999946|538223443|FG000|Overall Study|Participant not released from jail|2|||
149207192|NCT01999946|538223444|FG001|Overall Study|Participant not released from jail|2|||
149207193|NCT01999946|538223445|FG002|Overall Study|Participant not released from jail|0|||
149207194|NCT01999946|538223443|FG000|Overall Study|Not included in primary outcome analysis|0|||
149207195|NCT01999946|538223444|FG001|Overall Study|Not included in primary outcome analysis|0|||
149207196|NCT01999946|538223445|FG002|Overall Study|Not included in primary outcome analysis|79|||
149207197|NCT00719953|538223448|FG000|Overall Study|Adverse Event|4|||
149207198|NCT04021706|538225248|FG000|Overall Study|Adverse Event|2|||
149207199|NCT04021706|538225249|FG001|Overall Study|Adverse Event|0|||
149207200|NCT04021706|538225248|FG000|Overall Study|Withdrawal by Subject|1|||
149207201|NCT04021706|538225249|FG001|Overall Study|Withdrawal by Subject|2|||
149207202|NCT04021706|538225248|FG000|Overall Study|Physician Decision|1|||
149207203|NCT04021706|538225249|FG001|Overall Study|Physician Decision|0|||
149207204|NCT01375647|538225250|FG000|Overall Study|Lost to Follow-up|3|||
149207205|NCT01375647|538225251|FG001|Overall Study|Lost to Follow-up|3|||
149207206|NCT01375647|538225252|FG002|Overall Study|Lost to Follow-up|7|||
149207207|NCT01375647|538225253|FG003|Overall Study|Lost to Follow-up|10|||
149207208|NCT01375647|538225250|FG000|Overall Study|Death|1|||
149207209|NCT01375647|538225251|FG001|Overall Study|Death|2|||
149207210|NCT01375647|538225252|FG002|Overall Study|Death|1|||
149207211|NCT01375647|538225253|FG003|Overall Study|Death|0|||
149207212|NCT01375647|538225250|FG000|Overall Study|Withdrawal by Subject|17|||
149207213|NCT01375647|538225251|FG001|Overall Study|Withdrawal by Subject|20|||
149207214|NCT01375647|538225252|FG002|Overall Study|Withdrawal by Subject|26|||
149207215|NCT01375647|538225253|FG003|Overall Study|Withdrawal by Subject|14|||
149207216|NCT01375647|538225250|FG000|Overall Study|Physician Decision|1|||
149207217|NCT01375647|538225251|FG001|Overall Study|Physician Decision|0|||
148809214|NCT00410163|536777628|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
149207218|NCT01375647|538225252|FG002|Overall Study|Physician Decision|0|||
149207219|NCT01375647|538225253|FG003|Overall Study|Physician Decision|0|||
149207220|NCT02332798|538225256|FG000|Overall Study|Unwilling to Participate in Study|0|||
149207221|NCT02332798|538225257|FG001|Overall Study|Unwilling to Participate in Study|1|||
148809215|NCT00410163|536777629|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
148948794|NCT02101060|537297284|FG001|Overall Study|Withdrawal by Subject|1|||
148948795|NCT02101060|537297283|FG000|Overall Study|Lost to Follow-up|3|||
148948796|NCT02101060|537297284|FG001|Overall Study|Lost to Follow-up|3|||
149207222|NCT02332798|538225258|FG002|Overall Study|Unwilling to Participate in Study|1|||
149207223|NCT02332798|538225256|FG000|Overall Study|Positive Urine Drug Test|0|||
149207224|NCT02332798|538225257|FG001|Overall Study|Positive Urine Drug Test|1|||
149207225|NCT02332798|538225258|FG002|Overall Study|Positive Urine Drug Test|0|||
149207226|NCT02332798|538225256|FG000|Overall Study|Abnormal Laboratory Findings|1|||
149207227|NCT02332798|538225257|FG001|Overall Study|Abnormal Laboratory Findings|0|||
149207228|NCT02332798|538225258|FG002|Overall Study|Abnormal Laboratory Findings|0|||
149207229|NCT02688153|538225259|FG000|Overall Study|Death|7|||
149207230|NCT02688153|538225260|FG001|Overall Study|Death|5|||
149207231|NCT02688153|538225259|FG000|Overall Study|Withdrawal by Subject|4|||
149207232|NCT02688153|538225260|FG001|Overall Study|Withdrawal by Subject|2|||
149207233|NCT02688153|538225259|FG000|Overall Study|Valve Explant|1|||
149207234|NCT02688153|538225260|FG001|Overall Study|Valve Explant|0|||
149207235|NCT02688153|538225259|FG000|Overall Study|Conversion to Commercial Valve|3|||
149207236|NCT02688153|538225260|FG001|Overall Study|Conversion to Commercial Valve|0|||
149207237|NCT00595868|538225261|FG000|Overall Study|Lost to Follow-up|45|||
149207238|NCT00595868|538225262|FG001|Overall Study|Lost to Follow-up|50|||
149207239|NCT01102140|538225263|FG000|Overall Study|Lost to Follow-up|1|||
149207240|NCT01102140|538225264|FG001|Overall Study|Lost to Follow-up|0|||
149207241|NCT01102140|538225263|FG000|Overall Study|Investigator terminated study|2|||
149207242|NCT01102140|538225264|FG001|Overall Study|Investigator terminated study|2|||
149207243|NCT01742091|538225272|FG000|Overall Study|Adverse Event|0|||
149207244|NCT01742091|538225273|FG001|Overall Study|Adverse Event|0|||
149207245|NCT01742091|538225274|FG002|Overall Study|Adverse Event|0|||
149207246|NCT01742091|538225275|FG003|Overall Study|Adverse Event|0|||
149207247|NCT01742091|538225276|FG004|Overall Study|Adverse Event|1|||
149207248|NCT01742091|538225277|FG005|Overall Study|Adverse Event|0|||
149207249|NCT01742091|538225272|FG000|Overall Study|Physician Decision|0|||
149207250|NCT01742091|538225273|FG001|Overall Study|Physician Decision|0|||
149207251|NCT01742091|538225274|FG002|Overall Study|Physician Decision|0|||
149207252|NCT01742091|538225275|FG003|Overall Study|Physician Decision|0|||
149207253|NCT01742091|538225276|FG004|Overall Study|Physician Decision|0|||
149207254|NCT01742091|538225277|FG005|Overall Study|Physician Decision|1|||
149207255|NCT01742091|538225272|FG000|Overall Study|Withdrawal by Subject|0|||
149207256|NCT01742091|538225273|FG001|Overall Study|Withdrawal by Subject|0|||
149207257|NCT01742091|538225274|FG002|Overall Study|Withdrawal by Subject|0|||
149207258|NCT01742091|538225275|FG003|Overall Study|Withdrawal by Subject|1|||
149207259|NCT01742091|538225276|FG004|Overall Study|Withdrawal by Subject|0|||
149207260|NCT01742091|538225277|FG005|Overall Study|Withdrawal by Subject|0|||
149207261|NCT01742091|538225272|FG000|Overall Study|Lost to Follow-up|0|||
149207262|NCT01742091|538225273|FG001|Overall Study|Lost to Follow-up|0|||
149207263|NCT01742091|538225274|FG002|Overall Study|Lost to Follow-up|0|||
149207264|NCT01742091|538225275|FG003|Overall Study|Lost to Follow-up|0|||
149207265|NCT01742091|538225276|FG004|Overall Study|Lost to Follow-up|0|||
149207266|NCT01742091|538225277|FG005|Overall Study|Lost to Follow-up|1|||
149207267|NCT03750240|538225279|FG000|Overall Study|Technical Difficulties|2|||
149207268|NCT03706040|538225280|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
149207269|NCT03706040|538225281|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
149207270|NCT03706040|538225282|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
149207271|NCT03706040|538225283|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
149207272|NCT03706040|538225284|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
149207273|NCT03706040|538225285|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
149207274|NCT03706040|538225286|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
149207275|NCT03706040|538225280|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
149207276|NCT03706040|538225281|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
149207277|NCT03706040|538225282|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
149207278|NCT03706040|538225283|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149207279|NCT03706040|538225284|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149207280|NCT03706040|538225285|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149207281|NCT03706040|538225286|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
149207282|NCT03706040|538225280|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
149207283|NCT03706040|538225281|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
149207284|NCT03706040|538225282|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
149207285|NCT03706040|538225283|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149016454|NCT02222896|537538811|FG000|Abdomen|Did not qualify|34|||
149207286|NCT03706040|538225284|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149207287|NCT03706040|538225285|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149207288|NCT03706040|538225286|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
149207289|NCT03706040|538225280|FG000|Period A (Week 0 to Week 16)|Other|2|||
149207290|NCT03706040|538225281|FG001|Period A (Week 0 to Week 16)|Other|0|||
149207291|NCT03706040|538225282|FG002|Period A (Week 0 to Week 16)|Other|2|||
149207292|NCT03706040|538225283|FG003|Period A (Week 0 to Week 16)|Other|0|||
149207293|NCT03706040|538225284|FG004|Period A (Week 0 to Week 16)|Other|0|||
149207294|NCT03706040|538225285|FG005|Period A (Week 0 to Week 16)|Other|0|||
149207295|NCT03706040|538225286|FG006|Period A (Week 0 to Week 16)|Other|0|||
149207296|NCT03706040|538225280|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
149207297|NCT03706040|538225281|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
149207298|NCT03706040|538225282|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
149207299|NCT03706040|538225283|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
149207300|NCT03706040|538225284|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
149207301|NCT03706040|538225285|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
149207302|NCT03706040|538225286|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
148809216|NCT00410163|536777628|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
148809217|NCT00410163|536777629|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
148809218|NCT00410163|536777628|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
148809219|NCT00410163|536777629|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
148809220|NCT00410163|536777628|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
148809221|NCT00410163|536777629|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
148809222|NCT00655889|536777632|FG000|Overall Study|Inadequate cell growth|1|||
148809223|NCT00655889|536777632|FG000|Overall Study|Protocol Violation|1|||
148809224|NCT05020015|536779211|FG000|Overall Study|Ongoing on study|1|||
148809225|NCT05020015|536779212|FG001|Overall Study|Ongoing on study|3|||
148809226|NCT05020015|536779213|FG002|Overall Study|Ongoing on study|4|||
148809227|NCT05020015|536779214|FG003|Overall Study|Ongoing on study|7|||
148809228|NCT05020015|536779211|FG000|Overall Study|Death|2|||
148809229|NCT05020015|536779212|FG001|Overall Study|Death|3|||
148809230|NCT05020015|536779213|FG002|Overall Study|Death|4|||
148809231|NCT05020015|536779214|FG003|Overall Study|Death|0|||
148809232|NCT05020015|536779211|FG000|Overall Study|Withdrawal by Subject|0|||
148809233|NCT05020015|536779212|FG001|Overall Study|Withdrawal by Subject|0|||
148809234|NCT05020015|536779213|FG002|Overall Study|Withdrawal by Subject|1|||
148809235|NCT05020015|536779214|FG003|Overall Study|Withdrawal by Subject|0|||
148809236|NCT05020015|536779211|FG000|Overall Study|Reason Not Specified|0|||
148809237|NCT05020015|536779212|FG001|Overall Study|Reason Not Specified|0|||
148809238|NCT05020015|536779213|FG002|Overall Study|Reason Not Specified|2|||
148809239|NCT05020015|536779214|FG003|Overall Study|Reason Not Specified|0|||
148809240|NCT00947544|536779221|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
148809241|NCT00947544|536779222|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
148809242|NCT00300053|536779223|FG000|Overall Study|Patient/Caregiver Preference|2|||
148809243|NCT00300053|536779224|FG001|Overall Study|Patient/Caregiver Preference|2|||
148809244|NCT00300053|536779225|FG002|Overall Study|Patient/Caregiver Preference|3|||
148809245|NCT00300053|536779223|FG000|Overall Study|Death|0|||
148809246|NCT00300053|536779224|FG001|Overall Study|Death|0|||
148809247|NCT00300053|536779225|FG002|Overall Study|Death|3|||
148809248|NCT00300053|536779223|FG000|Overall Study|Lost to Follow-up|0|||
148809249|NCT00300053|536779224|FG001|Overall Study|Lost to Follow-up|1|||
148809250|NCT00300053|536779225|FG002|Overall Study|Lost to Follow-up|0|||
148809251|NCT01963611|536779229|FG000|Overall Study|Adverse Event|1|||
148809252|NCT01963611|536779230|FG001|Overall Study|Adverse Event|1|||
148809253|NCT01963611|536779231|FG002|Overall Study|Adverse Event|3|||
148809254|NCT01963611|536779232|FG003|Overall Study|Adverse Event|4|||
148809255|NCT01963611|536779233|FG004|Overall Study|Adverse Event|3|||
148809256|NCT01963611|536779229|FG000|Overall Study|Protocol Violation|0|||
148809257|NCT01963611|536779230|FG001|Overall Study|Protocol Violation|0|||
148809258|NCT01963611|536779231|FG002|Overall Study|Protocol Violation|0|||
148809259|NCT01963611|536779232|FG003|Overall Study|Protocol Violation|1|||
148809260|NCT01963611|536779233|FG004|Overall Study|Protocol Violation|0|||
148809261|NCT01963611|536779229|FG000|Overall Study|Lack of Efficacy|0|||
149207303|NCT03706040|538225280|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
149207304|NCT03706040|538225281|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
149207305|NCT03706040|538225282|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
148809262|NCT01963611|536779230|FG001|Overall Study|Lack of Efficacy|0|||
148809263|NCT01963611|536779231|FG002|Overall Study|Lack of Efficacy|0|||
148809264|NCT01963611|536779232|FG003|Overall Study|Lack of Efficacy|1|||
148809265|NCT01963611|536779233|FG004|Overall Study|Lack of Efficacy|0|||
148809266|NCT01963611|536779229|FG000|Overall Study|Withdrawal by Subject|3|||
149207306|NCT03706040|538225283|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
149207307|NCT03706040|538225284|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
148809267|NCT01963611|536779230|FG001|Overall Study|Withdrawal by Subject|2|||
148809268|NCT01963611|536779231|FG002|Overall Study|Withdrawal by Subject|1|||
148809269|NCT01963611|536779232|FG003|Overall Study|Withdrawal by Subject|1|||
148809270|NCT01963611|536779233|FG004|Overall Study|Withdrawal by Subject|3|||
148809271|NCT01963611|536779229|FG000|Overall Study|Other|47|||
148948797|NCT01425281|537297290|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
148948798|NCT01425281|537297291|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
149207308|NCT03706040|538225285|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
149207309|NCT03706040|538225286|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
149207310|NCT03706040|538225280|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149207311|NCT03706040|538225281|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149207312|NCT03706040|538225282|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149207313|NCT03706040|538225283|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149207314|NCT03706040|538225284|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
149207315|NCT03706040|538225285|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
149207316|NCT03706040|538225286|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
149207317|NCT03706040|538225280|FG000|Period B (Week 16 to Week 52)|Other|0|||
149207318|NCT03706040|538225281|FG001|Period B (Week 16 to Week 52)|Other|0|||
149207319|NCT03706040|538225282|FG002|Period B (Week 16 to Week 52)|Other|0|||
149207320|NCT03706040|538225283|FG003|Period B (Week 16 to Week 52)|Other|4|||
149207321|NCT03706040|538225284|FG004|Period B (Week 16 to Week 52)|Other|5|||
149207322|NCT03706040|538225285|FG005|Period B (Week 16 to Week 52)|Other|23|||
149207323|NCT03706040|538225286|FG006|Period B (Week 16 to Week 52)|Other|17|||
149207324|NCT02940860|538225291|FG000|Overall Study|Non-serious AE|1|||
149207325|NCT02940860|538225292|FG001|Overall Study|Non-serious AE|2|||
149207326|NCT02940860|538225291|FG000|Overall Study|Serious AE|7|||
149207327|NCT02940860|538225292|FG001|Overall Study|Serious AE|3|||
149207328|NCT02940860|538225291|FG000|Overall Study|Withdrawal by Subject|19|||
149207329|NCT02940860|538225292|FG001|Overall Study|Withdrawal by Subject|9|||
149207330|NCT02940860|538225291|FG000|Overall Study|Lost to Follow-up|13|||
149207331|NCT02940860|538225292|FG001|Overall Study|Lost to Follow-up|7|||
149207332|NCT02940860|538225291|FG000|Overall Study|Physician Decision|5|||
149207333|NCT02940860|538225292|FG001|Overall Study|Physician Decision|3|||
149207334|NCT02940860|538225291|FG000|Overall Study|Sponsor Decision|0|||
149207335|NCT02940860|538225292|FG001|Overall Study|Sponsor Decision|1|||
149207336|NCT02940860|538225291|FG000|Overall Study|Protocol Violation|0|||
149207337|NCT02940860|538225292|FG001|Overall Study|Protocol Violation|2|||
149207338|NCT02940860|538225291|FG000|Overall Study|Death|3|||
149207339|NCT02940860|538225292|FG001|Overall Study|Death|2|||
149207340|NCT02940860|538225291|FG000|Overall Study|Moved, poor venous access, transport|6|||
149207341|NCT02940860|538225292|FG001|Overall Study|Moved, poor venous access, transport|4|||
149207342|NCT02940860|538225291|FG000|Overall Study|Not treated|2|||
149207343|NCT02940860|538225292|FG001|Overall Study|Not treated|2|||
149207344|NCT00527072|538225294|FG000|Overall Study|Adverse Event|13|||
149207345|NCT00527072|538225294|FG000|Overall Study|Lack of Efficacy|11|||
149207346|NCT00527072|538225294|FG000|Overall Study|Lost to Follow-up|3|||
149207347|NCT00527072|538225294|FG000|Overall Study|Protocol Violation|2|||
149207348|NCT00527072|538225294|FG000|Overall Study|Withdrawal by Subject|7|||
149207349|NCT02007252|538225295|FG000|Overall Study|Administrative problems|3|||
149207350|NCT02007252|538225296|FG001|Overall Study|Administrative problems|7|||
149207351|NCT02007252|538225295|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149207352|NCT02007252|538225296|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149207353|NCT02007252|538225295|FG000|Overall Study|Adverse Event|7|||
148948799|NCT01425281|537297290|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
148948800|NCT01425281|537297291|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
148948801|NCT01425281|537297290|FG000|At 180-day Clinical Follow-up|Death|0|||
148948802|NCT01425281|537297291|FG001|At 180-day Clinical Follow-up|Death|1|||
148948803|NCT01425281|537297290|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
148948804|NCT01425281|537297291|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
148948805|NCT01425281|537297290|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
148948806|NCT01425281|537297291|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
148948807|NCT01425281|537297290|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
148948808|NCT01425281|537297291|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
149207354|NCT02007252|538225296|FG001|Overall Study|Adverse Event|4|||
149207355|NCT00608881|538225297|FG000|Overall Study|Death|22|||
149207356|NCT00608881|538225298|FG001|Overall Study|Death|13|||
149207357|NCT00608881|538225297|FG000|Overall Study|Adverse Event|5|||
149207358|NCT00608881|538225298|FG001|Overall Study|Adverse Event|3|||
148948809|NCT01425281|537297290|FG000|At 2-year Clinical Follow-up|Death|2|||
148948810|NCT01425281|537297291|FG001|At 2-year Clinical Follow-up|Death|0|||
148948811|NCT01425281|537297290|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
148948812|NCT01425281|537297291|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
148948813|NCT01425281|537297290|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
149016455|NCT02222896|537538812|FG001|Abdomen|Did not qualify|10|||
149207359|NCT00608881|538225297|FG000|Overall Study|Lost to Follow-up|28|||
149207360|NCT00608881|538225298|FG001|Overall Study|Lost to Follow-up|14|||
149016456|NCT02222896|537538813|FG002|Abdomen|Did not qualify|32|||
149207361|NCT00608881|538225297|FG000|Overall Study|Withdrawal by Subject|18|||
149207362|NCT00608881|538225298|FG001|Overall Study|Withdrawal by Subject|29|||
149207363|NCT00608881|538225297|FG000|Overall Study|Physician Decision|5|||
149207364|NCT00608881|538225298|FG001|Overall Study|Physician Decision|5|||
149207365|NCT00608881|538225297|FG000|Overall Study|Institutionalized|1|||
149207366|NCT00608881|538225298|FG001|Overall Study|Institutionalized|2|||
149207367|NCT02954952|538225299|FG000|Overall Study|Withdrawal by Subject|1|||
149207368|NCT02954952|538225300|FG001|Overall Study|Withdrawal by Subject|0|||
149207369|NCT02954952|538225301|FG002|Overall Study|Withdrawal by Subject|0|||
149207370|NCT02954952|538225299|FG000|Overall Study|No data collected|0|||
149207371|NCT02954952|538225300|FG001|Overall Study|No data collected|1|||
149207372|NCT02954952|538225301|FG002|Overall Study|No data collected|0|||
149207373|NCT02137837|538225302|FG000|Overall Study|Adverse Event|0|||
149207374|NCT02137837|538225303|FG001|Overall Study|Adverse Event|2|||
149207375|NCT02137837|538225304|FG002|Overall Study|Adverse Event|1|||
149207376|NCT02137837|538225302|FG000|Overall Study|Refusal unrelated to adverse event|2|||
149207377|NCT02137837|538225303|FG001|Overall Study|Refusal unrelated to adverse event|2|||
149207378|NCT02137837|538225304|FG002|Overall Study|Refusal unrelated to adverse event|1|||
149207379|NCT02137837|538225302|FG000|Overall Study|Progression/relapse|9|||
149207380|NCT02137837|538225303|FG001|Overall Study|Progression/relapse|7|||
149207381|NCT02137837|538225304|FG002|Overall Study|Progression/relapse|7|||
149207382|NCT02137837|538225302|FG000|Overall Study|Not protocol specified|2|||
149207383|NCT02137837|538225303|FG001|Overall Study|Not protocol specified|1|||
149207384|NCT02137837|538225304|FG002|Overall Study|Not protocol specified|3|||
149207385|NCT00724815|538225305|FG000|Overall Study|Randomized, not treated|31|||
149207386|NCT00724815|538225306|FG001|Overall Study|Randomized, not treated|30|||
149207387|NCT00724815|538225305|FG000|Overall Study|Adverse Event|5|||
149207388|NCT00724815|538225306|FG001|Overall Study|Adverse Event|3|||
149207389|NCT00724815|538225305|FG000|Overall Study|Lost to Follow-up|4|||
149207390|NCT00724815|538225306|FG001|Overall Study|Lost to Follow-up|1|||
149207391|NCT00724815|538225305|FG000|Overall Study|Other Various|3|||
149207392|NCT00724815|538225306|FG001|Overall Study|Other Various|5|||
149207393|NCT01181141|538225307|FG000|Overall Study|Adverse Event|2|||
149207394|NCT01181141|538225308|FG001|Overall Study|Adverse Event|1|||
149016457|NCT02222896|537538811|FG000|Groin|Did not qualify|43|||
149016458|NCT02222896|537538812|FG001|Groin|Did not qualify|9|||
149016459|NCT02222896|537538813|FG002|Groin|Did not qualify|40|||
149207395|NCT01181141|538225307|FG000|Overall Study|Lack of Efficacy|1|||
149207396|NCT01181141|538225308|FG001|Overall Study|Lack of Efficacy|0|||
149207397|NCT01181141|538225307|FG000|Overall Study|Lost to Follow-up|1|||
149207398|NCT01181141|538225308|FG001|Overall Study|Lost to Follow-up|1|||
149207399|NCT01181141|538225307|FG000|Overall Study|Physician Decision|2|||
149207400|NCT01181141|538225308|FG001|Overall Study|Physician Decision|0|||
149207401|NCT01181141|538225307|FG000|Overall Study|Protocol Violation|3|||
149207402|NCT01181141|538225308|FG001|Overall Study|Protocol Violation|1|||
149207403|NCT01181141|538225307|FG000|Overall Study|Withdrawal by Subject|3|||
149207404|NCT01181141|538225308|FG001|Overall Study|Withdrawal by Subject|1|||
149207405|NCT01628393|538225309|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
149207406|NCT01628393|538225310|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149207407|NCT01628393|538225311|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149207408|NCT01628393|538225312|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149207409|NCT01628393|538225313|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
149207410|NCT01628393|538225309|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
149207411|NCT01628393|538225310|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
149207412|NCT01628393|538225311|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
149207413|NCT01628393|538225312|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
149207414|NCT01628393|538225313|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
149207415|NCT01628393|538225309|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
149207416|NCT01628393|538225310|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
149207417|NCT01628393|538225311|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
149207418|NCT01628393|538225312|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149207419|NCT01628393|538225313|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
149207420|NCT01628393|538225309|FG000|Blinded Active Extension Period|Adverse Event|0|||
149207421|NCT01628393|538225310|FG001|Blinded Active Extension Period|Adverse Event|1|||
149207422|NCT01628393|538225311|FG002|Blinded Active Extension Period|Adverse Event|0|||
149207423|NCT01628393|538225312|FG003|Blinded Active Extension Period|Adverse Event|2|||
149207424|NCT01628393|538225313|FG004|Blinded Active Extension Period|Adverse Event|2|||
149207425|NCT01628393|538225309|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
149207426|NCT01628393|538225310|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
149207427|NCT01628393|538225311|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
149207428|NCT01628393|538225312|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
149207429|NCT01628393|538225313|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
149207430|NCT01628393|538225309|FG000|Blinded Active Extension Period|Physician Decision|0|||
148809272|NCT01963611|536779230|FG001|Overall Study|Other|46|||
148809273|NCT01963611|536779231|FG002|Overall Study|Other|48|||
148809274|NCT01963611|536779232|FG003|Overall Study|Other|45|||
148809275|NCT01963611|536779233|FG004|Overall Study|Other|45|||
148809276|NCT02394275|536779234|FG000|Overall Study|Adverse Event|22|||
148809277|NCT02394275|536779234|FG000|Overall Study|Lost to Follow-up|7|||
148809278|NCT00782067|536779235|FG000|Overall Study|Adverse Event|35|||
148809279|NCT00782067|536779235|FG000|Overall Study|Subject withdrew consent|11|||
148809280|NCT00782067|536779235|FG000|Overall Study|Lost to Follow-up|2|||
148809281|NCT00782067|536779235|FG000|Overall Study|Administrative problems|14|||
148809282|NCT00782067|536779235|FG000|Overall Study|Death|9|||
148809283|NCT00782067|536779235|FG000|Overall Study|Disease progression|43|||
148809284|NCT00782067|536779235|FG000|Overall Study|Protocol deviation|2|||
148809285|NCT02471183|536779236|FG000|Main Treatment Period|Adverse Event|1|||
148809286|NCT02471183|536779236|FG000|Main Treatment Period|Withdrawal by Subject|1|||
148809287|NCT02471183|536779236|FG000|Extended Treatment Period|Lack of Efficacy|1|||
148809288|NCT01208051|536779255|FG000|Total Enrollment|Withdrawal by Subject|0|||
148809289|NCT01208051|536779256|FG001|Total Enrollment|Withdrawal by Subject|1|||
149016460|NCT01463293|537538818|FG000|Overall Study|Lost to Follow-up|1|||
149016461|NCT01463293|537538819|FG001|Overall Study|Lost to Follow-up|4|||
149207431|NCT01628393|538225310|FG001|Blinded Active Extension Period|Physician Decision|3|||
149207432|NCT01628393|538225311|FG002|Blinded Active Extension Period|Physician Decision|0|||
149207433|NCT01628393|538225312|FG003|Blinded Active Extension Period|Physician Decision|1|||
149207434|NCT01628393|538225313|FG004|Blinded Active Extension Period|Physician Decision|0|||
149207435|NCT01628393|538225309|FG000|Blinded Active Extension Period|Protocol Violation|0|||
149207436|NCT01628393|538225310|FG001|Blinded Active Extension Period|Protocol Violation|0|||
149207437|NCT01628393|538225311|FG002|Blinded Active Extension Period|Protocol Violation|2|||
149207438|NCT01628393|538225312|FG003|Blinded Active Extension Period|Protocol Violation|1|||
149207439|NCT01628393|538225313|FG004|Blinded Active Extension Period|Protocol Violation|0|||
149207440|NCT01628393|538225309|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
149207441|NCT01628393|538225310|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
149207442|NCT01628393|538225311|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
149207443|NCT01628393|538225312|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
149207444|NCT01628393|538225313|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
149207445|NCT00561340|538225314|FG000|Overall Study|refused to drink pediasure|6|||
149207446|NCT00561340|538225315|FG001|Overall Study|refused to drink pediasure|0|||
149207447|NCT01989754|538225316|FG000|Overall Study|Withdrawal by Subject|10|||
149207448|NCT01989754|538225317|FG001|Overall Study|Withdrawal by Subject|14|||
149207449|NCT01989754|538225316|FG000|Overall Study|Lost to Follow-up|28|||
149207450|NCT01989754|538225317|FG001|Overall Study|Lost to Follow-up|20|||
149207451|NCT01989754|538225316|FG000|Overall Study|Closed Site|1|||
149207452|NCT01989754|538225317|FG001|Overall Study|Closed Site|1|||
149207453|NCT01369225|538225320|FG000|Overall Study|Withdrawal by Subject|1|||
149207454|NCT01369225|538225321|FG001|Overall Study|Withdrawal by Subject|0|||
149207455|NCT01369225|538225322|FG002|Overall Study|Withdrawal by Subject|2|||
149207456|NCT01369225|538225323|FG003|Overall Study|Withdrawal by Subject|1|||
149207457|NCT01369225|538225324|FG004|Overall Study|Withdrawal by Subject|0|||
149207458|NCT01369225|538225325|FG005|Overall Study|Withdrawal by Subject|0|||
149207459|NCT01369225|538225320|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
149207460|NCT01369225|538225321|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
149207461|NCT01369225|538225322|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
149207462|NCT01369225|538225323|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
149207463|NCT01369225|538225324|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
149016462|NCT01463293|537538820|FG002|Overall Study|Lost to Follow-up|5|||
149016463|NCT01463293|537538818|FG000|Overall Study|Adverse Event|1|||
149016464|NCT01463293|537538819|FG001|Overall Study|Adverse Event|2|||
149207464|NCT01369225|538225325|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
149207465|NCT01369225|538225320|FG000|Overall Study|Other|1|||
149207466|NCT01369225|538225321|FG001|Overall Study|Other|0|||
149207467|NCT01369225|538225322|FG002|Overall Study|Other|0|||
149207468|NCT01369225|538225323|FG003|Overall Study|Other|0|||
149207469|NCT01369225|538225324|FG004|Overall Study|Other|1|||
149207470|NCT01369225|538225325|FG005|Overall Study|Other|0|||
149207471|NCT01369225|538225320|FG000|Overall Study|Adverse Event|0|||
148809290|NCT01208051|536779257|FG002|Total Enrollment|Withdrawal by Subject|0|||
148809291|NCT01208051|536779258|FG003|Total Enrollment|Withdrawal by Subject|0|||
148809292|NCT01208051|536779259|FG004|Total Enrollment|Withdrawal by Subject|2|||
148809293|NCT01208051|536779255|FG000|Total Enrollment|Brain metastases|0|||
148809294|NCT01208051|536779256|FG001|Total Enrollment|Brain metastases|0|||
148809295|NCT01208051|536779257|FG002|Total Enrollment|Brain metastases|1|||
148809296|NCT01208051|536779258|FG003|Total Enrollment|Brain metastases|0|||
149207472|NCT01369225|538225321|FG001|Overall Study|Adverse Event|0|||
149207473|NCT01369225|538225322|FG002|Overall Study|Adverse Event|0|||
148809297|NCT01208051|536779259|FG004|Total Enrollment|Brain metastases|0|||
149016465|NCT01463293|537538820|FG002|Overall Study|Adverse Event|0|||
149016466|NCT01463293|537538818|FG000|Overall Study|Withdrawal by Subject|4|||
149016467|NCT01463293|537538819|FG001|Overall Study|Withdrawal by Subject|10|||
148948814|NCT01425281|537297291|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
148948815|NCT01425281|537297290|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
148948816|NCT01425281|537297291|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
148948817|NCT01425281|537297290|FG000|At 3-year Clinical Follow-up|Death|2|||
148948818|NCT01425281|537297291|FG001|At 3-year Clinical Follow-up|Death|3|||
148948819|NCT01425281|537297290|FG000|At 4-year Clinical Follow-up|Death|7|||
148948820|NCT01425281|537297291|FG001|At 4-year Clinical Follow-up|Death|3|||
148948821|NCT01425281|537297290|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
148948822|NCT01425281|537297291|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
148948823|NCT01425281|537297290|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
148948824|NCT01425281|537297291|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
148948825|NCT01425281|537297290|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
148948826|NCT01425281|537297291|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
148948827|NCT01425281|537297290|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
148948828|NCT01425281|537297291|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
148948829|NCT01425281|537297290|FG000|At 5-year Clinical Follow-up|Death|2|||
148948830|NCT01425281|537297291|FG001|At 5-year Clinical Follow-up|Death|0|||
148948831|NCT01425281|537297290|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
148948832|NCT01425281|537297291|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
148948833|NCT01425281|537297290|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
148948834|NCT01425281|537297291|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
148948835|NCT01425281|537297290|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
148948836|NCT01425281|537297291|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
148948837|NCT00279305|537297294|FG000|Overall Study|Pregnancy|1|||
148948838|NCT00279305|537297295|FG001|Overall Study|Pregnancy|0|||
148948839|NCT00279305|537297294|FG000|Overall Study|Withdrawal by Subject|2|||
148948840|NCT00279305|537297295|FG001|Overall Study|Withdrawal by Subject|0|||
148948841|NCT00279305|537297294|FG000|Overall Study|Dificulting establishing IV|1|||
148948842|NCT00279305|537297295|FG001|Overall Study|Dificulting establishing IV|0|||
148948843|NCT00279305|537297294|FG000|Overall Study|FDA Safety Alert|4|||
148948844|NCT00279305|537297295|FG001|Overall Study|FDA Safety Alert|1|||
148948845|NCT02521870|537297298|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948846|NCT02521870|537297299|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
148948847|NCT02521870|537297300|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148683989|NCT00529568|536315071|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
148683990|NCT00529568|536315072|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
148683991|NCT00529568|536315070|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
148683992|NCT00529568|536315071|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
148683993|NCT00529568|536315072|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
148683994|NCT00529568|536315070|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
148683995|NCT00529568|536315071|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
148683996|NCT00529568|536315072|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
148683997|NCT00529568|536315070|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
148683998|NCT00529568|536315071|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
148683999|NCT00529568|536315072|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
148684000|NCT00529568|536315070|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
148684001|NCT00529568|536315071|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
148684002|NCT00529568|536315072|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
148684003|NCT00529568|536315070|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
148684004|NCT00529568|536315071|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
148948848|NCT02521870|537297301|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948849|NCT02521870|537297302|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948850|NCT02521870|537297303|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948851|NCT02521870|537297304|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948852|NCT02521870|537297305|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948853|NCT02521870|537297306|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948854|NCT02521870|537297307|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948855|NCT02521870|537297308|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948856|NCT02521870|537297309|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148948857|NCT02521870|537297298|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
148684005|NCT00529568|536315072|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
148948858|NCT02521870|537297299|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
148948859|NCT02521870|537297300|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
148948860|NCT02521870|537297301|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
148948861|NCT02521870|537297302|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
148948862|NCT02521870|537297303|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
148684006|NCT00529568|536315070|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
148948863|NCT02521870|537297304|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
148948864|NCT02521870|537297305|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
148948865|NCT02521870|537297306|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
148948866|NCT02521870|537297307|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
148948867|NCT02521870|537297308|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
148948868|NCT02521870|537297309|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
148948869|NCT02521870|537297298|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
148948870|NCT02521870|537297299|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
148948871|NCT02521870|537297300|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
148948872|NCT02521870|537297301|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
148948873|NCT02521870|537297302|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
148948874|NCT02521870|537297303|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
148948875|NCT02521870|537297304|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
148948876|NCT02521870|537297305|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
148948877|NCT02521870|537297306|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
149207474|NCT01369225|538225323|FG003|Overall Study|Adverse Event|1|||
149207475|NCT01369225|538225324|FG004|Overall Study|Adverse Event|1|||
149207476|NCT01369225|538225325|FG005|Overall Study|Adverse Event|0|||
148948878|NCT02521870|537297307|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
148948879|NCT02521870|537297308|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
148948880|NCT02521870|537297309|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
148948881|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
149207477|NCT00118911|538225326|FG000|Overall Study|Withdrawal by Subject|2|||
149207478|NCT00118911|538225327|FG001|Overall Study|Withdrawal by Subject|5|||
149207479|NCT05507580|538225328|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
148948882|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148948883|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148948884|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148948885|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
148948886|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
148948887|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
148948888|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148948889|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
148948890|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
148948891|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
148948892|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148948893|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
148948894|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
148948895|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
148948896|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
148948897|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
148948898|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
148948899|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
148948900|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
148948901|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
148948902|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
148948903|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
148948904|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
148948905|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
148948906|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
149207480|NCT05507580|538225329|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149207481|NCT05507580|538225330|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
149207482|NCT05507580|538225331|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
149207483|NCT05507580|538225332|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
149207484|NCT05507580|538225333|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
149207485|NCT05507580|538225328|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
149207486|NCT05507580|538225329|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
149207487|NCT05507580|538225330|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149207488|NCT05507580|538225331|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149207489|NCT05507580|538225332|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149207490|NCT05507580|538225333|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149207491|NCT05507580|538225328|FG000|Double-Blind Treatment Period|Other, not specified|5|||
149207492|NCT05507580|538225329|FG001|Double-Blind Treatment Period|Other, not specified|4|||
149207493|NCT05507580|538225330|FG002|Double-Blind Treatment Period|Other, not specified|0|||
149207494|NCT05507580|538225331|FG003|Double-Blind Treatment Period|Other, not specified|0|||
149207495|NCT05507580|538225332|FG004|Double-Blind Treatment Period|Other, not specified|0|||
149207496|NCT05507580|538225333|FG005|Double-Blind Treatment Period|Other, not specified|0|||
149207497|NCT05507580|538225328|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
149207498|NCT05507580|538225329|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
149207499|NCT05507580|538225330|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
149207500|NCT05507580|538225331|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
149207501|NCT05507580|538225332|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
149207502|NCT05507580|538225333|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
149207503|NCT05507580|538225328|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
149207504|NCT05507580|538225329|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
148948907|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
148948908|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
148948909|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
149207505|NCT05507580|538225330|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
149207506|NCT05507580|538225331|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
149207507|NCT05507580|538225332|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
149207508|NCT05507580|538225333|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
149207509|NCT05507580|538225328|FG000|Single-Blind Treatment Period|Other, not specified|0|||
149207510|NCT05507580|538225329|FG001|Single-Blind Treatment Period|Other, not specified|0|||
149207511|NCT05507580|538225330|FG002|Single-Blind Treatment Period|Other, not specified|2|||
149207512|NCT05507580|538225331|FG003|Single-Blind Treatment Period|Other, not specified|7|||
149207513|NCT05507580|538225332|FG004|Single-Blind Treatment Period|Other, not specified|3|||
149207514|NCT05507580|538225333|FG005|Single-Blind Treatment Period|Other, not specified|5|||
148684007|NCT00529568|536315071|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
148684008|NCT00529568|536315072|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
148684009|NCT04049552|536315073|FG000|Overall Study|Lost to Follow-up|1|||
148684010|NCT01201356|536315074|FG000|Overall Study|Adverse Event|170|||
148684011|NCT01201356|536315074|FG000|Overall Study|Abnormal laboratory value(s)|51|||
148684012|NCT01201356|536315074|FG000|Overall Study|Abnormal test procedure result(s)|3|||
148684013|NCT01201356|536315074|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
148684014|NCT01201356|536315074|FG000|Overall Study|Condition no longer requires study drug|12|||
148684015|NCT01201356|536315074|FG000|Overall Study|Withdrawal by Subject|144|||
148684016|NCT01201356|536315074|FG000|Overall Study|Lost to Follow-up|50|||
148684017|NCT01201356|536315074|FG000|Overall Study|administrative problems|74|||
148684018|NCT01201356|536315074|FG000|Overall Study|Death|16|||
148684019|NCT01201356|536315074|FG000|Overall Study|Protocol Violation|12|||
148684020|NCT00931385|536315075|FG000|Overall Study|Adverse Event|2|||
148684021|NCT00931385|536315076|FG001|Overall Study|Adverse Event|1|||
148684022|NCT00931385|536315077|FG002|Overall Study|Adverse Event|0|||
148684023|NCT00931385|536315078|FG003|Overall Study|Adverse Event|3|||
148684024|NCT00931385|536315075|FG000|Overall Study|Protocol Violation|0|||
148684025|NCT00931385|536315076|FG001|Overall Study|Protocol Violation|0|||
148684026|NCT00931385|536315077|FG002|Overall Study|Protocol Violation|1|||
148684027|NCT00931385|536315078|FG003|Overall Study|Protocol Violation|0|||
148684028|NCT00931385|536315075|FG000|Overall Study|Withdrawal by Subject|0|||
148684029|NCT00931385|536315076|FG001|Overall Study|Withdrawal by Subject|1|||
148684030|NCT00931385|536315077|FG002|Overall Study|Withdrawal by Subject|0|||
148684031|NCT00931385|536315078|FG003|Overall Study|Withdrawal by Subject|1|||
148684032|NCT00931385|536315075|FG000|Overall Study|Lost to Follow-up|0|||
148684033|NCT00931385|536315076|FG001|Overall Study|Lost to Follow-up|0|||
148684034|NCT00931385|536315077|FG002|Overall Study|Lost to Follow-up|0|||
148684035|NCT00931385|536315078|FG003|Overall Study|Lost to Follow-up|1|||
148684036|NCT00738920|536315080|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
148684037|NCT00738920|536315081|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
148684038|NCT00738920|536315082|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
148684039|NCT00738920|536315080|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
148684040|NCT00738920|536315081|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
148684041|NCT00738920|536315082|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
148684042|NCT00738920|536315080|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
148684043|NCT00738920|536315081|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
148684044|NCT00738920|536315082|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
148684045|NCT00738920|536315080|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
148684046|NCT00738920|536315081|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
148684047|NCT00738920|536315082|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
148684048|NCT00738920|536315080|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
148684049|NCT00738920|536315081|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
148684050|NCT00738920|536315082|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
148948910|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
149207515|NCT03395223|538225334|FG000|Overall Study|Lost to Follow-up|3|||
149207516|NCT03395223|538225334|FG000|Overall Study|Other|1|||
148684051|NCT00738920|536315080|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
148684052|NCT00738920|536315081|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
148684053|NCT00738920|536315082|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
148684054|NCT00738920|536315080|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
148684055|NCT00738920|536315081|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
148684056|NCT00738920|536315082|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
148948911|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
148948912|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
149207517|NCT01248364|538225338|FG000|Overall Study|Adverse Event|0|||
149207518|NCT01248364|538225339|FG001|Overall Study|Adverse Event|1|||
149207519|NCT01248364|538225340|FG002|Overall Study|Adverse Event|0|||
149207520|NCT01248364|538225341|FG003|Overall Study|Adverse Event|0|||
149207521|NCT01117012|538225344|FG000|Overall Study|Adverse Event|0|||
149207522|NCT01117012|538225345|FG001|Overall Study|Adverse Event|1|||
149207523|NCT01117012|538225344|FG000|Overall Study|Death|1|||
149207524|NCT01117012|538225345|FG001|Overall Study|Death|1|||
149207525|NCT01117012|538225344|FG000|Overall Study|Withdrawal by Subject|3|||
149207526|NCT01117012|538225345|FG001|Overall Study|Withdrawal by Subject|0|||
148948913|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
148948914|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
148948915|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
148948916|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
148948917|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Death|0|||
149207527|NCT01117012|538225344|FG000|Overall Study|Undefined|4|||
149207528|NCT01117012|538225345|FG001|Overall Study|Undefined|3|||
149207529|NCT05425719|538225348|FG000|Overall Study|Lost to Follow-up|4|||
149207530|NCT05425719|538225349|FG001|Overall Study|Lost to Follow-up|0|||
149207531|NCT05425719|538225348|FG000|Overall Study|Withdrew consent|1|||
149207532|NCT05425719|538225349|FG001|Overall Study|Withdrew consent|1|||
149207533|NCT04682353|538225352|FG000|Overall Study|Lost to Follow-up|0|||
149207534|NCT04682353|538225353|FG001|Overall Study|Lost to Follow-up|1|||
149207535|NCT04682353|538225354|FG002|Overall Study|Lost to Follow-up|0|||
149207536|NCT04682353|538225355|FG003|Overall Study|Lost to Follow-up|1|||
149207537|NCT04682353|538225352|FG000|Overall Study|Personal reasons|0|||
149207538|NCT04682353|538225353|FG001|Overall Study|Personal reasons|1|||
149207539|NCT04682353|538225354|FG002|Overall Study|Personal reasons|0|||
149207540|NCT04682353|538225355|FG003|Overall Study|Personal reasons|0|||
149207541|NCT02849626|538225356|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
149207542|NCT02849626|538225357|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
149207543|NCT02849626|538225358|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
149207544|NCT02849626|538225359|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
149207545|NCT02849626|538225356|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
149207546|NCT02849626|538225357|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
149207547|NCT02849626|538225358|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
149207548|NCT02849626|538225359|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
149207549|NCT02849626|538225356|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
149207550|NCT02849626|538225357|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
149207551|NCT02849626|538225358|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
149207552|NCT02849626|538225359|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
149207553|NCT02849626|538225356|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
149207554|NCT02849626|538225357|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
149207555|NCT02849626|538225358|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
149207556|NCT02849626|538225359|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
149207557|NCT02849626|538225356|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
149207558|NCT02849626|538225357|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
149207559|NCT02849626|538225358|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
149207560|NCT02849626|538225359|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
149207561|NCT02849626|538225356|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
149207562|NCT02849626|538225357|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
149207563|NCT02849626|538225358|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
149207564|NCT02849626|538225359|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
149207565|NCT02849626|538225356|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
149207566|NCT02849626|538225357|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
149207567|NCT02849626|538225358|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
149207568|NCT02849626|538225359|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
149207569|NCT02849626|538225356|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
149207570|NCT02849626|538225357|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
149207571|NCT02849626|538225358|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
149207572|NCT02849626|538225359|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
149207573|NCT02849626|538225356|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
149207574|NCT02849626|538225357|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
149207575|NCT02849626|538225358|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
149207576|NCT02849626|538225359|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
148948918|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Death|0|||
149207577|NCT02849626|538225356|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
149207578|NCT02849626|538225357|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
148809298|NCT02349386|536779261|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
148948919|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Death|0|||
149207579|NCT02849626|538225358|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
148948920|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Death|0|||
148948921|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Death|1|||
148948922|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Death|1|||
148948923|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Death|3|||
148948924|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Death|1|||
148948925|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Death|1|||
148948926|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Death|5|||
148948927|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Death|2|||
148948928|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Death|2|||
148948929|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Other|0|||
148948930|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Other|0|||
148948931|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Other|0|||
148948932|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Other|0|||
148948933|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Other|10|||
148948934|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Other|3|||
148948935|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Other|2|||
148948936|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Other|0|||
148948937|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Other|10|||
148948938|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Other|5|||
148948939|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Other|1|||
148948940|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Other|7|||
148948941|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948942|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948943|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948944|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948945|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
148948946|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948947|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948948|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948949|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948950|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948951|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948952|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148948953|NCT02521870|537297298|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948954|NCT02521870|537297299|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948955|NCT02521870|537297300|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948956|NCT02521870|537297301|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948957|NCT02521870|537297302|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
148948958|NCT02521870|537297303|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948959|NCT02521870|537297304|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948960|NCT02521870|537297305|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948961|NCT02521870|537297306|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948962|NCT02521870|537297307|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948963|NCT02521870|537297308|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948964|NCT02521870|537297309|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
148948965|NCT02862171|537297312|FG000|Overall Study|Death|1|||
148948966|NCT02862171|537297312|FG000|Overall Study|Lost to Follow-up|13|||
148948967|NCT02862171|537297312|FG000|Overall Study|Withdrawal by Subject|57|||
148948968|NCT02862171|537297312|FG000|Overall Study|Non-compliance|4|||
148948969|NCT02862171|537297312|FG000|Overall Study|HIV-1 seroconversion|18|||
148948970|NCT03930797|537297313|FG000|Overall Study|Lost to Follow-up|3|||
148948971|NCT03930797|537297314|FG001|Overall Study|Lost to Follow-up|10|||
148948972|NCT00662012|537297315|FG000|Overall Study|Lost to Follow-up|85|||
148948973|NCT00662012|537297315|FG000|Overall Study|Death|1|||
148948974|NCT00662012|537297315|FG000|Overall Study|Withdrawal by Subject|1|||
148948975|NCT02144012|537297318|FG000|Overall Study|Adverse Event|1|||
148948976|NCT02144012|537297319|FG001|Overall Study|Adverse Event|0|||
148948977|NCT02144012|537297318|FG000|Overall Study|Death|1|||
148948978|NCT02144012|537297319|FG001|Overall Study|Death|0|||
148948979|NCT02144012|537297318|FG000|Overall Study|Withdrawal by Subject|11|||
148948980|NCT02144012|537297319|FG001|Overall Study|Withdrawal by Subject|3|||
148948981|NCT02144012|537297318|FG000|Overall Study|Study Terminated by Sponsor|18|||
148948982|NCT02144012|537297319|FG001|Overall Study|Study Terminated by Sponsor|12|||
148948983|NCT02144012|537297318|FG000|Overall Study|Other|3|||
148948984|NCT02144012|537297319|FG001|Overall Study|Other|0|||
148948985|NCT00753415|537297320|FG000|Part A|Disease progression|1|||
148684057|NCT00738920|536315080|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
148948986|NCT00753415|537297321|FG001|Part A|Disease progression|0|||
148948987|NCT00753415|537297322|FG002|Part A|Disease progression|1|||
148948988|NCT00753415|537297323|FG003|Part A|Disease progression|2|||
148948989|NCT00753415|537297324|FG004|Part A|Disease progression|0|||
148948990|NCT00753415|537297325|FG005|Part A|Disease progression|0|||
148948991|NCT00753415|537297326|FG006|Part A|Disease progression|0|||
148948992|NCT00753415|537297327|FG007|Part A|Disease progression|0|||
148948993|NCT00753415|537297328|FG008|Part A|Disease progression|0|||
148948994|NCT00753415|537297329|FG009|Part A|Disease progression|0|||
148948995|NCT00753415|537297320|FG000|Part A|Withdrawal by Subject|0|||
149207580|NCT02849626|538225359|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
149207581|NCT02849626|538225356|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
149207582|NCT02849626|538225357|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
149207583|NCT02849626|538225358|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
149207584|NCT02849626|538225359|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
149207585|NCT03505749|538225362|FG000|Overall Study|Lost to Follow-up|7|||
149207586|NCT03505749|538225363|FG001|Overall Study|Lost to Follow-up|11|||
149207587|NCT03505749|538225362|FG000|Overall Study|Withdrawal by Subject|6|||
149207588|NCT03505749|538225363|FG001|Overall Study|Withdrawal by Subject|0|||
149207589|NCT03505749|538225362|FG000|Overall Study|Discharged from treatment|3|||
149207590|NCT03505749|538225363|FG001|Overall Study|Discharged from treatment|6|||
149207591|NCT01151540|538225364|FG000|Overall Study|Other|2|||
149207592|NCT01151540|538225364|FG000|Overall Study|Adverse event, non-fatal|4|||
149207593|NCT01151540|538225364|FG000|Overall Study|Withdrawal by Subject|7|||
149207594|NCT03846219|538225365|FG000|Overall Study|Withdrawal by Subject|3|||
149207595|NCT03846219|538225366|FG001|Overall Study|Withdrawal by Subject|2|||
149207596|NCT03846219|538225367|FG002|Overall Study|Withdrawal by Subject|2|||
149207597|NCT03846219|538225365|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
149207598|NCT03846219|538225366|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
149207599|NCT03846219|538225367|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
149207600|NCT03846219|538225365|FG000|Overall Study|Physician Decision|0|||
149207601|NCT03846219|538225366|FG001|Overall Study|Physician Decision|0|||
149207602|NCT03846219|538225367|FG002|Overall Study|Physician Decision|2|||
149207603|NCT04199793|538225370|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
149207604|NCT04199793|538225371|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
149207605|NCT04199793|538225370|FG000|Overall Study|Withdrawal by Subject|1|||
149207606|NCT04199793|538225371|FG001|Overall Study|Withdrawal by Subject|1|||
149207607|NCT03820726|538225376|FG000|Overall Study|Other than listed|23|||
149207608|NCT03820726|538225376|FG000|Overall Study|Withdrawal by Subject|37|||
149207609|NCT03820726|538225376|FG000|Overall Study|Lost to Follow-up|3|||
149207610|NCT03820726|538225376|FG000|Overall Study|Protocol deviation|1|||
149207611|NCT03820726|538225376|FG000|Overall Study|Adverse Event|146|||
149207612|NCT03820726|538225376|FG000|Overall Study|Not treated|1|||
148948996|NCT00753415|537297321|FG001|Part A|Withdrawal by Subject|0|||
149207613|NCT00628758|538225377|FG000|Overall Study|Adverse Event|2|||
149207614|NCT00628758|538225378|FG001|Overall Study|Adverse Event|3|||
149207615|NCT00628758|538225377|FG000|Overall Study|Withdrawal by Subject|6|||
149207616|NCT00628758|538225378|FG001|Overall Study|Withdrawal by Subject|3|||
148948997|NCT00753415|537297322|FG002|Part A|Withdrawal by Subject|1|||
148948998|NCT00753415|537297323|FG003|Part A|Withdrawal by Subject|0|||
148948999|NCT00753415|537297324|FG004|Part A|Withdrawal by Subject|0|||
149207617|NCT00628758|538225377|FG000|Overall Study|Death|1|||
149207618|NCT00628758|538225378|FG001|Overall Study|Death|0|||
149207619|NCT00628758|538225377|FG000|Overall Study|Protocol Violation|5|||
149207620|NCT00628758|538225378|FG001|Overall Study|Protocol Violation|1|||
149207621|NCT00628758|538225377|FG000|Overall Study|Lost to Follow-up|25|||
149207622|NCT00628758|538225378|FG001|Overall Study|Lost to Follow-up|31|||
149207623|NCT00628758|538225377|FG000|Overall Study|Pregnancy|2|||
149207624|NCT00628758|538225378|FG001|Overall Study|Pregnancy|2|||
149207625|NCT00628758|538225377|FG000|Overall Study|Investigator Moved|3|||
149207626|NCT00628758|538225378|FG001|Overall Study|Investigator Moved|0|||
149207627|NCT00628758|538225377|FG000|Overall Study|Treatment Failure|0|||
149207628|NCT00628758|538225378|FG001|Overall Study|Treatment Failure|2|||
149207629|NCT01938001|538225379|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
149207630|NCT01938001|538225380|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
149207631|NCT01938001|538225379|FG000|Pre-Treatment|Death|1|||
149207632|NCT01938001|538225380|FG001|Pre-Treatment|Death|0|||
149207633|NCT01938001|538225379|FG000|Treatment|Death|2|||
149207634|NCT01938001|538225380|FG001|Treatment|Death|0|||
149207635|NCT01938001|538225379|FG000|Treatment|Adverse Event|14|||
149207636|NCT01938001|538225380|FG001|Treatment|Adverse Event|8|||
149207637|NCT01938001|538225379|FG000|Treatment|Progressive Disease|21|||
149207638|NCT01938001|538225380|FG001|Treatment|Progressive Disease|54|||
149207639|NCT01938001|538225379|FG000|Treatment|Withdrawal by Subject|13|||
149207640|NCT01938001|538225380|FG001|Treatment|Withdrawal by Subject|7|||
149207641|NCT01938001|538225379|FG000|Treatment|Other reasons|2|||
149207642|NCT01938001|538225380|FG001|Treatment|Other reasons|1|||
149207643|NCT01626989|538225391|FG000|Screening Period|Screen Failure|15|||
149207644|NCT01626989|538225392|FG001|Screening Period|Screen Failure|0|||
149207645|NCT01626989|538225393|FG002|Screening Period|Screen Failure|0|||
149207646|NCT01626989|538225391|FG000|Screening Period|Withdrawal by Subject|2|||
149207647|NCT01626989|538225392|FG001|Screening Period|Withdrawal by Subject|0|||
149207648|NCT01626989|538225393|FG002|Screening Period|Withdrawal by Subject|0|||
149207649|NCT02293902|538225396|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
149207650|NCT02293902|538225397|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
149207651|NCT02293902|538225398|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
149207652|NCT02293902|538225399|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
149207653|NCT02293902|538225400|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
149207654|NCT02293902|538225396|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
149207655|NCT02293902|538225397|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
149207656|NCT02293902|538225398|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
149207657|NCT02293902|538225399|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
149207658|NCT02293902|538225400|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
149207659|NCT02293902|538225396|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
149207660|NCT02293902|538225397|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149207661|NCT02293902|538225398|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149207662|NCT02293902|538225399|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149207663|NCT02293902|538225400|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
149207664|NCT02293902|538225396|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
149207665|NCT02293902|538225397|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
149207666|NCT02293902|538225398|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
149207667|NCT02293902|538225399|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
149207668|NCT02293902|538225400|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
149207669|NCT02293902|538225396|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
149207670|NCT02293902|538225397|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
149207671|NCT02293902|538225398|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
149207672|NCT02293902|538225399|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
149207673|NCT02293902|538225400|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
149207674|NCT02947022|538225402|FG000|Overall Study|Study Stopped|1|||
149207675|NCT00107172|538226967|FG000|Overall Study|Withdrawal by Subject|1|||
149207676|NCT00107172|538226968|FG001|Overall Study|Withdrawal by Subject|0|||
149207677|NCT00107172|538226967|FG000|Overall Study|Death|0|||
149207678|NCT00107172|538226968|FG001|Overall Study|Death|2|||
149207679|NCT00107172|538226967|FG000|Overall Study|Other Reason|4|||
149207680|NCT00107172|538226968|FG001|Overall Study|Other Reason|3|||
148949000|NCT00753415|537297325|FG005|Part A|Withdrawal by Subject|0|||
149207681|NCT00927758|538226969|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149207682|NCT00927758|538226970|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149207683|NCT00927758|538226971|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
148949001|NCT00753415|537297326|FG006|Part A|Withdrawal by Subject|0|||
148949002|NCT00753415|537297327|FG007|Part A|Withdrawal by Subject|0|||
148949003|NCT00753415|537297328|FG008|Part A|Withdrawal by Subject|0|||
148949004|NCT00753415|537297329|FG009|Part A|Withdrawal by Subject|0|||
148949005|NCT00753415|537297320|FG000|Part B|Lost to Follow-up|0|||
148949006|NCT00753415|537297321|FG001|Part B|Lost to Follow-up|0|||
148949007|NCT00753415|537297322|FG002|Part B|Lost to Follow-up|0|||
148949008|NCT00753415|537297323|FG003|Part B|Lost to Follow-up|0|||
148949009|NCT00753415|537297324|FG004|Part B|Lost to Follow-up|0|||
148949010|NCT00753415|537297325|FG005|Part B|Lost to Follow-up|0|||
148949011|NCT00753415|537297326|FG006|Part B|Lost to Follow-up|0|||
148949012|NCT00753415|537297327|FG007|Part B|Lost to Follow-up|1|||
148949013|NCT00753415|537297328|FG008|Part B|Lost to Follow-up|1|||
148949014|NCT00753415|537297329|FG009|Part B|Lost to Follow-up|0|||
148949015|NCT00753415|537297320|FG000|Part B|Disease progression|0|||
148949016|NCT00753415|537297321|FG001|Part B|Disease progression|0|||
148949017|NCT00753415|537297322|FG002|Part B|Disease progression|0|||
148949018|NCT00753415|537297323|FG003|Part B|Disease progression|0|||
148949019|NCT00753415|537297324|FG004|Part B|Disease progression|0|||
148949020|NCT00753415|537297325|FG005|Part B|Disease progression|0|||
148949021|NCT00753415|537297326|FG006|Part B|Disease progression|0|||
148949022|NCT00753415|537297327|FG007|Part B|Disease progression|0|||
148949023|NCT00753415|537297328|FG008|Part B|Disease progression|2|||
148949024|NCT00753415|537297329|FG009|Part B|Disease progression|1|||
148949025|NCT04212650|537297330|FG000|Overall Study|Withdrawal by Subject|1|||
148949026|NCT04212650|537297331|FG001|Overall Study|Withdrawal by Subject|0|||
148949027|NCT04656691|537297333|FG000|Overall Study|Adverse Event|1|||
148949028|NCT02846779|537297336|FG000|Overall Study|Lost Enrollment|83|||
148949029|NCT02846779|537297337|FG001|Overall Study|Lost Enrollment|82|||
148949030|NCT02846779|537297338|FG002|Overall Study|Lost Enrollment|86|||
148949031|NCT02846779|537297336|FG000|Overall Study|Less than 31 days of follow-up|56|||
148949032|NCT02846779|537297337|FG001|Overall Study|Less than 31 days of follow-up|45|||
148949033|NCT02846779|537297338|FG002|Overall Study|Less than 31 days of follow-up|52|||
148949034|NCT01753856|537297341|FG000|Overall Study|Adverse Event|1|||
148949035|NCT01753856|537297342|FG001|Overall Study|Adverse Event|0|||
148949036|NCT01753856|537297341|FG000|Overall Study|Withdrawal by Subject|0|||
148949037|NCT01753856|537297342|FG001|Overall Study|Withdrawal by Subject|2|||
149207684|NCT00927758|538226972|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
149207685|NCT00927758|538226973|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
149207686|NCT00927758|538226974|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
149207687|NCT00927758|538226969|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
149207688|NCT00927758|538226970|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
149207689|NCT00927758|538226971|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
149207690|NCT00927758|538226972|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
149207691|NCT00927758|538226973|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
149207692|NCT00927758|538226974|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
149207693|NCT00439725|538226976|FG000|Treatment Period|Withdrawal by Subject|22|||
149207694|NCT00439725|538226977|FG001|Treatment Period|Withdrawal by Subject|19|||
149207695|NCT00439725|538226976|FG000|Treatment Period|Study terminated by sponsor|156|||
149207696|NCT00439725|538226977|FG001|Treatment Period|Study terminated by sponsor|148|||
149207697|NCT00439725|538226976|FG000|Treatment Period|Site closed by investigator|1|||
149207698|NCT00439725|538226977|FG001|Treatment Period|Site closed by investigator|2|||
149207699|NCT00439725|538226976|FG000|Treatment Period|Adverse Event|39|||
149207700|NCT00439725|538226977|FG001|Treatment Period|Adverse Event|18|||
149207701|NCT00439725|538226976|FG000|Treatment Period|Physician Decision|1|||
149207702|NCT00439725|538226977|FG001|Treatment Period|Physician Decision|1|||
149207703|NCT00439725|538226976|FG000|Treatment Period|Protocol Violation|2|||
149207704|NCT00439725|538226977|FG001|Treatment Period|Protocol Violation|1|||
149207705|NCT00439725|538226976|FG000|Treatment Period|Clinical endpoint reached|6|||
149207706|NCT00439725|538226977|FG001|Treatment Period|Clinical endpoint reached|50|||
148949038|NCT01753856|537297341|FG000|Overall Study|Sponsor Decision|2|||
148949039|NCT01753856|537297342|FG001|Overall Study|Sponsor Decision|0|||
148949040|NCT00887978|537297343|FG000|Overall Study|Adverse Event|18|||
148949041|NCT00887978|537297344|FG001|Overall Study|Adverse Event|5|||
148949042|NCT00887978|537297343|FG000|Overall Study|Clinical Worsening|4|||
148949043|NCT00887978|537297344|FG001|Overall Study|Clinical Worsening|4|||
148949044|NCT00887978|537297343|FG000|Overall Study|Death|2|||
148949045|NCT00887978|537297344|FG001|Overall Study|Death|3|||
148949046|NCT00887978|537297343|FG000|Overall Study|Withdrawal by Subject|1|||
148949047|NCT00887978|537297344|FG001|Overall Study|Withdrawal by Subject|2|||
148684058|NCT00738920|536315081|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
148684059|NCT00738920|536315082|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
148684060|NCT00738920|536315080|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
148684061|NCT00738920|536315081|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
149207707|NCT00439725|538226976|FG000|Treatment Period|Technical problems|1|||
148684062|NCT00738920|536315082|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
149207708|NCT00439725|538226977|FG001|Treatment Period|Technical problems|0|||
149207709|NCT00439725|538226976|FG000|Treatment Period|Lost to Follow-up|1|||
149207710|NCT00439725|538226977|FG001|Treatment Period|Lost to Follow-up|1|||
149207711|NCT00439725|538226976|FG000|Treatment Period|Participant convenience|1|||
149207712|NCT00439725|538226977|FG001|Treatment Period|Participant convenience|0|||
149207713|NCT00439725|538226976|FG000|Treatment Period|Protocol driven decision point|1|||
149207714|NCT00439725|538226977|FG001|Treatment Period|Protocol driven decision point|1|||
149207715|NCT00439725|538226976|FG000|Treatment Period|Death|1|||
149207716|NCT00439725|538226977|FG001|Treatment Period|Death|1|||
149207717|NCT00439725|538226976|FG000|Treatment Period|Participant did not receive treatment|4|||
149207718|NCT00439725|538226977|FG001|Treatment Period|Participant did not receive treatment|4|||
149207719|NCT00439725|538226976|FG000|Observational Period|Withdrawal by Subject|2|||
149207720|NCT00439725|538226977|FG001|Observational Period|Withdrawal by Subject|2|||
149207721|NCT00439725|538226976|FG000|Observational Period|Lost to Follow-up|0|||
149207722|NCT00439725|538226977|FG001|Observational Period|Lost to Follow-up|1|||
149207723|NCT00439725|538226976|FG000|Observational Period|Death|0|||
149207724|NCT00439725|538226977|FG001|Observational Period|Death|2|||
149207725|NCT00439725|538226976|FG000|Observational Period|Study termination by sponsor|1|||
149207726|NCT00439725|538226977|FG001|Observational Period|Study termination by sponsor|1|||
149207727|NCT00439725|538226976|FG000|Observational Period|Clinical endpoint reached|3|||
149207728|NCT00439725|538226977|FG001|Observational Period|Clinical endpoint reached|1|||
149207729|NCT00439725|538226976|FG000|Observational Period|Technical problems|1|||
149207730|NCT00439725|538226977|FG001|Observational Period|Technical problems|0|||
149207731|NCT00439725|538226976|FG000|Observational Period|Participant convenience|1|||
149207732|NCT00439725|538226977|FG001|Observational Period|Participant convenience|0|||
149207733|NCT01544478|538226978|FG000|Overall Study|Adverse Event|1|||
149207734|NCT01544478|538226978|FG000|Overall Study|Death|1|||
149207735|NCT01544478|538226978|FG000|Overall Study|Lost to Follow-up|48|||
149207736|NCT01544478|538226978|FG000|Overall Study|Physician Decision|15|||
149207737|NCT01544478|538226978|FG000|Overall Study|Pregnancy|1|||
149207738|NCT01544478|538226978|FG000|Overall Study|Withdrawal by Subject|52|||
149207739|NCT00212758|538226979|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
148684063|NCT00738920|536315080|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
148684064|NCT00738920|536315081|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
148684065|NCT00738920|536315082|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
148684066|NCT00811070|536315083|FG000|Overall Study|Death|0|||
148684067|NCT00811070|536315084|FG001|Overall Study|Death|0|||
148684068|NCT00811070|536315085|FG002|Overall Study|Death|0|||
148684069|NCT00811070|536315086|FG003|Overall Study|Death|2|||
148684070|NCT00811070|536315087|FG004|Overall Study|Death|5|||
148684071|NCT00811070|536315088|FG005|Overall Study|Death|0|||
148684072|NCT00811070|536315083|FG000|Overall Study|Other|1|||
148684073|NCT00811070|536315084|FG001|Overall Study|Other|0|||
148684074|NCT00811070|536315085|FG002|Overall Study|Other|0|||
148684075|NCT00811070|536315086|FG003|Overall Study|Other|0|||
148684076|NCT00811070|536315087|FG004|Overall Study|Other|0|||
148684077|NCT00811070|536315088|FG005|Overall Study|Other|0|||
148684078|NCT00811070|536315083|FG000|Overall Study|Withdrawal by Subject|0|||
148684079|NCT00811070|536315084|FG001|Overall Study|Withdrawal by Subject|1|||
148684080|NCT00811070|536315085|FG002|Overall Study|Withdrawal by Subject|0|||
148684081|NCT00811070|536315086|FG003|Overall Study|Withdrawal by Subject|0|||
148684082|NCT00811070|536315087|FG004|Overall Study|Withdrawal by Subject|0|||
148684083|NCT00811070|536315088|FG005|Overall Study|Withdrawal by Subject|0|||
149207740|NCT00212758|538226980|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
148684084|NCT00811070|536315083|FG000|Overall Study|Physician Decision|0|||
148684085|NCT00811070|536315084|FG001|Overall Study|Physician Decision|0|||
148684086|NCT00811070|536315085|FG002|Overall Study|Physician Decision|0|||
148684087|NCT00811070|536315086|FG003|Overall Study|Physician Decision|0|||
148684088|NCT00811070|536315087|FG004|Overall Study|Physician Decision|0|||
148684089|NCT00811070|536315088|FG005|Overall Study|Physician Decision|1|||
149207741|NCT00212758|538226979|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
148684090|NCT00665626|536315094|FG000|Overall Study|Lack of Efficacy|8|||
148684091|NCT00665626|536315095|FG001|Overall Study|Lack of Efficacy|5|||
148684092|NCT00665626|536315094|FG000|Overall Study|Lost to Follow-up|0|||
149207742|NCT00212758|538226980|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
149207743|NCT02574481|538226981|FG000|Overall Study|Withdrawal by Subject|29|||
148684093|NCT00665626|536315095|FG001|Overall Study|Lost to Follow-up|2|||
148684094|NCT00665626|536315094|FG000|Overall Study|Withdrawal by Subject|0|||
149207744|NCT02574481|538226982|FG001|Overall Study|Withdrawal by Subject|15|||
149207745|NCT02574481|538226983|FG002|Overall Study|Withdrawal by Subject|4|||
149207746|NCT02574481|538226984|FG003|Overall Study|Withdrawal by Subject|1|||
149207747|NCT02574481|538226981|FG000|Overall Study|Adverse Event|5|||
149207748|NCT02574481|538226982|FG001|Overall Study|Adverse Event|1|||
149207749|NCT02574481|538226983|FG002|Overall Study|Adverse Event|1|||
149207750|NCT02574481|538226984|FG003|Overall Study|Adverse Event|0|||
149207751|NCT02574481|538226981|FG000|Overall Study|Visit Missed|15|||
149207752|NCT02574481|538226982|FG001|Overall Study|Visit Missed|7|||
149207753|NCT02574481|538226983|FG002|Overall Study|Visit Missed|5|||
149207754|NCT02574481|538226984|FG003|Overall Study|Visit Missed|0|||
149207755|NCT02574481|538226981|FG000|Overall Study|Other|7|||
149207756|NCT02574481|538226982|FG001|Overall Study|Other|2|||
149207757|NCT02574481|538226983|FG002|Overall Study|Other|0|||
149207758|NCT02574481|538226984|FG003|Overall Study|Other|0|||
149207759|NCT02574481|538226981|FG000|Overall Study|Death|48|||
149207760|NCT02574481|538226982|FG001|Overall Study|Death|26|||
149207761|NCT02574481|538226983|FG002|Overall Study|Death|12|||
149207762|NCT02574481|538226984|FG003|Overall Study|Death|4|||
149207763|NCT02574481|538226981|FG000|Overall Study|Physician Decision|5|||
149207764|NCT02574481|538226982|FG001|Overall Study|Physician Decision|2|||
149207765|NCT02574481|538226983|FG002|Overall Study|Physician Decision|0|||
149207766|NCT02574481|538226984|FG003|Overall Study|Physician Decision|0|||
149207767|NCT02574481|538226981|FG000|Overall Study|Lost to Follow-up|5|||
149207768|NCT02574481|538226982|FG001|Overall Study|Lost to Follow-up|1|||
149207769|NCT02574481|538226983|FG002|Overall Study|Lost to Follow-up|3|||
149207770|NCT02574481|538226984|FG003|Overall Study|Lost to Follow-up|0|||
149207771|NCT04209530|538226991|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
149207772|NCT04209530|538226992|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
149207773|NCT04209530|538226991|FG000|Overall Study|Withdrawal by Subject|0|||
149207774|NCT04209530|538226992|FG001|Overall Study|Withdrawal by Subject|1|||
149207775|NCT00810043|538226995|FG000|Overall Study|Withdrawal by Subject|1|||
149207776|NCT00810043|538226996|FG001|Overall Study|Withdrawal by Subject|0|||
149207777|NCT00810043|538226997|FG002|Overall Study|Withdrawal by Subject|2|||
149207778|NCT00810043|538226995|FG000|Overall Study|Lost to Follow-up|1|||
149207779|NCT00810043|538226996|FG001|Overall Study|Lost to Follow-up|0|||
149207780|NCT00810043|538226997|FG002|Overall Study|Lost to Follow-up|0|||
149207781|NCT00810043|538226995|FG000|Overall Study|Physician Decision|0|||
149207782|NCT00810043|538226996|FG001|Overall Study|Physician Decision|0|||
149207783|NCT00810043|538226997|FG002|Overall Study|Physician Decision|2|||
149207784|NCT00810043|538226995|FG000|Overall Study|Death|2|||
149207785|NCT00810043|538226996|FG001|Overall Study|Death|0|||
149207786|NCT00810043|538226997|FG002|Overall Study|Death|0|||
149207787|NCT00810043|538226995|FG000|Overall Study|Unrelated medical problem|0|||
149207788|NCT00810043|538226996|FG001|Overall Study|Unrelated medical problem|1|||
149207789|NCT00810043|538226997|FG002|Overall Study|Unrelated medical problem|0|||
149207790|NCT00810043|538226995|FG000|Overall Study|Non-medical problem|0|||
149207791|NCT00810043|538226996|FG001|Overall Study|Non-medical problem|0|||
149207792|NCT00810043|538226997|FG002|Overall Study|Non-medical problem|1|||
149207793|NCT00810043|538226995|FG000|Overall Study|No longer met enrollment criteria|0|||
149207794|NCT00810043|538226996|FG001|Overall Study|No longer met enrollment criteria|0|||
149207795|NCT00810043|538226997|FG002|Overall Study|No longer met enrollment criteria|3|||
149207796|NCT02001688|538226998|FG000|Overall Study|Withdrawal by Subject|0|||
149207797|NCT02001688|538226999|FG001|Overall Study|Withdrawal by Subject|0|||
149207798|NCT02001688|538227000|FG002|Overall Study|Withdrawal by Subject|1|||
149207799|NCT02001688|538226998|FG000|Overall Study|Adverse Event|0|||
149207800|NCT02001688|538226999|FG001|Overall Study|Adverse Event|1|||
149207801|NCT02001688|538227000|FG002|Overall Study|Adverse Event|0|||
149207802|NCT00105183|538227004|FG000|Overall Study|Death|19|||
149207803|NCT00105183|538227005|FG001|Overall Study|Death|13|||
149207804|NCT00105183|538227006|FG002|Overall Study|Death|15|||
149207805|NCT00105183|538227004|FG000|Overall Study|Withdrawal by Subject|1|||
149207806|NCT00105183|538227005|FG001|Overall Study|Withdrawal by Subject|1|||
149207807|NCT00105183|538227006|FG002|Overall Study|Withdrawal by Subject|4|||
149207808|NCT00105183|538227004|FG000|Overall Study|Physician Decision|1|||
149207809|NCT00105183|538227005|FG001|Overall Study|Physician Decision|2|||
149207810|NCT00105183|538227006|FG002|Overall Study|Physician Decision|3|||
149207811|NCT00105183|538227004|FG000|Overall Study|Lost to Follow-up|0|||
149207812|NCT00105183|538227005|FG001|Overall Study|Lost to Follow-up|1|||
149207813|NCT00105183|538227006|FG002|Overall Study|Lost to Follow-up|1|||
149207814|NCT00105183|538227004|FG000|Overall Study|Other reason|1|||
149207815|NCT00105183|538227005|FG001|Overall Study|Other reason|2|||
149207816|NCT00105183|538227006|FG002|Overall Study|Other reason|0|||
149207817|NCT04702984|538227008|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
149207818|NCT01467661|538227011|FG000|Overall Study|Adverse Event|16|||
149207819|NCT01467661|538227011|FG000|Overall Study|Withdrawal by Subject|1|||
149207820|NCT01467661|538227011|FG000|Overall Study|Lack of Efficacy|3|||
149207821|NCT01467661|538227011|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
149207822|NCT03037307|538227012|FG000|Period 1|Did Not Meet Study Criteria|0|||
148949048|NCT00887978|537297343|FG000|Overall Study|Lost to Follow-up|0|||
148949049|NCT00887978|537297344|FG001|Overall Study|Lost to Follow-up|1|||
148949050|NCT02700815|537299522|FG000|Overall Study|Adverse Event|0|||
148949051|NCT02700815|537299523|FG001|Overall Study|Adverse Event|6|||
149207823|NCT03037307|538227013|FG001|Period 1|Did Not Meet Study Criteria|0|||
149207824|NCT03037307|538227014|FG002|Period 1|Did Not Meet Study Criteria|0|||
149207825|NCT03037307|538227015|FG003|Period 1|Did Not Meet Study Criteria|1|||
149207826|NCT03037307|538227016|FG004|Period 1|Did Not Meet Study Criteria|0|||
149207827|NCT03037307|538227017|FG005|Period 1|Did Not Meet Study Criteria|0|||
149207828|NCT00270998|538227020|FG000|3 Month Follow-up|Adverse Event|1|||
149207829|NCT00270998|538227021|FG001|3 Month Follow-up|Adverse Event|0|||
149207830|NCT00270998|538227022|FG002|3 Month Follow-up|Adverse Event|0|||
149207831|NCT00270998|538227020|FG000|3 Month Follow-up|Lack of Efficacy|1|||
149207832|NCT00270998|538227021|FG001|3 Month Follow-up|Lack of Efficacy|2|||
149207833|NCT00270998|538227022|FG002|3 Month Follow-up|Lack of Efficacy|1|||
149207834|NCT00270998|538227020|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
149207835|NCT00270998|538227021|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
149207836|NCT00270998|538227022|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
149207837|NCT00270998|538227020|FG000|3 Month Follow-up|Pessary did not fit|12|||
149207838|NCT00270998|538227021|FG001|3 Month Follow-up|Pessary did not fit|0|||
149207839|NCT00270998|538227022|FG002|3 Month Follow-up|Pessary did not fit|0|||
149207840|NCT00270998|538227020|FG000|3 Month Follow-up|Personal/family health|1|||
149207841|NCT00270998|538227021|FG001|3 Month Follow-up|Personal/family health|1|||
149207842|NCT00270998|538227022|FG002|3 Month Follow-up|Personal/family health|0|||
149207843|NCT00270998|538227020|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
149207844|NCT00270998|538227021|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
149207845|NCT00270998|538227022|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
149207846|NCT00270998|538227020|FG000|12 Month Follow-up|Lack of Efficacy|5|||
149207847|NCT00270998|538227021|FG001|12 Month Follow-up|Lack of Efficacy|4|||
149207848|NCT00270998|538227022|FG002|12 Month Follow-up|Lack of Efficacy|3|||
149207849|NCT00270998|538227020|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
149207850|NCT00270998|538227021|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
149207851|NCT00270998|538227022|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
149207852|NCT00270998|538227020|FG000|12 Month Follow-up|Pessary did not fit|1|||
149207853|NCT00270998|538227021|FG001|12 Month Follow-up|Pessary did not fit|0|||
149207854|NCT00270998|538227022|FG002|12 Month Follow-up|Pessary did not fit|0|||
149207855|NCT00270998|538227020|FG000|12 Month Follow-up|Personal/family health|0|||
149207856|NCT00270998|538227021|FG001|12 Month Follow-up|Personal/family health|5|||
149207857|NCT00270998|538227022|FG002|12 Month Follow-up|Personal/family health|1|||
149207858|NCT00270998|538227020|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
149207859|NCT00270998|538227021|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
149207860|NCT00270998|538227022|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
149207861|NCT01855945|538227023|FG000|Overall Study|Adverse Event|0|||
149207862|NCT01855945|538227024|FG001|Overall Study|Adverse Event|0|||
149207863|NCT01855945|538227025|FG002|Overall Study|Adverse Event|0|||
149207864|NCT01855945|538227026|FG003|Overall Study|Adverse Event|0|||
149207865|NCT01855945|538227027|FG004|Overall Study|Adverse Event|0|||
149207866|NCT01855945|538227028|FG005|Overall Study|Adverse Event|0|||
149207867|NCT01855945|538227029|FG006|Overall Study|Adverse Event|1|||
149207868|NCT01855945|538227030|FG007|Overall Study|Adverse Event|0|||
149207869|NCT01855945|538227031|FG008|Overall Study|Adverse Event|0|||
149207870|NCT01855945|538227032|FG009|Overall Study|Adverse Event|0|||
149207871|NCT01855945|538227033|FG010|Overall Study|Adverse Event|0|||
149207872|NCT01855945|538227034|FG011|Overall Study|Adverse Event|0|||
149207873|NCT01855945|538227023|FG000|Overall Study|Death|0|||
149207874|NCT01855945|538227024|FG001|Overall Study|Death|0|||
149207875|NCT01855945|538227025|FG002|Overall Study|Death|0|||
149207876|NCT01855945|538227026|FG003|Overall Study|Death|0|||
149207877|NCT01855945|538227027|FG004|Overall Study|Death|0|||
149207878|NCT01855945|538227028|FG005|Overall Study|Death|0|||
149207879|NCT01855945|538227029|FG006|Overall Study|Death|2|||
149207880|NCT01855945|538227030|FG007|Overall Study|Death|0|||
149207881|NCT01855945|538227031|FG008|Overall Study|Death|0|||
149207882|NCT01855945|538227032|FG009|Overall Study|Death|0|||
149207883|NCT01855945|538227033|FG010|Overall Study|Death|0|||
149207884|NCT01855945|538227034|FG011|Overall Study|Death|0|||
149207885|NCT01855945|538227023|FG000|Overall Study|Lost to Follow-up|11|||
149207886|NCT01855945|538227024|FG001|Overall Study|Lost to Follow-up|10|||
148949052|NCT02700815|537299524|FG002|Overall Study|Adverse Event|2|||
149207887|NCT01855945|538227025|FG002|Overall Study|Lost to Follow-up|7|||
149207888|NCT01855945|538227026|FG003|Overall Study|Lost to Follow-up|3|||
149207889|NCT01855945|538227027|FG004|Overall Study|Lost to Follow-up|0|||
149207890|NCT01855945|538227028|FG005|Overall Study|Lost to Follow-up|3|||
148949053|NCT02700815|537299525|FG003|Overall Study|Adverse Event|3|||
149207891|NCT01855945|538227029|FG006|Overall Study|Lost to Follow-up|4|||
148949054|NCT02700815|537299522|FG000|Overall Study|Lack of Efficacy|0|||
148949055|NCT02700815|537299523|FG001|Overall Study|Lack of Efficacy|0|||
148949056|NCT02700815|537299524|FG002|Overall Study|Lack of Efficacy|1|||
149207892|NCT01855945|538227030|FG007|Overall Study|Lost to Follow-up|7|||
149207893|NCT01855945|538227031|FG008|Overall Study|Lost to Follow-up|2|||
149207894|NCT01855945|538227032|FG009|Overall Study|Lost to Follow-up|0|||
149207895|NCT01855945|538227033|FG010|Overall Study|Lost to Follow-up|0|||
149207896|NCT01855945|538227034|FG011|Overall Study|Lost to Follow-up|2|||
149207897|NCT01855945|538227023|FG000|Overall Study|Other - Unclassified|1|||
148949057|NCT02700815|537299525|FG003|Overall Study|Lack of Efficacy|2|||
148949058|NCT02700815|537299522|FG000|Overall Study|Lost to Follow-up|1|||
148949059|NCT02700815|537299523|FG001|Overall Study|Lost to Follow-up|0|||
148949060|NCT02700815|537299524|FG002|Overall Study|Lost to Follow-up|0|||
148949061|NCT02700815|537299525|FG003|Overall Study|Lost to Follow-up|1|||
148949062|NCT02700815|537299522|FG000|Overall Study|Refusal to continue medication|0|||
148949063|NCT02700815|537299523|FG001|Overall Study|Refusal to continue medication|1|||
148949064|NCT02700815|537299524|FG002|Overall Study|Refusal to continue medication|0|||
148949065|NCT02700815|537299525|FG003|Overall Study|Refusal to continue medication|1|||
148949066|NCT02700815|537299522|FG000|Overall Study|Withdrawal by Subject|0|||
148949067|NCT02700815|537299523|FG001|Overall Study|Withdrawal by Subject|0|||
148949068|NCT02700815|537299524|FG002|Overall Study|Withdrawal by Subject|1|||
148949069|NCT02700815|537299525|FG003|Overall Study|Withdrawal by Subject|0|||
148949070|NCT02495168|537299526|FG000|Overall Study|Other than Specified|18|||
148949071|NCT02495168|537299527|FG001|Overall Study|Other than Specified|22|||
148949072|NCT02495168|537299528|FG002|Overall Study|Other than Specified|5|||
148949073|NCT02495168|537299526|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
148949074|NCT02495168|537299527|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
148949075|NCT02495168|537299528|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
148949076|NCT02495168|537299526|FG000|Overall Study|Physician Decision|1|||
148949077|NCT02495168|537299527|FG001|Overall Study|Physician Decision|1|||
148949078|NCT02495168|537299528|FG002|Overall Study|Physician Decision|0|||
148949079|NCT02495168|537299526|FG000|Overall Study|Lost to Follow-up|10|||
148949080|NCT02495168|537299527|FG001|Overall Study|Lost to Follow-up|6|||
148949081|NCT02495168|537299528|FG002|Overall Study|Lost to Follow-up|1|||
148949082|NCT02495168|537299526|FG000|Overall Study|Withdrawal by Subject|1|||
148949083|NCT02495168|537299527|FG001|Overall Study|Withdrawal by Subject|4|||
148949084|NCT02495168|537299528|FG002|Overall Study|Withdrawal by Subject|2|||
148949085|NCT02495168|537299526|FG000|Overall Study|Protocol Violation|0|||
148949086|NCT02495168|537299527|FG001|Overall Study|Protocol Violation|10|||
148949087|NCT02495168|537299528|FG002|Overall Study|Protocol Violation|1|||
148949088|NCT02495168|537299526|FG000|Overall Study|Adverse Event|4|||
148949089|NCT02495168|537299527|FG001|Overall Study|Adverse Event|8|||
148949090|NCT02495168|537299528|FG002|Overall Study|Adverse Event|3|||
148949091|NCT02495168|537299526|FG000|Overall Study|Lack of Efficacy|0|||
148949092|NCT02495168|537299527|FG001|Overall Study|Lack of Efficacy|0|||
148949093|NCT02495168|537299528|FG002|Overall Study|Lack of Efficacy|3|||
148949094|NCT00284050|537299531|FG000|Overall Study|Adverse Event|1|||
148949095|NCT00284050|537299532|FG001|Overall Study|Adverse Event|1|||
148949096|NCT00284050|537299533|FG002|Overall Study|Adverse Event|1|||
148949097|NCT00284050|537299531|FG000|Overall Study|Lack of Efficacy|0|||
148949098|NCT00284050|537299532|FG001|Overall Study|Lack of Efficacy|1|||
148949099|NCT00284050|537299533|FG002|Overall Study|Lack of Efficacy|3|||
148949100|NCT00284050|537299531|FG000|Overall Study|Protocol Violation|0|||
148949101|NCT00284050|537299532|FG001|Overall Study|Protocol Violation|1|||
148949102|NCT00284050|537299533|FG002|Overall Study|Protocol Violation|2|||
148949103|NCT00284050|537299531|FG000|Overall Study|Withdrawal by Subject|2|||
148949104|NCT00284050|537299532|FG001|Overall Study|Withdrawal by Subject|2|||
148949105|NCT00284050|537299533|FG002|Overall Study|Withdrawal by Subject|2|||
148949106|NCT00284050|537299531|FG000|Overall Study|Lost to Follow-up|1|||
149207898|NCT01855945|538227024|FG001|Overall Study|Other - Unclassified|1|||
149207899|NCT01855945|538227025|FG002|Overall Study|Other - Unclassified|1|||
149207900|NCT01855945|538227026|FG003|Overall Study|Other - Unclassified|0|||
148949107|NCT00284050|537299532|FG001|Overall Study|Lost to Follow-up|0|||
148949108|NCT00284050|537299533|FG002|Overall Study|Lost to Follow-up|1|||
148949109|NCT00284050|537299531|FG000|Overall Study|Death|1|||
148949110|NCT00284050|537299532|FG001|Overall Study|Death|0|||
148949111|NCT00284050|537299533|FG002|Overall Study|Death|0|||
148949112|NCT02573350|537299534|FG000|Overall Study|Lost to Follow-up|2|||
148949113|NCT02573350|537299535|FG001|Overall Study|Lost to Follow-up|1|||
148949114|NCT02573350|537299534|FG000|Overall Study|Adverse Event|3|||
148949115|NCT02573350|537299535|FG001|Overall Study|Adverse Event|4|||
149207901|NCT01855945|538227027|FG004|Overall Study|Other - Unclassified|0|||
148949116|NCT02573350|537299534|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
148949117|NCT02573350|537299535|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
148949118|NCT02573350|537299534|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
148949119|NCT02573350|537299535|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
149207902|NCT01855945|538227028|FG005|Overall Study|Other - Unclassified|0|||
149207903|NCT01855945|538227029|FG006|Overall Study|Other - Unclassified|2|||
149207904|NCT01855945|538227030|FG007|Overall Study|Other - Unclassified|1|||
149207905|NCT01855945|538227031|FG008|Overall Study|Other - Unclassified|0|||
149207906|NCT01855945|538227032|FG009|Overall Study|Other - Unclassified|0|||
148949120|NCT02573350|537299534|FG000|Overall Study|Subject withdrew consent to participate|6|||
148949121|NCT02573350|537299535|FG001|Overall Study|Subject withdrew consent to participate|1|||
148949122|NCT02573350|537299534|FG000|Overall Study|Protocol Deviation|1|||
148949123|NCT02573350|537299535|FG001|Overall Study|Protocol Deviation|1|||
148949124|NCT02708121|537299536|FG000|Overall Study|Withdrawn by Study Team|1|||
148949125|NCT02708121|537299537|FG001|Overall Study|Withdrawn by Study Team|1|||
148949126|NCT02708121|537299536|FG000|Overall Study|Withdrawal by Subject|0|||
148949127|NCT02708121|537299537|FG001|Overall Study|Withdrawal by Subject|4|||
148949128|NCT01987505|537299538|FG000|Overall Study|Other|9|||
148949129|NCT01987505|537299538|FG000|Overall Study|Withdrawal by Subject|2|||
148949130|NCT01987505|537299538|FG000|Overall Study|Other Reason|2|||
148949131|NCT01987505|537299538|FG000|Overall Study|Lost to Follow-up|15|||
148949132|NCT01987505|537299538|FG000|Overall Study|Investigator Decision|2|||
148949133|NCT01987505|537299538|FG000|Overall Study|Death|4|||
148949134|NCT03454997|537299539|FG000|Overall Study|Staff Coach - Left Oranization|1|||
148949135|NCT03454997|537299540|FG001|Overall Study|Staff Coach - Left Oranization|1|||
148949136|NCT03454997|537299539|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
148949137|NCT03454997|537299540|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
148949138|NCT03454997|537299539|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
148949139|NCT03454997|537299540|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
148949140|NCT03454997|537299539|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
148949141|NCT03454997|537299540|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
148949142|NCT03454997|537299539|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
148949143|NCT03454997|537299540|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
148949144|NCT03454997|537299539|FG000|Overall Study|Client with SMI - Left organization|0|||
148949145|NCT03454997|537299540|FG001|Overall Study|Client with SMI - Left organization|1|||
148949146|NCT03454997|537299539|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
148949147|NCT03454997|537299540|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
148949148|NCT01111149|537299541|FG000|Overall Study|Protocol Violation|1|||
148949149|NCT01111149|537299542|FG001|Overall Study|Protocol Violation|1|||
148949150|NCT01111149|537299543|FG002|Overall Study|Protocol Violation|2|||
148949151|NCT01111149|537299541|FG000|Overall Study|Withdrawal by Subject|1|||
148949152|NCT01111149|537299542|FG001|Overall Study|Withdrawal by Subject|0|||
148949153|NCT01111149|537299543|FG002|Overall Study|Withdrawal by Subject|2|||
148949154|NCT03765918|537299553|FG000|Overall Study|Death|109|||
148949155|NCT03765918|537299554|FG001|Overall Study|Death|127|||
148949156|NCT03765918|537299553|FG000|Overall Study|Lost to Follow-up|2|||
148949157|NCT03765918|537299554|FG001|Overall Study|Lost to Follow-up|3|||
148949158|NCT03765918|537299553|FG000|Overall Study|Withdrawal by Subject|12|||
148949159|NCT03765918|537299554|FG001|Overall Study|Withdrawal by Subject|16|||
148949160|NCT03765918|537299553|FG000|Overall Study|Participants Ongoing|240|||
148949161|NCT03765918|537299554|FG001|Overall Study|Participants Ongoing|205|||
148949162|NCT04202965|537299555|FG000|Overall Study|Adverse Event|3|||
148949163|NCT04202965|537299555|FG000|Overall Study|Did not meet inclusion criteria|1|||
148949164|NCT02794883|537299559|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
148949165|NCT02794883|537299560|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
148949166|NCT02794883|537299561|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
148949167|NCT02794883|537299559|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
148949168|NCT02794883|537299560|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
148949169|NCT02794883|537299561|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
148949170|NCT02794883|537299559|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
148949171|NCT02794883|537299560|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
148949172|NCT02794883|537299561|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
149207907|NCT01855945|538227033|FG010|Overall Study|Other - Unclassified|1|||
149207908|NCT01855945|538227034|FG011|Overall Study|Other - Unclassified|0|||
149207909|NCT01855945|538227023|FG000|Overall Study|Withdrawal by Subject|4|||
149207910|NCT01855945|538227024|FG001|Overall Study|Withdrawal by Subject|0|||
148949173|NCT02794883|537299559|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
148949174|NCT02794883|537299560|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
148949175|NCT02794883|537299561|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
148949176|NCT02794883|537299559|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
148949177|NCT02794883|537299560|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
148949178|NCT02794883|537299561|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
148949179|NCT02794883|537299559|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
148949180|NCT02794883|537299560|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
148949181|NCT02794883|537299561|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
149207911|NCT01855945|538227025|FG002|Overall Study|Withdrawal by Subject|4|||
149207912|NCT01855945|538227026|FG003|Overall Study|Withdrawal by Subject|1|||
149207913|NCT01855945|538227027|FG004|Overall Study|Withdrawal by Subject|1|||
149207914|NCT01855945|538227028|FG005|Overall Study|Withdrawal by Subject|0|||
149207915|NCT01855945|538227029|FG006|Overall Study|Withdrawal by Subject|1|||
149207916|NCT01855945|538227030|FG007|Overall Study|Withdrawal by Subject|0|||
149207917|NCT01855945|538227031|FG008|Overall Study|Withdrawal by Subject|0|||
149207918|NCT01855945|538227032|FG009|Overall Study|Withdrawal by Subject|2|||
149207919|NCT01855945|538227033|FG010|Overall Study|Withdrawal by Subject|4|||
149207920|NCT01855945|538227034|FG011|Overall Study|Withdrawal by Subject|1|||
149207921|NCT02156804|538227035|FG000|Overall Study|Withdrawal by Subject|1|||
149207922|NCT00389441|538227036|FG000|Overall Study|Adverse Event|7|||
149207923|NCT00389441|538227036|FG000|Overall Study|Death|4|||
149207924|NCT00389441|538227036|FG000|Overall Study|Lost to Follow-up|2|||
149207925|NCT00389441|538227036|FG000|Overall Study|Withdrawal by Subject|4|||
149207926|NCT00389441|538227036|FG000|Overall Study|Physician Decision|1|||
149207927|NCT00389441|538227036|FG000|Overall Study|Protocol Violation|1|||
149207928|NCT00389441|538227036|FG000|Overall Study|Global deterioration of health status|4|||
149207929|NCT00389441|538227036|FG000|Overall Study|Objective progression or relapse|26|||
149207930|NCT00389441|538227036|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
149207931|NCT00389441|538227036|FG000|Overall Study|Clinical progression|1|||
149207932|NCT00305604|538227037|FG000|Overall Study|Adverse Event|6|||
149207933|NCT00305604|538227038|FG001|Overall Study|Adverse Event|3|||
149207934|NCT00305604|538227037|FG000|Overall Study|Lack of Efficacy|11|||
148949182|NCT02794883|537299559|FG000|Follow-up Period (up to 2 Years)|Death|12|||
148949183|NCT02794883|537299560|FG001|Follow-up Period (up to 2 Years)|Death|10|||
148949184|NCT02794883|537299561|FG002|Follow-up Period (up to 2 Years)|Death|10|||
148949185|NCT01484197|537299566|FG000|Treatment Period 1|Adverse Event|1|||
148949186|NCT01484197|537299567|FG001|Treatment Period 1|Adverse Event|0|||
148949187|NCT01484197|537299568|FG002|Treatment Period 1|Adverse Event|0|||
148949188|NCT01484197|537299569|FG003|Treatment Period 1|Adverse Event|0|||
148949189|NCT01484197|537299566|FG000|Treatment Period 2|Subject withdrew consent|0|||
148949190|NCT01484197|537299567|FG001|Treatment Period 2|Subject withdrew consent|0|||
148949191|NCT01484197|537299568|FG002|Treatment Period 2|Subject withdrew consent|0|||
148949192|NCT01484197|537299569|FG003|Treatment Period 2|Subject withdrew consent|1|||
148949193|NCT01727297|537299570|FG000|Overall Study|Death|13|||
148949194|NCT01727297|537299571|FG001|Overall Study|Death|0|||
148949195|NCT01727297|537299570|FG000|Overall Study|Protocol Violation|1|||
148949196|NCT01727297|537299571|FG001|Overall Study|Protocol Violation|10|||
148949197|NCT01727297|537299570|FG000|Overall Study|Adverse Event|3|||
148949198|NCT01727297|537299571|FG001|Overall Study|Adverse Event|1|||
148949199|NCT01727297|537299570|FG000|Overall Study|Lost to Follow-up|11|||
148949200|NCT01727297|537299571|FG001|Overall Study|Lost to Follow-up|0|||
148949201|NCT01727297|537299570|FG000|Overall Study|Withdrawal by Subject|26|||
148949202|NCT01727297|537299571|FG001|Overall Study|Withdrawal by Subject|27|||
148949203|NCT01727297|537299570|FG000|Overall Study|Physician Decision|19|||
148949204|NCT01727297|537299571|FG001|Overall Study|Physician Decision|5|||
148949205|NCT01727297|537299570|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
148949206|NCT01727297|537299571|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
148949207|NCT00814164|537299579|FG000|Overall Study|Progression|7|||
148949208|NCT00814164|537299579|FG000|Overall Study|not stated|7|||
148949209|NCT00814164|537299579|FG000|Overall Study|Death|5|||
148949210|NCT01980992|537299580|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
148949211|NCT01980992|537299581|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
148949212|NCT01980992|537299580|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
148949213|NCT01980992|537299581|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
148949214|NCT01980992|537299580|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
149207935|NCT00305604|538227038|FG001|Overall Study|Lack of Efficacy|18|||
149207936|NCT00305604|538227037|FG000|Overall Study|Lost to Follow-up|0|||
149207937|NCT00305604|538227038|FG001|Overall Study|Lost to Follow-up|4|||
149207938|NCT00305604|538227037|FG000|Overall Study|Protocol Violation|2|||
148949215|NCT01980992|537299581|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
148949216|NCT01980992|537299580|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
148949217|NCT01980992|537299581|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
149207939|NCT00305604|538227038|FG001|Overall Study|Protocol Violation|1|||
149207940|NCT00305604|538227037|FG000|Overall Study|Withdrawal by Subject|12|||
149207941|NCT00305604|538227038|FG001|Overall Study|Withdrawal by Subject|21|||
149207942|NCT00305604|538227037|FG000|Overall Study|Patient moved|1|||
149207943|NCT00305604|538227038|FG001|Overall Study|Patient moved|0|||
149207944|NCT00636441|538227040|FG000|Overall Study|Adverse Event|0|||
149207945|NCT00636441|538227041|FG001|Overall Study|Adverse Event|1|||
149207946|NCT00636441|538227042|FG002|Overall Study|Adverse Event|1|||
149207947|NCT00636441|538227043|FG003|Overall Study|Adverse Event|0|||
148949218|NCT01980992|537299580|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
149207948|NCT00636441|538227044|FG004|Overall Study|Adverse Event|0|||
149207949|NCT00636441|538227045|FG005|Overall Study|Adverse Event|1|||
149207950|NCT00636441|538227046|FG006|Overall Study|Adverse Event|0|||
149207951|NCT00636441|538227040|FG000|Overall Study|Late, ineligible|0|||
148949219|NCT01980992|537299581|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
148949220|NCT01980992|537299580|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
148949221|NCT01980992|537299581|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
148949222|NCT00299975|537299582|FG000|Overall Study|Adverse Event|1|||
148949223|NCT00299975|537299583|FG001|Overall Study|Adverse Event|0|||
148949224|NCT00299975|537299584|FG002|Overall Study|Adverse Event|2|||
148949225|NCT00299975|537299582|FG000|Overall Study|Pregnancy|0|||
148949226|NCT00299975|537299583|FG001|Overall Study|Pregnancy|0|||
148949227|NCT00299975|537299584|FG002|Overall Study|Pregnancy|1|||
148949228|NCT00299975|537299582|FG000|Overall Study|Lack of Efficacy|1|||
148949229|NCT00299975|537299583|FG001|Overall Study|Lack of Efficacy|0|||
148949230|NCT00299975|537299584|FG002|Overall Study|Lack of Efficacy|1|||
148949231|NCT00299975|537299582|FG000|Overall Study|Lost to Follow-up|1|||
148949232|NCT00299975|537299583|FG001|Overall Study|Lost to Follow-up|0|||
148949233|NCT00299975|537299584|FG002|Overall Study|Lost to Follow-up|0|||
148949234|NCT00299975|537299582|FG000|Overall Study|Withdrawal by Subject|0|||
148949235|NCT00299975|537299583|FG001|Overall Study|Withdrawal by Subject|1|||
148949236|NCT00299975|537299584|FG002|Overall Study|Withdrawal by Subject|3|||
148949237|NCT00299975|537299582|FG000|Overall Study|Physician Decision|0|||
148949238|NCT00299975|537299583|FG001|Overall Study|Physician Decision|0|||
148949239|NCT00299975|537299584|FG002|Overall Study|Physician Decision|1|||
148949240|NCT01169493|537299591|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
148949241|NCT01169493|537299592|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
148949242|NCT01169493|537299593|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
148949243|NCT01169493|537299594|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
148949244|NCT01169493|537299595|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
148949245|NCT01169493|537299596|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
148949246|NCT01169493|537299591|FG000|Period 3 (6 Months)|Adverse Event|0|||
148949247|NCT01169493|537299592|FG001|Period 3 (6 Months)|Adverse Event|1|||
148949248|NCT01169493|537299593|FG002|Period 3 (6 Months)|Adverse Event|0|||
148949249|NCT01169493|537299594|FG003|Period 3 (6 Months)|Adverse Event|0|||
148949250|NCT01169493|537299595|FG004|Period 3 (6 Months)|Adverse Event|0|||
148949251|NCT01169493|537299596|FG005|Period 3 (6 Months)|Adverse Event|0|||
148949252|NCT01169493|537299591|FG000|Period 3 (6 Months)|Physician Decision|0|||
148949253|NCT01169493|537299592|FG001|Period 3 (6 Months)|Physician Decision|1|||
148949254|NCT01169493|537299593|FG002|Period 3 (6 Months)|Physician Decision|1|||
148949255|NCT01169493|537299594|FG003|Period 3 (6 Months)|Physician Decision|0|||
148949256|NCT01169493|537299595|FG004|Period 3 (6 Months)|Physician Decision|0|||
148949257|NCT01169493|537299596|FG005|Period 3 (6 Months)|Physician Decision|0|||
148949258|NCT05228132|537299597|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
148949259|NCT05228132|537299597|FG000|Overall Study|Adverse Event|3|||
148949260|NCT05228132|537299597|FG000|Overall Study|Lost to Follow-up|1|||
148949261|NCT05228132|537299597|FG000|Overall Study|Arteriovenous-fistula mature|1|||
148949262|NCT03167411|537299598|FG000|Overall Study|Adverse Event|0|||
148949263|NCT03167411|537299599|FG001|Overall Study|Adverse Event|1|||
148949264|NCT02627144|537299602|FG000|Overall Study|Serious adverse event|32|||
148949265|NCT02627144|537299602|FG000|Overall Study|Cancer progression|171|||
148949266|NCT02627144|537299602|FG000|Overall Study|Death from cancer|20|||
148949267|NCT02627144|537299602|FG000|Overall Study|Death from other cause|8|||
148949268|NCT02627144|537299602|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
148949269|NCT02627144|537299602|FG000|Overall Study|Administrative reasons|65|||
148949270|NCT02627144|537299602|FG000|Overall Study|Lost to Follow-up|8|||
148949271|NCT02627144|537299602|FG000|Overall Study|Enrolled, not treated|6|||
148949272|NCT02627144|537299602|FG000|Overall Study|Other|17|||
148949273|NCT01053221|537299612|FG000|Overall Study|The study was closed prematurely|5|||
148949274|NCT01053221|537299613|FG001|Overall Study|The study was closed prematurely|9|||
148949275|NCT02266225|537299614|FG000|Overall Study|Lost to Follow-up|2|||
148949276|NCT02266225|537299614|FG000|Overall Study|Death|1|||
148949277|NCT02266225|537299614|FG000|Overall Study|Withdrawal by Subject|13|||
148949278|NCT00420927|537299615|FG000|Period 1|Adverse Event|19|||
148949279|NCT00420927|537299616|FG001|Period 1|Adverse Event|15|||
148949280|NCT00420927|537299617|FG002|Period 1|Adverse Event|0|||
148949281|NCT00420927|537299618|FG003|Period 1|Adverse Event|0|||
148949282|NCT00420927|537299619|FG004|Period 1|Adverse Event|0|||
148949283|NCT00420927|537299620|FG005|Period 1|Adverse Event|0|||
148949284|NCT00420927|537299621|FG006|Period 1|Adverse Event|0|||
148949285|NCT00420927|537299615|FG000|Period 1|Withdrawal by Subject|7|||
148949286|NCT00420927|537299616|FG001|Period 1|Withdrawal by Subject|12|||
148949287|NCT00420927|537299617|FG002|Period 1|Withdrawal by Subject|0|||
148949288|NCT00420927|537299618|FG003|Period 1|Withdrawal by Subject|0|||
148949289|NCT00420927|537299619|FG004|Period 1|Withdrawal by Subject|0|||
148949290|NCT00420927|537299620|FG005|Period 1|Withdrawal by Subject|0|||
148949291|NCT00420927|537299621|FG006|Period 1|Withdrawal by Subject|0|||
149207952|NCT00636441|538227041|FG001|Overall Study|Late, ineligible|0|||
148949292|NCT00420927|537299615|FG000|Period 1|Lost to Follow-up|8|||
148949293|NCT00420927|537299616|FG001|Period 1|Lost to Follow-up|6|||
148949294|NCT00420927|537299617|FG002|Period 1|Lost to Follow-up|0|||
148949295|NCT00420927|537299618|FG003|Period 1|Lost to Follow-up|0|||
148949296|NCT00420927|537299619|FG004|Period 1|Lost to Follow-up|0|||
148949297|NCT00420927|537299620|FG005|Period 1|Lost to Follow-up|0|||
148949298|NCT00420927|537299621|FG006|Period 1|Lost to Follow-up|0|||
148949299|NCT00420927|537299615|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
148949300|NCT00420927|537299616|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
148949301|NCT00420927|537299617|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
148949302|NCT00420927|537299618|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
148949303|NCT00420927|537299619|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
148949304|NCT00420927|537299620|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
148949305|NCT00420927|537299621|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
148949306|NCT00420927|537299615|FG000|Period 1|Death|2|||
148949307|NCT00420927|537299616|FG001|Period 1|Death|0|||
148949308|NCT00420927|537299617|FG002|Period 1|Death|0|||
148949309|NCT00420927|537299618|FG003|Period 1|Death|0|||
148949310|NCT00420927|537299619|FG004|Period 1|Death|0|||
148949311|NCT00420927|537299620|FG005|Period 1|Death|0|||
148949312|NCT00420927|537299621|FG006|Period 1|Death|0|||
148949313|NCT00420927|537299615|FG000|Period 1|Subject moved/relocated|0|||
148949314|NCT00420927|537299616|FG001|Period 1|Subject moved/relocated|2|||
148949315|NCT00420927|537299617|FG002|Period 1|Subject moved/relocated|0|||
148949316|NCT00420927|537299618|FG003|Period 1|Subject moved/relocated|0|||
148949317|NCT00420927|537299619|FG004|Period 1|Subject moved/relocated|0|||
148949318|NCT00420927|537299620|FG005|Period 1|Subject moved/relocated|0|||
148949319|NCT00420927|537299621|FG006|Period 1|Subject moved/relocated|0|||
148949320|NCT00420927|537299615|FG000|Period 1|Noncompliant with study drug|1|||
148949321|NCT00420927|537299616|FG001|Period 1|Noncompliant with study drug|1|||
148949322|NCT00420927|537299617|FG002|Period 1|Noncompliant with study drug|0|||
148949323|NCT00420927|537299618|FG003|Period 1|Noncompliant with study drug|0|||
148949324|NCT00420927|537299619|FG004|Period 1|Noncompliant with study drug|0|||
149207953|NCT00636441|538227042|FG002|Overall Study|Late, ineligible|0|||
149207954|NCT00636441|538227043|FG003|Overall Study|Late, ineligible|0|||
149207955|NCT00636441|538227044|FG004|Overall Study|Late, ineligible|0|||
149207956|NCT00636441|538227045|FG005|Overall Study|Late, ineligible|0|||
149207957|NCT00636441|538227046|FG006|Overall Study|Late, ineligible|1|||
149207958|NCT00636441|538227040|FG000|Overall Study|Screen Failure|0|||
149207959|NCT00636441|538227041|FG001|Overall Study|Screen Failure|0|||
149207960|NCT00636441|538227042|FG002|Overall Study|Screen Failure|0|||
149207961|NCT00636441|538227043|FG003|Overall Study|Screen Failure|0|||
149207962|NCT00636441|538227044|FG004|Overall Study|Screen Failure|0|||
149207963|NCT00636441|538227045|FG005|Overall Study|Screen Failure|0|||
149207964|NCT00636441|538227046|FG006|Overall Study|Screen Failure|17|||
149207965|NCT03332303|538227048|FG000|Overall Study|Participant did not dose|1|||
149207966|NCT03332303|538227049|FG001|Overall Study|Participant did not dose|2|||
149207967|NCT03332303|538227050|FG002|Overall Study|Participant did not dose|0|||
149207968|NCT03332303|538227048|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
149207969|NCT03332303|538227049|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
149207970|NCT03332303|538227050|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
149207971|NCT03332303|538227048|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
149207972|NCT03332303|538227049|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
149207973|NCT03332303|538227050|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
149207974|NCT03332303|538227048|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
149207975|NCT03332303|538227049|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
149207976|NCT03332303|538227050|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
149207977|NCT03332303|538227048|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
148809299|NCT02349386|536779262|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
148949325|NCT00420927|537299620|FG005|Period 1|Noncompliant with study drug|0|||
149207978|NCT03332303|538227049|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
149207979|NCT03332303|538227050|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
149207980|NCT03332303|538227048|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
148949326|NCT00420927|537299621|FG006|Period 1|Noncompliant with study drug|0|||
148949327|NCT00420927|537299615|FG000|Period 1|Randomization error|1|||
148949328|NCT00420927|537299616|FG001|Period 1|Randomization error|0|||
148949329|NCT00420927|537299617|FG002|Period 1|Randomization error|0|||
148949330|NCT00420927|537299618|FG003|Period 1|Randomization error|0|||
148949331|NCT00420927|537299619|FG004|Period 1|Randomization error|0|||
148949332|NCT00420927|537299620|FG005|Period 1|Randomization error|0|||
148949333|NCT00420927|537299621|FG006|Period 1|Randomization error|0|||
148949334|NCT00420927|537299615|FG000|Period 1|Suspected tuberculosis/positive test|1|||
148949335|NCT00420927|537299616|FG001|Period 1|Suspected tuberculosis/positive test|1|||
148949336|NCT00420927|537299617|FG002|Period 1|Suspected tuberculosis/positive test|0|||
149207981|NCT03332303|538227049|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
149207982|NCT03332303|538227050|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
149207983|NCT03332303|538227048|FG000|Overall Study|Participant had a significant protocol deviation|0|||
149207984|NCT03332303|538227049|FG001|Overall Study|Participant had a significant protocol deviation|1|||
149207985|NCT03332303|538227050|FG002|Overall Study|Participant had a significant protocol deviation|0|||
149207986|NCT03495817|538227052|FG000|26 Week Open Label|Adverse Event|3|||
149207987|NCT03495817|538227052|FG000|26 Week Open Label|Withdrawal by Subject|4|||
149207988|NCT03495817|538227052|FG000|26 Week Open Label|Lost to Follow-up|1|||
149207989|NCT03495817|538227052|FG000|26 Week Extension|Lost to Follow-up|2|||
149207990|NCT00326417|538227056|FG000|Overall Study|Withdrawal by Subject|0|||
149207991|NCT00326417|538227057|FG001|Overall Study|Withdrawal by Subject|0|||
149207992|NCT00326417|538227058|FG002|Overall Study|Withdrawal by Subject|1|||
149207993|NCT00326417|538227059|FG003|Overall Study|Withdrawal by Subject|0|||
149207994|NCT00326417|538227056|FG000|Overall Study|Arm Closed|7|||
149207995|NCT00326417|538227057|FG001|Overall Study|Arm Closed|0|||
149207996|NCT00326417|538227058|FG002|Overall Study|Arm Closed|0|||
149207997|NCT00326417|538227059|FG003|Overall Study|Arm Closed|3|||
149207998|NCT00326417|538227056|FG000|Overall Study|Death|7|||
149207999|NCT00326417|538227057|FG001|Overall Study|Death|0|||
149208000|NCT00326417|538227058|FG002|Overall Study|Death|0|||
149208001|NCT00326417|538227059|FG003|Overall Study|Death|0|||
149208002|NCT00844285|538227060|FG000|Overall Study|Other|0|||
149208003|NCT00844285|538227061|FG001|Overall Study|Other|1|||
149208004|NCT00844285|538227062|FG002|Overall Study|Other|0|||
149208005|NCT00844285|538227060|FG000|Overall Study|Other than specified|95|||
149208006|NCT00844285|538227061|FG001|Overall Study|Other than specified|129|||
149208007|NCT00844285|538227062|FG002|Overall Study|Other than specified|12|||
149208008|NCT00844285|538227060|FG000|Overall Study|Site closure|256|||
149208009|NCT00844285|538227061|FG001|Overall Study|Site closure|450|||
149208010|NCT00844285|538227062|FG002|Overall Study|Site closure|50|||
149208011|NCT00844285|538227060|FG000|Overall Study|Follow-up < 8 years|16|||
149208012|NCT00844285|538227061|FG001|Overall Study|Follow-up < 8 years|23|||
149208013|NCT00844285|538227062|FG002|Overall Study|Follow-up < 8 years|4|||
149208014|NCT00844285|538227060|FG000|Overall Study|Protocol Violation|26|||
149208015|NCT00844285|538227061|FG001|Overall Study|Protocol Violation|28|||
149208016|NCT00844285|538227062|FG002|Overall Study|Protocol Violation|54|||
149208017|NCT00844285|538227060|FG000|Overall Study|Death|22|||
149208018|NCT00844285|538227061|FG001|Overall Study|Death|21|||
149208019|NCT00844285|538227062|FG002|Overall Study|Death|8|||
149208020|NCT00844285|538227060|FG000|Overall Study|Withdrew Consent|344|||
149208021|NCT00844285|538227061|FG001|Overall Study|Withdrew Consent|466|||
149208022|NCT00844285|538227062|FG002|Overall Study|Withdrew Consent|70|||
149208023|NCT00844285|538227060|FG000|Overall Study|Lost to Follow-up|330|||
149208024|NCT00844285|538227061|FG001|Overall Study|Lost to Follow-up|486|||
148684095|NCT00665626|536315095|FG001|Overall Study|Withdrawal by Subject|1|||
148684096|NCT00665626|536315094|FG000|Overall Study|Protocol Violation|0|||
149208025|NCT00844285|538227062|FG002|Overall Study|Lost to Follow-up|74|||
149208026|NCT01586806|538227063|FG000|Overall Study|Protocol Violation|0|||
149208027|NCT01586806|538227064|FG001|Overall Study|Protocol Violation|1|||
149208028|NCT01586806|538227065|FG002|Overall Study|Protocol Violation|0|||
149208029|NCT01586806|538227063|FG000|Overall Study|Withdrawal by Subject|1|||
149208030|NCT01586806|538227064|FG001|Overall Study|Withdrawal by Subject|0|||
149208031|NCT01586806|538227065|FG002|Overall Study|Withdrawal by Subject|0|||
149208032|NCT01586806|538227063|FG000|Overall Study|Lost to Follow-up|2|||
148684097|NCT00665626|536315095|FG001|Overall Study|Protocol Violation|2|||
149208033|NCT01586806|538227064|FG001|Overall Study|Lost to Follow-up|3|||
149208034|NCT01586806|538227065|FG002|Overall Study|Lost to Follow-up|2|||
149208035|NCT01185704|538227066|FG000|Overall Study|Randomized but not treated|3|||
148949337|NCT00420927|537299618|FG003|Period 1|Suspected tuberculosis/positive test|0|||
148949338|NCT00420927|537299619|FG004|Period 1|Suspected tuberculosis/positive test|0|||
149208036|NCT01185704|538227067|FG001|Overall Study|Randomized but not treated|3|||
149208037|NCT01185704|538227066|FG000|Overall Study|Lack of ovarian response|5|||
149208038|NCT01185704|538227067|FG001|Overall Study|Lack of ovarian response|1|||
149208039|NCT01185704|538227066|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
149208040|NCT01185704|538227067|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
149208041|NCT01185704|538227066|FG000|Overall Study|Ectopic pregnancy|0|||
149208042|NCT01185704|538227067|FG001|Overall Study|Ectopic pregnancy|1|||
149208043|NCT01313208|538227068|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
149208044|NCT01313208|538227069|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
149208045|NCT01313208|538227068|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
149208046|NCT01313208|538227069|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
149208047|NCT01313208|538227068|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
149208048|NCT01313208|538227069|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
149208049|NCT01313208|538227068|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
149208050|NCT01313208|538227069|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
149208051|NCT01313208|538227068|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
149208052|NCT01313208|538227069|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
149208053|NCT01313208|538227068|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
149208054|NCT01313208|538227069|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
149208055|NCT01313208|538227068|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
149208056|NCT01313208|538227069|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
149208057|NCT01313208|538227068|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
148949339|NCT00420927|537299620|FG005|Period 1|Suspected tuberculosis/positive test|0|||
148949340|NCT00420927|537299621|FG006|Period 1|Suspected tuberculosis/positive test|0|||
149208058|NCT01313208|538227069|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
149208059|NCT01313208|538227068|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
149208060|NCT01313208|538227069|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
149208061|NCT01957787|538227070|FG000|Overall Study|Death|18|||
149208062|NCT01957787|538227070|FG000|Overall Study|Lost to Follow-up|3|||
149208063|NCT01957787|538227070|FG000|Overall Study|Withdrawal by Subject|3|||
149208064|NCT01957787|538227070|FG000|Overall Study|Entered Hospice or Similar Program|2|||
149208065|NCT01957787|538227070|FG000|Overall Study|Index Tumor(s) Resected|2|||
149208066|NCT01957787|538227070|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
149208067|NCT01957787|538227070|FG000|Overall Study|Local therapy, not cryoablation|6|||
149208068|NCT00187889|538227071|FG000|Overall Study|Withdrawal by Subject|6|||
149208069|NCT00187889|538227072|FG001|Overall Study|Withdrawal by Subject|4|||
149208070|NCT00435994|538227074|FG000|Overall Study|Lost to Follow-up|7|||
149208071|NCT00435994|538227075|FG001|Overall Study|Lost to Follow-up|0|||
149208072|NCT00435994|538227076|FG002|Overall Study|Lost to Follow-up|0|||
149208073|NCT00788697|538227078|FG000|Overall Study|No study drug administered|12|||
149208074|NCT00788697|538227078|FG000|Overall Study|Training Patients|74|||
149208075|NCT00788697|538227078|FG000|Overall Study|no truth standard procedure available|5|||
149208076|NCT00788697|538227078|FG000|Overall Study|Technically inadequate truth standard|1|||
149208077|NCT00788697|538227078|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
149208078|NCT01998880|538227079|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
149208079|NCT01998880|538227080|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
149208080|NCT01998880|538227079|FG000|Overall Study|Disease Progression|1|||
149208081|NCT01998880|538227080|FG001|Overall Study|Disease Progression|8|||
149208082|NCT01998880|538227079|FG000|Overall Study|Withdrew Consent|2|||
149208083|NCT01998880|538227080|FG001|Overall Study|Withdrew Consent|1|||
149208084|NCT01998880|538227079|FG000|Overall Study|Death|3|||
149208085|NCT01998880|538227080|FG001|Overall Study|Death|6|||
149208086|NCT01998880|538227079|FG000|Overall Study|Insufficient Therapeutic Response|1|||
149208087|NCT01998880|538227080|FG001|Overall Study|Insufficient Therapeutic Response|5|||
149208088|NCT01998880|538227079|FG000|Overall Study|Administrative/Other|1|||
149208089|NCT01998880|538227080|FG001|Overall Study|Administrative/Other|1|||
149208090|NCT01998880|538227079|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
149208091|NCT01998880|538227080|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
149208092|NCT01998880|538227079|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
149208093|NCT01998880|538227080|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
149208094|NCT01998880|538227079|FG000|Overall Study|Did Not Receive Treatment|3|||
149208095|NCT01998880|538227080|FG001|Overall Study|Did Not Receive Treatment|2|||
149208096|NCT02248857|538227081|FG000|3 Month|Withdrawal by Subject|9|||
149208097|NCT02248857|538227082|FG001|3 Month|Withdrawal by Subject|3|||
148949341|NCT00420927|537299615|FG000|Period 1|Study site closure|0|||
149208098|NCT02248857|538227083|FG002|3 Month|Withdrawal by Subject|4|||
149208099|NCT02248857|538227081|FG000|3 Month|Unable to reach for 3 month|35|||
148949342|NCT00420927|537299616|FG001|Period 1|Study site closure|1|||
149208100|NCT02248857|538227082|FG001|3 Month|Unable to reach for 3 month|29|||
149208101|NCT02248857|538227083|FG002|3 Month|Unable to reach for 3 month|26|||
148684098|NCT00665626|536315094|FG000|Overall Study|Adverse Event|1|||
148684099|NCT00665626|536315095|FG001|Overall Study|Adverse Event|9|||
148684100|NCT00665626|536315094|FG000|Overall Study|Due to exclusion criteria|0|||
148684101|NCT00665626|536315095|FG001|Overall Study|Due to exclusion criteria|1|||
149208102|NCT02248857|538227081|FG000|3 Month|Partially completed, unable to finish|2|||
148949343|NCT00420927|537299617|FG002|Period 1|Study site closure|0|||
148949344|NCT00420927|537299618|FG003|Period 1|Study site closure|0|||
148949345|NCT00420927|537299619|FG004|Period 1|Study site closure|0|||
148949346|NCT00420927|537299620|FG005|Period 1|Study site closure|0|||
149208103|NCT02248857|538227082|FG001|3 Month|Partially completed, unable to finish|2|||
149208104|NCT02248857|538227083|FG002|3 Month|Partially completed, unable to finish|1|||
149208105|NCT02248857|538227081|FG000|6 Month|Lost to Follow-up|27|||
149208106|NCT02248857|538227082|FG001|6 Month|Lost to Follow-up|26|||
148949347|NCT00420927|537299621|FG006|Period 1|Study site closure|0|||
148949348|NCT00420927|537299615|FG000|Period 1|Subject received new diagnosis|0|||
148949349|NCT00420927|537299616|FG001|Period 1|Subject received new diagnosis|2|||
148949350|NCT00420927|537299617|FG002|Period 1|Subject received new diagnosis|0|||
148949351|NCT00420927|537299618|FG003|Period 1|Subject received new diagnosis|0|||
148949352|NCT00420927|537299619|FG004|Period 1|Subject received new diagnosis|0|||
148949353|NCT00420927|537299620|FG005|Period 1|Subject received new diagnosis|0|||
148949354|NCT00420927|537299621|FG006|Period 1|Subject received new diagnosis|0|||
148949355|NCT00420927|537299615|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
148949356|NCT00420927|537299616|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
148949357|NCT00420927|537299617|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
148949358|NCT00420927|537299618|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
148949359|NCT00420927|537299619|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
148949360|NCT00420927|537299620|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
148949361|NCT00420927|537299621|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
148949362|NCT00420927|537299615|FG000|Period 1|Failed to meet entry criteria|8|||
148949363|NCT00420927|537299616|FG001|Period 1|Failed to meet entry criteria|7|||
148949364|NCT00420927|537299617|FG002|Period 1|Failed to meet entry criteria|0|||
148949365|NCT00420927|537299618|FG003|Period 1|Failed to meet entry criteria|0|||
148949366|NCT00420927|537299619|FG004|Period 1|Failed to meet entry criteria|0|||
148949367|NCT00420927|537299620|FG005|Period 1|Failed to meet entry criteria|0|||
148949368|NCT00420927|537299621|FG006|Period 1|Failed to meet entry criteria|0|||
148949369|NCT00420927|537299615|FG000|Period 1|Took prohibited medication|1|||
148949370|NCT00420927|537299616|FG001|Period 1|Took prohibited medication|3|||
148949371|NCT00420927|537299617|FG002|Period 1|Took prohibited medication|0|||
148949372|NCT00420927|537299618|FG003|Period 1|Took prohibited medication|0|||
148949373|NCT00420927|537299619|FG004|Period 1|Took prohibited medication|0|||
148949374|NCT00420927|537299620|FG005|Period 1|Took prohibited medication|0|||
148949375|NCT00420927|537299621|FG006|Period 1|Took prohibited medication|0|||
148949376|NCT00420927|537299615|FG000|Period 2|Adverse Event|0|||
148949377|NCT00420927|537299616|FG001|Period 2|Adverse Event|0|||
148949378|NCT00420927|537299617|FG002|Period 2|Adverse Event|7|||
148949379|NCT00420927|537299618|FG003|Period 2|Adverse Event|3|||
148949380|NCT00420927|537299619|FG004|Period 2|Adverse Event|17|||
148949381|NCT00420927|537299620|FG005|Period 2|Adverse Event|6|||
148949382|NCT00420927|537299621|FG006|Period 2|Adverse Event|20|||
148949383|NCT00420927|537299615|FG000|Period 2|Withdrawal by Subject|0|||
148949384|NCT00420927|537299616|FG001|Period 2|Withdrawal by Subject|0|||
149208107|NCT02248857|538227083|FG002|6 Month|Lost to Follow-up|15|||
149208108|NCT02248857|538227081|FG000|6 Month|Partially completed, unable to finish|0|||
148949385|NCT00420927|537299617|FG002|Period 2|Withdrawal by Subject|1|||
149208109|NCT02248857|538227082|FG001|6 Month|Partially completed, unable to finish|1|||
149208110|NCT02248857|538227083|FG002|6 Month|Partially completed, unable to finish|0|||
149208111|NCT02248857|538227081|FG000|6 Month|Withdrawal by Subject|0|||
149208112|NCT02248857|538227082|FG001|6 Month|Withdrawal by Subject|2|||
149208113|NCT02248857|538227083|FG002|6 Month|Withdrawal by Subject|2|||
149208114|NCT02248857|538227081|FG000|6 Month|Death|1|||
149208115|NCT02248857|538227082|FG001|6 Month|Death|0|||
149208116|NCT02248857|538227083|FG002|6 Month|Death|0|||
149208117|NCT02261883|538227084|FG000|Overall Study|Death|3|||
149208118|NCT02261883|538227085|FG001|Overall Study|Death|2|||
149208119|NCT02261883|538227084|FG000|Overall Study|Physician Decision|1|||
149208120|NCT02261883|538227085|FG001|Overall Study|Physician Decision|0|||
149208121|NCT02261883|538227084|FG000|Overall Study|Protocol Violation|1|||
149208122|NCT02261883|538227085|FG001|Overall Study|Protocol Violation|0|||
149208123|NCT02261883|538227084|FG000|Overall Study|Withdrawal by Subject|0|||
148949386|NCT00420927|537299618|FG003|Period 2|Withdrawal by Subject|3|||
148949387|NCT00420927|537299619|FG004|Period 2|Withdrawal by Subject|11|||
148949388|NCT00420927|537299620|FG005|Period 2|Withdrawal by Subject|2|||
148949389|NCT00420927|537299621|FG006|Period 2|Withdrawal by Subject|12|||
148949390|NCT00420927|537299615|FG000|Period 2|Lost to Follow-up|0|||
148949391|NCT00420927|537299616|FG001|Period 2|Lost to Follow-up|0|||
149208124|NCT02261883|538227085|FG001|Overall Study|Withdrawal by Subject|1|||
149208125|NCT02261883|538227084|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
148949392|NCT00420927|537299617|FG002|Period 2|Lost to Follow-up|2|||
148949393|NCT00420927|537299618|FG003|Period 2|Lost to Follow-up|2|||
148949394|NCT00420927|537299619|FG004|Period 2|Lost to Follow-up|6|||
148949395|NCT00420927|537299620|FG005|Period 2|Lost to Follow-up|3|||
148949396|NCT00420927|537299621|FG006|Period 2|Lost to Follow-up|9|||
148949397|NCT00420927|537299615|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
148949398|NCT00420927|537299616|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
148949399|NCT00420927|537299617|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
148949400|NCT00420927|537299618|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
148949401|NCT00420927|537299619|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
148949402|NCT00420927|537299620|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
148949403|NCT00420927|537299621|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
148949404|NCT00420927|537299615|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
148949405|NCT00420927|537299616|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
148949406|NCT00420927|537299617|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
148949407|NCT00420927|537299618|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
148949408|NCT00420927|537299619|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
148949409|NCT00420927|537299620|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
148949410|NCT00420927|537299621|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
148949411|NCT00420927|537299615|FG000|Period 2|Subject unable to find transportation|0|||
148949412|NCT00420927|537299616|FG001|Period 2|Subject unable to find transportation|0|||
148949413|NCT00420927|537299617|FG002|Period 2|Subject unable to find transportation|0|||
148949414|NCT00420927|537299618|FG003|Period 2|Subject unable to find transportation|0|||
148949415|NCT00420927|537299619|FG004|Period 2|Subject unable to find transportation|0|||
148949416|NCT00420927|537299620|FG005|Period 2|Subject unable to find transportation|0|||
148949417|NCT00420927|537299621|FG006|Period 2|Subject unable to find transportation|1|||
148949418|NCT00420927|537299615|FG000|Period 2|Physician Decision|0|||
148949419|NCT00420927|537299616|FG001|Period 2|Physician Decision|0|||
148949420|NCT00420927|537299617|FG002|Period 2|Physician Decision|0|||
148949421|NCT00420927|537299618|FG003|Period 2|Physician Decision|0|||
148949422|NCT00420927|537299619|FG004|Period 2|Physician Decision|1|||
148949423|NCT00420927|537299620|FG005|Period 2|Physician Decision|1|||
148949424|NCT00420927|537299621|FG006|Period 2|Physician Decision|0|||
148949425|NCT00420927|537299615|FG000|Period 2|Sponsor decision|0|||
148949426|NCT00420927|537299616|FG001|Period 2|Sponsor decision|0|||
148949427|NCT00420927|537299617|FG002|Period 2|Sponsor decision|1|||
148949428|NCT00420927|537299618|FG003|Period 2|Sponsor decision|0|||
148949429|NCT00420927|537299619|FG004|Period 2|Sponsor decision|0|||
148949430|NCT00420927|537299620|FG005|Period 2|Sponsor decision|0|||
148949431|NCT00420927|537299621|FG006|Period 2|Sponsor decision|1|||
148949432|NCT00420927|537299615|FG000|Period 2|Randomization error|0|||
148949433|NCT00420927|537299616|FG001|Period 2|Randomization error|0|||
148949434|NCT00420927|537299617|FG002|Period 2|Randomization error|0|||
149208126|NCT02261883|538227085|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
149208127|NCT03549117|538227089|FG000|Overall Study|Withdrawal by Subject|1|||
149208128|NCT03549117|538227090|FG001|Overall Study|Withdrawal by Subject|0|||
149208129|NCT00014911|538227091|FG000|Overall Study|Adverse Event|1|||
149208130|NCT00014911|538227091|FG000|Overall Study|Lost to Follow-up|1|||
149208131|NCT00014911|538227091|FG000|Overall Study|Withdrawal by Subject|6|||
149208132|NCT00014911|538227091|FG000|Overall Study|Unknown Reasons|2|||
149208133|NCT00014911|538227091|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
149208134|NCT00345540|538227092|FG000|Overall Study|Withdrawal by Subject|1|||
149208135|NCT00861380|538227093|FG000|Overall Study|Withdrawal Information not recorded|8427|||
149208136|NCT00861380|538227094|FG001|Overall Study|Withdrawal Information not recorded|9112|||
149208137|NCT00861380|538227095|FG002|Overall Study|Withdrawal Information not recorded|8872|||
149208138|NCT00861380|538227096|FG003|Overall Study|Withdrawal Information not recorded|3689|||
149208139|NCT00861380|538227097|FG004|Overall Study|Withdrawal Information not recorded|1812|||
149208140|NCT00861380|538227098|FG005|Overall Study|Withdrawal Information not recorded|6249|||
149208141|NCT00861380|538227099|FG006|Overall Study|Withdrawal Information not recorded|3020|||
149208142|NCT04179786|538227100|FG000|Overall Study|Withdrawal by Subject|8|||
148684102|NCT00665626|536315094|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
148949435|NCT00420927|537299618|FG003|Period 2|Randomization error|0|||
148949436|NCT00420927|537299619|FG004|Period 2|Randomization error|1|||
148949437|NCT00420927|537299620|FG005|Period 2|Randomization error|1|||
148949438|NCT00420927|537299621|FG006|Period 2|Randomization error|0|||
148949439|NCT00420927|537299615|FG000|Period 2|Noncompliant with study drug|0|||
148949440|NCT00420927|537299616|FG001|Period 2|Noncompliant with study drug|0|||
148949441|NCT00420927|537299617|FG002|Period 2|Noncompliant with study drug|0|||
148949442|NCT00420927|537299618|FG003|Period 2|Noncompliant with study drug|1|||
148949443|NCT00420927|537299619|FG004|Period 2|Noncompliant with study drug|0|||
148949444|NCT00420927|537299620|FG005|Period 2|Noncompliant with study drug|0|||
148949445|NCT00420927|537299621|FG006|Period 2|Noncompliant with study drug|2|||
148949446|NCT00420927|537299615|FG000|Period 2|Methotrexate intolerance|0|||
148949447|NCT00420927|537299616|FG001|Period 2|Methotrexate intolerance|0|||
148949448|NCT00420927|537299617|FG002|Period 2|Methotrexate intolerance|0|||
148949449|NCT00420927|537299618|FG003|Period 2|Methotrexate intolerance|0|||
149208143|NCT03310580|538227101|FG000|Overall Study|Adverse Event|0|||
149208144|NCT03310580|538227102|FG001|Overall Study|Adverse Event|1|||
149208145|NCT03310580|538227103|FG002|Overall Study|Adverse Event|0|||
149208146|NCT03205982|538227110|FG000|Overall Study|Lost to Follow-up|20|||
149208147|NCT03205982|538227111|FG001|Overall Study|Lost to Follow-up|19|||
149208148|NCT03205982|538227110|FG000|Overall Study|Withdrawal by Subject|4|||
149208149|NCT03205982|538227111|FG001|Overall Study|Withdrawal by Subject|3|||
149208150|NCT03205982|538227110|FG000|Overall Study|Withdrawal by PI|0|||
149208151|NCT03205982|538227111|FG001|Overall Study|Withdrawal by PI|1|||
149208152|NCT00994162|538227112|FG000|Overall Study|Withdrawal by Subject|1|||
149208153|NCT00994162|538227112|FG000|Overall Study|Lost to Follow-up|2|||
149208154|NCT00994162|538227112|FG000|Overall Study|Product Complaint|1|||
149208155|NCT00994162|538227112|FG000|Overall Study|Poor Compliance|5|||
149208156|NCT00994162|538227112|FG000|Overall Study|Lack of Response|3|||
149208157|NCT00994162|538227112|FG000|Overall Study|Discharged from Hospital|4|||
149208158|NCT00994162|538227112|FG000|Overall Study|Death|2|||
149208159|NCT00994162|538227112|FG000|Overall Study|Care Transferred to Another Physician|2|||
149208160|NCT00994162|538227112|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
149208161|NCT00994162|538227112|FG000|Overall Study|Physician Decision|2|||
149208162|NCT00994162|538227112|FG000|Overall Study|Surrounding Wound Erythematous|1|||
149208163|NCT00994162|538227112|FG000|Overall Study|Machine Losing Vaccum|1|||
149208164|NCT00994162|538227112|FG000|Overall Study|Patient Lived Too Far Away|1|||
149208165|NCT00994162|538227112|FG000|Overall Study|Above Knee Amputation|1|||
149208166|NCT00994162|538227112|FG000|Overall Study|Reason Not Reported By Site|1|||
149208167|NCT02983799|538227113|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
149208168|NCT02983799|538227114|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
149208169|NCT02983799|538227115|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
149208170|NCT02983799|538227116|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
149208171|NCT02983799|538227117|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
149208172|NCT02983799|538227113|FG000|Overall Study|Death|20|||
149208173|NCT02983799|538227114|FG001|Overall Study|Death|5|||
149208174|NCT02983799|538227115|FG002|Overall Study|Death|23|||
149208175|NCT02983799|538227116|FG003|Overall Study|Death|47|||
149208176|NCT02983799|538227117|FG004|Overall Study|Death|7|||
149208177|NCT02983799|538227113|FG000|Overall Study|Withdrawal by Subject|1|||
149208178|NCT02983799|538227114|FG001|Overall Study|Withdrawal by Subject|0|||
149208179|NCT02983799|538227115|FG002|Overall Study|Withdrawal by Subject|3|||
149208180|NCT02983799|538227116|FG003|Overall Study|Withdrawal by Subject|4|||
149208181|NCT02983799|538227117|FG004|Overall Study|Withdrawal by Subject|1|||
149208182|NCT02983799|538227113|FG000|Overall Study|Protocol Violation|0|||
149208183|NCT02983799|538227114|FG001|Overall Study|Protocol Violation|1|||
149208184|NCT02983799|538227115|FG002|Overall Study|Protocol Violation|0|||
149208185|NCT02983799|538227116|FG003|Overall Study|Protocol Violation|0|||
149208186|NCT02983799|538227117|FG004|Overall Study|Protocol Violation|1|||
149208187|NCT02983799|538227113|FG000|Overall Study|Lost to Follow-up|1|||
149208188|NCT02983799|538227114|FG001|Overall Study|Lost to Follow-up|0|||
149208189|NCT02983799|538227115|FG002|Overall Study|Lost to Follow-up|1|||
149208190|NCT02983799|538227116|FG003|Overall Study|Lost to Follow-up|0|||
149208191|NCT02983799|538227117|FG004|Overall Study|Lost to Follow-up|0|||
149208192|NCT00795509|538227124|FG000|Overall Study|Protocol Violation|31|||
149208193|NCT00970268|538227125|FG000|Overall Study|Withdrawal by Subject|12|||
149208194|NCT00970268|538227126|FG001|Overall Study|Withdrawal by Subject|19|||
149208195|NCT00970268|538227125|FG000|Overall Study|Adverse Event|15|||
149208196|NCT00970268|538227126|FG001|Overall Study|Adverse Event|12|||
149208197|NCT00970268|538227125|FG000|Overall Study|Lack of Efficacy|3|||
149208198|NCT00970268|538227126|FG001|Overall Study|Lack of Efficacy|6|||
149208199|NCT00970268|538227125|FG000|Overall Study|Protocol Violation|4|||
149208200|NCT00970268|538227126|FG001|Overall Study|Protocol Violation|7|||
149208201|NCT00970268|538227125|FG000|Overall Study|Other Reason|3|||
148949450|NCT00420927|537299619|FG004|Period 2|Methotrexate intolerance|0|||
148949451|NCT00420927|537299620|FG005|Period 2|Methotrexate intolerance|0|||
149208202|NCT00970268|538227126|FG001|Overall Study|Other Reason|1|||
149208203|NCT00970268|538227125|FG000|Overall Study|COPD Exacerbation|4|||
149208204|NCT00970268|538227126|FG001|Overall Study|COPD Exacerbation|2|||
149208205|NCT00970268|538227125|FG000|Overall Study|Lost to Follow-up|1|||
149208206|NCT00970268|538227126|FG001|Overall Study|Lost to Follow-up|2|||
149208207|NCT00970268|538227125|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
149208208|NCT00970268|538227126|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
148949452|NCT00420927|537299621|FG006|Period 2|Methotrexate intolerance|1|||
149208209|NCT03136367|538227127|FG000|T1 Consultation|discontinued mistakenly included|2|||
149208210|NCT03136367|538227128|FG001|T1 Consultation|discontinued mistakenly included|6|||
149208211|NCT03136367|538227129|FG002|T1 Consultation|discontinued mistakenly included|1|||
149208212|NCT03136367|538227127|FG000|T1 Consultation|Discontinued other|0|||
149208213|NCT03136367|538227128|FG001|T1 Consultation|Discontinued other|1|||
149208214|NCT03136367|538227129|FG002|T1 Consultation|Discontinued other|0|||
149208215|NCT03136367|538227127|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
149208216|NCT03136367|538227128|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
149208217|NCT03136367|538227129|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
149208218|NCT03136367|538227127|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
149208219|NCT03136367|538227128|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
149208220|NCT03136367|538227129|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
149208221|NCT03136367|538227127|FG000|T2 Post-consultation|Discontinued other|0|||
149208222|NCT03136367|538227128|FG001|T2 Post-consultation|Discontinued other|2|||
149208223|NCT03136367|538227129|FG002|T2 Post-consultation|Discontinued other|6|||
149208224|NCT03136367|538227127|FG000|T2 Post-consultation|Discontinued transferred care|0|||
149208225|NCT03136367|538227128|FG001|T2 Post-consultation|Discontinued transferred care|0|||
149208226|NCT03136367|538227129|FG002|T2 Post-consultation|Discontinued transferred care|3|||
149208227|NCT03136367|538227127|FG000|T2 Post-consultation|Discontinued lost contact|0|||
149208228|NCT03136367|538227128|FG001|T2 Post-consultation|Discontinued lost contact|1|||
149208229|NCT03136367|538227129|FG002|T2 Post-consultation|Discontinued lost contact|0|||
149208230|NCT03136367|538227127|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
149208231|NCT03136367|538227128|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
149208232|NCT03136367|538227129|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
149208233|NCT03136367|538227127|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
149208234|NCT03136367|538227128|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
149208235|NCT03136367|538227129|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
149208236|NCT03136367|538227127|FG000|T3 1 Week After Surgery|other discontinued|2|||
149208237|NCT03136367|538227128|FG001|T3 1 Week After Surgery|other discontinued|4|||
149208238|NCT03136367|538227129|FG002|T3 1 Week After Surgery|other discontinued|3|||
149208239|NCT03136367|538227127|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
149208240|NCT03136367|538227128|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
149208241|NCT03136367|538227129|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
149208242|NCT03136367|538227127|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
149208243|NCT03136367|538227128|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
149208244|NCT03136367|538227129|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
149208245|NCT03136367|538227127|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
149208246|NCT03136367|538227128|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
149208247|NCT03136367|538227129|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
149208248|NCT03136367|538227127|FG000|T4 12 Weeks After Surgery|Death|0|||
149208249|NCT03136367|538227128|FG001|T4 12 Weeks After Surgery|Death|1|||
149208250|NCT03136367|538227129|FG002|T4 12 Weeks After Surgery|Death|3|||
149208251|NCT03136367|538227127|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
149208252|NCT03136367|538227128|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
149208253|NCT03136367|538227129|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
149208254|NCT03136367|538227127|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
149208255|NCT03136367|538227128|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
149208256|NCT03136367|538227129|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
148949453|NCT00420927|537299615|FG000|Period 2|Took prohibited medication|0|||
148949454|NCT00420927|537299616|FG001|Period 2|Took prohibited medication|0|||
148949455|NCT00420927|537299617|FG002|Period 2|Took prohibited medication|0|||
148949456|NCT00420927|537299618|FG003|Period 2|Took prohibited medication|0|||
148949457|NCT00420927|537299619|FG004|Period 2|Took prohibited medication|1|||
148949458|NCT00420927|537299620|FG005|Period 2|Took prohibited medication|0|||
148949459|NCT00420927|537299621|FG006|Period 2|Took prohibited medication|0|||
149208257|NCT03136367|538227127|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
149208258|NCT03136367|538227128|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
148949460|NCT03018704|537299622|FG000|Overall Study|Lost to Follow-up|1|||
148949461|NCT03018704|537299623|FG001|Overall Study|Lost to Follow-up|1|||
148949462|NCT00642460|537299624|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
148949463|NCT00642460|537299625|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
148949464|NCT00642460|537299626|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
148949465|NCT00642460|537299627|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
148949466|NCT00642460|537299628|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
148949467|NCT00642460|537299629|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
148949468|NCT00642460|537299624|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
148949469|NCT00642460|537299625|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
148949470|NCT00642460|537299626|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
148949471|NCT00642460|537299627|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
148949472|NCT00642460|537299628|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
148949473|NCT00642460|537299629|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
148949474|NCT00642460|537299624|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
148949475|NCT00642460|537299625|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
148949476|NCT00642460|537299626|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
148949477|NCT00642460|537299627|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
148949478|NCT00642460|537299628|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
148949479|NCT00642460|537299629|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
149208259|NCT03136367|538227129|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
149208260|NCT03136367|538227127|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
148949480|NCT00642460|537299624|FG000|Part II: Open-Label Up to Week 92|Death|0|||
148949481|NCT00642460|537299625|FG001|Part II: Open-Label Up to Week 92|Death|1|||
148949482|NCT00642460|537299626|FG002|Part II: Open-Label Up to Week 92|Death|0|||
148949483|NCT00642460|537299627|FG003|Part II: Open-Label Up to Week 92|Death|2|||
148949484|NCT00642460|537299628|FG004|Part II: Open-Label Up to Week 92|Death|0|||
148949485|NCT00642460|537299629|FG005|Part II: Open-Label Up to Week 92|Death|0|||
148949486|NCT00642460|537299624|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
148949487|NCT00642460|537299625|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
148949488|NCT00642460|537299626|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
148949489|NCT00642460|537299627|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
148949490|NCT00642460|537299628|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
148949491|NCT00642460|537299629|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
148949492|NCT00642460|537299624|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
148949493|NCT00642460|537299625|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
148949494|NCT00642460|537299626|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
148949495|NCT00642460|537299627|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
148949496|NCT00642460|537299628|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
148949497|NCT00642460|537299629|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
148949498|NCT00642460|537299624|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
149208261|NCT03136367|538227128|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
149208262|NCT03136367|538227129|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
149208263|NCT03136367|538227127|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
149208264|NCT03136367|538227128|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
149208265|NCT03136367|538227129|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
149208266|NCT03136367|538227127|FG000|T5 1 Year After Surgery|Death|0|||
149208267|NCT03136367|538227128|FG001|T5 1 Year After Surgery|Death|0|||
149208268|NCT03136367|538227129|FG002|T5 1 Year After Surgery|Death|1|||
148684103|NCT00665626|536315095|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
148684104|NCT00665626|536315094|FG000|Overall Study|Unably to comply with dosing regimen|0|||
148684105|NCT00665626|536315095|FG001|Overall Study|Unably to comply with dosing regimen|1|||
148684106|NCT00665626|536315094|FG000|Overall Study|Death|1|||
148684107|NCT00665626|536315095|FG001|Overall Study|Death|0|||
148684108|NCT00585039|536315096|FG000|Overall Study|medication spilled|2|||
148684109|NCT00585039|536315097|FG001|Overall Study|medication spilled|0|||
149208269|NCT03136367|538227127|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
149208270|NCT03136367|538227128|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
149208271|NCT03136367|538227129|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
149208272|NCT03136367|538227127|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
149208273|NCT03136367|538227128|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
149208274|NCT03136367|538227129|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
149208275|NCT03136367|538227127|FG000|T5 1 Year After Surgery|study ended before due|31|||
149208276|NCT03136367|538227128|FG001|T5 1 Year After Surgery|study ended before due|103|||
149208277|NCT03136367|538227129|FG002|T5 1 Year After Surgery|study ended before due|110|||
149208278|NCT03136367|538227127|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
149208279|NCT03136367|538227128|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
149208280|NCT03136367|538227129|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
149208281|NCT03175562|538227133|FG000|Overall Study|Adverse Event|1|||
149208282|NCT03175562|538227133|FG000|Overall Study|Lost to Follow-up|3|||
148949499|NCT00642460|537299625|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
148684110|NCT00530439|536315098|FG000|Overall Study|GDM|9|||
148684111|NCT00530439|536315099|FG001|Overall Study|GDM|3|||
149016468|NCT01463293|537538820|FG002|Overall Study|Withdrawal by Subject|5|||
148684112|NCT00530439|536315098|FG000|Overall Study|Withdraw|18|||
148684113|NCT00530439|536315099|FG001|Overall Study|Withdraw|14|||
148684114|NCT00530439|536315098|FG000|Overall Study|Missed abortion|1|||
149208283|NCT03175562|538227133|FG000|Overall Study|Withdrawal by Subject|7|||
149208284|NCT03175562|538227133|FG000|Overall Study|Other (Not Specified)|5|||
149208285|NCT02146833|538227134|FG000|Overall Study|Death|10|||
149208286|NCT02146833|538227134|FG000|Overall Study|No longer consented to study treatment|1|||
149208287|NCT01105936|538229142|FG000|Period 1|Adverse Event|0|||
149208288|NCT01105936|538229143|FG001|Period 1|Adverse Event|0|||
149208289|NCT01105936|538229144|FG002|Period 1|Adverse Event|0|||
149208290|NCT01105936|538229145|FG003|Period 1|Adverse Event|1|||
148684115|NCT00530439|536315099|FG001|Overall Study|Missed abortion|4|||
148684116|NCT00530439|536315098|FG000|Overall Study|Misclassification|2|||
148684117|NCT00530439|536315099|FG001|Overall Study|Misclassification|0|||
148684118|NCT00530439|536315098|FG000|Overall Study|Twin pregnancy|0|||
149208291|NCT01105936|538229142|FG000|Period 2|Adverse Event|1|||
149208292|NCT01105936|538229143|FG001|Period 2|Adverse Event|0|||
149208293|NCT01105936|538229144|FG002|Period 2|Adverse Event|0|||
149208294|NCT01105936|538229145|FG003|Period 2|Adverse Event|0|||
149208295|NCT01105936|538229142|FG000|Period 3|Protocol Violation|0|||
149208296|NCT01105936|538229143|FG001|Period 3|Protocol Violation|2|||
149208297|NCT01105936|538229144|FG002|Period 3|Protocol Violation|0|||
149208298|NCT01105936|538229145|FG003|Period 3|Protocol Violation|0|||
149208299|NCT01563107|538229146|FG000|Overall Study|Physician Decision|0|||
149208300|NCT01563107|538229147|FG001|Overall Study|Physician Decision|1|||
149208301|NCT01563107|538229148|FG002|Overall Study|Physician Decision|1|||
149208302|NCT01563107|538229149|FG003|Overall Study|Physician Decision|3|||
149208303|NCT01563107|538229146|FG000|Overall Study|Withdrawal by Subject|1|||
149208304|NCT01563107|538229147|FG001|Overall Study|Withdrawal by Subject|2|||
149208305|NCT01563107|538229148|FG002|Overall Study|Withdrawal by Subject|1|||
149208306|NCT01563107|538229149|FG003|Overall Study|Withdrawal by Subject|2|||
149208307|NCT02707601|538229150|FG000|Overall Study|Death|0|||
149208308|NCT02707601|538229151|FG001|Overall Study|Death|1|||
149208309|NCT02707601|538229150|FG000|Overall Study|Lack of Efficacy|0|||
149208310|NCT02707601|538229151|FG001|Overall Study|Lack of Efficacy|1|||
149208311|NCT02707601|538229150|FG000|Overall Study|Investigator's Discretion|1|||
149208312|NCT02707601|538229151|FG001|Overall Study|Investigator's Discretion|0|||
149208313|NCT02707601|538229150|FG000|Overall Study|Withdrew Consent|0|||
149208314|NCT02707601|538229151|FG001|Overall Study|Withdrew Consent|1|||
149208315|NCT02707601|538229150|FG000|Overall Study|Lost to Follow-up|1|||
149208316|NCT02707601|538229151|FG001|Overall Study|Lost to Follow-up|1|||
149208317|NCT02707601|538229150|FG000|Overall Study|Participants Randomized but Not Treated|2|||
149208318|NCT02707601|538229151|FG001|Overall Study|Participants Randomized but Not Treated|0|||
149208319|NCT03907969|538229153|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
149208320|NCT03907969|538229154|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
149208321|NCT03907969|538229155|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
149208322|NCT03907969|538229156|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
149208323|NCT03907969|538229157|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
149208324|NCT03907969|538229158|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
148684119|NCT00530439|536315099|FG001|Overall Study|Twin pregnancy|2|||
148684120|NCT00530439|536315098|FG000|Overall Study|Severe malformation/abortion|0|||
148684121|NCT00530439|536315099|FG001|Overall Study|Severe malformation/abortion|3|||
148684122|NCT01629693|536315102|FG000|Overall Study|Lost to Follow-up|2|||
148684123|NCT01629693|536315103|FG001|Overall Study|Lost to Follow-up|4|||
148684124|NCT01629693|536315102|FG000|Overall Study|Withdrawal by Subject|2|||
149208325|NCT03907969|538229159|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
149208326|NCT03907969|538229160|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
149208327|NCT03907969|538229161|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
149208328|NCT03907969|538229162|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
149208329|NCT03907969|538229163|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
149208330|NCT03907969|538229153|FG000|Monotherapy Part A|Progressive Disease|0|||
149208331|NCT03907969|538229154|FG001|Monotherapy Part A|Progressive Disease|1|||
149208332|NCT03907969|538229155|FG002|Monotherapy Part A|Progressive Disease|0|||
149208333|NCT03907969|538229156|FG003|Monotherapy Part A|Progressive Disease|0|||
149208334|NCT03907969|538229157|FG004|Monotherapy Part A|Progressive Disease|0|||
149208335|NCT03907969|538229158|FG005|Monotherapy Part A|Progressive Disease|1|||
149208336|NCT03907969|538229159|FG006|Monotherapy Part A|Progressive Disease|2|||
149208337|NCT03907969|538229160|FG007|Monotherapy Part A|Progressive Disease|0|||
149208338|NCT03907969|538229161|FG008|Monotherapy Part A|Progressive Disease|0|||
149208339|NCT03907969|538229162|FG009|Monotherapy Part A|Progressive Disease|0|||
149208340|NCT03907969|538229163|FG010|Monotherapy Part A|Progressive Disease|0|||
149208341|NCT03907969|538229153|FG000|Monotherapy Part A|Death|0|||
149208342|NCT03907969|538229154|FG001|Monotherapy Part A|Death|0|||
149208343|NCT03907969|538229155|FG002|Monotherapy Part A|Death|1|||
149208344|NCT03907969|538229156|FG003|Monotherapy Part A|Death|1|||
149208345|NCT03907969|538229157|FG004|Monotherapy Part A|Death|0|||
149208346|NCT03907969|538229158|FG005|Monotherapy Part A|Death|1|||
149208347|NCT03907969|538229159|FG006|Monotherapy Part A|Death|0|||
149208348|NCT03907969|538229160|FG007|Monotherapy Part A|Death|0|||
149208349|NCT03907969|538229161|FG008|Monotherapy Part A|Death|0|||
149208350|NCT03907969|538229162|FG009|Monotherapy Part A|Death|0|||
149208351|NCT03907969|538229163|FG010|Monotherapy Part A|Death|0|||
148684125|NCT01629693|536315103|FG001|Overall Study|Withdrawal by Subject|2|||
149208352|NCT03907969|538229153|FG000|Combination Therapy Part A|Adverse Event|0|||
149208353|NCT03907969|538229154|FG001|Combination Therapy Part A|Adverse Event|0|||
149208354|NCT03907969|538229155|FG002|Combination Therapy Part A|Adverse Event|0|||
149208355|NCT03907969|538229156|FG003|Combination Therapy Part A|Adverse Event|0|||
149208356|NCT03907969|538229157|FG004|Combination Therapy Part A|Adverse Event|0|||
149208357|NCT03907969|538229158|FG005|Combination Therapy Part A|Adverse Event|0|||
149208358|NCT03907969|538229159|FG006|Combination Therapy Part A|Adverse Event|0|||
149208359|NCT03907969|538229160|FG007|Combination Therapy Part A|Adverse Event|0|||
149208360|NCT03907969|538229161|FG008|Combination Therapy Part A|Adverse Event|0|||
149208361|NCT03907969|538229162|FG009|Combination Therapy Part A|Adverse Event|1|||
149208362|NCT03907969|538229163|FG010|Combination Therapy Part A|Adverse Event|1|||
149208363|NCT03907969|538229153|FG000|Combination Therapy Part A|Progressive disease|0|||
149208364|NCT03907969|538229154|FG001|Combination Therapy Part A|Progressive disease|0|||
149208365|NCT03907969|538229155|FG002|Combination Therapy Part A|Progressive disease|0|||
149208366|NCT03907969|538229156|FG003|Combination Therapy Part A|Progressive disease|0|||
149208367|NCT03907969|538229157|FG004|Combination Therapy Part A|Progressive disease|0|||
149208368|NCT03907969|538229158|FG005|Combination Therapy Part A|Progressive disease|0|||
149208369|NCT03907969|538229159|FG006|Combination Therapy Part A|Progressive disease|0|||
149208370|NCT03907969|538229160|FG007|Combination Therapy Part A|Progressive disease|1|||
149208371|NCT03907969|538229161|FG008|Combination Therapy Part A|Progressive disease|0|||
149208372|NCT03907969|538229162|FG009|Combination Therapy Part A|Progressive disease|2|||
149208373|NCT03907969|538229163|FG010|Combination Therapy Part A|Progressive disease|3|||
149208374|NCT03907969|538229153|FG000|Combination Therapy Part A|Death|0|||
149208375|NCT03907969|538229154|FG001|Combination Therapy Part A|Death|0|||
149208376|NCT03907969|538229155|FG002|Combination Therapy Part A|Death|0|||
149208377|NCT03907969|538229156|FG003|Combination Therapy Part A|Death|0|||
149208378|NCT03907969|538229157|FG004|Combination Therapy Part A|Death|0|||
149208379|NCT03907969|538229158|FG005|Combination Therapy Part A|Death|0|||
149208380|NCT03907969|538229159|FG006|Combination Therapy Part A|Death|0|||
149208381|NCT03907969|538229160|FG007|Combination Therapy Part A|Death|0|||
149208382|NCT03907969|538229161|FG008|Combination Therapy Part A|Death|1|||
149208383|NCT03907969|538229162|FG009|Combination Therapy Part A|Death|0|||
149208384|NCT03907969|538229163|FG010|Combination Therapy Part A|Death|1|||
149208385|NCT03907969|538229153|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
149208386|NCT03907969|538229154|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
149208387|NCT03907969|538229155|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
149208388|NCT03907969|538229156|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
149208389|NCT03907969|538229157|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
149208390|NCT03907969|538229158|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
149208391|NCT03907969|538229159|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
149208392|NCT03907969|538229160|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
149208393|NCT03907969|538229161|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
149208394|NCT03907969|538229162|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
149208395|NCT03907969|538229163|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
149208396|NCT03907969|538229153|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
149208397|NCT03907969|538229154|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
149208398|NCT03907969|538229155|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
148949500|NCT00642460|537299626|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
148949501|NCT00642460|537299627|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
149208399|NCT03907969|538229156|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
148684126|NCT01629693|536315102|FG000|Overall Study|Adverse Event|1|||
149208400|NCT03907969|538229157|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
149208401|NCT03907969|538229158|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
149208402|NCT03907969|538229159|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
148949502|NCT00642460|537299628|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
149208403|NCT03907969|538229160|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
149016469|NCT01463293|537538818|FG000|Overall Study|Other|0|||
149208404|NCT03907969|538229161|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
149208405|NCT03907969|538229162|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
149208406|NCT03907969|538229163|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
149208407|NCT03907969|538229153|FG000|Combination Therapy Part A|Physician Decision|0|||
149208408|NCT03907969|538229154|FG001|Combination Therapy Part A|Physician Decision|0|||
149208409|NCT03907969|538229155|FG002|Combination Therapy Part A|Physician Decision|0|||
149208410|NCT03907969|538229156|FG003|Combination Therapy Part A|Physician Decision|0|||
149208411|NCT03907969|538229157|FG004|Combination Therapy Part A|Physician Decision|0|||
149208412|NCT03907969|538229158|FG005|Combination Therapy Part A|Physician Decision|0|||
149208413|NCT03907969|538229159|FG006|Combination Therapy Part A|Physician Decision|0|||
149208414|NCT03907969|538229160|FG007|Combination Therapy Part A|Physician Decision|1|||
149208415|NCT03907969|538229161|FG008|Combination Therapy Part A|Physician Decision|0|||
149208416|NCT03907969|538229162|FG009|Combination Therapy Part A|Physician Decision|0|||
149208417|NCT03907969|538229163|FG010|Combination Therapy Part A|Physician Decision|1|||
149208418|NCT00247273|538229164|FG000|Overall Study|Adverse Event|85|||
149208419|NCT00247273|538229165|FG001|Overall Study|Adverse Event|80|||
149208420|NCT00247273|538229164|FG000|Overall Study|Physician Decision|6|||
149208421|NCT00247273|538229165|FG001|Overall Study|Physician Decision|3|||
149208422|NCT00247273|538229164|FG000|Overall Study|Lost to Follow-up|7|||
149208423|NCT00247273|538229165|FG001|Overall Study|Lost to Follow-up|7|||
149208424|NCT00247273|538229164|FG000|Overall Study|Withdrawal by Subject|46|||
149208425|NCT00247273|538229165|FG001|Overall Study|Withdrawal by Subject|47|||
149208426|NCT00247273|538229164|FG000|Overall Study|Did not take any study drug|2|||
149208427|NCT00247273|538229165|FG001|Overall Study|Did not take any study drug|0|||
149208428|NCT03276572|538229166|FG000|Overall Study|In follow-up|0|||
149208429|NCT03276572|538229167|FG001|Overall Study|In follow-up|0|||
149208430|NCT03276572|538229168|FG002|Overall Study|In follow-up|0|||
149208431|NCT03276572|538229169|FG003|Overall Study|In follow-up|0|||
149208432|NCT03276572|538229170|FG004|Overall Study|In follow-up|0|||
149208433|NCT03276572|538229171|FG005|Overall Study|In follow-up|1|||
149208434|NCT03276572|538229172|FG006|Overall Study|In follow-up|1|||
149208435|NCT03276572|538229166|FG000|Overall Study|Lost to Follow-up|0|||
148684127|NCT01629693|536315103|FG001|Overall Study|Adverse Event|0|||
148949503|NCT00642460|537299629|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
149016470|NCT01463293|537538819|FG001|Overall Study|Other|0|||
149208436|NCT03276572|538229167|FG001|Overall Study|Lost to Follow-up|0|||
149208437|NCT03276572|538229168|FG002|Overall Study|Lost to Follow-up|0|||
149208438|NCT03276572|538229169|FG003|Overall Study|Lost to Follow-up|0|||
149208439|NCT03276572|538229170|FG004|Overall Study|Lost to Follow-up|0|||
149208440|NCT03276572|538229171|FG005|Overall Study|Lost to Follow-up|0|||
149208441|NCT03276572|538229172|FG006|Overall Study|Lost to Follow-up|1|||
148684128|NCT01629693|536315102|FG000|Overall Study|Investigator decision|0|||
148684129|NCT01629693|536315103|FG001|Overall Study|Investigator decision|1|||
148684130|NCT01629693|536315102|FG000|Overall Study|Poor comfort of study lenses|0|||
148684131|NCT01629693|536315103|FG001|Overall Study|Poor comfort of study lenses|2|||
148684132|NCT01629693|536315102|FG000|Overall Study|Subject decision unrelated to AE|0|||
148684133|NCT01629693|536315103|FG001|Overall Study|Subject decision unrelated to AE|1|||
148684134|NCT04385199|536315110|FG000|Overall Study|Withdrawal by Subject|1|||
148684135|NCT04385199|536315111|FG001|Overall Study|Withdrawal by Subject|0|||
148684136|NCT01025193|536315113|FG000|Overall Study|Protocol Violation|1|||
148684137|NCT01025193|536315113|FG000|Overall Study|Adverse Event|3|||
148684138|NCT04079842|536315114|FG000|Overall Study|Request of subject|2|||
148684139|NCT04079842|536315114|FG000|Overall Study|Unable to draw Arterial samples|1|||
148684140|NCT02904200|536315115|FG000|Overall Study|Withdrawal by Subject|1|||
148684141|NCT02904200|536315116|FG001|Overall Study|Withdrawal by Subject|0|||
148684142|NCT02133352|536315119|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
148684143|NCT03705169|536315120|FG000|Overall Study|Lost to Follow-up|0|||
148684144|NCT03705169|536315121|FG001|Overall Study|Lost to Follow-up|0|||
148684145|NCT03705169|536315122|FG002|Overall Study|Lost to Follow-up|0|||
148684146|NCT03705169|536315123|FG003|Overall Study|Lost to Follow-up|2|||
148684147|NCT03705169|536315124|FG004|Overall Study|Lost to Follow-up|0|||
148684148|NCT03705169|536315125|FG005|Overall Study|Lost to Follow-up|2|||
148684149|NCT03705169|536315126|FG006|Overall Study|Lost to Follow-up|1|||
148684150|NCT03705169|536315127|FG007|Overall Study|Lost to Follow-up|0|||
148684151|NCT03705169|536315128|FG008|Overall Study|Lost to Follow-up|0|||
148684152|NCT03705169|536315129|FG009|Overall Study|Lost to Follow-up|1|||
148684153|NCT03705169|536315120|FG000|Overall Study|Adverse Event|0|||
148684154|NCT03705169|536315121|FG001|Overall Study|Adverse Event|0|||
148684155|NCT03705169|536315122|FG002|Overall Study|Adverse Event|0|||
148684156|NCT03705169|536315123|FG003|Overall Study|Adverse Event|1|||
149208442|NCT00607919|538229173|FG000|Acute Phase|Adverse Event|9|||
149208443|NCT00607919|538229174|FG001|Acute Phase|Adverse Event|2|||
148684157|NCT03705169|536315124|FG004|Overall Study|Adverse Event|0|||
148684158|NCT03705169|536315125|FG005|Overall Study|Adverse Event|0|||
148684159|NCT03705169|536315126|FG006|Overall Study|Adverse Event|0|||
148684160|NCT03705169|536315127|FG007|Overall Study|Adverse Event|0|||
148684161|NCT03705169|536315128|FG008|Overall Study|Adverse Event|0|||
149208444|NCT00607919|538229173|FG000|Acute Phase|Entry Criteria Not Met|1|||
149208445|NCT00607919|538229174|FG001|Acute Phase|Entry Criteria Not Met|1|||
148684162|NCT03705169|536315129|FG009|Overall Study|Adverse Event|0|||
149208446|NCT00607919|538229173|FG000|Acute Phase|Lack of Efficacy|1|||
149208447|NCT00607919|538229174|FG001|Acute Phase|Lack of Efficacy|2|||
149208448|NCT00607919|538229173|FG000|Acute Phase|Lost to Follow-up|9|||
148949504|NCT00642460|537299624|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
148684163|NCT03705169|536315120|FG000|Overall Study|Site Closure|0|||
148684164|NCT03705169|536315121|FG001|Overall Study|Site Closure|0|||
148684165|NCT03705169|536315122|FG002|Overall Study|Site Closure|0|||
148684166|NCT03705169|536315123|FG003|Overall Study|Site Closure|1|||
148684167|NCT03705169|536315124|FG004|Overall Study|Site Closure|0|||
148684168|NCT03705169|536315125|FG005|Overall Study|Site Closure|0|||
148684169|NCT03705169|536315126|FG006|Overall Study|Site Closure|0|||
148684170|NCT03705169|536315127|FG007|Overall Study|Site Closure|0|||
148684171|NCT03705169|536315128|FG008|Overall Study|Site Closure|0|||
148684172|NCT03705169|536315129|FG009|Overall Study|Site Closure|0|||
148684173|NCT03705169|536315120|FG000|Overall Study|Did not receive study treatment|0|||
148684174|NCT03705169|536315121|FG001|Overall Study|Did not receive study treatment|0|||
148684175|NCT03705169|536315122|FG002|Overall Study|Did not receive study treatment|0|||
148684176|NCT03705169|536315123|FG003|Overall Study|Did not receive study treatment|1|||
148684177|NCT03705169|536315124|FG004|Overall Study|Did not receive study treatment|0|||
148684178|NCT03705169|536315125|FG005|Overall Study|Did not receive study treatment|0|||
148684179|NCT03705169|536315126|FG006|Overall Study|Did not receive study treatment|0|||
148684180|NCT03705169|536315127|FG007|Overall Study|Did not receive study treatment|0|||
148684181|NCT03705169|536315128|FG008|Overall Study|Did not receive study treatment|0|||
148684182|NCT03705169|536315129|FG009|Overall Study|Did not receive study treatment|0|||
148684183|NCT03705169|536315120|FG000|Overall Study|Concerns about study visit compliance|0|||
148684184|NCT03705169|536315121|FG001|Overall Study|Concerns about study visit compliance|0|||
148684185|NCT03705169|536315122|FG002|Overall Study|Concerns about study visit compliance|0|||
148684186|NCT03705169|536315123|FG003|Overall Study|Concerns about study visit compliance|1|||
148684187|NCT03705169|536315124|FG004|Overall Study|Concerns about study visit compliance|0|||
148684188|NCT03705169|536315125|FG005|Overall Study|Concerns about study visit compliance|0|||
148684189|NCT03705169|536315126|FG006|Overall Study|Concerns about study visit compliance|0|||
148684190|NCT03705169|536315127|FG007|Overall Study|Concerns about study visit compliance|0|||
148684191|NCT03705169|536315128|FG008|Overall Study|Concerns about study visit compliance|0|||
148684192|NCT03705169|536315129|FG009|Overall Study|Concerns about study visit compliance|0|||
148684193|NCT00185211|536315130|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
148684194|NCT00185211|536315131|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
148684195|NCT00185211|536315130|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
148684196|NCT00185211|536315131|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
148684197|NCT00185211|536315130|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
148684198|NCT00185211|536315131|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
148684199|NCT00185211|536315130|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
148684200|NCT00185211|536315131|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
148684201|NCT00185211|536315130|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
148684202|NCT00185211|536315131|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
148684203|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
148684204|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
148684205|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
148684206|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
148684207|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
148684208|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
148684209|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
148684210|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
148684211|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
148684212|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
148684213|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
148684214|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
148684215|NCT00185211|536315130|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
148684216|NCT00185211|536315131|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
148684217|NCT01759537|536315132|FG000|Overall Study|Death|1|||
148684218|NCT01759537|536315133|FG001|Overall Study|Death|1|||
148684219|NCT01759537|536315132|FG000|Overall Study|Pregnancy|1|||
148684220|NCT01759537|536315133|FG001|Overall Study|Pregnancy|1|||
148684221|NCT01759537|536315132|FG000|Overall Study|Lost to Follow-up|9|||
148684222|NCT01759537|536315133|FG001|Overall Study|Lost to Follow-up|9|||
148684223|NCT01759537|536315132|FG000|Overall Study|Accident involving jaw fracture|1|||
148684224|NCT01759537|536315133|FG001|Overall Study|Accident involving jaw fracture|1|||
148684225|NCT01759537|536315132|FG000|Overall Study|Subcrestal implant too coronal|1|||
148684226|NCT01759537|536315133|FG001|Overall Study|Subcrestal implant too coronal|1|||
148684227|NCT02257632|536316714|FG000|Overall Study|Withdrawal by Subject|0|||
148684228|NCT02257632|536316715|FG001|Overall Study|Withdrawal by Subject|1|||
148949505|NCT00642460|537299625|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
148949506|NCT00642460|537299626|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
149208449|NCT00607919|538229174|FG001|Acute Phase|Lost to Follow-up|3|||
149208450|NCT00607919|538229173|FG000|Acute Phase|Parent/Caregiver Decision|6|||
149208451|NCT00607919|538229174|FG001|Acute Phase|Parent/Caregiver Decision|4|||
149208452|NCT00607919|538229173|FG000|Acute Phase|Protocol Violation|5|||
149208453|NCT00607919|538229174|FG001|Acute Phase|Protocol Violation|1|||
149208454|NCT00607919|538229173|FG000|Acute Phase|Withdrawal by Subject|3|||
149208455|NCT00607919|538229174|FG001|Acute Phase|Withdrawal by Subject|3|||
149208456|NCT00607919|538229173|FG000|Open-Label Phase|Adverse Event|1|||
148949507|NCT00642460|537299627|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
149016471|NCT01463293|537538820|FG002|Overall Study|Other|2|||
149208457|NCT00607919|538229174|FG001|Open-Label Phase|Adverse Event|5|||
149208458|NCT00607919|538229173|FG000|Open-Label Phase|Lost to Follow-up|4|||
149208459|NCT00607919|538229174|FG001|Open-Label Phase|Lost to Follow-up|1|||
149208460|NCT00607919|538229173|FG000|Open-Label Phase|Protocol Violation|2|||
149208461|NCT00607919|538229174|FG001|Open-Label Phase|Protocol Violation|2|||
149208462|NCT00607919|538229173|FG000|Open-Label Phase|Withdrawal by Subject|2|||
149208463|NCT00607919|538229174|FG001|Open-Label Phase|Withdrawal by Subject|2|||
149208464|NCT00607919|538229173|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
149208465|NCT00607919|538229174|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
149208466|NCT02580240|538229175|FG000|Overall Study|Physician Decision|2|||
149208467|NCT02580240|538229176|FG001|Overall Study|Physician Decision|0|||
149208468|NCT00445341|538229200|FG000|Overall Study|refused further treatment|1|||
149208469|NCT00445341|538229200|FG000|Overall Study|taken off treatment too early|1|||
149208470|NCT03051217|538229203|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
149208471|NCT03051217|538229204|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149208472|NCT03051217|538229205|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
149208473|NCT03051217|538229206|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149208474|NCT03051217|538229207|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149208475|NCT03051217|538229208|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149208476|NCT03051217|538229209|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
149208477|NCT03051217|538229203|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149208478|NCT03051217|538229204|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
149208479|NCT03051217|538229205|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149208480|NCT03051217|538229206|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149208481|NCT03051217|538229207|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149208482|NCT03051217|538229208|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149208483|NCT03051217|538229209|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
149208484|NCT03051217|538229203|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149208485|NCT03051217|538229204|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149208486|NCT03051217|538229205|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
149208487|NCT03051217|538229206|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149208488|NCT03051217|538229207|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149208489|NCT03051217|538229208|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149208490|NCT03051217|538229209|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
149208491|NCT03051217|538229203|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
149208492|NCT03051217|538229204|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
149208493|NCT03051217|538229205|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
149208494|NCT03051217|538229206|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
149208495|NCT03051217|538229207|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
149208496|NCT03051217|538229208|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
149208497|NCT03051217|538229209|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
149208498|NCT03051217|538229203|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149208499|NCT03051217|538229204|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149208500|NCT03051217|538229205|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149208501|NCT03051217|538229206|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
149208502|NCT03051217|538229207|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149208503|NCT03051217|538229208|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149208504|NCT03051217|538229209|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
149208505|NCT03051217|538229203|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149208506|NCT03051217|538229204|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149208507|NCT03051217|538229205|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149208508|NCT03051217|538229206|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
149208509|NCT03051217|538229207|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149208510|NCT03051217|538229208|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149208511|NCT03051217|538229209|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
149208512|NCT03051217|538229203|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149208513|NCT03051217|538229204|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
148949508|NCT00642460|537299628|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
148949509|NCT00642460|537299629|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
148949510|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
148949511|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
148949512|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
148949513|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
148949514|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
148949515|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
148949516|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
149208514|NCT03051217|538229205|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149208515|NCT03051217|538229206|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149208516|NCT03051217|538229207|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
149208517|NCT03051217|538229208|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
148949517|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
148949518|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
148949519|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
148949520|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
148949521|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
148949522|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
148949523|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
148949524|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
148949525|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
148949526|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
148949527|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
148949528|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
148949529|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
148949530|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
148949531|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
148949532|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
148949533|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
148949534|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Other|0|||
148949535|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Other|0|||
149208518|NCT03051217|538229209|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
149208519|NCT03051217|538229203|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149208520|NCT03051217|538229204|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149208521|NCT03051217|538229205|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149208522|NCT03051217|538229206|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149208523|NCT03051217|538229207|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149208524|NCT03051217|538229208|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
149208525|NCT03051217|538229209|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
149208526|NCT00641706|538229210|FG000|Overall Study|Adverse Event|2|||
149208527|NCT00641706|538229211|FG001|Overall Study|Adverse Event|1|||
149208528|NCT00641706|538229210|FG000|Overall Study|Withdrawal by Subject|6|||
149208529|NCT00641706|538229211|FG001|Overall Study|Withdrawal by Subject|1|||
149208530|NCT00641706|538229210|FG000|Overall Study|Clinical Decline|1|||
149208531|NCT00641706|538229211|FG001|Overall Study|Clinical Decline|0|||
149208532|NCT00641706|538229210|FG000|Overall Study|Lead Investigator Decision|0|||
148949536|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Other|0|||
149208533|NCT00641706|538229211|FG001|Overall Study|Lead Investigator Decision|1|||
149208534|NCT00109772|538229212|FG000|Double-blind Treatment|Adverse Event|14|||
149208535|NCT00109772|538229213|FG001|Double-blind Treatment|Adverse Event|5|||
149208536|NCT00109772|538229212|FG000|Double-blind Treatment|Lack of Efficacy|1|||
149208537|NCT00109772|538229213|FG001|Double-blind Treatment|Lack of Efficacy|0|||
149208538|NCT00109772|538229212|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
149208539|NCT00109772|538229213|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
149208540|NCT00109772|538229212|FG000|Double-blind Treatment|Lost to Follow-up|2|||
149208541|NCT00109772|538229213|FG001|Double-blind Treatment|Lost to Follow-up|3|||
149208542|NCT00109772|538229212|FG000|Double-blind Treatment|Protocol Violation|0|||
149208543|NCT00109772|538229213|FG001|Double-blind Treatment|Protocol Violation|1|||
149208544|NCT00109772|538229212|FG000|Double-blind Treatment|Other|0|||
149208545|NCT00109772|538229213|FG001|Double-blind Treatment|Other|4|||
149208546|NCT00109772|538229212|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
149208547|NCT00109772|538229213|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
149208548|NCT00109772|538229212|FG000|Open-label Extension|Adverse Event|10|||
149208549|NCT00109772|538229213|FG001|Open-label Extension|Adverse Event|19|||
149208550|NCT00109772|538229212|FG000|Open-label Extension|Lack of Efficacy|19|||
149208551|NCT00109772|538229213|FG001|Open-label Extension|Lack of Efficacy|11|||
149208552|NCT00109772|538229212|FG000|Open-label Extension|Withdrawal by Subject|9|||
149208553|NCT00109772|538229213|FG001|Open-label Extension|Withdrawal by Subject|6|||
149208554|NCT00109772|538229212|FG000|Open-label Extension|Lost to Follow-up|1|||
149208555|NCT00109772|538229213|FG001|Open-label Extension|Lost to Follow-up|0|||
149208556|NCT00109772|538229212|FG000|Open-label Extension|Death|0|||
149208557|NCT00109772|538229213|FG001|Open-label Extension|Death|1|||
149208558|NCT00109772|538229212|FG000|Open-label Extension|Protocol Violation|2|||
149208559|NCT00109772|538229213|FG001|Open-label Extension|Protocol Violation|2|||
149208560|NCT00109772|538229212|FG000|Open-label Extension|Other|4|||
149208561|NCT00109772|538229213|FG001|Open-label Extension|Other|10|||
149208562|NCT05441540|538229214|FG000|Overall Study|Withdrawal by Subject|2|||
149208563|NCT00813917|538229215|FG000|Overall Study|Adverse Event|0|||
149208564|NCT00813917|538229216|FG001|Overall Study|Adverse Event|1|||
149208565|NCT00813917|538229215|FG000|Overall Study|Withdrawal by Subject|3|||
149208566|NCT00813917|538229216|FG001|Overall Study|Withdrawal by Subject|4|||
149208567|NCT00813917|538229215|FG000|Overall Study|Lost to Follow-up|3|||
149208568|NCT00813917|538229216|FG001|Overall Study|Lost to Follow-up|1|||
149208569|NCT01359046|538229217|FG000|Overall Study|Did not receive allocated intervention|6|||
148949537|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Other|0|||
149208570|NCT01359046|538229218|FG001|Overall Study|Did not receive allocated intervention|6|||
149208571|NCT01359046|538229217|FG000|Overall Study|Physician Decision|1|||
149208572|NCT01359046|538229218|FG001|Overall Study|Physician Decision|11|||
149208573|NCT04539262|538229225|FG000|Overall Study|Adverse Event|0|||
149208574|NCT04539262|538229226|FG001|Overall Study|Adverse Event|0|||
149208575|NCT04539262|538229227|FG002|Overall Study|Adverse Event|1|||
149208576|NCT04539262|538229228|FG003|Overall Study|Adverse Event|0|||
149208577|NCT04539262|538229229|FG004|Overall Study|Adverse Event|0|||
149208578|NCT04539262|538229230|FG005|Overall Study|Adverse Event|0|||
149208579|NCT04539262|538229231|FG006|Overall Study|Adverse Event|0|||
149208580|NCT04539262|538229232|FG007|Overall Study|Adverse Event|0|||
149208581|NCT04539262|538229225|FG000|Overall Study|Withdrew Consent|0|||
149208582|NCT04539262|538229226|FG001|Overall Study|Withdrew Consent|0|||
149208583|NCT04539262|538229227|FG002|Overall Study|Withdrew Consent|0|||
149208584|NCT04539262|538229228|FG003|Overall Study|Withdrew Consent|1|||
149208585|NCT04539262|538229229|FG004|Overall Study|Withdrew Consent|0|||
149208586|NCT04539262|538229230|FG005|Overall Study|Withdrew Consent|0|||
149208587|NCT04539262|538229231|FG006|Overall Study|Withdrew Consent|0|||
149208588|NCT04539262|538229232|FG007|Overall Study|Withdrew Consent|0|||
149208589|NCT04539262|538229225|FG000|Overall Study|Randomized, Not treated|0|||
149208590|NCT04539262|538229226|FG001|Overall Study|Randomized, Not treated|1|||
149208591|NCT04539262|538229227|FG002|Overall Study|Randomized, Not treated|0|||
149208592|NCT04539262|538229228|FG003|Overall Study|Randomized, Not treated|0|||
149208593|NCT04539262|538229229|FG004|Overall Study|Randomized, Not treated|0|||
149208594|NCT04539262|538229230|FG005|Overall Study|Randomized, Not treated|0|||
149208595|NCT04539262|538229231|FG006|Overall Study|Randomized, Not treated|1|||
149208596|NCT04539262|538229232|FG007|Overall Study|Randomized, Not treated|0|||
149208597|NCT00792701|538229233|FG000|Overall Study|Adverse Event|0|||
149208598|NCT00792701|538229234|FG001|Overall Study|Adverse Event|22|||
149208599|NCT00792701|538229233|FG000|Overall Study|Ineligible|1|||
149208600|NCT00792701|538229234|FG001|Overall Study|Ineligible|3|||
149208601|NCT00792701|538229233|FG000|Overall Study|Withdrawal by Subject|1|||
149208602|NCT00792701|538229234|FG001|Overall Study|Withdrawal by Subject|19|||
149208603|NCT00792701|538229233|FG000|Overall Study|Not protocol specified|17|||
149208604|NCT00792701|538229234|FG001|Overall Study|Not protocol specified|0|||
149208605|NCT00615914|538229237|FG000|Overall Study|Adverse Event|274|||
149208606|NCT00615914|538229237|FG000|Overall Study|Death|20|||
149208607|NCT00615914|538229237|FG000|Overall Study|Lack of Efficacy|59|||
149208608|NCT00615914|538229237|FG000|Overall Study|Lost to Follow-up|187|||
149208609|NCT00615914|538229237|FG000|Overall Study|Withdrawal by Subject|16|||
149208610|NCT00615914|538229237|FG000|Overall Study|Physician Decision|4|||
149208611|NCT00615914|538229237|FG000|Overall Study|No data was collected.|65|||
149208612|NCT00615914|538229237|FG000|Overall Study|No treatment|2|||
149208613|NCT00615914|538229237|FG000|Overall Study|Irregularly enrolled patients|10|||
149208614|NCT03673956|538229238|FG000|Overall Study|Lost to Follow-up|1|||
149208615|NCT03673956|538229239|FG001|Overall Study|Lost to Follow-up|0|||
149208616|NCT03673956|538229240|FG002|Overall Study|Lost to Follow-up|0|||
149208617|NCT03673956|538229241|FG003|Overall Study|Lost to Follow-up|0|||
149208618|NCT03673956|538229238|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
149208619|NCT03673956|538229239|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
149208620|NCT03673956|538229240|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
149208621|NCT03673956|538229241|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
149208622|NCT04075396|538229246|FG000|Overall Study|Death|11|||
149208623|NCT04075396|538229247|FG001|Overall Study|Death|9|||
149208624|NCT04075396|538229246|FG000|Overall Study|Withdrawal by Subject|1|||
148949538|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Other|2|||
148949539|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Other|2|||
148949540|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Death|0|||
148949541|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Death|0|||
148949542|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Death|0|||
148949543|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Death|0|||
148949544|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Death|0|||
148949545|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Death|3|||
148949546|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
148949547|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
148949548|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
148949549|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
148949550|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
148949551|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
148949552|NCT00642460|537299624|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
148949553|NCT00642460|537299625|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
148949554|NCT00642460|537299626|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
148949555|NCT00642460|537299627|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
148949556|NCT00642460|537299628|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
148949557|NCT00642460|537299629|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
148949558|NCT00320411|537299630|FG000|Overall Study|No investigational product admin.|4|||
148949559|NCT04448171|537299633|FG000|Overall Study|Procedure Cancelled|1|||
148949560|NCT04448171|537299634|FG001|Overall Study|Procedure Cancelled|0|||
148949561|NCT04448171|537299633|FG000|Overall Study|Protocol Violation|1|||
148949562|NCT04448171|537299634|FG001|Overall Study|Protocol Violation|0|||
148949563|NCT02088047|537299635|FG000|Overall Study|Withdrawal by Subject|1|||
148949564|NCT02088047|537299636|FG001|Overall Study|Withdrawal by Subject|0|||
148949565|NCT00660309|537299639|FG000|Overall Study|Adverse Event|2|||
148949566|NCT00660309|537299640|FG001|Overall Study|Adverse Event|0|||
148949567|NCT00660309|537299639|FG000|Overall Study|Withdrawal by Subject|0|||
148949568|NCT00660309|537299640|FG001|Overall Study|Withdrawal by Subject|3|||
148949569|NCT00211809|537299643|FG000|Overall Study|Lack of Efficacy|1|||
148949570|NCT00211809|537299643|FG000|Overall Study|Lost to Follow-up|2|||
148949571|NCT00211809|537299643|FG000|Overall Study|Pregnancy|1|||
148949572|NCT00211809|537299643|FG000|Overall Study|side effects|2|||
148949573|NCT01417234|537299644|FG000|Overall Study|Subject non-compliant|3|||
148949574|NCT00023764|537299645|FG000|Overall Study|Other|1|||
148949575|NCT00023764|537299645|FG000|Overall Study|Adverse Event|4|||
148949576|NCT00023764|537299645|FG000|Overall Study|Withdrawal by Subject|1|||
148949577|NCT00023764|537299645|FG000|Overall Study|Progression of disease|6|||
148949578|NCT00023764|537299645|FG000|Overall Study|patient received other treatment|1|||
148949579|NCT00023764|537299645|FG000|Overall Study|delay in obtaining staging images|1|||
148949580|NCT01844518|537299651|FG000|Overall Study|Adverse Event|7|||
148949581|NCT01844518|537299652|FG001|Overall Study|Adverse Event|1|||
148949582|NCT01844518|537299651|FG000|Overall Study|Lack of Efficacy|17|||
148949583|NCT01844518|537299652|FG001|Overall Study|Lack of Efficacy|5|||
148949584|NCT01844518|537299651|FG000|Overall Study|Participant's request to discontinue|4|||
149208625|NCT04075396|538229247|FG001|Overall Study|Withdrawal by Subject|2|||
149208626|NCT04075396|538229246|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
149208627|NCT04075396|538229247|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
149208628|NCT04075396|538229246|FG000|Overall Study|Enrolled but not-treated|0|||
149208629|NCT04075396|538229247|FG001|Overall Study|Enrolled but not-treated|1|||
149208630|NCT01156532|538229248|FG000|Overall Study|Family Reasons|1|||
149208631|NCT01156532|538229248|FG000|Overall Study|Lost to Follow-up|1|||
149208632|NCT03228394|538229249|FG000|Overall Study|Lost to Follow-up|0|||
149208633|NCT03228394|538229250|FG001|Overall Study|Lost to Follow-up|0|||
149208634|NCT03228394|538229251|FG002|Overall Study|Lost to Follow-up|1|||
149208635|NCT03228394|538229252|FG003|Overall Study|Lost to Follow-up|1|||
149208636|NCT03228394|538229253|FG004|Overall Study|Lost to Follow-up|0|||
149208637|NCT03228394|538229254|FG005|Overall Study|Lost to Follow-up|0|||
149208638|NCT03228394|538229255|FG006|Overall Study|Lost to Follow-up|2|||
149208639|NCT03228394|538229256|FG007|Overall Study|Lost to Follow-up|0|||
149208640|NCT03228394|538229249|FG000|Overall Study|Withdrawal by Subject|0|||
149208641|NCT03228394|538229250|FG001|Overall Study|Withdrawal by Subject|0|||
149208642|NCT03228394|538229251|FG002|Overall Study|Withdrawal by Subject|1|||
148684229|NCT02257632|536316714|FG000|Overall Study|Adverse Event|1|||
148949585|NCT01844518|537299652|FG001|Overall Study|Participant's request to discontinue|1|||
148949586|NCT01844518|537299651|FG000|Overall Study|Poor/Non-compliance|1|||
148949587|NCT01844518|537299652|FG001|Overall Study|Poor/Non-compliance|0|||
148949588|NCT01844518|537299651|FG000|Overall Study|No Longer Met Study Criteria|2|||
149208643|NCT03228394|538229252|FG003|Overall Study|Withdrawal by Subject|0|||
149208644|NCT03228394|538229253|FG004|Overall Study|Withdrawal by Subject|0|||
149208645|NCT03228394|538229254|FG005|Overall Study|Withdrawal by Subject|0|||
149208646|NCT03228394|538229255|FG006|Overall Study|Withdrawal by Subject|1|||
148949589|NCT01844518|537299652|FG001|Overall Study|No Longer Met Study Criteria|0|||
148949590|NCT01844518|537299651|FG000|Overall Study|Withdrawal by Subject|9|||
148949591|NCT01844518|537299652|FG001|Overall Study|Withdrawal by Subject|0|||
148949592|NCT01844518|537299651|FG000|Overall Study|Pregnancy|1|||
148949593|NCT01844518|537299652|FG001|Overall Study|Pregnancy|0|||
148949594|NCT03129100|537299653|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
148949595|NCT03129100|537299654|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
149016472|NCT01751113|537538825|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
149208647|NCT03228394|538229256|FG007|Overall Study|Withdrawal by Subject|3|||
149208648|NCT03228394|538229249|FG000|Overall Study|Protocol Violation|0|||
149208649|NCT03228394|538229250|FG001|Overall Study|Protocol Violation|0|||
149208650|NCT03228394|538229251|FG002|Overall Study|Protocol Violation|0|||
149208651|NCT03228394|538229252|FG003|Overall Study|Protocol Violation|1|||
149208652|NCT03228394|538229253|FG004|Overall Study|Protocol Violation|0|||
149208653|NCT03228394|538229254|FG005|Overall Study|Protocol Violation|0|||
149208654|NCT03228394|538229255|FG006|Overall Study|Protocol Violation|0|||
149208655|NCT03228394|538229256|FG007|Overall Study|Protocol Violation|0|||
149208656|NCT03228394|538229249|FG000|Overall Study|Physician Decision|0|||
149208657|NCT03228394|538229250|FG001|Overall Study|Physician Decision|0|||
149208658|NCT03228394|538229251|FG002|Overall Study|Physician Decision|0|||
149208659|NCT03228394|538229252|FG003|Overall Study|Physician Decision|0|||
149208660|NCT03228394|538229253|FG004|Overall Study|Physician Decision|0|||
149208661|NCT03228394|538229254|FG005|Overall Study|Physician Decision|0|||
149208662|NCT03228394|538229255|FG006|Overall Study|Physician Decision|1|||
149208663|NCT03228394|538229256|FG007|Overall Study|Physician Decision|0|||
149208664|NCT03228394|538229249|FG000|Overall Study|Noncompliance|0|||
149208665|NCT03228394|538229250|FG001|Overall Study|Noncompliance|0|||
149208666|NCT03228394|538229251|FG002|Overall Study|Noncompliance|0|||
148684230|NCT02257632|536316715|FG001|Overall Study|Adverse Event|2|||
148684231|NCT02468557|536316716|FG000|Overall Study|Adverse Event|1|||
148684232|NCT02468557|536316716|FG000|Overall Study|Death|1|||
148684233|NCT02468557|536316716|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
148684234|NCT02468557|536316716|FG000|Overall Study|All Enrolled but Never Dosed|4|||
148684235|NCT01764854|536316719|FG000|Overall Study|Adverse Event|0|||
148684236|NCT01764854|536316720|FG001|Overall Study|Adverse Event|0|||
148684237|NCT01764854|536316721|FG002|Overall Study|Adverse Event|2|||
148684238|NCT01764854|536316722|FG003|Overall Study|Adverse Event|0|||
148684239|NCT01764854|536316719|FG000|Overall Study|Withdrawal by Subject|0|||
148684240|NCT01764854|536316720|FG001|Overall Study|Withdrawal by Subject|0|||
148684241|NCT01764854|536316721|FG002|Overall Study|Withdrawal by Subject|1|||
148684242|NCT01764854|536316722|FG003|Overall Study|Withdrawal by Subject|0|||
148684243|NCT01764854|536316719|FG000|Overall Study|relocation|0|||
148684244|NCT01764854|536316720|FG001|Overall Study|relocation|0|||
148684245|NCT01764854|536316721|FG002|Overall Study|relocation|2|||
148684246|NCT01764854|536316722|FG003|Overall Study|relocation|0|||
148684247|NCT01764854|536316719|FG000|Overall Study|Protocol Violation|0|||
148684248|NCT01764854|536316720|FG001|Overall Study|Protocol Violation|0|||
148684249|NCT01764854|536316721|FG002|Overall Study|Protocol Violation|1|||
148684250|NCT01764854|536316722|FG003|Overall Study|Protocol Violation|2|||
148684251|NCT01759381|536316731|FG000|Overall Study|Death|1|||
148684252|NCT01759381|536316732|FG001|Overall Study|Death|0|||
149208667|NCT03228394|538229252|FG003|Overall Study|Noncompliance|0|||
148684253|NCT03377556|536316733|FG000|Overall Study|Adverse Event|5|||
148684254|NCT03377556|536316733|FG000|Overall Study|Refusal unrelated to adverse events|1|||
148684255|NCT03377556|536316733|FG000|Overall Study|Progression/relapse|38|||
148949596|NCT03129100|537299655|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
148949597|NCT03129100|537299656|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
149016473|NCT01751113|537538826|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
149208668|NCT03228394|538229253|FG004|Overall Study|Noncompliance|0|||
149208669|NCT03228394|538229254|FG005|Overall Study|Noncompliance|0|||
149208670|NCT03228394|538229255|FG006|Overall Study|Noncompliance|1|||
149208671|NCT03228394|538229256|FG007|Overall Study|Noncompliance|0|||
149208672|NCT00770224|538229263|FG000|Step 1: Induction|Adverse Event|3|||
149208673|NCT00770224|538229264|FG001|Step 1: Induction|Adverse Event|0|||
149208674|NCT00770224|538229263|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
149208675|NCT00770224|538229264|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
149208676|NCT00770224|538229263|FG000|Step 1: Induction|Other reason not protocol specified|2|||
149208677|NCT00770224|538229264|FG001|Step 1: Induction|Other reason not protocol specified|0|||
149208678|NCT00770224|538229263|FG000|Step 1: Induction|Ineligible|2|||
149208679|NCT00770224|538229264|FG001|Step 1: Induction|Ineligible|0|||
148684256|NCT03377556|536316733|FG000|Overall Study|Death|3|||
148684257|NCT00472446|536316734|FG000|Overall Study|Protocol Violation|0|||
148684258|NCT00472446|536316735|FG001|Overall Study|Protocol Violation|0|||
148684259|NCT00472446|536316736|FG002|Overall Study|Protocol Violation|0|||
149016474|NCT01751113|537538827|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
149208680|NCT00770224|538229263|FG000|Step 1: Induction|No protocol treatment given|1|||
149208681|NCT00770224|538229264|FG001|Step 1: Induction|No protocol treatment given|0|||
148949598|NCT03129100|537299657|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
148949599|NCT03129100|537299658|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
148949600|NCT03129100|537299659|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
148949601|NCT03129100|537299660|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
149208682|NCT00770224|538229263|FG000|Step 2: Maintenance|Adverse Event|0|||
149208683|NCT00770224|538229264|FG001|Step 2: Maintenance|Adverse Event|10|||
149208684|NCT00770224|538229263|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
149208685|NCT00770224|538229264|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
148949602|NCT03129100|537299661|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
148949603|NCT03129100|537299662|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
148949604|NCT03129100|537299663|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
148949605|NCT03129100|537299664|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
148949606|NCT03129100|537299665|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
148949607|NCT03129100|537299666|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
148949608|NCT03129100|537299667|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
148949609|NCT03129100|537299668|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
148949610|NCT03129100|537299669|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
148949611|NCT03129100|537299670|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
148949612|NCT03129100|537299671|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
148949613|NCT03129100|537299672|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
148949614|NCT03129100|537299673|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
148949615|NCT03129100|537299674|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
148949616|NCT03129100|537299675|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
148949617|NCT03129100|537299676|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
148949618|NCT03129100|537299677|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
148949619|NCT03129100|537299678|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
148949620|NCT03129100|537299653|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
148949621|NCT03129100|537299654|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949622|NCT03129100|537299655|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949623|NCT03129100|537299656|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949624|NCT03129100|537299657|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949625|NCT03129100|537299658|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949626|NCT03129100|537299659|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949627|NCT03129100|537299660|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949628|NCT03129100|537299661|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949629|NCT03129100|537299662|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949630|NCT03129100|537299663|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949631|NCT03129100|537299664|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949632|NCT03129100|537299665|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949633|NCT03129100|537299666|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949634|NCT03129100|537299667|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949635|NCT03129100|537299668|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949636|NCT03129100|537299669|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949637|NCT03129100|537299670|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949638|NCT03129100|537299671|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949639|NCT03129100|537299672|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949640|NCT03129100|537299673|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949641|NCT03129100|537299674|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949642|NCT03129100|537299675|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949643|NCT03129100|537299676|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949644|NCT03129100|537299677|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949645|NCT03129100|537299678|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
148949646|NCT03129100|537299653|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
148949647|NCT03129100|537299654|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
148949648|NCT03129100|537299655|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949649|NCT03129100|537299656|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
149208686|NCT00770224|538229263|FG000|Step 2: Maintenance|Progression/relapse|0|||
149208687|NCT00770224|538229264|FG001|Step 2: Maintenance|Progression/relapse|1|||
148949650|NCT03129100|537299657|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949651|NCT03129100|537299658|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949652|NCT03129100|537299659|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949653|NCT03129100|537299660|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949654|NCT03129100|537299661|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949655|NCT03129100|537299662|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949656|NCT03129100|537299663|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949657|NCT03129100|537299664|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949658|NCT03129100|537299665|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949659|NCT03129100|537299666|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949660|NCT03129100|537299667|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949661|NCT03129100|537299668|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
149208688|NCT00770224|538229263|FG000|Step 2: Maintenance|Death|0|||
149208689|NCT00770224|538229264|FG001|Step 2: Maintenance|Death|2|||
148684260|NCT00472446|536316737|FG003|Overall Study|Protocol Violation|1|||
148684261|NCT00472446|536316734|FG000|Overall Study|Reintervention|0|||
148684262|NCT00472446|536316735|FG001|Overall Study|Reintervention|0|||
148684263|NCT00472446|536316736|FG002|Overall Study|Reintervention|1|||
148684264|NCT00472446|536316737|FG003|Overall Study|Reintervention|1|||
148684265|NCT00472446|536316734|FG000|Overall Study|Questionnaires not returned|5|||
148684266|NCT00472446|536316735|FG001|Overall Study|Questionnaires not returned|6|||
148684267|NCT00472446|536316736|FG002|Overall Study|Questionnaires not returned|6|||
148684268|NCT00472446|536316737|FG003|Overall Study|Questionnaires not returned|4|||
148949662|NCT03129100|537299669|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949663|NCT03129100|537299670|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949664|NCT03129100|537299671|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949665|NCT03129100|537299672|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949666|NCT03129100|537299673|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949667|NCT03129100|537299674|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949668|NCT03129100|537299675|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949669|NCT03129100|537299676|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949670|NCT03129100|537299677|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949671|NCT03129100|537299678|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
148949672|NCT03129100|537299653|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
148949673|NCT03129100|537299654|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
148949674|NCT03129100|537299655|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949675|NCT03129100|537299656|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949676|NCT03129100|537299657|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949677|NCT03129100|537299658|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949678|NCT03129100|537299659|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949679|NCT03129100|537299660|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949680|NCT03129100|537299661|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
149208690|NCT00770224|538229263|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
149208691|NCT00770224|538229264|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
149208692|NCT00770224|538229263|FG000|Step 2: Maintenance|Ineligible|0|||
149208693|NCT00770224|538229264|FG001|Step 2: Maintenance|Ineligible|2|||
149208694|NCT01112982|538229265|FG000|Overall Study|Withdrawal by Subject|1|||
149208695|NCT01112982|538229265|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
149208696|NCT00294684|538229268|FG000|Overall Study|Lost to Follow-up|5|||
149208697|NCT00294684|538229269|FG001|Overall Study|Lost to Follow-up|8|||
149208698|NCT02443805|538229270|FG000|Overall Study|Adverse Event|100|||
149208699|NCT02443805|538229271|FG001|Overall Study|Adverse Event|18|||
149208700|NCT02443805|538229270|FG000|Overall Study|Withdrawal by Subject|73|||
149208701|NCT02443805|538229271|FG001|Overall Study|Withdrawal by Subject|74|||
149208702|NCT02443805|538229270|FG000|Overall Study|Lost to Follow-up|19|||
149208703|NCT02443805|538229271|FG001|Overall Study|Lost to Follow-up|14|||
149208704|NCT02443805|538229270|FG000|Overall Study|Pregnancy|6|||
149208705|NCT02443805|538229271|FG001|Overall Study|Pregnancy|5|||
149208706|NCT02443805|538229270|FG000|Overall Study|Protocol Violation|2|||
149208707|NCT02443805|538229271|FG001|Overall Study|Protocol Violation|4|||
149208708|NCT02443805|538229270|FG000|Overall Study|Lack of Efficacy|1|||
149208709|NCT02443805|538229271|FG001|Overall Study|Lack of Efficacy|1|||
149208710|NCT02443805|538229270|FG000|Overall Study|Non-compliance with study drug|6|||
149208711|NCT02443805|538229271|FG001|Overall Study|Non-compliance with study drug|4|||
149208712|NCT02443805|538229270|FG000|Overall Study|Withdrawal by parent/guardian|3|||
149208713|NCT02443805|538229271|FG001|Overall Study|Withdrawal by parent/guardian|5|||
149208714|NCT02443805|538229270|FG000|Overall Study|Any other reason not above-mentioned|3|||
149208715|NCT02443805|538229271|FG001|Overall Study|Any other reason not above-mentioned|2|||
149208716|NCT00968708|538229272|FG000|Overall Study|Adverse Event|169|||
149208717|NCT00968708|538229273|FG001|Overall Study|Adverse Event|150|||
149208718|NCT00968708|538229272|FG000|Overall Study|Major Protocol Deviation|0|||
149208719|NCT00968708|538229273|FG001|Overall Study|Major Protocol Deviation|1|||
149208720|NCT00968708|538229272|FG000|Overall Study|Lost to Follow-up|19|||
149208721|NCT00968708|538229273|FG001|Overall Study|Lost to Follow-up|11|||
149208722|NCT00968708|538229272|FG000|Overall Study|Voluntary Withdrawal|104|||
149208723|NCT00968708|538229273|FG001|Overall Study|Voluntary Withdrawal|101|||
149208724|NCT00968708|538229272|FG000|Overall Study|Investigator Discretion|0|||
149208725|NCT00968708|538229273|FG001|Overall Study|Investigator Discretion|1|||
149208726|NCT00968708|538229272|FG000|Overall Study|Other|26|||
149208727|NCT00968708|538229273|FG001|Overall Study|Other|34|||
149208728|NCT02708966|538229274|FG000|Overall Study|Lost to Follow-up|2|||
149208729|NCT02708966|538229275|FG001|Overall Study|Lost to Follow-up|2|||
148949681|NCT03129100|537299662|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949682|NCT03129100|537299663|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949683|NCT03129100|537299664|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
149208730|NCT02260388|538229276|FG000|Overall Study|Lost to Follow-up|2|||
149208731|NCT02260388|538229277|FG001|Overall Study|Lost to Follow-up|8|||
149208732|NCT02260388|538229278|FG002|Overall Study|Lost to Follow-up|3|||
148684269|NCT00910858|536316738|FG000|Pharmacokinetic Phase|Adverse Event|1|||
149208733|NCT02260388|538229279|FG003|Overall Study|Lost to Follow-up|4|||
149208734|NCT03407170|538229280|FG000|Overall Study|Adverse Event|1|||
149208735|NCT00126672|538229282|FG000|Overall Study|Adverse Event|4|||
149208736|NCT00126672|538229282|FG000|Overall Study|Lost to Follow-up|4|||
149208737|NCT01001234|538229283|FG000|Overall Study|Withdrawal by Subject|2|||
149208738|NCT01001234|538229284|FG001|Overall Study|Withdrawal by Subject|0|||
149208739|NCT01001234|538229285|FG002|Overall Study|Withdrawal by Subject|3|||
149208740|NCT01001234|538229286|FG003|Overall Study|Withdrawal by Subject|0|||
149208741|NCT01001234|538229287|FG004|Overall Study|Withdrawal by Subject|0|||
149208742|NCT01001234|538229283|FG000|Overall Study|Protocol Violation|34|||
149208743|NCT01001234|538229284|FG001|Overall Study|Protocol Violation|3|||
149208744|NCT01001234|538229285|FG002|Overall Study|Protocol Violation|19|||
149208745|NCT01001234|538229286|FG003|Overall Study|Protocol Violation|18|||
149208746|NCT01001234|538229287|FG004|Overall Study|Protocol Violation|0|||
149208747|NCT01001234|538229283|FG000|Overall Study|Lost to Follow-up|0|||
149208748|NCT01001234|538229284|FG001|Overall Study|Lost to Follow-up|0|||
149208749|NCT01001234|538229285|FG002|Overall Study|Lost to Follow-up|1|||
149208750|NCT01001234|538229286|FG003|Overall Study|Lost to Follow-up|2|||
149208751|NCT01001234|538229287|FG004|Overall Study|Lost to Follow-up|0|||
149208752|NCT01001234|538229283|FG000|Overall Study|Physician Decision|1|||
149208753|NCT01001234|538229284|FG001|Overall Study|Physician Decision|0|||
149208754|NCT01001234|538229285|FG002|Overall Study|Physician Decision|0|||
149208755|NCT01001234|538229286|FG003|Overall Study|Physician Decision|0|||
149208756|NCT01001234|538229287|FG004|Overall Study|Physician Decision|0|||
149208757|NCT01001234|538229283|FG000|Overall Study|Not Treated: Adverse Event|1|||
149208758|NCT01001234|538229284|FG001|Overall Study|Not Treated: Adverse Event|0|||
149208759|NCT01001234|538229285|FG002|Overall Study|Not Treated: Adverse Event|0|||
149208760|NCT01001234|538229286|FG003|Overall Study|Not Treated: Adverse Event|0|||
149208761|NCT01001234|538229287|FG004|Overall Study|Not Treated: Adverse Event|0|||
149208762|NCT01001234|538229283|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
149208763|NCT01001234|538229284|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
149208764|NCT01001234|538229285|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
149208765|NCT01001234|538229286|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
149208766|NCT01001234|538229287|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
149208767|NCT01001234|538229283|FG000|Overall Study|Not Treated: Protocol Violation|3|||
149208768|NCT01001234|538229284|FG001|Overall Study|Not Treated: Protocol Violation|0|||
149208769|NCT01001234|538229285|FG002|Overall Study|Not Treated: Protocol Violation|0|||
149208770|NCT01001234|538229286|FG003|Overall Study|Not Treated: Protocol Violation|0|||
149208771|NCT01001234|538229287|FG004|Overall Study|Not Treated: Protocol Violation|0|||
149208772|NCT01001234|538229283|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
149208773|NCT01001234|538229284|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
149208774|NCT01001234|538229285|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
149208775|NCT01001234|538229286|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
149208776|NCT01001234|538229287|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
148949684|NCT03129100|537299665|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
149208777|NCT01001234|538229283|FG000|Overall Study|Not Treated: Pregnancy|3|||
149208778|NCT01001234|538229284|FG001|Overall Study|Not Treated: Pregnancy|0|||
149208779|NCT01001234|538229285|FG002|Overall Study|Not Treated: Pregnancy|0|||
149208780|NCT01001234|538229286|FG003|Overall Study|Not Treated: Pregnancy|0|||
149208781|NCT01001234|538229287|FG004|Overall Study|Not Treated: Pregnancy|0|||
149208782|NCT01001234|538229283|FG000|Overall Study|Not Treated: Physician Decision|37|||
149208783|NCT01001234|538229284|FG001|Overall Study|Not Treated: Physician Decision|4|||
149208784|NCT01001234|538229285|FG002|Overall Study|Not Treated: Physician Decision|0|||
149208785|NCT01001234|538229286|FG003|Overall Study|Not Treated: Physician Decision|0|||
149208786|NCT01001234|538229287|FG004|Overall Study|Not Treated: Physician Decision|0|||
149208787|NCT01001234|538229283|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
149208788|NCT01001234|538229284|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
149208789|NCT01001234|538229285|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
149208790|NCT01001234|538229286|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
149208791|NCT01001234|538229287|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
149208792|NCT01851863|538229289|FG000|Overall Study|Did not receive study medication|2|||
149208793|NCT01851863|538229290|FG001|Overall Study|Did not receive study medication|5|||
149208794|NCT01851863|538229291|FG002|Overall Study|Did not receive study medication|3|||
149208795|NCT01851863|538229292|FG003|Overall Study|Did not receive study medication|0|||
149208796|NCT01851863|538229289|FG000|Overall Study|Lost to Follow-up|3|||
149208797|NCT01851863|538229290|FG001|Overall Study|Lost to Follow-up|4|||
149208798|NCT01851863|538229291|FG002|Overall Study|Lost to Follow-up|2|||
149208799|NCT01851863|538229292|FG003|Overall Study|Lost to Follow-up|3|||
149208800|NCT02076334|538229293|FG000|Overall Study|Protocol Violation|1|||
149208801|NCT02076334|538229294|FG001|Overall Study|Protocol Violation|0|||
149208802|NCT02076334|538229295|FG002|Overall Study|Protocol Violation|0|||
149208803|NCT02076334|538229296|FG003|Overall Study|Protocol Violation|0|||
149208804|NCT02076334|538229293|FG000|Overall Study|Lost to Follow-up|0|||
149208805|NCT02076334|538229294|FG001|Overall Study|Lost to Follow-up|1|||
149208806|NCT02076334|538229295|FG002|Overall Study|Lost to Follow-up|1|||
149208807|NCT02076334|538229296|FG003|Overall Study|Lost to Follow-up|0|||
149208808|NCT02076334|538229293|FG000|Overall Study|muscle soreness|0|||
148949685|NCT03129100|537299666|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949686|NCT03129100|537299667|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949687|NCT03129100|537299668|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949688|NCT03129100|537299669|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949689|NCT03129100|537299670|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949690|NCT03129100|537299671|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949691|NCT03129100|537299672|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949692|NCT03129100|537299673|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949693|NCT03129100|537299674|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
149208809|NCT02076334|538229294|FG001|Overall Study|muscle soreness|0|||
149208810|NCT02076334|538229295|FG002|Overall Study|muscle soreness|0|||
149208811|NCT02076334|538229296|FG003|Overall Study|muscle soreness|1|||
149208812|NCT03379376|538229297|FG000|Overall Study|Lost to Follow-up|2|||
149208813|NCT03379376|538229297|FG000|Overall Study|Did not wish to complete follow up|1|||
149208814|NCT03379376|538229297|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
149208815|NCT03379376|538229297|FG000|Overall Study|Death|1|||
149208816|NCT01611298|538229298|FG000|Overall Study|Relapsed|2|||
149208817|NCT00753623|538229299|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
149208818|NCT00753623|538229300|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
149208819|NCT00753623|538229299|FG000|Phase I (14 Days)|Physician Decision|1|||
149208820|NCT00753623|538229300|FG001|Phase I (14 Days)|Physician Decision|2|||
149208821|NCT00753623|538229299|FG000|Phase I (14 Days)|Adverse Event|0|||
149208822|NCT00753623|538229300|FG001|Phase I (14 Days)|Adverse Event|1|||
149208823|NCT00753623|538229299|FG000|Washout (7 Days)|Physician Decision|1|||
149208824|NCT00753623|538229300|FG001|Washout (7 Days)|Physician Decision|0|||
149208825|NCT00753623|538229299|FG000|Phase II (14 Days)|Physician Decision|0|||
149208826|NCT00753623|538229300|FG001|Phase II (14 Days)|Physician Decision|1|||
149208827|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
149208828|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
149208829|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
149208830|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
149208831|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
149208832|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
148949694|NCT03129100|537299675|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949695|NCT03129100|537299676|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949696|NCT03129100|537299677|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
149208833|NCT00996593|538229301|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
149208834|NCT00996593|538229301|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
149208835|NCT00996593|538229301|FG000|Long-Term Follow-Up|Site Closed|1|||
149208836|NCT00871572|538229302|FG000|Overall Study|Adverse Event|0|||
149208837|NCT00871572|538229303|FG001|Overall Study|Adverse Event|2|||
149208838|NCT00871572|538229304|FG002|Overall Study|Adverse Event|0|||
149208839|NCT00871572|538229305|FG003|Overall Study|Adverse Event|3|||
149208840|NCT00871572|538229302|FG000|Overall Study|Investigator Decision|0|||
149208841|NCT00871572|538229303|FG001|Overall Study|Investigator Decision|1|||
149208842|NCT00871572|538229304|FG002|Overall Study|Investigator Decision|0|||
149208843|NCT00871572|538229305|FG003|Overall Study|Investigator Decision|1|||
149208844|NCT00871572|538229302|FG000|Overall Study|Lost to Follow-up|0|||
149208845|NCT00871572|538229303|FG001|Overall Study|Lost to Follow-up|1|||
149208846|NCT00871572|538229304|FG002|Overall Study|Lost to Follow-up|0|||
149208847|NCT00871572|538229305|FG003|Overall Study|Lost to Follow-up|1|||
149208848|NCT00871572|538229302|FG000|Overall Study|Protocol Violation|0|||
149208849|NCT00871572|538229303|FG001|Overall Study|Protocol Violation|0|||
149208850|NCT00871572|538229304|FG002|Overall Study|Protocol Violation|1|||
149208851|NCT00871572|538229305|FG003|Overall Study|Protocol Violation|1|||
149208852|NCT00871572|538229302|FG000|Overall Study|Sponsor Decision|1|||
149208853|NCT00871572|538229303|FG001|Overall Study|Sponsor Decision|0|||
149208854|NCT00871572|538229304|FG002|Overall Study|Sponsor Decision|0|||
149208855|NCT00871572|538229305|FG003|Overall Study|Sponsor Decision|0|||
149208856|NCT00871572|538229302|FG000|Overall Study|Withdrawal by Subject|1|||
149208857|NCT00871572|538229303|FG001|Overall Study|Withdrawal by Subject|2|||
149208858|NCT00871572|538229304|FG002|Overall Study|Withdrawal by Subject|3|||
149208859|NCT00871572|538229305|FG003|Overall Study|Withdrawal by Subject|1|||
149208860|NCT01686958|538229310|FG000|Overall Study|Withdrawal by Subject|1|||
149208861|NCT04294095|538229319|FG000|Overall Study|Adverse Event|1|||
149208862|NCT04294095|538229320|FG001|Overall Study|Adverse Event|0|||
149208863|NCT02224638|538229324|FG000|Overall Study|Adverse Event|1|||
149208864|NCT02224638|538229325|FG001|Overall Study|Adverse Event|1|||
149208865|NCT01406652|538229326|FG000|Overall Study|Lost-to-follow-up|3|||
149208866|NCT01406652|538229327|FG001|Overall Study|Lost-to-follow-up|4|||
149208867|NCT01406652|538229326|FG000|Overall Study|Withdrawal by Subject|2|||
149208868|NCT01406652|538229327|FG001|Overall Study|Withdrawal by Subject|2|||
149208869|NCT01406652|538229326|FG000|Overall Study|Insufficient follow-up|5|||
149208870|NCT01406652|538229327|FG001|Overall Study|Insufficient follow-up|4|||
149208871|NCT01406652|538229326|FG000|Overall Study|Infection not sure|10|||
149208872|NCT01406652|538229327|FG001|Overall Study|Infection not sure|10|||
149208873|NCT01230749|538229328|FG000|Overall Study|Adverse Event|0|||
149208874|NCT01230749|538229329|FG001|Overall Study|Adverse Event|0|||
149208875|NCT01230749|538229330|FG002|Overall Study|Adverse Event|0|||
149208876|NCT01230749|538229331|FG003|Overall Study|Adverse Event|1|||
149208877|NCT01230749|538229328|FG000|Overall Study|Physician Decision|0|||
149208878|NCT01230749|538229329|FG001|Overall Study|Physician Decision|0|||
149208879|NCT01230749|538229330|FG002|Overall Study|Physician Decision|1|||
149208880|NCT01230749|538229331|FG003|Overall Study|Physician Decision|0|||
149208881|NCT01230749|538229328|FG000|Overall Study|Withdrawal by Subject|0|||
149208882|NCT01230749|538229329|FG001|Overall Study|Withdrawal by Subject|1|||
149208883|NCT01230749|538229330|FG002|Overall Study|Withdrawal by Subject|0|||
149208884|NCT01230749|538229331|FG003|Overall Study|Withdrawal by Subject|0|||
149208885|NCT01230749|538229328|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
149208886|NCT01230749|538229329|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
149208887|NCT01230749|538229330|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
149208888|NCT01230749|538229331|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
149208889|NCT03366844|538231039|FG000|Overall Study|Physician Decision|1|||
149208890|NCT03366844|538231039|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
149208891|NCT02687711|538231045|FG000|Overall Study|Adverse Event|89|||
149208892|NCT02687711|538231045|FG000|Overall Study|Lack of Efficacy|70|||
149208893|NCT02687711|538231045|FG000|Overall Study|Lost to Follow-up|20|||
149208894|NCT02687711|538231045|FG000|Overall Study|Consent withdrawn|15|||
149208895|NCT02687711|538231045|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
148684270|NCT00910858|536316739|FG001|Pharmacokinetic Phase|Adverse Event|0|||
148684271|NCT00910858|536316740|FG002|Pharmacokinetic Phase|Adverse Event|0|||
148684272|NCT00910858|536316738|FG000|Monotherapy Phase|Adverse Event|3|||
148684273|NCT00910858|536316739|FG001|Monotherapy Phase|Adverse Event|2|||
148684274|NCT00910858|536316740|FG002|Monotherapy Phase|Adverse Event|0|||
148684275|NCT00910858|536316738|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
149208896|NCT02687711|538231045|FG000|Overall Study|Too expensive|4|||
149208897|NCT02687711|538231045|FG000|Overall Study|Participant moved abroad|1|||
149208898|NCT02687711|538231045|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
149208899|NCT02687711|538231045|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
149208900|NCT02687711|538231045|FG000|Overall Study|Disliked taste|1|||
149208901|NCT02687711|538231045|FG000|Overall Study|Low mood|1|||
149208902|NCT02687711|538231045|FG000|Overall Study|Side effects|1|||
149208903|NCT02687711|538231045|FG000|Overall Study|Change of Hospital|1|||
149208904|NCT02687711|538231045|FG000|Overall Study|Liver Encephalopathy|1|||
149016475|NCT01751113|537538828|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
149208905|NCT02687711|538231045|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
149208906|NCT02687711|538231045|FG000|Overall Study|Withdrawn due to intake interruption|1|||
149208907|NCT02687711|538231045|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
149208908|NCT02687711|538231045|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
149208909|NCT02687711|538231045|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
149208910|NCT00191386|538231046|FG000|Overall Study|Adverse Event|16|||
149208911|NCT00191386|538231046|FG000|Overall Study|Lost to Follow-up|1|||
149208912|NCT00191386|538231046|FG000|Overall Study|Entry Criteria Exclusion|3|||
149208913|NCT00191386|538231046|FG000|Overall Study|Protocol Violation|18|||
149208914|NCT00191386|538231046|FG000|Overall Study|Withdrawal by Subject|96|||
149208915|NCT00191386|538231046|FG000|Overall Study|Physician Decision|11|||
149208916|NCT00191386|538231046|FG000|Overall Study|Lack of Efficacy|15|||
149208917|NCT03077243|538231047|FG000|Overall Study|Death|1|||
149208918|NCT03077243|538231048|FG001|Overall Study|Death|2|||
149208919|NCT03077243|538231049|FG002|Overall Study|Death|0|||
149208920|NCT03077243|538231050|FG003|Overall Study|Death|0|||
149208921|NCT03077243|538231047|FG000|Overall Study|Withdrawal by Subject|1|||
149208922|NCT03077243|538231048|FG001|Overall Study|Withdrawal by Subject|3|||
149208923|NCT03077243|538231049|FG002|Overall Study|Withdrawal by Subject|0|||
149208924|NCT03077243|538231050|FG003|Overall Study|Withdrawal by Subject|0|||
149208925|NCT03077243|538231047|FG000|Overall Study|Physician Decision|1|||
149208926|NCT03077243|538231048|FG001|Overall Study|Physician Decision|0|||
149208927|NCT03077243|538231049|FG002|Overall Study|Physician Decision|0|||
149208928|NCT03077243|538231050|FG003|Overall Study|Physician Decision|0|||
149208929|NCT03077243|538231047|FG000|Overall Study|Research at two study sites terminated early|0|||
149208930|NCT03077243|538231048|FG001|Overall Study|Research at two study sites terminated early|0|||
149208931|NCT03077243|538231049|FG002|Overall Study|Research at two study sites terminated early|0|||
149208932|NCT03077243|538231050|FG003|Overall Study|Research at two study sites terminated early|69|||
149208933|NCT03984812|538231051|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208934|NCT03984812|538231052|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208935|NCT03984812|538231053|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
149208936|NCT03984812|538231054|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208937|NCT03984812|538231055|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208938|NCT03984812|538231056|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208939|NCT03984812|538231057|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208940|NCT03984812|538231058|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208941|NCT03984812|538231059|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208942|NCT03984812|538231060|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208943|NCT03984812|538231061|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
149208944|NCT01826448|538231062|FG000|Overall Study|Adverse Event|1|||
149208945|NCT01826448|538231063|FG001|Overall Study|Adverse Event|3|||
149208946|NCT01826448|538231062|FG000|Overall Study|Disease progression|2|||
149208947|NCT01826448|538231063|FG001|Overall Study|Disease progression|4|||
149208948|NCT01826448|538231062|FG000|Overall Study|Withdrawal by Subject|1|||
149208949|NCT01826448|538231063|FG001|Overall Study|Withdrawal by Subject|0|||
149208950|NCT01826448|538231062|FG000|Overall Study|Physician Decision|0|||
149208951|NCT01826448|538231063|FG001|Overall Study|Physician Decision|1|||
149208952|NCT01826448|538231062|FG000|Overall Study|2 active cancers|0|||
149208953|NCT01826448|538231063|FG001|Overall Study|2 active cancers|1|||
149208954|NCT04038385|538231064|FG000|Overall Study|Completed baseline assessment only|7|||
149208955|NCT04038385|538231065|FG001|Overall Study|Completed baseline assessment only|4|||
149208956|NCT04038385|538231064|FG000|Overall Study|Moved out of area|4|||
149208957|NCT04038385|538231065|FG001|Overall Study|Moved out of area|2|||
149208958|NCT04038385|538231064|FG000|Overall Study|Discontinued study involvement|6|||
149208959|NCT04038385|538231065|FG001|Overall Study|Discontinued study involvement|1|||
149208960|NCT02971007|538231066|FG000|Overall Study|Adverse Event|1|||
149208961|NCT02971007|538231067|FG001|Overall Study|Adverse Event|0|||
149208962|NCT02971007|538231068|FG002|Overall Study|Adverse Event|0|||
149208963|NCT02971007|538231066|FG000|Overall Study|Lost to Follow-up|0|||
149208964|NCT02971007|538231067|FG001|Overall Study|Lost to Follow-up|1|||
149208965|NCT02971007|538231068|FG002|Overall Study|Lost to Follow-up|1|||
149208966|NCT02971007|538231066|FG000|Overall Study|Withdrawal by Subject|0|||
149208967|NCT02971007|538231067|FG001|Overall Study|Withdrawal by Subject|1|||
149208968|NCT02971007|538231068|FG002|Overall Study|Withdrawal by Subject|0|||
149208969|NCT02971007|538231066|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
149208970|NCT02971007|538231067|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
149208971|NCT02971007|538231068|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
149208972|NCT02971007|538231066|FG000|Overall Study|Patient discontinued study drug|0|||
149208973|NCT02971007|538231067|FG001|Overall Study|Patient discontinued study drug|1|||
149208974|NCT02971007|538231068|FG002|Overall Study|Patient discontinued study drug|0|||
149208975|NCT02038790|538231072|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
149208976|NCT02038790|538231073|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
149208977|NCT02431793|538231074|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
149208978|NCT02431793|538231075|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
149208979|NCT02431793|538231076|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
149208980|NCT02431793|538231074|FG000|Overall Study|Withdrawal by Subject|7|||
149208981|NCT02431793|538231075|FG001|Overall Study|Withdrawal by Subject|5|||
149208982|NCT02431793|538231076|FG002|Overall Study|Withdrawal by Subject|5|||
149208983|NCT02431793|538231074|FG000|Overall Study|Lost to Follow-up|101|||
149208984|NCT02431793|538231075|FG001|Overall Study|Lost to Follow-up|122|||
149208985|NCT02431793|538231076|FG002|Overall Study|Lost to Follow-up|104|||
149208986|NCT03170258|538231084|FG000|Overall Study|Physician Decision|4|||
149208987|NCT03170258|538231085|FG001|Overall Study|Physician Decision|0|||
149208988|NCT03170258|538231084|FG000|Overall Study|Equipment issues|1|||
149208989|NCT03170258|538231085|FG001|Overall Study|Equipment issues|0|||
149208990|NCT03170258|538231084|FG000|Overall Study|Medication|1|||
149208991|NCT03170258|538231085|FG001|Overall Study|Medication|0|||
149208992|NCT03170258|538231084|FG000|Overall Study|Sleep issues|1|||
149208993|NCT03170258|538231085|FG001|Overall Study|Sleep issues|0|||
149208994|NCT00063986|538231089|FG000|Overall Study|Withdrawal by Subject|1|||
149208995|NCT00063986|538231089|FG000|Overall Study|Ineligible|1|||
149208996|NCT00063986|538231089|FG000|Overall Study|Intra-operatively ineligible|4|||
149208997|NCT01419015|538231097|FG000|Overall Study|Death|2|||
149208998|NCT02911519|538231098|FG000|Overall Study|Lost to Follow-up|2|||
149208999|NCT02911519|538231099|FG001|Overall Study|Lost to Follow-up|2|||
149209000|NCT02911519|538231098|FG000|Overall Study|Death|0|||
149209001|NCT02911519|538231099|FG001|Overall Study|Death|2|||
149209002|NCT01237223|538231100|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
149209003|NCT01237223|538231101|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149209004|NCT01237223|538231102|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149209005|NCT01237223|538231103|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149209006|NCT01237223|538231104|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149209007|NCT01237223|538231105|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
149209008|NCT01237223|538231100|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
149209009|NCT01237223|538231101|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149209010|NCT01237223|538231102|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149209011|NCT01237223|538231103|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149209012|NCT01237223|538231104|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149209013|NCT01237223|538231105|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
149209014|NCT01237223|538231100|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
149209015|NCT01237223|538231101|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149209016|NCT01237223|538231102|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149209017|NCT01237223|538231103|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149209018|NCT01237223|538231104|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149209019|NCT01237223|538231105|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
149209020|NCT01237223|538231100|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
149209021|NCT01237223|538231101|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149209022|NCT01237223|538231102|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149209023|NCT01237223|538231103|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149209024|NCT01237223|538231104|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149209025|NCT01237223|538231105|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
149209026|NCT01237223|538231100|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
149209027|NCT01237223|538231101|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149209028|NCT01237223|538231102|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149209029|NCT01237223|538231103|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149209030|NCT01237223|538231104|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149209031|NCT01237223|538231105|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
149209032|NCT01237223|538231100|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
149209033|NCT01237223|538231101|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
149209034|NCT01237223|538231102|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
149209035|NCT01237223|538231103|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
148949697|NCT03129100|537299678|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
148949698|NCT03129100|537299653|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949699|NCT03129100|537299654|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
148949700|NCT03129100|537299655|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
149209036|NCT01237223|538231104|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
149209037|NCT01237223|538231105|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
149209038|NCT01237223|538231100|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
149209039|NCT01237223|538231101|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
149209040|NCT01237223|538231102|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
149209041|NCT01237223|538231103|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
149209042|NCT01237223|538231104|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
149209043|NCT01237223|538231105|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
149209044|NCT01237223|538231100|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
149209045|NCT01237223|538231101|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
148949701|NCT03129100|537299656|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949702|NCT03129100|537299657|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949703|NCT03129100|537299658|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949704|NCT03129100|537299659|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949705|NCT03129100|537299660|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949706|NCT03129100|537299661|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949707|NCT03129100|537299662|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949708|NCT03129100|537299663|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949709|NCT03129100|537299664|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949710|NCT03129100|537299665|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949711|NCT03129100|537299666|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949712|NCT03129100|537299667|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949713|NCT03129100|537299668|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949714|NCT03129100|537299669|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949715|NCT03129100|537299670|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949716|NCT03129100|537299671|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949717|NCT03129100|537299672|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949718|NCT03129100|537299673|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949719|NCT03129100|537299674|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949720|NCT03129100|537299675|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949721|NCT03129100|537299676|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949722|NCT03129100|537299677|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949723|NCT03129100|537299678|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
148949724|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949725|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949726|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
148949727|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
148949728|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949729|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
148949730|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949731|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949732|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949733|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949734|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949735|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949736|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949737|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949738|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949739|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949740|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949741|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949742|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949743|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949744|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949745|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949746|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949747|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949748|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949749|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
148949750|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Death|0|||
148949751|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Death|0|||
148949752|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Death|1|||
148949753|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Death|0|||
148949754|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Death|0|||
148949755|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Death|0|||
149209046|NCT01237223|538231102|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
149209047|NCT01237223|538231103|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
149209048|NCT01237223|538231104|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
149209049|NCT01237223|538231105|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
149209050|NCT01237223|538231100|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149209051|NCT01237223|538231101|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149209052|NCT01237223|538231102|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149209053|NCT01237223|538231103|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149209054|NCT01237223|538231104|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
149209055|NCT01237223|538231105|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
149209056|NCT01237223|538231100|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
149209057|NCT01237223|538231101|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149209058|NCT01237223|538231102|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149209059|NCT01237223|538231103|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
149209060|NCT01237223|538231104|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149209061|NCT01237223|538231105|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
149209062|NCT00443846|538231106|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
149209063|NCT00443846|538231107|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
149209064|NCT00443846|538231106|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
149209065|NCT00443846|538231107|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
149209066|NCT00443846|538231106|FG000|Overall Study|Adverse Event|0|||
149209067|NCT00443846|538231107|FG001|Overall Study|Adverse Event|1|||
149209068|NCT00443846|538231106|FG000|Overall Study|Personal reason|8|||
149209069|NCT00443846|538231107|FG001|Overall Study|Personal reason|3|||
149209070|NCT00443846|538231106|FG000|Overall Study|Lost to Follow-up|1|||
149209071|NCT00443846|538231107|FG001|Overall Study|Lost to Follow-up|2|||
149209072|NCT01675141|538231109|FG000|Overall Study|Lenalidomide outside NIH|3|||
149209073|NCT01675141|538231109|FG000|Overall Study|Withdrawal by Subject|3|||
149209074|NCT01675141|538231109|FG000|Overall Study|Physician Decision|4|||
149209075|NCT01675141|538231109|FG000|Overall Study|No treatment, per protocol|1|||
149209076|NCT00802867|538231118|FG000|Overall Study|Lost to Follow-up|6|||
149209077|NCT00802867|538231118|FG000|Overall Study|Protocol Violation|6|||
149209078|NCT00802867|538231118|FG000|Overall Study|Withdrawal by Subject|1|||
148949756|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Death|0|||
148949757|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Death|0|||
148949758|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Death|0|||
149209079|NCT01809197|538231119|FG000|Overall Study|Lost to Follow-up|4|||
149209080|NCT01809197|538231120|FG001|Overall Study|Lost to Follow-up|2|||
148949759|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Death|0|||
148949760|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Death|0|||
148949761|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Death|0|||
148949762|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Death|0|||
148949763|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Death|0|||
148949764|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Death|0|||
148949765|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Death|0|||
148949766|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Death|0|||
148949767|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Death|0|||
148949768|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Death|0|||
148949769|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Death|0|||
148949770|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Death|0|||
148949771|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Death|0|||
148949772|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Death|0|||
149209081|NCT01809197|538231119|FG000|Overall Study|Adverse Event|2|||
149209082|NCT01809197|538231120|FG001|Overall Study|Adverse Event|3|||
149209083|NCT01809197|538231119|FG000|Overall Study|Failed slit lamp exam|1|||
149209084|NCT01809197|538231120|FG001|Overall Study|Failed slit lamp exam|0|||
149209085|NCT01809197|538231119|FG000|Overall Study|Non-Compliance|1|||
149209086|NCT01809197|538231120|FG001|Overall Study|Non-Compliance|1|||
149209087|NCT01809197|538231119|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
149209088|NCT01809197|538231120|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
149209089|NCT01809197|538231119|FG000|Overall Study|Withdrawal by Subject|1|||
149209090|NCT01809197|538231120|FG001|Overall Study|Withdrawal by Subject|1|||
149209091|NCT01809197|538231119|FG000|Overall Study|Product not available|0|||
149209092|NCT01809197|538231120|FG001|Overall Study|Product not available|1|||
149209093|NCT00268463|538231125|FG000|Overall Study|study terminated due to low accrual|10|||
149209094|NCT00268463|538231126|FG001|Overall Study|study terminated due to low accrual|12|||
149209095|NCT03000686|538231127|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
149209096|NCT03000686|538231128|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
149209097|NCT03000686|538231129|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
149209098|NCT03000686|538231130|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
149209099|NCT02920450|538231131|FG000|Overall Study|Death|1|||
149209100|NCT02920450|538231132|FG001|Overall Study|Death|0|||
149209101|NCT02920450|538231133|FG002|Overall Study|Death|0|||
149209102|NCT02920450|538231134|FG003|Overall Study|Death|0|||
149209103|NCT02920450|538231131|FG000|Overall Study|Withdrawal by Subject|1|||
149209104|NCT02920450|538231132|FG001|Overall Study|Withdrawal by Subject|0|||
149209105|NCT02920450|538231133|FG002|Overall Study|Withdrawal by Subject|0|||
149209106|NCT02920450|538231134|FG003|Overall Study|Withdrawal by Subject|0|||
149209107|NCT04737759|538231137|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
149209108|NCT04737759|538231138|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
149209109|NCT04737759|538231137|FG000|Overall Study|Death|2|||
149209110|NCT04737759|538231138|FG001|Overall Study|Death|0|||
149209111|NCT04737759|538231137|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
149209112|NCT04737759|538231138|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
149209113|NCT04737759|538231137|FG000|Overall Study|Lost to Follow-up|4|||
149209114|NCT04737759|538231138|FG001|Overall Study|Lost to Follow-up|12|||
149209115|NCT03371251|538231139|FG000|Overall Study|Withdrawal by Subject|1|||
149209116|NCT03371251|538231140|FG001|Overall Study|Withdrawal by Subject|0|||
148684276|NCT00910858|536316739|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
148809300|NCT02349386|536779263|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
149209117|NCT03371251|538231141|FG002|Overall Study|Withdrawal by Subject|1|||
149209118|NCT03371251|538231142|FG003|Overall Study|Withdrawal by Subject|0|||
149209119|NCT03371251|538231143|FG004|Overall Study|Withdrawal by Subject|2|||
149209120|NCT03371251|538231144|FG005|Overall Study|Withdrawal by Subject|2|||
148809301|NCT02349386|536779264|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
148809302|NCT02349386|536779261|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
148809303|NCT02349386|536779262|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
148949773|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Death|0|||
148949774|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Death|0|||
149209121|NCT03371251|538231139|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
149209122|NCT03371251|538231140|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
149209123|NCT03371251|538231141|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
149209124|NCT03371251|538231142|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
149209125|NCT03371251|538231143|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
149209126|NCT03371251|538231144|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
149209127|NCT03371251|538231139|FG000|Overall Study|Adverse Event|0|||
149209128|NCT03371251|538231140|FG001|Overall Study|Adverse Event|0|||
149209129|NCT03371251|538231141|FG002|Overall Study|Adverse Event|0|||
149209130|NCT03371251|538231142|FG003|Overall Study|Adverse Event|0|||
149209131|NCT03371251|538231143|FG004|Overall Study|Adverse Event|1|||
149209132|NCT03371251|538231144|FG005|Overall Study|Adverse Event|0|||
149209133|NCT03371251|538231139|FG000|Overall Study|Decision by Sponsor|0|||
149209134|NCT03371251|538231140|FG001|Overall Study|Decision by Sponsor|0|||
149209135|NCT03371251|538231141|FG002|Overall Study|Decision by Sponsor|0|||
149209136|NCT03371251|538231142|FG003|Overall Study|Decision by Sponsor|0|||
148809304|NCT02349386|536779263|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
148809305|NCT02349386|536779264|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
148809306|NCT02349386|536779261|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
148809307|NCT02349386|536779262|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
148809308|NCT02349386|536779263|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
148809309|NCT02349386|536779264|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
148809310|NCT02349386|536779261|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
148809311|NCT02349386|536779262|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
148809312|NCT02349386|536779263|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
148809313|NCT02349386|536779264|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
148809314|NCT02349386|536779261|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
148809315|NCT02349386|536779262|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
149209137|NCT03371251|538231143|FG004|Overall Study|Decision by Sponsor|2|||
149209138|NCT03371251|538231144|FG005|Overall Study|Decision by Sponsor|0|||
149209139|NCT04362813|538231147|FG000|Overall Study|Death|12|||
149209140|NCT04362813|538231148|FG001|Overall Study|Death|16|||
149209141|NCT04362813|538231147|FG000|Overall Study|Withdrawal by Subject|3|||
149209142|NCT04362813|538231148|FG001|Overall Study|Withdrawal by Subject|1|||
149209143|NCT04362813|538231147|FG000|Overall Study|Protocol Violation|0|||
149209144|NCT04362813|538231148|FG001|Overall Study|Protocol Violation|3|||
149209145|NCT04362813|538231147|FG000|Overall Study|Lost to Follow-up|1|||
149209146|NCT04362813|538231148|FG001|Overall Study|Lost to Follow-up|1|||
149209147|NCT04362813|538231147|FG000|Overall Study|Enrolled but did not receive treatment|2|||
149209148|NCT04362813|538231148|FG001|Overall Study|Enrolled but did not receive treatment|4|||
149209149|NCT00961116|538231149|FG000|Washout Period of 7 Days|Adverse Event|1|||
149209150|NCT00961116|538231150|FG001|Washout Period of 7 Days|Adverse Event|1|||
149209151|NCT00961116|538231149|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
149209152|NCT00961116|538231150|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
149209153|NCT00961116|538231149|FG000|Washout Period of 7 Days|Protocol Violation|0|||
149209154|NCT00961116|538231150|FG001|Washout Period of 7 Days|Protocol Violation|1|||
149209155|NCT01981109|538231153|FG000|Overall Study|Death|36|||
149209156|NCT01981109|538231153|FG000|Overall Study|Withdrawal by Subject|40|||
149209157|NCT01981109|538231153|FG000|Overall Study|Lost to Follow-up|9|||
149209158|NCT01981109|538231153|FG000|Overall Study|No Discontinuation Documentation|37|||
149209159|NCT01981109|538231153|FG000|Overall Study|Study Termination|100|||
149209160|NCT01981109|538231153|FG000|Overall Study|No data available|2|||
149209161|NCT01202760|538231160|FG000|Overall Study|Entry Criteria Not Met|0|||
149209162|NCT01202760|538231161|FG001|Overall Study|Entry Criteria Not Met|3|||
149209163|NCT01202760|538231162|FG002|Overall Study|Entry Criteria Not Met|1|||
149209164|NCT01202760|538231160|FG000|Overall Study|Adverse Event|11|||
149209165|NCT01202760|538231161|FG001|Overall Study|Adverse Event|9|||
149209166|NCT01202760|538231162|FG002|Overall Study|Adverse Event|10|||
148809316|NCT02349386|536779263|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
149209167|NCT01202760|538231160|FG000|Overall Study|Death|2|||
149209168|NCT01202760|538231161|FG001|Overall Study|Death|1|||
149209169|NCT01202760|538231162|FG002|Overall Study|Death|0|||
149209170|NCT01202760|538231160|FG000|Overall Study|Lack of Efficacy|6|||
149209171|NCT01202760|538231161|FG001|Overall Study|Lack of Efficacy|8|||
149209172|NCT01202760|538231162|FG002|Overall Study|Lack of Efficacy|7|||
149209173|NCT01202760|538231160|FG000|Overall Study|Lost to Follow-up|0|||
149209174|NCT01202760|538231161|FG001|Overall Study|Lost to Follow-up|2|||
149209175|NCT01202760|538231162|FG002|Overall Study|Lost to Follow-up|1|||
149209176|NCT01202760|538231160|FG000|Overall Study|Parent / Caregiver Decision|0|||
149209177|NCT01202760|538231161|FG001|Overall Study|Parent / Caregiver Decision|1|||
149209178|NCT01202760|538231162|FG002|Overall Study|Parent / Caregiver Decision|0|||
149209179|NCT01202760|538231160|FG000|Overall Study|Withdrawal by Subject|17|||
149209180|NCT01202760|538231161|FG001|Overall Study|Withdrawal by Subject|18|||
149209181|NCT01202760|538231162|FG002|Overall Study|Withdrawal by Subject|14|||
148809317|NCT02349386|536779264|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
149209182|NCT01202760|538231160|FG000|Overall Study|Physician Decision|0|||
149209183|NCT01202760|538231161|FG001|Overall Study|Physician Decision|1|||
149209184|NCT01202760|538231162|FG002|Overall Study|Physician Decision|0|||
149209185|NCT01202760|538231160|FG000|Overall Study|Protocol Violation|7|||
149209186|NCT01202760|538231161|FG001|Overall Study|Protocol Violation|5|||
149209187|NCT01202760|538231162|FG002|Overall Study|Protocol Violation|2|||
149209188|NCT01202760|538231160|FG000|Overall Study|Sponsor Decision|4|||
149209189|NCT01202760|538231161|FG001|Overall Study|Sponsor Decision|4|||
149209190|NCT01202760|538231162|FG002|Overall Study|Sponsor Decision|0|||
149209191|NCT01654523|538231163|FG000|Overall Study|Withdrawal by Subject|1|||
149209192|NCT04354155|538231164|FG000|Overall Study|Withdrawal by Subject|1|||
149209193|NCT04354155|538231164|FG000|Overall Study|Did not meet criteria for study intervention|1|||
149209194|NCT01998399|538231172|FG000|Overall Study|Lost to Follow-up|1|||
149209195|NCT01998399|538231173|FG001|Overall Study|Lost to Follow-up|3|||
149209196|NCT01998399|538231172|FG000|Overall Study|Death|4|||
149209197|NCT01998399|538231173|FG001|Overall Study|Death|2|||
149209198|NCT01998399|538231172|FG000|Overall Study|Study stopped before dosing completed|3|||
149209199|NCT01998399|538231173|FG001|Overall Study|Study stopped before dosing completed|3|||
149209200|NCT01998399|538231172|FG000|Overall Study|Withdrawal by Subject|0|||
149209201|NCT01998399|538231173|FG001|Overall Study|Withdrawal by Subject|1|||
149209202|NCT00376246|538231174|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
149209203|NCT00376246|538231175|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
149209204|NCT00376246|538231174|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
149209205|NCT00376246|538231175|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
149209206|NCT00376246|538231174|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
149209207|NCT00376246|538231175|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
149209208|NCT02762708|538231177|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
149209209|NCT02762708|538231178|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
149209210|NCT02762708|538231179|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
149209211|NCT02762708|538231180|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
149209212|NCT01468701|538231186|FG000|Overall Study|Not eligible|91|||
149209213|NCT01468701|538231187|FG001|Overall Study|Not eligible|140|||
148809318|NCT02349386|536779261|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
148809319|NCT02349386|536779262|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
148949775|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Death|0|||
149209214|NCT01468701|538231188|FG002|Overall Study|Not eligible|29|||
149209215|NCT01468701|538231189|FG003|Overall Study|Not eligible|12|||
149209216|NCT01468701|538231190|FG004|Overall Study|Not eligible|22|||
149209217|NCT01468701|538231191|FG005|Overall Study|Not eligible|2|||
149209218|NCT01468701|538231192|FG006|Overall Study|Not eligible|39|||
149209219|NCT01468701|538231193|FG007|Overall Study|Not eligible|1|||
149209220|NCT01468701|538231194|FG008|Overall Study|Not eligible|40|||
149209221|NCT01468701|538231195|FG009|Overall Study|Not eligible|126|||
148949776|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949777|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949778|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
148949779|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
148949780|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
149209222|NCT01468701|538231196|FG010|Overall Study|Not eligible|39|||
149209223|NCT01468701|538231197|FG011|Overall Study|Not eligible|33|||
149209224|NCT01468701|538231198|FG012|Overall Study|Not eligible|1|||
149209225|NCT01468701|538231199|FG013|Overall Study|Not eligible|19|||
149209226|NCT01468701|538231200|FG014|Overall Study|Not eligible|1|||
149209227|NCT01468701|538231201|FG015|Overall Study|Not eligible|32|||
149209228|NCT01468701|538231202|FG016|Overall Study|Not eligible|0|||
149209229|NCT01468701|538231186|FG000|Overall Study|Lost to Follow-up|306|||
149209230|NCT01468701|538231187|FG001|Overall Study|Lost to Follow-up|0|||
149209231|NCT01468701|538231188|FG002|Overall Study|Lost to Follow-up|0|||
149209232|NCT01468701|538231189|FG003|Overall Study|Lost to Follow-up|0|||
149209233|NCT01468701|538231190|FG004|Overall Study|Lost to Follow-up|0|||
149209234|NCT01468701|538231191|FG005|Overall Study|Lost to Follow-up|0|||
149209235|NCT01468701|538231192|FG006|Overall Study|Lost to Follow-up|0|||
149209236|NCT01468701|538231193|FG007|Overall Study|Lost to Follow-up|0|||
149209237|NCT01468701|538231194|FG008|Overall Study|Lost to Follow-up|215|||
149209238|NCT01468701|538231195|FG009|Overall Study|Lost to Follow-up|309|||
149209239|NCT01468701|538231196|FG010|Overall Study|Lost to Follow-up|224|||
149209240|NCT01468701|538231197|FG011|Overall Study|Lost to Follow-up|212|||
149209241|NCT01468701|538231198|FG012|Overall Study|Lost to Follow-up|11|||
149209242|NCT01468701|538231199|FG013|Overall Study|Lost to Follow-up|164|||
149209243|NCT01468701|538231200|FG014|Overall Study|Lost to Follow-up|17|||
149209244|NCT01468701|538231201|FG015|Overall Study|Lost to Follow-up|127|||
149209245|NCT01468701|538231202|FG016|Overall Study|Lost to Follow-up|1|||
149209246|NCT01468701|538231186|FG000|Overall Study|Withdrawal by Subject|165|||
149209247|NCT01468701|538231187|FG001|Overall Study|Withdrawal by Subject|0|||
149209248|NCT01468701|538231188|FG002|Overall Study|Withdrawal by Subject|0|||
149209249|NCT01468701|538231189|FG003|Overall Study|Withdrawal by Subject|0|||
149209250|NCT01468701|538231190|FG004|Overall Study|Withdrawal by Subject|0|||
149209251|NCT01468701|538231191|FG005|Overall Study|Withdrawal by Subject|0|||
149209252|NCT01468701|538231192|FG006|Overall Study|Withdrawal by Subject|0|||
149209253|NCT01468701|538231193|FG007|Overall Study|Withdrawal by Subject|0|||
149209254|NCT01468701|538231194|FG008|Overall Study|Withdrawal by Subject|83|||
149209255|NCT01468701|538231195|FG009|Overall Study|Withdrawal by Subject|88|||
149209256|NCT01468701|538231196|FG010|Overall Study|Withdrawal by Subject|100|||
149209257|NCT01468701|538231197|FG011|Overall Study|Withdrawal by Subject|114|||
149209258|NCT01468701|538231198|FG012|Overall Study|Withdrawal by Subject|9|||
149209259|NCT01468701|538231199|FG013|Overall Study|Withdrawal by Subject|47|||
149209260|NCT01468701|538231200|FG014|Overall Study|Withdrawal by Subject|6|||
149209261|NCT01468701|538231201|FG015|Overall Study|Withdrawal by Subject|31|||
149209262|NCT01468701|538231202|FG016|Overall Study|Withdrawal by Subject|0|||
149209263|NCT01468701|538231186|FG000|Overall Study|Other reasons than listed|437|||
149209264|NCT01468701|538231187|FG001|Overall Study|Other reasons than listed|0|||
149209265|NCT01468701|538231188|FG002|Overall Study|Other reasons than listed|0|||
149209266|NCT01468701|538231189|FG003|Overall Study|Other reasons than listed|0|||
148949781|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
148949782|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
149209267|NCT01468701|538231190|FG004|Overall Study|Other reasons than listed|0|||
149209268|NCT01468701|538231191|FG005|Overall Study|Other reasons than listed|0|||
149209269|NCT01468701|538231192|FG006|Overall Study|Other reasons than listed|0|||
149209270|NCT01468701|538231193|FG007|Overall Study|Other reasons than listed|0|||
149209271|NCT01468701|538231194|FG008|Overall Study|Other reasons than listed|318|||
149209272|NCT01468701|538231195|FG009|Overall Study|Other reasons than listed|658|||
149209273|NCT01468701|538231196|FG010|Overall Study|Other reasons than listed|433|||
149209274|NCT01468701|538231197|FG011|Overall Study|Other reasons than listed|504|||
149209275|NCT01468701|538231198|FG012|Overall Study|Other reasons than listed|28|||
149209276|NCT01468701|538231199|FG013|Overall Study|Other reasons than listed|239|||
149209277|NCT01468701|538231200|FG014|Overall Study|Other reasons than listed|39|||
149209278|NCT01468701|538231201|FG015|Overall Study|Other reasons than listed|172|||
149209279|NCT01468701|538231202|FG016|Overall Study|Other reasons than listed|0|||
149209280|NCT01468701|538231186|FG000|Overall Study|No end of study case report form|0|||
149209281|NCT01468701|538231187|FG001|Overall Study|No end of study case report form|0|||
149209282|NCT01468701|538231188|FG002|Overall Study|No end of study case report form|0|||
149209283|NCT01468701|538231189|FG003|Overall Study|No end of study case report form|0|||
149209284|NCT01468701|538231190|FG004|Overall Study|No end of study case report form|0|||
149209285|NCT01468701|538231191|FG005|Overall Study|No end of study case report form|0|||
149209286|NCT01468701|538231192|FG006|Overall Study|No end of study case report form|0|||
149209287|NCT01468701|538231193|FG007|Overall Study|No end of study case report form|0|||
149209288|NCT01468701|538231194|FG008|Overall Study|No end of study case report form|4|||
149209289|NCT01468701|538231195|FG009|Overall Study|No end of study case report form|1|||
149209290|NCT01468701|538231196|FG010|Overall Study|No end of study case report form|2|||
149209291|NCT01468701|538231197|FG011|Overall Study|No end of study case report form|3|||
149209292|NCT01468701|538231198|FG012|Overall Study|No end of study case report form|0|||
149209293|NCT01468701|538231199|FG013|Overall Study|No end of study case report form|1|||
149209294|NCT01468701|538231200|FG014|Overall Study|No end of study case report form|0|||
148684277|NCT00910858|536316740|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
148684278|NCT00910858|536316738|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
149209295|NCT01468701|538231201|FG015|Overall Study|No end of study case report form|0|||
149209296|NCT01468701|538231202|FG016|Overall Study|No end of study case report form|0|||
149209297|NCT01468701|538231186|FG000|Overall Study|Not being followed up|0|||
149209298|NCT01468701|538231187|FG001|Overall Study|Not being followed up|4963|||
148684279|NCT00910858|536316739|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
148684280|NCT00910858|536316740|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
148949783|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
149209299|NCT01468701|538231188|FG002|Overall Study|Not being followed up|1755|||
149209300|NCT01468701|538231189|FG003|Overall Study|Not being followed up|703|||
149209301|NCT01468701|538231190|FG004|Overall Study|Not being followed up|1714|||
149209302|NCT01468701|538231191|FG005|Overall Study|Not being followed up|126|||
149209303|NCT01468701|538231192|FG006|Overall Study|Not being followed up|1170|||
149209304|NCT01468701|538231193|FG007|Overall Study|Not being followed up|4|||
149209305|NCT01468701|538231194|FG008|Overall Study|Not being followed up|0|||
149209306|NCT01468701|538231195|FG009|Overall Study|Not being followed up|0|||
149209307|NCT01468701|538231196|FG010|Overall Study|Not being followed up|0|||
149209308|NCT01468701|538231197|FG011|Overall Study|Not being followed up|0|||
149209309|NCT01468701|538231198|FG012|Overall Study|Not being followed up|0|||
149209310|NCT01468701|538231199|FG013|Overall Study|Not being followed up|0|||
149209311|NCT01468701|538231200|FG014|Overall Study|Not being followed up|0|||
149209312|NCT01468701|538231201|FG015|Overall Study|Not being followed up|0|||
149209313|NCT01468701|538231202|FG016|Overall Study|Not being followed up|0|||
149209314|NCT00631540|538231212|FG000|Overall Study|Withdrawal by Subject|5|||
149209315|NCT00631540|538231212|FG000|Overall Study|Death|4|||
149209316|NCT00631540|538231212|FG000|Overall Study|Lost to Follow-up|2|||
149209317|NCT00631540|538231212|FG000|Overall Study|Core Lab Data Unavailable|3|||
149209318|NCT01079195|538231213|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
149209319|NCT01079195|538231213|FG000|Overall Study|No Documentation Available|437|||
149209320|NCT01079195|538231213|FG000|Overall Study|Adverse Event|157|||
149209321|NCT01079195|538231213|FG000|Overall Study|Reason Unknown|39|||
149209322|NCT01079195|538231213|FG000|Overall Study|Withdrawal by Subject|18|||
149209323|NCT01079195|538231213|FG000|Overall Study|Financial Reasons|15|||
149209324|NCT01079195|538231213|FG000|Overall Study|Lack of Effectiveness|12|||
149209325|NCT01079195|538231213|FG000|Overall Study|Physician Decision|4|||
149209326|NCT01079195|538231213|FG000|Overall Study|Improved Status of Participant|4|||
149209327|NCT01079195|538231213|FG000|Overall Study|No Follow-up Documentation Available|4|||
149209328|NCT01079195|538231213|FG000|Overall Study|Non-compliance|2|||
149209329|NCT03726333|538231218|FG000|Overall Study|Progressive Disease|0|||
149209330|NCT03726333|538231219|FG001|Overall Study|Progressive Disease|0|||
149209331|NCT03726333|538231220|FG002|Overall Study|Progressive Disease|1|||
149209332|NCT03726333|538231221|FG003|Overall Study|Progressive Disease|0|||
149209333|NCT03726333|538231222|FG004|Overall Study|Progressive Disease|0|||
149209334|NCT00402285|538233073|FG000|Overall Study|insufficient RNA quality|7|||
149209335|NCT00402285|538233074|FG001|Overall Study|insufficient RNA quality|6|||
149209336|NCT00402285|538233075|FG002|Overall Study|insufficient RNA quality|2|||
149209337|NCT01510028|538233076|FG000|Overall Study|Lack of Efficacy|1|||
149209338|NCT01510028|538233077|FG001|Overall Study|Lack of Efficacy|0|||
149209339|NCT01510028|538233078|FG002|Overall Study|Lack of Efficacy|0|||
149209340|NCT01510028|538233079|FG003|Overall Study|Lack of Efficacy|0|||
149209341|NCT02741310|538233080|FG000|Overall Study|Sponsor Decision|2|||
149209342|NCT02741310|538233081|FG001|Overall Study|Sponsor Decision|2|||
149209343|NCT05091918|538233082|FG000|Overall Study|Adverse Event|1|||
149209344|NCT05091918|538233082|FG000|Overall Study|Withdrawal by Subject|81|||
149209345|NCT01784211|538233086|FG000|Part A (Days 1-15)|Adverse Event|1|||
149209346|NCT01784211|538233087|FG001|Part A (Days 1-15)|Adverse Event|1|||
149209347|NCT01784211|538233088|FG002|Part A (Days 1-15)|Adverse Event|0|||
149209348|NCT01784211|538233089|FG003|Part A (Days 1-15)|Adverse Event|0|||
149209349|NCT01784211|538233090|FG004|Part A (Days 1-15)|Adverse Event|0|||
149209350|NCT01784211|538233091|FG005|Part A (Days 1-15)|Adverse Event|0|||
149209351|NCT01784211|538233086|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
149209352|NCT01784211|538233087|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
149209353|NCT01784211|538233088|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
149209354|NCT01784211|538233089|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
149209355|NCT01784211|538233090|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
149209356|NCT01784211|538233091|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
149209357|NCT00239356|538233092|FG000|Overall Study|Lack of Efficacy|1|||
149209358|NCT00239356|538233093|FG001|Overall Study|Lack of Efficacy|0|||
149209359|NCT00239356|538233092|FG000|Overall Study|Adverse Event|6|||
149209360|NCT00239356|538233093|FG001|Overall Study|Adverse Event|0|||
149209361|NCT00239356|538233092|FG000|Overall Study|Withdrawal by Subject|15|||
149209362|NCT00239356|538233093|FG001|Overall Study|Withdrawal by Subject|6|||
149209363|NCT00239356|538233092|FG000|Overall Study|Lost to Follow-up|3|||
149209364|NCT00239356|538233093|FG001|Overall Study|Lost to Follow-up|0|||
148684281|NCT00910858|536316738|FG000|Monotherapy Phase|Protocol Violation|1|||
149209365|NCT00239356|538233092|FG000|Overall Study|poor/non-compliance|2|||
149209366|NCT00239356|538233093|FG001|Overall Study|poor/non-compliance|0|||
149209367|NCT00239356|538233092|FG000|Overall Study|Pregnancy|1|||
149209368|NCT00239356|538233093|FG001|Overall Study|Pregnancy|0|||
149209369|NCT00239356|538233092|FG000|Overall Study|Administrative reason|0|||
149209370|NCT00239356|538233093|FG001|Overall Study|Administrative reason|1|||
149209371|NCT00239356|538233092|FG000|Overall Study|Drug available on market|11|||
149209372|NCT00239356|538233093|FG001|Overall Study|Drug available on market|2|||
149209373|NCT03417505|538233094|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
149209374|NCT03417505|538233095|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
149209375|NCT03551626|538233096|FG000|Overall Study|Adverse Event|88|||
149209376|NCT03551626|538233096|FG000|Overall Study|Disease relapse|18|||
149209377|NCT03551626|538233096|FG000|Overall Study|Withdrawal of informed consent|6|||
149209378|NCT03551626|538233096|FG000|Overall Study|Patient decision|5|||
149209379|NCT03551626|538233096|FG000|Overall Study|Physician Decision|4|||
149209380|NCT03551626|538233096|FG000|Overall Study|Lost to Follow-up|3|||
149209381|NCT03551626|538233096|FG000|Overall Study|Pregnancy|1|||
149209382|NCT03551626|538233096|FG000|Overall Study|Protocol deviation|1|||
149209383|NCT03551626|538233096|FG000|Overall Study|Technical problems|1|||
149209384|NCT00653328|538233097|FG000|Overall Study|Withdrawal by Subject|1|||
149209385|NCT00653328|538233097|FG000|Overall Study|Adverse Event|2|||
149209386|NCT00653328|538233097|FG000|Overall Study|Disease progression|10|||
149209387|NCT00653328|538233097|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
149209388|NCT01017549|538233100|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
149209389|NCT01017549|538233100|FG000|One-year Follow-up|Lost to Follow-up|2|||
149209390|NCT01017549|538233100|FG000|One-year Follow-up|Withdrawal by Subject|5|||
149209391|NCT01017549|538233100|FG000|5 Year Follow-up|Lost to Follow-up|9|||
149209392|NCT01017549|538233100|FG000|5 Year Follow-up|Mastectomy|3|||
149209393|NCT00391807|538233111|FG000|Overall Study|Did not receive study medication|23|||
149209394|NCT00391807|538233111|FG000|Overall Study|Adverse Event|177|||
149209395|NCT00391807|538233111|FG000|Overall Study|Pregnancy|25|||
149209396|NCT00391807|538233111|FG000|Overall Study|Lost to Follow-up|227|||
149209397|NCT00391807|538233111|FG000|Overall Study|Withdrawal by Subject|147|||
149209398|NCT00391807|538233111|FG000|Overall Study|Protocol Violation|20|||
149209399|NCT00391807|538233111|FG000|Overall Study|Various|96|||
149209400|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
149209401|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
149209402|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
149209403|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
149209404|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
149209405|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
149209406|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
149209407|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
149209408|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
149209409|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
149209410|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149209411|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149209412|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149209413|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
149209414|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
149209415|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
149209416|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
149209417|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
149209418|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
149209419|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
149209420|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
149209421|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
149209422|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
149209423|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
149209424|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
149209425|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Other|1|||
149209426|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Other|0|||
149209427|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Other|0|||
149209428|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Other|0|||
149209429|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Other|1|||
149209430|NCT02980692|538233114|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
149209431|NCT02980692|538233115|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
149209432|NCT02980692|538233116|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
149234088|NCT00423137|538326384|FG000|Overall Study|Adverse Event Study disease worse|1|||
149234089|NCT00423137|538326385|FG001|Overall Study|Adverse Event Study disease worse|0|||
148949784|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949785|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949786|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949787|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
149209433|NCT02980692|538233117|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
149209434|NCT02980692|538233118|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
149209435|NCT02980692|538233114|FG000|Double-blind Follow-up Period|Adverse Event|0|||
149209436|NCT02980692|538233115|FG001|Double-blind Follow-up Period|Adverse Event|0|||
149209437|NCT02980692|538233116|FG002|Double-blind Follow-up Period|Adverse Event|0|||
149209438|NCT02980692|538233117|FG003|Double-blind Follow-up Period|Adverse Event|1|||
149209439|NCT02980692|538233118|FG004|Double-blind Follow-up Period|Adverse Event|1|||
149209440|NCT02980692|538233114|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
149209441|NCT02980692|538233115|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
149209442|NCT02980692|538233116|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
149209443|NCT02980692|538233117|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
149209444|NCT02980692|538233118|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
149209445|NCT02980692|538233114|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
149209446|NCT02980692|538233115|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
149209447|NCT02980692|538233116|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
149209448|NCT02980692|538233117|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
149209449|NCT02980692|538233118|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
149209450|NCT02980692|538233114|FG000|Double-blind Follow-up Period|Pregnancy|0|||
149209451|NCT02980692|538233115|FG001|Double-blind Follow-up Period|Pregnancy|0|||
149209452|NCT02980692|538233116|FG002|Double-blind Follow-up Period|Pregnancy|1|||
149209453|NCT02980692|538233117|FG003|Double-blind Follow-up Period|Pregnancy|1|||
149209454|NCT02980692|538233118|FG004|Double-blind Follow-up Period|Pregnancy|0|||
149209455|NCT02980692|538233114|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
149209456|NCT02980692|538233115|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
149209457|NCT02980692|538233116|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
149209458|NCT02980692|538233117|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
149209459|NCT02980692|538233118|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
149209460|NCT02980692|538233114|FG000|Double-blind Follow-up Period|Other|0|||
149209461|NCT02980692|538233115|FG001|Double-blind Follow-up Period|Other|0|||
149209462|NCT02980692|538233116|FG002|Double-blind Follow-up Period|Other|1|||
149209463|NCT02980692|538233117|FG003|Double-blind Follow-up Period|Other|1|||
149209464|NCT02980692|538233118|FG004|Double-blind Follow-up Period|Other|3|||
149209465|NCT03725293|538233126|FG000|Overall Study|Physician Decision|9|||
149209466|NCT03725293|538233127|FG001|Overall Study|Physician Decision|6|||
149209467|NCT03725293|538233126|FG000|Overall Study|alternative vascular access needs|1|||
149209468|NCT03725293|538233127|FG001|Overall Study|alternative vascular access needs|2|||
149209469|NCT03725293|538233126|FG000|Overall Study|venous anatomy screen failures|2|||
149209470|NCT03725293|538233127|FG001|Overall Study|venous anatomy screen failures|1|||
149209471|NCT02143141|538233128|FG000|Overall Study|pain scores at 24 hours not collected|1|||
149209472|NCT02143141|538233129|FG001|Overall Study|pain scores at 24 hours not collected|0|||
149209473|NCT03862495|538233130|FG000|Overall Study|Lost to Follow-up|37|||
149209474|NCT03862495|538233131|FG001|Overall Study|Lost to Follow-up|35|||
149209475|NCT00064077|538233132|FG000|Overall Study|Improper prior treatment|1|||
149209476|NCT00064077|538233133|FG001|Overall Study|Improper prior treatment|0|||
149209477|NCT00064077|538233134|FG002|Overall Study|Improper prior treatment|0|||
149209478|NCT00064077|538233135|FG003|Overall Study|Improper prior treatment|0|||
149209479|NCT00064077|538233132|FG000|Overall Study|Poor risk|2|||
149209480|NCT00064077|538233133|FG001|Overall Study|Poor risk|0|||
149209481|NCT00064077|538233134|FG002|Overall Study|Poor risk|1|||
149209482|NCT00064077|538233135|FG003|Overall Study|Poor risk|1|||
149209483|NCT00064077|538233132|FG000|Overall Study|Pathology|10|||
149209484|NCT00064077|538233133|FG001|Overall Study|Pathology|7|||
149209485|NCT00064077|538233134|FG002|Overall Study|Pathology|3|||
149209486|NCT00064077|538233135|FG003|Overall Study|Pathology|4|||
149209487|NCT00064077|538233132|FG000|Overall Study|No surgery|0|||
149209488|NCT00064077|538233133|FG001|Overall Study|No surgery|0|||
149209489|NCT00064077|538233134|FG002|Overall Study|No surgery|1|||
149209490|NCT00064077|538233135|FG003|Overall Study|No surgery|0|||
149209491|NCT00064077|538233132|FG000|Overall Study|No tumor|0|||
149209492|NCT00064077|538233133|FG001|Overall Study|No tumor|0|||
149209493|NCT00064077|538233134|FG002|Overall Study|No tumor|1|||
149209494|NCT00064077|538233135|FG003|Overall Study|No tumor|0|||
149209495|NCT00064077|538233132|FG000|Overall Study|Other reasons|2|||
149209496|NCT00064077|538233133|FG001|Overall Study|Other reasons|2|||
149209497|NCT00064077|538233134|FG002|Overall Study|Other reasons|1|||
149209498|NCT00064077|538233135|FG003|Overall Study|Other reasons|2|||
149209499|NCT04397796|538233136|FG000|Overall Study|Death|3|||
148949788|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
149209500|NCT04397796|538233137|FG001|Overall Study|Death|1|||
149209501|NCT01057862|538233138|FG000|Overall Study|Withdrawal by Subject|1|||
149209502|NCT01057862|538233139|FG001|Overall Study|Withdrawal by Subject|2|||
149209503|NCT03363165|538233142|FG000|3-month Follow-up|Death|0|||
149209504|NCT03363165|538233143|FG001|3-month Follow-up|Death|1|||
149209505|NCT03363165|538233142|FG000|6-month Follow-up|Death|0|||
149209506|NCT03363165|538233143|FG001|6-month Follow-up|Death|1|||
149209507|NCT03363165|538233142|FG000|6-month Follow-up|Withdrawal by Subject|1|||
149209508|NCT03363165|538233143|FG001|6-month Follow-up|Withdrawal by Subject|1|||
149209509|NCT03363165|538233142|FG000|12-month Follow-up|Death|1|||
149209510|NCT03363165|538233143|FG001|12-month Follow-up|Death|1|||
149209511|NCT03363165|538233142|FG000|12-month Follow-up|Withdrawal by Subject|1|||
149209512|NCT03363165|538233143|FG001|12-month Follow-up|Withdrawal by Subject|1|||
149209513|NCT02255760|538233144|FG000|Overall Study|Lost to Follow-up|0|||
149209514|NCT02255760|538233145|FG001|Overall Study|Lost to Follow-up|1|||
149209515|NCT02255760|538233146|FG002|Overall Study|Lost to Follow-up|0|||
149209516|NCT02255760|538233147|FG003|Overall Study|Lost to Follow-up|0|||
149209517|NCT02255760|538233148|FG004|Overall Study|Lost to Follow-up|0|||
149209518|NCT00618813|538233149|FG000|Overall Study|Lack of Efficacy|1|||
149209519|NCT00618813|538233149|FG000|Overall Study|Physician Decision|2|||
149209520|NCT00618813|538233149|FG000|Overall Study|Withdrawal by Subject|1|||
149209521|NCT00003838|538233150|FG000|Overall Study|Death|0|||
149209522|NCT00003838|538233151|FG001|Overall Study|Death|12|||
149209523|NCT00003838|538233152|FG002|Overall Study|Death|7|||
149209524|NCT00003838|538233150|FG000|Overall Study|Lost to Follow-up|0|||
149209525|NCT00003838|538233151|FG001|Overall Study|Lost to Follow-up|1|||
149209526|NCT00003838|538233152|FG002|Overall Study|Lost to Follow-up|1|||
149209527|NCT00003838|538233150|FG000|Overall Study|Disease Progression|0|||
149209528|NCT00003838|538233151|FG001|Overall Study|Disease Progression|12|||
149209529|NCT00003838|538233152|FG002|Overall Study|Disease Progression|0|||
149209530|NCT00425113|538233153|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
149209531|NCT00425113|538233154|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
149209532|NCT00425113|538233153|FG000|Overall Study|diagnosis of abdominal TB|0|||
149209533|NCT00425113|538233154|FG001|Overall Study|diagnosis of abdominal TB|1|||
149209534|NCT00425113|538233153|FG000|Overall Study|missing study drug more than 14 days|0|||
149209535|NCT00425113|538233154|FG001|Overall Study|missing study drug more than 14 days|1|||
149209536|NCT00425113|538233153|FG000|Overall Study|Withdrawal by Subject|1|||
149209537|NCT00425113|538233154|FG001|Overall Study|Withdrawal by Subject|0|||
149209538|NCT00879437|538233155|FG000|Overall Study|Protocol Violation|0|||
149209539|NCT00879437|538233156|FG001|Overall Study|Protocol Violation|1|||
149209540|NCT00879437|538233155|FG000|Overall Study|Death|1|||
149209541|NCT00879437|538233156|FG001|Overall Study|Death|0|||
149209542|NCT01484561|538233157|FG000|Overall Study|Lack of Efficacy|3|||
149209543|NCT01484561|538233158|FG001|Overall Study|Lack of Efficacy|1|||
149209544|NCT01484561|538233157|FG000|Overall Study|Lost to Follow-up|1|||
149209545|NCT01484561|538233158|FG001|Overall Study|Lost to Follow-up|0|||
149209546|NCT01484561|538233157|FG000|Overall Study|Withdrawal by Subject|3|||
149209547|NCT01484561|538233158|FG001|Overall Study|Withdrawal by Subject|0|||
149209548|NCT01484561|538233157|FG000|Overall Study|Other|1|||
149209549|NCT01484561|538233158|FG001|Overall Study|Other|1|||
149209550|NCT01484561|538233157|FG000|Overall Study|Adverse Event|1|||
149209551|NCT01484561|538233158|FG001|Overall Study|Adverse Event|4|||
149209552|NCT00291187|538233159|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
149209553|NCT00291187|538233160|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
149209554|NCT00291187|538233161|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
149209555|NCT00291187|538233162|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
149209556|NCT02023268|538233163|FG000|Overall Study|Lack of Efficacy|0|||
149209557|NCT02023268|538233164|FG001|Overall Study|Lack of Efficacy|1|||
149209558|NCT02023268|538233163|FG000|Overall Study|Adverse Event|0|||
149209559|NCT02023268|538233164|FG001|Overall Study|Adverse Event|2|||
149209560|NCT02023268|538233163|FG000|Overall Study|Withdrawal by Subject|0|||
149016476|NCT01751113|537538829|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
149016477|NCT01751113|537538830|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
149209561|NCT02023268|538233164|FG001|Overall Study|Withdrawal by Subject|1|||
149209562|NCT00615459|538233166|FG000|Period I|Adverse Event|2|||
149209563|NCT00615459|538233167|FG001|Period I|Adverse Event|0|||
149016478|NCT01751113|537538825|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
149209564|NCT00615459|538233168|FG002|Period I|Adverse Event|1|||
149209565|NCT00615459|538233169|FG003|Period I|Adverse Event|0|||
149209566|NCT00615459|538233166|FG000|Period I|Subject withdrew consent|1|||
149209567|NCT00615459|538233167|FG001|Period I|Subject withdrew consent|0|||
149209568|NCT00615459|538233168|FG002|Period I|Subject withdrew consent|0|||
149209569|NCT00615459|538233169|FG003|Period I|Subject withdrew consent|1|||
149016479|NCT01751113|537538826|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
149209570|NCT00615459|538233166|FG000|Period I|Abnormal test procedure results|1|||
149209571|NCT00615459|538233167|FG001|Period I|Abnormal test procedure results|1|||
149209572|NCT00615459|538233168|FG002|Period I|Abnormal test procedure results|1|||
149209573|NCT00615459|538233169|FG003|Period I|Abnormal test procedure results|0|||
149209574|NCT00615459|538233166|FG000|Period II|Adverse Event|1|||
149209575|NCT00615459|538233167|FG001|Period II|Adverse Event|0|||
149209576|NCT00615459|538233168|FG002|Period II|Adverse Event|0|||
149209577|NCT00615459|538233169|FG003|Period II|Adverse Event|0|||
149209578|NCT00615459|538233166|FG000|Period II|Lost to Follow-up|0|||
149209579|NCT00615459|538233167|FG001|Period II|Lost to Follow-up|0|||
149209580|NCT00615459|538233168|FG002|Period II|Lost to Follow-up|0|||
149209581|NCT00615459|538233169|FG003|Period II|Lost to Follow-up|1|||
149209582|NCT00615459|538233166|FG000|Period III|Adverse Event|0|||
149209583|NCT00615459|538233167|FG001|Period III|Adverse Event|1|||
149209584|NCT00615459|538233168|FG002|Period III|Adverse Event|0|||
149209585|NCT00615459|538233169|FG003|Period III|Adverse Event|0|||
149209586|NCT00615459|538233166|FG000|Period III|Administrative problems|0|||
149209587|NCT00615459|538233167|FG001|Period III|Administrative problems|1|||
149209588|NCT00615459|538233168|FG002|Period III|Administrative problems|1|||
149209589|NCT00615459|538233169|FG003|Period III|Administrative problems|0|||
149209590|NCT00615459|538233166|FG000|Period III|Unsatisfactory therapeutic effect|0|||
149209591|NCT00615459|538233167|FG001|Period III|Unsatisfactory therapeutic effect|1|||
149209592|NCT00615459|538233168|FG002|Period III|Unsatisfactory therapeutic effect|0|||
149209593|NCT00615459|538233169|FG003|Period III|Unsatisfactory therapeutic effect|0|||
149209594|NCT00918346|538233170|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
149209595|NCT00918346|538233171|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
149209596|NCT03238352|538233172|FG000|Overall Study|Lost to Follow-up|0|||
149209597|NCT03238352|538233173|FG001|Overall Study|Lost to Follow-up|2|||
149209598|NCT03238352|538233174|FG002|Overall Study|Lost to Follow-up|1|||
149209599|NCT03238352|538233172|FG000|Overall Study|Withdrawal by Subject|0|||
149209600|NCT03238352|538233173|FG001|Overall Study|Withdrawal by Subject|1|||
149209601|NCT03238352|538233174|FG002|Overall Study|Withdrawal by Subject|0|||
149209602|NCT04153929|538233175|FG000|Overall Study|Other than listed|2|||
149209603|NCT04153929|538233176|FG001|Overall Study|Other than listed|2|||
149209604|NCT04153929|538233177|FG002|Overall Study|Other than listed|0|||
149209605|NCT04153929|538233178|FG003|Overall Study|Other than listed|1|||
149209606|NCT04153929|538233179|FG004|Overall Study|Other than listed|0|||
149209607|NCT04153929|538233180|FG005|Overall Study|Other than listed|2|||
149209608|NCT04153929|538233181|FG006|Overall Study|Other than listed|2|||
149209609|NCT04153929|538233182|FG007|Overall Study|Other than listed|1|||
149209610|NCT04153929|538233175|FG000|Overall Study|Lost to Follow-up|2|||
149209611|NCT04153929|538233176|FG001|Overall Study|Lost to Follow-up|1|||
149209612|NCT04153929|538233177|FG002|Overall Study|Lost to Follow-up|0|||
149209613|NCT04153929|538233178|FG003|Overall Study|Lost to Follow-up|1|||
149209614|NCT04153929|538233179|FG004|Overall Study|Lost to Follow-up|1|||
149209615|NCT04153929|538233180|FG005|Overall Study|Lost to Follow-up|0|||
149209616|NCT04153929|538233181|FG006|Overall Study|Lost to Follow-up|0|||
149209617|NCT04153929|538233182|FG007|Overall Study|Lost to Follow-up|0|||
149209618|NCT04153929|538233175|FG000|Overall Study|Withdrawal by Subject|3|||
149209619|NCT04153929|538233176|FG001|Overall Study|Withdrawal by Subject|1|||
149209620|NCT04153929|538233177|FG002|Overall Study|Withdrawal by Subject|0|||
149209621|NCT04153929|538233178|FG003|Overall Study|Withdrawal by Subject|3|||
149209622|NCT04153929|538233179|FG004|Overall Study|Withdrawal by Subject|1|||
149209623|NCT04153929|538233180|FG005|Overall Study|Withdrawal by Subject|0|||
149209624|NCT04153929|538233181|FG006|Overall Study|Withdrawal by Subject|1|||
149209625|NCT04153929|538233182|FG007|Overall Study|Withdrawal by Subject|0|||
149209626|NCT04153929|538233175|FG000|Overall Study|Protocol Violation|0|||
149209627|NCT04153929|538233176|FG001|Overall Study|Protocol Violation|0|||
149209628|NCT04153929|538233177|FG002|Overall Study|Protocol Violation|0|||
149209629|NCT04153929|538233178|FG003|Overall Study|Protocol Violation|0|||
149209630|NCT04153929|538233179|FG004|Overall Study|Protocol Violation|0|||
149209631|NCT04153929|538233180|FG005|Overall Study|Protocol Violation|0|||
149209632|NCT04153929|538233181|FG006|Overall Study|Protocol Violation|1|||
149209633|NCT04153929|538233182|FG007|Overall Study|Protocol Violation|2|||
149209634|NCT04153929|538233175|FG000|Overall Study|Adverse Event|3|||
149209635|NCT04153929|538233176|FG001|Overall Study|Adverse Event|5|||
149209636|NCT04153929|538233177|FG002|Overall Study|Adverse Event|5|||
149209637|NCT04153929|538233178|FG003|Overall Study|Adverse Event|11|||
149209638|NCT04153929|538233179|FG004|Overall Study|Adverse Event|15|||
149209639|NCT04153929|538233180|FG005|Overall Study|Adverse Event|4|||
149209640|NCT04153929|538233181|FG006|Overall Study|Adverse Event|8|||
149209641|NCT04153929|538233182|FG007|Overall Study|Adverse Event|2|||
149209642|NCT04153929|538233175|FG000|Overall Study|Not treated|1|||
149209643|NCT04153929|538233176|FG001|Overall Study|Not treated|0|||
149209644|NCT04153929|538233177|FG002|Overall Study|Not treated|0|||
148809320|NCT02349386|536779263|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
148809321|NCT02349386|536779264|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
148809322|NCT00973973|536779265|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
148809323|NCT00973973|536779266|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
148949789|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949790|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949791|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949792|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949793|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949794|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949795|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949796|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949797|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949798|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949799|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949800|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949801|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
148949802|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949803|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949804|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
149209645|NCT04153929|538233178|FG003|Overall Study|Not treated|0|||
149209646|NCT04153929|538233179|FG004|Overall Study|Not treated|0|||
149209647|NCT04153929|538233180|FG005|Overall Study|Not treated|0|||
149209648|NCT04153929|538233181|FG006|Overall Study|Not treated|1|||
149209649|NCT04153929|538233182|FG007|Overall Study|Not treated|0|||
149209650|NCT04083794|538233183|FG000|Overall Study|Lost to Follow-up|9|||
149209651|NCT00224003|538233186|FG000|Overall Study|Adverse Event|1|||
149209652|NCT00224003|538233186|FG000|Overall Study|Protocol Violation|2|||
149209653|NCT00224003|538233186|FG000|Overall Study|Withdrawal by Subject|1|||
149209654|NCT00224003|538233186|FG000|Overall Study|unk|3|||
149209655|NCT02228564|538233193|FG000|Overall Study|Withdrawal by Subject|10|||
149209656|NCT02228564|538233193|FG000|Overall Study|Death|11|||
149209657|NCT02228564|538233193|FG000|Overall Study|Physician Decision|5|||
149209658|NCT02228564|538233193|FG000|Overall Study|Lost to Follow-up|17|||
149209659|NCT02228564|538233193|FG000|Overall Study|Other|6|||
149209660|NCT01455415|538233201|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
149209661|NCT01455415|538233202|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
149209662|NCT01455415|538233201|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
149209663|NCT01455415|538233202|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
149209664|NCT01455415|538233201|FG000|Period 1|Drug Error not Associated to AE|0|||
149209665|NCT01455415|538233202|FG001|Period 1|Drug Error not Associated to AE|1|||
149209666|NCT01455415|538233201|FG000|Period 1|AE Not Related to Study Drug|2|||
149209667|NCT01455415|538233202|FG001|Period 1|AE Not Related to Study Drug|6|||
149209668|NCT01455415|538233201|FG000|Period 1|Withdrawal by Subject|4|||
149209669|NCT01455415|538233202|FG001|Period 1|Withdrawal by Subject|5|||
149209670|NCT01455415|538233201|FG000|Period 1|Unspecified Reason|1|||
149209671|NCT01455415|538233202|FG001|Period 1|Unspecified Reason|1|||
149209672|NCT01455415|538233201|FG000|Period 1|Protocol Violation|0|||
149209673|NCT01455415|538233202|FG001|Period 1|Protocol Violation|2|||
149209674|NCT01455415|538233201|FG000|Washout|AE Related to Study Drug|2|||
149209675|NCT01455415|538233202|FG001|Washout|AE Related to Study Drug|0|||
149209676|NCT01455415|538233201|FG000|Washout|Lost to Follow-up|1|||
149209677|NCT01455415|538233202|FG001|Washout|Lost to Follow-up|0|||
149209678|NCT01455415|538233201|FG000|Washout|Drug Error not Associated to AE|2|||
149209679|NCT01455415|538233202|FG001|Washout|Drug Error not Associated to AE|1|||
148809324|NCT00973973|536779265|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
149209680|NCT01455415|538233201|FG000|Washout|AE Not Related to Study Drug|2|||
149209681|NCT01455415|538233202|FG001|Washout|AE Not Related to Study Drug|3|||
149209682|NCT01455415|538233201|FG000|Washout|Unspecified Reason|1|||
149209683|NCT01455415|538233202|FG001|Washout|Unspecified Reason|2|||
149209684|NCT01455415|538233201|FG000|Washout|Protocol Violation|0|||
149209685|NCT01455415|538233202|FG001|Washout|Protocol Violation|1|||
149209686|NCT01455415|538233201|FG000|Period 2|AE Related to Study Drug|1|||
149209687|NCT01455415|538233202|FG001|Period 2|AE Related to Study Drug|2|||
149209688|NCT01455415|538233201|FG000|Period 2|Lost to Follow-up|2|||
149209689|NCT01455415|538233202|FG001|Period 2|Lost to Follow-up|1|||
149209690|NCT01455415|538233201|FG000|Period 2|AE Not Related to Study Drug|2|||
149209691|NCT01455415|538233202|FG001|Period 2|AE Not Related to Study Drug|1|||
149209692|NCT01455415|538233201|FG000|Period 2|Lack of Efficacy|2|||
149209693|NCT01455415|538233202|FG001|Period 2|Lack of Efficacy|0|||
149209694|NCT01455415|538233201|FG000|Period 2|Withdrawal by Subject|2|||
149209695|NCT01455415|538233202|FG001|Period 2|Withdrawal by Subject|3|||
149209696|NCT01455415|538233201|FG000|Period 2|Unspecified Reason|2|||
149209697|NCT01455415|538233202|FG001|Period 2|Unspecified Reason|3|||
149209698|NCT01455415|538233201|FG000|Period 2|Protocol Violation|2|||
149209699|NCT01455415|538233202|FG001|Period 2|Protocol Violation|0|||
149209700|NCT01455415|538233201|FG000|Follow-up|AE Related to Study Drug|0|||
149209701|NCT01455415|538233202|FG001|Follow-up|AE Related to Study Drug|1|||
149209702|NCT01455415|538233201|FG000|Follow-up|Lack of Efficacy|0|||
148949805|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949806|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949807|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949808|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
149209703|NCT01455415|538233202|FG001|Follow-up|Lack of Efficacy|1|||
149209704|NCT01455415|538233201|FG000|Follow-up|Withdrawal by Subject|2|||
149209705|NCT01455415|538233202|FG001|Follow-up|Withdrawal by Subject|0|||
149209706|NCT01455415|538233201|FG000|Follow-up|Unspecified Reason|1|||
149209707|NCT01455415|538233202|FG001|Follow-up|Unspecified Reason|0|||
149209708|NCT00587301|538233203|FG000|Overall Study|Screen Failure|9|||
149209709|NCT00587301|538233203|FG000|Overall Study|Lost to Follow-up|22|||
149209710|NCT00587301|538233203|FG000|Overall Study|Withdrawal by Subject|7|||
149209711|NCT00587301|538233203|FG000|Overall Study|Protocol Violation|7|||
149209712|NCT00351819|538233205|FG000|Overall Study|Lost to Follow-up|4|||
149209713|NCT00351819|538233206|FG001|Overall Study|Lost to Follow-up|4|||
149209714|NCT00351819|538233205|FG000|Overall Study|Withdrawal by Subject|0|||
149209715|NCT00351819|538233206|FG001|Overall Study|Withdrawal by Subject|4|||
149209716|NCT00351819|538233205|FG000|Overall Study|Elevated PSA|1|||
149209717|NCT00351819|538233206|FG001|Overall Study|Elevated PSA|1|||
149209718|NCT00351819|538233205|FG000|Overall Study|Traumatic ankle fracture|1|||
149209719|NCT00351819|538233206|FG001|Overall Study|Traumatic ankle fracture|0|||
149209720|NCT00351819|538233205|FG000|Overall Study|Unprofessional behavior|1|||
149209721|NCT00351819|538233206|FG001|Overall Study|Unprofessional behavior|0|||
149209722|NCT00351819|538233205|FG000|Overall Study|Non-compliance|0|||
149209723|NCT00351819|538233206|FG001|Overall Study|Non-compliance|1|||
149209724|NCT00351819|538233205|FG000|Overall Study|Incarcerated|0|||
149209725|NCT00351819|538233206|FG001|Overall Study|Incarcerated|1|||
149209726|NCT00351819|538233205|FG000|Overall Study|Enrolled in another trial|0|||
149209727|NCT00351819|538233206|FG001|Overall Study|Enrolled in another trial|1|||
149209728|NCT00418717|538233207|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
149209729|NCT00418717|538233207|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
149209730|NCT01400139|538233208|FG000|HYD Core Study|Adverse Event|210|||
149209731|NCT01400139|538233208|FG000|HYD Core Study|Lack of Efficacy|59|||
149209732|NCT01400139|538233208|FG000|HYD Core Study|Withdrawal by Subject|114|||
149209733|NCT01400139|538233208|FG000|HYD Core Study|Lost to Follow-up|39|||
149209734|NCT01400139|538233208|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
149209735|NCT01400139|538233208|FG000|HYD Core Study|Administrative|56|||
149209736|NCT01400139|538233208|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
149209737|NCT01400139|538233208|FG000|HYD Extension Period|Adverse Event|8|||
149209738|NCT01400139|538233208|FG000|HYD Extension Period|Withdrawal by Subject|5|||
149209739|NCT01400139|538233208|FG000|HYD Extension Period|Administrative|10|||
149209740|NCT00249795|538233211|FG000|Overall Study|Not treated|16|||
149209741|NCT00249795|538233212|FG001|Overall Study|Not treated|14|||
149209742|NCT00249795|538233211|FG000|Overall Study|Symptomatic hypotension|127|||
149209743|NCT00249795|538233212|FG001|Overall Study|Symptomatic hypotension|64|||
149209744|NCT00249795|538233211|FG000|Overall Study|Other Serious Adverse Event|84|||
149209745|NCT00249795|538233212|FG001|Overall Study|Other Serious Adverse Event|93|||
149209746|NCT00249795|538233211|FG000|Overall Study|Qualifying condition not present|26|||
149209747|NCT00249795|538233212|FG001|Overall Study|Qualifying condition not present|29|||
149209748|NCT00249795|538233211|FG000|Overall Study|Withdrawal by Subject|678|||
149209749|NCT00249795|538233212|FG001|Overall Study|Withdrawal by Subject|742|||
149209750|NCT00249795|538233211|FG000|Overall Study|Thromboembolic / outcome event|39|||
149209751|NCT00249795|538233212|FG001|Overall Study|Thromboembolic / outcome event|45|||
149209752|NCT00249795|538233211|FG000|Overall Study|Oral anticoagulant required|2|||
149209753|NCT00249795|538233212|FG001|Overall Study|Oral anticoagulant required|0|||
149209754|NCT00249795|538233211|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
149209755|NCT00249795|538233212|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
149209756|NCT00249795|538233211|FG000|Overall Study|Non-compliance|71|||
148809325|NCT00973973|536779266|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
148809326|NCT00973973|536779265|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
148809327|NCT00973973|536779266|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
148949809|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
149209757|NCT00249795|538233212|FG001|Overall Study|Non-compliance|69|||
149209758|NCT00249795|538233211|FG000|Overall Study|Study drug intolerance|3|||
149209759|NCT00249795|538233212|FG001|Overall Study|Study drug intolerance|3|||
149209760|NCT00249795|538233211|FG000|Overall Study|Other adverse events (non-serious)|188|||
149209761|NCT00249795|538233212|FG001|Overall Study|Other adverse events (non-serious)|159|||
148809328|NCT00973973|536779265|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
149209762|NCT00249795|538233211|FG000|Overall Study|Physician withdrew consent|71|||
149209763|NCT00249795|538233212|FG001|Overall Study|Physician withdrew consent|63|||
149209764|NCT00249795|538233211|FG000|Overall Study|Surgery / procedure|4|||
149209765|NCT00249795|538233212|FG001|Overall Study|Surgery / procedure|5|||
149209766|NCT00249795|538233211|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
149209767|NCT00249795|538233212|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
149209768|NCT00249795|538233211|FG000|Overall Study|Lightheadedness / dizziness|15|||
149209769|NCT00249795|538233212|FG001|Overall Study|Lightheadedness / dizziness|11|||
149209770|NCT00249795|538233211|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
149209771|NCT00249795|538233212|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
149209772|NCT00249795|538233211|FG000|Overall Study|Other contraindicated medication|1|||
149209773|NCT00249795|538233212|FG001|Overall Study|Other contraindicated medication|1|||
149209774|NCT00249795|538233211|FG000|Overall Study|Event related to cardiac condition|17|||
149209775|NCT00249795|538233212|FG001|Overall Study|Event related to cardiac condition|16|||
149209776|NCT00249795|538233211|FG000|Overall Study|Patient not wish to continue after May08|4|||
149209777|NCT00249795|538233212|FG001|Overall Study|Patient not wish to continue after May08|6|||
149209778|NCT00249795|538233211|FG000|Overall Study|Site not agree to continue after May08|1|||
148809329|NCT00973973|536779266|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
149209779|NCT00249795|538233212|FG001|Overall Study|Site not agree to continue after May08|1|||
149209780|NCT00249795|538233211|FG000|Overall Study|Lost to Follow-up|0|||
149209781|NCT00249795|538233212|FG001|Overall Study|Lost to Follow-up|2|||
149209782|NCT00249795|538233211|FG000|Overall Study|Missing|0|||
149209783|NCT00249795|538233212|FG001|Overall Study|Missing|1|||
149209784|NCT00719537|538233213|FG000|Overall Study|Withdrawal by Subject|1|||
149209785|NCT00719537|538233214|FG001|Overall Study|Withdrawal by Subject|0|||
149209786|NCT00719537|538233213|FG000|Overall Study|Lost to Follow-up|0|||
149209787|NCT00719537|538233214|FG001|Overall Study|Lost to Follow-up|1|||
149209788|NCT01142193|538233215|FG000|Overall Study|Adverse Event|12|||
149209789|NCT01142193|538233216|FG001|Overall Study|Adverse Event|4|||
149209790|NCT01142193|538233215|FG000|Overall Study|Lack of Efficacy|2|||
149209791|NCT01142193|538233216|FG001|Overall Study|Lack of Efficacy|1|||
149209792|NCT01142193|538233215|FG000|Overall Study|Physician Decision|1|||
149209793|NCT01142193|538233216|FG001|Overall Study|Physician Decision|1|||
149209794|NCT01142193|538233215|FG000|Overall Study|Withdrawal by Subject|4|||
149209795|NCT01142193|538233216|FG001|Overall Study|Withdrawal by Subject|3|||
149209796|NCT01142193|538233215|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
149209797|NCT01142193|538233216|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
149209798|NCT01142193|538233215|FG000|Overall Study|Other|1|||
149209799|NCT01142193|538233216|FG001|Overall Study|Other|2|||
149209800|NCT03549429|538233219|FG000|Overall Study|Protocol Violation|5|||
149209801|NCT03549429|538233220|FG001|Overall Study|Protocol Violation|3|||
149209802|NCT01425749|538233221|FG000|Overall Study|progression of melanoma|0|||
149209803|NCT01425749|538233222|FG001|Overall Study|progression of melanoma|1|||
148809330|NCT00973973|536779265|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
148809331|NCT00973973|536779266|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
149209804|NCT02910219|538233223|FG000|Overall Study|Withdrawal by Subject|1|||
149209805|NCT02910219|538233224|FG001|Overall Study|Withdrawal by Subject|1|||
149209806|NCT02096042|538233225|FG000|Overall Study|Disease Progression|1|||
149209807|NCT02096042|538233226|FG001|Overall Study|Disease Progression|0|||
149209808|NCT02096042|538233227|FG002|Overall Study|Disease Progression|0|||
148949810|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949811|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949812|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949813|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949814|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949815|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949816|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949817|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949818|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949819|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949820|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949821|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949822|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949823|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949824|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949825|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949826|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949827|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
148949828|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949829|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949830|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
148949831|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949832|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949833|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949834|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949835|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949836|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949837|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949838|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949839|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949840|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
149016480|NCT01751113|537538827|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
149209809|NCT05200455|538233233|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
149209810|NCT00807014|538233234|FG000|Overall Study|Participant Considered Disease Cured|13|||
149209811|NCT00807014|538233235|FG001|Overall Study|Participant Considered Disease Cured|2|||
149209812|NCT00807014|538233234|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
149209813|NCT00807014|538233235|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
149209814|NCT00807014|538233234|FG000|Overall Study|Protocol Violation|2|||
149209815|NCT00807014|538233235|FG001|Overall Study|Protocol Violation|8|||
149209816|NCT00807014|538233234|FG000|Overall Study|Adverse Event|0|||
149209817|NCT00807014|538233235|FG001|Overall Study|Adverse Event|2|||
149209818|NCT00807014|538233234|FG000|Overall Study|Lost to Follow-up|9|||
149209819|NCT00807014|538233235|FG001|Overall Study|Lost to Follow-up|7|||
149209820|NCT00807014|538233234|FG000|Overall Study|Recovery|1|||
149209821|NCT00807014|538233235|FG001|Overall Study|Recovery|0|||
149209822|NCT00807014|538233234|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
149209823|NCT00807014|538233235|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
149209824|NCT02091921|538233236|FG000|Overall Study|Adverse Event|3|||
149209825|NCT03307629|538233237|FG000|Overall Study|Withdrawal by Subject|0|||
149209826|NCT03307629|538233238|FG001|Overall Study|Withdrawal by Subject|0|||
149209827|NCT03307629|538233239|FG002|Overall Study|Withdrawal by Subject|0|||
149209828|NCT03307629|538233240|FG003|Overall Study|Withdrawal by Subject|2|||
149209829|NCT03307629|538233237|FG000|Overall Study|Disease Progression|0|||
149209830|NCT03307629|538233238|FG001|Overall Study|Disease Progression|0|||
149209831|NCT03307629|538233239|FG002|Overall Study|Disease Progression|0|||
149209832|NCT03307629|538233240|FG003|Overall Study|Disease Progression|3|||
149209833|NCT03307629|538233237|FG000|Overall Study|Death|0|||
149209834|NCT03307629|538233238|FG001|Overall Study|Death|3|||
149209835|NCT03307629|538233239|FG002|Overall Study|Death|0|||
149209836|NCT03307629|538233240|FG003|Overall Study|Death|1|||
149209837|NCT02483078|538233245|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
149209838|NCT02483078|538233246|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
149209839|NCT02483078|538233245|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
149209840|NCT02483078|538233246|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
149209841|NCT02483078|538233245|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
149016481|NCT01751113|537538828|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
149209842|NCT02483078|538233246|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
149209843|NCT02483078|538233245|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
149209844|NCT02483078|538233246|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
149209845|NCT02483078|538233245|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
149209846|NCT02483078|538233246|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
149209847|NCT02483078|538233245|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
149209848|NCT02483078|538233246|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
149209849|NCT02853032|538233247|FG000|Overall Study|Adverse Event|4|||
149209850|NCT02853032|538233248|FG001|Overall Study|Adverse Event|0|||
149209851|NCT02853032|538233247|FG000|Overall Study|Withdrawal by Subject|3|||
149209852|NCT02853032|538233248|FG001|Overall Study|Withdrawal by Subject|1|||
149209853|NCT02853032|538233247|FG000|Overall Study|Requested to withdraw from all treatment|2|||
149209854|NCT02853032|538233248|FG001|Overall Study|Requested to withdraw from all treatment|2|||
149209855|NCT04876599|538233249|FG000|Overall Study|Missed|2|||
149209856|NCT04876599|538233250|FG001|Overall Study|Missed|0|||
149209857|NCT04876599|538233249|FG000|Overall Study|Declined|2|||
149209858|NCT04876599|538233250|FG001|Overall Study|Declined|3|||
149209859|NCT03700736|538233253|FG000|Overall Study|Pregnancy|1|||
149209860|NCT03700736|538233254|FG001|Overall Study|Pregnancy|1|||
149209861|NCT03700736|538233253|FG000|Overall Study|Withdrawal by Subject|2|||
149209862|NCT03700736|538233254|FG001|Overall Study|Withdrawal by Subject|6|||
149209863|NCT01280812|538235206|FG000|Overall Study|Withdrawal by Subject|2|||
149209864|NCT01280812|538235207|FG001|Overall Study|Withdrawal by Subject|1|||
149209865|NCT01280812|538235208|FG002|Overall Study|Withdrawal by Subject|0|||
149209866|NCT01280812|538235206|FG000|Overall Study|Lost to Follow-up|1|||
149209867|NCT01280812|538235207|FG001|Overall Study|Lost to Follow-up|1|||
149209868|NCT01280812|538235208|FG002|Overall Study|Lost to Follow-up|1|||
149209869|NCT03682055|538235209|FG000|Overall Study|Lack of Efficacy|1|||
149209870|NCT03682055|538235210|FG001|Overall Study|Lack of Efficacy|2|||
149209871|NCT03682055|538235211|FG002|Overall Study|Lack of Efficacy|1|||
149209872|NCT03682055|538235212|FG003|Overall Study|Lack of Efficacy|2|||
149209873|NCT03682055|538235213|FG004|Overall Study|Lack of Efficacy|1|||
149209874|NCT03682055|538235214|FG005|Overall Study|Lack of Efficacy|3|||
149209875|NCT03682055|538235209|FG000|Overall Study|Withdrawal by Subject|0|||
149209876|NCT03682055|538235210|FG001|Overall Study|Withdrawal by Subject|0|||
149209877|NCT03682055|538235211|FG002|Overall Study|Withdrawal by Subject|0|||
149209878|NCT03682055|538235212|FG003|Overall Study|Withdrawal by Subject|0|||
149209879|NCT03682055|538235213|FG004|Overall Study|Withdrawal by Subject|0|||
149209880|NCT03682055|538235214|FG005|Overall Study|Withdrawal by Subject|1|||
149209881|NCT03682055|538235209|FG000|Overall Study|Termination of Study by Sponsor|0|||
149209882|NCT03682055|538235210|FG001|Overall Study|Termination of Study by Sponsor|0|||
149209883|NCT03682055|538235211|FG002|Overall Study|Termination of Study by Sponsor|0|||
149209884|NCT03682055|538235212|FG003|Overall Study|Termination of Study by Sponsor|0|||
149209885|NCT03682055|538235213|FG004|Overall Study|Termination of Study by Sponsor|0|||
149209886|NCT03682055|538235214|FG005|Overall Study|Termination of Study by Sponsor|3|||
149209887|NCT00880100|538235215|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
149209888|NCT00880100|538235215|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
149209889|NCT00880100|538235215|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
149209890|NCT03424044|538235217|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209891|NCT03424044|538235218|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209892|NCT03424044|538235219|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
149209893|NCT03424044|538235220|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209894|NCT03424044|538235221|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209895|NCT03424044|538235222|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209896|NCT03424044|538235223|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209897|NCT03424044|538235224|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209898|NCT03424044|538235225|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
149209899|NCT03424044|538235217|FG000|First Intervention (76 Hours)|Adverse Event|0|||
149209900|NCT03424044|538235218|FG001|First Intervention (76 Hours)|Adverse Event|0|||
149209901|NCT03424044|538235219|FG002|First Intervention (76 Hours)|Adverse Event|0|||
149209902|NCT03424044|538235220|FG003|First Intervention (76 Hours)|Adverse Event|0|||
149209903|NCT03424044|538235221|FG004|First Intervention (76 Hours)|Adverse Event|1|||
149209904|NCT03424044|538235222|FG005|First Intervention (76 Hours)|Adverse Event|0|||
149209905|NCT03424044|538235223|FG006|First Intervention (76 Hours)|Adverse Event|0|||
149209906|NCT03424044|538235224|FG007|First Intervention (76 Hours)|Adverse Event|0|||
149209907|NCT03424044|538235225|FG008|First Intervention (76 Hours)|Adverse Event|0|||
149209908|NCT03424044|538235217|FG000|First Intervention (76 Hours)|device issues|0|||
149209909|NCT03424044|538235218|FG001|First Intervention (76 Hours)|device issues|0|||
149209910|NCT03424044|538235219|FG002|First Intervention (76 Hours)|device issues|0|||
149209911|NCT03424044|538235220|FG003|First Intervention (76 Hours)|device issues|0|||
149209912|NCT03424044|538235221|FG004|First Intervention (76 Hours)|device issues|0|||
149209913|NCT03424044|538235222|FG005|First Intervention (76 Hours)|device issues|0|||
149209914|NCT03424044|538235223|FG006|First Intervention (76 Hours)|device issues|1|||
149209915|NCT03424044|538235224|FG007|First Intervention (76 Hours)|device issues|1|||
149209916|NCT03424044|538235225|FG008|First Intervention (76 Hours)|device issues|1|||
149209917|NCT03424044|538235217|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
149209918|NCT03424044|538235218|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
149209919|NCT03424044|538235219|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
149209920|NCT03424044|538235220|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
149209921|NCT03424044|538235221|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
149209922|NCT03424044|538235222|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
149209923|NCT03424044|538235223|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
149209924|NCT03424044|538235224|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
149209925|NCT03424044|538235225|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
149209926|NCT03424044|538235217|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209927|NCT03424044|538235218|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209928|NCT03424044|538235219|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209929|NCT03424044|538235220|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
149209930|NCT03424044|538235221|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209931|NCT03424044|538235222|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209932|NCT03424044|538235223|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209933|NCT03424044|538235224|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209934|NCT03424044|538235225|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
149209935|NCT00784459|538235227|FG000|Overall Study|Adverse Event|0|||
149209936|NCT00784459|538235228|FG001|Overall Study|Adverse Event|2|||
149209937|NCT02431702|538235229|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
149209938|NCT02431702|538235230|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149209939|NCT02431702|538235231|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149209940|NCT02431702|538235232|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149209941|NCT02431702|538235233|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149209942|NCT02431702|538235234|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149209943|NCT02431702|538235235|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
149209944|NCT02431702|538235229|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
149209945|NCT02431702|538235230|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149209946|NCT02431702|538235231|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149209947|NCT02431702|538235232|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149209948|NCT02431702|538235233|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149209949|NCT02431702|538235234|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
149209950|NCT02431702|538235235|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
149209951|NCT02431702|538235229|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
149209952|NCT02431702|538235230|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149209953|NCT02431702|538235231|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149209954|NCT02431702|538235232|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149209955|NCT02431702|538235233|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149209956|NCT02431702|538235234|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
149209957|NCT02431702|538235235|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
149209958|NCT02431702|538235229|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
149209959|NCT02431702|538235230|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149209960|NCT02431702|538235231|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149209961|NCT02431702|538235232|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149209962|NCT02431702|538235233|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149209963|NCT02431702|538235234|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
149209964|NCT02431702|538235235|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
149209965|NCT02431702|538235229|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
149209966|NCT02431702|538235230|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149209967|NCT02431702|538235231|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
148949841|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949842|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
149209968|NCT02431702|538235232|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149209969|NCT02431702|538235233|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149209970|NCT02431702|538235234|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149209971|NCT02431702|538235235|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
149209972|NCT02431702|538235229|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149209973|NCT02431702|538235230|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
149209974|NCT02431702|538235231|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
149209975|NCT02431702|538235232|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149209976|NCT02431702|538235233|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149209977|NCT02431702|538235234|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149209978|NCT02431702|538235235|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
149209979|NCT02431702|538235229|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
148809332|NCT00973973|536779265|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
148809333|NCT00973973|536779266|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
148809334|NCT00973973|536779265|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
149209980|NCT02431702|538235230|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
149209981|NCT02431702|538235231|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
149209982|NCT02431702|538235232|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149209983|NCT02431702|538235233|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149209984|NCT02431702|538235234|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149209985|NCT02431702|538235235|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
149209986|NCT02431702|538235229|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149209987|NCT02431702|538235230|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
149209988|NCT02431702|538235231|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
149209989|NCT02431702|538235232|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149209990|NCT02431702|538235233|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149209991|NCT02431702|538235234|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149209992|NCT02431702|538235235|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
149209993|NCT02431702|538235229|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149209994|NCT02431702|538235230|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
149209995|NCT02431702|538235231|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149209996|NCT02431702|538235232|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149209997|NCT02431702|538235233|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149209998|NCT02431702|538235234|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149209999|NCT02431702|538235235|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
149210000|NCT02431702|538235229|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
149210001|NCT02431702|538235230|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
148809335|NCT00973973|536779266|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
148809336|NCT00973973|536779265|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
149210002|NCT02431702|538235231|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
149210003|NCT02431702|538235232|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
149210004|NCT02431702|538235233|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
149210005|NCT02431702|538235234|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
149210006|NCT02431702|538235235|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
149210007|NCT02431702|538235229|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149210008|NCT02431702|538235230|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149210009|NCT02431702|538235231|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
149210010|NCT02431702|538235232|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149210011|NCT02431702|538235233|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149210012|NCT02431702|538235234|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149210013|NCT02431702|538235235|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
149210014|NCT02431702|538235229|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149210015|NCT02431702|538235230|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149210016|NCT02431702|538235231|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149210017|NCT02431702|538235232|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
149210018|NCT02431702|538235233|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
149210019|NCT02431702|538235234|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149210020|NCT02431702|538235235|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
149210021|NCT02431702|538235229|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149210022|NCT02431702|538235230|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149210023|NCT02431702|538235231|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149210024|NCT02431702|538235232|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
149210025|NCT02431702|538235233|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149210026|NCT02431702|538235234|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
149210027|NCT02431702|538235235|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
149210028|NCT02431702|538235229|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149210029|NCT02431702|538235230|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149210030|NCT02431702|538235231|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149210031|NCT02431702|538235232|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
149210032|NCT02431702|538235233|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
149210033|NCT02431702|538235234|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
149210034|NCT02431702|538235235|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
149210035|NCT02431702|538235229|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
149210036|NCT02431702|538235230|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
149210037|NCT02431702|538235231|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
149210038|NCT02431702|538235232|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
149210039|NCT02431702|538235233|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
149210040|NCT02431702|538235234|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
149210041|NCT02431702|538235235|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
149210042|NCT04839393|538235236|FG000|Overall Study|Adverse Event|0|||
149210043|NCT04839393|538235237|FG001|Overall Study|Adverse Event|0|||
149210044|NCT04839393|538235238|FG002|Overall Study|Adverse Event|2|||
149210045|NCT04839393|538235236|FG000|Overall Study|Withdrawal by participant|0|||
149210046|NCT04839393|538235237|FG001|Overall Study|Withdrawal by participant|0|||
149210047|NCT04839393|538235238|FG002|Overall Study|Withdrawal by participant|1|||
149210048|NCT00633893|538235241|FG000|Overall Study|Death|1|||
149210049|NCT00633893|538235242|FG001|Overall Study|Death|3|||
149210050|NCT00633893|538235243|FG002|Overall Study|Death|9|||
149210051|NCT00633893|538235241|FG000|Overall Study|Adverse Event|65|||
149210052|NCT00633893|538235242|FG001|Overall Study|Adverse Event|58|||
149210053|NCT00633893|538235243|FG002|Overall Study|Adverse Event|126|||
149210054|NCT00633893|538235241|FG000|Overall Study|Withdrawal by Subject|7|||
149210055|NCT00633893|538235242|FG001|Overall Study|Withdrawal by Subject|12|||
149210056|NCT00633893|538235243|FG002|Overall Study|Withdrawal by Subject|6|||
149210057|NCT00633893|538235241|FG000|Overall Study|Lost to Follow-up|2|||
149210058|NCT00633893|538235242|FG001|Overall Study|Lost to Follow-up|4|||
149210059|NCT00633893|538235243|FG002|Overall Study|Lost to Follow-up|8|||
149210060|NCT00633893|538235241|FG000|Overall Study|Poor/non-compliance|5|||
149210061|NCT00633893|538235242|FG001|Overall Study|Poor/non-compliance|12|||
149210062|NCT00633893|538235243|FG002|Overall Study|Poor/non-compliance|3|||
149210063|NCT00633893|538235241|FG000|Overall Study|Pregnancy|2|||
149210064|NCT00633893|538235242|FG001|Overall Study|Pregnancy|1|||
149210065|NCT00633893|538235243|FG002|Overall Study|Pregnancy|1|||
149210066|NCT00633893|538235241|FG000|Overall Study|Not meet/no longer meets criteria|4|||
149210067|NCT00633893|538235242|FG001|Overall Study|Not meet/no longer meets criteria|6|||
149210068|NCT00633893|538235243|FG002|Overall Study|Not meet/no longer meets criteria|4|||
149210069|NCT00633893|538235241|FG000|Overall Study|Other|28|||
149210070|NCT00633893|538235242|FG001|Overall Study|Other|33|||
149210071|NCT00633893|538235243|FG002|Overall Study|Other|31|||
149210072|NCT01100658|538235245|FG000|Overall Study|Withdrawal by Subject|1|||
149210073|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
149210074|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
149210075|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
149210076|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
149210077|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
149210078|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
149210079|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
149210080|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
149210081|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
149210082|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
149210083|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
149210084|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
149210085|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
149210086|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
149210087|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
149210088|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
149210089|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
149210090|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
149210091|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
149210092|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
149210093|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
149210094|NCT01001572|538235248|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
149210095|NCT01001572|538235249|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
149210096|NCT01001572|538235250|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
149210097|NCT01001572|538235248|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149210098|NCT01001572|538235249|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
149210099|NCT01001572|538235250|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
149210100|NCT01001572|538235248|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149210101|NCT01001572|538235249|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
149210102|NCT01001572|538235250|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
149210103|NCT01001572|538235248|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
149210104|NCT01001572|538235249|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
149210105|NCT01001572|538235250|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
149210106|NCT01001572|538235248|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
149210107|NCT01001572|538235249|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
149210108|NCT01001572|538235250|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
149210109|NCT01001572|538235248|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
149210110|NCT01001572|538235249|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
149210111|NCT01001572|538235250|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
149210112|NCT01001572|538235248|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149210113|NCT01001572|538235249|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149210114|NCT01001572|538235250|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149210115|NCT01094808|538235251|FG000|Overall Study|Withdrawal by Subject|1|||
149210116|NCT01094808|538235252|FG001|Overall Study|Withdrawal by Subject|1|||
149210117|NCT01094808|538235253|FG002|Overall Study|Withdrawal by Subject|0|||
149210118|NCT00369278|538235254|FG000|Overall Study|Adverse Event|14|||
149210119|NCT00369278|538235255|FG001|Overall Study|Adverse Event|11|||
149210120|NCT00369278|538235254|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149210121|NCT00369278|538235255|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
149210122|NCT00369278|538235254|FG000|Overall Study|Protocol Violation|2|||
149210123|NCT00369278|538235255|FG001|Overall Study|Protocol Violation|1|||
149210124|NCT00369278|538235254|FG000|Overall Study|Withdrawal by Subject|2|||
149210125|NCT00369278|538235255|FG001|Overall Study|Withdrawal by Subject|2|||
149210126|NCT00369278|538235254|FG000|Overall Study|Lost to Follow-up|1|||
149210127|NCT00369278|538235255|FG001|Overall Study|Lost to Follow-up|0|||
149210128|NCT00369278|538235254|FG000|Overall Study|Graft loss|1|||
149210129|NCT00369278|538235255|FG001|Overall Study|Graft loss|2|||
149210130|NCT02044822|538235256|FG000|Overall Study|Study Terminated by Sponsor|77|||
149210131|NCT02044822|538235256|FG000|Overall Study|Investigator's Discretion|10|||
149210132|NCT02044822|538235256|FG000|Overall Study|Withdrew Consent|3|||
148949843|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949844|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
149210133|NCT02044822|538235256|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
149210134|NCT02044822|538235256|FG000|Overall Study|Lost to Follow-up|1|||
149210135|NCT02025530|538235259|FG000|Overall Study|No longer met elligibility criteria|5|||
149210136|NCT02025530|538235260|FG001|Overall Study|No longer met elligibility criteria|1|||
149210137|NCT01040845|538235265|FG000|Overall Study|Withdrawal by Subject|1|||
149210138|NCT01040845|538235266|FG001|Overall Study|Withdrawal by Subject|1|||
148809337|NCT00973973|536779266|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
148949845|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949846|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949847|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949848|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949849|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949850|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
149210139|NCT01040845|538235265|FG000|Overall Study|Physician Decision|1|||
149210140|NCT01040845|538235266|FG001|Overall Study|Physician Decision|0|||
149210141|NCT04445688|538235270|FG000|Washout (One Week)|Adverse Event|2|||
149210142|NCT04445688|538235270|FG000|Washout (One Week)|Withdrawal by Subject|1|||
149210143|NCT00928512|538235275|FG000|Overall Study|Adverse Event|4|||
149016482|NCT01751113|537538829|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
149210144|NCT00928512|538235276|FG001|Overall Study|Adverse Event|3|||
149210145|NCT00928512|538235277|FG002|Overall Study|Adverse Event|2|||
149210146|NCT00928512|538235278|FG003|Overall Study|Adverse Event|8|||
149210147|NCT00928512|538235279|FG004|Overall Study|Adverse Event|6|||
149210148|NCT00928512|538235275|FG000|Overall Study|Lack of Efficacy|2|||
149210149|NCT00928512|538235276|FG001|Overall Study|Lack of Efficacy|0|||
149210150|NCT00928512|538235277|FG002|Overall Study|Lack of Efficacy|4|||
149210151|NCT00928512|538235278|FG003|Overall Study|Lack of Efficacy|7|||
149210152|NCT00928512|538235279|FG004|Overall Study|Lack of Efficacy|3|||
149210153|NCT00928512|538235275|FG000|Overall Study|Protocol Violation|0|||
149210154|NCT00928512|538235276|FG001|Overall Study|Protocol Violation|1|||
149210155|NCT00928512|538235277|FG002|Overall Study|Protocol Violation|0|||
149210156|NCT00928512|538235278|FG003|Overall Study|Protocol Violation|1|||
149210157|NCT00928512|538235279|FG004|Overall Study|Protocol Violation|3|||
149210158|NCT00928512|538235275|FG000|Overall Study|Withdrawal by Subject|3|||
149210159|NCT00928512|538235276|FG001|Overall Study|Withdrawal by Subject|0|||
149210160|NCT00928512|538235277|FG002|Overall Study|Withdrawal by Subject|3|||
149210161|NCT00928512|538235278|FG003|Overall Study|Withdrawal by Subject|4|||
149210162|NCT00928512|538235279|FG004|Overall Study|Withdrawal by Subject|0|||
149210163|NCT00928512|538235275|FG000|Overall Study|Lost to Follow-up|1|||
149210164|NCT00928512|538235276|FG001|Overall Study|Lost to Follow-up|1|||
149210165|NCT00928512|538235277|FG002|Overall Study|Lost to Follow-up|2|||
149210166|NCT00928512|538235278|FG003|Overall Study|Lost to Follow-up|1|||
149210167|NCT00928512|538235279|FG004|Overall Study|Lost to Follow-up|3|||
149210168|NCT00928512|538235275|FG000|Overall Study|Administrative Problems|0|||
149210169|NCT00928512|538235276|FG001|Overall Study|Administrative Problems|1|||
149210170|NCT00928512|538235277|FG002|Overall Study|Administrative Problems|0|||
149210171|NCT00928512|538235278|FG003|Overall Study|Administrative Problems|0|||
149210172|NCT00928512|538235279|FG004|Overall Study|Administrative Problems|0|||
149210173|NCT01296698|538235280|FG000|Overall Study|Adverse Event|1|||
149210174|NCT01296698|538235281|FG001|Overall Study|Adverse Event|0|||
149210175|NCT01296698|538235280|FG000|Overall Study|Death|1|||
149210176|NCT01296698|538235281|FG001|Overall Study|Death|0|||
149210177|NCT01296698|538235280|FG000|Overall Study|Lost to Follow-up|19|||
149210178|NCT01296698|538235281|FG001|Overall Study|Lost to Follow-up|1|||
149210179|NCT01296698|538235280|FG000|Overall Study|Withdrawal by Subject|12|||
149210180|NCT01296698|538235281|FG001|Overall Study|Withdrawal by Subject|0|||
149210181|NCT01296698|538235280|FG000|Overall Study|Difficulty Contacting Subject|2|||
149210182|NCT01296698|538235281|FG001|Overall Study|Difficulty Contacting Subject|0|||
149210183|NCT01296698|538235280|FG000|Overall Study|Study Terminated by Sponsor|209|||
149210184|NCT01296698|538235281|FG001|Overall Study|Study Terminated by Sponsor|12|||
149210185|NCT01975675|538235282|FG000|Overall Study|Death|0|||
149210186|NCT01975675|538235283|FG001|Overall Study|Death|1|||
149210187|NCT01975675|538235284|FG002|Overall Study|Death|0|||
148809338|NCT00973973|536779265|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
148809339|NCT00973973|536779266|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
149210188|NCT01975675|538235285|FG003|Overall Study|Death|0|||
149210189|NCT03639987|538235286|FG000|Overall Study|Study terminated by sponsor|26|||
149210190|NCT03639987|538235287|FG001|Overall Study|Study terminated by sponsor|25|||
149210191|NCT03639987|538235286|FG000|Overall Study|Lost to Follow-up|0|||
149210192|NCT03639987|538235287|FG001|Overall Study|Lost to Follow-up|1|||
149210193|NCT00729326|538235294|FG000|Overall Study|Lost to Follow-up|2|||
149210194|NCT00729326|538235295|FG001|Overall Study|Lost to Follow-up|0|||
149210195|NCT00729326|538235294|FG000|Overall Study|Physician Decision|0|||
149210196|NCT00729326|538235295|FG001|Overall Study|Physician Decision|1|||
149210197|NCT00729326|538235294|FG000|Overall Study|Protocol Violation|3|||
149210198|NCT00729326|538235295|FG001|Overall Study|Protocol Violation|2|||
149210199|NCT00729326|538235294|FG000|Overall Study|Subject Decision|4|||
149210200|NCT00729326|538235295|FG001|Overall Study|Subject Decision|4|||
149210201|NCT00729326|538235294|FG000|Overall Study|Sponsor Decision|1|||
149210202|NCT00729326|538235295|FG001|Overall Study|Sponsor Decision|2|||
149210203|NCT01235728|538235296|FG000|Overall Study|Protocol Violation|0|||
149210204|NCT01235728|538235297|FG001|Overall Study|Protocol Violation|0|||
149210205|NCT01235728|538235298|FG002|Overall Study|Protocol Violation|0|||
149210206|NCT01235728|538235299|FG003|Overall Study|Protocol Violation|1|||
149210207|NCT01235728|538235300|FG004|Overall Study|Protocol Violation|0|||
149210208|NCT01235728|538235301|FG005|Overall Study|Protocol Violation|0|||
149210209|NCT01235728|538235302|FG006|Overall Study|Protocol Violation|0|||
149210210|NCT01235728|538235303|FG007|Overall Study|Protocol Violation|0|||
149210211|NCT02810951|538235304|FG000|Overall Study|Adverse Event|1|||
149210212|NCT03199638|538235305|FG000|Overall Study|inability to drink glutamine during regularly|0|||
149210213|NCT03199638|538235306|FG001|Overall Study|inability to drink glutamine during regularly|2|||
149210214|NCT01575899|538235307|FG000|Overall Study|Lost to Follow-up|3|||
149210215|NCT01575899|538235308|FG001|Overall Study|Lost to Follow-up|4|||
149210216|NCT01575899|538235309|FG002|Overall Study|Lost to Follow-up|2|||
149210217|NCT01575899|538235307|FG000|Overall Study|Protocol Violation|2|||
149210218|NCT01575899|538235308|FG001|Overall Study|Protocol Violation|1|||
149210219|NCT01575899|538235309|FG002|Overall Study|Protocol Violation|0|||
149210220|NCT02807844|538235310|FG000|Overall Study|Physician Decision|0|||
149210221|NCT02807844|538235311|FG001|Overall Study|Physician Decision|0|||
149210222|NCT02807844|538235312|FG002|Overall Study|Physician Decision|0|||
149210223|NCT02807844|538235313|FG003|Overall Study|Physician Decision|0|||
149210224|NCT02807844|538235314|FG004|Overall Study|Physician Decision|0|||
149210225|NCT02807844|538235315|FG005|Overall Study|Physician Decision|0|||
149210226|NCT02807844|538235316|FG006|Overall Study|Physician Decision|3|||
149210227|NCT02807844|538235317|FG007|Overall Study|Physician Decision|0|||
149210228|NCT02807844|538235318|FG008|Overall Study|Physician Decision|1|||
149210229|NCT02807844|538235319|FG009|Overall Study|Physician Decision|2|||
149210230|NCT02807844|538235310|FG000|Overall Study|Death|0|||
149210231|NCT02807844|538235311|FG001|Overall Study|Death|0|||
149210232|NCT02807844|538235312|FG002|Overall Study|Death|2|||
149210233|NCT02807844|538235313|FG003|Overall Study|Death|4|||
149210234|NCT02807844|538235314|FG004|Overall Study|Death|1|||
149210235|NCT02807844|538235315|FG005|Overall Study|Death|2|||
149210236|NCT02807844|538235316|FG006|Overall Study|Death|1|||
149210237|NCT02807844|538235317|FG007|Overall Study|Death|2|||
149210238|NCT02807844|538235318|FG008|Overall Study|Death|0|||
149210239|NCT02807844|538235319|FG009|Overall Study|Death|1|||
149210240|NCT02807844|538235310|FG000|Overall Study|Withdrawal by Subject|0|||
149210241|NCT02807844|538235311|FG001|Overall Study|Withdrawal by Subject|0|||
149210242|NCT02807844|538235312|FG002|Overall Study|Withdrawal by Subject|2|||
149210243|NCT02807844|538235313|FG003|Overall Study|Withdrawal by Subject|1|||
149210244|NCT02807844|538235314|FG004|Overall Study|Withdrawal by Subject|1|||
149210245|NCT02807844|538235315|FG005|Overall Study|Withdrawal by Subject|0|||
149210246|NCT02807844|538235316|FG006|Overall Study|Withdrawal by Subject|1|||
148949851|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949852|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949853|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
148949854|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949855|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949856|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
148949857|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210247|NCT02807844|538235317|FG007|Overall Study|Withdrawal by Subject|0|||
148949858|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949859|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210248|NCT02807844|538235318|FG008|Overall Study|Withdrawal by Subject|0|||
149210249|NCT02807844|538235319|FG009|Overall Study|Withdrawal by Subject|0|||
149210250|NCT02807844|538235310|FG000|Overall Study|Progressive disease|5|||
149210251|NCT02807844|538235311|FG001|Overall Study|Progressive disease|12|||
149210252|NCT02807844|538235312|FG002|Overall Study|Progressive disease|8|||
149210253|NCT02807844|538235313|FG003|Overall Study|Progressive disease|8|||
149210254|NCT02807844|538235314|FG004|Overall Study|Progressive disease|3|||
149210255|NCT02807844|538235315|FG005|Overall Study|Progressive disease|8|||
149210256|NCT02807844|538235316|FG006|Overall Study|Progressive disease|14|||
149210257|NCT02807844|538235317|FG007|Overall Study|Progressive disease|17|||
149210258|NCT02807844|538235318|FG008|Overall Study|Progressive disease|19|||
149210259|NCT02807844|538235319|FG009|Overall Study|Progressive disease|15|||
149210260|NCT02807844|538235310|FG000|Overall Study|Adverse Event|1|||
149210261|NCT02807844|538235311|FG001|Overall Study|Adverse Event|0|||
149210262|NCT02807844|538235312|FG002|Overall Study|Adverse Event|0|||
149210263|NCT02807844|538235313|FG003|Overall Study|Adverse Event|0|||
149210264|NCT02807844|538235314|FG004|Overall Study|Adverse Event|1|||
149210265|NCT02807844|538235315|FG005|Overall Study|Adverse Event|1|||
149210266|NCT02807844|538235316|FG006|Overall Study|Adverse Event|1|||
149210267|NCT02807844|538235317|FG007|Overall Study|Adverse Event|1|||
149210268|NCT02807844|538235318|FG008|Overall Study|Adverse Event|1|||
149210269|NCT02807844|538235319|FG009|Overall Study|Adverse Event|2|||
149210270|NCT03097029|538235320|FG000|Overall Study|Withdrawal by Subject|1|||
149210271|NCT00709124|538235321|FG000|Overall Study|Death|3|||
149210272|NCT00709124|538235322|FG001|Overall Study|Death|1|||
149210273|NCT00709124|538235321|FG000|Overall Study|encephalopathy; can't do assessment|1|||
149210274|NCT00709124|538235322|FG001|Overall Study|encephalopathy; can't do assessment|0|||
149210275|NCT00373490|538235323|FG000|Overall Study|Adverse Event|0|||
149210276|NCT00373490|538235324|FG001|Overall Study|Adverse Event|1|||
149210277|NCT00373490|538235323|FG000|Overall Study|Lack of Efficacy|9|||
149210278|NCT00373490|538235324|FG001|Overall Study|Lack of Efficacy|4|||
149210279|NCT00373490|538235323|FG000|Overall Study|Withdrawal by Subject|0|||
149210280|NCT00373490|538235324|FG001|Overall Study|Withdrawal by Subject|1|||
149210281|NCT00108953|538235331|FG000|Follow-up|Death|18|||
149210282|NCT00108953|538235332|FG001|Follow-up|Death|26|||
149210283|NCT00108953|538235331|FG000|Follow-up|Lost to Follow-up|1|||
149210284|NCT00108953|538235332|FG001|Follow-up|Lost to Follow-up|1|||
149210285|NCT00108953|538235331|FG000|Follow-up|Study terminated by sponsor|10|||
149210286|NCT00108953|538235332|FG001|Follow-up|Study terminated by sponsor|6|||
149210287|NCT00753688|538235333|FG000|Overall Study|Death|102|||
149210288|NCT00753688|538235334|FG001|Overall Study|Death|203|||
149210289|NCT00753688|538235333|FG000|Overall Study|Missing|4|||
149210290|NCT00753688|538235334|FG001|Overall Study|Missing|9|||
149210291|NCT00753688|538235333|FG000|Overall Study|Participant Withdrew Consent|2|||
149210292|NCT00753688|538235334|FG001|Overall Study|Participant Withdrew Consent|2|||
149210293|NCT00753688|538235333|FG000|Overall Study|Ongoing - in Follow-up|15|||
149210294|NCT00753688|538235334|FG001|Overall Study|Ongoing - in Follow-up|31|||
149210295|NCT00753688|538235333|FG000|Overall Study|Adverse Event|0|||
149210296|NCT00753688|538235334|FG001|Overall Study|Adverse Event|1|||
149210297|NCT01125293|538235337|FG000|Overall Study|Disease Progression|1|||
149210298|NCT01125293|538235338|FG001|Overall Study|Disease Progression|3|||
149210299|NCT01125293|538235339|FG002|Overall Study|Disease Progression|4|||
148949860|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210300|NCT01125293|538235340|FG003|Overall Study|Disease Progression|3|||
149210301|NCT01125293|538235341|FG004|Overall Study|Disease Progression|5|||
149210302|NCT01125293|538235342|FG005|Overall Study|Disease Progression|12|||
149210303|NCT01125293|538235337|FG000|Overall Study|Adverse Event|1|||
149210304|NCT01125293|538235338|FG001|Overall Study|Adverse Event|0|||
149210305|NCT01125293|538235339|FG002|Overall Study|Adverse Event|0|||
149210306|NCT01125293|538235340|FG003|Overall Study|Adverse Event|0|||
149210307|NCT01125293|538235341|FG004|Overall Study|Adverse Event|2|||
149210308|NCT01125293|538235342|FG005|Overall Study|Adverse Event|8|||
149210309|NCT01125293|538235337|FG000|Overall Study|Symptomatic Deterioration|1|||
149210310|NCT01125293|538235338|FG001|Overall Study|Symptomatic Deterioration|0|||
149210311|NCT01125293|538235339|FG002|Overall Study|Symptomatic Deterioration|0|||
149210312|NCT01125293|538235340|FG003|Overall Study|Symptomatic Deterioration|0|||
149210313|NCT01125293|538235341|FG004|Overall Study|Symptomatic Deterioration|0|||
149210314|NCT01125293|538235342|FG005|Overall Study|Symptomatic Deterioration|0|||
149210315|NCT01125293|538235337|FG000|Overall Study|Death|0|||
149210316|NCT01125293|538235338|FG001|Overall Study|Death|0|||
149210317|NCT01125293|538235339|FG002|Overall Study|Death|0|||
149210318|NCT01125293|538235340|FG003|Overall Study|Death|0|||
149210319|NCT01125293|538235341|FG004|Overall Study|Death|1|||
148949861|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949862|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949863|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949864|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949865|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949866|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949867|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949868|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949869|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949870|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949871|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949872|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949873|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949874|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210320|NCT01125293|538235342|FG005|Overall Study|Death|0|||
149210321|NCT01125293|538235337|FG000|Overall Study|Withdrawal by Subject|0|||
149210322|NCT01125293|538235338|FG001|Overall Study|Withdrawal by Subject|0|||
149210323|NCT01125293|538235339|FG002|Overall Study|Withdrawal by Subject|0|||
149210324|NCT01125293|538235340|FG003|Overall Study|Withdrawal by Subject|0|||
149210325|NCT01125293|538235341|FG004|Overall Study|Withdrawal by Subject|2|||
149210326|NCT01125293|538235342|FG005|Overall Study|Withdrawal by Subject|1|||
149210327|NCT01125293|538235337|FG000|Overall Study|Physician Decision|0|||
149210328|NCT01125293|538235338|FG001|Overall Study|Physician Decision|0|||
149210329|NCT01125293|538235339|FG002|Overall Study|Physician Decision|0|||
149210330|NCT01125293|538235340|FG003|Overall Study|Physician Decision|0|||
149210331|NCT01125293|538235341|FG004|Overall Study|Physician Decision|0|||
149210332|NCT01125293|538235342|FG005|Overall Study|Physician Decision|2|||
149210333|NCT00260429|538235345|FG000|Overall Study|failure to follow appointments|1|||
149210334|NCT00260429|538235346|FG001|Overall Study|failure to follow appointments|0|||
149210335|NCT00260429|538235345|FG000|Overall Study|scheduled hand surgery|1|||
149210336|NCT00260429|538235346|FG001|Overall Study|scheduled hand surgery|0|||
149210337|NCT00659126|538235347|FG000|Overall Study|Adverse Event|2|||
149210338|NCT00659126|538235348|FG001|Overall Study|Adverse Event|2|||
149210339|NCT00659126|538235347|FG000|Overall Study|Screen failure|1|||
149210340|NCT00659126|538235348|FG001|Overall Study|Screen failure|1|||
149210341|NCT00659126|538235347|FG000|Overall Study|Technical problems with MRI|0|||
149210342|NCT00659126|538235348|FG001|Overall Study|Technical problems with MRI|1|||
149210343|NCT02633046|538235352|FG000|Overall Study|Adverse Event|8|||
149210344|NCT02633046|538235352|FG000|Overall Study|Physician Decision|7|||
149210345|NCT02633046|538235352|FG000|Overall Study|Withdrawal by Subject|8|||
149210346|NCT02633046|538235352|FG000|Overall Study|Increased proteinuria|2|||
149210347|NCT02633046|538235352|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
149210348|NCT02633046|538235352|FG000|Overall Study|Mutual decision patient and physician|1|||
149210349|NCT01496274|538235355|FG000|Overall Study|Protocol Violation|0|||
149210350|NCT01496274|538235356|FG001|Overall Study|Protocol Violation|1|||
149210351|NCT01496274|538235355|FG000|Overall Study|Adverse Event|1|||
149210352|NCT01496274|538235356|FG001|Overall Study|Adverse Event|1|||
149210353|NCT01496274|538235355|FG000|Overall Study|Withdrawal by Subject|2|||
149210354|NCT01496274|538235356|FG001|Overall Study|Withdrawal by Subject|0|||
149210355|NCT01496274|538235355|FG000|Overall Study|Lost to Follow-up|0|||
149210356|NCT01496274|538235356|FG001|Overall Study|Lost to Follow-up|3|||
149210357|NCT02758613|538235358|FG000|Treatment|Physician and Sponsor Decision|1|||
149210358|NCT02758613|538235359|FG001|Treatment|Physician and Sponsor Decision|0|||
149210359|NCT02758613|538235360|FG002|Treatment|Physician and Sponsor Decision|0|||
149210360|NCT02758613|538235361|FG003|Treatment|Physician and Sponsor Decision|0|||
149210361|NCT02758613|538235358|FG000|Treatment|Withdrawal by Subject|1|||
149210362|NCT02758613|538235359|FG001|Treatment|Withdrawal by Subject|0|||
149210363|NCT02758613|538235360|FG002|Treatment|Withdrawal by Subject|1|||
149210364|NCT02758613|538235361|FG003|Treatment|Withdrawal by Subject|0|||
149210365|NCT01068717|538235363|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
149210366|NCT01068717|538235364|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
149210367|NCT01068717|538235365|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
149210368|NCT01068717|538235366|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
149210369|NCT02679781|538235367|FG000|Overall Study|Lost to Follow-up|1|||
149210370|NCT02679781|538235368|FG001|Overall Study|Lost to Follow-up|2|||
149210371|NCT02679781|538235367|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
148949875|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
148949876|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210372|NCT02679781|538235368|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
148949877|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210373|NCT01822223|538235371|FG000|Overall Study|Death|0|||
149210374|NCT01822223|538235372|FG001|Overall Study|Death|1|||
149210375|NCT04209400|538235373|FG000|Overall Study|Withdrawal by Subject|0|||
149210376|NCT04209400|538235374|FG001|Overall Study|Withdrawal by Subject|1|||
149210377|NCT01602549|538235375|FG000|Overall Study|Protocol Violation|0|||
149210378|NCT01602549|538235376|FG001|Overall Study|Protocol Violation|1|||
149210379|NCT01602549|538235375|FG000|Overall Study|Withdrawal by Subject|1|||
149210380|NCT01602549|538235376|FG001|Overall Study|Withdrawal by Subject|0|||
149210381|NCT00676208|538235383|FG000|Overall Study|Lost to Follow-up|0|||
149210382|NCT00676208|538235384|FG001|Overall Study|Lost to Follow-up|2|||
149210383|NCT00676208|538235383|FG000|Overall Study|Incomplete data|2|||
149210384|NCT00676208|538235384|FG001|Overall Study|Incomplete data|4|||
149210385|NCT00323310|538238025|FG000|Overall Study|Withdrawal by Subject|1|||
149210386|NCT00323310|538238025|FG000|Overall Study|a parent refused blood draw|1|||
149210387|NCT00323310|538238025|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
149210388|NCT03565991|538238026|FG000|Overall Study|Other|11|||
149210389|NCT03565991|538238027|FG001|Overall Study|Other|0|||
149210390|NCT03565991|538238026|FG000|Overall Study|Global deterioration of health status|14|||
149210391|NCT03565991|538238027|FG001|Overall Study|Global deterioration of health status|4|||
149210392|NCT03565991|538238026|FG000|Overall Study|Withdrawal by Subject|2|||
149210393|NCT03565991|538238027|FG001|Overall Study|Withdrawal by Subject|6|||
149210394|NCT03565991|538238026|FG000|Overall Study|Progressive disease|121|||
149210395|NCT03565991|538238027|FG001|Overall Study|Progressive disease|29|||
149210396|NCT03565991|538238026|FG000|Overall Study|Death|3|||
149210397|NCT03565991|538238027|FG001|Overall Study|Death|0|||
149210398|NCT03565991|538238026|FG000|Overall Study|Adverse Event|7|||
149210399|NCT03565991|538238027|FG001|Overall Study|Adverse Event|2|||
149210400|NCT00086385|538238030|FG000|Overall Study|Death|2|||
149210401|NCT00086385|538238031|FG001|Overall Study|Death|2|||
149210402|NCT00086385|538238032|FG002|Overall Study|Death|1|||
149210403|NCT00086385|538238033|FG003|Overall Study|Death|1|||
149210404|NCT01376388|538238040|FG000|Overall Study|Adverse Event|13|||
149210405|NCT01376388|538238040|FG000|Overall Study|Lack of Efficacy|2|||
149210406|NCT01376388|538238040|FG000|Overall Study|Withdrawal by Subject|3|||
149210407|NCT02009930|538238048|FG000|Overall Study|withdrawn|5|||
149210408|NCT02471586|538238059|FG000|Overall Study|Lost to Follow-up|3|||
149210409|NCT02471586|538238060|FG001|Overall Study|Lost to Follow-up|8|||
149210410|NCT02471586|538238061|FG002|Overall Study|Lost to Follow-up|4|||
149210411|NCT02471586|538238059|FG000|Overall Study|Death|2|||
149210412|NCT02471586|538238060|FG001|Overall Study|Death|2|||
149210413|NCT02471586|538238061|FG002|Overall Study|Death|0|||
149210414|NCT03235726|538238067|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210415|NCT03235726|538238068|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210416|NCT03235726|538238069|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210417|NCT03235726|538238070|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210418|NCT03235726|538238071|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
149210419|NCT03235726|538238072|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210420|NCT03235726|538238073|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210421|NCT03235726|538238074|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210422|NCT03235726|538238075|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210423|NCT03235726|538238076|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
149210424|NCT03235726|538238067|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210425|NCT03235726|538238068|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210426|NCT03235726|538238069|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210427|NCT03235726|538238070|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210428|NCT03235726|538238071|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
149210429|NCT03235726|538238072|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210430|NCT03235726|538238073|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210431|NCT03235726|538238074|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210432|NCT03235726|538238075|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210433|NCT03235726|538238076|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
149210434|NCT00563368|538238077|FG000|Overall Study|Lost to Follow-up|14|||
149210435|NCT00563368|538238078|FG001|Overall Study|Lost to Follow-up|14|||
149210436|NCT00563368|538238079|FG002|Overall Study|Lost to Follow-up|12|||
149210437|NCT00563368|538238080|FG003|Overall Study|Lost to Follow-up|6|||
149210438|NCT00563368|538238081|FG004|Overall Study|Lost to Follow-up|9|||
149210439|NCT00563368|538238082|FG005|Overall Study|Lost to Follow-up|8|||
149210440|NCT00563368|538238083|FG006|Overall Study|Lost to Follow-up|9|||
149210441|NCT00563368|538238077|FG000|Overall Study|Adverse Event|3|||
148949878|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210442|NCT00563368|538238078|FG001|Overall Study|Adverse Event|4|||
149210443|NCT00563368|538238079|FG002|Overall Study|Adverse Event|5|||
149210444|NCT00563368|538238080|FG003|Overall Study|Adverse Event|9|||
149210445|NCT00563368|538238081|FG004|Overall Study|Adverse Event|6|||
149210446|NCT00563368|538238082|FG005|Overall Study|Adverse Event|10|||
149210447|NCT00563368|538238083|FG006|Overall Study|Adverse Event|17|||
149210448|NCT00563368|538238077|FG000|Overall Study|Withdrawal by Subject|11|||
149210449|NCT00563368|538238078|FG001|Overall Study|Withdrawal by Subject|6|||
149210450|NCT00563368|538238079|FG002|Overall Study|Withdrawal by Subject|5|||
149210451|NCT00563368|538238080|FG003|Overall Study|Withdrawal by Subject|7|||
149210452|NCT00563368|538238081|FG004|Overall Study|Withdrawal by Subject|8|||
149210453|NCT00563368|538238082|FG005|Overall Study|Withdrawal by Subject|5|||
149210454|NCT00563368|538238083|FG006|Overall Study|Withdrawal by Subject|4|||
149210455|NCT00563368|538238077|FG000|Overall Study|protocol non-compliance|1|||
149210456|NCT00563368|538238078|FG001|Overall Study|protocol non-compliance|1|||
149210457|NCT00563368|538238079|FG002|Overall Study|protocol non-compliance|2|||
149210458|NCT00563368|538238080|FG003|Overall Study|protocol non-compliance|1|||
149210459|NCT00563368|538238081|FG004|Overall Study|protocol non-compliance|0|||
149210460|NCT00563368|538238082|FG005|Overall Study|protocol non-compliance|1|||
149210461|NCT00563368|538238083|FG006|Overall Study|protocol non-compliance|3|||
149210462|NCT00563368|538238077|FG000|Overall Study|Pregnancy|1|||
149210463|NCT00563368|538238078|FG001|Overall Study|Pregnancy|0|||
149210464|NCT00563368|538238079|FG002|Overall Study|Pregnancy|1|||
149210465|NCT00563368|538238080|FG003|Overall Study|Pregnancy|2|||
149210466|NCT00563368|538238081|FG004|Overall Study|Pregnancy|1|||
149210467|NCT00563368|538238082|FG005|Overall Study|Pregnancy|2|||
149210468|NCT00563368|538238083|FG006|Overall Study|Pregnancy|0|||
149210469|NCT00563368|538238077|FG000|Overall Study|requirement for restricted medication|0|||
149210470|NCT00563368|538238078|FG001|Overall Study|requirement for restricted medication|0|||
149210471|NCT00563368|538238079|FG002|Overall Study|requirement for restricted medication|2|||
149210472|NCT00563368|538238080|FG003|Overall Study|requirement for restricted medication|0|||
149210473|NCT00563368|538238081|FG004|Overall Study|requirement for restricted medication|0|||
149210474|NCT00563368|538238082|FG005|Overall Study|requirement for restricted medication|0|||
149210475|NCT00563368|538238083|FG006|Overall Study|requirement for restricted medication|0|||
149210476|NCT00563368|538238077|FG000|Overall Study|Other|5|||
148949879|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
149210477|NCT00563368|538238078|FG001|Overall Study|Other|5|||
149210478|NCT00563368|538238079|FG002|Overall Study|Other|3|||
149210479|NCT00563368|538238080|FG003|Overall Study|Other|4|||
149210480|NCT00563368|538238081|FG004|Overall Study|Other|4|||
149210481|NCT00563368|538238082|FG005|Overall Study|Other|4|||
149210482|NCT00563368|538238083|FG006|Overall Study|Other|0|||
149210483|NCT00114218|538238092|FG000|Overall Study|Wrong Cell Type|2|||
149210484|NCT00114218|538238092|FG000|Overall Study|Wrong Primary|1|||
149210485|NCT00114218|538238092|FG000|Overall Study|Never Treated|1|||
149210486|NCT01505114|538238094|FG000|Overall Study|Withdrawal by Subject|5|||
149210487|NCT01505114|538238095|FG001|Overall Study|Withdrawal by Subject|4|||
149210488|NCT01505114|538238096|FG002|Overall Study|Withdrawal by Subject|4|||
149210489|NCT01505114|538238097|FG003|Overall Study|Withdrawal by Subject|7|||
149210490|NCT01505114|538238094|FG000|Overall Study|Death|1|||
149210491|NCT01505114|538238095|FG001|Overall Study|Death|0|||
149210492|NCT01505114|538238096|FG002|Overall Study|Death|0|||
149210493|NCT01505114|538238097|FG003|Overall Study|Death|1|||
149210494|NCT01505114|538238094|FG000|Overall Study|unable to adhere to visit schedule|3|||
149210495|NCT01505114|538238095|FG001|Overall Study|unable to adhere to visit schedule|2|||
149210496|NCT01505114|538238096|FG002|Overall Study|unable to adhere to visit schedule|3|||
149210497|NCT01505114|538238097|FG003|Overall Study|unable to adhere to visit schedule|3|||
149210498|NCT01505114|538238094|FG000|Overall Study|Lost to Follow-up|11|||
149210499|NCT01505114|538238095|FG001|Overall Study|Lost to Follow-up|5|||
149210500|NCT01505114|538238096|FG002|Overall Study|Lost to Follow-up|8|||
149210501|NCT01505114|538238097|FG003|Overall Study|Lost to Follow-up|7|||
149210502|NCT01505114|538238094|FG000|Overall Study|relocated|4|||
149210503|NCT01505114|538238095|FG001|Overall Study|relocated|2|||
149210504|NCT01505114|538238096|FG002|Overall Study|relocated|2|||
149210505|NCT01505114|538238097|FG003|Overall Study|relocated|3|||
149210506|NCT01505114|538238094|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
149210507|NCT01505114|538238095|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
149210508|NCT01505114|538238096|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
149210509|NCT01505114|538238097|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
149210510|NCT01505114|538238094|FG000|Overall Study|staff safety concerns|0|||
149210511|NCT01505114|538238095|FG001|Overall Study|staff safety concerns|0|||
149210512|NCT01505114|538238096|FG002|Overall Study|staff safety concerns|0|||
149210513|NCT01505114|538238097|FG003|Overall Study|staff safety concerns|1|||
149210514|NCT01505114|538238094|FG000|Overall Study|investigator decision|1|||
149210515|NCT01505114|538238095|FG001|Overall Study|investigator decision|0|||
149210516|NCT01505114|538238096|FG002|Overall Study|investigator decision|1|||
149210517|NCT01505114|538238097|FG003|Overall Study|investigator decision|0|||
149210518|NCT03168555|538238098|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
149210519|NCT03168555|538238098|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
149210520|NCT03168555|538238098|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
149210521|NCT03168555|538238098|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
149210522|NCT01732107|538238101|FG000|Overall Study|Adverse Event|2|||
149210523|NCT01732107|538238101|FG000|Overall Study|Disease Progression|8|||
149210524|NCT01732107|538238101|FG000|Overall Study|Physician Decision|1|||
149210525|NCT01732107|538238101|FG000|Overall Study|Withdrawal by Subject|2|||
149210526|NCT01963780|538238106|FG000|Overall Study|Death|7|||
149210527|NCT01749800|538238107|FG000|Overall Study|not meeting inclusion criteria|3|||
149210528|NCT01749800|538238108|FG001|Overall Study|not meeting inclusion criteria|0|||
149210529|NCT01749800|538238109|FG002|Overall Study|not meeting inclusion criteria|0|||
149210530|NCT01749800|538238107|FG000|Overall Study|Withdrawal by Subject|0|||
149210531|NCT01749800|538238108|FG001|Overall Study|Withdrawal by Subject|1|||
149210532|NCT01749800|538238109|FG002|Overall Study|Withdrawal by Subject|0|||
149210533|NCT01000025|538238113|FG000|Overall Study|Adverse Event|43|||
149210534|NCT01000025|538238114|FG001|Overall Study|Adverse Event|2|||
149210535|NCT01000025|538238113|FG000|Overall Study|Withdrawal by Subject|13|||
149210536|NCT01000025|538238114|FG001|Overall Study|Withdrawal by Subject|8|||
149210537|NCT01000025|538238113|FG000|Overall Study|Death|23|||
149210538|NCT01000025|538238114|FG001|Overall Study|Death|13|||
149210539|NCT01000025|538238113|FG000|Overall Study|Lack of Efficacy|363|||
149210540|NCT01000025|538238114|FG001|Overall Study|Lack of Efficacy|208|||
149210541|NCT01000025|538238113|FG000|Overall Study|Intercurrent Illness|26|||
149210542|NCT01000025|538238114|FG001|Overall Study|Intercurrent Illness|7|||
149210543|NCT04423757|538238115|FG000|Overall Study|Adverse Event|2|||
149210544|NCT04423757|538238116|FG001|Overall Study|Adverse Event|0|||
149210545|NCT04423757|538238115|FG000|Overall Study|Not treated|1|||
149210546|NCT04423757|538238116|FG001|Overall Study|Not treated|1|||
149210547|NCT02738580|538238117|FG000|Overall Study|Adverse Event|1|||
149210548|NCT02738580|538238118|FG001|Overall Study|Adverse Event|0|||
149210549|NCT02738580|538238117|FG000|Overall Study|Lack of Efficacy|3|||
149210550|NCT02738580|538238118|FG001|Overall Study|Lack of Efficacy|2|||
149210551|NCT02738580|538238117|FG000|Overall Study|Withdrawal by Subject|0|||
149210552|NCT02738580|538238118|FG001|Overall Study|Withdrawal by Subject|1|||
149210553|NCT02738580|538238117|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
149210554|NCT02738580|538238118|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
149210555|NCT01250756|538238121|FG000|Infant Series|Withdrawal by Subject|4|||
149210556|NCT01250756|538238122|FG001|Infant Series|Withdrawal by Subject|5|||
149210557|NCT01250756|538238121|FG000|Infant Series|Randomized, Not Vaccinated|2|||
149210558|NCT01250756|538238122|FG001|Infant Series|Randomized, Not Vaccinated|2|||
149210559|NCT01250756|538238121|FG000|Infant Series|Other|22|||
149210560|NCT01250756|538238122|FG001|Infant Series|Other|0|||
149210561|NCT01250756|538238121|FG000|After Infant Series|Adverse Event|5|||
149210562|NCT01250756|538238122|FG001|After Infant Series|Adverse Event|2|||
149210563|NCT01250756|538238121|FG000|After Infant Series|Withdrawal by Subject|4|||
149210564|NCT01250756|538238122|FG001|After Infant Series|Withdrawal by Subject|1|||
149210565|NCT01250756|538238121|FG000|After Infant Series|Other|2|||
149210566|NCT01250756|538238122|FG001|After Infant Series|Other|1|||
149210567|NCT01250756|538238121|FG000|Toddler Dose|Adverse Event|0|||
149210568|NCT01250756|538238122|FG001|Toddler Dose|Adverse Event|1|||
149210569|NCT01250756|538238121|FG000|After Toddler Dose|Adverse Event|0|||
149210570|NCT01250756|538238122|FG001|After Toddler Dose|Adverse Event|1|||
149210571|NCT02999100|538238123|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
149210572|NCT02999100|538238124|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
149210573|NCT02999100|538238125|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
149210574|NCT02999100|538238126|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
149210575|NCT02999100|538238127|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
149210576|NCT02999100|538238128|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
149210577|NCT02999100|538238123|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149210578|NCT02999100|538238124|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149210579|NCT02999100|538238125|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149210580|NCT02999100|538238126|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149210581|NCT02999100|538238127|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
149210582|NCT02999100|538238128|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
149210583|NCT02999100|538238123|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149210584|NCT02999100|538238124|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149210585|NCT02999100|538238125|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
149210586|NCT02999100|538238126|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149210587|NCT02999100|538238127|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149210588|NCT02999100|538238128|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
149210589|NCT00293241|538238129|FG000|Overall Study|Lost to Follow-up|9|||
149210590|NCT00293241|538238130|FG001|Overall Study|Lost to Follow-up|16|||
149210591|NCT00293241|538238129|FG000|Overall Study|Physician Decision|23|||
149210592|NCT00293241|538238130|FG001|Overall Study|Physician Decision|17|||
149210593|NCT00293241|538238129|FG000|Overall Study|Withdrawal by Subject|4|||
149210594|NCT00293241|538238130|FG001|Overall Study|Withdrawal by Subject|8|||
149210595|NCT03803202|538238131|FG000|Overall Study|Other|0|||
149210596|NCT03803202|538238132|FG001|Overall Study|Other|1|||
149210597|NCT03803202|538238133|FG002|Overall Study|Other|0|||
149210598|NCT03803202|538238134|FG003|Overall Study|Other|0|||
149210599|NCT03803202|538238135|FG004|Overall Study|Other|0|||
149210600|NCT03803202|538238136|FG005|Overall Study|Other|0|||
149210601|NCT03803202|538238137|FG006|Overall Study|Other|0|||
149210602|NCT03803202|538238138|FG007|Overall Study|Other|0|||
149210603|NCT03803202|538238139|FG008|Overall Study|Other|0|||
149210604|NCT03803202|538238131|FG000|Overall Study|Death|0|||
149210605|NCT03803202|538238132|FG001|Overall Study|Death|0|||
149210606|NCT03803202|538238133|FG002|Overall Study|Death|0|||
149210607|NCT03803202|538238134|FG003|Overall Study|Death|0|||
149210608|NCT03803202|538238135|FG004|Overall Study|Death|0|||
149210609|NCT03803202|538238136|FG005|Overall Study|Death|1|||
149210610|NCT03803202|538238137|FG006|Overall Study|Death|0|||
149210611|NCT03803202|538238138|FG007|Overall Study|Death|0|||
149210612|NCT03803202|538238139|FG008|Overall Study|Death|0|||
149210613|NCT03803202|538238131|FG000|Overall Study|Withdrawal by Subject|0|||
149210614|NCT03803202|538238132|FG001|Overall Study|Withdrawal by Subject|0|||
149210615|NCT03803202|538238133|FG002|Overall Study|Withdrawal by Subject|1|||
149210616|NCT03803202|538238134|FG003|Overall Study|Withdrawal by Subject|0|||
149210617|NCT03803202|538238135|FG004|Overall Study|Withdrawal by Subject|0|||
149210618|NCT03803202|538238136|FG005|Overall Study|Withdrawal by Subject|0|||
149210619|NCT03803202|538238137|FG006|Overall Study|Withdrawal by Subject|0|||
149210620|NCT03803202|538238138|FG007|Overall Study|Withdrawal by Subject|1|||
149210621|NCT03803202|538238139|FG008|Overall Study|Withdrawal by Subject|0|||
149210622|NCT03803202|538238131|FG000|Overall Study|Lost to Follow-up|0|||
149210623|NCT03803202|538238132|FG001|Overall Study|Lost to Follow-up|0|||
149210624|NCT03803202|538238133|FG002|Overall Study|Lost to Follow-up|0|||
149210625|NCT03803202|538238134|FG003|Overall Study|Lost to Follow-up|1|||
149210626|NCT03803202|538238135|FG004|Overall Study|Lost to Follow-up|1|||
149210627|NCT03803202|538238136|FG005|Overall Study|Lost to Follow-up|0|||
149210628|NCT03803202|538238137|FG006|Overall Study|Lost to Follow-up|1|||
149210629|NCT03803202|538238138|FG007|Overall Study|Lost to Follow-up|0|||
149210630|NCT03803202|538238139|FG008|Overall Study|Lost to Follow-up|0|||
149210631|NCT03595384|538238140|FG000|Overall Study|Other time commitments|8|||
149210632|NCT03595384|538238140|FG000|Overall Study|Changes to session time|7|||
149210633|NCT03595384|538238140|FG000|Overall Study|Relocation out of country|1|||
149210634|NCT01270958|538238144|FG000|Overall Study|Lost to Follow-up|2|||
149210635|NCT01270958|538238144|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
149210636|NCT02142504|538238145|FG000|Overall Study|Protocol Violation|2|||
149210637|NCT02142504|538238146|FG001|Overall Study|Protocol Violation|1|||
149210638|NCT02142504|538238147|FG002|Overall Study|Protocol Violation|2|||
149210639|NCT02142504|538238145|FG000|Overall Study|Adverse Event|2|||
149210640|NCT02142504|538238146|FG001|Overall Study|Adverse Event|3|||
149210641|NCT02142504|538238147|FG002|Overall Study|Adverse Event|4|||
149210642|NCT02142504|538238145|FG000|Overall Study|Lost to Follow-up|12|||
149210643|NCT02142504|538238146|FG001|Overall Study|Lost to Follow-up|19|||
149210644|NCT02142504|538238147|FG002|Overall Study|Lost to Follow-up|17|||
149210645|NCT02142504|538238145|FG000|Overall Study|Withdrawal by Subject|7|||
149210646|NCT02142504|538238146|FG001|Overall Study|Withdrawal by Subject|9|||
149210647|NCT02142504|538238147|FG002|Overall Study|Withdrawal by Subject|11|||
149210648|NCT02142504|538238145|FG000|Overall Study|Pregnancy|4|||
149210649|NCT02142504|538238146|FG001|Overall Study|Pregnancy|4|||
149210650|NCT02142504|538238147|FG002|Overall Study|Pregnancy|2|||
149210651|NCT02142504|538238145|FG000|Overall Study|Physician Decision|0|||
149210652|NCT02142504|538238146|FG001|Overall Study|Physician Decision|1|||
149210653|NCT02142504|538238147|FG002|Overall Study|Physician Decision|3|||
149210654|NCT02142504|538238145|FG000|Overall Study|Reason Not Specified|4|||
149210655|NCT02142504|538238146|FG001|Overall Study|Reason Not Specified|5|||
149210656|NCT02142504|538238147|FG002|Overall Study|Reason Not Specified|4|||
149210657|NCT00617591|538238148|FG000|Overall Study|Withdrew consent during Induction|4|||
149210658|NCT00617591|538238148|FG000|Overall Study|Withdrew consent during Maintenance|6|||
149210659|NCT04114539|538238150|FG000|Overall Study|Adverse Event|14|||
149210660|NCT04114539|538238150|FG000|Overall Study|Lost to Follow-up|2|||
149210661|NCT04114539|538238150|FG000|Overall Study|Non-compliance with Protocol|2|||
149210662|NCT04114539|538238150|FG000|Overall Study|Non-compliance with Study Drug|1|||
149210663|NCT04114539|538238150|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
149210664|NCT04114539|538238150|FG000|Overall Study|Withdrew consent|10|||
149210665|NCT04114539|538238150|FG000|Overall Study|Others not specified|5|||
149210666|NCT04114539|538238150|FG000|Overall Study|Investigator Decision|2|||
149210667|NCT03094611|538238156|FG000|Overall Study|Lack of Efficacy|1|||
149210668|NCT03094611|538238156|FG000|Overall Study|Stem Cell Transplant|1|||
149210669|NCT02186561|538238157|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
149210670|NCT02186561|538238157|FG000|Enrollment|Enrollment Cap Reached|5|||
149210671|NCT02186561|538238157|FG000|Enrollment|Insurance Denial|2|||
149210672|NCT02186561|538238157|FG000|Enrollment|Withdrawal by Subject|2|||
149210673|NCT02186561|538238157|FG000|Enrollment|Investigator Withdrew Consent|1|||
149210674|NCT02186561|538238157|FG000|30-Day Post Index Procedure Visit|Death|1|||
149210675|NCT02186561|538238157|FG000|1- Year Post Index Procedure Visit|Death|1|||
149210676|NCT02186561|538238157|FG000|1- Year Post Index Procedure Visit|Missed|1|||
149210677|NCT04285853|538238158|FG000|Overall Study|Withdrawal by Subject|1|||
149210678|NCT04285853|538238159|FG001|Overall Study|Withdrawal by Subject|0|||
149210679|NCT04285853|538238158|FG000|Overall Study|Lost to Follow-up|9|||
149210680|NCT04285853|538238159|FG001|Overall Study|Lost to Follow-up|5|||
149210681|NCT02460978|538238162|FG000|Overall Study|Adverse Event|17|||
149210682|NCT02460978|538238163|FG001|Overall Study|Adverse Event|11|||
149210683|NCT02460978|538238164|FG002|Overall Study|Adverse Event|11|||
149210684|NCT02460978|538238162|FG000|Overall Study|Withdrawal by Subject|5|||
149210685|NCT02460978|538238163|FG001|Overall Study|Withdrawal by Subject|5|||
149210686|NCT02460978|538238164|FG002|Overall Study|Withdrawal by Subject|14|||
149210687|NCT02460978|538238162|FG000|Overall Study|Lost to Follow-up|2|||
149210688|NCT02460978|538238163|FG001|Overall Study|Lost to Follow-up|3|||
149210689|NCT02460978|538238164|FG002|Overall Study|Lost to Follow-up|1|||
149210690|NCT02460978|538238162|FG000|Overall Study|Protocol Violation|1|||
149210691|NCT02460978|538238163|FG001|Overall Study|Protocol Violation|1|||
148949880|NCT03129100|537299653|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
149210692|NCT02460978|538238164|FG002|Overall Study|Protocol Violation|1|||
149210693|NCT02460978|538238162|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
149210694|NCT02460978|538238163|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
149210695|NCT02460978|538238164|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
149210696|NCT02460978|538238162|FG000|Overall Study|Pregnancy|0|||
149210697|NCT02460978|538238163|FG001|Overall Study|Pregnancy|0|||
149210698|NCT02460978|538238164|FG002|Overall Study|Pregnancy|2|||
149210699|NCT00588523|538238168|FG000|Overall Study|Not treated|3|||
149210700|NCT01459068|538238169|FG000|Overall Study|Withdrawal by Subject|8|||
149210701|NCT01459068|538238170|FG001|Overall Study|Withdrawal by Subject|18|||
149210702|NCT01459068|538238169|FG000|Overall Study|Lost to Follow-up|31|||
149210703|NCT01459068|538238170|FG001|Overall Study|Lost to Follow-up|15|||
149210704|NCT01459068|538238169|FG000|Overall Study|Death|0|||
149210705|NCT01459068|538238170|FG001|Overall Study|Death|1|||
149210706|NCT02023112|538238175|FG000|Overall Study|Withdrawal by Subject|2|||
149210707|NCT02023112|538238176|FG001|Overall Study|Withdrawal by Subject|1|||
149210708|NCT00701441|538238177|FG000|Overall Study|failure in cpap compliance|0|||
149210709|NCT00701441|538238178|FG001|Overall Study|failure in cpap compliance|4|||
149210710|NCT01225172|538238182|FG000|Overall Study|Subject decision to stop|1|||
149210711|NCT01225172|538238183|FG001|Overall Study|Subject decision to stop|0|||
149210712|NCT01225172|538238182|FG000|Overall Study|Subject request to discontinue treatment|3|||
149210713|NCT01225172|538238183|FG001|Overall Study|Subject request to discontinue treatment|1|||
149210714|NCT01225172|538238182|FG000|Overall Study|Subject no longer meets study criteria|1|||
149210715|NCT01225172|538238183|FG001|Overall Study|Subject no longer meets study criteria|0|||
149210716|NCT01225172|538238182|FG000|Overall Study|Withdrawal by Subject|1|||
149210717|NCT01225172|538238183|FG001|Overall Study|Withdrawal by Subject|0|||
149210718|NCT03404518|538238190|FG000|Overall Study|Lost to Follow-up|28|||
149210719|NCT03404518|538238191|FG001|Overall Study|Lost to Follow-up|30|||
149210720|NCT03404518|538238190|FG000|Overall Study|Protocol Violation|13|||
149210721|NCT03404518|538238191|FG001|Overall Study|Protocol Violation|6|||
149210722|NCT03693404|538238193|FG000|Overall Study|Withdrawal by Subject|1|||
149210723|NCT03693404|538238194|FG001|Overall Study|Withdrawal by Subject|0|||
149210724|NCT03693404|538238193|FG000|Overall Study|Lost to Follow-up|0|||
149210725|NCT03693404|538238194|FG001|Overall Study|Lost to Follow-up|5|||
149210726|NCT03693404|538238193|FG000|Overall Study|Excluded from Analysis|0|||
149210727|NCT03693404|538238194|FG001|Overall Study|Excluded from Analysis|1|||
149210728|NCT01576406|538238195|FG000|Overall Study|Lost to Follow-up|1|||
149210729|NCT01576406|538238196|FG001|Overall Study|Lost to Follow-up|2|||
149210730|NCT01576406|538238197|FG002|Overall Study|Lost to Follow-up|0|||
149210731|NCT01576406|538238198|FG003|Overall Study|Lost to Follow-up|0|||
149210732|NCT01576406|538238199|FG004|Overall Study|Lost to Follow-up|0|||
149210733|NCT01576406|538238200|FG005|Overall Study|Lost to Follow-up|0|||
149210734|NCT01576406|538238195|FG000|Overall Study|Death|3|||
149210735|NCT01576406|538238196|FG001|Overall Study|Death|4|||
149210736|NCT01576406|538238197|FG002|Overall Study|Death|8|||
149210737|NCT01576406|538238198|FG003|Overall Study|Death|5|||
149210738|NCT01576406|538238199|FG004|Overall Study|Death|7|||
149210739|NCT01576406|538238200|FG005|Overall Study|Death|9|||
149210740|NCT01576406|538238195|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149210741|NCT01576406|538238196|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149210742|NCT01576406|538238197|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
149210743|NCT01576406|538238198|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
149210744|NCT01576406|538238199|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149210745|NCT01576406|538238200|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
149210746|NCT01576406|538238195|FG000|Overall Study|Withdrawal the consent|2|||
149210747|NCT01576406|538238196|FG001|Overall Study|Withdrawal the consent|2|||
149210748|NCT01576406|538238197|FG002|Overall Study|Withdrawal the consent|5|||
148949881|NCT03129100|537299654|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
149210749|NCT01576406|538238198|FG003|Overall Study|Withdrawal the consent|1|||
149210750|NCT01576406|538238199|FG004|Overall Study|Withdrawal the consent|1|||
149210751|NCT01576406|538238200|FG005|Overall Study|Withdrawal the consent|3|||
149210752|NCT01576406|538238195|FG000|Overall Study|Other|0|||
149210753|NCT01576406|538238196|FG001|Overall Study|Other|0|||
149210754|NCT01576406|538238197|FG002|Overall Study|Other|2|||
149210755|NCT01576406|538238198|FG003|Overall Study|Other|2|||
149210756|NCT01576406|538238199|FG004|Overall Study|Other|0|||
149210757|NCT01576406|538238200|FG005|Overall Study|Other|0|||
149210758|NCT00651313|538238201|FG000|Overall Study|Adverse Event|0|||
149210759|NCT00651313|538238202|FG001|Overall Study|Adverse Event|1|||
149210760|NCT00651313|538238201|FG000|Overall Study|Withdrawal by Subject|3|||
149210761|NCT00651313|538238202|FG001|Overall Study|Withdrawal by Subject|1|||
149210762|NCT00651313|538238201|FG000|Overall Study|Lost to Follow-up|1|||
149210763|NCT00651313|538238202|FG001|Overall Study|Lost to Follow-up|1|||
149210764|NCT00651313|538238201|FG000|Overall Study|Adminstrative Discontinuation|2|||
149210765|NCT00651313|538238202|FG001|Overall Study|Adminstrative Discontinuation|3|||
149210766|NCT00892957|538238204|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
149210767|NCT00892957|538238205|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
148684282|NCT00910858|536316739|FG001|Monotherapy Phase|Protocol Violation|0|||
148684283|NCT00910858|536316740|FG002|Monotherapy Phase|Protocol Violation|0|||
148684284|NCT00910858|536316738|FG000|Monotherapy Phase|Other|3|||
148684285|NCT00910858|536316739|FG001|Monotherapy Phase|Other|4|||
148684286|NCT00910858|536316740|FG002|Monotherapy Phase|Other|2|||
148684287|NCT00910858|536316738|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
148684288|NCT00910858|536316739|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
148684289|NCT00910858|536316740|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
148684290|NCT00910858|536316738|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
148684291|NCT00910858|536316739|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
148684292|NCT00910858|536316740|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
148684293|NCT00910858|536316738|FG000|Combined Treatment Phase|Protocol Violation|1|||
148684294|NCT00910858|536316739|FG001|Combined Treatment Phase|Protocol Violation|0|||
148809340|NCT00973973|536779265|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
148809341|NCT00973973|536779266|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
149210768|NCT00892957|538238204|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
148684295|NCT00910858|536316740|FG002|Combined Treatment Phase|Protocol Violation|0|||
148684296|NCT00910858|536316738|FG000|Combined Treatment Phase|Other|0|||
148684297|NCT00910858|536316739|FG001|Combined Treatment Phase|Other|2|||
149210769|NCT00892957|538238205|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
149210770|NCT00669032|538238213|FG000|Overall Study|Lost to Follow-up|6|||
149210771|NCT00669032|538238214|FG001|Overall Study|Lost to Follow-up|5|||
149210772|NCT00669032|538238213|FG000|Overall Study|Lack of Efficacy|8|||
149210773|NCT00669032|538238214|FG001|Overall Study|Lack of Efficacy|19|||
149210774|NCT00669032|538238213|FG000|Overall Study|Withdrawal by Subject|12|||
149210775|NCT00669032|538238214|FG001|Overall Study|Withdrawal by Subject|13|||
149210776|NCT00669032|538238213|FG000|Overall Study|Adverse Event|12|||
149210777|NCT00669032|538238214|FG001|Overall Study|Adverse Event|16|||
149210778|NCT00669032|538238213|FG000|Overall Study|Physician Decision|1|||
149210779|NCT00669032|538238214|FG001|Overall Study|Physician Decision|1|||
149210780|NCT00669032|538238213|FG000|Overall Study|No fulfilment of the selection criteria|5|||
149210781|NCT00669032|538238214|FG001|Overall Study|No fulfilment of the selection criteria|5|||
149210782|NCT00642018|538238215|FG000|Overall Study|Adverse Event|11|||
149210783|NCT00642018|538238216|FG001|Overall Study|Adverse Event|36|||
149210784|NCT00642018|538238215|FG000|Overall Study|Withdrawal by Subject|4|||
149210785|NCT00642018|538238216|FG001|Overall Study|Withdrawal by Subject|10|||
149210786|NCT00642018|538238215|FG000|Overall Study|Progressive Disease|13|||
149210787|NCT00642018|538238216|FG001|Overall Study|Progressive Disease|18|||
149210788|NCT00642018|538238215|FG000|Overall Study|Physician Decision|0|||
149210789|NCT00642018|538238216|FG001|Overall Study|Physician Decision|10|||
149210790|NCT00642018|538238215|FG000|Overall Study|Protocol Violation|0|||
149210791|NCT00642018|538238216|FG001|Overall Study|Protocol Violation|1|||
149210792|NCT00642018|538238215|FG000|Overall Study|Death|0|||
149210793|NCT00642018|538238216|FG001|Overall Study|Death|3|||
149210794|NCT00642018|538238215|FG000|Overall Study|Entry Criteria Not Met|0|||
149210795|NCT00642018|538238216|FG001|Overall Study|Entry Criteria Not Met|1|||
149210796|NCT01607073|538238217|FG000|Overall Study|Adverse Event|1|||
149210797|NCT01410799|538238218|FG000|Overall Study|PI decision|13|||
149210798|NCT04126031|538238220|FG000|Part A|Withdrawal by Subject|0|||
149210799|NCT04126031|538238221|FG001|Part A|Withdrawal by Subject|0|||
149210800|NCT04126031|538238222|FG002|Part A|Withdrawal by Subject|1|||
149210801|NCT04126031|538238223|FG003|Part A|Withdrawal by Subject|0|||
149210802|NCT04126031|538238224|FG004|Part A|Withdrawal by Subject|0|||
149210803|NCT04126031|538238225|FG005|Part A|Withdrawal by Subject|0|||
149210804|NCT04126031|538238220|FG000|Part A|Other|1|||
149210805|NCT04126031|538238221|FG001|Part A|Other|0|||
149210806|NCT04126031|538238222|FG002|Part A|Other|0|||
149210807|NCT04126031|538238223|FG003|Part A|Other|0|||
149210808|NCT04126031|538238224|FG004|Part A|Other|0|||
149210809|NCT04126031|538238225|FG005|Part A|Other|0|||
149210810|NCT04126031|538238220|FG000|Part B|Adverse Event|0|||
149210811|NCT04126031|538238221|FG001|Part B|Adverse Event|0|||
149210812|NCT04126031|538238222|FG002|Part B|Adverse Event|0|||
149210813|NCT04126031|538238223|FG003|Part B|Adverse Event|0|||
149210814|NCT04126031|538238224|FG004|Part B|Adverse Event|0|||
149210815|NCT04126031|538238225|FG005|Part B|Adverse Event|2|||
149210816|NCT04126031|538238220|FG000|Part B|Pre-existing hypertransaminasemia|0|||
149210817|NCT04126031|538238221|FG001|Part B|Pre-existing hypertransaminasemia|0|||
149210818|NCT04126031|538238222|FG002|Part B|Pre-existing hypertransaminasemia|0|||
149210819|NCT04126031|538238223|FG003|Part B|Pre-existing hypertransaminasemia|0|||
149210820|NCT04126031|538238224|FG004|Part B|Pre-existing hypertransaminasemia|1|||
149210821|NCT04126031|538238225|FG005|Part B|Pre-existing hypertransaminasemia|0|||
149210822|NCT00131664|538238226|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
149210823|NCT00131664|538238227|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
149210824|NCT00131664|538238228|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
149210825|NCT00131664|538238229|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
149210826|NCT00131664|538238230|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
149210827|NCT00131664|538238231|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
149210828|NCT00131664|538238226|FG000|First Period (First 6 Months)|Death|0|||
149210829|NCT00131664|538238227|FG001|First Period (First 6 Months)|Death|1|||
149210830|NCT00131664|538238228|FG002|First Period (First 6 Months)|Death|0|||
149210831|NCT00131664|538238229|FG003|First Period (First 6 Months)|Death|0|||
149210832|NCT00131664|538238230|FG004|First Period (First 6 Months)|Death|0|||
149210833|NCT00131664|538238231|FG005|First Period (First 6 Months)|Death|0|||
149210834|NCT00131664|538238226|FG000|First Period (First 6 Months)|Protocol Violation|2|||
149210835|NCT00131664|538238227|FG001|First Period (First 6 Months)|Protocol Violation|2|||
149210836|NCT00131664|538238228|FG002|First Period (First 6 Months)|Protocol Violation|1|||
149210837|NCT00131664|538238229|FG003|First Period (First 6 Months)|Protocol Violation|0|||
149210838|NCT00131664|538238230|FG004|First Period (First 6 Months)|Protocol Violation|0|||
149210839|NCT00131664|538238231|FG005|First Period (First 6 Months)|Protocol Violation|0|||
149210840|NCT00131664|538238226|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
149210841|NCT00131664|538238227|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
149210842|NCT00131664|538238228|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
149210843|NCT00131664|538238229|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
149210844|NCT00131664|538238230|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
149210845|NCT00131664|538238231|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
149210846|NCT00131664|538238226|FG000|First Period (First 6 Months)|Adverse Event|9|||
149210847|NCT00131664|538238227|FG001|First Period (First 6 Months)|Adverse Event|4|||
149210848|NCT00131664|538238228|FG002|First Period (First 6 Months)|Adverse Event|5|||
149210849|NCT00131664|538238229|FG003|First Period (First 6 Months)|Adverse Event|0|||
149210850|NCT00131664|538238230|FG004|First Period (First 6 Months)|Adverse Event|0|||
149210851|NCT00131664|538238231|FG005|First Period (First 6 Months)|Adverse Event|0|||
149210852|NCT00131664|538238226|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
149210853|NCT00131664|538238227|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
149210854|NCT00131664|538238228|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149210855|NCT00131664|538238229|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149210856|NCT00131664|538238230|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149210857|NCT00131664|538238231|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
149210858|NCT00131664|538238226|FG000|First Period (First 6 Months)|Administrative reasons|2|||
149210859|NCT00131664|538238227|FG001|First Period (First 6 Months)|Administrative reasons|0|||
148684298|NCT00910858|536316740|FG002|Combined Treatment Phase|Other|1|||
149210860|NCT00131664|538238228|FG002|First Period (First 6 Months)|Administrative reasons|5|||
149210861|NCT00131664|538238229|FG003|First Period (First 6 Months)|Administrative reasons|0|||
149210862|NCT00131664|538238230|FG004|First Period (First 6 Months)|Administrative reasons|0|||
149210863|NCT00131664|538238231|FG005|First Period (First 6 Months)|Administrative reasons|0|||
149210864|NCT00131664|538238226|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
149210865|NCT00131664|538238227|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
149210866|NCT00131664|538238228|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
149210867|NCT00131664|538238229|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
149210868|NCT00131664|538238230|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
149210869|NCT00131664|538238231|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
149210870|NCT00131664|538238226|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
149210871|NCT00131664|538238227|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
149210872|NCT00131664|538238228|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
149210873|NCT00131664|538238229|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
149210874|NCT00131664|538238230|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
149210875|NCT00131664|538238231|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
149210876|NCT00131664|538238226|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
149210877|NCT00131664|538238227|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149210878|NCT00131664|538238228|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149210879|NCT00131664|538238229|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149210880|NCT00131664|538238230|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149210881|NCT00131664|538238231|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
149210882|NCT00131664|538238226|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
149210883|NCT00131664|538238227|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
149210884|NCT00131664|538238228|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
149210885|NCT00131664|538238229|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
149210886|NCT00131664|538238230|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
148684299|NCT00827827|536316741|FG000|Overall Study|Lost to Follow-up|3|||
148684300|NCT00827827|536316742|FG001|Overall Study|Lost to Follow-up|0|||
148684301|NCT00827827|536316741|FG000|Overall Study|Fall at home- hospitalization|1|||
148684302|NCT00827827|536316742|FG001|Overall Study|Fall at home- hospitalization|0|||
148684303|NCT00827827|536316741|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
148684304|NCT00827827|536316742|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
148684305|NCT00827827|536316741|FG000|Overall Study|Gout|1|||
148684306|NCT00827827|536316742|FG001|Overall Study|Gout|0|||
148684307|NCT00827827|536316741|FG000|Overall Study|Transportation issues|1|||
148684308|NCT00827827|536316742|FG001|Overall Study|Transportation issues|0|||
148684309|NCT00827827|536316741|FG000|Overall Study|Burned with water at home|1|||
148684310|NCT00827827|536316742|FG001|Overall Study|Burned with water at home|0|||
148684311|NCT00447603|536316749|FG000|Screening|Withdrawal by Subject|1|||
148684312|NCT00447603|536316750|FG001|Screening|Withdrawal by Subject|0|||
148684313|NCT00447603|536316751|FG002|Screening|Withdrawal by Subject|0|||
148684314|NCT00447603|536316749|FG000|Screening|Protocol Violation|1|||
149210887|NCT00131664|538238231|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
149210888|NCT00131664|538238226|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149210889|NCT00131664|538238227|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149210890|NCT00131664|538238228|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
148684315|NCT00447603|536316750|FG001|Screening|Protocol Violation|0|||
148684316|NCT00447603|536316751|FG002|Screening|Protocol Violation|0|||
148684317|NCT00447603|536316749|FG000|Screening|Screen Failure|4|||
148684318|NCT00447603|536316750|FG001|Screening|Screen Failure|0|||
148684319|NCT00447603|536316751|FG002|Screening|Screen Failure|0|||
148684320|NCT00447603|536316749|FG000|Screening|Study Terminated by Sponsor|15|||
148949882|NCT03129100|537299655|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949883|NCT03129100|537299656|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949884|NCT03129100|537299657|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
148949885|NCT03129100|537299658|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
149210891|NCT00131664|538238229|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
149210892|NCT00131664|538238230|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149210893|NCT00131664|538238231|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
149210894|NCT00131664|538238226|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
149210895|NCT00131664|538238227|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
149210896|NCT00131664|538238228|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
149210897|NCT00131664|538238229|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
149210898|NCT00131664|538238230|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
149210899|NCT00131664|538238231|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
149210900|NCT01946412|538238232|FG000|Overall Study|Adverse Event|1|||
149210901|NCT01946412|538238232|FG000|Overall Study|Non-Compliance|1|||
149210902|NCT01946412|538238232|FG000|Overall Study|Continued with commercial Kalydeco|2|||
149210903|NCT01946412|538238232|FG000|Overall Study|Difficulty in swallowing|1|||
149210904|NCT00617656|538238233|FG000|Overall Study|Inclusion error|4|||
149210905|NCT00617656|538238234|FG001|Overall Study|Inclusion error|4|||
149210906|NCT00617656|538238235|FG002|Overall Study|Inclusion error|0|||
149210907|NCT00617656|538238236|FG003|Overall Study|Inclusion error|0|||
149210908|NCT00617656|538238233|FG000|Overall Study|Missing data|44|||
149210909|NCT00617656|538238234|FG001|Overall Study|Missing data|30|||
149210910|NCT00617656|538238235|FG002|Overall Study|Missing data|13|||
149210911|NCT00617656|538238236|FG003|Overall Study|Missing data|6|||
149210912|NCT00617656|538238233|FG000|Overall Study|Withdrawal by Subject|0|||
149210913|NCT00617656|538238234|FG001|Overall Study|Withdrawal by Subject|2|||
149210914|NCT00617656|538238235|FG002|Overall Study|Withdrawal by Subject|0|||
149210915|NCT00617656|538238236|FG003|Overall Study|Withdrawal by Subject|0|||
149210916|NCT03906136|538240240|FG000|Overall Study|Adverse Event|1|||
149210917|NCT03906136|538240241|FG001|Overall Study|Adverse Event|0|||
149210918|NCT03906136|538240240|FG000|Overall Study|Lost to Follow-up|7|||
149210919|NCT03906136|538240241|FG001|Overall Study|Lost to Follow-up|4|||
149210920|NCT03906136|538240240|FG000|Overall Study|Physician Decision|1|||
149210921|NCT03906136|538240241|FG001|Overall Study|Physician Decision|0|||
149210922|NCT03906136|538240240|FG000|Overall Study|Withdrawal by Subject|3|||
149210923|NCT03906136|538240241|FG001|Overall Study|Withdrawal by Subject|7|||
149210924|NCT02371980|538240249|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
149210925|NCT02371980|538240250|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
149210926|NCT02371980|538240251|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
149210927|NCT02371980|538240252|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
149210928|NCT02371980|538240253|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
149210929|NCT02371980|538240249|FG000|Open-label Period|Significant Protocol Deviation|19|||
149210930|NCT02371980|538240250|FG001|Open-label Period|Significant Protocol Deviation|0|||
149210931|NCT02371980|538240251|FG002|Open-label Period|Significant Protocol Deviation|0|||
149210932|NCT02371980|538240252|FG003|Open-label Period|Significant Protocol Deviation|0|||
149210933|NCT02371980|538240253|FG004|Open-label Period|Significant Protocol Deviation|0|||
149210934|NCT02371980|538240249|FG000|Open-label Period|Noncompliance with Study Drug|10|||
149210935|NCT02371980|538240250|FG001|Open-label Period|Noncompliance with Study Drug|0|||
149210936|NCT02371980|538240251|FG002|Open-label Period|Noncompliance with Study Drug|0|||
149210937|NCT02371980|538240252|FG003|Open-label Period|Noncompliance with Study Drug|0|||
149210938|NCT02371980|538240253|FG004|Open-label Period|Noncompliance with Study Drug|0|||
149210939|NCT02371980|538240249|FG000|Open-label Period|Lost to Follow-up|55|||
149210940|NCT02371980|538240250|FG001|Open-label Period|Lost to Follow-up|0|||
149210941|NCT02371980|538240251|FG002|Open-label Period|Lost to Follow-up|0|||
149210942|NCT02371980|538240252|FG003|Open-label Period|Lost to Follow-up|0|||
149210943|NCT02371980|538240253|FG004|Open-label Period|Lost to Follow-up|0|||
149210944|NCT02371980|538240249|FG000|Open-label Period|Voluntary Withdrawal|91|||
149210945|NCT02371980|538240250|FG001|Open-label Period|Voluntary Withdrawal|0|||
149210946|NCT02371980|538240251|FG002|Open-label Period|Voluntary Withdrawal|0|||
149210947|NCT02371980|538240252|FG003|Open-label Period|Voluntary Withdrawal|0|||
149210948|NCT02371980|538240253|FG004|Open-label Period|Voluntary Withdrawal|0|||
149210949|NCT02371980|538240249|FG000|Open-label Period|Pregnancy|1|||
149210950|NCT02371980|538240250|FG001|Open-label Period|Pregnancy|0|||
148949886|NCT03129100|537299659|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
149210951|NCT02371980|538240251|FG002|Open-label Period|Pregnancy|0|||
149210952|NCT02371980|538240252|FG003|Open-label Period|Pregnancy|0|||
149210953|NCT02371980|538240253|FG004|Open-label Period|Pregnancy|0|||
149210954|NCT02371980|538240249|FG000|Open-label Period|Lack of Efficacy|116|||
148949887|NCT03129100|537299660|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949888|NCT03129100|537299661|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949889|NCT03129100|537299662|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949890|NCT03129100|537299663|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949891|NCT03129100|537299664|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949892|NCT03129100|537299665|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949893|NCT03129100|537299666|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949894|NCT03129100|537299667|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949895|NCT03129100|537299668|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949896|NCT03129100|537299669|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949897|NCT03129100|537299670|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949898|NCT03129100|537299671|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949899|NCT03129100|537299672|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949900|NCT03129100|537299673|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949901|NCT03129100|537299674|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949902|NCT03129100|537299675|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949903|NCT03129100|537299676|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949904|NCT03129100|537299677|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949905|NCT03129100|537299678|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
148949906|NCT03129100|537299653|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949907|NCT03129100|537299654|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949908|NCT03129100|537299655|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949909|NCT03129100|537299656|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949910|NCT03129100|537299657|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949911|NCT03129100|537299658|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949912|NCT03129100|537299659|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949913|NCT03129100|537299660|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949914|NCT03129100|537299661|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949915|NCT03129100|537299662|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
148949916|NCT03129100|537299663|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949917|NCT03129100|537299664|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949918|NCT03129100|537299665|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949919|NCT03129100|537299666|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949920|NCT03129100|537299667|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949921|NCT03129100|537299668|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949922|NCT03129100|537299669|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949923|NCT03129100|537299670|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949924|NCT03129100|537299671|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949925|NCT03129100|537299672|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949926|NCT03129100|537299673|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949927|NCT03129100|537299674|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949928|NCT03129100|537299675|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949929|NCT03129100|537299676|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949930|NCT03129100|537299677|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949931|NCT03129100|537299678|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
148949932|NCT03129100|537299653|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949933|NCT03129100|537299654|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949934|NCT03129100|537299655|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949935|NCT03129100|537299656|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949936|NCT03129100|537299657|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949937|NCT03129100|537299658|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
149210955|NCT02371980|538240250|FG001|Open-label Period|Lack of Efficacy|0|||
149210956|NCT02371980|538240251|FG002|Open-label Period|Lack of Efficacy|0|||
149210957|NCT02371980|538240252|FG003|Open-label Period|Lack of Efficacy|0|||
149210958|NCT02371980|538240253|FG004|Open-label Period|Lack of Efficacy|0|||
149210959|NCT02371980|538240249|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
149210960|NCT02371980|538240250|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
149210961|NCT02371980|538240251|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
149210962|NCT02371980|538240252|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
149210963|NCT02371980|538240253|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
149210964|NCT02371980|538240249|FG000|Open-label Period|Reason not Specified|9|||
148809342|NCT00973973|536779265|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
148949938|NCT03129100|537299659|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949939|NCT03129100|537299660|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949940|NCT03129100|537299661|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949941|NCT03129100|537299662|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949942|NCT03129100|537299663|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949943|NCT03129100|537299664|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
148949944|NCT03129100|537299665|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949945|NCT03129100|537299666|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949946|NCT03129100|537299667|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949947|NCT03129100|537299668|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949948|NCT03129100|537299669|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949949|NCT03129100|537299670|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949950|NCT03129100|537299671|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949951|NCT03129100|537299672|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949952|NCT03129100|537299673|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949953|NCT03129100|537299674|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949954|NCT03129100|537299675|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949955|NCT03129100|537299676|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949956|NCT03129100|537299677|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
149210965|NCT02371980|538240250|FG001|Open-label Period|Reason not Specified|0|||
149210966|NCT02371980|538240251|FG002|Open-label Period|Reason not Specified|0|||
149210967|NCT02371980|538240252|FG003|Open-label Period|Reason not Specified|0|||
149210968|NCT02371980|538240253|FG004|Open-label Period|Reason not Specified|0|||
149210969|NCT02371980|538240249|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
149210970|NCT02371980|538240250|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
149210971|NCT02371980|538240251|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
149210972|NCT02371980|538240252|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
149210973|NCT02371980|538240253|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
149210974|NCT02371980|538240249|FG000|Double-blind Period|Significant Protocol Deviation|0|||
149210975|NCT02371980|538240250|FG001|Double-blind Period|Significant Protocol Deviation|2|||
149210976|NCT02371980|538240251|FG002|Double-blind Period|Significant Protocol Deviation|7|||
149210977|NCT02371980|538240252|FG003|Double-blind Period|Significant Protocol Deviation|3|||
149210978|NCT02371980|538240253|FG004|Double-blind Period|Significant Protocol Deviation|3|||
149210979|NCT02371980|538240249|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
149210980|NCT02371980|538240250|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
149210981|NCT02371980|538240251|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
149210982|NCT02371980|538240252|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
149210983|NCT02371980|538240253|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
149210984|NCT02371980|538240249|FG000|Double-blind Period|Lost to Follow-up|0|||
149210985|NCT02371980|538240250|FG001|Double-blind Period|Lost to Follow-up|8|||
149210986|NCT02371980|538240251|FG002|Double-blind Period|Lost to Follow-up|8|||
149210987|NCT02371980|538240252|FG003|Double-blind Period|Lost to Follow-up|6|||
149210988|NCT02371980|538240253|FG004|Double-blind Period|Lost to Follow-up|5|||
149210989|NCT02371980|538240249|FG000|Double-blind Period|Voluntary Withdrawal|0|||
149210990|NCT02371980|538240250|FG001|Double-blind Period|Voluntary Withdrawal|12|||
149210991|NCT02371980|538240251|FG002|Double-blind Period|Voluntary Withdrawal|8|||
149210992|NCT02371980|538240252|FG003|Double-blind Period|Voluntary Withdrawal|9|||
149210993|NCT02371980|538240253|FG004|Double-blind Period|Voluntary Withdrawal|11|||
149210994|NCT02371980|538240249|FG000|Double-blind Period|Relapse|0|||
149210995|NCT02371980|538240250|FG001|Double-blind Period|Relapse|50|||
149210996|NCT02371980|538240251|FG002|Double-blind Period|Relapse|25|||
149210997|NCT02371980|538240252|FG003|Double-blind Period|Relapse|25|||
149210998|NCT02371980|538240253|FG004|Double-blind Period|Relapse|26|||
149210999|NCT02371980|538240249|FG000|Double-blind Period|Reason not Specified|0|||
149211000|NCT02371980|538240250|FG001|Double-blind Period|Reason not Specified|3|||
149211001|NCT02371980|538240251|FG002|Double-blind Period|Reason not Specified|3|||
149211002|NCT02371980|538240252|FG003|Double-blind Period|Reason not Specified|2|||
148949957|NCT03129100|537299678|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
148949958|NCT03129100|537299653|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949959|NCT03129100|537299654|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
149211003|NCT02371980|538240253|FG004|Double-blind Period|Reason not Specified|1|||
149211004|NCT02371980|538240249|FG000|Double-blind Period|Missing|0|||
149211005|NCT02371980|538240250|FG001|Double-blind Period|Missing|1|||
149211006|NCT02371980|538240251|FG002|Double-blind Period|Missing|0|||
149211007|NCT02371980|538240252|FG003|Double-blind Period|Missing|0|||
149211008|NCT02371980|538240253|FG004|Double-blind Period|Missing|0|||
149211009|NCT00959894|538240254|FG000|Overall Study|Lost to Follow-up|10|||
149211010|NCT00959894|538240254|FG000|Overall Study|Adverse Event|3|||
149211011|NCT00959894|538240254|FG000|Overall Study|Withdrawal by Subject|1|||
149211012|NCT00959894|538240254|FG000|Overall Study|Need for contraindicated medication|1|||
149211013|NCT00959894|538240254|FG000|Overall Study|Subject moved out of town|1|||
149211014|NCT00922974|538240255|FG000|Phase II Component|Protocol Violation|2|||
149211015|NCT00922974|538240256|FG001|Phase II Component|Protocol Violation|0|||
149211016|NCT00922974|538240255|FG000|Phase II Component|Not evaluable for treatment review|5|||
149211017|NCT00922974|538240256|FG001|Phase II Component|Not evaluable for treatment review|0|||
149211018|NCT00922974|538240255|FG000|Phase III Component|Protocol Violation|8|||
149211019|NCT00922974|538240256|FG001|Phase III Component|Protocol Violation|6|||
149211020|NCT00446641|538240257|FG000|Overall Study|Withdrawal by Subject|8|||
149211021|NCT00446641|538240258|FG001|Overall Study|Withdrawal by Subject|3|||
149211022|NCT00446641|538240257|FG000|Overall Study|poor compliance|8|||
149211023|NCT00446641|538240258|FG001|Overall Study|poor compliance|6|||
149211024|NCT00446641|538240257|FG000|Overall Study|Lost to Follow-up|1|||
149211025|NCT00446641|538240258|FG001|Overall Study|Lost to Follow-up|1|||
149211026|NCT00405275|538240260|FG000|Overall Study|Death|1|||
149211027|NCT00405275|538240261|FG001|Overall Study|Death|0|||
149211028|NCT00405275|538240260|FG000|Overall Study|Lost to Follow-up|5|||
149211029|NCT00405275|538240261|FG001|Overall Study|Lost to Follow-up|1|||
149211030|NCT00405275|538240260|FG000|Overall Study|Withdrawal by Subject|7|||
149211031|NCT00405275|538240261|FG001|Overall Study|Withdrawal by Subject|9|||
149211032|NCT00405275|538240260|FG000|Overall Study|Unwilling to continue|10|||
149211033|NCT00405275|538240261|FG001|Overall Study|Unwilling to continue|9|||
149211034|NCT00088595|538240262|FG000|Overall Study|Adverse Event|11|||
149211035|NCT00088595|538240262|FG000|Overall Study|Withdrawal by Subject|8|||
149211036|NCT00088595|538240262|FG000|Overall Study|Ongoing (After Core)|7|||
149211037|NCT00088595|538240262|FG000|Overall Study|New Cancer Therapy|2|||
149211038|NCT01308853|538240273|FG000|Overall Study|Adverse Event|1|||
149211039|NCT01308853|538240273|FG000|Overall Study|Lost to Follow-up|2|||
149211040|NCT01308853|538240273|FG000|Overall Study|Insertion of permanent implants|1|||
149211041|NCT02959970|538240278|FG000|Overall Study|Adverse Event|1|||
149211042|NCT02959970|538240279|FG001|Overall Study|Adverse Event|0|||
149211043|NCT02959970|538240278|FG000|Overall Study|Withdrawal by Subject|0|||
149211044|NCT02959970|538240279|FG001|Overall Study|Withdrawal by Subject|2|||
149211045|NCT02959970|538240278|FG000|Overall Study|Lost to Follow-up|1|||
149211046|NCT02959970|538240279|FG001|Overall Study|Lost to Follow-up|5|||
149211047|NCT00693420|538240282|FG000|Overall Study|Adverse Event|4|||
149211048|NCT00693420|538240283|FG001|Overall Study|Adverse Event|4|||
149211049|NCT00693420|538240282|FG000|Overall Study|Lost to Follow-up|0|||
149211050|NCT00693420|538240283|FG001|Overall Study|Lost to Follow-up|3|||
149211051|NCT00693420|538240282|FG000|Overall Study|Withdrawal by Subject|1|||
149211052|NCT00693420|538240283|FG001|Overall Study|Withdrawal by Subject|0|||
148809343|NCT00973973|536779266|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
149211053|NCT00693420|538240282|FG000|Overall Study|Protocol Violation|0|||
149211054|NCT00693420|538240283|FG001|Overall Study|Protocol Violation|2|||
149211055|NCT00693420|538240282|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
149211056|NCT00693420|538240283|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
149211057|NCT00693420|538240282|FG000|Overall Study|Personal Reasons|1|||
149211058|NCT00693420|538240283|FG001|Overall Study|Personal Reasons|4|||
149211059|NCT02853123|538240284|FG000|Treatment Period 1|Adverse Event|0|||
149211060|NCT02853123|538240285|FG001|Treatment Period 1|Adverse Event|3|||
149211061|NCT02853123|538240284|FG000|Washout Period|Worsening of COPD|0|||
149211062|NCT02853123|538240285|FG001|Washout Period|Worsening of COPD|3|||
149211063|NCT02853123|538240284|FG000|Washout Period|Adverse Event|1|||
148809344|NCT00973973|536779265|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
149211064|NCT02853123|538240285|FG001|Washout Period|Adverse Event|0|||
149211065|NCT03250624|538240286|FG000|Overall Study|Lack of Efficacy|1|||
149211066|NCT03250624|538240287|FG001|Overall Study|Lack of Efficacy|4|||
149211067|NCT03250624|538240286|FG000|Overall Study|Adverse Event|0|||
149211068|NCT03250624|538240287|FG001|Overall Study|Adverse Event|1|||
149211069|NCT03250624|538240286|FG000|Overall Study|Other|1|||
149211070|NCT03250624|538240287|FG001|Overall Study|Other|2|||
149211071|NCT03805971|538240296|FG000|Overall Study|Withdrawal by Subject|1|||
149211072|NCT03805971|538240296|FG000|Overall Study|Protocol Violation|2|||
149211073|NCT00136357|538240306|FG000|Overall Study|Withdrawal by Subject|3|||
148949960|NCT03129100|537299655|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949961|NCT03129100|537299656|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
149211074|NCT00136357|538240307|FG001|Overall Study|Withdrawal by Subject|2|||
149211075|NCT01355497|538240308|FG000|Overall Study|Death|19|||
149211076|NCT01355497|538240309|FG001|Overall Study|Death|18|||
149211077|NCT01355497|538240308|FG000|Overall Study|Lost to Follow-up|3|||
149211078|NCT01355497|538240309|FG001|Overall Study|Lost to Follow-up|0|||
149211079|NCT01355497|538240308|FG000|Overall Study|Protocol Violation|0|||
149211080|NCT01355497|538240309|FG001|Overall Study|Protocol Violation|1|||
149211081|NCT01355497|538240308|FG000|Overall Study|other-not provided|9|||
149211082|NCT01355497|538240309|FG001|Overall Study|other-not provided|4|||
149211083|NCT01355497|538240308|FG000|Overall Study|Withdrawal by Subject|12|||
149211084|NCT01355497|538240309|FG001|Overall Study|Withdrawal by Subject|20|||
148949962|NCT03129100|537299657|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949963|NCT03129100|537299658|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949964|NCT03129100|537299659|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949965|NCT03129100|537299660|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949966|NCT03129100|537299661|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949967|NCT03129100|537299662|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949968|NCT03129100|537299663|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949969|NCT03129100|537299664|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
148949970|NCT03129100|537299665|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
149211085|NCT01355497|538240308|FG000|Overall Study|noncompliance|1|||
149211086|NCT01355497|538240309|FG001|Overall Study|noncompliance|2|||
149211087|NCT01355497|538240308|FG000|Overall Study|progressive disease|11|||
149211088|NCT01355497|538240309|FG001|Overall Study|progressive disease|8|||
149211089|NCT01355497|538240308|FG000|Overall Study|Adverse Event|11|||
149211090|NCT01355497|538240309|FG001|Overall Study|Adverse Event|10|||
149211091|NCT00441727|538240315|FG000|Overall Study|Protocol Violation|19|||
149211092|NCT00441727|538240316|FG001|Overall Study|Protocol Violation|28|||
149211093|NCT00441727|538240317|FG002|Overall Study|Protocol Violation|32|||
149211094|NCT00441727|538240315|FG000|Overall Study|Adverse Event|26|||
149211095|NCT00441727|538240316|FG001|Overall Study|Adverse Event|33|||
149211096|NCT00441727|538240317|FG002|Overall Study|Adverse Event|28|||
149211097|NCT00441727|538240315|FG000|Overall Study|Lack of Efficacy|7|||
149211098|NCT00441727|538240316|FG001|Overall Study|Lack of Efficacy|8|||
149211099|NCT00441727|538240317|FG002|Overall Study|Lack of Efficacy|48|||
149211100|NCT00441727|538240315|FG000|Overall Study|Withdrawal by Subject|40|||
149211101|NCT00441727|538240316|FG001|Overall Study|Withdrawal by Subject|34|||
149211102|NCT00441727|538240317|FG002|Overall Study|Withdrawal by Subject|47|||
149211103|NCT00441727|538240315|FG000|Overall Study|Lost to Follow-up|5|||
149211104|NCT00441727|538240316|FG001|Overall Study|Lost to Follow-up|6|||
149211105|NCT00441727|538240317|FG002|Overall Study|Lost to Follow-up|5|||
149211106|NCT00441727|538240315|FG000|Overall Study|Safety Reasons|3|||
149211107|NCT00441727|538240316|FG001|Overall Study|Safety Reasons|1|||
149211108|NCT00441727|538240317|FG002|Overall Study|Safety Reasons|3|||
149211109|NCT00441727|538240315|FG000|Overall Study|Various reason specified|6|||
149211110|NCT00441727|538240316|FG001|Overall Study|Various reason specified|8|||
149211111|NCT00441727|538240317|FG002|Overall Study|Various reason specified|5|||
149211112|NCT02133001|538240318|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
149211113|NCT02133001|538240319|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
149211114|NCT02133001|538240318|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
149211115|NCT02133001|538240319|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
149211116|NCT02133001|538240318|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
149211117|NCT02133001|538240319|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
149211118|NCT02133001|538240318|FG000|Double Blind (Day 1-25)|Other|2|||
149211119|NCT02133001|538240319|FG001|Double Blind (Day 1-25)|Other|2|||
149211120|NCT02133001|538240318|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
149211121|NCT02133001|538240319|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
149211122|NCT02133001|538240318|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
149211123|NCT02133001|538240319|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
149211124|NCT02133001|538240318|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
149211125|NCT02133001|538240319|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
149211126|NCT02133001|538240318|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
149211127|NCT02133001|538240319|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
149211128|NCT04211961|538240320|FG000|Overall Study|Death|0|||
149211129|NCT04211961|538240321|FG001|Overall Study|Death|1|||
149211130|NCT04211961|538240320|FG000|Overall Study|Lost to Follow-up|0|||
149211131|NCT04211961|538240321|FG001|Overall Study|Lost to Follow-up|1|||
149211132|NCT04211961|538240320|FG000|Overall Study|Withdrawal by Subject|0|||
149211133|NCT04211961|538240321|FG001|Overall Study|Withdrawal by Subject|1|||
149211134|NCT03210220|538240322|FG000|Overall Study|Physician Decision|1|||
149211135|NCT03210220|538240323|FG001|Overall Study|Physician Decision|0|||
149211136|NCT01444898|538240326|FG000|Overall Study|Withdrawal by Subject|1|||
149211137|NCT04583969|538240327|FG000|Overall Study|Death|31|||
149211138|NCT04583969|538240328|FG001|Overall Study|Death|38|||
149211139|NCT04583969|538240327|FG000|Overall Study|Lost to Follow-up|16|||
149211140|NCT04583969|538240328|FG001|Overall Study|Lost to Follow-up|13|||
149211141|NCT04583969|538240327|FG000|Overall Study|Protocol Violation|1|||
149211142|NCT04583969|538240328|FG001|Overall Study|Protocol Violation|0|||
149211143|NCT04583969|538240327|FG000|Overall Study|Withdrawal by Subject|3|||
149211144|NCT04583969|538240328|FG001|Overall Study|Withdrawal by Subject|3|||
149211145|NCT04583969|538240327|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
149211146|NCT04583969|538240328|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
149211147|NCT04583969|538240327|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
149211148|NCT04583969|538240328|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
149211149|NCT04583969|538240327|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
149211150|NCT04583969|538240328|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
149211151|NCT04583969|538240327|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
149211152|NCT04583969|538240328|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
149211153|NCT04583969|538240327|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
149211154|NCT04583969|538240328|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
149211155|NCT01061567|538240329|FG000|Overall Study|Adverse Event|32|||
149211156|NCT01061567|538240329|FG000|Overall Study|Death|2|||
149211157|NCT01061567|538240329|FG000|Overall Study|Lack of Efficacy|3|||
149211158|NCT01061567|538240329|FG000|Overall Study|Lost to Follow-up|24|||
149211159|NCT01061567|538240329|FG000|Overall Study|Protocol Violation|1|||
149211160|NCT01061567|538240329|FG000|Overall Study|Withdrawal by Subject|11|||
149211161|NCT01061567|538240329|FG000|Overall Study|Other reason than stated above|3|||
149211162|NCT01831804|538240330|FG000|Overall Study|Adverse Event|0|||
149211163|NCT01831804|538240331|FG001|Overall Study|Adverse Event|0|||
149211164|NCT01831804|538240332|FG002|Overall Study|Adverse Event|0|||
149211165|NCT01831804|538240333|FG003|Overall Study|Adverse Event|0|||
149211166|NCT01831804|538240334|FG004|Overall Study|Adverse Event|0|||
149211167|NCT01831804|538240335|FG005|Overall Study|Adverse Event|0|||
149211168|NCT01831804|538240336|FG006|Overall Study|Adverse Event|1|||
149211169|NCT01831804|538240337|FG007|Overall Study|Adverse Event|0|||
149211170|NCT01831804|538240338|FG008|Overall Study|Adverse Event|1|||
149211171|NCT01831804|538240330|FG000|Overall Study|Protocol Violation|0|||
149211172|NCT01831804|538240331|FG001|Overall Study|Protocol Violation|0|||
149211173|NCT01831804|538240332|FG002|Overall Study|Protocol Violation|2|||
149211174|NCT01831804|538240333|FG003|Overall Study|Protocol Violation|0|||
149211175|NCT01831804|538240334|FG004|Overall Study|Protocol Violation|0|||
149211176|NCT01831804|538240335|FG005|Overall Study|Protocol Violation|0|||
149211177|NCT01831804|538240336|FG006|Overall Study|Protocol Violation|0|||
149211178|NCT01831804|538240337|FG007|Overall Study|Protocol Violation|0|||
149211179|NCT01831804|538240338|FG008|Overall Study|Protocol Violation|0|||
149211180|NCT01831804|538240330|FG000|Overall Study|Protocol defined stopping criteria|1|||
149211181|NCT01831804|538240331|FG001|Overall Study|Protocol defined stopping criteria|1|||
149211182|NCT01831804|538240332|FG002|Overall Study|Protocol defined stopping criteria|3|||
149211183|NCT01831804|538240333|FG003|Overall Study|Protocol defined stopping criteria|0|||
149211184|NCT01831804|538240334|FG004|Overall Study|Protocol defined stopping criteria|1|||
149211185|NCT01831804|538240335|FG005|Overall Study|Protocol defined stopping criteria|0|||
149211186|NCT01831804|538240336|FG006|Overall Study|Protocol defined stopping criteria|0|||
149211187|NCT01831804|538240337|FG007|Overall Study|Protocol defined stopping criteria|0|||
149211188|NCT01831804|538240338|FG008|Overall Study|Protocol defined stopping criteria|0|||
149211189|NCT01831804|538240330|FG000|Overall Study|Lost to Follow-up|0|||
149211190|NCT01831804|538240331|FG001|Overall Study|Lost to Follow-up|0|||
149211191|NCT01831804|538240332|FG002|Overall Study|Lost to Follow-up|1|||
149211192|NCT01831804|538240333|FG003|Overall Study|Lost to Follow-up|0|||
149211193|NCT01831804|538240334|FG004|Overall Study|Lost to Follow-up|0|||
149211194|NCT01831804|538240335|FG005|Overall Study|Lost to Follow-up|0|||
149211195|NCT01831804|538240336|FG006|Overall Study|Lost to Follow-up|0|||
149211196|NCT01831804|538240337|FG007|Overall Study|Lost to Follow-up|0|||
149211197|NCT01831804|538240338|FG008|Overall Study|Lost to Follow-up|1|||
148684321|NCT00447603|536316750|FG001|Screening|Study Terminated by Sponsor|0|||
148684322|NCT00447603|536316751|FG002|Screening|Study Terminated by Sponsor|0|||
148684323|NCT00447603|536316749|FG000|Filter Period|Adverse Event|0|||
148684324|NCT00447603|536316750|FG001|Filter Period|Adverse Event|0|||
148684325|NCT00447603|536316751|FG002|Filter Period|Adverse Event|1|||
148684326|NCT00447603|536316749|FG000|Filter Period|Screen Failure|0|||
148684327|NCT00447603|536316750|FG001|Filter Period|Screen Failure|3|||
148684328|NCT00447603|536316751|FG002|Filter Period|Screen Failure|4|||
148809345|NCT00973973|536779266|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
149211198|NCT01831804|538240330|FG000|Overall Study|Investigator discretion|0|||
149211199|NCT01831804|538240331|FG001|Overall Study|Investigator discretion|0|||
149211200|NCT01831804|538240332|FG002|Overall Study|Investigator discretion|0|||
149211201|NCT01831804|538240333|FG003|Overall Study|Investigator discretion|0|||
149211202|NCT01831804|538240334|FG004|Overall Study|Investigator discretion|1|||
149211203|NCT01831804|538240335|FG005|Overall Study|Investigator discretion|0|||
149211204|NCT01831804|538240336|FG006|Overall Study|Investigator discretion|0|||
149211205|NCT01831804|538240337|FG007|Overall Study|Investigator discretion|1|||
149211206|NCT01831804|538240338|FG008|Overall Study|Investigator discretion|0|||
149211207|NCT01831804|538240330|FG000|Overall Study|Withdrew Consent|0|||
149211208|NCT01831804|538240331|FG001|Overall Study|Withdrew Consent|1|||
149211209|NCT01831804|538240332|FG002|Overall Study|Withdrew Consent|0|||
149211210|NCT01831804|538240333|FG003|Overall Study|Withdrew Consent|0|||
149211211|NCT01831804|538240334|FG004|Overall Study|Withdrew Consent|0|||
149211212|NCT01831804|538240335|FG005|Overall Study|Withdrew Consent|0|||
148684329|NCT00447603|536316749|FG000|Filter Period|Study terminated by Sponsor|0|||
148684330|NCT00447603|536316750|FG001|Filter Period|Study terminated by Sponsor|1|||
149211213|NCT01831804|538240336|FG006|Overall Study|Withdrew Consent|0|||
149211214|NCT01831804|538240337|FG007|Overall Study|Withdrew Consent|2|||
149211215|NCT01831804|538240338|FG008|Overall Study|Withdrew Consent|0|||
149211216|NCT01819506|538240339|FG000|Overall Study|Physician Decision|5|||
149211217|NCT01819506|538240340|FG001|Overall Study|Physician Decision|2|||
149211218|NCT01819506|538240339|FG000|Overall Study|Withdrawal by Subject|3|||
149211219|NCT01819506|538240340|FG001|Overall Study|Withdrawal by Subject|3|||
149211220|NCT03447821|538240345|FG000|Overall Study|Withdrawal by Subject|1|||
149211221|NCT03447821|538240346|FG001|Overall Study|Withdrawal by Subject|1|||
149211222|NCT03447821|538240347|FG002|Overall Study|Withdrawal by Subject|0|||
149211223|NCT03447821|538240345|FG000|Overall Study|Lost to Follow-up|0|||
149211224|NCT03447821|538240346|FG001|Overall Study|Lost to Follow-up|0|||
149211225|NCT03447821|538240347|FG002|Overall Study|Lost to Follow-up|1|||
149211226|NCT04685538|538240349|FG000|Overall Study|Adverse Event|0|||
149211227|NCT04685538|538240350|FG001|Overall Study|Adverse Event|1|||
149211228|NCT04685538|538240349|FG000|Overall Study|Lost to Follow-up|0|||
149211229|NCT04685538|538240350|FG001|Overall Study|Lost to Follow-up|2|||
149211230|NCT02475629|538240352|FG000|Overall Study|Adverse Event|1|||
149211231|NCT02475629|538240352|FG000|Overall Study|Death|4|||
149211232|NCT02475629|538240352|FG000|Overall Study|Physician Decision|1|||
149211233|NCT02475629|538240352|FG000|Overall Study|Withdrawal by Subject|1|||
149211234|NCT02475629|538240352|FG000|Overall Study|Lost to Follow-up|1|||
149211235|NCT02475629|538240352|FG000|Overall Study|Subject non-compliance|1|||
149211236|NCT01421069|538240353|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
149211237|NCT01421069|538240353|FG000|Parent Study|Failed to return|3|||
149211238|NCT01421069|538240353|FG000|Parent Study|Withdrawal by Subject|1|||
149211239|NCT01421069|538240353|FG000|Parent Study|Lost to Follow-up|2|||
149211240|NCT01421069|538240353|FG000|Parent Study|Lack of Efficacy|1|||
149211241|NCT01421069|538240353|FG000|Overall Period for Extension Study|Other|2|||
149211242|NCT01421069|538240353|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
149211243|NCT01421069|538240353|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
149211244|NCT01421069|538240353|FG000|Overall Period for Extension Study|Pregnancy|1|||
149211245|NCT01421069|538240353|FG000|Overall Period for Extension Study|Adverse Event|1|||
149211246|NCT01421069|538240353|FG000|Overall Period for Extension Study|Protocol Violation|1|||
149211247|NCT01421069|538240353|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
149211248|NCT01421069|538240353|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
149211249|NCT01421069|538240353|FG000|Active Treatment Period|Other|1|||
149211250|NCT01421069|538240353|FG000|Active Treatment Period|No longer willing to participate in study|8|||
149211251|NCT01421069|538240353|FG000|Active Treatment Period|Insufficient clinical response|1|||
149211252|NCT01421069|538240353|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
149211253|NCT01421069|538240353|FG000|Active Treatment Period|Pregnancy|1|||
149211254|NCT01421069|538240353|FG000|Active Treatment Period|Adverse Event|1|||
149211255|NCT01421069|538240353|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
149211256|NCT01421069|538240353|FG000|Active Treatment Period|Enrolled in observational period|29|||
149211257|NCT01421069|538240353|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
149211258|NCT01421069|538240353|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
149211259|NCT01421069|538240353|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
149211260|NCT01421069|538240353|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
149211261|NCT01421069|538240353|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
149211262|NCT01421069|538240353|FG000|2b. Retreatment Period|Protocol Violation|1|||
149211263|NCT01421069|538240353|FG000|Observational Period|Other|1|||
149211264|NCT01421069|538240353|FG000|Observational Period|No longer willing to participate in study|4|||
149211265|NCT01421069|538240353|FG000|Observational Period|Lost to Follow-up|3|||
149211266|NCT01641081|538240354|FG000|Period 1|Sponsor request (potential unblinding)|0|||
149211267|NCT01641081|538240355|FG001|Period 1|Sponsor request (potential unblinding)|0|||
149211268|NCT01641081|538240356|FG002|Period 1|Sponsor request (potential unblinding)|0|||
149211269|NCT01641081|538240357|FG003|Period 1|Sponsor request (potential unblinding)|0|||
149211270|NCT01641081|538240358|FG004|Period 1|Sponsor request (potential unblinding)|0|||
149211271|NCT01641081|538240359|FG005|Period 1|Sponsor request (potential unblinding)|0|||
149016483|NCT01751113|537538830|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
149016484|NCT01551303|537538831|FG000|Overall Study|failed awareness check on vision test|4|||
149016485|NCT01551303|537538832|FG001|Overall Study|failed awareness check on vision test|7|||
149016486|NCT04297241|537538833|FG000|Overall Study|Withdrawal by Subject|1|||
149211272|NCT01641081|538240360|FG006|Period 1|Sponsor request (potential unblinding)|1|||
149211273|NCT01641081|538240361|FG007|Period 1|Sponsor request (potential unblinding)|0|||
149211274|NCT01641081|538240362|FG008|Period 1|Sponsor request (potential unblinding)|0|||
149016487|NCT04297241|537538833|FG000|Overall Study|Adverse Event|1|||
149211275|NCT01641081|538240363|FG009|Period 1|Sponsor request (potential unblinding)|0|||
149211276|NCT01641081|538240354|FG000|Period 1|Protocol Violation|0|||
149211277|NCT01641081|538240355|FG001|Period 1|Protocol Violation|0|||
149211278|NCT01641081|538240356|FG002|Period 1|Protocol Violation|0|||
149211279|NCT01641081|538240357|FG003|Period 1|Protocol Violation|0|||
149211280|NCT01641081|538240358|FG004|Period 1|Protocol Violation|1|||
149211281|NCT01641081|538240359|FG005|Period 1|Protocol Violation|0|||
149211282|NCT01641081|538240360|FG006|Period 1|Protocol Violation|0|||
149211283|NCT01641081|538240361|FG007|Period 1|Protocol Violation|1|||
149211284|NCT01641081|538240362|FG008|Period 1|Protocol Violation|0|||
149211285|NCT01641081|538240363|FG009|Period 1|Protocol Violation|0|||
149211286|NCT01641081|538240354|FG000|Period 1|Adverse Event|1|||
149211287|NCT01641081|538240355|FG001|Period 1|Adverse Event|0|||
149211288|NCT01641081|538240356|FG002|Period 1|Adverse Event|0|||
149211289|NCT01641081|538240357|FG003|Period 1|Adverse Event|0|||
149211290|NCT01641081|538240358|FG004|Period 1|Adverse Event|0|||
149211291|NCT01641081|538240359|FG005|Period 1|Adverse Event|0|||
149211292|NCT01641081|538240360|FG006|Period 1|Adverse Event|0|||
149211293|NCT01641081|538240361|FG007|Period 1|Adverse Event|2|||
149211294|NCT01641081|538240362|FG008|Period 1|Adverse Event|0|||
149211295|NCT01641081|538240363|FG009|Period 1|Adverse Event|0|||
149211296|NCT01641081|538240354|FG000|Period 2|Adverse Event|0|||
149211297|NCT01641081|538240355|FG001|Period 2|Adverse Event|0|||
149211298|NCT01641081|538240356|FG002|Period 2|Adverse Event|0|||
149211299|NCT01641081|538240357|FG003|Period 2|Adverse Event|0|||
149211300|NCT01641081|538240358|FG004|Period 2|Adverse Event|0|||
149211301|NCT01641081|538240359|FG005|Period 2|Adverse Event|1|||
149211302|NCT01641081|538240360|FG006|Period 2|Adverse Event|0|||
149211303|NCT01641081|538240361|FG007|Period 2|Adverse Event|0|||
149211304|NCT01641081|538240362|FG008|Period 2|Adverse Event|0|||
149211305|NCT01641081|538240363|FG009|Period 2|Adverse Event|0|||
149211306|NCT01641081|538240354|FG000|Period 2|Withdrawal by Subject|0|||
149211307|NCT01641081|538240355|FG001|Period 2|Withdrawal by Subject|0|||
149211308|NCT01641081|538240356|FG002|Period 2|Withdrawal by Subject|0|||
149211309|NCT01641081|538240357|FG003|Period 2|Withdrawal by Subject|1|||
149211310|NCT01641081|538240358|FG004|Period 2|Withdrawal by Subject|0|||
149211311|NCT01641081|538240359|FG005|Period 2|Withdrawal by Subject|0|||
149211312|NCT01641081|538240360|FG006|Period 2|Withdrawal by Subject|2|||
149211313|NCT01641081|538240361|FG007|Period 2|Withdrawal by Subject|0|||
149211314|NCT01641081|538240362|FG008|Period 2|Withdrawal by Subject|0|||
149211315|NCT01641081|538240363|FG009|Period 2|Withdrawal by Subject|0|||
149211316|NCT01641081|538240354|FG000|Period 2|Protocol Violation|1|||
149211317|NCT01641081|538240355|FG001|Period 2|Protocol Violation|0|||
149211318|NCT01641081|538240356|FG002|Period 2|Protocol Violation|0|||
149211319|NCT01641081|538240357|FG003|Period 2|Protocol Violation|0|||
149211320|NCT01641081|538240358|FG004|Period 2|Protocol Violation|0|||
149211321|NCT01641081|538240359|FG005|Period 2|Protocol Violation|0|||
149211322|NCT01641081|538240360|FG006|Period 2|Protocol Violation|0|||
149211323|NCT01641081|538240361|FG007|Period 2|Protocol Violation|0|||
149211324|NCT01641081|538240362|FG008|Period 2|Protocol Violation|0|||
149211325|NCT01641081|538240363|FG009|Period 2|Protocol Violation|0|||
149211326|NCT01641081|538240354|FG000|Period 3|Adverse Event|0|||
149211327|NCT01641081|538240355|FG001|Period 3|Adverse Event|0|||
149211328|NCT01641081|538240356|FG002|Period 3|Adverse Event|1|||
149211329|NCT01641081|538240357|FG003|Period 3|Adverse Event|0|||
149211330|NCT01641081|538240358|FG004|Period 3|Adverse Event|0|||
149211331|NCT01641081|538240359|FG005|Period 3|Adverse Event|0|||
149211332|NCT01641081|538240360|FG006|Period 3|Adverse Event|0|||
149211333|NCT01641081|538240361|FG007|Period 3|Adverse Event|0|||
149211334|NCT01641081|538240362|FG008|Period 3|Adverse Event|0|||
149211335|NCT01641081|538240363|FG009|Period 3|Adverse Event|0|||
149211336|NCT01641081|538240354|FG000|Period 3|Withdrawal by Subject|0|||
149211337|NCT01641081|538240355|FG001|Period 3|Withdrawal by Subject|0|||
149211338|NCT01641081|538240356|FG002|Period 3|Withdrawal by Subject|0|||
149211339|NCT01641081|538240357|FG003|Period 3|Withdrawal by Subject|0|||
149211340|NCT01641081|538240358|FG004|Period 3|Withdrawal by Subject|0|||
149211341|NCT01641081|538240359|FG005|Period 3|Withdrawal by Subject|0|||
149211342|NCT01641081|538240360|FG006|Period 3|Withdrawal by Subject|0|||
149211343|NCT01641081|538240361|FG007|Period 3|Withdrawal by Subject|0|||
149211344|NCT01641081|538240362|FG008|Period 3|Withdrawal by Subject|1|||
149211345|NCT01641081|538240363|FG009|Period 3|Withdrawal by Subject|0|||
149211346|NCT01641081|538240354|FG000|Period 4|Adverse Event|0|||
149211347|NCT01641081|538240355|FG001|Period 4|Adverse Event|1|||
149211348|NCT01641081|538240356|FG002|Period 4|Adverse Event|0|||
149211349|NCT01641081|538240357|FG003|Period 4|Adverse Event|1|||
149211350|NCT01641081|538240358|FG004|Period 4|Adverse Event|0|||
149211351|NCT01641081|538240359|FG005|Period 4|Adverse Event|0|||
149211352|NCT01641081|538240360|FG006|Period 4|Adverse Event|0|||
149211353|NCT01641081|538240361|FG007|Period 4|Adverse Event|0|||
149211354|NCT01641081|538240362|FG008|Period 4|Adverse Event|0|||
149211355|NCT01641081|538240363|FG009|Period 4|Adverse Event|0|||
149211356|NCT01641081|538240354|FG000|Period 5|Adverse Event|0|||
149211357|NCT01641081|538240355|FG001|Period 5|Adverse Event|0|||
149211358|NCT01641081|538240356|FG002|Period 5|Adverse Event|2|||
149211359|NCT01641081|538240357|FG003|Period 5|Adverse Event|0|||
149211360|NCT01641081|538240358|FG004|Period 5|Adverse Event|0|||
149211361|NCT01641081|538240359|FG005|Period 5|Adverse Event|0|||
149211362|NCT01641081|538240360|FG006|Period 5|Adverse Event|0|||
149211363|NCT01641081|538240361|FG007|Period 5|Adverse Event|0|||
149211364|NCT01641081|538240362|FG008|Period 5|Adverse Event|0|||
149211365|NCT01641081|538240363|FG009|Period 5|Adverse Event|0|||
149211366|NCT03383614|538240364|FG000|Overall Study|Withdrawal by Subject|0|||
149211367|NCT03383614|538240365|FG001|Overall Study|Withdrawal by Subject|1|||
149211368|NCT03383614|538240366|FG002|Overall Study|Withdrawal by Subject|0|||
149211369|NCT03383614|538240367|FG003|Overall Study|Withdrawal by Subject|0|||
149211370|NCT02925312|538240373|FG000|Overall Study|Lost to Follow-up|25|||
149211371|NCT02925312|538240374|FG001|Overall Study|Lost to Follow-up|0|||
149211372|NCT02925312|538240373|FG000|Overall Study|Adverse Event|2|||
149211373|NCT02925312|538240374|FG001|Overall Study|Adverse Event|0|||
149211374|NCT00166517|538240378|FG000|Overall Study|Lost to Follow-up|1|||
149211375|NCT00166517|538240379|FG001|Overall Study|Lost to Follow-up|0|||
149211376|NCT00166517|538240378|FG000|Overall Study|Protocol Violation|4|||
149211377|NCT00166517|538240379|FG001|Overall Study|Protocol Violation|1|||
149211378|NCT00166517|538240378|FG000|Overall Study|Withdrawal by Subject|0|||
149211379|NCT00166517|538240379|FG001|Overall Study|Withdrawal by Subject|1|||
149211380|NCT00842361|538240380|FG000|Overall Study|Protocol Violation|1|||
149211381|NCT00842361|538240381|FG001|Overall Study|Protocol Violation|0|||
149211382|NCT00842361|538240380|FG000|Overall Study|Unclassified|0|||
149211383|NCT00842361|538240381|FG001|Overall Study|Unclassified|2|||
149211384|NCT01072448|538240382|FG000|Overall Study|Adverse Event|9|||
149211385|NCT01072448|538240383|FG001|Overall Study|Adverse Event|10|||
149211386|NCT01072448|538240382|FG000|Overall Study|Subject withdrew consent|4|||
149211387|NCT01072448|538240383|FG001|Overall Study|Subject withdrew consent|9|||
149211388|NCT01072448|538240382|FG000|Overall Study|Protocol deviation|3|||
149211389|NCT01072448|538240383|FG001|Overall Study|Protocol deviation|4|||
149211390|NCT01072448|538240382|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149211391|NCT01072448|538240383|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149211392|NCT01072448|538240382|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149211393|NCT01072448|538240383|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149211394|NCT01072448|538240382|FG000|Overall Study|Lost to Follow-up|1|||
149211395|NCT01072448|538240383|FG001|Overall Study|Lost to Follow-up|1|||
149211396|NCT01072448|538240382|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149211397|NCT01072448|538240383|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149211398|NCT01072448|538240382|FG000|Overall Study|Death|0|||
149211399|NCT01072448|538240383|FG001|Overall Study|Death|2|||
149211400|NCT01015820|538240386|FG000|Overall Study|Suboptimal measurements|1|||
149211401|NCT01015820|538240387|FG001|Overall Study|Suboptimal measurements|0|||
149211402|NCT01313078|538240388|FG000|Overall Study|Death|1|||
149211403|NCT01313078|538240388|FG000|Overall Study|Discontinued study drug|1|||
149211404|NCT01313078|538240388|FG000|Overall Study|Withdrawal by Subject|1|||
149211405|NCT03136484|538240389|FG000|Overall Study|Withdrawal by Subject|19|||
149211406|NCT03136484|538240390|FG001|Overall Study|Withdrawal by Subject|14|||
149211407|NCT03136484|538240389|FG000|Overall Study|Lost to Follow-up|7|||
149211408|NCT03136484|538240390|FG001|Overall Study|Lost to Follow-up|8|||
149211409|NCT03136484|538240389|FG000|Overall Study|Death|1|||
149211410|NCT03136484|538240390|FG001|Overall Study|Death|0|||
149211411|NCT01449955|538240393|FG000|Overall Study|Withdrawal by Subject|1|||
149211412|NCT01449955|538240394|FG001|Overall Study|Withdrawal by Subject|2|||
149211413|NCT01203787|538240395|FG000|Overall Study|Death|12|||
149211414|NCT01203787|538240396|FG001|Overall Study|Death|10|||
149211415|NCT01203787|538240395|FG000|Overall Study|Withdrawal by Subject|6|||
149211416|NCT01203787|538240396|FG001|Overall Study|Withdrawal by Subject|2|||
149211417|NCT01203787|538240395|FG000|Overall Study|Lost to Follow-up|2|||
149211418|NCT01203787|538240396|FG001|Overall Study|Lost to Follow-up|0|||
149211419|NCT01203787|538240395|FG000|Overall Study|Adverse Event|11|||
149211420|NCT01203787|538240396|FG001|Overall Study|Adverse Event|15|||
149211421|NCT01601470|538240397|FG000|Period 2 - LCZ696|Physician Decision|1|||
149211422|NCT02079519|538240400|FG000|Overall Study|Disease Progression|9|||
149211423|NCT02079519|538240400|FG000|Overall Study|Adverse Event|1|||
149211424|NCT01176240|538240401|FG000|Study 306A|Lack of Efficacy|2|||
149211425|NCT01176240|538240402|FG001|Study 306A|Lack of Efficacy|1|||
149211426|NCT01176240|538240401|FG000|Study 306A|Protocol Violation|0|||
149211427|NCT01176240|538240402|FG001|Study 306A|Protocol Violation|1|||
149211428|NCT01176240|538240401|FG000|Study 306A|Withdrawal by Subject|0|||
149211429|NCT01176240|538240402|FG001|Study 306A|Withdrawal by Subject|1|||
149211430|NCT01176240|538240401|FG000|Study 306A|Stop due to diverse problems|1|||
149211431|NCT01176240|538240402|FG001|Study 306A|Stop due to diverse problems|0|||
149211432|NCT01176240|538240401|FG000|Study 306B|Lack of Efficacy|5|||
149211433|NCT01176240|538240402|FG001|Study 306B|Lack of Efficacy|3|||
149016488|NCT04297241|537538833|FG000|Overall Study|Physician Decision|3|||
149211434|NCT01176240|538240401|FG000|Study 306B|Adverse Event|10|||
149211435|NCT01176240|538240402|FG001|Study 306B|Adverse Event|5|||
149211436|NCT01176240|538240401|FG000|Study 306B|Protocol Violation|2|||
149211437|NCT01176240|538240402|FG001|Study 306B|Protocol Violation|3|||
149211438|NCT01176240|538240401|FG000|Study 306B|Withdrawal by Subject|4|||
149211439|NCT01176240|538240402|FG001|Study 306B|Withdrawal by Subject|1|||
149211440|NCT01176240|538240401|FG000|Study 306B|Physician Decision|2|||
149211441|NCT01176240|538240402|FG001|Study 306B|Physician Decision|1|||
149211442|NCT01176240|538240401|FG000|Study 306B|Supine Hypertension|1|||
149211443|NCT01176240|538240402|FG001|Study 306B|Supine Hypertension|2|||
149211444|NCT01176240|538240401|FG000|Study 306B|Lost to Follow-up|0|||
149211445|NCT01176240|538240402|FG001|Study 306B|Lost to Follow-up|1|||
149211446|NCT01176240|538240401|FG000|Study 306B|withdrew prior to dosing|2|||
149211447|NCT01176240|538240402|FG001|Study 306B|withdrew prior to dosing|1|||
149211448|NCT00937326|538242880|FG000|Overall Study|Adverse Event|0|||
149211449|NCT00937326|538242881|FG001|Overall Study|Adverse Event|3|||
149211450|NCT00937326|538242882|FG002|Overall Study|Adverse Event|1|||
149211451|NCT00937326|538242883|FG003|Overall Study|Adverse Event|1|||
149211452|NCT00937326|538242884|FG004|Overall Study|Adverse Event|2|||
149211453|NCT00937326|538242880|FG000|Overall Study|Death|0|||
149211454|NCT00937326|538242881|FG001|Overall Study|Death|0|||
149211455|NCT00937326|538242882|FG002|Overall Study|Death|1|||
149211456|NCT00937326|538242883|FG003|Overall Study|Death|0|||
149211457|NCT00937326|538242884|FG004|Overall Study|Death|0|||
149211458|NCT00937326|538242880|FG000|Overall Study|Withdrawal by Subject|3|||
149211459|NCT00937326|538242881|FG001|Overall Study|Withdrawal by Subject|4|||
149211460|NCT00937326|538242882|FG002|Overall Study|Withdrawal by Subject|1|||
149211461|NCT00937326|538242883|FG003|Overall Study|Withdrawal by Subject|4|||
149211462|NCT00937326|538242884|FG004|Overall Study|Withdrawal by Subject|3|||
149211463|NCT00937326|538242880|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149211464|NCT00937326|538242881|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149211465|NCT00937326|538242882|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
149211466|NCT00937326|538242883|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149211467|NCT00937326|538242884|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
149211468|NCT02578992|538242885|FG000|Overall Study|equipment not available or malfunction|3|||
149211469|NCT02578992|538242886|FG001|Overall Study|equipment not available or malfunction|3|||
149211470|NCT00790218|538242887|FG000|Overall Study|Death|1|||
149211471|NCT00790218|538242888|FG001|Overall Study|Death|0|||
149211472|NCT00790218|538242889|FG002|Overall Study|Death|0|||
149211473|NCT02443155|538242890|FG000|Overall Study|Adverse Event|3|||
149211474|NCT02443155|538242891|FG001|Overall Study|Adverse Event|4|||
149211475|NCT02443155|538242892|FG002|Overall Study|Adverse Event|1|||
149211476|NCT02443155|538242893|FG003|Overall Study|Adverse Event|2|||
149211477|NCT02443155|538242890|FG000|Overall Study|Unclassified|0|||
149211478|NCT02443155|538242891|FG001|Overall Study|Unclassified|0|||
149211479|NCT02443155|538242892|FG002|Overall Study|Unclassified|2|||
149211480|NCT02443155|538242893|FG003|Overall Study|Unclassified|1|||
149211481|NCT02443155|538242890|FG000|Overall Study|Withdrawal by Subject|4|||
149211482|NCT02443155|538242891|FG001|Overall Study|Withdrawal by Subject|7|||
149211483|NCT02443155|538242892|FG002|Overall Study|Withdrawal by Subject|3|||
149211484|NCT02443155|538242893|FG003|Overall Study|Withdrawal by Subject|9|||
149211485|NCT02443155|538242890|FG000|Overall Study|Pregnancy|3|||
149211486|NCT02443155|538242891|FG001|Overall Study|Pregnancy|1|||
149211487|NCT02443155|538242892|FG002|Overall Study|Pregnancy|1|||
149211488|NCT02443155|538242893|FG003|Overall Study|Pregnancy|2|||
149211489|NCT02443155|538242890|FG000|Overall Study|Lost to Follow-up|1|||
149211490|NCT02443155|538242891|FG001|Overall Study|Lost to Follow-up|2|||
149211491|NCT02443155|538242892|FG002|Overall Study|Lost to Follow-up|0|||
149211492|NCT02443155|538242893|FG003|Overall Study|Lost to Follow-up|1|||
149211493|NCT02443155|538242890|FG000|Overall Study|Protocol Violation|1|||
148684331|NCT00447603|536316751|FG002|Filter Period|Study terminated by Sponsor|10|||
148684332|NCT01907737|536316762|FG000|Overall Study|Withdrawal by Subject|1|||
148684333|NCT02008721|536316767|FG000|Overall Study|Withdrawal by Subject|5|||
149211494|NCT02443155|538242891|FG001|Overall Study|Protocol Violation|0|||
149211495|NCT02443155|538242892|FG002|Overall Study|Protocol Violation|1|||
149211496|NCT02443155|538242893|FG003|Overall Study|Protocol Violation|1|||
149211497|NCT02443155|538242890|FG000|Overall Study|Death|0|||
149211498|NCT02443155|538242891|FG001|Overall Study|Death|0|||
149211499|NCT02443155|538242892|FG002|Overall Study|Death|1|||
148684334|NCT02008721|536316768|FG001|Overall Study|Withdrawal by Subject|1|||
149211500|NCT02443155|538242893|FG003|Overall Study|Death|0|||
149211501|NCT00731666|538242901|FG000|Overall Study|Adverse Event|2|||
149211502|NCT00731666|538242901|FG000|Overall Study|Lost to Follow-up|8|||
149211503|NCT00731666|538242901|FG000|Overall Study|Withdrawal by Subject|2|||
149211504|NCT00666536|538242902|FG000|Overall Study|Adverse Event|9|||
149211505|NCT00666536|538242903|FG001|Overall Study|Adverse Event|19|||
149211506|NCT00666536|538242902|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149211507|NCT00666536|538242903|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149211508|NCT00666536|538242902|FG000|Overall Study|Protocol deviation(s)|8|||
149211509|NCT00666536|538242903|FG001|Overall Study|Protocol deviation(s)|6|||
149211510|NCT00666536|538242902|FG000|Overall Study|Withdrawal by Subject|10|||
148949971|NCT03129100|537299666|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
148949972|NCT03129100|537299667|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
148949973|NCT03129100|537299668|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949974|NCT03129100|537299669|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949975|NCT03129100|537299670|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949976|NCT03129100|537299671|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949977|NCT03129100|537299672|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949978|NCT03129100|537299673|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949979|NCT03129100|537299674|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949980|NCT03129100|537299675|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949981|NCT03129100|537299676|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949982|NCT03129100|537299677|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949983|NCT03129100|537299678|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
148949984|NCT03129100|537299653|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949985|NCT03129100|537299654|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949986|NCT03129100|537299655|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949987|NCT03129100|537299656|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949988|NCT03129100|537299657|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949989|NCT03129100|537299658|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949990|NCT03129100|537299659|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949991|NCT03129100|537299660|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949992|NCT03129100|537299661|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949993|NCT03129100|537299662|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949994|NCT03129100|537299663|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949995|NCT03129100|537299664|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
148949996|NCT03129100|537299665|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148949997|NCT03129100|537299666|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
148949998|NCT03129100|537299667|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
148809346|NCT02471339|536779267|FG000|Overall Study|Did not provide follow-up data|2|||
148809347|NCT02471339|536779268|FG001|Overall Study|Did not provide follow-up data|0|||
148809348|NCT06057064|536779269|FG000|Overall Study|Death|2|||
148809349|NCT06057064|536779270|FG001|Overall Study|Death|0|||
148809350|NCT06057064|536779269|FG000|Overall Study|Physician Decision|1|||
148809351|NCT06057064|536779270|FG001|Overall Study|Physician Decision|0|||
148809352|NCT06057064|536779269|FG000|Overall Study|Withdrawal by Subject|1|||
148809353|NCT06057064|536779270|FG001|Overall Study|Withdrawal by Subject|1|||
148809354|NCT01541748|536779271|FG000|Overall Study|Lost to Follow-up|17|||
148809355|NCT01541748|536779271|FG000|Overall Study|Moved out of state|1|||
148809356|NCT01541748|536779271|FG000|Overall Study|Withdrawal by Subject|7|||
148809357|NCT01541748|536779271|FG000|Overall Study|Screen failure|5|||
148809358|NCT01541748|536779271|FG000|Overall Study|Did not receive study device|1|||
148809359|NCT00626639|536779279|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
148809360|NCT00626639|536779280|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
148809361|NCT00851591|536779281|FG000|Overall Study|Withdrawal by Subject|2|||
148809362|NCT00851591|536779282|FG001|Overall Study|Withdrawal by Subject|0|||
148809363|NCT00634504|536779285|FG000|Overall Study|Protocol Violation|1|||
148809364|NCT00634504|536779286|FG001|Overall Study|Protocol Violation|0|||
148809365|NCT01283386|536779287|FG000|Overall Study|Death|2|||
148809366|NCT01283386|536779288|FG001|Overall Study|Death|0|||
148949999|NCT03129100|537299668|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950000|NCT03129100|537299669|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950001|NCT03129100|537299670|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950002|NCT03129100|537299671|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
149211511|NCT00666536|538242903|FG001|Overall Study|Withdrawal by Subject|9|||
149211512|NCT00666536|538242902|FG000|Overall Study|Lost to Follow-up|4|||
149211513|NCT00666536|538242903|FG001|Overall Study|Lost to Follow-up|3|||
149211514|NCT01473355|538242905|FG000|Overall Study|Protocol Violation|2|||
149211515|NCT01473355|538242905|FG000|Overall Study|Adverse Event|2|||
149211516|NCT01473355|538242905|FG000|Overall Study|Lost to Follow-up|2|||
149211517|NCT00106249|538242906|FG000|Overall Study|Lost to Follow-up|3|||
149211518|NCT00106249|538242907|FG001|Overall Study|Lost to Follow-up|2|||
149211519|NCT00509028|538242910|FG000|Overall Study|Adverse Event|2|||
149211520|NCT00509028|538242911|FG001|Overall Study|Adverse Event|0|||
149211521|NCT00509028|538242910|FG000|Overall Study|Withdrawal by Subject|4|||
149211522|NCT00509028|538242911|FG001|Overall Study|Withdrawal by Subject|3|||
149211523|NCT00509028|538242910|FG000|Overall Study|Lost to Follow-up|0|||
149211524|NCT00509028|538242911|FG001|Overall Study|Lost to Follow-up|1|||
149211525|NCT00509028|538242910|FG000|Overall Study|Protocol Violation|4|||
149211526|NCT00509028|538242911|FG001|Overall Study|Protocol Violation|2|||
149211527|NCT00509028|538242910|FG000|Overall Study|Non-compliance|2|||
149211528|NCT00509028|538242911|FG001|Overall Study|Non-compliance|1|||
149211529|NCT00948428|538242912|FG000|Overall Study|Withdrawal by Subject|6|||
149211530|NCT00948428|538242913|FG001|Overall Study|Withdrawal by Subject|12|||
149211531|NCT00948428|538242914|FG002|Overall Study|Withdrawal by Subject|7|||
149211532|NCT00948428|538242912|FG000|Overall Study|Adverse Event|6|||
149211533|NCT00948428|538242913|FG001|Overall Study|Adverse Event|3|||
149211534|NCT00948428|538242914|FG002|Overall Study|Adverse Event|0|||
149211535|NCT00948428|538242912|FG000|Overall Study|Lost to Follow-up|2|||
149211536|NCT00948428|538242913|FG001|Overall Study|Lost to Follow-up|1|||
149211537|NCT00948428|538242914|FG002|Overall Study|Lost to Follow-up|1|||
149211538|NCT00948428|538242912|FG000|Overall Study|Death|2|||
149211539|NCT00948428|538242913|FG001|Overall Study|Death|0|||
149211540|NCT00948428|538242914|FG002|Overall Study|Death|0|||
149211541|NCT00948428|538242912|FG000|Overall Study|Intercurrent Illness|1|||
149211542|NCT00948428|538242913|FG001|Overall Study|Intercurrent Illness|0|||
149211543|NCT00948428|538242914|FG002|Overall Study|Intercurrent Illness|0|||
149211544|NCT00948428|538242912|FG000|Overall Study|Non-compliance|1|||
149211545|NCT00948428|538242913|FG001|Overall Study|Non-compliance|2|||
149211546|NCT00948428|538242914|FG002|Overall Study|Non-compliance|0|||
149211547|NCT01495689|538242919|FG000|Overall Study|Death|0|||
148684335|NCT02008721|536316767|FG000|Overall Study|Death|4|||
148809367|NCT01283386|536779287|FG000|Overall Study|Withdrawal by Subject|2|||
148809368|NCT01283386|536779288|FG001|Overall Study|Withdrawal by Subject|1|||
148809369|NCT01283386|536779287|FG000|Overall Study|Relapse of underlying disease|1|||
148809370|NCT01283386|536779288|FG001|Overall Study|Relapse of underlying disease|3|||
148809371|NCT01283386|536779287|FG000|Overall Study|Progression of underlying disease|2|||
148809372|NCT01283386|536779288|FG001|Overall Study|Progression of underlying disease|7|||
148809373|NCT01283386|536779287|FG000|Overall Study|Reason not specified|1|||
149211548|NCT01495689|538242920|FG001|Overall Study|Death|1|||
149211549|NCT01495689|538242919|FG000|Overall Study|Withdrawal by Subject|3|||
149211550|NCT01495689|538242920|FG001|Overall Study|Withdrawal by Subject|0|||
149211551|NCT01495689|538242919|FG000|Overall Study|Lost to Follow-up|7|||
149211552|NCT01495689|538242920|FG001|Overall Study|Lost to Follow-up|6|||
149211553|NCT05516134|538242921|FG000|Overall Study|Lost to Follow-up|1|||
149211554|NCT05516134|538242922|FG001|Overall Study|Lost to Follow-up|0|||
149211555|NCT05516134|538242923|FG002|Overall Study|Lost to Follow-up|0|||
148950003|NCT03129100|537299672|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950004|NCT03129100|537299673|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950005|NCT03129100|537299674|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950006|NCT03129100|537299675|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950007|NCT03129100|537299676|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950008|NCT03129100|537299677|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950009|NCT03129100|537299678|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
148950010|NCT03129100|537299653|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950011|NCT03129100|537299654|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950012|NCT03129100|537299655|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950013|NCT03129100|537299656|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950014|NCT03129100|537299657|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950015|NCT03129100|537299658|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950016|NCT03129100|537299659|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950017|NCT03129100|537299660|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950018|NCT03129100|537299661|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950019|NCT03129100|537299662|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950020|NCT03129100|537299663|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950021|NCT03129100|537299664|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950022|NCT03129100|537299665|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950023|NCT03129100|537299666|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950024|NCT03129100|537299667|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950025|NCT03129100|537299668|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
148950026|NCT03129100|537299669|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950027|NCT03129100|537299670|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950028|NCT03129100|537299671|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950029|NCT03129100|537299672|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950030|NCT03129100|537299673|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950031|NCT03129100|537299674|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950032|NCT03129100|537299675|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950033|NCT03129100|537299676|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950034|NCT03129100|537299677|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950035|NCT03129100|537299678|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
148950036|NCT03129100|537299653|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950037|NCT03129100|537299654|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950038|NCT03129100|537299655|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950039|NCT03129100|537299656|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950040|NCT03129100|537299657|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950041|NCT03129100|537299658|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950042|NCT03129100|537299659|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950043|NCT03129100|537299660|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950044|NCT03129100|537299661|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950045|NCT03129100|537299662|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
149016489|NCT04642469|537538842|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
149016490|NCT04642469|537538843|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
149016491|NCT04642469|537538842|FG000|Overall Study|Death|1|||
149211556|NCT00254163|538242928|FG000|Overall Study|Adverse Event|29|||
149211557|NCT00254163|538242929|FG001|Overall Study|Adverse Event|26|||
149211558|NCT00254163|538242928|FG000|Overall Study|Patient request/withdrew consent|6|||
149211559|NCT00254163|538242929|FG001|Overall Study|Patient request/withdrew consent|4|||
149211560|NCT00254163|538242928|FG000|Overall Study|Investigator request|1|||
149211561|NCT00254163|538242929|FG001|Overall Study|Investigator request|3|||
149211562|NCT00254163|538242928|FG000|Overall Study|Failed entry|1|||
149211563|NCT00254163|538242929|FG001|Overall Study|Failed entry|3|||
149211564|NCT00254163|538242928|FG000|Overall Study|Progressive disease|0|||
149211565|NCT00254163|538242929|FG001|Overall Study|Progressive disease|1|||
149211566|NCT00254163|538242928|FG000|Overall Study|Death|0|||
149211567|NCT00254163|538242929|FG001|Overall Study|Death|1|||
149211568|NCT00254163|538242928|FG000|Overall Study|Other|8|||
149211569|NCT00254163|538242929|FG001|Overall Study|Other|8|||
148684336|NCT02008721|536316768|FG001|Overall Study|Death|2|||
148684337|NCT02008721|536316767|FG000|Overall Study|Adverse Event|3|||
148684338|NCT02008721|536316768|FG001|Overall Study|Adverse Event|5|||
149016492|NCT04642469|537538843|FG001|Overall Study|Death|2|||
148684339|NCT02008721|536316767|FG000|Overall Study|Protocol Violation|3|||
149211570|NCT01843205|538242932|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
149211571|NCT01843205|538242933|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
148684340|NCT02008721|536316768|FG001|Overall Study|Protocol Violation|2|||
149211572|NCT00517413|538242934|FG000|Overall Study|Adverse Event|7|||
149211573|NCT00517413|538242934|FG000|Overall Study|Death|13|||
149211574|NCT00517413|538242934|FG000|Overall Study|Protocol Violation|15|||
149211575|NCT00517413|538242934|FG000|Overall Study|Withdrawal by Subject|2|||
149211576|NCT00517413|538242934|FG000|Overall Study|Failure to return|1|||
149211577|NCT00517413|538242934|FG000|Overall Study|Other-Reasons|23|||
149211578|NCT00606177|538242935|FG000|Overall Study|Adverse Event|9|||
149211579|NCT00606177|538242936|FG001|Overall Study|Adverse Event|5|||
149211580|NCT00606177|538242935|FG000|Overall Study|Lack of Efficacy|3|||
149211581|NCT00606177|538242936|FG001|Overall Study|Lack of Efficacy|7|||
149211582|NCT00606177|538242935|FG000|Overall Study|Physician Decision|1|||
149211583|NCT00606177|538242936|FG001|Overall Study|Physician Decision|0|||
149211584|NCT00606177|538242935|FG000|Overall Study|Protocol Violation|1|||
149211585|NCT00606177|538242936|FG001|Overall Study|Protocol Violation|4|||
149211586|NCT00606177|538242935|FG000|Overall Study|Withdrawal by Subject|5|||
148684341|NCT01612156|536316775|FG000|Overall Study|Protocol Violation|2|||
148684342|NCT01612156|536316776|FG001|Overall Study|Protocol Violation|0|||
148684343|NCT00686920|536316777|FG000|Overall Study|Death|45|||
148684344|NCT00686920|536316778|FG001|Overall Study|Death|14|||
148684345|NCT00686920|536316777|FG000|Overall Study|Liver Transplant|23|||
148684346|NCT00686920|536316778|FG001|Overall Study|Liver Transplant|8|||
148684347|NCT00686920|536316777|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
148684348|NCT00686920|536316778|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
148684349|NCT00686920|536316777|FG000|Overall Study|Withdrawal by Subject|23|||
148684350|NCT00686920|536316778|FG001|Overall Study|Withdrawal by Subject|5|||
148684351|NCT00686920|536316777|FG000|Overall Study|Protocol Violation|2|||
148684352|NCT00686920|536316778|FG001|Overall Study|Protocol Violation|1|||
148684353|NCT00686920|536316777|FG000|Overall Study|Adverse Event|10|||
148684354|NCT00686920|536316778|FG001|Overall Study|Adverse Event|2|||
148684355|NCT00686920|536316777|FG000|Overall Study|Personal Reason|0|||
149211587|NCT00606177|538242936|FG001|Overall Study|Withdrawal by Subject|6|||
149211588|NCT00606177|538242935|FG000|Overall Study|Progression to depressive phase|6|||
149211589|NCT00606177|538242936|FG001|Overall Study|Progression to depressive phase|1|||
149211590|NCT00606177|538242935|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
149211591|NCT00606177|538242936|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
149211592|NCT00606177|538242935|FG000|Overall Study|Change of residence or other commitments|1|||
149211593|NCT00606177|538242936|FG001|Overall Study|Change of residence or other commitments|1|||
149211594|NCT02603172|538242937|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211595|NCT02603172|538242938|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211596|NCT02603172|538242939|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
149211597|NCT02603172|538242940|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211598|NCT02603172|538242941|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211599|NCT02603172|538242942|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211600|NCT02603172|538242943|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211601|NCT02603172|538242944|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
149211602|NCT00420342|538242949|FG000|Overall Study|Lost to Follow-up|1|||
149211603|NCT00420342|538242950|FG001|Overall Study|Lost to Follow-up|0|||
149211604|NCT00420342|538242951|FG002|Overall Study|Lost to Follow-up|1|||
149211605|NCT00420342|538242949|FG000|Overall Study|Withdrawal by Subject|0|||
148684356|NCT00686920|536316778|FG001|Overall Study|Personal Reason|1|||
148684357|NCT00686920|536316777|FG000|Overall Study|Lost to Follow-up|15|||
148684358|NCT00686920|536316778|FG001|Overall Study|Lost to Follow-up|3|||
148684359|NCT00686920|536316777|FG000|Overall Study|Moved to Another State|1|||
148684360|NCT00686920|536316778|FG001|Overall Study|Moved to Another State|0|||
148684361|NCT00686920|536316777|FG000|Overall Study|Transferred to Nursing Home|1|||
149211606|NCT00420342|538242950|FG001|Overall Study|Withdrawal by Subject|2|||
149211607|NCT00420342|538242951|FG002|Overall Study|Withdrawal by Subject|0|||
149211608|NCT00839436|538242952|FG000|Overall Study|Developed exclusionary condition|1|||
149211609|NCT00839436|538242953|FG001|Overall Study|Developed exclusionary condition|0|||
149211610|NCT00839436|538242954|FG002|Overall Study|Developed exclusionary condition|0|||
149211611|NCT00839436|538242952|FG000|Overall Study|Withdrawal by Subject|0|||
149211612|NCT00839436|538242953|FG001|Overall Study|Withdrawal by Subject|1|||
149211613|NCT00839436|538242954|FG002|Overall Study|Withdrawal by Subject|0|||
149211614|NCT00839436|538242952|FG000|Overall Study|Study drug no longer available|0|||
148684362|NCT00686920|536316778|FG001|Overall Study|Transferred to Nursing Home|0|||
148684363|NCT00686920|536316777|FG000|Overall Study|Noncompliance|9|||
149211615|NCT00839436|538242953|FG001|Overall Study|Study drug no longer available|0|||
149211616|NCT00839436|538242954|FG002|Overall Study|Study drug no longer available|1|||
149211617|NCT01440972|538242955|FG000|Overall Study|Withdrawal by Subject|3|||
149211618|NCT01440972|538242956|FG001|Overall Study|Withdrawal by Subject|2|||
148684364|NCT00686920|536316778|FG001|Overall Study|Noncompliance|0|||
148684365|NCT00686920|536316777|FG000|Overall Study|Principal Investigator Decision|2|||
148684366|NCT00686920|536316778|FG001|Overall Study|Principal Investigator Decision|0|||
149211619|NCT03933215|538242957|FG000|Overall Study|Other|6|||
149211620|NCT03933215|538242957|FG000|Overall Study|Sponsor decision|5|||
149211621|NCT03933215|538242957|FG000|Overall Study|Protocol Violation|5|||
148684367|NCT02974114|536316785|FG000|Overall Study|Other (Not specified)|0|||
149211622|NCT03933215|538242957|FG000|Overall Study|Withdrawal by Subject|6|||
149211623|NCT03933215|538242957|FG000|Overall Study|Lost to Follow-up|6|||
149211624|NCT03933215|538242957|FG000|Overall Study|Enrolled but not treated|38|||
149211625|NCT05784129|538242958|FG000|Overall Study|Study terminated by sponsor|2|||
149211626|NCT05784129|538242959|FG001|Overall Study|Study terminated by sponsor|2|||
149211627|NCT00407550|538242960|FG000|Overall Study|Adverse Event|0|||
149211628|NCT00407550|538242961|FG001|Overall Study|Adverse Event|1|||
149211629|NCT00407550|538242960|FG000|Overall Study|Withdrawal by Subject|0|||
149211630|NCT00407550|538242961|FG001|Overall Study|Withdrawal by Subject|2|||
149211631|NCT00407550|538242960|FG000|Overall Study|Death|1|||
149211632|NCT00407550|538242961|FG001|Overall Study|Death|0|||
149211633|NCT00407550|538242960|FG000|Overall Study|Insurance or Other medical condition|2|||
149211634|NCT00407550|538242961|FG001|Overall Study|Insurance or Other medical condition|1|||
149211635|NCT02580591|538242963|FG000|Overall Study|Adverse Event|0|||
149211636|NCT02580591|538242964|FG001|Overall Study|Adverse Event|1|||
149211637|NCT02580591|538242965|FG002|Overall Study|Adverse Event|2|||
149211638|NCT02580591|538242966|FG003|Overall Study|Adverse Event|5|||
149211639|NCT02580591|538242963|FG000|Overall Study|Protocol Violation|3|||
149211640|NCT02580591|538242964|FG001|Overall Study|Protocol Violation|2|||
149211641|NCT02580591|538242965|FG002|Overall Study|Protocol Violation|1|||
149211642|NCT02580591|538242966|FG003|Overall Study|Protocol Violation|1|||
149211643|NCT02580591|538242963|FG000|Overall Study|Lost to Follow-up|5|||
149211644|NCT02580591|538242964|FG001|Overall Study|Lost to Follow-up|3|||
149211645|NCT02580591|538242965|FG002|Overall Study|Lost to Follow-up|3|||
149211646|NCT02580591|538242966|FG003|Overall Study|Lost to Follow-up|1|||
149211647|NCT02580591|538242963|FG000|Overall Study|Withdrawal by Subject|6|||
148684368|NCT02974114|536316786|FG001|Overall Study|Other (Not specified)|1|||
148684369|NCT02974114|536316787|FG002|Overall Study|Other (Not specified)|2|||
148684370|NCT01138150|536316790|FG000|Overall Study|blood unable to be processed|0|||
148684371|NCT01138150|536316791|FG001|Overall Study|blood unable to be processed|1|||
148684372|NCT01138150|536316790|FG000|Overall Study|Physician Decision|1|||
148684373|NCT01138150|536316791|FG001|Overall Study|Physician Decision|0|||
148684374|NCT00545233|536316792|FG000|Overall Study|Adverse Event|10|||
148684375|NCT00545233|536316793|FG001|Overall Study|Adverse Event|5|||
148684376|NCT00545233|536316792|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
148684377|NCT00545233|536316793|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
148684378|NCT00545233|536316792|FG000|Overall Study|Protocol Violation|2|||
148684379|NCT00545233|536316793|FG001|Overall Study|Protocol Violation|0|||
148684380|NCT00545233|536316792|FG000|Overall Study|Refused Treatment|9|||
148684381|NCT00545233|536316793|FG001|Overall Study|Refused Treatment|7|||
148684382|NCT00545233|536316792|FG000|Overall Study|Failure to Return|4|||
148684383|NCT00545233|536316793|FG001|Overall Study|Failure to Return|6|||
149211648|NCT02580591|538242964|FG001|Overall Study|Withdrawal by Subject|1|||
149211649|NCT02580591|538242965|FG002|Overall Study|Withdrawal by Subject|2|||
149211650|NCT02580591|538242966|FG003|Overall Study|Withdrawal by Subject|3|||
149211651|NCT02580591|538242963|FG000|Overall Study|Not treated|1|||
149211652|NCT02580591|538242964|FG001|Overall Study|Not treated|1|||
149211653|NCT02580591|538242965|FG002|Overall Study|Not treated|0|||
148684384|NCT00545233|536316792|FG000|Overall Study|Insufficient response|14|||
148684385|NCT00545233|536316793|FG001|Overall Study|Insufficient response|15|||
148684386|NCT00545233|536316792|FG000|Overall Study|Physician Decision|2|||
148684387|NCT00545233|536316793|FG001|Overall Study|Physician Decision|1|||
148684388|NCT03811249|536316798|FG000|Overall Study|Withdrawal by Subject|44|||
148684389|NCT03811249|536316798|FG000|Overall Study|Missed Visit|24|||
148684390|NCT01504867|536316802|FG000|Overall Study|Inclusion criteria not met|2|||
148684391|NCT01504867|536316803|FG001|Overall Study|Inclusion criteria not met|2|||
148950046|NCT03129100|537299663|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950047|NCT03129100|537299664|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950048|NCT03129100|537299665|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
148950049|NCT03129100|537299666|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950050|NCT03129100|537299667|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
148950051|NCT03129100|537299668|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
148950052|NCT03129100|537299669|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950053|NCT03129100|537299670|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950054|NCT03129100|537299671|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950055|NCT03129100|537299672|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950056|NCT03129100|537299673|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148684392|NCT01504867|536316802|FG000|Overall Study|Consent revoked|5|||
148684393|NCT01504867|536316803|FG001|Overall Study|Consent revoked|1|||
148684394|NCT00571922|536316804|FG000|Overall Study|Completion unknown|36|||
148684395|NCT00571922|536316805|FG001|Overall Study|Completion unknown|36|||
148950057|NCT03129100|537299674|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
149211654|NCT02580591|538242966|FG003|Overall Study|Not treated|0|||
149211655|NCT02580591|538242963|FG000|Overall Study|Other than specified|3|||
149211656|NCT02580591|538242964|FG001|Overall Study|Other than specified|2|||
148684396|NCT01783730|536316812|FG000|Overall Study|Failed to meet inclusion criteria|6|||
148684397|NCT02151461|536316813|FG000|Overall Study|Adverse Event|5|||
148684398|NCT02151461|536316814|FG001|Overall Study|Adverse Event|1|||
149211657|NCT02580591|538242965|FG002|Overall Study|Other than specified|5|||
149211658|NCT02580591|538242966|FG003|Overall Study|Other than specified|2|||
149211659|NCT01599806|538242970|FG000|Overall Study|Lost to Follow-up|20|||
149211660|NCT01599806|538242971|FG001|Overall Study|Lost to Follow-up|20|||
149211661|NCT01599806|538242970|FG000|Overall Study|Withdrawal by Subject|12|||
149211662|NCT01599806|538242971|FG001|Overall Study|Withdrawal by Subject|12|||
148684399|NCT02151461|536316815|FG002|Overall Study|Adverse Event|0|||
148684400|NCT02151461|536316816|FG003|Overall Study|Adverse Event|2|||
148684401|NCT02151461|536316813|FG000|Overall Study|Lost to Follow-up|0|||
149211663|NCT01599806|538242970|FG000|Overall Study|Other Eligibility criteria|11|||
149211664|NCT01599806|538242971|FG001|Overall Study|Other Eligibility criteria|9|||
149211665|NCT00282568|538242983|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
149211666|NCT00282568|538242983|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
149211667|NCT00282568|538242983|FG000|Extended Treatment Period|Adverse Event|17|||
149211668|NCT00282568|538242983|FG000|Extended Treatment Period|Non-compliance|4|||
149211669|NCT00282568|538242983|FG000|Extended Treatment Period|Physician Decision|1|||
149211670|NCT00282568|538242983|FG000|Extended Treatment Period|Lost to Follow-up|2|||
149211671|NCT03006926|538242984|FG000|Overall Study|Adverse Event|0|||
149211672|NCT03006926|538242985|FG001|Overall Study|Adverse Event|27|||
149211673|NCT03006926|538242984|FG000|Overall Study|Withdrawal by Subject|0|||
149211674|NCT03006926|538242985|FG001|Overall Study|Withdrawal by Subject|1|||
149211675|NCT03006926|538242984|FG000|Overall Study|Radiological Disease Progression|0|||
149211676|NCT03006926|538242985|FG001|Overall Study|Radiological Disease Progression|52|||
149211677|NCT03006926|538242984|FG000|Overall Study|Clinical Disease Progression|0|||
149211678|NCT03006926|538242985|FG001|Overall Study|Clinical Disease Progression|10|||
149211679|NCT03006926|538242984|FG000|Overall Study|Other|0|||
149211680|NCT03006926|538242985|FG001|Overall Study|Other|8|||
149211681|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
149211682|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
149211683|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
149211684|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
149211685|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
149211686|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149211687|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
149211688|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149211689|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149211690|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
149211691|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149211692|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
149211693|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149211694|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149211695|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
149211696|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
149211697|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
149211698|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
149211699|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
149211700|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
149211701|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
149211702|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
149211703|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
149211704|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
149211705|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
149211706|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
149211707|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
149211708|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
149211709|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
149211710|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
149211711|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
149211712|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
149211713|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
149211714|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
149211715|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
149211716|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
148684402|NCT02151461|536316814|FG001|Overall Study|Lost to Follow-up|0|||
148684403|NCT02151461|536316815|FG002|Overall Study|Lost to Follow-up|1|||
149211717|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
148684404|NCT02151461|536316816|FG003|Overall Study|Lost to Follow-up|1|||
149211718|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
149211719|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
149211720|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
149211721|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
149211722|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
149211723|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
149211724|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
149211725|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
149211726|NCT03689972|538242986|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
149211727|NCT03689972|538242987|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
149016493|NCT04642469|537538842|FG000|Overall Study|Study/site closed following amendment 1|11|||
148809374|NCT01283386|536779288|FG001|Overall Study|Reason not specified|0|||
148809375|NCT01283386|536779287|FG000|Overall Study|Protocol Violation|0|||
148809376|NCT01283386|536779288|FG001|Overall Study|Protocol Violation|1|||
148809377|NCT02110693|536779289|FG000|Overall Study|Withdrawal by Subject|6|||
148809378|NCT02110693|536779290|FG001|Overall Study|Withdrawal by Subject|7|||
148809379|NCT02110693|536779289|FG000|Overall Study|skipped assessment|15|||
148809380|NCT02110693|536779290|FG001|Overall Study|skipped assessment|18|||
148809381|NCT02110693|536779289|FG000|Overall Study|technical difficulties|6|||
148809382|NCT02110693|536779290|FG001|Overall Study|technical difficulties|4|||
148809383|NCT02110693|536779289|FG000|Overall Study|Other|1|||
148809384|NCT02110693|536779290|FG001|Overall Study|Other|0|||
148809385|NCT04167462|536779297|FG000|Overall Study|Other reasons|3|||
148809386|NCT04167462|536779298|FG001|Overall Study|Other reasons|2|||
148809387|NCT04167462|536779297|FG000|Overall Study|Withdrawal by Subject|6|||
148809388|NCT04167462|536779298|FG001|Overall Study|Withdrawal by Subject|7|||
148809389|NCT04167462|536779297|FG000|Overall Study|Adverse Event|4|||
148809390|NCT04167462|536779298|FG001|Overall Study|Adverse Event|0|||
148809391|NCT04167462|536779297|FG000|Overall Study|Pregnancy|1|||
148809392|NCT04167462|536779298|FG001|Overall Study|Pregnancy|0|||
148809393|NCT04167462|536779297|FG000|Overall Study|Lack of Efficacy|0|||
148809394|NCT04167462|536779298|FG001|Overall Study|Lack of Efficacy|1|||
148809395|NCT01186770|536779299|FG000|Overall Study|Ineligibility|0|||
148809396|NCT01186770|536779300|FG001|Overall Study|Ineligibility|0|||
148809397|NCT01186770|536779301|FG002|Overall Study|Ineligibility|2|||
148809398|NCT01186770|536779302|FG003|Overall Study|Ineligibility|0|||
148809399|NCT01186770|536779299|FG000|Overall Study|Protocol Violation|7|||
148809400|NCT01186770|536779300|FG001|Overall Study|Protocol Violation|9|||
148809401|NCT01186770|536779301|FG002|Overall Study|Protocol Violation|12|||
148809402|NCT01186770|536779302|FG003|Overall Study|Protocol Violation|14|||
149016494|NCT04642469|537538843|FG001|Overall Study|Study/site closed following amendment 1|11|||
149016495|NCT04642469|537538842|FG000|Overall Study|Other|1|||
149016496|NCT04642469|537538843|FG001|Overall Study|Other|1|||
149016497|NCT04642469|537538842|FG000|Overall Study|Withdrawal by Subject|1|||
149016498|NCT04642469|537538843|FG001|Overall Study|Withdrawal by Subject|0|||
149016499|NCT01088529|537538845|FG000|Overall Study|Did not receive study treatment|0|||
149016500|NCT01088529|537538846|FG001|Overall Study|Did not receive study treatment|1|||
149016501|NCT01265823|537538847|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
149016502|NCT01265823|537538847|FG000|Overall Study|Failure to Return|4|||
149016503|NCT01265823|537538847|FG000|Overall Study|Protocol Violation|1|||
149016504|NCT01265823|537538847|FG000|Overall Study|Participant Request|1|||
149016505|NCT01263106|537538848|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
149211728|NCT03689972|538242988|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
149211729|NCT03689972|538242989|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
149211730|NCT03689972|538242990|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
149211731|NCT03689972|538242986|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149211732|NCT03689972|538242987|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149211733|NCT03689972|538242988|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
149211734|NCT03689972|538242989|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149211735|NCT03689972|538242990|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
149211736|NCT03689972|538242986|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149211737|NCT03689972|538242987|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149211738|NCT03689972|538242988|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
149211739|NCT03689972|538242989|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149211740|NCT03689972|538242990|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
149211741|NCT03689972|538242986|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149211742|NCT03689972|538242987|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149211743|NCT03689972|538242988|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
149211744|NCT03689972|538242989|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149211745|NCT03689972|538242990|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
149211746|NCT03689972|538242986|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
149211747|NCT03689972|538242987|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
149211748|NCT03689972|538242988|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
149211749|NCT03689972|538242989|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
149211750|NCT03689972|538242990|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
149211751|NCT03689972|538242986|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
149211752|NCT03689972|538242987|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
149211753|NCT03689972|538242988|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
149211754|NCT03689972|538242989|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
149211755|NCT03689972|538242990|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
149211756|NCT03689972|538242986|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
149211757|NCT03689972|538242987|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
149211758|NCT03689972|538242988|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
149211759|NCT03689972|538242989|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
149211760|NCT03689972|538242990|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
149211761|NCT03689972|538242986|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149211762|NCT03689972|538242987|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149211763|NCT03689972|538242988|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149211764|NCT03689972|538242989|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
149211765|NCT03689972|538242990|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
149211766|NCT03689972|538242986|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
149211767|NCT03689972|538242987|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
149211768|NCT03689972|538242988|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
149211769|NCT03689972|538242989|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
149211770|NCT03689972|538242990|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
149211771|NCT03689972|538242986|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149211772|NCT03689972|538242987|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149211773|NCT03689972|538242988|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149211774|NCT03689972|538242989|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
149211775|NCT03689972|538242990|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
149211776|NCT02417064|538242995|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
149211777|NCT02417064|538242996|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
149211778|NCT02417064|538242997|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
149211779|NCT02417064|538242995|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
149211780|NCT02417064|538242996|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
149211781|NCT02417064|538242997|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
149211782|NCT02417064|538242995|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
149211783|NCT02417064|538242996|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
149211784|NCT02417064|538242997|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
149211785|NCT02417064|538242995|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
149211786|NCT02417064|538242996|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
149211787|NCT02417064|538242997|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
149211788|NCT02417064|538242995|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
149211789|NCT02417064|538242996|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
149211790|NCT02417064|538242997|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
149211791|NCT02417064|538242995|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
149211792|NCT02417064|538242996|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
149211793|NCT02417064|538242997|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
149211794|NCT02417064|538242995|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
149211795|NCT02417064|538242996|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
149211796|NCT02417064|538242997|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
149211797|NCT02417064|538242995|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
149211798|NCT02417064|538242996|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
149211799|NCT02417064|538242997|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
149211800|NCT02417064|538242995|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
149211801|NCT02417064|538242996|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
149211802|NCT02417064|538242997|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
149211803|NCT02417064|538242995|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
149211804|NCT02417064|538242996|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
149211805|NCT02417064|538242997|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
149211806|NCT02417064|538242995|FG000|Follow-up Phase (24 Weeks)|Other|2|||
148950058|NCT03129100|537299675|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950059|NCT03129100|537299676|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950060|NCT03129100|537299677|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950061|NCT03129100|537299678|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
148950062|NCT03129100|537299653|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950063|NCT03129100|537299654|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950064|NCT03129100|537299655|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950065|NCT03129100|537299656|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950066|NCT03129100|537299657|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950067|NCT03129100|537299658|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950068|NCT03129100|537299659|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950069|NCT03129100|537299660|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950070|NCT03129100|537299661|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950071|NCT03129100|537299662|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950072|NCT03129100|537299663|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950073|NCT03129100|537299664|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950074|NCT03129100|537299665|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950075|NCT03129100|537299666|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950076|NCT03129100|537299667|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950077|NCT03129100|537299668|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950078|NCT03129100|537299669|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950079|NCT03129100|537299670|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
148950080|NCT03129100|537299671|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950081|NCT03129100|537299672|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
148950082|NCT03129100|537299673|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950083|NCT03129100|537299674|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950084|NCT03129100|537299675|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950085|NCT03129100|537299676|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950086|NCT03129100|537299677|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950087|NCT03129100|537299678|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
148950088|NCT03129100|537299653|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950089|NCT03129100|537299654|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950090|NCT03129100|537299655|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950091|NCT03129100|537299656|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950092|NCT03129100|537299657|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950093|NCT03129100|537299658|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950094|NCT03129100|537299659|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950095|NCT03129100|537299660|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950096|NCT03129100|537299661|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950097|NCT03129100|537299662|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950098|NCT03129100|537299663|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
149211807|NCT02417064|538242996|FG001|Follow-up Phase (24 Weeks)|Other|2|||
149211808|NCT02417064|538242997|FG002|Follow-up Phase (24 Weeks)|Other|3|||
149211809|NCT00990249|538242998|FG000|Overall Study|Disease Progression|8|||
149211810|NCT00990249|538242998|FG000|Overall Study|Non-Compliance|1|||
149211811|NCT00990249|538242998|FG000|Overall Study|Death|2|||
149211812|NCT00990249|538242998|FG000|Overall Study|Not treated|2|||
149211813|NCT01548417|538242999|FG000|Overall Study|Withdrawal by Subject|0|||
149211814|NCT01548417|538243000|FG001|Overall Study|Withdrawal by Subject|2|||
149211815|NCT00732641|538243003|FG000|Overall Study|Relapse or Progressive Disease|65|||
149211816|NCT00732641|538243004|FG001|Overall Study|Relapse or Progressive Disease|101|||
149211817|NCT00732641|538243003|FG000|Overall Study|Serious Adverse Events|12|||
149211818|NCT00732641|538243004|FG001|Overall Study|Serious Adverse Events|3|||
148950099|NCT03129100|537299664|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950100|NCT03129100|537299665|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950101|NCT03129100|537299666|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
149211819|NCT00732641|538243003|FG000|Overall Study|Physician Decision|6|||
149211820|NCT00732641|538243004|FG001|Overall Study|Physician Decision|0|||
149211821|NCT00732641|538243003|FG000|Overall Study|Withdrawal by Subject|4|||
149211822|NCT00732641|538243004|FG001|Overall Study|Withdrawal by Subject|2|||
149211823|NCT00732641|538243003|FG000|Overall Study|Unable to Complete|1|||
149211824|NCT00732641|538243004|FG001|Overall Study|Unable to Complete|1|||
149016506|NCT01263106|537538849|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
149016507|NCT02302066|537538852|FG000|Overall Study|Adverse Event|1|||
149016508|NCT02302066|537538853|FG001|Overall Study|Adverse Event|1|||
149016509|NCT02302066|537538854|FG002|Overall Study|Adverse Event|3|||
149016510|NCT02302066|537538855|FG003|Overall Study|Adverse Event|0|||
149016511|NCT02302066|537538852|FG000|Overall Study|Lost to Follow-up|4|||
149016512|NCT02302066|537538853|FG001|Overall Study|Lost to Follow-up|5|||
149016513|NCT02302066|537538854|FG002|Overall Study|Lost to Follow-up|24|||
149016514|NCT02302066|537538855|FG003|Overall Study|Lost to Follow-up|7|||
149016515|NCT02302066|537538852|FG000|Overall Study|Withdrawal by Subject|25|||
149016516|NCT02302066|537538853|FG001|Overall Study|Withdrawal by Subject|58|||
148809403|NCT01186770|536779299|FG000|Overall Study|Adverse Event|2|||
148809404|NCT01186770|536779300|FG001|Overall Study|Adverse Event|9|||
148809405|NCT01186770|536779301|FG002|Overall Study|Adverse Event|7|||
148809406|NCT01186770|536779302|FG003|Overall Study|Adverse Event|9|||
148684405|NCT02151461|536316813|FG000|Overall Study|Withdrawal by Subject|1|||
148684406|NCT02151461|536316814|FG001|Overall Study|Withdrawal by Subject|0|||
148684407|NCT02151461|536316815|FG002|Overall Study|Withdrawal by Subject|1|||
149016517|NCT02302066|537538854|FG002|Overall Study|Withdrawal by Subject|124|||
149016518|NCT02302066|537538855|FG003|Overall Study|Withdrawal by Subject|33|||
149016519|NCT02302066|537538852|FG000|Overall Study|Pregnancy|2|||
149016520|NCT02302066|537538853|FG001|Overall Study|Pregnancy|10|||
149016521|NCT02302066|537538854|FG002|Overall Study|Pregnancy|12|||
149016522|NCT02302066|537538855|FG003|Overall Study|Pregnancy|0|||
149016523|NCT02302066|537538852|FG000|Overall Study|Reason Not Specified|1|||
149016524|NCT02302066|537538853|FG001|Overall Study|Reason Not Specified|1|||
149016525|NCT02302066|537538854|FG002|Overall Study|Reason Not Specified|9|||
149016526|NCT02302066|537538855|FG003|Overall Study|Reason Not Specified|1|||
149016527|NCT02180438|537538871|FG000|Overall Study|Lost to Follow-up|1|||
149016528|NCT02058290|537538872|FG000|Overall Study|Protocol Violation|2|||
149016529|NCT02058290|537538873|FG001|Overall Study|Protocol Violation|1|||
149016530|NCT02058290|537538872|FG000|Overall Study|Physician Decision|1|||
149016531|NCT02058290|537538873|FG001|Overall Study|Physician Decision|0|||
149016532|NCT02058290|537538872|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
149016533|NCT02058290|537538873|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
149016534|NCT02058290|537538872|FG000|Overall Study|Withdrawal by Subject|0|||
149016535|NCT02058290|537538873|FG001|Overall Study|Withdrawal by Subject|1|||
148684408|NCT02151461|536316816|FG003|Overall Study|Withdrawal by Subject|1|||
148684409|NCT02151461|536316813|FG000|Overall Study|Treatment discontinuation|0|||
148684410|NCT02151461|536316814|FG001|Overall Study|Treatment discontinuation|0|||
148684411|NCT02151461|536316815|FG002|Overall Study|Treatment discontinuation|1|||
148684412|NCT02151461|536316816|FG003|Overall Study|Treatment discontinuation|0|||
148684413|NCT01154153|536316817|FG000|Overall Study|Poor compliance to protocol|2|||
148684414|NCT01154153|536316818|FG001|Overall Study|Poor compliance to protocol|0|||
148684415|NCT01154153|536316817|FG000|Overall Study|Unable to use labs|2|||
148684416|NCT01154153|536316818|FG001|Overall Study|Unable to use labs|3|||
148684417|NCT01154153|536316817|FG000|Overall Study|Withdrew consent|1|||
148684418|NCT01154153|536316818|FG001|Overall Study|Withdrew consent|0|||
148684419|NCT02473510|536316819|FG000|Overall Study|Lost to Follow-up|1|||
148684420|NCT02473510|536316820|FG001|Overall Study|Lost to Follow-up|2|||
148684421|NCT00964223|536316830|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
148684422|NCT04304950|536316831|FG000|Overall Study|Lost to Follow-up|1|||
148684423|NCT04304950|536316832|FG001|Overall Study|Lost to Follow-up|1|||
148684424|NCT00408876|536316837|FG000|Overall Study|Adverse Event|9|||
148684425|NCT00408876|536316838|FG001|Overall Study|Adverse Event|17|||
149016536|NCT00785707|537538875|FG000|Overall Study|Lost to Follow-up|7|||
149016537|NCT00105586|537538878|FG000|Overall Study|Adverse Event|4|||
149016538|NCT00105586|537538879|FG001|Overall Study|Adverse Event|3|||
148684426|NCT00408876|536316839|FG002|Overall Study|Adverse Event|27|||
149016539|NCT00105586|537538878|FG000|Overall Study|Physician Decision|13|||
149016540|NCT00105586|537538879|FG001|Overall Study|Physician Decision|13|||
149016541|NCT02262260|537538882|FG000|Overall Study|Adverse Event|4|||
149016542|NCT02262260|537538883|FG001|Overall Study|Adverse Event|1|||
149016543|NCT02262260|537538882|FG000|Overall Study|Withdrawal of consent|4|||
149016544|NCT02262260|537538883|FG001|Overall Study|Withdrawal of consent|2|||
149016545|NCT02262260|537538882|FG000|Overall Study|Lost to Follow-up|1|||
149016546|NCT02262260|537538883|FG001|Overall Study|Lost to Follow-up|2|||
149016547|NCT02262260|537538882|FG000|Overall Study|Protocol deviation|2|||
149016548|NCT02262260|537538883|FG001|Overall Study|Protocol deviation|5|||
149016549|NCT01794117|537538884|FG000|Overall Study|Adverse Event|1|||
149211825|NCT00732641|538243003|FG000|Overall Study|Other|18|||
149211826|NCT00732641|538243004|FG001|Overall Study|Other|5|||
149211827|NCT02873208|538243005|FG000|Overall Study|Withdrawal by Subject|36|||
149211828|NCT02873208|538243005|FG000|Overall Study|Lost to Follow-up|22|||
148950102|NCT03129100|537299667|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
149211829|NCT02873208|538243005|FG000|Overall Study|Adverse Event|15|||
149211830|NCT02873208|538243005|FG000|Overall Study|Non-compliance with study drug|12|||
149211831|NCT02873208|538243005|FG000|Overall Study|Protocol Violation|8|||
148950103|NCT03129100|537299668|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
149211832|NCT02873208|538243005|FG000|Overall Study|Pregnancy|2|||
149211833|NCT02873208|538243005|FG000|Overall Study|Incarceration|1|||
149211834|NCT02873208|538243005|FG000|Overall Study|Lack of Efficacy|1|||
149211835|NCT02873208|538243005|FG000|Overall Study|Physician Decision|1|||
149211836|NCT00415584|538243006|FG000|Overall Study|Withdrawal by Subject|1|||
149211837|NCT02640755|538243007|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
149211838|NCT02640755|538243008|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
149211839|NCT02640755|538243007|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
149211840|NCT02640755|538243008|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
149211841|NCT02640755|538243007|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
149211842|NCT02640755|538243008|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
149211843|NCT01192100|538243015|FG000|Overall Study|Withdrawal by Subject|0|||
149211844|NCT01192100|538243016|FG001|Overall Study|Withdrawal by Subject|0|||
149211845|NCT01192100|538243017|FG002|Overall Study|Withdrawal by Subject|0|||
149211846|NCT01192100|538243018|FG003|Overall Study|Withdrawal by Subject|0|||
149211847|NCT01192100|538243019|FG004|Overall Study|Withdrawal by Subject|1|||
149211848|NCT01192100|538243020|FG005|Overall Study|Withdrawal by Subject|0|||
149211849|NCT01192100|538243015|FG000|Overall Study|Protocol Violation|0|||
149211850|NCT01192100|538243016|FG001|Overall Study|Protocol Violation|0|||
149211851|NCT01192100|538243017|FG002|Overall Study|Protocol Violation|0|||
149211852|NCT01192100|538243018|FG003|Overall Study|Protocol Violation|1|||
149211853|NCT01192100|538243019|FG004|Overall Study|Protocol Violation|0|||
149211854|NCT01192100|538243020|FG005|Overall Study|Protocol Violation|0|||
149211855|NCT02057068|538243021|FG000|Overall Study|Withdrawal by Subject|2|||
149211856|NCT02057068|538243022|FG001|Overall Study|Withdrawal by Subject|2|||
149211857|NCT02057068|538243021|FG000|Overall Study|Caregiver (CG) Health|0|||
149211858|NCT02057068|538243022|FG001|Overall Study|Caregiver (CG) Health|2|||
149211859|NCT02057068|538243021|FG000|Overall Study|Carepartner (CP) Health|4|||
149211860|NCT02057068|538243022|FG001|Overall Study|Carepartner (CP) Health|2|||
149211861|NCT02057068|538243021|FG000|Overall Study|Lost to Follow-up|2|||
149211862|NCT02057068|538243022|FG001|Overall Study|Lost to Follow-up|2|||
149211863|NCT00865046|538243023|FG000|Overall Study|Lost to Follow-up|1|||
149211864|NCT00865046|538243024|FG001|Overall Study|Lost to Follow-up|4|||
149211865|NCT00865046|538243025|FG002|Overall Study|Lost to Follow-up|0|||
149211866|NCT00865046|538243023|FG000|Overall Study|Death|0|||
149211867|NCT00865046|538243024|FG001|Overall Study|Death|1|||
149211868|NCT00865046|538243025|FG002|Overall Study|Death|1|||
149211869|NCT00865046|538243023|FG000|Overall Study|Withdrawal by Subject|5|||
149211870|NCT00865046|538243024|FG001|Overall Study|Withdrawal by Subject|0|||
149211871|NCT00865046|538243025|FG002|Overall Study|Withdrawal by Subject|0|||
149211872|NCT02959190|538243026|FG000|Open Label|Adverse Event|5|||
149211873|NCT02959190|538243027|FG001|Open Label|Adverse Event|7|||
149211874|NCT02959190|538243028|FG002|Open Label|Adverse Event|3|||
149211875|NCT02959190|538243029|FG003|Open Label|Adverse Event|4|||
149211876|NCT02959190|538243026|FG000|Open Label|Pregnancy|0|||
149211877|NCT02959190|538243027|FG001|Open Label|Pregnancy|1|||
149211878|NCT02959190|538243028|FG002|Open Label|Pregnancy|0|||
149211879|NCT02959190|538243029|FG003|Open Label|Pregnancy|0|||
149211880|NCT02959190|538243026|FG000|Open Label|Withdrawal by Subject|2|||
149211881|NCT02959190|538243027|FG001|Open Label|Withdrawal by Subject|8|||
149211882|NCT02959190|538243028|FG002|Open Label|Withdrawal by Subject|0|||
149211883|NCT02959190|538243029|FG003|Open Label|Withdrawal by Subject|0|||
149211884|NCT02959190|538243026|FG000|Open Label|Physician Decision|0|||
149211885|NCT02959190|538243027|FG001|Open Label|Physician Decision|0|||
149211886|NCT02959190|538243028|FG002|Open Label|Physician Decision|1|||
148950104|NCT03129100|537299669|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950105|NCT03129100|537299670|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
149211887|NCT02959190|538243029|FG003|Open Label|Physician Decision|0|||
149211888|NCT02959190|538243026|FG000|Open Label|Protocol Violation|0|||
149211889|NCT02959190|538243027|FG001|Open Label|Protocol Violation|0|||
149211890|NCT02959190|538243028|FG002|Open Label|Protocol Violation|0|||
149211891|NCT02959190|538243029|FG003|Open Label|Protocol Violation|2|||
149211892|NCT02959190|538243026|FG000|Post Treatment Follow Up|Adverse Event|1|||
149211893|NCT02959190|538243027|FG001|Post Treatment Follow Up|Adverse Event|1|||
149211894|NCT02959190|538243028|FG002|Post Treatment Follow Up|Adverse Event|0|||
149211895|NCT02959190|538243029|FG003|Post Treatment Follow Up|Adverse Event|0|||
149211896|NCT02959190|538243026|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
149211897|NCT02959190|538243027|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
149211898|NCT02959190|538243028|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
149211899|NCT02959190|538243029|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
149211900|NCT01235507|538243031|FG000|Overall Study|Adverse Event|1|||
149211901|NCT01235507|538243031|FG000|Overall Study|Withdrawal by Subject|1|||
149211902|NCT02017704|538243034|FG000|Overall Study|Withdrawal by Subject|2|||
149211903|NCT02017704|538243035|FG001|Overall Study|Withdrawal by Subject|0|||
149211904|NCT01587274|538243036|FG000|Overall Study|Lost to Follow-up|4|||
149211905|NCT01587274|538243037|FG001|Overall Study|Lost to Follow-up|5|||
149211906|NCT01587274|538243038|FG002|Overall Study|Lost to Follow-up|3|||
149211907|NCT01095666|538243042|FG000|Overall Study|Lack of Efficacy|0|||
149211908|NCT01095666|538243043|FG001|Overall Study|Lack of Efficacy|0|||
149211909|NCT01095666|538243044|FG002|Overall Study|Lack of Efficacy|1|||
149211910|NCT01095666|538243042|FG000|Overall Study|Adverse Event|2|||
149211911|NCT01095666|538243043|FG001|Overall Study|Adverse Event|1|||
149211912|NCT01095666|538243044|FG002|Overall Study|Adverse Event|3|||
149211913|NCT01095666|538243042|FG000|Overall Study|Lost to Follow-up|2|||
149211914|NCT01095666|538243043|FG001|Overall Study|Lost to Follow-up|2|||
149211915|NCT01095666|538243044|FG002|Overall Study|Lost to Follow-up|0|||
149211916|NCT01095666|538243042|FG000|Overall Study|Withdrawal by Subject|6|||
149211917|NCT01095666|538243043|FG001|Overall Study|Withdrawal by Subject|6|||
149211918|NCT01095666|538243044|FG002|Overall Study|Withdrawal by Subject|1|||
149211919|NCT01095666|538243042|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
149211920|NCT01095666|538243043|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
149211921|NCT01095666|538243044|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
149211922|NCT03619837|538243049|FG000|Screening|received organs from HCV-negative donors|47|||
149211923|NCT03619837|538243049|FG000|Screening|died on the wait-list|2|||
149211924|NCT03619837|538243049|FG000|Screening|remained on the wait list|40|||
149211925|NCT03619837|538243049|FG000|Screening|didn't meet eligibility criteria|3|||
149211926|NCT03619837|538243049|FG000|Screening|withdrew consent|2|||
149211927|NCT03619837|538243049|FG000|Screening|never listed for HCV-viremic donor|1|||
149211928|NCT03619837|538243049|FG000|Screening|developed exclusion criteria|2|||
149211929|NCT03619837|538243049|FG000|Screening|excluded by the investigator due to non-compliance|1|||
149211930|NCT03627494|538243050|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
149211931|NCT03627494|538243051|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211932|NCT03627494|538243052|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
149211933|NCT03627494|538243053|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211934|NCT03627494|538243054|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211935|NCT03627494|538243055|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211936|NCT03627494|538243056|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211937|NCT03627494|538243057|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211938|NCT03627494|538243058|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211939|NCT03627494|538243059|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211940|NCT03627494|538243060|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211941|NCT03627494|538243061|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
149211942|NCT03627494|538243050|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211943|NCT03627494|538243051|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211944|NCT03627494|538243052|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211945|NCT03627494|538243053|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211946|NCT03627494|538243054|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211947|NCT03627494|538243055|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211948|NCT03627494|538243056|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211949|NCT03627494|538243057|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211950|NCT03627494|538243058|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
149211951|NCT03627494|538243059|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211952|NCT03627494|538243060|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211953|NCT03627494|538243061|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
149211954|NCT03627494|538243050|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211955|NCT03627494|538243051|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211956|NCT03627494|538243052|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211957|NCT03627494|538243053|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211958|NCT03627494|538243054|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211959|NCT03627494|538243055|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211960|NCT03627494|538243056|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211961|NCT03627494|538243057|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211962|NCT03627494|538243058|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211963|NCT03627494|538243059|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
149211964|NCT03627494|538243060|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
149211965|NCT03627494|538243061|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
149211966|NCT01696396|538244598|FG000|Overall Study|Withdrawal by Subject|19|||
149211967|NCT01696396|538244599|FG001|Overall Study|Withdrawal by Subject|5|||
149211968|NCT01696396|538244600|FG002|Overall Study|Withdrawal by Subject|19|||
149211969|NCT01696396|538244601|FG003|Overall Study|Withdrawal by Subject|11|||
149211970|NCT01696396|538244598|FG000|Overall Study|Decision by Sponsor|3|||
149211971|NCT01696396|538244599|FG001|Overall Study|Decision by Sponsor|1|||
148950106|NCT03129100|537299671|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950107|NCT03129100|537299672|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950108|NCT03129100|537299673|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
148950109|NCT03129100|537299674|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950110|NCT03129100|537299675|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950111|NCT03129100|537299676|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950112|NCT03129100|537299677|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950113|NCT03129100|537299678|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
148950114|NCT03129100|537299653|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
148950115|NCT03129100|537299654|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
148950116|NCT03129100|537299655|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
148950117|NCT03129100|537299656|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
148950118|NCT03129100|537299657|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
148950119|NCT03129100|537299658|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
149211972|NCT01696396|538244600|FG002|Overall Study|Decision by Sponsor|2|||
148950120|NCT03129100|537299659|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
148950121|NCT03129100|537299660|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
148950122|NCT03129100|537299661|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
148950123|NCT03129100|537299662|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
148950124|NCT03129100|537299663|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
148950125|NCT03129100|537299664|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
148950126|NCT03129100|537299665|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
148950127|NCT03129100|537299666|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
148950128|NCT03129100|537299667|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
148950129|NCT03129100|537299668|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
148950130|NCT03129100|537299669|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
148950131|NCT03129100|537299670|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
148950132|NCT03129100|537299671|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
148950133|NCT03129100|537299672|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
148950134|NCT03129100|537299673|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
149211973|NCT01696396|538244601|FG003|Overall Study|Decision by Sponsor|2|||
149211974|NCT01696396|538244598|FG000|Overall Study|Lost to Follow-up|9|||
149211975|NCT01696396|538244599|FG001|Overall Study|Lost to Follow-up|1|||
149211976|NCT01696396|538244600|FG002|Overall Study|Lost to Follow-up|4|||
148809407|NCT01186770|536779299|FG000|Overall Study|Withdrawal by Subject|15|||
148809408|NCT01186770|536779300|FG001|Overall Study|Withdrawal by Subject|13|||
148809409|NCT01186770|536779301|FG002|Overall Study|Withdrawal by Subject|11|||
148809410|NCT01186770|536779302|FG003|Overall Study|Withdrawal by Subject|17|||
148809411|NCT01186770|536779299|FG000|Overall Study|Lost to Follow-up|10|||
148809412|NCT01186770|536779300|FG001|Overall Study|Lost to Follow-up|6|||
148809413|NCT01186770|536779301|FG002|Overall Study|Lost to Follow-up|14|||
148809414|NCT01186770|536779302|FG003|Overall Study|Lost to Follow-up|9|||
148809415|NCT01186770|536779299|FG000|Overall Study|Insufficient response to treatment|7|||
148809416|NCT01186770|536779300|FG001|Overall Study|Insufficient response to treatment|8|||
148809417|NCT01186770|536779301|FG002|Overall Study|Insufficient response to treatment|5|||
148809418|NCT01186770|536779302|FG003|Overall Study|Insufficient response to treatment|7|||
148809419|NCT01186770|536779299|FG000|Overall Study|Other than specified|0|||
148809420|NCT01186770|536779300|FG001|Overall Study|Other than specified|1|||
148809421|NCT01186770|536779301|FG002|Overall Study|Other than specified|1|||
148809422|NCT01186770|536779302|FG003|Overall Study|Other than specified|2|||
148809423|NCT00505921|536779303|FG000|Overall Study|Ineligible|1|||
148950135|NCT03129100|537299674|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
148950136|NCT03129100|537299675|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
148950137|NCT03129100|537299676|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
148950138|NCT03129100|537299677|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
148950139|NCT03129100|537299678|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
148950140|NCT03129100|537299653|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950141|NCT03129100|537299654|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
149211977|NCT01696396|538244601|FG003|Overall Study|Lost to Follow-up|1|||
149211978|NCT01696396|538244598|FG000|Overall Study|Death|0|||
148809424|NCT00505921|536779303|FG000|Overall Study|Failed to Mobilize|8|||
148950142|NCT03129100|537299655|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950143|NCT03129100|537299656|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950144|NCT03129100|537299657|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950145|NCT03129100|537299658|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
149211979|NCT01696396|538244599|FG001|Overall Study|Death|0|||
149211980|NCT01696396|538244600|FG002|Overall Study|Death|1|||
148809425|NCT01033136|536779304|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
148809426|NCT01033136|536779305|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
148809427|NCT00630292|536779306|FG000|Overall Study|Withdrawal by Subject|1|||
148950146|NCT03129100|537299659|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950147|NCT03129100|537299660|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
149211981|NCT01696396|538244601|FG003|Overall Study|Death|0|||
149211982|NCT01731990|538244603|FG000|Overall Study|Adverse Event|1|||
149211983|NCT01731990|538244604|FG001|Overall Study|Adverse Event|5|||
149211984|NCT01731990|538244603|FG000|Overall Study|Withdrawal by Subject|1|||
149211985|NCT01731990|538244604|FG001|Overall Study|Withdrawal by Subject|1|||
149211986|NCT01731990|538244603|FG000|Overall Study|Protocol deviation|1|||
149211987|NCT01731990|538244604|FG001|Overall Study|Protocol deviation|2|||
149211988|NCT01731990|538244603|FG000|Overall Study|Death|1|||
149211989|NCT01731990|538244604|FG001|Overall Study|Death|0|||
149211990|NCT02944513|538244605|FG000|Overall Study|Withdrawal by Subject|4|||
149211991|NCT02944513|538244606|FG001|Overall Study|Withdrawal by Subject|1|||
149211992|NCT00688623|538244609|FG000|Overall Study|Adverse Event|22|||
149211993|NCT00688623|538244609|FG000|Overall Study|abnormal lab value|1|||
149211994|NCT00688623|538244609|FG000|Overall Study|Withdrawal by Subject|4|||
149211995|NCT00688623|538244609|FG000|Overall Study|Death|3|||
149211996|NCT00688623|538244609|FG000|Overall Study|disease progression|23|||
149211997|NCT00688623|538244609|FG000|Overall Study|Protocol Violation|2|||
149211998|NCT02667236|538244610|FG000|Overall Study|Adverse Event|1|||
149211999|NCT02667236|538244611|FG001|Overall Study|Adverse Event|1|||
149212000|NCT02667236|538244610|FG000|Overall Study|Withdrawal by Subject|2|||
149212001|NCT02667236|538244611|FG001|Overall Study|Withdrawal by Subject|0|||
149212002|NCT04402385|538244613|FG000|Overall Study|Withdrawal by Subject|4|||
149212003|NCT04402385|538244614|FG001|Overall Study|Withdrawal by Subject|4|||
149212004|NCT04402385|538244613|FG000|Overall Study|Lost to Follow-up|1|||
149212005|NCT04402385|538244614|FG001|Overall Study|Lost to Follow-up|1|||
149212006|NCT04402385|538244613|FG000|Overall Study|Physician Decision|0|||
149212007|NCT04402385|538244614|FG001|Overall Study|Physician Decision|1|||
149212008|NCT02809118|538244616|FG000|Overall Study|Withdrawal by Subject|0|||
149212009|NCT02809118|538244617|FG001|Overall Study|Withdrawal by Subject|1|||
149212010|NCT02809118|538244618|FG002|Overall Study|Withdrawal by Subject|1|||
149212011|NCT01235338|538244619|FG000|Overall Study|Adverse Event|3|||
149212012|NCT01235338|538244620|FG001|Overall Study|Adverse Event|2|||
149212013|NCT01235338|538244619|FG000|Overall Study|Protocol Violation|1|||
149212014|NCT01235338|538244620|FG001|Overall Study|Protocol Violation|1|||
149212015|NCT01235338|538244619|FG000|Overall Study|Withdrawal by Subject|5|||
149212016|NCT01235338|538244620|FG001|Overall Study|Withdrawal by Subject|0|||
149212017|NCT01235338|538244619|FG000|Overall Study|Exclusion criteria violations|1|||
149212018|NCT01235338|538244620|FG001|Overall Study|Exclusion criteria violations|1|||
149212019|NCT01235338|538244619|FG000|Overall Study|Positive drug screen|0|||
149212020|NCT01235338|538244620|FG001|Overall Study|Positive drug screen|1|||
149212021|NCT01235338|538244619|FG000|Overall Study|Prohibited meds|1|||
149212022|NCT01235338|538244620|FG001|Overall Study|Prohibited meds|0|||
149212023|NCT05283499|538244624|FG000|Overall Study|Did not receive intervention|1|||
149212024|NCT05283499|538244625|FG001|Overall Study|Did not receive intervention|2|||
149212025|NCT02436915|538244626|FG000|Overall Study|Withdrawal by Subject|0|||
149212026|NCT02436915|538244627|FG001|Overall Study|Withdrawal by Subject|1|||
149212027|NCT01518309|538244629|FG000|Overall Study|Adverse Event|6|||
149212028|NCT01518309|538244629|FG000|Overall Study|Death|6|||
149212029|NCT01518309|538244629|FG000|Overall Study|Lack of Efficacy|7|||
149212030|NCT01518309|538244629|FG000|Overall Study|Withdrawal by Subject|6|||
149212031|NCT01518309|538244629|FG000|Overall Study|Physician Decision|3|||
149212032|NCT01518309|538244629|FG000|Overall Study|Sponsor Decision|2|||
149212033|NCT01518309|538244629|FG000|Overall Study|Not in Predefined Categories|9|||
149212034|NCT00863317|538244630|FG000|Overall Study|Lost to Follow-up|8|||
149212035|NCT00863317|538244631|FG001|Overall Study|Lost to Follow-up|9|||
149212036|NCT00038142|538244634|FG000|Overall Study|Ineligible|1|||
149212037|NCT00038142|538244635|FG001|Overall Study|Ineligible|0|||
149212038|NCT00038142|538244634|FG000|Overall Study|Progressive Disease|11|||
149212039|NCT00038142|538244635|FG001|Overall Study|Progressive Disease|7|||
149212040|NCT00038142|538244634|FG000|Overall Study|Death|1|||
149212041|NCT00038142|538244635|FG001|Overall Study|Death|0|||
149212042|NCT00038142|538244634|FG000|Overall Study|Adverse Event|1|||
149016550|NCT01794117|537538885|FG001|Overall Study|Adverse Event|0|||
149016551|NCT01794117|537538886|FG002|Overall Study|Adverse Event|0|||
149016552|NCT01794117|537538887|FG003|Overall Study|Adverse Event|0|||
149016553|NCT01794117|537538884|FG000|Overall Study|Participant noncompliance|0|||
149016554|NCT01794117|537538885|FG001|Overall Study|Participant noncompliance|1|||
149016555|NCT01794117|537538886|FG002|Overall Study|Participant noncompliance|0|||
149212043|NCT00038142|538244635|FG001|Overall Study|Adverse Event|0|||
149212044|NCT00038142|538244634|FG000|Overall Study|Unknown Reason|8|||
149212045|NCT00038142|538244635|FG001|Overall Study|Unknown Reason|0|||
149212046|NCT00809614|538244636|FG000|Overall Study|Lack of Efficacy|2|||
149212047|NCT00809614|538244637|FG001|Overall Study|Lack of Efficacy|3|||
149212048|NCT00809614|538244636|FG000|Overall Study|Withdrawal by Subject|1|||
149212049|NCT00809614|538244637|FG001|Overall Study|Withdrawal by Subject|1|||
149212050|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
149016556|NCT01794117|537538887|FG003|Overall Study|Participant noncompliance|0|||
149212051|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
149212052|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
148950148|NCT03129100|537299661|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950149|NCT03129100|537299662|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950150|NCT03129100|537299663|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
149212053|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
149212054|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
149212055|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
149212056|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
149212057|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
149212058|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
149212059|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
149212060|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
149212061|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
149212062|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
149212063|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
149212064|NCT03434041|538244642|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
149212065|NCT03434041|538244643|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
149212066|NCT03434041|538244642|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
149212067|NCT03434041|538244643|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
149212068|NCT03434041|538244642|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
149212069|NCT03434041|538244643|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
149212070|NCT03434041|538244642|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
149212071|NCT03434041|538244643|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
149212072|NCT00654420|538244644|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
149212073|NCT00654420|538244645|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
149212074|NCT00654420|538244646|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
149212075|NCT00654420|538244647|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
149212076|NCT00654420|538244644|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
149212077|NCT00654420|538244645|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
149212078|NCT00654420|538244646|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
149212079|NCT00654420|538244647|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
149212080|NCT00654420|538244644|FG000|Phase II|Adverse Event|0|||
149212081|NCT00654420|538244645|FG001|Phase II|Adverse Event|0|||
149212082|NCT00654420|538244646|FG002|Phase II|Adverse Event|3|||
149212083|NCT00654420|538244647|FG003|Phase II|Adverse Event|3|||
149212084|NCT00654420|538244644|FG000|Phase II|Lost to Follow-up|0|||
149212085|NCT00654420|538244645|FG001|Phase II|Lost to Follow-up|0|||
149212086|NCT00654420|538244646|FG002|Phase II|Lost to Follow-up|0|||
149212087|NCT00654420|538244647|FG003|Phase II|Lost to Follow-up|1|||
149212088|NCT00654420|538244644|FG000|Phase II|Physician Decision|0|||
149212089|NCT00654420|538244645|FG001|Phase II|Physician Decision|0|||
149212090|NCT00654420|538244646|FG002|Phase II|Physician Decision|0|||
149212091|NCT00654420|538244647|FG003|Phase II|Physician Decision|4|||
149212092|NCT00654420|538244644|FG000|Phase II|Progressive Disease|0|||
149212093|NCT00654420|538244645|FG001|Phase II|Progressive Disease|0|||
149212094|NCT00654420|538244646|FG002|Phase II|Progressive Disease|29|||
149212095|NCT00654420|538244647|FG003|Phase II|Progressive Disease|29|||
149212096|NCT00654420|538244644|FG000|Phase II|Withdrawal by Subject|0|||
149212097|NCT00654420|538244645|FG001|Phase II|Withdrawal by Subject|0|||
149212098|NCT00654420|538244646|FG002|Phase II|Withdrawal by Subject|4|||
149212099|NCT00654420|538244647|FG003|Phase II|Withdrawal by Subject|1|||
149212100|NCT00654420|538244644|FG000|Phase II|Missing Disposition Record|0|||
149212101|NCT00654420|538244645|FG001|Phase II|Missing Disposition Record|0|||
149212102|NCT00654420|538244646|FG002|Phase II|Missing Disposition Record|1|||
149212103|NCT00654420|538244647|FG003|Phase II|Missing Disposition Record|0|||
149212104|NCT00841672|538244653|FG000|Overall Study|Adverse Event|7|||
149212105|NCT00841672|538244654|FG001|Overall Study|Adverse Event|16|||
149212106|NCT00841672|538244653|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149212107|NCT00841672|538244654|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149212108|NCT00841672|538244653|FG000|Overall Study|Subject withdrew consent|2|||
148809428|NCT02382939|536779307|FG000|Overall Study|Adverse Event|1|||
148950151|NCT03129100|537299664|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950152|NCT03129100|537299665|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950153|NCT03129100|537299666|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950154|NCT03129100|537299667|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950155|NCT03129100|537299668|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950156|NCT03129100|537299669|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950157|NCT03129100|537299670|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950158|NCT03129100|537299671|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950159|NCT03129100|537299672|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
149212109|NCT00841672|538244654|FG001|Overall Study|Subject withdrew consent|4|||
149212110|NCT00841672|538244653|FG000|Overall Study|Lost to Follow-up|1|||
149212111|NCT00841672|538244654|FG001|Overall Study|Lost to Follow-up|1|||
149212112|NCT00841672|538244653|FG000|Overall Study|Administrative problems|9|||
149212113|NCT00841672|538244654|FG001|Overall Study|Administrative problems|9|||
149212114|NCT00841672|538244653|FG000|Overall Study|Misrandomized|1|||
149212115|NCT00841672|538244654|FG001|Overall Study|Misrandomized|0|||
149212116|NCT00841672|538244653|FG000|Overall Study|Protocol Deviation|0|||
149212117|NCT00841672|538244654|FG001|Overall Study|Protocol Deviation|1|||
149212118|NCT02709109|538244655|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
149212119|NCT02709109|538244656|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
149212120|NCT02709109|538244657|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
149212121|NCT02709109|538244658|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
149212122|NCT02709109|538244655|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
149212123|NCT02709109|538244656|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
149212124|NCT02709109|538244657|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
149212125|NCT02709109|538244658|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
149212126|NCT02709109|538244655|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
149212127|NCT02709109|538244656|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
149212128|NCT02709109|538244657|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
149212129|NCT02709109|538244658|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
149212130|NCT02709109|538244655|FG000|Washout Period (28 Days)|Other|2|||
149212131|NCT02709109|538244656|FG001|Washout Period (28 Days)|Other|2|||
149212132|NCT02709109|538244657|FG002|Washout Period (28 Days)|Other|3|||
149212133|NCT02709109|538244658|FG003|Washout Period (28 Days)|Other|0|||
149212134|NCT02709109|538244655|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
149212135|NCT02709109|538244656|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
149212136|NCT02709109|538244657|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
149212137|NCT02709109|538244658|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
149212138|NCT02709109|538244655|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
149212139|NCT02709109|538244656|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
149212140|NCT02709109|538244657|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
149212141|NCT02709109|538244658|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
149212142|NCT02709109|538244655|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
149212143|NCT02709109|538244656|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
149212144|NCT02709109|538244657|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
148950160|NCT03129100|537299673|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
149212145|NCT02709109|538244658|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
149212146|NCT02709109|538244655|FG000|Treatment Period 2 (28 Days)|Other|0|||
149212147|NCT02709109|538244656|FG001|Treatment Period 2 (28 Days)|Other|0|||
149212148|NCT02709109|538244657|FG002|Treatment Period 2 (28 Days)|Other|1|||
149212149|NCT02709109|538244658|FG003|Treatment Period 2 (28 Days)|Other|0|||
149212150|NCT01928082|538244660|FG000|Overall Study|Study terminated.|1|||
149212151|NCT01815580|538244664|FG000|Overall Study|Lost to Follow-up|4|||
149212152|NCT01815580|538244665|FG001|Overall Study|Lost to Follow-up|7|||
149212153|NCT01815580|538244664|FG000|Overall Study|Withdrawal by Subject|3|||
149212154|NCT01815580|538244665|FG001|Overall Study|Withdrawal by Subject|4|||
149212155|NCT01815580|538244664|FG000|Overall Study|Excluded from analysis|5|||
149212156|NCT01815580|538244665|FG001|Overall Study|Excluded from analysis|4|||
149212157|NCT00924729|538244673|FG000|Overall Study|insufficient volume for analysis|1|||
149212158|NCT00924729|538244674|FG001|Overall Study|insufficient volume for analysis|0|||
149212159|NCT00924729|538244673|FG000|Overall Study|Protocol Violation|1|||
149212160|NCT00924729|538244674|FG001|Overall Study|Protocol Violation|0|||
149212161|NCT00196196|538244675|FG000|Overall Study|Withdrawal by Subject|2|||
149212162|NCT00196196|538244675|FG000|Overall Study|Did not have required condition (hydroce|5|||
149212163|NCT03034057|538244680|FG000|Overall Study|Withdrawal by Subject|10|||
149212164|NCT03034057|538244680|FG000|Overall Study|Protocol Violation|1|||
149212165|NCT03034057|538244680|FG000|Overall Study|Not defined|2|||
148950161|NCT03129100|537299674|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950162|NCT03129100|537299675|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950163|NCT03129100|537299676|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950164|NCT03129100|537299677|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950165|NCT03129100|537299678|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
148950166|NCT03129100|537299653|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
148950167|NCT03129100|537299654|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
148950168|NCT03129100|537299655|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
148950169|NCT03129100|537299656|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
148950170|NCT03129100|537299657|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
149212166|NCT03034057|538244680|FG000|Overall Study|Lost to Follow-up|19|||
149212167|NCT03034057|538244680|FG000|Overall Study|Adverse Event|22|||
149212168|NCT03034057|538244680|FG000|Overall Study|Medication error without associated AE|1|||
149212169|NCT01814826|538244681|FG000|Overall Study|Other|3|||
149212170|NCT01814826|538244682|FG001|Overall Study|Other|5|||
149212171|NCT01814826|538244683|FG002|Overall Study|Other|0|||
149212172|NCT01814826|538244681|FG000|Overall Study|Death|29|||
149016557|NCT01794117|537538884|FG000|Overall Study|Refused further treatment|0|||
149016558|NCT01794117|537538885|FG001|Overall Study|Refused further treatment|2|||
149016559|NCT01794117|537538886|FG002|Overall Study|Refused further treatment|0|||
149016560|NCT01794117|537538887|FG003|Overall Study|Refused further treatment|0|||
149016561|NCT02696902|537538890|FG000|Overall Study|Lost to Follow-up|0|||
149016562|NCT02696902|537538891|FG001|Overall Study|Lost to Follow-up|1|||
149016563|NCT02696902|537538892|FG002|Overall Study|Lost to Follow-up|1|||
149016564|NCT02696902|537538890|FG000|Overall Study|Withdrawal by Subject|0|||
149016565|NCT02696902|537538891|FG001|Overall Study|Withdrawal by Subject|0|||
149016566|NCT02696902|537538892|FG002|Overall Study|Withdrawal by Subject|1|||
149016567|NCT02696902|537538890|FG000|Overall Study|Death|19|||
149016568|NCT02696902|537538891|FG001|Overall Study|Death|3|||
149016569|NCT02696902|537538892|FG002|Overall Study|Death|24|||
149016570|NCT02696902|537538890|FG000|Overall Study|Participant not fit post-randomization|0|||
149016571|NCT02696902|537538891|FG001|Overall Study|Participant not fit post-randomization|0|||
149016572|NCT02696902|537538892|FG002|Overall Study|Participant not fit post-randomization|1|||
149016573|NCT02696902|537538890|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
149016574|NCT02696902|537538891|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
149016575|NCT02696902|537538892|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
149016576|NCT02696902|537538890|FG000|Overall Study|Principal investigator's decision|1|||
149016577|NCT02696902|537538891|FG001|Overall Study|Principal investigator's decision|0|||
149016578|NCT02696902|537538892|FG002|Overall Study|Principal investigator's decision|0|||
149016579|NCT02696902|537538890|FG000|Overall Study|Sponsor's decision|1|||
149016580|NCT02696902|537538891|FG001|Overall Study|Sponsor's decision|0|||
149016581|NCT02696902|537538892|FG002|Overall Study|Sponsor's decision|0|||
148684427|NCT00408876|536316840|FG003|Overall Study|Adverse Event|10|||
148684428|NCT00408876|536316837|FG000|Overall Study|Withdrawal by Subject|3|||
148684429|NCT00408876|536316838|FG001|Overall Study|Withdrawal by Subject|6|||
148684430|NCT00408876|536316839|FG002|Overall Study|Withdrawal by Subject|6|||
148684431|NCT00408876|536316840|FG003|Overall Study|Withdrawal by Subject|14|||
148684432|NCT00408876|536316837|FG000|Overall Study|Lack of Efficacy|2|||
148684433|NCT00408876|536316838|FG001|Overall Study|Lack of Efficacy|4|||
148684434|NCT00408876|536316839|FG002|Overall Study|Lack of Efficacy|5|||
148684435|NCT00408876|536316840|FG003|Overall Study|Lack of Efficacy|6|||
148684436|NCT00408876|536316837|FG000|Overall Study|Lost to Follow-up|1|||
148684437|NCT00408876|536316838|FG001|Overall Study|Lost to Follow-up|6|||
148684438|NCT00408876|536316839|FG002|Overall Study|Lost to Follow-up|5|||
148950171|NCT03129100|537299658|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
148950172|NCT03129100|537299659|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
148950173|NCT03129100|537299660|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
148950174|NCT03129100|537299661|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
148950175|NCT03129100|537299662|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
148950176|NCT03129100|537299663|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
148684439|NCT00408876|536316840|FG003|Overall Study|Lost to Follow-up|2|||
148684440|NCT00408876|536316837|FG000|Overall Study|Protocol Violation|0|||
148684441|NCT00408876|536316838|FG001|Overall Study|Protocol Violation|3|||
148684442|NCT00408876|536316839|FG002|Overall Study|Protocol Violation|4|||
148684443|NCT00408876|536316840|FG003|Overall Study|Protocol Violation|3|||
148684444|NCT00408876|536316837|FG000|Overall Study|Physician Decision|1|||
148684445|NCT00408876|536316838|FG001|Overall Study|Physician Decision|0|||
148684446|NCT00408876|536316839|FG002|Overall Study|Physician Decision|3|||
148684447|NCT00408876|536316840|FG003|Overall Study|Physician Decision|0|||
148684448|NCT03404206|536316843|FG000|Overall Study|Withdrawal by Subject|1|||
148684449|NCT03404206|536316844|FG001|Overall Study|Withdrawal by Subject|1|||
148684450|NCT03404206|536316845|FG002|Overall Study|Withdrawal by Subject|0|||
148684451|NCT03404206|536316843|FG000|Overall Study|Lost to Follow-up|3|||
148684452|NCT03404206|536316844|FG001|Overall Study|Lost to Follow-up|1|||
148684453|NCT03404206|536316845|FG002|Overall Study|Lost to Follow-up|0|||
148950177|NCT03129100|537299664|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
148950178|NCT03129100|537299665|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
148950179|NCT03129100|537299666|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
148950180|NCT03129100|537299667|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
149016582|NCT02696902|537538890|FG000|Overall Study|Transferred to other hospital|1|||
149016583|NCT02696902|537538891|FG001|Overall Study|Transferred to other hospital|0|||
149016584|NCT02696902|537538892|FG002|Overall Study|Transferred to other hospital|0|||
149016585|NCT02401308|537538898|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
149016586|NCT02401308|537538899|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
148684454|NCT05478603|536316846|FG000|Overall Study|Withdrawal by Subject|0|||
148684455|NCT05478603|536316847|FG001|Overall Study|Withdrawal by Subject|1|||
148684456|NCT05478603|536316848|FG002|Overall Study|Withdrawal by Subject|0|||
148684457|NCT05478603|536316849|FG003|Overall Study|Withdrawal by Subject|0|||
148684458|NCT03634488|536316852|FG000|Overall Study|Death|1|||
148684459|NCT03634488|536316853|FG001|Overall Study|Death|0|||
148950181|NCT03129100|537299668|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
148684460|NCT03634488|536316854|FG002|Overall Study|Death|0|||
148809429|NCT02382939|536779308|FG001|Overall Study|Adverse Event|1|||
149212173|NCT01814826|538244682|FG001|Overall Study|Death|24|||
149212174|NCT01814826|538244683|FG002|Overall Study|Death|3|||
149212175|NCT02917629|538244684|FG000|Overall Study|Withdrawal by Subject|0|||
149212176|NCT02917629|538244685|FG001|Overall Study|Withdrawal by Subject|1|||
149212177|NCT03339401|538244686|FG000|Overall Study|Death|2|||
149212178|NCT03339401|538244687|FG001|Overall Study|Death|1|||
149212179|NCT03339401|538244686|FG000|Overall Study|Withdrawal by Subject|2|||
149212180|NCT03339401|538244687|FG001|Overall Study|Withdrawal by Subject|0|||
149212181|NCT03339401|538244686|FG000|Overall Study|Study terminated|4|||
149212182|NCT03339401|538244687|FG001|Overall Study|Study terminated|3|||
149212183|NCT03339401|538244686|FG000|Overall Study|Investigator Decision|1|||
149212184|NCT03339401|538244687|FG001|Overall Study|Investigator Decision|0|||
149212185|NCT00718523|538244688|FG000|Overall Study|Withdrawal by Subject|5|||
149212186|NCT00718523|538244689|FG001|Overall Study|Withdrawal by Subject|7|||
149212187|NCT00718523|538244688|FG000|Overall Study|Death|13|||
149212188|NCT00718523|538244689|FG001|Overall Study|Death|17|||
149212189|NCT03271307|538244690|FG000|Overall Study|Lost to Follow-up|0|||
149212190|NCT03271307|538244691|FG001|Overall Study|Lost to Follow-up|0|||
149212191|NCT03271307|538244692|FG002|Overall Study|Lost to Follow-up|0|||
149212192|NCT03271307|538244693|FG003|Overall Study|Lost to Follow-up|28|||
149212193|NCT03271307|538244694|FG004|Overall Study|Lost to Follow-up|91|||
149212194|NCT00910728|538244695|FG000|Overall Study|Lack of Efficacy|2|||
149212195|NCT00910728|538244696|FG001|Overall Study|Lack of Efficacy|3|||
149212196|NCT00910728|538244697|FG002|Overall Study|Lack of Efficacy|1|||
149212197|NCT00910728|538244698|FG003|Overall Study|Lack of Efficacy|2|||
149212198|NCT00910728|538244699|FG004|Overall Study|Lack of Efficacy|1|||
149212199|NCT00910728|538244700|FG005|Overall Study|Lack of Efficacy|0|||
149212200|NCT00910728|538244701|FG006|Overall Study|Lack of Efficacy|2|||
149212201|NCT00910728|538244702|FG007|Overall Study|Lack of Efficacy|2|||
149212202|NCT00910728|538244703|FG008|Overall Study|Lack of Efficacy|2|||
149212203|NCT00910728|538244695|FG000|Overall Study|Withdrawal by Subject|0|||
149212204|NCT00910728|538244696|FG001|Overall Study|Withdrawal by Subject|0|||
149212205|NCT00910728|538244697|FG002|Overall Study|Withdrawal by Subject|0|||
149212206|NCT00910728|538244698|FG003|Overall Study|Withdrawal by Subject|0|||
149212207|NCT00910728|538244699|FG004|Overall Study|Withdrawal by Subject|3|||
149212208|NCT00910728|538244700|FG005|Overall Study|Withdrawal by Subject|1|||
149212209|NCT00910728|538244701|FG006|Overall Study|Withdrawal by Subject|2|||
149212210|NCT00910728|538244702|FG007|Overall Study|Withdrawal by Subject|0|||
149212211|NCT00910728|538244703|FG008|Overall Study|Withdrawal by Subject|0|||
149212212|NCT00910728|538244695|FG000|Overall Study|(not specified)|2|||
149212213|NCT00910728|538244696|FG001|Overall Study|(not specified)|0|||
149212214|NCT00910728|538244697|FG002|Overall Study|(not specified)|1|||
149212215|NCT00910728|538244698|FG003|Overall Study|(not specified)|0|||
149212216|NCT00910728|538244699|FG004|Overall Study|(not specified)|1|||
149212217|NCT00910728|538244700|FG005|Overall Study|(not specified)|0|||
149212218|NCT00910728|538244701|FG006|Overall Study|(not specified)|0|||
149212219|NCT00910728|538244702|FG007|Overall Study|(not specified)|0|||
149212220|NCT00910728|538244703|FG008|Overall Study|(not specified)|0|||
149212221|NCT00910728|538244695|FG000|Overall Study|Adverse Event|2|||
149212222|NCT00910728|538244696|FG001|Overall Study|Adverse Event|0|||
149212223|NCT00910728|538244697|FG002|Overall Study|Adverse Event|1|||
149212224|NCT00910728|538244698|FG003|Overall Study|Adverse Event|1|||
149212225|NCT00910728|538244699|FG004|Overall Study|Adverse Event|0|||
149212226|NCT00910728|538244700|FG005|Overall Study|Adverse Event|0|||
149212227|NCT00910728|538244701|FG006|Overall Study|Adverse Event|2|||
149212228|NCT00910728|538244702|FG007|Overall Study|Adverse Event|1|||
149016587|NCT02998021|537538900|FG000|Overall Study|Withdrawal by Subject|3|||
149212229|NCT00910728|538244703|FG008|Overall Study|Adverse Event|1|||
149212230|NCT01042938|538244704|FG000|Overall Study|Withdrawal by Subject|1|||
149212231|NCT01042938|538244705|FG001|Overall Study|Withdrawal by Subject|1|||
149212232|NCT01042938|538244704|FG000|Overall Study|Protocol Violation|1|||
149212233|NCT01042938|538244705|FG001|Overall Study|Protocol Violation|1|||
149212234|NCT01042938|538244704|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
149212235|NCT01042938|538244705|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
149212236|NCT03997760|538244706|FG000|Overall Study|Protocol Deviation|0|||
149212237|NCT03997760|538244707|FG001|Overall Study|Protocol Deviation|1|||
149212238|NCT03997760|538244708|FG002|Overall Study|Protocol Deviation|0|||
149212239|NCT03997760|538244709|FG003|Overall Study|Protocol Deviation|0|||
149212240|NCT00856986|538244710|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
149212241|NCT00856986|538244711|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
149212242|NCT00856986|538244712|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
149212243|NCT00856986|538244713|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
149212244|NCT00856986|538244714|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
149212245|NCT00856986|538244710|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149212246|NCT00856986|538244711|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149212247|NCT00856986|538244712|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149212248|NCT00856986|538244713|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
149212249|NCT00856986|538244714|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
149212250|NCT00856986|538244710|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149212251|NCT00856986|538244711|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149212252|NCT00856986|538244712|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149212253|NCT00856986|538244713|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
149212254|NCT00856986|538244714|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
149212255|NCT00856986|538244710|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149212256|NCT00856986|538244711|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149212257|NCT00856986|538244712|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149212258|NCT00856986|538244713|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
149212259|NCT00856986|538244714|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
149212260|NCT00856986|538244710|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149212261|NCT00856986|538244711|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
148809430|NCT02382939|536779307|FG000|Overall Study|Withdrawal by Subject|2|||
148809431|NCT02382939|536779308|FG001|Overall Study|Withdrawal by Subject|2|||
148809432|NCT00142415|536779309|FG000|Overall Study|Physician Decision|0|||
148809433|NCT00142415|536779310|FG001|Overall Study|Physician Decision|0|||
148809434|NCT00142415|536779311|FG002|Overall Study|Physician Decision|0|||
148809435|NCT00142415|536779312|FG003|Overall Study|Physician Decision|0|||
148809436|NCT00142415|536779313|FG004|Overall Study|Physician Decision|1|||
148809437|NCT00142415|536779314|FG005|Overall Study|Physician Decision|2|||
148809438|NCT01572792|536779317|FG000|Lead-in Study|Lost to Follow-up|5|||
148809439|NCT01572792|536779318|FG001|Lead-in Study|Lost to Follow-up|9|||
148809440|NCT01572792|536779319|FG002|Lead-in Study|Lost to Follow-up|4|||
148809441|NCT01572792|536779320|FG003|Lead-in Study|Lost to Follow-up|2|||
148809442|NCT01572792|536779321|FG004|Lead-in Study|Lost to Follow-up|4|||
148809443|NCT01572792|536779317|FG000|Lead-in Study|Withdrawal by Subject|22|||
148809444|NCT01572792|536779318|FG001|Lead-in Study|Withdrawal by Subject|11|||
148809445|NCT01572792|536779319|FG002|Lead-in Study|Withdrawal by Subject|12|||
148809446|NCT01572792|536779320|FG003|Lead-in Study|Withdrawal by Subject|24|||
148809447|NCT01572792|536779321|FG004|Lead-in Study|Withdrawal by Subject|11|||
148809448|NCT01572792|536779317|FG000|Lead-in Study|Protocol Violation|19|||
148809449|NCT01572792|536779318|FG001|Lead-in Study|Protocol Violation|10|||
148809450|NCT01572792|536779319|FG002|Lead-in Study|Protocol Violation|12|||
148809451|NCT01572792|536779320|FG003|Lead-in Study|Protocol Violation|13|||
148809452|NCT01572792|536779321|FG004|Lead-in Study|Protocol Violation|21|||
148809453|NCT01572792|536779317|FG000|Lead-in Study|Lack of Efficacy|20|||
148809454|NCT01572792|536779318|FG001|Lead-in Study|Lack of Efficacy|5|||
148809455|NCT01572792|536779319|FG002|Lead-in Study|Lack of Efficacy|4|||
148809456|NCT01572792|536779320|FG003|Lead-in Study|Lack of Efficacy|8|||
148809457|NCT01572792|536779321|FG004|Lead-in Study|Lack of Efficacy|10|||
148809458|NCT01572792|536779317|FG000|Lead-in Study|Adverse Event|21|||
148809459|NCT01572792|536779318|FG001|Lead-in Study|Adverse Event|21|||
148809460|NCT01572792|536779319|FG002|Lead-in Study|Adverse Event|22|||
148809461|NCT01572792|536779320|FG003|Lead-in Study|Adverse Event|16|||
148809462|NCT01572792|536779321|FG004|Lead-in Study|Adverse Event|14|||
148809463|NCT01572792|536779317|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
148809464|NCT01572792|536779318|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
148950182|NCT03129100|537299669|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
148950183|NCT03129100|537299670|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
148950184|NCT03129100|537299671|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
148950185|NCT03129100|537299672|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
148950186|NCT03129100|537299673|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
148950187|NCT03129100|537299674|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
149212262|NCT00856986|538244712|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149212263|NCT00856986|538244713|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
149212264|NCT00856986|538244714|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
149212265|NCT00856986|538244710|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
149212266|NCT00856986|538244711|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
149212267|NCT00856986|538244712|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
149212268|NCT00856986|538244713|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
149212269|NCT00856986|538244714|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
149212270|NCT00856986|538244710|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
148809465|NCT01572792|536779319|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
148809466|NCT01572792|536779320|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
148809467|NCT01572792|536779321|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
148809468|NCT01572792|536779317|FG000|Extension Study|Lost to Follow-up|6|||
148809469|NCT01572792|536779318|FG001|Extension Study|Lost to Follow-up|2|||
148809470|NCT01572792|536779319|FG002|Extension Study|Lost to Follow-up|0|||
148809471|NCT01572792|536779320|FG003|Extension Study|Lost to Follow-up|3|||
148809472|NCT01572792|536779321|FG004|Extension Study|Lost to Follow-up|3|||
148809473|NCT01572792|536779317|FG000|Extension Study|Withdrawal by Subject|7|||
148809474|NCT01572792|536779318|FG001|Extension Study|Withdrawal by Subject|6|||
149212271|NCT00856986|538244711|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
149212272|NCT00856986|538244712|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
149212273|NCT00856986|538244713|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
149212274|NCT00856986|538244714|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
149212275|NCT00856986|538244710|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
149212276|NCT00856986|538244711|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
149212277|NCT00856986|538244712|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
149212278|NCT00856986|538244713|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
149212279|NCT00856986|538244714|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
149212280|NCT00856986|538244710|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
149212281|NCT00856986|538244711|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
149212282|NCT00856986|538244712|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
149212283|NCT00856986|538244713|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
149212284|NCT00856986|538244714|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
149212285|NCT00856986|538244710|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
149212286|NCT00856986|538244711|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
149212287|NCT00856986|538244712|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
149212288|NCT00856986|538244713|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
149212289|NCT00856986|538244714|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
149212290|NCT00856986|538244710|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
149212291|NCT00856986|538244711|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
149212292|NCT00856986|538244712|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
149212293|NCT00856986|538244713|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
149212294|NCT00856986|538244714|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
149212295|NCT00856986|538244710|FG000|Main Period, Weeks 0-26|Unclassified|7|||
149212296|NCT00856986|538244711|FG001|Main Period, Weeks 0-26|Unclassified|6|||
149212297|NCT00856986|538244712|FG002|Main Period, Weeks 0-26|Unclassified|7|||
149212298|NCT00856986|538244713|FG003|Main Period, Weeks 0-26|Unclassified|0|||
149212299|NCT00856986|538244714|FG004|Main Period, Weeks 0-26|Unclassified|0|||
149212300|NCT00856986|538244710|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
149212301|NCT00856986|538244711|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
149212302|NCT00856986|538244712|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
149212303|NCT00856986|538244713|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
149212304|NCT00856986|538244714|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
149212305|NCT00856986|538244710|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
149212306|NCT00856986|538244711|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
149212307|NCT00856986|538244712|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
149212308|NCT00856986|538244713|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
149212309|NCT00856986|538244714|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
149212310|NCT00856986|538244710|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
149212311|NCT00856986|538244711|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
149212312|NCT00856986|538244712|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
149212313|NCT00856986|538244713|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
149212314|NCT00856986|538244714|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
149212315|NCT00856986|538244710|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
149212316|NCT00856986|538244711|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
149212317|NCT00856986|538244712|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
149212318|NCT00856986|538244713|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
149212319|NCT00856986|538244714|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
149212320|NCT00856986|538244710|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
149212321|NCT00856986|538244711|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
149212322|NCT00856986|538244712|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
149212323|NCT00856986|538244713|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
149212324|NCT00856986|538244714|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
149212325|NCT00856986|538244710|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
149212326|NCT00856986|538244711|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
149212327|NCT00856986|538244712|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
149212328|NCT00856986|538244713|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
149212329|NCT00856986|538244714|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
149016588|NCT02998021|537538901|FG001|Overall Study|Withdrawal by Subject|1|||
149016589|NCT02998021|537538900|FG000|Overall Study|unsafe home|0|||
149212330|NCT03032510|538244715|FG000|Overall Study|Adverse Event|5|||
149212331|NCT03032510|538244716|FG001|Overall Study|Adverse Event|2|||
149212332|NCT03032510|538244715|FG000|Overall Study|Lost to Follow-up|8|||
149212333|NCT03032510|538244716|FG001|Overall Study|Lost to Follow-up|7|||
149212334|NCT03032510|538244715|FG000|Overall Study|Withdrawal by Subject|8|||
149212335|NCT03032510|538244716|FG001|Overall Study|Withdrawal by Subject|7|||
149212336|NCT03032510|538244715|FG000|Overall Study|Subject noncompliance|4|||
149212337|NCT03032510|538244716|FG001|Overall Study|Subject noncompliance|2|||
149212338|NCT03032510|538244715|FG000|Overall Study|Physician Decision|2|||
149212339|NCT03032510|538244716|FG001|Overall Study|Physician Decision|0|||
149212340|NCT05041062|538244719|FG000|Overall Study|Adverse Event|2|||
149212341|NCT04018612|538244720|FG000|Overall Study|Withdrawal by Subject|1|||
149212342|NCT04018612|538244721|FG001|Overall Study|Withdrawal by Subject|0|||
149212343|NCT04018612|538244722|FG002|Overall Study|Withdrawal by Subject|1|||
149212344|NCT00361218|538244723|FG000|Overall Study|Lost to Follow-up|11|||
149212345|NCT00361218|538244723|FG000|Overall Study|Personal Reasons|7|||
149212346|NCT00361218|538244723|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
149212347|NCT01802515|538244729|FG000|Overall Study|Withdrawal by Subject|3|||
149212348|NCT01802515|538244730|FG001|Overall Study|Withdrawal by Subject|0|||
149212349|NCT01802515|538244731|FG002|Overall Study|Withdrawal by Subject|0|||
149212350|NCT02566109|538244732|FG000|Overall Study|Withdrawal by Subject|1|||
149212351|NCT01906476|538244733|FG000|Overall Study|Lost to Follow-up|17|||
149212352|NCT01906476|538244734|FG001|Overall Study|Lost to Follow-up|16|||
149212353|NCT01041404|538244739|FG000|Overall Study|Adverse Event|45|||
149212354|NCT01041404|538244740|FG001|Overall Study|Adverse Event|35|||
148809475|NCT01572792|536779319|FG002|Extension Study|Withdrawal by Subject|11|||
148809476|NCT01572792|536779320|FG003|Extension Study|Withdrawal by Subject|8|||
148809477|NCT01572792|536779321|FG004|Extension Study|Withdrawal by Subject|14|||
149212355|NCT01041404|538244739|FG000|Overall Study|Lack of Efficacy|200|||
149212356|NCT01041404|538244740|FG001|Overall Study|Lack of Efficacy|210|||
149212357|NCT01041404|538244739|FG000|Overall Study|Violation of Selection Criteria|0|||
149212358|NCT01041404|538244740|FG001|Overall Study|Violation of Selection Criteria|1|||
149212359|NCT01041404|538244739|FG000|Overall Study|Protocol Violation|4|||
149212360|NCT01041404|538244740|FG001|Overall Study|Protocol Violation|0|||
149212361|NCT01041404|538244739|FG000|Overall Study|Withdrawal by Subject|29|||
149212362|NCT01041404|538244740|FG001|Overall Study|Withdrawal by Subject|23|||
149212363|NCT01041404|538244739|FG000|Overall Study|Failure to Return|1|||
149212364|NCT01041404|538244740|FG001|Overall Study|Failure to Return|2|||
149212365|NCT01041404|538244739|FG000|Overall Study|Other|11|||
149212366|NCT01041404|538244740|FG001|Overall Study|Other|23|||
149212367|NCT01993667|538244742|FG000|Overall Study|Insufficient data to analyze|16|||
149212368|NCT01993667|538244743|FG001|Overall Study|Insufficient data to analyze|16|||
149212369|NCT01993667|538244742|FG000|Overall Study|Insufficient altitude reached|3|||
149212370|NCT01993667|538244743|FG001|Overall Study|Insufficient altitude reached|1|||
149212371|NCT01993667|538244742|FG000|Overall Study|Lost to Follow-up|2|||
149212372|NCT01993667|538244743|FG001|Overall Study|Lost to Follow-up|2|||
149212373|NCT01931150|538244744|FG000|Overall Study|Withdrawal by Subject|1|||
149212374|NCT01931150|538244745|FG001|Overall Study|Withdrawal by Subject|2|||
149212375|NCT01957215|538246510|FG000|Overall Study|Adverse Event|2|||
149212376|NCT01957215|538246511|FG001|Overall Study|Adverse Event|2|||
149212377|NCT01957215|538246510|FG000|Overall Study|Lost to Follow-up|3|||
149212378|NCT01957215|538246511|FG001|Overall Study|Lost to Follow-up|3|||
149212379|NCT01957215|538246510|FG000|Overall Study|Protocol Violation|1|||
149212380|NCT01957215|538246511|FG001|Overall Study|Protocol Violation|2|||
149212381|NCT01957215|538246510|FG000|Overall Study|Withdrawal by Subject|7|||
149212382|NCT01957215|538246511|FG001|Overall Study|Withdrawal by Subject|5|||
149212383|NCT03597503|538246515|FG000|Overall Study|Withdrawal by Subject|0|||
149212384|NCT03597503|538246516|FG001|Overall Study|Withdrawal by Subject|2|||
149212385|NCT03597503|538246515|FG000|Overall Study|Lost to Follow-up|1|||
149212386|NCT03597503|538246516|FG001|Overall Study|Lost to Follow-up|2|||
149212387|NCT03597503|538246515|FG000|Overall Study|Protocol Violation|1|||
149212388|NCT03597503|538246516|FG001|Overall Study|Protocol Violation|0|||
149212389|NCT02000219|538246519|FG000|14-Week Study Period|Physician Decision|1|||
149212390|NCT02000219|538246519|FG000|14-Week Study Period|Adverse Event|1|||
149212391|NCT02000219|538246519|FG000|14-Week Study Period|Underwent transplantation|1|||
149212392|NCT02000219|538246519|FG000|Continuation Period|Withdrawal by Subject|1|||
149212393|NCT02000219|538246519|FG000|Continuation Period|Had liver transplant|2|||
149212394|NCT02000219|538246519|FG000|Continuation Period|Non-compliance with study drug|2|||
149212395|NCT00608894|538246523|FG000|Overall Study|Withdrawal by Subject|0|||
149212396|NCT00608894|538246524|FG001|Overall Study|Withdrawal by Subject|2|||
149212397|NCT00209092|538246529|FG000|Overall Study|Progression of disease|7|||
149212398|NCT00209092|538246530|FG001|Overall Study|Progression of disease|1|||
148809478|NCT01572792|536779317|FG000|Extension Study|Protocol Violation|0|||
148809479|NCT01572792|536779318|FG001|Extension Study|Protocol Violation|4|||
148809480|NCT01572792|536779319|FG002|Extension Study|Protocol Violation|3|||
148809481|NCT01572792|536779320|FG003|Extension Study|Protocol Violation|4|||
148809482|NCT01572792|536779321|FG004|Extension Study|Protocol Violation|3|||
148809483|NCT01572792|536779317|FG000|Extension Study|Lack of Efficacy|2|||
148809484|NCT01572792|536779318|FG001|Extension Study|Lack of Efficacy|3|||
148809485|NCT01572792|536779319|FG002|Extension Study|Lack of Efficacy|3|||
148809486|NCT01572792|536779320|FG003|Extension Study|Lack of Efficacy|2|||
148809487|NCT01572792|536779321|FG004|Extension Study|Lack of Efficacy|2|||
148809488|NCT01572792|536779317|FG000|Extension Study|Adverse Event|7|||
148809489|NCT01572792|536779318|FG001|Extension Study|Adverse Event|6|||
148809490|NCT01572792|536779319|FG002|Extension Study|Adverse Event|5|||
148809491|NCT01572792|536779320|FG003|Extension Study|Adverse Event|6|||
148809492|NCT01572792|536779321|FG004|Extension Study|Adverse Event|4|||
148809493|NCT01572792|536779317|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
148809494|NCT01572792|536779318|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
148809495|NCT01572792|536779319|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
148809496|NCT01572792|536779320|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
149212399|NCT00209092|538246529|FG000|Overall Study|Adverse Event|0|||
149212400|NCT00209092|538246530|FG001|Overall Study|Adverse Event|1|||
148809497|NCT01572792|536779321|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
148809498|NCT03530696|536779322|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
148809499|NCT03530696|536779323|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
148809500|NCT00797563|536779324|FG000|Overall Study|Adverse Event|1|||
148809501|NCT03416179|536779325|FG000|Overall Study|Death|90|||
148809502|NCT03416179|536779326|FG001|Overall Study|Death|87|||
148809503|NCT03416179|536779327|FG002|Overall Study|Death|117|||
148809504|NCT03416179|536779328|FG003|Overall Study|Death|113|||
148809505|NCT03416179|536779325|FG000|Overall Study|Withdrawal by Subject|15|||
148809506|NCT03416179|536779326|FG001|Overall Study|Withdrawal by Subject|20|||
148809507|NCT03416179|536779327|FG002|Overall Study|Withdrawal by Subject|6|||
148809508|NCT03416179|536779328|FG003|Overall Study|Withdrawal by Subject|9|||
148809509|NCT03416179|536779325|FG000|Overall Study|Lost to Follow-up|1|||
148809510|NCT03416179|536779326|FG001|Overall Study|Lost to Follow-up|1|||
148809511|NCT03416179|536779327|FG002|Overall Study|Lost to Follow-up|0|||
148809512|NCT03416179|536779328|FG003|Overall Study|Lost to Follow-up|3|||
148809513|NCT03416179|536779325|FG000|Overall Study|Study participation terminated by Sponsor|93|||
148809514|NCT03416179|536779326|FG001|Overall Study|Study participation terminated by Sponsor|91|||
148809515|NCT03416179|536779327|FG002|Overall Study|Study participation terminated by Sponsor|26|||
148809516|NCT03416179|536779328|FG003|Overall Study|Study participation terminated by Sponsor|31|||
148809517|NCT03416179|536779325|FG000|Overall Study|Other|2|||
148809518|NCT03416179|536779326|FG001|Overall Study|Other|3|||
148809519|NCT03416179|536779327|FG002|Overall Study|Other|1|||
148809520|NCT03416179|536779328|FG003|Overall Study|Other|0|||
148809521|NCT00688597|536779330|FG000|Overall Study|Adverse Event|2|||
148809522|NCT00688597|536779331|FG001|Overall Study|Adverse Event|0|||
148809523|NCT00688597|536779332|FG002|Overall Study|Adverse Event|0|||
148809524|NCT00688597|536779330|FG000|Overall Study|Physician Decision|1|||
148809525|NCT00688597|536779331|FG001|Overall Study|Physician Decision|0|||
148809526|NCT00688597|536779332|FG002|Overall Study|Physician Decision|0|||
148809527|NCT01129128|536779333|FG000|Overall Study|Lost to Follow-up|2|||
148809528|NCT01129128|536779334|FG001|Overall Study|Lost to Follow-up|2|||
148809529|NCT01129128|536779335|FG002|Overall Study|Lost to Follow-up|1|||
149212401|NCT00209092|538246529|FG000|Overall Study|Withdrawal by Subject|1|||
149212402|NCT00209092|538246530|FG001|Overall Study|Withdrawal by Subject|0|||
149212403|NCT02408484|538246531|FG000|Overall Study|Withdrawal by Subject|3|||
149212404|NCT02408484|538246531|FG000|Overall Study|Not treated during study period|1|||
148809530|NCT01129128|536779333|FG000|Overall Study|Protocol Violation|0|||
149016590|NCT02998021|537538901|FG001|Overall Study|unsafe home|1|||
148809531|NCT01129128|536779334|FG001|Overall Study|Protocol Violation|1|||
148809532|NCT01129128|536779335|FG002|Overall Study|Protocol Violation|0|||
148809533|NCT01129128|536779333|FG000|Overall Study|Withdrawal by Subject|0|||
148809534|NCT01129128|536779334|FG001|Overall Study|Withdrawal by Subject|1|||
148809535|NCT01129128|536779335|FG002|Overall Study|Withdrawal by Subject|3|||
148809536|NCT01129128|536779333|FG000|Overall Study|Physician Decision|1|||
148809537|NCT01129128|536779334|FG001|Overall Study|Physician Decision|0|||
148809538|NCT01129128|536779335|FG002|Overall Study|Physician Decision|0|||
148809539|NCT06438601|536779336|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
149016591|NCT00654940|537540829|FG000|Period 1|Adverse Event|0|||
149212405|NCT01117181|538246533|FG000|Overall Study|Lost to Follow-up|1|||
149212406|NCT01117181|538246534|FG001|Overall Study|Lost to Follow-up|0|||
149212407|NCT01117181|538246533|FG000|Overall Study|Withdrawal by Subject|0|||
149212408|NCT01117181|538246534|FG001|Overall Study|Withdrawal by Subject|2|||
149212409|NCT00216086|538246535|FG000|Overall Study|Protocol Violation|1|||
149212410|NCT00216086|538246535|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
149212411|NCT00216086|538246535|FG000|Overall Study|Social Reasons|2|||
149212412|NCT01080625|538246536|FG000|Overall Study|Physician Decision|0|||
149212413|NCT01080625|538246537|FG001|Overall Study|Physician Decision|2|||
149212414|NCT01080625|538246538|FG002|Overall Study|Physician Decision|1|||
149212415|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Death|3|||
149212416|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Death|0|||
149212417|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Death|0|||
149212418|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Death|0|||
149212419|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Death|0|||
149212420|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
149212421|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
149212422|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
149212423|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
149212424|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
149212425|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
149212426|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
149212427|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
149212428|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149212429|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
149212430|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Other|0|||
149212431|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Other|0|||
149212432|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Other|1|||
149212433|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Other|0|||
149212434|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Other|0|||
149212435|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
149212436|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
149212437|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
149212438|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
149212439|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
149212440|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
149212441|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
149212442|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
149212443|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
149212444|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
149212445|NCT01224106|538246539|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149212446|NCT01224106|538246540|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149212447|NCT01224106|538246541|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149212448|NCT01224106|538246542|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149212449|NCT01224106|538246543|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149212450|NCT01224106|538246539|FG000|Open-Label Extension (OLE) Phase|Death|0|||
149212451|NCT01224106|538246540|FG001|Open-Label Extension (OLE) Phase|Death|0|||
149212452|NCT01224106|538246541|FG002|Open-Label Extension (OLE) Phase|Death|0|||
148950188|NCT03129100|537299675|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
148950189|NCT03129100|537299676|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
148950190|NCT03129100|537299677|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
148950191|NCT03129100|537299678|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
148950192|NCT03129100|537299653|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
149212453|NCT01224106|538246542|FG003|Open-Label Extension (OLE) Phase|Death|1|||
149212454|NCT01224106|538246543|FG004|Open-Label Extension (OLE) Phase|Death|3|||
149212455|NCT01224106|538246539|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
149212456|NCT01224106|538246540|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
148950193|NCT03129100|537299654|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950194|NCT03129100|537299655|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950195|NCT03129100|537299656|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950196|NCT03129100|537299657|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950197|NCT03129100|537299658|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950198|NCT03129100|537299659|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950199|NCT03129100|537299660|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950200|NCT03129100|537299661|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950201|NCT03129100|537299662|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950202|NCT03129100|537299663|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950203|NCT03129100|537299664|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950204|NCT03129100|537299665|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950205|NCT03129100|537299666|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950206|NCT03129100|537299667|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950207|NCT03129100|537299668|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950208|NCT03129100|537299669|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950209|NCT03129100|537299670|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950210|NCT03129100|537299671|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950211|NCT03129100|537299672|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950212|NCT03129100|537299673|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950213|NCT03129100|537299674|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950214|NCT03129100|537299675|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950215|NCT03129100|537299676|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
148950216|NCT03129100|537299677|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
148950217|NCT03129100|537299678|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
148950218|NCT03129100|537299653|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950219|NCT03129100|537299654|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950220|NCT03129100|537299655|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950221|NCT03129100|537299656|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950222|NCT03129100|537299657|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950223|NCT03129100|537299658|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950224|NCT03129100|537299659|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950225|NCT03129100|537299660|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950226|NCT03129100|537299661|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950227|NCT03129100|537299662|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950228|NCT03129100|537299663|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950229|NCT03129100|537299664|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950230|NCT03129100|537299665|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950231|NCT03129100|537299666|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950232|NCT03129100|537299667|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950233|NCT03129100|537299668|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950234|NCT03129100|537299669|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950235|NCT03129100|537299670|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950236|NCT03129100|537299671|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950237|NCT03129100|537299672|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950238|NCT03129100|537299673|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950239|NCT03129100|537299674|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
148950240|NCT03129100|537299675|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
149212457|NCT01224106|538246541|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
149212458|NCT01224106|538246542|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
149212459|NCT01224106|538246543|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
149212460|NCT01224106|538246539|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
149212461|NCT01224106|538246540|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
149212462|NCT01224106|538246541|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
149212463|NCT01224106|538246542|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
149212464|NCT01224106|538246543|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
149212465|NCT01224106|538246539|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
148950241|NCT03129100|537299676|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
148950242|NCT03129100|537299677|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
148950243|NCT03129100|537299678|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
148950244|NCT03129100|537299653|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950245|NCT03129100|537299654|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
149212466|NCT01224106|538246540|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
149212467|NCT01224106|538246541|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
149212468|NCT01224106|538246542|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
149212469|NCT01224106|538246543|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
149212470|NCT01224106|538246539|FG000|Open-Label Extension (OLE) Phase|Other|0|||
149212471|NCT01224106|538246540|FG001|Open-Label Extension (OLE) Phase|Other|0|||
149212472|NCT01224106|538246541|FG002|Open-Label Extension (OLE) Phase|Other|0|||
149212473|NCT01224106|538246542|FG003|Open-Label Extension (OLE) Phase|Other|5|||
149212474|NCT01224106|538246543|FG004|Open-Label Extension (OLE) Phase|Other|3|||
149212475|NCT00446797|538246546|FG000|Overall Study|Lack of Efficacy|0|||
149212476|NCT00446797|538246547|FG001|Overall Study|Lack of Efficacy|2|||
149212477|NCT00446797|538246546|FG000|Overall Study|Lost to Follow-up|5|||
149212478|NCT00446797|538246547|FG001|Overall Study|Lost to Follow-up|3|||
149212479|NCT00446797|538246546|FG000|Overall Study|Withdrawal by Subject|2|||
149212480|NCT00446797|538246547|FG001|Overall Study|Withdrawal by Subject|2|||
149212481|NCT00446797|538246546|FG000|Overall Study|Protocol Violation|1|||
149212482|NCT00446797|538246547|FG001|Overall Study|Protocol Violation|3|||
148950246|NCT03129100|537299655|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950247|NCT03129100|537299656|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950248|NCT03129100|537299657|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950249|NCT03129100|537299658|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950250|NCT03129100|537299659|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950251|NCT03129100|537299660|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950252|NCT03129100|537299661|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950253|NCT03129100|537299662|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950254|NCT03129100|537299663|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950255|NCT03129100|537299664|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950256|NCT03129100|537299665|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950257|NCT03129100|537299666|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950258|NCT03129100|537299667|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950259|NCT03129100|537299668|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950260|NCT03129100|537299669|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950261|NCT03129100|537299670|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950262|NCT03129100|537299671|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950263|NCT03129100|537299672|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950264|NCT03129100|537299673|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950265|NCT03129100|537299674|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950266|NCT03129100|537299675|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950267|NCT03129100|537299676|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
149016592|NCT00654940|537540830|FG001|Period 1|Adverse Event|1|||
149212483|NCT00446797|538246546|FG000|Overall Study|subject entered at another site|0|||
149212484|NCT00446797|538246547|FG001|Overall Study|subject entered at another site|1|||
149212485|NCT00446797|538246546|FG000|Overall Study|did not meet entrance criteria|0|||
149212486|NCT00446797|538246547|FG001|Overall Study|did not meet entrance criteria|1|||
148950268|NCT03129100|537299677|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
148950269|NCT03129100|537299678|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
148950270|NCT03129100|537299653|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950271|NCT03129100|537299654|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950272|NCT03129100|537299655|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950273|NCT03129100|537299656|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950274|NCT03129100|537299657|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
149212487|NCT00364832|538246548|FG000|Core Period|Early Withdrawals|2|||
149212488|NCT00364832|538246549|FG001|Core Period|Early Withdrawals|2|||
149212489|NCT00364832|538246550|FG002|Core Period|Early Withdrawals|1|||
149212490|NCT00364832|538246551|FG003|Core Period|Early Withdrawals|1|||
149212491|NCT00364832|538246552|FG004|Core Period|Early Withdrawals|0|||
149212492|NCT00364832|538246553|FG005|Core Period|Early Withdrawals|0|||
148950275|NCT03129100|537299658|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950276|NCT03129100|537299659|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950277|NCT03129100|537299660|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950278|NCT03129100|537299661|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950279|NCT03129100|537299662|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950280|NCT03129100|537299663|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950281|NCT03129100|537299664|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950282|NCT03129100|537299665|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950283|NCT03129100|537299666|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950284|NCT03129100|537299667|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950285|NCT03129100|537299668|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950286|NCT03129100|537299669|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
149212493|NCT00364832|538246554|FG006|Core Period|Early Withdrawals|4|||
149212494|NCT00364832|538246555|FG007|Core Period|Early Withdrawals|1|||
149212495|NCT00364832|538246556|FG008|Core Period|Early Withdrawals|0|||
149212496|NCT00364832|538246557|FG009|Core Period|Early Withdrawals|0|||
149212497|NCT00364832|538246558|FG010|Core Period|Early Withdrawals|0|||
149212498|NCT00364832|538246559|FG011|Core Period|Early Withdrawals|0|||
149212499|NCT00364832|538246548|FG000|Extension Year 1|Early Withdrawals|0|||
149212500|NCT00364832|538246549|FG001|Extension Year 1|Early Withdrawals|0|||
149212501|NCT00364832|538246550|FG002|Extension Year 1|Early Withdrawals|0|||
148950287|NCT03129100|537299670|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950288|NCT03129100|537299671|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950289|NCT03129100|537299672|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950290|NCT03129100|537299673|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950291|NCT03129100|537299674|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
149016593|NCT00654940|537540829|FG000|Period 1|Intolerable Pain Level|1|||
149212502|NCT00364832|538246551|FG003|Extension Year 1|Early Withdrawals|0|||
149212503|NCT00364832|538246552|FG004|Extension Year 1|Early Withdrawals|0|||
149212504|NCT00364832|538246553|FG005|Extension Year 1|Early Withdrawals|0|||
149212505|NCT00364832|538246554|FG006|Extension Year 1|Early Withdrawals|0|||
149212506|NCT00364832|538246555|FG007|Extension Year 1|Early Withdrawals|0|||
149212507|NCT00364832|538246556|FG008|Extension Year 1|Early Withdrawals|0|||
149212508|NCT00364832|538246557|FG009|Extension Year 1|Early Withdrawals|4|||
149212509|NCT00364832|538246558|FG010|Extension Year 1|Early Withdrawals|2|||
149212510|NCT00364832|538246559|FG011|Extension Year 1|Early Withdrawals|10|||
149212511|NCT00364832|538246548|FG000|Extension Year 2|Early Withdrawals|0|||
149212512|NCT00364832|538246549|FG001|Extension Year 2|Early Withdrawals|0|||
149212513|NCT00364832|538246550|FG002|Extension Year 2|Early Withdrawals|0|||
149212514|NCT00364832|538246551|FG003|Extension Year 2|Early Withdrawals|0|||
149212515|NCT00364832|538246552|FG004|Extension Year 2|Early Withdrawals|0|||
149212516|NCT00364832|538246553|FG005|Extension Year 2|Early Withdrawals|0|||
149212517|NCT00364832|538246554|FG006|Extension Year 2|Early Withdrawals|0|||
149212518|NCT00364832|538246555|FG007|Extension Year 2|Early Withdrawals|0|||
149212519|NCT00364832|538246556|FG008|Extension Year 2|Early Withdrawals|0|||
149212520|NCT00364832|538246557|FG009|Extension Year 2|Early Withdrawals|5|||
149212521|NCT00364832|538246558|FG010|Extension Year 2|Early Withdrawals|5|||
149212522|NCT00364832|538246559|FG011|Extension Year 2|Early Withdrawals|3|||
149212523|NCT04072575|538246564|FG000|Overall Study|Physician Decision|1|||
149212524|NCT04072575|538246564|FG000|Overall Study|Adverse Event|7|||
149212525|NCT04072575|538246564|FG000|Overall Study|Withdrawal by Subject|14|||
149212526|NCT04072575|538246564|FG000|Overall Study|Other|2|||
149212527|NCT01266070|538246565|FG000|Overall Study|Adverse Event|3|||
149212528|NCT01266070|538246565|FG000|Overall Study|Protocol Violation|1|||
149212529|NCT01838213|538246566|FG000|Overall Study|Ineligible|166|||
149212530|NCT01838213|538246567|FG001|Overall Study|Ineligible|191|||
149212531|NCT04882072|538246568|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
149212532|NCT04882072|538246569|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
149212533|NCT04882072|538246568|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
149212534|NCT04882072|538246569|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
149212535|NCT04882072|538246568|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
149212536|NCT04882072|538246569|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
149212537|NCT02918318|538246570|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
149212538|NCT02918318|538246571|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
149212539|NCT02918318|538246572|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
149212540|NCT02918318|538246573|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
149212541|NCT02918318|538246574|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
149212542|NCT02918318|538246570|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149212543|NCT02918318|538246571|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149212544|NCT02918318|538246572|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149212545|NCT02918318|538246573|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
149212546|NCT02918318|538246574|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
149212547|NCT02918318|538246570|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149212548|NCT02918318|538246571|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149212549|NCT02918318|538246572|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149212550|NCT02918318|538246573|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
149212551|NCT02918318|538246574|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
149212552|NCT02918318|538246570|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
149212553|NCT02918318|538246571|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
149212554|NCT02918318|538246572|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
149212555|NCT02918318|538246573|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
149212556|NCT02918318|538246574|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
149212557|NCT02918318|538246570|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149212558|NCT02918318|538246571|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149212559|NCT02918318|538246572|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149212560|NCT02918318|538246573|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
148950292|NCT03129100|537299675|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950293|NCT03129100|537299676|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
149212561|NCT02918318|538246574|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
149212562|NCT02918318|538246570|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
149212563|NCT02918318|538246571|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
149212564|NCT02918318|538246572|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
149212565|NCT02918318|538246573|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
149212566|NCT02918318|538246574|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
149212567|NCT02918318|538246570|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149212568|NCT02918318|538246571|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149212569|NCT02918318|538246572|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149212570|NCT02918318|538246573|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
149212571|NCT02918318|538246574|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
149212572|NCT02918318|538246570|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
149212573|NCT02918318|538246571|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
149212574|NCT02918318|538246572|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
149212575|NCT02918318|538246573|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
149212576|NCT02918318|538246574|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
149212577|NCT02918318|538246570|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
149212578|NCT02918318|538246571|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
149212579|NCT02918318|538246572|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
149212580|NCT02918318|538246573|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
149212581|NCT02918318|538246574|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
149212582|NCT02918318|538246570|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
149212583|NCT02918318|538246571|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
149212584|NCT02918318|538246572|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
149212585|NCT02918318|538246573|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
149212586|NCT02918318|538246574|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
149212587|NCT02918318|538246570|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149212588|NCT02918318|538246571|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149212589|NCT02918318|538246572|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149212590|NCT02918318|538246573|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
149212591|NCT02918318|538246574|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
149212592|NCT02918318|538246570|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149212593|NCT02918318|538246571|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149212594|NCT02918318|538246572|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149212595|NCT02918318|538246573|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
149212596|NCT02918318|538246574|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
149212597|NCT03185819|538246575|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
149212598|NCT03185819|538246576|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
149212599|NCT03185819|538246577|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
149212600|NCT03185819|538246578|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
149212601|NCT03185819|538246575|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
149212602|NCT03185819|538246576|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
149212603|NCT03185819|538246577|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
149212604|NCT03185819|538246578|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
149212605|NCT03185819|538246575|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
149212606|NCT03185819|538246576|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
149212607|NCT03185819|538246577|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
149212608|NCT03185819|538246578|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
149212609|NCT03185819|538246575|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
149212610|NCT03185819|538246576|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
149212611|NCT03185819|538246577|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
149212612|NCT03185819|538246578|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
149212613|NCT03185819|538246575|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
149212614|NCT03185819|538246576|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
149212615|NCT03185819|538246577|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
149212616|NCT03185819|538246578|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
149212617|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
149212618|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
149212619|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
149212620|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
149212621|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
149212622|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
149212623|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
149212624|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
149212625|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
149212626|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
149212627|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
148950294|NCT03129100|537299677|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
148950295|NCT03129100|537299678|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
148950296|NCT03129100|537299653|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
148950297|NCT03129100|537299654|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
148950298|NCT03129100|537299655|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
148950299|NCT03129100|537299656|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
148950300|NCT03129100|537299657|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
148950301|NCT03129100|537299658|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
148950302|NCT03129100|537299659|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
148950303|NCT03129100|537299660|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
148950304|NCT03129100|537299661|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
148950305|NCT03129100|537299662|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
148950306|NCT03129100|537299663|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
148950307|NCT03129100|537299664|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
148950308|NCT03129100|537299665|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
148950309|NCT03129100|537299666|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
148950310|NCT03129100|537299667|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
148950311|NCT03129100|537299668|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
148950312|NCT03129100|537299669|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
148950313|NCT03129100|537299670|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
148950314|NCT03129100|537299671|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
149016594|NCT00654940|537540830|FG001|Period 1|Intolerable Pain Level|0|||
148950315|NCT03129100|537299672|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
148950316|NCT03129100|537299673|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
148950317|NCT03129100|537299674|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
149212628|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
149234090|NCT00423137|538326386|FG002|Overall Study|Adverse Event Study disease worse|3|||
148950318|NCT03129100|537299675|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
149212629|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
149212630|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
149212631|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
149212632|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
149212633|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
149212634|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
149212635|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
149212636|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
149212637|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
149212638|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
149212639|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
149212640|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
149212641|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
149212642|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
149212643|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
149212644|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
149212645|NCT03185819|538246575|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
149212646|NCT03185819|538246576|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
149212647|NCT03185819|538246577|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
149212648|NCT03185819|538246578|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
149212649|NCT03097133|538246579|FG000|Overall Study|Lost to Follow-up|3|||
149212650|NCT03097133|538246580|FG001|Overall Study|Lost to Follow-up|2|||
149212651|NCT03097133|538246579|FG000|Overall Study|Withdrawal by Subject|2|||
149212652|NCT03097133|538246580|FG001|Overall Study|Withdrawal by Subject|5|||
149212653|NCT03097133|538246579|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
149212654|NCT03097133|538246580|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
149212655|NCT03097133|538246579|FG000|Overall Study|Other|3|||
149212656|NCT03097133|538246580|FG001|Overall Study|Other|2|||
149212657|NCT03097133|538246579|FG000|Overall Study|Adverse Event|1|||
149212658|NCT03097133|538246580|FG001|Overall Study|Adverse Event|0|||
149212659|NCT02910089|538246583|FG000|Overall Study|Lost insurance eligibility|22|||
149212660|NCT02910089|538246584|FG001|Overall Study|Lost insurance eligibility|16|||
149212661|NCT02939976|538246585|FG000|Overall Study|Lost to Follow-up|7|||
149212662|NCT02939976|538246586|FG001|Overall Study|Lost to Follow-up|1|||
149212663|NCT02939976|538246587|FG002|Overall Study|Lost to Follow-up|1|||
149212664|NCT02939976|538246588|FG003|Overall Study|Lost to Follow-up|2|||
149212665|NCT02939976|538246585|FG000|Overall Study|Withdrawal by Subject|4|||
149212666|NCT02939976|538246586|FG001|Overall Study|Withdrawal by Subject|0|||
149212667|NCT02939976|538246587|FG002|Overall Study|Withdrawal by Subject|2|||
149212668|NCT02939976|538246588|FG003|Overall Study|Withdrawal by Subject|4|||
149212669|NCT02939976|538246585|FG000|Overall Study|Due to early study closure|4|||
149212670|NCT02939976|538246586|FG001|Overall Study|Due to early study closure|3|||
149212671|NCT02939976|538246587|FG002|Overall Study|Due to early study closure|2|||
149212672|NCT02939976|538246588|FG003|Overall Study|Due to early study closure|3|||
149212673|NCT04080752|538246589|FG000|Overall Study|Adverse Event|2|||
149212674|NCT04080752|538246590|FG001|Overall Study|Adverse Event|3|||
149212675|NCT04080752|538246589|FG000|Overall Study|Lack of Efficacy|1|||
149212676|NCT04080752|538246590|FG001|Overall Study|Lack of Efficacy|0|||
149212677|NCT04080752|538246589|FG000|Overall Study|Lost to Follow-up|1|||
149212678|NCT04080752|538246590|FG001|Overall Study|Lost to Follow-up|0|||
149212679|NCT04080752|538246589|FG000|Overall Study|Pregnancy|0|||
149212680|NCT04080752|538246590|FG001|Overall Study|Pregnancy|1|||
149212681|NCT04080752|538246589|FG000|Overall Study|Withdrawal by Subject|7|||
149212682|NCT04080752|538246590|FG001|Overall Study|Withdrawal by Subject|0|||
149212683|NCT04080752|538246589|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149212684|NCT04080752|538246590|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149212685|NCT04080752|538246589|FG000|Overall Study|Other|2|||
149212686|NCT04080752|538246590|FG001|Overall Study|Other|1|||
149212687|NCT01585168|538246591|FG000|Overall Study|Lost to Follow-up|3|||
149212688|NCT01585168|538246592|FG001|Overall Study|Lost to Follow-up|1|||
148950319|NCT03129100|537299676|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
148950320|NCT03129100|537299677|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
148950321|NCT03129100|537299678|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
149212689|NCT01585168|538246593|FG002|Overall Study|Lost to Follow-up|1|||
149212690|NCT01585168|538246594|FG003|Overall Study|Lost to Follow-up|1|||
149212691|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
149212692|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
149212693|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
149212694|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
148809540|NCT06438601|536779337|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
148809541|NCT06438601|536779336|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
148809542|NCT06438601|536779337|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
148809543|NCT01900314|536779338|FG000|Overall Study|Lost to Follow-up|1|||
148809544|NCT01900314|536779339|FG001|Overall Study|Lost to Follow-up|0|||
148809545|NCT01900314|536779338|FG000|Overall Study|Protocol Violation|0|||
148809546|NCT01900314|536779339|FG001|Overall Study|Protocol Violation|1|||
148809547|NCT01900314|536779338|FG000|Overall Study|Withdrawal by Subject|3|||
148950322|NCT01587001|537299681|FG000|Overall Study|Lost to Follow-up|2|||
148950323|NCT01587001|537299682|FG001|Overall Study|Lost to Follow-up|0|||
148809548|NCT01900314|536779339|FG001|Overall Study|Withdrawal by Subject|3|||
148809549|NCT03282097|536779341|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
148950324|NCT01587001|537299681|FG000|Overall Study|Insufficient samples to complete testing|4|||
148950325|NCT01587001|537299682|FG001|Overall Study|Insufficient samples to complete testing|1|||
148950326|NCT02756013|537299683|FG000|Overall Study|Adverse Event|1|||
148950327|NCT02756013|537299683|FG000|Overall Study|Hypersensitivity|1|||
148950328|NCT01197560|537299684|FG000|Overall Study|Adverse Event|6|||
148950329|NCT01197560|537299685|FG001|Overall Study|Adverse Event|8|||
148950330|NCT01197560|537299684|FG000|Overall Study|Death|3|||
148950331|NCT01197560|537299685|FG001|Overall Study|Death|5|||
148950332|NCT01197560|537299684|FG000|Overall Study|Withdrawal by Subject|1|||
148950333|NCT01197560|537299685|FG001|Overall Study|Withdrawal by Subject|1|||
148950334|NCT01197560|537299684|FG000|Overall Study|Disease progression|40|||
148950335|NCT01197560|537299685|FG001|Overall Study|Disease progression|35|||
148950336|NCT01197560|537299684|FG000|Overall Study|Miscellaneous|4|||
148950337|NCT01197560|537299685|FG001|Overall Study|Miscellaneous|3|||
148950338|NCT01197560|537299684|FG000|Overall Study|Missing|0|||
149212695|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
149212696|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
149212697|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
149212698|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
149212699|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
149212700|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
149212701|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
149212702|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
149212703|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
149212704|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
149212705|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
149212706|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
149212707|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
149212708|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
149212709|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
149212710|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
149212711|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
149212712|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
149212713|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
149212714|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
149212715|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Other|0|||
149212716|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Other|1|||
149212717|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Other|0|||
149212718|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Other|0|||
149212719|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
149212720|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
149212721|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
149212722|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
149212723|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
149212724|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
149212725|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
148950339|NCT01197560|537299685|FG001|Overall Study|Missing|1|||
148950340|NCT00211510|537299686|FG000|Overall Study|Physician Decision|3|||
148950341|NCT00211510|537299687|FG001|Overall Study|Physician Decision|1|||
149212726|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
148809550|NCT03282097|536779342|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
148809551|NCT03282097|536779341|FG000|Intervention Visit Complete|Patient Death|13|||
148950342|NCT00211510|537299686|FG000|Overall Study|Withdrawal by Subject|3|||
148950343|NCT00211510|537299687|FG001|Overall Study|Withdrawal by Subject|1|||
148950344|NCT01487200|537299688|FG000|Overall Study|Withdrawal by Subject|0|||
148950345|NCT01487200|537299689|FG001|Overall Study|Withdrawal by Subject|1|||
148950346|NCT01487200|537299690|FG002|Overall Study|Withdrawal by Subject|0|||
148950347|NCT01487200|537299691|FG003|Overall Study|Withdrawal by Subject|0|||
148950348|NCT00496054|537299692|FG000|Overall Study|Adverse Event|1|||
148950349|NCT00496054|537299692|FG000|Overall Study|Lost to Follow-up|7|||
148950350|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
148950351|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
148950352|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
148950353|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
149212727|NCT01194414|538246595|FG000|24 Weeks Double Blind Period|Death|0|||
149212728|NCT01194414|538246596|FG001|24 Weeks Double Blind Period|Death|1|||
149212729|NCT01194414|538246597|FG002|24 Weeks Double Blind Period|Death|0|||
149212730|NCT01194414|538246598|FG003|24 Weeks Double Blind Period|Death|0|||
149212731|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
149212732|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
149212733|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
149212734|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
149212735|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
149212736|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
149212737|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
149212738|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
149212739|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
149212740|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
149212741|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
149212742|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
149212743|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
149212744|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
149212745|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
149212746|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
149212747|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
149212748|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
149212749|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
149212750|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
149212751|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
149212752|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
149212753|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
149212754|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
149212755|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Other|2|||
149212756|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Other|1|||
149212757|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Other|0|||
149212758|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Other|0|||
149212759|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
149212760|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
149212761|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
149212762|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
149212763|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
149212764|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
149212765|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
149212766|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
149212767|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
149212768|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
149212769|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
149212770|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
149212771|NCT01194414|538246595|FG000|72 Weeks Open Label Extension|Death|1|||
149212772|NCT01194414|538246596|FG001|72 Weeks Open Label Extension|Death|2|||
149212773|NCT01194414|538246597|FG002|72 Weeks Open Label Extension|Death|0|||
149212774|NCT01194414|538246598|FG003|72 Weeks Open Label Extension|Death|2|||
149212775|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
149212776|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
149212777|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
149212778|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
149212779|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
149212780|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
149212781|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
149212782|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
149212783|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
149212784|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
148950354|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
148950355|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
148950356|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
149016595|NCT00802737|537540831|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
149212785|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
149212786|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
149212787|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
149212788|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
149212789|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
148950357|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
148950358|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
149212790|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
149212791|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
149212792|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
149212793|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
149212794|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
149212795|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
149212796|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
149212797|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
149212798|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
149212799|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
149212800|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
149212801|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
149212802|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
149212803|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
149212804|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
149212805|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
149212806|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
149212807|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
149212808|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
149212809|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
149212810|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
149212811|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
149212812|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
149212813|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
149212814|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
149212815|NCT03605836|538246599|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
149212816|NCT03605836|538246600|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
149212817|NCT03605836|538246601|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
149212818|NCT03605836|538246602|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
149212819|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
149212820|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
149212821|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
149212822|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
149212823|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
148684461|NCT03634488|536316852|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
148684462|NCT03634488|536316853|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
148684463|NCT03634488|536316854|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
148684464|NCT03182686|536316855|FG000|Overall Study|Lost to Follow-up|2|||
148684465|NCT03182686|536316856|FG001|Overall Study|Lost to Follow-up|0|||
148684466|NCT03182686|536316855|FG000|Overall Study|Adverse Event|2|||
148684467|NCT03182686|536316856|FG001|Overall Study|Adverse Event|0|||
148684468|NCT03182686|536316855|FG000|Overall Study|Withdrawal by Subject|3|||
148684469|NCT03182686|536316856|FG001|Overall Study|Withdrawal by Subject|0|||
148684470|NCT01512979|536316857|FG000|Overall Study|Adverse Event|2|||
148684471|NCT01512979|536316858|FG001|Overall Study|Adverse Event|2|||
148684472|NCT01512979|536316857|FG000|Overall Study|Protocol Violation|1|||
148684473|NCT01512979|536316858|FG001|Overall Study|Protocol Violation|4|||
148684474|NCT01512979|536316857|FG000|Overall Study|Lost to Follow-up|2|||
148684475|NCT01512979|536316858|FG001|Overall Study|Lost to Follow-up|5|||
148684476|NCT01512979|536316857|FG000|Overall Study|Withdrawal by Subject|1|||
148684477|NCT01512979|536316858|FG001|Overall Study|Withdrawal by Subject|2|||
148684478|NCT01512979|536316857|FG000|Overall Study|Reason other than stated above|13|||
148950359|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
148950360|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
148684479|NCT01512979|536316858|FG001|Overall Study|Reason other than stated above|9|||
148950361|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
148684480|NCT01606137|536316861|FG000|Overall Study|Adverse Event|85|||
149212824|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
149212825|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
149212826|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
149212827|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
149212828|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
149212829|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
149212830|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
149212831|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
149212832|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
149212833|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
149212834|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
149212835|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
149212836|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
149212837|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
149212838|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
149212839|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
149212840|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
149212841|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
149212842|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
149212843|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
149212844|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
149212845|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
149212846|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
149212847|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
149212848|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
149212849|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
149212850|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
149212851|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
149212852|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
149212853|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
149212854|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
149212855|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
149212856|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
149212857|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
149212858|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
149212859|NCT03605836|538246599|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
149212860|NCT03605836|538246600|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
149212861|NCT03605836|538246601|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
149212862|NCT03605836|538246602|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
149212863|NCT01782885|538246605|FG000|Overall Study|Lost to Follow-up|4|||
149212864|NCT01782885|538246606|FG001|Overall Study|Lost to Follow-up|6|||
149212865|NCT02977507|538246609|FG000|Overall Study|Protocol Deviation|1|||
149212866|NCT02977507|538246610|FG001|Overall Study|Protocol Deviation|0|||
149212867|NCT02977507|538246609|FG000|Overall Study|Lost to Follow-up|1|||
149212868|NCT02977507|538246610|FG001|Overall Study|Lost to Follow-up|0|||
149212869|NCT00422669|538246613|FG000|Overall Study|The study was terminated early.|98|||
149212870|NCT00422669|538246614|FG001|Overall Study|The study was terminated early.|100|||
149212871|NCT00422669|538246615|FG002|Overall Study|The study was terminated early.|7|||
149212872|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
149212873|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
149212874|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
149212875|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
149212876|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
149212877|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
149212878|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
149212879|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
149212880|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149212881|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149212882|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149212883|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149212884|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149212885|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
149212886|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
149212887|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
149212888|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
149212889|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
149212890|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
149212891|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
149212892|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
149212893|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
149212894|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149212895|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149212896|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149212897|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149212898|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149212899|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
149212900|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
149212901|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149212902|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149212903|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149212904|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149212905|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149212906|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
149212907|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
149212908|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149212909|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149212910|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149212911|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149212912|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149212913|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
149212914|NCT02120352|538246618|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
149212915|NCT02120352|538246619|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
149212916|NCT02120352|538246620|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
149212917|NCT02120352|538246621|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
149212918|NCT02120352|538246622|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
149212919|NCT02120352|538246623|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
149212920|NCT02120352|538246624|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
149212921|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149212922|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
149212923|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
149212924|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
149212925|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149212926|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149212927|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
149212928|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149212929|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
149212930|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149212931|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
149212932|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149212933|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149212934|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
149212935|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149212936|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
149212937|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
149212938|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149212939|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149212940|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149212941|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
149212942|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149212943|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149212944|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
149212945|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
149212946|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149212947|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149212948|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
149212949|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149212950|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149212951|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149212952|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
149212953|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149212954|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149212955|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
149212956|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149212957|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
149212958|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
149212959|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
149212960|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149212961|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149212962|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
149212963|NCT02120352|538246618|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149212964|NCT02120352|538246619|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
149212965|NCT02120352|538246620|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149212966|NCT02120352|538246621|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149212967|NCT02120352|538246622|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149212968|NCT02120352|538246623|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149212969|NCT02120352|538246624|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
149212970|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
149212971|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
149212972|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
149212973|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
149212974|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
149212975|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
149212976|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
149212977|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149212978|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149212979|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149212980|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149212981|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
149212982|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149212983|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
149212984|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149212985|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
149212986|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
149212987|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149212988|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
149212989|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149212990|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
149212991|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149212992|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
149212993|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
149212994|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149212995|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
149212996|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149212997|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
149212998|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149212999|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
149213000|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
149213001|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
148684481|NCT01606137|536316861|FG000|Overall Study|Withdrawal by Subject|74|||
148684482|NCT01606137|536316861|FG000|Overall Study|Lack of Efficacy|56|||
148684483|NCT01606137|536316861|FG000|Overall Study|Lost to Follow-up|15|||
148684484|NCT01606137|536316861|FG000|Overall Study|Protocol Violation|1|||
148684485|NCT01606137|536316861|FG000|Overall Study|Patient non-compliance|9|||
148684486|NCT01606137|536316861|FG000|Overall Study|Death|1|||
148684487|NCT01606137|536316861|FG000|Overall Study|Decreased/no pain|4|||
148684488|NCT01606137|536316861|FG000|Overall Study|Issues with driving|4|||
148684489|NCT01606137|536316861|FG000|Overall Study|multiple sclerosis less stable|1|||
148684490|NCT01606137|536316861|FG000|Overall Study|Increased bilirubin|1|||
148684491|NCT01606137|536316861|FG000|Overall Study|Spray causes nausea|1|||
148684492|NCT01606137|536316861|FG000|Overall Study|Not enough improvement|4|||
148684493|NCT01606137|536316861|FG000|Overall Study|Wanted to try another treatment|1|||
148684494|NCT01606137|536316861|FG000|Overall Study|Patient leaving country|1|||
148684495|NCT01606137|536316861|FG000|Overall Study|Personal reasons|1|||
148684496|NCT01606137|536316861|FG000|Overall Study|Unable to tolerate study med. taste|1|||
148684497|NCT01606137|536316861|FG000|Overall Study|Patient moving|1|||
149213002|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
148684498|NCT01606137|536316861|FG000|Overall Study|Unable to collect consistent data|1|||
148684499|NCT00066807|536316862|FG000|Overall Study|Study was terminated early|14|||
148684500|NCT00066807|536316863|FG001|Overall Study|Study was terminated early|15|||
148684501|NCT00420290|536316864|FG000|Overall Study|Adverse Event|3|||
149213003|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149213004|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
149213005|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149213006|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
149213007|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
149213008|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149213009|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149213010|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149213011|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
149213012|NCT02120352|538246618|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
149213013|NCT02120352|538246619|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
149213014|NCT02120352|538246620|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
149213015|NCT02120352|538246621|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
149213016|NCT02120352|538246622|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
149213017|NCT02120352|538246623|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
149213018|NCT02120352|538246624|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
149213019|NCT02120352|538246618|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149213020|NCT02120352|538246619|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149213021|NCT02120352|538246620|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149213022|NCT02120352|538246621|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149213023|NCT02120352|538246622|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149213024|NCT02120352|538246623|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
149213025|NCT02120352|538246624|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
149213026|NCT02427100|538246625|FG000|Overall Study|Lost to Follow-up|0|||
149213027|NCT02427100|538246626|FG001|Overall Study|Lost to Follow-up|2|||
149213028|NCT01610206|538246627|FG000|Overall Study|Adverse Event|10|||
149213029|NCT01610206|538246628|FG001|Overall Study|Adverse Event|30|||
149213030|NCT01929707|538246630|FG000|Intervention Period 1|Lost to Follow-up|0|||
149213031|NCT01929707|538246631|FG001|Intervention Period 1|Lost to Follow-up|0|||
149213032|NCT01929707|538246632|FG002|Intervention Period 1|Lost to Follow-up|0|||
149213033|NCT01929707|538246633|FG003|Intervention Period 1|Lost to Follow-up|1|||
149213034|NCT01929707|538246634|FG004|Intervention Period 1|Lost to Follow-up|0|||
149213035|NCT01929707|538246635|FG005|Intervention Period 1|Lost to Follow-up|0|||
149213036|NCT01929707|538246636|FG006|Intervention Period 1|Lost to Follow-up|0|||
149213037|NCT01929707|538246637|FG007|Intervention Period 1|Lost to Follow-up|0|||
149213038|NCT01929707|538246630|FG000|Intervention Period 1|Withdrawal by Subject|0|||
149213039|NCT01929707|538246631|FG001|Intervention Period 1|Withdrawal by Subject|0|||
149213040|NCT01929707|538246632|FG002|Intervention Period 1|Withdrawal by Subject|0|||
149213041|NCT01929707|538246633|FG003|Intervention Period 1|Withdrawal by Subject|2|||
149213042|NCT01929707|538246634|FG004|Intervention Period 1|Withdrawal by Subject|0|||
149213043|NCT01929707|538246635|FG005|Intervention Period 1|Withdrawal by Subject|0|||
149213044|NCT01929707|538246636|FG006|Intervention Period 1|Withdrawal by Subject|0|||
149213045|NCT01929707|538246637|FG007|Intervention Period 1|Withdrawal by Subject|0|||
149213046|NCT01929707|538246630|FG000|Intervention Period 2|Withdrawal by Subject|0|||
149213047|NCT01929707|538246631|FG001|Intervention Period 2|Withdrawal by Subject|0|||
149213048|NCT01929707|538246632|FG002|Intervention Period 2|Withdrawal by Subject|0|||
149213049|NCT01929707|538246633|FG003|Intervention Period 2|Withdrawal by Subject|0|||
149213050|NCT01929707|538246634|FG004|Intervention Period 2|Withdrawal by Subject|0|||
149213051|NCT01929707|538246635|FG005|Intervention Period 2|Withdrawal by Subject|2|||
149213052|NCT01929707|538246636|FG006|Intervention Period 2|Withdrawal by Subject|0|||
149213053|NCT01929707|538246637|FG007|Intervention Period 2|Withdrawal by Subject|0|||
149213054|NCT00437203|538246638|FG000|Overall Study|Death|0|||
149213055|NCT00437203|538246639|FG001|Overall Study|Death|0|||
149213056|NCT00437203|538246640|FG002|Overall Study|Death|1|||
149213057|NCT00437203|538246641|FG003|Overall Study|Death|0|||
149213058|NCT00437203|538246642|FG004|Overall Study|Death|0|||
149213059|NCT00437203|538246643|FG005|Overall Study|Death|0|||
149213060|NCT00437203|538246644|FG006|Overall Study|Death|0|||
149213061|NCT00437203|538246645|FG007|Overall Study|Death|1|||
149213062|NCT00437203|538246646|FG008|Overall Study|Death|0|||
149213063|NCT00437203|538246647|FG009|Overall Study|Death|1|||
149213064|NCT00437203|538246638|FG000|Overall Study|Adverse Event|1|||
149213065|NCT00437203|538246639|FG001|Overall Study|Adverse Event|1|||
149213066|NCT00437203|538246640|FG002|Overall Study|Adverse Event|0|||
149213067|NCT00437203|538246641|FG003|Overall Study|Adverse Event|0|||
149213068|NCT00437203|538246642|FG004|Overall Study|Adverse Event|0|||
149213069|NCT00437203|538246643|FG005|Overall Study|Adverse Event|0|||
149213070|NCT00437203|538246644|FG006|Overall Study|Adverse Event|0|||
149213071|NCT00437203|538246645|FG007|Overall Study|Adverse Event|1|||
149213072|NCT00437203|538246646|FG008|Overall Study|Adverse Event|0|||
149213073|NCT00437203|538246647|FG009|Overall Study|Adverse Event|1|||
149213074|NCT00437203|538246638|FG000|Overall Study|Study terminated by sponsor|0|||
149213075|NCT00437203|538246639|FG001|Overall Study|Study terminated by sponsor|0|||
149213076|NCT00437203|538246640|FG002|Overall Study|Study terminated by sponsor|0|||
149213077|NCT00437203|538246641|FG003|Overall Study|Study terminated by sponsor|0|||
149213078|NCT00437203|538246642|FG004|Overall Study|Study terminated by sponsor|0|||
149213079|NCT00437203|538246643|FG005|Overall Study|Study terminated by sponsor|0|||
149213080|NCT00437203|538246644|FG006|Overall Study|Study terminated by sponsor|0|||
149213081|NCT00437203|538246645|FG007|Overall Study|Study terminated by sponsor|0|||
149213082|NCT00437203|538246646|FG008|Overall Study|Study terminated by sponsor|1|||
149213083|NCT00437203|538246647|FG009|Overall Study|Study terminated by sponsor|0|||
149213084|NCT00437203|538246638|FG000|Overall Study|Objective progression or relapse|5|||
149213085|NCT00437203|538246639|FG001|Overall Study|Objective progression or relapse|6|||
149213086|NCT00437203|538246640|FG002|Overall Study|Objective progression or relapse|2|||
149213087|NCT00437203|538246641|FG003|Overall Study|Objective progression or relapse|3|||
149213088|NCT00437203|538246642|FG004|Overall Study|Objective progression or relapse|3|||
149213089|NCT00437203|538246643|FG005|Overall Study|Objective progression or relapse|3|||
149213090|NCT00437203|538246644|FG006|Overall Study|Objective progression or relapse|6|||
149213091|NCT00437203|538246645|FG007|Overall Study|Objective progression or relapse|1|||
149213092|NCT00437203|538246646|FG008|Overall Study|Objective progression or relapse|2|||
149213093|NCT00437203|538246647|FG009|Overall Study|Objective progression or relapse|2|||
149213094|NCT00437203|538246638|FG000|Overall Study|Other|0|||
149213095|NCT00437203|538246639|FG001|Overall Study|Other|1|||
149213096|NCT00437203|538246640|FG002|Overall Study|Other|0|||
149213097|NCT00437203|538246641|FG003|Overall Study|Other|0|||
149213098|NCT00437203|538246642|FG004|Overall Study|Other|0|||
149213099|NCT00437203|538246643|FG005|Overall Study|Other|0|||
149213100|NCT00437203|538246644|FG006|Overall Study|Other|1|||
149213101|NCT00437203|538246645|FG007|Overall Study|Other|0|||
149213102|NCT00437203|538246646|FG008|Overall Study|Other|0|||
149213103|NCT00437203|538246647|FG009|Overall Study|Other|0|||
149213104|NCT00431496|538246654|FG000|Overall Study|Adverse Event|3|||
149213105|NCT00431496|538246654|FG000|Overall Study|Lost to Follow-up|1|||
149213106|NCT00431496|538246654|FG000|Overall Study|Withdrawal by Subject|2|||
149213107|NCT00431496|538246654|FG000|Overall Study|Protocol-specified criteria|5|||
149213108|NCT01915095|538246655|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
149213109|NCT01915095|538246656|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
149213110|NCT01915095|538246657|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
149213111|NCT01915095|538246658|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
149213112|NCT01915095|538246659|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
149213113|NCT02343952|538246660|FG000|Study Treatment|Disease Progression|23|||
149213114|NCT02343952|538246660|FG000|Study Treatment|Death|3|||
149213115|NCT02343952|538246660|FG000|Study Treatment|Adverse Event|19|||
149213116|NCT02343952|538246660|FG000|Study Treatment|Withdrawal by Subject|7|||
149213117|NCT02343952|538246660|FG000|Study Treatment|other complicating Diseases|1|||
149213118|NCT02343952|538246660|FG000|Follow up|Withdrawal by Subject|3|||
149213119|NCT02343952|538246660|FG000|Follow up|Death|33|||
149213120|NCT02343952|538246660|FG000|Follow up|Patient does not meet eligibility for study.|1|||
149213121|NCT02343952|538246660|FG000|Follow up|Research department closed by the practice.|5|||
149213122|NCT02343952|538246660|FG000|Follow up|Patient went home to Russia|1|||
149213123|NCT02343952|538246660|FG000|Follow up|Disease Progression|1|||
149213124|NCT02343952|538246660|FG000|Follow up|study terminated|1|||
149213125|NCT02067533|538246661|FG000|Overall Study|Lost to Follow-up|4|||
149213126|NCT02067533|538246662|FG001|Overall Study|Lost to Follow-up|2|||
149213127|NCT02671760|538246663|FG000|Overall Study|Lost to Follow-up|0|||
149213128|NCT02671760|538246664|FG001|Overall Study|Lost to Follow-up|1|||
149213129|NCT02671760|538246665|FG002|Overall Study|Lost to Follow-up|0|||
148684502|NCT00420290|536316865|FG001|Overall Study|Adverse Event|1|||
148684503|NCT00420290|536316864|FG000|Overall Study|Withdrawal by Subject|0|||
149213130|NCT02999191|538246666|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
149213131|NCT02999191|538246667|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
149213132|NCT02999191|538246668|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
149213133|NCT04968353|538246673|FG000|Overall Study|Non-compliance|1|||
149213134|NCT04968353|538246674|FG001|Overall Study|Non-compliance|0|||
149213135|NCT04968353|538246675|FG002|Overall Study|Non-compliance|2|||
149213136|NCT04968353|538246676|FG003|Overall Study|Non-compliance|0|||
149213137|NCT00845845|538246677|FG000|Overall Study|Lost to Follow-up|0|||
149213138|NCT00845845|538246678|FG001|Overall Study|Lost to Follow-up|4|||
149213139|NCT01685203|538246679|FG000|Overall Study|Lost to Follow-up|3|||
149213140|NCT01685203|538246680|FG001|Overall Study|Lost to Follow-up|3|||
148684504|NCT00420290|536316865|FG001|Overall Study|Withdrawal by Subject|2|||
148684505|NCT00420290|536316864|FG000|Overall Study|did not meet inclusion/exclusion|1|||
149213141|NCT01685203|538246681|FG002|Overall Study|Lost to Follow-up|0|||
149213142|NCT01685203|538246682|FG003|Overall Study|Lost to Follow-up|1|||
149213143|NCT01685203|538246683|FG004|Overall Study|Lost to Follow-up|0|||
149213144|NCT01685203|538246684|FG005|Overall Study|Lost to Follow-up|0|||
149213145|NCT01685203|538246685|FG006|Overall Study|Lost to Follow-up|0|||
149213146|NCT01685203|538246679|FG000|Overall Study|Adverse Event|0|||
149213147|NCT01685203|538246680|FG001|Overall Study|Adverse Event|0|||
149213148|NCT01685203|538246681|FG002|Overall Study|Adverse Event|0|||
149213149|NCT01685203|538246682|FG003|Overall Study|Adverse Event|0|||
149213150|NCT01685203|538246683|FG004|Overall Study|Adverse Event|0|||
149213151|NCT01685203|538246684|FG005|Overall Study|Adverse Event|2|||
149213152|NCT01685203|538246685|FG006|Overall Study|Adverse Event|0|||
149213153|NCT01685203|538246679|FG000|Overall Study|Adverse event and withdrew consent|1|||
149213154|NCT01685203|538246680|FG001|Overall Study|Adverse event and withdrew consent|0|||
149213155|NCT01685203|538246681|FG002|Overall Study|Adverse event and withdrew consent|0|||
149213156|NCT01685203|538246682|FG003|Overall Study|Adverse event and withdrew consent|0|||
149213157|NCT01685203|538246683|FG004|Overall Study|Adverse event and withdrew consent|0|||
149213158|NCT01685203|538246684|FG005|Overall Study|Adverse event and withdrew consent|0|||
149213159|NCT01685203|538246685|FG006|Overall Study|Adverse event and withdrew consent|0|||
149213160|NCT01685203|538246679|FG000|Overall Study|Patient's decision|0|||
149213161|NCT01685203|538246680|FG001|Overall Study|Patient's decision|0|||
149213162|NCT01685203|538246681|FG002|Overall Study|Patient's decision|0|||
149213163|NCT01685203|538246682|FG003|Overall Study|Patient's decision|0|||
149213164|NCT01685203|538246683|FG004|Overall Study|Patient's decision|0|||
149213165|NCT01685203|538246684|FG005|Overall Study|Patient's decision|1|||
149213166|NCT01685203|538246685|FG006|Overall Study|Patient's decision|0|||
149213167|NCT02896192|538246686|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
149213168|NCT02896192|538246686|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
149213169|NCT02896192|538246686|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
149213170|NCT00383708|538246687|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
149213171|NCT00383708|538246687|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
149213172|NCT00383708|538246687|FG000|Run-in Period|Protocol Violation|4|||
149213173|NCT00383708|538246687|FG000|Run-in Period|Adverse Event|2|||
149213174|NCT00383708|538246687|FG000|Run-in Period|Claustrophobia|1|||
149213175|NCT00383708|538246687|FG000|Co-administration Period|Adverse Event|5|||
149213176|NCT00318370|538246688|FG000|Period 1|Lack of Efficacy|5|||
149213177|NCT00318370|538246689|FG001|Period 1|Lack of Efficacy|0|||
149213178|NCT00318370|538246690|FG002|Period 1|Lack of Efficacy|0|||
149213179|NCT00318370|538246688|FG000|Period 1|Physician Decision|1|||
149213180|NCT00318370|538246689|FG001|Period 1|Physician Decision|0|||
149213181|NCT00318370|538246690|FG002|Period 1|Physician Decision|0|||
149213182|NCT00318370|538246688|FG000|Period 1|Withdrawal by Subject|1|||
149213183|NCT00318370|538246689|FG001|Period 1|Withdrawal by Subject|0|||
149213184|NCT00318370|538246690|FG002|Period 1|Withdrawal by Subject|0|||
149213185|NCT00318370|538246688|FG000|Period 2|Adverse Event|0|||
149213186|NCT00318370|538246689|FG001|Period 2|Adverse Event|3|||
149213187|NCT00318370|538246690|FG002|Period 2|Adverse Event|0|||
149213188|NCT00318370|538246688|FG000|Period 2|Lack of Efficacy|0|||
149213189|NCT00318370|538246689|FG001|Period 2|Lack of Efficacy|5|||
149213190|NCT00318370|538246690|FG002|Period 2|Lack of Efficacy|0|||
149213191|NCT00318370|538246688|FG000|Period 2|Physician Decision|0|||
149213192|NCT00318370|538246689|FG001|Period 2|Physician Decision|1|||
149213193|NCT00318370|538246690|FG002|Period 2|Physician Decision|0|||
149213194|NCT00318370|538246688|FG000|Period 2|Withdrawal by Subject|0|||
149213195|NCT00318370|538246689|FG001|Period 2|Withdrawal by Subject|1|||
149213196|NCT00318370|538246690|FG002|Period 2|Withdrawal by Subject|0|||
149213197|NCT00318370|538246688|FG000|Period 2|Other|0|||
149213198|NCT00318370|538246689|FG001|Period 2|Other|1|||
149213199|NCT00318370|538246690|FG002|Period 2|Other|0|||
149213200|NCT00318370|538246688|FG000|Period 3|Adverse Event|0|||
149213201|NCT00318370|538246689|FG001|Period 3|Adverse Event|0|||
149213202|NCT00318370|538246690|FG002|Period 3|Adverse Event|1|||
149213203|NCT00318370|538246688|FG000|Period 3|Lack of Efficacy|0|||
149213204|NCT00318370|538246689|FG001|Period 3|Lack of Efficacy|0|||
149016596|NCT00802737|537540832|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
149016597|NCT00802737|537540833|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
149016598|NCT00802737|537540831|FG000|Overall Study|Death|6|||
149016599|NCT00802737|537540832|FG001|Overall Study|Death|5|||
149016600|NCT00802737|537540833|FG002|Overall Study|Death|1|||
149213205|NCT00318370|538246690|FG002|Period 3|Lack of Efficacy|24|||
149213206|NCT00318370|538246688|FG000|Period 3|Death|0|||
149213207|NCT00318370|538246689|FG001|Period 3|Death|0|||
149213208|NCT00318370|538246690|FG002|Period 3|Death|1|||
149213209|NCT00318370|538246688|FG000|Period 3|Physician Decision|0|||
149213210|NCT00318370|538246689|FG001|Period 3|Physician Decision|0|||
149213211|NCT00318370|538246690|FG002|Period 3|Physician Decision|1|||
149213212|NCT00318370|538246688|FG000|Period 3|Withdrawal by Subject|0|||
149213213|NCT00318370|538246689|FG001|Period 3|Withdrawal by Subject|0|||
149213214|NCT00318370|538246690|FG002|Period 3|Withdrawal by Subject|3|||
149213215|NCT00318370|538246688|FG000|Period 3|Other|0|||
149213216|NCT00318370|538246689|FG001|Period 3|Other|0|||
149213217|NCT00318370|538246690|FG002|Period 3|Other|3|||
149213218|NCT01750840|538246694|FG000|Overall Study|Lost to Follow-up|4|||
149213219|NCT02650895|538246695|FG000|Overall Study|Withdrawal by Subject|0|||
149213220|NCT02650895|538246696|FG001|Overall Study|Withdrawal by Subject|1|||
149213221|NCT02650895|538246697|FG002|Overall Study|Withdrawal by Subject|0|||
149213222|NCT02650895|538246698|FG003|Overall Study|Withdrawal by Subject|0|||
149213223|NCT02650895|538246699|FG004|Overall Study|Withdrawal by Subject|0|||
148950362|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950363|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
149213224|NCT02650895|538246700|FG005|Overall Study|Withdrawal by Subject|0|||
149213225|NCT00981682|538246704|FG000|Overall Study|Adverse Event|48|||
149213226|NCT00981682|538246704|FG000|Overall Study|Withdrawal by Subject|52|||
149213227|NCT00981682|538246704|FG000|Overall Study|Lost to Follow-up|14|||
149213228|NCT00981682|538246704|FG000|Overall Study|Lack of Efficacy|13|||
149213229|NCT00981682|538246704|FG000|Overall Study|Protocol Violation|6|||
149213230|NCT00981682|538246704|FG000|Overall Study|administrative|9|||
149213231|NCT04507360|538248669|FG000|Week 1|Lost to Follow-up|0|||
149213232|NCT04507360|538248670|FG001|Week 1|Lost to Follow-up|0|||
149213233|NCT04507360|538248671|FG002|Week 1|Lost to Follow-up|0|||
149213234|NCT04507360|538248672|FG003|Week 1|Lost to Follow-up|0|||
149213235|NCT04507360|538248673|FG004|Week 1|Lost to Follow-up|0|||
149213236|NCT04507360|538248674|FG005|Week 1|Lost to Follow-up|0|||
149213237|NCT04507360|538248675|FG006|Week 1|Lost to Follow-up|0|||
149213238|NCT04507360|538248676|FG007|Week 1|Lost to Follow-up|0|||
149213239|NCT04507360|538248677|FG008|Week 1|Lost to Follow-up|72|||
149213240|NCT04507360|538248678|FG009|Week 1|Lost to Follow-up|22|||
149213241|NCT04507360|538248679|FG010|Week 1|Lost to Follow-up|10|||
149213242|NCT04507360|538248669|FG000|Week 2|Lost to Follow-up|0|||
149213243|NCT04507360|538248670|FG001|Week 2|Lost to Follow-up|0|||
149213244|NCT04507360|538248671|FG002|Week 2|Lost to Follow-up|0|||
149213245|NCT04507360|538248672|FG003|Week 2|Lost to Follow-up|0|||
149213246|NCT04507360|538248673|FG004|Week 2|Lost to Follow-up|0|||
149213247|NCT04507360|538248674|FG005|Week 2|Lost to Follow-up|0|||
149213248|NCT04507360|538248675|FG006|Week 2|Lost to Follow-up|0|||
149213249|NCT04507360|538248676|FG007|Week 2|Lost to Follow-up|0|||
149213250|NCT04507360|538248677|FG008|Week 2|Lost to Follow-up|121|||
149213251|NCT04507360|538248678|FG009|Week 2|Lost to Follow-up|85|||
149213252|NCT04507360|538248679|FG010|Week 2|Lost to Follow-up|82|||
149213253|NCT04507360|538248669|FG000|Week 3|Lost to Follow-up|0|||
149213254|NCT04507360|538248670|FG001|Week 3|Lost to Follow-up|0|||
149213255|NCT04507360|538248671|FG002|Week 3|Lost to Follow-up|0|||
149213256|NCT04507360|538248672|FG003|Week 3|Lost to Follow-up|0|||
149213257|NCT04507360|538248673|FG004|Week 3|Lost to Follow-up|0|||
149213258|NCT04507360|538248674|FG005|Week 3|Lost to Follow-up|0|||
149213259|NCT04507360|538248675|FG006|Week 3|Lost to Follow-up|0|||
149213260|NCT04507360|538248676|FG007|Week 3|Lost to Follow-up|0|||
149213261|NCT04507360|538248677|FG008|Week 3|Lost to Follow-up|123|||
149213262|NCT04507360|538248678|FG009|Week 3|Lost to Follow-up|92|||
149213263|NCT04507360|538248679|FG010|Week 3|Lost to Follow-up|84|||
149213264|NCT04507360|538248669|FG000|Week 4|Lost to Follow-up|0|||
149213265|NCT04507360|538248670|FG001|Week 4|Lost to Follow-up|0|||
149213266|NCT04507360|538248671|FG002|Week 4|Lost to Follow-up|0|||
149213267|NCT04507360|538248672|FG003|Week 4|Lost to Follow-up|0|||
149213268|NCT04507360|538248673|FG004|Week 4|Lost to Follow-up|0|||
149213269|NCT04507360|538248674|FG005|Week 4|Lost to Follow-up|0|||
149213270|NCT04507360|538248675|FG006|Week 4|Lost to Follow-up|0|||
149213271|NCT04507360|538248676|FG007|Week 4|Lost to Follow-up|0|||
149213272|NCT04507360|538248677|FG008|Week 4|Lost to Follow-up|131|||
149213273|NCT04507360|538248678|FG009|Week 4|Lost to Follow-up|115|||
149213274|NCT04507360|538248679|FG010|Week 4|Lost to Follow-up|102|||
149213275|NCT04507360|538248669|FG000|Week 5|Lost to Follow-up|0|||
149213276|NCT04507360|538248670|FG001|Week 5|Lost to Follow-up|0|||
149213277|NCT04507360|538248671|FG002|Week 5|Lost to Follow-up|0|||
149213278|NCT04507360|538248672|FG003|Week 5|Lost to Follow-up|0|||
149213279|NCT04507360|538248673|FG004|Week 5|Lost to Follow-up|0|||
149213280|NCT04507360|538248674|FG005|Week 5|Lost to Follow-up|0|||
149213281|NCT04507360|538248675|FG006|Week 5|Lost to Follow-up|0|||
149213282|NCT04507360|538248676|FG007|Week 5|Lost to Follow-up|0|||
149213283|NCT04507360|538248677|FG008|Week 5|Lost to Follow-up|103|||
148950364|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
149213284|NCT04507360|538248678|FG009|Week 5|Lost to Follow-up|135|||
149213285|NCT04507360|538248679|FG010|Week 5|Lost to Follow-up|143|||
149213286|NCT04507360|538248669|FG000|Week 8|Lost to Follow-up|0|||
149213287|NCT04507360|538248670|FG001|Week 8|Lost to Follow-up|0|||
148950365|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950366|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
149213288|NCT04507360|538248671|FG002|Week 8|Lost to Follow-up|0|||
149213289|NCT04507360|538248672|FG003|Week 8|Lost to Follow-up|0|||
149213290|NCT04507360|538248673|FG004|Week 8|Lost to Follow-up|0|||
149213291|NCT04507360|538248674|FG005|Week 8|Lost to Follow-up|0|||
149213292|NCT04507360|538248675|FG006|Week 8|Lost to Follow-up|0|||
149213293|NCT04507360|538248676|FG007|Week 8|Lost to Follow-up|0|||
149213294|NCT04507360|538248677|FG008|Week 8|Lost to Follow-up|139|||
149213295|NCT04507360|538248678|FG009|Week 8|Lost to Follow-up|145|||
149213296|NCT04507360|538248679|FG010|Week 8|Lost to Follow-up|152|||
149213297|NCT01004159|538248680|FG000|Overall Study|Adverse Event|2|||
149213298|NCT01004159|538248680|FG000|Overall Study|Disease Progression|18|||
149213299|NCT02712008|538248681|FG000|Baseline (Day 1) up to Week 12|Death|3|||
149213300|NCT02712008|538248682|FG001|Baseline (Day 1) up to Week 12|Death|0|||
149213301|NCT02712008|538248683|FG002|Baseline (Day 1) up to Week 12|Death|0|||
149213302|NCT02712008|538248684|FG003|Baseline (Day 1) up to Week 12|Death|0|||
149213303|NCT02712008|538248685|FG004|Baseline (Day 1) up to Week 12|Death|0|||
149213304|NCT02712008|538248686|FG005|Baseline (Day 1) up to Week 12|Death|0|||
149213305|NCT02712008|538248687|FG006|Baseline (Day 1) up to Week 12|Death|0|||
149213306|NCT02712008|538248688|FG007|Baseline (Day 1) up to Week 12|Death|0|||
149213307|NCT02712008|538248681|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149213308|NCT02712008|538248682|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
149213309|NCT02712008|538248683|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
149213310|NCT02712008|538248684|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149213311|NCT02712008|538248685|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149213312|NCT02712008|538248686|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149213313|NCT02712008|538248687|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149213314|NCT02712008|538248688|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
149213315|NCT02712008|538248681|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
149213316|NCT02712008|538248682|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149213317|NCT02712008|538248683|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
149213318|NCT02712008|538248684|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149213319|NCT02712008|538248685|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149213320|NCT02712008|538248686|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149213321|NCT02712008|538248687|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149213322|NCT02712008|538248688|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
149213323|NCT02712008|538248681|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213324|NCT02712008|538248682|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213325|NCT02712008|538248683|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
149213326|NCT02712008|538248684|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213327|NCT02712008|538248685|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213328|NCT02712008|538248686|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213329|NCT02712008|538248687|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213330|NCT02712008|538248688|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
149213331|NCT02712008|538248681|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213332|NCT02712008|538248682|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
149213333|NCT02712008|538248683|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213334|NCT02712008|538248684|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213335|NCT02712008|538248685|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213336|NCT02712008|538248686|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213337|NCT02712008|538248687|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213338|NCT02712008|538248688|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
149213339|NCT02712008|538248681|FG000|From Week 12 up to Week 36|Adverse Event|0|||
149213340|NCT02712008|538248682|FG001|From Week 12 up to Week 36|Adverse Event|0|||
149213341|NCT02712008|538248683|FG002|From Week 12 up to Week 36|Adverse Event|0|||
149213342|NCT02712008|538248684|FG003|From Week 12 up to Week 36|Adverse Event|0|||
149213343|NCT02712008|538248685|FG004|From Week 12 up to Week 36|Adverse Event|1|||
149213344|NCT02712008|538248686|FG005|From Week 12 up to Week 36|Adverse Event|0|||
149213345|NCT02712008|538248687|FG006|From Week 12 up to Week 36|Adverse Event|0|||
149213346|NCT02712008|538248688|FG007|From Week 12 up to Week 36|Adverse Event|2|||
149213347|NCT02712008|538248681|FG000|From Week 12 up to Week 36|Death|1|||
149213348|NCT02712008|538248682|FG001|From Week 12 up to Week 36|Death|0|||
149213349|NCT02712008|538248683|FG002|From Week 12 up to Week 36|Death|0|||
149213350|NCT02712008|538248684|FG003|From Week 12 up to Week 36|Death|0|||
149213351|NCT02712008|538248685|FG004|From Week 12 up to Week 36|Death|0|||
149213352|NCT02712008|538248686|FG005|From Week 12 up to Week 36|Death|0|||
149213353|NCT02712008|538248687|FG006|From Week 12 up to Week 36|Death|1|||
149213354|NCT02712008|538248688|FG007|From Week 12 up to Week 36|Death|0|||
149213355|NCT02712008|538248681|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
149213356|NCT02712008|538248682|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
149213357|NCT02712008|538248683|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
149213358|NCT02712008|538248684|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
149213359|NCT02712008|538248685|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
149213360|NCT02712008|538248686|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
149213361|NCT02712008|538248687|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
149213362|NCT02712008|538248688|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
149016601|NCT00802737|537540831|FG000|Overall Study|Adverse Event|1|||
149016602|NCT00802737|537540832|FG001|Overall Study|Adverse Event|0|||
149016603|NCT00802737|537540833|FG002|Overall Study|Adverse Event|0|||
149016604|NCT00802737|537540831|FG000|Overall Study|Received Prohibited Therapy|1|||
149016605|NCT00802737|537540832|FG001|Overall Study|Received Prohibited Therapy|0|||
149016606|NCT00802737|537540833|FG002|Overall Study|Received Prohibited Therapy|0|||
149016607|NCT00802737|537540831|FG000|Overall Study|Ongoing CLL-Treatment|0|||
149213363|NCT02712008|538248681|FG000|From Week 12 up to Week 36|Physician Decision|0|||
149213364|NCT02712008|538248682|FG001|From Week 12 up to Week 36|Physician Decision|0|||
149213365|NCT02712008|538248683|FG002|From Week 12 up to Week 36|Physician Decision|0|||
149213366|NCT02712008|538248684|FG003|From Week 12 up to Week 36|Physician Decision|1|||
149213367|NCT02712008|538248685|FG004|From Week 12 up to Week 36|Physician Decision|1|||
149213368|NCT02712008|538248686|FG005|From Week 12 up to Week 36|Physician Decision|0|||
149213369|NCT02712008|538248687|FG006|From Week 12 up to Week 36|Physician Decision|0|||
149213370|NCT02712008|538248688|FG007|From Week 12 up to Week 36|Physician Decision|0|||
149213371|NCT02712008|538248681|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149213372|NCT02712008|538248682|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149213373|NCT02712008|538248683|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149213374|NCT02712008|538248684|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149213375|NCT02712008|538248685|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149213376|NCT02712008|538248686|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
149213377|NCT02712008|538248687|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
149213378|NCT02712008|538248688|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
149213379|NCT04483544|538248690|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
149213380|NCT04483544|538248690|FG000|Post-Treatment|Admitted to hospice|2|||
149213381|NCT04483544|538248690|FG000|Post-Treatment|Study terminated|3|||
149213382|NCT01131078|538248691|FG000|Overall Study|Adverse Event|22|||
149213383|NCT01131078|538248692|FG001|Overall Study|Adverse Event|12|||
149213384|NCT01131078|538248693|FG002|Overall Study|Adverse Event|17|||
149213385|NCT01131078|538248691|FG000|Overall Study|Progressive Disease|58|||
149213386|NCT01131078|538248692|FG001|Overall Study|Progressive Disease|77|||
149213387|NCT01131078|538248693|FG002|Overall Study|Progressive Disease|71|||
149213388|NCT01131078|538248691|FG000|Overall Study|Protocol Violation|1|||
149213389|NCT01131078|538248692|FG001|Overall Study|Protocol Violation|0|||
149213390|NCT01131078|538248693|FG002|Overall Study|Protocol Violation|0|||
149213391|NCT01131078|538248691|FG000|Overall Study|Lost to Follow-up|1|||
149213392|NCT01131078|538248692|FG001|Overall Study|Lost to Follow-up|1|||
149213393|NCT01131078|538248693|FG002|Overall Study|Lost to Follow-up|1|||
149213394|NCT01131078|538248691|FG000|Overall Study|Withdrawal by Subject|2|||
149213395|NCT01131078|538248692|FG001|Overall Study|Withdrawal by Subject|4|||
149213396|NCT01131078|538248693|FG002|Overall Study|Withdrawal by Subject|3|||
149213397|NCT01131078|538248691|FG000|Overall Study|Non-compliance|3|||
149213398|NCT01131078|538248692|FG001|Overall Study|Non-compliance|0|||
149213399|NCT01131078|538248693|FG002|Overall Study|Non-compliance|0|||
149213400|NCT01131078|538248691|FG000|Overall Study|Physician Decision|10|||
149213401|NCT01131078|538248692|FG001|Overall Study|Physician Decision|6|||
149213402|NCT01131078|538248693|FG002|Overall Study|Physician Decision|8|||
149213403|NCT01131078|538248691|FG000|Overall Study|Death|4|||
149213404|NCT01131078|538248692|FG001|Overall Study|Death|0|||
149213405|NCT01131078|538248693|FG002|Overall Study|Death|2|||
149213406|NCT01131078|538248691|FG000|Overall Study|Other|0|||
149213407|NCT01131078|538248692|FG001|Overall Study|Other|1|||
149213408|NCT01131078|538248693|FG002|Overall Study|Other|0|||
149213409|NCT01199198|538248698|FG000|Overall Study|Adverse Event|3|||
149213410|NCT01199198|538248699|FG001|Overall Study|Adverse Event|0|||
149213411|NCT01199198|538248698|FG000|Overall Study|Lost to Follow-up|1|||
149213412|NCT01199198|538248699|FG001|Overall Study|Lost to Follow-up|5|||
149213413|NCT01199198|538248698|FG000|Overall Study|Withdrawal by Subject|1|||
149213414|NCT01199198|538248699|FG001|Overall Study|Withdrawal by Subject|2|||
149213415|NCT01199198|538248698|FG000|Overall Study|ICU Transfer|1|||
149213416|NCT01199198|538248699|FG001|Overall Study|ICU Transfer|2|||
149213417|NCT01199198|538248698|FG000|Overall Study|Hospice-care transfer|1|||
149213418|NCT01199198|538248699|FG001|Overall Study|Hospice-care transfer|2|||
149213419|NCT04315298|538248700|FG000|Overall Study|Withdrawal by Subject|0|||
148684506|NCT00420290|536316865|FG001|Overall Study|did not meet inclusion/exclusion|1|||
148684507|NCT05028751|536316866|FG000|Overall Study|Study Terminated by Sponsor|3|||
148684508|NCT05028751|536316867|FG001|Overall Study|Study Terminated by Sponsor|0|||
148684509|NCT05028751|536316868|FG002|Overall Study|Study Terminated by Sponsor|0|||
148684510|NCT05028751|536316869|FG003|Overall Study|Study Terminated by Sponsor|0|||
148684511|NCT05028751|536316866|FG000|Overall Study|Death|9|||
148684512|NCT05028751|536316867|FG001|Overall Study|Death|3|||
148684513|NCT05028751|536316868|FG002|Overall Study|Death|2|||
148684514|NCT05028751|536316869|FG003|Overall Study|Death|4|||
148684515|NCT05028751|536316866|FG000|Overall Study|Withdrawal by Subject|0|||
148684516|NCT05028751|536316867|FG001|Overall Study|Withdrawal by Subject|0|||
148684517|NCT05028751|536316868|FG002|Overall Study|Withdrawal by Subject|1|||
148684518|NCT05028751|536316869|FG003|Overall Study|Withdrawal by Subject|0|||
149213420|NCT04315298|538248701|FG001|Overall Study|Withdrawal by Subject|0|||
148684519|NCT05028751|536316866|FG000|Overall Study|Miscellaneous|2|||
149213421|NCT04315298|538248702|FG002|Overall Study|Withdrawal by Subject|0|||
149213422|NCT04315298|538248703|FG003|Overall Study|Withdrawal by Subject|2|||
149213423|NCT04315298|538248704|FG004|Overall Study|Withdrawal by Subject|2|||
149213424|NCT04315298|538248705|FG005|Overall Study|Withdrawal by Subject|2|||
149213425|NCT04315298|538248706|FG006|Overall Study|Withdrawal by Subject|0|||
149213426|NCT04315298|538248707|FG007|Overall Study|Withdrawal by Subject|1|||
148684520|NCT05028751|536316867|FG001|Overall Study|Miscellaneous|0|||
148684521|NCT05028751|536316868|FG002|Overall Study|Miscellaneous|0|||
149213427|NCT04315298|538248708|FG008|Overall Study|Withdrawal by Subject|1|||
149213428|NCT04315298|538248709|FG009|Overall Study|Withdrawal by Subject|1|||
149213429|NCT04315298|538248710|FG010|Overall Study|Withdrawal by Subject|0|||
149213430|NCT04315298|538248711|FG011|Overall Study|Withdrawal by Subject|0|||
149213431|NCT04315298|538248712|FG012|Overall Study|Withdrawal by Subject|0|||
149213432|NCT04315298|538248713|FG013|Overall Study|Withdrawal by Subject|0|||
149213433|NCT04315298|538248714|FG014|Overall Study|Withdrawal by Subject|0|||
149213434|NCT04315298|538248715|FG015|Overall Study|Withdrawal by Subject|0|||
149213435|NCT04315298|538248716|FG016|Overall Study|Withdrawal by Subject|0|||
149213436|NCT04315298|538248717|FG017|Overall Study|Withdrawal by Subject|0|||
149213437|NCT04315298|538248718|FG018|Overall Study|Withdrawal by Subject|0|||
149213438|NCT04315298|538248700|FG000|Overall Study|Physician Decision|0|||
149213439|NCT04315298|538248701|FG001|Overall Study|Physician Decision|0|||
149213440|NCT04315298|538248702|FG002|Overall Study|Physician Decision|0|||
149213441|NCT04315298|538248703|FG003|Overall Study|Physician Decision|0|||
149213442|NCT04315298|538248704|FG004|Overall Study|Physician Decision|1|||
149213443|NCT04315298|538248705|FG005|Overall Study|Physician Decision|0|||
149213444|NCT04315298|538248706|FG006|Overall Study|Physician Decision|0|||
149213445|NCT04315298|538248707|FG007|Overall Study|Physician Decision|0|||
149213446|NCT04315298|538248708|FG008|Overall Study|Physician Decision|0|||
149213447|NCT04315298|538248709|FG009|Overall Study|Physician Decision|0|||
149213448|NCT04315298|538248710|FG010|Overall Study|Physician Decision|0|||
149213449|NCT04315298|538248711|FG011|Overall Study|Physician Decision|0|||
149213450|NCT04315298|538248712|FG012|Overall Study|Physician Decision|0|||
149213451|NCT04315298|538248713|FG013|Overall Study|Physician Decision|0|||
149213452|NCT04315298|538248714|FG014|Overall Study|Physician Decision|0|||
149213453|NCT04315298|538248715|FG015|Overall Study|Physician Decision|0|||
149213454|NCT04315298|538248716|FG016|Overall Study|Physician Decision|0|||
149213455|NCT04315298|538248717|FG017|Overall Study|Physician Decision|0|||
149213456|NCT04315298|538248718|FG018|Overall Study|Physician Decision|0|||
149213457|NCT04315298|538248700|FG000|Overall Study|Lost to Follow-up|5|||
149213458|NCT04315298|538248701|FG001|Overall Study|Lost to Follow-up|10|||
149213459|NCT04315298|538248702|FG002|Overall Study|Lost to Follow-up|6|||
149213460|NCT04315298|538248703|FG003|Overall Study|Lost to Follow-up|8|||
149213461|NCT04315298|538248704|FG004|Overall Study|Lost to Follow-up|12|||
149213462|NCT04315298|538248705|FG005|Overall Study|Lost to Follow-up|13|||
149213463|NCT04315298|538248706|FG006|Overall Study|Lost to Follow-up|9|||
149213464|NCT04315298|538248707|FG007|Overall Study|Lost to Follow-up|16|||
149213465|NCT04315298|538248708|FG008|Overall Study|Lost to Follow-up|14|||
149213466|NCT04315298|538248709|FG009|Overall Study|Lost to Follow-up|0|||
149213467|NCT04315298|538248710|FG010|Overall Study|Lost to Follow-up|2|||
149213468|NCT04315298|538248711|FG011|Overall Study|Lost to Follow-up|1|||
149213469|NCT04315298|538248712|FG012|Overall Study|Lost to Follow-up|0|||
149213470|NCT04315298|538248713|FG013|Overall Study|Lost to Follow-up|0|||
149213471|NCT04315298|538248714|FG014|Overall Study|Lost to Follow-up|0|||
149213472|NCT04315298|538248715|FG015|Overall Study|Lost to Follow-up|2|||
149213473|NCT04315298|538248716|FG016|Overall Study|Lost to Follow-up|0|||
149213474|NCT04315298|538248717|FG017|Overall Study|Lost to Follow-up|0|||
149213475|NCT04315298|538248718|FG018|Overall Study|Lost to Follow-up|0|||
149213476|NCT04315298|538248700|FG000|Overall Study|Death|24|||
149213477|NCT04315298|538248701|FG001|Overall Study|Death|60|||
149213478|NCT04315298|538248702|FG002|Overall Study|Death|49|||
149213479|NCT04315298|538248703|FG003|Overall Study|Death|59|||
149213480|NCT04315298|538248704|FG004|Overall Study|Death|70|||
149213481|NCT04315298|538248705|FG005|Overall Study|Death|114|||
149213482|NCT04315298|538248706|FG006|Overall Study|Death|9|||
149213483|NCT04315298|538248707|FG007|Overall Study|Death|12|||
149213484|NCT04315298|538248708|FG008|Overall Study|Death|21|||
149213485|NCT04315298|538248709|FG009|Overall Study|Death|16|||
149213486|NCT04315298|538248710|FG010|Overall Study|Death|40|||
149213487|NCT04315298|538248711|FG011|Overall Study|Death|40|||
149213488|NCT04315298|538248712|FG012|Overall Study|Death|3|||
149213489|NCT04315298|538248713|FG013|Overall Study|Death|4|||
149213490|NCT04315298|538248714|FG014|Overall Study|Death|6|||
149213491|NCT04315298|538248715|FG015|Overall Study|Death|4|||
149213492|NCT04315298|538248716|FG016|Overall Study|Death|3|||
149213493|NCT04315298|538248717|FG017|Overall Study|Death|1|||
149213494|NCT04315298|538248718|FG018|Overall Study|Death|0|||
149213495|NCT00736385|538248719|FG000|Overall Study|Withdrawal by Subject|2|||
149213496|NCT00736385|538248720|FG001|Overall Study|Withdrawal by Subject|2|||
149213497|NCT00736385|538248719|FG000|Overall Study|Adverse Event|0|||
149213498|NCT00736385|538248720|FG001|Overall Study|Adverse Event|1|||
149213499|NCT01183104|538248721|FG000|Overall Study|Adverse Event|8|||
149213500|NCT01183104|538248722|FG001|Overall Study|Adverse Event|6|||
149213501|NCT01183104|538248721|FG000|Overall Study|Death|0|||
149213502|NCT01183104|538248722|FG001|Overall Study|Death|1|||
149213503|NCT01183104|538248721|FG000|Overall Study|Lost to Follow-up|14|||
149213504|NCT01183104|538248722|FG001|Overall Study|Lost to Follow-up|7|||
149213505|NCT01183104|538248721|FG000|Overall Study|Physician Decision|5|||
149213506|NCT01183104|538248722|FG001|Overall Study|Physician Decision|8|||
149213507|NCT01183104|538248721|FG000|Overall Study|Withdrawal by Subject|6|||
149213508|NCT01183104|538248722|FG001|Overall Study|Withdrawal by Subject|11|||
149213509|NCT01183104|538248721|FG000|Overall Study|Nonparticipation in Extension Study|39|||
149213510|NCT01183104|538248722|FG001|Overall Study|Nonparticipation in Extension Study|50|||
149213511|NCT01183104|538248721|FG000|Overall Study|Did not receive study drug|5|||
149213512|NCT01183104|538248722|FG001|Overall Study|Did not receive study drug|9|||
148809552|NCT03282097|536779342|FG001|Intervention Visit Complete|Patient Death|15|||
148809553|NCT03282097|536779341|FG000|Intervention Visit Complete|Caregiver Death|0|||
148809554|NCT03282097|536779342|FG001|Intervention Visit Complete|Caregiver Death|3|||
148809555|NCT03282097|536779341|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
149213513|NCT03267511|538248723|FG000|Overall Study|Lost to Follow-up|0|||
149213514|NCT03267511|538248724|FG001|Overall Study|Lost to Follow-up|0|||
149213515|NCT03267511|538248725|FG002|Overall Study|Lost to Follow-up|0|||
149213516|NCT03267511|538248726|FG003|Overall Study|Lost to Follow-up|1|||
149213517|NCT01594749|538248727|FG000|Overall Study|Adverse Event|2|||
149213518|NCT01594749|538248728|FG001|Overall Study|Adverse Event|1|||
149213519|NCT01594749|538248727|FG000|Overall Study|Withdrawal by Subject|2|||
149213520|NCT01594749|538248728|FG001|Overall Study|Withdrawal by Subject|2|||
149213521|NCT01594749|538248727|FG000|Overall Study|Protocol Violation|2|||
149213522|NCT01594749|538248728|FG001|Overall Study|Protocol Violation|0|||
149213523|NCT01594749|538248727|FG000|Overall Study|Physician Decision|1|||
149213524|NCT01594749|538248728|FG001|Overall Study|Physician Decision|1|||
149213525|NCT01594749|538248727|FG000|Overall Study|Non-compliance with Protocol|0|||
149213526|NCT01594749|538248728|FG001|Overall Study|Non-compliance with Protocol|1|||
149213527|NCT01594749|538248727|FG000|Overall Study|Lost to Follow-up|1|||
149213528|NCT01594749|538248728|FG001|Overall Study|Lost to Follow-up|0|||
149213529|NCT01594749|538248727|FG000|Overall Study|Death|9|||
149213530|NCT01594749|538248728|FG001|Overall Study|Death|3|||
149016608|NCT00802737|537540832|FG001|Overall Study|Ongoing CLL-Treatment|1|||
149016609|NCT00802737|537540833|FG002|Overall Study|Ongoing CLL-Treatment|0|||
149016610|NCT00802737|537540831|FG000|Overall Study|Participant too Unwell|0|||
149016611|NCT00802737|537540832|FG001|Overall Study|Participant too Unwell|2|||
149016612|NCT00802737|537540833|FG002|Overall Study|Participant too Unwell|0|||
149016613|NCT00619476|537540841|FG000|Overall Study|Adverse Event|12|||
149016614|NCT00619476|537540842|FG001|Overall Study|Adverse Event|6|||
149016615|NCT00619476|537540843|FG002|Overall Study|Adverse Event|12|||
149016616|NCT00619476|537540844|FG003|Overall Study|Adverse Event|16|||
149016617|NCT00619476|537540841|FG000|Overall Study|Lack of Efficacy|6|||
149016618|NCT00619476|537540842|FG001|Overall Study|Lack of Efficacy|1|||
149016619|NCT00619476|537540843|FG002|Overall Study|Lack of Efficacy|1|||
149016620|NCT00619476|537540844|FG003|Overall Study|Lack of Efficacy|4|||
149016621|NCT00619476|537540841|FG000|Overall Study|Protocol Violation|5|||
149016622|NCT00619476|537540842|FG001|Overall Study|Protocol Violation|4|||
149016623|NCT00619476|537540843|FG002|Overall Study|Protocol Violation|4|||
149016624|NCT00619476|537540844|FG003|Overall Study|Protocol Violation|9|||
149016625|NCT00619476|537540841|FG000|Overall Study|Lost to Follow-up|1|||
149016626|NCT00619476|537540842|FG001|Overall Study|Lost to Follow-up|2|||
149016627|NCT00619476|537540843|FG002|Overall Study|Lost to Follow-up|0|||
149016628|NCT00619476|537540844|FG003|Overall Study|Lost to Follow-up|1|||
149016629|NCT00619476|537540841|FG000|Overall Study|Investigator Discretion|2|||
149016630|NCT00619476|537540842|FG001|Overall Study|Investigator Discretion|2|||
149016631|NCT00619476|537540843|FG002|Overall Study|Investigator Discretion|2|||
149016632|NCT00619476|537540844|FG003|Overall Study|Investigator Discretion|0|||
149016633|NCT00619476|537540841|FG000|Overall Study|Withdrawal by Subject|5|||
149016634|NCT00619476|537540842|FG001|Overall Study|Withdrawal by Subject|7|||
149016635|NCT00619476|537540843|FG002|Overall Study|Withdrawal by Subject|5|||
149016636|NCT00619476|537540844|FG003|Overall Study|Withdrawal by Subject|4|||
149016637|NCT01625910|537540845|FG000|Overall Study|Lost to Follow-up|3|||
149016638|NCT01625910|537540846|FG001|Overall Study|Lost to Follow-up|4|||
149016639|NCT02959138|537540847|FG000|Overall Study|Enrolled but Never Treated|0|||
149016640|NCT02959138|537540848|FG001|Overall Study|Enrolled but Never Treated|1|||
149016641|NCT02959138|537540849|FG002|Overall Study|Enrolled but Never Treated|0|||
148809556|NCT03282097|536779342|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
149016642|NCT02391038|537540850|FG000|Overall Study|Progressive disease|3|||
149016643|NCT02391038|537540851|FG001|Overall Study|Progressive disease|3|||
149016644|NCT02391038|537540852|FG002|Overall Study|Progressive disease|6|||
149016645|NCT01327547|537540858|FG000|Overall Study|Adverse Event|4|||
149016646|NCT01327547|537540859|FG001|Overall Study|Adverse Event|1|||
149016647|NCT01327547|537540858|FG000|Overall Study|Death|1|||
149016648|NCT01327547|537540859|FG001|Overall Study|Death|2|||
149016649|NCT01327547|537540858|FG000|Overall Study|Lost to Follow-up|6|||
149213531|NCT01594749|538248727|FG000|Overall Study|Not Treated|4|||
149213532|NCT01594749|538248728|FG001|Overall Study|Not Treated|10|||
149213533|NCT01594749|538248727|FG000|Overall Study|Lost Source Documentation|1|||
149016650|NCT01327547|537540859|FG001|Overall Study|Lost to Follow-up|6|||
149016651|NCT01327547|537540858|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
149213534|NCT01594749|538248728|FG001|Overall Study|Lost Source Documentation|0|||
149213535|NCT00364351|538248729|FG000|Overall Study|Adverse Event|90|||
149016652|NCT01327547|537540859|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
149213536|NCT00364351|538248730|FG001|Overall Study|Adverse Event|44|||
148950367|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950368|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950369|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950370|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950371|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
148950372|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
148950373|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
148950374|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
148950375|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950376|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950377|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950378|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950379|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950380|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950381|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950382|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
148950383|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
148950384|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
148950385|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
148950386|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
149213537|NCT00364351|538248729|FG000|Overall Study|Condition under investigation worsened|469|||
149213538|NCT00364351|538248730|FG001|Overall Study|Condition under investigation worsened|497|||
148950387|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
149213539|NCT00364351|538248729|FG000|Overall Study|Prohibited concomitant medication|0|||
149213540|NCT00364351|538248730|FG001|Overall Study|Prohibited concomitant medication|2|||
149213541|NCT00364351|538248729|FG000|Overall Study|Lost to Follow-up|1|||
149213542|NCT00364351|538248730|FG001|Overall Study|Lost to Follow-up|1|||
149213543|NCT00364351|538248729|FG000|Overall Study|Withdrawal by Subject|30|||
149213544|NCT00364351|538248730|FG001|Overall Study|Withdrawal by Subject|29|||
149213545|NCT00364351|538248729|FG000|Overall Study|Incorrect enrollment|1|||
149213546|NCT00364351|538248730|FG001|Overall Study|Incorrect enrollment|1|||
149213547|NCT00364351|538248729|FG000|Overall Study|Sponsor decision|1|||
149213548|NCT00364351|538248730|FG001|Overall Study|Sponsor decision|0|||
149213549|NCT00364351|538248729|FG000|Overall Study|Poor treatment compliance|0|||
149213550|NCT00364351|538248730|FG001|Overall Study|Poor treatment compliance|3|||
148950388|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
149213551|NCT00364351|538248729|FG000|Overall Study|Investigator error|0|||
149213552|NCT00364351|538248730|FG001|Overall Study|Investigator error|2|||
149213553|NCT00364351|538248729|FG000|Overall Study|Patient could not travel to site|0|||
149213554|NCT00364351|538248730|FG001|Overall Study|Patient could not travel to site|1|||
149213555|NCT00364351|538248729|FG000|Overall Study|Randomised treatment not started|0|||
149213556|NCT00364351|538248730|FG001|Overall Study|Randomised treatment not started|3|||
149213557|NCT00653068|538248732|FG000|Overall Study|Death|9|||
149213558|NCT00653068|538248732|FG000|Overall Study|Lack of Efficacy|34|||
148950389|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
148950390|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
148950391|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
148950392|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
148950393|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
148950394|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
148950395|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
148950396|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
148950397|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950398|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950399|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950400|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950401|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
149213559|NCT00653068|538248732|FG000|Overall Study|Physician Decision|4|||
149213560|NCT00653068|538248732|FG000|Overall Study|Withdrawal by Subject|1|||
149213561|NCT00653068|538248732|FG000|Overall Study|Ineligible|2|||
149213562|NCT02177786|538248733|FG000|Overall Study|Withdrew Consent|2|||
149213563|NCT02177786|538248734|FG001|Overall Study|Withdrew Consent|6|||
148950402|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950403|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950404|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
148950405|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
149213564|NCT02177786|538248735|FG002|Overall Study|Withdrew Consent|9|||
148950406|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
149213565|NCT02177786|538248736|FG003|Overall Study|Withdrew Consent|5|||
149213566|NCT02177786|538248733|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
149213567|NCT02177786|538248734|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
149213568|NCT02177786|538248735|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
149213569|NCT02177786|538248736|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
149213570|NCT02177786|538248733|FG000|Overall Study|Adverse Event|1|||
149213571|NCT02177786|538248734|FG001|Overall Study|Adverse Event|1|||
149213572|NCT02177786|538248735|FG002|Overall Study|Adverse Event|2|||
149213573|NCT02177786|538248736|FG003|Overall Study|Adverse Event|3|||
149213574|NCT02177786|538248733|FG000|Overall Study|Death|1|||
149213575|NCT02177786|538248734|FG001|Overall Study|Death|1|||
149213576|NCT02177786|538248735|FG002|Overall Study|Death|1|||
149213577|NCT02177786|538248736|FG003|Overall Study|Death|1|||
149213578|NCT02177786|538248733|FG000|Overall Study|Lost to Follow-up|0|||
149213579|NCT02177786|538248734|FG001|Overall Study|Lost to Follow-up|0|||
149213580|NCT02177786|538248735|FG002|Overall Study|Lost to Follow-up|2|||
149213581|NCT02177786|538248736|FG003|Overall Study|Lost to Follow-up|2|||
149213582|NCT02177786|538248733|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149213583|NCT02177786|538248734|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149213584|NCT02177786|538248735|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149213585|NCT02177786|538248736|FG003|Overall Study|Non-Compliance with Study Drug|1|||
149213586|NCT02177786|538248733|FG000|Overall Study|Protocol Violation|0|||
149213587|NCT02177786|538248734|FG001|Overall Study|Protocol Violation|0|||
149213588|NCT02177786|538248735|FG002|Overall Study|Protocol Violation|2|||
149213589|NCT02177786|538248736|FG003|Overall Study|Protocol Violation|0|||
149213590|NCT02177786|538248733|FG000|Overall Study|Progressive Disease|0|||
149213591|NCT02177786|538248734|FG001|Overall Study|Progressive Disease|1|||
149213592|NCT02177786|538248735|FG002|Overall Study|Progressive Disease|0|||
149213593|NCT02177786|538248736|FG003|Overall Study|Progressive Disease|0|||
149213594|NCT02177786|538248733|FG000|Overall Study|Missing study completion status|0|||
149213595|NCT02177786|538248734|FG001|Overall Study|Missing study completion status|1|||
149213596|NCT02177786|538248735|FG002|Overall Study|Missing study completion status|0|||
149213597|NCT02177786|538248736|FG003|Overall Study|Missing study completion status|0|||
149213598|NCT01305941|538248737|FG000|Overall Study|Adverse Event|6|||
149213599|NCT01305941|538248737|FG000|Overall Study|Clinical decline|2|||
149213600|NCT01305941|538248737|FG000|Overall Study|Withdrawal by Subject|1|||
149213601|NCT01305941|538248737|FG000|Overall Study|Death|1|||
149213602|NCT03950440|538248738|FG000|Overall Study|Death|8|||
149213603|NCT03950440|538248739|FG001|Overall Study|Death|2|||
149213604|NCT03950440|538248740|FG002|Overall Study|Death|1|||
149213605|NCT02892734|538248741|FG000|Treatment on Study|Progressive Disease|2|||
149213606|NCT02892734|538248741|FG000|Follow up for 2 Years|Death|2|||
149213607|NCT02892734|538248741|FG000|Follow up for 2 Years|Study closed early|1|||
149213608|NCT02043509|538248742|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
149213609|NCT02043509|538248743|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
149213610|NCT02043509|538248742|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
149213611|NCT02043509|538248743|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
149213612|NCT02043509|538248742|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
149213613|NCT02043509|538248743|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
149213614|NCT02043509|538248742|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
149213615|NCT02043509|538248743|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
149016653|NCT01327547|537540858|FG000|Overall Study|Withdrawal by Subject|3|||
149016654|NCT01327547|537540859|FG001|Overall Study|Withdrawal by Subject|7|||
149016655|NCT01327547|537540858|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
149016656|NCT01327547|537540859|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
149016657|NCT01327547|537540858|FG000|Overall Study|Protocol Violation|1|||
149016658|NCT01327547|537540859|FG001|Overall Study|Protocol Violation|0|||
149016659|NCT01327547|537540858|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
149213616|NCT00608244|538248748|FG000|Overall Study|Adverse Event|1|||
149213617|NCT00608244|538248748|FG000|Overall Study|Low trough levels|1|||
149213618|NCT01977040|538248753|FG000|Overall Study|Vasa previa not confirmed|2|||
149213619|NCT01685060|538248754|FG000|Overall Study|Rollover patients|16|||
149213620|NCT01685060|538248754|FG000|Overall Study|Adverse Event|12|||
149213621|NCT01685060|538248754|FG000|Overall Study|Progressive disease|69|||
149213622|NCT01685060|538248754|FG000|Overall Study|Physician Decision|14|||
149213623|NCT01685060|538248754|FG000|Overall Study|Subject/guardian decision|20|||
149213624|NCT01685060|538248754|FG000|Overall Study|Lost to Follow-up|1|||
149213625|NCT01685060|538248754|FG000|Overall Study|Death|8|||
149213626|NCT00634751|538248755|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
149213627|NCT00634751|538248756|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
149213628|NCT00634751|538248757|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
148809557|NCT03282097|536779341|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
148809558|NCT03282097|536779342|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
148809559|NCT03282097|536779341|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
148809560|NCT03282097|536779342|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
148809561|NCT03282097|536779341|FG000|Primary Outcome Data Collection Complete|Missing|2|||
148809562|NCT03282097|536779342|FG001|Primary Outcome Data Collection Complete|Missing|3|||
148809563|NCT03282097|536779341|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
148809564|NCT03282097|536779342|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
148809565|NCT03282097|536779341|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
148809566|NCT03282097|536779342|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
148809567|NCT03282097|536779341|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
148809568|NCT03282097|536779342|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
148809569|NCT01056536|536779345|FG000|Overall Study|Lost to Follow-up|202|||
148809570|NCT01056536|536779346|FG001|Overall Study|Lost to Follow-up|116|||
148809571|NCT01056536|536779347|FG002|Overall Study|Lost to Follow-up|248|||
148809572|NCT01394276|536779354|FG000|Overall Study|Related Adverse event (AEs)|15|||
148809573|NCT01394276|536779354|FG000|Overall Study|Not related AEs|9|||
148809574|NCT01394276|536779354|FG000|Overall Study|Remission of disease|2|||
148809575|NCT01394276|536779354|FG000|Overall Study|Insufficient therapeutic effect|17|||
148809576|NCT01394276|536779354|FG000|Overall Study|Insufficient compliance|9|||
148809577|NCT01394276|536779354|FG000|Overall Study|Lost to Follow-up|5|||
148809578|NCT01394276|536779354|FG000|Overall Study|Participant moved to another site|1|||
148809579|NCT01394276|536779354|FG000|Overall Study|Pregnancy|1|||
148809580|NCT01394276|536779354|FG000|Overall Study|unavailability of drug at the Hospital|2|||
149213629|NCT00634751|538248758|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
149213630|NCT00634751|538248755|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
149213631|NCT00634751|538248756|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
148809581|NCT01394276|536779354|FG000|Overall Study|Symptoms of concurrent diseases|1|||
148809582|NCT04058717|536779355|FG000|Randomization Period|Lost to Follow-up|2|||
148809583|NCT04058717|536779356|FG001|Randomization Period|Lost to Follow-up|3|||
148809584|NCT04058717|536779357|FG002|Randomization Period|Lost to Follow-up|4|||
149213632|NCT00634751|538248757|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
149213633|NCT00634751|538248758|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
149213634|NCT00634751|538248755|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
149213635|NCT00634751|538248756|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
149213636|NCT00634751|538248757|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
149213637|NCT00634751|538248758|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
149213638|NCT03654560|538248759|FG000|Overall Study|Death|3|||
149213639|NCT03654560|538248760|FG001|Overall Study|Death|1|||
149213640|NCT03654560|538248759|FG000|Overall Study|Lost to Follow-up|1|||
149213641|NCT03654560|538248760|FG001|Overall Study|Lost to Follow-up|0|||
149213642|NCT03135262|538248761|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
149213643|NCT03135262|538248762|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149213644|NCT03135262|538248763|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149213645|NCT03135262|538248764|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149213646|NCT03135262|538248765|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
149213647|NCT03135262|538248761|FG000|Overall Study|Progression of disease|0|||
149213648|NCT03135262|538248762|FG001|Overall Study|Progression of disease|0|||
149213649|NCT03135262|538248763|FG002|Overall Study|Progression of disease|0|||
149213650|NCT03135262|538248764|FG003|Overall Study|Progression of disease|1|||
149213651|NCT03135262|538248765|FG004|Overall Study|Progression of disease|0|||
149213652|NCT03135262|538248761|FG000|Overall Study|Death|6|||
149213653|NCT03135262|538248762|FG001|Overall Study|Death|2|||
149213654|NCT03135262|538248763|FG002|Overall Study|Death|2|||
149213655|NCT03135262|538248764|FG003|Overall Study|Death|2|||
149213656|NCT03135262|538248765|FG004|Overall Study|Death|0|||
148684522|NCT05028751|536316869|FG003|Overall Study|Miscellaneous|0|||
148809585|NCT04058717|536779358|FG003|Randomization Period|Lost to Follow-up|4|||
148809586|NCT04058717|536779355|FG000|Randomization Period|Withdrawal by Subject|1|||
148809587|NCT04058717|536779356|FG001|Randomization Period|Withdrawal by Subject|3|||
148809588|NCT04058717|536779357|FG002|Randomization Period|Withdrawal by Subject|3|||
148809589|NCT04058717|536779358|FG003|Randomization Period|Withdrawal by Subject|3|||
148809590|NCT04058717|536779355|FG000|Randomization Period|PI decision|0|||
148809591|NCT04058717|536779356|FG001|Randomization Period|PI decision|1|||
148809592|NCT04058717|536779357|FG002|Randomization Period|PI decision|0|||
148809593|NCT04058717|536779358|FG003|Randomization Period|PI decision|0|||
149213657|NCT03135262|538248761|FG000|Overall Study|Withdrawal by Subject|0|||
149213658|NCT03135262|538248762|FG001|Overall Study|Withdrawal by Subject|0|||
149213659|NCT03135262|538248763|FG002|Overall Study|Withdrawal by Subject|1|||
149213660|NCT03135262|538248764|FG003|Overall Study|Withdrawal by Subject|0|||
149213661|NCT03135262|538248765|FG004|Overall Study|Withdrawal by Subject|1|||
149213662|NCT03135262|538248761|FG000|Overall Study|Study terminated by sponsor|2|||
149213663|NCT03135262|538248762|FG001|Overall Study|Study terminated by sponsor|4|||
148809594|NCT02696798|536779359|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
148809595|NCT02696798|536779360|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
148809596|NCT02696798|536779361|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
148950407|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
148950408|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950409|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950410|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950411|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950412|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950413|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950414|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950415|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
148950416|NCT02207244|537299693|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
149213664|NCT03135262|538248763|FG002|Overall Study|Study terminated by sponsor|4|||
149213665|NCT03135262|538248764|FG003|Overall Study|Study terminated by sponsor|3|||
149213666|NCT03135262|538248765|FG004|Overall Study|Study terminated by sponsor|0|||
149213667|NCT02728206|538248766|FG000|Overall Study|Death|1|||
149213668|NCT00732238|538248767|FG000|Overall Study|Bacteremia|4|||
149213669|NCT00732238|538248768|FG001|Overall Study|Bacteremia|1|||
149213670|NCT00732238|538248767|FG000|Overall Study|Asymptomatic bacteriuria|1|||
149213671|NCT00732238|538248768|FG001|Overall Study|Asymptomatic bacteriuria|0|||
149213672|NCT00481988|538248771|FG000|Overall Study|Withdrawal by Subject|1|||
149213673|NCT00481988|538248772|FG001|Overall Study|Withdrawal by Subject|1|||
149213674|NCT00610207|538248776|FG000|Overall Study|Lost to Follow-up|3|||
149213675|NCT01594411|538248785|FG000|Overall Study|Lost to Follow-up|2|||
149213676|NCT01451398|538248794|FG000|Overall Study|Adverse Event|7|||
149213677|NCT01451398|538248795|FG001|Overall Study|Adverse Event|9|||
149213678|NCT01451398|538248794|FG000|Overall Study|Protocol Violation|1|||
149213679|NCT01451398|538248795|FG001|Overall Study|Protocol Violation|2|||
149213680|NCT01451398|538248794|FG000|Overall Study|Physician Decision|1|||
149213681|NCT01451398|538248795|FG001|Overall Study|Physician Decision|1|||
149213682|NCT01451398|538248794|FG000|Overall Study|Withdrawal by Subject|10|||
149213683|NCT01451398|538248795|FG001|Overall Study|Withdrawal by Subject|14|||
149213684|NCT01451398|538248794|FG000|Overall Study|Lost to Follow-up|6|||
149213685|NCT01451398|538248795|FG001|Overall Study|Lost to Follow-up|4|||
149213686|NCT01451398|538248794|FG000|Overall Study|Non-compliance with study drug|1|||
149213687|NCT01451398|538248795|FG001|Overall Study|Non-compliance with study drug|3|||
149213688|NCT01451398|538248794|FG000|Overall Study|Non-compliance with protocol|1|||
149213689|NCT01451398|538248795|FG001|Overall Study|Non-compliance with protocol|1|||
149213690|NCT01451398|538248794|FG000|Overall Study|Moved out of country|0|||
149213691|NCT01451398|538248795|FG001|Overall Study|Moved out of country|1|||
149213692|NCT01451398|538248794|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
149213693|NCT01451398|538248795|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
149213694|NCT01451398|538248794|FG000|Overall Study|Lack of Efficacy|0|||
149213695|NCT01451398|538248795|FG001|Overall Study|Lack of Efficacy|1|||
149213696|NCT00741260|538248797|FG000|Overall Study|Disease Progression|3|||
149213697|NCT00741260|538248798|FG001|Overall Study|Disease Progression|5|||
149213698|NCT00741260|538248799|FG002|Overall Study|Disease Progression|3|||
149213699|NCT00741260|538248800|FG003|Overall Study|Disease Progression|3|||
149213700|NCT00741260|538248801|FG004|Overall Study|Disease Progression|5|||
149213701|NCT00741260|538248802|FG005|Overall Study|Disease Progression|37|||
149213702|NCT00741260|538248803|FG006|Overall Study|Disease Progression|4|||
149213703|NCT00741260|538248797|FG000|Overall Study|Death|0|||
149213704|NCT00741260|538248798|FG001|Overall Study|Death|1|||
149213705|NCT00741260|538248799|FG002|Overall Study|Death|0|||
149213706|NCT00741260|538248800|FG003|Overall Study|Death|1|||
149213707|NCT00741260|538248801|FG004|Overall Study|Death|2|||
149213708|NCT00741260|538248802|FG005|Overall Study|Death|2|||
148950417|NCT02207244|537299694|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
148950418|NCT02207244|537299695|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
149213709|NCT00741260|538248803|FG006|Overall Study|Death|1|||
149213710|NCT00741260|538248797|FG000|Overall Study|Withdrawal by Subject|0|||
149213711|NCT00741260|538248798|FG001|Overall Study|Withdrawal by Subject|0|||
149213712|NCT00741260|538248799|FG002|Overall Study|Withdrawal by Subject|0|||
149213713|NCT00741260|538248800|FG003|Overall Study|Withdrawal by Subject|0|||
149213714|NCT00741260|538248801|FG004|Overall Study|Withdrawal by Subject|1|||
149213715|NCT00741260|538248802|FG005|Overall Study|Withdrawal by Subject|3|||
149213716|NCT00741260|538248803|FG006|Overall Study|Withdrawal by Subject|1|||
149213717|NCT00741260|538248797|FG000|Overall Study|Physician Decision|1|||
149213718|NCT00741260|538248798|FG001|Overall Study|Physician Decision|1|||
149213719|NCT00741260|538248799|FG002|Overall Study|Physician Decision|0|||
149213720|NCT00741260|538248800|FG003|Overall Study|Physician Decision|0|||
149213721|NCT00741260|538248801|FG004|Overall Study|Physician Decision|0|||
149213722|NCT00741260|538248802|FG005|Overall Study|Physician Decision|0|||
149213723|NCT00741260|538248803|FG006|Overall Study|Physician Decision|0|||
149213724|NCT00741260|538248797|FG000|Overall Study|Other|2|||
149213725|NCT00741260|538248798|FG001|Overall Study|Other|1|||
149213726|NCT00741260|538248799|FG002|Overall Study|Other|1|||
149213727|NCT00741260|538248800|FG003|Overall Study|Other|2|||
149213728|NCT00741260|538248801|FG004|Overall Study|Other|1|||
149213729|NCT00741260|538248802|FG005|Overall Study|Other|3|||
149213730|NCT00741260|538248803|FG006|Overall Study|Other|1|||
149213731|NCT02565615|538248804|FG000|Overall Study|Death|0|||
149213732|NCT02565615|538248805|FG001|Overall Study|Death|1|||
149213733|NCT02565615|538248806|FG002|Overall Study|Death|0|||
149213734|NCT02565615|538248807|FG003|Overall Study|Death|0|||
149213735|NCT02565615|538248808|FG004|Overall Study|Death|4|||
149213736|NCT02565615|538248804|FG000|Overall Study|Not willing to participate in study|2|||
149213737|NCT02565615|538248805|FG001|Overall Study|Not willing to participate in study|21|||
149213738|NCT02565615|538248806|FG002|Overall Study|Not willing to participate in study|0|||
149213739|NCT02565615|538248807|FG003|Overall Study|Not willing to participate in study|1|||
149213740|NCT02565615|538248808|FG004|Overall Study|Not willing to participate in study|169|||
149213741|NCT02565615|538248804|FG000|Overall Study|Lost to Follow-up|0|||
149213742|NCT02565615|538248805|FG001|Overall Study|Lost to Follow-up|4|||
149213743|NCT02565615|538248806|FG002|Overall Study|Lost to Follow-up|0|||
149213744|NCT02565615|538248807|FG003|Overall Study|Lost to Follow-up|1|||
149213745|NCT02565615|538248808|FG004|Overall Study|Lost to Follow-up|765|||
149213746|NCT02565615|538248804|FG000|Overall Study|Not meeting eligibility criteria|0|||
149213747|NCT02565615|538248805|FG001|Overall Study|Not meeting eligibility criteria|7|||
149213748|NCT02565615|538248806|FG002|Overall Study|Not meeting eligibility criteria|0|||
149213749|NCT02565615|538248807|FG003|Overall Study|Not meeting eligibility criteria|0|||
149213750|NCT02565615|538248808|FG004|Overall Study|Not meeting eligibility criteria|25|||
149213751|NCT02565615|538248804|FG000|Overall Study|Reason not defined|0|||
149213752|NCT02565615|538248805|FG001|Overall Study|Reason not defined|2|||
149213753|NCT02565615|538248806|FG002|Overall Study|Reason not defined|0|||
149213754|NCT02565615|538248807|FG003|Overall Study|Reason not defined|1|||
149213755|NCT02565615|538248808|FG004|Overall Study|Reason not defined|62|||
149213756|NCT02565615|538248804|FG000|Overall Study|Adverse Event|1|||
149213757|NCT02565615|538248805|FG001|Overall Study|Adverse Event|1|||
149213758|NCT02565615|538248806|FG002|Overall Study|Adverse Event|0|||
149213759|NCT02565615|538248807|FG003|Overall Study|Adverse Event|0|||
149213760|NCT02565615|538248808|FG004|Overall Study|Adverse Event|9|||
149213761|NCT02565615|538248804|FG000|Overall Study|Untreated|0|||
149213762|NCT02565615|538248805|FG001|Overall Study|Untreated|0|||
149213763|NCT02565615|538248806|FG002|Overall Study|Untreated|0|||
149213764|NCT02565615|538248807|FG003|Overall Study|Untreated|0|||
149213765|NCT02565615|538248808|FG004|Overall Study|Untreated|567|||
149213766|NCT05563714|538248812|FG000|Overall Study|Death|2|||
149213767|NCT05563714|538248813|FG001|Overall Study|Death|2|||
149213768|NCT05563714|538248814|FG002|Overall Study|Death|0|||
149213769|NCT05563714|538248815|FG003|Overall Study|Death|0|||
149213770|NCT05563714|538248812|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
149213771|NCT05563714|538248813|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
149213772|NCT05563714|538248814|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
149213773|NCT05563714|538248815|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
149213774|NCT05563714|538248812|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
149213775|NCT05563714|538248813|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
149213776|NCT05563714|538248814|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
149213777|NCT05563714|538248815|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
148809597|NCT02696798|536779359|FG000|Blinded Treatment Dosing Period|Death|0|||
149213778|NCT05563714|538248812|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
149213779|NCT05563714|538248813|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
149213780|NCT05563714|538248814|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
149213781|NCT05563714|538248815|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
149213782|NCT05563714|538248812|FG000|Overall Study|Lost to Follow-up|22|||
149213783|NCT05563714|538248813|FG001|Overall Study|Lost to Follow-up|19|||
149213784|NCT05563714|538248814|FG002|Overall Study|Lost to Follow-up|0|||
149213785|NCT05563714|538248815|FG003|Overall Study|Lost to Follow-up|0|||
149213786|NCT00479167|538248819|FG000|Overall Study|Withdrawal by Subject|1|||
149213787|NCT01997281|538248822|FG000|Overall Study|Withdrawal by Subject|1|||
149213788|NCT01997281|538248823|FG001|Overall Study|Withdrawal by Subject|0|||
149213789|NCT00560794|538248826|FG000|Overall Study|Adverse Event|2|||
149213790|NCT00560794|538248826|FG000|Overall Study|Patient was not Compliant|1|||
149213791|NCT00560794|538248826|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
149213792|NCT00560794|538248826|FG000|Overall Study|Hematological Relapse|1|||
149213793|NCT00560794|538248826|FG000|Overall Study|Received Bone Marrow Transplant|6|||
149213794|NCT02384993|538248829|FG000|Overall Study|Adverse Event|0|||
149213795|NCT02384993|538248830|FG001|Overall Study|Adverse Event|1|||
149213796|NCT00880607|538248832|FG000|Overall Study|Physician Decision|2|||
149213797|NCT00880607|538248833|FG001|Overall Study|Physician Decision|2|||
149213798|NCT00880607|538248832|FG000|Overall Study|Protocol Violation|2|||
149213799|NCT00880607|538248833|FG001|Overall Study|Protocol Violation|1|||
149213800|NCT00880607|538248832|FG000|Overall Study|surgery did not extend past L1 level|3|||
149213801|NCT00880607|538248833|FG001|Overall Study|surgery did not extend past L1 level|0|||
149213802|NCT02828644|538250067|FG000|Overall Study|Lost to Follow-up|23|||
149213803|NCT02828644|538250068|FG001|Overall Study|Lost to Follow-up|22|||
149213804|NCT02996110|538250069|FG000|Pre-Treatment|Other Reasons|0|||
149213805|NCT02996110|538250070|FG001|Pre-Treatment|Other Reasons|1|||
149213806|NCT02996110|538250071|FG002|Pre-Treatment|Other Reasons|0|||
149213807|NCT02996110|538250072|FG003|Pre-Treatment|Other Reasons|0|||
149213808|NCT02996110|538250073|FG004|Pre-Treatment|Other Reasons|1|||
149213809|NCT02996110|538250069|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
149213810|NCT02996110|538250070|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
149213811|NCT02996110|538250071|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
149213812|NCT02996110|538250072|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
149213813|NCT02996110|538250073|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
149213814|NCT02996110|538250069|FG000|Track 1|Disease Progression|15|||
149213815|NCT02996110|538250070|FG001|Track 1|Disease Progression|17|||
149213816|NCT02996110|538250071|FG002|Track 1|Disease Progression|0|||
149213817|NCT02996110|538250072|FG003|Track 1|Disease Progression|0|||
149213818|NCT02996110|538250073|FG004|Track 1|Disease Progression|0|||
149213819|NCT02996110|538250069|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
149213820|NCT02996110|538250070|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
149213821|NCT02996110|538250071|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
149213822|NCT02996110|538250072|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
149213823|NCT02996110|538250073|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
149213824|NCT02996110|538250069|FG000|Track 1|Study Drug Toxicity|5|||
149213825|NCT02996110|538250070|FG001|Track 1|Study Drug Toxicity|3|||
149213826|NCT02996110|538250071|FG002|Track 1|Study Drug Toxicity|0|||
149213827|NCT02996110|538250072|FG003|Track 1|Study Drug Toxicity|0|||
149213828|NCT02996110|538250073|FG004|Track 1|Study Drug Toxicity|0|||
149213829|NCT02996110|538250069|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
149213830|NCT02996110|538250070|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149213831|NCT02996110|538250071|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149213832|NCT02996110|538250072|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149213833|NCT02996110|538250073|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
149213834|NCT02996110|538250069|FG000|Track 1|Administrative Reason by Sponsor|0|||
149213835|NCT02996110|538250070|FG001|Track 1|Administrative Reason by Sponsor|1|||
149213836|NCT02996110|538250071|FG002|Track 1|Administrative Reason by Sponsor|0|||
149213837|NCT02996110|538250072|FG003|Track 1|Administrative Reason by Sponsor|0|||
149213838|NCT02996110|538250073|FG004|Track 1|Administrative Reason by Sponsor|0|||
149213839|NCT02996110|538250069|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
149213840|NCT02996110|538250070|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
149213841|NCT02996110|538250071|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
149213842|NCT02996110|538250072|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
149213843|NCT02996110|538250073|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
149213844|NCT02996110|538250069|FG000|Track 2|Disease Progression|33|||
149213845|NCT02996110|538250070|FG001|Track 2|Disease Progression|26|||
149213846|NCT02996110|538250071|FG002|Track 2|Disease Progression|19|||
149213847|NCT02996110|538250072|FG003|Track 2|Disease Progression|16|||
149213848|NCT02996110|538250073|FG004|Track 2|Disease Progression|15|||
149213849|NCT02996110|538250069|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
149213850|NCT02996110|538250070|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
149213851|NCT02996110|538250071|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
149213852|NCT02996110|538250072|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
149213853|NCT02996110|538250073|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
149213854|NCT02996110|538250069|FG000|Track 2|Death|0|||
149213855|NCT02996110|538250070|FG001|Track 2|Death|0|||
149213856|NCT02996110|538250071|FG002|Track 2|Death|1|||
149213857|NCT02996110|538250072|FG003|Track 2|Death|0|||
149213858|NCT02996110|538250073|FG004|Track 2|Death|1|||
148684523|NCT03322462|536319421|FG000|Overall Study|Technical difficulties|2|||
148684524|NCT03322462|536319421|FG000|Overall Study|Other|1|||
149213859|NCT02996110|538250069|FG000|Track 2|Study Drug Toxicity|4|||
149213860|NCT02996110|538250070|FG001|Track 2|Study Drug Toxicity|1|||
149213861|NCT02996110|538250071|FG002|Track 2|Study Drug Toxicity|4|||
149213862|NCT02996110|538250072|FG003|Track 2|Study Drug Toxicity|1|||
149213863|NCT02996110|538250073|FG004|Track 2|Study Drug Toxicity|0|||
149213864|NCT02996110|538250069|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
149213865|NCT02996110|538250070|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
149213866|NCT02996110|538250071|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
149213867|NCT02996110|538250072|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
149213868|NCT02996110|538250073|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
148809598|NCT02696798|536779360|FG001|Blinded Treatment Dosing Period|Death|0|||
148809599|NCT02696798|536779361|FG002|Blinded Treatment Dosing Period|Death|1|||
148809600|NCT02696798|536779359|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
148809601|NCT02696798|536779360|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
148809602|NCT02696798|536779361|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
148809603|NCT02696798|536779359|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
148809604|NCT02696798|536779360|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
148809605|NCT02696798|536779361|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
148809606|NCT02696798|536779359|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
148809607|NCT02696798|536779360|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
148809608|NCT02696798|536779361|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
148809609|NCT02696798|536779359|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
148809610|NCT02696798|536779360|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
148809611|NCT02696798|536779361|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
148809612|NCT02696798|536779359|FG000|Extended Treatment Period|Adverse Event|1|||
148809613|NCT02696798|536779360|FG001|Extended Treatment Period|Adverse Event|4|||
149213869|NCT02996110|538250069|FG000|Track 2|Participant Withdrew Consent|1|||
149213870|NCT02996110|538250070|FG001|Track 2|Participant Withdrew Consent|2|||
149213871|NCT02996110|538250071|FG002|Track 2|Participant Withdrew Consent|3|||
149213872|NCT02996110|538250072|FG003|Track 2|Participant Withdrew Consent|1|||
149213873|NCT02996110|538250073|FG004|Track 2|Participant Withdrew Consent|1|||
149213874|NCT02996110|538250069|FG000|Track 2|Other Reasons|0|||
149213875|NCT02996110|538250070|FG001|Track 2|Other Reasons|0|||
149213876|NCT02996110|538250071|FG002|Track 2|Other Reasons|1|||
149213877|NCT02996110|538250072|FG003|Track 2|Other Reasons|0|||
149213878|NCT02996110|538250073|FG004|Track 2|Other Reasons|1|||
149213879|NCT01119963|538250077|FG000|Overall Study|Lost to Follow-up|1|||
149213880|NCT01119963|538250078|FG001|Overall Study|Lost to Follow-up|1|||
149213881|NCT00524043|538250079|FG000|Overall Study|Lack of Efficacy|15|||
149213882|NCT00524043|538250080|FG001|Overall Study|Lack of Efficacy|13|||
149213883|NCT00524043|538250081|FG002|Overall Study|Lack of Efficacy|14|||
149213884|NCT00524043|538250079|FG000|Overall Study|Withdrawal by Subject|5|||
149213885|NCT00524043|538250080|FG001|Overall Study|Withdrawal by Subject|7|||
149213886|NCT00524043|538250081|FG002|Overall Study|Withdrawal by Subject|7|||
149213887|NCT00524043|538250079|FG000|Overall Study|Adverse Event|5|||
149213888|NCT00524043|538250080|FG001|Overall Study|Adverse Event|2|||
149213889|NCT00524043|538250081|FG002|Overall Study|Adverse Event|7|||
149213890|NCT00524043|538250079|FG000|Overall Study|Lost to Follow-up|3|||
149213891|NCT00524043|538250080|FG001|Overall Study|Lost to Follow-up|5|||
149213892|NCT00524043|538250081|FG002|Overall Study|Lost to Follow-up|3|||
149213893|NCT00524043|538250079|FG000|Overall Study|Various (eg, incarceration)|2|||
149213894|NCT00524043|538250080|FG001|Overall Study|Various (eg, incarceration)|1|||
149213895|NCT00524043|538250081|FG002|Overall Study|Various (eg, incarceration)|0|||
149213896|NCT03938636|538250082|FG000|Overall Study|Protocol Violation|0|||
149213897|NCT03938636|538250083|FG001|Overall Study|Protocol Violation|1|||
149213898|NCT03938636|538250084|FG002|Overall Study|Protocol Violation|1|||
149213899|NCT03938636|538250082|FG000|Overall Study|Subject withdrew due to death in family|0|||
149213900|NCT03938636|538250083|FG001|Overall Study|Subject withdrew due to death in family|1|||
149213901|NCT03938636|538250084|FG002|Overall Study|Subject withdrew due to death in family|0|||
149213902|NCT03938636|538250082|FG000|Overall Study|Missed visit|0|||
149213903|NCT03938636|538250083|FG001|Overall Study|Missed visit|1|||
149213904|NCT03938636|538250084|FG002|Overall Study|Missed visit|0|||
149213905|NCT03938636|538250082|FG000|Overall Study|Adverse Event|0|||
149213906|NCT03938636|538250083|FG001|Overall Study|Adverse Event|0|||
149213907|NCT03938636|538250084|FG002|Overall Study|Adverse Event|1|||
149213908|NCT03938636|538250082|FG000|Overall Study|Lost to Follow-up|0|||
149213909|NCT03938636|538250083|FG001|Overall Study|Lost to Follow-up|0|||
149213910|NCT03938636|538250084|FG002|Overall Study|Lost to Follow-up|1|||
149213911|NCT02579863|538250085|FG000|Overall Study|Final Disposition Unknown|2|||
149213912|NCT02579863|538250086|FG001|Overall Study|Final Disposition Unknown|1|||
149213913|NCT02579863|538250085|FG000|Overall Study|Adverse Event|18|||
149213914|NCT02579863|538250086|FG001|Overall Study|Adverse Event|11|||
149213915|NCT02579863|538250085|FG000|Overall Study|Death|31|||
149213916|NCT02579863|538250086|FG001|Overall Study|Death|29|||
149213917|NCT02579863|538250085|FG000|Overall Study|Lost to Follow-up|2|||
148950419|NCT02207244|537299696|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
149213918|NCT02579863|538250086|FG001|Overall Study|Lost to Follow-up|1|||
148809614|NCT02696798|536779361|FG002|Extended Treatment Period|Adverse Event|5|||
148950420|NCT02207244|537299697|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
148950421|NCT02207244|537299698|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
148809615|NCT02696798|536779359|FG000|Extended Treatment Period|Lack of Efficacy|7|||
149213919|NCT02579863|538250085|FG000|Overall Study|Physician Decision|1|||
149213920|NCT02579863|538250086|FG001|Overall Study|Physician Decision|2|||
149213921|NCT02579863|538250085|FG000|Overall Study|Screen Failure|0|||
149213922|NCT02579863|538250086|FG001|Overall Study|Screen Failure|2|||
149213923|NCT02579863|538250085|FG000|Overall Study|Study Terminated at Selected Sites|82|||
149213924|NCT02579863|538250086|FG001|Overall Study|Study Terminated at Selected Sites|88|||
149213925|NCT02579863|538250085|FG000|Overall Study|Withdrawal by Subject|20|||
149213926|NCT02579863|538250086|FG001|Overall Study|Withdrawal by Subject|20|||
149213927|NCT04097028|538250112|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
149213928|NCT04097028|538250112|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
149213929|NCT04097028|538250112|FG000|Overall Study|Disease Progression prior to Surgery|2|||
149213930|NCT04097028|538250112|FG000|Overall Study|Adverse Event prior to Surgery|1|||
149213931|NCT02473289|538250113|FG000|Overall Study|Adverse Event|2|||
149213932|NCT02473289|538250114|FG001|Overall Study|Adverse Event|3|||
149213933|NCT02473289|538250113|FG000|Overall Study|Lost to Follow-up|1|||
149213934|NCT02473289|538250114|FG001|Overall Study|Lost to Follow-up|1|||
149213935|NCT02473289|538250113|FG000|Overall Study|Protocol Violation|0|||
149213936|NCT02473289|538250114|FG001|Overall Study|Protocol Violation|1|||
149213937|NCT02473289|538250113|FG000|Overall Study|Withdrawal of consent|6|||
149213938|NCT02473289|538250114|FG001|Overall Study|Withdrawal of consent|7|||
149213939|NCT02473289|538250113|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
149213940|NCT02473289|538250114|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
149213941|NCT02473289|538250113|FG000|Overall Study|Other|2|||
149213942|NCT02473289|538250114|FG001|Overall Study|Other|0|||
149213943|NCT01156363|538250115|FG000|Overall Study|Adverse Event|6|||
149213944|NCT01156363|538250115|FG000|Overall Study|Insufficient Therapeutic Response|5|||
149213945|NCT01156363|538250115|FG000|Overall Study|Failure to Return|1|||
149213946|NCT01156363|538250115|FG000|Overall Study|Refused Treatment|4|||
149213947|NCT01156363|538250115|FG000|Overall Study|Other|6|||
148950422|NCT02207244|537299699|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
148950423|NCT02207244|537299700|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
148950424|NCT02207244|537299701|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
148950425|NCT02207244|537299702|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
148950426|NCT02207244|537299703|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
148950427|NCT02207244|537299693|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950428|NCT02207244|537299694|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950429|NCT02207244|537299695|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950430|NCT02207244|537299696|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950431|NCT02207244|537299697|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
148950432|NCT02207244|537299698|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
148950433|NCT02207244|537299699|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950434|NCT02207244|537299700|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950435|NCT02207244|537299701|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950436|NCT02207244|537299702|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148684525|NCT01393990|536319422|FG000|Overall Study|Adverse Event|0|||
148684526|NCT01393990|536319423|FG001|Overall Study|Adverse Event|0|||
149213948|NCT03285490|538250117|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
148684527|NCT01393990|536319424|FG002|Overall Study|Adverse Event|0|||
148684528|NCT01393990|536319425|FG003|Overall Study|Adverse Event|0|||
148684529|NCT01393990|536319426|FG004|Overall Study|Adverse Event|0|||
148684530|NCT01393990|536319427|FG005|Overall Study|Adverse Event|0|||
148684531|NCT01393990|536319428|FG006|Overall Study|Adverse Event|0|||
148684532|NCT01393990|536319429|FG007|Overall Study|Adverse Event|0|||
148684533|NCT01393990|536319430|FG008|Overall Study|Adverse Event|0|||
148684534|NCT01393990|536319431|FG009|Overall Study|Adverse Event|0|||
148684535|NCT01393990|536319432|FG010|Overall Study|Adverse Event|0|||
148684536|NCT01393990|536319433|FG011|Overall Study|Adverse Event|0|||
148684537|NCT01393990|536319434|FG012|Overall Study|Adverse Event|0|||
148684538|NCT01393990|536319435|FG013|Overall Study|Adverse Event|0|||
148684539|NCT01393990|536319436|FG014|Overall Study|Adverse Event|1|||
148684540|NCT01393990|536319437|FG015|Overall Study|Adverse Event|1|||
148684541|NCT01393990|536319438|FG016|Overall Study|Adverse Event|0|||
148684542|NCT01393990|536319439|FG017|Overall Study|Adverse Event|0|||
148684543|NCT01393990|536319422|FG000|Overall Study|Progressive Disease|1|||
148684544|NCT01393990|536319423|FG001|Overall Study|Progressive Disease|0|||
148684545|NCT01393990|536319424|FG002|Overall Study|Progressive Disease|0|||
148684546|NCT01393990|536319425|FG003|Overall Study|Progressive Disease|1|||
148684547|NCT01393990|536319426|FG004|Overall Study|Progressive Disease|1|||
148684548|NCT01393990|536319427|FG005|Overall Study|Progressive Disease|1|||
148684549|NCT01393990|536319428|FG006|Overall Study|Progressive Disease|1|||
148684550|NCT01393990|536319429|FG007|Overall Study|Progressive Disease|1|||
148684551|NCT01393990|536319430|FG008|Overall Study|Progressive Disease|3|||
148950437|NCT02207244|537299703|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
148950438|NCT02207244|537299693|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
149213949|NCT03285490|538250118|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
149213950|NCT03285490|538250117|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
148684552|NCT01393990|536319431|FG009|Overall Study|Progressive Disease|1|||
148684553|NCT01393990|536319432|FG010|Overall Study|Progressive Disease|0|||
148684554|NCT01393990|536319433|FG011|Overall Study|Progressive Disease|0|||
148684555|NCT01393990|536319434|FG012|Overall Study|Progressive Disease|0|||
148950439|NCT02207244|537299694|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950440|NCT02207244|537299695|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950441|NCT02207244|537299696|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950442|NCT02207244|537299697|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950443|NCT02207244|537299698|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
148950444|NCT02207244|537299699|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950445|NCT02207244|537299700|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950446|NCT02207244|537299701|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950447|NCT02207244|537299702|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950448|NCT02207244|537299703|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
148950449|NCT02207244|537299693|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950450|NCT02207244|537299694|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950451|NCT02207244|537299695|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950452|NCT02207244|537299696|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
148950453|NCT02207244|537299697|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
148950454|NCT02207244|537299698|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
148950455|NCT02207244|537299699|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950456|NCT02207244|537299700|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950457|NCT02207244|537299701|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950458|NCT02207244|537299702|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950459|NCT02207244|537299703|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
148950460|NCT02207244|537299693|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
148950461|NCT02207244|537299694|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
148950462|NCT02207244|537299695|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
148950463|NCT02207244|537299696|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
148950464|NCT02207244|537299697|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
148950465|NCT02207244|537299698|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
148950466|NCT02207244|537299699|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
149213951|NCT03285490|538250118|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
149213952|NCT03745989|538250119|FG000|Overall Study|Death|3|||
149213953|NCT03745989|538250120|FG001|Overall Study|Death|7|||
149213954|NCT03745989|538250121|FG002|Overall Study|Death|4|||
149213955|NCT03745989|538250119|FG000|Overall Study|Lost to Follow-up|0|||
149213956|NCT03745989|538250120|FG001|Overall Study|Lost to Follow-up|2|||
149213957|NCT03745989|538250121|FG002|Overall Study|Lost to Follow-up|0|||
149213958|NCT03745989|538250119|FG000|Overall Study|Sponsor Decision|0|||
149213959|NCT03745989|538250120|FG001|Overall Study|Sponsor Decision|2|||
149213960|NCT03745989|538250121|FG002|Overall Study|Sponsor Decision|8|||
149213961|NCT03745989|538250119|FG000|Overall Study|Withdrawal by Subject|0|||
149213962|NCT03745989|538250120|FG001|Overall Study|Withdrawal by Subject|1|||
149213963|NCT03745989|538250121|FG002|Overall Study|Withdrawal by Subject|3|||
149213964|NCT00735072|538250130|FG000|Overall Study|interrupted study med during ARV change|1|||
149213965|NCT00735072|538250131|FG001|Overall Study|interrupted study med during ARV change|0|||
149213966|NCT00735072|538250130|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
149213967|NCT00735072|538250131|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
149213968|NCT00911144|538250132|FG000|Overall Study|Withdrawal by Subject|16|||
149213969|NCT00911144|538250133|FG001|Overall Study|Withdrawal by Subject|5|||
149213970|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
149213971|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
149213972|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
149213973|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
149213974|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
149213975|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
149213976|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
149213977|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
149213978|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
149213979|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
149213980|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
149213981|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
149213982|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
149213983|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
149213984|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
149213985|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
149213986|NCT01291511|538250134|FG000|Cross-Titration and Stabilization Phase|Death|1|||
149213987|NCT01291511|538250135|FG001|Cross-Titration and Stabilization Phase|Death|0|||
149213988|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
149213989|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
149213990|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
149213991|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
149213992|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
149213993|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
149213994|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
149213995|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
149213996|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
149213997|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
149213998|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
149213999|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
149214000|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
149214001|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
149214002|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
149214003|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
149214004|NCT01291511|538250134|FG000|Double-blind Relapse Prevention Phase|Death|1|||
149214005|NCT01291511|538250135|FG001|Double-blind Relapse Prevention Phase|Death|0|||
149214006|NCT00047008|538250137|FG000|Overall Study|Withdrawn consent|2|||
149214007|NCT00047008|538250138|FG001|Overall Study|Withdrawn consent|3|||
149214008|NCT00047008|538250137|FG000|Overall Study|Ineligible|9|||
149214009|NCT00047008|538250138|FG001|Overall Study|Ineligible|8|||
149214010|NCT02773368|538250139|FG000|Overall Study|Lost to Follow-up|4|||
149214011|NCT02773368|538250140|FG001|Overall Study|Lost to Follow-up|1|||
149214012|NCT02773368|538250139|FG000|Overall Study|Withdrawal by Subject|5|||
149214013|NCT02773368|538250140|FG001|Overall Study|Withdrawal by Subject|1|||
149214014|NCT02773368|538250139|FG000|Overall Study|Unclassified|1|||
149214015|NCT02773368|538250140|FG001|Overall Study|Unclassified|1|||
149214016|NCT02773368|538250139|FG000|Overall Study|Missing|0|||
149214017|NCT02773368|538250140|FG001|Overall Study|Missing|1|||
149214018|NCT01366534|538250142|FG000|Overall Study|Lost to Follow-up|1|||
149214019|NCT01366534|538250143|FG001|Overall Study|Lost to Follow-up|0|||
149214020|NCT01366534|538250144|FG002|Overall Study|Lost to Follow-up|0|||
149214021|NCT01366534|538250142|FG000|Overall Study|Migrated|1|||
149214022|NCT01366534|538250143|FG001|Overall Study|Migrated|1|||
149214023|NCT01366534|538250144|FG002|Overall Study|Migrated|0|||
149214024|NCT01366534|538250142|FG000|Overall Study|Declined challenged|0|||
149214025|NCT01366534|538250143|FG001|Overall Study|Declined challenged|1|||
149214026|NCT01366534|538250144|FG002|Overall Study|Declined challenged|0|||
149214027|NCT01929018|538250147|FG000|Overall Study|Lost to Follow-up|1|||
149214028|NCT01929018|538250148|FG001|Overall Study|Lost to Follow-up|0|||
149214029|NCT01929018|538250147|FG000|Overall Study|Hospitalization|0|||
149214030|NCT01929018|538250148|FG001|Overall Study|Hospitalization|1|||
149214031|NCT01047436|538250150|FG000|Overall Study|Protocol Violation|1|||
149214032|NCT01047436|538250151|FG001|Overall Study|Protocol Violation|0|||
149214033|NCT02635867|538250154|FG000|Overall Study|Lost to Follow-up|4|||
149214034|NCT02635867|538250155|FG001|Overall Study|Lost to Follow-up|3|||
149214035|NCT02635867|538250156|FG002|Overall Study|Lost to Follow-up|3|||
149214036|NCT02635867|538250157|FG003|Overall Study|Lost to Follow-up|4|||
149214037|NCT02635867|538250158|FG004|Overall Study|Lost to Follow-up|1|||
149214038|NCT02565576|538250161|FG000|Overall Study|abnormal lab value|2|||
149214039|NCT02565576|538250162|FG001|Overall Study|abnormal lab value|0|||
149214040|NCT02565576|538250161|FG000|Overall Study|subject / guardian decision|1|||
149214041|NCT02565576|538250162|FG001|Overall Study|subject / guardian decision|3|||
149214042|NCT02565576|538250161|FG000|Overall Study|Lost to Follow-up|1|||
149214043|NCT02565576|538250162|FG001|Overall Study|Lost to Follow-up|0|||
149214044|NCT02565576|538250161|FG000|Overall Study|Death|0|||
149214045|NCT02565576|538250162|FG001|Overall Study|Death|2|||
149214046|NCT02565576|538250161|FG000|Overall Study|Adverse Event|1|||
149214047|NCT02565576|538250162|FG001|Overall Study|Adverse Event|0|||
149214048|NCT00939341|538250163|FG000|Overall Study|Adverse Event|15|||
149214049|NCT00939341|538250163|FG000|Overall Study|Pregnancy|1|||
149214050|NCT00939341|538250163|FG000|Overall Study|Lost to Follow-up|23|||
149214051|NCT00939341|538250163|FG000|Overall Study|Withdrawal by Subject|13|||
149214052|NCT00939341|538250163|FG000|Overall Study|Protocol Violation|6|||
149214053|NCT00939341|538250163|FG000|Overall Study|Incorrect enrolment|8|||
149214054|NCT01131130|538250166|FG000|Period 1 - Baseline|Pregnancy|1|||
149214055|NCT01131130|538250166|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
149214056|NCT01849562|538250175|FG000|Overall Study|Lost to Follow-up|1|||
149214057|NCT01849562|538250176|FG001|Overall Study|Lost to Follow-up|0|||
149214058|NCT01849562|538250177|FG002|Overall Study|Lost to Follow-up|0|||
149214059|NCT01849562|538250175|FG000|Overall Study|Non-compliance with Study Drug|1|||
149214060|NCT01849562|538250176|FG001|Overall Study|Non-compliance with Study Drug|0|||
149214061|NCT01849562|538250177|FG002|Overall Study|Non-compliance with Study Drug|0|||
149214062|NCT00633360|538250178|FG000|Overall Study|Lost to Follow-up|1|||
149214063|NCT00633360|538250179|FG001|Overall Study|Lost to Follow-up|1|||
149214064|NCT00633360|538250178|FG000|Overall Study|Adverse Event|3|||
149214065|NCT00633360|538250179|FG001|Overall Study|Adverse Event|1|||
149214066|NCT00633360|538250178|FG000|Overall Study|Protocol Violation|0|||
149214067|NCT00633360|538250179|FG001|Overall Study|Protocol Violation|1|||
149214068|NCT01098032|538250180|FG000|Overall Study|Withdrawal by Subject|1|||
149214069|NCT01098032|538250181|FG001|Overall Study|Withdrawal by Subject|1|||
149214070|NCT00089999|538250201|FG000|Overall Study|Adverse Event|4|||
149214071|NCT00089999|538250202|FG001|Overall Study|Adverse Event|7|||
149214072|NCT00089999|538250201|FG000|Overall Study|Withdrawal by Subject|0|||
149214073|NCT00089999|538250202|FG001|Overall Study|Withdrawal by Subject|4|||
149214074|NCT00089999|538250201|FG000|Overall Study|Lost to Follow-up|2|||
149214075|NCT00089999|538250202|FG001|Overall Study|Lost to Follow-up|1|||
149214076|NCT00089999|538250201|FG000|Overall Study|Radiological Progression of Cancer|52|||
149214077|NCT00089999|538250202|FG001|Overall Study|Radiological Progression of Cancer|44|||
149214078|NCT00089999|538250201|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
149214079|NCT00089999|538250202|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
149214080|NCT00089999|538250201|FG000|Overall Study|Death|3|||
149214081|NCT00089999|538250202|FG001|Overall Study|Death|3|||
149214082|NCT00089999|538250201|FG000|Overall Study|Poor General Condition|1|||
149214083|NCT00089999|538250202|FG001|Overall Study|Poor General Condition|0|||
149214084|NCT00089999|538250201|FG000|Overall Study|Clinical Progression|1|||
149214085|NCT00089999|538250202|FG001|Overall Study|Clinical Progression|2|||
149214086|NCT00089999|538250201|FG000|Overall Study|Physician Decision|2|||
149214087|NCT00089999|538250202|FG001|Overall Study|Physician Decision|2|||
149214088|NCT00089999|538250201|FG000|Overall Study|Patient Underwent Surgery|2|||
149214089|NCT00089999|538250202|FG001|Overall Study|Patient Underwent Surgery|0|||
149214090|NCT00089999|538250201|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
149214091|NCT00089999|538250202|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
149214092|NCT01167153|538250203|FG000|Overall Study|Non-effective therapy|1|||
149214093|NCT01167153|538250204|FG001|Overall Study|Non-effective therapy|4|||
149214094|NCT01167153|538250203|FG000|Overall Study|AE including clinical laboratory AE|2|||
149214095|NCT01167153|538250204|FG001|Overall Study|AE including clinical laboratory AE|8|||
149214096|NCT01167153|538250203|FG000|Overall Study|Hypotension|1|||
149214097|NCT01167153|538250204|FG001|Overall Study|Hypotension|0|||
149214098|NCT01167153|538250203|FG000|Overall Study|Lost to Follow-up|7|||
149214099|NCT01167153|538250204|FG001|Overall Study|Lost to Follow-up|9|||
149214100|NCT01167153|538250203|FG000|Overall Study|Non-compliance to concomitant medication|0|||
149214101|NCT01167153|538250204|FG001|Overall Study|Non-compliance to concomitant medication|2|||
149214102|NCT01167153|538250203|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
149214103|NCT01167153|538250204|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
149214104|NCT01167153|538250203|FG000|Overall Study|Withdrawal consent|1|||
149214105|NCT01167153|538250204|FG001|Overall Study|Withdrawal consent|1|||
149214106|NCT01167153|538250203|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
149214107|NCT01167153|538250204|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
149214108|NCT03050307|538252652|FG000|Overall Study|Adverse Event|4|||
149214109|NCT03050307|538252653|FG001|Overall Study|Adverse Event|2|||
149214110|NCT03050307|538252652|FG000|Overall Study|Significant Protocol Deviation|0|||
149214111|NCT03050307|538252653|FG001|Overall Study|Significant Protocol Deviation|1|||
149214112|NCT03050307|538252652|FG000|Overall Study|Lost to Follow-up|0|||
149214113|NCT03050307|538252653|FG001|Overall Study|Lost to Follow-up|1|||
149214114|NCT03050307|538252652|FG000|Overall Study|Voluntary Withdrawal|3|||
149214115|NCT03050307|538252653|FG001|Overall Study|Voluntary Withdrawal|4|||
149214116|NCT03050307|538252652|FG000|Overall Study|Reason not Specified|1|||
149214117|NCT03050307|538252653|FG001|Overall Study|Reason not Specified|1|||
149214118|NCT01536418|538252654|FG000|Overall Study|Protocol Violation|2|||
149214119|NCT01536418|538252655|FG001|Overall Study|Protocol Violation|3|||
149214120|NCT01536418|538252654|FG000|Overall Study|Physician Decision|1|||
149214121|NCT01536418|538252655|FG001|Overall Study|Physician Decision|3|||
149214122|NCT01536418|538252654|FG000|Overall Study|Study closed/terminated|41|||
149214123|NCT01536418|538252655|FG001|Overall Study|Study closed/terminated|37|||
149214124|NCT01536418|538252654|FG000|Overall Study|Lack of Efficacy|10|||
149214125|NCT01536418|538252655|FG001|Overall Study|Lack of Efficacy|16|||
149214126|NCT01536418|538252654|FG000|Overall Study|Adverse Event|9|||
149214127|NCT01536418|538252655|FG001|Overall Study|Adverse Event|4|||
149214128|NCT01536418|538252654|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
149214129|NCT01536418|538252655|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
149214130|NCT01536418|538252654|FG000|Overall Study|Withdrawal by Subject|5|||
149214131|NCT01536418|538252655|FG001|Overall Study|Withdrawal by Subject|3|||
149214132|NCT02658149|538252656|FG000|Overall Study|Physician Decision|1|||
149214133|NCT02658149|538252657|FG001|Overall Study|Physician Decision|0|||
149214134|NCT00711412|538252658|FG000|Induction Treatment|Death|2|||
149214135|NCT00711412|538252658|FG000|Induction Treatment|Adverse Event|1|||
149214136|NCT00711412|538252658|FG000|Induction Treatment|Other|1|||
149214137|NCT00711412|538252658|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
149214138|NCT00711412|538252658|FG000|Evaluated for Combination Treatment|Death|1|||
149214139|NCT00711412|538252658|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
149214140|NCT00711412|538252658|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
149214141|NCT00711412|538252658|FG000|Combination Treatment|Progressive Disease|1|||
149214142|NCT00711412|538252658|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
149214143|NCT00711412|538252658|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
149214144|NCT00711412|538252658|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
149214145|NCT00711412|538252658|FG000|Evaluation for Response and Surgery|Death|1|||
149214146|NCT00711412|538252658|FG000|Survival Follow up Until Death|Other|12|||
149214147|NCT01680991|538252661|FG000|Overall Study|Adverse Event|1|||
149214148|NCT01680991|538252662|FG001|Overall Study|Adverse Event|0|||
149214149|NCT01680991|538252663|FG002|Overall Study|Adverse Event|0|||
149214150|NCT01680991|538252661|FG000|Overall Study|Death|1|||
149214151|NCT01680991|538252662|FG001|Overall Study|Death|0|||
149214152|NCT01680991|538252663|FG002|Overall Study|Death|1|||
149214153|NCT01680991|538252661|FG000|Overall Study|Protocol Violation|0|||
149214154|NCT01680991|538252662|FG001|Overall Study|Protocol Violation|1|||
149214155|NCT01680991|538252663|FG002|Overall Study|Protocol Violation|0|||
149214156|NCT01680991|538252661|FG000|Overall Study|Withdrawal by Subject|5|||
149214157|NCT01680991|538252662|FG001|Overall Study|Withdrawal by Subject|1|||
149214158|NCT01680991|538252663|FG002|Overall Study|Withdrawal by Subject|0|||
149214159|NCT01680991|538252661|FG000|Overall Study|Progressive disease (PD)|0|||
149214160|NCT01680991|538252662|FG001|Overall Study|Progressive disease (PD)|10|||
149214161|NCT01680991|538252663|FG002|Overall Study|Progressive disease (PD)|0|||
149214162|NCT01680991|538252661|FG000|Overall Study|Physician Decision|0|||
149214163|NCT01680991|538252662|FG001|Overall Study|Physician Decision|7|||
149214164|NCT01680991|538252663|FG002|Overall Study|Physician Decision|2|||
149214165|NCT01680991|538252661|FG000|Overall Study|Bad physical condition|0|||
149214166|NCT01680991|538252662|FG001|Overall Study|Bad physical condition|0|||
149214167|NCT01680991|538252663|FG002|Overall Study|Bad physical condition|1|||
149214168|NCT01680991|538252661|FG000|Overall Study|PD confirmed in other hospital|1|||
149214169|NCT01680991|538252662|FG001|Overall Study|PD confirmed in other hospital|0|||
149214170|NCT01680991|538252663|FG002|Overall Study|PD confirmed in other hospital|0|||
149214171|NCT02498392|538252664|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
149214172|NCT02498392|538252665|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
149214173|NCT02498392|538252664|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
149214174|NCT02498392|538252665|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
149214175|NCT02498392|538252664|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
149214176|NCT02498392|538252665|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
149214177|NCT02498392|538252664|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
149214178|NCT02498392|538252665|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
149214179|NCT02498392|538252664|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
149214180|NCT02498392|538252665|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
149214181|NCT02498392|538252664|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
149214182|NCT02498392|538252665|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
149214183|NCT06073054|538252666|FG000|Overall Study|Withdrawal by Subject|2|||
149214184|NCT02244619|538252667|FG000|Overall Study|Did not receive study intervention|8|||
149214185|NCT02244619|538252668|FG001|Overall Study|Did not receive study intervention|21|||
149214186|NCT03687827|538252669|FG000|Treatment Period 1|Death|0|||
149214187|NCT03687827|538252670|FG001|Treatment Period 1|Death|1|||
149214188|NCT03687827|538252669|FG000|Treatment Period 1|Lost to Follow-up|2|||
149214189|NCT03687827|538252670|FG001|Treatment Period 1|Lost to Follow-up|2|||
149214190|NCT03687827|538252669|FG000|Treatment Period 1|Physician Decision|5|||
149214191|NCT03687827|538252670|FG001|Treatment Period 1|Physician Decision|2|||
149214192|NCT03687827|538252669|FG000|Treatment Period 1|Withdrawal by Subject|7|||
149214193|NCT03687827|538252670|FG001|Treatment Period 1|Withdrawal by Subject|3|||
149214194|NCT03687827|538252669|FG000|Treatment Period 2|Physician Decision|4|||
149214195|NCT03687827|538252670|FG001|Treatment Period 2|Physician Decision|1|||
149214196|NCT03687827|538252669|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149214197|NCT03687827|538252670|FG001|Treatment Period 2|Withdrawal by Subject|2|||
149214198|NCT00068822|538252671|FG000|First Randomized Intervention|Lost to Follow-up|1|||
149214199|NCT00068822|538252672|FG001|First Randomized Intervention|Lost to Follow-up|2|||
149214200|NCT00429572|538252674|FG000|Overall Study|Disease progression|1|||
149214201|NCT00424099|538252677|FG000|Overall Study|Adverse Event|0|||
149214202|NCT00424099|538252678|FG001|Overall Study|Adverse Event|1|||
149214203|NCT00424099|538252679|FG002|Overall Study|Adverse Event|1|||
149214204|NCT00424099|538252680|FG003|Overall Study|Adverse Event|0|||
149214205|NCT00424099|538252677|FG000|Overall Study|Death|0|||
149214206|NCT00424099|538252678|FG001|Overall Study|Death|1|||
149214207|NCT00424099|538252679|FG002|Overall Study|Death|0|||
149214208|NCT00424099|538252680|FG003|Overall Study|Death|0|||
149214209|NCT00424099|538252677|FG000|Overall Study|Illness|2|||
149214210|NCT00424099|538252678|FG001|Overall Study|Illness|0|||
149214211|NCT00424099|538252679|FG002|Overall Study|Illness|1|||
149214212|NCT00424099|538252680|FG003|Overall Study|Illness|4|||
149214213|NCT00424099|538252677|FG000|Overall Study|Lost to Follow-up|0|||
149214214|NCT00424099|538252678|FG001|Overall Study|Lost to Follow-up|0|||
149214215|NCT00424099|538252679|FG002|Overall Study|Lost to Follow-up|3|||
149214216|NCT00424099|538252680|FG003|Overall Study|Lost to Follow-up|0|||
149214217|NCT00424099|538252677|FG000|Overall Study|Hospitalized|1|||
149214218|NCT00424099|538252678|FG001|Overall Study|Hospitalized|2|||
149214219|NCT00424099|538252679|FG002|Overall Study|Hospitalized|1|||
149214220|NCT00424099|538252680|FG003|Overall Study|Hospitalized|3|||
149214221|NCT00424099|538252677|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
149214222|NCT00424099|538252678|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
149214223|NCT00424099|538252679|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
149214224|NCT00424099|538252680|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
149214225|NCT00424099|538252677|FG000|Overall Study|Withdrawal by Subject|1|||
149214226|NCT00424099|538252678|FG001|Overall Study|Withdrawal by Subject|9|||
149214227|NCT00424099|538252679|FG002|Overall Study|Withdrawal by Subject|4|||
149214228|NCT00424099|538252680|FG003|Overall Study|Withdrawal by Subject|6|||
149214229|NCT00424099|538252677|FG000|Overall Study|Physician Decision|0|||
149214230|NCT00424099|538252678|FG001|Overall Study|Physician Decision|0|||
149214231|NCT00424099|538252679|FG002|Overall Study|Physician Decision|1|||
149214232|NCT00424099|538252680|FG003|Overall Study|Physician Decision|0|||
149214233|NCT00424099|538252677|FG000|Overall Study|Missing|0|||
149214234|NCT00424099|538252678|FG001|Overall Study|Missing|0|||
149214235|NCT00424099|538252679|FG002|Overall Study|Missing|1|||
149214236|NCT00424099|538252680|FG003|Overall Study|Missing|0|||
149214237|NCT01408732|538252681|FG000|Overall Study|Withdrawal by Subject|2|||
149214238|NCT01408732|538252682|FG001|Overall Study|Withdrawal by Subject|2|||
149214239|NCT00764322|538252683|FG000|Overall Study|Withdrawal by Subject|11|||
149214240|NCT00764322|538252683|FG000|Overall Study|No CYP2D6 genotyping|9|||
149214241|NCT01989572|538252684|FG000|Overall Study|Lack of Efficacy|35|||
149214242|NCT01989572|538252685|FG001|Overall Study|Lack of Efficacy|48|||
149214243|NCT01989572|538252686|FG002|Overall Study|Lack of Efficacy|48|||
149214244|NCT01989572|538252687|FG003|Overall Study|Lack of Efficacy|43|||
149214245|NCT01989572|538252688|FG004|Overall Study|Lack of Efficacy|71|||
149214246|NCT01989572|538252689|FG005|Overall Study|Lack of Efficacy|79|||
149214247|NCT01989572|538252684|FG000|Overall Study|Adverse Event|2|||
149214248|NCT01989572|538252685|FG001|Overall Study|Adverse Event|1|||
149214249|NCT01989572|538252686|FG002|Overall Study|Adverse Event|3|||
149214250|NCT01989572|538252687|FG003|Overall Study|Adverse Event|0|||
149214251|NCT01989572|538252688|FG004|Overall Study|Adverse Event|3|||
149214252|NCT01989572|538252689|FG005|Overall Study|Adverse Event|0|||
148684556|NCT01393990|536319435|FG013|Overall Study|Progressive Disease|1|||
148684557|NCT01393990|536319436|FG014|Overall Study|Progressive Disease|6|||
148684558|NCT01393990|536319437|FG015|Overall Study|Progressive Disease|1|||
149016660|NCT01327547|537540859|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
149016661|NCT01327547|537540858|FG000|Overall Study|Required prohibited medication|2|||
149016662|NCT01327547|537540859|FG001|Overall Study|Required prohibited medication|0|||
149016663|NCT01327547|537540858|FG000|Overall Study|Non-compliance with study procedures|1|||
149016664|NCT01327547|537540859|FG001|Overall Study|Non-compliance with study procedures|0|||
149016665|NCT01327547|537540858|FG000|Overall Study|By investigator in subject's interest|0|||
149016666|NCT01327547|537540859|FG001|Overall Study|By investigator in subject's interest|1|||
149214253|NCT01989572|538252684|FG000|Overall Study|Death|0|||
149214254|NCT01989572|538252685|FG001|Overall Study|Death|0|||
149214255|NCT01989572|538252686|FG002|Overall Study|Death|0|||
149214256|NCT01989572|538252687|FG003|Overall Study|Death|0|||
149214257|NCT01989572|538252688|FG004|Overall Study|Death|1|||
149214258|NCT01989572|538252689|FG005|Overall Study|Death|0|||
149214259|NCT01989572|538252684|FG000|Overall Study|Withdrawal by Subject|4|||
149016667|NCT02930122|537540860|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
148684559|NCT01393990|536319438|FG016|Overall Study|Progressive Disease|0|||
149214260|NCT01989572|538252685|FG001|Overall Study|Withdrawal by Subject|1|||
149214261|NCT01989572|538252686|FG002|Overall Study|Withdrawal by Subject|5|||
149214262|NCT01989572|538252687|FG003|Overall Study|Withdrawal by Subject|1|||
149016668|NCT02930122|537540861|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
149214263|NCT01989572|538252688|FG004|Overall Study|Withdrawal by Subject|12|||
149214264|NCT01989572|538252689|FG005|Overall Study|Withdrawal by Subject|4|||
149214265|NCT01989572|538252684|FG000|Overall Study|complicating disease|1|||
149214266|NCT01989572|538252685|FG001|Overall Study|complicating disease|1|||
149214267|NCT01989572|538252686|FG002|Overall Study|complicating disease|2|||
149214268|NCT01989572|538252687|FG003|Overall Study|complicating disease|0|||
149214269|NCT01989572|538252688|FG004|Overall Study|complicating disease|1|||
149214270|NCT01989572|538252689|FG005|Overall Study|complicating disease|0|||
149214271|NCT01989572|538252684|FG000|Overall Study|error|2|||
149214272|NCT01989572|538252685|FG001|Overall Study|error|1|||
149214273|NCT01989572|538252686|FG002|Overall Study|error|1|||
149214274|NCT01989572|538252687|FG003|Overall Study|error|1|||
149214275|NCT01989572|538252688|FG004|Overall Study|error|1|||
149214276|NCT01989572|538252689|FG005|Overall Study|error|1|||
149214277|NCT01989572|538252684|FG000|Overall Study|maximum dose reached|0|||
149214278|NCT01989572|538252685|FG001|Overall Study|maximum dose reached|1|||
149214279|NCT01989572|538252686|FG002|Overall Study|maximum dose reached|0|||
149214280|NCT01989572|538252687|FG003|Overall Study|maximum dose reached|0|||
149214281|NCT01989572|538252688|FG004|Overall Study|maximum dose reached|1|||
149214282|NCT01989572|538252689|FG005|Overall Study|maximum dose reached|0|||
149214283|NCT01989572|538252684|FG000|Overall Study|unknown/not specify|3|||
149214284|NCT01989572|538252685|FG001|Overall Study|unknown/not specify|4|||
149214285|NCT01989572|538252686|FG002|Overall Study|unknown/not specify|1|||
149016669|NCT01681368|537540864|FG000|Overall Study|Refused further treatment|1|||
149016670|NCT01681368|537540864|FG000|Overall Study|Refused further follow up|1|||
149016671|NCT00900627|537540867|FG000|Overall Study|Condition under investigation worsened|4|||
149016672|NCT00900627|537540868|FG001|Overall Study|Condition under investigation worsened|0|||
149016673|NCT00900627|537540869|FG002|Overall Study|Condition under investigation worsened|5|||
149016674|NCT00900627|537540870|FG003|Overall Study|Condition under investigation worsened|3|||
149016675|NCT00900627|537540871|FG004|Overall Study|Condition under investigation worsened|0|||
149016676|NCT00900627|537540872|FG005|Overall Study|Condition under investigation worsened|0|||
149016677|NCT00900627|537540867|FG000|Overall Study|Withdrawal by Subject|1|||
149016678|NCT00900627|537540868|FG001|Overall Study|Withdrawal by Subject|0|||
149016679|NCT00900627|537540869|FG002|Overall Study|Withdrawal by Subject|1|||
149016680|NCT00900627|537540870|FG003|Overall Study|Withdrawal by Subject|0|||
149016681|NCT00900627|537540871|FG004|Overall Study|Withdrawal by Subject|1|||
149016682|NCT00900627|537540872|FG005|Overall Study|Withdrawal by Subject|2|||
149016683|NCT00900627|537540867|FG000|Overall Study|Adverse Event|1|||
149016684|NCT00900627|537540868|FG001|Overall Study|Adverse Event|2|||
149016685|NCT00900627|537540869|FG002|Overall Study|Adverse Event|0|||
149016686|NCT00900627|537540870|FG003|Overall Study|Adverse Event|3|||
149016687|NCT00900627|537540871|FG004|Overall Study|Adverse Event|0|||
149016688|NCT00900627|537540872|FG005|Overall Study|Adverse Event|0|||
149016689|NCT00900627|537540867|FG000|Overall Study|Death|0|||
149016690|NCT00900627|537540868|FG001|Overall Study|Death|0|||
149016691|NCT00900627|537540869|FG002|Overall Study|Death|0|||
149016692|NCT00900627|537540870|FG003|Overall Study|Death|0|||
149016693|NCT00900627|537540871|FG004|Overall Study|Death|28|||
149016694|NCT00900627|537540872|FG005|Overall Study|Death|24|||
149016695|NCT01238575|537540877|FG000|Overall Study|Lack of Efficacy|2|||
149016696|NCT01238575|537540878|FG001|Overall Study|Lack of Efficacy|4|||
149016697|NCT01238575|537540877|FG000|Overall Study|Adverse Event|2|||
149016698|NCT01238575|537540878|FG001|Overall Study|Adverse Event|0|||
148684560|NCT01393990|536319439|FG017|Overall Study|Progressive Disease|0|||
149016699|NCT03685708|537540884|FG000|Overall Study|Withdrawal by Subject|0|||
149016700|NCT03685708|537540885|FG001|Overall Study|Withdrawal by Subject|0|||
149016701|NCT03685708|537540886|FG002|Overall Study|Withdrawal by Subject|1|||
149016702|NCT03685708|537540884|FG000|Overall Study|Screen Fail|0|||
149016703|NCT03685708|537540885|FG001|Overall Study|Screen Fail|1|||
149214286|NCT01989572|538252687|FG003|Overall Study|unknown/not specify|3|||
149214287|NCT01989572|538252688|FG004|Overall Study|unknown/not specify|3|||
148950467|NCT02207244|537299700|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
149214288|NCT01989572|538252689|FG005|Overall Study|unknown/not specify|5|||
149214289|NCT01989572|538252684|FG000|Overall Study|not start protocol therapy|5|||
149214290|NCT01989572|538252685|FG001|Overall Study|not start protocol therapy|1|||
149214291|NCT01989572|538252686|FG002|Overall Study|not start protocol therapy|2|||
149214292|NCT01989572|538252687|FG003|Overall Study|not start protocol therapy|3|||
149214293|NCT01989572|538252688|FG004|Overall Study|not start protocol therapy|4|||
149214294|NCT01989572|538252689|FG005|Overall Study|not start protocol therapy|18|||
149214295|NCT01989572|538252684|FG000|Overall Study|alternative therapy|3|||
149214296|NCT01989572|538252685|FG001|Overall Study|alternative therapy|0|||
149214297|NCT01989572|538252686|FG002|Overall Study|alternative therapy|0|||
149214298|NCT01989572|538252687|FG003|Overall Study|alternative therapy|0|||
149214299|NCT01989572|538252688|FG004|Overall Study|alternative therapy|1|||
149214300|NCT01989572|538252689|FG005|Overall Study|alternative therapy|3|||
149214301|NCT02280096|538252694|FG000|Overall Study|Pregnancy|1|||
149214302|NCT02280096|538252695|FG001|Overall Study|Pregnancy|0|||
149214303|NCT02280096|538252694|FG000|Overall Study|Functional neurological disorder|1|||
149214304|NCT02280096|538252695|FG001|Overall Study|Functional neurological disorder|0|||
149214305|NCT02280096|538252694|FG000|Overall Study|Lack of attachment|0|||
149214306|NCT02280096|538252695|FG001|Overall Study|Lack of attachment|1|||
149214307|NCT00246376|538252696|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
149214308|NCT00246376|538252697|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
149214309|NCT00246376|538252698|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
149214310|NCT00246376|538252699|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
149214311|NCT00246376|538252700|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
149214312|NCT00246376|538252696|FG000|Overall Study|Adverse Event|2|||
149214313|NCT00246376|538252697|FG001|Overall Study|Adverse Event|3|||
149214314|NCT00246376|538252698|FG002|Overall Study|Adverse Event|1|||
149214315|NCT00246376|538252699|FG003|Overall Study|Adverse Event|3|||
149214316|NCT00246376|538252700|FG004|Overall Study|Adverse Event|1|||
149214317|NCT00246376|538252696|FG000|Overall Study|Lost to Follow-up|2|||
149214318|NCT00246376|538252697|FG001|Overall Study|Lost to Follow-up|11|||
149214319|NCT00246376|538252698|FG002|Overall Study|Lost to Follow-up|11|||
149214320|NCT00246376|538252699|FG003|Overall Study|Lost to Follow-up|16|||
149214321|NCT00246376|538252700|FG004|Overall Study|Lost to Follow-up|13|||
149214322|NCT01872897|538252701|FG000|Overall Study|Withdrawal by Subject|1|||
149214323|NCT01872897|538252702|FG001|Overall Study|Withdrawal by Subject|0|||
149214324|NCT01024920|538252703|FG000|Overall Study|Progressive disease|47|||
149214325|NCT01024920|538252704|FG001|Overall Study|Progressive disease|25|||
149214326|NCT01024920|538252703|FG000|Overall Study|Adverse Event|8|||
149214327|NCT01024920|538252704|FG001|Overall Study|Adverse Event|4|||
149214328|NCT01024920|538252703|FG000|Overall Study|Lost to Follow-up|0|||
149214329|NCT01024920|538252704|FG001|Overall Study|Lost to Follow-up|1|||
149214330|NCT01024920|538252703|FG000|Overall Study|Patient refusal to continue|4|||
149214331|NCT01024920|538252704|FG001|Overall Study|Patient refusal to continue|0|||
149214332|NCT01024920|538252703|FG000|Overall Study|Other than listed|5|||
149214333|NCT01024920|538252704|FG001|Overall Study|Other than listed|1|||
149214334|NCT01024920|538252703|FG000|Overall Study|Not treated|3|||
149214335|NCT01024920|538252704|FG001|Overall Study|Not treated|0|||
149214336|NCT01024920|538252703|FG000|Overall Study|Protocol Violation|0|||
149214337|NCT01024920|538252704|FG001|Overall Study|Protocol Violation|1|||
149214338|NCT00329784|538252705|FG000|Overall Study|Lost to Follow-up|0|||
149214339|NCT00329784|538252706|FG001|Overall Study|Lost to Follow-up|1|||
149214340|NCT00329784|538252707|FG002|Overall Study|Lost to Follow-up|0|||
149214341|NCT00329784|538252708|FG003|Overall Study|Lost to Follow-up|0|||
149214342|NCT00329784|538252705|FG000|Overall Study|Withdrawal by Subject|4|||
149214343|NCT00329784|538252706|FG001|Overall Study|Withdrawal by Subject|2|||
149214344|NCT00329784|538252707|FG002|Overall Study|Withdrawal by Subject|0|||
149214345|NCT00329784|538252708|FG003|Overall Study|Withdrawal by Subject|0|||
149214346|NCT00329784|538252705|FG000|Overall Study|Other|1|||
149214347|NCT00329784|538252706|FG001|Overall Study|Other|2|||
149214348|NCT00329784|538252707|FG002|Overall Study|Other|0|||
149214349|NCT00329784|538252708|FG003|Overall Study|Other|0|||
149214350|NCT04599972|538252713|FG000|Overall Study|Withdrawal by Subject|6|||
149214351|NCT04599972|538252714|FG001|Overall Study|Withdrawal by Subject|1|||
148950468|NCT02207244|537299701|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
148950469|NCT02207244|537299702|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
148950470|NCT02207244|537299703|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
149214352|NCT04599972|538252713|FG000|Overall Study|Adverse Event|1|||
149214353|NCT04599972|538252714|FG001|Overall Study|Adverse Event|1|||
148950471|NCT02207244|537299693|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
149214354|NCT04599972|538252713|FG000|Overall Study|Lost to Follow-up|1|||
149214355|NCT04599972|538252714|FG001|Overall Study|Lost to Follow-up|6|||
149214356|NCT04599972|538252713|FG000|Overall Study|Protocol Violation|1|||
149214357|NCT04599972|538252714|FG001|Overall Study|Protocol Violation|0|||
149214358|NCT04599972|538252713|FG000|Overall Study|Other reason|1|||
149214359|NCT04599972|538252714|FG001|Overall Study|Other reason|0|||
149214360|NCT00638690|538252715|FG000|Overall Study|Death|655|||
149214361|NCT00638690|538252716|FG001|Overall Study|Death|335|||
148950472|NCT02207244|537299694|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950473|NCT02207244|537299695|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950474|NCT02207244|537299696|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
148950475|NCT02207244|537299697|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950476|NCT02207244|537299698|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
148950477|NCT02207244|537299699|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950478|NCT02207244|537299700|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950479|NCT02207244|537299701|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950480|NCT02207244|537299702|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950481|NCT02207244|537299703|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
148950482|NCT02207244|537299693|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950483|NCT02207244|537299694|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950484|NCT02207244|537299695|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950485|NCT02207244|537299696|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
149214362|NCT00638690|538252715|FG000|Overall Study|Withdrawal by Subject|22|||
149214363|NCT00638690|538252716|FG001|Overall Study|Withdrawal by Subject|5|||
149214364|NCT00638690|538252715|FG000|Overall Study|Lost to Follow-up|4|||
149214365|NCT00638690|538252716|FG001|Overall Study|Lost to Follow-up|2|||
149214366|NCT01347073|538252725|FG000|Overall Study|Adverse Event|1|||
149214367|NCT01347073|538252725|FG000|Overall Study|Liver Transplant|1|||
149214368|NCT03236506|538252726|FG000|Overall Study|Death|1|||
149214369|NCT03236506|538252727|FG001|Overall Study|Death|1|||
149214370|NCT03236506|538252728|FG002|Overall Study|Death|1|||
149214371|NCT03236506|538252726|FG000|Overall Study|Withdrawal by Subject|3|||
149214372|NCT03236506|538252727|FG001|Overall Study|Withdrawal by Subject|3|||
149214373|NCT03236506|538252728|FG002|Overall Study|Withdrawal by Subject|4|||
149214374|NCT03236506|538252726|FG000|Overall Study|Did not initiate treatment|2|||
149214375|NCT03236506|538252727|FG001|Overall Study|Did not initiate treatment|1|||
148950486|NCT02207244|537299697|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950487|NCT02207244|537299698|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950488|NCT02207244|537299699|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950489|NCT02207244|537299700|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950490|NCT02207244|537299701|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950491|NCT02207244|537299702|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950492|NCT02207244|537299703|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
148950493|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
148950494|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
148950495|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
148950496|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
148950497|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
148950498|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
148950499|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
148950500|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
148950501|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
149214376|NCT03236506|538252728|FG002|Overall Study|Did not initiate treatment|2|||
149214377|NCT00621244|538252729|FG000|Overall Study|Withdrawal by Subject|7|||
149214378|NCT00621244|538252730|FG001|Overall Study|Withdrawal by Subject|3|||
149214379|NCT00621244|538252731|FG002|Overall Study|Withdrawal by Subject|3|||
148809616|NCT02696798|536779360|FG001|Extended Treatment Period|Lack of Efficacy|2|||
148809617|NCT02696798|536779361|FG002|Extended Treatment Period|Lack of Efficacy|2|||
148809618|NCT02696798|536779359|FG000|Extended Treatment Period|Lost to Follow-up|1|||
148809619|NCT02696798|536779360|FG001|Extended Treatment Period|Lost to Follow-up|0|||
148809620|NCT02696798|536779361|FG002|Extended Treatment Period|Lost to Follow-up|0|||
148809621|NCT02696798|536779359|FG000|Extended Treatment Period|Physician Decision|0|||
148950502|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
148950503|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
149214380|NCT00621244|538252732|FG003|Overall Study|Withdrawal by Subject|3|||
149214381|NCT00621244|538252729|FG000|Overall Study|Disease progression|44|||
149214382|NCT00621244|538252730|FG001|Overall Study|Disease progression|20|||
149214383|NCT00621244|538252731|FG002|Overall Study|Disease progression|20|||
149214384|NCT00621244|538252732|FG003|Overall Study|Disease progression|15|||
149214385|NCT00621244|538252729|FG000|Overall Study|Death|3|||
149214386|NCT00621244|538252730|FG001|Overall Study|Death|3|||
149214387|NCT00621244|538252731|FG002|Overall Study|Death|1|||
149214388|NCT00621244|538252732|FG003|Overall Study|Death|1|||
149214389|NCT00621244|538252729|FG000|Overall Study|Adverse Event|27|||
149214390|NCT00621244|538252730|FG001|Overall Study|Adverse Event|7|||
149214391|NCT00621244|538252731|FG002|Overall Study|Adverse Event|9|||
149214392|NCT00621244|538252732|FG003|Overall Study|Adverse Event|2|||
149214393|NCT00621244|538252729|FG000|Overall Study|Administrative problems|5|||
149214394|NCT00621244|538252730|FG001|Overall Study|Administrative problems|1|||
149214395|NCT00621244|538252731|FG002|Overall Study|Administrative problems|0|||
149214396|NCT00621244|538252732|FG003|Overall Study|Administrative problems|2|||
149214397|NCT02865928|538252733|FG000|Overall Study|Withdrawal by Subject|1|||
149214398|NCT02865928|538252734|FG001|Overall Study|Withdrawal by Subject|0|||
149214399|NCT02865928|538252733|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
149214400|NCT02865928|538252734|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
149214401|NCT02865928|538252733|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
149214402|NCT02865928|538252734|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
149214403|NCT01925014|538252743|FG000|Overall Study|Inappropriate enrollment|4|||
149214404|NCT01925014|538252744|FG001|Overall Study|Inappropriate enrollment|6|||
149214405|NCT01925014|538252743|FG000|Overall Study|Withdrawal by Subject|5|||
149214406|NCT01925014|538252744|FG001|Overall Study|Withdrawal by Subject|13|||
149214407|NCT01690988|538252745|FG000|Overall Study|Withdrawal by Subject|2|||
149214408|NCT01690988|538252746|FG001|Overall Study|Withdrawal by Subject|2|||
149214409|NCT01690988|538252747|FG002|Overall Study|Withdrawal by Subject|3|||
149214410|NCT01690988|538252745|FG000|Overall Study|Physician Decision|0|||
148809622|NCT02696798|536779360|FG001|Extended Treatment Period|Physician Decision|1|||
148950504|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950505|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950506|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950507|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950508|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950509|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950510|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950511|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
148950512|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
148950513|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
149016704|NCT03685708|537540886|FG002|Overall Study|Screen Fail|1|||
149214411|NCT01690988|538252746|FG001|Overall Study|Physician Decision|0|||
149214412|NCT01690988|538252747|FG002|Overall Study|Physician Decision|1|||
149214413|NCT01690988|538252745|FG000|Overall Study|Operation Cancelled|1|||
149214414|NCT01690988|538252746|FG001|Overall Study|Operation Cancelled|1|||
149214415|NCT01690988|538252747|FG002|Overall Study|Operation Cancelled|0|||
149214416|NCT01690988|538252745|FG000|Overall Study|Determined ineligible|1|||
148809623|NCT02696798|536779361|FG002|Extended Treatment Period|Physician Decision|0|||
149214417|NCT01690988|538252746|FG001|Overall Study|Determined ineligible|0|||
149214418|NCT01690988|538252747|FG002|Overall Study|Determined ineligible|0|||
149214419|NCT01690988|538252745|FG000|Overall Study|Death|1|||
149214420|NCT01690988|538252746|FG001|Overall Study|Death|1|||
149214421|NCT01690988|538252747|FG002|Overall Study|Death|1|||
149214422|NCT01690988|538252745|FG000|Overall Study|Sedated|1|||
149214423|NCT01690988|538252746|FG001|Overall Study|Sedated|1|||
149214424|NCT01690988|538252747|FG002|Overall Study|Sedated|2|||
149214425|NCT03696576|538252757|FG000|Overall Study|Soreness of throat after therapy|1|||
149214426|NCT03696576|538252758|FG001|Overall Study|Soreness of throat after therapy|1|||
149214427|NCT03696576|538252757|FG000|Overall Study|Lost to Follow-up|2|||
149214428|NCT03696576|538252758|FG001|Overall Study|Lost to Follow-up|4|||
148809624|NCT02696798|536779359|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
149214429|NCT00312728|538252759|FG000|Overall Study|Progressive disease|53|||
149214430|NCT00312728|538252759|FG000|Overall Study|Adverse Event|32|||
148809625|NCT02696798|536779360|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
148950514|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
149214431|NCT00312728|538252759|FG000|Overall Study|Withdrawal by Subject|10|||
149214432|NCT00312728|538252759|FG000|Overall Study|Required non-protocol cancer treatment|2|||
149214433|NCT00312728|538252759|FG000|Overall Study|Protocol Violation|2|||
149214434|NCT00312728|538252759|FG000|Overall Study|Other|10|||
148684561|NCT01393990|536319422|FG000|Overall Study|Death|0|||
148684562|NCT01393990|536319423|FG001|Overall Study|Death|0|||
148684563|NCT01393990|536319424|FG002|Overall Study|Death|0|||
148684564|NCT01393990|536319425|FG003|Overall Study|Death|0|||
148950515|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950516|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950517|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950518|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950519|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950520|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950521|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
148950522|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
148950523|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
148950524|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
148950525|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
148950526|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950527|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950528|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950529|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950530|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950531|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950532|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
148950533|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
148950534|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950535|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
148950536|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
148950537|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950538|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950539|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950540|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950541|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950542|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950543|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
148950544|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
148950545|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
148950546|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
148950547|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
148950548|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950549|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950550|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950551|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950552|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950553|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950554|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950555|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
148950556|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
148950557|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950558|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
148950559|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950560|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950561|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950562|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950563|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950564|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950565|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950566|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950567|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
148950568|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
148950569|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
149214435|NCT00312728|538252759|FG000|Overall Study|Other|1|||
148684565|NCT01393990|536319426|FG004|Overall Study|Death|1|||
149214436|NCT00552344|538252760|FG000|Overall Study|Lack of Efficacy|55|||
149214437|NCT00552344|538252760|FG000|Overall Study|Loss of efficacy|75|||
149214438|NCT00552344|538252760|FG000|Overall Study|Lost to Follow-up|8|||
149214439|NCT00552344|538252760|FG000|Overall Study|Withdrawal by Subject|48|||
149214440|NCT00552344|538252760|FG000|Overall Study|SAE, non-fatal|6|||
149214441|NCT00552344|538252760|FG000|Overall Study|AE, non-serious non-fatal|38|||
149214442|NCT00552344|538252760|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
149214443|NCT00552344|538252760|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
149214444|NCT00552344|538252760|FG000|Overall Study|Other Reason|22|||
148809626|NCT02696798|536779361|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
148809627|NCT02696798|536779359|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
148809628|NCT02696798|536779360|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
148809629|NCT02696798|536779361|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
148809630|NCT02696798|536779359|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
148809631|NCT02696798|536779360|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
148809632|NCT02696798|536779361|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
148809633|NCT02696798|536779359|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
148809634|NCT02696798|536779360|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
148809635|NCT02696798|536779361|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
148809636|NCT02696798|536779359|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
148809637|NCT02696798|536779360|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
148809638|NCT02696798|536779361|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
148809639|NCT02696798|536779359|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
148809640|NCT02696798|536779360|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
148809641|NCT02696798|536779361|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
148809642|NCT02696798|536779359|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
148809643|NCT02696798|536779360|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
148809644|NCT02696798|536779361|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
148809645|NCT01277861|536779362|FG000|Overall Study|Physician Decision|2|||
148809646|NCT01277861|536779363|FG001|Overall Study|Physician Decision|2|||
148809647|NCT01157845|536779366|FG000|Overall Study|Lost to Follow-up|5|||
148809648|NCT01157845|536779366|FG000|Overall Study|Withdrawal by Subject|12|||
148809649|NCT01157845|536779366|FG000|Overall Study|Physician Decision|3|||
148809650|NCT01157845|536779366|FG000|Overall Study|Protocol Violation|13|||
148809651|NCT01157845|536779366|FG000|Overall Study|Study was ended|1|||
148809652|NCT01157845|536779366|FG000|Overall Study|Device malfunction|1|||
148950570|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950571|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950572|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950573|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950574|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950575|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950576|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950577|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
148950578|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950579|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950580|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
148950581|NCT02207244|537299693|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950582|NCT02207244|537299694|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950583|NCT02207244|537299695|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950584|NCT02207244|537299696|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950585|NCT02207244|537299697|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950586|NCT02207244|537299698|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950587|NCT02207244|537299699|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
148950588|NCT02207244|537299700|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950589|NCT02207244|537299701|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950590|NCT02207244|537299702|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
149214445|NCT01975376|538252761|FG000|Overall Study|Adverse Event|5|||
149214446|NCT01975376|538252762|FG001|Overall Study|Adverse Event|5|||
149214447|NCT01975376|538252761|FG000|Overall Study|Death|65|||
149214448|NCT01975376|538252762|FG001|Overall Study|Death|72|||
149214449|NCT01975376|538252761|FG000|Overall Study|Lost to Follow-up|70|||
149214450|NCT01975376|538252762|FG001|Overall Study|Lost to Follow-up|66|||
149214451|NCT01975376|538252761|FG000|Overall Study|Withdrew consent|68|||
148809653|NCT03311555|536779367|FG000|Overall Study|Adverse Event|1|||
148809654|NCT02566005|536780819|FG000|Overall Study|vaginal bleeding|0|||
148809655|NCT02566005|536780820|FG001|Overall Study|vaginal bleeding|1|||
148809656|NCT02566005|536780819|FG000|Overall Study|received foley|8|||
148809657|NCT02566005|536780820|FG001|Overall Study|received foley|0|||
149214452|NCT01975376|538252762|FG001|Overall Study|Withdrew consent|62|||
149214453|NCT01975376|538252761|FG000|Overall Study|Other|2|||
149214454|NCT01975376|538252762|FG001|Overall Study|Other|4|||
149214455|NCT01975376|538252761|FG000|Overall Study|Randomized, Not Treated|16|||
149214456|NCT01975376|538252762|FG001|Overall Study|Randomized, Not Treated|8|||
149214457|NCT00179517|538252763|FG000|Overall Study|Withdrawal by Subject|2|||
149214458|NCT00179517|538252764|FG001|Overall Study|Withdrawal by Subject|1|||
149214459|NCT00023712|538252765|FG000|Overall Study|Not platinum sensitive|1|||
149214460|NCT00023712|538252766|FG001|Overall Study|Not platinum sensitive|0|||
149214461|NCT00023712|538252765|FG000|Overall Study|Never treated|1|||
149214462|NCT00023712|538252766|FG001|Overall Study|Never treated|1|||
149214463|NCT00565812|538252767|FG000|Overall Study|Death|2|||
149214464|NCT00565812|538252768|FG001|Overall Study|Death|1|||
149214465|NCT00565812|538252769|FG002|Overall Study|Death|3|||
149214466|NCT00565812|538252767|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
149214467|NCT00565812|538252768|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
149214468|NCT00565812|538252769|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
149214469|NCT00565812|538252767|FG000|Overall Study|Lost to Follow-up|10|||
149214470|NCT00565812|538252768|FG001|Overall Study|Lost to Follow-up|8|||
149214471|NCT00565812|538252769|FG002|Overall Study|Lost to Follow-up|8|||
149214472|NCT00565812|538252767|FG000|Overall Study|Withdrawal by Subject|58|||
149214473|NCT00565812|538252768|FG001|Overall Study|Withdrawal by Subject|47|||
149214474|NCT00565812|538252769|FG002|Overall Study|Withdrawal by Subject|48|||
149214475|NCT00565812|538252767|FG000|Overall Study|Work Schedule|5|||
149214476|NCT00565812|538252768|FG001|Overall Study|Work Schedule|3|||
149214477|NCT00565812|538252769|FG002|Overall Study|Work Schedule|1|||
149214478|NCT00565812|538252767|FG000|Overall Study|Protocol Violation|2|||
149214479|NCT00565812|538252768|FG001|Overall Study|Protocol Violation|6|||
149214480|NCT00565812|538252769|FG002|Overall Study|Protocol Violation|4|||
149214481|NCT00565812|538252767|FG000|Overall Study|Adverse Event|41|||
149214482|NCT00565812|538252768|FG001|Overall Study|Adverse Event|54|||
149214483|NCT00565812|538252769|FG002|Overall Study|Adverse Event|40|||
149214484|NCT00565812|538252767|FG000|Overall Study|Jury Duty|1|||
149214485|NCT00565812|538252768|FG001|Overall Study|Jury Duty|0|||
149214486|NCT00565812|538252769|FG002|Overall Study|Jury Duty|0|||
149214487|NCT00565812|538252767|FG000|Overall Study|Relocated Out of Area|5|||
149214488|NCT00565812|538252768|FG001|Overall Study|Relocated Out of Area|8|||
149214489|NCT00565812|538252769|FG002|Overall Study|Relocated Out of Area|9|||
149214490|NCT00565812|538252767|FG000|Overall Study|Sponsor Decision|1|||
149214491|NCT00565812|538252768|FG001|Overall Study|Sponsor Decision|5|||
149214492|NCT00565812|538252769|FG002|Overall Study|Sponsor Decision|1|||
149214493|NCT00565812|538252767|FG000|Overall Study|Domestic Reasons|7|||
149214494|NCT00565812|538252768|FG001|Overall Study|Domestic Reasons|1|||
149214495|NCT00565812|538252769|FG002|Overall Study|Domestic Reasons|3|||
149214496|NCT00565812|538252767|FG000|Overall Study|Research Site Closure|6|||
149214497|NCT00565812|538252768|FG001|Overall Study|Research Site Closure|1|||
149214498|NCT00565812|538252769|FG002|Overall Study|Research Site Closure|8|||
149214499|NCT00565812|538252767|FG000|Overall Study|Surgical Intervention|0|||
149214500|NCT00565812|538252768|FG001|Overall Study|Surgical Intervention|1|||
149214501|NCT00565812|538252769|FG002|Overall Study|Surgical Intervention|2|||
149214502|NCT00565812|538252767|FG000|Overall Study|Low Compliance|1|||
149214503|NCT00565812|538252768|FG001|Overall Study|Low Compliance|0|||
148684566|NCT01393990|536319427|FG005|Overall Study|Death|0|||
148684567|NCT01393990|536319428|FG006|Overall Study|Death|0|||
148684568|NCT01393990|536319429|FG007|Overall Study|Death|0|||
148684569|NCT01393990|536319430|FG008|Overall Study|Death|0|||
148684570|NCT01393990|536319431|FG009|Overall Study|Death|0|||
148684571|NCT01393990|536319432|FG010|Overall Study|Death|0|||
148684572|NCT01393990|536319433|FG011|Overall Study|Death|0|||
148684573|NCT01393990|536319434|FG012|Overall Study|Death|0|||
148684574|NCT01393990|536319435|FG013|Overall Study|Death|1|||
149214504|NCT00565812|538252769|FG002|Overall Study|Low Compliance|1|||
149214505|NCT00565812|538252767|FG000|Overall Study|Follow-up Visit Not Completed|2|||
149214506|NCT00565812|538252768|FG001|Overall Study|Follow-up Visit Not Completed|0|||
148684575|NCT01393990|536319436|FG014|Overall Study|Death|1|||
149214507|NCT00565812|538252769|FG002|Overall Study|Follow-up Visit Not Completed|1|||
149214508|NCT00565812|538252767|FG000|Overall Study|Physician Decision|2|||
149214509|NCT00565812|538252768|FG001|Overall Study|Physician Decision|0|||
149214510|NCT00565812|538252769|FG002|Overall Study|Physician Decision|0|||
148684576|NCT01393990|536319437|FG015|Overall Study|Death|0|||
148684577|NCT01393990|536319438|FG016|Overall Study|Death|0|||
149214511|NCT01570309|538252771|FG000|Overall Study|Withdrawal by Subject|3|||
149214512|NCT01570309|538252772|FG001|Overall Study|Withdrawal by Subject|3|||
149214513|NCT00614991|538252773|FG000|Overall Study|Adverse Event|3|||
149214514|NCT00614991|538252774|FG001|Overall Study|Adverse Event|3|||
149214515|NCT00614991|538252775|FG002|Overall Study|Adverse Event|0|||
148809658|NCT02566005|536780819|FG000|Overall Study|did not receive foley|0|||
149214516|NCT00614991|538252776|FG003|Overall Study|Adverse Event|0|||
148684578|NCT01393990|536319439|FG017|Overall Study|Death|0|||
148684579|NCT01393990|536319422|FG000|Overall Study|Withdrawal by Subject|0|||
149214517|NCT00614991|538252777|FG004|Overall Study|Adverse Event|1|||
149214518|NCT00614991|538252778|FG005|Overall Study|Adverse Event|0|||
149214519|NCT04857892|538252779|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
149214520|NCT04857892|538252780|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149214521|NCT04857892|538252781|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149214522|NCT04857892|538252782|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149214523|NCT04857892|538252783|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
149214524|NCT04857892|538252779|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
149214525|NCT04857892|538252780|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
149214526|NCT04857892|538252781|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
149214527|NCT04857892|538252782|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
149214528|NCT04857892|538252783|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
149214529|NCT04857892|538252779|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149214530|NCT04857892|538252780|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149214531|NCT04857892|538252781|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149214532|NCT04857892|538252782|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
149214533|NCT04857892|538252783|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
149214534|NCT00368472|538252788|FG000|Overall Study|Adverse Event|22|||
149214535|NCT00368472|538252788|FG000|Overall Study|Medication non-compliance|4|||
149214536|NCT00368472|538252788|FG000|Overall Study|Protocol Violation|2|||
149214537|NCT00368472|538252788|FG000|Overall Study|Request of Investigator or Sponsor|3|||
149214538|NCT00368472|538252788|FG000|Overall Study|Withdrawal by Subject|40|||
149214539|NCT00368472|538252788|FG000|Overall Study|Diary non-compliance|1|||
149214540|NCT00368472|538252788|FG000|Overall Study|Other|32|||
149214541|NCT00368472|538252788|FG000|Overall Study|Missing Final Disposition Date|1|||
149214542|NCT04095793|538252792|FG000|Overall Study|Adverse Event|3|||
149214543|NCT04095793|538252792|FG000|Overall Study|Study Terminated by Sponsor|103|||
148684580|NCT01393990|536319423|FG001|Overall Study|Withdrawal by Subject|0|||
148684581|NCT01393990|536319424|FG002|Overall Study|Withdrawal by Subject|0|||
148684582|NCT01393990|536319425|FG003|Overall Study|Withdrawal by Subject|0|||
149214544|NCT04095793|538252792|FG000|Overall Study|Withdrawal by Subject|4|||
149214545|NCT02224274|538252798|FG000|Overall Study|Death|1|||
149214546|NCT02224274|538252799|FG001|Overall Study|Death|0|||
149214547|NCT00499460|538252800|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
149214548|NCT00499460|538252801|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
149214549|NCT00499460|538252800|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
149214550|NCT00499460|538252801|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
149214551|NCT00499460|538252800|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
149214552|NCT00499460|538252801|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
149214553|NCT00887068|538252802|FG000|Overall Study|Withdrawal by Subject|2|||
149214554|NCT00887068|538252803|FG001|Overall Study|Withdrawal by Subject|0|||
149214555|NCT00887068|538252802|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
149214556|NCT00887068|538252803|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
149214557|NCT00901394|538252804|FG000|Overall Study|Physician Decision|1|||
149214558|NCT00901394|538252805|FG001|Overall Study|Physician Decision|1|||
149214559|NCT00901394|538252806|FG002|Overall Study|Physician Decision|2|||
149214560|NCT02290340|538252808|FG000|Overall Study|Lost to Follow-up|0|||
149214561|NCT02290340|538252809|FG001|Overall Study|Lost to Follow-up|0|||
149214562|NCT02290340|538252810|FG002|Overall Study|Lost to Follow-up|0|||
149214563|NCT02290340|538252811|FG003|Overall Study|Lost to Follow-up|1|||
149214564|NCT02290340|538252808|FG000|Overall Study|Withdrawal by Subject|1|||
149214565|NCT02290340|538252809|FG001|Overall Study|Withdrawal by Subject|0|||
149214566|NCT02290340|538252810|FG002|Overall Study|Withdrawal by Subject|0|||
149214567|NCT02290340|538252811|FG003|Overall Study|Withdrawal by Subject|0|||
149214568|NCT02290340|538252808|FG000|Overall Study|Other|1|||
149214569|NCT02290340|538252809|FG001|Overall Study|Other|0|||
149214570|NCT02290340|538252810|FG002|Overall Study|Other|0|||
149214571|NCT02290340|538252811|FG003|Overall Study|Other|1|||
149214572|NCT03209362|538252813|FG000|Overall Study|Adverse Event|0|||
148684583|NCT01393990|536319426|FG004|Overall Study|Withdrawal by Subject|0|||
148684584|NCT01393990|536319427|FG005|Overall Study|Withdrawal by Subject|0|||
148684585|NCT01393990|536319428|FG006|Overall Study|Withdrawal by Subject|0|||
148684586|NCT01393990|536319429|FG007|Overall Study|Withdrawal by Subject|0|||
149214573|NCT03209362|538252814|FG001|Overall Study|Adverse Event|1|||
149214574|NCT03209362|538252813|FG000|Overall Study|Lost to Follow-up|0|||
149214575|NCT03209362|538252814|FG001|Overall Study|Lost to Follow-up|1|||
149214576|NCT03209362|538252813|FG000|Overall Study|Withdrawal by Subject|2|||
149214577|NCT03209362|538252814|FG001|Overall Study|Withdrawal by Subject|0|||
148684587|NCT01393990|536319430|FG008|Overall Study|Withdrawal by Subject|0|||
149214578|NCT03209362|538252813|FG000|Overall Study|Other|0|||
149214579|NCT03209362|538252814|FG001|Overall Study|Other|1|||
149214580|NCT00251589|538252815|FG000|Overall Study|Adverse Event|5|||
149214581|NCT00251589|538252816|FG001|Overall Study|Adverse Event|1|||
149214582|NCT00251589|538252817|FG002|Overall Study|Adverse Event|2|||
148684588|NCT01393990|536319431|FG009|Overall Study|Withdrawal by Subject|0|||
149214583|NCT00251589|538252818|FG003|Overall Study|Adverse Event|1|||
149214584|NCT00251589|538252815|FG000|Overall Study|Withdrawal by Subject|1|||
149214585|NCT00251589|538252816|FG001|Overall Study|Withdrawal by Subject|1|||
149214586|NCT00251589|538252817|FG002|Overall Study|Withdrawal by Subject|0|||
149214587|NCT00251589|538252818|FG003|Overall Study|Withdrawal by Subject|0|||
149214588|NCT00251589|538252815|FG000|Overall Study|Discontinued due to progressive disease|9|||
148950591|NCT02207244|537299703|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
148950592|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950593|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950594|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950595|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
149214589|NCT00251589|538252816|FG001|Overall Study|Discontinued due to progressive disease|1|||
149214590|NCT00251589|538252817|FG002|Overall Study|Discontinued due to progressive disease|0|||
149214591|NCT00251589|538252818|FG003|Overall Study|Discontinued due to progressive disease|1|||
149214592|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Adverse Event|22|||
149214593|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Adverse Event|0|||
149214594|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
149214595|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
149214596|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
149214597|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
149214598|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
149214599|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
149214600|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
149214601|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
149214602|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
149214603|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
149214604|NCT02493868|538252821|FG000|Induction Phase: DE Participants|Other|8|||
149214605|NCT02493868|538252822|FG001|Induction Phase: DE Participants|Other|0|||
149214606|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
149214607|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
149214608|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
149214609|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
149214610|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
149214611|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
149214612|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
149214613|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
149214614|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
149214615|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
149214616|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
149214617|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
149214618|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
149214619|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
149214620|NCT02493868|538252821|FG000|Optimization Phase: DE+TE Participants|Other|10|||
149214621|NCT02493868|538252822|FG001|Optimization Phase: DE+TE Participants|Other|2|||
149214622|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
149214623|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
149214624|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
149214625|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
149214626|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
149214627|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
149214628|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
149214629|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
149214630|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
149214631|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
149214632|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
149214633|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
149214634|NCT02493868|538252821|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
149214635|NCT02493868|538252822|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
148950596|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950597|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950598|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950599|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950600|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
148950601|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
148950602|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
148684589|NCT01393990|536319432|FG010|Overall Study|Withdrawal by Subject|0|||
148684590|NCT01393990|536319433|FG011|Overall Study|Withdrawal by Subject|0|||
148684591|NCT01393990|536319434|FG012|Overall Study|Withdrawal by Subject|0|||
148684592|NCT01393990|536319435|FG013|Overall Study|Withdrawal by Subject|0|||
148684593|NCT01393990|536319436|FG014|Overall Study|Withdrawal by Subject|1|||
148684594|NCT01393990|536319437|FG015|Overall Study|Withdrawal by Subject|1|||
148684595|NCT01393990|536319438|FG016|Overall Study|Withdrawal by Subject|0|||
148684596|NCT01393990|536319439|FG017|Overall Study|Withdrawal by Subject|0|||
148684597|NCT00720798|536319446|FG000|Overall Study|Adverse Event|304|||
148684598|NCT00720798|536319446|FG000|Overall Study|Death|39|||
148684599|NCT00720798|536319446|FG000|Overall Study|Insufficient Therapeutic Response|129|||
148684600|NCT00720798|536319446|FG000|Overall Study|Protocol Violation|4|||
148684601|NCT00720798|536319446|FG000|Overall Study|Refused Treatment|151|||
148684602|NCT00720798|536319446|FG000|Overall Study|Failure to Return|46|||
148684603|NCT00720798|536319446|FG000|Overall Study|Reason not Specified|83|||
148684604|NCT00433381|536319447|FG000|Overall Study|Ineligible / no protocol treatment|3|||
148684605|NCT00433381|536319448|FG001|Overall Study|Ineligible / no protocol treatment|3|||
148684606|NCT00434161|536319451|FG000|Overall Study|Adverse Event|5|||
148684607|NCT00434161|536319452|FG001|Overall Study|Adverse Event|1|||
148684608|NCT00434161|536319453|FG002|Overall Study|Adverse Event|4|||
148684609|NCT00434161|536319451|FG000|Overall Study|Lost to Follow-up|0|||
148684610|NCT00434161|536319452|FG001|Overall Study|Lost to Follow-up|1|||
148684611|NCT00434161|536319453|FG002|Overall Study|Lost to Follow-up|0|||
148684612|NCT00434161|536319451|FG000|Overall Study|Death|1|||
148950603|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950604|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950605|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950606|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950607|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950608|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950609|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950610|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950611|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
149016705|NCT03685708|537540884|FG000|Overall Study|COVID 19 Pandemic|1|||
149214636|NCT02493868|538252821|FG000|Follow-up Phase|Lost to Follow-up|1|||
149214637|NCT02493868|538252822|FG001|Follow-up Phase|Lost to Follow-up|0|||
149214638|NCT02493868|538252821|FG000|Follow-up Phase|Withdrawal by Subject|3|||
149214639|NCT02493868|538252822|FG001|Follow-up Phase|Withdrawal by Subject|0|||
149214640|NCT02493868|538252821|FG000|Follow-up Phase|Investigator Decision|5|||
149214641|NCT02493868|538252822|FG001|Follow-up Phase|Investigator Decision|1|||
149214642|NCT02493868|538252821|FG000|Follow-up Phase|Other|2|||
149214643|NCT02493868|538252822|FG001|Follow-up Phase|Other|1|||
149214644|NCT02407236|538252823|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
149214645|NCT02407236|538252824|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
149214646|NCT02407236|538252825|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
149214647|NCT02407236|538252826|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
149214648|NCT02407236|538252827|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
149214649|NCT02407236|538252828|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
149214650|NCT02407236|538252829|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
149214651|NCT02407236|538252830|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
149214652|NCT02407236|538252831|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
149214653|NCT02407236|538252832|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
149214654|NCT02407236|538252833|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
149214655|NCT02407236|538252834|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
148684613|NCT00434161|536319452|FG001|Overall Study|Death|0|||
148684614|NCT00434161|536319453|FG002|Overall Study|Death|1|||
148950612|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
148950613|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
148950614|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950615|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950616|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950617|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950618|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
149214656|NCT02407236|538252835|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
149214657|NCT02407236|538252823|FG000|Induction Study (8 Weeks)|Death|0|||
149214658|NCT02407236|538252824|FG001|Induction Study (8 Weeks)|Death|0|||
149214659|NCT02407236|538252825|FG002|Induction Study (8 Weeks)|Death|1|||
149214660|NCT02407236|538252826|FG003|Induction Study (8 Weeks)|Death|0|||
149214661|NCT02407236|538252827|FG004|Induction Study (8 Weeks)|Death|0|||
149214662|NCT02407236|538252828|FG005|Induction Study (8 Weeks)|Death|0|||
149214663|NCT02407236|538252829|FG006|Induction Study (8 Weeks)|Death|0|||
149214664|NCT02407236|538252830|FG007|Induction Study (8 Weeks)|Death|0|||
149214665|NCT02407236|538252831|FG008|Induction Study (8 Weeks)|Death|0|||
149214666|NCT02407236|538252832|FG009|Induction Study (8 Weeks)|Death|0|||
149214667|NCT02407236|538252833|FG010|Induction Study (8 Weeks)|Death|0|||
149214668|NCT02407236|538252834|FG011|Induction Study (8 Weeks)|Death|0|||
149214669|NCT02407236|538252835|FG012|Induction Study (8 Weeks)|Death|0|||
149214670|NCT02407236|538252823|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
149214671|NCT02407236|538252824|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
149214672|NCT02407236|538252825|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
149214673|NCT02407236|538252826|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214674|NCT02407236|538252827|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214675|NCT02407236|538252828|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214676|NCT02407236|538252829|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214677|NCT02407236|538252830|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214678|NCT02407236|538252831|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
148950619|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950620|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950621|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950622|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
148950623|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
148950624|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
148950625|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950626|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950627|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950628|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950629|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950630|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950631|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950632|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950633|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
148950634|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
148950635|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
148950636|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
148950637|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
148950638|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
148950639|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
148950640|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
149214679|NCT02407236|538252832|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214680|NCT02407236|538252833|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214681|NCT02407236|538252834|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214682|NCT02407236|538252835|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
149214683|NCT02407236|538252823|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214684|NCT02407236|538252824|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214685|NCT02407236|538252825|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
149214686|NCT02407236|538252826|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214687|NCT02407236|538252827|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214688|NCT02407236|538252828|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
148950641|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
148950642|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
148950643|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
149214689|NCT02407236|538252829|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214690|NCT02407236|538252830|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214691|NCT02407236|538252831|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214692|NCT02407236|538252832|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214693|NCT02407236|538252833|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214694|NCT02407236|538252834|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
149214695|NCT02407236|538252835|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
148950644|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
148950645|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
148950646|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
148950647|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
148950648|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
148950649|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
148950650|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
148950651|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
148950652|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
148950653|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
148950654|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
148950655|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
148950656|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
148950657|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
148950658|NCT02207244|537299693|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950659|NCT02207244|537299694|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950660|NCT02207244|537299695|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950661|NCT02207244|537299696|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950662|NCT02207244|537299697|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950663|NCT02207244|537299698|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950664|NCT02207244|537299699|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950665|NCT02207244|537299700|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950666|NCT02207244|537299701|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950667|NCT02207244|537299702|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
148950668|NCT02207244|537299703|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
148950669|NCT02216591|537299704|FG000|Overall Study|Lost to Follow-up|0|||
148950670|NCT02216591|537299705|FG001|Overall Study|Lost to Follow-up|1|||
148950671|NCT01950741|537299710|FG000|Overall Study|Lost to Follow-up|1|||
148950672|NCT01950741|537299710|FG000|Overall Study|Death|1|||
148950673|NCT01950741|537299710|FG000|Overall Study|Withdrawal by Subject|1|||
148950674|NCT02854631|537299713|FG000|Overall Study|Adverse Event|1|||
148950675|NCT02854631|537299714|FG001|Overall Study|Adverse Event|2|||
148950676|NCT02854631|537299713|FG000|Overall Study|Withdrew Consent|3|||
148950677|NCT02854631|537299714|FG001|Overall Study|Withdrew Consent|2|||
148950678|NCT02854631|537299713|FG000|Overall Study|Investigator's Discretion|2|||
148950679|NCT02854631|537299714|FG001|Overall Study|Investigator's Discretion|0|||
148950680|NCT02854631|537299713|FG000|Overall Study|Death|12|||
148950681|NCT02854631|537299714|FG001|Overall Study|Death|8|||
148950682|NCT02854631|537299713|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
148950683|NCT02854631|537299714|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
148950684|NCT02854631|537299713|FG000|Overall Study|Protocol Violation|0|||
148950685|NCT02854631|537299714|FG001|Overall Study|Protocol Violation|1|||
148950686|NCT02854631|537299713|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
148950687|NCT02854631|537299714|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
148950688|NCT02854631|537299713|FG000|Overall Study|Lost to Follow-up|4|||
148950689|NCT02854631|537299714|FG001|Overall Study|Lost to Follow-up|2|||
148950690|NCT01962896|537299715|FG000|Overall Study|Lack of Efficacy|4|||
148950691|NCT02837783|537299716|FG000|Overall Study|Adverse Event|1|||
148950692|NCT02837783|537299717|FG001|Overall Study|Adverse Event|0|||
148950693|NCT02837783|537299716|FG000|Overall Study|Other, Not Specified|1|||
148950694|NCT02837783|537299717|FG001|Overall Study|Other, Not Specified|2|||
148950695|NCT02233647|537299718|FG000|Overall Study|Adverse Event|1|||
148950696|NCT00621153|537299722|FG000|Overall Study|Safety Reason|8|||
148950697|NCT00621153|537299723|FG001|Overall Study|Safety Reason|7|||
148950698|NCT00621153|537299722|FG000|Overall Study|Adverse Event|3|||
148950699|NCT00621153|537299723|FG001|Overall Study|Adverse Event|2|||
148950700|NCT00621153|537299722|FG000|Overall Study|Lost to Follow-up|5|||
148950701|NCT00621153|537299723|FG001|Overall Study|Lost to Follow-up|1|||
148950702|NCT00621153|537299722|FG000|Overall Study|Withdrawal by Subject|4|||
148950703|NCT00621153|537299723|FG001|Overall Study|Withdrawal by Subject|5|||
148950704|NCT00598832|537299728|FG000|Overall Study|Lack of Efficacy|3|||
149214696|NCT02407236|538252823|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
149214697|NCT02407236|538252824|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
149214698|NCT02407236|538252825|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
149214699|NCT02407236|538252826|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
149214700|NCT02407236|538252827|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
149214701|NCT02407236|538252828|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
148950705|NCT00598832|537299729|FG001|Overall Study|Lack of Efficacy|7|||
148950706|NCT00598832|537299728|FG000|Overall Study|Adverse Event|6|||
148950707|NCT00598832|537299729|FG001|Overall Study|Adverse Event|2|||
148950708|NCT00598832|537299728|FG000|Overall Study|Withdrawal by Subject|25|||
148950709|NCT00598832|537299729|FG001|Overall Study|Withdrawal by Subject|36|||
148950710|NCT00598832|537299728|FG000|Overall Study|Protocol Violation|0|||
149214702|NCT02407236|538252829|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
149214703|NCT02407236|538252830|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
149214704|NCT02407236|538252831|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
149214705|NCT02407236|538252832|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
149214706|NCT02407236|538252833|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
149214707|NCT02407236|538252834|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
149214708|NCT02407236|538252835|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
148950711|NCT00598832|537299729|FG001|Overall Study|Protocol Violation|2|||
148950712|NCT00598832|537299728|FG000|Overall Study|Lost to Follow-up|24|||
148950713|NCT00598832|537299729|FG001|Overall Study|Lost to Follow-up|29|||
148950714|NCT00598832|537299728|FG000|Overall Study|Pregnancy|2|||
148950715|NCT00598832|537299729|FG001|Overall Study|Pregnancy|2|||
148950716|NCT00598832|537299728|FG000|Overall Study|Physician Decision|1|||
148950717|NCT00598832|537299729|FG001|Overall Study|Physician Decision|4|||
148950718|NCT00598832|537299728|FG000|Overall Study|Non compliance|1|||
148950719|NCT00598832|537299729|FG001|Overall Study|Non compliance|0|||
148950720|NCT00357968|537299733|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
148950721|NCT00357968|537299734|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
148950722|NCT00357968|537299733|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
148950723|NCT00357968|537299734|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
148950724|NCT02142959|537299740|FG000|Overall Study|Adverse Event|1|||
148950725|NCT02142959|537299741|FG001|Overall Study|Adverse Event|0|||
148950726|NCT02142959|537299742|FG002|Overall Study|Adverse Event|0|||
148950727|NCT02142959|537299740|FG000|Overall Study|Death|0|||
148950728|NCT02142959|537299741|FG001|Overall Study|Death|1|||
148950729|NCT02142959|537299742|FG002|Overall Study|Death|0|||
148950730|NCT02142959|537299740|FG000|Overall Study|Withdrawal by Subject|3|||
148950731|NCT02142959|537299741|FG001|Overall Study|Withdrawal by Subject|1|||
148950732|NCT02142959|537299742|FG002|Overall Study|Withdrawal by Subject|3|||
148950733|NCT02142959|537299740|FG000|Overall Study|Administrative Reasons|1|||
148950734|NCT02142959|537299741|FG001|Overall Study|Administrative Reasons|0|||
148950735|NCT02142959|537299742|FG002|Overall Study|Administrative Reasons|1|||
148950736|NCT02142959|537299740|FG000|Overall Study|Missing|0|||
148950737|NCT02142959|537299741|FG001|Overall Study|Missing|1|||
148950738|NCT02142959|537299742|FG002|Overall Study|Missing|0|||
148950739|NCT02142959|537299740|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
148950740|NCT02142959|537299741|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
148950741|NCT02142959|537299742|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
148950742|NCT02142959|537299740|FG000|Overall Study|Patient didn't complete end of study visit|0|||
148950743|NCT02142959|537299741|FG001|Overall Study|Patient didn't complete end of study visit|0|||
148950744|NCT02142959|537299742|FG002|Overall Study|Patient didn't complete end of study visit|1|||
148950745|NCT00679302|537299743|FG000|Overall Study|Lost to Follow-up|8|||
148950746|NCT00679302|537299744|FG001|Overall Study|Lost to Follow-up|4|||
148950747|NCT03547687|537299745|FG000|Overall Study|Withdrawal by Subject|1|||
148950748|NCT03547687|537299745|FG000|Overall Study|Death|1|||
148956494|NCT01949051|537324443|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
148956495|NCT01949051|537324444|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
148956496|NCT01949051|537324445|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
148956497|NCT01949051|537324446|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
148956498|NCT01949051|537324447|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
148956499|NCT01949051|537324442|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
148956500|NCT01949051|537324443|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
148956501|NCT01949051|537324444|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
149016706|NCT03685708|537540885|FG001|Overall Study|COVID 19 Pandemic|1|||
149214709|NCT02407236|538252823|FG000|Induction Study (8 Weeks)|Other|2|||
149214710|NCT02407236|538252824|FG001|Induction Study (8 Weeks)|Other|1|||
149214711|NCT02407236|538252825|FG002|Induction Study (8 Weeks)|Other|5|||
149214712|NCT02407236|538252826|FG003|Induction Study (8 Weeks)|Other|0|||
149214713|NCT02407236|538252827|FG004|Induction Study (8 Weeks)|Other|0|||
149214714|NCT02407236|538252828|FG005|Induction Study (8 Weeks)|Other|0|||
149214715|NCT02407236|538252829|FG006|Induction Study (8 Weeks)|Other|0|||
149214716|NCT02407236|538252830|FG007|Induction Study (8 Weeks)|Other|0|||
149214717|NCT02407236|538252831|FG008|Induction Study (8 Weeks)|Other|0|||
148956502|NCT01949051|537324445|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
148956503|NCT01949051|537324446|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
148956504|NCT01949051|537324447|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
148956505|NCT01506479|537324449|FG000|Overall Study|Lost to Follow-up|1|||
148956506|NCT01506479|537324450|FG001|Overall Study|Lost to Follow-up|2|||
148956507|NCT01506479|537324451|FG002|Overall Study|Lost to Follow-up|2|||
148956508|NCT01506479|537324449|FG000|Overall Study|Withdrawal by Subject|1|||
149016707|NCT03685708|537540886|FG002|Overall Study|COVID 19 Pandemic|6|||
149214718|NCT02407236|538252832|FG009|Induction Study (8 Weeks)|Other|0|||
149214719|NCT02407236|538252833|FG010|Induction Study (8 Weeks)|Other|0|||
149214720|NCT02407236|538252834|FG011|Induction Study (8 Weeks)|Other|0|||
149214721|NCT02407236|538252835|FG012|Induction Study (8 Weeks)|Other|0|||
149016708|NCT03685708|537540884|FG000|Overall Study|Disease Progression|0|||
149016709|NCT03685708|537540885|FG001|Overall Study|Disease Progression|0|||
149016710|NCT03685708|537540886|FG002|Overall Study|Disease Progression|1|||
149016711|NCT02771210|537540890|FG000|Period 1|Adverse Event|5|||
149016712|NCT02771210|537540891|FG001|Period 1|Adverse Event|3|||
149016713|NCT02771210|537540890|FG000|Period 1|Lack of Efficacy|3|||
149016714|NCT02771210|537540891|FG001|Period 1|Lack of Efficacy|6|||
149016715|NCT02771210|537540890|FG000|Period 1|Lost to Follow-up|2|||
149016716|NCT02771210|537540891|FG001|Period 1|Lost to Follow-up|0|||
149016717|NCT02771210|537540890|FG000|Period 1|Physician Decision|0|||
149016718|NCT02771210|537540891|FG001|Period 1|Physician Decision|1|||
149016719|NCT02771210|537540890|FG000|Period 1|Withdrawal by Subject|0|||
149016720|NCT02771210|537540891|FG001|Period 1|Withdrawal by Subject|3|||
149016721|NCT02771210|537540890|FG000|Period 1|Withdrawal of informed consent|1|||
149016722|NCT02771210|537540891|FG001|Period 1|Withdrawal of informed consent|5|||
149016723|NCT02771210|537540890|FG000|Period 2|Adverse Event|1|||
149016724|NCT02771210|537540891|FG001|Period 2|Adverse Event|0|||
149016725|NCT02771210|537540890|FG000|Period 2|Lack of Efficacy|0|||
149016726|NCT02771210|537540891|FG001|Period 2|Lack of Efficacy|1|||
149016727|NCT02771210|537540890|FG000|Period 2|Withdrawal by Subject|1|||
149016728|NCT02771210|537540891|FG001|Period 2|Withdrawal by Subject|0|||
149016729|NCT02771210|537540890|FG000|Period 2|Withdrawal of informed consent|0|||
149016730|NCT02771210|537540891|FG001|Period 2|Withdrawal of informed consent|2|||
149016731|NCT01744496|537540896|FG000|Titration Period|Adverse Event|2|||
149016732|NCT01744496|537540897|FG001|Titration Period|Adverse Event|1|||
149016733|NCT01744496|537540896|FG000|Titration Period|Personal reasons|0|||
149016734|NCT01744496|537540897|FG001|Titration Period|Personal reasons|1|||
149016735|NCT01744496|537540896|FG000|Maintenance Period|Adverse Event|1|||
149016736|NCT01744496|537540897|FG001|Maintenance Period|Adverse Event|3|||
149016737|NCT01744496|537540896|FG000|Maintenance Period|Protocol Violation|1|||
149016738|NCT01744496|537540897|FG001|Maintenance Period|Protocol Violation|0|||
149016739|NCT01744496|537540896|FG000|Maintenance Period|Withdrawal by Subject|1|||
149016740|NCT01744496|537540897|FG001|Maintenance Period|Withdrawal by Subject|1|||
149016741|NCT01744496|537540896|FG000|Maintenance Period|Subject left town|1|||
149016742|NCT01744496|537540897|FG001|Maintenance Period|Subject left town|0|||
149016743|NCT01729728|537540898|FG000|Overall Study|Adverse Event|0|||
149016744|NCT01729728|537540899|FG001|Overall Study|Adverse Event|6|||
149016745|NCT01729728|537540900|FG002|Overall Study|Adverse Event|0|||
149016746|NCT01729728|537540898|FG000|Overall Study|Protocol Violation|1|||
149016747|NCT01729728|537540899|FG001|Overall Study|Protocol Violation|0|||
149016748|NCT01729728|537540900|FG002|Overall Study|Protocol Violation|1|||
149016749|NCT03772314|537540901|FG000|Overall Study|Adverse Event|7|||
149016750|NCT03772314|537540902|FG001|Overall Study|Adverse Event|2|||
149016751|NCT00672958|537540903|FG000|Overall Study|Adverse Event|11|||
149016752|NCT00672958|537540904|FG001|Overall Study|Adverse Event|9|||
149016753|NCT00672958|537540903|FG000|Overall Study|Lack of Efficacy|6|||
149016754|NCT00672958|537540904|FG001|Overall Study|Lack of Efficacy|11|||
148809659|NCT02566005|536780820|FG001|Overall Study|did not receive foley|1|||
148809660|NCT02566005|536780819|FG000|Overall Study|labor after randomization|0|||
149016755|NCT00672958|537540903|FG000|Overall Study|Non-compliance with study drug|2|||
148809661|NCT02566005|536780820|FG001|Overall Study|labor after randomization|4|||
149016756|NCT00672958|537540904|FG001|Overall Study|Non-compliance with study drug|3|||
149016757|NCT00672958|537540903|FG000|Overall Study|Protocol deviations|11|||
149016758|NCT00672958|537540904|FG001|Overall Study|Protocol deviations|5|||
149016759|NCT00672958|537540903|FG000|Overall Study|Voluntary withdrawal|12|||
149016760|NCT00672958|537540904|FG001|Overall Study|Voluntary withdrawal|8|||
149016761|NCT00672958|537540903|FG000|Overall Study|Lost to Follow-up|22|||
149016762|NCT00672958|537540904|FG001|Overall Study|Lost to Follow-up|17|||
149016763|NCT00672958|537540903|FG000|Overall Study|Reason not specified|0|||
149016764|NCT00672958|537540904|FG001|Overall Study|Reason not specified|3|||
149016765|NCT04422639|537540905|FG000|Overall Study|Death|1|||
149016766|NCT04422639|537540906|FG001|Overall Study|Death|0|||
149016767|NCT04422639|537540905|FG000|Overall Study|study closed prior to completion of FU visits|0|||
149016768|NCT04422639|537540906|FG001|Overall Study|study closed prior to completion of FU visits|2|||
149016769|NCT01964521|537540907|FG000|Overall Study|Lost to Follow-up|4|||
149016770|NCT02796963|537540908|FG000|Overall Study|Lost to Follow-up|89|||
149016771|NCT02796963|537540909|FG001|Overall Study|Lost to Follow-up|76|||
149016772|NCT02796963|537540910|FG002|Overall Study|Lost to Follow-up|69|||
148809662|NCT03095287|536780821|FG000|Overall Study|Treatment Failure|1|||
149016773|NCT02796963|537540911|FG003|Overall Study|Lost to Follow-up|72|||
149016774|NCT00119262|537540915|FG000|Overall Study|Lack of Efficacy|0|||
149016775|NCT00119262|537540916|FG001|Overall Study|Lack of Efficacy|3|||
148809663|NCT03095287|536780821|FG000|Overall Study|Adverse Event|1|||
149016776|NCT00119262|537540915|FG000|Overall Study|Withdrawal by Subject|12|||
149016777|NCT00119262|537540916|FG001|Overall Study|Withdrawal by Subject|11|||
149016778|NCT00119262|537540915|FG000|Overall Study|Adverse Event|33|||
149016779|NCT00119262|537540916|FG001|Overall Study|Adverse Event|35|||
149016780|NCT00119262|537540915|FG000|Overall Study|other disease|0|||
149016781|NCT00119262|537540916|FG001|Overall Study|other disease|2|||
149016782|NCT00119262|537540915|FG000|Overall Study|ineligble|1|||
149016783|NCT00119262|537540916|FG001|Overall Study|ineligble|2|||
149016784|NCT00119262|537540915|FG000|Overall Study|others|0|||
149016785|NCT00119262|537540916|FG001|Overall Study|others|5|||
149016786|NCT00988351|537540917|FG000|Overall Study|Withdrawal by Subject|8|||
149016787|NCT00988351|537540918|FG001|Overall Study|Withdrawal by Subject|0|||
149016788|NCT00988351|537540917|FG000|Overall Study|Lost to Follow-up|6|||
149016789|NCT00988351|537540918|FG001|Overall Study|Lost to Follow-up|9|||
149016790|NCT00988351|537540917|FG000|Overall Study|not using CPAP|5|||
149016791|NCT00988351|537540918|FG001|Overall Study|not using CPAP|3|||
149016792|NCT03853317|537540919|FG000|Overall Study|Progressive Disease|5|||
149016793|NCT03853317|537540919|FG000|Overall Study|Adverse Event|1|||
149016794|NCT03853317|537540919|FG000|Overall Study|Death|1|||
149016795|NCT03853317|537540919|FG000|Overall Study|other event|2|||
148950749|NCT01852110|537301386|FG000|Overall Study|Adverse Event|12|||
148950750|NCT01852110|537301387|FG001|Overall Study|Adverse Event|5|||
148950751|NCT01852110|537301388|FG002|Overall Study|Adverse Event|0|||
148950752|NCT01852110|537301389|FG003|Overall Study|Adverse Event|0|||
148950753|NCT01852110|537301390|FG004|Overall Study|Adverse Event|0|||
148950754|NCT01852110|537301391|FG005|Overall Study|Adverse Event|0|||
148950755|NCT01852110|537301386|FG000|Overall Study|Lost to Follow-up|1|||
148950756|NCT01852110|537301387|FG001|Overall Study|Lost to Follow-up|3|||
148950757|NCT01852110|537301388|FG002|Overall Study|Lost to Follow-up|0|||
148950758|NCT01852110|537301389|FG003|Overall Study|Lost to Follow-up|0|||
148950759|NCT01852110|537301390|FG004|Overall Study|Lost to Follow-up|0|||
148950760|NCT01852110|537301391|FG005|Overall Study|Lost to Follow-up|0|||
148950761|NCT01852110|537301386|FG000|Overall Study|Non-compliance with Study Drug|2|||
149016796|NCT01630590|537540933|FG000|Overall Study|Adverse Event|9|||
149016797|NCT01630590|537540933|FG000|Overall Study|Lack of Efficacy|37|||
149016798|NCT01630590|537540933|FG000|Overall Study|Withdrawal by Subject|4|||
149016799|NCT01630590|537540933|FG000|Overall Study|2nd primary tumor|2|||
149016800|NCT01630590|537540933|FG000|Overall Study|Automobile accident|1|||
149016801|NCT01630590|537540933|FG000|Overall Study|Maximum benefit|4|||
149016802|NCT02366936|537540937|FG000|Overall Study|Withdrawal by Subject|2|||
149016803|NCT02366936|537540937|FG000|Overall Study|Lost to Follow-up|4|||
149016804|NCT02366936|537540937|FG000|Overall Study|Physician Decision|2|||
149016805|NCT02878213|537540938|FG000|Overall Study|Withdrawal by Subject|2|||
149016806|NCT02878213|537540938|FG000|Overall Study|Adverse Event|1|||
149016807|NCT02141659|537540944|FG000|Overall Study|Major Protocol Deviation|0|||
149016808|NCT02141659|537540945|FG001|Overall Study|Major Protocol Deviation|1|||
149016809|NCT02141659|537540946|FG002|Overall Study|Major Protocol Deviation|0|||
149016810|NCT02141659|537540947|FG003|Overall Study|Major Protocol Deviation|0|||
149016811|NCT02141659|537540948|FG004|Overall Study|Major Protocol Deviation|0|||
149016812|NCT02141659|537540949|FG005|Overall Study|Major Protocol Deviation|0|||
149016813|NCT02141659|537540944|FG000|Overall Study|Lack of Efficacy|0|||
149016814|NCT02141659|537540945|FG001|Overall Study|Lack of Efficacy|0|||
149016815|NCT02141659|537540946|FG002|Overall Study|Lack of Efficacy|0|||
149016816|NCT02141659|537540947|FG003|Overall Study|Lack of Efficacy|0|||
149016817|NCT02141659|537540948|FG004|Overall Study|Lack of Efficacy|0|||
149016818|NCT02141659|537540949|FG005|Overall Study|Lack of Efficacy|1|||
149016819|NCT02141659|537540944|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
149016820|NCT02141659|537540945|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
149016821|NCT02141659|537540946|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
149016822|NCT02141659|537540947|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
149016823|NCT02141659|537540948|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
149016824|NCT02141659|537540949|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
149016825|NCT02471404|537540952|FG000|Overall Study|Adverse Event|7|||
149016826|NCT02471404|537540953|FG001|Overall Study|Adverse Event|1|||
149016827|NCT02471404|537540954|FG002|Overall Study|Adverse Event|2|||
149016828|NCT02471404|537540952|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
149016829|NCT02471404|537540953|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
149016830|NCT02471404|537540954|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
149016831|NCT02471404|537540952|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
149016832|NCT02471404|537540953|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
149016833|NCT02471404|537540954|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
148950762|NCT01852110|537301387|FG001|Overall Study|Non-compliance with Study Drug|1|||
148950763|NCT01852110|537301388|FG002|Overall Study|Non-compliance with Study Drug|0|||
148950764|NCT01852110|537301389|FG003|Overall Study|Non-compliance with Study Drug|0|||
149016834|NCT02471404|537540952|FG000|Overall Study|Lost to Follow-up|1|||
149016835|NCT02471404|537540953|FG001|Overall Study|Lost to Follow-up|1|||
149016836|NCT02471404|537540954|FG002|Overall Study|Lost to Follow-up|3|||
149016837|NCT02471404|537540952|FG000|Overall Study|Protocol Violation|1|||
149016838|NCT02471404|537540953|FG001|Overall Study|Protocol Violation|0|||
149016839|NCT02471404|537540954|FG002|Overall Study|Protocol Violation|0|||
149016840|NCT02471404|537540952|FG000|Overall Study|Withdrawal by Subject|8|||
149016841|NCT02471404|537540953|FG001|Overall Study|Withdrawal by Subject|4|||
149016842|NCT02471404|537540954|FG002|Overall Study|Withdrawal by Subject|5|||
149016843|NCT02471404|537540952|FG000|Overall Study|Other reasons not specified|10|||
149214722|NCT02407236|538252823|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
149214723|NCT02407236|538252824|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
149214724|NCT02407236|538252825|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
149214725|NCT02407236|538252826|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
149214726|NCT02407236|538252827|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
149214727|NCT02407236|538252828|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
149214728|NCT02407236|538252829|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
149214729|NCT02407236|538252830|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
149214730|NCT02407236|538252831|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
149214731|NCT02407236|538252832|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
148809664|NCT01294514|536780824|FG000|Overall Study|Excluded due to Arrhythmia|1|||
148809665|NCT00984867|536780829|FG000|Overall Study|Adverse Event|3|||
148809666|NCT00984867|536780830|FG001|Overall Study|Adverse Event|7|||
148950765|NCT01852110|537301390|FG004|Overall Study|Non-compliance with Study Drug|0|||
148950766|NCT01852110|537301391|FG005|Overall Study|Non-compliance with Study Drug|0|||
148950767|NCT01852110|537301386|FG000|Overall Study|Physician Decision|1|||
148950768|NCT01852110|537301387|FG001|Overall Study|Physician Decision|0|||
148950769|NCT01852110|537301388|FG002|Overall Study|Physician Decision|0|||
148950770|NCT01852110|537301389|FG003|Overall Study|Physician Decision|0|||
148950771|NCT01852110|537301390|FG004|Overall Study|Physician Decision|0|||
148950772|NCT01852110|537301391|FG005|Overall Study|Physician Decision|0|||
148950773|NCT01852110|537301386|FG000|Overall Study|Protocol Violation|0|||
148950774|NCT01852110|537301387|FG001|Overall Study|Protocol Violation|1|||
148950775|NCT01852110|537301388|FG002|Overall Study|Protocol Violation|0|||
148950776|NCT01852110|537301389|FG003|Overall Study|Protocol Violation|0|||
148950777|NCT01852110|537301390|FG004|Overall Study|Protocol Violation|0|||
148950778|NCT01852110|537301391|FG005|Overall Study|Protocol Violation|0|||
148950779|NCT01852110|537301386|FG000|Overall Study|Study Terminated by Sponsor|30|||
148950780|NCT01852110|537301387|FG001|Overall Study|Study Terminated by Sponsor|32|||
148950781|NCT01852110|537301388|FG002|Overall Study|Study Terminated by Sponsor|0|||
148950782|NCT01852110|537301389|FG003|Overall Study|Study Terminated by Sponsor|0|||
148950783|NCT01852110|537301390|FG004|Overall Study|Study Terminated by Sponsor|0|||
148950784|NCT01852110|537301391|FG005|Overall Study|Study Terminated by Sponsor|0|||
148950785|NCT01852110|537301386|FG000|Overall Study|Withdrawal by Subject|4|||
148950786|NCT01852110|537301387|FG001|Overall Study|Withdrawal by Subject|4|||
148950787|NCT01852110|537301388|FG002|Overall Study|Withdrawal by Subject|0|||
148950788|NCT01852110|537301389|FG003|Overall Study|Withdrawal by Subject|0|||
148950789|NCT01852110|537301390|FG004|Overall Study|Withdrawal by Subject|0|||
148950790|NCT01852110|537301391|FG005|Overall Study|Withdrawal by Subject|0|||
148950791|NCT00793403|537301392|FG000|Overall Study|Other|73|||
148950792|NCT02990910|537301397|FG000|Overall Study|Lack of Efficacy|6|||
148950793|NCT02990910|537301398|FG001|Overall Study|Lack of Efficacy|10|||
148950794|NCT02899988|537301401|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
148950795|NCT02899988|537301402|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
148950796|NCT02899988|537301403|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950797|NCT02899988|537301404|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950798|NCT02899988|537301405|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950799|NCT02899988|537301406|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950800|NCT02899988|537301407|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950801|NCT02899988|537301408|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950802|NCT02899988|537301409|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950803|NCT02899988|537301410|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950804|NCT02899988|537301411|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148950805|NCT02899988|537301401|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
148950806|NCT02899988|537301402|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
148950807|NCT02899988|537301403|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
148950808|NCT02899988|537301404|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
148950809|NCT02899988|537301405|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
148950810|NCT02899988|537301406|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
148950811|NCT02899988|537301407|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
148950812|NCT02899988|537301408|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
148950813|NCT02899988|537301409|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
148950814|NCT02899988|537301410|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
148950815|NCT02899988|537301411|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
148950816|NCT02899988|537301401|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
148950817|NCT02899988|537301402|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
148950818|NCT02899988|537301403|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
148950819|NCT02899988|537301404|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
148950820|NCT02899988|537301405|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
148950821|NCT02899988|537301406|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
149214732|NCT02407236|538252833|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
148950822|NCT02899988|537301407|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
148950823|NCT02899988|537301408|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
148950824|NCT02899988|537301409|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
148950825|NCT02899988|537301410|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
148950826|NCT02899988|537301411|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
148950827|NCT02899988|537301401|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
148950828|NCT02899988|537301402|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
148950829|NCT02899988|537301403|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
148950830|NCT02899988|537301404|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
148950831|NCT02899988|537301405|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
148950832|NCT02899988|537301406|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
148950833|NCT02899988|537301407|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
148950834|NCT02899988|537301408|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
148950835|NCT02899988|537301409|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
148950836|NCT02899988|537301410|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
148950837|NCT02899988|537301411|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
148950838|NCT02899988|537301401|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950839|NCT02899988|537301402|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
149214733|NCT02407236|538252834|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
149214734|NCT02407236|538252835|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
149214735|NCT02407236|538252823|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214736|NCT02407236|538252824|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214737|NCT02407236|538252825|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214738|NCT02407236|538252826|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
149214739|NCT02407236|538252827|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
149214740|NCT02407236|538252828|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
149214741|NCT02407236|538252829|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
149214742|NCT02407236|538252830|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
149214743|NCT02407236|538252831|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214744|NCT02407236|538252832|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214745|NCT02407236|538252833|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214746|NCT02407236|538252834|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214747|NCT02407236|538252835|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
149214748|NCT02407236|538252823|FG000|Maintenance Study (44 Weeks)|Other|0|||
149214749|NCT02407236|538252824|FG001|Maintenance Study (44 Weeks)|Other|0|||
149214750|NCT02407236|538252825|FG002|Maintenance Study (44 Weeks)|Other|0|||
149214751|NCT02407236|538252826|FG003|Maintenance Study (44 Weeks)|Other|5|||
149214752|NCT02407236|538252827|FG004|Maintenance Study (44 Weeks)|Other|7|||
149214753|NCT02407236|538252828|FG005|Maintenance Study (44 Weeks)|Other|8|||
149214754|NCT02407236|538252829|FG006|Maintenance Study (44 Weeks)|Other|4|||
149214755|NCT02407236|538252830|FG007|Maintenance Study (44 Weeks)|Other|6|||
149214756|NCT02407236|538252831|FG008|Maintenance Study (44 Weeks)|Other|0|||
149214757|NCT02407236|538252832|FG009|Maintenance Study (44 Weeks)|Other|0|||
149214758|NCT02407236|538252833|FG010|Maintenance Study (44 Weeks)|Other|0|||
149214759|NCT02407236|538252834|FG011|Maintenance Study (44 Weeks)|Other|0|||
149214760|NCT02407236|538252835|FG012|Maintenance Study (44 Weeks)|Other|0|||
149214761|NCT02407236|538252823|FG000|Maintenance Study (44 Weeks)|Death|0|||
149214762|NCT02407236|538252824|FG001|Maintenance Study (44 Weeks)|Death|0|||
149214763|NCT02407236|538252825|FG002|Maintenance Study (44 Weeks)|Death|0|||
149214764|NCT02407236|538252826|FG003|Maintenance Study (44 Weeks)|Death|0|||
149214765|NCT02407236|538252827|FG004|Maintenance Study (44 Weeks)|Death|0|||
149214766|NCT02407236|538252828|FG005|Maintenance Study (44 Weeks)|Death|0|||
149214767|NCT02407236|538252829|FG006|Maintenance Study (44 Weeks)|Death|0|||
149214768|NCT02407236|538252830|FG007|Maintenance Study (44 Weeks)|Death|1|||
149214769|NCT02407236|538252831|FG008|Maintenance Study (44 Weeks)|Death|0|||
149214770|NCT02407236|538252832|FG009|Maintenance Study (44 Weeks)|Death|0|||
149214771|NCT02407236|538252833|FG010|Maintenance Study (44 Weeks)|Death|0|||
149214772|NCT02407236|538252834|FG011|Maintenance Study (44 Weeks)|Death|0|||
149214773|NCT02407236|538252835|FG012|Maintenance Study (44 Weeks)|Death|0|||
149214774|NCT02407236|538252823|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214775|NCT02407236|538252824|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214776|NCT02407236|538252825|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214777|NCT02407236|538252826|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214778|NCT02407236|538252827|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214779|NCT02407236|538252828|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214780|NCT02407236|538252829|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214781|NCT02407236|538252830|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
149214782|NCT02407236|538252831|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
149214783|NCT02407236|538252832|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
149214784|NCT02407236|538252833|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
149214785|NCT02407236|538252834|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
149214786|NCT02407236|538252835|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
148950840|NCT02899988|537301403|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950841|NCT02899988|537301404|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950842|NCT02899988|537301405|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950843|NCT02899988|537301406|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
148950844|NCT02899988|537301407|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950845|NCT02899988|537301408|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
148950846|NCT02899988|537301409|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950847|NCT02899988|537301410|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950848|NCT02899988|537301411|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
148950849|NCT02899988|537301401|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
148950850|NCT02899988|537301402|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
148950851|NCT02899988|537301403|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
148950852|NCT02899988|537301404|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
148950853|NCT02899988|537301405|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
148950854|NCT02899988|537301406|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
148950855|NCT02899988|537301407|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
148950856|NCT02899988|537301408|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
148950857|NCT02899988|537301409|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
148950858|NCT02899988|537301410|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
148950859|NCT02899988|537301411|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
148950860|NCT04271605|537301413|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
148950861|NCT02485301|537301414|FG000|Overall Study|Serious Adverse Events|2|||
148950862|NCT02485301|537301415|FG001|Overall Study|Serious Adverse Events|1|||
148950863|NCT02485301|537301414|FG000|Overall Study|Protocol Violation|0|||
148950864|NCT02485301|537301415|FG001|Overall Study|Protocol Violation|1|||
148950865|NCT02485301|537301414|FG000|Overall Study|Withdrawal by Subject|6|||
148950866|NCT02485301|537301415|FG001|Overall Study|Withdrawal by Subject|7|||
148950867|NCT02485301|537301414|FG000|Overall Study|Migrated/moved from study area|10|||
148950868|NCT02485301|537301415|FG001|Overall Study|Migrated/moved from study area|19|||
148950869|NCT02485301|537301414|FG000|Overall Study|Lost to Follow-up|17|||
148950870|NCT02485301|537301415|FG001|Overall Study|Lost to Follow-up|17|||
148950871|NCT02485301|537301414|FG000|Overall Study|Other|3|||
148950872|NCT02485301|537301415|FG001|Overall Study|Other|4|||
148950873|NCT01059825|537301419|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
148950874|NCT01059825|537301420|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
149016844|NCT02471404|537540953|FG001|Overall Study|Other reasons not specified|7|||
149016845|NCT02471404|537540954|FG002|Overall Study|Other reasons not specified|12|||
149016846|NCT01927731|537540955|FG000|Overall Study|Graft Failure|1|||
149016847|NCT01927731|537540956|FG001|Overall Study|Graft Failure|2|||
149016848|NCT01927731|537540955|FG000|Overall Study|Physician Decision|2|||
149016849|NCT01927731|537540956|FG001|Overall Study|Physician Decision|3|||
149016850|NCT01927731|537540955|FG000|Overall Study|Withdrawal by Subject|0|||
149016851|NCT01927731|537540956|FG001|Overall Study|Withdrawal by Subject|2|||
149016852|NCT01927731|537540955|FG000|Overall Study|Death|0|||
149016853|NCT01927731|537540956|FG001|Overall Study|Death|3|||
149016854|NCT00305864|537540959|FG000|Overall Study|Ineligible / No protocol treatment|0|||
149016855|NCT00305864|537540960|FG001|Overall Study|Ineligible / No protocol treatment|1|||
149016856|NCT00305864|537540961|FG002|Overall Study|Ineligible / No protocol treatment|1|||
149016857|NCT00305864|537540962|FG003|Overall Study|Ineligible / No protocol treatment|13|||
149016858|NCT01464255|537540965|FG000|Overall Study|unresolve corneal staining|0|||
149016859|NCT01464255|537540966|FG001|Overall Study|unresolve corneal staining|1|||
149016860|NCT02836613|537540967|FG000|Overall Study|Accidental drowning|1|||
149016861|NCT02836613|537540968|FG001|Overall Study|Accidental drowning|0|||
149016862|NCT02836613|537540967|FG000|Overall Study|Lost to Follow-up|0|||
149016863|NCT02836613|537540968|FG001|Overall Study|Lost to Follow-up|1|||
149016864|NCT02836613|537540967|FG000|Overall Study|Withdrawal by Subject|0|||
149016865|NCT02836613|537540968|FG001|Overall Study|Withdrawal by Subject|2|||
149016866|NCT03881059|537540969|FG000|Treatment Period - Part A|Adverse Event|1|||
149016867|NCT03881059|537540970|FG001|Treatment Period - Part A|Adverse Event|3|||
148684615|NCT00434161|536319451|FG000|Overall Study|Non-Compliance|1|||
148684616|NCT00434161|536319452|FG001|Overall Study|Non-Compliance|1|||
148684617|NCT00434161|536319453|FG002|Overall Study|Non-Compliance|0|||
148950875|NCT01059825|537301421|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
148950876|NCT01059825|537301422|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
148950877|NCT01059825|537301423|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
148950878|NCT01059825|537301424|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
148950879|NCT01059825|537301425|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
148950880|NCT01059825|537301419|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
149016868|NCT03881059|537540971|FG002|Treatment Period - Part A|Adverse Event|4|||
149016869|NCT03881059|537540969|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
149016870|NCT03881059|537540970|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
148950881|NCT01059825|537301420|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
148950882|NCT01059825|537301421|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
148950883|NCT01059825|537301422|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
148950884|NCT01059825|537301423|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
148950885|NCT01059825|537301424|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
148950886|NCT01059825|537301425|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
148950887|NCT01059825|537301419|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
148950888|NCT01059825|537301420|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
148950889|NCT01059825|537301421|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
148950890|NCT01059825|537301422|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
148950891|NCT01059825|537301423|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
148950892|NCT01059825|537301424|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
148950893|NCT01059825|537301425|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
148950894|NCT01059825|537301419|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
148950895|NCT01059825|537301420|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
148950896|NCT01059825|537301421|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
148950897|NCT01059825|537301422|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
148950898|NCT01059825|537301423|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
148950899|NCT01059825|537301424|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
148950900|NCT01059825|537301425|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
148950901|NCT01059825|537301419|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
148950902|NCT01059825|537301420|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
148950903|NCT01059825|537301421|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
148950904|NCT01059825|537301422|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
148950905|NCT01059825|537301423|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
148950906|NCT01059825|537301424|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
148950907|NCT01059825|537301425|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
148950908|NCT01059825|537301419|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
148950909|NCT01059825|537301420|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
148950910|NCT01059825|537301421|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
148950911|NCT01059825|537301422|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
148950912|NCT01059825|537301423|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
148950913|NCT01059825|537301424|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
148950914|NCT01059825|537301425|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
148950915|NCT01059825|537301419|FG000|Treatment Period|Lost to Follow-up|2|||
148950916|NCT01059825|537301420|FG001|Treatment Period|Lost to Follow-up|1|||
148950917|NCT01059825|537301421|FG002|Treatment Period|Lost to Follow-up|0|||
148950918|NCT01059825|537301422|FG003|Treatment Period|Lost to Follow-up|1|||
148950919|NCT01059825|537301423|FG004|Treatment Period|Lost to Follow-up|2|||
149214787|NCT02407236|538252823|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214788|NCT02407236|538252824|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214789|NCT02407236|538252825|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214790|NCT02407236|538252826|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214791|NCT02407236|538252827|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214792|NCT02407236|538252828|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214793|NCT02407236|538252829|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214794|NCT02407236|538252830|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214795|NCT02407236|538252831|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214796|NCT02407236|538252832|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214797|NCT02407236|538252833|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
149214798|NCT02407236|538252834|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214799|NCT02407236|538252835|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
149214800|NCT02407236|538252823|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214801|NCT02407236|538252824|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214802|NCT02407236|538252825|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214803|NCT02407236|538252826|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214804|NCT02407236|538252827|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214805|NCT02407236|538252828|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214806|NCT02407236|538252829|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214807|NCT02407236|538252830|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
149214808|NCT02407236|538252831|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
149214809|NCT02407236|538252832|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
149214810|NCT02407236|538252833|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
149214811|NCT02407236|538252834|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
149214812|NCT02407236|538252835|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
148950920|NCT01059825|537301424|FG005|Treatment Period|Lost to Follow-up|0|||
148950921|NCT01059825|537301425|FG006|Treatment Period|Lost to Follow-up|0|||
149016871|NCT03881059|537540971|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
149016872|NCT03881059|537540969|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
149016873|NCT03881059|537540970|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
149016874|NCT03881059|537540971|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
149016875|NCT03881059|537540969|FG000|Treatment Period - Part A|Other reasons|2|||
149016876|NCT03881059|537540970|FG001|Treatment Period - Part A|Other reasons|1|||
149016877|NCT03881059|537540971|FG002|Treatment Period - Part A|Other reasons|0|||
149016878|NCT03881059|537540969|FG000|Treatment Period - Part B|Adverse Event|0|||
149016879|NCT03881059|537540970|FG001|Treatment Period - Part B|Adverse Event|0|||
149016880|NCT03881059|537540971|FG002|Treatment Period - Part B|Adverse Event|3|||
149016881|NCT03881059|537540969|FG000|Treatment Period - Part B|Death|0|||
149016882|NCT03881059|537540970|FG001|Treatment Period - Part B|Death|1|||
149214813|NCT02407236|538252823|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
149214814|NCT02407236|538252824|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
149214815|NCT02407236|538252825|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
149214816|NCT02407236|538252826|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
149214817|NCT02407236|538252827|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
149214818|NCT02407236|538252828|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
149214819|NCT02407236|538252829|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
149214820|NCT02407236|538252830|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
149214821|NCT02407236|538252831|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
149214822|NCT02407236|538252832|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
149214823|NCT02407236|538252833|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
149214824|NCT02407236|538252834|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
149214825|NCT02407236|538252835|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
149214826|NCT01627782|538252840|FG000|Overall Study|Adverse Event|1|||
149214827|NCT01627782|538252841|FG001|Overall Study|Adverse Event|2|||
149214828|NCT01627782|538252842|FG002|Overall Study|Adverse Event|0|||
149214829|NCT01627782|538252843|FG003|Overall Study|Adverse Event|1|||
149214830|NCT01627782|538252840|FG000|Overall Study|Lack of Efficacy|11|||
149214831|NCT01627782|538252841|FG001|Overall Study|Lack of Efficacy|1|||
149214832|NCT01627782|538252842|FG002|Overall Study|Lack of Efficacy|15|||
149214833|NCT01627782|538252843|FG003|Overall Study|Lack of Efficacy|2|||
149214834|NCT01627782|538252840|FG000|Overall Study|Protocol Violation|1|||
149214835|NCT01627782|538252841|FG001|Overall Study|Protocol Violation|0|||
149214836|NCT01627782|538252842|FG002|Overall Study|Protocol Violation|0|||
149214837|NCT01627782|538252843|FG003|Overall Study|Protocol Violation|0|||
149214838|NCT01627782|538252840|FG000|Overall Study|Withdrawal by Subject|2|||
149214839|NCT01627782|538252841|FG001|Overall Study|Withdrawal by Subject|1|||
149214840|NCT01627782|538252842|FG002|Overall Study|Withdrawal by Subject|0|||
149214841|NCT01627782|538252843|FG003|Overall Study|Withdrawal by Subject|0|||
149214842|NCT01627782|538252840|FG000|Overall Study|Other|0|||
149214843|NCT01627782|538252841|FG001|Overall Study|Other|2|||
149214844|NCT01627782|538252842|FG002|Overall Study|Other|0|||
149214845|NCT01627782|538252843|FG003|Overall Study|Other|3|||
149214846|NCT01627782|538252840|FG000|Overall Study|Randomized But Not Treated|1|||
149214847|NCT01627782|538252841|FG001|Overall Study|Randomized But Not Treated|0|||
149214848|NCT01627782|538252842|FG002|Overall Study|Randomized But Not Treated|0|||
149214849|NCT01627782|538252843|FG003|Overall Study|Randomized But Not Treated|0|||
149214850|NCT00643448|538252844|FG000|Overall Study|Lack of Efficacy|2|||
149214851|NCT00643448|538252845|FG001|Overall Study|Lack of Efficacy|0|||
149214852|NCT00643448|538252846|FG002|Overall Study|Lack of Efficacy|4|||
149214853|NCT00643448|538252844|FG000|Overall Study|Adverse Event|2|||
149214854|NCT00643448|538252845|FG001|Overall Study|Adverse Event|2|||
149214855|NCT00643448|538252846|FG002|Overall Study|Adverse Event|2|||
149214856|NCT00643448|538252844|FG000|Overall Study|QTcF>550 ms|0|||
149214857|NCT00643448|538252845|FG001|Overall Study|QTcF>550 ms|3|||
149214858|NCT00643448|538252846|FG002|Overall Study|QTcF>550 ms|0|||
149214859|NCT02177812|538252850|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149214860|NCT02177812|538252851|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149214861|NCT02177812|538252852|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149214862|NCT02177812|538252853|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
148684618|NCT00434161|536319451|FG000|Overall Study|Withdrawal by Subject|2|||
148684619|NCT00434161|536319452|FG001|Overall Study|Withdrawal by Subject|0|||
149016883|NCT03881059|537540971|FG002|Treatment Period - Part B|Death|1|||
149214863|NCT02177812|538252854|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149214864|NCT02177812|538252855|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
149214865|NCT02177812|538252856|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
149214866|NCT02177812|538252857|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
149214867|NCT02177812|538252858|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
149016884|NCT03881059|537540969|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
149214868|NCT02177812|538252850|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149214869|NCT02177812|538252851|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149214870|NCT02177812|538252852|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149214871|NCT02177812|538252853|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
148950922|NCT01059825|537301419|FG000|Treatment Period|Withdrawal by Subject|3|||
148950923|NCT01059825|537301420|FG001|Treatment Period|Withdrawal by Subject|0|||
148950924|NCT01059825|537301421|FG002|Treatment Period|Withdrawal by Subject|1|||
148950925|NCT01059825|537301422|FG003|Treatment Period|Withdrawal by Subject|5|||
148950926|NCT01059825|537301423|FG004|Treatment Period|Withdrawal by Subject|4|||
148950927|NCT01059825|537301424|FG005|Treatment Period|Withdrawal by Subject|1|||
148950928|NCT01059825|537301425|FG006|Treatment Period|Withdrawal by Subject|0|||
148950929|NCT01059825|537301419|FG000|Treatment Period|Other reason not specified|1|||
148950930|NCT01059825|537301420|FG001|Treatment Period|Other reason not specified|2|||
148950931|NCT01059825|537301421|FG002|Treatment Period|Other reason not specified|1|||
148950932|NCT01059825|537301422|FG003|Treatment Period|Other reason not specified|2|||
148950933|NCT01059825|537301423|FG004|Treatment Period|Other reason not specified|0|||
148950934|NCT01059825|537301424|FG005|Treatment Period|Other reason not specified|0|||
148950935|NCT01059825|537301425|FG006|Treatment Period|Other reason not specified|0|||
148950936|NCT01059825|537301419|FG000|Treatment Period|Protocol Violation|0|||
148950937|NCT01059825|537301420|FG001|Treatment Period|Protocol Violation|0|||
148950938|NCT01059825|537301421|FG002|Treatment Period|Protocol Violation|1|||
148950939|NCT01059825|537301422|FG003|Treatment Period|Protocol Violation|1|||
148950940|NCT01059825|537301423|FG004|Treatment Period|Protocol Violation|1|||
148950941|NCT01059825|537301424|FG005|Treatment Period|Protocol Violation|1|||
148950942|NCT01059825|537301425|FG006|Treatment Period|Protocol Violation|0|||
148950943|NCT01059825|537301419|FG000|Treatment Period|Adverse event related to study drug|1|||
148950944|NCT01059825|537301420|FG001|Treatment Period|Adverse event related to study drug|0|||
148950945|NCT01059825|537301421|FG002|Treatment Period|Adverse event related to study drug|1|||
148950946|NCT01059825|537301422|FG003|Treatment Period|Adverse event related to study drug|1|||
148950947|NCT01059825|537301423|FG004|Treatment Period|Adverse event related to study drug|0|||
148950948|NCT01059825|537301424|FG005|Treatment Period|Adverse event related to study drug|0|||
148950949|NCT01059825|537301425|FG006|Treatment Period|Adverse event related to study drug|0|||
148950950|NCT01059825|537301419|FG000|Treatment Period|Insufficient clinical response|3|||
148950951|NCT01059825|537301420|FG001|Treatment Period|Insufficient clinical response|0|||
148950952|NCT01059825|537301421|FG002|Treatment Period|Insufficient clinical response|0|||
148950953|NCT01059825|537301422|FG003|Treatment Period|Insufficient clinical response|0|||
148950954|NCT01059825|537301423|FG004|Treatment Period|Insufficient clinical response|0|||
148950955|NCT01059825|537301424|FG005|Treatment Period|Insufficient clinical response|0|||
148950956|NCT01059825|537301425|FG006|Treatment Period|Insufficient clinical response|0|||
148950957|NCT01059825|537301419|FG000|Treatment Period|Adverse event not related to study drug|0|||
148950958|NCT01059825|537301420|FG001|Treatment Period|Adverse event not related to study drug|1|||
148950959|NCT01059825|537301421|FG002|Treatment Period|Adverse event not related to study drug|2|||
148950960|NCT01059825|537301422|FG003|Treatment Period|Adverse event not related to study drug|1|||
148950961|NCT01059825|537301423|FG004|Treatment Period|Adverse event not related to study drug|1|||
148950962|NCT01059825|537301424|FG005|Treatment Period|Adverse event not related to study drug|1|||
148950963|NCT01059825|537301425|FG006|Treatment Period|Adverse event not related to study drug|0|||
148950964|NCT02041286|537301426|FG000|Overall Study|Adverse Event|1|||
148950965|NCT01750242|537301433|FG000|Overall Study|Unreadable Images|3|||
148950966|NCT00006903|537301434|FG000|Overall Study|Still receiving treatment|0|||
148950967|NCT00006903|537301435|FG001|Overall Study|Still receiving treatment|0|||
148950968|NCT00006903|537301436|FG002|Overall Study|Still receiving treatment|1|||
148950969|NCT00006903|537301434|FG000|Overall Study|Refused further treatment|0|||
148950970|NCT00006903|537301435|FG001|Overall Study|Refused further treatment|2|||
148950971|NCT00006903|537301436|FG002|Overall Study|Refused further treatment|1|||
148950972|NCT00006903|537301434|FG000|Overall Study|Adverse Event|0|||
148950973|NCT00006903|537301435|FG001|Overall Study|Adverse Event|0|||
148950974|NCT00006903|537301436|FG002|Overall Study|Adverse Event|1|||
148950975|NCT00006903|537301434|FG000|Overall Study|Death|0|||
148950976|NCT00006903|537301435|FG001|Overall Study|Death|1|||
148950977|NCT00006903|537301436|FG002|Overall Study|Death|0|||
148950978|NCT00006903|537301434|FG000|Overall Study|Patient never treated|0|||
148950979|NCT00006903|537301435|FG001|Overall Study|Patient never treated|0|||
148950980|NCT00006903|537301436|FG002|Overall Study|Patient never treated|1|||
148950981|NCT00006903|537301434|FG000|Overall Study|Ineligible|10|||
148950982|NCT00006903|537301435|FG001|Overall Study|Ineligible|1|||
148950983|NCT00006903|537301436|FG002|Overall Study|Ineligible|2|||
148950984|NCT01909674|537301437|FG000|Overall Study|Withdrawal by Subject|5|||
148950985|NCT01909674|537301438|FG001|Overall Study|Withdrawal by Subject|2|||
148950986|NCT02651922|537301441|FG000|Overall Study|due to exclusion criteria|2|||
148950987|NCT01366209|537301442|FG000|Overall Study|Adverse Event|6|||
148950988|NCT01366209|537301443|FG001|Overall Study|Adverse Event|7|||
148950989|NCT01366209|537301442|FG000|Overall Study|Withdrawal by Subject|4|||
148950990|NCT01366209|537301443|FG001|Overall Study|Withdrawal by Subject|4|||
148950991|NCT01366209|537301442|FG000|Overall Study|Death|12|||
148950992|NCT01366209|537301443|FG001|Overall Study|Death|19|||
148950993|NCT01366209|537301442|FG000|Overall Study|Lung transplantation|6|||
148950994|NCT01366209|537301443|FG001|Overall Study|Lung transplantation|1|||
148950995|NCT01366209|537301442|FG000|Overall Study|Lost to Follow-up|2|||
149016885|NCT03881059|537540970|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
149016886|NCT03881059|537540971|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
149016887|NCT03881059|537540969|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
149016888|NCT03881059|537540970|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
149016889|NCT03881059|537540971|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
149016890|NCT03881059|537540969|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
149016891|NCT03881059|537540970|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
149016892|NCT03881059|537540971|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
149016893|NCT03881059|537540969|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
149016894|NCT03881059|537540970|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
149016895|NCT03881059|537540971|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
149016896|NCT03881059|537540969|FG000|Treatment Period - Part B|Other reasons|4|||
149016897|NCT03881059|537540970|FG001|Treatment Period - Part B|Other reasons|3|||
149016898|NCT03881059|537540971|FG002|Treatment Period - Part B|Other reasons|3|||
149016899|NCT02065570|537540972|FG000|Induction Study|Adverse Event|5|||
149016900|NCT02065570|537540973|FG001|Induction Study|Adverse Event|12|||
149016901|NCT02065570|537540974|FG002|Induction Study|Adverse Event|0|||
149016902|NCT02065570|537540975|FG003|Induction Study|Adverse Event|0|||
149016903|NCT02065570|537540972|FG000|Induction Study|Withdrawal by Subject|2|||
149016904|NCT02065570|537540973|FG001|Induction Study|Withdrawal by Subject|3|||
149016905|NCT02065570|537540974|FG002|Induction Study|Withdrawal by Subject|0|||
148950996|NCT01366209|537301443|FG001|Overall Study|Lost to Follow-up|1|||
148950997|NCT01366209|537301442|FG000|Overall Study|Physician Decision|1|||
148950998|NCT01366209|537301443|FG001|Overall Study|Physician Decision|0|||
148950999|NCT01366209|537301442|FG000|Overall Study|Sponsors decision|0|||
148951000|NCT01366209|537301443|FG001|Overall Study|Sponsors decision|1|||
148951001|NCT01366209|537301442|FG000|Overall Study|Withdrew consent|4|||
148951002|NCT01366209|537301443|FG001|Overall Study|Withdrew consent|3|||
148951003|NCT00496470|537301446|FG000|Overall Study|Adverse Event|8|||
148951004|NCT00496470|537301447|FG001|Overall Study|Adverse Event|10|||
148951005|NCT00496470|537301446|FG000|Overall Study|Withdrawal by Subject|5|||
148951006|NCT00496470|537301447|FG001|Overall Study|Withdrawal by Subject|12|||
148951007|NCT00496470|537301446|FG000|Overall Study|Incorrectly enrolled|13|||
148951008|NCT00496470|537301447|FG001|Overall Study|Incorrectly enrolled|5|||
148951009|NCT00496470|537301446|FG000|Overall Study|Other reason|0|||
148951010|NCT00496470|537301447|FG001|Overall Study|Other reason|2|||
148951011|NCT01217814|537301448|FG000|Overall Study|Adverse Event|1|||
148951012|NCT01217814|537301449|FG001|Overall Study|Adverse Event|1|||
148951013|NCT01217814|537301450|FG002|Overall Study|Adverse Event|0|||
148951014|NCT01217814|537301448|FG000|Overall Study|Lack of Efficacy|0|||
148951015|NCT01217814|537301449|FG001|Overall Study|Lack of Efficacy|0|||
148951016|NCT01217814|537301450|FG002|Overall Study|Lack of Efficacy|1|||
148951017|NCT00729651|537301452|FG000|Overall Study|Withdrawal by Subject|5|||
148951018|NCT00729651|537301453|FG001|Overall Study|Withdrawal by Subject|6|||
148951019|NCT00729651|537301452|FG000|Overall Study|Lost to Follow-up|5|||
148951020|NCT00729651|537301453|FG001|Overall Study|Lost to Follow-up|4|||
148951021|NCT00729651|537301452|FG000|Overall Study|Protocol Violation|0|||
148951022|NCT00729651|537301453|FG001|Overall Study|Protocol Violation|1|||
148951023|NCT00729651|537301452|FG000|Overall Study|Adverse Event|7|||
148951024|NCT00729651|537301453|FG001|Overall Study|Adverse Event|3|||
148951025|NCT00729651|537301452|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
148951026|NCT00729651|537301453|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
148951027|NCT00729651|537301452|FG000|Overall Study|Subject's private reason|2|||
148951028|NCT00729651|537301453|FG001|Overall Study|Subject's private reason|0|||
148951029|NCT01218243|537301454|FG000|Overall Study|Lack of Efficacy|1|||
148951030|NCT01218243|537301455|FG001|Overall Study|Lack of Efficacy|1|||
148951031|NCT01218243|537301454|FG000|Overall Study|Lost to Follow-up|3|||
148951032|NCT01218243|537301455|FG001|Overall Study|Lost to Follow-up|3|||
148951033|NCT01218243|537301454|FG000|Overall Study|Protocol Violation|5|||
148951034|NCT01218243|537301455|FG001|Overall Study|Protocol Violation|10|||
148951035|NCT01637272|537301458|FG000|Overall Study|Adverse Event|6|||
148951036|NCT01637272|537301458|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148951037|NCT01637272|537301458|FG000|Overall Study|Withdrawal by Subject|3|||
149016906|NCT02065570|537540975|FG003|Induction Study|Withdrawal by Subject|0|||
149016907|NCT02065570|537540972|FG000|Induction Study|Lost to Follow-up|1|||
148951038|NCT01637272|537301458|FG000|Overall Study|Lost to Follow-up|2|||
148951039|NCT01637272|537301458|FG000|Overall Study|completed core, did not enter ext. phase|4|||
148951040|NCT01637272|537301458|FG000|Overall Study|Administrative problems|1|||
148951041|NCT01637272|537301458|FG000|Overall Study|Protocol Violation|2|||
148951042|NCT01496612|537301459|FG000|1st Intervention|Adverse Event|1|||
148951043|NCT01496612|537301460|FG001|1st Intervention|Adverse Event|0|||
148951044|NCT01496612|537301459|FG000|1st Intervention|Withdrawal by Subject|1|||
148951045|NCT01496612|537301460|FG001|1st Intervention|Withdrawal by Subject|0|||
149016908|NCT02065570|537540973|FG001|Induction Study|Lost to Follow-up|1|||
149016909|NCT02065570|537540974|FG002|Induction Study|Lost to Follow-up|0|||
149016910|NCT02065570|537540975|FG003|Induction Study|Lost to Follow-up|0|||
148684620|NCT00434161|536319453|FG002|Overall Study|Withdrawal by Subject|3|||
148951046|NCT00291577|537301461|FG000|Overall Study|Adverse Event|1|||
148951047|NCT00291577|537301461|FG000|Overall Study|Other|4|||
148951048|NCT00291577|537301461|FG000|Overall Study|Withdrawal by Subject|2|||
148951049|NCT00291577|537301461|FG000|Overall Study|Lack of Efficacy|14|||
148951050|NCT01666782|537301468|FG000|Overall Study|Received 2 doses of vaccine|0|||
148951051|NCT01666782|537301469|FG001|Overall Study|Received 2 doses of vaccine|1|||
148951052|NCT01666782|537301468|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
148951053|NCT01666782|537301469|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
148951054|NCT00833794|537301472|FG000|Open-label Phase|Adverse Event|225|||
148951055|NCT00833794|537301473|FG001|Open-label Phase|Adverse Event|0|||
148951056|NCT00833794|537301472|FG000|Open-label Phase|Lack of Efficacy|28|||
148951057|NCT00833794|537301473|FG001|Open-label Phase|Lack of Efficacy|0|||
148951058|NCT00833794|537301472|FG000|Open-label Phase|Withdrawal by Subject|48|||
148951059|NCT00833794|537301473|FG001|Open-label Phase|Withdrawal by Subject|0|||
148951060|NCT00833794|537301472|FG000|Open-label Phase|Physician Decision|20|||
148951061|NCT00833794|537301473|FG001|Open-label Phase|Physician Decision|0|||
148951062|NCT00833794|537301472|FG000|Open-label Phase|Administrative reason|1|||
148951063|NCT00833794|537301473|FG001|Open-label Phase|Administrative reason|0|||
148951064|NCT00833794|537301472|FG000|Open-label Phase|Protocol Violation|47|||
148951065|NCT00833794|537301473|FG001|Open-label Phase|Protocol Violation|0|||
148951066|NCT00833794|537301472|FG000|Open-label Phase|Did not complete wash-out period|12|||
148951067|NCT00833794|537301473|FG001|Open-label Phase|Did not complete wash-out period|0|||
148951068|NCT00833794|537301472|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
148951069|NCT00833794|537301473|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
148951070|NCT00833794|537301472|FG000|Double-blind Phase|Adverse Event|44|||
148951071|NCT00833794|537301473|FG001|Double-blind Phase|Adverse Event|11|||
148951072|NCT00833794|537301472|FG000|Double-blind Phase|Lack of Efficacy|34|||
148951073|NCT00833794|537301473|FG001|Double-blind Phase|Lack of Efficacy|22|||
148951074|NCT00833794|537301472|FG000|Double-blind Phase|Withdrawal by Subject|23|||
148951075|NCT00833794|537301473|FG001|Double-blind Phase|Withdrawal by Subject|6|||
148951076|NCT00833794|537301472|FG000|Double-blind Phase|Physician Decision|4|||
148951077|NCT00833794|537301473|FG001|Double-blind Phase|Physician Decision|7|||
148951078|NCT00833794|537301472|FG000|Double-blind Phase|Administrative reason|1|||
148951079|NCT00833794|537301473|FG001|Double-blind Phase|Administrative reason|3|||
148951080|NCT00519831|537301476|FG000|Overall Study|Adverse Event|3|||
148951081|NCT00471328|537301477|FG000|Core Phase|Adverse Event|18|||
148951082|NCT00471328|537301478|FG001|Core Phase|Adverse Event|6|||
148951083|NCT00471328|537301477|FG000|Core Phase|Death|8|||
148951084|NCT00471328|537301478|FG001|Core Phase|Death|4|||
148951085|NCT00471328|537301477|FG000|Core Phase|Withdrawal by Subject|2|||
148951086|NCT00471328|537301478|FG001|Core Phase|Withdrawal by Subject|2|||
148951087|NCT00471328|537301477|FG000|Core Phase|Abnormal laboratory value|1|||
148951088|NCT00471328|537301478|FG001|Core Phase|Abnormal laboratory value|0|||
148951089|NCT00471328|537301477|FG000|Core Phase|Disease Progression|78|||
148951090|NCT00471328|537301478|FG001|Core Phase|Disease Progression|53|||
148951091|NCT00471328|537301477|FG000|Core Phase|Administrative Problem|0|||
148951092|NCT00471328|537301478|FG001|Core Phase|Administrative Problem|1|||
148951093|NCT00471328|537301477|FG000|Core Phase|Protocol Deviation|0|||
149214872|NCT02177812|538252854|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149214873|NCT02177812|538252855|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
149214874|NCT02177812|538252856|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
148809667|NCT00984867|536780829|FG000|Overall Study|Death|1|||
148951094|NCT00471328|537301478|FG001|Core Phase|Protocol Deviation|1|||
148951095|NCT00471328|537301477|FG000|Extension Phase|Adverse Event|3|||
148951096|NCT00471328|537301478|FG001|Extension Phase|Adverse Event|12|||
149214875|NCT02177812|538252857|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149214876|NCT02177812|538252858|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
149214877|NCT02177812|538252850|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149214878|NCT02177812|538252851|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149214879|NCT02177812|538252852|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149214880|NCT02177812|538252853|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149214881|NCT02177812|538252854|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149214882|NCT02177812|538252855|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149214883|NCT02177812|538252856|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
149214884|NCT02177812|538252857|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
149214885|NCT02177812|538252858|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
149214886|NCT03695471|538255461|FG000|Overall Study|Cancellation|1|||
149214887|NCT02859558|538255462|FG000|Step 1|Not Eligible|0|||
149214888|NCT02859558|538255463|FG001|Step 1|Not Eligible|0|||
148951097|NCT00471328|537301477|FG000|Extension Phase|Withdrawal by Subject|0|||
148951098|NCT00471328|537301478|FG001|Extension Phase|Withdrawal by Subject|2|||
148951099|NCT00471328|537301477|FG000|Extension Phase|Death|1|||
148951100|NCT00471328|537301478|FG001|Extension Phase|Death|7|||
148951101|NCT00471328|537301477|FG000|Extension Phase|Protocol Deviation|3|||
149214889|NCT02859558|538255464|FG002|Step 1|Not Eligible|0|||
148951102|NCT00471328|537301478|FG001|Extension Phase|Protocol Deviation|1|||
148951103|NCT00471328|537301477|FG000|Extension Phase|Treatment duration as per protocol|0|||
148951104|NCT00471328|537301478|FG001|Extension Phase|Treatment duration as per protocol|1|||
148951105|NCT00471328|537301477|FG000|Extension Phase|Disease Progression|32|||
148951106|NCT00471328|537301478|FG001|Extension Phase|Disease Progression|44|||
148951107|NCT00471328|537301477|FG000|Extension Phase|New cancer Therapy|1|||
148951108|NCT00471328|537301478|FG001|Extension Phase|New cancer Therapy|0|||
148951109|NCT00471328|537301477|FG000|Extension Phase|Administrative Problem|1|||
148951110|NCT00471328|537301478|FG001|Extension Phase|Administrative Problem|0|||
148951111|NCT04051008|537301479|FG000|Overall Study|Withdrawal by Subject|2|||
148951112|NCT04051008|537301480|FG001|Overall Study|Withdrawal by Subject|0|||
148951113|NCT04051008|537301481|FG002|Overall Study|Withdrawal by Subject|1|||
148951114|NCT03200860|537301482|FG000|Overall Study|Withdrawal by Subject|1|||
148951115|NCT03200860|537301483|FG001|Overall Study|Withdrawal by Subject|0|||
148951116|NCT00844896|537301484|FG000|Overall Study|Lost to Follow-up|12|||
148951117|NCT00844896|537301485|FG001|Overall Study|Lost to Follow-up|16|||
148951118|NCT00844896|537301484|FG000|Overall Study|Parents did not have time to complete|0|||
148951119|NCT00844896|537301485|FG001|Overall Study|Parents did not have time to complete|1|||
148951120|NCT00458211|537301489|FG000|Overall Study|Lack of Efficacy|12|||
148951121|NCT00458211|537301489|FG000|Overall Study|Withdrawal by Subject|2|||
148951122|NCT00458211|537301489|FG000|Overall Study|Protocol Violation|2|||
148951123|NCT04342897|537301490|FG000|Overall Study|Death|7|||
148951124|NCT04342897|537301491|FG001|Overall Study|Death|4|||
148951125|NCT04342897|537301490|FG000|Overall Study|Lost to Follow-up|6|||
148951126|NCT04342897|537301491|FG001|Overall Study|Lost to Follow-up|6|||
148951127|NCT04342897|537301490|FG000|Overall Study|Withdrawal by Subject|1|||
148951128|NCT04342897|537301491|FG001|Overall Study|Withdrawal by Subject|2|||
148951129|NCT02634320|537301492|FG000|Overall Study|Adverse Event|2|||
148951130|NCT02634320|537301492|FG000|Overall Study|Lost to Follow-up|3|||
148951131|NCT02634320|537301492|FG000|Overall Study|Moved out of area|2|||
148951132|NCT02634320|537301492|FG000|Overall Study|Out of window for study visits|1|||
148951133|NCT02634320|537301492|FG000|Overall Study|Protocol Violation|1|||
148951134|NCT02634320|537301492|FG000|Overall Study|Withdrawal by Subject|5|||
148951135|NCT02634320|537301492|FG000|Overall Study|Lack of Efficacy|2|||
148951136|NCT00687323|537301493|FG000|Overall Study|Death|25|||
148951137|NCT00687323|537301493|FG000|Overall Study|Withdrawal by Subject|1|||
148951138|NCT00687323|537301493|FG000|Overall Study|Excluded from efficacy evaluations|6|||
148951139|NCT00687323|537301493|FG000|Overall Study|Screen failure|148|||
148951140|NCT00838578|537301494|FG000|Overall Study|Protocol Violation|2|||
148951141|NCT03919799|537301500|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
148951142|NCT03919799|537301501|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
148951143|NCT03919799|537301502|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
148951144|NCT03919799|537301503|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
148951145|NCT03919799|537301504|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
148951146|NCT03919799|537301500|FG000|DB Period (28 Weeks)|Adverse Event|1|||
148951147|NCT03919799|537301501|FG001|DB Period (28 Weeks)|Adverse Event|1|||
148951148|NCT03919799|537301502|FG002|DB Period (28 Weeks)|Adverse Event|1|||
148951149|NCT03919799|537301503|FG003|DB Period (28 Weeks)|Adverse Event|0|||
148951150|NCT03919799|537301504|FG004|DB Period (28 Weeks)|Adverse Event|0|||
148951151|NCT03919799|537301500|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
148951152|NCT03919799|537301501|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
148951153|NCT03919799|537301502|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
148951154|NCT03919799|537301503|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
148951155|NCT03919799|537301504|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
148951156|NCT03919799|537301500|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
148951157|NCT03919799|537301501|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
148951158|NCT03919799|537301502|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
148951159|NCT03919799|537301503|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
148951160|NCT03919799|537301504|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
148951161|NCT03919799|537301500|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
148951162|NCT03919799|537301501|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
148951163|NCT03919799|537301502|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
149214890|NCT02859558|538255465|FG003|Step 1|Not Eligible|0|||
148951164|NCT03919799|537301503|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
148951165|NCT03919799|537301504|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
148951166|NCT04600921|537301510|FG000|Overall Study|Withdrawal by Subject|3|||
148951167|NCT04600921|537301511|FG001|Overall Study|Withdrawal by Subject|5|||
148951168|NCT04600921|537301510|FG000|Overall Study|Death|0|||
148951169|NCT04600921|537301511|FG001|Overall Study|Death|1|||
148951170|NCT05425745|537301514|FG000|Overall Study|Withdrawal of Consent|3|||
148951171|NCT05425745|537301515|FG001|Overall Study|Withdrawal of Consent|3|||
148951172|NCT05425745|537301514|FG000|Overall Study|Death|2|||
148951173|NCT05425745|537301515|FG001|Overall Study|Death|3|||
148951174|NCT05425745|537301514|FG000|Overall Study|Lost to Follow-up|1|||
148951175|NCT05425745|537301515|FG001|Overall Study|Lost to Follow-up|2|||
148951176|NCT05425745|537301514|FG000|Overall Study|Adverse Event|0|||
148951177|NCT05425745|537301515|FG001|Overall Study|Adverse Event|1|||
148951178|NCT05425745|537301514|FG000|Overall Study|Did not return for end of study visit|0|||
148951179|NCT05425745|537301515|FG001|Overall Study|Did not return for end of study visit|1|||
148951180|NCT05425745|537301514|FG000|Overall Study|End of study visit completed by phone|1|||
148951181|NCT05425745|537301515|FG001|Overall Study|End of study visit completed by phone|0|||
148951182|NCT05425745|537301514|FG000|Overall Study|Subject decision|1|||
148951183|NCT05425745|537301515|FG001|Overall Study|Subject decision|0|||
148951184|NCT02239978|537303281|FG000|Overall Study|Withdrawal by Subject|2|||
148951185|NCT02239978|537303282|FG001|Overall Study|Withdrawal by Subject|0|||
148951186|NCT00410046|537303290|FG000|Overall Study|Adverse Event|3|||
148951187|NCT00410046|537303290|FG000|Overall Study|Withdrawal by Subject|1|||
148951188|NCT00410046|537303290|FG000|Overall Study|Lost to Follow-up|1|||
148951189|NCT03909295|537303291|FG000|Overall Study|Adverse Event|2|||
148951190|NCT03909295|537303291|FG000|Overall Study|Study terminated by sponsor|50|||
148951191|NCT02141282|537303293|FG000|Overall Study|Adverse event, not related to progression|8|||
148951192|NCT02141282|537303294|FG001|Overall Study|Adverse event, not related to progression|1|||
148951193|NCT02141282|537303295|FG002|Overall Study|Adverse event, not related to progression|3|||
148951194|NCT02141282|537303296|FG003|Overall Study|Adverse event, not related to progression|1|||
148951195|NCT02141282|537303293|FG000|Overall Study|Adverse event, related to progression|1|||
148951196|NCT02141282|537303294|FG001|Overall Study|Adverse event, related to progression|0|||
148951197|NCT02141282|537303295|FG002|Overall Study|Adverse event, related to progression|2|||
148951198|NCT02141282|537303296|FG003|Overall Study|Adverse event, related to progression|0|||
148951199|NCT02141282|537303293|FG000|Overall Study|COVID-19 infection|1|||
148951200|NCT02141282|537303294|FG001|Overall Study|COVID-19 infection|0|||
148951201|NCT02141282|537303295|FG002|Overall Study|COVID-19 infection|0|||
149214891|NCT02859558|538255466|FG004|Step 1|Not Eligible|3|||
149214892|NCT02859558|538255462|FG000|Step 1|Lost to Follow-up|1|||
149214893|NCT02859558|538255463|FG001|Step 1|Lost to Follow-up|3|||
149214894|NCT02859558|538255464|FG002|Step 1|Lost to Follow-up|3|||
148951202|NCT02141282|537303296|FG003|Overall Study|COVID-19 infection|0|||
148951203|NCT02141282|537303293|FG000|Overall Study|Lost to Follow-up|0|||
148951204|NCT02141282|537303294|FG001|Overall Study|Lost to Follow-up|0|||
148951205|NCT02141282|537303295|FG002|Overall Study|Lost to Follow-up|4|||
148951206|NCT02141282|537303296|FG003|Overall Study|Lost to Follow-up|2|||
148951207|NCT02141282|537303293|FG000|Overall Study|Other, not specified|14|||
148951208|NCT02141282|537303294|FG001|Overall Study|Other, not specified|11|||
148951209|NCT02141282|537303295|FG002|Overall Study|Other, not specified|23|||
148951210|NCT02141282|537303296|FG003|Overall Study|Other, not specified|9|||
148951211|NCT02141282|537303293|FG000|Overall Study|Progressive disease, Richter's|4|||
148951212|NCT02141282|537303294|FG001|Overall Study|Progressive disease, Richter's|1|||
149214895|NCT02859558|538255465|FG003|Step 1|Lost to Follow-up|0|||
149214896|NCT02859558|538255466|FG004|Step 1|Lost to Follow-up|0|||
149214897|NCT02859558|538255462|FG000|Step 1|Did Not Return to Clinic|2|||
149214898|NCT02859558|538255463|FG001|Step 1|Did Not Return to Clinic|3|||
149214899|NCT02859558|538255464|FG002|Step 1|Did Not Return to Clinic|4|||
149214900|NCT02859558|538255465|FG003|Step 1|Did Not Return to Clinic|0|||
149214901|NCT02859558|538255466|FG004|Step 1|Did Not Return to Clinic|0|||
149214902|NCT02859558|538255462|FG000|Step 1|Moved|0|||
149214903|NCT02859558|538255463|FG001|Step 1|Moved|1|||
149214904|NCT02859558|538255464|FG002|Step 1|Moved|1|||
149214905|NCT02859558|538255465|FG003|Step 1|Moved|0|||
149214906|NCT02859558|538255466|FG004|Step 1|Moved|0|||
149214907|NCT02859558|538255462|FG000|Step 1|Withdrawal By Participant|1|||
149214908|NCT02859558|538255463|FG001|Step 1|Withdrawal By Participant|2|||
149214909|NCT02859558|538255464|FG002|Step 1|Withdrawal By Participant|1|||
149214910|NCT02859558|538255465|FG003|Step 1|Withdrawal By Participant|0|||
149214911|NCT02859558|538255466|FG004|Step 1|Withdrawal By Participant|0|||
149214912|NCT02859558|538255462|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
149214913|NCT02859558|538255463|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149214914|NCT02859558|538255464|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149214915|NCT02859558|538255465|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149214916|NCT02859558|538255466|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
149214917|NCT02859558|538255462|FG000|Step 1|Incarceration|0|||
149214918|NCT02859558|538255463|FG001|Step 1|Incarceration|1|||
149214919|NCT02859558|538255464|FG002|Step 1|Incarceration|0|||
149214920|NCT02859558|538255465|FG003|Step 1|Incarceration|0|||
149214921|NCT02859558|538255466|FG004|Step 1|Incarceration|0|||
149214922|NCT02859558|538255462|FG000|Step 1|Non-Adherence to Study Drug|2|||
149214923|NCT02859558|538255463|FG001|Step 1|Non-Adherence to Study Drug|0|||
149214924|NCT02859558|538255464|FG002|Step 1|Non-Adherence to Study Drug|1|||
149214925|NCT02859558|538255465|FG003|Step 1|Non-Adherence to Study Drug|0|||
149214926|NCT02859558|538255466|FG004|Step 1|Non-Adherence to Study Drug|0|||
149214927|NCT02859558|538255462|FG000|Step 1|Non-Adherence to Study Requirements|3|||
149214928|NCT02859558|538255463|FG001|Step 1|Non-Adherence to Study Requirements|1|||
149214929|NCT02859558|538255464|FG002|Step 1|Non-Adherence to Study Requirements|0|||
149214930|NCT02859558|538255465|FG003|Step 1|Non-Adherence to Study Requirements|0|||
149016911|NCT02065570|537540972|FG000|Induction Study|Other, Not Specified|6|||
149016912|NCT02065570|537540973|FG001|Induction Study|Other, Not Specified|5|||
149016913|NCT02065570|537540974|FG002|Induction Study|Other, Not Specified|0|||
149016914|NCT02065570|537540975|FG003|Induction Study|Other, Not Specified|0|||
149016915|NCT02065570|537540972|FG000|Maintenance Study|Adverse Event|0|||
149016916|NCT02065570|537540973|FG001|Maintenance Study|Adverse Event|0|||
149016917|NCT02065570|537540974|FG002|Maintenance Study|Adverse Event|8|||
149016918|NCT02065570|537540975|FG003|Maintenance Study|Adverse Event|8|||
149016919|NCT02065570|537540972|FG000|Maintenance Study|Withdrawal by Subject|0|||
149214931|NCT02859558|538255466|FG004|Step 1|Non-Adherence to Study Requirements|0|||
149214932|NCT02859558|538255462|FG000|Step 1|Virologic Failure|2|||
149214933|NCT02859558|538255463|FG001|Step 1|Virologic Failure|1|||
149214934|NCT02859558|538255464|FG002|Step 1|Virologic Failure|1|||
149214935|NCT02859558|538255465|FG003|Step 1|Virologic Failure|0|||
149214936|NCT02859558|538255466|FG004|Step 1|Virologic Failure|0|||
149214937|NCT02859558|538255462|FG000|Step 2|Lost to Follow-up|3|||
149214938|NCT02859558|538255463|FG001|Step 2|Lost to Follow-up|3|||
149214939|NCT02859558|538255464|FG002|Step 2|Lost to Follow-up|1|||
149214940|NCT02859558|538255465|FG003|Step 2|Lost to Follow-up|0|||
149214941|NCT02859558|538255466|FG004|Step 2|Lost to Follow-up|0|||
149214942|NCT02859558|538255462|FG000|Step 2|Withdrawal by Subject|0|||
149214943|NCT02859558|538255463|FG001|Step 2|Withdrawal by Subject|1|||
149214944|NCT02859558|538255464|FG002|Step 2|Withdrawal by Subject|1|||
149214945|NCT02859558|538255465|FG003|Step 2|Withdrawal by Subject|0|||
149214946|NCT02859558|538255466|FG004|Step 2|Withdrawal by Subject|0|||
149214947|NCT02859558|538255462|FG000|Step 2|Unexpected Closure of Site|0|||
149214948|NCT02859558|538255463|FG001|Step 2|Unexpected Closure of Site|1|||
149214949|NCT02859558|538255464|FG002|Step 2|Unexpected Closure of Site|1|||
149214950|NCT02859558|538255465|FG003|Step 2|Unexpected Closure of Site|0|||
149214951|NCT02859558|538255466|FG004|Step 2|Unexpected Closure of Site|0|||
149214952|NCT02859558|538255462|FG000|Step 2|Death|1|||
149214953|NCT02859558|538255463|FG001|Step 2|Death|0|||
149214954|NCT02859558|538255464|FG002|Step 2|Death|0|||
149214955|NCT02859558|538255465|FG003|Step 2|Death|0|||
149214956|NCT02859558|538255466|FG004|Step 2|Death|0|||
149214957|NCT02859558|538255462|FG000|Step 2|Incarceration|0|||
149214958|NCT02859558|538255463|FG001|Step 2|Incarceration|0|||
149214959|NCT02859558|538255464|FG002|Step 2|Incarceration|1|||
149214960|NCT02859558|538255465|FG003|Step 2|Incarceration|0|||
148951213|NCT02141282|537303295|FG002|Overall Study|Progressive disease, Richter's|1|||
148951214|NCT02141282|537303296|FG003|Overall Study|Progressive disease, Richter's|1|||
148951215|NCT02141282|537303293|FG000|Overall Study|Progressive disease per protocol|12|||
148951216|NCT02141282|537303294|FG001|Overall Study|Progressive disease per protocol|7|||
148951217|NCT02141282|537303295|FG002|Overall Study|Progressive disease per protocol|9|||
148951218|NCT02141282|537303296|FG003|Overall Study|Progressive disease per protocol|2|||
148951219|NCT02141282|537303293|FG000|Overall Study|Stem cell transplant|1|||
148951220|NCT02141282|537303294|FG001|Overall Study|Stem cell transplant|0|||
148951221|NCT02141282|537303295|FG002|Overall Study|Stem cell transplant|1|||
148951222|NCT02141282|537303296|FG003|Overall Study|Stem cell transplant|0|||
148951223|NCT02141282|537303293|FG000|Overall Study|Study terminated by Sponsor|0|||
148951224|NCT02141282|537303294|FG001|Overall Study|Study terminated by Sponsor|1|||
148951225|NCT02141282|537303295|FG002|Overall Study|Study terminated by Sponsor|0|||
148951226|NCT02141282|537303296|FG003|Overall Study|Study terminated by Sponsor|0|||
148951227|NCT02141282|537303293|FG000|Overall Study|Subject non-compliance|0|||
148951228|NCT02141282|537303294|FG001|Overall Study|Subject non-compliance|0|||
148951229|NCT02141282|537303295|FG002|Overall Study|Subject non-compliance|1|||
148951230|NCT02141282|537303296|FG003|Overall Study|Subject non-compliance|0|||
148951231|NCT02141282|537303293|FG000|Overall Study|Withdrew consent|2|||
148951232|NCT02141282|537303294|FG001|Overall Study|Withdrew consent|0|||
148951233|NCT02141282|537303295|FG002|Overall Study|Withdrew consent|4|||
148951234|NCT02141282|537303296|FG003|Overall Study|Withdrew consent|0|||
148951235|NCT03312933|537303299|FG000|Overall Study|Protocol Violation|15|||
148951236|NCT03312933|537303299|FG000|Overall Study|Lost to Follow-up|36|||
148951237|NCT03312933|537303299|FG000|Overall Study|Withdrawal by Subject|3|||
148951238|NCT01752907|537303301|FG000|Overall Study|Withdrawal by Subject|4|||
148951239|NCT01752907|537303302|FG001|Overall Study|Withdrawal by Subject|10|||
148951240|NCT01752907|537303301|FG000|Overall Study|Lost to Follow-up|2|||
148951241|NCT01752907|537303302|FG001|Overall Study|Lost to Follow-up|1|||
148951242|NCT01752907|537303301|FG000|Overall Study|Decision by Sponsor|6|||
148951243|NCT01752907|537303302|FG001|Overall Study|Decision by Sponsor|9|||
148951244|NCT03098550|537303303|FG000|Overall Study|Disease Progression|30|||
148951245|NCT03098550|537303304|FG001|Overall Study|Disease Progression|19|||
148951246|NCT03098550|537303305|FG002|Overall Study|Disease Progression|41|||
148951247|NCT03098550|537303303|FG000|Overall Study|Study Drug Toxicity|2|||
148951248|NCT03098550|537303304|FG001|Overall Study|Study Drug Toxicity|1|||
148951249|NCT03098550|537303305|FG002|Overall Study|Study Drug Toxicity|0|||
148951250|NCT03098550|537303303|FG000|Overall Study|Death|1|||
148951251|NCT03098550|537303304|FG001|Overall Study|Death|0|||
148951252|NCT03098550|537303305|FG002|Overall Study|Death|0|||
149016920|NCT02065570|537540973|FG001|Maintenance Study|Withdrawal by Subject|0|||
149016921|NCT02065570|537540974|FG002|Maintenance Study|Withdrawal by Subject|1|||
149016922|NCT02065570|537540975|FG003|Maintenance Study|Withdrawal by Subject|4|||
149016923|NCT02065570|537540972|FG000|Maintenance Study|Lost to Follow-up|0|||
149016924|NCT02065570|537540973|FG001|Maintenance Study|Lost to Follow-up|0|||
149016925|NCT02065570|537540974|FG002|Maintenance Study|Lost to Follow-up|2|||
149016926|NCT02065570|537540975|FG003|Maintenance Study|Lost to Follow-up|2|||
149016927|NCT02065570|537540972|FG000|Maintenance Study|Other, Not Specified|0|||
149016928|NCT02065570|537540973|FG001|Maintenance Study|Other, Not Specified|0|||
149016929|NCT02065570|537540974|FG002|Maintenance Study|Other, Not Specified|11|||
149016930|NCT02065570|537540975|FG003|Maintenance Study|Other, Not Specified|5|||
149214961|NCT02859558|538255466|FG004|Step 2|Incarceration|0|||
149214962|NCT01432756|538255467|FG000|Overall Study|Lost to Follow-up|1|||
149214963|NCT01432756|538255468|FG001|Overall Study|Lost to Follow-up|0|||
149214964|NCT01432756|538255469|FG002|Overall Study|Lost to Follow-up|2|||
149214965|NCT01432756|538255470|FG003|Overall Study|Lost to Follow-up|1|||
149214966|NCT00098865|538255473|FG000|Overall Study|Progressive Disease|6|||
149214967|NCT00098865|538255473|FG000|Overall Study|Adverse Event|2|||
149214968|NCT00098865|538255473|FG000|Overall Study|Alternative Therapy|1|||
149214969|NCT00439309|538255474|FG000|Follow-Up|Death|1|||
149214970|NCT00439309|538255475|FG001|Follow-Up|Death|0|||
149214971|NCT00439309|538255474|FG000|Follow-Up|Lost to Follow-up|2|||
149214972|NCT00439309|538255475|FG001|Follow-Up|Lost to Follow-up|0|||
149214973|NCT00439309|538255474|FG000|Follow-Up|Withdrawal by Subject|0|||
149214974|NCT00439309|538255475|FG001|Follow-Up|Withdrawal by Subject|1|||
149214975|NCT00439309|538255474|FG000|Follow-Up|Late response by subject|0|||
149214976|NCT00439309|538255475|FG001|Follow-Up|Late response by subject|1|||
149214977|NCT00430027|538255477|FG000|Overall Study|Study terminated|8|||
149214978|NCT00464620|538255478|FG000|Overall Study|Physician Decision|1|||
149214979|NCT00464620|538255479|FG001|Overall Study|Physician Decision|0|||
149214980|NCT00464620|538255480|FG002|Overall Study|Physician Decision|0|||
149214981|NCT00464620|538255478|FG000|Overall Study|Withdrawal by Subject|1|||
149214982|NCT00464620|538255479|FG001|Overall Study|Withdrawal by Subject|0|||
149214983|NCT00464620|538255480|FG002|Overall Study|Withdrawal by Subject|3|||
149214984|NCT00464620|538255478|FG000|Overall Study|Ineligible sarcoma subtype|0|||
149214985|NCT00464620|538255479|FG001|Overall Study|Ineligible sarcoma subtype|2|||
149214986|NCT00464620|538255480|FG002|Overall Study|Ineligible sarcoma subtype|2|||
149214987|NCT00464620|538255478|FG000|Overall Study|Use of prohibited concomitant medication|0|||
149214988|NCT00464620|538255479|FG001|Overall Study|Use of prohibited concomitant medication|0|||
149214989|NCT00464620|538255480|FG002|Overall Study|Use of prohibited concomitant medication|2|||
149214990|NCT01998906|538255481|FG000|Overall Study|Participants ongoing in follow-up|77|||
149214991|NCT01998906|538255482|FG001|Overall Study|Participants ongoing in follow-up|60|||
149214992|NCT01998906|538255483|FG002|Overall Study|Participants ongoing in follow-up|58|||
149214993|NCT01998906|538255481|FG000|Overall Study|Death|21|||
149016931|NCT00849680|537540978|FG000|Overall Study|Adverse Event|0|||
149016932|NCT00849680|537540979|FG001|Overall Study|Adverse Event|0|||
149016933|NCT00849680|537540980|FG002|Overall Study|Adverse Event|0|||
149016934|NCT00849680|537540981|FG003|Overall Study|Adverse Event|0|||
149016935|NCT00849680|537540982|FG004|Overall Study|Adverse Event|0|||
149016936|NCT00849680|537540983|FG005|Overall Study|Adverse Event|0|||
149016937|NCT00849680|537540984|FG006|Overall Study|Adverse Event|2|||
149016938|NCT00849680|537540985|FG007|Overall Study|Adverse Event|0|||
149016939|NCT00849680|537540978|FG000|Overall Study|Lost to Follow-up|7|||
149016940|NCT00849680|537540979|FG001|Overall Study|Lost to Follow-up|3|||
149016941|NCT00849680|537540980|FG002|Overall Study|Lost to Follow-up|12|||
149016942|NCT00849680|537540981|FG003|Overall Study|Lost to Follow-up|11|||
149016943|NCT00849680|537540982|FG004|Overall Study|Lost to Follow-up|8|||
149016944|NCT00849680|537540983|FG005|Overall Study|Lost to Follow-up|11|||
149214994|NCT01998906|538255482|FG001|Overall Study|Death|30|||
149214995|NCT01998906|538255483|FG002|Overall Study|Death|17|||
149214996|NCT01998906|538255481|FG000|Overall Study|Lack of Efficacy|10|||
148809668|NCT00984867|536780830|FG001|Overall Study|Death|0|||
149214997|NCT01998906|538255482|FG001|Overall Study|Lack of Efficacy|9|||
149214998|NCT01998906|538255483|FG002|Overall Study|Lack of Efficacy|8|||
148809669|NCT00984867|536780829|FG000|Overall Study|Withdrawal by Subject|13|||
149214999|NCT01998906|538255481|FG000|Overall Study|Failure to return|0|||
149215000|NCT01998906|538255482|FG001|Overall Study|Failure to return|2|||
149215001|NCT01998906|538255483|FG002|Overall Study|Failure to return|4|||
149215002|NCT01998906|538255481|FG000|Overall Study|Violation of Selection Criteria|0|||
149215003|NCT01998906|538255482|FG001|Overall Study|Violation of Selection Criteria|0|||
149215004|NCT01998906|538255483|FG002|Overall Study|Violation of Selection Criteria|1|||
149016945|NCT00849680|537540984|FG006|Overall Study|Lost to Follow-up|12|||
149016946|NCT00849680|537540985|FG007|Overall Study|Lost to Follow-up|5|||
149016947|NCT00849680|537540978|FG000|Overall Study|Subject moved|1|||
149215005|NCT01998906|538255481|FG000|Overall Study|Withdrawal by Subject|1|||
149016948|NCT00849680|537540979|FG001|Overall Study|Subject moved|0|||
149016949|NCT00849680|537540980|FG002|Overall Study|Subject moved|3|||
149215006|NCT01998906|538255482|FG001|Overall Study|Withdrawal by Subject|4|||
149215007|NCT01998906|538255483|FG002|Overall Study|Withdrawal by Subject|3|||
149215008|NCT01998906|538255481|FG000|Overall Study|Administrative/Other|2|||
149215009|NCT01998906|538255482|FG001|Overall Study|Administrative/Other|1|||
149215010|NCT01998906|538255483|FG002|Overall Study|Administrative/Other|3|||
149215011|NCT01998906|538255481|FG000|Overall Study|Other|3|||
148684621|NCT00434161|536319451|FG000|Overall Study|Logistical error study assessments|1|||
148684622|NCT00434161|536319452|FG001|Overall Study|Logistical error study assessments|0|||
148684623|NCT00434161|536319453|FG002|Overall Study|Logistical error study assessments|3|||
148684624|NCT03342898|536319454|FG000|Overall Study|Adverse Event|3|||
148684625|NCT03342898|536319455|FG001|Overall Study|Adverse Event|1|||
148684626|NCT03342898|536319456|FG002|Overall Study|Adverse Event|0|||
148684627|NCT03342898|536319454|FG000|Overall Study|Lost to Follow-up|44|||
148684628|NCT03342898|536319455|FG001|Overall Study|Lost to Follow-up|40|||
148684629|NCT03342898|536319456|FG002|Overall Study|Lost to Follow-up|42|||
148684630|NCT03342898|536319454|FG000|Overall Study|Withdrawal of Consent|5|||
148684631|NCT03342898|536319455|FG001|Overall Study|Withdrawal of Consent|9|||
148684632|NCT03342898|536319456|FG002|Overall Study|Withdrawal of Consent|11|||
148951253|NCT03098550|537303303|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
148951254|NCT03098550|537303304|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
148951255|NCT03098550|537303305|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
148951256|NCT03098550|537303303|FG000|Overall Study|Administrative reason by sponsor|0|||
148951257|NCT03098550|537303304|FG001|Overall Study|Administrative reason by sponsor|0|||
148951258|NCT03098550|537303305|FG002|Overall Study|Administrative reason by sponsor|1|||
148951259|NCT03098550|537303303|FG000|Overall Study|Other reasons|2|||
148951260|NCT03098550|537303304|FG001|Overall Study|Other reasons|0|||
148951261|NCT03098550|537303305|FG002|Overall Study|Other reasons|0|||
148951262|NCT01384760|537303307|FG000|Overall Study|Lost to Follow-up|0|||
148951263|NCT01384760|537303308|FG001|Overall Study|Lost to Follow-up|6|||
148951264|NCT01384760|537303307|FG000|Overall Study|Protocol Violation|16|||
148951265|NCT01384760|537303308|FG001|Overall Study|Protocol Violation|0|||
148951266|NCT00630396|537303309|FG000|Overall Study|Death|4|||
148951267|NCT00630396|537303309|FG000|Overall Study|Lost to Follow-up|3|||
148951268|NCT02989194|537303320|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
148951269|NCT02989194|537303321|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
148951270|NCT02989194|537303322|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
148951271|NCT02989194|537303320|FG000|Overall Study|Lost to Follow-up|0|||
148951272|NCT02989194|537303321|FG001|Overall Study|Lost to Follow-up|1|||
148951273|NCT02989194|537303322|FG002|Overall Study|Lost to Follow-up|0|||
148951274|NCT02989194|537303320|FG000|Overall Study|Withdrawal by Subject|0|||
148951275|NCT02989194|537303321|FG001|Overall Study|Withdrawal by Subject|1|||
148951276|NCT02989194|537303322|FG002|Overall Study|Withdrawal by Subject|0|||
148951277|NCT01549860|537303323|FG000|Overall Study|Withdrawal by Subject|1|||
148951278|NCT01549860|537303324|FG001|Overall Study|Withdrawal by Subject|0|||
148951279|NCT01549860|537303323|FG000|Overall Study|Physician Decision|1|||
148951280|NCT01549860|537303324|FG001|Overall Study|Physician Decision|1|||
148951281|NCT01366521|537303325|FG000|Overall Study|Adverse Event|1|||
148951282|NCT01366521|537303326|FG001|Overall Study|Adverse Event|0|||
148951283|NCT01366521|537303327|FG002|Overall Study|Adverse Event|0|||
148951284|NCT01366521|537303328|FG003|Overall Study|Adverse Event|0|||
148951285|NCT01366521|537303325|FG000|Overall Study|Protocol Violation|0|||
148951286|NCT01366521|537303326|FG001|Overall Study|Protocol Violation|0|||
148951287|NCT01366521|537303327|FG002|Overall Study|Protocol Violation|1|||
148951288|NCT01366521|537303328|FG003|Overall Study|Protocol Violation|0|||
148951289|NCT01366521|537303325|FG000|Overall Study|Physician Decision|0|||
148951290|NCT01366521|537303326|FG001|Overall Study|Physician Decision|0|||
148951291|NCT01366521|537303327|FG002|Overall Study|Physician Decision|1|||
148951292|NCT01366521|537303328|FG003|Overall Study|Physician Decision|0|||
148951293|NCT01366521|537303325|FG000|Overall Study|Withdrawal by Subject|0|||
148951294|NCT01366521|537303326|FG001|Overall Study|Withdrawal by Subject|1|||
148951295|NCT01366521|537303327|FG002|Overall Study|Withdrawal by Subject|0|||
149215012|NCT01998906|538255482|FG001|Overall Study|Other|8|||
148951296|NCT01366521|537303328|FG003|Overall Study|Withdrawal by Subject|0|||
149215013|NCT01998906|538255483|FG002|Overall Study|Other|4|||
149215014|NCT01572844|538255484|FG000|Overall Study|Physician Decision|1|||
148684633|NCT03342898|536319454|FG000|Overall Study|Death|0|||
148684634|NCT03342898|536319455|FG001|Overall Study|Death|1|||
148951297|NCT00660023|537303329|FG000|Overall Study|Adverse Event|2|||
148951298|NCT00660023|537303329|FG000|Overall Study|Death|8|||
148951299|NCT00660023|537303329|FG000|Overall Study|Blood Transfusion|5|||
148951300|NCT00660023|537303329|FG000|Overall Study|Renal Transplantation|3|||
148951301|NCT00660023|537303329|FG000|Overall Study|Withdrawal by Subject|1|||
148951302|NCT00660023|537303329|FG000|Overall Study|Missed Pregnancy Test|1|||
148951303|NCT00660023|537303329|FG000|Overall Study|Other Screening Failure|9|||
149215015|NCT01572844|538255485|FG001|Overall Study|Physician Decision|1|||
148684635|NCT03342898|536319456|FG002|Overall Study|Death|1|||
148684636|NCT03342898|536319454|FG000|Overall Study|Reason not Specified|2|||
148951304|NCT04180488|537303330|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
148951305|NCT04180488|537303331|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
149215016|NCT06048809|538255504|FG000|Overall Study|Adverse Event|2|||
149215017|NCT06048809|538255505|FG001|Overall Study|Adverse Event|0|||
149215018|NCT06048809|538255504|FG000|Overall Study|Withdrawal by Subject|1|||
149215019|NCT06048809|538255505|FG001|Overall Study|Withdrawal by Subject|1|||
149215020|NCT04960202|538255507|FG000|Overall Study|Other|5|||
149215021|NCT04960202|538255508|FG001|Overall Study|Other|0|||
149215022|NCT04960202|538255507|FG000|Overall Study|Withdrawal by Subject|37|||
149215023|NCT04960202|538255508|FG001|Overall Study|Withdrawal by Subject|43|||
149215024|NCT04960202|538255507|FG000|Overall Study|Lost to Follow-up|20|||
149215025|NCT04960202|538255508|FG001|Overall Study|Lost to Follow-up|16|||
149215026|NCT04960202|538255507|FG000|Overall Study|Death|0|||
148951306|NCT04180488|537303332|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
148951307|NCT04180488|537303333|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
148951308|NCT04180488|537303334|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
148951309|NCT04180488|537303335|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
148951310|NCT04180488|537303330|FG000|Overall Study|Withdrawal by Subject|8|||
148951311|NCT04180488|537303331|FG001|Overall Study|Withdrawal by Subject|4|||
148951312|NCT04180488|537303332|FG002|Overall Study|Withdrawal by Subject|5|||
148951313|NCT04180488|537303333|FG003|Overall Study|Withdrawal by Subject|2|||
148951314|NCT04180488|537303334|FG004|Overall Study|Withdrawal by Subject|8|||
148951315|NCT04180488|537303335|FG005|Overall Study|Withdrawal by Subject|6|||
148951316|NCT04180488|537303330|FG000|Overall Study|Adverse Event|3|||
148951317|NCT04180488|537303331|FG001|Overall Study|Adverse Event|2|||
148951318|NCT04180488|537303332|FG002|Overall Study|Adverse Event|0|||
148951319|NCT04180488|537303333|FG003|Overall Study|Adverse Event|0|||
148951320|NCT04180488|537303334|FG004|Overall Study|Adverse Event|0|||
148951321|NCT04180488|537303335|FG005|Overall Study|Adverse Event|0|||
148951322|NCT04180488|537303330|FG000|Overall Study|Poor compliance to protocol|0|||
148951323|NCT04180488|537303331|FG001|Overall Study|Poor compliance to protocol|0|||
148951324|NCT04180488|537303332|FG002|Overall Study|Poor compliance to protocol|1|||
148951325|NCT04180488|537303333|FG003|Overall Study|Poor compliance to protocol|0|||
148951326|NCT04180488|537303334|FG004|Overall Study|Poor compliance to protocol|0|||
148951327|NCT04180488|537303335|FG005|Overall Study|Poor compliance to protocol|0|||
148951328|NCT03506815|537303336|FG000|Overall Study|Adverse Event|8|||
149215027|NCT04960202|538255508|FG001|Overall Study|Death|15|||
149215028|NCT02158728|538255509|FG000|Overall Study|no procedure according to CIP done|3|||
149215029|NCT02158728|538255509|FG000|Overall Study|no qualified dataset|24|||
149215030|NCT02234050|538255523|FG000|Overall Study|Lack of Efficacy|38|||
149215031|NCT02234050|538255524|FG001|Overall Study|Lack of Efficacy|22|||
149215032|NCT02234050|538255523|FG000|Overall Study|Adverse Event|13|||
149215033|NCT02234050|538255524|FG001|Overall Study|Adverse Event|1|||
149215034|NCT02234050|538255523|FG000|Overall Study|Withdrawal by Subject|4|||
149215035|NCT02234050|538255524|FG001|Overall Study|Withdrawal by Subject|2|||
149215036|NCT02234050|538255523|FG000|Overall Study|Sponsor's decision|6|||
149215037|NCT02234050|538255524|FG001|Overall Study|Sponsor's decision|0|||
149215038|NCT03774875|538255526|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
149215039|NCT03774875|538255527|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
149215040|NCT03774875|538255526|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
149215041|NCT03774875|538255527|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
149215042|NCT03774875|538255526|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
149215043|NCT03774875|538255527|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
149215044|NCT03774875|538255526|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
149215045|NCT03774875|538255527|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
149215046|NCT03774875|538255526|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
149215047|NCT03774875|538255527|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
149215048|NCT03774875|538255526|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
149215049|NCT03774875|538255527|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
149215050|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
149215051|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
149215052|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
149215053|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
149215054|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
148951329|NCT03506815|537303337|FG001|Overall Study|Adverse Event|0|||
148951330|NCT03506815|537303336|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
148951331|NCT03506815|537303337|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
149016950|NCT00849680|537540981|FG003|Overall Study|Subject moved|1|||
149016951|NCT00849680|537540982|FG004|Overall Study|Subject moved|0|||
149215055|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
149215056|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
149215057|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
149215058|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
149215059|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
149215060|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
149215061|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
149215062|NCT03774875|538255526|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
149215063|NCT03774875|538255527|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
149215064|NCT02352090|538255528|FG000|Overall Study|general malaise|1|||
149215065|NCT02352090|538255529|FG001|Overall Study|general malaise|0|||
149215066|NCT02352090|538255530|FG002|Overall Study|general malaise|0|||
149215067|NCT02352090|538255528|FG000|Overall Study|non-specified mild side-effects|0|||
149215068|NCT02352090|538255529|FG001|Overall Study|non-specified mild side-effects|0|||
149215069|NCT02352090|538255530|FG002|Overall Study|non-specified mild side-effects|2|||
149215070|NCT01678313|538255535|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
149215071|NCT01678313|538255536|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
149215072|NCT01678313|538255535|FG000|Completed the 3-month Therapy|Physician Decision|3|||
149215073|NCT01678313|538255536|FG001|Completed the 3-month Therapy|Physician Decision|4|||
149215074|NCT01678313|538255535|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
149215075|NCT01678313|538255536|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
149215076|NCT01678313|538255535|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
148951332|NCT03506815|537303336|FG000|Overall Study|Protocol Violation|1|||
148951333|NCT03506815|537303337|FG001|Overall Study|Protocol Violation|0|||
148951334|NCT03506815|537303336|FG000|Overall Study|Elective Surgery|1|||
148951335|NCT03506815|537303337|FG001|Overall Study|Elective Surgery|0|||
148951336|NCT04160091|537303340|FG000|Overall Study|Terminated by Sponsor|7|||
148951337|NCT04160091|537303341|FG001|Overall Study|Terminated by Sponsor|3|||
148951338|NCT04160091|537303342|FG002|Overall Study|Terminated by Sponsor|5|||
149215077|NCT01678313|538255536|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
149215078|NCT00981292|538255537|FG000|Day 1|Protocol Violation|1|||
149215079|NCT00981292|538255538|FG001|Day 1|Protocol Violation|0|||
149215080|NCT00981292|538255539|FG002|Day 1|Protocol Violation|0|||
149215081|NCT00981292|538255540|FG003|Day 1|Protocol Violation|0|||
149215082|NCT00981292|538255541|FG004|Day 1|Protocol Violation|0|||
149215083|NCT00981292|538255542|FG005|Day 1|Protocol Violation|2|||
149215084|NCT00981292|538255537|FG000|Day 2|Protocol Violation|2|||
149215085|NCT00981292|538255538|FG001|Day 2|Protocol Violation|0|||
149215086|NCT00981292|538255539|FG002|Day 2|Protocol Violation|0|||
149215087|NCT00981292|538255540|FG003|Day 2|Protocol Violation|0|||
149215088|NCT00981292|538255541|FG004|Day 2|Protocol Violation|0|||
149215089|NCT00981292|538255542|FG005|Day 2|Protocol Violation|0|||
149215090|NCT00981292|538255537|FG000|Day 3|Protocol Violation|0|||
149215091|NCT00981292|538255538|FG001|Day 3|Protocol Violation|0|||
149215092|NCT00981292|538255539|FG002|Day 3|Protocol Violation|0|||
149215093|NCT00981292|538255540|FG003|Day 3|Protocol Violation|0|||
149215094|NCT00981292|538255541|FG004|Day 3|Protocol Violation|0|||
149215095|NCT00981292|538255542|FG005|Day 3|Protocol Violation|1|||
149215096|NCT03377452|538255543|FG000|Overall Study|Refused assessment|0|||
149215097|NCT03377452|538255544|FG001|Overall Study|Refused assessment|2|||
149215098|NCT03377452|538255543|FG000|Overall Study|Lost to Follow-up|5|||
149215099|NCT03377452|538255544|FG001|Overall Study|Lost to Follow-up|4|||
149215100|NCT00796003|538255545|FG000|Overall Study|Disease Progression|2|||
149215101|NCT00796003|538255546|FG001|Overall Study|Disease Progression|13|||
149215102|NCT00796003|538255545|FG000|Overall Study|Adverse Event|1|||
149215103|NCT00796003|538255546|FG001|Overall Study|Adverse Event|7|||
149215104|NCT00796003|538255545|FG000|Overall Study|Specified organ function not met|0|||
149215105|NCT00796003|538255546|FG001|Overall Study|Specified organ function not met|1|||
149215106|NCT00796003|538255545|FG000|Overall Study|Physician Decision|0|||
149215107|NCT00796003|538255546|FG001|Overall Study|Physician Decision|4|||
148951339|NCT04160091|537303343|FG003|Overall Study|Terminated by Sponsor|2|||
148951340|NCT04160091|537303340|FG000|Overall Study|Noncompliance|0|||
148951341|NCT04160091|537303341|FG001|Overall Study|Noncompliance|0|||
148951342|NCT04160091|537303342|FG002|Overall Study|Noncompliance|0|||
148951343|NCT04160091|537303343|FG003|Overall Study|Noncompliance|1|||
148951344|NCT04160091|537303340|FG000|Overall Study|Withdrawal by Subject|0|||
148951345|NCT04160091|537303341|FG001|Overall Study|Withdrawal by Subject|0|||
148951346|NCT04160091|537303342|FG002|Overall Study|Withdrawal by Subject|0|||
148951347|NCT04160091|537303343|FG003|Overall Study|Withdrawal by Subject|1|||
149215108|NCT00796003|538255545|FG000|Overall Study|Withdrawal by Subject|0|||
149215109|NCT00796003|538255546|FG001|Overall Study|Withdrawal by Subject|1|||
149215110|NCT00796003|538255545|FG000|Overall Study|Other|0|||
149215111|NCT00796003|538255546|FG001|Overall Study|Other|1|||
149215112|NCT00796003|538255545|FG000|Overall Study|Participants Not treated|0|||
149215113|NCT00796003|538255546|FG001|Overall Study|Participants Not treated|2|||
149215114|NCT05179057|538255547|FG000|Overall Study|Adverse Event|3|||
149215115|NCT05179057|538255548|FG001|Overall Study|Adverse Event|2|||
149234091|NCT00423137|538326387|FG003|Overall Study|Adverse Event Study disease worse|1|||
149234092|NCT00423137|538326384|FG000|Overall Study|Adverse Event Other|0|||
149234093|NCT00423137|538326385|FG001|Overall Study|Adverse Event Other|0|||
149016952|NCT00849680|537540983|FG005|Overall Study|Subject moved|2|||
149016953|NCT00849680|537540984|FG006|Overall Study|Subject moved|2|||
149016954|NCT00849680|537540985|FG007|Overall Study|Subject moved|2|||
149016955|NCT00849680|537540978|FG000|Overall Study|Withdrawal by Subject|2|||
149016956|NCT00849680|537540979|FG001|Overall Study|Withdrawal by Subject|0|||
149016957|NCT00849680|537540980|FG002|Overall Study|Withdrawal by Subject|0|||
149016958|NCT00849680|537540981|FG003|Overall Study|Withdrawal by Subject|2|||
149016959|NCT00849680|537540982|FG004|Overall Study|Withdrawal by Subject|2|||
149016960|NCT00849680|537540983|FG005|Overall Study|Withdrawal by Subject|2|||
149016961|NCT00849680|537540984|FG006|Overall Study|Withdrawal by Subject|1|||
149016962|NCT00849680|537540985|FG007|Overall Study|Withdrawal by Subject|1|||
149016963|NCT00849680|537540978|FG000|Overall Study|Subject unable to comply with protocol|1|||
149016964|NCT00849680|537540979|FG001|Overall Study|Subject unable to comply with protocol|0|||
149016965|NCT00849680|537540980|FG002|Overall Study|Subject unable to comply with protocol|0|||
149016966|NCT00849680|537540981|FG003|Overall Study|Subject unable to comply with protocol|0|||
149215116|NCT05179057|538255547|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
149215117|NCT05179057|538255548|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
149215118|NCT05179057|538255547|FG000|Overall Study|Study terminated|13|||
149215119|NCT05179057|538255548|FG001|Overall Study|Study terminated|7|||
149215120|NCT05179057|538255547|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
149215121|NCT05179057|538255548|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
149215122|NCT05179057|538255547|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
149215123|NCT05179057|538255548|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
149215124|NCT03345342|538255549|FG000|Open-Label Phase|Adverse Event|30|||
149215125|NCT03345342|538255550|FG001|Open-Label Phase|Adverse Event|0|||
149215126|NCT03345342|538255551|FG002|Open-Label Phase|Adverse Event|0|||
149215127|NCT03345342|538255552|FG003|Open-Label Phase|Adverse Event|0|||
149215128|NCT03345342|538255553|FG004|Open-Label Phase|Adverse Event|0|||
149215129|NCT03345342|538255549|FG000|Open-Label Phase|Death|1|||
149215130|NCT03345342|538255550|FG001|Open-Label Phase|Death|0|||
149215131|NCT03345342|538255551|FG002|Open-Label Phase|Death|0|||
149215132|NCT03345342|538255552|FG003|Open-Label Phase|Death|0|||
149215133|NCT03345342|538255553|FG004|Open-Label Phase|Death|0|||
149215134|NCT03345342|538255549|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
149215135|NCT03345342|538255550|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
149215136|NCT03345342|538255551|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
149215137|NCT03345342|538255552|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
149215138|NCT03345342|538255553|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
149215139|NCT03345342|538255549|FG000|Open-Label Phase|Lack of Efficacy|6|||
149215140|NCT03345342|538255550|FG001|Open-Label Phase|Lack of Efficacy|0|||
148809670|NCT00984867|536780830|FG001|Overall Study|Withdrawal by Subject|4|||
148809671|NCT00984867|536780829|FG000|Overall Study|Lost to Follow-up|3|||
148809672|NCT00984867|536780830|FG001|Overall Study|Lost to Follow-up|4|||
148809673|NCT00984867|536780829|FG000|Overall Study|Poor/non-compliance|0|||
148951348|NCT00381095|537303347|FG000|Overall Study|Death|3|||
148951349|NCT00381095|537303348|FG001|Overall Study|Death|4|||
148951350|NCT00381095|537303347|FG000|Overall Study|Lack of Efficacy|2|||
148951351|NCT00381095|537303348|FG001|Overall Study|Lack of Efficacy|4|||
148951352|NCT00381095|537303347|FG000|Overall Study|Other|2|||
148951353|NCT00381095|537303348|FG001|Overall Study|Other|2|||
148951354|NCT00381095|537303347|FG000|Overall Study|Protocol Violation|1|||
148951355|NCT00381095|537303348|FG001|Overall Study|Protocol Violation|1|||
148951356|NCT00381095|537303347|FG000|Overall Study|Withdrawal by Subject|3|||
148951357|NCT00381095|537303348|FG001|Overall Study|Withdrawal by Subject|3|||
148951358|NCT00381095|537303347|FG000|Overall Study|Adverse Event|2|||
148951359|NCT00381095|537303348|FG001|Overall Study|Adverse Event|7|||
148951360|NCT02692716|537303349|FG000|Overall Study|Lost to Follow-up|2|||
148951361|NCT02692716|537303350|FG001|Overall Study|Lost to Follow-up|5|||
148951362|NCT02692716|537303349|FG000|Overall Study|Withdrawal by Subject|3|||
148951363|NCT02692716|537303350|FG001|Overall Study|Withdrawal by Subject|1|||
148951364|NCT00856284|537303359|FG000|Overall Study|Hyperglycemic rescue|231|||
148951365|NCT00856284|537303360|FG001|Overall Study|Hyperglycemic rescue|201|||
148951366|NCT00856284|537303361|FG002|Overall Study|Hyperglycemic rescue|235|||
148951367|NCT00856284|537303359|FG000|Overall Study|Adverse Event|60|||
148951368|NCT00856284|537303360|FG001|Overall Study|Adverse Event|74|||
148951369|NCT00856284|537303361|FG002|Overall Study|Adverse Event|82|||
148951370|NCT00856284|537303359|FG000|Overall Study|Major protocol deviation|24|||
148951371|NCT00856284|537303360|FG001|Overall Study|Major protocol deviation|16|||
148951372|NCT00856284|537303361|FG002|Overall Study|Major protocol deviation|15|||
148951373|NCT00856284|537303359|FG000|Overall Study|Lost to Follow-up|20|||
148951374|NCT00856284|537303360|FG001|Overall Study|Lost to Follow-up|22|||
148951375|NCT00856284|537303361|FG002|Overall Study|Lost to Follow-up|28|||
148951376|NCT00856284|537303359|FG000|Overall Study|Voluntary withdrawal|48|||
148951377|NCT00856284|537303360|FG001|Overall Study|Voluntary withdrawal|52|||
148951378|NCT00856284|537303361|FG002|Overall Study|Voluntary withdrawal|62|||
148809674|NCT00984867|536780830|FG001|Overall Study|Poor/non-compliance|1|||
148809675|NCT00984867|536780829|FG000|Overall Study|Subject no longer meets study criteria|1|||
148809676|NCT00984867|536780830|FG001|Overall Study|Subject no longer meets study criteria|1|||
148809677|NCT00984867|536780829|FG000|Overall Study|site closing|1|||
148809678|NCT00984867|536780830|FG001|Overall Study|site closing|0|||
148809679|NCT00984867|536780829|FG000|Overall Study|lack of efficacy and subject compliance|1|||
148809680|NCT00984867|536780830|FG001|Overall Study|lack of efficacy and subject compliance|0|||
148809681|NCT00671060|536780831|FG000|Overall Study|Protocol Violation|1|||
148809682|NCT00671060|536780832|FG001|Overall Study|Protocol Violation|0|||
148809683|NCT00671060|536780831|FG000|Overall Study|Physician Decision|0|||
148809684|NCT00671060|536780832|FG001|Overall Study|Physician Decision|1|||
148809685|NCT01461551|536780833|FG000|Overall Study|Physician Decision|2|||
148809686|NCT01461551|536780834|FG001|Overall Study|Physician Decision|1|||
148809687|NCT01461551|536780835|FG002|Overall Study|Physician Decision|2|||
148809688|NCT00303186|536780837|FG000|Overall Study|Other|52|||
148809689|NCT03473197|536780838|FG000|Overall Study|Adverse Event|4|||
148809690|NCT03473197|536780838|FG000|Overall Study|Lost to Follow-up|1|||
148809691|NCT03473197|536780838|FG000|Overall Study|Withdrawal by Subject|5|||
148809692|NCT00785629|536780839|FG000|Overall Study|Adverse Event|2|||
148809693|NCT00785629|536780840|FG001|Overall Study|Adverse Event|1|||
148809694|NCT00785629|536780841|FG002|Overall Study|Adverse Event|1|||
148809695|NCT00785629|536780842|FG003|Overall Study|Adverse Event|5|||
148809696|NCT00785629|536780839|FG000|Overall Study|Protocol Violation|1|||
148809697|NCT00785629|536780840|FG001|Overall Study|Protocol Violation|2|||
148809698|NCT00785629|536780841|FG002|Overall Study|Protocol Violation|4|||
148809699|NCT00785629|536780842|FG003|Overall Study|Protocol Violation|5|||
148809700|NCT00785629|536780839|FG000|Overall Study|administrative decision|5|||
148809701|NCT00785629|536780840|FG001|Overall Study|administrative decision|1|||
148809702|NCT00785629|536780841|FG002|Overall Study|administrative decision|3|||
148809703|NCT00785629|536780842|FG003|Overall Study|administrative decision|4|||
148809704|NCT00785629|536780839|FG000|Overall Study|Withdrawal by Subject|0|||
148809705|NCT00785629|536780840|FG001|Overall Study|Withdrawal by Subject|1|||
148809706|NCT00785629|536780841|FG002|Overall Study|Withdrawal by Subject|2|||
148809707|NCT00785629|536780842|FG003|Overall Study|Withdrawal by Subject|2|||
148809708|NCT02832037|536780845|FG000|Overall Study|Administrative reasons|0|||
148809709|NCT02832037|536780846|FG001|Overall Study|Administrative reasons|0|||
148809710|NCT02832037|536780847|FG002|Overall Study|Administrative reasons|1|||
148809711|NCT02832037|536780848|FG003|Overall Study|Administrative reasons|0|||
148809712|NCT02832037|536780849|FG004|Overall Study|Administrative reasons|0|||
148809713|NCT02832037|536780845|FG000|Overall Study|Protocol Violation|3|||
148951379|NCT00856284|537303359|FG000|Overall Study|Pregnancy|1|||
148951380|NCT00856284|537303360|FG001|Overall Study|Pregnancy|2|||
148951381|NCT00856284|537303361|FG002|Overall Study|Pregnancy|0|||
148951382|NCT00856284|537303359|FG000|Overall Study|Investigator discretion|9|||
148951383|NCT00856284|537303360|FG001|Overall Study|Investigator discretion|8|||
148951384|NCT00856284|537303361|FG002|Overall Study|Investigator discretion|10|||
148951385|NCT00856284|537303359|FG000|Overall Study|Other|15|||
148951386|NCT00856284|537303360|FG001|Overall Study|Other|17|||
148951387|NCT00856284|537303361|FG002|Overall Study|Other|14|||
148951388|NCT00856284|537303359|FG000|Overall Study|Randomized in error|0|||
148951389|NCT00856284|537303360|FG001|Overall Study|Randomized in error|0|||
148951390|NCT00856284|537303361|FG002|Overall Study|Randomized in error|1|||
148951391|NCT01327885|537303365|FG000|Overall Study|Disease progression-according to RECIST|173|||
148951392|NCT01327885|537303366|FG001|Overall Study|Disease progression-according to RECIST|165|||
148951393|NCT01327885|537303365|FG000|Overall Study|Clinical progression|24|||
148951394|NCT01327885|537303366|FG001|Overall Study|Clinical progression|27|||
148951395|NCT01327885|537303365|FG000|Overall Study|Adverse Event|14|||
148951396|NCT01327885|537303366|FG001|Overall Study|Adverse Event|10|||
148951397|NCT01327885|537303365|FG000|Overall Study|Subject choice|5|||
148951398|NCT01327885|537303366|FG001|Overall Study|Subject choice|10|||
148951399|NCT01327885|537303365|FG000|Overall Study|Other|8|||
148951400|NCT01327885|537303366|FG001|Overall Study|Other|6|||
148951401|NCT01327885|537303365|FG000|Overall Study|Withdrawal of consent from study|3|||
148951402|NCT01327885|537303366|FG001|Overall Study|Withdrawal of consent from study|4|||
148951403|NCT01327885|537303365|FG000|Overall Study|Not treated|1|||
148951404|NCT01327885|537303366|FG001|Overall Study|Not treated|1|||
148951405|NCT01327885|537303365|FG000|Overall Study|Administrative decision|0|||
148809714|NCT02832037|536780846|FG001|Overall Study|Protocol Violation|0|||
148809715|NCT02832037|536780847|FG002|Overall Study|Protocol Violation|4|||
148809716|NCT02832037|536780848|FG003|Overall Study|Protocol Violation|1|||
148809717|NCT02832037|536780849|FG004|Overall Study|Protocol Violation|2|||
148951406|NCT01327885|537303366|FG001|Overall Study|Administrative decision|1|||
148951407|NCT03342690|537303373|FG000|Overall Study|Missing Information|9|||
148951408|NCT03342690|537303373|FG000|Overall Study|Protocol Violation|16|||
148951409|NCT03138889|537303374|FG000|Overall Study|Withdrawal by Subject|5|||
148809718|NCT02832037|536780845|FG000|Overall Study|Lost to Follow-up|2|||
148809719|NCT02832037|536780846|FG001|Overall Study|Lost to Follow-up|0|||
148951410|NCT03138889|537303375|FG001|Overall Study|Withdrawal by Subject|5|||
148951411|NCT03138889|537303376|FG002|Overall Study|Withdrawal by Subject|0|||
149016967|NCT00849680|537540982|FG004|Overall Study|Subject unable to comply with protocol|0|||
149016968|NCT00849680|537540983|FG005|Overall Study|Subject unable to comply with protocol|0|||
149016969|NCT00849680|537540984|FG006|Overall Study|Subject unable to comply with protocol|0|||
149016970|NCT00849680|537540985|FG007|Overall Study|Subject unable to comply with protocol|0|||
149016971|NCT00785538|537540987|FG000|Treatment Period|Adverse Event|1|||
149016972|NCT00785538|537540988|FG001|Treatment Period|Adverse Event|2|||
149016973|NCT00785538|537540989|FG002|Treatment Period|Adverse Event|2|||
149016974|NCT00785538|537540990|FG003|Treatment Period|Adverse Event|0|||
149016975|NCT00785538|537540987|FG000|Treatment Period|Withdrawal by Subject|0|||
149016976|NCT00785538|537540988|FG001|Treatment Period|Withdrawal by Subject|0|||
149016977|NCT00785538|537540989|FG002|Treatment Period|Withdrawal by Subject|0|||
149016978|NCT00785538|537540990|FG003|Treatment Period|Withdrawal by Subject|1|||
149215141|NCT03345342|538255551|FG002|Open-Label Phase|Lack of Efficacy|0|||
149215142|NCT03345342|538255552|FG003|Open-Label Phase|Lack of Efficacy|0|||
149215143|NCT03345342|538255553|FG004|Open-Label Phase|Lack of Efficacy|0|||
149215144|NCT03345342|538255549|FG000|Open-Label Phase|Lost to Follow-up|9|||
149215145|NCT03345342|538255550|FG001|Open-Label Phase|Lost to Follow-up|0|||
149215146|NCT03345342|538255551|FG002|Open-Label Phase|Lost to Follow-up|0|||
148684637|NCT03342898|536319455|FG001|Overall Study|Reason not Specified|2|||
148951412|NCT03138889|537303377|FG003|Overall Study|Withdrawal by Subject|2|||
148951413|NCT03138889|537303378|FG004|Overall Study|Withdrawal by Subject|1|||
148951414|NCT03138889|537303379|FG005|Overall Study|Withdrawal by Subject|3|||
148951415|NCT03138889|537303380|FG006|Overall Study|Withdrawal by Subject|0|||
148951416|NCT03138889|537303381|FG007|Overall Study|Withdrawal by Subject|1|||
148951417|NCT00105482|537303382|FG000|Overall Study|Adverse Event|1|||
148951418|NCT00105482|537303383|FG001|Overall Study|Adverse Event|1|||
148951419|NCT00105482|537303382|FG000|Overall Study|Lost to Follow-up|26|||
148951420|NCT00105482|537303383|FG001|Overall Study|Lost to Follow-up|17|||
148951421|NCT00105482|537303382|FG000|Overall Study|Withdrawal by Subject|0|||
148951422|NCT00105482|537303383|FG001|Overall Study|Withdrawal by Subject|1|||
148951423|NCT00105482|537303382|FG000|Overall Study|Lost Interest|29|||
148951424|NCT00105482|537303383|FG001|Overall Study|Lost Interest|32|||
148951425|NCT00105482|537303382|FG000|Overall Study|Scheduling Conflict|2|||
148951426|NCT00105482|537303383|FG001|Overall Study|Scheduling Conflict|3|||
148951427|NCT00105482|537303382|FG000|Overall Study|Withdrawn by PI|1|||
148951428|NCT00105482|537303383|FG001|Overall Study|Withdrawn by PI|1|||
148951429|NCT00411645|537303384|FG000|Overall Study|Consent Withdrawn|13|||
148951430|NCT00411645|537303385|FG001|Overall Study|Consent Withdrawn|22|||
148951431|NCT00411645|537303384|FG000|Overall Study|Death|56|||
148951432|NCT00411645|537303385|FG001|Overall Study|Death|135|||
148951433|NCT00411645|537303384|FG000|Overall Study|Investigator/Sponsor Decision|10|||
148951434|NCT00411645|537303385|FG001|Overall Study|Investigator/Sponsor Decision|7|||
148951435|NCT00411645|537303384|FG000|Overall Study|Lost to Follow-up|2|||
148951436|NCT00411645|537303385|FG001|Overall Study|Lost to Follow-up|0|||
148951437|NCT04016285|537303386|FG000|Overall Study|Did not progress to surgery|2|||
148951438|NCT04016285|537303387|FG001|Overall Study|Did not progress to surgery|5|||
148951439|NCT04016285|537303386|FG000|Overall Study|Failed to collect outcome data|5|||
148951440|NCT04016285|537303387|FG001|Overall Study|Failed to collect outcome data|3|||
148951441|NCT01749514|537303390|FG000|Overall Study|Lost to Follow-up|0|||
148951442|NCT01749514|537303391|FG001|Overall Study|Lost to Follow-up|0|||
148951443|NCT01749514|537303392|FG002|Overall Study|Lost to Follow-up|0|||
148951444|NCT01749514|537303393|FG003|Overall Study|Lost to Follow-up|0|||
148951445|NCT01749514|537303394|FG004|Overall Study|Lost to Follow-up|0|||
148951446|NCT01749514|537303395|FG005|Overall Study|Lost to Follow-up|0|||
148951447|NCT01749514|537303396|FG006|Overall Study|Lost to Follow-up|0|||
148951448|NCT01749514|537303397|FG007|Overall Study|Lost to Follow-up|1|||
148951449|NCT01749514|537303390|FG000|Overall Study|Withdrawal by Subject|0|||
148951450|NCT01749514|537303391|FG001|Overall Study|Withdrawal by Subject|0|||
148951451|NCT01749514|537303392|FG002|Overall Study|Withdrawal by Subject|0|||
148951452|NCT01749514|537303393|FG003|Overall Study|Withdrawal by Subject|0|||
148684638|NCT03342898|536319456|FG002|Overall Study|Reason not Specified|0|||
148951453|NCT01749514|537303394|FG004|Overall Study|Withdrawal by Subject|0|||
148951454|NCT01749514|537303395|FG005|Overall Study|Withdrawal by Subject|1|||
149016979|NCT03382600|537540991|FG000|Overall Study|Adverse Event|3|||
149215147|NCT03345342|538255552|FG003|Open-Label Phase|Lost to Follow-up|0|||
149215148|NCT03345342|538255553|FG004|Open-Label Phase|Lost to Follow-up|0|||
148951455|NCT01749514|537303396|FG006|Overall Study|Withdrawal by Subject|0|||
148951456|NCT01749514|537303397|FG007|Overall Study|Withdrawal by Subject|1|||
148951457|NCT01749514|537303390|FG000|Overall Study|Not Reported|0|||
148951458|NCT01749514|537303391|FG001|Overall Study|Not Reported|0|||
148951459|NCT01749514|537303392|FG002|Overall Study|Not Reported|0|||
148951460|NCT01749514|537303393|FG003|Overall Study|Not Reported|0|||
149016980|NCT03382600|537540992|FG001|Overall Study|Adverse Event|3|||
149016981|NCT03382600|537540991|FG000|Overall Study|Clinical Disease Progression|2|||
149215149|NCT03345342|538255549|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
148684639|NCT01387282|536319457|FG000|Overall Study|Death|47|||
149016982|NCT03382600|537540992|FG001|Overall Study|Clinical Disease Progression|4|||
149016983|NCT03382600|537540991|FG000|Overall Study|Radiological Progression|40|||
149016984|NCT03382600|537540992|FG001|Overall Study|Radiological Progression|31|||
149215150|NCT03345342|538255550|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
149215151|NCT03345342|538255551|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
149016985|NCT03382600|537540991|FG000|Overall Study|Withdrawal by Subject|0|||
149016986|NCT03382600|537540992|FG001|Overall Study|Withdrawal by Subject|1|||
149215152|NCT03345342|538255552|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
149215153|NCT03345342|538255553|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
149215154|NCT03345342|538255549|FG000|Open-Label Phase|Physician Decision|4|||
149215155|NCT03345342|538255550|FG001|Open-Label Phase|Physician Decision|0|||
149215156|NCT03345342|538255551|FG002|Open-Label Phase|Physician Decision|0|||
149215157|NCT03345342|538255552|FG003|Open-Label Phase|Physician Decision|0|||
149016987|NCT03382600|537540991|FG000|Overall Study|Other|9|||
149016988|NCT03382600|537540992|FG001|Overall Study|Other|7|||
149016989|NCT04276090|537540995|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
149016990|NCT04276090|537540996|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
149016991|NCT02066532|537541000|FG000|Phase II|Withdrawal by Subject|1|||
149016992|NCT02066532|537541001|FG001|Phase II|Withdrawal by Subject|0|||
149016993|NCT02066532|537541002|FG002|Phase II|Withdrawal by Subject|0|||
149016994|NCT02066532|537541003|FG003|Phase II|Withdrawal by Subject|0|||
149016995|NCT05033080|537541004|FG000|Overall Study|Adverse Event|4|||
149016996|NCT05033080|537541005|FG001|Overall Study|Adverse Event|4|||
149016997|NCT05033080|537541004|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
149215158|NCT03345342|538255553|FG004|Open-Label Phase|Physician Decision|0|||
149215159|NCT03345342|538255549|FG000|Open-Label Phase|Protocol Violation|8|||
149016998|NCT05033080|537541005|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
149016999|NCT05033080|537541004|FG000|Overall Study|Lost to Follow-up|1|||
149017000|NCT05033080|537541005|FG001|Overall Study|Lost to Follow-up|0|||
149017001|NCT05033080|537541004|FG000|Overall Study|Other non-compliance|0|||
149017002|NCT05033080|537541005|FG001|Overall Study|Other non-compliance|1|||
149017003|NCT05033080|537541004|FG000|Overall Study|Physician Decision|0|||
149017004|NCT05033080|537541005|FG001|Overall Study|Physician Decision|1|||
149017005|NCT05033080|537541004|FG000|Overall Study|Other|1|||
149017006|NCT05033080|537541005|FG001|Overall Study|Other|1|||
149017007|NCT03560245|537541007|FG000|Overall Study|Withdrawal by Subject|3|||
149017008|NCT03560245|537541008|FG001|Overall Study|Withdrawal by Subject|2|||
149017009|NCT03560245|537541007|FG000|Overall Study|Adverse Event|1|||
149215160|NCT03345342|538255550|FG001|Open-Label Phase|Protocol Violation|0|||
149215161|NCT03345342|538255551|FG002|Open-Label Phase|Protocol Violation|0|||
149215162|NCT03345342|538255552|FG003|Open-Label Phase|Protocol Violation|0|||
149215163|NCT03345342|538255553|FG004|Open-Label Phase|Protocol Violation|0|||
149215164|NCT03345342|538255549|FG000|Open-Label Phase|Withdrawal by Subject|57|||
149215165|NCT03345342|538255550|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149215166|NCT03345342|538255551|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149215167|NCT03345342|538255552|FG003|Open-Label Phase|Withdrawal by Subject|0|||
149215168|NCT03345342|538255553|FG004|Open-Label Phase|Withdrawal by Subject|0|||
149215169|NCT03345342|538255549|FG000|Open-Label Phase|Other|15|||
149215170|NCT03345342|538255550|FG001|Open-Label Phase|Other|0|||
149215171|NCT03345342|538255551|FG002|Open-Label Phase|Other|0|||
149215172|NCT03345342|538255552|FG003|Open-Label Phase|Other|0|||
149215173|NCT03345342|538255553|FG004|Open-Label Phase|Other|0|||
149215174|NCT03345342|538255549|FG000|Double-Blind Phase|Adverse Event|0|||
149215175|NCT03345342|538255550|FG001|Double-Blind Phase|Adverse Event|1|||
149215176|NCT03345342|538255551|FG002|Double-Blind Phase|Adverse Event|6|||
149215177|NCT03345342|538255552|FG003|Double-Blind Phase|Adverse Event|0|||
149215178|NCT03345342|538255553|FG004|Double-Blind Phase|Adverse Event|0|||
149215179|NCT03345342|538255549|FG000|Double-Blind Phase|Death|0|||
149215180|NCT03345342|538255550|FG001|Double-Blind Phase|Death|2|||
149215181|NCT03345342|538255551|FG002|Double-Blind Phase|Death|1|||
149215182|NCT03345342|538255552|FG003|Double-Blind Phase|Death|0|||
149215183|NCT03345342|538255553|FG004|Double-Blind Phase|Death|0|||
149215184|NCT03345342|538255549|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
149215185|NCT03345342|538255550|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
149215186|NCT03345342|538255551|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
149017010|NCT03560245|537541008|FG001|Overall Study|Adverse Event|1|||
149215187|NCT03345342|538255552|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
149017011|NCT03560245|537541007|FG000|Overall Study|Protocol Violation|1|||
149017012|NCT03560245|537541008|FG001|Overall Study|Protocol Violation|0|||
149017013|NCT03560245|537541007|FG000|Overall Study|Death|0|||
149017014|NCT03560245|537541008|FG001|Overall Study|Death|1|||
149017015|NCT03560245|537541007|FG000|Overall Study|Lost to Follow-up|0|||
149017016|NCT03560245|537541008|FG001|Overall Study|Lost to Follow-up|1|||
149017017|NCT03560245|537541007|FG000|Overall Study|Physician Decision|0|||
149215188|NCT03345342|538255553|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
149215189|NCT03345342|538255549|FG000|Double-Blind Phase|Lost to Follow-up|0|||
148951461|NCT01749514|537303394|FG004|Overall Study|Not Reported|0|||
148951462|NCT01749514|537303395|FG005|Overall Study|Not Reported|0|||
148951463|NCT01749514|537303396|FG006|Overall Study|Not Reported|0|||
149215190|NCT03345342|538255550|FG001|Double-Blind Phase|Lost to Follow-up|1|||
149215191|NCT03345342|538255551|FG002|Double-Blind Phase|Lost to Follow-up|7|||
149215192|NCT03345342|538255552|FG003|Double-Blind Phase|Lost to Follow-up|0|||
149215193|NCT03345342|538255553|FG004|Double-Blind Phase|Lost to Follow-up|0|||
149215194|NCT03345342|538255549|FG000|Double-Blind Phase|Physician Decision|0|||
149215195|NCT03345342|538255550|FG001|Double-Blind Phase|Physician Decision|1|||
149215196|NCT03345342|538255551|FG002|Double-Blind Phase|Physician Decision|4|||
149215197|NCT03345342|538255552|FG003|Double-Blind Phase|Physician Decision|0|||
149215198|NCT03345342|538255553|FG004|Double-Blind Phase|Physician Decision|0|||
149215199|NCT03345342|538255549|FG000|Double-Blind Phase|Protocol Violation|0|||
149215200|NCT03345342|538255550|FG001|Double-Blind Phase|Protocol Violation|0|||
149215201|NCT03345342|538255551|FG002|Double-Blind Phase|Protocol Violation|1|||
149215202|NCT03345342|538255552|FG003|Double-Blind Phase|Protocol Violation|0|||
149215203|NCT03345342|538255553|FG004|Double-Blind Phase|Protocol Violation|0|||
149215204|NCT03345342|538255549|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
149215205|NCT03345342|538255550|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
149215206|NCT03345342|538255551|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
149215207|NCT03345342|538255552|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
149215208|NCT03345342|538255553|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
149215209|NCT03345342|538255549|FG000|Double-Blind Phase|Other|0|||
149215210|NCT03345342|538255550|FG001|Double-Blind Phase|Other|1|||
149215211|NCT03345342|538255551|FG002|Double-Blind Phase|Other|3|||
149215212|NCT03345342|538255552|FG003|Double-Blind Phase|Other|0|||
149215213|NCT03345342|538255553|FG004|Double-Blind Phase|Other|0|||
149215214|NCT03345342|538255549|FG000|Follow-Up Phase|Adverse Event|0|||
149215215|NCT03345342|538255550|FG001|Follow-Up Phase|Adverse Event|0|||
149215216|NCT03345342|538255551|FG002|Follow-Up Phase|Adverse Event|0|||
149215217|NCT03345342|538255552|FG003|Follow-Up Phase|Adverse Event|0|||
149215218|NCT03345342|538255553|FG004|Follow-Up Phase|Adverse Event|4|||
149215219|NCT03345342|538255549|FG000|Follow-Up Phase|Lost to Follow-up|0|||
149215220|NCT03345342|538255550|FG001|Follow-Up Phase|Lost to Follow-up|0|||
149215221|NCT03345342|538255551|FG002|Follow-Up Phase|Lost to Follow-up|0|||
149215222|NCT03345342|538255552|FG003|Follow-Up Phase|Lost to Follow-up|0|||
149215223|NCT03345342|538255553|FG004|Follow-Up Phase|Lost to Follow-up|6|||
148951464|NCT01749514|537303397|FG007|Overall Study|Not Reported|5|||
148951465|NCT02509156|537303400|FG000|Randomized Phase|Death|1|||
149215224|NCT03345342|538255549|FG000|Follow-Up Phase|Physician Decision|0|||
148684640|NCT01387282|536319458|FG001|Overall Study|Death|16|||
148684641|NCT01387282|536319457|FG000|Overall Study|Other|5|||
148684642|NCT01387282|536319458|FG001|Overall Study|Other|1|||
148951466|NCT02509156|537303401|FG001|Randomized Phase|Death|0|||
149215225|NCT03345342|538255550|FG001|Follow-Up Phase|Physician Decision|0|||
149215226|NCT03345342|538255551|FG002|Follow-Up Phase|Physician Decision|0|||
149215227|NCT03345342|538255552|FG003|Follow-Up Phase|Physician Decision|0|||
149215228|NCT03345342|538255553|FG004|Follow-Up Phase|Physician Decision|5|||
149215229|NCT03345342|538255549|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
149215230|NCT03345342|538255550|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
149215231|NCT03345342|538255551|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
149215232|NCT03345342|538255552|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
149215233|NCT03345342|538255553|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
149215234|NCT03345342|538255549|FG000|Follow-Up Phase|Other|0|||
149215235|NCT03345342|538255550|FG001|Follow-Up Phase|Other|0|||
149215236|NCT03345342|538255551|FG002|Follow-Up Phase|Other|0|||
149215237|NCT03345342|538255552|FG003|Follow-Up Phase|Other|3|||
149215238|NCT03345342|538255553|FG004|Follow-Up Phase|Other|1|||
149215239|NCT02437162|538255554|FG000|Overall Study|Protocol Violation|0|||
149215240|NCT02437162|538255555|FG001|Overall Study|Protocol Violation|1|||
149215241|NCT02437162|538255556|FG002|Overall Study|Protocol Violation|0|||
149215242|NCT02437162|538255554|FG000|Overall Study|Randomized but not treated|0|||
149215243|NCT02437162|538255555|FG001|Overall Study|Randomized but not treated|0|||
149215244|NCT02437162|538255556|FG002|Overall Study|Randomized but not treated|1|||
149215245|NCT02437162|538255554|FG000|Overall Study|Study discontinued by Sponsor|93|||
149215246|NCT02437162|538255555|FG001|Overall Study|Study discontinued by Sponsor|98|||
149215247|NCT02437162|538255556|FG002|Overall Study|Study discontinued by Sponsor|97|||
149215248|NCT02437162|538255554|FG000|Overall Study|Withdrawal by Subject|13|||
148684643|NCT01387282|536319457|FG000|Overall Study|Unrelated AE|6|||
148951467|NCT02509156|537303400|FG000|Randomized Phase|Withdrawal by Subject|1|||
149215249|NCT02437162|538255555|FG001|Overall Study|Withdrawal by Subject|7|||
149215250|NCT02437162|538255556|FG002|Overall Study|Withdrawal by Subject|9|||
149215251|NCT02437162|538255554|FG000|Overall Study|Adverse Event|0|||
148684644|NCT01387282|536319458|FG001|Overall Study|Unrelated AE|4|||
149017018|NCT03560245|537541008|FG001|Overall Study|Physician Decision|1|||
149215252|NCT02437162|538255555|FG001|Overall Study|Adverse Event|1|||
149215253|NCT02437162|538255556|FG002|Overall Study|Adverse Event|0|||
149215254|NCT02437162|538255554|FG000|Overall Study|Lost to Follow-up|1|||
149215255|NCT02437162|538255555|FG001|Overall Study|Lost to Follow-up|0|||
149215256|NCT02437162|538255556|FG002|Overall Study|Lost to Follow-up|1|||
149215257|NCT02437162|538255554|FG000|Overall Study|Death|0|||
149215258|NCT02437162|538255555|FG001|Overall Study|Death|1|||
149215259|NCT02437162|538255556|FG002|Overall Study|Death|0|||
149215260|NCT02437162|538255554|FG000|Overall Study|Other|0|||
149215261|NCT02437162|538255555|FG001|Overall Study|Other|0|||
149215262|NCT02437162|538255556|FG002|Overall Study|Other|1|||
149215263|NCT03981744|538255561|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
149215264|NCT03981744|538255562|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
149215265|NCT03981744|538255563|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
149215266|NCT03981744|538255564|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
149215267|NCT03981744|538255561|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
149215268|NCT03981744|538255562|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
149215269|NCT03981744|538255563|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
149215270|NCT03981744|538255564|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
149215271|NCT03981744|538255561|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
149215272|NCT03981744|538255562|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
149215273|NCT03981744|538255563|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
149215274|NCT03981744|538255564|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
149215275|NCT02782104|538255565|FG000|Overall Study|Other|215|||
149215276|NCT02782104|538255565|FG000|Overall Study|Induction Day 28 Non Responder|9|||
149215277|NCT02782104|538255565|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149215278|NCT02782104|538255565|FG000|Overall Study|Death|8|||
149215279|NCT02782104|538255565|FG000|Overall Study|Pregnancy|6|||
149215280|NCT02782104|538255565|FG000|Overall Study|Withdrawal by Subject|63|||
149215281|NCT02782104|538255565|FG000|Overall Study|Protocol Violation|7|||
149215282|NCT02782104|538255565|FG000|Overall Study|Lack of Efficacy|61|||
149215283|NCT02782104|538255565|FG000|Overall Study|Lost to Follow-up|23|||
149215284|NCT02782104|538255565|FG000|Overall Study|Adverse Event|74|||
149215285|NCT03464136|538255566|FG000|Overall Study|Lost to Follow-up|5|||
149215286|NCT03464136|538255567|FG001|Overall Study|Lost to Follow-up|8|||
149215287|NCT03464136|538255566|FG000|Overall Study|Withdrawal by Subject|16|||
149215288|NCT03464136|538255567|FG001|Overall Study|Withdrawal by Subject|13|||
149215289|NCT03464136|538255566|FG000|Overall Study|Death|1|||
149215290|NCT03464136|538255567|FG001|Overall Study|Death|0|||
149215291|NCT03464136|538255566|FG000|Overall Study|Other|8|||
149215292|NCT03464136|538255567|FG001|Overall Study|Other|4|||
149215293|NCT04338321|538255568|FG000|Overall Study|Adverse Event|4|||
149215294|NCT04338321|538255569|FG001|Overall Study|Adverse Event|10|||
149215295|NCT04338321|538255568|FG000|Overall Study|Death|1|||
149215296|NCT04338321|538255569|FG001|Overall Study|Death|1|||
149215297|NCT04338321|538255568|FG000|Overall Study|Lost to Follow-up|4|||
149215298|NCT04338321|538255569|FG001|Overall Study|Lost to Follow-up|9|||
149215299|NCT04338321|538255568|FG000|Overall Study|Withdrawal by Subject|45|||
149215300|NCT04338321|538255569|FG001|Overall Study|Withdrawal by Subject|69|||
149215301|NCT04338321|538255568|FG000|Overall Study|Physician Decision|5|||
149215302|NCT04338321|538255569|FG001|Overall Study|Physician Decision|9|||
149215303|NCT04338321|538255568|FG000|Overall Study|Other|3|||
149215304|NCT04338321|538255569|FG001|Overall Study|Other|10|||
149215305|NCT02438787|538255570|FG000|Overall Study|Adverse Event|1|||
149215306|NCT02438787|538255571|FG001|Overall Study|Adverse Event|0|||
149215307|NCT02438787|538255572|FG002|Overall Study|Adverse Event|2|||
149215308|NCT02438787|538255570|FG000|Overall Study|Lack of Efficacy|1|||
149215309|NCT02438787|538255571|FG001|Overall Study|Lack of Efficacy|2|||
149215310|NCT02438787|538255572|FG002|Overall Study|Lack of Efficacy|0|||
149215311|NCT02438787|538255570|FG000|Overall Study|Lost to Follow-up|0|||
149215312|NCT02438787|538255571|FG001|Overall Study|Lost to Follow-up|1|||
149215313|NCT02438787|538255572|FG002|Overall Study|Lost to Follow-up|0|||
149215314|NCT02438787|538255570|FG000|Overall Study|Protocol Violation|0|||
149215315|NCT02438787|538255571|FG001|Overall Study|Protocol Violation|0|||
149215316|NCT02438787|538255572|FG002|Overall Study|Protocol Violation|1|||
149215317|NCT02438787|538255570|FG000|Overall Study|Withdrawal by Subject|15|||
149215318|NCT02438787|538255571|FG001|Overall Study|Withdrawal by Subject|7|||
149215319|NCT02438787|538255572|FG002|Overall Study|Withdrawal by Subject|10|||
149215320|NCT02438787|538255570|FG000|Overall Study|Study discontinued by sponsor|64|||
149215321|NCT02438787|538255571|FG001|Overall Study|Study discontinued by sponsor|72|||
149215322|NCT02438787|538255572|FG002|Overall Study|Study discontinued by sponsor|69|||
149215323|NCT02438787|538255570|FG000|Overall Study|Other|0|||
149215324|NCT02438787|538255571|FG001|Overall Study|Other|1|||
149215325|NCT02438787|538255572|FG002|Overall Study|Other|0|||
149215326|NCT02438787|538255570|FG000|Overall Study|Site terminated by sponsor|0|||
148809720|NCT02832037|536780847|FG002|Overall Study|Lost to Follow-up|3|||
149215327|NCT02438787|538255571|FG001|Overall Study|Site terminated by sponsor|0|||
149215328|NCT02438787|538255572|FG002|Overall Study|Site terminated by sponsor|1|||
149215329|NCT03412565|538255573|FG000|Overall Study|Lost to Follow-up|0|||
149215330|NCT03412565|538255574|FG001|Overall Study|Lost to Follow-up|0|||
149215331|NCT03412565|538255575|FG002|Overall Study|Lost to Follow-up|1|||
149215332|NCT03412565|538255576|FG003|Overall Study|Lost to Follow-up|0|||
149215333|NCT03412565|538255573|FG000|Overall Study|Physician Decision|0|||
149215334|NCT03412565|538255574|FG001|Overall Study|Physician Decision|0|||
149215335|NCT03412565|538255575|FG002|Overall Study|Physician Decision|0|||
149215336|NCT03412565|538255576|FG003|Overall Study|Physician Decision|1|||
149017019|NCT03560245|537541007|FG000|Overall Study|Other|0|||
149017020|NCT03560245|537541008|FG001|Overall Study|Other|1|||
149017021|NCT01040780|537542462|FG000|Overall Study|Protocol Violation|1|||
149017022|NCT01040780|537542463|FG001|Overall Study|Protocol Violation|3|||
149017023|NCT03681639|537542464|FG000|Overall Study|Death|4|||
149017024|NCT03681639|537542464|FG000|Overall Study|Lost to Follow-up|2|||
149017025|NCT03681639|537542464|FG000|Overall Study|Withdrawal by Subject|1|||
149017026|NCT03681639|537542464|FG000|Overall Study|Adverse Event|2|||
149017027|NCT00581113|537542465|FG000|Overall Study|Withdrawal by Subject|0|||
149017028|NCT00581113|537542466|FG001|Overall Study|Withdrawal by Subject|1|||
149017029|NCT01818141|537542467|FG000|Overall Study|Withdrawal by Subject|2|||
149017030|NCT01818141|537542468|FG001|Overall Study|Withdrawal by Subject|0|||
149017031|NCT01818141|537542467|FG000|Overall Study|No baseline C.diff colonies|1|||
149017032|NCT01818141|537542468|FG001|Overall Study|No baseline C.diff colonies|1|||
149017033|NCT01818141|537542467|FG000|Overall Study|Lost to Follow-up|0|||
149017034|NCT01818141|537542468|FG001|Overall Study|Lost to Follow-up|2|||
149017035|NCT02169830|537542474|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
149017036|NCT02169830|537542475|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
149017037|NCT02169830|537542476|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
149017038|NCT02169830|537542474|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
149017039|NCT02169830|537542475|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
149017040|NCT02169830|537542476|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
149017041|NCT02169830|537542474|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
149017042|NCT02169830|537542475|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
149017043|NCT02169830|537542476|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
149017044|NCT02169830|537542474|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
149017045|NCT02169830|537542475|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
149017046|NCT02169830|537542476|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
149017047|NCT02169830|537542474|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
149017048|NCT02169830|537542475|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
149017049|NCT02169830|537542476|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
149017050|NCT02001974|537542479|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
149017051|NCT02001974|537542480|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
149017052|NCT02001974|537542481|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
149017053|NCT02001974|537542479|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
149017054|NCT02001974|537542480|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
149017055|NCT02001974|537542481|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
149017056|NCT02001974|537542479|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
149017057|NCT02001974|537542480|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
149017058|NCT02001974|537542481|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
149017059|NCT02001974|537542479|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
149017060|NCT02001974|537542480|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
149017061|NCT02001974|537542481|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
149017062|NCT00993317|537542482|FG000|Overall Study|Adverse Event|2|||
149017063|NCT00993317|537542483|FG001|Overall Study|Adverse Event|4|||
149017064|NCT00993317|537542482|FG000|Overall Study|Lack of Efficacy|18|||
149017065|NCT00993317|537542483|FG001|Overall Study|Lack of Efficacy|18|||
149215337|NCT03412565|538255573|FG000|Overall Study|Withdrawal by Subject|0|||
149215338|NCT03412565|538255574|FG001|Overall Study|Withdrawal by Subject|4|||
149215339|NCT03412565|538255575|FG002|Overall Study|Withdrawal by Subject|5|||
149215340|NCT03412565|538255576|FG003|Overall Study|Withdrawal by Subject|5|||
149215341|NCT03412565|538255573|FG000|Overall Study|Death|1|||
149215342|NCT03412565|538255574|FG001|Overall Study|Death|3|||
149215343|NCT03412565|538255575|FG002|Overall Study|Death|4|||
149215344|NCT03412565|538255576|FG003|Overall Study|Death|5|||
149215345|NCT03412565|538255573|FG000|Overall Study|Data collection ended|0|||
149215346|NCT03412565|538255574|FG001|Overall Study|Data collection ended|41|||
149215347|NCT03412565|538255575|FG002|Overall Study|Data collection ended|41|||
149215348|NCT03412565|538255576|FG003|Overall Study|Data collection ended|40|||
149215349|NCT03375203|538255577|FG000|Overall Study|Protocol Violation|0|||
149215350|NCT03375203|538255578|FG001|Overall Study|Protocol Violation|0|||
149017066|NCT00993317|537542482|FG000|Overall Study|Withdrawal by Subject|0|||
149017067|NCT00993317|537542483|FG001|Overall Study|Withdrawal by Subject|2|||
149215351|NCT03375203|538255579|FG002|Overall Study|Protocol Violation|1|||
149017068|NCT00993317|537542482|FG000|Overall Study|Investigator's opinion|0|||
149017069|NCT00993317|537542483|FG001|Overall Study|Investigator's opinion|1|||
149017070|NCT00993317|537542482|FG000|Overall Study|Early study termination at the site|1|||
149215352|NCT03375203|538255580|FG003|Overall Study|Protocol Violation|0|||
149215353|NCT03375203|538255581|FG004|Overall Study|Protocol Violation|0|||
149215354|NCT03375203|538255577|FG000|Overall Study|Adverse Event|2|||
149017071|NCT00993317|537542483|FG001|Overall Study|Early study termination at the site|0|||
149017072|NCT01380990|537542484|FG000|Overall Study|Treatment Failure|1|||
149017073|NCT01380990|537542485|FG001|Overall Study|Treatment Failure|0|||
149017074|NCT01380990|537542484|FG000|Overall Study|Death|0|||
149017075|NCT01380990|537542485|FG001|Overall Study|Death|1|||
149017076|NCT02374593|537542486|FG000|Overall Study|non-compliant|2|||
149017077|NCT02374593|537542487|FG001|Overall Study|non-compliant|0|||
149017078|NCT00579982|537542488|FG000|Overall Study|Adverse Event|4|||
149017079|NCT00579982|537542488|FG000|Overall Study|Protocol Violation|4|||
149017080|NCT03192215|537542489|FG000|Overall Study|Death|28|||
149017081|NCT03192215|537542490|FG001|Overall Study|Death|23|||
149017082|NCT03192215|537542489|FG000|Overall Study|Lost to Follow-up|10|||
149017083|NCT03192215|537542490|FG001|Overall Study|Lost to Follow-up|15|||
149017084|NCT03192215|537542489|FG000|Overall Study|Withdrawal by Subject|49|||
149017085|NCT03192215|537542490|FG001|Overall Study|Withdrawal by Subject|48|||
149017086|NCT03192215|537542489|FG000|Overall Study|Other as reported in analysis|4|||
149017087|NCT03192215|537542490|FG001|Overall Study|Other as reported in analysis|1|||
149017088|NCT02038764|537542491|FG000|Overall Study|Adverse Event|0|||
149017089|NCT02038764|537542492|FG001|Overall Study|Adverse Event|0|||
149017090|NCT02038764|537542493|FG002|Overall Study|Adverse Event|1|||
149017091|NCT02038764|537542494|FG003|Overall Study|Adverse Event|0|||
149017092|NCT02038764|537542495|FG004|Overall Study|Adverse Event|0|||
149017093|NCT02038764|537542491|FG000|Overall Study|Lost to Follow-up|0|||
149017094|NCT02038764|537542492|FG001|Overall Study|Lost to Follow-up|1|||
149017095|NCT02038764|537542493|FG002|Overall Study|Lost to Follow-up|0|||
149017096|NCT02038764|537542494|FG003|Overall Study|Lost to Follow-up|0|||
149017097|NCT02038764|537542495|FG004|Overall Study|Lost to Follow-up|0|||
149017098|NCT02038764|537542491|FG000|Overall Study|Withdrawal by Subject|0|||
149017099|NCT02038764|537542492|FG001|Overall Study|Withdrawal by Subject|0|||
149017100|NCT02038764|537542493|FG002|Overall Study|Withdrawal by Subject|0|||
149017101|NCT02038764|537542494|FG003|Overall Study|Withdrawal by Subject|0|||
149017102|NCT02038764|537542495|FG004|Overall Study|Withdrawal by Subject|1|||
149017103|NCT02038764|537542491|FG000|Overall Study|Other|1|||
149017104|NCT02038764|537542492|FG001|Overall Study|Other|0|||
149017105|NCT02038764|537542493|FG002|Overall Study|Other|1|||
149017106|NCT02038764|537542494|FG003|Overall Study|Other|0|||
149017107|NCT02038764|537542495|FG004|Overall Study|Other|0|||
149017108|NCT04844918|537542497|FG000|Overall Study|Adverse Event|7|||
148684645|NCT01387282|536319457|FG000|Overall Study|Withdrawal by patient|33|||
148684646|NCT01387282|536319458|FG001|Overall Study|Withdrawal by patient|23|||
148684647|NCT01387282|536319457|FG000|Overall Study|Study drug-related AE|2|||
148684648|NCT01387282|536319458|FG001|Overall Study|Study drug-related AE|2|||
148684649|NCT01387282|536319457|FG000|Overall Study|Lost to Follow-up|4|||
148684650|NCT01387282|536319458|FG001|Overall Study|Lost to Follow-up|1|||
148684651|NCT03997448|536319461|FG000|Study Treatment|Disease Progression|1|||
148684652|NCT03997448|536319461|FG000|Study Treatment|Symptomatic Deterioration|1|||
148684653|NCT03997448|536319461|FG000|Follow up|Death|2|||
148684654|NCT03997448|536319461|FG000|Follow up|study terminated|1|||
148684655|NCT01312779|536319462|FG000|Overall Study|Withdrawal by Subject|2|||
148684656|NCT01312779|536319462|FG000|Overall Study|Death|3|||
148684657|NCT01312779|536319462|FG000|Overall Study|Not Implanted with Device|27|||
148684658|NCT01621490|536319463|FG000|Overall Study|Subject no longer meets study criteria|0|||
148684659|NCT01621490|536319464|FG001|Overall Study|Subject no longer meets study criteria|0|||
148684660|NCT01621490|536319465|FG002|Overall Study|Subject no longer meets study criteria|0|||
148684661|NCT01621490|536319466|FG003|Overall Study|Subject no longer meets study criteria|0|||
148684662|NCT01621490|536319467|FG004|Overall Study|Subject no longer meets study criteria|1|||
148684663|NCT01621490|536319468|FG005|Overall Study|Subject no longer meets study criteria|0|||
148684664|NCT01621490|536319469|FG006|Overall Study|Subject no longer meets study criteria|0|||
148684665|NCT01621490|536319470|FG007|Overall Study|Subject no longer meets study criteria|0|||
148684666|NCT01621490|536319471|FG008|Overall Study|Subject no longer meets study criteria|0|||
148684667|NCT01621490|536319472|FG009|Overall Study|Subject no longer meets study criteria|0|||
148684668|NCT01621490|536319473|FG010|Overall Study|Subject no longer meets study criteria|0|||
148684669|NCT01621490|536319463|FG000|Overall Study|Maximum clinical benefit|3|||
148684670|NCT01621490|536319464|FG001|Overall Study|Maximum clinical benefit|2|||
149017109|NCT04844918|537542498|FG001|Overall Study|Adverse Event|8|||
149017110|NCT04844918|537542499|FG002|Overall Study|Adverse Event|5|||
149017111|NCT04844918|537542497|FG000|Overall Study|Physician Decision|0|||
149017112|NCT04844918|537542498|FG001|Overall Study|Physician Decision|1|||
149017113|NCT04844918|537542499|FG002|Overall Study|Physician Decision|0|||
149017114|NCT04844918|537542497|FG000|Overall Study|Withdrawal by Subject|6|||
149017115|NCT04844918|537542498|FG001|Overall Study|Withdrawal by Subject|3|||
149017116|NCT04844918|537542499|FG002|Overall Study|Withdrawal by Subject|3|||
148684671|NCT01621490|536319465|FG002|Overall Study|Maximum clinical benefit|0|||
149017117|NCT04844918|537542497|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
149017118|NCT04844918|537542498|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
149017119|NCT04844918|537542499|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
148951468|NCT02509156|537303401|FG001|Randomized Phase|Withdrawal by Subject|1|||
148951469|NCT03042533|537303402|FG000|Overall Study|MD left program|1|||
148951470|NCT03042533|537303403|FG001|Overall Study|MD left program|4|||
148951471|NCT03042533|537303404|FG002|Overall Study|MD left program|1|||
148951472|NCT02547649|537303405|FG000|Overall Study|Lost to Follow-up|3|||
148951473|NCT02547649|537303406|FG001|Overall Study|Lost to Follow-up|1|||
148951474|NCT02547649|537303407|FG002|Overall Study|Lost to Follow-up|1|||
149215355|NCT03375203|538255578|FG001|Overall Study|Adverse Event|3|||
149215356|NCT03375203|538255579|FG002|Overall Study|Adverse Event|0|||
149215357|NCT03375203|538255580|FG003|Overall Study|Adverse Event|2|||
149215358|NCT03375203|538255581|FG004|Overall Study|Adverse Event|2|||
149215359|NCT03375203|538255577|FG000|Overall Study|Withdrawal by Subject|3|||
149215360|NCT03375203|538255578|FG001|Overall Study|Withdrawal by Subject|0|||
148951475|NCT02547649|537303405|FG000|Overall Study|Not vaccinated|0|||
148951476|NCT02547649|537303406|FG001|Overall Study|Not vaccinated|0|||
148951477|NCT02547649|537303407|FG002|Overall Study|Not vaccinated|1|||
148951478|NCT02547649|537303405|FG000|Overall Study|Withdrawal by Subject|0|||
148951479|NCT02547649|537303406|FG001|Overall Study|Withdrawal by Subject|4|||
148951480|NCT02547649|537303407|FG002|Overall Study|Withdrawal by Subject|2|||
148951481|NCT02969369|537303409|FG000|Study|Adverse Event|1|||
148951482|NCT02969369|537303410|FG001|Study|Adverse Event|6|||
148951483|NCT02969369|537303409|FG000|Study|Lack of Efficacy|0|||
148951484|NCT02969369|537303410|FG001|Study|Lack of Efficacy|1|||
148951485|NCT02969369|537303409|FG000|Study|Lost to Follow-up|0|||
148951486|NCT02969369|537303410|FG001|Study|Lost to Follow-up|1|||
148951487|NCT02969369|537303409|FG000|Study|Withdrawal by Subject|3|||
148951488|NCT02969369|537303410|FG001|Study|Withdrawal by Subject|5|||
148951489|NCT02969369|537303409|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
148951490|NCT02969369|537303410|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
148951491|NCT02969369|537303409|FG000|Double-blind Period|Adverse Event|1|||
148951492|NCT02969369|537303410|FG001|Double-blind Period|Adverse Event|5|||
148951493|NCT02969369|537303409|FG000|Double-blind Period|Lost to Follow-up|0|||
148951494|NCT02969369|537303410|FG001|Double-blind Period|Lost to Follow-up|1|||
148951495|NCT02969369|537303409|FG000|Double-blind Period|Withdrawal by Subject|2|||
148951496|NCT02969369|537303410|FG001|Double-blind Period|Withdrawal by Subject|3|||
148951497|NCT02969369|537303409|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
148951498|NCT02969369|537303410|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
148951499|NCT02969369|537303409|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
148951500|NCT02969369|537303410|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
148951501|NCT02969369|537303409|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
148951502|NCT02969369|537303410|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
148951503|NCT02969369|537303409|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
148951504|NCT02969369|537303410|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
148951505|NCT01678911|537303412|FG000|Second Intervention|Lost to Follow-up|2|||
148951506|NCT01678911|537303413|FG001|Second Intervention|Lost to Follow-up|0|||
148951507|NCT01465997|537303414|FG000|Overall Study|Adverse Event|12|||
148951508|NCT01465997|537303415|FG001|Overall Study|Adverse Event|22|||
148951509|NCT01465997|537303414|FG000|Overall Study|Lack of Efficacy|13|||
148951510|NCT01465997|537303415|FG001|Overall Study|Lack of Efficacy|1|||
148951511|NCT01465997|537303414|FG000|Overall Study|Protocol Violation|1|||
148951512|NCT01465997|537303415|FG001|Overall Study|Protocol Violation|4|||
148951513|NCT01465997|537303414|FG000|Overall Study|Lost to Follow-up|6|||
148951514|NCT01465997|537303415|FG001|Overall Study|Lost to Follow-up|9|||
148951515|NCT01465997|537303414|FG000|Overall Study|Withdrawal by Subject|32|||
148951516|NCT01465997|537303415|FG001|Overall Study|Withdrawal by Subject|35|||
148951517|NCT01465997|537303414|FG000|Overall Study|investigator's decision|1|||
148951518|NCT01465997|537303415|FG001|Overall Study|investigator's decision|1|||
148951519|NCT01465997|537303414|FG000|Overall Study|Death|0|||
148951520|NCT01465997|537303415|FG001|Overall Study|Death|1|||
148951521|NCT01465997|537303414|FG000|Overall Study|sponsor's decision|1|||
148951522|NCT01465997|537303415|FG001|Overall Study|sponsor's decision|1|||
148951523|NCT01465997|537303414|FG000|Overall Study|subject withdrew consent|1|||
148951524|NCT01465997|537303415|FG001|Overall Study|subject withdrew consent|0|||
149215361|NCT03375203|538255579|FG002|Overall Study|Withdrawal by Subject|1|||
149215362|NCT03375203|538255580|FG003|Overall Study|Withdrawal by Subject|0|||
149215363|NCT03375203|538255581|FG004|Overall Study|Withdrawal by Subject|2|||
149215364|NCT03375203|538255577|FG000|Overall Study|Non-compliance with study drug|1|||
149215365|NCT03375203|538255578|FG001|Overall Study|Non-compliance with study drug|0|||
149215366|NCT03375203|538255579|FG002|Overall Study|Non-compliance with study drug|0|||
149234094|NCT00423137|538326386|FG002|Overall Study|Adverse Event Other|2|||
148951525|NCT01465997|537303414|FG000|Overall Study|local lab unblinded site|1|||
148951526|NCT01465997|537303415|FG001|Overall Study|local lab unblinded site|0|||
148951527|NCT01465997|537303414|FG000|Overall Study|withdrew before follow-up|0|||
148951528|NCT01465997|537303415|FG001|Overall Study|withdrew before follow-up|13|||
148951529|NCT01465997|537303414|FG000|Overall Study|decision by site staff|0|||
148951530|NCT01465997|537303415|FG001|Overall Study|decision by site staff|1|||
148951531|NCT01465997|537303414|FG000|Overall Study|subject left participation SP0993|0|||
148951532|NCT01465997|537303415|FG001|Overall Study|subject left participation SP0993|1|||
149215367|NCT03375203|538255580|FG003|Overall Study|Non-compliance with study drug|0|||
149215368|NCT03375203|538255581|FG004|Overall Study|Non-compliance with study drug|0|||
149215369|NCT03375203|538255577|FG000|Overall Study|Randomized, not treated.|0|||
149215370|NCT03375203|538255578|FG001|Overall Study|Randomized, not treated.|1|||
149215371|NCT03375203|538255579|FG002|Overall Study|Randomized, not treated.|0|||
149215372|NCT03375203|538255580|FG003|Overall Study|Randomized, not treated.|0|||
149215373|NCT03375203|538255581|FG004|Overall Study|Randomized, not treated.|0|||
149215374|NCT03107793|538255582|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
149215375|NCT03107793|538255583|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
149215376|NCT03107793|538255584|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
149215377|NCT03107793|538255585|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
149215378|NCT03107793|538255586|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
149215379|NCT03107793|538255582|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
149215380|NCT03107793|538255583|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
149215381|NCT03107793|538255584|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
149215382|NCT03107793|538255585|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
149215383|NCT03107793|538255586|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
149215384|NCT03107793|538255582|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
149215385|NCT03107793|538255583|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
149215386|NCT03107793|538255584|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
149215387|NCT03107793|538255585|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
149215388|NCT03107793|538255586|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
149215389|NCT03107793|538255582|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
149215390|NCT03107793|538255583|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149215391|NCT03107793|538255584|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149215392|NCT03107793|538255585|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149215393|NCT03107793|538255586|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149215394|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
148951533|NCT02246660|537303416|FG000|Overall Study|Withdrawal by Subject|0|||
148951534|NCT02246660|537303417|FG001|Overall Study|Withdrawal by Subject|1|||
148951535|NCT02246660|537303418|FG002|Overall Study|Withdrawal by Subject|0|||
148951536|NCT02246660|537303416|FG000|Overall Study|Death|0|||
148951537|NCT02246660|537303417|FG001|Overall Study|Death|0|||
148951538|NCT02246660|537303418|FG002|Overall Study|Death|1|||
148951539|NCT05227027|537303421|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
148951540|NCT05227027|537303422|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
148951541|NCT00646776|537303441|FG000|Overall Study|Adverse Event|1|||
148951542|NCT00646776|537303442|FG001|Overall Study|Adverse Event|9|||
148951543|NCT00646776|537303441|FG000|Overall Study|Investigator discretion|0|||
148951544|NCT00646776|537303442|FG001|Overall Study|Investigator discretion|4|||
148951545|NCT01482884|537303450|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
148951546|NCT01482884|537303451|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
148951547|NCT01482884|537303450|FG000|Overall Study|Protocol Violation|1|||
148951548|NCT01482884|537303451|FG001|Overall Study|Protocol Violation|0|||
148951549|NCT01482884|537303450|FG000|Overall Study|Lost to Follow-up|2|||
148951550|NCT01482884|537303451|FG001|Overall Study|Lost to Follow-up|2|||
148951551|NCT01482884|537303450|FG000|Overall Study|Lack of Efficacy|0|||
148951552|NCT01482884|537303451|FG001|Overall Study|Lack of Efficacy|1|||
148951553|NCT01482884|537303450|FG000|Overall Study|Adverse Event|2|||
148951554|NCT01482884|537303451|FG001|Overall Study|Adverse Event|1|||
148951555|NCT01482884|537303450|FG000|Overall Study|Withdrawal by Subject|8|||
148951556|NCT01482884|537303451|FG001|Overall Study|Withdrawal by Subject|13|||
148951557|NCT00524368|537305411|FG000|Overall Study|Adverse Event|10|||
149215395|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
149215396|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
149215397|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149215398|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
149215399|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149215400|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
149215401|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
149215402|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149215403|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
149215404|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149215405|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
148951558|NCT00524368|537305412|FG001|Overall Study|Adverse Event|12|||
148951559|NCT00524368|537305411|FG000|Overall Study|Lost to Follow-up|9|||
148951560|NCT00524368|537305412|FG001|Overall Study|Lost to Follow-up|13|||
148951561|NCT00524368|537305411|FG000|Overall Study|Withdrawal by Subject|4|||
148951562|NCT00524368|537305412|FG001|Overall Study|Withdrawal by Subject|5|||
148951563|NCT00524368|537305411|FG000|Overall Study|Non-compliant|8|||
148951564|NCT00524368|537305412|FG001|Overall Study|Non-compliant|9|||
149017120|NCT01009047|537542502|FG000|Overall Study|Adverse Event|5|||
149017121|NCT01009047|537542503|FG001|Overall Study|Adverse Event|0|||
149017122|NCT01009047|537542502|FG000|Overall Study|Lost to Follow-up|0|||
149017123|NCT01009047|537542503|FG001|Overall Study|Lost to Follow-up|2|||
149017124|NCT01009047|537542502|FG000|Overall Study|Lack of Efficacy|4|||
149017125|NCT01009047|537542503|FG001|Overall Study|Lack of Efficacy|11|||
149017126|NCT01009047|537542502|FG000|Overall Study|Withdrawal by consent|16|||
149017127|NCT01009047|537542503|FG001|Overall Study|Withdrawal by consent|11|||
149017128|NCT01009047|537542502|FG000|Overall Study|Other|3|||
149017129|NCT01009047|537542503|FG001|Overall Study|Other|2|||
149017130|NCT04716881|537542505|FG000|Overall Study|Adverse Event|1|||
149017131|NCT04716881|537542505|FG000|Overall Study|Lost to Follow-up|1|||
149017132|NCT01558674|537542506|FG000|Part 1|Study Terminated by Sponsor|10|||
149017133|NCT01558674|537542507|FG001|Part 1|Study Terminated by Sponsor|0|||
149017134|NCT01558674|537542506|FG000|Part 1|Withdrawal by Subject|1|||
149017135|NCT01558674|537542507|FG001|Part 1|Withdrawal by Subject|0|||
149017136|NCT00924469|537542508|FG000|Overall Study|Adverse Event|2|||
149017137|NCT00924469|537542509|FG001|Overall Study|Adverse Event|0|||
149017138|NCT00924469|537542508|FG000|Overall Study|Withdrawal by Subject|0|||
149017139|NCT00924469|537542509|FG001|Overall Study|Withdrawal by Subject|1|||
149017140|NCT00924469|537542508|FG000|Overall Study|Lost to Follow-up|0|||
149017141|NCT00924469|537542509|FG001|Overall Study|Lost to Follow-up|1|||
149017142|NCT00630058|537542510|FG000|Overall Study|Adverse Event|1|||
149017143|NCT00630058|537542511|FG001|Overall Study|Adverse Event|1|||
149215406|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
149215407|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149215408|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
149215409|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149215410|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
149215411|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
149215412|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149215413|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
149215414|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
149215415|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
149215416|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
149215417|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
149215418|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
149215419|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
149017144|NCT00630058|537542510|FG000|Overall Study|Withdrawal by Subject|0|||
149017145|NCT00630058|537542511|FG001|Overall Study|Withdrawal by Subject|1|||
149017146|NCT00630058|537542510|FG000|Overall Study|stopping criteria|3|||
149017147|NCT00630058|537542511|FG001|Overall Study|stopping criteria|2|||
149017148|NCT02743793|537542514|FG000|Overall Study|Death|1|||
149017149|NCT02743793|537542515|FG001|Overall Study|Death|1|||
149017150|NCT02743793|537542514|FG000|Overall Study|Withdrawal by Subject|0|||
149017151|NCT02743793|537542515|FG001|Overall Study|Withdrawal by Subject|1|||
149017152|NCT02743793|537542514|FG000|Overall Study|Screen Failure|4|||
149017153|NCT02743793|537542515|FG001|Overall Study|Screen Failure|0|||
149017154|NCT02743793|537542514|FG000|Overall Study|No Primary Care Physician|0|||
149017155|NCT02743793|537542515|FG001|Overall Study|No Primary Care Physician|1|||
149017156|NCT02743793|537542514|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
149017157|NCT02743793|537542515|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
149215420|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
149215421|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
149215422|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
149215423|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
149215424|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149215425|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
148684672|NCT01621490|536319466|FG003|Overall Study|Maximum clinical benefit|0|||
148684673|NCT01621490|536319467|FG004|Overall Study|Maximum clinical benefit|0|||
148684674|NCT01621490|536319468|FG005|Overall Study|Maximum clinical benefit|0|||
148684675|NCT01621490|536319469|FG006|Overall Study|Maximum clinical benefit|1|||
148684676|NCT01621490|536319470|FG007|Overall Study|Maximum clinical benefit|2|||
148684677|NCT01621490|536319471|FG008|Overall Study|Maximum clinical benefit|2|||
149215426|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149215427|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148684678|NCT01621490|536319472|FG009|Overall Study|Maximum clinical benefit|0|||
148684679|NCT01621490|536319473|FG010|Overall Study|Maximum clinical benefit|0|||
148684680|NCT01621490|536319463|FG000|Overall Study|Withdrawal by Subject|1|||
149017158|NCT02743793|537542514|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
149017159|NCT02743793|537542515|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
149017160|NCT03285113|537542517|FG000|Overall Study|Unable to implant leads|2|||
149017161|NCT02207374|537542518|FG000|Overall Study|Withdrawal by Subject|5|||
149017162|NCT02207374|537542519|FG001|Overall Study|Withdrawal by Subject|9|||
149215428|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
149215429|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
149215430|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
149215431|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
148951565|NCT00524368|537305411|FG000|Overall Study|Reached a Virologic Endpoint|3|||
148951566|NCT00524368|537305412|FG001|Overall Study|Reached a Virologic Endpoint|2|||
148951567|NCT00524368|537305411|FG000|Overall Study|Sponsor's Decision|2|||
148951568|NCT00524368|537305412|FG001|Overall Study|Sponsor's Decision|0|||
148951569|NCT00524368|537305411|FG000|Overall Study|Ineligible to Continue the study|2|||
148951570|NCT00524368|537305412|FG001|Overall Study|Ineligible to Continue the study|5|||
148951571|NCT00524368|537305411|FG000|Overall Study|Other|3|||
149215432|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
149215433|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
149215434|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149215435|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149215436|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
149215437|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149215438|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
149215439|NCT03107793|538255582|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149215440|NCT03107793|538255583|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
149215441|NCT03107793|538255584|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
149215442|NCT03107793|538255585|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149215443|NCT03107793|538255586|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
149215444|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
149215445|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
149215446|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
149215447|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
149215448|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
149215449|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149215450|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149215451|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149215452|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
149215453|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
149215454|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
149215455|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
149215456|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
149215457|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
149215458|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
149215459|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Death|0|||
149215460|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Death|0|||
149215461|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Death|0|||
149215462|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Death|0|||
148951572|NCT00524368|537305412|FG001|Overall Study|Other|2|||
148951573|NCT01955733|537305414|FG000|Period 1|Lost to Follow-up|1|||
148951574|NCT01955733|537305415|FG001|Period 1|Lost to Follow-up|0|||
148951575|NCT01955733|537305416|FG002|Period 1|Lost to Follow-up|0|||
148951576|NCT01955733|537305414|FG000|Period 2|Adverse Event|1|||
148951577|NCT01955733|537305415|FG001|Period 2|Adverse Event|0|||
148951578|NCT01955733|537305416|FG002|Period 2|Adverse Event|0|||
148951579|NCT01955733|537305414|FG000|Period 2|Physician Decision|0|||
148951580|NCT01955733|537305415|FG001|Period 2|Physician Decision|0|||
148951581|NCT01955733|537305416|FG002|Period 2|Physician Decision|1|||
148951582|NCT01955733|537305414|FG000|Period 2|Withdrawal by Subject|1|||
148951583|NCT01955733|537305415|FG001|Period 2|Withdrawal by Subject|3|||
148951584|NCT01955733|537305416|FG002|Period 2|Withdrawal by Subject|2|||
148951585|NCT01955733|537305414|FG000|Period 2|Study terminated by sponsor|8|||
148951586|NCT01955733|537305415|FG001|Period 2|Study terminated by sponsor|14|||
148951587|NCT01955733|537305416|FG002|Period 2|Study terminated by sponsor|16|||
148951588|NCT01955733|537305414|FG000|Period 2|Lost to Follow-up|2|||
148951589|NCT01955733|537305415|FG001|Period 2|Lost to Follow-up|0|||
148951590|NCT01955733|537305416|FG002|Period 2|Lost to Follow-up|0|||
148951591|NCT01955733|537305414|FG000|Period 2|Other not defined above|0|||
148951592|NCT01955733|537305415|FG001|Period 2|Other not defined above|2|||
148951593|NCT01955733|537305416|FG002|Period 2|Other not defined above|2|||
148951594|NCT02762266|537305417|FG000|Overall Study|Physician Decision|2|||
148951595|NCT02762266|537305418|FG001|Overall Study|Physician Decision|0|||
148951596|NCT02961751|537305431|FG000|Overall Study|Lost to Follow-up|11|||
148951597|NCT02961751|537305431|FG000|Overall Study|Physician Decision|2|||
148951598|NCT02961751|537305431|FG000|Overall Study|Not Eligible at Enrollment|1|||
148684681|NCT01621490|536319464|FG001|Overall Study|Withdrawal by Subject|0|||
148684682|NCT01621490|536319465|FG002|Overall Study|Withdrawal by Subject|0|||
148684683|NCT01621490|536319466|FG003|Overall Study|Withdrawal by Subject|0|||
148684684|NCT01621490|536319467|FG004|Overall Study|Withdrawal by Subject|0|||
148684685|NCT01621490|536319468|FG005|Overall Study|Withdrawal by Subject|1|||
148684686|NCT01621490|536319469|FG006|Overall Study|Withdrawal by Subject|0|||
149017163|NCT02207374|537542520|FG002|Overall Study|Withdrawal by Subject|4|||
149017164|NCT02207374|537542518|FG000|Overall Study|Death|1|||
148684687|NCT01621490|536319470|FG007|Overall Study|Withdrawal by Subject|0|||
148684688|NCT01621490|536319471|FG008|Overall Study|Withdrawal by Subject|0|||
148684689|NCT01621490|536319472|FG009|Overall Study|Withdrawal by Subject|0|||
148684690|NCT01621490|536319473|FG010|Overall Study|Withdrawal by Subject|0|||
148684691|NCT01621490|536319463|FG000|Overall Study|Subject request to discontinue study|1|||
148684692|NCT01621490|536319464|FG001|Overall Study|Subject request to discontinue study|3|||
149017165|NCT02207374|537542519|FG001|Overall Study|Death|0|||
149017166|NCT02207374|537542520|FG002|Overall Study|Death|1|||
149215463|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Death|1|||
149215464|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149215465|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149215466|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149215467|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
149215468|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
149215469|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
149215470|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
148684693|NCT01621490|536319465|FG002|Overall Study|Subject request to discontinue study|1|||
148684694|NCT01621490|536319466|FG003|Overall Study|Subject request to discontinue study|1|||
148684695|NCT01621490|536319467|FG004|Overall Study|Subject request to discontinue study|0|||
148684696|NCT01621490|536319468|FG005|Overall Study|Subject request to discontinue study|2|||
148684697|NCT01621490|536319469|FG006|Overall Study|Subject request to discontinue study|1|||
148684698|NCT01621490|536319470|FG007|Overall Study|Subject request to discontinue study|0|||
149215471|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
149215472|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
149215473|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
149215474|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
149215475|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
148809721|NCT02832037|536780848|FG003|Overall Study|Lost to Follow-up|0|||
148809722|NCT02832037|536780849|FG004|Overall Study|Lost to Follow-up|5|||
148809723|NCT02832037|536780845|FG000|Overall Study|Withdrawal by Subject|9|||
148951599|NCT02961751|537305431|FG000|Overall Study|Protocol Violation|1|||
148951600|NCT00842712|537305432|FG000|Safety Run-in Part|Adverse Event|0|||
149215476|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
149215477|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
149215478|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
149215479|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149215480|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149215481|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149215482|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
149215483|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
149215484|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149215485|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149215486|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
148809724|NCT02832037|536780846|FG001|Overall Study|Withdrawal by Subject|8|||
148951601|NCT00842712|537305433|FG001|Safety Run-in Part|Adverse Event|1|||
148951602|NCT00842712|537305434|FG002|Safety Run-in Part|Adverse Event|0|||
148951603|NCT00842712|537305435|FG003|Safety Run-in Part|Adverse Event|0|||
148951604|NCT00842712|537305436|FG004|Safety Run-in Part|Adverse Event|0|||
148951605|NCT00842712|537305437|FG005|Safety Run-in Part|Adverse Event|0|||
148951606|NCT00842712|537305438|FG006|Safety Run-in Part|Adverse Event|0|||
149017167|NCT02207374|537542518|FG000|Overall Study|Missing follow-up information|0|||
149017168|NCT02207374|537542519|FG001|Overall Study|Missing follow-up information|1|||
149017169|NCT02207374|537542520|FG002|Overall Study|Missing follow-up information|1|||
149017170|NCT00322374|537542521|FG000|Starting Dose|Physician Decision|2|||
149215487|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
149215488|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
149234095|NCT00423137|538326387|FG003|Overall Study|Adverse Event Other|0|||
148684699|NCT01621490|536319471|FG008|Overall Study|Subject request to discontinue study|1|||
148809725|NCT02832037|536780847|FG002|Overall Study|Withdrawal by Subject|0|||
148951607|NCT00842712|537305432|FG000|Safety Run-in Part|Progressive disease|3|||
148951608|NCT00842712|537305433|FG001|Safety Run-in Part|Progressive disease|1|||
149017171|NCT00322374|537542522|FG001|Starting Dose|Physician Decision|0|||
148951609|NCT00842712|537305434|FG002|Safety Run-in Part|Progressive disease|0|||
148951610|NCT00842712|537305435|FG003|Safety Run-in Part|Progressive disease|1|||
148951611|NCT00842712|537305436|FG004|Safety Run-in Part|Progressive disease|0|||
148951612|NCT00842712|537305437|FG005|Safety Run-in Part|Progressive disease|0|||
148951613|NCT00842712|537305438|FG006|Safety Run-in Part|Progressive disease|0|||
148951614|NCT00842712|537305432|FG000|Randomized Part|Randomized but not treated|0|||
148951615|NCT00842712|537305433|FG001|Randomized Part|Randomized but not treated|0|||
149017172|NCT00322374|537542523|FG002|Starting Dose|Physician Decision|0|||
149017173|NCT00322374|537542524|FG003|Starting Dose|Physician Decision|0|||
149017174|NCT00322374|537542521|FG000|Starting Dose|Study Drug Toxicity|4|||
149017175|NCT00322374|537542522|FG001|Starting Dose|Study Drug Toxicity|0|||
149017176|NCT00322374|537542523|FG002|Starting Dose|Study Drug Toxicity|0|||
149017177|NCT00322374|537542524|FG003|Starting Dose|Study Drug Toxicity|0|||
149017178|NCT00322374|537542521|FG000|First Escalation|Documented Disease Progression|0|||
149017179|NCT00322374|537542522|FG001|First Escalation|Documented Disease Progression|6|||
149017180|NCT00322374|537542523|FG002|First Escalation|Documented Disease Progression|0|||
149017181|NCT00322374|537542524|FG003|First Escalation|Documented Disease Progression|0|||
149215489|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Other|0|||
149215490|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Other|0|||
149215491|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Other|0|||
149215492|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Other|1|||
149215493|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Other|3|||
149215494|NCT03107793|538255582|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
149215495|NCT03107793|538255583|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
149215496|NCT03107793|538255584|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
149215497|NCT03107793|538255585|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
149215498|NCT03107793|538255586|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
149215499|NCT03277105|538255587|FG000|Overall Study|Death|129|||
148684700|NCT01621490|536319472|FG009|Overall Study|Subject request to discontinue study|0|||
148684701|NCT01621490|536319473|FG010|Overall Study|Subject request to discontinue study|0|||
148684702|NCT01621490|536319463|FG000|Overall Study|Adverse event unrelated to study drug|1|||
148684703|NCT01621490|536319464|FG001|Overall Study|Adverse event unrelated to study drug|1|||
148684704|NCT01621490|536319465|FG002|Overall Study|Adverse event unrelated to study drug|0|||
148684705|NCT01621490|536319466|FG003|Overall Study|Adverse event unrelated to study drug|0|||
148684706|NCT01621490|536319467|FG004|Overall Study|Adverse event unrelated to study drug|0|||
148684707|NCT01621490|536319468|FG005|Overall Study|Adverse event unrelated to study drug|0|||
148684708|NCT01621490|536319469|FG006|Overall Study|Adverse event unrelated to study drug|0|||
148684709|NCT01621490|536319470|FG007|Overall Study|Adverse event unrelated to study drug|2|||
148684710|NCT01621490|536319471|FG008|Overall Study|Adverse event unrelated to study drug|0|||
148684711|NCT01621490|536319472|FG009|Overall Study|Adverse event unrelated to study drug|0|||
148684712|NCT01621490|536319473|FG010|Overall Study|Adverse event unrelated to study drug|0|||
148684713|NCT01621490|536319463|FG000|Overall Study|Disease progression|27|||
148684714|NCT01621490|536319464|FG001|Overall Study|Disease progression|28|||
148684715|NCT01621490|536319465|FG002|Overall Study|Disease progression|1|||
148684716|NCT01621490|536319466|FG003|Overall Study|Disease progression|5|||
148951616|NCT00842712|537305434|FG002|Randomized Part|Randomized but not treated|0|||
148951617|NCT00842712|537305435|FG003|Randomized Part|Randomized but not treated|0|||
148951618|NCT00842712|537305436|FG004|Randomized Part|Randomized but not treated|0|||
148951619|NCT00842712|537305437|FG005|Randomized Part|Randomized but not treated|1|||
148951620|NCT00842712|537305438|FG006|Randomized Part|Randomized but not treated|4|||
149017182|NCT00322374|537542521|FG000|First Escalation|Physician Decision|0|||
149215500|NCT03277105|538255588|FG001|Overall Study|Death|124|||
149215501|NCT03277105|538255587|FG000|Overall Study|Lost to Follow-up|2|||
149215502|NCT03277105|538255588|FG001|Overall Study|Lost to Follow-up|4|||
149215503|NCT03277105|538255587|FG000|Overall Study|Withdrawal by Subject|10|||
149215504|NCT03277105|538255588|FG001|Overall Study|Withdrawal by Subject|10|||
148684717|NCT01621490|536319467|FG004|Overall Study|Disease progression|3|||
148951621|NCT00842712|537305432|FG000|Randomized Part|Ongoing at cut-off date|0|||
149017183|NCT00322374|537542522|FG001|First Escalation|Physician Decision|12|||
149215505|NCT03277105|538255587|FG000|Overall Study|Other|118|||
149215506|NCT03277105|538255588|FG001|Overall Study|Other|125|||
149215507|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
149215508|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
149215509|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
149215510|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
149215511|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
149215512|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
149215513|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
149215514|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
149215515|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
149215516|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
148951622|NCT00842712|537305433|FG001|Randomized Part|Ongoing at cut-off date|0|||
148951623|NCT00842712|537305434|FG002|Randomized Part|Ongoing at cut-off date|0|||
148951624|NCT00842712|537305435|FG003|Randomized Part|Ongoing at cut-off date|0|||
148951625|NCT00842712|537305436|FG004|Randomized Part|Ongoing at cut-off date|0|||
148951626|NCT00842712|537305437|FG005|Randomized Part|Ongoing at cut-off date|0|||
148951627|NCT00842712|537305438|FG006|Randomized Part|Ongoing at cut-off date|2|||
148951628|NCT02310568|537305449|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
148951629|NCT02310568|537305450|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
148951630|NCT02310568|537305451|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
148951631|NCT02310568|537305452|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
148951632|NCT02310568|537305453|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
148951633|NCT02310568|537305449|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
148951634|NCT02310568|537305450|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
148951635|NCT02310568|537305451|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
148951636|NCT02310568|537305452|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
148951637|NCT02310568|537305453|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
148951638|NCT02310568|537305449|FG000|Stage 1 ( 4 Weeks)|Other|1|||
148951639|NCT02310568|537305450|FG001|Stage 1 ( 4 Weeks)|Other|1|||
148951640|NCT02310568|537305451|FG002|Stage 1 ( 4 Weeks)|Other|0|||
148951641|NCT02310568|537305452|FG003|Stage 1 ( 4 Weeks)|Other|0|||
148951642|NCT02310568|537305453|FG004|Stage 1 ( 4 Weeks)|Other|0|||
148951643|NCT02310568|537305449|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
148951644|NCT02310568|537305450|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
148951645|NCT02310568|537305451|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
148951646|NCT02310568|537305452|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
148951647|NCT02310568|537305453|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
148951648|NCT02310568|537305449|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
148951649|NCT02310568|537305450|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
148951650|NCT02310568|537305451|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
148951651|NCT02310568|537305452|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
148951652|NCT02310568|537305453|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
148951653|NCT02310568|537305449|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
148951654|NCT02310568|537305450|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
148951655|NCT02310568|537305451|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
148951656|NCT02310568|537305452|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
148951657|NCT02310568|537305453|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
148951658|NCT02310568|537305449|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
148951659|NCT02310568|537305450|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
148951660|NCT02310568|537305451|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
148951661|NCT02310568|537305452|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
148951662|NCT02310568|537305453|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
148951663|NCT02310568|537305449|FG000|Stage 2 (4 Weeks)|Other|0|||
148951664|NCT02310568|537305450|FG001|Stage 2 (4 Weeks)|Other|1|||
148951665|NCT02310568|537305451|FG002|Stage 2 (4 Weeks)|Other|1|||
148951666|NCT02310568|537305452|FG003|Stage 2 (4 Weeks)|Other|0|||
148951667|NCT02310568|537305453|FG004|Stage 2 (4 Weeks)|Other|0|||
148951668|NCT02310568|537305449|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
148951669|NCT02310568|537305450|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
148951670|NCT02310568|537305451|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
148951671|NCT02310568|537305452|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
148951672|NCT02310568|537305453|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
148951673|NCT02310568|537305449|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
148951674|NCT02310568|537305450|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
148951675|NCT02310568|537305451|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
148951676|NCT02310568|537305452|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
148951677|NCT02310568|537305453|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
148951678|NCT02310568|537305449|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
148951679|NCT02310568|537305450|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
148951680|NCT02310568|537305451|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
148951681|NCT02310568|537305452|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
148951682|NCT02310568|537305453|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
148951683|NCT02289690|537305463|FG000|Overall Study|Adverse Event Related to Progression|0|||
148951684|NCT02289690|537305464|FG001|Overall Study|Adverse Event Related to Progression|1|||
148951685|NCT02289690|537305465|FG002|Overall Study|Adverse Event Related to Progression|1|||
148951686|NCT02289690|537305466|FG003|Overall Study|Adverse Event Related to Progression|0|||
148684718|NCT01621490|536319468|FG005|Overall Study|Disease progression|8|||
148684719|NCT01621490|536319469|FG006|Overall Study|Disease progression|7|||
148684720|NCT01621490|536319470|FG007|Overall Study|Disease progression|1|||
148684721|NCT01621490|536319471|FG008|Overall Study|Disease progression|4|||
148684722|NCT01621490|536319472|FG009|Overall Study|Disease progression|1|||
148684723|NCT01621490|536319473|FG010|Overall Study|Disease progression|1|||
148684724|NCT01621490|536319463|FG000|Overall Study|Study drug toxicity|1|||
148684725|NCT01621490|536319464|FG001|Overall Study|Study drug toxicity|4|||
148684726|NCT01621490|536319465|FG002|Overall Study|Study drug toxicity|5|||
148684727|NCT01621490|536319466|FG003|Overall Study|Study drug toxicity|3|||
148684728|NCT01621490|536319467|FG004|Overall Study|Study drug toxicity|1|||
148684729|NCT01621490|536319468|FG005|Overall Study|Study drug toxicity|10|||
148684730|NCT01621490|536319469|FG006|Overall Study|Study drug toxicity|1|||
148684731|NCT01621490|536319470|FG007|Overall Study|Study drug toxicity|4|||
148684732|NCT01621490|536319471|FG008|Overall Study|Study drug toxicity|1|||
148684733|NCT01621490|536319472|FG009|Overall Study|Study drug toxicity|0|||
148684734|NCT01621490|536319473|FG010|Overall Study|Study drug toxicity|0|||
148684735|NCT01621490|536319463|FG000|Overall Study|Death|0|||
148684736|NCT01621490|536319464|FG001|Overall Study|Death|0|||
148684737|NCT01621490|536319465|FG002|Overall Study|Death|0|||
148684738|NCT01621490|536319466|FG003|Overall Study|Death|0|||
148951687|NCT02289690|537305467|FG004|Overall Study|Adverse Event Related to Progression|1|||
148951688|NCT02289690|537305468|FG005|Overall Study|Adverse Event Related to Progression|0|||
148951689|NCT02289690|537305469|FG006|Overall Study|Adverse Event Related to Progression|1|||
148684739|NCT01621490|536319467|FG004|Overall Study|Death|0|||
148951690|NCT02289690|537305470|FG007|Overall Study|Adverse Event Related to Progression|0|||
148951691|NCT02289690|537305471|FG008|Overall Study|Adverse Event Related to Progression|0|||
148951692|NCT02289690|537305472|FG009|Overall Study|Adverse Event Related to Progression|0|||
148951693|NCT02289690|537305463|FG000|Overall Study|Withdrawal by Subject|1|||
148951694|NCT02289690|537305464|FG001|Overall Study|Withdrawal by Subject|0|||
148951695|NCT02289690|537305465|FG002|Overall Study|Withdrawal by Subject|0|||
148951696|NCT02289690|537305466|FG003|Overall Study|Withdrawal by Subject|0|||
148951697|NCT02289690|537305467|FG004|Overall Study|Withdrawal by Subject|1|||
148951698|NCT02289690|537305468|FG005|Overall Study|Withdrawal by Subject|1|||
148951699|NCT02289690|537305469|FG006|Overall Study|Withdrawal by Subject|0|||
148951700|NCT02289690|537305470|FG007|Overall Study|Withdrawal by Subject|0|||
148951701|NCT02289690|537305471|FG008|Overall Study|Withdrawal by Subject|4|||
148951702|NCT02289690|537305472|FG009|Overall Study|Withdrawal by Subject|2|||
148951703|NCT02289690|537305463|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
148951704|NCT02289690|537305464|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
148951705|NCT02289690|537305465|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
148951706|NCT02289690|537305466|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
148951707|NCT02289690|537305467|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
148951708|NCT02289690|537305468|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
149215517|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
149215518|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
149215519|NCT03321526|538255589|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
149215520|NCT03321526|538255590|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
149215521|NCT03321526|538255589|FG000|Follow-up Phase (2 Weeks)|Other|24|||
149215522|NCT03321526|538255590|FG001|Follow-up Phase (2 Weeks)|Other|24|||
148684740|NCT01621490|536319468|FG005|Overall Study|Death|0|||
148809726|NCT02832037|536780848|FG003|Overall Study|Withdrawal by Subject|4|||
148951709|NCT02289690|537305469|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
148951710|NCT02289690|537305470|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
148951711|NCT02289690|537305471|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
149215523|NCT02418585|538255598|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
148684741|NCT01621490|536319469|FG006|Overall Study|Death|0|||
148684742|NCT01621490|536319470|FG007|Overall Study|Death|0|||
148684743|NCT01621490|536319471|FG008|Overall Study|Death|1|||
148684744|NCT01621490|536319472|FG009|Overall Study|Death|0|||
148951712|NCT02289690|537305472|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
148951713|NCT02289690|537305463|FG000|Overall Study|Lost to Follow-up|0|||
148951714|NCT02289690|537305464|FG001|Overall Study|Lost to Follow-up|0|||
148951715|NCT02289690|537305465|FG002|Overall Study|Lost to Follow-up|0|||
148951716|NCT02289690|537305466|FG003|Overall Study|Lost to Follow-up|0|||
148951717|NCT02289690|537305467|FG004|Overall Study|Lost to Follow-up|0|||
148951718|NCT02289690|537305468|FG005|Overall Study|Lost to Follow-up|0|||
148951719|NCT02289690|537305469|FG006|Overall Study|Lost to Follow-up|0|||
148951720|NCT02289690|537305470|FG007|Overall Study|Lost to Follow-up|1|||
148951721|NCT02289690|537305471|FG008|Overall Study|Lost to Follow-up|0|||
148951722|NCT02289690|537305472|FG009|Overall Study|Lost to Follow-up|2|||
148951723|NCT02289690|537305463|FG000|Overall Study|Death|0|||
148951724|NCT02289690|537305464|FG001|Overall Study|Death|0|||
148951725|NCT02289690|537305465|FG002|Overall Study|Death|0|||
149215524|NCT02418585|538255599|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
149215525|NCT02418585|538255598|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
149215526|NCT02418585|538255599|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
149215527|NCT02418585|538255598|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
149215528|NCT02418585|538255599|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
149215529|NCT02418585|538255598|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
149215530|NCT02418585|538255599|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
149215531|NCT02418585|538255598|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
149215532|NCT02418585|538255599|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
149215533|NCT02418585|538255598|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
149215534|NCT02418585|538255599|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
149215535|NCT02418585|538255598|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
149215536|NCT02418585|538255599|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
149215537|NCT02418585|538255598|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
148809727|NCT02832037|536780849|FG004|Overall Study|Withdrawal by Subject|8|||
148951726|NCT02289690|537305466|FG003|Overall Study|Death|0|||
148951727|NCT02289690|537305467|FG004|Overall Study|Death|0|||
148951728|NCT02289690|537305468|FG005|Overall Study|Death|0|||
148951729|NCT02289690|537305469|FG006|Overall Study|Death|0|||
148951730|NCT02289690|537305470|FG007|Overall Study|Death|49|||
148951731|NCT02289690|537305471|FG008|Overall Study|Death|45|||
148951732|NCT02289690|537305472|FG009|Overall Study|Death|41|||
148951733|NCT02289690|537305463|FG000|Overall Study|Sponsor Discontinued Study|0|||
148951734|NCT02289690|537305464|FG001|Overall Study|Sponsor Discontinued Study|0|||
148951735|NCT02289690|537305465|FG002|Overall Study|Sponsor Discontinued Study|0|||
148951736|NCT02289690|537305466|FG003|Overall Study|Sponsor Discontinued Study|0|||
148951737|NCT02289690|537305467|FG004|Overall Study|Sponsor Discontinued Study|0|||
148951738|NCT02289690|537305468|FG005|Overall Study|Sponsor Discontinued Study|0|||
148951739|NCT02289690|537305469|FG006|Overall Study|Sponsor Discontinued Study|0|||
148951740|NCT02289690|537305470|FG007|Overall Study|Sponsor Discontinued Study|9|||
148951741|NCT02289690|537305471|FG008|Overall Study|Sponsor Discontinued Study|7|||
148951742|NCT02289690|537305472|FG009|Overall Study|Sponsor Discontinued Study|15|||
148951743|NCT02289690|537305463|FG000|Overall Study|Other|0|||
148951744|NCT02289690|537305464|FG001|Overall Study|Other|0|||
148951745|NCT02289690|537305465|FG002|Overall Study|Other|0|||
148951746|NCT02289690|537305466|FG003|Overall Study|Other|1|||
148951747|NCT02289690|537305467|FG004|Overall Study|Other|1|||
148951748|NCT02289690|537305468|FG005|Overall Study|Other|0|||
148951749|NCT02289690|537305469|FG006|Overall Study|Other|1|||
148951750|NCT02289690|537305470|FG007|Overall Study|Other|2|||
148951751|NCT02289690|537305471|FG008|Overall Study|Other|3|||
148951752|NCT02289690|537305472|FG009|Overall Study|Other|1|||
148951753|NCT00779467|537305475|FG000|Overall Study|Lack of Efficacy|11|||
148951754|NCT00779467|537305476|FG001|Overall Study|Lack of Efficacy|2|||
148951755|NCT00779467|537305477|FG002|Overall Study|Lack of Efficacy|6|||
148951756|NCT00779467|537305478|FG003|Overall Study|Lack of Efficacy|11|||
148951757|NCT00779467|537305475|FG000|Overall Study|failed inclusion criteria|3|||
148951758|NCT00779467|537305476|FG001|Overall Study|failed inclusion criteria|3|||
148951759|NCT00779467|537305477|FG002|Overall Study|failed inclusion criteria|1|||
148951760|NCT00779467|537305478|FG003|Overall Study|failed inclusion criteria|2|||
148951761|NCT00779467|537305475|FG000|Overall Study|missing data|1|||
148951762|NCT00779467|537305476|FG001|Overall Study|missing data|0|||
148951763|NCT00779467|537305477|FG002|Overall Study|missing data|1|||
148951764|NCT00779467|537305478|FG003|Overall Study|missing data|4|||
149017184|NCT00322374|537542523|FG002|First Escalation|Physician Decision|0|||
149215538|NCT02418585|538255599|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
149215539|NCT02418585|538255598|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
148951765|NCT00779467|537305475|FG000|Overall Study|technical issue|0|||
148951766|NCT00779467|537305476|FG001|Overall Study|technical issue|0|||
148951767|NCT00779467|537305477|FG002|Overall Study|technical issue|2|||
148951768|NCT00779467|537305478|FG003|Overall Study|technical issue|1|||
148951769|NCT00779467|537305475|FG000|Overall Study|unavailable research staff|0|||
148951770|NCT00779467|537305476|FG001|Overall Study|unavailable research staff|0|||
148809728|NCT02832037|536780845|FG000|Overall Study|Adverse Event|5|||
148809729|NCT02832037|536780846|FG001|Overall Study|Adverse Event|4|||
148809730|NCT02832037|536780847|FG002|Overall Study|Adverse Event|0|||
148809731|NCT02832037|536780848|FG003|Overall Study|Adverse Event|2|||
148951771|NCT00779467|537305477|FG002|Overall Study|unavailable research staff|0|||
148951772|NCT00779467|537305478|FG003|Overall Study|unavailable research staff|1|||
148951773|NCT00644995|537305479|FG000|Overall Study|Lost to Follow-up|1|||
148951774|NCT00644995|537305480|FG001|Overall Study|Lost to Follow-up|4|||
148951775|NCT00644995|537305479|FG000|Overall Study|Refused|1|||
148951776|NCT00644995|537305480|FG001|Overall Study|Refused|0|||
148951777|NCT00865124|537305487|FG000|Overall Study|Physician Decision|2|||
148951778|NCT00865124|537305488|FG001|Overall Study|Physician Decision|1|||
149215540|NCT02418585|538255599|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
149215541|NCT02418585|538255598|FG000|Follow-up Phase (24 Weeks)|Other|3|||
149215542|NCT02418585|538255599|FG001|Follow-up Phase (24 Weeks)|Other|2|||
149215543|NCT02040857|538255600|FG000|Overall Study|Adverse Event|14|||
149215544|NCT02040857|538255600|FG000|Overall Study|Physician Decision|5|||
148951779|NCT00865124|537305489|FG002|Overall Study|Physician Decision|0|||
148951780|NCT00865124|537305487|FG000|Overall Study|Withdrawn consent|2|||
148951781|NCT00865124|537305488|FG001|Overall Study|Withdrawn consent|0|||
148951782|NCT00865124|537305489|FG002|Overall Study|Withdrawn consent|0|||
148951783|NCT02743520|537305490|FG000|Overall Study|Withdrawal by Subject|1|||
148951784|NCT03247530|537305493|FG000|Overall Study|Withdrawal by caregiver|19|||
148951785|NCT03247530|537305494|FG001|Overall Study|Withdrawal by caregiver|8|||
148951786|NCT03247530|537305495|FG002|Overall Study|Withdrawal by caregiver|10|||
148951787|NCT03247530|537305493|FG000|Overall Study|Lost to Follow-up|3|||
148951788|NCT03247530|537305494|FG001|Overall Study|Lost to Follow-up|9|||
148951789|NCT03247530|537305495|FG002|Overall Study|Lost to Follow-up|6|||
148951790|NCT03247530|537305493|FG000|Overall Study|Adverse Event|2|||
148951791|NCT03247530|537305494|FG001|Overall Study|Adverse Event|5|||
148951792|NCT03247530|537305495|FG002|Overall Study|Adverse Event|2|||
148951793|NCT03247530|537305493|FG000|Overall Study|Failure to follow procedure|1|||
148951794|NCT03247530|537305494|FG001|Overall Study|Failure to follow procedure|1|||
148951795|NCT03247530|537305495|FG002|Overall Study|Failure to follow procedure|1|||
148951796|NCT03247530|537305493|FG000|Overall Study|Withdrawal by Subject|1|||
148951797|NCT03247530|537305494|FG001|Overall Study|Withdrawal by Subject|1|||
148951798|NCT03247530|537305495|FG002|Overall Study|Withdrawal by Subject|0|||
148951799|NCT03247530|537305493|FG000|Overall Study|Study medication misuse|0|||
148951800|NCT03247530|537305494|FG001|Overall Study|Study medication misuse|1|||
148951801|NCT03247530|537305495|FG002|Overall Study|Study medication misuse|0|||
148951802|NCT03247530|537305493|FG000|Overall Study|Other, multiple categories|1|||
148951803|NCT03247530|537305494|FG001|Overall Study|Other, multiple categories|3|||
148951804|NCT03247530|537305495|FG002|Overall Study|Other, multiple categories|1|||
148951805|NCT02551731|537305496|FG000|Overall Study|Withdrawal by Subject|2|||
149215545|NCT02040857|538255600|FG000|Overall Study|Withdrawal by Subject|31|||
149215546|NCT02040857|538255600|FG000|Overall Study|patient non-compliance|3|||
149215547|NCT02040857|538255600|FG000|Overall Study|Lost to Follow-up|2|||
149215548|NCT02040857|538255600|FG000|Overall Study|recurrence|4|||
149215549|NCT02040857|538255600|FG000|Overall Study|ineligible|1|||
149215550|NCT04159701|538255601|FG000|Period 1: Treatment Period|Pregnancy|1|||
149215551|NCT04159701|538255602|FG001|Period 1: Treatment Period|Pregnancy|0|||
149215552|NCT04159701|538255601|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
149215553|NCT04159701|538255602|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
149215554|NCT04159701|538255601|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
149215555|NCT04159701|538255602|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
149215556|NCT04159701|538255601|FG000|Washout Period|site terminated by sponsor|0|||
149215557|NCT04159701|538255602|FG001|Washout Period|site terminated by sponsor|1|||
148951806|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
148951807|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
148951808|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
149215558|NCT04159701|538255601|FG000|Washout Period|study terminated by sponsor|10|||
148951809|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
148951810|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
148951811|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
148951812|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
148951813|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
148951814|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Patient Request|1|||
148951815|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Patient Request|0|||
148951816|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
148951817|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
148951818|NCT04649060|537305498|FG000|Arm A/Arm B Treatment|Other|1|||
148951819|NCT04649060|537305499|FG001|Arm A/Arm B Treatment|Other|0|||
148951820|NCT04649060|537305498|FG000|Crossover (Arm B)|Adverse Event|0|||
148951821|NCT04649060|537305499|FG001|Crossover (Arm B)|Adverse Event|1|||
148951822|NCT04649060|537305498|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
148951823|NCT04649060|537305499|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
148951824|NCT01906008|537305503|FG000|Overall Study|Lost to Follow-up|2|||
148951825|NCT01906008|537305504|FG001|Overall Study|Lost to Follow-up|0|||
148951826|NCT01906008|537305503|FG000|Overall Study|Oxaliplatin toxicity|2|||
148951827|NCT01906008|537305504|FG001|Overall Study|Oxaliplatin toxicity|0|||
148951828|NCT01906008|537305503|FG000|Overall Study|Protocol Violation|0|||
148951829|NCT01906008|537305504|FG001|Overall Study|Protocol Violation|1|||
148951830|NCT01906008|537305503|FG000|Overall Study|Withdrawal by Subject|1|||
148951831|NCT01906008|537305504|FG001|Overall Study|Withdrawal by Subject|5|||
148951832|NCT01906008|537305503|FG000|Overall Study|Did not start study med|3|||
148951833|NCT01906008|537305504|FG001|Overall Study|Did not start study med|4|||
148951834|NCT01906008|537305503|FG000|Overall Study|Oxaliplatin stops|10|||
148951835|NCT01906008|537305504|FG001|Overall Study|Oxaliplatin stops|8|||
148951836|NCT01906008|537305503|FG000|Overall Study|Hospice|1|||
148951837|NCT01906008|537305504|FG001|Overall Study|Hospice|0|||
148951838|NCT01906008|537305503|FG000|Overall Study|Physician Decision|3|||
148951839|NCT01906008|537305504|FG001|Overall Study|Physician Decision|3|||
148951840|NCT01906008|537305503|FG000|Overall Study|Lack of compliance of study med|5|||
148951841|NCT01906008|537305504|FG001|Overall Study|Lack of compliance of study med|3|||
148951842|NCT01906008|537305503|FG000|Overall Study|Adverse Event|0|||
148951843|NCT01906008|537305504|FG001|Overall Study|Adverse Event|3|||
148951844|NCT02117648|537305505|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
148951845|NCT02117648|537305505|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
148951846|NCT02117648|537305505|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
148951847|NCT02117648|537305505|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
148951848|NCT02117648|537305505|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
148951849|NCT02117648|537305505|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
148951850|NCT02117648|537305505|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
148951851|NCT02117648|537305505|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
148951852|NCT02117648|537305505|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
148951853|NCT02117648|537305505|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
148951854|NCT02117648|537305505|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
148951855|NCT00171730|537305507|FG000|Overall Study|Adverse Event|3|||
148951856|NCT00171730|537305507|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
148951857|NCT00171730|537305507|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
148951858|NCT00171730|537305507|FG000|Overall Study|Withdrawal by Subject|3|||
148951859|NCT05025241|537305508|FG000|Screening|Failed Screening|5|||
148951860|NCT05025241|537305508|FG000|Treatment and Follow Up|Adverse Event|3|||
148951861|NCT01985867|537305509|FG000|Overall Study|Lost to Follow-up|3|||
148951862|NCT01985867|537305510|FG001|Overall Study|Lost to Follow-up|4|||
148951863|NCT01985867|537305509|FG000|Overall Study|Adverse Event|3|||
148951864|NCT01985867|537305510|FG001|Overall Study|Adverse Event|2|||
148951865|NCT01985867|537305509|FG000|Overall Study|Lack of Efficacy|1|||
148951866|NCT01985867|537305510|FG001|Overall Study|Lack of Efficacy|0|||
148951867|NCT02670837|537305511|FG000|Overall Study|Death|2|||
148951868|NCT02670837|537305512|FG001|Overall Study|Death|0|||
148951869|NCT02670837|537305513|FG002|Overall Study|Death|0|||
149215559|NCT04159701|538255602|FG001|Washout Period|study terminated by sponsor|3|||
149215560|NCT04159701|538255601|FG000|Washout Period|Withdrawal by Subject|1|||
149215561|NCT04159701|538255602|FG001|Washout Period|Withdrawal by Subject|0|||
149215562|NCT04159701|538255601|FG000|Washout Period|Inadvertent Enrollment|1|||
149215563|NCT04159701|538255602|FG001|Washout Period|Inadvertent Enrollment|0|||
149215564|NCT04159701|538255601|FG000|Washout Period|Miscellaneous|1|||
148809732|NCT02832037|536780849|FG004|Overall Study|Adverse Event|4|||
148951870|NCT02220205|537305514|FG000|Overall Study|Withdrawal by Subject|1|||
148951871|NCT02220205|537305515|FG001|Overall Study|Withdrawal by Subject|0|||
148951872|NCT02557646|537305516|FG000|Overall Study|Adverse Event|40|||
148951873|NCT02557646|537305516|FG000|Overall Study|Death|1|||
148951874|NCT02557646|537305516|FG000|Overall Study|Lack of Efficacy|186|||
148951875|NCT02557646|537305516|FG000|Overall Study|Withdrawal by Subject|18|||
148951876|NCT02557646|537305516|FG000|Overall Study|Lost to Follow-up|17|||
149215565|NCT04159701|538255602|FG001|Washout Period|Miscellaneous|0|||
149215566|NCT04159701|538255601|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
149215567|NCT04159701|538255602|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
149215568|NCT04159701|538255601|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
149215569|NCT04159701|538255602|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
149215570|NCT04159701|538255601|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
149215571|NCT04159701|538255602|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
149215572|NCT04159701|538255601|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
149215573|NCT04159701|538255602|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
149215574|NCT04159701|538255601|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
149215575|NCT04159701|538255602|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
149215576|NCT02348840|538255610|FG000|Overall Study|Withdrawal by Subject|2|||
149215577|NCT02348840|538255611|FG001|Overall Study|Withdrawal by Subject|1|||
149215578|NCT02348840|538255612|FG002|Overall Study|Withdrawal by Subject|0|||
149215579|NCT02348840|538255613|FG003|Overall Study|Withdrawal by Subject|0|||
149215580|NCT00373880|538255614|FG000|Overall Study|Physician Decision|3|||
149215581|NCT00373880|538255614|FG000|Overall Study|Arrested|1|||
149215582|NCT00373880|538255614|FG000|Overall Study|Protocol Violation|14|||
149215583|NCT01466062|538255616|FG000|Overall Study|Adverse Event|1|||
149215584|NCT01466062|538255616|FG000|Overall Study|Withdrawal by Subject|1|||
149215585|NCT03152110|538255617|FG000|Overall Study|Withdrawal by Subject|3|||
149017185|NCT00322374|537542524|FG003|First Escalation|Physician Decision|0|||
149017186|NCT00322374|537542521|FG000|First Escalation|Study Drug Toxicity|0|||
149017187|NCT00322374|537542522|FG001|First Escalation|Study Drug Toxicity|11|||
149017188|NCT00322374|537542523|FG002|First Escalation|Study Drug Toxicity|0|||
149017189|NCT00322374|537542524|FG003|First Escalation|Study Drug Toxicity|0|||
149017190|NCT00322374|537542521|FG000|First Escalation|Participant Request|0|||
149017191|NCT00322374|537542522|FG001|First Escalation|Participant Request|1|||
149017192|NCT00322374|537542523|FG002|First Escalation|Participant Request|0|||
149017193|NCT00322374|537542524|FG003|First Escalation|Participant Request|0|||
149017194|NCT00322374|537542521|FG000|Second Escalation|Physician Decision|0|||
149017195|NCT00322374|537542522|FG001|Second Escalation|Physician Decision|0|||
149017196|NCT00322374|537542523|FG002|Second Escalation|Physician Decision|5|||
149017197|NCT00322374|537542524|FG003|Second Escalation|Physician Decision|0|||
149017198|NCT00322374|537542521|FG000|Second Escalation|Study Drug Toxicity|0|||
149017199|NCT00322374|537542522|FG001|Second Escalation|Study Drug Toxicity|0|||
148951877|NCT02557646|537305516|FG000|Overall Study|Other|14|||
148951878|NCT03944954|537305517|FG000|Overall Study|Withdrawal by Subject|22|||
148951879|NCT03944954|537305518|FG001|Overall Study|Withdrawal by Subject|4|||
148951880|NCT03944954|537305517|FG000|Overall Study|Lost to Follow-up|18|||
148951881|NCT03944954|537305518|FG001|Overall Study|Lost to Follow-up|0|||
148951882|NCT03944954|537305517|FG000|Overall Study|Failed Medical Screening|7|||
148951883|NCT03944954|537305518|FG001|Overall Study|Failed Medical Screening|0|||
148951884|NCT02268084|537305521|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
148951885|NCT02268084|537305522|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
148951886|NCT02268084|537305521|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
148951887|NCT02268084|537305522|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
148951888|NCT00855920|537305526|FG000|Overall Study|Protocol Violation|0|||
148951889|NCT00855920|537305527|FG001|Overall Study|Protocol Violation|0|||
148951890|NCT00855920|537305528|FG002|Overall Study|Protocol Violation|2|||
148951891|NCT00855920|537305526|FG000|Overall Study|Adverse Event|2|||
148951892|NCT00855920|537305527|FG001|Overall Study|Adverse Event|1|||
148951893|NCT00855920|537305528|FG002|Overall Study|Adverse Event|1|||
148951894|NCT00855920|537305526|FG000|Overall Study|Lack of Efficacy|2|||
148951895|NCT00855920|537305527|FG001|Overall Study|Lack of Efficacy|2|||
148951896|NCT00855920|537305528|FG002|Overall Study|Lack of Efficacy|2|||
149017200|NCT00322374|537542523|FG002|Second Escalation|Study Drug Toxicity|1|||
149017201|NCT00322374|537542524|FG003|Second Escalation|Study Drug Toxicity|0|||
149017202|NCT01000376|537542525|FG000|Cycle 1 Day 1|Adverse Event|1|||
149017203|NCT01000376|537542526|FG001|Cycle 1 Day 1|Adverse Event|0|||
149215586|NCT01634100|538255620|FG000|Overall Study|Withdrawal by Subject|1|||
149215587|NCT01634100|538255621|FG001|Overall Study|Withdrawal by Subject|0|||
149215588|NCT01634100|538255622|FG002|Overall Study|Withdrawal by Subject|1|||
149215589|NCT01634100|538255623|FG003|Overall Study|Withdrawal by Subject|0|||
149017204|NCT01000376|537542525|FG000|Cycle 1 Day 1|Progressive Disease|1|||
148951897|NCT00855920|537305526|FG000|Overall Study|Withdrawal by Subject|2|||
149017205|NCT01000376|537542526|FG001|Cycle 1 Day 1|Progressive Disease|0|||
149215590|NCT01634100|538255624|FG004|Overall Study|Withdrawal by Subject|0|||
149215591|NCT01634100|538255625|FG005|Overall Study|Withdrawal by Subject|0|||
149215592|NCT00471276|538255626|FG000|Overall Study|Death|2|||
149017206|NCT02372058|537542527|FG000|Overall Study|Withdrawal by Subject|3|||
149215593|NCT00471276|538255626|FG000|Overall Study|Adverse Event|16|||
149215594|NCT00471276|538255626|FG000|Overall Study|Protocol Violation|1|||
149215595|NCT00471276|538255626|FG000|Overall Study|Objective progression or relapse|54|||
149215596|NCT00471276|538255626|FG000|Overall Study|Global deterioration of health status|1|||
149215597|NCT00471276|538255626|FG000|Overall Study|Other|3|||
149215598|NCT00471276|538255626|FG000|Overall Study|Refused treatment|6|||
149215599|NCT00744991|538255627|FG000|Overall Study|Progressive Disease|11|||
149215600|NCT00744991|538255627|FG000|Overall Study|Withdrawal by Subject|8|||
149215601|NCT00744991|538255627|FG000|Overall Study|Physician Decision|3|||
149215602|NCT00744991|538255627|FG000|Overall Study|Adverse Event|2|||
149215603|NCT00744991|538255627|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
149215604|NCT01662986|538255628|FG000|Overall Study|Adverse Event|5|||
149215605|NCT01662986|538255629|FG001|Overall Study|Adverse Event|4|||
149215606|NCT01662986|538255628|FG000|Overall Study|Protocol Violation|2|||
149215607|NCT01662986|538255629|FG001|Overall Study|Protocol Violation|3|||
149215608|NCT01662986|538255628|FG000|Overall Study|Lost to Follow-up|5|||
149215609|NCT01662986|538255629|FG001|Overall Study|Lost to Follow-up|4|||
149215610|NCT01662986|538255628|FG000|Overall Study|Withdrawal by Subject|2|||
149215611|NCT01662986|538255629|FG001|Overall Study|Withdrawal by Subject|2|||
149215612|NCT01662986|538255628|FG000|Overall Study|Not Treated|1|||
149215613|NCT01662986|538255629|FG001|Overall Study|Not Treated|0|||
149215614|NCT01662986|538255628|FG000|Overall Study|Other than stated above|3|||
149215615|NCT01662986|538255629|FG001|Overall Study|Other than stated above|0|||
149215616|NCT01487863|538255630|FG000|Overall Study|Death|19|||
149215617|NCT01487863|538255631|FG001|Overall Study|Death|19|||
149215618|NCT04449276|538255633|FG000|Overall Study|Adverse Event|1|||
149215619|NCT04449276|538255634|FG001|Overall Study|Adverse Event|2|||
149215620|NCT04449276|538255635|FG002|Overall Study|Adverse Event|0|||
149215621|NCT04449276|538255636|FG003|Overall Study|Adverse Event|0|||
149215622|NCT04449276|538255637|FG004|Overall Study|Adverse Event|2|||
149215623|NCT04449276|538255638|FG005|Overall Study|Adverse Event|0|||
149215624|NCT04449276|538255639|FG006|Overall Study|Adverse Event|0|||
148951898|NCT00855920|537305527|FG001|Overall Study|Withdrawal by Subject|3|||
148951899|NCT00855920|537305528|FG002|Overall Study|Withdrawal by Subject|2|||
148951900|NCT00855920|537305526|FG000|Overall Study|Lost to Follow-up|1|||
148951901|NCT00855920|537305527|FG001|Overall Study|Lost to Follow-up|0|||
148951902|NCT00855920|537305528|FG002|Overall Study|Lost to Follow-up|2|||
148951903|NCT00855920|537305526|FG000|Overall Study|Death|0|||
148951904|NCT00855920|537305527|FG001|Overall Study|Death|1|||
148951905|NCT00855920|537305528|FG002|Overall Study|Death|0|||
148951906|NCT00855920|537305526|FG000|Overall Study|Decision by the sponsor|0|||
148951907|NCT00855920|537305527|FG001|Overall Study|Decision by the sponsor|1|||
148951908|NCT00855920|537305528|FG002|Overall Study|Decision by the sponsor|1|||
148951909|NCT00855920|537305526|FG000|Overall Study|Other than specified above|1|||
148951910|NCT00855920|537305527|FG001|Overall Study|Other than specified above|1|||
148951911|NCT00855920|537305528|FG002|Overall Study|Other than specified above|1|||
148951912|NCT04786990|537305529|FG000|Overall Study|Withdrawal by Subject|1|||
148951913|NCT04786990|537305529|FG000|Overall Study|Adverse Event|1|||
148951914|NCT04786990|537305529|FG000|Overall Study|Lost to Follow-up|1|||
148951915|NCT04786990|537305529|FG000|Overall Study|Noncompliance|1|||
148951916|NCT04786990|537305529|FG000|Overall Study|Unable to complete site visits|1|||
148951917|NCT04786990|537305529|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
148951918|NCT01782222|537305532|FG000|Overall Study|Adverse Event|4|||
148951919|NCT01782222|537305533|FG001|Overall Study|Adverse Event|5|||
148951920|NCT01782222|537305534|FG002|Overall Study|Adverse Event|3|||
148951921|NCT01782222|537305532|FG000|Overall Study|Lack of Efficacy|2|||
148951922|NCT01782222|537305533|FG001|Overall Study|Lack of Efficacy|1|||
148951923|NCT01782222|537305534|FG002|Overall Study|Lack of Efficacy|0|||
148951924|NCT01782222|537305532|FG000|Overall Study|Protocol Violation|1|||
148951925|NCT01782222|537305533|FG001|Overall Study|Protocol Violation|0|||
149215625|NCT04449276|538255640|FG007|Overall Study|Adverse Event|1|||
149215626|NCT04449276|538255633|FG000|Overall Study|Withdrawal by Subject|2|||
148951926|NCT01782222|537305534|FG002|Overall Study|Protocol Violation|0|||
149215627|NCT04449276|538255634|FG001|Overall Study|Withdrawal by Subject|0|||
149215628|NCT04449276|538255635|FG002|Overall Study|Withdrawal by Subject|0|||
149215629|NCT04449276|538255636|FG003|Overall Study|Withdrawal by Subject|1|||
149215630|NCT04449276|538255637|FG004|Overall Study|Withdrawal by Subject|0|||
149215631|NCT04449276|538255638|FG005|Overall Study|Withdrawal by Subject|0|||
149215632|NCT04449276|538255639|FG006|Overall Study|Withdrawal by Subject|0|||
148684745|NCT01621490|536319473|FG010|Overall Study|Death|0|||
148951927|NCT01782222|537305532|FG000|Overall Study|Withdrawal by Subject|1|||
148951928|NCT01782222|537305533|FG001|Overall Study|Withdrawal by Subject|4|||
148951929|NCT01782222|537305534|FG002|Overall Study|Withdrawal by Subject|1|||
148951930|NCT01782222|537305532|FG000|Overall Study|Moved to other state|0|||
148951931|NCT01782222|537305533|FG001|Overall Study|Moved to other state|1|||
149215633|NCT04449276|538255640|FG007|Overall Study|Withdrawal by Subject|0|||
149215634|NCT04449276|538255633|FG000|Overall Study|Other|0|||
149215635|NCT04449276|538255634|FG001|Overall Study|Other|2|||
149215636|NCT04449276|538255635|FG002|Overall Study|Other|3|||
149215637|NCT04449276|538255636|FG003|Overall Study|Other|2|||
149215638|NCT04449276|538255637|FG004|Overall Study|Other|0|||
149215639|NCT04449276|538255638|FG005|Overall Study|Other|0|||
149215640|NCT04449276|538255639|FG006|Overall Study|Other|0|||
149215641|NCT04449276|538255640|FG007|Overall Study|Other|1|||
149215642|NCT01614795|538255643|FG000|Overall Study|Adverse Event|0|||
149215643|NCT01614795|538255644|FG001|Overall Study|Adverse Event|0|||
149215644|NCT01614795|538255645|FG002|Overall Study|Adverse Event|1|||
149215645|NCT01614795|538255646|FG003|Overall Study|Adverse Event|1|||
149215646|NCT01614795|538255643|FG000|Overall Study|Lack of Efficacy|10|||
149215647|NCT01614795|538255644|FG001|Overall Study|Lack of Efficacy|10|||
149215648|NCT01614795|538255645|FG002|Overall Study|Lack of Efficacy|9|||
149215649|NCT01614795|538255646|FG003|Overall Study|Lack of Efficacy|8|||
149215650|NCT01614795|538255643|FG000|Overall Study|Physician Decision|1|||
149215651|NCT01614795|538255644|FG001|Overall Study|Physician Decision|0|||
149215652|NCT01614795|538255645|FG002|Overall Study|Physician Decision|1|||
149215653|NCT01614795|538255646|FG003|Overall Study|Physician Decision|1|||
149215654|NCT01614795|538255643|FG000|Overall Study|Withdrawal by Subject|0|||
149215655|NCT01614795|538255644|FG001|Overall Study|Withdrawal by Subject|1|||
149215656|NCT01614795|538255645|FG002|Overall Study|Withdrawal by Subject|0|||
149215657|NCT01614795|538255646|FG003|Overall Study|Withdrawal by Subject|2|||
148951932|NCT01782222|537305534|FG002|Overall Study|Moved to other state|0|||
148951933|NCT01756898|537305538|FG000|Overall Study|Adverse Event|7|||
148951934|NCT01756898|537305539|FG001|Overall Study|Adverse Event|1|||
148951935|NCT01756898|537305540|FG002|Overall Study|Adverse Event|0|||
148951936|NCT01756898|537305541|FG003|Overall Study|Adverse Event|0|||
148951937|NCT01756898|537305538|FG000|Overall Study|Lack of Efficacy|4|||
148951938|NCT01756898|537305539|FG001|Overall Study|Lack of Efficacy|7|||
148951939|NCT01756898|537305540|FG002|Overall Study|Lack of Efficacy|6|||
148951940|NCT01756898|537305541|FG003|Overall Study|Lack of Efficacy|6|||
149215658|NCT01614795|538255643|FG000|Overall Study|Ineligible|0|||
148684746|NCT01621490|536319463|FG000|Overall Study|Other reasons|7|||
148951941|NCT01756898|537305538|FG000|Overall Study|Lost to Follow-up|2|||
148951942|NCT01756898|537305539|FG001|Overall Study|Lost to Follow-up|4|||
148951943|NCT01756898|537305540|FG002|Overall Study|Lost to Follow-up|2|||
148951944|NCT01756898|537305541|FG003|Overall Study|Lost to Follow-up|3|||
148951945|NCT01756898|537305538|FG000|Overall Study|Protocol Violation|1|||
148951946|NCT01756898|537305539|FG001|Overall Study|Protocol Violation|2|||
148951947|NCT01756898|537305540|FG002|Overall Study|Protocol Violation|2|||
148951948|NCT01756898|537305541|FG003|Overall Study|Protocol Violation|1|||
148951949|NCT01756898|537305538|FG000|Overall Study|Withdrew Consent|5|||
148951950|NCT01756898|537305539|FG001|Overall Study|Withdrew Consent|3|||
148951951|NCT01756898|537305540|FG002|Overall Study|Withdrew Consent|5|||
148951952|NCT01756898|537305541|FG003|Overall Study|Withdrew Consent|6|||
148951953|NCT01756898|537305538|FG000|Overall Study|Other|0|||
148951954|NCT01756898|537305539|FG001|Overall Study|Other|2|||
148951955|NCT01756898|537305540|FG002|Overall Study|Other|2|||
148951956|NCT01756898|537305541|FG003|Overall Study|Other|0|||
148951957|NCT01500694|537305542|FG000|Overall Study|Adverse Event|4|||
148951958|NCT01500694|537305543|FG001|Overall Study|Adverse Event|3|||
148951959|NCT01500694|537305542|FG000|Overall Study|Protocol Violation|0|||
148951960|NCT01500694|537305543|FG001|Overall Study|Protocol Violation|1|||
148951961|NCT01500694|537305542|FG000|Overall Study|Withdrawal by Subject|23|||
148951962|NCT01500694|537305543|FG001|Overall Study|Withdrawal by Subject|14|||
149017207|NCT01994720|537542528|FG000|Overall Study|Withdrawal by Subject|46|||
149017208|NCT01994720|537542529|FG001|Overall Study|Withdrawal by Subject|56|||
149017209|NCT00967018|537542535|FG000|Overall Study|Adverse Event|2|||
148684747|NCT01621490|536319464|FG001|Overall Study|Other reasons|6|||
148684748|NCT01621490|536319465|FG002|Overall Study|Other reasons|4|||
148684749|NCT01621490|536319466|FG003|Overall Study|Other reasons|1|||
148684750|NCT01621490|536319467|FG004|Overall Study|Other reasons|1|||
148684751|NCT01621490|536319468|FG005|Overall Study|Other reasons|3|||
148684752|NCT01621490|536319469|FG006|Overall Study|Other reasons|1|||
149017210|NCT00967018|537542535|FG000|Overall Study|Physician Decision|7|||
149017211|NCT00967018|537542535|FG000|Overall Study|Lost to Follow-up|2|||
149017212|NCT00967018|537542535|FG000|Overall Study|Withdrawal by Subject|1|||
149017213|NCT00967018|537542535|FG000|Overall Study|Miscellaneous Reasons|9|||
149215659|NCT01614795|538255644|FG001|Overall Study|Ineligible|1|||
149215660|NCT01614795|538255645|FG002|Overall Study|Ineligible|0|||
149215661|NCT01614795|538255646|FG003|Overall Study|Ineligible|0|||
149215662|NCT00701103|538255652|FG000|Overall Study|Adverse Event|0|||
148684753|NCT01621490|536319470|FG007|Overall Study|Other reasons|1|||
148951963|NCT01500694|537305542|FG000|Overall Study|Lost to Follow-up|2|||
148951964|NCT01500694|537305543|FG001|Overall Study|Lost to Follow-up|3|||
148951965|NCT01500694|537305542|FG000|Overall Study|Lack of Efficacy|14|||
148951966|NCT01500694|537305543|FG001|Overall Study|Lack of Efficacy|5|||
149215663|NCT00701103|538255653|FG001|Overall Study|Adverse Event|0|||
148951967|NCT01500694|537305542|FG000|Overall Study|Other|9|||
148951968|NCT01500694|537305543|FG001|Overall Study|Other|3|||
148951969|NCT02007109|537305544|FG000|Overall Study|Diary not returned or excluded|102|||
149215664|NCT00701103|538255654|FG002|Overall Study|Adverse Event|1|||
149215665|NCT00701103|538255655|FG003|Overall Study|Adverse Event|1|||
148951970|NCT02007109|537305544|FG000|Overall Study|Excluded - Age<7yo|9|||
148951971|NCT01605877|537305546|FG000|Overall Study|Withdrawal by Subject|1|||
149215666|NCT00701103|538255656|FG004|Overall Study|Adverse Event|0|||
149215667|NCT00701103|538255657|FG005|Overall Study|Adverse Event|1|||
149215668|NCT00701103|538255658|FG006|Overall Study|Adverse Event|1|||
149215669|NCT00701103|538255659|FG007|Overall Study|Adverse Event|0|||
149215670|NCT00701103|538255660|FG008|Overall Study|Adverse Event|0|||
149215671|NCT00701103|538255661|FG009|Overall Study|Adverse Event|2|||
149215672|NCT00701103|538255662|FG010|Overall Study|Adverse Event|0|||
148951972|NCT02132130|537305549|FG000|Overall Study|Lost to Follow-up|0|||
148951973|NCT02132130|537305550|FG001|Overall Study|Lost to Follow-up|2|||
148951974|NCT02132130|537305551|FG002|Overall Study|Lost to Follow-up|0|||
148951975|NCT02132130|537305552|FG003|Overall Study|Lost to Follow-up|0|||
148951976|NCT02132130|537305549|FG000|Overall Study|Withdrawal by Subject|0|||
148951977|NCT02132130|537305550|FG001|Overall Study|Withdrawal by Subject|0|||
148951978|NCT02132130|537305551|FG002|Overall Study|Withdrawal by Subject|0|||
148951979|NCT02132130|537305552|FG003|Overall Study|Withdrawal by Subject|1|||
148951980|NCT02760069|537305553|FG000|Overall Study|Withdrawal by Subject|0|||
148951981|NCT02760069|537305554|FG001|Overall Study|Withdrawal by Subject|1|||
148951982|NCT02760069|537305555|FG002|Overall Study|Withdrawal by Subject|1|||
148951983|NCT00600483|537305561|FG000|Overall Study|Lost to Follow-up|26|||
148951984|NCT00600483|537305562|FG001|Overall Study|Lost to Follow-up|47|||
148951985|NCT00600483|537305561|FG000|Overall Study|Randomized but not treated|10|||
148951986|NCT00600483|537305562|FG001|Overall Study|Randomized but not treated|0|||
148951987|NCT00580606|537305574|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
148951988|NCT00580606|537305575|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
148951989|NCT00580606|537305574|FG000|Open Label (OL)|Withdrawal by Subject|4|||
148951990|NCT00580606|537305575|FG001|Open Label (OL)|Withdrawal by Subject|6|||
148951991|NCT00580606|537305574|FG000|Open Label (OL)|Dosing Symptoms|0|||
148951992|NCT00580606|537305575|FG001|Open Label (OL)|Dosing Symptoms|1|||
148951993|NCT00580606|537305574|FG000|Open Label (OL)|Lost to Follow-up|0|||
148951994|NCT00580606|537305575|FG001|Open Label (OL)|Lost to Follow-up|1|||
148951995|NCT00580606|537305574|FG000|Open Label (OL)|Pregnancy|0|||
148951996|NCT00580606|537305575|FG001|Open Label (OL)|Pregnancy|1|||
148951997|NCT00580606|537305574|FG000|Open Label (OL)|Non-compliance|2|||
148951998|NCT00580606|537305575|FG001|Open Label (OL)|Non-compliance|0|||
148951999|NCT00580606|537305574|FG000|Open Label (OL)|Physician Decision|1|||
148952000|NCT00580606|537305575|FG001|Open Label (OL)|Physician Decision|1|||
148952001|NCT00580606|537305574|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
148952002|NCT00580606|537305575|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
148952003|NCT03031678|537305579|FG000|Overall Study|Study closed prior to completion|1|||
148952004|NCT00439244|537305580|FG000|Overall Study|Adverse Event|5|||
148952005|NCT00439244|537305581|FG001|Overall Study|Adverse Event|2|||
148952006|NCT00439244|537305582|FG002|Overall Study|Adverse Event|3|||
148952007|NCT00439244|537305580|FG000|Overall Study|Withdrawal by Subject|3|||
148952008|NCT00439244|537305581|FG001|Overall Study|Withdrawal by Subject|1|||
149017214|NCT01680458|537542541|FG000|Overall Study|Protocol Violation|3|||
149017215|NCT02138747|537542542|FG000|Treatment Period 1|Adverse Event|10|||
149215673|NCT00701103|538255652|FG000|Overall Study|Progressive Disease|5|||
149215674|NCT00701103|538255653|FG001|Overall Study|Progressive Disease|2|||
149215675|NCT00701103|538255654|FG002|Overall Study|Progressive Disease|6|||
149215676|NCT00701103|538255655|FG003|Overall Study|Progressive Disease|5|||
149215677|NCT00701103|538255656|FG004|Overall Study|Progressive Disease|6|||
149215678|NCT00701103|538255657|FG005|Overall Study|Progressive Disease|5|||
149215679|NCT00701103|538255658|FG006|Overall Study|Progressive Disease|7|||
149215680|NCT00701103|538255659|FG007|Overall Study|Progressive Disease|7|||
149215681|NCT00701103|538255660|FG008|Overall Study|Progressive Disease|8|||
149215682|NCT00701103|538255661|FG009|Overall Study|Progressive Disease|8|||
149215683|NCT00701103|538255662|FG010|Overall Study|Progressive Disease|11|||
149215684|NCT00701103|538255652|FG000|Overall Study|Withdrawal by Subject|0|||
149215685|NCT00701103|538255653|FG001|Overall Study|Withdrawal by Subject|1|||
149215686|NCT00701103|538255654|FG002|Overall Study|Withdrawal by Subject|1|||
149215687|NCT00701103|538255655|FG003|Overall Study|Withdrawal by Subject|0|||
149215688|NCT00701103|538255656|FG004|Overall Study|Withdrawal by Subject|0|||
149215689|NCT00701103|538255657|FG005|Overall Study|Withdrawal by Subject|0|||
148952009|NCT00439244|537305582|FG002|Overall Study|Withdrawal by Subject|2|||
148952010|NCT00439244|537305580|FG000|Overall Study|Lost to Follow-up|2|||
149215690|NCT00701103|538255658|FG006|Overall Study|Withdrawal by Subject|0|||
149215691|NCT00701103|538255659|FG007|Overall Study|Withdrawal by Subject|0|||
149215692|NCT00701103|538255660|FG008|Overall Study|Withdrawal by Subject|0|||
149215693|NCT00701103|538255661|FG009|Overall Study|Withdrawal by Subject|0|||
149215694|NCT00701103|538255662|FG010|Overall Study|Withdrawal by Subject|0|||
149215695|NCT00701103|538255652|FG000|Overall Study|Other|0|||
148952011|NCT00439244|537305581|FG001|Overall Study|Lost to Follow-up|1|||
148952012|NCT00439244|537305582|FG002|Overall Study|Lost to Follow-up|2|||
148952013|NCT00439244|537305580|FG000|Overall Study|Death|0|||
148952014|NCT00439244|537305581|FG001|Overall Study|Death|1|||
149017216|NCT02138747|537542543|FG001|Treatment Period 1|Adverse Event|14|||
149215696|NCT00701103|538255653|FG001|Overall Study|Other|0|||
149215697|NCT00701103|538255654|FG002|Overall Study|Other|0|||
149215698|NCT00701103|538255655|FG003|Overall Study|Other|0|||
149215699|NCT00701103|538255656|FG004|Overall Study|Other|0|||
149215700|NCT00701103|538255657|FG005|Overall Study|Other|0|||
149215701|NCT00701103|538255658|FG006|Overall Study|Other|0|||
149215702|NCT00701103|538255659|FG007|Overall Study|Other|0|||
149215703|NCT00701103|538255660|FG008|Overall Study|Other|1|||
149215704|NCT00701103|538255661|FG009|Overall Study|Other|1|||
148952015|NCT00439244|537305582|FG002|Overall Study|Death|0|||
148952016|NCT00439244|537305580|FG000|Overall Study|Protocol Violation|0|||
148952017|NCT00439244|537305581|FG001|Overall Study|Protocol Violation|1|||
148952018|NCT00439244|537305582|FG002|Overall Study|Protocol Violation|0|||
148952019|NCT00439244|537305580|FG000|Overall Study|Administrative problems|1|||
148952020|NCT00439244|537305581|FG001|Overall Study|Administrative problems|0|||
148952021|NCT00439244|537305582|FG002|Overall Study|Administrative problems|0|||
148952022|NCT03655691|537305583|FG000|Overall Study|Adverse Event|0|||
148952023|NCT03655691|537305584|FG001|Overall Study|Adverse Event|0|||
148952024|NCT03655691|537305585|FG002|Overall Study|Adverse Event|1|||
148952025|NCT03655691|537305583|FG000|Overall Study|Lost to Follow-up|1|||
148952026|NCT03655691|537305584|FG001|Overall Study|Lost to Follow-up|1|||
148952027|NCT03655691|537305585|FG002|Overall Study|Lost to Follow-up|2|||
148952028|NCT03655691|537305583|FG000|Overall Study|Protocol Violation|0|||
148952029|NCT03655691|537305584|FG001|Overall Study|Protocol Violation|1|||
148952030|NCT03655691|537305585|FG002|Overall Study|Protocol Violation|0|||
148952031|NCT03655691|537305583|FG000|Overall Study|Withdrawal by Subject|1|||
148952032|NCT03655691|537305584|FG001|Overall Study|Withdrawal by Subject|1|||
148952033|NCT03655691|537305585|FG002|Overall Study|Withdrawal by Subject|0|||
148952034|NCT04557371|537305586|FG000|Overall Study|Covid-19-related|0|||
148952035|NCT04557371|537305587|FG001|Overall Study|Covid-19-related|1|||
148952036|NCT04557371|537305588|FG002|Overall Study|Covid-19-related|0|||
148952037|NCT04557371|537305586|FG000|Overall Study|Withdrawal by Subject|0|||
148952038|NCT04557371|537305587|FG001|Overall Study|Withdrawal by Subject|1|||
148952039|NCT04557371|537305588|FG002|Overall Study|Withdrawal by Subject|0|||
148952040|NCT04557371|537305586|FG000|Overall Study|Adverse Event|1|||
148952041|NCT04557371|537305587|FG001|Overall Study|Adverse Event|0|||
148952042|NCT04557371|537305588|FG002|Overall Study|Adverse Event|0|||
148952043|NCT03694821|537305589|FG000|Overall Study|Study terminated|4|||
148952044|NCT03694821|537305590|FG001|Overall Study|Study terminated|8|||
148952045|NCT03694821|537305591|FG002|Overall Study|Study terminated|4|||
148952046|NCT05109442|537305594|FG000|Overall Study|Withdrawal by Subject|0|||
148952047|NCT05109442|537305595|FG001|Overall Study|Withdrawal by Subject|0|||
148952048|NCT05109442|537305596|FG002|Overall Study|Withdrawal by Subject|1|||
148952049|NCT05109442|537305597|FG003|Overall Study|Withdrawal by Subject|0|||
148952050|NCT05109442|537305598|FG004|Overall Study|Withdrawal by Subject|0|||
148952051|NCT05109442|537305599|FG005|Overall Study|Withdrawal by Subject|0|||
148952052|NCT05109442|537305594|FG000|Overall Study|Adverse Event|0|||
148952053|NCT05109442|537305595|FG001|Overall Study|Adverse Event|1|||
149215705|NCT00701103|538255662|FG010|Overall Study|Other|0|||
149215706|NCT01448707|538255668|FG000|Overall Study|Adverse Event|3|||
149215707|NCT01448707|538255669|FG001|Overall Study|Adverse Event|1|||
149215708|NCT01448707|538255668|FG000|Overall Study|Lost to Follow-up|2|||
149215709|NCT01448707|538255669|FG001|Overall Study|Lost to Follow-up|6|||
149215710|NCT01448707|538255668|FG000|Overall Study|Withdrawal by Subject|6|||
149215711|NCT01448707|538255669|FG001|Overall Study|Withdrawal by Subject|7|||
149215712|NCT01448707|538255668|FG000|Overall Study|Other|7|||
149215713|NCT01448707|538255669|FG001|Overall Study|Other|4|||
149215714|NCT02623699|538255676|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215715|NCT02623699|538255677|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
149215716|NCT02623699|538255678|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215717|NCT02623699|538255679|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215718|NCT02623699|538255680|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215719|NCT02623699|538255681|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215720|NCT02623699|538255682|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
148952054|NCT05109442|537305596|FG002|Overall Study|Adverse Event|5|||
149017217|NCT02138747|537542544|FG002|Treatment Period 1|Adverse Event|2|||
149017218|NCT02138747|537542545|FG003|Treatment Period 1|Adverse Event|1|||
148952055|NCT05109442|537305597|FG003|Overall Study|Adverse Event|0|||
149017219|NCT02138747|537542542|FG000|Treatment Period 1|Lost to Follow-up|0|||
149017220|NCT02138747|537542543|FG001|Treatment Period 1|Lost to Follow-up|1|||
149017221|NCT02138747|537542544|FG002|Treatment Period 1|Lost to Follow-up|1|||
149215721|NCT02623699|538255683|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
148952056|NCT05109442|537305598|FG004|Overall Study|Adverse Event|0|||
149215722|NCT02623699|538255684|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215723|NCT02623699|538255685|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215724|NCT02623699|538255686|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215725|NCT02623699|538255687|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
149215726|NCT02623699|538255676|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
148952057|NCT05109442|537305599|FG005|Overall Study|Adverse Event|2|||
149215727|NCT02623699|538255677|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215728|NCT02623699|538255678|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215729|NCT02623699|538255679|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215730|NCT02623699|538255680|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215731|NCT02623699|538255681|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215732|NCT02623699|538255682|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
149215733|NCT02623699|538255683|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215734|NCT02623699|538255684|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215735|NCT02623699|538255685|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215736|NCT02623699|538255686|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215737|NCT02623699|538255687|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
149215738|NCT02623699|538255676|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215739|NCT02623699|538255677|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215740|NCT02623699|538255678|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215741|NCT02623699|538255679|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215742|NCT02623699|538255680|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215743|NCT02623699|538255681|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
149215744|NCT02623699|538255682|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215745|NCT02623699|538255683|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215746|NCT02623699|538255684|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215747|NCT02623699|538255685|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215748|NCT02623699|538255686|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215749|NCT02623699|538255687|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
149215750|NCT02623699|538255676|FG000|Part B (Up to 289 Days)|Death|0|||
149215751|NCT02623699|538255677|FG001|Part B (Up to 289 Days)|Death|0|||
149215752|NCT02623699|538255678|FG002|Part B (Up to 289 Days)|Death|0|||
149215753|NCT02623699|538255679|FG003|Part B (Up to 289 Days)|Death|0|||
149215754|NCT02623699|538255680|FG004|Part B (Up to 289 Days)|Death|0|||
149215755|NCT02623699|538255681|FG005|Part B (Up to 289 Days)|Death|1|||
149215756|NCT02623699|538255682|FG006|Part B (Up to 289 Days)|Death|1|||
149215757|NCT02623699|538255683|FG007|Part B (Up to 289 Days)|Death|0|||
149215758|NCT02623699|538255684|FG008|Part B (Up to 289 Days)|Death|1|||
149215759|NCT02623699|538255685|FG009|Part B (Up to 289 Days)|Death|0|||
149215760|NCT02623699|538255686|FG010|Part B (Up to 289 Days)|Death|0|||
149215761|NCT02623699|538255687|FG011|Part B (Up to 289 Days)|Death|0|||
149215762|NCT02623699|538255676|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
149215763|NCT02623699|538255677|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
149215764|NCT02623699|538255678|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
149215765|NCT02623699|538255679|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
149215766|NCT02623699|538255680|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
149215767|NCT02623699|538255681|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
149215768|NCT02623699|538255682|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
149215769|NCT02623699|538255683|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
149215770|NCT02623699|538255684|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
149215771|NCT02623699|538255685|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
149215772|NCT02623699|538255686|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
149215773|NCT02623699|538255687|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
149215774|NCT02623699|538255676|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215775|NCT02623699|538255677|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215776|NCT02623699|538255678|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215777|NCT02623699|538255679|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215778|NCT02623699|538255680|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215779|NCT02623699|538255681|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215780|NCT02623699|538255682|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215781|NCT02623699|538255683|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215782|NCT02623699|538255684|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215783|NCT02623699|538255685|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
149215784|NCT02623699|538255686|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
149215785|NCT02623699|538255687|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
149215786|NCT02623699|538255676|FG000|Part C (Up to 236 Days)|Death|0|||
149215787|NCT02623699|538255677|FG001|Part C (Up to 236 Days)|Death|0|||
149215788|NCT02623699|538255678|FG002|Part C (Up to 236 Days)|Death|0|||
149215789|NCT02623699|538255679|FG003|Part C (Up to 236 Days)|Death|0|||
149215790|NCT02623699|538255680|FG004|Part C (Up to 236 Days)|Death|0|||
149215791|NCT02623699|538255681|FG005|Part C (Up to 236 Days)|Death|0|||
149215792|NCT02623699|538255682|FG006|Part C (Up to 236 Days)|Death|0|||
149215793|NCT02623699|538255683|FG007|Part C (Up to 236 Days)|Death|0|||
149215794|NCT02623699|538255684|FG008|Part C (Up to 236 Days)|Death|0|||
149215795|NCT02623699|538255685|FG009|Part C (Up to 236 Days)|Death|0|||
149215796|NCT02623699|538255686|FG010|Part C (Up to 236 Days)|Death|0|||
149215797|NCT02623699|538255687|FG011|Part C (Up to 236 Days)|Death|1|||
149215798|NCT02623699|538255676|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
149215799|NCT02623699|538255677|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
149215800|NCT02623699|538255678|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
149215801|NCT02623699|538255679|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
149215802|NCT02623699|538255680|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
148811251|NCT01995201|536787049|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
149215803|NCT02623699|538255681|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
149215804|NCT02623699|538255682|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
149215805|NCT02623699|538255683|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
149215806|NCT02623699|538255684|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
149215807|NCT02623699|538255685|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
149215808|NCT02623699|538255686|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
149215809|NCT02623699|538255687|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
149215810|NCT00033371|538255688|FG000|Overall Study|Adverse Event|1|||
149215811|NCT00033371|538255689|FG001|Overall Study|Adverse Event|5|||
149215812|NCT00033371|538255688|FG000|Overall Study|Lost to Follow-up|2|||
149215813|NCT00033371|538255689|FG001|Overall Study|Lost to Follow-up|1|||
149215814|NCT00033371|538255688|FG000|Overall Study|Withdrawal by Subject|3|||
149215815|NCT00033371|538255689|FG001|Overall Study|Withdrawal by Subject|3|||
149215816|NCT00033371|538255688|FG000|Overall Study|Disease Progression|0|||
149215817|NCT00033371|538255689|FG001|Overall Study|Disease Progression|1|||
149215818|NCT00044213|538255690|FG000|Overall Study|Withdrawal by Subject|50|||
149215819|NCT00044213|538255691|FG001|Overall Study|Withdrawal by Subject|65|||
149215820|NCT00044213|538255692|FG002|Overall Study|Withdrawal by Subject|91|||
149215821|NCT00044213|538255693|FG003|Overall Study|Withdrawal by Subject|83|||
149215822|NCT00044213|538255690|FG000|Overall Study|Death|42|||
149215823|NCT00044213|538255691|FG001|Overall Study|Death|42|||
149215824|NCT00044213|538255692|FG002|Overall Study|Death|42|||
149215825|NCT00044213|538255693|FG003|Overall Study|Death|49|||
149215826|NCT00044213|538255690|FG000|Overall Study|Lost to Follow-up|8|||
149215827|NCT00044213|538255691|FG001|Overall Study|Lost to Follow-up|5|||
149215828|NCT00044213|538255692|FG002|Overall Study|Lost to Follow-up|5|||
149215829|NCT00044213|538255693|FG003|Overall Study|Lost to Follow-up|4|||
149215830|NCT00636155|538257513|FG000|Overall Study|Adverse Event|8|||
149215831|NCT00636155|538257513|FG000|Overall Study|Lack of Efficacy|1|||
149215832|NCT00636155|538257513|FG000|Overall Study|Withdrawal by Subject|3|||
149215833|NCT00636155|538257513|FG000|Overall Study|Stem cell transplant|1|||
149215834|NCT00636155|538257513|FG000|Overall Study|Physician Decision|5|||
149215835|NCT00766142|538257514|FG000|Overall Study|Protocol Violation|4|||
149215836|NCT05426460|538257516|FG000|Overall Study|Protocol Violation|1|||
149215837|NCT05426460|538257517|FG001|Overall Study|Protocol Violation|1|||
149215838|NCT05426460|538257518|FG002|Overall Study|Protocol Violation|1|||
149215839|NCT05426460|538257519|FG003|Overall Study|Protocol Violation|0|||
149215840|NCT02973997|538257523|FG000|Overall Study|Withdrawal by Subject|4|||
149215841|NCT02973997|538257524|FG001|Overall Study|Withdrawal by Subject|0|||
149215842|NCT02973997|538257523|FG000|Overall Study|Adverse Event|4|||
149215843|NCT02973997|538257524|FG001|Overall Study|Adverse Event|1|||
149215844|NCT02973997|538257523|FG000|Overall Study|Disease Progression|11|||
149215845|NCT02973997|538257524|FG001|Overall Study|Disease Progression|20|||
149215846|NCT02973997|538257523|FG000|Overall Study|Alternative Therapy|3|||
149215847|NCT02973997|538257524|FG001|Overall Study|Alternative Therapy|0|||
149215848|NCT02973997|538257523|FG000|Overall Study|Other complicating disease|0|||
149215849|NCT02973997|538257524|FG001|Overall Study|Other complicating disease|1|||
149215850|NCT02973997|538257523|FG000|Overall Study|Death|0|||
149215851|NCT02973997|538257524|FG001|Overall Study|Death|1|||
149215852|NCT01431521|538257525|FG000|Overall Study|Withdrawal by Subject|0|||
149215853|NCT01431521|538257526|FG001|Overall Study|Withdrawal by Subject|0|||
149215854|NCT01431521|538257527|FG002|Overall Study|Withdrawal by Subject|1|||
149215855|NCT01431521|538257528|FG003|Overall Study|Withdrawal by Subject|0|||
149215856|NCT00444951|538257529|FG000|Overall Study|Lost to Follow-up|1|||
149215857|NCT00444951|538257530|FG001|Overall Study|Lost to Follow-up|1|||
149215858|NCT00444951|538257531|FG002|Overall Study|Lost to Follow-up|0|||
149215859|NCT00444951|538257529|FG000|Overall Study|Withdrawal by Subject|4|||
149215860|NCT00444951|538257530|FG001|Overall Study|Withdrawal by Subject|5|||
149215861|NCT00444951|538257531|FG002|Overall Study|Withdrawal by Subject|3|||
149215862|NCT00366444|538257533|FG000|Overall Study|Withdrawal by Subject|1|||
149215863|NCT00366444|538257534|FG001|Overall Study|Withdrawal by Subject|1|||
149215864|NCT00366444|538257533|FG000|Overall Study|Lack of Efficacy|0|||
149215865|NCT00366444|538257534|FG001|Overall Study|Lack of Efficacy|1|||
149215866|NCT04984876|538257535|FG000|Overall Study|Subject decision|2|||
149215867|NCT04984876|538257536|FG001|Overall Study|Subject decision|10|||
149215868|NCT04984876|538257537|FG002|Overall Study|Subject decision|3|||
149215869|NCT04984876|538257538|FG003|Overall Study|Subject decision|3|||
149215870|NCT04984876|538257539|FG004|Overall Study|Subject decision|3|||
149215871|NCT04984876|538257540|FG005|Overall Study|Subject decision|0|||
149215872|NCT04984876|538257535|FG000|Overall Study|Guardian decision|0|||
149215873|NCT04984876|538257536|FG001|Overall Study|Guardian decision|1|||
149215874|NCT04984876|538257537|FG002|Overall Study|Guardian decision|0|||
149215875|NCT04984876|538257538|FG003|Overall Study|Guardian decision|2|||
149215876|NCT04984876|538257539|FG004|Overall Study|Guardian decision|0|||
149215877|NCT04984876|538257540|FG005|Overall Study|Guardian decision|1|||
149215878|NCT04984876|538257535|FG000|Overall Study|Lost to Follow-up|0|||
149215879|NCT04984876|538257536|FG001|Overall Study|Lost to Follow-up|0|||
149215880|NCT04984876|538257537|FG002|Overall Study|Lost to Follow-up|1|||
149215881|NCT04984876|538257538|FG003|Overall Study|Lost to Follow-up|1|||
149215882|NCT04984876|538257539|FG004|Overall Study|Lost to Follow-up|0|||
149215883|NCT04984876|538257540|FG005|Overall Study|Lost to Follow-up|0|||
149215884|NCT04984876|538257535|FG000|Overall Study|Physician Decision|1|||
149215885|NCT04984876|538257536|FG001|Overall Study|Physician Decision|0|||
149215886|NCT04984876|538257537|FG002|Overall Study|Physician Decision|0|||
149215887|NCT04984876|538257538|FG003|Overall Study|Physician Decision|1|||
149215888|NCT04984876|538257539|FG004|Overall Study|Physician Decision|0|||
149215889|NCT04984876|538257540|FG005|Overall Study|Physician Decision|0|||
149215890|NCT04984876|538257535|FG000|Overall Study|Adverse Event|0|||
149215891|NCT04984876|538257536|FG001|Overall Study|Adverse Event|0|||
149215892|NCT04984876|538257537|FG002|Overall Study|Adverse Event|1|||
149215893|NCT04984876|538257538|FG003|Overall Study|Adverse Event|0|||
149215894|NCT04984876|538257539|FG004|Overall Study|Adverse Event|0|||
149215895|NCT04984876|538257540|FG005|Overall Study|Adverse Event|0|||
149215896|NCT02204410|538257541|FG000|Overall Study|Lost to Follow-up|5|||
149215897|NCT02204410|538257541|FG000|Overall Study|Physician Decision|2|||
149215898|NCT02204410|538257541|FG000|Overall Study|Protocol Violation|1|||
149215899|NCT02204410|538257541|FG000|Overall Study|Withdrawal by Subject|3|||
149215900|NCT02000622|538257544|FG000|Overall Study|Withdrawal by Subject|5|||
149215901|NCT02000622|538257545|FG001|Overall Study|Withdrawal by Subject|7|||
149215902|NCT02000622|538257544|FG000|Overall Study|Lost to Follow-up|4|||
149215903|NCT02000622|538257545|FG001|Overall Study|Lost to Follow-up|0|||
149215904|NCT02000622|538257544|FG000|Overall Study|Death|159|||
149215905|NCT02000622|538257545|FG001|Overall Study|Death|73|||
149215906|NCT02000622|538257544|FG000|Overall Study|Withdrawn due to site closure|1|||
149215907|NCT02000622|538257545|FG001|Overall Study|Withdrawn due to site closure|0|||
149215908|NCT01405027|538257546|FG000|Overall Study|Withdrawn consent|3|||
149215909|NCT01405027|538257547|FG001|Overall Study|Withdrawn consent|0|||
149215910|NCT01405027|538257546|FG000|Overall Study|Lost to Follow-up|16|||
149215911|NCT01405027|538257547|FG001|Overall Study|Lost to Follow-up|24|||
149215912|NCT01405027|538257546|FG000|Overall Study|Investigator judgement|0|||
149215913|NCT01405027|538257547|FG001|Overall Study|Investigator judgement|2|||
149215914|NCT01405027|538257546|FG000|Overall Study|Death|1|||
149215915|NCT01405027|538257547|FG001|Overall Study|Death|0|||
149215916|NCT01405027|538257546|FG000|Overall Study|Other or Unknown|12|||
149215917|NCT01405027|538257547|FG001|Overall Study|Other or Unknown|25|||
149215918|NCT01462045|538257548|FG000|Overall Study|Family matter|0|||
149215919|NCT01462045|538257549|FG001|Overall Study|Family matter|1|||
149215920|NCT01462045|538257550|FG002|Overall Study|Family matter|0|||
149215921|NCT01938391|538257554|FG000|6 Month Follow up|Withdrawal by Subject|1|||
149215922|NCT01938391|538257554|FG000|12 Month Follow up|Physician Decision|1|||
149215923|NCT01938391|538257554|FG000|12 Month Follow up|Withdrawal by Subject|1|||
149215924|NCT01077193|538257561|FG000|Overall Study|Lost to Follow-up|1|||
149215925|NCT01077193|538257561|FG000|Overall Study|Withdrawal by Subject|2|||
149215926|NCT01077193|538257561|FG000|Overall Study|Lack of Efficacy|1|||
149017222|NCT02138747|537542545|FG003|Treatment Period 1|Lost to Follow-up|0|||
149017223|NCT02138747|537542542|FG000|Treatment Period 1|Protocol Violation|0|||
149017224|NCT02138747|537542543|FG001|Treatment Period 1|Protocol Violation|2|||
149017225|NCT02138747|537542544|FG002|Treatment Period 1|Protocol Violation|0|||
149215927|NCT01077193|538257561|FG000|Overall Study|Study Terminated by Sponsor|40|||
149215928|NCT03558828|538257562|FG000|Overall Study|Lost to Follow-up|4|||
149215929|NCT03558828|538257563|FG001|Overall Study|Lost to Follow-up|3|||
149215930|NCT03558828|538257564|FG002|Overall Study|Lost to Follow-up|3|||
149215931|NCT03558828|538257565|FG003|Overall Study|Lost to Follow-up|5|||
149215932|NCT03558828|538257566|FG004|Overall Study|Lost to Follow-up|2|||
149215933|NCT03558828|538257567|FG005|Overall Study|Lost to Follow-up|3|||
149215934|NCT03558828|538257562|FG000|Overall Study|dropped before the intervention|1|||
149215935|NCT03558828|538257563|FG001|Overall Study|dropped before the intervention|1|||
149215936|NCT03558828|538257564|FG002|Overall Study|dropped before the intervention|0|||
149215937|NCT03558828|538257565|FG003|Overall Study|dropped before the intervention|0|||
149215938|NCT03558828|538257566|FG004|Overall Study|dropped before the intervention|0|||
149215939|NCT03558828|538257567|FG005|Overall Study|dropped before the intervention|0|||
149215940|NCT03146403|538257572|FG000|Overall Study|Withdrawal by Subject|0|||
149215941|NCT03146403|538257573|FG001|Overall Study|Withdrawal by Subject|3|||
149215942|NCT03146403|538257572|FG000|Overall Study|Lost to Follow-up|2|||
149215943|NCT03146403|538257573|FG001|Overall Study|Lost to Follow-up|0|||
149215944|NCT02182999|538257575|FG000|Overall Study|Adverse Event|4|||
149215945|NCT02182999|538257576|FG001|Overall Study|Adverse Event|3|||
149215946|NCT02182999|538257575|FG000|Overall Study|Physician Decision|1|||
149215947|NCT02182999|538257576|FG001|Overall Study|Physician Decision|0|||
149215948|NCT02252588|538257578|FG000|Overall Study|Withdrawal by Subject|4|||
149215949|NCT02252588|538257579|FG001|Overall Study|Withdrawal by Subject|0|||
149215950|NCT02972593|538257580|FG000|Overall Study|Lost to Follow-up|19|||
149215951|NCT02972593|538257581|FG001|Overall Study|Lost to Follow-up|15|||
149215952|NCT02972593|538257580|FG000|Overall Study|Protocol Violation|1|||
149215953|NCT02972593|538257581|FG001|Overall Study|Protocol Violation|0|||
149215954|NCT00285649|538257582|FG000|Overall Study|Lost to Follow-up|6|||
149215955|NCT00285649|538257583|FG001|Overall Study|Lost to Follow-up|4|||
149215956|NCT00285649|538257584|FG002|Overall Study|Lost to Follow-up|4|||
149215957|NCT00285649|538257582|FG000|Overall Study|Withdrawal by Subject|3|||
149215958|NCT00285649|538257583|FG001|Overall Study|Withdrawal by Subject|2|||
149215959|NCT00285649|538257584|FG002|Overall Study|Withdrawal by Subject|2|||
149215960|NCT02465489|538257585|FG000|Overall Study|Adverse Event|5|||
148809733|NCT02326883|536780851|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
148809734|NCT02326883|536780852|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
148809735|NCT02326883|536780853|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
149215961|NCT00693693|538257586|FG000|Overall Study|Lost to Follow-up|1|||
149215962|NCT00693693|538257587|FG001|Overall Study|Lost to Follow-up|1|||
149215963|NCT00693693|538257588|FG002|Overall Study|Lost to Follow-up|2|||
149215964|NCT02203916|538257589|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149215965|NCT02203916|538257590|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
149215966|NCT02203916|538257591|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
149215967|NCT02203916|538257589|FG000|Overall Study|Major Protocol Deviation|1|||
149215968|NCT02203916|538257590|FG001|Overall Study|Major Protocol Deviation|1|||
149215969|NCT02203916|538257591|FG002|Overall Study|Major Protocol Deviation|0|||
149215970|NCT02203916|538257589|FG000|Overall Study|Lost to Follow-up|0|||
149215971|NCT02203916|538257590|FG001|Overall Study|Lost to Follow-up|1|||
149215972|NCT02203916|538257591|FG002|Overall Study|Lost to Follow-up|0|||
149215973|NCT02203916|538257589|FG000|Overall Study|Voluntary Withdrawal|3|||
149215974|NCT02203916|538257590|FG001|Overall Study|Voluntary Withdrawal|3|||
149215975|NCT02203916|538257591|FG002|Overall Study|Voluntary Withdrawal|8|||
149215976|NCT02203916|538257589|FG000|Overall Study|Lack of Efficacy|3|||
149215977|NCT02203916|538257590|FG001|Overall Study|Lack of Efficacy|0|||
149215978|NCT02203916|538257591|FG002|Overall Study|Lack of Efficacy|0|||
149215979|NCT02203916|538257589|FG000|Overall Study|Reason Not Specified|0|||
149215980|NCT02203916|538257590|FG001|Overall Study|Reason Not Specified|2|||
149215981|NCT02203916|538257591|FG002|Overall Study|Reason Not Specified|1|||
149215982|NCT00338806|538257592|FG000|Acute Phase|Withdrawal by Subject|0|||
149215983|NCT00338806|538257593|FG001|Acute Phase|Withdrawal by Subject|1|||
149215984|NCT00338806|538257592|FG000|Follow-up|Lost to Follow-up|1|||
149215985|NCT00338806|538257593|FG001|Follow-up|Lost to Follow-up|3|||
149215986|NCT01819194|538257596|FG000|Overall Study|Loss of study articles|2|||
149215987|NCT00045630|538257597|FG000|Overall Study|Adverse Event|1|||
149215988|NCT00045630|538257597|FG000|Overall Study|Refusal unrelated to adverse event|1|||
149215989|NCT00045630|538257597|FG000|Overall Study|Progression/relapse|1|||
149215990|NCT00045630|538257597|FG000|Overall Study|Death|1|||
149215991|NCT00045630|538257597|FG000|Overall Study|Ineligible|2|||
149215992|NCT02820038|538257601|FG000|Overall Study|Lost to Follow-up|7|||
149215993|NCT02820038|538257602|FG001|Overall Study|Lost to Follow-up|11|||
149215994|NCT02820038|538257603|FG002|Overall Study|Lost to Follow-up|2|||
149215995|NCT02820038|538257604|FG003|Overall Study|Lost to Follow-up|9|||
149215996|NCT02820038|538257601|FG000|Overall Study|Withdrawal by Subject|3|||
149215997|NCT02820038|538257602|FG001|Overall Study|Withdrawal by Subject|14|||
149215998|NCT02820038|538257603|FG002|Overall Study|Withdrawal by Subject|3|||
149215999|NCT02820038|538257604|FG003|Overall Study|Withdrawal by Subject|13|||
149216000|NCT03215667|538257605|FG000|Overall Study|Physician Decision|4|||
149216001|NCT01810380|538257607|FG000|Overall Study|Randomised not treated|2|||
149216002|NCT01810380|538257608|FG001|Overall Study|Randomised not treated|1|||
148809736|NCT02107898|536780855|FG000|Overall Study|Adverse Event|4|||
148809737|NCT02107898|536780856|FG001|Overall Study|Adverse Event|7|||
148809738|NCT02107898|536780855|FG000|Overall Study|Poor compliance to protocol|0|||
148809739|NCT02107898|536780856|FG001|Overall Study|Poor compliance to protocol|1|||
148809740|NCT02107898|536780855|FG000|Overall Study|Participant moved|0|||
148809741|NCT02107898|536780856|FG001|Overall Study|Participant moved|2|||
148809742|NCT02107898|536780855|FG000|Overall Study|Consent withdrawn by participant|2|||
148809743|NCT02107898|536780856|FG001|Overall Study|Consent withdrawn by participant|1|||
148809744|NCT02107898|536780855|FG000|Overall Study|Randomized but not treated|0|||
148809745|NCT02107898|536780856|FG001|Overall Study|Randomized but not treated|1|||
149216003|NCT01810380|538257609|FG002|Overall Study|Randomised not treated|1|||
148809746|NCT03329989|536780857|FG000|Overall Study|Withdrawal by Subject|9|||
148809747|NCT03329989|536780857|FG000|Overall Study|Lost to Follow-up|8|||
148809748|NCT03329989|536780857|FG000|Overall Study|Adverse Event|5|||
149216004|NCT01810380|538257607|FG000|Overall Study|Adverse Event|11|||
149216005|NCT01810380|538257608|FG001|Overall Study|Adverse Event|14|||
149216006|NCT01810380|538257609|FG002|Overall Study|Adverse Event|4|||
148809749|NCT03329989|536780857|FG000|Overall Study|Protocol Violation|1|||
149216007|NCT01810380|538257607|FG000|Overall Study|Lack of Efficacy|24|||
149216008|NCT01810380|538257608|FG001|Overall Study|Lack of Efficacy|10|||
149216009|NCT01810380|538257609|FG002|Overall Study|Lack of Efficacy|11|||
149216010|NCT01810380|538257607|FG000|Overall Study|Protocol Violation|1|||
149216011|NCT01810380|538257608|FG001|Overall Study|Protocol Violation|0|||
149216012|NCT01810380|538257609|FG002|Overall Study|Protocol Violation|1|||
149216013|NCT01810380|538257607|FG000|Overall Study|Withdrawal by Subject|6|||
149216014|NCT01810380|538257608|FG001|Overall Study|Withdrawal by Subject|0|||
149216015|NCT01810380|538257609|FG002|Overall Study|Withdrawal by Subject|6|||
149216016|NCT01810380|538257607|FG000|Overall Study|Administrative or other reasons|11|||
149216017|NCT01810380|538257608|FG001|Overall Study|Administrative or other reasons|13|||
149216018|NCT01810380|538257609|FG002|Overall Study|Administrative or other reasons|9|||
149216019|NCT00441480|538257610|FG000|Overall Study|Protocol Violation|1|||
149216020|NCT00441480|538257611|FG001|Overall Study|Protocol Violation|1|||
149216021|NCT00441480|538257610|FG000|Overall Study|Withdrawal by Subject|2|||
149216022|NCT00441480|538257611|FG001|Overall Study|Withdrawal by Subject|3|||
149216023|NCT01390038|538257612|FG000|Overall Study|Death|1|||
149216024|NCT01390038|538257612|FG000|Overall Study|Lost to Follow-up|1|||
149216025|NCT01390038|538257612|FG000|Overall Study|Withdrawal by Subject|4|||
149216026|NCT01390038|538257612|FG000|Overall Study|Simpliciti System Removal|2|||
149216027|NCT01922739|538257613|FG000|Titration/Adjustment Period|Adverse Event|3|||
149216028|NCT01922739|538257613|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
149216029|NCT01922739|538257613|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
149216030|NCT01922739|538257613|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
149216031|NCT01922739|538257613|FG000|Open-label Treatment Period|Adverse Event|6|||
149216032|NCT01922739|538257613|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
149216033|NCT01922739|538257613|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
149216034|NCT01922739|538257613|FG000|Open-label Treatment Period|Protocol Violation|5|||
149216035|NCT01922739|538257613|FG000|Open-label Treatment Period|Pregnancy|1|||
149216036|NCT01922739|538257613|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
149216037|NCT01922739|538257613|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
149216038|NCT01922739|538257613|FG000|Open-label Treatment Period|Physician Decision|1|||
149216039|NCT01922739|538257613|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
149216040|NCT00422240|538257614|FG000|Overall Study|Lack of Efficacy|1|||
149216041|NCT00422240|538257615|FG001|Overall Study|Lack of Efficacy|2|||
149216042|NCT00422240|538257616|FG002|Overall Study|Lack of Efficacy|0|||
149216043|NCT00422240|538257617|FG003|Overall Study|Lack of Efficacy|1|||
149216044|NCT00422240|538257614|FG000|Overall Study|Adverse Event|11|||
149216045|NCT00422240|538257615|FG001|Overall Study|Adverse Event|4|||
149216046|NCT00422240|538257616|FG002|Overall Study|Adverse Event|5|||
149216047|NCT00422240|538257617|FG003|Overall Study|Adverse Event|2|||
149216048|NCT00422240|538257614|FG000|Overall Study|Subject request|21|||
149216049|NCT00422240|538257615|FG001|Overall Study|Subject request|17|||
149216050|NCT00422240|538257616|FG002|Overall Study|Subject request|18|||
149216051|NCT00422240|538257617|FG003|Overall Study|Subject request|30|||
149216052|NCT00422240|538257614|FG000|Overall Study|Protocol Violation|0|||
149216053|NCT00422240|538257615|FG001|Overall Study|Protocol Violation|1|||
149216054|NCT00422240|538257616|FG002|Overall Study|Protocol Violation|0|||
149216055|NCT00422240|538257617|FG003|Overall Study|Protocol Violation|1|||
149216056|NCT00422240|538257614|FG000|Overall Study|Lost to Follow-up|31|||
149216057|NCT00422240|538257615|FG001|Overall Study|Lost to Follow-up|32|||
149216058|NCT00422240|538257616|FG002|Overall Study|Lost to Follow-up|19|||
149216059|NCT00422240|538257617|FG003|Overall Study|Lost to Follow-up|34|||
149216060|NCT00422240|538257614|FG000|Overall Study|Other|1|||
149216061|NCT00422240|538257615|FG001|Overall Study|Other|0|||
149216062|NCT00422240|538257616|FG002|Overall Study|Other|0|||
149216063|NCT00422240|538257617|FG003|Overall Study|Other|1|||
149216064|NCT00422240|538257614|FG000|Overall Study|Pregnancy|3|||
149216065|NCT00422240|538257615|FG001|Overall Study|Pregnancy|1|||
149216066|NCT00422240|538257616|FG002|Overall Study|Pregnancy|1|||
149216067|NCT00422240|538257617|FG003|Overall Study|Pregnancy|2|||
149216068|NCT01927068|538257618|FG000|Overall Study|Death|37|||
149216069|NCT01927068|538257619|FG001|Overall Study|Death|3|||
149216070|NCT01927068|538257618|FG000|Overall Study|Withdrawal by Subject|50|||
149216071|NCT01927068|538257619|FG001|Overall Study|Withdrawal by Subject|3|||
149216072|NCT01927068|538257618|FG000|Overall Study|Lost to Follow-up|10|||
149216073|NCT01927068|538257619|FG001|Overall Study|Lost to Follow-up|2|||
149216074|NCT01927068|538257618|FG000|Overall Study|Physician Decision|9|||
149216075|NCT01927068|538257619|FG001|Overall Study|Physician Decision|0|||
149216076|NCT01927068|538257618|FG000|Overall Study|Missed last follow-up visit|2|||
149216077|NCT01927068|538257619|FG001|Overall Study|Missed last follow-up visit|0|||
149216078|NCT00441012|538257620|FG000|Overall Study|Adverse Event|0|||
149216079|NCT00441012|538257621|FG001|Overall Study|Adverse Event|1|||
149216080|NCT00441012|538257620|FG000|Overall Study|Lost to Follow-up|3|||
149216081|NCT00441012|538257621|FG001|Overall Study|Lost to Follow-up|3|||
149216082|NCT00441012|538257620|FG000|Overall Study|Protocol Violation|10|||
149216083|NCT00441012|538257621|FG001|Overall Study|Protocol Violation|9|||
149216084|NCT00441012|538257620|FG000|Overall Study|Withdrawal by Subject|4|||
149216085|NCT00441012|538257621|FG001|Overall Study|Withdrawal by Subject|0|||
149216086|NCT00441012|538257620|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
149216087|NCT00441012|538257621|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
149216088|NCT04489940|538257622|FG000|Overall Study|Other|2|||
149216089|NCT04489940|538257622|FG000|Overall Study|Withdrawal by Subject|2|||
149216090|NCT04489940|538257622|FG000|Overall Study|Death|5|||
149216091|NCT04489940|538257622|FG000|Overall Study|Lost to Follow-up|1|||
149216092|NCT02725268|538257623|FG000|Overall Study|Death|58|||
149216093|NCT02725268|538257624|FG001|Overall Study|Death|59|||
149216094|NCT02725268|538257625|FG002|Overall Study|Death|30|||
149216095|NCT02725268|538257626|FG003|Overall Study|Death|16|||
149216096|NCT02725268|538257623|FG000|Overall Study|Lost to Follow-up|4|||
149216097|NCT02725268|538257624|FG001|Overall Study|Lost to Follow-up|3|||
149216098|NCT02725268|538257625|FG002|Overall Study|Lost to Follow-up|0|||
149216099|NCT02725268|538257626|FG003|Overall Study|Lost to Follow-up|1|||
149216100|NCT02725268|538257623|FG000|Overall Study|Site Terminated by Sponsor|0|||
149216101|NCT02725268|538257624|FG001|Overall Study|Site Terminated by Sponsor|1|||
149216102|NCT02725268|538257625|FG002|Overall Study|Site Terminated by Sponsor|0|||
149216103|NCT02725268|538257626|FG003|Overall Study|Site Terminated by Sponsor|0|||
149216104|NCT02725268|538257623|FG000|Overall Study|Withdrawal by Subject|8|||
149216105|NCT02725268|538257624|FG001|Overall Study|Withdrawal by Subject|6|||
149216106|NCT02725268|538257625|FG002|Overall Study|Withdrawal by Subject|8|||
149216107|NCT02725268|538257626|FG003|Overall Study|Withdrawal by Subject|1|||
149216108|NCT02725268|538257623|FG000|Overall Study|Reason not Specified|2|||
149216109|NCT02725268|538257624|FG001|Overall Study|Reason not Specified|1|||
149216110|NCT02725268|538257625|FG002|Overall Study|Reason not Specified|0|||
149216111|NCT02725268|538257626|FG003|Overall Study|Reason not Specified|0|||
149216112|NCT04498468|538257627|FG000|Overall Study|Lost to Follow-up|3|||
149216113|NCT01624467|538257628|FG000|Overall Study|Withdrawal by Subject|2|||
149017226|NCT02138747|537542545|FG003|Treatment Period 1|Protocol Violation|0|||
149017227|NCT02138747|537542542|FG000|Treatment Period 1|Withdrawal by Subject|8|||
149017228|NCT02138747|537542543|FG001|Treatment Period 1|Withdrawal by Subject|4|||
149017229|NCT02138747|537542544|FG002|Treatment Period 1|Withdrawal by Subject|1|||
149017230|NCT02138747|537542545|FG003|Treatment Period 1|Withdrawal by Subject|3|||
149017231|NCT02138747|537542542|FG000|Treatment Period 1|Other - Miscellaneous|2|||
149216114|NCT01624467|538257628|FG000|Overall Study|Lost to Follow-up|1|||
149216115|NCT01624467|538257628|FG000|Overall Study|Adverse Event|7|||
149216116|NCT01624467|538257628|FG000|Overall Study|Progressive Disease|19|||
149216117|NCT01624467|538257628|FG000|Overall Study|Per Sponsor Requirement|1|||
149216118|NCT01624467|538257628|FG000|Overall Study|Subject Withdrew from Treatment|1|||
149216119|NCT00262314|538257634|FG000|Overall Study|Changing physicians|38|||
149216120|NCT00262314|538257634|FG000|Overall Study|Death|12|||
149216121|NCT00262314|538257634|FG000|Overall Study|Patient's decision|92|||
149216122|NCT00262314|538257634|FG000|Overall Study|Other|95|||
149216123|NCT00262314|538257634|FG000|Overall Study|Lost to Follow-up|70|||
149216124|NCT00262314|538257634|FG000|Overall Study|Administrative withdrawal|30|||
149216125|NCT05104749|538257635|FG000|Overall Study|Lost to Follow-up|2|||
149216126|NCT05104749|538257636|FG001|Overall Study|Lost to Follow-up|3|||
149216127|NCT03964493|538257637|FG000|Overall Study|Withdrawal by Subject|4|||
149216128|NCT03964493|538257638|FG001|Overall Study|Withdrawal by Subject|1|||
149216129|NCT03964493|538257637|FG000|Overall Study|Lost to Follow-up|13|||
149216130|NCT03964493|538257638|FG001|Overall Study|Lost to Follow-up|4|||
149216131|NCT02963766|538257639|FG000|Double-Blind Period|Adverse Event|1|||
149216132|NCT02963766|538257640|FG001|Double-Blind Period|Adverse Event|0|||
149216133|NCT02963766|538257641|FG002|Double-Blind Period|Adverse Event|1|||
149216134|NCT02963766|538257639|FG000|Double-Blind Period|Physician Decision|1|||
149216135|NCT02963766|538257640|FG001|Double-Blind Period|Physician Decision|0|||
149216136|NCT02963766|538257641|FG002|Double-Blind Period|Physician Decision|0|||
149216137|NCT02963766|538257639|FG000|Double-Blind Period|Withdrawal by Subject|1|||
149216138|NCT02963766|538257640|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149216139|NCT02963766|538257641|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149216140|NCT02963766|538257639|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
149216141|NCT02963766|538257640|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
149216142|NCT02963766|538257641|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
149216143|NCT02963766|538257639|FG000|Double-Blind Period|Protocol Violation|1|||
149216144|NCT02963766|538257640|FG001|Double-Blind Period|Protocol Violation|0|||
149216145|NCT02963766|538257641|FG002|Double-Blind Period|Protocol Violation|0|||
149216146|NCT02963766|538257639|FG000|Double-Blind Period|Lost to Follow-up|0|||
149216147|NCT02963766|538257640|FG001|Double-Blind Period|Lost to Follow-up|1|||
149216148|NCT02963766|538257641|FG002|Double-Blind Period|Lost to Follow-up|0|||
149216149|NCT02963766|538257639|FG000|Open Label Extension (OLE)|Physician Decision|1|||
148809750|NCT02469857|536780862|FG000|Overall Study|Death|24|||
149017232|NCT02138747|537542543|FG001|Treatment Period 1|Other - Miscellaneous|4|||
149216150|NCT02963766|538257640|FG001|Open Label Extension (OLE)|Physician Decision|2|||
149216151|NCT02963766|538257641|FG002|Open Label Extension (OLE)|Physician Decision|2|||
148684754|NCT01621490|536319471|FG008|Overall Study|Other reasons|1|||
148809751|NCT02469857|536780863|FG001|Overall Study|Death|29|||
149017233|NCT02138747|537542544|FG002|Treatment Period 1|Other - Miscellaneous|0|||
149017234|NCT02138747|537542545|FG003|Treatment Period 1|Other - Miscellaneous|0|||
149017235|NCT02138747|537542542|FG000|Treatment Period 2|Adverse Event|6|||
149216152|NCT02963766|538257639|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
149216153|NCT02963766|538257640|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
149216154|NCT02963766|538257641|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
149216155|NCT00814307|538257642|FG000|Overall Study|Randomized but not treated|1|||
149216156|NCT00814307|538257643|FG001|Overall Study|Randomized but not treated|0|||
149216157|NCT00814307|538257644|FG002|Overall Study|Randomized but not treated|0|||
149216158|NCT00814307|538257645|FG003|Overall Study|Randomized but not treated|0|||
149216159|NCT00814307|538257642|FG000|Overall Study|Adverse Event|3|||
149216160|NCT00814307|538257643|FG001|Overall Study|Adverse Event|9|||
149216161|NCT00814307|538257644|FG002|Overall Study|Adverse Event|3|||
149216162|NCT00814307|538257645|FG003|Overall Study|Adverse Event|2|||
149216163|NCT00814307|538257642|FG000|Overall Study|Lack of Efficacy|1|||
149216164|NCT00814307|538257643|FG001|Overall Study|Lack of Efficacy|1|||
149216165|NCT00814307|538257644|FG002|Overall Study|Lack of Efficacy|3|||
149216166|NCT00814307|538257645|FG003|Overall Study|Lack of Efficacy|4|||
149216167|NCT00814307|538257642|FG000|Overall Study|Other|1|||
149216168|NCT00814307|538257643|FG001|Overall Study|Other|2|||
149216169|NCT00814307|538257644|FG002|Overall Study|Other|0|||
149216170|NCT00814307|538257645|FG003|Overall Study|Other|1|||
149216171|NCT00814307|538257642|FG000|Overall Study|Protocol Violation|2|||
149216172|NCT00814307|538257643|FG001|Overall Study|Protocol Violation|8|||
149216173|NCT00814307|538257644|FG002|Overall Study|Protocol Violation|1|||
149216174|NCT00814307|538257645|FG003|Overall Study|Protocol Violation|1|||
149216175|NCT00814307|538257642|FG000|Overall Study|Withdrawal by Subject|4|||
149216176|NCT00814307|538257643|FG001|Overall Study|Withdrawal by Subject|6|||
149216177|NCT00814307|538257644|FG002|Overall Study|Withdrawal by Subject|0|||
149216178|NCT00814307|538257645|FG003|Overall Study|Withdrawal by Subject|2|||
149216179|NCT00814307|538257642|FG000|Overall Study|Death|0|||
149216180|NCT00814307|538257643|FG001|Overall Study|Death|1|||
149216181|NCT00814307|538257644|FG002|Overall Study|Death|0|||
149216182|NCT00814307|538257645|FG003|Overall Study|Death|0|||
149216183|NCT03073200|538257654|FG000|Double Blind Treatment Period|Protocol Violation|1|||
149216184|NCT03073200|538257655|FG001|Double Blind Treatment Period|Protocol Violation|0|||
149216185|NCT03073200|538257656|FG002|Double Blind Treatment Period|Protocol Violation|0|||
149216186|NCT03073200|538257657|FG003|Double Blind Treatment Period|Protocol Violation|0|||
149216187|NCT03073200|538257658|FG004|Double Blind Treatment Period|Protocol Violation|0|||
149216188|NCT03073200|538257659|FG005|Double Blind Treatment Period|Protocol Violation|0|||
149216189|NCT03073200|538257660|FG006|Double Blind Treatment Period|Protocol Violation|0|||
149216190|NCT03073200|538257661|FG007|Double Blind Treatment Period|Protocol Violation|0|||
149216191|NCT03073200|538257662|FG008|Double Blind Treatment Period|Protocol Violation|0|||
149216192|NCT03073200|538257663|FG009|Double Blind Treatment Period|Protocol Violation|0|||
149216193|NCT03073200|538257664|FG010|Double Blind Treatment Period|Protocol Violation|0|||
149216194|NCT03073200|538257665|FG011|Double Blind Treatment Period|Protocol Violation|0|||
149216195|NCT03073200|538257666|FG012|Double Blind Treatment Period|Protocol Violation|0|||
149216196|NCT03073200|538257667|FG013|Double Blind Treatment Period|Protocol Violation|0|||
149216197|NCT03073200|538257668|FG014|Double Blind Treatment Period|Protocol Violation|0|||
149216198|NCT03073200|538257654|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216199|NCT03073200|538257655|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
149216200|NCT03073200|538257656|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216201|NCT03073200|538257657|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216202|NCT03073200|538257658|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216203|NCT03073200|538257659|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216204|NCT03073200|538257660|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216205|NCT03073200|538257661|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216206|NCT03073200|538257662|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216207|NCT03073200|538257663|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216208|NCT03073200|538257664|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216209|NCT03073200|538257665|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216210|NCT03073200|538257666|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216211|NCT03073200|538257667|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216212|NCT03073200|538257668|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
149216213|NCT03073200|538257654|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
149216214|NCT03073200|538257655|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216215|NCT03073200|538257656|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216216|NCT03073200|538257657|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216217|NCT03073200|538257658|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216218|NCT03073200|538257659|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216219|NCT03073200|538257660|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216220|NCT03073200|538257661|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216221|NCT03073200|538257662|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216222|NCT03073200|538257663|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216223|NCT03073200|538257664|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216224|NCT03073200|538257665|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216225|NCT03073200|538257666|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216226|NCT03073200|538257667|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216227|NCT03073200|538257668|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
149216228|NCT03073200|538257654|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216229|NCT03073200|538257655|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216230|NCT03073200|538257656|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216231|NCT03073200|538257657|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
149216232|NCT03073200|538257658|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
149216233|NCT03073200|538257659|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216234|NCT03073200|538257660|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216235|NCT03073200|538257661|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216236|NCT03073200|538257662|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216237|NCT03073200|538257663|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216238|NCT03073200|538257664|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216239|NCT03073200|538257665|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216240|NCT03073200|538257666|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216241|NCT03073200|538257667|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216242|NCT03073200|538257668|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
149216243|NCT03073200|538257654|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
149216244|NCT03073200|538257655|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
149216245|NCT03073200|538257656|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
149216246|NCT03073200|538257657|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
149216247|NCT03073200|538257658|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
149216248|NCT03073200|538257659|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
149216249|NCT03073200|538257660|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
149216250|NCT03073200|538257661|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
149216251|NCT03073200|538257662|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
149216252|NCT03073200|538257663|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
149216253|NCT03073200|538257664|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
149216254|NCT03073200|538257665|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
149216255|NCT03073200|538257666|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
149216256|NCT03073200|538257667|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
149216257|NCT03073200|538257668|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
149216258|NCT03073200|538257654|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216259|NCT03073200|538257655|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216260|NCT03073200|538257656|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216261|NCT03073200|538257657|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216262|NCT03073200|538257658|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
149216263|NCT03073200|538257659|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216264|NCT03073200|538257660|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216265|NCT03073200|538257661|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216266|NCT03073200|538257662|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216267|NCT03073200|538257663|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216268|NCT03073200|538257664|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216269|NCT03073200|538257665|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216270|NCT03073200|538257666|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
148684755|NCT01621490|536319472|FG009|Overall Study|Other reasons|0|||
148684756|NCT01621490|536319473|FG010|Overall Study|Other reasons|0|||
148684757|NCT00506753|536319474|FG000|Overall Study|Lost to Follow-up|21|||
148684758|NCT00506753|536319475|FG001|Overall Study|Lost to Follow-up|15|||
149216271|NCT03073200|538257667|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216272|NCT03073200|538257668|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
149216273|NCT03073200|538257654|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216274|NCT03073200|538257655|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216275|NCT03073200|538257656|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216276|NCT03073200|538257657|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
149216277|NCT03073200|538257658|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
149216278|NCT03073200|538257659|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216279|NCT03073200|538257660|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216280|NCT03073200|538257661|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216281|NCT03073200|538257662|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216282|NCT03073200|538257663|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216283|NCT03073200|538257664|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216284|NCT03073200|538257665|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149017236|NCT02138747|537542543|FG001|Treatment Period 2|Adverse Event|3|||
149216285|NCT03073200|538257666|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216286|NCT03073200|538257667|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216287|NCT03073200|538257668|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
149216288|NCT03073200|538257654|FG000|Extension Period|Lost to Follow-up|0|||
148684759|NCT00125359|536319476|FG000|Overall Study|Death|4|||
148684760|NCT00125359|536319476|FG000|Overall Study|Adverse Event|5|||
149216289|NCT03073200|538257655|FG001|Extension Period|Lost to Follow-up|0|||
149216290|NCT03073200|538257656|FG002|Extension Period|Lost to Follow-up|0|||
149216291|NCT03073200|538257657|FG003|Extension Period|Lost to Follow-up|0|||
149216292|NCT03073200|538257658|FG004|Extension Period|Lost to Follow-up|0|||
149216293|NCT03073200|538257659|FG005|Extension Period|Lost to Follow-up|0|||
149216294|NCT03073200|538257660|FG006|Extension Period|Lost to Follow-up|1|||
149216295|NCT03073200|538257661|FG007|Extension Period|Lost to Follow-up|1|||
149216296|NCT03073200|538257662|FG008|Extension Period|Lost to Follow-up|0|||
149216297|NCT03073200|538257663|FG009|Extension Period|Lost to Follow-up|0|||
149216298|NCT03073200|538257664|FG010|Extension Period|Lost to Follow-up|0|||
149216299|NCT03073200|538257665|FG011|Extension Period|Lost to Follow-up|0|||
149216300|NCT03073200|538257666|FG012|Extension Period|Lost to Follow-up|0|||
149216301|NCT03073200|538257667|FG013|Extension Period|Lost to Follow-up|0|||
149216302|NCT03073200|538257668|FG014|Extension Period|Lost to Follow-up|0|||
149216303|NCT03073200|538257654|FG000|Extension Period|Sponsor Decision|0|||
149216304|NCT03073200|538257655|FG001|Extension Period|Sponsor Decision|0|||
149216305|NCT03073200|538257656|FG002|Extension Period|Sponsor Decision|0|||
149216306|NCT03073200|538257657|FG003|Extension Period|Sponsor Decision|0|||
149216307|NCT03073200|538257658|FG004|Extension Period|Sponsor Decision|0|||
149216308|NCT03073200|538257659|FG005|Extension Period|Sponsor Decision|0|||
149216309|NCT03073200|538257660|FG006|Extension Period|Sponsor Decision|0|||
149216310|NCT03073200|538257661|FG007|Extension Period|Sponsor Decision|0|||
149216311|NCT03073200|538257662|FG008|Extension Period|Sponsor Decision|1|||
149216312|NCT03073200|538257663|FG009|Extension Period|Sponsor Decision|0|||
149216313|NCT03073200|538257664|FG010|Extension Period|Sponsor Decision|0|||
149216314|NCT03073200|538257665|FG011|Extension Period|Sponsor Decision|0|||
149216315|NCT03073200|538257666|FG012|Extension Period|Sponsor Decision|0|||
149216316|NCT03073200|538257667|FG013|Extension Period|Sponsor Decision|0|||
149216317|NCT03073200|538257668|FG014|Extension Period|Sponsor Decision|0|||
149216318|NCT03073200|538257654|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
149216319|NCT03073200|538257655|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
149216320|NCT03073200|538257656|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
149216321|NCT03073200|538257657|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
149216322|NCT03073200|538257658|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
149216323|NCT03073200|538257659|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
149216324|NCT03073200|538257660|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
149216325|NCT03073200|538257661|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
149216326|NCT03073200|538257662|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
149216327|NCT03073200|538257663|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
149216328|NCT03073200|538257664|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
149216329|NCT03073200|538257665|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
149216330|NCT03073200|538257666|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
148684761|NCT00125359|536319476|FG000|Overall Study|Physician Decision|14|||
148684762|NCT02451670|536319477|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
148684763|NCT02451670|536319478|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
148684764|NCT00461500|536319479|FG000|Overall Study|Adverse Event|1|||
148684765|NCT00461500|536319480|FG001|Overall Study|Adverse Event|0|||
148684766|NCT00461500|536319479|FG000|Overall Study|Lack of Efficacy|0|||
148684767|NCT00461500|536319480|FG001|Overall Study|Lack of Efficacy|1|||
148684768|NCT00461500|536319479|FG000|Overall Study|Expired Drug Treatment|1|||
148684769|NCT00461500|536319480|FG001|Overall Study|Expired Drug Treatment|1|||
148684770|NCT00461500|536319479|FG000|Overall Study|Study Stopped|1|||
148684771|NCT00461500|536319480|FG001|Overall Study|Study Stopped|2|||
148684772|NCT00461500|536319479|FG000|Overall Study|Drug Treatment Misuse|1|||
148684773|NCT00461500|536319480|FG001|Overall Study|Drug Treatment Misuse|0|||
148684774|NCT00461500|536319479|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
148684775|NCT00461500|536319480|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
148684776|NCT00461500|536319479|FG000|Overall Study|Lost to Follow-up|2|||
148684777|NCT00461500|536319480|FG001|Overall Study|Lost to Follow-up|2|||
148684778|NCT01513551|536319485|FG000|Overall Study|Death|0|||
148684779|NCT01513551|536319486|FG001|Overall Study|Death|1|||
148684780|NCT01513551|536319487|FG002|Overall Study|Death|0|||
148684781|NCT01513551|536319485|FG000|Overall Study|Lost to Follow-up|3|||
148684782|NCT01513551|536319486|FG001|Overall Study|Lost to Follow-up|5|||
148684783|NCT01513551|536319487|FG002|Overall Study|Lost to Follow-up|2|||
148684784|NCT01513551|536319485|FG000|Overall Study|Withdrawal by Subject|1|||
149216331|NCT03073200|538257667|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
149216332|NCT03073200|538257668|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
149216333|NCT03073200|538257654|FG000|Extension Period|Withdrawal by Subject|0|||
148684785|NCT01513551|536319486|FG001|Overall Study|Withdrawal by Subject|0|||
148684786|NCT01513551|536319487|FG002|Overall Study|Withdrawal by Subject|2|||
148684787|NCT01513551|536319485|FG000|Overall Study|Randomized but not vaccinated|0|||
148684788|NCT01513551|536319486|FG001|Overall Study|Randomized but not vaccinated|0|||
148684789|NCT01513551|536319487|FG002|Overall Study|Randomized but not vaccinated|1|||
149216334|NCT03073200|538257655|FG001|Extension Period|Withdrawal by Subject|0|||
149216335|NCT03073200|538257656|FG002|Extension Period|Withdrawal by Subject|0|||
149216336|NCT03073200|538257657|FG003|Extension Period|Withdrawal by Subject|0|||
149216337|NCT03073200|538257658|FG004|Extension Period|Withdrawal by Subject|0|||
149216338|NCT03073200|538257659|FG005|Extension Period|Withdrawal by Subject|0|||
149216339|NCT03073200|538257660|FG006|Extension Period|Withdrawal by Subject|1|||
149216340|NCT03073200|538257661|FG007|Extension Period|Withdrawal by Subject|2|||
149216341|NCT03073200|538257662|FG008|Extension Period|Withdrawal by Subject|0|||
149216342|NCT03073200|538257663|FG009|Extension Period|Withdrawal by Subject|0|||
149216343|NCT03073200|538257664|FG010|Extension Period|Withdrawal by Subject|0|||
149216344|NCT03073200|538257665|FG011|Extension Period|Withdrawal by Subject|0|||
149216345|NCT03073200|538257666|FG012|Extension Period|Withdrawal by Subject|0|||
149216346|NCT03073200|538257667|FG013|Extension Period|Withdrawal by Subject|0|||
149216347|NCT03073200|538257668|FG014|Extension Period|Withdrawal by Subject|0|||
149216348|NCT03073200|538257654|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216349|NCT03073200|538257655|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216350|NCT03073200|538257656|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216351|NCT03073200|538257657|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216352|NCT03073200|538257658|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216353|NCT03073200|538257659|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216354|NCT03073200|538257660|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216355|NCT03073200|538257661|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216356|NCT03073200|538257662|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216357|NCT03073200|538257663|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216358|NCT03073200|538257664|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216359|NCT03073200|538257665|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
149216360|NCT03073200|538257666|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216361|NCT03073200|538257667|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216362|NCT03073200|538257668|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
149216363|NCT03073200|538257654|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216364|NCT03073200|538257655|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216365|NCT03073200|538257656|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216366|NCT03073200|538257657|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216367|NCT03073200|538257658|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216368|NCT03073200|538257659|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216369|NCT03073200|538257660|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216370|NCT03073200|538257661|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216371|NCT03073200|538257662|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216372|NCT03073200|538257663|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216373|NCT03073200|538257664|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216374|NCT03073200|538257665|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
149216375|NCT03073200|538257666|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216376|NCT03073200|538257667|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216377|NCT03073200|538257668|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
149216378|NCT03073200|538257654|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216379|NCT03073200|538257655|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216380|NCT03073200|538257656|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216381|NCT03073200|538257657|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216382|NCT03073200|538257658|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216383|NCT03073200|538257659|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216384|NCT03073200|538257660|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216385|NCT03073200|538257661|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216386|NCT03073200|538257662|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216387|NCT03073200|538257663|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216388|NCT03073200|538257664|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
149216389|NCT03073200|538257665|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
149216390|NCT03073200|538257666|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216391|NCT03073200|538257667|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216392|NCT03073200|538257668|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
149216393|NCT03073200|538257654|FG000|Randomized Withdrawal Period|Adverse Event|0|||
149216394|NCT03073200|538257655|FG001|Randomized Withdrawal Period|Adverse Event|0|||
149216395|NCT03073200|538257656|FG002|Randomized Withdrawal Period|Adverse Event|0|||
149216396|NCT03073200|538257657|FG003|Randomized Withdrawal Period|Adverse Event|0|||
148684790|NCT00549198|536319491|FG000|Overall Study|Adverse Event|28|||
149216397|NCT03073200|538257658|FG004|Randomized Withdrawal Period|Adverse Event|0|||
149216398|NCT03073200|538257659|FG005|Randomized Withdrawal Period|Adverse Event|0|||
149216399|NCT03073200|538257660|FG006|Randomized Withdrawal Period|Adverse Event|0|||
149216400|NCT03073200|538257661|FG007|Randomized Withdrawal Period|Adverse Event|0|||
149216401|NCT03073200|538257662|FG008|Randomized Withdrawal Period|Adverse Event|0|||
149216402|NCT03073200|538257663|FG009|Randomized Withdrawal Period|Adverse Event|0|||
148952058|NCT05109442|537305594|FG000|Overall Study|Death|0|||
148952059|NCT05109442|537305595|FG001|Overall Study|Death|0|||
148952060|NCT05109442|537305596|FG002|Overall Study|Death|4|||
148952061|NCT05109442|537305597|FG003|Overall Study|Death|0|||
148952062|NCT05109442|537305598|FG004|Overall Study|Death|0|||
149216403|NCT03073200|538257664|FG010|Randomized Withdrawal Period|Adverse Event|1|||
149216404|NCT03073200|538257665|FG011|Randomized Withdrawal Period|Adverse Event|0|||
149216405|NCT03073200|538257666|FG012|Randomized Withdrawal Period|Adverse Event|0|||
149216406|NCT03073200|538257667|FG013|Randomized Withdrawal Period|Adverse Event|0|||
149216407|NCT03073200|538257668|FG014|Randomized Withdrawal Period|Adverse Event|0|||
149216408|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216409|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216410|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216411|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216412|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216413|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216414|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216415|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216416|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216417|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216418|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216419|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216420|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216421|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
149216422|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
149216423|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148684791|NCT00549198|536319492|FG001|Overall Study|Adverse Event|26|||
148684792|NCT00549198|536319491|FG000|Overall Study|Insufficient Viral Load Response|4|||
148684793|NCT00549198|536319492|FG001|Overall Study|Insufficient Viral Load Response|2|||
148684794|NCT00549198|536319491|FG000|Overall Study|Protocol-defined Virological Failure|7|||
148684795|NCT00549198|536319492|FG001|Overall Study|Protocol-defined Virological Failure|0|||
148684796|NCT00549198|536319491|FG000|Overall Study|Non-compliance|2|||
148684797|NCT00549198|536319492|FG001|Overall Study|Non-compliance|4|||
148684798|NCT00549198|536319491|FG000|Overall Study|Lost to Follow-up|7|||
148684799|NCT00549198|536319492|FG001|Overall Study|Lost to Follow-up|8|||
148684800|NCT00549198|536319491|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
148684801|NCT00549198|536319492|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148684802|NCT00549198|536319491|FG000|Overall Study|Protocol Violation|7|||
148684803|NCT00549198|536319492|FG001|Overall Study|Protocol Violation|2|||
148684804|NCT00549198|536319491|FG000|Overall Study|Investigator Decision|4|||
148684805|NCT00549198|536319492|FG001|Overall Study|Investigator Decision|3|||
148684806|NCT00549198|536319491|FG000|Overall Study|Withdrawal by Subject|7|||
148684807|NCT00549198|536319492|FG001|Overall Study|Withdrawal by Subject|7|||
148684808|NCT00549198|536319491|FG000|Overall Study|Disease Progression|1|||
148684809|NCT00549198|536319492|FG001|Overall Study|Disease Progression|0|||
148684810|NCT00549198|536319491|FG000|Overall Study|Participant Moved|2|||
148684811|NCT00549198|536319492|FG001|Overall Study|Participant Moved|0|||
148684812|NCT00549198|536319491|FG000|Overall Study|Participant not able to perform Week 96|1|||
148684813|NCT00549198|536319492|FG001|Overall Study|Participant not able to perform Week 96|0|||
148684814|NCT00549198|536319491|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
148684815|NCT00549198|536319492|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
148684816|NCT00549198|536319491|FG000|Overall Study|Prohibited Medication|1|||
148684817|NCT00549198|536319492|FG001|Overall Study|Prohibited Medication|2|||
148684818|NCT00549198|536319491|FG000|Overall Study|Participant planning pregnancy|1|||
148684819|NCT00549198|536319492|FG001|Overall Study|Participant planning pregnancy|0|||
148684820|NCT00549198|536319491|FG000|Overall Study|Participant overweight, no scan possible|1|||
148684821|NCT00549198|536319492|FG001|Overall Study|Participant overweight, no scan possible|0|||
148684822|NCT00549198|536319491|FG000|Overall Study|No scan facilities|0|||
148684823|NCT00549198|536319492|FG001|Overall Study|No scan facilities|2|||
148684824|NCT00549198|536319491|FG000|Overall Study|Pregnancy|0|||
148684825|NCT00549198|536319492|FG001|Overall Study|Pregnancy|3|||
148684826|NCT00549198|536319491|FG000|Overall Study|Not Exposed to Study Drug|3|||
148684827|NCT00549198|536319492|FG001|Overall Study|Not Exposed to Study Drug|4|||
148952063|NCT05109442|537305599|FG005|Overall Study|Death|1|||
148684828|NCT01473758|536319493|FG000|Cycle 1|Adverse Event|10|||
148952064|NCT05109442|537305594|FG000|Overall Study|Physician Decision|1|||
148952065|NCT05109442|537305595|FG001|Overall Study|Physician Decision|0|||
148952066|NCT05109442|537305596|FG002|Overall Study|Physician Decision|1|||
148952067|NCT05109442|537305597|FG003|Overall Study|Physician Decision|0|||
149216424|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216425|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216426|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216427|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148952068|NCT05109442|537305598|FG004|Overall Study|Physician Decision|0|||
149216428|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216429|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216430|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216431|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216432|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216433|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216434|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216435|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216436|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
149216437|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
149216438|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216439|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216440|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216441|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216442|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216443|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216444|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216445|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216446|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216447|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216448|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216449|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216450|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216451|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
149216452|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
149216453|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216454|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216455|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216456|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216457|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216458|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216459|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216460|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216461|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216462|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216463|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216464|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216465|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216466|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
149216467|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
149216468|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216469|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216470|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216471|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216472|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216473|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216474|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216475|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216476|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216477|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216478|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216479|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216480|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216481|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
149216482|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
149216483|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216484|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216485|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216486|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216487|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216488|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216489|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
148809752|NCT02469857|536780862|FG000|Overall Study|Discontinuation|1|||
149216490|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
148684829|NCT01473758|536319494|FG001|Cycle 1|Adverse Event|2|||
148684830|NCT01473758|536319495|FG002|Cycle 1|Adverse Event|0|||
148684831|NCT01473758|536319496|FG003|Cycle 1|Adverse Event|0|||
148684832|NCT01473758|536319493|FG000|Cycle 1|Withdrawal by Subject|1|||
148684833|NCT01473758|536319494|FG001|Cycle 1|Withdrawal by Subject|1|||
149216491|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
148684834|NCT01473758|536319495|FG002|Cycle 1|Withdrawal by Subject|0|||
148952069|NCT05109442|537305599|FG005|Overall Study|Physician Decision|2|||
148952070|NCT05109442|537305594|FG000|Overall Study|Other than listed|0|||
148952071|NCT05109442|537305595|FG001|Overall Study|Other than listed|0|||
148952072|NCT05109442|537305596|FG002|Overall Study|Other than listed|9|||
148952073|NCT05109442|537305597|FG003|Overall Study|Other than listed|2|||
148952074|NCT05109442|537305598|FG004|Overall Study|Other than listed|0|||
149216492|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216493|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216494|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216495|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216496|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
149216497|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
149216498|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216499|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216500|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216501|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216502|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148952075|NCT05109442|537305599|FG005|Overall Study|Other than listed|8|||
148952076|NCT05109442|537305594|FG000|Overall Study|Lack of Efficacy|3|||
148952077|NCT05109442|537305595|FG001|Overall Study|Lack of Efficacy|5|||
148952078|NCT05109442|537305596|FG002|Overall Study|Lack of Efficacy|29|||
148952079|NCT05109442|537305597|FG003|Overall Study|Lack of Efficacy|10|||
148952080|NCT05109442|537305598|FG004|Overall Study|Lack of Efficacy|11|||
148952081|NCT05109442|537305599|FG005|Overall Study|Lack of Efficacy|17|||
148952082|NCT01774968|537305604|FG000|Overall Study|Adverse Event|4|||
148952083|NCT01774968|537305605|FG001|Overall Study|Adverse Event|4|||
148952084|NCT01774968|537305604|FG000|Overall Study|Death|0|||
148952085|NCT01774968|537305605|FG001|Overall Study|Death|1|||
148952086|NCT01774968|537305604|FG000|Overall Study|Lost to Follow-up|1|||
148952087|NCT01774968|537305605|FG001|Overall Study|Lost to Follow-up|3|||
148952088|NCT01774968|537305604|FG000|Overall Study|Physician Decision|5|||
148952089|NCT01774968|537305605|FG001|Overall Study|Physician Decision|1|||
148952090|NCT01774968|537305604|FG000|Overall Study|Protocol Violation|14|||
148952091|NCT01774968|537305605|FG001|Overall Study|Protocol Violation|13|||
148952092|NCT01774968|537305604|FG000|Overall Study|Sponsor Decision|0|||
148952093|NCT01774968|537305605|FG001|Overall Study|Sponsor Decision|2|||
148952094|NCT01774968|537305604|FG000|Overall Study|Withdrawal by Subject|6|||
148952095|NCT01774968|537305605|FG001|Overall Study|Withdrawal by Subject|11|||
148952096|NCT04847557|537305606|FG000|Overall Study|Adverse Event|1|||
148952097|NCT04847557|537305607|FG001|Overall Study|Adverse Event|0|||
148952098|NCT04847557|537305606|FG000|Overall Study|Death|19|||
148952099|NCT04847557|537305607|FG001|Overall Study|Death|15|||
148952100|NCT04847557|537305606|FG000|Overall Study|Lost to Follow-up|3|||
148952101|NCT04847557|537305607|FG001|Overall Study|Lost to Follow-up|6|||
148952102|NCT04847557|537305606|FG000|Overall Study|Physician Decision|1|||
148952103|NCT04847557|537305607|FG001|Overall Study|Physician Decision|0|||
148952104|NCT04847557|537305606|FG000|Overall Study|Protocol Violation|0|||
148952105|NCT04847557|537305607|FG001|Overall Study|Protocol Violation|1|||
148952106|NCT04847557|537305606|FG000|Overall Study|Withdrawal by Subject|8|||
148952107|NCT04847557|537305607|FG001|Overall Study|Withdrawal by Subject|14|||
148952108|NCT04419714|537305608|FG000|Overall Study|Technical Fault|5|||
148952109|NCT04419714|537305608|FG000|Overall Study|Protocol Deviation|2|||
148952110|NCT04419714|537305608|FG000|Overall Study|Withdrawal by Subject|1|||
148952111|NCT01325584|537305609|FG000|Overall Study|Death|1|||
148952112|NCT04221009|537307277|FG000|Overall Study|Withdrawal by Subject|4|||
148952113|NCT00793598|537307278|FG000|Overall Study|Patient Request|0|||
148952114|NCT00793598|537307279|FG001|Overall Study|Patient Request|1|||
148952115|NCT00793598|537307280|FG002|Overall Study|Patient Request|0|||
148952116|NCT00793598|537307281|FG003|Overall Study|Patient Request|0|||
148952117|NCT00793598|537307282|FG004|Overall Study|Patient Request|0|||
149216503|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216504|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216505|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216506|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216507|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216508|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216509|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216510|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216511|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
148809753|NCT02469857|536780863|FG001|Overall Study|Discontinuation|3|||
148809754|NCT00937950|536780864|FG000|Overall Study|Withdrawal by Subject|23|||
148809755|NCT00937950|536780864|FG000|Overall Study|Migrated/moved from study area|27|||
148809756|NCT00937950|536780864|FG000|Overall Study|Lost to Follow-up|144|||
148809757|NCT00937950|536780864|FG000|Overall Study|Missing confirmed|4|||
148809758|NCT00937950|536780864|FG000|Overall Study|Other|18|||
148809759|NCT01531153|536780865|FG000|Overall Study|Withdrawal by Subject|10|||
148809760|NCT01531153|536780866|FG001|Overall Study|Withdrawal by Subject|9|||
148809761|NCT01531153|536780867|FG002|Overall Study|Withdrawal by Subject|15|||
148809762|NCT03483103|536780868|FG000|Pre-Treatment Phase|Other reasons|1|||
148809763|NCT03483103|536780868|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
148809764|NCT03483103|536780868|FG000|Pre-Treatment Phase|Disease-related complications|1|||
148809765|NCT03483103|536780868|FG000|Pre-Treatment Phase|Death|5|||
148809766|NCT03483103|536780868|FG000|Treatment Phase|Withdrawal by Subject|7|||
148809767|NCT03483103|536780868|FG000|Treatment Phase|Other reasons|1|||
148809768|NCT03483103|536780868|FG000|Treatment Phase|Death|23|||
148809769|NCT03483103|536780868|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
148809770|NCT03483103|536780868|FG000|Treatment Phase|Received nonconforming product|1|||
148809771|NCT00435942|536780869|FG000|Overall Study|Death|17|||
148809772|NCT00435942|536780870|FG001|Overall Study|Death|10|||
148809773|NCT00435942|536780869|FG000|Overall Study|Withdrawal by Subject|2|||
148809774|NCT00435942|536780870|FG001|Overall Study|Withdrawal by Subject|0|||
148809775|NCT00435942|536780869|FG000|Overall Study|Lost to Follow-up|0|||
148809776|NCT00435942|536780870|FG001|Overall Study|Lost to Follow-up|16|||
148809777|NCT00435942|536780869|FG000|Overall Study|Conversion to Open Repair|1|||
148809778|NCT00435942|536780870|FG001|Overall Study|Conversion to Open Repair|0|||
148809779|NCT00435942|536780869|FG000|Overall Study|Technical Failure|3|||
148809780|NCT00435942|536780870|FG001|Overall Study|Technical Failure|0|||
148809781|NCT00435942|536780869|FG000|Overall Study|Other|0|||
149216512|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
149216513|NCT03073200|538257654|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216514|NCT03073200|538257655|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216515|NCT03073200|538257656|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216516|NCT03073200|538257657|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216517|NCT03073200|538257658|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216518|NCT03073200|538257659|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216519|NCT03073200|538257660|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216520|NCT03073200|538257661|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216521|NCT03073200|538257662|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216522|NCT03073200|538257663|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216523|NCT03073200|538257664|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216524|NCT03073200|538257665|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216525|NCT03073200|538257666|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216526|NCT03073200|538257667|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
149216527|NCT03073200|538257668|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
149216528|NCT01474889|538257669|FG000|Overall Study|Physician Decision|1|||
149216529|NCT01474889|538257670|FG001|Overall Study|Physician Decision|0|||
149216530|NCT01474889|538257671|FG002|Overall Study|Physician Decision|0|||
149216531|NCT01474889|538257669|FG000|Overall Study|Did not meet inclusion|1|||
149216532|NCT01474889|538257670|FG001|Overall Study|Did not meet inclusion|0|||
149216533|NCT01474889|538257671|FG002|Overall Study|Did not meet inclusion|0|||
149216534|NCT01474889|538257669|FG000|Overall Study|Withdrawal by Subject|0|||
149216535|NCT01474889|538257670|FG001|Overall Study|Withdrawal by Subject|1|||
149216536|NCT01474889|538257671|FG002|Overall Study|Withdrawal by Subject|0|||
149216537|NCT04964557|538257673|FG000|Overall Study|Withdrawal by Subject|3|||
149216538|NCT04964557|538257674|FG001|Overall Study|Withdrawal by Subject|2|||
148809782|NCT00435942|536780870|FG001|Overall Study|Other|1|||
149216539|NCT04964557|538257673|FG000|Overall Study|Lost to Follow-up|1|||
148952118|NCT00793598|537307283|FG005|Overall Study|Patient Request|0|||
148952119|NCT00793598|537307284|FG006|Overall Study|Patient Request|0|||
148952120|NCT00793598|537307285|FG007|Overall Study|Patient Request|0|||
148952121|NCT00793598|537307278|FG000|Overall Study|Protocol Violation|0|||
148952122|NCT00793598|537307279|FG001|Overall Study|Protocol Violation|0|||
148952123|NCT00793598|537307280|FG002|Overall Study|Protocol Violation|0|||
148952124|NCT00793598|537307281|FG003|Overall Study|Protocol Violation|0|||
149216540|NCT04964557|538257674|FG001|Overall Study|Lost to Follow-up|2|||
149216541|NCT04964557|538257673|FG000|Overall Study|Physician Decision|2|||
148809783|NCT02378181|536780871|FG000|Overall Study|Lost to Follow-up|2|||
148809784|NCT02378181|536780872|FG001|Overall Study|Lost to Follow-up|5|||
148809785|NCT02378181|536780871|FG000|Overall Study|Withdrawal by Subject|1|||
148952125|NCT00793598|537307282|FG004|Overall Study|Protocol Violation|0|||
148952126|NCT00793598|537307283|FG005|Overall Study|Protocol Violation|0|||
148952127|NCT00793598|537307284|FG006|Overall Study|Protocol Violation|0|||
148952128|NCT00793598|537307285|FG007|Overall Study|Protocol Violation|1|||
148952129|NCT00793598|537307278|FG000|Overall Study|Subject not dosed|0|||
148952130|NCT00793598|537307279|FG001|Overall Study|Subject not dosed|0|||
148952131|NCT00793598|537307280|FG002|Overall Study|Subject not dosed|0|||
148952132|NCT00793598|537307281|FG003|Overall Study|Subject not dosed|0|||
148952133|NCT00793598|537307282|FG004|Overall Study|Subject not dosed|0|||
148952134|NCT00793598|537307283|FG005|Overall Study|Subject not dosed|1|||
148952135|NCT00793598|537307284|FG006|Overall Study|Subject not dosed|0|||
148952136|NCT00793598|537307285|FG007|Overall Study|Subject not dosed|0|||
149216542|NCT04964557|538257674|FG001|Overall Study|Physician Decision|0|||
149216543|NCT04964557|538257673|FG000|Overall Study|Death|3|||
149216544|NCT04964557|538257674|FG001|Overall Study|Death|0|||
149216545|NCT04964557|538257673|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
149216546|NCT04964557|538257674|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
149216547|NCT02569398|538257679|FG000|Overall Study|Adverse Event|0|||
149216548|NCT02569398|538257680|FG001|Overall Study|Adverse Event|1|||
149216549|NCT02569398|538257681|FG002|Overall Study|Adverse Event|6|||
149216550|NCT02569398|538257679|FG000|Overall Study|Withdrawal by Subject|43|||
149216551|NCT02569398|538257680|FG001|Overall Study|Withdrawal by Subject|43|||
149216552|NCT02569398|538257681|FG002|Overall Study|Withdrawal by Subject|30|||
149216553|NCT02569398|538257679|FG000|Overall Study|Study terminated by sponsor|130|||
149216554|NCT02569398|538257680|FG001|Overall Study|Study terminated by sponsor|131|||
149216555|NCT02569398|538257681|FG002|Overall Study|Study terminated by sponsor|134|||
149216556|NCT02569398|538257679|FG000|Overall Study|Other|12|||
149216557|NCT02569398|538257680|FG001|Overall Study|Other|14|||
149216558|NCT02569398|538257681|FG002|Overall Study|Other|13|||
149216559|NCT02571972|538257682|FG000|Overall Study|Protocol Violation|2|||
149216560|NCT02571972|538257682|FG000|Overall Study|Withdrawal by Subject|2|||
149216561|NCT03559192|538257685|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
149216562|NCT03559192|538257686|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
149216563|NCT03559192|538257687|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
149216564|NCT03559192|538257685|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
149216565|NCT03559192|538257686|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
149216566|NCT03559192|538257687|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
149216567|NCT03559192|538257685|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
149216568|NCT03559192|538257686|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
149216569|NCT03559192|538257687|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
149216570|NCT03559192|538257685|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
149216571|NCT03559192|538257686|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
149216572|NCT03559192|538257687|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
148952137|NCT02154490|537307286|FG000|Overall Study|No tissue submitted|23|||
148952138|NCT02154490|537307286|FG000|Overall Study|No biomarker results|167|||
148952139|NCT02154490|537307286|FG000|Overall Study|Not assigned to a sub-study|270|||
148952140|NCT02154490|537307286|FG000|Overall Study|Did not register to a sub-study|749|||
149216573|NCT03559192|538257685|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
149216574|NCT03559192|538257686|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
149216575|NCT03559192|538257687|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
149216576|NCT03559192|538257685|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
149216577|NCT03559192|538257686|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
149216578|NCT03559192|538257687|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
149216579|NCT03559192|538257685|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
149216580|NCT03559192|538257686|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
149216581|NCT03559192|538257687|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
149216582|NCT03559192|538257685|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
148684835|NCT01473758|536319496|FG003|Cycle 1|Withdrawal by Subject|0|||
148684836|NCT01473758|536319493|FG000|Cycle 2|Adverse Event|0|||
148684837|NCT01473758|536319494|FG001|Cycle 2|Adverse Event|0|||
148684838|NCT01473758|536319495|FG002|Cycle 2|Adverse Event|5|||
148684839|NCT01473758|536319496|FG003|Cycle 2|Adverse Event|0|||
148684840|NCT02480010|536319497|FG000|Overall Study|Adverse Event|3|||
148684841|NCT02480010|536319498|FG001|Overall Study|Adverse Event|1|||
148684842|NCT02480010|536319497|FG000|Overall Study|Death|1|||
148684843|NCT02480010|536319498|FG001|Overall Study|Death|0|||
148684844|NCT02480010|536319497|FG000|Overall Study|Insufficient therapeutic response|31|||
148684845|NCT02480010|536319498|FG001|Overall Study|Insufficient therapeutic response|29|||
148952141|NCT02373202|537307288|FG000|Overall Study|Adverse Event|2|||
149216583|NCT03559192|538257686|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
148952142|NCT02373202|537307289|FG001|Overall Study|Adverse Event|5|||
149216584|NCT03559192|538257687|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
148684846|NCT02480010|536319497|FG000|Overall Study|Refused Treatment|0|||
148684847|NCT02480010|536319498|FG001|Overall Study|Refused Treatment|3|||
148952143|NCT02373202|537307290|FG002|Overall Study|Adverse Event|2|||
148952144|NCT02373202|537307291|FG003|Overall Study|Adverse Event|1|||
148952145|NCT02373202|537307288|FG000|Overall Study|Lack of Efficacy|0|||
148952146|NCT02373202|537307289|FG001|Overall Study|Lack of Efficacy|0|||
149216585|NCT03559192|538257685|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
149216586|NCT03559192|538257686|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
149216587|NCT03559192|538257687|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
149216588|NCT03039192|538257688|FG000|Overall Study|Lost to Follow-up|4|||
149216589|NCT03039192|538257689|FG001|Overall Study|Lost to Follow-up|4|||
149216590|NCT03039192|538257688|FG000|Overall Study|Adverse event, serious fatal|0|||
149216591|NCT03039192|538257689|FG001|Overall Study|Adverse event, serious fatal|1|||
149216592|NCT03039192|538257688|FG000|Overall Study|Adverse event, non-fatal|0|||
149216593|NCT03039192|538257689|FG001|Overall Study|Adverse event, non-fatal|2|||
149017237|NCT02138747|537542544|FG002|Treatment Period 2|Adverse Event|1|||
149017238|NCT02138747|537542545|FG003|Treatment Period 2|Adverse Event|1|||
149017239|NCT02138747|537542542|FG000|Treatment Period 2|Lost to Follow-up|2|||
149017240|NCT02138747|537542543|FG001|Treatment Period 2|Lost to Follow-up|0|||
149017241|NCT02138747|537542544|FG002|Treatment Period 2|Lost to Follow-up|0|||
149017242|NCT02138747|537542545|FG003|Treatment Period 2|Lost to Follow-up|0|||
149017243|NCT02138747|537542542|FG000|Treatment Period 2|Protocol Violation|1|||
149017244|NCT02138747|537542543|FG001|Treatment Period 2|Protocol Violation|0|||
149017245|NCT02138747|537542544|FG002|Treatment Period 2|Protocol Violation|0|||
149017246|NCT02138747|537542545|FG003|Treatment Period 2|Protocol Violation|0|||
149017247|NCT02138747|537542542|FG000|Treatment Period 2|Withdrawal by Subject|5|||
149017248|NCT02138747|537542543|FG001|Treatment Period 2|Withdrawal by Subject|4|||
149017249|NCT02138747|537542544|FG002|Treatment Period 2|Withdrawal by Subject|1|||
149017250|NCT02138747|537542545|FG003|Treatment Period 2|Withdrawal by Subject|2|||
149017251|NCT02138747|537542542|FG000|Treatment Period 2|Other - Miscellaneous|3|||
149017252|NCT02138747|537542543|FG001|Treatment Period 2|Other - Miscellaneous|0|||
149017253|NCT02138747|537542544|FG002|Treatment Period 2|Other - Miscellaneous|0|||
149017254|NCT02138747|537542545|FG003|Treatment Period 2|Other - Miscellaneous|0|||
149216594|NCT03039192|538257688|FG000|Overall Study|Withdrawal by Subject|6|||
149216595|NCT03039192|538257689|FG001|Overall Study|Withdrawal by Subject|9|||
149216596|NCT03039192|538257688|FG000|Overall Study|Discontinued from treatment phase|19|||
149216597|NCT03039192|538257689|FG001|Overall Study|Discontinued from treatment phase|12|||
149216598|NCT03039192|538257688|FG000|Overall Study|Other|3|||
149216599|NCT03039192|538257689|FG001|Overall Study|Other|2|||
149216600|NCT04888507|538259510|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
149216601|NCT00400946|538259511|FG000|Overall Study|Ineligible|0|||
149216602|NCT00400946|538259512|FG001|Overall Study|Ineligible|0|||
149216603|NCT00400946|538259513|FG002|Overall Study|Ineligible|0|||
149216604|NCT00400946|538259514|FG003|Overall Study|Ineligible|5|||
149216605|NCT00400946|538259515|FG004|Overall Study|Ineligible|1|||
149216606|NCT00400946|538259511|FG000|Overall Study|Induction Failure|0|||
149216607|NCT00400946|538259512|FG001|Overall Study|Induction Failure|0|||
149216608|NCT00400946|538259513|FG002|Overall Study|Induction Failure|0|||
149216609|NCT00400946|538259514|FG003|Overall Study|Induction Failure|11|||
149216610|NCT00400946|538259515|FG004|Overall Study|Induction Failure|8|||
149216611|NCT00400946|538259511|FG000|Overall Study|Induction Death|0|||
149216612|NCT00400946|538259512|FG001|Overall Study|Induction Death|0|||
149216613|NCT00400946|538259513|FG002|Overall Study|Induction Death|0|||
149216614|NCT00400946|538259514|FG003|Overall Study|Induction Death|13|||
149216615|NCT00400946|538259515|FG004|Overall Study|Induction Death|3|||
149216616|NCT00400946|538259511|FG000|Overall Study|Lost to Follow-up|1|||
149216617|NCT00400946|538259512|FG001|Overall Study|Lost to Follow-up|1|||
149216618|NCT00400946|538259513|FG002|Overall Study|Lost to Follow-up|0|||
149216619|NCT00400946|538259514|FG003|Overall Study|Lost to Follow-up|0|||
149216620|NCT00400946|538259515|FG004|Overall Study|Lost to Follow-up|1|||
149216621|NCT00400946|538259511|FG000|Overall Study|Remission Death|1|||
149216622|NCT00400946|538259512|FG001|Overall Study|Remission Death|1|||
149216623|NCT00400946|538259513|FG002|Overall Study|Remission Death|0|||
149216624|NCT00400946|538259514|FG003|Overall Study|Remission Death|0|||
149216625|NCT00400946|538259515|FG004|Overall Study|Remission Death|1|||
149216626|NCT00400946|538259511|FG000|Overall Study|Relapse|9|||
149216627|NCT00400946|538259512|FG001|Overall Study|Relapse|2|||
149216628|NCT00400946|538259513|FG002|Overall Study|Relapse|1|||
149017255|NCT03406702|537542553|FG000|Overall Study|Missed Day 27 Dosing|1|||
149017256|NCT04318093|537542557|FG000|Overall Study|Adverse Event|2|||
149216629|NCT00400946|538259514|FG003|Overall Study|Relapse|1|||
149017257|NCT04318093|537542558|FG001|Overall Study|Adverse Event|2|||
149017258|NCT04318093|537542557|FG000|Overall Study|Participant withdrew consent|1|||
149216630|NCT00400946|538259515|FG004|Overall Study|Relapse|5|||
149216631|NCT00400946|538259511|FG000|Overall Study|Transplant in CR1|0|||
149216632|NCT00400946|538259512|FG001|Overall Study|Transplant in CR1|0|||
149216633|NCT00400946|538259513|FG002|Overall Study|Transplant in CR1|0|||
149216634|NCT00400946|538259514|FG003|Overall Study|Transplant in CR1|10|||
149216635|NCT00400946|538259515|FG004|Overall Study|Transplant in CR1|1|||
149216636|NCT00400946|538259511|FG000|Overall Study|Withdrawal by Subject|2|||
149216637|NCT00400946|538259512|FG001|Overall Study|Withdrawal by Subject|5|||
149216638|NCT00400946|538259513|FG002|Overall Study|Withdrawal by Subject|1|||
149216639|NCT00400946|538259514|FG003|Overall Study|Withdrawal by Subject|5|||
149216640|NCT00400946|538259515|FG004|Overall Study|Withdrawal by Subject|8|||
149216641|NCT00400946|538259511|FG000|Overall Study|Clinical|1|||
149216642|NCT00400946|538259512|FG001|Overall Study|Clinical|2|||
149216643|NCT00400946|538259513|FG002|Overall Study|Clinical|0|||
149216644|NCT00400946|538259514|FG003|Overall Study|Clinical|2|||
149216645|NCT00400946|538259515|FG004|Overall Study|Clinical|9|||
149216646|NCT00400946|538259511|FG000|Overall Study|Other|0|||
149216647|NCT00400946|538259512|FG001|Overall Study|Other|0|||
149216648|NCT00400946|538259513|FG002|Overall Study|Other|0|||
149216649|NCT00400946|538259514|FG003|Overall Study|Other|0|||
149216650|NCT00400946|538259515|FG004|Overall Study|Other|1|||
149216651|NCT05643170|538259521|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
149216652|NCT05643170|538259521|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
149216653|NCT02358863|538259526|FG000|Overall Study|Physician Decision|3|||
149216654|NCT02632344|538259538|FG000|Overall Study|Adverse Event|3|||
149216655|NCT02632344|538259538|FG000|Overall Study|Lack of Efficacy|3|||
149216656|NCT02632344|538259538|FG000|Overall Study|Withdrawal by Subject|2|||
149216657|NCT00777257|538259539|FG000|Overall Study|Adverse Event|3|||
149216658|NCT00777257|538259540|FG001|Overall Study|Adverse Event|1|||
149216659|NCT00777257|538259541|FG002|Overall Study|Adverse Event|0|||
149216660|NCT00777257|538259539|FG000|Overall Study|Lost to Follow-up|3|||
149216661|NCT00777257|538259540|FG001|Overall Study|Lost to Follow-up|3|||
149216662|NCT00777257|538259541|FG002|Overall Study|Lost to Follow-up|2|||
149216663|NCT00777257|538259539|FG000|Overall Study|Protocol Violation|2|||
149216664|NCT00777257|538259540|FG001|Overall Study|Protocol Violation|2|||
149216665|NCT00777257|538259541|FG002|Overall Study|Protocol Violation|2|||
149216666|NCT00777257|538259539|FG000|Overall Study|Withdrawal by Subject|3|||
149216667|NCT00777257|538259540|FG001|Overall Study|Withdrawal by Subject|6|||
149216668|NCT00777257|538259541|FG002|Overall Study|Withdrawal by Subject|5|||
149216669|NCT04924114|538259543|FG000|Overall Study|Withdrawal by Subject|0|||
149216670|NCT04924114|538259544|FG001|Overall Study|Withdrawal by Subject|2|||
149216671|NCT04924114|538259545|FG002|Overall Study|Withdrawal by Subject|2|||
149216672|NCT04924114|538259546|FG003|Overall Study|Withdrawal by Subject|0|||
149216673|NCT04924114|538259547|FG004|Overall Study|Withdrawal by Subject|2|||
149216674|NCT00673816|538259548|FG000|Overall Study|Adverse Event|1|||
149216675|NCT00673816|538259548|FG000|Overall Study|Withdrawal by Subject|1|||
149216676|NCT00498368|538259562|FG000|Overall Study|Withdrawal by Subject|3|||
149216677|NCT00498368|538259563|FG001|Overall Study|Withdrawal by Subject|2|||
149216678|NCT02266004|538259564|FG000|Overall Study|unrelated adverse event|1|||
149216679|NCT02266004|538259564|FG000|Overall Study|Physician Decision|1|||
149216680|NCT00537771|538259569|FG000|Overall Study|Withdrawal by Subject|6|||
149216681|NCT00537771|538259570|FG001|Overall Study|Withdrawal by Subject|23|||
149216682|NCT00537771|538259569|FG000|Overall Study|Adverse Event|8|||
149216683|NCT00537771|538259570|FG001|Overall Study|Adverse Event|15|||
149216684|NCT00537771|538259569|FG000|Overall Study|Lost to Follow-up|9|||
149216685|NCT00537771|538259570|FG001|Overall Study|Lost to Follow-up|15|||
149216686|NCT00537771|538259569|FG000|Overall Study|Protocol Violation|2|||
149216687|NCT00537771|538259570|FG001|Overall Study|Protocol Violation|6|||
149216688|NCT00537771|538259569|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
149216689|NCT00537771|538259570|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
149216690|NCT02736929|538259572|FG000|Main Study|Lost to Follow-up|7|||
149216691|NCT02736929|538259573|FG001|Main Study|Lost to Follow-up|1|||
148952147|NCT02373202|537307290|FG002|Overall Study|Lack of Efficacy|1|||
148952148|NCT02373202|537307291|FG003|Overall Study|Lack of Efficacy|0|||
148952149|NCT02373202|537307288|FG000|Overall Study|Other|0|||
148952150|NCT02373202|537307289|FG001|Overall Study|Other|1|||
149216692|NCT02736929|538259574|FG002|Main Study|Lost to Follow-up|0|||
149216693|NCT02736929|538259572|FG000|Main Study|Withdrawal by Subject|1|||
149216694|NCT02736929|538259573|FG001|Main Study|Withdrawal by Subject|1|||
149216695|NCT02736929|538259574|FG002|Main Study|Withdrawal by Subject|0|||
149216696|NCT02736929|538259572|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
149216697|NCT02736929|538259573|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
148952151|NCT02373202|537307290|FG002|Overall Study|Other|0|||
148952152|NCT02373202|537307291|FG003|Overall Study|Other|0|||
148952153|NCT00482612|537307294|FG000|In-treatment Period|No study medication administered|0|||
149216698|NCT02736929|538259574|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
149216699|NCT02148952|538259583|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
149216700|NCT02148952|538259584|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
149216701|NCT02148952|538259583|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
149216702|NCT02148952|538259584|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
149216703|NCT02148952|538259583|FG000|Follow-Up|Lost to Follow-up|219|||
149216704|NCT02148952|538259584|FG001|Follow-Up|Lost to Follow-up|231|||
149216705|NCT02148952|538259583|FG000|Follow-Up|Withdrawal by Subject|46|||
149216706|NCT02148952|538259584|FG001|Follow-Up|Withdrawal by Subject|48|||
149216707|NCT04007367|538259585|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
149216708|NCT04007367|538259586|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
149216709|NCT04007367|538259587|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
149216710|NCT04007367|538259585|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
149216711|NCT04007367|538259586|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
149216712|NCT04007367|538259587|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
149216713|NCT04007367|538259585|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
149216714|NCT04007367|538259586|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
148952154|NCT00482612|537307295|FG001|In-treatment Period|No study medication administered|0|||
148952155|NCT00482612|537307296|FG002|In-treatment Period|No study medication administered|1|||
149216715|NCT04007367|538259587|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
149216716|NCT04007367|538259585|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
149216717|NCT04007367|538259586|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
149216718|NCT04007367|538259587|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
149216719|NCT04007367|538259585|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
149216720|NCT04007367|538259586|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
149216721|NCT04007367|538259587|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
149216722|NCT01764022|538259588|FG000|Overall Study|Death|3|||
149216723|NCT01764022|538259589|FG001|Overall Study|Death|5|||
149216724|NCT01764022|538259588|FG000|Overall Study|Withdrawal by Subject|2|||
149216725|NCT01764022|538259589|FG001|Overall Study|Withdrawal by Subject|6|||
149216726|NCT01764022|538259588|FG000|Overall Study|Lack of Efficacy|0|||
149216727|NCT01764022|538259589|FG001|Overall Study|Lack of Efficacy|1|||
149216728|NCT01764022|538259588|FG000|Overall Study|Physician Decision|0|||
149216729|NCT01764022|538259589|FG001|Overall Study|Physician Decision|2|||
149216730|NCT01764022|538259588|FG000|Overall Study|Lost to Follow-up|2|||
149216731|NCT01764022|538259589|FG001|Overall Study|Lost to Follow-up|0|||
149216732|NCT01764022|538259588|FG000|Overall Study|Protocol Violation|1|||
149216733|NCT01764022|538259589|FG001|Overall Study|Protocol Violation|0|||
149216734|NCT00414973|538259590|FG000|Overall Study|Withdrawal by Subject|14|||
149216735|NCT00414973|538259591|FG001|Overall Study|Withdrawal by Subject|4|||
149216736|NCT00414973|538259592|FG002|Overall Study|Withdrawal by Subject|1|||
149216737|NCT00414973|538259593|FG003|Overall Study|Withdrawal by Subject|0|||
149216738|NCT00414973|538259590|FG000|Overall Study|Adverse Event|10|||
149216739|NCT00414973|538259591|FG001|Overall Study|Adverse Event|0|||
149216740|NCT00414973|538259592|FG002|Overall Study|Adverse Event|1|||
149216741|NCT00414973|538259593|FG003|Overall Study|Adverse Event|0|||
149216742|NCT00414973|538259590|FG000|Overall Study|Protocol Violation|3|||
149216743|NCT00414973|538259591|FG001|Overall Study|Protocol Violation|4|||
149216744|NCT00414973|538259592|FG002|Overall Study|Protocol Violation|0|||
149216745|NCT00414973|538259593|FG003|Overall Study|Protocol Violation|0|||
148684848|NCT01165684|536319508|FG000|Overall Study|Adverse Event|1|||
148684849|NCT01165684|536319509|FG001|Overall Study|Adverse Event|1|||
148684850|NCT01165684|536319508|FG000|Overall Study|Lack of Efficacy|2|||
148684851|NCT01165684|536319509|FG001|Overall Study|Lack of Efficacy|1|||
148684852|NCT01165684|536319508|FG000|Overall Study|Protocol Violation|7|||
148684853|NCT01165684|536319509|FG001|Overall Study|Protocol Violation|15|||
148684854|NCT01165684|536319508|FG000|Overall Study|Withdrawal Criteria|2|||
148684855|NCT01165684|536319509|FG001|Overall Study|Withdrawal Criteria|13|||
148684856|NCT01165684|536319508|FG000|Overall Study|Unclassified|16|||
148684857|NCT01165684|536319509|FG001|Overall Study|Unclassified|22|||
148684858|NCT00901628|536319526|FG000|Overall Study|disconnection of catheter|4|||
148684859|NCT00901628|536319527|FG001|Overall Study|disconnection of catheter|8|||
148684860|NCT00901628|536319526|FG000|Overall Study|disconnection of drain|0|||
148684861|NCT00901628|536319527|FG001|Overall Study|disconnection of drain|1|||
149216746|NCT00414973|538259590|FG000|Overall Study|Lost to Follow-up|0|||
149216747|NCT00414973|538259591|FG001|Overall Study|Lost to Follow-up|2|||
149216748|NCT00414973|538259592|FG002|Overall Study|Lost to Follow-up|0|||
149216749|NCT00414973|538259593|FG003|Overall Study|Lost to Follow-up|0|||
148952156|NCT00482612|537307297|FG003|In-treatment Period|No study medication administered|0|||
148952157|NCT00482612|537307294|FG000|Follow-up Period|Other|4|||
148952158|NCT00482612|537307295|FG001|Follow-up Period|Other|2|||
148952159|NCT00482612|537307296|FG002|Follow-up Period|Other|1|||
148952160|NCT00482612|537307297|FG003|Follow-up Period|Other|2|||
148952161|NCT00482612|537307294|FG000|Follow-up Period|Lack of compliance|0|||
149216750|NCT00414973|538259590|FG000|Overall Study|Sponsor Decision|1|||
149216751|NCT00414973|538259591|FG001|Overall Study|Sponsor Decision|0|||
149216752|NCT00414973|538259592|FG002|Overall Study|Sponsor Decision|0|||
149216753|NCT00414973|538259593|FG003|Overall Study|Sponsor Decision|0|||
149216754|NCT00414973|538259590|FG000|Overall Study|Death|0|||
149216755|NCT00414973|538259591|FG001|Overall Study|Death|0|||
148684862|NCT00901628|536319526|FG000|Overall Study|peroneal nerve palsy|0|||
148952162|NCT00482612|537307295|FG001|Follow-up Period|Lack of compliance|0|||
148952163|NCT00482612|537307296|FG002|Follow-up Period|Lack of compliance|1|||
148952164|NCT00482612|537307297|FG003|Follow-up Period|Lack of compliance|0|||
149216756|NCT00414973|538259592|FG002|Overall Study|Death|1|||
149216757|NCT00414973|538259593|FG003|Overall Study|Death|0|||
149216758|NCT01512693|538259599|FG000|Overall Study|Withdrawal by Subject|0|||
149216759|NCT01512693|538259600|FG001|Overall Study|Withdrawal by Subject|1|||
149216760|NCT03077711|538259601|FG000|Overall Study|Lost to Follow-up|2|||
149216761|NCT03077711|538259602|FG001|Overall Study|Lost to Follow-up|2|||
149216762|NCT03077711|538259601|FG000|Overall Study|noncompliant taking medication|2|||
149216763|NCT03077711|538259602|FG001|Overall Study|noncompliant taking medication|0|||
149216764|NCT01526928|538259603|FG000|Overall Study|Progressive Disease|35|||
149216765|NCT01526928|538259604|FG001|Overall Study|Progressive Disease|17|||
149216766|NCT01526928|538259605|FG002|Overall Study|Progressive Disease|150|||
149216767|NCT01526928|538259606|FG003|Overall Study|Progressive Disease|182|||
149216768|NCT01526928|538259607|FG004|Overall Study|Progressive Disease|76|||
149216769|NCT01526928|538259608|FG005|Overall Study|Progressive Disease|4|||
149216770|NCT01526928|538259603|FG000|Overall Study|Adverse Event|2|||
149216771|NCT01526928|538259604|FG001|Overall Study|Adverse Event|1|||
149216772|NCT01526928|538259605|FG002|Overall Study|Adverse Event|29|||
149216773|NCT01526928|538259606|FG003|Overall Study|Adverse Event|40|||
149216774|NCT01526928|538259607|FG004|Overall Study|Adverse Event|13|||
149216775|NCT01526928|538259608|FG005|Overall Study|Adverse Event|2|||
149216776|NCT01526928|538259603|FG000|Overall Study|Death|0|||
149216777|NCT01526928|538259604|FG001|Overall Study|Death|0|||
149216778|NCT01526928|538259605|FG002|Overall Study|Death|3|||
149216779|NCT01526928|538259606|FG003|Overall Study|Death|0|||
149216780|NCT01526928|538259607|FG004|Overall Study|Death|0|||
149216781|NCT01526928|538259608|FG005|Overall Study|Death|0|||
149216782|NCT01526928|538259603|FG000|Overall Study|Withdrawal by Subject|1|||
149216783|NCT01526928|538259604|FG001|Overall Study|Withdrawal by Subject|0|||
149216784|NCT01526928|538259605|FG002|Overall Study|Withdrawal by Subject|13|||
149216785|NCT01526928|538259606|FG003|Overall Study|Withdrawal by Subject|11|||
149216786|NCT01526928|538259607|FG004|Overall Study|Withdrawal by Subject|3|||
149216787|NCT01526928|538259608|FG005|Overall Study|Withdrawal by Subject|0|||
149216788|NCT01526928|538259603|FG000|Overall Study|Physician Decision|0|||
149216789|NCT01526928|538259604|FG001|Overall Study|Physician Decision|0|||
149216790|NCT01526928|538259605|FG002|Overall Study|Physician Decision|2|||
149216791|NCT01526928|538259606|FG003|Overall Study|Physician Decision|5|||
149216792|NCT01526928|538259607|FG004|Overall Study|Physician Decision|0|||
149216793|NCT01526928|538259608|FG005|Overall Study|Physician Decision|0|||
149216794|NCT01526928|538259603|FG000|Overall Study|Other Reason|0|||
149216795|NCT01526928|538259604|FG001|Overall Study|Other Reason|1|||
149216796|NCT01526928|538259605|FG002|Overall Study|Other Reason|11|||
149216797|NCT01526928|538259606|FG003|Overall Study|Other Reason|4|||
149216798|NCT01526928|538259607|FG004|Overall Study|Other Reason|1|||
149216799|NCT01526928|538259608|FG005|Overall Study|Other Reason|0|||
149216800|NCT01526928|538259603|FG000|Overall Study|Lost to Follow-up|0|||
149216801|NCT01526928|538259604|FG001|Overall Study|Lost to Follow-up|0|||
149216802|NCT01526928|538259605|FG002|Overall Study|Lost to Follow-up|0|||
149216803|NCT01526928|538259606|FG003|Overall Study|Lost to Follow-up|1|||
149216804|NCT01526928|538259607|FG004|Overall Study|Lost to Follow-up|0|||
149216805|NCT01526928|538259608|FG005|Overall Study|Lost to Follow-up|0|||
149216806|NCT01526928|538259603|FG000|Overall Study|Protocol Deviation|0|||
149216807|NCT01526928|538259604|FG001|Overall Study|Protocol Deviation|0|||
149216808|NCT01526928|538259605|FG002|Overall Study|Protocol Deviation|0|||
149216809|NCT01526928|538259606|FG003|Overall Study|Protocol Deviation|2|||
149216810|NCT01526928|538259607|FG004|Overall Study|Protocol Deviation|0|||
148684863|NCT00901628|536319527|FG001|Overall Study|peroneal nerve palsy|1|||
148684864|NCT00608205|536319530|FG000|Overall Study|Adverse Event|3|||
148684865|NCT00608205|536319531|FG001|Overall Study|Adverse Event|2|||
148684866|NCT00608205|536319530|FG000|Overall Study|Patient non-compliant|0|||
148684867|NCT00608205|536319531|FG001|Overall Study|Patient non-compliant|1|||
148684868|NCT01003886|536319532|FG000|Overall Study|Lack of Efficacy|5|||
148684869|NCT01003886|536319532|FG000|Overall Study|Lost to Follow-up|169|||
148684870|NCT01003886|536319532|FG000|Overall Study|Withdrawal by Subject|39|||
148684871|NCT01003886|536319532|FG000|Overall Study|Other|14|||
148684872|NCT01003886|536319532|FG000|Overall Study|Adverse Event|3|||
148684873|NCT00909727|536319553|FG000|Overall Study|Adverse Event|1|||
148952165|NCT00482612|537307294|FG000|Follow-up Period|Lost to Follow-up|0|||
149216811|NCT01526928|538259608|FG005|Overall Study|Protocol Deviation|0|||
149216812|NCT01526928|538259603|FG000|Overall Study|Missing|0|||
149216813|NCT01526928|538259604|FG001|Overall Study|Missing|0|||
149216814|NCT01526928|538259605|FG002|Overall Study|Missing|1|||
149216815|NCT01526928|538259606|FG003|Overall Study|Missing|0|||
148684874|NCT00909727|536319554|FG001|Overall Study|Adverse Event|0|||
149216816|NCT01526928|538259607|FG004|Overall Study|Missing|2|||
149216817|NCT01526928|538259608|FG005|Overall Study|Missing|0|||
149216818|NCT04157751|538259618|FG000|Overall Study|Withdrawal by Subject|12|||
149216819|NCT04157751|538259619|FG001|Overall Study|Withdrawal by Subject|17|||
148684875|NCT00909727|536319553|FG000|Overall Study|Wrong Genotype|1|||
149216820|NCT04157751|538259618|FG000|Overall Study|Lost to Follow-up|6|||
149216821|NCT04157751|538259619|FG001|Overall Study|Lost to Follow-up|2|||
148952166|NCT00482612|537307295|FG001|Follow-up Period|Lost to Follow-up|4|||
148952167|NCT00482612|537307296|FG002|Follow-up Period|Lost to Follow-up|2|||
148952168|NCT00482612|537307297|FG003|Follow-up Period|Lost to Follow-up|1|||
148952169|NCT00482612|537307294|FG000|Follow-up Period|Adverse Event|4|||
149216822|NCT04157751|538259618|FG000|Overall Study|Adverse Event|34|||
149216823|NCT04157751|538259619|FG001|Overall Study|Adverse Event|23|||
149216824|NCT04157751|538259618|FG000|Overall Study|Not treated|1|||
149216825|NCT04157751|538259619|FG001|Overall Study|Not treated|5|||
149216826|NCT04157751|538259618|FG000|Overall Study|Other reason not stated above|10|||
149216827|NCT04157751|538259619|FG001|Overall Study|Other reason not stated above|10|||
149216828|NCT04731922|538259620|FG000|Overall Study|Adverse Event|0|||
149216829|NCT04731922|538259621|FG001|Overall Study|Adverse Event|0|||
149216830|NCT04731922|538259622|FG002|Overall Study|Adverse Event|0|||
149216831|NCT04731922|538259623|FG003|Overall Study|Adverse Event|0|||
149017259|NCT04318093|537542558|FG001|Overall Study|Participant withdrew consent|0|||
148952170|NCT00482612|537307295|FG001|Follow-up Period|Adverse Event|7|||
148952171|NCT00482612|537307296|FG002|Follow-up Period|Adverse Event|9|||
149017260|NCT04318093|537542557|FG000|Overall Study|Other reasons|0|||
149216832|NCT04731922|538259624|FG004|Overall Study|Adverse Event|0|||
148952172|NCT00482612|537307297|FG003|Follow-up Period|Adverse Event|0|||
149017261|NCT04318093|537542558|FG001|Overall Study|Other reasons|1|||
149017262|NCT00514046|537542567|FG000|Overall Study|transferred to another protocol|2|||
149017263|NCT00514046|537542568|FG001|Overall Study|transferred to another protocol|1|||
149017264|NCT00514046|537542569|FG002|Overall Study|transferred to another protocol|3|||
149017265|NCT00514046|537542570|FG003|Overall Study|transferred to another protocol|0|||
149017266|NCT00514046|537542571|FG004|Overall Study|transferred to another protocol|1|||
149017267|NCT00514046|537542572|FG005|Overall Study|transferred to another protocol|0|||
149017268|NCT00514046|537542573|FG006|Overall Study|transferred to another protocol|0|||
149017269|NCT00514046|537542574|FG007|Overall Study|transferred to another protocol|0|||
149017270|NCT00514046|537542575|FG008|Overall Study|transferred to another protocol|0|||
149017271|NCT00514046|537542567|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
149017272|NCT00514046|537542568|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
149017273|NCT00514046|537542569|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
149017274|NCT00514046|537542570|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
149017275|NCT00514046|537542571|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
149017276|NCT00514046|537542572|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
149017277|NCT00514046|537542573|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
149017278|NCT00514046|537542574|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
149017279|NCT00514046|537542575|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
149017280|NCT00514046|537542567|FG000|Overall Study|Disease progression on study|0|||
149017281|NCT00514046|537542568|FG001|Overall Study|Disease progression on study|0|||
149017282|NCT00514046|537542569|FG002|Overall Study|Disease progression on study|2|||
149017283|NCT00514046|537542570|FG003|Overall Study|Disease progression on study|0|||
149017284|NCT00514046|537542571|FG004|Overall Study|Disease progression on study|0|||
149017285|NCT00514046|537542572|FG005|Overall Study|Disease progression on study|1|||
149017286|NCT00514046|537542573|FG006|Overall Study|Disease progression on study|0|||
149017287|NCT00514046|537542574|FG007|Overall Study|Disease progression on study|0|||
149017288|NCT00514046|537542575|FG008|Overall Study|Disease progression on study|0|||
149017289|NCT00655551|537542576|FG000|All Periods Combined|Adverse Event|0|||
149017290|NCT00655551|537542577|FG001|All Periods Combined|Adverse Event|3|||
149017291|NCT00655551|537542578|FG002|All Periods Combined|Adverse Event|4|||
149017292|NCT00655551|537542576|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
149017293|NCT00655551|537542577|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
149017294|NCT00655551|537542578|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
149017295|NCT00655551|537542576|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
149017296|NCT00655551|537542577|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
149017297|NCT00655551|537542578|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
149017298|NCT00655551|537542576|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
149017299|NCT00655551|537542577|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
149216833|NCT04731922|538259625|FG005|Overall Study|Adverse Event|0|||
149216834|NCT04731922|538259626|FG006|Overall Study|Adverse Event|0|||
148952173|NCT00482612|537307294|FG000|Follow-up Period|Lack of Efficacy|2|||
148952174|NCT00482612|537307295|FG001|Follow-up Period|Lack of Efficacy|0|||
148952175|NCT00482612|537307296|FG002|Follow-up Period|Lack of Efficacy|1|||
148952176|NCT00482612|537307297|FG003|Follow-up Period|Lack of Efficacy|0|||
148952177|NCT00482612|537307294|FG000|Follow-up Period|Withdrawal by Subject|3|||
148952178|NCT00482612|537307295|FG001|Follow-up Period|Withdrawal by Subject|5|||
148952179|NCT00482612|537307296|FG002|Follow-up Period|Withdrawal by Subject|7|||
148952180|NCT00482612|537307297|FG003|Follow-up Period|Withdrawal by Subject|2|||
148952181|NCT00482612|537307294|FG000|Follow-up Period|Reasons not related to trial|1|||
148952182|NCT00482612|537307295|FG001|Follow-up Period|Reasons not related to trial|0|||
148952183|NCT00482612|537307296|FG002|Follow-up Period|Reasons not related to trial|1|||
148952184|NCT00482612|537307297|FG003|Follow-up Period|Reasons not related to trial|3|||
149216835|NCT04731922|538259627|FG007|Overall Study|Adverse Event|0|||
149216836|NCT04731922|538259628|FG008|Overall Study|Adverse Event|0|||
149216837|NCT04731922|538259629|FG009|Overall Study|Adverse Event|0|||
149216838|NCT04731922|538259630|FG010|Overall Study|Adverse Event|1|||
149216839|NCT04731922|538259631|FG011|Overall Study|Adverse Event|0|||
149216840|NCT04731922|538259632|FG012|Overall Study|Adverse Event|0|||
149216841|NCT04731922|538259633|FG013|Overall Study|Adverse Event|0|||
149216842|NCT04731922|538259634|FG014|Overall Study|Adverse Event|0|||
149216843|NCT04731922|538259635|FG015|Overall Study|Adverse Event|0|||
149216844|NCT04731922|538259636|FG016|Overall Study|Adverse Event|0|||
149216845|NCT04731922|538259620|FG000|Overall Study|Lost to Follow-up|0|||
149216846|NCT04731922|538259621|FG001|Overall Study|Lost to Follow-up|0|||
149216847|NCT04731922|538259622|FG002|Overall Study|Lost to Follow-up|0|||
149216848|NCT04731922|538259623|FG003|Overall Study|Lost to Follow-up|1|||
149216849|NCT04731922|538259624|FG004|Overall Study|Lost to Follow-up|0|||
149216850|NCT04731922|538259625|FG005|Overall Study|Lost to Follow-up|1|||
149216851|NCT04731922|538259626|FG006|Overall Study|Lost to Follow-up|0|||
149216852|NCT04731922|538259627|FG007|Overall Study|Lost to Follow-up|0|||
149216853|NCT04731922|538259628|FG008|Overall Study|Lost to Follow-up|0|||
149216854|NCT04731922|538259629|FG009|Overall Study|Lost to Follow-up|0|||
149216855|NCT04731922|538259630|FG010|Overall Study|Lost to Follow-up|0|||
149216856|NCT04731922|538259631|FG011|Overall Study|Lost to Follow-up|0|||
149216857|NCT04731922|538259632|FG012|Overall Study|Lost to Follow-up|0|||
149216858|NCT04731922|538259633|FG013|Overall Study|Lost to Follow-up|0|||
149216859|NCT04731922|538259634|FG014|Overall Study|Lost to Follow-up|0|||
149216860|NCT04731922|538259635|FG015|Overall Study|Lost to Follow-up|0|||
149216861|NCT04731922|538259636|FG016|Overall Study|Lost to Follow-up|0|||
148684876|NCT00909727|536319554|FG001|Overall Study|Wrong Genotype|0|||
148684877|NCT00909727|536319553|FG000|Overall Study|Withdrawal of Consent|1|||
148684878|NCT00909727|536319554|FG001|Overall Study|Withdrawal of Consent|0|||
148684879|NCT00909727|536319553|FG000|Overall Study|Prohibited Medication|1|||
148684880|NCT00909727|536319554|FG001|Overall Study|Prohibited Medication|0|||
148684881|NCT01339910|536319556|FG000|Overall Study|Withdrawal by Subject|1|||
148684882|NCT01339910|536319557|FG001|Overall Study|Withdrawal by Subject|0|||
148684883|NCT01339910|536319556|FG000|Overall Study|Physician Decision|1|||
148684884|NCT01339910|536319557|FG001|Overall Study|Physician Decision|0|||
148684885|NCT01339910|536319556|FG000|Overall Study|Disease relapse|1|||
148684886|NCT01339910|536319557|FG001|Overall Study|Disease relapse|4|||
148684887|NCT02965820|536319559|FG000|Period 2, Second 30 Days|Adverse Event|1|||
148684888|NCT02965820|536319560|FG001|Period 2, Second 30 Days|Adverse Event|1|||
148684889|NCT01567306|536319561|FG000|Overall Study|Protocol Violation|2|||
148684890|NCT01567306|536319562|FG001|Overall Study|Protocol Violation|2|||
148684891|NCT01567306|536319563|FG002|Overall Study|Protocol Violation|0|||
148684892|NCT01567306|536319564|FG003|Overall Study|Protocol Violation|3|||
148684893|NCT01567306|536319565|FG004|Overall Study|Protocol Violation|1|||
149017300|NCT00655551|537542578|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
149017301|NCT01734434|537542579|FG000|Overall Study|Death Infant|3|||
149216862|NCT04731922|538259620|FG000|Overall Study|Withdrawal by Subject|1|||
149216863|NCT04731922|538259621|FG001|Overall Study|Withdrawal by Subject|0|||
149017302|NCT01734434|537542580|FG001|Overall Study|Death Infant|1|||
149017303|NCT01734434|537542581|FG002|Overall Study|Death Infant|17|||
149017304|NCT01734434|537542582|FG003|Overall Study|Death Infant|5|||
149017305|NCT01734434|537542579|FG000|Overall Study|Lost to Follow-up|2|||
149017306|NCT01734434|537542580|FG001|Overall Study|Lost to Follow-up|9|||
149017307|NCT01734434|537542581|FG002|Overall Study|Lost to Follow-up|67|||
149017308|NCT01734434|537542582|FG003|Overall Study|Lost to Follow-up|11|||
149017309|NCT01734434|537542579|FG000|Overall Study|No Live Birth|1|||
149017310|NCT01734434|537542580|FG001|Overall Study|No Live Birth|2|||
149017311|NCT01734434|537542581|FG002|Overall Study|No Live Birth|32|||
149017312|NCT01734434|537542582|FG003|Overall Study|No Live Birth|6|||
149017313|NCT01734434|537542579|FG000|Overall Study|Withdrawal by Subject|4|||
149216864|NCT04731922|538259622|FG002|Overall Study|Withdrawal by Subject|0|||
149216865|NCT04731922|538259623|FG003|Overall Study|Withdrawal by Subject|0|||
148684894|NCT01567306|536319566|FG005|Overall Study|Protocol Violation|1|||
149017314|NCT01734434|537542580|FG001|Overall Study|Withdrawal by Subject|0|||
149216866|NCT04731922|538259624|FG004|Overall Study|Withdrawal by Subject|1|||
149017315|NCT01734434|537542581|FG002|Overall Study|Withdrawal by Subject|8|||
149216867|NCT04731922|538259625|FG005|Overall Study|Withdrawal by Subject|0|||
149216868|NCT04731922|538259626|FG006|Overall Study|Withdrawal by Subject|1|||
148684895|NCT01567306|536319561|FG000|Overall Study|Change site living|1|||
148684896|NCT01567306|536319562|FG001|Overall Study|Change site living|0|||
148684897|NCT01567306|536319563|FG002|Overall Study|Change site living|0|||
149017316|NCT01734434|537542582|FG003|Overall Study|Withdrawal by Subject|1|||
149017317|NCT01734434|537542579|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
149216869|NCT04731922|538259627|FG007|Overall Study|Withdrawal by Subject|0|||
149017318|NCT01734434|537542580|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
149017319|NCT01734434|537542581|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
149017320|NCT01734434|537542582|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
149216870|NCT04731922|538259628|FG008|Overall Study|Withdrawal by Subject|0|||
149216871|NCT04731922|538259629|FG009|Overall Study|Withdrawal by Subject|0|||
149216872|NCT04731922|538259630|FG010|Overall Study|Withdrawal by Subject|0|||
149216873|NCT04731922|538259631|FG011|Overall Study|Withdrawal by Subject|0|||
149216874|NCT04731922|538259632|FG012|Overall Study|Withdrawal by Subject|0|||
149216875|NCT04731922|538259633|FG013|Overall Study|Withdrawal by Subject|1|||
149216876|NCT04731922|538259634|FG014|Overall Study|Withdrawal by Subject|0|||
149216877|NCT04731922|538259635|FG015|Overall Study|Withdrawal by Subject|0|||
149216878|NCT04731922|538259636|FG016|Overall Study|Withdrawal by Subject|0|||
149216879|NCT04731922|538259620|FG000|Overall Study|Other|0|||
149216880|NCT04731922|538259621|FG001|Overall Study|Other|0|||
149216881|NCT04731922|538259622|FG002|Overall Study|Other|0|||
149216882|NCT04731922|538259623|FG003|Overall Study|Other|0|||
149216883|NCT04731922|538259624|FG004|Overall Study|Other|0|||
149017321|NCT01734434|537542579|FG000|Overall Study|Subject Not Reachable|0|||
149017322|NCT01734434|537542580|FG001|Overall Study|Subject Not Reachable|0|||
149017323|NCT01734434|537542581|FG002|Overall Study|Subject Not Reachable|1|||
149017324|NCT01734434|537542582|FG003|Overall Study|Subject Not Reachable|0|||
149017325|NCT01734434|537542579|FG000|Overall Study|Treatment Defaulter|0|||
149017326|NCT01734434|537542580|FG001|Overall Study|Treatment Defaulter|0|||
149017327|NCT01734434|537542581|FG002|Overall Study|Treatment Defaulter|1|||
149017328|NCT01734434|537542582|FG003|Overall Study|Treatment Defaulter|0|||
149017329|NCT01734434|537542579|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
149017330|NCT01734434|537542580|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
149017331|NCT01734434|537542581|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
149017332|NCT01734434|537542582|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
149017333|NCT01734434|537542579|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
149017334|NCT01734434|537542580|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
149017335|NCT01734434|537542581|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
149017336|NCT01734434|537542582|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
149017337|NCT02049710|537542587|FG000|Overall Study|Lost to Follow-up|319|||
149017338|NCT02049710|537542588|FG001|Overall Study|Lost to Follow-up|324|||
149017339|NCT03391960|537542589|FG000|Overall Study|Protocol Violation|0|||
149017340|NCT03391960|537542590|FG001|Overall Study|Protocol Violation|0|||
149017341|NCT03204695|537544825|FG000|Overall Study|Death|1|||
149017342|NCT03204695|537544825|FG000|Overall Study|Participant was treated with another device|1|||
149017343|NCT03204695|537544825|FG000|Overall Study|Physician Decision|2|||
149017344|NCT04834362|537544826|FG000|Overall Study|Death|1|||
149017345|NCT04834362|537544827|FG001|Overall Study|Death|2|||
149017346|NCT02555371|537544828|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
149017347|NCT02555371|537544829|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
149017348|NCT02555371|537544830|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
149017349|NCT02555371|537544831|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
149017350|NCT02555371|537544832|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
149017351|NCT02555371|537544828|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
149017352|NCT02555371|537544829|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
149017353|NCT02555371|537544830|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
149017354|NCT02555371|537544831|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
149017355|NCT02555371|537544832|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
149017356|NCT02555371|537544828|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
149017357|NCT02555371|537544829|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
149017358|NCT02555371|537544830|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
149017359|NCT02555371|537544831|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
149017360|NCT02555371|537544832|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
149017361|NCT02555371|537544828|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
149017362|NCT02555371|537544829|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
149017363|NCT02555371|537544830|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
149017364|NCT02555371|537544831|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
149017365|NCT02555371|537544832|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
149017366|NCT02555371|537544828|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
149017367|NCT02555371|537544829|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
149017368|NCT02555371|537544830|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
149017369|NCT02555371|537544831|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
149017370|NCT02555371|537544832|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
149216884|NCT04731922|538259625|FG005|Overall Study|Other|0|||
149017371|NCT02555371|537544828|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
149017372|NCT02555371|537544829|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
149017373|NCT02555371|537544830|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
149216885|NCT04731922|538259626|FG006|Overall Study|Other|1|||
149216886|NCT04731922|538259627|FG007|Overall Study|Other|0|||
149017374|NCT02555371|537544831|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
149017375|NCT02555371|537544832|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
149216887|NCT04731922|538259628|FG008|Overall Study|Other|0|||
149216888|NCT04731922|538259629|FG009|Overall Study|Other|0|||
149216889|NCT04731922|538259630|FG010|Overall Study|Other|0|||
149216890|NCT04731922|538259631|FG011|Overall Study|Other|0|||
149216891|NCT04731922|538259632|FG012|Overall Study|Other|0|||
149216892|NCT04731922|538259633|FG013|Overall Study|Other|0|||
149216893|NCT04731922|538259634|FG014|Overall Study|Other|0|||
149216894|NCT04731922|538259635|FG015|Overall Study|Other|0|||
149216895|NCT04731922|538259636|FG016|Overall Study|Other|0|||
149216896|NCT00981747|538259645|FG000|Losartan|Withdrawal by Subject|1|||
149216897|NCT00981747|538259645|FG000|Losartan|Death|1|||
149216898|NCT00981747|538259645|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
149216899|NCT02033850|538259649|FG000|Overall Study|Death|1|||
149216900|NCT02033850|538259650|FG001|Overall Study|Death|0|||
149216901|NCT02033850|538259649|FG000|Overall Study|unrelated medical reason|1|||
149216902|NCT02033850|538259650|FG001|Overall Study|unrelated medical reason|1|||
149216903|NCT01437267|538259651|FG000|Overall Study|Withdrawal by Subject|0|||
149216904|NCT01437267|538259652|FG001|Overall Study|Withdrawal by Subject|0|||
149216905|NCT01437267|538259653|FG002|Overall Study|Withdrawal by Subject|0|||
149216906|NCT01437267|538259654|FG003|Overall Study|Withdrawal by Subject|1|||
149216907|NCT01437267|538259655|FG004|Overall Study|Withdrawal by Subject|0|||
149216908|NCT01437267|538259656|FG005|Overall Study|Withdrawal by Subject|0|||
149216909|NCT01437267|538259651|FG000|Overall Study|Protocol Violation|0|||
149216910|NCT01437267|538259652|FG001|Overall Study|Protocol Violation|1|||
149216911|NCT01437267|538259653|FG002|Overall Study|Protocol Violation|0|||
149216912|NCT01437267|538259654|FG003|Overall Study|Protocol Violation|0|||
149216913|NCT01437267|538259655|FG004|Overall Study|Protocol Violation|0|||
149216914|NCT01437267|538259656|FG005|Overall Study|Protocol Violation|0|||
149216915|NCT03934203|538259657|FG000|Overall Study|Adverse Event|0|||
149216916|NCT03934203|538259658|FG001|Overall Study|Adverse Event|0|||
149216917|NCT03934203|538259659|FG002|Overall Study|Adverse Event|1|||
148684898|NCT01567306|536319564|FG003|Overall Study|Change site living|0|||
148684899|NCT01567306|536319565|FG004|Overall Study|Change site living|0|||
148952185|NCT00464087|537307298|FG000|Overall Study|No PCI per inclusion criteria|0|||
148952186|NCT00464087|537307299|FG001|Overall Study|No PCI per inclusion criteria|0|||
148952187|NCT00464087|537307300|FG002|Overall Study|No PCI per inclusion criteria|29|||
148952188|NCT01224431|537307302|FG000|Overall Study|not randomized|0|||
148952189|NCT01224431|537307303|FG001|Overall Study|not randomized|4|||
148952190|NCT01224431|537307302|FG000|Overall Study|no video record|0|||
148952191|NCT01224431|537307303|FG001|Overall Study|no video record|1|||
148952192|NCT03654651|537307305|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
148952193|NCT03654651|537307306|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
148952194|NCT01401283|537307307|FG000|Overall Study|surgery cancelled|5|||
148952195|NCT01401283|537307308|FG001|Overall Study|surgery cancelled|8|||
148952196|NCT01401283|537307307|FG000|Overall Study|preoperative arrhythmia|5|||
148952197|NCT01401283|537307308|FG001|Overall Study|preoperative arrhythmia|0|||
148952198|NCT01401283|537307307|FG000|Overall Study|no central venous access|0|||
148952199|NCT01401283|537307308|FG001|Overall Study|no central venous access|1|||
148952200|NCT01401283|537307307|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
148952201|NCT01401283|537307308|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
148952202|NCT02433483|537307309|FG000|Overall Study|Unacceptable toxicity|1|||
148952203|NCT02433483|537307309|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
148952204|NCT03824912|537307311|FG000|Overall Study|Lost to Follow-up|18|||
148952205|NCT03824912|537307312|FG001|Overall Study|Lost to Follow-up|15|||
148952206|NCT03824912|537307313|FG002|Overall Study|Lost to Follow-up|8|||
148952207|NCT03824912|537307311|FG000|Overall Study|Negative Baseline Culture Result|118|||
148684900|NCT01567306|536319566|FG005|Overall Study|Change site living|0|||
148684901|NCT01567306|536319561|FG000|Overall Study|Adverse Event|0|||
148684902|NCT01567306|536319562|FG001|Overall Study|Adverse Event|0|||
148684903|NCT01567306|536319563|FG002|Overall Study|Adverse Event|0|||
148684904|NCT01567306|536319564|FG003|Overall Study|Adverse Event|2|||
148684905|NCT01567306|536319565|FG004|Overall Study|Adverse Event|4|||
148684906|NCT01567306|536319566|FG005|Overall Study|Adverse Event|1|||
148952208|NCT03824912|537307312|FG001|Overall Study|Negative Baseline Culture Result|112|||
148952209|NCT03824912|537307313|FG002|Overall Study|Negative Baseline Culture Result|57|||
149216918|NCT03934203|538259660|FG003|Overall Study|Adverse Event|0|||
149216919|NCT03934203|538259661|FG004|Overall Study|Adverse Event|1|||
149216920|NCT03934203|538259662|FG005|Overall Study|Adverse Event|0|||
149216921|NCT03934203|538259663|FG006|Overall Study|Adverse Event|2|||
148684907|NCT01567306|536319561|FG000|Overall Study|Lost to Follow-up|0|||
148952210|NCT03824912|537307311|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148952211|NCT03824912|537307312|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149216922|NCT03934203|538259664|FG007|Overall Study|Adverse Event|0|||
149216923|NCT03934203|538259665|FG008|Overall Study|Adverse Event|0|||
149216924|NCT03934203|538259666|FG009|Overall Study|Adverse Event|0|||
149216925|NCT03934203|538259667|FG010|Overall Study|Adverse Event|0|||
148684908|NCT01567306|536319562|FG001|Overall Study|Lost to Follow-up|0|||
149216926|NCT03934203|538259668|FG011|Overall Study|Adverse Event|0|||
149216927|NCT03934203|538259669|FG012|Overall Study|Adverse Event|0|||
149216928|NCT03934203|538259670|FG013|Overall Study|Adverse Event|1|||
149216929|NCT03934203|538259671|FG014|Overall Study|Adverse Event|0|||
149216930|NCT00608842|538259674|FG000|Overall Study|Participant's Request|0|||
149216931|NCT00608842|538259675|FG001|Overall Study|Participant's Request|1|||
149216932|NCT00608842|538259676|FG002|Overall Study|Participant's Request|2|||
149216933|NCT00608842|538259677|FG003|Overall Study|Participant's Request|1|||
149216934|NCT00608842|538259674|FG000|Overall Study|Lost to Follow-up|1|||
149216935|NCT00608842|538259675|FG001|Overall Study|Lost to Follow-up|0|||
149216936|NCT00608842|538259676|FG002|Overall Study|Lost to Follow-up|0|||
148952212|NCT03824912|537307313|FG002|Overall Study|Non-Compliance with Study Drug|1|||
148952213|NCT03824912|537307311|FG000|Overall Study|Protocol Violation|1|||
149017376|NCT02555371|537544828|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
149017377|NCT02555371|537544829|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
149017378|NCT02555371|537544830|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
149017379|NCT02555371|537544831|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
149017380|NCT02555371|537544832|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
149017381|NCT02555371|537544828|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
149017382|NCT02555371|537544829|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
148952214|NCT03824912|537307312|FG001|Overall Study|Protocol Violation|4|||
148952215|NCT03824912|537307313|FG002|Overall Study|Protocol Violation|1|||
148952216|NCT03824912|537307311|FG000|Overall Study|Withdrawal by Subject|3|||
148952217|NCT03824912|537307312|FG001|Overall Study|Withdrawal by Subject|2|||
148952218|NCT03824912|537307313|FG002|Overall Study|Withdrawal by Subject|1|||
148952219|NCT03824912|537307311|FG000|Overall Study|Participation in another study|0|||
148952220|NCT03824912|537307312|FG001|Overall Study|Participation in another study|1|||
148952221|NCT03824912|537307313|FG002|Overall Study|Participation in another study|0|||
148952222|NCT02904512|537307314|FG000|Overall Study|Withdrawal by Subject|1|||
148952223|NCT02904512|537307315|FG001|Overall Study|Withdrawal by Subject|0|||
148952224|NCT02904512|537307314|FG000|Overall Study|Transferred to ICU|1|||
148952225|NCT02904512|537307315|FG001|Overall Study|Transferred to ICU|0|||
148952226|NCT02904512|537307314|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
148952227|NCT02904512|537307315|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
148952228|NCT01963403|537307322|FG000|Overall Study|Lost to Follow-up|2|||
148952229|NCT01963403|537307323|FG001|Overall Study|Lost to Follow-up|3|||
148952230|NCT01963403|537307322|FG000|Overall Study|Implant removal|0|||
148952231|NCT01963403|537307323|FG001|Overall Study|Implant removal|1|||
148952232|NCT00549302|537307328|FG000|Double-Blind|Death|2|||
148952233|NCT00549302|537307329|FG001|Double-Blind|Death|9|||
148952234|NCT00549302|537307330|FG002|Double-Blind|Death|0|||
148952235|NCT00549302|537307328|FG000|Double-Blind|Adverse Event|3|||
148952236|NCT00549302|537307329|FG001|Double-Blind|Adverse Event|16|||
148952237|NCT00549302|537307330|FG002|Double-Blind|Adverse Event|0|||
148952238|NCT00549302|537307328|FG000|Double-Blind|Withdrawal by Subject|3|||
148952239|NCT00549302|537307329|FG001|Double-Blind|Withdrawal by Subject|8|||
148952240|NCT00549302|537307330|FG002|Double-Blind|Withdrawal by Subject|0|||
148952241|NCT00549302|537307328|FG000|Double-Blind|Investigator Decision|1|||
148952242|NCT00549302|537307329|FG001|Double-Blind|Investigator Decision|5|||
148952243|NCT00549302|537307330|FG002|Double-Blind|Investigator Decision|0|||
148952244|NCT00549302|537307328|FG000|Double-Blind|Sponsor Decision|0|||
148952245|NCT00549302|537307329|FG001|Double-Blind|Sponsor Decision|1|||
148952246|NCT00549302|537307330|FG002|Double-Blind|Sponsor Decision|0|||
148952247|NCT00549302|537307328|FG000|Double-Blind|Lost to Follow-up|1|||
148952248|NCT00549302|537307329|FG001|Double-Blind|Lost to Follow-up|2|||
148952249|NCT00549302|537307330|FG002|Double-Blind|Lost to Follow-up|0|||
148952250|NCT00549302|537307328|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
148952251|NCT00549302|537307329|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
148952252|NCT00549302|537307330|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
148952253|NCT00549302|537307328|FG000|Double-Blind|New condition or starts new therapy|0|||
148952254|NCT00549302|537307329|FG001|Double-Blind|New condition or starts new therapy|2|||
148952255|NCT00549302|537307330|FG002|Double-Blind|New condition or starts new therapy|0|||
148952256|NCT00549302|537307328|FG000|Open-Label|Adverse Event|0|||
148952257|NCT00549302|537307329|FG001|Open-Label|Adverse Event|0|||
148952258|NCT00549302|537307330|FG002|Open-Label|Adverse Event|11|||
148952259|NCT00549302|537307328|FG000|Open-Label|Death|0|||
148952260|NCT00549302|537307329|FG001|Open-Label|Death|0|||
148952261|NCT00549302|537307330|FG002|Open-Label|Death|40|||
148952262|NCT00549302|537307328|FG000|Open-Label|Investigator Decision|0|||
148952263|NCT00549302|537307329|FG001|Open-Label|Investigator Decision|0|||
148952264|NCT00549302|537307330|FG002|Open-Label|Investigator Decision|5|||
148952265|NCT00549302|537307328|FG000|Open-Label|Lost to Follow-up|0|||
148952266|NCT00549302|537307329|FG001|Open-Label|Lost to Follow-up|0|||
148952267|NCT00549302|537307330|FG002|Open-Label|Lost to Follow-up|2|||
149216937|NCT00608842|538259677|FG003|Overall Study|Lost to Follow-up|0|||
148952268|NCT00549302|537307328|FG000|Open-Label|Other|0|||
149216938|NCT02699125|538259680|FG000|Placebo|Lost to Follow-up|2|||
149216939|NCT02699125|538259681|FG001|Placebo|Lost to Follow-up|0|||
148952269|NCT00549302|537307329|FG001|Open-Label|Other|0|||
148952270|NCT00549302|537307330|FG002|Open-Label|Other|3|||
149216940|NCT02699125|538259680|FG000|Placebo|Protocol Violation|1|||
149216941|NCT02699125|538259681|FG001|Placebo|Protocol Violation|0|||
149216942|NCT02699125|538259680|FG000|Placebo|Withdrawal by Subject|0|||
149216943|NCT02699125|538259681|FG001|Placebo|Withdrawal by Subject|4|||
149216944|NCT02699125|538259680|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
149216945|NCT02699125|538259681|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
149216946|NCT04445051|538259682|FG000|Overall Study|Adverse Event|0|||
149216947|NCT04445051|538259683|FG001|Overall Study|Adverse Event|0|||
149216948|NCT04445051|538259684|FG002|Overall Study|Adverse Event|1|||
149216949|NCT04445051|538259685|FG003|Overall Study|Adverse Event|0|||
149216950|NCT04445051|538259686|FG004|Overall Study|Adverse Event|0|||
149216951|NCT04445051|538259687|FG005|Overall Study|Adverse Event|0|||
149216952|NCT03799627|538259689|FG000|Overall Study|Adverse Event|1|||
149216953|NCT03799627|538259690|FG001|Overall Study|Adverse Event|2|||
149216954|NCT03799627|538259691|FG002|Overall Study|Adverse Event|0|||
149216955|NCT03799627|538259692|FG003|Overall Study|Adverse Event|0|||
149216956|NCT03799627|538259693|FG004|Overall Study|Adverse Event|2|||
149216957|NCT03799627|538259694|FG005|Overall Study|Adverse Event|5|||
149216958|NCT03799627|538259695|FG006|Overall Study|Adverse Event|0|||
149216959|NCT03799627|538259696|FG007|Overall Study|Adverse Event|2|||
149216960|NCT03799627|538259697|FG008|Overall Study|Adverse Event|0|||
149216961|NCT03799627|538259689|FG000|Overall Study|Physician Decision|2|||
149216962|NCT03799627|538259690|FG001|Overall Study|Physician Decision|2|||
149216963|NCT03799627|538259691|FG002|Overall Study|Physician Decision|0|||
149216964|NCT03799627|538259692|FG003|Overall Study|Physician Decision|0|||
149216965|NCT03799627|538259693|FG004|Overall Study|Physician Decision|2|||
149216966|NCT03799627|538259694|FG005|Overall Study|Physician Decision|2|||
149216967|NCT03799627|538259695|FG006|Overall Study|Physician Decision|0|||
149216968|NCT03799627|538259696|FG007|Overall Study|Physician Decision|0|||
149216969|NCT03799627|538259697|FG008|Overall Study|Physician Decision|0|||
149216970|NCT03799627|538259689|FG000|Overall Study|Withdrawal by Subject|1|||
149216971|NCT03799627|538259690|FG001|Overall Study|Withdrawal by Subject|1|||
149216972|NCT03799627|538259691|FG002|Overall Study|Withdrawal by Subject|0|||
149216973|NCT03799627|538259692|FG003|Overall Study|Withdrawal by Subject|2|||
149216974|NCT03799627|538259693|FG004|Overall Study|Withdrawal by Subject|0|||
149216975|NCT03799627|538259694|FG005|Overall Study|Withdrawal by Subject|3|||
149216976|NCT03799627|538259695|FG006|Overall Study|Withdrawal by Subject|0|||
149216977|NCT03799627|538259696|FG007|Overall Study|Withdrawal by Subject|0|||
149216978|NCT03799627|538259697|FG008|Overall Study|Withdrawal by Subject|0|||
149216979|NCT03799627|538259689|FG000|Overall Study|Lack of Efficacy|0|||
149216980|NCT03799627|538259690|FG001|Overall Study|Lack of Efficacy|0|||
149216981|NCT03799627|538259691|FG002|Overall Study|Lack of Efficacy|0|||
149216982|NCT03799627|538259692|FG003|Overall Study|Lack of Efficacy|1|||
149216983|NCT03799627|538259693|FG004|Overall Study|Lack of Efficacy|0|||
149216984|NCT03799627|538259694|FG005|Overall Study|Lack of Efficacy|0|||
149216985|NCT03799627|538259695|FG006|Overall Study|Lack of Efficacy|0|||
149216986|NCT03799627|538259696|FG007|Overall Study|Lack of Efficacy|0|||
149216987|NCT03799627|538259697|FG008|Overall Study|Lack of Efficacy|0|||
149216988|NCT03799627|538259689|FG000|Overall Study|Lost to Follow-up|0|||
149216989|NCT03799627|538259690|FG001|Overall Study|Lost to Follow-up|0|||
149216990|NCT03799627|538259691|FG002|Overall Study|Lost to Follow-up|0|||
149216991|NCT03799627|538259692|FG003|Overall Study|Lost to Follow-up|0|||
149216992|NCT03799627|538259693|FG004|Overall Study|Lost to Follow-up|0|||
148952271|NCT00549302|537307328|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
149216993|NCT03799627|538259694|FG005|Overall Study|Lost to Follow-up|0|||
149216994|NCT03799627|538259695|FG006|Overall Study|Lost to Follow-up|1|||
149216995|NCT03799627|538259696|FG007|Overall Study|Lost to Follow-up|0|||
149216996|NCT03799627|538259697|FG008|Overall Study|Lost to Follow-up|1|||
149216997|NCT03799627|538259689|FG000|Overall Study|Death|0|||
149216998|NCT03799627|538259690|FG001|Overall Study|Death|0|||
149216999|NCT03799627|538259691|FG002|Overall Study|Death|0|||
148809786|NCT02378181|536780872|FG001|Overall Study|Withdrawal by Subject|1|||
149217000|NCT03799627|538259692|FG003|Overall Study|Death|1|||
149217001|NCT03799627|538259693|FG004|Overall Study|Death|0|||
149217002|NCT03799627|538259694|FG005|Overall Study|Death|0|||
149217003|NCT03799627|538259695|FG006|Overall Study|Death|0|||
148684909|NCT01567306|536319563|FG002|Overall Study|Lost to Follow-up|0|||
148684910|NCT01567306|536319564|FG003|Overall Study|Lost to Follow-up|0|||
148952272|NCT00549302|537307329|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
148952273|NCT00549302|537307330|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
148952274|NCT00549302|537307328|FG000|Open-Label|Withdrawal by Subject|0|||
148952275|NCT00549302|537307329|FG001|Open-Label|Withdrawal by Subject|0|||
148952276|NCT00549302|537307330|FG002|Open-Label|Withdrawal by Subject|6|||
148952277|NCT03585504|537307331|FG000|Overall Study|Lost to Follow-up|26|||
149217004|NCT03799627|538259696|FG007|Overall Study|Death|0|||
149217005|NCT03799627|538259697|FG008|Overall Study|Death|0|||
149217006|NCT03799627|538259689|FG000|Overall Study|Study Drug Put on Hold|1|||
149217007|NCT03799627|538259690|FG001|Overall Study|Study Drug Put on Hold|0|||
149217008|NCT03799627|538259691|FG002|Overall Study|Study Drug Put on Hold|0|||
149217009|NCT03799627|538259692|FG003|Overall Study|Study Drug Put on Hold|0|||
149217010|NCT03799627|538259693|FG004|Overall Study|Study Drug Put on Hold|0|||
149217011|NCT03799627|538259694|FG005|Overall Study|Study Drug Put on Hold|0|||
149217012|NCT03799627|538259695|FG006|Overall Study|Study Drug Put on Hold|0|||
149217013|NCT03799627|538259696|FG007|Overall Study|Study Drug Put on Hold|0|||
149217014|NCT03799627|538259697|FG008|Overall Study|Study Drug Put on Hold|0|||
149217015|NCT03799627|538259689|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
149217016|NCT03799627|538259690|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
149217017|NCT03799627|538259691|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
148952278|NCT03585504|537307332|FG001|Overall Study|Lost to Follow-up|29|||
148952279|NCT01414114|537307333|FG000|Overall Study|Adverse Event|2|||
148952280|NCT01414114|537307333|FG000|Overall Study|Withdrawal by Subject|1|||
148952281|NCT01414114|537307333|FG000|Overall Study|Other|2|||
148952282|NCT05620563|537307334|FG000|Overall Study|Adverse Event|3|||
148952283|NCT05620563|537307335|FG001|Overall Study|Adverse Event|1|||
148952284|NCT05620563|537307334|FG000|Overall Study|Lost to Follow-up|0|||
148952285|NCT05620563|537307335|FG001|Overall Study|Lost to Follow-up|2|||
148952286|NCT05620563|537307334|FG000|Overall Study|Protocol Deviation|1|||
148952287|NCT05620563|537307335|FG001|Overall Study|Protocol Deviation|2|||
148952288|NCT05620563|537307334|FG000|Overall Study|Withdrawal by Subject|3|||
148952289|NCT05620563|537307335|FG001|Overall Study|Withdrawal by Subject|3|||
148952290|NCT05620563|537307334|FG000|Overall Study|Physician Decision|0|||
148952291|NCT05620563|537307335|FG001|Overall Study|Physician Decision|1|||
148952292|NCT02085785|537307339|FG000|Overall Study|Withdrawal by Subject|2|||
148952293|NCT02085785|537307340|FG001|Overall Study|Withdrawal by Subject|1|||
148952294|NCT02085785|537307339|FG000|Overall Study|Lost to Follow-up|0|||
148952295|NCT02085785|537307340|FG001|Overall Study|Lost to Follow-up|1|||
148952296|NCT04626297|537307341|FG000|Overall Study|Adverse Event|5|||
148952297|NCT04626297|537307342|FG001|Overall Study|Adverse Event|3|||
148952298|NCT04626297|537307341|FG000|Overall Study|Lost to Follow-up|7|||
148952299|NCT04626297|537307342|FG001|Overall Study|Lost to Follow-up|3|||
148952300|NCT04626297|537307341|FG000|Overall Study|Protocol Violation|5|||
148952301|NCT04626297|537307342|FG001|Overall Study|Protocol Violation|1|||
148952302|NCT04626297|537307341|FG000|Overall Study|Withdrawal by Subject|20|||
148952303|NCT04626297|537307342|FG001|Overall Study|Withdrawal by Subject|6|||
148952304|NCT04626297|537307341|FG000|Overall Study|Sponsor decision|2|||
149217018|NCT03799627|538259692|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
149217019|NCT03799627|538259693|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
149217020|NCT03799627|538259694|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
149217021|NCT03799627|538259695|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
149217022|NCT03799627|538259696|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
149217023|NCT03799627|538259697|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
149217024|NCT03799627|538259689|FG000|Overall Study|Kidney Transplantation|1|||
149217025|NCT03799627|538259690|FG001|Overall Study|Kidney Transplantation|0|||
149217026|NCT03799627|538259691|FG002|Overall Study|Kidney Transplantation|0|||
149217027|NCT03799627|538259692|FG003|Overall Study|Kidney Transplantation|1|||
149217028|NCT03799627|538259693|FG004|Overall Study|Kidney Transplantation|1|||
149217029|NCT03799627|538259694|FG005|Overall Study|Kidney Transplantation|0|||
149217030|NCT03799627|538259695|FG006|Overall Study|Kidney Transplantation|0|||
149217031|NCT03799627|538259696|FG007|Overall Study|Kidney Transplantation|0|||
149217032|NCT03799627|538259697|FG008|Overall Study|Kidney Transplantation|0|||
149217033|NCT03799627|538259689|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
149217034|NCT03799627|538259690|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
149217035|NCT03799627|538259691|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
149217036|NCT03799627|538259692|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
149217037|NCT03799627|538259693|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
149217038|NCT03799627|538259694|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
149217039|NCT03799627|538259695|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
149217040|NCT03799627|538259696|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
149217041|NCT03799627|538259697|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
149217042|NCT03799627|538259689|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149217043|NCT03799627|538259690|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
149217044|NCT03799627|538259691|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149217045|NCT03799627|538259692|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149217046|NCT03799627|538259693|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149217047|NCT03799627|538259694|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
148952305|NCT04626297|537307342|FG001|Overall Study|Sponsor decision|1|||
148952306|NCT02254486|537307343|FG000|Overall Study|Adverse Event|1|||
148952307|NCT02254486|537307344|FG001|Overall Study|Adverse Event|1|||
149217048|NCT03799627|538259695|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149217049|NCT03799627|538259696|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
149217050|NCT03799627|538259697|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
148952308|NCT02254486|537307343|FG000|Overall Study|Lack of Efficacy|1|||
148952309|NCT02254486|537307344|FG001|Overall Study|Lack of Efficacy|0|||
148952310|NCT02254486|537307343|FG000|Overall Study|Lost to Follow-up|2|||
149217051|NCT03799627|538259689|FG000|Overall Study|Met Exclusion Criteria|0|||
149217052|NCT03799627|538259690|FG001|Overall Study|Met Exclusion Criteria|0|||
149217053|NCT03799627|538259691|FG002|Overall Study|Met Exclusion Criteria|0|||
149217054|NCT03799627|538259692|FG003|Overall Study|Met Exclusion Criteria|1|||
149217055|NCT03799627|538259693|FG004|Overall Study|Met Exclusion Criteria|0|||
149217056|NCT03799627|538259694|FG005|Overall Study|Met Exclusion Criteria|0|||
149217057|NCT03799627|538259695|FG006|Overall Study|Met Exclusion Criteria|0|||
149217058|NCT03799627|538259696|FG007|Overall Study|Met Exclusion Criteria|0|||
149217059|NCT03799627|538259697|FG008|Overall Study|Met Exclusion Criteria|0|||
149217060|NCT03799627|538259689|FG000|Overall Study|Investigational Product Noncompliance|0|||
149217061|NCT03799627|538259690|FG001|Overall Study|Investigational Product Noncompliance|0|||
149217062|NCT03799627|538259691|FG002|Overall Study|Investigational Product Noncompliance|0|||
149217063|NCT03799627|538259692|FG003|Overall Study|Investigational Product Noncompliance|1|||
149217064|NCT03799627|538259693|FG004|Overall Study|Investigational Product Noncompliance|0|||
149217065|NCT03799627|538259694|FG005|Overall Study|Investigational Product Noncompliance|0|||
149217066|NCT03799627|538259695|FG006|Overall Study|Investigational Product Noncompliance|0|||
149217067|NCT03799627|538259696|FG007|Overall Study|Investigational Product Noncompliance|0|||
149217068|NCT03799627|538259697|FG008|Overall Study|Investigational Product Noncompliance|0|||
149217069|NCT03799627|538259689|FG000|Overall Study|Participant Relocation|0|||
149217070|NCT03799627|538259690|FG001|Overall Study|Participant Relocation|0|||
149217071|NCT03799627|538259691|FG002|Overall Study|Participant Relocation|0|||
149217072|NCT03799627|538259692|FG003|Overall Study|Participant Relocation|1|||
149217073|NCT03799627|538259693|FG004|Overall Study|Participant Relocation|0|||
149217074|NCT03799627|538259694|FG005|Overall Study|Participant Relocation|1|||
149217075|NCT03799627|538259695|FG006|Overall Study|Participant Relocation|0|||
149217076|NCT03799627|538259696|FG007|Overall Study|Participant Relocation|0|||
149217077|NCT03799627|538259697|FG008|Overall Study|Participant Relocation|0|||
149217078|NCT03799627|538259689|FG000|Overall Study|Eurofin Issue|0|||
149217079|NCT03799627|538259690|FG001|Overall Study|Eurofin Issue|0|||
149217080|NCT03799627|538259691|FG002|Overall Study|Eurofin Issue|0|||
149217081|NCT03799627|538259692|FG003|Overall Study|Eurofin Issue|0|||
149217082|NCT03799627|538259693|FG004|Overall Study|Eurofin Issue|1|||
149217083|NCT03799627|538259694|FG005|Overall Study|Eurofin Issue|0|||
149217084|NCT03799627|538259695|FG006|Overall Study|Eurofin Issue|0|||
149217085|NCT03799627|538259696|FG007|Overall Study|Eurofin Issue|0|||
149217086|NCT03799627|538259697|FG008|Overall Study|Eurofin Issue|0|||
149217087|NCT03799627|538259689|FG000|Overall Study|Noncompliance with Site Instructions|0|||
149217088|NCT03799627|538259690|FG001|Overall Study|Noncompliance with Site Instructions|0|||
149217089|NCT03799627|538259691|FG002|Overall Study|Noncompliance with Site Instructions|0|||
149217090|NCT03799627|538259692|FG003|Overall Study|Noncompliance with Site Instructions|0|||
149217091|NCT03799627|538259693|FG004|Overall Study|Noncompliance with Site Instructions|1|||
149217092|NCT03799627|538259694|FG005|Overall Study|Noncompliance with Site Instructions|0|||
149217093|NCT03799627|538259695|FG006|Overall Study|Noncompliance with Site Instructions|0|||
149217094|NCT03799627|538259696|FG007|Overall Study|Noncompliance with Site Instructions|0|||
149217095|NCT03799627|538259697|FG008|Overall Study|Noncompliance with Site Instructions|0|||
149217096|NCT03799627|538259689|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217097|NCT03799627|538259690|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217098|NCT03799627|538259691|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217099|NCT03799627|538259692|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217100|NCT03799627|538259693|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
149217101|NCT03799627|538259694|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217102|NCT03799627|538259695|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217103|NCT03799627|538259696|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217104|NCT03799627|538259697|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
149217105|NCT03799627|538259689|FG000|Overall Study|Changes In Hemoglobin Values|1|||
149217106|NCT03799627|538259690|FG001|Overall Study|Changes In Hemoglobin Values|2|||
149217107|NCT03799627|538259691|FG002|Overall Study|Changes In Hemoglobin Values|1|||
149217108|NCT03799627|538259692|FG003|Overall Study|Changes In Hemoglobin Values|0|||
149217109|NCT03799627|538259693|FG004|Overall Study|Changes In Hemoglobin Values|0|||
149217110|NCT03799627|538259694|FG005|Overall Study|Changes In Hemoglobin Values|2|||
148952311|NCT02254486|537307344|FG001|Overall Study|Lost to Follow-up|4|||
149217111|NCT03799627|538259695|FG006|Overall Study|Changes In Hemoglobin Values|1|||
149217112|NCT03799627|538259696|FG007|Overall Study|Changes In Hemoglobin Values|0|||
148952312|NCT02254486|537307343|FG000|Overall Study|Protocol Violation|1|||
148952313|NCT02254486|537307344|FG001|Overall Study|Protocol Violation|2|||
148952314|NCT02254486|537307343|FG000|Overall Study|Withdrawal by Subject|17|||
149217113|NCT03799627|538259697|FG008|Overall Study|Changes In Hemoglobin Values|1|||
149217114|NCT03039569|538259705|FG000|Overall Study|Lost to Follow-up|5|||
149217115|NCT03039569|538259706|FG001|Overall Study|Lost to Follow-up|4|||
149217116|NCT01673373|538261173|FG000|Overall Study|Death|2|||
148952315|NCT02254486|537307344|FG001|Overall Study|Withdrawal by Subject|15|||
149217117|NCT00589602|538261178|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
149217118|NCT01804842|538261179|FG000|Overall Study|Adverse Event|1|||
149217119|NCT01804842|538261180|FG001|Overall Study|Adverse Event|1|||
149217120|NCT01804842|538261181|FG002|Overall Study|Adverse Event|0|||
149217121|NCT01804842|538261179|FG000|Overall Study|Lost to Follow-up|1|||
149217122|NCT01804842|538261180|FG001|Overall Study|Lost to Follow-up|0|||
149217123|NCT01804842|538261181|FG002|Overall Study|Lost to Follow-up|0|||
149217124|NCT01804842|538261179|FG000|Overall Study|Non-Compliance|1|||
149217125|NCT01804842|538261180|FG001|Overall Study|Non-Compliance|1|||
149217126|NCT01804842|538261181|FG002|Overall Study|Non-Compliance|0|||
149217127|NCT01804842|538261179|FG000|Overall Study|Personal Reason|0|||
149217128|NCT01804842|538261180|FG001|Overall Study|Personal Reason|0|||
149217129|NCT01804842|538261181|FG002|Overall Study|Personal Reason|1|||
149217130|NCT00413777|538261182|FG000|Fixed-dose Period|Lost to Follow-up|1|||
149217131|NCT00413777|538261183|FG001|Fixed-dose Period|Lost to Follow-up|1|||
149217132|NCT00413777|538261182|FG000|Fixed-dose Period|Adverse Event|2|||
149217133|NCT00413777|538261183|FG001|Fixed-dose Period|Adverse Event|1|||
149217134|NCT00413777|538261182|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
149217135|NCT00413777|538261183|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
149217136|NCT00413777|538261182|FG000|Fixed-dose Period|Withdrew Consent|0|||
149217137|NCT00413777|538261183|FG001|Fixed-dose Period|Withdrew Consent|1|||
149217138|NCT03287830|538261184|FG000|Overall Study|Withdrawal by Subject|1|||
149217139|NCT03287830|538261185|FG001|Overall Study|Withdrawal by Subject|1|||
149217140|NCT03287830|538261184|FG000|Overall Study|not meeting inclusion criteria|5|||
149217141|NCT03287830|538261185|FG001|Overall Study|not meeting inclusion criteria|12|||
149217142|NCT02155712|538261188|FG000|Overall Study|Death|12|||
149217143|NCT02155712|538261189|FG001|Overall Study|Death|0|||
149217144|NCT02155712|538261188|FG000|Overall Study|Lost to Follow-up|37|||
149217145|NCT02155712|538261189|FG001|Overall Study|Lost to Follow-up|22|||
149217146|NCT02155712|538261188|FG000|Overall Study|Revision of device|4|||
149217147|NCT02155712|538261189|FG001|Overall Study|Revision of device|3|||
149217148|NCT02155712|538261188|FG000|Overall Study|Withdrawal by Subject|39|||
149217149|NCT02155712|538261189|FG001|Overall Study|Withdrawal by Subject|21|||
149217150|NCT02155712|538261188|FG000|Overall Study|Site termination|77|||
149217151|NCT02155712|538261189|FG001|Overall Study|Site termination|19|||
149217152|NCT02155712|538261188|FG000|Overall Study|Sponsor terminated study early|150|||
149217153|NCT02155712|538261189|FG001|Overall Study|Sponsor terminated study early|0|||
149217154|NCT02155712|538261188|FG000|Overall Study|Missed final 5-year protocol visit|0|||
149217155|NCT02155712|538261189|FG001|Overall Study|Missed final 5-year protocol visit|32|||
149217156|NCT02155712|538261188|FG000|Overall Study|Censored because surgery cancelled|6|||
149217157|NCT02155712|538261189|FG001|Overall Study|Censored because surgery cancelled|10|||
149217158|NCT02155712|538261188|FG000|Overall Study|Censored because study device was not implanted|61|||
149217159|NCT02155712|538261189|FG001|Overall Study|Censored because study device was not implanted|66|||
149217160|NCT02155712|538261188|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
149217161|NCT02155712|538261189|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
149217162|NCT05180721|538261190|FG000|Overall Study|Lost to Follow-up|4|||
149217163|NCT04288089|538261191|FG000|Overall Study|Ongoing Treatment|2|||
149217164|NCT04288089|538261192|FG001|Overall Study|Ongoing Treatment|1|||
149217165|NCT04288089|538261193|FG002|Overall Study|Ongoing Treatment|1|||
149217166|NCT04288089|538261194|FG003|Overall Study|Ongoing Treatment|4|||
149217167|NCT00976963|538261195|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
149217168|NCT00976963|538261196|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
149217169|NCT00976963|538261195|FG000|Overall Study|administrative error|1|||
149217170|NCT00976963|538261196|FG001|Overall Study|administrative error|0|||
149217171|NCT00976963|538261195|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
149217172|NCT00976963|538261196|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
149217173|NCT00557323|538261214|FG000|Overall Study|Death|3|||
149217174|NCT00557323|538261214|FG000|Overall Study|Withdrawal by Subject|2|||
149217175|NCT00557323|538261214|FG000|Overall Study|Administrative change|2|||
149217176|NCT03039790|538261215|FG000|Overall Study|Lost to Follow-up|2|||
149217177|NCT03039790|538261216|FG001|Overall Study|Lost to Follow-up|0|||
149217178|NCT03039790|538261217|FG002|Overall Study|Lost to Follow-up|1|||
149217179|NCT03039790|538261218|FG003|Overall Study|Lost to Follow-up|1|||
149217180|NCT03039790|538261219|FG004|Overall Study|Lost to Follow-up|0|||
149217181|NCT03039790|538261220|FG005|Overall Study|Lost to Follow-up|1|||
149217182|NCT03039790|538261221|FG006|Overall Study|Lost to Follow-up|1|||
149217183|NCT03039790|538261222|FG007|Overall Study|Lost to Follow-up|1|||
149017383|NCT02555371|537544830|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
149217184|NCT03039790|538261223|FG008|Overall Study|Lost to Follow-up|0|||
149217185|NCT03039790|538261224|FG009|Overall Study|Lost to Follow-up|1|||
149217186|NCT03039790|538261225|FG010|Overall Study|Lost to Follow-up|1|||
149217187|NCT03039790|538261226|FG011|Overall Study|Lost to Follow-up|0|||
149217188|NCT03039790|538261227|FG012|Overall Study|Lost to Follow-up|1|||
149217189|NCT03039790|538261228|FG013|Overall Study|Lost to Follow-up|0|||
149217190|NCT03039790|538261229|FG014|Overall Study|Lost to Follow-up|3|||
149217191|NCT03039790|538261230|FG015|Overall Study|Lost to Follow-up|1|||
149217192|NCT03039790|538261231|FG016|Overall Study|Lost to Follow-up|2|||
149217193|NCT03039790|538261232|FG017|Overall Study|Lost to Follow-up|2|||
149217194|NCT03039790|538261233|FG018|Overall Study|Lost to Follow-up|1|||
149217195|NCT03039790|538261234|FG019|Overall Study|Lost to Follow-up|3|||
149217196|NCT03039790|538261215|FG000|Overall Study|Withdrawal of Consent|1|||
149217197|NCT03039790|538261216|FG001|Overall Study|Withdrawal of Consent|0|||
149217198|NCT03039790|538261217|FG002|Overall Study|Withdrawal of Consent|0|||
149217199|NCT03039790|538261218|FG003|Overall Study|Withdrawal of Consent|1|||
149217200|NCT03039790|538261219|FG004|Overall Study|Withdrawal of Consent|0|||
149217201|NCT03039790|538261220|FG005|Overall Study|Withdrawal of Consent|0|||
149217202|NCT03039790|538261221|FG006|Overall Study|Withdrawal of Consent|0|||
149217203|NCT03039790|538261222|FG007|Overall Study|Withdrawal of Consent|0|||
149217204|NCT03039790|538261223|FG008|Overall Study|Withdrawal of Consent|0|||
149217205|NCT03039790|538261224|FG009|Overall Study|Withdrawal of Consent|1|||
149217206|NCT03039790|538261225|FG010|Overall Study|Withdrawal of Consent|0|||
149217207|NCT03039790|538261226|FG011|Overall Study|Withdrawal of Consent|0|||
149217208|NCT03039790|538261227|FG012|Overall Study|Withdrawal of Consent|2|||
149217209|NCT03039790|538261228|FG013|Overall Study|Withdrawal of Consent|0|||
149217210|NCT03039790|538261229|FG014|Overall Study|Withdrawal of Consent|1|||
149217211|NCT03039790|538261230|FG015|Overall Study|Withdrawal of Consent|5|||
149217212|NCT03039790|538261231|FG016|Overall Study|Withdrawal of Consent|3|||
149217213|NCT03039790|538261232|FG017|Overall Study|Withdrawal of Consent|0|||
149217214|NCT03039790|538261233|FG018|Overall Study|Withdrawal of Consent|2|||
149217215|NCT03039790|538261234|FG019|Overall Study|Withdrawal of Consent|5|||
149217216|NCT03039790|538261215|FG000|Overall Study|Death|0|||
149217217|NCT03039790|538261216|FG001|Overall Study|Death|0|||
149217218|NCT03039790|538261217|FG002|Overall Study|Death|0|||
149217219|NCT03039790|538261218|FG003|Overall Study|Death|0|||
149217220|NCT03039790|538261219|FG004|Overall Study|Death|0|||
149217221|NCT03039790|538261220|FG005|Overall Study|Death|0|||
149217222|NCT03039790|538261221|FG006|Overall Study|Death|0|||
149217223|NCT03039790|538261222|FG007|Overall Study|Death|0|||
149217224|NCT03039790|538261223|FG008|Overall Study|Death|0|||
149217225|NCT03039790|538261224|FG009|Overall Study|Death|0|||
149217226|NCT03039790|538261225|FG010|Overall Study|Death|0|||
149217227|NCT03039790|538261226|FG011|Overall Study|Death|0|||
149217228|NCT03039790|538261227|FG012|Overall Study|Death|0|||
149217229|NCT03039790|538261228|FG013|Overall Study|Death|0|||
149217230|NCT03039790|538261229|FG014|Overall Study|Death|0|||
149217231|NCT03039790|538261230|FG015|Overall Study|Death|1|||
149217232|NCT03039790|538261231|FG016|Overall Study|Death|3|||
149217233|NCT03039790|538261232|FG017|Overall Study|Death|0|||
149217234|NCT03039790|538261233|FG018|Overall Study|Death|2|||
149217235|NCT03039790|538261234|FG019|Overall Study|Death|0|||
149217236|NCT03039790|538261215|FG000|Overall Study|Reason, not Specified|1|||
149217237|NCT03039790|538261216|FG001|Overall Study|Reason, not Specified|0|||
149217238|NCT03039790|538261217|FG002|Overall Study|Reason, not Specified|0|||
149217239|NCT03039790|538261218|FG003|Overall Study|Reason, not Specified|0|||
149217240|NCT03039790|538261219|FG004|Overall Study|Reason, not Specified|0|||
149217241|NCT03039790|538261220|FG005|Overall Study|Reason, not Specified|0|||
149217242|NCT03039790|538261221|FG006|Overall Study|Reason, not Specified|0|||
149217243|NCT03039790|538261222|FG007|Overall Study|Reason, not Specified|0|||
149217244|NCT03039790|538261223|FG008|Overall Study|Reason, not Specified|0|||
149217245|NCT03039790|538261224|FG009|Overall Study|Reason, not Specified|0|||
149217246|NCT03039790|538261225|FG010|Overall Study|Reason, not Specified|0|||
149217247|NCT03039790|538261226|FG011|Overall Study|Reason, not Specified|0|||
149217248|NCT03039790|538261227|FG012|Overall Study|Reason, not Specified|0|||
149217249|NCT03039790|538261228|FG013|Overall Study|Reason, not Specified|0|||
149017384|NCT02555371|537544831|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
149017385|NCT02555371|537544832|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
149017386|NCT02555371|537544828|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
149017387|NCT02555371|537544829|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
148684911|NCT01567306|536319565|FG004|Overall Study|Lost to Follow-up|2|||
148684912|NCT01567306|536319566|FG005|Overall Study|Lost to Follow-up|0|||
148684913|NCT01567306|536319561|FG000|Overall Study|Withdrawal by Subject|0|||
148684914|NCT01567306|536319562|FG001|Overall Study|Withdrawal by Subject|0|||
149217250|NCT03039790|538261229|FG014|Overall Study|Reason, not Specified|0|||
149217251|NCT03039790|538261230|FG015|Overall Study|Reason, not Specified|0|||
149217252|NCT03039790|538261231|FG016|Overall Study|Reason, not Specified|2|||
149217253|NCT03039790|538261232|FG017|Overall Study|Reason, not Specified|0|||
149217254|NCT03039790|538261233|FG018|Overall Study|Reason, not Specified|1|||
148684915|NCT01567306|536319563|FG002|Overall Study|Withdrawal by Subject|0|||
149217255|NCT03039790|538261234|FG019|Overall Study|Reason, not Specified|0|||
149217256|NCT01855425|538261245|FG000|Overall Study|Physician Decision|20|||
149217257|NCT01025232|538261246|FG000|Overall Study|Study drug no longer available|3|||
149217258|NCT01025232|538261247|FG001|Overall Study|Study drug no longer available|6|||
149217259|NCT01600105|538261248|FG000|Total Participants|Withdrawal by Subject|1|||
149017388|NCT02555371|537544830|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
149017389|NCT02555371|537544831|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
149017390|NCT02555371|537544832|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
149017391|NCT02555371|537544828|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
149017392|NCT02555371|537544829|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
149017393|NCT02555371|537544830|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
149017394|NCT02555371|537544831|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
149017395|NCT02555371|537544832|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
149017396|NCT02555371|537544828|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
149017397|NCT02555371|537544829|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
149017398|NCT02555371|537544830|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
149017399|NCT02555371|537544831|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
149017400|NCT02555371|537544832|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
149017401|NCT02555371|537544828|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
149017402|NCT02555371|537544829|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
149017403|NCT02555371|537544830|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
149017404|NCT02555371|537544831|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
149017405|NCT02555371|537544832|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
149217260|NCT01600105|538261249|FG001|Total Participants|Withdrawal by Subject|0|||
149217261|NCT01600105|538261248|FG000|Total Participants|No images in PACS|10|||
149217262|NCT01600105|538261249|FG001|Total Participants|No images in PACS|0|||
149217263|NCT01600105|538261248|FG000|Total Participants|Insufficient image quality|30|||
149217264|NCT01600105|538261249|FG001|Total Participants|Insufficient image quality|10|||
149217265|NCT01600105|538261248|FG000|Sub Study I|Insufficient image quality|0|||
149217266|NCT01600105|538261249|FG001|Sub Study I|Insufficient image quality|10|||
149217267|NCT01600105|538261248|FG000|Sub Study II|Withdrawal by Subject|1|||
149217268|NCT01600105|538261249|FG001|Sub Study II|Withdrawal by Subject|0|||
149217269|NCT01600105|538261248|FG000|Sub Study II|No images in PACS|1|||
149217270|NCT01600105|538261249|FG001|Sub Study II|No images in PACS|0|||
149217271|NCT01600105|538261248|FG000|Sub Study II|Insufficient image quality|3|||
149217272|NCT01600105|538261249|FG001|Sub Study II|Insufficient image quality|0|||
149217273|NCT01600105|538261248|FG000|Sub Study III|Insufficient image quality|5|||
149217274|NCT01600105|538261249|FG001|Sub Study III|Insufficient image quality|0|||
149217275|NCT01600105|538261248|FG000|Sub Study V|Poor Image Quality|2|||
149217276|NCT01600105|538261249|FG001|Sub Study V|Poor Image Quality|0|||
149217277|NCT01196091|538261250|FG000|Overall Study|Adverse Event|22|||
149217278|NCT01196091|538261251|FG001|Overall Study|Adverse Event|27|||
149217279|NCT01196091|538261252|FG002|Overall Study|Adverse Event|26|||
149217280|NCT01196091|538261250|FG000|Overall Study|Death|3|||
149217281|NCT01196091|538261251|FG001|Overall Study|Death|2|||
149217282|NCT01196091|538261252|FG002|Overall Study|Death|2|||
149217283|NCT01196091|538261250|FG000|Overall Study|Entry Criteria Not Met|11|||
149217284|NCT01196091|538261251|FG001|Overall Study|Entry Criteria Not Met|11|||
149217285|NCT01196091|538261252|FG002|Overall Study|Entry Criteria Not Met|10|||
149217286|NCT01196091|538261250|FG000|Overall Study|Lack of Efficacy|15|||
149217287|NCT01196091|538261251|FG001|Overall Study|Lack of Efficacy|12|||
149217288|NCT01196091|538261252|FG002|Overall Study|Lack of Efficacy|17|||
149217289|NCT01196091|538261250|FG000|Overall Study|Lost to Follow-up|5|||
149217290|NCT01196091|538261251|FG001|Overall Study|Lost to Follow-up|5|||
149217291|NCT01196091|538261252|FG002|Overall Study|Lost to Follow-up|6|||
149217292|NCT01196091|538261250|FG000|Overall Study|Parent/Caregiver Decision|0|||
149217293|NCT01196091|538261251|FG001|Overall Study|Parent/Caregiver Decision|0|||
149217294|NCT01196091|538261252|FG002|Overall Study|Parent/Caregiver Decision|1|||
149217295|NCT01196091|538261250|FG000|Overall Study|Withdrawal by Subject|16|||
149217296|NCT01196091|538261251|FG001|Overall Study|Withdrawal by Subject|19|||
149217297|NCT01196091|538261252|FG002|Overall Study|Withdrawal by Subject|22|||
149217298|NCT01196091|538261250|FG000|Overall Study|Physician Decision|3|||
149017406|NCT02555371|537544828|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
149217299|NCT01196091|538261251|FG001|Overall Study|Physician Decision|3|||
149217300|NCT01196091|538261252|FG002|Overall Study|Physician Decision|4|||
149217301|NCT01196091|538261250|FG000|Overall Study|Protocol Violation|1|||
149217302|NCT01196091|538261251|FG001|Overall Study|Protocol Violation|3|||
149217303|NCT01196091|538261252|FG002|Overall Study|Protocol Violation|3|||
149217304|NCT01196091|538261250|FG000|Overall Study|Sponsor Decision|6|||
149217305|NCT01196091|538261251|FG001|Overall Study|Sponsor Decision|5|||
149217306|NCT01196091|538261252|FG002|Overall Study|Sponsor Decision|4|||
149217307|NCT01196091|538261250|FG000|Overall Study|Excluded Site|5|||
149217308|NCT01196091|538261251|FG001|Overall Study|Excluded Site|11|||
149217309|NCT01196091|538261252|FG002|Overall Study|Excluded Site|8|||
149217310|NCT01196091|538261250|FG000|Overall Study|Randomized, No Study Drug Received|1|||
149217311|NCT01196091|538261251|FG001|Overall Study|Randomized, No Study Drug Received|0|||
149217312|NCT01196091|538261252|FG002|Overall Study|Randomized, No Study Drug Received|1|||
149217313|NCT04247828|538261259|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
149217314|NCT02324049|538261263|FG000|Part C|Study terminated|11|||
149217315|NCT02159365|538261264|FG000|Overall Study|Disease Progression|23|||
149217316|NCT02159365|538261264|FG000|Overall Study|Other reasons|11|||
149217317|NCT02159365|538261264|FG000|Overall Study|Administrative reason by Sponsor|9|||
149217318|NCT02159365|538261264|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
149217319|NCT02159365|538261264|FG000|Overall Study|Study drug toxicity|7|||
149217320|NCT02159365|538261264|FG000|Overall Study|Maximum clinical benefit|3|||
149217321|NCT02159365|538261264|FG000|Overall Study|Subject request to discontinue treatment|3|||
149217322|NCT02159365|538261264|FG000|Overall Study|Subject withdrew consent|3|||
149217323|NCT02159365|538261264|FG000|Overall Study|Death|1|||
149217324|NCT02159365|538261264|FG000|Overall Study|Lost to Follow-up|1|||
149217325|NCT03198728|538261266|FG000|Overall Study|Adverse Event|10|||
149217326|NCT03198728|538261267|FG001|Overall Study|Adverse Event|5|||
149217327|NCT03198728|538261266|FG000|Overall Study|Lost to Follow-up|21|||
149217328|NCT03198728|538261267|FG001|Overall Study|Lost to Follow-up|7|||
149217329|NCT03198728|538261266|FG000|Overall Study|Physician Decision|7|||
149217330|NCT03198728|538261267|FG001|Overall Study|Physician Decision|2|||
149217331|NCT03198728|538261266|FG000|Overall Study|Withdrawal by Subject|14|||
149217332|NCT03198728|538261267|FG001|Overall Study|Withdrawal by Subject|10|||
149217333|NCT04051944|538261269|FG000|Overall Study|Study ending|1|||
149217334|NCT04051944|538261270|FG001|Overall Study|Study ending|1|||
149217335|NCT04051944|538261269|FG000|Overall Study|Early study termination by participant|1|||
149217336|NCT04051944|538261270|FG001|Overall Study|Early study termination by participant|0|||
149217337|NCT04051944|538261269|FG000|Overall Study|Withdrawal by Subject|2|||
149217338|NCT04051944|538261270|FG001|Overall Study|Withdrawal by Subject|2|||
149217339|NCT04051944|538261269|FG000|Overall Study|Lack of Efficacy|3|||
149217340|NCT04051944|538261270|FG001|Overall Study|Lack of Efficacy|0|||
149217341|NCT04051944|538261269|FG000|Overall Study|Adverse event, non- fatal|1|||
149217342|NCT04051944|538261270|FG001|Overall Study|Adverse event, non- fatal|1|||
149217343|NCT03083470|538261271|FG000|Overall Study|Lost to Follow-up|0|||
149217344|NCT03083470|538261272|FG001|Overall Study|Lost to Follow-up|0|||
149217345|NCT03083470|538261273|FG002|Overall Study|Lost to Follow-up|0|||
149217346|NCT03083470|538261274|FG003|Overall Study|Lost to Follow-up|0|||
149217347|NCT03083470|538261275|FG004|Overall Study|Lost to Follow-up|1|||
149217348|NCT03083470|538261271|FG000|Overall Study|Withdrawal by Subject|0|||
149217349|NCT03083470|538261272|FG001|Overall Study|Withdrawal by Subject|0|||
149217350|NCT03083470|538261273|FG002|Overall Study|Withdrawal by Subject|0|||
149217351|NCT03083470|538261274|FG003|Overall Study|Withdrawal by Subject|0|||
149217352|NCT03083470|538261275|FG004|Overall Study|Withdrawal by Subject|1|||
149217353|NCT00736450|538261276|FG000|Overall Study|Not ABC gene eligible|19|||
149217354|NCT00736450|538261276|FG000|Overall Study|Withdrawal by Subject|5|||
149217355|NCT00736450|538261276|FG000|Overall Study|Physician Decision|1|||
149217356|NCT01302691|538261279|FG000|Overall Study|Adverse Event|2|||
149217357|NCT01302691|538261280|FG001|Overall Study|Adverse Event|0|||
149217358|NCT01302691|538261279|FG000|Overall Study|Death|0|||
149217359|NCT01302691|538261280|FG001|Overall Study|Death|1|||
149217360|NCT01302691|538261279|FG000|Overall Study|Lost to Follow-up|1|||
149217361|NCT01302691|538261280|FG001|Overall Study|Lost to Follow-up|0|||
149217362|NCT01302691|538261279|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
149217363|NCT01302691|538261280|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
149217364|NCT01302691|538261279|FG000|Overall Study|Physician Decision|0|||
149217365|NCT01302691|538261280|FG001|Overall Study|Physician Decision|1|||
149217366|NCT01302691|538261279|FG000|Overall Study|Protocol Violation|1|||
149217367|NCT01302691|538261280|FG001|Overall Study|Protocol Violation|0|||
149217368|NCT03446612|538261281|FG000|Overall Study|Protocol defined stopping criteria|0|||
149217369|NCT03446612|538261282|FG001|Overall Study|Protocol defined stopping criteria|1|||
149217370|NCT00333970|538261284|FG000|Overall Study|Withdrawal by Subject|13|||
149217371|NCT00333970|538261285|FG001|Overall Study|Withdrawal by Subject|7|||
149217372|NCT02829775|538261287|FG000|Overall Study|Death|1|||
149217373|NCT02829775|538261287|FG000|Overall Study|Withdrawal by Subject|3|||
149217374|NCT02829775|538261287|FG000|Overall Study|Disease remission|1|||
148952316|NCT02254486|537307343|FG000|Overall Study|GFR<60mL/min|16|||
148952317|NCT02254486|537307344|FG001|Overall Study|GFR<60mL/min|21|||
148952318|NCT02254486|537307343|FG000|Overall Study|Various|12|||
148952319|NCT02254486|537307344|FG001|Overall Study|Various|12|||
149217375|NCT00899678|538261288|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
149217376|NCT00899678|538261289|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
149217377|NCT00899678|538261290|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
149217378|NCT00899678|538261288|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
149217379|NCT00899678|538261289|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
149217380|NCT00899678|538261290|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
149217381|NCT00899678|538261288|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
149217382|NCT00899678|538261289|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
149217383|NCT00899678|538261290|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
149217384|NCT00899678|538261288|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
149217385|NCT00899678|538261289|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
148809787|NCT02378181|536780871|FG000|Overall Study|Incarcerated|0|||
148809788|NCT02378181|536780872|FG001|Overall Study|Incarcerated|1|||
148809789|NCT00297167|536780874|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
148809790|NCT00297167|536780875|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
148809791|NCT00297167|536780876|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
148809792|NCT00297167|536780874|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
148809793|NCT00297167|536780875|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
148952320|NCT01350414|537307345|FG000|Overall Study|Lost to Follow-up|13|||
148952321|NCT01350414|537307345|FG000|Overall Study|Withdrawal by Subject|4|||
148952322|NCT01350414|537307345|FG000|Overall Study|Physician Decision|2|||
148952323|NCT00460408|537307346|FG000|Overall Study|Adverse Event|1|||
149217386|NCT00899678|538261290|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
149217387|NCT00899678|538261288|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
149217388|NCT00899678|538261289|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
149217389|NCT00899678|538261290|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
149217390|NCT00899678|538261288|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
149217391|NCT00899678|538261289|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
149217392|NCT00899678|538261290|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
149217393|NCT00899678|538261288|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
149217394|NCT00899678|538261289|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
149217395|NCT00899678|538261290|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
149217396|NCT00899678|538261288|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
149217397|NCT00899678|538261289|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
149217398|NCT00899678|538261290|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
149217399|NCT00899678|538261288|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
149217400|NCT00899678|538261289|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
149217401|NCT00899678|538261290|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
149217402|NCT02092324|538261299|FG000|Overall Study|Adverse Event|1|||
149217403|NCT02092324|538261299|FG000|Overall Study|Lack of Efficacy|6|||
149217404|NCT02092324|538261299|FG000|Overall Study|Proceed to Transplant|3|||
149217405|NCT02092324|538261299|FG000|Overall Study|Physician Decision|7|||
149217406|NCT02092324|538261299|FG000|Overall Study|Misdiagnosis|2|||
149217407|NCT03148795|538261304|FG000|Overall Study|Progressive Disease|1|||
149217408|NCT00398138|538261309|FG000|Overall Study|Adverse Event|2|||
149217409|NCT04973085|538261314|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
149217410|NCT04973085|538261315|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
149217411|NCT03924427|538261324|FG000|Overall Study|Adverse Event|4|||
148684916|NCT01567306|536319564|FG003|Overall Study|Withdrawal by Subject|0|||
148952324|NCT00460408|537307347|FG001|Overall Study|Adverse Event|0|||
148952325|NCT00460408|537307348|FG002|Overall Study|Adverse Event|0|||
148952326|NCT00460408|537307349|FG003|Overall Study|Adverse Event|0|||
148952327|NCT00460408|537307346|FG000|Overall Study|Death|7|||
149217412|NCT03924427|538261324|FG000|Overall Study|Lack of Efficacy|1|||
149217413|NCT03924427|538261324|FG000|Overall Study|Withdrawal by Subject|1|||
149217414|NCT01316380|538261329|FG000|Overall Study|Adverse Event|0|||
149217415|NCT01316380|538261330|FG001|Overall Study|Adverse Event|2|||
149217416|NCT01316380|538261331|FG002|Overall Study|Adverse Event|1|||
148684917|NCT01567306|536319565|FG004|Overall Study|Withdrawal by Subject|0|||
148684918|NCT01567306|536319566|FG005|Overall Study|Withdrawal by Subject|1|||
148684919|NCT00829413|536319571|FG000|Overall Study|No study drug admimnistered|13|||
148684920|NCT00829413|536319571|FG000|Overall Study|Training Patients|67|||
149217417|NCT01316380|538261329|FG000|Overall Study|Protocol Violation|0|||
148684921|NCT00829413|536319571|FG000|Overall Study|No truth standard procedure available|9|||
148684922|NCT00829413|536319571|FG000|Overall Study|Technically inadequate truth standard|2|||
148684923|NCT00829413|536319571|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
148684924|NCT04272775|536319573|FG000|Overall Study|Study Terminated by Sponsor|1|||
148809794|NCT00297167|536780876|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
148952328|NCT00460408|537307347|FG001|Overall Study|Death|0|||
149217418|NCT01316380|538261330|FG001|Overall Study|Protocol Violation|0|||
149217419|NCT01316380|538261331|FG002|Overall Study|Protocol Violation|1|||
149217420|NCT01316380|538261329|FG000|Overall Study|Withdrawal by Subject|1|||
149217421|NCT01316380|538261330|FG001|Overall Study|Withdrawal by Subject|2|||
148952329|NCT00460408|537307348|FG002|Overall Study|Death|0|||
148952330|NCT00460408|537307349|FG003|Overall Study|Death|0|||
148952331|NCT00460408|537307346|FG000|Overall Study|Lost to Follow-up|11|||
148952332|NCT00460408|537307347|FG001|Overall Study|Lost to Follow-up|0|||
148952333|NCT00460408|537307348|FG002|Overall Study|Lost to Follow-up|1|||
148952334|NCT00460408|537307349|FG003|Overall Study|Lost to Follow-up|0|||
149217422|NCT01316380|538261331|FG002|Overall Study|Withdrawal by Subject|0|||
149217423|NCT01316380|538261329|FG000|Overall Study|Other|0|||
149217424|NCT01316380|538261330|FG001|Overall Study|Other|1|||
149217425|NCT01316380|538261331|FG002|Overall Study|Other|1|||
149217426|NCT01316380|538261329|FG000|Overall Study|Not treated|1|||
149217427|NCT01316380|538261330|FG001|Overall Study|Not treated|0|||
149217428|NCT01316380|538261331|FG002|Overall Study|Not treated|0|||
149217429|NCT00149890|538261335|FG000|Overall Study|Adverse Event|1|||
149217430|NCT00149890|538261336|FG001|Overall Study|Adverse Event|8|||
149217431|NCT00149890|538261335|FG000|Overall Study|Lack of Efficacy|8|||
149217432|NCT00149890|538261336|FG001|Overall Study|Lack of Efficacy|9|||
149217433|NCT00149890|538261335|FG000|Overall Study|Protocol Violation|1|||
149217434|NCT00149890|538261336|FG001|Overall Study|Protocol Violation|0|||
149217435|NCT00149890|538261335|FG000|Overall Study|Lost to Follow-up|1|||
149217436|NCT00149890|538261336|FG001|Overall Study|Lost to Follow-up|0|||
149217437|NCT00149890|538261335|FG000|Overall Study|Graft Loss|2|||
149217438|NCT00149890|538261336|FG001|Overall Study|Graft Loss|1|||
149217439|NCT01387594|538261337|FG000|Overall Study|Withdrawal by Subject|0|||
149217440|NCT01387594|538261338|FG001|Overall Study|Withdrawal by Subject|2|||
149217441|NCT01387594|538261337|FG000|Overall Study|Lost to Follow-up|0|||
148684925|NCT04272775|536319574|FG001|Overall Study|Study Terminated by Sponsor|0|||
149217442|NCT01387594|538261338|FG001|Overall Study|Lost to Follow-up|1|||
149217443|NCT00712270|538261339|FG000|Overall Study|Withdrawal by Subject|11|||
148684926|NCT04272775|536319573|FG000|Overall Study|Protocol Violation|0|||
148684927|NCT04272775|536319574|FG001|Overall Study|Protocol Violation|1|||
148684928|NCT04272775|536319573|FG000|Overall Study|Symptomatic Deterioration|1|||
148684929|NCT04272775|536319574|FG001|Overall Study|Symptomatic Deterioration|1|||
148684930|NCT04272775|536319573|FG000|Overall Study|Withdrawal by Subject|1|||
148684931|NCT04272775|536319574|FG001|Overall Study|Withdrawal by Subject|2|||
148684932|NCT04272775|536319573|FG000|Overall Study|Adverse Event|1|||
148684933|NCT04272775|536319574|FG001|Overall Study|Adverse Event|2|||
148684934|NCT04272775|536319573|FG000|Overall Study|Progressive Disease|3|||
148684935|NCT04272775|536319574|FG001|Overall Study|Progressive Disease|1|||
148684936|NCT00738673|536319575|FG000|Overall Study|Adverse Event|1|||
148684937|NCT00738673|536319576|FG001|Overall Study|Adverse Event|0|||
148684938|NCT00738673|536319575|FG000|Overall Study|Lack of Efficacy|19|||
148684939|NCT00738673|536319576|FG001|Overall Study|Lack of Efficacy|8|||
148684940|NCT00738673|536319575|FG000|Overall Study|Protocol Violation|1|||
148684941|NCT00738673|536319576|FG001|Overall Study|Protocol Violation|2|||
148684942|NCT00738673|536319575|FG000|Overall Study|Withdrawal by Subject|3|||
148684943|NCT00738673|536319576|FG001|Overall Study|Withdrawal by Subject|1|||
148684944|NCT01967888|536319577|FG000|Overall Study|Lost to Follow-up|6|||
148684945|NCT01967888|536319578|FG001|Overall Study|Lost to Follow-up|4|||
148684946|NCT01967888|536319577|FG000|Overall Study|Withdrawal by Subject|1|||
148684947|NCT01967888|536319578|FG001|Overall Study|Withdrawal by Subject|1|||
148684948|NCT01967888|536319577|FG000|Overall Study|Did Not Have Transplant|1|||
148684949|NCT01967888|536319578|FG001|Overall Study|Did Not Have Transplant|0|||
148684950|NCT01967888|536319577|FG000|Overall Study|Research visit not done, data recorded|1|||
148684951|NCT01967888|536319578|FG001|Overall Study|Research visit not done, data recorded|0|||
148684952|NCT01967888|536319577|FG000|Overall Study|Subject excluded after randomization|1|||
148684953|NCT01967888|536319578|FG001|Overall Study|Subject excluded after randomization|0|||
148684954|NCT01967888|536319577|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
148684955|NCT01967888|536319578|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
148684956|NCT01967888|536319577|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
148684957|NCT01967888|536319578|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
148684958|NCT00891774|536319579|FG000|Overall Study|Lost to Follow-up|5|||
149217444|NCT00712270|538261339|FG000|Overall Study|Screen Failure|3|||
149217445|NCT02574520|538261340|FG000|Overall Study|Not dosed|2|||
149217446|NCT02574520|538261341|FG001|Overall Study|Not dosed|0|||
149217447|NCT02574520|538261342|FG002|Overall Study|Not dosed|5|||
149217448|NCT02574520|538261343|FG003|Overall Study|Not dosed|4|||
148684959|NCT00891774|536319579|FG000|Overall Study|Illness (Self/Mother)|3|||
148684960|NCT00891774|536319579|FG000|Overall Study|Withdrawal by Subject|2|||
148684961|NCT00891774|536319579|FG000|Overall Study|Protocol Violation|4|||
148684962|NCT03175120|536319581|FG000|Overall Study|Adverse Event|2|||
148684963|NCT03175120|536319582|FG001|Overall Study|Adverse Event|2|||
148809795|NCT01898130|536780877|FG000|Treatment|Withdrawal by Subject|2|||
148809796|NCT01898130|536780877|FG000|Treatment|Progressive Disease|4|||
148684964|NCT03175120|536319581|FG000|Overall Study|Protocol Violation|5|||
149217449|NCT02574520|538261340|FG000|Overall Study|Adverse Event|0|||
149217450|NCT02574520|538261341|FG001|Overall Study|Adverse Event|0|||
148684965|NCT03175120|536319582|FG001|Overall Study|Protocol Violation|2|||
148684966|NCT03175120|536319581|FG000|Overall Study|Lost to Follow-up|1|||
148809797|NCT01898130|536780877|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
149217451|NCT02574520|538261342|FG002|Overall Study|Adverse Event|0|||
149217452|NCT02574520|538261343|FG003|Overall Study|Adverse Event|1|||
149217453|NCT02574520|538261340|FG000|Overall Study|Withdrawal by Subject|0|||
149217454|NCT02574520|538261341|FG001|Overall Study|Withdrawal by Subject|0|||
148809798|NCT00920816|536780878|FG000|Overall Study|Death|116|||
148809799|NCT00920816|536780879|FG001|Overall Study|Death|63|||
148809800|NCT00920816|536780880|FG002|Overall Study|Death|8|||
148809801|NCT00920816|536780881|FG003|Overall Study|Death|3|||
148809802|NCT00920816|536780878|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
148809803|NCT00920816|536780879|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
148809804|NCT00920816|536780880|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
148809805|NCT00920816|536780881|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
148809806|NCT00920816|536780878|FG000|Overall Study|Global deterioration of health status|2|||
148809807|NCT00920816|536780879|FG001|Overall Study|Global deterioration of health status|0|||
149017407|NCT02555371|537544829|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
149217455|NCT02574520|538261342|FG002|Overall Study|Withdrawal by Subject|0|||
148809808|NCT00920816|536780880|FG002|Overall Study|Global deterioration of health status|0|||
148809809|NCT00920816|536780881|FG003|Overall Study|Global deterioration of health status|0|||
148809810|NCT00920816|536780878|FG000|Overall Study|Objective progression or relapse|6|||
148809811|NCT00920816|536780879|FG001|Overall Study|Objective progression or relapse|2|||
148809812|NCT00920816|536780880|FG002|Overall Study|Objective progression or relapse|0|||
148809813|NCT00920816|536780881|FG003|Overall Study|Objective progression or relapse|0|||
149017408|NCT02555371|537544830|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
149017409|NCT02555371|537544831|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
149017410|NCT02555371|537544832|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
149217456|NCT02574520|538261343|FG003|Overall Study|Withdrawal by Subject|1|||
149217457|NCT02574520|538261340|FG000|Overall Study|Other|0|||
149217458|NCT02574520|538261341|FG001|Overall Study|Other|0|||
149217459|NCT02574520|538261342|FG002|Overall Study|Other|0|||
149217460|NCT02574520|538261343|FG003|Overall Study|Other|2|||
149217461|NCT01365091|538261352|FG000|Period 1|Adverse Event|1|||
149217462|NCT01365091|538261353|FG001|Period 1|Adverse Event|0|||
149217463|NCT01365091|538261354|FG002|Period 1|Adverse Event|2|||
149217464|NCT01365091|538261355|FG003|Period 1|Adverse Event|3|||
149217465|NCT01365091|538261352|FG000|Period 1|Positive test result for drugs of abuse|1|||
149217466|NCT01365091|538261353|FG001|Period 1|Positive test result for drugs of abuse|0|||
149217467|NCT01365091|538261354|FG002|Period 1|Positive test result for drugs of abuse|0|||
149217468|NCT01365091|538261355|FG003|Period 1|Positive test result for drugs of abuse|0|||
149217469|NCT01365091|538261352|FG000|Period 1|No longer met study criteria|0|||
149217470|NCT01365091|538261353|FG001|Period 1|No longer met study criteria|1|||
149217471|NCT01365091|538261354|FG002|Period 1|No longer met study criteria|0|||
149217472|NCT01365091|538261355|FG003|Period 1|No longer met study criteria|0|||
149217473|NCT01365091|538261352|FG000|Period 1|Withdrawal by Subject|0|||
149217474|NCT01365091|538261353|FG001|Period 1|Withdrawal by Subject|1|||
149217475|NCT01365091|538261354|FG002|Period 1|Withdrawal by Subject|0|||
149217476|NCT01365091|538261355|FG003|Period 1|Withdrawal by Subject|0|||
149217477|NCT01365091|538261352|FG000|Period 1|Personal reasons|0|||
149217478|NCT01365091|538261353|FG001|Period 1|Personal reasons|0|||
149217479|NCT01365091|538261354|FG002|Period 1|Personal reasons|1|||
149217480|NCT01365091|538261355|FG003|Period 1|Personal reasons|0|||
149217481|NCT01365091|538261352|FG000|Period 2|Withdrawal by Subject|1|||
149217482|NCT01365091|538261353|FG001|Period 2|Withdrawal by Subject|0|||
149217483|NCT01365091|538261354|FG002|Period 2|Withdrawal by Subject|0|||
149217484|NCT01365091|538261355|FG003|Period 2|Withdrawal by Subject|0|||
149217485|NCT01365091|538261352|FG000|Period 2|Adverse Event|0|||
149217486|NCT01365091|538261353|FG001|Period 2|Adverse Event|0|||
149217487|NCT01365091|538261354|FG002|Period 2|Adverse Event|1|||
149217488|NCT01365091|538261355|FG003|Period 2|Adverse Event|0|||
149217489|NCT05116683|538261356|FG000|Overall Study|Physician Decision|4|||
149217490|NCT01435122|538261357|FG000|Overall Study|Early withdrawal due to toxicity|8|||
149217491|NCT03671148|538262841|FG000|Overall Study|Adverse Event|3|||
149217492|NCT03671148|538262842|FG001|Overall Study|Adverse Event|2|||
149217493|NCT03671148|538262841|FG000|Overall Study|Withdrawal by Subject|8|||
149217494|NCT03671148|538262842|FG001|Overall Study|Withdrawal by Subject|2|||
149217495|NCT03671148|538262841|FG000|Overall Study|Lost to Follow-up|1|||
148684967|NCT03175120|536319582|FG001|Overall Study|Lost to Follow-up|0|||
148684968|NCT03175120|536319581|FG000|Overall Study|Withdrawal by Subject|2|||
149017411|NCT02555371|537544828|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
149017412|NCT02555371|537544829|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
149017413|NCT02555371|537544830|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
149217496|NCT03671148|538262842|FG001|Overall Study|Lost to Follow-up|2|||
149217497|NCT03671148|538262841|FG000|Overall Study|Lack of Efficacy|7|||
149217498|NCT03671148|538262842|FG001|Overall Study|Lack of Efficacy|2|||
149217499|NCT03671148|538262841|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
149217500|NCT03671148|538262842|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
149217501|NCT03671148|538262841|FG000|Overall Study|Other|1|||
149217502|NCT03671148|538262842|FG001|Overall Study|Other|0|||
149217503|NCT03671148|538262841|FG000|Overall Study|Incomplete Randomization Visit|1|||
149217504|NCT03671148|538262842|FG001|Overall Study|Incomplete Randomization Visit|0|||
148809814|NCT00920816|536780878|FG000|Overall Study|Other|26|||
148809815|NCT00920816|536780879|FG001|Overall Study|Other|15|||
148809816|NCT00920816|536780880|FG002|Overall Study|Other|1|||
148809817|NCT00920816|536780881|FG003|Overall Study|Other|2|||
148809818|NCT00920816|536780878|FG000|Overall Study|Lost to Follow-up|11|||
148809819|NCT00920816|536780879|FG001|Overall Study|Lost to Follow-up|2|||
148809820|NCT00920816|536780880|FG002|Overall Study|Lost to Follow-up|0|||
148809821|NCT00920816|536780881|FG003|Overall Study|Lost to Follow-up|0|||
148809822|NCT00920816|536780878|FG000|Overall Study|Adverse Event|1|||
148809823|NCT00920816|536780879|FG001|Overall Study|Adverse Event|1|||
148809824|NCT00920816|536780880|FG002|Overall Study|Adverse Event|1|||
148809825|NCT00920816|536780881|FG003|Overall Study|Adverse Event|0|||
148809826|NCT00920816|536780878|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
148809827|NCT00920816|536780879|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
148809828|NCT00920816|536780880|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
148809829|NCT00920816|536780881|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
148809830|NCT00920816|536780878|FG000|Overall Study|Randomized but not treated|3|||
148809831|NCT00920816|536780879|FG001|Overall Study|Randomized but not treated|0|||
148809832|NCT00920816|536780880|FG002|Overall Study|Randomized but not treated|0|||
148809833|NCT00920816|536780881|FG003|Overall Study|Randomized but not treated|0|||
148809834|NCT01180777|536780882|FG000|Overall Study|Protocol Violation|6|||
148809835|NCT01180777|536780882|FG000|Overall Study|Poor lens fit|4|||
148809836|NCT01180777|536780882|FG000|Overall Study|Lost to Follow-up|1|||
148809837|NCT01180777|536780882|FG000|Overall Study|Adverse Event|1|||
148809838|NCT04491994|536780883|FG000|Overall Study|Withdrawal by Subject|10|||
148809839|NCT04491994|536780884|FG001|Overall Study|Withdrawal by Subject|5|||
148809840|NCT04491994|536780883|FG000|Overall Study|developed fever > 3 days|4|||
149217505|NCT03878160|538262846|FG000|Overall Study|Lost to Follow-up|1|||
149217506|NCT03878160|538262847|FG001|Overall Study|Lost to Follow-up|1|||
149217507|NCT03878160|538262848|FG002|Overall Study|Lost to Follow-up|1|||
149217508|NCT03878160|538262846|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
149217509|NCT03878160|538262847|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
149217510|NCT03878160|538262848|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
149217511|NCT03887052|538262852|FG000|Overall Study|Adverse Event|2|||
149217512|NCT03887052|538262852|FG000|Overall Study|Physician Decision|2|||
149217513|NCT03887052|538262852|FG000|Overall Study|Withdrawal by Subject|3|||
149217514|NCT03887052|538262852|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
149217515|NCT03887052|538262852|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
149217516|NCT02365506|538262853|FG000|Overall Study|Investigator's Discretion|0|||
149217517|NCT02365506|538262854|FG001|Overall Study|Investigator's Discretion|0|||
149217518|NCT02365506|538262855|FG002|Overall Study|Investigator's Discretion|1|||
149217519|NCT05505734|538262856|FG000|Overall Study|Withdrawal by Subject|51|||
149217520|NCT05505734|538262857|FG001|Overall Study|Withdrawal by Subject|64|||
149217521|NCT05505734|538262856|FG000|Overall Study|Adverse Event|6|||
149217522|NCT05505734|538262857|FG001|Overall Study|Adverse Event|20|||
149217523|NCT05505734|538262856|FG000|Overall Study|Protocol Violation|8|||
149217524|NCT05505734|538262857|FG001|Overall Study|Protocol Violation|15|||
149217525|NCT05505734|538262856|FG000|Overall Study|Lack of therapeutic response|0|||
149217526|NCT05505734|538262857|FG001|Overall Study|Lack of therapeutic response|1|||
149217527|NCT05505734|538262856|FG000|Overall Study|Lost to Follow-up|247|||
149217528|NCT05505734|538262857|FG001|Overall Study|Lost to Follow-up|237|||
149217529|NCT05505734|538262856|FG000|Overall Study|Physician Decision|22|||
149217530|NCT05505734|538262857|FG001|Overall Study|Physician Decision|13|||
149217531|NCT05505734|538262856|FG000|Overall Study|Death|2|||
149217532|NCT05505734|538262857|FG001|Overall Study|Death|1|||
149217533|NCT05505734|538262856|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149217534|NCT05505734|538262857|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149217535|NCT05505734|538262856|FG000|Overall Study|Pregnancy|1|||
149217536|NCT05505734|538262857|FG001|Overall Study|Pregnancy|0|||
149217537|NCT05505734|538262856|FG000|Overall Study|Other|17|||
149217538|NCT05505734|538262857|FG001|Overall Study|Other|13|||
149217539|NCT03575351|538262858|FG000|Overall Study|Adverse Event|1|||
148809841|NCT04491994|536780884|FG001|Overall Study|developed fever > 3 days|1|||
148809842|NCT04491994|536780883|FG000|Overall Study|Protocol Violation|11|||
148809843|NCT04491994|536780884|FG001|Overall Study|Protocol Violation|2|||
148809844|NCT04491994|536780883|FG000|Overall Study|Lost to Follow-up|4|||
148809845|NCT04491994|536780884|FG001|Overall Study|Lost to Follow-up|3|||
149217540|NCT03575351|538262859|FG001|Overall Study|Adverse Event|0|||
149217541|NCT03575351|538262858|FG000|Overall Study|Death|2|||
149217542|NCT03575351|538262859|FG001|Overall Study|Death|2|||
148809846|NCT03331562|536780885|FG000|Overall Study|Adverse Event|2|||
148809847|NCT03331562|536780886|FG001|Overall Study|Adverse Event|0|||
149217543|NCT03575351|538262858|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
148809848|NCT03331562|536780885|FG000|Overall Study|Death|1|||
148809849|NCT03331562|536780886|FG001|Overall Study|Death|0|||
148809850|NCT02475213|536780889|FG000|Overall Study|Adverse Event|2|||
149217544|NCT03575351|538262859|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
149217545|NCT03575351|538262858|FG000|Overall Study|Lack of Efficacy|28|||
149217546|NCT03575351|538262859|FG001|Overall Study|Lack of Efficacy|0|||
149217547|NCT03575351|538262858|FG000|Overall Study|Withdrawal by Subject|1|||
149217548|NCT03575351|538262859|FG001|Overall Study|Withdrawal by Subject|1|||
149217549|NCT03575351|538262858|FG000|Overall Study|Physician Decision|3|||
149217550|NCT03575351|538262859|FG001|Overall Study|Physician Decision|0|||
149217551|NCT03575351|538262858|FG000|Overall Study|Disease relapse|15|||
149217552|NCT03575351|538262859|FG001|Overall Study|Disease relapse|6|||
149217553|NCT03575351|538262858|FG000|Overall Study|Study drug manufacturing failure|0|||
149217554|NCT03575351|538262859|FG001|Overall Study|Study drug manufacturing failure|1|||
149217555|NCT03575351|538262858|FG000|Overall Study|other reasons|5|||
149217556|NCT03575351|538262859|FG001|Overall Study|other reasons|0|||
149217557|NCT01688999|538262862|FG000|Overall Study|Withdrawal by Subject|5|||
149217558|NCT01688999|538262863|FG001|Overall Study|Withdrawal by Subject|1|||
149217559|NCT01688999|538262864|FG002|Overall Study|Withdrawal by Subject|1|||
149217560|NCT01688999|538262862|FG000|Overall Study|Adverse Event|2|||
149217561|NCT01688999|538262863|FG001|Overall Study|Adverse Event|0|||
149017414|NCT02555371|537544831|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
149017415|NCT02555371|537544832|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
149017416|NCT03095599|537544833|FG000|Overall Study|Withdrawal by Subject|1|||
149017417|NCT03095599|537544834|FG001|Overall Study|Withdrawal by Subject|0|||
149017418|NCT03095599|537544833|FG000|Overall Study|Lost to Follow-up|1|||
149017419|NCT03095599|537544834|FG001|Overall Study|Lost to Follow-up|0|||
149017420|NCT03095599|537544833|FG000|Overall Study|Withdrawal prior to vaccination|1|||
149017421|NCT03095599|537544834|FG001|Overall Study|Withdrawal prior to vaccination|0|||
149017422|NCT00742885|537544838|FG000|Overall Study|Lost to Follow-up|1|||
149017423|NCT00742885|537544839|FG001|Overall Study|Lost to Follow-up|0|||
149017424|NCT04781647|537544840|FG000|Overall Study|Study terminated by Sponsor|11|||
149017425|NCT04781647|537544841|FG001|Overall Study|Study terminated by Sponsor|9|||
148684969|NCT03175120|536319582|FG001|Overall Study|Withdrawal by Subject|5|||
148684970|NCT03175120|536319581|FG000|Overall Study|Other|2|||
149017426|NCT04781647|537544842|FG002|Overall Study|Study terminated by Sponsor|9|||
149217562|NCT01688999|538262864|FG002|Overall Study|Adverse Event|2|||
149217563|NCT01688999|538262862|FG000|Overall Study|Ineligible/Not treated|1|||
149217564|NCT01688999|538262863|FG001|Overall Study|Ineligible/Not treated|0|||
149217565|NCT01688999|538262864|FG002|Overall Study|Ineligible/Not treated|0|||
149217566|NCT02768103|538262865|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
149217567|NCT03748420|538262869|FG000|Overall Study|No 12 month medication adherence data available|0|||
149217568|NCT03748420|538262870|FG001|Overall Study|No 12 month medication adherence data available|1|||
149217569|NCT03748420|538262869|FG000|Overall Study|Death|24|||
149217570|NCT03748420|538262870|FG001|Overall Study|Death|28|||
149217571|NCT03748420|538262869|FG000|Overall Study|Lost to Follow-up|231|||
149217572|NCT03748420|538262870|FG001|Overall Study|Lost to Follow-up|230|||
149217573|NCT01263444|538262871|FG000|Overall Study|Adverse Event|8|||
149217574|NCT01263444|538262871|FG000|Overall Study|Withdrawal by Subject|1|||
149217575|NCT01263444|538262871|FG000|Overall Study|Protocol Violation|1|||
149217576|NCT01899768|538262873|FG000|Part A|Adverse Event|2|||
149217577|NCT01899768|538262873|FG000|Part A|Withdrawal by Subject|1|||
149217578|NCT01899768|538262873|FG000|Part B|Adverse Event|1|||
149217579|NCT01899768|538262873|FG000|Part B|Withdrawal by Subject|1|||
149217580|NCT04043416|538262874|FG000|Washout|Change in health condition|0|||
149217581|NCT04043416|538262875|FG001|Washout|Change in health condition|1|||
149217582|NCT00372489|538262877|FG000|Overall Study|Adverse Event|18|||
149217583|NCT00372489|538262877|FG000|Overall Study|Lack of Efficacy|1|||
149217584|NCT00372489|538262877|FG000|Overall Study|Lost to Follow-up|3|||
149217585|NCT00372489|538262877|FG000|Overall Study|Physician Decision|3|||
149217586|NCT00372489|538262877|FG000|Overall Study|Withdrawal by Subject|5|||
149217587|NCT00372489|538262877|FG000|Overall Study|Patient Relocation|2|||
149217588|NCT00372489|538262877|FG000|Overall Study|Renal transplant|6|||
149217589|NCT00372489|538262877|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
149217590|NCT04476108|538262878|FG000|Overall Study|Adverse Event|4|||
149217591|NCT04476108|538262879|FG001|Overall Study|Adverse Event|1|||
148684971|NCT03175120|536319582|FG001|Overall Study|Other|3|||
148684972|NCT03882047|536319583|FG000|Overall Study|Adverse Event|0|||
148684973|NCT03882047|536319584|FG001|Overall Study|Adverse Event|2|||
149017427|NCT04781647|537544840|FG000|Overall Study|Withdrawal by Subject|1|||
149017428|NCT04781647|537544841|FG001|Overall Study|Withdrawal by Subject|2|||
149217592|NCT04476108|538262878|FG000|Overall Study|Lost to Follow-up|1|||
149217593|NCT04476108|538262879|FG001|Overall Study|Lost to Follow-up|0|||
149217594|NCT04476108|538262878|FG000|Overall Study|Inadvertent Enrollment|1|||
149217595|NCT04476108|538262879|FG001|Overall Study|Inadvertent Enrollment|0|||
149217596|NCT04476108|538262878|FG000|Overall Study|Protocol Violation|1|||
149217597|NCT04476108|538262879|FG001|Overall Study|Protocol Violation|1|||
149217598|NCT04476108|538262878|FG000|Overall Study|Withdrawal by Subject|1|||
149017429|NCT04781647|537544842|FG002|Overall Study|Withdrawal by Subject|0|||
149217599|NCT04476108|538262879|FG001|Overall Study|Withdrawal by Subject|1|||
148684974|NCT03882047|536319585|FG002|Overall Study|Adverse Event|2|||
149217600|NCT00355615|538262881|FG000|Randomized Double Blind Period|Adverse Event|1|||
149217601|NCT00355615|538262882|FG001|Randomized Double Blind Period|Adverse Event|0|||
149217602|NCT00355615|538262883|FG002|Randomized Double Blind Period|Adverse Event|0|||
149217603|NCT00355615|538262884|FG003|Randomized Double Blind Period|Adverse Event|0|||
149217604|NCT00355615|538262885|FG004|Randomized Double Blind Period|Adverse Event|0|||
149217605|NCT00355615|538262881|FG000|Randomized Double Blind Period|Protocol Violation|0|||
149217606|NCT00355615|538262882|FG001|Randomized Double Blind Period|Protocol Violation|0|||
149217607|NCT00355615|538262883|FG002|Randomized Double Blind Period|Protocol Violation|1|||
149217608|NCT00355615|538262884|FG003|Randomized Double Blind Period|Protocol Violation|1|||
149217609|NCT00355615|538262885|FG004|Randomized Double Blind Period|Protocol Violation|0|||
149217610|NCT00355615|538262881|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149217611|NCT00355615|538262882|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149217612|NCT00355615|538262883|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149217613|NCT00355615|538262884|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
149217614|NCT00355615|538262885|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
149217615|NCT00355615|538262881|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149217616|NCT00355615|538262882|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149217617|NCT00355615|538262883|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149217618|NCT00355615|538262884|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
149217619|NCT00355615|538262885|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
149217620|NCT00355615|538262881|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149217621|NCT00355615|538262882|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149217622|NCT00355615|538262883|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149217623|NCT00355615|538262884|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
149217624|NCT00355615|538262885|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
149217625|NCT00355615|538262881|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149217626|NCT00355615|538262882|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149217627|NCT00355615|538262883|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149217628|NCT00355615|538262884|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
149217629|NCT00355615|538262885|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
149217630|NCT00085644|538262886|FG000|Double-Blind Period|Adverse Event|5|||
149217631|NCT00085644|538262887|FG001|Double-Blind Period|Adverse Event|2|||
148684975|NCT03882047|536319583|FG000|Overall Study|Treatment Failure|3|||
148684976|NCT03882047|536319584|FG001|Overall Study|Treatment Failure|3|||
148684977|NCT03882047|536319585|FG002|Overall Study|Treatment Failure|12|||
148684978|NCT03882047|536319583|FG000|Overall Study|Lost to Follow-up|0|||
148684979|NCT03882047|536319584|FG001|Overall Study|Lost to Follow-up|1|||
148684980|NCT03882047|536319585|FG002|Overall Study|Lost to Follow-up|0|||
148684981|NCT03882047|536319583|FG000|Overall Study|Did Not Wish to Continue|1|||
148684982|NCT03882047|536319584|FG001|Overall Study|Did Not Wish to Continue|4|||
148684983|NCT03882047|536319585|FG002|Overall Study|Did Not Wish to Continue|1|||
148684984|NCT03882047|536319583|FG000|Overall Study|Noncompliance With Protocol|2|||
148684985|NCT03882047|536319584|FG001|Overall Study|Noncompliance With Protocol|0|||
148684986|NCT03882047|536319585|FG002|Overall Study|Noncompliance With Protocol|0|||
148684987|NCT03882047|536319583|FG000|Overall Study|Did Not Meet Eligibility|0|||
148684988|NCT03882047|536319584|FG001|Overall Study|Did Not Meet Eligibility|0|||
148684989|NCT03882047|536319585|FG002|Overall Study|Did Not Meet Eligibility|1|||
148684990|NCT00723554|536319586|FG000|Overall Study|Adverse Event|12|||
148684991|NCT00723554|536319586|FG000|Overall Study|Investigator's judgement|5|||
148684992|NCT00723554|536319586|FG000|Overall Study|Inhaled medication other than iloprost|4|||
148684993|NCT00723554|536319586|FG000|Overall Study|Withdrawal of consent|3|||
148684994|NCT00723554|536319586|FG000|Overall Study|Other|3|||
148684995|NCT00723554|536319586|FG000|Overall Study|Lost to Follow-up|1|||
148684996|NCT00723554|536319586|FG000|Overall Study|Non-compliance|1|||
148684997|NCT01894984|536319590|FG000|Overall Study|Other|314|||
148684998|NCT01894984|536319591|FG001|Overall Study|Other|175|||
148684999|NCT00827359|536319592|FG000|Overall Study|Progressive Diseas|19|||
148685000|NCT00827359|536319592|FG000|Overall Study|Unacceptable Toxicity|5|||
148685001|NCT00827359|536319592|FG000|Overall Study|Ineligible|1|||
148685002|NCT02436135|536319594|FG000|Overall Study|Progressive Disease|3|||
148685003|NCT02436135|536319595|FG001|Overall Study|Progressive Disease|1|||
148685004|NCT02436135|536319594|FG000|Overall Study|Investigator Discretion|1|||
148685005|NCT02436135|536319595|FG001|Overall Study|Investigator Discretion|2|||
148685006|NCT02436135|536319594|FG000|Overall Study|Adverse Event|1|||
148685007|NCT02436135|536319595|FG001|Overall Study|Adverse Event|0|||
148685008|NCT02436135|536319594|FG000|Overall Study|Withdrawal by Participant|1|||
148685009|NCT02436135|536319595|FG001|Overall Study|Withdrawal by Participant|0|||
148685010|NCT02436135|536319594|FG000|Overall Study|Study Terminated By Sponsor|0|||
148685011|NCT02436135|536319595|FG001|Overall Study|Study Terminated By Sponsor|1|||
148685012|NCT00475852|536319596|FG000|Overall Study|Death|444|||
148685013|NCT00475852|536319597|FG001|Overall Study|Death|456|||
148685014|NCT00475852|536319596|FG000|Overall Study|Withdrawal by Subject|19|||
148952335|NCT00460408|537307346|FG000|Overall Study|Withdrawal by Subject|31|||
148952336|NCT00460408|537307347|FG001|Overall Study|Withdrawal by Subject|0|||
148952337|NCT00460408|537307348|FG002|Overall Study|Withdrawal by Subject|0|||
148952338|NCT00460408|537307349|FG003|Overall Study|Withdrawal by Subject|0|||
148952339|NCT00460408|537307346|FG000|Overall Study|Insufficient clinical response|5|||
148952340|NCT00460408|537307347|FG001|Overall Study|Insufficient clinical response|1|||
148952341|NCT00460408|537307348|FG002|Overall Study|Insufficient clinical response|5|||
148952342|NCT00460408|537307349|FG003|Overall Study|Insufficient clinical response|0|||
149017430|NCT04781647|537544840|FG000|Overall Study|Adverse Event|0|||
149017431|NCT04781647|537544841|FG001|Overall Study|Adverse Event|1|||
149017432|NCT04781647|537544842|FG002|Overall Study|Adverse Event|1|||
149017433|NCT04781647|537544840|FG000|Overall Study|Protocol Violation|1|||
149017434|NCT04781647|537544841|FG001|Overall Study|Protocol Violation|0|||
149017435|NCT04781647|537544842|FG002|Overall Study|Protocol Violation|0|||
149017436|NCT04781647|537544840|FG000|Overall Study|Pregnancy|0|||
149017437|NCT04781647|537544841|FG001|Overall Study|Pregnancy|0|||
149017438|NCT04781647|537544842|FG002|Overall Study|Pregnancy|1|||
149017439|NCT04781647|537544840|FG000|Overall Study|Virology rebounded|1|||
149017440|NCT04781647|537544841|FG001|Overall Study|Virology rebounded|0|||
149017441|NCT04781647|537544842|FG002|Overall Study|Virology rebounded|0|||
149017442|NCT01755689|537544843|FG000|Overall Study|Withdrawal by Subject|1|||
149017443|NCT01755689|537544844|FG001|Overall Study|Withdrawal by Subject|3|||
149017444|NCT01755689|537544845|FG002|Overall Study|Withdrawal by Subject|2|||
149017445|NCT01755689|537544846|FG003|Overall Study|Withdrawal by Subject|1|||
149017446|NCT01755689|537544847|FG004|Overall Study|Withdrawal by Subject|1|||
149017447|NCT01755689|537544843|FG000|Overall Study|Migrated/moved from study area|0|||
149017448|NCT01755689|537544844|FG001|Overall Study|Migrated/moved from study area|1|||
149017449|NCT01755689|537544845|FG002|Overall Study|Migrated/moved from study area|1|||
149017450|NCT01755689|537544846|FG003|Overall Study|Migrated/moved from study area|1|||
149017451|NCT01755689|537544847|FG004|Overall Study|Migrated/moved from study area|1|||
149017452|NCT01755689|537544843|FG000|Overall Study|Lost to Follow-up|1|||
149017453|NCT01755689|537544844|FG001|Overall Study|Lost to Follow-up|0|||
149017454|NCT01755689|537544845|FG002|Overall Study|Lost to Follow-up|1|||
149017455|NCT01755689|537544846|FG003|Overall Study|Lost to Follow-up|0|||
149017456|NCT01755689|537544847|FG004|Overall Study|Lost to Follow-up|2|||
149017457|NCT01755689|537544843|FG000|Overall Study|Pregnancy|1|||
149017458|NCT01755689|537544844|FG001|Overall Study|Pregnancy|1|||
149017459|NCT01755689|537544845|FG002|Overall Study|Pregnancy|2|||
149017460|NCT01755689|537544846|FG003|Overall Study|Pregnancy|4|||
149017461|NCT01755689|537544847|FG004|Overall Study|Pregnancy|2|||
149017462|NCT02609659|537544848|FG000|Overall Study|Adverse Event|1|||
149017463|NCT02609659|537544848|FG000|Overall Study|Lost to Follow-up|6|||
149017464|NCT02609659|537544848|FG000|Overall Study|Other|1|||
149017465|NCT03943589|537544849|FG000|Overall Study|Death|1|||
149017466|NCT03943589|537544849|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
149017467|NCT04329104|537544850|FG000|Efficacy Study|Withdrawal by Subject|0|||
149017468|NCT04329104|537544851|FG001|Efficacy Study|Withdrawal by Subject|0|||
149017469|NCT04329104|537544852|FG002|Efficacy Study|Withdrawal by Subject|0|||
149017470|NCT04329104|537544853|FG003|Efficacy Study|Withdrawal by Subject|5|||
149017471|NCT04329104|537544854|FG004|Efficacy Study|Withdrawal by Subject|6|||
149017472|NCT04329104|537544855|FG005|Efficacy Study|Withdrawal by Subject|8|||
149017473|NCT00830947|537544856|FG000|Overall Study|Lost to Follow-up|4|||
149017474|NCT00830947|537544857|FG001|Overall Study|Lost to Follow-up|4|||
149017475|NCT01642186|537544858|FG000|Overall Study|Death|0|||
149017476|NCT01642186|537544859|FG001|Overall Study|Death|2|||
149017477|NCT01642186|537544860|FG002|Overall Study|Death|2|||
149017478|NCT01642186|537544858|FG000|Overall Study|Lost to Follow-up|0|||
149017479|NCT01642186|537544859|FG001|Overall Study|Lost to Follow-up|0|||
149017480|NCT01642186|537544860|FG002|Overall Study|Lost to Follow-up|1|||
149017481|NCT00962585|537544863|FG000|Overall Study|Adverse Event|0|||
149017482|NCT00962585|537544864|FG001|Overall Study|Adverse Event|2|||
149017483|NCT00962585|537544865|FG002|Overall Study|Adverse Event|1|||
149017484|NCT00962585|537544866|FG003|Overall Study|Adverse Event|0|||
149017485|NCT00962585|537544863|FG000|Overall Study|Lost to Follow-up|3|||
149017486|NCT00962585|537544864|FG001|Overall Study|Lost to Follow-up|0|||
149017487|NCT00962585|537544865|FG002|Overall Study|Lost to Follow-up|1|||
149017488|NCT00962585|537544866|FG003|Overall Study|Lost to Follow-up|0|||
149017489|NCT00962585|537544863|FG000|Overall Study|Protocol Violation|0|||
149017490|NCT00962585|537544864|FG001|Overall Study|Protocol Violation|0|||
149217632|NCT00085644|538262888|FG002|Double-Blind Period|Adverse Event|0|||
148952343|NCT00460408|537307346|FG000|Overall Study|Other|12|||
148952344|NCT00460408|537307347|FG001|Overall Study|Other|2|||
148952345|NCT00460408|537307348|FG002|Overall Study|Other|0|||
149017491|NCT00962585|537544865|FG002|Overall Study|Protocol Violation|1|||
149017492|NCT00962585|537544866|FG003|Overall Study|Protocol Violation|0|||
149017493|NCT00962585|537544863|FG000|Overall Study|Withdrawal by Subject|1|||
149017494|NCT00962585|537544864|FG001|Overall Study|Withdrawal by Subject|0|||
149017495|NCT00962585|537544865|FG002|Overall Study|Withdrawal by Subject|0|||
149017496|NCT00962585|537544866|FG003|Overall Study|Withdrawal by Subject|0|||
148685015|NCT00475852|536319597|FG001|Overall Study|Withdrawal by Subject|24|||
148685016|NCT00475852|536319596|FG000|Overall Study|Lost to Follow-up|54|||
148685017|NCT00475852|536319597|FG001|Overall Study|Lost to Follow-up|68|||
148685018|NCT02063698|536319598|FG000|Overall Study|did not complete booklet for days 2-8|1|||
148685019|NCT02063698|536319599|FG001|Overall Study|did not complete booklet for days 2-8|2|||
148685020|NCT00297479|536319600|FG000|Overall Study|Lost to Follow-up|37|||
148685021|NCT00297479|536319601|FG001|Overall Study|Lost to Follow-up|54|||
148685022|NCT00297479|536319602|FG002|Overall Study|Lost to Follow-up|51|||
148685023|NCT01664494|536319603|FG000|Overall Study|Withdrawal by Subject|27|||
149217633|NCT00085644|538262886|FG000|Double-Blind Period|Withdrawal by Subject|3|||
149217634|NCT00085644|538262887|FG001|Double-Blind Period|Withdrawal by Subject|0|||
149217635|NCT00085644|538262888|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149217636|NCT00085644|538262886|FG000|Double-Blind Period|Lost to Follow-up|2|||
149217637|NCT00085644|538262887|FG001|Double-Blind Period|Lost to Follow-up|1|||
149217638|NCT00085644|538262888|FG002|Double-Blind Period|Lost to Follow-up|0|||
149217639|NCT00085644|538262886|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
149217640|NCT00085644|538262887|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
149217641|NCT00085644|538262888|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
149217642|NCT00085644|538262886|FG000|Double-Blind Period|Contemplating pregnancy|1|||
149217643|NCT00085644|538262887|FG001|Double-Blind Period|Contemplating pregnancy|0|||
149217644|NCT00085644|538262888|FG002|Double-Blind Period|Contemplating pregnancy|0|||
149217645|NCT00085644|538262886|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
149217646|NCT00085644|538262887|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
149217647|NCT00085644|538262888|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
149217648|NCT00085644|538262886|FG000|Open-Label Period|Adverse Event|0|||
149217649|NCT00085644|538262887|FG001|Open-Label Period|Adverse Event|0|||
149217650|NCT00085644|538262888|FG002|Open-Label Period|Adverse Event|38|||
149217651|NCT00085644|538262886|FG000|Open-Label Period|Withdrawal by Subject|0|||
149217652|NCT00085644|538262887|FG001|Open-Label Period|Withdrawal by Subject|0|||
149217653|NCT00085644|538262888|FG002|Open-Label Period|Withdrawal by Subject|29|||
148685024|NCT01664494|536319603|FG000|Overall Study|Death|18|||
148685025|NCT01664494|536319603|FG000|Overall Study|Other|49|||
148685026|NCT01664494|536319603|FG000|Overall Study|Lost to Follow-up|99|||
148809851|NCT02475213|536780890|FG001|Overall Study|Adverse Event|0|||
148809852|NCT02475213|536780891|FG002|Overall Study|Adverse Event|0|||
148809853|NCT02475213|536780892|FG003|Overall Study|Adverse Event|1|||
148952346|NCT00460408|537307349|FG003|Overall Study|Other|0|||
148952347|NCT00372112|537307352|FG000|Overall Study|Adverse Event|0|||
148952348|NCT00372112|537307353|FG001|Overall Study|Adverse Event|1|||
148952349|NCT00372112|537307354|FG002|Overall Study|Adverse Event|1|||
148952350|NCT00372112|537307355|FG003|Overall Study|Adverse Event|1|||
148952351|NCT00372112|537307352|FG000|Overall Study|Withdrawal by Subject|0|||
148952352|NCT00372112|537307353|FG001|Overall Study|Withdrawal by Subject|0|||
148952353|NCT00372112|537307354|FG002|Overall Study|Withdrawal by Subject|2|||
148952354|NCT00372112|537307355|FG003|Overall Study|Withdrawal by Subject|1|||
148952355|NCT00372112|537307352|FG000|Overall Study|Exacerbation|0|||
148952356|NCT00372112|537307353|FG001|Overall Study|Exacerbation|0|||
148952357|NCT00372112|537307354|FG002|Overall Study|Exacerbation|0|||
148952358|NCT00372112|537307355|FG003|Overall Study|Exacerbation|1|||
148952359|NCT00372112|537307352|FG000|Overall Study|PR >240 at Visit 3|0|||
148952360|NCT00372112|537307353|FG001|Overall Study|PR >240 at Visit 3|0|||
148952361|NCT00372112|537307354|FG002|Overall Study|PR >240 at Visit 3|0|||
148952362|NCT00372112|537307355|FG003|Overall Study|PR >240 at Visit 3|1|||
148952363|NCT00372112|537307352|FG000|Overall Study|Hepatitis B|1|||
148952364|NCT00372112|537307353|FG001|Overall Study|Hepatitis B|0|||
148952365|NCT00372112|537307354|FG002|Overall Study|Hepatitis B|0|||
148952366|NCT00372112|537307355|FG003|Overall Study|Hepatitis B|0|||
148952367|NCT00372112|537307352|FG000|Overall Study|Other-protocol violation|0|||
148952368|NCT00372112|537307353|FG001|Overall Study|Other-protocol violation|0|||
148952369|NCT00372112|537307354|FG002|Overall Study|Other-protocol violation|1|||
148952370|NCT00372112|537307355|FG003|Overall Study|Other-protocol violation|0|||
148952371|NCT01574326|537307356|FG000|Overall Study|Randomized but not treated|0|||
148952372|NCT01574326|537307357|FG001|Overall Study|Randomized but not treated|1|||
148952373|NCT01574326|537307356|FG000|Overall Study|Withdrawal by Participant|2|||
148952374|NCT01574326|537307357|FG001|Overall Study|Withdrawal by Participant|4|||
148952375|NCT01574326|537307356|FG000|Overall Study|Physician Decision|5|||
148952376|NCT01574326|537307357|FG001|Overall Study|Physician Decision|3|||
149217654|NCT00085644|538262886|FG000|Open-Label Period|Lost to Follow-up|0|||
149217655|NCT00085644|538262887|FG001|Open-Label Period|Lost to Follow-up|0|||
149217656|NCT00085644|538262888|FG002|Open-Label Period|Lost to Follow-up|13|||
148952377|NCT01574326|537307356|FG000|Overall Study|Adverse Event|1|||
148952378|NCT01574326|537307357|FG001|Overall Study|Adverse Event|3|||
148952379|NCT01574326|537307356|FG000|Overall Study|Other: Mainly kidney transplant|8|||
148952380|NCT01574326|537307357|FG001|Overall Study|Other: Mainly kidney transplant|8|||
148952381|NCT00137046|537307358|FG000|Overall Study|Death|2|||
148952382|NCT00137046|537307359|FG001|Overall Study|Death|1|||
148952383|NCT00137046|537307358|FG000|Overall Study|Adverse Event|16|||
149217657|NCT00085644|538262886|FG000|Open-Label Period|Lack of Efficacy|0|||
148685027|NCT03263819|536319604|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
148685028|NCT03263819|536319605|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
148685029|NCT01427803|536319607|FG000|Overall Study|Lost to Follow-up|32|||
149217658|NCT00085644|538262887|FG001|Open-Label Period|Lack of Efficacy|0|||
149217659|NCT00085644|538262888|FG002|Open-Label Period|Lack of Efficacy|15|||
149217660|NCT00085644|538262886|FG000|Open-Label Period|Pregnancy|0|||
149217661|NCT00085644|538262887|FG001|Open-Label Period|Pregnancy|0|||
149217662|NCT00085644|538262888|FG002|Open-Label Period|Pregnancy|3|||
149217663|NCT00085644|538262886|FG000|Open-Label Period|Contemplating pregnancy|0|||
149217664|NCT00085644|538262887|FG001|Open-Label Period|Contemplating pregnancy|0|||
149217665|NCT00085644|538262888|FG002|Open-Label Period|Contemplating pregnancy|3|||
149217666|NCT00085644|538262886|FG000|Open-Label Period|Protocol Violation|0|||
149217667|NCT00085644|538262887|FG001|Open-Label Period|Protocol Violation|0|||
149217668|NCT00085644|538262888|FG002|Open-Label Period|Protocol Violation|4|||
149217669|NCT00085644|538262886|FG000|Open-Label Period|Personal reason|0|||
149217670|NCT00085644|538262887|FG001|Open-Label Period|Personal reason|0|||
149217671|NCT00085644|538262888|FG002|Open-Label Period|Personal reason|4|||
149217672|NCT04259346|538262889|FG000|Overall Study|Lost to Follow-up|1|||
149217673|NCT04259346|538262890|FG001|Overall Study|Lost to Follow-up|3|||
149217674|NCT04259346|538262889|FG000|Overall Study|Protocol Violation|1|||
149217675|NCT04259346|538262890|FG001|Overall Study|Protocol Violation|0|||
149217676|NCT04259346|538262889|FG000|Overall Study|Withdrawal by Subject|1|||
149217677|NCT04259346|538262890|FG001|Overall Study|Withdrawal by Subject|0|||
149217678|NCT04259346|538262889|FG000|Overall Study|Adverse Event|1|||
149217679|NCT04259346|538262890|FG001|Overall Study|Adverse Event|1|||
149217680|NCT03330106|538262891|FG000|Part A|Withdrawal by Subject|1|||
149217681|NCT03330106|538262892|FG001|Part A|Withdrawal by Subject|1|||
149217682|NCT03330106|538262893|FG002|Part A|Withdrawal by Subject|0|||
149217683|NCT03330106|538262894|FG003|Part A|Withdrawal by Subject|0|||
149217684|NCT03330106|538262891|FG000|Part A|Death|2|||
149217685|NCT03330106|538262892|FG001|Part A|Death|1|||
149217686|NCT03330106|538262893|FG002|Part A|Death|0|||
149217687|NCT03330106|538262894|FG003|Part A|Death|0|||
149217688|NCT03330106|538262891|FG000|Part A|Adverse Event|0|||
149217689|NCT03330106|538262892|FG001|Part A|Adverse Event|1|||
149217690|NCT03330106|538262893|FG002|Part A|Adverse Event|0|||
149217691|NCT03330106|538262894|FG003|Part A|Adverse Event|0|||
149217692|NCT03330106|538262891|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
149217693|NCT03330106|538262892|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
149217694|NCT03330106|538262893|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
149217695|NCT03330106|538262894|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
149217696|NCT03330106|538262891|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
148685030|NCT01427803|536319608|FG001|Overall Study|Lost to Follow-up|26|||
148685031|NCT01427803|536319607|FG000|Overall Study|Withdrawal by Subject|20|||
148685032|NCT01427803|536319608|FG001|Overall Study|Withdrawal by Subject|0|||
148685033|NCT01427803|536319607|FG000|Overall Study|Unable to complete full treatment period|6|||
148685034|NCT01427803|536319608|FG001|Overall Study|Unable to complete full treatment period|0|||
148685035|NCT01427803|536319607|FG000|Overall Study|Protocol Violation|1|||
148685036|NCT01427803|536319608|FG001|Overall Study|Protocol Violation|0|||
148685037|NCT01427803|536319607|FG000|Overall Study|Physician Decision|3|||
148685038|NCT01427803|536319608|FG001|Overall Study|Physician Decision|0|||
148685039|NCT01427803|536319607|FG000|Overall Study|did not take product|1|||
148685040|NCT01427803|536319608|FG001|Overall Study|did not take product|0|||
148685041|NCT00863057|536319611|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
148685042|NCT00863057|536319612|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
148685043|NCT00863057|536319613|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
148685044|NCT00863057|536319614|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
148685045|NCT00863057|536319611|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
148685046|NCT00863057|536319612|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
148685047|NCT00863057|536319613|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
148685048|NCT00863057|536319614|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
148685049|NCT00863057|536319611|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
148685050|NCT00863057|536319612|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
148685051|NCT00863057|536319613|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
148685052|NCT00863057|536319614|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
148685053|NCT00863057|536319611|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
149217697|NCT03330106|538262892|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
149217698|NCT03330106|538262893|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
149217699|NCT03330106|538262894|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
149217700|NCT03330106|538262891|FG000|Part A|Progressive Disease|0|||
148685054|NCT00863057|536319612|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
149217701|NCT03330106|538262892|FG001|Part A|Progressive Disease|1|||
149217702|NCT03330106|538262893|FG002|Part A|Progressive Disease|0|||
149217703|NCT03330106|538262894|FG003|Part A|Progressive Disease|0|||
149217704|NCT03330106|538262891|FG000|Part B|Lost to Follow-up|0|||
149217705|NCT03330106|538262892|FG001|Part B|Lost to Follow-up|0|||
149217706|NCT03330106|538262893|FG002|Part B|Lost to Follow-up|0|||
149217707|NCT03330106|538262894|FG003|Part B|Lost to Follow-up|1|||
149217708|NCT03330106|538262891|FG000|Part B|Withdrawal by Subject|0|||
149217709|NCT03330106|538262892|FG001|Part B|Withdrawal by Subject|0|||
149217710|NCT03330106|538262893|FG002|Part B|Withdrawal by Subject|4|||
149217711|NCT03330106|538262894|FG003|Part B|Withdrawal by Subject|0|||
149217712|NCT03330106|538262891|FG000|Part B|Death|0|||
149217713|NCT03330106|538262892|FG001|Part B|Death|0|||
149217714|NCT03330106|538262893|FG002|Part B|Death|2|||
149217715|NCT03330106|538262894|FG003|Part B|Death|0|||
148809854|NCT02475213|536780893|FG004|Overall Study|Adverse Event|1|||
148809855|NCT02475213|536780894|FG005|Overall Study|Adverse Event|4|||
148809856|NCT02475213|536780895|FG006|Overall Study|Adverse Event|6|||
148809857|NCT02475213|536780896|FG007|Overall Study|Adverse Event|2|||
148809858|NCT02475213|536780889|FG000|Overall Study|Physician Decision|1|||
148809859|NCT02475213|536780890|FG001|Overall Study|Physician Decision|1|||
148809860|NCT02475213|536780891|FG002|Overall Study|Physician Decision|1|||
148809861|NCT02475213|536780892|FG003|Overall Study|Physician Decision|0|||
148809862|NCT02475213|536780893|FG004|Overall Study|Physician Decision|0|||
148809863|NCT02475213|536780894|FG005|Overall Study|Physician Decision|1|||
148809864|NCT02475213|536780895|FG006|Overall Study|Physician Decision|4|||
149217716|NCT03330106|538262891|FG000|Part B|Clinical Progression|0|||
149217717|NCT03330106|538262892|FG001|Part B|Clinical Progression|0|||
149217718|NCT03330106|538262893|FG002|Part B|Clinical Progression|1|||
149217719|NCT03330106|538262894|FG003|Part B|Clinical Progression|1|||
149217720|NCT03330106|538262891|FG000|Part B|Symptomatic Deterioration|0|||
149217721|NCT03330106|538262892|FG001|Part B|Symptomatic Deterioration|0|||
149217722|NCT03330106|538262893|FG002|Part B|Symptomatic Deterioration|0|||
149217723|NCT03330106|538262894|FG003|Part B|Symptomatic Deterioration|1|||
149217724|NCT03330106|538262891|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
149217725|NCT03330106|538262892|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
149217726|NCT03330106|538262893|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
149217727|NCT03330106|538262894|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
149217728|NCT03330106|538262891|FG000|Part B|Progressive Disease|0|||
149217729|NCT03330106|538262892|FG001|Part B|Progressive Disease|0|||
149217730|NCT03330106|538262893|FG002|Part B|Progressive Disease|11|||
149217731|NCT03330106|538262894|FG003|Part B|Progressive Disease|4|||
148809865|NCT02475213|536780896|FG007|Overall Study|Physician Decision|0|||
148809866|NCT02475213|536780889|FG000|Overall Study|Progressive Disease|3|||
148809867|NCT02475213|536780890|FG001|Overall Study|Progressive Disease|2|||
148809868|NCT02475213|536780891|FG002|Overall Study|Progressive Disease|2|||
148809869|NCT02475213|536780892|FG003|Overall Study|Progressive Disease|13|||
148809870|NCT02475213|536780893|FG004|Overall Study|Progressive Disease|15|||
148809871|NCT02475213|536780894|FG005|Overall Study|Progressive Disease|25|||
148809872|NCT02475213|536780895|FG006|Overall Study|Progressive Disease|30|||
148809873|NCT02475213|536780896|FG007|Overall Study|Progressive Disease|10|||
148952384|NCT00137046|537307359|FG001|Overall Study|Adverse Event|5|||
148952385|NCT00137046|537307358|FG000|Overall Study|Laboratory Abnormality|2|||
148952386|NCT00137046|537307359|FG001|Overall Study|Laboratory Abnormality|0|||
148952387|NCT00137046|537307358|FG000|Overall Study|Lack of Efficacy|13|||
148952388|NCT00137046|537307359|FG001|Overall Study|Lack of Efficacy|1|||
148952389|NCT00137046|537307358|FG000|Overall Study|Lost to Follow-up|8|||
148952390|NCT00137046|537307359|FG001|Overall Study|Lost to Follow-up|24|||
148952391|NCT00137046|537307358|FG000|Overall Study|Other|23|||
149217732|NCT00623766|538262897|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
148809874|NCT02475213|536780889|FG000|Overall Study|Death|0|||
148809875|NCT02475213|536780890|FG001|Overall Study|Death|0|||
148809876|NCT02475213|536780891|FG002|Overall Study|Death|0|||
148809877|NCT02475213|536780892|FG003|Overall Study|Death|0|||
148809878|NCT02475213|536780893|FG004|Overall Study|Death|0|||
148809879|NCT02475213|536780894|FG005|Overall Study|Death|4|||
148809880|NCT02475213|536780895|FG006|Overall Study|Death|1|||
148809881|NCT02475213|536780896|FG007|Overall Study|Death|0|||
148809882|NCT02475213|536780889|FG000|Overall Study|Protocol Violation|0|||
148809883|NCT02475213|536780890|FG001|Overall Study|Protocol Violation|0|||
148952392|NCT00137046|537307359|FG001|Overall Study|Other|19|||
148952393|NCT00137046|537307358|FG000|Overall Study|Withdrawal by Subject|33|||
148952394|NCT00137046|537307359|FG001|Overall Study|Withdrawal by Subject|42|||
148952395|NCT00137046|537307358|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
149017497|NCT00962585|537544863|FG000|Overall Study|Withdrew Consent|2|||
149217733|NCT00623766|538262898|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
148809884|NCT02475213|536780891|FG002|Overall Study|Protocol Violation|0|||
148809885|NCT02475213|536780892|FG003|Overall Study|Protocol Violation|0|||
149217734|NCT00623766|538262897|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
149217735|NCT00623766|538262898|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
149217736|NCT00623766|538262897|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
149217737|NCT00623766|538262898|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
148952396|NCT00137046|537307359|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
148952397|NCT00137046|537307358|FG000|Overall Study|Withdrew prior to study treatment|1|||
148952398|NCT00137046|537307359|FG001|Overall Study|Withdrew prior to study treatment|1|||
149217738|NCT00623766|538262897|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
149217739|NCT00623766|538262898|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
149217740|NCT00623766|538262897|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
149217741|NCT00623766|538262898|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
149217742|NCT00486889|538262899|FG000|Overall Study|Death|3|||
149217743|NCT00486889|538262899|FG000|Overall Study|Non-compliant|2|||
149217744|NCT00486889|538262899|FG000|Overall Study|Withdrawal by Subject|6|||
149217745|NCT00893763|538262900|FG000|Overall Study|extubated|110|||
149217746|NCT00893763|538262901|FG001|Overall Study|extubated|110|||
149217747|NCT01678560|538262902|FG000|Overall Study|Physician Decision|4|||
149217748|NCT01678560|538262903|FG001|Overall Study|Physician Decision|4|||
149217749|NCT01678560|538262902|FG000|Overall Study|Death|0|||
149217750|NCT01678560|538262903|FG001|Overall Study|Death|1|||
149217751|NCT01678560|538262902|FG000|Overall Study|Withdrawal by Subject|0|||
149217752|NCT01678560|538262903|FG001|Overall Study|Withdrawal by Subject|1|||
149217753|NCT02201472|538262904|FG000|Overall Study|Lack of Efficacy|2|||
149217754|NCT00117572|538262905|FG000|Overall Study|Site withdrew before starting treatment|2|||
149217755|NCT00117572|538262906|FG001|Overall Study|Site withdrew before starting treatment|3|||
149217756|NCT00117572|538262905|FG000|Overall Study|Withdrawal by Subject|3|||
149217757|NCT00117572|538262906|FG001|Overall Study|Withdrawal by Subject|3|||
149217758|NCT00117572|538262905|FG000|Overall Study|Protocol Violation|1|||
149217759|NCT00117572|538262906|FG001|Overall Study|Protocol Violation|0|||
149217760|NCT01188811|538262909|FG000|Overall Study|Withdrawal by Subject|0|||
149217761|NCT01188811|538262910|FG001|Overall Study|Withdrawal by Subject|2|||
149217762|NCT01188811|538262909|FG000|Overall Study|Adverse Event|6|||
149217763|NCT01188811|538262910|FG001|Overall Study|Adverse Event|0|||
149217764|NCT00090766|538262911|FG000|Overall Study|Nephrectomy Planned|0|||
149217765|NCT00090766|538262912|FG001|Overall Study|Nephrectomy Planned|0|||
149217766|NCT00090766|538262913|FG002|Overall Study|Nephrectomy Planned|1|||
149217767|NCT00090766|538262911|FG000|Overall Study|Death|1|||
149217768|NCT00090766|538262912|FG001|Overall Study|Death|0|||
149217769|NCT00090766|538262913|FG002|Overall Study|Death|0|||
149217770|NCT00090766|538262911|FG000|Overall Study|Admin|0|||
149217771|NCT00090766|538262912|FG001|Overall Study|Admin|2|||
149217772|NCT00090766|538262913|FG002|Overall Study|Admin|0|||
149217773|NCT00090766|538262911|FG000|Overall Study|Lost to Follow-up|2|||
149217774|NCT00090766|538262912|FG001|Overall Study|Lost to Follow-up|0|||
149217775|NCT00090766|538262913|FG002|Overall Study|Lost to Follow-up|2|||
149217776|NCT00654368|538262914|FG000|Overall Study|Ineligibility determined|6|||
149217777|NCT00654368|538262915|FG001|Overall Study|Ineligibility determined|0|||
149217778|NCT00654368|538262916|FG002|Overall Study|Ineligibility determined|0|||
149217779|NCT00654368|538262914|FG000|Overall Study|Protocol deviation|3|||
149217780|NCT00654368|538262915|FG001|Overall Study|Protocol deviation|2|||
148685055|NCT00863057|536319613|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
148685056|NCT00863057|536319614|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
148685057|NCT00479401|536319616|FG000|Overall Study|Adverse Event|24|||
148685058|NCT00479401|536319617|FG001|Overall Study|Adverse Event|20|||
148685059|NCT00479401|536319618|FG002|Overall Study|Adverse Event|4|||
148685060|NCT00479401|536319616|FG000|Overall Study|Lack of Efficacy|2|||
148685061|NCT00479401|536319617|FG001|Overall Study|Lack of Efficacy|2|||
148685062|NCT00479401|536319618|FG002|Overall Study|Lack of Efficacy|4|||
148685063|NCT00479401|536319616|FG000|Overall Study|Protocol Violation|2|||
148685064|NCT00479401|536319617|FG001|Overall Study|Protocol Violation|1|||
148685065|NCT00479401|536319618|FG002|Overall Study|Protocol Violation|1|||
148685066|NCT00479401|536319616|FG000|Overall Study|Lost to Follow-up|1|||
148685067|NCT00479401|536319617|FG001|Overall Study|Lost to Follow-up|1|||
148685068|NCT00479401|536319618|FG002|Overall Study|Lost to Follow-up|1|||
148685069|NCT00479401|536319616|FG000|Overall Study|Withdrawal by Subject|16|||
149217781|NCT00654368|538262916|FG002|Overall Study|Protocol deviation|1|||
148685070|NCT00479401|536319617|FG001|Overall Study|Withdrawal by Subject|10|||
148685071|NCT00479401|536319618|FG002|Overall Study|Withdrawal by Subject|2|||
148952399|NCT01288469|537307360|FG000|Overall Study|Adverse Event|4|||
148952400|NCT01288469|537307361|FG001|Overall Study|Adverse Event|1|||
148685072|NCT00479401|536319616|FG000|Overall Study|Exclusion criteria, relocation|4|||
148952401|NCT01288469|537307362|FG002|Overall Study|Adverse Event|1|||
148952402|NCT01288469|537307360|FG000|Overall Study|Poor compliance to protocol|0|||
148952403|NCT01288469|537307361|FG001|Overall Study|Poor compliance to protocol|1|||
149217782|NCT00654368|538262914|FG000|Overall Study|Non-compliance|2|||
149217783|NCT00654368|538262915|FG001|Overall Study|Non-compliance|1|||
149217784|NCT00654368|538262916|FG002|Overall Study|Non-compliance|2|||
149217785|NCT00654368|538262914|FG000|Overall Study|Withdrawal by Subject|5|||
149217786|NCT00654368|538262915|FG001|Overall Study|Withdrawal by Subject|2|||
149217787|NCT00654368|538262916|FG002|Overall Study|Withdrawal by Subject|2|||
149217788|NCT00654368|538262914|FG000|Overall Study|Disease progression|21|||
149217789|NCT00654368|538262915|FG001|Overall Study|Disease progression|31|||
148809886|NCT02475213|536780893|FG004|Overall Study|Protocol Violation|1|||
148809887|NCT02475213|536780894|FG005|Overall Study|Protocol Violation|0|||
148809888|NCT02475213|536780895|FG006|Overall Study|Protocol Violation|0|||
148809889|NCT02475213|536780896|FG007|Overall Study|Protocol Violation|0|||
148809890|NCT02475213|536780889|FG000|Overall Study|Withdrawal by Subject|0|||
148809891|NCT02475213|536780890|FG001|Overall Study|Withdrawal by Subject|0|||
148809892|NCT02475213|536780891|FG002|Overall Study|Withdrawal by Subject|0|||
148809893|NCT02475213|536780892|FG003|Overall Study|Withdrawal by Subject|1|||
148809894|NCT02475213|536780893|FG004|Overall Study|Withdrawal by Subject|0|||
148952404|NCT01288469|537307362|FG002|Overall Study|Poor compliance to protocol|0|||
148952405|NCT01288469|537307360|FG000|Overall Study|Participant Moved|1|||
148952406|NCT01288469|537307361|FG001|Overall Study|Participant Moved|0|||
148952407|NCT01288469|537307362|FG002|Overall Study|Participant Moved|0|||
148952408|NCT01288469|537307360|FG000|Overall Study|Consent withdrawn by subject|1|||
148952409|NCT01288469|537307361|FG001|Overall Study|Consent withdrawn by subject|1|||
148952410|NCT01288469|537307362|FG002|Overall Study|Consent withdrawn by subject|1|||
148952411|NCT01288469|537307360|FG000|Overall Study|Exclusion criteria finally met|1|||
148952412|NCT01288469|537307361|FG001|Overall Study|Exclusion criteria finally met|0|||
148952413|NCT01288469|537307362|FG002|Overall Study|Exclusion criteria finally met|0|||
148952414|NCT01606436|537307365|FG000|Overall Study|Withdrawal by Subject|0|||
148952415|NCT01606436|537307366|FG001|Overall Study|Withdrawal by Subject|0|||
148952416|NCT01606436|537307367|FG002|Overall Study|Withdrawal by Subject|1|||
148952417|NCT01606436|537307368|FG003|Overall Study|Withdrawal by Subject|1|||
148952418|NCT01606436|537307369|FG004|Overall Study|Withdrawal by Subject|1|||
148952419|NCT01606436|537307370|FG005|Overall Study|Withdrawal by Subject|0|||
148952420|NCT01606436|537307365|FG000|Overall Study|Adverse Event|0|||
148952421|NCT01606436|537307366|FG001|Overall Study|Adverse Event|0|||
148952422|NCT01606436|537307367|FG002|Overall Study|Adverse Event|1|||
148952423|NCT01606436|537307368|FG003|Overall Study|Adverse Event|0|||
148952424|NCT01606436|537307369|FG004|Overall Study|Adverse Event|0|||
148952425|NCT01606436|537307370|FG005|Overall Study|Adverse Event|0|||
148952426|NCT01606436|537307365|FG000|Overall Study|Sponsor Decision|0|||
148952427|NCT01606436|537307366|FG001|Overall Study|Sponsor Decision|0|||
148952428|NCT01606436|537307367|FG002|Overall Study|Sponsor Decision|0|||
148952429|NCT01606436|537307368|FG003|Overall Study|Sponsor Decision|1|||
148952430|NCT01606436|537307369|FG004|Overall Study|Sponsor Decision|0|||
148952431|NCT01606436|537307370|FG005|Overall Study|Sponsor Decision|0|||
148952432|NCT04294472|537307371|FG000|Overall Study|Adverse Event|0|||
148952433|NCT04294472|537307372|FG001|Overall Study|Adverse Event|1|||
148952434|NCT04294472|537307373|FG002|Overall Study|Adverse Event|1|||
148952435|NCT04294472|537307371|FG000|Overall Study|Randomized but not treated|0|||
148952436|NCT04294472|537307372|FG001|Overall Study|Randomized but not treated|1|||
148952437|NCT04294472|537307373|FG002|Overall Study|Randomized but not treated|1|||
148952438|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
148952439|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
148952440|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
148952441|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
148952442|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
148952443|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
148952444|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
148952445|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
148952446|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
148952447|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
148952448|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
148952449|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
148952450|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
148952451|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
148952452|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
148952453|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
148952454|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
148952455|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
148952456|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
148952457|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
148952458|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
148952459|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
148952460|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
148952461|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
148809895|NCT02475213|536780894|FG005|Overall Study|Withdrawal by Subject|2|||
148685073|NCT00479401|536319617|FG001|Overall Study|Exclusion criteria, relocation|3|||
148685074|NCT00479401|536319618|FG002|Overall Study|Exclusion criteria, relocation|0|||
148685075|NCT02124746|536319621|FG000|Overall Study|Adverse Event|2|||
148685076|NCT02124746|536319622|FG001|Overall Study|Adverse Event|1|||
148685077|NCT02124746|536319623|FG002|Overall Study|Adverse Event|2|||
148685078|NCT02124746|536319621|FG000|Overall Study|Death|2|||
148685079|NCT02124746|536319622|FG001|Overall Study|Death|1|||
148685080|NCT02124746|536319623|FG002|Overall Study|Death|3|||
149217790|NCT00654368|538262916|FG002|Overall Study|Disease progression|13|||
149217791|NCT00654368|538262914|FG000|Overall Study|Requirement for alternative therapy|1|||
149217792|NCT00654368|538262915|FG001|Overall Study|Requirement for alternative therapy|1|||
149217793|NCT00654368|538262916|FG002|Overall Study|Requirement for alternative therapy|1|||
149217794|NCT00654368|538262914|FG000|Overall Study|Physician Decision|0|||
149217795|NCT00654368|538262915|FG001|Overall Study|Physician Decision|0|||
149217796|NCT00654368|538262916|FG002|Overall Study|Physician Decision|2|||
149217797|NCT00654368|538262914|FG000|Overall Study|Death|1|||
149217798|NCT00654368|538262915|FG001|Overall Study|Death|0|||
149217799|NCT00654368|538262916|FG002|Overall Study|Death|0|||
149217800|NCT00654368|538262914|FG000|Overall Study|Pregnancy|0|||
149217801|NCT00654368|538262915|FG001|Overall Study|Pregnancy|0|||
149217802|NCT00654368|538262916|FG002|Overall Study|Pregnancy|2|||
149217803|NCT00654368|538262914|FG000|Overall Study|Other|0|||
149217804|NCT00654368|538262915|FG001|Overall Study|Other|2|||
149217805|NCT00654368|538262916|FG002|Overall Study|Other|3|||
149217806|NCT00654368|538262914|FG000|Overall Study|Adverse Event|14|||
149217807|NCT00654368|538262915|FG001|Overall Study|Adverse Event|9|||
149217808|NCT00654368|538262916|FG002|Overall Study|Adverse Event|6|||
149217809|NCT01602744|538262917|FG000|Overall Study|Death|17|||
149217810|NCT01602744|538262918|FG001|Overall Study|Death|15|||
149217811|NCT01602744|538262917|FG000|Overall Study|Lost to Follow-up|13|||
149217812|NCT01602744|538262918|FG001|Overall Study|Lost to Follow-up|8|||
149217813|NCT04228445|538262922|FG000|Overall Study|Lost to Follow-up|1|||
148685081|NCT02124746|536319621|FG000|Overall Study|Lack of Efficacy|3|||
148685082|NCT02124746|536319622|FG001|Overall Study|Lack of Efficacy|2|||
148685083|NCT02124746|536319623|FG002|Overall Study|Lack of Efficacy|2|||
148685084|NCT02124746|536319621|FG000|Overall Study|Physician Decision|6|||
148685085|NCT02124746|536319622|FG001|Overall Study|Physician Decision|4|||
148685086|NCT02124746|536319623|FG002|Overall Study|Physician Decision|5|||
148685087|NCT02124746|536319621|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148685088|NCT02124746|536319622|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148685089|NCT02124746|536319623|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148685090|NCT02124746|536319621|FG000|Overall Study|Withdrawal by Subject|3|||
148685091|NCT02124746|536319622|FG001|Overall Study|Withdrawal by Subject|3|||
148685092|NCT02124746|536319623|FG002|Overall Study|Withdrawal by Subject|0|||
148685093|NCT02124746|536319621|FG000|Overall Study|Study Terminated by Sponsor|0|||
148685094|NCT02124746|536319622|FG001|Overall Study|Study Terminated by Sponsor|0|||
148685095|NCT02124746|536319623|FG002|Overall Study|Study Terminated by Sponsor|6|||
148685096|NCT02124746|536319621|FG000|Overall Study|Disease Progression|3|||
148685097|NCT02124746|536319622|FG001|Overall Study|Disease Progression|6|||
148685098|NCT02124746|536319623|FG002|Overall Study|Disease Progression|4|||
148685099|NCT01208402|536319626|FG000|Overall Study|Withdrawal by Subject|1|||
148685100|NCT01208402|536319627|FG001|Overall Study|Withdrawal by Subject|0|||
148685101|NCT01571635|536319628|FG000|Overall Study|Adverse Event|3|||
148952462|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
149217814|NCT04228445|538262923|FG001|Overall Study|Lost to Follow-up|1|||
149217815|NCT04228445|538262922|FG000|Overall Study|Physician Decision|1|||
149217816|NCT04228445|538262923|FG001|Overall Study|Physician Decision|2|||
149217817|NCT04228445|538262922|FG000|Overall Study|Withdrawal by Subject|0|||
149217818|NCT04228445|538262923|FG001|Overall Study|Withdrawal by Subject|1|||
148685102|NCT01571635|536319629|FG001|Overall Study|Adverse Event|0|||
148952463|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
148952464|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
148952465|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
148685103|NCT01571635|536319630|FG002|Overall Study|Adverse Event|2|||
148685104|NCT01571635|536319631|FG003|Overall Study|Adverse Event|3|||
148685105|NCT01571635|536319632|FG004|Overall Study|Adverse Event|5|||
148685106|NCT01571635|536319628|FG000|Overall Study|Other reasons|2|||
148685107|NCT01571635|536319629|FG001|Overall Study|Other reasons|1|||
148685108|NCT01571635|536319630|FG002|Overall Study|Other reasons|2|||
149017498|NCT00962585|537544864|FG001|Overall Study|Withdrew Consent|0|||
149217819|NCT04228445|538262922|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
149217820|NCT04228445|538262923|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
149217821|NCT00606294|538262924|FG000|Overall Study|Withdrawal by Subject|36|||
149217822|NCT00606294|538262925|FG001|Overall Study|Withdrawal by Subject|0|||
149217823|NCT03418376|538262926|FG000|Overall Study|Musculoskeletal injury|1|||
149217824|NCT03418376|538262927|FG001|Overall Study|Musculoskeletal injury|2|||
148685109|NCT01571635|536319631|FG003|Overall Study|Other reasons|2|||
148952466|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
148952467|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
148952468|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
148952469|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
149217825|NCT03418376|538262928|FG002|Overall Study|Musculoskeletal injury|1|||
149217826|NCT03418376|538262929|FG003|Overall Study|Musculoskeletal injury|0|||
149217827|NCT03418376|538262926|FG000|Overall Study|Personal reasons|0|||
149217828|NCT03418376|538262927|FG001|Overall Study|Personal reasons|2|||
149217829|NCT03418376|538262928|FG002|Overall Study|Personal reasons|2|||
149217830|NCT03418376|538262929|FG003|Overall Study|Personal reasons|1|||
149217831|NCT03418376|538262926|FG000|Overall Study|Exacerbation|0|||
149217832|NCT03418376|538262927|FG001|Overall Study|Exacerbation|1|||
149217833|NCT03418376|538262928|FG002|Overall Study|Exacerbation|0|||
149217834|NCT03418376|538262929|FG003|Overall Study|Exacerbation|0|||
149217835|NCT02774291|538262930|FG000|Overall Study|Lost to Follow-up|1|||
149217836|NCT00471315|538262931|FG000|Overall Study|Adverse Event|7|||
149217837|NCT00471315|538262931|FG000|Overall Study|Withdrawal by Subject|1|||
149217838|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
149217839|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
149217840|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
149217841|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
149217842|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
149217843|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
149217844|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
149217845|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
149217846|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
149217847|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
149217848|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
149217849|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
149217850|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
149217851|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
149217852|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
149217853|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149217854|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
149217855|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149217856|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149217857|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
149217858|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
149217859|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149217860|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149217861|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149217862|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
149217863|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149217864|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
149217865|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149217866|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149217867|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
149217868|NCT04757376|538262937|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
149217869|NCT04757376|538262938|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
149217870|NCT04757376|538262939|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
149217871|NCT04757376|538262940|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
149217872|NCT04757376|538262941|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
149217873|NCT04757376|538262937|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149217874|NCT04757376|538262938|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149217875|NCT04757376|538262939|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
149217876|NCT04757376|538262940|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149217877|NCT04757376|538262941|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
149217878|NCT00609167|538262942|FG000|Overall Study|Withdrawal by Subject|1|||
149217879|NCT00609167|538262943|FG001|Overall Study|Withdrawal by Subject|0|||
149217880|NCT00609167|538262942|FG000|Overall Study|Lack of Efficacy|1|||
149217881|NCT00609167|538262943|FG001|Overall Study|Lack of Efficacy|0|||
149217882|NCT00609167|538262942|FG000|Overall Study|Adverse Event|5|||
149217883|NCT00609167|538262943|FG001|Overall Study|Adverse Event|1|||
149217884|NCT00609167|538262942|FG000|Overall Study|Disease Progression|1|||
149217885|NCT00609167|538262943|FG001|Overall Study|Disease Progression|0|||
149217886|NCT00609167|538262942|FG000|Overall Study|Stem Cell Transplant|0|||
149217887|NCT00609167|538262943|FG001|Overall Study|Stem Cell Transplant|6|||
149217888|NCT01307046|538262944|FG000|Overall Study|Adverse Event|3|||
149217889|NCT01307046|538262945|FG001|Overall Study|Adverse Event|3|||
149217890|NCT01307046|538262944|FG000|Overall Study|Lack of Efficacy|0|||
149217891|NCT01307046|538262945|FG001|Overall Study|Lack of Efficacy|2|||
149217892|NCT01307046|538262944|FG000|Overall Study|Physician Decision|2|||
149217893|NCT01307046|538262945|FG001|Overall Study|Physician Decision|0|||
149217894|NCT01307046|538262944|FG000|Overall Study|Withdrawal by Subject|1|||
149217895|NCT01307046|538262945|FG001|Overall Study|Withdrawal by Subject|1|||
149217896|NCT01307046|538262944|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
149217897|NCT01307046|538262945|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
149217898|NCT01307046|538262944|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
149217899|NCT01307046|538262945|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
149217900|NCT03898323|538262946|FG000|Overall Study|Physician Decision|1|||
149217901|NCT03935594|538262960|FG000|Overall Study|Physician Decision|3|||
149217902|NCT03954704|538262963|FG000|Overall Study|Death|1|||
149217903|NCT03954704|538262964|FG001|Overall Study|Death|1|||
149217904|NCT03954704|538262965|FG002|Overall Study|Death|1|||
149217905|NCT03954704|538262966|FG003|Overall Study|Death|3|||
149217906|NCT03954704|538262967|FG004|Overall Study|Death|2|||
149217907|NCT03954704|538262968|FG005|Overall Study|Death|2|||
149217908|NCT03954704|538262969|FG006|Overall Study|Death|0|||
149217909|NCT03954704|538262963|FG000|Overall Study|Withdrew Consent|0|||
149217910|NCT03954704|538262964|FG001|Overall Study|Withdrew Consent|0|||
149217911|NCT03954704|538262965|FG002|Overall Study|Withdrew Consent|1|||
149217912|NCT03954704|538262966|FG003|Overall Study|Withdrew Consent|0|||
149217913|NCT03954704|538262967|FG004|Overall Study|Withdrew Consent|0|||
149217914|NCT03954704|538262968|FG005|Overall Study|Withdrew Consent|1|||
149217915|NCT03954704|538262969|FG006|Overall Study|Withdrew Consent|0|||
149217916|NCT03954704|538262963|FG000|Overall Study|Lost to Follow-up|0|||
149217917|NCT03954704|538262964|FG001|Overall Study|Lost to Follow-up|0|||
149217918|NCT03954704|538262965|FG002|Overall Study|Lost to Follow-up|0|||
149217919|NCT03954704|538262966|FG003|Overall Study|Lost to Follow-up|0|||
149217920|NCT03954704|538262967|FG004|Overall Study|Lost to Follow-up|0|||
149217921|NCT03954704|538262968|FG005|Overall Study|Lost to Follow-up|0|||
149217922|NCT03954704|538262969|FG006|Overall Study|Lost to Follow-up|1|||
149217923|NCT03954704|538262963|FG000|Overall Study|Study Terminated by Sponsor|0|||
149217924|NCT03954704|538262964|FG001|Overall Study|Study Terminated by Sponsor|0|||
149217925|NCT03954704|538262965|FG002|Overall Study|Study Terminated by Sponsor|1|||
149217926|NCT03954704|538262966|FG003|Overall Study|Study Terminated by Sponsor|0|||
149217927|NCT03954704|538262967|FG004|Overall Study|Study Terminated by Sponsor|1|||
149217928|NCT03954704|538262968|FG005|Overall Study|Study Terminated by Sponsor|4|||
149217929|NCT03954704|538262969|FG006|Overall Study|Study Terminated by Sponsor|2|||
149217930|NCT03954704|538262963|FG000|Overall Study|Enrolled but not Treated|0|||
149217931|NCT03954704|538262964|FG001|Overall Study|Enrolled but not Treated|0|||
149217932|NCT03954704|538262965|FG002|Overall Study|Enrolled but not Treated|0|||
149217933|NCT03954704|538262966|FG003|Overall Study|Enrolled but not Treated|0|||
149217934|NCT03954704|538262967|FG004|Overall Study|Enrolled but not Treated|0|||
149217935|NCT03954704|538262968|FG005|Overall Study|Enrolled but not Treated|1|||
149217936|NCT03954704|538262969|FG006|Overall Study|Enrolled but not Treated|0|||
149217937|NCT02406027|538262972|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149217938|NCT02406027|538262973|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
149217939|NCT02406027|538262974|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
149217940|NCT02406027|538262975|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149217941|NCT02406027|538262976|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149217942|NCT02406027|538262977|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149217943|NCT02406027|538262978|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
149217944|NCT02406027|538262972|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
149217945|NCT02406027|538262973|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149217946|NCT02406027|538262974|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
149217947|NCT02406027|538262975|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149217948|NCT02406027|538262976|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149217949|NCT02406027|538262977|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149217950|NCT02406027|538262978|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
149217951|NCT02406027|538262972|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
149217952|NCT02406027|538262973|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
149217953|NCT02406027|538262974|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
149217954|NCT02406027|538262975|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149217955|NCT02406027|538262976|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149017499|NCT00962585|537544865|FG002|Overall Study|Withdrew Consent|0|||
149017500|NCT00962585|537544866|FG003|Overall Study|Withdrew Consent|0|||
149017501|NCT02254421|537544867|FG000|Overall Study|Randomized but Not Treated|1|||
149017502|NCT02254421|537544868|FG001|Overall Study|Randomized but Not Treated|0|||
149017503|NCT02254421|537544867|FG000|Overall Study|Death|0|||
149017504|NCT02254421|537544868|FG001|Overall Study|Death|2|||
149017505|NCT02254421|537544867|FG000|Overall Study|Withdrew Consent|1|||
149017506|NCT02254421|537544868|FG001|Overall Study|Withdrew Consent|1|||
149017507|NCT00867490|537544869|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
149017508|NCT00867490|537544869|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
149017509|NCT00867490|537544869|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
149017510|NCT00867490|537544869|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
149017511|NCT00867490|537544869|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
149017512|NCT00358150|537544870|FG000|Overall Study|Adverse Event|3|||
149017513|NCT00358150|537544870|FG000|Overall Study|Withdrawal by Subject|1|||
149017514|NCT00358150|537544870|FG000|Overall Study|Undefined|3|||
149017515|NCT00179010|537544871|FG000|Overall Study|Muscle probe defective|1|||
149017516|NCT00179010|537544872|FG001|Overall Study|Muscle probe defective|1|||
149017517|NCT00179010|537544871|FG000|Overall Study|Failure to place arterial line|0|||
149017518|NCT00179010|537544872|FG001|Overall Study|Failure to place arterial line|1|||
149017519|NCT00531011|537544886|FG000|Overall Study|Withdrawal by Subject|2|||
149017520|NCT00531011|537544887|FG001|Overall Study|Withdrawal by Subject|4|||
149017521|NCT00531011|537544886|FG000|Overall Study|Death|1|||
149017522|NCT00531011|537544887|FG001|Overall Study|Death|0|||
149017523|NCT00531011|537544886|FG000|Overall Study|Lost to Follow-up|1|||
149017524|NCT00531011|537544887|FG001|Overall Study|Lost to Follow-up|0|||
149017525|NCT00531011|537544886|FG000|Overall Study|Physician Decision|0|||
149017526|NCT00531011|537544887|FG001|Overall Study|Physician Decision|3|||
149017527|NCT03268590|537544888|FG000|Overall Study|Previously unknown exclusion criteria|1|||
149017528|NCT02823964|537544911|FG000|Overall Study|Adverse Event|2|||
149017529|NCT02823964|537544911|FG000|Overall Study|Physician Decision|1|||
149017530|NCT02823964|537544911|FG000|Overall Study|Lack of Efficacy|1|||
149017531|NCT02823964|537544911|FG000|Overall Study|Withdrawal by Subject|1|||
149017532|NCT03537261|537544932|FG000|Overall Study|Lost to Follow-up|4|||
149017533|NCT03537261|537544933|FG001|Overall Study|Lost to Follow-up|5|||
149017534|NCT03537261|537544932|FG000|Overall Study|Withdrawal by Subject|4|||
149017535|NCT03537261|537544933|FG001|Overall Study|Withdrawal by Subject|6|||
149017536|NCT03537261|537544932|FG000|Overall Study|Did not return study questionnaires|0|||
149017537|NCT03537261|537544933|FG001|Overall Study|Did not return study questionnaires|1|||
149017538|NCT01177813|537544934|FG000|Overall Study|Adverse Event|8|||
149017539|NCT01177813|537544935|FG001|Overall Study|Adverse Event|2|||
148952470|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
148952471|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
148952472|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
149217956|NCT02406027|538262977|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149217957|NCT02406027|538262978|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
149217958|NCT02406027|538262972|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
149217959|NCT02406027|538262973|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149217960|NCT02406027|538262974|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
149217961|NCT02406027|538262975|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149217962|NCT02406027|538262976|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149217963|NCT02406027|538262977|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149217964|NCT02406027|538262978|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
149217965|NCT02406027|538262972|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
149217966|NCT02406027|538262973|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
149217967|NCT02406027|538262974|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
149217968|NCT02406027|538262975|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
149217969|NCT02406027|538262976|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
149217970|NCT02406027|538262977|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
149217971|NCT02406027|538262978|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
149217972|NCT02406027|538262972|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
149217973|NCT02406027|538262973|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
149217974|NCT02406027|538262974|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
149217975|NCT02406027|538262975|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
149217976|NCT02406027|538262976|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
148952473|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
149217977|NCT02406027|538262977|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
149217978|NCT02406027|538262978|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
149217979|NCT02406027|538262972|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149217980|NCT02406027|538262973|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
148952474|NCT02603419|537307374|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
149217981|NCT02406027|538262974|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149217982|NCT02406027|538262975|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
149217983|NCT02406027|538262976|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
149217984|NCT02406027|538262977|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
149217985|NCT02406027|538262978|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
149217986|NCT02406027|538262972|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
149217987|NCT02406027|538262973|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
148952475|NCT02603419|537307375|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
148952476|NCT02603419|537307376|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
148952477|NCT02603419|537307377|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
149017540|NCT01177813|537544936|FG002|Overall Study|Adverse Event|4|||
149017541|NCT01177813|537544937|FG003|Overall Study|Adverse Event|6|||
149017542|NCT01177813|537544938|FG004|Overall Study|Adverse Event|3|||
149017543|NCT01177813|537544934|FG000|Overall Study|Lack of Efficacy|1|||
149217988|NCT02406027|538262974|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
149217989|NCT02406027|538262975|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
149217990|NCT02406027|538262976|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
149217991|NCT02406027|538262977|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
149217992|NCT02406027|538262978|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
149217993|NCT02406027|538262972|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149217994|NCT02406027|538262973|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149217995|NCT02406027|538262974|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149217996|NCT02406027|538262975|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149217997|NCT02406027|538262976|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149217998|NCT02406027|538262977|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
149217999|NCT02406027|538262978|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
149218000|NCT02406027|538262972|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149218001|NCT02406027|538262973|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149218002|NCT02406027|538262974|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149218003|NCT02406027|538262975|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149218004|NCT02406027|538262976|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
149218005|NCT02406027|538262977|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149218006|NCT02406027|538262978|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
149218007|NCT03277794|538262981|FG000|Overall Study|Lost to Follow-up|2|||
149218008|NCT03277794|538262982|FG001|Overall Study|Lost to Follow-up|4|||
149218009|NCT03277794|538262981|FG000|Overall Study|Withdrew due to high acuity|1|||
149218010|NCT03277794|538262982|FG001|Overall Study|Withdrew due to high acuity|0|||
149218011|NCT05166603|538262983|FG000|Overall Study|Withdrawal by Subject|68|||
149218012|NCT05166603|538262984|FG001|Overall Study|Withdrawal by Subject|0|||
149218013|NCT04969900|538265362|FG000|Overall Study|Physician Decision|1|||
149218014|NCT04969900|538265363|FG001|Overall Study|Physician Decision|1|||
149218015|NCT04969900|538265362|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
149218016|NCT04969900|538265363|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
149218017|NCT02881151|538265369|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
149218018|NCT03258593|538265371|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
149218019|NCT03258593|538265372|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
149218020|NCT03258593|538265373|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
149218021|NCT03258593|538265374|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
149218022|NCT03258593|538265371|FG000|Run-In Maintenance Phase|Disease progression|3|||
149218023|NCT03258593|538265372|FG001|Run-In Maintenance Phase|Disease progression|0|||
149218024|NCT03258593|538265373|FG002|Run-In Maintenance Phase|Disease progression|0|||
149218025|NCT03258593|538265374|FG003|Run-In Maintenance Phase|Disease progression|0|||
149218026|NCT03258593|538265371|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
149218027|NCT03258593|538265372|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
149218028|NCT03258593|538265373|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
149218029|NCT03258593|538265374|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
149218030|NCT03258593|538265371|FG000|Expansion Maintenance Phase|Physician Decision|0|||
149218031|NCT03258593|538265372|FG001|Expansion Maintenance Phase|Physician Decision|1|||
149218032|NCT03258593|538265373|FG002|Expansion Maintenance Phase|Physician Decision|0|||
149218033|NCT03258593|538265374|FG003|Expansion Maintenance Phase|Physician Decision|0|||
149218034|NCT05618808|538265375|FG000|Overall Study|Withdrawal by Subject|3|||
149218035|NCT05618808|538265376|FG001|Overall Study|Withdrawal by Subject|1|||
149218036|NCT05618808|538265377|FG002|Overall Study|Withdrawal by Subject|3|||
149218037|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
149218038|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
149218039|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Death|1|||
149218040|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Death|1|||
149218041|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
149218042|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
149218043|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
149218044|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
149218045|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
149218046|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
149218047|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
149218048|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
149218049|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
149218050|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
149218051|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
149218052|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
149218053|NCT03728881|538265380|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
149218054|NCT03728881|538265381|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
149218055|NCT03728881|538265380|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
149017544|NCT01177813|537544935|FG001|Overall Study|Lack of Efficacy|0|||
149218056|NCT03728881|538265381|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
149218057|NCT03728881|538265380|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
149218058|NCT03728881|538265381|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
149218059|NCT04517253|538265384|FG000|Primary Treatment Period|Adverse Event|1|||
149218060|NCT04517253|538265385|FG001|Primary Treatment Period|Adverse Event|0|||
149218061|NCT04517253|538265386|FG002|Primary Treatment Period|Adverse Event|0|||
149218062|NCT04517253|538265384|FG000|Primary Treatment Period|Death|0|||
149218063|NCT04517253|538265385|FG001|Primary Treatment Period|Death|1|||
149218064|NCT04517253|538265386|FG002|Primary Treatment Period|Death|0|||
149218065|NCT04517253|538265384|FG000|Maintenance Period|Withdrawal by Subject|1|||
149218066|NCT04517253|538265385|FG001|Maintenance Period|Withdrawal by Subject|0|||
149218067|NCT04517253|538265386|FG002|Maintenance Period|Withdrawal by Subject|0|||
149218068|NCT04517253|538265384|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
149218069|NCT04517253|538265385|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
149218070|NCT04517253|538265386|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
149218071|NCT04651777|538265390|FG000|Overall Study|Adverse Event|1|||
149218072|NCT04651777|538265390|FG000|Overall Study|Withdrawal by Subject|2|||
149218073|NCT06048367|538265391|FG000|Overall Study|Withdrawal by Subject|0|||
149218074|NCT06048367|538265392|FG001|Overall Study|Withdrawal by Subject|1|||
149218075|NCT06048367|538265393|FG002|Overall Study|Withdrawal by Subject|0|||
149218076|NCT06048367|538265394|FG003|Overall Study|Withdrawal by Subject|0|||
149218077|NCT06048367|538265395|FG004|Overall Study|Withdrawal by Subject|0|||
149218078|NCT06048367|538265391|FG000|Overall Study|Withdrawal by Subject|0|||
149218079|NCT06048367|538265392|FG001|Overall Study|Withdrawal by Subject|0|||
149218080|NCT06048367|538265393|FG002|Overall Study|Withdrawal by Subject|1|||
149218081|NCT06048367|538265394|FG003|Overall Study|Withdrawal by Subject|0|||
149218082|NCT06048367|538265395|FG004|Overall Study|Withdrawal by Subject|0|||
149218083|NCT06048367|538265391|FG000|Overall Study|Withdrawal by Subject|0|||
149218084|NCT06048367|538265392|FG001|Overall Study|Withdrawal by Subject|0|||
149218085|NCT06048367|538265393|FG002|Overall Study|Withdrawal by Subject|0|||
149218086|NCT06048367|538265394|FG003|Overall Study|Withdrawal by Subject|1|||
149218087|NCT06048367|538265395|FG004|Overall Study|Withdrawal by Subject|0|||
149218088|NCT06048367|538265391|FG000|Overall Study|Withdrawal by Subject|0|||
149218089|NCT06048367|538265392|FG001|Overall Study|Withdrawal by Subject|0|||
149218090|NCT06048367|538265393|FG002|Overall Study|Withdrawal by Subject|0|||
149218091|NCT06048367|538265394|FG003|Overall Study|Withdrawal by Subject|1|||
149218092|NCT06048367|538265395|FG004|Overall Study|Withdrawal by Subject|0|||
149218093|NCT04088331|538265396|FG000|Overall Study|Lost to Follow-up|3|||
149218094|NCT04088331|538265396|FG000|Overall Study|Withdrawal by Subject|7|||
149218095|NCT04088331|538265396|FG000|Overall Study|Adverse Event|4|||
149218096|NCT02136134|538265402|FG000|Overall Study|Death|170|||
149218097|NCT02136134|538265403|FG001|Overall Study|Death|148|||
149218098|NCT02136134|538265402|FG000|Overall Study|Withdrawal by Subject|19|||
149218099|NCT02136134|538265403|FG001|Overall Study|Withdrawal by Subject|10|||
149218100|NCT02136134|538265402|FG000|Overall Study|Lost to Follow-up|3|||
149218101|NCT02136134|538265403|FG001|Overall Study|Lost to Follow-up|3|||
149218102|NCT02136134|538265402|FG000|Overall Study|Uspecified|55|||
149218103|NCT02136134|538265403|FG001|Overall Study|Uspecified|90|||
149218104|NCT03070119|538265406|FG000|Overall Study|Adverse Event|0|||
149218105|NCT03070119|538265407|FG001|Overall Study|Adverse Event|0|||
149218106|NCT03070119|538265408|FG002|Overall Study|Adverse Event|1|||
149218107|NCT03070119|538265406|FG000|Overall Study|Lost to Follow-up|0|||
149218108|NCT03070119|538265407|FG001|Overall Study|Lost to Follow-up|1|||
149218109|NCT03070119|538265408|FG002|Overall Study|Lost to Follow-up|0|||
149218110|NCT03070119|538265406|FG000|Overall Study|Consent Withdrawn|6|||
149218111|NCT03070119|538265407|FG001|Overall Study|Consent Withdrawn|5|||
149218112|NCT03070119|538265408|FG002|Overall Study|Consent Withdrawn|3|||
149218113|NCT03070119|538265406|FG000|Overall Study|Investigator Decision|0|||
149218114|NCT03070119|538265407|FG001|Overall Study|Investigator Decision|0|||
149218115|NCT03070119|538265408|FG002|Overall Study|Investigator Decision|1|||
149218116|NCT03070119|538265406|FG000|Overall Study|Death|7|||
149218117|NCT03070119|538265407|FG001|Overall Study|Death|14|||
149218118|NCT03070119|538265408|FG002|Overall Study|Death|5|||
149218119|NCT03070119|538265406|FG000|Overall Study|Disease Progression|5|||
149218120|NCT03070119|538265407|FG001|Overall Study|Disease Progression|7|||
149218121|NCT03070119|538265408|FG002|Overall Study|Disease Progression|7|||
149218122|NCT03070119|538265406|FG000|Overall Study|Reason not Specified|2|||
149218123|NCT03070119|538265407|FG001|Overall Study|Reason not Specified|2|||
149218124|NCT03070119|538265408|FG002|Overall Study|Reason not Specified|1|||
149218125|NCT02974621|538265410|FG000|Overall Study|Didn't receive study treatment|1|||
149218126|NCT02974621|538265411|FG001|Overall Study|Didn't receive study treatment|10|||
149218127|NCT00732472|538265412|FG000|Overall Study|Adverse Event|0|||
149218128|NCT00732472|538265413|FG001|Overall Study|Adverse Event|1|||
149218129|NCT00732472|538265414|FG002|Overall Study|Adverse Event|1|||
149218130|NCT00732472|538265415|FG003|Overall Study|Adverse Event|1|||
149218131|NCT00732472|538265412|FG000|Overall Study|Protocol Violation|0|||
149218132|NCT00732472|538265413|FG001|Overall Study|Protocol Violation|0|||
149218133|NCT00732472|538265414|FG002|Overall Study|Protocol Violation|0|||
149218134|NCT00732472|538265415|FG003|Overall Study|Protocol Violation|1|||
149218135|NCT00732472|538265412|FG000|Overall Study|Withdrawal by Subject|0|||
149218136|NCT00732472|538265413|FG001|Overall Study|Withdrawal by Subject|2|||
149218137|NCT00732472|538265414|FG002|Overall Study|Withdrawal by Subject|0|||
149218138|NCT00732472|538265415|FG003|Overall Study|Withdrawal by Subject|1|||
149218139|NCT02559115|538265417|FG000|Overall Study|Withdrawal by Subject|3|||
149218140|NCT01266876|538265418|FG000|Overall Study|Adverse Event|0|||
149218141|NCT01266876|538265419|FG001|Overall Study|Adverse Event|0|||
149218142|NCT01266876|538265420|FG002|Overall Study|Adverse Event|0|||
149218143|NCT01266876|538265421|FG003|Overall Study|Adverse Event|1|||
149218144|NCT01266876|538265422|FG004|Overall Study|Adverse Event|0|||
149218145|NCT01058395|538265423|FG000|Overall Study|Death|2|||
149218146|NCT01058395|538265424|FG001|Overall Study|Death|1|||
149218147|NCT01058395|538265423|FG000|Overall Study|Lost to Follow-up|1|||
149218148|NCT01058395|538265424|FG001|Overall Study|Lost to Follow-up|0|||
149218149|NCT05016037|538265426|FG000|Overall Study|Lost to Follow-up|2|||
149218150|NCT03715205|538265427|FG000|Overall Study|Death|13|||
149218151|NCT03715205|538265427|FG000|Overall Study|Lost to Follow-up|2|||
149218152|NCT03715205|538265427|FG000|Overall Study|Physician Decision|93|||
149218153|NCT03715205|538265427|FG000|Overall Study|Withdrawal by Subject|26|||
149218154|NCT02756845|538265432|FG000|Overall Study|Death|12|||
149218155|NCT02756845|538265433|FG001|Overall Study|Death|2|||
149218156|NCT02756845|538265432|FG000|Overall Study|Withdrawal by Subject|1|||
149218157|NCT02756845|538265433|FG001|Overall Study|Withdrawal by Subject|0|||
149218158|NCT03342404|538265434|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
149218159|NCT03342404|538265435|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
149218160|NCT03342404|538265434|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
149218161|NCT03342404|538265435|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
149218162|NCT03342404|538265434|FG000|Blinded Treatment Phase|Adverse Event|5|||
149218163|NCT03342404|538265435|FG001|Blinded Treatment Phase|Adverse Event|4|||
149218164|NCT03342404|538265434|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
149218165|NCT03342404|538265435|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
149218166|NCT03342404|538265434|FG000|Blinded Treatment Phase|Other reasons|1|||
149218167|NCT03342404|538265435|FG001|Blinded Treatment Phase|Other reasons|0|||
149218168|NCT03342404|538265434|FG000|Blinded Treatment Phase|Physician Decision|1|||
149218169|NCT03342404|538265435|FG001|Blinded Treatment Phase|Physician Decision|0|||
149218170|NCT03342404|538265434|FG000|Blinded Treatment Phase|Death|1|||
149218171|NCT03342404|538265435|FG001|Blinded Treatment Phase|Death|0|||
149218172|NCT03342404|538265434|FG000|Open-Label Phase|Lost to Follow-up|0|||
149218173|NCT03342404|538265435|FG001|Open-Label Phase|Lost to Follow-up|1|||
149218174|NCT03342404|538265434|FG000|Open-Label Phase|Other reasons|0|||
149218175|NCT03342404|538265435|FG001|Open-Label Phase|Other reasons|1|||
149017545|NCT01177813|537544936|FG002|Overall Study|Lack of Efficacy|0|||
149017546|NCT01177813|537544937|FG003|Overall Study|Lack of Efficacy|0|||
149017547|NCT01177813|537544938|FG004|Overall Study|Lack of Efficacy|0|||
149017548|NCT01177813|537544934|FG000|Overall Study|Protocol Violation|3|||
149017549|NCT01177813|537544935|FG001|Overall Study|Protocol Violation|2|||
149017550|NCT01177813|537544936|FG002|Overall Study|Protocol Violation|2|||
149017551|NCT01177813|537544937|FG003|Overall Study|Protocol Violation|0|||
149017552|NCT01177813|537544938|FG004|Overall Study|Protocol Violation|1|||
149017553|NCT01177813|537544934|FG000|Overall Study|Lost to Follow-up|12|||
149017554|NCT01177813|537544935|FG001|Overall Study|Lost to Follow-up|5|||
149017555|NCT01177813|537544936|FG002|Overall Study|Lost to Follow-up|6|||
149017556|NCT01177813|537544937|FG003|Overall Study|Lost to Follow-up|3|||
149017557|NCT01177813|537544938|FG004|Overall Study|Lost to Follow-up|0|||
149017558|NCT01177813|537544934|FG000|Overall Study|Withdrawal by Subject|12|||
149017559|NCT01177813|537544935|FG001|Overall Study|Withdrawal by Subject|7|||
149017560|NCT01177813|537544936|FG002|Overall Study|Withdrawal by Subject|6|||
149017561|NCT01177813|537544937|FG003|Overall Study|Withdrawal by Subject|5|||
149017562|NCT01177813|537544938|FG004|Overall Study|Withdrawal by Subject|3|||
149017563|NCT01177813|537544934|FG000|Overall Study|Other reason not defined above|5|||
149017564|NCT01177813|537544935|FG001|Overall Study|Other reason not defined above|2|||
149017565|NCT01177813|537544936|FG002|Overall Study|Other reason not defined above|2|||
149017566|NCT01177813|537544937|FG003|Overall Study|Other reason not defined above|3|||
149017567|NCT01177813|537544938|FG004|Overall Study|Other reason not defined above|2|||
149017568|NCT04011384|537544945|FG000|Overall Study|Withdrawal by Subject|2|||
149017569|NCT04011384|537544946|FG001|Overall Study|Withdrawal by Subject|0|||
149017570|NCT00363896|537544947|FG000|Overall Study|Withdrawal by Subject|29|||
149017571|NCT00363896|537544948|FG001|Overall Study|Withdrawal by Subject|16|||
149218176|NCT03342404|538265434|FG000|Open-Label Phase|Adverse Event|0|||
149218177|NCT03342404|538265435|FG001|Open-Label Phase|Adverse Event|3|||
149218178|NCT03342404|538265434|FG000|Open-Label Phase|Withdrawal by Subject|0|||
149218179|NCT03342404|538265435|FG001|Open-Label Phase|Withdrawal by Subject|6|||
149017572|NCT00363896|537544947|FG000|Overall Study|Adverse Event|24|||
149017573|NCT00363896|537544948|FG001|Overall Study|Adverse Event|13|||
149218180|NCT03733249|538265437|FG000|Overall Study|Death|7|||
149218181|NCT03733249|538265437|FG000|Overall Study|Disease relapse|16|||
148809896|NCT02475213|536780895|FG006|Overall Study|Withdrawal by Subject|2|||
148809897|NCT02475213|536780896|FG007|Overall Study|Withdrawal by Subject|0|||
148809898|NCT02475213|536780889|FG000|Overall Study|Other|0|||
148809899|NCT02475213|536780890|FG001|Overall Study|Other|0|||
148809900|NCT02475213|536780891|FG002|Overall Study|Other|0|||
148809901|NCT02475213|536780892|FG003|Overall Study|Other|1|||
148809902|NCT02475213|536780893|FG004|Overall Study|Other|3|||
148809903|NCT02475213|536780894|FG005|Overall Study|Other|1|||
148809904|NCT02475213|536780895|FG006|Overall Study|Other|0|||
148809905|NCT02475213|536780896|FG007|Overall Study|Other|0|||
148809906|NCT02441283|536780897|FG000|Overall Study|Withdrew consent|15|||
148952478|NCT02603419|537307378|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
148952479|NCT02603419|537307379|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
148952480|NCT02603419|537307374|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
148952481|NCT02603419|537307375|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
148952482|NCT02603419|537307376|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
148952483|NCT02603419|537307377|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
148952484|NCT02603419|537307378|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
148952485|NCT02603419|537307379|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
148952486|NCT02603419|537307374|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
148952487|NCT02603419|537307375|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
148952488|NCT02603419|537307376|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
148952489|NCT02603419|537307377|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
148952490|NCT02603419|537307378|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
148952491|NCT02603419|537307379|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
148952492|NCT02603419|537307374|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
148952493|NCT02603419|537307375|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
148952494|NCT02603419|537307376|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
148952495|NCT02603419|537307377|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
148952496|NCT02603419|537307378|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
148952497|NCT02603419|537307379|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
148952498|NCT03552198|537307380|FG000|Overall Study|Lost to Follow-up|42|||
148952499|NCT03552198|537307381|FG001|Overall Study|Lost to Follow-up|48|||
148952500|NCT03552198|537307382|FG002|Overall Study|Lost to Follow-up|15|||
148952501|NCT03552198|537307383|FG003|Overall Study|Lost to Follow-up|19|||
149218182|NCT03733249|538265437|FG000|Overall Study|Lost to Follow-up|4|||
149218183|NCT03733249|538265437|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
149218184|NCT03733249|538265437|FG000|Overall Study|Withdrawal by Subject|1|||
149218185|NCT00850135|538265438|FG000|Overall Study|Physician Decision|1|||
149218186|NCT02253992|538265439|FG000|Overall Study|Study drug toxicity|1|||
149218187|NCT02253992|538265440|FG001|Overall Study|Study drug toxicity|0|||
149218188|NCT02253992|538265441|FG002|Overall Study|Study drug toxicity|10|||
149218189|NCT02253992|538265439|FG000|Overall Study|Disease progression|4|||
149218190|NCT02253992|538265440|FG001|Overall Study|Disease progression|3|||
149218191|NCT02253992|538265441|FG002|Overall Study|Disease progression|98|||
149218192|NCT02253992|538265439|FG000|Overall Study|Withdrawal by Subject|0|||
149218193|NCT02253992|538265440|FG001|Overall Study|Withdrawal by Subject|0|||
149218194|NCT02253992|538265441|FG002|Overall Study|Withdrawal by Subject|3|||
149218195|NCT02253992|538265439|FG000|Overall Study|Adverse Event|0|||
149218196|NCT02253992|538265440|FG001|Overall Study|Adverse Event|0|||
149218197|NCT02253992|538265441|FG002|Overall Study|Adverse Event|8|||
149218198|NCT02253992|538265439|FG000|Overall Study|Death|0|||
149218199|NCT02253992|538265440|FG001|Overall Study|Death|0|||
149218200|NCT02253992|538265441|FG002|Overall Study|Death|1|||
149218201|NCT02253992|538265439|FG000|Overall Study|Subject discontinued study drug|1|||
149218202|NCT02253992|538265440|FG001|Overall Study|Subject discontinued study drug|0|||
149218203|NCT02253992|538265441|FG002|Overall Study|Subject discontinued study drug|1|||
149218204|NCT02253992|538265439|FG000|Overall Study|Completed treatment as per protocol|0|||
149218205|NCT02253992|538265440|FG001|Overall Study|Completed treatment as per protocol|1|||
149218206|NCT02253992|538265441|FG002|Overall Study|Completed treatment as per protocol|22|||
149218207|NCT02253992|538265439|FG000|Overall Study|Other|0|||
149218208|NCT02253992|538265440|FG001|Overall Study|Other|0|||
148809907|NCT02441283|536780897|FG000|Overall Study|Lost to Follow-up|42|||
148809908|NCT02441283|536780897|FG000|Overall Study|Death|1|||
149218209|NCT02253992|538265441|FG002|Overall Study|Other|1|||
149218210|NCT00772889|538265442|FG000|Overall Study|Adverse Event|7|||
149218211|NCT00772889|538265443|FG001|Overall Study|Adverse Event|4|||
149218212|NCT00772889|538265444|FG002|Overall Study|Adverse Event|0|||
149218213|NCT00772889|538265442|FG000|Overall Study|Withdrawal by Subject|9|||
148809909|NCT02441283|536780897|FG000|Overall Study|Other, not specified|32|||
148809910|NCT00717886|536780900|FG000|Overall Study|Withdrawal by Subject|3|||
148809911|NCT00717886|536780900|FG000|Overall Study|Treatment Failure|1|||
148809912|NCT01553851|536780901|FG000|Overall Study|Adverse Event|2|||
148952502|NCT03552198|537307380|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
149218214|NCT00772889|538265443|FG001|Overall Study|Withdrawal by Subject|8|||
149218215|NCT00772889|538265444|FG002|Overall Study|Withdrawal by Subject|9|||
149218216|NCT00772889|538265442|FG000|Overall Study|Lost to Follow-up|6|||
149218217|NCT00772889|538265443|FG001|Overall Study|Lost to Follow-up|6|||
149218218|NCT00772889|538265444|FG002|Overall Study|Lost to Follow-up|7|||
149218219|NCT03323086|538265445|FG000|Overall Study|Lost to Follow-up|3|||
149218220|NCT03323086|538265446|FG001|Overall Study|Lost to Follow-up|2|||
149218221|NCT00796549|538265458|FG000|Overall Study|Adverse Event|11|||
149218222|NCT00796549|538265458|FG000|Overall Study|not entered|149|||
149218223|NCT00796549|538265458|FG000|Overall Study|Other|2|||
149218224|NCT00796549|538265458|FG000|Overall Study|Progressive disease|56|||
149218225|NCT03523715|538265461|FG000|Overall Study|Lost to Follow-up|11|||
149218226|NCT03523715|538265462|FG001|Overall Study|Lost to Follow-up|14|||
149218227|NCT03523715|538265461|FG000|Overall Study|Did not meet inclusion criteria|1|||
149218228|NCT03523715|538265462|FG001|Overall Study|Did not meet inclusion criteria|0|||
149218229|NCT03523715|538265461|FG000|Overall Study|Internally inconsistent reporting|0|||
149218230|NCT03523715|538265462|FG001|Overall Study|Internally inconsistent reporting|2|||
149218231|NCT00606229|538265463|FG000|Overall Study|Adverse Event|11|||
149218232|NCT00606229|538265463|FG000|Overall Study|Lack of Efficacy|1|||
149218233|NCT00606229|538265463|FG000|Overall Study|Withdrawal by Subject|4|||
149218234|NCT00606229|538265463|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
149218235|NCT00606229|538265463|FG000|Overall Study|change of residence or other commitments|2|||
149218236|NCT02139280|538265464|FG000|Overall Study|No longer eligible|2|||
149218237|NCT02139280|538265465|FG001|Overall Study|No longer eligible|0|||
149218238|NCT01332851|538265466|FG000|Overall Study|Withdrawal by Subject|4|||
149218239|NCT01332851|538265467|FG001|Overall Study|Withdrawal by Subject|2|||
149218240|NCT01332851|538265466|FG000|Overall Study|Lost to Follow-up|7|||
149218241|NCT01332851|538265467|FG001|Overall Study|Lost to Follow-up|11|||
149218242|NCT03299166|538265468|FG000|Overall Study|Adverse Event|9|||
149218243|NCT03299166|538265469|FG001|Overall Study|Adverse Event|4|||
149218244|NCT03299166|538265468|FG000|Overall Study|Withdrawal by Subject|6|||
149218245|NCT03299166|538265469|FG001|Overall Study|Withdrawal by Subject|5|||
149218246|NCT03299166|538265468|FG000|Overall Study|Physician Decision|1|||
149218247|NCT03299166|538265469|FG001|Overall Study|Physician Decision|1|||
149218248|NCT03299166|538265468|FG000|Overall Study|Sponsor Decision|3|||
149218249|NCT03299166|538265469|FG001|Overall Study|Sponsor Decision|0|||
149218250|NCT03299166|538265468|FG000|Overall Study|Lost to Follow-up|2|||
149218251|NCT03299166|538265469|FG001|Overall Study|Lost to Follow-up|4|||
149218252|NCT03299166|538265468|FG000|Overall Study|Randomization Error|0|||
149218253|NCT03299166|538265469|FG001|Overall Study|Randomization Error|1|||
149218254|NCT03299166|538265468|FG000|Overall Study|Subject unable to return due to COVID|1|||
149218255|NCT03299166|538265469|FG001|Overall Study|Subject unable to return due to COVID|0|||
149218256|NCT03299166|538265468|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
149218257|NCT03299166|538265469|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
149218258|NCT00422903|538265472|FG000|Overall Study|Disease Progression|3|||
149218259|NCT00422903|538265473|FG001|Overall Study|Disease Progression|1|||
149218260|NCT00422903|538265472|FG000|Overall Study|Adverse Event|0|||
149218261|NCT00422903|538265473|FG001|Overall Study|Adverse Event|2|||
149218262|NCT00422903|538265472|FG000|Overall Study|Informed Consent Withdrawn|1|||
149218263|NCT00422903|538265473|FG001|Overall Study|Informed Consent Withdrawn|2|||
149218264|NCT01249157|538265478|FG000|Overall Study|Withdrawal by Subject|1|||
149218265|NCT02392468|538265484|FG000|Overall Study|Adverse Event|0|||
149218266|NCT02392468|538265485|FG001|Overall Study|Adverse Event|1|||
149218267|NCT02392468|538265486|FG002|Overall Study|Adverse Event|0|||
148952503|NCT03552198|537307381|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
148952504|NCT03552198|537307382|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
148952505|NCT03552198|537307383|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
148952506|NCT03552198|537307380|FG000|Overall Study|Did not receive air alerts|1|||
148952507|NCT03552198|537307381|FG001|Overall Study|Did not receive air alerts|0|||
148952508|NCT03552198|537307382|FG002|Overall Study|Did not receive air alerts|0|||
148952509|NCT03552198|537307383|FG003|Overall Study|Did not receive air alerts|1|||
148952510|NCT06149247|537307384|FG000|Overall Study|Adverse Event|0|||
148952511|NCT06149247|537307385|FG001|Overall Study|Adverse Event|1|||
149218268|NCT02392468|538265487|FG003|Overall Study|Adverse Event|0|||
149218269|NCT02392468|538265488|FG004|Overall Study|Adverse Event|0|||
149218270|NCT02392468|538265489|FG005|Overall Study|Adverse Event|1|||
149218271|NCT01039428|538265490|FG000|Overall Study|Protocol Violation|1|||
149218272|NCT01039428|538265491|FG001|Overall Study|Protocol Violation|0|||
149218273|NCT01039428|538265490|FG000|Overall Study|Withdrawal by Subject|1|||
149218274|NCT01039428|538265491|FG001|Overall Study|Withdrawal by Subject|0|||
149218275|NCT01313039|538265492|FG000|Overall Study|Physician Decision|1|||
149218276|NCT01313039|538265492|FG000|Overall Study|Adverse Event|1|||
148952512|NCT02289417|537307386|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
149218277|NCT03630016|538265493|FG000|Overall Study|Poor Sensor Placement|1|||
149218278|NCT01300767|538265496|FG000|Overall Study|Discomfort|2|||
149218279|NCT01300767|538265496|FG000|Overall Study|Biomicroscopy|1|||
149218280|NCT01300767|538265496|FG000|Overall Study|Unacceptable fit|1|||
149218281|NCT00126425|538265499|FG000|Overall Study|Withdrawal by Subject|17|||
149218282|NCT00126425|538265500|FG001|Overall Study|Withdrawal by Subject|1|||
149218283|NCT00126425|538265499|FG000|Overall Study|Lost to Follow-up|8|||
149218284|NCT00126425|538265500|FG001|Overall Study|Lost to Follow-up|4|||
149218285|NCT00126425|538265499|FG000|Overall Study|Protocol Violation|9|||
149218286|NCT00126425|538265500|FG001|Overall Study|Protocol Violation|6|||
149218287|NCT00126425|538265499|FG000|Overall Study|Adverse Event|1|||
149218288|NCT00126425|538265500|FG001|Overall Study|Adverse Event|0|||
149017574|NCT00363896|537544947|FG000|Overall Study|COPD exacerbation|13|||
149017575|NCT00363896|537544948|FG001|Overall Study|COPD exacerbation|7|||
149017576|NCT00363896|537544947|FG000|Overall Study|Lack of Efficacy|12|||
149017577|NCT00363896|537544948|FG001|Overall Study|Lack of Efficacy|8|||
149017578|NCT00363896|537544947|FG000|Overall Study|Protocol Violation|6|||
149017579|NCT00363896|537544948|FG001|Overall Study|Protocol Violation|1|||
149017580|NCT00363896|537544947|FG000|Overall Study|Lost to Follow-up|3|||
149017581|NCT00363896|537544948|FG001|Overall Study|Lost to Follow-up|0|||
149017582|NCT00363896|537544947|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
149017583|NCT00363896|537544948|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
149017584|NCT00363896|537544947|FG000|Overall Study|Other|1|||
149017585|NCT00363896|537544948|FG001|Overall Study|Other|2|||
149017586|NCT04147260|537544950|FG000|Overall Study|Adverse Event|1|||
149017587|NCT04147260|537544951|FG001|Overall Study|Adverse Event|0|||
149017588|NCT04147260|537544952|FG002|Overall Study|Adverse Event|1|||
149017589|NCT04147260|537544953|FG003|Overall Study|Adverse Event|2|||
149017590|NCT04147260|537544954|FG004|Overall Study|Adverse Event|0|||
149017591|NCT04147260|537544950|FG000|Overall Study|Withdrawal by Subject|0|||
149017592|NCT04147260|537544951|FG001|Overall Study|Withdrawal by Subject|0|||
149017593|NCT04147260|537544952|FG002|Overall Study|Withdrawal by Subject|1|||
149017594|NCT04147260|537544953|FG003|Overall Study|Withdrawal by Subject|1|||
149017595|NCT04147260|537544954|FG004|Overall Study|Withdrawal by Subject|0|||
149017596|NCT01651936|537544955|FG000|Base Study|Adverse Event|3|||
149017597|NCT01651936|537544956|FG001|Base Study|Adverse Event|0|||
149017598|NCT01651936|537544957|FG002|Base Study|Adverse Event|0|||
149017599|NCT01651936|537544955|FG000|Base Study|Withdrawal by Subject|1|||
149017600|NCT01651936|537544956|FG001|Base Study|Withdrawal by Subject|1|||
149017601|NCT01651936|537544957|FG002|Base Study|Withdrawal by Subject|0|||
149017602|NCT01651936|537544955|FG000|Base Study|Early Escape|2|||
149017603|NCT01651936|537544956|FG001|Base Study|Early Escape|8|||
149017604|NCT01651936|537544957|FG002|Base Study|Early Escape|0|||
149017605|NCT01651936|537544955|FG000|Base Study|Study terminated by sponsor|21|||
149017606|NCT01651936|537544956|FG001|Base Study|Study terminated by sponsor|16|||
149017607|NCT01651936|537544957|FG002|Base Study|Study terminated by sponsor|0|||
149017608|NCT01651936|537544955|FG000|Extension Study|Lack of Efficacy|0|||
149017609|NCT01651936|537544956|FG001|Extension Study|Lack of Efficacy|0|||
149017610|NCT01651936|537544957|FG002|Extension Study|Lack of Efficacy|1|||
149017611|NCT01651936|537544955|FG000|Extension Study|Study terminated by sponsor|0|||
149017612|NCT01651936|537544956|FG001|Extension Study|Study terminated by sponsor|0|||
149017613|NCT01651936|537544957|FG002|Extension Study|Study terminated by sponsor|13|||
149017614|NCT03044353|537544958|FG000|Overall Study|Adverse Event|0|||
149017615|NCT03044353|537544959|FG001|Overall Study|Adverse Event|1|||
149017616|NCT03044353|537544960|FG002|Overall Study|Adverse Event|0|||
149017617|NCT01555021|537544967|FG000|Overall Study|Lost to Follow-up|1|||
149017618|NCT01555021|537544968|FG001|Overall Study|Lost to Follow-up|2|||
149017619|NCT01388530|537544972|FG000|Overall Study|Lost to Follow-up|5|||
149017620|NCT05284019|537544973|FG000|Overall Study|Study terminated|2|||
149017621|NCT05284019|537544974|FG001|Overall Study|Study terminated|2|||
149017622|NCT05284019|537544975|FG002|Overall Study|Study terminated|2|||
149017623|NCT05284019|537544976|FG003|Overall Study|Study terminated|5|||
149218289|NCT00126425|538265499|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
149218290|NCT00126425|538265500|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
149218291|NCT00126425|538265499|FG000|Overall Study|Other|5|||
149017624|NCT05284019|537544977|FG004|Overall Study|Study terminated|15|||
149017625|NCT05284019|537544973|FG000|Overall Study|Withdrawal by Subject|0|||
149017626|NCT05284019|537544974|FG001|Overall Study|Withdrawal by Subject|0|||
149017627|NCT05284019|537544975|FG002|Overall Study|Withdrawal by Subject|0|||
149017628|NCT05284019|537544976|FG003|Overall Study|Withdrawal by Subject|1|||
149017629|NCT05284019|537544977|FG004|Overall Study|Withdrawal by Subject|1|||
149017630|NCT05284019|537544973|FG000|Overall Study|Lost to Follow-up|1|||
149218292|NCT00126425|538265500|FG001|Overall Study|Other|0|||
149218293|NCT01388491|538265501|FG000|Overall Study|Adverse Event|10|||
149218294|NCT01388491|538265502|FG001|Overall Study|Adverse Event|9|||
149017631|NCT05284019|537544974|FG001|Overall Study|Lost to Follow-up|0|||
149017632|NCT05284019|537544975|FG002|Overall Study|Lost to Follow-up|0|||
149017633|NCT05284019|537544976|FG003|Overall Study|Lost to Follow-up|2|||
149017634|NCT05284019|537544977|FG004|Overall Study|Lost to Follow-up|1|||
149218295|NCT01388491|538265501|FG000|Overall Study|Sponsor Request|9|||
149218296|NCT01388491|538265502|FG001|Overall Study|Sponsor Request|7|||
149218297|NCT01388491|538265501|FG000|Overall Study|Withdrawal by Subject|6|||
149218298|NCT01388491|538265502|FG001|Overall Study|Withdrawal by Subject|10|||
149218299|NCT01388491|538265501|FG000|Overall Study|Lost to Follow-up|4|||
149218300|NCT01388491|538265502|FG001|Overall Study|Lost to Follow-up|3|||
149218301|NCT01388491|538265501|FG000|Overall Study|Protocol Violation|2|||
149218302|NCT01388491|538265502|FG001|Overall Study|Protocol Violation|0|||
149218303|NCT01388491|538265501|FG000|Overall Study|Noncompliance|2|||
149218304|NCT01388491|538265502|FG001|Overall Study|Noncompliance|0|||
149218305|NCT01388491|538265501|FG000|Overall Study|Pregnancy|1|||
149218306|NCT01388491|538265502|FG001|Overall Study|Pregnancy|0|||
149218307|NCT04035473|538265503|FG000|Screening/Baseline|Death|0|||
149218308|NCT04035473|538265504|FG001|Screening/Baseline|Death|1|||
149218309|NCT04035473|538265503|FG000|Screening/Baseline|Adverse Event|0|||
149218310|NCT04035473|538265504|FG001|Screening/Baseline|Adverse Event|1|||
149218311|NCT04035473|538265503|FG000|Follow-up Period|Adverse Event|2|||
149218312|NCT04035473|538265504|FG001|Follow-up Period|Adverse Event|0|||
149218313|NCT02735044|538265506|FG000|Overall Study|Adverse Event|3|||
149218314|NCT02735044|538265507|FG001|Overall Study|Adverse Event|3|||
149218315|NCT02735044|538265506|FG000|Overall Study|Lack of Efficacy|1|||
149218316|NCT02735044|538265507|FG001|Overall Study|Lack of Efficacy|0|||
149218317|NCT02735044|538265506|FG000|Overall Study|Poor compliance to protocol|7|||
149218318|NCT02735044|538265507|FG001|Overall Study|Poor compliance to protocol|7|||
149017635|NCT02204293|537544978|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
149017636|NCT02204293|537544979|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
149218319|NCT02735044|538265506|FG000|Overall Study|Randomized and not treated|0|||
149218320|NCT02735044|538265507|FG001|Overall Study|Randomized and not treated|2|||
149218321|NCT02735044|538265506|FG000|Overall Study|Other, not specified above|5|||
149218322|NCT02735044|538265507|FG001|Overall Study|Other, not specified above|11|||
149218323|NCT01682759|538265509|FG000|Overall Study|Death|2|||
149218324|NCT01682759|538265510|FG001|Overall Study|Death|1|||
149218325|NCT01682759|538265509|FG000|Overall Study|Lost to Follow-up|10|||
149218326|NCT01682759|538265510|FG001|Overall Study|Lost to Follow-up|13|||
149218327|NCT01682759|538265509|FG000|Overall Study|Physician Decision|1|||
149218328|NCT01682759|538265510|FG001|Overall Study|Physician Decision|1|||
149218329|NCT01682759|538265509|FG000|Overall Study|Withdrawal by Subject|56|||
149218330|NCT01682759|538265510|FG001|Overall Study|Withdrawal by Subject|55|||
149218331|NCT00397891|538265511|FG000|Overall Study|Withdrawal by Subject|1|||
149218332|NCT00397891|538265512|FG001|Overall Study|Withdrawal by Subject|0|||
149218333|NCT00397891|538265513|FG002|Overall Study|Withdrawal by Subject|0|||
149218334|NCT00397891|538265514|FG003|Overall Study|Withdrawal by Subject|0|||
149218335|NCT00397891|538265515|FG004|Overall Study|Withdrawal by Subject|1|||
149218336|NCT00412113|538265516|FG000|Overall Study|Adverse Event|11|||
149218337|NCT00412113|538265517|FG001|Overall Study|Adverse Event|15|||
149218338|NCT00412113|538265516|FG000|Overall Study|did not receive treatment|1|||
149218339|NCT00412113|538265517|FG001|Overall Study|did not receive treatment|0|||
149218340|NCT00796224|538265518|FG000|Overall Study|Adverse Event|1|||
149218341|NCT00796224|538265519|FG001|Overall Study|Adverse Event|0|||
149218342|NCT00796224|538265518|FG000|Overall Study|Protocol Violation|0|||
149218343|NCT00796224|538265519|FG001|Overall Study|Protocol Violation|1|||
149218344|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
149218345|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
149218346|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
149218347|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
149218348|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
149218349|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
149218350|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
149218351|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
149218352|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
149218353|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
149218354|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
149218355|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
149218356|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
149218357|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149218358|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149218359|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
149218360|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
149218361|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
149218362|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
149218363|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
149218364|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
149218365|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
149218366|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
149218367|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
149218368|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
149218369|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
148685110|NCT01571635|536319632|FG004|Overall Study|Other reasons|1|||
148685111|NCT01571635|536319628|FG000|Overall Study|Study terminated by sponsor|0|||
148685112|NCT01571635|536319629|FG001|Overall Study|Study terminated by sponsor|4|||
148685113|NCT01571635|536319630|FG002|Overall Study|Study terminated by sponsor|1|||
148685114|NCT01571635|536319631|FG003|Overall Study|Study terminated by sponsor|3|||
148685115|NCT01571635|536319632|FG004|Overall Study|Study terminated by sponsor|1|||
148685116|NCT01571635|536319628|FG000|Overall Study|Withdrew consent|1|||
148685117|NCT01571635|536319629|FG001|Overall Study|Withdrew consent|1|||
148685118|NCT01571635|536319630|FG002|Overall Study|Withdrew consent|2|||
148685119|NCT01571635|536319631|FG003|Overall Study|Withdrew consent|3|||
148685120|NCT01571635|536319632|FG004|Overall Study|Withdrew consent|0|||
148685121|NCT01571635|536319628|FG000|Overall Study|Lack of Efficacy|0|||
148685122|NCT01571635|536319629|FG001|Overall Study|Lack of Efficacy|2|||
148952513|NCT02289417|537307387|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
148952514|NCT02289417|537307388|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
148952515|NCT02289417|537307389|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
148952516|NCT02289417|537307390|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
149218370|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
149218371|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
149218372|NCT03227224|538265522|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
148685123|NCT01571635|536319630|FG002|Overall Study|Lack of Efficacy|0|||
148685124|NCT01571635|536319631|FG003|Overall Study|Lack of Efficacy|1|||
148685125|NCT01571635|536319632|FG004|Overall Study|Lack of Efficacy|2|||
148809913|NCT01553851|536780901|FG000|Overall Study|constipation|1|||
148685126|NCT02868281|536319633|FG000|Overall Study|Adverse Event|2|||
148685127|NCT02868281|536319634|FG001|Overall Study|Adverse Event|2|||
148685128|NCT02868281|536319633|FG000|Overall Study|Protocol Violation|13|||
149218373|NCT03227224|538265523|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
149218374|NCT03227224|538265524|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
149218375|NCT03227224|538265525|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
149218376|NCT03227224|538265522|FG000|Follow-up Phase (2 Weeks)|Other|4|||
149218377|NCT03227224|538265523|FG001|Follow-up Phase (2 Weeks)|Other|4|||
149218378|NCT03227224|538265524|FG002|Follow-up Phase (2 Weeks)|Other|6|||
149218379|NCT03227224|538265525|FG003|Follow-up Phase (2 Weeks)|Other|3|||
149218380|NCT04195750|538265526|FG000|Overall Study|Death|245|||
149218381|NCT04195750|538265527|FG001|Overall Study|Death|253|||
149218382|NCT04195750|538265528|FG002|Overall Study|Death|5|||
149218383|NCT04195750|538265526|FG000|Overall Study|Physician Decision|0|||
149218384|NCT04195750|538265527|FG001|Overall Study|Physician Decision|1|||
149218385|NCT04195750|538265528|FG002|Overall Study|Physician Decision|0|||
149218386|NCT04195750|538265526|FG000|Overall Study|Withdrawal by Subject|9|||
149218387|NCT04195750|538265527|FG001|Overall Study|Withdrawal by Subject|8|||
149218388|NCT04195750|538265528|FG002|Overall Study|Withdrawal by Subject|0|||
149218389|NCT04195750|538265526|FG000|Overall Study|Ongoing|120|||
149218390|NCT04195750|538265527|FG001|Overall Study|Ongoing|110|||
149218391|NCT04195750|538265528|FG002|Overall Study|Ongoing|4|||
149218392|NCT03782376|538265529|FG000|Overall Study|Lost to Follow-up|2|||
149218393|NCT03782376|538265530|FG001|Overall Study|Lost to Follow-up|2|||
149218394|NCT03782376|538265529|FG000|Overall Study|Withdrawal by Subject|7|||
149218395|NCT03782376|538265530|FG001|Overall Study|Withdrawal by Subject|11|||
149218396|NCT03782376|538265529|FG000|Overall Study|Death|1|||
149218397|NCT03782376|538265530|FG001|Overall Study|Death|0|||
149218398|NCT03782376|538265529|FG000|Overall Study|Other|16|||
149218399|NCT03782376|538265530|FG001|Overall Study|Other|17|||
149218400|NCT02254304|538265535|FG000|Overall Study|Adverse Event|2|||
149218401|NCT02254304|538265536|FG001|Overall Study|Adverse Event|1|||
149218402|NCT02254304|538265535|FG000|Overall Study|Lost to Follow-up|2|||
148685129|NCT02868281|536319634|FG001|Overall Study|Protocol Violation|10|||
148685130|NCT02868281|536319633|FG000|Overall Study|Lost to Follow-up|3|||
148685131|NCT02868281|536319634|FG001|Overall Study|Lost to Follow-up|6|||
148685132|NCT02868281|536319633|FG000|Overall Study|Withdrawal by Subject|11|||
148685133|NCT02868281|536319634|FG001|Overall Study|Withdrawal by Subject|15|||
148685134|NCT02868281|536319633|FG000|Overall Study|Physician Decision|2|||
148685135|NCT02868281|536319634|FG001|Overall Study|Physician Decision|0|||
148685136|NCT02868281|536319633|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
148685137|NCT02868281|536319634|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
148685138|NCT02868281|536319633|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
148685139|NCT02868281|536319634|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
148685140|NCT02868281|536319633|FG000|Overall Study|Long journey/moving away|1|||
148685141|NCT02868281|536319634|FG001|Overall Study|Long journey/moving away|1|||
148685142|NCT01722266|536319635|FG000|Overall Study|Withdrawal by Subject|1|||
148685143|NCT01722266|536319636|FG001|Overall Study|Withdrawal by Subject|2|||
148685144|NCT01722266|536319637|FG002|Overall Study|Withdrawal by Subject|0|||
148685145|NCT01722266|536319638|FG003|Overall Study|Withdrawal by Subject|0|||
148685146|NCT01722266|536319635|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
148685147|NCT01722266|536319636|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
148685148|NCT01722266|536319637|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
148685149|NCT01722266|536319638|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
148685150|NCT01722266|536319635|FG000|Overall Study|Dropped out due to Nausea|0|||
148685151|NCT01722266|536319636|FG001|Overall Study|Dropped out due to Nausea|0|||
148685152|NCT01722266|536319637|FG002|Overall Study|Dropped out due to Nausea|2|||
148685153|NCT01722266|536319638|FG003|Overall Study|Dropped out due to Nausea|0|||
149218403|NCT02254304|538265536|FG001|Overall Study|Lost to Follow-up|2|||
149218404|NCT02254304|538265535|FG000|Overall Study|Protocol Violation|1|||
149218405|NCT02254304|538265536|FG001|Overall Study|Protocol Violation|0|||
149218406|NCT02254304|538265535|FG000|Overall Study|Withdrawal by Subject|3|||
149218407|NCT02254304|538265536|FG001|Overall Study|Withdrawal by Subject|0|||
149218408|NCT02254304|538265535|FG000|Overall Study|Injection site pain and Injection fear|1|||
149218409|NCT02254304|538265536|FG001|Overall Study|Injection site pain and Injection fear|0|||
149218410|NCT02254304|538265535|FG000|Overall Study|Personal causes|4|||
149218411|NCT02254304|538265536|FG001|Overall Study|Personal causes|1|||
149218412|NCT02254304|538265535|FG000|Overall Study|Personal decision|1|||
149218413|NCT02254304|538265536|FG001|Overall Study|Personal decision|0|||
149218414|NCT01226472|538265537|FG000|Overall Study|Progressive Disease|1|||
148952517|NCT02289417|537307391|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
148952518|NCT02289417|537307392|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
149218415|NCT02531633|538267636|FG000|Part A (52 Weeks)|Sponsor request|24|||
148685154|NCT00331630|536321390|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
148685155|NCT00331630|536321390|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
148685156|NCT00331630|536321390|FG000|Follow up for 5 Years|Death|5|||
148685157|NCT00331630|536321390|FG000|Follow up for 5 Years|Data collection was stopped|24|||
148685158|NCT02806232|536321391|FG000|Overall Study|Lost to Follow-up|1|||
148685159|NCT02806232|536321392|FG001|Overall Study|Lost to Follow-up|2|||
148685160|NCT02806232|536321393|FG002|Overall Study|Lost to Follow-up|1|||
148809914|NCT02472353|536780903|FG000|Overall Study|Lost to Follow-up|1|||
148809915|NCT02472353|536780904|FG001|Overall Study|Lost to Follow-up|1|||
148809916|NCT02472353|536780903|FG000|Overall Study|Withdrawal by Subject|2|||
148809917|NCT02472353|536780904|FG001|Overall Study|Withdrawal by Subject|1|||
148809918|NCT02472353|536780903|FG000|Overall Study|Study Termination|1|||
148809919|NCT02472353|536780904|FG001|Overall Study|Study Termination|4|||
148809920|NCT02101294|536780905|FG000|Overall Study|Withdrawal by Subject|5|||
148809921|NCT02101294|536780905|FG000|Overall Study|Lost to Follow-up|6|||
148809922|NCT03822416|536780908|FG000|Overall Study|Lost to Follow-up|1|||
148809923|NCT03822416|536780909|FG001|Overall Study|Lost to Follow-up|0|||
148809924|NCT03822416|536780908|FG000|Overall Study|Withdrawal by Subject|0|||
148809925|NCT03822416|536780909|FG001|Overall Study|Withdrawal by Subject|1|||
148809926|NCT00844519|536780910|FG000|Overall Study|Withdrawal by Subject|1|||
148952519|NCT02289417|537307393|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
148952520|NCT02289417|537307394|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
148952521|NCT02289417|537307386|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
148952522|NCT02289417|537307387|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
148952523|NCT02289417|537307388|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
148952524|NCT02289417|537307389|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
148952525|NCT02289417|537307390|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
148952526|NCT02289417|537307391|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
148952527|NCT02289417|537307392|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
148952528|NCT02289417|537307393|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
148952529|NCT02289417|537307394|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
148952530|NCT02289417|537307386|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952531|NCT02289417|537307387|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
148952532|NCT02289417|537307388|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952533|NCT02289417|537307389|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952534|NCT02289417|537307390|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952535|NCT02289417|537307391|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952536|NCT02289417|537307392|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952537|NCT02289417|537307393|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952538|NCT02289417|537307394|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
148952539|NCT02289417|537307386|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
148952540|NCT02289417|537307387|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952541|NCT02289417|537307388|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952542|NCT02289417|537307389|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952543|NCT02289417|537307390|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952544|NCT02289417|537307391|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952545|NCT02289417|537307392|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952546|NCT02289417|537307393|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952547|NCT02289417|537307394|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
148952548|NCT02289417|537307386|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
148952549|NCT02289417|537307387|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
148952550|NCT02289417|537307388|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
148952551|NCT02289417|537307389|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
148952552|NCT02289417|537307390|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
148952553|NCT02289417|537307391|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
148952554|NCT02289417|537307392|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
148952555|NCT02289417|537307393|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
148952556|NCT02289417|537307394|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
148952557|NCT02289417|537307386|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952558|NCT02289417|537307387|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952559|NCT02289417|537307388|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
148952560|NCT02289417|537307389|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952561|NCT02289417|537307390|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952562|NCT02289417|537307391|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952563|NCT02289417|537307392|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148809927|NCT00844519|536780911|FG001|Overall Study|Withdrawal by Subject|1|||
148809928|NCT00844519|536780910|FG000|Overall Study|Adverse Event|1|||
148809929|NCT00844519|536780911|FG001|Overall Study|Adverse Event|0|||
148952564|NCT02289417|537307393|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952565|NCT02289417|537307394|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
148952566|NCT02289417|537307386|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
148952567|NCT02289417|537307387|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
148809930|NCT02709369|536780913|FG000|Overall Study|Lost to Follow-up|15|||
148809931|NCT02709369|536780913|FG000|Overall Study|Withdrawal by Subject|10|||
148809932|NCT02709369|536780913|FG000|Overall Study|Did not received intervention|2|||
148809933|NCT05233761|536780914|FG000|Treatment Period A|Withdrawal by Subject|12|||
149218416|NCT02531633|538267637|FG001|Part A (52 Weeks)|Sponsor request|24|||
149218417|NCT02531633|538267638|FG002|Part A (52 Weeks)|Sponsor request|18|||
149218418|NCT02531633|538267639|FG003|Part A (52 Weeks)|Sponsor request|18|||
149218419|NCT02531633|538267640|FG004|Part A (52 Weeks)|Sponsor request|19|||
149218420|NCT02531633|538267641|FG005|Part A (52 Weeks)|Sponsor request|0|||
149218421|NCT02531633|538267642|FG006|Part A (52 Weeks)|Sponsor request|0|||
149218422|NCT02531633|538267643|FG007|Part A (52 Weeks)|Sponsor request|0|||
149218423|NCT02531633|538267644|FG008|Part A (52 Weeks)|Sponsor request|0|||
149218424|NCT02531633|538267645|FG009|Part A (52 Weeks)|Sponsor request|0|||
148952568|NCT02289417|537307388|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
148952569|NCT02289417|537307389|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
148952570|NCT02289417|537307390|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
148952571|NCT02289417|537307391|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
148952572|NCT02289417|537307392|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
148952573|NCT02289417|537307393|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
148952574|NCT02289417|537307394|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
148952575|NCT02289417|537307386|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
148952576|NCT02289417|537307387|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
148952577|NCT02289417|537307388|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
148952578|NCT02289417|537307389|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
148952579|NCT02289417|537307390|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
148952580|NCT02289417|537307391|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
148952581|NCT02289417|537307392|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
148952582|NCT02289417|537307393|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
148952583|NCT02289417|537307394|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
148952584|NCT02289417|537307386|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952585|NCT02289417|537307387|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952586|NCT02289417|537307388|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952587|NCT02289417|537307389|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952588|NCT02289417|537307390|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952589|NCT02289417|537307391|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952590|NCT02289417|537307392|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
148952591|NCT02289417|537307393|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952592|NCT02289417|537307394|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
148952593|NCT02289417|537307386|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952594|NCT02289417|537307387|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952595|NCT02289417|537307388|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952596|NCT02289417|537307389|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
148952597|NCT02289417|537307390|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952598|NCT02289417|537307391|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952599|NCT02289417|537307392|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
148952600|NCT02289417|537307393|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952601|NCT02289417|537307394|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
148952602|NCT02289417|537307386|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
148952603|NCT02289417|537307387|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
148952604|NCT02289417|537307388|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
148952605|NCT02289417|537307389|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
148952606|NCT02289417|537307390|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
148952607|NCT02289417|537307391|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
148952608|NCT02289417|537307392|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
148952609|NCT02289417|537307393|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
148809934|NCT05233761|536780915|FG001|Treatment Period A|Withdrawal by Subject|10|||
148952610|NCT02289417|537307394|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
148952611|NCT02289417|537307386|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
148952612|NCT02289417|537307387|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
149218425|NCT02531633|538267636|FG000|Part A (52 Weeks)|Protocol Violation|1|||
148952613|NCT02289417|537307388|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
148952614|NCT02289417|537307389|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
148952615|NCT02289417|537307390|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
148952616|NCT02289417|537307391|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
148952617|NCT02289417|537307392|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
148952618|NCT02289417|537307393|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
148952619|NCT02289417|537307394|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
148952620|NCT02289417|537307386|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952621|NCT02289417|537307387|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952622|NCT02289417|537307388|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952623|NCT02289417|537307389|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952624|NCT02289417|537307390|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952625|NCT02289417|537307391|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952626|NCT02289417|537307392|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
148952627|NCT02289417|537307393|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
148952628|NCT02289417|537307394|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
148952629|NCT02289417|537307386|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952630|NCT02289417|537307387|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952631|NCT02289417|537307388|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952632|NCT02289417|537307389|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952633|NCT02289417|537307390|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952634|NCT02289417|537307391|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952635|NCT02289417|537307392|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952636|NCT02289417|537307393|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
148952637|NCT02289417|537307394|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
148952638|NCT02725710|537307395|FG000|Overall Study|Lost to Follow-up|1|||
148952639|NCT02725710|537307396|FG001|Overall Study|Lost to Follow-up|0|||
148952640|NCT01858389|537307397|FG000|Overall Study|Death|1|||
148952641|NCT01858389|537307398|FG001|Overall Study|Death|3|||
148952642|NCT01858389|537307397|FG000|Overall Study|Study terminated by sponsor|0|||
148952643|NCT01858389|537307398|FG001|Overall Study|Study terminated by sponsor|2|||
148952644|NCT01858389|537307397|FG000|Overall Study|Withdrawal by Subject|0|||
148952645|NCT01858389|537307398|FG001|Overall Study|Withdrawal by Subject|1|||
148952646|NCT01858389|537307397|FG000|Overall Study|Progressive disease|10|||
148952647|NCT01858389|537307398|FG001|Overall Study|Progressive disease|11|||
148952648|NCT01858389|537307397|FG000|Overall Study|Other|2|||
148952649|NCT01858389|537307398|FG001|Overall Study|Other|4|||
148952650|NCT01858389|537307397|FG000|Overall Study|Adverse Event|3|||
148952651|NCT01858389|537307398|FG001|Overall Study|Adverse Event|1|||
148952652|NCT01858389|537307397|FG000|Overall Study|Did not receive treatment|0|||
148952653|NCT01858389|537307398|FG001|Overall Study|Did not receive treatment|3|||
148952654|NCT03572062|537307399|FG000|Overall Study|Adverse Event|0|||
148952655|NCT03572062|537307400|FG001|Overall Study|Adverse Event|0|||
148952656|NCT03572062|537307401|FG002|Overall Study|Adverse Event|0|||
148952657|NCT03572062|537307402|FG003|Overall Study|Adverse Event|0|||
148952658|NCT03572062|537307403|FG004|Overall Study|Adverse Event|0|||
148952659|NCT03572062|537307404|FG005|Overall Study|Adverse Event|0|||
148952660|NCT03572062|537307405|FG006|Overall Study|Adverse Event|0|||
148952661|NCT03572062|537307406|FG007|Overall Study|Adverse Event|0|||
148952662|NCT03572062|537307407|FG008|Overall Study|Adverse Event|1|||
148952663|NCT03572062|537307408|FG009|Overall Study|Adverse Event|3|||
148952664|NCT03572062|537307399|FG000|Overall Study|Death|0|||
148952665|NCT03572062|537307400|FG001|Overall Study|Death|0|||
148952666|NCT03572062|537307401|FG002|Overall Study|Death|0|||
148952667|NCT03572062|537307402|FG003|Overall Study|Death|0|||
148952668|NCT03572062|537307403|FG004|Overall Study|Death|0|||
148952669|NCT03572062|537307404|FG005|Overall Study|Death|1|||
149218426|NCT02531633|538267637|FG001|Part A (52 Weeks)|Protocol Violation|0|||
149218427|NCT02531633|538267638|FG002|Part A (52 Weeks)|Protocol Violation|0|||
149218428|NCT02531633|538267639|FG003|Part A (52 Weeks)|Protocol Violation|0|||
149218429|NCT02531633|538267640|FG004|Part A (52 Weeks)|Protocol Violation|0|||
149218430|NCT02531633|538267641|FG005|Part A (52 Weeks)|Protocol Violation|0|||
149218431|NCT02531633|538267642|FG006|Part A (52 Weeks)|Protocol Violation|0|||
149218432|NCT02531633|538267643|FG007|Part A (52 Weeks)|Protocol Violation|0|||
149218433|NCT02531633|538267644|FG008|Part A (52 Weeks)|Protocol Violation|0|||
149218434|NCT02531633|538267645|FG009|Part A (52 Weeks)|Protocol Violation|0|||
149218435|NCT02531633|538267636|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
149218436|NCT02531633|538267637|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
149218437|NCT02531633|538267638|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
149218438|NCT02531633|538267639|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
149218439|NCT02531633|538267640|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
148952670|NCT03572062|537307405|FG006|Overall Study|Death|0|||
148952671|NCT03572062|537307406|FG007|Overall Study|Death|0|||
148952672|NCT03572062|537307407|FG008|Overall Study|Death|0|||
148952673|NCT03572062|537307408|FG009|Overall Study|Death|0|||
148952674|NCT03572062|537307399|FG000|Overall Study|Lost to Follow-up|0|||
149218440|NCT02531633|538267641|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
149218441|NCT02531633|538267642|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
149218442|NCT02531633|538267643|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
149218443|NCT02531633|538267644|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
149218444|NCT02531633|538267645|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
149218445|NCT02531633|538267636|FG000|Part A (52 Weeks)|Physician Decision|1|||
149218446|NCT02531633|538267637|FG001|Part A (52 Weeks)|Physician Decision|4|||
149218447|NCT02531633|538267638|FG002|Part A (52 Weeks)|Physician Decision|3|||
149218448|NCT02531633|538267639|FG003|Part A (52 Weeks)|Physician Decision|1|||
149218449|NCT02531633|538267640|FG004|Part A (52 Weeks)|Physician Decision|0|||
149218450|NCT02531633|538267641|FG005|Part A (52 Weeks)|Physician Decision|0|||
149218451|NCT02531633|538267642|FG006|Part A (52 Weeks)|Physician Decision|0|||
149218452|NCT02531633|538267643|FG007|Part A (52 Weeks)|Physician Decision|0|||
149218453|NCT02531633|538267644|FG008|Part A (52 Weeks)|Physician Decision|0|||
149218454|NCT02531633|538267645|FG009|Part A (52 Weeks)|Physician Decision|0|||
149218455|NCT02531633|538267636|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
149218456|NCT02531633|538267637|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
149218457|NCT02531633|538267638|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
149218458|NCT02531633|538267639|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
149218459|NCT02531633|538267640|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
148952675|NCT03572062|537307400|FG001|Overall Study|Lost to Follow-up|0|||
148952676|NCT03572062|537307401|FG002|Overall Study|Lost to Follow-up|0|||
148952677|NCT03572062|537307402|FG003|Overall Study|Lost to Follow-up|0|||
148952678|NCT03572062|537307403|FG004|Overall Study|Lost to Follow-up|0|||
148952679|NCT03572062|537307404|FG005|Overall Study|Lost to Follow-up|1|||
148952680|NCT03572062|537307405|FG006|Overall Study|Lost to Follow-up|1|||
149218460|NCT02531633|538267641|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
149218461|NCT02531633|538267642|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
149218462|NCT02531633|538267643|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
149218463|NCT02531633|538267644|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
149218464|NCT02531633|538267645|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
149218465|NCT02531633|538267636|FG000|Part A (52 Weeks)|Other|2|||
149218466|NCT02531633|538267637|FG001|Part A (52 Weeks)|Other|0|||
149218467|NCT02531633|538267638|FG002|Part A (52 Weeks)|Other|0|||
149218468|NCT02531633|538267639|FG003|Part A (52 Weeks)|Other|0|||
149218469|NCT02531633|538267640|FG004|Part A (52 Weeks)|Other|0|||
149218470|NCT02531633|538267641|FG005|Part A (52 Weeks)|Other|0|||
149218471|NCT02531633|538267642|FG006|Part A (52 Weeks)|Other|0|||
149218472|NCT02531633|538267643|FG007|Part A (52 Weeks)|Other|0|||
149218473|NCT02531633|538267644|FG008|Part A (52 Weeks)|Other|0|||
149218474|NCT02531633|538267645|FG009|Part A (52 Weeks)|Other|0|||
149218475|NCT02531633|538267636|FG000|Part B (104 Weeks)|Sponsor request|0|||
149218476|NCT02531633|538267637|FG001|Part B (104 Weeks)|Sponsor request|0|||
149218477|NCT02531633|538267638|FG002|Part B (104 Weeks)|Sponsor request|0|||
149218478|NCT02531633|538267639|FG003|Part B (104 Weeks)|Sponsor request|0|||
149218479|NCT02531633|538267640|FG004|Part B (104 Weeks)|Sponsor request|0|||
149218480|NCT02531633|538267641|FG005|Part B (104 Weeks)|Sponsor request|8|||
149218481|NCT02531633|538267642|FG006|Part B (104 Weeks)|Sponsor request|5|||
149218482|NCT02531633|538267643|FG007|Part B (104 Weeks)|Sponsor request|3|||
149218483|NCT02531633|538267644|FG008|Part B (104 Weeks)|Sponsor request|5|||
149218484|NCT02531633|538267645|FG009|Part B (104 Weeks)|Sponsor request|4|||
148685161|NCT02806232|536321394|FG003|Overall Study|Lost to Follow-up|0|||
149218485|NCT02531633|538267636|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
149218486|NCT02531633|538267637|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
149218487|NCT02531633|538267638|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
149218488|NCT02531633|538267639|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
149218489|NCT02531633|538267640|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
149218490|NCT02531633|538267641|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
148685162|NCT02806232|536321395|FG004|Overall Study|Lost to Follow-up|0|||
148685163|NCT02806232|536321396|FG005|Overall Study|Lost to Follow-up|1|||
149218491|NCT02531633|538267642|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
149218492|NCT02531633|538267643|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
149218493|NCT02531633|538267644|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
149218494|NCT02531633|538267645|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
149218495|NCT01952041|538267647|FG000|Overall Study|Lost to Follow-up|9|||
148685164|NCT02806232|536321397|FG006|Overall Study|Lost to Follow-up|0|||
148685165|NCT02806232|536321398|FG007|Overall Study|Lost to Follow-up|0|||
149218496|NCT01952041|538267648|FG001|Overall Study|Lost to Follow-up|16|||
149218497|NCT01952041|538267647|FG000|Overall Study|Withdrawal by Subject|7|||
149218498|NCT01952041|538267648|FG001|Overall Study|Withdrawal by Subject|5|||
149218499|NCT01952041|538267647|FG000|Overall Study|Death|1|||
149218500|NCT01952041|538267648|FG001|Overall Study|Death|0|||
149218501|NCT03650387|538267649|FG000|Overall Study|Withdrawal by Subject|13|||
149218502|NCT03650387|538267649|FG000|Overall Study|Lost to Follow-up|12|||
149218503|NCT03650387|538267649|FG000|Overall Study|Adverse Event (Not related)|1|||
149218504|NCT03650387|538267649|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
149218505|NCT01370499|538267650|FG000|Overall Study|Adverse Event|38|||
149218506|NCT01370499|538267651|FG001|Overall Study|Adverse Event|12|||
149218507|NCT01370499|538267650|FG000|Overall Study|Lack of Efficacy|4|||
149218508|NCT01370499|538267651|FG001|Overall Study|Lack of Efficacy|2|||
149218509|NCT01370499|538267650|FG000|Overall Study|Lost to Follow-up|2|||
149218510|NCT01370499|538267651|FG001|Overall Study|Lost to Follow-up|1|||
149218511|NCT01370499|538267650|FG000|Overall Study|Physician Decision|3|||
149218512|NCT01370499|538267651|FG001|Overall Study|Physician Decision|3|||
149218513|NCT01370499|538267650|FG000|Overall Study|Protocol Violation|5|||
149218514|NCT01370499|538267651|FG001|Overall Study|Protocol Violation|4|||
149218515|NCT01370499|538267650|FG000|Overall Study|Withdrawal by Subject|18|||
149218516|NCT01370499|538267651|FG001|Overall Study|Withdrawal by Subject|7|||
149218517|NCT01370499|538267650|FG000|Overall Study|Sponsor Decision|41|||
149218518|NCT01370499|538267651|FG001|Overall Study|Sponsor Decision|15|||
149218519|NCT00887822|538267652|FG000|Overall Study|Insufficient therapeutic response|53|||
149218520|NCT00887822|538267653|FG001|Overall Study|Insufficient therapeutic response|55|||
149218521|NCT00887822|538267652|FG000|Overall Study|Adverse Event|14|||
149218522|NCT00887822|538267653|FG001|Overall Study|Adverse Event|17|||
149218523|NCT00887822|538267652|FG000|Overall Study|Failure to return|11|||
149218524|NCT00887822|538267653|FG001|Overall Study|Failure to return|11|||
149218525|NCT00887822|538267652|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
149218526|NCT00887822|538267653|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
149218527|NCT00887822|538267652|FG000|Overall Study|Administrative/Other than specified|5|||
149218528|NCT00887822|538267653|FG001|Overall Study|Administrative/Other than specified|4|||
149218529|NCT00887822|538267652|FG000|Overall Study|Death|2|||
148952681|NCT03572062|537307406|FG007|Overall Study|Lost to Follow-up|0|||
148952682|NCT03572062|537307407|FG008|Overall Study|Lost to Follow-up|0|||
149218530|NCT00887822|538267653|FG001|Overall Study|Death|3|||
149218531|NCT00887822|538267652|FG000|Overall Study|Protocol Violation|0|||
148685166|NCT02806232|536321399|FG008|Overall Study|Lost to Follow-up|0|||
148685167|NCT02806232|536321391|FG000|Overall Study|Withdrawal by Subject|0|||
148685168|NCT02806232|536321392|FG001|Overall Study|Withdrawal by Subject|2|||
148685169|NCT02806232|536321393|FG002|Overall Study|Withdrawal by Subject|0|||
148685170|NCT02806232|536321394|FG003|Overall Study|Withdrawal by Subject|0|||
148685171|NCT02806232|536321395|FG004|Overall Study|Withdrawal by Subject|2|||
148685172|NCT02806232|536321396|FG005|Overall Study|Withdrawal by Subject|1|||
148685173|NCT02806232|536321397|FG006|Overall Study|Withdrawal by Subject|0|||
148685174|NCT02806232|536321398|FG007|Overall Study|Withdrawal by Subject|0|||
148685175|NCT02806232|536321399|FG008|Overall Study|Withdrawal by Subject|0|||
148685176|NCT01133821|536321400|FG000|Overall Study|Lost to Follow-up|8|||
148809935|NCT05233761|536780914|FG000|Treatment Period A|Lost to Follow-up|6|||
149218532|NCT00887822|538267653|FG001|Overall Study|Protocol Violation|1|||
149218533|NCT00887822|538267652|FG000|Overall Study|Randomized but not treated|0|||
149218534|NCT00887822|538267653|FG001|Overall Study|Randomized but not treated|1|||
149218535|NCT03661983|538267654|FG000|Open Label Stabilization Phase|Adverse Event|5|||
148685177|NCT01133821|536321401|FG001|Overall Study|Lost to Follow-up|11|||
148685178|NCT01133821|536321400|FG000|Overall Study|Withdrawal by Subject|8|||
148685179|NCT01133821|536321401|FG001|Overall Study|Withdrawal by Subject|3|||
148685180|NCT01133821|536321400|FG000|Overall Study|preferred other treatment|1|||
149218536|NCT03661983|538267655|FG001|Open Label Stabilization Phase|Adverse Event|0|||
149218537|NCT03661983|538267656|FG002|Open Label Stabilization Phase|Adverse Event|0|||
149218538|NCT03661983|538267657|FG003|Open Label Stabilization Phase|Adverse Event|0|||
149218539|NCT03661983|538267654|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
149218540|NCT03661983|538267655|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
149218541|NCT03661983|538267656|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
148952683|NCT03572062|537307408|FG009|Overall Study|Lost to Follow-up|0|||
148952684|NCT03572062|537307399|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
149218542|NCT03661983|538267657|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
148952685|NCT03572062|537307400|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952686|NCT03572062|537307401|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952687|NCT03572062|537307402|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952688|NCT03572062|537307403|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952689|NCT03572062|537307404|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952690|NCT03572062|537307405|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
149218543|NCT03661983|538267654|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
149218544|NCT03661983|538267655|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
148952691|NCT03572062|537307406|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952692|NCT03572062|537307407|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
148952693|NCT03572062|537307408|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
148952694|NCT03572062|537307399|FG000|Overall Study|Study Terminated By Sponsor|0|||
148952695|NCT03572062|537307400|FG001|Overall Study|Study Terminated By Sponsor|0|||
148952696|NCT03572062|537307401|FG002|Overall Study|Study Terminated By Sponsor|0|||
148952697|NCT03572062|537307402|FG003|Overall Study|Study Terminated By Sponsor|0|||
148952698|NCT03572062|537307403|FG004|Overall Study|Study Terminated By Sponsor|0|||
148952699|NCT03572062|537307404|FG005|Overall Study|Study Terminated By Sponsor|0|||
148952700|NCT03572062|537307405|FG006|Overall Study|Study Terminated By Sponsor|0|||
148952701|NCT03572062|537307406|FG007|Overall Study|Study Terminated By Sponsor|0|||
148952702|NCT03572062|537307407|FG008|Overall Study|Study Terminated By Sponsor|29|||
148952703|NCT03572062|537307408|FG009|Overall Study|Study Terminated By Sponsor|27|||
148952704|NCT03572062|537307399|FG000|Overall Study|Physician Decision|0|||
148952705|NCT03572062|537307400|FG001|Overall Study|Physician Decision|0|||
148952706|NCT03572062|537307401|FG002|Overall Study|Physician Decision|0|||
148952707|NCT03572062|537307402|FG003|Overall Study|Physician Decision|0|||
148952708|NCT03572062|537307403|FG004|Overall Study|Physician Decision|0|||
148952709|NCT03572062|537307404|FG005|Overall Study|Physician Decision|0|||
148952710|NCT03572062|537307405|FG006|Overall Study|Physician Decision|0|||
148952711|NCT03572062|537307406|FG007|Overall Study|Physician Decision|0|||
148952712|NCT03572062|537307407|FG008|Overall Study|Physician Decision|1|||
148952713|NCT03572062|537307408|FG009|Overall Study|Physician Decision|0|||
148952714|NCT03572062|537307399|FG000|Overall Study|Withdrawal by Subject|0|||
148952715|NCT03572062|537307400|FG001|Overall Study|Withdrawal by Subject|0|||
148952716|NCT03572062|537307401|FG002|Overall Study|Withdrawal by Subject|0|||
148952717|NCT03572062|537307402|FG003|Overall Study|Withdrawal by Subject|0|||
148952718|NCT03572062|537307403|FG004|Overall Study|Withdrawal by Subject|0|||
148952719|NCT03572062|537307404|FG005|Overall Study|Withdrawal by Subject|0|||
148952720|NCT03572062|537307405|FG006|Overall Study|Withdrawal by Subject|0|||
148952721|NCT03572062|537307406|FG007|Overall Study|Withdrawal by Subject|0|||
148952722|NCT03572062|537307407|FG008|Overall Study|Withdrawal by Subject|0|||
148952723|NCT03572062|537307408|FG009|Overall Study|Withdrawal by Subject|1|||
148952724|NCT03572062|537307399|FG000|Overall Study|Randomized But Not Treated|0|||
148952725|NCT03572062|537307400|FG001|Overall Study|Randomized But Not Treated|0|||
148952726|NCT03572062|537307401|FG002|Overall Study|Randomized But Not Treated|0|||
148952727|NCT03572062|537307402|FG003|Overall Study|Randomized But Not Treated|0|||
148952728|NCT03572062|537307403|FG004|Overall Study|Randomized But Not Treated|1|||
148952729|NCT03572062|537307404|FG005|Overall Study|Randomized But Not Treated|2|||
148952730|NCT03572062|537307405|FG006|Overall Study|Randomized But Not Treated|0|||
148952731|NCT03572062|537307406|FG007|Overall Study|Randomized But Not Treated|1|||
148952732|NCT03572062|537307407|FG008|Overall Study|Randomized But Not Treated|0|||
148952733|NCT03572062|537307408|FG009|Overall Study|Randomized But Not Treated|0|||
148952734|NCT01691781|537307409|FG000|Overall Study|Withdrawal by Subject|4|||
148952735|NCT01691781|537307410|FG001|Overall Study|Withdrawal by Subject|3|||
148952736|NCT01691781|537307409|FG000|Overall Study|Physician Decision|1|||
148952737|NCT01691781|537307410|FG001|Overall Study|Physician Decision|1|||
148952738|NCT01691781|537307409|FG000|Overall Study|Protocol Violation|2|||
148952739|NCT01691781|537307410|FG001|Overall Study|Protocol Violation|2|||
148952740|NCT01691781|537307409|FG000|Overall Study|Adverse Event|0|||
148952741|NCT01691781|537307410|FG001|Overall Study|Adverse Event|1|||
148952742|NCT03978520|537307411|FG000|Overall Study|Adverse Event|2|||
149218545|NCT03661983|538267656|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
149218546|NCT03661983|538267657|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
149218547|NCT03661983|538267654|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
149218548|NCT03661983|538267655|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
149218549|NCT03661983|538267656|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
149218550|NCT03661983|538267657|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
149218551|NCT03661983|538267654|FG000|Double-blind Randomized Phase|Adverse Event|0|||
149218552|NCT03661983|538267655|FG001|Double-blind Randomized Phase|Adverse Event|1|||
149218553|NCT03661983|538267656|FG002|Double-blind Randomized Phase|Adverse Event|0|||
149218554|NCT03661983|538267657|FG003|Double-blind Randomized Phase|Adverse Event|0|||
149218555|NCT03661983|538267654|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
149218556|NCT03661983|538267655|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
149218557|NCT03661983|538267656|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
149218558|NCT03661983|538267657|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
149218559|NCT03661983|538267654|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
149218560|NCT03661983|538267655|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
149218561|NCT03661983|538267656|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
149218562|NCT03661983|538267657|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
148952743|NCT03978520|537307412|FG001|Overall Study|Adverse Event|5|||
148952744|NCT03978520|537307413|FG002|Overall Study|Adverse Event|3|||
148952745|NCT03978520|537307414|FG003|Overall Study|Adverse Event|5|||
148952746|NCT03978520|537307415|FG004|Overall Study|Adverse Event|6|||
149218563|NCT03661983|538267654|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
149218564|NCT03661983|538267655|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
149218565|NCT03661983|538267656|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
149218566|NCT03661983|538267657|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
149218567|NCT02903966|538267658|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
149218568|NCT02903966|538267659|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
149218569|NCT02903966|538267658|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
149218570|NCT02903966|538267659|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
149218571|NCT02903966|538267658|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
148952747|NCT03978520|537307411|FG000|Overall Study|Withdrawal by Subject|10|||
148952748|NCT03978520|537307412|FG001|Overall Study|Withdrawal by Subject|4|||
148952749|NCT03978520|537307413|FG002|Overall Study|Withdrawal by Subject|5|||
148952750|NCT03978520|537307414|FG003|Overall Study|Withdrawal by Subject|6|||
149218572|NCT02903966|538267659|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
149218573|NCT02045979|538267660|FG000|Overall Study|Informed Consent Withdrawn|2|||
149218574|NCT02045979|538267661|FG001|Overall Study|Informed Consent Withdrawn|0|||
149218575|NCT02045979|538267662|FG002|Overall Study|Informed Consent Withdrawn|1|||
149218576|NCT02045979|538267660|FG000|Overall Study|not specified above|0|||
149218577|NCT02045979|538267661|FG001|Overall Study|not specified above|1|||
149218578|NCT02045979|538267662|FG002|Overall Study|not specified above|0|||
149218579|NCT01320033|538267663|FG000|Overall Study|Lack of Efficacy|0|||
149218580|NCT01320033|538267664|FG001|Overall Study|Lack of Efficacy|0|||
149218581|NCT01320033|538267665|FG002|Overall Study|Lack of Efficacy|1|||
149218582|NCT01320033|538267663|FG000|Overall Study|Adverse Event|9|||
149218583|NCT01320033|538267664|FG001|Overall Study|Adverse Event|7|||
149218584|NCT01320033|538267665|FG002|Overall Study|Adverse Event|8|||
149218585|NCT01320033|538267663|FG000|Overall Study|Withdrawal by Subject|22|||
149218586|NCT01320033|538267664|FG001|Overall Study|Withdrawal by Subject|23|||
149218587|NCT01320033|538267665|FG002|Overall Study|Withdrawal by Subject|23|||
149218588|NCT01320033|538267663|FG000|Overall Study|Protocol Violation|3|||
149218589|NCT01320033|538267664|FG001|Overall Study|Protocol Violation|5|||
149218590|NCT01320033|538267665|FG002|Overall Study|Protocol Violation|3|||
149218591|NCT01320033|538267663|FG000|Overall Study|Lost to Follow-up|22|||
149218592|NCT01320033|538267664|FG001|Overall Study|Lost to Follow-up|26|||
149218593|NCT01320033|538267665|FG002|Overall Study|Lost to Follow-up|17|||
149218594|NCT01320033|538267663|FG000|Overall Study|Other|2|||
149218595|NCT01320033|538267664|FG001|Overall Study|Other|3|||
149218596|NCT01320033|538267665|FG002|Overall Study|Other|1|||
149218597|NCT00963469|538267666|FG000|Overall Study|Adverse Event|15|||
149218598|NCT00963469|538267667|FG001|Overall Study|Adverse Event|11|||
148952751|NCT03978520|537307415|FG004|Overall Study|Withdrawal by Subject|5|||
148952752|NCT03978520|537307411|FG000|Overall Study|Lost to Follow-up|2|||
148952753|NCT03978520|537307412|FG001|Overall Study|Lost to Follow-up|2|||
148952754|NCT03978520|537307413|FG002|Overall Study|Lost to Follow-up|2|||
148952755|NCT03978520|537307414|FG003|Overall Study|Lost to Follow-up|0|||
148685181|NCT01133821|536321401|FG001|Overall Study|preferred other treatment|1|||
148952756|NCT03978520|537307415|FG004|Overall Study|Lost to Follow-up|1|||
148952757|NCT03978520|537307411|FG000|Overall Study|COVID-19 infection|0|||
148952758|NCT03978520|537307412|FG001|Overall Study|COVID-19 infection|1|||
148952759|NCT03978520|537307413|FG002|Overall Study|COVID-19 infection|0|||
148952760|NCT03978520|537307414|FG003|Overall Study|COVID-19 infection|0|||
148952761|NCT03978520|537307415|FG004|Overall Study|COVID-19 infection|0|||
148952762|NCT03978520|537307411|FG000|Overall Study|Other, not specified|9|||
148952763|NCT03978520|537307412|FG001|Overall Study|Other, not specified|4|||
148952764|NCT03978520|537307413|FG002|Overall Study|Other, not specified|1|||
148952765|NCT03978520|537307414|FG003|Overall Study|Other, not specified|1|||
148952766|NCT03978520|537307415|FG004|Overall Study|Other, not specified|2|||
148952767|NCT03978520|537307411|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
148952768|NCT03978520|537307412|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
148952769|NCT03978520|537307413|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
148952770|NCT03978520|537307414|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
148952771|NCT03978520|537307415|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
148952772|NCT01918085|537307416|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
148952773|NCT01918085|537307417|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
148952774|NCT02547454|537307424|FG000|Overall Study|Due to hemodialysis|53|||
148952775|NCT02547454|537307424|FG000|Overall Study|Due to transplantation|1|||
148952776|NCT02547454|537307424|FG000|Overall Study|Due to no further need to treat|4|||
148952777|NCT02547454|537307424|FG000|Overall Study|Death|38|||
148952778|NCT02547454|537307424|FG000|Overall Study|Lost to Follow-up|26|||
148952779|NCT02547454|537307424|FG000|Overall Study|Other|39|||
148952780|NCT02547454|537307424|FG000|Overall Study|No data|11|||
148952781|NCT04102020|537307427|FG000|Overall Study|Adverse Event|1|||
148952782|NCT04102020|537307428|FG001|Overall Study|Adverse Event|0|||
148952783|NCT04102020|537307429|FG002|Overall Study|Adverse Event|0|||
148952784|NCT04102020|537307430|FG003|Overall Study|Adverse Event|1|||
148952785|NCT04102020|537307431|FG004|Overall Study|Adverse Event|0|||
148952786|NCT04102020|537307427|FG000|Overall Study|Withdrawal by Subject|0|||
148952787|NCT04102020|537307428|FG001|Overall Study|Withdrawal by Subject|1|||
148952788|NCT04102020|537307429|FG002|Overall Study|Withdrawal by Subject|1|||
148952789|NCT04102020|537307430|FG003|Overall Study|Withdrawal by Subject|1|||
148952790|NCT04102020|537307431|FG004|Overall Study|Withdrawal by Subject|1|||
148952791|NCT04102020|537307427|FG000|Overall Study|Death|1|||
148952792|NCT04102020|537307428|FG001|Overall Study|Death|4|||
148952793|NCT04102020|537307429|FG002|Overall Study|Death|1|||
148952794|NCT04102020|537307430|FG003|Overall Study|Death|1|||
148952795|NCT04102020|537307431|FG004|Overall Study|Death|0|||
148952796|NCT04102020|537307427|FG000|Overall Study|Physician Decision|1|||
148952797|NCT04102020|537307428|FG001|Overall Study|Physician Decision|2|||
148952798|NCT04102020|537307429|FG002|Overall Study|Physician Decision|2|||
148952799|NCT04102020|537307430|FG003|Overall Study|Physician Decision|0|||
148952800|NCT04102020|537307431|FG004|Overall Study|Physician Decision|1|||
148952801|NCT04102020|537307427|FG000|Overall Study|COVID-19 Infection|1|||
148952802|NCT04102020|537307428|FG001|Overall Study|COVID-19 Infection|0|||
148952803|NCT04102020|537307429|FG002|Overall Study|COVID-19 Infection|0|||
148952804|NCT04102020|537307430|FG003|Overall Study|COVID-19 Infection|0|||
148952805|NCT04102020|537307431|FG004|Overall Study|COVID-19 Infection|0|||
148952806|NCT04102020|537307427|FG000|Overall Study|Not disclosed|5|||
148952807|NCT04102020|537307428|FG001|Overall Study|Not disclosed|3|||
148952808|NCT04102020|537307429|FG002|Overall Study|Not disclosed|8|||
148952809|NCT04102020|537307430|FG003|Overall Study|Not disclosed|0|||
148952810|NCT04102020|537307431|FG004|Overall Study|Not disclosed|1|||
149218599|NCT00963469|538267668|FG002|Overall Study|Adverse Event|1|||
149218600|NCT00963469|538267666|FG000|Overall Study|Lack of Efficacy|10|||
149218601|NCT00963469|538267667|FG001|Overall Study|Lack of Efficacy|7|||
149218602|NCT00963469|538267668|FG002|Overall Study|Lack of Efficacy|2|||
148952811|NCT04102020|537307427|FG000|Overall Study|MIssing|1|||
148952812|NCT04102020|537307428|FG001|Overall Study|MIssing|0|||
148952813|NCT04102020|537307429|FG002|Overall Study|MIssing|1|||
149218603|NCT00963469|538267666|FG000|Overall Study|Lost to Follow-up|1|||
149218604|NCT00963469|538267667|FG001|Overall Study|Lost to Follow-up|1|||
149218605|NCT00963469|538267668|FG002|Overall Study|Lost to Follow-up|0|||
149218606|NCT00963469|538267666|FG000|Overall Study|Protocol Violation|5|||
149218607|NCT00963469|538267667|FG001|Overall Study|Protocol Violation|5|||
149218608|NCT00963469|538267668|FG002|Overall Study|Protocol Violation|3|||
149218609|NCT00963469|538267666|FG000|Overall Study|Withdrawal by Subject|4|||
149218610|NCT00963469|538267667|FG001|Overall Study|Withdrawal by Subject|1|||
149218611|NCT00963469|538267668|FG002|Overall Study|Withdrawal by Subject|1|||
149218612|NCT00963469|538267666|FG000|Overall Study|Pre-randomization Adverse Event|1|||
149218613|NCT00963469|538267667|FG001|Overall Study|Pre-randomization Adverse Event|2|||
148952814|NCT04102020|537307430|FG003|Overall Study|MIssing|1|||
149218614|NCT00963469|538267668|FG002|Overall Study|Pre-randomization Adverse Event|0|||
149218615|NCT00963469|538267666|FG000|Overall Study|Moved|1|||
149218616|NCT00963469|538267667|FG001|Overall Study|Moved|0|||
148952815|NCT04102020|537307431|FG004|Overall Study|MIssing|1|||
149218617|NCT00963469|538267668|FG002|Overall Study|Moved|0|||
149218618|NCT00963469|538267666|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
149218619|NCT00963469|538267667|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
149218620|NCT00963469|538267668|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
149218621|NCT00378534|538267675|FG000|Overall Study|Participants did not receive transplant|3|||
149218622|NCT00378534|538267676|FG001|Overall Study|Participants did not receive transplant|0|||
148952816|NCT04102020|537307427|FG000|Overall Study|Continuing in ongoing study|13|||
148952817|NCT04102020|537307428|FG001|Overall Study|Continuing in ongoing study|13|||
148952818|NCT04102020|537307429|FG002|Overall Study|Continuing in ongoing study|7|||
148952819|NCT04102020|537307430|FG003|Overall Study|Continuing in ongoing study|26|||
149218623|NCT03261037|538267677|FG000|Overall Study|Withdrawal by Subject|2|||
149218624|NCT03261037|538267678|FG001|Overall Study|Withdrawal by Subject|13|||
149218625|NCT03261037|538267679|FG002|Overall Study|Withdrawal by Subject|0|||
149218626|NCT03261037|538267680|FG003|Overall Study|Withdrawal by Subject|18|||
149218627|NCT03261037|538267677|FG000|Overall Study|Non-compliance with study procedures|0|||
149218628|NCT03261037|538267678|FG001|Overall Study|Non-compliance with study procedures|2|||
149218629|NCT03261037|538267679|FG002|Overall Study|Non-compliance with study procedures|0|||
149218630|NCT03261037|538267680|FG003|Overall Study|Non-compliance with study procedures|6|||
149218631|NCT03261037|538267677|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
149218632|NCT03261037|538267678|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
149218633|NCT03261037|538267679|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
148952820|NCT04102020|537307431|FG004|Overall Study|Continuing in ongoing study|12|||
148952821|NCT03918447|537307432|FG000|Overall Study|Death|1|||
148952822|NCT03918447|537307433|FG001|Overall Study|Death|0|||
148952823|NCT03918447|537307432|FG000|Overall Study|Lost to Follow-up|13|||
148952824|NCT03918447|537307433|FG001|Overall Study|Lost to Follow-up|6|||
148952825|NCT03918447|537307432|FG000|Overall Study|Withdrawal by Subject|19|||
148952826|NCT03918447|537307433|FG001|Overall Study|Withdrawal by Subject|17|||
148952827|NCT03918447|537307432|FG000|Overall Study|Study Terminated by Sponsor|195|||
148952828|NCT03918447|537307433|FG001|Overall Study|Study Terminated by Sponsor|197|||
148952829|NCT03918447|537307432|FG000|Overall Study|Reason not Specified|0|||
149218634|NCT03261037|538267680|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
149218635|NCT03261037|538267677|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
149218636|NCT03261037|538267678|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
149218637|NCT03261037|538267679|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
149218638|NCT03261037|538267680|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
149218639|NCT03261037|538267677|FG000|Overall Study|Diagnosed but protocol deviation|1|||
149218640|NCT03261037|538267678|FG001|Overall Study|Diagnosed but protocol deviation|0|||
149218641|NCT03261037|538267679|FG002|Overall Study|Diagnosed but protocol deviation|0|||
149218642|NCT03261037|538267680|FG003|Overall Study|Diagnosed but protocol deviation|0|||
148952830|NCT03918447|537307433|FG001|Overall Study|Reason not Specified|1|||
148952831|NCT03278613|537307434|FG000|Overall Study|Lost to Follow-up|3|||
148952832|NCT03278613|537307435|FG001|Overall Study|Lost to Follow-up|1|||
148952833|NCT01405456|537307436|FG000|Overall Study|Lost to Follow-up|2|||
148952834|NCT01405456|537307437|FG001|Overall Study|Lost to Follow-up|1|||
149218643|NCT03261037|538267677|FG000|Overall Study|Participant did not want to continue the study|0|||
149218644|NCT03261037|538267678|FG001|Overall Study|Participant did not want to continue the study|1|||
148952835|NCT01405456|537307436|FG000|Overall Study|Physician Decision|1|||
148952836|NCT01405456|537307437|FG001|Overall Study|Physician Decision|0|||
148952837|NCT05353985|537307439|FG000|Overall Study|Adverse Event|5|||
148952838|NCT05353985|537307440|FG001|Overall Study|Adverse Event|7|||
148952839|NCT05353985|537307439|FG000|Overall Study|Lost to Follow-up|1|||
148952840|NCT05353985|537307440|FG001|Overall Study|Lost to Follow-up|1|||
148952841|NCT05353985|537307439|FG000|Overall Study|Protocol Violation|1|||
148952842|NCT05353985|537307440|FG001|Overall Study|Protocol Violation|0|||
148952843|NCT05353985|537307439|FG000|Overall Study|Withdrawal by Subject|13|||
148952844|NCT05353985|537307440|FG001|Overall Study|Withdrawal by Subject|17|||
148952845|NCT05353985|537307439|FG000|Overall Study|Reason Not Specified|1|||
148952846|NCT05353985|537307440|FG001|Overall Study|Reason Not Specified|0|||
148952847|NCT05353985|537307439|FG000|Overall Study|Randomized in Error & Not Treated|0|||
148952848|NCT05353985|537307440|FG001|Overall Study|Randomized in Error & Not Treated|1|||
148952849|NCT03010254|537308556|FG000|Overall Study|Adverse Event|0|||
148952850|NCT03010254|537308557|FG001|Overall Study|Adverse Event|1|||
148952851|NCT03010254|537308556|FG000|Overall Study|Lost to Follow-up|4|||
148952852|NCT03010254|537308557|FG001|Overall Study|Lost to Follow-up|0|||
148952853|NCT03010254|537308556|FG000|Overall Study|Withdrawal by Subject|1|||
149218645|NCT03261037|538267679|FG002|Overall Study|Participant did not want to continue the study|0|||
149218646|NCT03261037|538267680|FG003|Overall Study|Participant did not want to continue the study|0|||
149218647|NCT03261037|538267677|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
149218648|NCT03261037|538267678|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
149218649|NCT03261037|538267679|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
149218650|NCT03261037|538267680|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
148952854|NCT03010254|537308557|FG001|Overall Study|Withdrawal by Subject|1|||
148952855|NCT03010254|537308556|FG000|Overall Study|Other|2|||
149218651|NCT03261037|538267677|FG000|Overall Study|Participant presented clinical improvement|0|||
148952856|NCT03010254|537308557|FG001|Overall Study|Other|3|||
148952857|NCT00848081|537308558|FG000|Overall Study|Adverse Event|6|||
148952858|NCT00848081|537308559|FG001|Overall Study|Adverse Event|7|||
148952859|NCT00848081|537308558|FG000|Overall Study|Protocol Violation|8|||
148952860|NCT00848081|537308559|FG001|Overall Study|Protocol Violation|5|||
148952861|NCT00848081|537308558|FG000|Overall Study|Lost to Follow-up|1|||
149218652|NCT03261037|538267678|FG001|Overall Study|Participant presented clinical improvement|2|||
149218653|NCT03261037|538267679|FG002|Overall Study|Participant presented clinical improvement|0|||
149218654|NCT03261037|538267680|FG003|Overall Study|Participant presented clinical improvement|0|||
149218655|NCT03261037|538267677|FG000|Overall Study|Technical difficulties|0|||
149218656|NCT03261037|538267678|FG001|Overall Study|Technical difficulties|0|||
149218657|NCT03261037|538267679|FG002|Overall Study|Technical difficulties|0|||
149218658|NCT03261037|538267680|FG003|Overall Study|Technical difficulties|1|||
149218659|NCT03261037|538267677|FG000|Overall Study|Equipment failed to work|0|||
149218660|NCT03261037|538267678|FG001|Overall Study|Equipment failed to work|0|||
149218661|NCT03261037|538267679|FG002|Overall Study|Equipment failed to work|0|||
149218662|NCT03261037|538267680|FG003|Overall Study|Equipment failed to work|1|||
148952862|NCT00848081|537308559|FG001|Overall Study|Lost to Follow-up|0|||
148952863|NCT00848081|537308558|FG000|Overall Study|Physician Decision|0|||
148952864|NCT00848081|537308559|FG001|Overall Study|Physician Decision|3|||
148952865|NCT00848081|537308558|FG000|Overall Study|Withdrawal by Subject|5|||
149218663|NCT03261037|538267677|FG000|Overall Study|End of study for participant and no follow up|0|||
149218664|NCT03261037|538267678|FG001|Overall Study|End of study for participant and no follow up|0|||
148952866|NCT00848081|537308559|FG001|Overall Study|Withdrawal by Subject|3|||
148952867|NCT02064868|537308562|FG000|Overall Study|Lost to Follow-up|14|||
148952868|NCT02064868|537308563|FG001|Overall Study|Lost to Follow-up|8|||
148952869|NCT02064868|537308562|FG000|Overall Study|Physician Decision|1|||
148952870|NCT02064868|537308563|FG001|Overall Study|Physician Decision|0|||
148952871|NCT02064868|537308562|FG000|Overall Study|Withdrawal by Subject|14|||
148952872|NCT02064868|537308563|FG001|Overall Study|Withdrawal by Subject|3|||
148952873|NCT02064868|537308562|FG000|Overall Study|Technical Problems or Missing|5|||
148952874|NCT02064868|537308563|FG001|Overall Study|Technical Problems or Missing|2|||
148952875|NCT00418314|537308567|FG000|Overall Study|Withdrawal by Subject|1|||
148952876|NCT00418314|537308568|FG001|Overall Study|Withdrawal by Subject|2|||
148952877|NCT02057406|537308569|FG000|Overall Study|Physician Decision|0|||
148952878|NCT02057406|537308570|FG001|Overall Study|Physician Decision|0|||
148952879|NCT02057406|537308571|FG002|Overall Study|Physician Decision|2|||
148952880|NCT02057406|537308569|FG000|Overall Study|Withdrawal by Subject|0|||
148952881|NCT02057406|537308570|FG001|Overall Study|Withdrawal by Subject|2|||
148952882|NCT02057406|537308571|FG002|Overall Study|Withdrawal by Subject|0|||
148952883|NCT02057406|537308569|FG000|Overall Study|Lost to Follow-up|0|||
148952884|NCT02057406|537308570|FG001|Overall Study|Lost to Follow-up|0|||
148952885|NCT02057406|537308571|FG002|Overall Study|Lost to Follow-up|1|||
148952886|NCT02057406|537308569|FG000|Overall Study|Death|1|||
148952887|NCT02057406|537308570|FG001|Overall Study|Death|0|||
148952888|NCT02057406|537308571|FG002|Overall Study|Death|0|||
148952889|NCT02057406|537308569|FG000|Overall Study|Protocol Violation|0|||
148952890|NCT02057406|537308570|FG001|Overall Study|Protocol Violation|1|||
148952891|NCT02057406|537308571|FG002|Overall Study|Protocol Violation|0|||
148952892|NCT02057406|537308569|FG000|Overall Study|Patient transportation issues|0|||
148952893|NCT02057406|537308570|FG001|Overall Study|Patient transportation issues|0|||
148952894|NCT02057406|537308571|FG002|Overall Study|Patient transportation issues|1|||
148952895|NCT03562481|537308572|FG000|First Intervention|Lost to Follow-up|1|||
148952896|NCT03562481|537308573|FG001|First Intervention|Lost to Follow-up|0|||
148952897|NCT02782780|537308574|FG000|Overall Study|dropped out after randomization.|7|||
148952898|NCT02782780|537308575|FG001|Overall Study|dropped out after randomization.|5|||
148952899|NCT02782780|537308574|FG000|Overall Study|Protocol Violation|0|||
148952900|NCT02782780|537308575|FG001|Overall Study|Protocol Violation|2|||
148952901|NCT03590041|537308585|FG000|Overall Study|Protocol Violation|4|||
148952902|NCT03590041|537308586|FG001|Overall Study|Protocol Violation|3|||
148952903|NCT03590041|537308585|FG000|Overall Study|No session data recorded|14|||
148952904|NCT03590041|537308586|FG001|Overall Study|No session data recorded|2|||
148952905|NCT02692703|537308587|FG000|Overall Study|Lost to Follow-up|1|||
148952906|NCT02692703|537308587|FG000|Overall Study|Other|1|||
148952907|NCT04118166|537308588|FG000|Overall Study|Adverse Event|1|||
148952908|NCT03519932|537308591|FG000|First Intervention|Adverse Event|1|||
148952909|NCT03519932|537308592|FG001|First Intervention|Adverse Event|3|||
148952910|NCT03303079|537308597|FG000|Overall Study|Adverse Event|0|||
148952911|NCT03303079|537308598|FG001|Overall Study|Adverse Event|1|||
148952912|NCT03303079|537308599|FG002|Overall Study|Adverse Event|3|||
148952913|NCT03303079|537308597|FG000|Overall Study|Protocol Violation|5|||
148952914|NCT03303079|537308598|FG001|Overall Study|Protocol Violation|4|||
148952915|NCT03303079|537308599|FG002|Overall Study|Protocol Violation|7|||
148952916|NCT03303079|537308597|FG000|Overall Study|Withdrawal by Subject|2|||
148952917|NCT03303079|537308598|FG001|Overall Study|Withdrawal by Subject|4|||
148952918|NCT03303079|537308599|FG002|Overall Study|Withdrawal by Subject|2|||
148952919|NCT03303079|537308597|FG000|Overall Study|Other than specified|0|||
148952920|NCT03303079|537308598|FG001|Overall Study|Other than specified|2|||
148952921|NCT03303079|537308599|FG002|Overall Study|Other than specified|0|||
148952922|NCT00010374|537308600|FG000|Overall Study|False positive phrenic nerve test|1|||
148952923|NCT03315208|537308601|FG000|Overall Study|Lost to Follow-up|11|||
148952924|NCT03315208|537308602|FG001|Overall Study|Lost to Follow-up|6|||
148952925|NCT03315208|537308601|FG000|Overall Study|Withdrawal by Subject|2|||
148952926|NCT03315208|537308602|FG001|Overall Study|Withdrawal by Subject|0|||
148952927|NCT02706691|537308605|FG000|Overall Study|Adverse Event|1|||
148952928|NCT00356369|537308606|FG000|Active Phase|Withdrawal by Subject|2|||
148952929|NCT00356369|537308607|FG001|Active Phase|Withdrawal by Subject|1|||
148952930|NCT01426373|537308614|FG000|Overall Study|Adverse Event|6|||
148952931|NCT01426373|537308614|FG000|Overall Study|Lost to Follow-up|14|||
148952932|NCT01426373|537308614|FG000|Overall Study|Participant Convenience|10|||
148952933|NCT01426373|537308614|FG000|Overall Study|Miscellaneous Reasons|4|||
148952934|NCT01919723|537308619|FG000|Overall Study|Blood Samples Hemolyzed|2|||
148952935|NCT01919723|537308620|FG001|Overall Study|Blood Samples Hemolyzed|2|||
148952936|NCT04502589|537308621|FG000|Overall Study|Physician Decision|1|||
148952937|NCT04502589|537308622|FG001|Overall Study|Physician Decision|0|||
148952938|NCT00582166|537308629|FG000|Overall Study|Death|1|||
148952939|NCT00582166|537308629|FG000|Overall Study|Ineligible pathology|1|||
148952940|NCT02859454|537308630|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
148952941|NCT00110149|537308631|FG000|Overall Study|Physician Decision|3|||
148952942|NCT02452398|537308632|FG000|Overall Study|Adverse Event|1|||
148952943|NCT02452398|537308632|FG000|Overall Study|Lost to Follow-up|28|||
148952944|NCT02452398|537308632|FG000|Overall Study|Physician Decision|2|||
148952945|NCT02452398|537308632|FG000|Overall Study|Withdrawal by Subject|6|||
148952946|NCT02452398|537308632|FG000|Overall Study|Moved away|4|||
148952947|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
148952948|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
148952949|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
148952950|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
148952951|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
148952952|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
148952953|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
148952954|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
148952955|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Other|1|||
148952956|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Other|4|||
149218665|NCT03261037|538267679|FG002|Overall Study|End of study for participant and no follow up|0|||
149218666|NCT03261037|538267680|FG003|Overall Study|End of study for participant and no follow up|1|||
149218667|NCT03261037|538267677|FG000|Overall Study|Participant was too weak to continue in study|1|||
149218668|NCT03261037|538267678|FG001|Overall Study|Participant was too weak to continue in study|0|||
149218669|NCT03261037|538267679|FG002|Overall Study|Participant was too weak to continue in study|0|||
149218670|NCT03261037|538267680|FG003|Overall Study|Participant was too weak to continue in study|0|||
149218671|NCT04423718|538267681|FG000|Main Study|Adverse Event|9|||
149218672|NCT04423718|538267682|FG001|Main Study|Adverse Event|5|||
149218673|NCT04423718|538267683|FG002|Main Study|Adverse Event|8|||
149218674|NCT04423718|538267681|FG000|Main Study|Physician Decision|3|||
149218675|NCT04423718|538267682|FG001|Main Study|Physician Decision|3|||
149218676|NCT04423718|538267683|FG002|Main Study|Physician Decision|2|||
149218677|NCT04423718|538267681|FG000|Main Study|Protocol Violation|0|||
149218678|NCT04423718|538267682|FG001|Main Study|Protocol Violation|0|||
149218679|NCT04423718|538267683|FG002|Main Study|Protocol Violation|1|||
149218680|NCT04423718|538267681|FG000|Main Study|Lost to Follow-up|3|||
149218681|NCT04423718|538267682|FG001|Main Study|Lost to Follow-up|3|||
149218682|NCT04423718|538267683|FG002|Main Study|Lost to Follow-up|4|||
149218683|NCT04423718|538267681|FG000|Main Study|Lack of Efficacy|2|||
149218684|NCT04423718|538267682|FG001|Main Study|Lack of Efficacy|1|||
149218685|NCT04423718|538267683|FG002|Main Study|Lack of Efficacy|0|||
149218686|NCT04423718|538267681|FG000|Main Study|Withdrawal by Subject|14|||
149218687|NCT04423718|538267682|FG001|Main Study|Withdrawal by Subject|20|||
149218688|NCT04423718|538267683|FG002|Main Study|Withdrawal by Subject|20|||
149218689|NCT04423718|538267681|FG000|Main Study|Death|10|||
149218690|NCT04423718|538267682|FG001|Main Study|Death|7|||
149218691|NCT04423718|538267683|FG002|Main Study|Death|7|||
149218692|NCT04423718|538267681|FG000|Main Study|COVID-19 pandemic|2|||
149218693|NCT04423718|538267682|FG001|Main Study|COVID-19 pandemic|2|||
148952957|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Other|3|||
148952958|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Other|6|||
148952959|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
148952960|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
148952961|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
148952962|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
148952963|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
148952964|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
148952965|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
148952966|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
148952967|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
148952968|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
148952969|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
148952970|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
148952971|NCT02925494|537308635|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
148952972|NCT02925494|537308636|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
148952973|NCT02925494|537308637|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
148952974|NCT02925494|537308638|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
148952975|NCT03334448|537308641|FG000|Washout|Personal Reason|0|||
148952976|NCT03334448|537308642|FG001|Washout|Personal Reason|1|||
148952977|NCT03334448|537308643|FG002|Washout|Personal Reason|0|||
148952978|NCT03334448|537308644|FG003|Washout|Personal Reason|0|||
148952979|NCT03334448|537308641|FG000|Washout|Protocol Violation|0|||
148952980|NCT03334448|537308642|FG001|Washout|Protocol Violation|0|||
148952981|NCT03334448|537308643|FG002|Washout|Protocol Violation|0|||
148952982|NCT03334448|537308644|FG003|Washout|Protocol Violation|1|||
148952983|NCT01365910|537308648|FG000|Overall Study|Withdrawal by Subject|7|||
148952984|NCT01365910|537308648|FG000|Overall Study|disease progression|18|||
148952985|NCT01365910|537308648|FG000|Overall Study|Adverse Event|3|||
148952986|NCT01365910|537308648|FG000|Overall Study|other complicating disease|1|||
149218694|NCT04423718|538267683|FG002|Main Study|COVID-19 pandemic|2|||
149218695|NCT04423718|538267681|FG000|Main Study|Other|7|||
148952987|NCT01365910|537308648|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
148952988|NCT00371137|537308649|FG000|Overall Study|Adverse Event|20|||
148952989|NCT00371137|537308650|FG001|Overall Study|Adverse Event|35|||
148952990|NCT00371137|537308651|FG002|Overall Study|Adverse Event|42|||
148952991|NCT00371137|537308649|FG000|Overall Study|Withdrawal by Subject|11|||
148952992|NCT00371137|537308650|FG001|Overall Study|Withdrawal by Subject|10|||
148952993|NCT00371137|537308651|FG002|Overall Study|Withdrawal by Subject|15|||
148952994|NCT00371137|537308649|FG000|Overall Study|Lost to Follow-up|6|||
148952995|NCT00371137|537308650|FG001|Overall Study|Lost to Follow-up|3|||
148952996|NCT00371137|537308651|FG002|Overall Study|Lost to Follow-up|5|||
148952997|NCT00371137|537308649|FG000|Overall Study|Lack of Efficacy|30|||
148952998|NCT00371137|537308650|FG001|Overall Study|Lack of Efficacy|12|||
149218696|NCT04423718|538267682|FG001|Main Study|Other|3|||
149218697|NCT04423718|538267683|FG002|Main Study|Other|2|||
149218698|NCT04423718|538267681|FG000|Extension Phase|Other|1|||
149218699|NCT04423718|538267682|FG001|Extension Phase|Other|0|||
149218700|NCT04423718|538267683|FG002|Extension Phase|Other|0|||
149218701|NCT04423718|538267681|FG000|Extension Phase|Logistical problems|0|||
149218702|NCT04423718|538267682|FG001|Extension Phase|Logistical problems|1|||
149218703|NCT04423718|538267683|FG002|Extension Phase|Logistical problems|1|||
149218704|NCT04423718|538267681|FG000|Extension Phase|Physician Decision|1|||
149218705|NCT04423718|538267682|FG001|Extension Phase|Physician Decision|0|||
149218706|NCT04423718|538267683|FG002|Extension Phase|Physician Decision|1|||
149218707|NCT04423718|538267681|FG000|Extension Phase|Lack of Efficacy|2|||
149218708|NCT04423718|538267682|FG001|Extension Phase|Lack of Efficacy|0|||
149218709|NCT04423718|538267683|FG002|Extension Phase|Lack of Efficacy|1|||
149218710|NCT04423718|538267681|FG000|Extension Phase|Lost to Follow-up|0|||
149218711|NCT04423718|538267682|FG001|Extension Phase|Lost to Follow-up|2|||
149218712|NCT04423718|538267683|FG002|Extension Phase|Lost to Follow-up|3|||
149218713|NCT04423718|538267681|FG000|Extension Phase|Adverse Event|2|||
149218714|NCT04423718|538267682|FG001|Extension Phase|Adverse Event|3|||
149218715|NCT04423718|538267683|FG002|Extension Phase|Adverse Event|1|||
149218716|NCT04423718|538267681|FG000|Extension Phase|Death|4|||
149218717|NCT04423718|538267682|FG001|Extension Phase|Death|7|||
149218718|NCT04423718|538267683|FG002|Extension Phase|Death|2|||
149218719|NCT04423718|538267681|FG000|Extension Phase|Withdrawal by Subject|11|||
149218720|NCT04423718|538267682|FG001|Extension Phase|Withdrawal by Subject|11|||
149218721|NCT04423718|538267683|FG002|Extension Phase|Withdrawal by Subject|7|||
149218722|NCT00425945|538267684|FG000|Overall Study|Concern about Supplement|2|||
149218723|NCT00425945|538267685|FG001|Overall Study|Concern about Supplement|0|||
149218724|NCT00425945|538267684|FG000|Overall Study|Inconvenience|0|||
149218725|NCT00425945|538267685|FG001|Overall Study|Inconvenience|2|||
149218726|NCT00425945|538267684|FG000|Overall Study|Lost to Follow-up|0|||
149218727|NCT00425945|538267685|FG001|Overall Study|Lost to Follow-up|2|||
149218728|NCT00425945|538267684|FG000|Overall Study|Began hypertension medication|1|||
149218729|NCT00425945|538267685|FG001|Overall Study|Began hypertension medication|0|||
149218730|NCT00425945|538267684|FG000|Overall Study|Began cancer treatments|1|||
149218731|NCT00425945|538267685|FG001|Overall Study|Began cancer treatments|0|||
149218732|NCT00425945|538267684|FG000|Overall Study|Moved from area|0|||
149218733|NCT00425945|538267685|FG001|Overall Study|Moved from area|1|||
149218734|NCT03381274|538267689|FG000|Overall Study|Death|2|||
149218735|NCT03381274|538267690|FG001|Overall Study|Death|9|||
149218736|NCT03381274|538267691|FG002|Overall Study|Death|3|||
149218737|NCT03381274|538267692|FG003|Overall Study|Death|2|||
149218738|NCT03381274|538267693|FG004|Overall Study|Death|3|||
149218739|NCT03381274|538267689|FG000|Overall Study|Lost to Follow-up|0|||
149218740|NCT03381274|538267690|FG001|Overall Study|Lost to Follow-up|0|||
149218741|NCT03381274|538267691|FG002|Overall Study|Lost to Follow-up|0|||
149218742|NCT03381274|538267692|FG003|Overall Study|Lost to Follow-up|1|||
149218743|NCT03381274|538267693|FG004|Overall Study|Lost to Follow-up|0|||
149218744|NCT03381274|538267689|FG000|Overall Study|Withdrawal by Subject|2|||
149218745|NCT03381274|538267690|FG001|Overall Study|Withdrawal by Subject|1|||
148952999|NCT00371137|537308651|FG002|Overall Study|Lack of Efficacy|13|||
149218746|NCT03381274|538267691|FG002|Overall Study|Withdrawal by Subject|3|||
149218747|NCT03381274|538267692|FG003|Overall Study|Withdrawal by Subject|1|||
149218748|NCT03381274|538267693|FG004|Overall Study|Withdrawal by Subject|0|||
149218749|NCT03381274|538267689|FG000|Overall Study|Other|1|||
148953000|NCT00371137|537308649|FG000|Overall Study|Sponsor Decision|2|||
148953001|NCT00371137|537308650|FG001|Overall Study|Sponsor Decision|1|||
148953002|NCT00371137|537308651|FG002|Overall Study|Sponsor Decision|2|||
148953003|NCT00371137|537308649|FG000|Overall Study|Physician Decision|1|||
148953004|NCT00371137|537308650|FG001|Overall Study|Physician Decision|1|||
148953005|NCT00371137|537308651|FG002|Overall Study|Physician Decision|1|||
148953006|NCT00371137|537308649|FG000|Overall Study|Protocol Violation|2|||
148953007|NCT00371137|537308650|FG001|Overall Study|Protocol Violation|1|||
148953008|NCT00371137|537308651|FG002|Overall Study|Protocol Violation|1|||
149218750|NCT03381274|538267690|FG001|Overall Study|Other|11|||
149218751|NCT03381274|538267691|FG002|Overall Study|Other|0|||
149218752|NCT03381274|538267692|FG003|Overall Study|Other|2|||
149218753|NCT03381274|538267693|FG004|Overall Study|Other|2|||
149218754|NCT04284787|538267694|FG000|Overall Study|Disease Progression|9|||
148953009|NCT02013791|537308652|FG000|Period 1|Lost to Follow-up|0|||
148953010|NCT02013791|537308653|FG001|Period 1|Lost to Follow-up|0|||
149218755|NCT04284787|538267695|FG001|Overall Study|Disease Progression|12|||
149218756|NCT04284787|538267694|FG000|Overall Study|Physician Decision|12|||
148953011|NCT02013791|537308654|FG002|Period 1|Lost to Follow-up|0|||
148953012|NCT02013791|537308655|FG003|Period 1|Lost to Follow-up|1|||
148953013|NCT02013791|537308656|FG004|Period 1|Lost to Follow-up|0|||
148953014|NCT02013791|537308657|FG005|Period 1|Lost to Follow-up|0|||
148953015|NCT02013791|537308658|FG006|Period 1|Lost to Follow-up|1|||
148953016|NCT02013791|537308659|FG007|Period 1|Lost to Follow-up|1|||
148953017|NCT02013791|537308660|FG008|Period 1|Lost to Follow-up|0|||
148953018|NCT02013791|537308652|FG000|Period 1|Other Miscellaneous Reasons|0|||
148953019|NCT02013791|537308653|FG001|Period 1|Other Miscellaneous Reasons|2|||
148953020|NCT02013791|537308654|FG002|Period 1|Other Miscellaneous Reasons|0|||
148953021|NCT02013791|537308655|FG003|Period 1|Other Miscellaneous Reasons|0|||
148953022|NCT02013791|537308656|FG004|Period 1|Other Miscellaneous Reasons|0|||
148953023|NCT02013791|537308657|FG005|Period 1|Other Miscellaneous Reasons|0|||
148953024|NCT02013791|537308658|FG006|Period 1|Other Miscellaneous Reasons|0|||
148953025|NCT02013791|537308659|FG007|Period 1|Other Miscellaneous Reasons|0|||
148953026|NCT02013791|537308660|FG008|Period 1|Other Miscellaneous Reasons|0|||
148953027|NCT03798483|537308661|FG000|Overall Study|Lost to Follow-up|2|||
148953028|NCT01835587|537308664|FG000|Overall Study|Disease Recurrence or Relapse|0|||
148953029|NCT01835587|537308665|FG001|Overall Study|Disease Recurrence or Relapse|3|||
149218757|NCT04284787|538267695|FG001|Overall Study|Physician Decision|7|||
149218758|NCT04284787|538267694|FG000|Overall Study|Transplant|5|||
149218759|NCT04284787|538267695|FG001|Overall Study|Transplant|4|||
148953030|NCT01835587|537308666|FG002|Overall Study|Disease Recurrence or Relapse|0|||
148953031|NCT01835587|537308667|FG003|Overall Study|Disease Recurrence or Relapse|3|||
148953032|NCT01835587|537308664|FG000|Overall Study|Withdrawal by Subject|2|||
149218760|NCT04284787|538267694|FG000|Overall Study|Death|1|||
148809936|NCT05233761|536780915|FG001|Treatment Period A|Lost to Follow-up|12|||
149218761|NCT04284787|538267695|FG001|Overall Study|Death|2|||
149218762|NCT04284787|538267694|FG000|Overall Study|Adverse Event|0|||
149218763|NCT04284787|538267695|FG001|Overall Study|Adverse Event|4|||
149218764|NCT04284787|538267694|FG000|Overall Study|Non-adherence|2|||
149218765|NCT04284787|538267695|FG001|Overall Study|Non-adherence|0|||
149218766|NCT04284787|538267694|FG000|Overall Study|Lack of Efficacy|2|||
149218767|NCT04284787|538267695|FG001|Overall Study|Lack of Efficacy|0|||
149218768|NCT01874353|538267696|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
149218769|NCT01874353|538267697|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
149218770|NCT01874353|538267698|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
149218771|NCT01874353|538267699|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
149218772|NCT01874353|538267696|FG000|Overall Study|Lost to Follow-up|2|||
149218773|NCT01874353|538267697|FG001|Overall Study|Lost to Follow-up|2|||
149218774|NCT01874353|538267698|FG002|Overall Study|Lost to Follow-up|2|||
149218775|NCT01874353|538267699|FG003|Overall Study|Lost to Follow-up|0|||
149218776|NCT01874353|538267696|FG000|Overall Study|Death|110|||
149218777|NCT01874353|538267697|FG001|Overall Study|Death|60|||
149218778|NCT01874353|538267698|FG002|Overall Study|Death|13|||
149218779|NCT01874353|538267699|FG003|Overall Study|Death|7|||
149218780|NCT01874353|538267696|FG000|Overall Study|Withdrawal by Subject|13|||
149218781|NCT01874353|538267697|FG001|Overall Study|Withdrawal by Subject|11|||
149218782|NCT01874353|538267698|FG002|Overall Study|Withdrawal by Subject|0|||
149218783|NCT01874353|538267699|FG003|Overall Study|Withdrawal by Subject|0|||
149218784|NCT05298774|538267708|FG000|Overall Study|Physician Decision|3|||
149218785|NCT05298774|538267708|FG000|Overall Study|Withdrawal by Subject|2|||
149218786|NCT05298774|538267708|FG000|Overall Study|Lost to Follow-up|3|||
149218787|NCT05298774|538267708|FG000|Overall Study|Screen failure|1|||
149218788|NCT04992507|538267709|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
148809937|NCT05233761|536780914|FG000|Treatment Period A|Protocol Violation|8|||
148953033|NCT01835587|537308665|FG001|Overall Study|Withdrawal by Subject|0|||
148953034|NCT01835587|537308666|FG002|Overall Study|Withdrawal by Subject|0|||
149218789|NCT04992507|538267710|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
149218790|NCT04992507|538267709|FG000|Overall Study|Death|0|||
149218791|NCT04992507|538267710|FG001|Overall Study|Death|1|||
149218792|NCT00081263|538267711|FG000|Overall Study|clerical error|1|||
149218793|NCT00081263|538267712|FG001|Overall Study|clerical error|0|||
148953035|NCT01835587|537308667|FG003|Overall Study|Withdrawal by Subject|3|||
148953036|NCT01835587|537308664|FG000|Overall Study|Adverse Event|0|||
148953037|NCT01835587|537308665|FG001|Overall Study|Adverse Event|0|||
148953038|NCT01835587|537308666|FG002|Overall Study|Adverse Event|2|||
148953039|NCT01835587|537308667|FG003|Overall Study|Adverse Event|2|||
148953040|NCT01835587|537308664|FG000|Overall Study|Death|0|||
148953041|NCT01835587|537308665|FG001|Overall Study|Death|0|||
148953042|NCT01835587|537308666|FG002|Overall Study|Death|0|||
148953043|NCT01835587|537308667|FG003|Overall Study|Death|1|||
148953044|NCT01835587|537308664|FG000|Overall Study|Miscellaneous|0|||
148685182|NCT01133821|536321400|FG000|Overall Study|Protocol Violation|0|||
148685183|NCT01133821|536321401|FG001|Overall Study|Protocol Violation|1|||
148685184|NCT01133821|536321400|FG000|Overall Study|Refused participation|1|||
148685185|NCT01133821|536321401|FG001|Overall Study|Refused participation|3|||
148685186|NCT01267266|536321406|FG000|Enrollment Phase|Withdrawal by Subject|2|||
148685187|NCT01267266|536321407|FG001|Enrollment Phase|Withdrawal by Subject|0|||
148685188|NCT01267266|536321406|FG000|Lead-in Phase|Lack of Efficacy|20|||
148685189|NCT01267266|536321407|FG001|Lead-in Phase|Lack of Efficacy|0|||
148685190|NCT01267266|536321406|FG000|Lead-in Phase|Adverse Event|2|||
148685191|NCT01267266|536321407|FG001|Lead-in Phase|Adverse Event|0|||
148685192|NCT01267266|536321406|FG000|Lead-in Phase|Withdrawal by Subject|1|||
148809938|NCT05233761|536780915|FG001|Treatment Period A|Protocol Violation|15|||
148809939|NCT01551173|536780920|FG000|Overall Study|Withdrawal by Subject|11|||
148953045|NCT01835587|537308665|FG001|Overall Study|Miscellaneous|1|||
148953046|NCT01835587|537308666|FG002|Overall Study|Miscellaneous|0|||
148953047|NCT01835587|537308667|FG003|Overall Study|Miscellaneous|0|||
148953048|NCT03310775|537308670|FG000|Overall Study|Lost to Follow-up|2|||
148953049|NCT03310775|537308671|FG001|Overall Study|Lost to Follow-up|3|||
148953050|NCT03310775|537308670|FG000|Overall Study|aggravation of depression|0|||
148953051|NCT03310775|537308671|FG001|Overall Study|aggravation of depression|1|||
148953052|NCT00126568|537308672|FG000|Overall Study|Death|2|||
148953053|NCT03064451|537308673|FG000|Overall Study|Lost to Follow-up|1|||
148953054|NCT03064451|537308673|FG000|Overall Study|Mapping Failure|4|||
148953055|NCT03064451|537308673|FG000|Overall Study|Exited prior to procedure|8|||
148953056|NCT03064451|537308673|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
148953057|NCT05475236|537308674|FG000|Overall Study|Withdrawal by Subject|0|||
148953058|NCT05475236|537308675|FG001|Overall Study|Withdrawal by Subject|1|||
148953059|NCT00477971|537308676|FG000|Overall Study|Disease progression|6|||
148953060|NCT00477971|537308677|FG001|Overall Study|Disease progression|0|||
148953061|NCT00477971|537308676|FG000|Overall Study|Withdrawal by Subject|3|||
148953062|NCT00477971|537308677|FG001|Overall Study|Withdrawal by Subject|1|||
148953063|NCT00477971|537308676|FG000|Overall Study|Adverse Event|3|||
148953064|NCT00477971|537308677|FG001|Overall Study|Adverse Event|0|||
148953065|NCT00477971|537308676|FG000|Overall Study|Death|2|||
148953066|NCT00477971|537308677|FG001|Overall Study|Death|4|||
148953067|NCT00477971|537308676|FG000|Overall Study|Alternative treatment|3|||
148953068|NCT00477971|537308677|FG001|Overall Study|Alternative treatment|1|||
148953069|NCT05355805|537308678|FG000|Overall Study|Lost to Follow-up|6|||
148953070|NCT05355805|537308679|FG001|Overall Study|Lost to Follow-up|11|||
148953071|NCT05355805|537308680|FG002|Overall Study|Lost to Follow-up|10|||
148953072|NCT05355805|537308681|FG003|Overall Study|Lost to Follow-up|6|||
148953073|NCT05355805|537308678|FG000|Overall Study|Decision by Sponsor|0|||
148953074|NCT05355805|537308679|FG001|Overall Study|Decision by Sponsor|0|||
148953075|NCT05355805|537308680|FG002|Overall Study|Decision by Sponsor|1|||
148953076|NCT05355805|537308681|FG003|Overall Study|Decision by Sponsor|0|||
148953077|NCT05355805|537308678|FG000|Overall Study|Withdrawal by Subject|7|||
148953078|NCT05355805|537308679|FG001|Overall Study|Withdrawal by Subject|14|||
148953079|NCT05355805|537308680|FG002|Overall Study|Withdrawal by Subject|15|||
148953080|NCT05355805|537308681|FG003|Overall Study|Withdrawal by Subject|13|||
148953081|NCT00609492|537310324|FG000|Overall Study|Withdrawal by Subject|0|||
148953082|NCT00609492|537310325|FG001|Overall Study|Withdrawal by Subject|2|||
148953083|NCT00609492|537310326|FG002|Overall Study|Withdrawal by Subject|3|||
148953084|NCT00609492|537310324|FG000|Overall Study|Lost to Follow-up|1|||
148953085|NCT00609492|537310325|FG001|Overall Study|Lost to Follow-up|1|||
148953086|NCT00609492|537310326|FG002|Overall Study|Lost to Follow-up|4|||
148953087|NCT00589914|537310333|FG000|Overall Study|Adverse Event|19|||
148953088|NCT00589914|537310334|FG001|Overall Study|Adverse Event|10|||
148953089|NCT00589914|537310333|FG000|Overall Study|Death|2|||
148953090|NCT00589914|537310334|FG001|Overall Study|Death|0|||
148953091|NCT00589914|537310333|FG000|Overall Study|Lack of Efficacy|40|||
148953092|NCT00589914|537310334|FG001|Overall Study|Lack of Efficacy|43|||
148953093|NCT00589914|537310333|FG000|Overall Study|Lost to Follow-up|11|||
148953094|NCT00589914|537310334|FG001|Overall Study|Lost to Follow-up|18|||
148953095|NCT00589914|537310333|FG000|Overall Study|Pregnancy|1|||
148953096|NCT00589914|537310334|FG001|Overall Study|Pregnancy|0|||
149218794|NCT00081263|538267711|FG000|Overall Study|wrong cell type|7|||
149218795|NCT00081263|538267712|FG001|Overall Study|wrong cell type|5|||
149218796|NCT00081263|538267711|FG000|Overall Study|improper pre-protocol therapy|0|||
149218797|NCT00081263|538267712|FG001|Overall Study|improper pre-protocol therapy|1|||
149218798|NCT00081263|538267711|FG000|Overall Study|Inadequate pathology|0|||
148953097|NCT00589914|537310333|FG000|Overall Study|Withdrawal by Subject|55|||
148685193|NCT01267266|536321407|FG001|Lead-in Phase|Withdrawal by Subject|0|||
148685194|NCT01335477|536321409|FG000|Overall Study|Adverse Event|30|||
148685195|NCT01335477|536321410|FG001|Overall Study|Adverse Event|42|||
148953098|NCT00589914|537310334|FG001|Overall Study|Withdrawal by Subject|49|||
148953099|NCT00589914|537310333|FG000|Overall Study|Other|22|||
148953100|NCT00589914|537310334|FG001|Overall Study|Other|17|||
148953101|NCT01356966|537310335|FG000|Overall Study|Withdrawal by Subject|1|||
148953102|NCT01356966|537310336|FG001|Overall Study|Withdrawal by Subject|2|||
149218799|NCT00081263|538267712|FG001|Overall Study|Inadequate pathology|1|||
149218800|NCT00081263|538267711|FG000|Overall Study|Never treated|4|||
149218801|NCT00081263|538267712|FG001|Overall Study|Never treated|5|||
149218802|NCT00081263|538267711|FG000|Overall Study|Inadequate data|5|||
149218803|NCT00081263|538267712|FG001|Overall Study|Inadequate data|10|||
149218804|NCT01852591|538267713|FG000|Overall Study|Withdrawal by Subject|2|||
149218805|NCT01852591|538267713|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
149218806|NCT01996865|538267714|FG000|Induction Period|Protocol Violation|1|||
149218807|NCT01996865|538267715|FG001|Induction Period|Protocol Violation|0|||
149218808|NCT01996865|538267716|FG002|Induction Period|Protocol Violation|0|||
149218809|NCT01996865|538267714|FG000|Induction Period|Progressive Disease|4|||
149218810|NCT01996865|538267715|FG001|Induction Period|Progressive Disease|0|||
149218811|NCT01996865|538267716|FG002|Induction Period|Progressive Disease|0|||
149218812|NCT01996865|538267714|FG000|Induction Period|Lost to Follow-up|10|||
149218813|NCT01996865|538267715|FG001|Induction Period|Lost to Follow-up|0|||
149218814|NCT01996865|538267716|FG002|Induction Period|Lost to Follow-up|0|||
149218815|NCT01996865|538267714|FG000|Induction Period|Other Reasons|13|||
149218816|NCT01996865|538267715|FG001|Induction Period|Other Reasons|0|||
149218817|NCT01996865|538267716|FG002|Induction Period|Other Reasons|0|||
149218818|NCT01996865|538267714|FG000|Induction Period|Adverse Event|20|||
149218819|NCT01996865|538267715|FG001|Induction Period|Adverse Event|0|||
149218820|NCT01996865|538267716|FG002|Induction Period|Adverse Event|0|||
149218821|NCT01996865|538267714|FG000|Induction Period|Withdrawal by Subject|60|||
149218822|NCT01996865|538267715|FG001|Induction Period|Withdrawal by Subject|0|||
149218823|NCT01996865|538267716|FG002|Induction Period|Withdrawal by Subject|0|||
149218824|NCT01996865|538267714|FG000|Induction Period|Death|111|||
149218825|NCT01996865|538267715|FG001|Induction Period|Death|0|||
149218826|NCT01996865|538267716|FG002|Induction Period|Death|0|||
149218827|NCT01996865|538267714|FG000|Maintenance Period|Protocol Violation|0|||
149218828|NCT01996865|538267715|FG001|Maintenance Period|Protocol Violation|1|||
149218829|NCT01996865|538267716|FG002|Maintenance Period|Protocol Violation|1|||
149218830|NCT01996865|538267714|FG000|Maintenance Period|Other reasons|0|||
149218831|NCT01996865|538267715|FG001|Maintenance Period|Other reasons|8|||
148953103|NCT01356966|537310335|FG000|Overall Study|Physician Decision|1|||
148953104|NCT01356966|537310336|FG001|Overall Study|Physician Decision|0|||
148953105|NCT00103142|537310337|FG000|Overall Study|Adverse Event|1|||
148953106|NCT00103142|537310338|FG001|Overall Study|Adverse Event|0|||
148953107|NCT00103142|537310337|FG000|Overall Study|Progression of disease|2|||
148953108|NCT00103142|537310338|FG001|Overall Study|Progression of disease|1|||
148953109|NCT00938639|537310339|FG000|Overall Study|Moved away from study area|0|||
148953110|NCT00938639|537310340|FG001|Overall Study|Moved away from study area|1|||
148953111|NCT00938639|537310339|FG000|Overall Study|Lost to Follow-up|1|||
148953112|NCT00938639|537310340|FG001|Overall Study|Lost to Follow-up|2|||
148953113|NCT00938639|537310339|FG000|Overall Study|Family issues|1|||
148953114|NCT00938639|537310340|FG001|Overall Study|Family issues|1|||
148953115|NCT00938639|537310339|FG000|Overall Study|Participant noncompliance|1|||
148953116|NCT00938639|537310340|FG001|Overall Study|Participant noncompliance|0|||
148953117|NCT00759954|537310345|FG000|Overall Study|Personal reason|1|||
148953118|NCT00759954|537310346|FG001|Overall Study|Personal reason|0|||
148953119|NCT00759954|537310345|FG000|Overall Study|Adverse Event|1|||
148953120|NCT00759954|537310346|FG001|Overall Study|Adverse Event|2|||
148953121|NCT02875860|537310347|FG000|Overall Study|Withdrawal by Subject|0|||
149218832|NCT01996865|538267716|FG002|Maintenance Period|Other reasons|5|||
149218833|NCT01996865|538267714|FG000|Maintenance Period|Progressive Disease|0|||
149218834|NCT01996865|538267715|FG001|Maintenance Period|Progressive Disease|6|||
149218835|NCT01996865|538267716|FG002|Maintenance Period|Progressive Disease|23|||
149218836|NCT01996865|538267714|FG000|Maintenance Period|Withdrawal by Subject|0|||
149218837|NCT01996865|538267715|FG001|Maintenance Period|Withdrawal by Subject|18|||
149218838|NCT01996865|538267716|FG002|Maintenance Period|Withdrawal by Subject|4|||
149218839|NCT01996865|538267714|FG000|Maintenance Period|Adverse Event|0|||
149218840|NCT01996865|538267715|FG001|Maintenance Period|Adverse Event|7|||
149218841|NCT01996865|538267716|FG002|Maintenance Period|Adverse Event|7|||
149218842|NCT01996865|538267714|FG000|Maintenance Period|Death|0|||
149218843|NCT01996865|538267715|FG001|Maintenance Period|Death|15|||
149218844|NCT01996865|538267716|FG002|Maintenance Period|Death|3|||
149218845|NCT01996865|538267714|FG000|Maintenance Period|Lost to Follow-up|0|||
149218846|NCT01996865|538267715|FG001|Maintenance Period|Lost to Follow-up|2|||
149218847|NCT01996865|538267716|FG002|Maintenance Period|Lost to Follow-up|0|||
149218848|NCT01947894|538267720|FG000|Overall Study|Other|3|||
149218849|NCT01947894|538267721|FG001|Overall Study|Other|4|||
149218850|NCT01947894|538267722|FG002|Overall Study|Other|3|||
149218851|NCT01947894|538267720|FG000|Overall Study|Withdrawal by Subject|12|||
149218852|NCT01947894|538267721|FG001|Overall Study|Withdrawal by Subject|4|||
149218853|NCT01947894|538267722|FG002|Overall Study|Withdrawal by Subject|1|||
149218854|NCT01947894|538267720|FG000|Overall Study|Death|12|||
149218855|NCT01947894|538267721|FG001|Overall Study|Death|1|||
149218856|NCT01947894|538267722|FG002|Overall Study|Death|0|||
149218857|NCT01947894|538267720|FG000|Overall Study|Physician Decision|2|||
149218858|NCT01947894|538267721|FG001|Overall Study|Physician Decision|0|||
149218859|NCT01947894|538267722|FG002|Overall Study|Physician Decision|0|||
149218860|NCT01947894|538267720|FG000|Overall Study|Adverse Event|5|||
149218861|NCT01947894|538267721|FG001|Overall Study|Adverse Event|1|||
149218862|NCT01947894|538267722|FG002|Overall Study|Adverse Event|0|||
149218863|NCT01947894|538267720|FG000|Overall Study|Switched to other growth hormone brand|53|||
149218864|NCT01947894|538267721|FG001|Overall Study|Switched to other growth hormone brand|8|||
149218865|NCT01947894|538267722|FG002|Overall Study|Switched to other growth hormone brand|23|||
149218866|NCT03796195|538267723|FG000|Overall Study|Study closed early|1|||
149218867|NCT00062647|538267724|FG000|Overall Study|Death|2|||
149218868|NCT00062647|538267725|FG001|Overall Study|Death|2|||
149218869|NCT00062647|538267724|FG000|Overall Study|Adverse Event|1|||
148953122|NCT02875860|537310348|FG001|Overall Study|Withdrawal by Subject|1|||
148953123|NCT01741701|537310357|FG000|Overall Study|Adverse Event|5|||
148953124|NCT01741701|537310358|FG001|Overall Study|Adverse Event|1|||
148953125|NCT01741701|537310357|FG000|Overall Study|Withdrawal by Subject|0|||
148953126|NCT01741701|537310358|FG001|Overall Study|Withdrawal by Subject|1|||
148953127|NCT03033394|537310365|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
148953128|NCT03033394|537310365|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
148953129|NCT03033394|537310365|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
148953130|NCT03033394|537310365|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
148953131|NCT03033394|537310365|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
148953132|NCT01830972|537310367|FG000|Part II|Withdrawal by Subject|2|||
148953133|NCT01830972|537310368|FG001|Part II|Withdrawal by Subject|2|||
148953134|NCT01830972|537310367|FG000|Part III|Withdrawal by Subject|1|||
148953135|NCT01830972|537310368|FG001|Part III|Withdrawal by Subject|0|||
148953136|NCT01830972|537310367|FG000|Part III|Noncompliance|1|||
148953137|NCT01830972|537310368|FG001|Part III|Noncompliance|0|||
148953138|NCT01830972|537310367|FG000|Part IV|Withdrawal by Subject|2|||
148953139|NCT01830972|537310368|FG001|Part IV|Withdrawal by Subject|1|||
148953140|NCT01830972|537310367|FG000|Part IV|Non-Compliance|1|||
148953141|NCT01830972|537310368|FG001|Part IV|Non-Compliance|0|||
148953142|NCT00673465|537310369|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953143|NCT00673465|537310370|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953144|NCT00673465|537310371|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953145|NCT00673465|537310372|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953146|NCT00673465|537310373|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
148953147|NCT00673465|537310374|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
148953148|NCT00673465|537310375|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953149|NCT00673465|537310376|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953150|NCT00673465|537310377|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953151|NCT00673465|537310378|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953152|NCT00673465|537310379|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953153|NCT00673465|537310380|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
148953154|NCT00673465|537310369|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953155|NCT00673465|537310370|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953156|NCT00673465|537310371|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953157|NCT00673465|537310372|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953158|NCT00673465|537310373|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
148953159|NCT00673465|537310374|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953160|NCT00673465|537310375|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953161|NCT00673465|537310376|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953162|NCT00673465|537310377|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953163|NCT00673465|537310378|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953164|NCT00673465|537310379|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953165|NCT00673465|537310380|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
148953166|NCT01829191|537310381|FG000|Overall Study|Relocation|0|||
148953167|NCT01829191|537310382|FG001|Overall Study|Relocation|1|||
148953168|NCT01829191|537310381|FG000|Overall Study|Lens discomfort|0|||
148953169|NCT01829191|537310382|FG001|Overall Study|Lens discomfort|3|||
148953170|NCT01829191|537310381|FG000|Overall Study|Lens handling difficulty|1|||
148953171|NCT01829191|537310382|FG001|Overall Study|Lens handling difficulty|4|||
148953172|NCT01829191|537310381|FG000|Overall Study|Protocol Violation|4|||
148953173|NCT01829191|537310382|FG001|Overall Study|Protocol Violation|1|||
148953174|NCT01829191|537310381|FG000|Overall Study|Withdrawal by Subject|2|||
148953175|NCT01829191|537310382|FG001|Overall Study|Withdrawal by Subject|3|||
148953176|NCT01829191|537310381|FG000|Overall Study|Lost to Follow-up|0|||
148953177|NCT01829191|537310382|FG001|Overall Study|Lost to Follow-up|1|||
149218870|NCT00062647|538267725|FG001|Overall Study|Adverse Event|1|||
148953178|NCT01829191|537310381|FG000|Overall Study|Subject was fit for ortho - k|0|||
148953179|NCT01829191|537310382|FG001|Overall Study|Subject was fit for ortho - k|1|||
149218871|NCT00062647|538267724|FG000|Overall Study|Withdrawal by Subject|2|||
149218872|NCT00062647|538267725|FG001|Overall Study|Withdrawal by Subject|1|||
148953180|NCT01276353|537310383|FG000|Double-blind|Adverse Event|2|||
148953181|NCT01276353|537310384|FG001|Double-blind|Adverse Event|0|||
148953182|NCT01276353|537310383|FG000|Double-blind|Withdrawal by Subject|1|||
149218873|NCT00062647|538267724|FG000|Overall Study|Protocol Violation|1|||
149218874|NCT00062647|538267725|FG001|Overall Study|Protocol Violation|0|||
149218875|NCT00062647|538267724|FG000|Overall Study|Lost to Follow-up|1|||
149218876|NCT00062647|538267725|FG001|Overall Study|Lost to Follow-up|2|||
149218877|NCT00062647|538267724|FG000|Overall Study|Failed continuation criteria|4|||
149218878|NCT00062647|538267725|FG001|Overall Study|Failed continuation criteria|2|||
149218879|NCT00062647|538267724|FG000|Overall Study|Other|4|||
149218880|NCT00062647|538267725|FG001|Overall Study|Other|4|||
149218881|NCT00062647|538267724|FG000|Overall Study|Never received study treatment|1|||
149218882|NCT00062647|538267725|FG001|Overall Study|Never received study treatment|1|||
149218883|NCT02470429|538267726|FG000|Overall Study|Adverse Event|1|||
149218884|NCT02470429|538267727|FG001|Overall Study|Adverse Event|0|||
149218885|NCT02470429|538267726|FG000|Overall Study|Withdrawal by Subject|1|||
149218886|NCT02470429|538267727|FG001|Overall Study|Withdrawal by Subject|0|||
149218887|NCT00804986|538267728|FG000|Overall Study|Adverse Event|0|||
149218888|NCT00804986|538267729|FG001|Overall Study|Adverse Event|1|||
149218889|NCT00804986|538267730|FG002|Overall Study|Adverse Event|2|||
149218890|NCT00804986|538267731|FG003|Overall Study|Adverse Event|1|||
149218891|NCT00804986|538267732|FG004|Overall Study|Adverse Event|3|||
149218892|NCT00804986|538267733|FG005|Overall Study|Adverse Event|0|||
149218893|NCT00804986|538267728|FG000|Overall Study|Lack of Efficacy|0|||
149218894|NCT00804986|538267729|FG001|Overall Study|Lack of Efficacy|0|||
149218895|NCT00804986|538267730|FG002|Overall Study|Lack of Efficacy|0|||
149218896|NCT00804986|538267731|FG003|Overall Study|Lack of Efficacy|1|||
149218897|NCT00804986|538267732|FG004|Overall Study|Lack of Efficacy|0|||
149218898|NCT00804986|538267733|FG005|Overall Study|Lack of Efficacy|3|||
149218899|NCT00804986|538267728|FG000|Overall Study|Lost to Follow-up|0|||
149218900|NCT00804986|538267729|FG001|Overall Study|Lost to Follow-up|0|||
149218901|NCT00804986|538267730|FG002|Overall Study|Lost to Follow-up|0|||
149218902|NCT00804986|538267731|FG003|Overall Study|Lost to Follow-up|1|||
149218903|NCT00804986|538267732|FG004|Overall Study|Lost to Follow-up|1|||
149218904|NCT00804986|538267733|FG005|Overall Study|Lost to Follow-up|3|||
148953183|NCT01276353|537310384|FG001|Double-blind|Withdrawal by Subject|0|||
149218905|NCT00804986|538267728|FG000|Overall Study|Protocol Violation|0|||
149218906|NCT00804986|538267729|FG001|Overall Study|Protocol Violation|1|||
149218907|NCT00804986|538267730|FG002|Overall Study|Protocol Violation|0|||
149218908|NCT00804986|538267731|FG003|Overall Study|Protocol Violation|1|||
149218909|NCT00804986|538267732|FG004|Overall Study|Protocol Violation|0|||
149218910|NCT00804986|538267733|FG005|Overall Study|Protocol Violation|0|||
149218911|NCT00804986|538267728|FG000|Overall Study|Withdrawal by Subject|0|||
149218912|NCT00804986|538267729|FG001|Overall Study|Withdrawal by Subject|3|||
149218913|NCT00804986|538267730|FG002|Overall Study|Withdrawal by Subject|0|||
149218914|NCT00804986|538267731|FG003|Overall Study|Withdrawal by Subject|3|||
149218915|NCT00804986|538267732|FG004|Overall Study|Withdrawal by Subject|5|||
148685196|NCT01335477|536321409|FG000|Overall Study|Non compliant with protocol|0|||
148685197|NCT01335477|536321410|FG001|Overall Study|Non compliant with protocol|2|||
148685198|NCT01335477|536321409|FG000|Overall Study|Lost to Follow-up|1|||
148685199|NCT01335477|536321410|FG001|Overall Study|Lost to Follow-up|2|||
148685200|NCT01335477|536321409|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
148685201|NCT01335477|536321410|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
148685202|NCT01335477|536321409|FG000|Overall Study|Not treated|1|||
148685203|NCT01335477|536321410|FG001|Overall Study|Not treated|2|||
148685204|NCT01335477|536321409|FG000|Overall Study|Reason other than those stated above|2|||
148685205|NCT01335477|536321410|FG001|Overall Study|Reason other than those stated above|2|||
148685206|NCT02038634|536321412|FG000|Overall Study|Lost to Follow-up|0|||
148685207|NCT02038634|536321413|FG001|Overall Study|Lost to Follow-up|1|||
148685208|NCT02763579|536321415|FG000|Global Period|Death|167|||
148685209|NCT02763579|536321416|FG001|Global Period|Death|151|||
148685210|NCT02763579|536321417|FG002|Global Period|Death|0|||
148685211|NCT02763579|536321418|FG003|Global Period|Death|0|||
148685212|NCT02763579|536321415|FG000|Global Period|Lost to Follow-up|2|||
148685213|NCT02763579|536321416|FG001|Global Period|Lost to Follow-up|4|||
148685214|NCT02763579|536321417|FG002|Global Period|Lost to Follow-up|0|||
148685215|NCT02763579|536321418|FG003|Global Period|Lost to Follow-up|0|||
148685216|NCT02763579|536321415|FG000|Global Period|Physician Decision|0|||
148685217|NCT02763579|536321416|FG001|Global Period|Physician Decision|2|||
148685218|NCT02763579|536321417|FG002|Global Period|Physician Decision|0|||
148685219|NCT02763579|536321418|FG003|Global Period|Physician Decision|0|||
148685220|NCT02763579|536321415|FG000|Global Period|Study Terminated By Sponsor|21|||
148685221|NCT02763579|536321416|FG001|Global Period|Study Terminated By Sponsor|26|||
148685222|NCT02763579|536321417|FG002|Global Period|Study Terminated By Sponsor|0|||
148685223|NCT02763579|536321418|FG003|Global Period|Study Terminated By Sponsor|0|||
148685224|NCT02763579|536321415|FG000|Global Period|Withdrawal by Subject|12|||
148685225|NCT02763579|536321416|FG001|Global Period|Withdrawal by Subject|18|||
148685226|NCT02763579|536321417|FG002|Global Period|Withdrawal by Subject|0|||
148685227|NCT02763579|536321418|FG003|Global Period|Withdrawal by Subject|0|||
148685228|NCT02763579|536321415|FG000|China Period|Death|0|||
148685229|NCT02763579|536321416|FG001|China Period|Death|0|||
148685230|NCT02763579|536321417|FG002|China Period|Death|46|||
148685231|NCT02763579|536321418|FG003|China Period|Death|48|||
148685232|NCT02763579|536321415|FG000|China Period|Lost to Follow-up|0|||
148685233|NCT02763579|536321416|FG001|China Period|Lost to Follow-up|0|||
148685234|NCT02763579|536321417|FG002|China Period|Lost to Follow-up|1|||
148685235|NCT02763579|536321418|FG003|China Period|Lost to Follow-up|1|||
148685236|NCT02763579|536321415|FG000|China Period|Physician Decision|0|||
148685237|NCT02763579|536321416|FG001|China Period|Physician Decision|0|||
148685238|NCT02763579|536321417|FG002|China Period|Physician Decision|0|||
148685239|NCT02763579|536321418|FG003|China Period|Physician Decision|1|||
148685240|NCT02763579|536321415|FG000|China Period|Study Terminated By Sponsor|0|||
148685241|NCT02763579|536321416|FG001|China Period|Study Terminated By Sponsor|0|||
148685242|NCT02763579|536321417|FG002|China Period|Study Terminated By Sponsor|3|||
148685243|NCT02763579|536321418|FG003|China Period|Study Terminated By Sponsor|4|||
148685244|NCT02763579|536321415|FG000|China Period|Withdrawal by Subject|0|||
148953184|NCT01276353|537310383|FG000|Extension|Adverse Event|2|||
148953185|NCT01276353|537310384|FG001|Extension|Adverse Event|5|||
148953186|NCT01276353|537310383|FG000|Extension|Withdrawal by Subject|1|||
149218916|NCT00804986|538267733|FG005|Overall Study|Withdrawal by Subject|3|||
149218917|NCT00804986|538267728|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
149218918|NCT00804986|538267729|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
149218919|NCT00804986|538267730|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
149218920|NCT00804986|538267731|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
149218921|NCT00804986|538267732|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
149218922|NCT00804986|538267733|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
149218923|NCT00804986|538267728|FG000|Overall Study|Sponsor Decision|0|||
149218924|NCT00804986|538267729|FG001|Overall Study|Sponsor Decision|1|||
149218925|NCT00804986|538267730|FG002|Overall Study|Sponsor Decision|0|||
148685245|NCT02763579|536321416|FG001|China Period|Withdrawal by Subject|0|||
148685246|NCT02763579|536321417|FG002|China Period|Withdrawal by Subject|3|||
148685247|NCT02763579|536321418|FG003|China Period|Withdrawal by Subject|3|||
148685248|NCT02668783|536321422|FG000|Overall Study|Pregnancy|0|||
148685249|NCT02668783|536321423|FG001|Overall Study|Pregnancy|1|||
148685250|NCT02668783|536321422|FG000|Overall Study|Protocol Violation|2|||
148953187|NCT01276353|537310384|FG001|Extension|Withdrawal by Subject|2|||
148953188|NCT01276353|537310383|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
149218926|NCT00804986|538267731|FG003|Overall Study|Sponsor Decision|0|||
149218927|NCT00804986|538267732|FG004|Overall Study|Sponsor Decision|0|||
148685251|NCT02668783|536321423|FG001|Overall Study|Protocol Violation|1|||
148685252|NCT02668783|536321422|FG000|Overall Study|Study terminated by sponsor|9|||
148685253|NCT02668783|536321423|FG001|Overall Study|Study terminated by sponsor|10|||
148685254|NCT02668783|536321422|FG000|Overall Study|Subject moved|1|||
148685255|NCT02668783|536321423|FG001|Overall Study|Subject moved|0|||
148685256|NCT02668783|536321422|FG000|Overall Study|Withdrawal by Subject|1|||
148685257|NCT02668783|536321423|FG001|Overall Study|Withdrawal by Subject|0|||
148685258|NCT00112489|536321424|FG000|Overall Study|Refused further treatment|8|||
148685259|NCT00112489|536321424|FG000|Overall Study|Adverse Event|12|||
148685260|NCT00112489|536321424|FG000|Overall Study|Death|2|||
148685261|NCT00112489|536321424|FG000|Overall Study|Other, Not Specified|9|||
148685262|NCT00112489|536321424|FG000|Overall Study|Patient never treated|2|||
148685263|NCT00112489|536321424|FG000|Overall Study|Ineligible|7|||
148685264|NCT04467697|536321426|FG000|Overall Study|Adverse Event|2|||
148685265|NCT04467697|536321426|FG000|Overall Study|Lost to Follow-up|6|||
148685266|NCT04467697|536321426|FG000|Overall Study|Withdrawal by Subject|9|||
148685267|NCT04467697|536321426|FG000|Overall Study|Protocol Violation|3|||
148685268|NCT05751629|536321427|FG000|Overall Study|Withdrawal by Subject|6|||
148685269|NCT05751629|536321427|FG000|Overall Study|Death|25|||
148685270|NCT05751629|536321427|FG000|Overall Study|Study Site Closed|9|||
148685271|NCT05751629|536321427|FG000|Overall Study|Physician Decision|1|||
148685272|NCT01909466|536321428|FG000|Overall Study|Lost to Follow-up|5|||
148685273|NCT01909466|536321429|FG001|Overall Study|Lost to Follow-up|7|||
148685274|NCT01909466|536321428|FG000|Overall Study|Adverse Event|3|||
148685275|NCT01909466|536321429|FG001|Overall Study|Adverse Event|4|||
148685276|NCT01909466|536321428|FG000|Overall Study|Met Withdrawal Criteria|0|||
148685277|NCT01909466|536321429|FG001|Overall Study|Met Withdrawal Criteria|3|||
148685278|NCT01909466|536321428|FG000|Overall Study|Physician Decision|2|||
148685279|NCT01909466|536321429|FG001|Overall Study|Physician Decision|0|||
148685280|NCT01909466|536321428|FG000|Overall Study|Withdrawal by Subject|11|||
148685281|NCT01909466|536321429|FG001|Overall Study|Withdrawal by Subject|9|||
148685282|NCT01909466|536321428|FG000|Overall Study|Lack of Efficacy|1|||
148685283|NCT01909466|536321429|FG001|Overall Study|Lack of Efficacy|0|||
148685284|NCT02231710|536321430|FG000|Overall Study|Physician Decision|1|||
148685285|NCT00673361|536321434|FG000|Overall Study|Screen Failure|2|||
148685286|NCT00124020|536321435|FG000|Overall Study|Death|67|||
148685287|NCT00124020|536321436|FG001|Overall Study|Death|71|||
148685288|NCT00124020|536321435|FG000|Overall Study|Withdrawal by Subject|13|||
148685289|NCT00124020|536321436|FG001|Overall Study|Withdrawal by Subject|11|||
148685290|NCT00124020|536321435|FG000|Overall Study|Lost to Follow-up|5|||
148685291|NCT00124020|536321436|FG001|Overall Study|Lost to Follow-up|8|||
148685292|NCT00124020|536321435|FG000|Overall Study|Other|1|||
148685293|NCT00124020|536321436|FG001|Overall Study|Other|1|||
148685294|NCT00124020|536321435|FG000|Overall Study|Transfer to another hospital|2|||
148685295|NCT00124020|536321436|FG001|Overall Study|Transfer to another hospital|0|||
148685296|NCT00268346|536321437|FG000|Overall Study|Adverse Event|0|||
148685297|NCT00268346|536321438|FG001|Overall Study|Adverse Event|1|||
148685298|NCT00268346|536321437|FG000|Overall Study|Death|0|||
148685299|NCT00268346|536321438|FG001|Overall Study|Death|1|||
148685300|NCT00268346|536321437|FG000|Overall Study|Withdrawal by Subject|0|||
148685301|NCT00268346|536321438|FG001|Overall Study|Withdrawal by Subject|1|||
148685302|NCT01799590|536321439|FG000|Overall Study|Adverse Event|13|||
148685303|NCT01799590|536321440|FG001|Overall Study|Adverse Event|7|||
148685304|NCT01799590|536321441|FG002|Overall Study|Adverse Event|5|||
148685305|NCT01799590|536321439|FG000|Overall Study|Pregnancy|2|||
148953189|NCT01276353|537310384|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
148953190|NCT01276353|537310383|FG000|Extension|Physician Decision|1|||
148953191|NCT01276353|537310384|FG001|Extension|Physician Decision|0|||
148953192|NCT01276353|537310383|FG000|Extension|Prohibited concomitant medications|0|||
149218928|NCT00804986|538267733|FG005|Overall Study|Sponsor Decision|0|||
148685306|NCT01799590|536321440|FG001|Overall Study|Pregnancy|0|||
148685307|NCT01799590|536321441|FG002|Overall Study|Pregnancy|0|||
148685308|NCT01799590|536321439|FG000|Overall Study|Lack of Efficacy|3|||
148685309|NCT01799590|536321440|FG001|Overall Study|Lack of Efficacy|1|||
148685310|NCT01799590|536321441|FG002|Overall Study|Lack of Efficacy|3|||
148685311|NCT01799590|536321439|FG000|Overall Study|Participants convenience|4|||
148685312|NCT01799590|536321440|FG001|Overall Study|Participants convenience|4|||
148685313|NCT01799590|536321441|FG002|Overall Study|Participants convenience|2|||
148685314|NCT01799590|536321439|FG000|Overall Study|Aggravation of complications|0|||
148685315|NCT01799590|536321440|FG001|Overall Study|Aggravation of complications|1|||
148685316|NCT01799590|536321441|FG002|Overall Study|Aggravation of complications|1|||
148685317|NCT01799590|536321439|FG000|Overall Study|Using drugs with restricted days of use|0|||
148685318|NCT01799590|536321440|FG001|Overall Study|Using drugs with restricted days of use|3|||
148685319|NCT01799590|536321441|FG002|Overall Study|Using drugs with restricted days of use|2|||
148685320|NCT01799590|536321439|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
148685321|NCT01799590|536321440|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
148685322|NCT01799590|536321441|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
148685323|NCT01799590|536321439|FG000|Overall Study|Other|3|||
148685324|NCT01799590|536321440|FG001|Overall Study|Other|0|||
148685325|NCT01799590|536321441|FG002|Overall Study|Other|1|||
148685326|NCT00294723|536321444|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
149218929|NCT00804986|538267728|FG000|Overall Study|Physician Decision|1|||
148953193|NCT01276353|537310384|FG001|Extension|Prohibited concomitant medications|1|||
148685327|NCT00294723|536321445|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
148953194|NCT00553514|537310386|FG000|Overall Study|Protocol deviation|0|||
148953195|NCT00553514|537310387|FG001|Overall Study|Protocol deviation|0|||
148953196|NCT00553514|537310388|FG002|Overall Study|Protocol deviation|0|||
148953197|NCT00553514|537310389|FG003|Overall Study|Protocol deviation|1|||
148953198|NCT00553514|537310390|FG004|Overall Study|Protocol deviation|0|||
148953199|NCT00553514|537310386|FG000|Overall Study|Lack of ovarian response|4|||
148953200|NCT00553514|537310387|FG001|Overall Study|Lack of ovarian response|5|||
148953201|NCT00553514|537310388|FG002|Overall Study|Lack of ovarian response|5|||
148953202|NCT00553514|537310389|FG003|Overall Study|Lack of ovarian response|5|||
148953203|NCT00553514|537310390|FG004|Overall Study|Lack of ovarian response|6|||
149218930|NCT00804986|538267729|FG001|Overall Study|Physician Decision|0|||
149218931|NCT00804986|538267730|FG002|Overall Study|Physician Decision|0|||
149218932|NCT00804986|538267731|FG003|Overall Study|Physician Decision|0|||
149218933|NCT00804986|538267732|FG004|Overall Study|Physician Decision|0|||
149218934|NCT00804986|538267733|FG005|Overall Study|Physician Decision|0|||
149218935|NCT00959699|538267734|FG000|Treatment Period|Adverse Event|3|||
149218936|NCT00959699|538267735|FG001|Treatment Period|Adverse Event|13|||
149218937|NCT00959699|538267734|FG000|Treatment Period|Lack of Efficacy|15|||
149218938|NCT00959699|538267735|FG001|Treatment Period|Lack of Efficacy|6|||
149218939|NCT00959699|538267734|FG000|Treatment Period|Lost to Follow-up|0|||
149218940|NCT00959699|538267735|FG001|Treatment Period|Lost to Follow-up|1|||
149218941|NCT00959699|538267734|FG000|Treatment Period|Withdrawal by Subject|1|||
149218942|NCT00959699|538267735|FG001|Treatment Period|Withdrawal by Subject|3|||
149218943|NCT00959699|538267734|FG000|Treatment Period|Non-Compliance with Protocol|0|||
149218944|NCT00959699|538267735|FG001|Treatment Period|Non-Compliance with Protocol|1|||
149218945|NCT00959699|538267734|FG000|Treatment Period|Did not receive treatment|0|||
149218946|NCT00959699|538267735|FG001|Treatment Period|Did not receive treatment|1|||
149218947|NCT00959699|538267734|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
149218948|NCT00959699|538267735|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
149218949|NCT00959699|538267734|FG000|Follow-up Period|Lost to Follow-up|3|||
149218950|NCT00959699|538267735|FG001|Follow-up Period|Lost to Follow-up|2|||
149218951|NCT00959699|538267734|FG000|Follow-up Period|Withdrawal by Subject|3|||
149218952|NCT00959699|538267735|FG001|Follow-up Period|Withdrawal by Subject|4|||
149218953|NCT01976624|538267736|FG000|Overall Study|Participants contraindicated|2|||
149218954|NCT01976624|538267736|FG000|Overall Study|Participants age less than 19 years|12|||
149218955|NCT01885104|538267737|FG000|Overall Study|Withdrawal of Consent|1|||
149218956|NCT01885104|538267738|FG001|Overall Study|Withdrawal of Consent|0|||
149218957|NCT01885104|538267737|FG000|Overall Study|Lost to Follow-up|0|||
149218958|NCT01885104|538267738|FG001|Overall Study|Lost to Follow-up|1|||
149218959|NCT01885104|538267737|FG000|Overall Study|Physician Decision|1|||
149218960|NCT01885104|538267738|FG001|Overall Study|Physician Decision|0|||
149218961|NCT03325010|538267741|FG000|Overall Study|Adverse Event|3|||
149218962|NCT03325010|538267742|FG001|Overall Study|Adverse Event|8|||
149218963|NCT03325010|538267741|FG000|Overall Study|Protocol Violation|1|||
149218964|NCT03325010|538267742|FG001|Overall Study|Protocol Violation|8|||
149218965|NCT03325010|538267741|FG000|Overall Study|Withdrawal by Subject|1|||
149218966|NCT03325010|538267742|FG001|Overall Study|Withdrawal by Subject|3|||
149218967|NCT03325010|538267741|FG000|Overall Study|Lost to Follow-up|1|||
149218968|NCT03325010|538267742|FG001|Overall Study|Lost to Follow-up|0|||
149218969|NCT03325010|538267741|FG000|Overall Study|Physician Decision|1|||
149218970|NCT03325010|538267742|FG001|Overall Study|Physician Decision|1|||
148953204|NCT00553514|537310386|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
148953205|NCT00553514|537310387|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
148953206|NCT00553514|537310388|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
148953207|NCT00553514|537310389|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
149218971|NCT03325010|538267741|FG000|Overall Study|Lack of Efficacy|2|||
149218972|NCT03325010|538267742|FG001|Overall Study|Lack of Efficacy|0|||
149218973|NCT04350372|538267745|FG000|Overall Study|Death|1|||
149218974|NCT05307523|538267746|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
149218975|NCT05307523|538267747|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
149218976|NCT05307523|538267746|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
149218977|NCT05307523|538267747|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
149218978|NCT03864627|538267748|FG000|Overall Study|Adverse Event|0|||
149218979|NCT03864627|538267749|FG001|Overall Study|Adverse Event|1|||
149218980|NCT03864627|538267748|FG000|Overall Study|Lack of Efficacy|0|||
148953208|NCT00553514|537310390|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
148953209|NCT00553514|537310386|FG000|Overall Study|Risk of multiple pregnancy|0|||
149218981|NCT03864627|538267749|FG001|Overall Study|Lack of Efficacy|1|||
149218982|NCT03864627|538267748|FG000|Overall Study|Lost to Follow-up|0|||
149218983|NCT03864627|538267749|FG001|Overall Study|Lost to Follow-up|1|||
149218984|NCT03864627|538267748|FG000|Overall Study|Withdrawal by Subject|4|||
148953210|NCT00553514|537310387|FG001|Overall Study|Risk of multiple pregnancy|2|||
148953211|NCT00553514|537310388|FG002|Overall Study|Risk of multiple pregnancy|0|||
148953212|NCT00553514|537310389|FG003|Overall Study|Risk of multiple pregnancy|1|||
148953213|NCT00553514|537310390|FG004|Overall Study|Risk of multiple pregnancy|0|||
149218985|NCT03864627|538267749|FG001|Overall Study|Withdrawal by Subject|8|||
149218986|NCT03864627|538267748|FG000|Overall Study|Study terminated by sponsor|0|||
149218987|NCT03864627|538267749|FG001|Overall Study|Study terminated by sponsor|1|||
149218988|NCT00112840|538267750|FG000|Overall Study|Physician Decision|1|||
149218989|NCT00112840|538267751|FG001|Overall Study|Physician Decision|0|||
149218990|NCT00112840|538267752|FG002|Overall Study|Physician Decision|0|||
149218991|NCT00112840|538267750|FG000|Overall Study|Withdrawal by Subject|1|||
149218992|NCT00112840|538267751|FG001|Overall Study|Withdrawal by Subject|0|||
149218993|NCT00112840|538267752|FG002|Overall Study|Withdrawal by Subject|1|||
149218994|NCT00112840|538267750|FG000|Overall Study|Protocol Violation|0|||
149218995|NCT00112840|538267751|FG001|Overall Study|Protocol Violation|0|||
149218996|NCT00112840|538267752|FG002|Overall Study|Protocol Violation|5|||
148953214|NCT00553514|537310386|FG000|Overall Study|Other|1|||
148953215|NCT00553514|537310387|FG001|Overall Study|Other|1|||
149218997|NCT00683774|538267753|FG000|Overall Study|Withdrawal by Subject|0|||
149218998|NCT00683774|538267754|FG001|Overall Study|Withdrawal by Subject|1|||
149218999|NCT00683774|538267753|FG000|Overall Study|Physician Decision|3|||
149219000|NCT00683774|538267754|FG001|Overall Study|Physician Decision|0|||
148953216|NCT00553514|537310388|FG002|Overall Study|Other|0|||
148953217|NCT00553514|537310389|FG003|Overall Study|Other|0|||
148953218|NCT00553514|537310390|FG004|Overall Study|Other|1|||
148953219|NCT02205814|537310391|FG000|Overall Study|Lost to Follow-up|0|||
148953220|NCT02205814|537310392|FG001|Overall Study|Lost to Follow-up|0|||
148953221|NCT02205814|537310393|FG002|Overall Study|Lost to Follow-up|0|||
148953222|NCT02205814|537310394|FG003|Overall Study|Lost to Follow-up|1|||
148953223|NCT02205814|537310391|FG000|Overall Study|Lack of Efficacy|1|||
148953224|NCT02205814|537310392|FG001|Overall Study|Lack of Efficacy|0|||
148953225|NCT02205814|537310393|FG002|Overall Study|Lack of Efficacy|1|||
148953226|NCT02205814|537310394|FG003|Overall Study|Lack of Efficacy|1|||
148953227|NCT02205814|537310391|FG000|Overall Study|Physician Decision|0|||
148953228|NCT02205814|537310392|FG001|Overall Study|Physician Decision|0|||
148953229|NCT02205814|537310393|FG002|Overall Study|Physician Decision|1|||
148953230|NCT02205814|537310394|FG003|Overall Study|Physician Decision|0|||
148953231|NCT02205814|537310391|FG000|Overall Study|Protocol Violation|1|||
148953232|NCT02205814|537310392|FG001|Overall Study|Protocol Violation|0|||
148953233|NCT02205814|537310393|FG002|Overall Study|Protocol Violation|0|||
148953234|NCT02205814|537310394|FG003|Overall Study|Protocol Violation|1|||
148953235|NCT02205814|537310391|FG000|Overall Study|Withdrawal by Subject|0|||
148953236|NCT02205814|537310392|FG001|Overall Study|Withdrawal by Subject|1|||
148953237|NCT02205814|537310393|FG002|Overall Study|Withdrawal by Subject|2|||
148953238|NCT02205814|537310394|FG003|Overall Study|Withdrawal by Subject|1|||
148953239|NCT02205814|537310391|FG000|Overall Study|not compliant with study procedures|0|||
148953240|NCT02205814|537310392|FG001|Overall Study|not compliant with study procedures|0|||
148953241|NCT02205814|537310393|FG002|Overall Study|not compliant with study procedures|1|||
148953242|NCT02205814|537310394|FG003|Overall Study|not compliant with study procedures|0|||
148953243|NCT04952402|537310395|FG000|Overall Study|Lost to Follow-up|1|||
148953244|NCT04952402|537310396|FG001|Overall Study|Lost to Follow-up|3|||
148953245|NCT04952402|537310395|FG000|Overall Study|Lack Of Venous Access|0|||
148953246|NCT04952402|537310396|FG001|Overall Study|Lack Of Venous Access|1|||
148953247|NCT00726661|537310397|FG000|Overall Study|Lost to Follow-up|36|||
148953248|NCT00726661|537310398|FG001|Overall Study|Lost to Follow-up|11|||
148953249|NCT00726661|537310397|FG000|Overall Study|Withdrawal by Subject|17|||
148953250|NCT00726661|537310398|FG001|Overall Study|Withdrawal by Subject|13|||
148953251|NCT00726661|537310397|FG000|Overall Study|Trial terminated by sponsor|214|||
148953252|NCT00726661|537310398|FG001|Overall Study|Trial terminated by sponsor|187|||
148953253|NCT00726661|537310397|FG000|Overall Study|Death|475|||
148953254|NCT00726661|537310398|FG001|Overall Study|Death|159|||
148953255|NCT00726661|537310397|FG000|Overall Study|Physician Decision|25|||
148953256|NCT00726661|537310398|FG001|Overall Study|Physician Decision|13|||
148953257|NCT00726661|537310397|FG000|Overall Study|Other|47|||
148953258|NCT00726661|537310398|FG001|Overall Study|Other|35|||
148953259|NCT00143403|537310401|FG000|Overall Study|Adverse Event|3|||
148953260|NCT00143403|537310402|FG001|Overall Study|Adverse Event|8|||
148953261|NCT00143403|537310401|FG000|Overall Study|Death|1|||
148953262|NCT00143403|537310402|FG001|Overall Study|Death|0|||
148953263|NCT00143403|537310401|FG000|Overall Study|Withdrawal by Subject|3|||
148953264|NCT00143403|537310402|FG001|Overall Study|Withdrawal by Subject|12|||
148953265|NCT00143403|537310401|FG000|Overall Study|Relapse|15|||
148953266|NCT00143403|537310402|FG001|Overall Study|Relapse|7|||
148953267|NCT00143403|537310401|FG000|Overall Study|Protocol Violation|2|||
148953268|NCT00143403|537310402|FG001|Overall Study|Protocol Violation|2|||
148953269|NCT00143403|537310401|FG000|Overall Study|specified by site|4|||
148953270|NCT00143403|537310402|FG001|Overall Study|specified by site|9|||
148953271|NCT00143403|537310401|FG000|Overall Study|Randomized Not Treated|7|||
148953272|NCT00143403|537310402|FG001|Overall Study|Randomized Not Treated|8|||
148953273|NCT00587639|537310403|FG000|Overall Study|Withdrawal by Subject|1|||
148953274|NCT00160251|537310408|FG000|Prior to Amendment 2|Adverse Event|2|||
148953275|NCT00160251|537310409|FG001|Prior to Amendment 2|Adverse Event|1|||
148953276|NCT00160251|537310410|FG002|Prior to Amendment 2|Adverse Event|3|||
148953277|NCT00160251|537310411|FG003|Prior to Amendment 2|Adverse Event|1|||
148953278|NCT00160251|537310412|FG004|Prior to Amendment 2|Adverse Event|1|||
148953279|NCT00160251|537310413|FG005|Prior to Amendment 2|Adverse Event|1|||
148953280|NCT00160251|537310414|FG006|Prior to Amendment 2|Adverse Event|1|||
149219001|NCT02875366|538267755|FG000|Overall Study|Adverse Event|0|||
149219002|NCT02875366|538267756|FG001|Overall Study|Adverse Event|2|||
149219003|NCT02875366|538267755|FG000|Overall Study|Noncompliance|0|||
149219004|NCT02875366|538267756|FG001|Overall Study|Noncompliance|1|||
149219005|NCT03595176|538267757|FG000|Overall Study|Death|0|||
149219006|NCT03595176|538267758|FG001|Overall Study|Death|2|||
148953281|NCT00160251|537310415|FG007|Prior to Amendment 2|Adverse Event|0|||
148953282|NCT00160251|537310408|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
148953283|NCT00160251|537310409|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
148953284|NCT00160251|537310410|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
148953285|NCT00160251|537310411|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
148953286|NCT00160251|537310412|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
148953287|NCT00160251|537310413|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
148953288|NCT00160251|537310414|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
148953289|NCT00160251|537310415|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
148953290|NCT00160251|537310408|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
148953291|NCT00160251|537310409|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
148953292|NCT00160251|537310410|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
148953293|NCT00160251|537310411|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
148953294|NCT00160251|537310412|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
148953295|NCT00160251|537310413|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
148953296|NCT00160251|537310414|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
148953297|NCT00160251|537310415|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
148953298|NCT00160251|537310408|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
148953299|NCT00160251|537310409|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
148953300|NCT00160251|537310410|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
148953301|NCT00160251|537310411|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
148953302|NCT00160251|537310412|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
148953303|NCT00160251|537310413|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
148953304|NCT00160251|537310414|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
148953305|NCT00160251|537310415|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
148953306|NCT00160251|537310408|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
148953307|NCT00160251|537310409|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
148953308|NCT00160251|537310410|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
148953309|NCT00160251|537310411|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
148953310|NCT00160251|537310412|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
148953311|NCT00160251|537310413|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
148953312|NCT00160251|537310414|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
148953313|NCT00160251|537310415|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
148953314|NCT00160251|537310408|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
148953315|NCT00160251|537310409|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
148953316|NCT00160251|537310410|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
149219007|NCT03595176|538267757|FG000|Overall Study|Lost to Follow-up|0|||
148953317|NCT00160251|537310411|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
148953318|NCT00160251|537310412|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
148953319|NCT00160251|537310413|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
148953320|NCT00160251|537310414|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
148953321|NCT00160251|537310415|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
148953322|NCT00160251|537310408|FG000|Post-amendment 2|Adverse Event|0|||
148953323|NCT00160251|537310409|FG001|Post-amendment 2|Adverse Event|0|||
148953324|NCT00160251|537310410|FG002|Post-amendment 2|Adverse Event|0|||
148953325|NCT00160251|537310411|FG003|Post-amendment 2|Adverse Event|0|||
148953326|NCT00160251|537310412|FG004|Post-amendment 2|Adverse Event|0|||
148953327|NCT00160251|537310413|FG005|Post-amendment 2|Adverse Event|0|||
148953328|NCT00160251|537310414|FG006|Post-amendment 2|Adverse Event|0|||
148953329|NCT00160251|537310415|FG007|Post-amendment 2|Adverse Event|20|||
148953330|NCT00160251|537310408|FG000|Post-amendment 2|Lack of Efficacy|0|||
148953331|NCT00160251|537310409|FG001|Post-amendment 2|Lack of Efficacy|0|||
148953332|NCT00160251|537310410|FG002|Post-amendment 2|Lack of Efficacy|0|||
148953333|NCT00160251|537310411|FG003|Post-amendment 2|Lack of Efficacy|0|||
148953334|NCT00160251|537310412|FG004|Post-amendment 2|Lack of Efficacy|0|||
148953335|NCT00160251|537310413|FG005|Post-amendment 2|Lack of Efficacy|0|||
148953336|NCT00160251|537310414|FG006|Post-amendment 2|Lack of Efficacy|0|||
148953337|NCT00160251|537310415|FG007|Post-amendment 2|Lack of Efficacy|24|||
148953338|NCT00160251|537310408|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953339|NCT00160251|537310409|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953340|NCT00160251|537310410|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953341|NCT00160251|537310411|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953342|NCT00160251|537310412|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953343|NCT00160251|537310413|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953344|NCT00160251|537310414|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
148953345|NCT00160251|537310415|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
148953346|NCT01574612|537310418|FG000|Overall Study|Adverse Event|3|||
148953347|NCT01574612|537310418|FG000|Overall Study|non compliant with drug|2|||
148953348|NCT01574612|537310418|FG000|Overall Study|Withdrawal by Subject|1|||
148953349|NCT01574612|537310418|FG000|Overall Study|Lost to Follow-up|2|||
148953350|NCT02532972|537310419|FG000|Overall Study|Withdrawal by Subject|1|||
148953351|NCT02407704|537310422|FG000|Overall Study|Lost to Follow-up|0|||
148953352|NCT02407704|537310423|FG001|Overall Study|Lost to Follow-up|0|||
148953353|NCT02407704|537310424|FG002|Overall Study|Lost to Follow-up|0|||
148953354|NCT02407704|537310425|FG003|Overall Study|Lost to Follow-up|2|||
148953355|NCT02407704|537310422|FG000|Overall Study|Protocol Violation|0|||
148953356|NCT02407704|537310423|FG001|Overall Study|Protocol Violation|0|||
148953357|NCT02407704|537310424|FG002|Overall Study|Protocol Violation|0|||
148953358|NCT02407704|537310425|FG003|Overall Study|Protocol Violation|1|||
148953359|NCT02407704|537310422|FG000|Overall Study|Withdrawal by Subject|0|||
148953360|NCT02407704|537310423|FG001|Overall Study|Withdrawal by Subject|0|||
148953361|NCT02407704|537310424|FG002|Overall Study|Withdrawal by Subject|1|||
148953362|NCT02407704|537310425|FG003|Overall Study|Withdrawal by Subject|0|||
148953363|NCT00748033|537310426|FG000|Overall Study|Adverse Event|0|||
148953364|NCT00748033|537310427|FG001|Overall Study|Adverse Event|1|||
148953365|NCT01018186|537310428|FG000|2-week Run-in Period|Protocol Violation|1|||
148953366|NCT01018186|537310429|FG001|2-week Run-in Period|Protocol Violation|0|||
149219008|NCT03595176|538267758|FG001|Overall Study|Lost to Follow-up|1|||
149219009|NCT01201967|538267765|FG000|Overall Study|Lost to Follow-up|6|||
149219010|NCT01201967|538267766|FG001|Overall Study|Lost to Follow-up|5|||
149219011|NCT01190020|538267767|FG000|Overall Study|Adverse Event|2|||
149219012|NCT01190020|538267768|FG001|Overall Study|Adverse Event|0|||
149219013|NCT01190020|538267767|FG000|Overall Study|Lost to Follow-up|2|||
149219014|NCT01190020|538267768|FG001|Overall Study|Lost to Follow-up|0|||
149219015|NCT01190020|538267767|FG000|Overall Study|Withdrawal by Subject|3|||
149219016|NCT01190020|538267768|FG001|Overall Study|Withdrawal by Subject|0|||
149219017|NCT02116361|538267769|FG000|Overall Study|Pregnancy|0|||
148685328|NCT00294723|536321446|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
148685329|NCT00294723|536321444|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
148685330|NCT00294723|536321445|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
148685331|NCT00294723|536321446|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
148685332|NCT00294723|536321444|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
149219018|NCT02116361|538267770|FG001|Overall Study|Pregnancy|0|||
149219019|NCT02116361|538267771|FG002|Overall Study|Pregnancy|0|||
148685333|NCT00294723|536321445|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
148685334|NCT00294723|536321446|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
148685335|NCT00294723|536321444|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
148953367|NCT01018186|537310430|FG002|2-week Run-in Period|Protocol Violation|0|||
148953368|NCT01018186|537310431|FG003|2-week Run-in Period|Protocol Violation|0|||
148953369|NCT01018186|537310428|FG000|2-week Run-in Period|Lost to Follow-up|2|||
148953370|NCT01018186|537310429|FG001|2-week Run-in Period|Lost to Follow-up|0|||
149219020|NCT02116361|538267772|FG003|Overall Study|Pregnancy|1|||
149219021|NCT02116361|538267769|FG000|Overall Study|Protocol Violation|1|||
148953371|NCT01018186|537310430|FG002|2-week Run-in Period|Lost to Follow-up|0|||
148953372|NCT01018186|537310431|FG003|2-week Run-in Period|Lost to Follow-up|0|||
148953373|NCT01018186|537310428|FG000|2-week Run-in Period|Physician Decision|3|||
149219022|NCT02116361|538267770|FG001|Overall Study|Protocol Violation|0|||
149219023|NCT02116361|538267771|FG002|Overall Study|Protocol Violation|0|||
149219024|NCT02116361|538267772|FG003|Overall Study|Protocol Violation|2|||
149219025|NCT02116361|538267769|FG000|Overall Study|Physician Decision|2|||
149219026|NCT02116361|538267770|FG001|Overall Study|Physician Decision|3|||
149219027|NCT02116361|538267771|FG002|Overall Study|Physician Decision|0|||
149219028|NCT02116361|538267772|FG003|Overall Study|Physician Decision|0|||
149219029|NCT02116361|538267769|FG000|Overall Study|Adverse Event|1|||
149219030|NCT02116361|538267770|FG001|Overall Study|Adverse Event|0|||
149219031|NCT02116361|538267771|FG002|Overall Study|Adverse Event|0|||
149219032|NCT02116361|538267772|FG003|Overall Study|Adverse Event|3|||
149219033|NCT02116361|538267769|FG000|Overall Study|Other Reasons|3|||
149219034|NCT02116361|538267770|FG001|Overall Study|Other Reasons|3|||
149219035|NCT02116361|538267771|FG002|Overall Study|Other Reasons|3|||
149219036|NCT02116361|538267772|FG003|Overall Study|Other Reasons|3|||
149219037|NCT02116361|538267769|FG000|Overall Study|Lack of Efficacy|5|||
149219038|NCT02116361|538267770|FG001|Overall Study|Lack of Efficacy|7|||
149219039|NCT02116361|538267771|FG002|Overall Study|Lack of Efficacy|4|||
149219040|NCT02116361|538267772|FG003|Overall Study|Lack of Efficacy|3|||
149219041|NCT02116361|538267769|FG000|Overall Study|Lost to Follow-up|4|||
149219042|NCT02116361|538267770|FG001|Overall Study|Lost to Follow-up|5|||
149219043|NCT02116361|538267771|FG002|Overall Study|Lost to Follow-up|7|||
149219044|NCT02116361|538267772|FG003|Overall Study|Lost to Follow-up|5|||
149219045|NCT02116361|538267769|FG000|Overall Study|Personal Reasons|6|||
149219046|NCT02116361|538267770|FG001|Overall Study|Personal Reasons|6|||
149219047|NCT02116361|538267771|FG002|Overall Study|Personal Reasons|4|||
149219048|NCT02116361|538267772|FG003|Overall Study|Personal Reasons|9|||
149219049|NCT02116361|538267769|FG000|Overall Study|Investigator Decision - Relapse|9|||
149219050|NCT02116361|538267770|FG001|Overall Study|Investigator Decision - Relapse|7|||
149219051|NCT02116361|538267771|FG002|Overall Study|Investigator Decision - Relapse|8|||
149219052|NCT02116361|538267772|FG003|Overall Study|Investigator Decision - Relapse|5|||
149219053|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
149219054|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
149219055|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
149219056|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
149219057|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Other|13|||
149219058|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
149219059|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
149219060|NCT02497287|538267773|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
149219061|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
149219062|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
149219063|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
149219064|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
149219065|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
149219066|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
149219067|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
149219068|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
149219069|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
148953374|NCT01018186|537310429|FG001|2-week Run-in Period|Physician Decision|0|||
148953375|NCT01018186|537310430|FG002|2-week Run-in Period|Physician Decision|0|||
148953376|NCT01018186|537310431|FG003|2-week Run-in Period|Physician Decision|0|||
148953377|NCT01018186|537310428|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
149219070|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
149219071|NCT02497287|538267773|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
149219072|NCT02497287|538267773|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
149219073|NCT02497287|538267773|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
149219074|NCT02497287|538267773|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
149219075|NCT02497287|538267773|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
149219076|NCT02497287|538267773|FG000|Follow-up Phase (4 Week)|Other|1|||
149219077|NCT02659098|538267774|FG000|Overall Study|Withdrawal by Subject|7|||
149219078|NCT04363944|538267775|FG000|Overall Study|Withdrawal by Subject|2|||
149219079|NCT04363944|538267776|FG001|Overall Study|Withdrawal by Subject|0|||
149219080|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
149219081|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
148953378|NCT01018186|537310429|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149219082|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Death|0|||
149219083|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Death|4|||
149219084|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
149219085|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
149219086|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
149219087|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
149219088|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
149219089|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
149219090|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
149219091|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
149219092|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
149219093|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
149219094|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Other|4|||
149219095|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Other|3|||
149219096|NCT03517722|538267777|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
149219097|NCT03517722|538267778|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
149219098|NCT03517722|538267777|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
149219099|NCT03517722|538267778|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
149219100|NCT03517722|538267777|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
149219101|NCT03517722|538267778|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
149219102|NCT03517722|538267777|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
149219103|NCT03517722|538267778|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
149219104|NCT03517722|538267777|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
149219105|NCT03517722|538267778|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
149219106|NCT02422186|538267779|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
149219107|NCT02422186|538267780|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
149219108|NCT02422186|538267779|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
149219109|NCT02422186|538267780|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
149219110|NCT02422186|538267779|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
149219111|NCT02422186|538267780|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
149219112|NCT02422186|538267779|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
149219113|NCT02422186|538267780|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
149219114|NCT02422186|538267779|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
149219115|NCT02422186|538267780|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
149219116|NCT02422186|538267779|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
149219117|NCT02422186|538267780|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
149219118|NCT02422186|538267779|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
149219119|NCT02422186|538267780|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
149219120|NCT02422186|538267779|FG000|Follow-up Phase (2 Weeks)|Other|3|||
149219121|NCT02422186|538267780|FG001|Follow-up Phase (2 Weeks)|Other|0|||
149219122|NCT03074318|538267781|FG000|Overall Study|Adverse Event|0|||
149219123|NCT03074318|538267782|FG001|Overall Study|Adverse Event|1|||
149219124|NCT03074318|538267783|FG002|Overall Study|Adverse Event|1|||
149219125|NCT03074318|538267784|FG003|Overall Study|Adverse Event|1|||
149219126|NCT03074318|538267781|FG000|Overall Study|Death|1|||
149219127|NCT03074318|538267782|FG001|Overall Study|Death|0|||
149219128|NCT03074318|538267783|FG002|Overall Study|Death|0|||
148953379|NCT01018186|537310430|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
148953380|NCT01018186|537310431|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
148953381|NCT01018186|537310428|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
149219129|NCT03074318|538267784|FG003|Overall Study|Death|0|||
149219130|NCT03074318|538267781|FG000|Overall Study|Withdrawal by Subject|1|||
149219131|NCT03074318|538267782|FG001|Overall Study|Withdrawal by Subject|2|||
149219132|NCT03074318|538267783|FG002|Overall Study|Withdrawal by Subject|2|||
148685336|NCT00294723|536321445|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
148685337|NCT00294723|536321446|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
148685338|NCT00294723|536321444|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
148685339|NCT00294723|536321445|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
148685340|NCT00294723|536321446|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
148685341|NCT00294723|536321444|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
148953382|NCT01018186|537310429|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
148953383|NCT01018186|537310430|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
149219133|NCT03074318|538267784|FG003|Overall Study|Withdrawal by Subject|4|||
149219134|NCT03074318|538267781|FG000|Overall Study|Trial Closure|2|||
149219135|NCT03074318|538267782|FG001|Overall Study|Trial Closure|2|||
149219136|NCT03074318|538267783|FG002|Overall Study|Trial Closure|3|||
149219137|NCT03074318|538267784|FG003|Overall Study|Trial Closure|11|||
148685342|NCT00294723|536321445|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
148685343|NCT00294723|536321446|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
148685344|NCT00294723|536321444|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
148685345|NCT00294723|536321445|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
148953384|NCT01018186|537310431|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
148953385|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
148685346|NCT00294723|536321446|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
148953386|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
148953387|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
148953388|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
148953389|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
149219138|NCT03573804|538267785|FG000|Overall Study|claustrophobia or MRI table problems|10|||
149219139|NCT00952419|538267789|FG000|Overall Study|Adverse Event|2|||
149219140|NCT00952419|538267790|FG001|Overall Study|Adverse Event|0|||
149219141|NCT00952419|538267791|FG002|Overall Study|Adverse Event|0|||
149219142|NCT00952419|538267789|FG000|Overall Study|Protocol Violation|3|||
149219143|NCT00952419|538267790|FG001|Overall Study|Protocol Violation|7|||
149219144|NCT00952419|538267791|FG002|Overall Study|Protocol Violation|0|||
149219145|NCT00952419|538267789|FG000|Overall Study|Withdrawal by Subject|1|||
149219146|NCT00952419|538267790|FG001|Overall Study|Withdrawal by Subject|3|||
149219147|NCT00952419|538267791|FG002|Overall Study|Withdrawal by Subject|0|||
149219148|NCT02710422|538269325|FG000|Overall Study|Termination of study|9|||
149219149|NCT02710422|538269326|FG001|Overall Study|Termination of study|9|||
149219150|NCT01736176|538269331|FG000|Overall Study|Adverse Event|3|||
149219151|NCT01736176|538269331|FG000|Overall Study|Withdrawal by Subject|4|||
149219152|NCT01736176|538269331|FG000|Overall Study|Lack of Efficacy|3|||
149219153|NCT01736176|538269331|FG000|Overall Study|Unable to Complete PEG Placement|1|||
149219154|NCT05815758|538269332|FG000|Overall Study|Adverse Event|6|||
149219155|NCT05815758|538269333|FG001|Overall Study|Adverse Event|2|||
149219156|NCT05815758|538269332|FG000|Overall Study|Lost to Follow-up|14|||
149219157|NCT05815758|538269333|FG001|Overall Study|Lost to Follow-up|1|||
149219158|NCT05815758|538269332|FG000|Overall Study|Withdrawal by Subject|6|||
149219159|NCT05815758|538269333|FG001|Overall Study|Withdrawal by Subject|6|||
149219160|NCT05815758|538269332|FG000|Overall Study|Protocol Violation|1|||
149219161|NCT05815758|538269333|FG001|Overall Study|Protocol Violation|1|||
149219162|NCT05815758|538269332|FG000|Overall Study|Discontinued|4|||
149219163|NCT05815758|538269333|FG001|Overall Study|Discontinued|4|||
149219164|NCT02425891|538269335|FG000|Overall Study|Death|333|||
149219165|NCT02425891|538269336|FG001|Overall Study|Death|314|||
149219166|NCT02425891|538269335|FG000|Overall Study|Lost to Follow-up|4|||
149219167|NCT02425891|538269336|FG001|Overall Study|Lost to Follow-up|6|||
149219168|NCT02425891|538269335|FG000|Overall Study|Non-Compliance|1|||
149219169|NCT02425891|538269336|FG001|Overall Study|Non-Compliance|1|||
149219170|NCT02425891|538269335|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
149219171|NCT02425891|538269336|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
149219172|NCT02425891|538269335|FG000|Overall Study|Physician Decision|0|||
149219173|NCT02425891|538269336|FG001|Overall Study|Physician Decision|1|||
149219174|NCT02425891|538269335|FG000|Overall Study|Protocol Violation|1|||
149219175|NCT02425891|538269336|FG001|Overall Study|Protocol Violation|1|||
149219176|NCT02425891|538269335|FG000|Overall Study|Study Terminated By Sponsor|85|||
149219177|NCT02425891|538269336|FG001|Overall Study|Study Terminated By Sponsor|95|||
149219178|NCT02425891|538269335|FG000|Overall Study|Withdrawal by Subject|27|||
149219179|NCT02425891|538269336|FG001|Overall Study|Withdrawal by Subject|32|||
149219180|NCT00515099|538269341|FG000|Overall Study|Lost to Follow-up|0|||
149219181|NCT00515099|538269342|FG001|Overall Study|Lost to Follow-up|4|||
149219182|NCT00515099|538269341|FG000|Overall Study|Withdrawal by Subject|2|||
149219183|NCT00515099|538269342|FG001|Overall Study|Withdrawal by Subject|0|||
149219184|NCT00515099|538269341|FG000|Overall Study|IRB Recommendation|1|||
149219185|NCT00515099|538269342|FG001|Overall Study|IRB Recommendation|0|||
149219186|NCT00592072|538269343|FG000|Wash Out Period|Lost to Follow-up|1|||
148953390|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
148953391|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
148953392|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
149219187|NCT00592072|538269344|FG001|Wash Out Period|Lost to Follow-up|1|||
149219188|NCT03369704|538269345|FG000|Treatment Epoch|technical problems|1|||
149219189|NCT03369704|538269346|FG001|Treatment Epoch|technical problems|0|||
149219190|NCT03369704|538269345|FG000|Treatment Epoch|Protocol Violation|1|||
149219191|NCT03369704|538269346|FG001|Treatment Epoch|Protocol Violation|0|||
149219192|NCT03369704|538269345|FG000|Treatment Epoch|Lost to Follow-up|0|||
149219193|NCT03369704|538269346|FG001|Treatment Epoch|Lost to Follow-up|1|||
149219194|NCT03369704|538269345|FG000|Treatment Epoch|Lack of Efficacy|0|||
149219195|NCT03369704|538269346|FG001|Treatment Epoch|Lack of Efficacy|2|||
149219196|NCT03369704|538269345|FG000|Treatment Epoch|Adverse Event|2|||
149219197|NCT03369704|538269346|FG001|Treatment Epoch|Adverse Event|0|||
149219198|NCT03369704|538269345|FG000|Follow-up Epoch|Lost to Follow-up|1|||
149219199|NCT03369704|538269346|FG001|Follow-up Epoch|Lost to Follow-up|0|||
149219200|NCT05333289|538269347|FG000|Overall Study|Other|1|||
149219201|NCT05333289|538269348|FG001|Overall Study|Other|0|||
148685347|NCT00294723|536321444|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
148685348|NCT00294723|536321445|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
148685349|NCT00294723|536321446|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
148685350|NCT00294723|536321444|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
148685351|NCT00294723|536321445|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
148685352|NCT00294723|536321446|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
148685353|NCT00294723|536321444|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
148685354|NCT00294723|536321445|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
148685355|NCT00294723|536321446|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
148685356|NCT00294723|536321444|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
148685357|NCT00294723|536321445|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
149219202|NCT05333289|538269349|FG002|Overall Study|Other|0|||
149219203|NCT05333289|538269350|FG003|Overall Study|Other|1|||
149219204|NCT05333289|538269351|FG004|Overall Study|Other|1|||
149219205|NCT05333289|538269352|FG005|Overall Study|Other|2|||
149219206|NCT05333289|538269353|FG006|Overall Study|Other|2|||
149219207|NCT05333289|538269354|FG007|Overall Study|Other|0|||
149219208|NCT05333289|538269347|FG000|Overall Study|Withdrawal by Subject|1|||
149219209|NCT05333289|538269348|FG001|Overall Study|Withdrawal by Subject|2|||
149219210|NCT05333289|538269349|FG002|Overall Study|Withdrawal by Subject|2|||
149219211|NCT05333289|538269350|FG003|Overall Study|Withdrawal by Subject|1|||
149219212|NCT05333289|538269351|FG004|Overall Study|Withdrawal by Subject|1|||
149219213|NCT05333289|538269352|FG005|Overall Study|Withdrawal by Subject|2|||
149219214|NCT05333289|538269353|FG006|Overall Study|Withdrawal by Subject|1|||
149219215|NCT05333289|538269354|FG007|Overall Study|Withdrawal by Subject|3|||
149219216|NCT05333289|538269347|FG000|Overall Study|Protocol Violation|1|||
149219217|NCT05333289|538269348|FG001|Overall Study|Protocol Violation|0|||
149219218|NCT05333289|538269349|FG002|Overall Study|Protocol Violation|0|||
149219219|NCT05333289|538269350|FG003|Overall Study|Protocol Violation|0|||
149219220|NCT05333289|538269351|FG004|Overall Study|Protocol Violation|0|||
149219221|NCT05333289|538269352|FG005|Overall Study|Protocol Violation|0|||
149219222|NCT05333289|538269353|FG006|Overall Study|Protocol Violation|0|||
149219223|NCT05333289|538269354|FG007|Overall Study|Protocol Violation|0|||
149219224|NCT05333289|538269347|FG000|Overall Study|Physician Decision|0|||
149219225|NCT05333289|538269348|FG001|Overall Study|Physician Decision|0|||
149219226|NCT05333289|538269349|FG002|Overall Study|Physician Decision|1|||
149219227|NCT05333289|538269350|FG003|Overall Study|Physician Decision|0|||
149219228|NCT05333289|538269351|FG004|Overall Study|Physician Decision|0|||
148685358|NCT00294723|536321446|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
149219229|NCT05333289|538269352|FG005|Overall Study|Physician Decision|2|||
148685359|NCT00294723|536321444|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
149219230|NCT05333289|538269353|FG006|Overall Study|Physician Decision|0|||
149219231|NCT05333289|538269354|FG007|Overall Study|Physician Decision|0|||
149219232|NCT05333289|538269347|FG000|Overall Study|Lost to Follow-up|6|||
149219233|NCT05333289|538269348|FG001|Overall Study|Lost to Follow-up|0|||
149219234|NCT05333289|538269349|FG002|Overall Study|Lost to Follow-up|1|||
149219235|NCT05333289|538269350|FG003|Overall Study|Lost to Follow-up|6|||
148953393|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
148953394|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
148953395|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
149219236|NCT05333289|538269351|FG004|Overall Study|Lost to Follow-up|3|||
149219237|NCT05333289|538269352|FG005|Overall Study|Lost to Follow-up|3|||
149219238|NCT05333289|538269353|FG006|Overall Study|Lost to Follow-up|2|||
149219239|NCT05333289|538269354|FG007|Overall Study|Lost to Follow-up|1|||
149219240|NCT05333289|538269347|FG000|Overall Study|Death|1|||
149219241|NCT05333289|538269348|FG001|Overall Study|Death|0|||
149219242|NCT05333289|538269349|FG002|Overall Study|Death|0|||
149219243|NCT05333289|538269350|FG003|Overall Study|Death|0|||
149219244|NCT05333289|538269351|FG004|Overall Study|Death|0|||
149219245|NCT05333289|538269352|FG005|Overall Study|Death|0|||
149219246|NCT05333289|538269353|FG006|Overall Study|Death|0|||
149219247|NCT05333289|538269354|FG007|Overall Study|Death|0|||
149219248|NCT02010567|538269357|FG000|Overall Study|Adverse Event|0|||
149219249|NCT02010567|538269358|FG001|Overall Study|Adverse Event|0|||
149219250|NCT02010567|538269359|FG002|Overall Study|Adverse Event|1|||
149219251|NCT02010567|538269360|FG003|Overall Study|Adverse Event|0|||
149219252|NCT02010567|538269361|FG004|Overall Study|Adverse Event|1|||
149219253|NCT00118040|538269362|FG000|Overall Study|Adverse Event|0|||
149219254|NCT00118040|538269363|FG001|Overall Study|Adverse Event|1|||
149219255|NCT00118040|538269364|FG002|Overall Study|Adverse Event|0|||
149219256|NCT00118040|538269362|FG000|Overall Study|Withdrawal by Subject|0|||
149219257|NCT00118040|538269363|FG001|Overall Study|Withdrawal by Subject|0|||
149219258|NCT00118040|538269364|FG002|Overall Study|Withdrawal by Subject|2|||
149219259|NCT00118040|538269362|FG000|Overall Study|Medical Contraindication|0|||
149219260|NCT00118040|538269363|FG001|Overall Study|Medical Contraindication|0|||
149219261|NCT00118040|538269364|FG002|Overall Study|Medical Contraindication|1|||
149219262|NCT00118040|538269362|FG000|Overall Study|Non-Compliant Participant|1|||
149219263|NCT00118040|538269363|FG001|Overall Study|Non-Compliant Participant|1|||
149219264|NCT00118040|538269364|FG002|Overall Study|Non-Compliant Participant|2|||
149219265|NCT00118040|538269362|FG000|Overall Study|Other|0|||
149219266|NCT00118040|538269363|FG001|Overall Study|Other|0|||
149219267|NCT00118040|538269364|FG002|Overall Study|Other|1|||
149219268|NCT02750501|538269365|FG000|Overall Study|Adverse Event|4|||
149219269|NCT02750501|538269365|FG000|Overall Study|Physician Decision|1|||
149219270|NCT02750501|538269365|FG000|Overall Study|Protocol Violation|1|||
149219271|NCT02750501|538269365|FG000|Overall Study|G-tube came out|1|||
149219272|NCT02750501|538269365|FG000|Overall Study|Non-compliant use of PERT|1|||
149219273|NCT03685643|538269366|FG000|Overall Study|Lost to Follow-up|14|||
149219274|NCT03685643|538269367|FG001|Overall Study|Lost to Follow-up|22|||
149219275|NCT01738594|538269368|FG000|Registration and Treatment Start|Adverse Event|0|||
149219276|NCT01738594|538269369|FG001|Registration and Treatment Start|Adverse Event|1|||
149219277|NCT01738594|538269370|FG002|Registration and Treatment Start|Adverse Event|0|||
149219278|NCT01738594|538269371|FG003|Registration and Treatment Start|Adverse Event|0|||
149219279|NCT01738594|538269372|FG004|Registration and Treatment Start|Adverse Event|0|||
149219280|NCT01738594|538269373|FG005|Registration and Treatment Start|Adverse Event|0|||
149219281|NCT01738594|538269374|FG006|Registration and Treatment Start|Adverse Event|0|||
149219282|NCT01738594|538269375|FG007|Registration and Treatment Start|Adverse Event|0|||
149219283|NCT01738594|538269368|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219284|NCT01738594|538269369|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219285|NCT01738594|538269370|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219286|NCT01738594|538269371|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219287|NCT01738594|538269372|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219288|NCT01738594|538269373|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
149219289|NCT01738594|538269374|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219290|NCT01738594|538269375|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
149219291|NCT01738594|538269368|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219292|NCT01738594|538269369|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
148953396|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
148953397|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
148953398|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
148953399|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
149219293|NCT01738594|538269370|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219294|NCT01738594|538269371|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219295|NCT01738594|538269372|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219296|NCT01738594|538269373|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219297|NCT01738594|538269374|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219298|NCT01738594|538269375|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
149219299|NCT01738594|538269368|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219300|NCT01738594|538269369|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219301|NCT01738594|538269370|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219302|NCT01738594|538269371|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219303|NCT01738594|538269372|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219304|NCT01738594|538269373|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
149219305|NCT01738594|538269374|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219306|NCT01738594|538269375|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
149219307|NCT01738594|538269368|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219308|NCT01738594|538269369|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219309|NCT01738594|538269370|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219310|NCT01738594|538269371|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219311|NCT01738594|538269372|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219312|NCT01738594|538269373|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
149219313|NCT01738594|538269374|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219314|NCT01738594|538269375|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
149219315|NCT01738594|538269368|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219316|NCT01738594|538269369|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219317|NCT01738594|538269370|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219318|NCT01738594|538269371|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219319|NCT01738594|538269372|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
149219320|NCT01738594|538269373|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219321|NCT01738594|538269374|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219322|NCT01738594|538269375|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
149219323|NCT01738594|538269368|FG000|Follow up for 1 Year|Death|0|||
149219324|NCT01738594|538269369|FG001|Follow up for 1 Year|Death|0|||
149219325|NCT01738594|538269370|FG002|Follow up for 1 Year|Death|0|||
149219326|NCT01738594|538269371|FG003|Follow up for 1 Year|Death|0|||
149219327|NCT01738594|538269372|FG004|Follow up for 1 Year|Death|0|||
149219328|NCT01738594|538269373|FG005|Follow up for 1 Year|Death|1|||
149219329|NCT01738594|538269374|FG006|Follow up for 1 Year|Death|0|||
149219330|NCT01738594|538269375|FG007|Follow up for 1 Year|Death|0|||
149219331|NCT01738594|538269368|FG000|Follow up for 1 Year|Other|0|||
149219332|NCT01738594|538269369|FG001|Follow up for 1 Year|Other|0|||
149219333|NCT01738594|538269370|FG002|Follow up for 1 Year|Other|0|||
149219334|NCT01738594|538269371|FG003|Follow up for 1 Year|Other|0|||
149219335|NCT01738594|538269372|FG004|Follow up for 1 Year|Other|0|||
149219336|NCT01738594|538269373|FG005|Follow up for 1 Year|Other|2|||
149219337|NCT01738594|538269374|FG006|Follow up for 1 Year|Other|0|||
149219338|NCT01738594|538269375|FG007|Follow up for 1 Year|Other|0|||
149219339|NCT03797144|538269376|FG000|Enrollment|Protocol Violation|4|||
149219340|NCT03797144|538269377|FG001|Enrollment|Protocol Violation|1|||
149219341|NCT03797144|538269376|FG000|Surgery|Protocol Violation|1|||
149219342|NCT03797144|538269377|FG001|Surgery|Protocol Violation|0|||
149219343|NCT03797144|538269376|FG000|3 Month|Early termination cut-off date|2|||
149219344|NCT03797144|538269377|FG001|3 Month|Early termination cut-off date|0|||
149219345|NCT03797144|538269376|FG000|12 Month|Early termination cut-off date|8|||
149219346|NCT03797144|538269377|FG001|12 Month|Early termination cut-off date|9|||
149219347|NCT03797144|538269376|FG000|24 Month|Early termination cut-off date|1|||
149219348|NCT03797144|538269377|FG001|24 Month|Early termination cut-off date|1|||
149219349|NCT00403390|538269378|FG000|Overall Study|Withdrawal by Subject|1|||
149219350|NCT00403390|538269379|FG001|Overall Study|Withdrawal by Subject|0|||
149219351|NCT00403390|538269378|FG000|Overall Study|samples lost|1|||
149219352|NCT00403390|538269379|FG001|Overall Study|samples lost|0|||
149219353|NCT00403390|538269378|FG000|Overall Study|non-compliant|1|||
149219354|NCT00403390|538269379|FG001|Overall Study|non-compliant|0|||
149219355|NCT04430036|538269380|FG000|Safety Run in Phase|Progression of disease|2|||
149219356|NCT01842334|538269381|FG000|Overall Study|Withdrawal by Subject|3|||
149219357|NCT01842334|538269382|FG001|Overall Study|Withdrawal by Subject|3|||
149219358|NCT01842334|538269381|FG000|Overall Study|Moved away mid-study|0|||
149219359|NCT01842334|538269382|FG001|Overall Study|Moved away mid-study|1|||
149219360|NCT00376675|538269383|FG000|Overall Study|Withdrawal by Subject|9|||
149219361|NCT00376675|538269384|FG001|Overall Study|Withdrawal by Subject|2|||
149219362|NCT00376675|538269383|FG000|Overall Study|Adverse Event|10|||
149219363|NCT00376675|538269384|FG001|Overall Study|Adverse Event|5|||
149219364|NCT00376675|538269383|FG000|Overall Study|Other Reason|1|||
149219365|NCT00376675|538269384|FG001|Overall Study|Other Reason|7|||
149219366|NCT00942422|538269388|FG000|Overall Study|Withdrawal by Subject|1|||
149219367|NCT00942422|538269388|FG000|Overall Study|Death|1|||
149219368|NCT00942422|538269388|FG000|Overall Study|Progressive diease|1|||
149219369|NCT05559203|538269395|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
149219370|NCT00423592|538269397|FG000|Overall Study|Adverse Event (through Week 12)|2|||
149219371|NCT00423592|538269397|FG000|Overall Study|Adverse Event (post Week 12)|5|||
149219372|NCT00002981|538269402|FG000|Overall Study|Inevaluable|6|||
149219373|NCT00255008|538269403|FG000|Overall Study|Adverse Event|1|||
148809940|NCT01551173|536780921|FG001|Overall Study|Withdrawal by Subject|16|||
148809941|NCT01551173|536780920|FG000|Overall Study|Adverse Event|7|||
149219374|NCT00255008|538269404|FG001|Overall Study|Adverse Event|1|||
149219375|NCT00255008|538269405|FG002|Overall Study|Adverse Event|2|||
149219376|NCT00255008|538269406|FG003|Overall Study|Adverse Event|0|||
149219377|NCT00255008|538269403|FG000|Overall Study|Lost to Follow-up|1|||
149219378|NCT00255008|538269404|FG001|Overall Study|Lost to Follow-up|0|||
149219379|NCT00255008|538269405|FG002|Overall Study|Lost to Follow-up|1|||
149219380|NCT00255008|538269406|FG003|Overall Study|Lost to Follow-up|2|||
149219381|NCT00255008|538269403|FG000|Overall Study|Did not meet viral reduction criteria|4|||
149219382|NCT00255008|538269404|FG001|Overall Study|Did not meet viral reduction criteria|5|||
149219383|NCT00255008|538269405|FG002|Overall Study|Did not meet viral reduction criteria|0|||
149219384|NCT00255008|538269406|FG003|Overall Study|Did not meet viral reduction criteria|1|||
149219385|NCT00255008|538269403|FG000|Overall Study|Withdrew consent|0|||
149219386|NCT00255008|538269404|FG001|Overall Study|Withdrew consent|0|||
149219387|NCT00255008|538269405|FG002|Overall Study|Withdrew consent|2|||
149219388|NCT00255008|538269406|FG003|Overall Study|Withdrew consent|0|||
149219389|NCT00255008|538269403|FG000|Overall Study|Sponsor request|18|||
149219390|NCT00255008|538269404|FG001|Overall Study|Sponsor request|3|||
149219391|NCT00255008|538269405|FG002|Overall Study|Sponsor request|8|||
149219392|NCT00255008|538269406|FG003|Overall Study|Sponsor request|17|||
149219393|NCT00255008|538269403|FG000|Overall Study|Adverse lab experience|1|||
149219394|NCT00255008|538269404|FG001|Overall Study|Adverse lab experience|0|||
149219395|NCT00255008|538269405|FG002|Overall Study|Adverse lab experience|0|||
149219396|NCT00255008|538269406|FG003|Overall Study|Adverse lab experience|0|||
149219397|NCT00255008|538269403|FG000|Overall Study|Other|7|||
149219398|NCT00255008|538269404|FG001|Overall Study|Other|0|||
149219399|NCT00255008|538269405|FG002|Overall Study|Other|3|||
149219400|NCT00255008|538269406|FG003|Overall Study|Other|2|||
149219401|NCT05083949|538269410|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
149219402|NCT05083949|538269411|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
149219403|NCT05083949|538269410|FG000|Period 1|Adverse Event|1|||
149219404|NCT05083949|538269411|FG001|Period 1|Adverse Event|1|||
149219405|NCT05083949|538269410|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
149219406|NCT05083949|538269411|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
149219407|NCT05083949|538269410|FG000|Period 2|Adverse Event|0|||
149219408|NCT05083949|538269411|FG001|Period 2|Adverse Event|2|||
149219409|NCT01833806|538269412|FG000|Overall Study|Alternative treatment|2|||
149219410|NCT01833806|538269412|FG000|Overall Study|Death|5|||
149219411|NCT01833806|538269412|FG000|Overall Study|Physician Decision|1|||
149219412|NCT01833806|538269412|FG000|Overall Study|Lost to Follow-up|1|||
149219413|NCT00322387|538269414|FG000|Treatment Period|Adverse Event|0|||
149219414|NCT00322387|538269415|FG001|Treatment Period|Adverse Event|1|||
149219415|NCT00322387|538269414|FG000|Follow-up Period|Final assessment not done|1|||
149219416|NCT00322387|538269415|FG001|Follow-up Period|Final assessment not done|3|||
149219417|NCT00322387|538269414|FG000|Follow-up Period|Death|1|||
149219418|NCT00322387|538269415|FG001|Follow-up Period|Death|0|||
149219419|NCT00707486|538269420|FG000|Overall Study|Withdrawal by Subject|1|||
149219420|NCT01894776|538269431|FG000|Overall Study|Withdrawal by Subject|1|||
149219421|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
149219422|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
149219423|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
149219424|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
149219425|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
149219426|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149219427|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149219428|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
149219429|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
149219430|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
149219431|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
149219432|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
149219433|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
149219434|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
149219435|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
149219436|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
149219437|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
149219438|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
149219439|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
149219440|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
149219441|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
149219442|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
149219443|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
149219444|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
149219445|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Screen failure|0|||
149219446|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Screen failure|1|||
149219447|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Screen failure|2|||
149219448|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Screen failure|0|||
149219449|NCT02614261|538269434|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
149219450|NCT02614261|538269435|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
149219451|NCT02614261|538269436|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
149219452|NCT02614261|538269437|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149219453|NCT02614261|538269434|FG000|Open-Label Extension Phase|Adverse Event|23|||
149219454|NCT02614261|538269435|FG001|Open-Label Extension Phase|Adverse Event|12|||
149219455|NCT02614261|538269436|FG002|Open-Label Extension Phase|Adverse Event|11|||
149219456|NCT02614261|538269437|FG003|Open-Label Extension Phase|Adverse Event|0|||
149219457|NCT02614261|538269434|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
149219458|NCT02614261|538269435|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
149219459|NCT02614261|538269436|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
149219460|NCT02614261|538269437|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
149219461|NCT02614261|538269434|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
149219462|NCT02614261|538269435|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
149219463|NCT02614261|538269436|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
149219464|NCT02614261|538269437|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
149219465|NCT02614261|538269434|FG000|Open-Label Extension Phase|Physician Decision|2|||
149219466|NCT02614261|538269435|FG001|Open-Label Extension Phase|Physician Decision|0|||
149219467|NCT02614261|538269436|FG002|Open-Label Extension Phase|Physician Decision|0|||
149219468|NCT02614261|538269437|FG003|Open-Label Extension Phase|Physician Decision|0|||
149219469|NCT02614261|538269434|FG000|Open-Label Extension Phase|Pregnancy|1|||
149219470|NCT02614261|538269435|FG001|Open-Label Extension Phase|Pregnancy|2|||
149219471|NCT02614261|538269436|FG002|Open-Label Extension Phase|Pregnancy|1|||
149219472|NCT02614261|538269437|FG003|Open-Label Extension Phase|Pregnancy|0|||
149219473|NCT02614261|538269434|FG000|Open-Label Extension Phase|Protocol Violation|3|||
149219474|NCT02614261|538269435|FG001|Open-Label Extension Phase|Protocol Violation|4|||
149219475|NCT02614261|538269436|FG002|Open-Label Extension Phase|Protocol Violation|1|||
149219476|NCT02614261|538269437|FG003|Open-Label Extension Phase|Protocol Violation|0|||
149219477|NCT02614261|538269434|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
149219478|NCT02614261|538269435|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
149219479|NCT02614261|538269436|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
149219480|NCT02614261|538269437|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
149219481|NCT02614261|538269434|FG000|Follow-up Phase|Adverse Event|2|||
149219482|NCT02614261|538269435|FG001|Follow-up Phase|Adverse Event|0|||
149219483|NCT02614261|538269436|FG002|Follow-up Phase|Adverse Event|1|||
149219484|NCT02614261|538269437|FG003|Follow-up Phase|Adverse Event|0|||
149219485|NCT02614261|538269434|FG000|Follow-up Phase|Lost to Follow-up|12|||
149219486|NCT02614261|538269435|FG001|Follow-up Phase|Lost to Follow-up|5|||
149219487|NCT02614261|538269436|FG002|Follow-up Phase|Lost to Follow-up|2|||
149219488|NCT02614261|538269437|FG003|Follow-up Phase|Lost to Follow-up|0|||
149219489|NCT02614261|538269434|FG000|Follow-up Phase|Physician Decision|5|||
149219490|NCT02614261|538269435|FG001|Follow-up Phase|Physician Decision|1|||
149219491|NCT02614261|538269436|FG002|Follow-up Phase|Physician Decision|0|||
149219492|NCT02614261|538269437|FG003|Follow-up Phase|Physician Decision|0|||
149219493|NCT02614261|538269434|FG000|Follow-up Phase|Pregnancy|0|||
149219494|NCT02614261|538269435|FG001|Follow-up Phase|Pregnancy|1|||
149219495|NCT02614261|538269436|FG002|Follow-up Phase|Pregnancy|0|||
149219496|NCT02614261|538269437|FG003|Follow-up Phase|Pregnancy|0|||
149219497|NCT02614261|538269434|FG000|Follow-up Phase|Protocol Violation|1|||
149219498|NCT02614261|538269435|FG001|Follow-up Phase|Protocol Violation|0|||
148685360|NCT00294723|536321445|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
148809942|NCT01551173|536780921|FG001|Overall Study|Adverse Event|6|||
149219499|NCT02614261|538269436|FG002|Follow-up Phase|Protocol Violation|0|||
149219500|NCT02614261|538269437|FG003|Follow-up Phase|Protocol Violation|0|||
149219501|NCT02614261|538269434|FG000|Follow-up Phase|Withdrawal by Subject|12|||
149219502|NCT02614261|538269435|FG001|Follow-up Phase|Withdrawal by Subject|4|||
149219503|NCT02614261|538269436|FG002|Follow-up Phase|Withdrawal by Subject|11|||
148809943|NCT01551173|536780920|FG000|Overall Study|Lost to Follow-up|5|||
149219504|NCT02614261|538269437|FG003|Follow-up Phase|Withdrawal by Subject|0|||
149219505|NCT02614261|538269434|FG000|Israel Addendum|Withdrawal by Subject|0|||
148809944|NCT01551173|536780921|FG001|Overall Study|Lost to Follow-up|7|||
149219506|NCT02614261|538269435|FG001|Israel Addendum|Withdrawal by Subject|0|||
149219507|NCT02614261|538269436|FG002|Israel Addendum|Withdrawal by Subject|0|||
149219508|NCT02614261|538269437|FG003|Israel Addendum|Withdrawal by Subject|4|||
149219509|NCT03512275|538269439|FG000|Overall Study|Withdrawal by Subject|1|||
149219510|NCT03512275|538269440|FG001|Overall Study|Withdrawal by Subject|3|||
149219511|NCT03512275|538269439|FG000|Overall Study|Physician Decision|0|||
149219512|NCT03512275|538269440|FG001|Overall Study|Physician Decision|1|||
149219513|NCT03512275|538269439|FG000|Overall Study|Lost to Follow-up|0|||
149219514|NCT03512275|538269440|FG001|Overall Study|Lost to Follow-up|3|||
149219515|NCT03512275|538269439|FG000|Overall Study|Other|1|||
149219516|NCT03512275|538269440|FG001|Overall Study|Other|0|||
149219517|NCT00113555|538269441|FG000|Overall Study|Baseline Failure|59|||
149219518|NCT00113555|538269441|FG000|Overall Study|Permanently Explanted|7|||
149219519|NCT00113555|538269441|FG000|Overall Study|Death|1|||
149219520|NCT00113555|538269441|FG000|Overall Study|Missed Followup|4|||
149219521|NCT00113555|538269441|FG000|Overall Study|Lost to Follow-up|8|||
149219522|NCT04474366|538269442|FG000|Overall Study|Lost to Follow-up|2|||
149219523|NCT04474366|538269443|FG001|Overall Study|Lost to Follow-up|5|||
149219524|NCT00320190|538269444|FG000|First 12 Months|Completed but did not enter extension|5|||
149219525|NCT00320190|538269445|FG001|First 12 Months|Completed but did not enter extension|3|||
149219526|NCT00320190|538269444|FG000|First 12 Months|Sponsor terminated study|2|||
149219527|NCT00320190|538269445|FG001|First 12 Months|Sponsor terminated study|2|||
149219528|NCT00320190|538269444|FG000|First 12 Months|Lost to Follow-up|0|||
149219529|NCT00320190|538269445|FG001|First 12 Months|Lost to Follow-up|1|||
149219530|NCT00320190|538269444|FG000|First 12 Months|Enrollment failure|0|||
149219531|NCT00320190|538269445|FG001|First 12 Months|Enrollment failure|1|||
149219532|NCT00320190|538269444|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
149219533|NCT00320190|538269445|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
149219534|NCT00320190|538269444|FG000|First 12 Months|Investigator request|0|||
149219535|NCT00320190|538269445|FG001|First 12 Months|Investigator request|1|||
149219536|NCT00320190|538269444|FG000|First 12 Months|Study drug toxicity|0|||
149219537|NCT00320190|538269445|FG001|First 12 Months|Study drug toxicity|1|||
149219538|NCT00320190|538269444|FG000|First 12 Months|Withdrawal by Subject|0|||
149219539|NCT00320190|538269445|FG001|First 12 Months|Withdrawal by Subject|1|||
149219540|NCT00320190|538269444|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
149219541|NCT00320190|538269445|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
149219542|NCT00320190|538269444|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
149219543|NCT00320190|538269445|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
149219544|NCT00320190|538269444|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
149219545|NCT00320190|538269445|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
149219546|NCT04412668|538269449|FG000|Overall Study|Death - multiple comorbidities|2|||
149219547|NCT04412668|538269450|FG001|Overall Study|Death - multiple comorbidities|0|||
149219548|NCT04412668|538269451|FG002|Overall Study|Death - multiple comorbidities|0|||
149219549|NCT04412668|538269449|FG000|Overall Study|Withdrawal by Subject|3|||
149219550|NCT04412668|538269450|FG001|Overall Study|Withdrawal by Subject|0|||
149219551|NCT04412668|538269451|FG002|Overall Study|Withdrawal by Subject|0|||
149219552|NCT04412668|538269449|FG000|Overall Study|Other than Specified|2|||
149219553|NCT04412668|538269450|FG001|Overall Study|Other than Specified|0|||
148953400|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
148953401|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
148953402|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
148953403|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
148953404|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
148953405|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
148953406|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
148953407|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
148953408|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
148953409|NCT01018186|537310428|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
149219554|NCT04412668|538269451|FG002|Overall Study|Other than Specified|0|||
149219555|NCT00102804|538269452|FG000|Overall Study|Progressive Disease (PD)|307|||
149219556|NCT00102804|538269453|FG001|Overall Study|Progressive Disease (PD)|196|||
149219557|NCT00102804|538269452|FG000|Overall Study|Withdrawal by Subject|46|||
149219558|NCT00102804|538269453|FG001|Overall Study|Withdrawal by Subject|7|||
149219559|NCT00102804|538269452|FG000|Overall Study|Adverse Event|37|||
149219560|NCT00102804|538269453|FG001|Overall Study|Adverse Event|3|||
149219561|NCT00102804|538269452|FG000|Overall Study|Physician Decision|24|||
149219562|NCT00102804|538269453|FG001|Overall Study|Physician Decision|6|||
149219563|NCT00102804|538269452|FG000|Overall Study|Death|5|||
148953410|NCT01018186|537310429|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
149219564|NCT00102804|538269453|FG001|Overall Study|Death|6|||
149219565|NCT00102804|538269452|FG000|Overall Study|Enrollment Criteria Not Met|6|||
149219566|NCT00102804|538269453|FG001|Overall Study|Enrollment Criteria Not Met|0|||
149219567|NCT00102804|538269452|FG000|Overall Study|Lost to Follow-up|4|||
149219568|NCT00102804|538269453|FG001|Overall Study|Lost to Follow-up|1|||
149219569|NCT00102804|538269452|FG000|Overall Study|Protocol Violation|2|||
149219570|NCT00102804|538269453|FG001|Overall Study|Protocol Violation|1|||
149219571|NCT00102804|538269452|FG000|Overall Study|Satisfactory Response|2|||
149219572|NCT00102804|538269453|FG001|Overall Study|Satisfactory Response|0|||
149219573|NCT00102804|538269452|FG000|Overall Study|Sponsor Decision|1|||
149219574|NCT00102804|538269453|FG001|Overall Study|Sponsor Decision|0|||
149219575|NCT00102804|538269452|FG000|Overall Study|Alive, Receiving Treatment|7|||
149219576|NCT00102804|538269453|FG001|Overall Study|Alive, Receiving Treatment|2|||
149219577|NCT03858686|538269454|FG000|Period 1|Adverse Event|1|||
149219578|NCT03858686|538269455|FG001|Period 1|Adverse Event|1|||
149219579|NCT03858686|538269454|FG000|Period 1|Lack of compliance|0|||
149219580|NCT03858686|538269455|FG001|Period 1|Lack of compliance|1|||
149219581|NCT03858686|538269454|FG000|Period 1|Adverse Event|0|||
149219582|NCT03858686|538269455|FG001|Period 1|Adverse Event|1|||
149219583|NCT03858686|538269454|FG000|Period 2|Adverse Event|0|||
149219584|NCT03858686|538269455|FG001|Period 2|Adverse Event|1|||
149219585|NCT02299206|538269462|FG000|Overall Study|Lost to Follow-up|1|||
149219586|NCT02299206|538269462|FG000|Overall Study|Withdrawal by Subject|1|||
149219587|NCT00691054|538269463|FG000|Overall Study|Withdrawal by Subject|1|||
149219588|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
149219589|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149219590|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149219591|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149219592|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149219593|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
149219594|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
149219595|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149219596|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149219597|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149219598|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149219599|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
149219600|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
149219601|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149219602|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149219603|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149219604|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149219605|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
149219606|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Other|14|||
149219607|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Other|0|||
149219608|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Other|0|||
149219609|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Other|0|||
149219610|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Other|0|||
149219611|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Other|0|||
149219612|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
149219613|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
149219614|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
149219615|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
149219616|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
149219617|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
149219618|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
149219619|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148953411|NCT01018186|537310430|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
148953412|NCT01018186|537310431|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
149219620|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149219621|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149219622|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149219623|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
149219624|NCT02141854|538269465|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
149219625|NCT02141854|538269466|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149219626|NCT02141854|538269467|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149219627|NCT02141854|538269468|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149219628|NCT02141854|538269469|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149219629|NCT02141854|538269470|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
149219630|NCT02141854|538269465|FG000|Treatment Period|Protocol Violation|0|||
149219631|NCT02141854|538269466|FG001|Treatment Period|Protocol Violation|1|||
149219632|NCT02141854|538269467|FG002|Treatment Period|Protocol Violation|0|||
148953413|NCT01922089|537310436|FG000|Overall Study|Adverse Event|18|||
148953414|NCT01922089|537310437|FG001|Overall Study|Adverse Event|13|||
149219633|NCT02141854|538269468|FG003|Treatment Period|Protocol Violation|2|||
149219634|NCT02141854|538269469|FG004|Treatment Period|Protocol Violation|2|||
149219635|NCT02141854|538269470|FG005|Treatment Period|Protocol Violation|1|||
149219636|NCT02141854|538269465|FG000|Treatment Period|Noncompliance|0|||
149219637|NCT02141854|538269466|FG001|Treatment Period|Noncompliance|0|||
149219638|NCT02141854|538269467|FG002|Treatment Period|Noncompliance|0|||
149219639|NCT02141854|538269468|FG003|Treatment Period|Noncompliance|1|||
149219640|NCT02141854|538269469|FG004|Treatment Period|Noncompliance|0|||
149219641|NCT02141854|538269470|FG005|Treatment Period|Noncompliance|0|||
149219642|NCT02141854|538269465|FG000|Treatment Period|Lack of Efficacy|0|||
149219643|NCT02141854|538269466|FG001|Treatment Period|Lack of Efficacy|0|||
149219644|NCT02141854|538269467|FG002|Treatment Period|Lack of Efficacy|0|||
149219645|NCT02141854|538269468|FG003|Treatment Period|Lack of Efficacy|1|||
149219646|NCT02141854|538269469|FG004|Treatment Period|Lack of Efficacy|1|||
149219647|NCT02141854|538269470|FG005|Treatment Period|Lack of Efficacy|7|||
149219648|NCT02141854|538269465|FG000|Treatment Period|Pregnancy|0|||
149219649|NCT02141854|538269466|FG001|Treatment Period|Pregnancy|1|||
149219650|NCT02141854|538269467|FG002|Treatment Period|Pregnancy|0|||
149219651|NCT02141854|538269468|FG003|Treatment Period|Pregnancy|0|||
149219652|NCT02141854|538269469|FG004|Treatment Period|Pregnancy|0|||
149219653|NCT02141854|538269470|FG005|Treatment Period|Pregnancy|0|||
149219654|NCT02141854|538269465|FG000|Treatment Period|Other|0|||
149219655|NCT02141854|538269466|FG001|Treatment Period|Other|1|||
149219656|NCT02141854|538269467|FG002|Treatment Period|Other|2|||
149219657|NCT02141854|538269468|FG003|Treatment Period|Other|0|||
149219658|NCT02141854|538269469|FG004|Treatment Period|Other|1|||
149219659|NCT02141854|538269470|FG005|Treatment Period|Other|2|||
149219660|NCT02141854|538269465|FG000|Treatment Period|Adverse Event|0|||
149219661|NCT02141854|538269466|FG001|Treatment Period|Adverse Event|2|||
149219662|NCT02141854|538269467|FG002|Treatment Period|Adverse Event|2|||
149219663|NCT02141854|538269468|FG003|Treatment Period|Adverse Event|0|||
149219664|NCT02141854|538269469|FG004|Treatment Period|Adverse Event|2|||
149219665|NCT02141854|538269470|FG005|Treatment Period|Adverse Event|2|||
149219666|NCT02141854|538269465|FG000|Treatment Period|Withdrawal by Subject|0|||
149219667|NCT02141854|538269466|FG001|Treatment Period|Withdrawal by Subject|2|||
149219668|NCT02141854|538269467|FG002|Treatment Period|Withdrawal by Subject|3|||
149219669|NCT02141854|538269468|FG003|Treatment Period|Withdrawal by Subject|3|||
149219670|NCT02141854|538269469|FG004|Treatment Period|Withdrawal by Subject|4|||
149219671|NCT02141854|538269470|FG005|Treatment Period|Withdrawal by Subject|7|||
149219672|NCT02141854|538269465|FG000|Treatment Period|Disease progression|0|||
149219673|NCT02141854|538269466|FG001|Treatment Period|Disease progression|2|||
148685361|NCT00294723|536321446|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
148685362|NCT03038113|536321451|FG000|Overall Study|Withdrawal by Subject|0|||
148685363|NCT03038113|536321452|FG001|Overall Study|Withdrawal by Subject|0|||
148685364|NCT03038113|536321453|FG002|Overall Study|Withdrawal by Subject|1|||
148685365|NCT03038113|536321454|FG003|Overall Study|Withdrawal by Subject|0|||
148685366|NCT03038113|536321455|FG004|Overall Study|Withdrawal by Subject|0|||
148685367|NCT03038113|536321456|FG005|Overall Study|Withdrawal by Subject|0|||
148685368|NCT03038113|536321457|FG006|Overall Study|Withdrawal by Subject|0|||
148685369|NCT03038113|536321458|FG007|Overall Study|Withdrawal by Subject|0|||
148685370|NCT03038113|536321459|FG008|Overall Study|Withdrawal by Subject|0|||
148685371|NCT03038113|536321460|FG009|Overall Study|Withdrawal by Subject|0|||
148685372|NCT03038113|536321461|FG010|Overall Study|Withdrawal by Subject|0|||
148685373|NCT03038113|536321462|FG011|Overall Study|Withdrawal by Subject|0|||
148685374|NCT03038113|536321463|FG012|Overall Study|Withdrawal by Subject|0|||
148685375|NCT03038113|536321464|FG013|Overall Study|Withdrawal by Subject|1|||
149219674|NCT02141854|538269467|FG002|Treatment Period|Disease progression|1|||
149219675|NCT02141854|538269468|FG003|Treatment Period|Disease progression|3|||
149219676|NCT02141854|538269469|FG004|Treatment Period|Disease progression|0|||
149219677|NCT02141854|538269470|FG005|Treatment Period|Disease progression|18|||
149219678|NCT02141854|538269465|FG000|Treatment Period|Lost to Follow-up|0|||
149219679|NCT02141854|538269466|FG001|Treatment Period|Lost to Follow-up|1|||
149219680|NCT02141854|538269467|FG002|Treatment Period|Lost to Follow-up|1|||
148685376|NCT03038113|536321451|FG000|Overall Study|Lost to Follow-up|0|||
148685377|NCT03038113|536321452|FG001|Overall Study|Lost to Follow-up|0|||
148685378|NCT03038113|536321453|FG002|Overall Study|Lost to Follow-up|0|||
148809945|NCT01551173|536780920|FG000|Overall Study|Other|5|||
148953415|NCT01922089|537310436|FG000|Overall Study|Protocol Deviation|10|||
149219681|NCT02141854|538269468|FG003|Treatment Period|Lost to Follow-up|1|||
149219682|NCT02141854|538269469|FG004|Treatment Period|Lost to Follow-up|0|||
149219683|NCT02141854|538269470|FG005|Treatment Period|Lost to Follow-up|1|||
149219684|NCT01868594|538269471|FG000|Overall Study|Do not meet inclusion criteria|4|||
149219685|NCT01868594|538269472|FG001|Overall Study|Do not meet inclusion criteria|3|||
148685379|NCT03038113|536321454|FG003|Overall Study|Lost to Follow-up|0|||
148685380|NCT03038113|536321455|FG004|Overall Study|Lost to Follow-up|0|||
148685381|NCT03038113|536321456|FG005|Overall Study|Lost to Follow-up|0|||
148685382|NCT03038113|536321457|FG006|Overall Study|Lost to Follow-up|1|||
148809946|NCT01551173|536780921|FG001|Overall Study|Other|3|||
149219686|NCT01592773|538270961|FG000|Overall Study|Study Terminated by Sponsor|582|||
149219687|NCT01592773|538270961|FG000|Overall Study|Withdrawal by Subject|35|||
149219688|NCT01592773|538270961|FG000|Overall Study|Lost to Follow-up|19|||
149219689|NCT01592773|538270961|FG000|Overall Study|Adverse Event|17|||
149219690|NCT01592773|538270961|FG000|Overall Study|Lack of Efficacy|9|||
149219691|NCT01592773|538270961|FG000|Overall Study|Protocol Violation|2|||
149219692|NCT01592773|538270961|FG000|Overall Study|Inclusion/exclusion not meet|1|||
149219693|NCT01592773|538270961|FG000|Overall Study|Other Reason|1|||
149219694|NCT04418427|538270962|FG000|Overall Study|Death|0|||
149219695|NCT04418427|538270963|FG001|Overall Study|Death|1|||
149219696|NCT04418427|538270964|FG002|Overall Study|Death|0|||
149219697|NCT04418427|538270962|FG000|Overall Study|Lost to Follow-up|0|||
149219698|NCT04418427|538270963|FG001|Overall Study|Lost to Follow-up|2|||
149219699|NCT04418427|538270964|FG002|Overall Study|Lost to Follow-up|2|||
149219700|NCT04418427|538270962|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
149219701|NCT04418427|538270963|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
149219702|NCT04418427|538270964|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
149219703|NCT04418427|538270962|FG000|Overall Study|Pre-existing medical condition|0|||
149219704|NCT04418427|538270963|FG001|Overall Study|Pre-existing medical condition|1|||
149219705|NCT04418427|538270964|FG002|Overall Study|Pre-existing medical condition|0|||
149219706|NCT01293123|538270965|FG000|Overall Study|Lost to Follow-up|0|||
149219707|NCT01293123|538270966|FG001|Overall Study|Lost to Follow-up|1|||
149219708|NCT00121485|538270967|FG000|Overall Study|Not implanted|1|||
149219709|NCT00121485|538270968|FG001|Overall Study|Not implanted|5|||
149219710|NCT00121485|538270967|FG000|Overall Study|Crossover|0|||
149219711|NCT00121485|538270968|FG001|Overall Study|Crossover|2|||
149219712|NCT01888965|538270975|FG000|Overall Study|Adverse Event|5|||
149219713|NCT01888965|538270975|FG000|Overall Study|Lack of Efficacy|4|||
149219714|NCT04076579|538270976|FG000|Overall Study|Adverse Event|2|||
149219715|NCT04076579|538270977|FG001|Overall Study|Adverse Event|0|||
149219716|NCT04076579|538270976|FG000|Overall Study|discontinued due to toxicity|1|||
149219717|NCT04076579|538270977|FG001|Overall Study|discontinued due to toxicity|0|||
149219718|NCT04076579|538270976|FG000|Overall Study|Physician Decision|1|||
149219719|NCT04076579|538270977|FG001|Overall Study|Physician Decision|0|||
149219720|NCT04076579|538270976|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
149219721|NCT04076579|538270977|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
149219722|NCT04076579|538270976|FG000|Overall Study|Noncompliance|0|||
149219723|NCT04076579|538270977|FG001|Overall Study|Noncompliance|1|||
149219724|NCT04076579|538270976|FG000|Overall Study|Withdrawal by Subject|0|||
149219725|NCT04076579|538270977|FG001|Overall Study|Withdrawal by Subject|2|||
149219726|NCT03793010|538270978|FG000|Overall Study|Withdrawal by Subject|5|||
149219727|NCT03793010|538270979|FG001|Overall Study|Withdrawal by Subject|7|||
149219728|NCT03793010|538270978|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
149219729|NCT03793010|538270979|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
149219730|NCT03793010|538270978|FG000|Overall Study|Lost to Follow-up|1|||
149219731|NCT03793010|538270979|FG001|Overall Study|Lost to Follow-up|2|||
149219732|NCT03793010|538270978|FG000|Overall Study|Patient couldn't sit still for injection|1|||
149219733|NCT03793010|538270979|FG001|Overall Study|Patient couldn't sit still for injection|0|||
149219734|NCT03793010|538270978|FG000|Overall Study|Withdrew to pursue other treatment|1|||
149219735|NCT03793010|538270979|FG001|Overall Study|Withdrew to pursue other treatment|0|||
149219736|NCT03793010|538270978|FG000|Overall Study|Did not meet eligibility criteria|1|||
149219737|NCT03793010|538270979|FG001|Overall Study|Did not meet eligibility criteria|0|||
149219738|NCT02608099|538270980|FG000|Overall Study|Ablation procedure not initiated|3|||
149219739|NCT02608099|538270981|FG001|Overall Study|Ablation procedure not initiated|2|||
149219740|NCT00186121|538270985|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
149219741|NCT00186121|538270985|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
149219742|NCT00186121|538270985|FG000|Overall Study|Not eligible (no treatment)|1|||
149219743|NCT00417248|538270986|FG000|Overall Study|Study Terminated|6|||
149219744|NCT00417248|538270986|FG000|Overall Study|Death|1|||
149219745|NCT00417248|538270986|FG000|Overall Study|Lack of Efficacy|1|||
149219746|NCT01569568|538270987|FG000|Overall Study|Physician Decision|0|||
149219747|NCT01569568|538270988|FG001|Overall Study|Physician Decision|2|||
149219748|NCT00934791|538270989|FG000|Overall Study|Withdrawal by Subject|1|||
149219749|NCT00934791|538270990|FG001|Overall Study|Withdrawal by Subject|0|||
149219750|NCT04124952|538270991|FG000|Overall Study|Lost to Follow-up|1|||
149219751|NCT01654224|538270992|FG000|Overall Study|Lost to Follow-up|2|||
149219752|NCT01654224|538270993|FG001|Overall Study|Lost to Follow-up|2|||
149219753|NCT01654224|538270992|FG000|Overall Study|Did not receive allocation|1|||
149219754|NCT01654224|538270993|FG001|Overall Study|Did not receive allocation|8|||
149219755|NCT01654224|538270992|FG000|Overall Study|Insufficient blood sample|3|||
149219756|NCT01654224|538270993|FG001|Overall Study|Insufficient blood sample|2|||
149219757|NCT03763942|538270995|FG000|Overall Study|Lost to Follow-up|114|||
149219758|NCT03763942|538270996|FG001|Overall Study|Lost to Follow-up|54|||
149219759|NCT03763942|538270995|FG000|Overall Study|Protocol Violation|1|||
149219760|NCT03763942|538270996|FG001|Overall Study|Protocol Violation|0|||
149219761|NCT03763942|538270995|FG000|Overall Study|Withdrawal by Subject|2|||
149219762|NCT03763942|538270996|FG001|Overall Study|Withdrawal by Subject|0|||
149219763|NCT03763942|538270995|FG000|Overall Study|Other|2|||
149219764|NCT03763942|538270996|FG001|Overall Study|Other|3|||
149219765|NCT00166504|538270997|FG000|Overall Study|Adverse Event|3|||
149219766|NCT00166504|538270998|FG001|Overall Study|Adverse Event|3|||
149219767|NCT00166504|538270997|FG000|Overall Study|Lost to Follow-up|1|||
149219768|NCT00166504|538270998|FG001|Overall Study|Lost to Follow-up|1|||
149219769|NCT00166504|538270997|FG000|Overall Study|Withdrawal by Subject|1|||
149219770|NCT00166504|538270998|FG001|Overall Study|Withdrawal by Subject|0|||
149219771|NCT02145429|538270999|FG000|Overall Study|Death|4|||
149219772|NCT02145429|538271000|FG001|Overall Study|Death|5|||
149219773|NCT02145429|538270999|FG000|Overall Study|Lost to Follow-up|4|||
148953416|NCT01922089|537310437|FG001|Overall Study|Protocol Deviation|7|||
148953417|NCT01922089|537310436|FG000|Overall Study|Withdrawal by Subject|3|||
148953418|NCT01922089|537310437|FG001|Overall Study|Withdrawal by Subject|4|||
148953419|NCT01922089|537310436|FG000|Overall Study|administrative problems|4|||
148953420|NCT01922089|537310437|FG001|Overall Study|administrative problems|1|||
148953421|NCT01922089|537310436|FG000|Overall Study|Physician Decision|2|||
148953422|NCT01922089|537310437|FG001|Overall Study|Physician Decision|3|||
148953423|NCT01922089|537310436|FG000|Overall Study|Death|2|||
148953424|NCT01922089|537310437|FG001|Overall Study|Death|1|||
148953425|NCT01922089|537310436|FG000|Overall Study|Lost to Follow-up|0|||
148953426|NCT01922089|537310437|FG001|Overall Study|Lost to Follow-up|1|||
148953427|NCT01683383|537310441|FG000|Overall Study|Infant was not transported|1|||
148953428|NCT01683383|537310442|FG001|Overall Study|Infant was not transported|0|||
148953429|NCT00996307|537310443|FG000|Overall Study|Adverse Event|0|||
148953430|NCT00996307|537310444|FG001|Overall Study|Adverse Event|1|||
148953431|NCT00996307|537310445|FG002|Overall Study|Adverse Event|0|||
148953432|NCT00996307|537310446|FG003|Overall Study|Adverse Event|0|||
148953433|NCT00996307|537310443|FG000|Overall Study|Withdrawal by Subject|3|||
148953434|NCT00996307|537310444|FG001|Overall Study|Withdrawal by Subject|2|||
148953435|NCT00996307|537310445|FG002|Overall Study|Withdrawal by Subject|5|||
148953436|NCT00996307|537310446|FG003|Overall Study|Withdrawal by Subject|5|||
148953437|NCT00996307|537310443|FG000|Overall Study|Lost to Follow-up|13|||
148953438|NCT00996307|537310444|FG001|Overall Study|Lost to Follow-up|13|||
148953439|NCT00996307|537310445|FG002|Overall Study|Lost to Follow-up|7|||
148953440|NCT00996307|537310446|FG003|Overall Study|Lost to Follow-up|15|||
148953441|NCT00996307|537310443|FG000|Overall Study|Administrative reason|0|||
148953442|NCT00996307|537310444|FG001|Overall Study|Administrative reason|1|||
148953443|NCT00996307|537310445|FG002|Overall Study|Administrative reason|0|||
148953444|NCT00996307|537310446|FG003|Overall Study|Administrative reason|0|||
149219774|NCT02145429|538271000|FG001|Overall Study|Lost to Follow-up|3|||
149219775|NCT02145429|538270999|FG000|Overall Study|Withdrawal by Subject|8|||
149219776|NCT02145429|538271000|FG001|Overall Study|Withdrawal by Subject|3|||
148953445|NCT00996307|537310443|FG000|Overall Study|Unable to classify|4|||
148953446|NCT00996307|537310444|FG001|Overall Study|Unable to classify|0|||
148953447|NCT00996307|537310445|FG002|Overall Study|Unable to classify|2|||
148953448|NCT00996307|537310446|FG003|Overall Study|Unable to classify|1|||
148953449|NCT02496611|537310447|FG000|Overall Study|Lost to Follow-up|2|||
148953450|NCT02496611|537310448|FG001|Overall Study|Lost to Follow-up|1|||
148953451|NCT02496611|537310447|FG000|Overall Study|Withdrawal by Subject|5|||
148953452|NCT02496611|537310448|FG001|Overall Study|Withdrawal by Subject|2|||
148953453|NCT02850965|537310449|FG000|Overall Study|Other than listed|3|||
148953454|NCT02850965|537310450|FG001|Overall Study|Other than listed|4|||
148953455|NCT02850965|537310449|FG000|Overall Study|Protocol Violation|0|||
148953456|NCT02850965|537310450|FG001|Overall Study|Protocol Violation|2|||
148953457|NCT02850965|537310449|FG000|Overall Study|Lost to Follow-up|5|||
148953458|NCT02850965|537310450|FG001|Overall Study|Lost to Follow-up|3|||
148953459|NCT02850965|537310449|FG000|Overall Study|Lack of Efficacy|4|||
148953460|NCT02850965|537310450|FG001|Overall Study|Lack of Efficacy|8|||
148953461|NCT02850965|537310449|FG000|Overall Study|Adverse Event|3|||
148953462|NCT02850965|537310450|FG001|Overall Study|Adverse Event|2|||
148953463|NCT02850965|537310449|FG000|Overall Study|Withdrawal by Subject|3|||
148953464|NCT02850965|537310450|FG001|Overall Study|Withdrawal by Subject|4|||
148953465|NCT02850965|537310449|FG000|Overall Study|Physician Decision|0|||
148953466|NCT02850965|537310450|FG001|Overall Study|Physician Decision|1|||
148953467|NCT02850965|537310449|FG000|Overall Study|Randomized but not treated|0|||
148953468|NCT02850965|537310450|FG001|Overall Study|Randomized but not treated|1|||
148953469|NCT02788357|537310451|FG000|Overall Study|Lost to Follow-up|3|||
148953470|NCT02788357|537310452|FG001|Overall Study|Lost to Follow-up|0|||
148953471|NCT02170051|537310453|FG000|Overall Study|Withdrawal by Subject|10|||
148953472|NCT02170051|537310454|FG001|Overall Study|Withdrawal by Subject|10|||
148953473|NCT02170051|537310453|FG000|Overall Study|Lost to Follow-up|1|||
148953474|NCT02170051|537310454|FG001|Overall Study|Lost to Follow-up|3|||
148953475|NCT00276744|537310455|FG000|PART A|Reason unknown|98|||
148953476|NCT02860169|537310460|FG000|Part A|Withdrawal by Subject|1|||
148953477|NCT02860169|537310460|FG000|Part A|Other (Screening failure)|6|||
148953478|NCT02860169|537310460|FG000|Part A|Other (Survey not completed)|3|||
148953479|NCT02860169|537310460|FG000|Part A|Other (did not completed consent)|1|||
149219777|NCT02200510|538271001|FG000|Overall Study|Death|1|||
149219778|NCT02200510|538271002|FG001|Overall Study|Death|1|||
149219779|NCT02200510|538271001|FG000|Overall Study|Protocol Violation|0|||
149219780|NCT02200510|538271002|FG001|Overall Study|Protocol Violation|1|||
149219781|NCT02200510|538271001|FG000|Overall Study|Lost to Follow-up|7|||
149219782|NCT02200510|538271002|FG001|Overall Study|Lost to Follow-up|1|||
149219783|NCT02200510|538271001|FG000|Overall Study|potential COI - joined study team|1|||
149219784|NCT02200510|538271002|FG001|Overall Study|potential COI - joined study team|0|||
149219785|NCT02943577|538271003|FG000|Overall Study|Protocol Violation|0|||
149219786|NCT02943577|538271004|FG001|Overall Study|Protocol Violation|1|||
149219787|NCT02943577|538271003|FG000|Overall Study|Adverse Event|3|||
149219788|NCT02943577|538271004|FG001|Overall Study|Adverse Event|2|||
149219789|NCT02943577|538271003|FG000|Overall Study|Lost to Follow-up|0|||
149219790|NCT02943577|538271004|FG001|Overall Study|Lost to Follow-up|1|||
149219791|NCT02943577|538271003|FG000|Overall Study|Withdrawal by Subject|1|||
149219792|NCT02943577|538271004|FG001|Overall Study|Withdrawal by Subject|1|||
149219793|NCT02943577|538271003|FG000|Overall Study|Pregnancy|1|||
149219794|NCT02943577|538271004|FG001|Overall Study|Pregnancy|0|||
149219795|NCT00939055|538271009|FG000|Overall Study|Discontinuation prior to procedure|4|||
149219796|NCT00939055|538271010|FG001|Overall Study|Discontinuation prior to procedure|0|||
149219797|NCT00808028|538271014|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
149219798|NCT00808028|538271015|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
149219799|NCT00808028|538271016|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
149219800|NCT00808028|538271017|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
149219801|NCT00808028|538271014|FG000|Stage 1 (6 Months)|Other|1|||
149219802|NCT00808028|538271015|FG001|Stage 1 (6 Months)|Other|0|||
149219803|NCT00808028|538271016|FG002|Stage 1 (6 Months)|Other|2|||
149219804|NCT00808028|538271017|FG003|Stage 1 (6 Months)|Other|4|||
149219805|NCT00808028|538271014|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
149219806|NCT00808028|538271015|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
148685383|NCT03038113|536321458|FG007|Overall Study|Lost to Follow-up|0|||
148685384|NCT03038113|536321459|FG008|Overall Study|Lost to Follow-up|0|||
149219807|NCT00808028|538271016|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
148953480|NCT02860169|537310460|FG000|Part B|Other (Screening failure)|10|||
149219808|NCT00808028|538271017|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
149219809|NCT00808028|538271014|FG000|Stage 1 (6 Months)|Adverse Event|0|||
149219810|NCT00808028|538271015|FG001|Stage 1 (6 Months)|Adverse Event|0|||
149219811|NCT00808028|538271016|FG002|Stage 1 (6 Months)|Adverse Event|1|||
149219812|NCT00808028|538271017|FG003|Stage 1 (6 Months)|Adverse Event|2|||
148953481|NCT02860169|537310460|FG000|Part B|Withdrawal by Subject|1|||
148953482|NCT02860169|537310460|FG000|Part C|Other (Screening failure)|1|||
148953483|NCT00165776|537310461|FG000|Overall Study|Lack of Efficacy|0|||
148953484|NCT00165776|537310462|FG001|Overall Study|Lack of Efficacy|0|||
148953485|NCT00165776|537310463|FG002|Overall Study|Lack of Efficacy|0|||
149219813|NCT00808028|538271014|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
149219814|NCT00808028|538271015|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
149219815|NCT00808028|538271016|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
149219816|NCT00808028|538271017|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
149219817|NCT00808028|538271014|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
149219818|NCT00808028|538271015|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
149219819|NCT00808028|538271016|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
149219820|NCT00808028|538271017|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
149219821|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
149219822|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
149219823|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
149219824|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
149219825|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
149219826|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
149219827|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
149219828|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
149219829|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
149219830|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
149219831|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
149219832|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
149219833|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
149219834|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
149219835|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
149219836|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
149219837|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
149219838|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
149219839|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
149219840|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
149219841|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
149219842|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
149219843|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
149219844|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
149219845|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
149219846|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
149219847|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
149219848|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
149219849|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
149219850|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
149219851|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
149219852|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
149219853|NCT00808028|538271014|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
149219854|NCT00808028|538271015|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
149219855|NCT00808028|538271016|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
149219856|NCT00808028|538271017|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
149219857|NCT01222767|538271020|FG000|Overall Study|Progressive disease|13|||
149219858|NCT01222767|538271020|FG000|Overall Study|Adverse Event|2|||
149219859|NCT01222767|538271020|FG000|Overall Study|Surgical resection|1|||
149219860|NCT01222767|538271020|FG000|Overall Study|Never treated|1|||
149219861|NCT00508001|538271021|FG000|Overall Study|Adverse Event|2|||
149219862|NCT00508001|538271022|FG001|Overall Study|Adverse Event|0|||
149219863|NCT00508001|538271023|FG002|Overall Study|Adverse Event|4|||
149219864|NCT00508001|538271021|FG000|Overall Study|condition under investigation worsened|13|||
149219865|NCT00508001|538271022|FG001|Overall Study|condition under investigation worsened|7|||
149219866|NCT00508001|538271023|FG002|Overall Study|condition under investigation worsened|1|||
149219867|NCT00508001|538271021|FG000|Overall Study|Death|0|||
149219868|NCT00508001|538271022|FG001|Overall Study|Death|1|||
149219869|NCT00508001|538271023|FG002|Overall Study|Death|1|||
149219870|NCT00508001|538271021|FG000|Overall Study|Withdrawal by Subject|4|||
149219871|NCT00508001|538271022|FG001|Overall Study|Withdrawal by Subject|4|||
149219872|NCT00508001|538271023|FG002|Overall Study|Withdrawal by Subject|1|||
149219873|NCT04437511|538271024|FG000|Overall Study|Adverse Event|50|||
149219874|NCT04437511|538271025|FG001|Overall Study|Adverse Event|21|||
149219875|NCT04437511|538271024|FG000|Overall Study|Death|15|||
149219876|NCT04437511|538271025|FG001|Overall Study|Death|10|||
149219877|NCT04437511|538271024|FG000|Overall Study|Lost to Follow-up|11|||
149219878|NCT04437511|538271025|FG001|Overall Study|Lost to Follow-up|11|||
149219879|NCT04437511|538271024|FG000|Overall Study|Physician Decision|19|||
149219880|NCT04437511|538271025|FG001|Overall Study|Physician Decision|10|||
149219881|NCT04437511|538271024|FG000|Overall Study|Progressive Disease|4|||
149219882|NCT04437511|538271025|FG001|Overall Study|Progressive Disease|7|||
149219883|NCT04437511|538271024|FG000|Overall Study|Withdrawal by Subject|111|||
149219884|NCT04437511|538271025|FG001|Overall Study|Withdrawal by Subject|94|||
149219885|NCT04437511|538271024|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
149219886|NCT04437511|538271025|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
149219887|NCT04437511|538271024|FG000|Overall Study|Continuing Study|7|||
149219888|NCT04437511|538271025|FG001|Overall Study|Continuing Study|5|||
149219889|NCT03093350|538271030|FG000|Overall Study|Death|1|||
149219890|NCT03093350|538271030|FG000|Overall Study|Signed consent, never began treartment|1|||
149219891|NCT01267955|538271038|FG000|Stage 1 (6 Months)|Death|3|||
149219892|NCT01267955|538271038|FG000|Stage 2 (6 Months)|Death|5|||
149219893|NCT01267955|538271038|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
149219894|NCT00729560|538271039|FG000|Overall Study|Withdrawal by Subject|3|||
149219895|NCT03233308|538271040|FG000|Overall Study|Adverse Event|1|||
149219896|NCT03233308|538271040|FG000|Overall Study|Protocol Violation|1|||
149219897|NCT03662789|538271041|FG000|Overall Study|Lost to Follow-up|1|||
149219898|NCT03662789|538271042|FG001|Overall Study|Lost to Follow-up|2|||
149219899|NCT03662789|538271041|FG000|Overall Study|Could not perform treadmill test|4|||
149219900|NCT03662789|538271042|FG001|Overall Study|Could not perform treadmill test|4|||
149219901|NCT03662789|538271041|FG000|Overall Study|Death|0|||
149219902|NCT03662789|538271042|FG001|Overall Study|Death|1|||
149219903|NCT03598140|538271043|FG000|Overall Study|enrolled but didn't start|1|||
149219904|NCT03598140|538271044|FG001|Overall Study|enrolled but didn't start|0|||
149219905|NCT01023516|538271046|FG000|Overall Study|Voluntary discontinuation|7|||
149219906|NCT01023516|538271047|FG001|Overall Study|Voluntary discontinuation|5|||
149219907|NCT01023516|538271046|FG000|Overall Study|Adverse Event|9|||
149219908|NCT01023516|538271047|FG001|Overall Study|Adverse Event|6|||
149219909|NCT01023516|538271046|FG000|Overall Study|Safety reason|0|||
149219910|NCT01023516|538271047|FG001|Overall Study|Safety reason|3|||
149219911|NCT01023516|538271046|FG000|Overall Study|Study-specific criteria|4|||
149219912|NCT01023516|538271047|FG001|Overall Study|Study-specific criteria|2|||
149219913|NCT01023516|538271046|FG000|Overall Study|Incorrect enrolment|4|||
149219914|NCT01023516|538271047|FG001|Overall Study|Incorrect enrolment|2|||
149219915|NCT02060903|538271048|FG000|Overall Study|Lost to Follow-up|4|||
149219916|NCT02060903|538271049|FG001|Overall Study|Lost to Follow-up|0|||
149219917|NCT02060903|538271048|FG000|Overall Study|Withdrawal by Subject|0|||
149219918|NCT02060903|538271049|FG001|Overall Study|Withdrawal by Subject|7|||
149219919|NCT05304611|538271050|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219920|NCT05304611|538271051|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219921|NCT05304611|538271052|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219922|NCT05304611|538271053|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219923|NCT05304611|538271054|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219924|NCT05304611|538271055|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219925|NCT05304611|538271056|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
149219926|NCT05304611|538271057|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219927|NCT05304611|538271058|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
149219928|NCT05304611|538271059|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219929|NCT05304611|538271060|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219930|NCT05304611|538271061|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
149219931|NCT05304611|538271050|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
149219932|NCT05304611|538271051|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
149219933|NCT05304611|538271052|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
148809947|NCT04530344|536780922|FG000|Overall Study|Lost to Follow-up|3|||
148809948|NCT04530344|536780923|FG001|Overall Study|Lost to Follow-up|3|||
148809949|NCT04530344|536780924|FG002|Overall Study|Lost to Follow-up|3|||
149219934|NCT05304611|538271053|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
149219935|NCT05304611|538271054|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
149219936|NCT05304611|538271055|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
149219937|NCT05304611|538271056|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
149219938|NCT05304611|538271057|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
149219939|NCT05304611|538271058|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
149219940|NCT05304611|538271059|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
149219941|NCT05304611|538271060|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
149219942|NCT05304611|538271061|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
149219943|NCT05304611|538271050|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
149219944|NCT05304611|538271051|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
149219945|NCT05304611|538271052|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
149219946|NCT05304611|538271053|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
149219947|NCT05304611|538271054|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
149219948|NCT05304611|538271055|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
149219949|NCT05304611|538271056|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
149219950|NCT05304611|538271057|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
148809950|NCT04530344|536780925|FG003|Overall Study|Lost to Follow-up|10|||
149219951|NCT05304611|538271058|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
149219952|NCT05304611|538271059|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
149219953|NCT05304611|538271060|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
149219954|NCT05304611|538271061|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
149219955|NCT02354690|538271066|FG000|Overall Study|Physician Decision|1|||
149219956|NCT00963820|538271067|FG000|Dose Escalation Phase|Progressive Disease|3|||
149219957|NCT00963820|538271068|FG001|Dose Escalation Phase|Progressive Disease|3|||
149219958|NCT00963820|538271069|FG002|Dose Escalation Phase|Progressive Disease|3|||
149219959|NCT00963820|538271070|FG003|Dose Escalation Phase|Progressive Disease|3|||
149219960|NCT00963820|538271071|FG004|Dose Escalation Phase|Progressive Disease|4|||
149219961|NCT00963820|538271072|FG005|Dose Escalation Phase|Progressive Disease|3|||
149219962|NCT00963820|538271073|FG006|Dose Escalation Phase|Progressive Disease|3|||
149219963|NCT00963820|538271074|FG007|Dose Escalation Phase|Progressive Disease|2|||
149219964|NCT00963820|538271075|FG008|Dose Escalation Phase|Progressive Disease|0|||
149219965|NCT00963820|538271076|FG009|Dose Escalation Phase|Progressive Disease|0|||
149219966|NCT00963820|538271077|FG010|Dose Escalation Phase|Progressive Disease|0|||
149219967|NCT00963820|538271078|FG011|Dose Escalation Phase|Progressive Disease|0|||
149219968|NCT00963820|538271067|FG000|Dose Escalation Phase|Adverse Event|0|||
149219969|NCT00963820|538271068|FG001|Dose Escalation Phase|Adverse Event|0|||
149219970|NCT00963820|538271069|FG002|Dose Escalation Phase|Adverse Event|0|||
149219971|NCT00963820|538271070|FG003|Dose Escalation Phase|Adverse Event|0|||
149219972|NCT00963820|538271071|FG004|Dose Escalation Phase|Adverse Event|0|||
149219973|NCT00963820|538271072|FG005|Dose Escalation Phase|Adverse Event|0|||
149219974|NCT00963820|538271073|FG006|Dose Escalation Phase|Adverse Event|3|||
149219975|NCT00963820|538271074|FG007|Dose Escalation Phase|Adverse Event|1|||
149219976|NCT00963820|538271075|FG008|Dose Escalation Phase|Adverse Event|0|||
149219977|NCT00963820|538271076|FG009|Dose Escalation Phase|Adverse Event|0|||
149219978|NCT00963820|538271077|FG010|Dose Escalation Phase|Adverse Event|0|||
149219979|NCT00963820|538271078|FG011|Dose Escalation Phase|Adverse Event|0|||
149219980|NCT00963820|538271067|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
149219981|NCT00963820|538271068|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
149219982|NCT00963820|538271069|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
149219983|NCT00963820|538271070|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149219984|NCT00963820|538271071|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
149219985|NCT00963820|538271072|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
149219986|NCT00963820|538271073|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
149219987|NCT00963820|538271074|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
149219988|NCT00963820|538271075|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
149219989|NCT00963820|538271076|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
149219990|NCT00963820|538271077|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
149219991|NCT00963820|538271078|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
149219992|NCT00963820|538271067|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149219993|NCT00963820|538271068|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149219994|NCT00963820|538271069|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149219995|NCT00963820|538271070|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149219996|NCT00963820|538271071|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149219997|NCT00963820|538271072|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149219998|NCT00963820|538271073|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
149219999|NCT00963820|538271074|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149220000|NCT00963820|538271075|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149220001|NCT00963820|538271076|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149220002|NCT00963820|538271077|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149220003|NCT00963820|538271078|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
149220004|NCT00963820|538271067|FG000|Expansion Phase|Progressive Disease|0|||
149220005|NCT00963820|538271068|FG001|Expansion Phase|Progressive Disease|0|||
149220006|NCT00963820|538271069|FG002|Expansion Phase|Progressive Disease|0|||
149220007|NCT00963820|538271070|FG003|Expansion Phase|Progressive Disease|0|||
149220008|NCT00963820|538271071|FG004|Expansion Phase|Progressive Disease|0|||
149220009|NCT00963820|538271072|FG005|Expansion Phase|Progressive Disease|0|||
149220010|NCT00963820|538271073|FG006|Expansion Phase|Progressive Disease|0|||
149220011|NCT00963820|538271074|FG007|Expansion Phase|Progressive Disease|0|||
149220012|NCT00963820|538271075|FG008|Expansion Phase|Progressive Disease|8|||
149220013|NCT00963820|538271076|FG009|Expansion Phase|Progressive Disease|6|||
149220014|NCT00963820|538271077|FG010|Expansion Phase|Progressive Disease|4|||
149220015|NCT00963820|538271078|FG011|Expansion Phase|Progressive Disease|2|||
149220016|NCT00963820|538271067|FG000|Expansion Phase|Adverse Event|0|||
149220017|NCT00963820|538271068|FG001|Expansion Phase|Adverse Event|0|||
149220018|NCT00963820|538271069|FG002|Expansion Phase|Adverse Event|0|||
149220019|NCT00963820|538271070|FG003|Expansion Phase|Adverse Event|0|||
149220020|NCT00963820|538271071|FG004|Expansion Phase|Adverse Event|0|||
149220021|NCT00963820|538271072|FG005|Expansion Phase|Adverse Event|0|||
149220022|NCT00963820|538271073|FG006|Expansion Phase|Adverse Event|0|||
149220023|NCT00963820|538271074|FG007|Expansion Phase|Adverse Event|0|||
149220024|NCT00963820|538271075|FG008|Expansion Phase|Adverse Event|1|||
149220025|NCT00963820|538271076|FG009|Expansion Phase|Adverse Event|3|||
149220026|NCT00963820|538271077|FG010|Expansion Phase|Adverse Event|0|||
149220027|NCT00963820|538271078|FG011|Expansion Phase|Adverse Event|0|||
149220028|NCT00963820|538271067|FG000|Expansion Phase|Withdrawal by Subject|0|||
149220029|NCT00963820|538271068|FG001|Expansion Phase|Withdrawal by Subject|0|||
149220030|NCT00963820|538271069|FG002|Expansion Phase|Withdrawal by Subject|0|||
149220031|NCT00963820|538271070|FG003|Expansion Phase|Withdrawal by Subject|0|||
149220032|NCT00963820|538271071|FG004|Expansion Phase|Withdrawal by Subject|0|||
149220033|NCT00963820|538271072|FG005|Expansion Phase|Withdrawal by Subject|0|||
149220034|NCT00963820|538271073|FG006|Expansion Phase|Withdrawal by Subject|0|||
149220035|NCT00963820|538271074|FG007|Expansion Phase|Withdrawal by Subject|0|||
149220036|NCT00963820|538271075|FG008|Expansion Phase|Withdrawal by Subject|1|||
149220037|NCT00963820|538271076|FG009|Expansion Phase|Withdrawal by Subject|0|||
149220038|NCT00963820|538271077|FG010|Expansion Phase|Withdrawal by Subject|1|||
149220039|NCT00963820|538271078|FG011|Expansion Phase|Withdrawal by Subject|1|||
149220040|NCT00963820|538271067|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220041|NCT00963820|538271068|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220042|NCT00963820|538271069|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220043|NCT00963820|538271070|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220044|NCT00963820|538271071|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220045|NCT00963820|538271072|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220046|NCT00963820|538271073|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220047|NCT00963820|538271074|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220048|NCT00963820|538271075|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220049|NCT00963820|538271076|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220050|NCT00963820|538271077|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
149220051|NCT00963820|538271078|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
149220052|NCT04556175|538271082|FG000|Overall Study|Study terminated due to COVID-19|8|||
149220053|NCT04556175|538271083|FG001|Overall Study|Study terminated due to COVID-19|8|||
149220054|NCT05549505|538271085|FG000|Overall Study|Lost to Follow-up|2|||
149220055|NCT05549505|538271086|FG001|Overall Study|Lost to Follow-up|0|||
149220056|NCT05549505|538271085|FG000|Overall Study|Withdrawal by Subject|3|||
149220057|NCT05549505|538271086|FG001|Overall Study|Withdrawal by Subject|3|||
149220058|NCT05549505|538271085|FG000|Overall Study|Other: Miscellaneous|3|||
149220059|NCT05549505|538271086|FG001|Overall Study|Other: Miscellaneous|6|||
149220060|NCT02871791|538271090|FG000|Phase 1b|Death|0|||
149220061|NCT02871791|538271091|FG001|Phase 1b|Death|1|||
149220062|NCT02871791|538271090|FG000|Phase 1b|progressive disease|6|||
149220063|NCT02871791|538271091|FG001|Phase 1b|progressive disease|2|||
149220064|NCT02871791|538271090|FG000|Phase 2|Death|1|||
149220065|NCT02871791|538271091|FG001|Phase 2|Death|0|||
149220066|NCT02871791|538271090|FG000|Phase 2|Lost to Follow-up|2|||
149220067|NCT02871791|538271091|FG001|Phase 2|Lost to Follow-up|0|||
149220068|NCT03128307|538271099|FG000|Overall Study|Lost to Follow-up|29|||
149220069|NCT03128307|538271099|FG000|Overall Study|Withdrawal by Subject|5|||
149220070|NCT03399786|538271100|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
149220071|NCT03399786|538271101|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149220072|NCT03399786|538271102|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149220073|NCT03399786|538271103|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
149220074|NCT03399786|538271100|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
149220075|NCT03399786|538271101|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
149220076|NCT03399786|538271102|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
149220077|NCT03399786|538271103|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
149220078|NCT03399786|538271100|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
149220079|NCT03399786|538271101|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
149220080|NCT03399786|538271102|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
149220081|NCT03399786|538271103|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
149220082|NCT02499172|538272256|FG000|Overall Study|Financial reason|0|||
149220083|NCT02499172|538272257|FG001|Overall Study|Financial reason|0|||
149220084|NCT02499172|538272258|FG002|Overall Study|Financial reason|523|||
149220085|NCT02499172|538272259|FG003|Overall Study|Financial reason|436|||
149220086|NCT02499172|538272256|FG000|Overall Study|Lost to Follow-up|65|||
149220087|NCT02499172|538272257|FG001|Overall Study|Lost to Follow-up|64|||
149220088|NCT02499172|538272258|FG002|Overall Study|Lost to Follow-up|0|||
149220089|NCT02499172|538272259|FG003|Overall Study|Lost to Follow-up|0|||
149220090|NCT00724243|538272262|FG000|Overall Study|Lack of Efficacy|10|||
149220091|NCT00724243|538272262|FG000|Overall Study|Adverse Event|5|||
149220092|NCT00908895|538272264|FG000|Overall Study|Lost to Follow-up|1|||
149220093|NCT00908895|538272265|FG001|Overall Study|Lost to Follow-up|3|||
149220094|NCT00908895|538272264|FG000|Overall Study|algodystrophy|2|||
149220095|NCT00908895|538272265|FG001|Overall Study|algodystrophy|2|||
149220096|NCT00908895|538272264|FG000|Overall Study|Adverse Event|1|||
149220097|NCT00908895|538272265|FG001|Overall Study|Adverse Event|1|||
149220098|NCT01997892|538272268|FG000|Overall Study|Physician Decision|2|||
149220099|NCT01997892|538272268|FG000|Overall Study|Lost to Follow-up|6|||
149220100|NCT01997892|538272268|FG000|Overall Study|Death|14|||
149220101|NCT01997892|538272268|FG000|Overall Study|Renal transplant|8|||
149220102|NCT01997892|538272268|FG000|Overall Study|Other|3|||
149220103|NCT01997892|538272268|FG000|Overall Study|Study completion data not recorded|35|||
149220104|NCT00584987|538272288|FG000|Overall Study|Protocol Violation|1|||
149220105|NCT00584987|538272289|FG001|Overall Study|Protocol Violation|1|||
149220106|NCT00584987|538272290|FG002|Overall Study|Protocol Violation|1|||
149220107|NCT00584987|538272291|FG003|Overall Study|Protocol Violation|0|||
149220108|NCT00584987|538272288|FG000|Overall Study|Adverse Event|0|||
149220109|NCT00584987|538272289|FG001|Overall Study|Adverse Event|0|||
149220110|NCT00584987|538272290|FG002|Overall Study|Adverse Event|0|||
149220111|NCT00584987|538272291|FG003|Overall Study|Adverse Event|1|||
149220112|NCT01944462|538272294|FG000|PPPP Educational Program|Lost to Follow-up|60|||
149220113|NCT03225833|538272295|FG000|Overall Study|Adverse Event|0|||
149220114|NCT03225833|538272296|FG001|Overall Study|Adverse Event|1|||
149220115|NCT03225833|538272297|FG002|Overall Study|Adverse Event|2|||
149220116|NCT03225833|538272298|FG003|Overall Study|Adverse Event|0|||
149220117|NCT03225833|538272299|FG004|Overall Study|Adverse Event|0|||
149220118|NCT03225833|538272300|FG005|Overall Study|Adverse Event|2|||
149220119|NCT03225833|538272295|FG000|Overall Study|Withdrawal by Subject|1|||
149220120|NCT03225833|538272296|FG001|Overall Study|Withdrawal by Subject|0|||
149220121|NCT03225833|538272297|FG002|Overall Study|Withdrawal by Subject|0|||
149220122|NCT03225833|538272298|FG003|Overall Study|Withdrawal by Subject|0|||
149220123|NCT03225833|538272299|FG004|Overall Study|Withdrawal by Subject|1|||
149220124|NCT03225833|538272300|FG005|Overall Study|Withdrawal by Subject|0|||
149220125|NCT03225833|538272295|FG000|Overall Study|Termination of Study by Sponsor|4|||
149220126|NCT03225833|538272296|FG001|Overall Study|Termination of Study by Sponsor|0|||
149220127|NCT03225833|538272297|FG002|Overall Study|Termination of Study by Sponsor|0|||
149220128|NCT03225833|538272298|FG003|Overall Study|Termination of Study by Sponsor|0|||
149220129|NCT03225833|538272299|FG004|Overall Study|Termination of Study by Sponsor|0|||
149220130|NCT03225833|538272300|FG005|Overall Study|Termination of Study by Sponsor|7|||
149220131|NCT03225833|538272295|FG000|Overall Study|Sponsor Decision|0|||
149220132|NCT03225833|538272296|FG001|Overall Study|Sponsor Decision|0|||
149220133|NCT03225833|538272297|FG002|Overall Study|Sponsor Decision|0|||
149220134|NCT03225833|538272298|FG003|Overall Study|Sponsor Decision|0|||
149220135|NCT03225833|538272299|FG004|Overall Study|Sponsor Decision|0|||
149220136|NCT03225833|538272300|FG005|Overall Study|Sponsor Decision|1|||
149220137|NCT00723489|538272301|FG000|Overall Study|Physician Decision|0|||
149220138|NCT00723489|538272302|FG001|Overall Study|Physician Decision|1|||
149220139|NCT00723489|538272303|FG002|Overall Study|Physician Decision|0|||
148953486|NCT00165776|537310464|FG003|Overall Study|Lack of Efficacy|1|||
148953487|NCT00165776|537310461|FG000|Overall Study|Withdrawal by Subject|4|||
148953488|NCT00165776|537310462|FG001|Overall Study|Withdrawal by Subject|1|||
148953489|NCT00165776|537310463|FG002|Overall Study|Withdrawal by Subject|2|||
148953490|NCT00165776|537310464|FG003|Overall Study|Withdrawal by Subject|0|||
148953491|NCT00165776|537310461|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
148953492|NCT00165776|537310462|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
148953493|NCT00165776|537310463|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
148953494|NCT00165776|537310464|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
148953495|NCT00434330|537310471|FG000|Overall Study|Adverse Event|0|||
149220140|NCT00723489|538272304|FG003|Overall Study|Physician Decision|0|||
149220141|NCT00723489|538272301|FG000|Overall Study|Pregnancy|0|||
149220142|NCT00723489|538272302|FG001|Overall Study|Pregnancy|0|||
149220143|NCT00723489|538272303|FG002|Overall Study|Pregnancy|0|||
149220144|NCT00723489|538272304|FG003|Overall Study|Pregnancy|1|||
149220145|NCT00723489|538272301|FG000|Overall Study|Withdrawal by Subject|0|||
149220146|NCT00723489|538272302|FG001|Overall Study|Withdrawal by Subject|0|||
149220147|NCT00723489|538272303|FG002|Overall Study|Withdrawal by Subject|0|||
149220148|NCT00723489|538272304|FG003|Overall Study|Withdrawal by Subject|1|||
149220149|NCT00723489|538272301|FG000|Overall Study|Seropositive at baseline|1|||
149220150|NCT00723489|538272302|FG001|Overall Study|Seropositive at baseline|0|||
149220151|NCT00723489|538272303|FG002|Overall Study|Seropositive at baseline|0|||
149220152|NCT00723489|538272304|FG003|Overall Study|Seropositive at baseline|0|||
149220153|NCT00723489|538272301|FG000|Overall Study|Prohibited Medication|0|||
149220154|NCT00723489|538272302|FG001|Overall Study|Prohibited Medication|0|||
149220155|NCT00723489|538272303|FG002|Overall Study|Prohibited Medication|0|||
149220156|NCT00723489|538272304|FG003|Overall Study|Prohibited Medication|1|||
149220157|NCT00723489|538272301|FG000|Overall Study|Samples Collected Out of Window|0|||
149220158|NCT00723489|538272302|FG001|Overall Study|Samples Collected Out of Window|3|||
149220159|NCT00723489|538272303|FG002|Overall Study|Samples Collected Out of Window|0|||
149220160|NCT00723489|538272304|FG003|Overall Study|Samples Collected Out of Window|0|||
149220161|NCT02274311|538272305|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
149220162|NCT03657576|538272306|FG000|Overall Study|Death|0|||
149220163|NCT03657576|538272307|FG001|Overall Study|Death|1|||
149220164|NCT03657576|538272308|FG002|Overall Study|Death|1|||
149220165|NCT03657576|538272309|FG003|Overall Study|Death|0|||
149220166|NCT03657576|538272310|FG004|Overall Study|Death|0|||
149220167|NCT03657576|538272311|FG005|Overall Study|Death|0|||
149220168|NCT03657576|538272306|FG000|Overall Study|Withdrawal by Subject|0|||
149220169|NCT03657576|538272307|FG001|Overall Study|Withdrawal by Subject|0|||
149220170|NCT03657576|538272308|FG002|Overall Study|Withdrawal by Subject|0|||
149220171|NCT03657576|538272309|FG003|Overall Study|Withdrawal by Subject|1|||
149220172|NCT03657576|538272310|FG004|Overall Study|Withdrawal by Subject|0|||
149220173|NCT03657576|538272311|FG005|Overall Study|Withdrawal by Subject|0|||
149220174|NCT03657576|538272306|FG000|Overall Study|Screen Fail|0|||
149220175|NCT03657576|538272307|FG001|Overall Study|Screen Fail|0|||
149220176|NCT03657576|538272308|FG002|Overall Study|Screen Fail|0|||
149220177|NCT03657576|538272309|FG003|Overall Study|Screen Fail|0|||
149220178|NCT03657576|538272310|FG004|Overall Study|Screen Fail|0|||
149220179|NCT03657576|538272311|FG005|Overall Study|Screen Fail|5|||
149220180|NCT03657576|538272306|FG000|Overall Study|Disease Progression|1|||
149220181|NCT03657576|538272307|FG001|Overall Study|Disease Progression|1|||
149220182|NCT03657576|538272308|FG002|Overall Study|Disease Progression|0|||
149220183|NCT03657576|538272309|FG003|Overall Study|Disease Progression|5|||
149220184|NCT03657576|538272310|FG004|Overall Study|Disease Progression|0|||
149220185|NCT03657576|538272311|FG005|Overall Study|Disease Progression|0|||
149220186|NCT03657576|538272306|FG000|Overall Study|Insurance Coverage|0|||
149220187|NCT03657576|538272307|FG001|Overall Study|Insurance Coverage|0|||
149220188|NCT03657576|538272308|FG002|Overall Study|Insurance Coverage|0|||
149220189|NCT03657576|538272309|FG003|Overall Study|Insurance Coverage|1|||
149220190|NCT03657576|538272310|FG004|Overall Study|Insurance Coverage|0|||
149220191|NCT03657576|538272311|FG005|Overall Study|Insurance Coverage|0|||
149220192|NCT05492877|538272312|FG000|Overall Study|Adverse Event|11|||
149220193|NCT05492877|538272313|FG001|Overall Study|Adverse Event|7|||
149220194|NCT05492877|538272312|FG000|Overall Study|Death|1|||
149220195|NCT05492877|538272313|FG001|Overall Study|Death|0|||
149220196|NCT05492877|538272312|FG000|Overall Study|Lost to Follow-up|1|||
149220197|NCT05492877|538272313|FG001|Overall Study|Lost to Follow-up|1|||
149220198|NCT05492877|538272312|FG000|Overall Study|Physician Decision|1|||
149220199|NCT05492877|538272313|FG001|Overall Study|Physician Decision|2|||
149220200|NCT05492877|538272312|FG000|Overall Study|Protocol Violation|1|||
149220201|NCT05492877|538272313|FG001|Overall Study|Protocol Violation|1|||
149220202|NCT05492877|538272312|FG000|Overall Study|Withdrawal by Subject|3|||
149220203|NCT05492877|538272313|FG001|Overall Study|Withdrawal by Subject|7|||
149220204|NCT05492877|538272312|FG000|Overall Study|Reason not specified|6|||
149220205|NCT05492877|538272313|FG001|Overall Study|Reason not specified|4|||
149220206|NCT01426009|538272314|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
149220207|NCT01426009|538272314|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
149220208|NCT01426009|538272314|FG000|Washout 1|Withdrawal by Subject|1|||
149220209|NCT01426009|538272314|FG000|Washout 1|Personal Reasons|1|||
149220210|NCT01426009|538272314|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
149220211|NCT01426009|538272314|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
149220212|NCT01426009|538272314|FG000|Washout 2|electrive surgery|1|||
149220213|NCT01426009|538272314|FG000|Washout 3|personal reasons|1|||
149220214|NCT01426009|538272314|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
149220215|NCT01426009|538272314|FG000|Washout 4|Lost to Follow-up|1|||
149220216|NCT00397631|538272323|FG000|Overall Study|Adverse Event|5|||
149220217|NCT00397631|538272324|FG001|Overall Study|Adverse Event|6|||
149220218|NCT00397631|538272323|FG000|Overall Study|Lack of Efficacy|7|||
149220219|NCT00397631|538272324|FG001|Overall Study|Lack of Efficacy|10|||
149220220|NCT00397631|538272323|FG000|Overall Study|Lost to Follow-up|8|||
149220221|NCT00397631|538272324|FG001|Overall Study|Lost to Follow-up|9|||
148685385|NCT03038113|536321460|FG009|Overall Study|Lost to Follow-up|0|||
149220222|NCT00397631|538272323|FG000|Overall Study|Physician Decision|2|||
149220223|NCT00397631|538272324|FG001|Overall Study|Physician Decision|0|||
149220224|NCT00397631|538272323|FG000|Overall Study|Protocol Violation|0|||
149220225|NCT00397631|538272324|FG001|Overall Study|Protocol Violation|1|||
149220226|NCT00397631|538272323|FG000|Overall Study|Withdrawal by Subject|7|||
149220227|NCT00397631|538272324|FG001|Overall Study|Withdrawal by Subject|14|||
149220228|NCT00397631|538272323|FG000|Overall Study|protocol discontinuation criteria|1|||
149220229|NCT00397631|538272324|FG001|Overall Study|protocol discontinuation criteria|4|||
149220230|NCT01878175|538272326|FG000|Overall Study|Developed contraindicated health problem|2|||
149220231|NCT01796106|538272327|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
149220232|NCT01796106|538272328|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
149220233|NCT04107935|538272329|FG000|Overall Study|Death|1|||
149220234|NCT04107935|538272330|FG001|Overall Study|Death|0|||
149220235|NCT02943668|538272332|FG000|Overall Study|Disease Progression|1|||
149220236|NCT02711553|538272336|FG000|Overall Study|Withdrawal by Subject|2|||
149220237|NCT02711553|538272337|FG001|Overall Study|Withdrawal by Subject|1|||
149220238|NCT02711553|538272338|FG002|Overall Study|Withdrawal by Subject|1|||
149220239|NCT02711553|538272339|FG003|Overall Study|Withdrawal by Subject|0|||
149220240|NCT02711553|538272336|FG000|Overall Study|Lost to Follow-up|3|||
149220241|NCT02711553|538272337|FG001|Overall Study|Lost to Follow-up|3|||
149220242|NCT02711553|538272338|FG002|Overall Study|Lost to Follow-up|6|||
149220243|NCT02711553|538272339|FG003|Overall Study|Lost to Follow-up|3|||
149220244|NCT02711553|538272336|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
149220245|NCT02711553|538272337|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
149220246|NCT02711553|538272338|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
149220247|NCT02711553|538272339|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
149220248|NCT00572728|538272342|FG000|Overall Study|Withdrawal by Subject|10|||
149220249|NCT00572728|538272342|FG000|Overall Study|Ineligible|3|||
149220250|NCT00572728|538272342|FG000|Overall Study|Enrolled under Amendment 4|5|||
149220251|NCT00572728|538272342|FG000|Overall Study|Offstudy due to complicating disease|1|||
149220252|NCT00572728|538272342|FG000|Overall Study|FLT1 not completed|4|||
149220253|NCT00572728|538272342|FG000|Overall Study|First Chemotherapy not initiated|2|||
149220254|NCT00572728|538272342|FG000|Overall Study|FLT2 not completed|5|||
149220255|NCT00572728|538272342|FG000|Overall Study|Second chemotherapy not initiated|1|||
149220256|NCT00572728|538272342|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
149220257|NCT00572728|538272342|FG000|Overall Study|Pathology missing|1|||
149220258|NCT03457636|538272345|FG000|Overall Study|Lost to Follow-up|2|||
149220259|NCT02724111|538272346|FG000|Overall Study|Protocol Violation|2|||
149220260|NCT02724111|538272347|FG001|Overall Study|Protocol Violation|5|||
149220261|NCT01828567|538272350|FG000|Overall Study|Lost to Follow-up|27|||
149220262|NCT01828567|538272351|FG001|Overall Study|Lost to Follow-up|9|||
149220263|NCT01828567|538272350|FG000|Overall Study|Excluded - did not meet criteria|4|||
149220264|NCT01828567|538272351|FG001|Overall Study|Excluded - did not meet criteria|1|||
149220265|NCT02332876|538272352|FG000|Overall Study|Lost to Follow-up|1|||
149220266|NCT02332876|538272353|FG001|Overall Study|Lost to Follow-up|1|||
149220267|NCT02415595|538272354|FG000|Overall Study|Administrative reason by sponsor|39|||
149220268|NCT02415595|538272355|FG001|Overall Study|Administrative reason by sponsor|40|||
149220269|NCT02415595|538272356|FG002|Overall Study|Administrative reason by sponsor|41|||
149220270|NCT02415595|538272357|FG003|Overall Study|Administrative reason by sponsor|39|||
149220271|NCT02415595|538272354|FG000|Overall Study|Adverse Event|1|||
149220272|NCT02415595|538272355|FG001|Overall Study|Adverse Event|3|||
149220273|NCT02415595|538272356|FG002|Overall Study|Adverse Event|5|||
149220274|NCT02415595|538272357|FG003|Overall Study|Adverse Event|10|||
149220275|NCT02415595|538272354|FG000|Overall Study|Lack of Efficacy|4|||
149220276|NCT02415595|538272355|FG001|Overall Study|Lack of Efficacy|4|||
149220277|NCT02415595|538272356|FG002|Overall Study|Lack of Efficacy|0|||
149220278|NCT02415595|538272357|FG003|Overall Study|Lack of Efficacy|0|||
149220279|NCT02415595|538272354|FG000|Overall Study|Lost to Follow-up|1|||
149220280|NCT02415595|538272355|FG001|Overall Study|Lost to Follow-up|3|||
149220281|NCT02415595|538272356|FG002|Overall Study|Lost to Follow-up|1|||
149220282|NCT02415595|538272357|FG003|Overall Study|Lost to Follow-up|1|||
149220283|NCT02415595|538272354|FG000|Overall Study|Poor/Non-compliance|1|||
149220284|NCT02415595|538272355|FG001|Overall Study|Poor/Non-compliance|0|||
149220285|NCT02415595|538272356|FG002|Overall Study|Poor/Non-compliance|1|||
149220286|NCT02415595|538272357|FG003|Overall Study|Poor/Non-compliance|0|||
149220287|NCT02415595|538272354|FG000|Overall Study|Reached stopping criteria|0|||
149220288|NCT02415595|538272355|FG001|Overall Study|Reached stopping criteria|1|||
149220289|NCT02415595|538272356|FG002|Overall Study|Reached stopping criteria|1|||
149220290|NCT02415595|538272357|FG003|Overall Study|Reached stopping criteria|0|||
149220291|NCT02415595|538272354|FG000|Overall Study|Withdrawal by Subject|4|||
149220292|NCT02415595|538272355|FG001|Overall Study|Withdrawal by Subject|0|||
149220293|NCT02415595|538272356|FG002|Overall Study|Withdrawal by Subject|1|||
149220294|NCT02415595|538272357|FG003|Overall Study|Withdrawal by Subject|3|||
149220295|NCT02415595|538272354|FG000|Overall Study|Other|0|||
149220296|NCT02415595|538272355|FG001|Overall Study|Other|1|||
149220297|NCT02415595|538272356|FG002|Overall Study|Other|1|||
149220298|NCT02415595|538272357|FG003|Overall Study|Other|0|||
149220299|NCT04063865|538272359|FG000|Overall Study|Physician Decision|1|||
149220300|NCT04063865|538272360|FG001|Overall Study|Physician Decision|3|||
149220301|NCT04063865|538272359|FG000|Overall Study|Study Closed Prior to Completion|4|||
149220302|NCT04063865|538272360|FG001|Overall Study|Study Closed Prior to Completion|4|||
149220303|NCT04063865|538272359|FG000|Overall Study|Withdrawal by Subject|1|||
149220304|NCT04063865|538272360|FG001|Overall Study|Withdrawal by Subject|1|||
149220305|NCT01700140|538272361|FG000|Overall Study|Use of rescue drugs|3|||
149220306|NCT01700140|538272362|FG001|Overall Study|Use of rescue drugs|3|||
149220307|NCT01700140|538272363|FG002|Overall Study|Use of rescue drugs|1|||
149220308|NCT01700140|538272361|FG000|Overall Study|Discontinuation of radiotherapy|1|||
148685386|NCT03038113|536321461|FG010|Overall Study|Lost to Follow-up|0|||
148685387|NCT03038113|536321462|FG011|Overall Study|Lost to Follow-up|0|||
148685388|NCT03038113|536321463|FG012|Overall Study|Lost to Follow-up|0|||
148685389|NCT03038113|536321464|FG013|Overall Study|Lost to Follow-up|0|||
148685390|NCT01755858|536321467|FG000|Overall Study|Adverse Event|1|||
148685391|NCT01755858|536321468|FG001|Overall Study|Adverse Event|1|||
148685392|NCT01809314|536321470|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
149017637|NCT02204293|537544980|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
149017638|NCT02204293|537544981|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
149017639|NCT02204293|537544982|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
149017640|NCT02204293|537544983|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
149017641|NCT02204293|537544978|FG000|Core Study Part I|Adverse Event|1|||
149017642|NCT02204293|537544979|FG001|Core Study Part I|Adverse Event|0|||
149017643|NCT02204293|537544980|FG002|Core Study Part I|Adverse Event|0|||
149017644|NCT02204293|537544981|FG003|Core Study Part I|Adverse Event|0|||
149017645|NCT02204293|537544982|FG004|Core Study Part I|Adverse Event|0|||
149017646|NCT02204293|537544983|FG005|Core Study Part I|Adverse Event|0|||
149017647|NCT02204293|537544978|FG000|Core Study Part I|Physician Decision|0|||
149017648|NCT02204293|537544979|FG001|Core Study Part I|Physician Decision|3|||
149017649|NCT02204293|537544980|FG002|Core Study Part I|Physician Decision|0|||
149017650|NCT02204293|537544981|FG003|Core Study Part I|Physician Decision|0|||
149017651|NCT02204293|537544982|FG004|Core Study Part I|Physician Decision|0|||
149017652|NCT02204293|537544983|FG005|Core Study Part I|Physician Decision|0|||
149017653|NCT02204293|537544978|FG000|LTE Phase|Study Suspended|0|||
149017654|NCT02204293|537544979|FG001|LTE Phase|Study Suspended|0|||
149017655|NCT02204293|537544980|FG002|LTE Phase|Study Suspended|0|||
149017656|NCT02204293|537544981|FG003|LTE Phase|Study Suspended|0|||
149017657|NCT02204293|537544982|FG004|LTE Phase|Study Suspended|0|||
149017658|NCT02204293|537544983|FG005|LTE Phase|Study Suspended|7|||
149017659|NCT01231503|537544984|FG000|Overall Study|Adverse Event|0|||
149017660|NCT01231503|537544985|FG001|Overall Study|Adverse Event|0|||
149017661|NCT01231503|537544986|FG002|Overall Study|Adverse Event|0|||
149017662|NCT01231503|537544987|FG003|Overall Study|Adverse Event|0|||
149017663|NCT01231503|537544988|FG004|Overall Study|Adverse Event|0|||
149017664|NCT01231503|537544989|FG005|Overall Study|Adverse Event|1|||
149017665|NCT01231503|537544990|FG006|Overall Study|Adverse Event|0|||
149017666|NCT01231503|537544991|FG007|Overall Study|Adverse Event|0|||
149017667|NCT01231503|537544984|FG000|Overall Study|Adverse event, serious fatal|0|||
149017668|NCT01231503|537544985|FG001|Overall Study|Adverse event, serious fatal|0|||
149017669|NCT01231503|537544986|FG002|Overall Study|Adverse event, serious fatal|1|||
149017670|NCT01231503|537544987|FG003|Overall Study|Adverse event, serious fatal|1|||
149017671|NCT01231503|537544988|FG004|Overall Study|Adverse event, serious fatal|0|||
149017672|NCT01231503|537544989|FG005|Overall Study|Adverse event, serious fatal|1|||
149017673|NCT01231503|537544990|FG006|Overall Study|Adverse event, serious fatal|0|||
149017674|NCT01231503|537544991|FG007|Overall Study|Adverse event, serious fatal|0|||
149017675|NCT01231503|537544984|FG000|Overall Study|Withdrawal by Subject|6|||
149017676|NCT01231503|537544985|FG001|Overall Study|Withdrawal by Subject|3|||
149017677|NCT01231503|537544986|FG002|Overall Study|Withdrawal by Subject|3|||
149017678|NCT01231503|537544987|FG003|Overall Study|Withdrawal by Subject|1|||
149017679|NCT01231503|537544988|FG004|Overall Study|Withdrawal by Subject|3|||
149017680|NCT01231503|537544989|FG005|Overall Study|Withdrawal by Subject|5|||
149017681|NCT01231503|537544990|FG006|Overall Study|Withdrawal by Subject|1|||
149017682|NCT01231503|537544991|FG007|Overall Study|Withdrawal by Subject|2|||
149017683|NCT01231503|537544984|FG000|Overall Study|Lost to Follow-up|8|||
149017684|NCT01231503|537544985|FG001|Overall Study|Lost to Follow-up|10|||
149017685|NCT01231503|537544986|FG002|Overall Study|Lost to Follow-up|8|||
149017686|NCT01231503|537544987|FG003|Overall Study|Lost to Follow-up|5|||
149017687|NCT01231503|537544988|FG004|Overall Study|Lost to Follow-up|7|||
149017688|NCT01231503|537544989|FG005|Overall Study|Lost to Follow-up|9|||
149017689|NCT01231503|537544990|FG006|Overall Study|Lost to Follow-up|6|||
149017690|NCT01231503|537544991|FG007|Overall Study|Lost to Follow-up|6|||
149017691|NCT01231503|537544984|FG000|Overall Study|Protocol Violation|0|||
149017692|NCT01231503|537544985|FG001|Overall Study|Protocol Violation|0|||
149017693|NCT01231503|537544986|FG002|Overall Study|Protocol Violation|0|||
149017694|NCT01231503|537544987|FG003|Overall Study|Protocol Violation|1|||
149017695|NCT01231503|537544988|FG004|Overall Study|Protocol Violation|0|||
149017696|NCT01231503|537544989|FG005|Overall Study|Protocol Violation|0|||
149017697|NCT01231503|537544990|FG006|Overall Study|Protocol Violation|0|||
148685393|NCT01809314|536321470|FG000|Overall Study|Adverse Event|6|||
148685394|NCT01809314|536321470|FG000|Overall Study|Insufficient Therapeutic Response|14|||
149017698|NCT01231503|537544991|FG007|Overall Study|Protocol Violation|0|||
149017699|NCT01146574|537544998|FG000|Overall Study|Death|0|||
149017700|NCT01146574|537544999|FG001|Overall Study|Death|1|||
149017701|NCT01146574|537545000|FG002|Overall Study|Death|1|||
149017702|NCT01146574|537545001|FG003|Overall Study|Death|0|||
149017703|NCT01146574|537545002|FG004|Overall Study|Death|0|||
149017704|NCT01146574|537545003|FG005|Overall Study|Death|0|||
149017705|NCT01146574|537545004|FG006|Overall Study|Death|0|||
149017706|NCT01146574|537544998|FG000|Overall Study|Other reasons|0|||
149220309|NCT01700140|538272362|FG001|Overall Study|Discontinuation of radiotherapy|0|||
149220310|NCT01700140|538272363|FG002|Overall Study|Discontinuation of radiotherapy|0|||
149220311|NCT01700140|538272361|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
149220312|NCT01700140|538272362|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
149220313|NCT01700140|538272363|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
149220314|NCT01700140|538272361|FG000|Overall Study|Aggravation of symptoms|1|||
149220315|NCT01700140|538272362|FG001|Overall Study|Aggravation of symptoms|0|||
149220316|NCT01700140|538272363|FG002|Overall Study|Aggravation of symptoms|0|||
149220317|NCT01700140|538272361|FG000|Overall Study|Adverse Event|0|||
149220318|NCT01700140|538272362|FG001|Overall Study|Adverse Event|1|||
149220319|NCT01700140|538272363|FG002|Overall Study|Adverse Event|0|||
149220320|NCT01700140|538272361|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
149220321|NCT01700140|538272362|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
149220322|NCT01700140|538272363|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
149220323|NCT01060124|538272364|FG000|Overall Study|Other|16|||
149220324|NCT01060124|538272364|FG000|Overall Study|Adverse Event|14|||
149220325|NCT01060124|538272364|FG000|Overall Study|Withdrawal by Subject|7|||
149220326|NCT01708915|538272365|FG000|Overall Study|Adverse Event|1|||
149220327|NCT01708915|538272366|FG001|Overall Study|Adverse Event|0|||
149220328|NCT01708915|538272367|FG002|Overall Study|Adverse Event|9|||
149220329|NCT01708915|538272368|FG003|Overall Study|Adverse Event|13|||
149220330|NCT01708915|538272365|FG000|Overall Study|Lack of Efficacy|84|||
149220331|NCT01708915|538272366|FG001|Overall Study|Lack of Efficacy|60|||
149220332|NCT01708915|538272367|FG002|Overall Study|Lack of Efficacy|35|||
149220333|NCT01708915|538272368|FG003|Overall Study|Lack of Efficacy|15|||
149220334|NCT01708915|538272365|FG000|Overall Study|Protocol Violation|0|||
149220335|NCT01708915|538272366|FG001|Overall Study|Protocol Violation|0|||
149220336|NCT01708915|538272367|FG002|Overall Study|Protocol Violation|0|||
149220337|NCT01708915|538272368|FG003|Overall Study|Protocol Violation|1|||
149220338|NCT01708915|538272365|FG000|Overall Study|Withdrawal by Subject|0|||
149220339|NCT01708915|538272366|FG001|Overall Study|Withdrawal by Subject|1|||
149220340|NCT01708915|538272367|FG002|Overall Study|Withdrawal by Subject|2|||
149220341|NCT01708915|538272368|FG003|Overall Study|Withdrawal by Subject|2|||
149017707|NCT01146574|537544999|FG001|Overall Study|Other reasons|0|||
149017708|NCT01146574|537545000|FG002|Overall Study|Other reasons|3|||
149017709|NCT01146574|537545001|FG003|Overall Study|Other reasons|0|||
149017710|NCT01146574|537545002|FG004|Overall Study|Other reasons|0|||
149017711|NCT01146574|537545003|FG005|Overall Study|Other reasons|0|||
149017712|NCT01146574|537545004|FG006|Overall Study|Other reasons|0|||
149017713|NCT01146574|537544998|FG000|Overall Study|Kidney transplant|0|||
149017714|NCT01146574|537544999|FG001|Overall Study|Kidney transplant|0|||
149017715|NCT01146574|537545000|FG002|Overall Study|Kidney transplant|1|||
149017716|NCT01146574|537545001|FG003|Overall Study|Kidney transplant|1|||
149017717|NCT01146574|537545002|FG004|Overall Study|Kidney transplant|0|||
149017718|NCT01146574|537545003|FG005|Overall Study|Kidney transplant|0|||
149017719|NCT01146574|537545004|FG006|Overall Study|Kidney transplant|0|||
149017720|NCT01146574|537544998|FG000|Overall Study|Withdrew consent|0|||
149017721|NCT01146574|537544999|FG001|Overall Study|Withdrew consent|0|||
149017722|NCT01146574|537545000|FG002|Overall Study|Withdrew consent|1|||
149017723|NCT01146574|537545001|FG003|Overall Study|Withdrew consent|1|||
149220342|NCT01708915|538272365|FG000|Overall Study|Other reasons than stated above|1|||
149220343|NCT01708915|538272366|FG001|Overall Study|Other reasons than stated above|1|||
149220344|NCT01708915|538272367|FG002|Overall Study|Other reasons than stated above|0|||
149220345|NCT01708915|538272368|FG003|Overall Study|Other reasons than stated above|2|||
149220346|NCT03231228|538272370|FG000|Overall Study|Lost to Follow-up|2|||
149220347|NCT03231228|538272371|FG001|Overall Study|Lost to Follow-up|0|||
149220348|NCT03231228|538272370|FG000|Overall Study|Physician Decision|1|||
149220349|NCT03231228|538272371|FG001|Overall Study|Physician Decision|0|||
149220350|NCT01222416|538272372|FG000|Overall Study|ineligible;metastasis|3|||
149017724|NCT01146574|537545002|FG004|Overall Study|Withdrew consent|2|||
149017725|NCT01146574|537545003|FG005|Overall Study|Withdrew consent|1|||
149220351|NCT01222416|538272373|FG001|Overall Study|ineligible;metastasis|0|||
149220352|NCT01222416|538272372|FG000|Overall Study|Adverse Event|4|||
149017726|NCT01146574|537545004|FG006|Overall Study|Withdrew consent|1|||
149017727|NCT01266993|537545005|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
149017728|NCT01266993|537545006|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
149220353|NCT01222416|538272373|FG001|Overall Study|Adverse Event|0|||
149220354|NCT01222416|538272372|FG000|Overall Study|Withdrawal by Subject|5|||
149220355|NCT01222416|538272373|FG001|Overall Study|Withdrawal by Subject|0|||
149220356|NCT01222416|538272372|FG000|Overall Study|scheduling|6|||
149220357|NCT01222416|538272373|FG001|Overall Study|scheduling|0|||
149220358|NCT01222416|538272372|FG000|Overall Study|missed view/scan|1|||
149220359|NCT01222416|538272373|FG001|Overall Study|missed view/scan|0|||
149220360|NCT01222416|538272372|FG000|Overall Study|Death|1|||
149220361|NCT01222416|538272373|FG001|Overall Study|Death|0|||
149220362|NCT00518336|538272376|FG000|Year 7|Lost to Follow-up|2|||
149220363|NCT00518336|538272377|FG001|Year 7|Lost to Follow-up|0|||
149220364|NCT00518336|538272376|FG000|Year 7|Could not attend in time|0|||
149220365|NCT00518336|538272377|FG001|Year 7|Could not attend in time|3|||
149220366|NCT00518336|538272376|FG000|Year 8|Lost to Follow-up|1|||
149220367|NCT00518336|538272377|FG001|Year 8|Lost to Follow-up|1|||
149220368|NCT00518336|538272376|FG000|Year 8|Could not attend in time|0|||
149220369|NCT00518336|538272377|FG001|Year 8|Could not attend in time|1|||
149220370|NCT00518336|538272376|FG000|Year 9|Migrated/moved from study area|1|||
149220371|NCT00518336|538272377|FG001|Year 9|Migrated/moved from study area|1|||
149220372|NCT00518336|538272376|FG000|Year 9|Lost to Follow-up|3|||
149220373|NCT00518336|538272377|FG001|Year 9|Lost to Follow-up|0|||
149220374|NCT00518336|538272376|FG000|Year 9|Personal reasons|1|||
149220375|NCT00518336|538272377|FG001|Year 9|Personal reasons|0|||
149220376|NCT01855919|538274896|FG000|Overall Study|Adverse Event|16|||
149220377|NCT01855919|538274897|FG001|Overall Study|Adverse Event|8|||
149220378|NCT01855919|538274896|FG000|Overall Study|Lack of Efficacy|1|||
149220379|NCT01855919|538274897|FG001|Overall Study|Lack of Efficacy|3|||
149220380|NCT01855919|538274896|FG000|Overall Study|Withdrawal by Subject|4|||
149220381|NCT01855919|538274897|FG001|Overall Study|Withdrawal by Subject|10|||
149220382|NCT01855919|538274896|FG000|Overall Study|Entry Criteria Not Met|1|||
149220383|NCT01855919|538274897|FG001|Overall Study|Entry Criteria Not Met|1|||
149220384|NCT01855919|538274896|FG000|Overall Study|Protocol Violation|1|||
149220385|NCT01855919|538274897|FG001|Overall Study|Protocol Violation|4|||
149220386|NCT03455530|538274898|FG000|Overall Study|Withdrawal by Subject|9|||
149220387|NCT03455530|538274899|FG001|Overall Study|Withdrawal by Subject|1|||
149220388|NCT03455530|538274900|FG002|Overall Study|Withdrawal by Subject|3|||
149220389|NCT03455530|538274901|FG003|Overall Study|Withdrawal by Subject|3|||
149220390|NCT00740116|538274910|FG000|Overall Study|Withdrawal by Subject|1|||
149220391|NCT00740116|538274911|FG001|Overall Study|Withdrawal by Subject|1|||
149220392|NCT00740116|538274910|FG000|Overall Study|Protocol Violation|1|||
149220393|NCT00740116|538274911|FG001|Overall Study|Protocol Violation|4|||
149220394|NCT03037489|538274912|FG000|Overall Study|Adverse Event|4|||
149220395|NCT03037489|538274913|FG001|Overall Study|Adverse Event|0|||
149220396|NCT03037489|538274912|FG000|Overall Study|Withdrawal by Subject|3|||
149220397|NCT03037489|538274913|FG001|Overall Study|Withdrawal by Subject|0|||
149220398|NCT00364611|538274914|FG000|Overall Study|Did not receive study medication|0|||
149220399|NCT00364611|538274915|FG001|Overall Study|Did not receive study medication|1|||
149220400|NCT00364611|538274914|FG000|Overall Study|Adverse Event|7|||
149220401|NCT00364611|538274915|FG001|Overall Study|Adverse Event|4|||
149220402|NCT00364611|538274914|FG000|Overall Study|Participant's Request|3|||
149220403|NCT00364611|538274915|FG001|Overall Study|Participant's Request|4|||
149220404|NCT00364611|538274914|FG000|Overall Study|Disease Progression|38|||
149220405|NCT00364611|538274915|FG001|Overall Study|Disease Progression|8|||
149220406|NCT00364611|538274914|FG000|Overall Study|Investigator decision|2|||
149220407|NCT00364611|538274915|FG001|Overall Study|Investigator decision|2|||
149220408|NCT00364611|538274914|FG000|Overall Study|Found Ineligible|1|||
149220409|NCT00364611|538274915|FG001|Overall Study|Found Ineligible|0|||
149220410|NCT00364611|538274914|FG000|Overall Study|Presumed CR on Study|0|||
149220411|NCT00364611|538274915|FG001|Overall Study|Presumed CR on Study|1|||
149220412|NCT00364611|538274914|FG000|Overall Study|Receiving Liver Ablation|0|||
149220413|NCT00364611|538274915|FG001|Overall Study|Receiving Liver Ablation|1|||
149220414|NCT04097925|538274928|FG000|Overall Study|Withdrawal by Subject|1|||
149220415|NCT02059174|538274931|FG000|Period 1|Withdrawal by Subject|0|||
149220416|NCT02059174|538274932|FG001|Period 1|Withdrawal by Subject|2|||
149220417|NCT02059174|538274931|FG000|Period 2|Withdrawal by Subject|0|||
149220418|NCT02059174|538274932|FG001|Period 2|Withdrawal by Subject|2|||
149220419|NCT02059174|538274931|FG000|Period 2|Protocol Violation|1|||
149220420|NCT02059174|538274932|FG001|Period 2|Protocol Violation|0|||
149220421|NCT02059174|538274931|FG000|Period 3|Physician Decision|1|||
149220422|NCT02059174|538274932|FG001|Period 3|Physician Decision|0|||
149220423|NCT02306148|538274933|FG000|Overall Study|Adverse Event|12|||
149220424|NCT02306148|538274934|FG001|Overall Study|Adverse Event|6|||
149220425|NCT02306148|538274933|FG000|Overall Study|Lost to Follow-up|1|||
149220426|NCT02306148|538274934|FG001|Overall Study|Lost to Follow-up|4|||
149220427|NCT04397757|538274935|FG000|Overall Study|Death|3|||
149220428|NCT04397757|538274936|FG001|Overall Study|Death|11|||
149220429|NCT04397757|538274935|FG000|Overall Study|Withdrawal by Subject|2|||
149220430|NCT04397757|538274936|FG001|Overall Study|Withdrawal by Subject|0|||
149220431|NCT04397757|538274935|FG000|Overall Study|Lost to Follow-up|4|||
149220432|NCT04397757|538274936|FG001|Overall Study|Lost to Follow-up|3|||
149220433|NCT04167514|538274943|FG000|Overall Study|Adverse event, not serious|0|||
149220434|NCT04167514|538274944|FG001|Overall Study|Adverse event, not serious|1|||
149220435|NCT04167514|538274943|FG000|Overall Study|Lost to Follow-up|1|||
149220436|NCT04167514|538274944|FG001|Overall Study|Lost to Follow-up|0|||
149017729|NCT01266993|537545005|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
149017730|NCT01266993|537545006|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
149017731|NCT03051659|537545007|FG000|Treatment Period|Withdrawal by Subject|0|||
149017732|NCT03051659|537545008|FG001|Treatment Period|Withdrawal by Subject|2|||
149017733|NCT03051659|537545007|FG000|Survival Follow-up|Lost to Follow-up|23|||
149017734|NCT03051659|537545008|FG001|Survival Follow-up|Lost to Follow-up|22|||
149017735|NCT01076088|537545009|FG000|Overall Study|Adverse Event|1|||
149017736|NCT01076088|537545010|FG001|Overall Study|Adverse Event|6|||
149017737|NCT01076088|537545011|FG002|Overall Study|Adverse Event|3|||
149220437|NCT04167514|538274943|FG000|Overall Study|Participant Decision|2|||
149220438|NCT04167514|538274944|FG001|Overall Study|Participant Decision|4|||
149220439|NCT04167514|538274943|FG000|Overall Study|Physician Decision|3|||
149220440|NCT04167514|538274944|FG001|Overall Study|Physician Decision|2|||
149220441|NCT04167514|538274943|FG000|Overall Study|Death|14|||
149220442|NCT04167514|538274944|FG001|Overall Study|Death|18|||
149220443|NCT04167514|538274943|FG000|Overall Study|Enrolled but treatment not administered|2|||
149220444|NCT04167514|538274944|FG001|Overall Study|Enrolled but treatment not administered|0|||
149220445|NCT04167514|538274943|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
149220446|NCT04167514|538274944|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
149220447|NCT04167514|538274943|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
149220448|NCT04167514|538274944|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
149017738|NCT01076088|537545012|FG003|Overall Study|Adverse Event|2|||
149017739|NCT01076088|537545013|FG004|Overall Study|Adverse Event|3|||
149017740|NCT01076088|537545014|FG005|Overall Study|Adverse Event|3|||
149017741|NCT01076088|537545009|FG000|Overall Study|Lost to Follow-up|1|||
149017742|NCT01076088|537545010|FG001|Overall Study|Lost to Follow-up|1|||
149017743|NCT01076088|537545011|FG002|Overall Study|Lost to Follow-up|0|||
149017744|NCT01076088|537545012|FG003|Overall Study|Lost to Follow-up|1|||
149017745|NCT01076088|537545013|FG004|Overall Study|Lost to Follow-up|1|||
149017746|NCT01076088|537545014|FG005|Overall Study|Lost to Follow-up|2|||
149017747|NCT01076088|537545009|FG000|Overall Study|Non-compliance with study drug|0|||
149017748|NCT01076088|537545010|FG001|Overall Study|Non-compliance with study drug|0|||
149017749|NCT01076088|537545011|FG002|Overall Study|Non-compliance with study drug|0|||
149017750|NCT01076088|537545012|FG003|Overall Study|Non-compliance with study drug|1|||
149017751|NCT01076088|537545013|FG004|Overall Study|Non-compliance with study drug|0|||
149017752|NCT01076088|537545014|FG005|Overall Study|Non-compliance with study drug|0|||
149017753|NCT01076088|537545009|FG000|Overall Study|Physician Decision|1|||
149017754|NCT01076088|537545010|FG001|Overall Study|Physician Decision|3|||
149017755|NCT01076088|537545011|FG002|Overall Study|Physician Decision|0|||
149017756|NCT01076088|537545012|FG003|Overall Study|Physician Decision|1|||
149017757|NCT01076088|537545013|FG004|Overall Study|Physician Decision|1|||
149017758|NCT01076088|537545014|FG005|Overall Study|Physician Decision|0|||
149220449|NCT00290355|538274945|FG000|Overall Study|Serious adverse event|7|||
149220450|NCT00290355|538274946|FG001|Overall Study|Serious adverse event|4|||
149220451|NCT00290355|538274945|FG000|Overall Study|Study product reactogenicity|1|||
149017759|NCT01076088|537545009|FG000|Overall Study|Withdrawal by Subject|8|||
149017760|NCT01076088|537545010|FG001|Overall Study|Withdrawal by Subject|8|||
149017761|NCT01076088|537545011|FG002|Overall Study|Withdrawal by Subject|14|||
149017762|NCT01076088|537545012|FG003|Overall Study|Withdrawal by Subject|10|||
149017763|NCT01076088|537545013|FG004|Overall Study|Withdrawal by Subject|11|||
149220452|NCT00290355|538274946|FG001|Overall Study|Study product reactogenicity|0|||
149220453|NCT00290355|538274945|FG000|Overall Study|Protocol Violation|1|||
149220454|NCT00290355|538274946|FG001|Overall Study|Protocol Violation|0|||
149220455|NCT00290355|538274945|FG000|Overall Study|Withdrawal by Subject|2|||
149220456|NCT00290355|538274946|FG001|Overall Study|Withdrawal by Subject|0|||
149220457|NCT00290355|538274945|FG000|Overall Study|Migrated / moved from the study area|1|||
149220458|NCT00290355|538274946|FG001|Overall Study|Migrated / moved from the study area|0|||
149220459|NCT00290355|538274945|FG000|Overall Study|Lost to Follow-up|3|||
149220460|NCT00290355|538274946|FG001|Overall Study|Lost to Follow-up|1|||
149220461|NCT00290355|538274945|FG000|Overall Study|Other|2|||
149220462|NCT00290355|538274946|FG001|Overall Study|Other|0|||
149220463|NCT03345849|538274947|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
149220464|NCT03345849|538274948|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
149017764|NCT01076088|537545014|FG005|Overall Study|Withdrawal by Subject|17|||
149017765|NCT01076088|537545009|FG000|Overall Study|Other protocol specified criteria|0|||
149017766|NCT01076088|537545010|FG001|Overall Study|Other protocol specified criteria|0|||
149017767|NCT01076088|537545011|FG002|Overall Study|Other protocol specified criteria|0|||
149017768|NCT01076088|537545012|FG003|Overall Study|Other protocol specified criteria|0|||
149220465|NCT03345849|538274949|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
149220466|NCT03345849|538274950|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
149220467|NCT03345849|538274947|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
149220468|NCT03345849|538274948|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
149220469|NCT03345849|538274949|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
149220470|NCT03345849|538274950|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
149220471|NCT03345849|538274947|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
149220472|NCT03345849|538274948|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
149220473|NCT03345849|538274949|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
149220474|NCT03345849|538274950|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
149220475|NCT03345849|538274947|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
149220476|NCT03345849|538274948|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
149220477|NCT03345849|538274949|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
149220478|NCT03345849|538274950|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
149220479|NCT03345849|538274947|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
149220480|NCT03345849|538274948|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
149220481|NCT03345849|538274949|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
149220482|NCT03345849|538274950|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
149220483|NCT03345849|538274947|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
149220484|NCT03345849|538274948|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
149220485|NCT03345849|538274949|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
149220486|NCT03345849|538274950|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
149220487|NCT03345849|538274947|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
149220488|NCT03345849|538274948|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
149220489|NCT03345849|538274949|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
149220490|NCT03345849|538274950|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
149220491|NCT03345849|538274947|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
149220492|NCT03345849|538274948|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
149220493|NCT03345849|538274949|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
149220494|NCT03345849|538274950|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
149220495|NCT03345849|538274947|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
149220496|NCT03345849|538274948|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
149220497|NCT03345849|538274949|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
149220498|NCT03345849|538274950|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
149220499|NCT03345849|538274947|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
149220500|NCT03345849|538274948|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
149220501|NCT03345849|538274949|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
149220502|NCT03345849|538274950|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
149220503|NCT03345849|538274947|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
149220504|NCT03345849|538274948|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
149220505|NCT03345849|538274949|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
149220506|NCT03345849|538274950|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
149220507|NCT00033514|538274951|FG000|Overall Study|Lost to Follow-up|1|||
149220508|NCT00033514|538274952|FG001|Overall Study|Lost to Follow-up|1|||
149220509|NCT00033514|538274951|FG000|Overall Study|Withdrawal by Subject|0|||
149220510|NCT00033514|538274952|FG001|Overall Study|Withdrawal by Subject|3|||
149220511|NCT01599585|538274962|FG000|Overall Study|Withdrawal by Subject|16|||
149220512|NCT01599585|538274963|FG001|Overall Study|Withdrawal by Subject|9|||
149220513|NCT01599585|538274962|FG000|Overall Study|Lost to Follow-up|3|||
149220514|NCT01599585|538274963|FG001|Overall Study|Lost to Follow-up|5|||
149220515|NCT01599585|538274962|FG000|Overall Study|randomized did not start treatment|3|||
149220516|NCT01599585|538274963|FG001|Overall Study|randomized did not start treatment|3|||
149220517|NCT04564027|538274964|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
149220518|NCT04564027|538274965|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
149220519|NCT04564027|538274966|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
149220520|NCT04564027|538274967|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
149220521|NCT00777036|538274968|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
149220522|NCT00777036|538274969|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
149220523|NCT00777036|538274970|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
149220524|NCT00777036|538274971|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
149220525|NCT00777036|538274968|FG000|On Treatment|Administrative Reason By Sponsor|1|||
148809951|NCT04530344|536780922|FG000|Overall Study|Withdrawal by Subject|14|||
149220526|NCT00777036|538274969|FG001|On Treatment|Administrative Reason By Sponsor|0|||
149220527|NCT00777036|538274970|FG002|On Treatment|Administrative Reason By Sponsor|9|||
149220528|NCT00777036|538274971|FG003|On Treatment|Administrative Reason By Sponsor|0|||
149220529|NCT00777036|538274968|FG000|On Treatment|Failure to Meet Study Criteria|0|||
149220530|NCT00777036|538274969|FG001|On Treatment|Failure to Meet Study Criteria|1|||
149220531|NCT00777036|538274970|FG002|On Treatment|Failure to Meet Study Criteria|4|||
149220532|NCT00777036|538274971|FG003|On Treatment|Failure to Meet Study Criteria|0|||
149220533|NCT00777036|538274968|FG000|On Treatment|Pregnancy|1|||
149220534|NCT00777036|538274969|FG001|On Treatment|Pregnancy|0|||
149220535|NCT00777036|538274970|FG002|On Treatment|Pregnancy|1|||
149220536|NCT00777036|538274971|FG003|On Treatment|Pregnancy|0|||
149220537|NCT00777036|538274968|FG000|On Treatment|Non-compliance with Study Drug|1|||
149220538|NCT00777036|538274969|FG001|On Treatment|Non-compliance with Study Drug|0|||
149220539|NCT00777036|538274970|FG002|On Treatment|Non-compliance with Study Drug|1|||
149220540|NCT00777036|538274971|FG003|On Treatment|Non-compliance with Study Drug|0|||
149220541|NCT00777036|538274968|FG000|On Treatment|Maximum Clinical Benefit|2|||
149220542|NCT00777036|538274969|FG001|On Treatment|Maximum Clinical Benefit|0|||
149220543|NCT00777036|538274970|FG002|On Treatment|Maximum Clinical Benefit|5|||
149220544|NCT00777036|538274971|FG003|On Treatment|Maximum Clinical Benefit|0|||
149220545|NCT00777036|538274968|FG000|On Treatment|Withdrawal by Subject|0|||
149220546|NCT00777036|538274969|FG001|On Treatment|Withdrawal by Subject|2|||
149220547|NCT00777036|538274970|FG002|On Treatment|Withdrawal by Subject|2|||
149220548|NCT00777036|538274971|FG003|On Treatment|Withdrawal by Subject|0|||
149220549|NCT00777036|538274968|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
149220550|NCT00777036|538274969|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
149220551|NCT00777036|538274970|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
149220552|NCT00777036|538274971|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
149220553|NCT00777036|538274968|FG000|On Treatment|Death|0|||
149220554|NCT00777036|538274969|FG001|On Treatment|Death|2|||
149220555|NCT00777036|538274970|FG002|On Treatment|Death|0|||
149220556|NCT00777036|538274971|FG003|On Treatment|Death|0|||
149220557|NCT00777036|538274968|FG000|On Treatment|Study Drug Toxicity|1|||
149220558|NCT00777036|538274969|FG001|On Treatment|Study Drug Toxicity|0|||
149220559|NCT00777036|538274970|FG002|On Treatment|Study Drug Toxicity|4|||
149220560|NCT00777036|538274971|FG003|On Treatment|Study Drug Toxicity|0|||
149220561|NCT00777036|538274968|FG000|On Treatment|Progressive Disease|6|||
149220562|NCT00777036|538274969|FG001|On Treatment|Progressive Disease|4|||
149220563|NCT00777036|538274970|FG002|On Treatment|Progressive Disease|7|||
149220564|NCT00777036|538274971|FG003|On Treatment|Progressive Disease|0|||
149220565|NCT00777036|538274968|FG000|On Treatment|Not Reported|0|||
149220566|NCT00777036|538274969|FG001|On Treatment|Not Reported|0|||
149220567|NCT00777036|538274970|FG002|On Treatment|Not Reported|2|||
149220568|NCT00777036|538274971|FG003|On Treatment|Not Reported|0|||
149220569|NCT00777036|538274968|FG000|On Treatment|Site Closed|0|||
149220570|NCT00777036|538274969|FG001|On Treatment|Site Closed|1|||
149220571|NCT00777036|538274970|FG002|On Treatment|Site Closed|1|||
149220572|NCT00777036|538274971|FG003|On Treatment|Site Closed|0|||
149220573|NCT00777036|538274968|FG000|Follow-Up|Withdrawal by Subject|0|||
149220574|NCT00777036|538274969|FG001|Follow-Up|Withdrawal by Subject|0|||
149220575|NCT00777036|538274970|FG002|Follow-Up|Withdrawal by Subject|5|||
149220576|NCT00777036|538274971|FG003|Follow-Up|Withdrawal by Subject|0|||
149220577|NCT00777036|538274968|FG000|Follow-Up|Death|1|||
149220578|NCT00777036|538274969|FG001|Follow-Up|Death|9|||
149220579|NCT00777036|538274970|FG002|Follow-Up|Death|0|||
149220580|NCT00777036|538274971|FG003|Follow-Up|Death|0|||
149220581|NCT00777036|538274968|FG000|Follow-Up|Lost to Follow-up|3|||
149220582|NCT00777036|538274969|FG001|Follow-Up|Lost to Follow-up|0|||
149220583|NCT00777036|538274970|FG002|Follow-Up|Lost to Follow-up|0|||
149220584|NCT00777036|538274971|FG003|Follow-Up|Lost to Follow-up|0|||
149220585|NCT00777036|538274968|FG000|Follow-Up|Reason Not Specified|4|||
149220586|NCT00777036|538274969|FG001|Follow-Up|Reason Not Specified|0|||
149220587|NCT00777036|538274970|FG002|Follow-Up|Reason Not Specified|13|||
149220588|NCT00777036|538274971|FG003|Follow-Up|Reason Not Specified|0|||
149220589|NCT00777036|538274968|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
149220590|NCT00777036|538274969|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
149220591|NCT00777036|538274970|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
149220592|NCT00777036|538274971|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
149220593|NCT05827978|538274974|FG000|Overall Study|Adverse Event|1|||
149220594|NCT05827978|538274975|FG001|Overall Study|Adverse Event|0|||
149220595|NCT05827978|538274976|FG002|Overall Study|Adverse Event|0|||
148685395|NCT01809314|536321470|FG000|Overall Study|Lost to Follow-up|724|||
148685396|NCT03412019|536321471|FG000|Overall Study|Withdrawal by Subject|1|||
148685397|NCT03412019|536321472|FG001|Overall Study|Withdrawal by Subject|1|||
148685398|NCT01698320|536321477|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
148685399|NCT01698320|536321478|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
148685400|NCT01698320|536321479|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
149220596|NCT05827978|538274977|FG003|Overall Study|Adverse Event|1|||
149220597|NCT05827978|538274978|FG004|Overall Study|Adverse Event|0|||
149220598|NCT05827978|538274979|FG005|Overall Study|Adverse Event|0|||
149220599|NCT05827978|538274974|FG000|Overall Study|Death|1|||
149220600|NCT05827978|538274975|FG001|Overall Study|Death|5|||
149220601|NCT05827978|538274976|FG002|Overall Study|Death|2|||
149220602|NCT05827978|538274977|FG003|Overall Study|Death|3|||
149220603|NCT05827978|538274978|FG004|Overall Study|Death|1|||
149220604|NCT05827978|538274979|FG005|Overall Study|Death|3|||
149220605|NCT05827978|538274974|FG000|Overall Study|Lost to Follow-up|57|||
149220606|NCT05827978|538274975|FG001|Overall Study|Lost to Follow-up|88|||
149220607|NCT05827978|538274976|FG002|Overall Study|Lost to Follow-up|54|||
149220608|NCT05827978|538274977|FG003|Overall Study|Lost to Follow-up|47|||
149220609|NCT05827978|538274978|FG004|Overall Study|Lost to Follow-up|25|||
149220610|NCT05827978|538274979|FG005|Overall Study|Lost to Follow-up|10|||
149220611|NCT05827978|538274974|FG000|Overall Study|Noncompliance with Study Procedures|0|||
149220612|NCT05827978|538274975|FG001|Overall Study|Noncompliance with Study Procedures|1|||
149220613|NCT05827978|538274976|FG002|Overall Study|Noncompliance with Study Procedures|1|||
149220614|NCT05827978|538274977|FG003|Overall Study|Noncompliance with Study Procedures|1|||
149220615|NCT05827978|538274978|FG004|Overall Study|Noncompliance with Study Procedures|1|||
149220616|NCT05827978|538274979|FG005|Overall Study|Noncompliance with Study Procedures|0|||
149220617|NCT05827978|538274974|FG000|Overall Study|Physician Decision|2|||
149220618|NCT05827978|538274975|FG001|Overall Study|Physician Decision|0|||
149220619|NCT05827978|538274976|FG002|Overall Study|Physician Decision|1|||
149220620|NCT05827978|538274977|FG003|Overall Study|Physician Decision|2|||
149220621|NCT05827978|538274978|FG004|Overall Study|Physician Decision|1|||
149220622|NCT05827978|538274979|FG005|Overall Study|Physician Decision|1|||
149220623|NCT05827978|538274974|FG000|Overall Study|Protocol Violation|5|||
149220624|NCT05827978|538274975|FG001|Overall Study|Protocol Violation|2|||
149220625|NCT05827978|538274976|FG002|Overall Study|Protocol Violation|0|||
149220626|NCT05827978|538274977|FG003|Overall Study|Protocol Violation|0|||
149220627|NCT05827978|538274978|FG004|Overall Study|Protocol Violation|0|||
149220628|NCT05827978|538274979|FG005|Overall Study|Protocol Violation|0|||
149220629|NCT05827978|538274974|FG000|Overall Study|Withdrawal by Subject|17|||
149220630|NCT05827978|538274975|FG001|Overall Study|Withdrawal by Subject|16|||
149220631|NCT05827978|538274976|FG002|Overall Study|Withdrawal by Subject|10|||
149220632|NCT05827978|538274977|FG003|Overall Study|Withdrawal by Subject|12|||
149220633|NCT05827978|538274978|FG004|Overall Study|Withdrawal by Subject|10|||
149220634|NCT05827978|538274979|FG005|Overall Study|Withdrawal by Subject|9|||
149220635|NCT05827978|538274974|FG000|Overall Study|Other Than Specified|0|||
149220636|NCT05827978|538274975|FG001|Overall Study|Other Than Specified|0|||
149220637|NCT05827978|538274976|FG002|Overall Study|Other Than Specified|1|||
149220638|NCT05827978|538274977|FG003|Overall Study|Other Than Specified|0|||
149220639|NCT05827978|538274978|FG004|Overall Study|Other Than Specified|2|||
149220640|NCT05827978|538274979|FG005|Overall Study|Other Than Specified|0|||
149220641|NCT05564039|538274980|FG000|Overall Study|Adverse Event|1|||
149220642|NCT05564039|538274981|FG001|Overall Study|Adverse Event|0|||
149220643|NCT05564039|538274980|FG000|Overall Study|Death|1|||
149220644|NCT05564039|538274981|FG001|Overall Study|Death|1|||
149220645|NCT05564039|538274980|FG000|Overall Study|Lost to Follow-up|3|||
149220646|NCT05564039|538274981|FG001|Overall Study|Lost to Follow-up|2|||
149220647|NCT05564039|538274980|FG000|Overall Study|Withdrawal by Subject|2|||
149220648|NCT05564039|538274981|FG001|Overall Study|Withdrawal by Subject|0|||
149220649|NCT05564039|538274980|FG000|Overall Study|Inadvertent enrollment|3|||
148685401|NCT01698320|536321477|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
148685402|NCT01698320|536321478|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
149220650|NCT05564039|538274981|FG001|Overall Study|Inadvertent enrollment|6|||
149220651|NCT04566445|538274982|FG000|Overall Study|Death|4|||
149220652|NCT04566445|538274983|FG001|Overall Study|Death|1|||
149220653|NCT04566445|538274984|FG002|Overall Study|Death|1|||
149220654|NCT04566445|538274982|FG000|Overall Study|Lost to Follow-up|3|||
149220655|NCT04566445|538274983|FG001|Overall Study|Lost to Follow-up|1|||
148685403|NCT01698320|536321479|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
148685404|NCT01698320|536321477|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
148685405|NCT01698320|536321478|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
148685406|NCT01698320|536321479|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
149220656|NCT04566445|538274984|FG002|Overall Study|Lost to Follow-up|1|||
149220657|NCT04566445|538274982|FG000|Overall Study|Study terminated by sponsor|11|||
149220658|NCT04566445|538274983|FG001|Overall Study|Study terminated by sponsor|17|||
149220659|NCT04566445|538274984|FG002|Overall Study|Study terminated by sponsor|32|||
149220660|NCT04566445|538274982|FG000|Overall Study|Withdrawal by Subject|12|||
149220661|NCT04566445|538274983|FG001|Overall Study|Withdrawal by Subject|14|||
149220662|NCT04566445|538274984|FG002|Overall Study|Withdrawal by Subject|13|||
149220663|NCT04566445|538274982|FG000|Overall Study|Randomized but not treated due to AE|2|||
149220664|NCT04566445|538274983|FG001|Overall Study|Randomized but not treated due to AE|1|||
149220665|NCT04566445|538274984|FG002|Overall Study|Randomized but not treated due to AE|0|||
149220666|NCT04566445|538274982|FG000|Overall Study|Adverse Event|1|||
149220667|NCT04566445|538274983|FG001|Overall Study|Adverse Event|1|||
149220668|NCT04566445|538274984|FG002|Overall Study|Adverse Event|0|||
149220669|NCT04785144|538274985|FG000|Overall Study|Withdrawal by Subject|4|||
149220670|NCT04785144|538274986|FG001|Overall Study|Withdrawal by Subject|1|||
149220671|NCT04785144|538274987|FG002|Overall Study|Withdrawal by Subject|0|||
149220672|NCT04785144|538274988|FG003|Overall Study|Withdrawal by Subject|0|||
149220673|NCT04785144|538274989|FG004|Overall Study|Withdrawal by Subject|0|||
149220674|NCT04785144|538274990|FG005|Overall Study|Withdrawal by Subject|2|||
149220675|NCT04785144|538274991|FG006|Overall Study|Withdrawal by Subject|2|||
149220676|NCT04785144|538274992|FG007|Overall Study|Withdrawal by Subject|0|||
149220677|NCT04785144|538274993|FG008|Overall Study|Withdrawal by Subject|1|||
149220678|NCT04785144|538274994|FG009|Overall Study|Withdrawal by Subject|0|||
149220679|NCT04785144|538274985|FG000|Overall Study|Lost to Follow-up|1|||
149220680|NCT04785144|538274986|FG001|Overall Study|Lost to Follow-up|0|||
149220681|NCT04785144|538274987|FG002|Overall Study|Lost to Follow-up|0|||
149220682|NCT04785144|538274988|FG003|Overall Study|Lost to Follow-up|0|||
149220683|NCT04785144|538274989|FG004|Overall Study|Lost to Follow-up|1|||
149220684|NCT04785144|538274990|FG005|Overall Study|Lost to Follow-up|2|||
149220685|NCT04785144|538274991|FG006|Overall Study|Lost to Follow-up|1|||
149220686|NCT04785144|538274992|FG007|Overall Study|Lost to Follow-up|2|||
149220687|NCT04785144|538274993|FG008|Overall Study|Lost to Follow-up|4|||
149220688|NCT04785144|538274994|FG009|Overall Study|Lost to Follow-up|1|||
149220689|NCT04785144|538274985|FG000|Overall Study|Protocol Violation|0|||
149220690|NCT04785144|538274986|FG001|Overall Study|Protocol Violation|0|||
149220691|NCT04785144|538274987|FG002|Overall Study|Protocol Violation|0|||
149220692|NCT04785144|538274988|FG003|Overall Study|Protocol Violation|0|||
149220693|NCT04785144|538274989|FG004|Overall Study|Protocol Violation|0|||
149220694|NCT04785144|538274990|FG005|Overall Study|Protocol Violation|0|||
149220695|NCT04785144|538274991|FG006|Overall Study|Protocol Violation|1|||
149220696|NCT04785144|538274992|FG007|Overall Study|Protocol Violation|0|||
149220697|NCT04785144|538274993|FG008|Overall Study|Protocol Violation|0|||
149220698|NCT04785144|538274994|FG009|Overall Study|Protocol Violation|0|||
149220699|NCT04785144|538274985|FG000|Overall Study|Physician Decision|0|||
149220700|NCT04785144|538274986|FG001|Overall Study|Physician Decision|0|||
149220701|NCT04785144|538274987|FG002|Overall Study|Physician Decision|0|||
149220702|NCT04785144|538274988|FG003|Overall Study|Physician Decision|0|||
149220703|NCT04785144|538274989|FG004|Overall Study|Physician Decision|0|||
149220704|NCT04785144|538274990|FG005|Overall Study|Physician Decision|0|||
149220705|NCT04785144|538274991|FG006|Overall Study|Physician Decision|0|||
149220706|NCT04785144|538274992|FG007|Overall Study|Physician Decision|0|||
149220707|NCT04785144|538274993|FG008|Overall Study|Physician Decision|0|||
149220708|NCT04785144|538274994|FG009|Overall Study|Physician Decision|1|||
149220709|NCT04785144|538274985|FG000|Overall Study|Unable to continue due to work schedule|0|||
149220710|NCT04785144|538274986|FG001|Overall Study|Unable to continue due to work schedule|0|||
149220711|NCT04785144|538274987|FG002|Overall Study|Unable to continue due to work schedule|0|||
149220712|NCT04785144|538274988|FG003|Overall Study|Unable to continue due to work schedule|0|||
149220713|NCT04785144|538274989|FG004|Overall Study|Unable to continue due to work schedule|0|||
149220714|NCT04785144|538274990|FG005|Overall Study|Unable to continue due to work schedule|0|||
149220715|NCT04785144|538274991|FG006|Overall Study|Unable to continue due to work schedule|0|||
149220716|NCT04785144|538274992|FG007|Overall Study|Unable to continue due to work schedule|0|||
149220717|NCT04785144|538274993|FG008|Overall Study|Unable to continue due to work schedule|0|||
149220718|NCT04785144|538274994|FG009|Overall Study|Unable to continue due to work schedule|1|||
149220719|NCT00610714|538274997|FG000|Overall Study|Adverse Event|3|||
149220720|NCT00610714|538274998|FG001|Overall Study|Adverse Event|1|||
149220721|NCT00610714|538274997|FG000|Overall Study|Death|12|||
149220722|NCT00610714|538274998|FG001|Overall Study|Death|18|||
149220723|NCT00610714|538274997|FG000|Overall Study|Withdrawal by Subject|9|||
149220724|NCT00610714|538274998|FG001|Overall Study|Withdrawal by Subject|3|||
149220725|NCT00610714|538274997|FG000|Overall Study|Study completion at 120 PFS events|2|||
149220726|NCT00610714|538274998|FG001|Overall Study|Study completion at 120 PFS events|2|||
149220727|NCT00829010|538274999|FG000|Overall Study|Adverse Event|1|||
149220728|NCT00829010|538275000|FG001|Overall Study|Adverse Event|0|||
148953496|NCT00434330|537310472|FG001|Overall Study|Adverse Event|0|||
149220729|NCT00829010|538275001|FG002|Overall Study|Adverse Event|0|||
149220730|NCT00829010|538275002|FG003|Overall Study|Adverse Event|0|||
149220731|NCT00829010|538275003|FG004|Overall Study|Adverse Event|0|||
149220732|NCT00829010|538274999|FG000|Overall Study|Withdrawal by Subject|0|||
149220733|NCT00829010|538275000|FG001|Overall Study|Withdrawal by Subject|1|||
149220734|NCT00829010|538275001|FG002|Overall Study|Withdrawal by Subject|1|||
149220735|NCT00829010|538275002|FG003|Overall Study|Withdrawal by Subject|0|||
149220736|NCT00829010|538275003|FG004|Overall Study|Withdrawal by Subject|2|||
149220737|NCT00829010|538274999|FG000|Overall Study|Lost to Follow-up|1|||
149220738|NCT00829010|538275000|FG001|Overall Study|Lost to Follow-up|0|||
149220739|NCT00829010|538275001|FG002|Overall Study|Lost to Follow-up|2|||
149220740|NCT00829010|538275002|FG003|Overall Study|Lost to Follow-up|0|||
149220741|NCT00829010|538275003|FG004|Overall Study|Lost to Follow-up|0|||
149220742|NCT00829010|538274999|FG000|Overall Study|Fatality|5|||
149220743|NCT00829010|538275000|FG001|Overall Study|Fatality|4|||
149220744|NCT00829010|538275001|FG002|Overall Study|Fatality|0|||
149220745|NCT00829010|538275002|FG003|Overall Study|Fatality|3|||
149220746|NCT00829010|538275003|FG004|Overall Study|Fatality|0|||
149220747|NCT00829010|538274999|FG000|Overall Study|Migrated/Moved from study area|3|||
149220748|NCT00829010|538275000|FG001|Overall Study|Migrated/Moved from study area|4|||
149220749|NCT00829010|538275001|FG002|Overall Study|Migrated/Moved from study area|0|||
149220750|NCT00829010|538275002|FG003|Overall Study|Migrated/Moved from study area|5|||
149220751|NCT00829010|538275003|FG004|Overall Study|Migrated/Moved from study area|0|||
149220752|NCT00137267|538275006|FG000|Overall Study|Lost to Follow-up|15|||
149220753|NCT00137267|538275007|FG001|Overall Study|Lost to Follow-up|21|||
149220754|NCT00638989|538275008|FG000|Overall Study|Lost to Follow-up|0|||
149220755|NCT00638989|538275009|FG001|Overall Study|Lost to Follow-up|0|||
149220756|NCT00638989|538275010|FG002|Overall Study|Lost to Follow-up|1|||
149220757|NCT00853112|538275013|FG000|Overall Study|Randomized but not treated|0|||
149220758|NCT00853112|538275014|FG001|Overall Study|Randomized but not treated|1|||
149220759|NCT00853112|538275015|FG002|Overall Study|Randomized but not treated|0|||
149220760|NCT00853112|538275016|FG003|Overall Study|Randomized but not treated|2|||
149220761|NCT00853112|538275017|FG004|Overall Study|Randomized but not treated|0|||
149220762|NCT00853112|538275018|FG005|Overall Study|Randomized but not treated|0|||
149220763|NCT00853112|538275019|FG006|Overall Study|Randomized but not treated|1|||
149220764|NCT01553591|538275020|FG000|Overall Study|Voluntarily withdrew|94|||
149220765|NCT01553591|538275021|FG001|Overall Study|Voluntarily withdrew|79|||
149220766|NCT01553591|538275022|FG002|Overall Study|Voluntarily withdrew|96|||
149220767|NCT01553591|538275020|FG000|Overall Study|Adverse Event|36|||
149220768|NCT01553591|538275021|FG001|Overall Study|Adverse Event|45|||
149220769|NCT01553591|538275022|FG002|Overall Study|Adverse Event|16|||
149220770|NCT01553591|538275020|FG000|Overall Study|Lost to Follow-up|25|||
149220771|NCT01553591|538275021|FG001|Overall Study|Lost to Follow-up|23|||
149220772|NCT01553591|538275022|FG002|Overall Study|Lost to Follow-up|16|||
149220773|NCT01553591|538275020|FG000|Overall Study|Physician decision: other|11|||
149220774|NCT01553591|538275021|FG001|Overall Study|Physician decision: other|14|||
149220775|NCT01553591|538275022|FG002|Overall Study|Physician decision: other|16|||
149220776|NCT01553591|538275020|FG000|Overall Study|Physician decision: lack of efficacy|2|||
149017769|NCT01076088|537545013|FG004|Overall Study|Other protocol specified criteria|0|||
149017770|NCT01076088|537545014|FG005|Overall Study|Other protocol specified criteria|1|||
149017771|NCT03053492|537545019|FG000|Overall Study|Adverse Event|1|||
149017772|NCT03053492|537545020|FG001|Overall Study|Adverse Event|1|||
149017773|NCT03053492|537545019|FG000|Overall Study|Withdrawal by Subject|7|||
149017774|NCT03053492|537545020|FG001|Overall Study|Withdrawal by Subject|5|||
149017775|NCT02269943|537545021|FG000|Treatment Period|Death|0|||
149017776|NCT02269943|537545022|FG001|Treatment Period|Death|1|||
149017777|NCT02269943|537545021|FG000|Treatment Period|Adverse Event|1|||
149017778|NCT02269943|537545022|FG001|Treatment Period|Adverse Event|10|||
149017779|NCT02269943|537545021|FG000|Treatment Period|Progressive Disease|5|||
149017780|NCT02269943|537545022|FG001|Treatment Period|Progressive Disease|17|||
149017781|NCT02269943|537545021|FG000|Treatment Period|Symptomatic Deterioration|0|||
149017782|NCT02269943|537545022|FG001|Treatment Period|Symptomatic Deterioration|2|||
149017783|NCT02269943|537545021|FG000|Follow-Up Survival Period|Death|3|||
149017784|NCT02269943|537545022|FG001|Follow-Up Survival Period|Death|16|||
149017785|NCT02269943|537545021|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
149220777|NCT01553591|538275021|FG001|Overall Study|Physician decision: lack of efficacy|3|||
149017786|NCT02269943|537545022|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
149017787|NCT02269943|537545021|FG000|Follow-Up Survival Period|Alive|2|||
149017788|NCT02269943|537545022|FG001|Follow-Up Survival Period|Alive|8|||
149017789|NCT04793464|537545023|FG000|Overall Study|Lost to Follow-up|458|||
149220778|NCT01553591|538275022|FG002|Overall Study|Physician decision: lack of efficacy|7|||
149220779|NCT01553591|538275020|FG000|Overall Study|Protocol Violation|3|||
149017790|NCT04793464|537545024|FG001|Overall Study|Lost to Follow-up|168|||
149220780|NCT01553591|538275021|FG001|Overall Study|Protocol Violation|4|||
149220781|NCT01553591|538275022|FG002|Overall Study|Protocol Violation|4|||
149220782|NCT01553591|538275020|FG000|Overall Study|Sponsor decision|1|||
149220783|NCT01553591|538275021|FG001|Overall Study|Sponsor decision|0|||
149220784|NCT01553591|538275022|FG002|Overall Study|Sponsor decision|3|||
149220785|NCT01553591|538275020|FG000|Overall Study|Randomized and never dispensed drug|0|||
149220786|NCT01553591|538275021|FG001|Overall Study|Randomized and never dispensed drug|1|||
149220787|NCT01553591|538275022|FG002|Overall Study|Randomized and never dispensed drug|0|||
149220788|NCT01818765|538275027|FG000|Overall Study|Death|2|||
149220789|NCT02005211|538275032|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149220790|NCT02005211|538275033|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149220791|NCT02005211|538275034|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149220792|NCT02005211|538275035|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149220793|NCT02005211|538275036|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
149220794|NCT02005211|538275037|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149220795|NCT02005211|538275038|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
149220796|NCT02202161|538275041|FG000|Overall Study|Adverse Event|1|||
149220797|NCT02202161|538275042|FG001|Overall Study|Adverse Event|1|||
149220798|NCT02202161|538275043|FG002|Overall Study|Adverse Event|0|||
149220799|NCT02202161|538275044|FG003|Overall Study|Adverse Event|0|||
149220800|NCT02202161|538275045|FG004|Overall Study|Adverse Event|0|||
149220801|NCT02202161|538275046|FG005|Overall Study|Adverse Event|1|||
149220802|NCT02202161|538275047|FG006|Overall Study|Adverse Event|0|||
149220803|NCT02202161|538275048|FG007|Overall Study|Adverse Event|0|||
149220804|NCT02202161|538275041|FG000|Overall Study|Did not meet continuation criteria|0|||
149220805|NCT02202161|538275042|FG001|Overall Study|Did not meet continuation criteria|0|||
149220806|NCT02202161|538275043|FG002|Overall Study|Did not meet continuation criteria|0|||
149220807|NCT02202161|538275044|FG003|Overall Study|Did not meet continuation criteria|0|||
149220808|NCT02202161|538275045|FG004|Overall Study|Did not meet continuation criteria|0|||
149220809|NCT02202161|538275046|FG005|Overall Study|Did not meet continuation criteria|0|||
149220810|NCT02202161|538275047|FG006|Overall Study|Did not meet continuation criteria|0|||
149220811|NCT02202161|538275048|FG007|Overall Study|Did not meet continuation criteria|3|||
149220812|NCT02202161|538275041|FG000|Overall Study|Physician Decision|0|||
149220813|NCT02202161|538275042|FG001|Overall Study|Physician Decision|0|||
149220814|NCT02202161|538275043|FG002|Overall Study|Physician Decision|0|||
149220815|NCT02202161|538275044|FG003|Overall Study|Physician Decision|0|||
149220816|NCT02202161|538275045|FG004|Overall Study|Physician Decision|0|||
149220817|NCT02202161|538275046|FG005|Overall Study|Physician Decision|0|||
149220818|NCT02202161|538275047|FG006|Overall Study|Physician Decision|0|||
149220819|NCT02202161|538275048|FG007|Overall Study|Physician Decision|3|||
149220820|NCT02202161|538275041|FG000|Overall Study|Withdrawal by Subject|0|||
149220821|NCT02202161|538275042|FG001|Overall Study|Withdrawal by Subject|0|||
149220822|NCT02202161|538275043|FG002|Overall Study|Withdrawal by Subject|0|||
149220823|NCT02202161|538275044|FG003|Overall Study|Withdrawal by Subject|0|||
149220824|NCT02202161|538275045|FG004|Overall Study|Withdrawal by Subject|1|||
149220825|NCT02202161|538275046|FG005|Overall Study|Withdrawal by Subject|0|||
149220826|NCT02202161|538275047|FG006|Overall Study|Withdrawal by Subject|0|||
149220827|NCT02202161|538275048|FG007|Overall Study|Withdrawal by Subject|0|||
149220828|NCT01603628|538275051|FG000|Overall Study|Personal Reasons|1|||
149220829|NCT01603628|538275052|FG001|Overall Study|Personal Reasons|1|||
149220830|NCT01603628|538275053|FG002|Overall Study|Personal Reasons|2|||
149220831|NCT01603628|538275051|FG000|Overall Study|Protocol Violation|1|||
149220832|NCT01603628|538275052|FG001|Overall Study|Protocol Violation|1|||
149220833|NCT01603628|538275053|FG002|Overall Study|Protocol Violation|0|||
149220834|NCT01603628|538275051|FG000|Overall Study|Lost to Follow-up|0|||
149220835|NCT01603628|538275052|FG001|Overall Study|Lost to Follow-up|1|||
149220836|NCT01603628|538275053|FG002|Overall Study|Lost to Follow-up|0|||
149220837|NCT01603628|538275051|FG000|Overall Study|Other Miscellaneous Reason|1|||
149220838|NCT01603628|538275052|FG001|Overall Study|Other Miscellaneous Reason|0|||
149220839|NCT01603628|538275053|FG002|Overall Study|Other Miscellaneous Reason|0|||
148685407|NCT01698320|536321477|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
148685408|NCT01698320|536321478|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
148685409|NCT01698320|536321479|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
148685410|NCT01698320|536321477|FG000|12-Week Double-Blind Period|Adverse Event|0|||
148685411|NCT01698320|536321478|FG001|12-Week Double-Blind Period|Adverse Event|1|||
148685412|NCT01698320|536321479|FG002|12-Week Double-Blind Period|Adverse Event|1|||
149220840|NCT01969565|538275054|FG000|Overall Study|Withdrawal by Subject|1|||
149220841|NCT00832091|538275055|FG000|Overall Study|Adverse Event|1|||
149220842|NCT00832091|538275056|FG001|Overall Study|Adverse Event|1|||
148685413|NCT01698320|536321477|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
148685414|NCT01698320|536321478|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
148685415|NCT01698320|536321479|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
149220843|NCT00832091|538275055|FG000|Overall Study|Protocol Violation|1|||
149220844|NCT00832091|538275056|FG001|Overall Study|Protocol Violation|0|||
149220845|NCT00832091|538275055|FG000|Overall Study|Withdrawal by Subject|2|||
149220846|NCT00832091|538275056|FG001|Overall Study|Withdrawal by Subject|1|||
149220847|NCT00832091|538275055|FG000|Overall Study|Prohibited Medication|1|||
149220848|NCT00832091|538275056|FG001|Overall Study|Prohibited Medication|0|||
149220849|NCT00952588|538275061|FG000|Overall Study|Death|28|||
149220850|NCT00952588|538275062|FG001|Overall Study|Death|13|||
149220851|NCT00952588|538275061|FG000|Overall Study|Withdrawal by Subject|2|||
149220852|NCT00952588|538275062|FG001|Overall Study|Withdrawal by Subject|5|||
149220853|NCT00952588|538275061|FG000|Overall Study|Adverse Event|2|||
149220854|NCT00952588|538275062|FG001|Overall Study|Adverse Event|3|||
149220855|NCT00952588|538275061|FG000|Overall Study|Lost to Follow-up|2|||
149220856|NCT00952588|538275062|FG001|Overall Study|Lost to Follow-up|0|||
149220857|NCT00952588|538275061|FG000|Overall Study|Physician Decision|0|||
149220858|NCT00952588|538275062|FG001|Overall Study|Physician Decision|1|||
149220859|NCT00952588|538275061|FG000|Overall Study|Lack of Efficacy|2|||
149220860|NCT00952588|538275062|FG001|Overall Study|Lack of Efficacy|2|||
149220861|NCT01108068|538275063|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
149220862|NCT01108068|538275064|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
149220863|NCT00836953|538275065|FG000|Overall Study|Withdrawal by Subject|1|||
149220864|NCT00836953|538275065|FG000|Overall Study|Lost to Follow-up|1|||
149220865|NCT01021553|538275066|FG000|Overall Study|Adverse Event|1|||
149220866|NCT01021553|538275067|FG001|Overall Study|Adverse Event|0|||
149220867|NCT01021553|538275068|FG002|Overall Study|Adverse Event|0|||
149220868|NCT01021553|538275066|FG000|Overall Study|Lack of Efficacy|2|||
149220869|NCT01021553|538275067|FG001|Overall Study|Lack of Efficacy|2|||
149220870|NCT01021553|538275068|FG002|Overall Study|Lack of Efficacy|0|||
149220871|NCT01021553|538275066|FG000|Overall Study|Protocol Violation|0|||
149220872|NCT01021553|538275067|FG001|Overall Study|Protocol Violation|2|||
149220873|NCT01021553|538275068|FG002|Overall Study|Protocol Violation|2|||
149220874|NCT01021553|538275066|FG000|Overall Study|Lost to Follow-up|0|||
149220875|NCT01021553|538275067|FG001|Overall Study|Lost to Follow-up|0|||
149220876|NCT01021553|538275068|FG002|Overall Study|Lost to Follow-up|1|||
149220877|NCT01021553|538275066|FG000|Overall Study|Withdrawal by Subject|1|||
149220878|NCT01021553|538275067|FG001|Overall Study|Withdrawal by Subject|1|||
149220879|NCT01021553|538275068|FG002|Overall Study|Withdrawal by Subject|0|||
149220880|NCT01950364|538275069|FG000|Overall Study|Adverse Event|3|||
149220881|NCT01950364|538275070|FG001|Overall Study|Adverse Event|0|||
149220882|NCT01950364|538275069|FG000|Overall Study|Stem Cell Transplant|2|||
149220883|NCT01950364|538275070|FG001|Overall Study|Stem Cell Transplant|6|||
149220884|NCT01950364|538275069|FG000|Overall Study|Disease Progression|5|||
149220885|NCT01950364|538275070|FG001|Overall Study|Disease Progression|2|||
149220886|NCT01950364|538275069|FG000|Overall Study|Withdrawal by Subject|0|||
149220887|NCT01950364|538275070|FG001|Overall Study|Withdrawal by Subject|1|||
149220888|NCT01950364|538275069|FG000|Overall Study|Protocol Violation|0|||
149220889|NCT01950364|538275070|FG001|Overall Study|Protocol Violation|1|||
149220890|NCT00935701|538275071|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
149220891|NCT02201251|538275072|FG000|Overall Study|Adverse Event|1|||
149220892|NCT02201251|538275073|FG001|Overall Study|Adverse Event|1|||
149220893|NCT02201251|538275072|FG000|Overall Study|Protocol Violation|1|||
149220894|NCT02201251|538275073|FG001|Overall Study|Protocol Violation|0|||
149220895|NCT02201251|538275072|FG000|Overall Study|Noncompliance with Study Drug|0|||
149220896|NCT02201251|538275073|FG001|Overall Study|Noncompliance with Study Drug|1|||
149220897|NCT02201251|538275072|FG000|Overall Study|Withdrawal by Subject|2|||
149220898|NCT02201251|538275073|FG001|Overall Study|Withdrawal by Subject|1|||
149220899|NCT04048876|538275076|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
149220900|NCT04048876|538275077|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
149220901|NCT04048876|538275078|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
149220902|NCT04048876|538275079|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
149220903|NCT04048876|538275076|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
149220904|NCT04048876|538275077|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
149220905|NCT04048876|538275078|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
149220906|NCT04048876|538275079|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
149220907|NCT04048876|538275076|FG000|Placebo Controlled Phase|Adverse Event|0|||
149220908|NCT04048876|538275077|FG001|Placebo Controlled Phase|Adverse Event|1|||
149220909|NCT04048876|538275078|FG002|Placebo Controlled Phase|Adverse Event|0|||
149220910|NCT04048876|538275079|FG003|Placebo Controlled Phase|Adverse Event|0|||
149220911|NCT04048876|538275076|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
149220912|NCT04048876|538275077|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
149220913|NCT04048876|538275078|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
149220914|NCT04048876|538275079|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
149220915|NCT04055844|538275080|FG000|Overall Study|Adverse Event|12|||
149220916|NCT04055844|538275080|FG000|Overall Study|Poor Performance|1|||
149220917|NCT04055844|538275080|FG000|Overall Study|Death|1|||
149220918|NCT02996500|538275089|FG000|Overall Study|Adverse Event|1|||
148685416|NCT01698320|536321477|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
148685417|NCT01698320|536321478|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
149220919|NCT02996500|538275090|FG001|Overall Study|Adverse Event|1|||
149220920|NCT02996500|538275091|FG002|Overall Study|Adverse Event|4|||
149220921|NCT02996500|538275092|FG003|Overall Study|Adverse Event|3|||
149220922|NCT02996500|538275093|FG004|Overall Study|Adverse Event|1|||
149220923|NCT02996500|538275094|FG005|Overall Study|Adverse Event|2|||
149220924|NCT02996500|538275089|FG000|Overall Study|Lack of Efficacy|0|||
149220925|NCT02996500|538275090|FG001|Overall Study|Lack of Efficacy|0|||
149220926|NCT02996500|538275091|FG002|Overall Study|Lack of Efficacy|0|||
149220927|NCT02996500|538275092|FG003|Overall Study|Lack of Efficacy|0|||
149220928|NCT02996500|538275093|FG004|Overall Study|Lack of Efficacy|2|||
149220929|NCT02996500|538275094|FG005|Overall Study|Lack of Efficacy|0|||
149220930|NCT02996500|538275089|FG000|Overall Study|Lost to Follow-up|1|||
149220931|NCT02996500|538275090|FG001|Overall Study|Lost to Follow-up|0|||
149220932|NCT02996500|538275091|FG002|Overall Study|Lost to Follow-up|0|||
149220933|NCT02996500|538275092|FG003|Overall Study|Lost to Follow-up|0|||
149220934|NCT02996500|538275093|FG004|Overall Study|Lost to Follow-up|0|||
149220935|NCT02996500|538275094|FG005|Overall Study|Lost to Follow-up|1|||
149220936|NCT02996500|538275089|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
149220937|NCT02996500|538275090|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
149220938|NCT02996500|538275091|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
149220939|NCT02996500|538275092|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
149220940|NCT02996500|538275093|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
149220941|NCT02996500|538275094|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
149220942|NCT02996500|538275089|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149220943|NCT02996500|538275090|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149220944|NCT02996500|538275091|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149220945|NCT02996500|538275092|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149220946|NCT02996500|538275093|FG004|Overall Study|Non-Compliance With Study Drug|0|||
149220947|NCT02996500|538275094|FG005|Overall Study|Non-Compliance With Study Drug|1|||
149220948|NCT02996500|538275089|FG000|Overall Study|Progressive Disease|1|||
149220949|NCT02996500|538275090|FG001|Overall Study|Progressive Disease|0|||
149220950|NCT02996500|538275091|FG002|Overall Study|Progressive Disease|0|||
149220951|NCT02996500|538275092|FG003|Overall Study|Progressive Disease|0|||
149220952|NCT02996500|538275093|FG004|Overall Study|Progressive Disease|0|||
149220953|NCT02996500|538275094|FG005|Overall Study|Progressive Disease|0|||
149220954|NCT02996500|538275089|FG000|Overall Study|Other|2|||
149220955|NCT02996500|538275090|FG001|Overall Study|Other|0|||
149220956|NCT02996500|538275091|FG002|Overall Study|Other|2|||
149220957|NCT02996500|538275092|FG003|Overall Study|Other|0|||
149220958|NCT02996500|538275093|FG004|Overall Study|Other|0|||
149220959|NCT02996500|538275094|FG005|Overall Study|Other|0|||
149220960|NCT02996500|538275089|FG000|Overall Study|Protocol Violation|0|||
149220961|NCT02996500|538275090|FG001|Overall Study|Protocol Violation|0|||
149220962|NCT02996500|538275091|FG002|Overall Study|Protocol Violation|0|||
149220963|NCT02996500|538275092|FG003|Overall Study|Protocol Violation|1|||
149220964|NCT02996500|538275093|FG004|Overall Study|Protocol Violation|0|||
149220965|NCT02996500|538275094|FG005|Overall Study|Protocol Violation|0|||
149220966|NCT02996500|538275089|FG000|Overall Study|Withdrawal by Subject|3|||
149220967|NCT02996500|538275090|FG001|Overall Study|Withdrawal by Subject|0|||
149220968|NCT02996500|538275091|FG002|Overall Study|Withdrawal by Subject|3|||
149220969|NCT02996500|538275092|FG003|Overall Study|Withdrawal by Subject|0|||
149017791|NCT04793464|537545025|FG002|Overall Study|Lost to Follow-up|5|||
149017792|NCT04793464|537545023|FG000|Overall Study|Withdrawal by Subject|43|||
149017793|NCT04793464|537545024|FG001|Overall Study|Withdrawal by Subject|15|||
149017794|NCT04793464|537545025|FG002|Overall Study|Withdrawal by Subject|0|||
149017795|NCT00845871|537545029|FG000|Assessment Period|Adverse Event|2|||
149017796|NCT00845871|537545029|FG000|Assessment Period|Abnormal laboratory values|1|||
149017797|NCT00845871|537545029|FG000|Assessment Period|Abnormal test procedure results|1|||
149017798|NCT00845871|537545029|FG000|Assessment Period|Patient withdrew consent|3|||
149017799|NCT01291225|537545032|FG000|Overall Study|Lost to Follow-up|85|||
149017800|NCT01291225|537545033|FG001|Overall Study|Lost to Follow-up|39|||
149017801|NCT02855164|537545035|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
149017802|NCT02855164|537545036|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
149017803|NCT02855164|537545037|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
149220970|NCT02996500|538275093|FG004|Overall Study|Withdrawal by Subject|2|||
149220971|NCT02996500|538275094|FG005|Overall Study|Withdrawal by Subject|0|||
149220972|NCT01347840|538275099|FG000|Overall Study|Withdrawal by Subject|1|||
149220973|NCT04223778|538275105|FG000|Overall Study|Death|1|||
149220974|NCT04223778|538275106|FG001|Overall Study|Death|1|||
149220975|NCT04223778|538275105|FG000|Overall Study|Lost to Follow-up|4|||
149220976|NCT04223778|538275106|FG001|Overall Study|Lost to Follow-up|5|||
149220977|NCT04223778|538275105|FG000|Overall Study|Physician Decision|10|||
149220978|NCT04223778|538275106|FG001|Overall Study|Physician Decision|6|||
149220979|NCT04223778|538275105|FG000|Overall Study|Withdrawal by Subject|35|||
149220980|NCT04223778|538275106|FG001|Overall Study|Withdrawal by Subject|17|||
149220981|NCT04223778|538275105|FG000|Overall Study|Not Reported|7|||
149220982|NCT04223778|538275106|FG001|Overall Study|Not Reported|8|||
149220983|NCT03053180|538277103|FG000|Overall Study|Failure to Return|1|||
149220984|NCT02972658|538277107|FG000|Overall Study|Adverse Event|0|||
149220985|NCT02972658|538277108|FG001|Overall Study|Adverse Event|3|||
149220986|NCT02972658|538277109|FG002|Overall Study|Adverse Event|0|||
149220987|NCT02972658|538277110|FG003|Overall Study|Adverse Event|2|||
149220988|NCT02972658|538277107|FG000|Overall Study|Other-determined by Investigator|1|||
149220989|NCT02972658|538277108|FG001|Overall Study|Other-determined by Investigator|1|||
149220990|NCT02972658|538277109|FG002|Overall Study|Other-determined by Investigator|0|||
149220991|NCT02972658|538277110|FG003|Overall Study|Other-determined by Investigator|0|||
149220992|NCT02972658|538277107|FG000|Overall Study|Death|0|||
149220993|NCT02972658|538277108|FG001|Overall Study|Death|0|||
149220994|NCT02972658|538277109|FG002|Overall Study|Death|0|||
149220995|NCT02972658|538277110|FG003|Overall Study|Death|1|||
149220996|NCT02972658|538277107|FG000|Overall Study|Lost to Follow-up|0|||
149220997|NCT02972658|538277108|FG001|Overall Study|Lost to Follow-up|1|||
149220998|NCT02972658|538277109|FG002|Overall Study|Lost to Follow-up|1|||
149220999|NCT02972658|538277110|FG003|Overall Study|Lost to Follow-up|2|||
149221000|NCT02972658|538277107|FG000|Overall Study|Progressive Disease|0|||
149221001|NCT02972658|538277108|FG001|Overall Study|Progressive Disease|1|||
149221002|NCT02972658|538277109|FG002|Overall Study|Progressive Disease|0|||
149221003|NCT02972658|538277110|FG003|Overall Study|Progressive Disease|1|||
149221004|NCT02972658|538277107|FG000|Overall Study|Withdrawal by Subject|4|||
149221005|NCT02972658|538277108|FG001|Overall Study|Withdrawal by Subject|4|||
149221006|NCT02972658|538277109|FG002|Overall Study|Withdrawal by Subject|1|||
149221007|NCT02972658|538277110|FG003|Overall Study|Withdrawal by Subject|6|||
149221008|NCT02972658|538277107|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
149221009|NCT02972658|538277108|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
149221010|NCT02972658|538277109|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
149221011|NCT02972658|538277110|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
149221012|NCT02972658|538277107|FG000|Overall Study|Sponsor Decision|70|||
149221013|NCT02972658|538277108|FG001|Overall Study|Sponsor Decision|127|||
149221014|NCT02972658|538277109|FG002|Overall Study|Sponsor Decision|72|||
149221015|NCT02972658|538277110|FG003|Overall Study|Sponsor Decision|119|||
149221016|NCT03958149|538277111|FG000|Overall Study|Withdrawal by Subject|0|||
149221017|NCT03958149|538277112|FG001|Overall Study|Withdrawal by Subject|1|||
149221018|NCT00621764|538277114|FG000|Overall Study|Protocol Violation|0|||
149221019|NCT00621764|538277115|FG001|Overall Study|Protocol Violation|0|||
149221020|NCT00621764|538277116|FG002|Overall Study|Protocol Violation|0|||
148685418|NCT01698320|536321479|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
149221021|NCT00621764|538277117|FG003|Overall Study|Protocol Violation|1|||
149221022|NCT03031327|538277122|FG000|Overall Study|Withdrawal by Subject|0|||
149221023|NCT03031327|538277123|FG001|Overall Study|Withdrawal by Subject|1|||
149221024|NCT03031327|538277124|FG002|Overall Study|Withdrawal by Subject|1|||
149221025|NCT00669240|538277125|FG000|Overall Study|Lack of Efficacy|33|||
149221026|NCT00669240|538277125|FG000|Overall Study|Withdrawal by Subject|42|||
149221027|NCT00669240|538277125|FG000|Overall Study|Lost to Follow-up|34|||
149221028|NCT00669240|538277125|FG000|Overall Study|Adverse Event|21|||
149221029|NCT00669240|538277125|FG000|Overall Study|Other|19|||
149221030|NCT00669240|538277125|FG000|Overall Study|Enrolled but not treated|15|||
149221031|NCT00669240|538277125|FG000|Overall Study|Enrolled but no dosing record|1|||
149221032|NCT02583399|538277126|FG000|Overall Study|Able to be discharged|3|||
149221033|NCT02583399|538277126|FG000|Overall Study|Wanted to use a restricted medication|3|||
149221034|NCT00686699|538277127|FG000|Treatment Period 1|Adverse Event|0|||
149221035|NCT00686699|538277128|FG001|Treatment Period 1|Adverse Event|2|||
149221036|NCT04610827|538277130|FG000|Overall Study|Withdrawal by Subject|1|||
149221037|NCT04610827|538277131|FG001|Overall Study|Withdrawal by Subject|1|||
149221038|NCT04610827|538277132|FG002|Overall Study|Withdrawal by Subject|0|||
149221039|NCT01693562|538277133|FG000|Escalation Phase|Withdrawal by Subject|0|||
149221040|NCT01693562|538277134|FG001|Escalation Phase|Withdrawal by Subject|1|||
149221041|NCT01693562|538277135|FG002|Escalation Phase|Withdrawal by Subject|0|||
149221042|NCT01693562|538277136|FG003|Escalation Phase|Withdrawal by Subject|0|||
149221043|NCT01693562|538277137|FG004|Escalation Phase|Withdrawal by Subject|0|||
149221044|NCT01693562|538277138|FG005|Escalation Phase|Withdrawal by Subject|2|||
149221045|NCT01693562|538277139|FG006|Escalation Phase|Withdrawal by Subject|0|||
149017804|NCT02855164|537545038|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
149017805|NCT02855164|537545039|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
149017806|NCT02855164|537545040|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
149221046|NCT01693562|538277140|FG007|Escalation Phase|Withdrawal by Subject|0|||
149221047|NCT01693562|538277141|FG008|Escalation Phase|Withdrawal by Subject|0|||
149221048|NCT01693562|538277142|FG009|Escalation Phase|Withdrawal by Subject|0|||
149221049|NCT01693562|538277143|FG010|Escalation Phase|Withdrawal by Subject|0|||
149221050|NCT01693562|538277144|FG011|Escalation Phase|Withdrawal by Subject|0|||
149221051|NCT01693562|538277145|FG012|Escalation Phase|Withdrawal by Subject|0|||
149221052|NCT01693562|538277146|FG013|Escalation Phase|Withdrawal by Subject|0|||
149221053|NCT01693562|538277147|FG014|Escalation Phase|Withdrawal by Subject|0|||
149221054|NCT01693562|538277148|FG015|Escalation Phase|Withdrawal by Subject|0|||
149221055|NCT01693562|538277149|FG016|Escalation Phase|Withdrawal by Subject|0|||
149221056|NCT01693562|538277150|FG017|Escalation Phase|Withdrawal by Subject|0|||
149221057|NCT01693562|538277151|FG018|Escalation Phase|Withdrawal by Subject|0|||
149221058|NCT01693562|538277152|FG019|Escalation Phase|Withdrawal by Subject|0|||
149221059|NCT01693562|538277153|FG020|Escalation Phase|Withdrawal by Subject|0|||
149221060|NCT01693562|538277154|FG021|Escalation Phase|Withdrawal by Subject|0|||
149221061|NCT01693562|538277155|FG022|Escalation Phase|Withdrawal by Subject|0|||
149221062|NCT01693562|538277133|FG000|Escalation Phase|Death|4|||
149221063|NCT01693562|538277134|FG001|Escalation Phase|Death|2|||
149221064|NCT01693562|538277135|FG002|Escalation Phase|Death|0|||
149221065|NCT01693562|538277136|FG003|Escalation Phase|Death|3|||
149221066|NCT01693562|538277137|FG004|Escalation Phase|Death|6|||
149221067|NCT01693562|538277138|FG005|Escalation Phase|Death|4|||
149221068|NCT01693562|538277139|FG006|Escalation Phase|Death|0|||
149221069|NCT01693562|538277140|FG007|Escalation Phase|Death|0|||
149221070|NCT01693562|538277141|FG008|Escalation Phase|Death|0|||
149221071|NCT01693562|538277142|FG009|Escalation Phase|Death|0|||
149221072|NCT01693562|538277143|FG010|Escalation Phase|Death|0|||
149221073|NCT01693562|538277144|FG011|Escalation Phase|Death|0|||
149221074|NCT01693562|538277145|FG012|Escalation Phase|Death|0|||
149221075|NCT01693562|538277146|FG013|Escalation Phase|Death|0|||
149221076|NCT01693562|538277147|FG014|Escalation Phase|Death|0|||
149221077|NCT01693562|538277148|FG015|Escalation Phase|Death|0|||
149221078|NCT01693562|538277149|FG016|Escalation Phase|Death|0|||
149221079|NCT01693562|538277150|FG017|Escalation Phase|Death|0|||
149221080|NCT01693562|538277151|FG018|Escalation Phase|Death|0|||
149221081|NCT01693562|538277152|FG019|Escalation Phase|Death|0|||
149221082|NCT01693562|538277153|FG020|Escalation Phase|Death|0|||
149221083|NCT01693562|538277154|FG021|Escalation Phase|Death|0|||
149221084|NCT01693562|538277155|FG022|Escalation Phase|Death|0|||
149221085|NCT01693562|538277133|FG000|Escalation Phase|Lost to Follow-up|0|||
149221086|NCT01693562|538277134|FG001|Escalation Phase|Lost to Follow-up|1|||
149221087|NCT01693562|538277135|FG002|Escalation Phase|Lost to Follow-up|1|||
149221088|NCT01693562|538277136|FG003|Escalation Phase|Lost to Follow-up|0|||
149221089|NCT01693562|538277137|FG004|Escalation Phase|Lost to Follow-up|0|||
149221090|NCT01693562|538277138|FG005|Escalation Phase|Lost to Follow-up|0|||
149221091|NCT01693562|538277139|FG006|Escalation Phase|Lost to Follow-up|0|||
149221092|NCT01693562|538277140|FG007|Escalation Phase|Lost to Follow-up|0|||
149221093|NCT01693562|538277141|FG008|Escalation Phase|Lost to Follow-up|0|||
149221094|NCT01693562|538277142|FG009|Escalation Phase|Lost to Follow-up|0|||
149221095|NCT01693562|538277143|FG010|Escalation Phase|Lost to Follow-up|0|||
149221096|NCT01693562|538277144|FG011|Escalation Phase|Lost to Follow-up|0|||
149221097|NCT01693562|538277145|FG012|Escalation Phase|Lost to Follow-up|0|||
149221098|NCT01693562|538277146|FG013|Escalation Phase|Lost to Follow-up|0|||
149221099|NCT01693562|538277147|FG014|Escalation Phase|Lost to Follow-up|0|||
149221100|NCT01693562|538277148|FG015|Escalation Phase|Lost to Follow-up|0|||
149221101|NCT01693562|538277149|FG016|Escalation Phase|Lost to Follow-up|0|||
149221102|NCT01693562|538277150|FG017|Escalation Phase|Lost to Follow-up|0|||
149221103|NCT01693562|538277151|FG018|Escalation Phase|Lost to Follow-up|0|||
149221104|NCT01693562|538277152|FG019|Escalation Phase|Lost to Follow-up|0|||
149221105|NCT01693562|538277153|FG020|Escalation Phase|Lost to Follow-up|0|||
149221106|NCT01693562|538277154|FG021|Escalation Phase|Lost to Follow-up|0|||
149221107|NCT01693562|538277155|FG022|Escalation Phase|Lost to Follow-up|0|||
149221108|NCT01693562|538277133|FG000|Escalation Phase|Other|0|||
149221109|NCT01693562|538277134|FG001|Escalation Phase|Other|0|||
149221110|NCT01693562|538277135|FG002|Escalation Phase|Other|2|||
149221111|NCT01693562|538277136|FG003|Escalation Phase|Other|0|||
149221112|NCT01693562|538277137|FG004|Escalation Phase|Other|0|||
149221113|NCT01693562|538277138|FG005|Escalation Phase|Other|1|||
149221114|NCT01693562|538277139|FG006|Escalation Phase|Other|0|||
149221115|NCT01693562|538277140|FG007|Escalation Phase|Other|0|||
149221116|NCT01693562|538277141|FG008|Escalation Phase|Other|0|||
149221117|NCT01693562|538277142|FG009|Escalation Phase|Other|0|||
149221118|NCT01693562|538277143|FG010|Escalation Phase|Other|0|||
149221119|NCT01693562|538277144|FG011|Escalation Phase|Other|0|||
149221120|NCT01693562|538277145|FG012|Escalation Phase|Other|0|||
149221121|NCT01693562|538277146|FG013|Escalation Phase|Other|0|||
149221122|NCT01693562|538277147|FG014|Escalation Phase|Other|0|||
149221123|NCT01693562|538277148|FG015|Escalation Phase|Other|0|||
149221124|NCT01693562|538277149|FG016|Escalation Phase|Other|0|||
149221125|NCT01693562|538277150|FG017|Escalation Phase|Other|0|||
149221126|NCT01693562|538277151|FG018|Escalation Phase|Other|0|||
149221127|NCT01693562|538277152|FG019|Escalation Phase|Other|0|||
149221128|NCT01693562|538277153|FG020|Escalation Phase|Other|0|||
149221129|NCT01693562|538277154|FG021|Escalation Phase|Other|0|||
149221130|NCT01693562|538277155|FG022|Escalation Phase|Other|0|||
149221131|NCT01693562|538277133|FG000|Exploration Phase|Withdrawal by Subject|0|||
149221132|NCT01693562|538277134|FG001|Exploration Phase|Withdrawal by Subject|0|||
149221133|NCT01693562|538277135|FG002|Exploration Phase|Withdrawal by Subject|0|||
149221134|NCT01693562|538277136|FG003|Exploration Phase|Withdrawal by Subject|0|||
149221135|NCT01693562|538277137|FG004|Exploration Phase|Withdrawal by Subject|0|||
149221136|NCT01693562|538277138|FG005|Exploration Phase|Withdrawal by Subject|0|||
149221137|NCT01693562|538277139|FG006|Exploration Phase|Withdrawal by Subject|2|||
149221138|NCT01693562|538277140|FG007|Exploration Phase|Withdrawal by Subject|0|||
149221139|NCT01693562|538277141|FG008|Exploration Phase|Withdrawal by Subject|0|||
149221140|NCT01693562|538277142|FG009|Exploration Phase|Withdrawal by Subject|0|||
149221141|NCT01693562|538277143|FG010|Exploration Phase|Withdrawal by Subject|0|||
149221142|NCT01693562|538277144|FG011|Exploration Phase|Withdrawal by Subject|0|||
149221143|NCT01693562|538277145|FG012|Exploration Phase|Withdrawal by Subject|0|||
149221144|NCT01693562|538277146|FG013|Exploration Phase|Withdrawal by Subject|0|||
149221145|NCT01693562|538277147|FG014|Exploration Phase|Withdrawal by Subject|0|||
149221146|NCT01693562|538277148|FG015|Exploration Phase|Withdrawal by Subject|0|||
149221147|NCT01693562|538277149|FG016|Exploration Phase|Withdrawal by Subject|0|||
149221148|NCT01693562|538277150|FG017|Exploration Phase|Withdrawal by Subject|0|||
149221149|NCT01693562|538277151|FG018|Exploration Phase|Withdrawal by Subject|0|||
149221150|NCT01693562|538277152|FG019|Exploration Phase|Withdrawal by Subject|0|||
149221151|NCT01693562|538277153|FG020|Exploration Phase|Withdrawal by Subject|0|||
149221152|NCT01693562|538277154|FG021|Exploration Phase|Withdrawal by Subject|0|||
149221153|NCT01693562|538277155|FG022|Exploration Phase|Withdrawal by Subject|0|||
149221154|NCT01693562|538277133|FG000|Exploration Phase|Death|0|||
149221155|NCT01693562|538277134|FG001|Exploration Phase|Death|0|||
149221156|NCT01693562|538277135|FG002|Exploration Phase|Death|0|||
149221157|NCT01693562|538277136|FG003|Exploration Phase|Death|0|||
149221158|NCT01693562|538277137|FG004|Exploration Phase|Death|0|||
149221159|NCT01693562|538277138|FG005|Exploration Phase|Death|0|||
149221160|NCT01693562|538277139|FG006|Exploration Phase|Death|17|||
149221161|NCT01693562|538277140|FG007|Exploration Phase|Death|0|||
149221162|NCT01693562|538277141|FG008|Exploration Phase|Death|0|||
149221163|NCT01693562|538277142|FG009|Exploration Phase|Death|0|||
149221164|NCT01693562|538277143|FG010|Exploration Phase|Death|0|||
148685419|NCT01698320|536321477|FG000|12-Week Double-Blind Period|Pregnancy|0|||
148685420|NCT01698320|536321478|FG001|12-Week Double-Blind Period|Pregnancy|1|||
148685421|NCT01698320|536321479|FG002|12-Week Double-Blind Period|Pregnancy|1|||
149221165|NCT01693562|538277144|FG011|Exploration Phase|Death|0|||
149221166|NCT01693562|538277145|FG012|Exploration Phase|Death|0|||
149221167|NCT01693562|538277146|FG013|Exploration Phase|Death|0|||
149221168|NCT01693562|538277147|FG014|Exploration Phase|Death|0|||
149221169|NCT01693562|538277148|FG015|Exploration Phase|Death|0|||
149221170|NCT01693562|538277149|FG016|Exploration Phase|Death|0|||
149221171|NCT01693562|538277150|FG017|Exploration Phase|Death|0|||
149221172|NCT01693562|538277151|FG018|Exploration Phase|Death|0|||
149221173|NCT01693562|538277152|FG019|Exploration Phase|Death|0|||
149221174|NCT01693562|538277153|FG020|Exploration Phase|Death|0|||
149221175|NCT01693562|538277154|FG021|Exploration Phase|Death|0|||
149221176|NCT01693562|538277155|FG022|Exploration Phase|Death|0|||
149221177|NCT01693562|538277133|FG000|Exploration Phase|Other|0|||
149221178|NCT01693562|538277134|FG001|Exploration Phase|Other|0|||
149221179|NCT01693562|538277135|FG002|Exploration Phase|Other|0|||
149221180|NCT01693562|538277136|FG003|Exploration Phase|Other|0|||
149221181|NCT01693562|538277137|FG004|Exploration Phase|Other|0|||
149221182|NCT01693562|538277138|FG005|Exploration Phase|Other|0|||
149221183|NCT01693562|538277139|FG006|Exploration Phase|Other|2|||
149221184|NCT01693562|538277140|FG007|Exploration Phase|Other|0|||
149221185|NCT01693562|538277141|FG008|Exploration Phase|Other|0|||
149221186|NCT01693562|538277142|FG009|Exploration Phase|Other|0|||
149221187|NCT01693562|538277143|FG010|Exploration Phase|Other|0|||
149221188|NCT01693562|538277144|FG011|Exploration Phase|Other|0|||
149221189|NCT01693562|538277145|FG012|Exploration Phase|Other|0|||
149221190|NCT01693562|538277146|FG013|Exploration Phase|Other|0|||
149221191|NCT01693562|538277147|FG014|Exploration Phase|Other|0|||
149221192|NCT01693562|538277148|FG015|Exploration Phase|Other|0|||
149221193|NCT01693562|538277149|FG016|Exploration Phase|Other|0|||
149221194|NCT01693562|538277150|FG017|Exploration Phase|Other|0|||
149221195|NCT01693562|538277151|FG018|Exploration Phase|Other|0|||
149221196|NCT01693562|538277152|FG019|Exploration Phase|Other|0|||
149221197|NCT01693562|538277153|FG020|Exploration Phase|Other|0|||
149221198|NCT01693562|538277154|FG021|Exploration Phase|Other|0|||
149221199|NCT01693562|538277155|FG022|Exploration Phase|Other|0|||
149221200|NCT01693562|538277133|FG000|Expansion Phase|Withdrawal by Subject|0|||
149221201|NCT01693562|538277134|FG001|Expansion Phase|Withdrawal by Subject|0|||
149221202|NCT01693562|538277135|FG002|Expansion Phase|Withdrawal by Subject|0|||
149221203|NCT01693562|538277136|FG003|Expansion Phase|Withdrawal by Subject|0|||
149221204|NCT01693562|538277137|FG004|Expansion Phase|Withdrawal by Subject|0|||
149221205|NCT01693562|538277138|FG005|Expansion Phase|Withdrawal by Subject|0|||
149221206|NCT01693562|538277139|FG006|Expansion Phase|Withdrawal by Subject|0|||
148953497|NCT00434330|537310473|FG002|Overall Study|Adverse Event|1|||
149221207|NCT01693562|538277140|FG007|Expansion Phase|Withdrawal by Subject|16|||
149221208|NCT01693562|538277141|FG008|Expansion Phase|Withdrawal by Subject|2|||
149221209|NCT01693562|538277142|FG009|Expansion Phase|Withdrawal by Subject|54|||
149221210|NCT01693562|538277143|FG010|Expansion Phase|Withdrawal by Subject|2|||
149221211|NCT01693562|538277144|FG011|Expansion Phase|Withdrawal by Subject|2|||
149221212|NCT01693562|538277145|FG012|Expansion Phase|Withdrawal by Subject|3|||
149221213|NCT01693562|538277146|FG013|Expansion Phase|Withdrawal by Subject|5|||
149221214|NCT01693562|538277147|FG014|Expansion Phase|Withdrawal by Subject|16|||
149221215|NCT01693562|538277148|FG015|Expansion Phase|Withdrawal by Subject|7|||
149221216|NCT01693562|538277149|FG016|Expansion Phase|Withdrawal by Subject|40|||
149221217|NCT01693562|538277150|FG017|Expansion Phase|Withdrawal by Subject|4|||
148809952|NCT04530344|536780923|FG001|Overall Study|Withdrawal by Subject|5|||
148809953|NCT04530344|536780924|FG002|Overall Study|Withdrawal by Subject|18|||
149221218|NCT01693562|538277151|FG018|Expansion Phase|Withdrawal by Subject|8|||
149221219|NCT01693562|538277152|FG019|Expansion Phase|Withdrawal by Subject|3|||
149221220|NCT01693562|538277153|FG020|Expansion Phase|Withdrawal by Subject|1|||
149221221|NCT01693562|538277154|FG021|Expansion Phase|Withdrawal by Subject|8|||
149221222|NCT01693562|538277155|FG022|Expansion Phase|Withdrawal by Subject|1|||
149221223|NCT01693562|538277133|FG000|Expansion Phase|Death|0|||
149221224|NCT01693562|538277134|FG001|Expansion Phase|Death|0|||
149221225|NCT01693562|538277135|FG002|Expansion Phase|Death|0|||
149221226|NCT01693562|538277136|FG003|Expansion Phase|Death|0|||
149221227|NCT01693562|538277137|FG004|Expansion Phase|Death|0|||
149221228|NCT01693562|538277138|FG005|Expansion Phase|Death|0|||
149221229|NCT01693562|538277139|FG006|Expansion Phase|Death|0|||
149221230|NCT01693562|538277140|FG007|Expansion Phase|Death|42|||
149221231|NCT01693562|538277141|FG008|Expansion Phase|Death|17|||
149221232|NCT01693562|538277142|FG009|Expansion Phase|Death|208|||
149221233|NCT01693562|538277143|FG010|Expansion Phase|Death|30|||
149221234|NCT01693562|538277144|FG011|Expansion Phase|Death|8|||
149221235|NCT01693562|538277145|FG012|Expansion Phase|Death|19|||
149221236|NCT01693562|538277146|FG013|Expansion Phase|Death|42|||
149221237|NCT01693562|538277147|FG014|Expansion Phase|Death|23|||
149221238|NCT01693562|538277148|FG015|Expansion Phase|Death|23|||
149221239|NCT01693562|538277149|FG016|Expansion Phase|Death|128|||
149221240|NCT01693562|538277150|FG017|Expansion Phase|Death|16|||
149221241|NCT01693562|538277151|FG018|Expansion Phase|Death|36|||
149221242|NCT01693562|538277152|FG019|Expansion Phase|Death|16|||
149221243|NCT01693562|538277153|FG020|Expansion Phase|Death|17|||
149221244|NCT01693562|538277154|FG021|Expansion Phase|Death|35|||
149221245|NCT01693562|538277155|FG022|Expansion Phase|Death|7|||
149221246|NCT01693562|538277133|FG000|Expansion Phase|Lost to Follow-up|0|||
149221247|NCT01693562|538277134|FG001|Expansion Phase|Lost to Follow-up|0|||
149221248|NCT01693562|538277135|FG002|Expansion Phase|Lost to Follow-up|0|||
149221249|NCT01693562|538277136|FG003|Expansion Phase|Lost to Follow-up|0|||
149221250|NCT01693562|538277137|FG004|Expansion Phase|Lost to Follow-up|0|||
149221251|NCT01693562|538277138|FG005|Expansion Phase|Lost to Follow-up|0|||
149221252|NCT01693562|538277139|FG006|Expansion Phase|Lost to Follow-up|0|||
149221253|NCT01693562|538277140|FG007|Expansion Phase|Lost to Follow-up|1|||
149221254|NCT01693562|538277141|FG008|Expansion Phase|Lost to Follow-up|2|||
149221255|NCT01693562|538277142|FG009|Expansion Phase|Lost to Follow-up|10|||
149221256|NCT01693562|538277143|FG010|Expansion Phase|Lost to Follow-up|4|||
149221257|NCT01693562|538277144|FG011|Expansion Phase|Lost to Follow-up|4|||
149221258|NCT01693562|538277145|FG012|Expansion Phase|Lost to Follow-up|1|||
149221259|NCT01693562|538277146|FG013|Expansion Phase|Lost to Follow-up|3|||
149221260|NCT01693562|538277147|FG014|Expansion Phase|Lost to Follow-up|0|||
149221261|NCT01693562|538277148|FG015|Expansion Phase|Lost to Follow-up|1|||
149221262|NCT01693562|538277149|FG016|Expansion Phase|Lost to Follow-up|1|||
149221263|NCT01693562|538277150|FG017|Expansion Phase|Lost to Follow-up|0|||
149221264|NCT01693562|538277151|FG018|Expansion Phase|Lost to Follow-up|2|||
149221265|NCT01693562|538277152|FG019|Expansion Phase|Lost to Follow-up|1|||
149221266|NCT01693562|538277153|FG020|Expansion Phase|Lost to Follow-up|2|||
149221267|NCT01693562|538277154|FG021|Expansion Phase|Lost to Follow-up|2|||
149221268|NCT01693562|538277155|FG022|Expansion Phase|Lost to Follow-up|1|||
149017807|NCT02855164|537545041|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
149017808|NCT02855164|537545042|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
149017809|NCT02855164|537545035|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
149017810|NCT02855164|537545036|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
149017811|NCT02855164|537545037|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
149017812|NCT02855164|537545038|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
149017813|NCT02855164|537545039|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
149017814|NCT02855164|537545040|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
149017815|NCT02855164|537545041|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
149221269|NCT01693562|538277133|FG000|Expansion Phase|Other|0|||
149221270|NCT01693562|538277134|FG001|Expansion Phase|Other|0|||
149221271|NCT01693562|538277135|FG002|Expansion Phase|Other|0|||
149221272|NCT01693562|538277136|FG003|Expansion Phase|Other|0|||
149017816|NCT02855164|537545042|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
149221273|NCT01693562|538277137|FG004|Expansion Phase|Other|0|||
148809954|NCT04530344|536780925|FG003|Overall Study|Withdrawal by Subject|33|||
149221274|NCT01693562|538277138|FG005|Expansion Phase|Other|0|||
149221275|NCT01693562|538277139|FG006|Expansion Phase|Other|0|||
149221276|NCT01693562|538277140|FG007|Expansion Phase|Other|3|||
149221277|NCT01693562|538277141|FG008|Expansion Phase|Other|1|||
149221278|NCT01693562|538277142|FG009|Expansion Phase|Other|28|||
149221279|NCT01693562|538277143|FG010|Expansion Phase|Other|4|||
149221280|NCT01693562|538277144|FG011|Expansion Phase|Other|7|||
149221281|NCT01693562|538277145|FG012|Expansion Phase|Other|0|||
149221282|NCT01693562|538277146|FG013|Expansion Phase|Other|1|||
149221283|NCT01693562|538277147|FG014|Expansion Phase|Other|1|||
149221284|NCT01693562|538277148|FG015|Expansion Phase|Other|0|||
149221285|NCT01693562|538277149|FG016|Expansion Phase|Other|28|||
149221286|NCT01693562|538277150|FG017|Expansion Phase|Other|0|||
149221287|NCT01693562|538277151|FG018|Expansion Phase|Other|1|||
149221288|NCT01693562|538277152|FG019|Expansion Phase|Other|0|||
149221289|NCT01693562|538277153|FG020|Expansion Phase|Other|1|||
149221290|NCT01693562|538277154|FG021|Expansion Phase|Other|17|||
149221291|NCT01693562|538277155|FG022|Expansion Phase|Other|1|||
149221292|NCT02759939|538277156|FG000|Overall Study|Missing data on first outcome assessed|11|||
149221293|NCT02759939|538277157|FG001|Overall Study|Missing data on first outcome assessed|2|||
149221294|NCT02759939|538277158|FG002|Overall Study|Missing data on first outcome assessed|5|||
149221295|NCT02759939|538277159|FG003|Overall Study|Missing data on first outcome assessed|2|||
149221296|NCT02759939|538277156|FG000|Overall Study|Ineligible for T2 and T3|310|||
149221297|NCT02759939|538277157|FG001|Overall Study|Ineligible for T2 and T3|179|||
149221298|NCT02759939|538277158|FG002|Overall Study|Ineligible for T2 and T3|366|||
149221299|NCT02759939|538277159|FG003|Overall Study|Ineligible for T2 and T3|391|||
149221300|NCT02759939|538277156|FG000|Overall Study|Lost to Follow-up|735|||
149221301|NCT02759939|538277157|FG001|Overall Study|Lost to Follow-up|791|||
149221302|NCT02759939|538277158|FG002|Overall Study|Lost to Follow-up|783|||
149221303|NCT02759939|538277159|FG003|Overall Study|Lost to Follow-up|650|||
149221304|NCT00087594|538277160|FG000|Overall Study|Adverse Event|2|||
149221305|NCT00087594|538277161|FG001|Overall Study|Adverse Event|3|||
149221306|NCT00087594|538277160|FG000|Overall Study|Lost to Follow-up|0|||
149221307|NCT00087594|538277161|FG001|Overall Study|Lost to Follow-up|2|||
149221308|NCT00087594|538277160|FG000|Overall Study|Withdrawal by Subject|4|||
149221309|NCT00087594|538277161|FG001|Overall Study|Withdrawal by Subject|2|||
149221310|NCT00087594|538277160|FG000|Overall Study|Lack of Efficacy|2|||
149221311|NCT00087594|538277161|FG001|Overall Study|Lack of Efficacy|5|||
149221312|NCT00768040|538277162|FG000|Overall Study|Adverse Event|3|||
149221313|NCT00768040|538277163|FG001|Overall Study|Adverse Event|2|||
149221314|NCT00768040|538277162|FG000|Overall Study|Abnormal laboratory value|1|||
149221315|NCT00768040|538277163|FG001|Overall Study|Abnormal laboratory value|1|||
149221316|NCT03347279|538277165|FG000|Overall Study|Withdrawal by Subject|8|||
149221317|NCT03347279|538277166|FG001|Overall Study|Withdrawal by Subject|15|||
149221318|NCT03347279|538277165|FG000|Overall Study|Death|0|||
149221319|NCT03347279|538277166|FG001|Overall Study|Death|2|||
149221320|NCT03347279|538277165|FG000|Overall Study|Lost to Follow-up|5|||
149221321|NCT03347279|538277166|FG001|Overall Study|Lost to Follow-up|2|||
149221322|NCT03347279|538277165|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
149221323|NCT03347279|538277166|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
149221324|NCT02094612|538277168|FG000|Overall Study|Lost to Follow-up|47|||
149221325|NCT02094612|538277169|FG001|Overall Study|Lost to Follow-up|47|||
149221326|NCT02094612|538277168|FG000|Overall Study|Never started ADHD medication|32|||
149221327|NCT02094612|538277169|FG001|Overall Study|Never started ADHD medication|23|||
149221328|NCT01542632|538277170|FG000|Overall Study|Withdrawal of Consent|0|||
149221329|NCT01542632|538277171|FG001|Overall Study|Withdrawal of Consent|0|||
149221330|NCT01542632|538277172|FG002|Overall Study|Withdrawal of Consent|0|||
149221331|NCT01542632|538277173|FG003|Overall Study|Withdrawal of Consent|2|||
149221332|NCT01542632|538277174|FG004|Overall Study|Withdrawal of Consent|3|||
149221333|NCT01542632|538277175|FG005|Overall Study|Withdrawal of Consent|0|||
149221334|NCT01542632|538277170|FG000|Overall Study|Adverse Event|0|||
149221335|NCT01542632|538277171|FG001|Overall Study|Adverse Event|0|||
149221336|NCT01542632|538277172|FG002|Overall Study|Adverse Event|1|||
148953498|NCT00434330|537310474|FG003|Overall Study|Adverse Event|0|||
148953499|NCT00434330|537310475|FG004|Overall Study|Adverse Event|0|||
148953500|NCT00434330|537310476|FG005|Overall Study|Adverse Event|0|||
148953501|NCT00434330|537310471|FG000|Overall Study|Death|1|||
148953502|NCT00434330|537310472|FG001|Overall Study|Death|0|||
148953503|NCT00434330|537310473|FG002|Overall Study|Death|0|||
148953504|NCT00434330|537310474|FG003|Overall Study|Death|0|||
148953505|NCT00434330|537310475|FG004|Overall Study|Death|1|||
148953506|NCT00434330|537310476|FG005|Overall Study|Death|1|||
148953507|NCT00434330|537310471|FG000|Overall Study|Withdrawal by Subject|0|||
148953508|NCT00434330|537310472|FG001|Overall Study|Withdrawal by Subject|0|||
148953509|NCT00434330|537310473|FG002|Overall Study|Withdrawal by Subject|1|||
148953510|NCT00434330|537310474|FG003|Overall Study|Withdrawal by Subject|1|||
148953511|NCT00434330|537310475|FG004|Overall Study|Withdrawal by Subject|0|||
148953512|NCT00434330|537310476|FG005|Overall Study|Withdrawal by Subject|0|||
148953513|NCT00434330|537310471|FG000|Overall Study|Renal transplant|0|||
148953514|NCT00434330|537310472|FG001|Overall Study|Renal transplant|0|||
148953515|NCT00434330|537310473|FG002|Overall Study|Renal transplant|0|||
148953516|NCT00434330|537310474|FG003|Overall Study|Renal transplant|1|||
148953517|NCT00434330|537310475|FG004|Overall Study|Renal transplant|0|||
148953518|NCT00434330|537310476|FG005|Overall Study|Renal transplant|0|||
148953519|NCT00434330|537310471|FG000|Overall Study|Subject Not Compliant With Study|0|||
148953520|NCT00434330|537310472|FG001|Overall Study|Subject Not Compliant With Study|0|||
148953521|NCT00434330|537310473|FG002|Overall Study|Subject Not Compliant With Study|1|||
149221337|NCT01542632|538277173|FG003|Overall Study|Adverse Event|0|||
149221338|NCT01542632|538277174|FG004|Overall Study|Adverse Event|0|||
149221339|NCT01542632|538277175|FG005|Overall Study|Adverse Event|0|||
149221340|NCT01542632|538277170|FG000|Overall Study|Lost to Follow-up|0|||
149221341|NCT01542632|538277171|FG001|Overall Study|Lost to Follow-up|1|||
149221342|NCT01542632|538277172|FG002|Overall Study|Lost to Follow-up|0|||
149221343|NCT01542632|538277173|FG003|Overall Study|Lost to Follow-up|0|||
149221344|NCT01542632|538277174|FG004|Overall Study|Lost to Follow-up|0|||
149221345|NCT01542632|538277175|FG005|Overall Study|Lost to Follow-up|0|||
149221346|NCT01542632|538277170|FG000|Overall Study|Sponsor/Investigator Decision|0|||
149221347|NCT01542632|538277171|FG001|Overall Study|Sponsor/Investigator Decision|0|||
149221348|NCT01542632|538277172|FG002|Overall Study|Sponsor/Investigator Decision|0|||
149221349|NCT01542632|538277173|FG003|Overall Study|Sponsor/Investigator Decision|0|||
149221350|NCT01542632|538277174|FG004|Overall Study|Sponsor/Investigator Decision|1|||
149221351|NCT01542632|538277175|FG005|Overall Study|Sponsor/Investigator Decision|0|||
149221352|NCT03991936|538277176|FG000|Overall Study|Lost to Follow-up|1|||
149221353|NCT03991936|538277177|FG001|Overall Study|Lost to Follow-up|1|||
149221354|NCT03991936|538277178|FG002|Overall Study|Lost to Follow-up|1|||
149221355|NCT03991936|538277179|FG003|Overall Study|Lost to Follow-up|1|||
149221356|NCT03991936|538277180|FG004|Overall Study|Lost to Follow-up|1|||
149221357|NCT02773849|538277181|FG000|Overall Study|Lost to Follow-up|11|||
149221358|NCT02773849|538277181|FG000|Overall Study|Death|26|||
149221359|NCT02773849|538277181|FG000|Overall Study|Withdrawal by Subject|5|||
149221360|NCT02773849|538277181|FG000|Overall Study|Withdrawal of Consent|9|||
149221361|NCT02773849|538277181|FG000|Overall Study|Other: not due to lack of tolerability|11|||
149221362|NCT01263470|538277192|FG000|Overall Study|Adverse Event|2|||
149221363|NCT01263470|538277193|FG001|Overall Study|Adverse Event|2|||
149221364|NCT01263470|538277194|FG002|Overall Study|Adverse Event|1|||
149221365|NCT01263470|538277195|FG003|Overall Study|Adverse Event|1|||
149221366|NCT01263470|538277196|FG004|Overall Study|Adverse Event|2|||
149221367|NCT01263470|538277197|FG005|Overall Study|Adverse Event|2|||
149221368|NCT01263470|538277192|FG000|Overall Study|Protocol Violation|0|||
149221369|NCT01263470|538277193|FG001|Overall Study|Protocol Violation|1|||
149221370|NCT01263470|538277194|FG002|Overall Study|Protocol Violation|0|||
149221371|NCT01263470|538277195|FG003|Overall Study|Protocol Violation|0|||
149221372|NCT01263470|538277196|FG004|Overall Study|Protocol Violation|0|||
149221373|NCT01263470|538277197|FG005|Overall Study|Protocol Violation|1|||
149221374|NCT01263470|538277192|FG000|Overall Study|Withdrawal by Subject|0|||
149221375|NCT01263470|538277193|FG001|Overall Study|Withdrawal by Subject|1|||
149221376|NCT01263470|538277194|FG002|Overall Study|Withdrawal by Subject|1|||
149221377|NCT01263470|538277195|FG003|Overall Study|Withdrawal by Subject|2|||
149221378|NCT01263470|538277196|FG004|Overall Study|Withdrawal by Subject|0|||
149221379|NCT01263470|538277197|FG005|Overall Study|Withdrawal by Subject|2|||
149221380|NCT01263470|538277192|FG000|Overall Study|Lack of Efficacy|0|||
149221381|NCT01263470|538277193|FG001|Overall Study|Lack of Efficacy|0|||
149221382|NCT01263470|538277194|FG002|Overall Study|Lack of Efficacy|2|||
149221383|NCT01263470|538277195|FG003|Overall Study|Lack of Efficacy|0|||
149221384|NCT01263470|538277196|FG004|Overall Study|Lack of Efficacy|0|||
149221385|NCT01263470|538277197|FG005|Overall Study|Lack of Efficacy|0|||
149221386|NCT01263470|538277192|FG000|Overall Study|Participant Unavailability|0|||
149221387|NCT01263470|538277193|FG001|Overall Study|Participant Unavailability|1|||
149221388|NCT01263470|538277194|FG002|Overall Study|Participant Unavailability|0|||
149221389|NCT01263470|538277195|FG003|Overall Study|Participant Unavailability|0|||
149221390|NCT01263470|538277196|FG004|Overall Study|Participant Unavailability|0|||
149221391|NCT01263470|538277197|FG005|Overall Study|Participant Unavailability|0|||
149221392|NCT01263470|538277192|FG000|Overall Study|Study Drug Non-compliance|0|||
149221393|NCT01263470|538277193|FG001|Overall Study|Study Drug Non-compliance|0|||
149221394|NCT01263470|538277194|FG002|Overall Study|Study Drug Non-compliance|0|||
149221395|NCT01263470|538277195|FG003|Overall Study|Study Drug Non-compliance|0|||
149221396|NCT01263470|538277196|FG004|Overall Study|Study Drug Non-compliance|1|||
149221397|NCT01263470|538277197|FG005|Overall Study|Study Drug Non-compliance|0|||
149221398|NCT01327573|538277198|FG000|Overall Study|Physician Decision|3|||
149221399|NCT01327573|538277199|FG001|Overall Study|Physician Decision|1|||
149221400|NCT01108263|538277200|FG000|Overall Study|Adverse Event|0|||
149221401|NCT01108263|538277201|FG001|Overall Study|Adverse Event|1|||
149221402|NCT00712712|538277202|FG000|Overall Study|Protocol Violation|11|||
149221403|NCT00712712|538277202|FG000|Overall Study|Radiofrequency not done|3|||
149221404|NCT00712712|538277202|FG000|Overall Study|Death|8|||
149221405|NCT00712712|538277202|FG000|Overall Study|Withdrawal by Subject|1|||
149221406|NCT01685372|538277203|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
149221407|NCT01685372|538277204|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
149221408|NCT01029691|538277207|FG000|Continued APAP to Delivery|Death|0|||
149221409|NCT01029691|538277208|FG001|Continued APAP to Delivery|Death|0|||
149221410|NCT01029691|538277209|FG002|Continued APAP to Delivery|Death|1|||
149221411|NCT05245071|538277210|FG000|Overall Study|Progressive disease|18|||
149221412|NCT05245071|538277210|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
149221413|NCT05245071|538277210|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
149221414|NCT01602822|538277211|FG000|Overall Study|Adverse Event|11|||
149221415|NCT02477800|538277214|FG000|Placebo-Controlled Period|Adverse Event|16|||
149221416|NCT02477800|538277215|FG001|Placebo-Controlled Period|Adverse Event|25|||
149221417|NCT02477800|538277216|FG002|Placebo-Controlled Period|Adverse Event|28|||
149221418|NCT02477800|538277217|FG003|Placebo-Controlled Period|Adverse Event|0|||
149221419|NCT02477800|538277218|FG004|Placebo-Controlled Period|Adverse Event|0|||
149221420|NCT02477800|538277219|FG005|Placebo-Controlled Period|Adverse Event|0|||
149221421|NCT02477800|538277220|FG006|Placebo-Controlled Period|Adverse Event|0|||
149221422|NCT02477800|538277214|FG000|Placebo-Controlled Period|Change of Treatment|1|||
149221423|NCT02477800|538277215|FG001|Placebo-Controlled Period|Change of Treatment|2|||
149221424|NCT02477800|538277216|FG002|Placebo-Controlled Period|Change of Treatment|1|||
149221425|NCT02477800|538277217|FG003|Placebo-Controlled Period|Change of Treatment|0|||
149221426|NCT02477800|538277218|FG004|Placebo-Controlled Period|Change of Treatment|0|||
149221427|NCT02477800|538277219|FG005|Placebo-Controlled Period|Change of Treatment|0|||
149221428|NCT02477800|538277220|FG006|Placebo-Controlled Period|Change of Treatment|0|||
149221429|NCT02477800|538277214|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
149221430|NCT02477800|538277215|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
149221431|NCT02477800|538277216|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
149221432|NCT02477800|538277217|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
149221433|NCT02477800|538277218|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
149221434|NCT02477800|538277219|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
149221435|NCT02477800|538277220|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
149221436|NCT02477800|538277214|FG000|Placebo-Controlled Period|Death|0|||
149221437|NCT02477800|538277215|FG001|Placebo-Controlled Period|Death|3|||
149221438|NCT02477800|538277216|FG002|Placebo-Controlled Period|Death|2|||
149221439|NCT02477800|538277217|FG003|Placebo-Controlled Period|Death|0|||
149221440|NCT02477800|538277218|FG004|Placebo-Controlled Period|Death|0|||
149221441|NCT02477800|538277219|FG005|Placebo-Controlled Period|Death|0|||
149221442|NCT02477800|538277220|FG006|Placebo-Controlled Period|Death|0|||
149221443|NCT02477800|538277214|FG000|Placebo-Controlled Period|Disease Progression|1|||
149221444|NCT02477800|538277215|FG001|Placebo-Controlled Period|Disease Progression|0|||
149221445|NCT02477800|538277216|FG002|Placebo-Controlled Period|Disease Progression|1|||
149221446|NCT02477800|538277217|FG003|Placebo-Controlled Period|Disease Progression|0|||
149221447|NCT02477800|538277218|FG004|Placebo-Controlled Period|Disease Progression|0|||
149221448|NCT02477800|538277219|FG005|Placebo-Controlled Period|Disease Progression|0|||
149221449|NCT02477800|538277220|FG006|Placebo-Controlled Period|Disease Progression|0|||
149221450|NCT02477800|538277214|FG000|Placebo-Controlled Period|Investigator Decision|3|||
149221451|NCT02477800|538277215|FG001|Placebo-Controlled Period|Investigator Decision|2|||
149221452|NCT02477800|538277216|FG002|Placebo-Controlled Period|Investigator Decision|1|||
149221453|NCT02477800|538277217|FG003|Placebo-Controlled Period|Investigator Decision|0|||
149221454|NCT02477800|538277218|FG004|Placebo-Controlled Period|Investigator Decision|0|||
149221455|NCT02477800|538277219|FG005|Placebo-Controlled Period|Investigator Decision|0|||
149221456|NCT02477800|538277220|FG006|Placebo-Controlled Period|Investigator Decision|0|||
149221457|NCT02477800|538277214|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
149221458|NCT02477800|538277215|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
149221459|NCT02477800|538277216|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
149221460|NCT02477800|538277217|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
149221461|NCT02477800|538277218|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
149221462|NCT02477800|538277219|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
149221463|NCT02477800|538277220|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
149221464|NCT02477800|538277214|FG000|Placebo-Controlled Period|Relocation|2|||
149221465|NCT02477800|538277215|FG001|Placebo-Controlled Period|Relocation|0|||
149221466|NCT02477800|538277216|FG002|Placebo-Controlled Period|Relocation|0|||
149221467|NCT02477800|538277217|FG003|Placebo-Controlled Period|Relocation|0|||
149221468|NCT02477800|538277218|FG004|Placebo-Controlled Period|Relocation|0|||
149221469|NCT02477800|538277219|FG005|Placebo-Controlled Period|Relocation|0|||
149221470|NCT02477800|538277220|FG006|Placebo-Controlled Period|Relocation|0|||
149221471|NCT02477800|538277214|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
149221472|NCT02477800|538277215|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
149221473|NCT02477800|538277216|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
149221474|NCT02477800|538277217|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149221475|NCT02477800|538277218|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149221476|NCT02477800|538277219|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149221477|NCT02477800|538277220|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
149221478|NCT02477800|538277214|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
149221479|NCT02477800|538277215|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
149221480|NCT02477800|538277216|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149221481|NCT02477800|538277217|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149221482|NCT02477800|538277218|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149221483|NCT02477800|538277219|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149221484|NCT02477800|538277220|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
149221485|NCT02477800|538277214|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
149221486|NCT02477800|538277215|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
149221487|NCT02477800|538277216|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
149221488|NCT02477800|538277217|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
149221489|NCT02477800|538277218|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
149221490|NCT02477800|538277219|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
149221491|NCT02477800|538277220|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
149221492|NCT02477800|538277214|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
149221493|NCT02477800|538277215|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
149221494|NCT02477800|538277216|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
149221495|NCT02477800|538277217|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149221496|NCT02477800|538277218|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149221497|NCT02477800|538277219|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149221498|NCT02477800|538277220|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149221499|NCT02477800|538277214|FG000|Placebo-Controlled Period|Reason not Specified|161|||
149221500|NCT02477800|538277215|FG001|Placebo-Controlled Period|Reason not Specified|161|||
149221501|NCT02477800|538277216|FG002|Placebo-Controlled Period|Reason not Specified|189|||
149221502|NCT02477800|538277217|FG003|Placebo-Controlled Period|Reason not Specified|0|||
149221503|NCT02477800|538277218|FG004|Placebo-Controlled Period|Reason not Specified|0|||
149221504|NCT02477800|538277219|FG005|Placebo-Controlled Period|Reason not Specified|0|||
149221505|NCT02477800|538277220|FG006|Placebo-Controlled Period|Reason not Specified|0|||
149221506|NCT02477800|538277214|FG000|Long Term Extension Period|Adverse Event|0|||
149221507|NCT02477800|538277215|FG001|Long Term Extension Period|Adverse Event|0|||
149221508|NCT02477800|538277216|FG002|Long Term Extension Period|Adverse Event|0|||
149221509|NCT02477800|538277217|FG003|Long Term Extension Period|Adverse Event|6|||
149221510|NCT02477800|538277218|FG004|Long Term Extension Period|Adverse Event|2|||
149221511|NCT02477800|538277219|FG005|Long Term Extension Period|Adverse Event|4|||
149221512|NCT02477800|538277220|FG006|Long Term Extension Period|Adverse Event|3|||
149221513|NCT02477800|538277214|FG000|Long Term Extension Period|Death|0|||
149221514|NCT02477800|538277215|FG001|Long Term Extension Period|Death|0|||
149221515|NCT02477800|538277216|FG002|Long Term Extension Period|Death|0|||
149221516|NCT02477800|538277217|FG003|Long Term Extension Period|Death|1|||
149221517|NCT02477800|538277218|FG004|Long Term Extension Period|Death|1|||
149221518|NCT02477800|538277219|FG005|Long Term Extension Period|Death|1|||
149221519|NCT02477800|538277220|FG006|Long Term Extension Period|Death|2|||
149221520|NCT02477800|538277214|FG000|Long Term Extension Period|Consent Withdrawn|0|||
149221521|NCT02477800|538277215|FG001|Long Term Extension Period|Consent Withdrawn|0|||
149221522|NCT02477800|538277216|FG002|Long Term Extension Period|Consent Withdrawn|0|||
149221523|NCT02477800|538277217|FG003|Long Term Extension Period|Consent Withdrawn|10|||
149221524|NCT02477800|538277218|FG004|Long Term Extension Period|Consent Withdrawn|4|||
149221525|NCT02477800|538277219|FG005|Long Term Extension Period|Consent Withdrawn|13|||
149017817|NCT02855164|537545035|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
149017818|NCT02855164|537545036|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
149017819|NCT02855164|537545037|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
149017820|NCT02855164|537545038|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
149017821|NCT02855164|537545039|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
149017822|NCT02855164|537545040|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
149017823|NCT02855164|537545041|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
149017824|NCT02855164|537545042|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
149017825|NCT02855164|537545035|FG000|Part C (Randomized Set)|Adverse Event|0|||
149017826|NCT02855164|537545036|FG001|Part C (Randomized Set)|Adverse Event|0|||
149017827|NCT02855164|537545037|FG002|Part C (Randomized Set)|Adverse Event|0|||
149017828|NCT02855164|537545038|FG003|Part C (Randomized Set)|Adverse Event|0|||
149017829|NCT02855164|537545039|FG004|Part C (Randomized Set)|Adverse Event|0|||
149017830|NCT02855164|537545040|FG005|Part C (Randomized Set)|Adverse Event|5|||
149017831|NCT02855164|537545041|FG006|Part C (Randomized Set)|Adverse Event|9|||
149017832|NCT02855164|537545042|FG007|Part C (Randomized Set)|Adverse Event|2|||
149017833|NCT02855164|537545035|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
149017834|NCT02855164|537545036|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
149017835|NCT02855164|537545037|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
149017836|NCT02855164|537545038|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
149221526|NCT02477800|538277220|FG006|Long Term Extension Period|Consent Withdrawn|16|||
149221527|NCT02477800|538277214|FG000|Long Term Extension Period|Disease Progression|0|||
149221528|NCT02477800|538277215|FG001|Long Term Extension Period|Disease Progression|0|||
149221529|NCT02477800|538277216|FG002|Long Term Extension Period|Disease Progression|0|||
149221530|NCT02477800|538277217|FG003|Long Term Extension Period|Disease Progression|3|||
149221531|NCT02477800|538277218|FG004|Long Term Extension Period|Disease Progression|1|||
149017837|NCT02855164|537545039|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
149017838|NCT02855164|537545040|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
149017839|NCT02855164|537545041|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
149221532|NCT02477800|538277219|FG005|Long Term Extension Period|Disease Progression|1|||
149221533|NCT02477800|538277220|FG006|Long Term Extension Period|Disease Progression|0|||
148685422|NCT01698320|536321477|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
148685423|NCT01698320|536321478|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
148685424|NCT01698320|536321479|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
148685425|NCT01698320|536321477|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
148685426|NCT01698320|536321478|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
148685427|NCT01698320|536321479|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
148685428|NCT01698320|536321477|FG000|40-Week Open-Label Period|Adverse Event|0|||
148685429|NCT01698320|536321478|FG001|40-Week Open-Label Period|Adverse Event|3|||
149221534|NCT02477800|538277214|FG000|Long Term Extension Period|Investigator Decision|0|||
149221535|NCT02477800|538277215|FG001|Long Term Extension Period|Investigator Decision|0|||
149221536|NCT02477800|538277216|FG002|Long Term Extension Period|Investigator Decision|0|||
149221537|NCT02477800|538277217|FG003|Long Term Extension Period|Investigator Decision|0|||
148685430|NCT01698320|536321479|FG002|40-Week Open-Label Period|Adverse Event|2|||
148685431|NCT01698320|536321477|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
148685432|NCT01698320|536321478|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
148685433|NCT01698320|536321479|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
149221538|NCT02477800|538277218|FG004|Long Term Extension Period|Investigator Decision|0|||
149221539|NCT02477800|538277219|FG005|Long Term Extension Period|Investigator Decision|0|||
149221540|NCT02477800|538277220|FG006|Long Term Extension Period|Investigator Decision|2|||
149221541|NCT02477800|538277214|FG000|Long Term Extension Period|Lost to Follow-up|0|||
149221542|NCT02477800|538277215|FG001|Long Term Extension Period|Lost to Follow-up|0|||
149221543|NCT02477800|538277216|FG002|Long Term Extension Period|Lost to Follow-up|0|||
149221544|NCT02477800|538277217|FG003|Long Term Extension Period|Lost to Follow-up|0|||
149221545|NCT02477800|538277218|FG004|Long Term Extension Period|Lost to Follow-up|1|||
149221546|NCT02477800|538277219|FG005|Long Term Extension Period|Lost to Follow-up|3|||
149221547|NCT02477800|538277220|FG006|Long Term Extension Period|Lost to Follow-up|0|||
149221548|NCT02477800|538277214|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
148685434|NCT01698320|536321477|FG000|40-Week Open-Label Period|Pregnancy|0|||
149221549|NCT02477800|538277215|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
149221550|NCT02477800|538277216|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
149221551|NCT02477800|538277217|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
149221552|NCT02477800|538277218|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
149221553|NCT02477800|538277219|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
149221554|NCT02477800|538277220|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
149221555|NCT02477800|538277214|FG000|Long Term Extension Period|Study Visit Burden|0|||
149221556|NCT02477800|538277215|FG001|Long Term Extension Period|Study Visit Burden|0|||
149221557|NCT02477800|538277216|FG002|Long Term Extension Period|Study Visit Burden|0|||
149221558|NCT02477800|538277217|FG003|Long Term Extension Period|Study Visit Burden|3|||
149221559|NCT02477800|538277218|FG004|Long Term Extension Period|Study Visit Burden|0|||
149221560|NCT02477800|538277219|FG005|Long Term Extension Period|Study Visit Burden|2|||
149221561|NCT02477800|538277220|FG006|Long Term Extension Period|Study Visit Burden|2|||
149221562|NCT02477800|538277214|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
149221563|NCT02477800|538277215|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
148685435|NCT01698320|536321478|FG001|40-Week Open-Label Period|Pregnancy|2|||
148685436|NCT01698320|536321479|FG002|40-Week Open-Label Period|Pregnancy|1|||
148685437|NCT01698320|536321477|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
148685438|NCT01698320|536321478|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
149221564|NCT02477800|538277216|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
149221565|NCT02477800|538277217|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
149221566|NCT02477800|538277218|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
149221567|NCT02477800|538277219|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
149221568|NCT02477800|538277220|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
149221569|NCT02477800|538277214|FG000|Long Term Extension Period|Reason not Specified|0|||
149221570|NCT02477800|538277215|FG001|Long Term Extension Period|Reason not Specified|0|||
149221571|NCT02477800|538277216|FG002|Long Term Extension Period|Reason not Specified|0|||
149221572|NCT02477800|538277217|FG003|Long Term Extension Period|Reason not Specified|126|||
149221573|NCT02477800|538277218|FG004|Long Term Extension Period|Reason not Specified|140|||
149221574|NCT02477800|538277219|FG005|Long Term Extension Period|Reason not Specified|270|||
149221575|NCT02477800|538277220|FG006|Long Term Extension Period|Reason not Specified|224|||
149221576|NCT00129376|538277221|FG000|Overall Study|Adverse Event|1|||
149221577|NCT00129376|538277221|FG000|Overall Study|Lack of Efficacy|1|||
149221578|NCT02061540|538277228|FG000|Overall Study|Adverse Event|2|||
148685439|NCT01698320|536321479|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
148685440|NCT01698320|536321477|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
148685441|NCT01698320|536321478|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
148685442|NCT01698320|536321479|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
148685443|NCT02040766|536321488|FG000|Overall Study|Adverse Event|1|||
148685444|NCT02040766|536321489|FG001|Overall Study|Adverse Event|1|||
149221579|NCT02061540|538277228|FG000|Overall Study|Withdrawal by Subject|2|||
149017840|NCT02855164|537545042|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
149017841|NCT02855164|537545035|FG000|Part C (Randomized Set)|Physician Decision|0|||
149017842|NCT02855164|537545036|FG001|Part C (Randomized Set)|Physician Decision|0|||
149017843|NCT02855164|537545037|FG002|Part C (Randomized Set)|Physician Decision|0|||
149017844|NCT02855164|537545038|FG003|Part C (Randomized Set)|Physician Decision|0|||
149017845|NCT02855164|537545039|FG004|Part C (Randomized Set)|Physician Decision|0|||
149017846|NCT02855164|537545040|FG005|Part C (Randomized Set)|Physician Decision|1|||
149221580|NCT04005755|538277231|FG000|Overall Study|Adverse Event|6|||
149221581|NCT04005755|538277231|FG000|Overall Study|Physician Decision|3|||
149221582|NCT04005755|538277231|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
149221583|NCT04005755|538277231|FG000|Overall Study|Withdrawal by Subject|3|||
149221584|NCT04005755|538277231|FG000|Overall Study|Lost to Follow-up|1|||
149221585|NCT02289833|538277232|FG000|Overall Study|Study discontinuation|0|||
149221586|NCT02289833|538277233|FG001|Overall Study|Study discontinuation|1|||
149221587|NCT02289833|538277232|FG000|Overall Study|Lost to Follow-up|4|||
149221588|NCT02289833|538277233|FG001|Overall Study|Lost to Follow-up|0|||
149221589|NCT02289833|538277232|FG000|Overall Study|Death|23|||
149221590|NCT02289833|538277233|FG001|Overall Study|Death|16|||
149221591|NCT02561273|538277240|FG000|Overall Study|Protocol Violation|1|||
149221592|NCT02561273|538277241|FG001|Overall Study|Protocol Violation|0|||
149221593|NCT02723019|538277242|FG000|Overall Study|Death|17|||
149221594|NCT02723019|538277243|FG001|Overall Study|Death|13|||
149221595|NCT02723019|538277242|FG000|Overall Study|Withdrawal by Subject|11|||
149221596|NCT02723019|538277243|FG001|Overall Study|Withdrawal by Subject|7|||
149221597|NCT02723019|538277242|FG000|Overall Study|Lost to Follow-up|57|||
149221598|NCT02723019|538277243|FG001|Overall Study|Lost to Follow-up|70|||
149221599|NCT00958191|538277245|FG000|Overall Study|Death|4|||
149221600|NCT00958191|538277245|FG000|Overall Study|Lost to Follow-up|5|||
149221601|NCT00958191|538277245|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
149221602|NCT00958191|538277245|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
149221603|NCT00958191|538277245|FG000|Overall Study|Revision of study device|4|||
149221604|NCT00958191|538277245|FG000|Overall Study|Site termination|11|||
149221605|NCT00958191|538277245|FG000|Overall Study|No 5 yr x-rays|56|||
149017847|NCT02855164|537545041|FG006|Part C (Randomized Set)|Physician Decision|0|||
149017848|NCT02855164|537545042|FG007|Part C (Randomized Set)|Physician Decision|1|||
149017849|NCT02855164|537545035|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
149017850|NCT02855164|537545036|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
149017851|NCT02855164|537545037|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
149017852|NCT02855164|537545038|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
149017853|NCT02855164|537545039|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
149017854|NCT02855164|537545040|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
149017855|NCT02855164|537545041|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
149017856|NCT02855164|537545042|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
149017857|NCT00876460|537545043|FG000|Combination Therapy Phase|Progressive disease|2|||
149017858|NCT00876460|537545044|FG001|Combination Therapy Phase|Progressive disease|3|||
149017859|NCT00876460|537545045|FG002|Combination Therapy Phase|Progressive disease|3|||
149017860|NCT00876460|537545046|FG003|Combination Therapy Phase|Progressive disease|3|||
149017861|NCT00876460|537545047|FG004|Combination Therapy Phase|Progressive disease|3|||
149017862|NCT00876460|537545048|FG005|Combination Therapy Phase|Progressive disease|1|||
149017863|NCT00876460|537545049|FG006|Combination Therapy Phase|Progressive disease|1|||
149017864|NCT00876460|537545050|FG007|Combination Therapy Phase|Progressive disease|1|||
149017865|NCT00876460|537545043|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
149017866|NCT00876460|537545044|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
149017867|NCT00876460|537545045|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
149017868|NCT00876460|537545046|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
149017869|NCT00876460|537545047|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
149017870|NCT00876460|537545048|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
149017871|NCT00876460|537545049|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
149017872|NCT00876460|537545050|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
149017873|NCT00876460|537545043|FG000|Combination Therapy Phase|Adverse Event|0|||
149017874|NCT00876460|537545044|FG001|Combination Therapy Phase|Adverse Event|2|||
149017875|NCT00876460|537545045|FG002|Combination Therapy Phase|Adverse Event|0|||
149221606|NCT00611767|538277246|FG000|Overall Study|Withdrawal by Subject|4|||
149017876|NCT00876460|537545046|FG003|Combination Therapy Phase|Adverse Event|2|||
149017877|NCT00876460|537545047|FG004|Combination Therapy Phase|Adverse Event|2|||
149017878|NCT00876460|537545048|FG005|Combination Therapy Phase|Adverse Event|0|||
149017879|NCT00876460|537545049|FG006|Combination Therapy Phase|Adverse Event|3|||
149221607|NCT00611767|538277247|FG001|Overall Study|Withdrawal by Subject|1|||
149221608|NCT00611767|538277246|FG000|Overall Study|Thiopental not available|3|||
149221609|NCT00611767|538277247|FG001|Overall Study|Thiopental not available|0|||
149221610|NCT00611767|538277246|FG000|Overall Study|didn't like the medication|1|||
149221611|NCT00611767|538277247|FG001|Overall Study|didn't like the medication|1|||
149221612|NCT00611767|538277246|FG000|Overall Study|Physician Decision|1|||
149221613|NCT00611767|538277247|FG001|Overall Study|Physician Decision|0|||
149221614|NCT01642004|538277248|FG000|Randomization|Adverse Event unrelated to study drug|1|||
149221615|NCT01642004|538277249|FG001|Randomization|Adverse Event unrelated to study drug|0|||
149221616|NCT01642004|538277248|FG000|Randomization|Participant withdrew consent|1|||
149221617|NCT01642004|538277249|FG001|Randomization|Participant withdrew consent|6|||
149221618|NCT01642004|538277248|FG000|Randomization|No longer meets study criteria|2|||
149221619|NCT01642004|538277249|FG001|Randomization|No longer meets study criteria|2|||
149221620|NCT01642004|538277248|FG000|Treatment|Disease progression|95|||
149221621|NCT01642004|538277249|FG001|Treatment|Disease progression|79|||
149221622|NCT01642004|538277248|FG000|Treatment|Study drug toxicity|10|||
149221623|NCT01642004|538277249|FG001|Treatment|Study drug toxicity|13|||
149221624|NCT01642004|538277248|FG000|Treatment|Death|1|||
149221625|NCT01642004|538277249|FG001|Treatment|Death|1|||
149221626|NCT01642004|538277248|FG000|Treatment|Adverse event unrelated to study drug|9|||
149221627|NCT01642004|538277249|FG001|Treatment|Adverse event unrelated to study drug|13|||
149221628|NCT01642004|538277248|FG000|Treatment|Maximum clinical benefit|1|||
149221629|NCT01642004|538277249|FG001|Treatment|Maximum clinical benefit|9|||
148809955|NCT04530344|536780922|FG000|Overall Study|Adverse Event|0|||
148809956|NCT04530344|536780923|FG001|Overall Study|Adverse Event|0|||
148809957|NCT04530344|536780924|FG002|Overall Study|Adverse Event|0|||
148809958|NCT04530344|536780925|FG003|Overall Study|Adverse Event|1|||
148809959|NCT04530344|536780922|FG000|Overall Study|Lack of Efficacy|0|||
148809960|NCT04530344|536780923|FG001|Overall Study|Lack of Efficacy|0|||
148809961|NCT04530344|536780924|FG002|Overall Study|Lack of Efficacy|0|||
148809962|NCT04530344|536780925|FG003|Overall Study|Lack of Efficacy|1|||
148809963|NCT04530344|536780922|FG000|Overall Study|Physician Decision|0|||
149221630|NCT01642004|538277248|FG000|Treatment|Poor/non-compliance|1|||
149221631|NCT01642004|538277249|FG001|Treatment|Poor/non-compliance|0|||
149221632|NCT01642004|538277248|FG000|Treatment|No longer meets study criteria|1|||
149221633|NCT01642004|538277249|FG001|Treatment|No longer meets study criteria|2|||
149221634|NCT01642004|538277248|FG000|Treatment|Other reasons|2|||
149221635|NCT01642004|538277249|FG001|Treatment|Other reasons|0|||
149221636|NCT01642004|538277248|FG000|Treatment|Not reported|0|||
149221637|NCT01642004|538277249|FG001|Treatment|Not reported|3|||
149221638|NCT01642004|538277248|FG000|Treatment|Participant request to discontinue study treatment|6|||
149221639|NCT01642004|538277249|FG001|Treatment|Participant request to discontinue study treatment|4|||
149221640|NCT01642004|538277248|FG000|Treatment|Participant withdrew consent|5|||
149221641|NCT01642004|538277249|FG001|Treatment|Participant withdrew consent|5|||
149221642|NCT02718625|538277250|FG000|Overall Study|Adverse Event|0|||
149221643|NCT02718625|538277251|FG001|Overall Study|Adverse Event|1|||
149221644|NCT02718625|538277250|FG000|Overall Study|Termination of Study by Sponsor|0|||
149221645|NCT02718625|538277251|FG001|Overall Study|Termination of Study by Sponsor|1|||
149221646|NCT00811395|538277254|FG000|Extension Treatment|Adverse Event|1|||
149221647|NCT00811395|538277255|FG001|Extension Treatment|Adverse Event|2|||
149221648|NCT00811395|538277256|FG002|Extension Treatment|Adverse Event|2|||
149221649|NCT00811395|538277257|FG003|Extension Treatment|Adverse Event|2|||
149221650|NCT00811395|538277258|FG004|Extension Treatment|Adverse Event|0|||
149221651|NCT00811395|538277259|FG005|Extension Treatment|Adverse Event|1|||
149221652|NCT00811395|538277254|FG000|Extension Treatment|Progressive disease|1|||
149221653|NCT00811395|538277255|FG001|Extension Treatment|Progressive disease|1|||
149017880|NCT00876460|537545050|FG007|Combination Therapy Phase|Adverse Event|2|||
149017881|NCT00876460|537545043|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
149221654|NCT00811395|538277256|FG002|Extension Treatment|Progressive disease|0|||
149221655|NCT00811395|538277257|FG003|Extension Treatment|Progressive disease|0|||
149221656|NCT00811395|538277258|FG004|Extension Treatment|Progressive disease|0|||
148809964|NCT04530344|536780923|FG001|Overall Study|Physician Decision|0|||
149017882|NCT00876460|537545044|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
149221657|NCT00811395|538277259|FG005|Extension Treatment|Progressive disease|0|||
149221658|NCT00811395|538277254|FG000|Extension Treatment|Participant did not wish to continue|0|||
149221659|NCT00811395|538277255|FG001|Extension Treatment|Participant did not wish to continue|3|||
149221660|NCT00811395|538277256|FG002|Extension Treatment|Participant did not wish to continue|0|||
149221661|NCT00811395|538277257|FG003|Extension Treatment|Participant did not wish to continue|1|||
149221662|NCT00811395|538277258|FG004|Extension Treatment|Participant did not wish to continue|0|||
148809965|NCT04530344|536780924|FG002|Overall Study|Physician Decision|1|||
149221663|NCT00811395|538277259|FG005|Extension Treatment|Participant did not wish to continue|1|||
149221664|NCT00811395|538277254|FG000|Extension Treatment|Other than above|0|||
149221665|NCT00811395|538277255|FG001|Extension Treatment|Other than above|0|||
149221666|NCT00811395|538277256|FG002|Extension Treatment|Other than above|1|||
149221667|NCT00811395|538277257|FG003|Extension Treatment|Other than above|0|||
149221668|NCT00811395|538277258|FG004|Extension Treatment|Other than above|0|||
149221669|NCT00811395|538277259|FG005|Extension Treatment|Other than above|0|||
149221670|NCT00170846|538277260|FG000|Overall Study|Subject withdrew Informed Consent|5|||
149221671|NCT00170846|538277261|FG001|Overall Study|Subject withdrew Informed Consent|12|||
149221672|NCT00170846|538277262|FG002|Overall Study|Subject withdrew Informed Consent|8|||
149221673|NCT00170846|538277260|FG000|Overall Study|Lost to Follow-up|6|||
149221674|NCT00170846|538277261|FG001|Overall Study|Lost to Follow-up|3|||
149017883|NCT00876460|537545045|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
149017884|NCT00876460|537545046|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
149017885|NCT00876460|537545047|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
149221675|NCT00170846|538277262|FG002|Overall Study|Lost to Follow-up|2|||
149221676|NCT00170846|538277260|FG000|Overall Study|Death|0|||
149221677|NCT00170846|538277261|FG001|Overall Study|Death|3|||
149221678|NCT00170846|538277262|FG002|Overall Study|Death|3|||
149221679|NCT00170846|538277260|FG000|Overall Study|Reason Missing|0|||
149221680|NCT00170846|538277261|FG001|Overall Study|Reason Missing|1|||
149221681|NCT00170846|538277262|FG002|Overall Study|Reason Missing|0|||
149221682|NCT00528840|538277263|FG000|Overall Study|Lost to Follow-up|10|||
149221683|NCT00528840|538277263|FG000|Overall Study|Adverse Event|1|||
149221684|NCT00528840|538277263|FG000|Overall Study|Withdrawal by Subject|17|||
149221685|NCT00528840|538277263|FG000|Overall Study|Death|2|||
149221686|NCT00528840|538277263|FG000|Overall Study|Administrative Reasons|1|||
149221687|NCT00528840|538277263|FG000|Overall Study|Other|2|||
149221688|NCT04554394|538277265|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
149221689|NCT04554394|538277266|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
149221690|NCT04554394|538277265|FG000|Overall Study|Withdrawal by Subject|2|||
149221691|NCT04554394|538277266|FG001|Overall Study|Withdrawal by Subject|2|||
149221692|NCT04554394|538277265|FG000|Overall Study|Lost to Follow-up|2|||
149221693|NCT04554394|538277266|FG001|Overall Study|Lost to Follow-up|2|||
149221694|NCT04554394|538277265|FG000|Overall Study|Physician Decision|1|||
149221695|NCT04554394|538277266|FG001|Overall Study|Physician Decision|1|||
149221696|NCT01766401|538277267|FG000|Overall Study|Adverse Event|7|||
149221697|NCT01766401|538277268|FG001|Overall Study|Adverse Event|22|||
149221698|NCT01766401|538277267|FG000|Overall Study|Lack of Efficacy|1|||
149221699|NCT01766401|538277268|FG001|Overall Study|Lack of Efficacy|2|||
149221700|NCT01766401|538277267|FG000|Overall Study|Protocol Violation|3|||
149221701|NCT01766401|538277268|FG001|Overall Study|Protocol Violation|8|||
149221702|NCT01766401|538277267|FG000|Overall Study|Withdrawal by Subject|15|||
149017886|NCT00876460|537545048|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
149017887|NCT00876460|537545049|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
149017888|NCT00876460|537545050|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
149017889|NCT00876460|537545043|FG000|Combination Therapy Phase|Other reason not defined above|0|||
149221703|NCT01766401|538277268|FG001|Overall Study|Withdrawal by Subject|12|||
149221704|NCT01766401|538277267|FG000|Overall Study|Lost to Follow-up|10|||
149221705|NCT01766401|538277268|FG001|Overall Study|Lost to Follow-up|11|||
149221706|NCT01766401|538277267|FG000|Overall Study|Pregnancy|1|||
149221707|NCT01766401|538277268|FG001|Overall Study|Pregnancy|1|||
149221708|NCT00808132|538277272|FG000|Overall Study|Adverse Event|34|||
149221709|NCT00808132|538277273|FG001|Overall Study|Adverse Event|33|||
149221710|NCT00808132|538277274|FG002|Overall Study|Adverse Event|16|||
149221711|NCT00808132|538277275|FG003|Overall Study|Adverse Event|31|||
149221712|NCT00808132|538277276|FG004|Overall Study|Adverse Event|33|||
149221713|NCT00808132|538277272|FG000|Overall Study|Death|0|||
149221714|NCT00808132|538277273|FG001|Overall Study|Death|0|||
149221715|NCT00808132|538277274|FG002|Overall Study|Death|0|||
149221716|NCT00808132|538277275|FG003|Overall Study|Death|0|||
148685445|NCT02040766|536321490|FG002|Overall Study|Adverse Event|1|||
148685446|NCT02040766|536321491|FG003|Overall Study|Adverse Event|0|||
148685447|NCT02040766|536321492|FG004|Overall Study|Adverse Event|2|||
148685448|NCT02040766|536321488|FG000|Overall Study|Withdrawal by Subject|4|||
148685449|NCT02040766|536321489|FG001|Overall Study|Withdrawal by Subject|3|||
149017890|NCT00876460|537545044|FG001|Combination Therapy Phase|Other reason not defined above|0|||
149221717|NCT00808132|538277276|FG004|Overall Study|Death|1|||
149221718|NCT00808132|538277272|FG000|Overall Study|Physician Decision|0|||
149221719|NCT00808132|538277273|FG001|Overall Study|Physician Decision|1|||
149221720|NCT00808132|538277274|FG002|Overall Study|Physician Decision|0|||
149221721|NCT00808132|538277275|FG003|Overall Study|Physician Decision|0|||
149221722|NCT00808132|538277276|FG004|Overall Study|Physician Decision|0|||
149221723|NCT00808132|538277272|FG000|Overall Study|Lost to Follow-up|8|||
149221724|NCT00808132|538277273|FG001|Overall Study|Lost to Follow-up|10|||
149221725|NCT00808132|538277274|FG002|Overall Study|Lost to Follow-up|11|||
149221726|NCT00808132|538277275|FG003|Overall Study|Lost to Follow-up|8|||
149221727|NCT00808132|538277276|FG004|Overall Study|Lost to Follow-up|9|||
149221728|NCT00808132|538277272|FG000|Overall Study|Protocol Violation|8|||
149221729|NCT00808132|538277273|FG001|Overall Study|Protocol Violation|9|||
149221730|NCT00808132|538277274|FG002|Overall Study|Protocol Violation|4|||
149221731|NCT00808132|538277275|FG003|Overall Study|Protocol Violation|9|||
149221732|NCT00808132|538277276|FG004|Overall Study|Protocol Violation|5|||
149221733|NCT00808132|538277272|FG000|Overall Study|Withdrawal by Subject|27|||
149221734|NCT00808132|538277273|FG001|Overall Study|Withdrawal by Subject|18|||
149221735|NCT00808132|538277274|FG002|Overall Study|Withdrawal by Subject|2|||
149221736|NCT00808132|538277275|FG003|Overall Study|Withdrawal by Subject|7|||
149221737|NCT00808132|538277276|FG004|Overall Study|Withdrawal by Subject|16|||
149221738|NCT00808132|538277272|FG000|Overall Study|Other|6|||
149221739|NCT00808132|538277273|FG001|Overall Study|Other|4|||
149221740|NCT00808132|538277274|FG002|Overall Study|Other|6|||
149221741|NCT00808132|538277275|FG003|Overall Study|Other|2|||
149221742|NCT00808132|538277276|FG004|Overall Study|Other|15|||
149221743|NCT00808132|538277272|FG000|Overall Study|Randomized, but not treated|10|||
149221744|NCT00808132|538277273|FG001|Overall Study|Randomized, but not treated|7|||
149221745|NCT00808132|538277274|FG002|Overall Study|Randomized, but not treated|9|||
149221746|NCT00808132|538277275|FG003|Overall Study|Randomized, but not treated|8|||
149221747|NCT00808132|538277276|FG004|Overall Study|Randomized, but not treated|9|||
149221748|NCT00808132|538277272|FG000|Overall Study|Unsatisfactory response|5|||
149221749|NCT00808132|538277273|FG001|Overall Study|Unsatisfactory response|6|||
149221750|NCT00808132|538277274|FG002|Overall Study|Unsatisfactory response|6|||
149221751|NCT00808132|538277275|FG003|Overall Study|Unsatisfactory response|4|||
149221752|NCT00808132|538277276|FG004|Overall Study|Unsatisfactory response|12|||
149221753|NCT02795182|538277277|FG000|Overall Study|Death|5|||
149221754|NCT02795182|538277278|FG001|Overall Study|Death|4|||
149221755|NCT02795182|538277279|FG002|Overall Study|Death|4|||
149221756|NCT02795182|538277280|FG003|Overall Study|Death|18|||
149221757|NCT02795182|538277277|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
149221758|NCT02795182|538277278|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
149221759|NCT02795182|538277279|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
149221760|NCT02795182|538277280|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
149221761|NCT02795182|538277277|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
149221762|NCT02795182|538277278|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
149221763|NCT02795182|538277279|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
149221764|NCT02795182|538277280|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
149221765|NCT02795182|538277277|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
149221766|NCT02795182|538277278|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
149221767|NCT02795182|538277279|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
149221768|NCT02795182|538277280|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
149017891|NCT00876460|537545045|FG002|Combination Therapy Phase|Other reason not defined above|0|||
149017892|NCT00876460|537545046|FG003|Combination Therapy Phase|Other reason not defined above|0|||
149017893|NCT00876460|537545047|FG004|Combination Therapy Phase|Other reason not defined above|0|||
149017894|NCT00876460|537545048|FG005|Combination Therapy Phase|Other reason not defined above|0|||
149017895|NCT00876460|537545049|FG006|Combination Therapy Phase|Other reason not defined above|1|||
149221769|NCT02795182|538277277|FG000|Overall Study|Withdrawal by Subject|4|||
149221770|NCT02795182|538277278|FG001|Overall Study|Withdrawal by Subject|0|||
149221771|NCT02795182|538277279|FG002|Overall Study|Withdrawal by Subject|0|||
149017896|NCT00876460|537545050|FG007|Combination Therapy Phase|Other reason not defined above|2|||
149221772|NCT02795182|538277280|FG003|Overall Study|Withdrawal by Subject|3|||
149017897|NCT00876460|537545043|FG000|Combination Therapy Phase|Not treated|0|||
149017898|NCT00876460|537545044|FG001|Combination Therapy Phase|Not treated|0|||
149017899|NCT00876460|537545045|FG002|Combination Therapy Phase|Not treated|0|||
149017900|NCT00876460|537545046|FG003|Combination Therapy Phase|Not treated|0|||
149017901|NCT00876460|537545047|FG004|Combination Therapy Phase|Not treated|0|||
149017902|NCT00876460|537545048|FG005|Combination Therapy Phase|Not treated|0|||
149017903|NCT00876460|537545049|FG006|Combination Therapy Phase|Not treated|1|||
149017904|NCT00876460|537545050|FG007|Combination Therapy Phase|Not treated|0|||
149017905|NCT00876460|537545043|FG000|Mono Therapy Phase|Progressive disease|0|||
149017906|NCT00876460|537545044|FG001|Mono Therapy Phase|Progressive disease|0|||
149017907|NCT00876460|537545045|FG002|Mono Therapy Phase|Progressive disease|0|||
149017908|NCT00876460|537545046|FG003|Mono Therapy Phase|Progressive disease|0|||
149017909|NCT00876460|537545047|FG004|Mono Therapy Phase|Progressive disease|2|||
149017910|NCT00876460|537545048|FG005|Mono Therapy Phase|Progressive disease|0|||
149017911|NCT00876460|537545049|FG006|Mono Therapy Phase|Progressive disease|1|||
149017912|NCT00876460|537545050|FG007|Mono Therapy Phase|Progressive disease|3|||
149017913|NCT00876460|537545043|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
149017914|NCT00876460|537545044|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
149017915|NCT00876460|537545045|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
149017916|NCT00876460|537545046|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
149017917|NCT00876460|537545047|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
149017918|NCT00876460|537545048|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
149017919|NCT00876460|537545049|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
149017920|NCT00876460|537545050|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
149017921|NCT00876460|537545043|FG000|Mono Therapy Phase|Adverse Event|0|||
149017922|NCT00876460|537545044|FG001|Mono Therapy Phase|Adverse Event|0|||
149017923|NCT00876460|537545045|FG002|Mono Therapy Phase|Adverse Event|0|||
149017924|NCT00876460|537545046|FG003|Mono Therapy Phase|Adverse Event|1|||
149017925|NCT00876460|537545047|FG004|Mono Therapy Phase|Adverse Event|0|||
149017926|NCT00876460|537545048|FG005|Mono Therapy Phase|Adverse Event|0|||
149017927|NCT00876460|537545049|FG006|Mono Therapy Phase|Adverse Event|0|||
149017928|NCT00876460|537545050|FG007|Mono Therapy Phase|Adverse Event|0|||
149017929|NCT02468934|537545051|FG000|Overall Study|Withdrawal by Subject|4|||
149017930|NCT02468934|537545051|FG000|Overall Study|Screen Failure|3|||
149017931|NCT00383240|537545052|FG000|Overall Study|Adverse Event|4|||
149017932|NCT00383240|537545053|FG001|Overall Study|Adverse Event|6|||
149017933|NCT00383240|537545054|FG002|Overall Study|Adverse Event|9|||
149017934|NCT00383240|537545055|FG003|Overall Study|Adverse Event|7|||
149017935|NCT00383240|537545052|FG000|Overall Study|Treatment Failure|8|||
149017936|NCT00383240|537545053|FG001|Overall Study|Treatment Failure|13|||
149017937|NCT00383240|537545054|FG002|Overall Study|Treatment Failure|47|||
149017938|NCT00383240|537545055|FG003|Overall Study|Treatment Failure|46|||
149017939|NCT00383240|537545052|FG000|Overall Study|Lost to Follow-up|3|||
149017940|NCT00383240|537545053|FG001|Overall Study|Lost to Follow-up|0|||
149017941|NCT00383240|537545054|FG002|Overall Study|Lost to Follow-up|0|||
149017942|NCT00383240|537545055|FG003|Overall Study|Lost to Follow-up|2|||
149017943|NCT00383240|537545052|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
149017944|NCT00383240|537545053|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
149017945|NCT00383240|537545054|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
149017946|NCT00383240|537545055|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
149017947|NCT00383240|537545052|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
149017948|NCT00383240|537545053|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
149017949|NCT00383240|537545054|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
149017950|NCT00383240|537545055|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
149017951|NCT00383240|537545052|FG000|Overall Study|Protocol Violation|4|||
149017952|NCT00383240|537545053|FG001|Overall Study|Protocol Violation|5|||
149221773|NCT02795182|538277277|FG000|Overall Study|Lost to Follow-up|0|||
149221774|NCT02795182|538277278|FG001|Overall Study|Lost to Follow-up|0|||
149221775|NCT02795182|538277279|FG002|Overall Study|Lost to Follow-up|1|||
149221776|NCT02795182|538277280|FG003|Overall Study|Lost to Follow-up|1|||
149221777|NCT02795182|538277277|FG000|Overall Study|Roll Over to Long Term Extension|3|||
149221778|NCT02795182|538277278|FG001|Overall Study|Roll Over to Long Term Extension|3|||
149221779|NCT02795182|538277279|FG002|Overall Study|Roll Over to Long Term Extension|2|||
149221780|NCT02795182|538277280|FG003|Overall Study|Roll Over to Long Term Extension|5|||
149221781|NCT02795182|538277277|FG000|Overall Study|Progressive Disease|0|||
149221782|NCT02795182|538277278|FG001|Overall Study|Progressive Disease|1|||
149017953|NCT00383240|537545054|FG002|Overall Study|Protocol Violation|9|||
149017954|NCT00383240|537545055|FG003|Overall Study|Protocol Violation|6|||
149017955|NCT00383240|537545052|FG000|Overall Study|Did not meet protocol eligibility|9|||
149017956|NCT00383240|537545053|FG001|Overall Study|Did not meet protocol eligibility|4|||
149017957|NCT00383240|537545054|FG002|Overall Study|Did not meet protocol eligibility|9|||
149017958|NCT00383240|537545055|FG003|Overall Study|Did not meet protocol eligibility|3|||
149017959|NCT00383240|537545052|FG000|Overall Study|Administrative|1|||
149221783|NCT02795182|538277279|FG002|Overall Study|Progressive Disease|0|||
149221784|NCT02795182|538277280|FG003|Overall Study|Progressive Disease|4|||
149017960|NCT00383240|537545053|FG001|Overall Study|Administrative|1|||
149017961|NCT00383240|537545054|FG002|Overall Study|Administrative|0|||
148809966|NCT04530344|536780925|FG003|Overall Study|Physician Decision|1|||
148809967|NCT04530344|536780922|FG000|Overall Study|Pregnancy|0|||
148953522|NCT00434330|537310474|FG003|Overall Study|Subject Not Compliant With Study|0|||
148953523|NCT00434330|537310475|FG004|Overall Study|Subject Not Compliant With Study|0|||
148953524|NCT00434330|537310476|FG005|Overall Study|Subject Not Compliant With Study|0|||
148953525|NCT00750204|537310477|FG000|Overall Study|study halted prematurely|1|||
148953526|NCT00750204|537310478|FG001|Overall Study|study halted prematurely|1|||
148953527|NCT04853225|537310481|FG000|Overall Study|Withdrawal by Subject|81|||
148953528|NCT04853225|537310482|FG001|Overall Study|Withdrawal by Subject|4|||
148953529|NCT04853225|537310483|FG002|Overall Study|Withdrawal by Subject|1|||
148953530|NCT04853225|537310481|FG000|Overall Study|Physician Decision|12|||
148953531|NCT04853225|537310482|FG001|Overall Study|Physician Decision|4|||
148953532|NCT04853225|537310483|FG002|Overall Study|Physician Decision|1|||
148953533|NCT04853225|537310481|FG000|Overall Study|Lost to Follow-up|50|||
148953534|NCT04853225|537310482|FG001|Overall Study|Lost to Follow-up|0|||
148953535|NCT04853225|537310483|FG002|Overall Study|Lost to Follow-up|0|||
148953536|NCT04853225|537310481|FG000|Overall Study|Other|102|||
148953537|NCT04853225|537310482|FG001|Overall Study|Other|11|||
148953538|NCT04853225|537310483|FG002|Overall Study|Other|5|||
148953539|NCT04853225|537310481|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
148953540|NCT04853225|537310482|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
148953541|NCT04853225|537310483|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
148953542|NCT04853225|537310481|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
148953543|NCT04853225|537310482|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
148953544|NCT04853225|537310483|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
148953545|NCT00850564|537310484|FG000|Overall Study|Withdrawal by Subject|2|||
148953546|NCT01404325|537313027|FG000|Overall Study|Lost to Follow-up|1|||
148953547|NCT01404325|537313028|FG001|Overall Study|Lost to Follow-up|0|||
148953548|NCT01404325|537313027|FG000|Overall Study|Death|2|||
148953549|NCT01404325|537313028|FG001|Overall Study|Death|0|||
148953550|NCT01404325|537313027|FG000|Overall Study|Graft loss/Retransplantation|1|||
148809968|NCT04530344|536780923|FG001|Overall Study|Pregnancy|0|||
148809969|NCT04530344|536780924|FG002|Overall Study|Pregnancy|2|||
148809970|NCT04530344|536780925|FG003|Overall Study|Pregnancy|1|||
149017962|NCT00383240|537545055|FG003|Overall Study|Administrative|0|||
149017963|NCT00003458|537545056|FG000|Overall Study|Not evaluable|4|||
149017964|NCT02133924|537545057|FG000|Overall Study|Death|38|||
149017965|NCT02133924|537545057|FG000|Overall Study|Physician Decision|1|||
149017966|NCT02133924|537545057|FG000|Overall Study|Withdrawal by Subject|3|||
149017967|NCT02044458|537545058|FG000|Overall Study|Protocol Violation|3|||
149017968|NCT02044458|537545059|FG001|Overall Study|Protocol Violation|8|||
149017969|NCT02924389|537545061|FG000|Overall Study|Lost to Follow-up|1|||
149017970|NCT02924389|537545062|FG001|Overall Study|Lost to Follow-up|0|||
149017971|NCT02924389|537545061|FG000|Overall Study|Physician Decision|2|||
149017972|NCT02924389|537545062|FG001|Overall Study|Physician Decision|0|||
149017973|NCT02924389|537545061|FG000|Overall Study|Withdrawal by Subject|3|||
149221785|NCT02795182|538277277|FG000|Overall Study|Physician Decision|0|||
149221786|NCT02795182|538277278|FG001|Overall Study|Physician Decision|0|||
149221787|NCT02795182|538277279|FG002|Overall Study|Physician Decision|0|||
149221788|NCT02795182|538277280|FG003|Overall Study|Physician Decision|1|||
149221789|NCT03893630|538277284|FG000|Overall Study|Lost to Follow-up|5|||
149221790|NCT03893630|538277285|FG001|Overall Study|Lost to Follow-up|4|||
149221791|NCT03893630|538277286|FG002|Overall Study|Lost to Follow-up|2|||
149221792|NCT03893630|538277284|FG000|Overall Study|Withdrawal by Subject|3|||
149221793|NCT03893630|538277285|FG001|Overall Study|Withdrawal by Subject|6|||
149221794|NCT03893630|538277286|FG002|Overall Study|Withdrawal by Subject|3|||
149221795|NCT03893630|538277284|FG000|Overall Study|Discontinued Intervention|0|||
149221796|NCT03893630|538277285|FG001|Overall Study|Discontinued Intervention|4|||
149221797|NCT03893630|538277286|FG002|Overall Study|Discontinued Intervention|2|||
149221798|NCT01465958|538278737|FG000|Run-in Phase|Protocol Violation|1|||
149221799|NCT01465958|538278738|FG001|Run-in Phase|Protocol Violation|0|||
149221800|NCT01465958|538278737|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
149221801|NCT01465958|538278738|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
149221802|NCT02785588|538278743|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
149221803|NCT02785588|538278743|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
149221804|NCT00211536|538278746|FG000|Overall Study|Withdrawal by Subject|2|||
149221805|NCT00211536|538278747|FG001|Overall Study|Withdrawal by Subject|2|||
149221806|NCT00211536|538278746|FG000|Overall Study|Physician Decision|0|||
149221807|NCT00211536|538278747|FG001|Overall Study|Physician Decision|5|||
149221808|NCT00211536|538278746|FG000|Overall Study|Adverse Event|2|||
149221809|NCT00211536|538278747|FG001|Overall Study|Adverse Event|0|||
149221810|NCT03558503|538278750|FG000|Overall Study|Adverse Event|1|||
149221811|NCT03558503|538278750|FG000|Overall Study|Death|1|||
149221812|NCT03558503|538278750|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
149017974|NCT02924389|537545062|FG001|Overall Study|Withdrawal by Subject|0|||
149017975|NCT02924389|537545061|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
149017976|NCT02924389|537545062|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
148809971|NCT04530344|536780922|FG000|Overall Study|Protocol Violation|0|||
149017977|NCT01155388|537547142|FG000|Overall Study|Adverse Event|1|||
149017978|NCT01155388|537547143|FG001|Overall Study|Adverse Event|0|||
149017979|NCT01004250|537547144|FG000|Induction Therapy Period|Adverse Event|10|||
149221813|NCT01756833|538278760|FG000|Overall Study|Withdrawal by Subject|4|||
149221814|NCT01756833|538278761|FG001|Overall Study|Withdrawal by Subject|3|||
149221815|NCT00398086|538278762|FG000|Overall Study|Unacceptable Toxicity|2|||
149221816|NCT00398086|538278763|FG001|Overall Study|Unacceptable Toxicity|8|||
148809972|NCT04530344|536780923|FG001|Overall Study|Protocol Violation|0|||
148685450|NCT02040766|536321490|FG002|Overall Study|Withdrawal by Subject|2|||
148685451|NCT02040766|536321491|FG003|Overall Study|Withdrawal by Subject|3|||
148685452|NCT02040766|536321492|FG004|Overall Study|Withdrawal by Subject|2|||
148685453|NCT02040766|536321488|FG000|Overall Study|Non-compliance|0|||
148685454|NCT02040766|536321489|FG001|Overall Study|Non-compliance|1|||
148685455|NCT02040766|536321490|FG002|Overall Study|Non-compliance|0|||
148685456|NCT02040766|536321491|FG003|Overall Study|Non-compliance|0|||
148685457|NCT02040766|536321492|FG004|Overall Study|Non-compliance|0|||
148685458|NCT02040766|536321488|FG000|Overall Study|Protocol Violation|2|||
148685459|NCT02040766|536321489|FG001|Overall Study|Protocol Violation|1|||
148685460|NCT02040766|536321490|FG002|Overall Study|Protocol Violation|2|||
148685461|NCT02040766|536321491|FG003|Overall Study|Protocol Violation|3|||
148685462|NCT02040766|536321492|FG004|Overall Study|Protocol Violation|0|||
148685463|NCT02040766|536321488|FG000|Overall Study|Lost to Follow-up|4|||
148685464|NCT02040766|536321489|FG001|Overall Study|Lost to Follow-up|1|||
149221817|NCT00398086|538278764|FG002|Overall Study|Unacceptable Toxicity|2|||
149221818|NCT00398086|538278762|FG000|Overall Study|Adverse Event|1|||
149221819|NCT00398086|538278763|FG001|Overall Study|Adverse Event|4|||
149221820|NCT00398086|538278764|FG002|Overall Study|Adverse Event|0|||
149221821|NCT00398086|538278762|FG000|Overall Study|Physician Decision|1|||
149221822|NCT00398086|538278763|FG001|Overall Study|Physician Decision|4|||
149221823|NCT00398086|538278764|FG002|Overall Study|Physician Decision|0|||
149221824|NCT00398086|538278762|FG000|Overall Study|Withdrawal by Subject|5|||
149221825|NCT00398086|538278763|FG001|Overall Study|Withdrawal by Subject|7|||
149221826|NCT00398086|538278764|FG002|Overall Study|Withdrawal by Subject|0|||
149221827|NCT00033293|538278765|FG000|Overall Study|Death|0|||
149221828|NCT00033293|538278766|FG001|Overall Study|Death|1|||
149221829|NCT00033293|538278765|FG000|Overall Study|Lack of Efficacy|5|||
149221830|NCT00033293|538278766|FG001|Overall Study|Lack of Efficacy|8|||
149221831|NCT00033293|538278765|FG000|Overall Study|Lost to Follow-up|0|||
149221832|NCT00033293|538278766|FG001|Overall Study|Lost to Follow-up|1|||
149221833|NCT00033293|538278765|FG000|Overall Study|Physician Decision|3|||
149221834|NCT00033293|538278766|FG001|Overall Study|Physician Decision|1|||
149221835|NCT00033293|538278765|FG000|Overall Study|Withdrawal by Subject|1|||
149221836|NCT00033293|538278766|FG001|Overall Study|Withdrawal by Subject|0|||
149221837|NCT00033293|538278765|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
149221838|NCT00033293|538278766|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
149221839|NCT00033293|538278765|FG000|Overall Study|Treatment refused|0|||
148685465|NCT02040766|536321490|FG002|Overall Study|Lost to Follow-up|3|||
148685466|NCT02040766|536321491|FG003|Overall Study|Lost to Follow-up|1|||
148685467|NCT02040766|536321492|FG004|Overall Study|Lost to Follow-up|4|||
148685468|NCT02040766|536321488|FG000|Overall Study|Not reported|1|||
148685469|NCT02040766|536321489|FG001|Overall Study|Not reported|0|||
148685470|NCT02040766|536321490|FG002|Overall Study|Not reported|0|||
148685471|NCT02040766|536321491|FG003|Overall Study|Not reported|0|||
148685472|NCT02040766|536321492|FG004|Overall Study|Not reported|0|||
148685473|NCT02040766|536321488|FG000|Overall Study|Lack of Efficacy|6|||
148685474|NCT02040766|536321489|FG001|Overall Study|Lack of Efficacy|3|||
148685475|NCT02040766|536321490|FG002|Overall Study|Lack of Efficacy|4|||
148685476|NCT02040766|536321491|FG003|Overall Study|Lack of Efficacy|6|||
148685477|NCT02040766|536321492|FG004|Overall Study|Lack of Efficacy|5|||
148685478|NCT00706706|536321493|FG000|Overall Study|Death|53|||
148685479|NCT00706706|536321493|FG000|Overall Study|Lost to Follow-up|7|||
148685480|NCT00706706|536321493|FG000|Overall Study|Study endpoint had reached|45|||
148685481|NCT02191579|536321494|FG000|Treatment 1|Multiple Reasons Specified|27|||
148685482|NCT02191579|536321495|FG001|Treatment 1|Multiple Reasons Specified|58|||
148685483|NCT02191579|536321494|FG000|Treatment 2|Multiple Reasons Specified|0|||
148685484|NCT02191579|536321495|FG001|Treatment 2|Multiple Reasons Specified|25|||
148685485|NCT03493698|536321501|FG000|Treatment Period C|Adverse Event|1|||
148685486|NCT03493698|536321501|FG000|Treatment Period C|Withdrawal by Subject|1|||
148685487|NCT03361956|536321502|FG000|Overall Study|Adverse Event|1|||
148685488|NCT03361956|536321503|FG001|Overall Study|Adverse Event|0|||
148685489|NCT03361956|536321504|FG002|Overall Study|Adverse Event|1|||
148685490|NCT03361956|536321505|FG003|Overall Study|Adverse Event|1|||
149221840|NCT00033293|538278766|FG001|Overall Study|Treatment refused|6|||
149221841|NCT02087241|538278767|FG000|Overall Study|Death|2|||
149221842|NCT02087241|538278768|FG001|Overall Study|Death|1|||
149221843|NCT02087241|538278769|FG002|Overall Study|Death|1|||
148685491|NCT03361956|536321506|FG004|Overall Study|Adverse Event|0|||
148685492|NCT03361956|536321502|FG000|Overall Study|Other|0|||
148685493|NCT03361956|536321503|FG001|Overall Study|Other|0|||
148685494|NCT03361956|536321504|FG002|Overall Study|Other|0|||
148685495|NCT03361956|536321505|FG003|Overall Study|Other|1|||
149221844|NCT02087241|538278770|FG003|Overall Study|Death|1|||
149221845|NCT02087241|538278767|FG000|Overall Study|Withdrawal by Subject|1|||
148685496|NCT03361956|536321506|FG004|Overall Study|Other|0|||
148685497|NCT03361956|536321502|FG000|Overall Study|Withdrawal by Subject|2|||
149221846|NCT02087241|538278768|FG001|Overall Study|Withdrawal by Subject|0|||
149221847|NCT02087241|538278769|FG002|Overall Study|Withdrawal by Subject|0|||
148685498|NCT03361956|536321503|FG001|Overall Study|Withdrawal by Subject|2|||
149221848|NCT02087241|538278770|FG003|Overall Study|Withdrawal by Subject|1|||
149221849|NCT02087241|538278767|FG000|Overall Study|Progressive Disease|0|||
149221850|NCT02087241|538278768|FG001|Overall Study|Progressive Disease|0|||
149221851|NCT02087241|538278769|FG002|Overall Study|Progressive Disease|0|||
149221852|NCT02087241|538278770|FG003|Overall Study|Progressive Disease|1|||
149221853|NCT02087241|538278767|FG000|Overall Study|Study Terminated by Sponsor|0|||
149221854|NCT02087241|538278768|FG001|Overall Study|Study Terminated by Sponsor|2|||
149221855|NCT02087241|538278769|FG002|Overall Study|Study Terminated by Sponsor|0|||
149221856|NCT02087241|538278770|FG003|Overall Study|Study Terminated by Sponsor|4|||
149221857|NCT02877134|538278771|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221858|NCT02877134|538278772|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
149221859|NCT02877134|538278773|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221860|NCT02877134|538278774|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221861|NCT02877134|538278775|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221862|NCT02877134|538278776|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
149221863|NCT02877134|538278777|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221864|NCT02877134|538278778|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221865|NCT02877134|538278779|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221866|NCT02877134|538278780|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221867|NCT02877134|538278781|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221868|NCT02877134|538278782|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
149221869|NCT02877134|538278771|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221870|NCT02877134|538278772|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
149221871|NCT02877134|538278773|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221872|NCT02877134|538278774|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
149221873|NCT02877134|538278775|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221874|NCT02877134|538278776|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221875|NCT02877134|538278777|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
149221876|NCT02877134|538278778|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221877|NCT02877134|538278779|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221878|NCT02877134|538278780|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221879|NCT02877134|538278781|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221880|NCT02877134|538278782|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
149221881|NCT02877134|538278771|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
149221882|NCT02877134|538278772|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
149221883|NCT02877134|538278773|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
149221884|NCT02877134|538278774|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
149221885|NCT02877134|538278775|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
149221886|NCT02877134|538278776|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
149221887|NCT02877134|538278777|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
149221888|NCT02877134|538278778|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
148809973|NCT04530344|536780924|FG002|Overall Study|Protocol Violation|0|||
149221889|NCT02877134|538278779|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149221890|NCT02877134|538278780|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149221891|NCT02877134|538278781|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149221892|NCT02877134|538278782|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
149221893|NCT02877134|538278771|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
149221894|NCT02877134|538278772|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
149221895|NCT02877134|538278773|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
149221896|NCT02877134|538278774|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
149221897|NCT02877134|538278775|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
149221898|NCT02877134|538278776|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
149221899|NCT02877134|538278777|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
149221900|NCT02877134|538278778|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
149221901|NCT02877134|538278779|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
149221902|NCT02877134|538278780|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
149221903|NCT02877134|538278781|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
149221904|NCT02877134|538278782|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
149221905|NCT02877134|538278771|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221906|NCT02877134|538278772|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221907|NCT02877134|538278773|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221908|NCT02877134|538278774|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221909|NCT02877134|538278775|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221910|NCT02877134|538278776|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221911|NCT02877134|538278777|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221912|NCT02877134|538278778|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221913|NCT02877134|538278779|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
149221914|NCT02877134|538278780|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221915|NCT02877134|538278781|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221916|NCT02877134|538278782|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
149221917|NCT02877134|538278771|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221918|NCT02877134|538278772|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221919|NCT02877134|538278773|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221920|NCT02877134|538278774|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221921|NCT02877134|538278775|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221922|NCT02877134|538278776|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221923|NCT02877134|538278777|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
149221924|NCT02877134|538278778|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
149221925|NCT02877134|538278779|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
149221926|NCT02877134|538278780|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
149221927|NCT02877134|538278781|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
149221928|NCT02877134|538278782|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
149221929|NCT02877134|538278771|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221930|NCT02877134|538278772|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221931|NCT02877134|538278773|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221932|NCT02877134|538278774|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221933|NCT02877134|538278775|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221934|NCT02877134|538278776|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221935|NCT02877134|538278777|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221936|NCT02877134|538278778|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
149221937|NCT02877134|538278779|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
149221938|NCT02877134|538278780|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
149221939|NCT02877134|538278781|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221940|NCT02877134|538278782|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
149221941|NCT02877134|538278771|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
149221942|NCT02877134|538278772|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
149221943|NCT02877134|538278773|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
149221944|NCT02877134|538278774|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
149221945|NCT02877134|538278775|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
149221946|NCT02877134|538278776|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
149221947|NCT02877134|538278777|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
149221948|NCT02877134|538278778|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
149221949|NCT02877134|538278779|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
149221950|NCT02877134|538278780|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
149221951|NCT02877134|538278781|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
149221952|NCT02877134|538278782|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
149221953|NCT01197794|538278783|FG000|Overall Study|Adverse Event|3|||
149221954|NCT01197794|538278784|FG001|Overall Study|Adverse Event|2|||
149221955|NCT01197794|538278785|FG002|Overall Study|Adverse Event|4|||
148809974|NCT04530344|536780925|FG003|Overall Study|Protocol Violation|1|||
148685499|NCT03361956|536321504|FG002|Overall Study|Withdrawal by Subject|2|||
148685500|NCT03361956|536321505|FG003|Overall Study|Withdrawal by Subject|0|||
148685501|NCT03361956|536321506|FG004|Overall Study|Withdrawal by Subject|3|||
148685502|NCT03361956|536321502|FG000|Overall Study|Disease Relapse|0|||
148685503|NCT03361956|536321503|FG001|Overall Study|Disease Relapse|0|||
148685504|NCT03361956|536321504|FG002|Overall Study|Disease Relapse|1|||
148685505|NCT03361956|536321505|FG003|Overall Study|Disease Relapse|0|||
148685506|NCT03361956|536321506|FG004|Overall Study|Disease Relapse|0|||
148685507|NCT03361956|536321502|FG000|Overall Study|Physician Decision|0|||
148685508|NCT03361956|536321503|FG001|Overall Study|Physician Decision|2|||
148685509|NCT03361956|536321504|FG002|Overall Study|Physician Decision|0|||
148685510|NCT03361956|536321505|FG003|Overall Study|Physician Decision|1|||
148685511|NCT03361956|536321506|FG004|Overall Study|Physician Decision|0|||
148685512|NCT03361956|536321502|FG000|Overall Study|Lost to Follow-up|0|||
148685513|NCT03361956|536321503|FG001|Overall Study|Lost to Follow-up|0|||
148685514|NCT03361956|536321504|FG002|Overall Study|Lost to Follow-up|1|||
148685515|NCT03361956|536321505|FG003|Overall Study|Lost to Follow-up|1|||
148685516|NCT03361956|536321506|FG004|Overall Study|Lost to Follow-up|2|||
148685517|NCT00291330|536321508|FG000|Overall Study|Adverse Event|47|||
148685518|NCT00291330|536321509|FG001|Overall Study|Adverse Event|40|||
148685519|NCT00291330|536321508|FG000|Overall Study|Protocol Violation|13|||
148953551|NCT01404325|537313028|FG001|Overall Study|Graft loss/Retransplantation|0|||
148953552|NCT01404325|537313027|FG000|Overall Study|non-specified reason|0|||
148953553|NCT01404325|537313028|FG001|Overall Study|non-specified reason|2|||
148953554|NCT01411228|537313031|FG000|Overall Study|Lost to Follow-up|0|||
148953555|NCT01411228|537313032|FG001|Overall Study|Lost to Follow-up|0|||
148953556|NCT01411228|537313033|FG002|Overall Study|Lost to Follow-up|1|||
149221956|NCT01197794|538278786|FG003|Overall Study|Adverse Event|4|||
148953557|NCT01411228|537313031|FG000|Overall Study|Withdrawal by Subject|1|||
149221957|NCT01197794|538278787|FG004|Overall Study|Adverse Event|4|||
149221958|NCT01197794|538278788|FG005|Overall Study|Adverse Event|2|||
149221959|NCT01197794|538278789|FG006|Overall Study|Adverse Event|3|||
149221960|NCT01197794|538278783|FG000|Overall Study|Protocol Violation|0|||
149221961|NCT01197794|538278784|FG001|Overall Study|Protocol Violation|0|||
149221962|NCT01197794|538278785|FG002|Overall Study|Protocol Violation|0|||
149221963|NCT01197794|538278786|FG003|Overall Study|Protocol Violation|0|||
149221964|NCT01197794|538278787|FG004|Overall Study|Protocol Violation|2|||
149221965|NCT01197794|538278788|FG005|Overall Study|Protocol Violation|0|||
149221966|NCT01197794|538278789|FG006|Overall Study|Protocol Violation|1|||
149221967|NCT01197794|538278783|FG000|Overall Study|Development of study withdrawal criteria|3|||
149221968|NCT01197794|538278784|FG001|Overall Study|Development of study withdrawal criteria|0|||
149221969|NCT01197794|538278785|FG002|Overall Study|Development of study withdrawal criteria|0|||
148685520|NCT00291330|536321509|FG001|Overall Study|Protocol Violation|20|||
148685521|NCT00291330|536321508|FG000|Overall Study|Lost to Follow-up|16|||
148953558|NCT01411228|537313032|FG001|Overall Study|Withdrawal by Subject|0|||
148953559|NCT01411228|537313033|FG002|Overall Study|Withdrawal by Subject|0|||
148953560|NCT01986855|537313035|FG000|Overall Study|Adverse Event|1|||
148953561|NCT01986855|537313036|FG001|Overall Study|Adverse Event|0|||
148953562|NCT01986855|537313037|FG002|Overall Study|Adverse Event|0|||
148953563|NCT01986855|537313035|FG000|Overall Study|Death|3|||
148953564|NCT01986855|537313036|FG001|Overall Study|Death|4|||
148953565|NCT01986855|537313037|FG002|Overall Study|Death|4|||
148953566|NCT01986855|537313035|FG000|Overall Study|Lost to Follow-up|2|||
148953567|NCT01986855|537313036|FG001|Overall Study|Lost to Follow-up|1|||
148953568|NCT01986855|537313037|FG002|Overall Study|Lost to Follow-up|0|||
148953569|NCT01986855|537313035|FG000|Overall Study|Screen Failure|0|||
148953570|NCT01986855|537313036|FG001|Overall Study|Screen Failure|1|||
148953571|NCT01986855|537313037|FG002|Overall Study|Screen Failure|0|||
148953572|NCT01986855|537313035|FG000|Overall Study|Participant Moved|0|||
148953573|NCT01986855|537313036|FG001|Overall Study|Participant Moved|0|||
148953574|NCT01986855|537313037|FG002|Overall Study|Participant Moved|2|||
148953575|NCT01986855|537313035|FG000|Overall Study|Withdrawal by Subject|7|||
148953576|NCT01986855|537313036|FG001|Overall Study|Withdrawal by Subject|8|||
148953577|NCT01986855|537313037|FG002|Overall Study|Withdrawal by Subject|5|||
148953578|NCT04317066|537313038|FG000|Overall Study|Sponsor decision|5|||
148953579|NCT04317066|537313038|FG000|Overall Study|Death|2|||
148953580|NCT02670083|537313042|FG000|Overall Study|Adverse Event|16|||
148953581|NCT02670083|537313043|FG001|Overall Study|Adverse Event|13|||
148953582|NCT02670083|537313042|FG000|Overall Study|Death|4|||
148685522|NCT00291330|536321509|FG001|Overall Study|Lost to Follow-up|11|||
148685523|NCT00291330|536321508|FG000|Overall Study|Withdrawal by Subject|22|||
148953583|NCT02670083|537313043|FG001|Overall Study|Death|6|||
148953584|NCT02670083|537313042|FG000|Overall Study|Lost to Follow-up|2|||
148953585|NCT02670083|537313043|FG001|Overall Study|Lost to Follow-up|2|||
148953586|NCT02670083|537313042|FG000|Overall Study|Multiple Reasons|9|||
149017980|NCT01004250|537547144|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
148953587|NCT02670083|537313043|FG001|Overall Study|Multiple Reasons|9|||
148685524|NCT00291330|536321509|FG001|Overall Study|Withdrawal by Subject|25|||
148685525|NCT00291330|536321508|FG000|Overall Study|Other|3|||
148953588|NCT02670083|537313042|FG000|Overall Study|Physician Decision|0|||
148809975|NCT04530344|536780922|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
148809976|NCT04530344|536780923|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
148809977|NCT04530344|536780924|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
148809978|NCT04530344|536780925|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
148809979|NCT04530344|536780922|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
148809980|NCT04530344|536780923|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
148809981|NCT04530344|536780924|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
148809982|NCT04530344|536780925|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
148809983|NCT04530344|536780922|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
148809984|NCT04530344|536780923|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
149221970|NCT01197794|538278786|FG003|Overall Study|Development of study withdrawal criteria|1|||
149221971|NCT01197794|538278787|FG004|Overall Study|Development of study withdrawal criteria|0|||
149221972|NCT01197794|538278788|FG005|Overall Study|Development of study withdrawal criteria|0|||
149221973|NCT01197794|538278789|FG006|Overall Study|Development of study withdrawal criteria|1|||
149221974|NCT01197794|538278783|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
149221975|NCT01197794|538278784|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
149221976|NCT01197794|538278785|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
149221977|NCT01197794|538278786|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
149221978|NCT01197794|538278787|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
149221979|NCT01197794|538278788|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
149221980|NCT01197794|538278789|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
149221981|NCT01197794|538278783|FG000|Overall Study|Withdrawal by Subject|3|||
149221982|NCT01197794|538278784|FG001|Overall Study|Withdrawal by Subject|3|||
149221983|NCT01197794|538278785|FG002|Overall Study|Withdrawal by Subject|4|||
149221984|NCT01197794|538278786|FG003|Overall Study|Withdrawal by Subject|1|||
149221985|NCT01197794|538278787|FG004|Overall Study|Withdrawal by Subject|1|||
149221986|NCT01197794|538278788|FG005|Overall Study|Withdrawal by Subject|5|||
149221987|NCT01197794|538278789|FG006|Overall Study|Withdrawal by Subject|6|||
149221988|NCT01197794|538278783|FG000|Overall Study|Lost to Follow-up|1|||
149221989|NCT01197794|538278784|FG001|Overall Study|Lost to Follow-up|1|||
148809985|NCT04530344|536780924|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
148809986|NCT04530344|536780925|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
148685526|NCT00291330|536321509|FG001|Overall Study|Other|1|||
148685527|NCT01829295|536321510|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
148685528|NCT01829295|536321511|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
148685529|NCT01829295|536321512|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
148685530|NCT01829295|536321513|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
148685531|NCT01829295|536321510|FG000|6-12 Months|Adverse Event|0|||
148685532|NCT01829295|536321511|FG001|6-12 Months|Adverse Event|0|||
148685533|NCT01829295|536321512|FG002|6-12 Months|Adverse Event|3|||
148685534|NCT01829295|536321513|FG003|6-12 Months|Adverse Event|2|||
148685535|NCT01829295|536321510|FG000|6-12 Months|Lost to Follow-up|2|||
148685536|NCT01829295|536321511|FG001|6-12 Months|Lost to Follow-up|0|||
148685537|NCT01829295|536321512|FG002|6-12 Months|Lost to Follow-up|0|||
148685538|NCT01829295|536321513|FG003|6-12 Months|Lost to Follow-up|0|||
148685539|NCT01829295|536321510|FG000|6-12 Months|Withdrawal by Subject|2|||
148685540|NCT01829295|536321511|FG001|6-12 Months|Withdrawal by Subject|2|||
148685541|NCT01829295|536321512|FG002|6-12 Months|Withdrawal by Subject|0|||
148685542|NCT01829295|536321513|FG003|6-12 Months|Withdrawal by Subject|0|||
148685543|NCT02629965|536321516|FG000|Period 1|Adverse Event|1|||
148685544|NCT02629965|536321517|FG001|Period 1|Adverse Event|0|||
148685545|NCT02629965|536321516|FG000|Period 1|Unexpected worsening of disease|2|||
148685546|NCT02629965|536321517|FG001|Period 1|Unexpected worsening of disease|0|||
148685547|NCT02629965|536321516|FG000|Period 1|Other than listed above|1|||
148685548|NCT02629965|536321517|FG001|Period 1|Other than listed above|2|||
148685549|NCT02629965|536321516|FG000|Period 2|Adverse Event|1|||
148685550|NCT02629965|536321517|FG001|Period 2|Adverse Event|0|||
148685551|NCT03443869|536321518|FG000|Overall Study|Death|3|||
148685552|NCT03443869|536321519|FG001|Overall Study|Death|3|||
148685553|NCT03443869|536321518|FG000|Overall Study|Withdrawal by Subject|34|||
148685554|NCT03443869|536321519|FG001|Overall Study|Withdrawal by Subject|22|||
148685555|NCT03443869|536321518|FG000|Overall Study|Lost to Follow-up|1|||
148685556|NCT03443869|536321519|FG001|Overall Study|Lost to Follow-up|2|||
148685557|NCT03443869|536321518|FG000|Overall Study|Physician Decision|3|||
148685558|NCT03443869|536321519|FG001|Overall Study|Physician Decision|3|||
148685559|NCT03443869|536321518|FG000|Overall Study|Other|4|||
148685560|NCT03443869|536321519|FG001|Overall Study|Other|4|||
148685561|NCT02390219|536321520|FG000|Overall Study|Death|1|||
148685562|NCT02390219|536321520|FG000|Overall Study|Physician Decision|1|||
148685563|NCT02390219|536321520|FG000|Overall Study|Adverse Event|6|||
148685564|NCT02390219|536321520|FG000|Overall Study|Withdrawal by Subject|1|||
148685565|NCT02390219|536321520|FG000|Overall Study|Lost to Follow-up|2|||
148685566|NCT02390219|536321520|FG000|Overall Study|Other|2|||
148685567|NCT00299728|536321521|FG000|Overall Study|Lost to Follow-up|0|||
148685568|NCT00299728|536321522|FG001|Overall Study|Lost to Follow-up|1|||
148685569|NCT00299728|536321521|FG000|Overall Study|Withdrawal by Subject|0|||
148685570|NCT00299728|536321522|FG001|Overall Study|Withdrawal by Subject|1|||
148685571|NCT00299728|536321521|FG000|Overall Study|Progressive disease|0|||
148685572|NCT00299728|536321522|FG001|Overall Study|Progressive disease|1|||
148685573|NCT02230085|536321523|FG000|Overall Study|Physician Decision|1|||
148685574|NCT02230085|536321523|FG000|Overall Study|Withdrawal by Subject|3|||
148685575|NCT00580983|536321524|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
148685576|NCT01360632|536321525|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
148685577|NCT01360632|536321526|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
148685578|NCT01360632|536321527|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
148685579|NCT01360632|536321528|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
148685580|NCT01360632|536321529|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
148685581|NCT01360632|536321525|FG000|Phase A (8 Weeks)|Adverse Event|60|||
149017981|NCT01004250|537547144|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
149017982|NCT01004250|537547144|FG000|Induction Therapy Period|Physician Decision|2|||
149017983|NCT01004250|537547144|FG000|Maintenance Therapy Period|Adverse Event|15|||
149017984|NCT01004250|537547144|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
149017985|NCT01004250|537547144|FG000|Maintenance Therapy Period|Protocol Violation|1|||
149017986|NCT01004250|537547144|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
149017987|NCT01004250|537547144|FG000|Maintenance Therapy Period|Physician Decision|4|||
149017988|NCT01004250|537547144|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
149017989|NCT03884231|537547145|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
149017990|NCT03884231|537547145|FG000|Overall Study|Subject Withdrew Consent|1|||
149017991|NCT03884231|537547145|FG000|Overall Study|MRI Scan Not Performed|1|||
149017992|NCT01853254|537547146|FG000|Overall Study|Abnormal Laboratory Test|1|||
149017993|NCT01853254|537547146|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
149017994|NCT01853254|537547146|FG000|Overall Study|Death|1|||
148685582|NCT01360632|536321526|FG001|Phase A (8 Weeks)|Adverse Event|0|||
148685583|NCT01360632|536321527|FG002|Phase A (8 Weeks)|Adverse Event|0|||
148685584|NCT01360632|536321528|FG003|Phase A (8 Weeks)|Adverse Event|0|||
148685585|NCT01360632|536321529|FG004|Phase A (8 Weeks)|Adverse Event|0|||
148685586|NCT01360632|536321525|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
148685587|NCT01360632|536321526|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
148685588|NCT01360632|536321527|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
148685589|NCT01360632|536321528|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
149221990|NCT01197794|538278785|FG002|Overall Study|Lost to Follow-up|0|||
149221991|NCT01197794|538278786|FG003|Overall Study|Lost to Follow-up|1|||
149221992|NCT01197794|538278787|FG004|Overall Study|Lost to Follow-up|0|||
149221993|NCT01197794|538278788|FG005|Overall Study|Lost to Follow-up|1|||
149221994|NCT01197794|538278789|FG006|Overall Study|Lost to Follow-up|0|||
149221995|NCT01197794|538278783|FG000|Overall Study|Other|1|||
149221996|NCT01197794|538278784|FG001|Overall Study|Other|1|||
149221997|NCT01197794|538278785|FG002|Overall Study|Other|3|||
149221998|NCT01197794|538278786|FG003|Overall Study|Other|0|||
149221999|NCT01197794|538278787|FG004|Overall Study|Other|2|||
149222000|NCT01197794|538278788|FG005|Overall Study|Other|2|||
149222001|NCT01197794|538278789|FG006|Overall Study|Other|4|||
149222002|NCT01055457|538278790|FG000|Overall Study|Lost to Follow-up|0|||
149222003|NCT01055457|538278791|FG001|Overall Study|Lost to Follow-up|1|||
149222004|NCT01055457|538278792|FG002|Overall Study|Lost to Follow-up|0|||
149222005|NCT01055457|538278793|FG003|Overall Study|Lost to Follow-up|0|||
149222006|NCT01055457|538278794|FG004|Overall Study|Lost to Follow-up|0|||
149222007|NCT01055457|538278795|FG005|Overall Study|Lost to Follow-up|1|||
149222008|NCT01055457|538278796|FG006|Overall Study|Lost to Follow-up|0|||
149222009|NCT01055457|538278797|FG007|Overall Study|Lost to Follow-up|0|||
149222010|NCT01055457|538278798|FG008|Overall Study|Lost to Follow-up|0|||
149222011|NCT01055457|538278799|FG009|Overall Study|Lost to Follow-up|0|||
149222012|NCT01055457|538278790|FG000|Overall Study|Protocol Violation|0|||
149222013|NCT01055457|538278791|FG001|Overall Study|Protocol Violation|0|||
149222014|NCT01055457|538278792|FG002|Overall Study|Protocol Violation|1|||
149222015|NCT01055457|538278793|FG003|Overall Study|Protocol Violation|1|||
149222016|NCT01055457|538278794|FG004|Overall Study|Protocol Violation|1|||
149222017|NCT01055457|538278795|FG005|Overall Study|Protocol Violation|2|||
149222018|NCT01055457|538278796|FG006|Overall Study|Protocol Violation|1|||
149222019|NCT01055457|538278797|FG007|Overall Study|Protocol Violation|0|||
149222020|NCT01055457|538278798|FG008|Overall Study|Protocol Violation|0|||
149222021|NCT01055457|538278799|FG009|Overall Study|Protocol Violation|1|||
149222022|NCT01055457|538278790|FG000|Overall Study|Subject Disinterest|0|||
149222023|NCT01055457|538278791|FG001|Overall Study|Subject Disinterest|0|||
149222024|NCT01055457|538278792|FG002|Overall Study|Subject Disinterest|0|||
149222025|NCT01055457|538278793|FG003|Overall Study|Subject Disinterest|0|||
149222026|NCT01055457|538278794|FG004|Overall Study|Subject Disinterest|0|||
149222027|NCT01055457|538278795|FG005|Overall Study|Subject Disinterest|0|||
149222028|NCT01055457|538278796|FG006|Overall Study|Subject Disinterest|0|||
149222029|NCT01055457|538278797|FG007|Overall Study|Subject Disinterest|1|||
149222030|NCT01055457|538278798|FG008|Overall Study|Subject Disinterest|0|||
149222031|NCT01055457|538278799|FG009|Overall Study|Subject Disinterest|0|||
149222032|NCT01055457|538278790|FG000|Overall Study|Subject Ineligible|1|||
149222033|NCT01055457|538278791|FG001|Overall Study|Subject Ineligible|0|||
149222034|NCT01055457|538278792|FG002|Overall Study|Subject Ineligible|1|||
149222035|NCT01055457|538278793|FG003|Overall Study|Subject Ineligible|0|||
149222036|NCT01055457|538278794|FG004|Overall Study|Subject Ineligible|1|||
149222037|NCT01055457|538278795|FG005|Overall Study|Subject Ineligible|0|||
149222038|NCT01055457|538278796|FG006|Overall Study|Subject Ineligible|0|||
149222039|NCT01055457|538278797|FG007|Overall Study|Subject Ineligible|0|||
149222040|NCT01055457|538278798|FG008|Overall Study|Subject Ineligible|0|||
149222041|NCT01055457|538278799|FG009|Overall Study|Subject Ineligible|0|||
149222042|NCT01055457|538278790|FG000|Overall Study|Discomfort|0|||
149222043|NCT01055457|538278791|FG001|Overall Study|Discomfort|0|||
149222044|NCT01055457|538278792|FG002|Overall Study|Discomfort|0|||
149222045|NCT01055457|538278793|FG003|Overall Study|Discomfort|0|||
149222046|NCT01055457|538278794|FG004|Overall Study|Discomfort|1|||
149222047|NCT01055457|538278795|FG005|Overall Study|Discomfort|0|||
149222048|NCT01055457|538278796|FG006|Overall Study|Discomfort|0|||
149222049|NCT01055457|538278797|FG007|Overall Study|Discomfort|0|||
149222050|NCT01055457|538278798|FG008|Overall Study|Discomfort|0|||
149222051|NCT01055457|538278799|FG009|Overall Study|Discomfort|0|||
149222052|NCT01055457|538278790|FG000|Overall Study|Pregnancy|0|||
149222053|NCT01055457|538278791|FG001|Overall Study|Pregnancy|0|||
148953589|NCT02670083|537313043|FG001|Overall Study|Physician Decision|2|||
148953590|NCT02670083|537313042|FG000|Overall Study|Study Terminated By Sponsor|257|||
149222054|NCT01055457|538278792|FG002|Overall Study|Pregnancy|0|||
149222055|NCT01055457|538278793|FG003|Overall Study|Pregnancy|1|||
149222056|NCT01055457|538278794|FG004|Overall Study|Pregnancy|0|||
149222057|NCT01055457|538278795|FG005|Overall Study|Pregnancy|0|||
149222058|NCT01055457|538278796|FG006|Overall Study|Pregnancy|0|||
149222059|NCT01055457|538278797|FG007|Overall Study|Pregnancy|0|||
149222060|NCT01055457|538278798|FG008|Overall Study|Pregnancy|0|||
149222061|NCT01055457|538278799|FG009|Overall Study|Pregnancy|0|||
149222062|NCT01055457|538278790|FG000|Overall Study|Adverse Event|0|||
149222063|NCT01055457|538278791|FG001|Overall Study|Adverse Event|0|||
149222064|NCT01055457|538278792|FG002|Overall Study|Adverse Event|0|||
149222065|NCT01055457|538278793|FG003|Overall Study|Adverse Event|1|||
149222066|NCT01055457|538278794|FG004|Overall Study|Adverse Event|0|||
149222067|NCT01055457|538278795|FG005|Overall Study|Adverse Event|0|||
149222068|NCT01055457|538278796|FG006|Overall Study|Adverse Event|0|||
149222069|NCT01055457|538278797|FG007|Overall Study|Adverse Event|0|||
149222070|NCT01055457|538278798|FG008|Overall Study|Adverse Event|0|||
149222071|NCT01055457|538278799|FG009|Overall Study|Adverse Event|0|||
149222072|NCT02187224|538278800|FG000|Overall Study|Did not show up for test day|1|||
149222073|NCT02187224|538278801|FG001|Overall Study|Did not show up for test day|0|||
149222074|NCT01010776|538278808|FG000|Main Phase|Withdrawal by Subject|14|||
149222075|NCT01010776|538278808|FG000|Main Phase|Lack of Efficacy|8|||
148685590|NCT01360632|536321529|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
148685591|NCT01360632|536321525|FG000|Phase A (8 Weeks)|Physician Decision|10|||
148685592|NCT01360632|536321526|FG001|Phase A (8 Weeks)|Physician Decision|0|||
148685593|NCT01360632|536321527|FG002|Phase A (8 Weeks)|Physician Decision|0|||
148685594|NCT01360632|536321528|FG003|Phase A (8 Weeks)|Physician Decision|0|||
148685595|NCT01360632|536321529|FG004|Phase A (8 Weeks)|Physician Decision|0|||
148685596|NCT01360632|536321525|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
148685597|NCT01360632|536321526|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
148685598|NCT01360632|536321527|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
148685599|NCT01360632|536321528|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
148685600|NCT01360632|536321529|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
148685601|NCT01360632|536321525|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
148685602|NCT01360632|536321526|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
148685603|NCT01360632|536321527|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
148685604|NCT01360632|536321528|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
148685605|NCT01360632|536321529|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
148685606|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
148685607|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
148685608|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
148685609|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
148685610|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
148685611|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Adverse Event|0|||
148685612|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Adverse Event|3|||
148685613|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Adverse Event|9|||
148685614|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Adverse Event|3|||
148685615|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Adverse Event|0|||
148685616|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
148685617|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
148685618|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
148685619|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
148685620|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
148685621|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Physician Decision|0|||
148809987|NCT04530344|536780922|FG000|Overall Study|Personal Reasons|0|||
149222076|NCT01010776|538278808|FG000|Main Phase|Adverse Event|7|||
149222077|NCT01010776|538278808|FG000|Main Phase|Lost to Follow-up|6|||
149222078|NCT01010776|538278808|FG000|Main Phase|Non-compliance to study medication|5|||
149222079|NCT01010776|538278808|FG000|Main Phase|Selection failure|2|||
148809988|NCT04530344|536780923|FG001|Overall Study|Personal Reasons|0|||
149222080|NCT01010776|538278808|FG000|Main Phase|Inform consent withdrawal|1|||
149222081|NCT01010776|538278808|FG000|Main Phase|Other|1|||
149222082|NCT01010776|538278808|FG000|Main Phase|Did not received study medication|5|||
149222083|NCT01010776|538278808|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
149222084|NCT01010776|538278808|FG000|Extension Phase|Other|3|||
149222085|NCT01846208|538278817|FG000|Overall Study|Withdrew prior to treatment|1|||
149222086|NCT01846208|538278818|FG001|Overall Study|Withdrew prior to treatment|1|||
149222087|NCT01846208|538278819|FG002|Overall Study|Withdrew prior to treatment|1|||
149222088|NCT01846208|538278817|FG000|Overall Study|Dosing Symptoms|1|||
149222089|NCT01846208|538278818|FG001|Overall Study|Dosing Symptoms|2|||
149222090|NCT01846208|538278819|FG002|Overall Study|Dosing Symptoms|6|||
149222091|NCT01846208|538278817|FG000|Overall Study|Withdrawal by Subject|5|||
149222092|NCT01846208|538278818|FG001|Overall Study|Withdrawal by Subject|0|||
149222093|NCT01846208|538278819|FG002|Overall Study|Withdrawal by Subject|0|||
149222094|NCT01846208|538278817|FG000|Overall Study|Non-compliance|1|||
149222095|NCT01846208|538278818|FG001|Overall Study|Non-compliance|1|||
149222096|NCT01846208|538278819|FG002|Overall Study|Non-compliance|0|||
149222097|NCT01846208|538278817|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
149222098|NCT01846208|538278818|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
149222099|NCT01846208|538278819|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
149222100|NCT01846208|538278817|FG000|Overall Study|Refused SU OFC|0|||
149222101|NCT01846208|538278818|FG001|Overall Study|Refused SU OFC|0|||
149222102|NCT01846208|538278819|FG002|Overall Study|Refused SU OFC|1|||
149222103|NCT01268514|538278820|FG000|Overall Study|Adverse Event|20|||
149222104|NCT01268514|538278820|FG000|Overall Study|Death|8|||
149222105|NCT01268514|538278820|FG000|Overall Study|Lost to Follow-up|5|||
149222106|NCT01268514|538278820|FG000|Overall Study|Withdrawal by Subject|3|||
149222107|NCT01268514|538278820|FG000|Overall Study|Withdrawal by Surgeon|5|||
149222108|NCT01424306|538278821|FG000|Overall Study|Protocol Violation|0|||
149222109|NCT01424306|538278822|FG001|Overall Study|Protocol Violation|0|||
149222110|NCT01424306|538278823|FG002|Overall Study|Protocol Violation|0|||
149222111|NCT01424306|538278824|FG003|Overall Study|Protocol Violation|0|||
149222112|NCT01424306|538278825|FG004|Overall Study|Protocol Violation|1|||
149222113|NCT01424306|538278826|FG005|Overall Study|Protocol Violation|0|||
149222114|NCT01875874|538278830|FG000|Overall Study|Death|3|||
149222115|NCT00374127|538278833|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
149222116|NCT00374127|538278833|FG000|Overall Study|Blood could not be drawn.|2|||
149222117|NCT00374127|538278833|FG000|Overall Study|Protocol Violation|5|||
149222118|NCT00374127|538278833|FG000|Overall Study|Pregnancy|1|||
149222119|NCT03344562|538278834|FG000|Overall Study|Withdrawal by Subject|2|||
149222120|NCT03344562|538278835|FG001|Overall Study|Withdrawal by Subject|0|||
149222121|NCT02736474|538278836|FG000|Overall Study|Lost to Follow-up|0|||
149222122|NCT02736474|538278837|FG001|Overall Study|Lost to Follow-up|1|||
149222123|NCT02382276|538278838|FG000|Overall Study|Withdrawal by Subject|4|||
149222124|NCT02382276|538278839|FG001|Overall Study|Withdrawal by Subject|8|||
149222125|NCT02382276|538278840|FG002|Overall Study|Withdrawal by Subject|5|||
149222126|NCT02382276|538278838|FG000|Overall Study|Adverse Event|7|||
149222127|NCT02382276|538278839|FG001|Overall Study|Adverse Event|2|||
149222128|NCT02382276|538278840|FG002|Overall Study|Adverse Event|32|||
149222129|NCT02382276|538278838|FG000|Overall Study|Physician Decision|0|||
149222130|NCT02382276|538278839|FG001|Overall Study|Physician Decision|0|||
149222131|NCT02382276|538278840|FG002|Overall Study|Physician Decision|2|||
148809989|NCT04530344|536780924|FG002|Overall Study|Personal Reasons|0|||
148685622|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Physician Decision|0|||
148953591|NCT02670083|537313043|FG001|Overall Study|Study Terminated By Sponsor|254|||
148953592|NCT02670083|537313042|FG000|Overall Study|Symptomatic Deterioration|0|||
148953593|NCT02670083|537313043|FG001|Overall Study|Symptomatic Deterioration|2|||
148953594|NCT02670083|537313042|FG000|Overall Study|Withdrawal by Subject|32|||
148953595|NCT02670083|537313043|FG001|Overall Study|Withdrawal by Subject|31|||
148953596|NCT02670083|537313042|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148685623|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Physician Decision|0|||
148685624|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Physician Decision|1|||
148685625|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Physician Decision|0|||
148685626|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
148685627|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
148685628|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
148685629|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
148685630|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
148685631|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
148685632|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
148685633|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
148685634|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
148685635|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
148685636|NCT01360632|536321525|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
148685637|NCT01360632|536321526|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
148685638|NCT01360632|536321527|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
148685639|NCT01360632|536321528|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
148685640|NCT01360632|536321529|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
148685641|NCT01360632|536321525|FG000|Phase A+|Lost to Follow-up|0|||
148685642|NCT01360632|536321526|FG001|Phase A+|Lost to Follow-up|0|||
148685643|NCT01360632|536321527|FG002|Phase A+|Lost to Follow-up|0|||
148685644|NCT01360632|536321528|FG003|Phase A+|Lost to Follow-up|0|||
148809990|NCT04530344|536780925|FG003|Overall Study|Personal Reasons|1|||
149222132|NCT02520141|538278843|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
149222133|NCT00703781|538278848|FG000|Overall Study|Withdrawal by Subject|1|||
149222134|NCT00703781|538278849|FG001|Overall Study|Withdrawal by Subject|2|||
149222135|NCT00703781|538278848|FG000|Overall Study|Cancelled surgery|1|||
149222136|NCT00703781|538278849|FG001|Overall Study|Cancelled surgery|0|||
149222137|NCT02168816|538278850|FG000|Overall Study|Lost to Follow-up|2|||
149222138|NCT02168816|538278851|FG001|Overall Study|Lost to Follow-up|2|||
149222139|NCT01066546|538278856|FG000|Overall Study|Study terminated by sponsor|5|||
149222140|NCT03258762|538278861|FG000|Overall Study|Lost to Follow-up|0|||
149222141|NCT03258762|538278862|FG001|Overall Study|Lost to Follow-up|1|||
149222142|NCT02545049|538278866|FG000|Overall Study|Withdrawal by Subject|1|||
149222143|NCT02545049|538278867|FG001|Overall Study|Withdrawal by Subject|7|||
149222144|NCT02545049|538278866|FG000|Overall Study|Lost to Follow-up|4|||
149222145|NCT02545049|538278867|FG001|Overall Study|Lost to Follow-up|6|||
148809991|NCT04530344|536780922|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
148809992|NCT04530344|536780923|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
148809993|NCT04530344|536780924|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
148809994|NCT04530344|536780925|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
148809995|NCT01977846|536780936|FG000|Total Study - Prospective|Death|0|||
148809996|NCT01977846|536780937|FG001|Total Study - Prospective|Death|1|||
148809997|NCT01977846|536780936|FG000|Total Study - Prospective|Lost to Follow-up|0|||
148809998|NCT01977846|536780937|FG001|Total Study - Prospective|Lost to Follow-up|8|||
148809999|NCT01977846|536780936|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
148810000|NCT01977846|536780937|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
148810001|NCT01977846|536780936|FG000|Total Study - Prospective|Not available at time of visit|0|||
148810002|NCT01977846|536780937|FG001|Total Study - Prospective|Not available at time of visit|5|||
148810003|NCT01977846|536780936|FG000|Total Study - Prospective|No show|0|||
148810004|NCT01977846|536780937|FG001|Total Study - Prospective|No show|1|||
148810005|NCT01977846|536780936|FG000|Total Study - Prospective|Protocol Violation|0|||
148810006|NCT01977846|536780937|FG001|Total Study - Prospective|Protocol Violation|1|||
148810007|NCT02164916|536780938|FG000|Overall Study|Adverse Event|3|||
148810008|NCT02164916|536780939|FG001|Overall Study|Adverse Event|8|||
148810009|NCT02164916|536780938|FG000|Overall Study|Death|1|||
148953597|NCT02670083|537313043|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148953598|NCT02825992|537313044|FG000|Overall Study|Withdrawal by Subject|4|||
148685645|NCT01360632|536321529|FG004|Phase A+|Lost to Follow-up|2|||
148685646|NCT01360632|536321525|FG000|Phase A+|Adverse Event|0|||
148685647|NCT01360632|536321526|FG001|Phase A+|Adverse Event|0|||
148810010|NCT02164916|536780939|FG001|Overall Study|Death|1|||
148953599|NCT02825992|537313044|FG000|Overall Study|Lost to Follow-up|2|||
149017995|NCT01853254|537547146|FG000|Overall Study|Failure to Return|43|||
149017996|NCT01853254|537547146|FG000|Overall Study|Insufficient Therapeutic Response|22|||
149222146|NCT02545049|538278866|FG000|Overall Study|GCP violations|37|||
149222147|NCT02545049|538278867|FG001|Overall Study|GCP violations|48|||
149222148|NCT04191096|538278879|FG000|Overall Study|Death|102|||
149222149|NCT04191096|538278880|FG001|Overall Study|Death|89|||
148685648|NCT01360632|536321527|FG002|Phase A+|Adverse Event|0|||
148685649|NCT01360632|536321528|FG003|Phase A+|Adverse Event|0|||
148685650|NCT01360632|536321529|FG004|Phase A+|Adverse Event|2|||
148685651|NCT01360632|536321525|FG000|Phase A+|Met Withdrawal Criteria|0|||
148685652|NCT01360632|536321526|FG001|Phase A+|Met Withdrawal Criteria|0|||
148685653|NCT01360632|536321527|FG002|Phase A+|Met Withdrawal Criteria|0|||
148685654|NCT01360632|536321528|FG003|Phase A+|Met Withdrawal Criteria|0|||
148685655|NCT01360632|536321529|FG004|Phase A+|Met Withdrawal Criteria|7|||
148685656|NCT01360632|536321525|FG000|Phase A+|Physician Decision|0|||
148685657|NCT01360632|536321526|FG001|Phase A+|Physician Decision|0|||
148685658|NCT01360632|536321527|FG002|Phase A+|Physician Decision|0|||
148685659|NCT01360632|536321528|FG003|Phase A+|Physician Decision|0|||
148685660|NCT01360632|536321529|FG004|Phase A+|Physician Decision|3|||
148685661|NCT01360632|536321525|FG000|Phase A+|Withdrawal by Subject|0|||
148685662|NCT01360632|536321526|FG001|Phase A+|Withdrawal by Subject|0|||
148685663|NCT01360632|536321527|FG002|Phase A+|Withdrawal by Subject|0|||
148685664|NCT01360632|536321528|FG003|Phase A+|Withdrawal by Subject|0|||
148685665|NCT01360632|536321529|FG004|Phase A+|Withdrawal by Subject|8|||
148685666|NCT01360632|536321525|FG000|Phase A+|Protocol Deviation|0|||
148685667|NCT01360632|536321526|FG001|Phase A+|Protocol Deviation|0|||
148685668|NCT01360632|536321527|FG002|Phase A+|Protocol Deviation|0|||
148685669|NCT01360632|536321528|FG003|Phase A+|Protocol Deviation|0|||
148685670|NCT01360632|536321529|FG004|Phase A+|Protocol Deviation|3|||
148685671|NCT01298596|536321530|FG000|Overall Study|Withdrawal by Subject|1|||
148685672|NCT01298596|536321531|FG001|Overall Study|Withdrawal by Subject|1|||
148685673|NCT01298596|536321530|FG000|Overall Study|Death|5|||
148685674|NCT01298596|536321531|FG001|Overall Study|Death|3|||
148685675|NCT01298596|536321530|FG000|Overall Study|Lost to Follow-up|6|||
148685676|NCT01298596|536321531|FG001|Overall Study|Lost to Follow-up|14|||
148685677|NCT01298596|536321530|FG000|Overall Study|Referred for further management|16|||
148685678|NCT01298596|536321531|FG001|Overall Study|Referred for further management|15|||
148685679|NCT04128696|536321532|FG000|Overall Study|Lost to Follow-up|3|||
148685680|NCT04128696|536321533|FG001|Overall Study|Lost to Follow-up|7|||
148685681|NCT04128696|536321532|FG000|Overall Study|Withdrawal by Subject|12|||
148685682|NCT04128696|536321533|FG001|Overall Study|Withdrawal by Subject|11|||
148685683|NCT04128696|536321532|FG000|Overall Study|Study Closed/Terminated|26|||
148685684|NCT04128696|536321533|FG001|Overall Study|Study Closed/Terminated|38|||
148685685|NCT04128696|536321532|FG000|Overall Study|Physician Decision|2|||
148685686|NCT04128696|536321533|FG001|Overall Study|Physician Decision|3|||
148685687|NCT02046369|536321534|FG000|Overall Study|Adverse Event|3|||
148685688|NCT02046369|536321535|FG001|Overall Study|Adverse Event|3|||
148685689|NCT02046369|536321534|FG000|Overall Study|Lack of Efficacy|3|||
148685690|NCT02046369|536321535|FG001|Overall Study|Lack of Efficacy|3|||
148685691|NCT02046369|536321534|FG000|Overall Study|Lost to Follow-up|3|||
148685692|NCT02046369|536321535|FG001|Overall Study|Lost to Follow-up|3|||
148685693|NCT02046369|536321534|FG000|Overall Study|Protocol Violation|1|||
148685694|NCT02046369|536321535|FG001|Overall Study|Protocol Violation|2|||
148685695|NCT02046369|536321534|FG000|Overall Study|Withdrawal by Subject|3|||
148685696|NCT02046369|536321535|FG001|Overall Study|Withdrawal by Subject|6|||
148685697|NCT02046369|536321534|FG000|Overall Study|never received study drug|0|||
148685698|NCT02046369|536321535|FG001|Overall Study|never received study drug|1|||
148685699|NCT02046369|536321534|FG000|Overall Study|non compliance|1|||
149222150|NCT04191096|538278879|FG000|Overall Study|Lost to Follow-up|1|||
149222151|NCT04191096|538278880|FG001|Overall Study|Lost to Follow-up|1|||
149222152|NCT04191096|538278879|FG000|Overall Study|Withdrawal by Subject|5|||
149222153|NCT04191096|538278880|FG001|Overall Study|Withdrawal by Subject|5|||
149222154|NCT04191096|538278879|FG000|Overall Study|Participants Ongoing|518|||
149222155|NCT04191096|538278880|FG001|Overall Study|Participants Ongoing|530|||
149222156|NCT01004861|538280600|FG000|Overall Study|Disease progression|3|||
149222157|NCT01004861|538280601|FG001|Overall Study|Disease progression|4|||
148685700|NCT02046369|536321535|FG001|Overall Study|non compliance|0|||
148685701|NCT02196506|536321540|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
148685702|NCT02196506|536321541|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
148685703|NCT02196506|536321542|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
148685704|NCT02196506|536321543|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
148685705|NCT02196506|536321540|FG000|Phase A|Withdrawal by Subject|34|||
148685706|NCT02196506|536321541|FG001|Phase A|Withdrawal by Subject|0|||
148685707|NCT02196506|536321542|FG002|Phase A|Withdrawal by Subject|0|||
148685708|NCT02196506|536321543|FG003|Phase A|Withdrawal by Subject|0|||
148685709|NCT02196506|536321540|FG000|Phase A|Adverse Event|22|||
148685710|NCT02196506|536321541|FG001|Phase A|Adverse Event|0|||
148685711|NCT02196506|536321542|FG002|Phase A|Adverse Event|0|||
148685712|NCT02196506|536321543|FG003|Phase A|Adverse Event|0|||
148685713|NCT02196506|536321540|FG000|Phase A|Lost to Follow-up|9|||
148685714|NCT02196506|536321541|FG001|Phase A|Lost to Follow-up|0|||
148685715|NCT02196506|536321542|FG002|Phase A|Lost to Follow-up|0|||
149222158|NCT01004861|538280602|FG002|Overall Study|Disease progression|5|||
149222159|NCT01004861|538280603|FG003|Overall Study|Disease progression|4|||
148685716|NCT02196506|536321543|FG003|Phase A|Lost to Follow-up|0|||
148685717|NCT02196506|536321540|FG000|Phase A|Protocol deviation|12|||
149017997|NCT01853254|537547146|FG000|Overall Study|Refusal of Treatment|1|||
149017998|NCT01853254|537547146|FG000|Overall Study|Other Protocol Violation|1|||
149017999|NCT01853254|537547146|FG000|Overall Study|Withdrawal of Consent|16|||
149018000|NCT01853254|537547146|FG000|Overall Study|Administrative/Other|16|||
149018001|NCT02462083|537547147|FG000|Overall Study|Sponsor request|39|||
149018002|NCT02462083|537547147|FG000|Overall Study|Withdrawal by Subject|87|||
149018003|NCT02462083|537547147|FG000|Overall Study|Lost to Follow-up|41|||
149018004|NCT02462083|537547147|FG000|Overall Study|Lack of Efficacy|151|||
149018005|NCT02462083|537547147|FG000|Overall Study|Pregnancy|1|||
149018006|NCT02462083|537547147|FG000|Overall Study|Protocol Violation|6|||
149018007|NCT02462083|537547147|FG000|Overall Study|Adverse Event|33|||
149018008|NCT02462083|537547147|FG000|Overall Study|Worsening condition|16|||
149018009|NCT02462083|537547147|FG000|Overall Study|Other than specified|45|||
149018010|NCT01474512|537547149|FG000|Induction Period|Adverse Event|6|||
149018011|NCT01474512|537547150|FG001|Induction Period|Adverse Event|10|||
149018012|NCT01474512|537547151|FG002|Induction Period|Adverse Event|10|||
149018013|NCT01474512|537547152|FG003|Induction Period|Adverse Event|0|||
149018014|NCT01474512|537547153|FG004|Induction Period|Adverse Event|0|||
149018015|NCT01474512|537547154|FG005|Induction Period|Adverse Event|0|||
149018016|NCT01474512|537547155|FG006|Induction Period|Adverse Event|0|||
149018017|NCT01474512|537547156|FG007|Induction Period|Adverse Event|0|||
149018018|NCT01474512|537547157|FG008|Induction Period|Adverse Event|0|||
149018019|NCT01474512|537547158|FG009|Induction Period|Adverse Event|0|||
149018020|NCT01474512|537547159|FG010|Induction Period|Adverse Event|0|||
149222160|NCT01004861|538280604|FG004|Overall Study|Disease progression|4|||
149222161|NCT01004861|538280605|FG005|Overall Study|Disease progression|4|||
149222162|NCT01004861|538280606|FG006|Overall Study|Disease progression|5|||
149222163|NCT01004861|538280607|FG007|Overall Study|Disease progression|1|||
149222164|NCT01004861|538280608|FG008|Overall Study|Disease progression|4|||
149222165|NCT01004861|538280609|FG009|Overall Study|Disease progression|7|||
149222166|NCT01004861|538280610|FG010|Overall Study|Disease progression|6|||
149222167|NCT01004861|538280611|FG011|Overall Study|Disease progression|3|||
149222168|NCT01004861|538280612|FG012|Overall Study|Disease progression|8|||
149222169|NCT01004861|538280600|FG000|Overall Study|Physician Decision|0|||
149222170|NCT01004861|538280601|FG001|Overall Study|Physician Decision|2|||
149018021|NCT01474512|537547160|FG011|Induction Period|Adverse Event|0|||
149222171|NCT01004861|538280602|FG002|Overall Study|Physician Decision|1|||
149222172|NCT01004861|538280603|FG003|Overall Study|Physician Decision|1|||
149222173|NCT01004861|538280604|FG004|Overall Study|Physician Decision|1|||
149222174|NCT01004861|538280605|FG005|Overall Study|Physician Decision|0|||
149222175|NCT01004861|538280606|FG006|Overall Study|Physician Decision|0|||
149222176|NCT01004861|538280607|FG007|Overall Study|Physician Decision|1|||
149222177|NCT01004861|538280608|FG008|Overall Study|Physician Decision|0|||
149222178|NCT01004861|538280609|FG009|Overall Study|Physician Decision|0|||
149222179|NCT01004861|538280610|FG010|Overall Study|Physician Decision|0|||
149222180|NCT01004861|538280611|FG011|Overall Study|Physician Decision|0|||
149018022|NCT01474512|537547161|FG012|Induction Period|Adverse Event|0|||
149018023|NCT01474512|537547162|FG013|Induction Period|Adverse Event|0|||
149018024|NCT01474512|537547163|FG014|Induction Period|Adverse Event|0|||
149222181|NCT01004861|538280612|FG012|Overall Study|Physician Decision|3|||
149222182|NCT01004861|538280600|FG000|Overall Study|Adverse Event|0|||
149222183|NCT01004861|538280601|FG001|Overall Study|Adverse Event|0|||
149222184|NCT01004861|538280602|FG002|Overall Study|Adverse Event|0|||
149222185|NCT01004861|538280603|FG003|Overall Study|Adverse Event|1|||
149222186|NCT01004861|538280604|FG004|Overall Study|Adverse Event|0|||
148953600|NCT02825992|537313044|FG000|Overall Study|Procedure terminated|2|||
148953601|NCT02279173|537313048|FG000|Overall Study|Protocol-specified Criteria|67|||
148953602|NCT02279173|537313048|FG000|Overall Study|Withdrawal by Subject|20|||
148953603|NCT02279173|537313048|FG000|Overall Study|Decision by Sponsor|4|||
148953604|NCT02279173|537313048|FG000|Overall Study|Lost to Follow-up|3|||
148953605|NCT01164956|537313051|FG000|Overall Study|Side Effects|1|||
148953606|NCT01164956|537313052|FG001|Overall Study|Side Effects|0|||
148953607|NCT01164956|537313053|FG002|Overall Study|Side Effects|1|||
149222187|NCT01004861|538280605|FG005|Overall Study|Adverse Event|2|||
149222188|NCT01004861|538280606|FG006|Overall Study|Adverse Event|1|||
149222189|NCT01004861|538280607|FG007|Overall Study|Adverse Event|1|||
149222190|NCT01004861|538280608|FG008|Overall Study|Adverse Event|13|||
149222191|NCT01004861|538280609|FG009|Overall Study|Adverse Event|1|||
149222192|NCT01004861|538280610|FG010|Overall Study|Adverse Event|1|||
149222193|NCT01004861|538280611|FG011|Overall Study|Adverse Event|0|||
149222194|NCT01004861|538280612|FG012|Overall Study|Adverse Event|2|||
149222195|NCT01004861|538280600|FG000|Overall Study|Protocol Violation|0|||
149222196|NCT01004861|538280601|FG001|Overall Study|Protocol Violation|0|||
149222197|NCT01004861|538280602|FG002|Overall Study|Protocol Violation|0|||
149222198|NCT01004861|538280603|FG003|Overall Study|Protocol Violation|0|||
149222199|NCT01004861|538280604|FG004|Overall Study|Protocol Violation|1|||
149222200|NCT01004861|538280605|FG005|Overall Study|Protocol Violation|0|||
149222201|NCT01004861|538280606|FG006|Overall Study|Protocol Violation|0|||
148953608|NCT00720434|537313054|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
148953609|NCT00720434|537313055|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
148953610|NCT00720434|537313056|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
148953611|NCT00720434|537313057|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
148953612|NCT00720434|537313054|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
148953613|NCT00720434|537313055|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
148953614|NCT00720434|537313056|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
148953615|NCT00720434|537313057|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
149222202|NCT01004861|538280607|FG007|Overall Study|Protocol Violation|0|||
149222203|NCT01004861|538280608|FG008|Overall Study|Protocol Violation|0|||
149222204|NCT01004861|538280609|FG009|Overall Study|Protocol Violation|0|||
149222205|NCT01004861|538280610|FG010|Overall Study|Protocol Violation|0|||
149222206|NCT01004861|538280611|FG011|Overall Study|Protocol Violation|0|||
149222207|NCT01004861|538280612|FG012|Overall Study|Protocol Violation|0|||
149222208|NCT01004861|538280600|FG000|Overall Study|Lost to Follow-up|0|||
149222209|NCT01004861|538280601|FG001|Overall Study|Lost to Follow-up|0|||
149222210|NCT01004861|538280602|FG002|Overall Study|Lost to Follow-up|0|||
149222211|NCT01004861|538280603|FG003|Overall Study|Lost to Follow-up|0|||
149222212|NCT01004861|538280604|FG004|Overall Study|Lost to Follow-up|0|||
149222213|NCT01004861|538280605|FG005|Overall Study|Lost to Follow-up|0|||
149222214|NCT01004861|538280606|FG006|Overall Study|Lost to Follow-up|0|||
149222215|NCT01004861|538280607|FG007|Overall Study|Lost to Follow-up|1|||
149222216|NCT01004861|538280608|FG008|Overall Study|Lost to Follow-up|3|||
149222217|NCT01004861|538280609|FG009|Overall Study|Lost to Follow-up|0|||
149222218|NCT01004861|538280610|FG010|Overall Study|Lost to Follow-up|0|||
149222219|NCT01004861|538280611|FG011|Overall Study|Lost to Follow-up|1|||
149222220|NCT01004861|538280612|FG012|Overall Study|Lost to Follow-up|0|||
149222221|NCT01004861|538280600|FG000|Overall Study|Non-compliance|0|||
149222222|NCT01004861|538280601|FG001|Overall Study|Non-compliance|0|||
149222223|NCT01004861|538280602|FG002|Overall Study|Non-compliance|0|||
149222224|NCT01004861|538280603|FG003|Overall Study|Non-compliance|0|||
149222225|NCT01004861|538280604|FG004|Overall Study|Non-compliance|0|||
149222226|NCT01004861|538280605|FG005|Overall Study|Non-compliance|0|||
148685718|NCT02196506|536321541|FG001|Phase A|Protocol deviation|0|||
148685719|NCT02196506|536321542|FG002|Phase A|Protocol deviation|0|||
148685720|NCT02196506|536321543|FG003|Phase A|Protocol deviation|0|||
148685721|NCT02196506|536321540|FG000|Phase A|Participant withdrawn by investigator|10|||
148685722|NCT02196506|536321541|FG001|Phase A|Participant withdrawn by investigator|0|||
148685723|NCT02196506|536321542|FG002|Phase A|Participant withdrawn by investigator|0|||
148685724|NCT02196506|536321543|FG003|Phase A|Participant withdrawn by investigator|0|||
148685725|NCT02196506|536321540|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
148685726|NCT02196506|536321541|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
148685727|NCT02196506|536321542|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
148685728|NCT02196506|536321543|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
148685729|NCT02196506|536321540|FG000|Phase B|Lack of Efficacy|0|||
148685730|NCT02196506|536321541|FG001|Phase B|Lack of Efficacy|1|||
148685731|NCT02196506|536321542|FG002|Phase B|Lack of Efficacy|2|||
148685732|NCT02196506|536321543|FG003|Phase B|Lack of Efficacy|0|||
148685733|NCT02196506|536321540|FG000|Phase B|Withdrawal by Participant|0|||
148685734|NCT02196506|536321541|FG001|Phase B|Withdrawal by Participant|8|||
148685735|NCT02196506|536321542|FG002|Phase B|Withdrawal by Participant|1|||
148685736|NCT02196506|536321543|FG003|Phase B|Withdrawal by Participant|0|||
148685737|NCT02196506|536321540|FG000|Phase B|Adverse Event|0|||
148685738|NCT02196506|536321541|FG001|Phase B|Adverse Event|4|||
148685739|NCT02196506|536321542|FG002|Phase B|Adverse Event|1|||
148685740|NCT02196506|536321543|FG003|Phase B|Adverse Event|0|||
148685741|NCT02196506|536321540|FG000|Phase B|Lost to Follow-up|0|||
148685742|NCT02196506|536321541|FG001|Phase B|Lost to Follow-up|2|||
148685743|NCT02196506|536321542|FG002|Phase B|Lost to Follow-up|1|||
148685744|NCT02196506|536321543|FG003|Phase B|Lost to Follow-up|0|||
148685745|NCT02196506|536321540|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
148685746|NCT02196506|536321541|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
148685747|NCT02196506|536321542|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
148685748|NCT02196506|536321543|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
148685749|NCT02196506|536321540|FG000|Phase A+|Withdrawal by Participant|0|||
148685750|NCT02196506|536321541|FG001|Phase A+|Withdrawal by Participant|0|||
148685751|NCT02196506|536321542|FG002|Phase A+|Withdrawal by Participant|0|||
148685752|NCT02196506|536321543|FG003|Phase A+|Withdrawal by Participant|5|||
148685753|NCT02196506|536321540|FG000|Phase A+|Adverse Event|0|||
148685754|NCT02196506|536321541|FG001|Phase A+|Adverse Event|0|||
148685755|NCT02196506|536321542|FG002|Phase A+|Adverse Event|0|||
148685756|NCT02196506|536321543|FG003|Phase A+|Adverse Event|1|||
148685757|NCT02196506|536321540|FG000|Phase A+|Lost to Follow-up|0|||
148685758|NCT02196506|536321541|FG001|Phase A+|Lost to Follow-up|0|||
148685759|NCT02196506|536321542|FG002|Phase A+|Lost to Follow-up|0|||
148685760|NCT02196506|536321543|FG003|Phase A+|Lost to Follow-up|6|||
148685761|NCT02196506|536321540|FG000|Phase A+|Participant withdrawn by investigator|0|||
148685762|NCT02196506|536321541|FG001|Phase A+|Participant withdrawn by investigator|0|||
148685763|NCT02196506|536321542|FG002|Phase A+|Participant withdrawn by investigator|0|||
148685764|NCT02196506|536321543|FG003|Phase A+|Participant withdrawn by investigator|1|||
148810011|NCT02164916|536780938|FG000|Overall Study|Refusal unrelated to adverse event|3|||
148953616|NCT00720434|537313054|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
148685765|NCT04578548|536321544|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
148685766|NCT04578548|536321545|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
148685767|NCT04578548|536321544|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
148685768|NCT04578548|536321545|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
148685769|NCT04578548|536321544|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
148953617|NCT00720434|537313055|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
148953618|NCT00720434|537313056|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
148685770|NCT04578548|536321545|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
148685771|NCT04578548|536321544|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
148685772|NCT04578548|536321545|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
148685773|NCT04578548|536321544|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
148685774|NCT04578548|536321545|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
148685775|NCT04578548|536321544|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
148685776|NCT04578548|536321545|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
148685777|NCT02482805|536323456|FG000|Overall Study|Lost to Follow-up|4|||
148685778|NCT02482805|536323457|FG001|Overall Study|Lost to Follow-up|4|||
148685779|NCT02482805|536323458|FG002|Overall Study|Lost to Follow-up|0|||
148685780|NCT01806597|536323459|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
148685781|NCT01806597|536323460|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
148685782|NCT01806597|536323461|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
148685783|NCT01806597|536323462|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
148953619|NCT00720434|537313057|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
148953620|NCT00720434|537313054|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
148953621|NCT00720434|537313055|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
149018025|NCT01474512|537547164|FG015|Induction Period|Adverse Event|0|||
148685784|NCT01806597|536323463|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
148685785|NCT01806597|536323464|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
148685786|NCT01806597|536323459|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
148685787|NCT01806597|536323460|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
148685788|NCT01806597|536323461|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
148685789|NCT01806597|536323462|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
148685790|NCT01806597|536323463|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
148685791|NCT01806597|536323464|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
148685792|NCT01806597|536323459|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
148685793|NCT01806597|536323460|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
148685794|NCT01806597|536323461|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
148685795|NCT01806597|536323462|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
148685796|NCT01806597|536323463|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
149222227|NCT01004861|538280606|FG006|Overall Study|Non-compliance|0|||
149222228|NCT01004861|538280607|FG007|Overall Study|Non-compliance|0|||
149222229|NCT01004861|538280608|FG008|Overall Study|Non-compliance|5|||
149222230|NCT01004861|538280609|FG009|Overall Study|Non-compliance|0|||
149222231|NCT01004861|538280610|FG010|Overall Study|Non-compliance|0|||
148685797|NCT01806597|536323464|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
148685798|NCT01806597|536323459|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
148685799|NCT01806597|536323460|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
148685800|NCT01806597|536323461|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
148685801|NCT01806597|536323462|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
148685802|NCT01806597|536323463|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
148685803|NCT01806597|536323464|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
148685804|NCT01806597|536323459|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
148685805|NCT01806597|536323460|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
148685806|NCT01806597|536323461|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
148685807|NCT01806597|536323462|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
148685808|NCT01806597|536323463|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
148685809|NCT01806597|536323464|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
148685810|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
148685811|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
148685812|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
148685813|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
148685814|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
148685815|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
148685816|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
148685817|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
148685818|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
148685819|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
148685820|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
148685821|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
148685822|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
148685823|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
148685824|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
148685825|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
148685826|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
148685827|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
148685828|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
148685829|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
148685830|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
148685831|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
148685832|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
148685833|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
148685834|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
148685835|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
148685836|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
148685837|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
148685838|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
148685839|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
148685840|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
148685841|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
148685842|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
148691444|NCT01325207|536344176|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149222232|NCT01004861|538280611|FG011|Overall Study|Non-compliance|0|||
148685843|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
148685844|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
148685845|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
148685846|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
148685847|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
148685848|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
148685849|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
148685850|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
148685851|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
148685852|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
148685853|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
148685854|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
148685855|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
148685856|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
148685857|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
148685858|NCT01806597|536323459|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
148685859|NCT01806597|536323460|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
148685860|NCT01806597|536323461|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
148685861|NCT01806597|536323462|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
148685862|NCT01806597|536323463|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
148685863|NCT01806597|536323464|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
148685864|NCT01806597|536323459|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
148685865|NCT01806597|536323460|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
148685866|NCT01806597|536323461|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
148685867|NCT01806597|536323462|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
148685868|NCT01806597|536323463|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
148685869|NCT01806597|536323464|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
148685870|NCT01806597|536323459|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
148685871|NCT01806597|536323460|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
148685872|NCT01806597|536323461|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
148685873|NCT01806597|536323462|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
148685874|NCT01806597|536323463|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
148685875|NCT01806597|536323464|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
148685876|NCT01806597|536323459|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
148685877|NCT01806597|536323460|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
148685878|NCT01806597|536323461|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
148685879|NCT01806597|536323462|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
148685880|NCT01806597|536323463|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
148685881|NCT01806597|536323464|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
148685882|NCT01806597|536323459|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
148685883|NCT01806597|536323460|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
148685884|NCT01806597|536323461|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
148685885|NCT01806597|536323462|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
148685886|NCT01806597|536323463|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
148685887|NCT01806597|536323464|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
148685888|NCT01806597|536323459|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
148685889|NCT01806597|536323460|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
148685890|NCT01806597|536323461|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
148685891|NCT01806597|536323462|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
148685892|NCT01806597|536323463|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
148685893|NCT01806597|536323464|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
148685894|NCT01034137|536323465|FG000|Overall Study|Adverse Event|9|||
148685895|NCT01034137|536323466|FG001|Overall Study|Adverse Event|10|||
148685896|NCT01034137|536323467|FG002|Overall Study|Adverse Event|8|||
148685897|NCT01034137|536323465|FG000|Overall Study|Withdrawal by Subject|4|||
148685898|NCT01034137|536323466|FG001|Overall Study|Withdrawal by Subject|3|||
148685899|NCT01034137|536323467|FG002|Overall Study|Withdrawal by Subject|3|||
148810012|NCT02164916|536780939|FG001|Overall Study|Refusal unrelated to adverse event|7|||
149222233|NCT01004861|538280612|FG012|Overall Study|Non-compliance|1|||
149222234|NCT01004861|538280600|FG000|Overall Study|Other|0|||
149222235|NCT01004861|538280601|FG001|Overall Study|Other|0|||
149222236|NCT01004861|538280602|FG002|Overall Study|Other|0|||
149222237|NCT01004861|538280603|FG003|Overall Study|Other|0|||
149222238|NCT01004861|538280604|FG004|Overall Study|Other|0|||
149222239|NCT01004861|538280605|FG005|Overall Study|Other|0|||
149222240|NCT01004861|538280606|FG006|Overall Study|Other|0|||
149222241|NCT01004861|538280607|FG007|Overall Study|Other|0|||
149222242|NCT01004861|538280608|FG008|Overall Study|Other|0|||
149222243|NCT01004861|538280609|FG009|Overall Study|Other|2|||
149222244|NCT01004861|538280610|FG010|Overall Study|Other|1|||
149222245|NCT01004861|538280611|FG011|Overall Study|Other|2|||
149222246|NCT01004861|538280612|FG012|Overall Study|Other|3|||
149222247|NCT01004861|538280600|FG000|Overall Study|Patient decision|0|||
149222248|NCT01004861|538280601|FG001|Overall Study|Patient decision|0|||
149222249|NCT01004861|538280602|FG002|Overall Study|Patient decision|0|||
149222250|NCT01004861|538280603|FG003|Overall Study|Patient decision|0|||
149222251|NCT01004861|538280604|FG004|Overall Study|Patient decision|1|||
149222252|NCT01004861|538280605|FG005|Overall Study|Patient decision|0|||
149222253|NCT01004861|538280606|FG006|Overall Study|Patient decision|1|||
149222254|NCT01004861|538280607|FG007|Overall Study|Patient decision|0|||
149222255|NCT01004861|538280608|FG008|Overall Study|Patient decision|7|||
149222256|NCT01004861|538280609|FG009|Overall Study|Patient decision|1|||
149222257|NCT01004861|538280610|FG010|Overall Study|Patient decision|1|||
149222258|NCT01004861|538280611|FG011|Overall Study|Patient decision|2|||
148685900|NCT01034137|536323465|FG000|Overall Study|Lack of Efficacy|9|||
148685901|NCT01034137|536323466|FG001|Overall Study|Lack of Efficacy|4|||
148685902|NCT01034137|536323467|FG002|Overall Study|Lack of Efficacy|13|||
148685903|NCT01034137|536323465|FG000|Overall Study|Protocol Violation|2|||
148685904|NCT01034137|536323466|FG001|Overall Study|Protocol Violation|2|||
148685905|NCT01034137|536323467|FG002|Overall Study|Protocol Violation|1|||
148685906|NCT01034137|536323465|FG000|Overall Study|Refused treatment or did not cooperate|2|||
148685907|NCT01034137|536323466|FG001|Overall Study|Refused treatment or did not cooperate|0|||
148685908|NCT01034137|536323467|FG002|Overall Study|Refused treatment or did not cooperate|1|||
148685909|NCT01034137|536323465|FG000|Overall Study|Administrative or other|2|||
148685910|NCT01034137|536323466|FG001|Overall Study|Administrative or other|3|||
148685911|NCT01034137|536323467|FG002|Overall Study|Administrative or other|4|||
148685912|NCT03572933|536323468|FG000|Overall Study|Adverse Event|4|||
148685913|NCT03572933|536323469|FG001|Overall Study|Adverse Event|1|||
148685914|NCT03572933|536323468|FG000|Overall Study|Withdrawal by Subject|0|||
148685915|NCT03572933|536323469|FG001|Overall Study|Withdrawal by Subject|1|||
148685916|NCT02049359|536323473|FG000|Overall Study|Lost to Follow-up|26|||
148685917|NCT02049359|536323474|FG001|Overall Study|Lost to Follow-up|19|||
148685918|NCT01405950|536323475|FG000|Overall Study|Withdrawal by Subject|1|||
148685919|NCT01405950|536323476|FG001|Overall Study|Withdrawal by Subject|0|||
148685920|NCT01405950|536323477|FG002|Overall Study|Withdrawal by Subject|0|||
148685921|NCT01405950|536323478|FG003|Overall Study|Withdrawal by Subject|0|||
148685922|NCT01381900|536323479|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
148685923|NCT01381900|536323480|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
148685924|NCT01381900|536323481|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
148685925|NCT01381900|536323479|FG000|Overall Study|Adverse Event|4|||
148685926|NCT01381900|536323480|FG001|Overall Study|Adverse Event|6|||
148685927|NCT01381900|536323481|FG002|Overall Study|Adverse Event|7|||
148685928|NCT01381900|536323479|FG000|Overall Study|Noncompliance with study drug|0|||
148685929|NCT01381900|536323480|FG001|Overall Study|Noncompliance with study drug|0|||
148685930|NCT01381900|536323481|FG002|Overall Study|Noncompliance with study drug|1|||
148685931|NCT01381900|536323479|FG000|Overall Study|Physician Decision|0|||
148685932|NCT01381900|536323480|FG001|Overall Study|Physician Decision|1|||
148685933|NCT01381900|536323481|FG002|Overall Study|Physician Decision|1|||
148685934|NCT01381900|536323479|FG000|Overall Study|Protocol Violation|0|||
148685935|NCT01381900|536323480|FG001|Overall Study|Protocol Violation|1|||
148685936|NCT01381900|536323481|FG002|Overall Study|Protocol Violation|1|||
148685937|NCT01381900|536323479|FG000|Overall Study|Withdrawal by Subject|0|||
148685938|NCT01381900|536323480|FG001|Overall Study|Withdrawal by Subject|0|||
148685939|NCT01381900|536323481|FG002|Overall Study|Withdrawal by Subject|1|||
148685940|NCT01381900|536323479|FG000|Overall Study|Early withdraw|3|||
148685941|NCT01381900|536323480|FG001|Overall Study|Early withdraw|1|||
148685942|NCT01381900|536323481|FG002|Overall Study|Early withdraw|1|||
148685943|NCT01772368|536323482|FG000|Overall Study|Adverse Event|1|||
148685944|NCT01772368|536323482|FG000|Overall Study|Withdrawal by Subject|3|||
148685945|NCT01772368|536323482|FG000|Overall Study|Protocol Violation|2|||
148685946|NCT01772368|536323482|FG000|Overall Study|Other|1|||
148685947|NCT03347695|536323489|FG000|Overall Study|Death|0|||
148685948|NCT03347695|536323490|FG001|Overall Study|Death|4|||
148685949|NCT03347695|536323489|FG000|Overall Study|Lost to Follow-up|0|||
148685950|NCT03347695|536323490|FG001|Overall Study|Lost to Follow-up|1|||
148685951|NCT02884206|536323491|FG000|Valsartan Run-in Period|Death|1|||
148685952|NCT02884206|536323492|FG001|Valsartan Run-in Period|Death|0|||
148685953|NCT02884206|536323493|FG002|Valsartan Run-in Period|Death|0|||
148685954|NCT02884206|536323491|FG000|Valsartan Run-in Period|Adverse Event|31|||
148685955|NCT02884206|536323492|FG001|Valsartan Run-in Period|Adverse Event|0|||
148685956|NCT02884206|536323493|FG002|Valsartan Run-in Period|Adverse Event|0|||
148685957|NCT02884206|536323491|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
148685958|NCT02884206|536323492|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
148685959|NCT02884206|536323493|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
148685960|NCT02884206|536323491|FG000|Valsartan Run-in Period|Protocol deviation|4|||
148685961|NCT02884206|536323492|FG001|Valsartan Run-in Period|Protocol deviation|0|||
148685962|NCT02884206|536323493|FG002|Valsartan Run-in Period|Protocol deviation|0|||
148685963|NCT02884206|536323491|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
148685964|NCT02884206|536323492|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
148685965|NCT02884206|536323493|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
148685966|NCT02884206|536323491|FG000|Valsartan Run-in Period|Physician Decision|1|||
148685967|NCT02884206|536323492|FG001|Valsartan Run-in Period|Physician Decision|0|||
148685968|NCT02884206|536323493|FG002|Valsartan Run-in Period|Physician Decision|0|||
148685969|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Adverse Event|38|||
148685970|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Adverse Event|0|||
148685971|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Adverse Event|0|||
148685972|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Death|2|||
148685973|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Death|0|||
148685974|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Death|0|||
148810013|NCT02164916|536780938|FG000|Overall Study|Progression|37|||
149222259|NCT01004861|538280612|FG012|Overall Study|Patient decision|3|||
149222260|NCT01004861|538280600|FG000|Overall Study|Transitioned to Phase 4 study|0|||
149222261|NCT01004861|538280601|FG001|Overall Study|Transitioned to Phase 4 study|0|||
149222262|NCT01004861|538280602|FG002|Overall Study|Transitioned to Phase 4 study|0|||
149222263|NCT01004861|538280603|FG003|Overall Study|Transitioned to Phase 4 study|0|||
149222264|NCT01004861|538280604|FG004|Overall Study|Transitioned to Phase 4 study|0|||
149222265|NCT01004861|538280605|FG005|Overall Study|Transitioned to Phase 4 study|0|||
149222266|NCT01004861|538280606|FG006|Overall Study|Transitioned to Phase 4 study|0|||
149222267|NCT01004861|538280607|FG007|Overall Study|Transitioned to Phase 4 study|0|||
149222268|NCT01004861|538280608|FG008|Overall Study|Transitioned to Phase 4 study|2|||
149222269|NCT01004861|538280609|FG009|Overall Study|Transitioned to Phase 4 study|0|||
149222270|NCT01004861|538280610|FG010|Overall Study|Transitioned to Phase 4 study|0|||
149222271|NCT01004861|538280611|FG011|Overall Study|Transitioned to Phase 4 study|0|||
149222272|NCT01004861|538280612|FG012|Overall Study|Transitioned to Phase 4 study|0|||
149222273|NCT01004861|538280600|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222274|NCT01004861|538280601|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222275|NCT01004861|538280602|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222276|NCT01004861|538280603|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222277|NCT01004861|538280604|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222278|NCT01004861|538280605|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222279|NCT01004861|538280606|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222280|NCT01004861|538280607|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222281|NCT01004861|538280608|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
149222282|NCT01004861|538280609|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222283|NCT01004861|538280610|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222284|NCT01004861|538280611|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222285|NCT01004861|538280612|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
149222286|NCT01004861|538280600|FG000|Overall Study|Patient withdrew|0|||
149222287|NCT01004861|538280601|FG001|Overall Study|Patient withdrew|0|||
149222288|NCT01004861|538280602|FG002|Overall Study|Patient withdrew|0|||
149222289|NCT01004861|538280603|FG003|Overall Study|Patient withdrew|0|||
149222290|NCT01004861|538280604|FG004|Overall Study|Patient withdrew|0|||
149222291|NCT01004861|538280605|FG005|Overall Study|Patient withdrew|0|||
149222292|NCT01004861|538280606|FG006|Overall Study|Patient withdrew|0|||
149222293|NCT01004861|538280607|FG007|Overall Study|Patient withdrew|0|||
149222294|NCT01004861|538280608|FG008|Overall Study|Patient withdrew|1|||
149222295|NCT01004861|538280609|FG009|Overall Study|Patient withdrew|0|||
149222296|NCT01004861|538280610|FG010|Overall Study|Patient withdrew|0|||
149222297|NCT01004861|538280611|FG011|Overall Study|Patient withdrew|0|||
149222298|NCT01004861|538280612|FG012|Overall Study|Patient withdrew|0|||
149222299|NCT01004861|538280600|FG000|Overall Study|Surgical resection|0|||
149222300|NCT01004861|538280601|FG001|Overall Study|Surgical resection|0|||
149222301|NCT01004861|538280602|FG002|Overall Study|Surgical resection|0|||
149222302|NCT01004861|538280603|FG003|Overall Study|Surgical resection|0|||
149222303|NCT01004861|538280604|FG004|Overall Study|Surgical resection|0|||
149222304|NCT01004861|538280605|FG005|Overall Study|Surgical resection|0|||
149222305|NCT01004861|538280606|FG006|Overall Study|Surgical resection|0|||
149222306|NCT01004861|538280607|FG007|Overall Study|Surgical resection|0|||
149222307|NCT01004861|538280608|FG008|Overall Study|Surgical resection|1|||
149222308|NCT01004861|538280609|FG009|Overall Study|Surgical resection|0|||
149222309|NCT01004861|538280610|FG010|Overall Study|Surgical resection|0|||
149222310|NCT01004861|538280611|FG011|Overall Study|Surgical resection|0|||
149222311|NCT01004861|538280612|FG012|Overall Study|Surgical resection|0|||
149222312|NCT01004861|538280600|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222313|NCT01004861|538280601|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222314|NCT01004861|538280602|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222315|NCT01004861|538280603|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
148685975|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
148685976|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
148685977|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
148685978|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
148685979|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
148685980|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
148685981|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
148685982|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
149222316|NCT01004861|538280604|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222317|NCT01004861|538280605|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222318|NCT01004861|538280606|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222319|NCT01004861|538280607|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222320|NCT01004861|538280608|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
149222321|NCT01004861|538280609|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222322|NCT01004861|538280610|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222323|NCT01004861|538280611|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222324|NCT01004861|538280612|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
149222325|NCT01004861|538280600|FG000|Overall Study|Study termination by Sponsor|0|||
149222326|NCT01004861|538280601|FG001|Overall Study|Study termination by Sponsor|0|||
149222327|NCT01004861|538280602|FG002|Overall Study|Study termination by Sponsor|0|||
149222328|NCT01004861|538280603|FG003|Overall Study|Study termination by Sponsor|0|||
149222329|NCT01004861|538280604|FG004|Overall Study|Study termination by Sponsor|0|||
149222330|NCT01004861|538280605|FG005|Overall Study|Study termination by Sponsor|0|||
149222331|NCT01004861|538280606|FG006|Overall Study|Study termination by Sponsor|0|||
149222332|NCT01004861|538280607|FG007|Overall Study|Study termination by Sponsor|0|||
149222333|NCT01004861|538280608|FG008|Overall Study|Study termination by Sponsor|1|||
149222334|NCT01004861|538280609|FG009|Overall Study|Study termination by Sponsor|0|||
149222335|NCT01004861|538280610|FG010|Overall Study|Study termination by Sponsor|0|||
149222336|NCT01004861|538280611|FG011|Overall Study|Study termination by Sponsor|0|||
149222337|NCT01004861|538280612|FG012|Overall Study|Study termination by Sponsor|0|||
149222338|NCT00003389|538280613|FG000|Overall Study|Disease progression|6|||
149222339|NCT00003389|538280614|FG001|Overall Study|Disease progression|1|||
148685983|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
148685984|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Physician Decision|1|||
148685985|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Physician Decision|0|||
148685986|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Physician Decision|0|||
148685987|NCT02884206|536323491|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
148685988|NCT02884206|536323492|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
148685989|NCT02884206|536323493|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
148685990|NCT02884206|536323491|FG000|Double-Blind Period|Death|0|||
148685991|NCT02884206|536323492|FG001|Double-Blind Period|Death|28|||
148685992|NCT02884206|536323493|FG002|Double-Blind Period|Death|39|||
148685993|NCT02884206|536323491|FG000|Double-Blind Period|Patient/guardian decision|0|||
148685994|NCT02884206|536323492|FG001|Double-Blind Period|Patient/guardian decision|10|||
148685995|NCT02884206|536323493|FG002|Double-Blind Period|Patient/guardian decision|13|||
148685996|NCT02884206|536323491|FG000|Double-Blind Period|Lost to Follow-up|0|||
148685997|NCT02884206|536323492|FG001|Double-Blind Period|Lost to Follow-up|4|||
148685998|NCT02884206|536323493|FG002|Double-Blind Period|Lost to Follow-up|4|||
148685999|NCT02884206|536323491|FG000|Double-Blind Period|Physician Decision|0|||
148686000|NCT02884206|536323492|FG001|Double-Blind Period|Physician Decision|2|||
148686001|NCT02884206|536323493|FG002|Double-Blind Period|Physician Decision|0|||
148686002|NCT02884206|536323491|FG000|Double-Blind Period|Adverse Event|0|||
148686003|NCT02884206|536323492|FG001|Double-Blind Period|Adverse Event|0|||
148686004|NCT02884206|536323493|FG002|Double-Blind Period|Adverse Event|3|||
148686005|NCT02884206|536323491|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
148686006|NCT02884206|536323492|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
148686007|NCT02884206|536323493|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
149222340|NCT00003389|538280613|FG000|Overall Study|Adverse Event|13|||
149222341|NCT00003389|538280614|FG001|Overall Study|Adverse Event|2|||
149222342|NCT00003389|538280613|FG000|Overall Study|Death|0|||
149222343|NCT00003389|538280614|FG001|Overall Study|Death|3|||
148686008|NCT03341507|536323496|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
148686009|NCT02927847|536323498|FG000|Overall Study|Lost to Follow-up|1|||
148686010|NCT02927847|536323499|FG001|Overall Study|Lost to Follow-up|0|||
148686011|NCT02927847|536323498|FG000|Overall Study|Withdrawal by Subject|4|||
148686012|NCT02927847|536323499|FG001|Overall Study|Withdrawal by Subject|2|||
148686013|NCT02927847|536323498|FG000|Overall Study|PI withdrawn due to missed visits|1|||
148686014|NCT02927847|536323499|FG001|Overall Study|PI withdrawn due to missed visits|1|||
148686015|NCT03255031|536323503|FG000|Overall Study|Adverse Event|5|||
149222344|NCT00003389|538280613|FG000|Overall Study|Withdrawal by Subject|12|||
148686016|NCT03255031|536323504|FG001|Overall Study|Adverse Event|3|||
148686017|NCT03255031|536323503|FG000|Overall Study|Physician Decision|2|||
148686018|NCT03255031|536323504|FG001|Overall Study|Physician Decision|1|||
148686019|NCT03255031|536323503|FG000|Overall Study|Withdrawal by Subject|9|||
148686020|NCT03255031|536323504|FG001|Overall Study|Withdrawal by Subject|3|||
148686021|NCT01092702|536323505|FG000|Overall Study|Withdrawal by Subject|7|||
148686022|NCT01092702|536323505|FG000|Overall Study|Lost to Follow-up|2|||
148686023|NCT01271933|536323506|FG000|Single-Blind Phase|Lack of Efficacy|37|||
148686024|NCT01271933|536323507|FG001|Single-Blind Phase|Lack of Efficacy|0|||
148686025|NCT01271933|536323508|FG002|Single-Blind Phase|Lack of Efficacy|0|||
148686026|NCT01271933|536323506|FG000|Single-Blind Phase|Lost to Follow-up|10|||
148686027|NCT01271933|536323507|FG001|Single-Blind Phase|Lost to Follow-up|0|||
148686028|NCT01271933|536323508|FG002|Single-Blind Phase|Lost to Follow-up|0|||
148686029|NCT01271933|536323506|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
148686030|NCT01271933|536323507|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
148686031|NCT01271933|536323508|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
148686032|NCT01271933|536323506|FG000|Single-Blind Phase|Protocol Violation|3|||
148686033|NCT01271933|536323507|FG001|Single-Blind Phase|Protocol Violation|0|||
148686034|NCT01271933|536323508|FG002|Single-Blind Phase|Protocol Violation|0|||
148686035|NCT01271933|536323506|FG000|Single-Blind Phase|Adverse Event|52|||
148686036|NCT01271933|536323507|FG001|Single-Blind Phase|Adverse Event|0|||
148686037|NCT01271933|536323508|FG002|Single-Blind Phase|Adverse Event|0|||
148686038|NCT01271933|536323506|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
148686039|NCT01271933|536323507|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
148686040|NCT01271933|536323508|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
148686041|NCT01271933|536323506|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
148686042|NCT01271933|536323507|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
148686043|NCT01271933|536323508|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
148686044|NCT01271933|536323506|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
148686045|NCT01271933|536323507|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
148686046|NCT01271933|536323508|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
148686047|NCT01271933|536323506|FG000|Double-Blind Phase|Randomized but not treated|0|||
148686048|NCT01271933|536323507|FG001|Double-Blind Phase|Randomized but not treated|0|||
148686049|NCT01271933|536323508|FG002|Double-Blind Phase|Randomized but not treated|1|||
148686050|NCT01271933|536323506|FG000|Double-Blind Phase|Lack of Efficacy|0|||
148686051|NCT01271933|536323507|FG001|Double-Blind Phase|Lack of Efficacy|6|||
148686052|NCT01271933|536323508|FG002|Double-Blind Phase|Lack of Efficacy|9|||
148686053|NCT01271933|536323506|FG000|Double-Blind Phase|Lost to Follow-up|0|||
148686054|NCT01271933|536323507|FG001|Double-Blind Phase|Lost to Follow-up|1|||
148686055|NCT01271933|536323508|FG002|Double-Blind Phase|Lost to Follow-up|1|||
148686056|NCT01271933|536323506|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
148686057|NCT01271933|536323507|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
149222345|NCT00003389|538280614|FG001|Overall Study|Withdrawal by Subject|5|||
149222346|NCT00003389|538280613|FG000|Overall Study|Alternative therapy|2|||
149222347|NCT00003389|538280614|FG001|Overall Study|Alternative therapy|1|||
149222348|NCT00003389|538280613|FG000|Overall Study|Complicating disease|1|||
149222349|NCT00003389|538280614|FG001|Overall Study|Complicating disease|0|||
149222350|NCT00003389|538280613|FG000|Overall Study|Off-treatment reason missing|31|||
149222351|NCT00003389|538280614|FG001|Overall Study|Off-treatment reason missing|21|||
149222352|NCT00003389|538280613|FG000|Overall Study|Ineligible|33|||
149222353|NCT00003389|538280614|FG001|Overall Study|Ineligible|27|||
149222354|NCT02554721|538280615|FG000|Overall Study|Adverse Event|1|||
149222355|NCT02554721|538280616|FG001|Overall Study|Adverse Event|0|||
149222356|NCT02554721|538280617|FG002|Overall Study|Adverse Event|0|||
149222357|NCT02554721|538280618|FG003|Overall Study|Adverse Event|0|||
149222358|NCT02554721|538280619|FG004|Overall Study|Adverse Event|1|||
149222359|NCT02554721|538280615|FG000|Overall Study|Noncompliance|0|||
149222360|NCT02554721|538280616|FG001|Overall Study|Noncompliance|0|||
149222361|NCT02554721|538280617|FG002|Overall Study|Noncompliance|0|||
149222362|NCT02554721|538280618|FG003|Overall Study|Noncompliance|0|||
149222363|NCT02554721|538280619|FG004|Overall Study|Noncompliance|1|||
149222364|NCT04657003|538280621|FG000|Overall Study|Adverse Event|5|||
149222365|NCT04657003|538280622|FG001|Overall Study|Adverse Event|1|||
149222366|NCT04657003|538280623|FG002|Overall Study|Adverse Event|5|||
149222367|NCT04657003|538280621|FG000|Overall Study|Death|0|||
149222368|NCT04657003|538280622|FG001|Overall Study|Death|2|||
148686058|NCT01271933|536323508|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
148686059|NCT01271933|536323506|FG000|Double-Blind Phase|Adverse Event|0|||
148686060|NCT01271933|536323507|FG001|Double-Blind Phase|Adverse Event|3|||
148686061|NCT01271933|536323508|FG002|Double-Blind Phase|Adverse Event|0|||
148686062|NCT01271933|536323506|FG000|Double-Blind Phase|Participant request-personal reason|0|||
149222369|NCT04657003|538280623|FG002|Overall Study|Death|0|||
149222370|NCT04657003|538280621|FG000|Overall Study|Lost to Follow-up|8|||
148686063|NCT01271933|536323507|FG001|Double-Blind Phase|Participant request-personal reason|1|||
148686064|NCT01271933|536323508|FG002|Double-Blind Phase|Participant request-personal reason|0|||
149222371|NCT04657003|538280622|FG001|Overall Study|Lost to Follow-up|4|||
148686065|NCT01620983|536323509|FG000|Overall Study|Lost to Follow-up|8|||
148686066|NCT01620983|536323510|FG001|Overall Study|Lost to Follow-up|4|||
148686067|NCT01620983|536323511|FG002|Overall Study|Lost to Follow-up|9|||
148686068|NCT01620983|536323509|FG000|Overall Study|Withdrawal by Subject|6|||
148686069|NCT01620983|536323510|FG001|Overall Study|Withdrawal by Subject|8|||
148686070|NCT01620983|536323511|FG002|Overall Study|Withdrawal by Subject|1|||
148686071|NCT01620983|536323509|FG000|Overall Study|Death|2|||
148686072|NCT01620983|536323510|FG001|Overall Study|Death|0|||
148686073|NCT01620983|536323511|FG002|Overall Study|Death|0|||
148686074|NCT01620983|536323509|FG000|Overall Study|Physician Decision|3|||
148686075|NCT01620983|536323510|FG001|Overall Study|Physician Decision|10|||
148686076|NCT01620983|536323511|FG002|Overall Study|Physician Decision|5|||
148686077|NCT01580020|536323512|FG000|Overall Study|Lack of Efficacy|0|||
148686078|NCT01580020|536323513|FG001|Overall Study|Lack of Efficacy|5|||
148686079|NCT01580020|536323514|FG002|Overall Study|Lack of Efficacy|0|||
148686080|NCT01580020|536323515|FG003|Overall Study|Lack of Efficacy|1|||
148686081|NCT01580020|536323512|FG000|Overall Study|Withdrawal by Subject|0|||
148686082|NCT01580020|536323513|FG001|Overall Study|Withdrawal by Subject|1|||
148686083|NCT01580020|536323514|FG002|Overall Study|Withdrawal by Subject|1|||
148686084|NCT01580020|536323515|FG003|Overall Study|Withdrawal by Subject|0|||
148686085|NCT01580020|536323512|FG000|Overall Study|Adverse Event|1|||
148686086|NCT01580020|536323513|FG001|Overall Study|Adverse Event|1|||
148686087|NCT01580020|536323514|FG002|Overall Study|Adverse Event|1|||
148686088|NCT01580020|536323515|FG003|Overall Study|Adverse Event|1|||
148686089|NCT01580020|536323512|FG000|Overall Study|Administrative Problems|0|||
148686090|NCT01580020|536323513|FG001|Overall Study|Administrative Problems|0|||
148686091|NCT01580020|536323514|FG002|Overall Study|Administrative Problems|1|||
148686092|NCT01580020|536323515|FG003|Overall Study|Administrative Problems|0|||
148686093|NCT01580020|536323512|FG000|Overall Study|Lost to Follow-up|0|||
148686094|NCT01580020|536323513|FG001|Overall Study|Lost to Follow-up|0|||
148686095|NCT01580020|536323514|FG002|Overall Study|Lost to Follow-up|1|||
148686096|NCT01580020|536323515|FG003|Overall Study|Lost to Follow-up|0|||
148686097|NCT01724359|536323516|FG000|Overall Study|Adverse Event|10|||
148686098|NCT01724359|536323516|FG000|Overall Study|Death|1|||
148686099|NCT01724359|536323516|FG000|Overall Study|Other|20|||
148686100|NCT01335464|536323518|FG000|Overall Study|Adverse Event|15|||
148686101|NCT01335464|536323519|FG001|Overall Study|Adverse Event|25|||
148686102|NCT01335464|536323518|FG000|Overall Study|Non compliant with protocol|2|||
148686103|NCT01335464|536323519|FG001|Overall Study|Non compliant with protocol|0|||
148686104|NCT01335464|536323518|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
148686105|NCT01335464|536323519|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
148686106|NCT01335464|536323518|FG000|Overall Study|Not treated|2|||
148686107|NCT01335464|536323519|FG001|Overall Study|Not treated|0|||
148686108|NCT01335464|536323518|FG000|Overall Study|Reason other than those stated above|1|||
148686109|NCT01335464|536323519|FG001|Overall Study|Reason other than those stated above|1|||
148686110|NCT00591253|536323520|FG000|Overall Study|Adverse Event|3|||
148686111|NCT00591253|536323521|FG001|Overall Study|Adverse Event|3|||
148686112|NCT00591253|536323522|FG002|Overall Study|Adverse Event|1|||
148686113|NCT00591253|536323520|FG000|Overall Study|Protocol Violation|2|||
148686114|NCT00591253|536323521|FG001|Overall Study|Protocol Violation|2|||
148686115|NCT00591253|536323522|FG002|Overall Study|Protocol Violation|2|||
148686116|NCT00591253|536323520|FG000|Overall Study|Lost to Follow-up|2|||
148686117|NCT00591253|536323521|FG001|Overall Study|Lost to Follow-up|4|||
148686118|NCT00591253|536323522|FG002|Overall Study|Lost to Follow-up|0|||
148686119|NCT00591253|536323520|FG000|Overall Study|Withdrawal by Subject|1|||
148686120|NCT00591253|536323521|FG001|Overall Study|Withdrawal by Subject|7|||
148686121|NCT00591253|536323522|FG002|Overall Study|Withdrawal by Subject|6|||
148686122|NCT00591253|536323520|FG000|Overall Study|Lack of Efficacy|1|||
148686123|NCT00591253|536323521|FG001|Overall Study|Lack of Efficacy|0|||
148686124|NCT00591253|536323522|FG002|Overall Study|Lack of Efficacy|3|||
148686125|NCT00591253|536323520|FG000|Overall Study|Other|5|||
148686126|NCT00591253|536323521|FG001|Overall Study|Other|5|||
148686127|NCT00591253|536323522|FG002|Overall Study|Other|3|||
148686128|NCT01841359|536323523|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
148686129|NCT01841359|536323523|FG000|Overall Study|Concommitant medical issues|2|||
148686130|NCT01841359|536323523|FG000|Overall Study|Adverse Event|3|||
149018026|NCT01474512|537547165|FG016|Induction Period|Adverse Event|0|||
149018027|NCT01474512|537547166|FG017|Induction Period|Adverse Event|0|||
149018028|NCT01474512|537547149|FG000|Induction Period|Lack of Efficacy|7|||
148686131|NCT01841359|536323523|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
148686132|NCT00871169|536323524|FG000|Overall Study|Protocol Violation|1|||
148686133|NCT00871169|536323524|FG000|Overall Study|Patient did not receive study treatment|2|||
148686134|NCT02168270|536323525|FG000|Overall Study|Lack of Efficacy|4|||
148686135|NCT00252187|536323526|FG000|Overall Study|Adverse Event|3|||
148686136|NCT00252187|536323527|FG001|Overall Study|Adverse Event|1|||
148686137|NCT00252187|536323526|FG000|Overall Study|Withdrawal by Subject|1|||
148686138|NCT00252187|536323527|FG001|Overall Study|Withdrawal by Subject|0|||
148686139|NCT01875445|536323530|FG000|Overall Study|Lost to Follow-up|5|||
148686140|NCT01875445|536323531|FG001|Overall Study|Lost to Follow-up|0|||
148953622|NCT00720434|537313056|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
148953623|NCT00720434|537313057|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
148953624|NCT00720434|537313054|FG000|Open-Label Period (Week 5-72)|Other|4|||
148953625|NCT00720434|537313055|FG001|Open-Label Period (Week 5-72)|Other|3|||
148953626|NCT00720434|537313056|FG002|Open-Label Period (Week 5-72)|Other|3|||
148953627|NCT00720434|537313057|FG003|Open-Label Period (Week 5-72)|Other|2|||
149222372|NCT04657003|538280623|FG002|Overall Study|Lost to Follow-up|10|||
149222373|NCT04657003|538280621|FG000|Overall Study|Other - As Reported by Investigator|3|||
149222374|NCT04657003|538280622|FG001|Overall Study|Other - As Reported by Investigator|2|||
149222375|NCT04657003|538280623|FG002|Overall Study|Other - As Reported by Investigator|2|||
149222376|NCT04657003|538280621|FG000|Overall Study|Pregnancy|2|||
149222377|NCT04657003|538280622|FG001|Overall Study|Pregnancy|0|||
149222378|NCT04657003|538280623|FG002|Overall Study|Pregnancy|2|||
149222379|NCT04657003|538280621|FG000|Overall Study|Withdrawal by Subject|16|||
149222380|NCT04657003|538280622|FG001|Overall Study|Withdrawal by Subject|7|||
149222381|NCT04657003|538280623|FG002|Overall Study|Withdrawal by Subject|10|||
149222382|NCT05158244|538280624|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
149222383|NCT05158244|538280625|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149222384|NCT05158244|538280626|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149222385|NCT05158244|538280627|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149222386|NCT05158244|538280628|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
149222387|NCT05158244|538280624|FG000|Overall Study|Withdrawal by Subject|0|||
149222388|NCT05158244|538280625|FG001|Overall Study|Withdrawal by Subject|0|||
149222389|NCT05158244|538280626|FG002|Overall Study|Withdrawal by Subject|1|||
149222390|NCT05158244|538280627|FG003|Overall Study|Withdrawal by Subject|0|||
149222391|NCT05158244|538280628|FG004|Overall Study|Withdrawal by Subject|0|||
149222392|NCT02185040|538280630|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
149222393|NCT02185040|538280631|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
149222394|NCT02185040|538280632|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
149222395|NCT02185040|538280633|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
149222396|NCT02185040|538280634|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
149222397|NCT02185040|538280635|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
149222398|NCT02185040|538280636|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
149222399|NCT02185040|538280630|FG000|Part 1 Treatment Phase|Adverse Event|1|||
149222400|NCT02185040|538280631|FG001|Part 1 Treatment Phase|Adverse Event|0|||
149222401|NCT02185040|538280632|FG002|Part 1 Treatment Phase|Adverse Event|0|||
149222402|NCT02185040|538280633|FG003|Part 1 Treatment Phase|Adverse Event|2|||
149222403|NCT02185040|538280634|FG004|Part 1 Treatment Phase|Adverse Event|3|||
149222404|NCT02185040|538280635|FG005|Part 1 Treatment Phase|Adverse Event|0|||
149222405|NCT02185040|538280636|FG006|Part 1 Treatment Phase|Adverse Event|0|||
149222406|NCT02185040|538280630|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149222407|NCT02185040|538280631|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
149222408|NCT02185040|538280632|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149222409|NCT02185040|538280633|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149222410|NCT02185040|538280634|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149222411|NCT02185040|538280635|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149222412|NCT02185040|538280636|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
149222413|NCT02185040|538280630|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
149222414|NCT02185040|538280631|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
149222415|NCT02185040|538280632|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
149222416|NCT02185040|538280633|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
149222417|NCT02185040|538280634|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
149222418|NCT02185040|538280635|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
149222419|NCT02185040|538280636|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
149222420|NCT02185040|538280630|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
149222421|NCT02185040|538280631|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
149222422|NCT02185040|538280632|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
149222423|NCT02185040|538280633|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
149222424|NCT02185040|538280634|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
149222425|NCT02185040|538280635|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
149222426|NCT02185040|538280636|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
149222427|NCT02185040|538280630|FG000|Active Treatment Extension Phase|Adverse Event|0|||
149222428|NCT02185040|538280631|FG001|Active Treatment Extension Phase|Adverse Event|0|||
149222429|NCT02185040|538280632|FG002|Active Treatment Extension Phase|Adverse Event|0|||
149222430|NCT02185040|538280633|FG003|Active Treatment Extension Phase|Adverse Event|0|||
149222431|NCT02185040|538280634|FG004|Active Treatment Extension Phase|Adverse Event|0|||
149222432|NCT02185040|538280635|FG005|Active Treatment Extension Phase|Adverse Event|1|||
149222433|NCT02185040|538280636|FG006|Active Treatment Extension Phase|Adverse Event|4|||
149222434|NCT02185040|538280630|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149222435|NCT02185040|538280631|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
148953628|NCT02425046|537313058|FG000|Overall Study|Lost to Follow-up|52|||
148686141|NCT01875445|536323530|FG000|Overall Study|Withdrawal by Subject|2|||
148686142|NCT01875445|536323531|FG001|Overall Study|Withdrawal by Subject|0|||
148686143|NCT01102777|536323532|FG000|Overall Study|Death|2|||
148686144|NCT01102777|536323533|FG001|Overall Study|Death|6|||
148686145|NCT01102777|536323532|FG000|Overall Study|Lost to Follow-up|7|||
148686146|NCT01102777|536323533|FG001|Overall Study|Lost to Follow-up|10|||
148686147|NCT00593333|536323538|FG000|Overall Study|Lost to Follow-up|10|||
148686148|NCT00593333|536323539|FG001|Overall Study|Lost to Follow-up|11|||
148686149|NCT02175966|536323540|FG000|Follow-up Period|Lack of Efficacy|10|||
148686150|NCT02175966|536323541|FG001|Follow-up Period|Lack of Efficacy|6|||
148686151|NCT01752920|536323542|FG000|Overall Study|Adverse Event|1|||
148686152|NCT01752920|536323543|FG001|Overall Study|Adverse Event|0|||
148686153|NCT01752920|536323544|FG002|Overall Study|Adverse Event|5|||
148686154|NCT01752920|536323545|FG003|Overall Study|Adverse Event|10|||
148686155|NCT01752920|536323542|FG000|Overall Study|Clinical Disease Progression|6|||
148686156|NCT01752920|536323543|FG001|Overall Study|Clinical Disease Progression|4|||
148686157|NCT01752920|536323544|FG002|Overall Study|Clinical Disease Progression|1|||
148686158|NCT01752920|536323545|FG003|Overall Study|Clinical Disease Progression|13|||
148686159|NCT01752920|536323542|FG000|Overall Study|Physician Decision|1|||
148686160|NCT01752920|536323543|FG001|Overall Study|Physician Decision|0|||
148686161|NCT01752920|536323544|FG002|Overall Study|Physician Decision|0|||
148686162|NCT01752920|536323545|FG003|Overall Study|Physician Decision|3|||
148686163|NCT01752920|536323542|FG000|Overall Study|Radiographic Disease Progression|20|||
148686164|NCT01752920|536323543|FG001|Overall Study|Radiographic Disease Progression|7|||
148686165|NCT01752920|536323544|FG002|Overall Study|Radiographic Disease Progression|12|||
148686166|NCT01752920|536323545|FG003|Overall Study|Radiographic Disease Progression|29|||
148686167|NCT01752920|536323542|FG000|Overall Study|Study Terminated by Sponsor|0|||
148686168|NCT01752920|536323543|FG001|Overall Study|Study Terminated by Sponsor|0|||
148686169|NCT01752920|536323544|FG002|Overall Study|Study Terminated by Sponsor|0|||
148686170|NCT01752920|536323545|FG003|Overall Study|Study Terminated by Sponsor|1|||
148686171|NCT01752920|536323542|FG000|Overall Study|Withdrawal by Subject|0|||
148686172|NCT01752920|536323543|FG001|Overall Study|Withdrawal by Subject|1|||
148686173|NCT01752920|536323544|FG002|Overall Study|Withdrawal by Subject|0|||
148686174|NCT01752920|536323545|FG003|Overall Study|Withdrawal by Subject|1|||
148686175|NCT01752920|536323542|FG000|Overall Study|Lack of clinical benefit|1|||
148686176|NCT01752920|536323543|FG001|Overall Study|Lack of clinical benefit|1|||
148686177|NCT01752920|536323544|FG002|Overall Study|Lack of clinical benefit|1|||
148686178|NCT01752920|536323545|FG003|Overall Study|Lack of clinical benefit|1|||
148686179|NCT01738581|536323546|FG000|Overall Study|Lost to Follow-up|1|||
148686180|NCT01738581|536323547|FG001|Overall Study|Lost to Follow-up|0|||
148686181|NCT00210626|536323554|FG000|Overall Study|Adverse Event|1|||
148686182|NCT00210626|536323555|FG001|Overall Study|Adverse Event|2|||
148686183|NCT00210626|536323554|FG000|Overall Study|Protocol Violation|1|||
148686184|NCT00210626|536323555|FG001|Overall Study|Protocol Violation|5|||
148686185|NCT00210626|536323554|FG000|Overall Study|Lost to Follow-up|11|||
148686186|NCT00210626|536323555|FG001|Overall Study|Lost to Follow-up|11|||
148686187|NCT00210626|536323554|FG000|Overall Study|Death|1|||
148686188|NCT00210626|536323555|FG001|Overall Study|Death|0|||
148686189|NCT00210626|536323554|FG000|Overall Study|Withdrawal by Subject|29|||
148686190|NCT00210626|536323555|FG001|Overall Study|Withdrawal by Subject|20|||
148686191|NCT00210626|536323554|FG000|Overall Study|Physician Decision|0|||
148686192|NCT00210626|536323555|FG001|Overall Study|Physician Decision|2|||
148686193|NCT00210626|536323554|FG000|Overall Study|Sponser Request|1|||
148686194|NCT00210626|536323555|FG001|Overall Study|Sponser Request|0|||
148686195|NCT00210626|536323554|FG000|Overall Study|Other|4|||
148686196|NCT00210626|536323555|FG001|Overall Study|Other|5|||
148686197|NCT00771901|536323556|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
148686198|NCT00771901|536323557|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
148686199|NCT00771901|536323558|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
148686200|NCT02862535|536323559|FG000|Overall Study|Death|7|||
148686201|NCT02862535|536323560|FG001|Overall Study|Death|3|||
148686202|NCT02862535|536323561|FG002|Overall Study|Death|2|||
148686203|NCT02862535|536323562|FG003|Overall Study|Death|5|||
148686204|NCT02862535|536323559|FG000|Overall Study|Study Terminated by Sponsor|1|||
148686205|NCT02862535|536323560|FG001|Overall Study|Study Terminated by Sponsor|3|||
148686206|NCT02862535|536323561|FG002|Overall Study|Study Terminated by Sponsor|8|||
148686207|NCT02862535|536323562|FG003|Overall Study|Study Terminated by Sponsor|5|||
148686208|NCT02862535|536323559|FG000|Overall Study|Enrolled, not Treated|1|||
148686209|NCT02862535|536323560|FG001|Overall Study|Enrolled, not Treated|0|||
148686210|NCT02862535|536323561|FG002|Overall Study|Enrolled, not Treated|0|||
149222436|NCT02185040|538280632|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
148686211|NCT02862535|536323562|FG003|Overall Study|Enrolled, not Treated|1|||
149222437|NCT02185040|538280633|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
148686212|NCT02280356|536323563|FG000|Overall Study|Not Treated|2|||
148686213|NCT02280356|536323563|FG000|Overall Study|Withdrawal by Subject|1|||
148686214|NCT02280356|536323563|FG000|Overall Study|Not evaluable|2|||
148686215|NCT01086215|536323564|FG000|Overall Study|Death|14|||
148686216|NCT01086215|536323565|FG001|Overall Study|Death|8|||
148686217|NCT01086215|536323566|FG002|Overall Study|Death|8|||
148686218|NCT01086215|536323567|FG003|Overall Study|Death|1|||
148686219|NCT01086215|536323564|FG000|Overall Study|Lost to Follow-up|22|||
148686220|NCT01086215|536323565|FG001|Overall Study|Lost to Follow-up|39|||
148686221|NCT01086215|536323566|FG002|Overall Study|Lost to Follow-up|18|||
148686222|NCT01086215|536323567|FG003|Overall Study|Lost to Follow-up|2|||
148686223|NCT01965652|536323568|FG000|Overall Study|Adverse Event|40|||
148686224|NCT01965652|536323569|FG001|Overall Study|Adverse Event|37|||
148686225|NCT01965652|536323568|FG000|Overall Study|Withdrawal by Subject|62|||
148686226|NCT01965652|536323569|FG001|Overall Study|Withdrawal by Subject|69|||
148686227|NCT01965652|536323568|FG000|Overall Study|Lost to Follow-up|53|||
148686228|NCT01965652|536323569|FG001|Overall Study|Lost to Follow-up|40|||
148686229|NCT01965652|536323568|FG000|Overall Study|Protocol Violation|34|||
148686230|NCT01965652|536323569|FG001|Overall Study|Protocol Violation|38|||
148686231|NCT01965652|536323568|FG000|Overall Study|Death|3|||
148686232|NCT01965652|536323569|FG001|Overall Study|Death|4|||
148686233|NCT01965652|536323568|FG000|Overall Study|Other - Miscellaneous|18|||
148686234|NCT01965652|536323569|FG001|Overall Study|Other - Miscellaneous|21|||
148686235|NCT01965652|536323568|FG000|Overall Study|Pregnancy|0|||
148686236|NCT01965652|536323569|FG001|Overall Study|Pregnancy|1|||
148686237|NCT01121900|536323572|FG000|First Intervention Period|Adverse Event|1|||
148686238|NCT01121900|536323573|FG001|First Intervention Period|Adverse Event|1|||
148686239|NCT01121900|536323572|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
148686240|NCT01121900|536323573|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
148686241|NCT03469271|536323574|FG000|Overall Study|Withdrawal by Subject|2|||
148686242|NCT03469271|536323575|FG001|Overall Study|Withdrawal by Subject|0|||
148686243|NCT03469271|536323576|FG002|Overall Study|Withdrawal by Subject|0|||
148686244|NCT03469271|536323577|FG003|Overall Study|Withdrawal by Subject|1|||
148686245|NCT01328054|536323578|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
148686246|NCT01328054|536323579|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
148686247|NCT01328054|536323578|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
148686248|NCT01328054|536323579|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
148686249|NCT01328054|536323578|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
148686250|NCT01328054|536323579|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
148686251|NCT04147715|536323580|FG000|Overall Study|Adverse Event|0|||
148953629|NCT02425046|537313059|FG001|Overall Study|Lost to Follow-up|50|||
148953630|NCT02425046|537313060|FG002|Overall Study|Lost to Follow-up|56|||
148686252|NCT04147715|536323581|FG001|Overall Study|Adverse Event|0|||
148686253|NCT04147715|536323582|FG002|Overall Study|Adverse Event|0|||
148686254|NCT04147715|536323583|FG003|Overall Study|Adverse Event|0|||
148686255|NCT04147715|536323584|FG004|Overall Study|Adverse Event|0|||
148686256|NCT04147715|536323585|FG005|Overall Study|Adverse Event|0|||
148686257|NCT04147715|536323586|FG006|Overall Study|Adverse Event|0|||
148686258|NCT04147715|536323587|FG007|Overall Study|Adverse Event|2|||
148686259|NCT04147715|536323588|FG008|Overall Study|Adverse Event|1|||
148686260|NCT04147715|536323589|FG009|Overall Study|Adverse Event|0|||
148686261|NCT04147715|536323590|FG010|Overall Study|Adverse Event|0|||
148686262|NCT04147715|536323591|FG011|Overall Study|Adverse Event|0|||
148686263|NCT00616928|536323593|FG000|Overall Study|Adverse Event|6|||
148686264|NCT00616928|536323594|FG001|Overall Study|Adverse Event|3|||
148686265|NCT00616928|536323595|FG002|Overall Study|Adverse Event|2|||
148686266|NCT00616928|536323596|FG003|Overall Study|Adverse Event|2|||
148686267|NCT00616928|536323593|FG000|Overall Study|Other|51|||
148686268|NCT00616928|536323594|FG001|Overall Study|Other|8|||
148686269|NCT00616928|536323595|FG002|Overall Study|Other|15|||
148686270|NCT00616928|536323596|FG003|Overall Study|Other|5|||
148686271|NCT00616928|536323593|FG000|Overall Study|Lost to Follow-up|5|||
148686272|NCT00616928|536323594|FG001|Overall Study|Lost to Follow-up|7|||
148686273|NCT00616928|536323595|FG002|Overall Study|Lost to Follow-up|0|||
148686274|NCT00616928|536323596|FG003|Overall Study|Lost to Follow-up|0|||
148953631|NCT02425046|537313058|FG000|Overall Study|Withdrawal by Subject|16|||
148686275|NCT02173301|536323597|FG000|Overall Study|Adverse Event|7|||
148686276|NCT02173301|536323598|FG001|Overall Study|Adverse Event|8|||
148686277|NCT02173301|536323599|FG002|Overall Study|Adverse Event|13|||
148686278|NCT02173301|536323600|FG003|Overall Study|Adverse Event|5|||
148686279|NCT02173301|536323597|FG000|Overall Study|Withdrawal by Subject|8|||
148686280|NCT02173301|536323598|FG001|Overall Study|Withdrawal by Subject|10|||
148686281|NCT02173301|536323599|FG002|Overall Study|Withdrawal by Subject|4|||
148686282|NCT02173301|536323600|FG003|Overall Study|Withdrawal by Subject|8|||
148686283|NCT02173301|536323597|FG000|Overall Study|Lost to Follow-up|4|||
148686284|NCT02173301|536323598|FG001|Overall Study|Lost to Follow-up|4|||
148953632|NCT02425046|537313059|FG001|Overall Study|Withdrawal by Subject|12|||
148686285|NCT02173301|536323599|FG002|Overall Study|Lost to Follow-up|2|||
148686286|NCT02173301|536323600|FG003|Overall Study|Lost to Follow-up|2|||
148686287|NCT02173301|536323597|FG000|Overall Study|Protocol Violation|0|||
148686288|NCT02173301|536323598|FG001|Overall Study|Protocol Violation|1|||
148686289|NCT02173301|536323599|FG002|Overall Study|Protocol Violation|0|||
148686290|NCT02173301|536323600|FG003|Overall Study|Protocol Violation|0|||
148810014|NCT02164916|536780939|FG001|Overall Study|Progression|26|||
149222438|NCT02185040|538280634|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
149222439|NCT02185040|538280635|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
149222440|NCT02185040|538280636|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
149222441|NCT02185040|538280630|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
149222442|NCT02185040|538280631|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
149222443|NCT02185040|538280632|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
149222444|NCT02185040|538280633|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
149222445|NCT02185040|538280634|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
149222446|NCT02185040|538280635|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
149222447|NCT02185040|538280636|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
148810015|NCT02164916|536780938|FG000|Overall Study|Not protocol specified|5|||
148810016|NCT02164916|536780939|FG001|Overall Study|Not protocol specified|1|||
148810017|NCT02164916|536780938|FG000|Overall Study|Reason under review|1|||
148810018|NCT02164916|536780939|FG001|Overall Study|Reason under review|6|||
148810019|NCT02164916|536780938|FG000|Overall Study|Not eligible|2|||
148810020|NCT02164916|536780939|FG001|Overall Study|Not eligible|5|||
148810021|NCT00846365|536780945|FG000|Overall Study|Adverse Event|20|||
148810022|NCT00846365|536780946|FG001|Overall Study|Adverse Event|30|||
148810023|NCT00846365|536780947|FG002|Overall Study|Adverse Event|11|||
148810024|NCT00846365|536780945|FG000|Overall Study|Protocol Violation|5|||
148810025|NCT00846365|536780946|FG001|Overall Study|Protocol Violation|4|||
148810026|NCT00846365|536780947|FG002|Overall Study|Protocol Violation|0|||
148810027|NCT00846365|536780945|FG000|Overall Study|Lost to Follow-up|8|||
148810028|NCT00846365|536780946|FG001|Overall Study|Lost to Follow-up|2|||
148953633|NCT02425046|537313060|FG002|Overall Study|Withdrawal by Subject|0|||
148953634|NCT01413191|537313061|FG000|Overall Study|Lost to Follow-up|5|||
148953635|NCT01413191|537313061|FG000|Overall Study|Disease Progression|5|||
148953636|NCT01413191|537313061|FG000|Overall Study|Death|1|||
148953637|NCT02564042|537313064|FG000|Overall Study|Adverse Event|4|||
148953638|NCT02564042|537313065|FG001|Overall Study|Adverse Event|4|||
148953639|NCT02564042|537313066|FG002|Overall Study|Adverse Event|3|||
148686291|NCT02173301|536323597|FG000|Overall Study|Physician Decision|0|||
148686292|NCT02173301|536323598|FG001|Overall Study|Physician Decision|0|||
148686293|NCT02173301|536323599|FG002|Overall Study|Physician Decision|1|||
148686294|NCT02173301|536323600|FG003|Overall Study|Physician Decision|0|||
148686295|NCT02173301|536323597|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
148686296|NCT02173301|536323598|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
148686297|NCT02173301|536323599|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
148686298|NCT02173301|536323600|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
148686299|NCT03740100|536323601|FG000|Overall Study|Adverse Event|1|||
148686300|NCT03740100|536323601|FG000|Overall Study|Death|1|||
148686301|NCT03120520|536323602|FG000|Overall Study|Lost to Follow-up|1|||
148686302|NCT03120520|536323603|FG001|Overall Study|Lost to Follow-up|1|||
148686303|NCT03120520|536323604|FG002|Overall Study|Lost to Follow-up|1|||
148686304|NCT03120520|536323605|FG003|Overall Study|Lost to Follow-up|1|||
148686305|NCT03120520|536323602|FG000|Overall Study|Withdrawal by Subject|3|||
148686306|NCT03120520|536323603|FG001|Overall Study|Withdrawal by Subject|2|||
148686307|NCT03120520|536323604|FG002|Overall Study|Withdrawal by Subject|3|||
148686308|NCT03120520|536323605|FG003|Overall Study|Withdrawal by Subject|2|||
148686309|NCT03120520|536323602|FG000|Overall Study|Other|0|||
148686310|NCT03120520|536323603|FG001|Overall Study|Other|1|||
148686311|NCT03120520|536323604|FG002|Overall Study|Other|0|||
148686312|NCT03120520|536323605|FG003|Overall Study|Other|0|||
148686313|NCT02123459|536323609|FG000|Washout Period (1 Day)|Adverse Event|1|||
148686314|NCT02123459|536323610|FG001|Washout Period (1 Day)|Adverse Event|0|||
148953640|NCT02564042|537313067|FG003|Overall Study|Adverse Event|0|||
148686315|NCT03387059|536323611|FG000|Overall Study|Study termination|5|||
148686316|NCT03387059|536323612|FG001|Overall Study|Study termination|4|||
148686317|NCT00395083|536323624|FG000|Overall Study|Withdrawal by Subject|6|||
148686318|NCT00395083|536323625|FG001|Overall Study|Withdrawal by Subject|5|||
148686319|NCT00395083|536323624|FG000|Overall Study|Developed another disease|4|||
148686320|NCT00395083|536323625|FG001|Overall Study|Developed another disease|3|||
148686321|NCT00972153|536323626|FG000|Overall Study|Equipment malfunction during case|0|||
148810029|NCT00846365|536780947|FG002|Overall Study|Lost to Follow-up|5|||
148810030|NCT00846365|536780945|FG000|Overall Study|Withdrawal by Subject|11|||
148810031|NCT00846365|536780946|FG001|Overall Study|Withdrawal by Subject|11|||
148810032|NCT00846365|536780947|FG002|Overall Study|Withdrawal by Subject|9|||
148686322|NCT00972153|536323627|FG001|Overall Study|Equipment malfunction during case|1|||
148686323|NCT00972153|536323628|FG002|Overall Study|Equipment malfunction during case|0|||
148686324|NCT01077713|536323629|FG000|Overall Study|Withdrawal by Subject|1|||
148686325|NCT01077713|536323630|FG001|Overall Study|Withdrawal by Subject|2|||
148686326|NCT01077713|536323629|FG000|Overall Study|Progressive Disease (PD)|0|||
148686327|NCT01077713|536323630|FG001|Overall Study|Progressive Disease (PD)|1|||
148686328|NCT01077713|536323629|FG000|Overall Study|Death|28|||
148686329|NCT01077713|536323630|FG001|Overall Study|Death|29|||
148686330|NCT01077713|536323629|FG000|Overall Study|Lost to Follow-up|1|||
148686331|NCT01077713|536323630|FG001|Overall Study|Lost to Follow-up|1|||
148686332|NCT01077713|536323629|FG000|Overall Study|Adverse Event|2|||
148686333|NCT01077713|536323630|FG001|Overall Study|Adverse Event|1|||
148686334|NCT01077713|536323629|FG000|Overall Study|Other|4|||
148686335|NCT01077713|536323630|FG001|Overall Study|Other|2|||
148686336|NCT04136626|536323631|FG000|Treatment Phase|Withdrawal by Subject|1|||
148686337|NCT04136626|536323632|FG001|Treatment Phase|Withdrawal by Subject|9|||
148686338|NCT04136626|536323631|FG000|Treatment Phase|Adverse Event|1|||
148686339|NCT04136626|536323632|FG001|Treatment Phase|Adverse Event|0|||
148686340|NCT04136626|536323631|FG000|Treatment Phase|Lost to Follow-up|1|||
148686341|NCT04136626|536323632|FG001|Treatment Phase|Lost to Follow-up|5|||
148686342|NCT04136626|536323631|FG000|12-month Follow-up|Lost to Follow-up|8|||
148686343|NCT04136626|536323632|FG001|12-month Follow-up|Lost to Follow-up|7|||
148686344|NCT00628745|536323633|FG000|Overall Study|Withdrawal by Subject|63|||
148686345|NCT00628745|536323634|FG001|Overall Study|Withdrawal by Subject|3|||
148686346|NCT00628745|536323635|FG002|Overall Study|Withdrawal by Subject|9|||
148686347|NCT00628745|536323636|FG003|Overall Study|Withdrawal by Subject|2|||
148686348|NCT00628745|536323637|FG004|Overall Study|Withdrawal by Subject|69|||
148686349|NCT00628745|536323633|FG000|Overall Study|Does not meet inclusion criteria|0|||
148686350|NCT00628745|536323634|FG001|Overall Study|Does not meet inclusion criteria|12|||
148686351|NCT00628745|536323635|FG002|Overall Study|Does not meet inclusion criteria|0|||
148686352|NCT00628745|536323636|FG003|Overall Study|Does not meet inclusion criteria|0|||
148686353|NCT00628745|536323637|FG004|Overall Study|Does not meet inclusion criteria|18|||
148953641|NCT02564042|537313068|FG004|Overall Study|Adverse Event|0|||
148953642|NCT02564042|537313069|FG005|Overall Study|Adverse Event|1|||
148686354|NCT00628745|536323633|FG000|Overall Study|Participation in an interventional clinical trial|81|||
148686355|NCT00628745|536323634|FG001|Overall Study|Participation in an interventional clinical trial|4|||
148686356|NCT00628745|536323635|FG002|Overall Study|Participation in an interventional clinical trial|7|||
148686357|NCT00628745|536323636|FG003|Overall Study|Participation in an interventional clinical trial|0|||
148686358|NCT00628745|536323637|FG004|Overall Study|Participation in an interventional clinical trial|63|||
148686359|NCT00628745|536323633|FG000|Overall Study|Physician Decision|8|||
148686360|NCT00628745|536323634|FG001|Overall Study|Physician Decision|4|||
148686361|NCT00628745|536323635|FG002|Overall Study|Physician Decision|3|||
148686362|NCT00628745|536323636|FG003|Overall Study|Physician Decision|0|||
148686363|NCT00628745|536323637|FG004|Overall Study|Physician Decision|30|||
148686364|NCT00628745|536323633|FG000|Overall Study|Lost to Follow-up|109|||
148686365|NCT00628745|536323634|FG001|Overall Study|Lost to Follow-up|7|||
148686366|NCT00628745|536323635|FG002|Overall Study|Lost to Follow-up|7|||
148686367|NCT00628745|536323636|FG003|Overall Study|Lost to Follow-up|0|||
148686368|NCT00628745|536323637|FG004|Overall Study|Lost to Follow-up|498|||
148953643|NCT02564042|537313064|FG000|Overall Study|Lost to Follow-up|1|||
148953644|NCT02564042|537313065|FG001|Overall Study|Lost to Follow-up|1|||
148953645|NCT02564042|537313066|FG002|Overall Study|Lost to Follow-up|1|||
148953646|NCT02564042|537313067|FG003|Overall Study|Lost to Follow-up|0|||
148953647|NCT02564042|537313068|FG004|Overall Study|Lost to Follow-up|1|||
149018029|NCT01474512|537547150|FG001|Induction Period|Lack of Efficacy|1|||
149018030|NCT01474512|537547151|FG002|Induction Period|Lack of Efficacy|0|||
148686369|NCT00628745|536323633|FG000|Overall Study|Death|197|||
148686370|NCT00628745|536323634|FG001|Overall Study|Death|81|||
148686371|NCT00628745|536323635|FG002|Overall Study|Death|12|||
148686372|NCT00628745|536323636|FG003|Overall Study|Death|4|||
148686373|NCT00628745|536323637|FG004|Overall Study|Death|939|||
148686374|NCT00628745|536323633|FG000|Overall Study|Participant transferred to another THAOS site|6|||
148686375|NCT00628745|536323634|FG001|Overall Study|Participant transferred to another THAOS site|0|||
148686376|NCT00628745|536323635|FG002|Overall Study|Participant transferred to another THAOS site|0|||
148686377|NCT00628745|536323636|FG003|Overall Study|Participant transferred to another THAOS site|0|||
148686378|NCT00628745|536323637|FG004|Overall Study|Participant transferred to another THAOS site|7|||
148686379|NCT00628745|536323633|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
148686380|NCT00628745|536323634|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
148686381|NCT00628745|536323635|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
148686382|NCT00628745|536323636|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
148953648|NCT02564042|537313069|FG005|Overall Study|Lost to Follow-up|1|||
148953649|NCT02564042|537313064|FG000|Overall Study|Physician Decision|1|||
148953650|NCT02564042|537313065|FG001|Overall Study|Physician Decision|0|||
148953651|NCT02564042|537313066|FG002|Overall Study|Physician Decision|0|||
148686383|NCT00628745|536323637|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
148686384|NCT00628745|536323633|FG000|Overall Study|Site closure|152|||
148686385|NCT00628745|536323634|FG001|Overall Study|Site closure|146|||
148686386|NCT00628745|536323635|FG002|Overall Study|Site closure|6|||
148686387|NCT00628745|536323636|FG003|Overall Study|Site closure|8|||
148686388|NCT00628745|536323637|FG004|Overall Study|Site closure|691|||
148686389|NCT00628745|536323633|FG000|Overall Study|Duplicate participant|0|||
148686390|NCT00628745|536323634|FG001|Overall Study|Duplicate participant|0|||
148686391|NCT00628745|536323635|FG002|Overall Study|Duplicate participant|0|||
148686392|NCT00628745|536323636|FG003|Overall Study|Duplicate participant|0|||
148686393|NCT00628745|536323637|FG004|Overall Study|Duplicate participant|1|||
148686394|NCT00628745|536323633|FG000|Overall Study|Missing|4|||
148686395|NCT00628745|536323634|FG001|Overall Study|Missing|3|||
148686396|NCT00628745|536323635|FG002|Overall Study|Missing|0|||
148686397|NCT00628745|536323636|FG003|Overall Study|Missing|0|||
148686398|NCT00628745|536323637|FG004|Overall Study|Missing|10|||
148686399|NCT00628745|536323633|FG000|Overall Study|Othe reasons|987|||
148686400|NCT00628745|536323634|FG001|Overall Study|Othe reasons|373|||
148686401|NCT00628745|536323635|FG002|Overall Study|Othe reasons|105|||
148686402|NCT00628745|536323636|FG003|Overall Study|Othe reasons|1|||
148686403|NCT00628745|536323637|FG004|Overall Study|Othe reasons|1772|||
148686404|NCT00387712|536324881|FG000|Overall Study|Physician Decision|6|||
148686405|NCT00387712|536324882|FG001|Overall Study|Physician Decision|4|||
148686406|NCT00387712|536324881|FG000|Overall Study|Lost to Follow-up|17|||
148686407|NCT00387712|536324882|FG001|Overall Study|Lost to Follow-up|20|||
148686408|NCT00387712|536324881|FG000|Overall Study|Withdrawal by Subject|6|||
148686409|NCT00387712|536324882|FG001|Overall Study|Withdrawal by Subject|12|||
148686410|NCT00671879|536324896|FG000|Overall Study|Withdrawal by Subject|0|||
148686411|NCT00671879|536324897|FG001|Overall Study|Withdrawal by Subject|4|||
148686412|NCT00671879|536324898|FG002|Overall Study|Withdrawal by Subject|6|||
148686413|NCT04633837|536324899|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
148686414|NCT04633837|536324900|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
148686415|NCT00752791|536324910|FG000|Overall Study|Adverse Event|7|||
148686416|NCT00752791|536324910|FG000|Overall Study|Withdrawal by Subject|1|||
148686417|NCT00752791|536324910|FG000|Overall Study|Physician Decision|1|||
148686418|NCT00752791|536324910|FG000|Overall Study|Death|1|||
148686419|NCT00752791|536324910|FG000|Overall Study|Renal transplant|3|||
148686420|NCT00752791|536324910|FG000|Overall Study|Switched to hemodialysis|2|||
148686421|NCT00752791|536324910|FG000|Overall Study|Protocol deviation|1|||
148686422|NCT01952574|536324911|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
148686423|NCT01952574|536324912|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
148686424|NCT01952574|536324913|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
148686425|NCT01952574|536324914|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
148686426|NCT01952574|536324915|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148686427|NCT01952574|536324916|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148686428|NCT01952574|536324917|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148686429|NCT01952574|536324911|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
148686430|NCT01952574|536324912|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
148686431|NCT01952574|536324913|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
148686432|NCT01952574|536324914|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
148686433|NCT01952574|536324915|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
148686434|NCT01952574|536324916|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
148686435|NCT01952574|536324917|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
148686436|NCT01952574|536324911|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
148953652|NCT02564042|537313067|FG003|Overall Study|Physician Decision|1|||
148953653|NCT02564042|537313068|FG004|Overall Study|Physician Decision|0|||
148686437|NCT01952574|536324912|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
148686438|NCT01952574|536324913|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
148810033|NCT00846365|536780945|FG000|Overall Study|Pregnancy|1|||
148810034|NCT00846365|536780946|FG001|Overall Study|Pregnancy|0|||
148810035|NCT00846365|536780947|FG002|Overall Study|Pregnancy|0|||
148686439|NCT01952574|536324914|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
148686440|NCT01952574|536324915|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
148686441|NCT01952574|536324916|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
148686442|NCT01952574|536324917|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
148686443|NCT01952574|536324911|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
148686444|NCT01952574|536324912|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
148686445|NCT01952574|536324913|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
148686446|NCT01952574|536324914|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
148686447|NCT01952574|536324915|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
148686448|NCT01952574|536324916|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
148686449|NCT01952574|536324917|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
148810036|NCT00846365|536780945|FG000|Overall Study|Lack of Efficacy|1|||
148953654|NCT02564042|537313069|FG005|Overall Study|Physician Decision|0|||
149222448|NCT00718887|538280638|FG000|Overall Study|Withdrawal by Subject|3|||
149222449|NCT00718887|538280639|FG001|Overall Study|Withdrawal by Subject|2|||
149222450|NCT00718887|538280638|FG000|Overall Study|Not identified|2|||
149222451|NCT00718887|538280639|FG001|Overall Study|Not identified|7|||
149222452|NCT00775138|538280640|FG000|Overall Study|Withdrawal by Subject|0|||
149222453|NCT00775138|538280641|FG001|Overall Study|Withdrawal by Subject|0|||
149222454|NCT00775138|538280642|FG002|Overall Study|Withdrawal by Subject|2|||
149222455|NCT00775138|538280643|FG003|Overall Study|Withdrawal by Subject|2|||
149222456|NCT00775138|538280640|FG000|Overall Study|Adverse Event|0|||
149222457|NCT00775138|538280641|FG001|Overall Study|Adverse Event|0|||
149222458|NCT00775138|538280642|FG002|Overall Study|Adverse Event|1|||
149222459|NCT00775138|538280643|FG003|Overall Study|Adverse Event|0|||
149222460|NCT03557801|538280644|FG000|Overall Study|Protocol Violation|1|||
149222461|NCT03557801|538280645|FG001|Overall Study|Protocol Violation|0|||
149222462|NCT03557801|538280646|FG002|Overall Study|Protocol Violation|0|||
149222463|NCT03557801|538280644|FG000|Overall Study|Withdrawal by Subject|1|||
149222464|NCT03557801|538280645|FG001|Overall Study|Withdrawal by Subject|0|||
149222465|NCT03557801|538280646|FG002|Overall Study|Withdrawal by Subject|3|||
149222466|NCT03557801|538280644|FG000|Overall Study|Lost to Follow-up|0|||
149222467|NCT03557801|538280645|FG001|Overall Study|Lost to Follow-up|1|||
149222468|NCT03557801|538280646|FG002|Overall Study|Lost to Follow-up|0|||
149222469|NCT00141297|538280647|FG000|Overall Study|Adverse Event|0|||
149222470|NCT00141297|538280648|FG001|Overall Study|Adverse Event|0|||
149222471|NCT00141297|538280649|FG002|Overall Study|Adverse Event|1|||
149222472|NCT00141297|538280650|FG003|Overall Study|Adverse Event|0|||
149222473|NCT00141297|538280651|FG004|Overall Study|Adverse Event|1|||
149222474|NCT00141297|538280652|FG005|Overall Study|Adverse Event|1|||
148686450|NCT01952574|536324911|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
149222475|NCT00141297|538280653|FG006|Overall Study|Adverse Event|0|||
149222476|NCT00141297|538280654|FG007|Overall Study|Adverse Event|1|||
149222477|NCT00141297|538280655|FG008|Overall Study|Adverse Event|1|||
149222478|NCT00141297|538280656|FG009|Overall Study|Adverse Event|0|||
149222479|NCT00141297|538280647|FG000|Overall Study|Death|1|||
149222480|NCT00141297|538280648|FG001|Overall Study|Death|0|||
149222481|NCT00141297|538280649|FG002|Overall Study|Death|0|||
149222482|NCT00141297|538280650|FG003|Overall Study|Death|0|||
149222483|NCT00141297|538280651|FG004|Overall Study|Death|0|||
149222484|NCT00141297|538280652|FG005|Overall Study|Death|0|||
149222485|NCT00141297|538280653|FG006|Overall Study|Death|0|||
149222486|NCT00141297|538280654|FG007|Overall Study|Death|0|||
149222487|NCT00141297|538280655|FG008|Overall Study|Death|1|||
149222488|NCT00141297|538280656|FG009|Overall Study|Death|0|||
149222489|NCT00141297|538280647|FG000|Overall Study|Withdrawal by Subject|0|||
149222490|NCT00141297|538280648|FG001|Overall Study|Withdrawal by Subject|0|||
149222491|NCT00141297|538280649|FG002|Overall Study|Withdrawal by Subject|0|||
149222492|NCT00141297|538280650|FG003|Overall Study|Withdrawal by Subject|0|||
149222493|NCT00141297|538280651|FG004|Overall Study|Withdrawal by Subject|0|||
149222494|NCT00141297|538280652|FG005|Overall Study|Withdrawal by Subject|0|||
149222495|NCT00141297|538280653|FG006|Overall Study|Withdrawal by Subject|0|||
149222496|NCT00141297|538280654|FG007|Overall Study|Withdrawal by Subject|0|||
149222497|NCT00141297|538280655|FG008|Overall Study|Withdrawal by Subject|1|||
149222498|NCT00141297|538280656|FG009|Overall Study|Withdrawal by Subject|0|||
149222499|NCT00141297|538280647|FG000|Overall Study|Other|0|||
149222500|NCT00141297|538280648|FG001|Overall Study|Other|0|||
149222501|NCT00141297|538280649|FG002|Overall Study|Other|0|||
149222502|NCT00141297|538280650|FG003|Overall Study|Other|1|||
149222503|NCT00141297|538280651|FG004|Overall Study|Other|5|||
149222504|NCT00141297|538280652|FG005|Overall Study|Other|0|||
149222505|NCT00141297|538280653|FG006|Overall Study|Other|0|||
149222506|NCT00141297|538280654|FG007|Overall Study|Other|0|||
149222507|NCT00141297|538280655|FG008|Overall Study|Other|2|||
149222508|NCT00141297|538280656|FG009|Overall Study|Other|0|||
149222509|NCT00141297|538280647|FG000|Overall Study|Progressive Disease|2|||
149222510|NCT00141297|538280648|FG001|Overall Study|Progressive Disease|3|||
149222511|NCT00141297|538280649|FG002|Overall Study|Progressive Disease|6|||
149222512|NCT00141297|538280650|FG003|Overall Study|Progressive Disease|2|||
149222513|NCT00141297|538280651|FG004|Overall Study|Progressive Disease|15|||
149222514|NCT00141297|538280652|FG005|Overall Study|Progressive Disease|2|||
149222515|NCT00141297|538280653|FG006|Overall Study|Progressive Disease|3|||
149222516|NCT00141297|538280654|FG007|Overall Study|Progressive Disease|3|||
149222517|NCT00141297|538280655|FG008|Overall Study|Progressive Disease|15|||
149222518|NCT00141297|538280656|FG009|Overall Study|Progressive Disease|6|||
148686451|NCT01952574|536324912|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
149222519|NCT00141297|538280647|FG000|Overall Study|Transitioned|0|||
149222520|NCT00141297|538280648|FG001|Overall Study|Transitioned|0|||
149222521|NCT00141297|538280649|FG002|Overall Study|Transitioned|0|||
149222522|NCT00141297|538280650|FG003|Overall Study|Transitioned|0|||
149222523|NCT00141297|538280651|FG004|Overall Study|Transitioned|1|||
149222524|NCT00141297|538280652|FG005|Overall Study|Transitioned|0|||
149222525|NCT00141297|538280653|FG006|Overall Study|Transitioned|0|||
149222526|NCT00141297|538280654|FG007|Overall Study|Transitioned|0|||
148686452|NCT01952574|536324913|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
148686453|NCT01952574|536324914|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
148686454|NCT01952574|536324915|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
148686455|NCT01952574|536324916|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
148686456|NCT01952574|536324917|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
148686457|NCT01952574|536324911|FG000|Open-label Treatment Phase|Missing|0|||
148686458|NCT01952574|536324912|FG001|Open-label Treatment Phase|Missing|0|||
148686459|NCT01952574|536324913|FG002|Open-label Treatment Phase|Missing|0|||
148686460|NCT01952574|536324914|FG003|Open-label Treatment Phase|Missing|0|||
148686461|NCT01952574|536324915|FG004|Open-label Treatment Phase|Missing|4|||
148686462|NCT01952574|536324916|FG005|Open-label Treatment Phase|Missing|0|||
148686463|NCT01952574|536324917|FG006|Open-label Treatment Phase|Missing|0|||
148686464|NCT01952574|536324911|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
148686465|NCT01952574|536324912|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
148686466|NCT01952574|536324913|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
148686467|NCT01952574|536324914|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
148686468|NCT01952574|536324915|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
148686469|NCT01952574|536324916|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
148686470|NCT01952574|536324917|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
148686471|NCT01952574|536324911|FG000|Open-label Treatment Phase|Death|0|||
148686472|NCT01952574|536324912|FG001|Open-label Treatment Phase|Death|0|||
148686473|NCT01952574|536324913|FG002|Open-label Treatment Phase|Death|0|||
148686474|NCT01952574|536324914|FG003|Open-label Treatment Phase|Death|0|||
148686475|NCT01952574|536324915|FG004|Open-label Treatment Phase|Death|1|||
148686476|NCT01952574|536324916|FG005|Open-label Treatment Phase|Death|0|||
148686477|NCT01952574|536324917|FG006|Open-label Treatment Phase|Death|0|||
149222527|NCT00141297|538280655|FG008|Overall Study|Transitioned|0|||
149222528|NCT00141297|538280656|FG009|Overall Study|Transitioned|0|||
149222529|NCT02646891|538280657|FG000|Overall Study|Adverse Event|0|||
149222530|NCT02646891|538280658|FG001|Overall Study|Adverse Event|1|||
149222531|NCT02646891|538280659|FG002|Overall Study|Adverse Event|0|||
149222532|NCT02646891|538280660|FG003|Overall Study|Adverse Event|0|||
149222533|NCT02646891|538280661|FG004|Overall Study|Adverse Event|0|||
149222534|NCT02646891|538280662|FG005|Overall Study|Adverse Event|0|||
149222535|NCT02646891|538280663|FG006|Overall Study|Adverse Event|0|||
149222536|NCT02646891|538280664|FG007|Overall Study|Adverse Event|0|||
149222537|NCT02646891|538280665|FG008|Overall Study|Adverse Event|0|||
149222538|NCT02646891|538280666|FG009|Overall Study|Adverse Event|0|||
149222539|NCT02646891|538280657|FG000|Overall Study|Lost to Follow-up|0|||
149222540|NCT02646891|538280658|FG001|Overall Study|Lost to Follow-up|0|||
149222541|NCT02646891|538280659|FG002|Overall Study|Lost to Follow-up|0|||
149222542|NCT02646891|538280660|FG003|Overall Study|Lost to Follow-up|0|||
149222543|NCT02646891|538280661|FG004|Overall Study|Lost to Follow-up|0|||
149222544|NCT02646891|538280662|FG005|Overall Study|Lost to Follow-up|0|||
149222545|NCT02646891|538280663|FG006|Overall Study|Lost to Follow-up|2|||
148686478|NCT01952574|536324911|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
148686479|NCT01952574|536324912|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
148686480|NCT01952574|536324913|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
148686481|NCT01952574|536324914|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
148686482|NCT01952574|536324915|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
148686483|NCT01952574|536324916|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
148686484|NCT01952574|536324917|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
149222546|NCT02646891|538280664|FG007|Overall Study|Lost to Follow-up|2|||
149222547|NCT02646891|538280665|FG008|Overall Study|Lost to Follow-up|2|||
148686485|NCT01952574|536324911|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
148686486|NCT01952574|536324912|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
148686487|NCT01952574|536324913|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
148686488|NCT01952574|536324914|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
148686489|NCT01952574|536324915|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
148686490|NCT01952574|536324916|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
149222548|NCT02646891|538280666|FG009|Overall Study|Lost to Follow-up|2|||
149222549|NCT02646891|538280657|FG000|Overall Study|Protocol Violation|0|||
149222550|NCT02646891|538280658|FG001|Overall Study|Protocol Violation|0|||
149222551|NCT02646891|538280659|FG002|Overall Study|Protocol Violation|0|||
149222552|NCT02646891|538280660|FG003|Overall Study|Protocol Violation|0|||
148686491|NCT01952574|536324917|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
148686492|NCT00770991|536324921|FG000|Overall Study|Physician Decision|2|||
148686493|NCT00770991|536324922|FG001|Overall Study|Physician Decision|0|||
148686494|NCT00770991|536324921|FG000|Overall Study|Withdrawal by Subject|1|||
148686495|NCT00770991|536324922|FG001|Overall Study|Withdrawal by Subject|0|||
148686496|NCT00770991|536324921|FG000|Overall Study|Adverse Event|1|||
149018031|NCT01474512|537547152|FG003|Induction Period|Lack of Efficacy|0|||
149222553|NCT02646891|538280661|FG004|Overall Study|Protocol Violation|0|||
149222554|NCT02646891|538280662|FG005|Overall Study|Protocol Violation|0|||
149222555|NCT02646891|538280663|FG006|Overall Study|Protocol Violation|1|||
149222556|NCT02646891|538280664|FG007|Overall Study|Protocol Violation|1|||
149222557|NCT02646891|538280665|FG008|Overall Study|Protocol Violation|0|||
148686497|NCT00770991|536324922|FG001|Overall Study|Adverse Event|5|||
148686498|NCT00770991|536324921|FG000|Overall Study|Pregnancy|1|||
148686499|NCT00770991|536324922|FG001|Overall Study|Pregnancy|0|||
148686500|NCT02087046|536324924|FG000|Overall Study|Adverse Event|4|||
148686501|NCT02087046|536324924|FG000|Overall Study|Death|1|||
148686502|NCT02087046|536324924|FG000|Overall Study|Lost to Follow-up|3|||
148686503|NCT02087046|536324924|FG000|Overall Study|Withdrawal by Subject|2|||
148686504|NCT02087046|536324924|FG000|Overall Study|Physician Decision|1|||
148686505|NCT01107535|536324925|FG000|Overall Study|Death|5|||
148686506|NCT02444533|536324926|FG000|Overall Study|Not able to complete forms|0|||
148686507|NCT02444533|536324927|FG001|Overall Study|Not able to complete forms|2|||
148686508|NCT02444533|536324926|FG000|Overall Study|Only gave post-procedure complications|2|||
148686509|NCT02444533|536324927|FG001|Overall Study|Only gave post-procedure complications|2|||
148686510|NCT03567057|536324928|FG000|Overall Study|Adverse Event|56|||
148686511|NCT03567057|536324929|FG001|Overall Study|Adverse Event|53|||
148686512|NCT03567057|536324930|FG002|Overall Study|Adverse Event|28|||
148686513|NCT03567057|536324928|FG000|Overall Study|Withdrawal by Subject|22|||
148686514|NCT03567057|536324929|FG001|Overall Study|Withdrawal by Subject|24|||
148686515|NCT03567057|536324930|FG002|Overall Study|Withdrawal by Subject|13|||
148686516|NCT03567057|536324928|FG000|Overall Study|Lost to Follow-up|3|||
148686517|NCT03567057|536324929|FG001|Overall Study|Lost to Follow-up|5|||
148686518|NCT03567057|536324930|FG002|Overall Study|Lost to Follow-up|2|||
148686519|NCT03567057|536324928|FG000|Overall Study|COVID-19 pandemic|4|||
148686520|NCT03567057|536324929|FG001|Overall Study|COVID-19 pandemic|3|||
148686521|NCT03567057|536324930|FG002|Overall Study|COVID-19 pandemic|0|||
148686522|NCT03567057|536324928|FG000|Overall Study|Non-compliance with study drug|4|||
149222558|NCT02646891|538280666|FG009|Overall Study|Protocol Violation|0|||
148686523|NCT03567057|536324929|FG001|Overall Study|Non-compliance with study drug|2|||
148686524|NCT03567057|536324930|FG002|Overall Study|Non-compliance with study drug|0|||
148686525|NCT03567057|536324928|FG000|Overall Study|Lack of Efficacy|3|||
148686526|NCT03567057|536324929|FG001|Overall Study|Lack of Efficacy|0|||
148686527|NCT03567057|536324930|FG002|Overall Study|Lack of Efficacy|1|||
148686528|NCT03567057|536324928|FG000|Overall Study|Death|1|||
148686529|NCT03567057|536324929|FG001|Overall Study|Death|0|||
148686530|NCT03567057|536324930|FG002|Overall Study|Death|0|||
148686531|NCT03567057|536324928|FG000|Overall Study|Physician Decision|1|||
148686532|NCT03567057|536324929|FG001|Overall Study|Physician Decision|0|||
148686533|NCT03567057|536324930|FG002|Overall Study|Physician Decision|0|||
148686534|NCT03567057|536324928|FG000|Overall Study|Unstable medical condition|1|||
148686535|NCT03567057|536324929|FG001|Overall Study|Unstable medical condition|0|||
148686536|NCT03567057|536324930|FG002|Overall Study|Unstable medical condition|0|||
148686537|NCT03567057|536324928|FG000|Overall Study|Medical history event|0|||
148686538|NCT03567057|536324929|FG001|Overall Study|Medical history event|0|||
148686539|NCT03567057|536324930|FG002|Overall Study|Medical history event|1|||
148686540|NCT03567057|536324928|FG000|Overall Study|Other|0|||
148686541|NCT03567057|536324929|FG001|Overall Study|Other|0|||
148686542|NCT03567057|536324930|FG002|Overall Study|Other|1|||
148686543|NCT00490061|536324931|FG000|Overall Study|Physician Decision|1|||
148686544|NCT01155583|536324932|FG000|Phase I|Screen failure - did not start treatment|0|||
148686545|NCT01155583|536324933|FG001|Phase I|Screen failure - did not start treatment|0|||
148686546|NCT01155583|536324934|FG002|Phase I|Screen failure - did not start treatment|0|||
148686547|NCT01155583|536324935|FG003|Phase I|Screen failure - did not start treatment|0|||
148686548|NCT01155583|536324936|FG004|Phase I|Screen failure - did not start treatment|1|||
148686549|NCT01155583|536324937|FG005|Phase I|Screen failure - did not start treatment|0|||
148686550|NCT01155583|536324938|FG006|Phase I|Screen failure - did not start treatment|0|||
148686551|NCT01155583|536324939|FG007|Phase I|Screen failure - did not start treatment|2|||
148686552|NCT01155583|536324940|FG008|Phase I|Screen failure - did not start treatment|0|||
148686553|NCT01155583|536324932|FG000|Phase I|Withdrawal by Subject|0|||
148686554|NCT01155583|536324933|FG001|Phase I|Withdrawal by Subject|0|||
148686555|NCT01155583|536324934|FG002|Phase I|Withdrawal by Subject|0|||
148686556|NCT01155583|536324935|FG003|Phase I|Withdrawal by Subject|0|||
148686557|NCT01155583|536324936|FG004|Phase I|Withdrawal by Subject|0|||
148686558|NCT01155583|536324937|FG005|Phase I|Withdrawal by Subject|0|||
148686559|NCT01155583|536324938|FG006|Phase I|Withdrawal by Subject|0|||
148686560|NCT01155583|536324939|FG007|Phase I|Withdrawal by Subject|1|||
148686561|NCT01155583|536324940|FG008|Phase I|Withdrawal by Subject|0|||
148686562|NCT00886483|536324945|FG000|Overall Study|Lost to Follow-up|0|||
148686563|NCT00886483|536324946|FG001|Overall Study|Lost to Follow-up|1|||
148686564|NCT00886483|536324945|FG000|Overall Study|Pursue medications|1|||
148686565|NCT00886483|536324946|FG001|Overall Study|Pursue medications|2|||
148686566|NCT00886483|536324945|FG000|Overall Study|Distance to center, poor grades|1|||
148686567|NCT00886483|536324946|FG001|Overall Study|Distance to center, poor grades|0|||
148686568|NCT00585351|536324947|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
148686569|NCT00585351|536324948|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
148686570|NCT00585351|536324949|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
148686571|NCT00585351|536324950|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
149222559|NCT02646891|538280657|FG000|Overall Study|Withdrawal by Subject|2|||
149222560|NCT02646891|538280658|FG001|Overall Study|Withdrawal by Subject|0|||
149222561|NCT02646891|538280659|FG002|Overall Study|Withdrawal by Subject|1|||
149222562|NCT02646891|538280660|FG003|Overall Study|Withdrawal by Subject|0|||
149222563|NCT02646891|538280661|FG004|Overall Study|Withdrawal by Subject|0|||
149222564|NCT02646891|538280662|FG005|Overall Study|Withdrawal by Subject|0|||
149222565|NCT02646891|538280663|FG006|Overall Study|Withdrawal by Subject|5|||
149222566|NCT02646891|538280664|FG007|Overall Study|Withdrawal by Subject|9|||
149222567|NCT02646891|538280665|FG008|Overall Study|Withdrawal by Subject|7|||
149222568|NCT02646891|538280666|FG009|Overall Study|Withdrawal by Subject|3|||
149222569|NCT02646891|538280657|FG000|Overall Study|Death|0|||
149222570|NCT02646891|538280658|FG001|Overall Study|Death|0|||
149222571|NCT02646891|538280659|FG002|Overall Study|Death|0|||
149222572|NCT02646891|538280660|FG003|Overall Study|Death|0|||
149222573|NCT02646891|538280661|FG004|Overall Study|Death|0|||
149222574|NCT02646891|538280662|FG005|Overall Study|Death|0|||
149222575|NCT02646891|538280663|FG006|Overall Study|Death|1|||
149222576|NCT02646891|538280664|FG007|Overall Study|Death|1|||
149222577|NCT02646891|538280665|FG008|Overall Study|Death|1|||
149222578|NCT02646891|538280666|FG009|Overall Study|Death|0|||
149222579|NCT01562327|538280669|FG000|Overall Study|Adverse Event|2|||
149222580|NCT01562327|538280669|FG000|Overall Study|Lack of Efficacy|1|||
149222581|NCT01562327|538280669|FG000|Overall Study|Participant drop-out|1|||
149222582|NCT01562327|538280669|FG000|Overall Study|Infusion not received at 6 month window|4|||
149222583|NCT02447952|538280672|FG000|Overall Study|Adverse Event|2|||
149222584|NCT02447952|538280672|FG000|Overall Study|Physician Decision|1|||
149222585|NCT02447952|538280672|FG000|Overall Study|Withdrawal by Subject|4|||
149222586|NCT00886587|538280673|FG000|Overall Study|Adverse Event|2|||
149222587|NCT00886587|538280674|FG001|Overall Study|Adverse Event|1|||
149222588|NCT00886587|538280673|FG000|Overall Study|Protocol Violation|2|||
149222589|NCT00886587|538280674|FG001|Overall Study|Protocol Violation|0|||
149222590|NCT00886587|538280673|FG000|Overall Study|Withdrawal by Subject|0|||
149222591|NCT00886587|538280674|FG001|Overall Study|Withdrawal by Subject|1|||
149222592|NCT00696774|538280677|FG000|Period II|Adverse Event|0|||
149222593|NCT00696774|538280678|FG001|Period II|Adverse Event|0|||
149222594|NCT00696774|538280679|FG002|Period II|Adverse Event|15|||
149222595|NCT00696774|538280677|FG000|Period II|Lost to Follow-up|0|||
149222596|NCT00696774|538280678|FG001|Period II|Lost to Follow-up|0|||
149222597|NCT00696774|538280679|FG002|Period II|Lost to Follow-up|4|||
149222598|NCT00696774|538280677|FG000|Period II|Protocol Violation|0|||
149222599|NCT00696774|538280678|FG001|Period II|Protocol Violation|0|||
149222600|NCT00696774|538280679|FG002|Period II|Protocol Violation|11|||
149222601|NCT00696774|538280677|FG000|Period II|Withdrawal by Subject|0|||
149222602|NCT00696774|538280678|FG001|Period II|Withdrawal by Subject|0|||
149222603|NCT00696774|538280679|FG002|Period II|Withdrawal by Subject|4|||
149222604|NCT00696774|538280677|FG000|Period II|Sponsor Decision|0|||
149222605|NCT00696774|538280678|FG001|Period II|Sponsor Decision|0|||
149222606|NCT00696774|538280679|FG002|Period II|Sponsor Decision|0|||
149222607|NCT00696774|538280677|FG000|Period II|Lack of Efficacy|0|||
149222608|NCT00696774|538280678|FG001|Period II|Lack of Efficacy|0|||
149222609|NCT00696774|538280679|FG002|Period II|Lack of Efficacy|2|||
149222610|NCT00696774|538280677|FG000|Period III|Adverse Event|1|||
149222611|NCT00696774|538280678|FG001|Period III|Adverse Event|1|||
149222612|NCT00696774|538280679|FG002|Period III|Adverse Event|0|||
149222613|NCT00696774|538280677|FG000|Period III|Lost to Follow-up|2|||
149222614|NCT00696774|538280678|FG001|Period III|Lost to Follow-up|1|||
149222615|NCT00696774|538280679|FG002|Period III|Lost to Follow-up|0|||
149222616|NCT00696774|538280677|FG000|Period III|Protocol Violation|1|||
149222617|NCT00696774|538280678|FG001|Period III|Protocol Violation|1|||
149222618|NCT00696774|538280679|FG002|Period III|Protocol Violation|0|||
149222619|NCT00696774|538280677|FG000|Period III|Withdrawal by Subject|1|||
149222620|NCT00696774|538280678|FG001|Period III|Withdrawal by Subject|2|||
149222621|NCT00696774|538280679|FG002|Period III|Withdrawal by Subject|0|||
149222622|NCT00696774|538280677|FG000|Period III|Sponsor Decision|2|||
149222623|NCT00696774|538280678|FG001|Period III|Sponsor Decision|0|||
149222624|NCT00696774|538280679|FG002|Period III|Sponsor Decision|0|||
149222625|NCT00696774|538280677|FG000|Period III|Lack of Efficacy|0|||
149222626|NCT00696774|538280678|FG001|Period III|Lack of Efficacy|2|||
149222627|NCT00696774|538280679|FG002|Period III|Lack of Efficacy|0|||
149222628|NCT00890201|538280686|FG000|Overall Study|Protocol Violation|5|||
149222629|NCT00890201|538280687|FG001|Overall Study|Protocol Violation|56|||
149222630|NCT01955005|538280688|FG000|Overall Study|Withdrawal by Subject|3|||
149222631|NCT01955005|538280689|FG001|Overall Study|Withdrawal by Subject|5|||
149222632|NCT02181504|538280690|FG000|Overall Study|Adverse Event|1|||
149222633|NCT02181504|538280691|FG001|Overall Study|Adverse Event|1|||
148686572|NCT00585351|536324951|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
148686573|NCT00585351|536324952|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
148686574|NCT00585351|536324953|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
148686575|NCT00585351|536324954|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
148686576|NCT00585351|536324947|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
148686577|NCT00585351|536324948|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
148686578|NCT00585351|536324949|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
148686579|NCT00585351|536324950|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
148686580|NCT00585351|536324951|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
148686581|NCT00585351|536324952|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
149222634|NCT02181504|538280692|FG002|Overall Study|Adverse Event|1|||
149222635|NCT00887913|538280693|FG000|Overall Study|Withdrawal by Subject|6|||
149222636|NCT01200758|538280696|FG000|Stage I|Death|0|||
149222637|NCT01200758|538280697|FG001|Stage I|Death|1|||
149222638|NCT01200758|538280698|FG002|Stage I|Death|0|||
148686582|NCT00585351|536324953|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
148686583|NCT00585351|536324954|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
148686584|NCT00585351|536324947|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
149222639|NCT01200758|538280699|FG003|Stage I|Death|0|||
149222640|NCT01200758|538280696|FG000|Stage I|Physician Decision|1|||
149222641|NCT01200758|538280697|FG001|Stage I|Physician Decision|1|||
149222642|NCT01200758|538280698|FG002|Stage I|Physician Decision|0|||
149222643|NCT01200758|538280699|FG003|Stage I|Physician Decision|0|||
149222644|NCT01200758|538280696|FG000|Stage I|Lack of Efficacy|2|||
149222645|NCT01200758|538280697|FG001|Stage I|Lack of Efficacy|1|||
149222646|NCT01200758|538280698|FG002|Stage I|Lack of Efficacy|0|||
149222647|NCT01200758|538280699|FG003|Stage I|Lack of Efficacy|0|||
149222648|NCT01200758|538280696|FG000|Stage I|Adverse Event|5|||
149222649|NCT01200758|538280697|FG001|Stage I|Adverse Event|5|||
149222650|NCT01200758|538280698|FG002|Stage I|Adverse Event|0|||
149222651|NCT01200758|538280699|FG003|Stage I|Adverse Event|0|||
149222652|NCT01200758|538280696|FG000|Stage I|Withdrawal by Subject|1|||
149222653|NCT01200758|538280697|FG001|Stage I|Withdrawal by Subject|2|||
149222654|NCT01200758|538280698|FG002|Stage I|Withdrawal by Subject|0|||
149222655|NCT01200758|538280699|FG003|Stage I|Withdrawal by Subject|0|||
148686585|NCT00585351|536324948|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
148686586|NCT00585351|536324949|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
148686587|NCT00585351|536324950|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
148686588|NCT00585351|536324951|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
148686589|NCT00585351|536324952|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
148686590|NCT00585351|536324953|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
148686591|NCT00585351|536324954|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
148686592|NCT00585351|536324947|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
148686593|NCT00585351|536324948|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
148686594|NCT00585351|536324949|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
148686595|NCT00585351|536324950|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
148686596|NCT00585351|536324951|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
148686597|NCT00585351|536324952|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
148686598|NCT00585351|536324953|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
148686599|NCT00585351|536324954|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
148686600|NCT00585351|536324947|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
148686601|NCT00585351|536324948|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
148810037|NCT00846365|536780946|FG001|Overall Study|Lack of Efficacy|1|||
149222656|NCT01200758|538280696|FG000|Stage I|Disease Progression|9|||
149222657|NCT01200758|538280697|FG001|Stage I|Disease Progression|7|||
149222658|NCT01200758|538280698|FG002|Stage I|Disease Progression|0|||
149222659|NCT01200758|538280699|FG003|Stage I|Disease Progression|0|||
149222660|NCT01200758|538280696|FG000|Stage 2|Disease Progression|0|||
149222661|NCT01200758|538280697|FG001|Stage 2|Disease Progression|0|||
149222662|NCT01200758|538280698|FG002|Stage 2|Disease Progression|16|||
149222663|NCT01200758|538280699|FG003|Stage 2|Disease Progression|21|||
149222664|NCT01200758|538280696|FG000|Stage 2|Lack of Efficacy|0|||
149222665|NCT01200758|538280697|FG001|Stage 2|Lack of Efficacy|0|||
149222666|NCT01200758|538280698|FG002|Stage 2|Lack of Efficacy|4|||
149222667|NCT01200758|538280699|FG003|Stage 2|Lack of Efficacy|2|||
149222668|NCT01200758|538280696|FG000|Stage 2|Physician Decision|0|||
149222669|NCT01200758|538280697|FG001|Stage 2|Physician Decision|0|||
149222670|NCT01200758|538280698|FG002|Stage 2|Physician Decision|5|||
149222671|NCT01200758|538280699|FG003|Stage 2|Physician Decision|7|||
149222672|NCT01200758|538280696|FG000|Stage 2|Adverse Event|0|||
149222673|NCT01200758|538280697|FG001|Stage 2|Adverse Event|0|||
149222674|NCT01200758|538280698|FG002|Stage 2|Adverse Event|5|||
149222675|NCT01200758|538280699|FG003|Stage 2|Adverse Event|9|||
149222676|NCT01200758|538280696|FG000|Stage 2|Withdrawal by Subject|0|||
149222677|NCT01200758|538280697|FG001|Stage 2|Withdrawal by Subject|0|||
149222678|NCT01200758|538280698|FG002|Stage 2|Withdrawal by Subject|4|||
149222679|NCT01200758|538280699|FG003|Stage 2|Withdrawal by Subject|1|||
149222680|NCT01200758|538280696|FG000|Stage 2|Lost to Follow-up|0|||
149222681|NCT01200758|538280697|FG001|Stage 2|Lost to Follow-up|0|||
149222682|NCT01200758|538280698|FG002|Stage 2|Lost to Follow-up|3|||
149222683|NCT01200758|538280699|FG003|Stage 2|Lost to Follow-up|1|||
149222684|NCT01200758|538280696|FG000|Stage 2|Protocol Violation|0|||
149222685|NCT01200758|538280697|FG001|Stage 2|Protocol Violation|0|||
149222686|NCT01200758|538280698|FG002|Stage 2|Protocol Violation|1|||
149222687|NCT01200758|538280699|FG003|Stage 2|Protocol Violation|4|||
149222688|NCT01200758|538280696|FG000|Stage 2|Death|0|||
149222689|NCT01200758|538280697|FG001|Stage 2|Death|0|||
149222690|NCT01200758|538280698|FG002|Stage 2|Death|3|||
149222691|NCT01200758|538280699|FG003|Stage 2|Death|5|||
149222692|NCT01371721|538280700|FG000|Overall Study|Adverse Event|5|||
149222693|NCT01371721|538280701|FG001|Overall Study|Adverse Event|4|||
149222694|NCT01371721|538280702|FG002|Overall Study|Adverse Event|5|||
149222695|NCT01371721|538280700|FG000|Overall Study|Protocol Violation|6|||
149222696|NCT01371721|538280701|FG001|Overall Study|Protocol Violation|4|||
149222697|NCT01371721|538280702|FG002|Overall Study|Protocol Violation|5|||
149222698|NCT01371721|538280700|FG000|Overall Study|Lost to Follow-up|8|||
149222699|NCT01371721|538280701|FG001|Overall Study|Lost to Follow-up|2|||
149222700|NCT01371721|538280702|FG002|Overall Study|Lost to Follow-up|6|||
149222701|NCT01371721|538280700|FG000|Overall Study|Withdrawal by Subject|5|||
149222702|NCT01371721|538280701|FG001|Overall Study|Withdrawal by Subject|7|||
149222703|NCT01371721|538280702|FG002|Overall Study|Withdrawal by Subject|11|||
149222704|NCT01371721|538280700|FG000|Overall Study|Other|2|||
149222705|NCT01371721|538280701|FG001|Overall Study|Other|3|||
149222706|NCT01371721|538280702|FG002|Overall Study|Other|0|||
149222707|NCT01371721|538280700|FG000|Overall Study|Lack of Efficacy|2|||
149222708|NCT01371721|538280701|FG001|Overall Study|Lack of Efficacy|4|||
149222709|NCT01371721|538280702|FG002|Overall Study|Lack of Efficacy|3|||
149222710|NCT01371721|538280700|FG000|Overall Study|Randomized but not treated|1|||
149222711|NCT01371721|538280701|FG001|Overall Study|Randomized but not treated|0|||
149222712|NCT01371721|538280702|FG002|Overall Study|Randomized but not treated|0|||
149222713|NCT00545584|538280703|FG000|Overall Study|Only one reason for discontinuation|62|||
149222714|NCT00545584|538280704|FG001|Overall Study|Only one reason for discontinuation|61|||
149222715|NCT00545584|538280705|FG002|Overall Study|Only one reason for discontinuation|48|||
149222716|NCT00545584|538280703|FG000|Overall Study|Two or more reasons for discontinuation|17|||
149222717|NCT00545584|538280704|FG001|Overall Study|Two or more reasons for discontinuation|19|||
149222718|NCT00545584|538280705|FG002|Overall Study|Two or more reasons for discontinuation|8|||
149222719|NCT00461552|538280710|FG000|Overall Study|Drug Dispensing error|0|||
149222720|NCT00461552|538280711|FG001|Overall Study|Drug Dispensing error|2|||
149222721|NCT01289028|538280712|FG000|Overall Study|Progressive Disease|49|||
149222722|NCT01289028|538280712|FG000|Overall Study|Adverse Event|14|||
149222723|NCT01289028|538280712|FG000|Overall Study|Withdrawal by Subject|6|||
149222724|NCT01289028|538280712|FG000|Overall Study|Death|4|||
149222725|NCT01289028|538280712|FG000|Overall Study|Lack of Efficacy|2|||
149222726|NCT01289028|538280712|FG000|Overall Study|No longer required|2|||
149222727|NCT01289028|538280712|FG000|Overall Study|Lost to Follow-up|2|||
149222728|NCT01289028|538280712|FG000|Overall Study|New Cancer Therapy|2|||
149222729|NCT01289028|538280712|FG000|Overall Study|Abnormal Lab Value|1|||
149222730|NCT01289028|538280712|FG000|Overall Study|Missing reason for discon|1|||
149222731|NCT00998985|538280714|FG000|Overall Study|Withdrawal by Subject|0|||
149222732|NCT00998985|538280715|FG001|Overall Study|Withdrawal by Subject|0|||
149222733|NCT00998985|538280716|FG002|Overall Study|Withdrawal by Subject|0|||
149222734|NCT00998985|538280717|FG003|Overall Study|Withdrawal by Subject|0|||
149222735|NCT00998985|538280718|FG004|Overall Study|Withdrawal by Subject|0|||
149222736|NCT00998985|538280719|FG005|Overall Study|Withdrawal by Subject|0|||
149222737|NCT00998985|538280720|FG006|Overall Study|Withdrawal by Subject|0|||
149222738|NCT00998985|538280721|FG007|Overall Study|Withdrawal by Subject|0|||
148810038|NCT00846365|536780947|FG002|Overall Study|Lack of Efficacy|2|||
149222739|NCT00998985|538280722|FG008|Overall Study|Withdrawal by Subject|1|||
149222740|NCT00998985|538280723|FG009|Overall Study|Withdrawal by Subject|0|||
149222741|NCT00998985|538280724|FG010|Overall Study|Withdrawal by Subject|0|||
149222742|NCT00998985|538280725|FG011|Overall Study|Withdrawal by Subject|0|||
149222743|NCT00998985|538280726|FG012|Overall Study|Withdrawal by Subject|0|||
149222744|NCT00998985|538280727|FG013|Overall Study|Withdrawal by Subject|0|||
149222745|NCT00998985|538280714|FG000|Overall Study|Protocol Violation|0|||
149222746|NCT00998985|538280715|FG001|Overall Study|Protocol Violation|0|||
149222747|NCT00998985|538280716|FG002|Overall Study|Protocol Violation|0|||
149222748|NCT00998985|538280717|FG003|Overall Study|Protocol Violation|0|||
149222749|NCT00998985|538280718|FG004|Overall Study|Protocol Violation|0|||
149222750|NCT00998985|538280719|FG005|Overall Study|Protocol Violation|1|||
149222751|NCT00998985|538280720|FG006|Overall Study|Protocol Violation|0|||
149222752|NCT00998985|538280721|FG007|Overall Study|Protocol Violation|0|||
149222753|NCT00998985|538280722|FG008|Overall Study|Protocol Violation|0|||
149222754|NCT00998985|538280723|FG009|Overall Study|Protocol Violation|0|||
149222755|NCT00998985|538280724|FG010|Overall Study|Protocol Violation|0|||
149222756|NCT00998985|538280725|FG011|Overall Study|Protocol Violation|0|||
149222757|NCT00998985|538280726|FG012|Overall Study|Protocol Violation|0|||
149222758|NCT00998985|538280727|FG013|Overall Study|Protocol Violation|0|||
149222759|NCT01012037|538280731|FG000|Overall Study|Adverse Event|0|||
149222760|NCT01012037|538280732|FG001|Overall Study|Adverse Event|8|||
149222761|NCT01012037|538280733|FG002|Overall Study|Adverse Event|3|||
148686602|NCT00585351|536324949|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
149222762|NCT01012037|538280731|FG000|Overall Study|Protocol Violation|0|||
149222763|NCT01012037|538280732|FG001|Overall Study|Protocol Violation|3|||
149222764|NCT01012037|538280733|FG002|Overall Study|Protocol Violation|5|||
149222765|NCT01012037|538280731|FG000|Overall Study|Withdrawal by Subject|0|||
149222766|NCT01012037|538280732|FG001|Overall Study|Withdrawal by Subject|4|||
149222767|NCT01012037|538280733|FG002|Overall Study|Withdrawal by Subject|1|||
149222768|NCT01012037|538280731|FG000|Overall Study|Other reason (not specified)|1|||
149222769|NCT01012037|538280732|FG001|Overall Study|Other reason (not specified)|1|||
149222770|NCT01012037|538280733|FG002|Overall Study|Other reason (not specified)|1|||
149222771|NCT00415623|538280736|FG000|Overall Study|Adverse Event|3|||
149222772|NCT00415623|538280737|FG001|Overall Study|Adverse Event|4|||
149222773|NCT00415623|538280736|FG000|Overall Study|Death|1|||
149222774|NCT00415623|538280737|FG001|Overall Study|Death|0|||
149222775|NCT00415623|538280736|FG000|Overall Study|Withdrawal by Subject|1|||
149222776|NCT00415623|538280737|FG001|Overall Study|Withdrawal by Subject|1|||
149222777|NCT03267576|538280740|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
149222778|NCT03267576|538280741|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
149222779|NCT03267576|538280740|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
149222780|NCT03267576|538280741|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
149222781|NCT01369069|538280742|FG000|Overall Study|Lost to Follow-up|8|||
149222782|NCT01369069|538280743|FG001|Overall Study|Lost to Follow-up|9|||
149222783|NCT01369069|538280742|FG000|Overall Study|Withdrawal by Subject|9|||
149222784|NCT01369069|538280743|FG001|Overall Study|Withdrawal by Subject|7|||
149222785|NCT02573012|538280744|FG000|Overall Study|Adverse Event|5|||
149222786|NCT02573012|538280745|FG001|Overall Study|Adverse Event|5|||
148810039|NCT00846365|536780945|FG000|Overall Study|Other|9|||
149222787|NCT02573012|538280744|FG000|Overall Study|Lack of Efficacy|5|||
149222788|NCT02573012|538280745|FG001|Overall Study|Lack of Efficacy|4|||
149222789|NCT02573012|538280744|FG000|Overall Study|Non-compliance|1|||
148686603|NCT00585351|536324950|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
148686604|NCT00585351|536324951|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
148686605|NCT00585351|536324952|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
148686606|NCT00585351|536324953|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
148686607|NCT00585351|536324954|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
148686608|NCT00585351|536324947|FG000|Enrollment Period (Intervention)|Death|0|||
148686609|NCT00585351|536324948|FG001|Enrollment Period (Intervention)|Death|0|||
148686610|NCT00585351|536324949|FG002|Enrollment Period (Intervention)|Death|0|||
148686611|NCT00585351|536324950|FG003|Enrollment Period (Intervention)|Death|0|||
148686612|NCT00585351|536324951|FG004|Enrollment Period (Intervention)|Death|1|||
148686613|NCT00585351|536324952|FG005|Enrollment Period (Intervention)|Death|0|||
148686614|NCT00585351|536324953|FG006|Enrollment Period (Intervention)|Death|1|||
148686615|NCT00585351|536324954|FG007|Enrollment Period (Intervention)|Death|0|||
148686616|NCT00585351|536324947|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
148686617|NCT00585351|536324948|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
148686618|NCT00585351|536324949|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
148686619|NCT00585351|536324950|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
148686620|NCT00585351|536324951|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
148810040|NCT00846365|536780946|FG001|Overall Study|Other|1|||
149222790|NCT02573012|538280745|FG001|Overall Study|Non-compliance|2|||
149222791|NCT02573012|538280744|FG000|Overall Study|Withdrawal by Subject|2|||
149222792|NCT02573012|538280745|FG001|Overall Study|Withdrawal by Subject|2|||
149222793|NCT02573012|538280744|FG000|Overall Study|Study Ended per Protocol|1|||
149222794|NCT02573012|538280745|FG001|Overall Study|Study Ended per Protocol|0|||
149222795|NCT02573012|538280744|FG000|Overall Study|Physician Decision|1|||
149222796|NCT02573012|538280745|FG001|Overall Study|Physician Decision|2|||
149222797|NCT00882362|538280746|FG000|Overall Study|Adverse Event|13|||
149222798|NCT00882362|538280747|FG001|Overall Study|Adverse Event|10|||
149222799|NCT00882362|538280746|FG000|Overall Study|Withdrawal by Subject|13|||
149222800|NCT00882362|538280747|FG001|Overall Study|Withdrawal by Subject|10|||
149222801|NCT00882362|538280746|FG000|Overall Study|Lack of Efficacy|3|||
149222802|NCT00882362|538280747|FG001|Overall Study|Lack of Efficacy|0|||
149222803|NCT00882362|538280746|FG000|Overall Study|Protocol Violation|7|||
149222804|NCT00882362|538280747|FG001|Overall Study|Protocol Violation|2|||
149222805|NCT00882362|538280746|FG000|Overall Study|Pregnancy|1|||
149222806|NCT00882362|538280747|FG001|Overall Study|Pregnancy|0|||
149222807|NCT00882362|538280746|FG000|Overall Study|Physician Decision|5|||
149222808|NCT00882362|538280747|FG001|Overall Study|Physician Decision|1|||
149222809|NCT00882362|538280746|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
149222810|NCT00882362|538280747|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
149222811|NCT00882362|538280746|FG000|Overall Study|change of residence or other commitments|5|||
149222812|NCT00882362|538280747|FG001|Overall Study|change of residence or other commitments|0|||
149222813|NCT01432938|538280748|FG000|First Intervention|Protocol Violation|1|||
149222814|NCT01432938|538280749|FG001|First Intervention|Protocol Violation|0|||
149222815|NCT01432938|538280748|FG000|First Intervention|Physician Decision|1|||
149222816|NCT01432938|538280749|FG001|First Intervention|Physician Decision|0|||
149222817|NCT01432938|538280748|FG000|Second Intervention|Adverse Event|1|||
149222818|NCT01432938|538280749|FG001|Second Intervention|Adverse Event|0|||
149222819|NCT02096471|538280750|FG000|Overall Study|Adverse Event|1|||
149222820|NCT02096471|538280750|FG000|Overall Study|Lack of Efficacy|7|||
149222821|NCT02096471|538280750|FG000|Overall Study|Withdrawal by Subject|3|||
149222822|NCT02096471|538280750|FG000|Overall Study|Non-Compliant|2|||
149222823|NCT02463331|538280757|FG000|Overall Study|Adverse Event|4|||
149222824|NCT02463331|538280758|FG001|Overall Study|Adverse Event|2|||
149222825|NCT02463331|538280757|FG000|Overall Study|Lost to Follow-up|1|||
149222826|NCT02463331|538280758|FG001|Overall Study|Lost to Follow-up|1|||
149222827|NCT02463331|538280757|FG000|Overall Study|Pregnancy|2|||
149222828|NCT02463331|538280758|FG001|Overall Study|Pregnancy|3|||
149222829|NCT02463331|538280757|FG000|Overall Study|Lack of Efficacy|6|||
149222830|NCT02463331|538280758|FG001|Overall Study|Lack of Efficacy|0|||
149222831|NCT02463331|538280757|FG000|Overall Study|Physician Decision|3|||
149222832|NCT02463331|538280758|FG001|Overall Study|Physician Decision|0|||
149222833|NCT01436357|538280763|FG000|Overall Study|Death|5|||
149222834|NCT01436357|538280764|FG001|Overall Study|Death|1|||
149222835|NCT01436357|538280763|FG000|Overall Study|Enrolled but not vaccinated|1|||
148686621|NCT00585351|536324952|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
148810041|NCT00846365|536780947|FG002|Overall Study|Other|6|||
148810042|NCT01925417|536780959|FG000|Overall Study|Withdrawal by Subject|2|||
148686622|NCT00585351|536324953|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
148810043|NCT01925417|536780959|FG000|Overall Study|Death|1|||
148810044|NCT01047319|536780964|FG000|Overall Study|Teva requested participant withdrawal|3|||
149222836|NCT01436357|538280764|FG001|Overall Study|Enrolled but not vaccinated|1|||
149222837|NCT01436357|538280763|FG000|Overall Study|Incarceration|18|||
149222838|NCT01436357|538280764|FG001|Overall Study|Incarceration|20|||
149222839|NCT01436357|538280763|FG000|Overall Study|Lost to Follow-up|67|||
149222840|NCT01436357|538280764|FG001|Overall Study|Lost to Follow-up|61|||
149222841|NCT01436357|538280763|FG000|Overall Study|Protocol Violation|1|||
149222842|NCT01436357|538280764|FG001|Overall Study|Protocol Violation|0|||
149222843|NCT01436357|538280763|FG000|Overall Study|Withdrawal by Subject|26|||
149222844|NCT01436357|538280764|FG001|Overall Study|Withdrawal by Subject|38|||
148810045|NCT01047319|536780965|FG001|Overall Study|Teva requested participant withdrawal|0|||
148810046|NCT01047319|536780966|FG002|Overall Study|Teva requested participant withdrawal|1|||
149222845|NCT01436357|538280763|FG000|Overall Study|Physician Decision|3|||
149222846|NCT01436357|538280764|FG001|Overall Study|Physician Decision|4|||
149222847|NCT01436357|538280763|FG000|Overall Study|Moved out of area|1|||
149222848|NCT01436357|538280764|FG001|Overall Study|Moved out of area|2|||
149222849|NCT01436357|538280763|FG000|Overall Study|Subject in rehab|0|||
149222850|NCT01436357|538280764|FG001|Overall Study|Subject in rehab|1|||
149222851|NCT00656799|538280765|FG000|Overall Study|Death|2|||
149222852|NCT05281094|538280766|FG000|Overall Study|Adverse Event|1|||
149222853|NCT05281094|538280767|FG001|Overall Study|Adverse Event|0|||
149222854|NCT05281094|538280766|FG000|Overall Study|Lost to Follow-up|29|||
149222855|NCT05281094|538280767|FG001|Overall Study|Lost to Follow-up|22|||
148686623|NCT00585351|536324954|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
148810047|NCT01047319|536780964|FG000|Overall Study|Protocol Violation|3|||
149222856|NCT05281094|538280766|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
148686624|NCT01001169|536324955|FG000|Overall Study|Withdrawal by Subject|2|||
148810048|NCT01047319|536780965|FG001|Overall Study|Protocol Violation|2|||
149222857|NCT05281094|538280767|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
149222858|NCT05281094|538280766|FG000|Overall Study|Death|1|||
149222859|NCT05281094|538280767|FG001|Overall Study|Death|2|||
149222860|NCT05281094|538280766|FG000|Overall Study|Not pre-specified reason|8|||
149222861|NCT05281094|538280767|FG001|Overall Study|Not pre-specified reason|5|||
149222862|NCT02683668|538280774|FG000|Period 2|Withdrawal by Subject|0|||
149222863|NCT02683668|538280775|FG001|Period 2|Withdrawal by Subject|1|||
149222864|NCT02683668|538280776|FG002|Period 2|Withdrawal by Subject|0|||
149222865|NCT02390167|538282623|FG000|Overall Study|Lost to Follow-up|1|||
149222866|NCT04144140|538282627|FG000|Overall Study|Other|0|||
149222867|NCT04144140|538282628|FG001|Overall Study|Other|0|||
149222868|NCT04144140|538282629|FG002|Overall Study|Other|0|||
149222869|NCT04144140|538282630|FG003|Overall Study|Other|0|||
149222870|NCT04144140|538282631|FG004|Overall Study|Other|0|||
149222871|NCT04144140|538282632|FG005|Overall Study|Other|1|||
149222872|NCT04144140|538282633|FG006|Overall Study|Other|0|||
149222873|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
149222874|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
149222875|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
149222876|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
149222877|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
149222878|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
149222879|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
149222880|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
149222881|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Death|0|||
149222882|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Death|0|||
149222883|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Death|0|||
149222884|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Death|1|||
149222885|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Death|1|||
149222886|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Death|0|||
149222887|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Death|2|||
149222888|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Death|0|||
149222889|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222890|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222891|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222892|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
149222893|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222894|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222895|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222896|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
149222897|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222898|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222899|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222900|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
149222901|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222902|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222903|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222904|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
149222905|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149222906|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149222907|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149222908|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
149222909|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149222910|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
149222911|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
149222912|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
149222913|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149222914|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149222915|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149222916|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
149222917|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149222918|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
149222919|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
149222920|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
149222921|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149222922|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149222923|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149222924|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
148686625|NCT01001169|536324956|FG001|Overall Study|Withdrawal by Subject|1|||
148686626|NCT02536378|536324961|FG000|Overall Study|Physician Decision|0|||
148686627|NCT02536378|536324962|FG001|Overall Study|Physician Decision|2|||
148686628|NCT02536378|536324961|FG000|Overall Study|Withdrawal by Subject|0|||
148686629|NCT02536378|536324962|FG001|Overall Study|Withdrawal by Subject|1|||
148686630|NCT02536378|536324961|FG000|Overall Study|Death|1|||
148686631|NCT02536378|536324962|FG001|Overall Study|Death|2|||
148686632|NCT02536378|536324961|FG000|Overall Study|Patient refused further follow up|6|||
148686633|NCT02536378|536324962|FG001|Overall Study|Patient refused further follow up|2|||
148686634|NCT00602030|536324963|FG000|Lead-in Phase|Disease Progression|2|||
148686635|NCT00602030|536324964|FG001|Lead-in Phase|Disease Progression|3|||
148686636|NCT00602030|536324965|FG002|Lead-in Phase|Disease Progression|0|||
148686637|NCT00602030|536324966|FG003|Lead-in Phase|Disease Progression|0|||
148686638|NCT00602030|536324967|FG004|Lead-in Phase|Disease Progression|0|||
148686639|NCT00602030|536324963|FG000|Lead-in Phase|Adverse Event|0|||
148686640|NCT00602030|536324964|FG001|Lead-in Phase|Adverse Event|2|||
148686641|NCT00602030|536324965|FG002|Lead-in Phase|Adverse Event|0|||
148686642|NCT00602030|536324966|FG003|Lead-in Phase|Adverse Event|0|||
148686643|NCT00602030|536324967|FG004|Lead-in Phase|Adverse Event|0|||
148686644|NCT00602030|536324963|FG000|Double-blind Phase|Disease progression|0|||
148686645|NCT00602030|536324964|FG001|Double-blind Phase|Disease progression|0|||
148686646|NCT00602030|536324965|FG002|Double-blind Phase|Disease progression|33|||
148686647|NCT00602030|536324966|FG003|Double-blind Phase|Disease progression|30|||
148686648|NCT00602030|536324967|FG004|Double-blind Phase|Disease progression|0|||
148686649|NCT00602030|536324963|FG000|Double-blind Phase|Adverse Event|0|||
148810049|NCT01047319|536780966|FG002|Overall Study|Protocol Violation|4|||
148810050|NCT01047319|536780964|FG000|Overall Study|Lack of Efficacy|4|||
148810051|NCT01047319|536780965|FG001|Overall Study|Lack of Efficacy|3|||
148810052|NCT01047319|536780966|FG002|Overall Study|Lack of Efficacy|3|||
148810053|NCT01047319|536780964|FG000|Overall Study|Death|5|||
148810054|NCT01047319|536780965|FG001|Overall Study|Death|1|||
148810055|NCT01047319|536780966|FG002|Overall Study|Death|5|||
148810056|NCT01047319|536780964|FG000|Overall Study|Pregnancy|13|||
148810057|NCT01047319|536780965|FG001|Overall Study|Pregnancy|8|||
148810058|NCT01047319|536780966|FG002|Overall Study|Pregnancy|8|||
148810059|NCT01047319|536780964|FG000|Overall Study|Physician Decision|12|||
148810060|NCT01047319|536780965|FG001|Overall Study|Physician Decision|9|||
148810061|NCT01047319|536780966|FG002|Overall Study|Physician Decision|10|||
148810062|NCT01047319|536780964|FG000|Overall Study|Lost to Follow-up|14|||
148810063|NCT01047319|536780965|FG001|Overall Study|Lost to Follow-up|10|||
148810064|NCT01047319|536780966|FG002|Overall Study|Lost to Follow-up|10|||
148810065|NCT01047319|536780964|FG000|Overall Study|Adverse Event|16|||
148810066|NCT01047319|536780965|FG001|Overall Study|Adverse Event|27|||
148810067|NCT01047319|536780966|FG002|Overall Study|Adverse Event|21|||
148810068|NCT01047319|536780964|FG000|Overall Study|Withdrawal by Subject|77|||
148810069|NCT01047319|536780965|FG001|Overall Study|Withdrawal by Subject|75|||
148810070|NCT01047319|536780966|FG002|Overall Study|Withdrawal by Subject|87|||
148810071|NCT01047319|536780964|FG000|Overall Study|Study terminated by Sponsor|198|||
148810072|NCT01047319|536780965|FG001|Overall Study|Study terminated by Sponsor|215|||
148810073|NCT01047319|536780966|FG002|Overall Study|Study terminated by Sponsor|203|||
148810074|NCT05350423|536782542|FG000|Overall Study|Lost to Follow-up|3|||
148810075|NCT05350423|536782543|FG001|Overall Study|Lost to Follow-up|3|||
148810076|NCT05350423|536782542|FG000|Overall Study|screen failure|5|||
148810077|NCT05350423|536782543|FG001|Overall Study|screen failure|6|||
148810078|NCT02097277|536782544|FG000|Overall Study|Subject no longer meets study criteria|0|||
148810079|NCT02097277|536782545|FG001|Overall Study|Subject no longer meets study criteria|1|||
148810080|NCT02097277|536782546|FG002|Overall Study|Subject no longer meets study criteria|0|||
149222925|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
148686650|NCT00602030|536324964|FG001|Double-blind Phase|Adverse Event|0|||
148686651|NCT00602030|536324965|FG002|Double-blind Phase|Adverse Event|9|||
148686652|NCT00602030|536324966|FG003|Double-blind Phase|Adverse Event|18|||
148686653|NCT00602030|536324967|FG004|Double-blind Phase|Adverse Event|0|||
148686654|NCT00602030|536324963|FG000|Double-blind Phase|Consent withdrawal|0|||
148810081|NCT02097277|536782547|FG003|Overall Study|Subject no longer meets study criteria|1|||
148810082|NCT02097277|536782548|FG004|Overall Study|Subject no longer meets study criteria|0|||
148810083|NCT02097277|536782544|FG000|Overall Study|Subject request to discontinue treatment|0|||
148810084|NCT02097277|536782545|FG001|Overall Study|Subject request to discontinue treatment|0|||
148810085|NCT02097277|536782546|FG002|Overall Study|Subject request to discontinue treatment|0|||
148810086|NCT02097277|536782547|FG003|Overall Study|Subject request to discontinue treatment|0|||
148810087|NCT02097277|536782548|FG004|Overall Study|Subject request to discontinue treatment|1|||
148686655|NCT00602030|536324964|FG001|Double-blind Phase|Consent withdrawal|0|||
148686656|NCT00602030|536324965|FG002|Double-blind Phase|Consent withdrawal|4|||
148686657|NCT00602030|536324966|FG003|Double-blind Phase|Consent withdrawal|3|||
148686658|NCT00602030|536324967|FG004|Double-blind Phase|Consent withdrawal|0|||
148686659|NCT00602030|536324963|FG000|Double-blind Phase|Death|0|||
148686660|NCT00602030|536324964|FG001|Double-blind Phase|Death|0|||
148686661|NCT00602030|536324965|FG002|Double-blind Phase|Death|3|||
148686662|NCT00602030|536324966|FG003|Double-blind Phase|Death|3|||
148686663|NCT00602030|536324967|FG004|Double-blind Phase|Death|0|||
148686664|NCT00602030|536324963|FG000|Double-blind Phase|Administrative decision|0|||
148686665|NCT00602030|536324964|FG001|Double-blind Phase|Administrative decision|0|||
148686666|NCT00602030|536324965|FG002|Double-blind Phase|Administrative decision|0|||
148686667|NCT00602030|536324966|FG003|Double-blind Phase|Administrative decision|2|||
148686668|NCT00602030|536324967|FG004|Double-blind Phase|Administrative decision|0|||
148686669|NCT00602030|536324963|FG000|Double-blind Phase|Ineligibility|0|||
148686670|NCT00602030|536324964|FG001|Double-blind Phase|Ineligibility|0|||
148686671|NCT00602030|536324965|FG002|Double-blind Phase|Ineligibility|0|||
148686672|NCT00602030|536324966|FG003|Double-blind Phase|Ineligibility|1|||
148686673|NCT00602030|536324967|FG004|Double-blind Phase|Ineligibility|0|||
148686674|NCT00602030|536324963|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
148686675|NCT00602030|536324964|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
148686676|NCT00602030|536324965|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
148686677|NCT00602030|536324966|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
148686678|NCT00602030|536324967|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
148686679|NCT00602030|536324963|FG000|Double-blind Phase|Reason not specified|0|||
148686680|NCT00602030|536324964|FG001|Double-blind Phase|Reason not specified|0|||
148686681|NCT00602030|536324965|FG002|Double-blind Phase|Reason not specified|4|||
148686682|NCT00602030|536324966|FG003|Double-blind Phase|Reason not specified|2|||
148686683|NCT00602030|536324967|FG004|Double-blind Phase|Reason not specified|0|||
148686684|NCT00602030|536324963|FG000|Crossover Phase|Disease Progression|0|||
148686685|NCT00602030|536324964|FG001|Crossover Phase|Disease Progression|0|||
148686686|NCT00602030|536324965|FG002|Crossover Phase|Disease Progression|0|||
148686687|NCT00602030|536324966|FG003|Crossover Phase|Disease Progression|0|||
148686688|NCT00602030|536324967|FG004|Crossover Phase|Disease Progression|11|||
148686689|NCT00602030|536324963|FG000|Crossover Phase|Adverse Event|0|||
148686690|NCT00602030|536324964|FG001|Crossover Phase|Adverse Event|0|||
148686691|NCT00602030|536324965|FG002|Crossover Phase|Adverse Event|0|||
148686692|NCT00602030|536324966|FG003|Crossover Phase|Adverse Event|0|||
148686693|NCT00602030|536324967|FG004|Crossover Phase|Adverse Event|3|||
148686694|NCT00602030|536324963|FG000|Crossover Phase|Consent withdrawal|0|||
148686695|NCT00602030|536324964|FG001|Crossover Phase|Consent withdrawal|0|||
148686696|NCT00602030|536324965|FG002|Crossover Phase|Consent withdrawal|0|||
148686697|NCT00602030|536324966|FG003|Crossover Phase|Consent withdrawal|0|||
148686698|NCT00602030|536324967|FG004|Crossover Phase|Consent withdrawal|2|||
148686699|NCT00798889|536324969|FG000|Overall Study|Adverse Event|53|||
148686700|NCT00798889|536324969|FG000|Overall Study|Protocol Violation|2|||
148686701|NCT00798889|536324969|FG000|Overall Study|Withdrawal by Subject|31|||
148686702|NCT00798889|536324969|FG000|Overall Study|Lost to Follow-up|1|||
148686703|NCT00798889|536324969|FG000|Overall Study|Lack of Efficacy|213|||
148686704|NCT00798889|536324969|FG000|Overall Study|Decision of Sponsor|11|||
148686705|NCT00798889|536324969|FG000|Overall Study|Enrolled, Not treated|3|||
148686706|NCT05085964|536324970|FG000|Overall Study|Premature termination of study|21|||
148686707|NCT05085964|536324971|FG001|Overall Study|Premature termination of study|0|||
148686708|NCT00947856|536324977|FG000|Treatment Period|Progressive Disease|33|||
148686709|NCT00947856|536324978|FG001|Treatment Period|Progressive Disease|12|||
148686710|NCT00947856|536324977|FG000|Treatment Period|Adverse Event|15|||
148686711|NCT00947856|536324978|FG001|Treatment Period|Adverse Event|9|||
148686712|NCT00947856|536324977|FG000|Treatment Period|Physician Decision|14|||
148686713|NCT00947856|536324978|FG001|Treatment Period|Physician Decision|6|||
148686714|NCT00947856|536324977|FG000|Treatment Period|Study Stopped by Sponsor|4|||
148686715|NCT00947856|536324978|FG001|Treatment Period|Study Stopped by Sponsor|4|||
148686716|NCT00947856|536324977|FG000|Treatment Period|Withdrawal by Subject|12|||
148686717|NCT00947856|536324978|FG001|Treatment Period|Withdrawal by Subject|1|||
148686718|NCT00947856|536324977|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
148686719|NCT00947856|536324978|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
148686720|NCT00947856|536324977|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
148686721|NCT00947856|536324978|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
148686722|NCT00947856|536324977|FG000|Follow-up Period|Lost to Follow-up|7|||
148686723|NCT00947856|536324978|FG001|Follow-up Period|Lost to Follow-up|0|||
149222926|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
149222927|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
149222928|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
149222929|NCT02442765|538282634|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149222930|NCT02442765|538282635|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149222931|NCT02442765|538282636|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149222932|NCT02442765|538282637|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149222933|NCT02442765|538282638|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
149222934|NCT02442765|538282639|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149222935|NCT02442765|538282640|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
149222936|NCT02442765|538282641|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
149222937|NCT04735432|538282644|FG000|Overall Study|Other - due to personal reason|1|||
149222938|NCT04735432|538282645|FG001|Overall Study|Other - due to personal reason|0|||
149222939|NCT04735432|538282644|FG000|Overall Study|Adverse Event|2|||
149222940|NCT04735432|538282645|FG001|Overall Study|Adverse Event|0|||
149222941|NCT01823991|538282648|FG000|Overall Study|Withdrawal by Subject|8|||
149222942|NCT01823991|538282649|FG001|Overall Study|Withdrawal by Subject|5|||
149222943|NCT01066819|538282650|FG000|Overall Study|Adverse Event|18|||
148686724|NCT00947856|536324977|FG000|Follow-up Period|Patient unavailable for site visits|1|||
148686725|NCT00947856|536324978|FG001|Follow-up Period|Patient unavailable for site visits|0|||
149222944|NCT01066819|538282651|FG001|Overall Study|Adverse Event|1|||
149222945|NCT01066819|538282652|FG002|Overall Study|Adverse Event|6|||
149222946|NCT01066819|538282653|FG003|Overall Study|Adverse Event|0|||
149222947|NCT01066819|538282654|FG004|Overall Study|Adverse Event|0|||
149222948|NCT01066819|538282655|FG005|Overall Study|Adverse Event|0|||
148686726|NCT00947856|536324977|FG000|Follow-up Period|Withdrawal by Subject|1|||
149222949|NCT01066819|538282650|FG000|Overall Study|Death|5|||
149222950|NCT01066819|538282651|FG001|Overall Study|Death|0|||
149222951|NCT01066819|538282652|FG002|Overall Study|Death|1|||
149222952|NCT01066819|538282653|FG003|Overall Study|Death|0|||
149222953|NCT01066819|538282654|FG004|Overall Study|Death|0|||
149222954|NCT01066819|538282655|FG005|Overall Study|Death|0|||
149222955|NCT01066819|538282650|FG000|Overall Study|Lack of Efficacy|22|||
149222956|NCT01066819|538282651|FG001|Overall Study|Lack of Efficacy|1|||
149222957|NCT01066819|538282652|FG002|Overall Study|Lack of Efficacy|2|||
149222958|NCT01066819|538282653|FG003|Overall Study|Lack of Efficacy|1|||
149222959|NCT01066819|538282654|FG004|Overall Study|Lack of Efficacy|0|||
149222960|NCT01066819|538282655|FG005|Overall Study|Lack of Efficacy|0|||
149222961|NCT01066819|538282650|FG000|Overall Study|Physician Decision|6|||
148686727|NCT00947856|536324978|FG001|Follow-up Period|Withdrawal by Subject|0|||
148686728|NCT03760510|536324981|FG000|Overall Study|Not ventilated for 24 hours|105|||
148686729|NCT03760510|536324982|FG001|Overall Study|Not ventilated for 24 hours|97|||
148686730|NCT00871728|536324983|FG000|Overall Study|Adverse Event|1|||
148686731|NCT00871728|536324983|FG000|Overall Study|Protocol Violation|7|||
148686732|NCT00871728|536324983|FG000|Overall Study|Lost to Follow-up|2|||
148686733|NCT00871728|536324983|FG000|Overall Study|Failed to Visit Hospital|4|||
148686734|NCT00871728|536324983|FG000|Overall Study|Participant Non-compliance|1|||
148686735|NCT00871728|536324983|FG000|Overall Study|Withdrawal of Informed Consent|5|||
148686736|NCT02418910|536324984|FG000|Overall Study|Lost to Follow-up|3|||
148686737|NCT02418910|536324984|FG000|Overall Study|Withdrawal by Subject|4|||
148686738|NCT02472977|536324991|FG000|Overall Study|Disease progression|4|||
148686739|NCT02472977|536324992|FG001|Overall Study|Disease progression|25|||
148686740|NCT02472977|536324993|FG002|Overall Study|Disease progression|6|||
148686741|NCT02472977|536324991|FG000|Overall Study|Withdrawal by Subject|0|||
148686742|NCT02472977|536324992|FG001|Overall Study|Withdrawal by Subject|1|||
148686743|NCT02472977|536324993|FG002|Overall Study|Withdrawal by Subject|0|||
148686744|NCT02472977|536324991|FG000|Overall Study|Study drug toxicity|2|||
148686745|NCT02472977|536324992|FG001|Overall Study|Study drug toxicity|0|||
148686746|NCT02472977|536324993|FG002|Overall Study|Study drug toxicity|2|||
148686747|NCT02472977|536324991|FG000|Overall Study|Subject request to discontinue treatment|0|||
148686748|NCT02472977|536324992|FG001|Overall Study|Subject request to discontinue treatment|1|||
148686749|NCT02472977|536324993|FG002|Overall Study|Subject request to discontinue treatment|0|||
148686750|NCT00566709|536324996|FG000|Overall Study|Protocol Violation|5|||
148686751|NCT00566709|536324997|FG001|Overall Study|Protocol Violation|0|||
148686752|NCT02668302|536325000|FG000|Overall Study|Withdrawal by Subject|1|||
148686753|NCT02668302|536325001|FG001|Overall Study|Withdrawal by Subject|0|||
148686754|NCT03775681|536325002|FG000|Overall Study|Physician Decision|3|||
148686755|NCT03558997|536325003|FG000|Overall Study|Adverse Event|0|||
148686756|NCT03558997|536325004|FG001|Overall Study|Adverse Event|2|||
148686757|NCT03558997|536325005|FG002|Overall Study|Adverse Event|5|||
148686758|NCT03558997|536325006|FG003|Overall Study|Adverse Event|1|||
148686759|NCT03558997|536325003|FG000|Overall Study|Physician Decision|0|||
148686760|NCT03558997|536325004|FG001|Overall Study|Physician Decision|0|||
148686761|NCT03558997|536325005|FG002|Overall Study|Physician Decision|1|||
148686762|NCT03558997|536325006|FG003|Overall Study|Physician Decision|0|||
148686763|NCT03558997|536325003|FG000|Overall Study|Withdrawal by Subject|1|||
148686764|NCT03558997|536325004|FG001|Overall Study|Withdrawal by Subject|0|||
148686765|NCT03558997|536325005|FG002|Overall Study|Withdrawal by Subject|1|||
148686766|NCT03558997|536325006|FG003|Overall Study|Withdrawal by Subject|1|||
148686767|NCT03558997|536325003|FG000|Overall Study|Lost to Follow-up|0|||
149222962|NCT01066819|538282651|FG001|Overall Study|Physician Decision|2|||
149222963|NCT01066819|538282652|FG002|Overall Study|Physician Decision|3|||
148686768|NCT03558997|536325004|FG001|Overall Study|Lost to Follow-up|0|||
148686769|NCT03558997|536325005|FG002|Overall Study|Lost to Follow-up|1|||
148686770|NCT03558997|536325006|FG003|Overall Study|Lost to Follow-up|0|||
148686771|NCT00895583|536325007|FG000|Overall Study|Adverse Event|28|||
148686772|NCT00895583|536325008|FG001|Overall Study|Adverse Event|4|||
148686773|NCT00895583|536325007|FG000|Overall Study|Death|2|||
148686774|NCT00895583|536325008|FG001|Overall Study|Death|1|||
148686775|NCT00895583|536325007|FG000|Overall Study|Physician Decision|3|||
148686776|NCT00895583|536325008|FG001|Overall Study|Physician Decision|1|||
148686777|NCT00895583|536325007|FG000|Overall Study|Lost to Follow-up|1|||
149222964|NCT01066819|538282653|FG003|Overall Study|Physician Decision|0|||
149222965|NCT01066819|538282654|FG004|Overall Study|Physician Decision|0|||
149018032|NCT01474512|537547153|FG004|Induction Period|Lack of Efficacy|0|||
149222966|NCT01066819|538282655|FG005|Overall Study|Physician Decision|0|||
148686778|NCT00895583|536325008|FG001|Overall Study|Lost to Follow-up|3|||
148686779|NCT00895583|536325007|FG000|Overall Study|Protocol Violation|1|||
148686780|NCT00895583|536325008|FG001|Overall Study|Protocol Violation|0|||
148686781|NCT00895583|536325007|FG000|Overall Study|Withdrawal by Subject|4|||
149222967|NCT01066819|538282650|FG000|Overall Study|Protocol Violation|12|||
149222968|NCT01066819|538282651|FG001|Overall Study|Protocol Violation|6|||
149222969|NCT01066819|538282652|FG002|Overall Study|Protocol Violation|0|||
149222970|NCT01066819|538282653|FG003|Overall Study|Protocol Violation|0|||
148953655|NCT02564042|537313064|FG000|Overall Study|Withdrawal by Subject|5|||
148953656|NCT02564042|537313065|FG001|Overall Study|Withdrawal by Subject|3|||
148953657|NCT02564042|537313066|FG002|Overall Study|Withdrawal by Subject|2|||
148953658|NCT02564042|537313067|FG003|Overall Study|Withdrawal by Subject|2|||
148953659|NCT02564042|537313068|FG004|Overall Study|Withdrawal by Subject|10|||
148953660|NCT02564042|537313069|FG005|Overall Study|Withdrawal by Subject|12|||
148953661|NCT02289898|537313076|FG000|Overall Study|Death|5|||
148953662|NCT02289898|537313077|FG001|Overall Study|Death|4|||
148953663|NCT02289898|537313078|FG002|Overall Study|Death|3|||
148953664|NCT02289898|537313076|FG000|Overall Study|Physician Decision|2|||
148953665|NCT02289898|537313077|FG001|Overall Study|Physician Decision|5|||
148953666|NCT02289898|537313078|FG002|Overall Study|Physician Decision|2|||
148953667|NCT02289898|537313076|FG000|Overall Study|Withdrawal by Subject|0|||
148953668|NCT02289898|537313077|FG001|Overall Study|Withdrawal by Subject|4|||
148953669|NCT02289898|537313078|FG002|Overall Study|Withdrawal by Subject|1|||
148953670|NCT02289898|537313076|FG000|Overall Study|Adverse Event|3|||
148953671|NCT02289898|537313077|FG001|Overall Study|Adverse Event|5|||
148953672|NCT02289898|537313078|FG002|Overall Study|Adverse Event|5|||
148953673|NCT02289898|537313076|FG000|Overall Study|Disease progression|34|||
148953674|NCT02289898|537313077|FG001|Overall Study|Disease progression|28|||
148953675|NCT02289898|537313078|FG002|Overall Study|Disease progression|34|||
148953676|NCT02289898|537313076|FG000|Overall Study|Use of another anticancer therapy|0|||
148953677|NCT02289898|537313077|FG001|Overall Study|Use of another anticancer therapy|0|||
149222971|NCT01066819|538282654|FG004|Overall Study|Protocol Violation|0|||
149222972|NCT01066819|538282655|FG005|Overall Study|Protocol Violation|0|||
149222973|NCT01066819|538282650|FG000|Overall Study|Withdrawal by Subject|29|||
149222974|NCT01066819|538282651|FG001|Overall Study|Withdrawal by Subject|11|||
149222975|NCT01066819|538282652|FG002|Overall Study|Withdrawal by Subject|6|||
149222976|NCT01066819|538282653|FG003|Overall Study|Withdrawal by Subject|0|||
149222977|NCT01066819|538282654|FG004|Overall Study|Withdrawal by Subject|0|||
149222978|NCT01066819|538282655|FG005|Overall Study|Withdrawal by Subject|0|||
149222979|NCT01066819|538282650|FG000|Overall Study|Administrative|6|||
149222980|NCT01066819|538282651|FG001|Overall Study|Administrative|4|||
149222981|NCT01066819|538282652|FG002|Overall Study|Administrative|2|||
149222982|NCT01066819|538282653|FG003|Overall Study|Administrative|0|||
149222983|NCT01066819|538282654|FG004|Overall Study|Administrative|0|||
149222984|NCT01066819|538282655|FG005|Overall Study|Administrative|0|||
149222985|NCT01066819|538282650|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
149222986|NCT01066819|538282651|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
149222987|NCT01066819|538282652|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
149222988|NCT01066819|538282653|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
149222989|NCT01066819|538282654|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
149222990|NCT01066819|538282655|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
149222991|NCT01066819|538282650|FG000|Overall Study|Early termination|2|||
149222992|NCT01066819|538282651|FG001|Overall Study|Early termination|0|||
149222993|NCT01066819|538282652|FG002|Overall Study|Early termination|0|||
149222994|NCT01066819|538282653|FG003|Overall Study|Early termination|0|||
149222995|NCT01066819|538282654|FG004|Overall Study|Early termination|0|||
149222996|NCT01066819|538282655|FG005|Overall Study|Early termination|0|||
149222997|NCT01066819|538282650|FG000|Overall Study|Failed to return|298|||
149222998|NCT01066819|538282651|FG001|Overall Study|Failed to return|107|||
149222999|NCT01066819|538282652|FG002|Overall Study|Failed to return|68|||
149223000|NCT01066819|538282653|FG003|Overall Study|Failed to return|7|||
149223001|NCT01066819|538282654|FG004|Overall Study|Failed to return|2|||
149223002|NCT01066819|538282655|FG005|Overall Study|Failed to return|3|||
149223003|NCT01066819|538282650|FG000|Overall Study|Lab test not done|9|||
149223004|NCT01066819|538282651|FG001|Overall Study|Lab test not done|0|||
149223005|NCT01066819|538282652|FG002|Overall Study|Lab test not done|2|||
149223006|NCT01066819|538282653|FG003|Overall Study|Lab test not done|1|||
149223007|NCT01066819|538282654|FG004|Overall Study|Lab test not done|0|||
148953678|NCT02289898|537313078|FG002|Overall Study|Use of another anticancer therapy|1|||
149223008|NCT01066819|538282655|FG005|Overall Study|Lab test not done|0|||
149223009|NCT01066819|538282650|FG000|Overall Study|Miscellaneous|28|||
149223010|NCT01066819|538282651|FG001|Overall Study|Miscellaneous|10|||
149223011|NCT01066819|538282652|FG002|Overall Study|Miscellaneous|18|||
149223012|NCT01066819|538282653|FG003|Overall Study|Miscellaneous|1|||
149223013|NCT01066819|538282654|FG004|Overall Study|Miscellaneous|0|||
149223014|NCT01066819|538282655|FG005|Overall Study|Miscellaneous|0|||
149223015|NCT01066819|538282650|FG000|Overall Study|Non responders|123|||
149223016|NCT01066819|538282651|FG001|Overall Study|Non responders|2|||
149223017|NCT01066819|538282652|FG002|Overall Study|Non responders|7|||
149223018|NCT01066819|538282653|FG003|Overall Study|Non responders|2|||
149223019|NCT01066819|538282654|FG004|Overall Study|Non responders|0|||
149223020|NCT01066819|538282655|FG005|Overall Study|Non responders|1|||
149223021|NCT01066819|538282650|FG000|Overall Study|Not categorised|9|||
148953679|NCT02289898|537313076|FG000|Overall Study|Other|8|||
148686782|NCT00895583|536325008|FG001|Overall Study|Withdrawal by Subject|2|||
148686783|NCT00895583|536325007|FG000|Overall Study|Lack of Efficacy|5|||
148686784|NCT00895583|536325008|FG001|Overall Study|Lack of Efficacy|0|||
148686785|NCT00895583|536325007|FG000|Overall Study|Other|0|||
148686786|NCT00895583|536325008|FG001|Overall Study|Other|1|||
148686787|NCT03529955|536325011|FG000|Overall Study|Adverse Event|1|||
148686788|NCT03529955|536325011|FG000|Overall Study|Lack of Efficacy|1|||
148686789|NCT03016078|536325017|FG000|Overall Study|Protocol Violation|1|||
148686790|NCT03016078|536325017|FG000|Overall Study|Protocol Violation|1|||
148686791|NCT02378506|536325019|FG000|Overall Study|Lack of Efficacy|3|||
148686792|NCT02378506|536325019|FG000|Overall Study|Withdrawal by Subject|4|||
148686793|NCT02378506|536325019|FG000|Overall Study|Protocol Violation|2|||
148686794|NCT02378506|536325019|FG000|Overall Study|Death|1|||
148686795|NCT02378506|536325019|FG000|Overall Study|Adverse Event|14|||
148686796|NCT02378506|536325019|FG000|Overall Study|Randomized But Not Treated|1|||
148686797|NCT00254397|536325020|FG000|Overall Study|Disease Progression|4|||
148686798|NCT00254397|536325021|FG001|Overall Study|Disease Progression|1|||
148686799|NCT00254397|536325022|FG002|Overall Study|Disease Progression|16|||
148686800|NCT00254397|536325023|FG003|Overall Study|Disease Progression|23|||
148686801|NCT00254397|536325020|FG000|Overall Study|Non-Compliant|0|||
148686802|NCT00254397|536325021|FG001|Overall Study|Non-Compliant|0|||
148686803|NCT00254397|536325022|FG002|Overall Study|Non-Compliant|0|||
148686804|NCT00254397|536325023|FG003|Overall Study|Non-Compliant|1|||
148686805|NCT00254397|536325020|FG000|Overall Study|Adverse Event|2|||
148686806|NCT00254397|536325021|FG001|Overall Study|Adverse Event|0|||
148686807|NCT00254397|536325022|FG002|Overall Study|Adverse Event|3|||
148686808|NCT00254397|536325023|FG003|Overall Study|Adverse Event|1|||
148686809|NCT01070394|536325025|FG000|Overall Study|Adverse Event|6|||
148686810|NCT01070394|536325025|FG000|Overall Study|Withdrawal by Subject|1|||
148686811|NCT01715415|536325027|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
148686812|NCT01715415|536325028|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
148686813|NCT01715415|536325027|FG000|Double-blind Treatment|Adverse Event|3|||
148686814|NCT01715415|536325028|FG001|Double-blind Treatment|Adverse Event|0|||
148686815|NCT01715415|536325027|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
148686816|NCT01715415|536325028|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
148686817|NCT01715415|536325027|FG000|Double-blind Treatment|Other|1|||
148686818|NCT01715415|536325028|FG001|Double-blind Treatment|Other|0|||
148686819|NCT01715415|536325027|FG000|Open-label Treatment|Adverse Event|0|||
148686820|NCT01715415|536325028|FG001|Open-label Treatment|Adverse Event|1|||
148686821|NCT01715415|536325027|FG000|Open-label Treatment|Subject Noncompliant|0|||
148686822|NCT01715415|536325028|FG001|Open-label Treatment|Subject Noncompliant|1|||
148686823|NCT03586830|536325029|FG000|Overall Study|Site terminated by Sponsor|1|||
148686824|NCT03586830|536325030|FG001|Overall Study|Site terminated by Sponsor|4|||
148686825|NCT03586830|536325031|FG002|Overall Study|Site terminated by Sponsor|3|||
148686826|NCT03586830|536325032|FG003|Overall Study|Site terminated by Sponsor|3|||
148686827|NCT03586830|536325029|FG000|Overall Study|Lost to Follow-up|0|||
148686828|NCT03586830|536325030|FG001|Overall Study|Lost to Follow-up|2|||
148686829|NCT03586830|536325031|FG002|Overall Study|Lost to Follow-up|2|||
148686830|NCT03586830|536325032|FG003|Overall Study|Lost to Follow-up|1|||
148686831|NCT03586830|536325029|FG000|Overall Study|Withdrawal by Subject|1|||
148686832|NCT03586830|536325030|FG001|Overall Study|Withdrawal by Subject|0|||
148686833|NCT03586830|536325031|FG002|Overall Study|Withdrawal by Subject|3|||
148686834|NCT03586830|536325032|FG003|Overall Study|Withdrawal by Subject|1|||
148686835|NCT01144663|536327257|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
148686836|NCT01144663|536327258|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
148686837|NCT01144663|536327259|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
149223022|NCT01066819|538282651|FG001|Overall Study|Not categorised|2|||
149223023|NCT01066819|538282652|FG002|Overall Study|Not categorised|6|||
149223024|NCT01066819|538282653|FG003|Overall Study|Not categorised|1|||
149223025|NCT01066819|538282654|FG004|Overall Study|Not categorised|0|||
149223026|NCT01066819|538282655|FG005|Overall Study|Not categorised|0|||
149223027|NCT01066819|538282650|FG000|Overall Study|Relapse|16|||
148686838|NCT01144663|536327260|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
148686839|NCT01144663|536327257|FG000|Primary Vaccination Phase|Adverse Event|1|||
148686840|NCT01144663|536327258|FG001|Primary Vaccination Phase|Adverse Event|0|||
148686841|NCT01144663|536327259|FG002|Primary Vaccination Phase|Adverse Event|0|||
148686842|NCT01144663|536327260|FG003|Primary Vaccination Phase|Adverse Event|1|||
148686843|NCT01144663|536327257|FG000|Primary Vaccination Phase|Protocol Violation|2|||
148686844|NCT01144663|536327258|FG001|Primary Vaccination Phase|Protocol Violation|0|||
148686845|NCT01144663|536327259|FG002|Primary Vaccination Phase|Protocol Violation|1|||
148686846|NCT01144663|536327260|FG003|Primary Vaccination Phase|Protocol Violation|0|||
148686847|NCT01144663|536327257|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
148686848|NCT01144663|536327258|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
148686849|NCT01144663|536327259|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
148686850|NCT01144663|536327260|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
148686851|NCT01144663|536327257|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
149223028|NCT01066819|538282651|FG001|Overall Study|Relapse|4|||
148810088|NCT02097277|536782544|FG000|Overall Study|Lost to Follow-up|0|||
148953680|NCT02289898|537313077|FG001|Overall Study|Other|7|||
148953681|NCT02289898|537313078|FG002|Overall Study|Other|10|||
148953682|NCT00267046|537313079|FG000|Overall Study|Disease progression|4|||
148953683|NCT00267046|537313080|FG001|Overall Study|Disease progression|2|||
148953684|NCT00267046|537313079|FG000|Overall Study|Chemotoxicity|2|||
148953685|NCT00267046|537313080|FG001|Overall Study|Chemotoxicity|0|||
148953686|NCT00267046|537313079|FG000|Overall Study|Open-label palifermin|2|||
148953687|NCT00267046|537313080|FG001|Overall Study|Open-label palifermin|7|||
148953688|NCT00267046|537313079|FG000|Overall Study|Surgery|3|||
148953689|NCT00267046|537313080|FG001|Overall Study|Surgery|1|||
148953690|NCT00267046|537313079|FG000|Overall Study|Withdrawal by Subject|1|||
148953691|NCT00267046|537313080|FG001|Overall Study|Withdrawal by Subject|0|||
148953692|NCT00267046|537313079|FG000|Overall Study|Radiation|0|||
148953693|NCT00267046|537313080|FG001|Overall Study|Radiation|1|||
148953694|NCT02066233|537313081|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
148953695|NCT02066233|537313082|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
149223029|NCT01066819|538282652|FG002|Overall Study|Relapse|3|||
149223030|NCT01066819|538282653|FG003|Overall Study|Relapse|0|||
149223031|NCT01066819|538282654|FG004|Overall Study|Relapse|0|||
149223032|NCT01066819|538282655|FG005|Overall Study|Relapse|0|||
148953696|NCT01979016|537313086|FG000|Overall Study|Withdrawal by Subject|2|||
148953697|NCT01979016|537313087|FG001|Overall Study|Withdrawal by Subject|0|||
148953698|NCT01979016|537313086|FG000|Overall Study|Adverse Event|0|||
149018033|NCT01474512|537547154|FG005|Induction Period|Lack of Efficacy|0|||
149223033|NCT01066819|538282650|FG000|Overall Study|Results not available|1|||
149223034|NCT01066819|538282651|FG001|Overall Study|Results not available|0|||
149223035|NCT01066819|538282652|FG002|Overall Study|Results not available|0|||
149223036|NCT01066819|538282653|FG003|Overall Study|Results not available|0|||
149223037|NCT01066819|538282654|FG004|Overall Study|Results not available|0|||
149223038|NCT01066819|538282655|FG005|Overall Study|Results not available|0|||
149223039|NCT01066819|538282650|FG000|Overall Study|Screen failure|1|||
149223040|NCT01066819|538282651|FG001|Overall Study|Screen failure|0|||
149223041|NCT01066819|538282652|FG002|Overall Study|Screen failure|0|||
149223042|NCT01066819|538282653|FG003|Overall Study|Screen failure|0|||
149223043|NCT01066819|538282654|FG004|Overall Study|Screen failure|0|||
149223044|NCT01066819|538282655|FG005|Overall Study|Screen failure|0|||
149223045|NCT01066819|538282650|FG000|Overall Study|Spontaneous cure|1|||
149223046|NCT01066819|538282651|FG001|Overall Study|Spontaneous cure|0|||
149223047|NCT01066819|538282652|FG002|Overall Study|Spontaneous cure|0|||
149223048|NCT01066819|538282653|FG003|Overall Study|Spontaneous cure|0|||
149223049|NCT01066819|538282654|FG004|Overall Study|Spontaneous cure|0|||
149223050|NCT01066819|538282655|FG005|Overall Study|Spontaneous cure|0|||
149223051|NCT01066819|538282650|FG000|Overall Study|Treatment never started|85|||
149223052|NCT01066819|538282651|FG001|Overall Study|Treatment never started|19|||
149223053|NCT01066819|538282652|FG002|Overall Study|Treatment never started|19|||
149223054|NCT01066819|538282653|FG003|Overall Study|Treatment never started|3|||
149223055|NCT01066819|538282654|FG004|Overall Study|Treatment never started|2|||
149223056|NCT01066819|538282655|FG005|Overall Study|Treatment never started|2|||
149223057|NCT01066819|538282650|FG000|Overall Study|Treatment stopped|12|||
149223058|NCT01066819|538282651|FG001|Overall Study|Treatment stopped|1|||
149223059|NCT01066819|538282652|FG002|Overall Study|Treatment stopped|2|||
149223060|NCT01066819|538282653|FG003|Overall Study|Treatment stopped|1|||
149223061|NCT01066819|538282654|FG004|Overall Study|Treatment stopped|0|||
149223062|NCT01066819|538282655|FG005|Overall Study|Treatment stopped|0|||
149223063|NCT01066819|538282650|FG000|Overall Study|Other|5|||
149223064|NCT01066819|538282651|FG001|Overall Study|Other|1|||
149223065|NCT01066819|538282652|FG002|Overall Study|Other|1|||
149223066|NCT01066819|538282653|FG003|Overall Study|Other|0|||
149223067|NCT01066819|538282654|FG004|Overall Study|Other|0|||
148953699|NCT01979016|537313087|FG001|Overall Study|Adverse Event|1|||
148953700|NCT04983264|537313088|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
148953701|NCT04983264|537313089|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
148953702|NCT04983264|537313090|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
149223068|NCT01066819|538282655|FG005|Overall Study|Other|0|||
149223069|NCT02408016|538282656|FG000|Overall Study|Death|6|||
149223070|NCT02408016|538282657|FG001|Overall Study|Death|1|||
149223071|NCT02408016|538282658|FG002|Overall Study|Death|0|||
149223072|NCT02408016|538282656|FG000|Overall Study|Physician Decision|0|||
149223073|NCT02408016|538282657|FG001|Overall Study|Physician Decision|2|||
149223074|NCT02408016|538282658|FG002|Overall Study|Physician Decision|0|||
148953703|NCT04983264|537313088|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
149223075|NCT00805194|538282659|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
149223076|NCT00805194|538282660|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
149223077|NCT00805194|538282659|FG000|Overall Study|Worsening or AE of underlying disease|64|||
149223078|NCT00805194|538282660|FG001|Overall Study|Worsening or AE of underlying disease|70|||
149223079|NCT00805194|538282659|FG000|Overall Study|Other AE|84|||
149223080|NCT00805194|538282660|FG001|Overall Study|Other AE|73|||
149223081|NCT00805194|538282659|FG000|Overall Study|Protocol Violation|9|||
149223082|NCT00805194|538282660|FG001|Overall Study|Protocol Violation|9|||
149223083|NCT00805194|538282659|FG000|Overall Study|Lost to Follow-up|5|||
149223084|NCT00805194|538282660|FG001|Overall Study|Lost to Follow-up|5|||
149223085|NCT00805194|538282659|FG000|Overall Study|Withdrawal by Subject|60|||
149223086|NCT00805194|538282660|FG001|Overall Study|Withdrawal by Subject|42|||
149223087|NCT00805194|538282659|FG000|Overall Study|Not treated|3|||
149223088|NCT00805194|538282660|FG001|Overall Study|Not treated|4|||
149223089|NCT00805194|538282659|FG000|Overall Study|Reasons other than stated above|20|||
149223090|NCT00805194|538282660|FG001|Overall Study|Reasons other than stated above|16|||
149223091|NCT03818399|538282666|FG000|Overall Study|Lost to Follow-up|11|||
149223092|NCT03818399|538282666|FG000|Overall Study|Withdrawal by Subject|1|||
149223093|NCT03818399|538282666|FG000|Overall Study|Protocol Violation|2|||
149223094|NCT00535236|538282667|FG000|Overall Study|Adverse Event|1|||
149223095|NCT00535236|538282668|FG001|Overall Study|Adverse Event|0|||
149223096|NCT00535236|538282669|FG002|Overall Study|Adverse Event|9|||
149223097|NCT00535236|538282670|FG003|Overall Study|Adverse Event|3|||
149223098|NCT00535236|538282671|FG004|Overall Study|Adverse Event|3|||
149223099|NCT00535236|538282672|FG005|Overall Study|Adverse Event|0|||
149223100|NCT00535236|538282673|FG006|Overall Study|Adverse Event|5|||
149223101|NCT00535236|538282674|FG007|Overall Study|Adverse Event|1|||
149223102|NCT00535236|538282675|FG008|Overall Study|Adverse Event|2|||
149223103|NCT00535236|538282676|FG009|Overall Study|Adverse Event|1|||
149223104|NCT00535236|538282667|FG000|Overall Study|Lost to Follow-up|1|||
149223105|NCT00535236|538282668|FG001|Overall Study|Lost to Follow-up|2|||
149223106|NCT00535236|538282669|FG002|Overall Study|Lost to Follow-up|0|||
149223107|NCT00535236|538282670|FG003|Overall Study|Lost to Follow-up|0|||
149223108|NCT00535236|538282671|FG004|Overall Study|Lost to Follow-up|2|||
149223109|NCT00535236|538282672|FG005|Overall Study|Lost to Follow-up|0|||
149223110|NCT00535236|538282673|FG006|Overall Study|Lost to Follow-up|0|||
149223111|NCT00535236|538282674|FG007|Overall Study|Lost to Follow-up|0|||
149223112|NCT00535236|538282675|FG008|Overall Study|Lost to Follow-up|6|||
149223113|NCT00535236|538282676|FG009|Overall Study|Lost to Follow-up|1|||
149223114|NCT00535236|538282667|FG000|Overall Study|Physician Decision|0|||
149223115|NCT00535236|538282668|FG001|Overall Study|Physician Decision|0|||
149223116|NCT00535236|538282669|FG002|Overall Study|Physician Decision|0|||
149223117|NCT00535236|538282670|FG003|Overall Study|Physician Decision|0|||
149223118|NCT00535236|538282671|FG004|Overall Study|Physician Decision|1|||
149223119|NCT00535236|538282672|FG005|Overall Study|Physician Decision|0|||
149223120|NCT00535236|538282673|FG006|Overall Study|Physician Decision|1|||
149223121|NCT00535236|538282674|FG007|Overall Study|Physician Decision|0|||
149223122|NCT00535236|538282675|FG008|Overall Study|Physician Decision|0|||
149223123|NCT00535236|538282676|FG009|Overall Study|Physician Decision|0|||
149223124|NCT00535236|538282667|FG000|Overall Study|Protocol Violation|2|||
149223125|NCT00535236|538282668|FG001|Overall Study|Protocol Violation|0|||
149223126|NCT00535236|538282669|FG002|Overall Study|Protocol Violation|1|||
149223127|NCT00535236|538282670|FG003|Overall Study|Protocol Violation|0|||
149223128|NCT00535236|538282671|FG004|Overall Study|Protocol Violation|0|||
149223129|NCT00535236|538282672|FG005|Overall Study|Protocol Violation|0|||
149223130|NCT00535236|538282673|FG006|Overall Study|Protocol Violation|0|||
149223131|NCT00535236|538282674|FG007|Overall Study|Protocol Violation|0|||
149223132|NCT00535236|538282675|FG008|Overall Study|Protocol Violation|1|||
149223133|NCT00535236|538282676|FG009|Overall Study|Protocol Violation|0|||
149223134|NCT00535236|538282667|FG000|Overall Study|Withdrawal by Subject|3|||
149223135|NCT00535236|538282668|FG001|Overall Study|Withdrawal by Subject|0|||
148953704|NCT04983264|537313089|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
149223136|NCT00535236|538282669|FG002|Overall Study|Withdrawal by Subject|2|||
149223137|NCT00535236|538282670|FG003|Overall Study|Withdrawal by Subject|1|||
149223138|NCT00535236|538282671|FG004|Overall Study|Withdrawal by Subject|6|||
149223139|NCT00535236|538282672|FG005|Overall Study|Withdrawal by Subject|1|||
149223140|NCT00535236|538282673|FG006|Overall Study|Withdrawal by Subject|5|||
148953705|NCT04983264|537313090|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
148953706|NCT01124422|537313091|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
148953707|NCT01124422|537313092|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
148953708|NCT01124422|537313093|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
148953709|NCT01124422|537313091|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
148953710|NCT01124422|537313092|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
148953711|NCT01124422|537313093|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
148953712|NCT01124422|537313091|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
148953713|NCT01124422|537313092|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
148953714|NCT01124422|537313093|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
149223141|NCT00535236|538282674|FG007|Overall Study|Withdrawal by Subject|0|||
149223142|NCT00535236|538282675|FG008|Overall Study|Withdrawal by Subject|4|||
149223143|NCT00535236|538282676|FG009|Overall Study|Withdrawal by Subject|2|||
149223144|NCT02987205|538282677|FG000|Overall Study|Adverse Event|1|||
149223145|NCT02987205|538282677|FG000|Overall Study|Withdrawal by Subject|3|||
149223146|NCT00103207|538282680|FG000|Overall Study|Adverse Event|3|||
149223147|NCT00103207|538282680|FG000|Overall Study|Death|1|||
149223148|NCT00103207|538282680|FG000|Overall Study|Withdrawal by Subject|2|||
149223149|NCT00103207|538282680|FG000|Overall Study|Other complicating disease|1|||
149223150|NCT00103207|538282680|FG000|Overall Study|Ineligible|4|||
149223151|NCT00103207|538282680|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
149223152|NCT03442595|538282681|FG000|Overall Study|Lost to Follow-up|94|||
149223153|NCT03442595|538282682|FG001|Overall Study|Lost to Follow-up|0|||
149223154|NCT01947127|538282683|FG000|Overall Study|Protocol Violation|18|||
149223155|NCT01947127|538282684|FG001|Overall Study|Protocol Violation|38|||
149223156|NCT01947127|538282683|FG000|Overall Study|Withdrawal by Subject|1|||
149223157|NCT01947127|538282684|FG001|Overall Study|Withdrawal by Subject|1|||
149223158|NCT01947127|538282683|FG000|Overall Study|Data loss|4|||
149223159|NCT01947127|538282684|FG001|Overall Study|Data loss|4|||
149223160|NCT04652102|538282685|FG000|Overall Study|Adverse Event|14|||
149223161|NCT04652102|538282686|FG001|Overall Study|Adverse Event|13|||
149223162|NCT04652102|538282685|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
149223163|NCT04652102|538282686|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
149223164|NCT04652102|538282685|FG000|Overall Study|Physician Decision|78|||
149223165|NCT04652102|538282686|FG001|Overall Study|Physician Decision|40|||
149223166|NCT04652102|538282685|FG000|Overall Study|Study Ended by Sponsor|64|||
149223167|NCT04652102|538282686|FG001|Overall Study|Study Ended by Sponsor|17|||
149223168|NCT04652102|538282685|FG000|Overall Study|Withdrawal by Subject|4625|||
149223169|NCT04652102|538282686|FG001|Overall Study|Withdrawal by Subject|5594|||
149223170|NCT04652102|538282685|FG000|Overall Study|Lost to Follow-up|2019|||
149223171|NCT04652102|538282686|FG001|Overall Study|Lost to Follow-up|1082|||
149223172|NCT04652102|538282685|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
149223173|NCT04652102|538282686|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
149223174|NCT04652102|538282685|FG000|Overall Study|Miscellaneous|80|||
149223175|NCT04652102|538282686|FG001|Overall Study|Miscellaneous|64|||
149223176|NCT02405091|538282689|FG000|Overall Study|Adverse Event|16|||
149223177|NCT02405091|538282690|FG001|Overall Study|Adverse Event|10|||
149223178|NCT02405091|538282691|FG002|Overall Study|Adverse Event|0|||
149223179|NCT02405091|538282689|FG000|Overall Study|Protocol Violation|1|||
149223180|NCT02405091|538282690|FG001|Overall Study|Protocol Violation|0|||
149223181|NCT02405091|538282691|FG002|Overall Study|Protocol Violation|0|||
149223182|NCT02405091|538282689|FG000|Overall Study|Noncompliance|1|||
149223183|NCT02405091|538282690|FG001|Overall Study|Noncompliance|6|||
149223184|NCT02405091|538282691|FG002|Overall Study|Noncompliance|2|||
149223185|NCT02405091|538282689|FG000|Overall Study|Withdrawal by Subject|4|||
149223186|NCT02405091|538282690|FG001|Overall Study|Withdrawal by Subject|8|||
149223187|NCT02405091|538282691|FG002|Overall Study|Withdrawal by Subject|0|||
149223188|NCT02405091|538282689|FG000|Overall Study|Death|0|||
149223189|NCT02405091|538282690|FG001|Overall Study|Death|1|||
149223190|NCT02405091|538282691|FG002|Overall Study|Death|0|||
149223191|NCT02405091|538282689|FG000|Overall Study|Lost to Follow-up|5|||
149223192|NCT02405091|538282690|FG001|Overall Study|Lost to Follow-up|6|||
149223193|NCT02405091|538282691|FG002|Overall Study|Lost to Follow-up|0|||
149223194|NCT02405091|538282689|FG000|Overall Study|Physician Decision|2|||
149223195|NCT02405091|538282690|FG001|Overall Study|Physician Decision|2|||
148953715|NCT01124422|537313091|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
148953716|NCT01124422|537313092|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
149223196|NCT02405091|538282691|FG002|Overall Study|Physician Decision|0|||
149223197|NCT00247962|538282703|FG000|Overall Study|Adverse Event|15|||
149223198|NCT00247962|538282704|FG001|Overall Study|Adverse Event|12|||
149223199|NCT00247962|538282703|FG000|Overall Study|Lost to Follow-up|3|||
149223200|NCT00247962|538282704|FG001|Overall Study|Lost to Follow-up|1|||
149223201|NCT00247962|538282703|FG000|Overall Study|Physician Decision|0|||
149223202|NCT00247962|538282704|FG001|Overall Study|Physician Decision|1|||
149223203|NCT00247962|538282703|FG000|Overall Study|Protocol Violation|1|||
148810089|NCT02097277|536782545|FG001|Overall Study|Lost to Follow-up|1|||
148810090|NCT02097277|536782546|FG002|Overall Study|Lost to Follow-up|1|||
148810091|NCT02097277|536782547|FG003|Overall Study|Lost to Follow-up|0|||
148953717|NCT01124422|537313093|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
148953718|NCT01124422|537313091|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
148953719|NCT01124422|537313092|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
148953720|NCT01124422|537313093|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
148953721|NCT01124422|537313091|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
148953722|NCT01124422|537313092|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
148953723|NCT01124422|537313093|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
148953724|NCT01124422|537313091|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
148953725|NCT01124422|537313092|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
148953726|NCT01124422|537313093|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
148953727|NCT01124422|537313091|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
148953728|NCT01124422|537313092|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
149223204|NCT00247962|538282704|FG001|Overall Study|Protocol Violation|1|||
149223205|NCT00247962|538282703|FG000|Overall Study|Withdrawal by Subject|3|||
149223206|NCT00247962|538282704|FG001|Overall Study|Withdrawal by Subject|2|||
149223207|NCT00247962|538282703|FG000|Overall Study|Lack of Efficacy|4|||
149223208|NCT00247962|538282704|FG001|Overall Study|Lack of Efficacy|2|||
149223209|NCT01469637|538282709|FG000|First Intervention|Unacceptable behavior|0|||
149223210|NCT01469637|538282710|FG001|First Intervention|Unacceptable behavior|1|||
149223211|NCT01469637|538282709|FG000|Second Intervention|Incarcerated|1|||
149223212|NCT01469637|538282710|FG001|Second Intervention|Incarcerated|0|||
149223213|NCT00598585|538282711|FG000|Overall Study|Lost to Follow-up|1|||
149223214|NCT00598585|538282712|FG001|Overall Study|Lost to Follow-up|0|||
149223215|NCT00542425|538282718|FG000|Initial 24 Weeks|Administrative reasons|0|||
149223216|NCT00542425|538282719|FG001|Initial 24 Weeks|Administrative reasons|0|||
149223217|NCT00542425|538282720|FG002|Initial 24 Weeks|Administrative reasons|1|||
149223218|NCT00542425|538282721|FG003|Initial 24 Weeks|Administrative reasons|1|||
149223219|NCT00542425|538282722|FG004|Initial 24 Weeks|Administrative reasons|0|||
149223220|NCT00542425|538282718|FG000|Initial 24 Weeks|Adverse Event|0|||
149223221|NCT00542425|538282719|FG001|Initial 24 Weeks|Adverse Event|1|||
149223222|NCT00542425|538282720|FG002|Initial 24 Weeks|Adverse Event|1|||
149223223|NCT00542425|538282721|FG003|Initial 24 Weeks|Adverse Event|3|||
149223224|NCT00542425|538282722|FG004|Initial 24 Weeks|Adverse Event|2|||
149223225|NCT00542425|538282718|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
149223226|NCT00542425|538282719|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
149223227|NCT00542425|538282720|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
149223228|NCT00542425|538282721|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
149223229|NCT00542425|538282722|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
149223230|NCT00542425|538282718|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
149223231|NCT00542425|538282719|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
149223232|NCT00542425|538282720|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
149223233|NCT00542425|538282721|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
149223234|NCT00542425|538282722|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
149223235|NCT00542425|538282718|FG000|Initial 24 Weeks|Non-compliance|0|||
149223236|NCT00542425|538282719|FG001|Initial 24 Weeks|Non-compliance|0|||
149223237|NCT00542425|538282720|FG002|Initial 24 Weeks|Non-compliance|0|||
149223238|NCT00542425|538282721|FG003|Initial 24 Weeks|Non-compliance|1|||
149223239|NCT00542425|538282722|FG004|Initial 24 Weeks|Non-compliance|1|||
149223240|NCT00542425|538282718|FG000|Initial 24 Weeks|Protocol Violation|0|||
149223241|NCT00542425|538282719|FG001|Initial 24 Weeks|Protocol Violation|0|||
149223242|NCT00542425|538282720|FG002|Initial 24 Weeks|Protocol Violation|0|||
149223243|NCT00542425|538282721|FG003|Initial 24 Weeks|Protocol Violation|1|||
149223244|NCT00542425|538282722|FG004|Initial 24 Weeks|Protocol Violation|0|||
149223245|NCT00542425|538282718|FG000|Initial 24 Weeks|Refusal of treatment|2|||
149223246|NCT00542425|538282719|FG001|Initial 24 Weeks|Refusal of treatment|2|||
149223247|NCT00542425|538282720|FG002|Initial 24 Weeks|Refusal of treatment|1|||
149223248|NCT00542425|538282721|FG003|Initial 24 Weeks|Refusal of treatment|4|||
149223249|NCT00542425|538282722|FG004|Initial 24 Weeks|Refusal of treatment|1|||
149223250|NCT00542425|538282718|FG000|Initial 24 Weeks|Other|0|||
149223251|NCT00542425|538282719|FG001|Initial 24 Weeks|Other|2|||
149223252|NCT00542425|538282720|FG002|Initial 24 Weeks|Other|1|||
148810092|NCT02097277|536782548|FG004|Overall Study|Lost to Follow-up|0|||
148810093|NCT02097277|536782544|FG000|Overall Study|Withdrawal by Subject|2|||
148953729|NCT01124422|537313093|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
149223253|NCT00542425|538282721|FG003|Initial 24 Weeks|Other|0|||
149223254|NCT00542425|538282722|FG004|Initial 24 Weeks|Other|0|||
149223255|NCT00542425|538282718|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
149223256|NCT00542425|538282719|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
149223257|NCT00542425|538282720|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
149223258|NCT00542425|538282721|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
149223259|NCT00542425|538282722|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
149223260|NCT00542425|538282718|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149223261|NCT00542425|538282719|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149223262|NCT00542425|538282720|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
149223263|NCT00542425|538282721|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149223264|NCT00542425|538282722|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
149223265|NCT00542425|538282718|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149223266|NCT00542425|538282719|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
149223267|NCT00542425|538282720|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149223268|NCT00542425|538282721|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149223269|NCT00542425|538282722|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
149223270|NCT00542425|538282718|FG000|Extended 24 Weeks of Treatment|Other|1|||
149223271|NCT00542425|538282719|FG001|Extended 24 Weeks of Treatment|Other|1|||
149223272|NCT00542425|538282720|FG002|Extended 24 Weeks of Treatment|Other|0|||
149223273|NCT00542425|538282721|FG003|Extended 24 Weeks of Treatment|Other|0|||
149223274|NCT00542425|538282722|FG004|Extended 24 Weeks of Treatment|Other|1|||
149223275|NCT01601873|538282725|FG000|Overall Study|Lost to Follow-up|2|||
149223276|NCT01601873|538282726|FG001|Overall Study|Lost to Follow-up|3|||
149223277|NCT03196973|538282727|FG000|Overall Study|Adverse Event|1|||
149223278|NCT03196973|538282728|FG001|Overall Study|Adverse Event|1|||
149223279|NCT03196973|538282729|FG002|Overall Study|Adverse Event|2|||
149223280|NCT03196973|538282727|FG000|Overall Study|Lack of Efficacy|2|||
149223281|NCT03196973|538282728|FG001|Overall Study|Lack of Efficacy|6|||
149223282|NCT03196973|538282729|FG002|Overall Study|Lack of Efficacy|1|||
149223283|NCT03196973|538282727|FG000|Overall Study|Lost to Follow-up|4|||
149223284|NCT03196973|538282728|FG001|Overall Study|Lost to Follow-up|3|||
149223285|NCT03196973|538282729|FG002|Overall Study|Lost to Follow-up|2|||
149223286|NCT03196973|538282727|FG000|Overall Study|Consent withdrawn|2|||
149223287|NCT03196973|538282728|FG001|Overall Study|Consent withdrawn|1|||
149223288|NCT03196973|538282729|FG002|Overall Study|Consent withdrawn|0|||
149223289|NCT03196973|538282727|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
149223290|NCT03196973|538282728|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
149223291|NCT03196973|538282729|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
149223292|NCT01809327|538282730|FG000|Overall Study|Lost to Follow-up|5|||
149223293|NCT01809327|538282731|FG001|Overall Study|Lost to Follow-up|2|||
148953730|NCT01124422|537313091|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
148953731|NCT01124422|537313092|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
148953732|NCT01124422|537313093|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
148953733|NCT01124422|537313091|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
148953734|NCT01124422|537313092|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
148953735|NCT01124422|537313093|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
148953736|NCT01442493|537313094|FG000|Overall Study|withdrawn from study|3|||
149018034|NCT01474512|537547155|FG006|Induction Period|Lack of Efficacy|0|||
148953737|NCT01442493|537313095|FG001|Overall Study|withdrawn from study|2|||
149223294|NCT01809327|538282732|FG002|Overall Study|Lost to Follow-up|4|||
149223295|NCT01809327|538282733|FG003|Overall Study|Lost to Follow-up|2|||
149223296|NCT01809327|538282734|FG004|Overall Study|Lost to Follow-up|3|||
149223297|NCT01809327|538282730|FG000|Overall Study|Withdrawal by Subject|6|||
149223298|NCT01809327|538282731|FG001|Overall Study|Withdrawal by Subject|4|||
149223299|NCT01809327|538282732|FG002|Overall Study|Withdrawal by Subject|4|||
149223300|NCT01809327|538282733|FG003|Overall Study|Withdrawal by Subject|2|||
149223301|NCT01809327|538282734|FG004|Overall Study|Withdrawal by Subject|5|||
149223302|NCT01809327|538282730|FG000|Overall Study|Adverse Event|4|||
149223303|NCT01809327|538282731|FG001|Overall Study|Adverse Event|3|||
149223304|NCT01809327|538282732|FG002|Overall Study|Adverse Event|7|||
149223305|NCT01809327|538282733|FG003|Overall Study|Adverse Event|4|||
149223306|NCT01809327|538282734|FG004|Overall Study|Adverse Event|8|||
149223307|NCT01809327|538282730|FG000|Overall Study|Death|1|||
149223308|NCT01809327|538282731|FG001|Overall Study|Death|0|||
149223309|NCT01809327|538282732|FG002|Overall Study|Death|0|||
149223310|NCT01809327|538282733|FG003|Overall Study|Death|0|||
149223311|NCT01809327|538282734|FG004|Overall Study|Death|0|||
149223312|NCT01809327|538282730|FG000|Overall Study|Protocol Violation|0|||
149223313|NCT01809327|538282731|FG001|Overall Study|Protocol Violation|1|||
149223314|NCT01809327|538282732|FG002|Overall Study|Protocol Violation|0|||
149223315|NCT01809327|538282733|FG003|Overall Study|Protocol Violation|0|||
149223316|NCT01809327|538282734|FG004|Overall Study|Protocol Violation|0|||
149223317|NCT01809327|538282730|FG000|Overall Study|Physician Decision|1|||
149223318|NCT01809327|538282731|FG001|Overall Study|Physician Decision|1|||
149223319|NCT01809327|538282732|FG002|Overall Study|Physician Decision|0|||
149223320|NCT01809327|538282733|FG003|Overall Study|Physician Decision|0|||
149223321|NCT01809327|538282734|FG004|Overall Study|Physician Decision|0|||
149223322|NCT01809327|538282730|FG000|Overall Study|Pregnancy|1|||
149223323|NCT01809327|538282731|FG001|Overall Study|Pregnancy|0|||
149223324|NCT01809327|538282732|FG002|Overall Study|Pregnancy|0|||
149223325|NCT01809327|538282733|FG003|Overall Study|Pregnancy|0|||
149223326|NCT01809327|538282734|FG004|Overall Study|Pregnancy|0|||
149223327|NCT01809327|538282730|FG000|Overall Study|Other|14|||
149223328|NCT01809327|538282731|FG001|Overall Study|Other|15|||
149223329|NCT01809327|538282732|FG002|Overall Study|Other|7|||
149223330|NCT01809327|538282733|FG003|Overall Study|Other|4|||
149223331|NCT01809327|538282734|FG004|Overall Study|Other|9|||
149223332|NCT02802735|538282739|FG000|Overall Study|Withdrawal by Subject|0|||
149223333|NCT02802735|538282740|FG001|Overall Study|Withdrawal by Subject|1|||
149223334|NCT02802735|538282741|FG002|Overall Study|Withdrawal by Subject|0|||
149223335|NCT02802735|538282742|FG003|Overall Study|Withdrawal by Subject|0|||
149223336|NCT02802735|538282743|FG004|Overall Study|Withdrawal by Subject|0|||
149223337|NCT01024946|538282744|FG000|Overall Study|Screen Failure|3|||
149223338|NCT01024946|538282744|FG000|Overall Study|Withdrawal by Subject|1|||
149223339|NCT01024946|538282744|FG000|Overall Study|Adverse Event|1|||
149223340|NCT03147495|538282745|FG000|Overall Study|Physician Decision|0|||
149223341|NCT03147495|538282746|FG001|Overall Study|Physician Decision|6|||
149223342|NCT02483611|538282747|FG000|Overall Study|Protocol Violation|0|||
149223343|NCT02483611|538282748|FG001|Overall Study|Protocol Violation|0|||
149223344|NCT02483611|538282749|FG002|Overall Study|Protocol Violation|1|||
149223345|NCT02608892|538282750|FG000|Overall Study|Lost to Follow-up|1|||
149223346|NCT02608892|538282751|FG001|Overall Study|Lost to Follow-up|0|||
149223347|NCT02590406|538282754|FG000|Overall Study|Adverse Event|1|||
149223348|NCT02590406|538282755|FG001|Overall Study|Adverse Event|0|||
149223349|NCT02590406|538282754|FG000|Overall Study|Saturometer malfunction|0|||
149223350|NCT02590406|538282755|FG001|Overall Study|Saturometer malfunction|1|||
149223351|NCT00957723|538282756|FG000|Overall Study|Death|3|||
149223352|NCT00957723|538282756|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
149223353|NCT00957723|538282756|FG000|Overall Study|Lost to Follow-up|8|||
149223354|NCT00957723|538282756|FG000|Overall Study|Withdrawal by Subject|24|||
149223355|NCT00957723|538282756|FG000|Overall Study|Investigative Site Terminated|61|||
149223356|NCT00957723|538282756|FG000|Overall Study|Intercurrent Illness|2|||
149223357|NCT00957723|538282756|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
149223358|NCT00877890|538282757|FG000|Overall Study|Adverse Event|6|||
149223359|NCT00877890|538282758|FG001|Overall Study|Adverse Event|6|||
149223360|NCT00877890|538282757|FG000|Overall Study|Lost to Follow-up|5|||
149223361|NCT00877890|538282758|FG001|Overall Study|Lost to Follow-up|5|||
149223362|NCT00877890|538282757|FG000|Overall Study|Protocol Violation|0|||
149223363|NCT00877890|538282758|FG001|Overall Study|Protocol Violation|1|||
149223364|NCT00877890|538282757|FG000|Overall Study|Withdrawal of Consent|6|||
149223365|NCT00877890|538282758|FG001|Overall Study|Withdrawal of Consent|12|||
149018035|NCT01474512|537547156|FG007|Induction Period|Lack of Efficacy|0|||
149223366|NCT00877890|538282757|FG000|Overall Study|Investigator Decision|0|||
149223367|NCT00877890|538282758|FG001|Overall Study|Investigator Decision|2|||
149223368|NCT00877890|538282757|FG000|Overall Study|Loss of Glucose Control|3|||
149223369|NCT00877890|538282758|FG001|Overall Study|Loss of Glucose Control|4|||
149223370|NCT00984009|538282759|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
149223371|NCT02036476|538282764|FG000|Overall Study|Withdrawal by Subject|2|||
149223372|NCT02036476|538282764|FG000|Overall Study|Progressive Disease|4|||
148686852|NCT01144663|536327258|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
148686853|NCT01144663|536327259|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
148686854|NCT01144663|536327260|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
148686855|NCT01144663|536327257|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
149223373|NCT02036476|538282764|FG000|Overall Study|Unacceptable Toxicity|2|||
149223374|NCT03049852|538282772|FG000|Overall Study|Lost to Follow-up|0|||
149223375|NCT03049852|538282773|FG001|Overall Study|Lost to Follow-up|1|||
149223376|NCT03049852|538282774|FG002|Overall Study|Lost to Follow-up|0|||
149223377|NCT02709889|538282775|FG000|Overall Study|Withdrawal by Subject|11|||
149223378|NCT02709889|538282776|FG001|Overall Study|Withdrawal by Subject|10|||
149223379|NCT02709889|538282777|FG002|Overall Study|Withdrawal by Subject|2|||
149223380|NCT02709889|538282778|FG003|Overall Study|Withdrawal by Subject|12|||
149223381|NCT02709889|538282775|FG000|Overall Study|Death|25|||
149223382|NCT02709889|538282776|FG001|Overall Study|Death|38|||
149223383|NCT02709889|538282777|FG002|Overall Study|Death|4|||
149223384|NCT02709889|538282778|FG003|Overall Study|Death|44|||
149223385|NCT02709889|538282775|FG000|Overall Study|Physician Decision|1|||
149223386|NCT02709889|538282776|FG001|Overall Study|Physician Decision|2|||
149223387|NCT02709889|538282777|FG002|Overall Study|Physician Decision|3|||
149223388|NCT02709889|538282778|FG003|Overall Study|Physician Decision|5|||
149223389|NCT02709889|538282775|FG000|Overall Study|Lost to Follow-up|2|||
149223390|NCT02709889|538282776|FG001|Overall Study|Lost to Follow-up|0|||
149223391|NCT02709889|538282777|FG002|Overall Study|Lost to Follow-up|0|||
149223392|NCT02709889|538282778|FG003|Overall Study|Lost to Follow-up|4|||
149223393|NCT02709889|538282775|FG000|Overall Study|Study Terminated by Sponsor|4|||
149223394|NCT02709889|538282776|FG001|Overall Study|Study Terminated by Sponsor|6|||
149223395|NCT02709889|538282777|FG002|Overall Study|Study Terminated by Sponsor|2|||
149223396|NCT02709889|538282778|FG003|Overall Study|Study Terminated by Sponsor|17|||
148686856|NCT01144663|536327258|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
149018036|NCT01474512|537547157|FG008|Induction Period|Lack of Efficacy|0|||
149223397|NCT02709889|538282775|FG000|Overall Study|Other, Not Specified|0|||
149223398|NCT02709889|538282776|FG001|Overall Study|Other, Not Specified|1|||
148686857|NCT01144663|536327259|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
149223399|NCT02709889|538282777|FG002|Overall Study|Other, Not Specified|1|||
149223400|NCT02709889|538282778|FG003|Overall Study|Other, Not Specified|6|||
149223401|NCT00537810|538282779|FG000|Overall Study|Withdrawal by Subject|4|||
148686858|NCT01144663|536327260|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
148686859|NCT01144663|536327257|FG000|Primary Vaccination Phase|Other|0|||
148686860|NCT01144663|536327258|FG001|Primary Vaccination Phase|Other|1|||
148686861|NCT01144663|536327259|FG002|Primary Vaccination Phase|Other|0|||
148686862|NCT01144663|536327260|FG003|Primary Vaccination Phase|Other|2|||
148686863|NCT01144663|536327257|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
148686864|NCT01144663|536327258|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
148686865|NCT01144663|536327259|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
148686866|NCT01144663|536327260|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
148686867|NCT01144663|536327257|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
148686868|NCT01144663|536327258|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
148686869|NCT01144663|536327259|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
148686870|NCT01144663|536327260|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
148686871|NCT01144663|536327257|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
148686872|NCT01144663|536327258|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
148686873|NCT01144663|536327259|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
148686874|NCT01144663|536327260|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
148686875|NCT01144663|536327257|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
148686876|NCT01144663|536327258|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
148686877|NCT01144663|536327259|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
148686878|NCT01144663|536327260|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
148686879|NCT01144663|536327257|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
148686880|NCT01144663|536327258|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
148686881|NCT01144663|536327259|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
148686882|NCT01144663|536327260|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
148686883|NCT01144663|536327257|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
148686884|NCT01144663|536327258|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
148686885|NCT01144663|536327259|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
148686886|NCT01144663|536327260|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
148686887|NCT01007916|536327272|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
148686888|NCT01007916|536327273|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
148686889|NCT01007916|536327272|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
148686890|NCT01007916|536327273|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
148686891|NCT02040428|536327274|FG000|Overall Study|Death|4|||
148686892|NCT02040428|536327275|FG001|Overall Study|Death|3|||
148686893|NCT02040428|536327274|FG000|Overall Study|Withdrawal by Subject|1|||
148686894|NCT02040428|536327275|FG001|Overall Study|Withdrawal by Subject|1|||
148686895|NCT02058628|536327276|FG000|Overall Study|Adverse Event|1|||
148686896|NCT02058628|536327277|FG001|Overall Study|Adverse Event|0|||
148686897|NCT02058628|536327276|FG000|Overall Study|Withdrawal by Subject|2|||
148686898|NCT02058628|536327277|FG001|Overall Study|Withdrawal by Subject|2|||
148686899|NCT02058628|536327276|FG000|Overall Study|Lost to Follow-up|2|||
149018037|NCT01474512|537547158|FG009|Induction Period|Lack of Efficacy|0|||
149018038|NCT01474512|537547159|FG010|Induction Period|Lack of Efficacy|0|||
149223402|NCT00537810|538282780|FG001|Overall Study|Withdrawal by Subject|11|||
148686900|NCT02058628|536327277|FG001|Overall Study|Lost to Follow-up|4|||
148686901|NCT02058628|536327276|FG000|Overall Study|Not in time schedule|0|||
148686902|NCT02058628|536327277|FG001|Overall Study|Not in time schedule|1|||
149018039|NCT01474512|537547160|FG011|Induction Period|Lack of Efficacy|0|||
149018040|NCT01474512|537547161|FG012|Induction Period|Lack of Efficacy|0|||
149223403|NCT00537810|538282781|FG002|Overall Study|Withdrawal by Subject|4|||
149223404|NCT00537810|538282782|FG003|Overall Study|Withdrawal by Subject|3|||
149223405|NCT00537810|538282779|FG000|Overall Study|Medically withdrawn|2|||
149223406|NCT00537810|538282780|FG001|Overall Study|Medically withdrawn|2|||
149223407|NCT00537810|538282781|FG002|Overall Study|Medically withdrawn|0|||
149223408|NCT00537810|538282782|FG003|Overall Study|Medically withdrawn|1|||
149223409|NCT03452397|538282783|FG000|Overall Study|Adverse Event|1|||
149223410|NCT03452397|538282784|FG001|Overall Study|Adverse Event|0|||
149223411|NCT03452397|538282785|FG002|Overall Study|Adverse Event|0|||
149223412|NCT03452397|538282786|FG003|Overall Study|Adverse Event|0|||
149223413|NCT03452397|538282783|FG000|Overall Study|Administrative reason|0|||
148686903|NCT02058628|536327276|FG000|Overall Study|The visit date was not in timeline|0|||
148686904|NCT02058628|536327277|FG001|Overall Study|The visit date was not in timeline|1|||
148686905|NCT02058628|536327276|FG000|Overall Study|A lot of time for study for participant|1|||
148686906|NCT02058628|536327277|FG001|Overall Study|A lot of time for study for participant|0|||
149018041|NCT01474512|537547162|FG013|Induction Period|Lack of Efficacy|0|||
149018042|NCT01474512|537547163|FG014|Induction Period|Lack of Efficacy|0|||
149223414|NCT03452397|538282784|FG001|Overall Study|Administrative reason|0|||
149223415|NCT03452397|538282785|FG002|Overall Study|Administrative reason|1|||
149223416|NCT03452397|538282786|FG003|Overall Study|Administrative reason|1|||
148686907|NCT02058628|536327276|FG000|Overall Study|Non compliance|1|||
148686908|NCT02058628|536327277|FG001|Overall Study|Non compliance|0|||
148686909|NCT02961920|536327278|FG000|Overall Study|did not achive stydy protocol schedule|1|||
149223417|NCT03452397|538282783|FG000|Overall Study|Withdrawal by Subject|0|||
149223418|NCT03452397|538282784|FG001|Overall Study|Withdrawal by Subject|0|||
149223419|NCT03452397|538282785|FG002|Overall Study|Withdrawal by Subject|1|||
149223420|NCT03452397|538282786|FG003|Overall Study|Withdrawal by Subject|0|||
149223421|NCT00125268|538282787|FG000|Overall Study|Withdrawal by Subject|1|||
149223422|NCT00125268|538282788|FG001|Overall Study|Withdrawal by Subject|1|||
149223423|NCT00925522|538282789|FG000|Overall Study|study closed -- business decision|20|||
149223424|NCT02985684|538282795|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
149223425|NCT02985684|538282795|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
149223426|NCT02985684|538282795|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
149223427|NCT00631969|538282796|FG000|Overall Study|Adverse Event|3|||
149223428|NCT00631969|538282797|FG001|Overall Study|Adverse Event|1|||
149223429|NCT00631969|538282796|FG000|Overall Study|Lack of Efficacy|2|||
149223430|NCT00631969|538282797|FG001|Overall Study|Lack of Efficacy|8|||
149223431|NCT00631969|538282796|FG000|Overall Study|Lost to Follow-up|2|||
149223432|NCT00631969|538282797|FG001|Overall Study|Lost to Follow-up|1|||
149223433|NCT00631969|538282796|FG000|Overall Study|Protocol Violation|1|||
149223434|NCT00631969|538282797|FG001|Overall Study|Protocol Violation|1|||
149223435|NCT00631969|538282796|FG000|Overall Study|Consent Withdrawn|5|||
149223436|NCT00631969|538282797|FG001|Overall Study|Consent Withdrawn|7|||
149223437|NCT00631969|538282796|FG000|Overall Study|Noncompliant With Study Medication|0|||
149223438|NCT00631969|538282797|FG001|Overall Study|Noncompliant With Study Medication|1|||
149223439|NCT00631969|538282796|FG000|Overall Study|No Drug Exposure|2|||
149223440|NCT00631969|538282797|FG001|Overall Study|No Drug Exposure|2|||
149223441|NCT01265719|538284758|FG000|Overall Study|Does not meet entrance criteria|0|||
149223442|NCT01265719|538284759|FG001|Overall Study|Does not meet entrance criteria|3|||
149223443|NCT01265719|538284758|FG000|Overall Study|Other reasons|2|||
149223444|NCT01265719|538284759|FG001|Overall Study|Other reasons|0|||
149018043|NCT01474512|537547164|FG015|Induction Period|Lack of Efficacy|0|||
149223445|NCT01265719|538284758|FG000|Overall Study|Withdrawal by Subject|8|||
149223446|NCT01265719|538284759|FG001|Overall Study|Withdrawal by Subject|3|||
149223447|NCT01265719|538284758|FG000|Overall Study|Lost to Follow-up|2|||
149223448|NCT01265719|538284759|FG001|Overall Study|Lost to Follow-up|7|||
149223449|NCT01265719|538284758|FG000|Overall Study|Adverse Event|2|||
149223450|NCT01265719|538284759|FG001|Overall Study|Adverse Event|0|||
149223451|NCT00027027|538284760|FG000|Overall Study|Adverse Event|0|||
149223452|NCT00027027|538284761|FG001|Overall Study|Adverse Event|0|||
149223453|NCT00027027|538284762|FG002|Overall Study|Adverse Event|1|||
149223454|NCT00027027|538284763|FG003|Overall Study|Adverse Event|0|||
149223455|NCT00027027|538284764|FG004|Overall Study|Adverse Event|1|||
149223456|NCT00027027|538284760|FG000|Overall Study|Admitted for Signs of PD|0|||
149223457|NCT00027027|538284761|FG001|Overall Study|Admitted for Signs of PD|0|||
149223458|NCT00027027|538284762|FG002|Overall Study|Admitted for Signs of PD|0|||
149223459|NCT00027027|538284763|FG003|Overall Study|Admitted for Signs of PD|0|||
149223460|NCT00027027|538284764|FG004|Overall Study|Admitted for Signs of PD|1|||
149223461|NCT00027027|538284760|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
149223462|NCT00027027|538284761|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
149223463|NCT00027027|538284762|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
149223464|NCT00027027|538284763|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
149223465|NCT00027027|538284764|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
149223466|NCT00027027|538284760|FG000|Overall Study|PD Requiring Surgery|0|||
149223467|NCT00027027|538284761|FG001|Overall Study|PD Requiring Surgery|0|||
149223468|NCT00027027|538284762|FG002|Overall Study|PD Requiring Surgery|1|||
149223469|NCT00027027|538284763|FG003|Overall Study|PD Requiring Surgery|0|||
149223470|NCT00027027|538284764|FG004|Overall Study|PD Requiring Surgery|0|||
149223471|NCT00027027|538284760|FG000|Overall Study|Physician Decision Due To PD|2|||
149223472|NCT00027027|538284761|FG001|Overall Study|Physician Decision Due To PD|3|||
149223473|NCT00027027|538284762|FG002|Overall Study|Physician Decision Due To PD|2|||
149223474|NCT00027027|538284763|FG003|Overall Study|Physician Decision Due To PD|3|||
149223475|NCT00027027|538284764|FG004|Overall Study|Physician Decision Due To PD|5|||
149223476|NCT00027027|538284760|FG000|Overall Study|Withdrawal by Subject|0|||
149223477|NCT00027027|538284761|FG001|Overall Study|Withdrawal by Subject|0|||
149223478|NCT00027027|538284762|FG002|Overall Study|Withdrawal by Subject|0|||
149223479|NCT00027027|538284763|FG003|Overall Study|Withdrawal by Subject|0|||
148686910|NCT02961920|536327279|FG001|Overall Study|did not achive stydy protocol schedule|1|||
149223480|NCT00027027|538284764|FG004|Overall Study|Withdrawal by Subject|1|||
149223481|NCT04880642|538284768|FG000|Randomization|Withdrawal by Subject|2|||
149223482|NCT04880642|538284769|FG001|Randomization|Withdrawal by Subject|3|||
149223483|NCT04880642|538284768|FG000|Treatment Period|Adverse Event|0|||
149223484|NCT04880642|538284769|FG001|Treatment Period|Adverse Event|1|||
148686911|NCT02891200|536327280|FG000|Overall Study|Lost to Follow-up|31|||
148686912|NCT02891200|536327281|FG001|Overall Study|Lost to Follow-up|36|||
149223485|NCT04880642|538284768|FG000|Treatment Period|Death|6|||
149223486|NCT04880642|538284769|FG001|Treatment Period|Death|6|||
149223487|NCT04880642|538284768|FG000|Treatment Period|Lost to Follow-up|1|||
149223488|NCT04880642|538284769|FG001|Treatment Period|Lost to Follow-up|0|||
149223489|NCT04880642|538284768|FG000|Treatment Period|Protocol Violation|0|||
149223490|NCT04880642|538284769|FG001|Treatment Period|Protocol Violation|1|||
149223491|NCT04880642|538284768|FG000|Treatment Period|Withdrawal by Subject|5|||
149223492|NCT04880642|538284769|FG001|Treatment Period|Withdrawal by Subject|3|||
149223493|NCT04880642|538284768|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
149223494|NCT04880642|538284769|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
149223495|NCT04880642|538284768|FG000|Follow-up|Death|4|||
149223496|NCT04880642|538284769|FG001|Follow-up|Death|3|||
149223497|NCT04880642|538284768|FG000|Follow-up|Withdrawal by Subject|1|||
149223498|NCT04880642|538284769|FG001|Follow-up|Withdrawal by Subject|0|||
149223499|NCT02275052|538284772|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149223500|NCT02275052|538284773|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
149223501|NCT02275052|538284774|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149223502|NCT02275052|538284775|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149223503|NCT02275052|538284772|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
149223504|NCT02275052|538284773|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
149223505|NCT02275052|538284774|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
149223506|NCT02275052|538284775|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
149223507|NCT02275052|538284772|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
149223508|NCT02275052|538284773|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
149223509|NCT02275052|538284774|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149223510|NCT02275052|538284775|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149223511|NCT02275052|538284772|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
149223512|NCT02275052|538284773|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
149223513|NCT02275052|538284774|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
149223514|NCT02275052|538284775|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
149223515|NCT02275052|538284772|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
149223516|NCT02275052|538284773|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149223517|NCT02275052|538284774|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149223518|NCT02275052|538284775|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
149223519|NCT02275052|538284772|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
149223520|NCT02275052|538284773|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
149223521|NCT02275052|538284774|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
149223522|NCT02275052|538284775|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
149223523|NCT02275052|538284772|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
149223524|NCT02275052|538284773|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
149223525|NCT02275052|538284774|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
149223526|NCT02275052|538284775|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
149223527|NCT02275052|538284772|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149223528|NCT02275052|538284773|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149223529|NCT02275052|538284774|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
149223530|NCT02275052|538284775|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
149223531|NCT02275052|538284772|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148686913|NCT02891200|536327280|FG000|Overall Study|Death|10|||
148686914|NCT02891200|536327281|FG001|Overall Study|Death|9|||
149223532|NCT02275052|538284773|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149223533|NCT02275052|538284774|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149223534|NCT02275052|538284775|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
148686915|NCT02891200|536327280|FG000|Overall Study|Withdrawal by Subject|1|||
148686916|NCT02891200|536327281|FG001|Overall Study|Withdrawal by Subject|4|||
148686917|NCT03907280|536327284|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
148686918|NCT03907280|536327285|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
148686919|NCT03907280|536327286|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
148686920|NCT01927757|536327287|FG000|Overall Study|Withdrawal by Subject|14|||
148686921|NCT01927757|536327287|FG000|Overall Study|Lost to Follow-up|2|||
148686922|NCT01927757|536327287|FG000|Overall Study|Decision by Sponsor|2|||
148686923|NCT01927757|536327287|FG000|Overall Study|Other|1|||
148686924|NCT01927757|536327287|FG000|Overall Study|Ethical Reasons|4|||
148686925|NCT04480463|536327290|FG000|Overall Study|Death|0|||
148686926|NCT04480463|536327291|FG001|Overall Study|Death|1|||
148686927|NCT04480463|536327290|FG000|Overall Study|Adverse Event|6|||
148686928|NCT04480463|536327291|FG001|Overall Study|Adverse Event|8|||
148686929|NCT04480463|536327290|FG000|Overall Study|Lost to Follow-up|3|||
148686930|NCT04480463|536327291|FG001|Overall Study|Lost to Follow-up|2|||
148686931|NCT04480463|536327290|FG000|Overall Study|Physician Decision|2|||
148686932|NCT04480463|536327291|FG001|Overall Study|Physician Decision|5|||
148686933|NCT04480463|536327290|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
148686934|NCT04480463|536327291|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
148686935|NCT04480463|536327290|FG000|Overall Study|Protocol Violation|2|||
149018044|NCT01474512|537547165|FG016|Induction Period|Lack of Efficacy|0|||
149018045|NCT01474512|537547166|FG017|Induction Period|Lack of Efficacy|0|||
149018046|NCT01474512|537547149|FG000|Induction Period|Withdrawal by Subject|6|||
149018047|NCT01474512|537547150|FG001|Induction Period|Withdrawal by Subject|6|||
149018048|NCT01474512|537547151|FG002|Induction Period|Withdrawal by Subject|5|||
148686936|NCT04480463|536327291|FG001|Overall Study|Protocol Violation|1|||
148686937|NCT04480463|536327290|FG000|Overall Study|Withdrawal by Subject|6|||
148686938|NCT04480463|536327291|FG001|Overall Study|Withdrawal by Subject|7|||
148686939|NCT04480463|536327290|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
148686940|NCT04480463|536327291|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
148686941|NCT04480463|536327290|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
148686942|NCT04480463|536327291|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
148686943|NCT04480463|536327290|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
148686944|NCT04480463|536327291|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
148686945|NCT04480463|536327290|FG000|Overall Study|Other|6|||
148686946|NCT04480463|536327291|FG001|Overall Study|Other|4|||
148686947|NCT00988169|536327292|FG000|Overall Study|Withdrawal by Subject|1|||
148686948|NCT01399723|536327293|FG000|Overall Study|Lost to Follow-up|0|||
148686949|NCT01399723|536327294|FG001|Overall Study|Lost to Follow-up|1|||
148686950|NCT00130520|536327295|FG000|Overall Study|Adverse Event|11|||
148686951|NCT00130520|536327295|FG000|Overall Study|Death|1|||
148686952|NCT00130520|536327295|FG000|Overall Study|Physician Decision|1|||
148686953|NCT00130520|536327295|FG000|Overall Study|Withdrawal by Subject|1|||
148686954|NCT00130520|536327295|FG000|Overall Study|Disease Progression|23|||
148686955|NCT00130520|536327295|FG000|Overall Study|Protocol non-compliance|1|||
148686956|NCT00130520|536327295|FG000|Overall Study|Did not meet re-treatment criteria|1|||
148686957|NCT01464827|536327296|FG000|Overall Study|Adverse Event|0|||
148686958|NCT01464827|536327297|FG001|Overall Study|Adverse Event|0|||
148686959|NCT01464827|536327298|FG002|Overall Study|Adverse Event|0|||
148686960|NCT01464827|536327299|FG003|Overall Study|Adverse Event|0|||
148686961|NCT01464827|536327300|FG004|Overall Study|Adverse Event|0|||
148686962|NCT01464827|536327301|FG005|Overall Study|Adverse Event|0|||
148686963|NCT01464827|536327302|FG006|Overall Study|Adverse Event|0|||
148686964|NCT01464827|536327303|FG007|Overall Study|Adverse Event|0|||
148686965|NCT01464827|536327304|FG008|Overall Study|Adverse Event|0|||
148686966|NCT01464827|536327305|FG009|Overall Study|Adverse Event|0|||
148686967|NCT01464827|536327306|FG010|Overall Study|Adverse Event|0|||
148686968|NCT01464827|536327307|FG011|Overall Study|Adverse Event|0|||
148686969|NCT01464827|536327308|FG012|Overall Study|Adverse Event|1|||
148686970|NCT01464827|536327309|FG013|Overall Study|Adverse Event|0|||
148686971|NCT01464827|536327296|FG000|Overall Study|Withdrawal by Subject|1|||
148686972|NCT01464827|536327297|FG001|Overall Study|Withdrawal by Subject|0|||
148686973|NCT01464827|536327298|FG002|Overall Study|Withdrawal by Subject|0|||
148686974|NCT01464827|536327299|FG003|Overall Study|Withdrawal by Subject|0|||
148686975|NCT01464827|536327300|FG004|Overall Study|Withdrawal by Subject|1|||
148686976|NCT01464827|536327301|FG005|Overall Study|Withdrawal by Subject|0|||
148686977|NCT01464827|536327302|FG006|Overall Study|Withdrawal by Subject|0|||
148686978|NCT01464827|536327303|FG007|Overall Study|Withdrawal by Subject|1|||
148686979|NCT01464827|536327304|FG008|Overall Study|Withdrawal by Subject|0|||
149018049|NCT01474512|537547152|FG003|Induction Period|Withdrawal by Subject|0|||
149223535|NCT02275052|538284772|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149223536|NCT02275052|538284773|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149223537|NCT02275052|538284774|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
149223538|NCT02275052|538284775|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
149223539|NCT02275052|538284772|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149223540|NCT02275052|538284773|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149223541|NCT02275052|538284774|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149223542|NCT02275052|538284775|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
149223543|NCT00561795|538284776|FG000|Overall Study|Adverse Event|3|||
149223544|NCT00561795|538284777|FG001|Overall Study|Adverse Event|3|||
149223545|NCT00561795|538284778|FG002|Overall Study|Adverse Event|0|||
149223546|NCT00561795|538284779|FG003|Overall Study|Adverse Event|0|||
149223547|NCT00561795|538284776|FG000|Overall Study|Study Closed/Terminated|0|||
149223548|NCT00561795|538284777|FG001|Overall Study|Study Closed/Terminated|3|||
149223549|NCT00561795|538284778|FG002|Overall Study|Study Closed/Terminated|0|||
149223550|NCT00561795|538284779|FG003|Overall Study|Study Closed/Terminated|0|||
149223551|NCT00561795|538284776|FG000|Overall Study|Physician Decision|1|||
149223552|NCT00561795|538284777|FG001|Overall Study|Physician Decision|0|||
149223553|NCT00561795|538284778|FG002|Overall Study|Physician Decision|0|||
149223554|NCT00561795|538284779|FG003|Overall Study|Physician Decision|0|||
149223555|NCT02807376|538284780|FG000|Overall Study|Intra-operative exclusion criteria|3|||
149223556|NCT02807376|538284781|FG001|Overall Study|Intra-operative exclusion criteria|0|||
149223557|NCT02807376|538284780|FG000|Overall Study|Lost to Follow-up|0|||
149223558|NCT02807376|538284781|FG001|Overall Study|Lost to Follow-up|1|||
149223559|NCT00846027|538284782|FG000|Overall Study|Death|3|||
149223560|NCT00846027|538284782|FG000|Overall Study|Disease Progression|30|||
149223561|NCT00846027|538284782|FG000|Overall Study|Toxicity|12|||
149223562|NCT00846027|538284782|FG000|Overall Study|Patient Decision|7|||
149223563|NCT00846027|538284782|FG000|Overall Study|Investigator Discretion|29|||
149223564|NCT00846027|538284782|FG000|Overall Study|Protocol Violation|2|||
149223565|NCT00846027|538284782|FG000|Overall Study|Subject Not Treated|7|||
149223566|NCT03228836|538284789|FG000|Overall Study|Adverse Event|3|||
149223567|NCT03228836|538284789|FG000|Overall Study|Withdrawal by Subject|1|||
149223568|NCT03228836|538284789|FG000|Overall Study|Death|1|||
149223569|NCT03228836|538284789|FG000|Overall Study|Physician Decision|1|||
149223570|NCT03228836|538284789|FG000|Overall Study|Disease Progression|7|||
149223571|NCT03228836|538284789|FG000|Overall Study|Other|4|||
149223572|NCT00948389|538284790|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
149223573|NCT00948389|538284791|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
149223574|NCT00948389|538284792|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
149223575|NCT00948389|538284793|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
149223576|NCT00948389|538284794|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
149223577|NCT00948389|538284790|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
149223578|NCT00948389|538284791|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
149223579|NCT00948389|538284792|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
149223580|NCT00948389|538284793|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
149223581|NCT00948389|538284794|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
149223582|NCT00948389|538284790|FG000|Overall Study|Both Progression and Toxicity|1|||
149223583|NCT00948389|538284791|FG001|Overall Study|Both Progression and Toxicity|0|||
149223584|NCT00948389|538284792|FG002|Overall Study|Both Progression and Toxicity|0|||
149223585|NCT00948389|538284793|FG003|Overall Study|Both Progression and Toxicity|0|||
149223586|NCT00948389|538284794|FG004|Overall Study|Both Progression and Toxicity|0|||
149223587|NCT00568399|538284798|FG000|Overall Study|Death|2|||
149223588|NCT00568399|538284798|FG000|Overall Study|Adverse Event|5|||
149223589|NCT00568399|538284798|FG000|Overall Study|Withdrawal by Subject|8|||
149223590|NCT02967562|538284799|FG000|Overall Study|Consent not obtained|1|||
149223591|NCT02967562|538284800|FG001|Overall Study|Consent not obtained|0|||
149223592|NCT02967562|538284799|FG000|Overall Study|High leak precluding analysis|1|||
149223593|NCT02967562|538284800|FG001|Overall Study|High leak precluding analysis|1|||
149223594|NCT02381795|538284805|FG000|Overall Study|Withdrawal by Subject|1|||
149223595|NCT02381795|538284805|FG000|Overall Study|Study Terminated|2|||
149223596|NCT02176226|538284806|FG000|Overall Study|Lost to Follow-up|3|||
149223597|NCT02176226|538284806|FG000|Overall Study|Withdrew prior to treatment|6|||
149223598|NCT01488994|538284813|FG000|Overall Study|Withdrawal by Subject|0|||
149223599|NCT01488994|538284814|FG001|Overall Study|Withdrawal by Subject|1|||
149223600|NCT01072500|538284815|FG000|Overall Study|Death|2|||
149223601|NCT01072500|538284816|FG001|Overall Study|Death|2|||
149223602|NCT01072500|538284815|FG000|Overall Study|Lost to Follow-up|5|||
149223603|NCT01072500|538284816|FG001|Overall Study|Lost to Follow-up|2|||
149223604|NCT01072500|538284815|FG000|Overall Study|Withdrawal by Subject|17|||
149223605|NCT01072500|538284816|FG001|Overall Study|Withdrawal by Subject|10|||
149223606|NCT02908841|538284817|FG000|Overall Study|Physician Decision|4|||
149223607|NCT02908841|538284818|FG001|Overall Study|Physician Decision|0|||
149223608|NCT01611558|538284819|FG000|Induction Phase|Study drug toxicity|15|||
149223609|NCT01611558|538284819|FG000|Induction Phase|Disease progression|18|||
149223610|NCT01611558|538284819|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
148686980|NCT01464827|536327305|FG009|Overall Study|Withdrawal by Subject|0|||
148686981|NCT01464827|536327306|FG010|Overall Study|Withdrawal by Subject|0|||
148686982|NCT01464827|536327307|FG011|Overall Study|Withdrawal by Subject|0|||
148686983|NCT01464827|536327308|FG012|Overall Study|Withdrawal by Subject|0|||
148686984|NCT01464827|536327309|FG013|Overall Study|Withdrawal by Subject|0|||
148686985|NCT01464827|536327296|FG000|Overall Study|Lost to Follow-up|0|||
148686986|NCT01464827|536327297|FG001|Overall Study|Lost to Follow-up|2|||
148686987|NCT01464827|536327298|FG002|Overall Study|Lost to Follow-up|0|||
148686988|NCT01464827|536327299|FG003|Overall Study|Lost to Follow-up|2|||
148686989|NCT01464827|536327300|FG004|Overall Study|Lost to Follow-up|3|||
148686990|NCT01464827|536327301|FG005|Overall Study|Lost to Follow-up|1|||
148686991|NCT01464827|536327302|FG006|Overall Study|Lost to Follow-up|2|||
148686992|NCT01464827|536327303|FG007|Overall Study|Lost to Follow-up|2|||
148686993|NCT01464827|536327304|FG008|Overall Study|Lost to Follow-up|0|||
148686994|NCT01464827|536327305|FG009|Overall Study|Lost to Follow-up|0|||
148686995|NCT01464827|536327306|FG010|Overall Study|Lost to Follow-up|0|||
148686996|NCT01464827|536327307|FG011|Overall Study|Lost to Follow-up|1|||
148686997|NCT01464827|536327308|FG012|Overall Study|Lost to Follow-up|0|||
148686998|NCT01464827|536327309|FG013|Overall Study|Lost to Follow-up|1|||
148686999|NCT01464827|536327296|FG000|Overall Study|Other|2|||
148687000|NCT01464827|536327297|FG001|Overall Study|Other|3|||
148687001|NCT01464827|536327298|FG002|Overall Study|Other|0|||
148687002|NCT01464827|536327299|FG003|Overall Study|Other|2|||
148687003|NCT01464827|536327300|FG004|Overall Study|Other|3|||
148687004|NCT01464827|536327301|FG005|Overall Study|Other|0|||
148687005|NCT01464827|536327302|FG006|Overall Study|Other|1|||
148687006|NCT01464827|536327303|FG007|Overall Study|Other|0|||
148687007|NCT01464827|536327304|FG008|Overall Study|Other|3|||
148687008|NCT01464827|536327305|FG009|Overall Study|Other|1|||
148687009|NCT01464827|536327306|FG010|Overall Study|Other|2|||
148687010|NCT01464827|536327307|FG011|Overall Study|Other|0|||
148687011|NCT01464827|536327308|FG012|Overall Study|Other|1|||
148687012|NCT01464827|536327309|FG013|Overall Study|Other|0|||
148687013|NCT01464827|536327296|FG000|Overall Study|Not Treated|0|||
148687014|NCT01464827|536327297|FG001|Overall Study|Not Treated|2|||
148687015|NCT01464827|536327298|FG002|Overall Study|Not Treated|0|||
148687016|NCT01464827|536327299|FG003|Overall Study|Not Treated|0|||
148687017|NCT01464827|536327300|FG004|Overall Study|Not Treated|1|||
148687018|NCT01464827|536327301|FG005|Overall Study|Not Treated|0|||
149223611|NCT01611558|538284819|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
149223612|NCT01611558|538284819|FG000|Induction Phase|Death|1|||
149223613|NCT01611558|538284819|FG000|Maintenance Phase|Withdrawal by Subject|1|||
149223614|NCT01611558|538284819|FG000|Maintenance Phase|Elevated Uric acid|1|||
149223615|NCT03798366|538284831|FG000|Overall Study|Lost to Follow-up|0|||
149223616|NCT03798366|538284832|FG001|Overall Study|Lost to Follow-up|1|||
149223617|NCT01412333|538284836|FG000|Overall Study|Adverse Event|40|||
149223618|NCT01412333|538284837|FG001|Overall Study|Adverse Event|42|||
149223619|NCT01412333|538284836|FG000|Overall Study|Death|5|||
149223620|NCT01412333|538284837|FG001|Overall Study|Death|6|||
149223621|NCT01412333|538284836|FG000|Overall Study|Lack of Efficacy|22|||
149223622|NCT01412333|538284837|FG001|Overall Study|Lack of Efficacy|10|||
149223623|NCT01412333|538284836|FG000|Overall Study|Lost to Follow-up|15|||
149223624|NCT01412333|538284837|FG001|Overall Study|Lost to Follow-up|12|||
149223625|NCT01412333|538284836|FG000|Overall Study|Non-Compliance|3|||
149223626|NCT01412333|538284837|FG001|Overall Study|Non-Compliance|7|||
148687019|NCT01464827|536327302|FG006|Overall Study|Not Treated|1|||
148687020|NCT01464827|536327303|FG007|Overall Study|Not Treated|0|||
148687021|NCT01464827|536327304|FG008|Overall Study|Not Treated|0|||
148687022|NCT01464827|536327305|FG009|Overall Study|Not Treated|2|||
148687023|NCT01464827|536327306|FG010|Overall Study|Not Treated|0|||
148687024|NCT01464827|536327307|FG011|Overall Study|Not Treated|1|||
148687025|NCT01464827|536327308|FG012|Overall Study|Not Treated|0|||
148687026|NCT01464827|536327309|FG013|Overall Study|Not Treated|2|||
148687027|NCT03487796|536327310|FG000|Overall Study|Lost to Follow-up|18|||
148687028|NCT03487796|536327311|FG001|Overall Study|Lost to Follow-up|6|||
148687029|NCT00613574|536327312|FG000|Overall Study|Adverse Event|3|||
148687030|NCT00613574|536327312|FG000|Overall Study|Lost to Follow-up|2|||
148687031|NCT00613574|536327312|FG000|Overall Study|Other|1|||
149223627|NCT01412333|538284836|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149223628|NCT01412333|538284837|FG001|Overall Study|Non-Compliance With Study Drug|1|||
149223629|NCT01412333|538284836|FG000|Overall Study|Other|30|||
148687032|NCT04604184|536327314|FG000|Overall Study|Adverse Event|5|||
148687033|NCT04604184|536327315|FG001|Overall Study|Adverse Event|5|||
148687034|NCT04604184|536327314|FG000|Overall Study|Death|2|||
149223630|NCT01412333|538284837|FG001|Overall Study|Other|33|||
149223631|NCT01412333|538284836|FG000|Overall Study|Physician Decision|11|||
149223632|NCT01412333|538284837|FG001|Overall Study|Physician Decision|16|||
149223633|NCT01412333|538284836|FG000|Overall Study|Pregnancy|6|||
149223634|NCT01412333|538284837|FG001|Overall Study|Pregnancy|4|||
149223635|NCT01412333|538284836|FG000|Overall Study|Protocol Violation|1|||
149223636|NCT01412333|538284837|FG001|Overall Study|Protocol Violation|2|||
149223637|NCT01412333|538284836|FG000|Overall Study|Study Terminated By Sponsor|3|||
149223638|NCT01412333|538284837|FG001|Overall Study|Study Terminated By Sponsor|2|||
149223639|NCT01412333|538284836|FG000|Overall Study|Withdrawal by Subject|51|||
149223640|NCT01412333|538284837|FG001|Overall Study|Withdrawal by Subject|54|||
149223641|NCT01412333|538284836|FG000|Overall Study|Missing|1|||
149223642|NCT01412333|538284837|FG001|Overall Study|Missing|3|||
149223643|NCT04005885|538284838|FG000|First Intervention|Withdrawal by Subject|1|||
149223644|NCT04005885|538284839|FG001|First Intervention|Withdrawal by Subject|1|||
149223645|NCT04005885|538284838|FG000|Second Intervention|Withdrawal by Subject|0|||
149223646|NCT04005885|538284839|FG001|Second Intervention|Withdrawal by Subject|2|||
149223647|NCT00750867|538284843|FG000|Overall Study|Adverse Event|2|||
149223648|NCT00474539|538284844|FG000|Infant Series|Withdrawal by Subject|3|||
149223649|NCT00474539|538284845|FG001|Infant Series|Withdrawal by Subject|4|||
149223650|NCT00474539|538284844|FG000|Infant Series|Randomization error|5|||
149223651|NCT00474539|538284845|FG001|Infant Series|Randomization error|0|||
149223652|NCT00474539|538284844|FG000|Infant Series|Lost to Follow-up|2|||
149223653|NCT00474539|538284845|FG001|Infant Series|Lost to Follow-up|1|||
149223654|NCT00474539|538284844|FG000|Infant Series|Protocol Violation|0|||
149223655|NCT00474539|538284845|FG001|Infant Series|Protocol Violation|1|||
149223656|NCT00474539|538284844|FG000|After Infant Series|Lost to Follow-up|3|||
149223657|NCT00474539|538284845|FG001|After Infant Series|Lost to Follow-up|0|||
149223658|NCT00474539|538284844|FG000|After Infant Series|Withdrawal by Subject|1|||
149223659|NCT00474539|538284845|FG001|After Infant Series|Withdrawal by Subject|0|||
149223660|NCT00474539|538284844|FG000|Toddler Dose|Protocol Violation|1|||
149223661|NCT00474539|538284845|FG001|Toddler Dose|Protocol Violation|0|||
149223662|NCT03018340|538284846|FG000|Overall Study|Adverse Event|1|||
149223663|NCT03018340|538284847|FG001|Overall Study|Adverse Event|2|||
149223664|NCT03018340|538284846|FG000|Overall Study|Withdrawal by Subject|0|||
149223665|NCT03018340|538284847|FG001|Overall Study|Withdrawal by Subject|8|||
149223666|NCT03018340|538284846|FG000|Overall Study|Lack of Efficacy|0|||
149223667|NCT03018340|538284847|FG001|Overall Study|Lack of Efficacy|1|||
149223668|NCT03018340|538284846|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
149223669|NCT03018340|538284847|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
149223670|NCT03018340|538284846|FG000|Overall Study|Lost to Follow-up|1|||
149223671|NCT03018340|538284847|FG001|Overall Study|Lost to Follow-up|7|||
149223672|NCT03018340|538284846|FG000|Overall Study|Protocol Violation|3|||
149223673|NCT03018340|538284847|FG001|Overall Study|Protocol Violation|7|||
149223674|NCT03018340|538284846|FG000|Overall Study|Not further specified|0|||
149223675|NCT03018340|538284847|FG001|Overall Study|Not further specified|1|||
149223676|NCT01836549|538284848|FG000|Overall Study|Did not receive study drug|0|||
149223677|NCT01836549|538284849|FG001|Overall Study|Did not receive study drug|0|||
149223678|NCT01836549|538284850|FG002|Overall Study|Did not receive study drug|1|||
149223679|NCT01836549|538284851|FG003|Overall Study|Did not receive study drug|0|||
149223680|NCT01836549|538284852|FG004|Overall Study|Did not receive study drug|0|||
149223681|NCT01836549|538284853|FG005|Overall Study|Did not receive study drug|0|||
149223682|NCT01836549|538284854|FG006|Overall Study|Did not receive study drug|0|||
149223683|NCT01836549|538284848|FG000|Overall Study|Patient declared ineligible|0|||
149223684|NCT01836549|538284849|FG001|Overall Study|Patient declared ineligible|0|||
149223685|NCT01836549|538284850|FG002|Overall Study|Patient declared ineligible|0|||
149223686|NCT01836549|538284851|FG003|Overall Study|Patient declared ineligible|1|||
149223687|NCT01836549|538284852|FG004|Overall Study|Patient declared ineligible|0|||
149223688|NCT01836549|538284853|FG005|Overall Study|Patient declared ineligible|0|||
149223689|NCT01836549|538284854|FG006|Overall Study|Patient declared ineligible|0|||
149223690|NCT01836549|538284848|FG000|Overall Study|Patient inevaluable to start therapy|0|||
149223691|NCT01836549|538284849|FG001|Overall Study|Patient inevaluable to start therapy|0|||
149223692|NCT01836549|538284850|FG002|Overall Study|Patient inevaluable to start therapy|0|||
149223693|NCT01836549|538284851|FG003|Overall Study|Patient inevaluable to start therapy|0|||
149223694|NCT01836549|538284852|FG004|Overall Study|Patient inevaluable to start therapy|0|||
149223695|NCT01836549|538284853|FG005|Overall Study|Patient inevaluable to start therapy|0|||
149223696|NCT01836549|538284854|FG006|Overall Study|Patient inevaluable to start therapy|1|||
149223697|NCT02192190|538284857|FG000|Overall Study|Adverse Event|1|||
149018050|NCT01474512|537547153|FG004|Induction Period|Withdrawal by Subject|0|||
149223698|NCT02192190|538284858|FG001|Overall Study|Adverse Event|1|||
149223699|NCT02192190|538284859|FG002|Overall Study|Adverse Event|0|||
149223700|NCT02192190|538284860|FG003|Overall Study|Adverse Event|0|||
149223701|NCT02192190|538284861|FG004|Overall Study|Adverse Event|0|||
149223702|NCT02192190|538284862|FG005|Overall Study|Adverse Event|0|||
149223703|NCT02192190|538284857|FG000|Overall Study|Lost to Follow-up|3|||
149223704|NCT02192190|538284858|FG001|Overall Study|Lost to Follow-up|3|||
149223705|NCT02192190|538284859|FG002|Overall Study|Lost to Follow-up|2|||
149223706|NCT02192190|538284860|FG003|Overall Study|Lost to Follow-up|1|||
149223707|NCT02192190|538284861|FG004|Overall Study|Lost to Follow-up|4|||
149223708|NCT02192190|538284862|FG005|Overall Study|Lost to Follow-up|3|||
149223709|NCT02192190|538284857|FG000|Overall Study|Physician Decision|2|||
149223710|NCT02192190|538284858|FG001|Overall Study|Physician Decision|0|||
149223711|NCT02192190|538284859|FG002|Overall Study|Physician Decision|0|||
149223712|NCT02192190|538284860|FG003|Overall Study|Physician Decision|0|||
149223713|NCT02192190|538284861|FG004|Overall Study|Physician Decision|0|||
149223714|NCT02192190|538284862|FG005|Overall Study|Physician Decision|0|||
149223715|NCT02192190|538284857|FG000|Overall Study|Terminated by Sponsor|43|||
149223716|NCT02192190|538284858|FG001|Overall Study|Terminated by Sponsor|23|||
149223717|NCT02192190|538284859|FG002|Overall Study|Terminated by Sponsor|20|||
149223718|NCT02192190|538284860|FG003|Overall Study|Terminated by Sponsor|23|||
149223719|NCT02192190|538284861|FG004|Overall Study|Terminated by Sponsor|21|||
149223720|NCT02192190|538284862|FG005|Overall Study|Terminated by Sponsor|23|||
149223721|NCT02192190|538284857|FG000|Overall Study|Withdrawal by Subject|4|||
149223722|NCT02192190|538284858|FG001|Overall Study|Withdrawal by Subject|1|||
149223723|NCT02192190|538284859|FG002|Overall Study|Withdrawal by Subject|2|||
149223724|NCT02192190|538284860|FG003|Overall Study|Withdrawal by Subject|1|||
149223725|NCT02192190|538284861|FG004|Overall Study|Withdrawal by Subject|5|||
149223726|NCT02192190|538284862|FG005|Overall Study|Withdrawal by Subject|3|||
149223727|NCT02192190|538284857|FG000|Overall Study|Could not Keep Visit Schedule|1|||
149223728|NCT02192190|538284858|FG001|Overall Study|Could not Keep Visit Schedule|0|||
149223729|NCT02192190|538284859|FG002|Overall Study|Could not Keep Visit Schedule|0|||
149223730|NCT02192190|538284860|FG003|Overall Study|Could not Keep Visit Schedule|0|||
149223731|NCT02192190|538284861|FG004|Overall Study|Could not Keep Visit Schedule|0|||
149223732|NCT02192190|538284862|FG005|Overall Study|Could not Keep Visit Schedule|0|||
149223733|NCT02192190|538284857|FG000|Overall Study|Positive Drug Screen|0|||
149223734|NCT02192190|538284858|FG001|Overall Study|Positive Drug Screen|0|||
149223735|NCT02192190|538284859|FG002|Overall Study|Positive Drug Screen|0|||
149223736|NCT02192190|538284860|FG003|Overall Study|Positive Drug Screen|1|||
149223737|NCT02192190|538284861|FG004|Overall Study|Positive Drug Screen|0|||
149223738|NCT02192190|538284862|FG005|Overall Study|Positive Drug Screen|0|||
149223739|NCT02192190|538284857|FG000|Overall Study|Inadequate Pain Relief|0|||
149223740|NCT02192190|538284858|FG001|Overall Study|Inadequate Pain Relief|1|||
149223741|NCT02192190|538284859|FG002|Overall Study|Inadequate Pain Relief|1|||
149223742|NCT02192190|538284860|FG003|Overall Study|Inadequate Pain Relief|0|||
149223743|NCT02192190|538284861|FG004|Overall Study|Inadequate Pain Relief|0|||
149223744|NCT02192190|538284862|FG005|Overall Study|Inadequate Pain Relief|0|||
149223745|NCT02607865|538284865|FG000|Overall Study|Lost to Follow-up|9|||
149223746|NCT02607865|538284866|FG001|Overall Study|Lost to Follow-up|7|||
149223747|NCT02607865|538284867|FG002|Overall Study|Lost to Follow-up|7|||
149223748|NCT02607865|538284868|FG003|Overall Study|Lost to Follow-up|5|||
149223749|NCT02607865|538284865|FG000|Overall Study|Withdrawal by Subject|18|||
149223750|NCT02607865|538284866|FG001|Overall Study|Withdrawal by Subject|18|||
149223751|NCT02607865|538284867|FG002|Overall Study|Withdrawal by Subject|17|||
149223752|NCT02607865|538284868|FG003|Overall Study|Withdrawal by Subject|8|||
149223753|NCT02607865|538284865|FG000|Overall Study|Death|5|||
149223754|NCT02607865|538284866|FG001|Overall Study|Death|4|||
149223755|NCT02607865|538284867|FG002|Overall Study|Death|1|||
149223756|NCT02607865|538284868|FG003|Overall Study|Death|3|||
149223757|NCT02607865|538284865|FG000|Overall Study|Unclassified|1|||
149223758|NCT02607865|538284866|FG001|Overall Study|Unclassified|1|||
149223759|NCT02607865|538284867|FG002|Overall Study|Unclassified|2|||
149223760|NCT02607865|538284868|FG003|Overall Study|Unclassified|0|||
149223761|NCT03227692|538284869|FG000|Overall Study|Protocol Violation|1|||
149223762|NCT03227692|538284870|FG001|Overall Study|Protocol Violation|1|||
149223763|NCT03227692|538284869|FG000|Overall Study|Lost to Follow-up|4|||
149223764|NCT03227692|538284870|FG001|Overall Study|Lost to Follow-up|2|||
149223765|NCT03227692|538284869|FG000|Overall Study|Adverse Event|0|||
149223766|NCT03227692|538284870|FG001|Overall Study|Adverse Event|2|||
149223767|NCT01657253|538284871|FG000|Overall Study|Lost to Follow-up|6|||
149223768|NCT01657253|538284872|FG001|Overall Study|Lost to Follow-up|5|||
149223769|NCT01657253|538284871|FG000|Overall Study|Withdrawal by Subject|11|||
148810094|NCT02097277|536782545|FG001|Overall Study|Withdrawal by Subject|1|||
148810095|NCT02097277|536782546|FG002|Overall Study|Withdrawal by Subject|0|||
148810096|NCT02097277|536782547|FG003|Overall Study|Withdrawal by Subject|1|||
149223770|NCT01657253|538284872|FG001|Overall Study|Withdrawal by Subject|12|||
148810097|NCT02097277|536782548|FG004|Overall Study|Withdrawal by Subject|0|||
148810098|NCT02097277|536782544|FG000|Overall Study|Adverse Event|0|||
148810099|NCT02097277|536782545|FG001|Overall Study|Adverse Event|0|||
149223771|NCT01657253|538284871|FG000|Overall Study|Adverse Event|0|||
148810100|NCT02097277|536782546|FG002|Overall Study|Adverse Event|1|||
149223772|NCT01657253|538284872|FG001|Overall Study|Adverse Event|1|||
149223773|NCT01970540|538284873|FG000|Overall Study|Non-treatment-related AE|0|||
149223774|NCT01970540|538284874|FG001|Overall Study|Non-treatment-related AE|0|||
149223775|NCT01970540|538284875|FG002|Overall Study|Non-treatment-related AE|1|||
149223776|NCT01970540|538284873|FG000|Overall Study|Progressive disease|55|||
149223777|NCT01970540|538284874|FG001|Overall Study|Progressive disease|23|||
149223778|NCT01970540|538284875|FG002|Overall Study|Progressive disease|10|||
149223779|NCT01970540|538284873|FG000|Overall Study|Treatment delay over protocol|0|||
149223780|NCT01970540|538284874|FG001|Overall Study|Treatment delay over protocol|0|||
149223781|NCT01970540|538284875|FG002|Overall Study|Treatment delay over protocol|1|||
149223782|NCT01970540|538284873|FG000|Overall Study|Physician Decision|7|||
149223783|NCT01970540|538284874|FG001|Overall Study|Physician Decision|2|||
149223784|NCT01970540|538284875|FG002|Overall Study|Physician Decision|0|||
149223785|NCT01970540|538284873|FG000|Overall Study|Clinical progression|0|||
149223786|NCT01970540|538284874|FG001|Overall Study|Clinical progression|1|||
149223787|NCT01970540|538284875|FG002|Overall Study|Clinical progression|1|||
149223788|NCT01970540|538284873|FG000|Overall Study|End of study|2|||
149223789|NCT01970540|538284874|FG001|Overall Study|End of study|0|||
149223790|NCT01970540|538284875|FG002|Overall Study|End of study|2|||
149223791|NCT01970540|538284873|FG000|Overall Study|Adverse Event|0|||
149223792|NCT01970540|538284874|FG001|Overall Study|Adverse Event|2|||
149223793|NCT01970540|538284875|FG002|Overall Study|Adverse Event|1|||
149223794|NCT01970540|538284873|FG000|Overall Study|Treatment-related AE|4|||
149223795|NCT01970540|538284874|FG001|Overall Study|Treatment-related AE|0|||
149223796|NCT01970540|538284875|FG002|Overall Study|Treatment-related AE|2|||
149223797|NCT01970540|538284873|FG000|Overall Study|Withdrawal by Subject|4|||
149223798|NCT01970540|538284874|FG001|Overall Study|Withdrawal by Subject|0|||
149223799|NCT01970540|538284875|FG002|Overall Study|Withdrawal by Subject|1|||
149223800|NCT01970540|538284873|FG000|Overall Study|Clinical deterioration|1|||
149223801|NCT01970540|538284874|FG001|Overall Study|Clinical deterioration|0|||
149223802|NCT01970540|538284875|FG002|Overall Study|Clinical deterioration|0|||
149223803|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Adverse Event|30|||
149223804|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Adverse Event|25|||
149223805|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Adverse Event|23|||
149223806|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Adverse Event|14|||
149223807|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Death|0|||
149223808|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Death|0|||
149223809|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Death|1|||
149223810|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Death|0|||
149223811|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Physician Decision|0|||
149223812|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Physician Decision|1|||
149223813|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Physician Decision|0|||
149223814|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Physician Decision|1|||
149223815|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
149223816|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
149223817|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
149223818|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
149223819|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Other|6|||
149223820|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Other|1|||
149223821|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Other|0|||
149223822|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Other|2|||
149223823|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
149223824|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
149223825|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
149223826|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
149223827|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
149223828|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
149223829|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
149223830|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
149223831|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
149223832|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
149223833|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
149223834|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
149223835|NCT00242710|538284876|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
149223836|NCT00242710|538284877|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
149223837|NCT00242710|538284878|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
149223838|NCT00242710|538284879|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
149223839|NCT00242710|538284876|FG000|Period Between Core Study and Extension|Adverse Event|2|||
149223840|NCT00242710|538284877|FG001|Period Between Core Study and Extension|Adverse Event|3|||
149223841|NCT00242710|538284878|FG002|Period Between Core Study and Extension|Adverse Event|5|||
149223842|NCT00242710|538284879|FG003|Period Between Core Study and Extension|Adverse Event|2|||
149223843|NCT00242710|538284876|FG000|Period Between Core Study and Extension|Physician Decision|1|||
149223844|NCT00242710|538284877|FG001|Period Between Core Study and Extension|Physician Decision|1|||
149223845|NCT00242710|538284878|FG002|Period Between Core Study and Extension|Physician Decision|0|||
149223846|NCT00242710|538284879|FG003|Period Between Core Study and Extension|Physician Decision|0|||
149223847|NCT00242710|538284876|FG000|Period Between Core Study and Extension|Other|24|||
149223848|NCT00242710|538284877|FG001|Period Between Core Study and Extension|Other|24|||
149223849|NCT00242710|538284878|FG002|Period Between Core Study and Extension|Other|9|||
149223850|NCT00242710|538284879|FG003|Period Between Core Study and Extension|Other|11|||
149223851|NCT00242710|538284876|FG000|Period Between Core Study and Extension|Extension not Available|17|||
149223852|NCT00242710|538284877|FG001|Period Between Core Study and Extension|Extension not Available|21|||
149223853|NCT00242710|538284878|FG002|Period Between Core Study and Extension|Extension not Available|8|||
149223854|NCT00242710|538284879|FG003|Period Between Core Study and Extension|Extension not Available|7|||
149223855|NCT00242710|538284876|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
149223856|NCT00242710|538284877|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
149223857|NCT00242710|538284878|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
149223858|NCT00242710|538284879|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
149223859|NCT00242710|538284876|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
149223860|NCT00242710|538284877|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
149223861|NCT00242710|538284878|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
149223862|NCT00242710|538284879|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
149223863|NCT00242710|538284876|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
149223864|NCT00242710|538284877|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
149223865|NCT00242710|538284878|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
149223866|NCT00242710|538284879|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
149223867|NCT00242710|538284876|FG000|Study Extension (up to Year 2)|Death|0|||
149223868|NCT00242710|538284877|FG001|Study Extension (up to Year 2)|Death|0|||
149223869|NCT00242710|538284878|FG002|Study Extension (up to Year 2)|Death|0|||
149223870|NCT00242710|538284879|FG003|Study Extension (up to Year 2)|Death|1|||
149223871|NCT00242710|538284876|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
149223872|NCT00242710|538284877|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
149223873|NCT00242710|538284878|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
149223874|NCT00242710|538284879|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
149223875|NCT00242710|538284876|FG000|Study Extension (up to Year 2)|Other|3|||
149223876|NCT00242710|538284877|FG001|Study Extension (up to Year 2)|Other|5|||
149223877|NCT00242710|538284878|FG002|Study Extension (up to Year 2)|Other|4|||
149223878|NCT00242710|538284879|FG003|Study Extension (up to Year 2)|Other|3|||
149223879|NCT00242710|538284876|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
149223880|NCT00242710|538284877|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
149223881|NCT00242710|538284878|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
149223882|NCT00242710|538284879|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
149223883|NCT00242710|538284876|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
149223884|NCT00242710|538284877|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
149223885|NCT00242710|538284878|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
149223886|NCT00242710|538284879|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
149223887|NCT00579527|538284880|FG000|Overall Study|Death|4|||
149223888|NCT00381706|538284881|FG000|Overall Study|Never treated|7|||
149223889|NCT00381706|538284882|FG001|Overall Study|Never treated|2|||
149223890|NCT00381706|538284883|FG002|Overall Study|Never treated|1|||
149223891|NCT00203294|538284884|FG000|Overall Study|Withdrawal by Subject|8|||
149223892|NCT00203294|538284885|FG001|Overall Study|Withdrawal by Subject|13|||
149223893|NCT02364999|538284886|FG000|Overall Study|Death|136|||
149223894|NCT02364999|538284887|FG001|Overall Study|Death|138|||
149223895|NCT02364999|538284886|FG000|Overall Study|Lost to Follow-up|10|||
149223896|NCT02364999|538284887|FG001|Overall Study|Lost to Follow-up|15|||
149223897|NCT02364999|538284886|FG000|Overall Study|Protocol Violation|3|||
149223898|NCT02364999|538284887|FG001|Overall Study|Protocol Violation|2|||
149223899|NCT02364999|538284886|FG000|Overall Study|Withdrawal by Subject|14|||
149223900|NCT02364999|538284887|FG001|Overall Study|Withdrawal by Subject|14|||
149223901|NCT02364999|538284886|FG000|Overall Study|Other|0|||
149223902|NCT02364999|538284887|FG001|Overall Study|Other|1|||
149223903|NCT02364999|538284886|FG000|Overall Study|Randomized but did not receive treatment|2|||
149223904|NCT02364999|538284887|FG001|Overall Study|Randomized but did not receive treatment|3|||
149223905|NCT00550615|538284891|FG000|Overall Study|Withdrawal by Subject|0|||
149223906|NCT00550615|538284892|FG001|Overall Study|Withdrawal by Subject|0|||
149223907|NCT00550615|538284893|FG002|Overall Study|Withdrawal by Subject|2|||
149223908|NCT00550615|538284894|FG003|Overall Study|Withdrawal by Subject|3|||
149223909|NCT00550615|538284891|FG000|Overall Study|Not evaluable|0|||
149223910|NCT00550615|538284892|FG001|Overall Study|Not evaluable|0|||
149223911|NCT00550615|538284893|FG002|Overall Study|Not evaluable|2|||
149223912|NCT00550615|538284894|FG003|Overall Study|Not evaluable|7|||
149223913|NCT01948791|538284896|FG000|Overall Study|Adverse Event|12|||
149223914|NCT01948791|538284896|FG000|Overall Study|Lack of Efficacy|3|||
149223915|NCT01948791|538284896|FG000|Overall Study|Protocol Violation|2|||
149223916|NCT01948791|538284896|FG000|Overall Study|Withdrawal by Subject|5|||
149223917|NCT01948791|538284896|FG000|Overall Study|Lost to Follow-up|6|||
149223918|NCT01948791|538284896|FG000|Overall Study|Management issues|1|||
149223919|NCT01948791|538284896|FG000|Overall Study|Others|7|||
149223920|NCT01948791|538284896|FG000|Overall Study|Screening failure|35|||
149223921|NCT02555722|538284897|FG000|Week 2|Adverse Event|0|||
149223922|NCT02555722|538284898|FG001|Week 2|Adverse Event|1|||
148687035|NCT04604184|536327315|FG001|Overall Study|Death|1|||
149223923|NCT02555722|538284897|FG000|Week 2|Withdrawal by Subject|1|||
149223924|NCT02555722|538284898|FG001|Week 2|Withdrawal by Subject|0|||
149223925|NCT02555722|538284897|FG000|Month 1|Lens Discomfort|1|||
149223926|NCT02555722|538284898|FG001|Month 1|Lens Discomfort|0|||
149223927|NCT02555722|538284897|FG000|Month 2|Withdrawal by Subject|3|||
149223928|NCT02555722|538284898|FG001|Month 2|Withdrawal by Subject|0|||
149223929|NCT02555722|538284897|FG000|Month 2|Lost to Follow-up|1|||
149223930|NCT02555722|538284898|FG001|Month 2|Lost to Follow-up|0|||
149018051|NCT01474512|537547154|FG005|Induction Period|Withdrawal by Subject|0|||
149018052|NCT01474512|537547155|FG006|Induction Period|Withdrawal by Subject|0|||
149018053|NCT01474512|537547156|FG007|Induction Period|Withdrawal by Subject|0|||
149018054|NCT01474512|537547157|FG008|Induction Period|Withdrawal by Subject|0|||
149018055|NCT01474512|537547158|FG009|Induction Period|Withdrawal by Subject|0|||
149018056|NCT01474512|537547159|FG010|Induction Period|Withdrawal by Subject|0|||
149018057|NCT01474512|537547160|FG011|Induction Period|Withdrawal by Subject|0|||
149018058|NCT01474512|537547161|FG012|Induction Period|Withdrawal by Subject|0|||
149223931|NCT00702949|538284899|FG000|Overall Study|Refusal|3|||
149223932|NCT00702949|538284900|FG001|Overall Study|Refusal|2|||
149223933|NCT00702949|538284901|FG002|Overall Study|Refusal|2|||
149223934|NCT00702949|538284899|FG000|Overall Study|Adverse Event|1|||
149223935|NCT00702949|538284900|FG001|Overall Study|Adverse Event|6|||
149223936|NCT00702949|538284901|FG002|Overall Study|Adverse Event|3|||
149018059|NCT01474512|537547162|FG013|Induction Period|Withdrawal by Subject|0|||
149018060|NCT01474512|537547163|FG014|Induction Period|Withdrawal by Subject|0|||
149018061|NCT01474512|537547164|FG015|Induction Period|Withdrawal by Subject|0|||
149018062|NCT01474512|537547165|FG016|Induction Period|Withdrawal by Subject|0|||
149018063|NCT01474512|537547166|FG017|Induction Period|Withdrawal by Subject|0|||
149223937|NCT00702949|538284899|FG000|Overall Study|Other Medical Reason/unknown|1|||
149223938|NCT00702949|538284900|FG001|Overall Study|Other Medical Reason/unknown|1|||
149223939|NCT00702949|538284901|FG002|Overall Study|Other Medical Reason/unknown|3|||
149223940|NCT00135694|538284902|FG000|Overall Study|Adverse Event|17|||
149223941|NCT00135694|538284903|FG001|Overall Study|Adverse Event|4|||
149223942|NCT00135694|538284904|FG002|Overall Study|Adverse Event|0|||
149223943|NCT00135694|538284902|FG000|Overall Study|Death|14|||
149223944|NCT00135694|538284903|FG001|Overall Study|Death|1|||
149223945|NCT00135694|538284904|FG002|Overall Study|Death|2|||
149223946|NCT00135694|538284902|FG000|Overall Study|Lost to Follow-up|8|||
149223947|NCT00135694|538284903|FG001|Overall Study|Lost to Follow-up|7|||
149223948|NCT00135694|538284904|FG002|Overall Study|Lost to Follow-up|1|||
149223949|NCT00135694|538284902|FG000|Overall Study|Withdrawal by Subject|41|||
149223950|NCT00135694|538284903|FG001|Overall Study|Withdrawal by Subject|7|||
149223951|NCT00135694|538284904|FG002|Overall Study|Withdrawal by Subject|4|||
149223952|NCT00135694|538284902|FG000|Overall Study|Protocol Violation|19|||
149223953|NCT00135694|538284903|FG001|Overall Study|Protocol Violation|1|||
149223954|NCT00135694|538284904|FG002|Overall Study|Protocol Violation|0|||
149223955|NCT00135694|538284902|FG000|Overall Study|Hepatitis C related reasons|39|||
149223956|NCT00135694|538284903|FG001|Overall Study|Hepatitis C related reasons|1|||
149223957|NCT00135694|538284904|FG002|Overall Study|Hepatitis C related reasons|0|||
149223958|NCT00135694|538284902|FG000|Overall Study|Ineligible for Random assignment|42|||
149223959|NCT00135694|538284903|FG001|Overall Study|Ineligible for Random assignment|0|||
149223960|NCT00135694|538284904|FG002|Overall Study|Ineligible for Random assignment|0|||
149223961|NCT02584660|538284905|FG000|Overall Study|Adverse Event|4|||
149223962|NCT02584660|538284906|FG001|Overall Study|Adverse Event|0|||
149223963|NCT02584660|538284905|FG000|Overall Study|Lost to Follow-up|3|||
149018064|NCT01474512|537547149|FG000|Induction Period|Protocol Violation|3|||
149018065|NCT01474512|537547150|FG001|Induction Period|Protocol Violation|6|||
149018066|NCT01474512|537547151|FG002|Induction Period|Protocol Violation|0|||
149223964|NCT02584660|538284906|FG001|Overall Study|Lost to Follow-up|4|||
149223965|NCT02584660|538284905|FG000|Overall Study|Protocol Violation|0|||
149223966|NCT02584660|538284906|FG001|Overall Study|Protocol Violation|1|||
149223967|NCT02584660|538284905|FG000|Overall Study|Withdrawal by Subject|0|||
149223968|NCT02584660|538284906|FG001|Overall Study|Withdrawal by Subject|2|||
149223969|NCT02584660|538284905|FG000|Overall Study|Other|0|||
149223970|NCT02584660|538284906|FG001|Overall Study|Other|1|||
149223971|NCT00523744|538284907|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
149223972|NCT00523744|538284907|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
149223973|NCT00523744|538284907|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
149223974|NCT00523744|538284907|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
149018067|NCT01474512|537547152|FG003|Induction Period|Protocol Violation|0|||
149018068|NCT01474512|537547153|FG004|Induction Period|Protocol Violation|0|||
149223975|NCT00523744|538284907|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
149223976|NCT00523744|538284907|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
149223977|NCT02120469|538284910|FG000|Overall Study|HER-2/neu-amplified|1|||
149223978|NCT02120469|538284911|FG001|Overall Study|HER-2/neu-amplified|0|||
149223979|NCT02120469|538284912|FG002|Overall Study|HER-2/neu-amplified|1|||
149223980|NCT01040728|538284913|FG000|Overall Study|Adverse Event|4|||
149223981|NCT01040728|538284914|FG001|Overall Study|Adverse Event|8|||
149223982|NCT01040728|538284915|FG002|Overall Study|Adverse Event|0|||
149223983|NCT01040728|538284916|FG003|Overall Study|Adverse Event|4|||
149223984|NCT01040728|538284913|FG000|Overall Study|Withdrawal by Subject|0|||
149223985|NCT01040728|538284914|FG001|Overall Study|Withdrawal by Subject|1|||
149223986|NCT01040728|538284915|FG002|Overall Study|Withdrawal by Subject|1|||
149223987|NCT01040728|538284916|FG003|Overall Study|Withdrawal by Subject|0|||
149223988|NCT01040728|538284913|FG000|Overall Study|Protocol Violation|0|||
149223989|NCT01040728|538284914|FG001|Overall Study|Protocol Violation|0|||
149223990|NCT01040728|538284915|FG002|Overall Study|Protocol Violation|0|||
149223991|NCT01040728|538284916|FG003|Overall Study|Protocol Violation|1|||
149223992|NCT01040728|538284913|FG000|Overall Study|Lack of Efficacy|0|||
149223993|NCT01040728|538284914|FG001|Overall Study|Lack of Efficacy|1|||
149223994|NCT01040728|538284915|FG002|Overall Study|Lack of Efficacy|0|||
149223995|NCT01040728|538284916|FG003|Overall Study|Lack of Efficacy|1|||
149223996|NCT01040728|538284913|FG000|Overall Study|Other reasons not listed above|0|||
149223997|NCT01040728|538284914|FG001|Overall Study|Other reasons not listed above|1|||
149223998|NCT01040728|538284915|FG002|Overall Study|Other reasons not listed above|0|||
149223999|NCT01040728|538284916|FG003|Overall Study|Other reasons not listed above|0|||
149224000|NCT02583711|538284919|FG000|Overall Study|Withdrawal by Subject|0|||
149224001|NCT02583711|538284920|FG001|Overall Study|Withdrawal by Subject|10|||
149224002|NCT02583711|538284921|FG002|Overall Study|Withdrawal by Subject|0|||
149224003|NCT00281528|538284923|FG000|Overall Study|Progressive Disease|28|||
149224004|NCT00281528|538284924|FG001|Overall Study|Progressive Disease|18|||
149224005|NCT00281528|538284925|FG002|Overall Study|Progressive Disease|27|||
149224006|NCT00281528|538284923|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
149224007|NCT00281528|538284924|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
149224008|NCT00281528|538284925|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
149224009|NCT00281528|538284923|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
149224010|NCT00281528|538284924|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
149224011|NCT00281528|538284925|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
149224012|NCT00281528|538284923|FG000|Overall Study|Physician Decision|11|||
149224013|NCT00281528|538284924|FG001|Overall Study|Physician Decision|4|||
149224014|NCT00281528|538284925|FG002|Overall Study|Physician Decision|5|||
149224015|NCT00281528|538284923|FG000|Overall Study|Protocol Violation|1|||
149224016|NCT00281528|538284924|FG001|Overall Study|Protocol Violation|0|||
149224017|NCT00281528|538284925|FG002|Overall Study|Protocol Violation|1|||
149224018|NCT00281528|538284923|FG000|Overall Study|Withdrawal by Subject|5|||
149224019|NCT00281528|538284924|FG001|Overall Study|Withdrawal by Subject|5|||
149224020|NCT00281528|538284925|FG002|Overall Study|Withdrawal by Subject|7|||
149224021|NCT00281528|538284923|FG000|Overall Study|Other|6|||
149224022|NCT00281528|538284924|FG001|Overall Study|Other|3|||
149224023|NCT00281528|538284925|FG002|Overall Study|Other|5|||
149224024|NCT01711359|538284930|FG000|Treatment Period|Withdrawal by Subject|18|||
149224025|NCT01711359|538284931|FG001|Treatment Period|Withdrawal by Subject|7|||
149224026|NCT01711359|538284932|FG002|Treatment Period|Withdrawal by Subject|13|||
149224027|NCT01711359|538284930|FG000|Treatment Period|Lack of Efficacy|13|||
149224028|NCT01711359|538284931|FG001|Treatment Period|Lack of Efficacy|2|||
149224029|NCT01711359|538284932|FG002|Treatment Period|Lack of Efficacy|2|||
149224030|NCT01711359|538284930|FG000|Treatment Period|Adverse Event|8|||
149224031|NCT01711359|538284931|FG001|Treatment Period|Adverse Event|10|||
149224032|NCT01711359|538284932|FG002|Treatment Period|Adverse Event|24|||
149224033|NCT01711359|538284930|FG000|Treatment Period|Physician Decision|4|||
149224034|NCT01711359|538284931|FG001|Treatment Period|Physician Decision|3|||
149224035|NCT01711359|538284932|FG002|Treatment Period|Physician Decision|2|||
149224036|NCT01711359|538284930|FG000|Treatment Period|Death|3|||
149224037|NCT01711359|538284931|FG001|Treatment Period|Death|0|||
149224038|NCT01711359|538284932|FG002|Treatment Period|Death|0|||
149224039|NCT01711359|538284930|FG000|Treatment Period|Entry Criteria Not Met|1|||
149224040|NCT01711359|538284931|FG001|Treatment Period|Entry Criteria Not Met|0|||
149224041|NCT01711359|538284932|FG002|Treatment Period|Entry Criteria Not Met|0|||
149224042|NCT01711359|538284930|FG000|Treatment Period|Sponsor Decision|1|||
149224043|NCT01711359|538284931|FG001|Treatment Period|Sponsor Decision|0|||
149018069|NCT01474512|537547154|FG005|Induction Period|Protocol Violation|0|||
149018070|NCT01474512|537547155|FG006|Induction Period|Protocol Violation|0|||
149018071|NCT01474512|537547156|FG007|Induction Period|Protocol Violation|0|||
149018072|NCT01474512|537547157|FG008|Induction Period|Protocol Violation|0|||
149018073|NCT01474512|537547158|FG009|Induction Period|Protocol Violation|0|||
149018074|NCT01474512|537547159|FG010|Induction Period|Protocol Violation|0|||
149224044|NCT01711359|538284932|FG002|Treatment Period|Sponsor Decision|0|||
149224045|NCT01711359|538284930|FG000|Treatment Period|Lost to Follow-up|1|||
149224046|NCT01711359|538284931|FG001|Treatment Period|Lost to Follow-up|1|||
149224047|NCT01711359|538284932|FG002|Treatment Period|Lost to Follow-up|1|||
149224048|NCT01711359|538284930|FG000|Treatment Period|Randomized, Not Treated|3|||
149224049|NCT01711359|538284931|FG001|Treatment Period|Randomized, Not Treated|1|||
149224050|NCT01711359|538284932|FG002|Treatment Period|Randomized, Not Treated|0|||
149224051|NCT02698176|538284933|FG000|Overall Study|Progressive disease|4|||
149224052|NCT02698176|538284934|FG001|Overall Study|Progressive disease|3|||
149224053|NCT02698176|538284935|FG002|Overall Study|Progressive disease|1|||
149224054|NCT02698176|538284936|FG003|Overall Study|Progressive disease|0|||
149224055|NCT02698176|538284933|FG000|Overall Study|Adverse Event|2|||
149224056|NCT02698176|538284934|FG001|Overall Study|Adverse Event|0|||
149224057|NCT02698176|538284935|FG002|Overall Study|Adverse Event|0|||
149224058|NCT02698176|538284936|FG003|Overall Study|Adverse Event|0|||
149224059|NCT02698176|538284933|FG000|Overall Study|Clinical progression|3|||
149224060|NCT02698176|538284934|FG001|Overall Study|Clinical progression|0|||
149224061|NCT02698176|538284935|FG002|Overall Study|Clinical progression|0|||
149224062|NCT02698176|538284936|FG003|Overall Study|Clinical progression|0|||
149224063|NCT00805142|538284937|FG000|Titration Period|Adverse Event|3|||
149224064|NCT00805142|538284938|FG001|Titration Period|Adverse Event|3|||
149224065|NCT00805142|538284937|FG000|Titration Period|Lack of Efficacy|1|||
149224066|NCT00805142|538284938|FG001|Titration Period|Lack of Efficacy|1|||
149224067|NCT00805142|538284937|FG000|Titration Period|Lost to Follow-up|0|||
149224068|NCT00805142|538284938|FG001|Titration Period|Lost to Follow-up|1|||
149224069|NCT00805142|538284937|FG000|Titration Period|Disease Progression|2|||
149224070|NCT00805142|538284938|FG001|Titration Period|Disease Progression|1|||
149224071|NCT00805142|538284937|FG000|Titration Period|Withdrawal of consent|0|||
149224072|NCT00805142|538284938|FG001|Titration Period|Withdrawal of consent|1|||
149224073|NCT00805142|538284937|FG000|Titration Period|Other|0|||
149224074|NCT00805142|538284938|FG001|Titration Period|Other|3|||
149224075|NCT00805142|538284937|FG000|Maintenance Period|Adverse Event|0|||
149224076|NCT00805142|538284938|FG001|Maintenance Period|Adverse Event|1|||
149224077|NCT00805142|538284937|FG000|Maintenance Period|Other|0|||
149224078|NCT00805142|538284938|FG001|Maintenance Period|Other|1|||
149224079|NCT00286156|538286398|FG000|Overall Study|Missed 12 month visit|0|||
149224080|NCT00286156|538286399|FG001|Overall Study|Missed 12 month visit|0|||
149224081|NCT00286156|538286400|FG002|Overall Study|Missed 12 month visit|1|||
149224082|NCT00286156|538286398|FG000|Overall Study|AE: pulmonary embolus|0|||
149224083|NCT00286156|538286399|FG001|Overall Study|AE: pulmonary embolus|1|||
149224084|NCT00286156|538286400|FG002|Overall Study|AE: pulmonary embolus|0|||
149224085|NCT00286156|538286398|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
149224086|NCT00286156|538286399|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
149224087|NCT00286156|538286400|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
149224088|NCT00286156|538286398|FG000|Overall Study|AE: pneumonia|1|||
148687036|NCT04604184|536327314|FG000|Overall Study|Withdrawal by Subject|1|||
149224089|NCT00286156|538286399|FG001|Overall Study|AE: pneumonia|0|||
149224090|NCT00286156|538286400|FG002|Overall Study|AE: pneumonia|0|||
149018075|NCT01474512|537547160|FG011|Induction Period|Protocol Violation|0|||
149224091|NCT01060150|538286406|FG000|Overall Study|Adverse Event|6|||
148687037|NCT04604184|536327315|FG001|Overall Study|Withdrawal by Subject|3|||
148687038|NCT04604184|536327314|FG000|Overall Study|Not treated|2|||
148687039|NCT04604184|536327315|FG001|Overall Study|Not treated|2|||
149224092|NCT01060150|538286406|FG000|Overall Study|Lost to Follow-up|1|||
149224093|NCT01060150|538286406|FG000|Overall Study|Protocol Violation|6|||
149224094|NCT01060150|538286406|FG000|Overall Study|Withdrawal by Subject|8|||
149224095|NCT01060150|538286406|FG000|Overall Study|Enrolled, but not treated|2|||
149224096|NCT02516306|538286407|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
149224097|NCT02516306|538286408|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
149224098|NCT00256204|538286419|FG000|Overall Study|Adverse Event|10|||
149224099|NCT00256204|538286420|FG001|Overall Study|Adverse Event|14|||
149224100|NCT00256204|538286421|FG002|Overall Study|Adverse Event|16|||
149224101|NCT00256204|538286422|FG003|Overall Study|Adverse Event|14|||
149224102|NCT00256204|538286419|FG000|Overall Study|Death|0|||
149224103|NCT00256204|538286420|FG001|Overall Study|Death|1|||
149224104|NCT00256204|538286421|FG002|Overall Study|Death|0|||
149224105|NCT00256204|538286422|FG003|Overall Study|Death|0|||
149224106|NCT00256204|538286419|FG000|Overall Study|Lost to Follow-up|1|||
149224107|NCT00256204|538286420|FG001|Overall Study|Lost to Follow-up|1|||
148687040|NCT04604184|536327314|FG000|Overall Study|Due to sponsor decision|9|||
149224108|NCT00256204|538286421|FG002|Overall Study|Lost to Follow-up|1|||
148687041|NCT04604184|536327315|FG001|Overall Study|Due to sponsor decision|7|||
148810101|NCT02097277|536782547|FG003|Overall Study|Adverse Event|2|||
149224109|NCT00256204|538286422|FG003|Overall Study|Lost to Follow-up|2|||
149224110|NCT00256204|538286419|FG000|Overall Study|Protocol Violation|1|||
149224111|NCT00256204|538286420|FG001|Overall Study|Protocol Violation|0|||
149224112|NCT00256204|538286421|FG002|Overall Study|Protocol Violation|2|||
149224113|NCT00256204|538286422|FG003|Overall Study|Protocol Violation|1|||
149224114|NCT00256204|538286419|FG000|Overall Study|Physician Decision|0|||
149224115|NCT00256204|538286420|FG001|Overall Study|Physician Decision|0|||
149224116|NCT00256204|538286421|FG002|Overall Study|Physician Decision|1|||
149224117|NCT00256204|538286422|FG003|Overall Study|Physician Decision|2|||
149224118|NCT00256204|538286419|FG000|Overall Study|Withdrawal by Subject|17|||
149224119|NCT00256204|538286420|FG001|Overall Study|Withdrawal by Subject|6|||
149224120|NCT00256204|538286421|FG002|Overall Study|Withdrawal by Subject|7|||
149224121|NCT00256204|538286422|FG003|Overall Study|Withdrawal by Subject|5|||
149224122|NCT00256204|538286419|FG000|Overall Study|Need for additional prohibited treatment|38|||
149224123|NCT00256204|538286420|FG001|Overall Study|Need for additional prohibited treatment|28|||
149224124|NCT00256204|538286421|FG002|Overall Study|Need for additional prohibited treatment|27|||
149224125|NCT00256204|538286422|FG003|Overall Study|Need for additional prohibited treatment|25|||
149224126|NCT01566981|538286423|FG000|Overall Study|Lost to Follow-up|5|||
149224127|NCT01566981|538286424|FG001|Overall Study|Lost to Follow-up|8|||
149224128|NCT02177942|538286425|FG000|Overall Study|Adverse Event|1|||
149224129|NCT02177942|538286426|FG001|Overall Study|Adverse Event|0|||
149224130|NCT02177942|538286425|FG000|Overall Study|Lost to Follow-up|1|||
148687042|NCT04604184|536327314|FG000|Overall Study|Physician Decision|0|||
148687043|NCT04604184|536327315|FG001|Overall Study|Physician Decision|1|||
149224131|NCT02177942|538286426|FG001|Overall Study|Lost to Follow-up|1|||
149224132|NCT02177942|538286425|FG000|Overall Study|Protocol Violation|4|||
149224133|NCT02177942|538286426|FG001|Overall Study|Protocol Violation|6|||
149224134|NCT02177942|538286425|FG000|Overall Study|Withdrawal by Subject|71|||
149224135|NCT02177942|538286426|FG001|Overall Study|Withdrawal by Subject|81|||
149224136|NCT01351415|538286427|FG000|Overall Study|Withdrawal by Subject|15|||
149224137|NCT01351415|538286428|FG001|Overall Study|Withdrawal by Subject|17|||
149224138|NCT01351415|538286427|FG000|Overall Study|Trial termination by the Sponsor|28|||
149224139|NCT01351415|538286428|FG001|Overall Study|Trial termination by the Sponsor|19|||
149224140|NCT01351415|538286427|FG000|Overall Study|Lost to Follow-up|5|||
149224141|NCT01351415|538286428|FG001|Overall Study|Lost to Follow-up|7|||
149224142|NCT01351415|538286427|FG000|Overall Study|Death|190|||
149224143|NCT01351415|538286428|FG001|Overall Study|Death|187|||
149224144|NCT01351415|538286427|FG000|Overall Study|Physician Decision|2|||
149224145|NCT01351415|538286428|FG001|Overall Study|Physician Decision|3|||
149224146|NCT01351415|538286427|FG000|Overall Study|Reason unknown|0|||
149224147|NCT01351415|538286428|FG001|Overall Study|Reason unknown|2|||
149224148|NCT01351415|538286427|FG000|Overall Study|Never Started|5|||
149224149|NCT01351415|538286428|FG001|Overall Study|Never Started|5|||
149224150|NCT01234337|538286429|FG000|Overall Study|Adverse Event|58|||
149224151|NCT01234337|538286430|FG001|Overall Study|Adverse Event|21|||
149224152|NCT01234337|538286429|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
149224153|NCT01234337|538286430|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
149224154|NCT01234337|538286429|FG000|Overall Study|Investi. decision not protocol driven|5|||
149224155|NCT01234337|538286430|FG001|Overall Study|Investi. decision not protocol driven|6|||
149224156|NCT01234337|538286429|FG000|Overall Study|Non-compliant with study medication|3|||
149224157|NCT01234337|538286430|FG001|Overall Study|Non-compliant with study medication|2|||
149224158|NCT01234337|538286429|FG000|Overall Study|Randomized but not treated|6|||
149224159|NCT01234337|538286430|FG001|Overall Study|Randomized but not treated|4|||
149224160|NCT01234337|538286429|FG000|Overall Study|Lost to Follow-up|0|||
149224161|NCT01234337|538286430|FG001|Overall Study|Lost to Follow-up|1|||
149224162|NCT01234337|538286429|FG000|Overall Study|Protocol Violation|2|||
149224163|NCT01234337|538286430|FG001|Overall Study|Protocol Violation|3|||
149224164|NCT01234337|538286429|FG000|Overall Study|Withdrawal by Subject|11|||
149224165|NCT01234337|538286430|FG001|Overall Study|Withdrawal by Subject|9|||
149224166|NCT01234337|538286429|FG000|Overall Study|Death|0|||
149224167|NCT01234337|538286430|FG001|Overall Study|Death|1|||
149224168|NCT01234337|538286429|FG000|Overall Study|Switch to commercial drug|0|||
149224169|NCT01234337|538286430|FG001|Overall Study|Switch to commercial drug|1|||
149224170|NCT03525613|538286437|FG000|Overall Study|Adverse Event|11|||
149224171|NCT03525613|538286438|FG001|Overall Study|Adverse Event|8|||
149224172|NCT03525613|538286439|FG002|Overall Study|Adverse Event|3|||
149224173|NCT03525613|538286440|FG003|Overall Study|Adverse Event|3|||
149224174|NCT03525613|538286437|FG000|Overall Study|Lost to Follow-up|4|||
148687044|NCT04604184|536327314|FG000|Overall Study|Transfer to healthcare|1|||
148687045|NCT04604184|536327315|FG001|Overall Study|Transfer to healthcare|0|||
148687046|NCT00582036|536327316|FG000|Overall Study|Withdrawal by Subject|0|||
148687047|NCT00582036|536327317|FG001|Overall Study|Withdrawal by Subject|1|||
148687048|NCT02711956|536327318|FG000|Overall Study|Adverse Event|0|||
148687049|NCT02711956|536327319|FG001|Overall Study|Adverse Event|0|||
148687050|NCT02711956|536327320|FG002|Overall Study|Adverse Event|0|||
149224175|NCT03525613|538286438|FG001|Overall Study|Lost to Follow-up|5|||
149224176|NCT03525613|538286439|FG002|Overall Study|Lost to Follow-up|3|||
149224177|NCT03525613|538286440|FG003|Overall Study|Lost to Follow-up|2|||
149224178|NCT03525613|538286437|FG000|Overall Study|Physician Decision|0|||
149224179|NCT03525613|538286438|FG001|Overall Study|Physician Decision|1|||
149224180|NCT03525613|538286439|FG002|Overall Study|Physician Decision|0|||
149224181|NCT03525613|538286440|FG003|Overall Study|Physician Decision|1|||
149224182|NCT03525613|538286437|FG000|Overall Study|Consent Withdrawal|25|||
149224183|NCT03525613|538286438|FG001|Overall Study|Consent Withdrawal|16|||
149224184|NCT03525613|538286439|FG002|Overall Study|Consent Withdrawal|12|||
149224185|NCT03525613|538286440|FG003|Overall Study|Consent Withdrawal|9|||
149224186|NCT03525613|538286437|FG000|Overall Study|Death|20|||
149224187|NCT03525613|538286438|FG001|Overall Study|Death|9|||
149224188|NCT03525613|538286439|FG002|Overall Study|Death|7|||
149224189|NCT03525613|538286440|FG003|Overall Study|Death|1|||
149224190|NCT03525613|538286437|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
149224191|NCT03525613|538286438|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
149224192|NCT03525613|538286439|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
149224193|NCT03525613|538286440|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
149224194|NCT03480360|538286441|FG000|Overall Study|Death|2|||
149224195|NCT00374452|538286444|FG000|Overall Study|Left clinic before intervention started|4|||
149224196|NCT00374452|538286445|FG001|Overall Study|Left clinic before intervention started|1|||
149224197|NCT00374452|538286444|FG000|Overall Study|Change in job role before intervention|0|||
149224198|NCT00374452|538286445|FG001|Overall Study|Change in job role before intervention|1|||
149224199|NCT00374452|538286444|FG000|Overall Study|Left clinic after intervention started|1|||
149224200|NCT00374452|538286445|FG001|Overall Study|Left clinic after intervention started|1|||
149224201|NCT00374452|538286444|FG000|Overall Study|Withdrawal by Subject|0|||
149224202|NCT00374452|538286445|FG001|Overall Study|Withdrawal by Subject|2|||
149224203|NCT03117309|538286450|FG000|Overall Study|Not meeting inclusion criteria|0|||
149224204|NCT03117309|538286451|FG001|Overall Study|Not meeting inclusion criteria|1|||
149224205|NCT00590031|538286453|FG000|Overall Study|Adverse Event|3|||
149224206|NCT00590031|538286453|FG000|Overall Study|Withdrawal by Subject|1|||
149224207|NCT00590031|538286453|FG000|Overall Study|Metastatic Disease|1|||
149224208|NCT00590031|538286453|FG000|Overall Study|Admin Hold|1|||
149224209|NCT01610414|538286454|FG000|Study Start - Month 13|Serious Adverse Event|65|||
149224210|NCT01610414|538286455|FG001|Study Start - Month 13|Serious Adverse Event|67|||
149224211|NCT01610414|538286454|FG000|Study Start - Month 13|Adverse Event|14|||
149224212|NCT01610414|538286455|FG001|Study Start - Month 13|Adverse Event|14|||
149224213|NCT01610414|538286454|FG000|Study Start - Month 13|Protocol Violation|3|||
149224214|NCT01610414|538286455|FG001|Study Start - Month 13|Protocol Violation|1|||
149224215|NCT01610414|538286454|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
149224216|NCT01610414|538286455|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
149224217|NCT01610414|538286454|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
149224218|NCT01610414|538286455|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
149224219|NCT01610414|538286454|FG000|Study Start - Month 13|Lost to Follow-up|4|||
149224220|NCT01610414|538286455|FG001|Study Start - Month 13|Lost to Follow-up|6|||
149224221|NCT01610414|538286454|FG000|Study Start - Month 13|Suspected HZ episode|1|||
149224222|NCT01610414|538286455|FG001|Study Start - Month 13|Suspected HZ episode|3|||
149224223|NCT01610414|538286454|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
149224224|NCT01610414|538286455|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
149224225|NCT01610414|538286454|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
149224226|NCT01610414|538286455|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
149224227|NCT01610414|538286454|FG000|Month 13 - Month 25|Adverse Event|8|||
149224228|NCT01610414|538286455|FG001|Month 13 - Month 25|Adverse Event|4|||
149224229|NCT01610414|538286454|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
149224230|NCT01610414|538286455|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
149224231|NCT01610414|538286454|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
149224232|NCT01610414|538286455|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
148687051|NCT02711956|536327321|FG003|Overall Study|Adverse Event|1|||
148687052|NCT02711956|536327322|FG004|Overall Study|Adverse Event|2|||
148687053|NCT02711956|536327323|FG005|Overall Study|Adverse Event|0|||
148687054|NCT02711956|536327324|FG006|Overall Study|Adverse Event|0|||
148687055|NCT02711956|536327325|FG007|Overall Study|Adverse Event|1|||
148687056|NCT02711956|536327326|FG008|Overall Study|Adverse Event|1|||
149224233|NCT01610414|538286454|FG000|Month 13 - Month 25|Protocol Violation|0|||
149224234|NCT01610414|538286455|FG001|Month 13 - Month 25|Protocol Violation|2|||
149224235|NCT01610414|538286454|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
149224236|NCT01610414|538286455|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
149224237|NCT01610414|538286454|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
149224238|NCT01610414|538286455|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
148953738|NCT04326231|537313099|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
148953739|NCT02927431|537313104|FG000|Overall Study|Withdrawal by Subject|0|||
148953740|NCT02927431|537313105|FG001|Overall Study|Withdrawal by Subject|0|||
148953741|NCT02927431|537313106|FG002|Overall Study|Withdrawal by Subject|1|||
148953742|NCT01285310|537313107|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
149224239|NCT01610414|538286454|FG000|After Month 25|Study end not reached|48|||
149224240|NCT01610414|538286455|FG001|After Month 25|Study end not reached|53|||
149224241|NCT00472043|538286463|FG000|Overall Study|Withdrawal by Subject|1|||
149224242|NCT00472043|538286464|FG001|Overall Study|Withdrawal by Subject|0|||
149224243|NCT00472043|538286463|FG000|Overall Study|Death|1|||
149224244|NCT00472043|538286464|FG001|Overall Study|Death|0|||
149224245|NCT00826540|538286466|FG000|Overall Study|ineligible|3|||
149224246|NCT00826540|538286466|FG000|Overall Study|Withdrawal by Subject|1|||
149224247|NCT01166386|538286467|FG000|Overall Study|Withdrawal by Subject|3|||
149224248|NCT01166386|538286468|FG001|Overall Study|Withdrawal by Subject|5|||
149224249|NCT03922711|538286471|FG000|Overall Study|Adverse Event|3|||
149224250|NCT03922711|538286472|FG001|Overall Study|Adverse Event|2|||
149224251|NCT03922711|538286473|FG002|Overall Study|Adverse Event|2|||
149224252|NCT03922711|538286471|FG000|Overall Study|Protocol Violation|1|||
149224253|NCT03922711|538286472|FG001|Overall Study|Protocol Violation|0|||
149224254|NCT03922711|538286473|FG002|Overall Study|Protocol Violation|0|||
149224255|NCT03922711|538286471|FG000|Overall Study|Withdrawal by Subject|0|||
149224256|NCT03922711|538286472|FG001|Overall Study|Withdrawal by Subject|3|||
149224257|NCT03922711|538286473|FG002|Overall Study|Withdrawal by Subject|1|||
149224258|NCT03922711|538286471|FG000|Overall Study|Not further specified|0|||
149224259|NCT03922711|538286472|FG001|Overall Study|Not further specified|0|||
149224260|NCT03922711|538286473|FG002|Overall Study|Not further specified|1|||
149224261|NCT02390362|538286476|FG000|Overall Study|Withdrawal by Subject|0|||
149224262|NCT02390362|538286477|FG001|Overall Study|Withdrawal by Subject|1|||
149224263|NCT04009824|538286478|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
149224264|NCT04009824|538286479|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
149224265|NCT04009824|538286480|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
149224266|NCT04009824|538286481|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
149224267|NCT04009824|538286482|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
149224268|NCT03032523|538286483|FG000|Overall Study|Withdrawal by Subject|2|||
149224269|NCT03032523|538286484|FG001|Overall Study|Withdrawal by Subject|2|||
149224270|NCT03032523|538286483|FG000|Overall Study|Physician Decision|1|||
149224271|NCT03032523|538286484|FG001|Overall Study|Physician Decision|0|||
149224272|NCT05375838|538286485|FG000|Overall Study|Other|0|||
149224273|NCT05375838|538286486|FG001|Overall Study|Other|0|||
149224274|NCT05375838|538286487|FG002|Overall Study|Other|0|||
149224275|NCT05375838|538286488|FG003|Overall Study|Other|1|||
149224276|NCT05375838|538286489|FG004|Overall Study|Other|1|||
149224277|NCT05375838|538286490|FG005|Overall Study|Other|0|||
149224278|NCT05375838|538286485|FG000|Overall Study|Withdrawal by Subject|2|||
149224279|NCT05375838|538286486|FG001|Overall Study|Withdrawal by Subject|1|||
149224280|NCT05375838|538286487|FG002|Overall Study|Withdrawal by Subject|3|||
149224281|NCT05375838|538286488|FG003|Overall Study|Withdrawal by Subject|2|||
149224282|NCT05375838|538286489|FG004|Overall Study|Withdrawal by Subject|2|||
149224283|NCT05375838|538286490|FG005|Overall Study|Withdrawal by Subject|0|||
149224284|NCT05375838|538286485|FG000|Overall Study|Protocol Violation|0|||
149224285|NCT05375838|538286486|FG001|Overall Study|Protocol Violation|0|||
149224286|NCT05375838|538286487|FG002|Overall Study|Protocol Violation|0|||
149224287|NCT05375838|538286488|FG003|Overall Study|Protocol Violation|0|||
149224288|NCT05375838|538286489|FG004|Overall Study|Protocol Violation|1|||
149224289|NCT05375838|538286490|FG005|Overall Study|Protocol Violation|0|||
149224290|NCT05375838|538286485|FG000|Overall Study|Physician Decision|0|||
149224291|NCT05375838|538286486|FG001|Overall Study|Physician Decision|1|||
149224292|NCT05375838|538286487|FG002|Overall Study|Physician Decision|0|||
149224293|NCT05375838|538286488|FG003|Overall Study|Physician Decision|0|||
149224294|NCT05375838|538286489|FG004|Overall Study|Physician Decision|0|||
149224295|NCT05375838|538286490|FG005|Overall Study|Physician Decision|1|||
149224296|NCT05375838|538286485|FG000|Overall Study|Lost to Follow-up|2|||
149224297|NCT05375838|538286486|FG001|Overall Study|Lost to Follow-up|7|||
149224298|NCT05375838|538286487|FG002|Overall Study|Lost to Follow-up|0|||
149224299|NCT05375838|538286488|FG003|Overall Study|Lost to Follow-up|4|||
149224300|NCT05375838|538286489|FG004|Overall Study|Lost to Follow-up|2|||
149224301|NCT05375838|538286490|FG005|Overall Study|Lost to Follow-up|3|||
149224302|NCT02178592|538286491|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
149224303|NCT02178592|538286492|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
149224304|NCT02178592|538286491|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
149224305|NCT02178592|538286492|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
149224306|NCT02178592|538286491|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
149224307|NCT02178592|538286492|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
149224308|NCT02178592|538286491|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
149224309|NCT02178592|538286492|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
149224310|NCT02178592|538286491|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
149224311|NCT02178592|538286492|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
149224312|NCT02178592|538286491|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
149224313|NCT02178592|538286492|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
149224314|NCT02178592|538286491|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
149224315|NCT02178592|538286492|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
149224316|NCT02178592|538286491|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
149224317|NCT02178592|538286492|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
149224318|NCT02178592|538286491|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
149224319|NCT02178592|538286492|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
149224320|NCT02178592|538286491|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
149224321|NCT02178592|538286492|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
149224322|NCT02178592|538286491|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
149224323|NCT02178592|538286492|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
149224324|NCT02178592|538286491|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
149224325|NCT02178592|538286492|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
149224326|NCT02975206|538286494|FG000|Overall Study|Withdrawal by Subject|14|||
149224327|NCT02975206|538286495|FG001|Overall Study|Withdrawal by Subject|11|||
149224328|NCT02975206|538286496|FG002|Overall Study|Withdrawal by Subject|11|||
149224329|NCT02975206|538286494|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
149224330|NCT02975206|538286495|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
149224331|NCT02975206|538286496|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
149224332|NCT01981096|538286497|FG000|Overall Study|Parent illness|1|||
149224333|NCT01981096|538286498|FG001|Overall Study|Parent illness|0|||
149224334|NCT01981096|538286497|FG000|Overall Study|Withdrawal by Subject|0|||
149224335|NCT01981096|538286498|FG001|Overall Study|Withdrawal by Subject|1|||
149224336|NCT01981096|538286497|FG000|Overall Study|Lost to Follow-up|2|||
149224337|NCT01981096|538286498|FG001|Overall Study|Lost to Follow-up|0|||
149224338|NCT01225211|538286499|FG000|Overall Study|Adverse Event|0|||
149224339|NCT01225211|538286500|FG001|Overall Study|Adverse Event|0|||
149224340|NCT01225211|538286501|FG002|Overall Study|Adverse Event|1|||
149224341|NCT01225211|538286502|FG003|Overall Study|Adverse Event|0|||
149224342|NCT01225211|538286503|FG004|Overall Study|Adverse Event|0|||
149224343|NCT01225211|538286504|FG005|Overall Study|Adverse Event|0|||
149224344|NCT01225211|538286505|FG006|Overall Study|Adverse Event|0|||
149224345|NCT01225211|538286506|FG007|Overall Study|Adverse Event|0|||
149224346|NCT01225211|538286507|FG008|Overall Study|Adverse Event|0|||
149224347|NCT01225211|538286508|FG009|Overall Study|Adverse Event|1|||
149224348|NCT01225211|538286499|FG000|Overall Study|Withdrawal by Subject|0|||
149224349|NCT01225211|538286500|FG001|Overall Study|Withdrawal by Subject|0|||
149224350|NCT01225211|538286501|FG002|Overall Study|Withdrawal by Subject|0|||
149224351|NCT01225211|538286502|FG003|Overall Study|Withdrawal by Subject|0|||
149224352|NCT01225211|538286503|FG004|Overall Study|Withdrawal by Subject|0|||
149224353|NCT01225211|538286504|FG005|Overall Study|Withdrawal by Subject|0|||
149224354|NCT01225211|538286505|FG006|Overall Study|Withdrawal by Subject|1|||
149224355|NCT01225211|538286506|FG007|Overall Study|Withdrawal by Subject|0|||
149224356|NCT01225211|538286507|FG008|Overall Study|Withdrawal by Subject|1|||
149224357|NCT01225211|538286508|FG009|Overall Study|Withdrawal by Subject|3|||
149224358|NCT01225211|538286499|FG000|Overall Study|Other|0|||
149224359|NCT01225211|538286500|FG001|Overall Study|Other|0|||
149224360|NCT01225211|538286501|FG002|Overall Study|Other|0|||
149224361|NCT01225211|538286502|FG003|Overall Study|Other|0|||
149224362|NCT01225211|538286503|FG004|Overall Study|Other|0|||
149224363|NCT01225211|538286504|FG005|Overall Study|Other|0|||
149224364|NCT01225211|538286505|FG006|Overall Study|Other|0|||
149224365|NCT01225211|538286506|FG007|Overall Study|Other|0|||
149224366|NCT01225211|538286507|FG008|Overall Study|Other|0|||
149224367|NCT01225211|538286508|FG009|Overall Study|Other|1|||
149224368|NCT01984294|538286513|FG000|Overall Study|Randomized but Never Treated|0|||
149224369|NCT01984294|538286514|FG001|Overall Study|Randomized but Never Treated|0|||
149224370|NCT01984294|538286515|FG002|Overall Study|Randomized but Never Treated|1|||
149224371|NCT01984294|538286513|FG000|Overall Study|Lack of Efficacy|4|||
149224372|NCT01984294|538286514|FG001|Overall Study|Lack of Efficacy|2|||
149224373|NCT01984294|538286515|FG002|Overall Study|Lack of Efficacy|6|||
149224374|NCT01984294|538286513|FG000|Overall Study|Adverse Event|0|||
149224375|NCT01984294|538286514|FG001|Overall Study|Adverse Event|1|||
149224376|NCT01984294|538286515|FG002|Overall Study|Adverse Event|0|||
149224377|NCT00392210|538286517|FG000|First Voiding Trial|Physician Decision|2|||
149224378|NCT00392210|538286518|FG001|First Voiding Trial|Physician Decision|2|||
149224379|NCT02067104|538286519|FG000|Overall Study|Study termination due to low accrual|4|||
149224380|NCT02067104|538286520|FG001|Overall Study|Study termination due to low accrual|5|||
149224381|NCT01987609|538286521|FG000|Overall Study|Adverse Event|1|||
149224382|NCT02610231|538286522|FG000|Overall Study|Withdrawal by Subject|27|||
149224383|NCT02610231|538286522|FG000|Overall Study|Adverse Event|20|||
149224384|NCT02610231|538286522|FG000|Overall Study|Death|5|||
149224385|NCT02610231|538286522|FG000|Overall Study|Surgery|2|||
149224386|NCT02610231|538286522|FG000|Overall Study|Physician Decision|1|||
149224387|NCT02610231|538286522|FG000|Overall Study|Non Compliance|2|||
149224388|NCT02610231|538286522|FG000|Overall Study|Other|3|||
149224389|NCT01279954|538286530|FG000|Overall Study|Lack of Efficacy|3|||
149224390|NCT01279954|538286531|FG001|Overall Study|Lack of Efficacy|4|||
149224391|NCT01385098|538286534|FG000|Overall Study|Adverse Event|10|||
149224392|NCT01385098|538286534|FG000|Overall Study|Lost to Follow-up|4|||
149224393|NCT00554840|538286535|FG000|Overall Study|Physician Decision|0|||
149224394|NCT00554840|538286536|FG001|Overall Study|Physician Decision|1|||
149224395|NCT02561572|538286539|FG000|Overall Study|Inadequate time before surgery|2|||
149224396|NCT02561572|538286540|FG001|Overall Study|Inadequate time before surgery|1|||
149224397|NCT02561572|538286539|FG000|Overall Study|Protocol Violation|0|||
149224398|NCT02561572|538286540|FG001|Overall Study|Protocol Violation|1|||
149224399|NCT02691468|538286543|FG000|Overall Study|Bronchial blocker use|2|||
149224400|NCT02691468|538286544|FG001|Overall Study|Bronchial blocker use|1|||
149224401|NCT02691468|538286543|FG000|Overall Study|Lost to Follow-up|2|||
149224402|NCT02691468|538286544|FG001|Overall Study|Lost to Follow-up|1|||
149224403|NCT02691468|538286543|FG000|Overall Study|Failure to advance FOB|2|||
149224404|NCT02691468|538286544|FG001|Overall Study|Failure to advance FOB|0|||
149224405|NCT00410514|538286545|FG000|Overall Study|Adverse Event|2|||
149224406|NCT00410514|538286546|FG001|Overall Study|Adverse Event|2|||
149224407|NCT00410514|538286547|FG002|Overall Study|Adverse Event|2|||
149224408|NCT00410514|538286545|FG000|Overall Study|Protocol Violation|0|||
149224409|NCT00410514|538286546|FG001|Overall Study|Protocol Violation|1|||
149224410|NCT00410514|538286547|FG002|Overall Study|Protocol Violation|1|||
149224411|NCT00410514|538286545|FG000|Overall Study|Lost to Follow-up|0|||
149224412|NCT00410514|538286546|FG001|Overall Study|Lost to Follow-up|0|||
149224413|NCT00410514|538286547|FG002|Overall Study|Lost to Follow-up|2|||
149224414|NCT00410514|538286545|FG000|Overall Study|Non-compliant with study procedures|0|||
149224415|NCT00410514|538286546|FG001|Overall Study|Non-compliant with study procedures|0|||
149224416|NCT00410514|538286547|FG002|Overall Study|Non-compliant with study procedures|2|||
149224417|NCT01021423|538286548|FG000|Overall Study|Study terminated|4|||
149224418|NCT01021423|538286549|FG001|Overall Study|Study terminated|5|||
149224419|NCT02886338|538286550|FG000|Overall Study|Withdrawal by Subject|1|||
149224420|NCT00394654|538286551|FG000|Overall Study|Lost to Follow-up|1|||
149224421|NCT00394654|538286552|FG001|Overall Study|Lost to Follow-up|0|||
149224422|NCT00394654|538286551|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
149224423|NCT00394654|538286552|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
149224424|NCT00122317|538286553|FG000|Overall Study|Death|3|||
149224425|NCT00122317|538286553|FG000|Overall Study|Adverse Event|4|||
149224426|NCT00122317|538286553|FG000|Overall Study|Physician Decision|2|||
149224427|NCT00122317|538286553|FG000|Overall Study|patient non-compliance|1|||
149224428|NCT00122317|538286553|FG000|Overall Study|Withdrawal by Subject|1|||
149224429|NCT03756285|538286555|FG000|Overall Study|Lost to Follow-up|0|||
149224430|NCT03756285|538286556|FG001|Overall Study|Lost to Follow-up|1|||
149224431|NCT03756285|538286555|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
149224432|NCT03756285|538286556|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
149224433|NCT03756285|538286555|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
149224434|NCT03756285|538286556|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
149224435|NCT06334055|538286557|FG000|Overall Study|Adverse Event|4|||
149224436|NCT06334055|538286557|FG000|Overall Study|Disqualified|72|||
149224437|NCT00424463|538286558|FG000|Overall Study|Adverse Event|2|||
149224438|NCT00424463|538286559|FG001|Overall Study|Adverse Event|3|||
149224439|NCT00424463|538286560|FG002|Overall Study|Adverse Event|2|||
149224440|NCT00424463|538286558|FG000|Overall Study|Physician Decision|0|||
149224441|NCT00424463|538286559|FG001|Overall Study|Physician Decision|2|||
149224442|NCT00424463|538286560|FG002|Overall Study|Physician Decision|2|||
149224443|NCT00424463|538286558|FG000|Overall Study|Withdrawal by Subject|4|||
149224444|NCT00424463|538286559|FG001|Overall Study|Withdrawal by Subject|2|||
149224445|NCT00424463|538286560|FG002|Overall Study|Withdrawal by Subject|5|||
149224446|NCT00424463|538286558|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
149224447|NCT00424463|538286559|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
149224448|NCT00424463|538286560|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
149224449|NCT00424463|538286558|FG000|Overall Study|Patient's convenience|0|||
149224450|NCT00424463|538286559|FG001|Overall Study|Patient's convenience|0|||
149224451|NCT00424463|538286560|FG002|Overall Study|Patient's convenience|1|||
149224452|NCT02449915|538286561|FG000|Overall Study|Exclusion criteria - drug use|1|||
149224453|NCT02449915|538286562|FG001|Overall Study|Exclusion criteria - drug use|0|||
149224454|NCT02449915|538286561|FG000|Overall Study|Withdrawal by Subject|0|||
149224455|NCT02449915|538286562|FG001|Overall Study|Withdrawal by Subject|2|||
149224456|NCT02449915|538286561|FG000|Overall Study|Intraoperative surgical findings|1|||
149224457|NCT02449915|538286562|FG001|Overall Study|Intraoperative surgical findings|1|||
149224458|NCT02449915|538286561|FG000|Overall Study|Abnormal preop lab|0|||
149224459|NCT02449915|538286562|FG001|Overall Study|Abnormal preop lab|1|||
148810102|NCT02097277|536782548|FG004|Overall Study|Adverse Event|0|||
149224460|NCT01021293|538286566|FG000|Overall Study|Serious Adverse Event|2|||
149224461|NCT01021293|538286567|FG001|Overall Study|Serious Adverse Event|1|||
149224462|NCT01021293|538286566|FG000|Overall Study|Adverse Event|2|||
149224463|NCT01021293|538286567|FG001|Overall Study|Adverse Event|1|||
149224464|NCT01021293|538286566|FG000|Overall Study|Withdrawal by Subject|1|||
149224465|NCT01021293|538286567|FG001|Overall Study|Withdrawal by Subject|3|||
149224466|NCT01021293|538286566|FG000|Overall Study|Migrated/moved from study area|6|||
149224467|NCT01021293|538286567|FG001|Overall Study|Migrated/moved from study area|18|||
149224468|NCT01021293|538286566|FG000|Overall Study|Lost to Follow-up|1|||
149224469|NCT01021293|538286567|FG001|Overall Study|Lost to Follow-up|1|||
149224470|NCT04728815|538286568|FG000|Overall Study|Lost to Follow-up|3|||
149224471|NCT04728815|538286569|FG001|Overall Study|Lost to Follow-up|0|||
149224472|NCT04728815|538286570|FG002|Overall Study|Lost to Follow-up|0|||
149224473|NCT04728815|538286571|FG003|Overall Study|Lost to Follow-up|1|||
149224474|NCT04728815|538286572|FG004|Overall Study|Lost to Follow-up|1|||
149224475|NCT04728815|538286573|FG005|Overall Study|Lost to Follow-up|0|||
149224476|NCT04728815|538286574|FG006|Overall Study|Lost to Follow-up|2|||
149224477|NCT04728815|538286575|FG007|Overall Study|Lost to Follow-up|0|||
149224478|NCT04728815|538286568|FG000|Overall Study|Physician Decision|0|||
149224479|NCT04728815|538286569|FG001|Overall Study|Physician Decision|0|||
149224480|NCT04728815|538286570|FG002|Overall Study|Physician Decision|1|||
149224481|NCT04728815|538286571|FG003|Overall Study|Physician Decision|0|||
149224482|NCT04728815|538286572|FG004|Overall Study|Physician Decision|0|||
149224483|NCT04728815|538286573|FG005|Overall Study|Physician Decision|0|||
149224484|NCT04728815|538286574|FG006|Overall Study|Physician Decision|0|||
149224485|NCT04728815|538286575|FG007|Overall Study|Physician Decision|0|||
149224486|NCT04728815|538286568|FG000|Overall Study|Treatment drop|0|||
149224487|NCT04728815|538286569|FG001|Overall Study|Treatment drop|2|||
149224488|NCT04728815|538286570|FG002|Overall Study|Treatment drop|1|||
149224489|NCT04728815|538286571|FG003|Overall Study|Treatment drop|0|||
149224490|NCT04728815|538286572|FG004|Overall Study|Treatment drop|3|||
149224491|NCT04728815|538286573|FG005|Overall Study|Treatment drop|1|||
149224492|NCT04728815|538286574|FG006|Overall Study|Treatment drop|3|||
149224493|NCT04728815|538286575|FG007|Overall Study|Treatment drop|0|||
149224494|NCT04728815|538286568|FG000|Overall Study|Study drop|0|||
149224495|NCT04728815|538286569|FG001|Overall Study|Study drop|3|||
149224496|NCT04728815|538286570|FG002|Overall Study|Study drop|3|||
149224497|NCT04728815|538286571|FG003|Overall Study|Study drop|0|||
149224498|NCT04728815|538286572|FG004|Overall Study|Study drop|0|||
149224499|NCT04728815|538286573|FG005|Overall Study|Study drop|0|||
149224500|NCT04728815|538286574|FG006|Overall Study|Study drop|7|||
149224501|NCT04728815|538286575|FG007|Overall Study|Study drop|0|||
149224502|NCT00957034|538286576|FG000|Overall Study|Adverse Event|0|||
149224503|NCT00957034|538286577|FG001|Overall Study|Adverse Event|1|||
149224504|NCT00957034|538286578|FG002|Overall Study|Adverse Event|1|||
149224505|NCT00957034|538286576|FG000|Overall Study|Sponsor Terminated Study|6|||
149224506|NCT00957034|538286577|FG001|Overall Study|Sponsor Terminated Study|1|||
149224507|NCT00957034|538286578|FG002|Overall Study|Sponsor Terminated Study|5|||
149224508|NCT00957034|538286576|FG000|Overall Study|Withdrawal by Subject|0|||
149224509|NCT00957034|538286577|FG001|Overall Study|Withdrawal by Subject|2|||
149224510|NCT00957034|538286578|FG002|Overall Study|Withdrawal by Subject|0|||
149224511|NCT00959192|538288056|FG000|Overall Study|Adverse Event|1|||
149224512|NCT00959192|538288057|FG001|Overall Study|Adverse Event|1|||
149224513|NCT00959192|538288058|FG002|Overall Study|Adverse Event|1|||
149224514|NCT00959192|538288059|FG003|Overall Study|Adverse Event|0|||
149224515|NCT00959192|538288056|FG000|Overall Study|Investigator Request|1|||
149224516|NCT00959192|538288057|FG001|Overall Study|Investigator Request|0|||
149224517|NCT00959192|538288058|FG002|Overall Study|Investigator Request|0|||
149224518|NCT00959192|538288059|FG003|Overall Study|Investigator Request|0|||
149224519|NCT00959192|538288056|FG000|Overall Study|Caregiver Request|0|||
149224520|NCT00959192|538288057|FG001|Overall Study|Caregiver Request|0|||
149224521|NCT00959192|538288058|FG002|Overall Study|Caregiver Request|2|||
149224522|NCT00959192|538288059|FG003|Overall Study|Caregiver Request|1|||
149224523|NCT00532441|538288060|FG000|Overall Study|Death|1|||
149224524|NCT00532441|538288061|FG001|Overall Study|Death|0|||
149224525|NCT01967134|538288062|FG000|Overall Study|Lost to Follow-up|0|||
149224526|NCT01967134|538288063|FG001|Overall Study|Lost to Follow-up|1|||
149224527|NCT01967134|538288064|FG002|Overall Study|Lost to Follow-up|0|||
148953743|NCT01285310|537313108|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
149224528|NCT00443534|538288065|FG000|Overall Study|Lack of Efficacy|67|||
149224529|NCT00443534|538288065|FG000|Overall Study|Adverse Event|16|||
149224530|NCT00443534|538288065|FG000|Overall Study|Death|9|||
149224531|NCT00443534|538288065|FG000|Overall Study|Withdrawal by Subject|8|||
149224532|NCT00443534|538288065|FG000|Overall Study|Study Terminated by Sponsor|12|||
149224533|NCT00443534|538288065|FG000|Overall Study|Other|10|||
149224534|NCT00443534|538288065|FG000|Overall Study|Enrolled, Not Treated|1|||
149224535|NCT05466240|538288067|FG000|Overall Study|Adverse Event|1|||
149224536|NCT05466240|538288068|FG001|Overall Study|Adverse Event|0|||
149224537|NCT05466240|538288067|FG000|Overall Study|Withdrawal by Subject|1|||
149224538|NCT05466240|538288068|FG001|Overall Study|Withdrawal by Subject|0|||
149224539|NCT00305773|538288069|FG000|Overall Study|Death|3|||
149224540|NCT00305773|538288070|FG001|Overall Study|Death|2|||
149224541|NCT00305773|538288069|FG000|Overall Study|Adverse Event|1|||
149224542|NCT00305773|538288070|FG001|Overall Study|Adverse Event|2|||
149224543|NCT00305773|538288069|FG000|Overall Study|Alternative Treatment|4|||
149224544|NCT00305773|538288070|FG001|Overall Study|Alternative Treatment|4|||
149224545|NCT00305773|538288069|FG000|Overall Study|Physician Decision|1|||
149224546|NCT00305773|538288070|FG001|Overall Study|Physician Decision|1|||
149224547|NCT00305773|538288069|FG000|Overall Study|Withdrawal by Subject|1|||
149224548|NCT00305773|538288070|FG001|Overall Study|Withdrawal by Subject|4|||
149224549|NCT00305773|538288069|FG000|Overall Study|Disease Progression|1|||
149224550|NCT00305773|538288070|FG001|Overall Study|Disease Progression|3|||
149224551|NCT00305773|538288069|FG000|Overall Study|All other reasons|3|||
149224552|NCT00305773|538288070|FG001|Overall Study|All other reasons|2|||
149224553|NCT02679222|538288071|FG000|Overall Study|No time for project|1|||
149224554|NCT00303329|538288072|FG000|Overall Study|Adverse Event|7|||
149224555|NCT00303329|538288073|FG001|Overall Study|Adverse Event|14|||
149224556|NCT00303329|538288072|FG000|Overall Study|Abnormal Laboratory Values|0|||
149224557|NCT00303329|538288073|FG001|Overall Study|Abnormal Laboratory Values|1|||
149224558|NCT00303329|538288072|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
149224559|NCT00303329|538288073|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149224560|NCT00303329|538288072|FG000|Overall Study|Condition no longer requires study drug|0|||
149224561|NCT00303329|538288073|FG001|Overall Study|Condition no longer requires study drug|8|||
149224562|NCT00303329|538288072|FG000|Overall Study|Protocol Violation|3|||
148810103|NCT01091259|536782552|FG000|Overall Study|Adverse Event|3|||
148810104|NCT01091259|536782552|FG000|Overall Study|Lack of Efficacy|2|||
148810105|NCT03320369|536782553|FG000|Overall Study|Adverse Event|1|||
148953744|NCT01285310|537313109|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
148953745|NCT01285310|537313110|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
149224563|NCT00303329|538288073|FG001|Overall Study|Protocol Violation|0|||
149224564|NCT00303329|538288072|FG000|Overall Study|Withdrawal by Subject|9|||
149224565|NCT00303329|538288073|FG001|Overall Study|Withdrawal by Subject|15|||
149224566|NCT00303329|538288072|FG000|Overall Study|Lost to Follow-up|0|||
149224567|NCT00303329|538288073|FG001|Overall Study|Lost to Follow-up|1|||
149224568|NCT00303329|538288072|FG000|Overall Study|Administrative problems|1|||
149224569|NCT00303329|538288073|FG001|Overall Study|Administrative problems|0|||
149224570|NCT00303329|538288072|FG000|Overall Study|Death|2|||
149224571|NCT00303329|538288073|FG001|Overall Study|Death|12|||
149224572|NCT00303329|538288072|FG000|Overall Study|Stopped at end of core|3|||
149224573|NCT00303329|538288073|FG001|Overall Study|Stopped at end of core|9|||
148953746|NCT01285310|537313111|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
148810106|NCT03320369|536782553|FG000|Overall Study|Withdrawal by Subject|2|||
148953747|NCT01285310|537313107|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
148687057|NCT02711956|536327327|FG009|Overall Study|Adverse Event|1|||
149224574|NCT00303329|538288072|FG000|Overall Study|Stopped at end of extension 1|1|||
149224575|NCT00303329|538288073|FG001|Overall Study|Stopped at end of extension 1|0|||
149224576|NCT00413231|538288074|FG000|0 to 30-day Post Treatment|Death|5|||
149224577|NCT00413231|538288074|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
149224578|NCT00413231|538288074|FG000|30-day to 365-day Post Treatment|Death|13|||
149224579|NCT00413231|538288074|FG000|365-day to 60-month Post Treatment|Death|36|||
149224580|NCT00413231|538288074|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
149224581|NCT00413231|538288074|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
149224582|NCT00413231|538288074|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
149224583|NCT00626327|538288079|FG000|Overall Study|Withdrawal by Subject|21|||
149224584|NCT00626327|538288080|FG001|Overall Study|Withdrawal by Subject|29|||
149224585|NCT00626327|538288081|FG002|Overall Study|Withdrawal by Subject|30|||
149224586|NCT00626327|538288079|FG000|Overall Study|Adverse Event|1|||
149224587|NCT00626327|538288080|FG001|Overall Study|Adverse Event|0|||
149224588|NCT00626327|538288081|FG002|Overall Study|Adverse Event|0|||
149224589|NCT00626327|538288079|FG000|Overall Study|Lost to Follow-up|24|||
149224590|NCT00626327|538288080|FG001|Overall Study|Lost to Follow-up|21|||
149224591|NCT00626327|538288081|FG002|Overall Study|Lost to Follow-up|23|||
149224592|NCT00626327|538288079|FG000|Overall Study|Inappropriate enrollment|4|||
149224593|NCT00626327|538288080|FG001|Overall Study|Inappropriate enrollment|5|||
149224594|NCT00626327|538288081|FG002|Overall Study|Inappropriate enrollment|3|||
149224595|NCT00626327|538288079|FG000|Overall Study|Administrative Reason|2|||
149224596|NCT00626327|538288080|FG001|Overall Study|Administrative Reason|0|||
149224597|NCT00626327|538288081|FG002|Overall Study|Administrative Reason|6|||
149224598|NCT00626327|538288079|FG000|Overall Study|Protocol Violation|26|||
149224599|NCT00626327|538288080|FG001|Overall Study|Protocol Violation|4|||
149224600|NCT00626327|538288081|FG002|Overall Study|Protocol Violation|26|||
149224601|NCT00945945|538288082|FG000|Overall Study|Adverse Event|15|||
149224602|NCT00945945|538288083|FG001|Overall Study|Adverse Event|35|||
149224603|NCT00945945|538288082|FG000|Overall Study|Withdrawal by Subject|7|||
149224604|NCT00945945|538288083|FG001|Overall Study|Withdrawal by Subject|10|||
149224605|NCT00945945|538288082|FG000|Overall Study|Lost to Follow-up|4|||
149224606|NCT00945945|538288083|FG001|Overall Study|Lost to Follow-up|5|||
149224607|NCT00945945|538288082|FG000|Overall Study|Lack of Efficacy|6|||
149224608|NCT00945945|538288083|FG001|Overall Study|Lack of Efficacy|2|||
149224609|NCT00945945|538288082|FG000|Overall Study|Protocol Violation|4|||
149224610|NCT00945945|538288083|FG001|Overall Study|Protocol Violation|2|||
149224611|NCT00945945|538288082|FG000|Overall Study|Entry Criteria Not Met|0|||
149224612|NCT00945945|538288083|FG001|Overall Study|Entry Criteria Not Met|1|||
149224613|NCT04235959|538288086|FG000|Overall Study|Protocol Violation|0|||
149224614|NCT04235959|538288087|FG001|Overall Study|Protocol Violation|1|||
149224615|NCT04235959|538288088|FG002|Overall Study|Protocol Violation|0|||
149224616|NCT04235959|538288086|FG000|Overall Study|Adverse Event|1|||
149224617|NCT04235959|538288087|FG001|Overall Study|Adverse Event|0|||
149224618|NCT04235959|538288088|FG002|Overall Study|Adverse Event|0|||
149224619|NCT03055806|538288089|FG000|Overall Study|Adverse Event|0|||
149224620|NCT03055806|538288090|FG001|Overall Study|Adverse Event|0|||
149018076|NCT01474512|537547161|FG012|Induction Period|Protocol Violation|0|||
149018077|NCT01474512|537547162|FG013|Induction Period|Protocol Violation|0|||
149018078|NCT01474512|537547163|FG014|Induction Period|Protocol Violation|0|||
149018079|NCT01474512|537547164|FG015|Induction Period|Protocol Violation|0|||
148810107|NCT01155141|536782554|FG000|Overall Study|Withdrawal by Subject|1|||
148810108|NCT01155141|536782554|FG000|Overall Study|Screen Failure|1|||
148810109|NCT02020941|536782555|FG000|Overall Study|Adverse Event|1|||
148810110|NCT02020941|536782555|FG000|Overall Study|Physician Decision|2|||
148810111|NCT02020941|536782555|FG000|Overall Study|Withdrawal by Subject|1|||
148810112|NCT02020941|536782555|FG000|Overall Study|Disease Progression|4|||
148810113|NCT04727749|536782560|FG000|Overall Study|Lost to Follow-up|10|||
148810114|NCT04727749|536782561|FG001|Overall Study|Lost to Follow-up|3|||
148810115|NCT02320396|536782562|FG000|Overall Study|Adverse Event|2|||
148810116|NCT02320396|536782563|FG001|Overall Study|Adverse Event|2|||
148810117|NCT02320396|536782562|FG000|Overall Study|Pregnancy|0|||
148810118|NCT02320396|536782563|FG001|Overall Study|Pregnancy|1|||
148810119|NCT02320396|536782562|FG000|Overall Study|Protocol Violation|0|||
148810120|NCT02320396|536782563|FG001|Overall Study|Protocol Violation|1|||
148810121|NCT02320396|536782562|FG000|Overall Study|Withdrawal by Subject|2|||
148810122|NCT02320396|536782563|FG001|Overall Study|Withdrawal by Subject|0|||
149018080|NCT01474512|537547165|FG016|Induction Period|Protocol Violation|0|||
149018081|NCT01474512|537547166|FG017|Induction Period|Protocol Violation|0|||
149018082|NCT01474512|537547149|FG000|Induction Period|Sponsor Decision|1|||
149018083|NCT01474512|537547150|FG001|Induction Period|Sponsor Decision|1|||
149018084|NCT01474512|537547151|FG002|Induction Period|Sponsor Decision|1|||
149018085|NCT01474512|537547152|FG003|Induction Period|Sponsor Decision|0|||
149224621|NCT03055806|538288091|FG002|Overall Study|Adverse Event|1|||
149224622|NCT03055806|538288092|FG003|Overall Study|Adverse Event|1|||
149224623|NCT03055806|538288089|FG000|Overall Study|Lost to Follow-up|0|||
149224624|NCT03055806|538288090|FG001|Overall Study|Lost to Follow-up|3|||
149224625|NCT03055806|538288091|FG002|Overall Study|Lost to Follow-up|6|||
149224626|NCT03055806|538288092|FG003|Overall Study|Lost to Follow-up|7|||
149224627|NCT03055806|538288089|FG000|Overall Study|Physician Decision|1|||
148810123|NCT03718000|536782564|FG000|Overall Study|Relocation|2|||
148810124|NCT03718000|536782565|FG001|Overall Study|Relocation|4|||
149018086|NCT01474512|537547153|FG004|Induction Period|Sponsor Decision|0|||
149018087|NCT01474512|537547154|FG005|Induction Period|Sponsor Decision|0|||
149018088|NCT01474512|537547155|FG006|Induction Period|Sponsor Decision|0|||
149224628|NCT03055806|538288090|FG001|Overall Study|Physician Decision|0|||
149224629|NCT03055806|538288091|FG002|Overall Study|Physician Decision|0|||
149018089|NCT01474512|537547156|FG007|Induction Period|Sponsor Decision|0|||
149018090|NCT01474512|537547157|FG008|Induction Period|Sponsor Decision|0|||
149018091|NCT01474512|537547158|FG009|Induction Period|Sponsor Decision|0|||
149018092|NCT01474512|537547159|FG010|Induction Period|Sponsor Decision|0|||
149018093|NCT01474512|537547160|FG011|Induction Period|Sponsor Decision|0|||
149018094|NCT01474512|537547161|FG012|Induction Period|Sponsor Decision|0|||
149018095|NCT01474512|537547162|FG013|Induction Period|Sponsor Decision|0|||
149018096|NCT01474512|537547163|FG014|Induction Period|Sponsor Decision|0|||
149018097|NCT01474512|537547164|FG015|Induction Period|Sponsor Decision|0|||
149018098|NCT01474512|537547165|FG016|Induction Period|Sponsor Decision|0|||
149018099|NCT01474512|537547166|FG017|Induction Period|Sponsor Decision|0|||
149018100|NCT01474512|537547149|FG000|Induction Period|Lost to Follow-up|1|||
149018101|NCT01474512|537547150|FG001|Induction Period|Lost to Follow-up|0|||
149018102|NCT01474512|537547151|FG002|Induction Period|Lost to Follow-up|2|||
149018103|NCT01474512|537547152|FG003|Induction Period|Lost to Follow-up|0|||
149018104|NCT01474512|537547153|FG004|Induction Period|Lost to Follow-up|0|||
149018105|NCT01474512|537547154|FG005|Induction Period|Lost to Follow-up|0|||
149018106|NCT01474512|537547155|FG006|Induction Period|Lost to Follow-up|0|||
149018107|NCT01474512|537547156|FG007|Induction Period|Lost to Follow-up|0|||
149018108|NCT01474512|537547157|FG008|Induction Period|Lost to Follow-up|0|||
149018109|NCT01474512|537547158|FG009|Induction Period|Lost to Follow-up|0|||
149018110|NCT01474512|537547159|FG010|Induction Period|Lost to Follow-up|0|||
149018111|NCT01474512|537547160|FG011|Induction Period|Lost to Follow-up|0|||
149018112|NCT01474512|537547161|FG012|Induction Period|Lost to Follow-up|0|||
149018113|NCT01474512|537547162|FG013|Induction Period|Lost to Follow-up|0|||
149018114|NCT01474512|537547163|FG014|Induction Period|Lost to Follow-up|0|||
149018115|NCT01474512|537547164|FG015|Induction Period|Lost to Follow-up|0|||
149018116|NCT01474512|537547165|FG016|Induction Period|Lost to Follow-up|0|||
149018117|NCT01474512|537547166|FG017|Induction Period|Lost to Follow-up|0|||
149018118|NCT01474512|537547149|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018119|NCT01474512|537547150|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018120|NCT01474512|537547151|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018121|NCT01474512|537547152|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
149018122|NCT01474512|537547153|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
149018123|NCT01474512|537547154|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
149018124|NCT01474512|537547155|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
149018125|NCT01474512|537547156|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018126|NCT01474512|537547157|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018127|NCT01474512|537547158|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018128|NCT01474512|537547159|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018129|NCT01474512|537547160|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018130|NCT01474512|537547161|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018131|NCT01474512|537547162|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018132|NCT01474512|537547163|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018133|NCT01474512|537547164|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018134|NCT01474512|537547165|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018135|NCT01474512|537547166|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
149018136|NCT01474512|537547149|FG000|Maintenance Period|Adverse Event|0|||
149018137|NCT01474512|537547150|FG001|Maintenance Period|Adverse Event|0|||
149018138|NCT01474512|537547151|FG002|Maintenance Period|Adverse Event|0|||
149018139|NCT01474512|537547152|FG003|Maintenance Period|Adverse Event|4|||
149018140|NCT01474512|537547153|FG004|Maintenance Period|Adverse Event|2|||
149018141|NCT01474512|537547154|FG005|Maintenance Period|Adverse Event|7|||
149018142|NCT01474512|537547155|FG006|Maintenance Period|Adverse Event|0|||
149018143|NCT01474512|537547156|FG007|Maintenance Period|Adverse Event|19|||
149018144|NCT01474512|537547157|FG008|Maintenance Period|Adverse Event|1|||
149018145|NCT01474512|537547158|FG009|Maintenance Period|Adverse Event|3|||
149018146|NCT01474512|537547159|FG010|Maintenance Period|Adverse Event|0|||
149018147|NCT01474512|537547160|FG011|Maintenance Period|Adverse Event|0|||
149018148|NCT01474512|537547161|FG012|Maintenance Period|Adverse Event|0|||
149018149|NCT01474512|537547162|FG013|Maintenance Period|Adverse Event|0|||
149018150|NCT01474512|537547163|FG014|Maintenance Period|Adverse Event|0|||
149018151|NCT01474512|537547164|FG015|Maintenance Period|Adverse Event|0|||
149018152|NCT01474512|537547165|FG016|Maintenance Period|Adverse Event|0|||
149018153|NCT01474512|537547166|FG017|Maintenance Period|Adverse Event|0|||
149018154|NCT01474512|537547149|FG000|Maintenance Period|Withdrawal by Subject|0|||
149018155|NCT01474512|537547150|FG001|Maintenance Period|Withdrawal by Subject|0|||
149018156|NCT01474512|537547151|FG002|Maintenance Period|Withdrawal by Subject|0|||
149018157|NCT01474512|537547152|FG003|Maintenance Period|Withdrawal by Subject|6|||
149018158|NCT01474512|537547153|FG004|Maintenance Period|Withdrawal by Subject|2|||
149018159|NCT01474512|537547154|FG005|Maintenance Period|Withdrawal by Subject|3|||
149018160|NCT01474512|537547155|FG006|Maintenance Period|Withdrawal by Subject|1|||
149018161|NCT01474512|537547156|FG007|Maintenance Period|Withdrawal by Subject|6|||
149018162|NCT01474512|537547157|FG008|Maintenance Period|Withdrawal by Subject|3|||
149018163|NCT01474512|537547158|FG009|Maintenance Period|Withdrawal by Subject|1|||
149018164|NCT01474512|537547159|FG010|Maintenance Period|Withdrawal by Subject|0|||
149018165|NCT01474512|537547160|FG011|Maintenance Period|Withdrawal by Subject|0|||
149018166|NCT01474512|537547161|FG012|Maintenance Period|Withdrawal by Subject|0|||
149018167|NCT01474512|537547162|FG013|Maintenance Period|Withdrawal by Subject|0|||
149018168|NCT01474512|537547163|FG014|Maintenance Period|Withdrawal by Subject|0|||
149018169|NCT01474512|537547164|FG015|Maintenance Period|Withdrawal by Subject|0|||
149018170|NCT01474512|537547165|FG016|Maintenance Period|Withdrawal by Subject|0|||
149018171|NCT01474512|537547166|FG017|Maintenance Period|Withdrawal by Subject|0|||
149018172|NCT01474512|537547149|FG000|Maintenance Period|Lost to Follow-up|0|||
149018173|NCT01474512|537547150|FG001|Maintenance Period|Lost to Follow-up|0|||
149018174|NCT01474512|537547151|FG002|Maintenance Period|Lost to Follow-up|0|||
149018175|NCT01474512|537547152|FG003|Maintenance Period|Lost to Follow-up|3|||
149018176|NCT01474512|537547153|FG004|Maintenance Period|Lost to Follow-up|3|||
149018177|NCT01474512|537547154|FG005|Maintenance Period|Lost to Follow-up|0|||
149018178|NCT01474512|537547155|FG006|Maintenance Period|Lost to Follow-up|0|||
149018179|NCT01474512|537547156|FG007|Maintenance Period|Lost to Follow-up|2|||
149018180|NCT01474512|537547157|FG008|Maintenance Period|Lost to Follow-up|1|||
149018181|NCT01474512|537547158|FG009|Maintenance Period|Lost to Follow-up|1|||
149018182|NCT01474512|537547159|FG010|Maintenance Period|Lost to Follow-up|0|||
149018183|NCT01474512|537547160|FG011|Maintenance Period|Lost to Follow-up|0|||
149018184|NCT01474512|537547161|FG012|Maintenance Period|Lost to Follow-up|0|||
149018185|NCT01474512|537547162|FG013|Maintenance Period|Lost to Follow-up|0|||
149018186|NCT01474512|537547163|FG014|Maintenance Period|Lost to Follow-up|0|||
149018187|NCT01474512|537547164|FG015|Maintenance Period|Lost to Follow-up|0|||
149018188|NCT01474512|537547165|FG016|Maintenance Period|Lost to Follow-up|0|||
149018189|NCT01474512|537547166|FG017|Maintenance Period|Lost to Follow-up|0|||
149018190|NCT01474512|537547149|FG000|Maintenance Period|Death|0|||
149018191|NCT01474512|537547150|FG001|Maintenance Period|Death|0|||
149018192|NCT01474512|537547151|FG002|Maintenance Period|Death|0|||
149018193|NCT01474512|537547152|FG003|Maintenance Period|Death|0|||
149018194|NCT01474512|537547153|FG004|Maintenance Period|Death|0|||
149018195|NCT01474512|537547154|FG005|Maintenance Period|Death|2|||
149018196|NCT01474512|537547155|FG006|Maintenance Period|Death|0|||
149018197|NCT01474512|537547156|FG007|Maintenance Period|Death|0|||
149018198|NCT01474512|537547157|FG008|Maintenance Period|Death|0|||
149018199|NCT01474512|537547158|FG009|Maintenance Period|Death|0|||
149018200|NCT01474512|537547159|FG010|Maintenance Period|Death|0|||
149018201|NCT01474512|537547160|FG011|Maintenance Period|Death|0|||
149018202|NCT01474512|537547161|FG012|Maintenance Period|Death|0|||
149018203|NCT01474512|537547162|FG013|Maintenance Period|Death|0|||
149018204|NCT01474512|537547163|FG014|Maintenance Period|Death|0|||
149018205|NCT01474512|537547164|FG015|Maintenance Period|Death|0|||
149018206|NCT01474512|537547165|FG016|Maintenance Period|Death|0|||
149018207|NCT01474512|537547166|FG017|Maintenance Period|Death|0|||
149018208|NCT01474512|537547149|FG000|Maintenance Period|Physician Decision|0|||
149018209|NCT01474512|537547150|FG001|Maintenance Period|Physician Decision|0|||
149018210|NCT01474512|537547151|FG002|Maintenance Period|Physician Decision|0|||
149018211|NCT01474512|537547152|FG003|Maintenance Period|Physician Decision|0|||
149018212|NCT01474512|537547153|FG004|Maintenance Period|Physician Decision|0|||
149018213|NCT01474512|537547154|FG005|Maintenance Period|Physician Decision|1|||
149018214|NCT01474512|537547155|FG006|Maintenance Period|Physician Decision|0|||
149018215|NCT01474512|537547156|FG007|Maintenance Period|Physician Decision|2|||
149018216|NCT01474512|537547157|FG008|Maintenance Period|Physician Decision|0|||
149018217|NCT01474512|537547158|FG009|Maintenance Period|Physician Decision|0|||
149018218|NCT01474512|537547159|FG010|Maintenance Period|Physician Decision|0|||
149018219|NCT01474512|537547160|FG011|Maintenance Period|Physician Decision|0|||
149018220|NCT01474512|537547161|FG012|Maintenance Period|Physician Decision|0|||
149018221|NCT01474512|537547162|FG013|Maintenance Period|Physician Decision|0|||
149018222|NCT01474512|537547163|FG014|Maintenance Period|Physician Decision|0|||
149018223|NCT01474512|537547164|FG015|Maintenance Period|Physician Decision|0|||
149018224|NCT01474512|537547165|FG016|Maintenance Period|Physician Decision|0|||
149018225|NCT01474512|537547166|FG017|Maintenance Period|Physician Decision|0|||
149018226|NCT01474512|537547149|FG000|Maintenance Period|Clinical Relapse|0|||
149018227|NCT01474512|537547150|FG001|Maintenance Period|Clinical Relapse|0|||
149018228|NCT01474512|537547151|FG002|Maintenance Period|Clinical Relapse|0|||
149018229|NCT01474512|537547152|FG003|Maintenance Period|Clinical Relapse|1|||
149018230|NCT01474512|537547153|FG004|Maintenance Period|Clinical Relapse|0|||
149018231|NCT01474512|537547154|FG005|Maintenance Period|Clinical Relapse|0|||
149018232|NCT01474512|537547155|FG006|Maintenance Period|Clinical Relapse|0|||
149018233|NCT01474512|537547156|FG007|Maintenance Period|Clinical Relapse|0|||
149018234|NCT01474512|537547157|FG008|Maintenance Period|Clinical Relapse|0|||
149018235|NCT01474512|537547158|FG009|Maintenance Period|Clinical Relapse|0|||
149018236|NCT01474512|537547159|FG010|Maintenance Period|Clinical Relapse|0|||
149018237|NCT01474512|537547160|FG011|Maintenance Period|Clinical Relapse|0|||
149018238|NCT01474512|537547161|FG012|Maintenance Period|Clinical Relapse|0|||
149018239|NCT01474512|537547162|FG013|Maintenance Period|Clinical Relapse|0|||
149018240|NCT01474512|537547163|FG014|Maintenance Period|Clinical Relapse|0|||
149018241|NCT01474512|537547164|FG015|Maintenance Period|Clinical Relapse|0|||
149224630|NCT03055806|538288092|FG003|Overall Study|Physician Decision|1|||
149018242|NCT01474512|537547165|FG016|Maintenance Period|Clinical Relapse|0|||
149224631|NCT03055806|538288089|FG000|Overall Study|Protocol Violation|1|||
149224632|NCT03055806|538288090|FG001|Overall Study|Protocol Violation|0|||
149224633|NCT03055806|538288091|FG002|Overall Study|Protocol Violation|0|||
149224634|NCT03055806|538288092|FG003|Overall Study|Protocol Violation|0|||
149224635|NCT03055806|538288089|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
149224636|NCT03055806|538288090|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
149224637|NCT03055806|538288091|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
149224638|NCT03055806|538288092|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
149224639|NCT03055806|538288089|FG000|Overall Study|Withdrawal of consent to continue study|2|||
149224640|NCT03055806|538288090|FG001|Overall Study|Withdrawal of consent to continue study|3|||
149224641|NCT03055806|538288091|FG002|Overall Study|Withdrawal of consent to continue study|4|||
149224642|NCT03055806|538288092|FG003|Overall Study|Withdrawal of consent to continue study|6|||
149224643|NCT03055806|538288089|FG000|Overall Study|Partner not willing to try intercourse|1|||
149224644|NCT03055806|538288090|FG001|Overall Study|Partner not willing to try intercourse|0|||
149224645|NCT03055806|538288091|FG002|Overall Study|Partner not willing to try intercourse|0|||
149224646|NCT03055806|538288092|FG003|Overall Study|Partner not willing to try intercourse|0|||
149224647|NCT04601194|538288093|FG000|Overall Study|Lost to Follow-up|7|||
149224648|NCT04905563|538288096|FG000|Overall Study|Withdrawal by Subject|1|||
149224649|NCT04905563|538288097|FG001|Overall Study|Withdrawal by Subject|0|||
149224650|NCT04905563|538288096|FG000|Overall Study|Standard of care orders entered by resident|1|||
149224651|NCT04905563|538288097|FG001|Overall Study|Standard of care orders entered by resident|0|||
149224652|NCT04905563|538288096|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
149224653|NCT04905563|538288097|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
149224654|NCT04905563|538288096|FG000|Overall Study|Withdrawal by Subject|0|||
149224655|NCT04905563|538288097|FG001|Overall Study|Withdrawal by Subject|1|||
148953748|NCT01285310|537313108|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
148953749|NCT01285310|537313109|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
149224656|NCT01797302|538288098|FG000|Overall Study|Lost to Follow-up|16|||
149224657|NCT01797302|538288099|FG001|Overall Study|Lost to Follow-up|23|||
149224658|NCT01797302|538288100|FG002|Overall Study|Lost to Follow-up|22|||
149224659|NCT01797302|538288098|FG000|Overall Study|Withdrawal by Subject|1|||
149224660|NCT01797302|538288099|FG001|Overall Study|Withdrawal by Subject|3|||
149224661|NCT01797302|538288100|FG002|Overall Study|Withdrawal by Subject|4|||
149224662|NCT02418000|538288101|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
149224663|NCT02418000|538288102|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224664|NCT02418000|538288103|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
148810125|NCT03718000|536782564|FG000|Overall Study|Pregnancy|0|||
148810126|NCT03718000|536782565|FG001|Overall Study|Pregnancy|1|||
148810127|NCT05383209|536782566|FG000|Overall Study|Adverse Event: Non-ocular|0|||
148810128|NCT05383209|536782567|FG001|Overall Study|Adverse Event: Non-ocular|1|||
148953750|NCT01285310|537313110|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
148953751|NCT01285310|537313111|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
148953752|NCT01285310|537313107|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
148953753|NCT01285310|537313108|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
148953754|NCT01285310|537313109|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
148953755|NCT01285310|537313110|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
148953756|NCT01285310|537313111|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
148953757|NCT01285310|537313107|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
148953758|NCT01285310|537313108|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
148953759|NCT01285310|537313109|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
148953760|NCT01285310|537313110|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
148953761|NCT01285310|537313111|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
148953762|NCT01285310|537313107|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
148953763|NCT01285310|537313108|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
148953764|NCT01285310|537313109|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
148953765|NCT01285310|537313110|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
148953766|NCT01285310|537313111|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
148953767|NCT01285310|537313107|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
148953768|NCT01285310|537313108|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
148953769|NCT01285310|537313109|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
148953770|NCT01285310|537313110|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
148953771|NCT01285310|537313111|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
148953772|NCT01285310|537313107|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
148953773|NCT01285310|537313108|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
148953774|NCT01285310|537313109|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
148953775|NCT01285310|537313110|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
148953776|NCT01285310|537313111|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
148953777|NCT01285310|537313107|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
148953778|NCT01285310|537313108|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
148953779|NCT01285310|537313109|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
148953780|NCT01285310|537313110|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
148953781|NCT01285310|537313111|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
148953782|NCT01285310|537313107|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
148953783|NCT01285310|537313108|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
148953784|NCT01285310|537313109|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
149224665|NCT02418000|538288104|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224666|NCT02418000|538288105|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224667|NCT02418000|538288101|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
149224668|NCT02418000|538288102|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149224669|NCT02418000|538288103|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149224670|NCT02418000|538288104|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149224671|NCT02418000|538288105|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
149224672|NCT02418000|538288101|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
149224673|NCT02418000|538288102|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149224674|NCT02418000|538288103|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149224675|NCT02418000|538288104|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149224676|NCT02418000|538288105|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
149224677|NCT02418000|538288101|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224678|NCT02418000|538288102|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
149224679|NCT02418000|538288103|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224680|NCT02418000|538288104|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224681|NCT02418000|538288105|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
149224682|NCT02418000|538288101|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149224683|NCT02418000|538288102|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
149224684|NCT02418000|538288103|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149224685|NCT02418000|538288104|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149224686|NCT02418000|538288105|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
149224687|NCT02418000|538288101|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224688|NCT02418000|538288102|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224689|NCT02418000|538288103|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
149224690|NCT02418000|538288104|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224691|NCT02418000|538288105|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224692|NCT02418000|538288101|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224693|NCT02418000|538288102|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224694|NCT02418000|538288103|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224695|NCT02418000|538288104|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
149224696|NCT02418000|538288105|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224697|NCT02418000|538288101|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149224698|NCT02418000|538288102|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149224699|NCT02418000|538288103|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149224700|NCT02418000|538288104|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
149018243|NCT01474512|537547166|FG017|Maintenance Period|Clinical Relapse|0|||
149018244|NCT01474512|537547149|FG000|Maintenance Period|Lack of Efficacy|0|||
149224701|NCT02418000|538288105|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
149224702|NCT02418000|538288101|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224703|NCT02418000|538288102|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224704|NCT02418000|538288103|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224705|NCT02418000|538288104|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
149224706|NCT02418000|538288105|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
149224707|NCT00689611|538288106|FG000|Overall Study|Death|6|||
149224708|NCT00689611|538288107|FG001|Overall Study|Death|9|||
149224709|NCT00689611|538288106|FG000|Overall Study|Withdrawal by Subject|8|||
149224710|NCT00689611|538288107|FG001|Overall Study|Withdrawal by Subject|9|||
149224711|NCT00689611|538288106|FG000|Overall Study|Lost to Follow-up|27|||
149224712|NCT00689611|538288107|FG001|Overall Study|Lost to Follow-up|28|||
149224713|NCT00405756|538288112|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
149224714|NCT00405756|538288113|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
149224715|NCT00405756|538288114|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
149224716|NCT00405756|538288112|FG000|Double-blind Treatment|Adverse Event|31|||
149224717|NCT00405756|538288113|FG001|Double-blind Treatment|Adverse Event|27|||
149224718|NCT00405756|538288114|FG002|Double-blind Treatment|Adverse Event|12|||
149224719|NCT00405756|538288112|FG000|Double-blind Treatment|Disease Progression|47|||
149224720|NCT00405756|538288113|FG001|Double-blind Treatment|Disease Progression|81|||
149224721|NCT00405756|538288114|FG002|Double-blind Treatment|Disease Progression|102|||
149224722|NCT00405756|538288112|FG000|Double-blind Treatment|Lack of Efficacy|1|||
149224723|NCT00405756|538288113|FG001|Double-blind Treatment|Lack of Efficacy|4|||
149224724|NCT00405756|538288114|FG002|Double-blind Treatment|Lack of Efficacy|2|||
149224725|NCT00405756|538288112|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
149224726|NCT00405756|538288113|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
149224727|NCT00405756|538288114|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
149224728|NCT00405756|538288112|FG000|Double-blind Treatment|Lost to Follow-up|1|||
149224729|NCT00405756|538288113|FG001|Double-blind Treatment|Lost to Follow-up|0|||
149224730|NCT00405756|538288114|FG002|Double-blind Treatment|Lost to Follow-up|0|||
149224731|NCT00405756|538288112|FG000|Double-blind Treatment|Death|4|||
149224732|NCT00405756|538288113|FG001|Double-blind Treatment|Death|4|||
149224733|NCT00405756|538288114|FG002|Double-blind Treatment|Death|4|||
149224734|NCT00405756|538288112|FG000|Double-blind Treatment|Protocol Violation|1|||
149224735|NCT00405756|538288113|FG001|Double-blind Treatment|Protocol Violation|0|||
149224736|NCT00405756|538288114|FG002|Double-blind Treatment|Protocol Violation|2|||
149224737|NCT00405756|538288112|FG000|Double-blind Treatment|Other|7|||
149224738|NCT00405756|538288113|FG001|Double-blind Treatment|Other|4|||
149224739|NCT00405756|538288114|FG002|Double-blind Treatment|Other|4|||
149224740|NCT00405756|538288112|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
149224741|NCT00405756|538288113|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
149224742|NCT00405756|538288114|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
149224743|NCT00405756|538288112|FG000|Open-label Extension|Adverse Event|1|||
149224744|NCT00405756|538288113|FG001|Open-label Extension|Adverse Event|3|||
149224745|NCT00405756|538288114|FG002|Open-label Extension|Adverse Event|7|||
149224746|NCT00405756|538288112|FG000|Open-label Extension|Disease Progression|8|||
149224747|NCT00405756|538288113|FG001|Open-label Extension|Disease Progression|23|||
149224748|NCT00405756|538288114|FG002|Open-label Extension|Disease Progression|26|||
149224749|NCT00405756|538288112|FG000|Open-label Extension|Withdrawal by Subject|2|||
149224750|NCT00405756|538288113|FG001|Open-label Extension|Withdrawal by Subject|3|||
148953785|NCT01285310|537313110|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
148953786|NCT01285310|537313111|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
148953787|NCT01285310|537313107|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
148953788|NCT01285310|537313108|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
148953789|NCT01285310|537313109|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
148953790|NCT01285310|537313110|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
148953791|NCT01285310|537313111|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
148953792|NCT01285310|537313107|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
149224751|NCT00405756|538288114|FG002|Open-label Extension|Withdrawal by Subject|3|||
149224752|NCT00405756|538288112|FG000|Open-label Extension|Death|1|||
149018245|NCT01474512|537547150|FG001|Maintenance Period|Lack of Efficacy|0|||
149018246|NCT01474512|537547151|FG002|Maintenance Period|Lack of Efficacy|0|||
149018247|NCT01474512|537547152|FG003|Maintenance Period|Lack of Efficacy|1|||
149018248|NCT01474512|537547153|FG004|Maintenance Period|Lack of Efficacy|0|||
149018249|NCT01474512|537547154|FG005|Maintenance Period|Lack of Efficacy|0|||
149018250|NCT01474512|537547155|FG006|Maintenance Period|Lack of Efficacy|0|||
149018251|NCT01474512|537547156|FG007|Maintenance Period|Lack of Efficacy|11|||
149018252|NCT01474512|537547157|FG008|Maintenance Period|Lack of Efficacy|11|||
149018253|NCT01474512|537547158|FG009|Maintenance Period|Lack of Efficacy|12|||
149018254|NCT01474512|537547159|FG010|Maintenance Period|Lack of Efficacy|0|||
149018255|NCT01474512|537547160|FG011|Maintenance Period|Lack of Efficacy|0|||
149018256|NCT01474512|537547161|FG012|Maintenance Period|Lack of Efficacy|0|||
149018257|NCT01474512|537547162|FG013|Maintenance Period|Lack of Efficacy|0|||
149018258|NCT01474512|537547163|FG014|Maintenance Period|Lack of Efficacy|0|||
149018259|NCT01474512|537547164|FG015|Maintenance Period|Lack of Efficacy|0|||
149018260|NCT01474512|537547165|FG016|Maintenance Period|Lack of Efficacy|0|||
149018261|NCT01474512|537547166|FG017|Maintenance Period|Lack of Efficacy|0|||
149018262|NCT01474512|537547149|FG000|Maintenance Period|Protocol Violation|0|||
149018263|NCT01474512|537547150|FG001|Maintenance Period|Protocol Violation|0|||
149018264|NCT01474512|537547151|FG002|Maintenance Period|Protocol Violation|0|||
149018265|NCT01474512|537547152|FG003|Maintenance Period|Protocol Violation|1|||
149018266|NCT01474512|537547153|FG004|Maintenance Period|Protocol Violation|0|||
149018267|NCT01474512|537547154|FG005|Maintenance Period|Protocol Violation|0|||
149018268|NCT01474512|537547155|FG006|Maintenance Period|Protocol Violation|0|||
149018269|NCT01474512|537547156|FG007|Maintenance Period|Protocol Violation|1|||
149018270|NCT01474512|537547157|FG008|Maintenance Period|Protocol Violation|0|||
149018271|NCT01474512|537547158|FG009|Maintenance Period|Protocol Violation|1|||
149018272|NCT01474512|537547159|FG010|Maintenance Period|Protocol Violation|0|||
149018273|NCT01474512|537547160|FG011|Maintenance Period|Protocol Violation|0|||
149018274|NCT01474512|537547161|FG012|Maintenance Period|Protocol Violation|0|||
149018275|NCT01474512|537547162|FG013|Maintenance Period|Protocol Violation|0|||
149018276|NCT01474512|537547163|FG014|Maintenance Period|Protocol Violation|0|||
149018277|NCT01474512|537547164|FG015|Maintenance Period|Protocol Violation|0|||
149018278|NCT01474512|537547165|FG016|Maintenance Period|Protocol Violation|0|||
149018279|NCT01474512|537547166|FG017|Maintenance Period|Protocol Violation|0|||
149018280|NCT01474512|537547149|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
149018281|NCT01474512|537547150|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
149018282|NCT01474512|537547151|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
149018283|NCT01474512|537547152|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
149018284|NCT01474512|537547153|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
149018285|NCT01474512|537547154|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
149018286|NCT01474512|537547155|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
149018287|NCT01474512|537547156|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
149018288|NCT01474512|537547157|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
149018289|NCT01474512|537547158|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
149018290|NCT01474512|537547159|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
149018291|NCT01474512|537547160|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
149018292|NCT01474512|537547161|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
149018293|NCT01474512|537547162|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
149018294|NCT01474512|537547163|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
149018295|NCT01474512|537547164|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
149018296|NCT01474512|537547165|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
149018297|NCT01474512|537547166|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
149018298|NCT01474512|537547149|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
149018299|NCT01474512|537547150|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
149018300|NCT01474512|537547151|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
149018301|NCT01474512|537547152|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
149018302|NCT01474512|537547153|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
149018303|NCT01474512|537547154|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
149018304|NCT01474512|537547155|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
149224753|NCT00405756|538288113|FG001|Open-label Extension|Death|2|||
149224754|NCT00405756|538288114|FG002|Open-label Extension|Death|4|||
149224755|NCT00405756|538288112|FG000|Open-label Extension|Other|0|||
149224756|NCT00405756|538288113|FG001|Open-label Extension|Other|1|||
149224757|NCT00405756|538288114|FG002|Open-label Extension|Other|7|||
149224758|NCT00405756|538288112|FG000|Follow-up|Ongoing in Follow-up Period|52|||
149224759|NCT00405756|538288113|FG001|Follow-up|Ongoing in Follow-up Period|51|||
149224760|NCT00405756|538288114|FG002|Follow-up|Ongoing in Follow-up Period|60|||
149224761|NCT00405756|538288112|FG000|Follow-up|Death|21|||
149018305|NCT01474512|537547156|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
149224762|NCT00405756|538288113|FG001|Follow-up|Death|31|||
149224763|NCT00405756|538288114|FG002|Follow-up|Death|24|||
149224764|NCT00405756|538288112|FG000|Follow-up|Lost to Follow-up|2|||
148687058|NCT02711956|536327328|FG010|Overall Study|Adverse Event|1|||
148687059|NCT02711956|536327329|FG011|Overall Study|Adverse Event|0|||
148687060|NCT02711956|536327330|FG012|Overall Study|Adverse Event|0|||
148687061|NCT02711956|536327331|FG013|Overall Study|Adverse Event|0|||
148687062|NCT02711956|536327332|FG014|Overall Study|Adverse Event|2|||
148687063|NCT02711956|536327318|FG000|Overall Study|Physician Decision|0|||
148687064|NCT02711956|536327319|FG001|Overall Study|Physician Decision|0|||
148687065|NCT02711956|536327320|FG002|Overall Study|Physician Decision|0|||
148687066|NCT02711956|536327321|FG003|Overall Study|Physician Decision|2|||
148687067|NCT02711956|536327322|FG004|Overall Study|Physician Decision|0|||
148687068|NCT02711956|536327323|FG005|Overall Study|Physician Decision|0|||
148687069|NCT02711956|536327324|FG006|Overall Study|Physician Decision|0|||
148687070|NCT02711956|536327325|FG007|Overall Study|Physician Decision|0|||
148687071|NCT02711956|536327326|FG008|Overall Study|Physician Decision|0|||
148687072|NCT02711956|536327327|FG009|Overall Study|Physician Decision|0|||
148687073|NCT02711956|536327328|FG010|Overall Study|Physician Decision|0|||
148687074|NCT02711956|536327329|FG011|Overall Study|Physician Decision|0|||
148687075|NCT02711956|536327330|FG012|Overall Study|Physician Decision|0|||
148687076|NCT02711956|536327331|FG013|Overall Study|Physician Decision|0|||
148687077|NCT02711956|536327332|FG014|Overall Study|Physician Decision|0|||
148687078|NCT02711956|536327318|FG000|Overall Study|Withdrawal by Subject|0|||
148687079|NCT02711956|536327319|FG001|Overall Study|Withdrawal by Subject|0|||
148687080|NCT02711956|536327320|FG002|Overall Study|Withdrawal by Subject|0|||
148687081|NCT02711956|536327321|FG003|Overall Study|Withdrawal by Subject|0|||
148687082|NCT02711956|536327322|FG004|Overall Study|Withdrawal by Subject|0|||
148687083|NCT02711956|536327323|FG005|Overall Study|Withdrawal by Subject|0|||
148687084|NCT02711956|536327324|FG006|Overall Study|Withdrawal by Subject|1|||
148687085|NCT02711956|536327325|FG007|Overall Study|Withdrawal by Subject|0|||
148687086|NCT02711956|536327326|FG008|Overall Study|Withdrawal by Subject|0|||
148687087|NCT02711956|536327327|FG009|Overall Study|Withdrawal by Subject|0|||
148687088|NCT02711956|536327328|FG010|Overall Study|Withdrawal by Subject|0|||
148687089|NCT02711956|536327329|FG011|Overall Study|Withdrawal by Subject|1|||
148687090|NCT02711956|536327330|FG012|Overall Study|Withdrawal by Subject|6|||
148687091|NCT02711956|536327331|FG013|Overall Study|Withdrawal by Subject|0|||
148687092|NCT02711956|536327332|FG014|Overall Study|Withdrawal by Subject|1|||
148687093|NCT02711956|536327318|FG000|Overall Study|Clinical progression|1|||
148687094|NCT02711956|536327319|FG001|Overall Study|Clinical progression|0|||
148687095|NCT02711956|536327320|FG002|Overall Study|Clinical progression|0|||
148687096|NCT02711956|536327321|FG003|Overall Study|Clinical progression|0|||
148687097|NCT02711956|536327322|FG004|Overall Study|Clinical progression|0|||
148687098|NCT02711956|536327323|FG005|Overall Study|Clinical progression|0|||
148687099|NCT02711956|536327324|FG006|Overall Study|Clinical progression|1|||
148687100|NCT02711956|536327325|FG007|Overall Study|Clinical progression|0|||
148687101|NCT02711956|536327326|FG008|Overall Study|Clinical progression|1|||
148687102|NCT02711956|536327327|FG009|Overall Study|Clinical progression|0|||
148687103|NCT02711956|536327328|FG010|Overall Study|Clinical progression|0|||
148687104|NCT02711956|536327329|FG011|Overall Study|Clinical progression|2|||
148687105|NCT02711956|536327330|FG012|Overall Study|Clinical progression|4|||
148687106|NCT02711956|536327331|FG013|Overall Study|Clinical progression|1|||
148687107|NCT02711956|536327332|FG014|Overall Study|Clinical progression|1|||
148687108|NCT02711956|536327318|FG000|Overall Study|Radiographic progression|1|||
148687109|NCT02711956|536327319|FG001|Overall Study|Radiographic progression|1|||
148687110|NCT02711956|536327320|FG002|Overall Study|Radiographic progression|2|||
148687111|NCT02711956|536327321|FG003|Overall Study|Radiographic progression|0|||
148687112|NCT02711956|536327322|FG004|Overall Study|Radiographic progression|1|||
148687113|NCT02711956|536327323|FG005|Overall Study|Radiographic progression|0|||
148687114|NCT02711956|536327324|FG006|Overall Study|Radiographic progression|0|||
148687115|NCT02711956|536327325|FG007|Overall Study|Radiographic progression|0|||
148687116|NCT02711956|536327326|FG008|Overall Study|Radiographic progression|2|||
148687117|NCT02711956|536327327|FG009|Overall Study|Radiographic progression|1|||
148687118|NCT02711956|536327328|FG010|Overall Study|Radiographic progression|0|||
148687119|NCT02711956|536327329|FG011|Overall Study|Radiographic progression|5|||
148687120|NCT02711956|536327330|FG012|Overall Study|Radiographic progression|3|||
148687121|NCT02711956|536327331|FG013|Overall Study|Radiographic progression|0|||
148810129|NCT05383209|536782568|FG002|Overall Study|Adverse Event: Non-ocular|0|||
148687122|NCT02711956|536327332|FG014|Overall Study|Radiographic progression|1|||
148687123|NCT02711956|536327318|FG000|Overall Study|PSA progression with clinical progression|0|||
148687124|NCT02711956|536327319|FG001|Overall Study|PSA progression with clinical progression|0|||
148687125|NCT02711956|536327320|FG002|Overall Study|PSA progression with clinical progression|0|||
148687126|NCT02711956|536327321|FG003|Overall Study|PSA progression with clinical progression|0|||
148687127|NCT02711956|536327322|FG004|Overall Study|PSA progression with clinical progression|1|||
148687128|NCT02711956|536327323|FG005|Overall Study|PSA progression with clinical progression|0|||
148687129|NCT02711956|536327324|FG006|Overall Study|PSA progression with clinical progression|0|||
148687130|NCT02711956|536327325|FG007|Overall Study|PSA progression with clinical progression|0|||
148687131|NCT02711956|536327326|FG008|Overall Study|PSA progression with clinical progression|0|||
149224765|NCT00405756|538288113|FG001|Follow-up|Lost to Follow-up|8|||
149224766|NCT00405756|538288114|FG002|Follow-up|Lost to Follow-up|4|||
149224767|NCT02870348|538288117|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
149224768|NCT01051856|538288118|FG000|Overall Study|Withdrawal by Subject|1|||
149224769|NCT01051856|538288119|FG001|Overall Study|Withdrawal by Subject|0|||
149224770|NCT00672139|538288120|FG000|Overall Study|Death|14|||
149224771|NCT00672139|538288121|FG001|Overall Study|Death|23|||
149224772|NCT00672139|538288120|FG000|Overall Study|Withdrawal by Subject|2|||
148953793|NCT01285310|537313108|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
148953794|NCT01285310|537313109|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
148953795|NCT01285310|537313110|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
148953796|NCT01285310|537313111|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
148953797|NCT01285310|537313107|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
148953798|NCT01285310|537313108|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
148953799|NCT01285310|537313109|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
148953800|NCT01285310|537313110|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
148953801|NCT01285310|537313111|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
148953802|NCT01996982|537313114|FG000|Overall Study|PI/team left institution|7|||
148953803|NCT01195415|537313135|FG000|Overall Study|No repeat biopsy due to progression|2|||
148953804|NCT01442675|537313136|FG000|Overall Study|Protocol Violation|6|||
148953805|NCT01442675|537313136|FG000|Overall Study|Lost to Follow-up|2|||
148953806|NCT01442675|537313136|FG000|Overall Study|Withdrawal by Subject|4|||
148953807|NCT00752232|537313137|FG000|Overall Study|Protocol Violation|0|||
148953808|NCT00752232|537313138|FG001|Overall Study|Protocol Violation|0|||
148953809|NCT00752232|537313139|FG002|Overall Study|Protocol Violation|0|||
148953810|NCT00752232|537313140|FG003|Overall Study|Protocol Violation|0|||
148953811|NCT00752232|537313141|FG004|Overall Study|Protocol Violation|0|||
148953812|NCT00752232|537313142|FG005|Overall Study|Protocol Violation|1|||
148953813|NCT00752232|537313143|FG006|Overall Study|Protocol Violation|0|||
148953814|NCT00752232|537313137|FG000|Overall Study|Caregiver request|2|||
148953815|NCT00752232|537313138|FG001|Overall Study|Caregiver request|0|||
148953816|NCT00752232|537313139|FG002|Overall Study|Caregiver request|0|||
148953817|NCT00752232|537313140|FG003|Overall Study|Caregiver request|0|||
148953818|NCT00752232|537313141|FG004|Overall Study|Caregiver request|1|||
148953819|NCT00752232|537313142|FG005|Overall Study|Caregiver request|0|||
148953820|NCT00752232|537313143|FG006|Overall Study|Caregiver request|0|||
148953821|NCT00752232|537313137|FG000|Overall Study|Investigator request|0|||
148953822|NCT00752232|537313138|FG001|Overall Study|Investigator request|0|||
148953823|NCT00752232|537313139|FG002|Overall Study|Investigator request|0|||
148953824|NCT00752232|537313140|FG003|Overall Study|Investigator request|0|||
148953825|NCT00752232|537313141|FG004|Overall Study|Investigator request|1|||
148953826|NCT00752232|537313142|FG005|Overall Study|Investigator request|0|||
148953827|NCT00752232|537313143|FG006|Overall Study|Investigator request|0|||
148953828|NCT00752232|537313137|FG000|Overall Study|Subject request|0|||
148953829|NCT00752232|537313138|FG001|Overall Study|Subject request|0|||
148953830|NCT00752232|537313139|FG002|Overall Study|Subject request|1|||
148953831|NCT00752232|537313140|FG003|Overall Study|Subject request|0|||
148953832|NCT00752232|537313141|FG004|Overall Study|Subject request|0|||
148953833|NCT00752232|537313142|FG005|Overall Study|Subject request|0|||
148953834|NCT00752232|537313143|FG006|Overall Study|Subject request|0|||
148953835|NCT00752232|537313137|FG000|Overall Study|Group home admission|0|||
148953836|NCT00752232|537313138|FG001|Overall Study|Group home admission|0|||
148953837|NCT00752232|537313139|FG002|Overall Study|Group home admission|0|||
148953838|NCT00752232|537313140|FG003|Overall Study|Group home admission|1|||
148953839|NCT00752232|537313141|FG004|Overall Study|Group home admission|0|||
148953840|NCT00752232|537313142|FG005|Overall Study|Group home admission|0|||
148953841|NCT00752232|537313143|FG006|Overall Study|Group home admission|0|||
148953842|NCT00752232|537313137|FG000|Overall Study|Caregiver could not attend the subject|0|||
148953843|NCT00752232|537313138|FG001|Overall Study|Caregiver could not attend the subject|0|||
148953844|NCT00752232|537313139|FG002|Overall Study|Caregiver could not attend the subject|0|||
148953845|NCT00752232|537313140|FG003|Overall Study|Caregiver could not attend the subject|0|||
148953846|NCT00752232|537313141|FG004|Overall Study|Caregiver could not attend the subject|1|||
148953847|NCT00752232|537313142|FG005|Overall Study|Caregiver could not attend the subject|0|||
148953848|NCT00752232|537313143|FG006|Overall Study|Caregiver could not attend the subject|0|||
148953849|NCT00555321|537313144|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
148953850|NCT00555321|537313145|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
148953851|NCT00555321|537313146|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
148953852|NCT00555321|537313147|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
148953853|NCT00555321|537313148|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
148953854|NCT00555321|537313144|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
149224773|NCT00672139|538288121|FG001|Overall Study|Withdrawal by Subject|11|||
149224774|NCT00672139|538288120|FG000|Overall Study|Adverse Event|4|||
149224775|NCT00672139|538288121|FG001|Overall Study|Adverse Event|7|||
149224776|NCT00672139|538288120|FG000|Overall Study|Physician Decision|2|||
149224777|NCT00672139|538288121|FG001|Overall Study|Physician Decision|0|||
148687132|NCT02711956|536327327|FG009|Overall Study|PSA progression with clinical progression|0|||
148687133|NCT02711956|536327328|FG010|Overall Study|PSA progression with clinical progression|0|||
148687134|NCT02711956|536327329|FG011|Overall Study|PSA progression with clinical progression|0|||
148687135|NCT02711956|536327330|FG012|Overall Study|PSA progression with clinical progression|1|||
148687136|NCT02711956|536327331|FG013|Overall Study|PSA progression with clinical progression|1|||
148687137|NCT02711956|536327332|FG014|Overall Study|PSA progression with clinical progression|0|||
148687138|NCT02711956|536327318|FG000|Overall Study|PSA progression with radiographic progression|0|||
148687139|NCT02711956|536327319|FG001|Overall Study|PSA progression with radiographic progression|1|||
148687140|NCT02711956|536327320|FG002|Overall Study|PSA progression with radiographic progression|0|||
148687141|NCT02711956|536327321|FG003|Overall Study|PSA progression with radiographic progression|0|||
148687142|NCT02711956|536327322|FG004|Overall Study|PSA progression with radiographic progression|0|||
148687143|NCT02711956|536327323|FG005|Overall Study|PSA progression with radiographic progression|2|||
148687144|NCT02711956|536327324|FG006|Overall Study|PSA progression with radiographic progression|2|||
148687145|NCT02711956|536327325|FG007|Overall Study|PSA progression with radiographic progression|1|||
148687146|NCT02711956|536327326|FG008|Overall Study|PSA progression with radiographic progression|0|||
148687147|NCT02711956|536327327|FG009|Overall Study|PSA progression with radiographic progression|1|||
148687148|NCT02711956|536327328|FG010|Overall Study|PSA progression with radiographic progression|0|||
148687149|NCT02711956|536327329|FG011|Overall Study|PSA progression with radiographic progression|1|||
148687150|NCT02711956|536327330|FG012|Overall Study|PSA progression with radiographic progression|2|||
148687151|NCT02711956|536327331|FG013|Overall Study|PSA progression with radiographic progression|3|||
148687152|NCT02711956|536327332|FG014|Overall Study|PSA progression with radiographic progression|3|||
148687153|NCT05487456|536327333|FG000|Overall Study|Withdrawal by Subject|0|||
148687154|NCT05487456|536327334|FG001|Overall Study|Withdrawal by Subject|0|||
148687155|NCT05487456|536327335|FG002|Overall Study|Withdrawal by Subject|1|||
148687156|NCT05487456|536327336|FG003|Overall Study|Withdrawal by Subject|0|||
148687157|NCT01625377|536327339|FG000|Overall Study|Death|1|||
148687158|NCT01625377|536327340|FG001|Overall Study|Death|1|||
148687159|NCT01625377|536327339|FG000|Overall Study|Administrative Problem|1|||
148687160|NCT01625377|536327340|FG001|Overall Study|Administrative Problem|1|||
148687161|NCT01625377|536327339|FG000|Overall Study|Protocol Violation|0|||
148687162|NCT01625377|536327340|FG001|Overall Study|Protocol Violation|3|||
148687163|NCT01625377|536327339|FG000|Overall Study|Adverse Event|3|||
148687164|NCT01625377|536327340|FG001|Overall Study|Adverse Event|16|||
148687165|NCT01625377|536327339|FG000|Overall Study|Graft loss|1|||
148687166|NCT01625377|536327340|FG001|Overall Study|Graft loss|0|||
148687167|NCT01625377|536327339|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148687168|NCT01625377|536327340|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148687169|NCT01625377|536327339|FG000|Overall Study|Abnormal laboratory values|1|||
148687170|NCT01625377|536327340|FG001|Overall Study|Abnormal laboratory values|0|||
148687171|NCT02043366|536327343|FG000|Overall Study|Lost to Follow-up|2|||
148687172|NCT02043366|536327344|FG001|Overall Study|Lost to Follow-up|2|||
148687173|NCT02043366|536327345|FG002|Overall Study|Lost to Follow-up|2|||
148687174|NCT02043366|536327346|FG003|Overall Study|Lost to Follow-up|2|||
148687175|NCT02043366|536327347|FG004|Overall Study|Lost to Follow-up|2|||
148687176|NCT02043366|536327348|FG005|Overall Study|Lost to Follow-up|2|||
148687177|NCT03294538|536327351|FG000|Overall Study|Adverse Event|0|||
148687178|NCT03294538|536327352|FG001|Overall Study|Adverse Event|1|||
148687179|NCT03294538|536327353|FG002|Overall Study|Adverse Event|1|||
148687180|NCT03294538|536327351|FG000|Overall Study|Lost to Follow-up|1|||
148687181|NCT03294538|536327352|FG001|Overall Study|Lost to Follow-up|0|||
148687182|NCT03294538|536327353|FG002|Overall Study|Lost to Follow-up|0|||
148687183|NCT03294538|536327351|FG000|Overall Study|Outside of Visit Window|4|||
148687184|NCT03294538|536327352|FG001|Overall Study|Outside of Visit Window|4|||
148687185|NCT03294538|536327353|FG002|Overall Study|Outside of Visit Window|1|||
148687186|NCT01489956|536327355|FG000|Overall Study|Lost to Follow-up|1|||
148687187|NCT01489956|536327356|FG001|Overall Study|Lost to Follow-up|0|||
148687188|NCT01489956|536327357|FG002|Overall Study|Lost to Follow-up|0|||
148687189|NCT01489956|536327355|FG000|Overall Study|Withdrawal by Subject|0|||
148687190|NCT01489956|536327356|FG001|Overall Study|Withdrawal by Subject|0|||
148687191|NCT01489956|536327357|FG002|Overall Study|Withdrawal by Subject|1|||
148687192|NCT01769378|536327361|FG000|Overall Study|Adverse Event|10|||
148687193|NCT01769378|536327362|FG001|Overall Study|Adverse Event|0|||
148687194|NCT01769378|536327361|FG000|Overall Study|Entry criteria not met|1|||
148687195|NCT01769378|536327362|FG001|Overall Study|Entry criteria not met|0|||
148687196|NCT01769378|536327361|FG000|Overall Study|Protocol Violation|1|||
148687197|NCT01769378|536327362|FG001|Overall Study|Protocol Violation|1|||
148687198|NCT01769378|536327361|FG000|Overall Study|Withdrawal by Subject|10|||
148687199|NCT01769378|536327362|FG001|Overall Study|Withdrawal by Subject|3|||
148687200|NCT01769378|536327361|FG000|Overall Study|Sponsor Decision|1|||
148687201|NCT01769378|536327362|FG001|Overall Study|Sponsor Decision|0|||
148687202|NCT01769378|536327361|FG000|Overall Study|Lost to Follow-up|2|||
148687203|NCT01769378|536327362|FG001|Overall Study|Lost to Follow-up|0|||
148687204|NCT01090765|536327363|FG000|Overall Study|Patient withdrew consent|0|||
149018306|NCT01474512|537547157|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
149018307|NCT01474512|537547158|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
149018308|NCT01474512|537547159|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
149018309|NCT01474512|537547160|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
149018310|NCT01474512|537547161|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
149018311|NCT01474512|537547162|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
149224778|NCT00672139|538288120|FG000|Overall Study|Lack of Efficacy|4|||
149224779|NCT00672139|538288121|FG001|Overall Study|Lack of Efficacy|1|||
149224780|NCT00672139|538288120|FG000|Overall Study|Protocol Violation|1|||
149224781|NCT00672139|538288121|FG001|Overall Study|Protocol Violation|1|||
149224782|NCT00672139|538288120|FG000|Overall Study|hospice discharge, caregiver requests|3|||
149018312|NCT01474512|537547163|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
149018313|NCT01474512|537547164|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
149018314|NCT01474512|537547165|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
149018315|NCT01474512|537547166|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
149018316|NCT01474512|537547149|FG000|Long-Term Extension Period|Adverse Event|0|||
149018317|NCT01474512|537547150|FG001|Long-Term Extension Period|Adverse Event|0|||
149224783|NCT00672139|538288121|FG001|Overall Study|hospice discharge, caregiver requests|2|||
148687205|NCT01090765|536327364|FG001|Overall Study|Patient withdrew consent|0|||
149018318|NCT01474512|537547151|FG002|Long-Term Extension Period|Adverse Event|0|||
149018319|NCT01474512|537547152|FG003|Long-Term Extension Period|Adverse Event|0|||
149018320|NCT01474512|537547153|FG004|Long-Term Extension Period|Adverse Event|0|||
149018321|NCT01474512|537547154|FG005|Long-Term Extension Period|Adverse Event|0|||
149224784|NCT01117428|538288122|FG000|Overall Study|Lack of Efficacy|1|||
148687206|NCT01090765|536327365|FG002|Overall Study|Patient withdrew consent|0|||
148687207|NCT01090765|536327366|FG003|Overall Study|Patient withdrew consent|0|||
148687208|NCT01090765|536327367|FG004|Overall Study|Patient withdrew consent|1|||
148687209|NCT01090765|536327368|FG005|Overall Study|Patient withdrew consent|1|||
148687210|NCT01090765|536327363|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
148687211|NCT01090765|536327364|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
148687212|NCT01090765|536327365|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
148687213|NCT01090765|536327366|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
148687214|NCT01090765|536327367|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
148687215|NCT01090765|536327368|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
148687216|NCT01090765|536327363|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
148687217|NCT01090765|536327364|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
148687218|NCT01090765|536327365|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
148687219|NCT01090765|536327366|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
148687220|NCT01090765|536327367|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
148687221|NCT01090765|536327368|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
148687222|NCT01977092|536327369|FG000|Overall Study|Death|3|||
148687223|NCT01977092|536327370|FG001|Overall Study|Death|4|||
148687224|NCT01977092|536327369|FG000|Overall Study|Lost to Follow-up|23|||
148687225|NCT01977092|536327370|FG001|Overall Study|Lost to Follow-up|14|||
148687226|NCT01977092|536327369|FG000|Overall Study|Withdrawal by Subject|2|||
148687227|NCT01977092|536327370|FG001|Overall Study|Withdrawal by Subject|1|||
148687228|NCT01977092|536327369|FG000|Overall Study|In prison|3|||
148687229|NCT01977092|536327370|FG001|Overall Study|In prison|11|||
148687230|NCT00678392|536327371|FG000|Overall Study|Adverse Event|0|||
148687231|NCT00678392|536327372|FG001|Overall Study|Adverse Event|6|||
148687232|NCT00678392|536327371|FG000|Overall Study|Death|280|||
148687233|NCT00678392|536327372|FG001|Overall Study|Death|269|||
148687234|NCT00678392|536327371|FG000|Overall Study|Lost to Follow-up|15|||
148687235|NCT00678392|536327372|FG001|Overall Study|Lost to Follow-up|13|||
148687236|NCT00678392|536327371|FG000|Overall Study|Objective Progression or Relapse|3|||
148687237|NCT00678392|536327372|FG001|Overall Study|Objective Progression or Relapse|8|||
148687238|NCT00678392|536327371|FG000|Overall Study|Sponsor's Decision|1|||
148687239|NCT00678392|536327372|FG001|Overall Study|Sponsor's Decision|2|||
148687240|NCT00678392|536327371|FG000|Overall Study|Withdrawal by Subject|4|||
148687241|NCT00678392|536327372|FG001|Overall Study|Withdrawal by Subject|4|||
148687242|NCT00678392|536327371|FG000|Overall Study|Randomized But Not Treated|2|||
148687243|NCT00678392|536327372|FG001|Overall Study|Randomized But Not Treated|7|||
148687244|NCT00678392|536327371|FG000|Overall Study|Other|56|||
148687245|NCT00678392|536327372|FG001|Overall Study|Other|53|||
148687246|NCT01958281|536327373|FG000|Overall Study|Lack of Efficacy|5|||
148687247|NCT01958281|536327374|FG001|Overall Study|Lack of Efficacy|2|||
148687248|NCT01958281|536327375|FG002|Overall Study|Lack of Efficacy|0|||
148687249|NCT01958281|536327373|FG000|Overall Study|Adverse Event|0|||
148687250|NCT01958281|536327374|FG001|Overall Study|Adverse Event|2|||
148687251|NCT01958281|536327375|FG002|Overall Study|Adverse Event|0|||
148687252|NCT01958281|536327373|FG000|Overall Study|Withdrew Consent|1|||
148687253|NCT01958281|536327374|FG001|Overall Study|Withdrew Consent|0|||
148687254|NCT01958281|536327375|FG002|Overall Study|Withdrew Consent|0|||
149018322|NCT01474512|537547155|FG006|Long-Term Extension Period|Adverse Event|0|||
149224785|NCT01117428|538288123|FG001|Overall Study|Lack of Efficacy|0|||
149018323|NCT01474512|537547156|FG007|Long-Term Extension Period|Adverse Event|0|||
149018324|NCT01474512|537547157|FG008|Long-Term Extension Period|Adverse Event|0|||
149018325|NCT01474512|537547158|FG009|Long-Term Extension Period|Adverse Event|0|||
149018326|NCT01474512|537547159|FG010|Long-Term Extension Period|Adverse Event|0|||
149018327|NCT01474512|537547160|FG011|Long-Term Extension Period|Adverse Event|1|||
149224786|NCT01117428|538288124|FG002|Overall Study|Lack of Efficacy|0|||
149224787|NCT01117428|538288125|FG003|Overall Study|Lack of Efficacy|0|||
149224788|NCT01117428|538288126|FG004|Overall Study|Lack of Efficacy|0|||
149224789|NCT01117428|538288127|FG005|Overall Study|Lack of Efficacy|0|||
149224790|NCT01117428|538288122|FG000|Overall Study|Adverse Event|4|||
149224791|NCT01117428|538288123|FG001|Overall Study|Adverse Event|0|||
149224792|NCT01117428|538288124|FG002|Overall Study|Adverse Event|0|||
149224793|NCT01117428|538288125|FG003|Overall Study|Adverse Event|0|||
149224794|NCT01117428|538288126|FG004|Overall Study|Adverse Event|1|||
149224795|NCT01117428|538288127|FG005|Overall Study|Adverse Event|2|||
149018328|NCT01474512|537547161|FG012|Long-Term Extension Period|Adverse Event|57|||
149018329|NCT01474512|537547162|FG013|Long-Term Extension Period|Adverse Event|58|||
149018330|NCT01474512|537547163|FG014|Long-Term Extension Period|Adverse Event|0|||
149018331|NCT01474512|537547164|FG015|Long-Term Extension Period|Adverse Event|0|||
149224796|NCT01117428|538288122|FG000|Overall Study|Death|0|||
149224797|NCT01117428|538288123|FG001|Overall Study|Death|1|||
149018332|NCT01474512|537547165|FG016|Long-Term Extension Period|Adverse Event|0|||
149018333|NCT01474512|537547166|FG017|Long-Term Extension Period|Adverse Event|0|||
149018334|NCT01474512|537547149|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
149018335|NCT01474512|537547150|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
149018336|NCT01474512|537547151|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
149018337|NCT01474512|537547152|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
149018338|NCT01474512|537547153|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
149018339|NCT01474512|537547154|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
149018340|NCT01474512|537547155|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
149018341|NCT01474512|537547156|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
149018342|NCT01474512|537547157|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
149018343|NCT01474512|537547158|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
149018344|NCT01474512|537547159|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
149018345|NCT01474512|537547160|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
149018346|NCT01474512|537547161|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
149018347|NCT01474512|537547162|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
149018348|NCT01474512|537547163|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
149018349|NCT01474512|537547164|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
149224798|NCT01117428|538288124|FG002|Overall Study|Death|2|||
149224799|NCT01117428|538288125|FG003|Overall Study|Death|0|||
149224800|NCT01117428|538288126|FG004|Overall Study|Death|0|||
148810130|NCT05383209|536782566|FG000|Overall Study|Lost to Follow-up|2|||
149018350|NCT01474512|537547165|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
149018351|NCT01474512|537547166|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
149018352|NCT01474512|537547149|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
149018353|NCT01474512|537547150|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
149018354|NCT01474512|537547151|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
149018355|NCT01474512|537547152|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
149018356|NCT01474512|537547153|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
149018357|NCT01474512|537547154|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
149018358|NCT01474512|537547155|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
149018359|NCT01474512|537547156|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
149018360|NCT01474512|537547157|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
149018361|NCT01474512|537547158|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
148687255|NCT02784106|536327378|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
148687256|NCT02784106|536327379|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
148687257|NCT02784106|536327380|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
148687258|NCT02784106|536327381|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
148687259|NCT02784106|536327378|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
148687260|NCT02784106|536327379|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
148687261|NCT02784106|536327380|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148687262|NCT02784106|536327381|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148687263|NCT02784106|536327378|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
148687264|NCT02784106|536327379|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
148687265|NCT02784106|536327380|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
148687266|NCT02784106|536327381|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
148687267|NCT02784106|536327378|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
148687268|NCT02784106|536327379|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
148687269|NCT02784106|536327380|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
148687270|NCT02784106|536327381|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
148687271|NCT02784106|536327378|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
148687272|NCT02784106|536327379|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
148687273|NCT02784106|536327380|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
148687274|NCT02784106|536327381|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
148687275|NCT02784106|536327378|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
148687276|NCT02784106|536327379|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
148687277|NCT02784106|536327380|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
148687278|NCT02784106|536327381|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
148687279|NCT00718159|536327382|FG000|Overall Study|Progressive Disease|3|||
148687280|NCT00718159|536327383|FG001|Overall Study|Progressive Disease|3|||
148687281|NCT00718159|536327384|FG002|Overall Study|Progressive Disease|2|||
148687282|NCT00718159|536327385|FG003|Overall Study|Progressive Disease|0|||
148687283|NCT00718159|536327386|FG004|Overall Study|Progressive Disease|6|||
148687284|NCT00718159|536327387|FG005|Overall Study|Progressive Disease|0|||
148687285|NCT00718159|536327388|FG006|Overall Study|Progressive Disease|0|||
148687286|NCT00718159|536327382|FG000|Overall Study|Death due to Adverse Event|0|||
148687287|NCT00718159|536327383|FG001|Overall Study|Death due to Adverse Event|0|||
148687288|NCT00718159|536327384|FG002|Overall Study|Death due to Adverse Event|0|||
148687289|NCT00718159|536327385|FG003|Overall Study|Death due to Adverse Event|2|||
148687290|NCT00718159|536327386|FG004|Overall Study|Death due to Adverse Event|2|||
148687291|NCT00718159|536327387|FG005|Overall Study|Death due to Adverse Event|0|||
148687292|NCT00718159|536327388|FG006|Overall Study|Death due to Adverse Event|0|||
148687293|NCT00718159|536327382|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
148687294|NCT00718159|536327383|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
148687295|NCT00718159|536327384|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
148687296|NCT00718159|536327385|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
148687297|NCT00718159|536327386|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
148687298|NCT00718159|536327387|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
148687299|NCT00718159|536327388|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
148687300|NCT00718159|536327382|FG000|Overall Study|Investigator Decision|0|||
149018362|NCT01474512|537547159|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
149018363|NCT01474512|537547160|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
149018364|NCT01474512|537547161|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
148687301|NCT00718159|536327383|FG001|Overall Study|Investigator Decision|0|||
149018365|NCT01474512|537547162|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
148687302|NCT00718159|536327384|FG002|Overall Study|Investigator Decision|0|||
148687303|NCT00718159|536327385|FG003|Overall Study|Investigator Decision|0|||
148810131|NCT05383209|536782567|FG001|Overall Study|Lost to Follow-up|1|||
148810132|NCT05383209|536782568|FG002|Overall Study|Lost to Follow-up|4|||
149018366|NCT01474512|537547163|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
149018367|NCT01474512|537547164|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
149018368|NCT01474512|537547165|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
149018369|NCT01474512|537547166|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
149018370|NCT01474512|537547149|FG000|Long-Term Extension Period|Physician Decision|0|||
149018371|NCT01474512|537547150|FG001|Long-Term Extension Period|Physician Decision|0|||
149018372|NCT01474512|537547151|FG002|Long-Term Extension Period|Physician Decision|0|||
149018373|NCT01474512|537547152|FG003|Long-Term Extension Period|Physician Decision|0|||
149018374|NCT01474512|537547153|FG004|Long-Term Extension Period|Physician Decision|0|||
149018375|NCT01474512|537547154|FG005|Long-Term Extension Period|Physician Decision|0|||
149018376|NCT01474512|537547155|FG006|Long-Term Extension Period|Physician Decision|0|||
149018377|NCT01474512|537547156|FG007|Long-Term Extension Period|Physician Decision|0|||
149018378|NCT01474512|537547157|FG008|Long-Term Extension Period|Physician Decision|0|||
149018379|NCT01474512|537547158|FG009|Long-Term Extension Period|Physician Decision|0|||
149018380|NCT01474512|537547159|FG010|Long-Term Extension Period|Physician Decision|0|||
149018381|NCT01474512|537547160|FG011|Long-Term Extension Period|Physician Decision|0|||
148687304|NCT00718159|536327386|FG004|Overall Study|Investigator Decision|0|||
148687305|NCT00718159|536327387|FG005|Overall Study|Investigator Decision|1|||
148687306|NCT00718159|536327388|FG006|Overall Study|Investigator Decision|1|||
148687307|NCT00782509|536327390|FG000|Overall Study|Adverse Event|20|||
148687308|NCT00782509|536327391|FG001|Overall Study|Adverse Event|10|||
148687309|NCT00782509|536327392|FG002|Overall Study|Adverse Event|20|||
148687310|NCT00782509|536327390|FG000|Overall Study|Lost to Follow-up|1|||
148687311|NCT00782509|536327391|FG001|Overall Study|Lost to Follow-up|2|||
148687312|NCT00782509|536327392|FG002|Overall Study|Lost to Follow-up|3|||
148687313|NCT00782509|536327390|FG000|Overall Study|Withdrawal by Subject|3|||
148687314|NCT00782509|536327391|FG001|Overall Study|Withdrawal by Subject|5|||
148687315|NCT00782509|536327392|FG002|Overall Study|Withdrawal by Subject|8|||
148687316|NCT00782509|536327390|FG000|Overall Study|Non compliance with protocol|2|||
148687317|NCT00782509|536327391|FG001|Overall Study|Non compliance with protocol|0|||
148687318|NCT00782509|536327392|FG002|Overall Study|Non compliance with protocol|0|||
148687319|NCT00782509|536327390|FG000|Overall Study|Other reasons not stated above|5|||
148687320|NCT00782509|536327391|FG001|Overall Study|Other reasons not stated above|2|||
148687321|NCT00782509|536327392|FG002|Overall Study|Other reasons not stated above|3|||
148687322|NCT00782509|536327390|FG000|Overall Study|Lack of Efficacy|10|||
148687323|NCT00782509|536327391|FG001|Overall Study|Lack of Efficacy|5|||
148687324|NCT00782509|536327392|FG002|Overall Study|Lack of Efficacy|2|||
148687325|NCT00175019|536327394|FG000|Overall Study|Adverse Event|54|||
148687326|NCT00175019|536327395|FG001|Overall Study|Adverse Event|22|||
148687327|NCT00175019|536327396|FG002|Overall Study|Adverse Event|2|||
148687328|NCT00175019|536327394|FG000|Overall Study|Protocol Violation|6|||
148687329|NCT00175019|536327395|FG001|Overall Study|Protocol Violation|3|||
148687330|NCT00175019|536327396|FG002|Overall Study|Protocol Violation|3|||
148687331|NCT00175019|536327394|FG000|Overall Study|Lost to Follow-up|42|||
148687332|NCT00175019|536327395|FG001|Overall Study|Lost to Follow-up|39|||
148687333|NCT00175019|536327396|FG002|Overall Study|Lost to Follow-up|9|||
148687334|NCT00175019|536327394|FG000|Overall Study|Did not continue under Amendment 4|1|||
148687335|NCT00175019|536327395|FG001|Overall Study|Did not continue under Amendment 4|1|||
148687336|NCT00175019|536327396|FG002|Overall Study|Did not continue under Amendment 4|2|||
148687337|NCT00175019|536327394|FG000|Overall Study|Personal Reason(s)|39|||
148687338|NCT00175019|536327395|FG001|Overall Study|Personal Reason(s)|31|||
148687339|NCT00175019|536327396|FG002|Overall Study|Personal Reason(s)|8|||
148687340|NCT00175019|536327394|FG000|Overall Study|Therapeutic Failure|10|||
148687341|NCT00175019|536327395|FG001|Overall Study|Therapeutic Failure|38|||
148687342|NCT00175019|536327396|FG002|Overall Study|Therapeutic Failure|22|||
148687343|NCT00175019|536327394|FG000|Overall Study|Gout Flare|2|||
148687344|NCT00175019|536327395|FG001|Overall Study|Gout Flare|3|||
148687345|NCT00175019|536327396|FG002|Overall Study|Gout Flare|0|||
148687346|NCT00175019|536327394|FG000|Overall Study|Reason Not Specified|40|||
149018382|NCT01474512|537547161|FG012|Long-Term Extension Period|Physician Decision|21|||
149018383|NCT01474512|537547162|FG013|Long-Term Extension Period|Physician Decision|21|||
149224801|NCT01117428|538288127|FG005|Overall Study|Death|1|||
149224802|NCT01117428|538288122|FG000|Overall Study|Physician Decision|0|||
149224803|NCT01117428|538288123|FG001|Overall Study|Physician Decision|1|||
149224804|NCT01117428|538288124|FG002|Overall Study|Physician Decision|0|||
149224805|NCT01117428|538288125|FG003|Overall Study|Physician Decision|0|||
149224806|NCT01117428|538288126|FG004|Overall Study|Physician Decision|0|||
149224807|NCT01117428|538288127|FG005|Overall Study|Physician Decision|0|||
148687347|NCT00175019|536327395|FG001|Overall Study|Reason Not Specified|34|||
148687348|NCT00175019|536327396|FG002|Overall Study|Reason Not Specified|11|||
148687349|NCT01405820|536327406|FG000|Randomized Treatment Period|Adverse Event|3|||
148687350|NCT01405820|536327407|FG001|Randomized Treatment Period|Adverse Event|3|||
148687351|NCT01405820|536327408|FG002|Randomized Treatment Period|Adverse Event|3|||
149224808|NCT01117428|538288122|FG000|Overall Study|Withdrawal by Subject|0|||
148687352|NCT01405820|536327409|FG003|Randomized Treatment Period|Adverse Event|0|||
148687353|NCT01405820|536327410|FG004|Randomized Treatment Period|Adverse Event|2|||
148687354|NCT01405820|536327411|FG005|Randomized Treatment Period|Adverse Event|1|||
148687355|NCT01405820|536327406|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
149224809|NCT01117428|538288123|FG001|Overall Study|Withdrawal by Subject|0|||
149224810|NCT01117428|538288124|FG002|Overall Study|Withdrawal by Subject|1|||
149224811|NCT01117428|538288125|FG003|Overall Study|Withdrawal by Subject|0|||
149224812|NCT01117428|538288126|FG004|Overall Study|Withdrawal by Subject|0|||
149224813|NCT01117428|538288127|FG005|Overall Study|Withdrawal by Subject|0|||
149224814|NCT01117428|538288122|FG000|Overall Study|Progressive disease|15|||
148953855|NCT00555321|537313145|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
148953856|NCT00555321|537313146|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
148953857|NCT00555321|537313147|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
148953858|NCT00555321|537313148|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
148953859|NCT00555321|537313144|FG000|Treatment Phase up to 12-months|Death|2|||
148953860|NCT00555321|537313145|FG001|Treatment Phase up to 12-months|Death|1|||
148953861|NCT00555321|537313146|FG002|Treatment Phase up to 12-months|Death|4|||
148953862|NCT00555321|537313147|FG003|Treatment Phase up to 12-months|Death|0|||
148953863|NCT00555321|537313148|FG004|Treatment Phase up to 12-months|Death|0|||
148953864|NCT00555321|537313144|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
148953865|NCT00555321|537313145|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
148953866|NCT00555321|537313146|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
148953867|NCT00555321|537313147|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
148953868|NCT00555321|537313148|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
148953869|NCT00555321|537313144|FG000|Treatment Phase up to 12-months|Other Reason|1|||
148953870|NCT00555321|537313145|FG001|Treatment Phase up to 12-months|Other Reason|3|||
148953871|NCT00555321|537313146|FG002|Treatment Phase up to 12-months|Other Reason|2|||
148953872|NCT00555321|537313147|FG003|Treatment Phase up to 12-months|Other Reason|0|||
148953873|NCT00555321|537313148|FG004|Treatment Phase up to 12-months|Other Reason|0|||
148953874|NCT00555321|537313144|FG000|Treatment Phase up to 12-months|Never treated|2|||
148953875|NCT00555321|537313145|FG001|Treatment Phase up to 12-months|Never treated|3|||
148953876|NCT00555321|537313146|FG002|Treatment Phase up to 12-months|Never treated|1|||
148953877|NCT00555321|537313147|FG003|Treatment Phase up to 12-months|Never treated|0|||
148953878|NCT00555321|537313148|FG004|Treatment Phase up to 12-months|Never treated|4|||
148953879|NCT00555321|537313144|FG000|Long-term Extension Phase|Adverse Event|2|||
148953880|NCT00555321|537313145|FG001|Long-term Extension Phase|Adverse Event|5|||
148953881|NCT00555321|537313146|FG002|Long-term Extension Phase|Adverse Event|2|||
148953882|NCT00555321|537313147|FG003|Long-term Extension Phase|Adverse Event|1|||
148953883|NCT00555321|537313148|FG004|Long-term Extension Phase|Adverse Event|0|||
148953884|NCT00555321|537313144|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
148953885|NCT00555321|537313145|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
148953886|NCT00555321|537313146|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
148953887|NCT00555321|537313147|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
148953888|NCT00555321|537313148|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
148953889|NCT00555321|537313144|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
148953890|NCT00555321|537313145|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
148953891|NCT00555321|537313146|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
148953892|NCT00555321|537313147|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
148953893|NCT00555321|537313148|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
148953894|NCT00555321|537313144|FG000|Long-term Extension Phase|Death|2|||
148953895|NCT00555321|537313145|FG001|Long-term Extension Phase|Death|0|||
148953896|NCT00555321|537313146|FG002|Long-term Extension Phase|Death|0|||
148953897|NCT00555321|537313147|FG003|Long-term Extension Phase|Death|3|||
148953898|NCT00555321|537313148|FG004|Long-term Extension Phase|Death|0|||
148953899|NCT00555321|537313144|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
148953900|NCT00555321|537313145|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
148953901|NCT00555321|537313146|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
148953902|NCT00555321|537313147|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
148953903|NCT00555321|537313148|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
149018384|NCT01474512|537547163|FG014|Long-Term Extension Period|Physician Decision|0|||
149018385|NCT01474512|537547164|FG015|Long-Term Extension Period|Physician Decision|0|||
149224815|NCT01117428|538288123|FG001|Overall Study|Progressive disease|27|||
149224816|NCT01117428|538288124|FG002|Overall Study|Progressive disease|10|||
149224817|NCT01117428|538288125|FG003|Overall Study|Progressive disease|12|||
149224818|NCT01117428|538288126|FG004|Overall Study|Progressive disease|16|||
149224819|NCT01117428|538288127|FG005|Overall Study|Progressive disease|17|||
149224820|NCT02519777|538288128|FG000|Overall Study|Death|1|||
149224821|NCT02519777|538288129|FG001|Overall Study|Death|0|||
149224822|NCT02519777|538288130|FG002|Overall Study|Death|0|||
149224823|NCT02519777|538288128|FG000|Overall Study|Lost to Follow-up|0|||
149224824|NCT02519777|538288129|FG001|Overall Study|Lost to Follow-up|4|||
149224825|NCT02519777|538288130|FG002|Overall Study|Lost to Follow-up|2|||
149224826|NCT02519777|538288128|FG000|Overall Study|Withdrawal by Subject|3|||
149224827|NCT02519777|538288129|FG001|Overall Study|Withdrawal by Subject|1|||
149224828|NCT02519777|538288130|FG002|Overall Study|Withdrawal by Subject|0|||
149224829|NCT02519777|538288128|FG000|Overall Study|Severe Debilitation|1|||
148953904|NCT00555321|537313144|FG000|Long-term Extension Phase|Other Reason|1|||
149018386|NCT01474512|537547165|FG016|Long-Term Extension Period|Physician Decision|0|||
149018387|NCT01474512|537547166|FG017|Long-Term Extension Period|Physician Decision|0|||
149018388|NCT01474512|537547149|FG000|Long-Term Extension Period|Clinical Relapse|0|||
149018389|NCT01474512|537547150|FG001|Long-Term Extension Period|Clinical Relapse|0|||
149018390|NCT01474512|537547151|FG002|Long-Term Extension Period|Clinical Relapse|0|||
149018391|NCT01474512|537547152|FG003|Long-Term Extension Period|Clinical Relapse|0|||
149018392|NCT01474512|537547153|FG004|Long-Term Extension Period|Clinical Relapse|0|||
149018393|NCT01474512|537547154|FG005|Long-Term Extension Period|Clinical Relapse|0|||
149018394|NCT01474512|537547155|FG006|Long-Term Extension Period|Clinical Relapse|0|||
149018395|NCT01474512|537547156|FG007|Long-Term Extension Period|Clinical Relapse|0|||
149018396|NCT01474512|537547157|FG008|Long-Term Extension Period|Clinical Relapse|0|||
149018397|NCT01474512|537547158|FG009|Long-Term Extension Period|Clinical Relapse|0|||
149018398|NCT01474512|537547159|FG010|Long-Term Extension Period|Clinical Relapse|0|||
149018399|NCT01474512|537547160|FG011|Long-Term Extension Period|Clinical Relapse|0|||
149018400|NCT01474512|537547161|FG012|Long-Term Extension Period|Clinical Relapse|9|||
149018401|NCT01474512|537547162|FG013|Long-Term Extension Period|Clinical Relapse|9|||
149018402|NCT01474512|537547163|FG014|Long-Term Extension Period|Clinical Relapse|0|||
149018403|NCT01474512|537547164|FG015|Long-Term Extension Period|Clinical Relapse|0|||
149018404|NCT01474512|537547165|FG016|Long-Term Extension Period|Clinical Relapse|0|||
149018405|NCT01474512|537547166|FG017|Long-Term Extension Period|Clinical Relapse|0|||
149018406|NCT01474512|537547149|FG000|Long-Term Extension Period|Death|0|||
149018407|NCT01474512|537547150|FG001|Long-Term Extension Period|Death|0|||
149018408|NCT01474512|537547151|FG002|Long-Term Extension Period|Death|0|||
149018409|NCT01474512|537547152|FG003|Long-Term Extension Period|Death|0|||
149018410|NCT01474512|537547153|FG004|Long-Term Extension Period|Death|0|||
149018411|NCT01474512|537547154|FG005|Long-Term Extension Period|Death|0|||
149018412|NCT01474512|537547155|FG006|Long-Term Extension Period|Death|0|||
149018413|NCT01474512|537547156|FG007|Long-Term Extension Period|Death|0|||
149018414|NCT01474512|537547157|FG008|Long-Term Extension Period|Death|0|||
149018415|NCT01474512|537547158|FG009|Long-Term Extension Period|Death|0|||
149018416|NCT01474512|537547159|FG010|Long-Term Extension Period|Death|0|||
149018417|NCT01474512|537547160|FG011|Long-Term Extension Period|Death|0|||
149018418|NCT01474512|537547161|FG012|Long-Term Extension Period|Death|9|||
149018419|NCT01474512|537547162|FG013|Long-Term Extension Period|Death|9|||
149018420|NCT01474512|537547163|FG014|Long-Term Extension Period|Death|0|||
149018421|NCT01474512|537547164|FG015|Long-Term Extension Period|Death|0|||
149018422|NCT01474512|537547165|FG016|Long-Term Extension Period|Death|0|||
149018423|NCT01474512|537547166|FG017|Long-Term Extension Period|Death|0|||
149018424|NCT01474512|537547149|FG000|Long-Term Extension Period|Sponsor Decision|0|||
149018425|NCT01474512|537547150|FG001|Long-Term Extension Period|Sponsor Decision|0|||
149018426|NCT01474512|537547151|FG002|Long-Term Extension Period|Sponsor Decision|0|||
149018427|NCT01474512|537547152|FG003|Long-Term Extension Period|Sponsor Decision|0|||
149018428|NCT01474512|537547153|FG004|Long-Term Extension Period|Sponsor Decision|0|||
149018429|NCT01474512|537547154|FG005|Long-Term Extension Period|Sponsor Decision|0|||
149018430|NCT01474512|537547155|FG006|Long-Term Extension Period|Sponsor Decision|0|||
149018431|NCT01474512|537547156|FG007|Long-Term Extension Period|Sponsor Decision|0|||
149018432|NCT01474512|537547157|FG008|Long-Term Extension Period|Sponsor Decision|0|||
149018433|NCT01474512|537547158|FG009|Long-Term Extension Period|Sponsor Decision|0|||
149018434|NCT01474512|537547159|FG010|Long-Term Extension Period|Sponsor Decision|0|||
149018435|NCT01474512|537547160|FG011|Long-Term Extension Period|Sponsor Decision|0|||
149018436|NCT01474512|537547161|FG012|Long-Term Extension Period|Sponsor Decision|6|||
149018437|NCT01474512|537547162|FG013|Long-Term Extension Period|Sponsor Decision|6|||
149018438|NCT01474512|537547163|FG014|Long-Term Extension Period|Sponsor Decision|0|||
149018439|NCT01474512|537547164|FG015|Long-Term Extension Period|Sponsor Decision|0|||
149018440|NCT01474512|537547165|FG016|Long-Term Extension Period|Sponsor Decision|0|||
149018441|NCT01474512|537547166|FG017|Long-Term Extension Period|Sponsor Decision|0|||
149018442|NCT01474512|537547149|FG000|Long-Term Extension Period|Protocol Violation|0|||
149018443|NCT01474512|537547150|FG001|Long-Term Extension Period|Protocol Violation|0|||
149018444|NCT01474512|537547151|FG002|Long-Term Extension Period|Protocol Violation|0|||
149018445|NCT01474512|537547152|FG003|Long-Term Extension Period|Protocol Violation|0|||
149018446|NCT01474512|537547153|FG004|Long-Term Extension Period|Protocol Violation|0|||
149018447|NCT01474512|537547154|FG005|Long-Term Extension Period|Protocol Violation|0|||
149018448|NCT01474512|537547155|FG006|Long-Term Extension Period|Protocol Violation|0|||
149018449|NCT01474512|537547156|FG007|Long-Term Extension Period|Protocol Violation|0|||
149018450|NCT01474512|537547157|FG008|Long-Term Extension Period|Protocol Violation|0|||
149018451|NCT01474512|537547158|FG009|Long-Term Extension Period|Protocol Violation|0|||
149018452|NCT01474512|537547159|FG010|Long-Term Extension Period|Protocol Violation|0|||
149018453|NCT01474512|537547160|FG011|Long-Term Extension Period|Protocol Violation|0|||
149018454|NCT01474512|537547161|FG012|Long-Term Extension Period|Protocol Violation|5|||
149018455|NCT01474512|537547162|FG013|Long-Term Extension Period|Protocol Violation|5|||
149224830|NCT02519777|538288129|FG001|Overall Study|Severe Debilitation|1|||
149224831|NCT02519777|538288130|FG002|Overall Study|Severe Debilitation|1|||
149224832|NCT02519777|538288128|FG000|Overall Study|Not able to get to clinic|1|||
149018456|NCT01474512|537547163|FG014|Long-Term Extension Period|Protocol Violation|0|||
149018457|NCT01474512|537547164|FG015|Long-Term Extension Period|Protocol Violation|0|||
149018458|NCT01474512|537547165|FG016|Long-Term Extension Period|Protocol Violation|0|||
149018459|NCT01474512|537547166|FG017|Long-Term Extension Period|Protocol Violation|0|||
149018460|NCT01474512|537547149|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018461|NCT01474512|537547150|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018462|NCT01474512|537547151|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018463|NCT01474512|537547152|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018464|NCT01474512|537547153|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018465|NCT01474512|537547154|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018466|NCT01474512|537547155|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018467|NCT01474512|537547156|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018468|NCT01474512|537547157|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018469|NCT01474512|537547158|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018470|NCT01474512|537547159|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018471|NCT01474512|537547160|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018472|NCT01474512|537547161|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
149018473|NCT01474512|537547162|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
149018474|NCT01474512|537547163|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018475|NCT01474512|537547164|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018476|NCT01474512|537547165|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018477|NCT01474512|537547166|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
149018478|NCT01474512|537547149|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018479|NCT01474512|537547150|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018480|NCT01474512|537547151|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018481|NCT01474512|537547152|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018482|NCT01474512|537547153|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018483|NCT01474512|537547154|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018484|NCT01474512|537547155|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018485|NCT01474512|537547156|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018486|NCT01474512|537547157|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018487|NCT01474512|537547158|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018488|NCT01474512|537547159|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018489|NCT01474512|537547160|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
149018490|NCT01474512|537547161|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018491|NCT01474512|537547162|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018492|NCT01474512|537547163|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018493|NCT01474512|537547164|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018494|NCT01474512|537547165|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018495|NCT01474512|537547166|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
149018496|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
149018497|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
149018498|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
149018499|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
149018500|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
149018501|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
149018502|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
149018503|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
149018504|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
149018505|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
149018506|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
149018507|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
149018508|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
149018509|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
149018510|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
149018511|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
149018512|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
149018513|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
149018514|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018515|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018516|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018517|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018518|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018519|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018520|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149224833|NCT02519777|538288129|FG001|Overall Study|Not able to get to clinic|2|||
149224834|NCT02519777|538288130|FG002|Overall Study|Not able to get to clinic|1|||
149018521|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149224835|NCT02195531|538288131|FG000|Overall Study|Withdrawal by Subject|1|||
149018522|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018523|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018524|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018525|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018526|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018527|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
149018528|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
149018529|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
149018530|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
149018531|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
149018532|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018533|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018534|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018535|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018536|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018537|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018538|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018539|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018540|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018541|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018542|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018543|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018544|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018545|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
149018546|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
149018547|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
149018548|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
149018549|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
149018550|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018551|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018552|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018553|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018554|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018555|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018556|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018557|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018558|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018559|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018560|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018561|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018562|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018563|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018564|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018565|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
149018566|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
149018567|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
149018568|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
149018569|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
149018570|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
149018571|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
149018572|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
149018573|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
149018574|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
149018575|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
149018576|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
149018577|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
149018578|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
149018579|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
149018580|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
149018581|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
149018582|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
149018583|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
149018584|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
149018585|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
149018586|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018587|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018588|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018589|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018590|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
148687356|NCT01405820|536327407|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
148687357|NCT01405820|536327408|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
148687358|NCT01405820|536327409|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
148687359|NCT01405820|536327410|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
148687360|NCT01405820|536327411|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
148687361|NCT01405820|536327406|FG000|Randomized Treatment Period|Other|2|||
148687362|NCT01405820|536327407|FG001|Randomized Treatment Period|Other|2|||
148687363|NCT01405820|536327408|FG002|Randomized Treatment Period|Other|1|||
148687364|NCT01405820|536327409|FG003|Randomized Treatment Period|Other|1|||
148687365|NCT01405820|536327410|FG004|Randomized Treatment Period|Other|0|||
148687366|NCT01405820|536327411|FG005|Randomized Treatment Period|Other|0|||
148687367|NCT01405820|536327406|FG000|Randomized Treatment Period|Physician Decision|0|||
148687368|NCT01405820|536327407|FG001|Randomized Treatment Period|Physician Decision|2|||
148687369|NCT01405820|536327408|FG002|Randomized Treatment Period|Physician Decision|1|||
148687370|NCT01405820|536327409|FG003|Randomized Treatment Period|Physician Decision|0|||
148687371|NCT01405820|536327410|FG004|Randomized Treatment Period|Physician Decision|0|||
148687372|NCT01405820|536327411|FG005|Randomized Treatment Period|Physician Decision|0|||
148687373|NCT01405820|536327406|FG000|Randomized Treatment Period|Rescue|0|||
148687374|NCT01405820|536327407|FG001|Randomized Treatment Period|Rescue|1|||
148687375|NCT01405820|536327408|FG002|Randomized Treatment Period|Rescue|13|||
148687376|NCT01405820|536327409|FG003|Randomized Treatment Period|Rescue|10|||
148687377|NCT01405820|536327410|FG004|Randomized Treatment Period|Rescue|8|||
148687378|NCT01405820|536327411|FG005|Randomized Treatment Period|Rescue|8|||
148687379|NCT01405820|536327406|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
148687380|NCT01405820|536327407|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
148687381|NCT01405820|536327408|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
148687382|NCT01405820|536327409|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
148687383|NCT01405820|536327410|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
148687384|NCT01405820|536327411|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
148687385|NCT01405820|536327406|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
148687386|NCT01405820|536327407|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
148687387|NCT01405820|536327408|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
148687388|NCT01405820|536327409|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
148687389|NCT01405820|536327410|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
148687390|NCT01405820|536327411|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
148687391|NCT01405820|536327406|FG000|Randomized Treatment Period|Death|0|||
148687392|NCT01405820|536327407|FG001|Randomized Treatment Period|Death|0|||
148687393|NCT01405820|536327408|FG002|Randomized Treatment Period|Death|0|||
148687394|NCT01405820|536327409|FG003|Randomized Treatment Period|Death|1|||
148687395|NCT01405820|536327410|FG004|Randomized Treatment Period|Death|0|||
148687396|NCT01405820|536327411|FG005|Randomized Treatment Period|Death|0|||
148687397|NCT01405820|536327406|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
148687398|NCT01405820|536327407|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
148687399|NCT01405820|536327408|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
148687400|NCT01405820|536327409|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
148687401|NCT01405820|536327410|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
148687402|NCT01405820|536327411|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
148687403|NCT01405820|536327406|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
148687404|NCT01405820|536327407|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
148687405|NCT01405820|536327408|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
148687406|NCT01405820|536327409|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
148687407|NCT01405820|536327410|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
148687408|NCT01405820|536327411|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
148687409|NCT01405820|536327406|FG000|Open-Label Treatment Period|Other|1|||
148687410|NCT01405820|536327407|FG001|Open-Label Treatment Period|Other|1|||
148687411|NCT01405820|536327408|FG002|Open-Label Treatment Period|Other|1|||
148687412|NCT01405820|536327409|FG003|Open-Label Treatment Period|Other|1|||
148687413|NCT01405820|536327410|FG004|Open-Label Treatment Period|Other|1|||
148687414|NCT01405820|536327411|FG005|Open-Label Treatment Period|Other|1|||
148687415|NCT01405820|536327406|FG000|Open-Label Treatment Period|Physician Decision|0|||
148687416|NCT01405820|536327407|FG001|Open-Label Treatment Period|Physician Decision|0|||
148687417|NCT01405820|536327408|FG002|Open-Label Treatment Period|Physician Decision|1|||
148687418|NCT01405820|536327409|FG003|Open-Label Treatment Period|Physician Decision|2|||
148687419|NCT01405820|536327410|FG004|Open-Label Treatment Period|Physician Decision|1|||
148687420|NCT01405820|536327411|FG005|Open-Label Treatment Period|Physician Decision|0|||
148687421|NCT01405820|536327406|FG000|Open-Label Treatment Period|Adverse Event|0|||
148687422|NCT01405820|536327407|FG001|Open-Label Treatment Period|Adverse Event|0|||
148687423|NCT01405820|536327408|FG002|Open-Label Treatment Period|Adverse Event|0|||
148687424|NCT01405820|536327409|FG003|Open-Label Treatment Period|Adverse Event|1|||
148687425|NCT01405820|536327410|FG004|Open-Label Treatment Period|Adverse Event|0|||
148687426|NCT01405820|536327411|FG005|Open-Label Treatment Period|Adverse Event|0|||
148687427|NCT03222141|536327414|FG000|Overall Study|Death|15|||
148687428|NCT03222141|536327414|FG000|Overall Study|Lost to Follow-up|3|||
148687429|NCT00441584|536327415|FG000|Overall Study|Lack of Efficacy|79|||
148687430|NCT00441584|536327415|FG000|Overall Study|Withdrawal by Subject|8|||
149018591|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018592|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018593|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018594|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018595|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018596|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018597|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018598|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018599|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018600|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018601|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
149018602|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
149018603|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
149018604|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
149018605|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
149018606|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
149018607|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
149018608|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
149018609|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
149018610|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
149018611|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
149018612|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
149018613|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
149018614|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
149018615|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
149018616|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
149018617|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
149018618|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
149018619|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
149018620|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
149018621|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
149018622|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018623|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018624|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018625|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018626|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018627|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018628|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018629|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018630|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018631|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018632|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018633|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018634|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018635|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018636|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
149018637|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018638|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
149018639|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
149018640|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018641|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018642|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018643|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018644|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018645|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018646|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018647|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018648|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018649|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018650|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018651|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018652|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018653|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018654|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
149018655|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018656|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
149018657|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
149018658|NCT01474512|537547149|FG000|Post-Treatment Follow-Up|Death|0|||
149018659|NCT01474512|537547150|FG001|Post-Treatment Follow-Up|Death|0|||
149018660|NCT01474512|537547151|FG002|Post-Treatment Follow-Up|Death|0|||
149018661|NCT01474512|537547152|FG003|Post-Treatment Follow-Up|Death|0|||
149018662|NCT01474512|537547153|FG004|Post-Treatment Follow-Up|Death|0|||
148687431|NCT00441584|536327415|FG000|Overall Study|Adverse Event|6|||
149018663|NCT01474512|537547154|FG005|Post-Treatment Follow-Up|Death|0|||
149018664|NCT01474512|537547155|FG006|Post-Treatment Follow-Up|Death|0|||
149018665|NCT01474512|537547156|FG007|Post-Treatment Follow-Up|Death|0|||
149018666|NCT01474512|537547157|FG008|Post-Treatment Follow-Up|Death|0|||
149018667|NCT01474512|537547158|FG009|Post-Treatment Follow-Up|Death|0|||
149018668|NCT01474512|537547159|FG010|Post-Treatment Follow-Up|Death|0|||
149018669|NCT01474512|537547160|FG011|Post-Treatment Follow-Up|Death|0|||
149018670|NCT01474512|537547161|FG012|Post-Treatment Follow-Up|Death|0|||
149018671|NCT01474512|537547162|FG013|Post-Treatment Follow-Up|Death|0|||
149018672|NCT01474512|537547163|FG014|Post-Treatment Follow-Up|Death|0|||
149018673|NCT01474512|537547164|FG015|Post-Treatment Follow-Up|Death|0|||
149018674|NCT01474512|537547165|FG016|Post-Treatment Follow-Up|Death|1|||
149018675|NCT01474512|537547166|FG017|Post-Treatment Follow-Up|Death|0|||
149018676|NCT02726399|537547172|FG000|Overall Study|Participant Non-Compliance|1|||
149018677|NCT02726399|537547172|FG000|Overall Study|Adverse Event|2|||
149018678|NCT02726399|537547172|FG000|Overall Study|Progression of disease|4|||
149018679|NCT04747275|537547179|FG000|Overall Study|Study terminated|0|||
149018680|NCT04747275|537547180|FG001|Overall Study|Study terminated|1|||
149018681|NCT04076020|537547181|FG000|Overall Study|Death|4|||
149018682|NCT04076020|537547182|FG001|Overall Study|Death|6|||
149018683|NCT04076020|537547181|FG000|Overall Study|Withdrawal by Subject|12|||
149018684|NCT04076020|537547182|FG001|Overall Study|Withdrawal by Subject|8|||
149018685|NCT02406261|537547184|FG000|Period 1|Lost to Follow-up|2|||
149018686|NCT02406261|537547185|FG001|Period 1|Lost to Follow-up|0|||
149018687|NCT02406261|537547184|FG000|Period 1|Adverse Event|1|||
149018688|NCT02406261|537547185|FG001|Period 1|Adverse Event|0|||
149018689|NCT02406261|537547184|FG000|Period 2|Physician Decision|0|||
148687432|NCT00441584|536327415|FG000|Overall Study|Protocol Violation|5|||
148687433|NCT00441584|536327415|FG000|Overall Study|Lost to Follow-up|4|||
148687434|NCT00441584|536327415|FG000|Overall Study|Failure to meet eligibility criteria|3|||
148687435|NCT01418352|536327418|FG000|Overall Study|Lost to Follow-up|2|||
148687436|NCT01418352|536327419|FG001|Overall Study|Lost to Follow-up|0|||
148687437|NCT01418352|536327420|FG002|Overall Study|Lost to Follow-up|0|||
148687438|NCT01418352|536327421|FG003|Overall Study|Lost to Follow-up|0|||
148687439|NCT01418352|536327418|FG000|Overall Study|Adverse Event|0|||
148687440|NCT01418352|536327419|FG001|Overall Study|Adverse Event|1|||
148687441|NCT01418352|536327420|FG002|Overall Study|Adverse Event|0|||
148687442|NCT01418352|536327421|FG003|Overall Study|Adverse Event|0|||
148687443|NCT01418352|536327418|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
148687444|NCT01418352|536327419|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
148687445|NCT01418352|536327420|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
148687446|NCT01418352|536327421|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
148687447|NCT01418352|536327418|FG000|Overall Study|Subject Withdrew Consent|0|||
148687448|NCT01418352|536327419|FG001|Overall Study|Subject Withdrew Consent|1|||
148687449|NCT01418352|536327420|FG002|Overall Study|Subject Withdrew Consent|2|||
148687450|NCT01418352|536327421|FG003|Overall Study|Subject Withdrew Consent|1|||
148687451|NCT01418352|536327418|FG000|Overall Study|Protocol Deviation|0|||
148687452|NCT01418352|536327419|FG001|Overall Study|Protocol Deviation|0|||
148687453|NCT01418352|536327420|FG002|Overall Study|Protocol Deviation|1|||
148687454|NCT01418352|536327421|FG003|Overall Study|Protocol Deviation|0|||
148687455|NCT01418352|536327418|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
148687456|NCT01418352|536327419|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
148687457|NCT01418352|536327420|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
148687458|NCT01418352|536327421|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
148687459|NCT00619619|536327422|FG000|Overall Study|Physician Decision|0|||
148687460|NCT00619619|536327423|FG001|Overall Study|Physician Decision|0|||
148687461|NCT00619619|536327424|FG002|Overall Study|Physician Decision|1|||
148687462|NCT00619619|536327425|FG003|Overall Study|Physician Decision|0|||
148687463|NCT00619619|536327426|FG004|Overall Study|Physician Decision|0|||
148687464|NCT00619619|536327427|FG005|Overall Study|Physician Decision|0|||
148687465|NCT00619619|536327428|FG006|Overall Study|Physician Decision|0|||
148687466|NCT00619619|536327429|FG007|Overall Study|Physician Decision|0|||
148687467|NCT00619619|536327422|FG000|Overall Study|Protocol Violation|0|||
148687468|NCT00619619|536327423|FG001|Overall Study|Protocol Violation|0|||
148810133|NCT05383209|536782566|FG000|Overall Study|Withdrawal by Subject|2|||
148810134|NCT05383209|536782567|FG001|Overall Study|Withdrawal by Subject|0|||
149018690|NCT02406261|537547185|FG001|Period 2|Physician Decision|1|||
149018691|NCT02406261|537547184|FG000|Period 2|Protocol Violation|0|||
149018692|NCT02406261|537547185|FG001|Period 2|Protocol Violation|1|||
149018693|NCT02406261|537547184|FG000|Period 2|Withdrawal by Subject|0|||
149018694|NCT02406261|537547185|FG001|Period 2|Withdrawal by Subject|1|||
148687469|NCT00619619|536327424|FG002|Overall Study|Protocol Violation|0|||
148687470|NCT00619619|536327425|FG003|Overall Study|Protocol Violation|1|||
148687471|NCT00619619|536327426|FG004|Overall Study|Protocol Violation|0|||
149018695|NCT01591460|537547188|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
149018696|NCT01591460|537547188|FG000|Overall Study|Futility Rule (Week 12)|7|||
149018697|NCT01591460|537547188|FG000|Overall Study|Futility Rule (Week 24)|3|||
149018698|NCT01591460|537547188|FG000|Overall Study|Rebound or Breakthrough|3|||
149018699|NCT01591460|537547188|FG000|Overall Study|Treatment Discontinued by Error|1|||
149018700|NCT01591460|537547188|FG000|Overall Study|Lost to Follow-up|1|||
149018701|NCT01591460|537547188|FG000|Overall Study|Noncompliance|1|||
149018702|NCT01591460|537547188|FG000|Overall Study|Participant Refusal|3|||
149018703|NCT01591460|537547188|FG000|Overall Study|Withdrawal by Subject|1|||
149018704|NCT01591460|537547188|FG000|Overall Study|Protocol Violation|1|||
149018705|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
149018706|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
149018707|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
149018708|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
149018709|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
149018710|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
149018711|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
149018712|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
149018713|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
149018714|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
149018715|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
149018716|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
149018717|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
149018718|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
149018719|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
149018720|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
149018721|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
149018722|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
149018723|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
149018724|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
149018725|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
149018726|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
149018727|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
149018728|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
149018729|NCT03230864|537547189|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
149018730|NCT03230864|537547190|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
149018731|NCT03230864|537547191|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
149018732|NCT03230864|537547192|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
149018733|NCT03230864|537547189|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
149018734|NCT03230864|537547190|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
149018735|NCT03230864|537547191|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
149018736|NCT03230864|537547192|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
149018737|NCT03230864|537547189|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149018738|NCT03230864|537547190|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
149018739|NCT03230864|537547191|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
149018740|NCT03230864|537547192|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
149018741|NCT03230864|537547189|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
149018742|NCT03230864|537547190|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
149018743|NCT03230864|537547191|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
149018744|NCT03230864|537547192|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
149018745|NCT00432679|537547197|FG000|Overall Study|Adverse Event|2|||
149018746|NCT00432679|537547198|FG001|Overall Study|Adverse Event|1|||
149018747|NCT00432679|537547197|FG000|Overall Study|Withdrawal by Subject|3|||
149018748|NCT00432679|537547198|FG001|Overall Study|Withdrawal by Subject|2|||
149018749|NCT00610675|537547201|FG000|Overall Study|Untreated|4|||
149018750|NCT00610675|537547201|FG000|Overall Study|Adverse Event|67|||
149018751|NCT00610675|537547201|FG000|Overall Study|Insufficient Effect|31|||
149018752|NCT00610675|537547201|FG000|Overall Study|Withdrawal by Subject|28|||
149018753|NCT00610675|537547201|FG000|Overall Study|Reasons unrelated to trial|27|||
149018754|NCT00610675|537547201|FG000|Overall Study|Lack of Compliance|7|||
149018755|NCT00610675|537547201|FG000|Overall Study|Lost to Follow-up|31|||
149018756|NCT00610675|537547201|FG000|Overall Study|Other reason (not specified)|25|||
149018757|NCT01458249|537547202|FG000|Overall Study|Not treated|1|||
149018758|NCT01458249|537547202|FG000|Overall Study|Adverse Event|4|||
149018759|NCT01458249|537547202|FG000|Overall Study|Other|2|||
149018760|NCT01458249|537547202|FG000|Overall Study|Ongoing|1|||
149018761|NCT02056119|537547205|FG000|Overall Study|Death|1|||
149018762|NCT02056119|537547206|FG001|Overall Study|Death|2|||
149018763|NCT02056119|537547205|FG000|Overall Study|Intubated for less than 24 hrs|2|||
149018764|NCT02056119|537547206|FG001|Overall Study|Intubated for less than 24 hrs|7|||
149018765|NCT02056119|537547205|FG000|Overall Study|No aerosol treatments were given.|3|||
148810135|NCT05383209|536782568|FG002|Overall Study|Withdrawal by Subject|1|||
149018766|NCT02056119|537547206|FG001|Overall Study|No aerosol treatments were given.|2|||
149018767|NCT02056119|537547205|FG000|Overall Study|Received Metaneb treatment|0|||
149018768|NCT02056119|537547206|FG001|Overall Study|Received Metaneb treatment|2|||
149018769|NCT02056119|537547205|FG000|Overall Study|Protocol Violation|4|||
149018770|NCT02056119|537547206|FG001|Overall Study|Protocol Violation|7|||
149018771|NCT03220737|537547207|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
149018772|NCT03220737|537547208|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
149018773|NCT03220737|537547209|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
149018774|NCT03220737|537547210|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
149018775|NCT03220737|537547211|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
149018776|NCT03220737|537547212|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
149018777|NCT03220737|537547213|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
149018778|NCT03220737|537547207|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
149018779|NCT03220737|537547208|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
149018780|NCT03220737|537547209|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
149018781|NCT03220737|537547210|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
149018782|NCT03220737|537547211|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
149018783|NCT03220737|537547212|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
149018784|NCT03220737|537547213|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
149018785|NCT03220737|537547207|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
149018786|NCT03220737|537547208|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
149018787|NCT03220737|537547209|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
149018788|NCT03220737|537547210|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
149018789|NCT03220737|537547211|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
149018790|NCT03220737|537547212|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
149018791|NCT03220737|537547213|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
149018792|NCT03220737|537547207|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
149018793|NCT03220737|537547208|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
149018794|NCT03220737|537547209|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
149018795|NCT03220737|537547210|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
149018796|NCT03220737|537547211|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
149018797|NCT03220737|537547212|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
149018798|NCT03220737|537547213|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
149018799|NCT03220737|537547207|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
149018800|NCT03220737|537547208|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
149018801|NCT03220737|537547209|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
149018802|NCT03220737|537547210|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
149018803|NCT03220737|537547211|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
149018804|NCT03220737|537547212|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
149018805|NCT03220737|537547213|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
149018806|NCT03220737|537547207|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
149018807|NCT03220737|537547208|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149018808|NCT03220737|537547209|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149018809|NCT03220737|537547210|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149018810|NCT03220737|537547211|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149018811|NCT03220737|537547212|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149018812|NCT03220737|537547213|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
149018813|NCT03220737|537547207|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
149018814|NCT03220737|537547208|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149018815|NCT03220737|537547209|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149018816|NCT03220737|537547210|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149018817|NCT03220737|537547211|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149018818|NCT03220737|537547212|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149018819|NCT03220737|537547213|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
149018820|NCT03220737|537547207|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
149018821|NCT03220737|537547208|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
149018822|NCT03220737|537547209|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
149018823|NCT03220737|537547210|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
149018824|NCT03220737|537547211|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
148687472|NCT00619619|536327427|FG005|Overall Study|Protocol Violation|0|||
148687473|NCT00619619|536327428|FG006|Overall Study|Protocol Violation|1|||
148810136|NCT05383209|536782566|FG000|Overall Study|Death|1|||
148810137|NCT05383209|536782567|FG001|Overall Study|Death|0|||
149018825|NCT03220737|537547212|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
149018826|NCT03220737|537547213|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
149018827|NCT01316692|537547214|FG000|Overall Study|Adverse Event|5|||
149018828|NCT01316692|537547214|FG000|Overall Study|Disease Progression|7|||
149018829|NCT01686932|537547226|FG000|Period 1|Adverse Event|1|||
149018830|NCT01686932|537547227|FG001|Period 1|Adverse Event|1|||
148687474|NCT00619619|536327429|FG007|Overall Study|Protocol Violation|1|||
149018831|NCT01284140|537547229|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
149018832|NCT01284140|537547230|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
149018833|NCT01284140|537547229|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
149018834|NCT01284140|537547230|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
149018835|NCT01313923|537547231|FG000|Overall Study|Physician Decision|3|||
149018836|NCT02420327|537547232|FG000|Overall Study|Adverse Event|7|||
149018837|NCT02420327|537547232|FG000|Overall Study|Pregnancy|1|||
149018838|NCT02420327|537547232|FG000|Overall Study|Withdrawal by Subject|6|||
149018839|NCT02420327|537547232|FG000|Overall Study|Lost to Follow-up|1|||
149018840|NCT02420327|537547232|FG000|Overall Study|Protocol Violation|1|||
149018841|NCT01990300|537547233|FG000|Overall Study|Case Report Forms Uncollected|89|||
149018842|NCT01990300|537547233|FG000|Overall Study|Protocol Deviation|53|||
149018843|NCT01225835|537547234|FG000|Overall Study|Completed protocol|2|||
149018844|NCT01225835|537547235|FG001|Overall Study|Completed protocol|1|||
149018845|NCT01225835|537547234|FG000|Overall Study|Did not meet hCG criterion|2|||
149018846|NCT01225835|537547235|FG001|Overall Study|Did not meet hCG criterion|0|||
149018847|NCT01225835|537547234|FG000|Overall Study|Adverse Event|2|||
149018848|NCT01225835|537547235|FG001|Overall Study|Adverse Event|1|||
149018849|NCT01225835|537547234|FG000|Overall Study|Other|1|||
149018850|NCT01225835|537547235|FG001|Overall Study|Other|1|||
149018851|NCT02589392|537547236|FG000|Overall Study|Adverse Event|1|||
149018852|NCT02589392|537547237|FG001|Overall Study|Adverse Event|1|||
149018853|NCT02589392|537547236|FG000|Overall Study|Withdrawal by Subject|1|||
149018854|NCT02589392|537547237|FG001|Overall Study|Withdrawal by Subject|2|||
149018855|NCT02589392|537547236|FG000|Overall Study|Protocol Violation|1|||
149018856|NCT02589392|537547237|FG001|Overall Study|Protocol Violation|1|||
149018857|NCT02589392|537547236|FG000|Overall Study|Lost to Follow-up|2|||
149018858|NCT02589392|537547237|FG001|Overall Study|Lost to Follow-up|2|||
149018859|NCT02589392|537547236|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
149018860|NCT02589392|537547237|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
149018861|NCT02293837|537547238|FG000|Overall Study|Lost to Follow-up|0|||
149018862|NCT02293837|537547239|FG001|Overall Study|Lost to Follow-up|2|||
149018863|NCT02293837|537547240|FG002|Overall Study|Lost to Follow-up|1|||
149018864|NCT02293837|537547241|FG003|Overall Study|Lost to Follow-up|0|||
149018865|NCT02293837|537547238|FG000|Overall Study|Withdrawal by Subject|2|||
149018866|NCT02293837|537547239|FG001|Overall Study|Withdrawal by Subject|1|||
149018867|NCT02293837|537547240|FG002|Overall Study|Withdrawal by Subject|2|||
149018868|NCT02293837|537547241|FG003|Overall Study|Withdrawal by Subject|1|||
149018869|NCT02293837|537547238|FG000|Overall Study|COVID-19 Related|1|||
149018870|NCT02293837|537547239|FG001|Overall Study|COVID-19 Related|1|||
149018871|NCT02293837|537547240|FG002|Overall Study|COVID-19 Related|0|||
149018872|NCT02293837|537547241|FG003|Overall Study|COVID-19 Related|0|||
149018873|NCT02293837|537547238|FG000|Overall Study|Participant ill and could not be infused|0|||
149018874|NCT02293837|537547239|FG001|Overall Study|Participant ill and could not be infused|0|||
149018875|NCT02293837|537547240|FG002|Overall Study|Participant ill and could not be infused|1|||
149018876|NCT02293837|537547241|FG003|Overall Study|Participant ill and could not be infused|0|||
149018877|NCT04779242|537547242|FG000|Overall Study|Adverse Event|1|||
149018878|NCT04779242|537547243|FG001|Overall Study|Adverse Event|1|||
149018879|NCT04779242|537547242|FG000|Overall Study|Lost to Follow-up|2|||
149018880|NCT04779242|537547243|FG001|Overall Study|Lost to Follow-up|4|||
149018881|NCT04779242|537547242|FG000|Overall Study|Withdrawal by Subject|7|||
149018882|NCT04779242|537547243|FG001|Overall Study|Withdrawal by Subject|9|||
149018883|NCT04779242|537547242|FG000|Overall Study|Death|6|||
149018884|NCT04779242|537547243|FG001|Overall Study|Death|6|||
149018885|NCT04779242|537547242|FG000|Overall Study|COVID-19 related reasons|2|||
149018886|NCT04779242|537547243|FG001|Overall Study|COVID-19 related reasons|1|||
149018887|NCT04779242|537547242|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
149018888|NCT04779242|537547243|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
149018889|NCT04779242|537547242|FG000|Overall Study|Martial Law in Ukraine|2|||
149018890|NCT04779242|537547243|FG001|Overall Study|Martial Law in Ukraine|3|||
149018891|NCT02087150|537547244|FG000|Overall Study|Death|0|||
149018892|NCT02087150|537547245|FG001|Overall Study|Death|1|||
149018893|NCT02087150|537547246|FG002|Overall Study|Death|0|||
149018894|NCT02087150|537547244|FG000|Overall Study|Lost to Follow-up|6|||
149018895|NCT02087150|537547245|FG001|Overall Study|Lost to Follow-up|13|||
149018896|NCT02087150|537547246|FG002|Overall Study|Lost to Follow-up|7|||
149018897|NCT02087150|537547244|FG000|Overall Study|Withdrawal by Subject|2|||
149018898|NCT02087150|537547245|FG001|Overall Study|Withdrawal by Subject|5|||
149018899|NCT02087150|537547246|FG002|Overall Study|Withdrawal by Subject|3|||
149018900|NCT02087150|537547244|FG000|Overall Study|Physician Decision|0|||
149018901|NCT02087150|537547245|FG001|Overall Study|Physician Decision|1|||
149018902|NCT02087150|537547246|FG002|Overall Study|Physician Decision|0|||
149018903|NCT02087150|537547244|FG000|Overall Study|Procedure not done|1|||
149018904|NCT02087150|537547245|FG001|Overall Study|Procedure not done|13|||
149018905|NCT02087150|537547246|FG002|Overall Study|Procedure not done|0|||
149018906|NCT02087150|537547244|FG000|Overall Study|F/U not completed w/in study window|0|||
149018907|NCT02087150|537547245|FG001|Overall Study|F/U not completed w/in study window|0|||
149018908|NCT02087150|537547246|FG002|Overall Study|F/U not completed w/in study window|1|||
149018909|NCT02087150|537547244|FG000|Overall Study|Other|1|||
149018910|NCT02087150|537547245|FG001|Overall Study|Other|0|||
149018911|NCT02087150|537547246|FG002|Overall Study|Other|0|||
149018912|NCT02087150|537547244|FG000|Overall Study|Pt moved out of town|0|||
149018913|NCT02087150|537547245|FG001|Overall Study|Pt moved out of town|1|||
149018914|NCT02087150|537547246|FG002|Overall Study|Pt moved out of town|0|||
149018915|NCT00683449|537547249|FG000|Overall Study|Lost to Follow-up|0|||
149018916|NCT00683449|537547250|FG001|Overall Study|Lost to Follow-up|1|||
149018917|NCT00683449|537547251|FG002|Overall Study|Lost to Follow-up|0|||
149018918|NCT00683449|537547252|FG003|Overall Study|Lost to Follow-up|0|||
149018919|NCT00683449|537547253|FG004|Overall Study|Lost to Follow-up|0|||
149018920|NCT01448044|537547256|FG000|Treatment Period|Adverse Event|4|||
149018921|NCT01448044|537547257|FG001|Treatment Period|Adverse Event|3|||
149018922|NCT01448044|537547256|FG000|Treatment Period|Lack of Efficacy|5|||
149018923|NCT01448044|537547257|FG001|Treatment Period|Lack of Efficacy|12|||
149018924|NCT01448044|537547256|FG000|Treatment Period|Subject requested discontinue study drug|1|||
149018925|NCT01448044|537547257|FG001|Treatment Period|Subject requested discontinue study drug|0|||
149018926|NCT01448044|537547256|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
149018927|NCT01448044|537547257|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
149018928|NCT01448044|537547256|FG000|Treatment Period|Participant does not meet study criteria|1|||
149018929|NCT01448044|537547257|FG001|Treatment Period|Participant does not meet study criteria|0|||
149018930|NCT01448044|537547256|FG000|Treatment Period|Lost to Follow-up|2|||
149018931|NCT01448044|537547257|FG001|Treatment Period|Lost to Follow-up|1|||
149018932|NCT01448044|537547256|FG000|Treatment Period|Other reason|2|||
149018933|NCT01448044|537547257|FG001|Treatment Period|Other reason|0|||
149018934|NCT01448044|537547256|FG000|Follow Up Period|Withdrawal by Subject|1|||
149018935|NCT01448044|537547257|FG001|Follow Up Period|Withdrawal by Subject|1|||
149018936|NCT01448044|537547256|FG000|Follow Up Period|Lost to Follow-up|6|||
149018937|NCT01448044|537547257|FG001|Follow Up Period|Lost to Follow-up|2|||
149018938|NCT01448044|537547256|FG000|Follow Up Period|Other|5|||
149018939|NCT01448044|537547257|FG001|Follow Up Period|Other|11|||
149018940|NCT00507026|537547261|FG000|Overall Study|Lack of Efficacy|6|||
149018941|NCT00507026|537547262|FG001|Overall Study|Lack of Efficacy|4|||
149018942|NCT00507026|537547263|FG002|Overall Study|Lack of Efficacy|21|||
149018943|NCT00507026|537547261|FG000|Overall Study|Withdrawal by Subject|2|||
149018944|NCT00507026|537547262|FG001|Overall Study|Withdrawal by Subject|0|||
149018945|NCT00507026|537547263|FG002|Overall Study|Withdrawal by Subject|0|||
149018946|NCT00507026|537547261|FG000|Overall Study|Investigator Decision|1|||
149018947|NCT00507026|537547262|FG001|Overall Study|Investigator Decision|0|||
149018948|NCT00507026|537547263|FG002|Overall Study|Investigator Decision|0|||
149018949|NCT00507026|537547261|FG000|Overall Study|Adverse Event|2|||
149018950|NCT00507026|537547262|FG001|Overall Study|Adverse Event|0|||
149018951|NCT00507026|537547263|FG002|Overall Study|Adverse Event|0|||
149018952|NCT00507026|537547261|FG000|Overall Study|Protocol Violation|1|||
149018953|NCT00507026|537547262|FG001|Overall Study|Protocol Violation|0|||
149018954|NCT00507026|537547263|FG002|Overall Study|Protocol Violation|0|||
149018955|NCT00507026|537547261|FG000|Overall Study|Other|1|||
149018956|NCT00507026|537547262|FG001|Overall Study|Other|0|||
149018957|NCT00507026|537547263|FG002|Overall Study|Other|0|||
149018958|NCT00681187|537547264|FG000|Overall Study|Withdrawal by Subject|1|||
149018959|NCT00681187|537547265|FG001|Overall Study|Withdrawal by Subject|0|||
149018960|NCT00681187|537547264|FG000|Overall Study|Death|0|||
149018961|NCT00681187|537547265|FG001|Overall Study|Death|1|||
149018962|NCT00681187|537547264|FG000|Overall Study|Adverse Event|0|||
149018963|NCT00681187|537547265|FG001|Overall Study|Adverse Event|1|||
149018964|NCT04230980|537547268|FG000|Overall Study|Lost to Follow-up|1|||
149018965|NCT04230980|537547269|FG001|Overall Study|Lost to Follow-up|2|||
149018966|NCT04230980|537547268|FG000|Overall Study|Adverse Event|0|||
149018967|NCT04230980|537547269|FG001|Overall Study|Adverse Event|1|||
149018968|NCT02788006|537547272|FG000|Overall Study|Patient not treated|1|||
149018969|NCT00318149|537547273|FG000|Overall Study|Adverse Event|0|||
149018970|NCT00318149|537547274|FG001|Overall Study|Adverse Event|0|||
149018971|NCT00318149|537547275|FG002|Overall Study|Adverse Event|0|||
149018972|NCT00318149|537547276|FG003|Overall Study|Adverse Event|0|||
149018973|NCT00318149|537547277|FG004|Overall Study|Adverse Event|0|||
149018974|NCT00318149|537547278|FG005|Overall Study|Adverse Event|2|||
149018975|NCT03541642|537547279|FG000|Overall Study|Withdrawal by Subject|1|||
149018976|NCT03541642|537547280|FG001|Overall Study|Withdrawal by Subject|2|||
149018977|NCT03541642|537547279|FG000|Overall Study|Lost to Follow-up|16|||
149018978|NCT03541642|537547280|FG001|Overall Study|Lost to Follow-up|12|||
149018979|NCT03541642|537547279|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
149119513|NCT00506441|537916364|FG000|Period 1; Open-label Period|Other Reasons|13|||
149119514|NCT00506441|537916365|FG001|Period 1; Open-label Period|Other Reasons|0|||
149119515|NCT00506441|537916364|FG000|Period 2; Double-blind Period|Adverse Event|0|||
148953905|NCT00555321|537313145|FG001|Long-term Extension Phase|Other Reason|0|||
148953906|NCT00555321|537313146|FG002|Long-term Extension Phase|Other Reason|2|||
148953907|NCT00555321|537313147|FG003|Long-term Extension Phase|Other Reason|0|||
148953908|NCT00555321|537313148|FG004|Long-term Extension Phase|Other Reason|0|||
148953909|NCT00005937|537313149|FG000|Overall Study|Lack of Efficacy|5|||
148953910|NCT01348347|537313150|FG000|Overall Study|Withdrawal by Subject|1|||
148953911|NCT01348347|537313151|FG001|Overall Study|Withdrawal by Subject|1|||
148953912|NCT01348347|537313152|FG002|Overall Study|Withdrawal by Subject|1|||
148953913|NCT01348347|537313150|FG000|Overall Study|Progressive disease|2|||
148953914|NCT01348347|537313151|FG001|Overall Study|Progressive disease|5|||
148953915|NCT01348347|537313152|FG002|Overall Study|Progressive disease|5|||
148953916|NCT03235154|537313153|FG000|Overall Study|Withdrawal by Subject|1|||
148953917|NCT03235154|537313153|FG000|Overall Study|Adverse Event|1|||
148953918|NCT03235154|537313153|FG000|Overall Study|Lost to Follow-up|2|||
148953919|NCT02326025|537313154|FG000|Overall Study|Adverse Event|3|||
148953920|NCT02326025|537313155|FG001|Overall Study|Adverse Event|0|||
148953921|NCT02326025|537313154|FG000|Overall Study|Physician Decision|1|||
148953922|NCT02326025|537313155|FG001|Overall Study|Physician Decision|2|||
148953923|NCT02326025|537313154|FG000|Overall Study|Physician and Participant Decision|1|||
148953924|NCT02326025|537313155|FG001|Overall Study|Physician and Participant Decision|0|||
148953925|NCT02326025|537313154|FG000|Overall Study|Withdrawal by Subject|0|||
148953926|NCT02326025|537313155|FG001|Overall Study|Withdrawal by Subject|2|||
148953927|NCT02326025|537313154|FG000|Overall Study|Protocol Violation|0|||
148953928|NCT02326025|537313155|FG001|Overall Study|Protocol Violation|1|||
148953929|NCT00001723|537313156|FG000|Overall Study|Lack of Efficacy|6|||
148953930|NCT00001723|537313157|FG001|Overall Study|Lack of Efficacy|7|||
148953931|NCT00001723|537313156|FG000|Overall Study|Lack of family interest|4|||
148953932|NCT00001723|537313157|FG001|Overall Study|Lack of family interest|5|||
148953933|NCT00001723|537313156|FG000|Overall Study|Lost to Follow-up|2|||
148953934|NCT00001723|537313157|FG001|Overall Study|Lost to Follow-up|2|||
148953935|NCT00001723|537313156|FG000|Overall Study|medication intolerance|1|||
148953936|NCT00001723|537313157|FG001|Overall Study|medication intolerance|2|||
148953937|NCT00536198|537313158|FG000|Overall Study|Lost to Follow-up|15|||
148953938|NCT00536198|537313159|FG001|Overall Study|Lost to Follow-up|14|||
148953939|NCT00536198|537313158|FG000|Overall Study|Withdrawal by Subject|16|||
148953940|NCT00536198|537313159|FG001|Overall Study|Withdrawal by Subject|12|||
148953941|NCT00536198|537313158|FG000|Overall Study|Adverse Event|2|||
148953942|NCT00536198|537313159|FG001|Overall Study|Adverse Event|2|||
148953943|NCT00536198|537313158|FG000|Overall Study|Rescue|3|||
148953944|NCT00536198|537313159|FG001|Overall Study|Rescue|9|||
148953945|NCT00536198|537313158|FG000|Overall Study|Pregnancy|1|||
148953946|NCT00536198|537313159|FG001|Overall Study|Pregnancy|1|||
148953947|NCT00536198|537313158|FG000|Overall Study|Protocol Violation|0|||
148953948|NCT00536198|537313159|FG001|Overall Study|Protocol Violation|1|||
148953949|NCT02643082|537313160|FG000|Period 1|Adverse Event|1|||
148953950|NCT02643082|537313161|FG001|Period 1|Adverse Event|0|||
148953951|NCT00881712|537313162|FG000|Overall Study|Death|1|||
148953952|NCT00881712|537313163|FG001|Overall Study|Death|0|||
148953953|NCT00881712|537313164|FG002|Overall Study|Death|0|||
148953954|NCT00881712|537313162|FG000|Overall Study|Withdrawal by Subject|1|||
148953955|NCT00881712|537313163|FG001|Overall Study|Withdrawal by Subject|0|||
148953956|NCT00881712|537313164|FG002|Overall Study|Withdrawal by Subject|0|||
148953957|NCT01324999|537313165|FG000|Overall Study|Adverse Event|3|||
148953958|NCT01324999|537313165|FG000|Overall Study|Withdrawal by Subject|2|||
148953959|NCT02505867|537313167|FG000|Overall Study|Lack of Efficacy|6|||
148953960|NCT02505867|537313168|FG001|Overall Study|Lack of Efficacy|6|||
148953961|NCT00230607|537313173|FG000|Overall Study|Other|3|||
148953962|NCT01648205|537313176|FG000|Placebo|Pregnancy|1|||
148953963|NCT01648205|537313176|FG000|Placebo|Withdrawal by Subject|1|||
148953964|NCT01648205|537313176|FG000|Placebo|Protocol Violation|2|||
148953965|NCT01648205|537313176|FG000|Ranolazine|Death|1|||
148953966|NCT01648205|537313176|FG000|Ranolazine|Withdrawal by Subject|1|||
148953967|NCT01648205|537313176|FG000|Ranolazine|Protocol Violation|3|||
148953968|NCT01958008|537313177|FG000|Overall Study|Worsening of disease under study|0|||
148953969|NCT01958008|537313178|FG001|Overall Study|Worsening of disease under study|0|||
148953970|NCT01958008|537313179|FG002|Overall Study|Worsening of disease under study|1|||
148953971|NCT01958008|537313180|FG003|Overall Study|Worsening of disease under study|0|||
148953972|NCT01958008|537313177|FG000|Overall Study|Other adverse event|1|||
148953973|NCT01958008|537313178|FG001|Overall Study|Other adverse event|0|||
148953974|NCT01958008|537313179|FG002|Overall Study|Other adverse event|0|||
148953975|NCT01958008|537313180|FG003|Overall Study|Other adverse event|0|||
148953976|NCT01428453|537313181|FG000|Overall Study|Adverse Event|2|||
148953977|NCT01428453|537313182|FG001|Overall Study|Adverse Event|7|||
148953978|NCT01428453|537313181|FG000|Overall Study|Protocol Violation|1|||
148953979|NCT01428453|537313182|FG001|Overall Study|Protocol Violation|0|||
148953980|NCT01428453|537313181|FG000|Overall Study|Lost to Follow-up|0|||
148953981|NCT01428453|537313182|FG001|Overall Study|Lost to Follow-up|1|||
148953982|NCT01428453|537313181|FG000|Overall Study|Withdrawal by Subject|3|||
148953983|NCT01428453|537313182|FG001|Overall Study|Withdrawal by Subject|1|||
148953984|NCT01996709|537313183|FG000|Overall Study|Withdrawal by Subject|1|||
148687475|NCT00619619|536327422|FG000|Overall Study|Adverse Event|0|||
148687476|NCT00619619|536327423|FG001|Overall Study|Adverse Event|0|||
148687477|NCT00619619|536327424|FG002|Overall Study|Adverse Event|0|||
148687478|NCT00619619|536327425|FG003|Overall Study|Adverse Event|0|||
148687479|NCT00619619|536327426|FG004|Overall Study|Adverse Event|2|||
148687480|NCT00619619|536327427|FG005|Overall Study|Adverse Event|0|||
148687481|NCT00619619|536327428|FG006|Overall Study|Adverse Event|0|||
148687482|NCT00619619|536327429|FG007|Overall Study|Adverse Event|2|||
148687483|NCT01401478|536327431|FG000|Overall Study|Study drug not available|6|||
148687484|NCT01401478|536327431|FG000|Overall Study|Adverse Event|5|||
148687485|NCT01401478|536327431|FG000|Overall Study|Hyperphosphatemia|5|||
148687486|NCT01401478|536327431|FG000|Overall Study|Lost to Follow-up|5|||
148687487|NCT01401478|536327431|FG000|Overall Study|Kidney transplantation|3|||
148687488|NCT01401478|536327431|FG000|Overall Study|Withdrawal by Subject|3|||
148687489|NCT01401478|536327431|FG000|Overall Study|Blood samples not available|1|||
148687490|NCT01401478|536327431|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
148687491|NCT01401478|536327431|FG000|Overall Study|Low intact parathyroid hormone|1|||
148687492|NCT01401478|536327431|FG000|Overall Study|Serious adverse event|1|||
148687493|NCT01814137|536327433|FG000|Overall Study|Adverse Event|0|||
148687494|NCT01814137|536327434|FG001|Overall Study|Adverse Event|1|||
148687495|NCT01814137|536327433|FG000|Overall Study|Withdrawal by Subject|2|||
148687496|NCT01814137|536327434|FG001|Overall Study|Withdrawal by Subject|2|||
148687497|NCT01814137|536327433|FG000|Overall Study|Physician Decision|1|||
148687498|NCT01814137|536327434|FG001|Overall Study|Physician Decision|1|||
148687499|NCT01814137|536327433|FG000|Overall Study|Unclassified|2|||
148687500|NCT01814137|536327434|FG001|Overall Study|Unclassified|1|||
148687501|NCT00415532|536327435|FG000|Treatment Period|Adverse Event|2|||
148687502|NCT00415532|536327436|FG001|Treatment Period|Adverse Event|3|||
148687503|NCT00415532|536327435|FG000|Treatment Period|Death|2|||
148687504|NCT00415532|536327436|FG001|Treatment Period|Death|1|||
148687505|NCT00415532|536327435|FG000|Treatment Period|Lost to Follow-up|1|||
148687506|NCT00415532|536327436|FG001|Treatment Period|Lost to Follow-up|1|||
148687507|NCT00415532|536327435|FG000|Treatment Period|Protocol Violation|1|||
148687508|NCT00415532|536327436|FG001|Treatment Period|Protocol Violation|0|||
148687509|NCT00415532|536327435|FG000|Treatment Period|Withdrawal by Subject|6|||
148687510|NCT00415532|536327436|FG001|Treatment Period|Withdrawal by Subject|6|||
148687511|NCT00415532|536327435|FG000|Treatment Period|Other|2|||
148687512|NCT00415532|536327436|FG001|Treatment Period|Other|2|||
148687513|NCT00415532|536327435|FG000|Treatment Period|Ineligibility determined|1|||
148687514|NCT00415532|536327436|FG001|Treatment Period|Ineligibility determined|1|||
148687515|NCT00415532|536327435|FG000|Treatment Period|Noncompliance|1|||
148687516|NCT00415532|536327436|FG001|Treatment Period|Noncompliance|1|||
148953985|NCT01996709|537313184|FG001|Overall Study|Withdrawal by Subject|0|||
148953986|NCT01996709|537313183|FG000|Overall Study|Lost to Follow-up|3|||
148953987|NCT01996709|537313184|FG001|Overall Study|Lost to Follow-up|0|||
148953988|NCT01996709|537313183|FG000|Overall Study|Subject Non-Compliant|1|||
148953989|NCT01996709|537313184|FG001|Overall Study|Subject Non-Compliant|0|||
148953990|NCT01996709|537313183|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
148953991|NCT01996709|537313184|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
148953992|NCT02167893|537313185|FG000|Overall Study|Investigator transferred|85|||
148953993|NCT02167893|537313185|FG000|Overall Study|Investigator health reasons|10|||
148953994|NCT02167893|537313185|FG000|Overall Study|Case report forms not collected|68|||
148953995|NCT00531232|537314620|FG000|Overall Study|Investigator decision|0|||
148953996|NCT00531232|537314621|FG001|Overall Study|Investigator decision|0|||
148953997|NCT00531232|537314622|FG002|Overall Study|Investigator decision|4|||
148953998|NCT00531232|537314620|FG000|Overall Study|Participants refused further treatment|0|||
148953999|NCT00531232|537314621|FG001|Overall Study|Participants refused further treatment|1|||
148954000|NCT00531232|537314622|FG002|Overall Study|Participants refused further treatment|2|||
148954001|NCT00531232|537314620|FG000|Overall Study|Adverse events (AEs)|1|||
148954002|NCT00531232|537314621|FG001|Overall Study|Adverse events (AEs)|2|||
148954003|NCT00531232|537314622|FG002|Overall Study|Adverse events (AEs)|2|||
148954004|NCT00531232|537314620|FG000|Overall Study|Treatment failure|1|||
148954005|NCT00531232|537314621|FG001|Overall Study|Treatment failure|3|||
148954006|NCT00531232|537314622|FG002|Overall Study|Treatment failure|7|||
148687517|NCT00415532|536327435|FG000|Treatment Period|Requirement for alternative therapy|1|||
148687518|NCT00415532|536327436|FG001|Treatment Period|Requirement for alternative therapy|0|||
148687519|NCT00415532|536327435|FG000|Safety Follow Up Period|Adverse Event|1|||
148687520|NCT00415532|536327436|FG001|Safety Follow Up Period|Adverse Event|3|||
148687521|NCT00415532|536327435|FG000|Safety Follow Up Period|Death|3|||
148687522|NCT00415532|536327436|FG001|Safety Follow Up Period|Death|0|||
148687523|NCT00415532|536327435|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
148687524|NCT00415532|536327436|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
148687525|NCT00415532|536327435|FG000|Safety Follow Up Period|Other|1|||
148687526|NCT00415532|536327436|FG001|Safety Follow Up Period|Other|4|||
148954007|NCT00531232|537314620|FG000|Overall Study|Disease recurrence|0|||
148954008|NCT00531232|537314621|FG001|Overall Study|Disease recurrence|0|||
148954009|NCT00531232|537314622|FG002|Overall Study|Disease recurrence|1|||
149018980|NCT03541642|537547280|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
149018981|NCT03523871|537547281|FG000|Overall Study|Death|1|||
149018982|NCT00219141|537547283|FG000|Overall Study|Adverse Event|4|||
149018983|NCT00219141|537547284|FG001|Overall Study|Adverse Event|10|||
149018984|NCT00219141|537547285|FG002|Overall Study|Adverse Event|5|||
149018985|NCT00219141|537547283|FG000|Overall Study|Lack of Efficacy|3|||
149018986|NCT00219141|537547284|FG001|Overall Study|Lack of Efficacy|2|||
149018987|NCT00219141|537547285|FG002|Overall Study|Lack of Efficacy|0|||
149018988|NCT00219141|537547283|FG000|Overall Study|Administrative problems|0|||
149018989|NCT00219141|537547284|FG001|Overall Study|Administrative problems|1|||
149018990|NCT00219141|537547285|FG002|Overall Study|Administrative problems|0|||
149018991|NCT00219141|537547283|FG000|Overall Study|Lost to Follow-up|2|||
149018992|NCT00219141|537547284|FG001|Overall Study|Lost to Follow-up|4|||
149018993|NCT00219141|537547285|FG002|Overall Study|Lost to Follow-up|1|||
149018994|NCT00219141|537547283|FG000|Overall Study|Protocol Violation|3|||
149018995|NCT00219141|537547284|FG001|Overall Study|Protocol Violation|1|||
149018996|NCT00219141|537547285|FG002|Overall Study|Protocol Violation|1|||
149018997|NCT00219141|537547283|FG000|Overall Study|Withdrawal by Subject|1|||
149018998|NCT00219141|537547284|FG001|Overall Study|Withdrawal by Subject|3|||
149018999|NCT00219141|537547285|FG002|Overall Study|Withdrawal by Subject|5|||
149019000|NCT00219141|537547283|FG000|Overall Study|Condition no longer requires study drug|1|||
149019001|NCT00219141|537547284|FG001|Overall Study|Condition no longer requires study drug|0|||
149019002|NCT00219141|537547285|FG002|Overall Study|Condition no longer requires study drug|0|||
149019003|NCT00972179|537547286|FG000|Overall Study|Noncompliance|1|||
149019004|NCT00972179|537547287|FG001|Overall Study|Noncompliance|0|||
149019005|NCT00972179|537547288|FG002|Overall Study|Noncompliance|0|||
149019006|NCT00972179|537547289|FG003|Overall Study|Noncompliance|0|||
149019007|NCT00972179|537547290|FG004|Overall Study|Noncompliance|1|||
149019008|NCT00972179|537547291|FG005|Overall Study|Noncompliance|0|||
149019009|NCT00972179|537547292|FG006|Overall Study|Noncompliance|1|||
149019010|NCT00972179|537547286|FG000|Overall Study|Withdrawal by Subject|0|||
149019011|NCT00972179|537547287|FG001|Overall Study|Withdrawal by Subject|3|||
149019012|NCT00972179|537547288|FG002|Overall Study|Withdrawal by Subject|0|||
149019013|NCT00972179|537547289|FG003|Overall Study|Withdrawal by Subject|1|||
149019014|NCT00972179|537547290|FG004|Overall Study|Withdrawal by Subject|0|||
149019015|NCT00972179|537547291|FG005|Overall Study|Withdrawal by Subject|0|||
149019016|NCT00972179|537547292|FG006|Overall Study|Withdrawal by Subject|2|||
149019017|NCT00972179|537547286|FG000|Overall Study|Administrative Decision|0|||
149019018|NCT00972179|537547287|FG001|Overall Study|Administrative Decision|0|||
149019019|NCT00972179|537547288|FG002|Overall Study|Administrative Decision|0|||
149019020|NCT00972179|537547289|FG003|Overall Study|Administrative Decision|0|||
149019021|NCT00972179|537547290|FG004|Overall Study|Administrative Decision|1|||
149019022|NCT00972179|537547291|FG005|Overall Study|Administrative Decision|0|||
149019023|NCT00972179|537547292|FG006|Overall Study|Administrative Decision|0|||
149019024|NCT00972179|537547286|FG000|Overall Study|Lost to Follow-up|0|||
149019025|NCT00972179|537547287|FG001|Overall Study|Lost to Follow-up|0|||
149019026|NCT00972179|537547288|FG002|Overall Study|Lost to Follow-up|1|||
149019027|NCT00972179|537547289|FG003|Overall Study|Lost to Follow-up|0|||
149019028|NCT00972179|537547290|FG004|Overall Study|Lost to Follow-up|0|||
149019029|NCT00972179|537547291|FG005|Overall Study|Lost to Follow-up|3|||
149019030|NCT00972179|537547292|FG006|Overall Study|Lost to Follow-up|1|||
149019031|NCT03055832|537547293|FG000|Week 2|Withdrawal by Subject|1|||
149019032|NCT03055832|537547294|FG001|Week 2|Withdrawal by Subject|0|||
149019033|NCT03619174|537547295|FG000|Overall Study|Lost to Follow-up|3|||
149019034|NCT03619174|537547296|FG001|Overall Study|Lost to Follow-up|0|||
149019035|NCT03619174|537547295|FG000|Overall Study|Withdrawal by Subject|4|||
149019036|NCT03619174|537547296|FG001|Overall Study|Withdrawal by Subject|3|||
149019037|NCT03619174|537547295|FG000|Overall Study|Pregnancy|1|||
149019038|NCT03619174|537547296|FG001|Overall Study|Pregnancy|1|||
149019039|NCT03619174|537547295|FG000|Overall Study|Discomfort during treatment|1|||
148687527|NCT00415532|536327435|FG000|Safety Follow Up Period|Ineligibility determined|1|||
149019040|NCT03619174|537547296|FG001|Overall Study|Discomfort during treatment|0|||
149019041|NCT04285229|537547299|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
149019042|NCT04285229|537547300|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149019043|NCT04285229|537547301|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149019044|NCT04285229|537547302|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148687528|NCT00415532|536327436|FG001|Safety Follow Up Period|Ineligibility determined|1|||
149019045|NCT04285229|537547303|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149019046|NCT04285229|537547304|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149019047|NCT04285229|537547299|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
149019048|NCT04285229|537547300|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
149019049|NCT04285229|537547301|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
149019050|NCT04285229|537547302|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
149019051|NCT04285229|537547303|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
148687529|NCT00415532|536327435|FG000|Safety Follow Up Period|Noncompliance|1|||
149019052|NCT04285229|537547304|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
149019053|NCT04285229|537547299|FG000|Extended Treatment Period|Adverse Event|0|||
149019054|NCT04285229|537547300|FG001|Extended Treatment Period|Adverse Event|0|||
149019055|NCT04285229|537547301|FG002|Extended Treatment Period|Adverse Event|0|||
149019056|NCT04285229|537547302|FG003|Extended Treatment Period|Adverse Event|1|||
149019057|NCT04285229|537547303|FG004|Extended Treatment Period|Adverse Event|0|||
149019058|NCT04285229|537547304|FG005|Extended Treatment Period|Adverse Event|0|||
148687530|NCT00415532|536327436|FG001|Safety Follow Up Period|Noncompliance|0|||
148687531|NCT00415532|536327435|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
148687532|NCT00415532|536327436|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
148687533|NCT01798485|536327437|FG000|Overall Study|Adverse Event|32|||
148687534|NCT01798485|536327438|FG001|Overall Study|Adverse Event|40|||
148687535|NCT01798485|536327437|FG000|Overall Study|Withdrawal by Subject|27|||
148687536|NCT01798485|536327438|FG001|Overall Study|Withdrawal by Subject|31|||
148687537|NCT01798485|536327437|FG000|Overall Study|Lost to Follow-up|0|||
148687538|NCT01798485|536327438|FG001|Overall Study|Lost to Follow-up|3|||
148687539|NCT01798485|536327437|FG000|Overall Study|Physician Decision|14|||
148687540|NCT01798485|536327438|FG001|Overall Study|Physician Decision|10|||
148687541|NCT01798485|536327437|FG000|Overall Study|Objective Disease Progression|152|||
148687542|NCT01798485|536327438|FG001|Overall Study|Objective Disease Progression|106|||
148687543|NCT01798485|536327437|FG000|Overall Study|Death|25|||
148687544|NCT01798485|536327438|FG001|Overall Study|Death|22|||
148687545|NCT01798485|536327437|FG000|Overall Study|Sponsor Decision|61|||
148687546|NCT01798485|536327438|FG001|Overall Study|Sponsor Decision|54|||
148687547|NCT01798485|536327437|FG000|Overall Study|Clinical Progression|35|||
148687548|NCT01798485|536327438|FG001|Overall Study|Clinical Progression|24|||
148687549|NCT03687125|536327439|FG000|Overall Study|Progressive Disease|2|||
148687550|NCT03687125|536327440|FG001|Overall Study|Progressive Disease|1|||
148687551|NCT03687125|536327439|FG000|Overall Study|Protocol Violation|1|||
148687552|NCT03687125|536327440|FG001|Overall Study|Protocol Violation|0|||
148687553|NCT01992107|536327441|FG000|Overall Study|Administrative reasons|2|||
148687554|NCT01992107|536327442|FG001|Overall Study|Administrative reasons|0|||
148687555|NCT01992107|536327443|FG002|Overall Study|Administrative reasons|0|||
148687556|NCT01992107|536327441|FG000|Overall Study|Adverse Event|0|||
148687557|NCT01992107|536327442|FG001|Overall Study|Adverse Event|1|||
148687558|NCT01992107|536327443|FG002|Overall Study|Adverse Event|0|||
148687559|NCT01992107|536327441|FG000|Overall Study|Lost to Follow-up|46|||
148687560|NCT01992107|536327442|FG001|Overall Study|Lost to Follow-up|22|||
148687561|NCT01992107|536327443|FG002|Overall Study|Lost to Follow-up|26|||
148687562|NCT01992107|536327441|FG000|Overall Study|noncompliance and were unavailable|7|||
148687563|NCT01992107|536327442|FG001|Overall Study|noncompliance and were unavailable|3|||
148687564|NCT01992107|536327443|FG002|Overall Study|noncompliance and were unavailable|2|||
148687565|NCT01992107|536327441|FG000|Overall Study|Withdrawal by Subject|13|||
148687566|NCT01992107|536327442|FG001|Overall Study|Withdrawal by Subject|7|||
148687567|NCT01992107|536327443|FG002|Overall Study|Withdrawal by Subject|8|||
148687568|NCT02022007|536327444|FG000|Overall Study|Withdrawal by Subject|1|||
148687569|NCT02022007|536327445|FG001|Overall Study|Withdrawal by Subject|1|||
148687570|NCT02022007|536327446|FG002|Overall Study|Withdrawal by Subject|1|||
148687571|NCT02022007|536327444|FG000|Overall Study|Noncompliant|0|||
148687572|NCT02022007|536327445|FG001|Overall Study|Noncompliant|0|||
148687573|NCT02022007|536327446|FG002|Overall Study|Noncompliant|1|||
148687574|NCT01214603|536327447|FG000|Overall Study|Adverse Event|0|||
148687575|NCT01214603|536327448|FG001|Overall Study|Adverse Event|0|||
148687576|NCT01214603|536327449|FG002|Overall Study|Adverse Event|1|||
148687577|NCT01214603|536327447|FG000|Overall Study|Death|1|||
148687578|NCT01214603|536327448|FG001|Overall Study|Death|0|||
148687579|NCT01214603|536327449|FG002|Overall Study|Death|0|||
148687580|NCT01214603|536327447|FG000|Overall Study|Progressive Disease|4|||
149019059|NCT04285229|537547299|FG000|Extended Treatment Period|Physician Decision|0|||
149019060|NCT04285229|537547300|FG001|Extended Treatment Period|Physician Decision|0|||
149224836|NCT02195531|538288132|FG001|Overall Study|Withdrawal by Subject|1|||
149224837|NCT02195531|538288133|FG002|Overall Study|Withdrawal by Subject|1|||
149224838|NCT01038635|538288135|FG000|Overall Study|Disease Progression|2|||
149224839|NCT01038635|538288136|FG001|Overall Study|Disease Progression|0|||
149224840|NCT01038635|538288137|FG002|Overall Study|Disease Progression|0|||
149224841|NCT01038635|538288138|FG003|Overall Study|Disease Progression|0|||
149224842|NCT01038635|538288139|FG004|Overall Study|Disease Progression|0|||
149224843|NCT01038635|538288140|FG005|Overall Study|Disease Progression|0|||
149224844|NCT01038635|538288141|FG006|Overall Study|Disease Progression|1|||
148687581|NCT01214603|536327448|FG001|Overall Study|Progressive Disease|1|||
148687582|NCT01214603|536327449|FG002|Overall Study|Progressive Disease|3|||
148687583|NCT01507896|536327450|FG000|Overall Study|Withdrawal by Subject|1|||
148687584|NCT01507896|536327450|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
148810138|NCT05383209|536782568|FG002|Overall Study|Death|0|||
148687585|NCT03156270|536327461|FG000|Overall Study|Failed pre-treatment screening|1|||
148687586|NCT03156270|536327461|FG000|Overall Study|Lost to Follow-up|1|||
148687587|NCT00446654|536327462|FG000|Overall Study|Withdrawal by Subject|1|||
149019061|NCT04285229|537547301|FG002|Extended Treatment Period|Physician Decision|1|||
149019062|NCT04285229|537547302|FG003|Extended Treatment Period|Physician Decision|0|||
149019063|NCT04285229|537547303|FG004|Extended Treatment Period|Physician Decision|0|||
149019064|NCT04285229|537547304|FG005|Extended Treatment Period|Physician Decision|0|||
149019065|NCT04285229|537547299|FG000|Follow-up Period|Adverse Event|0|||
149019066|NCT04285229|537547300|FG001|Follow-up Period|Adverse Event|0|||
149019067|NCT04285229|537547301|FG002|Follow-up Period|Adverse Event|0|||
149019068|NCT04285229|537547302|FG003|Follow-up Period|Adverse Event|0|||
149019069|NCT04285229|537547303|FG004|Follow-up Period|Adverse Event|1|||
149019070|NCT04285229|537547304|FG005|Follow-up Period|Adverse Event|4|||
149019071|NCT04285229|537547299|FG000|Follow-up Period|Withdrawal by Subject|0|||
149019072|NCT04285229|537547300|FG001|Follow-up Period|Withdrawal by Subject|0|||
149019073|NCT04285229|537547301|FG002|Follow-up Period|Withdrawal by Subject|0|||
149019074|NCT04285229|537547302|FG003|Follow-up Period|Withdrawal by Subject|0|||
149019075|NCT04285229|537547303|FG004|Follow-up Period|Withdrawal by Subject|0|||
149019076|NCT04285229|537547304|FG005|Follow-up Period|Withdrawal by Subject|5|||
149019077|NCT04285229|537547299|FG000|Follow-up Period|Covid-19|0|||
149019078|NCT04285229|537547300|FG001|Follow-up Period|Covid-19|0|||
149019079|NCT04285229|537547301|FG002|Follow-up Period|Covid-19|0|||
149019080|NCT04285229|537547302|FG003|Follow-up Period|Covid-19|0|||
149019081|NCT04285229|537547303|FG004|Follow-up Period|Covid-19|0|||
149019082|NCT04285229|537547304|FG005|Follow-up Period|Covid-19|2|||
149019083|NCT04285229|537547299|FG000|Follow-up Period|Physician Decision|0|||
149019084|NCT04285229|537547300|FG001|Follow-up Period|Physician Decision|0|||
149019085|NCT04285229|537547301|FG002|Follow-up Period|Physician Decision|0|||
149019086|NCT04285229|537547302|FG003|Follow-up Period|Physician Decision|0|||
149019087|NCT04285229|537547303|FG004|Follow-up Period|Physician Decision|0|||
149019088|NCT04285229|537547304|FG005|Follow-up Period|Physician Decision|1|||
149019089|NCT01012973|537547305|FG000|Overall Study|Adverse Event|5|||
149019090|NCT01012973|537547306|FG001|Overall Study|Adverse Event|5|||
149019091|NCT01012973|537547305|FG000|Overall Study|Lack of Efficacy|0|||
149019092|NCT01012973|537547306|FG001|Overall Study|Lack of Efficacy|5|||
149019093|NCT01012973|537547305|FG000|Overall Study|Lost to Follow-up|1|||
149019094|NCT01012973|537547306|FG001|Overall Study|Lost to Follow-up|0|||
149019095|NCT01012973|537547305|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
149019096|NCT01012973|537547306|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
149019097|NCT01012973|537547305|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
149019098|NCT01012973|537547306|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
149019099|NCT01012973|537547305|FG000|Overall Study|Protocol Violation|5|||
149019100|NCT01012973|537547306|FG001|Overall Study|Protocol Violation|2|||
149019101|NCT01012973|537547305|FG000|Overall Study|Withdrawal by Subject|4|||
149019102|NCT01012973|537547306|FG001|Overall Study|Withdrawal by Subject|6|||
149019103|NCT02061761|537547307|FG000|Overall Study|Disease progression|2|||
149019104|NCT02061761|537547308|FG001|Overall Study|Disease progression|8|||
149019105|NCT02061761|537547309|FG002|Overall Study|Disease progression|4|||
149019106|NCT02061761|537547310|FG003|Overall Study|Disease progression|5|||
149019107|NCT02061761|537547311|FG004|Overall Study|Disease progression|9|||
149019108|NCT02061761|537547312|FG005|Overall Study|Disease progression|3|||
149019109|NCT02061761|537547313|FG006|Overall Study|Disease progression|1|||
149019110|NCT02061761|537547314|FG007|Overall Study|Disease progression|2|||
149019111|NCT02061761|537547315|FG008|Overall Study|Disease progression|28|||
149019112|NCT02061761|537547307|FG000|Overall Study|Study Drug toxicity|0|||
149019113|NCT02061761|537547308|FG001|Overall Study|Study Drug toxicity|0|||
149019114|NCT02061761|537547309|FG002|Overall Study|Study Drug toxicity|0|||
149019115|NCT02061761|537547310|FG003|Overall Study|Study Drug toxicity|0|||
149019116|NCT02061761|537547311|FG004|Overall Study|Study Drug toxicity|0|||
149019117|NCT02061761|537547312|FG005|Overall Study|Study Drug toxicity|1|||
149019118|NCT02061761|537547313|FG006|Overall Study|Study Drug toxicity|0|||
149019119|NCT02061761|537547314|FG007|Overall Study|Study Drug toxicity|2|||
149019120|NCT02061761|537547315|FG008|Overall Study|Study Drug toxicity|6|||
149019121|NCT02061761|537547307|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
149019122|NCT02061761|537547308|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
149019123|NCT02061761|537547309|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
149019124|NCT02061761|537547310|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
149224845|NCT01038635|538288142|FG007|Overall Study|Disease Progression|4|||
149224846|NCT01038635|538288143|FG008|Overall Study|Disease Progression|0|||
149224847|NCT01038635|538288135|FG000|Overall Study|Death|0|||
149224848|NCT01038635|538288136|FG001|Overall Study|Death|0|||
149224849|NCT01038635|538288137|FG002|Overall Study|Death|0|||
149224850|NCT01038635|538288138|FG003|Overall Study|Death|0|||
149224851|NCT01038635|538288139|FG004|Overall Study|Death|1|||
149224852|NCT01038635|538288140|FG005|Overall Study|Death|0|||
149224853|NCT01038635|538288141|FG006|Overall Study|Death|1|||
149224854|NCT01038635|538288142|FG007|Overall Study|Death|1|||
149224855|NCT01038635|538288143|FG008|Overall Study|Death|2|||
149224856|NCT01227252|538288144|FG000|Overall Study|Sponsor Decision|0|||
149224857|NCT01227252|538288145|FG001|Overall Study|Sponsor Decision|1|||
149224858|NCT01227252|538288146|FG002|Overall Study|Sponsor Decision|0|||
149224859|NCT01227252|538288147|FG003|Overall Study|Sponsor Decision|0|||
149224860|NCT01227252|538288144|FG000|Overall Study|Lost to Follow-up|0|||
149224861|NCT01227252|538288145|FG001|Overall Study|Lost to Follow-up|1|||
148687588|NCT00446654|536327463|FG001|Overall Study|Withdrawal by Subject|0|||
149224862|NCT01227252|538288146|FG002|Overall Study|Lost to Follow-up|0|||
149224863|NCT01227252|538288147|FG003|Overall Study|Lost to Follow-up|0|||
149224864|NCT01227252|538288144|FG000|Overall Study|Withdrawal by Subject|0|||
149224865|NCT01227252|538288145|FG001|Overall Study|Withdrawal by Subject|1|||
149224866|NCT01227252|538288146|FG002|Overall Study|Withdrawal by Subject|0|||
149224867|NCT01227252|538288147|FG003|Overall Study|Withdrawal by Subject|0|||
149224868|NCT01034709|538288151|FG000|Overall Study|Protocol Violation|9|||
149224869|NCT01034709|538288152|FG001|Overall Study|Protocol Violation|16|||
149224870|NCT01284127|538288153|FG000|Overall Study|Adverse Event|2|||
149224871|NCT01284127|538288153|FG000|Overall Study|Withdrawal by Subject|4|||
149224872|NCT01284127|538288153|FG000|Overall Study|Physician Decision|1|||
149224873|NCT01683058|538288154|FG000|Overall Study|Lost to Follow-up|9|||
149224874|NCT01683058|538288154|FG000|Overall Study|Adverse Event|6|||
149224875|NCT01683058|538288154|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
149224876|NCT01683058|538288154|FG000|Overall Study|Withdrawal by Subject|7|||
149224877|NCT01683058|538288154|FG000|Overall Study|Lack of Efficacy|2|||
149224878|NCT01057394|538288155|FG000|Overall Study|Not eligible|0|||
149224879|NCT01057394|538288156|FG001|Overall Study|Not eligible|2|||
149224880|NCT01195636|538288157|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
149224881|NCT01195636|538288158|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
149224882|NCT01195636|538288157|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
149224883|NCT01195636|538288158|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
149224884|NCT01195636|538288157|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149224885|NCT01195636|538288158|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
149224886|NCT01195636|538288157|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
149224887|NCT01195636|538288158|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
149224888|NCT01195636|538288157|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
149224889|NCT01195636|538288158|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
149224890|NCT01195636|538288157|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
149224891|NCT01195636|538288158|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
149224892|NCT01195636|538288157|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
149224893|NCT01195636|538288158|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
149224894|NCT01195636|538288157|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
149224895|NCT01195636|538288158|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
149224896|NCT00660816|538288159|FG000|Overall Study|Adverse Event|1|||
149224897|NCT00660816|538288160|FG001|Overall Study|Adverse Event|2|||
149224898|NCT00660816|538288159|FG000|Overall Study|Withdrawal by Subject|1|||
149224899|NCT00660816|538288160|FG001|Overall Study|Withdrawal by Subject|0|||
149224900|NCT00660816|538288159|FG000|Overall Study|Death|0|||
149224901|NCT00660816|538288160|FG001|Overall Study|Death|2|||
149224902|NCT00660816|538288159|FG000|Overall Study|Lack of Efficacy|1|||
149224903|NCT00660816|538288160|FG001|Overall Study|Lack of Efficacy|0|||
149224904|NCT00660816|538288159|FG000|Overall Study|Physician Decision|0|||
149224905|NCT00660816|538288160|FG001|Overall Study|Physician Decision|2|||
149224906|NCT00660816|538288159|FG000|Overall Study|Protocol Violation|1|||
149224907|NCT00660816|538288160|FG001|Overall Study|Protocol Violation|0|||
149224908|NCT00660816|538288159|FG000|Overall Study|Disease Progression|16|||
149224909|NCT00660816|538288160|FG001|Overall Study|Disease Progression|12|||
149224910|NCT00660816|538288159|FG000|Overall Study|Complicating Disease|0|||
149224911|NCT00660816|538288160|FG001|Overall Study|Complicating Disease|1|||
149224912|NCT01142791|538288173|FG000|Overall Study|Alternative Treatment|1|||
149224913|NCT01142791|538288174|FG001|Overall Study|Alternative Treatment|0|||
149224914|NCT01142791|538288173|FG000|Overall Study|Lost to Follow-up|1|||
148810139|NCT05383209|536782566|FG000|Overall Study|Other|0|||
148954010|NCT00531232|537314620|FG000|Overall Study|Deceased|2|||
149224915|NCT01142791|538288174|FG001|Overall Study|Lost to Follow-up|0|||
149224916|NCT01142791|538288173|FG000|Overall Study|Withdrawal by Subject|5|||
149224917|NCT01142791|538288174|FG001|Overall Study|Withdrawal by Subject|0|||
149224918|NCT01142791|538288173|FG000|Overall Study|Received only 1 sonication|0|||
149224919|NCT01142791|538288174|FG001|Overall Study|Received only 1 sonication|6|||
149224920|NCT00866606|538288178|FG000|Overall Study|Lost to Follow-up|3|||
149224921|NCT00866606|538288178|FG000|Overall Study|Adverse Event|1|||
149224922|NCT00806494|538288179|FG000|Overall Study|Adverse Event|29|||
149224923|NCT00806494|538288179|FG000|Overall Study|Lack of Efficacy|6|||
149224924|NCT00806494|538288179|FG000|Overall Study|Lost to Follow-up|10|||
149224925|NCT00806494|538288179|FG000|Overall Study|Other|30|||
149224926|NCT00806494|538288179|FG000|Overall Study|Withdrawal by Subject|5|||
149224927|NCT02140762|538288180|FG000|Overall Study|Adverse Event|1|||
149224928|NCT02140762|538288181|FG001|Overall Study|Adverse Event|1|||
149224929|NCT02140762|538288180|FG000|Overall Study|Lost to Follow-up|9|||
149224930|NCT02140762|538288181|FG001|Overall Study|Lost to Follow-up|5|||
149224931|NCT02140762|538288180|FG000|Overall Study|Protocol Violation|1|||
149224932|NCT02140762|538288181|FG001|Overall Study|Protocol Violation|1|||
149224933|NCT02140762|538288180|FG000|Overall Study|Withdrawal by Subject|6|||
149224934|NCT02140762|538288181|FG001|Overall Study|Withdrawal by Subject|4|||
149224935|NCT02140762|538288180|FG000|Overall Study|Other|0|||
149224936|NCT02140762|538288181|FG001|Overall Study|Other|1|||
149224937|NCT01899729|538288182|FG000|Overall Study|Adverse Event|1|||
149224938|NCT01899729|538288183|FG001|Overall Study|Adverse Event|0|||
149224939|NCT01899729|538288184|FG002|Overall Study|Adverse Event|0|||
149224940|NCT01899729|538288185|FG003|Overall Study|Adverse Event|0|||
149224941|NCT01899729|538288186|FG004|Overall Study|Adverse Event|1|||
149224942|NCT01899729|538288182|FG000|Overall Study|Withdrawal by Subject|1|||
149224943|NCT01899729|538288183|FG001|Overall Study|Withdrawal by Subject|2|||
149224944|NCT01899729|538288184|FG002|Overall Study|Withdrawal by Subject|0|||
149224945|NCT01899729|538288185|FG003|Overall Study|Withdrawal by Subject|0|||
149224946|NCT01899729|538288186|FG004|Overall Study|Withdrawal by Subject|0|||
149224947|NCT01899729|538288182|FG000|Overall Study|Lack of Efficacy|0|||
149224948|NCT01899729|538288183|FG001|Overall Study|Lack of Efficacy|0|||
149224949|NCT01899729|538288184|FG002|Overall Study|Lack of Efficacy|2|||
149224950|NCT01899729|538288185|FG003|Overall Study|Lack of Efficacy|0|||
149224951|NCT01899729|538288186|FG004|Overall Study|Lack of Efficacy|1|||
149224952|NCT01454531|538288187|FG000|Overall Study|Adverse Event|14|||
149224953|NCT01454531|538288187|FG000|Overall Study|Withdrawal by Subject|5|||
149224954|NCT01454531|538288187|FG000|Overall Study|Lost to Follow-up|1|||
149224955|NCT01454531|538288187|FG000|Overall Study|Physician Decision|1|||
149224956|NCT01454531|538288187|FG000|Overall Study|Delay in IMP administration|1|||
149224957|NCT01454531|538288187|FG000|Overall Study|Other|1|||
149224958|NCT01277666|538288189|FG000|Overall Study|Adverse Event|26|||
149224959|NCT01277666|538288190|FG001|Overall Study|Adverse Event|25|||
149224960|NCT01277666|538288191|FG002|Overall Study|Adverse Event|20|||
149224961|NCT01277666|538288189|FG000|Overall Study|Lack of Efficacy|8|||
149224962|NCT01277666|538288190|FG001|Overall Study|Lack of Efficacy|20|||
149224963|NCT01277666|538288191|FG002|Overall Study|Lack of Efficacy|12|||
149224964|NCT01277666|538288189|FG000|Overall Study|Protocol Violation|2|||
149224965|NCT01277666|538288190|FG001|Overall Study|Protocol Violation|3|||
149224966|NCT01277666|538288191|FG002|Overall Study|Protocol Violation|2|||
149224967|NCT01277666|538288189|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
149224968|NCT01277666|538288190|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
149224969|NCT01277666|538288191|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
149224970|NCT01277666|538288189|FG000|Overall Study|Lost to Follow-up|1|||
149224971|NCT01277666|538288190|FG001|Overall Study|Lost to Follow-up|1|||
149224972|NCT01277666|538288191|FG002|Overall Study|Lost to Follow-up|2|||
149224973|NCT01277666|538288189|FG000|Overall Study|Withdrawal by Subject|7|||
149224974|NCT01277666|538288190|FG001|Overall Study|Withdrawal by Subject|8|||
149224975|NCT01277666|538288191|FG002|Overall Study|Withdrawal by Subject|6|||
149224976|NCT01277666|538288189|FG000|Overall Study|Death|0|||
149224977|NCT01277666|538288190|FG001|Overall Study|Death|0|||
149224978|NCT01277666|538288191|FG002|Overall Study|Death|1|||
149224979|NCT00795717|538288192|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
149224980|NCT00795717|538288193|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
149224981|NCT00795717|538288192|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
149224982|NCT00795717|538288193|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
149224983|NCT00795717|538288192|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
148954011|NCT00531232|537314621|FG001|Overall Study|Deceased|2|||
149224984|NCT00795717|538288193|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
149224985|NCT00795717|538288192|FG000|Phase II|too busy|0|||
149224986|NCT00795717|538288193|FG001|Phase II|too busy|1|||
149224987|NCT03458234|538288195|FG000|Overall Study|Withdrawal by Subject|1|||
149224988|NCT05315297|538288199|FG000|Overall Study|Lost to Follow-up|6|||
149224989|NCT05315297|538288200|FG001|Overall Study|Lost to Follow-up|4|||
149224990|NCT05315297|538288199|FG000|Overall Study|Withdrawal by Subject|0|||
149224991|NCT05315297|538288200|FG001|Overall Study|Withdrawal by Subject|1|||
149224992|NCT01084096|538290184|FG000|Overall Study|Lost to Follow-up|1501|||
149224993|NCT01084096|538290185|FG001|Overall Study|Lost to Follow-up|1833|||
149224994|NCT01084096|538290184|FG000|Overall Study|Withdrawal by Subject|3|||
149019125|NCT02061761|537547311|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
149224995|NCT01084096|538290185|FG001|Overall Study|Withdrawal by Subject|0|||
149224996|NCT01084096|538290184|FG000|Overall Study|Woman had a miscarriage|21|||
149224997|NCT01084096|538290185|FG001|Overall Study|Woman had a miscarriage|17|||
149224998|NCT00027846|538290186|FG000|Overall Study|Lost to Follow-up|0|||
149224999|NCT00027846|538290187|FG001|Overall Study|Lost to Follow-up|41|||
149225000|NCT00027846|538290188|FG002|Overall Study|Lost to Follow-up|9|||
149225001|NCT00027846|538290186|FG000|Overall Study|Withdrawal by Subject|0|||
149225002|NCT00027846|538290187|FG001|Overall Study|Withdrawal by Subject|14|||
149225003|NCT00027846|538290188|FG002|Overall Study|Withdrawal by Subject|7|||
149225004|NCT00027846|538290186|FG000|Overall Study|Ineligible for study|2|||
149225005|NCT00027846|538290187|FG001|Overall Study|Ineligible for study|6|||
149225006|NCT00027846|538290188|FG002|Overall Study|Ineligible for study|14|||
149225007|NCT00027846|538290186|FG000|Overall Study|Entry into another COG therapeutic study|0|||
149225008|NCT00027846|538290187|FG001|Overall Study|Entry into another COG therapeutic study|5|||
149225009|NCT00027846|538290188|FG002|Overall Study|Entry into another COG therapeutic study|2|||
149225010|NCT00027846|538290186|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
149225011|NCT00027846|538290187|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
149225012|NCT00027846|538290188|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
149225013|NCT02033369|538290189|FG000|Overall Study|Physician Decision|1|||
149225014|NCT02033369|538290190|FG001|Overall Study|Physician Decision|2|||
149225015|NCT02033369|538290189|FG000|Overall Study|Not a good demographic match|0|||
149225016|NCT02033369|538290190|FG001|Overall Study|Not a good demographic match|2|||
149225017|NCT02033369|538290189|FG000|Overall Study|Withdrawal by Subject|1|||
149225018|NCT02033369|538290190|FG001|Overall Study|Withdrawal by Subject|1|||
149225019|NCT02033369|538290189|FG000|Overall Study|Lost to Follow-up|1|||
149225020|NCT02033369|538290190|FG001|Overall Study|Lost to Follow-up|0|||
149225021|NCT02033369|538290189|FG000|Overall Study|Protocol Violation|2|||
149225022|NCT02033369|538290190|FG001|Overall Study|Protocol Violation|0|||
149225023|NCT01503229|538290191|FG000|Overall Study|Withdrew consent|1|||
149225024|NCT01354964|538290192|FG000|Overall Study|Lost to Follow-up|2|||
149225025|NCT01354964|538290193|FG001|Overall Study|Lost to Follow-up|0|||
149225026|NCT01354964|538290192|FG000|Overall Study|IV access issues|1|||
149225027|NCT01354964|538290193|FG001|Overall Study|IV access issues|1|||
149225028|NCT01354964|538290192|FG000|Overall Study|Physician Decision|1|||
149225029|NCT01354964|538290193|FG001|Overall Study|Physician Decision|0|||
149225030|NCT00711009|538290194|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
149225031|NCT00711009|538290195|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
149225032|NCT00711009|538290194|FG000|Overall Study|Withdrawal by Subject|4|||
149225033|NCT00711009|538290195|FG001|Overall Study|Withdrawal by Subject|2|||
149225034|NCT00711009|538290194|FG000|Overall Study|Lost to Follow-up|3|||
149225035|NCT00711009|538290195|FG001|Overall Study|Lost to Follow-up|9|||
149225036|NCT00711009|538290194|FG000|Overall Study|Participant Noncompliant|0|||
149225037|NCT00711009|538290195|FG001|Overall Study|Participant Noncompliant|1|||
149225038|NCT00711009|538290194|FG000|Overall Study|Virologic Failure|2|||
149225039|NCT00711009|538290195|FG001|Overall Study|Virologic Failure|1|||
149225040|NCT00711009|538290194|FG000|Overall Study|Pregnancy|1|||
149019126|NCT02061761|537547312|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
149019127|NCT02061761|537547313|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
149019128|NCT02061761|537547314|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
149019129|NCT02061761|537547315|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
149225041|NCT00711009|538290195|FG001|Overall Study|Pregnancy|0|||
149225042|NCT00711009|538290194|FG000|Overall Study|Site closing|0|||
149225043|NCT00711009|538290195|FG001|Overall Study|Site closing|1|||
149019130|NCT02061761|537547307|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149019131|NCT02061761|537547308|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149019132|NCT02061761|537547309|FG002|Overall Study|Participant request to discontinue study treatment|2|||
149225044|NCT00711009|538290194|FG000|Overall Study|Dose adjustment|1|||
149225045|NCT00711009|538290195|FG001|Overall Study|Dose adjustment|0|||
149225046|NCT04335929|538290197|FG000|Overall Study|Lost to Follow-up|10|||
149225047|NCT02534324|538290203|FG000|Overall Study|Protocol Violation|4|||
149019133|NCT02061761|537547310|FG003|Overall Study|Participant request to discontinue study treatment|2|||
149019134|NCT02061761|537547311|FG004|Overall Study|Participant request to discontinue study treatment|0|||
149225048|NCT02534324|538290204|FG001|Overall Study|Protocol Violation|1|||
149225049|NCT02534324|538290203|FG000|Overall Study|Lost to Follow-up|20|||
149225050|NCT02534324|538290204|FG001|Overall Study|Lost to Follow-up|7|||
149225051|NCT02534324|538290203|FG000|Overall Study|Adverse Event|1|||
149225052|NCT02534324|538290204|FG001|Overall Study|Adverse Event|0|||
149225053|NCT05604781|538290207|FG000|Overall Study|Lost to Follow-up|3|||
149225054|NCT05604781|538290207|FG000|Overall Study|Adverse Event|1|||
149019135|NCT02061761|537547312|FG005|Overall Study|Participant request to discontinue study treatment|1|||
149019136|NCT02061761|537547313|FG006|Overall Study|Participant request to discontinue study treatment|0|||
149019137|NCT02061761|537547314|FG007|Overall Study|Participant request to discontinue study treatment|0|||
149019138|NCT02061761|537547315|FG008|Overall Study|Participant request to discontinue study treatment|2|||
149019139|NCT02061761|537547307|FG000|Overall Study|Withdrawal by Subject|0|||
149019140|NCT02061761|537547308|FG001|Overall Study|Withdrawal by Subject|0|||
149019141|NCT02061761|537547309|FG002|Overall Study|Withdrawal by Subject|0|||
149019142|NCT02061761|537547310|FG003|Overall Study|Withdrawal by Subject|0|||
149019143|NCT02061761|537547311|FG004|Overall Study|Withdrawal by Subject|0|||
149019144|NCT02061761|537547312|FG005|Overall Study|Withdrawal by Subject|0|||
149019145|NCT02061761|537547313|FG006|Overall Study|Withdrawal by Subject|0|||
149019146|NCT02061761|537547314|FG007|Overall Study|Withdrawal by Subject|0|||
149019147|NCT02061761|537547315|FG008|Overall Study|Withdrawal by Subject|2|||
149019148|NCT02061761|537547307|FG000|Overall Study|Maximum clinical benefit|0|||
149019149|NCT02061761|537547308|FG001|Overall Study|Maximum clinical benefit|0|||
149019150|NCT02061761|537547309|FG002|Overall Study|Maximum clinical benefit|0|||
149019151|NCT02061761|537547310|FG003|Overall Study|Maximum clinical benefit|1|||
149019152|NCT02061761|537547311|FG004|Overall Study|Maximum clinical benefit|0|||
149019153|NCT02061761|537547312|FG005|Overall Study|Maximum clinical benefit|0|||
149225055|NCT01459016|538290208|FG000|Overall Study|Withdrawal by Subject|11|||
149225056|NCT01459016|538290208|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
149225057|NCT00303602|538290212|FG000|Overall Study|Adverse Event|2|||
149225058|NCT00303602|538290213|FG001|Overall Study|Adverse Event|2|||
149225059|NCT00303602|538290212|FG000|Overall Study|Withdrawal by Subject|5|||
149225060|NCT00303602|538290213|FG001|Overall Study|Withdrawal by Subject|6|||
148687589|NCT00446654|536327462|FG000|Overall Study|Adverse Event|1|||
149019154|NCT02061761|537547313|FG006|Overall Study|Maximum clinical benefit|0|||
149019155|NCT02061761|537547314|FG007|Overall Study|Maximum clinical benefit|0|||
149019156|NCT02061761|537547315|FG008|Overall Study|Maximum clinical benefit|6|||
149225061|NCT00303602|538290212|FG000|Overall Study|Lost to Follow-up|5|||
149225062|NCT00303602|538290213|FG001|Overall Study|Lost to Follow-up|2|||
148954012|NCT00531232|537314622|FG002|Overall Study|Deceased|2|||
148954013|NCT00531232|537314620|FG000|Overall Study|Withdrawal by Subject|0|||
148687590|NCT00446654|536327463|FG001|Overall Study|Adverse Event|0|||
148687591|NCT02087059|536327464|FG000|Overall Study|Disease Progression|1|||
148687592|NCT02087059|536327464|FG000|Overall Study|Adverse Event|5|||
148687593|NCT02087059|536327464|FG000|Overall Study|Lost to Follow-up|1|||
148687594|NCT01261325|536327465|FG000|Overall Study|Lack of Efficacy|1|||
148687595|NCT01261325|536327466|FG001|Overall Study|Lack of Efficacy|1|||
148687596|NCT01261325|536327467|FG002|Overall Study|Lack of Efficacy|0|||
148687597|NCT01261325|536327465|FG000|Overall Study|Withdrawal by Subject|2|||
148687598|NCT01261325|536327466|FG001|Overall Study|Withdrawal by Subject|2|||
148687599|NCT01261325|536327467|FG002|Overall Study|Withdrawal by Subject|4|||
148687600|NCT01261325|536327465|FG000|Overall Study|SAE, non-fatal|1|||
148687601|NCT01261325|536327466|FG001|Overall Study|SAE, non-fatal|5|||
148687602|NCT01261325|536327467|FG002|Overall Study|SAE, non-fatal|1|||
148687603|NCT01261325|536327465|FG000|Overall Study|AE, non-serious non-fatal|9|||
148687604|NCT01261325|536327466|FG001|Overall Study|AE, non-serious non-fatal|15|||
148687605|NCT01261325|536327467|FG002|Overall Study|AE, non-serious non-fatal|13|||
148687606|NCT01261325|536327465|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
148687607|NCT01261325|536327466|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148687608|NCT01261325|536327467|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148687609|NCT01261325|536327465|FG000|Overall Study|Non Compliance|2|||
148687610|NCT01261325|536327466|FG001|Overall Study|Non Compliance|0|||
148687611|NCT01261325|536327467|FG002|Overall Study|Non Compliance|0|||
148687612|NCT01261325|536327465|FG000|Overall Study|Patient Randomized by Mistake|0|||
148687613|NCT01261325|536327466|FG001|Overall Study|Patient Randomized by Mistake|1|||
148687614|NCT01261325|536327467|FG002|Overall Study|Patient Randomized by Mistake|0|||
148687615|NCT01261325|536327465|FG000|Overall Study|Erroneously Randomized|1|||
148687616|NCT01261325|536327466|FG001|Overall Study|Erroneously Randomized|0|||
148687617|NCT01261325|536327467|FG002|Overall Study|Erroneously Randomized|0|||
148687618|NCT01261325|536327465|FG000|Overall Study|Screen Failure|1|||
148687619|NCT01261325|536327466|FG001|Overall Study|Screen Failure|0|||
148687620|NCT01261325|536327467|FG002|Overall Study|Screen Failure|0|||
148687621|NCT01261325|536327465|FG000|Overall Study|Randomized in Error|0|||
148687622|NCT01261325|536327466|FG001|Overall Study|Randomized in Error|0|||
148687623|NCT01261325|536327467|FG002|Overall Study|Randomized in Error|1|||
148687624|NCT01261325|536327465|FG000|Overall Study|Protocol Violation|0|||
148687625|NCT01261325|536327466|FG001|Overall Study|Protocol Violation|3|||
148687626|NCT01261325|536327467|FG002|Overall Study|Protocol Violation|1|||
148687627|NCT01261325|536327465|FG000|Overall Study|Lost to Follow-up|0|||
148687628|NCT01261325|536327466|FG001|Overall Study|Lost to Follow-up|1|||
148687629|NCT01261325|536327467|FG002|Overall Study|Lost to Follow-up|3|||
148687630|NCT01261325|536327465|FG000|Overall Study|AE, serious fatal|0|||
148687631|NCT01261325|536327466|FG001|Overall Study|AE, serious fatal|0|||
148687632|NCT01261325|536327467|FG002|Overall Study|AE, serious fatal|2|||
148687633|NCT02330081|536327484|FG000|Overall Study|Adverse Event|1|||
148687634|NCT02330081|536327484|FG000|Overall Study|Donation did not meet criteria|1|||
148687635|NCT02330081|536327484|FG000|Overall Study|Protocol Violation|6|||
148687636|NCT01015612|536327490|FG000|Overall Study|Death|113|||
148687637|NCT01015612|536327490|FG000|Overall Study|Withdrawal by Subject|40|||
148687638|NCT02034799|536328846|FG000|Overall Study|Withdrawal by Subject|0|||
148687639|NCT02034799|536328847|FG001|Overall Study|Withdrawal by Subject|2|||
148687640|NCT02034799|536328846|FG000|Overall Study|Lost to Follow-up|0|||
148687641|NCT02034799|536328847|FG001|Overall Study|Lost to Follow-up|1|||
148687642|NCT02034799|536328846|FG000|Overall Study|Death|2|||
148687643|NCT02034799|536328847|FG001|Overall Study|Death|1|||
148687644|NCT00458302|536328857|FG000|Overall Study|Adverse Event|4|||
148687645|NCT00458302|536328858|FG001|Overall Study|Adverse Event|14|||
148687646|NCT00458302|536328857|FG000|Overall Study|Pregnancy|2|||
148687647|NCT00458302|536328858|FG001|Overall Study|Pregnancy|1|||
148687648|NCT00458302|536328857|FG000|Overall Study|Protocol Violation|0|||
148687649|NCT00458302|536328858|FG001|Overall Study|Protocol Violation|2|||
148687650|NCT00458302|536328857|FG000|Overall Study|Withdrawal by Subject|6|||
148687651|NCT00458302|536328858|FG001|Overall Study|Withdrawal by Subject|4|||
148687652|NCT00458302|536328857|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
148687653|NCT00458302|536328858|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
148687654|NCT00458302|536328857|FG000|Overall Study|Study Termination By Sponsor|1|||
148687655|NCT00458302|536328858|FG001|Overall Study|Study Termination By Sponsor|0|||
148687656|NCT00458302|536328857|FG000|Overall Study|Lost to Follow-up|2|||
148687657|NCT00458302|536328858|FG001|Overall Study|Lost to Follow-up|0|||
148687658|NCT00458302|536328857|FG000|Overall Study|Other|4|||
148687659|NCT00458302|536328858|FG001|Overall Study|Other|2|||
148687660|NCT02224456|536328859|FG000|Overall Study|Lack of Efficacy|1|||
148687661|NCT02224456|536328859|FG000|Overall Study|Lost to Follow-up|15|||
148687662|NCT02224456|536328859|FG000|Overall Study|Withdrawal by Subject|9|||
148687663|NCT02224456|536328859|FG000|Overall Study|Physician Decision|3|||
148687664|NCT02224456|536328859|FG000|Overall Study|Death|2|||
148687665|NCT02224456|536328859|FG000|Overall Study|Pregnancy|4|||
148687666|NCT02224456|536328859|FG000|Overall Study|Protocol Violation|1|||
149019157|NCT02061761|537547307|FG000|Overall Study|Participant no longer meets study criteria|0|||
149019158|NCT02061761|537547308|FG001|Overall Study|Participant no longer meets study criteria|0|||
149019159|NCT02061761|537547309|FG002|Overall Study|Participant no longer meets study criteria|0|||
149019160|NCT02061761|537547310|FG003|Overall Study|Participant no longer meets study criteria|0|||
149019161|NCT02061761|537547311|FG004|Overall Study|Participant no longer meets study criteria|0|||
149019162|NCT02061761|537547312|FG005|Overall Study|Participant no longer meets study criteria|0|||
149019163|NCT02061761|537547313|FG006|Overall Study|Participant no longer meets study criteria|0|||
149019164|NCT02061761|537547314|FG007|Overall Study|Participant no longer meets study criteria|0|||
149019165|NCT02061761|537547315|FG008|Overall Study|Participant no longer meets study criteria|1|||
149019166|NCT02061761|537547307|FG000|Overall Study|Other reasons|0|||
149019167|NCT02061761|537547308|FG001|Overall Study|Other reasons|0|||
149019168|NCT02061761|537547309|FG002|Overall Study|Other reasons|0|||
149019169|NCT02061761|537547310|FG003|Overall Study|Other reasons|0|||
149019170|NCT02061761|537547311|FG004|Overall Study|Other reasons|2|||
148687667|NCT02224456|536328859|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
148687668|NCT01241461|536328860|FG000|Overall Study|Progressive Disease|3|||
148687669|NCT01241461|536328861|FG001|Overall Study|Progressive Disease|6|||
148687670|NCT02497391|536328862|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
148687671|NCT02497391|536328863|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
148687672|NCT02497391|536328864|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
148687673|NCT02497391|536328865|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
148687674|NCT02497391|536328866|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
148687675|NCT02497391|536328867|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
148687676|NCT02497391|536328862|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
148687677|NCT02497391|536328863|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
148687678|NCT02497391|536328864|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
148687679|NCT02497391|536328865|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
148687680|NCT02497391|536328866|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
148687681|NCT02497391|536328867|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
148687682|NCT02497391|536328862|FG000|Period 3 (14 Days)|Adverse Event|0|||
148687683|NCT02497391|536328863|FG001|Period 3 (14 Days)|Adverse Event|1|||
148687684|NCT02497391|536328864|FG002|Period 3 (14 Days)|Adverse Event|0|||
148687685|NCT02497391|536328865|FG003|Period 3 (14 Days)|Adverse Event|0|||
148687686|NCT02497391|536328866|FG004|Period 3 (14 Days)|Adverse Event|0|||
148687687|NCT02497391|536328867|FG005|Period 3 (14 Days)|Adverse Event|0|||
148687688|NCT02497391|536328862|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
148687689|NCT02497391|536328863|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
148687690|NCT02497391|536328864|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
148687691|NCT02497391|536328865|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
148687692|NCT02497391|536328866|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
148687693|NCT02497391|536328867|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
148687694|NCT02497391|536328862|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
148687695|NCT02497391|536328863|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
148687696|NCT02497391|536328864|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
148687697|NCT02497391|536328865|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
148687698|NCT02497391|536328866|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
148687699|NCT02497391|536328867|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
148687700|NCT01664052|536328868|FG000|Phase 1|No device placement|6|||
148687701|NCT01664052|536328869|FG001|Phase 1|No device placement|0|||
148687702|NCT01664052|536328868|FG000|Phase 1|No HSG 1 hr post placement|1|||
148687703|NCT01664052|536328869|FG001|Phase 1|No HSG 1 hr post placement|0|||
148687704|NCT01664052|536328868|FG000|Phase 2|No device placement|0|||
148687705|NCT01664052|536328869|FG001|Phase 2|No device placement|4|||
148687706|NCT03740698|536328870|FG000|Overall Study|Physician Decision|0|||
148687707|NCT03740698|536328871|FG001|Overall Study|Physician Decision|1|||
148687708|NCT03740698|536328872|FG002|Overall Study|Physician Decision|1|||
149019171|NCT02061761|537547312|FG005|Overall Study|Other reasons|0|||
149019172|NCT02061761|537547313|FG006|Overall Study|Other reasons|0|||
149019173|NCT02061761|537547314|FG007|Overall Study|Other reasons|0|||
149225063|NCT00303602|538290212|FG000|Overall Study|Protocol entry criteria not met|2|||
149225064|NCT00303602|538290213|FG001|Overall Study|Protocol entry criteria not met|2|||
149225065|NCT00303602|538290212|FG000|Overall Study|Physician Decision|2|||
148687709|NCT01466686|536328878|FG000|Overall Study|Withdrawal by Subject|1|||
148687710|NCT00633152|536328884|FG000|Overall Study|Adverse Event|1|||
148687711|NCT00633152|536328885|FG001|Overall Study|Adverse Event|0|||
148687712|NCT00633152|536328884|FG000|Overall Study|Randomized, did not receive study drug|5|||
148687713|NCT00633152|536328885|FG001|Overall Study|Randomized, did not receive study drug|2|||
148687714|NCT00633152|536328884|FG000|Overall Study|Withdrawal by Subject|1|||
148687715|NCT00633152|536328885|FG001|Overall Study|Withdrawal by Subject|1|||
149019174|NCT02061761|537547315|FG008|Overall Study|Other reasons|6|||
149019175|NCT00903786|537547324|FG000|Overall Study|Physician Decision|6|||
149225066|NCT00303602|538290213|FG001|Overall Study|Physician Decision|1|||
148687716|NCT00633152|536328884|FG000|Overall Study|Lost to Follow-up|4|||
148687717|NCT00633152|536328885|FG001|Overall Study|Lost to Follow-up|1|||
148687718|NCT00633152|536328884|FG000|Overall Study|Miscellaneous Other|3|||
148687719|NCT00633152|536328885|FG001|Overall Study|Miscellaneous Other|2|||
148810140|NCT05383209|536782567|FG001|Overall Study|Other|1|||
149225067|NCT00303602|538290212|FG000|Overall Study|Noncompliance|2|||
149225068|NCT00303602|538290213|FG001|Overall Study|Noncompliance|2|||
149225069|NCT00303602|538290212|FG000|Overall Study|Protocol Violation|1|||
149225070|NCT00303602|538290213|FG001|Overall Study|Protocol Violation|0|||
149225071|NCT02889861|538290224|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
149225072|NCT02551874|538290231|FG000|Overall Study|Lost to Follow-up|0|||
149225073|NCT02551874|538290232|FG001|Overall Study|Lost to Follow-up|2|||
149225074|NCT02551874|538290231|FG000|Overall Study|Pregnancy|0|||
149225075|NCT02551874|538290232|FG001|Overall Study|Pregnancy|1|||
149225076|NCT02551874|538290231|FG000|Overall Study|Reason not reported|10|||
149225077|NCT02551874|538290232|FG001|Overall Study|Reason not reported|4|||
149225078|NCT02551874|538290231|FG000|Overall Study|Did not receive randomized treatment|0|||
149225079|NCT02551874|538290232|FG001|Overall Study|Did not receive randomized treatment|7|||
149225080|NCT02551874|538290231|FG000|Overall Study|Did not enter long-term study|18|||
149225081|NCT02551874|538290232|FG001|Overall Study|Did not enter long-term study|25|||
149225082|NCT01005966|538290233|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
149225083|NCT01005966|538290234|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
149225084|NCT01005966|538290235|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
149225085|NCT01005966|538290236|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
149225086|NCT01005966|538290237|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
149225087|NCT01005966|538290233|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
149225088|NCT01005966|538290234|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
149225089|NCT01005966|538290235|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
149225090|NCT01005966|538290236|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
149225091|NCT01005966|538290237|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
149225092|NCT01005966|538290233|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149225093|NCT01005966|538290234|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149225094|NCT01005966|538290235|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149225095|NCT01005966|538290236|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
149225096|NCT01005966|538290237|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
149225097|NCT01005966|538290233|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
149225098|NCT01005966|538290234|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
149225099|NCT01005966|538290235|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
149225100|NCT01005966|538290236|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
149225101|NCT01005966|538290237|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
149225102|NCT01005966|538290233|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149225103|NCT01005966|538290234|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149225104|NCT01005966|538290235|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149225105|NCT01005966|538290236|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
149225106|NCT01005966|538290237|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
149225107|NCT01005966|538290233|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149225108|NCT01005966|538290234|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149225109|NCT01005966|538290235|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
149225110|NCT01005966|538290236|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149225111|NCT01005966|538290237|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
149225112|NCT01005966|538290233|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
149225113|NCT01005966|538290234|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
149225114|NCT01005966|538290235|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
149225115|NCT01005966|538290236|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
148687720|NCT03273387|536328886|FG000|Overall Study|Death|2|||
148810141|NCT05383209|536782568|FG002|Overall Study|Other|0|||
148687721|NCT03273387|536328887|FG001|Overall Study|Death|2|||
148687722|NCT03273387|536328886|FG000|Overall Study|Withdrawal by Subject|1|||
148687723|NCT03273387|536328887|FG001|Overall Study|Withdrawal by Subject|1|||
148687724|NCT05216978|536328888|FG000|Overall Study|Withdrawal by Subject|3|||
148687725|NCT05216978|536328888|FG000|Overall Study|Lost to Follow-up|5|||
148687726|NCT00658320|536328890|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
148687727|NCT00658320|536328891|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
148687728|NCT00658320|536328890|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
148687729|NCT00658320|536328891|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
148687730|NCT00658320|536328890|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
148687731|NCT00658320|536328891|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
149225116|NCT01005966|538290237|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
149225117|NCT01005966|538290233|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149225118|NCT01005966|538290234|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
149225119|NCT01005966|538290235|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149225120|NCT01005966|538290236|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149225121|NCT01005966|538290237|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
149225122|NCT01005966|538290233|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
149225123|NCT01005966|538290234|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
149225124|NCT01005966|538290235|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
148810142|NCT00321763|536782570|FG000|Overall Study|Adverse Event|1|||
148810143|NCT00321763|536782571|FG001|Overall Study|Adverse Event|1|||
148810144|NCT00321763|536782572|FG002|Overall Study|Adverse Event|0|||
149225125|NCT01005966|538290236|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
149225126|NCT01005966|538290237|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
149225127|NCT01451203|538290239|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
149225128|NCT01451203|538290240|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
149225129|NCT01451203|538290239|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
149225130|NCT01451203|538290240|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
149225131|NCT01451203|538290239|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
149225132|NCT01451203|538290240|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
149225133|NCT01451203|538290239|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
149225134|NCT01451203|538290240|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
149225135|NCT01451203|538290239|FG000|Double-blind Treatment Period|Adverse Event|6|||
148810145|NCT00321763|536782573|FG003|Overall Study|Adverse Event|1|||
148810146|NCT00321763|536782570|FG000|Overall Study|Withdrawal by Subject|2|||
148810147|NCT00321763|536782571|FG001|Overall Study|Withdrawal by Subject|0|||
148810148|NCT00321763|536782572|FG002|Overall Study|Withdrawal by Subject|1|||
148810149|NCT00321763|536782573|FG003|Overall Study|Withdrawal by Subject|0|||
148810150|NCT00321763|536782570|FG000|Overall Study|Lost to Follow-up|3|||
148810151|NCT00321763|536782571|FG001|Overall Study|Lost to Follow-up|1|||
148810152|NCT00321763|536782572|FG002|Overall Study|Lost to Follow-up|5|||
148810153|NCT00321763|536782573|FG003|Overall Study|Lost to Follow-up|4|||
148810154|NCT00716417|536782574|FG000|Overall Study|Adverse Event|0|||
148810155|NCT00716417|536782575|FG001|Overall Study|Adverse Event|0|||
148810156|NCT00716417|536782576|FG002|Overall Study|Adverse Event|2|||
148810157|NCT00716417|536782577|FG003|Overall Study|Adverse Event|1|||
148810158|NCT00716417|536782578|FG004|Overall Study|Adverse Event|0|||
148810159|NCT00716417|536782579|FG005|Overall Study|Adverse Event|0|||
148810160|NCT00716417|536782580|FG006|Overall Study|Adverse Event|3|||
148810161|NCT00716417|536782581|FG007|Overall Study|Adverse Event|1|||
148810162|NCT00716417|536782582|FG008|Overall Study|Adverse Event|0|||
148810163|NCT00716417|536782583|FG009|Overall Study|Adverse Event|3|||
148810164|NCT00716417|536782574|FG000|Overall Study|Withdrawal by Subject|0|||
148810165|NCT00716417|536782575|FG001|Overall Study|Withdrawal by Subject|1|||
148810166|NCT00716417|536782576|FG002|Overall Study|Withdrawal by Subject|0|||
148810167|NCT00716417|536782577|FG003|Overall Study|Withdrawal by Subject|2|||
148810168|NCT00716417|536782578|FG004|Overall Study|Withdrawal by Subject|0|||
148810169|NCT00716417|536782579|FG005|Overall Study|Withdrawal by Subject|0|||
148810170|NCT00716417|536782580|FG006|Overall Study|Withdrawal by Subject|1|||
148810171|NCT00716417|536782581|FG007|Overall Study|Withdrawal by Subject|0|||
148810172|NCT00716417|536782582|FG008|Overall Study|Withdrawal by Subject|0|||
148810173|NCT00716417|536782583|FG009|Overall Study|Withdrawal by Subject|0|||
148810174|NCT00716417|536782574|FG000|Overall Study|Progressive disease|3|||
148810175|NCT00716417|536782575|FG001|Overall Study|Progressive disease|5|||
148810176|NCT00716417|536782576|FG002|Overall Study|Progressive disease|3|||
148810177|NCT00716417|536782577|FG003|Overall Study|Progressive disease|8|||
148810178|NCT00716417|536782578|FG004|Overall Study|Progressive disease|0|||
148810179|NCT00716417|536782579|FG005|Overall Study|Progressive disease|3|||
148687732|NCT00658320|536328890|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
148687733|NCT00658320|536328891|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
148687734|NCT02410252|536328901|FG000|Overall Study|Withdrawal by Subject|4|||
148810180|NCT00716417|536782580|FG006|Overall Study|Progressive disease|3|||
148810181|NCT00716417|536782581|FG007|Overall Study|Progressive disease|1|||
148810182|NCT00716417|536782582|FG008|Overall Study|Progressive disease|5|||
149225136|NCT01451203|538290240|FG001|Double-blind Treatment Period|Adverse Event|9|||
149225137|NCT01451203|538290239|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
149225138|NCT01451203|538290240|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
149225139|NCT01451203|538290239|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
148810183|NCT00716417|536782583|FG009|Overall Study|Progressive disease|0|||
148810184|NCT00716417|536782574|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
149225140|NCT01451203|538290240|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
149225141|NCT01451203|538290239|FG000|Double-blind Treatment Period|Investigator decision|2|||
149225142|NCT01451203|538290240|FG001|Double-blind Treatment Period|Investigator decision|0|||
149225143|NCT01451203|538290239|FG000|Post-treatment Period|Consent withdrawn|2|||
149225144|NCT01451203|538290240|FG001|Post-treatment Period|Consent withdrawn|4|||
149225145|NCT01451203|538290239|FG000|Post-treatment Period|Lack of Efficacy|12|||
149225146|NCT01451203|538290240|FG001|Post-treatment Period|Lack of Efficacy|28|||
149225147|NCT01451203|538290239|FG000|Post-treatment Period|Adverse Event|0|||
149225148|NCT01451203|538290240|FG001|Post-treatment Period|Adverse Event|1|||
149225149|NCT01451203|538290239|FG000|Post-treatment Period|Investigator decision|0|||
149225150|NCT01451203|538290240|FG001|Post-treatment Period|Investigator decision|1|||
149225151|NCT00039377|538290242|FG000|Initial Registration|Adverse Event|2|||
149225152|NCT00039377|538290243|FG001|Initial Registration|Adverse Event|0|||
149225153|NCT00039377|538290244|FG002|Initial Registration|Adverse Event|0|||
149225154|NCT00039377|538290245|FG003|Initial Registration|Adverse Event|0|||
149225155|NCT00039377|538290242|FG000|Initial Registration|Relapsed|6|||
149225156|NCT00039377|538290243|FG001|Initial Registration|Relapsed|0|||
149225157|NCT00039377|538290244|FG002|Initial Registration|Relapsed|0|||
149225158|NCT00039377|538290245|FG003|Initial Registration|Relapsed|0|||
149225159|NCT00039377|538290242|FG000|Initial Registration|Received non-protocol therapy|11|||
149225160|NCT00039377|538290243|FG001|Initial Registration|Received non-protocol therapy|0|||
148954014|NCT00531232|537314621|FG001|Overall Study|Withdrawal by Subject|1|||
148954015|NCT00531232|537314622|FG002|Overall Study|Withdrawal by Subject|2|||
148954016|NCT00531232|537314620|FG000|Overall Study|Other|0|||
148954017|NCT00531232|537314621|FG001|Overall Study|Other|0|||
148954018|NCT00531232|537314622|FG002|Overall Study|Other|5|||
148954019|NCT01438424|537314623|FG000|Overall Study|Continuing treatment|29|||
148954020|NCT01438424|537314623|FG000|Overall Study|Minimal virologic response|95|||
148954021|NCT01438424|537314623|FG000|Overall Study|Not identified|55|||
148954022|NCT01438424|537314623|FG000|Overall Study|Withdrawal by Subject|104|||
148954023|NCT01438424|537314623|FG000|Overall Study|Progression of chronic hepatitis B|22|||
148954024|NCT01438424|537314623|FG000|Overall Study|Death|22|||
148954025|NCT01438424|537314623|FG000|Overall Study|Adverse Event|17|||
148954026|NCT01438424|537314623|FG000|Overall Study|Lost to Follow-up|17|||
148954027|NCT01438424|537314623|FG000|Overall Study|Abnormal laboratory test result|14|||
148954028|NCT01438424|537314623|FG000|Overall Study|Need for drug prohibited by protocol|14|||
148954029|NCT01438424|537314623|FG000|Overall Study|Pregnancy|7|||
148954030|NCT01438424|537314623|FG000|Overall Study|No longer met inclusion criteria|1|||
148954031|NCT01438424|537314623|FG000|Overall Study|Participant noncompliance|20|||
148954032|NCT04232124|537314624|FG000|Overall Study|Lost to Follow-up|3|||
148954033|NCT02329730|537314630|FG000|Overall Study|Protocol Violation|0|||
148954034|NCT02329730|537314631|FG001|Overall Study|Protocol Violation|0|||
148954035|NCT02329730|537314632|FG002|Overall Study|Protocol Violation|0|||
148954036|NCT02329730|537314633|FG003|Overall Study|Protocol Violation|0|||
148954037|NCT02329730|537314634|FG004|Overall Study|Protocol Violation|2|||
148954038|NCT02329730|537314635|FG005|Overall Study|Protocol Violation|2|||
148954039|NCT02329730|537314636|FG006|Overall Study|Protocol Violation|0|||
148954040|NCT02329730|537314637|FG007|Overall Study|Protocol Violation|0|||
148954041|NCT02329730|537314638|FG008|Overall Study|Protocol Violation|0|||
148954042|NCT02329730|537314639|FG009|Overall Study|Protocol Violation|0|||
148954043|NCT02329730|537314640|FG010|Overall Study|Protocol Violation|0|||
148954044|NCT02329730|537314641|FG011|Overall Study|Protocol Violation|0|||
148954045|NCT02329730|537314630|FG000|Overall Study|Withdrawal by Subject|0|||
148954046|NCT02329730|537314631|FG001|Overall Study|Withdrawal by Subject|0|||
148954047|NCT02329730|537314632|FG002|Overall Study|Withdrawal by Subject|0|||
148954048|NCT02329730|537314633|FG003|Overall Study|Withdrawal by Subject|0|||
148954049|NCT02329730|537314634|FG004|Overall Study|Withdrawal by Subject|1|||
148954050|NCT02329730|537314635|FG005|Overall Study|Withdrawal by Subject|0|||
148954051|NCT02329730|537314636|FG006|Overall Study|Withdrawal by Subject|1|||
148954052|NCT02329730|537314637|FG007|Overall Study|Withdrawal by Subject|1|||
148954053|NCT02329730|537314638|FG008|Overall Study|Withdrawal by Subject|1|||
148954054|NCT02329730|537314639|FG009|Overall Study|Withdrawal by Subject|1|||
148954055|NCT02329730|537314640|FG010|Overall Study|Withdrawal by Subject|0|||
148954056|NCT02329730|537314641|FG011|Overall Study|Withdrawal by Subject|0|||
148954057|NCT02345850|537314644|FG000|Overall Study|Not transplanted|10|||
148954058|NCT02345850|537314645|FG001|Overall Study|Not transplanted|5|||
148954059|NCT02345850|537314646|FG002|Overall Study|Not transplanted|4|||
148954060|NCT02345850|537314644|FG000|Overall Study|Lost to Follow-up|2|||
148954061|NCT02345850|537314645|FG001|Overall Study|Lost to Follow-up|3|||
148954062|NCT02345850|537314646|FG002|Overall Study|Lost to Follow-up|2|||
148954063|NCT02345850|537314644|FG000|Overall Study|Withdrawal by Subject|1|||
148954064|NCT02345850|537314645|FG001|Overall Study|Withdrawal by Subject|0|||
148954065|NCT02345850|537314646|FG002|Overall Study|Withdrawal by Subject|0|||
148954066|NCT02392247|537314649|FG000|Overall Study|Withdrawal by Subject|1|||
148954067|NCT02392247|537314649|FG000|Overall Study|Surgery cancelled; no data|1|||
148954068|NCT02927080|537314650|FG000|Overall Study|Withdrawal by Subject|0|||
149019176|NCT00903786|537547324|FG000|Overall Study|Lack of Efficacy|5|||
149225161|NCT00039377|538290244|FG002|Initial Registration|Received non-protocol therapy|0|||
149225162|NCT00039377|538290245|FG003|Initial Registration|Received non-protocol therapy|0|||
149225163|NCT00039377|538290242|FG000|Initial Registration|Withdrawal by Subject|3|||
149225164|NCT00039377|538290243|FG001|Initial Registration|Withdrawal by Subject|0|||
149225165|NCT00039377|538290244|FG002|Initial Registration|Withdrawal by Subject|0|||
149019177|NCT00903786|537547324|FG000|Overall Study|Reason other than lack of efficacy|4|||
149019178|NCT01857622|537547328|FG000|Overall Study|Adverse Event|5|||
149019179|NCT01857622|537547329|FG001|Overall Study|Adverse Event|0|||
149019180|NCT01857622|537547330|FG002|Overall Study|Adverse Event|2|||
149019181|NCT01857622|537547328|FG000|Overall Study|Physician Decision|1|||
149019182|NCT01857622|537547329|FG001|Overall Study|Physician Decision|0|||
149019183|NCT01857622|537547330|FG002|Overall Study|Physician Decision|0|||
149019184|NCT01857622|537547328|FG000|Overall Study|Protocol Violation|4|||
149019185|NCT01857622|537547329|FG001|Overall Study|Protocol Violation|1|||
149019186|NCT01857622|537547330|FG002|Overall Study|Protocol Violation|0|||
149019187|NCT01857622|537547328|FG000|Overall Study|Withdrawal by Subject|1|||
149019188|NCT01857622|537547329|FG001|Overall Study|Withdrawal by Subject|0|||
149019189|NCT01857622|537547330|FG002|Overall Study|Withdrawal by Subject|0|||
149019190|NCT01267253|537547332|FG000|Overall Study|Ineligible - required test not done|1|||
149019191|NCT01267253|537547332|FG000|Overall Study|Inevaluable-never received study treatme|2|||
149019192|NCT00064025|537547333|FG000|Overall Study|Ineligible|4|||
149019193|NCT00064025|537547333|FG000|Overall Study|Inevaluable|3|||
149019194|NCT01370603|537547334|FG000|Period 1|Adverse Event|5|||
149019195|NCT01370603|537547335|FG001|Period 1|Adverse Event|3|||
149019196|NCT01370603|537547334|FG000|Period 1|Lost to Follow-up|2|||
149019197|NCT01370603|537547335|FG001|Period 1|Lost to Follow-up|0|||
149019198|NCT01370603|537547334|FG000|Period 1|Protocol Violation|2|||
149019199|NCT01370603|537547335|FG001|Period 1|Protocol Violation|2|||
149019200|NCT01370603|537547334|FG000|Period 1|Withdrawal by Subject|5|||
149225166|NCT00039377|538290245|FG003|Initial Registration|Withdrawal by Subject|0|||
149225167|NCT04067310|538290249|FG000|Overall Study|Physician Decision|2|||
149225168|NCT04067310|538290250|FG001|Overall Study|Physician Decision|6|||
149225169|NCT04067310|538290249|FG000|Overall Study|Lost to Follow-up|0|||
149225170|NCT04067310|538290250|FG001|Overall Study|Lost to Follow-up|1|||
149225171|NCT04067310|538290249|FG000|Overall Study|Withdrawal by Subject|3|||
149225172|NCT04067310|538290250|FG001|Overall Study|Withdrawal by Subject|0|||
149225173|NCT01041027|538290251|FG000|Overall Study|Withdrawal by Subject|2|||
149019201|NCT01370603|537547335|FG001|Period 1|Withdrawal by Subject|5|||
149019202|NCT01370603|537547334|FG000|Crossover Washout|Adverse Event|2|||
149019203|NCT01370603|537547335|FG001|Crossover Washout|Adverse Event|1|||
149019204|NCT01370603|537547334|FG000|Crossover Washout|Lost to Follow-up|2|||
149019205|NCT01370603|537547335|FG001|Crossover Washout|Lost to Follow-up|0|||
149019206|NCT01370603|537547334|FG000|Crossover Washout|Protocol Violation|1|||
149019207|NCT01370603|537547335|FG001|Crossover Washout|Protocol Violation|0|||
149019208|NCT01370603|537547334|FG000|Crossover Washout|Withdrawal by Subject|4|||
149019209|NCT01370603|537547335|FG001|Crossover Washout|Withdrawal by Subject|1|||
149019210|NCT01370603|537547334|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
149019211|NCT01370603|537547335|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
149019212|NCT01370603|537547334|FG000|Period 2|Adverse Event|1|||
149019213|NCT01370603|537547335|FG001|Period 2|Adverse Event|4|||
149225174|NCT01041027|538290251|FG000|Overall Study|Protocol Violation|1|||
149225175|NCT01041027|538290251|FG000|Overall Study|Delayed Radiation Therapy|1|||
149019214|NCT01370603|537547334|FG000|Period 2|Lost to Follow-up|1|||
149019215|NCT01370603|537547335|FG001|Period 2|Lost to Follow-up|0|||
149019216|NCT01370603|537547334|FG000|Period 2|Withdrawal by Subject|1|||
149019217|NCT01370603|537547335|FG001|Period 2|Withdrawal by Subject|0|||
149019218|NCT00547911|537547343|FG000|Overall Study|Adverse Event|0|||
149019219|NCT00547911|537547344|FG001|Overall Study|Adverse Event|0|||
149019220|NCT00547911|537547345|FG002|Overall Study|Adverse Event|0|||
149019221|NCT00547911|537547346|FG003|Overall Study|Adverse Event|1|||
149019222|NCT00547911|537547347|FG004|Overall Study|Adverse Event|0|||
149019223|NCT00547911|537547348|FG005|Overall Study|Adverse Event|0|||
149019224|NCT01644474|537547350|FG000|Overall Study|Poor compliance to protocol|1|||
149019225|NCT01644474|537547351|FG001|Overall Study|Poor compliance to protocol|0|||
149019226|NCT01644474|537547350|FG000|Overall Study|Consent withdrawn by participant|0|||
149019227|NCT01644474|537547351|FG001|Overall Study|Consent withdrawn by participant|1|||
149019228|NCT01644474|537547350|FG000|Overall Study|Participant moved|0|||
149019229|NCT01644474|537547351|FG001|Overall Study|Participant moved|1|||
149019230|NCT01644474|537547350|FG000|Overall Study|Adverse Event|4|||
149019231|NCT01644474|537547351|FG001|Overall Study|Adverse Event|5|||
149019232|NCT01644474|537547350|FG000|Overall Study|Site scheduling error|1|||
149019233|NCT01644474|537547351|FG001|Overall Study|Site scheduling error|1|||
149019234|NCT01644474|537547350|FG000|Overall Study|Protocol Violation|1|||
149019235|NCT01644474|537547351|FG001|Overall Study|Protocol Violation|0|||
149019236|NCT01163747|537547357|FG000|Overall Study|Adverse Event|0|||
149019237|NCT01163747|537547358|FG001|Overall Study|Adverse Event|5|||
149019238|NCT01163747|537547357|FG000|Overall Study|Insufficient Therapeutic Response|0|||
149019239|NCT01163747|537547358|FG001|Overall Study|Insufficient Therapeutic Response|1|||
149019240|NCT01163747|537547357|FG000|Overall Study|Protocol Violation|0|||
149019241|NCT01163747|537547358|FG001|Overall Study|Protocol Violation|1|||
149019242|NCT01163747|537547357|FG000|Overall Study|Refused Treatment|6|||
149019243|NCT01163747|537547358|FG001|Overall Study|Refused Treatment|4|||
148810185|NCT00716417|536782575|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
148810186|NCT00716417|536782576|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
149019244|NCT01349829|537549049|FG000|Overall Study|Lost to Follow-up|4|||
149019245|NCT01349829|537549050|FG001|Overall Study|Lost to Follow-up|8|||
149019246|NCT01349829|537549049|FG000|Overall Study|Consent withdrawal|3|||
149019247|NCT01349829|537549050|FG001|Overall Study|Consent withdrawal|8|||
149019248|NCT01349829|537549049|FG000|Overall Study|Migrated/moved|2|||
149019249|NCT01349829|537549050|FG001|Overall Study|Migrated/moved|7|||
149019250|NCT00513019|537549051|FG000|Overall Study|Adverse Event|1|||
149019251|NCT00513019|537549052|FG001|Overall Study|Adverse Event|0|||
149019252|NCT00513019|537549051|FG000|Overall Study|Withdrawal by Subject|4|||
149019253|NCT00513019|537549052|FG001|Overall Study|Withdrawal by Subject|5|||
149019254|NCT00777803|537549053|FG000|Overall Study|Lost to Follow-up|12|||
149019255|NCT00777803|537549054|FG001|Overall Study|Lost to Follow-up|5|||
149019256|NCT00777803|537549053|FG000|Overall Study|Adverse Event|1|||
149019257|NCT00777803|537549054|FG001|Overall Study|Adverse Event|0|||
149019258|NCT00777803|537549053|FG000|Overall Study|Non-compliance|2|||
149019259|NCT00777803|537549054|FG001|Overall Study|Non-compliance|2|||
149019260|NCT01995357|537549057|FG000|Period 5|Lack of Efficacy|1|||
149019261|NCT01995357|537549058|FG001|Period 5|Lack of Efficacy|0|||
149019262|NCT01995357|537549059|FG002|Period 5|Lack of Efficacy|0|||
149019263|NCT01995357|537549060|FG003|Period 5|Lack of Efficacy|0|||
149019264|NCT01995357|537549061|FG004|Period 5|Lack of Efficacy|0|||
149019265|NCT01995357|537549062|FG005|Period 5|Lack of Efficacy|0|||
149019266|NCT01995357|537549057|FG000|Period 5|Adverse Event|1|||
149019267|NCT01995357|537549058|FG001|Period 5|Adverse Event|0|||
149019268|NCT01995357|537549059|FG002|Period 5|Adverse Event|1|||
149019269|NCT01995357|537549060|FG003|Period 5|Adverse Event|0|||
149019270|NCT01995357|537549061|FG004|Period 5|Adverse Event|0|||
149019271|NCT01995357|537549062|FG005|Period 5|Adverse Event|0|||
148810187|NCT00716417|536782577|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
149019272|NCT01500226|537549065|FG000|Overall Study|Adverse Event|31|||
149019273|NCT01500226|537549066|FG001|Overall Study|Adverse Event|38|||
149225176|NCT01041027|538290251|FG000|Overall Study|Adverse Event|4|||
149225177|NCT02493712|538290252|FG000|Overall Study|Withdrawal by Subject|1|||
149225178|NCT02493712|538290253|FG001|Overall Study|Withdrawal by Subject|0|||
148810188|NCT00716417|536782578|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
149019274|NCT01500226|537549065|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
149019275|NCT01500226|537549066|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
149019276|NCT01500226|537549065|FG000|Overall Study|Withdrawal by Subject|93|||
149019277|NCT01500226|537549066|FG001|Overall Study|Withdrawal by Subject|96|||
149019278|NCT01500226|537549065|FG000|Overall Study|Death|12|||
149019279|NCT01500226|537549066|FG001|Overall Study|Death|4|||
149019280|NCT01500226|537549065|FG000|Overall Study|Disease Progression|16|||
149019281|NCT01500226|537549066|FG001|Overall Study|Disease Progression|14|||
149019282|NCT01500226|537549065|FG000|Overall Study|Protocol Violation|53|||
149019283|NCT01500226|537549066|FG001|Overall Study|Protocol Violation|39|||
149019284|NCT01500226|537549065|FG000|Overall Study|Physician Decision|17|||
149225179|NCT02493712|538290254|FG002|Overall Study|Withdrawal by Subject|2|||
149225180|NCT02493712|538290252|FG000|Overall Study|Protocol Violation|0|||
149019285|NCT01500226|537549066|FG001|Overall Study|Physician Decision|15|||
149019286|NCT01500226|537549065|FG000|Overall Study|Lack of Efficacy|14|||
149019287|NCT01500226|537549066|FG001|Overall Study|Lack of Efficacy|30|||
149019288|NCT01500226|537549065|FG000|Overall Study|Lost to Follow-up|9|||
149019289|NCT01500226|537549066|FG001|Overall Study|Lost to Follow-up|5|||
149019290|NCT01500226|537549065|FG000|Overall Study|Other Reasons|19|||
149019291|NCT01500226|537549066|FG001|Overall Study|Other Reasons|16|||
149225181|NCT02493712|538290253|FG001|Overall Study|Protocol Violation|0|||
149225182|NCT02493712|538290254|FG002|Overall Study|Protocol Violation|1|||
149225183|NCT02493712|538290252|FG000|Overall Study|Lost to Follow-up|1|||
149225184|NCT02493712|538290253|FG001|Overall Study|Lost to Follow-up|0|||
149019292|NCT04212169|537549067|FG000|Overall Study|Adverse Event|0|||
149019293|NCT04212169|537549068|FG001|Overall Study|Adverse Event|0|||
149019294|NCT04212169|537549069|FG002|Overall Study|Adverse Event|0|||
149019295|NCT04212169|537549070|FG003|Overall Study|Adverse Event|2|||
149019296|NCT04212169|537549067|FG000|Overall Study|Lost to Follow-up|1|||
149019297|NCT04212169|537549068|FG001|Overall Study|Lost to Follow-up|0|||
149225185|NCT02493712|538290254|FG002|Overall Study|Lost to Follow-up|0|||
149225186|NCT02493712|538290252|FG000|Overall Study|Physician Decision|0|||
149225187|NCT02493712|538290253|FG001|Overall Study|Physician Decision|1|||
149225188|NCT02493712|538290254|FG002|Overall Study|Physician Decision|0|||
149225189|NCT02493712|538290252|FG000|Overall Study|Lack of Efficacy|0|||
149225190|NCT02493712|538290253|FG001|Overall Study|Lack of Efficacy|5|||
149225191|NCT02493712|538290254|FG002|Overall Study|Lack of Efficacy|3|||
149225192|NCT02528643|538290255|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
149225193|NCT02528643|538290256|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
149225194|NCT02528643|538290255|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
149225195|NCT02528643|538290256|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
149225196|NCT02528643|538290255|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
149225197|NCT02528643|538290256|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
149225198|NCT02528643|538290255|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
149225199|NCT02528643|538290256|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
149225200|NCT02528643|538290255|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
149225201|NCT02528643|538290256|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
149019298|NCT04212169|537549069|FG002|Overall Study|Lost to Follow-up|0|||
149019299|NCT04212169|537549070|FG003|Overall Study|Lost to Follow-up|2|||
149019300|NCT04212169|537549067|FG000|Overall Study|Withdrawal by Subject|10|||
149019301|NCT04212169|537549068|FG001|Overall Study|Withdrawal by Subject|2|||
149019302|NCT04212169|537549069|FG002|Overall Study|Withdrawal by Subject|5|||
149019303|NCT04212169|537549070|FG003|Overall Study|Withdrawal by Subject|7|||
149019304|NCT04212169|537549067|FG000|Overall Study|Other reason, unspecified|3|||
149019305|NCT04212169|537549068|FG001|Overall Study|Other reason, unspecified|1|||
149019306|NCT04212169|537549069|FG002|Overall Study|Other reason, unspecified|0|||
149019307|NCT04212169|537549070|FG003|Overall Study|Other reason, unspecified|2|||
149019308|NCT02176928|537549071|FG000|Overall Study|Lost to Follow-up|2|||
149019309|NCT02176928|537549072|FG001|Overall Study|Lost to Follow-up|4|||
149225202|NCT02528643|538290255|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
149225203|NCT02528643|538290256|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
149225204|NCT02528643|538290255|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
149225205|NCT02528643|538290256|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
149225206|NCT02058940|538290257|FG000|Overall Study|Discharged from Critical Care Unit|1|||
149225207|NCT02146274|538290259|FG000|Overall Study|Protocol Violation|73|||
149225208|NCT02039687|538290262|FG000|Overall Study|Adverse Event|0|||
149225209|NCT02039687|538290263|FG001|Overall Study|Adverse Event|0|||
148687735|NCT02410252|536328901|FG000|Overall Study|Physician Decision|2|||
148687736|NCT03433001|536328902|FG000|Overall Study|Lack of Efficacy|109|||
148687737|NCT03433001|536328902|FG000|Overall Study|Adverse Event|69|||
148687738|NCT03433001|536328902|FG000|Overall Study|Withdrawal by Subject|10|||
148687739|NCT03433001|536328902|FG000|Overall Study|Death|12|||
148687740|NCT03433001|536328902|FG000|Overall Study|Lost to Follow-up|4|||
148687741|NCT03433001|536328902|FG000|Overall Study|Other|25|||
148687742|NCT01162499|536328912|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
149225210|NCT02039687|538290264|FG002|Overall Study|Adverse Event|1|||
149225211|NCT02039687|538290265|FG003|Overall Study|Adverse Event|0|||
148687743|NCT01162499|536328913|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
148687744|NCT01452529|536328914|FG000|Run-in Period|Adverse Event|96|||
148687745|NCT01452529|536328915|FG001|Run-in Period|Adverse Event|0|||
148687746|NCT01452529|536328916|FG002|Run-in Period|Adverse Event|0|||
149019310|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
149019311|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
149019312|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
149225212|NCT02039687|538290262|FG000|Overall Study|Withdrawal by Subject|0|||
149225213|NCT02039687|538290263|FG001|Overall Study|Withdrawal by Subject|1|||
148687747|NCT01452529|536328914|FG000|Run-in Period|Withdrawal by Subject|49|||
148687748|NCT01452529|536328915|FG001|Run-in Period|Withdrawal by Subject|0|||
149225214|NCT02039687|538290264|FG002|Overall Study|Withdrawal by Subject|0|||
149225215|NCT02039687|538290265|FG003|Overall Study|Withdrawal by Subject|0|||
149225216|NCT02039687|538290262|FG000|Overall Study|treatment assignment could not be confir|0|||
149225217|NCT02039687|538290263|FG001|Overall Study|treatment assignment could not be confir|0|||
149225218|NCT02039687|538290264|FG002|Overall Study|treatment assignment could not be confir|2|||
149225219|NCT02039687|538290265|FG003|Overall Study|treatment assignment could not be confir|0|||
148687749|NCT01452529|536328916|FG002|Run-in Period|Withdrawal by Subject|0|||
148687750|NCT01452529|536328914|FG000|Run-in Period|Lost to Follow-up|19|||
148687751|NCT01452529|536328915|FG001|Run-in Period|Lost to Follow-up|0|||
148687752|NCT01452529|536328916|FG002|Run-in Period|Lost to Follow-up|0|||
148687753|NCT01452529|536328914|FG000|Run-in Period|Lack of Efficacy|46|||
148687754|NCT01452529|536328915|FG001|Run-in Period|Lack of Efficacy|0|||
148687755|NCT01452529|536328916|FG002|Run-in Period|Lack of Efficacy|0|||
148687756|NCT01452529|536328914|FG000|Run-in Period|Confirmed or suspected diversion|23|||
148687757|NCT01452529|536328915|FG001|Run-in Period|Confirmed or suspected diversion|0|||
148687758|NCT01452529|536328916|FG002|Run-in Period|Confirmed or suspected diversion|0|||
148687759|NCT01452529|536328914|FG000|Run-in Period|Administrative|21|||
148687760|NCT01452529|536328915|FG001|Run-in Period|Administrative|0|||
148687761|NCT01452529|536328916|FG002|Run-in Period|Administrative|0|||
148687762|NCT01452529|536328914|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
148687763|NCT01452529|536328915|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
148687764|NCT01452529|536328916|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
148687765|NCT01452529|536328914|FG000|Double-blind (DB) Period|Adverse Event|0|||
148687766|NCT01452529|536328915|FG001|Double-blind (DB) Period|Adverse Event|18|||
148687767|NCT01452529|536328916|FG002|Double-blind (DB) Period|Adverse Event|11|||
148687768|NCT01452529|536328914|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
148687769|NCT01452529|536328915|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
148687770|NCT01452529|536328916|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
148687771|NCT01452529|536328914|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
148687772|NCT01452529|536328915|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
148687773|NCT01452529|536328916|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
148687774|NCT01452529|536328914|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
148687775|NCT01452529|536328915|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
148687776|NCT01452529|536328916|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
148687777|NCT01452529|536328914|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
148687778|NCT01452529|536328915|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
148687779|NCT01452529|536328916|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
148687780|NCT01452529|536328914|FG000|Double-blind (DB) Period|Administrative|0|||
148687781|NCT01452529|536328915|FG001|Double-blind (DB) Period|Administrative|11|||
148687782|NCT01452529|536328916|FG002|Double-blind (DB) Period|Administrative|7|||
148687783|NCT04527471|536328920|FG000|Overall Study|Adverse Event|1|||
148687784|NCT04527471|536328921|FG001|Overall Study|Adverse Event|0|||
148687785|NCT04527471|536328920|FG000|Overall Study|Lost to Follow-up|1|||
148687786|NCT04527471|536328921|FG001|Overall Study|Lost to Follow-up|0|||
148687787|NCT01628120|536328924|FG000|Overall Study|Withdrawal by Subject|7|||
148687788|NCT01628120|536328924|FG000|Overall Study|Adverse Event|12|||
148687789|NCT01628120|536328924|FG000|Overall Study|Lost to Follow-up|1|||
148687790|NCT01628120|536328924|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
148687791|NCT01628120|536328924|FG000|Overall Study|Non-compliant with Study Procedures|1|||
148687792|NCT01628120|536328924|FG000|Overall Study|Not Treated|3|||
148687793|NCT01628120|536328924|FG000|Overall Study|Sponsor Decision|5|||
148687794|NCT01628120|536328924|FG000|Overall Study|Switched Dialysis Method|2|||
148687795|NCT01628120|536328924|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
148687796|NCT01628120|536328924|FG000|Overall Study|Moved or Relocated|5|||
148687797|NCT01628120|536328924|FG000|Overall Study|Kidney Transplant|2|||
148687798|NCT01628120|536328924|FG000|Overall Study|Use of Standard of Care|1|||
148687799|NCT01165996|536328925|FG000|Overall Study|Death|1|||
148687800|NCT01165996|536328925|FG000|Overall Study|Physician Decision|1|||
148687801|NCT00444795|536328927|FG000|Overall Study|Not Treated|1|||
148687802|NCT00444795|536328927|FG000|Overall Study|Treated Prior to the Contract Date|2|||
148687803|NCT02322879|536328929|FG000|First Intervention|Physician Decision|1|||
148687804|NCT02322879|536328930|FG001|First Intervention|Physician Decision|0|||
149225220|NCT01640353|538290270|FG000|Overall Study|Withdrew prior to treatment|10|||
148687805|NCT04081337|536328931|FG000|Overall Study|Adverse Event|0|||
148687806|NCT04081337|536328932|FG001|Overall Study|Adverse Event|1|||
148954069|NCT02927080|537314651|FG001|Overall Study|Withdrawal by Subject|0|||
149225221|NCT01640353|538290270|FG000|Overall Study|Withdrawn from analysis at term site|12|||
148687807|NCT04081337|536328931|FG000|Overall Study|Withdrawal by Subject|2|||
148687808|NCT04081337|536328932|FG001|Overall Study|Withdrawal by Subject|0|||
148687809|NCT04081337|536328931|FG000|Overall Study|Physician Decision|1|||
148687810|NCT04081337|536328932|FG001|Overall Study|Physician Decision|2|||
148687811|NCT04081337|536328931|FG000|Overall Study|Lost to Follow-up|1|||
148687812|NCT04081337|536328932|FG001|Overall Study|Lost to Follow-up|0|||
148687813|NCT02637076|536328933|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
149225222|NCT01640353|538290270|FG000|Overall Study|Withdrawal by Subject|5|||
149225223|NCT01640353|538290270|FG000|Overall Study|Death|2|||
149225224|NCT01640353|538290270|FG000|Overall Study|Early site termination|3|||
149225225|NCT01640353|538290270|FG000|Overall Study|Lost to Follow-up|12|||
149225226|NCT01640353|538290270|FG000|Overall Study|Physician Decision|1|||
149225227|NCT01524900|538290271|FG000|Overall Study|Lost to Follow-up|3|||
149225228|NCT01524900|538290272|FG001|Overall Study|Lost to Follow-up|12|||
149225229|NCT01524900|538290273|FG002|Overall Study|Lost to Follow-up|1|||
149225230|NCT01524900|538290274|FG003|Overall Study|Lost to Follow-up|0|||
149225231|NCT01524900|538290275|FG004|Overall Study|Lost to Follow-up|0|||
149225232|NCT01524900|538290271|FG000|Overall Study|Other reason than stated above|1|||
149019313|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
149225233|NCT01524900|538290272|FG001|Overall Study|Other reason than stated above|1|||
149225234|NCT01524900|538290273|FG002|Overall Study|Other reason than stated above|0|||
148810189|NCT00716417|536782579|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
148810190|NCT00716417|536782580|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
148810191|NCT00716417|536782581|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
148810192|NCT00716417|536782582|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
148810193|NCT00716417|536782583|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
148810194|NCT00716417|536782574|FG000|Overall Study|On patient request due to toxicities|0|||
149225235|NCT01524900|538290274|FG003|Overall Study|Other reason than stated above|0|||
149225236|NCT01524900|538290275|FG004|Overall Study|Other reason than stated above|0|||
148687814|NCT02637076|536328934|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
148687815|NCT02637076|536328933|FG000|Overall Study|Withdrawal by Subject|0|||
148687816|NCT02637076|536328934|FG001|Overall Study|Withdrawal by Subject|4|||
148687817|NCT02295774|536328936|FG000|Overall Study|Physician Decision|1|||
148687818|NCT02295774|536328936|FG000|Overall Study|Withdrawal by Subject|2|||
148687819|NCT00583596|536328939|FG000|Overall Study|Lost to Follow-up|110|||
148687820|NCT00583596|536328939|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
148687821|NCT00583596|536328939|FG000|Overall Study|Death|2|||
148687822|NCT00583596|536328939|FG000|Overall Study|Withdrawal by Subject|6|||
148687823|NCT00583596|536328939|FG000|Overall Study|Lost to Follow-up|94|||
148687824|NCT00583596|536328939|FG000|Overall Study|Data not complete|1|||
148687825|NCT00583596|536328939|FG000|Overall Study|Not consented|15|||
148687826|NCT00583596|536328939|FG000|Overall Study|Outside f-up window|26|||
148687827|NCT01855126|536328940|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
148687828|NCT01855126|536328941|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
148687829|NCT01855126|536328940|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
148687830|NCT01855126|536328941|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
148687831|NCT04535583|536328955|FG000|Overall Study|Lost to Follow-up|1|||
148687832|NCT04535583|536328955|FG000|Overall Study|Physician Decision|1|||
148687833|NCT04535583|536328955|FG000|Overall Study|Withdrawal by Subject|1|||
148687834|NCT01078090|536328956|FG000|Overall Study|Lost to Follow-up|2363|||
148687835|NCT01078090|536328956|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
148687836|NCT01078090|536328956|FG000|Overall Study|Lack of Efficacy|1193|||
148687837|NCT01078090|536328956|FG000|Overall Study|ADR and lack of efficacy|61|||
148687838|NCT01078090|536328956|FG000|Overall Study|Other|523|||
148687839|NCT01748890|536328958|FG000|Overall Study|Insufficient recruitment for analysis|4|||
148687840|NCT02669264|536328959|FG000|Overall Study|Death|5|||
148687841|NCT02669264|536328960|FG001|Overall Study|Death|5|||
148687842|NCT02669264|536328961|FG002|Overall Study|Death|3|||
148687843|NCT02669264|536328962|FG003|Overall Study|Death|3|||
148687844|NCT02669264|536328963|FG004|Overall Study|Death|3|||
148687845|NCT02669264|536328964|FG005|Overall Study|Death|6|||
148687846|NCT02669264|536328965|FG006|Overall Study|Death|3|||
148687847|NCT02669264|536328959|FG000|Overall Study|Withdrawal by Subject|0|||
148687848|NCT02669264|536328960|FG001|Overall Study|Withdrawal by Subject|1|||
148687849|NCT02669264|536328961|FG002|Overall Study|Withdrawal by Subject|0|||
148687850|NCT02669264|536328962|FG003|Overall Study|Withdrawal by Subject|0|||
148687851|NCT02669264|536328963|FG004|Overall Study|Withdrawal by Subject|1|||
148687852|NCT02669264|536328964|FG005|Overall Study|Withdrawal by Subject|0|||
148687853|NCT02669264|536328965|FG006|Overall Study|Withdrawal by Subject|0|||
148687854|NCT02669264|536328959|FG000|Overall Study|Lost to Follow-up|0|||
148687855|NCT02669264|536328960|FG001|Overall Study|Lost to Follow-up|0|||
148687856|NCT02669264|536328961|FG002|Overall Study|Lost to Follow-up|0|||
148687857|NCT02669264|536328962|FG003|Overall Study|Lost to Follow-up|0|||
148687858|NCT02669264|536328963|FG004|Overall Study|Lost to Follow-up|1|||
148687859|NCT02669264|536328964|FG005|Overall Study|Lost to Follow-up|0|||
148687860|NCT02669264|536328965|FG006|Overall Study|Lost to Follow-up|0|||
148687861|NCT02669264|536328959|FG000|Overall Study|Miscellaneous|0|||
148687862|NCT02669264|536328960|FG001|Overall Study|Miscellaneous|0|||
148687863|NCT02669264|536328961|FG002|Overall Study|Miscellaneous|0|||
148687864|NCT02669264|536328962|FG003|Overall Study|Miscellaneous|0|||
148687865|NCT02669264|536328963|FG004|Overall Study|Miscellaneous|0|||
148687866|NCT02669264|536328964|FG005|Overall Study|Miscellaneous|0|||
148687867|NCT02669264|536328965|FG006|Overall Study|Miscellaneous|2|||
148687868|NCT00526890|536328966|FG000|Overall Study|Adverse Event|2|||
148687869|NCT01688037|536328967|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
148687870|NCT01688037|536328968|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
148687871|NCT01688037|536328969|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
148687872|NCT01688037|536328967|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
148687873|NCT01688037|536328968|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
148687874|NCT01688037|536328969|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
148687875|NCT01688037|536328967|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
148687876|NCT01688037|536328968|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
148687877|NCT01688037|536328969|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
148687878|NCT01688037|536328967|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
148687879|NCT01688037|536328968|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
148687880|NCT01688037|536328969|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
149019314|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
149019315|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
149225237|NCT01524900|538290271|FG000|Overall Study|No reason documented|2|||
149225238|NCT01524900|538290272|FG001|Overall Study|No reason documented|1|||
149225239|NCT01524900|538290273|FG002|Overall Study|No reason documented|0|||
149225240|NCT01524900|538290274|FG003|Overall Study|No reason documented|1|||
149225241|NCT01524900|538290275|FG004|Overall Study|No reason documented|0|||
149225242|NCT03758612|538290276|FG000|Washout Period|Withdrawal by Subject|0|||
149225243|NCT03758612|538290277|FG001|Washout Period|Withdrawal by Subject|0|||
149225244|NCT03758612|538290278|FG002|Washout Period|Withdrawal by Subject|2|||
149225245|NCT03758612|538290279|FG003|Washout Period|Withdrawal by Subject|0|||
149225246|NCT03758612|538290280|FG004|Washout Period|Withdrawal by Subject|0|||
149225247|NCT03758612|538290281|FG005|Washout Period|Withdrawal by Subject|0|||
149225248|NCT03758612|538290282|FG006|Washout Period|Withdrawal by Subject|0|||
149225249|NCT03758612|538290283|FG007|Washout Period|Withdrawal by Subject|0|||
149225250|NCT03758612|538290284|FG008|Washout Period|Withdrawal by Subject|0|||
149225251|NCT03758612|538290285|FG009|Washout Period|Withdrawal by Subject|0|||
149225252|NCT03758612|538290286|FG010|Washout Period|Withdrawal by Subject|0|||
149225253|NCT03758612|538290287|FG011|Washout Period|Withdrawal by Subject|0|||
149225254|NCT03758612|538290276|FG000|Period 2|Protocol Violation|0|||
149225255|NCT03758612|538290277|FG001|Period 2|Protocol Violation|0|||
149225256|NCT03758612|538290278|FG002|Period 2|Protocol Violation|0|||
149225257|NCT03758612|538290279|FG003|Period 2|Protocol Violation|0|||
149225258|NCT03758612|538290280|FG004|Period 2|Protocol Violation|1|||
149225259|NCT03758612|538290281|FG005|Period 2|Protocol Violation|0|||
149225260|NCT03758612|538290282|FG006|Period 2|Protocol Violation|0|||
149225261|NCT03758612|538290283|FG007|Period 2|Protocol Violation|0|||
149225262|NCT03758612|538290284|FG008|Period 2|Protocol Violation|0|||
149225263|NCT03758612|538290285|FG009|Period 2|Protocol Violation|0|||
149225264|NCT03758612|538290286|FG010|Period 2|Protocol Violation|0|||
149225265|NCT03758612|538290287|FG011|Period 2|Protocol Violation|0|||
149225266|NCT04450394|538290290|FG000|Overall Study|Adverse Event|2|||
149225267|NCT04450394|538290291|FG001|Overall Study|Adverse Event|0|||
149225268|NCT04450394|538290292|FG002|Overall Study|Adverse Event|0|||
149225269|NCT04450394|538290290|FG000|Overall Study|Death|0|||
149019316|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
149019317|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
149019318|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
149019319|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
149019320|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019321|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019322|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019323|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
149019324|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
149019325|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019326|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019327|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019328|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019329|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
149019330|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
149019331|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
149019332|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
149019333|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
149019334|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
149019335|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
149019336|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
149019337|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
149019338|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
149019339|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
149225270|NCT04450394|538290291|FG001|Overall Study|Death|1|||
149225271|NCT04450394|538290292|FG002|Overall Study|Death|0|||
149225272|NCT04450394|538290290|FG000|Overall Study|Lost to Follow-up|0|||
149225273|NCT04450394|538290291|FG001|Overall Study|Lost to Follow-up|3|||
149225274|NCT04450394|538290292|FG002|Overall Study|Lost to Follow-up|0|||
149225275|NCT04450394|538290290|FG000|Overall Study|Physician Decision|0|||
149225276|NCT04450394|538290291|FG001|Overall Study|Physician Decision|1|||
149019340|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
149019341|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019342|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019343|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
149019344|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
149019345|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019346|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019347|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019348|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019349|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
149019350|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019351|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019352|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
149019353|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
149019354|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019355|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019356|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019357|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019358|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019359|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
149019360|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019361|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019362|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019363|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019364|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
149019365|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019366|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019367|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019368|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019369|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
149019370|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019371|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019372|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019373|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
149019374|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
149019375|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
149019376|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019377|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019378|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019379|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
149019380|NCT02018861|537549080|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019381|NCT02018861|537549081|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019382|NCT02018861|537549082|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019383|NCT02018861|537549083|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
149019384|NCT02018861|537549084|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
149019385|NCT02018861|537549085|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019386|NCT02018861|537549086|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019387|NCT02018861|537549087|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019388|NCT02018861|537549088|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019389|NCT02018861|537549089|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
149019390|NCT02018861|537549080|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019391|NCT02018861|537549081|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019392|NCT02018861|537549082|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019393|NCT02018861|537549083|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019394|NCT02018861|537549084|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019395|NCT02018861|537549085|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019396|NCT02018861|537549086|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
149019397|NCT02018861|537549087|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
149019398|NCT02018861|537549088|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
149019399|NCT02018861|537549089|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
148954070|NCT02927080|537314652|FG002|Overall Study|Withdrawal by Subject|0|||
148954071|NCT02927080|537314653|FG003|Overall Study|Withdrawal by Subject|0|||
148954072|NCT02927080|537314654|FG004|Overall Study|Withdrawal by Subject|1|||
148954073|NCT02927080|537314655|FG005|Overall Study|Withdrawal by Subject|0|||
148954074|NCT02927080|537314656|FG006|Overall Study|Withdrawal by Subject|1|||
148954075|NCT02927080|537314657|FG007|Overall Study|Withdrawal by Subject|1|||
148954076|NCT02927080|537314658|FG008|Overall Study|Withdrawal by Subject|0|||
148954077|NCT02927080|537314659|FG009|Overall Study|Withdrawal by Subject|2|||
148954078|NCT02927080|537314650|FG000|Overall Study|Willingness to comply with protocol|0|||
148954079|NCT02927080|537314651|FG001|Overall Study|Willingness to comply with protocol|0|||
148954080|NCT02927080|537314652|FG002|Overall Study|Willingness to comply with protocol|0|||
148954081|NCT02927080|537314653|FG003|Overall Study|Willingness to comply with protocol|0|||
148954082|NCT02927080|537314654|FG004|Overall Study|Willingness to comply with protocol|0|||
148954083|NCT02927080|537314655|FG005|Overall Study|Willingness to comply with protocol|0|||
148954084|NCT02927080|537314656|FG006|Overall Study|Willingness to comply with protocol|0|||
148954085|NCT02927080|537314657|FG007|Overall Study|Willingness to comply with protocol|0|||
148954086|NCT02927080|537314658|FG008|Overall Study|Willingness to comply with protocol|0|||
148954087|NCT02927080|537314659|FG009|Overall Study|Willingness to comply with protocol|1|||
148954088|NCT02927080|537314650|FG000|Overall Study|Study terminated by Sponsor|0|||
148954089|NCT02927080|537314651|FG001|Overall Study|Study terminated by Sponsor|0|||
148954090|NCT02927080|537314652|FG002|Overall Study|Study terminated by Sponsor|0|||
148954091|NCT02927080|537314653|FG003|Overall Study|Study terminated by Sponsor|0|||
148954092|NCT02927080|537314654|FG004|Overall Study|Study terminated by Sponsor|0|||
148954093|NCT02927080|537314655|FG005|Overall Study|Study terminated by Sponsor|0|||
148954094|NCT02927080|537314656|FG006|Overall Study|Study terminated by Sponsor|6|||
148954095|NCT02927080|537314657|FG007|Overall Study|Study terminated by Sponsor|7|||
148954096|NCT02927080|537314658|FG008|Overall Study|Study terminated by Sponsor|2|||
148954097|NCT02927080|537314659|FG009|Overall Study|Study terminated by Sponsor|3|||
148954098|NCT02927080|537314650|FG000|Overall Study|Adverse Event|0|||
148954099|NCT02927080|537314651|FG001|Overall Study|Adverse Event|1|||
148954100|NCT02927080|537314652|FG002|Overall Study|Adverse Event|0|||
148954101|NCT02927080|537314653|FG003|Overall Study|Adverse Event|0|||
148954102|NCT02927080|537314654|FG004|Overall Study|Adverse Event|0|||
148954103|NCT02927080|537314655|FG005|Overall Study|Adverse Event|0|||
148954104|NCT02927080|537314656|FG006|Overall Study|Adverse Event|0|||
148954105|NCT02927080|537314657|FG007|Overall Study|Adverse Event|1|||
148954106|NCT02927080|537314658|FG008|Overall Study|Adverse Event|0|||
148954107|NCT02927080|537314659|FG009|Overall Study|Adverse Event|1|||
148954108|NCT02927080|537314650|FG000|Overall Study|Other|0|||
148954109|NCT02927080|537314651|FG001|Overall Study|Other|0|||
148954110|NCT02927080|537314652|FG002|Overall Study|Other|0|||
148954111|NCT02927080|537314653|FG003|Overall Study|Other|0|||
148954112|NCT02927080|537314654|FG004|Overall Study|Other|0|||
148954113|NCT02927080|537314655|FG005|Overall Study|Other|0|||
149019400|NCT02018861|537549080|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019401|NCT02018861|537549081|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019402|NCT02018861|537549082|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019403|NCT02018861|537549083|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019404|NCT02018861|537549084|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019405|NCT02018861|537549085|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019406|NCT02018861|537549086|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
149019407|NCT02018861|537549087|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
149019408|NCT02018861|537549088|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019409|NCT02018861|537549089|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
149019410|NCT02018861|537549080|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019411|NCT02018861|537549081|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019412|NCT02018861|537549082|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019413|NCT02018861|537549083|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019414|NCT02018861|537549084|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019415|NCT02018861|537549085|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019416|NCT02018861|537549086|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019417|NCT02018861|537549087|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019418|NCT02018861|537549088|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
149019419|NCT02018861|537549089|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
149019420|NCT02018861|537549080|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019421|NCT02018861|537549081|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019422|NCT02018861|537549082|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019423|NCT02018861|537549083|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019424|NCT02018861|537549084|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019425|NCT02018861|537549085|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019426|NCT02018861|537549086|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019427|NCT02018861|537549087|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019428|NCT02018861|537549088|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
149019429|NCT02018861|537549089|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
149019430|NCT02018861|537549080|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019431|NCT02018861|537549081|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019432|NCT02018861|537549082|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019433|NCT02018861|537549083|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019434|NCT02018861|537549084|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019435|NCT02018861|537549085|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019436|NCT02018861|537549086|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019437|NCT02018861|537549087|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019438|NCT02018861|537549088|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
149019439|NCT02018861|537549089|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
149019440|NCT01668147|537549093|FG000|Overall Study|Withdrawal by Subject|6|||
149019441|NCT00504348|537549094|FG000|Overall Study|Adverse Event|3|||
149019442|NCT00504348|537549094|FG000|Overall Study|Lack of Efficacy|4|||
149019443|NCT00504348|537549094|FG000|Overall Study|Physician Decision|1|||
149019444|NCT02819479|537549095|FG000|Overall Study|Adverse Event|2|||
149019445|NCT03699124|537549097|FG000|Overall Study|Adverse Event|6|||
149019446|NCT03699124|537549098|FG001|Overall Study|Adverse Event|5|||
149019447|NCT03699124|537549099|FG002|Overall Study|Adverse Event|2|||
149019448|NCT03699124|537549097|FG000|Overall Study|Death|0|||
149019449|NCT03699124|537549098|FG001|Overall Study|Death|2|||
149019450|NCT03699124|537549099|FG002|Overall Study|Death|0|||
149019451|NCT03699124|537549097|FG000|Overall Study|Lost to Follow-up|20|||
149019452|NCT03699124|537549098|FG001|Overall Study|Lost to Follow-up|16|||
149019453|NCT03699124|537549099|FG002|Overall Study|Lost to Follow-up|15|||
149019454|NCT03699124|537549097|FG000|Overall Study|Protocol Violation|1|||
149019455|NCT03699124|537549098|FG001|Overall Study|Protocol Violation|0|||
149019456|NCT03699124|537549099|FG002|Overall Study|Protocol Violation|0|||
149019457|NCT03699124|537549097|FG000|Overall Study|Withdrawal by Subject|13|||
149019458|NCT03699124|537549098|FG001|Overall Study|Withdrawal by Subject|14|||
149019459|NCT03699124|537549099|FG002|Overall Study|Withdrawal by Subject|13|||
149019460|NCT03699124|537549097|FG000|Overall Study|Other reasons|5|||
149019461|NCT03699124|537549098|FG001|Overall Study|Other reasons|3|||
149225277|NCT04450394|538290292|FG002|Overall Study|Physician Decision|0|||
148687881|NCT01688037|536328967|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
149019462|NCT03699124|537549099|FG002|Overall Study|Other reasons|10|||
149019463|NCT01118962|537549100|FG000|Overall Study|Adverse Event|2|||
149019464|NCT01118962|537549100|FG000|Overall Study|Lack of Efficacy|1|||
149019465|NCT01118962|537549100|FG000|Overall Study|Protocol Violation|1|||
149019466|NCT01118962|537549100|FG000|Overall Study|Withdrawal by Subject|4|||
149019467|NCT01118962|537549100|FG000|Overall Study|Pregnancy|1|||
149019468|NCT01118962|537549100|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
149019469|NCT00506285|537549103|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
149019470|NCT00506285|537549104|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
149019471|NCT00506285|537549103|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
149019472|NCT00506285|537549104|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
149019473|NCT00506285|537549103|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
149019474|NCT00506285|537549104|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
149019475|NCT00506285|537549103|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
149019476|NCT00506285|537549104|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
149019477|NCT00506285|537549103|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
149019478|NCT00506285|537549104|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
149019479|NCT01890967|537549105|FG000|Overall Study|Adverse Event|3|||
149019480|NCT01890967|537549106|FG001|Overall Study|Adverse Event|3|||
149019481|NCT01890967|537549107|FG002|Overall Study|Adverse Event|3|||
149019482|NCT01890967|537549108|FG003|Overall Study|Adverse Event|2|||
149019483|NCT01890967|537549109|FG004|Overall Study|Adverse Event|1|||
149019484|NCT01890967|537549110|FG005|Overall Study|Adverse Event|7|||
149019485|NCT01890967|537549105|FG000|Overall Study|Death|1|||
149019486|NCT01890967|537549106|FG001|Overall Study|Death|0|||
149019487|NCT01890967|537549107|FG002|Overall Study|Death|0|||
149019488|NCT01890967|537549108|FG003|Overall Study|Death|0|||
149019489|NCT01890967|537549109|FG004|Overall Study|Death|0|||
149019490|NCT01890967|537549110|FG005|Overall Study|Death|0|||
149019491|NCT01890967|537549105|FG000|Overall Study|Lost to Follow-up|1|||
149019492|NCT01890967|537549106|FG001|Overall Study|Lost to Follow-up|1|||
149019493|NCT01890967|537549107|FG002|Overall Study|Lost to Follow-up|1|||
149019494|NCT01890967|537549108|FG003|Overall Study|Lost to Follow-up|1|||
149019495|NCT01890967|537549109|FG004|Overall Study|Lost to Follow-up|0|||
149019496|NCT01890967|537549110|FG005|Overall Study|Lost to Follow-up|1|||
149019497|NCT01890967|537549105|FG000|Overall Study|Protocol Violation|0|||
149019498|NCT01890967|537549106|FG001|Overall Study|Protocol Violation|3|||
149019499|NCT01890967|537549107|FG002|Overall Study|Protocol Violation|3|||
149019500|NCT01890967|537549108|FG003|Overall Study|Protocol Violation|2|||
149019501|NCT01890967|537549109|FG004|Overall Study|Protocol Violation|4|||
149019502|NCT01890967|537549110|FG005|Overall Study|Protocol Violation|1|||
149019503|NCT01890967|537549105|FG000|Overall Study|Sponsor Decision|2|||
149019504|NCT01890967|537549106|FG001|Overall Study|Sponsor Decision|0|||
149019505|NCT01890967|537549107|FG002|Overall Study|Sponsor Decision|1|||
149019506|NCT01890967|537549108|FG003|Overall Study|Sponsor Decision|3|||
149019507|NCT01890967|537549109|FG004|Overall Study|Sponsor Decision|2|||
149019508|NCT01890967|537549110|FG005|Overall Study|Sponsor Decision|3|||
149019509|NCT01890967|537549105|FG000|Overall Study|Withdrawal by Subject|3|||
149019510|NCT01890967|537549106|FG001|Overall Study|Withdrawal by Subject|4|||
149019511|NCT01890967|537549107|FG002|Overall Study|Withdrawal by Subject|2|||
149019512|NCT01890967|537549108|FG003|Overall Study|Withdrawal by Subject|3|||
149019513|NCT01890967|537549109|FG004|Overall Study|Withdrawal by Subject|3|||
149019514|NCT01890967|537549110|FG005|Overall Study|Withdrawal by Subject|1|||
149019515|NCT01383993|537549112|FG000|Overall Study|Adverse Event|1|||
149019516|NCT01383993|537549113|FG001|Overall Study|Adverse Event|1|||
148954114|NCT02927080|537314656|FG006|Overall Study|Other|1|||
148954115|NCT02927080|537314657|FG007|Overall Study|Other|0|||
148954116|NCT02927080|537314658|FG008|Overall Study|Other|1|||
148954117|NCT02927080|537314659|FG009|Overall Study|Other|0|||
148954118|NCT01991067|537314661|FG000|Overall Study|Lost to Follow-up|6|||
148954119|NCT01991067|537314662|FG001|Overall Study|Lost to Follow-up|5|||
148954120|NCT02068443|537314664|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
148954121|NCT02068443|537314665|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
148954122|NCT02068443|537314666|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
148954123|NCT02068443|537314664|FG000|Overall Study|Voluntary Withdrawal|4|||
148954124|NCT02068443|537314665|FG001|Overall Study|Voluntary Withdrawal|0|||
148954125|NCT02068443|537314666|FG002|Overall Study|Voluntary Withdrawal|1|||
148954126|NCT02068443|537314664|FG000|Overall Study|Lack of Efficacy|2|||
148954127|NCT02068443|537314665|FG001|Overall Study|Lack of Efficacy|1|||
148954128|NCT02068443|537314666|FG002|Overall Study|Lack of Efficacy|0|||
148954129|NCT02068443|537314664|FG000|Overall Study|Other Reason Not Specified|1|||
148954130|NCT02068443|537314665|FG001|Overall Study|Other Reason Not Specified|0|||
148954131|NCT02068443|537314666|FG002|Overall Study|Other Reason Not Specified|0|||
148954132|NCT00664742|537314667|FG000|Overall Study|Withdrawn due to adverse events|3|||
148954133|NCT00664742|537314667|FG000|Overall Study|Withdrawal by Subject|31|||
148954134|NCT00664742|537314667|FG000|Overall Study|Lost to Follow-up|92|||
148954135|NCT04429061|537314674|FG000|Overall Study|Lost to Follow-up|62|||
148954136|NCT04429061|537314675|FG001|Overall Study|Lost to Follow-up|87|||
148954137|NCT04429061|537314674|FG000|Overall Study|Withdrawal by Subject|3|||
148954138|NCT04429061|537314675|FG001|Overall Study|Withdrawal by Subject|4|||
148954139|NCT01402544|537314681|FG000|Overall Study|Withdrawal by Subject|6|||
148954140|NCT01828281|537314682|FG000|Overall Study|Withdrawal by Subject|1|||
148954141|NCT01828281|537314683|FG001|Overall Study|Withdrawal by Subject|0|||
148954142|NCT00142584|537314684|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
149019517|NCT01383993|537549114|FG002|Overall Study|Adverse Event|0|||
149019518|NCT01383993|537549112|FG000|Overall Study|Withdrawal by Subject|0|||
149019519|NCT01383993|537549113|FG001|Overall Study|Withdrawal by Subject|0|||
149019520|NCT01383993|537549114|FG002|Overall Study|Withdrawal by Subject|1|||
149019521|NCT01383993|537549112|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
149019522|NCT01383993|537549113|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
149019523|NCT01383993|537549114|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
149019524|NCT00593554|537549115|FG000|Overall Study|Death|1|||
149019525|NCT00593554|537549116|FG001|Overall Study|Death|2|||
149019526|NCT00593554|537549115|FG000|Overall Study|Physician Decision|0|||
149019527|NCT00593554|537549116|FG001|Overall Study|Physician Decision|1|||
149019528|NCT00593554|537549115|FG000|Overall Study|Withdrawal by Subject|1|||
149019529|NCT00593554|537549116|FG001|Overall Study|Withdrawal by Subject|0|||
149019530|NCT00593554|537549115|FG000|Overall Study|Disease Progression|1|||
149019531|NCT00593554|537549116|FG001|Overall Study|Disease Progression|2|||
149019532|NCT00795132|537549120|FG000|Overall Study|Death|1|||
149019533|NCT00795132|537549120|FG000|Overall Study|Relapse|2|||
149019534|NCT02561455|537549121|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
149019535|NCT02561455|537549122|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
149019536|NCT02561455|537549123|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
149019537|NCT02561455|537549124|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
149019538|NCT02561455|537549121|FG000|Overall Study|Withdrawal by Subject|1|||
149019539|NCT02561455|537549122|FG001|Overall Study|Withdrawal by Subject|0|||
149019540|NCT02561455|537549123|FG002|Overall Study|Withdrawal by Subject|1|||
149019541|NCT02561455|537549124|FG003|Overall Study|Withdrawal by Subject|0|||
149019542|NCT02561455|537549121|FG000|Overall Study|Disease Progression|0|||
149019543|NCT02561455|537549122|FG001|Overall Study|Disease Progression|1|||
149019544|NCT02561455|537549123|FG002|Overall Study|Disease Progression|0|||
149019545|NCT02561455|537549124|FG003|Overall Study|Disease Progression|0|||
149019546|NCT00262743|537549129|FG000|Overall Study|Adverse Event|0|||
149019547|NCT00262743|537549130|FG001|Overall Study|Adverse Event|9|||
149019548|NCT00262743|537549129|FG000|Overall Study|Disease progression|0|||
149019549|NCT00262743|537549130|FG001|Overall Study|Disease progression|3|||
149019550|NCT01950273|537549142|FG000|Overall Study|Protocol Violation|1|||
149019551|NCT01950273|537549143|FG001|Overall Study|Protocol Violation|0|||
149019552|NCT01950273|537549142|FG000|Overall Study|Withdrawal by Subject|2|||
149019553|NCT01950273|537549143|FG001|Overall Study|Withdrawal by Subject|0|||
149019554|NCT01950273|537549142|FG000|Overall Study|Other not defined above|1|||
149019555|NCT01950273|537549143|FG001|Overall Study|Other not defined above|0|||
149019556|NCT00472186|537549144|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
149019557|NCT00472186|537549145|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
149019558|NCT01254565|537549146|FG000|Overall Study|Non-compliance to Study Procedures|0|||
149019559|NCT01254565|537549147|FG001|Overall Study|Non-compliance to Study Procedures|0|||
149019560|NCT01254565|537549148|FG002|Overall Study|Non-compliance to Study Procedures|0|||
149019561|NCT01254565|537549149|FG003|Overall Study|Non-compliance to Study Procedures|0|||
149019562|NCT01254565|537549150|FG004|Overall Study|Non-compliance to Study Procedures|1|||
149019563|NCT01254565|537549151|FG005|Overall Study|Non-compliance to Study Procedures|0|||
149019564|NCT01254565|537549146|FG000|Overall Study|Did not Receive Treatment|1|||
149019565|NCT01254565|537549147|FG001|Overall Study|Did not Receive Treatment|1|||
149019566|NCT01254565|537549148|FG002|Overall Study|Did not Receive Treatment|0|||
149019567|NCT01254565|537549149|FG003|Overall Study|Did not Receive Treatment|0|||
149019568|NCT01254565|537549150|FG004|Overall Study|Did not Receive Treatment|3|||
149019569|NCT01254565|537549151|FG005|Overall Study|Did not Receive Treatment|4|||
149019570|NCT01254565|537549146|FG000|Overall Study|Other|0|||
149019571|NCT01254565|537549147|FG001|Overall Study|Other|0|||
149019572|NCT01254565|537549148|FG002|Overall Study|Other|0|||
149019573|NCT01254565|537549149|FG003|Overall Study|Other|1|||
149019574|NCT01254565|537549150|FG004|Overall Study|Other|0|||
149019575|NCT01254565|537549151|FG005|Overall Study|Other|0|||
149019576|NCT04006366|537549158|FG000|Overall Study|Withdrawal by Subject|1|||
149019577|NCT04430335|537549159|FG000|Overall Study|Withdrawal by Subject|1|||
149019578|NCT03249376|537549166|FG000|Overall Study|Adverse Event|11|||
149019579|NCT03249376|537549167|FG001|Overall Study|Adverse Event|5|||
149019580|NCT03249376|537549166|FG000|Overall Study|Lack of Efficacy|2|||
149019581|NCT03249376|537549167|FG001|Overall Study|Lack of Efficacy|4|||
149019582|NCT03249376|537549166|FG000|Overall Study|Protocol Violation|3|||
149019583|NCT03249376|537549167|FG001|Overall Study|Protocol Violation|2|||
149019584|NCT03249376|537549166|FG000|Overall Study|Physician Decision|0|||
149019585|NCT03249376|537549167|FG001|Overall Study|Physician Decision|2|||
149019586|NCT03249376|537549166|FG000|Overall Study|Withdrawal by Subject|3|||
149019587|NCT03249376|537549167|FG001|Overall Study|Withdrawal by Subject|9|||
149019588|NCT03249376|537549166|FG000|Overall Study|LTFU|2|||
149019589|NCT03249376|537549167|FG001|Overall Study|LTFU|1|||
149019590|NCT00627042|537549171|FG000|Overall Study|Withdrawal by Subject|2|||
149019591|NCT01154036|537549174|FG000|Phase I|Physician Decision|0|||
149019592|NCT01154036|537549175|FG001|Phase I|Physician Decision|1|||
148687882|NCT01688037|536328968|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
148687883|NCT01688037|536328969|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
148687884|NCT01688037|536328967|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
148687885|NCT01688037|536328968|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
148687886|NCT01688037|536328969|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
148687887|NCT01688037|536328967|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
148687888|NCT01688037|536328968|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
148687889|NCT01688037|536328969|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
148687890|NCT01688037|536328967|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
148687891|NCT01688037|536328968|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
148687892|NCT01688037|536328969|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
148687893|NCT01688037|536328967|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
148687894|NCT01688037|536328968|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
148687895|NCT01688037|536328969|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
148687896|NCT01688037|536328967|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
148687897|NCT01688037|536328968|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
148687898|NCT01688037|536328969|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
148687899|NCT03035227|536328970|FG000|Overall Study|study stopped due to PI leaving institut|1|||
148687900|NCT03035227|536328971|FG001|Overall Study|study stopped due to PI leaving institut|1|||
148687901|NCT02100956|536328972|FG000|At Least One Week Between Injections|Adverse Event|0|||
148687902|NCT02100956|536328973|FG001|At Least One Week Between Injections|Adverse Event|1|||
148687903|NCT02220907|536328974|FG000|Overall Study|Adverse Event|7|||
148687904|NCT02220907|536328974|FG000|Overall Study|Physician Decision|1|||
148687905|NCT02220907|536328974|FG000|Overall Study|Withdrawal by Subject|2|||
148687906|NCT02220907|536328974|FG000|Overall Study|Conflict with the stopping criteria|1|||
148687907|NCT04345471|536328979|FG000|Overall Study|Adverse Event|8|||
148687908|NCT04345471|536328980|FG001|Overall Study|Adverse Event|5|||
148687909|NCT04345471|536328981|FG002|Overall Study|Adverse Event|6|||
148687910|NCT04345471|536328979|FG000|Overall Study|Lack of Efficacy|1|||
148687911|NCT04345471|536328980|FG001|Overall Study|Lack of Efficacy|1|||
148687912|NCT04345471|536328981|FG002|Overall Study|Lack of Efficacy|0|||
148687913|NCT04345471|536328979|FG000|Overall Study|Protocol Violation|0|||
148687914|NCT04345471|536328980|FG001|Overall Study|Protocol Violation|1|||
148687915|NCT04345471|536328981|FG002|Overall Study|Protocol Violation|2|||
148687916|NCT04345471|536328979|FG000|Overall Study|Withdrawal by Subject|10|||
148687917|NCT04345471|536328980|FG001|Overall Study|Withdrawal by Subject|5|||
148687918|NCT04345471|536328981|FG002|Overall Study|Withdrawal by Subject|10|||
148687919|NCT01098240|536328982|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
148687920|NCT01098240|536328983|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
148687921|NCT01098240|536328984|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
148687922|NCT01098240|536328982|FG000|Open-Label Phase|Protocol Violation|4|||
148687923|NCT01098240|536328983|FG001|Open-Label Phase|Protocol Violation|0|||
148687924|NCT01098240|536328984|FG002|Open-Label Phase|Protocol Violation|0|||
148687925|NCT01098240|536328982|FG000|Open-Label Phase|Lost to Follow-up|13|||
148687926|NCT01098240|536328983|FG001|Open-Label Phase|Lost to Follow-up|0|||
148687927|NCT01098240|536328984|FG002|Open-Label Phase|Lost to Follow-up|0|||
148687928|NCT01098240|536328982|FG000|Open-Label Phase|Other|19|||
148687929|NCT01098240|536328983|FG001|Open-Label Phase|Other|0|||
148687930|NCT01098240|536328984|FG002|Open-Label Phase|Other|0|||
148687931|NCT01098240|536328982|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
148687932|NCT01098240|536328983|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
148687933|NCT01098240|536328984|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
148687934|NCT01098240|536328982|FG000|Open-Label Phase|Pregnancy|1|||
148687935|NCT01098240|536328983|FG001|Open-Label Phase|Pregnancy|0|||
148687936|NCT01098240|536328984|FG002|Open-Label Phase|Pregnancy|0|||
148687937|NCT01098240|536328982|FG000|Open-Label Phase|Withdrawal by Subject|9|||
148687938|NCT01098240|536328983|FG001|Open-Label Phase|Withdrawal by Subject|0|||
148687939|NCT01098240|536328984|FG002|Open-Label Phase|Withdrawal by Subject|0|||
148687940|NCT01098240|536328982|FG000|Open-Label Phase|Adverse Event|12|||
148687941|NCT01098240|536328983|FG001|Open-Label Phase|Adverse Event|0|||
148687942|NCT01098240|536328984|FG002|Open-Label Phase|Adverse Event|0|||
148687943|NCT01098240|536328982|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
148687944|NCT01098240|536328983|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
148687945|NCT01098240|536328984|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
148687946|NCT01098240|536328982|FG000|Double-Blind Phase|Protocol Violation|0|||
148687947|NCT01098240|536328983|FG001|Double-Blind Phase|Protocol Violation|2|||
148687948|NCT01098240|536328984|FG002|Double-Blind Phase|Protocol Violation|4|||
148687949|NCT01098240|536328982|FG000|Double-Blind Phase|Lost to Follow-up|0|||
148687950|NCT01098240|536328983|FG001|Double-Blind Phase|Lost to Follow-up|2|||
148687951|NCT01098240|536328984|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148687952|NCT01098240|536328982|FG000|Double-Blind Phase|Other|0|||
148687953|NCT01098240|536328983|FG001|Double-Blind Phase|Other|2|||
148810195|NCT00716417|536782575|FG001|Overall Study|On patient request due to toxicities|0|||
149225278|NCT04450394|538290290|FG000|Overall Study|Protocol Violation|2|||
149019593|NCT01154036|537549176|FG002|Phase I|Physician Decision|0|||
149019594|NCT01154036|537549177|FG003|Phase I|Physician Decision|0|||
149019595|NCT01154036|537549178|FG004|Phase I|Physician Decision|0|||
149019596|NCT01154036|537549179|FG005|Phase I|Physician Decision|0|||
149019597|NCT01154036|537549180|FG006|Phase I|Physician Decision|0|||
149019598|NCT01154036|537549181|FG007|Phase I|Physician Decision|0|||
149019599|NCT01154036|537549174|FG000|Phase I|Lost to Follow-up|0|||
149019600|NCT01154036|537549175|FG001|Phase I|Lost to Follow-up|3|||
149019601|NCT01154036|537549176|FG002|Phase I|Lost to Follow-up|6|||
149019602|NCT01154036|537549177|FG003|Phase I|Lost to Follow-up|0|||
149019603|NCT01154036|537549178|FG004|Phase I|Lost to Follow-up|0|||
149019604|NCT01154036|537549179|FG005|Phase I|Lost to Follow-up|0|||
149019605|NCT01154036|537549180|FG006|Phase I|Lost to Follow-up|0|||
149019606|NCT01154036|537549181|FG007|Phase I|Lost to Follow-up|0|||
149019607|NCT01154036|537549174|FG000|Phase I|Protocol Violation|0|||
149019608|NCT01154036|537549175|FG001|Phase I|Protocol Violation|3|||
149019609|NCT01154036|537549176|FG002|Phase I|Protocol Violation|9|||
149019610|NCT01154036|537549177|FG003|Phase I|Protocol Violation|0|||
149019611|NCT01154036|537549178|FG004|Phase I|Protocol Violation|0|||
149019612|NCT01154036|537549179|FG005|Phase I|Protocol Violation|0|||
149019613|NCT01154036|537549180|FG006|Phase I|Protocol Violation|0|||
149019614|NCT01154036|537549181|FG007|Phase I|Protocol Violation|0|||
149019615|NCT01154036|537549174|FG000|Phase I|Withdrawal by Subject|2|||
149019616|NCT01154036|537549175|FG001|Phase I|Withdrawal by Subject|10|||
149019617|NCT01154036|537549176|FG002|Phase I|Withdrawal by Subject|29|||
149019618|NCT01154036|537549177|FG003|Phase I|Withdrawal by Subject|0|||
149019619|NCT01154036|537549178|FG004|Phase I|Withdrawal by Subject|0|||
149019620|NCT01154036|537549179|FG005|Phase I|Withdrawal by Subject|0|||
149019621|NCT01154036|537549180|FG006|Phase I|Withdrawal by Subject|0|||
149019622|NCT01154036|537549181|FG007|Phase I|Withdrawal by Subject|0|||
149019623|NCT01154036|537549174|FG000|Phase I|Adverse Event|1|||
149019624|NCT01154036|537549175|FG001|Phase I|Adverse Event|11|||
149019625|NCT01154036|537549176|FG002|Phase I|Adverse Event|12|||
149019626|NCT01154036|537549177|FG003|Phase I|Adverse Event|0|||
149019627|NCT01154036|537549178|FG004|Phase I|Adverse Event|0|||
149019628|NCT01154036|537549179|FG005|Phase I|Adverse Event|0|||
149019629|NCT01154036|537549180|FG006|Phase I|Adverse Event|0|||
149019630|NCT01154036|537549181|FG007|Phase I|Adverse Event|0|||
149019631|NCT01154036|537549174|FG000|Phase II|Adverse Event|0|||
149019632|NCT01154036|537549175|FG001|Phase II|Adverse Event|0|||
149019633|NCT01154036|537549176|FG002|Phase II|Adverse Event|0|||
149019634|NCT01154036|537549177|FG003|Phase II|Adverse Event|0|||
149019635|NCT01154036|537549178|FG004|Phase II|Adverse Event|1|||
149019636|NCT01154036|537549179|FG005|Phase II|Adverse Event|1|||
149019637|NCT01154036|537549180|FG006|Phase II|Adverse Event|1|||
149019638|NCT01154036|537549181|FG007|Phase II|Adverse Event|1|||
149019639|NCT01154036|537549174|FG000|Phase II|Physician Decision|0|||
149019640|NCT01154036|537549175|FG001|Phase II|Physician Decision|0|||
149019641|NCT01154036|537549176|FG002|Phase II|Physician Decision|0|||
149019642|NCT01154036|537549177|FG003|Phase II|Physician Decision|0|||
149019643|NCT01154036|537549178|FG004|Phase II|Physician Decision|0|||
149019644|NCT01154036|537549179|FG005|Phase II|Physician Decision|0|||
149019645|NCT01154036|537549180|FG006|Phase II|Physician Decision|1|||
149019646|NCT01154036|537549181|FG007|Phase II|Physician Decision|0|||
149019647|NCT01154036|537549174|FG000|Phase II|Lost to Follow-up|0|||
149019648|NCT01154036|537549175|FG001|Phase II|Lost to Follow-up|0|||
149019649|NCT01154036|537549176|FG002|Phase II|Lost to Follow-up|0|||
149019650|NCT01154036|537549177|FG003|Phase II|Lost to Follow-up|1|||
149019651|NCT01154036|537549178|FG004|Phase II|Lost to Follow-up|2|||
149019652|NCT01154036|537549179|FG005|Phase II|Lost to Follow-up|0|||
149019653|NCT01154036|537549180|FG006|Phase II|Lost to Follow-up|2|||
149019654|NCT01154036|537549181|FG007|Phase II|Lost to Follow-up|1|||
149019655|NCT01154036|537549174|FG000|Phase II|Protocol Violation|0|||
149019656|NCT01154036|537549175|FG001|Phase II|Protocol Violation|0|||
149019657|NCT01154036|537549176|FG002|Phase II|Protocol Violation|0|||
149019658|NCT01154036|537549177|FG003|Phase II|Protocol Violation|0|||
149019659|NCT01154036|537549178|FG004|Phase II|Protocol Violation|1|||
149019660|NCT01154036|537549179|FG005|Phase II|Protocol Violation|2|||
149019661|NCT01154036|537549180|FG006|Phase II|Protocol Violation|0|||
149019662|NCT01154036|537549181|FG007|Phase II|Protocol Violation|0|||
149019663|NCT01154036|537549174|FG000|Phase II|Withdrawal by Subject|0|||
149019664|NCT01154036|537549175|FG001|Phase II|Withdrawal by Subject|0|||
149019665|NCT01154036|537549176|FG002|Phase II|Withdrawal by Subject|0|||
149019666|NCT01154036|537549177|FG003|Phase II|Withdrawal by Subject|0|||
149019667|NCT01154036|537549178|FG004|Phase II|Withdrawal by Subject|4|||
149019668|NCT01154036|537549179|FG005|Phase II|Withdrawal by Subject|2|||
149019669|NCT01154036|537549180|FG006|Phase II|Withdrawal by Subject|5|||
149019670|NCT01154036|537549181|FG007|Phase II|Withdrawal by Subject|4|||
149019671|NCT02264574|537549182|FG000|Overall Study|Death|21|||
149019672|NCT02264574|537549183|FG001|Overall Study|Death|21|||
149019673|NCT02264574|537549182|FG000|Overall Study|Withdrawal by Subject|8|||
149019674|NCT02264574|537549183|FG001|Overall Study|Withdrawal by Subject|6|||
149019675|NCT02264574|537549182|FG000|Overall Study|Other, Not Specified|0|||
149019676|NCT02264574|537549183|FG001|Overall Study|Other, Not Specified|3|||
149019677|NCT04254679|537549186|FG000|Overall Study|Protocol Violation|1|||
149019678|NCT04254679|537549187|FG001|Overall Study|Protocol Violation|1|||
149019679|NCT04254679|537549186|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
149019680|NCT04254679|537549187|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
149019681|NCT02206152|537549192|FG000|Pre-Randomization|Withdrawal by Subject|2|||
149019682|NCT00478608|537549193|FG000|Overall Study|Adverse Event|1|||
149019683|NCT00478608|537549193|FG000|Overall Study|Serious Adverse Event|14|||
149019684|NCT00478608|537549193|FG000|Overall Study|Withdrawal by Subject|2|||
149019685|NCT00478608|537549193|FG000|Overall Study|Protocol Violation|3|||
149019686|NCT02080520|537549194|FG000|Overall Study|Self-reported symptoms|5|||
149019687|NCT02080520|537549195|FG001|Overall Study|Self-reported symptoms|6|||
149019688|NCT02080520|537549194|FG000|Overall Study|Unable to contact|2|||
149019689|NCT02080520|537549195|FG001|Overall Study|Unable to contact|1|||
149019690|NCT02080520|537549194|FG000|Overall Study|Initiated aspirin|2|||
149019691|NCT02080520|537549195|FG001|Overall Study|Initiated aspirin|0|||
149019692|NCT02080520|537549194|FG000|Overall Study|Atrial fibrillation|1|||
149019693|NCT02080520|537549195|FG001|Overall Study|Atrial fibrillation|1|||
149019694|NCT02080520|537549194|FG000|Overall Study|Cancer|1|||
149019695|NCT02080520|537549195|FG001|Overall Study|Cancer|2|||
149019696|NCT02080520|537549194|FG000|Overall Study|Not interested in study|1|||
149019697|NCT02080520|537549195|FG001|Overall Study|Not interested in study|3|||
149019698|NCT02080520|537549194|FG000|Overall Study|Too busy|1|||
149019699|NCT02080520|537549195|FG001|Overall Study|Too busy|1|||
149019700|NCT02080520|537549194|FG000|Overall Study|Work-related injury|1|||
149019701|NCT02080520|537549195|FG001|Overall Study|Work-related injury|0|||
149019702|NCT02080520|537549194|FG000|Overall Study|Personal reasons|0|||
149019703|NCT02080520|537549195|FG001|Overall Study|Personal reasons|3|||
149019704|NCT00390455|537549196|FG000|Overall Study|Adverse Event|17|||
149019705|NCT00390455|537549197|FG001|Overall Study|Adverse Event|3|||
149019706|NCT00390455|537549196|FG000|Overall Study|Withdrawal by Subject|8|||
149019707|NCT00390455|537549197|FG001|Overall Study|Withdrawal by Subject|8|||
149019708|NCT00390455|537549196|FG000|Overall Study|Alternate Treatment|0|||
149019709|NCT00390455|537549197|FG001|Overall Study|Alternate Treatment|1|||
149019710|NCT00390455|537549196|FG000|Overall Study|Other Medical Reasons|7|||
149019711|NCT00390455|537549197|FG001|Overall Study|Other Medical Reasons|11|||
149019712|NCT00794820|537549200|FG000|Overall Study|Adverse Event|11|||
149019713|NCT00794820|537549200|FG000|Overall Study|Secondary Malignancies|2|||
149019714|NCT00794820|537549200|FG000|Overall Study|Resistant Disease|2|||
149019715|NCT00794820|537549200|FG000|Overall Study|Ineligible/Screen Failure|1|||
149019716|NCT01216293|537549202|FG000|Main Study|Adverse Event|1|||
149019717|NCT01216293|537549203|FG001|Main Study|Adverse Event|4|||
149019718|NCT01216293|537549204|FG002|Main Study|Adverse Event|2|||
149019719|NCT01216293|537549202|FG000|Main Study|Major Protocol Deviation|1|||
149019720|NCT01216293|537549203|FG001|Main Study|Major Protocol Deviation|0|||
149019721|NCT01216293|537549204|FG002|Main Study|Major Protocol Deviation|1|||
149019722|NCT01216293|537549202|FG000|Main Study|Lost to Follow-up|3|||
149019723|NCT01216293|537549203|FG001|Main Study|Lost to Follow-up|1|||
149019724|NCT01216293|537549204|FG002|Main Study|Lost to Follow-up|0|||
149019725|NCT01216293|537549202|FG000|Main Study|Voluntary Withdrawal|2|||
149019726|NCT01216293|537549203|FG001|Main Study|Voluntary Withdrawal|2|||
149019727|NCT01216293|537549204|FG002|Main Study|Voluntary Withdrawal|2|||
149019728|NCT01216293|537549202|FG000|Main Study|Other Reason Not Specified|0|||
149019729|NCT01216293|537549203|FG001|Main Study|Other Reason Not Specified|1|||
149019730|NCT01216293|537549204|FG002|Main Study|Other Reason Not Specified|1|||
149019731|NCT01216293|537549202|FG000|Main Study|Randomized, Not Treated|1|||
149019732|NCT01216293|537549203|FG001|Main Study|Randomized, Not Treated|0|||
149019733|NCT01216293|537549204|FG002|Main Study|Randomized, Not Treated|0|||
149019734|NCT01216293|537549202|FG000|Calcium Absorption Substudy|Adverse Event|0|||
149019735|NCT01216293|537549203|FG001|Calcium Absorption Substudy|Adverse Event|2|||
149019736|NCT01216293|537549204|FG002|Calcium Absorption Substudy|Adverse Event|0|||
149019737|NCT01216293|537549202|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
149019738|NCT01216293|537549203|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
149019739|NCT01216293|537549204|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
149019740|NCT01216293|537549202|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
149019741|NCT01216293|537549203|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
149019742|NCT01216293|537549204|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
149019743|NCT04714216|537550961|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
149019744|NCT04714216|537550961|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
149019745|NCT01852162|537550962|FG000|Overall Study|Adverse Event|1|||
149019746|NCT01852162|537550963|FG001|Overall Study|Adverse Event|0|||
149019747|NCT01852162|537550962|FG000|Overall Study|Withdrawal by Subject|3|||
149019748|NCT01852162|537550963|FG001|Overall Study|Withdrawal by Subject|1|||
149019749|NCT02955277|537550964|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
149019750|NCT02955277|537550965|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
149019751|NCT02955277|537550964|FG000|Post to Follow-up|Lost to Follow-up|8|||
149019752|NCT02955277|537550965|FG001|Post to Follow-up|Lost to Follow-up|11|||
149019753|NCT00163215|537550968|FG000|Overall Study|Lack of Efficacy|3|||
149019754|NCT00163215|537550968|FG000|Overall Study|Withdrawal by Subject|5|||
149019755|NCT00163215|537550968|FG000|Overall Study|Other|7|||
149019756|NCT01809210|537550971|FG000|Overall Study|Withdrawal by Subject|0|||
149019757|NCT01809210|537550972|FG001|Overall Study|Withdrawal by Subject|0|||
149019758|NCT01809210|537550973|FG002|Overall Study|Withdrawal by Subject|1|||
149019759|NCT01809210|537550974|FG003|Overall Study|Withdrawal by Subject|1|||
149019760|NCT01809210|537550975|FG004|Overall Study|Withdrawal by Subject|1|||
149019761|NCT01809210|537550976|FG005|Overall Study|Withdrawal by Subject|0|||
149019762|NCT01809210|537550977|FG006|Overall Study|Withdrawal by Subject|4|||
149019763|NCT01809210|537550971|FG000|Overall Study|Death|1|||
149019764|NCT01809210|537550972|FG001|Overall Study|Death|1|||
149019765|NCT01809210|537550973|FG002|Overall Study|Death|2|||
149019766|NCT01809210|537550974|FG003|Overall Study|Death|0|||
149019767|NCT01809210|537550975|FG004|Overall Study|Death|1|||
149019768|NCT01809210|537550976|FG005|Overall Study|Death|3|||
149019769|NCT01809210|537550977|FG006|Overall Study|Death|1|||
149019770|NCT01115998|537550980|FG000|Overall Study|Lost to Follow-up|6|||
149019771|NCT01115998|537550981|FG001|Overall Study|Lost to Follow-up|6|||
149019772|NCT00224133|537550982|FG000|Overall Study|Adverse Event|93|||
149019773|NCT00224133|537550982|FG000|Overall Study|Protocol Violation|6|||
149019774|NCT00224133|537550982|FG000|Overall Study|Withdrawal by Subject|33|||
149019775|NCT00224133|537550982|FG000|Overall Study|Lack of Efficacy|58|||
149019776|NCT00224133|537550982|FG000|Overall Study|Lost to Follow-up|21|||
149019777|NCT00224133|537550982|FG000|Overall Study|Physician Decision|1|||
149019778|NCT00224133|537550982|FG000|Overall Study|Other|14|||
149019779|NCT00551213|537550988|FG000|Overall Study|Adverse Event|6|||
149019780|NCT00551213|537550989|FG001|Overall Study|Adverse Event|3|||
148810196|NCT00716417|536782576|FG002|Overall Study|On patient request due to toxicities|0|||
148810197|NCT00716417|536782577|FG003|Overall Study|On patient request due to toxicities|0|||
149019781|NCT00551213|537550988|FG000|Overall Study|Progressive Disease|41|||
149019782|NCT00551213|537550989|FG001|Overall Study|Progressive Disease|12|||
149019783|NCT00551213|537550988|FG000|Overall Study|Withdrawal by Subject|2|||
149019784|NCT00551213|537550989|FG001|Overall Study|Withdrawal by Subject|0|||
149019785|NCT00551213|537550988|FG000|Overall Study|Not Treated|1|||
149019786|NCT00551213|537550989|FG001|Overall Study|Not Treated|2|||
149019787|NCT01489020|537550996|FG000|Overall Study|Withdrawal by Subject|1|||
149019788|NCT01489020|537550997|FG001|Overall Study|Withdrawal by Subject|0|||
149019789|NCT01489020|537550998|FG002|Overall Study|Withdrawal by Subject|0|||
149019790|NCT01489020|537550999|FG003|Overall Study|Withdrawal by Subject|0|||
149019791|NCT01489020|537551000|FG004|Overall Study|Withdrawal by Subject|0|||
149019792|NCT01489020|537551001|FG005|Overall Study|Withdrawal by Subject|0|||
149019793|NCT01489020|537550996|FG000|Overall Study|Adverse Event|0|||
149019794|NCT01489020|537550997|FG001|Overall Study|Adverse Event|0|||
149019795|NCT01489020|537550998|FG002|Overall Study|Adverse Event|3|||
149019796|NCT01489020|537550999|FG003|Overall Study|Adverse Event|0|||
149019797|NCT01489020|537551000|FG004|Overall Study|Adverse Event|3|||
149019798|NCT01489020|537551001|FG005|Overall Study|Adverse Event|0|||
149019799|NCT01489020|537550996|FG000|Overall Study|Concomitant disease|0|||
148687954|NCT01098240|536328984|FG002|Double-Blind Phase|Other|2|||
148687955|NCT01098240|536328982|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
148687956|NCT01098240|536328983|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
148687957|NCT01098240|536328984|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
148687958|NCT01098240|536328982|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
148687959|NCT01098240|536328983|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
148687960|NCT01098240|536328984|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
148687961|NCT01098240|536328982|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
148687962|NCT01098240|536328983|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
148687963|NCT01098240|536328984|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
148687964|NCT01098240|536328982|FG000|Double-Blind Phase|Adverse Event|0|||
148687965|NCT01098240|536328983|FG001|Double-Blind Phase|Adverse Event|3|||
148687966|NCT01098240|536328984|FG002|Double-Blind Phase|Adverse Event|3|||
148687967|NCT03280537|536328985|FG000|Overall Study|Withdrawal by Subject|2|||
148687968|NCT03280537|536328986|FG001|Overall Study|Withdrawal by Subject|4|||
148687969|NCT01588106|536328987|FG000|Overall Study|Withdrawal by Subject|5|||
148687970|NCT01588106|536328988|FG001|Overall Study|Withdrawal by Subject|4|||
148687971|NCT02995837|536328989|FG000|Overall Study|Lost to Follow-up|9|||
148687972|NCT02995837|536328990|FG001|Overall Study|Lost to Follow-up|8|||
148687973|NCT01859702|536328991|FG000|Overall Study|Protocol deviation|3|||
148687974|NCT01859702|536328991|FG000|Overall Study|Adverse Event|2|||
148687975|NCT04014959|536330605|FG000|Baseline MRI and Assessments|Physician Decision|2|||
148687976|NCT04014959|536330605|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
148687977|NCT04014959|536330605|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
148687978|NCT02004847|536330607|FG000|Overall Study|Protocol Violation|1|||
148687979|NCT02004847|536330608|FG001|Overall Study|Protocol Violation|1|||
148687980|NCT03381248|536330611|FG000|0-6 Months|Withdrawal by Subject|4|||
148687981|NCT03381248|536330612|FG001|0-6 Months|Withdrawal by Subject|1|||
148687982|NCT03381248|536330611|FG000|0-6 Months|Lost to Follow-up|3|||
148687983|NCT03381248|536330612|FG001|0-6 Months|Lost to Follow-up|2|||
148687984|NCT03381248|536330611|FG000|0-6 Months|Lack of Efficacy|1|||
148687985|NCT03381248|536330612|FG001|0-6 Months|Lack of Efficacy|0|||
148687986|NCT03381248|536330611|FG000|0-6 Months|Adverse Event|1|||
148687987|NCT03381248|536330612|FG001|0-6 Months|Adverse Event|0|||
148687988|NCT03381248|536330611|FG000|0-6 Months|Protocol Violation|2|||
148687989|NCT03381248|536330612|FG001|0-6 Months|Protocol Violation|1|||
148687990|NCT03381248|536330611|FG000|0-6 Months|Physician Decision|1|||
148687991|NCT03381248|536330612|FG001|0-6 Months|Physician Decision|0|||
148687992|NCT03381248|536330611|FG000|0-6 Months|Planning another procedure|1|||
148687993|NCT03381248|536330612|FG001|0-6 Months|Planning another procedure|2|||
148687994|NCT03381248|536330611|FG000|6-12 Months|Withdrawal by Subject|1|||
148687995|NCT03381248|536330612|FG001|6-12 Months|Withdrawal by Subject|3|||
148687996|NCT03381248|536330611|FG000|6-12 Months|Lost to Follow-up|0|||
148687997|NCT03381248|536330612|FG001|6-12 Months|Lost to Follow-up|2|||
148687998|NCT03381248|536330611|FG000|6-12 Months|Protocol Violation|3|||
148687999|NCT03381248|536330612|FG001|6-12 Months|Protocol Violation|2|||
148688000|NCT03381248|536330611|FG000|6-12 Months|Planning another procedure|6|||
148688001|NCT03381248|536330612|FG001|6-12 Months|Planning another procedure|2|||
148688002|NCT03381248|536330611|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
148688003|NCT03381248|536330612|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
148688004|NCT03381248|536330611|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
149019800|NCT01489020|537550997|FG001|Overall Study|Concomitant disease|0|||
149019801|NCT01489020|537550998|FG002|Overall Study|Concomitant disease|0|||
149019802|NCT01489020|537550999|FG003|Overall Study|Concomitant disease|0|||
148688005|NCT03381248|536330612|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
148688006|NCT03381248|536330611|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
149019803|NCT01489020|537551000|FG004|Overall Study|Concomitant disease|3|||
149019804|NCT01489020|537551001|FG005|Overall Study|Concomitant disease|0|||
148688007|NCT03381248|536330612|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
148688008|NCT05188521|536330613|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
148688009|NCT05188521|536330614|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
148688010|NCT01341639|536330615|FG000|Infant Series|Protocol Violation|1|||
148688011|NCT01341639|536330616|FG001|Infant Series|Protocol Violation|0|||
148688012|NCT01341639|536330615|FG000|Infant Series|Not Vaccinated|0|||
149019805|NCT02485353|537551005|FG000|Overall Study|Death|1|||
148688013|NCT01341639|536330616|FG001|Infant Series|Not Vaccinated|1|||
148688014|NCT01341639|536330615|FG000|Infant Series|Adverse Event|0|||
148688015|NCT01341639|536330616|FG001|Infant Series|Adverse Event|5|||
148688016|NCT01341639|536330615|FG000|Infant Series|Withdrawal by Subject|11|||
148688017|NCT01341639|536330616|FG001|Infant Series|Withdrawal by Subject|8|||
148688018|NCT01341639|536330615|FG000|Infant Series|Lost to Follow-up|0|||
148688019|NCT01341639|536330616|FG001|Infant Series|Lost to Follow-up|2|||
148688020|NCT01341639|536330615|FG000|Infant Series|Site 0048 Participants|17|||
148688021|NCT01341639|536330616|FG001|Infant Series|Site 0048 Participants|16|||
148688022|NCT01341639|536330615|FG000|Interim Period|Withdrawal by Subject|6|||
148688023|NCT01341639|536330616|FG001|Interim Period|Withdrawal by Subject|7|||
148688024|NCT01341639|536330615|FG000|Interim Period|Lost to Follow-up|2|||
148688025|NCT01341639|536330616|FG001|Interim Period|Lost to Follow-up|0|||
148688026|NCT01341639|536330615|FG000|Interim Period|Physician Decision|0|||
148688027|NCT01341639|536330616|FG001|Interim Period|Physician Decision|1|||
148688028|NCT01341639|536330615|FG000|Interim Period|Protocol Violation|0|||
148688029|NCT01341639|536330616|FG001|Interim Period|Protocol Violation|1|||
148688030|NCT01341639|536330615|FG000|Post-Treatment|Withdrawal by Subject|0|||
148688031|NCT01341639|536330616|FG001|Post-Treatment|Withdrawal by Subject|1|||
148688032|NCT01341639|536330615|FG000|Post-Treatment|Adverse Event|0|||
148688033|NCT01341639|536330616|FG001|Post-Treatment|Adverse Event|2|||
148688034|NCT04582266|536330617|FG000|Overall Study|Lost to Follow-up|7|||
148688035|NCT04582266|536330618|FG001|Overall Study|Lost to Follow-up|5|||
148688036|NCT04582266|536330617|FG000|Overall Study|Withdrawal by Subject|1|||
148688037|NCT04582266|536330618|FG001|Overall Study|Withdrawal by Subject|0|||
148954143|NCT00142584|537314685|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
148688038|NCT04582266|536330617|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
148688039|NCT04582266|536330618|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
148688040|NCT01379781|536330622|FG000|Overall Study|Lost to Follow-up|11|||
148688041|NCT01379781|536330623|FG001|Overall Study|Lost to Follow-up|8|||
148688042|NCT02247479|536330624|FG000|Overall Study|Adverse Event|8|||
148688043|NCT02247479|536330625|FG001|Overall Study|Adverse Event|9|||
148688044|NCT02247479|536330626|FG002|Overall Study|Adverse Event|8|||
148688045|NCT02247479|536330624|FG000|Overall Study|Death|5|||
148688046|NCT02247479|536330625|FG001|Overall Study|Death|4|||
148688047|NCT02247479|536330626|FG002|Overall Study|Death|6|||
148688048|NCT02247479|536330624|FG000|Overall Study|Lost to Follow-up|3|||
148688049|NCT02247479|536330625|FG001|Overall Study|Lost to Follow-up|3|||
148688050|NCT02247479|536330626|FG002|Overall Study|Lost to Follow-up|1|||
148688051|NCT02247479|536330624|FG000|Overall Study|Non-compliance|0|||
148688052|NCT02247479|536330625|FG001|Overall Study|Non-compliance|0|||
148954144|NCT00142584|537314684|FG000|Overall Study|Withdrawal by Subject|30|||
148954145|NCT00142584|537314685|FG001|Overall Study|Withdrawal by Subject|16|||
148954146|NCT00142584|537314684|FG000|Overall Study|Lost to Follow-up|22|||
148954147|NCT00142584|537314685|FG001|Overall Study|Lost to Follow-up|12|||
148954148|NCT00142584|537314684|FG000|Overall Study|Adverse Event|14|||
148954149|NCT00142584|537314685|FG001|Overall Study|Adverse Event|5|||
148954150|NCT00142584|537314684|FG000|Overall Study|Protocol Violation|4|||
148954151|NCT00142584|537314685|FG001|Overall Study|Protocol Violation|7|||
148954152|NCT00142584|537314684|FG000|Overall Study|Treatment Failure|2|||
148954153|NCT00142584|537314685|FG001|Overall Study|Treatment Failure|0|||
148954154|NCT02709785|537314686|FG000|Overall Study|Withdrawal by Subject|1|||
148954155|NCT02709785|537314687|FG001|Overall Study|Withdrawal by Subject|2|||
148954156|NCT02709785|537314688|FG002|Overall Study|Withdrawal by Subject|1|||
148954157|NCT01961323|537314689|FG000|Overall Study|Withdrawal by Subject|7|||
148954158|NCT01961323|537314689|FG000|Overall Study|Lost to Follow-up|8|||
148954159|NCT01961323|537314689|FG000|Overall Study|screen failure|34|||
148954160|NCT01156311|537314693|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
148954161|NCT01156311|537314694|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
148954162|NCT01156311|537314695|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
148954163|NCT01156311|537314696|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
148954164|NCT01156311|537314693|FG000|2-Month Monotherapy Period|Physician Decision|0|||
148954165|NCT01156311|537314694|FG001|2-Month Monotherapy Period|Physician Decision|1|||
148954166|NCT01156311|537314695|FG002|2-Month Monotherapy Period|Physician Decision|0|||
148954167|NCT01156311|537314696|FG003|2-Month Monotherapy Period|Physician Decision|0|||
148954168|NCT01156311|537314693|FG000|2-Month Monotherapy Period|Other|1|||
148954169|NCT01156311|537314694|FG001|2-Month Monotherapy Period|Other|0|||
148688053|NCT02247479|536330626|FG002|Overall Study|Non-compliance|1|||
148688054|NCT02247479|536330624|FG000|Overall Study|Withdrawal by Subject|25|||
148688055|NCT02247479|536330625|FG001|Overall Study|Withdrawal by Subject|29|||
148688056|NCT02247479|536330626|FG002|Overall Study|Withdrawal by Subject|24|||
148688057|NCT02247479|536330624|FG000|Overall Study|Study Terminated by Sponsor|98|||
148688058|NCT02247479|536330625|FG001|Overall Study|Study Terminated by Sponsor|88|||
148954170|NCT01156311|537314695|FG002|2-Month Monotherapy Period|Other|0|||
148954171|NCT01156311|537314696|FG003|2-Month Monotherapy Period|Other|0|||
148954172|NCT01156311|537314693|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
148954173|NCT01156311|537314694|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
149019806|NCT02485353|537551005|FG000|Overall Study|Disease Progression|1|||
149019807|NCT02086552|537551006|FG000|Overall Study|Withdrawal by Subject|1|||
149019808|NCT04102540|537551010|FG000|Overall Study|Withdrawn by PI|2|||
149019809|NCT04102540|537551010|FG000|Overall Study|Lost to Follow-up|6|||
149019810|NCT01567163|537551013|FG000|Overall Study|Progressive Disease|2|||
149019811|NCT01567163|537551013|FG000|Overall Study|Lost to Follow-up|2|||
149019812|NCT03405662|537551014|FG000|Overall Study|COVID-19 restriction|1|||
149225279|NCT04450394|538290291|FG001|Overall Study|Protocol Violation|0|||
149225280|NCT04450394|538290292|FG002|Overall Study|Protocol Violation|0|||
149225281|NCT04450394|538290290|FG000|Overall Study|Withdrawal by Subject|6|||
149225282|NCT04450394|538290291|FG001|Overall Study|Withdrawal by Subject|9|||
149225283|NCT04450394|538290292|FG002|Overall Study|Withdrawal by Subject|0|||
149225284|NCT03812224|538290302|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
149225285|NCT03812224|538290303|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149225286|NCT03812224|538290302|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
149225287|NCT03812224|538290303|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
149225288|NCT03812224|538290302|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
149225289|NCT03812224|538290303|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
149225290|NCT03812224|538290302|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
149225291|NCT03812224|538290303|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
149225292|NCT00303719|538290304|FG000|Overall Study|Not evaluable, prior therapies|0|||
149225293|NCT00303719|538290305|FG001|Overall Study|Not evaluable, prior therapies|30|||
149225294|NCT00303719|538290304|FG000|Overall Study|Lost to Follow-up|0|||
149225295|NCT00303719|538290305|FG001|Overall Study|Lost to Follow-up|7|||
149225296|NCT01641952|538290306|FG000|Overall Study|Lost to Follow-up|28|||
149225297|NCT01641952|538290306|FG000|Overall Study|Adverse Event|6|||
149225298|NCT03633461|538290324|FG000|Overall Study|Lost to Follow-up|0|||
149225299|NCT03633461|538290325|FG001|Overall Study|Lost to Follow-up|1|||
149225300|NCT02516605|538290332|FG000|Overall Study|Protocol Violation|0|||
149225301|NCT02516605|538290333|FG001|Overall Study|Protocol Violation|0|||
149225302|NCT02516605|538290334|FG002|Overall Study|Protocol Violation|0|||
149225303|NCT02516605|538290335|FG003|Overall Study|Protocol Violation|0|||
149225304|NCT02516605|538290336|FG004|Overall Study|Protocol Violation|1|||
149225305|NCT02516605|538290332|FG000|Overall Study|Withdrawal by Subject|0|||
149225306|NCT02516605|538290333|FG001|Overall Study|Withdrawal by Subject|0|||
149225307|NCT02516605|538290334|FG002|Overall Study|Withdrawal by Subject|0|||
149225308|NCT02516605|538290335|FG003|Overall Study|Withdrawal by Subject|1|||
149225309|NCT02516605|538290336|FG004|Overall Study|Withdrawal by Subject|0|||
149225310|NCT02643420|538290337|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
149225311|NCT02643420|538290338|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
149225312|NCT02643420|538290337|FG000|Overall Study|Withdrawal by Subject|25|||
149225313|NCT02643420|538290338|FG001|Overall Study|Withdrawal by Subject|19|||
149225314|NCT02643420|538290337|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
149225315|NCT02643420|538290338|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
149225316|NCT02643420|538290337|FG000|Overall Study|Lost to Follow-up|6|||
149225317|NCT02643420|538290338|FG001|Overall Study|Lost to Follow-up|10|||
149225318|NCT02643420|538290337|FG000|Overall Study|Investigator Decision|2|||
149225319|NCT02643420|538290338|FG001|Overall Study|Investigator Decision|4|||
149225320|NCT02643420|538290337|FG000|Overall Study|Sponsor decision|1|||
149019813|NCT03405662|537551015|FG001|Overall Study|COVID-19 restriction|0|||
149019814|NCT03405662|537551014|FG000|Overall Study|unblinding|0|||
149019815|NCT03405662|537551015|FG001|Overall Study|unblinding|1|||
149019816|NCT03405662|537551014|FG000|Overall Study|placement in memory care facility|0|||
149019817|NCT03405662|537551015|FG001|Overall Study|placement in memory care facility|2|||
149019818|NCT00280293|537551016|FG000|Overall Study|Protocol Violation|3|||
149019819|NCT00280293|537551017|FG001|Overall Study|Protocol Violation|0|||
149019820|NCT00280293|537551016|FG000|Overall Study|Physician Decision|5|||
149019821|NCT00280293|537551017|FG001|Overall Study|Physician Decision|4|||
149019822|NCT00280293|537551016|FG000|Overall Study|Lost to Follow-up|14|||
149019823|NCT00280293|537551017|FG001|Overall Study|Lost to Follow-up|12|||
149019824|NCT00280293|537551016|FG000|Overall Study|Withdrawal by Subject|3|||
149019825|NCT00280293|537551017|FG001|Overall Study|Withdrawal by Subject|5|||
149019826|NCT00280293|537551016|FG000|Overall Study|Incarceration/Legal Reasons|1|||
149019827|NCT00280293|537551017|FG001|Overall Study|Incarceration/Legal Reasons|1|||
149225321|NCT02643420|538290338|FG001|Overall Study|Sponsor decision|1|||
149225322|NCT02643420|538290337|FG000|Overall Study|Death|0|||
149225323|NCT02643420|538290338|FG001|Overall Study|Death|2|||
149225324|NCT02643420|538290337|FG000|Overall Study|Reason not Specified|8|||
149225325|NCT02643420|538290338|FG001|Overall Study|Reason not Specified|7|||
149225326|NCT02127970|538290339|FG000|Overall Study|Adverse Event|2|||
149225327|NCT02127970|538290340|FG001|Overall Study|Adverse Event|1|||
149225328|NCT02127970|538290339|FG000|Overall Study|Death|1|||
149225329|NCT02127970|538290340|FG001|Overall Study|Death|1|||
149225330|NCT02127970|538290339|FG000|Overall Study|Lost to Follow-up|14|||
149225331|NCT02127970|538290340|FG001|Overall Study|Lost to Follow-up|14|||
149225332|NCT02127970|538290339|FG000|Overall Study|Reason not Specified|4|||
149225333|NCT02127970|538290340|FG001|Overall Study|Reason not Specified|7|||
149225334|NCT02127970|538290339|FG000|Overall Study|Pregnancy|0|||
149225335|NCT02127970|538290340|FG001|Overall Study|Pregnancy|1|||
149225336|NCT02127970|538290339|FG000|Overall Study|Subject Withdrew Consent|5|||
149225337|NCT02127970|538290340|FG001|Overall Study|Subject Withdrew Consent|3|||
149225338|NCT01710709|538290341|FG000|Overall Study|Lost to Follow-up|29|||
149225339|NCT01710709|538290341|FG000|Overall Study|Adverse Event|48|||
149225340|NCT01710709|538290341|FG000|Overall Study|Participant met withdrawal criteria|33|||
149225341|NCT01710709|538290341|FG000|Overall Study|Participant withdrawn by investigator|2|||
149225342|NCT01710709|538290341|FG000|Overall Study|Withdrawal by Subject|53|||
149225343|NCT01710709|538290341|FG000|Overall Study|Protocol Violation|5|||
149225344|NCT01710709|538290341|FG000|Overall Study|Lack of Efficacy|3|||
149225345|NCT00542321|538290343|FG000|Overall Study|Death|0|||
149225346|NCT00542321|538290344|FG001|Overall Study|Death|1|||
149225347|NCT02988115|538290351|FG000|Overall Study|Adverse Event|6|||
149019828|NCT00280293|537551016|FG000|Overall Study|Adverse Event|0|||
149019829|NCT00280293|537551017|FG001|Overall Study|Adverse Event|1|||
149019830|NCT01348854|537551020|FG000|Overall Study|Lost to Follow-up|2|||
149019831|NCT01348854|537551021|FG001|Overall Study|Lost to Follow-up|1|||
149019832|NCT01348854|537551020|FG000|Overall Study|Withdrawal by Subject|1|||
149019833|NCT01348854|537551021|FG001|Overall Study|Withdrawal by Subject|0|||
149019834|NCT01720797|537551022|FG000|Overall Study|Withdrawal by Subject|3|||
149019835|NCT01720797|537551023|FG001|Overall Study|Withdrawal by Subject|0|||
149019836|NCT00983619|537551026|FG000|Overall Study|Lost to Follow-up|0|||
149019837|NCT00983619|537551027|FG001|Overall Study|Lost to Follow-up|1|||
149019838|NCT00983619|537551028|FG002|Overall Study|Lost to Follow-up|0|||
149019839|NCT00983619|537551029|FG003|Overall Study|Lost to Follow-up|0|||
149019840|NCT00983619|537551030|FG004|Overall Study|Lost to Follow-up|0|||
149019841|NCT00983619|537551031|FG005|Overall Study|Lost to Follow-up|2|||
149019842|NCT00983619|537551032|FG006|Overall Study|Lost to Follow-up|0|||
149019843|NCT00983619|537551033|FG007|Overall Study|Lost to Follow-up|0|||
149019844|NCT00983619|537551034|FG008|Overall Study|Lost to Follow-up|0|||
149019845|NCT00983619|537551035|FG009|Overall Study|Lost to Follow-up|0|||
149225348|NCT02988115|538290352|FG001|Overall Study|Adverse Event|1|||
149225349|NCT02988115|538290351|FG000|Overall Study|Sponsor Decision|5|||
149225350|NCT02988115|538290352|FG001|Overall Study|Sponsor Decision|2|||
149225351|NCT02988115|538290351|FG000|Overall Study|Withdrawal by Subject|1|||
149225352|NCT02988115|538290352|FG001|Overall Study|Withdrawal by Subject|1|||
148688059|NCT02247479|536330626|FG002|Overall Study|Study Terminated by Sponsor|94|||
148688060|NCT02247479|536330624|FG000|Overall Study|Physician Decision|1|||
148688061|NCT02247479|536330625|FG001|Overall Study|Physician Decision|0|||
148688062|NCT02247479|536330626|FG002|Overall Study|Physician Decision|2|||
149225353|NCT02988115|538290351|FG000|Overall Study|Withdrawn by Mistake|1|||
148688063|NCT02247479|536330624|FG000|Overall Study|Unspecified Reason|2|||
149019846|NCT00983619|537551036|FG010|Overall Study|Lost to Follow-up|0|||
149019847|NCT00983619|537551037|FG011|Overall Study|Lost to Follow-up|2|||
149019848|NCT00983619|537551026|FG000|Overall Study|Withdrawal by Subject|2|||
149019849|NCT00983619|537551027|FG001|Overall Study|Withdrawal by Subject|1|||
149019850|NCT00983619|537551028|FG002|Overall Study|Withdrawal by Subject|1|||
149225354|NCT02988115|538290352|FG001|Overall Study|Withdrawn by Mistake|0|||
149225355|NCT02988115|538290351|FG000|Overall Study|Lost to Follow-up|1|||
149225356|NCT02988115|538290352|FG001|Overall Study|Lost to Follow-up|0|||
149225357|NCT01731951|538290353|FG000|Overall Study|Documented Disease Progression|1|||
149225358|NCT01731951|538290354|FG001|Overall Study|Documented Disease Progression|0|||
149225359|NCT01731951|538290355|FG002|Overall Study|Documented Disease Progression|0|||
149225360|NCT01731951|538290356|FG003|Overall Study|Documented Disease Progression|0|||
149225361|NCT01731951|538290357|FG004|Overall Study|Documented Disease Progression|0|||
149225362|NCT01731951|538290358|FG005|Overall Study|Documented Disease Progression|0|||
149225363|NCT01731951|538290353|FG000|Overall Study|Lost to Follow-up|2|||
149225364|NCT01731951|538290354|FG001|Overall Study|Lost to Follow-up|0|||
149225365|NCT01731951|538290355|FG002|Overall Study|Lost to Follow-up|0|||
149225366|NCT01731951|538290356|FG003|Overall Study|Lost to Follow-up|1|||
149225367|NCT01731951|538290357|FG004|Overall Study|Lost to Follow-up|3|||
149225368|NCT01731951|538290358|FG005|Overall Study|Lost to Follow-up|1|||
149225369|NCT01731951|538290353|FG000|Overall Study|Withdrawal of Consent|1|||
149225370|NCT01731951|538290354|FG001|Overall Study|Withdrawal of Consent|0|||
149225371|NCT01731951|538290355|FG002|Overall Study|Withdrawal of Consent|0|||
149225372|NCT01731951|538290356|FG003|Overall Study|Withdrawal of Consent|0|||
149225373|NCT01731951|538290357|FG004|Overall Study|Withdrawal of Consent|0|||
149225374|NCT01731951|538290358|FG005|Overall Study|Withdrawal of Consent|2|||
149225375|NCT01731951|538290353|FG000|Overall Study|Death|13|||
149225376|NCT01731951|538290354|FG001|Overall Study|Death|15|||
149225377|NCT01731951|538290355|FG002|Overall Study|Death|9|||
149225378|NCT01731951|538290356|FG003|Overall Study|Death|8|||
149225379|NCT01731951|538290357|FG004|Overall Study|Death|9|||
149225380|NCT01731951|538290358|FG005|Overall Study|Death|6|||
149225381|NCT00253747|538290359|FG000|Overall Study|Lost to Follow-up|13|||
149225382|NCT00253747|538290360|FG001|Overall Study|Lost to Follow-up|14|||
149225383|NCT00253747|538290359|FG000|Overall Study|Withdrawal by Subject|10|||
149225384|NCT00253747|538290360|FG001|Overall Study|Withdrawal by Subject|11|||
149225385|NCT00253747|538290359|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
149225386|NCT00253747|538290360|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
149225387|NCT00104299|538290361|FG000|Overall Study|Adverse Event|3|||
149225388|NCT00104299|538290362|FG001|Overall Study|Adverse Event|1|||
149225389|NCT00104299|538290361|FG000|Overall Study|Death|2|||
149225390|NCT00104299|538290362|FG001|Overall Study|Death|2|||
149225391|NCT00104299|538290361|FG000|Overall Study|Withdrawal by Subject|2|||
149225392|NCT00104299|538290362|FG001|Overall Study|Withdrawal by Subject|6|||
149225393|NCT00104299|538290361|FG000|Overall Study|Physician Decision|1|||
149225394|NCT00104299|538290362|FG001|Overall Study|Physician Decision|1|||
149225395|NCT00104299|538290361|FG000|Overall Study|To have renal transplant|1|||
149225396|NCT00104299|538290362|FG001|Overall Study|To have renal transplant|0|||
149225397|NCT02452034|538290363|FG000|Overall Study|Adverse Event|0|||
149225398|NCT02452034|538290364|FG001|Overall Study|Adverse Event|0|||
149225399|NCT02452034|538290365|FG002|Overall Study|Adverse Event|0|||
149225400|NCT02452034|538290366|FG003|Overall Study|Adverse Event|0|||
149225401|NCT02452034|538290367|FG004|Overall Study|Adverse Event|0|||
149225402|NCT02452034|538290368|FG005|Overall Study|Adverse Event|1|||
149225403|NCT02452034|538290363|FG000|Overall Study|Death|0|||
149225404|NCT02452034|538290364|FG001|Overall Study|Death|0|||
149225405|NCT02452034|538290365|FG002|Overall Study|Death|0|||
149225406|NCT02452034|538290366|FG003|Overall Study|Death|0|||
149225407|NCT02452034|538290367|FG004|Overall Study|Death|1|||
149225408|NCT02452034|538290368|FG005|Overall Study|Death|1|||
149225409|NCT02452034|538290363|FG000|Overall Study|Physician Decision|0|||
149225410|NCT02452034|538290364|FG001|Overall Study|Physician Decision|1|||
149225411|NCT02452034|538290365|FG002|Overall Study|Physician Decision|1|||
149225412|NCT02452034|538290366|FG003|Overall Study|Physician Decision|0|||
149225413|NCT02452034|538290367|FG004|Overall Study|Physician Decision|0|||
149225414|NCT02452034|538290368|FG005|Overall Study|Physician Decision|0|||
149225415|NCT02452034|538290363|FG000|Overall Study|Protocol Violation|0|||
149225416|NCT02452034|538290364|FG001|Overall Study|Protocol Violation|0|||
149225417|NCT02452034|538290365|FG002|Overall Study|Protocol Violation|0|||
149225418|NCT02452034|538290366|FG003|Overall Study|Protocol Violation|0|||
149225419|NCT02452034|538290367|FG004|Overall Study|Protocol Violation|0|||
149225420|NCT02452034|538290368|FG005|Overall Study|Protocol Violation|1|||
149225421|NCT02452034|538290363|FG000|Overall Study|Screen Failure|1|||
149225422|NCT02452034|538290364|FG001|Overall Study|Screen Failure|0|||
149225423|NCT02452034|538290365|FG002|Overall Study|Screen Failure|0|||
149225424|NCT02452034|538290366|FG003|Overall Study|Screen Failure|1|||
149225425|NCT02452034|538290367|FG004|Overall Study|Screen Failure|0|||
149225426|NCT02452034|538290368|FG005|Overall Study|Screen Failure|0|||
149225427|NCT02452034|538290363|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
149225428|NCT02452034|538290364|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
149225429|NCT02452034|538290365|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
149225430|NCT02452034|538290366|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
149225431|NCT02452034|538290367|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
149225432|NCT02452034|538290368|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
149225433|NCT01716585|538290369|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
149225434|NCT01716585|538290370|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
149225435|NCT01716585|538290369|FG000|Double-blind Treatment|Adverse Event|2|||
149019851|NCT00983619|537551029|FG003|Overall Study|Withdrawal by Subject|3|||
149019852|NCT00983619|537551030|FG004|Overall Study|Withdrawal by Subject|1|||
149019853|NCT00983619|537551031|FG005|Overall Study|Withdrawal by Subject|23|||
149019854|NCT00983619|537551032|FG006|Overall Study|Withdrawal by Subject|0|||
149019855|NCT00983619|537551033|FG007|Overall Study|Withdrawal by Subject|0|||
149019856|NCT00983619|537551034|FG008|Overall Study|Withdrawal by Subject|0|||
149019857|NCT00983619|537551035|FG009|Overall Study|Withdrawal by Subject|0|||
149019858|NCT00983619|537551036|FG010|Overall Study|Withdrawal by Subject|1|||
149019859|NCT00983619|537551037|FG011|Overall Study|Withdrawal by Subject|1|||
149019860|NCT00983619|537551026|FG000|Overall Study|Death|0|||
149019861|NCT00983619|537551027|FG001|Overall Study|Death|2|||
149019862|NCT00983619|537551028|FG002|Overall Study|Death|2|||
149019863|NCT00983619|537551029|FG003|Overall Study|Death|1|||
149019864|NCT00983619|537551030|FG004|Overall Study|Death|2|||
149019865|NCT00983619|537551031|FG005|Overall Study|Death|30|||
149019866|NCT00983619|537551032|FG006|Overall Study|Death|1|||
149019867|NCT00983619|537551033|FG007|Overall Study|Death|0|||
149019868|NCT00983619|537551034|FG008|Overall Study|Death|1|||
149019869|NCT00983619|537551035|FG009|Overall Study|Death|2|||
149019870|NCT00983619|537551036|FG010|Overall Study|Death|9|||
149019871|NCT00983619|537551037|FG011|Overall Study|Death|8|||
149019872|NCT00983619|537551026|FG000|Overall Study|Other|1|||
149019873|NCT00983619|537551027|FG001|Overall Study|Other|0|||
149019874|NCT00983619|537551028|FG002|Overall Study|Other|0|||
149019875|NCT00983619|537551029|FG003|Overall Study|Other|1|||
149019876|NCT00983619|537551030|FG004|Overall Study|Other|0|||
149019877|NCT00983619|537551031|FG005|Overall Study|Other|12|||
149019878|NCT00983619|537551032|FG006|Overall Study|Other|2|||
149019879|NCT00983619|537551033|FG007|Overall Study|Other|2|||
149019880|NCT00983619|537551034|FG008|Overall Study|Other|0|||
149019881|NCT00983619|537551035|FG009|Overall Study|Other|1|||
149019882|NCT00983619|537551036|FG010|Overall Study|Other|1|||
149019883|NCT00983619|537551037|FG011|Overall Study|Other|0|||
149019884|NCT00724061|537551038|FG000|Dose Escalation Phase|Adverse Event|2|||
149225436|NCT01716585|538290370|FG001|Double-blind Treatment|Adverse Event|1|||
149225437|NCT01716585|538290369|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
149225438|NCT01716585|538290370|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
149225439|NCT01716585|538290369|FG000|Double-blind Treatment|Lost to Follow-up|2|||
149225440|NCT01716585|538290370|FG001|Double-blind Treatment|Lost to Follow-up|0|||
149225441|NCT01716585|538290369|FG000|Double-blind Treatment|Subject Noncompliant|1|||
149225442|NCT01716585|538290370|FG001|Double-blind Treatment|Subject Noncompliant|0|||
149225443|NCT01716585|538290369|FG000|Double-blind Treatment|Other|1|||
149225444|NCT01716585|538290370|FG001|Double-blind Treatment|Other|0|||
149225445|NCT01716585|538290369|FG000|Open-label Treatment|Adverse Event|0|||
149225446|NCT01716585|538290370|FG001|Open-label Treatment|Adverse Event|2|||
149225447|NCT01716585|538290369|FG000|Open-label Treatment|Virologic Failure|0|||
149225448|NCT01716585|538290370|FG001|Open-label Treatment|Virologic Failure|2|||
149225449|NCT01716585|538290369|FG000|Open-label Treatment|Withdrawal by Subject|0|||
149225450|NCT01716585|538290370|FG001|Open-label Treatment|Withdrawal by Subject|3|||
149225451|NCT05102734|538290372|FG000|Overall Study|Did not require vasopressors|1|||
149225452|NCT05102734|538290373|FG001|Overall Study|Did not require vasopressors|0|||
149225453|NCT05102734|538290372|FG000|Overall Study|Did not have functioning PA catheter|1|||
149225454|NCT05102734|538290373|FG001|Overall Study|Did not have functioning PA catheter|0|||
149225455|NCT05102734|538290372|FG000|Overall Study|Inadequate video quality|2|||
149225456|NCT05102734|538290373|FG001|Overall Study|Inadequate video quality|0|||
149225457|NCT03288987|538290374|FG000|Overall Study|Protocol Violation|10|||
149225458|NCT03288987|538290375|FG001|Overall Study|Protocol Violation|4|||
149225459|NCT00125138|538290381|FG000|Overall Study|Adverse Event|1|||
149225460|NCT00125138|538290382|FG001|Overall Study|Adverse Event|0|||
149225461|NCT00125138|538290383|FG002|Overall Study|Adverse Event|3|||
149225462|NCT00125138|538290384|FG003|Overall Study|Adverse Event|2|||
149225463|NCT00125138|538290381|FG000|Overall Study|Withdrawal by Subject|2|||
149225464|NCT00125138|538290382|FG001|Overall Study|Withdrawal by Subject|3|||
149019885|NCT00724061|537551038|FG000|Dose Escalation Phase|Disease Progression|3|||
149019886|NCT04827134|537551039|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
149019887|NCT04827134|537551040|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
149019888|NCT04827134|537551041|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
149019889|NCT04827134|537551042|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
149019890|NCT02443103|537551047|FG000|Overall Study|Adverse Event|2|||
149019891|NCT02443103|537551047|FG000|Overall Study|Noncompliance|1|||
149019892|NCT03358329|537551048|FG000|Overall Study|Lost to Follow-up|2|||
149019893|NCT03358329|537551048|FG000|Overall Study|Withdrawal by Subject|2|||
149225465|NCT00125138|538290383|FG002|Overall Study|Withdrawal by Subject|1|||
149225466|NCT00125138|538290384|FG003|Overall Study|Withdrawal by Subject|1|||
149225467|NCT00125138|538290381|FG000|Overall Study|Lack of Efficacy|0|||
149225468|NCT00125138|538290382|FG001|Overall Study|Lack of Efficacy|0|||
149225469|NCT00125138|538290383|FG002|Overall Study|Lack of Efficacy|0|||
149225470|NCT00125138|538290384|FG003|Overall Study|Lack of Efficacy|1|||
149225471|NCT00125138|538290381|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
149225472|NCT00125138|538290382|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
149225473|NCT00125138|538290383|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
149225474|NCT00125138|538290384|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
149225475|NCT02630459|538290385|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149225476|NCT02630459|538290386|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
149225477|NCT02630459|538290387|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149225478|NCT02630459|538290388|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
149225479|NCT02630459|538290389|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149225480|NCT02630459|538290390|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149225481|NCT02630459|538290391|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149225482|NCT02630459|538290392|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
149225483|NCT02630459|538290385|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149225484|NCT02630459|538290386|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149225485|NCT02630459|538290387|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
149225486|NCT02630459|538290388|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149225487|NCT02630459|538290389|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149225488|NCT02630459|538290390|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149225489|NCT02630459|538290391|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149225490|NCT02630459|538290392|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
149019894|NCT02982720|537551049|FG000|Overall Study|Adverse Event|3|||
149225491|NCT02630459|538290385|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
149225492|NCT02630459|538290386|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
149225493|NCT02630459|538290387|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
149225494|NCT02630459|538290388|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
149225495|NCT02630459|538290389|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149225496|NCT02630459|538290390|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149225497|NCT02630459|538290391|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149225498|NCT02630459|538290392|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
149225499|NCT02630459|538290385|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
149225500|NCT02630459|538290386|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225501|NCT02630459|538290387|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225502|NCT02630459|538290388|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225503|NCT02630459|538290389|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225504|NCT02630459|538290390|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225505|NCT02630459|538290391|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225506|NCT02630459|538290392|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
149225507|NCT02630459|538290385|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149225508|NCT02630459|538290386|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149225509|NCT02630459|538290387|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149225510|NCT02630459|538290388|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149225511|NCT02630459|538290389|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
149225512|NCT02630459|538290390|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
149225513|NCT02630459|538290391|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149225514|NCT02630459|538290392|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
149225515|NCT02630459|538290385|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149225516|NCT02630459|538290386|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149225517|NCT02630459|538290387|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149225518|NCT02630459|538290388|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149225519|NCT02630459|538290389|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
149225520|NCT02630459|538290390|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
149019895|NCT02982720|537551049|FG000|Overall Study|Death|1|||
149019896|NCT03875911|537551052|FG000|Overall Study|Lost to Follow-up|3|||
149225521|NCT02630459|538290391|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149225522|NCT02630459|538290392|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
149225523|NCT02630459|538290385|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149225524|NCT02630459|538290386|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149225525|NCT02630459|538290387|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149225526|NCT02630459|538290388|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149225527|NCT02630459|538290389|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
149225528|NCT02630459|538290390|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149019897|NCT03875911|537551053|FG001|Overall Study|Lost to Follow-up|6|||
149019898|NCT03875911|537551054|FG002|Overall Study|Lost to Follow-up|2|||
149019899|NCT03875911|537551052|FG000|Overall Study|Surgery cancelled|1|||
149019900|NCT03875911|537551053|FG001|Overall Study|Surgery cancelled|0|||
149225529|NCT02630459|538290391|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149225530|NCT02630459|538290392|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
149225531|NCT00348686|538290393|FG000|Overall Study|Withdrawal by Subject|45|||
149225532|NCT00348686|538290393|FG000|Overall Study|Adverse Event|5|||
149225533|NCT00348686|538290393|FG000|Overall Study|Protocol Violation|6|||
149225534|NCT00348686|538290393|FG000|Overall Study|Lost to Follow-up|2|||
149225535|NCT00348686|538290393|FG000|Overall Study|Multiple Reasons|8|||
149225536|NCT01258738|538290396|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
149225537|NCT01258738|538290397|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
149225538|NCT01258738|538290396|FG000|Double-blind Period|Withdrawal by Subject|2|||
149225539|NCT01258738|538290397|FG001|Double-blind Period|Withdrawal by Subject|2|||
149225540|NCT01258738|538290396|FG000|Double-blind Period|Protocol Violation|1|||
149225541|NCT01258738|538290397|FG001|Double-blind Period|Protocol Violation|1|||
149225542|NCT01258738|538290396|FG000|Double-blind Period|Adverse Event|3|||
149225543|NCT01258738|538290397|FG001|Double-blind Period|Adverse Event|1|||
149225544|NCT01258738|538290396|FG000|Open-label Period|Did not meet inclusion criteria|0|||
149225545|NCT01258738|538290397|FG001|Open-label Period|Did not meet inclusion criteria|1|||
149225546|NCT01258738|538290396|FG000|Open-label Period|Insufficient clinical response|5|||
149225547|NCT01258738|538290397|FG001|Open-label Period|Insufficient clinical response|3|||
149225548|NCT01258738|538290396|FG000|Open-label Period|Lost to Follow-up|0|||
149225549|NCT01258738|538290397|FG001|Open-label Period|Lost to Follow-up|2|||
149225550|NCT01258738|538290396|FG000|Open-label Period|Withdrawal by Subject|5|||
149225551|NCT01258738|538290397|FG001|Open-label Period|Withdrawal by Subject|6|||
149225552|NCT01258738|538290396|FG000|Open-label Period|Protocol Violation|2|||
149225553|NCT01258738|538290397|FG001|Open-label Period|Protocol Violation|2|||
149225554|NCT01258738|538290396|FG000|Open-label Period|Adverse Event|4|||
149225555|NCT01258738|538290397|FG001|Open-label Period|Adverse Event|5|||
149225556|NCT01258738|538290396|FG000|Open-label Period|Other Reasons|0|||
149225557|NCT01258738|538290397|FG001|Open-label Period|Other Reasons|1|||
149225558|NCT01258738|538290396|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
149225559|NCT01258738|538290397|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
149225560|NCT00313716|538292869|FG000|Overall Study|Death|3|||
148954174|NCT01156311|537314695|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
148954175|NCT01156311|537314696|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
148954176|NCT01156311|537314693|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
148954177|NCT01156311|537314694|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
148954178|NCT01156311|537314695|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
148954179|NCT01156311|537314696|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
148954180|NCT01156311|537314693|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
148954181|NCT01156311|537314694|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
148954182|NCT01156311|537314695|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
148954183|NCT01156311|537314696|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
148954184|NCT01156311|537314693|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
148954185|NCT01156311|537314694|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
148954186|NCT01156311|537314695|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
148954187|NCT01156311|537314696|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
148954188|NCT01156311|537314693|FG000|6-month Add-on Therapy Period|Other|0|||
148954189|NCT01156311|537314694|FG001|6-month Add-on Therapy Period|Other|0|||
148954190|NCT01156311|537314695|FG002|6-month Add-on Therapy Period|Other|1|||
148954191|NCT01156311|537314696|FG003|6-month Add-on Therapy Period|Other|2|||
148954192|NCT06133348|537314697|FG000|Overall Study|Death|3|||
148954193|NCT06133348|537314697|FG000|Overall Study|Lost to Follow-up|1|||
148954194|NCT06133348|537314697|FG000|Overall Study|Physician Decision|1|||
148954195|NCT06133348|537314697|FG000|Overall Study|Withdrawal by Subject|5|||
148954196|NCT00514540|537314712|FG000|First-Line Chemo|Withdrawal by Subject|1|||
148954197|NCT00514540|537314712|FG000|First-Line Chemo|Protocol Violation|7|||
148954198|NCT00514540|537314712|FG000|Second-Line|Physician/Patient Decision|31|||
148954199|NCT00533845|537314715|FG000|Overall Study|Physician Decision|1|||
148954200|NCT00533845|537314716|FG001|Overall Study|Physician Decision|0|||
148954201|NCT00563381|537314728|FG000|Overall Study|Adverse Event|264|||
148954202|NCT00563381|537314729|FG001|Overall Study|Adverse Event|292|||
148954203|NCT00563381|537314728|FG000|Overall Study|Protocol Violation|66|||
148954204|NCT00563381|537314729|FG001|Overall Study|Protocol Violation|74|||
148954205|NCT00563381|537314728|FG000|Overall Study|Lost to Follow-up|7|||
148954206|NCT00563381|537314729|FG001|Overall Study|Lost to Follow-up|15|||
148954207|NCT00563381|537314728|FG000|Overall Study|Withdrawal by Subject|192|||
148954208|NCT00563381|537314729|FG001|Overall Study|Withdrawal by Subject|209|||
148954209|NCT00563381|537314728|FG000|Overall Study|Lack of Efficacy|32|||
148954210|NCT00563381|537314729|FG001|Overall Study|Lack of Efficacy|24|||
149225561|NCT00313716|538292870|FG001|Overall Study|Death|2|||
149225562|NCT00313716|538292871|FG002|Overall Study|Death|9|||
149225563|NCT00313716|538292872|FG003|Overall Study|Death|3|||
149225564|NCT00313716|538292873|FG004|Overall Study|Death|5|||
149225565|NCT00313716|538292874|FG005|Overall Study|Death|9|||
149225566|NCT00313716|538292869|FG000|Overall Study|Lost to Follow-up|2|||
149225567|NCT00313716|538292870|FG001|Overall Study|Lost to Follow-up|5|||
149225568|NCT00313716|538292871|FG002|Overall Study|Lost to Follow-up|2|||
149225569|NCT00313716|538292872|FG003|Overall Study|Lost to Follow-up|1|||
149225570|NCT00313716|538292873|FG004|Overall Study|Lost to Follow-up|0|||
149225571|NCT00313716|538292874|FG005|Overall Study|Lost to Follow-up|4|||
149225572|NCT00313716|538292869|FG000|Overall Study|Withdrawal by Subject|0|||
149225573|NCT00313716|538292870|FG001|Overall Study|Withdrawal by Subject|1|||
149225574|NCT00313716|538292871|FG002|Overall Study|Withdrawal by Subject|1|||
149225575|NCT00313716|538292872|FG003|Overall Study|Withdrawal by Subject|0|||
149225576|NCT00313716|538292873|FG004|Overall Study|Withdrawal by Subject|1|||
149225577|NCT00313716|538292874|FG005|Overall Study|Withdrawal by Subject|0|||
149225578|NCT02491463|538292875|FG000|Overall Study|Withdrawal by Subject|1|||
149225579|NCT02491463|538292876|FG001|Overall Study|Withdrawal by Subject|2|||
149225580|NCT02491463|538292877|FG002|Overall Study|Withdrawal by Subject|0|||
149225581|NCT02491463|538292878|FG003|Overall Study|Withdrawal by Subject|0|||
149225582|NCT02491463|538292875|FG000|Overall Study|Migrated/moved from study area|1|||
149225583|NCT02491463|538292876|FG001|Overall Study|Migrated/moved from study area|5|||
149225584|NCT02491463|538292877|FG002|Overall Study|Migrated/moved from study area|1|||
149225585|NCT02491463|538292878|FG003|Overall Study|Migrated/moved from study area|1|||
149225586|NCT02491463|538292875|FG000|Overall Study|Lost to Follow-up|0|||
149225587|NCT02491463|538292876|FG001|Overall Study|Lost to Follow-up|3|||
149225588|NCT02491463|538292877|FG002|Overall Study|Lost to Follow-up|3|||
149225589|NCT02491463|538292878|FG003|Overall Study|Lost to Follow-up|0|||
149225590|NCT01491802|538292879|FG000|Overall Study|Adverse Event|1|||
149225591|NCT01491802|538292880|FG001|Overall Study|Adverse Event|1|||
149225592|NCT01491802|538292879|FG000|Overall Study|Withdrawal by Subject|0|||
149225593|NCT01491802|538292880|FG001|Overall Study|Withdrawal by Subject|1|||
149225594|NCT01864746|538292883|FG000|Overall Study|Disease recurrence|25|||
149225595|NCT01864746|538292884|FG001|Overall Study|Disease recurrence|40|||
149225596|NCT01864746|538292883|FG000|Overall Study|Second primary invasive nonbreast|2|||
149225597|NCT01864746|538292884|FG001|Overall Study|Second primary invasive nonbreast|3|||
149225598|NCT01864746|538292883|FG000|Overall Study|Death|2|||
149225599|NCT01864746|538292884|FG001|Overall Study|Death|1|||
149225600|NCT01864746|538292883|FG000|Overall Study|Adverse Event|33|||
149225601|NCT01864746|538292884|FG001|Overall Study|Adverse Event|5|||
149225602|NCT01864746|538292883|FG000|Overall Study|Withdrawal by Subject|56|||
149225603|NCT01864746|538292884|FG001|Overall Study|Withdrawal by Subject|41|||
149225604|NCT01864746|538292883|FG000|Overall Study|Physician Decision|5|||
149225605|NCT01864746|538292884|FG001|Overall Study|Physician Decision|6|||
149225606|NCT00663208|538292885|FG000|Treatment Period|Lost to Follow-up|0|||
149225607|NCT00663208|538292886|FG001|Treatment Period|Lost to Follow-up|1|||
149225608|NCT00663208|538292887|FG002|Treatment Period|Lost to Follow-up|0|||
149225609|NCT00663208|538292888|FG003|Treatment Period|Lost to Follow-up|0|||
149225610|NCT00663208|538292889|FG004|Treatment Period|Lost to Follow-up|0|||
149225611|NCT00663208|538292890|FG005|Treatment Period|Lost to Follow-up|0|||
149225612|NCT00663208|538292891|FG006|Treatment Period|Lost to Follow-up|0|||
149225613|NCT00663208|538292885|FG000|Follow-up Period|Lost to Follow-up|2|||
149225614|NCT00663208|538292886|FG001|Follow-up Period|Lost to Follow-up|0|||
149225615|NCT00663208|538292887|FG002|Follow-up Period|Lost to Follow-up|3|||
149225616|NCT00663208|538292888|FG003|Follow-up Period|Lost to Follow-up|2|||
149225617|NCT00663208|538292889|FG004|Follow-up Period|Lost to Follow-up|0|||
149225618|NCT00663208|538292890|FG005|Follow-up Period|Lost to Follow-up|0|||
149225619|NCT00663208|538292891|FG006|Follow-up Period|Lost to Follow-up|0|||
149225620|NCT00663208|538292885|FG000|Follow-up Period|Other reason|1|||
149225621|NCT00663208|538292886|FG001|Follow-up Period|Other reason|0|||
149225622|NCT00663208|538292887|FG002|Follow-up Period|Other reason|0|||
149225623|NCT00663208|538292888|FG003|Follow-up Period|Other reason|0|||
149225624|NCT00663208|538292889|FG004|Follow-up Period|Other reason|0|||
149225625|NCT00663208|538292890|FG005|Follow-up Period|Other reason|0|||
149225626|NCT00663208|538292891|FG006|Follow-up Period|Other reason|1|||
149225627|NCT01249404|538292892|FG000|Overall Study|Study treatment not received|0|||
149225628|NCT01249404|538292893|FG001|Overall Study|Study treatment not received|1|||
149225629|NCT01249404|538292894|FG002|Overall Study|Study treatment not received|2|||
149225630|NCT01249404|538292892|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
149225631|NCT01249404|538292893|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
149225632|NCT01249404|538292894|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
149225633|NCT01249404|538292892|FG000|Overall Study|Adverse Event|2|||
149225634|NCT01249404|538292893|FG001|Overall Study|Adverse Event|2|||
149225635|NCT01249404|538292894|FG002|Overall Study|Adverse Event|2|||
149225636|NCT01249404|538292892|FG000|Overall Study|Withdrawal by Subject|2|||
149225637|NCT01249404|538292893|FG001|Overall Study|Withdrawal by Subject|2|||
149225638|NCT01249404|538292894|FG002|Overall Study|Withdrawal by Subject|0|||
149225639|NCT01249404|538292892|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
149225640|NCT01249404|538292893|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
149225641|NCT01249404|538292894|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
149225642|NCT01249404|538292892|FG000|Overall Study|Non compliance to visit schedule|0|||
149225643|NCT01249404|538292893|FG001|Overall Study|Non compliance to visit schedule|1|||
149225644|NCT01249404|538292894|FG002|Overall Study|Non compliance to visit schedule|0|||
149225645|NCT03890731|538292895|FG000|Overall Study|Progressive disease|1|||
149225646|NCT03890731|538292895|FG000|Overall Study|Patient's decision|1|||
149225647|NCT03890731|538292895|FG000|Overall Study|Adverse Event|4|||
149225648|NCT01539720|538292910|FG000|Overall Study|Screen Fail|15|||
149225649|NCT01539720|538292911|FG001|Overall Study|Screen Fail|3|||
149225650|NCT01539720|538292910|FG000|Overall Study|Lost to Follow-up|14|||
149225651|NCT01539720|538292911|FG001|Overall Study|Lost to Follow-up|7|||
149225652|NCT00298766|538292912|FG000|Overall Study|Adverse Event|18|||
149225653|NCT00298766|538292912|FG000|Overall Study|Death|2|||
149225654|NCT00298766|538292912|FG000|Overall Study|Withdrawal by Subject|9|||
149225655|NCT00298766|538292912|FG000|Overall Study|Treatment ongoing|4|||
149225656|NCT00298766|538292912|FG000|Overall Study|Progression of amyloid markers|4|||
149225657|NCT00298766|538292912|FG000|Overall Study|Deterioration in KPS and organ function|1|||
149225658|NCT00298766|538292912|FG000|Overall Study|Subjects overall condition deterioration|4|||
149225659|NCT00298766|538292912|FG000|Overall Study|Other|4|||
149225660|NCT00656136|538292917|FG000|Overall Study|Progressive disease|177|||
149225661|NCT00656136|538292918|FG001|Overall Study|Progressive disease|322|||
149225662|NCT00656136|538292917|FG000|Overall Study|Other Adverse Event|5|||
149225663|NCT00656136|538292918|FG001|Overall Study|Other Adverse Event|51|||
149225664|NCT00656136|538292917|FG000|Overall Study|Protocol Violation|2|||
149225665|NCT00656136|538292918|FG001|Overall Study|Protocol Violation|3|||
149225666|NCT00656136|538292917|FG000|Overall Study|Patient refused to take study medication|7|||
149225667|NCT00656136|538292918|FG001|Overall Study|Patient refused to take study medication|10|||
149225668|NCT00656136|538292917|FG000|Overall Study|Unknown and others|4|||
149225669|NCT00656136|538292918|FG001|Overall Study|Unknown and others|4|||
149225670|NCT02500901|538292919|FG000|Overall Study|Disease ProgressionDD|2|||
149225671|NCT03938857|538292921|FG000|Overall Study|Physician Decision|1|||
149225672|NCT03938857|538292922|FG001|Overall Study|Physician Decision|0|||
149225673|NCT03938857|538292923|FG002|Overall Study|Physician Decision|0|||
149225674|NCT03938857|538292924|FG003|Overall Study|Physician Decision|0|||
149225675|NCT01398176|538292925|FG000|Overall Study|Lost to Follow-up|1|||
149225676|NCT01398176|538292926|FG001|Overall Study|Lost to Follow-up|3|||
149225677|NCT01398176|538292925|FG000|Overall Study|Physician Decision|2|||
149225678|NCT01398176|538292926|FG001|Overall Study|Physician Decision|3|||
149225679|NCT01871870|538292927|FG000|Overall Study|Hardware issues|7|||
149225680|NCT01871870|538292927|FG000|Overall Study|hyperglycemia|2|||
149225681|NCT00490815|538292928|FG000|Overall Study|Adverse Event|2|||
149225682|NCT00490815|538292929|FG001|Overall Study|Adverse Event|3|||
149225683|NCT00490815|538292928|FG000|Overall Study|Withdrawal by Subject|4|||
149225684|NCT00490815|538292929|FG001|Overall Study|Withdrawal by Subject|0|||
149225685|NCT00490815|538292928|FG000|Overall Study|Lost to Follow-up|1|||
149019901|NCT03875911|537551054|FG002|Overall Study|Surgery cancelled|1|||
149019902|NCT03875911|537551052|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
149019903|NCT03875911|537551053|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
149019904|NCT03875911|537551054|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
149019905|NCT03824938|537551059|FG000|Overall Study|Withdrawal by Subject|2|||
149019906|NCT03824938|537551060|FG001|Overall Study|Withdrawal by Subject|1|||
149019907|NCT03824938|537551061|FG002|Overall Study|Withdrawal by Subject|0|||
149019908|NCT03824938|537551062|FG003|Overall Study|Withdrawal by Subject|2|||
149019909|NCT03824938|537551063|FG004|Overall Study|Withdrawal by Subject|0|||
149019910|NCT03824938|537551064|FG005|Overall Study|Withdrawal by Subject|1|||
149019911|NCT03824938|537551059|FG000|Overall Study|Lost to Follow-up|0|||
149019912|NCT03824938|537551060|FG001|Overall Study|Lost to Follow-up|1|||
149225686|NCT00490815|538292929|FG001|Overall Study|Lost to Follow-up|3|||
149225687|NCT00490815|538292928|FG000|Overall Study|Death|1|||
149225688|NCT00490815|538292929|FG001|Overall Study|Death|3|||
149225689|NCT01904760|538292931|FG000|Overall Study|Protocol Violation|1|||
149225690|NCT01904760|538292932|FG001|Overall Study|Protocol Violation|0|||
149225691|NCT00783263|538292933|FG000|Overall Study|Adverse Event|3|||
149225692|NCT00783263|538292934|FG001|Overall Study|Adverse Event|0|||
149225693|NCT00783263|538292935|FG002|Overall Study|Adverse Event|2|||
149225694|NCT00783263|538292936|FG003|Overall Study|Adverse Event|1|||
149225695|NCT00783263|538292933|FG000|Overall Study|Lost to Follow-up|1|||
149225696|NCT00783263|538292934|FG001|Overall Study|Lost to Follow-up|1|||
149225697|NCT00783263|538292935|FG002|Overall Study|Lost to Follow-up|0|||
149225698|NCT00783263|538292936|FG003|Overall Study|Lost to Follow-up|0|||
149019913|NCT03824938|537551061|FG002|Overall Study|Lost to Follow-up|0|||
149019914|NCT03824938|537551062|FG003|Overall Study|Lost to Follow-up|0|||
149225699|NCT00783263|538292933|FG000|Overall Study|Withdrawal by Subject|0|||
149225700|NCT00783263|538292934|FG001|Overall Study|Withdrawal by Subject|1|||
149225701|NCT00783263|538292935|FG002|Overall Study|Withdrawal by Subject|1|||
149225702|NCT00783263|538292936|FG003|Overall Study|Withdrawal by Subject|2|||
149225703|NCT00106626|538292937|FG000|Overall Study|Adverse Event|5|||
149225704|NCT00106626|538292938|FG001|Overall Study|Adverse Event|4|||
149225705|NCT00106626|538292939|FG002|Overall Study|Adverse Event|3|||
149225706|NCT00106626|538292940|FG003|Overall Study|Adverse Event|3|||
149019915|NCT03824938|537551063|FG004|Overall Study|Lost to Follow-up|1|||
149019916|NCT03824938|537551064|FG005|Overall Study|Lost to Follow-up|0|||
149019917|NCT00287469|537551065|FG000|Overall Study|serious adverse event|1|||
149019918|NCT00287469|537551066|FG001|Overall Study|serious adverse event|6|||
149019919|NCT00287469|537551065|FG000|Overall Study|Adverse Event|1|||
149019920|NCT00287469|537551066|FG001|Overall Study|Adverse Event|1|||
149019921|NCT00287469|537551065|FG000|Overall Study|moved from area|144|||
149019922|NCT00287469|537551066|FG001|Overall Study|moved from area|138|||
149019923|NCT00287469|537551065|FG000|Overall Study|Lost to Follow-up|74|||
149019924|NCT00287469|537551066|FG001|Overall Study|Lost to Follow-up|69|||
149225707|NCT00106626|538292937|FG000|Overall Study|Progressive Disease|4|||
149225708|NCT00106626|538292938|FG001|Overall Study|Progressive Disease|1|||
149225709|NCT00106626|538292939|FG002|Overall Study|Progressive Disease|9|||
149225710|NCT00106626|538292940|FG003|Overall Study|Progressive Disease|10|||
149225711|NCT00106626|538292937|FG000|Overall Study|Received radiation on new therapy|1|||
149225712|NCT00106626|538292938|FG001|Overall Study|Received radiation on new therapy|0|||
149225713|NCT00106626|538292939|FG002|Overall Study|Received radiation on new therapy|0|||
149225714|NCT00106626|538292940|FG003|Overall Study|Received radiation on new therapy|0|||
149225715|NCT00106626|538292937|FG000|Overall Study|> 14 day delay in therapy start|0|||
149019925|NCT00393094|537551071|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
149019926|NCT00393094|537551071|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
149019927|NCT02019602|537551072|FG000|Screening Period|Ineligibility|4|||
149019928|NCT02019602|537551073|FG001|Screening Period|Ineligibility|0|||
149019929|NCT02019602|537551072|FG000|Screening Period|Adverse Event|1|||
149019930|NCT02019602|537551073|FG001|Screening Period|Adverse Event|0|||
149019931|NCT01556763|537551079|FG000|Overall Study|Withdrawal by Subject|0|||
149019932|NCT01556763|537551080|FG001|Overall Study|Withdrawal by Subject|1|||
149019933|NCT01556763|537551081|FG002|Overall Study|Withdrawal by Subject|0|||
149019934|NCT02258464|537551082|FG000|Overall Study|Progressive disease (PD)|9|||
149019935|NCT02258464|537551083|FG001|Overall Study|Progressive disease (PD)|17|||
149019936|NCT02258464|537551082|FG000|Overall Study|Study drug never administered|1|||
149019937|NCT02258464|537551083|FG001|Overall Study|Study drug never administered|1|||
149019938|NCT02258464|537551082|FG000|Overall Study|AE not related to clinical PD|1|||
149019939|NCT02258464|537551083|FG001|Overall Study|AE not related to clinical PD|3|||
149019940|NCT02258464|537551082|FG000|Overall Study|Withdrawal by Subject|5|||
149019941|NCT02258464|537551083|FG001|Overall Study|Withdrawal by Subject|4|||
149019942|NCT02258464|537551082|FG000|Overall Study|AE related to clinical PD|1|||
149019943|NCT02258464|537551083|FG001|Overall Study|AE related to clinical PD|0|||
149019944|NCT04170296|537551084|FG000|Overall Study|Adverse Event|1|||
149019945|NCT04170296|537551085|FG001|Overall Study|Adverse Event|0|||
149019946|NCT04170296|537551084|FG000|Overall Study|Withdrawal by Subject|3|||
149019947|NCT04170296|537551085|FG001|Overall Study|Withdrawal by Subject|2|||
149019948|NCT04170296|537551084|FG000|Overall Study|Lost to Follow-up|4|||
149019949|NCT04170296|537551085|FG001|Overall Study|Lost to Follow-up|2|||
149019950|NCT00932646|537551086|FG000|Overall Study|Adverse Event|2|||
149019951|NCT00932646|537551087|FG001|Overall Study|Adverse Event|1|||
149019952|NCT00932646|537551088|FG002|Overall Study|Adverse Event|1|||
149019953|NCT00932646|537551089|FG003|Overall Study|Adverse Event|1|||
149019954|NCT00932646|537551086|FG000|Overall Study|Lost to Follow-up|2|||
149019955|NCT00932646|537551087|FG001|Overall Study|Lost to Follow-up|1|||
149019956|NCT00932646|537551088|FG002|Overall Study|Lost to Follow-up|0|||
149019957|NCT00932646|537551089|FG003|Overall Study|Lost to Follow-up|0|||
149019958|NCT00932646|537551086|FG000|Overall Study|Withdrawal by Subject|1|||
149019959|NCT00932646|537551087|FG001|Overall Study|Withdrawal by Subject|1|||
149019960|NCT00932646|537551088|FG002|Overall Study|Withdrawal by Subject|3|||
149019961|NCT00932646|537551089|FG003|Overall Study|Withdrawal by Subject|0|||
149019962|NCT00653263|537551090|FG000|Overall Study|Withdrawal by Subject|1|||
149019963|NCT00653263|537551090|FG000|Overall Study|Physician Decision|1|||
149225716|NCT00106626|538292938|FG001|Overall Study|> 14 day delay in therapy start|1|||
149225717|NCT00106626|538292939|FG002|Overall Study|> 14 day delay in therapy start|0|||
149225718|NCT00106626|538292940|FG003|Overall Study|> 14 day delay in therapy start|0|||
149019964|NCT00776100|537551093|FG000|Overall Study|Disease Progression|1|||
149019965|NCT00776100|537551094|FG001|Overall Study|Disease Progression|0|||
149019966|NCT03567993|537551095|FG000|Overall Study|Lost to Follow-up|4|||
149019967|NCT03567993|537551096|FG001|Overall Study|Lost to Follow-up|2|||
149019968|NCT03567993|537551095|FG000|Overall Study|Death|1|||
149019969|NCT03567993|537551096|FG001|Overall Study|Death|1|||
149019970|NCT03567993|537551095|FG000|Overall Study|Withdrawal by Subject|1|||
149019971|NCT03567993|537551096|FG001|Overall Study|Withdrawal by Subject|0|||
149225719|NCT03018028|538292959|FG000|Overall Study|Withdrawal by Subject|3|||
149019972|NCT02285595|537551097|FG000|Overall Study|Lost to Follow-up|14|||
149019973|NCT02285595|537551097|FG000|Overall Study|Withdrawal by Subject|1|||
149225720|NCT03018028|538292960|FG001|Overall Study|Withdrawal by Subject|0|||
149225721|NCT03018028|538292961|FG002|Overall Study|Withdrawal by Subject|1|||
149225722|NCT03018028|538292962|FG003|Overall Study|Withdrawal by Subject|2|||
149225723|NCT03018028|538292963|FG004|Overall Study|Withdrawal by Subject|0|||
149225724|NCT04062240|538292975|FG000|Overall Study|equipment malfunction|1|||
149225725|NCT01957111|538292976|FG000|Overall Study|Withdrawal by Subject|1|||
149225726|NCT01957111|538292977|FG001|Overall Study|Withdrawal by Subject|1|||
149225727|NCT03961529|538292978|FG000|Overall Study|Adverse Event|13|||
149225728|NCT03961529|538292979|FG001|Overall Study|Adverse Event|5|||
149225729|NCT03961529|538292980|FG002|Overall Study|Adverse Event|2|||
149225730|NCT03961529|538292978|FG000|Overall Study|Withdrawal by Subject|17|||
149225731|NCT03961529|538292979|FG001|Overall Study|Withdrawal by Subject|2|||
149225732|NCT03961529|538292980|FG002|Overall Study|Withdrawal by Subject|1|||
149225733|NCT03961529|538292978|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149225734|NCT03961529|538292979|FG001|Overall Study|Withdrawal by parent/guardian|7|||
149225735|NCT03961529|538292980|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149225736|NCT03961529|538292978|FG000|Overall Study|Physician Decision|2|||
149225737|NCT03961529|538292979|FG001|Overall Study|Physician Decision|1|||
149019974|NCT01960790|537551098|FG000|Overall Study|Survey forms could not be recovered|3|||
149225738|NCT03961529|538292980|FG002|Overall Study|Physician Decision|1|||
149225739|NCT03961529|538292978|FG000|Overall Study|Lost to Follow-up|2|||
149225740|NCT03961529|538292979|FG001|Overall Study|Lost to Follow-up|1|||
149225741|NCT03961529|538292980|FG002|Overall Study|Lost to Follow-up|0|||
149225742|NCT03961529|538292978|FG000|Overall Study|Lack of Efficacy|2|||
149225743|NCT03961529|538292979|FG001|Overall Study|Lack of Efficacy|0|||
149019975|NCT01960790|537551098|FG000|Overall Study|Treat with Humira outside survey period|3|||
149019976|NCT01960790|537551098|FG000|Overall Study|Transferred to another hospital|4|||
149019977|NCT01960790|537551098|FG000|Overall Study|Unevaluable for safety|1|||
149225744|NCT03961529|538292980|FG002|Overall Study|Lack of Efficacy|1|||
149225745|NCT03961529|538292978|FG000|Overall Study|Other|6|||
149225746|NCT03961529|538292979|FG001|Overall Study|Other|1|||
149225747|NCT03961529|538292980|FG002|Overall Study|Other|0|||
149225748|NCT03644173|538292983|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
149225749|NCT03644173|538292983|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
149225750|NCT03644173|538292983|FG000|Participants at the 1-month Follow up|Death|2|||
149225751|NCT03644173|538292983|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
149225752|NCT03500419|538292984|FG000|Overall Study|Withdrawal by Subject|2|||
149225753|NCT03500419|538292985|FG001|Overall Study|Withdrawal by Subject|25|||
149225754|NCT00082628|538292992|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149225755|NCT00082628|538292993|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
149225756|NCT00082628|538292994|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149225757|NCT00082628|538292995|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149225758|NCT00082628|538292996|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
149225759|NCT00082628|538292992|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
149225760|NCT00082628|538292993|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
149225761|NCT00082628|538292994|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
149225762|NCT00082628|538292995|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
149225763|NCT00082628|538292996|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
149225764|NCT00082628|538292992|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
149019978|NCT00195715|537551099|FG000|Overall Study|Adverse Event|122|||
149225765|NCT00082628|538292993|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
149225766|NCT00082628|538292994|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
149225767|NCT00082628|538292995|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
149225768|NCT00082628|538292996|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
149225769|NCT00082628|538292992|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
149225770|NCT00082628|538292993|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
149225771|NCT00082628|538292994|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
149225772|NCT00082628|538292995|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
149225773|NCT00082628|538292996|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
149019979|NCT00195715|537551099|FG000|Overall Study|Withdrawal by Subject|58|||
149225774|NCT00082628|538292992|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149225775|NCT00082628|538292993|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149225776|NCT00082628|538292994|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149225777|NCT00082628|538292995|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
149225778|NCT00082628|538292996|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
149225779|NCT00082628|538292992|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149225780|NCT00082628|538292993|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149225781|NCT00082628|538292994|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149225782|NCT00082628|538292995|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
149225783|NCT00082628|538292996|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
149225784|NCT00082628|538292992|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
149225785|NCT00082628|538292993|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
149225786|NCT00082628|538292994|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
149225787|NCT00082628|538292995|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
149225788|NCT00082628|538292996|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
149225789|NCT03490734|538293010|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
149225790|NCT03490734|538293011|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
149225791|NCT03490734|538293012|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
149225792|NCT03490734|538293013|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
149225793|NCT03490734|538293010|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
149225794|NCT03490734|538293011|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
149225795|NCT03490734|538293012|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
149225796|NCT03490734|538293013|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
149225797|NCT03490734|538293010|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
149225798|NCT03490734|538293011|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
149225799|NCT03490734|538293012|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
149225800|NCT03490734|538293013|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
149225801|NCT03490734|538293010|FG000|Post-intervention Scan Visit|Adverse Event|2|||
149225802|NCT03490734|538293011|FG001|Post-intervention Scan Visit|Adverse Event|0|||
149225803|NCT03490734|538293012|FG002|Post-intervention Scan Visit|Adverse Event|0|||
149225804|NCT03490734|538293013|FG003|Post-intervention Scan Visit|Adverse Event|0|||
149225805|NCT03490734|538293010|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
149225806|NCT03490734|538293011|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
149225807|NCT03490734|538293012|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
149225808|NCT03490734|538293013|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
149225809|NCT03490734|538293010|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
149225810|NCT03490734|538293011|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
149225811|NCT03490734|538293012|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
149225812|NCT03490734|538293013|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
149225813|NCT00994890|538293017|FG000|Overall Study|Adverse Event|13|||
149225814|NCT00994890|538293018|FG001|Overall Study|Adverse Event|9|||
149225815|NCT00994890|538293019|FG002|Overall Study|Adverse Event|11|||
149225816|NCT00994890|538293017|FG000|Overall Study|Lack of Efficacy|0|||
149225817|NCT00994890|538293018|FG001|Overall Study|Lack of Efficacy|0|||
149225818|NCT00994890|538293019|FG002|Overall Study|Lack of Efficacy|1|||
149225819|NCT00994890|538293017|FG000|Overall Study|Lost to Follow-up|6|||
149225820|NCT00994890|538293018|FG001|Overall Study|Lost to Follow-up|1|||
149225821|NCT00994890|538293019|FG002|Overall Study|Lost to Follow-up|3|||
149225822|NCT00994890|538293017|FG000|Overall Study|No longer willing to participate|8|||
149225823|NCT00994890|538293018|FG001|Overall Study|No longer willing to participate|5|||
149225824|NCT00994890|538293019|FG002|Overall Study|No longer willing to participate|13|||
149225825|NCT00994890|538293017|FG000|Overall Study|Protocol Violation|2|||
149225826|NCT00994890|538293018|FG001|Overall Study|Protocol Violation|4|||
149225827|NCT00994890|538293019|FG002|Overall Study|Protocol Violation|0|||
149225828|NCT00994890|538293017|FG000|Overall Study|Study terminated by sponsor|199|||
149225829|NCT00994890|538293018|FG001|Overall Study|Study terminated by sponsor|201|||
149225830|NCT00994890|538293019|FG002|Overall Study|Study terminated by sponsor|197|||
149225831|NCT00994890|538293017|FG000|Overall Study|Randomized, but not treated|1|||
149225832|NCT00994890|538293018|FG001|Overall Study|Randomized, but not treated|0|||
149225833|NCT00994890|538293019|FG002|Overall Study|Randomized, but not treated|0|||
149225834|NCT00994890|538293017|FG000|Overall Study|Other|2|||
149225835|NCT00994890|538293018|FG001|Overall Study|Other|2|||
149225836|NCT00994890|538293019|FG002|Overall Study|Other|1|||
149225837|NCT03323385|538293026|FG000|Overall Study|Withdrawal by Subject|1|||
149225838|NCT03323385|538293027|FG001|Overall Study|Withdrawal by Subject|2|||
149225839|NCT03323385|538293026|FG000|Overall Study|Noncompliance|0|||
149225840|NCT03323385|538293027|FG001|Overall Study|Noncompliance|1|||
149225841|NCT00699582|538293028|FG000|Overall Study|Adverse Event|4|||
149225842|NCT00699582|538293029|FG001|Overall Study|Adverse Event|11|||
149225843|NCT00699582|538293030|FG002|Overall Study|Adverse Event|23|||
149225844|NCT00699582|538293028|FG000|Overall Study|Withdrawal by Subject|6|||
149225845|NCT00699582|538293029|FG001|Overall Study|Withdrawal by Subject|7|||
149225846|NCT00699582|538293030|FG002|Overall Study|Withdrawal by Subject|4|||
149225847|NCT00699582|538293028|FG000|Overall Study|Lack of Efficacy|1|||
149225848|NCT00699582|538293029|FG001|Overall Study|Lack of Efficacy|0|||
149225849|NCT00699582|538293030|FG002|Overall Study|Lack of Efficacy|1|||
149225850|NCT00699582|538293028|FG000|Overall Study|Progressive Disease|1|||
149225851|NCT00699582|538293029|FG001|Overall Study|Progressive Disease|0|||
149225852|NCT00699582|538293030|FG002|Overall Study|Progressive Disease|0|||
149225853|NCT00699582|538293028|FG000|Overall Study|Administrative/Other|4|||
149225854|NCT00699582|538293029|FG001|Overall Study|Administrative/Other|3|||
149225855|NCT00699582|538293030|FG002|Overall Study|Administrative/Other|0|||
149225856|NCT00699582|538293028|FG000|Overall Study|Randomized, Not Treated|2|||
149225857|NCT00699582|538293029|FG001|Overall Study|Randomized, Not Treated|1|||
149225858|NCT00699582|538293030|FG002|Overall Study|Randomized, Not Treated|0|||
149225859|NCT01849289|538293031|FG000|Overall Study|Adverse Event|3|||
149225860|NCT01849289|538293032|FG001|Overall Study|Adverse Event|3|||
149225861|NCT01849289|538293031|FG000|Overall Study|Protocol Violation|3|||
149225862|NCT01849289|538293032|FG001|Overall Study|Protocol Violation|3|||
149225863|NCT01849289|538293031|FG000|Overall Study|Withdrawal criteria|1|||
149225864|NCT01849289|538293032|FG001|Overall Study|Withdrawal criteria|0|||
149225865|NCT01849289|538293031|FG000|Overall Study|Unclassified|25|||
149225866|NCT01849289|538293032|FG001|Overall Study|Unclassified|18|||
149225867|NCT03099304|538293034|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
149225868|NCT03099304|538293035|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
149225869|NCT03099304|538293036|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
149225870|NCT03099304|538293037|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
149225871|NCT03099304|538293038|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
149225872|NCT03099304|538293039|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
149225873|NCT03099304|538293034|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
149225874|NCT03099304|538293035|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
149225875|NCT03099304|538293036|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149225876|NCT03099304|538293037|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149225877|NCT03099304|538293038|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149225878|NCT03099304|538293039|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
149225879|NCT03099304|538293034|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
149225880|NCT03099304|538293035|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
149225881|NCT03099304|538293036|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
149225882|NCT03099304|538293037|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
149225883|NCT03099304|538293038|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
149225884|NCT03099304|538293039|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
149225885|NCT03099304|538293034|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
149225886|NCT03099304|538293035|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
149225887|NCT03099304|538293036|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
149225888|NCT03099304|538293037|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
149225889|NCT03099304|538293038|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
149225890|NCT03099304|538293039|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
149225891|NCT03099304|538293034|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149225892|NCT03099304|538293035|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149225893|NCT03099304|538293036|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
149225894|NCT03099304|538293037|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
149225895|NCT03099304|538293038|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149225896|NCT03099304|538293039|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
149225897|NCT03099304|538293034|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149225898|NCT03099304|538293035|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149225899|NCT03099304|538293036|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
148688064|NCT02247479|536330625|FG001|Overall Study|Unspecified Reason|5|||
148688065|NCT02247479|536330626|FG002|Overall Study|Unspecified Reason|2|||
148688066|NCT01132118|536330627|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
148688067|NCT01132118|536330628|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
148688068|NCT01132118|536330627|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
148688069|NCT01132118|536330628|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
148688070|NCT01132118|536330627|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
148688071|NCT01132118|536330628|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
148688072|NCT01299038|536330638|FG000|Overall Study|Withdrawal by Subject|1|||
148688073|NCT01299038|536330639|FG001|Overall Study|Withdrawal by Subject|0|||
148688074|NCT00322556|536330640|FG000|Overall Study|Adverse Event|1|||
148688075|NCT00322556|536330640|FG000|Overall Study|Withdrawal by Subject|1|||
148688076|NCT00322556|536330640|FG000|Overall Study|Lost to Follow-up|3|||
148688077|NCT00322556|536330640|FG000|Overall Study|Other Reason|7|||
148688078|NCT00832078|536330641|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
148688079|NCT00832078|536330642|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
148688080|NCT00832078|536330641|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
148688081|NCT00832078|536330642|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
148688082|NCT03551730|536330643|FG000|Overall Study|Adverse Event|1|||
148688083|NCT03551730|536330644|FG001|Overall Study|Adverse Event|0|||
148688084|NCT03551730|536330645|FG002|Overall Study|Adverse Event|0|||
148688085|NCT03551730|536330646|FG003|Overall Study|Adverse Event|0|||
148688086|NCT00096265|536330657|FG000|Overall Study|Ineligible|1|||
148688087|NCT00096265|536330658|FG001|Overall Study|Ineligible|0|||
148688088|NCT00096265|536330659|FG002|Overall Study|Ineligible|0|||
148688089|NCT00704418|536330660|FG000|Overall Study|Withdrawal by Subject|2|||
148688090|NCT00704418|536330661|FG001|Overall Study|Withdrawal by Subject|0|||
148688091|NCT00704418|536330660|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
148688092|NCT00704418|536330661|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
148688093|NCT01579474|536330662|FG000|Overall Study|Adverse Event|1|||
148688094|NCT01579474|536330663|FG001|Overall Study|Adverse Event|13|||
148688095|NCT01579474|536330664|FG002|Overall Study|Adverse Event|2|||
148688096|NCT01579474|536330665|FG003|Overall Study|Adverse Event|0|||
148688097|NCT01579474|536330666|FG004|Overall Study|Adverse Event|0|||
148688098|NCT01579474|536330667|FG005|Overall Study|Adverse Event|1|||
148688099|NCT01579474|536330662|FG000|Overall Study|Lack of Efficacy|1|||
148688100|NCT01579474|536330663|FG001|Overall Study|Lack of Efficacy|0|||
148688101|NCT01579474|536330664|FG002|Overall Study|Lack of Efficacy|0|||
148688102|NCT01579474|536330665|FG003|Overall Study|Lack of Efficacy|0|||
148688103|NCT01579474|536330666|FG004|Overall Study|Lack of Efficacy|1|||
148688104|NCT01579474|536330667|FG005|Overall Study|Lack of Efficacy|0|||
148688105|NCT01579474|536330662|FG000|Overall Study|Withdrawal by Subject|1|||
148688106|NCT01579474|536330663|FG001|Overall Study|Withdrawal by Subject|0|||
148688107|NCT01579474|536330664|FG002|Overall Study|Withdrawal by Subject|0|||
148688108|NCT01579474|536330665|FG003|Overall Study|Withdrawal by Subject|0|||
148688109|NCT01579474|536330666|FG004|Overall Study|Withdrawal by Subject|0|||
148810198|NCT00716417|536782578|FG004|Overall Study|On patient request due to toxicities|0|||
148810199|NCT00716417|536782579|FG005|Overall Study|On patient request due to toxicities|0|||
149225900|NCT03099304|538293037|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
148688110|NCT01579474|536330667|FG005|Overall Study|Withdrawal by Subject|0|||
148688111|NCT00586521|536330668|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
148688112|NCT03083483|536330670|FG000|Overall Study|Adverse Event|1|||
148688113|NCT03083483|536330671|FG001|Overall Study|Adverse Event|1|||
148688114|NCT03083483|536330672|FG002|Overall Study|Adverse Event|1|||
148688115|NCT03083483|536330670|FG000|Overall Study|Lost to Follow-up|2|||
148688116|NCT03083483|536330671|FG001|Overall Study|Lost to Follow-up|1|||
148688117|NCT03083483|536330672|FG002|Overall Study|Lost to Follow-up|1|||
148688118|NCT03083483|536330670|FG000|Overall Study|technological issues|1|||
148688119|NCT03083483|536330671|FG001|Overall Study|technological issues|0|||
149225901|NCT03099304|538293038|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149225902|NCT03099304|538293039|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
149225903|NCT03099304|538293034|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
149225904|NCT03099304|538293035|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
149225905|NCT03099304|538293036|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
149225906|NCT03099304|538293037|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
149225907|NCT03099304|538293038|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
149225908|NCT03099304|538293039|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
149225909|NCT03099304|538293034|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
149225910|NCT03099304|538293035|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
149225911|NCT03099304|538293036|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
149225912|NCT03099304|538293037|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
149225913|NCT03099304|538293038|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
149225914|NCT03099304|538293039|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
149225915|NCT03099304|538293034|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149225916|NCT03099304|538293035|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149225917|NCT03099304|538293036|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149225918|NCT03099304|538293037|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
149225919|NCT03099304|538293038|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
149225920|NCT03099304|538293039|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
149225921|NCT03099304|538293034|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
149225922|NCT03099304|538293035|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
149225923|NCT03099304|538293036|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
149225924|NCT03099304|538293037|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
149225925|NCT03099304|538293038|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
149225926|NCT03099304|538293039|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
149225927|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
149019980|NCT00195715|537551099|FG000|Overall Study|Lost to Follow-up|27|||
149019981|NCT00195715|537551099|FG000|Overall Study|Protocol Violation|13|||
149019982|NCT00195715|537551099|FG000|Overall Study|Lack of Efficacy|93|||
149019983|NCT00195715|537551099|FG000|Overall Study|Pregnancy|14|||
149019984|NCT00195715|537551099|FG000|Overall Study|Investigative site closure|8|||
149019985|NCT00195715|537551099|FG000|Overall Study|Subject moved/relocated|7|||
149019986|NCT00195715|537551099|FG000|Overall Study|Subject non-compliance|6|||
149019987|NCT00195715|537551099|FG000|Overall Study|Subject started commercial Humira|5|||
149225928|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
149225929|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
149225930|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
149225931|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
149225932|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
149225933|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
149225934|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
149225935|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
149225936|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
149225937|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
149225938|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
149225939|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
149225940|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
149225941|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
149225942|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
149225943|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
149225944|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
149225945|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
149225946|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
149225947|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
149225948|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
149225949|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
149225950|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
149225951|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
149225952|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
149019988|NCT00195715|537551099|FG000|Overall Study|Subject choice|3|||
149019989|NCT00195715|537551099|FG000|Overall Study|Loss of response/no improvement|3|||
149225953|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
149225954|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
149019990|NCT00195715|537551099|FG000|Overall Study|Sponsor stopped study|1|||
149225955|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
149225956|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
149225957|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
149225958|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
149225959|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
149225960|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
149225961|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
149225962|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
149225963|NCT03099304|538293034|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
149225964|NCT03099304|538293035|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
149225965|NCT03099304|538293036|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
149225966|NCT03099304|538293037|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
149225967|NCT03099304|538293038|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
149225968|NCT03099304|538293039|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
149225969|NCT02692560|538293040|FG000|Overall Study|Withdrawal by Subject|0|||
149225970|NCT02692560|538293041|FG001|Overall Study|Withdrawal by Subject|6|||
149225971|NCT00715949|538293044|FG000|Overall Study|could not finish first test|4|||
149225972|NCT00420212|538293045|FG000|Overall Study|Adverse Event|22|||
149225973|NCT00420212|538293046|FG001|Overall Study|Adverse Event|40|||
149225974|NCT00420212|538293047|FG002|Overall Study|Adverse Event|36|||
149225975|NCT00420212|538293045|FG000|Overall Study|Lost to Follow-up|9|||
149225976|NCT00420212|538293046|FG001|Overall Study|Lost to Follow-up|11|||
149225977|NCT00420212|538293047|FG002|Overall Study|Lost to Follow-up|11|||
149225978|NCT00420212|538293045|FG000|Overall Study|Withdrawal by Subject|31|||
149225979|NCT00420212|538293046|FG001|Overall Study|Withdrawal by Subject|22|||
149225980|NCT00420212|538293047|FG002|Overall Study|Withdrawal by Subject|19|||
149225981|NCT00420212|538293045|FG000|Overall Study|Physician Decision|4|||
149225982|NCT00420212|538293046|FG001|Overall Study|Physician Decision|4|||
149225983|NCT00420212|538293047|FG002|Overall Study|Physician Decision|3|||
149225984|NCT00420212|538293045|FG000|Overall Study|Protocol Violation|4|||
149225985|NCT00420212|538293046|FG001|Overall Study|Protocol Violation|4|||
149225986|NCT00420212|538293047|FG002|Overall Study|Protocol Violation|8|||
149225987|NCT00420212|538293045|FG000|Overall Study|Death|0|||
149225988|NCT00420212|538293046|FG001|Overall Study|Death|0|||
149225989|NCT00420212|538293047|FG002|Overall Study|Death|1|||
149225990|NCT00420212|538293045|FG000|Overall Study|Other-Unspecified|21|||
149225991|NCT00420212|538293046|FG001|Overall Study|Other-Unspecified|14|||
149225992|NCT00420212|538293047|FG002|Overall Study|Other-Unspecified|18|||
149225993|NCT01326910|538293048|FG000|Overall Study|Withdrawal by Subject|3|||
149225994|NCT01326910|538293049|FG001|Overall Study|Withdrawal by Subject|2|||
149225995|NCT01326910|538293048|FG000|Overall Study|Protocol Violation|1|||
149225996|NCT01326910|538293049|FG001|Overall Study|Protocol Violation|1|||
149225997|NCT01058356|538293054|FG000|Overall Study|Adverse Event|5|||
149225998|NCT01058356|538293054|FG000|Overall Study|Administration of contraindicated drugs|12|||
149225999|NCT01058356|538293054|FG000|Overall Study|Withdrawal by Subject|21|||
149226000|NCT01058356|538293054|FG000|Overall Study|Lost to Follow-up|4|||
149226001|NCT02993783|538293057|FG000|Overall Study|Reason not Specified|6|||
149226002|NCT02993783|538293058|FG001|Overall Study|Reason not Specified|9|||
149226003|NCT03922945|538294789|FG000|Overall Study|Adverse Event|1|||
149226004|NCT03922945|538294790|FG001|Overall Study|Adverse Event|1|||
149226005|NCT03922945|538294791|FG002|Overall Study|Adverse Event|2|||
149226006|NCT03922945|538294789|FG000|Overall Study|Lost to Follow-up|13|||
149226007|NCT03922945|538294790|FG001|Overall Study|Lost to Follow-up|9|||
149226008|NCT03922945|538294791|FG002|Overall Study|Lost to Follow-up|20|||
149226009|NCT03922945|538294789|FG000|Overall Study|Lack of Efficacy|2|||
149226010|NCT03922945|538294790|FG001|Overall Study|Lack of Efficacy|0|||
149226011|NCT03922945|538294791|FG002|Overall Study|Lack of Efficacy|1|||
149226012|NCT03922945|538294789|FG000|Overall Study|Protocol Non-Compliance|0|||
149226013|NCT03922945|538294790|FG001|Overall Study|Protocol Non-Compliance|0|||
149226014|NCT03922945|538294791|FG002|Overall Study|Protocol Non-Compliance|1|||
149226015|NCT03922945|538294789|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
149226016|NCT03922945|538294790|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
149226017|NCT03922945|538294791|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
148688120|NCT03083483|536330672|FG002|Overall Study|technological issues|1|||
149226018|NCT03922945|538294789|FG000|Overall Study|All Other Personal Reasons|1|||
148810200|NCT00716417|536782580|FG006|Overall Study|On patient request due to toxicities|0|||
148954211|NCT00563381|537314728|FG000|Overall Study|Individual different reasons|24|||
148954212|NCT00563381|537314729|FG001|Overall Study|Individual different reasons|34|||
149226019|NCT03922945|538294790|FG001|Overall Study|All Other Personal Reasons|1|||
149226020|NCT03922945|538294791|FG002|Overall Study|All Other Personal Reasons|2|||
149226021|NCT01347931|538294792|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
149226022|NCT01603615|538294800|FG000|Overall Study|Did not Receive Treatment|7|||
149226023|NCT01603615|538294800|FG000|Overall Study|Lost to Follow-up|9|||
149226024|NCT01603615|538294800|FG000|Overall Study|Personal Reasons|17|||
149226025|NCT01603615|538294800|FG000|Overall Study|Other Miscellaneous|1|||
149226026|NCT03419741|538294801|FG000|Overall Study|Adverse Event|1|||
149226027|NCT03419741|538294802|FG001|Overall Study|Adverse Event|0|||
149226028|NCT03419741|538294801|FG000|Overall Study|Withdrawal by Subject|1|||
149226029|NCT03419741|538294802|FG001|Overall Study|Withdrawal by Subject|2|||
149226030|NCT04354870|538294803|FG000|Overall Study|Lost to Follow-up|32|||
149226031|NCT04354870|538294804|FG001|Overall Study|Lost to Follow-up|12|||
149226032|NCT04354870|538294803|FG000|Overall Study|Withdrawal by Subject|10|||
149226033|NCT04354870|538294804|FG001|Overall Study|Withdrawal by Subject|16|||
149226034|NCT04354870|538294803|FG000|Overall Study|Did not complete all study visits|6|||
149226035|NCT04354870|538294804|FG001|Overall Study|Did not complete all study visits|5|||
149226036|NCT03384316|538294805|FG000|Overall Study|Screen failure|0|||
149226037|NCT03384316|538294806|FG001|Overall Study|Screen failure|1|||
149226038|NCT03287960|538294810|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
149226039|NCT03287960|538294810|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
149226040|NCT01667731|538294811|FG000|Overall Study|Enrolled but not treated|0|||
149226041|NCT01667731|538294812|FG001|Overall Study|Enrolled but not treated|0|||
149226042|NCT01667731|538294813|FG002|Overall Study|Enrolled but not treated|0|||
149226043|NCT01667731|538294814|FG003|Overall Study|Enrolled but not treated|0|||
149226044|NCT01667731|538294815|FG004|Overall Study|Enrolled but not treated|1|||
149226045|NCT01667731|538294811|FG000|Overall Study|Efficacy Failure|1|||
149226046|NCT01667731|538294812|FG001|Overall Study|Efficacy Failure|12|||
149226047|NCT01667731|538294813|FG002|Overall Study|Efficacy Failure|0|||
149226048|NCT01667731|538294814|FG003|Overall Study|Efficacy Failure|1|||
149226049|NCT01667731|538294815|FG004|Overall Study|Efficacy Failure|24|||
149226050|NCT01667731|538294811|FG000|Overall Study|Lost to Follow-up|2|||
149226051|NCT01667731|538294812|FG001|Overall Study|Lost to Follow-up|3|||
149226052|NCT01667731|538294813|FG002|Overall Study|Lost to Follow-up|1|||
149226053|NCT01667731|538294814|FG003|Overall Study|Lost to Follow-up|1|||
149226054|NCT01667731|538294815|FG004|Overall Study|Lost to Follow-up|2|||
149226055|NCT01667731|538294811|FG000|Overall Study|Subject Withdrew Consent|2|||
149226056|NCT01667731|538294812|FG001|Overall Study|Subject Withdrew Consent|0|||
149226057|NCT01667731|538294813|FG002|Overall Study|Subject Withdrew Consent|1|||
149226058|NCT01667731|538294814|FG003|Overall Study|Subject Withdrew Consent|0|||
149226059|NCT01667731|538294815|FG004|Overall Study|Subject Withdrew Consent|1|||
149226060|NCT01667731|538294811|FG000|Overall Study|Death|0|||
149226061|NCT01667731|538294812|FG001|Overall Study|Death|1|||
149226062|NCT01667731|538294813|FG002|Overall Study|Death|0|||
149226063|NCT01667731|538294814|FG003|Overall Study|Death|0|||
149226064|NCT01667731|538294815|FG004|Overall Study|Death|0|||
149226065|NCT00561912|538294816|FG000|Overall Study|ineligible|1|||
149226066|NCT01345162|538294817|FG000|Overall Study|Protocol Violation|2|||
149226067|NCT01345162|538294818|FG001|Overall Study|Protocol Violation|4|||
149226068|NCT01977651|538294822|FG000|4 Month Treatment Period|Adverse Event|34|||
149226069|NCT01977651|538294822|FG000|4 Month Treatment Period|Death|3|||
149226070|NCT01977651|538294822|FG000|4 Month Treatment Period|Progressive Disease|43|||
149226071|NCT01977651|538294822|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
149226072|NCT01977651|538294822|FG000|4 Month Treatment Period|Physician Decision|4|||
149226073|NCT01977651|538294822|FG000|1 Year Extension Period|Adverse Event|14|||
149226074|NCT01977651|538294822|FG000|1 Year Extension Period|Death|10|||
149226075|NCT01977651|538294822|FG000|1 Year Extension Period|Lost to Follow-up|2|||
149226076|NCT01977651|538294822|FG000|1 Year Extension Period|Progressive Disease|86|||
149226077|NCT01977651|538294822|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
148688121|NCT01751412|536330675|FG000|Overall Study|Disease Progression Before Treatment|1|||
148688122|NCT02623959|536330676|FG000|Overall Study|Progression|0|||
148688123|NCT02623959|536330677|FG001|Overall Study|Progression|1|||
148688124|NCT00617461|536330678|FG000|First Treatment Intervention Period|Adverse Event|2|||
148954213|NCT01957644|537314732|FG000|Overall Study|Adverse Event|4|||
148954214|NCT01957644|537314733|FG001|Overall Study|Adverse Event|2|||
148954215|NCT01957644|537314734|FG002|Overall Study|Adverse Event|0|||
148954216|NCT01957644|537314735|FG003|Overall Study|Adverse Event|0|||
148954217|NCT01957644|537314736|FG004|Overall Study|Adverse Event|1|||
148954218|NCT01957644|537314732|FG000|Overall Study|Progressive disease / relapse|0|||
148954219|NCT01957644|537314733|FG001|Overall Study|Progressive disease / relapse|1|||
148954220|NCT01957644|537314734|FG002|Overall Study|Progressive disease / relapse|0|||
148954221|NCT01957644|537314735|FG003|Overall Study|Progressive disease / relapse|1|||
148954222|NCT01957644|537314736|FG004|Overall Study|Progressive disease / relapse|0|||
148954223|NCT01957644|537314732|FG000|Overall Study|Other reason|1|||
149226078|NCT01977651|538294822|FG000|1 Year Extension Period|Physician Decision|6|||
149226079|NCT01977651|538294822|FG000|1 Year Extension Period|Miscellaneous|1|||
149226080|NCT01977651|538294822|FG000|Post 1 Year Extension Period|Adverse Event|5|||
149226081|NCT01977651|538294822|FG000|Post 1 Year Extension Period|Death|13|||
149226082|NCT01977651|538294822|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
149226083|NCT01977651|538294822|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
148954224|NCT01957644|537314733|FG001|Overall Study|Other reason|2|||
148688125|NCT00617461|536330679|FG001|First Treatment Intervention Period|Adverse Event|0|||
149226084|NCT01977651|538294822|FG000|Post 1 Year Extension Period|Physician Decision|4|||
149226085|NCT01977651|538294822|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
149226086|NCT04249076|538294843|FG000|Overall Study|Adverse Event|1|||
149226087|NCT04249076|538294844|FG001|Overall Study|Adverse Event|1|||
149226088|NCT04249076|538294843|FG000|Overall Study|Protocol Violation|1|||
149226089|NCT04249076|538294844|FG001|Overall Study|Protocol Violation|2|||
148688126|NCT00617461|536330678|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
148688127|NCT00617461|536330679|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
149226090|NCT04249076|538294843|FG000|Overall Study|Lack of Efficacy|0|||
149226091|NCT04249076|538294844|FG001|Overall Study|Lack of Efficacy|1|||
149226092|NCT04249076|538294843|FG000|Overall Study|Withdrawal by Subject|0|||
149226093|NCT04249076|538294844|FG001|Overall Study|Withdrawal by Subject|1|||
149226094|NCT00732199|538294845|FG000|Overall Study|Withdrawal by Subject|25|||
149226095|NCT00732199|538294846|FG001|Overall Study|Withdrawal by Subject|18|||
149226096|NCT00732199|538294845|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
149226097|NCT00732199|538294846|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
149226098|NCT00265382|538294847|FG000|Overall Study|Adverse Event|21|||
149226099|NCT00265382|538294847|FG000|Overall Study|Laboratory Abnormality|1|||
149226100|NCT00265382|538294847|FG000|Overall Study|Lost to Follow-up|3|||
149226101|NCT00265382|538294847|FG000|Overall Study|Lack of Efficacy|6|||
149226102|NCT00265382|538294847|FG000|Overall Study|Miscellaneous|6|||
149226103|NCT00265382|538294847|FG000|Overall Study|Withdrawal by Subject|13|||
149226104|NCT00265382|538294847|FG000|Overall Study|Study terminated by sponsor|94|||
149226105|NCT00265382|538294847|FG000|Overall Study|Death|1|||
149226106|NCT02242305|538294848|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
149226107|NCT02242305|538294849|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
149226108|NCT02242305|538294848|FG000|Overall Study|Adverse Event|1|||
149226109|NCT02242305|538294849|FG001|Overall Study|Adverse Event|0|||
149226110|NCT02242305|538294848|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
149226111|NCT02242305|538294849|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
149226112|NCT02242305|538294848|FG000|Overall Study|Subject withdraws inform consent|0|||
149226113|NCT02242305|538294849|FG001|Overall Study|Subject withdraws inform consent|4|||
149226114|NCT02242305|538294848|FG000|Overall Study|Lost to Follow-up|2|||
149226115|NCT02242305|538294849|FG001|Overall Study|Lost to Follow-up|0|||
149226116|NCT03481634|538294852|FG000|Overall Study|Withdrawal by Subject|16|||
149226117|NCT03481634|538294853|FG001|Overall Study|Withdrawal by Subject|19|||
149226118|NCT03481634|538294854|FG002|Overall Study|Withdrawal by Subject|14|||
149226119|NCT03481634|538294852|FG000|Overall Study|Protocol Violation|1|||
149226120|NCT03481634|538294853|FG001|Overall Study|Protocol Violation|0|||
149226121|NCT03481634|538294854|FG002|Overall Study|Protocol Violation|1|||
149226122|NCT03481634|538294852|FG000|Overall Study|Progressive disease|0|||
149226123|NCT03481634|538294853|FG001|Overall Study|Progressive disease|1|||
149226124|NCT03481634|538294854|FG002|Overall Study|Progressive disease|0|||
149226125|NCT03481634|538294852|FG000|Overall Study|Physician Decision|3|||
149226126|NCT03481634|538294853|FG001|Overall Study|Physician Decision|0|||
149226127|NCT03481634|538294854|FG002|Overall Study|Physician Decision|1|||
149226128|NCT03481634|538294852|FG000|Overall Study|Lost to Follow-up|3|||
148688128|NCT00617461|536330678|FG000|First Treatment Intervention Period|Protocol Violation|2|||
149226129|NCT03481634|538294853|FG001|Overall Study|Lost to Follow-up|4|||
149226130|NCT03481634|538294854|FG002|Overall Study|Lost to Follow-up|4|||
149226131|NCT03481634|538294852|FG000|Overall Study|Death|4|||
149226132|NCT03481634|538294853|FG001|Overall Study|Death|8|||
149226133|NCT03481634|538294854|FG002|Overall Study|Death|7|||
149226134|NCT03481634|538294852|FG000|Overall Study|Adverse Event|6|||
149226135|NCT03481634|538294853|FG001|Overall Study|Adverse Event|3|||
149226136|NCT03481634|538294854|FG002|Overall Study|Adverse Event|7|||
149226137|NCT00352027|538294857|FG000|Overall Study|Progressive disease|3|||
149226138|NCT04491591|538294858|FG000|Overall Study|Accidently randomized|3|||
149226139|NCT04491591|538294859|FG001|Overall Study|Accidently randomized|1|||
149226140|NCT04491591|538294860|FG002|Overall Study|Accidently randomized|0|||
149226141|NCT04491591|538294858|FG000|Overall Study|Did not complete survey|28|||
148810201|NCT00716417|536782581|FG007|Overall Study|On patient request due to toxicities|1|||
148954225|NCT01957644|537314734|FG002|Overall Study|Other reason|1|||
148954226|NCT01957644|537314735|FG003|Overall Study|Other reason|1|||
148954227|NCT01957644|537314736|FG004|Overall Study|Other reason|0|||
148954228|NCT01957644|537314732|FG000|Overall Study|Withdrawal by Subject|1|||
148954229|NCT01957644|537314733|FG001|Overall Study|Withdrawal by Subject|0|||
148954230|NCT01957644|537314734|FG002|Overall Study|Withdrawal by Subject|0|||
148954231|NCT01957644|537314735|FG003|Overall Study|Withdrawal by Subject|0|||
148954232|NCT01957644|537314736|FG004|Overall Study|Withdrawal by Subject|0|||
148954233|NCT01957644|537314732|FG000|Overall Study|Protocol Violation|0|||
148954234|NCT01957644|537314733|FG001|Overall Study|Protocol Violation|1|||
148954235|NCT01957644|537314734|FG002|Overall Study|Protocol Violation|0|||
148954236|NCT01957644|537314735|FG003|Overall Study|Protocol Violation|0|||
148954237|NCT01957644|537314736|FG004|Overall Study|Protocol Violation|0|||
148954238|NCT04044716|537314737|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
148954239|NCT04044716|537314738|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
148954240|NCT04044716|537314739|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
148954241|NCT04044716|537314737|FG000|Overall Study|Lost to Follow-up|2|||
148954242|NCT04044716|537314738|FG001|Overall Study|Lost to Follow-up|3|||
148954243|NCT04044716|537314739|FG002|Overall Study|Lost to Follow-up|0|||
148954244|NCT01957553|537314740|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
148954245|NCT01957553|537314741|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
148954246|NCT01957553|537314740|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
148954247|NCT01957553|537314741|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
148954248|NCT01957553|537314740|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
148954249|NCT01957553|537314741|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
148954250|NCT01957553|537314740|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
148954251|NCT01957553|537314741|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
148954252|NCT01957553|537314740|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
148954253|NCT01957553|537314741|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
148954254|NCT01957553|537314740|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
148954255|NCT01957553|537314741|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
148954256|NCT01957553|537314740|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
148954257|NCT01957553|537314741|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
148954258|NCT01957553|537314740|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
148954259|NCT01957553|537314741|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
148954260|NCT01957553|537314740|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
148954261|NCT01957553|537314741|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
148954262|NCT02730455|537314742|FG000|Overall Study|Death|5|||
148954263|NCT02730455|537314743|FG001|Overall Study|Death|6|||
148954264|NCT02730455|537314744|FG002|Overall Study|Death|4|||
148954265|NCT02730455|537314742|FG000|Overall Study|Consent withdrawn|2|||
148954266|NCT02730455|537314743|FG001|Overall Study|Consent withdrawn|4|||
148954267|NCT02730455|537314744|FG002|Overall Study|Consent withdrawn|1|||
148954268|NCT02730455|537314742|FG000|Overall Study|Lost to Follow-up|3|||
148954269|NCT02730455|537314743|FG001|Overall Study|Lost to Follow-up|1|||
148954270|NCT02730455|537314744|FG002|Overall Study|Lost to Follow-up|4|||
148954271|NCT02730455|537314742|FG000|Overall Study|Other|1|||
148954272|NCT02730455|537314743|FG001|Overall Study|Other|1|||
148954273|NCT02730455|537314744|FG002|Overall Study|Other|2|||
148954274|NCT02730455|537314742|FG000|Overall Study|Other|2|||
149226142|NCT04491591|538294859|FG001|Overall Study|Did not complete survey|20|||
149226143|NCT04491591|538294860|FG002|Overall Study|Did not complete survey|3|||
148954275|NCT02730455|537314743|FG001|Overall Study|Other|2|||
148954276|NCT02730455|537314744|FG002|Overall Study|Other|0|||
148954277|NCT02733367|537314745|FG000|Overall Study|Withdrawal by Subject|6|||
148688129|NCT00617461|536330679|FG001|First Treatment Intervention Period|Protocol Violation|1|||
148688130|NCT00617461|536330678|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
149226144|NCT02274766|538294863|FG000|Overall Study|Withdrawal by Subject|3|||
149226145|NCT02274766|538294864|FG001|Overall Study|Withdrawal by Subject|6|||
149226146|NCT02274766|538294863|FG000|Overall Study|Did Not Receive Study Drug|1|||
149226147|NCT02274766|538294864|FG001|Overall Study|Did Not Receive Study Drug|1|||
149226148|NCT02274766|538294863|FG000|Overall Study|Subject Unwilling to Proceed|0|||
149226149|NCT02274766|538294864|FG001|Overall Study|Subject Unwilling to Proceed|1|||
149226150|NCT02274766|538294863|FG000|Overall Study|Adverse Event|0|||
149226151|NCT02274766|538294864|FG001|Overall Study|Adverse Event|1|||
149226152|NCT02607735|538294865|FG000|Primary Study|Randomized but Never Treated|1|||
149226153|NCT02607735|538294866|FG001|Primary Study|Randomized but Never Treated|0|||
149226154|NCT02607735|538294867|FG002|Primary Study|Randomized but Never Treated|0|||
149226155|NCT02607735|538294865|FG000|Primary Study|Lost to Follow-up|4|||
149226156|NCT02607735|538294866|FG001|Primary Study|Lost to Follow-up|0|||
149226157|NCT02607735|538294867|FG002|Primary Study|Lost to Follow-up|0|||
149226158|NCT02607735|538294865|FG000|Primary Study|Withdrew Consent|2|||
149226159|NCT02607735|538294866|FG001|Primary Study|Withdrew Consent|0|||
149226160|NCT02607735|538294867|FG002|Primary Study|Withdrew Consent|0|||
149226161|NCT02607735|538294865|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
149226162|NCT02607735|538294866|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
149226163|NCT02607735|538294867|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
149226164|NCT02607735|538294865|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
149226165|NCT02607735|538294866|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
149226166|NCT02607735|538294867|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
149226167|NCT00606021|538294879|FG000|Induction Phase|Death|73|||
149226168|NCT00606021|538294880|FG001|Induction Phase|Death|0|||
149226169|NCT00606021|538294881|FG002|Induction Phase|Death|0|||
149226170|NCT00606021|538294879|FG000|Induction Phase|Physician Decision|2|||
149226171|NCT00606021|538294880|FG001|Induction Phase|Physician Decision|0|||
149226172|NCT00606021|538294881|FG002|Induction Phase|Physician Decision|0|||
149226173|NCT00606021|538294879|FG000|Induction Phase|Withdrawal by Subject|2|||
149226174|NCT00606021|538294880|FG001|Induction Phase|Withdrawal by Subject|0|||
149226175|NCT00606021|538294881|FG002|Induction Phase|Withdrawal by Subject|0|||
149226176|NCT00606021|538294879|FG000|Induction Phase|Lost to Follow-up|10|||
149226177|NCT00606021|538294880|FG001|Induction Phase|Lost to Follow-up|0|||
149226178|NCT00606021|538294881|FG002|Induction Phase|Lost to Follow-up|0|||
149226179|NCT00606021|538294879|FG000|Maintenance Phase|Death|0|||
149226180|NCT00606021|538294880|FG001|Maintenance Phase|Death|17|||
149226181|NCT00606021|538294881|FG002|Maintenance Phase|Death|15|||
149226182|NCT00606021|538294879|FG000|Maintenance Phase|Physician Decision|0|||
149226183|NCT00606021|538294880|FG001|Maintenance Phase|Physician Decision|1|||
149226184|NCT00606021|538294881|FG002|Maintenance Phase|Physician Decision|0|||
149226185|NCT00606021|538294879|FG000|Maintenance Phase|Lost to Follow-up|0|||
149226186|NCT00606021|538294880|FG001|Maintenance Phase|Lost to Follow-up|5|||
149226187|NCT00606021|538294881|FG002|Maintenance Phase|Lost to Follow-up|2|||
149226188|NCT03480841|538294882|FG000|Overall Study|Lost to Follow-up|2|||
149226189|NCT01362049|538294883|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
149226190|NCT01362049|538294884|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
149226191|NCT01362049|538294885|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
149226192|NCT01362049|538294886|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
148688131|NCT00617461|536330679|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
149226193|NCT01362049|538294883|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
149226194|NCT01362049|538294884|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
149226195|NCT01362049|538294885|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
149226196|NCT01362049|538294886|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
149226197|NCT02417935|538294892|FG000|Treatment Period|Adverse Event|12|||
149226198|NCT02417935|538294893|FG001|Treatment Period|Adverse Event|10|||
149226199|NCT02417935|538294892|FG000|Treatment Period|Lost to Follow-up|1|||
149226200|NCT02417935|538294893|FG001|Treatment Period|Lost to Follow-up|0|||
149226201|NCT02417935|538294892|FG000|Treatment Period|Entry Criteria not met|0|||
149226202|NCT02417935|538294893|FG001|Treatment Period|Entry Criteria not met|1|||
149226203|NCT02417935|538294892|FG000|Treatment Period|Protocol Violation|2|||
149226204|NCT02417935|538294893|FG001|Treatment Period|Protocol Violation|1|||
149226205|NCT02417935|538294892|FG000|Treatment Period|Withdrawal by Subject|3|||
149226206|NCT02417935|538294893|FG001|Treatment Period|Withdrawal by Subject|3|||
149226207|NCT02417935|538294892|FG000|Treatment Period|Physician Decision|3|||
149226208|NCT02417935|538294893|FG001|Treatment Period|Physician Decision|1|||
149226209|NCT02850276|538294896|FG000|Overall Study|screen failure|43|||
149226210|NCT02850276|538294896|FG000|Overall Study|Withdrawal by Subject|14|||
149226211|NCT02850276|538294896|FG000|Overall Study|Physician Decision|2|||
149226212|NCT02850276|538294896|FG000|Overall Study|Lost to Follow-up|2|||
149226213|NCT04815291|538294897|FG000|Overall Study|Lost to Follow-up|1|||
149226214|NCT04815291|538294897|FG000|Overall Study|Physician Decision|4|||
148954278|NCT03049280|537314752|FG000|Overall Study|Physician Decision|1|||
148954279|NCT01867021|537314753|FG000|Overall Study|Adverse Event|0|||
148688132|NCT00617461|536330678|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
148688133|NCT00617461|536330679|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
148688134|NCT00617461|536330678|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
148688135|NCT00617461|536330679|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
148688136|NCT00617461|536330678|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
148688137|NCT00617461|536330679|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
148688138|NCT00617461|536330678|FG000|Second Treatment Intervention Period|Adverse Event|0|||
148688139|NCT00617461|536330679|FG001|Second Treatment Intervention Period|Adverse Event|1|||
148688140|NCT00617461|536330678|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
148688141|NCT00617461|536330679|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
148688142|NCT00617461|536330678|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
148688143|NCT00617461|536330679|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
148688144|NCT00617461|536330678|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
148688145|NCT00617461|536330679|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
148688146|NCT01821625|536330680|FG000|Overall Study|Withdrawal by Subject|2|||
148688147|NCT01821625|536330680|FG000|Overall Study|Lack of Efficacy|2|||
148688148|NCT01821625|536330680|FG000|Overall Study|Adverse Event|1|||
148688149|NCT01821625|536330680|FG000|Overall Study|Medical contraindication|1|||
148688150|NCT00457665|536330686|FG000|12 Months|Drug allergy|1|||
148688151|NCT00457665|536330687|FG001|12 Months|Drug allergy|1|||
148688152|NCT00457665|536330686|FG000|12 Months|High HIV viral load|5|||
148688153|NCT00457665|536330687|FG001|12 Months|High HIV viral load|1|||
148688154|NCT00457665|536330686|FG000|12 Months|Lipodystrophy|2|||
148688155|NCT00457665|536330687|FG001|12 Months|Lipodystrophy|0|||
148688156|NCT00457665|536330686|FG000|12 Months|Withdrawal by Subject|0|||
148688157|NCT00457665|536330687|FG001|12 Months|Withdrawal by Subject|2|||
148688158|NCT00457665|536330686|FG000|12 Months|Abnormal Liver function tests|0|||
148688159|NCT00457665|536330687|FG001|12 Months|Abnormal Liver function tests|5|||
148688160|NCT00457665|536330686|FG000|24 Months|Withdrawal by Subject|3|||
148688161|NCT00457665|536330687|FG001|24 Months|Withdrawal by Subject|2|||
148688162|NCT00457665|536330686|FG000|24 Months|Lipodystrophy|1|||
148688163|NCT00457665|536330687|FG001|24 Months|Lipodystrophy|1|||
148688164|NCT00457665|536330686|FG000|24 Months|Abnormal liver function tests|1|||
148688165|NCT00457665|536330687|FG001|24 Months|Abnormal liver function tests|5|||
149226215|NCT04815291|538294897|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
149226216|NCT00095836|538294901|FG000|Overall Study|Lost to Follow-up|1|||
149226217|NCT00095836|538294901|FG000|Overall Study|Adverse Event|1|||
149226218|NCT00095836|538294901|FG000|Overall Study|Death|2|||
149226219|NCT00989664|538294904|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
149226220|NCT00989664|538294904|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
149226221|NCT00989664|538294904|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
149226222|NCT00989664|538294904|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
149226223|NCT00989664|538294904|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
149226224|NCT00989664|538294904|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
149226225|NCT00989664|538294904|FG000|Long-Term Follow-Up|Death|3|||
149226226|NCT00962780|538294906|FG000|Overall Study|Death|0|||
149226227|NCT00962780|538294907|FG001|Overall Study|Death|1|||
149226228|NCT00962780|538294906|FG000|Overall Study|Protocol Violation|9|||
149226229|NCT00962780|538294907|FG001|Overall Study|Protocol Violation|4|||
149226230|NCT00962780|538294906|FG000|Overall Study|Withdrawal by Subject|1|||
149226231|NCT00962780|538294907|FG001|Overall Study|Withdrawal by Subject|8|||
149226232|NCT00962780|538294906|FG000|Overall Study|Other|0|||
149226233|NCT00962780|538294907|FG001|Overall Study|Other|1|||
148688166|NCT02535000|536330689|FG000|Overall Study|Cancellation of surgery.|1|||
148688167|NCT02535000|536330690|FG001|Overall Study|Cancellation of surgery.|2|||
148688168|NCT01620489|536330695|FG000|Overall Study|Adverse Event|17|||
148688169|NCT01620489|536330696|FG001|Overall Study|Adverse Event|4|||
148688170|NCT01620489|536330695|FG000|Overall Study|Protocol Violation|0|||
148688171|NCT01620489|536330696|FG001|Overall Study|Protocol Violation|3|||
148688172|NCT01620489|536330695|FG000|Overall Study|Withdrawal Criteria|17|||
148688173|NCT01620489|536330696|FG001|Overall Study|Withdrawal Criteria|25|||
148688174|NCT01620489|536330695|FG000|Overall Study|Unclassified|1|||
148688175|NCT01620489|536330696|FG001|Overall Study|Unclassified|2|||
148688176|NCT01851590|536330699|FG000|Overall Study|Withdrawal by Subject|0|||
148688177|NCT01851590|536330700|FG001|Overall Study|Withdrawal by Subject|0|||
148954280|NCT01867021|537314754|FG001|Overall Study|Adverse Event|1|||
149226234|NCT02363322|538294910|FG000|Overall Study|Lost to Follow-up|1|||
149226235|NCT02363322|538294911|FG001|Overall Study|Lost to Follow-up|0|||
149226236|NCT02269709|538294912|FG000|Time of Enrollment|Withdrawal by Subject|3|||
149226237|NCT02269709|538294912|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
148688178|NCT01851590|536330701|FG002|Overall Study|Withdrawal by Subject|1|||
148688179|NCT01851590|536330699|FG000|Overall Study|Adverse Event|0|||
148688180|NCT01851590|536330700|FG001|Overall Study|Adverse Event|0|||
148688181|NCT01851590|536330701|FG002|Overall Study|Adverse Event|2|||
148688182|NCT01851590|536330699|FG000|Overall Study|Lack of Efficacy|0|||
149226238|NCT02269709|538294912|FG000|Six Month Follow-up|Lost to Follow-up|12|||
149226239|NCT02504424|538294914|FG000|Overall Study|Withdrawal by Subject|2|||
149226240|NCT00426842|538294915|FG000|Overall Study|Lost to Follow-up|1|||
149226241|NCT00982111|538294918|FG000|Overall Study|Adverse Event|1|||
149226242|NCT00982111|538294919|FG001|Overall Study|Adverse Event|1|||
149226243|NCT00982111|538294918|FG000|Overall Study|Progressive Disease|46|||
149226244|NCT00982111|538294919|FG001|Overall Study|Progressive Disease|39|||
149226245|NCT00982111|538294918|FG000|Overall Study|Lost to Follow-up|9|||
149226246|NCT00982111|538294919|FG001|Overall Study|Lost to Follow-up|6|||
149226247|NCT00982111|538294918|FG000|Overall Study|New Anti-Cancer Therapy|5|||
149226248|NCT00982111|538294919|FG001|Overall Study|New Anti-Cancer Therapy|5|||
149226249|NCT00982111|538294918|FG000|Overall Study|Medical Decision|1|||
149226250|NCT00982111|538294919|FG001|Overall Study|Medical Decision|0|||
149226251|NCT00982111|538294918|FG000|Overall Study|Withdrawal by Subject|17|||
149226252|NCT00982111|538294919|FG001|Overall Study|Withdrawal by Subject|19|||
149226253|NCT00982111|538294918|FG000|Overall Study|Global Study End|0|||
149226254|NCT00982111|538294919|FG001|Overall Study|Global Study End|1|||
149226255|NCT00982111|538294918|FG000|Overall Study|Sponsor's Decision|0|||
149226256|NCT00982111|538294919|FG001|Overall Study|Sponsor's Decision|1|||
149226257|NCT01070381|538294920|FG000|Period 2, 1 Week of Wear|Handling|0|||
149226258|NCT01070381|538294921|FG001|Period 2, 1 Week of Wear|Handling|1|||
149226259|NCT01070381|538294920|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
149226260|NCT01070381|538294921|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
149226261|NCT01230827|538294922|FG000|Overall Study|Lost to Follow-up|0|||
149226262|NCT01230827|538294923|FG001|Overall Study|Lost to Follow-up|0|||
149226263|NCT01230827|538294924|FG002|Overall Study|Lost to Follow-up|1|||
149226264|NCT01230827|538294925|FG003|Overall Study|Lost to Follow-up|3|||
149226265|NCT01230827|538294922|FG000|Overall Study|Withdrawal by Subject|1|||
149226266|NCT01230827|538294923|FG001|Overall Study|Withdrawal by Subject|0|||
149226267|NCT01230827|538294924|FG002|Overall Study|Withdrawal by Subject|3|||
149226268|NCT01230827|538294925|FG003|Overall Study|Withdrawal by Subject|2|||
149226269|NCT01230827|538294922|FG000|Overall Study|Lack of Efficacy|14|||
149226270|NCT01230827|538294923|FG001|Overall Study|Lack of Efficacy|1|||
149226271|NCT01230827|538294924|FG002|Overall Study|Lack of Efficacy|2|||
149226272|NCT01230827|538294925|FG003|Overall Study|Lack of Efficacy|3|||
149226273|NCT01230827|538294922|FG000|Overall Study|Adverse Event|4|||
149226274|NCT01230827|538294923|FG001|Overall Study|Adverse Event|2|||
149226275|NCT01230827|538294924|FG002|Overall Study|Adverse Event|3|||
149226276|NCT01230827|538294925|FG003|Overall Study|Adverse Event|7|||
149226277|NCT01230827|538294922|FG000|Overall Study|Recovery|0|||
149226278|NCT01230827|538294923|FG001|Overall Study|Recovery|6|||
149226279|NCT01230827|538294924|FG002|Overall Study|Recovery|0|||
149226280|NCT01230827|538294925|FG003|Overall Study|Recovery|0|||
149226281|NCT01230827|538294922|FG000|Overall Study|Study terminated by Sponsor|0|||
149226282|NCT01230827|538294923|FG001|Overall Study|Study terminated by Sponsor|2|||
149226283|NCT01230827|538294924|FG002|Overall Study|Study terminated by Sponsor|56|||
149226284|NCT01230827|538294925|FG003|Overall Study|Study terminated by Sponsor|63|||
149226285|NCT01854918|538294928|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
149226286|NCT01854918|538294929|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
149226287|NCT01854918|538294928|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
149226288|NCT01854918|538294929|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
149226289|NCT01854918|538294928|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
149226290|NCT01854918|538294929|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
149226291|NCT01854918|538294928|FG000|SOC-controlled Period (Year 1)|Death|5|||
149226292|NCT01854918|538294929|FG001|SOC-controlled Period (Year 1)|Death|5|||
149226293|NCT01854918|538294928|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
149226294|NCT01854918|538294929|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
148688183|NCT01851590|536330700|FG001|Overall Study|Lack of Efficacy|1|||
148688184|NCT01851590|536330701|FG002|Overall Study|Lack of Efficacy|0|||
148688185|NCT00696709|536330702|FG000|Overall Study|Withdrawal by Subject|1|||
149226295|NCT01854918|538294928|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
149226296|NCT01854918|538294929|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
149226297|NCT01854918|538294928|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
149226298|NCT01854918|538294929|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
149226299|NCT01854918|538294928|FG000|All-IP Period (Years 2 and 3)|Death|5|||
149226300|NCT01854918|538294929|FG001|All-IP Period (Years 2 and 3)|Death|16|||
149226301|NCT02918006|538294932|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
148688186|NCT00696709|536330703|FG001|Overall Study|Withdrawal by Subject|2|||
149226302|NCT02918006|538294933|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
148688187|NCT00696709|536330704|FG002|Overall Study|Withdrawal by Subject|1|||
149226303|NCT02918006|538294934|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
148688188|NCT00696709|536330705|FG003|Overall Study|Withdrawal by Subject|4|||
149226304|NCT02918006|538294932|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
149226305|NCT02918006|538294933|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
149226306|NCT02918006|538294934|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
149226307|NCT02918006|538294932|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
148810202|NCT00716417|536782582|FG008|Overall Study|On patient request due to toxicities|0|||
148810203|NCT00716417|536782583|FG009|Overall Study|On patient request due to toxicities|0|||
148810204|NCT01303419|536782584|FG000|Overall Study|Discontinuation of study|60|||
149019991|NCT00195715|537551099|FG000|Overall Study|Administrative reasons|2|||
149226308|NCT02918006|538294933|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
149226309|NCT02918006|538294934|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
149226310|NCT02918006|538294932|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
149226311|NCT02918006|538294933|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
149226312|NCT02918006|538294934|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
149226313|NCT02918006|538294932|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
149226314|NCT02918006|538294933|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
149226315|NCT02918006|538294934|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
149226316|NCT02918006|538294932|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
149226317|NCT02918006|538294933|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
149226318|NCT02918006|538294934|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
149226319|NCT02918006|538294932|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
149226320|NCT02918006|538294933|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
149226321|NCT02918006|538294934|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
149226322|NCT02918006|538294932|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
149226323|NCT02918006|538294933|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
149226324|NCT02918006|538294934|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
149226325|NCT02918006|538294932|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
149226326|NCT02918006|538294933|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
149226327|NCT02918006|538294934|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
149226328|NCT00453349|538294939|FG000|Randomized|Adverse Event|12|||
149226329|NCT00453349|538294940|FG001|Randomized|Adverse Event|11|||
149226330|NCT00453349|538294939|FG000|Randomized|Lack of Efficacy|2|||
149226331|NCT00453349|538294940|FG001|Randomized|Lack of Efficacy|1|||
149226332|NCT00453349|538294939|FG000|Randomized|Lost to Follow-up|7|||
149226333|NCT00453349|538294940|FG001|Randomized|Lost to Follow-up|5|||
149226334|NCT00453349|538294939|FG000|Randomized|Protocol Violation|1|||
149226335|NCT00453349|538294940|FG001|Randomized|Protocol Violation|1|||
149226336|NCT00453349|538294939|FG000|Randomized|Withdrawal by Subject|3|||
149226337|NCT00453349|538294940|FG001|Randomized|Withdrawal by Subject|5|||
149226338|NCT00453349|538294939|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
149226339|NCT00453349|538294940|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
149226340|NCT00453349|538294939|FG000|Completed Study|Adverse Event|12|||
149226341|NCT00453349|538294940|FG001|Completed Study|Adverse Event|11|||
149226342|NCT00453349|538294939|FG000|Completed Study|Lack of Efficacy|2|||
149226343|NCT00453349|538294940|FG001|Completed Study|Lack of Efficacy|1|||
149226344|NCT00453349|538294939|FG000|Completed Study|Lost to Follow-up|7|||
149226345|NCT00453349|538294940|FG001|Completed Study|Lost to Follow-up|5|||
149226346|NCT00453349|538294939|FG000|Completed Study|Protocol Violation|1|||
149226347|NCT00453349|538294940|FG001|Completed Study|Protocol Violation|1|||
149226348|NCT00453349|538294939|FG000|Completed Study|Withdrawal by Subject|3|||
149226349|NCT00453349|538294940|FG001|Completed Study|Withdrawal by Subject|5|||
149226350|NCT00453349|538294939|FG000|Completed Study|Lost to follow up after study treatment|2|||
149226351|NCT00453349|538294940|FG001|Completed Study|Lost to follow up after study treatment|11|||
149226352|NCT01513460|538294942|FG000|Overall Study|Death|0|||
149226353|NCT01513460|538294943|FG001|Overall Study|Death|0|||
149226354|NCT01513460|538294944|FG002|Overall Study|Death|1|||
149226355|NCT01513460|538294942|FG000|Overall Study|Lost to Follow-up|0|||
149226356|NCT01513460|538294943|FG001|Overall Study|Lost to Follow-up|0|||
149226357|NCT01513460|538294944|FG002|Overall Study|Lost to Follow-up|2|||
149226358|NCT01513460|538294942|FG000|Overall Study|Abnormal laboratory value|1|||
149226359|NCT01513460|538294943|FG001|Overall Study|Abnormal laboratory value|0|||
149226360|NCT01513460|538294944|FG002|Overall Study|Abnormal laboratory value|1|||
149226361|NCT01513460|538294942|FG000|Overall Study|Lack of Efficacy|1|||
149226362|NCT01513460|538294943|FG001|Overall Study|Lack of Efficacy|2|||
149226363|NCT01513460|538294944|FG002|Overall Study|Lack of Efficacy|5|||
149226364|NCT01513460|538294942|FG000|Overall Study|Protocol deviations|3|||
149226365|NCT01513460|538294943|FG001|Overall Study|Protocol deviations|4|||
149226366|NCT01513460|538294944|FG002|Overall Study|Protocol deviations|3|||
149226367|NCT01513460|538294942|FG000|Overall Study|Withdrawal by Subject|7|||
149226368|NCT01513460|538294943|FG001|Overall Study|Withdrawal by Subject|8|||
149226369|NCT01513460|538294944|FG002|Overall Study|Withdrawal by Subject|21|||
149226370|NCT01513460|538294942|FG000|Overall Study|Adverse Event|16|||
149226371|NCT01513460|538294943|FG001|Overall Study|Adverse Event|18|||
149226372|NCT01513460|538294944|FG002|Overall Study|Adverse Event|23|||
149226373|NCT01513460|538294942|FG000|Overall Study|Abnormal test procedure|1|||
149226374|NCT01513460|538294943|FG001|Overall Study|Abnormal test procedure|0|||
149226375|NCT01513460|538294944|FG002|Overall Study|Abnormal test procedure|0|||
149226376|NCT00489216|538294948|FG000|Overall Study|Adverse Event|1|||
149226377|NCT02312934|538294951|FG000|Overall Study|Lost to Follow-up|1|||
149226378|NCT02312934|538294952|FG001|Overall Study|Lost to Follow-up|0|||
148688189|NCT00696709|536330706|FG004|Overall Study|Withdrawal by Subject|3|||
148688190|NCT00696709|536330702|FG000|Overall Study|Protocol Violation|1|||
148688191|NCT00696709|536330703|FG001|Overall Study|Protocol Violation|0|||
148688192|NCT00696709|536330704|FG002|Overall Study|Protocol Violation|0|||
148688193|NCT00696709|536330705|FG003|Overall Study|Protocol Violation|0|||
148688194|NCT00696709|536330706|FG004|Overall Study|Protocol Violation|0|||
149226379|NCT02312934|538294951|FG000|Overall Study|Physician Decision|1|||
149226380|NCT02312934|538294952|FG001|Overall Study|Physician Decision|0|||
149226381|NCT03395704|538294953|FG000|Overall Study|Adverse Event|2|||
149226382|NCT03395704|538294954|FG001|Overall Study|Adverse Event|1|||
149226383|NCT03395704|538294953|FG000|Overall Study|Withdrawal by Subject|2|||
149226384|NCT03395704|538294954|FG001|Overall Study|Withdrawal by Subject|1|||
149226385|NCT03395704|538294953|FG000|Overall Study|Physician Decision|0|||
149226386|NCT03395704|538294954|FG001|Overall Study|Physician Decision|1|||
149226387|NCT02475564|538294955|FG000|Overall Study|Withdrawal by Subject|1|||
149226388|NCT02475564|538294956|FG001|Overall Study|Withdrawal by Subject|0|||
149226389|NCT02475564|538294955|FG000|Overall Study|Lost to Follow-up|2|||
149226390|NCT02475564|538294956|FG001|Overall Study|Lost to Follow-up|1|||
149226391|NCT02475564|538294955|FG000|Overall Study|Intense Menstrual bleeding|1|||
149226392|NCT02475564|538294956|FG001|Overall Study|Intense Menstrual bleeding|0|||
149226393|NCT00772031|538297556|FG000|Overall Study|Early termination of trial|12|||
149226394|NCT00772031|538297557|FG001|Overall Study|Early termination of trial|10|||
149226395|NCT00772031|538297556|FG000|Overall Study|Lost to Follow-up|20|||
149226396|NCT00772031|538297557|FG001|Overall Study|Lost to Follow-up|33|||
149226397|NCT02194699|538297562|FG000|Randomised|Did not receive treatment|1|||
149226398|NCT02194699|538297563|FG001|Randomised|Did not receive treatment|5|||
149226399|NCT02194699|538297562|FG000|Randomised|Without potential for 52 weeks of IP|5|||
149226400|NCT02194699|538297563|FG001|Randomised|Without potential for 52 weeks of IP|5|||
149226401|NCT02194699|538297562|FG000|Randomised|Duplicate patient|2|||
149226402|NCT02194699|538297563|FG001|Randomised|Duplicate patient|1|||
149226403|NCT02194699|538297562|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
149226404|NCT02194699|538297563|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
149226405|NCT02194699|538297562|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
149226406|NCT02194699|538297563|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
149226407|NCT02194699|538297562|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
149226408|NCT02194699|538297563|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
149226409|NCT02194699|538297562|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
149226410|NCT02194699|538297563|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
149226411|NCT02194699|538297562|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
149226412|NCT02194699|538297563|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
149226413|NCT02194699|538297562|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
149226414|NCT02194699|538297563|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
149226415|NCT02719028|538297564|FG000|Overall Study|Adverse Event|2|||
149226416|NCT02719028|538297565|FG001|Overall Study|Adverse Event|1|||
149226417|NCT02719028|538297566|FG002|Overall Study|Adverse Event|4|||
149226418|NCT02719028|538297567|FG003|Overall Study|Adverse Event|8|||
149226419|NCT02719028|538297564|FG000|Overall Study|Physician Decision|0|||
149226420|NCT02719028|538297565|FG001|Overall Study|Physician Decision|1|||
149226421|NCT02719028|538297566|FG002|Overall Study|Physician Decision|1|||
149226422|NCT02719028|538297567|FG003|Overall Study|Physician Decision|1|||
149226423|NCT02719028|538297564|FG000|Overall Study|Use of prohibited medication|0|||
149226424|NCT02719028|538297565|FG001|Overall Study|Use of prohibited medication|0|||
149226425|NCT02719028|538297566|FG002|Overall Study|Use of prohibited medication|1|||
149226426|NCT02719028|538297567|FG003|Overall Study|Use of prohibited medication|0|||
149226427|NCT02719028|538297564|FG000|Overall Study|Protocol Violation|0|||
149226428|NCT02719028|538297565|FG001|Overall Study|Protocol Violation|0|||
149226429|NCT02719028|538297566|FG002|Overall Study|Protocol Violation|0|||
149226430|NCT02719028|538297567|FG003|Overall Study|Protocol Violation|1|||
149226431|NCT01191190|538297568|FG000|Overall Study|Withdrawal by Subject|1|||
149226432|NCT00577382|538297570|FG000|Overall Study|Adverse Event|0|||
149226433|NCT00577382|538297571|FG001|Overall Study|Adverse Event|6|||
149226434|NCT00577382|538297570|FG000|Overall Study|Withdrawal by Subject|0|||
149226435|NCT00577382|538297571|FG001|Overall Study|Withdrawal by Subject|1|||
148688195|NCT00696709|536330702|FG000|Overall Study|Lost to Follow-up|1|||
148954281|NCT01867021|537314753|FG000|Overall Study|Not Eligible|0|||
148954282|NCT01867021|537314754|FG001|Overall Study|Not Eligible|1|||
148954283|NCT01867021|537314753|FG000|Overall Study|Death|1|||
149226436|NCT00577382|538297570|FG000|Overall Study|Progressive Disease|17|||
149226437|NCT00577382|538297571|FG001|Overall Study|Progressive Disease|19|||
149226438|NCT00577382|538297570|FG000|Overall Study|Intercurrent Illness|1|||
148688196|NCT00696709|536330703|FG001|Overall Study|Lost to Follow-up|1|||
148688197|NCT00696709|536330704|FG002|Overall Study|Lost to Follow-up|0|||
148688198|NCT00696709|536330705|FG003|Overall Study|Lost to Follow-up|0|||
148688199|NCT00696709|536330706|FG004|Overall Study|Lost to Follow-up|0|||
148954284|NCT01867021|537314754|FG001|Overall Study|Death|0|||
149226439|NCT00577382|538297571|FG001|Overall Study|Intercurrent Illness|2|||
149019992|NCT00195715|537551099|FG000|Overall Study|Investigator's decision|2|||
149019993|NCT00195715|537551099|FG000|Overall Study|Subject wants to get pregnant|4|||
149019994|NCT00195715|537551099|FG000|Overall Study|Use of prohibited medication|2|||
149019995|NCT00195715|537551099|FG000|Overall Study|Planned surgery|2|||
149019996|NCT00195715|537551099|FG000|Overall Study|Increased infection rate|1|||
149019997|NCT00195715|537551099|FG000|Overall Study|Ineligible|1|||
148688200|NCT00696709|536330702|FG000|Overall Study|Adverse Event|0|||
149019998|NCT00195715|537551099|FG000|Overall Study|Colonic stricture|1|||
149019999|NCT00195715|537551099|FG000|Overall Study|Sponsor discontinued trial|1|||
149020000|NCT00195715|537551099|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
149020001|NCT05822921|537551104|FG000|Overall Study|Lost to Follow-up|1|||
149020002|NCT05822921|537551105|FG001|Overall Study|Lost to Follow-up|1|||
149020003|NCT00544544|537551106|FG000|Overall Study|Withdrawal by Subject|1|||
149020004|NCT00544544|537551106|FG000|Overall Study|Adverse Event|1|||
149020005|NCT00544544|537551106|FG000|Overall Study|Lost to Follow-up|1|||
149020006|NCT02036515|537551112|FG000|Overall Study|Adverse Event|1|||
149020007|NCT02036515|537551113|FG001|Overall Study|Adverse Event|1|||
149020008|NCT02036515|537551114|FG002|Overall Study|Adverse Event|2|||
149020009|NCT02036515|537551112|FG000|Overall Study|Lost to Follow-up|0|||
149020010|NCT02036515|537551113|FG001|Overall Study|Lost to Follow-up|2|||
149020011|NCT02036515|537551114|FG002|Overall Study|Lost to Follow-up|0|||
149020012|NCT02036515|537551112|FG000|Overall Study|Non-compliance with study drug|0|||
149020013|NCT02036515|537551113|FG001|Overall Study|Non-compliance with study drug|0|||
149020014|NCT02036515|537551114|FG002|Overall Study|Non-compliance with study drug|2|||
149020015|NCT02036515|537551112|FG000|Overall Study|Screen failure|0|||
149020016|NCT02036515|537551113|FG001|Overall Study|Screen failure|2|||
149020017|NCT02036515|537551114|FG002|Overall Study|Screen failure|0|||
149020018|NCT02036515|537551112|FG000|Overall Study|Withdrawal by Subject|4|||
149020019|NCT02036515|537551113|FG001|Overall Study|Withdrawal by Subject|7|||
149020020|NCT02036515|537551114|FG002|Overall Study|Withdrawal by Subject|9|||
149020021|NCT02036515|537551112|FG000|Overall Study|Hyperglycemia|0|||
149020022|NCT02036515|537551113|FG001|Overall Study|Hyperglycemia|0|||
149020023|NCT02036515|537551114|FG002|Overall Study|Hyperglycemia|1|||
149020024|NCT01671748|537551121|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
149020025|NCT01671748|537551122|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
149020026|NCT01671748|537551121|FG000|4 Week run-in Phase|Adverse Event|1|||
149020027|NCT01671748|537551122|FG001|4 Week run-in Phase|Adverse Event|0|||
148688201|NCT00696709|536330703|FG001|Overall Study|Adverse Event|0|||
148688202|NCT00696709|536330704|FG002|Overall Study|Adverse Event|0|||
148688203|NCT00696709|536330705|FG003|Overall Study|Adverse Event|1|||
148688204|NCT00696709|536330706|FG004|Overall Study|Adverse Event|0|||
148688205|NCT00310856|536330707|FG000|Overall Study|Withdrawal by Subject|2|||
148688206|NCT00310856|536330708|FG001|Overall Study|Withdrawal by Subject|2|||
148688207|NCT00310856|536330709|FG002|Overall Study|Withdrawal by Subject|2|||
148688208|NCT00310856|536330707|FG000|Overall Study|Lost to Follow-up|1|||
148688209|NCT00310856|536330708|FG001|Overall Study|Lost to Follow-up|2|||
148688210|NCT00310856|536330709|FG002|Overall Study|Lost to Follow-up|6|||
148688211|NCT00310856|536330707|FG000|Overall Study|Inappropriate enrollment|1|||
148688212|NCT00310856|536330708|FG001|Overall Study|Inappropriate enrollment|1|||
148688213|NCT00310856|536330709|FG002|Overall Study|Inappropriate enrollment|0|||
148688214|NCT00310856|536330707|FG000|Overall Study|Unable to classify|1|||
148688215|NCT00310856|536330708|FG001|Overall Study|Unable to classify|0|||
148688216|NCT00310856|536330709|FG002|Overall Study|Unable to classify|0|||
148688217|NCT00321711|536330713|FG000|Part A|Adverse Event|3|||
148688218|NCT00321711|536330714|FG001|Part A|Adverse Event|3|||
148688219|NCT00321711|536330715|FG002|Part A|Adverse Event|2|||
148688220|NCT00321711|536330716|FG003|Part A|Adverse Event|0|||
148688221|NCT00321711|536330717|FG004|Part A|Adverse Event|0|||
148688222|NCT00321711|536330713|FG000|Part A|Withdrawal by Subject|1|||
148688223|NCT00321711|536330714|FG001|Part A|Withdrawal by Subject|1|||
149020028|NCT01671748|537551121|FG000|4 Week run-in Phase|Not eligible|9|||
148688224|NCT00321711|536330715|FG002|Part A|Withdrawal by Subject|1|||
148688225|NCT00321711|536330716|FG003|Part A|Withdrawal by Subject|0|||
148810205|NCT01303419|536782584|FG000|Overall Study|Did not complete both imaging methods|5|||
149020029|NCT01671748|537551122|FG001|4 Week run-in Phase|Not eligible|0|||
149020030|NCT02601937|537551123|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
148688226|NCT00321711|536330717|FG004|Part A|Withdrawal by Subject|0|||
148688227|NCT00321711|536330713|FG000|Part A|Disease progression|0|||
148688228|NCT00321711|536330714|FG001|Part A|Disease progression|1|||
148688229|NCT00321711|536330715|FG002|Part A|Disease progression|0|||
148688230|NCT00321711|536330716|FG003|Part A|Disease progression|0|||
149020031|NCT02601937|537551124|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020032|NCT02601937|537551125|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020033|NCT02601937|537551126|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020034|NCT02601937|537551127|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
148688231|NCT00321711|536330717|FG004|Part A|Disease progression|0|||
148810206|NCT01303419|536782584|FG000|Overall Study|Did not meet all I/E after screening|31|||
148688232|NCT00321711|536330713|FG000|Part A|Requirement for alternative therapy|0|||
148688233|NCT00321711|536330714|FG001|Part A|Requirement for alternative therapy|2|||
148688234|NCT00321711|536330715|FG002|Part A|Requirement for alternative therapy|1|||
148688235|NCT00321711|536330716|FG003|Part A|Requirement for alternative therapy|0|||
148688236|NCT00321711|536330717|FG004|Part A|Requirement for alternative therapy|0|||
148688237|NCT00321711|536330713|FG000|Part A|Physician Decision|0|||
148688238|NCT00321711|536330714|FG001|Part A|Physician Decision|1|||
148688239|NCT00321711|536330715|FG002|Part A|Physician Decision|3|||
148688240|NCT00321711|536330716|FG003|Part A|Physician Decision|0|||
148688241|NCT00321711|536330717|FG004|Part A|Physician Decision|0|||
148688242|NCT00321711|536330713|FG000|Part A|Other|1|||
148688243|NCT00321711|536330714|FG001|Part A|Other|2|||
148688244|NCT00321711|536330715|FG002|Part A|Other|3|||
148688245|NCT00321711|536330716|FG003|Part A|Other|0|||
148688246|NCT00321711|536330717|FG004|Part A|Other|0|||
148688247|NCT00321711|536330713|FG000|Part A|Protocol deviation|0|||
148688248|NCT00321711|536330714|FG001|Part A|Protocol deviation|0|||
148688249|NCT00321711|536330715|FG002|Part A|Protocol deviation|1|||
148688250|NCT00321711|536330716|FG003|Part A|Protocol deviation|0|||
148688251|NCT00321711|536330717|FG004|Part A|Protocol deviation|0|||
148688252|NCT00321711|536330713|FG000|Part B|Noncompliance|0|||
148688253|NCT00321711|536330714|FG001|Part B|Noncompliance|0|||
148688254|NCT00321711|536330715|FG002|Part B|Noncompliance|0|||
148688255|NCT00321711|536330716|FG003|Part B|Noncompliance|0|||
148688256|NCT00321711|536330717|FG004|Part B|Noncompliance|1|||
148688257|NCT00321711|536330713|FG000|Part B|Adverse Event|0|||
148688258|NCT00321711|536330714|FG001|Part B|Adverse Event|0|||
148688259|NCT00321711|536330715|FG002|Part B|Adverse Event|0|||
148688260|NCT00321711|536330716|FG003|Part B|Adverse Event|2|||
148688261|NCT00321711|536330717|FG004|Part B|Adverse Event|1|||
148688262|NCT00321711|536330713|FG000|Part B|Disease progression|0|||
148688263|NCT00321711|536330714|FG001|Part B|Disease progression|0|||
148688264|NCT00321711|536330715|FG002|Part B|Disease progression|0|||
148688265|NCT00321711|536330716|FG003|Part B|Disease progression|1|||
148688266|NCT00321711|536330717|FG004|Part B|Disease progression|0|||
148688267|NCT00321711|536330713|FG000|Part B|Physician Decision|0|||
148688268|NCT00321711|536330714|FG001|Part B|Physician Decision|0|||
148688269|NCT00321711|536330715|FG002|Part B|Physician Decision|0|||
148688270|NCT00321711|536330716|FG003|Part B|Physician Decision|1|||
148688271|NCT00321711|536330717|FG004|Part B|Physician Decision|2|||
148688272|NCT00321711|536330713|FG000|Part B|Death|0|||
148688273|NCT00321711|536330714|FG001|Part B|Death|0|||
148688274|NCT00321711|536330715|FG002|Part B|Death|0|||
148688275|NCT00321711|536330716|FG003|Part B|Death|2|||
148688276|NCT00321711|536330717|FG004|Part B|Death|1|||
148688277|NCT01186978|536330718|FG000|Overall Study|Withdrawal by Subject|1|||
148688278|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
148688279|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
148688280|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
148688281|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
148688282|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
148688283|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
148688284|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
149226440|NCT00577382|538297570|FG000|Overall Study|Death|1|||
149226441|NCT00577382|538297571|FG001|Overall Study|Death|1|||
149226442|NCT00577382|538297570|FG000|Overall Study|Lost to Follow-up|2|||
149226443|NCT00577382|538297571|FG001|Overall Study|Lost to Follow-up|2|||
149226444|NCT03007472|538297572|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
149226445|NCT03007472|538297572|FG000|Overall Study|Death|2|||
149226446|NCT03007472|538297572|FG000|Overall Study|Loss to Follow Up|1|||
149226447|NCT00649220|538297573|FG000|Overall Study|Adverse Event|2|||
148688285|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
148688286|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
148688287|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
148688288|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
148688289|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
148688290|NCT01227668|536330719|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
148688291|NCT01227668|536330720|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
148688292|NCT01227668|536330719|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
148688293|NCT01227668|536330720|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
148688294|NCT01227668|536330719|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
148688295|NCT01227668|536330720|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
148688296|NCT01227668|536330719|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
149226448|NCT00649220|538297573|FG000|Overall Study|Withdrawal by Subject|1|||
148688297|NCT01227668|536330720|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
148688298|NCT01227668|536330719|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
148688299|NCT01227668|536330720|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
148688300|NCT01227668|536330719|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
148688301|NCT01227668|536330720|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
149226449|NCT00525499|538297574|FG000|Overall Study|Lost to Follow-up|2|||
149226450|NCT00525499|538297575|FG001|Overall Study|Lost to Follow-up|4|||
149226451|NCT00525499|538297576|FG002|Overall Study|Lost to Follow-up|1|||
148810207|NCT02755090|536782586|FG000|Overall Study|equipment malfunction|1|||
148810208|NCT02755090|536782587|FG001|Overall Study|equipment malfunction|0|||
149226452|NCT00525499|538297577|FG003|Overall Study|Lost to Follow-up|4|||
148688302|NCT01306253|536330724|FG000|Overall Study|Lost to Follow-up|1|||
148688303|NCT01306253|536330725|FG001|Overall Study|Lost to Follow-up|1|||
148688304|NCT00543439|536330726|FG000|Period 1|Adverse Event|0|||
148688305|NCT00543439|536330727|FG001|Period 1|Adverse Event|2|||
148688306|NCT00543439|536330728|FG002|Period 1|Adverse Event|1|||
148688307|NCT00543439|536330726|FG000|Period 1|Withdrawal by Subject|1|||
148688308|NCT00543439|536330727|FG001|Period 1|Withdrawal by Subject|1|||
148688309|NCT00543439|536330728|FG002|Period 1|Withdrawal by Subject|0|||
148688310|NCT00543439|536330726|FG000|Period 1|Physician Decision|0|||
148688311|NCT00543439|536330727|FG001|Period 1|Physician Decision|0|||
148688312|NCT00543439|536330728|FG002|Period 1|Physician Decision|1|||
148688313|NCT00543439|536330726|FG000|Period 2|Protocol Violation|1|||
148688314|NCT00543439|536330727|FG001|Period 2|Protocol Violation|0|||
148688315|NCT00543439|536330728|FG002|Period 2|Protocol Violation|1|||
148688316|NCT00543439|536330726|FG000|Period 2|Adverse Event|0|||
148688317|NCT00543439|536330727|FG001|Period 2|Adverse Event|1|||
148688318|NCT00543439|536330728|FG002|Period 2|Adverse Event|1|||
148688319|NCT01709383|536330733|FG000|Overall Study|Lost to Follow-up|1|||
148688320|NCT01709383|536330734|FG001|Overall Study|Lost to Follow-up|0|||
148688321|NCT03264066|536330735|FG000|Overall Study|Adverse Event|1|||
148688322|NCT03264066|536330736|FG001|Overall Study|Adverse Event|1|||
148688323|NCT03264066|536330737|FG002|Overall Study|Adverse Event|0|||
149226453|NCT00525499|538297574|FG000|Overall Study|Adverse Event|0|||
149226454|NCT00525499|538297575|FG001|Overall Study|Adverse Event|1|||
149226455|NCT00525499|538297576|FG002|Overall Study|Adverse Event|0|||
149226456|NCT00525499|538297577|FG003|Overall Study|Adverse Event|1|||
149226457|NCT00525499|538297574|FG000|Overall Study|Withdrawal by Subject|5|||
149226458|NCT00525499|538297575|FG001|Overall Study|Withdrawal by Subject|1|||
149226459|NCT00525499|538297576|FG002|Overall Study|Withdrawal by Subject|5|||
149226460|NCT00525499|538297577|FG003|Overall Study|Withdrawal by Subject|2|||
149226461|NCT00525499|538297574|FG000|Overall Study|Protocol Violation|0|||
149226462|NCT00525499|538297575|FG001|Overall Study|Protocol Violation|1|||
149226463|NCT00525499|538297576|FG002|Overall Study|Protocol Violation|1|||
149226464|NCT00525499|538297577|FG003|Overall Study|Protocol Violation|0|||
149226465|NCT03287089|538297582|FG000|Overall Study|Lost to Follow-up|0|||
149226466|NCT03287089|538297583|FG001|Overall Study|Lost to Follow-up|2|||
149226467|NCT03287089|538297582|FG000|Overall Study|Physician Decision|0|||
149226468|NCT03287089|538297583|FG001|Overall Study|Physician Decision|2|||
149226469|NCT03287089|538297582|FG000|Overall Study|Withdrawal by Subject|0|||
149226470|NCT03287089|538297583|FG001|Overall Study|Withdrawal by Subject|2|||
149226471|NCT01729559|538297584|FG000|Overall Study|Protocol Violation|31|||
149226472|NCT01729559|538297585|FG001|Overall Study|Protocol Violation|28|||
149226473|NCT02906644|538297590|FG000|First 2 Weeks|Withdrawal by Subject|0|||
148688324|NCT03264066|536330738|FG003|Overall Study|Adverse Event|0|||
148688325|NCT03264066|536330739|FG004|Overall Study|Adverse Event|0|||
148688326|NCT03264066|536330740|FG005|Overall Study|Adverse Event|0|||
148688327|NCT03264066|536330735|FG000|Overall Study|Death|12|||
148688328|NCT03264066|536330736|FG001|Overall Study|Death|12|||
148810209|NCT02337829|536782590|FG000|Overall Study|Death|0|||
148810210|NCT02337829|536782591|FG001|Overall Study|Death|1|||
149226474|NCT02906644|538297591|FG001|First 2 Weeks|Withdrawal by Subject|2|||
149226475|NCT02906644|538297590|FG000|First 2 Weeks|Physician Decision|1|||
149226476|NCT02906644|538297591|FG001|First 2 Weeks|Physician Decision|1|||
149226477|NCT02906644|538297590|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
148810211|NCT02337829|536782592|FG002|Overall Study|Death|0|||
148688329|NCT03264066|536330737|FG002|Overall Study|Death|8|||
148688330|NCT03264066|536330738|FG003|Overall Study|Death|10|||
148688331|NCT03264066|536330739|FG004|Overall Study|Death|6|||
148688332|NCT03264066|536330740|FG005|Overall Study|Death|1|||
148688333|NCT03264066|536330735|FG000|Overall Study|Lost to Follow-up|1|||
148688334|NCT03264066|536330736|FG001|Overall Study|Lost to Follow-up|0|||
148688335|NCT03264066|536330737|FG002|Overall Study|Lost to Follow-up|0|||
148688336|NCT03264066|536330738|FG003|Overall Study|Lost to Follow-up|0|||
148688337|NCT03264066|536330739|FG004|Overall Study|Lost to Follow-up|0|||
148688338|NCT03264066|536330740|FG005|Overall Study|Lost to Follow-up|0|||
148688339|NCT03264066|536330735|FG000|Overall Study|Progressive Disease|0|||
148688340|NCT03264066|536330736|FG001|Overall Study|Progressive Disease|2|||
148688341|NCT03264066|536330737|FG002|Overall Study|Progressive Disease|1|||
148688342|NCT03264066|536330738|FG003|Overall Study|Progressive Disease|0|||
148688343|NCT03264066|536330739|FG004|Overall Study|Progressive Disease|0|||
148688344|NCT03264066|536330740|FG005|Overall Study|Progressive Disease|0|||
148688345|NCT03264066|536330735|FG000|Overall Study|Study Terminated by Sponsor|5|||
148688346|NCT03264066|536330736|FG001|Overall Study|Study Terminated by Sponsor|5|||
148688347|NCT03264066|536330737|FG002|Overall Study|Study Terminated by Sponsor|8|||
148688348|NCT03264066|536330738|FG003|Overall Study|Study Terminated by Sponsor|5|||
148688349|NCT03264066|536330739|FG004|Overall Study|Study Terminated by Sponsor|1|||
148688350|NCT03264066|536330740|FG005|Overall Study|Study Terminated by Sponsor|2|||
148688351|NCT03264066|536330735|FG000|Overall Study|Withdrawal by Subject|1|||
148688352|NCT03264066|536330736|FG001|Overall Study|Withdrawal by Subject|0|||
148688353|NCT03264066|536330737|FG002|Overall Study|Withdrawal by Subject|0|||
148688354|NCT03264066|536330738|FG003|Overall Study|Withdrawal by Subject|5|||
148688355|NCT03264066|536330739|FG004|Overall Study|Withdrawal by Subject|0|||
148688356|NCT03264066|536330740|FG005|Overall Study|Withdrawal by Subject|0|||
148688357|NCT01484028|536330741|FG000|Period 1|Lost to Follow-up|0|||
148688358|NCT01484028|536330742|FG001|Period 1|Lost to Follow-up|1|||
148688359|NCT01484028|536330743|FG002|Period 1|Lost to Follow-up|0|||
148688360|NCT01484028|536330744|FG003|Period 1|Lost to Follow-up|0|||
148688361|NCT01484028|536330741|FG000|Period 1|Non-Compliance to Protocol|0|||
148688362|NCT01484028|536330742|FG001|Period 1|Non-Compliance to Protocol|1|||
148688363|NCT01484028|536330743|FG002|Period 1|Non-Compliance to Protocol|0|||
148688364|NCT01484028|536330744|FG003|Period 1|Non-Compliance to Protocol|1|||
148688365|NCT01484028|536330741|FG000|Period 1|Lens Discomfort|0|||
148688366|NCT01484028|536330742|FG001|Period 1|Lens Discomfort|1|||
148688367|NCT01484028|536330743|FG002|Period 1|Lens Discomfort|0|||
148688368|NCT01484028|536330744|FG003|Period 1|Lens Discomfort|0|||
148688369|NCT01193517|536330750|FG000|Overall Study|Early Progression|1|||
148688370|NCT01193517|536330751|FG001|Overall Study|Early Progression|0|||
148688371|NCT01193517|536330752|FG002|Overall Study|Early Progression|0|||
148688372|NCT02115256|536330755|FG000|Overall Study|Withdrawal by Subject|0|||
148688373|NCT02115256|536330756|FG001|Overall Study|Withdrawal by Subject|1|||
148688374|NCT00146770|536330757|FG000|Overall Study|Adverse Event|2|||
148688375|NCT00146770|536330758|FG001|Overall Study|Adverse Event|0|||
148688376|NCT00146770|536330757|FG000|Overall Study|Pregnancy|1|||
148688377|NCT00146770|536330758|FG001|Overall Study|Pregnancy|0|||
148688378|NCT00146770|536330757|FG000|Overall Study|Withdrawal by Subject|2|||
148688379|NCT00146770|536330758|FG001|Overall Study|Withdrawal by Subject|0|||
148688380|NCT01185288|536330759|FG000|Overall Study|Adverse Event|7|||
148688381|NCT01185288|536330760|FG001|Overall Study|Adverse Event|6|||
148688382|NCT01185288|536330759|FG000|Overall Study|Withdrawal by Subject|6|||
148688383|NCT01185288|536330760|FG001|Overall Study|Withdrawal by Subject|4|||
148688384|NCT01185288|536330759|FG000|Overall Study|Lost to Follow-up|2|||
148688385|NCT01185288|536330760|FG001|Overall Study|Lost to Follow-up|5|||
148688386|NCT01185288|536330759|FG000|Overall Study|Lack of Efficacy|2|||
148688387|NCT01185288|536330760|FG001|Overall Study|Lack of Efficacy|0|||
148688388|NCT01185288|536330759|FG000|Overall Study|Investigator discretion|1|||
148688389|NCT01185288|536330760|FG001|Overall Study|Investigator discretion|0|||
148688390|NCT01185288|536330759|FG000|Overall Study|Did not meet inclusion criteria|1|||
148688391|NCT01185288|536330760|FG001|Overall Study|Did not meet inclusion criteria|0|||
148688392|NCT01185288|536330759|FG000|Overall Study|Noncompliance|0|||
148688393|NCT01185288|536330760|FG001|Overall Study|Noncompliance|1|||
148688394|NCT01626859|536330763|FG000|Overall Study|Adverse Event|1|||
148688395|NCT01626859|536330764|FG001|Overall Study|Adverse Event|3|||
148688396|NCT01626859|536330765|FG002|Overall Study|Adverse Event|2|||
148688397|NCT01626859|536330763|FG000|Overall Study|Physician Decision|0|||
148688398|NCT01626859|536330764|FG001|Overall Study|Physician Decision|1|||
148688399|NCT01626859|536330765|FG002|Overall Study|Physician Decision|0|||
148688400|NCT01626859|536330763|FG000|Overall Study|Withdrawal by Subject|1|||
148688401|NCT01626859|536330764|FG001|Overall Study|Withdrawal by Subject|4|||
148688402|NCT01626859|536330765|FG002|Overall Study|Withdrawal by Subject|2|||
148688403|NCT02427607|536330766|FG000|Overall Study|Withdrawal by Subject|1|||
148688404|NCT02277769|536330767|FG000|Overall Study|Protocol Violation|3|||
148688405|NCT02277769|536330768|FG001|Overall Study|Protocol Violation|3|||
148688406|NCT02277769|536330769|FG002|Overall Study|Protocol Violation|5|||
148688407|NCT02277769|536330767|FG000|Overall Study|Lack of Efficacy|17|||
148688408|NCT02277769|536330768|FG001|Overall Study|Lack of Efficacy|0|||
148688409|NCT02277769|536330769|FG002|Overall Study|Lack of Efficacy|4|||
148688410|NCT02277769|536330767|FG000|Overall Study|Adverse Event|14|||
148688411|NCT02277769|536330768|FG001|Overall Study|Adverse Event|2|||
148688412|NCT02277769|536330769|FG002|Overall Study|Adverse Event|4|||
148688413|NCT02277769|536330767|FG000|Overall Study|Other than specified above|12|||
148688414|NCT02277769|536330768|FG001|Overall Study|Other than specified above|8|||
148688415|NCT02277769|536330769|FG002|Overall Study|Other than specified above|5|||
148688416|NCT02826603|536330770|FG000|Overall Study|Adverse Event|17|||
148688417|NCT02826603|536330771|FG001|Overall Study|Adverse Event|9|||
148688418|NCT02826603|536330770|FG000|Overall Study|Lack of Efficacy|4|||
148688419|NCT02826603|536330771|FG001|Overall Study|Lack of Efficacy|9|||
148688420|NCT02826603|536330770|FG000|Overall Study|Lost to Follow-up|13|||
149226478|NCT02906644|538297591|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
148688421|NCT02826603|536330771|FG001|Overall Study|Lost to Follow-up|12|||
148688422|NCT02826603|536330770|FG000|Overall Study|Noncompliance with treatment|0|||
148688423|NCT02826603|536330771|FG001|Overall Study|Noncompliance with treatment|2|||
148688424|NCT02826603|536330770|FG000|Overall Study|Physician Decision|1|||
148688425|NCT02826603|536330771|FG001|Overall Study|Physician Decision|7|||
148688426|NCT02826603|536330770|FG000|Overall Study|Pregnancy|1|||
148688427|NCT02826603|536330771|FG001|Overall Study|Pregnancy|2|||
148688428|NCT02826603|536330770|FG000|Overall Study|Protocol Violation|3|||
148688429|NCT02826603|536330771|FG001|Overall Study|Protocol Violation|3|||
148688430|NCT02826603|536330770|FG000|Overall Study|Withdrawal by Subject|20|||
148688431|NCT02826603|536330771|FG001|Overall Study|Withdrawal by Subject|19|||
148688432|NCT02826603|536330770|FG000|Overall Study|Death|2|||
148688433|NCT02826603|536330771|FG001|Overall Study|Death|0|||
148688434|NCT02826603|536330770|FG000|Overall Study|New therapy for study indication|0|||
148688435|NCT02826603|536330771|FG001|Overall Study|New therapy for study indication|1|||
148688436|NCT00905489|536330772|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
148688437|NCT00905489|536330772|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
148688438|NCT00905489|536330772|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
148688439|NCT00656019|536330773|FG000|Overall Study|Not Eligible|10|||
148688440|NCT00656019|536330774|FG001|Overall Study|Not Eligible|0|||
148688441|NCT00656019|536330775|FG002|Overall Study|Not Eligible|0|||
148688442|NCT00656019|536330776|FG003|Overall Study|Not Eligible|0|||
148688443|NCT00656019|536330773|FG000|Overall Study|Withdrawal by Subject|2|||
148688444|NCT00656019|536330774|FG001|Overall Study|Withdrawal by Subject|0|||
148688445|NCT00656019|536330775|FG002|Overall Study|Withdrawal by Subject|0|||
148688446|NCT00656019|536330776|FG003|Overall Study|Withdrawal by Subject|0|||
148688447|NCT00656019|536330773|FG000|Overall Study|Lost to Follow-up|2|||
148688448|NCT00656019|536330774|FG001|Overall Study|Lost to Follow-up|1|||
148688449|NCT00656019|536330775|FG002|Overall Study|Lost to Follow-up|0|||
148688450|NCT00656019|536330776|FG003|Overall Study|Lost to Follow-up|0|||
148688451|NCT01626885|536330783|FG000|Overall Study|Adverse Event|8|||
148688452|NCT01626885|536330783|FG000|Overall Study|Withdrawal by Subject|4|||
148688453|NCT01506323|536332270|FG000|Overall Study|Lost to Follow-up|5|||
148688454|NCT01506323|536332271|FG001|Overall Study|Lost to Follow-up|4|||
148688455|NCT01506323|536332270|FG000|Overall Study|Withdrawal by Subject|4|||
148688456|NCT01506323|536332271|FG001|Overall Study|Withdrawal by Subject|4|||
148688457|NCT01506323|536332270|FG000|Overall Study|Lack of Efficacy|1|||
148688458|NCT01506323|536332271|FG001|Overall Study|Lack of Efficacy|3|||
148688459|NCT01506323|536332270|FG000|Overall Study|Moved out of area|5|||
148688460|NCT01506323|536332271|FG001|Overall Study|Moved out of area|2|||
148688461|NCT01506323|536332270|FG000|Overall Study|Schedule or Transportation conflict|8|||
148688462|NCT01506323|536332271|FG001|Overall Study|Schedule or Transportation conflict|0|||
148688463|NCT01506323|536332270|FG000|Overall Study|Started another treatment|1|||
148688464|NCT01506323|536332271|FG001|Overall Study|Started another treatment|0|||
148688465|NCT02232074|536332272|FG000|Overall Study|Withdrawal by Subject|5|||
148688466|NCT02232074|536332273|FG001|Overall Study|Withdrawal by Subject|3|||
148688467|NCT02232074|536332272|FG000|Overall Study|No legal concerns at baseline|36|||
148688468|NCT02232074|536332273|FG001|Overall Study|No legal concerns at baseline|41|||
148688469|NCT02232074|536332272|FG000|Overall Study|deemed ineligible|0|||
148688470|NCT02232074|536332273|FG001|Overall Study|deemed ineligible|1|||
148688471|NCT01075763|536332274|FG000|Overall Study|Lost to Follow-up|2|||
148688472|NCT01075763|536332275|FG001|Overall Study|Lost to Follow-up|1|||
148688473|NCT01075763|536332274|FG000|Overall Study|Lack of Efficacy|0|||
148688474|NCT01075763|536332275|FG001|Overall Study|Lack of Efficacy|1|||
148688475|NCT01075763|536332274|FG000|Overall Study|Withdrawal by Subject|2|||
148688476|NCT01075763|536332275|FG001|Overall Study|Withdrawal by Subject|2|||
148688477|NCT02710071|536332279|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
148688478|NCT02710071|536332280|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
148688479|NCT02710071|536332279|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
148688480|NCT02710071|536332280|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
148688481|NCT01673009|536332287|FG000|Overall Study|Physician Decision|5|||
148688482|NCT01673009|536332287|FG000|Overall Study|Withdrawal by Subject|8|||
148688483|NCT03734237|536332288|FG000|Overall Study|Lost to Follow-up|1|||
148688484|NCT03734237|536332289|FG001|Overall Study|Lost to Follow-up|3|||
148688485|NCT03734237|536332290|FG002|Overall Study|Lost to Follow-up|0|||
149226479|NCT02906644|538297590|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
148688486|NCT03734237|536332288|FG000|Overall Study|Withdrawal by Subject|7|||
148688487|NCT03734237|536332289|FG001|Overall Study|Withdrawal by Subject|9|||
148688488|NCT03734237|536332290|FG002|Overall Study|Withdrawal by Subject|10|||
148688489|NCT01844583|536332291|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
148810212|NCT02337829|536782593|FG003|Overall Study|Death|0|||
148688490|NCT01844583|536332292|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
148688491|NCT00449072|536332296|FG000|Overall Study|Adverse Event|3|||
148954285|NCT01867021|537314753|FG000|Overall Study|Lost to Follow-up|0|||
149226480|NCT02906644|538297591|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
149226481|NCT03672006|538297594|FG000|Overall Study|exclusion criteria met|0|||
149020035|NCT02601937|537551128|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
149020036|NCT02601937|537551129|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020037|NCT02601937|537551130|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020038|NCT02601937|537551131|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020039|NCT02601937|537551132|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020040|NCT02601937|537551133|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
149020041|NCT02601937|537551123|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
149020042|NCT02601937|537551124|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149226482|NCT03672006|538297595|FG001|Overall Study|exclusion criteria met|1|||
149226483|NCT00608426|538297596|FG000|Overall Study|Death|32|||
149226484|NCT00608426|538297597|FG001|Overall Study|Death|36|||
149226485|NCT00608426|538297596|FG000|Overall Study|Lost to Follow-up|485|||
149226486|NCT00608426|538297597|FG001|Overall Study|Lost to Follow-up|521|||
149226487|NCT00608426|538297596|FG000|Overall Study|refused, health issues, wrong address|319|||
149226488|NCT00608426|538297597|FG001|Overall Study|refused, health issues, wrong address|348|||
149226489|NCT00761891|538297598|FG000|Overall Study|Withdrawal by Subject|10|||
149226490|NCT01453439|538297602|FG000|Treatment Phase|Withdrawal by Subject|13|||
149226491|NCT01453439|538297603|FG001|Treatment Phase|Withdrawal by Subject|10|||
149226492|NCT01453439|538297602|FG000|Treatment Phase|Suicidal Ideation|2|||
149226493|NCT01453439|538297603|FG001|Treatment Phase|Suicidal Ideation|0|||
149226494|NCT01453439|538297602|FG000|Treatment Phase|Need for higher level of care|1|||
149226495|NCT01453439|538297603|FG001|Treatment Phase|Need for higher level of care|1|||
149226496|NCT01453439|538297602|FG000|Treatment Phase|Therapist conflict of interest|1|||
149226497|NCT01453439|538297603|FG001|Treatment Phase|Therapist conflict of interest|0|||
149226498|NCT01453439|538297602|FG000|Follow-up|Withdrawal by Subject|0|||
149226499|NCT01453439|538297603|FG001|Follow-up|Withdrawal by Subject|1|||
149226500|NCT01453439|538297602|FG000|Follow-up|Lost to Follow-up|5|||
149226501|NCT01453439|538297603|FG001|Follow-up|Lost to Follow-up|10|||
149226502|NCT01014442|538297604|FG000|Overall Study|Adverse Event|0|||
149226503|NCT01014442|538297605|FG001|Overall Study|Adverse Event|8|||
149226504|NCT01014442|538297604|FG000|Overall Study|Withdrawal by Subject|4|||
149226505|NCT01014442|538297605|FG001|Overall Study|Withdrawal by Subject|4|||
149226506|NCT01014442|538297604|FG000|Overall Study|Protocol Violation|2|||
149226507|NCT01014442|538297605|FG001|Overall Study|Protocol Violation|5|||
149226508|NCT01014442|538297604|FG000|Overall Study|Lack of Compliance|0|||
148688492|NCT00449072|536332297|FG001|Overall Study|Adverse Event|1|||
148688493|NCT00449072|536332296|FG000|Overall Study|Protocol Violation|14|||
148688494|NCT00449072|536332297|FG001|Overall Study|Protocol Violation|12|||
148688495|NCT00449072|536332296|FG000|Overall Study|Lost to Follow-up|5|||
148688496|NCT00449072|536332297|FG001|Overall Study|Lost to Follow-up|7|||
148688497|NCT00449072|536332296|FG000|Overall Study|Withdrawal by Subject|11|||
148688498|NCT00449072|536332297|FG001|Overall Study|Withdrawal by Subject|8|||
148688499|NCT00449072|536332296|FG000|Overall Study|Lack of Efficacy|1|||
148688500|NCT00449072|536332297|FG001|Overall Study|Lack of Efficacy|1|||
148688501|NCT00449072|536332296|FG000|Overall Study|Physician Decision|1|||
148688502|NCT00449072|536332297|FG001|Overall Study|Physician Decision|0|||
148688503|NCT00449072|536332296|FG000|Overall Study|Not treated|0|||
148688504|NCT00449072|536332297|FG001|Overall Study|Not treated|1|||
148688505|NCT00449072|536332296|FG000|Overall Study|Excluded medication|0|||
148688506|NCT00449072|536332297|FG001|Overall Study|Excluded medication|2|||
149226509|NCT01014442|538297605|FG001|Overall Study|Lack of Compliance|1|||
149226510|NCT01014442|538297604|FG000|Overall Study|Unspecified Reason|1|||
149226511|NCT01014442|538297605|FG001|Overall Study|Unspecified Reason|1|||
149226512|NCT02074059|538297606|FG000|Overall Study|Death|0|||
149226513|NCT02074059|538297607|FG001|Overall Study|Death|0|||
149226514|NCT02074059|538297608|FG002|Overall Study|Death|0|||
149226515|NCT02074059|538297609|FG003|Overall Study|Death|0|||
149226516|NCT02074059|538297610|FG004|Overall Study|Death|1|||
149226517|NCT02074059|538297611|FG005|Overall Study|Death|1|||
149226518|NCT02764229|538297614|FG000|Overall Study|Withdrawal by Subject|15|||
149226519|NCT02764229|538297614|FG000|Overall Study|Adverse Event|9|||
149226520|NCT02764229|538297614|FG000|Overall Study|Physician Decision|5|||
149226521|NCT02764229|538297614|FG000|Overall Study|Lost to Follow-up|3|||
149226522|NCT02764229|538297614|FG000|Overall Study|Lack of Efficacy|1|||
149226523|NCT02764229|538297614|FG000|Overall Study|Study Stopped by Sponsor|69|||
149226524|NCT02135848|538297616|FG000|Overall Study|Adverse Event|2|||
149226525|NCT02135848|538297617|FG001|Overall Study|Adverse Event|0|||
149226526|NCT02135848|538297616|FG000|Overall Study|Withdrawal by Subject|1|||
149226527|NCT02135848|538297617|FG001|Overall Study|Withdrawal by Subject|1|||
149226528|NCT02030067|538297621|FG000|Overall Study|Disease Progression|1|||
149226529|NCT02030067|538297622|FG001|Overall Study|Disease Progression|1|||
149226530|NCT02030067|538297623|FG002|Overall Study|Disease Progression|2|||
149226531|NCT02030067|538297624|FG003|Overall Study|Disease Progression|2|||
149226532|NCT02030067|538297625|FG004|Overall Study|Disease Progression|3|||
149226533|NCT02030067|538297626|FG005|Overall Study|Disease Progression|2|||
148688507|NCT00449072|536332296|FG000|Overall Study|Non-compliance|2|||
148688508|NCT00449072|536332297|FG001|Overall Study|Non-compliance|5|||
148688509|NCT00449072|536332296|FG000|Overall Study|Sponsor decision|1|||
149226534|NCT02030067|538297627|FG006|Overall Study|Disease Progression|3|||
149226535|NCT02030067|538297628|FG007|Overall Study|Disease Progression|3|||
149226536|NCT02030067|538297629|FG008|Overall Study|Disease Progression|4|||
149226537|NCT02030067|538297630|FG009|Overall Study|Disease Progression|3|||
149226538|NCT02030067|538297631|FG010|Overall Study|Disease Progression|7|||
149226539|NCT02030067|538297632|FG011|Overall Study|Disease Progression|2|||
149226540|NCT02030067|538297633|FG012|Overall Study|Disease Progression|59|||
149226541|NCT02030067|538297621|FG000|Overall Study|Withdrawal by Subject|0|||
148688510|NCT00449072|536332297|FG001|Overall Study|Sponsor decision|3|||
148688511|NCT00449072|536332296|FG000|Overall Study|Relocation|3|||
148688512|NCT00449072|536332297|FG001|Overall Study|Relocation|2|||
148954286|NCT01867021|537314754|FG001|Overall Study|Lost to Follow-up|2|||
149226542|NCT02030067|538297622|FG001|Overall Study|Withdrawal by Subject|0|||
149226543|NCT02030067|538297623|FG002|Overall Study|Withdrawal by Subject|0|||
149226544|NCT02030067|538297624|FG003|Overall Study|Withdrawal by Subject|1|||
149226545|NCT02030067|538297625|FG004|Overall Study|Withdrawal by Subject|0|||
149226546|NCT02030067|538297626|FG005|Overall Study|Withdrawal by Subject|0|||
149226547|NCT02030067|538297627|FG006|Overall Study|Withdrawal by Subject|0|||
149226548|NCT02030067|538297628|FG007|Overall Study|Withdrawal by Subject|1|||
149226549|NCT02030067|538297629|FG008|Overall Study|Withdrawal by Subject|0|||
149226550|NCT02030067|538297630|FG009|Overall Study|Withdrawal by Subject|0|||
149226551|NCT02030067|538297631|FG010|Overall Study|Withdrawal by Subject|3|||
149226552|NCT02030067|538297632|FG011|Overall Study|Withdrawal by Subject|0|||
149226553|NCT02030067|538297633|FG012|Overall Study|Withdrawal by Subject|6|||
149226554|NCT02030067|538297621|FG000|Overall Study|Physician Decision|0|||
149226555|NCT02030067|538297622|FG001|Overall Study|Physician Decision|0|||
149226556|NCT02030067|538297623|FG002|Overall Study|Physician Decision|0|||
149226557|NCT02030067|538297624|FG003|Overall Study|Physician Decision|0|||
149226558|NCT02030067|538297625|FG004|Overall Study|Physician Decision|0|||
149226559|NCT02030067|538297626|FG005|Overall Study|Physician Decision|0|||
149226560|NCT02030067|538297627|FG006|Overall Study|Physician Decision|0|||
149226561|NCT02030067|538297628|FG007|Overall Study|Physician Decision|0|||
149226562|NCT02030067|538297629|FG008|Overall Study|Physician Decision|0|||
149226563|NCT02030067|538297630|FG009|Overall Study|Physician Decision|0|||
149226564|NCT02030067|538297631|FG010|Overall Study|Physician Decision|1|||
149226565|NCT02030067|538297632|FG011|Overall Study|Physician Decision|0|||
149226566|NCT02030067|538297633|FG012|Overall Study|Physician Decision|3|||
149226567|NCT02030067|538297621|FG000|Overall Study|other reasons|0|||
149226568|NCT02030067|538297622|FG001|Overall Study|other reasons|0|||
149226569|NCT02030067|538297623|FG002|Overall Study|other reasons|0|||
149226570|NCT02030067|538297624|FG003|Overall Study|other reasons|0|||
149226571|NCT02030067|538297625|FG004|Overall Study|other reasons|0|||
149226572|NCT02030067|538297626|FG005|Overall Study|other reasons|1|||
149226573|NCT02030067|538297627|FG006|Overall Study|other reasons|0|||
149226574|NCT02030067|538297628|FG007|Overall Study|other reasons|0|||
149226575|NCT02030067|538297629|FG008|Overall Study|other reasons|2|||
149226576|NCT02030067|538297630|FG009|Overall Study|other reasons|0|||
149226577|NCT02030067|538297631|FG010|Overall Study|other reasons|0|||
149226578|NCT02030067|538297632|FG011|Overall Study|other reasons|0|||
149226579|NCT02030067|538297633|FG012|Overall Study|other reasons|4|||
149226580|NCT02030067|538297621|FG000|Overall Study|Adverse Event|0|||
149226581|NCT02030067|538297622|FG001|Overall Study|Adverse Event|0|||
149226582|NCT02030067|538297623|FG002|Overall Study|Adverse Event|0|||
149226583|NCT02030067|538297624|FG003|Overall Study|Adverse Event|0|||
149226584|NCT02030067|538297625|FG004|Overall Study|Adverse Event|0|||
149226585|NCT02030067|538297626|FG005|Overall Study|Adverse Event|0|||
149226586|NCT02030067|538297627|FG006|Overall Study|Adverse Event|0|||
149226587|NCT02030067|538297628|FG007|Overall Study|Adverse Event|0|||
149226588|NCT02030067|538297629|FG008|Overall Study|Adverse Event|0|||
149226589|NCT02030067|538297630|FG009|Overall Study|Adverse Event|0|||
149226590|NCT02030067|538297631|FG010|Overall Study|Adverse Event|0|||
149226591|NCT02030067|538297632|FG011|Overall Study|Adverse Event|1|||
149226592|NCT02030067|538297633|FG012|Overall Study|Adverse Event|8|||
149226593|NCT02543801|538297634|FG000|Overall Study|Protocol Violation|1|||
149226594|NCT02543801|538297635|FG001|Overall Study|Protocol Violation|2|||
149226595|NCT02543801|538297636|FG002|Overall Study|Protocol Violation|0|||
149226596|NCT02543801|538297637|FG003|Overall Study|Protocol Violation|0|||
149226597|NCT01756846|538297638|FG000|Overall Study|Lost to Follow-up|5|||
149226598|NCT01756846|538297639|FG001|Overall Study|Lost to Follow-up|10|||
149226599|NCT01756846|538297638|FG000|Overall Study|Withdrawal by Subject|1|||
149226600|NCT01756846|538297639|FG001|Overall Study|Withdrawal by Subject|2|||
149226601|NCT04118127|538297645|FG000|Overall Study|Trial terminated by sponsor|0|||
149226602|NCT04118127|538297646|FG001|Overall Study|Trial terminated by sponsor|12|||
149226603|NCT04118127|538297645|FG000|Overall Study|Adverse Event|1|||
149226604|NCT04118127|538297646|FG001|Overall Study|Adverse Event|2|||
148688513|NCT01787825|536332298|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
148688514|NCT01787825|536332299|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
148688515|NCT01787825|536332298|FG000|Overall Study|Data Not Analyzable|5|||
148688516|NCT01787825|536332299|FG001|Overall Study|Data Not Analyzable|1|||
149226605|NCT04118127|538297645|FG000|Overall Study|Physician Decision|0|||
149226606|NCT04118127|538297646|FG001|Overall Study|Physician Decision|1|||
149226607|NCT04118127|538297645|FG000|Overall Study|Withdrawal by Subject|2|||
149226608|NCT04118127|538297646|FG001|Overall Study|Withdrawal by Subject|1|||
149226609|NCT01646255|538297647|FG000|Overall Study|Adverse Event|7|||
149226610|NCT01646255|538297648|FG001|Overall Study|Adverse Event|8|||
149226611|NCT01646255|538297647|FG000|Overall Study|Lack of Efficacy|2|||
149226612|NCT01646255|538297648|FG001|Overall Study|Lack of Efficacy|0|||
149226613|NCT01646255|538297647|FG000|Overall Study|Withdrawal by Subject|10|||
149226614|NCT01646255|538297648|FG001|Overall Study|Withdrawal by Subject|6|||
149226615|NCT01646255|538297647|FG000|Overall Study|Compliance is not well|1|||
149226616|NCT01646255|538297648|FG001|Overall Study|Compliance is not well|0|||
149226617|NCT01646255|538297647|FG000|Overall Study|Inclusion Criteria Deviation|1|||
149226618|NCT01646255|538297648|FG001|Overall Study|Inclusion Criteria Deviation|0|||
148688517|NCT00989261|536332305|FG000|Overall Study|Still in follow up|12|||
148688518|NCT00989261|536332306|FG001|Overall Study|Still in follow up|21|||
149226619|NCT01376908|538297649|FG000|Overall Study|Protocol Violation|1|||
149226620|NCT01376908|538297650|FG001|Overall Study|Protocol Violation|1|||
149226621|NCT01376908|538297649|FG000|Overall Study|Withdrawal by Subject|1|||
149226622|NCT01376908|538297650|FG001|Overall Study|Withdrawal by Subject|2|||
149226623|NCT01681836|538297655|FG000|Second Intervention|Withdrawal by Subject|0|||
149226624|NCT01681836|538297656|FG001|Second Intervention|Withdrawal by Subject|1|||
149226625|NCT00742391|538297657|FG000|Overall Study|Adverse Event|2|||
149226626|NCT00742391|538297658|FG001|Overall Study|Adverse Event|1|||
149226627|NCT00742391|538297657|FG000|Overall Study|Lost to Follow-up|1|||
149226628|NCT00742391|538297658|FG001|Overall Study|Lost to Follow-up|0|||
149226629|NCT00742391|538297657|FG000|Overall Study|Protocol Violation|1|||
149226630|NCT00742391|538297658|FG001|Overall Study|Protocol Violation|0|||
149226631|NCT02394028|538297659|FG000|Induction Phase|Adverse Event|2|||
149226632|NCT02394028|538297660|FG001|Induction Phase|Adverse Event|4|||
149226633|NCT02394028|538297661|FG002|Induction Phase|Adverse Event|1|||
149226634|NCT02394028|538297662|FG003|Induction Phase|Adverse Event|2|||
149226635|NCT02394028|538297663|FG004|Induction Phase|Adverse Event|5|||
149226636|NCT02394028|538297664|FG005|Induction Phase|Adverse Event|2|||
149226637|NCT02394028|538297665|FG006|Induction Phase|Adverse Event|0|||
149226638|NCT02394028|538297666|FG007|Induction Phase|Adverse Event|0|||
149226639|NCT02394028|538297667|FG008|Induction Phase|Adverse Event|0|||
149226640|NCT02394028|538297668|FG009|Induction Phase|Adverse Event|0|||
149226641|NCT02394028|538297669|FG010|Induction Phase|Adverse Event|0|||
149226642|NCT02394028|538297659|FG000|Induction Phase|Lack of Efficacy|3|||
149226643|NCT02394028|538297660|FG001|Induction Phase|Lack of Efficacy|6|||
149226644|NCT02394028|538297661|FG002|Induction Phase|Lack of Efficacy|2|||
149226645|NCT02394028|538297662|FG003|Induction Phase|Lack of Efficacy|17|||
149226646|NCT02394028|538297663|FG004|Induction Phase|Lack of Efficacy|14|||
149226647|NCT02394028|538297664|FG005|Induction Phase|Lack of Efficacy|8|||
149226648|NCT02394028|538297665|FG006|Induction Phase|Lack of Efficacy|17|||
149226649|NCT02394028|538297666|FG007|Induction Phase|Lack of Efficacy|23|||
149226650|NCT02394028|538297667|FG008|Induction Phase|Lack of Efficacy|0|||
149226651|NCT02394028|538297668|FG009|Induction Phase|Lack of Efficacy|0|||
149226652|NCT02394028|538297669|FG010|Induction Phase|Lack of Efficacy|0|||
149226653|NCT02394028|538297659|FG000|Induction Phase|Lost to Follow-up|1|||
149226654|NCT02394028|538297660|FG001|Induction Phase|Lost to Follow-up|0|||
149226655|NCT02394028|538297661|FG002|Induction Phase|Lost to Follow-up|0|||
149226656|NCT02394028|538297662|FG003|Induction Phase|Lost to Follow-up|1|||
149226657|NCT02394028|538297663|FG004|Induction Phase|Lost to Follow-up|0|||
149226658|NCT02394028|538297664|FG005|Induction Phase|Lost to Follow-up|0|||
149226659|NCT02394028|538297665|FG006|Induction Phase|Lost to Follow-up|1|||
149226660|NCT02394028|538297666|FG007|Induction Phase|Lost to Follow-up|0|||
149226661|NCT02394028|538297667|FG008|Induction Phase|Lost to Follow-up|0|||
149226662|NCT02394028|538297668|FG009|Induction Phase|Lost to Follow-up|0|||
149226663|NCT02394028|538297669|FG010|Induction Phase|Lost to Follow-up|0|||
149226664|NCT02394028|538297659|FG000|Induction Phase|Non-compliance|0|||
149226665|NCT02394028|538297660|FG001|Induction Phase|Non-compliance|1|||
149226666|NCT02394028|538297661|FG002|Induction Phase|Non-compliance|3|||
149226667|NCT02394028|538297662|FG003|Induction Phase|Non-compliance|1|||
149226668|NCT02394028|538297663|FG004|Induction Phase|Non-compliance|3|||
149226669|NCT02394028|538297664|FG005|Induction Phase|Non-compliance|0|||
149226670|NCT02394028|538297665|FG006|Induction Phase|Non-compliance|1|||
149226671|NCT02394028|538297666|FG007|Induction Phase|Non-compliance|1|||
149226672|NCT02394028|538297667|FG008|Induction Phase|Non-compliance|0|||
149226673|NCT02394028|538297668|FG009|Induction Phase|Non-compliance|0|||
149226674|NCT02394028|538297669|FG010|Induction Phase|Non-compliance|0|||
149226675|NCT02394028|538297659|FG000|Induction Phase|Physician Decision|0|||
149226676|NCT02394028|538297660|FG001|Induction Phase|Physician Decision|0|||
149226677|NCT02394028|538297661|FG002|Induction Phase|Physician Decision|1|||
149226678|NCT02394028|538297662|FG003|Induction Phase|Physician Decision|4|||
149226679|NCT02394028|538297663|FG004|Induction Phase|Physician Decision|0|||
149226680|NCT02394028|538297664|FG005|Induction Phase|Physician Decision|2|||
149226681|NCT02394028|538297665|FG006|Induction Phase|Physician Decision|1|||
149226682|NCT02394028|538297666|FG007|Induction Phase|Physician Decision|0|||
149226683|NCT02394028|538297667|FG008|Induction Phase|Physician Decision|0|||
149226684|NCT02394028|538297668|FG009|Induction Phase|Physician Decision|0|||
149226685|NCT02394028|538297669|FG010|Induction Phase|Physician Decision|0|||
149226686|NCT02394028|538297659|FG000|Induction Phase|Protocol Violation|0|||
149226687|NCT02394028|538297660|FG001|Induction Phase|Protocol Violation|2|||
149226688|NCT02394028|538297661|FG002|Induction Phase|Protocol Violation|0|||
149226689|NCT02394028|538297662|FG003|Induction Phase|Protocol Violation|3|||
149226690|NCT02394028|538297663|FG004|Induction Phase|Protocol Violation|0|||
149226691|NCT02394028|538297664|FG005|Induction Phase|Protocol Violation|1|||
149226692|NCT02394028|538297665|FG006|Induction Phase|Protocol Violation|1|||
149226693|NCT02394028|538297666|FG007|Induction Phase|Protocol Violation|0|||
149226694|NCT02394028|538297667|FG008|Induction Phase|Protocol Violation|0|||
149226695|NCT02394028|538297668|FG009|Induction Phase|Protocol Violation|0|||
149226696|NCT02394028|538297669|FG010|Induction Phase|Protocol Violation|0|||
149226697|NCT02394028|538297659|FG000|Induction Phase|Withdrawal by Subject|1|||
149226698|NCT02394028|538297660|FG001|Induction Phase|Withdrawal by Subject|2|||
149226699|NCT02394028|538297661|FG002|Induction Phase|Withdrawal by Subject|4|||
149226700|NCT02394028|538297662|FG003|Induction Phase|Withdrawal by Subject|6|||
149226701|NCT02394028|538297663|FG004|Induction Phase|Withdrawal by Subject|7|||
149226702|NCT02394028|538297664|FG005|Induction Phase|Withdrawal by Subject|4|||
149226703|NCT02394028|538297665|FG006|Induction Phase|Withdrawal by Subject|3|||
149226704|NCT02394028|538297666|FG007|Induction Phase|Withdrawal by Subject|6|||
149226705|NCT02394028|538297667|FG008|Induction Phase|Withdrawal by Subject|0|||
149226706|NCT02394028|538297668|FG009|Induction Phase|Withdrawal by Subject|0|||
149226707|NCT02394028|538297669|FG010|Induction Phase|Withdrawal by Subject|0|||
149226708|NCT02394028|538297659|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226709|NCT02394028|538297660|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226710|NCT02394028|538297661|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226711|NCT02394028|538297662|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226712|NCT02394028|538297663|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226713|NCT02394028|538297664|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226714|NCT02394028|538297665|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
149226715|NCT02394028|538297666|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226716|NCT02394028|538297667|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226717|NCT02394028|538297668|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226718|NCT02394028|538297669|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
149226719|NCT02394028|538297659|FG000|Induction Phase|Sponsor decision|0|||
149226720|NCT02394028|538297660|FG001|Induction Phase|Sponsor decision|1|||
149226721|NCT02394028|538297661|FG002|Induction Phase|Sponsor decision|2|||
149226722|NCT02394028|538297662|FG003|Induction Phase|Sponsor decision|0|||
149226723|NCT02394028|538297663|FG004|Induction Phase|Sponsor decision|0|||
149226724|NCT02394028|538297664|FG005|Induction Phase|Sponsor decision|0|||
149226725|NCT02394028|538297665|FG006|Induction Phase|Sponsor decision|0|||
149226726|NCT02394028|538297666|FG007|Induction Phase|Sponsor decision|0|||
149226727|NCT02394028|538297667|FG008|Induction Phase|Sponsor decision|0|||
149226728|NCT02394028|538297668|FG009|Induction Phase|Sponsor decision|0|||
149226729|NCT02394028|538297669|FG010|Induction Phase|Sponsor decision|0|||
149226730|NCT02394028|538297659|FG000|Induction Phase|Technical reason|0|||
149226731|NCT02394028|538297660|FG001|Induction Phase|Technical reason|0|||
149226732|NCT02394028|538297661|FG002|Induction Phase|Technical reason|0|||
149226733|NCT02394028|538297662|FG003|Induction Phase|Technical reason|1|||
149226734|NCT02394028|538297663|FG004|Induction Phase|Technical reason|0|||
149226735|NCT02394028|538297664|FG005|Induction Phase|Technical reason|0|||
149226736|NCT02394028|538297665|FG006|Induction Phase|Technical reason|0|||
149226737|NCT02394028|538297666|FG007|Induction Phase|Technical reason|0|||
149226738|NCT02394028|538297667|FG008|Induction Phase|Technical reason|0|||
149226739|NCT02394028|538297668|FG009|Induction Phase|Technical reason|0|||
149226740|NCT02394028|538297669|FG010|Induction Phase|Technical reason|0|||
149226741|NCT02394028|538297659|FG000|Induction Phase|:ack of calculation|0|||
149226742|NCT02394028|538297660|FG001|Induction Phase|:ack of calculation|0|||
149226743|NCT02394028|538297661|FG002|Induction Phase|:ack of calculation|0|||
149226744|NCT02394028|538297662|FG003|Induction Phase|:ack of calculation|0|||
149226745|NCT02394028|538297663|FG004|Induction Phase|:ack of calculation|0|||
149226746|NCT02394028|538297664|FG005|Induction Phase|:ack of calculation|0|||
149226747|NCT02394028|538297665|FG006|Induction Phase|:ack of calculation|0|||
149226748|NCT02394028|538297666|FG007|Induction Phase|:ack of calculation|1|||
149226749|NCT02394028|538297667|FG008|Induction Phase|:ack of calculation|0|||
149226750|NCT02394028|538297668|FG009|Induction Phase|:ack of calculation|0|||
149226751|NCT02394028|538297669|FG010|Induction Phase|:ack of calculation|0|||
149226752|NCT02394028|538297659|FG000|Maintenance Phase|Protocol Violation|0|||
149226753|NCT02394028|538297660|FG001|Maintenance Phase|Protocol Violation|0|||
149226754|NCT02394028|538297661|FG002|Maintenance Phase|Protocol Violation|0|||
149226755|NCT02394028|538297662|FG003|Maintenance Phase|Protocol Violation|0|||
149226756|NCT02394028|538297663|FG004|Maintenance Phase|Protocol Violation|0|||
149226757|NCT02394028|538297664|FG005|Maintenance Phase|Protocol Violation|0|||
149226758|NCT02394028|538297665|FG006|Maintenance Phase|Protocol Violation|0|||
149226759|NCT02394028|538297666|FG007|Maintenance Phase|Protocol Violation|0|||
149226760|NCT02394028|538297667|FG008|Maintenance Phase|Protocol Violation|0|||
149226761|NCT02394028|538297668|FG009|Maintenance Phase|Protocol Violation|0|||
149226762|NCT02394028|538297669|FG010|Maintenance Phase|Protocol Violation|1|||
149226763|NCT02394028|538297659|FG000|Maintenance Phase|Physician Decision|0|||
149226764|NCT02394028|538297660|FG001|Maintenance Phase|Physician Decision|0|||
149226765|NCT02394028|538297661|FG002|Maintenance Phase|Physician Decision|0|||
149226766|NCT02394028|538297662|FG003|Maintenance Phase|Physician Decision|0|||
149226767|NCT02394028|538297663|FG004|Maintenance Phase|Physician Decision|0|||
149226768|NCT02394028|538297664|FG005|Maintenance Phase|Physician Decision|0|||
149226769|NCT02394028|538297665|FG006|Maintenance Phase|Physician Decision|0|||
149226770|NCT02394028|538297666|FG007|Maintenance Phase|Physician Decision|0|||
149226771|NCT02394028|538297667|FG008|Maintenance Phase|Physician Decision|1|||
149226772|NCT02394028|538297668|FG009|Maintenance Phase|Physician Decision|3|||
149226773|NCT02394028|538297669|FG010|Maintenance Phase|Physician Decision|2|||
149226774|NCT02394028|538297659|FG000|Maintenance Phase|Lack of Efficacy|0|||
149226775|NCT02394028|538297660|FG001|Maintenance Phase|Lack of Efficacy|0|||
149226776|NCT02394028|538297661|FG002|Maintenance Phase|Lack of Efficacy|0|||
149226777|NCT02394028|538297662|FG003|Maintenance Phase|Lack of Efficacy|0|||
149226778|NCT02394028|538297663|FG004|Maintenance Phase|Lack of Efficacy|0|||
149226779|NCT02394028|538297664|FG005|Maintenance Phase|Lack of Efficacy|0|||
149226780|NCT02394028|538297665|FG006|Maintenance Phase|Lack of Efficacy|0|||
149226781|NCT02394028|538297666|FG007|Maintenance Phase|Lack of Efficacy|0|||
149226782|NCT02394028|538297667|FG008|Maintenance Phase|Lack of Efficacy|7|||
149226783|NCT02394028|538297668|FG009|Maintenance Phase|Lack of Efficacy|25|||
149226784|NCT02394028|538297669|FG010|Maintenance Phase|Lack of Efficacy|33|||
149226785|NCT02394028|538297659|FG000|Maintenance Phase|Death|0|||
149226786|NCT02394028|538297660|FG001|Maintenance Phase|Death|0|||
149226787|NCT02394028|538297661|FG002|Maintenance Phase|Death|0|||
149226788|NCT02394028|538297662|FG003|Maintenance Phase|Death|0|||
149226789|NCT02394028|538297663|FG004|Maintenance Phase|Death|0|||
149226790|NCT02394028|538297664|FG005|Maintenance Phase|Death|0|||
149226791|NCT02394028|538297665|FG006|Maintenance Phase|Death|0|||
149226792|NCT02394028|538297666|FG007|Maintenance Phase|Death|0|||
149226793|NCT02394028|538297667|FG008|Maintenance Phase|Death|0|||
149226794|NCT02394028|538297668|FG009|Maintenance Phase|Death|0|||
149226795|NCT02394028|538297669|FG010|Maintenance Phase|Death|1|||
149226796|NCT02394028|538297659|FG000|Maintenance Phase|Adverse Event|0|||
149226797|NCT02394028|538297660|FG001|Maintenance Phase|Adverse Event|0|||
149226798|NCT02394028|538297661|FG002|Maintenance Phase|Adverse Event|0|||
149226799|NCT02394028|538297662|FG003|Maintenance Phase|Adverse Event|0|||
149226800|NCT02394028|538297663|FG004|Maintenance Phase|Adverse Event|0|||
149226801|NCT02394028|538297664|FG005|Maintenance Phase|Adverse Event|0|||
149226802|NCT02394028|538297665|FG006|Maintenance Phase|Adverse Event|0|||
149226803|NCT02394028|538297666|FG007|Maintenance Phase|Adverse Event|0|||
149226804|NCT02394028|538297667|FG008|Maintenance Phase|Adverse Event|1|||
149226805|NCT02394028|538297668|FG009|Maintenance Phase|Adverse Event|1|||
149226806|NCT02394028|538297669|FG010|Maintenance Phase|Adverse Event|3|||
149226807|NCT02394028|538297659|FG000|Maintenance Phase|Site closure|0|||
149226808|NCT02394028|538297660|FG001|Maintenance Phase|Site closure|0|||
149226809|NCT02394028|538297661|FG002|Maintenance Phase|Site closure|0|||
149226810|NCT02394028|538297662|FG003|Maintenance Phase|Site closure|0|||
149226811|NCT02394028|538297663|FG004|Maintenance Phase|Site closure|0|||
149226812|NCT02394028|538297664|FG005|Maintenance Phase|Site closure|0|||
149226813|NCT02394028|538297665|FG006|Maintenance Phase|Site closure|0|||
149226814|NCT02394028|538297666|FG007|Maintenance Phase|Site closure|0|||
149226815|NCT02394028|538297667|FG008|Maintenance Phase|Site closure|0|||
149226816|NCT02394028|538297668|FG009|Maintenance Phase|Site closure|1|||
149226817|NCT02394028|538297669|FG010|Maintenance Phase|Site closure|0|||
149226818|NCT02394028|538297659|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149226819|NCT02394028|538297660|FG001|Maintenance Phase|Withdrawal by Subject|0|||
149226820|NCT02394028|538297661|FG002|Maintenance Phase|Withdrawal by Subject|0|||
149226821|NCT02394028|538297662|FG003|Maintenance Phase|Withdrawal by Subject|0|||
149226822|NCT02394028|538297663|FG004|Maintenance Phase|Withdrawal by Subject|0|||
149226823|NCT02394028|538297664|FG005|Maintenance Phase|Withdrawal by Subject|0|||
149226824|NCT02394028|538297665|FG006|Maintenance Phase|Withdrawal by Subject|0|||
149226825|NCT02394028|538297666|FG007|Maintenance Phase|Withdrawal by Subject|0|||
149226826|NCT02394028|538297667|FG008|Maintenance Phase|Withdrawal by Subject|3|||
149226827|NCT02394028|538297668|FG009|Maintenance Phase|Withdrawal by Subject|12|||
149226828|NCT02394028|538297669|FG010|Maintenance Phase|Withdrawal by Subject|12|||
149226829|NCT02142712|538297672|FG000|Overall Study|Lost to Follow-up|1|||
149226830|NCT02142712|538297673|FG001|Overall Study|Lost to Follow-up|1|||
149226831|NCT02142712|538297674|FG002|Overall Study|Lost to Follow-up|1|||
149226832|NCT02142712|538297675|FG003|Overall Study|Lost to Follow-up|0|||
149226833|NCT01241318|538297683|FG000|Overall Study|Woman: false pregnancies|27|||
149226834|NCT01241318|538297684|FG001|Overall Study|Woman: false pregnancies|15|||
149226835|NCT01241318|538297683|FG000|Overall Study|Woman: miscarriage/abortion|46|||
149226836|NCT01241318|538297684|FG001|Overall Study|Woman: miscarriage/abortion|38|||
149226837|NCT01241318|538297683|FG000|Overall Study|Withdrawal by Subject|175|||
149226838|NCT01241318|538297684|FG001|Overall Study|Withdrawal by Subject|46|||
149226839|NCT01241318|538297683|FG000|Overall Study|Lost to Follow-up|740|||
149226840|NCT01241318|538297684|FG001|Overall Study|Lost to Follow-up|455|||
149226841|NCT01241318|538297683|FG000|Overall Study|Death|2|||
149226842|NCT01241318|538297684|FG001|Overall Study|Death|4|||
149226843|NCT01241318|538297683|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
149226844|NCT01241318|538297684|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
149226845|NCT01241318|538297683|FG000|Overall Study|Woman: Stillborn infant|129|||
149226846|NCT01241318|538297684|FG001|Overall Study|Woman: Stillborn infant|146|||
149226847|NCT02355665|538297685|FG000|Overall Study|Adverse Event|16|||
149226848|NCT02355665|538297686|FG001|Overall Study|Adverse Event|24|||
149226849|NCT02355665|538297685|FG000|Overall Study|Protocol Violation|2|||
149226850|NCT02355665|538297686|FG001|Overall Study|Protocol Violation|0|||
149226851|NCT02355665|538297685|FG000|Overall Study|Withdrawal by Subject|90|||
149226852|NCT02355665|538297686|FG001|Overall Study|Withdrawal by Subject|100|||
149226853|NCT02355665|538297685|FG000|Overall Study|Lost to Follow-up|131|||
149226854|NCT02355665|538297686|FG001|Overall Study|Lost to Follow-up|103|||
149226855|NCT02355665|538297685|FG000|Overall Study|Death|4|||
149226856|NCT02355665|538297686|FG001|Overall Study|Death|2|||
149226857|NCT02355665|538297685|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
149226858|NCT02355665|538297686|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
149226859|NCT04129242|538297687|FG000|Overall Study|Physician Decision|1|||
149226860|NCT04129242|538297688|FG001|Overall Study|Physician Decision|1|||
149226861|NCT04129242|538297687|FG000|Overall Study|Protocol Violation|0|||
149226862|NCT04129242|538297688|FG001|Overall Study|Protocol Violation|1|||
149226863|NCT02853318|538297691|FG000|Overall Study|Withdrawal by Subject|1|||
149226864|NCT02646332|538297692|FG000|Overall Study|Lost to Follow-up|0|||
149226865|NCT02646332|538297693|FG001|Overall Study|Lost to Follow-up|3|||
149226866|NCT01882439|538297699|FG000|Overall Study|Adverse event related to study drug|3|||
149226867|NCT01882439|538297700|FG001|Overall Study|Adverse event related to study drug|8|||
149226868|NCT01882439|538297701|FG002|Overall Study|Adverse event related to study drug|1|||
149226869|NCT01882439|538297702|FG003|Overall Study|Adverse event related to study drug|2|||
149226870|NCT01882439|538297699|FG000|Overall Study|Pregnancy|0|||
149226871|NCT01882439|538297700|FG001|Overall Study|Pregnancy|1|||
149226872|NCT01882439|538297701|FG002|Overall Study|Pregnancy|0|||
149226873|NCT01882439|538297702|FG003|Overall Study|Pregnancy|0|||
149226874|NCT01882439|538297699|FG000|Overall Study|Protocol Violation|2|||
149226875|NCT01882439|538297700|FG001|Overall Study|Protocol Violation|2|||
149226876|NCT01882439|538297701|FG002|Overall Study|Protocol Violation|0|||
149226877|NCT01882439|538297702|FG003|Overall Study|Protocol Violation|1|||
149226878|NCT01882439|538297699|FG000|Overall Study|No longer willing to participate|1|||
149226879|NCT01882439|538297700|FG001|Overall Study|No longer willing to participate|4|||
149226880|NCT01882439|538297701|FG002|Overall Study|No longer willing to participate|2|||
149226881|NCT01882439|538297702|FG003|Overall Study|No longer willing to participate|3|||
149226882|NCT01882439|538297699|FG000|Overall Study|Medication error with no associated AE|0|||
149226883|NCT01882439|538297700|FG001|Overall Study|Medication error with no associated AE|0|||
149226884|NCT01882439|538297701|FG002|Overall Study|Medication error with no associated AE|2|||
149226885|NCT01882439|538297702|FG003|Overall Study|Medication error with no associated AE|0|||
149226886|NCT01882439|538297699|FG000|Overall Study|Insufficient clinical response|1|||
149226887|NCT01882439|538297700|FG001|Overall Study|Insufficient clinical response|4|||
149226888|NCT01882439|538297701|FG002|Overall Study|Insufficient clinical response|4|||
149226889|NCT01882439|538297702|FG003|Overall Study|Insufficient clinical response|2|||
149226890|NCT01882439|538297699|FG000|Overall Study|Adverse event unrelated to study drug|2|||
149226891|NCT01882439|538297700|FG001|Overall Study|Adverse event unrelated to study drug|2|||
149226892|NCT01882439|538297701|FG002|Overall Study|Adverse event unrelated to study drug|1|||
149226893|NCT01882439|538297702|FG003|Overall Study|Adverse event unrelated to study drug|1|||
149226894|NCT02909504|538297705|FG000|Overall Study|Adverse Event|2|||
149226895|NCT02909504|538297705|FG000|Overall Study|Lack of Efficacy|3|||
149226896|NCT02909504|538297705|FG000|Overall Study|Withdrawal by Subject|4|||
149226897|NCT02909504|538297705|FG000|Overall Study|Pregnancy|1|||
149226898|NCT02909504|538297705|FG000|Overall Study|Subject moved|1|||
149226899|NCT02909504|538297705|FG000|Overall Study|Lost to Follow-up|1|||
149226900|NCT02055976|538297706|FG000|Overall Study|Other|0|||
149226901|NCT02055976|538297707|FG001|Overall Study|Other|0|||
149226902|NCT02055976|538297708|FG002|Overall Study|Other|1|||
149226903|NCT02055976|538297709|FG003|Overall Study|Other|0|||
149226904|NCT02055976|538297710|FG004|Overall Study|Other|0|||
149226905|NCT02055976|538297711|FG005|Overall Study|Other|0|||
149226906|NCT02055976|538297712|FG006|Overall Study|Other|0|||
149226907|NCT02055976|538297713|FG007|Overall Study|Other|0|||
149226908|NCT02055976|538297714|FG008|Overall Study|Other|0|||
149226909|NCT02055976|538297706|FG000|Overall Study|Adverse Event|0|||
149226910|NCT02055976|538297707|FG001|Overall Study|Adverse Event|0|||
149226911|NCT02055976|538297708|FG002|Overall Study|Adverse Event|0|||
149226912|NCT02055976|538297709|FG003|Overall Study|Adverse Event|0|||
149226913|NCT02055976|538297710|FG004|Overall Study|Adverse Event|0|||
149226914|NCT02055976|538297711|FG005|Overall Study|Adverse Event|1|||
149226915|NCT02055976|538297712|FG006|Overall Study|Adverse Event|1|||
149226916|NCT02055976|538297713|FG007|Overall Study|Adverse Event|0|||
149226917|NCT02055976|538297714|FG008|Overall Study|Adverse Event|0|||
149226918|NCT02055976|538297706|FG000|Overall Study|Does not meet entrance criteria|0|||
149226919|NCT02055976|538297707|FG001|Overall Study|Does not meet entrance criteria|0|||
149226920|NCT02055976|538297708|FG002|Overall Study|Does not meet entrance criteria|0|||
149226921|NCT02055976|538297709|FG003|Overall Study|Does not meet entrance criteria|0|||
149226922|NCT02055976|538297710|FG004|Overall Study|Does not meet entrance criteria|0|||
149226923|NCT02055976|538297711|FG005|Overall Study|Does not meet entrance criteria|0|||
149226924|NCT02055976|538297712|FG006|Overall Study|Does not meet entrance criteria|1|||
149226925|NCT02055976|538297713|FG007|Overall Study|Does not meet entrance criteria|0|||
149226926|NCT02055976|538297714|FG008|Overall Study|Does not meet entrance criteria|0|||
149226927|NCT02055976|538297706|FG000|Overall Study|Lost to Follow-up|0|||
149226928|NCT02055976|538297707|FG001|Overall Study|Lost to Follow-up|0|||
149226929|NCT02055976|538297708|FG002|Overall Study|Lost to Follow-up|0|||
149226930|NCT02055976|538297709|FG003|Overall Study|Lost to Follow-up|1|||
149226931|NCT02055976|538297710|FG004|Overall Study|Lost to Follow-up|0|||
149226932|NCT02055976|538297711|FG005|Overall Study|Lost to Follow-up|0|||
149226933|NCT02055976|538297712|FG006|Overall Study|Lost to Follow-up|0|||
149226934|NCT02055976|538297713|FG007|Overall Study|Lost to Follow-up|0|||
149226935|NCT02055976|538297714|FG008|Overall Study|Lost to Follow-up|0|||
149226936|NCT02146352|538297719|FG000|Overall Study|Death|1|||
149226937|NCT02146352|538297719|FG000|Overall Study|Patient entered hospice care|1|||
149226938|NCT03258710|538299917|FG000|Overall Study|Adverse Event|1|||
149226939|NCT03258710|538299917|FG000|Overall Study|Protocol-defined stopping criteria|1|||
149226940|NCT03258710|538299917|FG000|Overall Study|Physician Decision|1|||
149226941|NCT03451630|538299918|FG000|Overall Study|Death|15|||
149226942|NCT03451630|538299919|FG001|Overall Study|Death|16|||
149226943|NCT03451630|538299920|FG002|Overall Study|Death|11|||
149226944|NCT03451630|538299918|FG000|Overall Study|Lost to Follow-up|9|||
149226945|NCT03451630|538299919|FG001|Overall Study|Lost to Follow-up|0|||
149226946|NCT03451630|538299920|FG002|Overall Study|Lost to Follow-up|4|||
149226947|NCT03451630|538299918|FG000|Overall Study|Withdrawal by Subject|0|||
149226948|NCT03451630|538299919|FG001|Overall Study|Withdrawal by Subject|3|||
149226949|NCT03451630|538299920|FG002|Overall Study|Withdrawal by Subject|0|||
149226950|NCT03451630|538299918|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
149226951|NCT03451630|538299919|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
149226952|NCT03451630|538299920|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
149226953|NCT02041533|538299921|FG000|Pre-Treatment Period|Disease Progression|1|||
149226954|NCT02041533|538299922|FG001|Pre-Treatment Period|Disease Progression|1|||
149226955|NCT02041533|538299921|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
149226956|NCT02041533|538299922|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
149226957|NCT02041533|538299921|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
149226958|NCT02041533|538299922|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
149226959|NCT02041533|538299921|FG000|Treatment Period|Disease progression|189|||
149226960|NCT02041533|538299922|FG001|Treatment Period|Disease progression|146|||
149226961|NCT02041533|538299921|FG000|Treatment Period|Study drug toxicity|30|||
149226962|NCT02041533|538299922|FG001|Treatment Period|Study drug toxicity|34|||
149226963|NCT02041533|538299921|FG000|Treatment Period|Death|1|||
149226964|NCT02041533|538299922|FG001|Treatment Period|Death|0|||
149226965|NCT02041533|538299921|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
149226966|NCT02041533|538299922|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
149226967|NCT02041533|538299921|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
149226968|NCT02041533|538299922|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
149226969|NCT02041533|538299921|FG000|Treatment Period|Participant withdrew consent|2|||
149226970|NCT02041533|538299922|FG001|Treatment Period|Participant withdrew consent|2|||
149226971|NCT02041533|538299921|FG000|Treatment Period|Maximum clinical benefit|0|||
149226972|NCT02041533|538299922|FG001|Treatment Period|Maximum clinical benefit|18|||
149226973|NCT02041533|538299921|FG000|Treatment Period|Poor/Non-compliance|1|||
149226974|NCT02041533|538299922|FG001|Treatment Period|Poor/Non-compliance|0|||
149226975|NCT02041533|538299921|FG000|Treatment Period|Administrative reason by sponsor|1|||
149226976|NCT02041533|538299922|FG001|Treatment Period|Administrative reason by sponsor|0|||
149226977|NCT02041533|538299921|FG000|Treatment Period|Other reasons|9|||
149226978|NCT02041533|538299922|FG001|Treatment Period|Other reasons|2|||
149226979|NCT02041533|538299921|FG000|Treatment Period|Not Reported|0|||
149226980|NCT02041533|538299922|FG001|Treatment Period|Not Reported|1|||
149226981|NCT00545740|538299923|FG000|Overall Study|Lack of Efficacy|34|||
149226982|NCT00545740|538299924|FG001|Overall Study|Lack of Efficacy|35|||
149226983|NCT00545740|538299925|FG002|Overall Study|Lack of Efficacy|47|||
149226984|NCT00545740|538299926|FG003|Overall Study|Lack of Efficacy|36|||
149226985|NCT00545740|538299923|FG000|Overall Study|Withdrawal by Subject|17|||
149226986|NCT00545740|538299924|FG001|Overall Study|Withdrawal by Subject|15|||
149226987|NCT00545740|538299925|FG002|Overall Study|Withdrawal by Subject|16|||
149226988|NCT00545740|538299926|FG003|Overall Study|Withdrawal by Subject|18|||
149226989|NCT00545740|538299923|FG000|Overall Study|Adverse Event|10|||
149226990|NCT00545740|538299924|FG001|Overall Study|Adverse Event|18|||
149226991|NCT00545740|538299925|FG002|Overall Study|Adverse Event|19|||
149226992|NCT00545740|538299926|FG003|Overall Study|Adverse Event|9|||
149226993|NCT00545740|538299923|FG000|Overall Study|Lost to Follow-up|7|||
149226994|NCT00545740|538299924|FG001|Overall Study|Lost to Follow-up|5|||
149226995|NCT00545740|538299925|FG002|Overall Study|Lost to Follow-up|5|||
149226996|NCT00545740|538299926|FG003|Overall Study|Lost to Follow-up|6|||
149226997|NCT00545740|538299923|FG000|Overall Study|Protocol Violation|1|||
149226998|NCT00545740|538299924|FG001|Overall Study|Protocol Violation|3|||
149226999|NCT00545740|538299925|FG002|Overall Study|Protocol Violation|1|||
149227000|NCT00545740|538299926|FG003|Overall Study|Protocol Violation|0|||
148688519|NCT00989261|536332305|FG000|Overall Study|Withdrawal by Subject|0|||
148688520|NCT00989261|536332306|FG001|Overall Study|Withdrawal by Subject|1|||
148688521|NCT00989261|536332305|FG000|Overall Study|Lost to Follow-up|3|||
149227001|NCT00545740|538299923|FG000|Overall Study|Non-compliance|0|||
149227002|NCT00545740|538299924|FG001|Overall Study|Non-compliance|2|||
149227003|NCT00545740|538299925|FG002|Overall Study|Non-compliance|1|||
148954287|NCT01867021|537314753|FG000|Overall Study|Withdrawal by Subject|1|||
149227004|NCT00545740|538299926|FG003|Overall Study|Non-compliance|0|||
149227005|NCT00545740|538299923|FG000|Overall Study|Moved|2|||
148688522|NCT00989261|536332306|FG001|Overall Study|Lost to Follow-up|0|||
148688523|NCT01238848|536332307|FG000|Overall Study|Physician Decision|13|||
149227006|NCT00545740|538299924|FG001|Overall Study|Moved|0|||
149227007|NCT00545740|538299925|FG002|Overall Study|Moved|1|||
149227008|NCT00545740|538299926|FG003|Overall Study|Moved|0|||
149227009|NCT00545740|538299923|FG000|Overall Study|Diverticulitis attack|0|||
149227010|NCT00545740|538299924|FG001|Overall Study|Diverticulitis attack|0|||
149227011|NCT00545740|538299925|FG002|Overall Study|Diverticulitis attack|1|||
149227012|NCT00545740|538299926|FG003|Overall Study|Diverticulitis attack|1|||
149227013|NCT00545740|538299923|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
149227014|NCT00545740|538299924|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
149227015|NCT00545740|538299925|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
149227016|NCT00545740|538299926|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
149227017|NCT00545740|538299923|FG000|Overall Study|Site closure|1|||
149227018|NCT00545740|538299924|FG001|Overall Study|Site closure|0|||
149227019|NCT00545740|538299925|FG002|Overall Study|Site closure|0|||
149227020|NCT00545740|538299926|FG003|Overall Study|Site closure|0|||
149227021|NCT00545740|538299923|FG000|Overall Study|Missed visit|1|||
149227022|NCT00545740|538299924|FG001|Overall Study|Missed visit|0|||
149227023|NCT00545740|538299925|FG002|Overall Study|Missed visit|0|||
149227024|NCT00545740|538299926|FG003|Overall Study|Missed visit|0|||
149227025|NCT00545740|538299923|FG000|Overall Study|Physician Decision|0|||
149227026|NCT00545740|538299924|FG001|Overall Study|Physician Decision|0|||
149227027|NCT00545740|538299925|FG002|Overall Study|Physician Decision|3|||
149227028|NCT00545740|538299926|FG003|Overall Study|Physician Decision|0|||
149227029|NCT00545740|538299923|FG000|Overall Study|Accepted only monthly telephone calls|1|||
149227030|NCT00545740|538299924|FG001|Overall Study|Accepted only monthly telephone calls|0|||
149227031|NCT00545740|538299925|FG002|Overall Study|Accepted only monthly telephone calls|0|||
149227032|NCT00545740|538299926|FG003|Overall Study|Accepted only monthly telephone calls|0|||
149227033|NCT00545740|538299923|FG000|Overall Study|Sponsor decision|0|||
149227034|NCT00545740|538299924|FG001|Overall Study|Sponsor decision|1|||
149227035|NCT00545740|538299925|FG002|Overall Study|Sponsor decision|0|||
149227036|NCT00545740|538299926|FG003|Overall Study|Sponsor decision|0|||
149227037|NCT00545740|538299923|FG000|Overall Study|Lack of time|0|||
149227038|NCT00545740|538299924|FG001|Overall Study|Lack of time|1|||
149227039|NCT00545740|538299925|FG002|Overall Study|Lack of time|0|||
149227040|NCT00545740|538299926|FG003|Overall Study|Lack of time|0|||
149227041|NCT00545740|538299923|FG000|Overall Study|Non-adherence to visits|0|||
149227042|NCT00545740|538299924|FG001|Overall Study|Non-adherence to visits|1|||
149227043|NCT00545740|538299925|FG002|Overall Study|Non-adherence to visits|0|||
149227044|NCT00545740|538299926|FG003|Overall Study|Non-adherence to visits|0|||
149227045|NCT00545740|538299923|FG000|Overall Study|Patient difficulties|0|||
149227046|NCT00545740|538299924|FG001|Overall Study|Patient difficulties|1|||
149227047|NCT00545740|538299925|FG002|Overall Study|Patient difficulties|0|||
149227048|NCT00545740|538299926|FG003|Overall Study|Patient difficulties|0|||
149227049|NCT00545740|538299923|FG000|Overall Study|Husband against study|0|||
149227050|NCT00545740|538299924|FG001|Overall Study|Husband against study|0|||
149227051|NCT00545740|538299925|FG002|Overall Study|Husband against study|1|||
149227052|NCT00545740|538299926|FG003|Overall Study|Husband against study|0|||
149227053|NCT02117024|538299927|FG000|Overall Study|Progressive Disease|26|||
149227054|NCT02117024|538299928|FG001|Overall Study|Progressive Disease|9|||
149227055|NCT02117024|538299927|FG000|Overall Study|Significant Clinical Progression|7|||
149227056|NCT02117024|538299928|FG001|Overall Study|Significant Clinical Progression|4|||
149227057|NCT02117024|538299927|FG000|Overall Study|Death|5|||
149227058|NCT02117024|538299928|FG001|Overall Study|Death|0|||
149227059|NCT02117024|538299927|FG000|Overall Study|Withdrawal by Subject|3|||
149227060|NCT02117024|538299928|FG001|Overall Study|Withdrawal by Subject|1|||
149227061|NCT02117024|538299927|FG000|Overall Study|Protocol Violation|1|||
149227062|NCT02117024|538299928|FG001|Overall Study|Protocol Violation|0|||
149227063|NCT02117024|538299927|FG000|Overall Study|Adverse Event|1|||
149227064|NCT02117024|538299928|FG001|Overall Study|Adverse Event|2|||
149227065|NCT02117024|538299927|FG000|Overall Study|Randomized in Error|1|||
149227066|NCT02117024|538299928|FG001|Overall Study|Randomized in Error|0|||
149227067|NCT02117024|538299927|FG000|Overall Study|Patient returned to primary oncologist|0|||
149227068|NCT02117024|538299928|FG001|Overall Study|Patient returned to primary oncologist|1|||
149227069|NCT02117024|538299927|FG000|Overall Study|Patient took treatment break|0|||
149227070|NCT02117024|538299928|FG001|Overall Study|Patient took treatment break|1|||
149227071|NCT02117024|538299927|FG000|Overall Study|Physician Decision|0|||
149227072|NCT02117024|538299928|FG001|Overall Study|Physician Decision|2|||
149227073|NCT00565721|538299931|FG000|Overall Study|Screen Failure|2|||
149227074|NCT00565721|538299931|FG000|Overall Study|Lost to Follow-up|6|||
149227075|NCT00565721|538299931|FG000|Overall Study|Technical Problems|1|||
149227076|NCT00565721|538299931|FG000|Overall Study|Physician Decision|2|||
149227077|NCT00565721|538299931|FG000|Overall Study|Other reasons|6|||
149227078|NCT02813681|538299932|FG000|Overall Study|Physician Decision|5|||
149227079|NCT02813681|538299933|FG001|Overall Study|Physician Decision|5|||
149227080|NCT02813681|538299934|FG002|Overall Study|Physician Decision|0|||
149227081|NCT02813681|538299932|FG000|Overall Study|Lost to Follow-up|0|||
149227082|NCT02813681|538299933|FG001|Overall Study|Lost to Follow-up|1|||
149227083|NCT02813681|538299934|FG002|Overall Study|Lost to Follow-up|0|||
149227084|NCT00529152|538299935|FG000|Overall Study|Adverse Event|2|||
149227085|NCT00529152|538299935|FG000|Overall Study|Withdrawal by Subject|2|||
149227086|NCT00529152|538299935|FG000|Overall Study|Lost to Follow-up|1|||
149227087|NCT02500706|538299936|FG000|Overall Study|Adverse Event|0|||
149227088|NCT02500706|538299937|FG001|Overall Study|Adverse Event|0|||
149227089|NCT02500706|538299938|FG002|Overall Study|Adverse Event|1|||
149227090|NCT02500706|538299936|FG000|Overall Study|Lost to Follow-up|0|||
149227091|NCT02500706|538299937|FG001|Overall Study|Lost to Follow-up|1|||
149119516|NCT00506441|537916365|FG001|Period 2; Double-blind Period|Adverse Event|1|||
149119517|NCT00506441|537916364|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
149119518|NCT00506441|537916365|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
149119519|NCT00506441|537916364|FG000|Period 2; Double-blind Period|Physician Decision|1|||
149119520|NCT00506441|537916365|FG001|Period 2; Double-blind Period|Physician Decision|1|||
149119521|NCT00506441|537916364|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
149119522|NCT00506441|537916365|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
149119523|NCT00506441|537916364|FG000|Period 2; Double-blind Period|Other Reason|1|||
149119524|NCT00506441|537916365|FG001|Period 2; Double-blind Period|Other Reason|1|||
149119525|NCT01151410|537916367|FG000|Overall Study|Withdrawal by Subject|3|||
149119526|NCT01151410|537916368|FG001|Overall Study|Withdrawal by Subject|5|||
149119527|NCT01151410|537916367|FG000|Overall Study|Lost to Follow-up|3|||
149119528|NCT01151410|537916368|FG001|Overall Study|Lost to Follow-up|4|||
149119529|NCT01151410|537916367|FG000|Overall Study|Adverse Event|1|||
149119530|NCT01151410|537916368|FG001|Overall Study|Adverse Event|2|||
149119531|NCT01151410|537916367|FG000|Overall Study|Protocol deviation|2|||
149119532|NCT01151410|537916368|FG001|Overall Study|Protocol deviation|1|||
149119533|NCT01151410|537916367|FG000|Overall Study|Administrative problems|1|||
149119534|NCT01151410|537916368|FG001|Overall Study|Administrative problems|1|||
149119535|NCT01151410|537916367|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149119536|NCT01151410|537916368|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149119537|NCT01151410|537916367|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149119538|NCT01151410|537916368|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149119539|NCT02270515|537916369|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
149119540|NCT02270515|537916369|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
149119541|NCT02270515|537916369|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
149119542|NCT02270515|537916369|FG000|Intervention Period 1: 0-6 Months|Death|7|||
149119543|NCT02270515|537916369|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
149119544|NCT02270515|537916369|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
149119545|NCT02270515|537916369|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
149119546|NCT02270515|537916369|FG000|Intervention Period 2: 6-12 Months|Death|5|||
149119547|NCT02270515|537916369|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
149119548|NCT02270515|537916369|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
149119549|NCT02270515|537916369|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
149119550|NCT02270515|537916369|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
149119551|NCT02270515|537916369|FG000|Intervention Period 3: 12-18 Months|Death|3|||
149119552|NCT02270515|537916369|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
149119553|NCT04540887|537916373|FG000|Overall Study|Withdrawal by Subject|2|||
149119554|NCT02489968|537916381|FG000|Open-label Treatment Period|Adverse Event|14|||
149119555|NCT02489968|537916382|FG001|Open-label Treatment Period|Adverse Event|7|||
149119556|NCT02489968|537916383|FG002|Open-label Treatment Period|Adverse Event|0|||
149119557|NCT02489968|537916384|FG003|Open-label Treatment Period|Adverse Event|0|||
149119558|NCT02489968|537916385|FG004|Open-label Treatment Period|Adverse Event|0|||
149119559|NCT02489968|537916386|FG005|Open-label Treatment Period|Adverse Event|0|||
149119560|NCT02489968|537916381|FG000|Open-label Treatment Period|Protocol Violation|2|||
149119561|NCT02489968|537916382|FG001|Open-label Treatment Period|Protocol Violation|2|||
149119562|NCT02489968|537916383|FG002|Open-label Treatment Period|Protocol Violation|0|||
149119563|NCT02489968|537916384|FG003|Open-label Treatment Period|Protocol Violation|0|||
149119564|NCT02489968|537916385|FG004|Open-label Treatment Period|Protocol Violation|0|||
149119565|NCT02489968|537916386|FG005|Open-label Treatment Period|Protocol Violation|0|||
149119566|NCT02489968|537916381|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
149119567|NCT02489968|537916382|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
149119568|NCT02489968|537916383|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
149119569|NCT02489968|537916384|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
149119570|NCT02489968|537916385|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
149119571|NCT02489968|537916386|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
149119572|NCT02489968|537916381|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
149119573|NCT02489968|537916382|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
149227092|NCT02500706|538299938|FG002|Overall Study|Lost to Follow-up|1|||
149227093|NCT02500706|538299936|FG000|Overall Study|Withdrawal by Subject|4|||
149227094|NCT02500706|538299937|FG001|Overall Study|Withdrawal by Subject|6|||
149227095|NCT02500706|538299938|FG002|Overall Study|Withdrawal by Subject|4|||
149227096|NCT02500706|538299936|FG000|Overall Study|Unclassified|0|||
149227097|NCT02500706|538299937|FG001|Overall Study|Unclassified|0|||
149227098|NCT02500706|538299938|FG002|Overall Study|Unclassified|1|||
149227099|NCT01497899|538299939|FG000|Double-Blind Phase|Randomized but not Treated|1|||
149227100|NCT01497899|538299940|FG001|Double-Blind Phase|Randomized but not Treated|0|||
149227101|NCT01497899|538299941|FG002|Double-Blind Phase|Randomized but not Treated|0|||
149227102|NCT01497899|538299942|FG003|Double-Blind Phase|Randomized but not Treated|0|||
149227103|NCT01497899|538299939|FG000|Double-Blind Phase|Adverse Event|1|||
149227104|NCT01497899|538299940|FG001|Double-Blind Phase|Adverse Event|0|||
149227105|NCT01497899|538299941|FG002|Double-Blind Phase|Adverse Event|0|||
149227106|NCT01497899|538299942|FG003|Double-Blind Phase|Adverse Event|0|||
149227107|NCT01497899|538299939|FG000|Double-Blind Phase|Lack of Efficacy|0|||
149227108|NCT01497899|538299940|FG001|Double-Blind Phase|Lack of Efficacy|1|||
149227109|NCT01497899|538299941|FG002|Double-Blind Phase|Lack of Efficacy|0|||
149227110|NCT01497899|538299942|FG003|Double-Blind Phase|Lack of Efficacy|0|||
149227111|NCT01497899|538299939|FG000|Double-Blind Phase|Investigator's Discretion|1|||
149227112|NCT01497899|538299940|FG001|Double-Blind Phase|Investigator's Discretion|0|||
149227113|NCT01497899|538299941|FG002|Double-Blind Phase|Investigator's Discretion|0|||
149227114|NCT01497899|538299942|FG003|Double-Blind Phase|Investigator's Discretion|0|||
149227115|NCT01497899|538299939|FG000|Double-Blind Phase|Withdrew Consent|0|||
149227116|NCT01497899|538299940|FG001|Double-Blind Phase|Withdrew Consent|1|||
149227117|NCT01497899|538299941|FG002|Double-Blind Phase|Withdrew Consent|0|||
149227118|NCT01497899|538299942|FG003|Double-Blind Phase|Withdrew Consent|0|||
149227119|NCT01497899|538299939|FG000|Double-Blind Phase|Lost to Follow-up|3|||
149227120|NCT01497899|538299940|FG001|Double-Blind Phase|Lost to Follow-up|2|||
149227121|NCT01497899|538299941|FG002|Double-Blind Phase|Lost to Follow-up|0|||
149227122|NCT01497899|538299942|FG003|Double-Blind Phase|Lost to Follow-up|0|||
149227123|NCT01497899|538299939|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
149227124|NCT01497899|538299940|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
149227125|NCT01497899|538299941|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
149227126|NCT01497899|538299942|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
149227127|NCT01497899|538299939|FG000|Open-Label Extension Phase|Adverse Event|1|||
149227128|NCT01497899|538299940|FG001|Open-Label Extension Phase|Adverse Event|0|||
149227129|NCT01497899|538299941|FG002|Open-Label Extension Phase|Adverse Event|0|||
149227130|NCT01497899|538299942|FG003|Open-Label Extension Phase|Adverse Event|0|||
149227131|NCT01497899|538299939|FG000|Open-Label Extension Phase|Death|1|||
149227132|NCT01497899|538299940|FG001|Open-Label Extension Phase|Death|0|||
149227133|NCT01497899|538299941|FG002|Open-Label Extension Phase|Death|0|||
149227134|NCT01497899|538299942|FG003|Open-Label Extension Phase|Death|0|||
149227135|NCT01497899|538299939|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
149227136|NCT01497899|538299940|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
149227137|NCT01497899|538299941|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
149227138|NCT01497899|538299942|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
149227139|NCT01497899|538299939|FG000|Open-Label Extension Phase|Pregnancy|0|||
149227140|NCT01497899|538299940|FG001|Open-Label Extension Phase|Pregnancy|1|||
149227141|NCT01497899|538299941|FG002|Open-Label Extension Phase|Pregnancy|1|||
149227142|NCT01497899|538299942|FG003|Open-Label Extension Phase|Pregnancy|0|||
149227143|NCT01497899|538299939|FG000|Open-Label Extension Phase|Protocol Violation|0|||
149227144|NCT01497899|538299940|FG001|Open-Label Extension Phase|Protocol Violation|0|||
149227145|NCT01497899|538299941|FG002|Open-Label Extension Phase|Protocol Violation|1|||
149227146|NCT01497899|538299942|FG003|Open-Label Extension Phase|Protocol Violation|0|||
149227147|NCT01497899|538299939|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
149227148|NCT01497899|538299940|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
149227149|NCT01497899|538299941|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
149227150|NCT01497899|538299942|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
149227151|NCT01874288|538299947|FG000|Overall Study|Withdrawal by Subject|1|||
149227152|NCT01874288|538299948|FG001|Overall Study|Withdrawal by Subject|0|||
149227153|NCT01874288|538299949|FG002|Overall Study|Withdrawal by Subject|2|||
149227154|NCT01874288|538299950|FG003|Overall Study|Withdrawal by Subject|1|||
149227155|NCT01874288|538299951|FG004|Overall Study|Withdrawal by Subject|1|||
149227156|NCT01874288|538299947|FG000|Overall Study|Physician Decision|0|||
149227157|NCT01874288|538299948|FG001|Overall Study|Physician Decision|0|||
149227158|NCT01874288|538299949|FG002|Overall Study|Physician Decision|0|||
149227159|NCT01874288|538299950|FG003|Overall Study|Physician Decision|1|||
149227160|NCT01874288|538299951|FG004|Overall Study|Physician Decision|0|||
149227161|NCT01874288|538299947|FG000|Overall Study|Progressive disease|2|||
149227162|NCT01874288|538299948|FG001|Overall Study|Progressive disease|0|||
149227163|NCT01874288|538299949|FG002|Overall Study|Progressive disease|3|||
149227164|NCT01874288|538299950|FG003|Overall Study|Progressive disease|5|||
149227165|NCT01874288|538299951|FG004|Overall Study|Progressive disease|1|||
149227166|NCT04212221|538299952|FG000|Overall Study|Remained on Treatment|0|||
149227167|NCT04212221|538299953|FG001|Overall Study|Remained on Treatment|0|||
149227168|NCT04212221|538299954|FG002|Overall Study|Remained on Treatment|0|||
149227169|NCT04212221|538299955|FG003|Overall Study|Remained on Treatment|1|||
149227170|NCT04212221|538299956|FG004|Overall Study|Remained on Treatment|0|||
149227171|NCT04212221|538299957|FG005|Overall Study|Remained on Treatment|0|||
149227172|NCT04212221|538299958|FG006|Overall Study|Remained on Treatment|3|||
149227173|NCT04212221|538299959|FG007|Overall Study|Remained on Treatment|9|||
149227174|NCT04212221|538299952|FG000|Overall Study|Adverse Event|0|||
149227175|NCT04212221|538299953|FG001|Overall Study|Adverse Event|0|||
149227176|NCT04212221|538299954|FG002|Overall Study|Adverse Event|0|||
149227177|NCT04212221|538299955|FG003|Overall Study|Adverse Event|0|||
149227178|NCT04212221|538299956|FG004|Overall Study|Adverse Event|0|||
149227179|NCT04212221|538299957|FG005|Overall Study|Adverse Event|0|||
149227180|NCT04212221|538299958|FG006|Overall Study|Adverse Event|2|||
149227181|NCT04212221|538299959|FG007|Overall Study|Adverse Event|3|||
149227182|NCT04212221|538299952|FG000|Overall Study|Death|0|||
149227183|NCT04212221|538299953|FG001|Overall Study|Death|0|||
149227184|NCT04212221|538299954|FG002|Overall Study|Death|0|||
149227185|NCT04212221|538299955|FG003|Overall Study|Death|0|||
149227186|NCT04212221|538299956|FG004|Overall Study|Death|0|||
149227187|NCT04212221|538299957|FG005|Overall Study|Death|0|||
149227188|NCT04212221|538299958|FG006|Overall Study|Death|0|||
149227189|NCT04212221|538299959|FG007|Overall Study|Death|2|||
149227190|NCT04212221|538299952|FG000|Overall Study|Disease progression according to irRECIST|1|||
149227191|NCT04212221|538299953|FG001|Overall Study|Disease progression according to irRECIST|2|||
149227192|NCT04212221|538299954|FG002|Overall Study|Disease progression according to irRECIST|3|||
149227193|NCT04212221|538299955|FG003|Overall Study|Disease progression according to irRECIST|3|||
149227194|NCT04212221|538299956|FG004|Overall Study|Disease progression according to irRECIST|2|||
149227195|NCT04212221|538299957|FG005|Overall Study|Disease progression according to irRECIST|2|||
149227196|NCT04212221|538299958|FG006|Overall Study|Disease progression according to irRECIST|21|||
149227197|NCT04212221|538299959|FG007|Overall Study|Disease progression according to irRECIST|17|||
149227198|NCT04212221|538299952|FG000|Overall Study|Global Deterioration of Health Status|0|||
149227199|NCT04212221|538299953|FG001|Overall Study|Global Deterioration of Health Status|0|||
149227200|NCT04212221|538299954|FG002|Overall Study|Global Deterioration of Health Status|0|||
149227201|NCT04212221|538299955|FG003|Overall Study|Global Deterioration of Health Status|0|||
149227202|NCT04212221|538299956|FG004|Overall Study|Global Deterioration of Health Status|0|||
149227203|NCT04212221|538299957|FG005|Overall Study|Global Deterioration of Health Status|0|||
149227204|NCT04212221|538299958|FG006|Overall Study|Global Deterioration of Health Status|0|||
149227205|NCT04212221|538299959|FG007|Overall Study|Global Deterioration of Health Status|2|||
149227206|NCT04212221|538299952|FG000|Overall Study|Investigator's Decision|0|||
149227207|NCT04212221|538299953|FG001|Overall Study|Investigator's Decision|0|||
149227208|NCT04212221|538299954|FG002|Overall Study|Investigator's Decision|0|||
149227209|NCT04212221|538299955|FG003|Overall Study|Investigator's Decision|1|||
149227210|NCT04212221|538299956|FG004|Overall Study|Investigator's Decision|0|||
149227211|NCT04212221|538299957|FG005|Overall Study|Investigator's Decision|0|||
149227212|NCT04212221|538299958|FG006|Overall Study|Investigator's Decision|3|||
149227213|NCT04212221|538299959|FG007|Overall Study|Investigator's Decision|0|||
149227214|NCT04212221|538299952|FG000|Overall Study|Participant refused to continue treatment|0|||
149227215|NCT04212221|538299953|FG001|Overall Study|Participant refused to continue treatment|1|||
149227216|NCT04212221|538299954|FG002|Overall Study|Participant refused to continue treatment|0|||
149227217|NCT04212221|538299955|FG003|Overall Study|Participant refused to continue treatment|1|||
149227218|NCT04212221|538299956|FG004|Overall Study|Participant refused to continue treatment|1|||
149227219|NCT04212221|538299957|FG005|Overall Study|Participant refused to continue treatment|2|||
148688524|NCT01238848|536332308|FG001|Overall Study|Physician Decision|5|||
149227220|NCT04212221|538299958|FG006|Overall Study|Participant refused to continue treatment|4|||
149227221|NCT04212221|538299959|FG007|Overall Study|Participant refused to continue treatment|2|||
149227222|NCT04212221|538299952|FG000|Overall Study|Protocol Violation|0|||
149227223|NCT04212221|538299953|FG001|Overall Study|Protocol Violation|0|||
149227224|NCT04212221|538299954|FG002|Overall Study|Protocol Violation|0|||
149227225|NCT04212221|538299955|FG003|Overall Study|Protocol Violation|0|||
149227226|NCT04212221|538299956|FG004|Overall Study|Protocol Violation|0|||
149227227|NCT04212221|538299957|FG005|Overall Study|Protocol Violation|0|||
149227228|NCT04212221|538299958|FG006|Overall Study|Protocol Violation|0|||
149227229|NCT04212221|538299959|FG007|Overall Study|Protocol Violation|1|||
149227230|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
149227231|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
149227232|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
149227233|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
149227234|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
149227235|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
149227236|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Death|1|||
149227237|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Death|1|||
149227238|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Death|1|||
149227239|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Death|0|||
149227240|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Death|0|||
149227241|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Death|0|||
149227242|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
149227243|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
149227244|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149227245|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149227246|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149227247|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
149227248|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149227249|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149227250|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
149227251|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149227252|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149227253|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
149227254|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149227255|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
149227256|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149227257|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149227258|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149227259|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
149227260|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
149227261|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
149227262|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
149227263|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
149227264|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
149227265|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
149227266|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
149227267|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
149227268|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
149227269|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
149227270|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
149227271|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
149227272|NCT03370133|538299965|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
149227273|NCT03370133|538299966|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
149227274|NCT03370133|538299967|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
149227275|NCT03370133|538299968|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
149227276|NCT03370133|538299969|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
149227277|NCT03370133|538299970|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
148688525|NCT00576901|536332309|FG000|Overall Study|Withdrawal by Subject|1|||
148688526|NCT00576901|536332309|FG000|Overall Study|Disease course|1|||
148688527|NCT00576901|536332309|FG000|Overall Study|Protocol Violation|1|||
148688528|NCT02398188|536332310|FG000|Overall Study|Adverse Event|2|||
148954288|NCT01867021|537314754|FG001|Overall Study|Withdrawal by Subject|6|||
148954289|NCT00640601|537314755|FG000|Overall Study|Adverse Event|43|||
149227278|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
149227279|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
149227280|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
149227281|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
149227282|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
148688529|NCT02398188|536332311|FG001|Overall Study|Adverse Event|3|||
148688530|NCT02398188|536332310|FG000|Overall Study|Lost to Follow-up|5|||
148810213|NCT02337829|536782590|FG000|Overall Study|Study terminated by sponsor|12|||
148810214|NCT02337829|536782591|FG001|Overall Study|Study terminated by sponsor|10|||
149227283|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
149227284|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149227285|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149227286|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149227287|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
149227288|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
149227289|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
149227290|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149227291|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149227292|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149227293|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
149227294|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
149227295|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
149227296|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149227297|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149227298|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149227299|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
149227300|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
149227301|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
149227302|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
149227303|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
149227304|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
149227305|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
149227306|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
149227307|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
149227308|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149227309|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149227310|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149227311|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149227312|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
149227313|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
149227314|NCT03370133|538299965|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149227315|NCT03370133|538299966|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149227316|NCT03370133|538299967|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149227317|NCT03370133|538299968|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149227318|NCT03370133|538299969|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
149227319|NCT03370133|538299970|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
149227320|NCT00636506|538299971|FG000|Overall Study|Lost to Follow-up|8|||
149227321|NCT00636506|538299971|FG000|Overall Study|Explanted|1|||
149227322|NCT00636506|538299971|FG000|Overall Study|Withdrawal by Subject|6|||
149227323|NCT00636506|538299971|FG000|Overall Study|Procedure aborted|1|||
149227324|NCT01624974|538299972|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
149227325|NCT01624974|538299973|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
149227326|NCT01624974|538299972|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
148810215|NCT02337829|536782592|FG002|Overall Study|Study terminated by sponsor|5|||
148688531|NCT02398188|536332311|FG001|Overall Study|Lost to Follow-up|0|||
148688532|NCT02398188|536332310|FG000|Overall Study|Non-compliance|4|||
148688533|NCT02398188|536332311|FG001|Overall Study|Non-compliance|4|||
148688534|NCT02398188|536332310|FG000|Overall Study|Protocol Violation|6|||
148688535|NCT02398188|536332311|FG001|Overall Study|Protocol Violation|10|||
148688536|NCT02398188|536332310|FG000|Overall Study|Sponsor Decision|2|||
148688537|NCT02398188|536332311|FG001|Overall Study|Sponsor Decision|1|||
148688538|NCT02398188|536332310|FG000|Overall Study|Pregnancy|1|||
148688539|NCT02398188|536332311|FG001|Overall Study|Pregnancy|0|||
148688540|NCT02398188|536332310|FG000|Overall Study|Withdrawal by Subject|7|||
148688541|NCT02398188|536332311|FG001|Overall Study|Withdrawal by Subject|16|||
148688542|NCT01259869|536332312|FG000|Overall Study|Duplicated registration|1|||
148688543|NCT03209570|536332317|FG000|Overall Study|Death|1|||
148688544|NCT03209570|536332318|FG001|Overall Study|Death|0|||
148688545|NCT03209570|536332317|FG000|Overall Study|Incomplete Data|8|||
148688546|NCT03209570|536332318|FG001|Overall Study|Incomplete Data|10|||
148688547|NCT03209570|536332317|FG000|Overall Study|Protocol Violation|1|||
148688548|NCT03209570|536332318|FG001|Overall Study|Protocol Violation|0|||
148688549|NCT03209570|536332317|FG000|Overall Study|Withdrawal by Subject|0|||
148688550|NCT03209570|536332318|FG001|Overall Study|Withdrawal by Subject|3|||
148688551|NCT00220701|536332320|FG000|Overall Study|Lost to Follow-up|5|||
148688552|NCT00220701|536332321|FG001|Overall Study|Lost to Follow-up|4|||
148688553|NCT00755326|536332323|FG000|Overall Study|Lost to Follow-up|2|||
148688554|NCT00755326|536332324|FG001|Overall Study|Lost to Follow-up|3|||
148688555|NCT00368966|536332333|FG000|Infant Series|Withdrawal by Subject|11|||
148688556|NCT00368966|536332334|FG001|Infant Series|Withdrawal by Subject|6|||
148688557|NCT00368966|536332333|FG000|Infant Series|Protocol Violation|2|||
148688558|NCT00368966|536332334|FG001|Infant Series|Protocol Violation|1|||
148688559|NCT00368966|536332333|FG000|Infant Series|Lost to Follow-up|2|||
148688560|NCT00368966|536332334|FG001|Infant Series|Lost to Follow-up|0|||
148688561|NCT00368966|536332333|FG000|Infant Series|Randomization error|0|||
148688562|NCT00368966|536332334|FG001|Infant Series|Randomization error|1|||
148688563|NCT00368966|536332333|FG000|Infant Series|Failed to meet eligibility criteria|0|||
148688564|NCT00368966|536332334|FG001|Infant Series|Failed to meet eligibility criteria|1|||
148688565|NCT00368966|536332333|FG000|Infant Series|Adverse Event|0|||
148688566|NCT00368966|536332334|FG001|Infant Series|Adverse Event|1|||
148688567|NCT00368966|536332333|FG000|Infant Series|Failed to return|1|||
148688568|NCT00368966|536332334|FG001|Infant Series|Failed to return|0|||
148688569|NCT00368966|536332333|FG000|After Infant|Failed to return|3|||
148688570|NCT00368966|536332334|FG001|After Infant|Failed to return|1|||
148688571|NCT00368966|536332333|FG000|After Infant|Adverse Event|1|||
148688572|NCT00368966|536332334|FG001|After Infant|Adverse Event|2|||
148688573|NCT00368966|536332333|FG000|After Infant|Withdrawal by Subject|1|||
148688574|NCT00368966|536332334|FG001|After Infant|Withdrawal by Subject|1|||
148688575|NCT00368966|536332333|FG000|After Infant|Death|1|||
148688576|NCT00368966|536332334|FG001|After Infant|Death|0|||
148688577|NCT00368966|536332333|FG000|After Infant|Lost to Follow-up|0|||
148688578|NCT00368966|536332334|FG001|After Infant|Lost to Follow-up|1|||
149227327|NCT01624974|538299973|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
149227328|NCT01624974|538299972|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
149227329|NCT01624974|538299973|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
148810216|NCT02337829|536782593|FG003|Overall Study|Study terminated by sponsor|6|||
148810217|NCT02337829|536782590|FG000|Overall Study|discontinued for other reasons|6|||
148810218|NCT02337829|536782591|FG001|Overall Study|discontinued for other reasons|3|||
148810219|NCT02337829|536782592|FG002|Overall Study|discontinued for other reasons|1|||
148810220|NCT02337829|536782593|FG003|Overall Study|discontinued for other reasons|4|||
148810221|NCT00879658|536782596|FG000|Overall Study|Abnormal laboratory value(s)|3|||
148688579|NCT00368966|536332333|FG000|Toddler Dose|Withdrawal by Subject|1|||
148688580|NCT00368966|536332334|FG001|Toddler Dose|Withdrawal by Subject|1|||
148688581|NCT00368966|536332333|FG000|Toddler Dose|Lost to Follow-up|0|||
148688582|NCT00368966|536332334|FG001|Toddler Dose|Lost to Follow-up|2|||
149227330|NCT01624974|538299972|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
149227331|NCT01624974|538299973|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
149227332|NCT01624974|538299972|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
149227333|NCT01624974|538299973|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
149227334|NCT01624974|538299972|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
149227335|NCT01624974|538299973|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
149227336|NCT01624974|538299972|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
149227337|NCT01624974|538299973|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
149227338|NCT01624974|538299972|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
149227339|NCT01624974|538299973|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
149227340|NCT01624974|538299972|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
149227341|NCT01624974|538299973|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
149227342|NCT01624974|538299972|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
149227343|NCT01624974|538299973|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
149227344|NCT01624974|538299972|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
149227345|NCT01624974|538299973|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
148688583|NCT01689974|536332335|FG000|Overall Study|Termination of Study|5|||
148688584|NCT01689974|536332336|FG001|Overall Study|Termination of Study|5|||
148688585|NCT01333033|536332340|FG000|Overall Study|Ineligible|0|||
148688586|NCT01333033|536332341|FG001|Overall Study|Ineligible|0|||
148688587|NCT01333033|536332342|FG002|Overall Study|Ineligible|0|||
148688588|NCT01333033|536332343|FG003|Overall Study|Ineligible|0|||
148688589|NCT01333033|536332344|FG004|Overall Study|Ineligible|6|||
148688590|NCT01333033|536332345|FG005|Overall Study|Ineligible|8|||
148688591|NCT01333033|536332340|FG000|Overall Study|Withdrawal by Subject|0|||
148688592|NCT01333033|536332341|FG001|Overall Study|Withdrawal by Subject|0|||
148688593|NCT01333033|536332342|FG002|Overall Study|Withdrawal by Subject|0|||
148688594|NCT01333033|536332343|FG003|Overall Study|Withdrawal by Subject|0|||
148688595|NCT01333033|536332344|FG004|Overall Study|Withdrawal by Subject|4|||
148688596|NCT01333033|536332345|FG005|Overall Study|Withdrawal by Subject|2|||
148688597|NCT01333033|536332340|FG000|Overall Study|PET inevaluable|0|||
148688598|NCT01333033|536332341|FG001|Overall Study|PET inevaluable|0|||
148688599|NCT01333033|536332342|FG002|Overall Study|PET inevaluable|0|||
148688600|NCT01333033|536332343|FG003|Overall Study|PET inevaluable|0|||
148688601|NCT01333033|536332344|FG004|Overall Study|PET inevaluable|2|||
149227346|NCT01624974|538299972|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
149227347|NCT01624974|538299973|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
148688602|NCT01333033|536332345|FG005|Overall Study|PET inevaluable|4|||
148688603|NCT01333033|536332340|FG000|Overall Study|Adverse Event|0|||
148688604|NCT01333033|536332341|FG001|Overall Study|Adverse Event|0|||
148688605|NCT01333033|536332342|FG002|Overall Study|Adverse Event|0|||
148810222|NCT00879658|536782597|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148810223|NCT00879658|536782598|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149227348|NCT03607994|538299974|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
149227349|NCT03607994|538299975|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
149227350|NCT03125902|538299977|FG000|Overall Study|Adverse Event|0|||
149227351|NCT03125902|538299978|FG001|Overall Study|Adverse Event|1|||
149227352|NCT03125902|538299977|FG000|Overall Study|Death|119|||
149227353|NCT03125902|538299978|FG001|Overall Study|Death|229|||
149227354|NCT03125902|538299977|FG000|Overall Study|Lost to Follow-up|4|||
149227355|NCT03125902|538299978|FG001|Overall Study|Lost to Follow-up|13|||
149227356|NCT03125902|538299977|FG000|Overall Study|Other|0|||
149227357|NCT03125902|538299978|FG001|Overall Study|Other|4|||
149227358|NCT03125902|538299977|FG000|Overall Study|Physician Decision|2|||
149227359|NCT03125902|538299978|FG001|Overall Study|Physician Decision|1|||
148688606|NCT01333033|536332343|FG003|Overall Study|Adverse Event|0|||
148688607|NCT01333033|536332344|FG004|Overall Study|Adverse Event|2|||
148688608|NCT01333033|536332345|FG005|Overall Study|Adverse Event|1|||
148688609|NCT01333033|536332340|FG000|Overall Study|Progression|0|||
149227360|NCT03125902|538299977|FG000|Overall Study|Progressive Disease|0|||
149227361|NCT03125902|538299978|FG001|Overall Study|Progressive Disease|3|||
149020043|NCT02601937|537551125|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020044|NCT02601937|537551126|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020045|NCT02601937|537551127|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020046|NCT02601937|537551128|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020047|NCT02601937|537551129|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
149020048|NCT02601937|537551130|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020049|NCT02601937|537551131|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020050|NCT02601937|537551132|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020051|NCT02601937|537551133|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
149020052|NCT02601937|537551123|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020053|NCT02601937|537551124|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020054|NCT02601937|537551125|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
149020055|NCT02601937|537551126|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020056|NCT02601937|537551127|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020057|NCT02601937|537551128|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020058|NCT02601937|537551129|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020059|NCT02601937|537551130|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020060|NCT02601937|537551131|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020061|NCT02601937|537551132|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020062|NCT02601937|537551133|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
149020063|NCT02601937|537551123|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
149020064|NCT02601937|537551124|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
149020065|NCT02601937|537551125|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
149227362|NCT03125902|538299977|FG000|Overall Study|Study Terminated By Sponsor|74|||
148688610|NCT01333033|536332341|FG001|Overall Study|Progression|0|||
148688611|NCT01333033|536332342|FG002|Overall Study|Progression|0|||
149227363|NCT03125902|538299978|FG001|Overall Study|Study Terminated By Sponsor|143|||
149227364|NCT03125902|538299977|FG000|Overall Study|Withdrawal by Subject|21|||
149227365|NCT03125902|538299978|FG001|Overall Study|Withdrawal by Subject|37|||
148688612|NCT01333033|536332343|FG003|Overall Study|Progression|0|||
148688613|NCT01333033|536332344|FG004|Overall Study|Progression|0|||
148688614|NCT01333033|536332345|FG005|Overall Study|Progression|1|||
148688615|NCT01333033|536332340|FG000|Overall Study|MD Decision|0|||
148688616|NCT01333033|536332341|FG001|Overall Study|MD Decision|0|||
149227366|NCT01997333|538299979|FG000|Randomization and Treatment|Disease Progression|70|||
149227367|NCT01997333|538299980|FG001|Randomization and Treatment|Disease Progression|159|||
149227368|NCT01997333|538299979|FG000|Randomization and Treatment|Adverse Event|10|||
149227369|NCT01997333|538299980|FG001|Randomization and Treatment|Adverse Event|32|||
149227370|NCT01997333|538299979|FG000|Randomization and Treatment|Physician Decision|0|||
149227371|NCT01997333|538299980|FG001|Randomization and Treatment|Physician Decision|4|||
149227372|NCT01997333|538299979|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
149227373|NCT01997333|538299980|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
149227374|NCT01997333|538299979|FG000|Randomization and Treatment|Did not receive treatment|17|||
149227375|NCT01997333|538299980|FG001|Randomization and Treatment|Did not receive treatment|5|||
149227376|NCT01997333|538299979|FG000|Survival Follow up|Withdrawal by Subject|15|||
149227377|NCT01997333|538299980|FG001|Survival Follow up|Withdrawal by Subject|6|||
149227378|NCT01997333|538299979|FG000|Survival Follow up|Lost to Follow-up|0|||
149227379|NCT01997333|538299980|FG001|Survival Follow up|Lost to Follow-up|6|||
149227380|NCT01997333|538299979|FG000|Survival Follow up|Various|1|||
149227381|NCT01997333|538299980|FG001|Survival Follow up|Various|2|||
149227382|NCT04411472|538299981|FG000|Overall Study|Adverse Event|5|||
149227383|NCT04411472|538299982|FG001|Overall Study|Adverse Event|10|||
149227384|NCT04411472|538299983|FG002|Overall Study|Adverse Event|1|||
149227385|NCT04411472|538299984|FG003|Overall Study|Adverse Event|0|||
149227386|NCT04411472|538299985|FG004|Overall Study|Adverse Event|0|||
149227387|NCT04411472|538299986|FG005|Overall Study|Adverse Event|0|||
149227388|NCT04411472|538299981|FG000|Overall Study|Protocol Violation|1|||
149227389|NCT04411472|538299982|FG001|Overall Study|Protocol Violation|0|||
149227390|NCT04411472|538299983|FG002|Overall Study|Protocol Violation|0|||
149227391|NCT04411472|538299984|FG003|Overall Study|Protocol Violation|0|||
149227392|NCT04411472|538299985|FG004|Overall Study|Protocol Violation|0|||
149227393|NCT04411472|538299986|FG005|Overall Study|Protocol Violation|0|||
149227394|NCT04411472|538299981|FG000|Overall Study|Withdrawal by Subject|0|||
149227395|NCT04411472|538299982|FG001|Overall Study|Withdrawal by Subject|1|||
149227396|NCT04411472|538299983|FG002|Overall Study|Withdrawal by Subject|0|||
149227397|NCT04411472|538299984|FG003|Overall Study|Withdrawal by Subject|1|||
149227398|NCT04411472|538299985|FG004|Overall Study|Withdrawal by Subject|0|||
149227399|NCT04411472|538299986|FG005|Overall Study|Withdrawal by Subject|0|||
148688617|NCT01333033|536332342|FG002|Overall Study|MD Decision|0|||
148688618|NCT01333033|536332343|FG003|Overall Study|MD Decision|0|||
148688619|NCT01333033|536332344|FG004|Overall Study|MD Decision|0|||
148810224|NCT00879658|536782599|FG003|Overall Study|Abnormal laboratory value(s)|1|||
149227400|NCT04411472|538299981|FG000|Overall Study|Physician Decision|1|||
149227401|NCT04411472|538299982|FG001|Overall Study|Physician Decision|0|||
149227402|NCT04411472|538299983|FG002|Overall Study|Physician Decision|0|||
149227403|NCT04411472|538299984|FG003|Overall Study|Physician Decision|0|||
149227404|NCT04411472|538299985|FG004|Overall Study|Physician Decision|0|||
149227405|NCT04411472|538299986|FG005|Overall Study|Physician Decision|0|||
149227406|NCT04411472|538299981|FG000|Overall Study|Study terminated by sponsor|17|||
149227407|NCT04411472|538299982|FG001|Overall Study|Study terminated by sponsor|20|||
149227408|NCT04411472|538299983|FG002|Overall Study|Study terminated by sponsor|3|||
149227409|NCT04411472|538299984|FG003|Overall Study|Study terminated by sponsor|0|||
149227410|NCT04411472|538299985|FG004|Overall Study|Study terminated by sponsor|0|||
149227411|NCT04411472|538299986|FG005|Overall Study|Study terminated by sponsor|0|||
149227412|NCT05060003|538299987|FG000|Overall Study|ctDNA negative|7|||
149227413|NCT01747655|538299990|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
149227414|NCT01747655|538299991|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
149227415|NCT01747655|538299990|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
149227416|NCT01747655|538299991|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
149227417|NCT01747655|538299990|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
149227418|NCT01747655|538299991|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
149227419|NCT03769753|538299994|FG000|Overall Study|Not Treated|6|||
149227420|NCT03769753|538299994|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
149227421|NCT00684073|538299995|FG000|Selection|Selection/non-selection criteria|3|||
149227422|NCT00684073|538299995|FG000|Selection|Death|1|||
149227423|NCT00684073|538299995|FG000|Selection|noncompliance|1|||
149227424|NCT00684073|538299995|FG000|Selection|Lost to Follow-up|1|||
149227425|NCT00684073|538299995|FG000|Selection|request of the sponsor|1|||
149227426|NCT00684073|538299995|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
149227427|NCT01657903|538299998|FG000|Overall Study|Lost to Follow-up|1|||
149227428|NCT01657903|538299998|FG000|Overall Study|Withdrawal by Subject|1|||
149227429|NCT01259388|538299999|FG000|Overall Study|Adverse Event|3|||
149227430|NCT01259388|538300000|FG001|Overall Study|Adverse Event|0|||
149227431|NCT01259388|538299999|FG000|Overall Study|Withdrawal by Subject|1|||
149227432|NCT01259388|538300000|FG001|Overall Study|Withdrawal by Subject|1|||
149227433|NCT01259388|538299999|FG000|Overall Study|Physician Decision|1|||
149227434|NCT01259388|538300000|FG001|Overall Study|Physician Decision|0|||
149227435|NCT03512028|538300001|FG000|Overall Study|Withdrawal by Subject|2|||
149227436|NCT03512028|538300002|FG001|Overall Study|Withdrawal by Subject|0|||
149227437|NCT03512028|538300001|FG000|Overall Study|Protocol Violation|2|||
149227438|NCT03512028|538300002|FG001|Overall Study|Protocol Violation|0|||
149227439|NCT03529162|538300003|FG000|Overall Study|Lost to Follow-up|2|||
149227440|NCT03529162|538300004|FG001|Overall Study|Lost to Follow-up|2|||
149227441|NCT00620815|538300005|FG000|Overall Study|Adverse Event|1|||
149227442|NCT00620815|538300006|FG001|Overall Study|Adverse Event|1|||
149227443|NCT00620815|538300007|FG002|Overall Study|Adverse Event|2|||
149227444|NCT00620815|538300005|FG000|Overall Study|Withdrawal by Subject|1|||
149227445|NCT00620815|538300006|FG001|Overall Study|Withdrawal by Subject|2|||
149227446|NCT00620815|538300007|FG002|Overall Study|Withdrawal by Subject|0|||
149227447|NCT00620815|538300005|FG000|Overall Study|Lost to Follow-up|1|||
149227448|NCT00620815|538300006|FG001|Overall Study|Lost to Follow-up|6|||
149227449|NCT00620815|538300007|FG002|Overall Study|Lost to Follow-up|3|||
149227450|NCT00620815|538300005|FG000|Overall Study|Inappropriate enrolment|0|||
149227451|NCT00620815|538300006|FG001|Overall Study|Inappropriate enrolment|0|||
149227452|NCT00620815|538300007|FG002|Overall Study|Inappropriate enrolment|1|||
149227453|NCT00620815|538300005|FG000|Overall Study|Protocol Violation|1|||
149227454|NCT00620815|538300006|FG001|Overall Study|Protocol Violation|2|||
149227455|NCT00620815|538300007|FG002|Overall Study|Protocol Violation|1|||
149227456|NCT00983827|538300008|FG000|Overall Study|Withdrawal by Subject|1|||
149227457|NCT02728804|538300012|FG000|Overall Study|Ineligible|3|||
149227458|NCT02728804|538300012|FG000|Overall Study|Did not complete baseline questionnaire|9|||
149227459|NCT02728804|538300012|FG000|Overall Study|Death|99|||
149227460|NCT01888367|538300013|FG000|Overall Study|Physician Decision|3|||
149227461|NCT01888367|538300014|FG001|Overall Study|Physician Decision|4|||
149227462|NCT01888367|538300015|FG002|Overall Study|Physician Decision|2|||
149227463|NCT01888367|538300013|FG000|Overall Study|Death|2|||
149227464|NCT01888367|538300014|FG001|Overall Study|Death|0|||
149227465|NCT01888367|538300015|FG002|Overall Study|Death|1|||
149227466|NCT01888367|538300013|FG000|Overall Study|Withdrawal by Subject|1|||
149227467|NCT01888367|538300014|FG001|Overall Study|Withdrawal by Subject|0|||
149227468|NCT01888367|538300015|FG002|Overall Study|Withdrawal by Subject|1|||
149227469|NCT01888367|538300013|FG000|Overall Study|Lost to Follow-up|1|||
149227470|NCT01888367|538300014|FG001|Overall Study|Lost to Follow-up|1|||
149227471|NCT01888367|538300015|FG002|Overall Study|Lost to Follow-up|0|||
149227472|NCT01888367|538300013|FG000|Overall Study|Protocol Violation|0|||
149227473|NCT01888367|538300014|FG001|Overall Study|Protocol Violation|0|||
149227474|NCT01888367|538300015|FG002|Overall Study|Protocol Violation|1|||
149227475|NCT01888367|538300013|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
149227476|NCT01888367|538300014|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
149227477|NCT01888367|538300015|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
149227478|NCT00591786|538300016|FG000|Overall Study|Withdrawal of Informed Consent|0|||
149227479|NCT00591786|538300017|FG001|Overall Study|Withdrawal of Informed Consent|0|||
149227480|NCT00591786|538300018|FG002|Overall Study|Withdrawal of Informed Consent|1|||
149227481|NCT00591786|538300019|FG003|Overall Study|Withdrawal of Informed Consent|0|||
149227482|NCT00591786|538300020|FG004|Overall Study|Withdrawal of Informed Consent|0|||
149227483|NCT00591786|538300021|FG005|Overall Study|Withdrawal of Informed Consent|0|||
149227484|NCT00591786|538300022|FG006|Overall Study|Withdrawal of Informed Consent|0|||
149227485|NCT00591786|538300023|FG007|Overall Study|Withdrawal of Informed Consent|0|||
149227486|NCT00591786|538300024|FG008|Overall Study|Withdrawal of Informed Consent|0|||
149227487|NCT00591786|538300025|FG009|Overall Study|Withdrawal of Informed Consent|0|||
149227488|NCT01920061|538300026|FG000|Overall Study|Death|1|||
149227489|NCT01920061|538300027|FG001|Overall Study|Death|1|||
149227490|NCT01920061|538300028|FG002|Overall Study|Death|0|||
149227491|NCT01920061|538300029|FG003|Overall Study|Death|1|||
149227492|NCT01920061|538300030|FG004|Overall Study|Death|1|||
149227493|NCT01920061|538300031|FG005|Overall Study|Death|0|||
149227494|NCT01920061|538300032|FG006|Overall Study|Death|0|||
149227495|NCT01920061|538300033|FG007|Overall Study|Death|1|||
149227496|NCT01920061|538300034|FG008|Overall Study|Death|0|||
149227497|NCT01920061|538300035|FG009|Overall Study|Death|1|||
149227498|NCT01920061|538300036|FG010|Overall Study|Death|0|||
149227499|NCT01920061|538300037|FG011|Overall Study|Death|1|||
149227500|NCT01920061|538300038|FG012|Overall Study|Death|0|||
149227501|NCT01920061|538300039|FG013|Overall Study|Death|2|||
149227502|NCT01920061|538300040|FG014|Overall Study|Death|0|||
149227503|NCT01920061|538300041|FG015|Overall Study|Death|0|||
149227504|NCT01920061|538300042|FG016|Overall Study|Death|0|||
149227505|NCT01920061|538300043|FG017|Overall Study|Death|0|||
149227506|NCT01920061|538300044|FG018|Overall Study|Death|1|||
149227507|NCT01920061|538300045|FG019|Overall Study|Death|0|||
149227508|NCT01920061|538300026|FG000|Overall Study|Lost to Follow-up|0|||
149227509|NCT01920061|538300027|FG001|Overall Study|Lost to Follow-up|2|||
149227510|NCT01920061|538300028|FG002|Overall Study|Lost to Follow-up|0|||
149227511|NCT01920061|538300029|FG003|Overall Study|Lost to Follow-up|0|||
149227512|NCT01920061|538300030|FG004|Overall Study|Lost to Follow-up|0|||
149227513|NCT01920061|538300031|FG005|Overall Study|Lost to Follow-up|0|||
149227514|NCT01920061|538300032|FG006|Overall Study|Lost to Follow-up|1|||
149227515|NCT01920061|538300033|FG007|Overall Study|Lost to Follow-up|0|||
149227516|NCT01920061|538300034|FG008|Overall Study|Lost to Follow-up|0|||
149227517|NCT01920061|538300035|FG009|Overall Study|Lost to Follow-up|0|||
149227518|NCT01920061|538300036|FG010|Overall Study|Lost to Follow-up|3|||
149227519|NCT01920061|538300037|FG011|Overall Study|Lost to Follow-up|0|||
149227520|NCT01920061|538300038|FG012|Overall Study|Lost to Follow-up|0|||
149227521|NCT01920061|538300039|FG013|Overall Study|Lost to Follow-up|0|||
149227522|NCT01920061|538300040|FG014|Overall Study|Lost to Follow-up|0|||
149227523|NCT01920061|538300041|FG015|Overall Study|Lost to Follow-up|0|||
149227524|NCT01920061|538300042|FG016|Overall Study|Lost to Follow-up|0|||
149227525|NCT01920061|538300043|FG017|Overall Study|Lost to Follow-up|1|||
149227526|NCT01920061|538300044|FG018|Overall Study|Lost to Follow-up|4|||
149227527|NCT01920061|538300045|FG019|Overall Study|Lost to Follow-up|3|||
149227528|NCT01920061|538300026|FG000|Overall Study|Other|1|||
149227529|NCT01920061|538300027|FG001|Overall Study|Other|1|||
149227530|NCT01920061|538300028|FG002|Overall Study|Other|2|||
149227531|NCT01920061|538300029|FG003|Overall Study|Other|1|||
149227532|NCT01920061|538300030|FG004|Overall Study|Other|0|||
149227533|NCT01920061|538300031|FG005|Overall Study|Other|1|||
149227534|NCT01920061|538300032|FG006|Overall Study|Other|0|||
149227535|NCT01920061|538300033|FG007|Overall Study|Other|0|||
149227536|NCT01920061|538300034|FG008|Overall Study|Other|0|||
149227537|NCT01920061|538300035|FG009|Overall Study|Other|1|||
149227538|NCT01920061|538300036|FG010|Overall Study|Other|1|||
149227539|NCT01920061|538300037|FG011|Overall Study|Other|2|||
149227540|NCT01920061|538300038|FG012|Overall Study|Other|1|||
149227541|NCT01920061|538300039|FG013|Overall Study|Other|4|||
149227542|NCT01920061|538300040|FG014|Overall Study|Other|0|||
149227543|NCT01920061|538300041|FG015|Overall Study|Other|1|||
149227544|NCT01920061|538300042|FG016|Overall Study|Other|1|||
149227545|NCT01920061|538300043|FG017|Overall Study|Other|0|||
149227546|NCT01920061|538300044|FG018|Overall Study|Other|1|||
149227547|NCT01920061|538300045|FG019|Overall Study|Other|1|||
149227548|NCT01920061|538300026|FG000|Overall Study|Participant refused further follow-up|0|||
149227549|NCT01920061|538300027|FG001|Overall Study|Participant refused further follow-up|0|||
149227550|NCT01920061|538300028|FG002|Overall Study|Participant refused further follow-up|0|||
149227551|NCT01920061|538300029|FG003|Overall Study|Participant refused further follow-up|0|||
149227552|NCT01920061|538300030|FG004|Overall Study|Participant refused further follow-up|1|||
149227553|NCT01920061|538300031|FG005|Overall Study|Participant refused further follow-up|1|||
149227554|NCT01920061|538300032|FG006|Overall Study|Participant refused further follow-up|0|||
149227555|NCT01920061|538300033|FG007|Overall Study|Participant refused further follow-up|0|||
149227556|NCT01920061|538300034|FG008|Overall Study|Participant refused further follow-up|1|||
149227557|NCT01920061|538300035|FG009|Overall Study|Participant refused further follow-up|0|||
149227558|NCT01920061|538300036|FG010|Overall Study|Participant refused further follow-up|1|||
149227559|NCT01920061|538300037|FG011|Overall Study|Participant refused further follow-up|0|||
149227560|NCT01920061|538300038|FG012|Overall Study|Participant refused further follow-up|1|||
148810225|NCT00879658|536782600|FG004|Overall Study|Abnormal laboratory value(s)|0|||
148810226|NCT00879658|536782601|FG005|Overall Study|Abnormal laboratory value(s)|0|||
149227561|NCT01920061|538300039|FG013|Overall Study|Participant refused further follow-up|0|||
149227562|NCT01920061|538300040|FG014|Overall Study|Participant refused further follow-up|1|||
149227563|NCT01920061|538300041|FG015|Overall Study|Participant refused further follow-up|2|||
149227564|NCT01920061|538300042|FG016|Overall Study|Participant refused further follow-up|1|||
148688620|NCT01333033|536332345|FG005|Overall Study|MD Decision|2|||
149227565|NCT01920061|538300043|FG017|Overall Study|Participant refused further follow-up|1|||
149227566|NCT01920061|538300044|FG018|Overall Study|Participant refused further follow-up|0|||
149227567|NCT01920061|538300045|FG019|Overall Study|Participant refused further follow-up|0|||
149227568|NCT03969589|538300047|FG000|Overall Study|Lost to Follow-up|3|||
149227569|NCT03969589|538300048|FG001|Overall Study|Lost to Follow-up|2|||
148688621|NCT03361423|536332348|FG000|Overall Study|Withdrawal by Subject|4|||
148688622|NCT03361423|536332349|FG001|Overall Study|Withdrawal by Subject|3|||
148688623|NCT03361423|536332348|FG000|Overall Study|Did not treat|19|||
149020066|NCT02601937|537551126|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
149020067|NCT02601937|537551127|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
149020068|NCT02601937|537551128|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
149227570|NCT03969589|538300047|FG000|Overall Study|Declined Follow-Up|0|||
149227571|NCT03969589|538300048|FG001|Overall Study|Declined Follow-Up|1|||
148688624|NCT03361423|536332349|FG001|Overall Study|Did not treat|18|||
148688625|NCT03361423|536332348|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
149227572|NCT00517634|538300049|FG000|Second Treatment Period|Withdrawal by Subject|0|||
149227573|NCT00517634|538300050|FG001|Second Treatment Period|Withdrawal by Subject|0|||
149227574|NCT00517634|538300051|FG002|Second Treatment Period|Withdrawal by Subject|0|||
149227575|NCT00517634|538300052|FG003|Second Treatment Period|Withdrawal by Subject|0|||
149020069|NCT02601937|537551129|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
149020070|NCT02601937|537551130|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
149020071|NCT02601937|537551131|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
149020072|NCT02601937|537551132|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
149020073|NCT02601937|537551133|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
149020074|NCT02601937|537551123|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020075|NCT02601937|537551124|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020076|NCT02601937|537551125|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020077|NCT02601937|537551126|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020078|NCT02601937|537551127|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020079|NCT02601937|537551128|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020080|NCT02601937|537551129|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020081|NCT02601937|537551130|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020082|NCT02601937|537551131|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020083|NCT02601937|537551132|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
149020084|NCT02601937|537551133|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
149020085|NCT02601937|537551123|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020086|NCT02601937|537551124|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020087|NCT02601937|537551125|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020088|NCT02601937|537551126|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020089|NCT02601937|537551127|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020090|NCT02601937|537551128|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020091|NCT02601937|537551129|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020092|NCT02601937|537551130|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
149020093|NCT02601937|537551131|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020094|NCT02601937|537551132|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020095|NCT02601937|537551133|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
149020096|NCT02601937|537551123|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020097|NCT02601937|537551124|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149227576|NCT00517634|538300053|FG004|Second Treatment Period|Withdrawal by Subject|1|||
149227577|NCT00517634|538300054|FG005|Second Treatment Period|Withdrawal by Subject|0|||
149227578|NCT03091920|538300055|FG000|Overall Study|Adverse Event|0|||
149227579|NCT03091920|538300056|FG001|Overall Study|Adverse Event|1|||
149227580|NCT03091920|538300057|FG002|Overall Study|Adverse Event|0|||
149227581|NCT03143855|538300058|FG000|Overall Study|Withdrawal by Subject|4|||
149227582|NCT03143855|538300059|FG001|Overall Study|Withdrawal by Subject|3|||
149227583|NCT03143855|538300058|FG000|Overall Study|Protocol Violation|1|||
149227584|NCT03143855|538300059|FG001|Overall Study|Protocol Violation|0|||
149227585|NCT03143855|538300058|FG000|Overall Study|Participant experienced withdrawal|0|||
149227586|NCT03143855|538300059|FG001|Overall Study|Participant experienced withdrawal|1|||
149227587|NCT00422942|538300062|FG000|Overall Study|Study terminated by Sponsor|3|||
149227588|NCT02828982|538300063|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149227589|NCT02828982|538300064|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149227590|NCT00701064|538300066|FG000|Overall Study|Protocol Violation|1|||
149227591|NCT00701064|538300067|FG001|Overall Study|Protocol Violation|1|||
149227592|NCT00701064|538300066|FG000|Overall Study|Withdrawal by Subject|1|||
149227593|NCT00701064|538300067|FG001|Overall Study|Withdrawal by Subject|1|||
148688626|NCT03361423|536332349|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
148688627|NCT03361423|536332348|FG000|Overall Study|Missing data|4|||
149227594|NCT00701064|538300066|FG000|Overall Study|initiated other PTSD treatment|2|||
148688628|NCT03361423|536332349|FG001|Overall Study|Missing data|1|||
149227595|NCT00701064|538300067|FG001|Overall Study|initiated other PTSD treatment|2|||
148688629|NCT00818623|536332350|FG000|Overall Study|Adverse Event|1|||
148688630|NCT00818623|536332351|FG001|Overall Study|Adverse Event|0|||
149227596|NCT02098733|538300068|FG000|Overall Study|Data Not Available|5|||
148688631|NCT00818623|536332352|FG002|Overall Study|Adverse Event|1|||
148688632|NCT00818623|536332353|FG003|Overall Study|Adverse Event|0|||
148688633|NCT00818623|536332354|FG004|Overall Study|Adverse Event|0|||
148688634|NCT00818623|536332355|FG005|Overall Study|Adverse Event|1|||
148688635|NCT00818623|536332356|FG006|Overall Study|Adverse Event|0|||
149227597|NCT02098733|538300068|FG000|Overall Study|Lost to Follow-up|5|||
149227598|NCT00695318|538300069|FG000|Overall Study|Lost to Follow-up|1|||
149227599|NCT00695318|538300070|FG001|Overall Study|Lost to Follow-up|0|||
149227600|NCT00695318|538300069|FG000|Overall Study|Withdrawal by Subject|2|||
149227601|NCT00695318|538300070|FG001|Overall Study|Withdrawal by Subject|0|||
148688636|NCT00818623|536332357|FG007|Overall Study|Adverse Event|0|||
148688637|NCT00818623|536332350|FG000|Overall Study|Bad prostate specific antigen response|0|||
148688638|NCT00818623|536332351|FG001|Overall Study|Bad prostate specific antigen response|3|||
148688639|NCT00818623|536332352|FG002|Overall Study|Bad prostate specific antigen response|2|||
148688640|NCT00818623|536332353|FG003|Overall Study|Bad prostate specific antigen response|5|||
148688641|NCT00818623|536332354|FG004|Overall Study|Bad prostate specific antigen response|0|||
148688642|NCT00818623|536332355|FG005|Overall Study|Bad prostate specific antigen response|1|||
148688643|NCT00818623|536332356|FG006|Overall Study|Bad prostate specific antigen response|0|||
148688644|NCT00818623|536332357|FG007|Overall Study|Bad prostate specific antigen response|0|||
148688645|NCT00818623|536332350|FG000|Overall Study|Withdrawal by Subject|0|||
148688646|NCT00818623|536332351|FG001|Overall Study|Withdrawal by Subject|1|||
148688647|NCT00818623|536332352|FG002|Overall Study|Withdrawal by Subject|1|||
148688648|NCT00818623|536332353|FG003|Overall Study|Withdrawal by Subject|0|||
148688649|NCT00818623|536332354|FG004|Overall Study|Withdrawal by Subject|0|||
148688650|NCT00818623|536332355|FG005|Overall Study|Withdrawal by Subject|1|||
148688651|NCT00818623|536332356|FG006|Overall Study|Withdrawal by Subject|1|||
148688652|NCT00818623|536332357|FG007|Overall Study|Withdrawal by Subject|1|||
148688653|NCT00818623|536332350|FG000|Overall Study|Protocol Violation|1|||
148688654|NCT00818623|536332351|FG001|Overall Study|Protocol Violation|0|||
148688655|NCT00818623|536332352|FG002|Overall Study|Protocol Violation|0|||
148688656|NCT00818623|536332353|FG003|Overall Study|Protocol Violation|0|||
148688657|NCT00818623|536332354|FG004|Overall Study|Protocol Violation|1|||
148688658|NCT00818623|536332355|FG005|Overall Study|Protocol Violation|0|||
148688659|NCT00818623|536332356|FG006|Overall Study|Protocol Violation|1|||
148688660|NCT00818623|536332357|FG007|Overall Study|Protocol Violation|0|||
148688661|NCT00818623|536332350|FG000|Overall Study|Need of additional treatment|0|||
148688662|NCT00818623|536332351|FG001|Overall Study|Need of additional treatment|0|||
148688663|NCT00818623|536332352|FG002|Overall Study|Need of additional treatment|0|||
148688664|NCT00818623|536332353|FG003|Overall Study|Need of additional treatment|0|||
148688665|NCT00818623|536332354|FG004|Overall Study|Need of additional treatment|1|||
148688666|NCT00818623|536332355|FG005|Overall Study|Need of additional treatment|0|||
148688667|NCT00818623|536332356|FG006|Overall Study|Need of additional treatment|0|||
148688668|NCT00818623|536332357|FG007|Overall Study|Need of additional treatment|0|||
148688669|NCT00818623|536332350|FG000|Overall Study|Lack of trial drug at site|0|||
148688670|NCT00818623|536332351|FG001|Overall Study|Lack of trial drug at site|0|||
148688671|NCT00818623|536332352|FG002|Overall Study|Lack of trial drug at site|0|||
148688672|NCT00818623|536332353|FG003|Overall Study|Lack of trial drug at site|0|||
148688673|NCT00818623|536332354|FG004|Overall Study|Lack of trial drug at site|2|||
148688674|NCT00818623|536332355|FG005|Overall Study|Lack of trial drug at site|0|||
148688675|NCT00818623|536332356|FG006|Overall Study|Lack of trial drug at site|1|||
148688676|NCT00818623|536332357|FG007|Overall Study|Lack of trial drug at site|0|||
148688677|NCT00818623|536332350|FG000|Overall Study|Disease progression|0|||
149227602|NCT00695318|538300069|FG000|Overall Study|Death|1|||
149227603|NCT00695318|538300070|FG001|Overall Study|Death|1|||
149227604|NCT00695318|538300069|FG000|Overall Study|Study Terminated|1|||
149227605|NCT00695318|538300070|FG001|Overall Study|Study Terminated|0|||
149227606|NCT01156012|538300071|FG000|Overall Study|Adverse Event|3|||
148688678|NCT00818623|536332351|FG001|Overall Study|Disease progression|0|||
148688679|NCT00818623|536332352|FG002|Overall Study|Disease progression|0|||
148688680|NCT00818623|536332353|FG003|Overall Study|Disease progression|0|||
148688681|NCT00818623|536332354|FG004|Overall Study|Disease progression|0|||
148688682|NCT00818623|536332355|FG005|Overall Study|Disease progression|0|||
148688683|NCT00818623|536332356|FG006|Overall Study|Disease progression|1|||
148688684|NCT00818623|536332357|FG007|Overall Study|Disease progression|0|||
148688685|NCT00358826|536332358|FG000|Core Study|Adverse Event|1|||
148688686|NCT00358826|536332359|FG001|Core Study|Adverse Event|3|||
149227607|NCT01156012|538300072|FG001|Overall Study|Adverse Event|1|||
149227608|NCT01156012|538300071|FG000|Overall Study|Lost to Follow-up|1|||
148688687|NCT00358826|536332360|FG002|Core Study|Adverse Event|1|||
148688688|NCT00358826|536332361|FG003|Core Study|Adverse Event|1|||
148688689|NCT00358826|536332362|FG004|Core Study|Adverse Event|0|||
148688690|NCT00358826|536332363|FG005|Core Study|Adverse Event|0|||
148688691|NCT00358826|536332364|FG006|Core Study|Adverse Event|0|||
148688692|NCT00358826|536332365|FG007|Core Study|Adverse Event|0|||
148688693|NCT00358826|536332358|FG000|Core Study|Withdrawal by Subject|2|||
148688694|NCT00358826|536332359|FG001|Core Study|Withdrawal by Subject|2|||
149227609|NCT01156012|538300072|FG001|Overall Study|Lost to Follow-up|0|||
149227610|NCT01156012|538300071|FG000|Overall Study|Withdrawal by Subject|1|||
149227611|NCT01156012|538300072|FG001|Overall Study|Withdrawal by Subject|0|||
149227612|NCT01156012|538300071|FG000|Overall Study|use of commercial drug instead of study|0|||
149227613|NCT01156012|538300072|FG001|Overall Study|use of commercial drug instead of study|1|||
149227614|NCT01156012|538300071|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
149227615|NCT01156012|538300072|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
149227616|NCT00939094|538300074|FG000|Overall Study|Adverse Event|9|||
149227617|NCT00939094|538300075|FG001|Overall Study|Adverse Event|0|||
149227618|NCT00939094|538300074|FG000|Overall Study|Withdrawal by Subject|1|||
149227619|NCT00939094|538300075|FG001|Overall Study|Withdrawal by Subject|6|||
149227620|NCT00939094|538300074|FG000|Overall Study|Lost to Follow-up|1|||
149227621|NCT00939094|538300075|FG001|Overall Study|Lost to Follow-up|1|||
149227622|NCT00939094|538300074|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
149227623|NCT00939094|538300075|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149227624|NCT00939094|538300074|FG000|Overall Study|Severe non-compliance to protocol|0|||
149227625|NCT00939094|538300075|FG001|Overall Study|Severe non-compliance to protocol|1|||
149227626|NCT00939094|538300074|FG000|Overall Study|Study stopped by sponsor|0|||
149227627|NCT00939094|538300075|FG001|Overall Study|Study stopped by sponsor|2|||
149227628|NCT00939094|538300074|FG000|Overall Study|Abnormal ECG findings|1|||
149227629|NCT00939094|538300075|FG001|Overall Study|Abnormal ECG findings|0|||
149227630|NCT02705755|538300076|FG000|Part A (6 Days)|Adverse Event|1|||
149227631|NCT02705755|538300077|FG001|Part A (6 Days)|Adverse Event|0|||
149227632|NCT02705755|538300078|FG002|Part A (6 Days)|Adverse Event|0|||
149227633|NCT02705755|538300079|FG003|Part A (6 Days)|Adverse Event|0|||
149227634|NCT02705755|538300076|FG000|Part A (6 Days)|Physician Decision|3|||
149227635|NCT02705755|538300077|FG001|Part A (6 Days)|Physician Decision|0|||
149227636|NCT02705755|538300078|FG002|Part A (6 Days)|Physician Decision|0|||
149227637|NCT02705755|538300079|FG003|Part A (6 Days)|Physician Decision|0|||
149227638|NCT02705755|538300076|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
149227639|NCT02705755|538300077|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
149227640|NCT02705755|538300078|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
149227641|NCT02705755|538300079|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
149227642|NCT02705755|538300076|FG000|Part C (20 Weeks)|Physician Decision|0|||
149227643|NCT02705755|538300077|FG001|Part C (20 Weeks)|Physician Decision|0|||
149227644|NCT02705755|538300078|FG002|Part C (20 Weeks)|Physician Decision|0|||
149227645|NCT02705755|538300079|FG003|Part C (20 Weeks)|Physician Decision|2|||
149227646|NCT02705755|538300076|FG000|Part C (20 Weeks)|Adverse Event|0|||
149227647|NCT02705755|538300077|FG001|Part C (20 Weeks)|Adverse Event|0|||
149227648|NCT02705755|538300078|FG002|Part C (20 Weeks)|Adverse Event|0|||
149227649|NCT02705755|538300079|FG003|Part C (20 Weeks)|Adverse Event|6|||
149227650|NCT02705755|538300076|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
149227651|NCT02705755|538300077|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
149227652|NCT02705755|538300078|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
149227653|NCT02705755|538300079|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
149227654|NCT01906489|538300082|FG000|Overall Study|Adverse Event|10|||
149227655|NCT01906489|538300083|FG001|Overall Study|Adverse Event|3|||
149227656|NCT01906489|538300082|FG000|Overall Study|Worsening of CKD|6|||
149227657|NCT01906489|538300083|FG001|Overall Study|Worsening of CKD|4|||
149227658|NCT01906489|538300082|FG000|Overall Study|Withdrawal by Subject|5|||
149227659|NCT01906489|538300083|FG001|Overall Study|Withdrawal by Subject|0|||
149227660|NCT01906489|538300082|FG000|Overall Study|Worsening of Anemia|1|||
149227661|NCT01906489|538300083|FG001|Overall Study|Worsening of Anemia|0|||
149227662|NCT01906489|538300082|FG000|Overall Study|Protocol Violation|0|||
149227663|NCT01906489|538300083|FG001|Overall Study|Protocol Violation|1|||
149227664|NCT01906489|538300082|FG000|Overall Study|Non- Compliance|1|||
149227665|NCT01906489|538300083|FG001|Overall Study|Non- Compliance|0|||
149227666|NCT01906489|538300082|FG000|Overall Study|Sponsor Decision|1|||
149227667|NCT01906489|538300083|FG001|Overall Study|Sponsor Decision|0|||
149227668|NCT01906489|538300082|FG000|Overall Study|Lost to Follow-up|1|||
148688695|NCT00358826|536332360|FG002|Core Study|Withdrawal by Subject|0|||
149227669|NCT01906489|538300083|FG001|Overall Study|Lost to Follow-up|1|||
149227670|NCT01906489|538300082|FG000|Overall Study|Other|1|||
149227671|NCT01906489|538300083|FG001|Overall Study|Other|0|||
149227672|NCT01078389|538301742|FG000|Overall Study|Adverse Event|10|||
149227673|NCT01078389|538301743|FG001|Overall Study|Adverse Event|6|||
149227674|NCT01078389|538301742|FG000|Overall Study|Major Protocol Deviation|2|||
149227675|NCT01078389|538301743|FG001|Overall Study|Major Protocol Deviation|0|||
149227676|NCT01078389|538301742|FG000|Overall Study|Lost to Follow-up|23|||
149227677|NCT01078389|538301743|FG001|Overall Study|Lost to Follow-up|23|||
149227678|NCT01078389|538301742|FG000|Overall Study|Voluntary Withdrawal|20|||
149227679|NCT01078389|538301743|FG001|Overall Study|Voluntary Withdrawal|36|||
149227680|NCT01078389|538301742|FG000|Overall Study|Other|9|||
149227681|NCT01078389|538301743|FG001|Overall Study|Other|2|||
149227682|NCT04823494|538301744|FG000|Overall Study|Programming software malfunction.|1|||
149227683|NCT04823494|538301745|FG001|Overall Study|Programming software malfunction.|0|||
149227684|NCT04823494|538301744|FG000|Overall Study|Withdrawal by Subject|1|||
149227685|NCT04823494|538301745|FG001|Overall Study|Withdrawal by Subject|0|||
149227686|NCT04823494|538301744|FG000|Overall Study|Devices lost|0|||
149227687|NCT04823494|538301745|FG001|Overall Study|Devices lost|1|||
149227688|NCT03691831|538301746|FG000|Overall Study|Lost to Follow-up|16|||
149227689|NCT03691831|538301747|FG001|Overall Study|Lost to Follow-up|12|||
149227690|NCT03691831|538301746|FG000|Overall Study|Withdrawal by Subject|9|||
149227691|NCT03691831|538301747|FG001|Overall Study|Withdrawal by Subject|17|||
149227692|NCT03691831|538301746|FG000|Overall Study|Investigator Decision|2|||
149227693|NCT03691831|538301747|FG001|Overall Study|Investigator Decision|2|||
149227694|NCT02198040|538301748|FG000|Overall Study|Work reasons|0|||
149227695|NCT02198040|538301749|FG001|Overall Study|Work reasons|1|||
149227696|NCT02198040|538301750|FG002|Overall Study|Work reasons|0|||
149227697|NCT02198040|538301748|FG000|Overall Study|Withdrawal by Subject|0|||
149227698|NCT02198040|538301749|FG001|Overall Study|Withdrawal by Subject|0|||
149227699|NCT02198040|538301750|FG002|Overall Study|Withdrawal by Subject|1|||
149227700|NCT04524663|538301751|FG000|Overall Study|Withdrawal by Subject|0|||
149227701|NCT04524663|538301752|FG001|Overall Study|Withdrawal by Subject|2|||
149227702|NCT03359811|538301753|FG000|Overall Study|Protocol Violation|2|||
149227703|NCT03359811|538301754|FG001|Overall Study|Protocol Violation|0|||
149227704|NCT01189201|538301759|FG000|Overall Study|Adverse Event|1|||
149227705|NCT01682876|538301760|FG000|Overall Study|Administrative reason|4|||
149227706|NCT01682876|538301761|FG001|Overall Study|Administrative reason|4|||
149227707|NCT01682876|538301762|FG002|Overall Study|Administrative reason|0|||
149227708|NCT01682876|538301763|FG003|Overall Study|Administrative reason|3|||
149227709|NCT01682876|538301760|FG000|Overall Study|Adverse Event|0|||
149227710|NCT01682876|538301761|FG001|Overall Study|Adverse Event|0|||
149227711|NCT01682876|538301762|FG002|Overall Study|Adverse Event|0|||
149227712|NCT01682876|538301763|FG003|Overall Study|Adverse Event|1|||
149227713|NCT01682876|538301760|FG000|Overall Study|Lost to Follow-up|11|||
149227714|NCT01682876|538301761|FG001|Overall Study|Lost to Follow-up|15|||
149227715|NCT01682876|538301762|FG002|Overall Study|Lost to Follow-up|9|||
149227716|NCT01682876|538301763|FG003|Overall Study|Lost to Follow-up|11|||
149227717|NCT01682876|538301760|FG000|Overall Study|Protocol Violation|1|||
149227718|NCT01682876|538301761|FG001|Overall Study|Protocol Violation|1|||
149227719|NCT01682876|538301762|FG002|Overall Study|Protocol Violation|1|||
149227720|NCT01682876|538301763|FG003|Overall Study|Protocol Violation|1|||
149227721|NCT01682876|538301760|FG000|Overall Study|Withdrawal by Subject|4|||
149227722|NCT01682876|538301761|FG001|Overall Study|Withdrawal by Subject|0|||
149227723|NCT01682876|538301762|FG002|Overall Study|Withdrawal by Subject|0|||
149227724|NCT01682876|538301763|FG003|Overall Study|Withdrawal by Subject|2|||
149227725|NCT01682876|538301760|FG000|Overall Study|Other|1|||
149227726|NCT01682876|538301761|FG001|Overall Study|Other|0|||
149227727|NCT01682876|538301762|FG002|Overall Study|Other|1|||
149227728|NCT01682876|538301763|FG003|Overall Study|Other|1|||
149227729|NCT00911508|538301767|FG000|Overall Study|Lost to Follow-up|27|||
149227730|NCT00911508|538301768|FG001|Overall Study|Lost to Follow-up|18|||
149227731|NCT00911508|538301767|FG000|Overall Study|Withdrawal by Subject|79|||
149227732|NCT00911508|538301768|FG001|Overall Study|Withdrawal by Subject|112|||
149227733|NCT00240331|538301771|FG000|Overall Study|Withdrawal by Subject|125|||
149227734|NCT00240331|538301772|FG001|Overall Study|Withdrawal by Subject|132|||
149227735|NCT00240331|538301771|FG000|Overall Study|Option selected by investigator|1|||
149227736|NCT00240331|538301772|FG001|Overall Study|Option selected by investigator|2|||
149227737|NCT01409382|538301773|FG000|Overall Study|Lost to Follow-up|1|||
149227738|NCT01409382|538301774|FG001|Overall Study|Lost to Follow-up|1|||
149227739|NCT01409382|538301773|FG000|Overall Study|Protocol Violation|0|||
149227740|NCT01409382|538301774|FG001|Overall Study|Protocol Violation|3|||
149227741|NCT01409382|538301773|FG000|Overall Study|Multiple pregnancy|2|||
149227742|NCT01409382|538301774|FG001|Overall Study|Multiple pregnancy|4|||
149227743|NCT01409382|538301773|FG000|Overall Study|Still pregnant when study ended|13|||
149227744|NCT01409382|538301774|FG001|Overall Study|Still pregnant when study ended|2|||
149227745|NCT01409382|538301773|FG000|Overall Study|Did not manage to get pregnant|64|||
149227746|NCT01409382|538301774|FG001|Overall Study|Did not manage to get pregnant|70|||
149227747|NCT01409382|538301773|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
149227748|NCT01409382|538301774|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
149227749|NCT01233076|538301775|FG000|Period 2, One Week|Lost to Follow-up|1|||
149227750|NCT01233076|538301776|FG001|Period 2, One Week|Lost to Follow-up|0|||
149227751|NCT04308668|538301777|FG000|Overall Study|Lost to Follow-up|32|||
149227752|NCT04308668|538301778|FG001|Overall Study|Lost to Follow-up|38|||
149227753|NCT04308668|538301777|FG000|Overall Study|Withdrawal by Subject|4|||
149227754|NCT04308668|538301778|FG001|Overall Study|Withdrawal by Subject|4|||
149227755|NCT01266967|538301779|FG000|Overall Study|Death|69|||
149227756|NCT01266967|538301780|FG001|Overall Study|Death|61|||
149227757|NCT01266967|538301779|FG000|Overall Study|Study Closed/Terminated|15|||
149227758|NCT01266967|538301780|FG001|Overall Study|Study Closed/Terminated|17|||
149227759|NCT01266967|538301779|FG000|Overall Study|Lost to Follow-up|2|||
149227760|NCT01266967|538301780|FG001|Overall Study|Lost to Follow-up|1|||
149227761|NCT01266967|538301779|FG000|Overall Study|Physician Decision|0|||
149227762|NCT01266967|538301780|FG001|Overall Study|Physician Decision|1|||
149227763|NCT01266967|538301779|FG000|Overall Study|Withdrawal by Subject|3|||
148688696|NCT00358826|536332361|FG003|Core Study|Withdrawal by Subject|0|||
148688697|NCT00358826|536332362|FG004|Core Study|Withdrawal by Subject|0|||
149020098|NCT02601937|537551125|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020099|NCT02601937|537551126|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020100|NCT02601937|537551127|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020101|NCT02601937|537551128|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149227764|NCT01266967|538301780|FG001|Overall Study|Withdrawal by Subject|3|||
149227765|NCT04563845|538301781|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227766|NCT04563845|538301782|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227767|NCT04563845|538301783|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227768|NCT04563845|538301784|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227769|NCT04563845|538301785|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227770|NCT04563845|538301786|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227771|NCT04563845|538301787|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227772|NCT04563845|538301788|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
149227773|NCT04563845|538301789|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227774|NCT04563845|538301790|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227775|NCT04563845|538301791|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227776|NCT04563845|538301792|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227777|NCT04563845|538301793|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227778|NCT04563845|538301794|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
149227779|NCT04563845|538301781|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227780|NCT04563845|538301782|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227781|NCT04563845|538301783|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227782|NCT04563845|538301784|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227783|NCT04563845|538301785|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
149227784|NCT04563845|538301786|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227785|NCT04563845|538301787|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227786|NCT04563845|538301788|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227787|NCT04563845|538301789|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227788|NCT04563845|538301790|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227789|NCT04563845|538301791|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227790|NCT04563845|538301792|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227791|NCT04563845|538301793|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227792|NCT04563845|538301794|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
149227793|NCT01020812|538301795|FG000|Overall Study|Physician Decision|1|||
149227794|NCT01020812|538301795|FG000|Overall Study|Withdrawal by Subject|1|||
149227795|NCT01020812|538301795|FG000|Overall Study|Protocol Violation|1|||
149227796|NCT01519700|538301796|FG000|Overall Study|Death|1|||
149227797|NCT01519700|538301797|FG001|Overall Study|Death|0|||
149227798|NCT01519700|538301798|FG002|Overall Study|Death|0|||
149227799|NCT01519700|538301799|FG003|Overall Study|Death|0|||
149227800|NCT01519700|538301796|FG000|Overall Study|Lost to Follow-up|0|||
149227801|NCT01519700|538301797|FG001|Overall Study|Lost to Follow-up|0|||
149227802|NCT01519700|538301798|FG002|Overall Study|Lost to Follow-up|1|||
149227803|NCT01519700|538301799|FG003|Overall Study|Lost to Follow-up|1|||
149227804|NCT01519700|538301796|FG000|Overall Study|Physician Decision|1|||
149227805|NCT01519700|538301797|FG001|Overall Study|Physician Decision|1|||
149227806|NCT01519700|538301798|FG002|Overall Study|Physician Decision|3|||
148688698|NCT00358826|536332363|FG005|Core Study|Withdrawal by Subject|0|||
148688699|NCT00358826|536332364|FG006|Core Study|Withdrawal by Subject|0|||
148688700|NCT00358826|536332365|FG007|Core Study|Withdrawal by Subject|0|||
148688701|NCT00358826|536332358|FG000|Core Study|Lost to Follow-up|0|||
148688702|NCT00358826|536332359|FG001|Core Study|Lost to Follow-up|0|||
148688703|NCT00358826|536332360|FG002|Core Study|Lost to Follow-up|0|||
148688704|NCT00358826|536332361|FG003|Core Study|Lost to Follow-up|1|||
148688705|NCT00358826|536332362|FG004|Core Study|Lost to Follow-up|0|||
148688706|NCT00358826|536332363|FG005|Core Study|Lost to Follow-up|0|||
148688707|NCT00358826|536332364|FG006|Core Study|Lost to Follow-up|0|||
148688708|NCT00358826|536332365|FG007|Core Study|Lost to Follow-up|0|||
148688709|NCT00358826|536332358|FG000|Core Study|Physician Decision|0|||
149227807|NCT01519700|538301799|FG003|Overall Study|Physician Decision|0|||
149227808|NCT01519700|538301796|FG000|Overall Study|Withdrawal by Subject|5|||
149227809|NCT01519700|538301797|FG001|Overall Study|Withdrawal by Subject|3|||
149227810|NCT01519700|538301798|FG002|Overall Study|Withdrawal by Subject|3|||
149227811|NCT01519700|538301799|FG003|Overall Study|Withdrawal by Subject|2|||
148810227|NCT00879658|536782602|FG006|Overall Study|Abnormal laboratory value(s)|0|||
149227812|NCT01519700|538301796|FG000|Overall Study|Other Reason|2|||
149227813|NCT01519700|538301797|FG001|Overall Study|Other Reason|2|||
149227814|NCT01519700|538301798|FG002|Overall Study|Other Reason|0|||
149227815|NCT01519700|538301799|FG003|Overall Study|Other Reason|4|||
148688710|NCT00358826|536332359|FG001|Core Study|Physician Decision|0|||
148688711|NCT00358826|536332360|FG002|Core Study|Physician Decision|1|||
148688712|NCT00358826|536332361|FG003|Core Study|Physician Decision|0|||
149227816|NCT02927990|538301803|FG000|Overall Study|Protocol Violation|4|||
149227817|NCT02927990|538301803|FG000|Overall Study|Physician Decision|9|||
149227818|NCT02927990|538301803|FG000|Overall Study|Room switched and therefore no study device available|15|||
149227819|NCT02927990|538301803|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
149227820|NCT00960323|538301804|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
149227821|NCT03824704|538301814|FG000|Overall Study|Study Terminated by Sponsor|1|||
149227822|NCT02155660|538301817|FG000|Overall Study|Other Reason|8|||
149227823|NCT02155660|538301818|FG001|Overall Study|Other Reason|6|||
149227824|NCT02155660|538301819|FG002|Overall Study|Other Reason|10|||
149227825|NCT02155660|538301820|FG003|Overall Study|Other Reason|10|||
149227826|NCT02155660|538301817|FG000|Overall Study|Study-specific withdrawal criteria|0|||
149227827|NCT02155660|538301818|FG001|Overall Study|Study-specific withdrawal criteria|1|||
149227828|NCT02155660|538301819|FG002|Overall Study|Study-specific withdrawal criteria|1|||
149227829|NCT02155660|538301820|FG003|Overall Study|Study-specific withdrawal criteria|1|||
149227830|NCT02155660|538301817|FG000|Overall Study|Severe non-compliance|0|||
149227831|NCT02155660|538301818|FG001|Overall Study|Severe non-compliance|4|||
149227832|NCT02155660|538301819|FG002|Overall Study|Severe non-compliance|0|||
149227833|NCT02155660|538301820|FG003|Overall Study|Severe non-compliance|1|||
149227834|NCT02155660|538301817|FG000|Overall Study|Adverse Event|2|||
149227835|NCT02155660|538301818|FG001|Overall Study|Adverse Event|6|||
149227836|NCT02155660|538301819|FG002|Overall Study|Adverse Event|3|||
149227837|NCT02155660|538301820|FG003|Overall Study|Adverse Event|1|||
149227838|NCT02155660|538301817|FG000|Overall Study|Lost to Follow-up|3|||
149227839|NCT02155660|538301818|FG001|Overall Study|Lost to Follow-up|6|||
149227840|NCT02155660|538301819|FG002|Overall Study|Lost to Follow-up|5|||
149227841|NCT02155660|538301820|FG003|Overall Study|Lost to Follow-up|8|||
149227842|NCT02155660|538301817|FG000|Overall Study|Death|17|||
149227843|NCT02155660|538301818|FG001|Overall Study|Death|19|||
149227844|NCT02155660|538301819|FG002|Overall Study|Death|17|||
149227845|NCT02155660|538301820|FG003|Overall Study|Death|19|||
149227846|NCT02155660|538301817|FG000|Overall Study|Withdrawal by Subject|28|||
149227847|NCT02155660|538301818|FG001|Overall Study|Withdrawal by Subject|31|||
149227848|NCT02155660|538301819|FG002|Overall Study|Withdrawal by Subject|24|||
149227849|NCT02155660|538301820|FG003|Overall Study|Withdrawal by Subject|21|||
149227850|NCT03730987|538301821|FG000|Overall Study|Lost to Follow-up|2|||
149227851|NCT03730987|538301822|FG001|Overall Study|Lost to Follow-up|0|||
149227852|NCT03730987|538301823|FG002|Overall Study|Lost to Follow-up|2|||
149227853|NCT03730987|538301824|FG003|Overall Study|Lost to Follow-up|0|||
149227854|NCT02505945|538301825|FG000|Overall Study|Withdrawal by Subject|13|||
149227855|NCT02505945|538301826|FG001|Overall Study|Withdrawal by Subject|2|||
149227856|NCT02505945|538301825|FG000|Overall Study|Adverse Event|1|||
149227857|NCT02505945|538301826|FG001|Overall Study|Adverse Event|0|||
149227858|NCT02505945|538301825|FG000|Overall Study|Physician Decision|2|||
149227859|NCT02505945|538301826|FG001|Overall Study|Physician Decision|1|||
148688713|NCT00358826|536332362|FG004|Core Study|Physician Decision|0|||
148688714|NCT00358826|536332363|FG005|Core Study|Physician Decision|0|||
148688715|NCT00358826|536332364|FG006|Core Study|Physician Decision|0|||
148688716|NCT00358826|536332365|FG007|Core Study|Physician Decision|0|||
148688717|NCT00358826|536332358|FG000|MDCT Substudy|Adverse Event|0|||
148688718|NCT00358826|536332359|FG001|MDCT Substudy|Adverse Event|0|||
148688719|NCT00358826|536332360|FG002|MDCT Substudy|Adverse Event|0|||
149227860|NCT02505945|538301825|FG000|Overall Study|Lost to Follow-up|6|||
149227861|NCT02505945|538301826|FG001|Overall Study|Lost to Follow-up|1|||
149227862|NCT00386152|538301827|FG000|Overall Study|Adverse Event|6|||
149227863|NCT00386152|538301828|FG001|Overall Study|Adverse Event|5|||
149227864|NCT00386152|538301829|FG002|Overall Study|Adverse Event|4|||
149227865|NCT00386152|538301827|FG000|Overall Study|Chang from original chemo stratification|4|||
149227866|NCT00386152|538301828|FG001|Overall Study|Chang from original chemo stratification|5|||
149227867|NCT00386152|538301829|FG002|Overall Study|Chang from original chemo stratification|6|||
149227868|NCT00386152|538301827|FG000|Overall Study|Death|3|||
149227869|NCT00386152|538301828|FG001|Overall Study|Death|0|||
149227870|NCT00386152|538301829|FG002|Overall Study|Death|1|||
149227871|NCT00386152|538301827|FG000|Overall Study|Disease progression|7|||
149227872|NCT00386152|538301828|FG001|Overall Study|Disease progression|4|||
149227873|NCT00386152|538301829|FG002|Overall Study|Disease progression|5|||
149227874|NCT00386152|538301827|FG000|Overall Study|Physician Decision|13|||
149227875|NCT00386152|538301828|FG001|Overall Study|Physician Decision|10|||
149227876|NCT00386152|538301829|FG002|Overall Study|Physician Decision|4|||
149227877|NCT00386152|538301827|FG000|Overall Study|Lost to Follow-up|1|||
149227878|NCT00386152|538301828|FG001|Overall Study|Lost to Follow-up|0|||
149227879|NCT00386152|538301829|FG002|Overall Study|Lost to Follow-up|0|||
149227880|NCT00386152|538301827|FG000|Overall Study|Completed chemotherapy|4|||
149227881|NCT00386152|538301828|FG001|Overall Study|Completed chemotherapy|5|||
149227882|NCT00386152|538301829|FG002|Overall Study|Completed chemotherapy|1|||
148688720|NCT00358826|536332361|FG003|MDCT Substudy|Adverse Event|0|||
148688721|NCT00358826|536332362|FG004|MDCT Substudy|Adverse Event|1|||
148810228|NCT00879658|536782596|FG000|Overall Study|Administrative problems|2|||
148810229|NCT00879658|536782597|FG001|Overall Study|Administrative problems|1|||
149227883|NCT00386152|538301827|FG000|Overall Study|Protocol Violation|3|||
149227884|NCT00386152|538301828|FG001|Overall Study|Protocol Violation|5|||
149227885|NCT00386152|538301829|FG002|Overall Study|Protocol Violation|2|||
149227886|NCT00386152|538301827|FG000|Overall Study|Withdrawal by Subject|3|||
149227887|NCT00386152|538301828|FG001|Overall Study|Withdrawal by Subject|6|||
149227888|NCT00386152|538301829|FG002|Overall Study|Withdrawal by Subject|10|||
149227889|NCT02577107|538301833|FG000|Overall Study|Protocol deviation|0|||
149227890|NCT02577107|538301834|FG001|Overall Study|Protocol deviation|1|||
149227891|NCT00883896|538301842|FG000|Overall Study|Lost to Follow-up|0|||
149227892|NCT00883896|538301843|FG001|Overall Study|Lost to Follow-up|0|||
149227893|NCT00883896|538301844|FG002|Overall Study|Lost to Follow-up|0|||
149227894|NCT00883896|538301845|FG003|Overall Study|Lost to Follow-up|2|||
149227895|NCT00883896|538301842|FG000|Overall Study|Withdrawal by Subject|5|||
149227896|NCT00883896|538301843|FG001|Overall Study|Withdrawal by Subject|0|||
149227897|NCT00883896|538301844|FG002|Overall Study|Withdrawal by Subject|1|||
149227898|NCT00883896|538301845|FG003|Overall Study|Withdrawal by Subject|3|||
149227899|NCT00883896|538301842|FG000|Overall Study|Lack of Efficacy|0|||
149227900|NCT00883896|538301843|FG001|Overall Study|Lack of Efficacy|0|||
149227901|NCT00883896|538301844|FG002|Overall Study|Lack of Efficacy|0|||
149227902|NCT00883896|538301845|FG003|Overall Study|Lack of Efficacy|2|||
149227903|NCT00883896|538301842|FG000|Overall Study|Other|1|||
149227904|NCT00883896|538301843|FG001|Overall Study|Other|0|||
149227905|NCT00883896|538301844|FG002|Overall Study|Other|0|||
149227906|NCT00883896|538301845|FG003|Overall Study|Other|0|||
149227907|NCT01856920|538301855|FG000|Overall Study|Disease Progression On Study|3|||
149227908|NCT01856920|538301856|FG001|Overall Study|Disease Progression On Study|4|||
149227909|NCT01856920|538301855|FG000|Overall Study|Disease Progression before Treatment|1|||
149227910|NCT01856920|538301856|FG001|Overall Study|Disease Progression before Treatment|0|||
149227911|NCT01856920|538301855|FG000|Overall Study|Ineligible|0|||
149227912|NCT01856920|538301856|FG001|Overall Study|Ineligible|1|||
149227913|NCT01856920|538301855|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
149227914|NCT01856920|538301856|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
149227915|NCT01856920|538301855|FG000|Overall Study|Refused further Treatment|5|||
149227916|NCT01856920|538301856|FG001|Overall Study|Refused further Treatment|1|||
149227917|NCT01856920|538301855|FG000|Overall Study|Other Reasons|0|||
149227918|NCT01856920|538301856|FG001|Overall Study|Other Reasons|1|||
149227919|NCT01856920|538301855|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
149227920|NCT01856920|538301856|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
149227921|NCT03380091|538301859|FG000|Overall Study|Withdrawal by Subject|2|||
149227922|NCT03380091|538301860|FG001|Overall Study|Withdrawal by Subject|1|||
149227923|NCT01980056|538301866|FG000|Overall Study|Death|1|||
149227924|NCT01980056|538301867|FG001|Overall Study|Death|1|||
149227925|NCT01980056|538301868|FG002|Overall Study|Death|0|||
149227926|NCT03802331|538301869|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
149227927|NCT03802331|538301870|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
149227928|NCT00368069|538301872|FG000|Overall Study|Adverse Event|5|||
149227929|NCT00368069|538301873|FG001|Overall Study|Adverse Event|2|||
149227930|NCT00368069|538301872|FG000|Overall Study|Lack of Efficacy|0|||
149227931|NCT00368069|538301873|FG001|Overall Study|Lack of Efficacy|1|||
149227932|NCT00368069|538301872|FG000|Overall Study|Lost to Follow-up|1|||
149227933|NCT00368069|538301873|FG001|Overall Study|Lost to Follow-up|0|||
149227934|NCT00368069|538301872|FG000|Overall Study|Protocol Violation|0|||
149227935|NCT00368069|538301873|FG001|Overall Study|Protocol Violation|2|||
149227936|NCT00368069|538301872|FG000|Overall Study|Withdrawal of Consent|2|||
149227937|NCT00368069|538301873|FG001|Overall Study|Withdrawal of Consent|1|||
149227938|NCT00368069|538301872|FG000|Overall Study|no blood sampling possible|0|||
149227939|NCT00368069|538301873|FG001|Overall Study|no blood sampling possible|1|||
149227940|NCT03742271|538301888|FG000|Overall Study|Unsatisfactory Visual Response|1|||
149227941|NCT03742271|538301888|FG000|Overall Study|Withdrawal by Subject|3|||
149227942|NCT03742271|538301888|FG000|Overall Study|Lost to Follow-up|4|||
149227943|NCT03742271|538301888|FG000|Overall Study|Failed Insertion & removal|3|||
149227944|NCT03742271|538301888|FG000|Overall Study|Protocol Violation|1|||
149227945|NCT01775995|538301890|FG000|Overall Study|Lost to Follow-up|1|||
149227946|NCT01775995|538301891|FG001|Overall Study|Lost to Follow-up|1|||
149227947|NCT00440232|538301894|FG000|Overall Study|Lost to Follow-up|1|||
149227948|NCT00440232|538301895|FG001|Overall Study|Lost to Follow-up|1|||
149227949|NCT00440232|538301894|FG000|Overall Study|Unable to treat within allowed time|0|||
149227950|NCT00440232|538301895|FG001|Overall Study|Unable to treat within allowed time|1|||
149227951|NCT00440232|538301894|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
149227952|NCT00440232|538301895|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
149227953|NCT00362297|538301896|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
148810230|NCT00879658|536782598|FG002|Overall Study|Administrative problems|0|||
149227954|NCT00362297|538301897|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
149227955|NCT03417999|538301898|FG000|Overall Study|Withdrawal by Subject|1|||
148688722|NCT00358826|536332363|FG005|MDCT Substudy|Adverse Event|0|||
148688723|NCT00358826|536332364|FG006|MDCT Substudy|Adverse Event|0|||
148688724|NCT00358826|536332365|FG007|MDCT Substudy|Adverse Event|0|||
148688725|NCT00358826|536332358|FG000|MDCT Substudy|Lost to Follow-up|0|||
148688726|NCT00358826|536332359|FG001|MDCT Substudy|Lost to Follow-up|0|||
148688727|NCT00358826|536332360|FG002|MDCT Substudy|Lost to Follow-up|0|||
148688728|NCT00358826|536332361|FG003|MDCT Substudy|Lost to Follow-up|0|||
148688729|NCT00358826|536332362|FG004|MDCT Substudy|Lost to Follow-up|0|||
148688730|NCT00358826|536332363|FG005|MDCT Substudy|Lost to Follow-up|1|||
148688731|NCT00358826|536332364|FG006|MDCT Substudy|Lost to Follow-up|0|||
148688732|NCT00358826|536332365|FG007|MDCT Substudy|Lost to Follow-up|0|||
148688733|NCT00358826|536332358|FG000|MDCT Substudy|Withdrawal by Subject|0|||
148688734|NCT00358826|536332359|FG001|MDCT Substudy|Withdrawal by Subject|0|||
148688735|NCT00358826|536332360|FG002|MDCT Substudy|Withdrawal by Subject|0|||
148688736|NCT00358826|536332361|FG003|MDCT Substudy|Withdrawal by Subject|0|||
148688737|NCT00358826|536332362|FG004|MDCT Substudy|Withdrawal by Subject|0|||
148688738|NCT00358826|536332363|FG005|MDCT Substudy|Withdrawal by Subject|1|||
148688739|NCT00358826|536332364|FG006|MDCT Substudy|Withdrawal by Subject|0|||
148688740|NCT00358826|536332365|FG007|MDCT Substudy|Withdrawal by Subject|0|||
148688741|NCT02015793|536332367|FG000|Overall Study|Adverse Event|3|||
148688742|NCT02015793|536332368|FG001|Overall Study|Adverse Event|3|||
148688743|NCT02015793|536332367|FG000|Overall Study|Withdrawal by Subject|1|||
148688744|NCT02015793|536332368|FG001|Overall Study|Withdrawal by Subject|1|||
148688745|NCT04317781|536332369|FG000|Overall Study|Adverse Event|1|||
148688746|NCT04317781|536332369|FG000|Overall Study|Disease relapse|1|||
148688747|NCT04317781|536332369|FG000|Overall Study|Withdrawal by Subject|1|||
148688748|NCT02843074|536332374|FG000|Overall Study|Withdrawal by Subject|5|||
148688749|NCT02843074|536332374|FG000|Overall Study|Progressive disease|1|||
148688750|NCT02843074|536332374|FG000|Overall Study|Physician Decision|1|||
148688751|NCT02843074|536332374|FG000|Overall Study|Lost to Follow-up|1|||
148688752|NCT02843074|536332374|FG000|Overall Study|Death|9|||
148688753|NCT03521999|536332375|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
148688754|NCT03521999|536332376|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
148688755|NCT03521999|536332375|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
148688756|NCT03521999|536332376|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
148810231|NCT00879658|536782599|FG003|Overall Study|Administrative problems|1|||
148810232|NCT00879658|536782600|FG004|Overall Study|Administrative problems|0|||
149227956|NCT03417999|538301899|FG001|Overall Study|Withdrawal by Subject|0|||
149227957|NCT03417999|538301900|FG002|Overall Study|Withdrawal by Subject|0|||
149227958|NCT03417999|538301898|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
149227959|NCT03417999|538301899|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
149227960|NCT03417999|538301900|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
149227961|NCT03417999|538301898|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
149227962|NCT03417999|538301899|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
149227963|NCT03417999|538301900|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
149227964|NCT03417999|538301898|FG000|Overall Study|Inadequate study staff available to process samples|0|||
149227965|NCT03417999|538301899|FG001|Overall Study|Inadequate study staff available to process samples|0|||
149227966|NCT03417999|538301900|FG002|Overall Study|Inadequate study staff available to process samples|1|||
149227967|NCT05111548|538303305|FG000|Overall Study|Withdrawal by Subject|2|||
149227968|NCT05111548|538303306|FG001|Overall Study|Withdrawal by Subject|1|||
149227969|NCT05111548|538303305|FG000|Overall Study|Adverse Event|1|||
149227970|NCT05111548|538303306|FG001|Overall Study|Adverse Event|0|||
149227971|NCT01846039|538303307|FG000|Overall Study|Protocol Violation|1|||
149227972|NCT01846039|538303307|FG000|Overall Study|Subject Withdrew Consent|1|||
149227973|NCT01855607|538303318|FG000|Overall Study|Withdrawal by Subject|1|||
149227974|NCT01855607|538303318|FG000|Overall Study|Study was terminated|11|||
148688757|NCT03521999|536332375|FG000|Completed 3 Month Follow up|Death|0|||
148688758|NCT03521999|536332376|FG001|Completed 3 Month Follow up|Death|1|||
148688759|NCT03521999|536332375|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
148688760|NCT03521999|536332376|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
148688761|NCT01564758|536332377|FG000|Overall Study|Death|8|||
149227975|NCT01101321|538303319|FG000|Period 1|Withdrawal by Subject|1|||
149227976|NCT01101321|538303320|FG001|Period 1|Withdrawal by Subject|1|||
149227977|NCT01101321|538303319|FG000|Period 1|Adverse Event|3|||
149227978|NCT01101321|538303320|FG001|Period 1|Adverse Event|3|||
149227979|NCT00535262|538303323|FG000|Overall Study|No funding|3|||
149227980|NCT01707667|538303324|FG000|Period 1|expulsion of colonic sensor catheter|1|||
149227981|NCT01707667|538303325|FG001|Period 1|expulsion of colonic sensor catheter|0|||
149227982|NCT01654666|538303326|FG000|Overall Study|Protocol Violation|7|||
149227983|NCT01654666|538303327|FG001|Overall Study|Protocol Violation|4|||
149227984|NCT01654666|538303328|FG002|Overall Study|Protocol Violation|8|||
149227985|NCT01654666|538303326|FG000|Overall Study|Lost to Follow-up|4|||
149227986|NCT01654666|538303327|FG001|Overall Study|Lost to Follow-up|5|||
149227987|NCT01654666|538303328|FG002|Overall Study|Lost to Follow-up|5|||
149227988|NCT01654666|538303326|FG000|Overall Study|Withdrawal by Subject|4|||
149020102|NCT02601937|537551129|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020103|NCT02601937|537551130|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020104|NCT02601937|537551131|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
149020105|NCT02601937|537551132|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
149020106|NCT02601937|537551133|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
149020107|NCT02601937|537551123|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020108|NCT02601937|537551124|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020109|NCT02601937|537551125|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020110|NCT02601937|537551126|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020111|NCT02601937|537551127|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020112|NCT02601937|537551128|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020113|NCT02601937|537551129|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
149020114|NCT02601937|537551130|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
149020115|NCT02601937|537551131|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
149020116|NCT02601937|537551132|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
149020117|NCT02601937|537551133|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
149020118|NCT02601937|537551123|FG000|Period 2: Dose Expansion Cohort|Other|0|||
149020119|NCT02601937|537551124|FG001|Period 2: Dose Expansion Cohort|Other|0|||
149020120|NCT02601937|537551125|FG002|Period 2: Dose Expansion Cohort|Other|0|||
149020121|NCT02601937|537551126|FG003|Period 2: Dose Expansion Cohort|Other|0|||
149020122|NCT02601937|537551127|FG004|Period 2: Dose Expansion Cohort|Other|0|||
149020123|NCT02601937|537551128|FG005|Period 2: Dose Expansion Cohort|Other|0|||
149020124|NCT02601937|537551129|FG006|Period 2: Dose Expansion Cohort|Other|0|||
149020125|NCT02601937|537551130|FG007|Period 2: Dose Expansion Cohort|Other|0|||
149020126|NCT02601937|537551131|FG008|Period 2: Dose Expansion Cohort|Other|2|||
149020127|NCT02601937|537551132|FG009|Period 2: Dose Expansion Cohort|Other|2|||
149020128|NCT02601937|537551133|FG010|Period 2: Dose Expansion Cohort|Other|0|||
149020129|NCT02601937|537551123|FG000|Period 2: Dose Expansion Cohort|Death|0|||
149020130|NCT02601937|537551124|FG001|Period 2: Dose Expansion Cohort|Death|0|||
149020131|NCT02601937|537551125|FG002|Period 2: Dose Expansion Cohort|Death|0|||
149020132|NCT02601937|537551126|FG003|Period 2: Dose Expansion Cohort|Death|0|||
149020133|NCT02601937|537551127|FG004|Period 2: Dose Expansion Cohort|Death|0|||
149020134|NCT02601937|537551128|FG005|Period 2: Dose Expansion Cohort|Death|0|||
149020135|NCT02601937|537551129|FG006|Period 2: Dose Expansion Cohort|Death|0|||
149020136|NCT02601937|537551130|FG007|Period 2: Dose Expansion Cohort|Death|0|||
149020137|NCT02601937|537551131|FG008|Period 2: Dose Expansion Cohort|Death|1|||
149020138|NCT02601937|537551132|FG009|Period 2: Dose Expansion Cohort|Death|0|||
149020139|NCT02601937|537551133|FG010|Period 2: Dose Expansion Cohort|Death|0|||
149020140|NCT04129580|537552582|FG000|Overall Study|Lost to Follow-up|14|||
149020141|NCT04129580|537552583|FG001|Overall Study|Lost to Follow-up|25|||
149020142|NCT02711995|537552586|FG000|Washout (90 Days)|Conflicting medication|1|||
149020143|NCT00322868|537552587|FG000|Overall Study|disease progression|1|||
149020144|NCT03615482|537552588|FG000|Overall Study|Death|1|||
149020145|NCT03615482|537552589|FG001|Overall Study|Death|0|||
149020146|NCT03615482|537552588|FG000|Overall Study|Lost to Follow-up|7|||
149020147|NCT03615482|537552589|FG001|Overall Study|Lost to Follow-up|7|||
149020148|NCT03615482|537552588|FG000|Overall Study|Physician Decision|2|||
149020149|NCT03615482|537552589|FG001|Overall Study|Physician Decision|3|||
149020150|NCT03615482|537552588|FG000|Overall Study|Withdrawal by Subject|7|||
149020151|NCT03615482|537552589|FG001|Overall Study|Withdrawal by Subject|7|||
149227989|NCT01654666|538303327|FG001|Overall Study|Withdrawal by Subject|4|||
149227990|NCT01654666|538303328|FG002|Overall Study|Withdrawal by Subject|1|||
149227991|NCT03432819|538303330|FG000|Overall Study|Lost to Follow-up|2|||
149227992|NCT03432819|538303331|FG001|Overall Study|Lost to Follow-up|2|||
149227993|NCT03432819|538303330|FG000|Overall Study|Withdrawal by Subject|5|||
149227994|NCT03432819|538303331|FG001|Overall Study|Withdrawal by Subject|3|||
149227995|NCT04382066|538303332|FG000|Overall Study|Adverse Event|1|||
149020152|NCT00590980|537552602|FG000|Overall Study|Did not meet all inclusion criteria|10|||
149020153|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
149020154|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
149020155|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
149020156|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
149020157|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
149227996|NCT04382066|538303333|FG001|Overall Study|Adverse Event|0|||
149227997|NCT04382066|538303334|FG002|Overall Study|Adverse Event|0|||
149227998|NCT04382066|538303332|FG000|Overall Study|Death|1|||
149227999|NCT04382066|538303333|FG001|Overall Study|Death|0|||
149020158|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
149020159|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
149020160|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
149020161|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
149020162|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
149228000|NCT04382066|538303334|FG002|Overall Study|Death|1|||
149228001|NCT01430559|538303335|FG000|Overall Study|Adverse Event|7|||
149228002|NCT01430559|538303336|FG001|Overall Study|Adverse Event|3|||
149228003|NCT01430559|538303335|FG000|Overall Study|Entry criteria not met|1|||
149228004|NCT01430559|538303336|FG001|Overall Study|Entry criteria not met|1|||
149228005|NCT01430559|538303335|FG000|Overall Study|Lost to Follow-up|1|||
149228006|NCT01430559|538303336|FG001|Overall Study|Lost to Follow-up|0|||
149228007|NCT01430559|538303335|FG000|Overall Study|Medication error|1|||
149228008|NCT01430559|538303336|FG001|Overall Study|Medication error|0|||
149228009|NCT01430559|538303335|FG000|Overall Study|Withdrawal by Subject|3|||
149228010|NCT01430559|538303336|FG001|Overall Study|Withdrawal by Subject|2|||
149228011|NCT01430559|538303335|FG000|Overall Study|Protocol Violation|1|||
149228012|NCT01430559|538303336|FG001|Overall Study|Protocol Violation|0|||
149228013|NCT01430559|538303335|FG000|Overall Study|Other|3|||
149228014|NCT01430559|538303336|FG001|Overall Study|Other|3|||
149228015|NCT01430559|538303335|FG000|Overall Study|Randomized, Not Treated|3|||
149228016|NCT01430559|538303336|FG001|Overall Study|Randomized, Not Treated|3|||
149228017|NCT01220024|538303337|FG000|Overall Study|Lost to Follow-up|1|||
149228018|NCT01220024|538303338|FG001|Overall Study|Lost to Follow-up|1|||
149228019|NCT00174460|538303341|FG000|Overall Study|Withdrawal by Subject|0|||
149228020|NCT00174460|538303342|FG001|Overall Study|Withdrawal by Subject|1|||
149228021|NCT04225026|538303343|FG000|Overall Study|Withdrawal by Subject|4|||
149228022|NCT04225026|538303343|FG000|Overall Study|Adverse Event|1|||
149228023|NCT04225026|538303343|FG000|Overall Study|Other|1|||
149228024|NCT04225026|538303343|FG000|Overall Study|Death|11|||
149228025|NCT04225026|538303343|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
149228026|NCT00579059|538303344|FG000|Overall Study|Study Canceled at 1 Year|21|||
149228027|NCT00579059|538303345|FG001|Overall Study|Study Canceled at 1 Year|10|||
149228028|NCT00779506|538303346|FG000|Overall Study|Screening Failed|2|||
149228029|NCT00779506|538303346|FG000|Overall Study|Adverse Event|4|||
149228030|NCT00779506|538303346|FG000|Overall Study|Lack of Efficacy|11|||
149228031|NCT00779506|538303346|FG000|Overall Study|Protocol Violation|5|||
149228032|NCT00779506|538303346|FG000|Overall Study|Withdrawal by Subject|6|||
149228033|NCT00779506|538303346|FG000|Overall Study|Lost to Follow-up|1|||
149228034|NCT03982069|538303347|FG000|Overall Study|Lost to Follow-up|5|||
149228035|NCT03982069|538303348|FG001|Overall Study|Lost to Follow-up|5|||
149228036|NCT03982069|538303349|FG002|Overall Study|Lost to Follow-up|3|||
149228037|NCT03982069|538303350|FG003|Overall Study|Lost to Follow-up|5|||
149228038|NCT03982069|538303347|FG000|Overall Study|Physician Decision|0|||
149228039|NCT03982069|538303348|FG001|Overall Study|Physician Decision|1|||
149228040|NCT03982069|538303349|FG002|Overall Study|Physician Decision|0|||
149020163|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
149020164|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
149020165|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
149020166|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
149020167|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
149020168|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
149020169|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
149020170|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
149020171|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
149020172|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
149020173|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
149020174|NCT02718417|537552603|FG000|Chemotherapy Phase (CP)|Other|2|||
149020175|NCT02718417|537552604|FG001|Chemotherapy Phase (CP)|Other|0|||
149020176|NCT02718417|537552605|FG002|Chemotherapy Phase (CP)|Other|1|||
149020177|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Adverse Event|21|||
149020178|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Adverse Event|26|||
149020179|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Adverse Event|0|||
149020180|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
149020181|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
149228041|NCT03982069|538303350|FG003|Overall Study|Physician Decision|0|||
149228042|NCT03982069|538303347|FG000|Overall Study|Withdrawal by Subject|2|||
148688762|NCT01564758|536332377|FG000|Overall Study|Adverse Event|3|||
148688763|NCT01564758|536332377|FG000|Overall Study|Other|3|||
149228043|NCT03982069|538303348|FG001|Overall Study|Withdrawal by Subject|1|||
149228044|NCT03982069|538303349|FG002|Overall Study|Withdrawal by Subject|5|||
149228045|NCT03982069|538303350|FG003|Overall Study|Withdrawal by Subject|2|||
149228046|NCT03982069|538303347|FG000|Overall Study|Specimen loss|3|||
149228047|NCT03982069|538303348|FG001|Overall Study|Specimen loss|3|||
149228048|NCT03982069|538303349|FG002|Overall Study|Specimen loss|1|||
149228049|NCT03982069|538303350|FG003|Overall Study|Specimen loss|1|||
149020182|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
149020183|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
149228050|NCT01218477|538303351|FG000|Overall Study|Disease progression|2|||
149228051|NCT01218477|538303352|FG001|Overall Study|Disease progression|3|||
149228052|NCT01218477|538303353|FG002|Overall Study|Disease progression|6|||
149228053|NCT01218477|538303354|FG003|Overall Study|Disease progression|2|||
149228054|NCT01218477|538303351|FG000|Overall Study|Study drug toxicity|0|||
148688764|NCT01211769|536332378|FG000|Overall Study|Lost to Follow-up|7|||
148688765|NCT01211769|536332379|FG001|Overall Study|Lost to Follow-up|9|||
148688766|NCT01211769|536332380|FG002|Overall Study|Lost to Follow-up|5|||
148688767|NCT01211769|536332381|FG003|Overall Study|Lost to Follow-up|9|||
148688768|NCT01211769|536332378|FG000|Overall Study|Physician Decision|2|||
148688769|NCT01211769|536332379|FG001|Overall Study|Physician Decision|0|||
148688770|NCT01211769|536332380|FG002|Overall Study|Physician Decision|2|||
148688771|NCT01211769|536332381|FG003|Overall Study|Physician Decision|1|||
148688772|NCT01211769|536332378|FG000|Overall Study|Adverse Event|0|||
148688773|NCT01211769|536332379|FG001|Overall Study|Adverse Event|1|||
148688774|NCT01211769|536332380|FG002|Overall Study|Adverse Event|1|||
148688775|NCT01211769|536332381|FG003|Overall Study|Adverse Event|1|||
148688776|NCT01214330|536332382|FG000|Overall Study|Withdrawal by Subject|2|||
148688777|NCT01214330|536332382|FG000|Overall Study|Withdrawal by Subject|2|||
148688778|NCT00947427|536332383|FG000|Overall Study|Withdrawal by Subject|1|||
148688779|NCT00947427|536332384|FG001|Overall Study|Withdrawal by Subject|3|||
148688780|NCT00947427|536332383|FG000|Overall Study|Protocol Violation|0|||
148688781|NCT00947427|536332384|FG001|Overall Study|Protocol Violation|1|||
148688782|NCT01533428|536332385|FG000|Overall Study|Adverse Event|0|||
148688783|NCT01533428|536332386|FG001|Overall Study|Adverse Event|1|||
148688784|NCT01533428|536332385|FG000|Overall Study|Lost to Follow-up|2|||
148688785|NCT01533428|536332386|FG001|Overall Study|Lost to Follow-up|1|||
148688786|NCT01533428|536332385|FG000|Overall Study|Withdrawal by Subject|7|||
148688787|NCT01533428|536332386|FG001|Overall Study|Withdrawal by Subject|6|||
148688788|NCT00859469|536332388|FG000|Overall Study|Adverse Event|2|||
148688789|NCT00859469|536332388|FG000|Overall Study|Lack of Efficacy|9|||
148688790|NCT00859469|536332388|FG000|Overall Study|Withdrawal by Subject|1|||
148688791|NCT00859469|536332388|FG000|Overall Study|Death|16|||
148688792|NCT03896490|536332389|FG000|Overall Study|Withdrawal by Subject|1|||
148688793|NCT03896490|536332390|FG001|Overall Study|Withdrawal by Subject|1|||
148688794|NCT03083132|536332393|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
148688795|NCT03083132|536332394|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
148688796|NCT03083132|536332393|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
148688797|NCT03083132|536332394|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
148688798|NCT03083132|536332393|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
148688799|NCT03083132|536332394|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
148688800|NCT03118739|536332395|FG000|Overall Study|Physician Decision|0|||
148688801|NCT03118739|536332396|FG001|Overall Study|Physician Decision|1|||
148688802|NCT03118739|536332395|FG000|Overall Study|Withdrawal by Subject|5|||
148688803|NCT03118739|536332396|FG001|Overall Study|Withdrawal by Subject|3|||
148688804|NCT03118739|536332395|FG000|Overall Study|Lost to Follow-up|2|||
148688805|NCT03118739|536332396|FG001|Overall Study|Lost to Follow-up|0|||
148688806|NCT00669955|536332397|FG000|Overall Study|Adverse Event|3|||
148688807|NCT00669955|536332398|FG001|Overall Study|Adverse Event|5|||
148688808|NCT00669955|536332397|FG000|Overall Study|Death|0|||
148688809|NCT00669955|536332398|FG001|Overall Study|Death|1|||
148688810|NCT00669955|536332397|FG000|Overall Study|Withdrawal by Subject|2|||
148688811|NCT00669955|536332398|FG001|Overall Study|Withdrawal by Subject|3|||
148688812|NCT00669955|536332397|FG000|Overall Study|Lost to Follow-up|5|||
148688813|NCT00669955|536332398|FG001|Overall Study|Lost to Follow-up|7|||
148688814|NCT00669955|536332397|FG000|Overall Study|Protocol Violation|2|||
148688815|NCT00669955|536332398|FG001|Overall Study|Protocol Violation|7|||
148688816|NCT00669955|536332397|FG000|Overall Study|Investigator Sponsor Judgement|0|||
148688817|NCT00669955|536332398|FG001|Overall Study|Investigator Sponsor Judgement|1|||
148688818|NCT00669955|536332397|FG000|Overall Study|not compliant with study drug/visit|2|||
148688819|NCT00669955|536332398|FG001|Overall Study|not compliant with study drug/visit|3|||
148688820|NCT01893138|536332400|FG000|Double-Blind Period|Withdrawal by Subject|1|||
148688821|NCT01893138|536332401|FG001|Double-Blind Period|Withdrawal by Subject|1|||
148688822|NCT01893138|536332400|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
148688823|NCT01893138|536332401|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
148688824|NCT01893138|536332400|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
148810233|NCT00879658|536782601|FG005|Overall Study|Administrative problems|0|||
148688825|NCT01893138|536332401|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
148688826|NCT01893138|536332400|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
148688827|NCT01893138|536332401|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
148688828|NCT01893138|536332400|FG000|Open Label - Unblinded Period|Adverse Event|1|||
148688829|NCT01893138|536332401|FG001|Open Label - Unblinded Period|Adverse Event|0|||
148688830|NCT01326026|536332402|FG000|Overall Study|Adverse Event|4|||
148688831|NCT01326026|536332403|FG001|Overall Study|Adverse Event|3|||
148688832|NCT01326026|536332402|FG000|Overall Study|Withdrawal Criteria|5|||
148688833|NCT01326026|536332403|FG001|Overall Study|Withdrawal Criteria|7|||
148688834|NCT01326026|536332402|FG000|Overall Study|Other|3|||
148688835|NCT01326026|536332403|FG001|Overall Study|Other|3|||
148688836|NCT04317053|536332413|FG000|Overall Study|Withdrawn (screen failure)|4|||
148688837|NCT04317053|536332414|FG001|Overall Study|Withdrawn (screen failure)|2|||
148810234|NCT00879658|536782602|FG006|Overall Study|Administrative problems|0|||
148688838|NCT04274192|536332415|FG000|Overall Study|Protocol Violation|1|||
148688839|NCT04274192|536332416|FG001|Overall Study|Protocol Violation|0|||
148688840|NCT00289458|536332417|FG000|Overall Study|Death|1|||
148688841|NCT00289458|536332418|FG001|Overall Study|Death|0|||
148688842|NCT00289458|536332419|FG002|Overall Study|Death|0|||
148688843|NCT00289458|536332417|FG000|Overall Study|Physician Decision|3|||
148688844|NCT00289458|536332418|FG001|Overall Study|Physician Decision|4|||
148688845|NCT00289458|536332419|FG002|Overall Study|Physician Decision|2|||
148688846|NCT00289458|536332417|FG000|Overall Study|Withdrawal by Subject|2|||
148688847|NCT00289458|536332418|FG001|Overall Study|Withdrawal by Subject|2|||
148688848|NCT00289458|536332419|FG002|Overall Study|Withdrawal by Subject|4|||
148688849|NCT03507439|536332420|FG000|Overall Study|Other|2|||
148688850|NCT03507439|536332421|FG001|Overall Study|Other|1|||
148688851|NCT03507439|536332420|FG000|Overall Study|Withdrawal by Subject|1|||
148688852|NCT03507439|536332421|FG001|Overall Study|Withdrawal by Subject|0|||
148688853|NCT03507439|536332420|FG000|Overall Study|Death|1|||
148688854|NCT03507439|536332421|FG001|Overall Study|Death|1|||
148688855|NCT00874757|536332422|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
148688856|NCT00982410|536334193|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
148688857|NCT00982410|536334194|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
148688858|NCT00982410|536334193|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
148688859|NCT00982410|536334194|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
148688860|NCT00982410|536334193|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
148688861|NCT00982410|536334194|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
148688862|NCT00982410|536334193|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
148688863|NCT00982410|536334194|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
148688864|NCT00982410|536334193|FG000|6-month Follow-up Assessment|participant no transportation|1|||
148688865|NCT00982410|536334194|FG001|6-month Follow-up Assessment|participant no transportation|0|||
148688866|NCT00982410|536334193|FG000|6-month Follow-up Assessment|incarceration|0|||
148688867|NCT00982410|536334194|FG001|6-month Follow-up Assessment|incarceration|2|||
148688868|NCT00982410|536334193|FG000|6-month Follow-up Assessment|patent surgery|0|||
148688869|NCT00982410|536334194|FG001|6-month Follow-up Assessment|patent surgery|1|||
148688870|NCT00982410|536334193|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
148688871|NCT00982410|536334194|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
148688872|NCT00982410|536334193|FG000|12-month Follow-up Assessment|Death|0|||
148688873|NCT00982410|536334194|FG001|12-month Follow-up Assessment|Death|2|||
148688874|NCT00982410|536334193|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
148688875|NCT00982410|536334194|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
148688876|NCT00982410|536334193|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
148688877|NCT00982410|536334194|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
148688878|NCT00982410|536334193|FG000|12-month Follow-up Assessment|incarceration|2|||
148688879|NCT00982410|536334194|FG001|12-month Follow-up Assessment|incarceration|1|||
148688880|NCT00982410|536334193|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
148688881|NCT00982410|536334194|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
148688882|NCT00759148|536334196|FG000|Overall Study|Adverse Event|1|||
148688883|NCT00759148|536334197|FG001|Overall Study|Adverse Event|6|||
148688884|NCT00759148|536334196|FG000|Overall Study|Withdrawal by Subject|3|||
148688885|NCT00759148|536334197|FG001|Overall Study|Withdrawal by Subject|7|||
148688886|NCT00759148|536334196|FG000|Overall Study|Lost to Follow-up|3|||
148688887|NCT00759148|536334197|FG001|Overall Study|Lost to Follow-up|9|||
148688888|NCT00759148|536334196|FG000|Overall Study|Treatment Failure|6|||
148688889|NCT00759148|536334197|FG001|Overall Study|Treatment Failure|10|||
148688890|NCT00759148|536334196|FG000|Overall Study|Reason not given|1|||
148688891|NCT00759148|536334197|FG001|Overall Study|Reason not given|0|||
148688892|NCT01073020|536334198|FG000|Overall Study|Withdrawal by Subject|6|||
148688893|NCT01073020|536334199|FG001|Overall Study|Withdrawal by Subject|4|||
148688894|NCT01073020|536334200|FG002|Overall Study|Withdrawal by Subject|1|||
148688895|NCT01073020|536334201|FG003|Overall Study|Withdrawal by Subject|2|||
148688896|NCT01073020|536334198|FG000|Overall Study|Physician Decision|1|||
148688897|NCT01073020|536334199|FG001|Overall Study|Physician Decision|0|||
148688898|NCT01073020|536334200|FG002|Overall Study|Physician Decision|2|||
148688899|NCT01073020|536334201|FG003|Overall Study|Physician Decision|0|||
148688900|NCT01073020|536334198|FG000|Overall Study|Death|0|||
148688901|NCT01073020|536334199|FG001|Overall Study|Death|1|||
148688902|NCT01073020|536334200|FG002|Overall Study|Death|0|||
148688903|NCT01073020|536334201|FG003|Overall Study|Death|0|||
148688904|NCT01644890|536334202|FG000|Overall Study|Adverse Event|7|||
148688905|NCT01644890|536334203|FG001|Overall Study|Adverse Event|20|||
148688906|NCT01644890|536334202|FG000|Overall Study|Death|1|||
148688907|NCT01644890|536334203|FG001|Overall Study|Death|3|||
148688908|NCT01644890|536334202|FG000|Overall Study|Physician Decision|3|||
148688909|NCT01644890|536334203|FG001|Overall Study|Physician Decision|9|||
148688910|NCT01644890|536334202|FG000|Overall Study|Protocol Violation|6|||
148688911|NCT01644890|536334203|FG001|Overall Study|Protocol Violation|7|||
148810235|NCT00879658|536782596|FG000|Overall Study|Adverse Event|6|||
149228055|NCT01218477|538303352|FG001|Overall Study|Study drug toxicity|2|||
148688912|NCT01644890|536334202|FG000|Overall Study|Withdrawal by Subject|19|||
148688913|NCT01644890|536334203|FG001|Overall Study|Withdrawal by Subject|27|||
148688914|NCT01644890|536334202|FG000|Overall Study|Progression Disease|160|||
148688915|NCT01644890|536334203|FG001|Overall Study|Progression Disease|131|||
148688916|NCT01644890|536334202|FG000|Overall Study|Clinical Progression|6|||
148688917|NCT01644890|536334203|FG001|Overall Study|Clinical Progression|6|||
148688918|NCT01644890|536334202|FG000|Overall Study|> 28 days since last dose of study drug|6|||
148688919|NCT01644890|536334203|FG001|Overall Study|> 28 days since last dose of study drug|3|||
148688920|NCT01644890|536334202|FG000|Overall Study|Other|8|||
148688921|NCT01644890|536334203|FG001|Overall Study|Other|9|||
148688922|NCT03031899|536334208|FG000|Overall Study|Protocol Violation|1|||
148688923|NCT03031899|536334208|FG000|Overall Study|lesion disappeared after stopping habit|1|||
148688924|NCT01060670|536334209|FG000|Run In|screen failure|0|||
148688925|NCT01060670|536334210|FG001|Run In|screen failure|238|||
148688926|NCT00094302|536334211|FG000|Overall Study|Lost to Follow-up|43|||
148688927|NCT00094302|536334212|FG001|Overall Study|Lost to Follow-up|41|||
149228056|NCT01218477|538303353|FG002|Overall Study|Study drug toxicity|5|||
149228057|NCT01218477|538303354|FG003|Overall Study|Study drug toxicity|0|||
149228058|NCT01218477|538303351|FG000|Overall Study|No longer meets study criteria|1|||
149228059|NCT01218477|538303352|FG001|Overall Study|No longer meets study criteria|0|||
148688928|NCT00094302|536334211|FG000|Overall Study|Physician Decision|5|||
148688929|NCT00094302|536334212|FG001|Overall Study|Physician Decision|8|||
149228060|NCT01218477|538303353|FG002|Overall Study|No longer meets study criteria|0|||
149228061|NCT01218477|538303354|FG003|Overall Study|No longer meets study criteria|0|||
149228062|NCT01218477|538303351|FG000|Overall Study|Withdrawal by Subject|0|||
149228063|NCT01218477|538303352|FG001|Overall Study|Withdrawal by Subject|0|||
149228064|NCT01218477|538303353|FG002|Overall Study|Withdrawal by Subject|1|||
148688930|NCT00094302|536334211|FG000|Overall Study|Withdrawal by Subject|103|||
148688931|NCT00094302|536334212|FG001|Overall Study|Withdrawal by Subject|111|||
148688932|NCT00094302|536334211|FG000|Overall Study|Death|266|||
148688933|NCT00094302|536334212|FG001|Overall Study|Death|246|||
148688934|NCT03705351|536334218|FG000|Overall Study|Study termination|3|||
148688935|NCT03705351|536334218|FG000|Overall Study|Death|1|||
148688936|NCT03705351|536334218|FG000|Overall Study|Lack of Efficacy|2|||
148688937|NCT03705351|536334218|FG000|Overall Study|Withdrawal by Subject|1|||
148688938|NCT02180061|536334223|FG000|Overall Study|Adverse Event|4|||
148688939|NCT02180061|536334224|FG001|Overall Study|Adverse Event|2|||
148688940|NCT02180061|536334223|FG000|Overall Study|Clinical Progression|5|||
148688941|NCT02180061|536334224|FG001|Overall Study|Clinical Progression|1|||
148688942|NCT02180061|536334223|FG000|Overall Study|Progressive Disease|15|||
148688943|NCT02180061|536334224|FG001|Overall Study|Progressive Disease|5|||
148688944|NCT02180061|536334223|FG000|Overall Study|Physician Decision|1|||
148688945|NCT02180061|536334224|FG001|Overall Study|Physician Decision|0|||
148688946|NCT00056160|536334227|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
148688947|NCT00056160|536334228|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
148688948|NCT00056160|536334227|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
148688949|NCT00056160|536334228|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
148688950|NCT00056160|536334227|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
148688951|NCT00056160|536334228|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
148688952|NCT00056160|536334227|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
148688953|NCT00056160|536334228|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
148688954|NCT00056160|536334227|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
148688955|NCT00056160|536334228|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
148688956|NCT00056160|536334227|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
148688957|NCT00056160|536334228|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
148688958|NCT00056160|536334227|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
148688959|NCT00056160|536334228|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
148688960|NCT00056160|536334227|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
148688961|NCT00056160|536334228|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
148688962|NCT00056160|536334227|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
148688963|NCT00056160|536334228|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
148688964|NCT00056160|536334227|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
148688965|NCT00056160|536334228|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
148688966|NCT00056160|536334227|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
148688967|NCT00056160|536334228|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
148688968|NCT00056160|536334227|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
148688969|NCT00056160|536334228|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
148688970|NCT00056160|536334227|FG000|Final Follow-up|Transferred into expanded access study.|3|||
148688971|NCT00056160|536334228|FG001|Final Follow-up|Transferred into expanded access study.|0|||
148688972|NCT00056160|536334227|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
148688973|NCT00056160|536334228|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
148688974|NCT00056160|536334227|FG000|Final Follow-up|Adverse Event|1|||
149228065|NCT01218477|538303354|FG003|Overall Study|Withdrawal by Subject|0|||
148688975|NCT00056160|536334228|FG001|Final Follow-up|Adverse Event|0|||
149020184|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
149228066|NCT01218477|538303351|FG000|Overall Study|Prepared for cell transplantation|0|||
149020185|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
149228067|NCT01218477|538303352|FG001|Overall Study|Prepared for cell transplantation|1|||
149228068|NCT01218477|538303353|FG002|Overall Study|Prepared for cell transplantation|1|||
149228069|NCT01218477|538303354|FG003|Overall Study|Prepared for cell transplantation|0|||
149228070|NCT01218477|538303351|FG000|Overall Study|Administrative reason by sponsor|0|||
149228071|NCT01218477|538303352|FG001|Overall Study|Administrative reason by sponsor|0|||
149228072|NCT01218477|538303353|FG002|Overall Study|Administrative reason by sponsor|1|||
149228073|NCT01218477|538303354|FG003|Overall Study|Administrative reason by sponsor|0|||
149228074|NCT01218477|538303351|FG000|Overall Study|Maximum clinical benefit|0|||
149228075|NCT01218477|538303352|FG001|Overall Study|Maximum clinical benefit|2|||
149228076|NCT01218477|538303353|FG002|Overall Study|Maximum clinical benefit|0|||
149228077|NCT01218477|538303354|FG003|Overall Study|Maximum clinical benefit|0|||
149228078|NCT00787527|538303357|FG000|Overall Study|Toxicity|3|||
149228079|NCT03137433|538303358|FG000|Overall Study|Withdrawal by Subject|11|||
149228080|NCT03137433|538303359|FG001|Overall Study|Withdrawal by Subject|11|||
149228081|NCT03137433|538303358|FG000|Overall Study|Lost to Follow-up|5|||
149228082|NCT03137433|538303359|FG001|Overall Study|Lost to Follow-up|6|||
149228083|NCT03137433|538303358|FG000|Overall Study|Physician Decision|2|||
149228084|NCT03137433|538303359|FG001|Overall Study|Physician Decision|0|||
149228085|NCT03137433|538303358|FG000|Overall Study|Moved out of study area|1|||
149228086|NCT03137433|538303359|FG001|Overall Study|Moved out of study area|0|||
149228087|NCT03137433|538303358|FG000|Overall Study|Too far out of window due to COVID|0|||
149228088|NCT03137433|538303359|FG001|Overall Study|Too far out of window due to COVID|1|||
149228089|NCT00083616|538303360|FG000|Overall Study|Disease Progression|16|||
149228090|NCT00083616|538303360|FG000|Overall Study|Lost to Follow-up|1|||
149228091|NCT00083616|538303360|FG000|Overall Study|Physician Decision|2|||
149228092|NCT00083616|538303360|FG000|Overall Study|Withdrawal by Subject|3|||
149228093|NCT00083616|538303360|FG000|Overall Study|Ineligibility determined|2|||
149228094|NCT00083616|538303360|FG000|Overall Study|Non-compliance|1|||
149228095|NCT00083616|538303360|FG000|Overall Study|Other|6|||
149228096|NCT01474993|538303364|FG000|Overall Study|Lost to Follow-up|1|||
149228097|NCT01474993|538303365|FG001|Overall Study|Lost to Follow-up|2|||
149228098|NCT01474993|538303364|FG000|Overall Study|Adverse Event|0|||
149228099|NCT01474993|538303365|FG001|Overall Study|Adverse Event|1|||
149228100|NCT01853397|538303366|FG000|Overall Study|Withdrawal by Subject|0|||
149228101|NCT01853397|538303367|FG001|Overall Study|Withdrawal by Subject|0|||
149228102|NCT01853397|538303368|FG002|Overall Study|Withdrawal by Subject|0|||
149228103|NCT01853397|538303369|FG003|Overall Study|Withdrawal by Subject|1|||
149228104|NCT01853397|538303366|FG000|Overall Study|Subject Noncompliance|0|||
149228105|NCT01853397|538303367|FG001|Overall Study|Subject Noncompliance|0|||
149228106|NCT01853397|538303368|FG002|Overall Study|Subject Noncompliance|0|||
149228107|NCT01853397|538303369|FG003|Overall Study|Subject Noncompliance|1|||
149228108|NCT02132312|538303370|FG000|Overall Study|Adverse Event|2|||
149228109|NCT02132312|538303371|FG001|Overall Study|Adverse Event|0|||
149228110|NCT02132312|538303370|FG000|Overall Study|Physician Decision|1|||
149228111|NCT02132312|538303371|FG001|Overall Study|Physician Decision|1|||
149228112|NCT02132312|538303370|FG000|Overall Study|Protocol Violation|0|||
149228113|NCT02132312|538303371|FG001|Overall Study|Protocol Violation|1|||
149228114|NCT02132312|538303370|FG000|Overall Study|Withdrawal by Subject|1|||
149228115|NCT02132312|538303371|FG001|Overall Study|Withdrawal by Subject|0|||
149228116|NCT02132312|538303370|FG000|Overall Study|Lost to Follow-up|2|||
149228117|NCT02132312|538303371|FG001|Overall Study|Lost to Follow-up|1|||
149228118|NCT01632345|538303372|FG000|Treatment: Part I|Adverse Event|1|||
149228119|NCT01632345|538303373|FG001|Treatment: Part I|Adverse Event|4|||
149228120|NCT01632345|538303374|FG002|Treatment: Part I|Adverse Event|2|||
149228121|NCT01632345|538303375|FG003|Treatment: Part I|Adverse Event|1|||
149228122|NCT01632345|538303376|FG004|Treatment: Part I|Adverse Event|3|||
149228123|NCT01632345|538303377|FG005|Treatment: Part I|Adverse Event|0|||
149020186|NCT02718417|537552603|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
149228124|NCT01632345|538303378|FG006|Treatment: Part I|Adverse Event|0|||
149228125|NCT01632345|538303372|FG000|Treatment: Part I|Lack of Efficacy|0|||
149228126|NCT01632345|538303373|FG001|Treatment: Part I|Lack of Efficacy|1|||
149228127|NCT01632345|538303374|FG002|Treatment: Part I|Lack of Efficacy|0|||
149228128|NCT01632345|538303375|FG003|Treatment: Part I|Lack of Efficacy|1|||
149228129|NCT01632345|538303376|FG004|Treatment: Part I|Lack of Efficacy|1|||
149228130|NCT01632345|538303377|FG005|Treatment: Part I|Lack of Efficacy|0|||
149228131|NCT01632345|538303378|FG006|Treatment: Part I|Lack of Efficacy|0|||
149228132|NCT01632345|538303372|FG000|Treatment: Part I|Lost to Follow-up|3|||
149228133|NCT01632345|538303373|FG001|Treatment: Part I|Lost to Follow-up|2|||
149228134|NCT01632345|538303374|FG002|Treatment: Part I|Lost to Follow-up|1|||
149228135|NCT01632345|538303375|FG003|Treatment: Part I|Lost to Follow-up|3|||
149228136|NCT01632345|538303376|FG004|Treatment: Part I|Lost to Follow-up|4|||
149228137|NCT01632345|538303377|FG005|Treatment: Part I|Lost to Follow-up|0|||
149228138|NCT01632345|538303378|FG006|Treatment: Part I|Lost to Follow-up|0|||
149228139|NCT01632345|538303372|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
149228140|NCT01632345|538303373|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
149228141|NCT01632345|538303374|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
149228142|NCT01632345|538303375|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
149228143|NCT01632345|538303376|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
149228144|NCT01632345|538303377|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
149228145|NCT01632345|538303378|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
149228146|NCT01632345|538303372|FG000|Treatment: Part I|Physician Decision|2|||
149228147|NCT01632345|538303373|FG001|Treatment: Part I|Physician Decision|1|||
149228148|NCT01632345|538303374|FG002|Treatment: Part I|Physician Decision|0|||
149228149|NCT01632345|538303375|FG003|Treatment: Part I|Physician Decision|0|||
149228150|NCT01632345|538303376|FG004|Treatment: Part I|Physician Decision|1|||
149228151|NCT01632345|538303377|FG005|Treatment: Part I|Physician Decision|0|||
149228152|NCT01632345|538303378|FG006|Treatment: Part I|Physician Decision|0|||
149228153|NCT01632345|538303372|FG000|Treatment: Part I|Pregnancy|0|||
149228154|NCT01632345|538303373|FG001|Treatment: Part I|Pregnancy|1|||
149228155|NCT01632345|538303374|FG002|Treatment: Part I|Pregnancy|0|||
149228156|NCT01632345|538303375|FG003|Treatment: Part I|Pregnancy|0|||
149228157|NCT01632345|538303376|FG004|Treatment: Part I|Pregnancy|0|||
149228158|NCT01632345|538303377|FG005|Treatment: Part I|Pregnancy|0|||
149228159|NCT01632345|538303378|FG006|Treatment: Part I|Pregnancy|0|||
149228160|NCT01632345|538303372|FG000|Treatment: Part I|Protocol Deviation|0|||
149228161|NCT01632345|538303373|FG001|Treatment: Part I|Protocol Deviation|0|||
149228162|NCT01632345|538303374|FG002|Treatment: Part I|Protocol Deviation|1|||
149228163|NCT01632345|538303375|FG003|Treatment: Part I|Protocol Deviation|1|||
149228164|NCT01632345|538303376|FG004|Treatment: Part I|Protocol Deviation|0|||
149228165|NCT01632345|538303377|FG005|Treatment: Part I|Protocol Deviation|0|||
149228166|NCT01632345|538303378|FG006|Treatment: Part I|Protocol Deviation|0|||
149228167|NCT01632345|538303372|FG000|Treatment: Part I|Withdrawal by Subject|3|||
149228168|NCT01632345|538303373|FG001|Treatment: Part I|Withdrawal by Subject|4|||
149228169|NCT01632345|538303374|FG002|Treatment: Part I|Withdrawal by Subject|4|||
149228170|NCT01632345|538303375|FG003|Treatment: Part I|Withdrawal by Subject|1|||
149228171|NCT01632345|538303376|FG004|Treatment: Part I|Withdrawal by Subject|4|||
149228172|NCT01632345|538303377|FG005|Treatment: Part I|Withdrawal by Subject|0|||
149228173|NCT01632345|538303378|FG006|Treatment: Part I|Withdrawal by Subject|0|||
149228174|NCT01632345|538303372|FG000|Treatment: Part II|Adverse Event|0|||
149228175|NCT01632345|538303373|FG001|Treatment: Part II|Adverse Event|0|||
149228176|NCT01632345|538303374|FG002|Treatment: Part II|Adverse Event|0|||
149228177|NCT01632345|538303375|FG003|Treatment: Part II|Adverse Event|0|||
149228178|NCT01632345|538303376|FG004|Treatment: Part II|Adverse Event|0|||
149228179|NCT01632345|538303377|FG005|Treatment: Part II|Adverse Event|3|||
149228180|NCT01632345|538303378|FG006|Treatment: Part II|Adverse Event|8|||
149228181|NCT01632345|538303372|FG000|Treatment: Part II|Lost to Follow-up|0|||
149228182|NCT01632345|538303373|FG001|Treatment: Part II|Lost to Follow-up|0|||
149228183|NCT01632345|538303374|FG002|Treatment: Part II|Lost to Follow-up|0|||
149228184|NCT01632345|538303375|FG003|Treatment: Part II|Lost to Follow-up|0|||
149228185|NCT01632345|538303376|FG004|Treatment: Part II|Lost to Follow-up|0|||
149228186|NCT01632345|538303377|FG005|Treatment: Part II|Lost to Follow-up|3|||
149228187|NCT01632345|538303378|FG006|Treatment: Part II|Lost to Follow-up|1|||
149228188|NCT01632345|538303372|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
149228189|NCT01632345|538303373|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
149228190|NCT01632345|538303374|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
149228191|NCT01632345|538303375|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
149228192|NCT01632345|538303376|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
149228193|NCT01632345|538303377|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
149228194|NCT01632345|538303378|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
149228195|NCT01632345|538303372|FG000|Treatment: Part II|Withdrawal by Subject|0|||
149228196|NCT01632345|538303373|FG001|Treatment: Part II|Withdrawal by Subject|0|||
149228197|NCT01632345|538303374|FG002|Treatment: Part II|Withdrawal by Subject|0|||
149228198|NCT01632345|538303375|FG003|Treatment: Part II|Withdrawal by Subject|0|||
149228199|NCT01632345|538303376|FG004|Treatment: Part II|Withdrawal by Subject|0|||
149228200|NCT01632345|538303377|FG005|Treatment: Part II|Withdrawal by Subject|2|||
149228201|NCT01632345|538303378|FG006|Treatment: Part II|Withdrawal by Subject|2|||
149228202|NCT00089505|538303379|FG000|Overall Study|Death|4|||
149228203|NCT00089505|538303380|FG001|Overall Study|Death|1|||
149228204|NCT00089505|538303381|FG002|Overall Study|Death|5|||
149228205|NCT00089505|538303382|FG003|Overall Study|Death|8|||
149228206|NCT00089505|538303379|FG000|Overall Study|Withdrawal by Subject|3|||
149228207|NCT00089505|538303380|FG001|Overall Study|Withdrawal by Subject|0|||
149228208|NCT00089505|538303381|FG002|Overall Study|Withdrawal by Subject|6|||
149228209|NCT00089505|538303382|FG003|Overall Study|Withdrawal by Subject|6|||
149228210|NCT00089505|538303379|FG000|Overall Study|Lost to Follow-up|1|||
149228211|NCT00089505|538303380|FG001|Overall Study|Lost to Follow-up|1|||
149228212|NCT00089505|538303381|FG002|Overall Study|Lost to Follow-up|9|||
149228213|NCT00089505|538303382|FG003|Overall Study|Lost to Follow-up|7|||
149228214|NCT00089505|538303379|FG000|Overall Study|Physician Decision|1|||
149228215|NCT00089505|538303380|FG001|Overall Study|Physician Decision|0|||
149228216|NCT00089505|538303381|FG002|Overall Study|Physician Decision|0|||
149228217|NCT00089505|538303382|FG003|Overall Study|Physician Decision|0|||
149228218|NCT00089505|538303379|FG000|Overall Study|Protocol Violation|0|||
149228219|NCT00089505|538303380|FG001|Overall Study|Protocol Violation|0|||
149228220|NCT00089505|538303381|FG002|Overall Study|Protocol Violation|1|||
149228221|NCT00089505|538303382|FG003|Overall Study|Protocol Violation|0|||
149228222|NCT01724021|538303383|FG000|Overall Study|Adverse Event|11|||
149228223|NCT01724021|538303384|FG001|Overall Study|Adverse Event|6|||
149228224|NCT01724021|538303383|FG000|Overall Study|Death|46|||
149228225|NCT01724021|538303384|FG001|Overall Study|Death|58|||
149228226|NCT01724021|538303383|FG000|Overall Study|Participant request/ Withdrew consent|18|||
149228227|NCT01724021|538303384|FG001|Overall Study|Participant request/ Withdrew consent|14|||
149228228|NCT01724021|538303383|FG000|Overall Study|Lost to Follow-up|15|||
149228229|NCT01724021|538303384|FG001|Overall Study|Lost to Follow-up|15|||
149228230|NCT01724021|538303383|FG000|Overall Study|Reason Not Specified|36|||
149228231|NCT01724021|538303384|FG001|Overall Study|Reason Not Specified|39|||
149228232|NCT01724021|538303383|FG000|Overall Study|Missing|1|||
149228233|NCT01724021|538303384|FG001|Overall Study|Missing|1|||
149228234|NCT02543918|538303385|FG000|Overall Study|Never treated|0|||
148688976|NCT01469364|536334230|FG000|Overall Study|Adverse Event|1|||
148688977|NCT01469364|536334230|FG000|Overall Study|Withdrawal by Subject|1|||
148688978|NCT02742090|536334231|FG000|Overall Study|Adverse Event|10|||
148688979|NCT02742090|536334231|FG000|Overall Study|Death|3|||
148688980|NCT02742090|536334231|FG000|Overall Study|Disease Progression|25|||
149228235|NCT02543918|538303386|FG001|Overall Study|Never treated|1|||
149228236|NCT02543918|538303385|FG000|Overall Study|Lost to Follow-up|1|||
149228237|NCT02543918|538303386|FG001|Overall Study|Lost to Follow-up|1|||
149228238|NCT02543918|538303385|FG000|Overall Study|Withdrawal by Subject|1|||
149228239|NCT02543918|538303386|FG001|Overall Study|Withdrawal by Subject|1|||
148688981|NCT02742090|536334231|FG000|Overall Study|Investigator's Decision|1|||
148688982|NCT02742090|536334231|FG000|Overall Study|Lost to Follow-up|1|||
148688983|NCT02742090|536334231|FG000|Overall Study|Non-compliance with Study|1|||
148688984|NCT02742090|536334231|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
148688985|NCT02742090|536334231|FG000|Overall Study|Withdrawal by Subject|4|||
148688986|NCT02742090|536334231|FG000|Overall Study|Reason Not Specified|1|||
148688987|NCT01590433|536334232|FG000|Overall Study|Lost to Follow-up|20|||
148688988|NCT01590433|536334233|FG001|Overall Study|Lost to Follow-up|8|||
148688989|NCT01590433|536334232|FG000|Overall Study|Withdrawal by Subject|21|||
148688990|NCT01590433|536334233|FG001|Overall Study|Withdrawal by Subject|11|||
148688991|NCT01590433|536334232|FG000|Overall Study|Adverse Event|11|||
148688992|NCT01590433|536334233|FG001|Overall Study|Adverse Event|3|||
148688993|NCT00555009|536334234|FG000|Overall Study|Withdrawal by Subject|0|||
148688994|NCT00555009|536334235|FG001|Overall Study|Withdrawal by Subject|1|||
148688995|NCT00555009|536334234|FG000|Overall Study|Terminated by Sponsor|2|||
148688996|NCT00555009|536334235|FG001|Overall Study|Terminated by Sponsor|5|||
148688997|NCT01767597|536334236|FG000|Overall Study|Incomplete intervention|3|||
148688998|NCT01767597|536334237|FG001|Overall Study|Incomplete intervention|1|||
148688999|NCT01767597|536334236|FG000|Overall Study|Withdrawal by Subject|1|||
148689000|NCT01767597|536334237|FG001|Overall Study|Withdrawal by Subject|0|||
148689001|NCT03355742|536334238|FG000|Overall Study|Lost to Follow-up|4|||
148689002|NCT03355742|536334238|FG000|Overall Study|Withdrawal by Subject|29|||
149228240|NCT02543918|538303385|FG000|Overall Study|Adverse Event|1|||
149228241|NCT02543918|538303386|FG001|Overall Study|Adverse Event|1|||
149228242|NCT01005875|538303389|FG000|Overall Study|Death|3|||
148689003|NCT03355742|536334238|FG000|Overall Study|Physician Decision|6|||
148689004|NCT03355742|536334238|FG000|Overall Study|Death|55|||
149228243|NCT00606931|538303392|FG000|Overall Study|Withdrawal by Subject|3|||
149228244|NCT00266695|538303396|FG000|Overall Study|Adverse Event|1|||
149228245|NCT00266695|538303396|FG000|Overall Study|Death|9|||
149228246|NCT00266695|538303396|FG000|Overall Study|Physician Decision|1|||
149228247|NCT00266695|538303396|FG000|Overall Study|Lost to Follow-up|3|||
149228248|NCT00266695|538303396|FG000|Overall Study|Withdrawal by Subject|15|||
148689005|NCT03355742|536334238|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
149228249|NCT02380703|538303397|FG000|Overall Study|Withdrawal by Subject|12|||
148689006|NCT00836927|536334241|FG000|Overall Study|Progressive disease|2|||
148689007|NCT00836927|536334242|FG001|Overall Study|Progressive disease|0|||
149228250|NCT02380703|538303398|FG001|Overall Study|Withdrawal by Subject|9|||
149228251|NCT02380703|538303397|FG000|Overall Study|Lost to Follow-up|12|||
149228252|NCT02380703|538303398|FG001|Overall Study|Lost to Follow-up|12|||
149228253|NCT02380703|538303397|FG000|Overall Study|Caregiver death|1|||
149228254|NCT02380703|538303398|FG001|Overall Study|Caregiver death|0|||
149228255|NCT02380703|538303397|FG000|Overall Study|Person with dementia (PWD) death|7|||
149228256|NCT02380703|538303398|FG001|Overall Study|Person with dementia (PWD) death|8|||
149228257|NCT02380703|538303397|FG000|Overall Study|Entered Long-term Care|4|||
149228258|NCT02380703|538303398|FG001|Overall Study|Entered Long-term Care|7|||
149228259|NCT04490499|538303399|FG000|Overall Study|Withdrawal by Subject|2|||
149228260|NCT01843933|538303402|FG000|Overall Study|Data lost|6|||
149228261|NCT01843933|538303403|FG001|Overall Study|Data lost|4|||
149228262|NCT02694562|538303404|FG000|Overall Study|Death|8|||
149228263|NCT02694562|538303404|FG000|Overall Study|Protocol Violation|4|||
149228264|NCT02694562|538303404|FG000|Overall Study|Lost to Follow-up|3|||
149228265|NCT02694562|538303404|FG000|Overall Study|Screen Failure|2|||
149228266|NCT02694562|538303404|FG000|Overall Study|Physician Decision|1|||
149228267|NCT01373294|538303405|FG000|Overall Study|Adverse Event|1|||
149228268|NCT01373294|538303406|FG001|Overall Study|Adverse Event|0|||
149228269|NCT00554229|538303414|FG000|Overall Study|Lost to Follow-up|3|||
149228270|NCT00554229|538303415|FG001|Overall Study|Lost to Follow-up|6|||
149228271|NCT00554229|538303414|FG000|Overall Study|Withdrawal by Subject|29|||
149228272|NCT00554229|538303415|FG001|Overall Study|Withdrawal by Subject|37|||
149228273|NCT00554229|538303414|FG000|Overall Study|Adverse Event|71|||
149228274|NCT00554229|538303415|FG001|Overall Study|Adverse Event|39|||
149228275|NCT00554229|538303414|FG000|Overall Study|Protocol Violation|3|||
149228276|NCT00554229|538303415|FG001|Overall Study|Protocol Violation|3|||
148689008|NCT00836927|536334243|FG002|Overall Study|Progressive disease|0|||
148689009|NCT00836927|536334244|FG003|Overall Study|Progressive disease|1|||
149228277|NCT00554229|538303414|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
149228278|NCT00554229|538303415|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
149228279|NCT00554229|538303414|FG000|Overall Study|Randomised but no treatment received|1|||
149228280|NCT00554229|538303415|FG001|Overall Study|Randomised but no treatment received|0|||
149228281|NCT00877929|538303416|FG000|Overall Study|Adverse Event|11|||
149228282|NCT00877929|538303417|FG001|Overall Study|Adverse Event|20|||
149228283|NCT00877929|538303416|FG000|Overall Study|Protocol Violation|3|||
149228284|NCT00877929|538303417|FG001|Overall Study|Protocol Violation|3|||
149228285|NCT00877929|538303416|FG000|Overall Study|Lost to Follow-up|0|||
149228286|NCT00877929|538303417|FG001|Overall Study|Lost to Follow-up|1|||
149228287|NCT00877929|538303416|FG000|Overall Study|Withdrawal by Subject|4|||
149228288|NCT00877929|538303417|FG001|Overall Study|Withdrawal by Subject|4|||
149228289|NCT00877929|538303416|FG000|Overall Study|Lack of Efficacy|0|||
149228290|NCT00877929|538303417|FG001|Overall Study|Lack of Efficacy|1|||
149228291|NCT00877929|538303416|FG000|Overall Study|Other reason (not specified)|2|||
149228292|NCT00877929|538303417|FG001|Overall Study|Other reason (not specified)|6|||
149228293|NCT01140646|538303418|FG000|Overall Study|Adverse Event|4|||
149228294|NCT01140646|538303418|FG000|Overall Study|Refused Further Treatment|5|||
149228295|NCT00784836|538303426|FG000|Overall Study|Early Study Termination|3|||
149228296|NCT02612194|538303430|FG000|Overall Study|Death|5|||
149228297|NCT02612194|538303431|FG001|Overall Study|Death|0|||
149228298|NCT02612194|538303432|FG002|Overall Study|Death|2|||
149228299|NCT02612194|538303430|FG000|Overall Study|Early Study Termination|1|||
149228300|NCT02612194|538303431|FG001|Overall Study|Early Study Termination|0|||
149228301|NCT02612194|538303432|FG002|Overall Study|Early Study Termination|0|||
149228302|NCT02539160|538303433|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
149228303|NCT02539160|538303434|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
149228304|NCT02539160|538303435|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
149228305|NCT02539160|538303436|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
149228306|NCT02539160|538303433|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
149228307|NCT02539160|538303434|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
149228308|NCT02539160|538303435|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
149228309|NCT02539160|538303436|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
149228310|NCT02539160|538303433|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
149228311|NCT02539160|538303434|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
149228312|NCT02539160|538303435|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
149228313|NCT02539160|538303436|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
149228314|NCT01681004|538303437|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
149228315|NCT01681004|538303438|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
148689010|NCT00836927|536334245|FG004|Overall Study|Progressive disease|1|||
149228316|NCT01681004|538303437|FG000|Study Completion|Lost to Follow-up|8|||
149228317|NCT01681004|538303438|FG001|Study Completion|Lost to Follow-up|3|||
149228318|NCT01681004|538303437|FG000|Study Completion|Physician Decision|1|||
149228319|NCT01681004|538303438|FG001|Study Completion|Physician Decision|3|||
149228320|NCT01681004|538303437|FG000|Study Completion|Site Termination|2|||
149228321|NCT01681004|538303438|FG001|Study Completion|Site Termination|1|||
148689011|NCT00836927|536334241|FG000|Overall Study|Withdrawal by Subject|1|||
148689012|NCT00836927|536334242|FG001|Overall Study|Withdrawal by Subject|0|||
148689013|NCT00836927|536334243|FG002|Overall Study|Withdrawal by Subject|0|||
148689014|NCT00836927|536334244|FG003|Overall Study|Withdrawal by Subject|0|||
148689015|NCT00836927|536334245|FG004|Overall Study|Withdrawal by Subject|0|||
148689016|NCT00614055|536334249|FG000|Overall Study|Adverse Event|1|||
148689017|NCT00614055|536334250|FG001|Overall Study|Adverse Event|0|||
148689018|NCT00614055|536334251|FG002|Overall Study|Adverse Event|0|||
148689019|NCT00614055|536334249|FG000|Overall Study|Protocol Violation|2|||
148689020|NCT00614055|536334250|FG001|Overall Study|Protocol Violation|2|||
148689021|NCT00614055|536334251|FG002|Overall Study|Protocol Violation|1|||
148689022|NCT00614055|536334249|FG000|Overall Study|Lack of Efficacy|0|||
148689023|NCT00614055|536334250|FG001|Overall Study|Lack of Efficacy|0|||
148689024|NCT00614055|536334251|FG002|Overall Study|Lack of Efficacy|2|||
148689025|NCT00614055|536334249|FG000|Overall Study|Unclassified|1|||
148689026|NCT00614055|536334250|FG001|Overall Study|Unclassified|4|||
148689027|NCT00614055|536334251|FG002|Overall Study|Unclassified|2|||
148689028|NCT02637557|536334256|FG000|Overall Study|Adverse Event|3|||
148689029|NCT02637557|536334257|FG001|Overall Study|Adverse Event|1|||
148689030|NCT02637557|536334258|FG002|Overall Study|Adverse Event|3|||
148689031|NCT02637557|536334259|FG003|Overall Study|Adverse Event|3|||
148689032|NCT02637557|536334256|FG000|Overall Study|Lost to Follow-up|1|||
148689033|NCT02637557|536334257|FG001|Overall Study|Lost to Follow-up|1|||
148689034|NCT02637557|536334258|FG002|Overall Study|Lost to Follow-up|0|||
148689035|NCT02637557|536334259|FG003|Overall Study|Lost to Follow-up|1|||
148689036|NCT02637557|536334256|FG000|Overall Study|Physician Decision|1|||
148689037|NCT02637557|536334257|FG001|Overall Study|Physician Decision|0|||
148689038|NCT02637557|536334258|FG002|Overall Study|Physician Decision|0|||
148689039|NCT02637557|536334259|FG003|Overall Study|Physician Decision|0|||
148689040|NCT02637557|536334256|FG000|Overall Study|Protocol Violation|2|||
148689041|NCT02637557|536334257|FG001|Overall Study|Protocol Violation|0|||
148689042|NCT02637557|536334258|FG002|Overall Study|Protocol Violation|2|||
148689043|NCT02637557|536334259|FG003|Overall Study|Protocol Violation|1|||
148689044|NCT02637557|536334256|FG000|Overall Study|Withdrawal by Subject|1|||
148689045|NCT02637557|536334257|FG001|Overall Study|Withdrawal by Subject|3|||
148689046|NCT02637557|536334258|FG002|Overall Study|Withdrawal by Subject|4|||
148689047|NCT02637557|536334259|FG003|Overall Study|Withdrawal by Subject|2|||
148689048|NCT00634907|536334262|FG000|Overall Study|Withdrawal by Subject|3|||
148689049|NCT00634907|536334263|FG001|Overall Study|Withdrawal by Subject|0|||
148689050|NCT00634907|536334262|FG000|Overall Study|Physician Decision|3|||
148689051|NCT00634907|536334263|FG001|Overall Study|Physician Decision|9|||
148689052|NCT00634907|536334262|FG000|Overall Study|Withdrawal by Subject|11|||
148689053|NCT00634907|536334263|FG001|Overall Study|Withdrawal by Subject|8|||
148689054|NCT04041570|536334264|FG000|Overall Study|Moved from Area|0|||
148689055|NCT04041570|536334265|FG001|Overall Study|Moved from Area|2|||
148689056|NCT01338636|536334266|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
148689057|NCT02385526|536334267|FG000|Overall Study|Withdrawal by Subject|0|||
148689058|NCT02385526|536334268|FG001|Overall Study|Withdrawal by Subject|2|||
148689059|NCT02385526|536334269|FG002|Overall Study|Withdrawal by Subject|0|||
148689060|NCT02385526|536334267|FG000|Overall Study|Lost to Follow-up|0|||
148689061|NCT02385526|536334268|FG001|Overall Study|Lost to Follow-up|1|||
148689062|NCT02385526|536334269|FG002|Overall Study|Lost to Follow-up|0|||
148689063|NCT02385526|536334267|FG000|Overall Study|Physician Decision|1|||
148689064|NCT02385526|536334268|FG001|Overall Study|Physician Decision|0|||
148689065|NCT02385526|536334269|FG002|Overall Study|Physician Decision|0|||
148689066|NCT02385526|536334267|FG000|Overall Study|Protocol Violation|1|||
148689067|NCT02385526|536334268|FG001|Overall Study|Protocol Violation|0|||
148689068|NCT02385526|536334269|FG002|Overall Study|Protocol Violation|0|||
148689069|NCT03532009|536334272|FG000|Overall Study|Other|1|||
148689070|NCT03532009|536334273|FG001|Overall Study|Other|1|||
148689071|NCT03532009|536334272|FG000|Overall Study|Death|1|||
148689072|NCT03532009|536334273|FG001|Overall Study|Death|1|||
148689073|NCT03532009|536334272|FG000|Overall Study|Withdrawal by Patient|0|||
148689074|NCT03532009|536334273|FG001|Overall Study|Withdrawal by Patient|2|||
148689075|NCT02866175|536334278|FG000|Overall Study|Adverse Event|56|||
148689076|NCT02866175|536334279|FG001|Overall Study|Adverse Event|54|||
148689077|NCT02866175|536334278|FG000|Overall Study|Withdrawal by Subject|31|||
148689078|NCT02866175|536334279|FG001|Overall Study|Withdrawal by Subject|52|||
148689079|NCT02866175|536334278|FG000|Overall Study|Death|30|||
148689080|NCT02866175|536334279|FG001|Overall Study|Death|23|||
148689081|NCT02866175|536334278|FG000|Overall Study|Other|7|||
148689082|NCT02866175|536334279|FG001|Overall Study|Other|14|||
148689083|NCT02866175|536334278|FG000|Overall Study|Progressive disease|1|||
148689084|NCT02866175|536334279|FG001|Overall Study|Progressive disease|1|||
148689085|NCT02866175|536334278|FG000|Overall Study|Lost to Follow-up|2|||
148954290|NCT00640601|537314755|FG000|Overall Study|Withdrawal by Subject|20|||
148689086|NCT02866175|536334279|FG001|Overall Study|Lost to Follow-up|0|||
148689087|NCT02866175|536334278|FG000|Overall Study|Lack of Efficacy|0|||
148689088|NCT02866175|536334279|FG001|Overall Study|Lack of Efficacy|1|||
148689089|NCT02866175|536334278|FG000|Overall Study|Physician Decision|3|||
148689090|NCT02866175|536334279|FG001|Overall Study|Physician Decision|15|||
148689091|NCT02866175|536334278|FG000|Overall Study|Did not receive treatment|5|||
148689092|NCT02866175|536334279|FG001|Overall Study|Did not receive treatment|15|||
148689093|NCT01694485|536334280|FG000|Overall Study|Withdrawal by Subject|20|||
148689094|NCT01694485|536334281|FG001|Overall Study|Withdrawal by Subject|6|||
148689095|NCT01694485|536334282|FG002|Overall Study|Withdrawal by Subject|7|||
148689096|NCT01694485|536334283|FG003|Overall Study|Withdrawal by Subject|25|||
148689097|NCT01694485|536334284|FG004|Overall Study|Withdrawal by Subject|18|||
148689098|NCT01694485|536334280|FG000|Overall Study|Sponsor Decision|3|||
148689099|NCT01694485|536334281|FG001|Overall Study|Sponsor Decision|0|||
148689100|NCT01694485|536334282|FG002|Overall Study|Sponsor Decision|0|||
148689101|NCT01694485|536334283|FG003|Overall Study|Sponsor Decision|2|||
148689102|NCT01694485|536334284|FG004|Overall Study|Sponsor Decision|0|||
148689103|NCT01694485|536334280|FG000|Overall Study|Lost to Follow-up|9|||
148689104|NCT01694485|536334281|FG001|Overall Study|Lost to Follow-up|1|||
148689105|NCT01694485|536334282|FG002|Overall Study|Lost to Follow-up|6|||
148689106|NCT01694485|536334283|FG003|Overall Study|Lost to Follow-up|10|||
148689107|NCT01694485|536334284|FG004|Overall Study|Lost to Follow-up|7|||
148689108|NCT01694485|536334280|FG000|Overall Study|Death|1|||
148689109|NCT01694485|536334281|FG001|Overall Study|Death|0|||
148689110|NCT01694485|536334282|FG002|Overall Study|Death|0|||
148689111|NCT01694485|536334283|FG003|Overall Study|Death|1|||
148689112|NCT01694485|536334284|FG004|Overall Study|Death|0|||
148689113|NCT02907203|536334285|FG000|Overall Study|Death|1|||
148689114|NCT02907203|536334285|FG000|Overall Study|Lost to Follow-up|3|||
148689115|NCT02907203|536334285|FG000|Overall Study|Withdrawal by Subject|3|||
148689116|NCT02907203|536334285|FG000|Overall Study|Surgical bypass|1|||
148689117|NCT00681863|536334287|FG000|Overall Study|Adverse Event|1|||
148689118|NCT00681863|536334287|FG000|Overall Study|Lost to Follow-up|2|||
148689119|NCT00681863|536334287|FG000|Overall Study|Lack of Efficacy|2|||
148689120|NCT00681863|536334287|FG000|Overall Study|Other|18|||
148689121|NCT00384033|536334297|FG000|Overall Study|Adverse Event|10|||
148689122|NCT00384033|536334298|FG001|Overall Study|Adverse Event|8|||
148689123|NCT00384033|536334299|FG002|Overall Study|Adverse Event|11|||
148689124|NCT00384033|536334300|FG003|Overall Study|Adverse Event|20|||
148689125|NCT00384033|536334297|FG000|Overall Study|Failed to return|1|||
148689126|NCT00384033|536334298|FG001|Overall Study|Failed to return|3|||
148689127|NCT00384033|536334299|FG002|Overall Study|Failed to return|2|||
148689128|NCT00384033|536334300|FG003|Overall Study|Failed to return|2|||
148689129|NCT00384033|536334297|FG000|Overall Study|Physician Decision|1|||
148689130|NCT00384033|536334298|FG001|Overall Study|Physician Decision|0|||
148689131|NCT00384033|536334299|FG002|Overall Study|Physician Decision|0|||
148689132|NCT00384033|536334300|FG003|Overall Study|Physician Decision|0|||
148689133|NCT00384033|536334297|FG000|Overall Study|Lost to Follow-up|6|||
148689134|NCT00384033|536334298|FG001|Overall Study|Lost to Follow-up|12|||
148689135|NCT00384033|536334299|FG002|Overall Study|Lost to Follow-up|7|||
148689136|NCT00384033|536334300|FG003|Overall Study|Lost to Follow-up|7|||
148689137|NCT00384033|536334297|FG000|Overall Study|Other|2|||
148689138|NCT00384033|536334298|FG001|Overall Study|Other|0|||
148689139|NCT00384033|536334299|FG002|Overall Study|Other|0|||
148689140|NCT00384033|536334300|FG003|Overall Study|Other|0|||
148689141|NCT00384033|536334297|FG000|Overall Study|Protocol Violation|5|||
148689142|NCT00384033|536334298|FG001|Overall Study|Protocol Violation|0|||
148689143|NCT00384033|536334299|FG002|Overall Study|Protocol Violation|5|||
148689144|NCT00384033|536334300|FG003|Overall Study|Protocol Violation|6|||
148689145|NCT00384033|536334297|FG000|Overall Study|Withdrawal by Subject|6|||
148689146|NCT00384033|536334298|FG001|Overall Study|Withdrawal by Subject|2|||
148689147|NCT00384033|536334299|FG002|Overall Study|Withdrawal by Subject|5|||
148689148|NCT00384033|536334300|FG003|Overall Study|Withdrawal by Subject|2|||
148689149|NCT00384033|536334297|FG000|Overall Study|Lack of Efficacy|7|||
148689150|NCT00384033|536334298|FG001|Overall Study|Lack of Efficacy|3|||
148689151|NCT00384033|536334299|FG002|Overall Study|Lack of Efficacy|3|||
148689152|NCT00384033|536334300|FG003|Overall Study|Lack of Efficacy|1|||
148689153|NCT00384033|536334297|FG000|Overall Study|Randomized but not treated|3|||
148689154|NCT00384033|536334298|FG001|Overall Study|Randomized but not treated|7|||
148689155|NCT00384033|536334299|FG002|Overall Study|Randomized but not treated|10|||
148689156|NCT00384033|536334300|FG003|Overall Study|Randomized but not treated|2|||
148689157|NCT01388647|536334301|FG000|Overall Study|Adverse Event|1|||
148689158|NCT01388647|536334302|FG001|Overall Study|Adverse Event|2|||
148689159|NCT01006707|536334304|FG000|Study Session 1|Lost to Follow-up|2|||
148689160|NCT01006707|536334305|FG001|Study Session 1|Lost to Follow-up|0|||
148689161|NCT01006707|536334306|FG002|Study Session 1|Lost to Follow-up|0|||
148689162|NCT01006707|536334304|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
148689163|NCT01006707|536334305|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
148689164|NCT01006707|536334306|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
148689165|NCT00952484|536334307|FG000|Overall Study|Withdrawal by Subject|0|||
148689166|NCT00952484|536334308|FG001|Overall Study|Withdrawal by Subject|1|||
148689167|NCT00952484|536334309|FG002|Overall Study|Withdrawal by Subject|0|||
148689168|NCT02750306|536334310|FG000|Overall Study|Withdrawal by Subject|5|||
148689169|NCT02750306|536334311|FG001|Overall Study|Withdrawal by Subject|2|||
148689170|NCT02750306|536334310|FG000|Overall Study|Protocol Violation|1|||
148689171|NCT02750306|536334311|FG001|Overall Study|Protocol Violation|0|||
148689172|NCT00760383|536334313|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
148689173|NCT00760383|536334314|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
148689174|NCT00192296|536334316|FG000|Overall Study|Withdrawal by Subject|0|||
148689175|NCT00192296|536334317|FG001|Overall Study|Withdrawal by Subject|1|||
148689176|NCT00192296|536334318|FG002|Overall Study|Withdrawal by Subject|0|||
148689177|NCT00192296|536334319|FG003|Overall Study|Withdrawal by Subject|0|||
148689178|NCT01842958|536334320|FG000|Overall Study|Lost to Follow-up|1|||
148689179|NCT01842958|536334321|FG001|Overall Study|Lost to Follow-up|1|||
148689180|NCT01829477|536334322|FG000|Overall Study|Study Terminated by Sponsor|15|||
148689181|NCT01829477|536334323|FG001|Overall Study|Study Terminated by Sponsor|15|||
148689182|NCT01829477|536334322|FG000|Overall Study|Withdrawal by Subject|1|||
148689183|NCT01829477|536334323|FG001|Overall Study|Withdrawal by Subject|0|||
148689184|NCT01336894|536334325|FG000|Follow-up|Study terminated prematurely|2|||
148689185|NCT01336894|536334326|FG001|Follow-up|Study terminated prematurely|7|||
148689186|NCT00299156|536334329|FG000|Period 2 (Randomized)|Screen Failure|0|||
148689187|NCT00299156|536334330|FG001|Period 2 (Randomized)|Screen Failure|1|||
148689188|NCT00299156|536334331|FG002|Period 2 (Randomized)|Screen Failure|0|||
148689189|NCT01725451|536334332|FG000|Period 1|Withdrawal by Subject|1|||
148810236|NCT00879658|536782597|FG001|Overall Study|Adverse Event|4|||
148810237|NCT00879658|536782598|FG002|Overall Study|Adverse Event|3|||
148810238|NCT00879658|536782599|FG003|Overall Study|Adverse Event|1|||
148810239|NCT00879658|536782600|FG004|Overall Study|Adverse Event|2|||
149228322|NCT01681004|538303437|FG000|Study Completion|Death|1|||
149228323|NCT01681004|538303438|FG001|Study Completion|Death|1|||
149228324|NCT00372905|538303439|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
149228325|NCT00372905|538303440|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
149228326|NCT00372905|538303441|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
149228327|NCT00372905|538303442|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
149228328|NCT00372905|538303439|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
149228329|NCT00372905|538303440|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
149228330|NCT00372905|538303441|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
149228331|NCT00372905|538303442|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
149228332|NCT00372905|538303439|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
149228333|NCT00372905|538303440|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
149228334|NCT00372905|538303441|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
149228335|NCT00372905|538303442|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
149228336|NCT00372905|538303439|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
149228337|NCT00372905|538303440|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
149228338|NCT00372905|538303441|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
149228339|NCT00372905|538303442|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
149228340|NCT00372905|538303439|FG000|Follow up Until Relapse or Progression|Study closed|0|||
149228341|NCT00372905|538303440|FG001|Follow up Until Relapse or Progression|Study closed|0|||
149228342|NCT00372905|538303441|FG002|Follow up Until Relapse or Progression|Study closed|0|||
149228343|NCT00372905|538303442|FG003|Follow up Until Relapse or Progression|Study closed|3|||
149228344|NCT00372905|538303439|FG000|Follow up Until Relapse or Progression|Other|0|||
149228345|NCT00372905|538303440|FG001|Follow up Until Relapse or Progression|Other|1|||
149228346|NCT00372905|538303441|FG002|Follow up Until Relapse or Progression|Other|0|||
149228347|NCT00372905|538303442|FG003|Follow up Until Relapse or Progression|Other|0|||
149228348|NCT00434876|538303445|FG000|Overall Study|Lost to Follow-up|1|||
149228349|NCT00434876|538303446|FG001|Overall Study|Lost to Follow-up|1|||
149228350|NCT03726320|538304981|FG000|Overall Study|Lost to Follow-up|2|||
149228351|NCT03726320|538304982|FG001|Overall Study|Lost to Follow-up|4|||
149228352|NCT03726320|538304983|FG002|Overall Study|Lost to Follow-up|0|||
149228353|NCT03726320|538304981|FG000|Overall Study|Time Constraints|4|||
148689190|NCT01725451|536334333|FG001|Period 1|Withdrawal by Subject|0|||
148689191|NCT01725451|536334334|FG002|Period 1|Withdrawal by Subject|0|||
148954291|NCT00640601|537314755|FG000|Overall Study|Protocol Violation|6|||
148689192|NCT01725451|536334335|FG003|Period 1|Withdrawal by Subject|0|||
148689193|NCT01725451|536334332|FG000|Washout From Period 3|Protocol Violation|0|||
148689194|NCT01725451|536334333|FG001|Washout From Period 3|Protocol Violation|0|||
148810240|NCT00879658|536782601|FG005|Overall Study|Adverse Event|0|||
149228354|NCT03726320|538304982|FG001|Overall Study|Time Constraints|1|||
149228355|NCT03726320|538304983|FG002|Overall Study|Time Constraints|0|||
149228356|NCT03726320|538304981|FG000|Overall Study|Ineligible after enrollment|3|||
149228357|NCT03726320|538304982|FG001|Overall Study|Ineligible after enrollment|3|||
149228358|NCT03726320|538304983|FG002|Overall Study|Ineligible after enrollment|0|||
149228359|NCT03726320|538304981|FG000|Overall Study|Clinic / insurance issue|2|||
149228360|NCT03726320|538304982|FG001|Overall Study|Clinic / insurance issue|0|||
149228361|NCT03726320|538304983|FG002|Overall Study|Clinic / insurance issue|0|||
149228362|NCT03726320|538304981|FG000|Overall Study|Language barrier|1|||
149228363|NCT03726320|538304982|FG001|Overall Study|Language barrier|0|||
148689195|NCT01725451|536334334|FG002|Washout From Period 3|Protocol Violation|1|||
148810241|NCT00879658|536782602|FG006|Overall Study|Adverse Event|0|||
148689196|NCT01725451|536334335|FG003|Washout From Period 3|Protocol Violation|0|||
148689197|NCT01725451|536334332|FG000|Washout From Period 3|Adverse Event|0|||
148689198|NCT01725451|536334333|FG001|Washout From Period 3|Adverse Event|1|||
148689199|NCT01725451|536334334|FG002|Washout From Period 3|Adverse Event|0|||
148689200|NCT01725451|536334335|FG003|Washout From Period 3|Adverse Event|0|||
148689201|NCT01725451|536334332|FG000|Period 4|Adverse Event|0|||
148689202|NCT01725451|536334333|FG001|Period 4|Adverse Event|0|||
148689203|NCT01725451|536334334|FG002|Period 4|Adverse Event|1|||
148689204|NCT01725451|536334335|FG003|Period 4|Adverse Event|0|||
148689205|NCT00903383|536334342|FG000|Overall Study|Adverse Event|1|||
148689206|NCT00903383|536334343|FG001|Overall Study|Adverse Event|2|||
148689207|NCT00903383|536334344|FG002|Overall Study|Adverse Event|3|||
148689208|NCT00903383|536334345|FG003|Overall Study|Adverse Event|1|||
148689209|NCT00903383|536334342|FG000|Overall Study|Physician Decision|1|||
148689210|NCT00903383|536334343|FG001|Overall Study|Physician Decision|2|||
148689211|NCT00903383|536334344|FG002|Overall Study|Physician Decision|0|||
149228364|NCT03726320|538304983|FG002|Overall Study|Language barrier|0|||
149228365|NCT03726320|538304981|FG000|Overall Study|Provider left the clinic|0|||
149228366|NCT03726320|538304982|FG001|Overall Study|Provider left the clinic|0|||
149228367|NCT03726320|538304983|FG002|Overall Study|Provider left the clinic|1|||
149228368|NCT01684930|538304986|FG000|Overall Study|Withdrawal by Subject|3|||
149228369|NCT01684930|538304987|FG001|Overall Study|Withdrawal by Subject|1|||
149228370|NCT00337935|538304988|FG000|Overall Study|Adverse Event|2|||
149228371|NCT00337935|538304989|FG001|Overall Study|Adverse Event|5|||
149228372|NCT00337935|538304988|FG000|Overall Study|Death|2|||
149228373|NCT00337935|538304989|FG001|Overall Study|Death|8|||
149228374|NCT00337935|538304988|FG000|Overall Study|Physician Decision|1|||
149228375|NCT00337935|538304989|FG001|Overall Study|Physician Decision|1|||
149228376|NCT00337935|538304988|FG000|Overall Study|Lost to Follow-up|0|||
149228377|NCT00337935|538304989|FG001|Overall Study|Lost to Follow-up|1|||
149228378|NCT00337935|538304988|FG000|Overall Study|Protocol Violation|4|||
149228379|NCT00337935|538304989|FG001|Overall Study|Protocol Violation|3|||
149228380|NCT00337935|538304988|FG000|Overall Study|Withdrawal by Subject|1|||
149228381|NCT00337935|538304989|FG001|Overall Study|Withdrawal by Subject|7|||
149228382|NCT00337935|538304988|FG000|Overall Study|Other|0|||
149228383|NCT00337935|538304989|FG001|Overall Study|Other|1|||
149228384|NCT00337935|538304988|FG000|Overall Study|Lack of Efficacy|0|||
149228385|NCT00337935|538304989|FG001|Overall Study|Lack of Efficacy|1|||
149228386|NCT01884675|538304990|FG000|Overall Study|Study closed/terminated|3|||
149228387|NCT01884675|538304991|FG001|Overall Study|Study closed/terminated|2|||
149228388|NCT02361307|538304992|FG000|Overall Study|Unstable medical condition.|0|||
149228389|NCT02361307|538304993|FG001|Overall Study|Unstable medical condition.|1|||
149228390|NCT01336647|538304996|FG000|Overall Study|Lost to Follow-up|4|||
149228391|NCT01336647|538304997|FG001|Overall Study|Lost to Follow-up|1|||
149228392|NCT01336647|538304998|FG002|Overall Study|Lost to Follow-up|3|||
149228393|NCT01004822|538304999|FG000|Overall Study|Objective progression or relapse|3|||
149228394|NCT01004822|538305000|FG001|Overall Study|Objective progression or relapse|3|||
149228395|NCT01004822|538305001|FG002|Overall Study|Objective progression or relapse|0|||
149228396|NCT01004822|538305002|FG003|Overall Study|Objective progression or relapse|1|||
149228397|NCT01004822|538305003|FG004|Overall Study|Objective progression or relapse|2|||
149228398|NCT01004822|538305004|FG005|Overall Study|Objective progression or relapse|2|||
149228399|NCT01004822|538305005|FG006|Overall Study|Objective progression or relapse|1|||
149228400|NCT01004822|538305006|FG007|Overall Study|Objective progression or relapse|4|||
149228401|NCT01004822|538304999|FG000|Overall Study|Global deterioration of health status|0|||
149228402|NCT01004822|538305000|FG001|Overall Study|Global deterioration of health status|0|||
149228403|NCT01004822|538305001|FG002|Overall Study|Global deterioration of health status|0|||
149228404|NCT01004822|538305002|FG003|Overall Study|Global deterioration of health status|1|||
149228405|NCT01004822|538305003|FG004|Overall Study|Global deterioration of health status|0|||
149228406|NCT01004822|538305004|FG005|Overall Study|Global deterioration of health status|0|||
149228407|NCT01004822|538305005|FG006|Overall Study|Global deterioration of health status|1|||
149228408|NCT01004822|538305006|FG007|Overall Study|Global deterioration of health status|0|||
149228409|NCT01004822|538304999|FG000|Overall Study|No longer willing to continue|0|||
149228410|NCT01004822|538305000|FG001|Overall Study|No longer willing to continue|0|||
149228411|NCT01004822|538305001|FG002|Overall Study|No longer willing to continue|0|||
149228412|NCT01004822|538305002|FG003|Overall Study|No longer willing to continue|1|||
149228413|NCT01004822|538305003|FG004|Overall Study|No longer willing to continue|2|||
149228414|NCT01004822|538305004|FG005|Overall Study|No longer willing to continue|1|||
149228415|NCT01004822|538305005|FG006|Overall Study|No longer willing to continue|1|||
148689212|NCT00903383|536334345|FG003|Overall Study|Physician Decision|0|||
148689213|NCT00903383|536334342|FG000|Overall Study|Lost to Follow-up|0|||
148810242|NCT00879658|536782596|FG000|Overall Study|Protocol Violation|1|||
149228416|NCT01004822|538305006|FG007|Overall Study|No longer willing to continue|0|||
149228417|NCT01004822|538304999|FG000|Overall Study|Adverse Event|0|||
148689214|NCT00903383|536334343|FG001|Overall Study|Lost to Follow-up|0|||
148689215|NCT00903383|536334344|FG002|Overall Study|Lost to Follow-up|0|||
148689216|NCT00903383|536334345|FG003|Overall Study|Lost to Follow-up|1|||
148954292|NCT00640601|537314755|FG000|Overall Study|Lack of Efficacy|16|||
148954293|NCT00640601|537314755|FG000|Overall Study|Lost to Follow-up|9|||
149228418|NCT01004822|538305000|FG001|Overall Study|Adverse Event|0|||
149228419|NCT01004822|538305001|FG002|Overall Study|Adverse Event|0|||
149228420|NCT01004822|538305002|FG003|Overall Study|Adverse Event|0|||
149228421|NCT01004822|538305003|FG004|Overall Study|Adverse Event|0|||
149228422|NCT01004822|538305004|FG005|Overall Study|Adverse Event|0|||
149228423|NCT01004822|538305005|FG006|Overall Study|Adverse Event|1|||
149228424|NCT01004822|538305006|FG007|Overall Study|Adverse Event|1|||
149228425|NCT01004822|538304999|FG000|Overall Study|Other|0|||
149228426|NCT01004822|538305000|FG001|Overall Study|Other|0|||
149228427|NCT01004822|538305001|FG002|Overall Study|Other|4|||
149228428|NCT01004822|538305002|FG003|Overall Study|Other|1|||
149228429|NCT01004822|538305003|FG004|Overall Study|Other|0|||
149228430|NCT01004822|538305004|FG005|Overall Study|Other|1|||
149228431|NCT01004822|538305005|FG006|Overall Study|Other|0|||
149228432|NCT01004822|538305006|FG007|Overall Study|Other|0|||
149228433|NCT01858701|538305007|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
149228434|NCT01858701|538305008|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
149228435|NCT01858701|538305007|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
149228436|NCT01858701|538305008|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
149228437|NCT01858701|538305007|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
149228438|NCT01858701|538305008|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
149228439|NCT01858701|538305007|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
149228440|NCT01858701|538305008|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
149228441|NCT01801475|538305015|FG000|Overall Study|Withdrawal by Subject|0|||
149228442|NCT01801475|538305016|FG001|Overall Study|Withdrawal by Subject|0|||
149228443|NCT01801475|538305017|FG002|Overall Study|Withdrawal by Subject|0|||
149228444|NCT01801475|538305018|FG003|Overall Study|Withdrawal by Subject|0|||
149228445|NCT01801475|538305019|FG004|Overall Study|Withdrawal by Subject|1|||
149228446|NCT01786707|538305020|FG000|Overall Study|Lost to Follow-up|1|||
149228447|NCT01786707|538305021|FG001|Overall Study|Lost to Follow-up|1|||
149228448|NCT00421928|538305022|FG000|Overall Study|Adverse Event|61|||
149228449|NCT00421928|538305023|FG001|Overall Study|Adverse Event|140|||
149228450|NCT00421928|538305024|FG002|Overall Study|Adverse Event|22|||
149228451|NCT00421928|538305022|FG000|Overall Study|Lost to Follow-up|5|||
149228452|NCT00421928|538305023|FG001|Overall Study|Lost to Follow-up|0|||
149228453|NCT00421928|538305024|FG002|Overall Study|Lost to Follow-up|3|||
149228454|NCT00421928|538305022|FG000|Overall Study|Withdrawal by Subject|50|||
149228455|NCT00421928|538305023|FG001|Overall Study|Withdrawal by Subject|48|||
149228456|NCT00421928|538305024|FG002|Overall Study|Withdrawal by Subject|43|||
149020187|NCT02718417|537552604|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
149020188|NCT02718417|537552605|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
149020189|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Physician's decision|6|||
149020190|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Physician's decision|7|||
149020191|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Physician's decision|0|||
149020192|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Progressive disease|100|||
149020193|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Progressive disease|88|||
149020194|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Progressive disease|0|||
149020195|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Other|2|||
149020196|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Other|1|||
149020197|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Other|0|||
149020198|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
149020199|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
149020200|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
149020201|NCT02718417|537552603|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
149020202|NCT02718417|537552604|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
149020203|NCT02718417|537552605|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
149020204|NCT02718417|537552603|FG000|Observation Phase (OP)|Adverse Event|0|||
149020205|NCT02718417|537552604|FG001|Observation Phase (OP)|Adverse Event|0|||
149020206|NCT02718417|537552605|FG002|Observation Phase (OP)|Adverse Event|1|||
149020207|NCT02718417|537552603|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
149020208|NCT02718417|537552604|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
149020209|NCT02718417|537552605|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
149020210|NCT02718417|537552603|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
149020211|NCT02718417|537552604|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
149020212|NCT02718417|537552605|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
149020213|NCT02718417|537552603|FG000|Observation Phase (OP)|Physician Decision|0|||
149020214|NCT02718417|537552604|FG001|Observation Phase (OP)|Physician Decision|0|||
149020215|NCT02718417|537552605|FG002|Observation Phase (OP)|Physician Decision|9|||
149020216|NCT02718417|537552603|FG000|Observation Phase (OP)|Progressive disease|0|||
149020217|NCT02718417|537552604|FG001|Observation Phase (OP)|Progressive disease|0|||
149020218|NCT02718417|537552605|FG002|Observation Phase (OP)|Progressive disease|92|||
149020219|NCT02718417|537552603|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
149020220|NCT02718417|537552604|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
149020221|NCT02718417|537552605|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
149020222|NCT02718417|537552603|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
149020223|NCT02718417|537552604|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
149020224|NCT02718417|537552605|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
149020225|NCT02718417|537552603|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
149020226|NCT02718417|537552604|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
149020227|NCT02718417|537552605|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
149020228|NCT02718417|537552603|FG000|Observation Phase (OP)|Other|0|||
149020229|NCT02718417|537552604|FG001|Observation Phase (OP)|Other|0|||
149020230|NCT02718417|537552605|FG002|Observation Phase (OP)|Other|7|||
149020231|NCT02718417|537552603|FG000|Follow-up Phase|Adverse Event|3|||
149020232|NCT02718417|537552604|FG001|Follow-up Phase|Adverse Event|1|||
149020233|NCT02718417|537552605|FG002|Follow-up Phase|Adverse Event|1|||
149020234|NCT02718417|537552603|FG000|Follow-up Phase|Other|4|||
149020235|NCT02718417|537552604|FG001|Follow-up Phase|Other|6|||
149020236|NCT02718417|537552605|FG002|Follow-up Phase|Other|4|||
149020237|NCT02718417|537552603|FG000|Follow-up Phase|Withdrawal by Subject|19|||
149020238|NCT02718417|537552604|FG001|Follow-up Phase|Withdrawal by Subject|17|||
149020239|NCT02718417|537552605|FG002|Follow-up Phase|Withdrawal by Subject|5|||
149020240|NCT02718417|537552603|FG000|Follow-up Phase|Study terminated by sponsor|100|||
149020241|NCT02718417|537552604|FG001|Follow-up Phase|Study terminated by sponsor|138|||
149020242|NCT02718417|537552605|FG002|Follow-up Phase|Study terminated by sponsor|6|||
149020243|NCT02718417|537552603|FG000|Follow-up Phase|Lost to Follow-up|2|||
149020244|NCT02718417|537552604|FG001|Follow-up Phase|Lost to Follow-up|3|||
149020245|NCT02718417|537552605|FG002|Follow-up Phase|Lost to Follow-up|0|||
149020246|NCT02718417|537552603|FG000|Follow-up Phase|Death leading to discontinuation|7|||
149020247|NCT02718417|537552604|FG001|Follow-up Phase|Death leading to discontinuation|7|||
149228457|NCT00421928|538305022|FG000|Overall Study|Lack of Efficacy|15|||
149228458|NCT00421928|538305023|FG001|Overall Study|Lack of Efficacy|7|||
149228459|NCT00421928|538305024|FG002|Overall Study|Lack of Efficacy|35|||
149228460|NCT00421928|538305022|FG000|Overall Study|Study drug non-compliant|6|||
149228461|NCT00421928|538305023|FG001|Overall Study|Study drug non-compliant|7|||
149228462|NCT00421928|538305024|FG002|Overall Study|Study drug non-compliant|4|||
149228463|NCT00421928|538305022|FG000|Overall Study|All other|26|||
149228464|NCT00421928|538305023|FG001|Overall Study|All other|21|||
149228465|NCT00421928|538305024|FG002|Overall Study|All other|27|||
149228466|NCT00421928|538305022|FG000|Overall Study|Death|0|||
149228467|NCT00421928|538305023|FG001|Overall Study|Death|1|||
149228468|NCT00421928|538305024|FG002|Overall Study|Death|0|||
149228469|NCT04120116|538305040|FG000|Overall Study|Lost to Follow-up|0|||
149228470|NCT04120116|538305041|FG001|Overall Study|Lost to Follow-up|1|||
149228471|NCT04120116|538305042|FG002|Overall Study|Lost to Follow-up|0|||
149228472|NCT04120116|538305043|FG003|Overall Study|Lost to Follow-up|2|||
149228473|NCT04120116|538305040|FG000|Overall Study|Withdrawal by Subject|1|||
149228474|NCT04120116|538305041|FG001|Overall Study|Withdrawal by Subject|0|||
149228475|NCT04120116|538305042|FG002|Overall Study|Withdrawal by Subject|1|||
148689217|NCT00903383|536334342|FG000|Overall Study|Decision of Sponsor|1|||
148689218|NCT00903383|536334343|FG001|Overall Study|Decision of Sponsor|0|||
148689219|NCT00903383|536334344|FG002|Overall Study|Decision of Sponsor|0|||
148689220|NCT00903383|536334345|FG003|Overall Study|Decision of Sponsor|0|||
148689221|NCT00903383|536334342|FG000|Overall Study|Withdrawal by Subject|4|||
148689222|NCT00903383|536334343|FG001|Overall Study|Withdrawal by Subject|1|||
148689223|NCT00903383|536334344|FG002|Overall Study|Withdrawal by Subject|0|||
148689224|NCT00903383|536334345|FG003|Overall Study|Withdrawal by Subject|2|||
148689225|NCT00903383|536334342|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
148689226|NCT00903383|536334343|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
148689227|NCT00903383|536334344|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
148689228|NCT00903383|536334345|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
148689229|NCT00903383|536334342|FG000|Overall Study|Patient Decision|0|||
148689230|NCT00903383|536334343|FG001|Overall Study|Patient Decision|0|||
149228476|NCT04120116|538305043|FG003|Overall Study|Withdrawal by Subject|1|||
149228477|NCT04120116|538305040|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
149228478|NCT04120116|538305041|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
149228479|NCT04120116|538305042|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
149228480|NCT04120116|538305043|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
149228481|NCT00965458|538305044|FG000|Overall Study|Adverse Event|1|||
149228482|NCT00965458|538305045|FG001|Overall Study|Adverse Event|0|||
149228483|NCT00965458|538305044|FG000|Overall Study|Lost to Follow-up|1|||
149228484|NCT00965458|538305045|FG001|Overall Study|Lost to Follow-up|3|||
149228485|NCT00965458|538305044|FG000|Overall Study|Withdrawal by Subject|0|||
149228486|NCT00965458|538305045|FG001|Overall Study|Withdrawal by Subject|1|||
149228487|NCT00594958|538305049|FG000|Overall Study|Withdrawal by Subject|1|||
149228488|NCT00594958|538305050|FG001|Overall Study|Withdrawal by Subject|0|||
148689231|NCT00903383|536334344|FG002|Overall Study|Patient Decision|0|||
148689232|NCT00903383|536334345|FG003|Overall Study|Patient Decision|1|||
148689233|NCT00320593|536334350|FG000|Overall Study|Lost to Follow-up|3|||
149228489|NCT00594958|538305051|FG002|Overall Study|Withdrawal by Subject|1|||
149228490|NCT00594958|538305049|FG000|Overall Study|Adverse Event|4|||
149228491|NCT00594958|538305050|FG001|Overall Study|Adverse Event|1|||
149228492|NCT00594958|538305051|FG002|Overall Study|Adverse Event|2|||
148689234|NCT00320593|536334351|FG001|Overall Study|Lost to Follow-up|0|||
148689235|NCT00320593|536334350|FG000|Overall Study|Moved to another state|1|||
148689236|NCT00320593|536334351|FG001|Overall Study|Moved to another state|0|||
148689237|NCT00320593|536334350|FG000|Overall Study|Withdrawal by Subject|2|||
148689238|NCT00320593|536334351|FG001|Overall Study|Withdrawal by Subject|1|||
148689239|NCT00320593|536334350|FG000|Overall Study|Withdrawal by clinical center|1|||
149228493|NCT00594958|538305049|FG000|Overall Study|Pregnancy|0|||
149228494|NCT00594958|538305050|FG001|Overall Study|Pregnancy|2|||
149228495|NCT00594958|538305051|FG002|Overall Study|Pregnancy|0|||
149228496|NCT00594958|538305049|FG000|Overall Study|Protocol Violation|1|||
149228497|NCT00594958|538305050|FG001|Overall Study|Protocol Violation|0|||
149228498|NCT00594958|538305051|FG002|Overall Study|Protocol Violation|2|||
149228499|NCT00594958|538305049|FG000|Overall Study|Lost to Follow-up|5|||
149228500|NCT00594958|538305050|FG001|Overall Study|Lost to Follow-up|0|||
149228501|NCT00594958|538305051|FG002|Overall Study|Lost to Follow-up|3|||
149228502|NCT00594958|538305049|FG000|Overall Study|administrative|3|||
149228503|NCT00594958|538305050|FG001|Overall Study|administrative|0|||
149228504|NCT00594958|538305051|FG002|Overall Study|administrative|2|||
149228505|NCT03233009|538305052|FG000|Overall Study|Lost to Follow-up|1|||
149228506|NCT02181634|538305053|FG000|Overall Study|Lack of Efficacy|33|||
149228507|NCT02181634|538305053|FG000|Overall Study|Adverse Event|17|||
149228508|NCT02181634|538305053|FG000|Overall Study|Physician Decision|8|||
149228509|NCT02181634|538305053|FG000|Overall Study|Withdrawal by Subject|5|||
149228510|NCT02181634|538305053|FG000|Overall Study|Death|2|||
149228511|NCT02181634|538305053|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
149228512|NCT02181634|538305053|FG000|Overall Study|Ineligible|1|||
149228513|NCT02181634|538305053|FG000|Overall Study|Max number of dose reduction|1|||
149228514|NCT02181634|538305053|FG000|Overall Study|Symptomatic progression|1|||
149228515|NCT02181634|538305053|FG000|Overall Study|Patient opted to proceed to surgery|1|||
149228516|NCT00134563|538305054|FG000|Overall Study|Not treated due to protocol violation|0|||
149228517|NCT00134563|538305055|FG001|Overall Study|Not treated due to protocol violation|1|||
149228518|NCT00134563|538305056|FG002|Overall Study|Not treated due to protocol violation|1|||
148689240|NCT00320593|536334351|FG001|Overall Study|Withdrawal by clinical center|0|||
148689241|NCT00283686|536334352|FG000|Overall Study|Death|1|||
148689242|NCT00283686|536334353|FG001|Overall Study|Death|1|||
148689243|NCT00283686|536334354|FG002|Overall Study|Death|1|||
148689244|NCT00283686|536334355|FG003|Overall Study|Death|0|||
148689245|NCT00283686|536334352|FG000|Overall Study|Lost to Follow-up|21|||
148689246|NCT00283686|536334353|FG001|Overall Study|Lost to Follow-up|31|||
148689247|NCT00283686|536334354|FG002|Overall Study|Lost to Follow-up|26|||
148689248|NCT00283686|536334355|FG003|Overall Study|Lost to Follow-up|20|||
148689249|NCT00283686|536334352|FG000|Overall Study|Less than full participation|7|||
148689250|NCT00283686|536334353|FG001|Overall Study|Less than full participation|9|||
148689251|NCT00283686|536334354|FG002|Overall Study|Less than full participation|6|||
148689252|NCT00283686|536334355|FG003|Overall Study|Less than full participation|12|||
148689253|NCT01076166|536334356|FG000|Overall Study|Adverse Event|3|||
149228519|NCT00134563|538305054|FG000|Overall Study|Adverse Event|29|||
148689254|NCT01076166|536334356|FG000|Overall Study|Symptoms improved/resolved|6|||
148689255|NCT00481247|536334359|FG000|Overall Study|Death|0|||
148689256|NCT00481247|536334360|FG001|Overall Study|Death|1|||
148689257|NCT00481247|536334359|FG000|Overall Study|Disease progression|18|||
148689258|NCT00481247|536334360|FG001|Overall Study|Disease progression|22|||
148689259|NCT00481247|536334359|FG000|Overall Study|Intolerance|42|||
149228520|NCT00134563|538305055|FG001|Overall Study|Adverse Event|37|||
149228521|NCT00134563|538305056|FG002|Overall Study|Adverse Event|38|||
148810243|NCT00879658|536782597|FG001|Overall Study|Protocol Violation|0|||
148810244|NCT00879658|536782598|FG002|Overall Study|Protocol Violation|0|||
148810245|NCT00879658|536782599|FG003|Overall Study|Protocol Violation|0|||
148689260|NCT00481247|536334360|FG001|Overall Study|Intolerance|17|||
148689261|NCT00481247|536334359|FG000|Overall Study|Treatment failure|10|||
148689262|NCT00481247|536334360|FG001|Overall Study|Treatment failure|14|||
149228522|NCT00134563|538305054|FG000|Overall Study|Lack of Efficacy|24|||
149228523|NCT00134563|538305055|FG001|Overall Study|Lack of Efficacy|14|||
149228524|NCT00134563|538305056|FG002|Overall Study|Lack of Efficacy|17|||
149228525|NCT00134563|538305054|FG000|Overall Study|Protocol Violation|3|||
149228526|NCT00134563|538305055|FG001|Overall Study|Protocol Violation|2|||
149228527|NCT00134563|538305056|FG002|Overall Study|Protocol Violation|5|||
149228528|NCT00134563|538305054|FG000|Overall Study|Lost to Follow-up|4|||
149228529|NCT00134563|538305055|FG001|Overall Study|Lost to Follow-up|0|||
149228530|NCT00134563|538305056|FG002|Overall Study|Lost to Follow-up|2|||
149228531|NCT00134563|538305054|FG000|Overall Study|progressive disease|11|||
149228532|NCT00134563|538305055|FG001|Overall Study|progressive disease|4|||
149228533|NCT00134563|538305056|FG002|Overall Study|progressive disease|2|||
149228534|NCT00134563|538305054|FG000|Overall Study|did not wish to continue|33|||
149228535|NCT00134563|538305055|FG001|Overall Study|did not wish to continue|32|||
149228536|NCT00134563|538305056|FG002|Overall Study|did not wish to continue|26|||
149228537|NCT00134563|538305054|FG000|Overall Study|Reason other than above|0|||
149228538|NCT00134563|538305055|FG001|Overall Study|Reason other than above|2|||
149228539|NCT00134563|538305056|FG002|Overall Study|Reason other than above|5|||
149228540|NCT02406586|538305057|FG000|Overall Study|Lost to Follow-up|0|||
149228541|NCT02406586|538305058|FG001|Overall Study|Lost to Follow-up|4|||
149228542|NCT02406586|538305059|FG002|Overall Study|Lost to Follow-up|2|||
149228543|NCT02406586|538305057|FG000|Overall Study|Withdrawal by Subject|1|||
149228544|NCT02406586|538305058|FG001|Overall Study|Withdrawal by Subject|0|||
149228545|NCT02406586|538305059|FG002|Overall Study|Withdrawal by Subject|0|||
149228546|NCT02839330|538305060|FG000|Overall Study|Adverse Event|0|||
149228547|NCT02839330|538305061|FG001|Overall Study|Adverse Event|1|||
149228548|NCT02839330|538305062|FG002|Overall Study|Adverse Event|2|||
149228549|NCT02839330|538305063|FG003|Overall Study|Adverse Event|2|||
149228550|NCT02839330|538305060|FG000|Overall Study|Death|4|||
149228551|NCT02839330|538305061|FG001|Overall Study|Death|6|||
149228552|NCT02839330|538305062|FG002|Overall Study|Death|1|||
149228553|NCT02839330|538305063|FG003|Overall Study|Death|1|||
149228554|NCT02839330|538305060|FG000|Overall Study|Withdrawal by Subject|27|||
149228555|NCT02839330|538305061|FG001|Overall Study|Withdrawal by Subject|19|||
149228556|NCT02839330|538305062|FG002|Overall Study|Withdrawal by Subject|11|||
149228557|NCT02839330|538305063|FG003|Overall Study|Withdrawal by Subject|13|||
149228558|NCT02839330|538305060|FG000|Overall Study|Lost to Follow-up|22|||
149228559|NCT02839330|538305061|FG001|Overall Study|Lost to Follow-up|27|||
149228560|NCT02839330|538305062|FG002|Overall Study|Lost to Follow-up|29|||
149228561|NCT02839330|538305063|FG003|Overall Study|Lost to Follow-up|25|||
149228562|NCT02839330|538305060|FG000|Overall Study|Administrative Reason|0|||
149228563|NCT02839330|538305061|FG001|Overall Study|Administrative Reason|0|||
149228564|NCT02839330|538305062|FG002|Overall Study|Administrative Reason|0|||
149228565|NCT02839330|538305063|FG003|Overall Study|Administrative Reason|1|||
149228566|NCT02839330|538305060|FG000|Overall Study|Protocol Violation|1|||
149228567|NCT02839330|538305061|FG001|Overall Study|Protocol Violation|2|||
149228568|NCT02839330|538305062|FG002|Overall Study|Protocol Violation|2|||
149228569|NCT02839330|538305063|FG003|Overall Study|Protocol Violation|3|||
148689263|NCT00481247|536334359|FG000|Overall Study|AE unrelated to study drug|13|||
148689264|NCT00481247|536334360|FG001|Overall Study|AE unrelated to study drug|4|||
148689265|NCT00481247|536334359|FG000|Overall Study|Withdrawal by Subject|8|||
148810246|NCT00879658|536782600|FG004|Overall Study|Protocol Violation|0|||
149228570|NCT02839330|538305060|FG000|Overall Study|Other reason, not specified|4|||
148689266|NCT00481247|536334360|FG001|Overall Study|Withdrawal by Subject|13|||
148689267|NCT00481247|536334359|FG000|Overall Study|Pregnancy|2|||
148689268|NCT00481247|536334360|FG001|Overall Study|Pregnancy|1|||
148689269|NCT00481247|536334359|FG000|Overall Study|Lost to Follow-up|1|||
148689270|NCT00481247|536334360|FG001|Overall Study|Lost to Follow-up|2|||
148689271|NCT00481247|536334359|FG000|Overall Study|Poor compliance/noncompliance|1|||
149228571|NCT02839330|538305061|FG001|Overall Study|Other reason, not specified|3|||
149228572|NCT02839330|538305062|FG002|Overall Study|Other reason, not specified|3|||
149228573|NCT02839330|538305063|FG003|Overall Study|Other reason, not specified|6|||
149228574|NCT03339999|538305064|FG000|Overall Study|Adverse Event|1|||
149228575|NCT03339999|538305065|FG001|Overall Study|Adverse Event|2|||
149228576|NCT03339999|538305066|FG002|Overall Study|Adverse Event|2|||
149228577|NCT03339999|538305067|FG003|Overall Study|Adverse Event|1|||
149228578|NCT03339999|538305064|FG000|Overall Study|Lack of Efficacy|0|||
149228579|NCT03339999|538305065|FG001|Overall Study|Lack of Efficacy|1|||
149228580|NCT03339999|538305066|FG002|Overall Study|Lack of Efficacy|0|||
148689272|NCT00481247|536334360|FG001|Overall Study|Poor compliance/noncompliance|7|||
148689273|NCT00481247|536334359|FG000|Overall Study|Administrative reason by sponsor|157|||
148810247|NCT00879658|536782601|FG005|Overall Study|Protocol Violation|0|||
149228581|NCT03339999|538305067|FG003|Overall Study|Lack of Efficacy|0|||
149228582|NCT03339999|538305064|FG000|Overall Study|Lost to Follow-up|0|||
149228583|NCT03339999|538305065|FG001|Overall Study|Lost to Follow-up|0|||
149228584|NCT03339999|538305066|FG002|Overall Study|Lost to Follow-up|0|||
149228585|NCT03339999|538305067|FG003|Overall Study|Lost to Follow-up|1|||
149228586|NCT03339999|538305064|FG000|Overall Study|Study Terminated by Sponsor|6|||
149228587|NCT03339999|538305065|FG001|Overall Study|Study Terminated by Sponsor|3|||
149228588|NCT03339999|538305066|FG002|Overall Study|Study Terminated by Sponsor|4|||
149228589|NCT03339999|538305067|FG003|Overall Study|Study Terminated by Sponsor|3|||
149228590|NCT00661362|538305068|FG000|Overall Study|Adverse Event|5|||
149228591|NCT00661362|538305069|FG001|Overall Study|Adverse Event|4|||
149228592|NCT00661362|538305068|FG000|Overall Study|Incorrect enrollment|2|||
149228593|NCT00661362|538305069|FG001|Overall Study|Incorrect enrollment|0|||
149228594|NCT00661362|538305068|FG000|Overall Study|Study specific discontinuation criteria|4|||
149228595|NCT00661362|538305069|FG001|Overall Study|Study specific discontinuation criteria|11|||
149228596|NCT00661362|538305068|FG000|Overall Study|Withdrawal by Subject|13|||
149228597|NCT00661362|538305069|FG001|Overall Study|Withdrawal by Subject|23|||
149228598|NCT00661362|538305068|FG000|Overall Study|Lost to Follow-up|3|||
148810248|NCT00879658|536782602|FG006|Overall Study|Protocol Violation|0|||
149020248|NCT02718417|537552605|FG002|Follow-up Phase|Death leading to discontinuation|3|||
149020249|NCT02718417|537552603|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
149020250|NCT02718417|537552604|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
148810249|NCT00879658|536782596|FG000|Overall Study|Withdrawal by Subject|3|||
148810250|NCT00879658|536782597|FG001|Overall Study|Withdrawal by Subject|0|||
148810251|NCT00879658|536782598|FG002|Overall Study|Withdrawal by Subject|2|||
148810252|NCT00879658|536782599|FG003|Overall Study|Withdrawal by Subject|0|||
148810253|NCT00879658|536782600|FG004|Overall Study|Withdrawal by Subject|0|||
148810254|NCT00879658|536782601|FG005|Overall Study|Withdrawal by Subject|1|||
148810255|NCT00879658|536782602|FG006|Overall Study|Withdrawal by Subject|0|||
148810256|NCT00879658|536782596|FG000|Overall Study|Lack of Efficacy|0|||
148810257|NCT00879658|536782597|FG001|Overall Study|Lack of Efficacy|0|||
148810258|NCT00879658|536782598|FG002|Overall Study|Lack of Efficacy|2|||
148810259|NCT00879658|536782599|FG003|Overall Study|Lack of Efficacy|0|||
148810260|NCT00879658|536782600|FG004|Overall Study|Lack of Efficacy|0|||
148810261|NCT00879658|536782601|FG005|Overall Study|Lack of Efficacy|0|||
148810262|NCT00879658|536782602|FG006|Overall Study|Lack of Efficacy|0|||
148810263|NCT00879658|536782596|FG000|Overall Study|misrandomized (never received study med)|0|||
148810264|NCT00879658|536782597|FG001|Overall Study|misrandomized (never received study med)|0|||
148810265|NCT00879658|536782598|FG002|Overall Study|misrandomized (never received study med)|0|||
148810266|NCT00879658|536782599|FG003|Overall Study|misrandomized (never received study med)|1|||
148810267|NCT00879658|536782600|FG004|Overall Study|misrandomized (never received study med)|0|||
148810268|NCT00879658|536782601|FG005|Overall Study|misrandomized (never received study med)|0|||
148810269|NCT00879658|536782602|FG006|Overall Study|misrandomized (never received study med)|0|||
148810270|NCT03314935|536782605|FG000|Phase 1|Death|4|||
149020251|NCT02718417|537552605|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
149228599|NCT00661362|538305069|FG001|Overall Study|Lost to Follow-up|1|||
149228600|NCT00661362|538305068|FG000|Overall Study|Severe non-compliance to protocol|0|||
149228601|NCT00661362|538305069|FG001|Overall Study|Severe non-compliance to protocol|1|||
149228602|NCT00661362|538305068|FG000|Overall Study|Safety reasons|1|||
149228603|NCT00661362|538305069|FG001|Overall Study|Safety reasons|0|||
148810271|NCT03314935|536782606|FG001|Phase 1|Death|2|||
148810272|NCT03314935|536782607|FG002|Phase 1|Death|5|||
148810273|NCT03314935|536782608|FG003|Phase 1|Death|4|||
149228604|NCT00661362|538305068|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
149228605|NCT00661362|538305069|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
149228606|NCT00672490|538305074|FG000|Overall Study|Withdrawal by Subject|8|||
148689274|NCT00481247|536334360|FG001|Overall Study|Administrative reason by sponsor|162|||
148810274|NCT03314935|536782609|FG004|Phase 1|Death|3|||
148810275|NCT03314935|536782610|FG005|Phase 1|Death|4|||
148810276|NCT03314935|536782611|FG006|Phase 1|Death|5|||
148689275|NCT00481247|536334359|FG000|Overall Study|Varied|6|||
148689276|NCT00481247|536334360|FG001|Overall Study|Varied|15|||
149228607|NCT00672490|538305075|FG001|Overall Study|Withdrawal by Subject|8|||
149228608|NCT00672490|538305074|FG000|Overall Study|Lack of Compliance|2|||
149228609|NCT00672490|538305075|FG001|Overall Study|Lack of Compliance|7|||
149228610|NCT00672490|538305074|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
149228611|NCT00672490|538305075|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
149228612|NCT00672490|538305074|FG000|Overall Study|Adverse Event|5|||
149228613|NCT00672490|538305075|FG001|Overall Study|Adverse Event|8|||
149228614|NCT00672490|538305074|FG000|Overall Study|Violation of Concomitant Medicine|1|||
149228615|NCT00672490|538305075|FG001|Overall Study|Violation of Concomitant Medicine|0|||
149228616|NCT00672490|538305074|FG000|Overall Study|Intolerance|0|||
149228617|NCT00672490|538305075|FG001|Overall Study|Intolerance|2|||
149228618|NCT00672490|538305074|FG000|Overall Study|Lost to Follow-up|1|||
149228619|NCT00672490|538305075|FG001|Overall Study|Lost to Follow-up|5|||
149228620|NCT00672490|538305074|FG000|Overall Study|No reason was provided|6|||
149228621|NCT00672490|538305075|FG001|Overall Study|No reason was provided|2|||
149228622|NCT04738123|538305078|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
149228623|NCT04738123|538305079|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
149228624|NCT04738123|538305078|FG000|Overall Study|Progressive Disease|0|||
148689277|NCT00481247|536334359|FG000|Overall Study|Did not receive treatment|1|||
148689278|NCT00481247|536334360|FG001|Overall Study|Did not receive treatment|2|||
148689279|NCT01716754|536334361|FG000|Overall Study|Death|0|||
148689280|NCT01716754|536334362|FG001|Overall Study|Death|0|||
148689281|NCT01716754|536334363|FG002|Overall Study|Death|0|||
148689282|NCT01716754|536334364|FG003|Overall Study|Death|1|||
148689283|NCT01716754|536334361|FG000|Overall Study|Protocol deviation|0|||
148689284|NCT01716754|536334362|FG001|Overall Study|Protocol deviation|2|||
148689285|NCT01716754|536334363|FG002|Overall Study|Protocol deviation|7|||
148810277|NCT03314935|536782612|FG007|Phase 1|Death|4|||
149228625|NCT04738123|538305079|FG001|Overall Study|Progressive Disease|4|||
148689286|NCT01716754|536334364|FG003|Overall Study|Protocol deviation|2|||
148689287|NCT01716754|536334361|FG000|Overall Study|Non-compliance with study treatment|0|||
148689288|NCT01716754|536334362|FG001|Overall Study|Non-compliance with study treatment|0|||
148689289|NCT01716754|536334363|FG002|Overall Study|Non-compliance with study treatment|1|||
148689290|NCT01716754|536334364|FG003|Overall Study|Non-compliance with study treatment|0|||
148689291|NCT01716754|536334361|FG000|Overall Study|Physician Decision|1|||
148689292|NCT01716754|536334362|FG001|Overall Study|Physician Decision|0|||
148689293|NCT01716754|536334363|FG002|Overall Study|Physician Decision|0|||
148689294|NCT01716754|536334364|FG003|Overall Study|Physician Decision|0|||
148689295|NCT01716754|536334361|FG000|Overall Study|Lost to Follow-up|1|||
148689296|NCT01716754|536334362|FG001|Overall Study|Lost to Follow-up|0|||
149228626|NCT04738123|538305078|FG000|Overall Study|Adverse Event|8|||
148689297|NCT01716754|536334363|FG002|Overall Study|Lost to Follow-up|0|||
148689298|NCT01716754|536334364|FG003|Overall Study|Lost to Follow-up|1|||
148689299|NCT01716754|536334361|FG000|Overall Study|Adverse Event|4|||
148689300|NCT01716754|536334362|FG001|Overall Study|Adverse Event|2|||
148689301|NCT01716754|536334363|FG002|Overall Study|Adverse Event|2|||
148689302|NCT01716754|536334364|FG003|Overall Study|Adverse Event|1|||
149228627|NCT04738123|538305079|FG001|Overall Study|Adverse Event|7|||
149228628|NCT04738123|538305078|FG000|Overall Study|Other Reasons|0|||
148689303|NCT01716754|536334361|FG000|Overall Study|Withdrawal by Subject|5|||
148689304|NCT01716754|536334362|FG001|Overall Study|Withdrawal by Subject|0|||
148689305|NCT01716754|536334363|FG002|Overall Study|Withdrawal by Subject|4|||
148689306|NCT01716754|536334364|FG003|Overall Study|Withdrawal by Subject|3|||
148689307|NCT00638157|536334384|FG000|Overall Study|Adverse Event|0|||
148689308|NCT00638157|536334385|FG001|Overall Study|Adverse Event|1|||
148689309|NCT00638157|536334384|FG000|Overall Study|Clinical (symptomatic) failure|1|||
148689310|NCT00638157|536334385|FG001|Overall Study|Clinical (symptomatic) failure|1|||
148689311|NCT00638157|536334384|FG000|Overall Study|Microbiological failure|1|||
148689312|NCT00638157|536334385|FG001|Overall Study|Microbiological failure|0|||
148689313|NCT00638157|536334384|FG000|Overall Study|Lost to Follow-up|1|||
148689314|NCT00638157|536334385|FG001|Overall Study|Lost to Follow-up|0|||
149228629|NCT04738123|538305079|FG001|Overall Study|Other Reasons|1|||
148689315|NCT00638157|536334384|FG000|Overall Study|Physician Decision|1|||
148689316|NCT00638157|536334385|FG001|Overall Study|Physician Decision|0|||
148689317|NCT00638157|536334384|FG000|Overall Study|Other|1|||
148689318|NCT00638157|536334385|FG001|Overall Study|Other|2|||
148689319|NCT00638157|536334384|FG000|Overall Study|Randomized, not treated|2|||
148689320|NCT00638157|536334385|FG001|Overall Study|Randomized, not treated|0|||
148689321|NCT02110706|536334386|FG000|Overall Study|Adverse Event|2|||
148689322|NCT02110706|536334387|FG001|Overall Study|Adverse Event|3|||
148689323|NCT02110706|536334386|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
148689324|NCT02110706|536334387|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
148689325|NCT02970669|536334390|FG000|Double-blind Period|Adverse Event|4|||
148689326|NCT02970669|536334391|FG001|Double-blind Period|Adverse Event|0|||
148810278|NCT03314935|536782613|FG008|Phase 1|Death|3|||
149228630|NCT04738123|538305078|FG000|Overall Study|Suicidal or assaultive behavior|0|||
149228631|NCT04738123|538305079|FG001|Overall Study|Suicidal or assaultive behavior|2|||
149228632|NCT04738123|538305078|FG000|Overall Study|Protocol Violation|2|||
149228633|NCT04738123|538305079|FG001|Overall Study|Protocol Violation|2|||
149228634|NCT04738123|538305078|FG000|Overall Study|Consent Withdrawn|35|||
149228635|NCT04738123|538305079|FG001|Overall Study|Consent Withdrawn|22|||
149228636|NCT01303159|538305080|FG000|Overall Study|Death|16|||
149228637|NCT01303159|538305080|FG000|Overall Study|Study Termination|7|||
149228638|NCT00914940|538305086|FG000|D0 to D100 Post-transplant|Death|2|||
149228639|NCT00914940|538305086|FG000|D101 to 2 Years Post-transplant|Death|8|||
149228640|NCT00914940|538305086|FG000|2 Years to 5 Years Post-transplant|Death|3|||
149228641|NCT00760994|538305091|FG000|Overall Study|Lost to Follow-up|4|||
149228642|NCT00760994|538305092|FG001|Overall Study|Lost to Follow-up|4|||
149228643|NCT00760994|538305093|FG002|Overall Study|Lost to Follow-up|3|||
149228644|NCT00486720|538305094|FG000|Overall Study|Adverse Event|1|||
149228645|NCT00486720|538305095|FG001|Overall Study|Adverse Event|2|||
149228646|NCT00486720|538305094|FG000|Overall Study|Lack of Efficacy|4|||
149228647|NCT00486720|538305095|FG001|Overall Study|Lack of Efficacy|6|||
149228648|NCT00486720|538305094|FG000|Overall Study|Physician Decision|1|||
149228649|NCT00486720|538305095|FG001|Overall Study|Physician Decision|2|||
149228650|NCT00486720|538305094|FG000|Overall Study|Protocol Violation|1|||
149228651|NCT00486720|538305095|FG001|Overall Study|Protocol Violation|0|||
149228652|NCT00486720|538305094|FG000|Overall Study|Withdrawal by Subject|3|||
149228653|NCT00486720|538305095|FG001|Overall Study|Withdrawal by Subject|1|||
149228654|NCT00486720|538305094|FG000|Overall Study|Progressive Disease|0|||
149228655|NCT00486720|538305095|FG001|Overall Study|Progressive Disease|1|||
149228656|NCT00286234|538305096|FG000|Overall Study|Protocol Violation|1|||
149228657|NCT00286234|538305097|FG001|Overall Study|Protocol Violation|2|||
149228658|NCT00286234|538305098|FG002|Overall Study|Protocol Violation|0|||
149228659|NCT00286234|538305099|FG003|Overall Study|Protocol Violation|1|||
149228660|NCT00286234|538305096|FG000|Overall Study|Physician Decision|1|||
149228661|NCT00286234|538305097|FG001|Overall Study|Physician Decision|0|||
149228662|NCT00286234|538305098|FG002|Overall Study|Physician Decision|0|||
149228663|NCT00286234|538305099|FG003|Overall Study|Physician Decision|1|||
149228664|NCT00286234|538305096|FG000|Overall Study|Adverse Event|0|||
149228665|NCT00286234|538305097|FG001|Overall Study|Adverse Event|0|||
149228666|NCT00286234|538305098|FG002|Overall Study|Adverse Event|0|||
149228667|NCT00286234|538305099|FG003|Overall Study|Adverse Event|1|||
149228668|NCT00286234|538305096|FG000|Overall Study|Adverse Event|0|||
149228669|NCT00286234|538305097|FG001|Overall Study|Adverse Event|0|||
149228670|NCT00286234|538305098|FG002|Overall Study|Adverse Event|0|||
149228671|NCT00286234|538305099|FG003|Overall Study|Adverse Event|1|||
149228672|NCT00302731|538305101|FG000|Overall Study|Lost to Follow-up|1|||
149228673|NCT00302731|538305102|FG001|Overall Study|Lost to Follow-up|2|||
149228674|NCT00302731|538305103|FG002|Overall Study|Lost to Follow-up|0|||
149228675|NCT00302731|538305104|FG003|Overall Study|Lost to Follow-up|0|||
149228676|NCT00302731|538305101|FG000|Overall Study|Adverse Event|0|||
149228677|NCT00302731|538305102|FG001|Overall Study|Adverse Event|2|||
149228678|NCT00302731|538305103|FG002|Overall Study|Adverse Event|2|||
149228679|NCT00302731|538305104|FG003|Overall Study|Adverse Event|0|||
149228680|NCT00302731|538305101|FG000|Overall Study|Withdrawal by Subject|1|||
149228681|NCT00302731|538305102|FG001|Overall Study|Withdrawal by Subject|1|||
149228682|NCT00302731|538305103|FG002|Overall Study|Withdrawal by Subject|0|||
149228683|NCT00302731|538305104|FG003|Overall Study|Withdrawal by Subject|0|||
149228684|NCT00302731|538305101|FG000|Overall Study|Protocol Violation|1|||
149228685|NCT00302731|538305102|FG001|Overall Study|Protocol Violation|0|||
149228686|NCT00302731|538305103|FG002|Overall Study|Protocol Violation|0|||
149228687|NCT00302731|538305104|FG003|Overall Study|Protocol Violation|0|||
149228688|NCT00302731|538305101|FG000|Overall Study|cancer unrelated to study discovered|1|||
149228689|NCT00302731|538305102|FG001|Overall Study|cancer unrelated to study discovered|0|||
149228690|NCT00302731|538305103|FG002|Overall Study|cancer unrelated to study discovered|1|||
148689327|NCT02970669|536334390|FG000|Double-blind Period|Death|1|||
148689328|NCT02970669|536334391|FG001|Double-blind Period|Death|0|||
149228691|NCT00302731|538305104|FG003|Overall Study|cancer unrelated to study discovered|0|||
149228692|NCT01000311|538305105|FG000|Overall Study|Adverse Event|2|||
149228693|NCT01000311|538305106|FG001|Overall Study|Adverse Event|5|||
149228694|NCT01000311|538305105|FG000|Overall Study|Withdrawal by Subject|16|||
149228695|NCT01000311|538305106|FG001|Overall Study|Withdrawal by Subject|24|||
149228696|NCT01000311|538305105|FG000|Overall Study|Lost to Follow-up|15|||
149228697|NCT01000311|538305106|FG001|Overall Study|Lost to Follow-up|24|||
149228698|NCT01000311|538305105|FG000|Overall Study|Protocol Violation|1|||
149228699|NCT01000311|538305106|FG001|Overall Study|Protocol Violation|2|||
149228700|NCT01000311|538305105|FG000|Overall Study|Inappropriate enrollment|2|||
149228701|NCT01000311|538305106|FG001|Overall Study|Inappropriate enrollment|0|||
149228702|NCT01000311|538305105|FG000|Overall Study|Administrative reason|9|||
149228703|NCT01000311|538305106|FG001|Overall Study|Administrative reason|15|||
149228704|NCT01610752|538305109|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
149228705|NCT01610752|538305110|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
149228706|NCT01610752|538305111|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
148689329|NCT02970669|536334390|FG000|Double-blind Period|Study terminated by sponsor|1|||
148689330|NCT02970669|536334391|FG001|Double-blind Period|Study terminated by sponsor|2|||
148689331|NCT02970669|536334390|FG000|Double-blind Period|Physician Decision|0|||
148689332|NCT02970669|536334391|FG001|Double-blind Period|Physician Decision|2|||
148689333|NCT02970669|536334390|FG000|Double-blind Period|Withdrawal by Subject|2|||
148689334|NCT02970669|536334391|FG001|Double-blind Period|Withdrawal by Subject|2|||
148689335|NCT02970669|536334390|FG000|Open-label Period|Withdrawal by Subject|2|||
148689336|NCT02970669|536334391|FG001|Open-label Period|Withdrawal by Subject|2|||
149228707|NCT00283062|538305112|FG000|Overall Study|Did not receive any study medication|5|||
149228708|NCT00283062|538305113|FG001|Overall Study|Did not receive any study medication|4|||
149228709|NCT00283062|538305114|FG002|Overall Study|Did not receive any study medication|36|||
149228710|NCT00283062|538305115|FG003|Overall Study|Did not receive any study medication|45|||
149228711|NCT00283062|538305112|FG000|Overall Study|Adverse Event|2|||
149228712|NCT00283062|538305113|FG001|Overall Study|Adverse Event|0|||
149228713|NCT00283062|538305114|FG002|Overall Study|Adverse Event|1|||
149228714|NCT00283062|538305115|FG003|Overall Study|Adverse Event|0|||
149228715|NCT00283062|538305112|FG000|Overall Study|Lost to Follow-up|1|||
149228716|NCT00283062|538305113|FG001|Overall Study|Lost to Follow-up|0|||
149228717|NCT00283062|538305114|FG002|Overall Study|Lost to Follow-up|1|||
148689337|NCT02970669|536334390|FG000|Open-label Period|Adverse Event|1|||
148689338|NCT02970669|536334391|FG001|Open-label Period|Adverse Event|0|||
148689339|NCT02970669|536334390|FG000|Open-label Period|Physician Decision|1|||
149228718|NCT00283062|538305115|FG003|Overall Study|Lost to Follow-up|0|||
149228719|NCT00283062|538305112|FG000|Overall Study|Progressive disease|0|||
149228720|NCT00283062|538305113|FG001|Overall Study|Progressive disease|0|||
149020252|NCT02718417|537552603|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
149020253|NCT02718417|537552604|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
149020254|NCT02718417|537552605|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
149020255|NCT02718417|537552603|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
149020256|NCT02718417|537552604|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
149020257|NCT02718417|537552605|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
149020258|NCT02718417|537552603|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
149020259|NCT02718417|537552604|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
149020260|NCT02718417|537552605|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
149020261|NCT02718417|537552603|FG000|Long-term Follow-up Phase|Other|0|||
149020262|NCT02718417|537552604|FG001|Long-term Follow-up Phase|Other|2|||
149020263|NCT02718417|537552605|FG002|Long-term Follow-up Phase|Other|0|||
149020264|NCT01023308|537552606|FG000|Overall Study|Abnormal test proceedure results|3|||
149020265|NCT01023308|537552607|FG001|Overall Study|Abnormal test proceedure results|8|||
149020266|NCT01023308|537552606|FG000|Overall Study|Administrative problems|2|||
149020267|NCT01023308|537552607|FG001|Overall Study|Administrative problems|1|||
149020268|NCT01023308|537552606|FG000|Overall Study|Adverse Event|130|||
149020269|NCT01023308|537552607|FG001|Overall Study|Adverse Event|66|||
149020270|NCT01023308|537552606|FG000|Overall Study|Death|21|||
149020271|NCT01023308|537552607|FG001|Overall Study|Death|17|||
149020272|NCT01023308|537552606|FG000|Overall Study|Disease progression|82|||
149020273|NCT01023308|537552607|FG001|Overall Study|Disease progression|153|||
149020274|NCT01023308|537552606|FG000|Overall Study|New Cancer therapy|4|||
149020275|NCT01023308|537552607|FG001|Overall Study|New Cancer therapy|7|||
149020276|NCT01023308|537552606|FG000|Overall Study|Protocol Violation|3|||
149020277|NCT01023308|537552607|FG001|Overall Study|Protocol Violation|4|||
149020278|NCT01023308|537552606|FG000|Overall Study|Untreated|5|||
149020279|NCT01023308|537552607|FG001|Overall Study|Untreated|5|||
149020280|NCT01023308|537552606|FG000|Overall Study|Lost to Follow-up|1|||
149020281|NCT01023308|537552607|FG001|Overall Study|Lost to Follow-up|0|||
149020282|NCT01023308|537552606|FG000|Overall Study|Withdrawal by Subject|34|||
149020283|NCT01023308|537552607|FG001|Overall Study|Withdrawal by Subject|18|||
149020284|NCT01646320|537552608|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
149020285|NCT01646320|537552609|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
149020286|NCT01646320|537552608|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
149020287|NCT01646320|537552609|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
149020288|NCT01646320|537552608|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
149020289|NCT01646320|537552609|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
149020290|NCT01646320|537552608|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
149020291|NCT01646320|537552609|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
149020292|NCT01646320|537552608|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
149020293|NCT01646320|537552609|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
149020294|NCT01646320|537552608|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
149020295|NCT01646320|537552609|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
149020296|NCT01646320|537552608|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
149020297|NCT01646320|537552609|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
149020298|NCT01646320|537552608|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
149228721|NCT00283062|538305114|FG002|Overall Study|Progressive disease|1|||
149228722|NCT00283062|538305115|FG003|Overall Study|Progressive disease|0|||
149228723|NCT00283062|538305112|FG000|Overall Study|Participant did not wish to continue|3|||
149228724|NCT00283062|538305113|FG001|Overall Study|Participant did not wish to continue|2|||
149228725|NCT00283062|538305114|FG002|Overall Study|Participant did not wish to continue|1|||
149228726|NCT00283062|538305115|FG003|Overall Study|Participant did not wish to continue|0|||
149228727|NCT00283062|538305112|FG000|Overall Study|Undefined|0|||
149228728|NCT00283062|538305113|FG001|Overall Study|Undefined|1|||
149228729|NCT00283062|538305114|FG002|Overall Study|Undefined|1|||
149228730|NCT00283062|538305115|FG003|Overall Study|Undefined|4|||
149228731|NCT00283062|538305112|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
149228732|NCT00283062|538305113|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
149228733|NCT00283062|538305114|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
149228734|NCT00283062|538305115|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
149228735|NCT01468844|538305116|FG000|Overall Study|Adverse Event|1|||
149228736|NCT01468844|538305117|FG001|Overall Study|Adverse Event|0|||
149228737|NCT01468844|538305116|FG000|Overall Study|Withdrawal by Subject|1|||
149228738|NCT01468844|538305117|FG001|Overall Study|Withdrawal by Subject|0|||
149228739|NCT01535638|538305120|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
149228740|NCT01535638|538305121|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
149228741|NCT01535638|538305122|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
149228742|NCT01535638|538305123|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
149228743|NCT01535638|538305124|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
149228744|NCT01535638|538305125|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
148689340|NCT02970669|536334391|FG001|Open-label Period|Physician Decision|0|||
148689341|NCT00876733|536334394|FG000|Overall Study|Adverse Event|34|||
148810279|NCT03314935|536782614|FG009|Phase 1|Death|0|||
148810280|NCT03314935|536782615|FG010|Phase 1|Death|0|||
148810281|NCT03314935|536782616|FG011|Phase 1|Death|0|||
148810282|NCT03314935|536782617|FG012|Phase 1|Death|0|||
148810283|NCT03314935|536782618|FG013|Phase 1|Death|0|||
148810284|NCT03314935|536782619|FG014|Phase 1|Death|0|||
148810285|NCT03314935|536782605|FG000|Phase 1|Withdrawal by Subject|2|||
148810286|NCT03314935|536782606|FG001|Phase 1|Withdrawal by Subject|1|||
148810287|NCT03314935|536782607|FG002|Phase 1|Withdrawal by Subject|1|||
148810288|NCT03314935|536782608|FG003|Phase 1|Withdrawal by Subject|2|||
148810289|NCT03314935|536782609|FG004|Phase 1|Withdrawal by Subject|1|||
148810290|NCT03314935|536782610|FG005|Phase 1|Withdrawal by Subject|0|||
148810291|NCT03314935|536782611|FG006|Phase 1|Withdrawal by Subject|1|||
148810292|NCT03314935|536782612|FG007|Phase 1|Withdrawal by Subject|0|||
148810293|NCT03314935|536782613|FG008|Phase 1|Withdrawal by Subject|1|||
148810294|NCT03314935|536782614|FG009|Phase 1|Withdrawal by Subject|0|||
148810295|NCT03314935|536782615|FG010|Phase 1|Withdrawal by Subject|0|||
148810296|NCT03314935|536782616|FG011|Phase 1|Withdrawal by Subject|0|||
148810297|NCT03314935|536782617|FG012|Phase 1|Withdrawal by Subject|0|||
148810298|NCT03314935|536782618|FG013|Phase 1|Withdrawal by Subject|0|||
148810299|NCT03314935|536782619|FG014|Phase 1|Withdrawal by Subject|0|||
148810300|NCT03314935|536782605|FG000|Phase 1|Progressive Disease|2|||
148810301|NCT03314935|536782606|FG001|Phase 1|Progressive Disease|0|||
148810302|NCT03314935|536782607|FG002|Phase 1|Progressive Disease|0|||
148810303|NCT03314935|536782608|FG003|Phase 1|Progressive Disease|1|||
148810304|NCT03314935|536782609|FG004|Phase 1|Progressive Disease|0|||
148689342|NCT00876733|536334395|FG001|Overall Study|Adverse Event|20|||
148689343|NCT00876733|536334396|FG002|Overall Study|Adverse Event|10|||
148689344|NCT00876733|536334397|FG003|Overall Study|Adverse Event|3|||
148689345|NCT00876733|536334394|FG000|Overall Study|Lack of Efficacy|17|||
148689346|NCT00876733|536334395|FG001|Overall Study|Lack of Efficacy|9|||
148689347|NCT00876733|536334396|FG002|Overall Study|Lack of Efficacy|10|||
148689348|NCT00876733|536334397|FG003|Overall Study|Lack of Efficacy|1|||
148689349|NCT00876733|536334394|FG000|Overall Study|Lost to Follow-up|26|||
148689350|NCT00876733|536334395|FG001|Overall Study|Lost to Follow-up|10|||
148689351|NCT00876733|536334396|FG002|Overall Study|Lost to Follow-up|3|||
148689352|NCT00876733|536334397|FG003|Overall Study|Lost to Follow-up|2|||
148689353|NCT00876733|536334394|FG000|Overall Study|Data not available|14|||
148689354|NCT00876733|536334395|FG001|Overall Study|Data not available|3|||
148689355|NCT00876733|536334396|FG002|Overall Study|Data not available|7|||
148689356|NCT00876733|536334397|FG003|Overall Study|Data not available|1|||
148689357|NCT02611752|536334398|FG000|Overall Study|Adverse Event|0|||
148689358|NCT02611752|536334399|FG001|Overall Study|Adverse Event|1|||
148689359|NCT04820842|536336439|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
148689360|NCT04820842|536336440|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
148689361|NCT04820842|536336441|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
148689362|NCT04820842|536336442|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
148689363|NCT04820842|536336443|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
148689364|NCT04820842|536336444|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
148689365|NCT04820842|536336445|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
148689366|NCT04820842|536336439|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
148689367|NCT04820842|536336440|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
148689368|NCT04820842|536336441|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
148689369|NCT04820842|536336442|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689370|NCT04820842|536336443|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689371|NCT04820842|536336444|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689372|NCT04820842|536336445|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689373|NCT04820842|536336439|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
148689374|NCT04820842|536336440|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
148689375|NCT04820842|536336441|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
148689376|NCT04820842|536336442|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
148810305|NCT03314935|536782610|FG005|Phase 1|Progressive Disease|0|||
148954294|NCT00640601|537314755|FG000|Overall Study|Physician Decision|8|||
148810306|NCT03314935|536782611|FG006|Phase 1|Progressive Disease|0|||
148810307|NCT03314935|536782612|FG007|Phase 1|Progressive Disease|0|||
148810308|NCT03314935|536782613|FG008|Phase 1|Progressive Disease|0|||
148810309|NCT03314935|536782614|FG009|Phase 1|Progressive Disease|0|||
148810310|NCT03314935|536782615|FG010|Phase 1|Progressive Disease|0|||
148810311|NCT03314935|536782616|FG011|Phase 1|Progressive Disease|0|||
148689377|NCT04820842|536336443|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
149228745|NCT01535638|538305120|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
149228746|NCT01535638|538305121|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
149228747|NCT01535638|538305122|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
149228748|NCT01535638|538305123|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
149228749|NCT01535638|538305124|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
149228750|NCT01535638|538305125|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
149228751|NCT00819052|538305126|FG000|Overall Study|Adverse Event|0|||
149228752|NCT00819052|538305127|FG001|Overall Study|Adverse Event|5|||
149228753|NCT00819052|538305126|FG000|Overall Study|Protocol Violation|1|||
149228754|NCT00819052|538305127|FG001|Overall Study|Protocol Violation|2|||
149228755|NCT00819052|538305126|FG000|Overall Study|Lost to Follow-up|1|||
149228756|NCT00819052|538305127|FG001|Overall Study|Lost to Follow-up|2|||
149228757|NCT00819052|538305126|FG000|Overall Study|Withdrawal by Subject|1|||
149228758|NCT00819052|538305127|FG001|Overall Study|Withdrawal by Subject|2|||
149228759|NCT00819052|538305126|FG000|Overall Study|Lack of Efficacy|1|||
149228760|NCT00819052|538305127|FG001|Overall Study|Lack of Efficacy|1|||
149228761|NCT00819052|538305126|FG000|Overall Study|Pregnancy|1|||
149228762|NCT00819052|538305127|FG001|Overall Study|Pregnancy|2|||
149228763|NCT00819052|538305126|FG000|Overall Study|Death or events leading to death|1|||
149228764|NCT00819052|538305127|FG001|Overall Study|Death or events leading to death|0|||
149228765|NCT03524664|538305128|FG000|Overall Study|Withdrawal by Subject|1|||
148689378|NCT04820842|536336444|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
148954295|NCT00640601|537314755|FG000|Overall Study|treatment naive, combination therapy|10|||
149228766|NCT03524664|538305129|FG001|Overall Study|Withdrawal by Subject|2|||
148689379|NCT04820842|536336445|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
148689380|NCT04820842|536336439|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689381|NCT04820842|536336440|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689382|NCT04820842|536336441|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689383|NCT04820842|536336442|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
148689384|NCT04820842|536336443|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689385|NCT04820842|536336444|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
148689386|NCT04820842|536336445|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
148689387|NCT01691508|536336446|FG000|Overall Study|Adverse Event|3|||
148689388|NCT01691508|536336447|FG001|Overall Study|Adverse Event|3|||
148689389|NCT01691508|536336446|FG000|Overall Study|Withdrawal by Subject|1|||
148689390|NCT01691508|536336447|FG001|Overall Study|Withdrawal by Subject|0|||
148689391|NCT01296932|536336448|FG000|Overall Study|Dose limiting toxicity|0|||
148689392|NCT01296932|536336449|FG001|Overall Study|Dose limiting toxicity|0|||
148689393|NCT01296932|536336450|FG002|Overall Study|Dose limiting toxicity|0|||
148689394|NCT01296932|536336451|FG003|Overall Study|Dose limiting toxicity|0|||
148689395|NCT01296932|536336452|FG004|Overall Study|Dose limiting toxicity|0|||
148689396|NCT01296932|536336453|FG005|Overall Study|Dose limiting toxicity|0|||
148689397|NCT01296932|536336454|FG006|Overall Study|Dose limiting toxicity|1|||
148689398|NCT01296932|536336455|FG007|Overall Study|Dose limiting toxicity|0|||
148689399|NCT01296932|536336456|FG008|Overall Study|Dose limiting toxicity|1|||
148689400|NCT01296932|536336448|FG000|Overall Study|Progressive disease|2|||
148689401|NCT01296932|536336449|FG001|Overall Study|Progressive disease|0|||
148689402|NCT01296932|536336450|FG002|Overall Study|Progressive disease|1|||
148689403|NCT01296932|536336451|FG003|Overall Study|Progressive disease|1|||
148689404|NCT01296932|536336452|FG004|Overall Study|Progressive disease|2|||
148689405|NCT01296932|536336453|FG005|Overall Study|Progressive disease|3|||
148689406|NCT01296932|536336454|FG006|Overall Study|Progressive disease|1|||
148689407|NCT01296932|536336455|FG007|Overall Study|Progressive disease|0|||
148689408|NCT01296932|536336456|FG008|Overall Study|Progressive disease|0|||
148689409|NCT01296932|536336448|FG000|Overall Study|Withdrawal by Subject|0|||
148689410|NCT01296932|536336449|FG001|Overall Study|Withdrawal by Subject|0|||
148689411|NCT01296932|536336450|FG002|Overall Study|Withdrawal by Subject|1|||
148689412|NCT01296932|536336451|FG003|Overall Study|Withdrawal by Subject|1|||
148689413|NCT01296932|536336452|FG004|Overall Study|Withdrawal by Subject|0|||
148689414|NCT01296932|536336453|FG005|Overall Study|Withdrawal by Subject|0|||
148689415|NCT01296932|536336454|FG006|Overall Study|Withdrawal by Subject|3|||
148689416|NCT01296932|536336455|FG007|Overall Study|Withdrawal by Subject|0|||
149228767|NCT03524664|538305128|FG000|Overall Study|Lost to Follow-up|4|||
149228768|NCT03524664|538305129|FG001|Overall Study|Lost to Follow-up|13|||
149228769|NCT01482598|538305130|FG000|Overall Study|Death|7|||
149228770|NCT01482598|538305131|FG001|Overall Study|Death|10|||
149228771|NCT01482598|538305130|FG000|Overall Study|Physician Decision|0|||
149228772|NCT01482598|538305131|FG001|Overall Study|Physician Decision|3|||
148689417|NCT01296932|536336456|FG008|Overall Study|Withdrawal by Subject|0|||
149020299|NCT01646320|537552609|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
149020300|NCT01646320|537552608|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
149020301|NCT01646320|537552609|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
149228773|NCT01482598|538305130|FG000|Overall Study|Withdrawal by Subject|4|||
149228774|NCT01482598|538305131|FG001|Overall Study|Withdrawal by Subject|5|||
149228775|NCT01482598|538305130|FG000|Overall Study|Lost to Follow-up|5|||
149228776|NCT01482598|538305131|FG001|Overall Study|Lost to Follow-up|4|||
149228777|NCT00423267|538305132|FG000|Period A|Withdrawal by Subject|0|||
149228778|NCT00423267|538305133|FG001|Period A|Withdrawal by Subject|1|||
149228779|NCT00423267|538305132|FG000|Period A|Non-compliance with protocol|1|||
149228780|NCT00423267|538305133|FG001|Period A|Non-compliance with protocol|0|||
149228781|NCT00423267|538305132|FG000|Period A|Administrative|1|||
149228782|NCT00423267|538305133|FG001|Period A|Administrative|0|||
149228783|NCT00827112|538305134|FG000|Overall Study|Adverse Event|2|||
149228784|NCT00827112|538305135|FG001|Overall Study|Adverse Event|0|||
149228785|NCT00827112|538305134|FG000|Overall Study|Lack of Efficacy|2|||
149228786|NCT00827112|538305135|FG001|Overall Study|Lack of Efficacy|0|||
149228787|NCT00827112|538305134|FG000|Overall Study|Lost to Follow-up|3|||
149228788|NCT00827112|538305135|FG001|Overall Study|Lost to Follow-up|2|||
149228789|NCT00827112|538305134|FG000|Overall Study|Pregnancy|0|||
149228790|NCT00827112|538305135|FG001|Overall Study|Pregnancy|1|||
149228791|NCT00827112|538305134|FG000|Overall Study|Protocol Violation|0|||
149228792|NCT00827112|538305135|FG001|Overall Study|Protocol Violation|2|||
149228793|NCT00827112|538305134|FG000|Overall Study|Withdrawal by Subject|2|||
149228794|NCT00827112|538305135|FG001|Overall Study|Withdrawal by Subject|1|||
149228795|NCT00827112|538305134|FG000|Overall Study|Randomized but not treated|5|||
149228796|NCT00827112|538305135|FG001|Overall Study|Randomized but not treated|3|||
149228797|NCT00827112|538305134|FG000|Overall Study|Other|1|||
149228798|NCT00827112|538305135|FG001|Overall Study|Other|3|||
149228799|NCT03702166|538305136|FG000|Overall Study|Lost to Follow-up|1|||
149228800|NCT03702166|538305136|FG000|Overall Study|Withdrawal by Subject|1|||
149228801|NCT01333865|538305137|FG000|Overall Study|Adverse Event|2|||
149228802|NCT02613910|538305142|FG000|Overall Study|Termination of study|1|||
149228803|NCT02028182|538307496|FG000|Overall Study|Protocol Violation|2|||
149228804|NCT01277757|538307499|FG000|Overall Study|Disease Progression|1|||
149228805|NCT01277757|538307499|FG000|Overall Study|Withdrawal by Subject|1|||
149228806|NCT03808298|538307500|FG000|Overall Study|Adverse Event|3|||
149228807|NCT03808298|538307500|FG000|Overall Study|Physician Decision|1|||
149228808|NCT03808298|538307500|FG000|Overall Study|Withdrawal by Subject|1|||
149228809|NCT03808298|538307500|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
149228810|NCT02946515|538307503|FG000|Overall Study|Lost to Follow-up|2|||
149228811|NCT02946515|538307504|FG001|Overall Study|Lost to Follow-up|1|||
149228812|NCT03039686|538307509|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
149228813|NCT03039686|538307510|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
149228814|NCT03039686|538307511|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
149228815|NCT03039686|538307509|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
149228816|NCT03039686|538307510|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
149228817|NCT03039686|538307511|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
149228818|NCT03039686|538307509|FG000|Double-blind Period|Withdrawal by Subject|2|||
149228819|NCT03039686|538307510|FG001|Double-blind Period|Withdrawal by Subject|2|||
149228820|NCT03039686|538307511|FG002|Double-blind Period|Withdrawal by Subject|1|||
149228821|NCT03039686|538307509|FG000|Double-blind Period|Death|0|||
149228822|NCT03039686|538307510|FG001|Double-blind Period|Death|0|||
149228823|NCT03039686|538307511|FG002|Double-blind Period|Death|1|||
149228824|NCT03039686|538307509|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
149228825|NCT03039686|538307510|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
149228826|NCT03039686|538307511|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
149020302|NCT01646320|537552608|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
149020303|NCT01646320|537552609|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
149020304|NCT01646320|537552608|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
149020305|NCT01646320|537552609|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
149228827|NCT03039686|538307509|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
149228828|NCT03039686|538307510|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
149228829|NCT03039686|538307511|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
149228830|NCT03039686|538307509|FG000|Open Label Period|Withdrawal by Subject|0|||
149228831|NCT03039686|538307510|FG001|Open Label Period|Withdrawal by Subject|3|||
149228832|NCT03039686|538307511|FG002|Open Label Period|Withdrawal by Subject|1|||
149228833|NCT02528331|538307512|FG000|Overall Study|Withdrawal by Subject|2|||
149228834|NCT02392078|538307513|FG000|Overall Study|Did not have procedure|32|||
149228835|NCT02392078|538307514|FG001|Overall Study|Did not have procedure|43|||
149228836|NCT02392078|538307515|FG002|Overall Study|Did not have procedure|20|||
148810312|NCT03314935|536782617|FG012|Phase 1|Progressive Disease|0|||
149020306|NCT02892409|537552610|FG000|Overall Study|Adverse Event|1|||
149228837|NCT02392078|538307516|FG003|Overall Study|Did not have procedure|1|||
149228838|NCT02079077|538307517|FG000|Overall Study|Lost to Follow-up|5|||
148689418|NCT01296932|536336448|FG000|Overall Study|Adverse Event|1|||
148689419|NCT01296932|536336449|FG001|Overall Study|Adverse Event|1|||
148689420|NCT01296932|536336450|FG002|Overall Study|Adverse Event|1|||
148689421|NCT01296932|536336451|FG003|Overall Study|Adverse Event|2|||
148689422|NCT01296932|536336452|FG004|Overall Study|Adverse Event|1|||
148689423|NCT01296932|536336453|FG005|Overall Study|Adverse Event|0|||
148689424|NCT01296932|536336454|FG006|Overall Study|Adverse Event|0|||
148689425|NCT01296932|536336455|FG007|Overall Study|Adverse Event|0|||
148689426|NCT01296932|536336456|FG008|Overall Study|Adverse Event|1|||
148689427|NCT01296932|536336448|FG000|Overall Study|Investigator decision|0|||
148810313|NCT03314935|536782618|FG013|Phase 1|Progressive Disease|0|||
148689428|NCT01296932|536336449|FG001|Overall Study|Investigator decision|1|||
148689429|NCT01296932|536336450|FG002|Overall Study|Investigator decision|0|||
148689430|NCT01296932|536336451|FG003|Overall Study|Investigator decision|1|||
148689431|NCT01296932|536336452|FG004|Overall Study|Investigator decision|0|||
148689432|NCT01296932|536336453|FG005|Overall Study|Investigator decision|0|||
148689433|NCT01296932|536336454|FG006|Overall Study|Investigator decision|1|||
148689434|NCT01296932|536336455|FG007|Overall Study|Investigator decision|0|||
148689435|NCT01296932|536336456|FG008|Overall Study|Investigator decision|1|||
148810314|NCT03314935|536782619|FG014|Phase 1|Progressive Disease|0|||
148810315|NCT03314935|536782605|FG000|Phase 1|Study Terminated by Sponsor|0|||
148810316|NCT03314935|536782606|FG001|Phase 1|Study Terminated by Sponsor|1|||
148810317|NCT03314935|536782607|FG002|Phase 1|Study Terminated by Sponsor|0|||
148810318|NCT03314935|536782608|FG003|Phase 1|Study Terminated by Sponsor|0|||
148689436|NCT01296932|536336448|FG000|Overall Study|No clinical benefit anymore|0|||
148689437|NCT01296932|536336449|FG001|Overall Study|No clinical benefit anymore|1|||
148689438|NCT01296932|536336450|FG002|Overall Study|No clinical benefit anymore|0|||
148689439|NCT01296932|536336451|FG003|Overall Study|No clinical benefit anymore|0|||
148689440|NCT01296932|536336452|FG004|Overall Study|No clinical benefit anymore|0|||
148689441|NCT01296932|536336453|FG005|Overall Study|No clinical benefit anymore|0|||
148689442|NCT01296932|536336454|FG006|Overall Study|No clinical benefit anymore|0|||
148689443|NCT01296932|536336455|FG007|Overall Study|No clinical benefit anymore|0|||
148689444|NCT01296932|536336456|FG008|Overall Study|No clinical benefit anymore|0|||
148689445|NCT01296932|536336448|FG000|Overall Study|Physician Decision|0|||
148689446|NCT01296932|536336449|FG001|Overall Study|Physician Decision|0|||
148689447|NCT01296932|536336450|FG002|Overall Study|Physician Decision|1|||
148689448|NCT01296932|536336451|FG003|Overall Study|Physician Decision|0|||
148689449|NCT01296932|536336452|FG004|Overall Study|Physician Decision|0|||
148689450|NCT01296932|536336453|FG005|Overall Study|Physician Decision|0|||
148689451|NCT01296932|536336454|FG006|Overall Study|Physician Decision|0|||
148689452|NCT01296932|536336455|FG007|Overall Study|Physician Decision|0|||
148810319|NCT03314935|536782609|FG004|Phase 1|Study Terminated by Sponsor|0|||
148810320|NCT03314935|536782610|FG005|Phase 1|Study Terminated by Sponsor|0|||
148689453|NCT01296932|536336456|FG008|Overall Study|Physician Decision|0|||
148689454|NCT01296932|536336448|FG000|Overall Study|IV problems, administration not possible|0|||
148689455|NCT01296932|536336449|FG001|Overall Study|IV problems, administration not possible|0|||
148689456|NCT01296932|536336450|FG002|Overall Study|IV problems, administration not possible|1|||
148689457|NCT01296932|536336451|FG003|Overall Study|IV problems, administration not possible|0|||
148810321|NCT03314935|536782611|FG006|Phase 1|Study Terminated by Sponsor|0|||
148810322|NCT03314935|536782612|FG007|Phase 1|Study Terminated by Sponsor|0|||
148954296|NCT03681405|537314756|FG000|Overall Study|Found to be ineligible after randomized|1|||
148954297|NCT03681405|537314757|FG001|Overall Study|Found to be ineligible after randomized|0|||
148954298|NCT00203996|537314762|FG000|Overall Study|Lost to Follow-up|0|||
148954299|NCT00203996|537314763|FG001|Overall Study|Lost to Follow-up|0|||
148954300|NCT00203996|537314764|FG002|Overall Study|Lost to Follow-up|0|||
148954301|NCT00203996|537314765|FG003|Overall Study|Lost to Follow-up|1|||
148954302|NCT00203996|537314766|FG004|Overall Study|Lost to Follow-up|0|||
148954303|NCT00203996|537314767|FG005|Overall Study|Lost to Follow-up|0|||
148954304|NCT00203996|537314768|FG006|Overall Study|Lost to Follow-up|0|||
148954305|NCT00203996|537314769|FG007|Overall Study|Lost to Follow-up|0|||
148954306|NCT00203996|537314770|FG008|Overall Study|Lost to Follow-up|0|||
148954307|NCT00203996|537314771|FG009|Overall Study|Lost to Follow-up|0|||
148954308|NCT00203996|537314762|FG000|Overall Study|Protocol Violation|0|||
148954309|NCT00203996|537314763|FG001|Overall Study|Protocol Violation|0|||
148954310|NCT00203996|537314764|FG002|Overall Study|Protocol Violation|0|||
148954311|NCT00203996|537314765|FG003|Overall Study|Protocol Violation|6|||
148954312|NCT00203996|537314766|FG004|Overall Study|Protocol Violation|1|||
148954313|NCT00203996|537314767|FG005|Overall Study|Protocol Violation|0|||
148954314|NCT00203996|537314768|FG006|Overall Study|Protocol Violation|0|||
148954315|NCT00203996|537314769|FG007|Overall Study|Protocol Violation|0|||
148954316|NCT00203996|537314770|FG008|Overall Study|Protocol Violation|0|||
148954317|NCT00203996|537314771|FG009|Overall Study|Protocol Violation|0|||
148954318|NCT00203996|537314762|FG000|Overall Study|Physician Decision|0|||
149020307|NCT02892409|537552611|FG001|Overall Study|Adverse Event|0|||
148954319|NCT00203996|537314763|FG001|Overall Study|Physician Decision|0|||
149228839|NCT02079077|538307518|FG001|Overall Study|Lost to Follow-up|7|||
148810323|NCT03314935|536782613|FG008|Phase 1|Study Terminated by Sponsor|1|||
148954320|NCT00203996|537314764|FG002|Overall Study|Physician Decision|0|||
149020308|NCT02892409|537552610|FG000|Overall Study|Withdrawal by Subject|2|||
149020309|NCT02892409|537552611|FG001|Overall Study|Withdrawal by Subject|1|||
149020310|NCT02451930|537552612|FG000|Overall Study|Death|0|||
149020311|NCT02451930|537552613|FG001|Overall Study|Death|15|||
149020312|NCT02451930|537552612|FG000|Overall Study|Lost to Follow-up|0|||
149020313|NCT02451930|537552613|FG001|Overall Study|Lost to Follow-up|3|||
149020314|NCT02451930|537552612|FG000|Overall Study|Sponsor Decision|2|||
149020315|NCT02451930|537552613|FG001|Overall Study|Sponsor Decision|10|||
149020316|NCT02451930|537552612|FG000|Overall Study|Withdrawal by Subject|0|||
149020317|NCT02451930|537552613|FG001|Overall Study|Withdrawal by Subject|1|||
149020318|NCT02451930|537552612|FG000|Overall Study|Other|0|||
149020319|NCT02451930|537552613|FG001|Overall Study|Other|1|||
149020320|NCT03354637|537552618|FG000|Double-blind Period|Protocol Violation|2|||
149020321|NCT03354637|537552619|FG001|Double-blind Period|Protocol Violation|0|||
149020322|NCT03354637|537552620|FG002|Double-blind Period|Protocol Violation|0|||
149020323|NCT03354637|537552618|FG000|Double-blind Period|Adverse Event|1|||
149020324|NCT03354637|537552619|FG001|Double-blind Period|Adverse Event|2|||
149020325|NCT03354637|537552620|FG002|Double-blind Period|Adverse Event|0|||
149020326|NCT03354637|537552618|FG000|Double-blind Period|Lost to Follow-up|3|||
149020327|NCT03354637|537552619|FG001|Double-blind Period|Lost to Follow-up|4|||
149020328|NCT03354637|537552620|FG002|Double-blind Period|Lost to Follow-up|3|||
149020329|NCT03354637|537552618|FG000|Double-blind Period|Withdrawal by Subject|10|||
149020330|NCT03354637|537552619|FG001|Double-blind Period|Withdrawal by Subject|6|||
149020331|NCT03354637|537552620|FG002|Double-blind Period|Withdrawal by Subject|4|||
149020332|NCT03354637|537552618|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
149020333|NCT03354637|537552619|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
149020334|NCT03354637|537552620|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
149020335|NCT03354637|537552618|FG000|Open Label Extension|Adverse Event|0|||
149020336|NCT03354637|537552619|FG001|Open Label Extension|Adverse Event|0|||
149020337|NCT03354637|537552620|FG002|Open Label Extension|Adverse Event|1|||
149020338|NCT03354637|537552618|FG000|Open Label Extension|Lost to Follow-up|0|||
149020339|NCT03354637|537552619|FG001|Open Label Extension|Lost to Follow-up|0|||
149020340|NCT03354637|537552620|FG002|Open Label Extension|Lost to Follow-up|2|||
148689458|NCT01296932|536336452|FG004|Overall Study|IV problems, administration not possible|0|||
148689459|NCT01296932|536336453|FG005|Overall Study|IV problems, administration not possible|0|||
148689460|NCT01296932|536336454|FG006|Overall Study|IV problems, administration not possible|0|||
148689461|NCT01296932|536336455|FG007|Overall Study|IV problems, administration not possible|0|||
148689462|NCT01296932|536336456|FG008|Overall Study|IV problems, administration not possible|0|||
148689463|NCT01296932|536336448|FG000|Overall Study|per protocol|0|||
148689464|NCT01296932|536336449|FG001|Overall Study|per protocol|0|||
148689465|NCT01296932|536336450|FG002|Overall Study|per protocol|1|||
148689466|NCT01296932|536336451|FG003|Overall Study|per protocol|1|||
148689467|NCT01296932|536336452|FG004|Overall Study|per protocol|0|||
148954321|NCT00203996|537314765|FG003|Overall Study|Physician Decision|2|||
148954322|NCT00203996|537314766|FG004|Overall Study|Physician Decision|0|||
148954323|NCT00203996|537314767|FG005|Overall Study|Physician Decision|0|||
148954324|NCT00203996|537314768|FG006|Overall Study|Physician Decision|0|||
148954325|NCT00203996|537314769|FG007|Overall Study|Physician Decision|0|||
148954326|NCT00203996|537314770|FG008|Overall Study|Physician Decision|0|||
148954327|NCT00203996|537314771|FG009|Overall Study|Physician Decision|1|||
148954328|NCT00203996|537314762|FG000|Overall Study|CPAP machine malfunction|0|||
148954329|NCT00203996|537314763|FG001|Overall Study|CPAP machine malfunction|0|||
148954330|NCT00203996|537314764|FG002|Overall Study|CPAP machine malfunction|0|||
148954331|NCT00203996|537314765|FG003|Overall Study|CPAP machine malfunction|1|||
148954332|NCT00203996|537314766|FG004|Overall Study|CPAP machine malfunction|0|||
148954333|NCT00203996|537314767|FG005|Overall Study|CPAP machine malfunction|0|||
148954334|NCT00203996|537314768|FG006|Overall Study|CPAP machine malfunction|0|||
148954335|NCT00203996|537314769|FG007|Overall Study|CPAP machine malfunction|0|||
148954336|NCT00203996|537314770|FG008|Overall Study|CPAP machine malfunction|0|||
148954337|NCT00203996|537314771|FG009|Overall Study|CPAP machine malfunction|0|||
148954338|NCT00203996|537314762|FG000|Overall Study|Scheduling issue|0|||
148954339|NCT00203996|537314763|FG001|Overall Study|Scheduling issue|0|||
149020341|NCT03354637|537552618|FG000|Open Label Extension|Withdrawal by Subject|0|||
149020342|NCT03354637|537552619|FG001|Open Label Extension|Withdrawal by Subject|0|||
149020343|NCT03354637|537552620|FG002|Open Label Extension|Withdrawal by Subject|5|||
148689468|NCT01296932|536336453|FG005|Overall Study|per protocol|0|||
148689469|NCT01296932|536336454|FG006|Overall Study|per protocol|0|||
148689470|NCT01296932|536336455|FG007|Overall Study|per protocol|0|||
148689471|NCT01296932|536336456|FG008|Overall Study|per protocol|0|||
149020344|NCT03354637|537552618|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
149020345|NCT03354637|537552619|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
149020346|NCT03354637|537552620|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
148954340|NCT00203996|537314764|FG002|Overall Study|Scheduling issue|0|||
148954341|NCT00203996|537314765|FG003|Overall Study|Scheduling issue|0|||
149020347|NCT03354637|537552618|FG000|Open Label Extension|Subject Noncompliance|0|||
148954342|NCT00203996|537314766|FG004|Overall Study|Scheduling issue|0|||
148954343|NCT00203996|537314767|FG005|Overall Study|Scheduling issue|0|||
148954344|NCT00203996|537314768|FG006|Overall Study|Scheduling issue|0|||
148954345|NCT00203996|537314769|FG007|Overall Study|Scheduling issue|2|||
148954346|NCT00203996|537314770|FG008|Overall Study|Scheduling issue|0|||
148954347|NCT00203996|537314771|FG009|Overall Study|Scheduling issue|0|||
148954348|NCT00897104|537314774|FG000|Overall Study|Lost to Follow-up|12|||
148954349|NCT00897104|537314775|FG001|Overall Study|Lost to Follow-up|17|||
148954350|NCT00897104|537314776|FG002|Overall Study|Lost to Follow-up|2|||
148954351|NCT00897104|537314774|FG000|Overall Study|Pregnancy|0|||
148954352|NCT00897104|537314775|FG001|Overall Study|Pregnancy|1|||
148954353|NCT00897104|537314776|FG002|Overall Study|Pregnancy|0|||
148954354|NCT00897104|537314774|FG000|Overall Study|Protocol Violation|0|||
148954355|NCT00897104|537314775|FG001|Overall Study|Protocol Violation|1|||
148954356|NCT00897104|537314776|FG002|Overall Study|Protocol Violation|0|||
148954357|NCT00897104|537314774|FG000|Overall Study|Withdrawal by Subject|23|||
148954358|NCT00897104|537314775|FG001|Overall Study|Withdrawal by Subject|27|||
148954359|NCT00897104|537314776|FG002|Overall Study|Withdrawal by Subject|3|||
148954360|NCT00897104|537314774|FG000|Overall Study|Abnormal Prestudy Labs|2|||
148954361|NCT00897104|537314775|FG001|Overall Study|Abnormal Prestudy Labs|0|||
148954362|NCT00897104|537314776|FG002|Overall Study|Abnormal Prestudy Labs|0|||
148954363|NCT00897104|537314774|FG000|Overall Study|Abnormal Baseline ECG|2|||
148954364|NCT00897104|537314775|FG001|Overall Study|Abnormal Baseline ECG|2|||
148954365|NCT00897104|537314776|FG002|Overall Study|Abnormal Baseline ECG|0|||
148954366|NCT00897104|537314774|FG000|Overall Study|Need for Concom. Med.|0|||
148954367|NCT00897104|537314775|FG001|Overall Study|Need for Concom. Med.|1|||
148954368|NCT00897104|537314776|FG002|Overall Study|Need for Concom. Med.|1|||
148954369|NCT00897104|537314774|FG000|Overall Study|Lack of Migraine Attack|20|||
148954370|NCT00897104|537314775|FG001|Overall Study|Lack of Migraine Attack|22|||
148954371|NCT00897104|537314776|FG002|Overall Study|Lack of Migraine Attack|1|||
148954372|NCT00897104|537314774|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
148954373|NCT00897104|537314775|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
148954374|NCT00897104|537314776|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
148954375|NCT00897104|537314774|FG000|Overall Study|Other|3|||
148954376|NCT00897104|537314775|FG001|Overall Study|Other|0|||
148954377|NCT00897104|537314776|FG002|Overall Study|Other|0|||
148954378|NCT00897104|537314774|FG000|Overall Study|Protocol Violation|1|||
148954379|NCT00897104|537314775|FG001|Overall Study|Protocol Violation|0|||
148954380|NCT00897104|537314776|FG002|Overall Study|Protocol Violation|0|||
148954381|NCT00897104|537314774|FG000|Overall Study|Withdrawal by Subject|0|||
148954382|NCT00897104|537314775|FG001|Overall Study|Withdrawal by Subject|0|||
148954383|NCT00897104|537314776|FG002|Overall Study|Withdrawal by Subject|1|||
148954384|NCT03789318|537314777|FG000|Overall Study|Adverse Event|0|||
148954385|NCT03789318|537314778|FG001|Overall Study|Adverse Event|0|||
148954386|NCT03789318|537314779|FG002|Overall Study|Adverse Event|1|||
148954387|NCT03789318|537314780|FG003|Overall Study|Adverse Event|1|||
148954388|NCT03789318|537314781|FG004|Overall Study|Adverse Event|0|||
148954389|NCT03789318|537314777|FG000|Overall Study|Lost to Follow-up|0|||
149228840|NCT02079077|538307517|FG000|Overall Study|Became STIs Positive|1|||
149228841|NCT02079077|538307518|FG001|Overall Study|Became STIs Positive|2|||
149228842|NCT02087085|538307525|FG000|Overall Study|Adverse Event|10|||
149228843|NCT02087085|538307526|FG001|Overall Study|Adverse Event|14|||
149228844|NCT02087085|538307525|FG000|Overall Study|Lack of Efficacy|4|||
149228845|NCT02087085|538307526|FG001|Overall Study|Lack of Efficacy|3|||
149228846|NCT02087085|538307525|FG000|Overall Study|Lost to Follow-up|6|||
149228847|NCT02087085|538307526|FG001|Overall Study|Lost to Follow-up|4|||
149228848|NCT02087085|538307525|FG000|Overall Study|Withdrawal by Subject|9|||
149228849|NCT02087085|538307526|FG001|Overall Study|Withdrawal by Subject|11|||
149228850|NCT02087085|538307525|FG000|Overall Study|Protocol Violation|1|||
149228851|NCT02087085|538307526|FG001|Overall Study|Protocol Violation|0|||
149228852|NCT02087085|538307525|FG000|Overall Study|Study Terminated by Sponsor|87|||
149228853|NCT02087085|538307526|FG001|Overall Study|Study Terminated by Sponsor|80|||
149228854|NCT02087085|538307525|FG000|Overall Study|Other Miscellaneous Reasons|3|||
149228855|NCT02087085|538307526|FG001|Overall Study|Other Miscellaneous Reasons|4|||
149228856|NCT00635804|538307527|FG000|Overall Study|Adverse Event|0|||
149228857|NCT00635804|538307528|FG001|Overall Study|Adverse Event|0|||
149228858|NCT00635804|538307529|FG002|Overall Study|Adverse Event|0|||
149228859|NCT00635804|538307530|FG003|Overall Study|Adverse Event|0|||
149228860|NCT00635804|538307531|FG004|Overall Study|Adverse Event|0|||
149228861|NCT00635804|538307532|FG005|Overall Study|Adverse Event|1|||
149228862|NCT00635804|538307533|FG006|Overall Study|Adverse Event|0|||
149228863|NCT00635804|538307534|FG007|Overall Study|Adverse Event|0|||
149228864|NCT00635804|538307527|FG000|Overall Study|Withdrawal by Subject|1|||
149228865|NCT00635804|538307528|FG001|Overall Study|Withdrawal by Subject|0|||
149228866|NCT00635804|538307529|FG002|Overall Study|Withdrawal by Subject|0|||
149228867|NCT00635804|538307530|FG003|Overall Study|Withdrawal by Subject|0|||
149228868|NCT00635804|538307531|FG004|Overall Study|Withdrawal by Subject|0|||
149228869|NCT00635804|538307532|FG005|Overall Study|Withdrawal by Subject|0|||
149228870|NCT00635804|538307533|FG006|Overall Study|Withdrawal by Subject|0|||
149228871|NCT00635804|538307534|FG007|Overall Study|Withdrawal by Subject|0|||
149228872|NCT01425268|538307542|FG000|Overall Study|Withdrawal by Subject|2|||
149228873|NCT01425268|538307543|FG001|Overall Study|Withdrawal by Subject|0|||
149228874|NCT01425268|538307542|FG000|Overall Study|Sponsor Decision|5|||
149228875|NCT01425268|538307543|FG001|Overall Study|Sponsor Decision|0|||
149228876|NCT01425268|538307542|FG000|Overall Study|Physician Decision|1|||
149228877|NCT01425268|538307543|FG001|Overall Study|Physician Decision|0|||
149228878|NCT00719706|538307544|FG000|Overall Study|Adverse Event|5|||
149228879|NCT00719706|538307545|FG001|Overall Study|Adverse Event|4|||
149228880|NCT00719706|538307544|FG000|Overall Study|Withdrawal by Subject|1|||
148689472|NCT01296932|536336448|FG000|Overall Study|Low benefit and too many side effects|0|||
148689473|NCT01296932|536336449|FG001|Overall Study|Low benefit and too many side effects|0|||
148689474|NCT01296932|536336450|FG002|Overall Study|Low benefit and too many side effects|0|||
148689475|NCT01296932|536336451|FG003|Overall Study|Low benefit and too many side effects|0|||
148689476|NCT01296932|536336452|FG004|Overall Study|Low benefit and too many side effects|0|||
148689477|NCT01296932|536336453|FG005|Overall Study|Low benefit and too many side effects|0|||
148689478|NCT01296932|536336454|FG006|Overall Study|Low benefit and too many side effects|0|||
148689479|NCT01296932|536336455|FG007|Overall Study|Low benefit and too many side effects|1|||
148689480|NCT01296932|536336456|FG008|Overall Study|Low benefit and too many side effects|0|||
148689481|NCT01296932|536336448|FG000|Overall Study|No adequate treatment response|0|||
148689482|NCT01296932|536336449|FG001|Overall Study|No adequate treatment response|0|||
148689483|NCT01296932|536336450|FG002|Overall Study|No adequate treatment response|0|||
148689484|NCT01296932|536336451|FG003|Overall Study|No adequate treatment response|0|||
148689485|NCT01296932|536336452|FG004|Overall Study|No adequate treatment response|0|||
148689486|NCT01296932|536336453|FG005|Overall Study|No adequate treatment response|0|||
148689487|NCT01296932|536336454|FG006|Overall Study|No adequate treatment response|0|||
148689488|NCT01296932|536336455|FG007|Overall Study|No adequate treatment response|1|||
148689489|NCT01296932|536336456|FG008|Overall Study|No adequate treatment response|0|||
148689490|NCT01296932|536336448|FG000|Overall Study|Dosage already reduced, AE still present|0|||
149228881|NCT00719706|538307545|FG001|Overall Study|Withdrawal by Subject|2|||
149228882|NCT00719706|538307544|FG000|Overall Study|Protocol Violation|3|||
149228883|NCT00719706|538307545|FG001|Overall Study|Protocol Violation|0|||
149228884|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
149228885|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
149228886|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
149228887|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
149228888|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
149228889|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
149228890|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
149228891|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
149228892|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
149234096|NCT01243762|538326388|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149228893|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
149228894|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
149228895|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
149228896|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
149228897|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
149228898|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
149228899|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|Other|6|||
149228900|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|Other|6|||
149228901|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|Other|7|||
149228902|NCT02681094|538307546|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
149228903|NCT02681094|538307547|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
149228904|NCT02681094|538307548|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
149228905|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|Participant decision|7|||
149228906|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|Participant decision|10|||
149228907|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|Participant decision|9|||
149228908|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
149228909|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
149228910|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
149228911|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
149228912|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
149228913|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
149228914|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
149228915|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
149228916|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
149228917|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
149228918|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
149228919|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
149228920|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|Other|6|||
149228921|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|Other|6|||
149228922|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|Other|7|||
149228923|NCT02681094|538307546|FG000|2 - Enrolled Participants Set|No treatment given|0|||
149228924|NCT02681094|538307547|FG001|2 - Enrolled Participants Set|No treatment given|1|||
149228925|NCT02681094|538307548|FG002|2 - Enrolled Participants Set|No treatment given|1|||
149228926|NCT03382639|538307549|FG000|Overall Study|Adverse Event|2|||
149228927|NCT03382639|538307550|FG001|Overall Study|Adverse Event|0|||
149228928|NCT03382639|538307551|FG002|Overall Study|Adverse Event|1|||
149228929|NCT03382639|538307552|FG003|Overall Study|Adverse Event|1|||
149228930|NCT03382639|538307549|FG000|Overall Study|Lost to Follow-up|1|||
149228931|NCT03382639|538307550|FG001|Overall Study|Lost to Follow-up|0|||
149228932|NCT03382639|538307551|FG002|Overall Study|Lost to Follow-up|0|||
149228933|NCT03382639|538307552|FG003|Overall Study|Lost to Follow-up|0|||
149228934|NCT03382639|538307549|FG000|Overall Study|Withdrawal by Subject|4|||
149228935|NCT03382639|538307550|FG001|Overall Study|Withdrawal by Subject|3|||
149228936|NCT03382639|538307551|FG002|Overall Study|Withdrawal by Subject|2|||
149228937|NCT03382639|538307552|FG003|Overall Study|Withdrawal by Subject|3|||
149228938|NCT03382639|538307549|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
149228939|NCT03382639|538307550|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
149228940|NCT03382639|538307551|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
149228941|NCT03382639|538307552|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
149228942|NCT03382639|538307549|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
149228943|NCT03382639|538307550|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
149228944|NCT03382639|538307551|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
149228945|NCT03382639|538307552|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
149228946|NCT03382639|538307549|FG000|Overall Study|Other|2|||
149228947|NCT03382639|538307550|FG001|Overall Study|Other|0|||
149228948|NCT03382639|538307551|FG002|Overall Study|Other|0|||
149228949|NCT03382639|538307552|FG003|Overall Study|Other|3|||
149228950|NCT01072175|538307555|FG000|Part A (Drug-Drug Interaction)|Death|1|||
149228951|NCT01072175|538307556|FG001|Part A (Drug-Drug Interaction)|Death|0|||
149228952|NCT01072175|538307557|FG002|Part A (Drug-Drug Interaction)|Death|0|||
149228953|NCT01072175|538307558|FG003|Part A (Drug-Drug Interaction)|Death|0|||
149228954|NCT01072175|538307559|FG004|Part A (Drug-Drug Interaction)|Death|0|||
149228955|NCT01072175|538307560|FG005|Part A (Drug-Drug Interaction)|Death|0|||
149228956|NCT01072175|538307561|FG006|Part A (Drug-Drug Interaction)|Death|0|||
149228957|NCT01072175|538307562|FG007|Part A (Drug-Drug Interaction)|Death|0|||
149228958|NCT01072175|538307563|FG008|Part A (Drug-Drug Interaction)|Death|0|||
149228959|NCT01072175|538307564|FG009|Part A (Drug-Drug Interaction)|Death|0|||
149228960|NCT01072175|538307565|FG010|Part A (Drug-Drug Interaction)|Death|0|||
149228961|NCT01072175|538307566|FG011|Part A (Drug-Drug Interaction)|Death|0|||
149228962|NCT01072175|538307567|FG012|Part A (Drug-Drug Interaction)|Death|0|||
149228963|NCT01072175|538307555|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
149228964|NCT01072175|538307556|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228965|NCT01072175|538307557|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228966|NCT01072175|538307558|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228967|NCT01072175|538307559|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228968|NCT01072175|538307560|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228969|NCT01072175|538307561|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228970|NCT01072175|538307562|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228971|NCT01072175|538307563|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228972|NCT01072175|538307564|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228973|NCT01072175|538307565|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228974|NCT01072175|538307566|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228975|NCT01072175|538307567|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
149228976|NCT01072175|538307555|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
149228977|NCT01072175|538307556|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228978|NCT01072175|538307557|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228979|NCT01072175|538307558|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228980|NCT01072175|538307559|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228981|NCT01072175|538307560|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228982|NCT01072175|538307561|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228983|NCT01072175|538307562|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228984|NCT01072175|538307563|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228985|NCT01072175|538307564|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228986|NCT01072175|538307565|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228987|NCT01072175|538307566|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228988|NCT01072175|538307567|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
149228989|NCT01072175|538307555|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
149228990|NCT01072175|538307556|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
149228991|NCT01072175|538307557|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
149228992|NCT01072175|538307558|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
149228993|NCT01072175|538307559|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
149228994|NCT01072175|538307560|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
149228995|NCT01072175|538307561|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
149228996|NCT01072175|538307562|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
149228997|NCT01072175|538307563|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
149228998|NCT01072175|538307564|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
149228999|NCT01072175|538307565|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
149229000|NCT01072175|538307566|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
149229001|NCT01072175|538307567|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
149229002|NCT01072175|538307555|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229003|NCT01072175|538307556|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229004|NCT01072175|538307557|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
149229005|NCT01072175|538307558|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229006|NCT01072175|538307559|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
149229007|NCT01072175|538307560|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229008|NCT01072175|538307561|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229009|NCT01072175|538307562|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229010|NCT01072175|538307563|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229011|NCT01072175|538307564|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229012|NCT01072175|538307565|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229013|NCT01072175|538307566|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229014|NCT01072175|538307567|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
149229015|NCT01072175|538307555|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229016|NCT01072175|538307556|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
149229017|NCT01072175|538307557|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229018|NCT01072175|538307558|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
148689491|NCT01296932|536336449|FG001|Overall Study|Dosage already reduced, AE still present|0|||
148954390|NCT03789318|537314778|FG001|Overall Study|Lost to Follow-up|0|||
148954391|NCT03789318|537314779|FG002|Overall Study|Lost to Follow-up|1|||
148954392|NCT03789318|537314780|FG003|Overall Study|Lost to Follow-up|0|||
148954393|NCT03789318|537314781|FG004|Overall Study|Lost to Follow-up|0|||
148954394|NCT03789318|537314777|FG000|Overall Study|Withdrawal by Subject|0|||
148954395|NCT03789318|537314778|FG001|Overall Study|Withdrawal by Subject|0|||
148954396|NCT03789318|537314779|FG002|Overall Study|Withdrawal by Subject|1|||
148954397|NCT03789318|537314780|FG003|Overall Study|Withdrawal by Subject|0|||
148954398|NCT03789318|537314781|FG004|Overall Study|Withdrawal by Subject|0|||
148689492|NCT01296932|536336450|FG002|Overall Study|Dosage already reduced, AE still present|0|||
148689493|NCT01296932|536336451|FG003|Overall Study|Dosage already reduced, AE still present|0|||
148689494|NCT01296932|536336452|FG004|Overall Study|Dosage already reduced, AE still present|0|||
148689495|NCT01296932|536336453|FG005|Overall Study|Dosage already reduced, AE still present|0|||
148689496|NCT01296932|536336454|FG006|Overall Study|Dosage already reduced, AE still present|0|||
148689497|NCT01296932|536336455|FG007|Overall Study|Dosage already reduced, AE still present|0|||
148689498|NCT01296932|536336456|FG008|Overall Study|Dosage already reduced, AE still present|1|||
148689499|NCT03731182|536336457|FG000|Overall Study|Lost to Follow-up|2|||
148689500|NCT03731182|536336458|FG001|Overall Study|Lost to Follow-up|0|||
148689501|NCT03731182|536336457|FG000|Overall Study|Physician Decision|1|||
148689502|NCT03731182|536336458|FG001|Overall Study|Physician Decision|0|||
148689503|NCT03731182|536336457|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
148689504|NCT03731182|536336458|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
148689505|NCT02006706|536336459|FG000|Overall Study|Lost to Follow-up|1|||
148689506|NCT04161144|536336460|FG000|Overall Study|Withdrawal by Subject|0|||
148689507|NCT04161144|536336461|FG001|Overall Study|Withdrawal by Subject|1|||
148689508|NCT04161144|536336460|FG000|Overall Study|Protocol Violation|1|||
148689509|NCT04161144|536336461|FG001|Overall Study|Protocol Violation|0|||
148689510|NCT02207621|536336463|FG000|Overall Study|Adverse Event|71|||
148689511|NCT02207621|536336464|FG001|Overall Study|Adverse Event|15|||
148689512|NCT02207621|536336465|FG002|Overall Study|Adverse Event|132|||
148689513|NCT02207621|536336463|FG000|Overall Study|Withdrawal by Subject|9|||
148689514|NCT02207621|536336464|FG001|Overall Study|Withdrawal by Subject|9|||
148689515|NCT02207621|536336465|FG002|Overall Study|Withdrawal by Subject|13|||
148689516|NCT02207621|536336463|FG000|Overall Study|Non-Compliant|3|||
148689517|NCT02207621|536336464|FG001|Overall Study|Non-Compliant|3|||
148689518|NCT02207621|536336465|FG002|Overall Study|Non-Compliant|1|||
148689519|NCT02207621|536336463|FG000|Overall Study|Lost to Follow-up|1|||
148689520|NCT02207621|536336464|FG001|Overall Study|Lost to Follow-up|0|||
148689521|NCT02207621|536336465|FG002|Overall Study|Lost to Follow-up|3|||
148689522|NCT02207621|536336463|FG000|Overall Study|Lack of Efficacy|10|||
148689523|NCT02207621|536336464|FG001|Overall Study|Lack of Efficacy|2|||
148689524|NCT02207621|536336465|FG002|Overall Study|Lack of Efficacy|4|||
148689525|NCT02207621|536336463|FG000|Overall Study|Disallowed Concurrent Medication|2|||
148689526|NCT02207621|536336464|FG001|Overall Study|Disallowed Concurrent Medication|5|||
148689527|NCT02207621|536336465|FG002|Overall Study|Disallowed Concurrent Medication|2|||
148689528|NCT02207621|536336463|FG000|Overall Study|Physician Decision|1|||
148689529|NCT02207621|536336464|FG001|Overall Study|Physician Decision|2|||
148689530|NCT02207621|536336465|FG002|Overall Study|Physician Decision|2|||
148689531|NCT02207621|536336463|FG000|Overall Study|Protocol Violation|4|||
148689532|NCT02207621|536336464|FG001|Overall Study|Protocol Violation|10|||
148689533|NCT02207621|536336465|FG002|Overall Study|Protocol Violation|6|||
148689534|NCT02207621|536336463|FG000|Overall Study|Death|2|||
148689535|NCT02207621|536336464|FG001|Overall Study|Death|0|||
148689536|NCT02207621|536336465|FG002|Overall Study|Death|0|||
148689537|NCT02207621|536336463|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
148689538|NCT02207621|536336464|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
148689539|NCT02207621|536336465|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
148689540|NCT00958256|536336466|FG000|Overall Study|Adverse Event|3|||
148689541|NCT03036579|536336470|FG000|2 Years|Lost to Follow-up|1|||
148689542|NCT03036579|536336471|FG001|2 Years|Lost to Follow-up|0|||
148689543|NCT03036579|536336470|FG000|3 Years|Lost to Follow-up|0|||
148689544|NCT03036579|536336471|FG001|3 Years|Lost to Follow-up|1|||
148689545|NCT02848599|536336472|FG000|Overall Study|Protocol Violation|7|||
148689546|NCT02848599|536336473|FG001|Overall Study|Protocol Violation|9|||
148689547|NCT05431153|536336474|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
148689548|NCT05431153|536336475|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
148810324|NCT03314935|536782614|FG009|Phase 1|Study Terminated by Sponsor|0|||
148689549|NCT05431153|536336476|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
148689550|NCT05431153|536336477|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
148954399|NCT04818840|537314782|FG000|Overall Study|Lost to Follow-up|0|||
148689551|NCT05431153|536336478|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
148689552|NCT05431153|536336479|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
148689553|NCT04828161|536336480|FG000|Overall Study|Withdrawal by Subject|0|||
148689554|NCT04828161|536336481|FG001|Overall Study|Withdrawal by Subject|3|||
148689555|NCT04828161|536336482|FG002|Overall Study|Withdrawal by Subject|3|||
148810325|NCT03314935|536782615|FG010|Phase 1|Study Terminated by Sponsor|0|||
148810326|NCT03314935|536782616|FG011|Phase 1|Study Terminated by Sponsor|0|||
148810327|NCT03314935|536782617|FG012|Phase 1|Study Terminated by Sponsor|0|||
148810328|NCT03314935|536782618|FG013|Phase 1|Study Terminated by Sponsor|0|||
148810329|NCT03314935|536782619|FG014|Phase 1|Study Terminated by Sponsor|0|||
148954400|NCT04818840|537314783|FG001|Overall Study|Lost to Follow-up|5|||
148810330|NCT03314935|536782605|FG000|Phase 1|"Captured as Other in Database"|0|||
148810331|NCT03314935|536782606|FG001|Phase 1|"Captured as Other in Database"|2|||
148810332|NCT03314935|536782607|FG002|Phase 1|"Captured as Other in Database"|0|||
148810333|NCT03314935|536782608|FG003|Phase 1|"Captured as Other in Database"|0|||
148810334|NCT03314935|536782609|FG004|Phase 1|"Captured as Other in Database"|0|||
148810335|NCT03314935|536782610|FG005|Phase 1|"Captured as Other in Database"|0|||
148810336|NCT03314935|536782611|FG006|Phase 1|"Captured as Other in Database"|1|||
148810337|NCT03314935|536782612|FG007|Phase 1|"Captured as Other in Database"|1|||
148810338|NCT03314935|536782613|FG008|Phase 1|"Captured as Other in Database"|1|||
148810339|NCT03314935|536782614|FG009|Phase 1|"Captured as Other in Database"|0|||
148810340|NCT03314935|536782615|FG010|Phase 1|"Captured as Other in Database"|0|||
148810341|NCT03314935|536782616|FG011|Phase 1|"Captured as Other in Database"|0|||
148810342|NCT03314935|536782617|FG012|Phase 1|"Captured as Other in Database"|0|||
148810343|NCT03314935|536782618|FG013|Phase 1|"Captured as Other in Database"|0|||
148689556|NCT04828161|536336483|FG003|Overall Study|Withdrawal by Subject|4|||
148689557|NCT04828161|536336480|FG000|Overall Study|Lost to Follow-up|1|||
148689558|NCT04828161|536336481|FG001|Overall Study|Lost to Follow-up|4|||
148689559|NCT04828161|536336482|FG002|Overall Study|Lost to Follow-up|2|||
148689560|NCT04828161|536336483|FG003|Overall Study|Lost to Follow-up|2|||
148689561|NCT04828161|536336480|FG000|Overall Study|Other|2|||
148689562|NCT04828161|536336481|FG001|Overall Study|Other|0|||
148689563|NCT04828161|536336482|FG002|Overall Study|Other|2|||
148810344|NCT03314935|536782619|FG014|Phase 1|"Captured as Other in Database"|0|||
148810345|NCT03314935|536782605|FG000|Phase 1|Lost to Follow-up|0|||
148810346|NCT03314935|536782606|FG001|Phase 1|Lost to Follow-up|0|||
148954401|NCT04818840|537314782|FG000|Overall Study|Physician Decision|1|||
148954402|NCT04818840|537314783|FG001|Overall Study|Physician Decision|0|||
148954403|NCT04818840|537314782|FG000|Overall Study|Site Terminated by Sponsor|0|||
148954404|NCT04818840|537314783|FG001|Overall Study|Site Terminated by Sponsor|3|||
148954405|NCT04818840|537314782|FG000|Overall Study|Study Terminated by Sponsor|43|||
148954406|NCT04818840|537314783|FG001|Overall Study|Study Terminated by Sponsor|7|||
148954407|NCT04818840|537314782|FG000|Overall Study|Withdrawal by Subject|0|||
148954408|NCT04818840|537314783|FG001|Overall Study|Withdrawal by Subject|1|||
148954409|NCT00733408|537317090|FG000|Overall Study|Adverse Event|4|||
148954410|NCT00224055|537317091|FG000|Overall Study|Adverse Event|9|||
148954411|NCT00224055|537317092|FG001|Overall Study|Adverse Event|3|||
148954412|NCT00224055|537317091|FG000|Overall Study|Lost to Follow-up|1|||
148954413|NCT00224055|537317092|FG001|Overall Study|Lost to Follow-up|2|||
148954414|NCT00224055|537317091|FG000|Overall Study|Protocol Violation|1|||
148954415|NCT00224055|537317092|FG001|Overall Study|Protocol Violation|1|||
148954416|NCT00224055|537317091|FG000|Overall Study|Inclusion Violation|3|||
148954417|NCT00224055|537317092|FG001|Overall Study|Inclusion Violation|6|||
148954418|NCT00224055|537317091|FG000|Overall Study|Withdrawal by Subject|0|||
148954419|NCT00224055|537317092|FG001|Overall Study|Withdrawal by Subject|2|||
148954420|NCT00224055|537317091|FG000|Overall Study|Other|1|||
148954421|NCT00224055|537317092|FG001|Overall Study|Other|0|||
148954422|NCT02014597|537317093|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
148954423|NCT02014597|537317094|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
148954424|NCT05126901|537317095|FG000|Overall Study|Withdrawal by Subject|1|||
148954425|NCT05126901|537317096|FG001|Overall Study|Withdrawal by Subject|1|||
148954426|NCT05126901|537317097|FG002|Overall Study|Withdrawal by Subject|4|||
148954427|NCT05126901|537317095|FG000|Overall Study|Adverse Event|0|||
148954428|NCT05126901|537317096|FG001|Overall Study|Adverse Event|0|||
148954429|NCT05126901|537317097|FG002|Overall Study|Adverse Event|1|||
149229019|NCT01072175|538307559|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
149229020|NCT01072175|538307560|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229021|NCT01072175|538307561|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229022|NCT01072175|538307562|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229023|NCT01072175|538307563|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229024|NCT01072175|538307564|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229025|NCT01072175|538307565|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229026|NCT01072175|538307566|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
148689564|NCT04828161|536336483|FG003|Overall Study|Other|0|||
148810347|NCT03314935|536782607|FG002|Phase 1|Lost to Follow-up|0|||
148810348|NCT03314935|536782608|FG003|Phase 1|Lost to Follow-up|0|||
148810349|NCT03314935|536782609|FG004|Phase 1|Lost to Follow-up|0|||
148810350|NCT03314935|536782610|FG005|Phase 1|Lost to Follow-up|0|||
148810351|NCT03314935|536782611|FG006|Phase 1|Lost to Follow-up|0|||
148810352|NCT03314935|536782612|FG007|Phase 1|Lost to Follow-up|0|||
148810353|NCT03314935|536782613|FG008|Phase 1|Lost to Follow-up|1|||
148810354|NCT03314935|536782614|FG009|Phase 1|Lost to Follow-up|0|||
148954430|NCT05126901|537317095|FG000|Overall Study|Lost to Follow-up|0|||
148810355|NCT03314935|536782615|FG010|Phase 1|Lost to Follow-up|0|||
148810356|NCT03314935|536782616|FG011|Phase 1|Lost to Follow-up|0|||
148810357|NCT03314935|536782617|FG012|Phase 1|Lost to Follow-up|0|||
148810358|NCT03314935|536782618|FG013|Phase 1|Lost to Follow-up|0|||
148810359|NCT03314935|536782619|FG014|Phase 1|Lost to Follow-up|0|||
148810360|NCT03314935|536782605|FG000|Phase 2|Death|0|||
148810361|NCT03314935|536782606|FG001|Phase 2|Death|0|||
148810362|NCT03314935|536782607|FG002|Phase 2|Death|0|||
148810363|NCT03314935|536782608|FG003|Phase 2|Death|0|||
148810364|NCT03314935|536782609|FG004|Phase 2|Death|0|||
148810365|NCT03314935|536782610|FG005|Phase 2|Death|0|||
148954431|NCT05126901|537317096|FG001|Overall Study|Lost to Follow-up|2|||
148954432|NCT05126901|537317097|FG002|Overall Study|Lost to Follow-up|0|||
148954433|NCT00754624|537317098|FG000|Overall Study|Adverse Event|16|||
148954434|NCT00754624|537317098|FG000|Overall Study|Death|1|||
148810366|NCT03314935|536782611|FG006|Phase 2|Death|0|||
148810367|NCT03314935|536782612|FG007|Phase 2|Death|0|||
148810368|NCT03314935|536782613|FG008|Phase 2|Death|0|||
148954435|NCT00754624|537317098|FG000|Overall Study|Physician Decision|8|||
148810369|NCT03314935|536782614|FG009|Phase 2|Death|5|||
148810370|NCT03314935|536782615|FG010|Phase 2|Death|20|||
149229027|NCT01072175|538307567|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
149229028|NCT01072175|538307555|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229029|NCT01072175|538307556|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229030|NCT01072175|538307557|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
149229031|NCT01072175|538307558|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
149229032|NCT01072175|538307559|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
149229033|NCT01072175|538307560|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229034|NCT01072175|538307561|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229035|NCT01072175|538307562|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229036|NCT01072175|538307563|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229037|NCT01072175|538307564|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229038|NCT01072175|538307565|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229039|NCT01072175|538307566|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229040|NCT01072175|538307567|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
149229041|NCT01072175|538307555|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229042|NCT01072175|538307556|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
149229043|NCT01072175|538307557|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229044|NCT01072175|538307558|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
149229045|NCT01072175|538307559|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
149229046|NCT01072175|538307560|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229047|NCT01072175|538307561|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229048|NCT01072175|538307562|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229049|NCT01072175|538307563|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229050|NCT01072175|538307564|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229051|NCT01072175|538307565|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229052|NCT01072175|538307566|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229053|NCT01072175|538307567|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
149229054|NCT01072175|538307555|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
149229055|NCT01072175|538307556|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
149229056|NCT01072175|538307557|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
149229057|NCT01072175|538307558|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
149229058|NCT01072175|538307559|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
149229059|NCT01072175|538307560|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
149229060|NCT01072175|538307561|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
149229061|NCT01072175|538307562|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
149229062|NCT01072175|538307563|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
149229063|NCT01072175|538307564|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
149229064|NCT01072175|538307565|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
149229065|NCT01072175|538307566|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
149229066|NCT01072175|538307567|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
149229067|NCT01072175|538307555|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229068|NCT01072175|538307556|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229069|NCT01072175|538307557|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229070|NCT01072175|538307558|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229071|NCT01072175|538307559|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229072|NCT01072175|538307560|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
149229073|NCT01072175|538307561|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
149229074|NCT01072175|538307562|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
149229075|NCT01072175|538307563|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229076|NCT01072175|538307564|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229077|NCT01072175|538307565|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229078|NCT01072175|538307566|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229079|NCT01072175|538307567|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
149229080|NCT01072175|538307555|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229081|NCT01072175|538307556|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229082|NCT01072175|538307557|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
148810371|NCT03314935|536782616|FG011|Phase 2|Death|6|||
148810372|NCT03314935|536782617|FG012|Phase 2|Death|7|||
148810373|NCT03314935|536782618|FG013|Phase 2|Death|6|||
148810374|NCT03314935|536782619|FG014|Phase 2|Death|17|||
148810375|NCT03314935|536782605|FG000|Phase 2|Withdrawal by Subject|0|||
148810376|NCT03314935|536782606|FG001|Phase 2|Withdrawal by Subject|0|||
148810377|NCT03314935|536782607|FG002|Phase 2|Withdrawal by Subject|0|||
148810378|NCT03314935|536782608|FG003|Phase 2|Withdrawal by Subject|0|||
148954436|NCT00754624|537317098|FG000|Overall Study|Protocol Violation|1|||
148810379|NCT03314935|536782609|FG004|Phase 2|Withdrawal by Subject|0|||
148689565|NCT04828161|536336480|FG000|Overall Study|Death|0|||
148810380|NCT03314935|536782610|FG005|Phase 2|Withdrawal by Subject|0|||
148954437|NCT00754624|537317098|FG000|Overall Study|Withdrawal by Subject|28|||
148954438|NCT00754624|537317098|FG000|Overall Study|Various|12|||
148954439|NCT00754624|537317098|FG000|Overall Study|Lost to Follow-up|3|||
148954440|NCT04067544|537317099|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
148954441|NCT00931762|537317100|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
148954442|NCT00931762|537317100|FG000|Overall Study|Administrative Problems|5|||
148954443|NCT00931762|537317100|FG000|Overall Study|Death|1|||
148954444|NCT00931762|537317100|FG000|Overall Study|Disease Progression|3|||
148954445|NCT00931762|537317100|FG000|Overall Study|Adverse Event (s)|11|||
148954446|NCT00931762|537317100|FG000|Overall Study|Subject withdrew consent|13|||
148954447|NCT01320085|537317101|FG000|Overall Study|Disease Progression|26|||
148954448|NCT01320085|537317102|FG001|Overall Study|Disease Progression|93|||
148954449|NCT01320085|537317103|FG002|Overall Study|Disease Progression|17|||
148954450|NCT01320085|537317101|FG000|Overall Study|Adverse Event|12|||
148954451|NCT01320085|537317102|FG001|Overall Study|Adverse Event|20|||
148954452|NCT01320085|537317103|FG002|Overall Study|Adverse Event|5|||
148954453|NCT01320085|537317101|FG000|Overall Study|Withdrawal by Subject|2|||
148954454|NCT01320085|537317102|FG001|Overall Study|Withdrawal by Subject|4|||
148954455|NCT01320085|537317103|FG002|Overall Study|Withdrawal by Subject|1|||
148954456|NCT01320085|537317101|FG000|Overall Study|Protocol Deviation|1|||
148954457|NCT01320085|537317102|FG001|Overall Study|Protocol Deviation|0|||
148954458|NCT01320085|537317103|FG002|Overall Study|Protocol Deviation|1|||
148954459|NCT01320085|537317101|FG000|Overall Study|Administrative problems|0|||
148954460|NCT01320085|537317102|FG001|Overall Study|Administrative problems|0|||
148954461|NCT01320085|537317103|FG002|Overall Study|Administrative problems|1|||
148954462|NCT01702454|537317104|FG000|Overall Study|Consent withdrawal|0|||
148954463|NCT01702454|537317105|FG001|Overall Study|Consent withdrawal|1|||
149229083|NCT01072175|538307558|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229084|NCT01072175|538307559|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229085|NCT01072175|538307560|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229086|NCT01072175|538307561|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
149229087|NCT01072175|538307562|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
149229088|NCT01072175|538307563|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229089|NCT01072175|538307564|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229090|NCT01072175|538307565|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229091|NCT01072175|538307566|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229092|NCT01072175|538307567|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
149229093|NCT01072175|538307555|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229094|NCT01072175|538307556|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229095|NCT01072175|538307557|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229096|NCT01072175|538307558|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229097|NCT01072175|538307559|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229098|NCT01072175|538307560|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
149229099|NCT01072175|538307561|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
149229100|NCT01072175|538307562|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
149229101|NCT01072175|538307563|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229102|NCT01072175|538307564|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229103|NCT01072175|538307565|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229104|NCT01072175|538307566|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229105|NCT01072175|538307567|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
149229106|NCT01072175|538307555|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229107|NCT01072175|538307556|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229108|NCT01072175|538307557|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229109|NCT01072175|538307558|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229110|NCT01072175|538307559|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229111|NCT01072175|538307560|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
149229112|NCT01072175|538307561|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
149229113|NCT01072175|538307562|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229114|NCT01072175|538307563|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229115|NCT01072175|538307564|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229116|NCT01072175|538307565|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
148954464|NCT01702454|537317104|FG000|Overall Study|Migrated/moved from study area|0|||
148954465|NCT01702454|537317105|FG001|Overall Study|Migrated/moved from study area|1|||
148954466|NCT01702454|537317104|FG000|Overall Study|Lost to Follow-up|3|||
148954467|NCT01702454|537317105|FG001|Overall Study|Lost to Follow-up|6|||
148954468|NCT00710710|537317106|FG000|Overall Study|Consent withdrawn|2|||
148954469|NCT00710710|537317107|FG001|Overall Study|Consent withdrawn|2|||
148954470|NCT00710710|537317106|FG000|Overall Study|Protocol Violation|0|||
149020348|NCT03354637|537552619|FG001|Open Label Extension|Subject Noncompliance|0|||
148954471|NCT00710710|537317107|FG001|Overall Study|Protocol Violation|1|||
148810381|NCT03314935|536782611|FG006|Phase 2|Withdrawal by Subject|0|||
149229117|NCT01072175|538307566|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229118|NCT01072175|538307567|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
149229119|NCT01072175|538307555|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229120|NCT01072175|538307556|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229121|NCT01072175|538307557|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229122|NCT01072175|538307558|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229123|NCT01072175|538307559|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229124|NCT01072175|538307560|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229125|NCT01072175|538307561|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229126|NCT01072175|538307562|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229127|NCT01072175|538307563|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
149229128|NCT01072175|538307564|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229129|NCT01072175|538307565|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229130|NCT01072175|538307566|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229131|NCT01072175|538307567|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
149229132|NCT01072175|538307555|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229133|NCT01072175|538307556|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229134|NCT01072175|538307557|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229135|NCT01072175|538307558|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229136|NCT01072175|538307559|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229137|NCT01072175|538307560|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229138|NCT01072175|538307561|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229139|NCT01072175|538307562|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229140|NCT01072175|538307563|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
149229141|NCT01072175|538307564|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229142|NCT01072175|538307565|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229143|NCT01072175|538307566|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229144|NCT01072175|538307567|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
149229145|NCT01072175|538307555|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229146|NCT01072175|538307556|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229147|NCT01072175|538307557|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229148|NCT01072175|538307558|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229149|NCT01072175|538307559|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229150|NCT01072175|538307560|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229151|NCT01072175|538307561|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229152|NCT01072175|538307562|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229153|NCT01072175|538307563|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
149229154|NCT01072175|538307564|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229155|NCT01072175|538307565|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229156|NCT01072175|538307566|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229157|NCT01072175|538307567|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
149229158|NCT01072175|538307555|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229159|NCT01072175|538307556|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229160|NCT01072175|538307557|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229161|NCT01072175|538307558|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229162|NCT01072175|538307559|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
148689566|NCT04828161|536336481|FG001|Overall Study|Death|0|||
148689567|NCT04828161|536336482|FG002|Overall Study|Death|0|||
148689568|NCT04828161|536336483|FG003|Overall Study|Death|2|||
148689569|NCT02352337|536336484|FG000|Overall Study|Patients never treated|4|||
148689570|NCT02352337|536336485|FG001|Overall Study|Patients never treated|1|||
148689571|NCT02352337|536336486|FG002|Overall Study|Patients never treated|2|||
148689572|NCT02458638|536336487|FG000|Overall Study|Death|309|||
148689573|NCT02458638|536336487|FG000|Overall Study|End of Cohort/End of Study|67|||
148689574|NCT02458638|536336487|FG000|Overall Study|Lost to Follow-up|31|||
148689575|NCT02458638|536336487|FG000|Overall Study|Other Reasons|4|||
148689576|NCT02458638|536336487|FG000|Overall Study|Physician Decision|1|||
148689577|NCT02458638|536336487|FG000|Overall Study|Withdrawal by Subject|47|||
148689578|NCT00135707|536336498|FG000|Overall Study|Lost to Follow-up|94|||
148689579|NCT00135707|536336499|FG001|Overall Study|Lost to Follow-up|89|||
148689580|NCT00135707|536336498|FG000|Overall Study|Withdrawal by Subject|0|||
148689581|NCT00135707|536336499|FG001|Overall Study|Withdrawal by Subject|1|||
148689582|NCT00135707|536336498|FG000|Overall Study|Institutional review board request|1|||
148810382|NCT03314935|536782612|FG007|Phase 2|Withdrawal by Subject|0|||
148810383|NCT03314935|536782613|FG008|Phase 2|Withdrawal by Subject|0|||
148689583|NCT00135707|536336499|FG001|Overall Study|Institutional review board request|0|||
148810384|NCT03314935|536782614|FG009|Phase 2|Withdrawal by Subject|1|||
149229163|NCT01072175|538307560|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229164|NCT01072175|538307561|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229165|NCT01072175|538307562|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229166|NCT01072175|538307563|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
149229167|NCT01072175|538307564|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229168|NCT01072175|538307565|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229169|NCT01072175|538307566|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229170|NCT01072175|538307567|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
149229171|NCT01072175|538307555|FG000|Part D (HPMC Capsules)|Death|0|||
149229172|NCT01072175|538307556|FG001|Part D (HPMC Capsules)|Death|0|||
149229173|NCT01072175|538307557|FG002|Part D (HPMC Capsules)|Death|0|||
149229174|NCT01072175|538307558|FG003|Part D (HPMC Capsules)|Death|0|||
149229175|NCT01072175|538307559|FG004|Part D (HPMC Capsules)|Death|0|||
149229176|NCT01072175|538307560|FG005|Part D (HPMC Capsules)|Death|0|||
149229177|NCT01072175|538307561|FG006|Part D (HPMC Capsules)|Death|0|||
149229178|NCT01072175|538307562|FG007|Part D (HPMC Capsules)|Death|0|||
149229179|NCT01072175|538307563|FG008|Part D (HPMC Capsules)|Death|0|||
149229180|NCT01072175|538307564|FG009|Part D (HPMC Capsules)|Death|10|||
149229181|NCT01072175|538307565|FG010|Part D (HPMC Capsules)|Death|12|||
149229182|NCT01072175|538307566|FG011|Part D (HPMC Capsules)|Death|28|||
149229183|NCT01072175|538307567|FG012|Part D (HPMC Capsules)|Death|26|||
149229184|NCT01072175|538307555|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
149229185|NCT01072175|538307556|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
149229186|NCT01072175|538307557|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
149229187|NCT01072175|538307558|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
149229188|NCT01072175|538307559|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
149229189|NCT01072175|538307560|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
149229190|NCT01072175|538307561|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
149229191|NCT01072175|538307562|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
149229192|NCT01072175|538307563|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
149229193|NCT01072175|538307564|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
149229194|NCT01072175|538307565|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
149229195|NCT01072175|538307566|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
149229196|NCT01072175|538307567|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
149229197|NCT01072175|538307555|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229198|NCT01072175|538307556|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229199|NCT01072175|538307557|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229200|NCT01072175|538307558|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229201|NCT01072175|538307559|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229202|NCT01072175|538307560|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229203|NCT01072175|538307561|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229204|NCT01072175|538307562|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229205|NCT01072175|538307563|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229206|NCT01072175|538307564|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
149229207|NCT01072175|538307565|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
149229208|NCT01072175|538307566|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
149229209|NCT01072175|538307567|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
149229210|NCT01072175|538307555|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229211|NCT01072175|538307556|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229212|NCT01072175|538307557|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229213|NCT01072175|538307558|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229214|NCT01072175|538307559|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229215|NCT01072175|538307560|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229216|NCT01072175|538307561|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229217|NCT01072175|538307562|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229218|NCT01072175|538307563|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
149229219|NCT01072175|538307564|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
149229220|NCT01072175|538307565|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
149229221|NCT01072175|538307566|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
149229222|NCT01072175|538307567|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
149229223|NCT01072175|538307555|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229224|NCT01072175|538307556|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229225|NCT01072175|538307557|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229226|NCT01072175|538307558|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229227|NCT01072175|538307559|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229228|NCT01072175|538307560|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229229|NCT01072175|538307561|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229230|NCT01072175|538307562|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229231|NCT01072175|538307563|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229232|NCT01072175|538307564|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229233|NCT01072175|538307565|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
149229234|NCT01072175|538307566|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
149229235|NCT01072175|538307567|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
149229236|NCT00682539|538307568|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
149229237|NCT00682539|538307569|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
149229238|NCT00682539|538307570|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
149229239|NCT00682539|538307568|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
149229240|NCT00682539|538307569|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
149229241|NCT00682539|538307570|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
149229242|NCT02477215|538307575|FG000|Dose Escalation Phase|Physician Decision|1|||
149229243|NCT02477215|538307576|FG001|Dose Escalation Phase|Physician Decision|2|||
149229244|NCT02477215|538307577|FG002|Dose Escalation Phase|Physician Decision|0|||
149229245|NCT02477215|538307575|FG000|Fixed Dose Phase|Physician Decision|0|||
149229246|NCT02477215|538307576|FG001|Fixed Dose Phase|Physician Decision|7|||
149229247|NCT02477215|538307577|FG002|Fixed Dose Phase|Physician Decision|0|||
149229248|NCT00285857|538307578|FG000|Overall Study|Withdrawal by Subject|2|||
149229249|NCT00285857|538307578|FG000|Overall Study|Inadequate initial breast cytology|1|||
149229250|NCT00285857|538307578|FG000|Overall Study|Adverse Event|1|||
149229251|NCT00508872|538307579|FG000|Overall Study|Lost to Follow-up|1|||
149229252|NCT00508872|538307579|FG000|Overall Study|Physician Decision|1|||
149229253|NCT02210559|538307580|FG000|Overall Study|Progressive Disease|3|||
149229254|NCT02210559|538307581|FG001|Overall Study|Progressive Disease|2|||
149229255|NCT02210559|538307580|FG000|Overall Study|Adverse Event|2|||
149229256|NCT02210559|538307581|FG001|Overall Study|Adverse Event|2|||
149229257|NCT02210559|538307580|FG000|Overall Study|Physician Decision|1|||
149229258|NCT02210559|538307581|FG001|Overall Study|Physician Decision|0|||
149229259|NCT02210559|538307580|FG000|Overall Study|Withdrawal by Subject|0|||
149229260|NCT02210559|538307581|FG001|Overall Study|Withdrawal by Subject|1|||
149229261|NCT02210559|538307580|FG000|Overall Study|Other than specified|0|||
149229262|NCT02210559|538307581|FG001|Overall Study|Other than specified|1|||
149229263|NCT02546193|538307582|FG000|Overall Study|Withdrawal by Subject|2|||
149229264|NCT02546193|538307583|FG001|Overall Study|Withdrawal by Subject|0|||
149229265|NCT02546193|538307584|FG002|Overall Study|Withdrawal by Subject|1|||
149229266|NCT02546193|538307585|FG003|Overall Study|Withdrawal by Subject|0|||
149229267|NCT02546193|538307582|FG000|Overall Study|Not eligible at time of induction|4|||
149229268|NCT02546193|538307583|FG001|Overall Study|Not eligible at time of induction|6|||
149229269|NCT02546193|538307584|FG002|Overall Study|Not eligible at time of induction|1|||
149229270|NCT02546193|538307585|FG003|Overall Study|Not eligible at time of induction|0|||
149229271|NCT00310440|538307586|FG000|Overall Study|Lost to Follow-up|17|||
149229272|NCT00310440|538307587|FG001|Overall Study|Lost to Follow-up|8|||
149229273|NCT00310440|538307586|FG000|Overall Study|Withdrawal by Subject|2|||
149229274|NCT00310440|538307587|FG001|Overall Study|Withdrawal by Subject|1|||
149229275|NCT00310440|538307586|FG000|Overall Study|Missed 12 Month Visit|7|||
149229276|NCT00310440|538307587|FG001|Overall Study|Missed 12 Month Visit|4|||
149229277|NCT01287403|538307592|FG000|1st Intervention (1 Day)|Adverse Event|1|||
149229278|NCT00148109|538307593|FG000|Overall Study|Lack of Efficacy|10|||
149229279|NCT00148109|538307594|FG001|Overall Study|Lack of Efficacy|18|||
149229280|NCT00148109|538307593|FG000|Overall Study|Adverse Event|0|||
149229281|NCT00148109|538307594|FG001|Overall Study|Adverse Event|2|||
149229282|NCT00148109|538307593|FG000|Overall Study|Withdrawal by Subject|2|||
149229283|NCT00148109|538307594|FG001|Overall Study|Withdrawal by Subject|0|||
148689584|NCT03465891|536336500|FG000|Overall Study|Withdrawal by Subject|0|||
148689585|NCT03465891|536336501|FG001|Overall Study|Withdrawal by Subject|1|||
148689586|NCT03465891|536336500|FG000|Overall Study|Disease progression|1|||
148689587|NCT03465891|536336501|FG001|Overall Study|Disease progression|0|||
148689588|NCT02737306|536336503|FG000|Overall Study|Adverse Event|3|||
148689589|NCT02737306|536336504|FG001|Overall Study|Adverse Event|0|||
148689590|NCT02737306|536336503|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
148689591|NCT02737306|536336504|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
148689592|NCT05034731|536336505|FG000|Overall Study|Screen fail|1|||
148689593|NCT05034731|536336506|FG001|Overall Study|Screen fail|1|||
148689594|NCT00622908|536336507|FG000|Overall Study|Protocol Violation|1|||
148954472|NCT00710710|537317106|FG000|Overall Study|Adverse Event|3|||
148954473|NCT00710710|537317107|FG001|Overall Study|Adverse Event|3|||
148954474|NCT00710710|537317106|FG000|Overall Study|Progressive disease|40|||
148954475|NCT00710710|537317107|FG001|Overall Study|Progressive disease|38|||
149229284|NCT01098266|538307595|FG000|Overall Study|Physician Decision|1|||
149229285|NCT01098266|538307596|FG001|Overall Study|Physician Decision|0|||
149229286|NCT01098266|538307595|FG000|Overall Study|Death|3|||
149229287|NCT01098266|538307596|FG001|Overall Study|Death|2|||
149229288|NCT01098266|538307595|FG000|Overall Study|Withdrawal by Subject|3|||
149229289|NCT01098266|538307596|FG001|Overall Study|Withdrawal by Subject|5|||
149229290|NCT00438815|538307600|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
149229291|NCT00438815|538307600|FG000|Overall Study|3-month follow-up no longer required|12|||
149229292|NCT00438815|538307600|FG000|Overall Study|Noncompliance with protocol requirements|9|||
149229293|NCT00438815|538307600|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
149229294|NCT00438815|538307600|FG000|Overall Study|Lost to Follow-up|6|||
149229295|NCT00438815|538307600|FG000|Overall Study|Withdrawal by Subject|6|||
149229296|NCT00438815|538307600|FG000|Overall Study|Death|1|||
149229297|NCT01733758|538307601|FG000|Overall Study|Adverse Event|5|||
149229298|NCT01733758|538307602|FG001|Overall Study|Adverse Event|7|||
149229299|NCT01733758|538307603|FG002|Overall Study|Adverse Event|8|||
149229300|NCT01733758|538307604|FG003|Overall Study|Adverse Event|1|||
149229301|NCT01733758|538307601|FG000|Overall Study|Withdrawal by Subject|1|||
149229302|NCT01733758|538307602|FG001|Overall Study|Withdrawal by Subject|1|||
149229303|NCT01733758|538307603|FG002|Overall Study|Withdrawal by Subject|5|||
149229304|NCT01733758|538307604|FG003|Overall Study|Withdrawal by Subject|3|||
149229305|NCT01733758|538307601|FG000|Overall Study|Persistent Hyperglycemia|3|||
149229306|NCT01733758|538307602|FG001|Overall Study|Persistent Hyperglycemia|2|||
149229307|NCT01733758|538307603|FG002|Overall Study|Persistent Hyperglycemia|0|||
149229308|NCT01733758|538307604|FG003|Overall Study|Persistent Hyperglycemia|0|||
149229309|NCT01733758|538307601|FG000|Overall Study|Protocol Violation|0|||
149229310|NCT01733758|538307602|FG001|Overall Study|Protocol Violation|1|||
149229311|NCT01733758|538307603|FG002|Overall Study|Protocol Violation|2|||
149229312|NCT01733758|538307604|FG003|Overall Study|Protocol Violation|2|||
149229313|NCT01733758|538307601|FG000|Overall Study|Non-compliance|1|||
149229314|NCT01733758|538307602|FG001|Overall Study|Non-compliance|0|||
149229315|NCT01733758|538307603|FG002|Overall Study|Non-compliance|0|||
149229316|NCT01733758|538307604|FG003|Overall Study|Non-compliance|0|||
149229317|NCT01733758|538307601|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
149229318|NCT01733758|538307602|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
149229319|NCT01733758|538307603|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
149229320|NCT01733758|538307604|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
149229321|NCT01733758|538307601|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
149229322|NCT01733758|538307602|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
149229323|NCT01733758|538307603|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
149229324|NCT01733758|538307604|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
149229325|NCT02545270|538307609|FG000|Overall Study|technical difficulties|0|||
149229326|NCT02545270|538307610|FG001|Overall Study|technical difficulties|1|||
149229327|NCT02545270|538307611|FG002|Overall Study|technical difficulties|0|||
149229328|NCT02545270|538307609|FG000|Overall Study|Videos being too similar to other|0|||
149229329|NCT02545270|538307610|FG001|Overall Study|Videos being too similar to other|0|||
149229330|NCT02545270|538307611|FG002|Overall Study|Videos being too similar to other|2|||
149229331|NCT04594213|538307612|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
149229332|NCT04594213|538307613|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
149229333|NCT04594213|538307614|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
149229334|NCT04594213|538307615|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
149229335|NCT04594213|538307616|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
149229336|NCT04594213|538307617|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
149229337|NCT04594213|538307612|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149229338|NCT04594213|538307613|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
149229339|NCT04594213|538307614|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149229340|NCT04594213|538307615|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149229341|NCT04594213|538307616|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149229342|NCT04594213|538307617|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
149229343|NCT04594213|538307612|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
149229344|NCT04594213|538307613|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149229345|NCT04594213|538307614|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
149229346|NCT04594213|538307615|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
148954476|NCT03510884|537317108|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
148954477|NCT03510884|537317109|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
149229347|NCT04594213|538307616|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149229348|NCT04594213|538307617|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
149229349|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149229350|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149229351|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149229352|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149229353|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
148689595|NCT00622908|536336508|FG001|Overall Study|Protocol Violation|0|||
148689596|NCT00622908|536336507|FG000|Overall Study|Adverse Event|0|||
148689597|NCT00622908|536336508|FG001|Overall Study|Adverse Event|1|||
148689598|NCT00622908|536336507|FG000|Overall Study|Lack of Efficacy|1|||
148689599|NCT00622908|536336508|FG001|Overall Study|Lack of Efficacy|7|||
148689600|NCT00622908|536336507|FG000|Overall Study|Lost to Follow-up|1|||
148689601|NCT00622908|536336508|FG001|Overall Study|Lost to Follow-up|0|||
148689602|NCT00622908|536336507|FG000|Overall Study|Refusal|0|||
149229354|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
149229355|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
149229356|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
149229357|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
149229358|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
149229359|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
149229360|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
149229361|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149229362|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149229363|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149229364|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
148689603|NCT00622908|536336508|FG001|Overall Study|Refusal|1|||
148689604|NCT00622908|536336507|FG000|Overall Study|Termination by study sponser|0|||
148689605|NCT00622908|536336508|FG001|Overall Study|Termination by study sponser|1|||
148689606|NCT03937466|536336509|FG000|Overall Study|not eligbile after the 2-week diary|9|||
148689607|NCT03937466|536336509|FG000|Overall Study|never returned their diary|6|||
149229365|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
149229366|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
149229367|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149229368|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149229369|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149229370|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
149229371|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149229372|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
149229373|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149229374|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149229375|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149229376|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
149229377|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149229378|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
149229379|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
149229380|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
149229381|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
149229382|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
149229383|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
149229384|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
149229385|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
149229386|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
149229387|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
148689608|NCT03937466|536336509|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
148689609|NCT03937466|536336509|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
148689610|NCT03213210|536336510|FG000|Overall Study|Lost to Follow-up|2|||
148689611|NCT03213210|536336510|FG000|Overall Study|Study termination|3|||
148689612|NCT00684671|536336516|FG000|Overall Study|Adverse Event|1|||
148689613|NCT00684671|536336517|FG001|Overall Study|Adverse Event|0|||
148689614|NCT00684671|536336518|FG002|Overall Study|Adverse Event|0|||
148689615|NCT00684671|536336516|FG000|Overall Study|Lost to Follow-up|1|||
148689616|NCT00684671|536336517|FG001|Overall Study|Lost to Follow-up|0|||
148954478|NCT03510884|537317110|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
148689617|NCT00684671|536336518|FG002|Overall Study|Lost to Follow-up|0|||
148689618|NCT00684671|536336516|FG000|Overall Study|Alcoholic dependance|1|||
148689619|NCT00684671|536336517|FG001|Overall Study|Alcoholic dependance|0|||
148689620|NCT00684671|536336518|FG002|Overall Study|Alcoholic dependance|0|||
148954479|NCT03510884|537317111|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
148954480|NCT03510884|537317108|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
149229388|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
149229389|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
149229390|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
148689621|NCT02649231|536336521|FG000|Overall Study|Adverse Event|0|||
148689622|NCT02649231|536336522|FG001|Overall Study|Adverse Event|0|||
148689623|NCT02649231|536336523|FG002|Overall Study|Adverse Event|0|||
148689624|NCT02649231|536336524|FG003|Overall Study|Adverse Event|1|||
148689625|NCT02649231|536336521|FG000|Overall Study|Lost to Follow-up|2|||
149229391|NCT04594213|538307612|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
149229392|NCT04594213|538307613|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
149229393|NCT04594213|538307614|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
149229394|NCT04594213|538307615|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
149229395|NCT04594213|538307616|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
149229396|NCT04594213|538307617|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
149229397|NCT03764813|538307618|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
149229398|NCT03764813|538307619|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
149229399|NCT03764813|538307620|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
149229400|NCT03764813|538307621|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
149229401|NCT02898662|538307622|FG000|Overall Study|Adverse Event|1|||
149229402|NCT02898662|538307623|FG001|Overall Study|Adverse Event|0|||
149229403|NCT02898662|538307622|FG000|Overall Study|Loss of asthma control|23|||
149229404|NCT02898662|538307623|FG001|Overall Study|Loss of asthma control|24|||
149229405|NCT02898662|538307622|FG000|Overall Study|Withdrawal by Subject|4|||
149229406|NCT02898662|538307623|FG001|Overall Study|Withdrawal by Subject|1|||
149229407|NCT02898662|538307622|FG000|Overall Study|Technical issue|0|||
149229408|NCT02898662|538307623|FG001|Overall Study|Technical issue|1|||
149229409|NCT02898662|538307622|FG000|Overall Study|Randomized in error|0|||
149229410|NCT02898662|538307623|FG001|Overall Study|Randomized in error|1|||
149229411|NCT02898662|538307622|FG000|Overall Study|Subject decision|1|||
149229412|NCT02898662|538307623|FG001|Overall Study|Subject decision|0|||
149229413|NCT02898662|538307622|FG000|Overall Study|Other|0|||
149229414|NCT02898662|538307623|FG001|Overall Study|Other|1|||
149229415|NCT03172026|538307624|FG000|Overall Study|Withdrawal by Subject|1|||
149229416|NCT03172026|538307625|FG001|Overall Study|Withdrawal by Subject|0|||
149229417|NCT03172026|538307624|FG000|Overall Study|COVID restrictions|1|||
149229418|NCT03172026|538307625|FG001|Overall Study|COVID restrictions|0|||
149229419|NCT01177943|538307630|FG000|First Intervention|Withdrawal by Subject|2|||
149229420|NCT01177943|538307631|FG001|First Intervention|Withdrawal by Subject|0|||
149229421|NCT00779142|538307633|FG000|Overall Study|Screen Failures|3|||
149229422|NCT04652245|538307634|FG000|Wash-Out Period|Adverse Event|0|||
149229423|NCT04652245|538307635|FG001|Wash-Out Period|Adverse Event|2|||
149229424|NCT04652245|538307634|FG000|Wash-Out Period|Withdrawal by Subject|0|||
149229425|NCT04652245|538307635|FG001|Wash-Out Period|Withdrawal by Subject|2|||
149229426|NCT04047472|538307640|FG000|Overall Study|Adverse Event|3|||
149229427|NCT04047472|538307641|FG001|Overall Study|Adverse Event|3|||
149229428|NCT04047472|538307640|FG000|Overall Study|Death|0|||
149229429|NCT04047472|538307641|FG001|Overall Study|Death|1|||
149229430|NCT04047472|538307640|FG000|Overall Study|Lost to Follow-up|1|||
149229431|NCT04047472|538307641|FG001|Overall Study|Lost to Follow-up|0|||
149229432|NCT04047472|538307640|FG000|Overall Study|Physician Decision|1|||
149229433|NCT04047472|538307641|FG001|Overall Study|Physician Decision|2|||
149229434|NCT04047472|538307640|FG000|Overall Study|Protocol Violation|1|||
149229435|NCT04047472|538307641|FG001|Overall Study|Protocol Violation|0|||
149229436|NCT04047472|538307640|FG000|Overall Study|Withdrawal by Subject|10|||
149229437|NCT04047472|538307641|FG001|Overall Study|Withdrawal by Subject|10|||
149229438|NCT01016912|538307642|FG000|End of Treatment Period|Lack of Efficacy|0|||
149229439|NCT01016912|538307643|FG001|End of Treatment Period|Lack of Efficacy|1|||
149229440|NCT01016912|538307644|FG002|End of Treatment Period|Lack of Efficacy|0|||
149229441|NCT01016912|538307645|FG003|End of Treatment Period|Lack of Efficacy|4|||
149229442|NCT01016912|538307646|FG004|End of Treatment Period|Lack of Efficacy|4|||
149229443|NCT01016912|538307642|FG000|End of Treatment Period|Adverse Event|0|||
149229444|NCT01016912|538307643|FG001|End of Treatment Period|Adverse Event|1|||
149229445|NCT01016912|538307644|FG002|End of Treatment Period|Adverse Event|1|||
149229446|NCT01016912|538307645|FG003|End of Treatment Period|Adverse Event|0|||
149229447|NCT01016912|538307646|FG004|End of Treatment Period|Adverse Event|0|||
149229448|NCT01016912|538307642|FG000|End of Treatment Period|Completed double-blind period only|0|||
149229449|NCT01016912|538307643|FG001|End of Treatment Period|Completed double-blind period only|1|||
149229450|NCT01016912|538307644|FG002|End of Treatment Period|Completed double-blind period only|0|||
149229451|NCT01016912|538307645|FG003|End of Treatment Period|Completed double-blind period only|0|||
149229452|NCT01016912|538307646|FG004|End of Treatment Period|Completed double-blind period only|0|||
149229453|NCT01016912|538307642|FG000|Follow-up Period|Other reason|0|||
149229454|NCT01016912|538307643|FG001|Follow-up Period|Other reason|0|||
149229455|NCT01016912|538307644|FG002|Follow-up Period|Other reason|1|||
149229456|NCT01016912|538307645|FG003|Follow-up Period|Other reason|1|||
149229457|NCT01016912|538307646|FG004|Follow-up Period|Other reason|0|||
149229458|NCT00496782|538307647|FG000|Overall Study|Protocol Violation|1|||
149229459|NCT00496782|538307648|FG001|Overall Study|Protocol Violation|2|||
149229460|NCT01288911|538307649|FG000|Double-blind Period|Death|11|||
149229461|NCT01288911|538307650|FG001|Double-blind Period|Death|7|||
149229462|NCT01288911|538307649|FG000|Double-blind Period|Lost to Follow-up|0|||
149229463|NCT01288911|538307650|FG001|Double-blind Period|Lost to Follow-up|2|||
149229464|NCT01288911|538307649|FG000|Double-blind Period|Progressive Disease|75|||
149229465|NCT01288911|538307650|FG001|Double-blind Period|Progressive Disease|103|||
149229466|NCT01288911|538307649|FG000|Double-blind Period|Protocol Violation|1|||
149229467|NCT01288911|538307650|FG001|Double-blind Period|Protocol Violation|0|||
149229468|NCT01288911|538307649|FG000|Double-blind Period|Withdrawal by Subject|25|||
149229469|NCT01288911|538307650|FG001|Double-blind Period|Withdrawal by Subject|26|||
149229470|NCT01288911|538307649|FG000|Double-blind Period|Miscellaneous Reason|29|||
149229471|NCT01288911|538307650|FG001|Double-blind Period|Miscellaneous Reason|42|||
149229472|NCT01288911|538307649|FG000|Double-blind Period|Randomized but never received study drug|1|||
149229473|NCT01288911|538307650|FG001|Double-blind Period|Randomized but never received study drug|2|||
149229474|NCT01288911|538307649|FG000|Open-label Period (All Enzalutamide)|Death|0|||
149229475|NCT01288911|538307650|FG001|Open-label Period (All Enzalutamide)|Death|1|||
149229476|NCT01288911|538307649|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
149229477|NCT01288911|538307650|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
149229478|NCT01288911|538307649|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
149229479|NCT01288911|538307650|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
148810385|NCT03314935|536782615|FG010|Phase 2|Withdrawal by Subject|4|||
149229480|NCT01288911|538307649|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
149229481|NCT01288911|538307650|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
149229482|NCT01288911|538307649|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
149229483|NCT01288911|538307650|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
149229484|NCT01288911|538307649|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
149229485|NCT01288911|538307650|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
149229486|NCT02452892|538307651|FG000|Week 1 Initial Randommization|Adverse Event|1|||
148689626|NCT02649231|536336522|FG001|Overall Study|Lost to Follow-up|1|||
148689627|NCT02649231|536336523|FG002|Overall Study|Lost to Follow-up|1|||
148689628|NCT02649231|536336524|FG003|Overall Study|Lost to Follow-up|0|||
148689629|NCT02649231|536336521|FG000|Overall Study|Withdrawal by Subject|0|||
149229487|NCT02452892|538307652|FG001|Week 1 Initial Randommization|Adverse Event|0|||
149229488|NCT02452892|538307653|FG002|Week 1 Initial Randommization|Adverse Event|0|||
149229489|NCT02452892|538307654|FG003|Week 1 Initial Randommization|Adverse Event|0|||
149229490|NCT02452892|538307651|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
149229491|NCT02452892|538307652|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
149229492|NCT02452892|538307653|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
149229493|NCT02452892|538307654|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
149229494|NCT02452892|538307651|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
149229495|NCT02452892|538307652|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
149229496|NCT02452892|538307653|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
149229497|NCT02452892|538307654|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
149229498|NCT02452892|538307651|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
149229499|NCT02452892|538307652|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
149229500|NCT02452892|538307653|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
149229501|NCT02452892|538307654|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
149229502|NCT02452892|538307651|FG000|Follow-up|Withdrawal by Subject|0|||
149229503|NCT02452892|538307652|FG001|Follow-up|Withdrawal by Subject|0|||
149229504|NCT02452892|538307653|FG002|Follow-up|Withdrawal by Subject|0|||
149229505|NCT02452892|538307654|FG003|Follow-up|Withdrawal by Subject|1|||
149229506|NCT02452892|538307651|FG000|Follow-up|Subject left town on Day 42|1|||
149229507|NCT02452892|538307652|FG001|Follow-up|Subject left town on Day 42|0|||
149229508|NCT02452892|538307653|FG002|Follow-up|Subject left town on Day 42|0|||
149229509|NCT02452892|538307654|FG003|Follow-up|Subject left town on Day 42|0|||
149229510|NCT00252499|538307669|FG000|Overall Study|Lost to Follow-up|1|||
149229511|NCT00252499|538307670|FG001|Overall Study|Lost to Follow-up|0|||
149229512|NCT00252499|538307671|FG002|Overall Study|Lost to Follow-up|0|||
149229513|NCT01365468|538307672|FG000|Overall Study|Physician Decision|1|||
149229514|NCT01365468|538307673|FG001|Overall Study|Physician Decision|0|||
149229515|NCT01365468|538307672|FG000|Overall Study|Disease progression|1|||
149229516|NCT01365468|538307673|FG001|Overall Study|Disease progression|0|||
149229517|NCT01365468|538307672|FG000|Overall Study|Lost to Follow-up|2|||
149229518|NCT01365468|538307673|FG001|Overall Study|Lost to Follow-up|0|||
149229519|NCT01002573|538309510|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
149229520|NCT01002573|538309511|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
149229521|NCT00690612|538309517|FG000|Overall Study|Adverse Event|1|||
149229522|NCT00690612|538309517|FG000|Overall Study|Withdrawal by Subject|2|||
149229523|NCT02926833|538309518|FG000|Overall Study|Death|1|||
149229524|NCT02926833|538309519|FG001|Overall Study|Death|1|||
149229525|NCT02926833|538309520|FG002|Overall Study|Death|2|||
149229526|NCT02926833|538309521|FG003|Overall Study|Death|13|||
149229527|NCT02926833|538309518|FG000|Overall Study|Lost to Follow-up|1|||
149229528|NCT02926833|538309519|FG001|Overall Study|Lost to Follow-up|2|||
149229529|NCT02926833|538309520|FG002|Overall Study|Lost to Follow-up|0|||
149229530|NCT02926833|538309521|FG003|Overall Study|Lost to Follow-up|3|||
149229531|NCT02926833|538309518|FG000|Overall Study|Full Consent Withdrawal|0|||
149229532|NCT02926833|538309519|FG001|Overall Study|Full Consent Withdrawal|0|||
149229533|NCT02926833|538309520|FG002|Overall Study|Full Consent Withdrawal|0|||
149229534|NCT02926833|538309521|FG003|Overall Study|Full Consent Withdrawal|2|||
149229535|NCT02926833|538309518|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
149229536|NCT02926833|538309519|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
149229537|NCT02926833|538309520|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
149229538|NCT02926833|538309521|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
149229539|NCT02926833|538309518|FG000|Overall Study|Investigator Decision|0|||
149229540|NCT02926833|538309519|FG001|Overall Study|Investigator Decision|1|||
148689630|NCT02649231|536336522|FG001|Overall Study|Withdrawal by Subject|1|||
148810386|NCT03314935|536782616|FG011|Phase 2|Withdrawal by Subject|0|||
149229541|NCT02926833|538309520|FG002|Overall Study|Investigator Decision|0|||
149229542|NCT02926833|538309521|FG003|Overall Study|Investigator Decision|0|||
149229543|NCT02926833|538309518|FG000|Overall Study|Adverse Event|0|||
149229544|NCT02926833|538309519|FG001|Overall Study|Adverse Event|0|||
149229545|NCT02926833|538309520|FG002|Overall Study|Adverse Event|1|||
149229546|NCT02926833|538309521|FG003|Overall Study|Adverse Event|0|||
149229547|NCT02926833|538309518|FG000|Overall Study|Partial Withdrawal of Consent|0|||
148810387|NCT03314935|536782617|FG012|Phase 2|Withdrawal by Subject|1|||
148954481|NCT03510884|537317109|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
149229548|NCT02926833|538309519|FG001|Overall Study|Partial Withdrawal of Consent|0|||
148689631|NCT02649231|536336523|FG002|Overall Study|Withdrawal by Subject|0|||
148689632|NCT02649231|536336524|FG003|Overall Study|Withdrawal by Subject|1|||
149229549|NCT02926833|538309520|FG002|Overall Study|Partial Withdrawal of Consent|0|||
149229550|NCT02926833|538309521|FG003|Overall Study|Partial Withdrawal of Consent|1|||
148810388|NCT03314935|536782618|FG013|Phase 2|Withdrawal by Subject|0|||
148810389|NCT03314935|536782619|FG014|Phase 2|Withdrawal by Subject|1|||
148810390|NCT03314935|536782605|FG000|Phase 2|Progressive Disease|0|||
148810391|NCT03314935|536782606|FG001|Phase 2|Progressive Disease|0|||
148810392|NCT03314935|536782607|FG002|Phase 2|Progressive Disease|0|||
148810393|NCT03314935|536782608|FG003|Phase 2|Progressive Disease|0|||
148810394|NCT03314935|536782609|FG004|Phase 2|Progressive Disease|0|||
148810395|NCT03314935|536782610|FG005|Phase 2|Progressive Disease|0|||
148810396|NCT03314935|536782611|FG006|Phase 2|Progressive Disease|0|||
148810397|NCT03314935|536782612|FG007|Phase 2|Progressive Disease|0|||
148810398|NCT03314935|536782613|FG008|Phase 2|Progressive Disease|0|||
148810399|NCT03314935|536782614|FG009|Phase 2|Progressive Disease|1|||
148810400|NCT03314935|536782615|FG010|Phase 2|Progressive Disease|1|||
148810401|NCT03314935|536782616|FG011|Phase 2|Progressive Disease|1|||
148810402|NCT03314935|536782617|FG012|Phase 2|Progressive Disease|2|||
148810403|NCT03314935|536782618|FG013|Phase 2|Progressive Disease|0|||
148810404|NCT03314935|536782619|FG014|Phase 2|Progressive Disease|1|||
148810405|NCT03314935|536782605|FG000|Phase 2|Study Terminated by Sponsor|0|||
148810406|NCT03314935|536782606|FG001|Phase 2|Study Terminated by Sponsor|0|||
148810407|NCT03314935|536782607|FG002|Phase 2|Study Terminated by Sponsor|0|||
148810408|NCT03314935|536782608|FG003|Phase 2|Study Terminated by Sponsor|0|||
148810409|NCT03314935|536782609|FG004|Phase 2|Study Terminated by Sponsor|0|||
148810410|NCT03314935|536782610|FG005|Phase 2|Study Terminated by Sponsor|0|||
148810411|NCT03314935|536782611|FG006|Phase 2|Study Terminated by Sponsor|0|||
148810412|NCT03314935|536782612|FG007|Phase 2|Study Terminated by Sponsor|0|||
148810413|NCT03314935|536782613|FG008|Phase 2|Study Terminated by Sponsor|0|||
148810414|NCT03314935|536782614|FG009|Phase 2|Study Terminated by Sponsor|0|||
148689633|NCT02649231|536336521|FG000|Overall Study|Protocol Violation|2|||
148689634|NCT02649231|536336522|FG001|Overall Study|Protocol Violation|1|||
148689635|NCT02649231|536336523|FG002|Overall Study|Protocol Violation|1|||
148689636|NCT02649231|536336524|FG003|Overall Study|Protocol Violation|0|||
148689637|NCT00437281|536336525|FG000|Overall Study|Adverse Event|0|||
148689638|NCT00437281|536336526|FG001|Overall Study|Adverse Event|0|||
148689639|NCT00437281|536336527|FG002|Overall Study|Adverse Event|0|||
148689640|NCT00437281|536336528|FG003|Overall Study|Adverse Event|1|||
148689641|NCT00437281|536336529|FG004|Overall Study|Adverse Event|0|||
148689642|NCT00437281|536336530|FG005|Overall Study|Adverse Event|1|||
148810415|NCT03314935|536782615|FG010|Phase 2|Study Terminated by Sponsor|7|||
148810416|NCT03314935|536782616|FG011|Phase 2|Study Terminated by Sponsor|2|||
148810417|NCT03314935|536782617|FG012|Phase 2|Study Terminated by Sponsor|1|||
148810418|NCT03314935|536782618|FG013|Phase 2|Study Terminated by Sponsor|4|||
148810419|NCT03314935|536782619|FG014|Phase 2|Study Terminated by Sponsor|4|||
148810420|NCT03314935|536782605|FG000|Phase 2|Lost to Follow-up|0|||
148810421|NCT03314935|536782606|FG001|Phase 2|Lost to Follow-up|0|||
148810422|NCT03314935|536782607|FG002|Phase 2|Lost to Follow-up|0|||
148810423|NCT03314935|536782608|FG003|Phase 2|Lost to Follow-up|0|||
148810424|NCT03314935|536782609|FG004|Phase 2|Lost to Follow-up|0|||
148810425|NCT03314935|536782610|FG005|Phase 2|Lost to Follow-up|0|||
148810426|NCT03314935|536782611|FG006|Phase 2|Lost to Follow-up|0|||
148810427|NCT03314935|536782612|FG007|Phase 2|Lost to Follow-up|0|||
148810428|NCT03314935|536782613|FG008|Phase 2|Lost to Follow-up|0|||
148810429|NCT03314935|536782614|FG009|Phase 2|Lost to Follow-up|1|||
148810430|NCT03314935|536782615|FG010|Phase 2|Lost to Follow-up|0|||
148810431|NCT03314935|536782616|FG011|Phase 2|Lost to Follow-up|0|||
149229551|NCT00346775|538309526|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
149229552|NCT00346775|538309527|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
149229553|NCT00346775|538309526|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
149229554|NCT00346775|538309527|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
149229555|NCT00346775|538309526|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
148689643|NCT00437281|536336531|FG006|Overall Study|Adverse Event|0|||
149229556|NCT00346775|538309527|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
148689644|NCT00437281|536336532|FG007|Overall Study|Adverse Event|0|||
148689645|NCT00437281|536336533|FG008|Overall Study|Adverse Event|0|||
148810432|NCT03314935|536782617|FG012|Phase 2|Lost to Follow-up|0|||
148810433|NCT03314935|536782618|FG013|Phase 2|Lost to Follow-up|0|||
148810434|NCT03314935|536782619|FG014|Phase 2|Lost to Follow-up|1|||
148810435|NCT03314935|536782605|FG000|Phase 2|Physician Decision|0|||
148810436|NCT03314935|536782606|FG001|Phase 2|Physician Decision|0|||
148810437|NCT03314935|536782607|FG002|Phase 2|Physician Decision|0|||
148810438|NCT03314935|536782608|FG003|Phase 2|Physician Decision|0|||
148810439|NCT03314935|536782609|FG004|Phase 2|Physician Decision|0|||
148689646|NCT00437281|536336534|FG009|Overall Study|Adverse Event|1|||
148689647|NCT00437281|536336535|FG010|Overall Study|Adverse Event|0|||
148689648|NCT00437281|536336536|FG011|Overall Study|Adverse Event|0|||
148689649|NCT00437281|536336537|FG012|Overall Study|Adverse Event|0|||
148689650|NCT00437281|536336538|FG013|Overall Study|Adverse Event|1|||
148810440|NCT03314935|536782610|FG005|Phase 2|Physician Decision|0|||
148810441|NCT03314935|536782611|FG006|Phase 2|Physician Decision|0|||
148810442|NCT03314935|536782612|FG007|Phase 2|Physician Decision|0|||
148810443|NCT03314935|536782613|FG008|Phase 2|Physician Decision|0|||
149229557|NCT01096017|538309530|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
149229558|NCT01096017|538309531|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
149229559|NCT02600559|538309532|FG000|Overall Study|Withdrawal by Subject|3|||
149229560|NCT02600559|538309532|FG000|Overall Study|Lost to Follow-up|20|||
149229561|NCT00953576|538309533|FG000|Overall Study|Adverse Event|0|||
149229562|NCT00953576|538309534|FG001|Overall Study|Adverse Event|1|||
149229563|NCT00953576|538309533|FG000|Overall Study|Ineligible after Consent|2|||
149229564|NCT00953576|538309534|FG001|Overall Study|Ineligible after Consent|0|||
149229565|NCT00665366|538309537|FG000|Overall Study|Lack of Efficacy|11|||
149229566|NCT00665366|538309538|FG001|Overall Study|Lack of Efficacy|10|||
149229567|NCT00665366|538309537|FG000|Overall Study|Adverse Event|25|||
149229568|NCT00665366|538309538|FG001|Overall Study|Adverse Event|23|||
149229569|NCT00665366|538309537|FG000|Overall Study|Withdrawal by Subject|11|||
149229570|NCT00665366|538309538|FG001|Overall Study|Withdrawal by Subject|14|||
149229571|NCT00665366|538309537|FG000|Overall Study|Lost to Follow-up|3|||
149229572|NCT00665366|538309538|FG001|Overall Study|Lost to Follow-up|5|||
149229573|NCT00665366|538309537|FG000|Overall Study|Poor compliance/noncompliance|3|||
149229574|NCT00665366|538309538|FG001|Overall Study|Poor compliance/noncompliance|5|||
149229575|NCT00665366|538309537|FG000|Overall Study|Pregnancy|1|||
149229576|NCT00665366|538309538|FG001|Overall Study|Pregnancy|0|||
149229577|NCT00665366|538309537|FG000|Overall Study|No longer meets study criteria|0|||
149229578|NCT00665366|538309538|FG001|Overall Study|No longer meets study criteria|1|||
149229579|NCT00665366|538309537|FG000|Overall Study|Other reasons|4|||
149229580|NCT00665366|538309538|FG001|Overall Study|Other reasons|1|||
149229581|NCT01545375|538309540|FG000|Overall Study|Adverse Event|2|||
149229582|NCT01545375|538309541|FG001|Overall Study|Adverse Event|1|||
149229583|NCT01545375|538309540|FG000|Overall Study|Lost to Follow-up|34|||
149229584|NCT01545375|538309541|FG001|Overall Study|Lost to Follow-up|31|||
149229585|NCT01545375|538309540|FG000|Overall Study|Protocol Violation|3|||
149229586|NCT01545375|538309541|FG001|Overall Study|Protocol Violation|3|||
149229587|NCT01545375|538309540|FG000|Overall Study|Withdrawal by Subject|58|||
149229588|NCT01545375|538309541|FG001|Overall Study|Withdrawal by Subject|55|||
149229589|NCT04177862|538309542|FG000|Overall Study|Protocol Violation|2|||
149229590|NCT04177862|538309543|FG001|Overall Study|Protocol Violation|7|||
149229591|NCT05637515|538309544|FG000|Overall Study|Withdrawal by Subject|17|||
149229592|NCT05637515|538309545|FG001|Overall Study|Withdrawal by Subject|17|||
149229593|NCT04516291|538309546|FG000|Treatment Period (24 Weeks)|Other|1|||
149229594|NCT04516291|538309547|FG001|Treatment Period (24 Weeks)|Other|0|||
149229595|NCT04516291|538309548|FG002|Treatment Period (24 Weeks)|Other|0|||
149229596|NCT04516291|538309549|FG003|Treatment Period (24 Weeks)|Other|2|||
149229597|NCT04516291|538309550|FG004|Treatment Period (24 Weeks)|Other|2|||
149229598|NCT04516291|538309551|FG005|Treatment Period (24 Weeks)|Other|4|||
149229599|NCT04516291|538309552|FG006|Treatment Period (24 Weeks)|Other|2|||
149229600|NCT04516291|538309553|FG007|Treatment Period (24 Weeks)|Other|0|||
149229601|NCT04516291|538309546|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149229602|NCT04516291|538309547|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
149229603|NCT04516291|538309548|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149229604|NCT04516291|538309549|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149229605|NCT04516291|538309550|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149229606|NCT04516291|538309551|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149229607|NCT04516291|538309552|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149229608|NCT04516291|538309553|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149229609|NCT04516291|538309546|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229610|NCT04516291|538309547|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229611|NCT04516291|538309548|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229612|NCT04516291|538309549|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
149229613|NCT04516291|538309550|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229614|NCT04516291|538309551|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229615|NCT04516291|538309552|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229616|NCT04516291|538309553|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
149229617|NCT04516291|538309546|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229618|NCT04516291|538309547|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149229619|NCT04516291|538309548|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229620|NCT04516291|538309549|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229621|NCT04516291|538309550|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229622|NCT04516291|538309551|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229623|NCT04516291|538309552|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229624|NCT04516291|538309553|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149229625|NCT04516291|538309546|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
148689651|NCT00437281|536336539|FG014|Overall Study|Adverse Event|1|||
148689652|NCT00437281|536336540|FG015|Overall Study|Adverse Event|0|||
149229626|NCT04516291|538309547|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
149229627|NCT04516291|538309548|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
148689653|NCT00437281|536336541|FG016|Overall Study|Adverse Event|0|||
149229628|NCT04516291|538309549|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
149229629|NCT04516291|538309550|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
149229630|NCT04516291|538309551|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
149229631|NCT04516291|538309552|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
149229632|NCT04516291|538309553|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
149229633|NCT04516291|538309546|FG000|Follow-up Period (12 Weeks)|Other|0|||
149229634|NCT04516291|538309547|FG001|Follow-up Period (12 Weeks)|Other|1|||
149229635|NCT04516291|538309548|FG002|Follow-up Period (12 Weeks)|Other|0|||
149229636|NCT04516291|538309549|FG003|Follow-up Period (12 Weeks)|Other|2|||
149229637|NCT04516291|538309550|FG004|Follow-up Period (12 Weeks)|Other|0|||
149229638|NCT04516291|538309551|FG005|Follow-up Period (12 Weeks)|Other|0|||
149229639|NCT04516291|538309552|FG006|Follow-up Period (12 Weeks)|Other|0|||
149229640|NCT04516291|538309553|FG007|Follow-up Period (12 Weeks)|Other|0|||
149229641|NCT04516291|538309546|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229642|NCT04516291|538309547|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229643|NCT04516291|538309548|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229644|NCT04516291|538309549|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229645|NCT04516291|538309550|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
149229646|NCT04516291|538309551|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229647|NCT04516291|538309552|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229648|NCT04516291|538309553|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149229649|NCT04516291|538309546|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
149229650|NCT04516291|538309547|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
149229651|NCT04516291|538309548|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
149229652|NCT04516291|538309549|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
149229653|NCT04516291|538309550|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
149229654|NCT04516291|538309551|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
149229655|NCT04516291|538309552|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
149229656|NCT04516291|538309553|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
149229657|NCT02158949|538309554|FG000|Overall Study|Withdrawal by Subject|1|||
149229658|NCT02158949|538309555|FG001|Overall Study|Withdrawal by Subject|0|||
149229659|NCT02158949|538309554|FG000|Overall Study|Lost to Follow-up|5|||
149229660|NCT02158949|538309555|FG001|Overall Study|Lost to Follow-up|11|||
149229661|NCT02452320|538309564|FG000|Overall Study|Adverse Event|0|||
149229662|NCT02452320|538309565|FG001|Overall Study|Adverse Event|1|||
149229663|NCT01161173|538309568|FG000|Overall Study|Protocol Violation|13|||
149229664|NCT01161173|538309568|FG000|Overall Study|Lost to Follow-up|7|||
149229665|NCT01161173|538309568|FG000|Overall Study|Progressive Disease|82|||
149229666|NCT01161173|538309568|FG000|Overall Study|Withdrawal of Consent|5|||
149229667|NCT01161173|538309568|FG000|Overall Study|Unacceptable Toxicity|21|||
149229668|NCT01161173|538309568|FG000|Overall Study|Death|194|||
149229669|NCT01161173|538309568|FG000|Overall Study|End of Study|2|||
149229670|NCT01161173|538309568|FG000|Overall Study|Reasons Not Specified|23|||
148810444|NCT03314935|536782614|FG009|Phase 2|Physician Decision|0|||
149229671|NCT00792467|538309569|FG000|Overall Study|progression of disease|17|||
149229672|NCT00792467|538309569|FG000|Overall Study|Adverse Event|1|||
149229673|NCT00792467|538309569|FG000|Overall Study|patient request|1|||
149229674|NCT00792467|538309569|FG000|Overall Study|Lost to Follow-up|1|||
149229675|NCT00792467|538309569|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
149229676|NCT00792467|538309569|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
149229677|NCT02557308|538309570|FG000|Overall Study|Withdrawal by Subject|11|||
149229678|NCT02557308|538309571|FG001|Overall Study|Withdrawal by Subject|3|||
149229679|NCT02557308|538309572|FG002|Overall Study|Withdrawal by Subject|2|||
149229680|NCT02557308|538309573|FG003|Overall Study|Withdrawal by Subject|0|||
149229681|NCT02557308|538309574|FG004|Overall Study|Withdrawal by Subject|1|||
149229682|NCT02557308|538309575|FG005|Overall Study|Withdrawal by Subject|0|||
149229683|NCT02557308|538309576|FG006|Overall Study|Withdrawal by Subject|10|||
149229684|NCT02557308|538309577|FG007|Overall Study|Withdrawal by Subject|1|||
149229685|NCT02557308|538309570|FG000|Overall Study|Disease Progression|0|||
149229686|NCT02557308|538309571|FG001|Overall Study|Disease Progression|1|||
149229687|NCT02557308|538309572|FG002|Overall Study|Disease Progression|0|||
149229688|NCT02557308|538309573|FG003|Overall Study|Disease Progression|0|||
149229689|NCT02557308|538309574|FG004|Overall Study|Disease Progression|0|||
149229690|NCT02557308|538309575|FG005|Overall Study|Disease Progression|0|||
149229691|NCT02557308|538309576|FG006|Overall Study|Disease Progression|0|||
149229692|NCT02557308|538309577|FG007|Overall Study|Disease Progression|0|||
149229693|NCT02557308|538309570|FG000|Overall Study|Lack of Efficacy|3|||
149229694|NCT02557308|538309571|FG001|Overall Study|Lack of Efficacy|0|||
149229695|NCT02557308|538309572|FG002|Overall Study|Lack of Efficacy|0|||
149229696|NCT02557308|538309573|FG003|Overall Study|Lack of Efficacy|0|||
149229697|NCT02557308|538309574|FG004|Overall Study|Lack of Efficacy|0|||
149229698|NCT02557308|538309575|FG005|Overall Study|Lack of Efficacy|0|||
148810445|NCT03314935|536782615|FG010|Phase 2|Physician Decision|1|||
148810446|NCT03314935|536782616|FG011|Phase 2|Physician Decision|0|||
149229699|NCT02557308|538309576|FG006|Overall Study|Lack of Efficacy|1|||
149229700|NCT02557308|538309577|FG007|Overall Study|Lack of Efficacy|0|||
149229701|NCT02557308|538309570|FG000|Overall Study|Adverse Event|4|||
149229702|NCT02557308|538309571|FG001|Overall Study|Adverse Event|1|||
148810447|NCT03314935|536782617|FG012|Phase 2|Physician Decision|0|||
148810448|NCT03314935|536782618|FG013|Phase 2|Physician Decision|0|||
148810449|NCT03314935|536782619|FG014|Phase 2|Physician Decision|0|||
148810450|NCT05352399|536782626|FG000|Overall Study|Discontinued intervention|6|||
148810451|NCT01654276|536782627|FG000|Overall Study|Lack of Efficacy|1|||
148810452|NCT01654276|536782627|FG000|Overall Study|Lost to Follow-up|4|||
148810453|NCT01654276|536782627|FG000|Overall Study|Withdrawal by Subject|1|||
148810454|NCT02657551|536782628|FG000|Overall Study|Adverse Event|2|||
148810455|NCT02657551|536782628|FG000|Overall Study|Withdrawal by Subject|1|||
148810456|NCT02657551|536782628|FG000|Overall Study|Non-Compliance|1|||
148810457|NCT02657551|536782628|FG000|Overall Study|Progression / Relapse|4|||
148810458|NCT04478266|536782629|FG000|Overall Study|Adverse Event|20|||
148810459|NCT04478266|536782630|FG001|Overall Study|Adverse Event|21|||
148810460|NCT04478266|536782629|FG000|Overall Study|Progressive disease|146|||
148810461|NCT04478266|536782630|FG001|Overall Study|Progressive disease|168|||
148810462|NCT04478266|536782629|FG000|Overall Study|Poor compliance to protocol|1|||
148810463|NCT04478266|536782630|FG001|Overall Study|Poor compliance to protocol|0|||
148810464|NCT04478266|536782629|FG000|Overall Study|Withdrawal by Subject|19|||
148810465|NCT04478266|536782630|FG001|Overall Study|Withdrawal by Subject|16|||
148810466|NCT04478266|536782629|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
148810467|NCT04478266|536782630|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
148810468|NCT04478266|536782629|FG000|Overall Study|Study terminated by sponsor|33|||
148810469|NCT04478266|536782630|FG001|Overall Study|Study terminated by sponsor|35|||
148810470|NCT04478266|536782629|FG000|Overall Study|Other: unspecified|5|||
148810471|NCT04478266|536782630|FG001|Overall Study|Other: unspecified|7|||
148810472|NCT04478266|536782629|FG000|Overall Study|Randomized but not treated|1|||
148810473|NCT04478266|536782630|FG001|Overall Study|Randomized but not treated|1|||
148810474|NCT00296517|536782631|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
148810475|NCT00296517|536782632|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
148810476|NCT00296517|536782631|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
148810477|NCT00296517|536782632|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
148810478|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
148810479|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
148810480|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
148810481|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
148810482|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
148810483|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
148810484|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
148810485|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
148810486|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
148810487|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
148810488|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
148810489|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
148810490|NCT00296517|536782631|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
148810491|NCT00296517|536782632|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
148810492|NCT01143324|536782633|FG000|Overall Study|Lost to Follow-up|11|||
148810493|NCT01143324|536782633|FG000|Overall Study|Withdrawal by Subject|4|||
148810494|NCT01143324|536782633|FG000|Overall Study|Explant of the device|4|||
148810495|NCT00596635|536782635|FG000|Overall Study|Lost to Follow-up|0|||
148810496|NCT00596635|536782636|FG001|Overall Study|Lost to Follow-up|2|||
148810497|NCT00596635|536782637|FG002|Overall Study|Lost to Follow-up|0|||
148810498|NCT00596635|536782635|FG000|Overall Study|Treatment for symptomatic UTI|4|||
148810499|NCT00596635|536782636|FG001|Overall Study|Treatment for symptomatic UTI|6|||
148810500|NCT00596635|536782637|FG002|Overall Study|Treatment for symptomatic UTI|3|||
148810501|NCT00596635|536782635|FG000|Overall Study|Hip fracture|2|||
148810502|NCT00596635|536782636|FG001|Overall Study|Hip fracture|3|||
148810503|NCT00596635|536782637|FG002|Overall Study|Hip fracture|3|||
148810504|NCT00596635|536782635|FG000|Overall Study|Could not provide urine specimen|1|||
148689654|NCT00437281|536336542|FG017|Overall Study|Adverse Event|0|||
148689655|NCT00437281|536336543|FG018|Overall Study|Adverse Event|1|||
148689656|NCT00437281|536336544|FG019|Overall Study|Adverse Event|0|||
148689657|NCT00437281|536336525|FG000|Overall Study|Lost to Follow-up|0|||
148689658|NCT00437281|536336526|FG001|Overall Study|Lost to Follow-up|0|||
148689659|NCT00437281|536336527|FG002|Overall Study|Lost to Follow-up|0|||
148689660|NCT00437281|536336528|FG003|Overall Study|Lost to Follow-up|0|||
148810505|NCT00596635|536782636|FG001|Overall Study|Could not provide urine specimen|2|||
148810506|NCT00596635|536782637|FG002|Overall Study|Could not provide urine specimen|2|||
148810507|NCT01101178|536782640|FG000|Period 1|Withdrawal by Subject|1|||
148810508|NCT01101178|536782641|FG001|Period 1|Withdrawal by Subject|2|||
148810509|NCT01101178|536782640|FG000|Period 1|Positive drug screen|1|||
148810510|NCT01101178|536782641|FG001|Period 1|Positive drug screen|1|||
148810511|NCT01101178|536782640|FG000|Period 1|Adverse Event|2|||
148810512|NCT01101178|536782641|FG001|Period 1|Adverse Event|1|||
148689661|NCT00437281|536336529|FG004|Overall Study|Lost to Follow-up|0|||
148689662|NCT00437281|536336530|FG005|Overall Study|Lost to Follow-up|0|||
148689663|NCT00437281|536336531|FG006|Overall Study|Lost to Follow-up|0|||
149229703|NCT02557308|538309572|FG002|Overall Study|Adverse Event|2|||
149229704|NCT02557308|538309573|FG003|Overall Study|Adverse Event|0|||
149229705|NCT02557308|538309574|FG004|Overall Study|Adverse Event|0|||
149229706|NCT02557308|538309575|FG005|Overall Study|Adverse Event|0|||
149229707|NCT02557308|538309576|FG006|Overall Study|Adverse Event|4|||
149229708|NCT02557308|538309577|FG007|Overall Study|Adverse Event|1|||
149229709|NCT02557308|538309570|FG000|Overall Study|Lost to Follow-up|2|||
149229710|NCT02557308|538309571|FG001|Overall Study|Lost to Follow-up|0|||
149229711|NCT02557308|538309572|FG002|Overall Study|Lost to Follow-up|1|||
149229712|NCT02557308|538309573|FG003|Overall Study|Lost to Follow-up|0|||
149229713|NCT02557308|538309574|FG004|Overall Study|Lost to Follow-up|0|||
149229714|NCT02557308|538309575|FG005|Overall Study|Lost to Follow-up|0|||
149229715|NCT02557308|538309576|FG006|Overall Study|Lost to Follow-up|2|||
149229716|NCT02557308|538309577|FG007|Overall Study|Lost to Follow-up|0|||
149229717|NCT02557308|538309570|FG000|Overall Study|Death|1|||
149229718|NCT02557308|538309571|FG001|Overall Study|Death|0|||
149229719|NCT02557308|538309572|FG002|Overall Study|Death|0|||
149229720|NCT02557308|538309573|FG003|Overall Study|Death|0|||
149229721|NCT02557308|538309574|FG004|Overall Study|Death|0|||
149229722|NCT02557308|538309575|FG005|Overall Study|Death|0|||
149229723|NCT02557308|538309576|FG006|Overall Study|Death|0|||
149229724|NCT02557308|538309577|FG007|Overall Study|Death|0|||
149229725|NCT02557308|538309570|FG000|Overall Study|Study Close|98|||
149229726|NCT02557308|538309571|FG001|Overall Study|Study Close|18|||
149229727|NCT02557308|538309572|FG002|Overall Study|Study Close|5|||
149229728|NCT02557308|538309573|FG003|Overall Study|Study Close|3|||
149229729|NCT02557308|538309574|FG004|Overall Study|Study Close|1|||
149229730|NCT02557308|538309575|FG005|Overall Study|Study Close|0|||
149229731|NCT02557308|538309576|FG006|Overall Study|Study Close|123|||
149229732|NCT02557308|538309577|FG007|Overall Study|Study Close|5|||
149229733|NCT02557308|538309570|FG000|Overall Study|Except for study close|5|||
149229734|NCT02557308|538309571|FG001|Overall Study|Except for study close|0|||
149229735|NCT02557308|538309572|FG002|Overall Study|Except for study close|0|||
149229736|NCT02557308|538309573|FG003|Overall Study|Except for study close|0|||
149229737|NCT02557308|538309574|FG004|Overall Study|Except for study close|3|||
149229738|NCT02557308|538309575|FG005|Overall Study|Except for study close|0|||
149229739|NCT02557308|538309576|FG006|Overall Study|Except for study close|6|||
149229740|NCT02557308|538309577|FG007|Overall Study|Except for study close|10|||
149229741|NCT03911401|538309580|FG000|Overall Study|Adverse Event|1|||
149229742|NCT03911401|538309581|FG001|Overall Study|Adverse Event|2|||
149229743|NCT03911401|538309582|FG002|Overall Study|Adverse Event|5|||
149229744|NCT03911401|538309580|FG000|Overall Study|Lack of Efficacy|1|||
149229745|NCT03911401|538309581|FG001|Overall Study|Lack of Efficacy|1|||
149229746|NCT03911401|538309582|FG002|Overall Study|Lack of Efficacy|8|||
149229747|NCT03911401|538309580|FG000|Overall Study|Physician Decision|0|||
149229748|NCT03911401|538309581|FG001|Overall Study|Physician Decision|0|||
149229749|NCT03911401|538309582|FG002|Overall Study|Physician Decision|1|||
149229750|NCT03911401|538309580|FG000|Overall Study|Withdrawal by Subject|1|||
149229751|NCT03911401|538309581|FG001|Overall Study|Withdrawal by Subject|2|||
149229752|NCT03911401|538309582|FG002|Overall Study|Withdrawal by Subject|0|||
149229753|NCT03911401|538309580|FG000|Overall Study|Withdrawal by parent/guardian|4|||
149229754|NCT03911401|538309581|FG001|Overall Study|Withdrawal by parent/guardian|4|||
149229755|NCT03911401|538309582|FG002|Overall Study|Withdrawal by parent/guardian|11|||
149229756|NCT06104423|538309583|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
149229757|NCT06104423|538309584|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
149229758|NCT06104423|538309585|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
149229759|NCT06104423|538309583|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
149229760|NCT06104423|538309584|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
149229761|NCT06104423|538309585|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
149229762|NCT02918968|538309586|FG000|1st Line AAT|Progressive disease|9|||
149229763|NCT02918968|538309587|FG001|1st Line AAT|Progressive disease|4|||
149229764|NCT02918968|538309586|FG000|1st Line AAT|Adverse Event|12|||
149229765|NCT02918968|538309587|FG001|1st Line AAT|Adverse Event|3|||
149229766|NCT02918968|538309586|FG000|1st Line AAT|Physician Decision|4|||
149229767|NCT02918968|538309587|FG001|1st Line AAT|Physician Decision|2|||
149229768|NCT02918968|538309586|FG000|1st Line AAT|Withdrawal by Subject|2|||
149229769|NCT02918968|538309587|FG001|1st Line AAT|Withdrawal by Subject|1|||
149229770|NCT02918968|538309586|FG000|1st Line AAT|Lost to Follow-up|0|||
149229771|NCT02918968|538309587|FG001|1st Line AAT|Lost to Follow-up|1|||
149229772|NCT02918968|538309586|FG000|1st Line AAT|Death|1|||
149229773|NCT02918968|538309587|FG001|1st Line AAT|Death|0|||
149229774|NCT02918968|538309586|FG000|1st Line AAT|Miscellaneous|1|||
149229775|NCT02918968|538309587|FG001|1st Line AAT|Miscellaneous|0|||
149229776|NCT02918968|538309586|FG000|2nd Line AAT|Progressive disease|21|||
149229777|NCT02918968|538309587|FG001|2nd Line AAT|Progressive disease|3|||
149229778|NCT02918968|538309586|FG000|2nd Line AAT|Adverse Event|2|||
149229779|NCT02918968|538309587|FG001|2nd Line AAT|Adverse Event|5|||
149229780|NCT02918968|538309586|FG000|2nd Line AAT|Physician Decision|0|||
149229781|NCT02918968|538309587|FG001|2nd Line AAT|Physician Decision|1|||
149229782|NCT02918968|538309586|FG000|2nd Line AAT|Withdrawal by Subject|2|||
149229783|NCT02918968|538309587|FG001|2nd Line AAT|Withdrawal by Subject|2|||
149229784|NCT02918968|538309586|FG000|2nd Line AAT|Death|0|||
149229785|NCT02918968|538309587|FG001|2nd Line AAT|Death|1|||
149229786|NCT05602818|538309588|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
149229787|NCT05602818|538309589|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
149229788|NCT05602818|538309590|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
149229789|NCT05602818|538309591|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
149229790|NCT05602818|538309592|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
149229791|NCT05602818|538309593|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
149229792|NCT05602818|538309594|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
149229793|NCT05602818|538309595|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
149229794|NCT05602818|538309596|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
149229795|NCT05602818|538309597|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
149229796|NCT05602818|538309598|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
149229797|NCT05602818|538309599|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
149229798|NCT05602818|538309588|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
149229799|NCT05602818|538309589|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
149229800|NCT05602818|538309590|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229801|NCT05602818|538309591|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229802|NCT05602818|538309592|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229803|NCT05602818|538309593|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229804|NCT05602818|538309594|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229805|NCT05602818|538309595|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229806|NCT05602818|538309596|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229807|NCT05602818|538309597|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229808|NCT05602818|538309598|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229809|NCT05602818|538309599|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
149229810|NCT05602818|538309588|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
149229811|NCT05602818|538309589|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229812|NCT05602818|538309590|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229813|NCT05602818|538309591|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229814|NCT05602818|538309592|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229815|NCT05602818|538309593|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229816|NCT05602818|538309594|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229817|NCT05602818|538309595|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229818|NCT05602818|538309596|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229819|NCT05602818|538309597|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229820|NCT05602818|538309598|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229821|NCT05602818|538309599|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
149229822|NCT05602818|538309588|FG000|Qualification Phase (3 Days)|Other|1|||
149229823|NCT05602818|538309589|FG001|Qualification Phase (3 Days)|Other|0|||
149229824|NCT05602818|538309590|FG002|Qualification Phase (3 Days)|Other|0|||
149229825|NCT05602818|538309591|FG003|Qualification Phase (3 Days)|Other|0|||
149229826|NCT05602818|538309592|FG004|Qualification Phase (3 Days)|Other|0|||
149229827|NCT05602818|538309593|FG005|Qualification Phase (3 Days)|Other|0|||
149229828|NCT05602818|538309594|FG006|Qualification Phase (3 Days)|Other|0|||
149229829|NCT05602818|538309595|FG007|Qualification Phase (3 Days)|Other|0|||
149229830|NCT05602818|538309596|FG008|Qualification Phase (3 Days)|Other|0|||
149229831|NCT05602818|538309597|FG009|Qualification Phase (3 Days)|Other|0|||
149229832|NCT05602818|538309598|FG010|Qualification Phase (3 Days)|Other|0|||
149229833|NCT05602818|538309599|FG011|Qualification Phase (3 Days)|Other|0|||
149229834|NCT05602818|538309588|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229835|NCT05602818|538309589|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
149229836|NCT05602818|538309590|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229837|NCT05602818|538309591|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
148689664|NCT00437281|536336532|FG007|Overall Study|Lost to Follow-up|0|||
148689665|NCT00437281|536336533|FG008|Overall Study|Lost to Follow-up|0|||
148689666|NCT00437281|536336534|FG009|Overall Study|Lost to Follow-up|0|||
148689667|NCT00437281|536336535|FG010|Overall Study|Lost to Follow-up|0|||
148689668|NCT00437281|536336536|FG011|Overall Study|Lost to Follow-up|0|||
148689669|NCT00437281|536336537|FG012|Overall Study|Lost to Follow-up|0|||
148810513|NCT01101178|536782640|FG000|Period 2|Withdrawal by Subject|0|||
148810514|NCT01101178|536782641|FG001|Period 2|Withdrawal by Subject|1|||
148810515|NCT01850641|536782642|FG000|Overall Study|Physician Decision|1|||
148810516|NCT01850641|536782642|FG000|Overall Study|Decrease in serum phosphorus|1|||
148810517|NCT01850641|536782642|FG000|Overall Study|Decrease in serum calcium|2|||
148810518|NCT01850641|536782642|FG000|Overall Study|Increase in serum ferritin|1|||
148810519|NCT00141817|536782643|FG000|Overall Study|Protocol Violation|0|||
148810520|NCT00141817|536782644|FG001|Overall Study|Protocol Violation|0|||
148810521|NCT00141817|536782645|FG002|Overall Study|Protocol Violation|1|||
148810522|NCT00141817|536782646|FG003|Overall Study|Protocol Violation|0|||
148810523|NCT00141817|536782643|FG000|Overall Study|Parent request|1|||
148810524|NCT00141817|536782644|FG001|Overall Study|Parent request|0|||
148810525|NCT00141817|536782645|FG002|Overall Study|Parent request|0|||
149229838|NCT05602818|538309592|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229839|NCT05602818|538309593|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229840|NCT05602818|538309594|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229841|NCT05602818|538309595|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229842|NCT05602818|538309596|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229843|NCT05602818|538309597|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229844|NCT05602818|538309598|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229845|NCT05602818|538309599|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
149229846|NCT05602818|538309588|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
149229847|NCT05602818|538309589|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
149229848|NCT05602818|538309590|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
149229849|NCT05602818|538309591|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
149229850|NCT05602818|538309592|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
149229851|NCT05602818|538309593|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
149229852|NCT05602818|538309594|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
149229853|NCT05602818|538309595|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
149229854|NCT05602818|538309596|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
149229855|NCT05602818|538309597|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
149229856|NCT05602818|538309598|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
149229857|NCT05602818|538309599|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
149229858|NCT05602818|538309588|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229859|NCT05602818|538309589|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229860|NCT05602818|538309590|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229861|NCT05602818|538309591|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229862|NCT05602818|538309592|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229863|NCT05602818|538309593|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229864|NCT05602818|538309594|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229865|NCT05602818|538309595|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229866|NCT05602818|538309596|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229867|NCT05602818|538309597|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
149229868|NCT05602818|538309598|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
149229869|NCT05602818|538309599|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
149229870|NCT05602818|538309588|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
149229871|NCT05602818|538309589|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
149229872|NCT05602818|538309590|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
149229873|NCT05602818|538309591|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
149229874|NCT05602818|538309592|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
149229875|NCT05602818|538309593|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
149229876|NCT05602818|538309594|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
149229877|NCT05602818|538309595|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
149229878|NCT05602818|538309596|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
149229879|NCT05602818|538309597|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
149229880|NCT05602818|538309598|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
149229881|NCT05602818|538309599|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
149229882|NCT00727246|538309600|FG000|Overall Study|could not complete MRI|0|||
149229883|NCT00727246|538309601|FG001|Overall Study|could not complete MRI|1|||
149229884|NCT00727246|538309602|FG002|Overall Study|could not complete MRI|0|||
149229885|NCT00727246|538309603|FG003|Overall Study|could not complete MRI|1|||
148810526|NCT00141817|536782646|FG003|Overall Study|Parent request|0|||
149229886|NCT00727246|538309600|FG000|Overall Study|incidental finding|0|||
149229887|NCT00727246|538309601|FG001|Overall Study|incidental finding|0|||
148810527|NCT00127803|536782647|FG000|Overall Study|Adverse Event|2|||
148810528|NCT00127803|536782648|FG001|Overall Study|Adverse Event|0|||
148810529|NCT00127803|536782649|FG002|Overall Study|Adverse Event|0|||
149229888|NCT00727246|538309602|FG002|Overall Study|incidental finding|0|||
149229889|NCT00727246|538309603|FG003|Overall Study|incidental finding|1|||
148810530|NCT00127803|536782650|FG003|Overall Study|Adverse Event|0|||
148810531|NCT00127803|536782647|FG000|Overall Study|Withdrawal by Subject|1|||
149229890|NCT00727246|538309600|FG000|Overall Study|withdrawn|0|||
149229891|NCT00727246|538309601|FG001|Overall Study|withdrawn|0|||
149229892|NCT00727246|538309602|FG002|Overall Study|withdrawn|1|||
149229893|NCT00727246|538309603|FG003|Overall Study|withdrawn|0|||
149229894|NCT03814499|538309604|FG000|Overall Study|Lost to Follow-up|3|||
149229895|NCT00351611|538309605|FG000|Overall Study|Adverse Event|11|||
149229896|NCT00351611|538309606|FG001|Overall Study|Adverse Event|3|||
149229897|NCT00351611|538309605|FG000|Overall Study|Death|1|||
149229898|NCT00351611|538309606|FG001|Overall Study|Death|0|||
149229899|NCT00351611|538309605|FG000|Overall Study|Lost to Follow-up|1|||
149229900|NCT00351611|538309606|FG001|Overall Study|Lost to Follow-up|0|||
149229901|NCT00351611|538309605|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
149229902|NCT00351611|538309606|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
149229903|NCT00351611|538309605|FG000|Overall Study|Other|1|||
149229904|NCT00351611|538309606|FG001|Overall Study|Other|0|||
149229905|NCT00351611|538309605|FG000|Overall Study|Protocol Violation|0|||
149229906|NCT00351611|538309606|FG001|Overall Study|Protocol Violation|2|||
149229907|NCT02046993|538309607|FG000|Overall Study|Withdrawal by Subject|2|||
149229908|NCT02046993|538309608|FG001|Overall Study|Withdrawal by Subject|10|||
149229909|NCT02046993|538309607|FG000|Overall Study|Lost to Follow-up|1|||
149229910|NCT02046993|538309608|FG001|Overall Study|Lost to Follow-up|1|||
149229911|NCT01589185|538309609|FG000|Overall Study|Death|1|||
149229912|NCT01589185|538309610|FG001|Overall Study|Death|2|||
149229913|NCT01589185|538309611|FG002|Overall Study|Death|2|||
149229914|NCT01589185|538309612|FG003|Overall Study|Death|0|||
149229915|NCT01589185|538309613|FG004|Overall Study|Death|1|||
149229916|NCT01589185|538309609|FG000|Overall Study|Lost to Follow-up|1|||
149229917|NCT01589185|538309610|FG001|Overall Study|Lost to Follow-up|0|||
149229918|NCT01589185|538309611|FG002|Overall Study|Lost to Follow-up|2|||
149229919|NCT01589185|538309612|FG003|Overall Study|Lost to Follow-up|3|||
149229920|NCT01589185|538309613|FG004|Overall Study|Lost to Follow-up|0|||
149229921|NCT00598442|538309617|FG000|Overall Study|Adverse Event|3|||
149229922|NCT00598442|538309618|FG001|Overall Study|Adverse Event|0|||
149229923|NCT00598442|538309619|FG002|Overall Study|Adverse Event|0|||
149229924|NCT00598442|538309617|FG000|Overall Study|Death|19|||
149229925|NCT00598442|538309618|FG001|Overall Study|Death|11|||
149229926|NCT00598442|538309619|FG002|Overall Study|Death|11|||
149229927|NCT00598442|538309617|FG000|Overall Study|Lost to Follow-up|4|||
149229928|NCT00598442|538309618|FG001|Overall Study|Lost to Follow-up|3|||
149229929|NCT00598442|538309619|FG002|Overall Study|Lost to Follow-up|3|||
149229930|NCT00598442|538309617|FG000|Overall Study|Physician Decision|2|||
149229931|NCT00598442|538309618|FG001|Overall Study|Physician Decision|1|||
149229932|NCT00598442|538309619|FG002|Overall Study|Physician Decision|1|||
149229933|NCT00598442|538309617|FG000|Overall Study|Withdrawal by Subject|8|||
149229934|NCT00598442|538309618|FG001|Overall Study|Withdrawal by Subject|16|||
149229935|NCT00598442|538309619|FG002|Overall Study|Withdrawal by Subject|6|||
149229936|NCT00598442|538309617|FG000|Overall Study|Noncompliance|0|||
149229937|NCT00598442|538309618|FG001|Overall Study|Noncompliance|2|||
149229938|NCT00598442|538309619|FG002|Overall Study|Noncompliance|1|||
149229939|NCT00598442|538309617|FG000|Overall Study|Relocation|1|||
149229940|NCT00598442|538309618|FG001|Overall Study|Relocation|4|||
149229941|NCT00598442|538309619|FG002|Overall Study|Relocation|0|||
149229942|NCT00598442|538309617|FG000|Overall Study|Renal transplant|0|||
149229943|NCT00598442|538309618|FG001|Overall Study|Renal transplant|0|||
149229944|NCT00598442|538309619|FG002|Overall Study|Renal transplant|1|||
149229945|NCT00598442|538309617|FG000|Overall Study|Site closed by sponsor|5|||
149229946|NCT00598442|538309618|FG001|Overall Study|Site closed by sponsor|2|||
148689670|NCT00437281|536336538|FG013|Overall Study|Lost to Follow-up|0|||
148689671|NCT00437281|536336539|FG014|Overall Study|Lost to Follow-up|0|||
148689672|NCT00437281|536336540|FG015|Overall Study|Lost to Follow-up|0|||
149229947|NCT00598442|538309619|FG002|Overall Study|Site closed by sponsor|1|||
149229948|NCT00598442|538309617|FG000|Overall Study|Started dialysis|1|||
149229949|NCT00598442|538309618|FG001|Overall Study|Started dialysis|0|||
149229950|NCT00598442|538309619|FG002|Overall Study|Started dialysis|0|||
149229951|NCT03781167|538309623|FG000|Overall Study|Adverse Event|23|||
149229952|NCT03781167|538309624|FG001|Overall Study|Adverse Event|25|||
149229953|NCT03781167|538309623|FG000|Overall Study|Withdrew consent|16|||
149229954|NCT03781167|538309624|FG001|Overall Study|Withdrew consent|12|||
149229955|NCT03781167|538309623|FG000|Overall Study|Lost to Follow-up|0|||
149229956|NCT03781167|538309624|FG001|Overall Study|Lost to Follow-up|1|||
149229957|NCT03781167|538309623|FG000|Overall Study|Lack of Efficacy|4|||
149229958|NCT03781167|538309624|FG001|Overall Study|Lack of Efficacy|5|||
149229959|NCT03781167|538309623|FG000|Overall Study|Difficulty with drug delivery system|2|||
149229960|NCT03781167|538309624|FG001|Overall Study|Difficulty with drug delivery system|3|||
149229961|NCT03781167|538309623|FG000|Overall Study|Other, not specified|2|||
149229962|NCT03781167|538309624|FG001|Overall Study|Other, not specified|2|||
148689673|NCT00437281|536336541|FG016|Overall Study|Lost to Follow-up|0|||
148689674|NCT00437281|536336542|FG017|Overall Study|Lost to Follow-up|0|||
149229963|NCT00462501|538309625|FG000|Overall Study|Not treated|3|||
149229964|NCT00462501|538309625|FG000|Overall Study|Adverse Event|2|||
149229965|NCT00408408|538309627|FG000|Overall Study|No follow up data|2|||
149229966|NCT00408408|538309628|FG001|Overall Study|No follow up data|3|||
149229967|NCT00408408|538309629|FG002|Overall Study|No follow up data|0|||
149229968|NCT00408408|538309630|FG003|Overall Study|No follow up data|7|||
149229969|NCT00408408|538309631|FG004|Overall Study|No follow up data|5|||
149229970|NCT00408408|538309632|FG005|Overall Study|No follow up data|3|||
149229971|NCT00917553|538309633|FG000|Overall Study|Lost to Follow-up|2|||
149229972|NCT00917553|538309634|FG001|Overall Study|Lost to Follow-up|1|||
149229973|NCT01616173|538309635|FG000|Overall Study|Lost to Follow-up|0|||
149229974|NCT01616173|538309636|FG001|Overall Study|Lost to Follow-up|2|||
149229975|NCT01616173|538309637|FG002|Overall Study|Lost to Follow-up|0|||
149229976|NCT00504595|538309639|FG000|Overall Study|Lack of Efficacy|1|||
149229977|NCT00504595|538309640|FG001|Overall Study|Lack of Efficacy|0|||
148689675|NCT00437281|536336543|FG018|Overall Study|Lost to Follow-up|0|||
148689676|NCT00437281|536336544|FG019|Overall Study|Lost to Follow-up|1|||
148689677|NCT03402893|536336548|FG000|Overall Study|Withdrawal by Subject|1|||
148689678|NCT00686036|536336553|FG000|Overall Study|Adverse Event|3|||
148689679|NCT00686036|536336554|FG001|Overall Study|Adverse Event|0|||
148689680|NCT00686036|536336553|FG000|Overall Study|Withdrawal by Subject|3|||
148689681|NCT00686036|536336554|FG001|Overall Study|Withdrawal by Subject|1|||
148689682|NCT00686036|536336553|FG000|Overall Study|Study terminated by AstraZeneca|2|||
148689683|NCT00686036|536336554|FG001|Overall Study|Study terminated by AstraZeneca|1|||
148689684|NCT00686036|536336553|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
148689685|NCT00686036|536336554|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
148689686|NCT00686036|536336553|FG000|Overall Study|Other reasons not identified|0|||
148689687|NCT00686036|536336554|FG001|Overall Study|Other reasons not identified|4|||
148689688|NCT01411995|536336555|FG000|Overall Study|Failed IUD insertion|0|||
148689689|NCT01411995|536336556|FG001|Overall Study|Failed IUD insertion|1|||
148689690|NCT02292238|536336563|FG000|Overall Study|Protocol Violation|1|||
148689691|NCT02292238|536336564|FG001|Overall Study|Protocol Violation|2|||
148689692|NCT02292238|536336563|FG000|Overall Study|Withdrawal by Subject|2|||
148689693|NCT02292238|536336564|FG001|Overall Study|Withdrawal by Subject|1|||
148689694|NCT02292238|536336563|FG000|Overall Study|Lost to Follow-up|1|||
148689695|NCT02292238|536336564|FG001|Overall Study|Lost to Follow-up|0|||
148689696|NCT02292238|536336563|FG000|Overall Study|Physician Decision|0|||
148689697|NCT02292238|536336564|FG001|Overall Study|Physician Decision|1|||
148689698|NCT01754259|536336567|FG000|Overall Study|Withdrawal by Subject|2|||
148689699|NCT01754259|536336568|FG001|Overall Study|Withdrawal by Subject|4|||
148689700|NCT01754259|536336567|FG000|Overall Study|Adverse Event|3|||
148689701|NCT01754259|536336568|FG001|Overall Study|Adverse Event|1|||
148689702|NCT01754259|536336567|FG000|Overall Study|Lost to Follow-up|0|||
148689703|NCT01754259|536336568|FG001|Overall Study|Lost to Follow-up|1|||
148689704|NCT01364870|536336573|FG000|Overall Study|Withdrawal by Subject|13|||
148689705|NCT01364870|536336574|FG001|Overall Study|Withdrawal by Subject|24|||
148689706|NCT01364870|536336575|FG002|Overall Study|Withdrawal by Subject|10|||
148689707|NCT01364870|536336573|FG000|Overall Study|Adverse Event|8|||
149229978|NCT00504595|538309641|FG002|Overall Study|Lack of Efficacy|0|||
149229979|NCT00504595|538309642|FG003|Overall Study|Lack of Efficacy|0|||
149229980|NCT00504595|538309639|FG000|Overall Study|Other|0|||
149229981|NCT00504595|538309640|FG001|Overall Study|Other|0|||
148689708|NCT01364870|536336574|FG001|Overall Study|Adverse Event|6|||
148689709|NCT01364870|536336575|FG002|Overall Study|Adverse Event|4|||
148689710|NCT01364870|536336573|FG000|Overall Study|Protocol Violation|1|||
148689711|NCT01364870|536336574|FG001|Overall Study|Protocol Violation|0|||
148689712|NCT01364870|536336575|FG002|Overall Study|Protocol Violation|0|||
148689713|NCT01618305|536336576|FG000|Overall Study|Death|0|||
148689714|NCT01618305|536336577|FG001|Overall Study|Death|1|||
148689715|NCT01618305|536336576|FG000|Overall Study|Lost to Follow-up|11|||
148689716|NCT01618305|536336577|FG001|Overall Study|Lost to Follow-up|7|||
148689717|NCT01618305|536336576|FG000|Overall Study|Protocol Violation|1|||
148689718|NCT01618305|536336577|FG001|Overall Study|Protocol Violation|0|||
148689719|NCT01618305|536336576|FG000|Overall Study|Withdrawal by Subject|3|||
148689720|NCT01618305|536336577|FG001|Overall Study|Withdrawal by Subject|2|||
148810532|NCT00127803|536782648|FG001|Overall Study|Withdrawal by Subject|0|||
149229982|NCT00504595|538309641|FG002|Overall Study|Other|2|||
149229983|NCT00504595|538309642|FG003|Overall Study|Other|0|||
149229984|NCT02431559|538309643|FG000|Overall Study|Adverse Event|0|||
149229985|NCT02431559|538309644|FG001|Overall Study|Adverse Event|1|||
148689721|NCT01960816|536336578|FG000|Overall Study|Lost to Follow-up|1|||
148689722|NCT01309919|536336596|FG000|Overall Study|Did not receive a postpartum IUD|17|||
148689723|NCT01309919|536336597|FG001|Overall Study|Did not receive a postpartum IUD|48|||
148689724|NCT02102490|536336598|FG000|Overall Study|Death|6|||
148689725|NCT02102490|536336598|FG000|Overall Study|Lost to Follow-up|1|||
148689726|NCT00095199|536336601|FG000|Overall Study|Adverse Event|40|||
148689727|NCT00095199|536336602|FG001|Overall Study|Adverse Event|22|||
148689728|NCT00095199|536336603|FG002|Overall Study|Adverse Event|26|||
148689729|NCT00095199|536336604|FG003|Overall Study|Adverse Event|11|||
148689730|NCT00095199|536336601|FG000|Overall Study|Progressive disease|213|||
148689731|NCT00095199|536336602|FG001|Overall Study|Progressive disease|179|||
148689732|NCT00095199|536336603|FG002|Overall Study|Progressive disease|105|||
149229986|NCT02431559|538309645|FG002|Overall Study|Adverse Event|0|||
149229987|NCT02431559|538309646|FG003|Overall Study|Adverse Event|4|||
149229988|NCT02431559|538309643|FG000|Overall Study|Progressive disease|2|||
149229989|NCT02431559|538309644|FG001|Overall Study|Progressive disease|1|||
149229990|NCT02431559|538309645|FG002|Overall Study|Progressive disease|4|||
149229991|NCT02431559|538309646|FG003|Overall Study|Progressive disease|22|||
149229992|NCT02431559|538309643|FG000|Overall Study|Withdrawal by Subject|0|||
149229993|NCT02431559|538309644|FG001|Overall Study|Withdrawal by Subject|1|||
149229994|NCT02431559|538309645|FG002|Overall Study|Withdrawal by Subject|0|||
149229995|NCT02431559|538309646|FG003|Overall Study|Withdrawal by Subject|4|||
149229996|NCT02431559|538309643|FG000|Overall Study|Physician Decision|0|||
149229997|NCT02431559|538309644|FG001|Overall Study|Physician Decision|0|||
149229998|NCT02431559|538309645|FG002|Overall Study|Physician Decision|0|||
149229999|NCT02431559|538309646|FG003|Overall Study|Physician Decision|1|||
149230000|NCT00955682|538309649|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
149230001|NCT00955682|538309650|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
149230002|NCT05047601|538309654|FG000|Overall Study|Lost to Follow-up|9|||
149230003|NCT05047601|538309655|FG001|Overall Study|Lost to Follow-up|11|||
149230004|NCT05047601|538309656|FG002|Overall Study|Lost to Follow-up|7|||
149230005|NCT05047601|538309654|FG000|Overall Study|Withdrawal by Subject|25|||
149230006|NCT05047601|538309655|FG001|Overall Study|Withdrawal by Subject|36|||
149230007|NCT05047601|538309656|FG002|Overall Study|Withdrawal by Subject|23|||
149230008|NCT05047601|538309654|FG000|Overall Study|Other|10|||
149230009|NCT05047601|538309655|FG001|Overall Study|Other|6|||
149230010|NCT05047601|538309656|FG002|Overall Study|Other|5|||
149230011|NCT01521494|538309667|FG000|Overall Study|Adverse Event|1|||
149230012|NCT01521494|538309668|FG001|Overall Study|Adverse Event|2|||
149230013|NCT01521494|538309669|FG002|Overall Study|Adverse Event|9|||
149230014|NCT01521494|538309670|FG003|Overall Study|Adverse Event|6|||
149230015|NCT01521494|538309671|FG004|Overall Study|Adverse Event|2|||
149230016|NCT01521494|538309667|FG000|Overall Study|Lack of Efficacy|0|||
149230017|NCT01521494|538309668|FG001|Overall Study|Lack of Efficacy|0|||
149230018|NCT01521494|538309669|FG002|Overall Study|Lack of Efficacy|0|||
149230019|NCT01521494|538309670|FG003|Overall Study|Lack of Efficacy|0|||
149230020|NCT01521494|538309671|FG004|Overall Study|Lack of Efficacy|2|||
149230021|NCT01521494|538309667|FG000|Overall Study|Withdrawal by Subject|1|||
149230022|NCT01521494|538309668|FG001|Overall Study|Withdrawal by Subject|1|||
149230023|NCT01521494|538309669|FG002|Overall Study|Withdrawal by Subject|0|||
149230024|NCT01521494|538309670|FG003|Overall Study|Withdrawal by Subject|2|||
149230025|NCT01521494|538309671|FG004|Overall Study|Withdrawal by Subject|0|||
149230026|NCT01521494|538309667|FG000|Overall Study|Decrease in serum phosphate|0|||
149230027|NCT01521494|538309668|FG001|Overall Study|Decrease in serum phosphate|2|||
149230028|NCT01521494|538309669|FG002|Overall Study|Decrease in serum phosphate|3|||
149230029|NCT01521494|538309670|FG003|Overall Study|Decrease in serum phosphate|12|||
149230030|NCT01521494|538309671|FG004|Overall Study|Decrease in serum phosphate|0|||
149230031|NCT01521494|538309667|FG000|Overall Study|Decrease in serum calcium|0|||
149230032|NCT01521494|538309668|FG001|Overall Study|Decrease in serum calcium|0|||
149230033|NCT01521494|538309669|FG002|Overall Study|Decrease in serum calcium|0|||
149230034|NCT01521494|538309670|FG003|Overall Study|Decrease in serum calcium|1|||
149230035|NCT01521494|538309671|FG004|Overall Study|Decrease in serum calcium|1|||
149230036|NCT01521494|538309667|FG000|Overall Study|Physician Decision|0|||
149230037|NCT01521494|538309668|FG001|Overall Study|Physician Decision|0|||
149230038|NCT01521494|538309669|FG002|Overall Study|Physician Decision|0|||
148810533|NCT00127803|536782649|FG002|Overall Study|Withdrawal by Subject|0|||
148810534|NCT00127803|536782650|FG003|Overall Study|Withdrawal by Subject|0|||
149230039|NCT01521494|538309670|FG003|Overall Study|Physician Decision|0|||
149230040|NCT01521494|538309671|FG004|Overall Study|Physician Decision|2|||
149230041|NCT00689728|538309672|FG000|Double-Blind Treatment|Adverse Event|1|||
149230042|NCT00689728|538309673|FG001|Double-Blind Treatment|Adverse Event|0|||
149230043|NCT00689728|538309674|FG002|Double-Blind Treatment|Adverse Event|0|||
149230044|NCT00689728|538309672|FG000|Double-Blind Treatment|Protocol Violation|0|||
149230045|NCT00689728|538309673|FG001|Double-Blind Treatment|Protocol Violation|0|||
149230046|NCT00689728|538309674|FG002|Double-Blind Treatment|Protocol Violation|1|||
149230047|NCT00689728|538309672|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
149230048|NCT00689728|538309673|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
149230049|NCT00689728|538309674|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
148810535|NCT00127803|536782647|FG000|Overall Study|Lost to Follow-up|0|||
148810536|NCT00127803|536782648|FG001|Overall Study|Lost to Follow-up|0|||
149230050|NCT00689728|538309672|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
149230051|NCT00689728|538309673|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
149230052|NCT00689728|538309674|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
149230053|NCT00689728|538309672|FG000|Rescue|Adverse Event|0|||
149230054|NCT00689728|538309673|FG001|Rescue|Adverse Event|1|||
149230055|NCT00689728|538309674|FG002|Rescue|Adverse Event|0|||
149230056|NCT00689728|538309672|FG000|Rescue|Withdrawal by Subject|1|||
149230057|NCT00689728|538309673|FG001|Rescue|Withdrawal by Subject|1|||
149230058|NCT00689728|538309674|FG002|Rescue|Withdrawal by Subject|1|||
149230059|NCT00689728|538309672|FG000|Optional Follow-Up|Adverse Event|1|||
149230060|NCT00689728|538309673|FG001|Optional Follow-Up|Adverse Event|0|||
149230061|NCT00689728|538309674|FG002|Optional Follow-Up|Adverse Event|0|||
149230062|NCT00689728|538309672|FG000|Optional Follow-Up|Lack of Efficacy|0|||
149230063|NCT00689728|538309673|FG001|Optional Follow-Up|Lack of Efficacy|1|||
149230064|NCT00689728|538309674|FG002|Optional Follow-Up|Lack of Efficacy|1|||
149230065|NCT00689728|538309672|FG000|Optional Follow-Up|Lost to Follow-up|0|||
149230066|NCT00689728|538309673|FG001|Optional Follow-Up|Lost to Follow-up|1|||
149230067|NCT00689728|538309674|FG002|Optional Follow-Up|Lost to Follow-up|1|||
149230068|NCT00689728|538309672|FG000|Optional Follow-Up|Protocol Violation|0|||
149230069|NCT00689728|538309673|FG001|Optional Follow-Up|Protocol Violation|0|||
149230070|NCT00689728|538309674|FG002|Optional Follow-Up|Protocol Violation|1|||
149230071|NCT00689728|538309672|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
148689733|NCT00095199|536336604|FG003|Overall Study|Progressive disease|98|||
148689734|NCT00095199|536336601|FG000|Overall Study|Death|10|||
148689735|NCT00095199|536336602|FG001|Overall Study|Death|6|||
148689736|NCT00095199|536336603|FG002|Overall Study|Death|11|||
148689737|NCT00095199|536336604|FG003|Overall Study|Death|9|||
148689738|NCT00095199|536336601|FG000|Overall Study|Withdrawal by Subject|21|||
148689739|NCT00095199|536336602|FG001|Overall Study|Withdrawal by Subject|16|||
148689740|NCT00095199|536336603|FG002|Overall Study|Withdrawal by Subject|13|||
148689741|NCT00095199|536336604|FG003|Overall Study|Withdrawal by Subject|22|||
148689742|NCT00095199|536336601|FG000|Overall Study|Protocol Violation|4|||
148689743|NCT00095199|536336602|FG001|Overall Study|Protocol Violation|4|||
148689744|NCT00095199|536336603|FG002|Overall Study|Protocol Violation|2|||
148689745|NCT00095199|536336604|FG003|Overall Study|Protocol Violation|0|||
148689746|NCT00095199|536336601|FG000|Overall Study|Liver function test results elevated|0|||
148689747|NCT00095199|536336602|FG001|Overall Study|Liver function test results elevated|0|||
148689748|NCT00095199|536336603|FG002|Overall Study|Liver function test results elevated|1|||
148689749|NCT00095199|536336604|FG003|Overall Study|Liver function test results elevated|1|||
148689750|NCT00095199|536336601|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
148689751|NCT00095199|536336602|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
148689752|NCT00095199|536336603|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
148689753|NCT00095199|536336604|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
148689754|NCT00095199|536336601|FG000|Overall Study|Physician Decision|5|||
148689755|NCT00095199|536336602|FG001|Overall Study|Physician Decision|6|||
148689756|NCT00095199|536336603|FG002|Overall Study|Physician Decision|1|||
148689757|NCT00095199|536336604|FG003|Overall Study|Physician Decision|1|||
148689758|NCT00095199|536336601|FG000|Overall Study|Not eligible|1|||
148689759|NCT00095199|536336602|FG001|Overall Study|Not eligible|7|||
148689760|NCT00095199|536336603|FG002|Overall Study|Not eligible|0|||
148689761|NCT00095199|536336604|FG003|Overall Study|Not eligible|1|||
148689762|NCT00095199|536336601|FG000|Overall Study|Started Palliative Radiotherapy|1|||
148689763|NCT00095199|536336602|FG001|Overall Study|Started Palliative Radiotherapy|0|||
148689764|NCT00095199|536336603|FG002|Overall Study|Started Palliative Radiotherapy|0|||
148689765|NCT00095199|536336604|FG003|Overall Study|Started Palliative Radiotherapy|0|||
148689766|NCT00095199|536336601|FG000|Overall Study|Started radiotherapy regimen|0|||
148689767|NCT00095199|536336602|FG001|Overall Study|Started radiotherapy regimen|1|||
148689768|NCT00095199|536336603|FG002|Overall Study|Started radiotherapy regimen|0|||
148689769|NCT00095199|536336604|FG003|Overall Study|Started radiotherapy regimen|0|||
148689770|NCT00095199|536336601|FG000|Overall Study|Primary tumor removed in other surgery|0|||
148689771|NCT00095199|536336602|FG001|Overall Study|Primary tumor removed in other surgery|1|||
148689772|NCT00095199|536336603|FG002|Overall Study|Primary tumor removed in other surgery|0|||
148689773|NCT00095199|536336604|FG003|Overall Study|Primary tumor removed in other surgery|0|||
148689774|NCT00095199|536336601|FG000|Overall Study|Data inadvertently lost by site|1|||
148689775|NCT00095199|536336602|FG001|Overall Study|Data inadvertently lost by site|0|||
148689776|NCT00095199|536336603|FG002|Overall Study|Data inadvertently lost by site|0|||
148689777|NCT00095199|536336604|FG003|Overall Study|Data inadvertently lost by site|0|||
148689778|NCT01736553|536336643|FG000|Overall Study|Death|12|||
148689779|NCT01736553|536336644|FG001|Overall Study|Death|0|||
148689780|NCT01736553|536336643|FG000|Overall Study|Withdrawal by Subject|5|||
148689781|NCT01736553|536336644|FG001|Overall Study|Withdrawal by Subject|2|||
148689782|NCT01736553|536336643|FG000|Overall Study|Lost to Follow-up|2|||
148689783|NCT01736553|536336644|FG001|Overall Study|Lost to Follow-up|2|||
149230072|NCT00689728|538309673|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
149230073|NCT00689728|538309674|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
149230074|NCT00689299|538309677|FG000|Overall Study|Adverse Event|2|||
149230075|NCT00689299|538309678|FG001|Overall Study|Adverse Event|1|||
149230076|NCT00689299|538309679|FG002|Overall Study|Adverse Event|1|||
149230077|NCT00689299|538309677|FG000|Overall Study|Lost to Follow-up|0|||
148689784|NCT01896297|536336645|FG000|Overall Study|Died in post treatment phase|1|||
148689785|NCT00003782|536336646|FG000|Overall Study|No follow up data|30|||
149230078|NCT00689299|538309678|FG001|Overall Study|Lost to Follow-up|1|||
149230079|NCT00689299|538309679|FG002|Overall Study|Lost to Follow-up|1|||
148689786|NCT00003782|536336647|FG001|Overall Study|No follow up data|31|||
148689787|NCT00003782|536336648|FG002|Overall Study|No follow up data|26|||
148689788|NCT01890707|536336649|FG000|Overall Study|Lost to Follow-up|1|||
148954482|NCT03510884|537317110|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
148954483|NCT03510884|537317111|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
148954484|NCT03510884|537317108|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
148954485|NCT03510884|537317109|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
148954486|NCT03510884|537317110|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
148954487|NCT03510884|537317111|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
148954488|NCT03510884|537317108|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
148954489|NCT03510884|537317109|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
148954490|NCT03510884|537317110|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
149230080|NCT00689299|538309677|FG000|Overall Study|Withdrawal by Subject|4|||
148689789|NCT01890707|536336650|FG001|Overall Study|Lost to Follow-up|1|||
148689790|NCT00385541|536336652|FG000|Overall Study|severe pain, clinician requested unblind|0|||
148689791|NCT00385541|536336653|FG001|Overall Study|severe pain, clinician requested unblind|1|||
148689792|NCT00929708|536336654|FG000|Overall Study|Protocol Violation|2|||
148689793|NCT00929708|536336655|FG001|Overall Study|Protocol Violation|1|||
148689794|NCT00929708|536336656|FG002|Overall Study|Protocol Violation|1|||
148689795|NCT00929708|536336657|FG003|Overall Study|Protocol Violation|1|||
148689796|NCT00929708|536336658|FG004|Overall Study|Protocol Violation|1|||
148689797|NCT00929708|536336654|FG000|Overall Study|Withdrawal by Subject|2|||
148689798|NCT00929708|536336655|FG001|Overall Study|Withdrawal by Subject|0|||
148689799|NCT00929708|536336656|FG002|Overall Study|Withdrawal by Subject|0|||
148689800|NCT00929708|536336657|FG003|Overall Study|Withdrawal by Subject|2|||
148689801|NCT00929708|536336658|FG004|Overall Study|Withdrawal by Subject|1|||
148689802|NCT00929708|536336654|FG000|Overall Study|Adverse Event|0|||
148689803|NCT00929708|536336655|FG001|Overall Study|Adverse Event|0|||
148689804|NCT00929708|536336656|FG002|Overall Study|Adverse Event|0|||
148689805|NCT00929708|536336657|FG003|Overall Study|Adverse Event|0|||
148689806|NCT00929708|536336658|FG004|Overall Study|Adverse Event|3|||
148689807|NCT00929708|536336654|FG000|Overall Study|Physician Decision|0|||
148689808|NCT00929708|536336655|FG001|Overall Study|Physician Decision|2|||
148689809|NCT00929708|536336656|FG002|Overall Study|Physician Decision|2|||
148689810|NCT00929708|536336657|FG003|Overall Study|Physician Decision|2|||
148689811|NCT00929708|536336658|FG004|Overall Study|Physician Decision|1|||
148689812|NCT00929708|536336654|FG000|Overall Study|Lost to Follow-up|0|||
148689813|NCT00929708|536336655|FG001|Overall Study|Lost to Follow-up|0|||
148689814|NCT00929708|536336656|FG002|Overall Study|Lost to Follow-up|0|||
148689815|NCT00929708|536336657|FG003|Overall Study|Lost to Follow-up|1|||
148689816|NCT00929708|536336658|FG004|Overall Study|Lost to Follow-up|0|||
148689817|NCT02154529|536336659|FG000|Overall Study|Death|1|||
148689818|NCT02154529|536336660|FG001|Overall Study|Death|1|||
148689819|NCT02154529|536336661|FG002|Overall Study|Death|5|||
148689820|NCT02154529|536336662|FG003|Overall Study|Death|1|||
148689821|NCT02154529|536336659|FG000|Overall Study|Termination of study by sponsor|2|||
148689822|NCT02154529|536336660|FG001|Overall Study|Termination of study by sponsor|2|||
148689823|NCT02154529|536336661|FG002|Overall Study|Termination of study by sponsor|3|||
148689824|NCT02154529|536336662|FG003|Overall Study|Termination of study by sponsor|1|||
148689825|NCT02154529|536336659|FG000|Overall Study|Lost to Follow-up|1|||
148689826|NCT02154529|536336660|FG001|Overall Study|Lost to Follow-up|0|||
148689827|NCT02154529|536336661|FG002|Overall Study|Lost to Follow-up|0|||
148689828|NCT02154529|536336662|FG003|Overall Study|Lost to Follow-up|0|||
148689829|NCT00313703|536338416|FG000|Overall Study|Lost to Follow-up|11|||
148689830|NCT00313703|536338417|FG001|Overall Study|Lost to Follow-up|2|||
148689831|NCT00313703|536338418|FG002|Overall Study|Lost to Follow-up|5|||
148689832|NCT00313703|536338419|FG003|Overall Study|Lost to Follow-up|12|||
148689833|NCT03329027|536338420|FG000|Overall Study|Lost to Follow-up|1|||
148689834|NCT03329027|536338421|FG001|Overall Study|Lost to Follow-up|0|||
148689835|NCT03329027|536338422|FG002|Overall Study|Lost to Follow-up|1|||
148689836|NCT03329027|536338420|FG000|Overall Study|Protocol Violation|9|||
148689837|NCT03329027|536338421|FG001|Overall Study|Protocol Violation|5|||
148689838|NCT03329027|536338422|FG002|Overall Study|Protocol Violation|7|||
148689839|NCT04849988|536338425|FG000|Overall Study|Lack of Efficacy|3|||
148689840|NCT04849988|536338426|FG001|Overall Study|Lack of Efficacy|4|||
148689841|NCT04849988|536338427|FG002|Overall Study|Lack of Efficacy|1|||
148689842|NCT04849988|536338428|FG003|Overall Study|Lack of Efficacy|4|||
148689843|NCT04849988|536338425|FG000|Overall Study|Other reasons|1|||
148689844|NCT04849988|536338426|FG001|Overall Study|Other reasons|2|||
148689845|NCT04849988|536338427|FG002|Overall Study|Other reasons|2|||
148689846|NCT04849988|536338428|FG003|Overall Study|Other reasons|1|||
148689847|NCT02761980|536338433|FG000|Overall Study|Adverse Event|4|||
148689848|NCT02761980|536338434|FG001|Overall Study|Adverse Event|6|||
148689849|NCT02761980|536338435|FG002|Overall Study|Adverse Event|5|||
148689850|NCT02761980|536338436|FG003|Overall Study|Adverse Event|6|||
148689851|NCT02761980|536338433|FG000|Overall Study|Withdrawal by Subject|0|||
148689852|NCT02761980|536338434|FG001|Overall Study|Withdrawal by Subject|1|||
148810537|NCT00127803|536782649|FG002|Overall Study|Lost to Follow-up|0|||
148689853|NCT02761980|536338435|FG002|Overall Study|Withdrawal by Subject|0|||
148689854|NCT02761980|536338436|FG003|Overall Study|Withdrawal by Subject|0|||
148689855|NCT02761980|536338433|FG000|Overall Study|Other|0|||
148689856|NCT02761980|536338434|FG001|Overall Study|Other|0|||
148689857|NCT02761980|536338435|FG002|Overall Study|Other|1|||
148689858|NCT02761980|536338436|FG003|Overall Study|Other|0|||
148954491|NCT03510884|537317111|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
148954492|NCT03510884|537317108|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
148954493|NCT03510884|537317109|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
148689859|NCT01907087|536338443|FG000|Overall Study|Withdrawal by Subject|1|||
148689860|NCT03312530|536338444|FG000|Overall Study|Death|5|||
148689861|NCT03312530|536338445|FG001|Overall Study|Death|5|||
148689862|NCT03312530|536338446|FG002|Overall Study|Death|4|||
148954494|NCT03510884|537317110|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
148954495|NCT03510884|537317111|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
148954496|NCT03510884|537317108|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
148954497|NCT03510884|537317109|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
148954498|NCT03510884|537317110|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
148954499|NCT03510884|537317111|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
148954500|NCT03510884|537317108|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
148954501|NCT03510884|537317109|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
148689863|NCT03312530|536338447|FG003|Overall Study|Death|10|||
148689864|NCT03312530|536338448|FG004|Overall Study|Death|8|||
148689865|NCT03312530|536338444|FG000|Overall Study|Lost to Follow-up|0|||
148689866|NCT03312530|536338445|FG001|Overall Study|Lost to Follow-up|0|||
148689867|NCT03312530|536338446|FG002|Overall Study|Lost to Follow-up|0|||
148689868|NCT03312530|536338447|FG003|Overall Study|Lost to Follow-up|1|||
148689869|NCT03312530|536338448|FG004|Overall Study|Lost to Follow-up|0|||
148689870|NCT03312530|536338444|FG000|Overall Study|Participant in another sponsor study.|0|||
148689871|NCT03312530|536338445|FG001|Overall Study|Participant in another sponsor study.|0|||
148689872|NCT03312530|536338446|FG002|Overall Study|Participant in another sponsor study.|0|||
148689873|NCT03312530|536338447|FG003|Overall Study|Participant in another sponsor study.|1|||
148689874|NCT03312530|536338448|FG004|Overall Study|Participant in another sponsor study.|0|||
148689875|NCT03312530|536338444|FG000|Overall Study|Study terminated by sponsor|1|||
148689876|NCT03312530|536338445|FG001|Overall Study|Study terminated by sponsor|0|||
148689877|NCT03312530|536338446|FG002|Overall Study|Study terminated by sponsor|2|||
148954502|NCT03510884|537317110|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
148954503|NCT03510884|537317111|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
148954504|NCT03510884|537317108|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
148954505|NCT03510884|537317109|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
148954506|NCT03510884|537317110|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
148954507|NCT03510884|537317111|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
148954508|NCT03510884|537317108|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
149230081|NCT00689299|538309678|FG001|Overall Study|Withdrawal by Subject|1|||
149230082|NCT00689299|538309679|FG002|Overall Study|Withdrawal by Subject|3|||
149230083|NCT00689299|538309677|FG000|Overall Study|Protocol Violation|1|||
149230084|NCT00689299|538309678|FG001|Overall Study|Protocol Violation|0|||
149230085|NCT00689299|538309679|FG002|Overall Study|Protocol Violation|0|||
149230086|NCT00758394|538309680|FG000|2nd Intervention Order|Lost to Follow-up|0|||
149230087|NCT00758394|538309681|FG001|2nd Intervention Order|Lost to Follow-up|1|||
149230088|NCT00758394|538309682|FG002|2nd Intervention Order|Lost to Follow-up|0|||
149230089|NCT00758394|538309683|FG003|2nd Intervention Order|Lost to Follow-up|0|||
149230090|NCT00758394|538309680|FG000|3rd Intervention|Lost to Follow-up|1|||
149230091|NCT00758394|538309681|FG001|3rd Intervention|Lost to Follow-up|0|||
149230092|NCT00758394|538309682|FG002|3rd Intervention|Lost to Follow-up|0|||
149230093|NCT00758394|538309683|FG003|3rd Intervention|Lost to Follow-up|1|||
149230094|NCT01945866|538311248|FG000|Overall Study|Eyes did not complete or were dropped|2|||
149230095|NCT01945866|538311249|FG001|Overall Study|Eyes did not complete or were dropped|0|||
149230096|NCT01674010|538311250|FG000|Open Treatment Phase 1|Adverse Event|10|||
149230097|NCT01674010|538311251|FG001|Open Treatment Phase 1|Adverse Event|0|||
148689878|NCT03312530|536338447|FG003|Overall Study|Study terminated by sponsor|3|||
148689879|NCT03312530|536338448|FG004|Overall Study|Study terminated by sponsor|7|||
148689880|NCT03312530|536338444|FG000|Overall Study|Withdrawal by Subject|0|||
148689881|NCT03312530|536338445|FG001|Overall Study|Withdrawal by Subject|1|||
148689882|NCT03312530|536338446|FG002|Overall Study|Withdrawal by Subject|0|||
148689883|NCT03312530|536338447|FG003|Overall Study|Withdrawal by Subject|0|||
148689884|NCT03312530|536338448|FG004|Overall Study|Withdrawal by Subject|0|||
148689885|NCT03312530|536338444|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
148691445|NCT01325207|536344177|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149230098|NCT01674010|538311252|FG002|Open Treatment Phase 1|Adverse Event|0|||
149230099|NCT01674010|538311250|FG000|Open Treatment Phase 1|Death|1|||
149230100|NCT01674010|538311251|FG001|Open Treatment Phase 1|Death|0|||
149230101|NCT01674010|538311252|FG002|Open Treatment Phase 1|Death|0|||
149230102|NCT01674010|538311250|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
149230103|NCT01674010|538311251|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
149230104|NCT01674010|538311252|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
149230105|NCT01674010|538311250|FG000|Open Treatment Phase 1|Physician Decision|9|||
149230106|NCT01674010|538311251|FG001|Open Treatment Phase 1|Physician Decision|0|||
149230107|NCT01674010|538311252|FG002|Open Treatment Phase 1|Physician Decision|0|||
149230108|NCT01674010|538311250|FG000|Open Treatment Phase 1|Protocol Violation|7|||
149230109|NCT01674010|538311251|FG001|Open Treatment Phase 1|Protocol Violation|0|||
149230110|NCT01674010|538311252|FG002|Open Treatment Phase 1|Protocol Violation|0|||
149230111|NCT01674010|538311250|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
149230112|NCT01674010|538311251|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
149230113|NCT01674010|538311252|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
149230114|NCT01674010|538311250|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
149230115|NCT01674010|538311251|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
149230116|NCT01674010|538311252|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
149230117|NCT01674010|538311250|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
149230118|NCT01674010|538311251|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
149230119|NCT01674010|538311252|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
149230120|NCT01674010|538311250|FG000|Randomization Phase 2|Adverse Event|0|||
149230121|NCT01674010|538311251|FG001|Randomization Phase 2|Adverse Event|1|||
149230122|NCT01674010|538311252|FG002|Randomization Phase 2|Adverse Event|1|||
149230123|NCT01674010|538311250|FG000|Randomization Phase 2|Lost to Follow-up|0|||
149230124|NCT01674010|538311251|FG001|Randomization Phase 2|Lost to Follow-up|1|||
149230125|NCT01674010|538311252|FG002|Randomization Phase 2|Lost to Follow-up|2|||
149230126|NCT01674010|538311250|FG000|Randomization Phase 2|Mood episode recurrence|0|||
149230127|NCT01674010|538311251|FG001|Randomization Phase 2|Mood episode recurrence|8|||
149230128|NCT01674010|538311252|FG002|Randomization Phase 2|Mood episode recurrence|2|||
149230129|NCT01674010|538311250|FG000|Randomization Phase 2|Physician Decision|0|||
149230130|NCT01674010|538311251|FG001|Randomization Phase 2|Physician Decision|0|||
149230131|NCT01674010|538311252|FG002|Randomization Phase 2|Physician Decision|2|||
149230132|NCT01674010|538311250|FG000|Randomization Phase 2|Pregnancy|0|||
149230133|NCT01674010|538311251|FG001|Randomization Phase 2|Pregnancy|1|||
149230134|NCT01674010|538311252|FG002|Randomization Phase 2|Pregnancy|1|||
149230135|NCT01674010|538311250|FG000|Randomization Phase 2|Protocol Violation|0|||
149230136|NCT01674010|538311251|FG001|Randomization Phase 2|Protocol Violation|1|||
149230137|NCT01674010|538311252|FG002|Randomization Phase 2|Protocol Violation|1|||
149230138|NCT01674010|538311250|FG000|Randomization Phase 2|Sponsor Decision|0|||
149230139|NCT01674010|538311251|FG001|Randomization Phase 2|Sponsor Decision|42|||
149230140|NCT01674010|538311252|FG002|Randomization Phase 2|Sponsor Decision|45|||
149230141|NCT01674010|538311250|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
149230142|NCT01674010|538311251|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
149230143|NCT01674010|538311252|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
149230144|NCT03159455|538311253|FG000|Overall Study|Adverse Event|0|||
149230145|NCT03159455|538311254|FG001|Overall Study|Adverse Event|0|||
149230146|NCT03159455|538311255|FG002|Overall Study|Adverse Event|0|||
149230147|NCT03159455|538311256|FG003|Overall Study|Adverse Event|0|||
149230148|NCT03159455|538311257|FG004|Overall Study|Adverse Event|0|||
149230149|NCT03159455|538311258|FG005|Overall Study|Adverse Event|1|||
149230150|NCT02713490|538311259|FG000|Overall Study|Withdrawal by Subject|2|||
149230151|NCT02713490|538311260|FG001|Overall Study|Withdrawal by Subject|1|||
149230152|NCT02713490|538311259|FG000|Overall Study|Did not receive study drug|1|||
149230153|NCT02713490|538311260|FG001|Overall Study|Did not receive study drug|0|||
149230154|NCT02713490|538311259|FG000|Overall Study|Met exclusion criteria|0|||
149230155|NCT02713490|538311260|FG001|Overall Study|Met exclusion criteria|1|||
149230156|NCT01789476|538311263|FG000|Overall Study|Lack of Efficacy|6|||
149230157|NCT01789476|538311264|FG001|Overall Study|Lack of Efficacy|2|||
149230158|NCT01789476|538311263|FG000|Overall Study|Adverse Event|1|||
149230159|NCT01789476|538311264|FG001|Overall Study|Adverse Event|0|||
149230160|NCT01789476|538311263|FG000|Overall Study|Unable to get IV access|1|||
149230161|NCT01789476|538311264|FG001|Overall Study|Unable to get IV access|0|||
149230162|NCT00501969|538311265|FG000|Overall Study|Major Protocol Violation|4|||
149230163|NCT00501969|538311265|FG000|Overall Study|Lack of Efficacy|29|||
149230164|NCT00501969|538311265|FG000|Overall Study|Adverse Event|76|||
149230165|NCT00501969|538311265|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
149230166|NCT00501969|538311265|FG000|Overall Study|Subject withdrew consent|51|||
149230167|NCT00501969|538311265|FG000|Overall Study|Lost to Follow-up|4|||
149230168|NCT00501969|538311265|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
149230169|NCT00501969|538311265|FG000|Overall Study|Other: Sponsors Request|10|||
149230170|NCT00501969|538311265|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
149230171|NCT00501969|538311265|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
149230172|NCT00501969|538311265|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
149230173|NCT00501969|538311265|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
148810538|NCT00127803|536782650|FG003|Overall Study|Lost to Follow-up|1|||
148810539|NCT01020123|536782655|FG000|Main Period|Withdrawal by Subject|6|||
148810540|NCT01020123|536782656|FG001|Main Period|Withdrawal by Subject|5|||
148810541|NCT01020123|536782657|FG002|Main Period|Withdrawal by Subject|3|||
148810542|NCT01020123|536782658|FG003|Main Period|Withdrawal by Subject|1|||
148810543|NCT01020123|536782659|FG004|Main Period|Withdrawal by Subject|6|||
148810544|NCT01020123|536782660|FG005|Main Period|Withdrawal by Subject|3|||
148810545|NCT01020123|536782661|FG006|Main Period|Withdrawal by Subject|2|||
148810546|NCT01020123|536782655|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
148810547|NCT01020123|536782656|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
148810548|NCT01020123|536782657|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
148810549|NCT01020123|536782658|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
148810550|NCT01020123|536782659|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
148810551|NCT01020123|536782660|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
148810552|NCT01020123|536782661|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
148810553|NCT01020123|536782655|FG000|Main Period|Adverse Event|5|||
148810554|NCT01020123|536782656|FG001|Main Period|Adverse Event|2|||
148810555|NCT01020123|536782657|FG002|Main Period|Adverse Event|2|||
148810556|NCT01020123|536782658|FG003|Main Period|Adverse Event|1|||
148810557|NCT01020123|536782659|FG004|Main Period|Adverse Event|1|||
148810558|NCT01020123|536782660|FG005|Main Period|Adverse Event|2|||
148810559|NCT01020123|536782661|FG006|Main Period|Adverse Event|1|||
148810560|NCT01020123|536782655|FG000|Main Period|Protocol Violation|4|||
148810561|NCT01020123|536782656|FG001|Main Period|Protocol Violation|4|||
148810562|NCT01020123|536782657|FG002|Main Period|Protocol Violation|2|||
149230174|NCT00501969|538311265|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
149230175|NCT00501969|538311265|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
149230176|NCT00501969|538311265|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
149230177|NCT00501969|538311265|FG000|Overall Study|Other: As Required by Local EC|2|||
149230178|NCT00501969|538311265|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
149230179|NCT00501969|538311265|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
149230180|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
149230181|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
149230182|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230183|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230184|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230185|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230186|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230187|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230188|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230189|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230190|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230191|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
149230192|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
149230193|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230194|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230195|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230196|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230197|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230198|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
149230199|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230200|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230201|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230202|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
149230203|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
149230204|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230205|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
149230206|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230207|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230208|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230209|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230210|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
148810563|NCT01020123|536782658|FG003|Main Period|Protocol Violation|5|||
149230211|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230212|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230213|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230214|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
148810564|NCT01020123|536782659|FG004|Main Period|Protocol Violation|2|||
148810565|NCT01020123|536782660|FG005|Main Period|Protocol Violation|3|||
148689886|NCT03312530|536338445|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
148689887|NCT03312530|536338446|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
149230215|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
149230216|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
149230217|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
149230218|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
149230219|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
149230220|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
149230221|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
149230222|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
149230223|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
149230224|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
149230225|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
149230226|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
149230227|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
149230228|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230229|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230230|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230231|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230232|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230233|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
149230234|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230235|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230236|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230237|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230238|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230239|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
149230240|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230241|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230242|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230243|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230244|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230245|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
149230246|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230247|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230248|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230249|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230250|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230251|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
149230252|NCT00151775|538311270|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230253|NCT00151775|538311271|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230254|NCT00151775|538311272|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230255|NCT00151775|538311273|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230256|NCT00151775|538311274|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230257|NCT00151775|538311275|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230258|NCT00151775|538311276|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
149230259|NCT00151775|538311277|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230260|NCT00151775|538311278|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230261|NCT00151775|538311279|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230262|NCT00151775|538311280|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230263|NCT00151775|538311281|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
149230264|NCT00151775|538311270|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
148689888|NCT03312530|536338447|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
148691446|NCT01325207|536344178|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
149230265|NCT00151775|538311271|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230266|NCT00151775|538311272|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230267|NCT00151775|538311273|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230268|NCT00151775|538311274|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230269|NCT00151775|538311275|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
149230270|NCT00151775|538311276|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230271|NCT00151775|538311277|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230272|NCT00151775|538311278|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230273|NCT00151775|538311279|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230274|NCT00151775|538311280|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230275|NCT00151775|538311281|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
149230276|NCT00151775|538311270|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
149230277|NCT00151775|538311271|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
149230278|NCT00151775|538311272|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
149230279|NCT00151775|538311273|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
149230280|NCT00151775|538311274|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
149230281|NCT00151775|538311275|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
149230282|NCT00151775|538311276|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
149230283|NCT00151775|538311277|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
149230284|NCT00151775|538311278|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
149230285|NCT00151775|538311279|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
149230286|NCT00151775|538311280|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
149230287|NCT00151775|538311281|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
149230288|NCT00151775|538311270|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230289|NCT00151775|538311271|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230290|NCT00151775|538311272|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230291|NCT00151775|538311273|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230292|NCT00151775|538311274|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230293|NCT00151775|538311275|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230294|NCT00151775|538311276|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
149230295|NCT00151775|538311277|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230296|NCT00151775|538311278|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230297|NCT00151775|538311279|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230298|NCT00151775|538311280|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230299|NCT00151775|538311281|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
149230300|NCT00151775|538311270|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230301|NCT00151775|538311271|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230302|NCT00151775|538311272|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
149230303|NCT00151775|538311273|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230304|NCT00151775|538311274|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230305|NCT00151775|538311275|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230306|NCT00151775|538311276|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230307|NCT00151775|538311277|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230308|NCT00151775|538311278|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230309|NCT00151775|538311279|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230310|NCT00151775|538311280|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
149230311|NCT00151775|538311281|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
148689889|NCT03312530|536338448|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
149230312|NCT00151775|538311270|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230313|NCT00151775|538311271|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230314|NCT00151775|538311272|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
149230315|NCT00151775|538311273|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230316|NCT00151775|538311274|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230317|NCT00151775|538311275|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230318|NCT00151775|538311276|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230319|NCT00151775|538311277|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230320|NCT00151775|538311278|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230321|NCT00151775|538311279|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230322|NCT00151775|538311280|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230323|NCT00151775|538311281|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
149230324|NCT00151775|538311270|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230325|NCT00151775|538311271|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230326|NCT00151775|538311272|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230327|NCT00151775|538311273|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230328|NCT00151775|538311274|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230329|NCT00151775|538311275|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230330|NCT00151775|538311276|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230331|NCT00151775|538311277|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230332|NCT00151775|538311278|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230333|NCT00151775|538311279|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230334|NCT00151775|538311280|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
149230335|NCT00151775|538311281|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
149230336|NCT00151775|538311270|FG000|Period 4: Open Label|Increased blood pressure|0|||
149230337|NCT00151775|538311271|FG001|Period 4: Open Label|Increased blood pressure|0|||
149230338|NCT00151775|538311272|FG002|Period 4: Open Label|Increased blood pressure|0|||
149230339|NCT00151775|538311273|FG003|Period 4: Open Label|Increased blood pressure|0|||
149230340|NCT00151775|538311274|FG004|Period 4: Open Label|Increased blood pressure|1|||
149230341|NCT00151775|538311275|FG005|Period 4: Open Label|Increased blood pressure|0|||
149230342|NCT00151775|538311276|FG006|Period 4: Open Label|Increased blood pressure|0|||
149230343|NCT00151775|538311277|FG007|Period 4: Open Label|Increased blood pressure|0|||
149230344|NCT00151775|538311278|FG008|Period 4: Open Label|Increased blood pressure|0|||
149230345|NCT00151775|538311279|FG009|Period 4: Open Label|Increased blood pressure|1|||
149230346|NCT00151775|538311280|FG010|Period 4: Open Label|Increased blood pressure|0|||
149230347|NCT00151775|538311281|FG011|Period 4: Open Label|Increased blood pressure|0|||
149230348|NCT00151775|538311270|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
149230349|NCT00151775|538311271|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
149230350|NCT00151775|538311272|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
149230351|NCT00151775|538311273|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
149230352|NCT00151775|538311274|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
149230353|NCT00151775|538311275|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
149230354|NCT00151775|538311276|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
149230355|NCT00151775|538311277|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
149230356|NCT00151775|538311278|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
149230357|NCT00151775|538311279|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
149230358|NCT00151775|538311280|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
149230359|NCT00151775|538311281|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
149230360|NCT00151775|538311270|FG000|Period 4: Open Label|Adverse Event|0|||
148689890|NCT02192905|536338454|FG000|Overall Study|Lost to Follow-up|1|||
148689891|NCT04583579|536338455|FG000|Overall Study|Lost to Follow-up|4|||
148689892|NCT03093454|536338467|FG000|Overall Study|Withdrawal by Subject|1|||
148689893|NCT03093454|536338468|FG001|Overall Study|Withdrawal by Subject|1|||
148689894|NCT03093454|536338467|FG000|Overall Study|Scheduling conflict|3|||
148689895|NCT03093454|536338468|FG001|Overall Study|Scheduling conflict|1|||
148689896|NCT03093454|536338467|FG000|Overall Study|Physician Decision|2|||
148689897|NCT03093454|536338468|FG001|Overall Study|Physician Decision|1|||
149230361|NCT00151775|538311271|FG001|Period 4: Open Label|Adverse Event|0|||
149230362|NCT00151775|538311272|FG002|Period 4: Open Label|Adverse Event|0|||
149230363|NCT00151775|538311273|FG003|Period 4: Open Label|Adverse Event|0|||
149230364|NCT00151775|538311274|FG004|Period 4: Open Label|Adverse Event|1|||
149230365|NCT00151775|538311275|FG005|Period 4: Open Label|Adverse Event|0|||
149230366|NCT00151775|538311276|FG006|Period 4: Open Label|Adverse Event|0|||
149230367|NCT00151775|538311277|FG007|Period 4: Open Label|Adverse Event|0|||
149230368|NCT00151775|538311278|FG008|Period 4: Open Label|Adverse Event|0|||
149230369|NCT00151775|538311279|FG009|Period 4: Open Label|Adverse Event|2|||
149230370|NCT00151775|538311280|FG010|Period 4: Open Label|Adverse Event|0|||
149230371|NCT00151775|538311281|FG011|Period 4: Open Label|Adverse Event|0|||
149230372|NCT00151775|538311270|FG000|Period 4: Open Label|Lost to Follow-up|0|||
149230373|NCT00151775|538311271|FG001|Period 4: Open Label|Lost to Follow-up|0|||
149230374|NCT00151775|538311272|FG002|Period 4: Open Label|Lost to Follow-up|0|||
149230375|NCT00151775|538311273|FG003|Period 4: Open Label|Lost to Follow-up|0|||
149230376|NCT00151775|538311274|FG004|Period 4: Open Label|Lost to Follow-up|17|||
149230377|NCT00151775|538311275|FG005|Period 4: Open Label|Lost to Follow-up|0|||
149230378|NCT00151775|538311276|FG006|Period 4: Open Label|Lost to Follow-up|0|||
149230379|NCT00151775|538311277|FG007|Period 4: Open Label|Lost to Follow-up|0|||
149230380|NCT00151775|538311278|FG008|Period 4: Open Label|Lost to Follow-up|0|||
149230381|NCT00151775|538311279|FG009|Period 4: Open Label|Lost to Follow-up|7|||
149230382|NCT00151775|538311280|FG010|Period 4: Open Label|Lost to Follow-up|0|||
149230383|NCT00151775|538311281|FG011|Period 4: Open Label|Lost to Follow-up|0|||
149230384|NCT00151775|538311270|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
149230385|NCT00151775|538311271|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
149230386|NCT00151775|538311272|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
149230387|NCT00151775|538311273|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
149230388|NCT00151775|538311274|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
149230389|NCT00151775|538311275|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
149230390|NCT00151775|538311276|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
149230391|NCT00151775|538311277|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
149230392|NCT00151775|538311278|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
149230393|NCT00151775|538311279|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
149230394|NCT00151775|538311280|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
149230395|NCT00151775|538311281|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
149230396|NCT00151775|538311270|FG000|Period 4: Open Label|Other|0|||
149230397|NCT00151775|538311271|FG001|Period 4: Open Label|Other|0|||
149230398|NCT00151775|538311272|FG002|Period 4: Open Label|Other|0|||
149230399|NCT00151775|538311273|FG003|Period 4: Open Label|Other|0|||
149230400|NCT00151775|538311274|FG004|Period 4: Open Label|Other|1|||
149230401|NCT00151775|538311275|FG005|Period 4: Open Label|Other|0|||
149230402|NCT00151775|538311276|FG006|Period 4: Open Label|Other|0|||
149230403|NCT00151775|538311277|FG007|Period 4: Open Label|Other|0|||
149230404|NCT00151775|538311278|FG008|Period 4: Open Label|Other|0|||
149230405|NCT00151775|538311279|FG009|Period 4: Open Label|Other|3|||
149230406|NCT00151775|538311280|FG010|Period 4: Open Label|Other|0|||
149230407|NCT00151775|538311281|FG011|Period 4: Open Label|Other|0|||
149230408|NCT00151775|538311270|FG000|Period 4: Open Label|Physician Decision|0|||
149230409|NCT00151775|538311271|FG001|Period 4: Open Label|Physician Decision|0|||
149230410|NCT00151775|538311272|FG002|Period 4: Open Label|Physician Decision|0|||
149230411|NCT00151775|538311273|FG003|Period 4: Open Label|Physician Decision|0|||
149230412|NCT00151775|538311274|FG004|Period 4: Open Label|Physician Decision|0|||
149230413|NCT00151775|538311275|FG005|Period 4: Open Label|Physician Decision|0|||
149230414|NCT00151775|538311276|FG006|Period 4: Open Label|Physician Decision|0|||
149230415|NCT00151775|538311277|FG007|Period 4: Open Label|Physician Decision|0|||
149230416|NCT00151775|538311278|FG008|Period 4: Open Label|Physician Decision|0|||
149230417|NCT00151775|538311279|FG009|Period 4: Open Label|Physician Decision|2|||
149230418|NCT00151775|538311280|FG010|Period 4: Open Label|Physician Decision|0|||
149230419|NCT00151775|538311281|FG011|Period 4: Open Label|Physician Decision|0|||
149230420|NCT00151775|538311270|FG000|Period 4: Open Label|Protocol Violation|0|||
149230421|NCT00151775|538311271|FG001|Period 4: Open Label|Protocol Violation|0|||
149230422|NCT00151775|538311272|FG002|Period 4: Open Label|Protocol Violation|0|||
149230423|NCT00151775|538311273|FG003|Period 4: Open Label|Protocol Violation|0|||
149230424|NCT00151775|538311274|FG004|Period 4: Open Label|Protocol Violation|1|||
149230425|NCT00151775|538311275|FG005|Period 4: Open Label|Protocol Violation|0|||
149230426|NCT00151775|538311276|FG006|Period 4: Open Label|Protocol Violation|0|||
149230427|NCT00151775|538311277|FG007|Period 4: Open Label|Protocol Violation|0|||
149230428|NCT00151775|538311278|FG008|Period 4: Open Label|Protocol Violation|0|||
149230429|NCT00151775|538311279|FG009|Period 4: Open Label|Protocol Violation|0|||
149230430|NCT00151775|538311280|FG010|Period 4: Open Label|Protocol Violation|0|||
149230431|NCT00151775|538311281|FG011|Period 4: Open Label|Protocol Violation|0|||
149230432|NCT01238861|538311282|FG000|Overall Study|Lost to Follow-up|4|||
149230433|NCT01238861|538311283|FG001|Overall Study|Lost to Follow-up|2|||
149230434|NCT01238861|538311284|FG002|Overall Study|Lost to Follow-up|3|||
149230435|NCT01238861|538311285|FG003|Overall Study|Lost to Follow-up|1|||
149230436|NCT01238861|538311286|FG004|Overall Study|Lost to Follow-up|1|||
148689906|NCT02524379|536338478|FG000|Overall Study|Death|1|||
148689907|NCT01829464|536338479|FG000|Overall Study|Adverse Event|1|||
148689908|NCT01829464|536338480|FG001|Overall Study|Adverse Event|0|||
148689909|NCT01829464|536338481|FG002|Overall Study|Adverse Event|0|||
148689910|NCT01829464|536338479|FG000|Overall Study|Lost to Follow-up|0|||
148689911|NCT01829464|536338480|FG001|Overall Study|Lost to Follow-up|0|||
148689912|NCT01829464|536338481|FG002|Overall Study|Lost to Follow-up|1|||
148689913|NCT01829464|536338479|FG000|Overall Study|Withdrawal by Subject|2|||
148689914|NCT01829464|536338480|FG001|Overall Study|Withdrawal by Subject|0|||
148689915|NCT01829464|536338481|FG002|Overall Study|Withdrawal by Subject|0|||
148689916|NCT01829464|536338479|FG000|Overall Study|Study terminated by sponsor|25|||
148689917|NCT01829464|536338480|FG001|Overall Study|Study terminated by sponsor|28|||
148689918|NCT01829464|536338481|FG002|Overall Study|Study terminated by sponsor|25|||
148689919|NCT01829464|536338479|FG000|Overall Study|Lack of Efficacy|0|||
148689920|NCT01829464|536338480|FG001|Overall Study|Lack of Efficacy|1|||
148689921|NCT01829464|536338481|FG002|Overall Study|Lack of Efficacy|0|||
148689922|NCT01180244|536338496|FG000|Overall Study|Lack of Efficacy|0|||
148689923|NCT01180244|536338497|FG001|Overall Study|Lack of Efficacy|7|||
148689924|NCT01180244|536338496|FG000|Overall Study|Physician Decision|3|||
148689925|NCT01180244|536338497|FG001|Overall Study|Physician Decision|0|||
148689926|NCT01180244|536338496|FG000|Overall Study|Adverse Event|1|||
148689927|NCT01180244|536338497|FG001|Overall Study|Adverse Event|0|||
148689928|NCT01180244|536338496|FG000|Overall Study|Withdrawal by Subject|0|||
148689929|NCT01180244|536338497|FG001|Overall Study|Withdrawal by Subject|1|||
148689930|NCT01180244|536338496|FG000|Overall Study|Protocol Violation|1|||
148689931|NCT01180244|536338497|FG001|Overall Study|Protocol Violation|0|||
148689932|NCT01180244|536338496|FG000|Overall Study|Lost to Follow-up|1|||
148689933|NCT01180244|536338497|FG001|Overall Study|Lost to Follow-up|0|||
148689934|NCT00620763|536338500|FG000|Period: First Intervention|Withdrawal by Subject|0|||
148689935|NCT00620763|536338501|FG001|Period: First Intervention|Withdrawal by Subject|2|||
148689936|NCT00620763|536338500|FG000|Period: First Intervention|Protocol Violation|0|||
148689937|NCT00620763|536338501|FG001|Period: First Intervention|Protocol Violation|3|||
148689938|NCT00620763|536338500|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
148689939|NCT00620763|536338501|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
148689940|NCT01595009|536338502|FG000|Core|Patients completed per protocol|85|||
148689941|NCT01595009|536338503|FG001|Core|Patients completed per protocol|44|||
148689942|NCT01595009|536338504|FG002|Core|Patients completed per protocol|0|||
148689943|NCT01595009|536338505|FG003|Core|Patients completed per protocol|0|||
148689944|NCT01595009|536338502|FG000|Core|Adverse Event|19|||
148689945|NCT01595009|536338503|FG001|Core|Adverse Event|23|||
148689946|NCT01595009|536338504|FG002|Core|Adverse Event|0|||
148689947|NCT01595009|536338505|FG003|Core|Adverse Event|0|||
148689948|NCT01595009|536338502|FG000|Core|Disease progression|14|||
148689949|NCT01595009|536338503|FG001|Core|Disease progression|26|||
148689950|NCT01595009|536338504|FG002|Core|Disease progression|0|||
148689951|NCT01595009|536338505|FG003|Core|Disease progression|0|||
148689952|NCT01595009|536338502|FG000|Core|Withdrawal by Subject|4|||
148689953|NCT01595009|536338503|FG001|Core|Withdrawal by Subject|17|||
148689954|NCT01595009|536338504|FG002|Core|Withdrawal by Subject|0|||
149230437|NCT01238861|538311287|FG005|Overall Study|Lost to Follow-up|2|||
148689955|NCT01595009|536338505|FG003|Core|Withdrawal by Subject|0|||
148689956|NCT01595009|536338502|FG000|Core|Death|3|||
148689957|NCT01595009|536338503|FG001|Core|Death|6|||
148689958|NCT01595009|536338504|FG002|Core|Death|0|||
148689959|NCT01595009|536338505|FG003|Core|Death|0|||
149230438|NCT01238861|538311282|FG000|Overall Study|Unplanned surgery|1|||
149230439|NCT01238861|538311283|FG001|Overall Study|Unplanned surgery|0|||
149230440|NCT01238861|538311284|FG002|Overall Study|Unplanned surgery|0|||
149230441|NCT01238861|538311285|FG003|Overall Study|Unplanned surgery|0|||
149230442|NCT01238861|538311286|FG004|Overall Study|Unplanned surgery|0|||
149230443|NCT01238861|538311287|FG005|Overall Study|Unplanned surgery|0|||
149230444|NCT01238861|538311282|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
149230445|NCT01238861|538311283|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
149230446|NCT01238861|538311284|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
149230447|NCT01238861|538311285|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
149230448|NCT01238861|538311286|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
149230449|NCT01238861|538311287|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
149230450|NCT01238861|538311282|FG000|Overall Study|Incorrect enrollment/randomization|0|||
149230451|NCT01238861|538311283|FG001|Overall Study|Incorrect enrollment/randomization|0|||
149230452|NCT01238861|538311284|FG002|Overall Study|Incorrect enrollment/randomization|1|||
149230453|NCT01238861|538311285|FG003|Overall Study|Incorrect enrollment/randomization|0|||
149230454|NCT01238861|538311286|FG004|Overall Study|Incorrect enrollment/randomization|1|||
149230455|NCT01238861|538311287|FG005|Overall Study|Incorrect enrollment/randomization|0|||
148689960|NCT01595009|536338502|FG000|Core|Lost to Follow-up|1|||
148689961|NCT01595009|536338503|FG001|Core|Lost to Follow-up|2|||
148689962|NCT01595009|536338504|FG002|Core|Lost to Follow-up|0|||
148689963|NCT01595009|536338505|FG003|Core|Lost to Follow-up|0|||
148689964|NCT01595009|536338502|FG000|Core|Protocol deviation|0|||
148689965|NCT01595009|536338503|FG001|Core|Protocol deviation|1|||
148689966|NCT01595009|536338504|FG002|Core|Protocol deviation|0|||
148689967|NCT01595009|536338505|FG003|Core|Protocol deviation|0|||
148689968|NCT01595009|536338502|FG000|Core|Administrative problems|0|||
148689969|NCT01595009|536338503|FG001|Core|Administrative problems|1|||
148689970|NCT01595009|536338504|FG002|Core|Administrative problems|0|||
148689971|NCT01595009|536338505|FG003|Core|Administrative problems|0|||
148689972|NCT01595009|536338502|FG000|Extension|Administrative problems|0|||
148689973|NCT01595009|536338503|FG001|Extension|Administrative problems|0|||
148689974|NCT01595009|536338504|FG002|Extension|Administrative problems|0|||
148689975|NCT01595009|536338505|FG003|Extension|Administrative problems|1|||
148689976|NCT01595009|536338502|FG000|Extension|Patients completed per protocol|0|||
148689977|NCT01595009|536338503|FG001|Extension|Patients completed per protocol|0|||
148689978|NCT01595009|536338504|FG002|Extension|Patients completed per protocol|0|||
148689979|NCT01595009|536338505|FG003|Extension|Patients completed per protocol|2|||
148689980|NCT01595009|536338502|FG000|Extension|Disease progression|0|||
148689981|NCT01595009|536338503|FG001|Extension|Disease progression|0|||
148689982|NCT01595009|536338504|FG002|Extension|Disease progression|4|||
148689983|NCT01595009|536338505|FG003|Extension|Disease progression|7|||
148689984|NCT01595009|536338502|FG000|Extension|Adverse Event|0|||
148689985|NCT01595009|536338503|FG001|Extension|Adverse Event|0|||
148689986|NCT01595009|536338504|FG002|Extension|Adverse Event|0|||
148689987|NCT01595009|536338505|FG003|Extension|Adverse Event|1|||
148689988|NCT04956666|536338506|FG000|Overall Study|Adverse Event|18|||
148689989|NCT04956666|536338506|FG000|Overall Study|Physician Decision|5|||
148689990|NCT00729859|536338508|FG000|Overall Study|Adverse Event|0|||
148689991|NCT00729859|536338509|FG001|Overall Study|Adverse Event|1|||
148689992|NCT00729859|536338510|FG002|Overall Study|Adverse Event|0|||
148689993|NCT00729859|536338508|FG000|Overall Study|Withdrawal by Subject|0|||
148689994|NCT00729859|536338509|FG001|Overall Study|Withdrawal by Subject|1|||
148689995|NCT00729859|536338510|FG002|Overall Study|Withdrawal by Subject|0|||
148689996|NCT02623829|536338517|FG000|Overall Study|Lost to Follow-up|1|||
148689997|NCT02623829|536338518|FG001|Overall Study|Lost to Follow-up|1|||
148689998|NCT00662025|536338519|FG000|Overall Study|Objective progression or relapse|51|||
148689999|NCT00662025|536338519|FG000|Overall Study|Adverse Event|7|||
148690000|NCT00662025|536338519|FG000|Overall Study|Withdrawal by Subject|1|||
148690001|NCT00662025|536338519|FG000|Overall Study|Results of other clinical study|2|||
148690002|NCT00662025|536338519|FG000|Overall Study|Target lesion cannot be evaluated|1|||
148690003|NCT00662025|536338519|FG000|Overall Study|Domestic circumstances|1|||
148690004|NCT01700621|536338520|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
148690005|NCT01700621|536338521|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
148690006|NCT01700621|536338520|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
148690007|NCT01700621|536338521|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
148690008|NCT01700621|536338520|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
148690009|NCT01700621|536338521|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
148690010|NCT02035137|536338524|FG000|Overall Study|Physician Decision|0|||
148690011|NCT02035137|536338525|FG001|Overall Study|Physician Decision|0|||
148690012|NCT02035137|536338526|FG002|Overall Study|Physician Decision|1|||
148690013|NCT02035137|536338524|FG000|Overall Study|Withdrawal by Subject|0|||
148690014|NCT02035137|536338525|FG001|Overall Study|Withdrawal by Subject|1|||
148690015|NCT02035137|536338526|FG002|Overall Study|Withdrawal by Subject|2|||
148690016|NCT02035137|536338524|FG000|Overall Study|Ineligible|0|||
148690017|NCT02035137|536338525|FG001|Overall Study|Ineligible|1|||
148690018|NCT02035137|536338526|FG002|Overall Study|Ineligible|2|||
148690019|NCT02035137|536338524|FG000|Overall Study|Disease progression prior to treatment start|2|||
148690020|NCT02035137|536338525|FG001|Overall Study|Disease progression prior to treatment start|0|||
148690021|NCT02035137|536338526|FG002|Overall Study|Disease progression prior to treatment start|0|||
148690022|NCT03349333|536338533|FG000|Overall Study|Progression of Disease|36|||
148690023|NCT03349333|536338533|FG000|Overall Study|Adverse Event|11|||
148690024|NCT03349333|536338533|FG000|Overall Study|Other|6|||
148690025|NCT03349333|536338533|FG000|Overall Study|Withdrawal by Subject|5|||
148690026|NCT03349333|536338533|FG000|Overall Study|Conditions interfere with participation|2|||
148690027|NCT03349333|536338533|FG000|Overall Study|Physician Decision|2|||
148690028|NCT03349333|536338533|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
148690029|NCT03349333|536338533|FG000|Overall Study|Patients in treatment less than 24 month|8|||
148690030|NCT00290745|536338534|FG000|Overall Study|Withdrawal by Subject|4|||
148810566|NCT01020123|536782661|FG006|Main Period|Protocol Violation|2|||
148690031|NCT00290745|536338534|FG000|Overall Study|Physician Decision|2|||
148690032|NCT00290745|536338534|FG000|Overall Study|Surgery after 3 months for progression|3|||
148690033|NCT00290745|536338534|FG000|Overall Study|Baseline MRI not available|3|||
148690034|NCT02985151|536338535|FG000|Original Randomization|Withdrawal by Subject|0|||
148810567|NCT01020123|536782655|FG000|Main Period|Lost to Follow-up|0|||
149230456|NCT01238861|538311282|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
149230457|NCT01238861|538311283|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
149230458|NCT01238861|538311284|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
149230459|NCT01238861|538311285|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
149230460|NCT01238861|538311286|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
149230461|NCT01238861|538311287|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
149230462|NCT01238861|538311282|FG000|Overall Study|Subject moved out of state/area|0|||
149230463|NCT01238861|538311283|FG001|Overall Study|Subject moved out of state/area|0|||
149230464|NCT01238861|538311284|FG002|Overall Study|Subject moved out of state/area|1|||
149230465|NCT01238861|538311285|FG003|Overall Study|Subject moved out of state/area|1|||
149230466|NCT01238861|538311286|FG004|Overall Study|Subject moved out of state/area|0|||
149230467|NCT01238861|538311287|FG005|Overall Study|Subject moved out of state/area|0|||
149230468|NCT01238861|538311282|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
149230469|NCT01238861|538311283|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
149230470|NCT01238861|538311284|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
149230471|NCT01238861|538311285|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
149230472|NCT01238861|538311286|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
149230473|NCT01238861|538311287|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
149230474|NCT01238861|538311282|FG000|Overall Study|Personal problems|0|||
149230475|NCT01238861|538311283|FG001|Overall Study|Personal problems|0|||
149230476|NCT01238861|538311284|FG002|Overall Study|Personal problems|0|||
149230477|NCT01238861|538311285|FG003|Overall Study|Personal problems|1|||
149230478|NCT01238861|538311286|FG004|Overall Study|Personal problems|0|||
149230479|NCT01238861|538311287|FG005|Overall Study|Personal problems|0|||
149230480|NCT01238861|538311282|FG000|Overall Study|Unable to continue visits|0|||
149230481|NCT01238861|538311283|FG001|Overall Study|Unable to continue visits|0|||
149230482|NCT01238861|538311284|FG002|Overall Study|Unable to continue visits|0|||
149230483|NCT01238861|538311285|FG003|Overall Study|Unable to continue visits|1|||
149230484|NCT01238861|538311286|FG004|Overall Study|Unable to continue visits|0|||
149230485|NCT01238861|538311287|FG005|Overall Study|Unable to continue visits|1|||
149230486|NCT01238861|538311282|FG000|Overall Study|Serious adverse event|0|||
149230487|NCT01238861|538311283|FG001|Overall Study|Serious adverse event|0|||
149230488|NCT01238861|538311284|FG002|Overall Study|Serious adverse event|0|||
149230489|NCT01238861|538311285|FG003|Overall Study|Serious adverse event|0|||
149230490|NCT01238861|538311286|FG004|Overall Study|Serious adverse event|0|||
149230491|NCT01238861|538311287|FG005|Overall Study|Serious adverse event|1|||
149230492|NCT01238861|538311282|FG000|Overall Study|Lack of compliance|0|||
149230493|NCT01238861|538311283|FG001|Overall Study|Lack of compliance|0|||
149230494|NCT01238861|538311284|FG002|Overall Study|Lack of compliance|0|||
149230495|NCT01238861|538311285|FG003|Overall Study|Lack of compliance|0|||
149230496|NCT01238861|538311286|FG004|Overall Study|Lack of compliance|0|||
149230497|NCT01238861|538311287|FG005|Overall Study|Lack of compliance|1|||
149230498|NCT01238861|538311282|FG000|Overall Study|Adverse Event|0|||
149230499|NCT01238861|538311283|FG001|Overall Study|Adverse Event|1|||
149230500|NCT01238861|538311284|FG002|Overall Study|Adverse Event|0|||
149230501|NCT01238861|538311285|FG003|Overall Study|Adverse Event|0|||
149230502|NCT01238861|538311286|FG004|Overall Study|Adverse Event|0|||
149230503|NCT01238861|538311287|FG005|Overall Study|Adverse Event|0|||
149230504|NCT01238861|538311282|FG000|Overall Study|Withdrawal by Subject|6|||
149230505|NCT01238861|538311283|FG001|Overall Study|Withdrawal by Subject|5|||
149230506|NCT01238861|538311284|FG002|Overall Study|Withdrawal by Subject|4|||
149230507|NCT01238861|538311285|FG003|Overall Study|Withdrawal by Subject|8|||
149230508|NCT01238861|538311286|FG004|Overall Study|Withdrawal by Subject|10|||
149230509|NCT01238861|538311287|FG005|Overall Study|Withdrawal by Subject|9|||
149230510|NCT01097057|538311290|FG000|Overall Study|Physician Decision|3|||
149230511|NCT01270139|538311291|FG000|Overall Study|Adverse Event|8|||
149230512|NCT01270139|538311292|FG001|Overall Study|Adverse Event|17|||
149230513|NCT01270139|538311293|FG002|Overall Study|Adverse Event|18|||
149230514|NCT01270139|538311291|FG000|Overall Study|Lost to Follow-up|10|||
149230515|NCT01270139|538311292|FG001|Overall Study|Lost to Follow-up|9|||
149230516|NCT01270139|538311293|FG002|Overall Study|Lost to Follow-up|2|||
149230517|NCT03198559|538311299|FG000|Overall Study|Adverse Event|2|||
148810568|NCT01020123|536782656|FG001|Main Period|Lost to Follow-up|2|||
149230518|NCT03737812|538311300|FG000|Overall Study|Withdrawal by Subject|1|||
149230519|NCT03737812|538311301|FG001|Overall Study|Withdrawal by Subject|2|||
149230520|NCT03737812|538311302|FG002|Overall Study|Withdrawal by Subject|1|||
149230521|NCT03737812|538311300|FG000|Overall Study|Sponsor Discontinued the Study|4|||
149230522|NCT03737812|538311301|FG001|Overall Study|Sponsor Discontinued the Study|3|||
149230523|NCT03737812|538311302|FG002|Overall Study|Sponsor Discontinued the Study|2|||
149230524|NCT03737812|538311300|FG000|Overall Study|Adverse Event|0|||
149230525|NCT03737812|538311301|FG001|Overall Study|Adverse Event|1|||
149230526|NCT03737812|538311302|FG002|Overall Study|Adverse Event|0|||
149230527|NCT03737812|538311300|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
149230528|NCT03737812|538311301|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
149230529|NCT03737812|538311302|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
149230530|NCT02624713|538311303|FG000|Overall Study|Lost to Follow-up|14|||
149230531|NCT02624713|538311304|FG001|Overall Study|Lost to Follow-up|0|||
149230532|NCT00267202|538311320|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
149230533|NCT00267202|538311321|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
149230534|NCT00267202|538311320|FG000|Overall Study|Withdrawal by Subject|12|||
149230535|NCT00267202|538311321|FG001|Overall Study|Withdrawal by Subject|15|||
149230536|NCT00267202|538311320|FG000|Overall Study|Adverse Event|13|||
149230537|NCT00267202|538311321|FG001|Overall Study|Adverse Event|7|||
149230538|NCT00267202|538311320|FG000|Overall Study|Protocol Violation|2|||
149230539|NCT00267202|538311321|FG001|Overall Study|Protocol Violation|3|||
149230540|NCT00267202|538311320|FG000|Overall Study|Administrative problems|2|||
149230541|NCT00267202|538311321|FG001|Overall Study|Administrative problems|1|||
149230542|NCT00267202|538311320|FG000|Overall Study|Lost to Follow-up|3|||
149230543|NCT00267202|538311321|FG001|Overall Study|Lost to Follow-up|0|||
149230544|NCT00399542|538311322|FG000|Overall Study|Adverse Event|18|||
149230545|NCT00399542|538311323|FG001|Overall Study|Adverse Event|15|||
149230546|NCT00399542|538311322|FG000|Overall Study|Protocol Violation|13|||
149230547|NCT00399542|538311323|FG001|Overall Study|Protocol Violation|3|||
149230548|NCT00399542|538311322|FG000|Overall Study|Withdrawal by Subject|28|||
149230549|NCT00399542|538311323|FG001|Overall Study|Withdrawal by Subject|10|||
149230550|NCT00399542|538311322|FG000|Overall Study|Lack of Efficacy|18|||
149230551|NCT00399542|538311323|FG001|Overall Study|Lack of Efficacy|8|||
149230552|NCT00399542|538311322|FG000|Overall Study|Lost to Follow-up|6|||
149230553|NCT00399542|538311323|FG001|Overall Study|Lost to Follow-up|6|||
149230554|NCT00399542|538311322|FG000|Overall Study|Other|1|||
149230555|NCT00399542|538311323|FG001|Overall Study|Other|0|||
149230556|NCT00399542|538311322|FG000|Overall Study|Physician Decision|0|||
149230557|NCT00399542|538311323|FG001|Overall Study|Physician Decision|1|||
149230558|NCT00612456|538311324|FG000|Overall Study|Adverse Event|1|||
149230559|NCT00612456|538311325|FG001|Overall Study|Adverse Event|0|||
149230560|NCT00612456|538311326|FG002|Overall Study|Adverse Event|0|||
149230561|NCT00612456|538311324|FG000|Overall Study|Lack of Efficacy|1|||
149230562|NCT00612456|538311325|FG001|Overall Study|Lack of Efficacy|1|||
149230563|NCT00612456|538311326|FG002|Overall Study|Lack of Efficacy|0|||
149230564|NCT00612456|538311324|FG000|Overall Study|Withdrawal by Subject|0|||
149230565|NCT00612456|538311325|FG001|Overall Study|Withdrawal by Subject|1|||
149230566|NCT00612456|538311326|FG002|Overall Study|Withdrawal by Subject|0|||
149230567|NCT00808665|538311327|FG000|Overall Study|Withdrawal by Subject|1|||
149230568|NCT00808665|538311328|FG001|Overall Study|Withdrawal by Subject|0|||
149230569|NCT00808665|538311327|FG000|Overall Study|only required minimally invasive surgery|1|||
149230570|NCT00808665|538311328|FG001|Overall Study|only required minimally invasive surgery|0|||
149230571|NCT00808665|538311327|FG000|Overall Study|surgery cancelled|1|||
149230572|NCT00808665|538311328|FG001|Overall Study|surgery cancelled|0|||
149230573|NCT00808665|538311327|FG000|Overall Study|required an additional procedure|0|||
149230574|NCT00808665|538311328|FG001|Overall Study|required an additional procedure|1|||
149230575|NCT00808665|538311327|FG000|Overall Study|Physician Decision|3|||
149230576|NCT00808665|538311328|FG001|Overall Study|Physician Decision|1|||
149230577|NCT00808665|538311327|FG000|Overall Study|Medication stopped by resident|0|||
149230578|NCT00808665|538311328|FG001|Overall Study|Medication stopped by resident|1|||
149230579|NCT00334893|538311329|FG000|Overall Study|Not Treated|1|||
149230580|NCT00334893|538311330|FG001|Overall Study|Not Treated|0|||
149230581|NCT01552408|538311331|FG000|Overall Study|Lost to Follow-up|2|||
149230582|NCT01552408|538311332|FG001|Overall Study|Lost to Follow-up|0|||
149230583|NCT01552408|538311331|FG000|Overall Study|Relocation|0|||
149230584|NCT01552408|538311332|FG001|Overall Study|Relocation|1|||
149230585|NCT01552408|538311331|FG000|Overall Study|Withdrawal by Subject|2|||
149230586|NCT01552408|538311332|FG001|Overall Study|Withdrawal by Subject|1|||
149230587|NCT02260791|538311342|FG000|Overall Study|Lost to Follow-up|4|||
149230588|NCT02260791|538311343|FG001|Overall Study|Lost to Follow-up|4|||
149230589|NCT02260791|538311342|FG000|Overall Study|Lack of Efficacy|2|||
149230590|NCT02260791|538311343|FG001|Overall Study|Lack of Efficacy|1|||
149230591|NCT02260791|538311342|FG000|Overall Study|Adverse Event|13|||
149230592|NCT02260791|538311343|FG001|Overall Study|Adverse Event|9|||
149230593|NCT02260791|538311342|FG000|Overall Study|Death|1|||
149230594|NCT02260791|538311343|FG001|Overall Study|Death|0|||
149230595|NCT02260791|538311342|FG000|Overall Study|Withdrawal by Subject|11|||
149230596|NCT02260791|538311343|FG001|Overall Study|Withdrawal by Subject|16|||
149230597|NCT02260791|538311342|FG000|Overall Study|Screen failure|0|||
149230598|NCT02260791|538311343|FG001|Overall Study|Screen failure|1|||
149230599|NCT02260791|538311342|FG000|Overall Study|Protocol deviation|2|||
149230600|NCT02260791|538311343|FG001|Overall Study|Protocol deviation|3|||
149230601|NCT02924129|538311344|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
149230602|NCT02924129|538311345|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
149230603|NCT02924129|538311344|FG000|Overall Study|Withdrawal by Subject|2|||
149230604|NCT02924129|538311345|FG001|Overall Study|Withdrawal by Subject|2|||
149230605|NCT02924129|538311344|FG000|Overall Study|Physician Decision|1|||
149230606|NCT02924129|538311345|FG001|Overall Study|Physician Decision|0|||
149230607|NCT02924129|538311344|FG000|Overall Study|Missed Visit|0|||
149230608|NCT02924129|538311345|FG001|Overall Study|Missed Visit|1|||
149230609|NCT01348828|538311349|FG000|Overall Study|Death|20|||
149230610|NCT01348828|538311349|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
149230611|NCT01348828|538311349|FG000|Overall Study|Conversion|2|||
149230612|NCT01348828|538311349|FG000|Overall Study|missed visit|1|||
149230613|NCT02442284|538311352|FG000|Overall Study|Adverse Event|1|||
149230614|NCT02442284|538311352|FG000|Overall Study|Withdrew Consent|2|||
149230615|NCT02442284|538311352|FG000|Overall Study|Lost to Follow-up|3|||
149230616|NCT02442284|538311352|FG000|Overall Study|Other|1|||
149230617|NCT02815670|538311353|FG000|Overall Study|Prematurely discontinued of the trial|1|||
149230618|NCT03137173|538311354|FG000|Overall Study|Withdrawal by Subject|8|||
149230619|NCT03137173|538311355|FG001|Overall Study|Withdrawal by Subject|13|||
149230620|NCT03137173|538311354|FG000|Overall Study|Death|1|||
149230621|NCT03137173|538311355|FG001|Overall Study|Death|3|||
149230622|NCT03137173|538311354|FG000|Overall Study|Physician Decision|1|||
149230623|NCT03137173|538311355|FG001|Overall Study|Physician Decision|0|||
149230624|NCT03137173|538311354|FG000|Overall Study|Lost to Follow-up|13|||
149230625|NCT03137173|538311355|FG001|Overall Study|Lost to Follow-up|18|||
149230626|NCT03137173|538311354|FG000|Overall Study|Other reasons|3|||
149230627|NCT03137173|538311355|FG001|Overall Study|Other reasons|2|||
149230628|NCT00842829|538311356|FG000|Dose Titration Period|Adverse Event|11|||
149230629|NCT00842829|538311357|FG001|Dose Titration Period|Adverse Event|10|||
149230630|NCT00842829|538311358|FG002|Dose Titration Period|Adverse Event|0|||
149230631|NCT00842829|538311356|FG000|Dose Titration Period|Lack of Efficacy|4|||
149230632|NCT00842829|538311357|FG001|Dose Titration Period|Lack of Efficacy|1|||
149230633|NCT00842829|538311358|FG002|Dose Titration Period|Lack of Efficacy|0|||
149230634|NCT00842829|538311356|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
149230635|NCT00842829|538311357|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
149230636|NCT00842829|538311358|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
149230637|NCT00842829|538311356|FG000|Dose Titration Period|Withdrawal by Subject|2|||
149230638|NCT00842829|538311357|FG001|Dose Titration Period|Withdrawal by Subject|6|||
149230639|NCT00842829|538311358|FG002|Dose Titration Period|Withdrawal by Subject|0|||
149230640|NCT00842829|538311356|FG000|Dose Titration Period|Other|5|||
149230641|NCT00842829|538311357|FG001|Dose Titration Period|Other|4|||
149230642|NCT00842829|538311358|FG002|Dose Titration Period|Other|0|||
149230643|NCT00842829|538311356|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
149230644|NCT00842829|538311357|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
149230645|NCT00842829|538311358|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
149230646|NCT00842829|538311356|FG000|Dose Titration Period|Non-compliance to study drug|2|||
149230647|NCT00842829|538311357|FG001|Dose Titration Period|Non-compliance to study drug|1|||
149230648|NCT00842829|538311358|FG002|Dose Titration Period|Non-compliance to study drug|0|||
149230649|NCT00842829|538311356|FG000|Treatment Period|Adverse Event|0|||
149230650|NCT00842829|538311357|FG001|Treatment Period|Adverse Event|0|||
149230651|NCT00842829|538311358|FG002|Treatment Period|Adverse Event|15|||
149230652|NCT00842829|538311356|FG000|Treatment Period|Lack of Efficacy|0|||
149230653|NCT00842829|538311357|FG001|Treatment Period|Lack of Efficacy|0|||
149230654|NCT00842829|538311358|FG002|Treatment Period|Lack of Efficacy|6|||
149230655|NCT00842829|538311356|FG000|Treatment Period|Unstable persistent cancer pain|0|||
149230656|NCT00842829|538311357|FG001|Treatment Period|Unstable persistent cancer pain|0|||
149230657|NCT00842829|538311358|FG002|Treatment Period|Unstable persistent cancer pain|5|||
149230658|NCT00842829|538311356|FG000|Treatment Period|Withdrawal by Subject|0|||
149230659|NCT00842829|538311357|FG001|Treatment Period|Withdrawal by Subject|0|||
149230660|NCT00842829|538311358|FG002|Treatment Period|Withdrawal by Subject|11|||
149230661|NCT00842829|538311356|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
149230662|NCT00842829|538311357|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
149230663|NCT00842829|538311358|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
149230664|NCT00842829|538311356|FG000|Treatment Period|Protocol Violation|0|||
149230665|NCT00842829|538311357|FG001|Treatment Period|Protocol Violation|0|||
149230666|NCT00842829|538311358|FG002|Treatment Period|Protocol Violation|2|||
149230667|NCT00842829|538311356|FG000|Treatment Period|Other|0|||
149230668|NCT00842829|538311357|FG001|Treatment Period|Other|0|||
149230669|NCT00842829|538311358|FG002|Treatment Period|Other|18|||
149230670|NCT00842829|538311356|FG000|Treatment Period|Non-compliance to study procedures|0|||
149230671|NCT00842829|538311357|FG001|Treatment Period|Non-compliance to study procedures|0|||
149230672|NCT00842829|538311358|FG002|Treatment Period|Non-compliance to study procedures|4|||
149230673|NCT00842829|538311356|FG000|Treatment Period|Unclear completion status|0|||
149230674|NCT00842829|538311357|FG001|Treatment Period|Unclear completion status|0|||
149230675|NCT00842829|538311358|FG002|Treatment Period|Unclear completion status|1|||
149230676|NCT00842829|538311356|FG000|Continuation Period|Adverse Event|0|||
149230677|NCT00842829|538311357|FG001|Continuation Period|Adverse Event|0|||
149230678|NCT00842829|538311358|FG002|Continuation Period|Adverse Event|32|||
149230679|NCT00842829|538311356|FG000|Continuation Period|Lack of Efficacy|0|||
149230680|NCT00842829|538311357|FG001|Continuation Period|Lack of Efficacy|0|||
149230681|NCT00842829|538311358|FG002|Continuation Period|Lack of Efficacy|6|||
149230682|NCT00842829|538311356|FG000|Continuation Period|Unstable persistent cancer pain|0|||
149230683|NCT00842829|538311357|FG001|Continuation Period|Unstable persistent cancer pain|0|||
149230684|NCT00842829|538311358|FG002|Continuation Period|Unstable persistent cancer pain|3|||
149230685|NCT00842829|538311356|FG000|Continuation Period|Withdrawal by Subject|0|||
149230686|NCT00842829|538311357|FG001|Continuation Period|Withdrawal by Subject|0|||
149230687|NCT00842829|538311358|FG002|Continuation Period|Withdrawal by Subject|10|||
149230688|NCT00842829|538311356|FG000|Continuation Period|Other|0|||
149230689|NCT00842829|538311357|FG001|Continuation Period|Other|0|||
149230690|NCT00842829|538311358|FG002|Continuation Period|Other|7|||
149230691|NCT00842829|538311356|FG000|Continuation Period|Non-compliance to study procedures|0|||
149230692|NCT00842829|538311357|FG001|Continuation Period|Non-compliance to study procedures|0|||
149230693|NCT00842829|538311358|FG002|Continuation Period|Non-compliance to study procedures|2|||
149230694|NCT00842829|538311356|FG000|Continuation Period|Non-compliance to study drug|0|||
149230695|NCT00842829|538311357|FG001|Continuation Period|Non-compliance to study drug|0|||
149230696|NCT00842829|538311358|FG002|Continuation Period|Non-compliance to study drug|1|||
149230697|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Death|2|||
149230698|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Death|0|||
149230699|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Adverse Event|33|||
149230700|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Adverse Event|31|||
149230701|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
149230702|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
149230703|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
149230704|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
149230705|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
149230706|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
149230707|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Other|7|||
149230708|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Other|8|||
149230709|NCT00280059|538311361|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
149230710|NCT00280059|538311362|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
149230711|NCT00495794|538311363|FG000|Overall Study|Pharmacist did not activate patient|522|||
149230712|NCT00495794|538311364|FG001|Overall Study|Pharmacist did not activate patient|0|||
149230713|NCT02127931|538311365|FG000|Overall Study|Glitch in Game|1|||
149230714|NCT01130831|538311366|FG000|Overall Study|Withdrawal by Subject|7|||
149230715|NCT01130831|538311366|FG000|Overall Study|Death|4|||
149230716|NCT01130831|538311366|FG000|Overall Study|Information was missing|3|||
149230717|NCT00951912|538311367|FG000|Overall Study|Lack of Efficacy|1|||
149230718|NCT00951912|538311368|FG001|Overall Study|Lack of Efficacy|0|||
149230719|NCT00951912|538311369|FG002|Overall Study|Lack of Efficacy|0|||
149230720|NCT00951912|538311367|FG000|Overall Study|Adverse Event|0|||
149230721|NCT00951912|538311368|FG001|Overall Study|Adverse Event|1|||
149230722|NCT00951912|538311369|FG002|Overall Study|Adverse Event|1|||
149230723|NCT00951912|538311367|FG000|Overall Study|Lost to Follow-up|2|||
149230724|NCT00951912|538311368|FG001|Overall Study|Lost to Follow-up|2|||
149230725|NCT00951912|538311369|FG002|Overall Study|Lost to Follow-up|0|||
149230726|NCT00951912|538311367|FG000|Overall Study|Physician Decision|1|||
149230727|NCT00951912|538311368|FG001|Overall Study|Physician Decision|0|||
149230728|NCT00951912|538311369|FG002|Overall Study|Physician Decision|1|||
149230729|NCT00951912|538311367|FG000|Overall Study|Withdrawal by Subject|1|||
149230730|NCT00951912|538311368|FG001|Overall Study|Withdrawal by Subject|1|||
149230731|NCT00951912|538311369|FG002|Overall Study|Withdrawal by Subject|0|||
149230732|NCT00951912|538311367|FG000|Overall Study|Other:Depression|1|||
149230733|NCT00951912|538311368|FG001|Overall Study|Other:Depression|0|||
149230734|NCT00951912|538311369|FG002|Overall Study|Other:Depression|0|||
149230735|NCT00951912|538311367|FG000|Overall Study|Other: Colon cancer|1|||
149230736|NCT00951912|538311368|FG001|Overall Study|Other: Colon cancer|0|||
149230737|NCT00951912|538311369|FG002|Overall Study|Other: Colon cancer|0|||
149230738|NCT00951912|538311367|FG000|Overall Study|Other: Stroke|0|||
149230739|NCT00951912|538311368|FG001|Overall Study|Other: Stroke|1|||
149230740|NCT00951912|538311369|FG002|Overall Study|Other: Stroke|0|||
149230741|NCT02173158|538311371|FG000|Efficacy Phase|Adverse Event|1|||
149230742|NCT01377194|538311372|FG000|Overall Study|Adverse Event|3|||
148810569|NCT01020123|536782657|FG002|Main Period|Lost to Follow-up|0|||
148810570|NCT01020123|536782658|FG003|Main Period|Lost to Follow-up|0|||
148810571|NCT01020123|536782659|FG004|Main Period|Lost to Follow-up|0|||
148810572|NCT01020123|536782660|FG005|Main Period|Lost to Follow-up|0|||
148810573|NCT01020123|536782661|FG006|Main Period|Lost to Follow-up|0|||
148810574|NCT01020123|536782655|FG000|Main Period|Unclasified|2|||
148810575|NCT01020123|536782656|FG001|Main Period|Unclasified|0|||
148810576|NCT01020123|536782657|FG002|Main Period|Unclasified|1|||
148810577|NCT01020123|536782658|FG003|Main Period|Unclasified|0|||
148690035|NCT02985151|536338536|FG001|Original Randomization|Withdrawal by Subject|1|||
148690036|NCT00783796|536338537|FG000|Overall Study|Did not receive any stent|4|||
148690037|NCT00783796|536338537|FG000|Overall Study|Received non-XIENCE V stent|1|||
148690038|NCT00783796|536338537|FG000|Overall Study|Received commercial XIENCE V stent|1|||
148690039|NCT00626925|536338542|FG000|Overall Study|Lost to Follow-up|1|||
148690040|NCT00626925|536338543|FG001|Overall Study|Lost to Follow-up|2|||
148690041|NCT00626925|536338542|FG000|Overall Study|relapse|1|||
148690042|NCT00626925|536338543|FG001|Overall Study|relapse|0|||
148690043|NCT00626925|536338542|FG000|Overall Study|Adverse effect|6|||
148690044|NCT00626925|536338543|FG001|Overall Study|Adverse effect|2|||
148690045|NCT00626925|536338542|FG000|Overall Study|Lack of Efficacy|1|||
148690046|NCT00626925|536338543|FG001|Overall Study|Lack of Efficacy|4|||
149230743|NCT01377194|538311373|FG001|Overall Study|Adverse Event|12|||
149230744|NCT01377194|538311374|FG002|Overall Study|Adverse Event|19|||
149230745|NCT01377194|538311372|FG000|Overall Study|Lack of Efficacy|3|||
149230746|NCT01377194|538311373|FG001|Overall Study|Lack of Efficacy|3|||
149230747|NCT01377194|538311374|FG002|Overall Study|Lack of Efficacy|3|||
149230748|NCT01377194|538311372|FG000|Overall Study|Protocol Violation|4|||
149230749|NCT01377194|538311373|FG001|Overall Study|Protocol Violation|10|||
149230750|NCT01377194|538311374|FG002|Overall Study|Protocol Violation|6|||
149230751|NCT01377194|538311372|FG000|Overall Study|Withdrawal by Subject|8|||
149230752|NCT01377194|538311373|FG001|Overall Study|Withdrawal by Subject|10|||
149230753|NCT01377194|538311374|FG002|Overall Study|Withdrawal by Subject|7|||
149230754|NCT01377194|538311372|FG000|Overall Study|Lost to Follow-up|14|||
149230755|NCT01377194|538311373|FG001|Overall Study|Lost to Follow-up|8|||
149230756|NCT01377194|538311374|FG002|Overall Study|Lost to Follow-up|11|||
149230757|NCT01728454|538311375|FG000|Stage 1 and 2|Pregnancy|1|||
149230758|NCT01728454|538311376|FG001|Stage 1 and 2|Pregnancy|0|||
149230759|NCT01728454|538311377|FG002|Stage 1 and 2|Pregnancy|0|||
149230760|NCT01728454|538311375|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
149230761|NCT01728454|538311376|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
149230762|NCT01728454|538311377|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
149230763|NCT01728454|538311375|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
149230764|NCT01728454|538311376|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
148690047|NCT00626925|536338542|FG000|Overall Study|Time constraints|3|||
148690048|NCT00626925|536338543|FG001|Overall Study|Time constraints|1|||
148690049|NCT01215942|536338549|FG000|Treatment Period|Adverse Event|15|||
148690050|NCT01215942|536338550|FG001|Treatment Period|Adverse Event|26|||
148690051|NCT01215942|536338549|FG000|Treatment Period|Death|2|||
148690052|NCT01215942|536338550|FG001|Treatment Period|Death|4|||
148690053|NCT01215942|536338549|FG000|Treatment Period|Lack of Efficacy|23|||
148690054|NCT01215942|536338550|FG001|Treatment Period|Lack of Efficacy|62|||
148810578|NCT01020123|536782659|FG004|Main Period|Unclasified|1|||
149230765|NCT01728454|538311377|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
149230766|NCT01728454|538311375|FG000|Stage 1 and 2|Lost to Follow-up|1|||
149230767|NCT01728454|538311376|FG001|Stage 1 and 2|Lost to Follow-up|1|||
149230768|NCT01728454|538311377|FG002|Stage 1 and 2|Lost to Follow-up|0|||
149230769|NCT01728454|538311375|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
149230770|NCT01728454|538311376|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
149230771|NCT01728454|538311377|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
149230772|NCT01728454|538311375|FG000|Stage 3|Reason Missing|0|||
149230773|NCT01728454|538311376|FG001|Stage 3|Reason Missing|0|||
149230774|NCT01728454|538311377|FG002|Stage 3|Reason Missing|1|||
149230775|NCT01728454|538311375|FG000|Stage 3|Subject Required Other Treatment|0|||
149230776|NCT01728454|538311376|FG001|Stage 3|Subject Required Other Treatment|1|||
149230777|NCT01728454|538311377|FG002|Stage 3|Subject Required Other Treatment|0|||
149230778|NCT01728454|538311375|FG000|Stage 3|Pregnancy|1|||
149230779|NCT01728454|538311376|FG001|Stage 3|Pregnancy|0|||
149230780|NCT01728454|538311377|FG002|Stage 3|Pregnancy|0|||
149230781|NCT01728454|538311375|FG000|Stage 3|Withdrew Consent|1|||
149230782|NCT01728454|538311376|FG001|Stage 3|Withdrew Consent|0|||
149230783|NCT01728454|538311377|FG002|Stage 3|Withdrew Consent|1|||
148690055|NCT01215942|536338549|FG000|Treatment Period|Lost to Follow-up|3|||
148690056|NCT01215942|536338550|FG001|Treatment Period|Lost to Follow-up|4|||
149230784|NCT01728454|538311375|FG000|Stage 3|Non-compliance with Protocol|0|||
148690057|NCT01215942|536338549|FG000|Treatment Period|Withdrawal by Subject|17|||
148690058|NCT01215942|536338550|FG001|Treatment Period|Withdrawal by Subject|40|||
148690059|NCT01215942|536338549|FG000|Treatment Period|Physician Decision|5|||
148690060|NCT01215942|536338550|FG001|Treatment Period|Physician Decision|5|||
148810579|NCT01020123|536782660|FG005|Main Period|Unclasified|3|||
148810580|NCT01020123|536782661|FG006|Main Period|Unclasified|6|||
148690061|NCT01215942|536338549|FG000|Treatment Period|Protocol Violation|0|||
148690062|NCT01215942|536338550|FG001|Treatment Period|Protocol Violation|1|||
148690063|NCT01215942|536338549|FG000|Treatment Period|Sponsor Decision|349|||
148690064|NCT01215942|536338550|FG001|Treatment Period|Sponsor Decision|530|||
148690065|NCT01215942|536338549|FG000|Post-Treatment Follow-Up Period|Death|0|||
148690066|NCT01215942|536338550|FG001|Post-Treatment Follow-Up Period|Death|1|||
148690067|NCT01215942|536338549|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
149230785|NCT01728454|538311376|FG001|Stage 3|Non-compliance with Protocol|0|||
149230786|NCT01728454|538311377|FG002|Stage 3|Non-compliance with Protocol|1|||
149230787|NCT01728454|538311375|FG000|Stage 3|Lost to Follow-up|0|||
149230788|NCT01728454|538311376|FG001|Stage 3|Lost to Follow-up|3|||
149230789|NCT01728454|538311377|FG002|Stage 3|Lost to Follow-up|1|||
149230790|NCT01728454|538311375|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
149230791|NCT01728454|538311376|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
149230792|NCT01728454|538311377|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
149230793|NCT01190839|538311380|FG000|Overall Study|Adverse Event|32|||
149230794|NCT01190839|538311381|FG001|Overall Study|Adverse Event|41|||
149230795|NCT01190839|538311380|FG000|Overall Study|Protocol Violation|2|||
149230796|NCT01190839|538311381|FG001|Overall Study|Protocol Violation|2|||
149230797|NCT01190839|538311380|FG000|Overall Study|Lost to Follow-up|7|||
149230798|NCT01190839|538311381|FG001|Overall Study|Lost to Follow-up|1|||
149230799|NCT01190839|538311380|FG000|Overall Study|Death|1|||
149230800|NCT01190839|538311381|FG001|Overall Study|Death|0|||
149230801|NCT01190839|538311380|FG000|Overall Study|Trial stopped by Sponsor|71|||
149230802|NCT01190839|538311381|FG001|Overall Study|Trial stopped by Sponsor|68|||
149230803|NCT01190839|538311380|FG000|Overall Study|Undefined|35|||
149230804|NCT01190839|538311381|FG001|Overall Study|Undefined|31|||
149230805|NCT01190839|538311380|FG000|Overall Study|Randomized but not treated|2|||
149230806|NCT01190839|538311381|FG001|Overall Study|Randomized but not treated|4|||
149230807|NCT03077646|538311386|FG000|Overall Study|Lost to Follow-up|29|||
149230808|NCT03077646|538311387|FG001|Overall Study|Lost to Follow-up|30|||
149230809|NCT03077646|538311388|FG002|Overall Study|Lost to Follow-up|31|||
149230810|NCT02058966|538311389|FG000|Open-Label Methamphetamine|Adverse Event|1|||
149230811|NCT02058966|538311389|FG000|First Intervention|Withdrawal by Subject|1|||
149230812|NCT00765726|538311390|FG000|Overall Study|Withdrawal by Subject|1|||
149230813|NCT00765726|538311390|FG000|Overall Study|Discontinuation of study by sponsor|8|||
149230814|NCT01265511|538311391|FG000|Overall Study|Lack of Efficacy|2|||
149230815|NCT01265511|538311392|FG001|Overall Study|Lack of Efficacy|1|||
149230816|NCT01265511|538311391|FG000|Overall Study|Met stopping rules|0|||
149230817|NCT01265511|538311392|FG001|Overall Study|Met stopping rules|2|||
149230818|NCT02993731|538311393|FG000|Overall Study|Study Termination|101|||
149230819|NCT02993731|538311394|FG001|Overall Study|Study Termination|105|||
149230820|NCT00323479|538311397|FG000|Overall Study|Adverse Event|2|||
149230821|NCT00323479|538311397|FG000|Overall Study|Withdrawal by Subject|2|||
149230822|NCT00323479|538311397|FG000|Overall Study|Protocol Violation|3|||
149230823|NCT00323479|538311397|FG000|Overall Study|house moving|1|||
149230824|NCT01362062|538311398|FG000|Overall Study|Adverse Event|1|||
149230825|NCT01362062|538311399|FG001|Overall Study|Adverse Event|0|||
149230826|NCT01362062|538311398|FG000|Overall Study|Lost to Follow-up|11|||
149230827|NCT01362062|538311399|FG001|Overall Study|Lost to Follow-up|0|||
149230828|NCT01362062|538311398|FG000|Overall Study|Withdrawal by Subject|2|||
148690068|NCT01215942|536338550|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
148690069|NCT01215942|536338549|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
148690070|NCT01215942|536338550|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
148690071|NCT01215942|536338549|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
149230829|NCT01362062|538311399|FG001|Overall Study|Withdrawal by Subject|0|||
149230830|NCT01362062|538311398|FG000|Overall Study|Non-compliant participant|2|||
149230831|NCT01362062|538311399|FG001|Overall Study|Non-compliant participant|0|||
149230832|NCT01362062|538311398|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
149230833|NCT01362062|538311399|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
149230834|NCT01362062|538311398|FG000|Overall Study|Had significant improvement|9|||
149230835|NCT01362062|538311399|FG001|Overall Study|Had significant improvement|0|||
148690072|NCT01215942|536338550|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
148690073|NCT01215942|536338549|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
148690074|NCT01215942|536338550|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
148690075|NCT03305055|536338551|FG000|Overall Study|Withdrawal by Subject|0|||
149230836|NCT02545504|538311402|FG000|Overall Study|Death|174|||
149230837|NCT02545504|538311403|FG001|Overall Study|Death|168|||
149230838|NCT02545504|538311402|FG000|Overall Study|Unknown reason|30|||
149230839|NCT02545504|538311403|FG001|Overall Study|Unknown reason|32|||
149230840|NCT02545504|538311402|FG000|Overall Study|Withdrew consent|9|||
148690076|NCT03305055|536338552|FG001|Overall Study|Withdrawal by Subject|1|||
148690077|NCT03305055|536338551|FG000|Overall Study|Adverse Event|1|||
148690078|NCT03305055|536338552|FG001|Overall Study|Adverse Event|1|||
149230841|NCT02545504|538311403|FG001|Overall Study|Withdrew consent|11|||
149230842|NCT02545504|538311402|FG000|Overall Study|Investigator's discretion|3|||
149230843|NCT02545504|538311403|FG001|Overall Study|Investigator's discretion|1|||
149230844|NCT02545504|538311402|FG000|Overall Study|Lost to Follow-up|2|||
149230845|NCT02545504|538311403|FG001|Overall Study|Lost to Follow-up|2|||
149230846|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
149230847|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
149230848|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
149230849|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
149230850|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
149230851|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
149230852|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
149230853|NCT00950755|538311405|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
149230854|NCT00950755|538311405|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
149230855|NCT00950755|538311405|FG000|Long-Term Follow-Up|Death|8|||
149230856|NCT00508820|538311407|FG000|Overall Study|Adverse Event|6|||
149230857|NCT00508820|538311408|FG001|Overall Study|Adverse Event|10|||
149230858|NCT00508820|538311407|FG000|Overall Study|Death|6|||
149230859|NCT00508820|538311408|FG001|Overall Study|Death|8|||
149230860|NCT00508820|538311407|FG000|Overall Study|Lost to Follow-up|1|||
149230861|NCT00508820|538311408|FG001|Overall Study|Lost to Follow-up|1|||
149230862|NCT00508820|538311407|FG000|Overall Study|Physician Decision|8|||
149230863|NCT00508820|538311408|FG001|Overall Study|Physician Decision|2|||
149230864|NCT00508820|538311407|FG000|Overall Study|Pregnancy|0|||
149230865|NCT00508820|538311408|FG001|Overall Study|Pregnancy|2|||
149230866|NCT00508820|538311407|FG000|Overall Study|Protocol Violation|2|||
149230867|NCT00508820|538311408|FG001|Overall Study|Protocol Violation|0|||
149230868|NCT00508820|538311407|FG000|Overall Study|Withdrawal by Subject|10|||
149230869|NCT00508820|538311408|FG001|Overall Study|Withdrawal by Subject|12|||
149230870|NCT00508820|538311407|FG000|Overall Study|Other|11|||
149230871|NCT00508820|538311408|FG001|Overall Study|Other|2|||
149230872|NCT00508820|538311407|FG000|Overall Study|Noncompliance|1|||
149230873|NCT00508820|538311408|FG001|Overall Study|Noncompliance|0|||
149230874|NCT00508820|538311407|FG000|Overall Study|Requirement for alternative therapy|7|||
149230875|NCT00508820|538311408|FG001|Overall Study|Requirement for alternative therapy|15|||
149230876|NCT00508820|538311407|FG000|Overall Study|Protocol-specified Criteria|3|||
149230877|NCT00508820|538311408|FG001|Overall Study|Protocol-specified Criteria|12|||
149230878|NCT01018680|538313472|FG000|Overall Study|Adverse Event|23|||
149230879|NCT01018680|538313473|FG001|Overall Study|Adverse Event|40|||
149230880|NCT01018680|538313472|FG000|Overall Study|Withdrawal by Subject|10|||
149230881|NCT01018680|538313473|FG001|Overall Study|Withdrawal by Subject|10|||
149230882|NCT01018680|538313472|FG000|Overall Study|Protocol Violation|5|||
149230883|NCT01018680|538313473|FG001|Overall Study|Protocol Violation|8|||
149230884|NCT01018680|538313472|FG000|Overall Study|Sponsor Decision|6|||
149230885|NCT01018680|538313473|FG001|Overall Study|Sponsor Decision|7|||
149230886|NCT01018680|538313472|FG000|Overall Study|Lack of Efficacy|8|||
149230887|NCT01018680|538313473|FG001|Overall Study|Lack of Efficacy|2|||
149230888|NCT01018680|538313472|FG000|Overall Study|Lost to Follow-up|5|||
149230889|NCT01018680|538313473|FG001|Overall Study|Lost to Follow-up|3|||
149230890|NCT01018680|538313472|FG000|Overall Study|Entry Criteria Not Met|1|||
149230891|NCT01018680|538313473|FG001|Overall Study|Entry Criteria Not Met|4|||
149230892|NCT01018680|538313472|FG000|Overall Study|Physician Decision|3|||
149230893|NCT01018680|538313473|FG001|Overall Study|Physician Decision|1|||
149230894|NCT02930889|538313474|FG000|Overall Study|Lost to Follow-up|2|||
149230895|NCT02930889|538313474|FG000|Overall Study|Withdrawal by Subject|6|||
149230896|NCT02930889|538313474|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
149230897|NCT04398030|538313475|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
149230898|NCT04398030|538313476|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
149230899|NCT04398030|538313475|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
149230900|NCT04398030|538313476|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
149230901|NCT05056311|538313479|FG000|Overall Study|Lost to Follow-up|14|||
149230902|NCT05056311|538313479|FG000|Overall Study|Withdrawal by Subject|1|||
149230903|NCT05056311|538313479|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
149230904|NCT03799198|538313483|FG000|Overall Study|Lost to Follow-up|4|||
149230905|NCT03799198|538313484|FG001|Overall Study|Lost to Follow-up|8|||
148690079|NCT00113490|536338553|FG000|Overall Study|Withdrawal by Subject|1|||
148690080|NCT00113490|536338554|FG001|Overall Study|Withdrawal by Subject|3|||
148690081|NCT00113490|536338553|FG000|Overall Study|Lost to Follow-up|1|||
148690082|NCT00113490|536338554|FG001|Overall Study|Lost to Follow-up|0|||
149230906|NCT03799198|538313483|FG000|Overall Study|Death|0|||
148690083|NCT00819247|536338555|FG000|Overall Study|Adverse Event|0|||
149230907|NCT03799198|538313484|FG001|Overall Study|Death|1|||
149230908|NCT00960869|538313486|FG000|Overall Study|Adverse Event|17|||
149230909|NCT00960869|538313487|FG001|Overall Study|Adverse Event|26|||
149230910|NCT00960869|538313486|FG000|Overall Study|Withdrawal by Subject|16|||
149230911|NCT00960869|538313487|FG001|Overall Study|Withdrawal by Subject|14|||
149230912|NCT00960869|538313486|FG000|Overall Study|Lost to Follow-up|1|||
149230913|NCT00960869|538313487|FG001|Overall Study|Lost to Follow-up|4|||
149230914|NCT00960869|538313486|FG000|Overall Study|Misc|19|||
149230915|NCT00960869|538313487|FG001|Overall Study|Misc|18|||
149230916|NCT01714726|538313488|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
149230917|NCT01714726|538313489|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
149230918|NCT01714726|538313490|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
149230919|NCT01714726|538313491|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
149230920|NCT01714726|538313488|FG000|Double-Blinded Induction Period|Adverse Event|0|||
149230921|NCT01714726|538313489|FG001|Double-Blinded Induction Period|Adverse Event|1|||
149230922|NCT01714726|538313490|FG002|Double-Blinded Induction Period|Adverse Event|0|||
149230923|NCT01714726|538313491|FG003|Double-Blinded Induction Period|Adverse Event|0|||
149230924|NCT01714726|538313488|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
149230925|NCT01714726|538313489|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
149230926|NCT01714726|538313490|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
149230927|NCT01714726|538313491|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
149230928|NCT01714726|538313488|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
149230929|NCT01714726|538313489|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
149230930|NCT01714726|538313490|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
149230931|NCT01714726|538313491|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
149230932|NCT01714726|538313488|FG000|Open-Label Period|Other|0|||
149230933|NCT01714726|538313489|FG001|Open-Label Period|Other|0|||
149230934|NCT01714726|538313490|FG002|Open-Label Period|Other|1|||
149230935|NCT01714726|538313491|FG003|Open-Label Period|Other|3|||
149230936|NCT01714726|538313488|FG000|Open-Label Period|Adverse Event|0|||
149230937|NCT01714726|538313489|FG001|Open-Label Period|Adverse Event|0|||
149230938|NCT01714726|538313490|FG002|Open-Label Period|Adverse Event|1|||
149230939|NCT01714726|538313491|FG003|Open-Label Period|Adverse Event|0|||
149230940|NCT01714726|538313488|FG000|Open-Label Period|Withdrawal by Subject|0|||
149230941|NCT01714726|538313489|FG001|Open-Label Period|Withdrawal by Subject|0|||
149230942|NCT01714726|538313490|FG002|Open-Label Period|Withdrawal by Subject|9|||
149230943|NCT01714726|538313491|FG003|Open-Label Period|Withdrawal by Subject|19|||
149230944|NCT01714726|538313488|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
149230945|NCT01714726|538313489|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
149230946|NCT01714726|538313490|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
149230947|NCT01714726|538313491|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
149230948|NCT01714726|538313488|FG000|Open-Label Period|Lost to Follow-up|0|||
149230949|NCT01714726|538313489|FG001|Open-Label Period|Lost to Follow-up|0|||
149230950|NCT01714726|538313490|FG002|Open-Label Period|Lost to Follow-up|3|||
149230951|NCT01714726|538313491|FG003|Open-Label Period|Lost to Follow-up|4|||
149230952|NCT00548340|538313492|FG000|Overall Study|Protocol Violation|2|||
149230953|NCT00548340|538313493|FG001|Overall Study|Protocol Violation|3|||
149230954|NCT00548340|538313494|FG002|Overall Study|Protocol Violation|3|||
149230955|NCT00548340|538313492|FG000|Overall Study|Adverse Event|2|||
149230956|NCT00548340|538313493|FG001|Overall Study|Adverse Event|2|||
149230957|NCT00548340|538313494|FG002|Overall Study|Adverse Event|2|||
149230958|NCT00548340|538313492|FG000|Overall Study|Lost to Follow-up|1|||
149230959|NCT00548340|538313493|FG001|Overall Study|Lost to Follow-up|1|||
149230960|NCT00548340|538313494|FG002|Overall Study|Lost to Follow-up|0|||
149230961|NCT00548340|538313492|FG000|Overall Study|Withdrawal by Subject|2|||
149230962|NCT00548340|538313493|FG001|Overall Study|Withdrawal by Subject|4|||
149230963|NCT00548340|538313494|FG002|Overall Study|Withdrawal by Subject|3|||
149230964|NCT00548340|538313492|FG000|Overall Study|Other|1|||
149230965|NCT00548340|538313493|FG001|Overall Study|Other|1|||
149230966|NCT00548340|538313494|FG002|Overall Study|Other|1|||
149230967|NCT01153971|538313497|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
148690084|NCT00819247|536338556|FG001|Overall Study|Adverse Event|5|||
148690085|NCT00819247|536338557|FG002|Overall Study|Adverse Event|3|||
148690086|NCT00819247|536338555|FG000|Overall Study|Insufficient testosterone response|5|||
148690087|NCT00819247|536338556|FG001|Overall Study|Insufficient testosterone response|8|||
148810581|NCT01020123|536782655|FG000|Extention Period|Withdrawal by Subject|2|||
149230968|NCT01153971|538313497|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
149230969|NCT01153971|538313497|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
149230970|NCT01153971|538313497|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
149230971|NCT01153971|538313497|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
149230972|NCT01153971|538313497|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
149230973|NCT01153971|538313497|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
149230974|NCT03410693|538313498|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
149230975|NCT03410693|538313499|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
149230976|NCT03410693|538313498|FG000|Overall Study|Disc trt: Lost to follow up|0|||
149230977|NCT03410693|538313499|FG001|Overall Study|Disc trt: Lost to follow up|1|||
149230978|NCT03410693|538313498|FG000|Overall Study|Disc trt: radiological progression|58|||
149230979|NCT03410693|538313499|FG001|Overall Study|Disc trt: radiological progression|50|||
149230980|NCT03410693|538313498|FG000|Overall Study|Disc trt: Other|1|||
149230981|NCT03410693|538313499|FG001|Overall Study|Disc trt: Other|0|||
149230982|NCT03410693|538313498|FG000|Overall Study|Study drug never administered|1|||
149230983|NCT03410693|538313499|FG001|Overall Study|Study drug never administered|6|||
149230984|NCT03410693|538313498|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
149230985|NCT03410693|538313499|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
149230986|NCT03410693|538313498|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
149230987|NCT03410693|538313499|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
149230988|NCT03410693|538313498|FG000|Overall Study|Disc trt: Physician decision|0|||
149230989|NCT03410693|538313499|FG001|Overall Study|Disc trt: Physician decision|5|||
149230990|NCT03410693|538313498|FG000|Overall Study|Disc trt: clinical progression|1|||
149230991|NCT03410693|538313499|FG001|Overall Study|Disc trt: clinical progression|5|||
149230992|NCT03410693|538313498|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
149230993|NCT03410693|538313499|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
149230994|NCT03628781|538313500|FG000|Overall Study|Lost to Follow-up|16|||
149230995|NCT03628781|538313501|FG001|Overall Study|Lost to Follow-up|8|||
149230996|NCT03628781|538313500|FG000|Overall Study|Withdrawal by Subject|16|||
149230997|NCT03628781|538313501|FG001|Overall Study|Withdrawal by Subject|1|||
149230998|NCT03778021|538313505|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
149230999|NCT03778021|538313506|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
149231000|NCT02687815|538313507|FG000|Overall Study|Lost to Follow-up|2|||
149231001|NCT02687815|538313508|FG001|Overall Study|Lost to Follow-up|4|||
149231002|NCT02687815|538313507|FG000|Overall Study|Withdrawal by Subject|2|||
149231003|NCT02687815|538313508|FG001|Overall Study|Withdrawal by Subject|4|||
149231004|NCT00761761|538313511|FG000|Overall Study|Lost to Follow-up|3|||
149231005|NCT00761761|538313512|FG001|Overall Study|Lost to Follow-up|1|||
149231006|NCT00761761|538313511|FG000|Overall Study|Withdrawal by Subject|3|||
149231007|NCT00761761|538313512|FG001|Overall Study|Withdrawal by Subject|0|||
149231008|NCT03472586|538313520|FG000|Overall Study|Physician Decision|6|||
149231009|NCT03472586|538313520|FG000|Overall Study|Death|6|||
149231010|NCT03472586|538313520|FG000|Overall Study|Adverse Event|1|||
149231011|NCT02706327|538313521|FG000|Overall Study|Lost to Follow-up|1|||
149231012|NCT02706327|538313522|FG001|Overall Study|Lost to Follow-up|1|||
149231013|NCT02706327|538313523|FG002|Overall Study|Lost to Follow-up|2|||
149231014|NCT04963231|538313526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
149231015|NCT04963231|538313527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
149231016|NCT04963231|538313528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
149231017|NCT04963231|538313526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
149231018|NCT04963231|538313527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
149231019|NCT04963231|538313528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
149231020|NCT04963231|538313526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
149231021|NCT04963231|538313527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
149231022|NCT04963231|538313528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
149231023|NCT04963231|538313526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
149231024|NCT04963231|538313527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
149231025|NCT04963231|538313528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
149231026|NCT04963231|538313526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
149231027|NCT04963231|538313527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
149231028|NCT04963231|538313528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
149231029|NCT04963231|538313526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
149231030|NCT04963231|538313527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
149231031|NCT04963231|538313528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
149231032|NCT04963231|538313526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
149231033|NCT04963231|538313527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
149231034|NCT04963231|538313528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
149231035|NCT03868410|538313531|FG000|Overall Study|Physician Decision|0|||
149231036|NCT03868410|538313532|FG001|Overall Study|Physician Decision|1|||
149231037|NCT01059175|538313533|FG000|Overall Study|Death|17|||
149231038|NCT01059175|538313534|FG001|Overall Study|Death|17|||
149231039|NCT01059175|538313533|FG000|Overall Study|Adverse Event|4|||
149231040|NCT01059175|538313534|FG001|Overall Study|Adverse Event|2|||
149231041|NCT01059175|538313533|FG000|Overall Study|Lost to Follow-up|0|||
149231042|NCT01059175|538313534|FG001|Overall Study|Lost to Follow-up|1|||
149231043|NCT02957149|538313535|FG000|Overall Study|Withdrawal by Subject|5|||
149231044|NCT06045026|538313536|FG000|Overall Study|Lost to Follow-up|60|||
149231045|NCT06045026|538313536|FG000|Overall Study|Adverse Event|12|||
149231046|NCT06045026|538313536|FG000|Overall Study|Withdrawal by Subject|3|||
149231047|NCT06045026|538313536|FG000|Overall Study|Enrollment closed|1|||
149231048|NCT01399619|538313542|FG000|Overall Study|Adverse Event|10|||
149231049|NCT01399619|538313543|FG001|Overall Study|Adverse Event|0|||
149231050|NCT01399619|538313544|FG002|Overall Study|Adverse Event|4|||
149231051|NCT01399619|538313545|FG003|Overall Study|Adverse Event|10|||
149231052|NCT01399619|538313542|FG000|Overall Study|Lack of Efficacy|9|||
149231053|NCT01399619|538313543|FG001|Overall Study|Lack of Efficacy|0|||
149231054|NCT01399619|538313544|FG002|Overall Study|Lack of Efficacy|5|||
149231055|NCT01399619|538313545|FG003|Overall Study|Lack of Efficacy|0|||
149231056|NCT01399619|538313542|FG000|Overall Study|Withdrawal by Subject|6|||
149231057|NCT01399619|538313543|FG001|Overall Study|Withdrawal by Subject|0|||
149231058|NCT01399619|538313544|FG002|Overall Study|Withdrawal by Subject|3|||
149231059|NCT01399619|538313545|FG003|Overall Study|Withdrawal by Subject|4|||
149231060|NCT01399619|538313542|FG000|Overall Study|Protocol Violation|0|||
149231061|NCT01399619|538313543|FG001|Overall Study|Protocol Violation|0|||
149231062|NCT01399619|538313544|FG002|Overall Study|Protocol Violation|0|||
149231063|NCT01399619|538313545|FG003|Overall Study|Protocol Violation|1|||
149231064|NCT01399619|538313542|FG000|Overall Study|Not treated|0|||
149231065|NCT01399619|538313543|FG001|Overall Study|Not treated|0|||
149231066|NCT01399619|538313544|FG002|Overall Study|Not treated|0|||
149231067|NCT01399619|538313545|FG003|Overall Study|Not treated|2|||
149231068|NCT03417245|538313546|FG000|Overall Study|Adverse Event|1|||
149231069|NCT03417245|538313547|FG001|Overall Study|Adverse Event|0|||
149231070|NCT03417245|538313546|FG000|Overall Study|Protocol Violation|1|||
149231071|NCT03417245|538313547|FG001|Overall Study|Protocol Violation|0|||
149231072|NCT03417245|538313546|FG000|Overall Study|Withdrawal by Subject|1|||
149231073|NCT03417245|538313547|FG001|Overall Study|Withdrawal by Subject|1|||
149231074|NCT02708524|538313552|FG000|Overall Study|Adverse Event|0|||
149231075|NCT02708524|538313553|FG001|Overall Study|Adverse Event|1|||
149231076|NCT02708524|538313554|FG002|Overall Study|Adverse Event|0|||
149231077|NCT02708524|538313555|FG003|Overall Study|Adverse Event|0|||
149231078|NCT02708524|538313552|FG000|Overall Study|Lens Discomfort|1|||
149231079|NCT02708524|538313553|FG001|Overall Study|Lens Discomfort|0|||
149231080|NCT02708524|538313554|FG002|Overall Study|Lens Discomfort|1|||
149231081|NCT02708524|538313555|FG003|Overall Study|Lens Discomfort|0|||
149231082|NCT02708524|538313552|FG000|Overall Study|Lost to Follow-up|1|||
149231083|NCT02708524|538313553|FG001|Overall Study|Lost to Follow-up|1|||
149231084|NCT02708524|538313554|FG002|Overall Study|Lost to Follow-up|1|||
149231085|NCT02708524|538313555|FG003|Overall Study|Lost to Follow-up|0|||
149231086|NCT02708524|538313552|FG000|Overall Study|Protocol Violation|0|||
149231087|NCT02708524|538313553|FG001|Overall Study|Protocol Violation|1|||
149231088|NCT02708524|538313554|FG002|Overall Study|Protocol Violation|0|||
149231089|NCT02708524|538313555|FG003|Overall Study|Protocol Violation|0|||
149231090|NCT02708524|538313552|FG000|Overall Study|Withdrawal by Subject|1|||
149231091|NCT02708524|538313553|FG001|Overall Study|Withdrawal by Subject|1|||
149231092|NCT02708524|538313554|FG002|Overall Study|Withdrawal by Subject|0|||
148954509|NCT03510884|537317109|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
149231093|NCT02708524|538313555|FG003|Overall Study|Withdrawal by Subject|0|||
149231094|NCT02708524|538313552|FG000|Overall Study|Dispensed incorrect study lens|0|||
149231095|NCT02708524|538313553|FG001|Overall Study|Dispensed incorrect study lens|1|||
149231096|NCT02708524|538313554|FG002|Overall Study|Dispensed incorrect study lens|1|||
149231097|NCT02708524|538313555|FG003|Overall Study|Dispensed incorrect study lens|0|||
149231098|NCT02708524|538313552|FG000|Overall Study|Did not wear lens at final visit|0|||
149231099|NCT02708524|538313553|FG001|Overall Study|Did not wear lens at final visit|1|||
149231100|NCT02708524|538313554|FG002|Overall Study|Did not wear lens at final visit|0|||
149231101|NCT02708524|538313555|FG003|Overall Study|Did not wear lens at final visit|0|||
149231102|NCT02708524|538313552|FG000|Overall Study|Subject lost study lens|1|||
149231103|NCT02708524|538313553|FG001|Overall Study|Subject lost study lens|0|||
149231104|NCT02708524|538313554|FG002|Overall Study|Subject lost study lens|0|||
149231105|NCT02708524|538313555|FG003|Overall Study|Subject lost study lens|0|||
149231106|NCT00679354|538313568|FG000|Overall Study|Death|3|||
149231107|NCT00679354|538313568|FG000|Overall Study|Lack of Efficacy|22|||
149231108|NCT00679354|538313568|FG000|Overall Study|Physician Decision|4|||
149231109|NCT00679354|538313568|FG000|Overall Study|Ineligible|1|||
149231110|NCT01590628|538313575|FG000|Overall Study|Death|2|||
149231111|NCT01590628|538313576|FG001|Overall Study|Death|0|||
149231112|NCT00229931|538313577|FG000|Overall Study|Death|1|||
149231113|NCT00229931|538313578|FG001|Overall Study|Death|0|||
149231114|NCT00229931|538313577|FG000|Overall Study|Lost to Follow-up|3|||
149231115|NCT00229931|538313578|FG001|Overall Study|Lost to Follow-up|2|||
149231116|NCT00475657|538313579|FG000|Overall Study|Death|1|||
149231117|NCT00475657|538313579|FG000|Overall Study|Sponsor's Decision|3|||
149231118|NCT02992743|538313580|FG000|Overall Study|Withdrawal by Subject|1|||
149231119|NCT02992743|538313581|FG001|Overall Study|Withdrawal by Subject|1|||
149231120|NCT02992743|538313580|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
149231121|NCT02992743|538313581|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
149231122|NCT02992743|538313580|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
149231123|NCT02992743|538313581|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
149231124|NCT02992743|538313580|FG000|Overall Study|No measurable disease|1|||
149231125|NCT02992743|538313581|FG001|Overall Study|No measurable disease|0|||
149231126|NCT02992743|538313580|FG000|Overall Study|Lost to Follow-up|0|||
149231127|NCT02992743|538313581|FG001|Overall Study|Lost to Follow-up|1|||
149231128|NCT00761735|538313582|FG000|Overall Study|Lost to Follow-up|6|||
149231129|NCT00761735|538313582|FG000|Overall Study|Withdrawal by Subject|6|||
149231130|NCT00761735|538313582|FG000|Overall Study|Non-compliance with protocol|1|||
149231131|NCT00761735|538313582|FG000|Overall Study|Administrative|1|||
149231132|NCT00998166|538313585|FG000|Overall Study|Early Study Termination|8|||
149231133|NCT00450814|538313586|FG000|Overall Study|Failed to complete the initial therapy|0|||
149231134|NCT00450814|538313587|FG001|Overall Study|Failed to complete the initial therapy|0|||
149231135|NCT00450814|538313588|FG002|Overall Study|Failed to complete the initial therapy|0|||
149231136|NCT00450814|538313589|FG003|Overall Study|Failed to complete the initial therapy|1|||
149231137|NCT00450814|538313590|FG004|Overall Study|Failed to complete the initial therapy|1|||
149231138|NCT00450814|538313591|FG005|Overall Study|Failed to complete the initial therapy|1|||
149231139|NCT00450814|538313592|FG006|Overall Study|Failed to complete the initial therapy|0|||
149231140|NCT00450814|538313593|FG007|Overall Study|Failed to complete the initial therapy|0|||
149231141|NCT00450814|538313594|FG008|Overall Study|Failed to complete the initial therapy|0|||
149231142|NCT00450814|538313595|FG009|Overall Study|Failed to complete the initial therapy|0|||
149231143|NCT00450814|538313596|FG010|Overall Study|Failed to complete the initial therapy|0|||
149231144|NCT00450814|538313586|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
149231145|NCT00450814|538313587|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
149231146|NCT00450814|538313588|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
149231147|NCT00450814|538313589|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
149231148|NCT00450814|538313590|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
149231149|NCT00450814|538313591|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
149231150|NCT00450814|538313592|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
149231151|NCT00450814|538313593|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
149231152|NCT00450814|538313594|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
149231153|NCT00450814|538313595|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
149231154|NCT00450814|538313596|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
149231155|NCT01757821|538313599|FG000|Overall Study|Adverse Event|1|||
149231156|NCT03831282|538313600|FG000|Overall Study|Could not place sensor|1|||
149231157|NCT01258803|538313601|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
149231158|NCT01258803|538313602|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
149231159|NCT01258803|538313603|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
149231160|NCT01258803|538313604|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
149231161|NCT01258803|538313605|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
149231162|NCT01258803|538313606|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
149231163|NCT01258803|538313601|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149231164|NCT01258803|538313602|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
149231165|NCT01258803|538313603|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149231166|NCT01258803|538313604|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149231167|NCT01258803|538313605|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149231168|NCT01258803|538313606|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
149231169|NCT01258803|538313601|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149231170|NCT01258803|538313602|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149231171|NCT01258803|538313603|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
149231172|NCT01258803|538313604|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149231173|NCT01258803|538313605|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149231174|NCT01258803|538313606|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
149231175|NCT00920582|538313607|FG000|Overall Study|Lost to Follow-up|5|||
149231176|NCT00920582|538313608|FG001|Overall Study|Lost to Follow-up|1|||
149231177|NCT00920582|538313609|FG002|Overall Study|Lost to Follow-up|2|||
149231178|NCT00920582|538313610|FG003|Overall Study|Lost to Follow-up|0|||
149231179|NCT00920582|538313607|FG000|Overall Study|Withdrawal by Subject|5|||
149231180|NCT00920582|538313608|FG001|Overall Study|Withdrawal by Subject|4|||
149231181|NCT00920582|538313609|FG002|Overall Study|Withdrawal by Subject|6|||
149231182|NCT00920582|538313610|FG003|Overall Study|Withdrawal by Subject|3|||
149231183|NCT00920582|538313607|FG000|Overall Study|Protocol Violation|1|||
149231184|NCT00920582|538313608|FG001|Overall Study|Protocol Violation|0|||
149231185|NCT00920582|538313609|FG002|Overall Study|Protocol Violation|0|||
149231186|NCT00920582|538313610|FG003|Overall Study|Protocol Violation|0|||
149231187|NCT00920582|538313607|FG000|Overall Study|Other|2|||
149231188|NCT00920582|538313608|FG001|Overall Study|Other|1|||
149231189|NCT00920582|538313609|FG002|Overall Study|Other|3|||
149231190|NCT00920582|538313610|FG003|Overall Study|Other|2|||
149231191|NCT05146999|538313617|FG000|Overall Study|Withdrew consent|6|||
149231192|NCT05146999|538313618|FG001|Overall Study|Withdrew consent|1|||
149231193|NCT05146999|538313617|FG000|Overall Study|Lost to Follow-up|3|||
149231194|NCT05146999|538313618|FG001|Overall Study|Lost to Follow-up|2|||
149231195|NCT05146999|538313617|FG000|Overall Study|Other|1|||
149231196|NCT05146999|538313618|FG001|Overall Study|Other|3|||
149231197|NCT03319160|538313619|FG000|Overall Study|Data not available.|7|||
149231198|NCT00851721|538313620|FG000|Overall Study|planned surgery|1|||
149231199|NCT00851721|538313621|FG001|Overall Study|planned surgery|0|||
149231200|NCT00851721|538313620|FG000|Overall Study|Death|1|||
149231201|NCT00851721|538313621|FG001|Overall Study|Death|0|||
149231202|NCT00851721|538313620|FG000|Overall Study|Adverse Event|0|||
149231203|NCT00851721|538313621|FG001|Overall Study|Adverse Event|1|||
149231204|NCT03604159|538313622|FG000|Overall Study|Lost to Follow-up|6|||
149231205|NCT03604159|538313623|FG001|Overall Study|Lost to Follow-up|7|||
149231206|NCT00665002|538313624|FG000|Overall Study|Progression/relapse during treatment|11|||
149231207|NCT00665002|538313624|FG000|Overall Study|Cytogenetic resistance|1|||
149231208|NCT04533204|538313625|FG000|Overall Study|Unable to understand training instructions|1|||
149231209|NCT04533204|538313626|FG001|Overall Study|Unable to understand training instructions|1|||
149231210|NCT00383292|538313627|FG000|Overall Study|Adverse Event|4|||
149231211|NCT00383292|538313628|FG001|Overall Study|Adverse Event|1|||
149231212|NCT00383292|538313629|FG002|Overall Study|Adverse Event|2|||
149231213|NCT00383292|538313627|FG000|Overall Study|Death|3|||
149231214|NCT00383292|538313628|FG001|Overall Study|Death|3|||
149231215|NCT00383292|538313629|FG002|Overall Study|Death|3|||
149231216|NCT00383292|538313627|FG000|Overall Study|Physician Decision|4|||
149231217|NCT00383292|538313628|FG001|Overall Study|Physician Decision|0|||
149231218|NCT00383292|538313629|FG002|Overall Study|Physician Decision|1|||
149231219|NCT00383292|538313627|FG000|Overall Study|Withdrawal by Subject|3|||
149231220|NCT00383292|538313628|FG001|Overall Study|Withdrawal by Subject|2|||
149231221|NCT00383292|538313629|FG002|Overall Study|Withdrawal by Subject|2|||
149231222|NCT00383292|538313627|FG000|Overall Study|Other|1|||
149231223|NCT00383292|538313628|FG001|Overall Study|Other|0|||
149231224|NCT00383292|538313629|FG002|Overall Study|Other|0|||
149231225|NCT00697255|538313630|FG000|Stage 1a|Insufficient ovarian response|1|||
149231226|NCT00697255|538313631|FG001|Stage 1a|Insufficient ovarian response|0|||
149231227|NCT00697255|538313630|FG000|Stage 1a|Multifollicular growth|1|||
149231228|NCT00697255|538313631|FG001|Stage 1a|Multifollicular growth|0|||
149231229|NCT00697255|538313630|FG000|Stage 1a|Not growing of dominant follicle|1|||
149231230|NCT00697255|538313631|FG001|Stage 1a|Not growing of dominant follicle|0|||
149231231|NCT00697255|538313630|FG000|Stage 1b|Not growing of dominant follicle|0|||
149231232|NCT00697255|538313631|FG001|Stage 1b|Not growing of dominant follicle|1|||
149231233|NCT00697255|538313630|FG000|Stage 1b|Insufficient ovarian response|0|||
149231234|NCT00697255|538313631|FG001|Stage 1b|Insufficient ovarian response|1|||
149231235|NCT01333501|538313639|FG000|Overall Study|Adverse Event|3|||
149231236|NCT01333501|538313640|FG001|Overall Study|Adverse Event|1|||
149231237|NCT01333501|538313639|FG000|Overall Study|Abnormal laboratory value|2|||
149231238|NCT01333501|538313640|FG001|Overall Study|Abnormal laboratory value|1|||
149231239|NCT01333501|538313639|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149231240|NCT01333501|538313640|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
149231241|NCT01333501|538313639|FG000|Overall Study|Withdrawn consent|3|||
149231242|NCT01333501|538313640|FG001|Overall Study|Withdrawn consent|12|||
149231243|NCT04246996|538313641|FG000|Overall Study|Physician Decision|1|||
149231244|NCT04246996|538313642|FG001|Overall Study|Physician Decision|1|||
149231245|NCT04246996|538313641|FG000|Overall Study|Did not meet eligibility criteria|1|||
149231246|NCT04246996|538313642|FG001|Overall Study|Did not meet eligibility criteria|4|||
149231247|NCT02354599|538313645|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149231248|NCT02354599|538313646|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
149231249|NCT02354599|538313647|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
149231250|NCT02354599|538313648|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
149231251|NCT02354599|538313649|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
149231252|NCT02354599|538313650|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
149231253|NCT02354599|538313645|FG000|Overall Study|Withdrawal by Subject|1|||
149231254|NCT02354599|538313646|FG001|Overall Study|Withdrawal by Subject|1|||
149231255|NCT02354599|538313647|FG002|Overall Study|Withdrawal by Subject|0|||
149231256|NCT02354599|538313648|FG003|Overall Study|Withdrawal by Subject|0|||
149231257|NCT02354599|538313649|FG004|Overall Study|Withdrawal by Subject|0|||
149231258|NCT02354599|538313650|FG005|Overall Study|Withdrawal by Subject|0|||
149231259|NCT04806334|538313651|FG000|Overall Study|Withdrawal by Subject|1|||
149231260|NCT00660829|538313652|FG000|Overall Study|Adverse Event|3|||
149231261|NCT00660829|538313653|FG001|Overall Study|Adverse Event|4|||
149231262|NCT00660829|538313652|FG000|Overall Study|Lack of Efficacy|2|||
149231263|NCT00660829|538313653|FG001|Overall Study|Lack of Efficacy|3|||
149231264|NCT00660829|538313652|FG000|Overall Study|Non-Compliance|0|||
149231265|NCT00660829|538313653|FG001|Overall Study|Non-Compliance|4|||
149231266|NCT00660829|538313652|FG000|Overall Study|Withdrawal by Subject|1|||
149231267|NCT00660829|538313653|FG001|Overall Study|Withdrawal by Subject|2|||
149231268|NCT00660829|538313652|FG000|Overall Study|Lost to Follow-up|3|||
149231269|NCT00660829|538313653|FG001|Overall Study|Lost to Follow-up|2|||
149231270|NCT00660829|538313652|FG000|Overall Study|Other|9|||
149231271|NCT00660829|538313653|FG001|Overall Study|Other|4|||
149231272|NCT00967343|538313654|FG000|Overall Study|Study termination by sponsor|12|||
149231273|NCT00967343|538313654|FG000|Overall Study|Death|24|||
149231274|NCT00967343|538313654|FG000|Overall Study|Relapse|1|||
149231275|NCT00967343|538313654|FG000|Overall Study|Lost to Follow-up|1|||
149231276|NCT02501642|538315054|FG000|Overall Study|Lost to Follow-up|7|||
149231277|NCT02501642|538315055|FG001|Overall Study|Lost to Follow-up|11|||
149231278|NCT00934661|538315056|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
149231279|NCT00934661|538315057|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
149231280|NCT01846442|538315065|FG000|Overall Study|Adverse Event|2|||
149231281|NCT01846442|538315066|FG001|Overall Study|Adverse Event|4|||
149231282|NCT01846442|538315067|FG002|Overall Study|Adverse Event|2|||
149231283|NCT01846442|538315068|FG003|Overall Study|Adverse Event|1|||
149231284|NCT01846442|538315065|FG000|Overall Study|Lost to Follow-up|0|||
149231285|NCT01846442|538315066|FG001|Overall Study|Lost to Follow-up|0|||
149231286|NCT01846442|538315067|FG002|Overall Study|Lost to Follow-up|1|||
149231287|NCT01846442|538315068|FG003|Overall Study|Lost to Follow-up|0|||
149231288|NCT01846442|538315065|FG000|Overall Study|Withdrawal by Subject|3|||
149231289|NCT01846442|538315066|FG001|Overall Study|Withdrawal by Subject|2|||
149231290|NCT01846442|538315067|FG002|Overall Study|Withdrawal by Subject|0|||
149231291|NCT01846442|538315068|FG003|Overall Study|Withdrawal by Subject|1|||
149231292|NCT01846442|538315065|FG000|Overall Study|Left the city/Lost medication|1|||
149231293|NCT01846442|538315066|FG001|Overall Study|Left the city/Lost medication|0|||
149231294|NCT01846442|538315067|FG002|Overall Study|Left the city/Lost medication|1|||
149231295|NCT01846442|538315068|FG003|Overall Study|Left the city/Lost medication|1|||
149231296|NCT00679042|538315075|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
149231297|NCT00679042|538315075|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
149231298|NCT00679042|538315075|FG000|5-Year Follow Up|Death|1|||
149231299|NCT00679042|538315075|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
149231300|NCT00679042|538315075|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
149231301|NCT00379639|538315076|FG000|Overall Study|Disease Progression|3|||
149231302|NCT00379639|538315077|FG001|Overall Study|Disease Progression|3|||
149231303|NCT00379639|538315078|FG002|Overall Study|Disease Progression|3|||
149231304|NCT00379639|538315079|FG003|Overall Study|Disease Progression|4|||
148690088|NCT00819247|536338557|FG002|Overall Study|Insufficient testosterone response|10|||
149231305|NCT00379639|538315080|FG004|Overall Study|Disease Progression|4|||
149231306|NCT00379639|538315076|FG000|Overall Study|Physician Decision|0|||
149231307|NCT00379639|538315077|FG001|Overall Study|Physician Decision|2|||
149231308|NCT00379639|538315078|FG002|Overall Study|Physician Decision|1|||
149231309|NCT00379639|538315079|FG003|Overall Study|Physician Decision|1|||
149231310|NCT00379639|538315080|FG004|Overall Study|Physician Decision|0|||
149231311|NCT00379639|538315076|FG000|Overall Study|Symptomatic Deterioration|0|||
149231312|NCT00379639|538315077|FG001|Overall Study|Symptomatic Deterioration|0|||
149231313|NCT00379639|538315078|FG002|Overall Study|Symptomatic Deterioration|1|||
149231314|NCT00379639|538315079|FG003|Overall Study|Symptomatic Deterioration|0|||
149231315|NCT00379639|538315080|FG004|Overall Study|Symptomatic Deterioration|1|||
149231316|NCT00379639|538315076|FG000|Overall Study|Adverse Event|0|||
149231317|NCT00379639|538315077|FG001|Overall Study|Adverse Event|0|||
149231318|NCT00379639|538315078|FG002|Overall Study|Adverse Event|1|||
149231319|NCT00379639|538315079|FG003|Overall Study|Adverse Event|0|||
149231320|NCT00379639|538315080|FG004|Overall Study|Adverse Event|1|||
149231321|NCT00379639|538315076|FG000|Overall Study|Lost to Follow-up|0|||
149231322|NCT00379639|538315077|FG001|Overall Study|Lost to Follow-up|0|||
149231323|NCT00379639|538315078|FG002|Overall Study|Lost to Follow-up|0|||
149231324|NCT00379639|538315079|FG003|Overall Study|Lost to Follow-up|1|||
148690089|NCT00819247|536338555|FG000|Overall Study|Withdrawal by Subject|1|||
149231325|NCT00379639|538315080|FG004|Overall Study|Lost to Follow-up|0|||
149231326|NCT00379639|538315076|FG000|Overall Study|Other|0|||
149231327|NCT00379639|538315077|FG001|Overall Study|Other|0|||
149231328|NCT00379639|538315078|FG002|Overall Study|Other|3|||
149231329|NCT00379639|538315079|FG003|Overall Study|Other|0|||
149231330|NCT00379639|538315080|FG004|Overall Study|Other|0|||
149231331|NCT03053102|538315081|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
149231332|NCT03053102|538315081|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
149231333|NCT01798056|538315082|FG000|Overall Study|Serious Adverse Event|13|||
149231334|NCT01798056|538315083|FG001|Overall Study|Serious Adverse Event|12|||
149231335|NCT01798056|538315082|FG000|Overall Study|Withdrawal by Subject|12|||
149231336|NCT01798056|538315083|FG001|Overall Study|Withdrawal by Subject|9|||
149231337|NCT01798056|538315082|FG000|Overall Study|Migrated/moved from study area|1|||
149231338|NCT01798056|538315083|FG001|Overall Study|Migrated/moved from study area|1|||
149231339|NCT01798056|538315082|FG000|Overall Study|Lost to Follow-up|1|||
149231340|NCT01798056|538315083|FG001|Overall Study|Lost to Follow-up|1|||
149231341|NCT01798056|538315082|FG000|Overall Study|Other|0|||
149231342|NCT01798056|538315083|FG001|Overall Study|Other|2|||
149231343|NCT01269346|538315084|FG000|Treatment Phase|Disease progression|3|||
149231344|NCT01269346|538315084|FG000|Treatment Phase|Adverse Event|3|||
149231345|NCT01269346|538315084|FG000|Treatment Phase|Withdrawal by Subject|1|||
149231346|NCT01269346|538315084|FG000|Treatment Phase|Other|2|||
149231347|NCT01269346|538315084|FG000|Extension Phase|Adverse Event|6|||
149231348|NCT01269346|538315084|FG000|Extension Phase|Withdrawal by Subject|4|||
149231349|NCT01269346|538315084|FG000|Extension Phase|Disease progression|22|||
149231350|NCT01269346|538315084|FG000|Extension Phase|Physician decision or participant choice|9|||
149231351|NCT01269346|538315084|FG000|Extension Phase|Clinical progression|1|||
149231352|NCT01269346|538315084|FG000|Extension Phase|Started a prohibited con med|1|||
149231353|NCT00247416|538315085|FG000|Overall Study|3 patients were found to be ineligible|1|||
149231354|NCT00247416|538315086|FG001|Overall Study|3 patients were found to be ineligible|2|||
149231355|NCT00474994|538315087|FG000|Overall Study|Patient Not treated|1|||
149231356|NCT00474994|538315087|FG000|Overall Study|Patient evaluable for toxicity only|3|||
149231357|NCT00474994|538315087|FG000|Overall Study|Patient found to be ineligible|1|||
149231358|NCT02660489|538315088|FG000|Overall Study|Lost to Follow-up|1|||
149231359|NCT02660489|538315089|FG001|Overall Study|Lost to Follow-up|1|||
149231360|NCT02660489|538315088|FG000|Overall Study|Adverse Event|1|||
149231361|NCT02660489|538315089|FG001|Overall Study|Adverse Event|3|||
149231362|NCT02660489|538315088|FG000|Overall Study|no rhinovirus infection|4|||
149231363|NCT02660489|538315089|FG001|Overall Study|no rhinovirus infection|4|||
149231364|NCT05064436|538315092|FG000|Overall Study|Other Reasons|1|||
149231365|NCT05064436|538315093|FG001|Overall Study|Other Reasons|0|||
149231366|NCT01342445|538315094|FG000|Overall Study|Experienced side effects|0|||
149231367|NCT01342445|538315095|FG001|Overall Study|Experienced side effects|2|||
149231368|NCT02652793|538315096|FG000|Overall Study|Adverse Event|1|||
149231369|NCT02652793|538315096|FG000|Overall Study|Lost to Follow-up|2|||
149231370|NCT02652793|538315096|FG000|Overall Study|Withdrawal by Subject|1|||
149231371|NCT05450198|538315101|FG000|Overall Study|Withdrawal by Subject|1|||
149231372|NCT05450198|538315102|FG001|Overall Study|Withdrawal by Subject|1|||
149231373|NCT05450198|538315103|FG002|Overall Study|Withdrawal by Subject|2|||
149231374|NCT05450198|538315104|FG003|Overall Study|Withdrawal by Subject|0|||
149231375|NCT05450198|538315101|FG000|Overall Study|Lost to Follow-up|1|||
149231376|NCT05450198|538315102|FG001|Overall Study|Lost to Follow-up|0|||
149231377|NCT05450198|538315103|FG002|Overall Study|Lost to Follow-up|2|||
149231378|NCT05450198|538315104|FG003|Overall Study|Lost to Follow-up|1|||
149231379|NCT04511533|538315105|FG000|Treatment|Other|2|||
149231380|NCT04511533|538315105|FG000|Treatment|Withdrawal by Subject|11|||
149231381|NCT04511533|538315105|FG000|Treatment|Death|5|||
149231382|NCT04511533|538315105|FG000|Treatment|Physician Decision|1|||
149231383|NCT04511533|538315105|FG000|Treatment|Progressive Disease|61|||
149231384|NCT04511533|538315105|FG000|Follow-Up|Other|7|||
149231385|NCT04511533|538315105|FG000|Follow-Up|Withdrawal by Subject|5|||
149231386|NCT04511533|538315105|FG000|Follow-Up|Lost to Follow-up|2|||
149231387|NCT04511533|538315105|FG000|Follow-Up|Death|4|||
149231388|NCT01224171|538315106|FG000|Overall Study|Adverse Event|8|||
149231389|NCT01224171|538315107|FG001|Overall Study|Adverse Event|4|||
149231390|NCT01224171|538315106|FG000|Overall Study|Protocol Violation|0|||
149231391|NCT01224171|538315107|FG001|Overall Study|Protocol Violation|1|||
149231392|NCT01224171|538315106|FG000|Overall Study|Lack of Efficacy|5|||
149231393|NCT01224171|538315107|FG001|Overall Study|Lack of Efficacy|1|||
149231394|NCT01224171|538315106|FG000|Overall Study|Withdrawal of Consent|2|||
149231395|NCT01224171|538315107|FG001|Overall Study|Withdrawal of Consent|4|||
149231396|NCT01224171|538315106|FG000|Overall Study|Lost to Follow-up|0|||
149231397|NCT01224171|538315107|FG001|Overall Study|Lost to Follow-up|3|||
149231398|NCT01928758|538315108|FG000|Overall Study|Lost to Follow-up|14|||
149231399|NCT01928758|538315109|FG001|Overall Study|Lost to Follow-up|9|||
149231400|NCT01928758|538315108|FG000|Overall Study|Withdrawal by Subject|5|||
149231401|NCT01928758|538315109|FG001|Overall Study|Withdrawal by Subject|2|||
149231402|NCT01928758|538315108|FG000|Overall Study|Adverse Event|3|||
149231403|NCT01928758|538315109|FG001|Overall Study|Adverse Event|5|||
149231404|NCT01928758|538315108|FG000|Overall Study|Protocol Violation|3|||
149231405|NCT01928758|538315109|FG001|Overall Study|Protocol Violation|4|||
149231406|NCT02718131|538315110|FG000|Overall Study|Withdrawal by Subject|1|||
149231407|NCT02718131|538315111|FG001|Overall Study|Withdrawal by Subject|0|||
149231408|NCT02718131|538315110|FG000|Overall Study|Adverse Event|1|||
149231409|NCT02718131|538315111|FG001|Overall Study|Adverse Event|0|||
149231410|NCT02718131|538315110|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
149231411|NCT02718131|538315111|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
149231412|NCT01911546|538315114|FG000|Overall Study|Lost to Follow-up|1|||
149231413|NCT01911546|538315114|FG000|Overall Study|Everolimus was discontinued|5|||
149231414|NCT01474291|538315119|FG000|Overall Study|Not Evaluable for Efficacy|26|||
149231415|NCT01474291|538315119|FG000|Overall Study|Lack of Treatment Efficacy|88|||
149231416|NCT01474291|538315119|FG000|Overall Study|Adverse Event|53|||
149231417|NCT01474291|538315119|FG000|Overall Study|Lost to Follow-up|29|||
149231418|NCT01474291|538315119|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
149231419|NCT01474291|538315119|FG000|Overall Study|No Reason Reported|10|||
149231420|NCT01474291|538315119|FG000|Overall Study|Death|2|||
149231421|NCT03471507|538315120|FG000|Overall Study|Lost to Follow-up|1|||
149231422|NCT03471507|538315121|FG001|Overall Study|Lost to Follow-up|3|||
149231423|NCT03471507|538315120|FG000|Overall Study|Physician Decision|0|||
149231424|NCT03471507|538315121|FG001|Overall Study|Physician Decision|1|||
149231425|NCT03471507|538315120|FG000|Overall Study|Withdrawal by Subject|2|||
149231426|NCT03471507|538315121|FG001|Overall Study|Withdrawal by Subject|1|||
149231427|NCT02213666|538315122|FG000|Overall Study|Withdrawal by Subject|1|||
149231428|NCT01319422|538315123|FG000|Overall Study|Withdrawal by Subject|1|||
149231429|NCT01319422|538315124|FG001|Overall Study|Withdrawal by Subject|0|||
149231430|NCT00750061|538315126|FG000|Overall Study|Adverse Event|2|||
149231431|NCT00750061|538315127|FG001|Overall Study|Adverse Event|0|||
149231432|NCT00750061|538315126|FG000|Overall Study|Withdrawal by Subject|0|||
149231433|NCT00750061|538315127|FG001|Overall Study|Withdrawal by Subject|1|||
149231434|NCT00750061|538315126|FG000|Overall Study|Physician Decision|0|||
149231435|NCT00750061|538315127|FG001|Overall Study|Physician Decision|1|||
149231436|NCT03290131|538315135|FG000|Overall Study|Adverse Event|22|||
149231437|NCT03290131|538315136|FG001|Overall Study|Adverse Event|57|||
149231438|NCT03290131|538315137|FG002|Overall Study|Adverse Event|11|||
149231439|NCT03290131|538315135|FG000|Overall Study|Withdrawal by Subject|18|||
149231440|NCT03290131|538315136|FG001|Overall Study|Withdrawal by Subject|13|||
149231441|NCT03290131|538315137|FG002|Overall Study|Withdrawal by Subject|8|||
149231442|NCT03290131|538315135|FG000|Overall Study|MS Relapse|2|||
149231443|NCT03290131|538315136|FG001|Overall Study|MS Relapse|1|||
149231444|NCT03290131|538315137|FG002|Overall Study|MS Relapse|0|||
149231445|NCT03290131|538315135|FG000|Overall Study|Unknown reason|0|||
149231446|NCT03290131|538315136|FG001|Overall Study|Unknown reason|1|||
149231447|NCT03290131|538315137|FG002|Overall Study|Unknown reason|0|||
149231448|NCT00381680|538315138|FG000|Overall Study|Adverse Event|9|||
149231449|NCT00381680|538315139|FG001|Overall Study|Adverse Event|3|||
149231450|NCT00381680|538315138|FG000|Overall Study|Death|10|||
149231451|NCT00381680|538315139|FG001|Overall Study|Death|7|||
149231452|NCT00381680|538315138|FG000|Overall Study|Lost to Follow-up|3|||
149231453|NCT00381680|538315139|FG001|Overall Study|Lost to Follow-up|2|||
149231454|NCT00381680|538315138|FG000|Overall Study|Physician Decision|25|||
149231455|NCT00381680|538315139|FG001|Overall Study|Physician Decision|6|||
149231456|NCT00381680|538315138|FG000|Overall Study|Withdrawal by Subject|3|||
149231457|NCT00381680|538315139|FG001|Overall Study|Withdrawal by Subject|1|||
149231458|NCT00381680|538315138|FG000|Overall Study|Entry onto another COG Trial|1|||
149231459|NCT00381680|538315139|FG001|Overall Study|Entry onto another COG Trial|2|||
149231460|NCT00381680|538315138|FG000|Overall Study|Alternative Therapy|11|||
149231461|NCT00381680|538315139|FG001|Overall Study|Alternative Therapy|5|||
149231462|NCT00381680|538315138|FG000|Overall Study|Secondary Malignancy|3|||
149231463|NCT00381680|538315139|FG001|Overall Study|Secondary Malignancy|0|||
149231464|NCT00381680|538315138|FG000|Overall Study|Delay initiation|1|||
149231465|NCT00381680|538315139|FG001|Overall Study|Delay initiation|0|||
149231466|NCT00381680|538315138|FG000|Overall Study|Stem Cell Transplant|26|||
149231467|NCT00381680|538315139|FG001|Overall Study|Stem Cell Transplant|10|||
149231468|NCT00381680|538315138|FG000|Overall Study|Relapse|18|||
149231469|NCT00381680|538315139|FG001|Overall Study|Relapse|9|||
149231470|NCT00381680|538315138|FG000|Overall Study|Induction Failure|4|||
149231471|NCT00381680|538315139|FG001|Overall Study|Induction Failure|1|||
149231472|NCT00381680|538315138|FG000|Overall Study|Progression|1|||
149231473|NCT00381680|538315139|FG001|Overall Study|Progression|1|||
149231474|NCT00381680|538315138|FG000|Overall Study|Other not otherwise specified|7|||
149231475|NCT00381680|538315139|FG001|Overall Study|Other not otherwise specified|2|||
149231476|NCT00381680|538315138|FG000|Overall Study|Ineligible|3|||
149231477|NCT00381680|538315139|FG001|Overall Study|Ineligible|1|||
149231478|NCT00361504|538315142|FG000|Overall Study|Withdrawal by Subject|94|||
148810582|NCT01020123|536782656|FG001|Extention Period|Withdrawal by Subject|1|||
148810583|NCT01020123|536782657|FG002|Extention Period|Withdrawal by Subject|1|||
149231479|NCT00361504|538315143|FG001|Overall Study|Withdrawal by Subject|31|||
149231480|NCT00361504|538315142|FG000|Overall Study|Lost to Follow-up|40|||
149231481|NCT00361504|538315143|FG001|Overall Study|Lost to Follow-up|7|||
149231482|NCT00361504|538315142|FG000|Overall Study|Adverse Event|203|||
149231483|NCT00361504|538315143|FG001|Overall Study|Adverse Event|82|||
149231484|NCT00361504|538315142|FG000|Overall Study|Lack of Efficacy|72|||
149231485|NCT00361504|538315143|FG001|Overall Study|Lack of Efficacy|7|||
149231486|NCT00361504|538315142|FG000|Overall Study|Resolution of Pain|2|||
149231487|NCT00361504|538315143|FG001|Overall Study|Resolution of Pain|0|||
149231488|NCT00361504|538315142|FG000|Overall Study|Study medication non compliant|42|||
149231489|NCT00361504|538315143|FG001|Overall Study|Study medication non compliant|15|||
149231490|NCT00361504|538315142|FG000|Overall Study|All other|28|||
149231491|NCT00361504|538315143|FG001|Overall Study|All other|3|||
149231492|NCT01374516|538315159|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
149231493|NCT01374516|538315160|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
149231494|NCT01374516|538315159|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
149231495|NCT01374516|538315160|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
149231496|NCT01374516|538315159|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
149231497|NCT01374516|538315160|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
149231498|NCT01374516|538315159|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
149231499|NCT01374516|538315160|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
149231500|NCT01374516|538315159|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
149231501|NCT01374516|538315160|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
149231502|NCT01374516|538315159|FG000|Surveillance Expansion Period|Protocol Violation|386|||
149231503|NCT01374516|538315160|FG001|Surveillance Expansion Period|Protocol Violation|217|||
149231504|NCT01374516|538315159|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
149231505|NCT01374516|538315160|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
149231506|NCT01374516|538315159|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
149231507|NCT01374516|538315160|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
149231508|NCT01374516|538315159|FG000|Surveillance Expansion Period|Serious adverse event|20|||
149231509|NCT01374516|538315160|FG001|Surveillance Expansion Period|Serious adverse event|5|||
149231510|NCT01012765|538315167|FG000|Treatment Period 1|Adverse Event|1|||
149231511|NCT01012765|538315168|FG001|Treatment Period 1|Adverse Event|0|||
149231512|NCT01012765|538315169|FG002|Treatment Period 1|Adverse Event|1|||
149231513|NCT01012765|538315170|FG003|Treatment Period 1|Adverse Event|0|||
149231514|NCT01012765|538315171|FG004|Treatment Period 1|Adverse Event|0|||
149231515|NCT01012765|538315172|FG005|Treatment Period 1|Adverse Event|0|||
149231516|NCT01012765|538315167|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149231517|NCT01012765|538315168|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149231518|NCT01012765|538315169|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149231519|NCT01012765|538315170|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149231520|NCT01012765|538315171|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149231521|NCT01012765|538315172|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149231522|NCT01012765|538315167|FG000|Treatment Period 1|Administrative problems|0|||
149231523|NCT01012765|538315168|FG001|Treatment Period 1|Administrative problems|0|||
149231524|NCT01012765|538315169|FG002|Treatment Period 1|Administrative problems|1|||
149231525|NCT01012765|538315170|FG003|Treatment Period 1|Administrative problems|1|||
149231526|NCT01012765|538315171|FG004|Treatment Period 1|Administrative problems|1|||
149231527|NCT01012765|538315172|FG005|Treatment Period 1|Administrative problems|0|||
149231528|NCT01012765|538315167|FG000|Treatment Period 1|Protocol Violation|0|||
149231529|NCT01012765|538315168|FG001|Treatment Period 1|Protocol Violation|0|||
149231530|NCT01012765|538315169|FG002|Treatment Period 1|Protocol Violation|0|||
149231531|NCT01012765|538315170|FG003|Treatment Period 1|Protocol Violation|2|||
149231532|NCT01012765|538315171|FG004|Treatment Period 1|Protocol Violation|1|||
149231533|NCT01012765|538315172|FG005|Treatment Period 1|Protocol Violation|0|||
149231534|NCT01012765|538315167|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149231535|NCT01012765|538315168|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149231536|NCT01012765|538315169|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149231537|NCT01012765|538315170|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149231538|NCT01012765|538315171|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
149231539|NCT01012765|538315172|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
149231540|NCT01012765|538315167|FG000|Treatment Period 2|Withdrawal by Subject|1|||
149231541|NCT01012765|538315168|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149231542|NCT01012765|538315169|FG002|Treatment Period 2|Withdrawal by Subject|1|||
149231543|NCT01012765|538315170|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149231544|NCT01012765|538315171|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149231545|NCT01012765|538315172|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149231546|NCT01012765|538315167|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
149231547|NCT01012765|538315168|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
149231548|NCT01012765|538315169|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
149231549|NCT01012765|538315170|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
149231550|NCT01012765|538315171|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
149231551|NCT01012765|538315172|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
149231552|NCT01012765|538315167|FG000|Treatment Period 2|Adverse Event|0|||
149231553|NCT01012765|538315168|FG001|Treatment Period 2|Adverse Event|1|||
149231554|NCT01012765|538315169|FG002|Treatment Period 2|Adverse Event|1|||
149231555|NCT01012765|538315170|FG003|Treatment Period 2|Adverse Event|0|||
149231556|NCT01012765|538315171|FG004|Treatment Period 2|Adverse Event|0|||
149231557|NCT01012765|538315172|FG005|Treatment Period 2|Adverse Event|0|||
149231558|NCT01012765|538315167|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149231559|NCT01012765|538315168|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
149231560|NCT01012765|538315169|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
149231561|NCT01012765|538315170|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149231562|NCT01012765|538315171|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149231563|NCT01012765|538315172|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
149231564|NCT01326312|538315173|FG000|Overall Study|Adverse Event|11|||
149231565|NCT01326312|538315174|FG001|Overall Study|Adverse Event|11|||
149231566|NCT01326312|538315175|FG002|Overall Study|Adverse Event|1|||
149231567|NCT01326312|538315173|FG000|Overall Study|Withdrawal by Subject|1|||
149231568|NCT01326312|538315174|FG001|Overall Study|Withdrawal by Subject|2|||
149231569|NCT01326312|538315175|FG002|Overall Study|Withdrawal by Subject|1|||
149231570|NCT01326312|538315173|FG000|Overall Study|Protocol Violation|0|||
149231571|NCT01326312|538315174|FG001|Overall Study|Protocol Violation|1|||
149231572|NCT01326312|538315175|FG002|Overall Study|Protocol Violation|0|||
149231573|NCT01326312|538315173|FG000|Overall Study|Lack of Efficacy|13|||
148690090|NCT00819247|536338556|FG001|Overall Study|Withdrawal by Subject|0|||
148690091|NCT00819247|536338557|FG002|Overall Study|Withdrawal by Subject|0|||
148690092|NCT00819247|536338555|FG000|Overall Study|Protocol Violation|1|||
148690093|NCT00819247|536338556|FG001|Overall Study|Protocol Violation|0|||
148690094|NCT00819247|536338557|FG002|Overall Study|Protocol Violation|1|||
148690095|NCT00819247|536338555|FG000|Overall Study|Mistakenly withdrawn|0|||
148690096|NCT00819247|536338556|FG001|Overall Study|Mistakenly withdrawn|1|||
148690097|NCT00819247|536338557|FG002|Overall Study|Mistakenly withdrawn|0|||
148690098|NCT00819247|536338555|FG000|Overall Study|Bad prostate-specific antigen response|3|||
148690099|NCT00819247|536338556|FG001|Overall Study|Bad prostate-specific antigen response|2|||
148690100|NCT00819247|536338557|FG002|Overall Study|Bad prostate-specific antigen response|0|||
149231574|NCT01326312|538315174|FG001|Overall Study|Lack of Efficacy|7|||
149231575|NCT01326312|538315175|FG002|Overall Study|Lack of Efficacy|1|||
149231576|NCT01326312|538315173|FG000|Overall Study|Death|1|||
149231577|NCT01326312|538315174|FG001|Overall Study|Death|0|||
149231578|NCT01326312|538315175|FG002|Overall Study|Death|1|||
149231579|NCT01326312|538315173|FG000|Overall Study|progressive disease|0|||
149231580|NCT01326312|538315174|FG001|Overall Study|progressive disease|1|||
149231581|NCT01326312|538315175|FG002|Overall Study|progressive disease|1|||
149231582|NCT01326312|538315173|FG000|Overall Study|Study terminated by Sponsor|8|||
149231583|NCT01326312|538315174|FG001|Overall Study|Study terminated by Sponsor|32|||
149231584|NCT01326312|538315175|FG002|Overall Study|Study terminated by Sponsor|46|||
149231585|NCT01326312|538315173|FG000|Overall Study|Treatment arm terminated|19|||
149231586|NCT01326312|538315174|FG001|Overall Study|Treatment arm terminated|0|||
149231587|NCT01326312|538315175|FG002|Overall Study|Treatment arm terminated|0|||
149231588|NCT01326312|538315173|FG000|Overall Study|QTc > 500|0|||
149231589|NCT01326312|538315174|FG001|Overall Study|QTc > 500|1|||
149231590|NCT01326312|538315175|FG002|Overall Study|QTc > 500|0|||
149231591|NCT00499694|538315186|FG000|Overall Study|Patient never received treatment.|1|||
149231592|NCT03556202|538315189|FG000|Extension Treatment Period|Adverse Event|18|||
149231593|NCT03556202|538315190|FG001|Extension Treatment Period|Adverse Event|14|||
149231594|NCT03556202|538315191|FG002|Extension Treatment Period|Adverse Event|9|||
149231595|NCT03556202|538315189|FG000|Extension Treatment Period|Death|2|||
149231596|NCT03556202|538315190|FG001|Extension Treatment Period|Death|6|||
149231597|NCT03556202|538315191|FG002|Extension Treatment Period|Death|0|||
149231598|NCT03556202|538315189|FG000|Extension Treatment Period|Lack of Efficacy|5|||
149231599|NCT03556202|538315190|FG001|Extension Treatment Period|Lack of Efficacy|12|||
149231600|NCT03556202|538315191|FG002|Extension Treatment Period|Lack of Efficacy|18|||
149231601|NCT03556202|538315189|FG000|Extension Treatment Period|Lost to Follow-up|9|||
149231602|NCT03556202|538315190|FG001|Extension Treatment Period|Lost to Follow-up|20|||
149231603|NCT03556202|538315191|FG002|Extension Treatment Period|Lost to Follow-up|2|||
149231604|NCT03556202|538315189|FG000|Extension Treatment Period|Pregnancy|2|||
149231605|NCT03556202|538315190|FG001|Extension Treatment Period|Pregnancy|4|||
149231606|NCT03556202|538315191|FG002|Extension Treatment Period|Pregnancy|3|||
149231607|NCT03556202|538315189|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
149231608|NCT03556202|538315190|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
149231609|NCT03556202|538315191|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
149231610|NCT03556202|538315189|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
149231611|NCT03556202|538315190|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
149231612|NCT03556202|538315191|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
149231613|NCT03556202|538315189|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
149231614|NCT03556202|538315190|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
149231615|NCT03556202|538315191|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
149231616|NCT03556202|538315189|FG000|Extension Treatment Period|Physician Decision|0|||
149231617|NCT03556202|538315190|FG001|Extension Treatment Period|Physician Decision|8|||
149231618|NCT03556202|538315191|FG002|Extension Treatment Period|Physician Decision|2|||
149231619|NCT03556202|538315189|FG000|Extension Treatment Period|Protocol Violation|0|||
149231620|NCT03556202|538315190|FG001|Extension Treatment Period|Protocol Violation|1|||
149231621|NCT03556202|538315191|FG002|Extension Treatment Period|Protocol Violation|1|||
149231622|NCT03556202|538315189|FG000|Extension Treatment Period|Sponsor Decision|0|||
149231623|NCT03556202|538315190|FG001|Extension Treatment Period|Sponsor Decision|1|||
149231624|NCT03556202|538315191|FG002|Extension Treatment Period|Sponsor Decision|0|||
149231625|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
149231626|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
149231627|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
149231628|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Death|1|||
149231629|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Death|0|||
149231630|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Death|0|||
149231631|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
149231632|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
149231633|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
149231634|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
149231635|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
149231636|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
149231637|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
149231638|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
149231639|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
149231640|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
149231641|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
149231642|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
149231643|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
149231644|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
149231645|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
149231646|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
149231647|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
149231648|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
149231649|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
148954510|NCT03510884|537317110|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
148810584|NCT01020123|536782658|FG003|Extention Period|Withdrawal by Subject|0|||
148810585|NCT01020123|536782659|FG004|Extention Period|Withdrawal by Subject|0|||
149231650|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
149231651|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
149231652|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
149231653|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
149231654|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
149231655|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
149231656|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
149231657|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
149231658|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
149231659|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
149231660|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
149231661|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
148690101|NCT00819247|536338555|FG000|Overall Study|Other|1|||
148810586|NCT01020123|536782660|FG005|Extention Period|Withdrawal by Subject|0|||
148810587|NCT01020123|536782661|FG006|Extention Period|Withdrawal by Subject|0|||
148810588|NCT01020123|536782655|FG000|Extention Period|Adverse Event|0|||
148810589|NCT01020123|536782656|FG001|Extention Period|Adverse Event|0|||
148810590|NCT01020123|536782657|FG002|Extention Period|Adverse Event|0|||
148810591|NCT01020123|536782658|FG003|Extention Period|Adverse Event|1|||
148810592|NCT01020123|536782659|FG004|Extention Period|Adverse Event|0|||
148810593|NCT01020123|536782660|FG005|Extention Period|Adverse Event|0|||
148810594|NCT01020123|536782661|FG006|Extention Period|Adverse Event|0|||
148810595|NCT01020123|536782655|FG000|Extention Period|Protocol Violation|1|||
148810596|NCT01020123|536782656|FG001|Extention Period|Protocol Violation|1|||
148810597|NCT01020123|536782657|FG002|Extention Period|Protocol Violation|1|||
148810598|NCT01020123|536782658|FG003|Extention Period|Protocol Violation|0|||
148810599|NCT01020123|536782659|FG004|Extention Period|Protocol Violation|0|||
148810600|NCT01020123|536782660|FG005|Extention Period|Protocol Violation|0|||
148810601|NCT01020123|536782661|FG006|Extention Period|Protocol Violation|1|||
148810602|NCT01020123|536782655|FG000|Extention Period|Lost to Follow-up|0|||
148810603|NCT01020123|536782656|FG001|Extention Period|Lost to Follow-up|0|||
148810604|NCT01020123|536782657|FG002|Extention Period|Lost to Follow-up|0|||
148810605|NCT01020123|536782658|FG003|Extention Period|Lost to Follow-up|0|||
148810606|NCT01020123|536782659|FG004|Extention Period|Lost to Follow-up|0|||
148810607|NCT01020123|536782660|FG005|Extention Period|Lost to Follow-up|2|||
148810608|NCT01020123|536782661|FG006|Extention Period|Lost to Follow-up|0|||
148810609|NCT03479905|536782668|FG000|Overall Study|Other airway method used|4|||
148810610|NCT03479905|536782669|FG001|Overall Study|Other airway method used|5|||
148810611|NCT03479905|536782670|FG002|Overall Study|Other airway method used|5|||
148810612|NCT00862992|536782671|FG000|Overall Study|Adverse Event|2|||
148810613|NCT00862992|536782672|FG001|Overall Study|Adverse Event|1|||
148810614|NCT00862992|536782673|FG002|Overall Study|Adverse Event|1|||
148810615|NCT00862992|536782671|FG000|Overall Study|Physician Decision|1|||
148810616|NCT00862992|536782672|FG001|Overall Study|Physician Decision|0|||
148810617|NCT00862992|536782673|FG002|Overall Study|Physician Decision|0|||
148810618|NCT00862992|536782671|FG000|Overall Study|Withdrawal by Subject|0|||
148810619|NCT00862992|536782672|FG001|Overall Study|Withdrawal by Subject|0|||
148810620|NCT00862992|536782673|FG002|Overall Study|Withdrawal by Subject|2|||
148810621|NCT00720759|536782674|FG000|Overall Study|Lost to Follow-up|0|||
148810622|NCT00720759|536782675|FG001|Overall Study|Lost to Follow-up|1|||
148810623|NCT00720759|536782676|FG002|Overall Study|Lost to Follow-up|1|||
148810624|NCT00720759|536782677|FG003|Overall Study|Lost to Follow-up|0|||
148810625|NCT02318940|536782678|FG000|Overall Study|lost the record|1|||
148810626|NCT02318940|536782679|FG001|Overall Study|lost the record|0|||
148810627|NCT05032196|536782692|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
148810628|NCT05032196|536782693|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
148810629|NCT05032196|536782694|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
148810630|NCT05032196|536782695|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
148810631|NCT05032196|536782696|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
148810632|NCT05032196|536782697|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
148810633|NCT05032196|536782692|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
148810634|NCT05032196|536782693|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
148810635|NCT05032196|536782694|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
148810636|NCT05032196|536782695|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
148810637|NCT05032196|536782696|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
148810638|NCT05032196|536782697|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
148810639|NCT05032196|536782692|FG000|Period 2 (Multidose)|Physician Decision|0|||
148810640|NCT05032196|536782693|FG001|Period 2 (Multidose)|Physician Decision|0|||
148810641|NCT05032196|536782694|FG002|Period 2 (Multidose)|Physician Decision|0|||
148810642|NCT05032196|536782695|FG003|Period 2 (Multidose)|Physician Decision|0|||
148810643|NCT05032196|536782696|FG004|Period 2 (Multidose)|Physician Decision|1|||
148810644|NCT05032196|536782697|FG005|Period 2 (Multidose)|Physician Decision|0|||
148810645|NCT00857389|536782698|FG000|Overall Study|Did not proceed to transplant|2|||
148810646|NCT05260008|536782699|FG000|Overall Study|Physician Decision|0|||
148810647|NCT05260008|536782700|FG001|Overall Study|Physician Decision|1|||
148810648|NCT05260008|536782701|FG002|Overall Study|Physician Decision|0|||
149231662|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
149231663|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
149231664|NCT03556202|538315189|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
149231665|NCT03556202|538315190|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
149231666|NCT03556202|538315191|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
149231667|NCT04034225|538315194|FG000|Overall Study|Death|3|||
149231668|NCT04034225|538315194|FG000|Overall Study|Withdrawal by Subject|2|||
149231669|NCT04034225|538315194|FG000|Overall Study|Study termination by Sponsor|18|||
149231670|NCT04034225|538315194|FG000|Overall Study|Physician Decision|1|||
149231671|NCT04034225|538315194|FG000|Overall Study|Lack of Efficacy|1|||
149231672|NCT01815099|538315195|FG000|Overall Study|Lack of Efficacy|1|||
149231673|NCT01815099|538315195|FG000|Overall Study|unable to attend study visits|1|||
149231674|NCT01475214|538315196|FG000|Overall Study|Lost to Follow-up|1|||
149231675|NCT01475214|538315197|FG001|Overall Study|Lost to Follow-up|0|||
149231676|NCT01475214|538315198|FG002|Overall Study|Lost to Follow-up|1|||
149231677|NCT01475214|538315196|FG000|Overall Study|Physician Decision|2|||
149231678|NCT01475214|538315197|FG001|Overall Study|Physician Decision|0|||
149231679|NCT01475214|538315198|FG002|Overall Study|Physician Decision|0|||
149231680|NCT01475214|538315196|FG000|Overall Study|Withdrawal by Subject|2|||
149231681|NCT01475214|538315197|FG001|Overall Study|Withdrawal by Subject|4|||
149231682|NCT01475214|538315198|FG002|Overall Study|Withdrawal by Subject|1|||
149231683|NCT00643851|538315199|FG000|Overall Study|Death|0|||
149231684|NCT00643851|538315200|FG001|Overall Study|Death|1|||
149231685|NCT00643851|538315201|FG002|Overall Study|Death|0|||
149231686|NCT00643851|538315199|FG000|Overall Study|Lack of Efficacy|0|||
149231687|NCT00643851|538315200|FG001|Overall Study|Lack of Efficacy|1|||
149231688|NCT00643851|538315201|FG002|Overall Study|Lack of Efficacy|0|||
149231689|NCT00643851|538315199|FG000|Overall Study|Adverse Event|2|||
149231690|NCT00643851|538315200|FG001|Overall Study|Adverse Event|6|||
149231691|NCT00643851|538315201|FG002|Overall Study|Adverse Event|6|||
149231692|NCT00643851|538315199|FG000|Overall Study|Lost to Follow-up|4|||
149231693|NCT00643851|538315200|FG001|Overall Study|Lost to Follow-up|6|||
149231694|NCT00643851|538315201|FG002|Overall Study|Lost to Follow-up|9|||
149231695|NCT00643851|538315199|FG000|Overall Study|Withdrawal by Subject|8|||
149231696|NCT00643851|538315200|FG001|Overall Study|Withdrawal by Subject|15|||
149231697|NCT00643851|538315201|FG002|Overall Study|Withdrawal by Subject|9|||
149231698|NCT00643851|538315199|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
149231699|NCT00643851|538315200|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
149231700|NCT00643851|538315201|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
149231701|NCT03289676|538315202|FG000|Overall Study|Withdrawal by Subject|2|||
149231702|NCT03289676|538315203|FG001|Overall Study|Withdrawal by Subject|0|||
149231703|NCT03289676|538315202|FG000|Overall Study|Protocol Violation|2|||
149231704|NCT03289676|538315203|FG001|Overall Study|Protocol Violation|0|||
149231705|NCT03289676|538315202|FG000|Overall Study|Lost to Follow-up|0|||
149231706|NCT03289676|538315203|FG001|Overall Study|Lost to Follow-up|1|||
149231707|NCT03590613|538315204|FG000|Period 2, 4 Days|Physician Decision|0|||
149231708|NCT03590613|538315205|FG001|Period 2, 4 Days|Physician Decision|0|||
149231709|NCT03590613|538315206|FG002|Period 2, 4 Days|Physician Decision|0|||
149231710|NCT03590613|538315207|FG003|Period 2, 4 Days|Physician Decision|1|||
149231711|NCT04369742|538315208|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
149231712|NCT04369742|538315209|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
148690102|NCT00819247|536338556|FG001|Overall Study|Other|0|||
149231713|NCT04369742|538315208|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
149231714|NCT04369742|538315209|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
149231715|NCT03044730|538315210|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
149231716|NCT03044730|538315210|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
149231717|NCT03044730|538315210|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
149231718|NCT03044730|538315210|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
149231719|NCT03044730|538315210|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
149231720|NCT03044730|538315210|FG000|Cycles 4 and Beyond|Adverse Event|1|||
149231721|NCT03044730|538315210|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
149231722|NCT03044730|538315210|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
149231723|NCT03044730|538315210|FG000|On Follow-up for 2 Years|Death|17|||
149231724|NCT02777554|538317051|FG000|Overall Study|Adverse Event|4|||
149231725|NCT02777554|538317052|FG001|Overall Study|Adverse Event|4|||
148690103|NCT00819247|536338557|FG002|Overall Study|Other|0|||
149231726|NCT02777554|538317053|FG002|Overall Study|Adverse Event|0|||
149231727|NCT02777554|538317054|FG003|Overall Study|Adverse Event|1|||
149231728|NCT02777554|538317055|FG004|Overall Study|Adverse Event|0|||
149231729|NCT02777554|538317056|FG005|Overall Study|Adverse Event|0|||
149231730|NCT02777554|538317051|FG000|Overall Study|Withdrawal by Subject|3|||
149231731|NCT02777554|538317052|FG001|Overall Study|Withdrawal by Subject|1|||
149231732|NCT02777554|538317053|FG002|Overall Study|Withdrawal by Subject|1|||
149231733|NCT02777554|538317054|FG003|Overall Study|Withdrawal by Subject|0|||
149231734|NCT02777554|538317055|FG004|Overall Study|Withdrawal by Subject|0|||
148690104|NCT02162758|536338558|FG000|Overall Study|Study termination|0|||
148690105|NCT02162758|536338559|FG001|Overall Study|Study termination|1|||
148690106|NCT04471935|536338560|FG000|Overall Study|Withdrawal by Subject|1|||
148690107|NCT04471935|536338560|FG000|Overall Study|Deemed ineligible to participate|1|||
148690108|NCT02540356|536338563|FG000|Overall Study|Terminated due to disease progression|1|||
148690109|NCT02540356|536338564|FG001|Overall Study|Terminated due to disease progression|0|||
148690110|NCT01166568|536338565|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
149231735|NCT02777554|538317056|FG005|Overall Study|Withdrawal by Subject|0|||
149231736|NCT02777554|538317051|FG000|Overall Study|Discharged early due to hurricane|22|||
149231737|NCT02777554|538317052|FG001|Overall Study|Discharged early due to hurricane|20|||
149231738|NCT02777554|538317053|FG002|Overall Study|Discharged early due to hurricane|0|||
149231739|NCT02777554|538317054|FG003|Overall Study|Discharged early due to hurricane|0|||
149231740|NCT02777554|538317055|FG004|Overall Study|Discharged early due to hurricane|0|||
149231741|NCT02777554|538317056|FG005|Overall Study|Discharged early due to hurricane|0|||
149231742|NCT02777554|538317051|FG000|Overall Study|Other - Miscellaneous|1|||
149231743|NCT02777554|538317052|FG001|Overall Study|Other - Miscellaneous|0|||
149231744|NCT02777554|538317053|FG002|Overall Study|Other - Miscellaneous|0|||
149231745|NCT02777554|538317054|FG003|Overall Study|Other - Miscellaneous|0|||
148690111|NCT01166568|536338566|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
148690112|NCT01166568|536338567|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
148690113|NCT01166568|536338565|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
148690114|NCT01166568|536338566|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
149231746|NCT02777554|538317055|FG004|Overall Study|Other - Miscellaneous|0|||
149231747|NCT02777554|538317056|FG005|Overall Study|Other - Miscellaneous|0|||
149231748|NCT00278473|538317065|FG000|Overall Study|drop out|4|||
149231749|NCT00278473|538317066|FG001|Overall Study|drop out|3|||
149231750|NCT04854421|538317067|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
149231751|NCT04854421|538317068|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
149231752|NCT02322866|538317070|FG000|Overall Study|Adverse Event|6|||
149231753|NCT02322866|538317071|FG001|Overall Study|Adverse Event|11|||
149231754|NCT02322866|538317070|FG000|Overall Study|Withdrawal of Consent|16|||
149231755|NCT02322866|538317071|FG001|Overall Study|Withdrawal of Consent|25|||
149231756|NCT02322866|538317070|FG000|Overall Study|Lost to Follow-up|36|||
149231757|NCT02322866|538317071|FG001|Overall Study|Lost to Follow-up|39|||
149231758|NCT02322866|538317070|FG000|Overall Study|Protocol Violation|1|||
149231759|NCT02322866|538317071|FG001|Overall Study|Protocol Violation|0|||
149231760|NCT02322866|538317070|FG000|Overall Study|Noncompliance with Treatment|3|||
149231761|NCT02322866|538317071|FG001|Overall Study|Noncompliance with Treatment|4|||
148690115|NCT01166568|536338567|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
148690116|NCT01166568|536338565|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
148690117|NCT01166568|536338566|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
148690118|NCT01166568|536338567|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
148690119|NCT03335371|536338568|FG000|Overall Study|Lost to Follow-up|0|||
148690120|NCT03335371|536338569|FG001|Overall Study|Lost to Follow-up|0|||
148690121|NCT03335371|536338570|FG002|Overall Study|Lost to Follow-up|0|||
148690122|NCT03335371|536338571|FG003|Overall Study|Lost to Follow-up|0|||
148690123|NCT03335371|536338572|FG004|Overall Study|Lost to Follow-up|1|||
148690124|NCT03335371|536338568|FG000|Overall Study|Withdrawal by Subject|0|||
148690125|NCT03335371|536338569|FG001|Overall Study|Withdrawal by Subject|0|||
148690126|NCT03335371|536338570|FG002|Overall Study|Withdrawal by Subject|0|||
148690127|NCT03335371|536338571|FG003|Overall Study|Withdrawal by Subject|0|||
148690128|NCT03335371|536338572|FG004|Overall Study|Withdrawal by Subject|1|||
148690129|NCT03335371|536338568|FG000|Overall Study|Randomization Error|0|||
148690130|NCT03335371|536338569|FG001|Overall Study|Randomization Error|0|||
148690131|NCT03335371|536338570|FG002|Overall Study|Randomization Error|1|||
148690132|NCT03335371|536338571|FG003|Overall Study|Randomization Error|0|||
148690133|NCT03335371|536338572|FG004|Overall Study|Randomization Error|0|||
148690134|NCT00249821|536338575|FG000|Overall Study|Technical problem|0|||
148690135|NCT00249821|536338576|FG001|Overall Study|Technical problem|1|||
148690136|NCT01348542|536338577|FG000|Overall Study|Withdrawal by Subject|3|||
148954511|NCT03510884|537317111|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
148954512|NCT03510884|537317108|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
148954513|NCT03510884|537317109|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
148954514|NCT03510884|537317110|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
149231762|NCT02322866|538317070|FG000|Overall Study|Lack of Efficacy|3|||
149231763|NCT02322866|538317071|FG001|Overall Study|Lack of Efficacy|1|||
149231764|NCT02322866|538317070|FG000|Overall Study|Other Miscellaneous Reasons|6|||
149231765|NCT02322866|538317071|FG001|Overall Study|Other Miscellaneous Reasons|6|||
149231766|NCT00718809|538317072|FG000|Overall Study|Disease progression|9|||
148690137|NCT01348542|536338578|FG001|Overall Study|Withdrawal by Subject|0|||
148690138|NCT00467584|536338579|FG000|Overall Study|Withdrawal by Subject|4|||
148690139|NCT00467584|536338580|FG001|Overall Study|Withdrawal by Subject|5|||
148690140|NCT00467584|536338581|FG002|Overall Study|Withdrawal by Subject|1|||
149231767|NCT00718809|538317073|FG001|Overall Study|Disease progression|7|||
149231768|NCT00718809|538317072|FG000|Overall Study|Adverse Event|1|||
149231769|NCT00718809|538317073|FG001|Overall Study|Adverse Event|1|||
149231770|NCT00718809|538317072|FG000|Overall Study|Withdrawal by Subject|0|||
149231771|NCT00718809|538317073|FG001|Overall Study|Withdrawal by Subject|1|||
149231772|NCT00718809|538317072|FG000|Overall Study|Lost to Follow-up|1|||
149231773|NCT00718809|538317073|FG001|Overall Study|Lost to Follow-up|0|||
149231774|NCT00718809|538317072|FG000|Overall Study|Noncompliance|1|||
149231775|NCT00718809|538317073|FG001|Overall Study|Noncompliance|0|||
149231776|NCT01711736|538317074|FG000|Overall Study|Lost to Follow-up|4|||
149231777|NCT01711736|538317075|FG001|Overall Study|Lost to Follow-up|1|||
149231778|NCT01711736|538317074|FG000|Overall Study|Withdrawal by Subject|6|||
149231779|NCT01711736|538317075|FG001|Overall Study|Withdrawal by Subject|6|||
149231780|NCT01711736|538317074|FG000|Overall Study|Migrated/moved from study area|2|||
149231781|NCT01711736|538317075|FG001|Overall Study|Migrated/moved from study area|1|||
149231782|NCT04145531|538317076|FG000|Part A|Adverse Event|2|||
149231783|NCT04145531|538317077|FG001|Part A|Adverse Event|12|||
149231784|NCT04145531|538317078|FG002|Part A|Adverse Event|6|||
149231785|NCT04145531|538317079|FG003|Part A|Adverse Event|0|||
149231786|NCT04145531|538317076|FG000|Part A|Death|1|||
149231787|NCT04145531|538317077|FG001|Part A|Death|2|||
148690141|NCT00926289|536338582|FG000|Overall Study|Adverse Event|9|||
148690142|NCT00926289|536338583|FG001|Overall Study|Adverse Event|11|||
148690143|NCT00926289|536338582|FG000|Overall Study|Protocol Violation|8|||
149231788|NCT04145531|538317078|FG002|Part A|Death|0|||
149231789|NCT04145531|538317079|FG003|Part A|Death|0|||
149231790|NCT04145531|538317076|FG000|Part A|Physician Decision|2|||
149231791|NCT04145531|538317077|FG001|Part A|Physician Decision|5|||
149231792|NCT04145531|538317078|FG002|Part A|Physician Decision|2|||
149231793|NCT04145531|538317079|FG003|Part A|Physician Decision|0|||
149231794|NCT04145531|538317076|FG000|Part A|Progressive disease|0|||
149231795|NCT04145531|538317077|FG001|Part A|Progressive disease|2|||
149231796|NCT04145531|538317078|FG002|Part A|Progressive disease|1|||
149231797|NCT04145531|538317079|FG003|Part A|Progressive disease|0|||
149231798|NCT04145531|538317076|FG000|Part A|Protocol deviation|0|||
149231799|NCT04145531|538317077|FG001|Part A|Protocol deviation|0|||
149231800|NCT04145531|538317078|FG002|Part A|Protocol deviation|1|||
149231801|NCT04145531|538317079|FG003|Part A|Protocol deviation|0|||
149231802|NCT04145531|538317076|FG000|Part A|Withdrawal by parent or guardian|1|||
149231803|NCT04145531|538317077|FG001|Part A|Withdrawal by parent or guardian|0|||
149231804|NCT04145531|538317078|FG002|Part A|Withdrawal by parent or guardian|0|||
149231805|NCT04145531|538317079|FG003|Part A|Withdrawal by parent or guardian|0|||
149231806|NCT04145531|538317076|FG000|Part A|Withdrawal by participant|0|||
149231807|NCT04145531|538317077|FG001|Part A|Withdrawal by participant|0|||
149231808|NCT04145531|538317078|FG002|Part A|Withdrawal by participant|1|||
149231809|NCT04145531|538317079|FG003|Part A|Withdrawal by participant|0|||
149231810|NCT04145531|538317076|FG000|Part A|Other|0|||
149231811|NCT04145531|538317077|FG001|Part A|Other|0|||
149231812|NCT04145531|538317078|FG002|Part A|Other|1|||
149231813|NCT04145531|538317079|FG003|Part A|Other|0|||
149231814|NCT04145531|538317076|FG000|Part B|Adverse Event|0|||
149231815|NCT04145531|538317077|FG001|Part B|Adverse Event|0|||
149231816|NCT04145531|538317078|FG002|Part B|Adverse Event|0|||
149231817|NCT04145531|538317079|FG003|Part B|Adverse Event|21|||
149231818|NCT04145531|538317076|FG000|Part B|Physician Decision|0|||
149231819|NCT04145531|538317077|FG001|Part B|Physician Decision|0|||
149231820|NCT04145531|538317078|FG002|Part B|Physician Decision|0|||
149231821|NCT04145531|538317079|FG003|Part B|Physician Decision|7|||
149231822|NCT04145531|538317076|FG000|Part B|Progressive disease|0|||
149231823|NCT04145531|538317077|FG001|Part B|Progressive disease|0|||
149231824|NCT04145531|538317078|FG002|Part B|Progressive disease|0|||
149231825|NCT04145531|538317079|FG003|Part B|Progressive disease|1|||
148690144|NCT00926289|536338583|FG001|Overall Study|Protocol Violation|12|||
149231826|NCT04145531|538317076|FG000|Part B|Recurrent disease|0|||
149231827|NCT04145531|538317077|FG001|Part B|Recurrent disease|0|||
149231828|NCT04145531|538317078|FG002|Part B|Recurrent disease|0|||
149231829|NCT04145531|538317079|FG003|Part B|Recurrent disease|1|||
149231830|NCT04145531|538317076|FG000|Part B|Withdrawal by parent or guardian|0|||
149231831|NCT04145531|538317077|FG001|Part B|Withdrawal by parent or guardian|0|||
149231832|NCT04145531|538317078|FG002|Part B|Withdrawal by parent or guardian|0|||
149231833|NCT04145531|538317079|FG003|Part B|Withdrawal by parent or guardian|3|||
149231834|NCT04145531|538317076|FG000|Part B|Withdrawal by participant|0|||
149231835|NCT04145531|538317077|FG001|Part B|Withdrawal by participant|0|||
149231836|NCT04145531|538317078|FG002|Part B|Withdrawal by participant|0|||
149231837|NCT04145531|538317079|FG003|Part B|Withdrawal by participant|1|||
149231838|NCT04145531|538317076|FG000|Part B|Other|0|||
149231839|NCT04145531|538317077|FG001|Part B|Other|0|||
149231840|NCT04145531|538317078|FG002|Part B|Other|0|||
148690145|NCT00926289|536338582|FG000|Overall Study|Lost to Follow-up|3|||
149231841|NCT04145531|538317079|FG003|Part B|Other|1|||
149231842|NCT00933543|538317080|FG000|Overall Study|Adverse Event|2|||
149231843|NCT00933543|538317081|FG001|Overall Study|Adverse Event|1|||
149231844|NCT00933543|538317080|FG000|Overall Study|Lost to Follow-up|0|||
149231845|NCT00933543|538317081|FG001|Overall Study|Lost to Follow-up|1|||
149020349|NCT03354637|537552620|FG002|Open Label Extension|Subject Noncompliance|1|||
149020350|NCT03354637|537552618|FG000|Open Label Extension|Lack of Efficacy|0|||
149020351|NCT03354637|537552619|FG001|Open Label Extension|Lack of Efficacy|0|||
149020352|NCT03354637|537552620|FG002|Open Label Extension|Lack of Efficacy|1|||
149020353|NCT03354637|537552618|FG000|Open Label Extension|Physician Decision|0|||
149020354|NCT03354637|537552619|FG001|Open Label Extension|Physician Decision|0|||
149020355|NCT03354637|537552620|FG002|Open Label Extension|Physician Decision|1|||
149020356|NCT01440049|537552625|FG000|Overall Study|Adverse Event|5|||
149020357|NCT02268552|537552626|FG000|Part 1|Death|1|||
149020358|NCT02268552|537552627|FG001|Part 1|Death|1|||
149020359|NCT02268552|537552628|FG002|Part 1|Death|1|||
148690146|NCT00926289|536338583|FG001|Overall Study|Lost to Follow-up|6|||
148810649|NCT05260008|536782702|FG003|Overall Study|Physician Decision|0|||
148810650|NCT04584788|536782704|FG000|Overall Study|Physician Decision|8|||
148810651|NCT04584788|536782704|FG000|Overall Study|Withdrawal by Subject|1|||
148810652|NCT04584788|536782704|FG000|Overall Study|Adverse Event|3|||
148810653|NCT01134042|536784549|FG000|Overall Study|Adverse Event|3|||
148810654|NCT01134042|536784550|FG001|Overall Study|Adverse Event|7|||
148810655|NCT01134042|536784551|FG002|Overall Study|Adverse Event|2|||
148810656|NCT01134042|536784549|FG000|Overall Study|Lack of Efficacy|21|||
148810657|NCT01134042|536784550|FG001|Overall Study|Lack of Efficacy|6|||
148810658|NCT01134042|536784551|FG002|Overall Study|Lack of Efficacy|18|||
148810659|NCT01134042|536784549|FG000|Overall Study|Protocol Violation|5|||
148810660|NCT01134042|536784550|FG001|Overall Study|Protocol Violation|3|||
148810661|NCT01134042|536784551|FG002|Overall Study|Protocol Violation|5|||
148810662|NCT01134042|536784549|FG000|Overall Study|Lost to Follow-up|2|||
148810663|NCT01134042|536784550|FG001|Overall Study|Lost to Follow-up|0|||
148810664|NCT01134042|536784551|FG002|Overall Study|Lost to Follow-up|1|||
148810665|NCT01134042|536784549|FG000|Overall Study|Physician Decision|4|||
148810666|NCT01134042|536784550|FG001|Overall Study|Physician Decision|8|||
148810667|NCT01134042|536784551|FG002|Overall Study|Physician Decision|1|||
148810668|NCT01134042|536784549|FG000|Overall Study|Withdrawal by Subject|13|||
148810669|NCT01134042|536784550|FG001|Overall Study|Withdrawal by Subject|4|||
148810670|NCT01134042|536784551|FG002|Overall Study|Withdrawal by Subject|7|||
148810671|NCT01137786|536784558|FG000|Overall Study|Lost to Follow-up|0|||
148810672|NCT01137786|536784559|FG001|Overall Study|Lost to Follow-up|2|||
148810673|NCT01137786|536784558|FG000|Overall Study|Withdrawal by Subject|1|||
148810674|NCT01137786|536784559|FG001|Overall Study|Withdrawal by Subject|1|||
148810675|NCT00770367|536784560|FG000|First Intervention|Withdrawal by Subject|0|||
148690147|NCT00926289|536338582|FG000|Overall Study|Withdrawal by Subject|4|||
148690148|NCT00926289|536338583|FG001|Overall Study|Withdrawal by Subject|4|||
148690149|NCT00926289|536338582|FG000|Overall Study|Other|1|||
148690150|NCT00926289|536338583|FG001|Overall Study|Other|3|||
148690151|NCT00319956|536338584|FG000|Overall Study|Death|20|||
149231846|NCT00933543|538317080|FG000|Overall Study|Withdrawal by Subject|0|||
149231847|NCT00933543|538317081|FG001|Overall Study|Withdrawal by Subject|1|||
149231848|NCT00933543|538317080|FG000|Overall Study|Lack of Efficacy|0|||
149231849|NCT00933543|538317081|FG001|Overall Study|Lack of Efficacy|3|||
149231850|NCT00933543|538317080|FG000|Overall Study|Other|1|||
148690152|NCT00319956|536338585|FG001|Overall Study|Death|24|||
148690153|NCT00753714|536338586|FG000|Overall Study|Lack of Efficacy|21|||
148690154|NCT00753714|536338587|FG001|Overall Study|Lack of Efficacy|34|||
148690155|NCT00753714|536338586|FG000|Overall Study|Adverse Event|26|||
148690156|NCT00753714|536338587|FG001|Overall Study|Adverse Event|18|||
148690157|NCT00753714|536338586|FG000|Overall Study|Protocol Violation|1|||
148690158|NCT00753714|536338587|FG001|Overall Study|Protocol Violation|0|||
148690159|NCT00753714|536338586|FG000|Overall Study|Lost to Follow-up|0|||
148690160|NCT00753714|536338587|FG001|Overall Study|Lost to Follow-up|1|||
148690161|NCT00753714|536338586|FG000|Overall Study|Withdrawal by Subject|2|||
148690162|NCT00753714|536338587|FG001|Overall Study|Withdrawal by Subject|1|||
148690163|NCT00753714|536338586|FG000|Overall Study|Death|3|||
148690164|NCT00753714|536338587|FG001|Overall Study|Death|3|||
148690165|NCT00753714|536338586|FG000|Overall Study|Other|7|||
148690166|NCT00753714|536338587|FG001|Overall Study|Other|5|||
148690167|NCT01202747|536338588|FG000|Overall Study|Withdrawal by Subject|1|||
148690168|NCT01446913|536338589|FG000|Overall Study|Significant illness|1|||
148690169|NCT01446913|536338590|FG001|Overall Study|Significant illness|1|||
148690170|NCT01446913|536338591|FG002|Overall Study|Significant illness|1|||
148690171|NCT01446913|536338589|FG000|Overall Study|Withdrawal by Subject|5|||
148690172|NCT01446913|536338590|FG001|Overall Study|Withdrawal by Subject|3|||
148690173|NCT01446913|536338591|FG002|Overall Study|Withdrawal by Subject|5|||
148690174|NCT01446913|536338589|FG000|Overall Study|Physician Decision|0|||
148690175|NCT01446913|536338590|FG001|Overall Study|Physician Decision|0|||
148690176|NCT01446913|536338591|FG002|Overall Study|Physician Decision|2|||
148690177|NCT01446913|536338589|FG000|Overall Study|Lost to Follow-up|3|||
148690178|NCT01446913|536338590|FG001|Overall Study|Lost to Follow-up|5|||
148690179|NCT01446913|536338591|FG002|Overall Study|Lost to Follow-up|3|||
148690180|NCT04000009|536338592|FG000|Overall Study|Adverse Event|13|||
148690181|NCT04000009|536338592|FG000|Overall Study|Lack of Efficacy|7|||
148810676|NCT00770367|536784561|FG001|First Intervention|Withdrawal by Subject|2|||
148810677|NCT00770367|536784560|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
148810678|NCT00770367|536784561|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
149231851|NCT00933543|538317081|FG001|Overall Study|Other|1|||
149231852|NCT04988035|538317082|FG000|Overall Study|Death|19|||
149231853|NCT04988035|538317083|FG001|Overall Study|Death|13|||
148690182|NCT04000009|536338592|FG000|Overall Study|Lost to Follow-up|8|||
148690183|NCT04000009|536338592|FG000|Overall Study|Noncompliance with study drug|4|||
149231854|NCT04988035|538317082|FG000|Overall Study|Lost to Follow-up|12|||
148690184|NCT04000009|536338592|FG000|Overall Study|Physician Decision|1|||
148690185|NCT04000009|536338592|FG000|Overall Study|Use of prohibited medication|3|||
148690186|NCT04000009|536338592|FG000|Overall Study|Pregnancy|1|||
148810679|NCT00770367|536784560|FG000|Second Intervention|Lost to Follow-up|2|||
148690187|NCT04000009|536338592|FG000|Overall Study|Withdrawal by Subject|22|||
148690188|NCT04000009|536338592|FG000|Overall Study|Study terminated by sponsor|98|||
148690189|NCT04000009|536338592|FG000|Overall Study|Not further specified|8|||
148690190|NCT02041702|536338597|FG000|Overall Study|Lost to Follow-up|1|||
148690191|NCT02041702|536338598|FG001|Overall Study|Lost to Follow-up|6|||
148690192|NCT02041702|536338597|FG000|Overall Study|Death|4|||
148690193|NCT02041702|536338598|FG001|Overall Study|Death|0|||
148690194|NCT02041702|536338597|FG000|Overall Study|Withdrawal by Subject|4|||
148690195|NCT02041702|536338598|FG001|Overall Study|Withdrawal by Subject|3|||
148690196|NCT02041702|536338597|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
148690197|NCT02041702|536338598|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
148690198|NCT02041702|536338597|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
148690199|NCT02041702|536338598|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
148690200|NCT00203307|536338599|FG000|First Intervention|Adverse Event|2|||
148690201|NCT00203307|536338600|FG001|First Intervention|Adverse Event|0|||
148690202|NCT05328375|536340169|FG000|Overall Study|Withdrawal by Subject|0|||
148690203|NCT05328375|536340170|FG001|Overall Study|Withdrawal by Subject|1|||
148690204|NCT00101582|536340174|FG000|Overall Study|Ineligibility determined|0|||
148690205|NCT00101582|536340175|FG001|Overall Study|Ineligibility determined|1|||
148690206|NCT00101582|536340174|FG000|Overall Study|Adverse Event|1|||
148690207|NCT00101582|536340175|FG001|Overall Study|Adverse Event|4|||
148690208|NCT00101582|536340174|FG000|Overall Study|Withdrawal by Subject|6|||
148690209|NCT00101582|536340175|FG001|Overall Study|Withdrawal by Subject|4|||
148690210|NCT00101582|536340174|FG000|Overall Study|Physician Decision|1|||
148690211|NCT00101582|536340175|FG001|Overall Study|Physician Decision|0|||
148690212|NCT00101582|536340174|FG000|Overall Study|Death|3|||
148690213|NCT00101582|536340175|FG001|Overall Study|Death|5|||
148690214|NCT00101582|536340174|FG000|Overall Study|Other|0|||
148690215|NCT00101582|536340175|FG001|Overall Study|Other|1|||
148690216|NCT01919190|536340176|FG000|Overall Study|Intra-op findings, etc.|3|||
148690217|NCT01919190|536340177|FG001|Overall Study|Intra-op findings, etc.|0|||
148690218|NCT02146430|536340178|FG000|Overall Study|Protocol Violation|5|||
148690219|NCT02146430|536340179|FG001|Overall Study|Protocol Violation|4|||
149020360|NCT02268552|537552629|FG003|Part 1|Death|2|||
149231855|NCT04988035|538317083|FG001|Overall Study|Lost to Follow-up|6|||
149231856|NCT04988035|538317082|FG000|Overall Study|Protocol Violation|0|||
149231857|NCT04988035|538317083|FG001|Overall Study|Protocol Violation|1|||
149231858|NCT04988035|538317082|FG000|Overall Study|Withdrawal by Subject|2|||
149231859|NCT04988035|538317083|FG001|Overall Study|Withdrawal by Subject|4|||
149231860|NCT04988035|538317082|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
149231861|NCT04988035|538317083|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
149231862|NCT03602976|538317084|FG000|Overall Study|Withdrawal by Subject|1|||
149231863|NCT04837807|538317085|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
149231864|NCT04837807|538317086|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
149231865|NCT00308555|538317087|FG000|Overall Study|Withdrawal by Subject|1|||
149231866|NCT00308555|538317088|FG001|Overall Study|Withdrawal by Subject|0|||
149231867|NCT00308555|538317087|FG000|Overall Study|Physician Decision|2|||
149231868|NCT00308555|538317088|FG001|Overall Study|Physician Decision|0|||
149231869|NCT03732534|538317089|FG000|Overall Study|Study terminated by Sponsor|6|||
149231870|NCT02190604|538317090|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231871|NCT02190604|538317091|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231872|NCT02190604|538317092|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231873|NCT02190604|538317093|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231874|NCT02190604|538317094|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231875|NCT02190604|538317095|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231876|NCT02190604|538317096|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231877|NCT02190604|538317097|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
148690220|NCT02146430|536340180|FG002|Overall Study|Protocol Violation|8|||
148690221|NCT02146430|536340181|FG003|Overall Study|Protocol Violation|6|||
148690222|NCT02146430|536340178|FG000|Overall Study|Lack of Efficacy|13|||
149231878|NCT02190604|538317098|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231879|NCT02190604|538317099|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231880|NCT02190604|538317100|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231881|NCT02190604|538317101|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231882|NCT02190604|538317102|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231883|NCT02190604|538317103|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231884|NCT02190604|538317104|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
149231885|NCT02190604|538317105|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231886|NCT02190604|538317106|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231887|NCT02190604|538317107|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231888|NCT02190604|538317108|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
149231889|NCT02190604|538317090|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231890|NCT02190604|538317091|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231891|NCT02190604|538317092|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231892|NCT02190604|538317093|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231893|NCT02190604|538317094|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231894|NCT02190604|538317095|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231895|NCT02190604|538317096|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231896|NCT02190604|538317097|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231897|NCT02190604|538317098|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231898|NCT02190604|538317099|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231899|NCT02190604|538317100|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231900|NCT02190604|538317101|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231901|NCT02190604|538317102|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231902|NCT02190604|538317103|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
149231903|NCT02190604|538317104|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231904|NCT02190604|538317105|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231905|NCT02190604|538317106|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231906|NCT02190604|538317107|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231907|NCT02190604|538317108|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
149231908|NCT02797951|538317109|FG000|Overall Study|Adverse Event|4|||
149231909|NCT02797951|538317109|FG000|Overall Study|Death|1|||
149231910|NCT02797951|538317109|FG000|Overall Study|Lack of Efficacy|19|||
149231911|NCT02797951|538317109|FG000|Overall Study|Lost to Follow-up|4|||
149231912|NCT02797951|538317109|FG000|Overall Study|Physician Decision|6|||
149231913|NCT02797951|538317109|FG000|Overall Study|Withdrawal by Subject|15|||
149231914|NCT00814502|538317110|FG000|Overall Study|Adverse Event|1|||
149231915|NCT00814502|538317111|FG001|Overall Study|Adverse Event|0|||
149231916|NCT00814502|538317110|FG000|Overall Study|Withdrawal by Subject|0|||
149231917|NCT00814502|538317111|FG001|Overall Study|Withdrawal by Subject|2|||
149231918|NCT03735849|538317112|FG000|Overall Study|Lost to Follow-up|1|||
149231919|NCT03735849|538317113|FG001|Overall Study|Lost to Follow-up|0|||
149231920|NCT03735849|538317114|FG002|Overall Study|Lost to Follow-up|0|||
149231921|NCT03735849|538317112|FG000|Overall Study|Participant unable to adhere to visit|1|||
149231922|NCT03735849|538317113|FG001|Overall Study|Participant unable to adhere to visit|0|||
149231923|NCT03735849|538317114|FG002|Overall Study|Participant unable to adhere to visit|0|||
149231924|NCT03735849|538317112|FG000|Overall Study|Not Randomized|0|||
149231925|NCT03735849|538317113|FG001|Overall Study|Not Randomized|0|||
149231926|NCT03735849|538317114|FG002|Overall Study|Not Randomized|4|||
148810680|NCT00770367|536784561|FG001|Second Intervention|Lost to Follow-up|0|||
148810681|NCT03881371|536784565|FG000|Overall Study|Adverse Event|8|||
148810682|NCT03881371|536784566|FG001|Overall Study|Adverse Event|9|||
148810683|NCT03881371|536784565|FG000|Overall Study|Death|1|||
148810684|NCT03881371|536784566|FG001|Overall Study|Death|0|||
148954515|NCT03510884|537317111|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
148954516|NCT02282020|537317112|FG000|Overall Study|Objective Disease Progression|128|||
148810685|NCT03881371|536784565|FG000|Overall Study|Lost to Follow-up|1|||
149231927|NCT04585906|538317117|FG000|Overall Study|Lost to Follow-up|8|||
149231928|NCT04585906|538317118|FG001|Overall Study|Lost to Follow-up|5|||
149231929|NCT04626947|538317119|FG000|Overall Study|Study terminated|14|||
149231930|NCT03907072|538317128|FG000|Overall Study|Study Terminated by Sponsor|2|||
149231931|NCT03907072|538317129|FG001|Overall Study|Study Terminated by Sponsor|2|||
149231932|NCT03907072|538317130|FG002|Overall Study|Study Terminated by Sponsor|2|||
149231933|NCT02463097|538317133|FG000|Overall Study|Withdrawal by Subject|1|||
149231934|NCT03326323|538317134|FG000|Overall Study|Unable to receive ANH protocol|3|||
149231935|NCT02243306|538317139|FG000|Overall Study|Adverse Event|0|||
149231936|NCT02243306|538317140|FG001|Overall Study|Adverse Event|1|||
149231937|NCT02243306|538317139|FG000|Overall Study|Other: Reached stopping criteria|0|||
149231938|NCT02243306|538317140|FG001|Overall Study|Other: Reached stopping criteria|1|||
149231939|NCT02243306|538317139|FG000|Overall Study|Physician Decision|0|||
149231940|NCT02243306|538317140|FG001|Overall Study|Physician Decision|1|||
149231941|NCT02221882|538317141|FG000|Overall Study|Withdrawal by Subject|0|||
149231942|NCT02221882|538317142|FG001|Overall Study|Withdrawal by Subject|0|||
149231943|NCT02221882|538317143|FG002|Overall Study|Withdrawal by Subject|4|||
149231944|NCT02221882|538317144|FG003|Overall Study|Withdrawal by Subject|2|||
149231945|NCT02221882|538317145|FG004|Overall Study|Withdrawal by Subject|2|||
149231946|NCT02221882|538317146|FG005|Overall Study|Withdrawal by Subject|2|||
149231947|NCT02221882|538317141|FG000|Overall Study|Death|0|||
149231948|NCT02221882|538317142|FG001|Overall Study|Death|1|||
149231949|NCT02221882|538317143|FG002|Overall Study|Death|0|||
149231950|NCT02221882|538317144|FG003|Overall Study|Death|0|||
149231951|NCT02221882|538317145|FG004|Overall Study|Death|0|||
149231952|NCT02221882|538317146|FG005|Overall Study|Death|0|||
149231953|NCT00796367|538317147|FG000|Overall Study|Adverse Event|6|||
149231954|NCT00796367|538317148|FG001|Overall Study|Adverse Event|4|||
149231955|NCT00796367|538317149|FG002|Overall Study|Adverse Event|7|||
149231956|NCT00796367|538317147|FG000|Overall Study|Lost to Follow-up|5|||
149231957|NCT00796367|538317148|FG001|Overall Study|Lost to Follow-up|4|||
149231958|NCT00796367|538317149|FG002|Overall Study|Lost to Follow-up|21|||
149231959|NCT00796367|538317147|FG000|Overall Study|Withdrawal by Subject|9|||
149231960|NCT00796367|538317148|FG001|Overall Study|Withdrawal by Subject|11|||
149231961|NCT00796367|538317149|FG002|Overall Study|Withdrawal by Subject|12|||
148690223|NCT02146430|536340179|FG001|Overall Study|Lack of Efficacy|11|||
148690224|NCT02146430|536340180|FG002|Overall Study|Lack of Efficacy|8|||
149231962|NCT00796367|538317147|FG000|Overall Study|Lack of Efficacy|2|||
149231963|NCT00796367|538317148|FG001|Overall Study|Lack of Efficacy|1|||
149231964|NCT00796367|538317149|FG002|Overall Study|Lack of Efficacy|0|||
148690225|NCT02146430|536340181|FG003|Overall Study|Lack of Efficacy|5|||
148690226|NCT02146430|536340178|FG000|Overall Study|Adverse Event|20|||
148690227|NCT02146430|536340179|FG001|Overall Study|Adverse Event|40|||
148690228|NCT02146430|536340180|FG002|Overall Study|Adverse Event|32|||
148690229|NCT02146430|536340181|FG003|Overall Study|Adverse Event|49|||
148690230|NCT02146430|536340178|FG000|Overall Study|Reason missing or not reported|2|||
148690231|NCT02146430|536340179|FG001|Overall Study|Reason missing or not reported|3|||
148690232|NCT02146430|536340180|FG002|Overall Study|Reason missing or not reported|4|||
148690233|NCT02146430|536340181|FG003|Overall Study|Reason missing or not reported|5|||
148690234|NCT02146430|536340178|FG000|Overall Study|Withdrawal by Subject|27|||
148690235|NCT02146430|536340179|FG001|Overall Study|Withdrawal by Subject|29|||
148690236|NCT02146430|536340180|FG002|Overall Study|Withdrawal by Subject|30|||
148690237|NCT02146430|536340181|FG003|Overall Study|Withdrawal by Subject|34|||
148690238|NCT01893905|536340182|FG000|Overall Study|Withdrawal by Subject|1|||
148690239|NCT01893905|536340183|FG001|Overall Study|Withdrawal by Subject|0|||
148690240|NCT01893905|536340182|FG000|Overall Study|Adverse Event|9|||
148690241|NCT01893905|536340183|FG001|Overall Study|Adverse Event|3|||
148690242|NCT01893905|536340182|FG000|Overall Study|Lack of Efficacy|5|||
148690243|NCT01893905|536340183|FG001|Overall Study|Lack of Efficacy|7|||
148690244|NCT01893905|536340182|FG000|Overall Study|Lost to Follow-up|1|||
148690245|NCT01893905|536340183|FG001|Overall Study|Lost to Follow-up|0|||
148690246|NCT01893905|536340182|FG000|Overall Study|Protocol Violation|6|||
148690247|NCT01893905|536340183|FG001|Overall Study|Protocol Violation|1|||
148690248|NCT01893905|536340182|FG000|Overall Study|Lack of adherence to treatment|2|||
148690249|NCT01893905|536340183|FG001|Overall Study|Lack of adherence to treatment|0|||
148690250|NCT01893905|536340182|FG000|Overall Study|Other reason|1|||
149231965|NCT00796367|538317147|FG000|Overall Study|non compliance|3|||
149231966|NCT00796367|538317148|FG001|Overall Study|non compliance|1|||
149231967|NCT00796367|538317149|FG002|Overall Study|non compliance|1|||
149231968|NCT00796367|538317147|FG000|Overall Study|Pregnancy|1|||
149231969|NCT00796367|538317148|FG001|Overall Study|Pregnancy|0|||
148690251|NCT01893905|536340183|FG001|Overall Study|Other reason|3|||
148690252|NCT01768858|536340184|FG000|Overall Study|Lost to Follow-up|9|||
148690253|NCT01768858|536340184|FG000|Overall Study|Lack of Efficacy|8|||
148690254|NCT01768858|536340184|FG000|Overall Study|Serious Adverse Event|1|||
148690255|NCT01768858|536340184|FG000|Overall Study|Participant moved to Germany|1|||
148690256|NCT01768858|536340184|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
148690257|NCT01768858|536340184|FG000|Overall Study|Exanthema|1|||
148690258|NCT01768858|536340184|FG000|Overall Study|Withdrawal by Subject|1|||
148690259|NCT03093324|536340186|FG000|Overall Study|Adverse Event|4|||
148690260|NCT03093324|536340187|FG001|Overall Study|Adverse Event|15|||
148690261|NCT03093324|536340186|FG000|Overall Study|Lost to Follow-up|1|||
148690262|NCT03093324|536340187|FG001|Overall Study|Lost to Follow-up|0|||
148690263|NCT03093324|536340186|FG000|Overall Study|Protocol Deviation|2|||
148690264|NCT03093324|536340187|FG001|Overall Study|Protocol Deviation|2|||
148690265|NCT03093324|536340186|FG000|Overall Study|Withdrawal by Subject|2|||
148810686|NCT03881371|536784566|FG001|Overall Study|Lost to Follow-up|0|||
148690266|NCT03093324|536340187|FG001|Overall Study|Withdrawal by Subject|2|||
148690267|NCT00421174|536340192|FG000|Overall Study|Withdrawal by Subject|0|||
148690268|NCT00421174|536340193|FG001|Overall Study|Withdrawal by Subject|1|||
148690269|NCT00421174|536340192|FG000|Overall Study|Ineligible due to infection|2|||
148690270|NCT00421174|536340193|FG001|Overall Study|Ineligible due to infection|0|||
148690271|NCT00992407|536340194|FG000|Overall Study|Protocol Violation|2|||
148690272|NCT00992407|536340195|FG001|Overall Study|Protocol Violation|1|||
148690273|NCT00992407|536340194|FG000|Overall Study|Lost to Follow-up|3|||
148690274|NCT00992407|536340195|FG001|Overall Study|Lost to Follow-up|3|||
148690275|NCT00992407|536340194|FG000|Overall Study|Adverse Event|3|||
149231970|NCT00796367|538317149|FG002|Overall Study|Pregnancy|1|||
149231971|NCT00796367|538317147|FG000|Overall Study|Requirement for restricted medication|2|||
149231972|NCT00796367|538317148|FG001|Overall Study|Requirement for restricted medication|0|||
149231973|NCT00796367|538317149|FG002|Overall Study|Requirement for restricted medication|2|||
149231974|NCT00796367|538317147|FG000|Overall Study|other|2|||
149231975|NCT00796367|538317148|FG001|Overall Study|other|4|||
149231976|NCT00796367|538317149|FG002|Overall Study|other|3|||
149231977|NCT02370173|538317158|FG000|Overall Study|Protocol Violation|1|||
149231978|NCT02370173|538317159|FG001|Overall Study|Protocol Violation|1|||
149231979|NCT02370173|538317158|FG000|Overall Study|Withdrawal by Subject|2|||
149231980|NCT02370173|538317159|FG001|Overall Study|Withdrawal by Subject|2|||
149231981|NCT00307736|538317167|FG000|Overall Study|Adverse Event|0|||
149231982|NCT00307736|538317168|FG001|Overall Study|Adverse Event|0|||
149231983|NCT00307736|538317169|FG002|Overall Study|Adverse Event|1|||
149231984|NCT00307736|538317170|FG003|Overall Study|Adverse Event|3|||
149231985|NCT00307736|538317167|FG000|Overall Study|Withdrawal by Subject|0|||
149231986|NCT00307736|538317168|FG001|Overall Study|Withdrawal by Subject|0|||
149231987|NCT00307736|538317169|FG002|Overall Study|Withdrawal by Subject|2|||
149231988|NCT00307736|538317170|FG003|Overall Study|Withdrawal by Subject|0|||
149231989|NCT00736840|538317172|FG000|Overall Study|Lost to Follow-up|13|||
149231990|NCT01411917|538317173|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
149231991|NCT01411917|538317174|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
149231992|NCT01087944|538317195|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
149231993|NCT01087944|538317196|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
149231994|NCT01087944|538317195|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
149231995|NCT01087944|538317196|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
149231996|NCT00553319|538317197|FG000|Overall Study|Lost to Follow-up|10|||
149231997|NCT00553319|538317198|FG001|Overall Study|Lost to Follow-up|9|||
149231998|NCT00553319|538317199|FG002|Overall Study|Lost to Follow-up|5|||
149231999|NCT00553319|538317197|FG000|Overall Study|wanted treatment elsewhere|2|||
149232000|NCT00553319|538317198|FG001|Overall Study|wanted treatment elsewhere|1|||
149232001|NCT00553319|538317199|FG002|Overall Study|wanted treatment elsewhere|1|||
149232002|NCT00553319|538317197|FG000|Overall Study|non-compliance|0|||
149232003|NCT00553319|538317198|FG001|Overall Study|non-compliance|0|||
149232004|NCT00553319|538317199|FG002|Overall Study|non-compliance|2|||
149232005|NCT00553319|538317197|FG000|Overall Study|incarceration|1|||
149232006|NCT00553319|538317198|FG001|Overall Study|incarceration|0|||
149232007|NCT00553319|538317199|FG002|Overall Study|incarceration|0|||
149232008|NCT00553319|538317197|FG000|Overall Study|moved|1|||
149232009|NCT00553319|538317198|FG001|Overall Study|moved|0|||
149232010|NCT00553319|538317199|FG002|Overall Study|moved|1|||
149232011|NCT01731600|538317205|FG000|Overall Study|Adverse Event|2|||
149232012|NCT01731600|538317206|FG001|Overall Study|Adverse Event|0|||
149232013|NCT01731600|538317205|FG000|Overall Study|Withdrawal criteria|1|||
149232014|NCT01731600|538317206|FG001|Overall Study|Withdrawal criteria|0|||
149232015|NCT01731600|538317205|FG000|Overall Study|Other reasons|3|||
148810687|NCT03881371|536784565|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149232016|NCT01731600|538317206|FG001|Overall Study|Other reasons|0|||
149232017|NCT03575975|538317207|FG000|Overall Study|Lost to Follow-up|1|||
149232018|NCT03575975|538317208|FG001|Overall Study|Lost to Follow-up|0|||
149232019|NCT03575975|538317209|FG002|Overall Study|Lost to Follow-up|0|||
149232020|NCT00465894|538317212|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
149232021|NCT00465894|538317213|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
149232022|NCT00465894|538317212|FG000|Treatment For 12 Weeks|Family Issues|1|||
149232023|NCT00465894|538317213|FG001|Treatment For 12 Weeks|Family Issues|1|||
149232024|NCT00465894|538317212|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
149232025|NCT00465894|538317213|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
149232026|NCT01636076|538317214|FG000|Overall Study|Terminated by sponsor|1|||
149232027|NCT01636076|538317215|FG001|Overall Study|Terminated by sponsor|1|||
149232028|NCT01636076|538317214|FG000|Overall Study|Lack of Efficacy|0|||
149232029|NCT01636076|538317215|FG001|Overall Study|Lack of Efficacy|1|||
149232030|NCT01636076|538317214|FG000|Overall Study|Lost to Follow-up|1|||
149232031|NCT01636076|538317215|FG001|Overall Study|Lost to Follow-up|0|||
149232032|NCT01636076|538317214|FG000|Overall Study|Physician Decision|1|||
149232033|NCT01636076|538317215|FG001|Overall Study|Physician Decision|1|||
149232034|NCT01636076|538317214|FG000|Overall Study|Non-compliance with study treatment|1|||
149232035|NCT01636076|538317215|FG001|Overall Study|Non-compliance with study treatment|1|||
149232036|NCT01636076|538317214|FG000|Overall Study|Adverse Event|6|||
149232037|NCT01636076|538317215|FG001|Overall Study|Adverse Event|11|||
149232038|NCT01636076|538317214|FG000|Overall Study|Withdrawal by Subject|7|||
149232039|NCT01636076|538317215|FG001|Overall Study|Withdrawal by Subject|10|||
149232040|NCT01159665|538317216|FG000|Overall Study|Withdrawal by Subject|0|||
149232041|NCT01159665|538317217|FG001|Overall Study|Withdrawal by Subject|1|||
149232042|NCT01159665|538317218|FG002|Overall Study|Withdrawal by Subject|0|||
149232043|NCT01159665|538317219|FG003|Overall Study|Withdrawal by Subject|0|||
149232044|NCT01159665|538317220|FG004|Overall Study|Withdrawal by Subject|0|||
149232045|NCT01159665|538317221|FG005|Overall Study|Withdrawal by Subject|0|||
149232046|NCT00129220|538317224|FG000|Study Period II|Adverse Event|9|||
149232047|NCT00129220|538317225|FG001|Study Period II|Adverse Event|5|||
149232048|NCT00129220|538317226|FG002|Study Period II|Adverse Event|7|||
149232049|NCT00129220|538317224|FG000|Study Period II|Lack of Efficacy|15|||
149232050|NCT00129220|538317225|FG001|Study Period II|Lack of Efficacy|1|||
149232051|NCT00129220|538317226|FG002|Study Period II|Lack of Efficacy|28|||
149232052|NCT00129220|538317224|FG000|Study Period II|Entry Criteria Not Met|2|||
148690276|NCT00992407|536340195|FG001|Overall Study|Adverse Event|2|||
148690277|NCT00992407|536340194|FG000|Overall Study|protocol Violation & Adverse events|2|||
148690278|NCT00992407|536340195|FG001|Overall Study|protocol Violation & Adverse events|4|||
148690279|NCT00992407|536340194|FG000|Overall Study|Other|2|||
148690280|NCT00992407|536340195|FG001|Overall Study|Other|0|||
148690281|NCT00992407|536340194|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
149232053|NCT00129220|538317225|FG001|Study Period II|Entry Criteria Not Met|0|||
149232054|NCT00129220|538317226|FG002|Study Period II|Entry Criteria Not Met|2|||
149232055|NCT00129220|538317224|FG000|Study Period II|Protocol Violation|4|||
149232056|NCT00129220|538317225|FG001|Study Period II|Protocol Violation|2|||
149232057|NCT00129220|538317226|FG002|Study Period II|Protocol Violation|1|||
149232058|NCT00129220|538317224|FG000|Study Period II|Physician Decision|0|||
149232059|NCT00129220|538317225|FG001|Study Period II|Physician Decision|1|||
149232060|NCT00129220|538317226|FG002|Study Period II|Physician Decision|0|||
149232061|NCT00129220|538317224|FG000|Study Period II|Withdrawal by Subject|1|||
149232062|NCT00129220|538317225|FG001|Study Period II|Withdrawal by Subject|3|||
149232063|NCT00129220|538317226|FG002|Study Period II|Withdrawal by Subject|4|||
149232064|NCT00129220|538317224|FG000|Study Period II|Reason Not Specified|2|||
149232065|NCT00129220|538317225|FG001|Study Period II|Reason Not Specified|0|||
149232066|NCT00129220|538317226|FG002|Study Period II|Reason Not Specified|5|||
149232067|NCT00129220|538317224|FG000|Study Period III|Adverse Event|1|||
149232068|NCT00129220|538317225|FG001|Study Period III|Adverse Event|0|||
149232069|NCT00129220|538317226|FG002|Study Period III|Adverse Event|3|||
149232070|NCT00129220|538317224|FG000|Study Period III|Protocol Violation|1|||
149232071|NCT00129220|538317225|FG001|Study Period III|Protocol Violation|1|||
149232072|NCT00129220|538317226|FG002|Study Period III|Protocol Violation|2|||
149232073|NCT00129220|538317224|FG000|Study Period III|Withdrawal by Subject|1|||
149232074|NCT00129220|538317225|FG001|Study Period III|Withdrawal by Subject|0|||
149232075|NCT00129220|538317226|FG002|Study Period III|Withdrawal by Subject|3|||
149232076|NCT00129220|538317224|FG000|Study Period III|Sponsor Decision|1|||
149232077|NCT00129220|538317225|FG001|Study Period III|Sponsor Decision|0|||
149232078|NCT00129220|538317226|FG002|Study Period III|Sponsor Decision|0|||
149232079|NCT00129220|538317224|FG000|Study Period III|Reason Not Specified|9|||
149232080|NCT00129220|538317225|FG001|Study Period III|Reason Not Specified|0|||
149232081|NCT00129220|538317226|FG002|Study Period III|Reason Not Specified|2|||
149232082|NCT00540228|538317227|FG000|Overall Study|Adverse Event|2|||
149232083|NCT00540228|538317228|FG001|Overall Study|Adverse Event|0|||
149232084|NCT00540228|538317229|FG002|Overall Study|Adverse Event|0|||
149232085|NCT00540228|538317230|FG003|Overall Study|Adverse Event|0|||
149232086|NCT00540228|538317231|FG004|Overall Study|Adverse Event|0|||
149232087|NCT00540228|538317227|FG000|Overall Study|Lost to Follow-up|1|||
149232088|NCT00540228|538317228|FG001|Overall Study|Lost to Follow-up|1|||
149232089|NCT00540228|538317229|FG002|Overall Study|Lost to Follow-up|0|||
149232090|NCT00540228|538317230|FG003|Overall Study|Lost to Follow-up|0|||
149232091|NCT00540228|538317231|FG004|Overall Study|Lost to Follow-up|0|||
149232092|NCT01883362|538317232|FG000|Treatment|Adverse Event|1|||
149232093|NCT01883362|538317233|FG001|Treatment|Adverse Event|8|||
149232094|NCT01883362|538317232|FG000|Treatment|Withdrawal by Subject|6|||
149232095|NCT01883362|538317233|FG001|Treatment|Withdrawal by Subject|2|||
149232096|NCT01883362|538317232|FG000|Treatment|Administrative problems|4|||
149232097|NCT01883362|538317233|FG001|Treatment|Administrative problems|1|||
149232098|NCT01883362|538317232|FG000|Treatment|Relapse|4|||
149232099|NCT01883362|538317233|FG001|Treatment|Relapse|2|||
149232100|NCT01883362|538317232|FG000|Treatment|Randomized, not treated|1|||
149232101|NCT01883362|538317233|FG001|Treatment|Randomized, not treated|1|||
149232102|NCT01883362|538317232|FG000|Post Treatment Follow-up|Protocol Violation|0|||
149232103|NCT01883362|538317233|FG001|Post Treatment Follow-up|Protocol Violation|1|||
149232104|NCT01883362|538317232|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
149232105|NCT01883362|538317233|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
149232106|NCT01883362|538317232|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
149232107|NCT01883362|538317233|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
149232108|NCT01883362|538317232|FG000|Post Treatment Follow-up|Administrative problems|2|||
149232109|NCT01883362|538317233|FG001|Post Treatment Follow-up|Administrative problems|0|||
149232110|NCT01883362|538317232|FG000|Post Treatment Follow-up|Death|8|||
149232111|NCT01883362|538317233|FG001|Post Treatment Follow-up|Death|4|||
149232112|NCT01883362|538317232|FG000|Post Treatment Follow-up|Relapse|1|||
149232113|NCT01883362|538317233|FG001|Post Treatment Follow-up|Relapse|2|||
149232114|NCT01230489|538317235|FG000|Overall Study|Death|2|||
149232115|NCT01230489|538317235|FG000|Overall Study|Adverse Event|2|||
149232116|NCT01230489|538317235|FG000|Overall Study|Treatment modality changed|1|||
149232117|NCT02451137|538317236|FG000|Overall Study|Randomized but not treated|19|||
149232118|NCT02451137|538317237|FG001|Overall Study|Randomized but not treated|27|||
149232119|NCT02451137|538317236|FG000|Overall Study|Adverse Event|43|||
149232120|NCT02451137|538317237|FG001|Overall Study|Adverse Event|42|||
149232121|NCT02451137|538317236|FG000|Overall Study|Lack of Efficacy|4|||
149232122|NCT02451137|538317237|FG001|Overall Study|Lack of Efficacy|9|||
149020361|NCT02268552|537552630|FG004|Part 1|Death|0|||
149232123|NCT02451137|538317236|FG000|Overall Study|Participant decision:discontinue insulin|41|||
149232124|NCT02451137|538317237|FG001|Overall Study|Participant decision:discontinue insulin|43|||
149232125|NCT02451137|538317236|FG000|Overall Study|Hypoglycemia|2|||
149232126|NCT02451137|538317237|FG001|Overall Study|Hypoglycemia|1|||
149232127|NCT02451137|538317236|FG000|Overall Study|Investigator's decision|23|||
149232128|NCT02451137|538317237|FG001|Overall Study|Investigator's decision|19|||
149232129|NCT02451137|538317236|FG000|Overall Study|Lost to Follow-up|53|||
149232130|NCT02451137|538317237|FG001|Overall Study|Lost to Follow-up|61|||
149232131|NCT02451137|538317236|FG000|Overall Study|Physician Decision|6|||
149232132|NCT02451137|538317237|FG001|Overall Study|Physician Decision|5|||
149232133|NCT02451137|538317236|FG000|Overall Study|Sponsor decision|13|||
149232134|NCT02451137|538317237|FG001|Overall Study|Sponsor decision|25|||
149232135|NCT02451137|538317236|FG000|Overall Study|Withdrawal by Subject|40|||
149232136|NCT02451137|538317237|FG001|Overall Study|Withdrawal by Subject|63|||
149232137|NCT02451137|538317236|FG000|Overall Study|Other than specified above|2|||
149232138|NCT02451137|538317237|FG001|Overall Study|Other than specified above|3|||
149232139|NCT01977573|538317240|FG000|Overall Study|Adverse Event|7|||
149232140|NCT01977573|538317241|FG001|Overall Study|Adverse Event|0|||
149232141|NCT01977573|538317242|FG002|Overall Study|Adverse Event|2|||
149232142|NCT01977573|538317243|FG003|Overall Study|Adverse Event|1|||
149232143|NCT01977573|538317240|FG000|Overall Study|Lost to Follow-up|1|||
149232144|NCT01977573|538317241|FG001|Overall Study|Lost to Follow-up|0|||
149232145|NCT01977573|538317242|FG002|Overall Study|Lost to Follow-up|0|||
149232146|NCT01977573|538317243|FG003|Overall Study|Lost to Follow-up|1|||
149232147|NCT01977573|538317240|FG000|Overall Study|Physician Decision|1|||
149232148|NCT01977573|538317241|FG001|Overall Study|Physician Decision|0|||
149232149|NCT01977573|538317242|FG002|Overall Study|Physician Decision|0|||
149232150|NCT01977573|538317243|FG003|Overall Study|Physician Decision|0|||
149232151|NCT01977573|538317240|FG000|Overall Study|Protocol Violation|3|||
149232152|NCT01977573|538317241|FG001|Overall Study|Protocol Violation|1|||
149232153|NCT01977573|538317242|FG002|Overall Study|Protocol Violation|0|||
149232154|NCT01977573|538317243|FG003|Overall Study|Protocol Violation|0|||
149232155|NCT01977573|538317240|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
149232156|NCT01977573|538317241|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
149232157|NCT01977573|538317242|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
149232158|NCT01977573|538317243|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
149232159|NCT01977573|538317240|FG000|Overall Study|Withdrawal by Subject|6|||
149232160|NCT01977573|538317241|FG001|Overall Study|Withdrawal by Subject|1|||
149232161|NCT01977573|538317242|FG002|Overall Study|Withdrawal by Subject|1|||
149232162|NCT01977573|538317243|FG003|Overall Study|Withdrawal by Subject|1|||
149232163|NCT01302366|538318654|FG000|Overall Study|patient choice or noncompliance|5|||
149232164|NCT01541644|538318661|FG000|Overall Study|Withdrawal by Subject|3|||
149232165|NCT00463385|538318665|FG000|Overall Study|Other|4|||
149232166|NCT00463385|538318666|FG001|Overall Study|Other|3|||
149232167|NCT00463385|538318667|FG002|Overall Study|Other|6|||
149232168|NCT00463385|538318668|FG003|Overall Study|Other|4|||
149232169|NCT00463385|538318665|FG000|Overall Study|Adverse Event|5|||
149232170|NCT00463385|538318666|FG001|Overall Study|Adverse Event|8|||
149232171|NCT00463385|538318667|FG002|Overall Study|Adverse Event|4|||
149232172|NCT00463385|538318668|FG003|Overall Study|Adverse Event|2|||
149232173|NCT00463385|538318665|FG000|Overall Study|Lack of Efficacy|6|||
149232174|NCT00463385|538318666|FG001|Overall Study|Lack of Efficacy|6|||
149232175|NCT00463385|538318667|FG002|Overall Study|Lack of Efficacy|7|||
149232176|NCT00463385|538318668|FG003|Overall Study|Lack of Efficacy|9|||
149232177|NCT00463385|538318665|FG000|Overall Study|Withdrawal by Subject|3|||
149232178|NCT00463385|538318666|FG001|Overall Study|Withdrawal by Subject|3|||
149232179|NCT00463385|538318667|FG002|Overall Study|Withdrawal by Subject|3|||
149232180|NCT00463385|538318668|FG003|Overall Study|Withdrawal by Subject|4|||
149232181|NCT00463385|538318665|FG000|Overall Study|Lost to Follow-up|0|||
149232182|NCT00463385|538318666|FG001|Overall Study|Lost to Follow-up|0|||
149232183|NCT00463385|538318667|FG002|Overall Study|Lost to Follow-up|0|||
149232184|NCT00463385|538318668|FG003|Overall Study|Lost to Follow-up|1|||
149232185|NCT00463385|538318665|FG000|Overall Study|Death|2|||
149232186|NCT00463385|538318666|FG001|Overall Study|Death|1|||
149232187|NCT00463385|538318667|FG002|Overall Study|Death|2|||
149232188|NCT00463385|538318668|FG003|Overall Study|Death|0|||
149232189|NCT00463385|538318665|FG000|Overall Study|Missing|2|||
149232190|NCT00463385|538318666|FG001|Overall Study|Missing|0|||
149232191|NCT00463385|538318667|FG002|Overall Study|Missing|0|||
149232192|NCT00463385|538318668|FG003|Overall Study|Missing|2|||
149232193|NCT00463385|538318665|FG000|Overall Study|1 participant received commercial drug|0|||
149232194|NCT00463385|538318666|FG001|Overall Study|1 participant received commercial drug|1|||
149232195|NCT00463385|538318667|FG002|Overall Study|1 participant received commercial drug|0|||
149232196|NCT00463385|538318668|FG003|Overall Study|1 participant received commercial drug|0|||
149232197|NCT00798161|538318669|FG000|Overall Study|Adverse Event|3|||
149232198|NCT00798161|538318670|FG001|Overall Study|Adverse Event|4|||
149232199|NCT00798161|538318671|FG002|Overall Study|Adverse Event|6|||
149232200|NCT00798161|538318672|FG003|Overall Study|Adverse Event|6|||
149232201|NCT00798161|538318673|FG004|Overall Study|Adverse Event|5|||
149232202|NCT00798161|538318674|FG005|Overall Study|Adverse Event|2|||
149232203|NCT00798161|538318675|FG006|Overall Study|Adverse Event|4|||
149232204|NCT00798161|538318669|FG000|Overall Study|Protocol Violation|2|||
149232205|NCT00798161|538318670|FG001|Overall Study|Protocol Violation|1|||
149232206|NCT00798161|538318671|FG002|Overall Study|Protocol Violation|3|||
149232207|NCT00798161|538318672|FG003|Overall Study|Protocol Violation|3|||
149232208|NCT00798161|538318673|FG004|Overall Study|Protocol Violation|3|||
149232209|NCT00798161|538318674|FG005|Overall Study|Protocol Violation|2|||
149232210|NCT00798161|538318675|FG006|Overall Study|Protocol Violation|0|||
149232211|NCT00798161|538318669|FG000|Overall Study|Lost to Follow-up|1|||
149232212|NCT00798161|538318670|FG001|Overall Study|Lost to Follow-up|3|||
149232213|NCT00798161|538318671|FG002|Overall Study|Lost to Follow-up|4|||
149232214|NCT00798161|538318672|FG003|Overall Study|Lost to Follow-up|3|||
149232215|NCT00798161|538318673|FG004|Overall Study|Lost to Follow-up|4|||
149232216|NCT00798161|538318674|FG005|Overall Study|Lost to Follow-up|0|||
149232217|NCT00798161|538318675|FG006|Overall Study|Lost to Follow-up|0|||
149232218|NCT00798161|538318669|FG000|Overall Study|Withdrawal by Subject|5|||
149232219|NCT00798161|538318670|FG001|Overall Study|Withdrawal by Subject|4|||
149232220|NCT00798161|538318671|FG002|Overall Study|Withdrawal by Subject|5|||
149232221|NCT00798161|538318672|FG003|Overall Study|Withdrawal by Subject|4|||
149232222|NCT00798161|538318673|FG004|Overall Study|Withdrawal by Subject|2|||
149232223|NCT00798161|538318674|FG005|Overall Study|Withdrawal by Subject|3|||
149232224|NCT00798161|538318675|FG006|Overall Study|Withdrawal by Subject|1|||
149232225|NCT00798161|538318669|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
149232226|NCT00798161|538318670|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
149232227|NCT00798161|538318671|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
149232228|NCT00798161|538318672|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
149232229|NCT00798161|538318673|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
149232230|NCT00798161|538318674|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
149232231|NCT00798161|538318675|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
149232232|NCT00344968|538318676|FG000|Overall Study|Adverse Event|5|||
149232233|NCT00344968|538318677|FG001|Overall Study|Adverse Event|4|||
149232234|NCT00344968|538318678|FG002|Overall Study|Adverse Event|15|||
149232235|NCT00344968|538318676|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
149232236|NCT00344968|538318677|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149232237|NCT00344968|538318678|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
149232238|NCT00344968|538318676|FG000|Overall Study|Protocol Violation|2|||
149232239|NCT00344968|538318677|FG001|Overall Study|Protocol Violation|2|||
149232240|NCT00344968|538318678|FG002|Overall Study|Protocol Violation|5|||
149232241|NCT00344968|538318676|FG000|Overall Study|Withdrawal by Subject|14|||
149232242|NCT00344968|538318677|FG001|Overall Study|Withdrawal by Subject|31|||
149232243|NCT00344968|538318678|FG002|Overall Study|Withdrawal by Subject|27|||
149232244|NCT00344968|538318676|FG000|Overall Study|Lost to Follow-up|24|||
149232245|NCT00344968|538318677|FG001|Overall Study|Lost to Follow-up|37|||
149232246|NCT00344968|538318678|FG002|Overall Study|Lost to Follow-up|37|||
149232247|NCT00344968|538318676|FG000|Overall Study|Death|11|||
149232248|NCT00344968|538318677|FG001|Overall Study|Death|27|||
149232249|NCT00344968|538318678|FG002|Overall Study|Death|31|||
149232250|NCT00344968|538318676|FG000|Overall Study|Other|0|||
149232251|NCT00344968|538318677|FG001|Overall Study|Other|1|||
149232252|NCT00344968|538318678|FG002|Overall Study|Other|0|||
149232253|NCT03735680|538318679|FG000|Overall Study|Withdrawal by Subject|0|||
149232254|NCT03735680|538318680|FG001|Overall Study|Withdrawal by Subject|1|||
149232255|NCT03735680|538318681|FG002|Overall Study|Withdrawal by Subject|0|||
149232256|NCT03735680|538318682|FG003|Overall Study|Withdrawal by Subject|0|||
149232257|NCT03735680|538318683|FG004|Overall Study|Withdrawal by Subject|0|||
149232258|NCT03735680|538318684|FG005|Overall Study|Withdrawal by Subject|1|||
149232259|NCT03735680|538318679|FG000|Overall Study|Patient unable or unwilling to continue|0|||
149232260|NCT03735680|538318680|FG001|Overall Study|Patient unable or unwilling to continue|0|||
149232261|NCT03735680|538318681|FG002|Overall Study|Patient unable or unwilling to continue|1|||
149232262|NCT03735680|538318682|FG003|Overall Study|Patient unable or unwilling to continue|0|||
149232263|NCT03735680|538318683|FG004|Overall Study|Patient unable or unwilling to continue|0|||
149232264|NCT03735680|538318684|FG005|Overall Study|Patient unable or unwilling to continue|0|||
149232265|NCT00503035|538318696|FG000|Overall Study|Lost to Follow-up|2|||
149232266|NCT00503035|538318696|FG000|Overall Study|Physician Decision|3|||
149232267|NCT00503035|538318696|FG000|Overall Study|Ineligible|15|||
149232268|NCT04001790|538318697|FG000|Overall Study|Withdrawal by Subject|1|||
149232269|NCT04001790|538318698|FG001|Overall Study|Withdrawal by Subject|2|||
149232270|NCT05028816|538318700|FG000|Overall Study|Lost to Follow-up|5|||
149232271|NCT05028816|538318701|FG001|Overall Study|Lost to Follow-up|3|||
149232272|NCT05028816|538318700|FG000|Overall Study|Withdrawal by Subject|4|||
149232273|NCT05028816|538318701|FG001|Overall Study|Withdrawal by Subject|1|||
149232274|NCT05028816|538318700|FG000|Overall Study|Physician Decision|1|||
149232275|NCT05028816|538318701|FG001|Overall Study|Physician Decision|0|||
149232276|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Adverse Event|4|||
148810688|NCT03881371|536784566|FG001|Overall Study|Non-Compliance with Study Drug|2|||
149232277|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Adverse Event|3|||
149232278|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Adverse Event|0|||
149232279|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Adverse Event|0|||
149232280|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Death|24|||
149232281|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Death|9|||
149232282|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Death|0|||
149232283|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Death|0|||
149232284|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
149232285|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
149232286|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
149232287|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
149232288|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Physician Decision|4|||
149232289|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Physician Decision|1|||
149232290|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Physician Decision|0|||
149232291|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Physician Decision|0|||
149232292|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Progressive disease|1|||
149232293|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Progressive disease|0|||
149232294|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Progressive disease|0|||
149232295|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Progressive disease|0|||
149232296|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
149232297|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
149232298|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
149232299|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
149232300|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
149232301|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
149232302|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
149232303|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
149232304|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
149232305|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
149232306|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
149232307|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
149232308|NCT04579666|538318703|FG000|RTP (Up to Week 52)|Other|2|||
149232309|NCT04579666|538318704|FG001|RTP (Up to Week 52)|Other|0|||
149232310|NCT04579666|538318705|FG002|RTP (Up to Week 52)|Other|0|||
149232311|NCT04579666|538318706|FG003|RTP (Up to Week 52)|Other|0|||
149232312|NCT04579666|538318703|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
149232313|NCT04579666|538318704|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
149232314|NCT04579666|538318705|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
149232315|NCT04579666|538318706|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
149232316|NCT04579666|538318703|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
149232317|NCT04579666|538318704|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
149232318|NCT04579666|538318705|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
149232319|NCT04579666|538318706|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
149232320|NCT04579666|538318703|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
149232321|NCT04579666|538318704|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
149232322|NCT04579666|538318705|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
149232323|NCT04579666|538318706|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
149232324|NCT04579666|538318703|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
149232325|NCT04579666|538318704|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
149232326|NCT04579666|538318705|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
149232327|NCT04579666|538318706|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
149232328|NCT04579666|538318703|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
149232329|NCT04579666|538318704|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
149232330|NCT04579666|538318705|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
149232331|NCT04579666|538318706|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
149232332|NCT04576702|538318707|FG000|Overall Study|Death|1|||
149232333|NCT04576702|538318708|FG001|Overall Study|Death|0|||
149232334|NCT04576702|538318709|FG002|Overall Study|Death|0|||
149232335|NCT04576702|538318710|FG003|Overall Study|Death|0|||
149232336|NCT04576702|538318707|FG000|Overall Study|Withdrawal by Subject|0|||
149232337|NCT04576702|538318708|FG001|Overall Study|Withdrawal by Subject|2|||
149020362|NCT02268552|537552631|FG005|Part 1|Death|0|||
149232338|NCT04576702|538318709|FG002|Overall Study|Withdrawal by Subject|1|||
149232339|NCT04576702|538318710|FG003|Overall Study|Withdrawal by Subject|0|||
149020363|NCT02268552|537552632|FG006|Part 1|Death|0|||
149232340|NCT04576702|538318707|FG000|Overall Study|Lost to Follow-up|3|||
149232341|NCT04576702|538318708|FG001|Overall Study|Lost to Follow-up|3|||
149232342|NCT04576702|538318709|FG002|Overall Study|Lost to Follow-up|3|||
149232343|NCT04576702|538318710|FG003|Overall Study|Lost to Follow-up|4|||
149232344|NCT00465101|538318711|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
149232345|NCT00465101|538318711|FG000|Overall Study|Change in health precluded follow up|4|||
149232346|NCT00465101|538318711|FG000|Overall Study|Did not meet study criteria|4|||
149232347|NCT00465101|538318711|FG000|Overall Study|Lost to Follow-up|5|||
149232348|NCT00465101|538318711|FG000|Overall Study|Other|6|||
149232349|NCT00465101|538318711|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
149232350|NCT00465101|538318711|FG000|Overall Study|Patient postponed procedure|1|||
149232351|NCT00465101|538318711|FG000|Overall Study|Site closed due to IRB expiration|1|||
149232352|NCT00465101|538318711|FG000|Overall Study|Unable to obtain IRB approval|1|||
149232353|NCT00465101|538318711|FG000|Overall Study|Death|3|||
149232354|NCT00465101|538318711|FG000|Overall Study|Withdrawal by Subject|25|||
149232355|NCT00465101|538318711|FG000|Overall Study|Physician Decision|1|||
149232356|NCT00465101|538318711|FG000|Overall Study|Withdrew consent prior to procedure|3|||
149232357|NCT03099096|538318712|FG000|Overall Study|Adverse Event|1|||
149232358|NCT03099096|538318712|FG000|Overall Study|Physician Decision|1|||
149232359|NCT02985996|538318717|FG000|Overall Study|Withdrawal by Subject|0|||
149232360|NCT02985996|538318718|FG001|Overall Study|Withdrawal by Subject|0|||
149232361|NCT02985996|538318719|FG002|Overall Study|Withdrawal by Subject|1|||
149232362|NCT02985996|538318720|FG003|Overall Study|Withdrawal by Subject|0|||
149232363|NCT02985996|538318721|FG004|Overall Study|Withdrawal by Subject|0|||
149232364|NCT02985996|538318717|FG000|Overall Study|Protocol Violation|0|||
149232365|NCT02985996|538318718|FG001|Overall Study|Protocol Violation|1|||
149232366|NCT02985996|538318719|FG002|Overall Study|Protocol Violation|0|||
149232367|NCT02985996|538318720|FG003|Overall Study|Protocol Violation|0|||
149232368|NCT02985996|538318721|FG004|Overall Study|Protocol Violation|0|||
149232369|NCT00401726|538318722|FG000|Overall Study|Adverse Event|34|||
149232370|NCT00401726|538318723|FG001|Overall Study|Adverse Event|45|||
149232371|NCT00401726|538318722|FG000|Overall Study|Death|0|||
149232372|NCT00401726|538318723|FG001|Overall Study|Death|3|||
149232373|NCT00401726|538318722|FG000|Overall Study|Sponsor Request|0|||
149232374|NCT00401726|538318723|FG001|Overall Study|Sponsor Request|1|||
149232375|NCT00401726|538318722|FG000|Overall Study|Physician Decision|3|||
149232376|NCT00401726|538318723|FG001|Overall Study|Physician Decision|6|||
149232377|NCT00401726|538318722|FG000|Overall Study|Lost to Follow-up|23|||
149232378|NCT00401726|538318723|FG001|Overall Study|Lost to Follow-up|20|||
149232379|NCT00401726|538318722|FG000|Overall Study|Protocol Violation|6|||
149232380|NCT00401726|538318723|FG001|Overall Study|Protocol Violation|3|||
149232381|NCT00401726|538318722|FG000|Overall Study|Withdrawal by Subject|18|||
149232382|NCT00401726|538318723|FG001|Overall Study|Withdrawal by Subject|24|||
149232383|NCT00401726|538318722|FG000|Overall Study|Lack of Efficacy|4|||
149232384|NCT00401726|538318723|FG001|Overall Study|Lack of Efficacy|6|||
149232385|NCT00401726|538318722|FG000|Overall Study|Protocol Deviation|9|||
149232386|NCT00401726|538318723|FG001|Overall Study|Protocol Deviation|4|||
149232387|NCT02067728|538318724|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
149232388|NCT02067728|538318725|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
149232389|NCT02067728|538318724|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
149232390|NCT02067728|538318725|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
149232391|NCT02067728|538318724|FG000|6 Month Measurements|Unable to attend|114|||
149232392|NCT02067728|538318725|FG001|6 Month Measurements|Unable to attend|97|||
149232393|NCT03532048|538318728|FG000|Overall Study|Lost to Follow-up|12|||
149232394|NCT03532048|538318729|FG001|Overall Study|Lost to Follow-up|17|||
149232395|NCT03532048|538318728|FG000|Overall Study|Withdrawal by Subject|7|||
149232396|NCT03532048|538318729|FG001|Overall Study|Withdrawal by Subject|0|||
149232397|NCT04629534|538318730|FG000|Overall Study|Physician Decision|1|||
149232398|NCT04629534|538318731|FG001|Overall Study|Physician Decision|0|||
149232399|NCT04629534|538318730|FG000|Overall Study|Protocol Violation|0|||
149232400|NCT04629534|538318731|FG001|Overall Study|Protocol Violation|2|||
149232401|NCT01901393|538318732|FG000|Overall Study|Adverse Event|1|||
149232402|NCT01901393|538318733|FG001|Overall Study|Adverse Event|0|||
148690282|NCT00992407|536340195|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
148690283|NCT00992407|536340194|FG000|Overall Study|Study medication not administered|17|||
148690284|NCT00992407|536340195|FG001|Overall Study|Study medication not administered|13|||
149232403|NCT04113746|538318738|FG000|Overall Study|Lost to Follow-up|4|||
149232404|NCT04113746|538318739|FG001|Overall Study|Lost to Follow-up|4|||
149232405|NCT03125382|538318740|FG000|Randomization|screening failure|1|||
149232406|NCT03125382|538318741|FG001|Randomization|screening failure|4|||
149232407|NCT03125382|538318742|FG002|Randomization|screening failure|2|||
149232408|NCT03125382|538318743|FG003|Randomization|screening failure|0|||
149232409|NCT03125382|538318740|FG000|Follow-up|Death|1|||
149232410|NCT03125382|538318741|FG001|Follow-up|Death|2|||
149232411|NCT03125382|538318742|FG002|Follow-up|Death|1|||
149232412|NCT03125382|538318743|FG003|Follow-up|Death|2|||
149232413|NCT03125382|538318740|FG000|Follow-up|Lost to Follow-up|1|||
149232414|NCT03125382|538318741|FG001|Follow-up|Lost to Follow-up|4|||
149232415|NCT03125382|538318742|FG002|Follow-up|Lost to Follow-up|3|||
149232416|NCT03125382|538318743|FG003|Follow-up|Lost to Follow-up|1|||
149232417|NCT04246593|538318748|FG000|Overall Study|Withdrawal by Subject|14|||
149232418|NCT04246593|538318749|FG001|Overall Study|Withdrawal by Subject|13|||
149232419|NCT04246593|538318748|FG000|Overall Study|Lost to Follow-up|124|||
149232420|NCT04246593|538318749|FG001|Overall Study|Lost to Follow-up|71|||
149232421|NCT04246593|538318748|FG000|Overall Study|Moved out of area/became ineligible|3|||
149232422|NCT04246593|538318749|FG001|Overall Study|Moved out of area/became ineligible|1|||
149232423|NCT04246593|538318748|FG000|Overall Study|Reason unknown|4|||
149232424|NCT04246593|538318749|FG001|Overall Study|Reason unknown|2|||
149232425|NCT00429026|538318750|FG000|Overall Study|Inevaluable for response.|40|||
149232426|NCT00903357|538318751|FG000|First Intervention|Withdrawal by Subject|5|||
149232427|NCT00903357|538318752|FG001|First Intervention|Withdrawal by Subject|3|||
149232428|NCT00903357|538318751|FG000|First Intervention|Flu|0|||
149232429|NCT00903357|538318752|FG001|First Intervention|Flu|1|||
149232430|NCT00903357|538318751|FG000|Wash Out Period of 2 Weeks|Flu|0|||
149232431|NCT00903357|538318752|FG001|Wash Out Period of 2 Weeks|Flu|1|||
149232432|NCT00903357|538318751|FG000|Second Intervention|Lost to Follow-up|1|||
149232433|NCT00903357|538318752|FG001|Second Intervention|Lost to Follow-up|0|||
149232434|NCT00678652|538318755|FG000|Overall Study|Protocol Violation|2|||
149232435|NCT00678652|538318756|FG001|Overall Study|Protocol Violation|0|||
149232436|NCT00678652|538318757|FG002|Overall Study|Protocol Violation|0|||
149232437|NCT00678652|538318758|FG003|Overall Study|Protocol Violation|0|||
149232438|NCT00678652|538318755|FG000|Overall Study|Pregnancy|0|||
149232439|NCT00678652|538318756|FG001|Overall Study|Pregnancy|0|||
149232440|NCT00678652|538318757|FG002|Overall Study|Pregnancy|1|||
149232441|NCT00678652|538318758|FG003|Overall Study|Pregnancy|0|||
149232442|NCT00678652|538318755|FG000|Overall Study|Relocation|1|||
149232443|NCT00678652|538318756|FG001|Overall Study|Relocation|0|||
149232444|NCT00678652|538318757|FG002|Overall Study|Relocation|0|||
149232445|NCT00678652|538318758|FG003|Overall Study|Relocation|0|||
149232446|NCT00674440|538318759|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
149232447|NCT00674440|538318759|FG000|Overall Study|did not have surgery, so unevaluable|7|||
149232448|NCT00674440|538318759|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
149232449|NCT01365182|538318760|FG000|Overall Study|Withdrawal by Subject|10|||
149232450|NCT01365182|538318761|FG001|Overall Study|Withdrawal by Subject|13|||
149232451|NCT01365182|538318762|FG002|Overall Study|Withdrawal by Subject|12|||
149232452|NCT01990339|538318763|FG000|Overall Study|Data Not Available|49|||
149232453|NCT01990339|538318763|FG000|Overall Study|Voluntary Withdrawal|1402|||
149232454|NCT01990339|538318763|FG000|Overall Study|Lost to Follow-up|861|||
149232455|NCT04604015|538318765|FG000|Overall Study|Incomplete Data Collection|33|||
149232456|NCT02129192|538318768|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
149232457|NCT02129192|538318769|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
149232458|NCT02576652|538318771|FG000|Overall Study|Withdrawal by Subject|2|||
149232459|NCT02811640|538318776|FG000|Overall Study|Technology malfunction|2|||
149232460|NCT04557189|538318781|FG000|Overall Study|Adverse Event|0|||
149232461|NCT04557189|538318782|FG001|Overall Study|Adverse Event|1|||
149232462|NCT04557189|538318781|FG000|Overall Study|Lost to Follow-up|1|||
149232463|NCT04557189|538318782|FG001|Overall Study|Lost to Follow-up|1|||
149232464|NCT04557189|538318781|FG000|Overall Study|Withdrawal by Subject|2|||
149232465|NCT04557189|538318782|FG001|Overall Study|Withdrawal by Subject|1|||
149232466|NCT04557189|538318781|FG000|Overall Study|Reason not Specified|3|||
149232467|NCT04557189|538318782|FG001|Overall Study|Reason not Specified|6|||
149232468|NCT01349816|538318783|FG000|Overall Study|Withdrawal by Subject|4|||
149232469|NCT01349816|538318783|FG000|Overall Study|Physician Decision|1|||
149232470|NCT01349816|538318783|FG000|Overall Study|Adverse Event|14|||
149232471|NCT01349816|538318783|FG000|Overall Study|Lost to Follow-up|2|||
149232472|NCT01349816|538318783|FG000|Overall Study|Protocol Violation|1|||
149232473|NCT01349816|538318783|FG000|Overall Study|Protocol-specified criteria|8|||
149232474|NCT01383317|538318784|FG000|Overall Study|Lost to Follow-up|2|||
149232475|NCT01383317|538318785|FG001|Overall Study|Lost to Follow-up|1|||
149232476|NCT01383317|538318784|FG000|Overall Study|Death|1|||
149232477|NCT01383317|538318785|FG001|Overall Study|Death|0|||
149232478|NCT01383317|538318784|FG000|Overall Study|Adverse Event|0|||
149232479|NCT01383317|538318785|FG001|Overall Study|Adverse Event|1|||
149232480|NCT02569996|538318788|FG000|Overall Study|Adverse Event|6|||
149232481|NCT02569996|538318788|FG000|Overall Study|Physician Decision|3|||
149232482|NCT02569996|538318788|FG000|Overall Study|Progression of the disease|18|||
149232483|NCT02569996|538318788|FG000|Overall Study|New anti-lymphoma treatment|1|||
149232484|NCT02569996|538318788|FG000|Overall Study|Non-compliance|9|||
149232485|NCT02569996|538318788|FG000|Overall Study|Withdrawal by Subject|5|||
149232486|NCT02569996|538318788|FG000|Overall Study|Lost to Follow-up|5|||
149232487|NCT02569996|538318788|FG000|Overall Study|Complete remission|7|||
149232488|NCT02569996|538318788|FG000|Overall Study|Unknown reason|1|||
149232489|NCT01207427|538318789|FG000|Double-blind Treatment Period|Adverse Event|0|||
149232490|NCT01207427|538318790|FG001|Double-blind Treatment Period|Adverse Event|1|||
149232491|NCT01207427|538318791|FG002|Double-blind Treatment Period|Adverse Event|0|||
149232492|NCT01207427|538318789|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149232493|NCT01207427|538318790|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149232494|NCT01207427|538318791|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
149232495|NCT01207427|538318789|FG000|Double-blind Treatment Period|Protocol Violation|2|||
149232496|NCT01207427|538318790|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149232497|NCT01207427|538318791|FG002|Double-blind Treatment Period|Protocol Violation|1|||
149232498|NCT01207427|538318789|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
149232499|NCT01207427|538318790|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
149232500|NCT01207427|538318791|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149232501|NCT00198107|538320663|FG000|Double-Blind Period|Adverse Event|1|||
149232502|NCT00198107|538320664|FG001|Double-Blind Period|Adverse Event|1|||
149232503|NCT00198107|538320665|FG002|Double-Blind Period|Adverse Event|0|||
149232504|NCT00198107|538320663|FG000|Double-Blind Period|Lack of Efficacy|2|||
149232505|NCT00198107|538320664|FG001|Double-Blind Period|Lack of Efficacy|0|||
149232506|NCT00198107|538320665|FG002|Double-Blind Period|Lack of Efficacy|0|||
149232507|NCT00198107|538320663|FG000|Double-Blind Period|Lost to Follow-up|2|||
149232508|NCT00198107|538320664|FG001|Double-Blind Period|Lost to Follow-up|1|||
149232509|NCT00198107|538320665|FG002|Double-Blind Period|Lost to Follow-up|0|||
149232510|NCT00198107|538320663|FG000|Double-Blind Period|Physician Decision|1|||
149232511|NCT00198107|538320664|FG001|Double-Blind Period|Physician Decision|0|||
149232512|NCT00198107|538320665|FG002|Double-Blind Period|Physician Decision|0|||
149232513|NCT00198107|538320663|FG000|Double-Blind Period|Withdrawal by Subject|0|||
149232514|NCT00198107|538320664|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149232515|NCT00198107|538320665|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149232516|NCT00198107|538320663|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
149232517|NCT00198107|538320664|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
149232518|NCT00198107|538320665|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
149232519|NCT02513732|538320666|FG000|Overall Study|Lost to Follow-up|11|||
149232520|NCT02513732|538320666|FG000|Overall Study|Death|9|||
149232521|NCT02513732|538320666|FG000|Overall Study|Changing hospital|2|||
149232522|NCT00467051|538320667|FG000|Overall Study|Adverse Event|2|||
149232523|NCT02163759|538320672|FG000|Overall Study|Withdrawal by Subject|1|||
149232524|NCT02163759|538320673|FG001|Overall Study|Withdrawal by Subject|5|||
149232525|NCT02163759|538320674|FG002|Overall Study|Withdrawal by Subject|1|||
149232526|NCT02163759|538320672|FG000|Overall Study|Adverse Event|0|||
149232527|NCT02163759|538320673|FG001|Overall Study|Adverse Event|0|||
149232528|NCT02163759|538320674|FG002|Overall Study|Adverse Event|1|||
149232529|NCT02163759|538320672|FG000|Overall Study|Death|0|||
149232530|NCT02163759|538320673|FG001|Overall Study|Death|0|||
149232531|NCT02163759|538320674|FG002|Overall Study|Death|1|||
149232532|NCT03996694|538320675|FG000|First Washout (7 Days)|positive urine drug screen|0|||
149232533|NCT03996694|538320676|FG001|First Washout (7 Days)|positive urine drug screen|0|||
149232534|NCT03996694|538320677|FG002|First Washout (7 Days)|positive urine drug screen|1|||
149232535|NCT03996694|538320678|FG003|First Washout (7 Days)|positive urine drug screen|0|||
149232536|NCT03996694|538320679|FG004|First Washout (7 Days)|positive urine drug screen|0|||
149232537|NCT03996694|538320680|FG005|First Washout (7 Days)|positive urine drug screen|0|||
149232538|NCT03996694|538320675|FG000|First Washout (7 Days)|Adverse Event|0|||
149232539|NCT03996694|538320676|FG001|First Washout (7 Days)|Adverse Event|1|||
149232540|NCT03996694|538320677|FG002|First Washout (7 Days)|Adverse Event|0|||
149232541|NCT03996694|538320678|FG003|First Washout (7 Days)|Adverse Event|0|||
149232542|NCT03996694|538320679|FG004|First Washout (7 Days)|Adverse Event|0|||
149232543|NCT03996694|538320680|FG005|First Washout (7 Days)|Adverse Event|0|||
149232544|NCT03996694|538320675|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
149232545|NCT03996694|538320676|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
149232546|NCT03996694|538320677|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
149232547|NCT03996694|538320678|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
149232548|NCT03996694|538320679|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
149232549|NCT03996694|538320680|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
149232550|NCT03996694|538320675|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
149232551|NCT03996694|538320676|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
149232552|NCT03996694|538320677|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
149232553|NCT03996694|538320678|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
149232554|NCT03996694|538320679|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
148810689|NCT03881371|536784565|FG000|Overall Study|Physician Decision|3|||
148810690|NCT03881371|536784566|FG001|Overall Study|Physician Decision|3|||
148810691|NCT03881371|536784565|FG000|Overall Study|Withdrawal by Subject|2|||
148810692|NCT03881371|536784566|FG001|Overall Study|Withdrawal by Subject|10|||
148810693|NCT03881371|536784565|FG000|Overall Study|Discontinuation from Study|1|||
148810694|NCT03881371|536784566|FG001|Overall Study|Discontinuation from Study|0|||
148810695|NCT02178956|536784573|FG000|Overall Study|Lost to Follow-up|4|||
148810696|NCT02178956|536784574|FG001|Overall Study|Lost to Follow-up|4|||
149232555|NCT03996694|538320680|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
149232556|NCT00451191|538320683|FG000|Overall Study|withdrawal or received alternate tx|15|||
149232557|NCT00451191|538320684|FG001|Overall Study|withdrawal or received alternate tx|11|||
149232558|NCT00656669|538320692|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
149232559|NCT00656669|538320692|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
149232560|NCT00656669|538320692|FG000|AC (Cycles 6-9)|Adverse Event|1|||
149232561|NCT00656669|538320692|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
149232562|NCT03575806|538320697|FG000|Overall Study|Withdrawal by Subject|0|||
149232563|NCT03575806|538320698|FG001|Overall Study|Withdrawal by Subject|2|||
149232564|NCT03575806|538320697|FG000|Overall Study|Protocol Violation|0|||
149232565|NCT03575806|538320698|FG001|Overall Study|Protocol Violation|2|||
149232566|NCT00219349|538320699|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
149232567|NCT00219349|538320699|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
149232568|NCT00219349|538320699|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
149232569|NCT00219349|538320699|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
149232570|NCT00270205|538320703|FG000|Overall Study|Lost to Follow-up|1|||
149232571|NCT00270205|538320704|FG001|Overall Study|Lost to Follow-up|0|||
149232572|NCT00270205|538320705|FG002|Overall Study|Lost to Follow-up|0|||
149232573|NCT00270205|538320706|FG003|Overall Study|Lost to Follow-up|1|||
149232574|NCT00066573|538320710|FG000|Overall Study|Did not received protocol treatment|28|||
149232575|NCT00066573|538320711|FG001|Overall Study|Did not received protocol treatment|28|||
149232576|NCT00869362|538320712|FG000|Overall Study|Death|0|||
149232577|NCT00869362|538320713|FG001|Overall Study|Death|2|||
149232578|NCT00869362|538320712|FG000|Overall Study|Lost to Follow-up|1|||
149232579|NCT00869362|538320713|FG001|Overall Study|Lost to Follow-up|3|||
149232580|NCT02147132|538320714|FG000|Overall Study|Lost to Follow-up|1|||
149232581|NCT02147132|538320715|FG001|Overall Study|Lost to Follow-up|0|||
149232582|NCT02147132|538320716|FG002|Overall Study|Lost to Follow-up|0|||
149232583|NCT02147132|538320717|FG003|Overall Study|Lost to Follow-up|0|||
149232584|NCT01013207|538320718|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
149232585|NCT01458535|538320725|FG000|Overall Study|Other|0|||
149232586|NCT01458535|538320726|FG001|Overall Study|Other|0|||
149232587|NCT01458535|538320727|FG002|Overall Study|Other|0|||
149232588|NCT01458535|538320728|FG003|Overall Study|Other|0|||
149232589|NCT01458535|538320729|FG004|Overall Study|Other|1|||
149232590|NCT01458535|538320730|FG005|Overall Study|Other|1|||
149232591|NCT01458535|538320725|FG000|Overall Study|Withdrawal by Subject|0|||
149232592|NCT01458535|538320726|FG001|Overall Study|Withdrawal by Subject|0|||
149232593|NCT01458535|538320727|FG002|Overall Study|Withdrawal by Subject|2|||
149232594|NCT01458535|538320728|FG003|Overall Study|Withdrawal by Subject|0|||
149232595|NCT01458535|538320729|FG004|Overall Study|Withdrawal by Subject|1|||
148690285|NCT03738332|536340196|FG000|Overall Study|Withdrawal by Subject|1|||
148690286|NCT04700449|536340197|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
148690287|NCT04700449|536340198|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
148690288|NCT04700449|536340199|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
148690289|NCT04700449|536340200|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
148690290|NCT04700449|536340197|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
148690291|NCT04700449|536340198|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
148690292|NCT04700449|536340199|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
148690293|NCT04700449|536340200|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
148690294|NCT04700449|536340197|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
148690295|NCT04700449|536340198|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
148690296|NCT04700449|536340199|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
148690297|NCT04700449|536340200|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
148690298|NCT04700449|536340197|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
148690299|NCT04700449|536340198|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
148690300|NCT04700449|536340199|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
148690301|NCT04700449|536340200|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
148690302|NCT04700449|536340197|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
148690303|NCT04700449|536340198|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
148690304|NCT04700449|536340199|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
148690305|NCT04700449|536340200|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
148690306|NCT04700449|536340197|FG000|Stage 1: Double-Blind Period|Other|0|||
148690307|NCT04700449|536340198|FG001|Stage 1: Double-Blind Period|Other|0|||
148690308|NCT04700449|536340199|FG002|Stage 1: Double-Blind Period|Other|1|||
148690309|NCT04700449|536340200|FG003|Stage 1: Double-Blind Period|Other|0|||
148690310|NCT04700449|536340197|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
148690311|NCT04700449|536340198|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
148690312|NCT04700449|536340199|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
148690313|NCT04700449|536340200|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
148690314|NCT04700449|536340197|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
149020364|NCT02268552|537552626|FG000|Part 1|Subject/guardian decision|0|||
149232596|NCT01458535|538320730|FG005|Overall Study|Withdrawal by Subject|1|||
149232597|NCT01458535|538320725|FG000|Overall Study|Lost to Follow-up|0|||
148690315|NCT04700449|536340198|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
149020365|NCT02268552|537552627|FG001|Part 1|Subject/guardian decision|0|||
148690316|NCT04700449|536340199|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
149232598|NCT01458535|538320726|FG001|Overall Study|Lost to Follow-up|2|||
149232599|NCT01458535|538320727|FG002|Overall Study|Lost to Follow-up|0|||
149232600|NCT01458535|538320728|FG003|Overall Study|Lost to Follow-up|3|||
149232601|NCT01458535|538320729|FG004|Overall Study|Lost to Follow-up|2|||
148690317|NCT04700449|536340200|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
149020366|NCT02268552|537552628|FG002|Part 1|Subject/guardian decision|0|||
149232602|NCT01458535|538320730|FG005|Overall Study|Lost to Follow-up|2|||
149232603|NCT01458535|538320725|FG000|Overall Study|Adverse Event|0|||
149232604|NCT01458535|538320726|FG001|Overall Study|Adverse Event|0|||
149232605|NCT01458535|538320727|FG002|Overall Study|Adverse Event|0|||
149232606|NCT01458535|538320728|FG003|Overall Study|Adverse Event|1|||
149232607|NCT01458535|538320729|FG004|Overall Study|Adverse Event|0|||
149232608|NCT01458535|538320730|FG005|Overall Study|Adverse Event|0|||
149232609|NCT02842736|538320731|FG000|Overall Study|Lost to Follow-up|13|||
149232610|NCT02842736|538320731|FG000|Overall Study|Intervention for menstrual bleeding|17|||
149232611|NCT02842736|538320731|FG000|Overall Study|Withdrawal by Subject|4|||
149232612|NCT02842736|538320731|FG000|Overall Study|Pregnancy|3|||
149232613|NCT02842736|538320731|FG000|Overall Study|Hysterectomy for fibroids|2|||
149232614|NCT02842736|538320731|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
149232615|NCT02842736|538320731|FG000|Overall Study|IUD: Mirena|1|||
149232616|NCT02646566|538320734|FG000|Overall Study|Lost to Follow-up|5|||
149232617|NCT02646566|538320735|FG001|Overall Study|Lost to Follow-up|4|||
149232618|NCT02646566|538320736|FG002|Overall Study|Lost to Follow-up|5|||
149232619|NCT02646566|538320734|FG000|Overall Study|Treatment failure|1|||
149232620|NCT02646566|538320735|FG001|Overall Study|Treatment failure|0|||
149232621|NCT02646566|538320736|FG002|Overall Study|Treatment failure|0|||
149232622|NCT01050998|538320740|FG000|Overall Study|Adverse Event|1|||
149232623|NCT01050998|538320741|FG001|Overall Study|Adverse Event|0|||
149232624|NCT01050998|538320742|FG002|Overall Study|Adverse Event|1|||
149232625|NCT01050998|538320743|FG003|Overall Study|Adverse Event|0|||
149232626|NCT01050998|538320744|FG004|Overall Study|Adverse Event|2|||
149232627|NCT01050998|538320740|FG000|Overall Study|Withdrawal by Subject|0|||
149232628|NCT01050998|538320741|FG001|Overall Study|Withdrawal by Subject|0|||
149232629|NCT01050998|538320742|FG002|Overall Study|Withdrawal by Subject|0|||
149232630|NCT01050998|538320743|FG003|Overall Study|Withdrawal by Subject|1|||
149232631|NCT01050998|538320744|FG004|Overall Study|Withdrawal by Subject|3|||
149232632|NCT01050998|538320740|FG000|Overall Study|Other|3|||
149232633|NCT01050998|538320741|FG001|Overall Study|Other|2|||
149232634|NCT01050998|538320742|FG002|Overall Study|Other|1|||
149232635|NCT01050998|538320743|FG003|Overall Study|Other|1|||
149232636|NCT01050998|538320744|FG004|Overall Study|Other|5|||
149232637|NCT01050998|538320740|FG000|Overall Study|Data integrity issues|0|||
149232638|NCT01050998|538320741|FG001|Overall Study|Data integrity issues|0|||
149232639|NCT01050998|538320742|FG002|Overall Study|Data integrity issues|1|||
149232640|NCT01050998|538320743|FG003|Overall Study|Data integrity issues|1|||
149232641|NCT01050998|538320744|FG004|Overall Study|Data integrity issues|4|||
149232642|NCT00265109|538320745|FG000|Overall Study|Withdrawal by Subject|5|||
149232643|NCT00265109|538320745|FG000|Overall Study|Adverse Event|1|||
149232644|NCT00234533|538320752|FG000|Overall Study|Withdrawal by Subject|6|||
149232645|NCT00234533|538320752|FG000|Overall Study|Adverse Event|2|||
149232646|NCT00234533|538320752|FG000|Overall Study|Enrolled but not treated|3|||
148690318|NCT04700449|536340197|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
149232647|NCT02967055|538320753|FG000|Overall Study|Excluded|40|||
149232648|NCT02967055|538320753|FG000|Overall Study|Screen fail|3|||
149232649|NCT02967055|538320753|FG000|Overall Study|Lost to Follow-up|2|||
149232650|NCT02967055|538320753|FG000|Overall Study|Stopped due to side effects|3|||
149232651|NCT02967055|538320753|FG000|Overall Study|Stopped due to drug cost|1|||
149232652|NCT05664672|538320757|FG000|Overall Study|Adverse Event|0|||
149232653|NCT05664672|538320758|FG001|Overall Study|Adverse Event|0|||
149232654|NCT05664672|538320759|FG002|Overall Study|Adverse Event|0|||
149232655|NCT05664672|538320760|FG003|Overall Study|Adverse Event|0|||
149232656|NCT05664672|538320761|FG004|Overall Study|Adverse Event|0|||
149020367|NCT02268552|537552629|FG003|Part 1|Subject/guardian decision|1|||
149232657|NCT05664672|538320762|FG005|Overall Study|Adverse Event|1|||
149232658|NCT05664672|538320757|FG000|Overall Study|Withdrawal by Subject|0|||
149232659|NCT05664672|538320758|FG001|Overall Study|Withdrawal by Subject|1|||
149232660|NCT05664672|538320759|FG002|Overall Study|Withdrawal by Subject|3|||
149232661|NCT05664672|538320760|FG003|Overall Study|Withdrawal by Subject|0|||
149232662|NCT05664672|538320761|FG004|Overall Study|Withdrawal by Subject|5|||
149232663|NCT05664672|538320762|FG005|Overall Study|Withdrawal by Subject|6|||
149232664|NCT05664672|538320757|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
149232665|NCT05664672|538320758|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
149232666|NCT05664672|538320759|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
149232667|NCT05664672|538320760|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
149232668|NCT05664672|538320761|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
149232669|NCT05664672|538320762|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
149232670|NCT05664672|538320757|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
149232671|NCT05664672|538320758|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149232672|NCT05664672|538320759|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149232673|NCT05664672|538320760|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149232674|NCT05664672|538320761|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149232675|NCT05664672|538320762|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
149232676|NCT04768881|538320765|FG000|Overall Study|Completed Study Follow-up|0|||
149232677|NCT04768881|538320766|FG001|Overall Study|Completed Study Follow-up|2|||
149232678|NCT04768881|538320765|FG000|Overall Study|Death|3|||
149232679|NCT04768881|538320766|FG001|Overall Study|Death|2|||
149232680|NCT04768881|538320765|FG000|Overall Study|Study Terminated by Sponsor|2|||
149232681|NCT04768881|538320766|FG001|Overall Study|Study Terminated by Sponsor|2|||
149232682|NCT04768881|538320765|FG000|Overall Study|Withdrawal by Subject|2|||
149232683|NCT04768881|538320766|FG001|Overall Study|Withdrawal by Subject|0|||
149232684|NCT04768881|538320765|FG000|Overall Study|Other|2|||
149232685|NCT04768881|538320766|FG001|Overall Study|Other|0|||
149232686|NCT01038609|538320775|FG000|Overall Study|Adverse Event|0|||
149232687|NCT01038609|538320776|FG001|Overall Study|Adverse Event|0|||
149232688|NCT01038609|538320777|FG002|Overall Study|Adverse Event|1|||
149232689|NCT01038609|538320778|FG003|Overall Study|Adverse Event|0|||
149232690|NCT01038609|538320779|FG004|Overall Study|Adverse Event|0|||
149232691|NCT01038609|538320775|FG000|Overall Study|Dosing Error|0|||
149232692|NCT01038609|538320776|FG001|Overall Study|Dosing Error|0|||
149232693|NCT01038609|538320777|FG002|Overall Study|Dosing Error|0|||
149232694|NCT01038609|538320778|FG003|Overall Study|Dosing Error|1|||
149232695|NCT01038609|538320779|FG004|Overall Study|Dosing Error|1|||
149232696|NCT01038609|538320775|FG000|Overall Study|Death in the Family|1|||
149232697|NCT01038609|538320776|FG001|Overall Study|Death in the Family|0|||
149232698|NCT01038609|538320777|FG002|Overall Study|Death in the Family|0|||
149232699|NCT01038609|538320778|FG003|Overall Study|Death in the Family|0|||
149232700|NCT01038609|538320779|FG004|Overall Study|Death in the Family|0|||
149232701|NCT01038609|538320775|FG000|Overall Study|Refusal of Blood Draws|0|||
149232702|NCT01038609|538320776|FG001|Overall Study|Refusal of Blood Draws|1|||
149232703|NCT01038609|538320777|FG002|Overall Study|Refusal of Blood Draws|0|||
149232704|NCT01038609|538320778|FG003|Overall Study|Refusal of Blood Draws|0|||
149232705|NCT01038609|538320779|FG004|Overall Study|Refusal of Blood Draws|0|||
149232706|NCT01728194|538320782|FG000|Overall Study|Lost to Follow-up|4|||
149232707|NCT01728194|538320783|FG001|Overall Study|Lost to Follow-up|3|||
149232708|NCT01728194|538320782|FG000|Overall Study|Physician Decision|4|||
149232709|NCT01728194|538320783|FG001|Overall Study|Physician Decision|0|||
149232710|NCT01728194|538320782|FG000|Overall Study|Withdrawal by Subject|7|||
149232711|NCT01728194|538320783|FG001|Overall Study|Withdrawal by Subject|3|||
149232712|NCT01728194|538320782|FG000|Overall Study|Perceived Medication Side Effects|4|||
149232713|NCT01728194|538320783|FG001|Overall Study|Perceived Medication Side Effects|0|||
149232714|NCT01728194|538320782|FG000|Overall Study|Family Member Request|1|||
149232715|NCT01728194|538320783|FG001|Overall Study|Family Member Request|0|||
149232716|NCT02309372|538320784|FG000|Overall Study|Lost to Follow-up|3|||
149232717|NCT02309372|538320785|FG001|Overall Study|Lost to Follow-up|2|||
149232718|NCT00242658|538320786|FG000|Overall Study|Lost to Follow-up|22|||
149232719|NCT00242658|538320787|FG001|Overall Study|Lost to Follow-up|19|||
148690319|NCT04700449|536340198|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
149232720|NCT01314261|538320789|FG000|Overall Study|Adverse Event|1|||
148690320|NCT04700449|536340199|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
149232721|NCT01314261|538320790|FG001|Overall Study|Adverse Event|0|||
149232722|NCT01314261|538320791|FG002|Overall Study|Adverse Event|0|||
149232723|NCT01314261|538320792|FG003|Overall Study|Adverse Event|0|||
149232724|NCT01314261|538320789|FG000|Overall Study|Withdrawal by Subject|0|||
149232725|NCT01314261|538320790|FG001|Overall Study|Withdrawal by Subject|3|||
149232726|NCT01314261|538320791|FG002|Overall Study|Withdrawal by Subject|1|||
149232727|NCT01314261|538320792|FG003|Overall Study|Withdrawal by Subject|0|||
149232728|NCT01314261|538320789|FG000|Overall Study|Lost to Follow-up|1|||
149232729|NCT01314261|538320790|FG001|Overall Study|Lost to Follow-up|0|||
149020368|NCT02268552|537552630|FG004|Part 1|Subject/guardian decision|0|||
149232730|NCT01314261|538320791|FG002|Overall Study|Lost to Follow-up|2|||
149232731|NCT01314261|538320792|FG003|Overall Study|Lost to Follow-up|2|||
149232732|NCT01314261|538320789|FG000|Overall Study|Virologic Failure|0|||
149232733|NCT01314261|538320790|FG001|Overall Study|Virologic Failure|1|||
149232734|NCT01314261|538320791|FG002|Overall Study|Virologic Failure|0|||
149232735|NCT01314261|538320792|FG003|Overall Study|Virologic Failure|1|||
149232736|NCT01231620|538320793|FG000|Overall Study|Physician Decision|3|||
149232737|NCT01231620|538320794|FG001|Overall Study|Physician Decision|5|||
149232738|NCT01231620|538320795|FG002|Overall Study|Physician Decision|10|||
149232739|NCT01231620|538320793|FG000|Overall Study|Death|12|||
149232740|NCT01231620|538320794|FG001|Overall Study|Death|14|||
149232741|NCT01231620|538320795|FG002|Overall Study|Death|11|||
149232742|NCT01231620|538320793|FG000|Overall Study|Adverse Event|2|||
149232743|NCT01231620|538320794|FG001|Overall Study|Adverse Event|2|||
149232744|NCT01231620|538320795|FG002|Overall Study|Adverse Event|1|||
149232745|NCT01231620|538320793|FG000|Overall Study|Withdrawal by Subject|6|||
149232746|NCT01231620|538320794|FG001|Overall Study|Withdrawal by Subject|6|||
149232747|NCT01231620|538320795|FG002|Overall Study|Withdrawal by Subject|8|||
149232748|NCT01231620|538320793|FG000|Overall Study|Lost to Follow-up|3|||
149232749|NCT01231620|538320794|FG001|Overall Study|Lost to Follow-up|4|||
149232750|NCT01231620|538320795|FG002|Overall Study|Lost to Follow-up|9|||
149232751|NCT04524507|538320797|FG000|Overall Study|Lost to Follow-up|2|||
149232752|NCT04524507|538320798|FG001|Overall Study|Lost to Follow-up|4|||
149232753|NCT04524507|538320797|FG000|Overall Study|Withdrawal by Subject|2|||
149232754|NCT04524507|538320798|FG001|Overall Study|Withdrawal by Subject|9|||
149232755|NCT04524507|538320797|FG000|Overall Study|Death|2|||
149232756|NCT04524507|538320798|FG001|Overall Study|Death|10|||
149232757|NCT02441517|538320808|FG000|Overall Study|Lost to Follow-up|1|||
149232758|NCT02441517|538320808|FG000|Overall Study|Withdrawal by Subject|2|||
149232759|NCT02441517|538320808|FG000|Overall Study|Study Terminated by Sponsor|1|||
149232760|NCT01393444|538320809|FG000|Overall Study|Withdrawal by Subject|1|||
149232761|NCT01393444|538320809|FG000|Overall Study|Determined ineligible during screening.|2|||
149232762|NCT02911285|538320811|FG000|Overall Study|Lost to Follow-up|8|||
149232763|NCT02911285|538320812|FG001|Overall Study|Lost to Follow-up|5|||
149232764|NCT02911285|538320811|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
149232765|NCT02911285|538320812|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
149232766|NCT03418727|538320813|FG000|Overall Study|Adverse Event|1|||
149232767|NCT03418727|538320814|FG001|Overall Study|Adverse Event|2|||
149232768|NCT03418727|538320815|FG002|Overall Study|Adverse Event|0|||
149232769|NCT03418727|538320813|FG000|Overall Study|Withdrawal by Subject|0|||
149232770|NCT03418727|538320814|FG001|Overall Study|Withdrawal by Subject|0|||
149232771|NCT03418727|538320815|FG002|Overall Study|Withdrawal by Subject|2|||
149232772|NCT01740297|538322407|FG000|Overall Study|Withdrawal by Subject|4|||
149232773|NCT01740297|538322408|FG001|Overall Study|Withdrawal by Subject|16|||
149232774|NCT01740297|538322409|FG002|Overall Study|Withdrawal by Subject|17|||
149232775|NCT01740297|538322407|FG000|Overall Study|Death|8|||
149232776|NCT01740297|538322408|FG001|Overall Study|Death|46|||
149232777|NCT01740297|538322409|FG002|Overall Study|Death|40|||
149232778|NCT01740297|538322407|FG000|Overall Study|Lost to Follow-up|1|||
149232779|NCT01740297|538322408|FG001|Overall Study|Lost to Follow-up|2|||
149232780|NCT01740297|538322409|FG002|Overall Study|Lost to Follow-up|4|||
149232781|NCT00761462|538322410|FG000|Treatment|Subjects never received study medication|23|||
149232782|NCT00761462|538322411|FG001|Treatment|Subjects never received study medication|12|||
149232783|NCT00761462|538322410|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
149232784|NCT00761462|538322411|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
149232785|NCT00761462|538322410|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
149232786|NCT00761462|538322411|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
149232787|NCT00761462|538322410|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
149232788|NCT00761462|538322411|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
149232789|NCT02985541|538322415|FG000|Overall Study|Withdrawal by Subject|33|||
149232790|NCT02985541|538322415|FG000|Overall Study|Lost to Follow-up|26|||
149232791|NCT02985541|538322415|FG000|Overall Study|Adverse Event|27|||
149232792|NCT02985541|538322415|FG000|Overall Study|Physician Decision|2|||
149232793|NCT02985541|538322415|FG000|Overall Study|Pregnancy|2|||
149232794|NCT02985541|538322415|FG000|Overall Study|Wish for pregnancy|44|||
149232795|NCT02985541|538322415|FG000|Overall Study|Other reason|5|||
149232796|NCT02985541|538322415|FG000|Overall Study|Not valid for analysis|2|||
149232797|NCT02383966|538322416|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
149232798|NCT02383966|538322417|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
149232799|NCT02383966|538322416|FG000|Overall Study|Randomized, but not treated|1|||
149232800|NCT02383966|538322417|FG001|Overall Study|Randomized, but not treated|3|||
149232801|NCT01479777|538322426|FG000|Overall Study|Physician Decision|2|||
149232802|NCT02389621|538322432|FG000|Treatment Period|Withdrawal by Subject|1|||
149232803|NCT02389621|538322433|FG001|Treatment Period|Withdrawal by Subject|1|||
149232804|NCT02389621|538322432|FG000|Posttreatment Period|Adverse Event|3|||
149232805|NCT02389621|538322433|FG001|Posttreatment Period|Adverse Event|1|||
149232806|NCT02389621|538322432|FG000|Posttreatment Period|Withdrawal by Subject|3|||
149232807|NCT02389621|538322433|FG001|Posttreatment Period|Withdrawal by Subject|2|||
149232808|NCT02389621|538322432|FG000|Posttreatment Period|Lost to Follow-up|1|||
149232809|NCT02389621|538322433|FG001|Posttreatment Period|Lost to Follow-up|1|||
149232810|NCT02389621|538322432|FG000|Posttreatment Period|Other - Miscellaneous|2|||
149232811|NCT02389621|538322433|FG001|Posttreatment Period|Other - Miscellaneous|0|||
149232812|NCT03323034|538322436|FG000|Overall Study|Lack of Efficacy|5|||
149232813|NCT03323034|538322437|FG001|Overall Study|Lack of Efficacy|5|||
149232814|NCT03323034|538322438|FG002|Overall Study|Lack of Efficacy|6|||
149232815|NCT03323034|538322439|FG003|Overall Study|Lack of Efficacy|5|||
149232816|NCT03323034|538322440|FG004|Overall Study|Lack of Efficacy|5|||
149232817|NCT03323034|538322436|FG000|Overall Study|Physician Decision|0|||
149232818|NCT03323034|538322437|FG001|Overall Study|Physician Decision|0|||
149232819|NCT03323034|538322438|FG002|Overall Study|Physician Decision|0|||
149232820|NCT03323034|538322439|FG003|Overall Study|Physician Decision|0|||
149232821|NCT03323034|538322440|FG004|Overall Study|Physician Decision|1|||
149232822|NCT03323034|538322436|FG000|Overall Study|Withdrawal by Subject|1|||
149232823|NCT03323034|538322437|FG001|Overall Study|Withdrawal by Subject|1|||
149232824|NCT03323034|538322438|FG002|Overall Study|Withdrawal by Subject|0|||
149232825|NCT03323034|538322439|FG003|Overall Study|Withdrawal by Subject|1|||
149232826|NCT03323034|538322440|FG004|Overall Study|Withdrawal by Subject|0|||
149232827|NCT02815540|538322443|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
149232828|NCT02222246|538322444|FG000|Overall Study|No Emergency Department Visits|27|||
149232829|NCT02222246|538322445|FG001|Overall Study|No Emergency Department Visits|26|||
149232830|NCT02222246|538322444|FG000|Overall Study|Physician Decision|0|||
149232831|NCT02222246|538322445|FG001|Overall Study|Physician Decision|1|||
149232832|NCT02064231|538322446|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
149232833|NCT02064231|538322447|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
149232834|NCT02064231|538322448|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
149232835|NCT02064231|538322449|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
149232836|NCT02064231|538322446|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
149232837|NCT02064231|538322447|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
149232838|NCT02064231|538322448|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
149232839|NCT02064231|538322449|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
149232840|NCT02064231|538322446|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
149232841|NCT02064231|538322447|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
149232842|NCT02064231|538322448|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
149232843|NCT02064231|538322449|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
149232844|NCT02064231|538322446|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
149232845|NCT02064231|538322447|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
149232846|NCT02064231|538322448|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
149232847|NCT02064231|538322449|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
149232848|NCT04887922|538322457|FG000|1st Randomization|Decided not to have surgery|0|||
149232849|NCT04887922|538322458|FG001|1st Randomization|Decided not to have surgery|1|||
149232850|NCT04887922|538322459|FG002|1st Randomization|Decided not to have surgery|0|||
149232851|NCT04887922|538322460|FG003|1st Randomization|Decided not to have surgery|0|||
149232852|NCT04887922|538322461|FG004|1st Randomization|Decided not to have surgery|0|||
149232853|NCT00953017|538322462|FG000|Overall Study|DId not show up for colonoscopy|4|||
149232854|NCT00953017|538322463|FG001|Overall Study|DId not show up for colonoscopy|4|||
149232855|NCT00953017|538322464|FG002|Overall Study|DId not show up for colonoscopy|5|||
149232856|NCT00953017|538322465|FG003|Overall Study|DId not show up for colonoscopy|4|||
149232857|NCT00953017|538322462|FG000|Overall Study|Incomplete data|1|||
149232858|NCT00953017|538322463|FG001|Overall Study|Incomplete data|1|||
149232859|NCT00953017|538322464|FG002|Overall Study|Incomplete data|0|||
149232860|NCT00953017|538322465|FG003|Overall Study|Incomplete data|0|||
149232861|NCT00953017|538322462|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
149232862|NCT00953017|538322463|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
149232863|NCT00953017|538322464|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
149232864|NCT00953017|538322465|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
149232865|NCT00953017|538322462|FG000|Overall Study|Brown stool prior to procedure|0|||
149232866|NCT00953017|538322463|FG001|Overall Study|Brown stool prior to procedure|0|||
149232867|NCT00953017|538322464|FG002|Overall Study|Brown stool prior to procedure|1|||
149232868|NCT00953017|538322465|FG003|Overall Study|Brown stool prior to procedure|0|||
149232869|NCT01300741|538322466|FG000|Overall Study|Lens deposits|1|||
149232870|NCT01300741|538322466|FG000|Overall Study|Lost to Follow-up|1|||
149232871|NCT01300741|538322466|FG000|Overall Study|Discomfort|1|||
149232872|NCT01548573|538322468|FG000|Overall Study|Death|3|||
149232873|NCT01548573|538322468|FG000|Overall Study|Withdrawal by Subject|2|||
149232874|NCT00290511|538322474|FG000|Overall Study|Adverse Event|1|||
149232875|NCT00290511|538322474|FG000|Overall Study|Death|1|||
149232876|NCT00290511|538322474|FG000|Overall Study|Physician Decision|1|||
149232877|NCT00290511|538322474|FG000|Overall Study|Withdrawal by Subject|1|||
149232878|NCT00558831|538322475|FG000|Overall Study|Lost to Follow-up|1|||
149232879|NCT00447265|538322476|FG000|Overall Study|Physician Decision|1|||
149232880|NCT00447265|538322477|FG001|Overall Study|Physician Decision|0|||
149232881|NCT03557775|538322478|FG000|Overall Study|Withdrawal by Subject|1|||
149232882|NCT03557775|538322479|FG001|Overall Study|Withdrawal by Subject|2|||
149232883|NCT03557775|538322480|FG002|Overall Study|Withdrawal by Subject|4|||
149232884|NCT03557775|538322478|FG000|Overall Study|Physician Decision|0|||
149232885|NCT03557775|538322479|FG001|Overall Study|Physician Decision|1|||
149232886|NCT03557775|538322480|FG002|Overall Study|Physician Decision|0|||
149232887|NCT00276458|538322487|FG000|Overall Study|Adverse Event|0|||
149232888|NCT00276458|538322488|FG001|Overall Study|Adverse Event|2|||
149232889|NCT00276458|538322487|FG000|Overall Study|Lost to Follow-up|2|||
149232890|NCT00276458|538322488|FG001|Overall Study|Lost to Follow-up|2|||
149232891|NCT00276458|538322487|FG000|Overall Study|Protocol Violation|4|||
148690321|NCT04700449|536340200|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
148690322|NCT04700449|536340197|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
148690323|NCT04700449|536340198|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
148690324|NCT04700449|536340199|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
148690325|NCT04700449|536340200|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
148690326|NCT04700449|536340197|FG000|Stage 2 Sub-study 1|Other|1|||
148690327|NCT04700449|536340198|FG001|Stage 2 Sub-study 1|Other|2|||
148690328|NCT04700449|536340199|FG002|Stage 2 Sub-study 1|Other|0|||
148690329|NCT04700449|536340200|FG003|Stage 2 Sub-study 1|Other|0|||
148690330|NCT04700449|536340197|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
148690331|NCT04700449|536340198|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
148690332|NCT04700449|536340199|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
148690333|NCT04700449|536340200|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
148690334|NCT04700449|536340197|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
148690335|NCT04700449|536340198|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
148690336|NCT04700449|536340199|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
148690337|NCT04700449|536340200|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
148690338|NCT04700449|536340197|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
148690339|NCT04700449|536340198|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
149232892|NCT00276458|538322488|FG001|Overall Study|Protocol Violation|3|||
149232893|NCT01428882|538322489|FG000|Overall Study|Lack of Efficacy|2|||
149232894|NCT01428882|538322490|FG001|Overall Study|Lack of Efficacy|7|||
148690340|NCT04700449|536340199|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
148690341|NCT04700449|536340200|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
148690342|NCT04700449|536340197|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
148690343|NCT04700449|536340198|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
148690344|NCT04700449|536340199|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
148690345|NCT04700449|536340200|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
148690346|NCT04700449|536340197|FG000|Stage 2 Sub-study 2|Other|0|||
148690347|NCT04700449|536340198|FG001|Stage 2 Sub-study 2|Other|0|||
148690348|NCT04700449|536340199|FG002|Stage 2 Sub-study 2|Other|0|||
148690349|NCT04700449|536340200|FG003|Stage 2 Sub-study 2|Other|5|||
148690350|NCT02336737|536340201|FG000|Overall Study|Withdrawal by Subject|5|||
148954517|NCT02282020|537317113|FG001|Overall Study|Objective Disease Progression|30|||
148690351|NCT02336737|536340201|FG000|Overall Study|Physician Decision|8|||
148690352|NCT02396381|536340202|FG000|Overall Study|Adverse Event|3|||
149232895|NCT01428882|538322489|FG000|Overall Study|Protocol Violation|4|||
149232896|NCT01428882|538322490|FG001|Overall Study|Protocol Violation|3|||
149232897|NCT01049360|538322496|FG000|Period 1|Adverse Event|0|||
149232898|NCT01049360|538322497|FG001|Period 1|Adverse Event|1|||
149232899|NCT01049360|538322498|FG002|Period 1|Adverse Event|0|||
149232900|NCT01049360|538322499|FG003|Period 1|Adverse Event|1|||
149232901|NCT01049360|538322500|FG004|Period 1|Adverse Event|0|||
149232902|NCT01049360|538322501|FG005|Period 1|Adverse Event|0|||
149232903|NCT01049360|538322502|FG006|Period 1|Adverse Event|0|||
149232904|NCT01049360|538322503|FG007|Period 1|Adverse Event|1|||
149232905|NCT01049360|538322504|FG008|Period 1|Adverse Event|0|||
149232906|NCT01049360|538322505|FG009|Period 1|Adverse Event|0|||
148690353|NCT02396381|536340203|FG001|Overall Study|Adverse Event|2|||
148690354|NCT02396381|536340202|FG000|Overall Study|Withdrawal by Subject|33|||
148690355|NCT02396381|536340203|FG001|Overall Study|Withdrawal by Subject|24|||
148690356|NCT02396381|536340202|FG000|Overall Study|Lost to Follow-up|49|||
148690357|NCT02396381|536340203|FG001|Overall Study|Lost to Follow-up|31|||
148690358|NCT02396381|536340202|FG000|Overall Study|Protocol Violation|1|||
148690359|NCT02396381|536340203|FG001|Overall Study|Protocol Violation|0|||
148690360|NCT02396381|536340202|FG000|Overall Study|Site terminated by sponsor|7|||
148690361|NCT02396381|536340203|FG001|Overall Study|Site terminated by sponsor|8|||
148690362|NCT02396381|536340202|FG000|Overall Study|Physician Decision|5|||
148690363|NCT02396381|536340203|FG001|Overall Study|Physician Decision|5|||
148690364|NCT02396381|536340202|FG000|Overall Study|Pregnancy|2|||
148690365|NCT02396381|536340203|FG001|Overall Study|Pregnancy|0|||
148690366|NCT02396381|536340202|FG000|Overall Study|Non-compliance with study procedures|1|||
148690367|NCT02396381|536340203|FG001|Overall Study|Non-compliance with study procedures|0|||
148690368|NCT02396381|536340202|FG000|Overall Study|Moved out of town/state|1|||
148690369|NCT02396381|536340203|FG001|Overall Study|Moved out of town/state|3|||
148690370|NCT02396381|536340202|FG000|Overall Study|Could not complete visit|1|||
148690371|NCT02396381|536340203|FG001|Overall Study|Could not complete visit|0|||
148690372|NCT02396381|536340202|FG000|Overall Study|Possible conflict of interest|1|||
148690373|NCT02396381|536340203|FG001|Overall Study|Possible conflict of interest|0|||
148690374|NCT02396381|536340202|FG000|Overall Study|Randomization/Screening Error|3|||
148690375|NCT02396381|536340203|FG001|Overall Study|Randomization/Screening Error|1|||
148690376|NCT00356200|536340205|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
148690377|NCT00356200|536340206|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
148690378|NCT00356200|536340205|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
148690379|NCT00356200|536340206|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
148690380|NCT00635778|536340207|FG000|Overall Study|Adverse Event|1|||
148690381|NCT00635778|536340208|FG001|Overall Study|Adverse Event|0|||
148690382|NCT00635778|536340209|FG002|Overall Study|Adverse Event|0|||
148690383|NCT00635778|536340210|FG003|Overall Study|Adverse Event|3|||
148690384|NCT00635778|536340211|FG004|Overall Study|Adverse Event|3|||
148690385|NCT00635778|536340212|FG005|Overall Study|Adverse Event|6|||
148690386|NCT00635778|536340213|FG006|Overall Study|Adverse Event|1|||
148690387|NCT00635778|536340207|FG000|Overall Study|Withdrawal by Subject|0|||
148690388|NCT00635778|536340208|FG001|Overall Study|Withdrawal by Subject|0|||
148690389|NCT00635778|536340209|FG002|Overall Study|Withdrawal by Subject|0|||
148690390|NCT00635778|536340210|FG003|Overall Study|Withdrawal by Subject|1|||
148690391|NCT00635778|536340211|FG004|Overall Study|Withdrawal by Subject|0|||
148690392|NCT00635778|536340212|FG005|Overall Study|Withdrawal by Subject|1|||
148690393|NCT00635778|536340213|FG006|Overall Study|Withdrawal by Subject|1|||
148690394|NCT00635778|536340207|FG000|Overall Study|Progressive disease|0|||
148690395|NCT00635778|536340208|FG001|Overall Study|Progressive disease|3|||
148690396|NCT00635778|536340209|FG002|Overall Study|Progressive disease|3|||
148690397|NCT00635778|536340210|FG003|Overall Study|Progressive disease|4|||
148690398|NCT00635778|536340211|FG004|Overall Study|Progressive disease|5|||
148690399|NCT00635778|536340212|FG005|Overall Study|Progressive disease|14|||
148690400|NCT00635778|536340213|FG006|Overall Study|Progressive disease|4|||
148690401|NCT00812253|536340214|FG000|Overall Study|Withdrawal by Subject|3|||
148690402|NCT00812253|536340215|FG001|Overall Study|Withdrawal by Subject|2|||
148690403|NCT00812253|536340214|FG000|Overall Study|Protocol Violation|1|||
148690404|NCT00812253|536340215|FG001|Overall Study|Protocol Violation|1|||
148690405|NCT00812253|536340214|FG000|Overall Study|Lost to Follow-up|2|||
148690406|NCT00812253|536340215|FG001|Overall Study|Lost to Follow-up|0|||
148690407|NCT01884025|536340216|FG000|Overall Study|Lost to Follow-up|3|||
148690408|NCT01884025|536340217|FG001|Overall Study|Lost to Follow-up|4|||
148690409|NCT02655237|536340223|FG000|Overall Study|Adverse Event|10|||
148690410|NCT02655237|536340224|FG001|Overall Study|Adverse Event|7|||
148690411|NCT02655237|536340223|FG000|Overall Study|Protocol Deviation|2|||
148690412|NCT02655237|536340224|FG001|Overall Study|Protocol Deviation|0|||
148690413|NCT02655237|536340223|FG000|Overall Study|Withdrawal by Participant|1|||
148690414|NCT02655237|536340224|FG001|Overall Study|Withdrawal by Participant|2|||
148690415|NCT02655237|536340223|FG000|Overall Study|Lack of Efficacy|0|||
148954518|NCT02282020|537317112|FG000|Overall Study|Adverse Event|18|||
148954519|NCT02282020|537317113|FG001|Overall Study|Adverse Event|15|||
148690416|NCT02655237|536340224|FG001|Overall Study|Lack of Efficacy|1|||
148690417|NCT02655237|536340223|FG000|Overall Study|Recovery Leading to Surgery|2|||
148810697|NCT02178956|536784573|FG000|Overall Study|Sponsor terminated study|49|||
148690418|NCT02655237|536340224|FG001|Overall Study|Recovery Leading to Surgery|1|||
148690419|NCT02655237|536340223|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
148690420|NCT02655237|536340224|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
148690421|NCT02655237|536340223|FG000|Overall Study|Randomized but Not Treated|1|||
148690422|NCT02655237|536340224|FG001|Overall Study|Randomized but Not Treated|0|||
148690423|NCT03679741|536340225|FG000|Period 1|No longer meet eligibility criteria|1|||
148690424|NCT03679741|536340226|FG001|Period 1|No longer meet eligibility criteria|0|||
148690425|NCT03679741|536340225|FG000|Period 1|Lost to Follow-up|0|||
148690426|NCT03679741|536340226|FG001|Period 1|Lost to Follow-up|1|||
149232907|NCT01049360|538322506|FG010|Period 1|Adverse Event|0|||
149232908|NCT01049360|538322507|FG011|Period 1|Adverse Event|0|||
149232909|NCT01049360|538322508|FG012|Period 1|Adverse Event|1|||
149232910|NCT01049360|538322509|FG013|Period 1|Adverse Event|1|||
149232911|NCT01049360|538322510|FG014|Period 1|Adverse Event|0|||
149232912|NCT01049360|538322511|FG015|Period 1|Adverse Event|0|||
149232913|NCT01049360|538322512|FG016|Period 1|Adverse Event|1|||
149232914|NCT01049360|538322513|FG017|Period 1|Adverse Event|0|||
149232915|NCT01049360|538322514|FG018|Period 1|Adverse Event|1|||
149232916|NCT01049360|538322515|FG019|Period 1|Adverse Event|0|||
149232917|NCT01049360|538322496|FG000|Period 1|Did not meet inc/exc criteria|0|||
149232918|NCT01049360|538322497|FG001|Period 1|Did not meet inc/exc criteria|0|||
149232919|NCT01049360|538322498|FG002|Period 1|Did not meet inc/exc criteria|0|||
149232920|NCT01049360|538322499|FG003|Period 1|Did not meet inc/exc criteria|0|||
149232921|NCT01049360|538322500|FG004|Period 1|Did not meet inc/exc criteria|0|||
149232922|NCT01049360|538322501|FG005|Period 1|Did not meet inc/exc criteria|0|||
149232923|NCT01049360|538322502|FG006|Period 1|Did not meet inc/exc criteria|0|||
149232924|NCT01049360|538322503|FG007|Period 1|Did not meet inc/exc criteria|1|||
149232925|NCT01049360|538322504|FG008|Period 1|Did not meet inc/exc criteria|1|||
149232926|NCT01049360|538322505|FG009|Period 1|Did not meet inc/exc criteria|0|||
149232927|NCT01049360|538322506|FG010|Period 1|Did not meet inc/exc criteria|0|||
149232928|NCT01049360|538322507|FG011|Period 1|Did not meet inc/exc criteria|0|||
149232929|NCT01049360|538322508|FG012|Period 1|Did not meet inc/exc criteria|0|||
149232930|NCT01049360|538322509|FG013|Period 1|Did not meet inc/exc criteria|0|||
149232931|NCT01049360|538322510|FG014|Period 1|Did not meet inc/exc criteria|0|||
149232932|NCT01049360|538322511|FG015|Period 1|Did not meet inc/exc criteria|0|||
149232933|NCT01049360|538322512|FG016|Period 1|Did not meet inc/exc criteria|0|||
149232934|NCT01049360|538322513|FG017|Period 1|Did not meet inc/exc criteria|0|||
149232935|NCT01049360|538322514|FG018|Period 1|Did not meet inc/exc criteria|0|||
149232936|NCT01049360|538322515|FG019|Period 1|Did not meet inc/exc criteria|0|||
149232937|NCT01049360|538322496|FG000|Period 1|Withdrawal by Subject|0|||
149232938|NCT01049360|538322497|FG001|Period 1|Withdrawal by Subject|0|||
149232939|NCT01049360|538322498|FG002|Period 1|Withdrawal by Subject|0|||
149232940|NCT01049360|538322499|FG003|Period 1|Withdrawal by Subject|0|||
149232941|NCT01049360|538322500|FG004|Period 1|Withdrawal by Subject|0|||
149232942|NCT01049360|538322501|FG005|Period 1|Withdrawal by Subject|0|||
149232943|NCT01049360|538322502|FG006|Period 1|Withdrawal by Subject|0|||
149232944|NCT01049360|538322503|FG007|Period 1|Withdrawal by Subject|0|||
149232945|NCT01049360|538322504|FG008|Period 1|Withdrawal by Subject|1|||
149232946|NCT01049360|538322505|FG009|Period 1|Withdrawal by Subject|0|||
149232947|NCT01049360|538322506|FG010|Period 1|Withdrawal by Subject|1|||
149232948|NCT01049360|538322507|FG011|Period 1|Withdrawal by Subject|0|||
149232949|NCT01049360|538322508|FG012|Period 1|Withdrawal by Subject|1|||
149232950|NCT01049360|538322509|FG013|Period 1|Withdrawal by Subject|0|||
149232951|NCT01049360|538322510|FG014|Period 1|Withdrawal by Subject|0|||
149232952|NCT01049360|538322511|FG015|Period 1|Withdrawal by Subject|0|||
149232953|NCT01049360|538322512|FG016|Period 1|Withdrawal by Subject|0|||
149232954|NCT01049360|538322513|FG017|Period 1|Withdrawal by Subject|0|||
149232955|NCT01049360|538322514|FG018|Period 1|Withdrawal by Subject|0|||
149020369|NCT02268552|537552631|FG005|Part 1|Subject/guardian decision|0|||
149232956|NCT01049360|538322515|FG019|Period 1|Withdrawal by Subject|0|||
149232957|NCT01049360|538322496|FG000|Period 2|Protocol Violation|0|||
149232958|NCT01049360|538322497|FG001|Period 2|Protocol Violation|0|||
149232959|NCT01049360|538322498|FG002|Period 2|Protocol Violation|0|||
149232960|NCT01049360|538322499|FG003|Period 2|Protocol Violation|1|||
149232961|NCT01049360|538322500|FG004|Period 2|Protocol Violation|0|||
149232962|NCT01049360|538322501|FG005|Period 2|Protocol Violation|0|||
149232963|NCT01049360|538322502|FG006|Period 2|Protocol Violation|0|||
149232964|NCT01049360|538322503|FG007|Period 2|Protocol Violation|0|||
149232965|NCT01049360|538322504|FG008|Period 2|Protocol Violation|0|||
149232966|NCT01049360|538322505|FG009|Period 2|Protocol Violation|0|||
149232967|NCT01049360|538322506|FG010|Period 2|Protocol Violation|0|||
149232968|NCT01049360|538322507|FG011|Period 2|Protocol Violation|0|||
149232969|NCT01049360|538322508|FG012|Period 2|Protocol Violation|0|||
149232970|NCT01049360|538322509|FG013|Period 2|Protocol Violation|0|||
149232971|NCT01049360|538322510|FG014|Period 2|Protocol Violation|1|||
149232972|NCT01049360|538322511|FG015|Period 2|Protocol Violation|1|||
149232973|NCT01049360|538322512|FG016|Period 2|Protocol Violation|0|||
149232974|NCT01049360|538322513|FG017|Period 2|Protocol Violation|0|||
149232975|NCT01049360|538322514|FG018|Period 2|Protocol Violation|0|||
149232976|NCT01049360|538322515|FG019|Period 2|Protocol Violation|0|||
149232977|NCT01049360|538322496|FG000|Period 2|Adverse Event|0|||
149232978|NCT01049360|538322497|FG001|Period 2|Adverse Event|1|||
149232979|NCT01049360|538322498|FG002|Period 2|Adverse Event|0|||
149232980|NCT01049360|538322499|FG003|Period 2|Adverse Event|0|||
149232981|NCT01049360|538322500|FG004|Period 2|Adverse Event|0|||
149232982|NCT01049360|538322501|FG005|Period 2|Adverse Event|0|||
149232983|NCT01049360|538322502|FG006|Period 2|Adverse Event|0|||
149232984|NCT01049360|538322503|FG007|Period 2|Adverse Event|0|||
149232985|NCT01049360|538322504|FG008|Period 2|Adverse Event|1|||
149232986|NCT01049360|538322505|FG009|Period 2|Adverse Event|0|||
149232987|NCT01049360|538322506|FG010|Period 2|Adverse Event|0|||
149232988|NCT01049360|538322507|FG011|Period 2|Adverse Event|0|||
149232989|NCT01049360|538322508|FG012|Period 2|Adverse Event|0|||
149232990|NCT01049360|538322509|FG013|Period 2|Adverse Event|0|||
149232991|NCT01049360|538322510|FG014|Period 2|Adverse Event|0|||
149232992|NCT01049360|538322511|FG015|Period 2|Adverse Event|0|||
149232993|NCT01049360|538322512|FG016|Period 2|Adverse Event|0|||
149232994|NCT01049360|538322513|FG017|Period 2|Adverse Event|0|||
149232995|NCT01049360|538322514|FG018|Period 2|Adverse Event|0|||
149232996|NCT01049360|538322515|FG019|Period 2|Adverse Event|1|||
149232997|NCT01049360|538322496|FG000|Period 2|Withdrawal by Subject|0|||
149232998|NCT01049360|538322497|FG001|Period 2|Withdrawal by Subject|0|||
149232999|NCT01049360|538322498|FG002|Period 2|Withdrawal by Subject|0|||
149233000|NCT01049360|538322499|FG003|Period 2|Withdrawal by Subject|1|||
149233001|NCT01049360|538322500|FG004|Period 2|Withdrawal by Subject|0|||
149233002|NCT01049360|538322501|FG005|Period 2|Withdrawal by Subject|0|||
149020370|NCT02268552|537552632|FG006|Part 1|Subject/guardian decision|0|||
149233003|NCT01049360|538322502|FG006|Period 2|Withdrawal by Subject|0|||
149233004|NCT01049360|538322503|FG007|Period 2|Withdrawal by Subject|0|||
149233005|NCT01049360|538322504|FG008|Period 2|Withdrawal by Subject|0|||
149233006|NCT01049360|538322505|FG009|Period 2|Withdrawal by Subject|0|||
149233007|NCT01049360|538322506|FG010|Period 2|Withdrawal by Subject|0|||
148690427|NCT03679741|536340225|FG000|Period 1|Adverse Event|1|||
148690428|NCT03679741|536340226|FG001|Period 1|Adverse Event|1|||
148690429|NCT03679741|536340225|FG000|Period 1|Withdrawal by Subject|0|||
148690430|NCT03679741|536340226|FG001|Period 1|Withdrawal by Subject|1|||
148690431|NCT03679741|536340225|FG000|Period 2|Adverse Event|2|||
148690432|NCT03679741|536340226|FG001|Period 2|Adverse Event|1|||
148690433|NCT03679741|536340225|FG000|Period 2|Withdrawal by Subject|1|||
148690434|NCT03679741|536340226|FG001|Period 2|Withdrawal by Subject|1|||
148690435|NCT01000337|536340231|FG000|Overall Study|Lost to Follow-up|4|||
148690436|NCT01000337|536340232|FG001|Overall Study|Lost to Follow-up|3|||
148690437|NCT02750761|536340233|FG000|Overall Study|Lost to Follow-up|0|||
148690438|NCT02750761|536340234|FG001|Overall Study|Lost to Follow-up|0|||
148690439|NCT02750761|536340235|FG002|Overall Study|Lost to Follow-up|1|||
148690440|NCT02750761|536340236|FG003|Overall Study|Lost to Follow-up|0|||
148690441|NCT02750761|536340237|FG004|Overall Study|Lost to Follow-up|0|||
148690442|NCT02750761|536340238|FG005|Overall Study|Lost to Follow-up|0|||
148690443|NCT02227862|536340239|FG000|Overall Study|Protocol Violation|7|||
148690444|NCT02227862|536340240|FG001|Overall Study|Protocol Violation|9|||
148690445|NCT02227862|536340239|FG000|Overall Study|Other|0|||
148690446|NCT02227862|536340240|FG001|Overall Study|Other|2|||
148690447|NCT02227862|536340239|FG000|Overall Study|Adverse Event|4|||
148690448|NCT02227862|536340240|FG001|Overall Study|Adverse Event|3|||
148690449|NCT02227862|536340239|FG000|Overall Study|Withdrawal by Subject|7|||
148690450|NCT02227862|536340240|FG001|Overall Study|Withdrawal by Subject|6|||
148690451|NCT02227862|536340239|FG000|Overall Study|Lost to Follow-up|1|||
148690452|NCT02227862|536340240|FG001|Overall Study|Lost to Follow-up|2|||
148690453|NCT01612000|536340242|FG000|Overall Study|Lost to Follow-up|6|||
148690454|NCT01612000|536340243|FG001|Overall Study|Lost to Follow-up|4|||
148690455|NCT01612000|536340244|FG002|Overall Study|Lost to Follow-up|4|||
148690456|NCT01612000|536340245|FG003|Overall Study|Lost to Follow-up|8|||
148690457|NCT01612000|536340242|FG000|Overall Study|Physician Decision|0|||
148690458|NCT01612000|536340243|FG001|Overall Study|Physician Decision|0|||
148690459|NCT01612000|536340244|FG002|Overall Study|Physician Decision|1|||
148690460|NCT01612000|536340245|FG003|Overall Study|Physician Decision|0|||
148690461|NCT01612000|536340242|FG000|Overall Study|Withdrawal by Subject|3|||
148690462|NCT01612000|536340243|FG001|Overall Study|Withdrawal by Subject|1|||
148690463|NCT01612000|536340244|FG002|Overall Study|Withdrawal by Subject|2|||
148690464|NCT01612000|536340245|FG003|Overall Study|Withdrawal by Subject|2|||
148690465|NCT02173704|536340246|FG000|Overall Study|Adverse Event|1|||
148690466|NCT02173704|536340247|FG001|Overall Study|Adverse Event|0|||
148690467|NCT02173704|536340246|FG000|Overall Study|Lost to Follow-up|1|||
148690468|NCT02173704|536340247|FG001|Overall Study|Lost to Follow-up|0|||
148690469|NCT02173704|536340246|FG000|Overall Study|Other|1|||
148690470|NCT02173704|536340247|FG001|Overall Study|Other|0|||
148690471|NCT02173704|536340246|FG000|Overall Study|Protocol Violation|1|||
148690472|NCT02173704|536340247|FG001|Overall Study|Protocol Violation|0|||
148690473|NCT02173704|536340246|FG000|Overall Study|Withdrawal by Subject|9|||
148690474|NCT02173704|536340247|FG001|Overall Study|Withdrawal by Subject|4|||
148690475|NCT00419926|536340248|FG000|Overall Study|Withdrawal by Subject|7|||
148690476|NCT00419926|536340249|FG001|Overall Study|Withdrawal by Subject|3|||
148690477|NCT00419926|536340248|FG000|Overall Study|Administrative Problem|4|||
148690478|NCT00419926|536340249|FG001|Overall Study|Administrative Problem|4|||
148690479|NCT00419926|536340248|FG000|Overall Study|Lost to Follow-up|1|||
148690480|NCT00419926|536340249|FG001|Overall Study|Lost to Follow-up|2|||
148690481|NCT00419926|536340248|FG000|Overall Study|Death|2|||
148690482|NCT00419926|536340249|FG001|Overall Study|Death|1|||
148690483|NCT01816477|536340254|FG000|Overall Study|Withdrawal by Subject|13|||
148690484|NCT01816477|536340255|FG001|Overall Study|Withdrawal by Subject|1|||
148690485|NCT01816477|536340254|FG000|Overall Study|Unable to tolerate catheter placement|3|||
148690486|NCT01816477|536340255|FG001|Overall Study|Unable to tolerate catheter placement|0|||
148690487|NCT02116803|536340256|FG000|Overall Study|Adverse Event|2|||
148690488|NCT02116803|536340257|FG001|Overall Study|Adverse Event|1|||
148690489|NCT02116803|536340256|FG000|Overall Study|Physician Decision|1|||
148690490|NCT02116803|536340257|FG001|Overall Study|Physician Decision|0|||
148690491|NCT02116803|536340256|FG000|Overall Study|Progressive disease|4|||
148690492|NCT02116803|536340257|FG001|Overall Study|Progressive disease|0|||
148690493|NCT02116803|536340256|FG000|Overall Study|Study terminated by sponsor|2|||
148690494|NCT02116803|536340257|FG001|Overall Study|Study terminated by sponsor|1|||
148690495|NCT02116803|536340256|FG000|Overall Study|Death|1|||
148690496|NCT02116803|536340257|FG001|Overall Study|Death|0|||
148690497|NCT05476679|536340261|FG000|Overall Study|Withdrawal by Subject|0|||
148690498|NCT05476679|536340262|FG001|Overall Study|Withdrawal by Subject|0|||
148690499|NCT05476679|536340263|FG002|Overall Study|Withdrawal by Subject|0|||
148690500|NCT05476679|536340264|FG003|Overall Study|Withdrawal by Subject|1|||
148690501|NCT05476679|536340265|FG004|Overall Study|Withdrawal by Subject|0|||
148690502|NCT05476679|536340261|FG000|Overall Study|Lost to Follow-up|0|||
148690503|NCT05476679|536340262|FG001|Overall Study|Lost to Follow-up|0|||
148690504|NCT05476679|536340263|FG002|Overall Study|Lost to Follow-up|0|||
148690505|NCT05476679|536340264|FG003|Overall Study|Lost to Follow-up|1|||
148690506|NCT05476679|536340265|FG004|Overall Study|Lost to Follow-up|0|||
149233008|NCT01049360|538322507|FG011|Period 2|Withdrawal by Subject|0|||
149233009|NCT01049360|538322508|FG012|Period 2|Withdrawal by Subject|0|||
149233010|NCT01049360|538322509|FG013|Period 2|Withdrawal by Subject|0|||
149233011|NCT01049360|538322510|FG014|Period 2|Withdrawal by Subject|1|||
149233012|NCT01049360|538322511|FG015|Period 2|Withdrawal by Subject|0|||
149233013|NCT01049360|538322512|FG016|Period 2|Withdrawal by Subject|0|||
149233014|NCT01049360|538322513|FG017|Period 2|Withdrawal by Subject|0|||
149233015|NCT01049360|538322514|FG018|Period 2|Withdrawal by Subject|0|||
149233016|NCT01049360|538322515|FG019|Period 2|Withdrawal by Subject|1|||
149233017|NCT01049360|538322496|FG000|Period 2|Lack of Efficacy|0|||
149233018|NCT01049360|538322497|FG001|Period 2|Lack of Efficacy|0|||
149233019|NCT01049360|538322498|FG002|Period 2|Lack of Efficacy|0|||
149233020|NCT01049360|538322499|FG003|Period 2|Lack of Efficacy|0|||
149233021|NCT01049360|538322500|FG004|Period 2|Lack of Efficacy|0|||
149233022|NCT01049360|538322501|FG005|Period 2|Lack of Efficacy|1|||
149233023|NCT01049360|538322502|FG006|Period 2|Lack of Efficacy|0|||
149233024|NCT01049360|538322503|FG007|Period 2|Lack of Efficacy|0|||
149233025|NCT01049360|538322504|FG008|Period 2|Lack of Efficacy|0|||
149233026|NCT01049360|538322505|FG009|Period 2|Lack of Efficacy|0|||
149233027|NCT01049360|538322506|FG010|Period 2|Lack of Efficacy|0|||
149233028|NCT01049360|538322507|FG011|Period 2|Lack of Efficacy|0|||
149233029|NCT01049360|538322508|FG012|Period 2|Lack of Efficacy|0|||
149233030|NCT01049360|538322509|FG013|Period 2|Lack of Efficacy|0|||
149233031|NCT01049360|538322510|FG014|Period 2|Lack of Efficacy|0|||
149233032|NCT01049360|538322511|FG015|Period 2|Lack of Efficacy|0|||
149233033|NCT01049360|538322512|FG016|Period 2|Lack of Efficacy|0|||
149233034|NCT01049360|538322513|FG017|Period 2|Lack of Efficacy|0|||
149233035|NCT01049360|538322514|FG018|Period 2|Lack of Efficacy|0|||
149233036|NCT01049360|538322515|FG019|Period 2|Lack of Efficacy|0|||
149233037|NCT01049360|538322496|FG000|Period 4|Protocol Violation|0|||
149233038|NCT01049360|538322497|FG001|Period 4|Protocol Violation|0|||
149233039|NCT01049360|538322498|FG002|Period 4|Protocol Violation|0|||
149233040|NCT01049360|538322499|FG003|Period 4|Protocol Violation|0|||
149233041|NCT01049360|538322500|FG004|Period 4|Protocol Violation|0|||
149233042|NCT01049360|538322501|FG005|Period 4|Protocol Violation|0|||
149233043|NCT01049360|538322502|FG006|Period 4|Protocol Violation|0|||
149233044|NCT01049360|538322503|FG007|Period 4|Protocol Violation|0|||
149233045|NCT01049360|538322504|FG008|Period 4|Protocol Violation|0|||
149233046|NCT01049360|538322505|FG009|Period 4|Protocol Violation|0|||
149233047|NCT01049360|538322506|FG010|Period 4|Protocol Violation|0|||
149233048|NCT01049360|538322507|FG011|Period 4|Protocol Violation|0|||
149233049|NCT01049360|538322508|FG012|Period 4|Protocol Violation|0|||
149233050|NCT01049360|538322509|FG013|Period 4|Protocol Violation|0|||
149233051|NCT01049360|538322510|FG014|Period 4|Protocol Violation|0|||
149233052|NCT01049360|538322511|FG015|Period 4|Protocol Violation|0|||
149233053|NCT01049360|538322512|FG016|Period 4|Protocol Violation|0|||
149233054|NCT01049360|538322513|FG017|Period 4|Protocol Violation|1|||
149233055|NCT01049360|538322514|FG018|Period 4|Protocol Violation|0|||
149233056|NCT01049360|538322515|FG019|Period 4|Protocol Violation|0|||
149233057|NCT01049360|538322496|FG000|Period 4|Withdrawal by Subject|0|||
149233058|NCT01049360|538322497|FG001|Period 4|Withdrawal by Subject|0|||
149233059|NCT01049360|538322498|FG002|Period 4|Withdrawal by Subject|0|||
149233060|NCT01049360|538322499|FG003|Period 4|Withdrawal by Subject|1|||
149233061|NCT01049360|538322500|FG004|Period 4|Withdrawal by Subject|0|||
149233062|NCT01049360|538322501|FG005|Period 4|Withdrawal by Subject|0|||
149233063|NCT01049360|538322502|FG006|Period 4|Withdrawal by Subject|0|||
149233064|NCT01049360|538322503|FG007|Period 4|Withdrawal by Subject|0|||
149233065|NCT01049360|538322504|FG008|Period 4|Withdrawal by Subject|0|||
149233066|NCT01049360|538322505|FG009|Period 4|Withdrawal by Subject|0|||
149233067|NCT01049360|538322506|FG010|Period 4|Withdrawal by Subject|0|||
149233068|NCT01049360|538322507|FG011|Period 4|Withdrawal by Subject|0|||
149233069|NCT01049360|538322508|FG012|Period 4|Withdrawal by Subject|0|||
149233070|NCT01049360|538322509|FG013|Period 4|Withdrawal by Subject|0|||
149233071|NCT01049360|538322510|FG014|Period 4|Withdrawal by Subject|0|||
149233072|NCT01049360|538322511|FG015|Period 4|Withdrawal by Subject|0|||
149233073|NCT01049360|538322512|FG016|Period 4|Withdrawal by Subject|0|||
149233074|NCT01049360|538322513|FG017|Period 4|Withdrawal by Subject|0|||
149233075|NCT01049360|538322514|FG018|Period 4|Withdrawal by Subject|0|||
149233076|NCT01049360|538322515|FG019|Period 4|Withdrawal by Subject|0|||
149233077|NCT02304484|538322516|FG000|Overall Study|Death|9|||
149233078|NCT02304484|538322516|FG000|Overall Study|Withdrawal by Subject|14|||
149233079|NCT02304484|538322516|FG000|Overall Study|Lost to Follow-up|2|||
149233080|NCT04338685|538322517|FG000|Overall Study|Death|3|||
149233081|NCT04338685|538322518|FG001|Overall Study|Death|4|||
149233082|NCT04338685|538322519|FG002|Overall Study|Death|2|||
149233083|NCT04338685|538322520|FG003|Overall Study|Death|4|||
149233084|NCT04338685|538322521|FG004|Overall Study|Death|4|||
149233085|NCT04338685|538322522|FG005|Overall Study|Death|8|||
149233086|NCT04338685|538322523|FG006|Overall Study|Death|1|||
149233087|NCT04338685|538322524|FG007|Overall Study|Death|0|||
149233088|NCT04338685|538322525|FG008|Overall Study|Death|0|||
149233089|NCT04338685|538322517|FG000|Overall Study|Study terminated by Sponsor|0|||
149233090|NCT04338685|538322518|FG001|Overall Study|Study terminated by Sponsor|0|||
148690507|NCT00601354|536340266|FG000|Overall Study|Lost to Follow-up|4|||
148690508|NCT00601354|536340267|FG001|Overall Study|Lost to Follow-up|5|||
148690509|NCT00278512|536340269|FG000|Overall Study|Death|1|||
148690510|NCT00278512|536340270|FG001|Overall Study|Death|0|||
148690511|NCT01620177|536340271|FG000|Overall Study|Failure at Screening Visit|43|||
148690512|NCT01620177|536340271|FG000|Overall Study|Withdrawal by Subject|26|||
148690513|NCT01620177|536340271|FG000|Overall Study|Lost to Follow-up|7|||
148690514|NCT01620177|536340271|FG000|Overall Study|Physician Decision|2|||
148690515|NCT01620177|536340271|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
148690516|NCT01789320|536340275|FG000|Overall Study|Re-enrolled into study|1|||
148690517|NCT01789320|536340275|FG000|Overall Study|Lost to Follow-up|1|||
148690518|NCT00619385|536340280|FG000|Overall Study|Adverse Event|0|||
148690519|NCT00619385|536340281|FG001|Overall Study|Adverse Event|0|||
148690520|NCT00619385|536340282|FG002|Overall Study|Adverse Event|3|||
148690521|NCT00619385|536340280|FG000|Overall Study|Other|1|||
148690522|NCT00619385|536340281|FG001|Overall Study|Other|2|||
148690523|NCT00619385|536340282|FG002|Overall Study|Other|1|||
148690524|NCT03730103|536340283|FG000|Overall Study|Did not meet inclusion criteria|0|||
148690525|NCT03730103|536340284|FG001|Overall Study|Did not meet inclusion criteria|5|||
148690526|NCT02626949|536340285|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
148690527|NCT02626949|536340286|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
148690528|NCT02626949|536340285|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
148690529|NCT02626949|536340286|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
148690530|NCT02626949|536340285|FG000|Enrolled|Lost to Follow-up|7|||
148690531|NCT02626949|536340286|FG001|Enrolled|Lost to Follow-up|6|||
148690532|NCT02626949|536340285|FG000|Enrolled|Withdrawal by Subject|3|||
148690533|NCT02626949|536340286|FG001|Enrolled|Withdrawal by Subject|2|||
148690534|NCT02789111|536340287|FG000|Overall Study|Withdrawal by Subject|1|||
148690535|NCT02789111|536340288|FG001|Overall Study|Withdrawal by Subject|4|||
148690536|NCT01488578|536340289|FG000|Overall Study|Protocol Violation|1836|||
148690537|NCT02308111|536340290|FG000|Overall Study|Adverse Event|31|||
148690538|NCT02308111|536340291|FG001|Overall Study|Adverse Event|19|||
148690539|NCT02308111|536340290|FG000|Overall Study|Death|9|||
148690540|NCT02308111|536340291|FG001|Overall Study|Death|6|||
148690541|NCT02308111|536340290|FG000|Overall Study|Lost to Follow-up|2|||
148690542|NCT02308111|536340291|FG001|Overall Study|Lost to Follow-up|7|||
148690543|NCT02308111|536340290|FG000|Overall Study|Physician Decision|6|||
148690544|NCT02308111|536340291|FG001|Overall Study|Physician Decision|17|||
148690545|NCT02308111|536340290|FG000|Overall Study|Protocol Violation|0|||
148690546|NCT02308111|536340291|FG001|Overall Study|Protocol Violation|1|||
148690547|NCT02308111|536340290|FG000|Overall Study|Withdrawal by Subject|28|||
148690548|NCT02308111|536340291|FG001|Overall Study|Withdrawal by Subject|38|||
148690549|NCT02308111|536340290|FG000|Overall Study|Study Terminated by Sponsor|72|||
148690550|NCT02308111|536340291|FG001|Overall Study|Study Terminated by Sponsor|61|||
148690551|NCT02308111|536340290|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
148690552|NCT02308111|536340291|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
148690553|NCT02308111|536340290|FG000|Overall Study|Site Closure|3|||
148690554|NCT02308111|536340291|FG001|Overall Study|Site Closure|3|||
148690555|NCT02308111|536340290|FG000|Overall Study|Non-compliance with Study Drug|3|||
148690556|NCT02308111|536340291|FG001|Overall Study|Non-compliance with Study Drug|1|||
148690557|NCT02308111|536340290|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
148690558|NCT02308111|536340291|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
148690559|NCT02308111|536340290|FG000|Overall Study|Liver Transplant|3|||
148690560|NCT02308111|536340291|FG001|Overall Study|Liver Transplant|3|||
148690561|NCT02308111|536340290|FG000|Overall Study|Liver Transplant Waitlist|2|||
148690562|NCT02308111|536340291|FG001|Overall Study|Liver Transplant Waitlist|2|||
148690563|NCT02308111|536340290|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
148690564|NCT02308111|536340291|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
148690565|NCT03271528|536340293|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
148690566|NCT03271528|536340294|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
148690567|NCT03271528|536340293|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
148690568|NCT03271528|536340294|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
148690569|NCT03271528|536340293|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
148690570|NCT03271528|536340294|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
148690571|NCT03271528|536340293|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
148690572|NCT03271528|536340294|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
148690573|NCT03271528|536340293|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
148690574|NCT03271528|536340294|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
148690575|NCT03271528|536340293|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
148690576|NCT03271528|536340294|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
148690577|NCT03271528|536340293|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
149020371|NCT02268552|537552626|FG000|Part 2|Death|0|||
148690578|NCT03271528|536340294|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
148690579|NCT00717756|536340295|FG000|Overall Study|Withdrawal by Subject|1|||
148690580|NCT00673790|536340296|FG000|Overall Study|Adverse Event|23|||
148690581|NCT00673790|536340297|FG001|Overall Study|Adverse Event|14|||
148690582|NCT00673790|536340298|FG002|Overall Study|Adverse Event|2|||
148690583|NCT00673790|536340296|FG000|Overall Study|Lack of Efficacy|2|||
149233091|NCT04338685|538322519|FG002|Overall Study|Study terminated by Sponsor|1|||
149233092|NCT04338685|538322520|FG003|Overall Study|Study terminated by Sponsor|4|||
149233093|NCT04338685|538322521|FG004|Overall Study|Study terminated by Sponsor|0|||
149233094|NCT04338685|538322522|FG005|Overall Study|Study terminated by Sponsor|5|||
149233095|NCT04338685|538322523|FG006|Overall Study|Study terminated by Sponsor|2|||
149233096|NCT04338685|538322524|FG007|Overall Study|Study terminated by Sponsor|4|||
149233097|NCT04338685|538322525|FG008|Overall Study|Study terminated by Sponsor|1|||
149233098|NCT04338685|538322517|FG000|Overall Study|Withdrawal by Subject|1|||
149233099|NCT04338685|538322518|FG001|Overall Study|Withdrawal by Subject|2|||
149233100|NCT04338685|538322519|FG002|Overall Study|Withdrawal by Subject|0|||
149233101|NCT04338685|538322520|FG003|Overall Study|Withdrawal by Subject|2|||
149233102|NCT04338685|538322521|FG004|Overall Study|Withdrawal by Subject|0|||
149233103|NCT04338685|538322522|FG005|Overall Study|Withdrawal by Subject|5|||
149233104|NCT04338685|538322523|FG006|Overall Study|Withdrawal by Subject|1|||
149233105|NCT04338685|538322524|FG007|Overall Study|Withdrawal by Subject|1|||
149233106|NCT04338685|538322525|FG008|Overall Study|Withdrawal by Subject|0|||
149233107|NCT00976989|538322526|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
148690584|NCT00673790|536340297|FG001|Overall Study|Lack of Efficacy|2|||
148690585|NCT00673790|536340298|FG002|Overall Study|Lack of Efficacy|2|||
148690586|NCT00673790|536340296|FG000|Overall Study|Protocol Violation|6|||
148690587|NCT00673790|536340297|FG001|Overall Study|Protocol Violation|9|||
148690588|NCT00673790|536340298|FG002|Overall Study|Protocol Violation|1|||
148690589|NCT00673790|536340296|FG000|Overall Study|Withdrawal by Subject|7|||
148690590|NCT00673790|536340297|FG001|Overall Study|Withdrawal by Subject|4|||
148690591|NCT00673790|536340298|FG002|Overall Study|Withdrawal by Subject|1|||
148690592|NCT00673790|536340296|FG000|Overall Study|Lost to Follow-up|6|||
148690593|NCT00673790|536340297|FG001|Overall Study|Lost to Follow-up|6|||
148690594|NCT00673790|536340298|FG002|Overall Study|Lost to Follow-up|5|||
148690595|NCT00673790|536340296|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
148690596|NCT00673790|536340297|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
148690597|NCT00673790|536340298|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
148690598|NCT00673790|536340296|FG000|Overall Study|Poor compliance|1|||
148690599|NCT00673790|536340297|FG001|Overall Study|Poor compliance|0|||
148690600|NCT00673790|536340298|FG002|Overall Study|Poor compliance|0|||
148690601|NCT00673790|536340296|FG000|Overall Study|Participated in two Nebivolol studies|0|||
148690602|NCT00673790|536340297|FG001|Overall Study|Participated in two Nebivolol studies|0|||
148690603|NCT00673790|536340298|FG002|Overall Study|Participated in two Nebivolol studies|1|||
148690604|NCT00673790|536340296|FG000|Overall Study|Unconfirmed pregnancy|0|||
148690605|NCT00673790|536340297|FG001|Overall Study|Unconfirmed pregnancy|1|||
148690606|NCT00673790|536340298|FG002|Overall Study|Unconfirmed pregnancy|0|||
148690607|NCT00673790|536340296|FG000|Overall Study|Randomization criteria not met|0|||
148690608|NCT00673790|536340297|FG001|Overall Study|Randomization criteria not met|1|||
148690609|NCT00673790|536340298|FG002|Overall Study|Randomization criteria not met|0|||
148690610|NCT00306384|536340299|FG000|Overall Study|Adverse Event|103|||
148690611|NCT00306384|536340300|FG001|Overall Study|Adverse Event|87|||
148690612|NCT00306384|536340301|FG002|Overall Study|Adverse Event|40|||
149233108|NCT00976989|538322527|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
149233109|NCT00976989|538322528|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
148690613|NCT00306384|536340299|FG000|Overall Study|Major protocol deviation|43|||
148690614|NCT00306384|536340300|FG001|Overall Study|Major protocol deviation|51|||
148690615|NCT00306384|536340301|FG002|Overall Study|Major protocol deviation|18|||
148690616|NCT00306384|536340299|FG000|Overall Study|Lost to Follow-up|57|||
148690617|NCT00306384|536340300|FG001|Overall Study|Lost to Follow-up|41|||
148690618|NCT00306384|536340301|FG002|Overall Study|Lost to Follow-up|35|||
148690619|NCT00306384|536340299|FG000|Overall Study|Voluntary withdrawal|199|||
148690620|NCT00306384|536340300|FG001|Overall Study|Voluntary withdrawal|187|||
148690621|NCT00306384|536340301|FG002|Overall Study|Voluntary withdrawal|91|||
148690622|NCT00306384|536340299|FG000|Overall Study|Study termination|1|||
148690623|NCT00306384|536340300|FG001|Overall Study|Study termination|0|||
148690624|NCT00306384|536340301|FG002|Overall Study|Study termination|1|||
148690625|NCT00306384|536340299|FG000|Overall Study|Pregnancy|3|||
148690626|NCT00306384|536340300|FG001|Overall Study|Pregnancy|1|||
148690627|NCT00306384|536340301|FG002|Overall Study|Pregnancy|1|||
148690628|NCT00306384|536340299|FG000|Overall Study|Lack of Efficacy|26|||
148690629|NCT00306384|536340300|FG001|Overall Study|Lack of Efficacy|40|||
148690630|NCT00306384|536340301|FG002|Overall Study|Lack of Efficacy|38|||
148690631|NCT00306384|536340299|FG000|Overall Study|Investigator discretion|28|||
149233110|NCT00976989|538322526|FG000|Overall Study|Death|5|||
149233111|NCT00976989|538322527|FG001|Overall Study|Death|7|||
149233112|NCT00976989|538322528|FG002|Overall Study|Death|10|||
148690632|NCT00306384|536340300|FG001|Overall Study|Investigator discretion|31|||
148690633|NCT00306384|536340301|FG002|Overall Study|Investigator discretion|21|||
149233113|NCT00976989|538322526|FG000|Overall Study|Refused Treatment|4|||
149233114|NCT00976989|538322527|FG001|Overall Study|Refused Treatment|3|||
149233115|NCT00976989|538322528|FG002|Overall Study|Refused Treatment|5|||
149233116|NCT00976989|538322526|FG000|Overall Study|Failure to Return|2|||
148690634|NCT00306384|536340299|FG000|Overall Study|Other|80|||
148690635|NCT00306384|536340300|FG001|Overall Study|Other|70|||
148690636|NCT00306384|536340301|FG002|Overall Study|Other|32|||
148690637|NCT00306384|536340299|FG000|Overall Study|Site closure|2|||
148690638|NCT00306384|536340300|FG001|Overall Study|Site closure|0|||
148690639|NCT00306384|536340301|FG002|Overall Study|Site closure|0|||
148690640|NCT01873859|536340304|FG000|Overall Study|Withdrawal by Subject|0|||
148690641|NCT01873859|536340305|FG001|Overall Study|Withdrawal by Subject|4|||
148690642|NCT03977584|536340306|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
148690643|NCT03977584|536340307|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
148690644|NCT03977584|536340308|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
148690645|NCT00745251|536340312|FG000|Overall Study|Adverse Event|1|||
148690646|NCT00745251|536340313|FG001|Overall Study|Adverse Event|2|||
148690647|NCT00745251|536340312|FG000|Overall Study|Withdrawal by Subject|1|||
148690648|NCT00745251|536340313|FG001|Overall Study|Withdrawal by Subject|1|||
148690649|NCT02928848|536340314|FG000|Arm 2|Withdrawal by Subject|1|||
148690650|NCT02928848|536340315|FG001|Arm 2|Withdrawal by Subject|0|||
148690651|NCT01463683|536340316|FG000|Overall Study|Adverse Event|2|||
148690652|NCT01463683|536340317|FG001|Overall Study|Adverse Event|0|||
148690653|NCT01463683|536340318|FG002|Overall Study|Adverse Event|0|||
148690654|NCT01463683|536340316|FG000|Overall Study|Lost to Follow-up|10|||
148690655|NCT01463683|536340317|FG001|Overall Study|Lost to Follow-up|9|||
148690656|NCT01463683|536340318|FG002|Overall Study|Lost to Follow-up|7|||
149233117|NCT00976989|538322527|FG001|Overall Study|Failure to Return|1|||
149233118|NCT00976989|538322528|FG002|Overall Study|Failure to Return|0|||
149233119|NCT00976989|538322526|FG000|Overall Study|Recurrence of Disease|0|||
149233120|NCT00976989|538322527|FG001|Overall Study|Recurrence of Disease|1|||
149233121|NCT00976989|538322528|FG002|Overall Study|Recurrence of Disease|0|||
149233122|NCT00976989|538322526|FG000|Overall Study|Other|1|||
149233123|NCT00976989|538322527|FG001|Overall Study|Other|0|||
149233124|NCT00976989|538322528|FG002|Overall Study|Other|1|||
149233125|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
149233126|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
149233127|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
149233128|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
149233129|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
149233130|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
149233131|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
149233132|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
149233133|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
149233134|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
149233135|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
149233136|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
149233137|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
149233138|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
149233139|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
149233140|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
149233141|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
149233142|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
148690657|NCT01463683|536340316|FG000|Overall Study|Physician Decision|0|||
149233143|NCT00570492|538322529|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
149233144|NCT00570492|538322530|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
149233145|NCT00570492|538322531|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
149233146|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
149233147|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
148690658|NCT01463683|536340317|FG001|Overall Study|Physician Decision|3|||
148690659|NCT01463683|536340318|FG002|Overall Study|Physician Decision|1|||
148690660|NCT01463683|536340316|FG000|Overall Study|Pregnancy|2|||
149233148|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
148690661|NCT01463683|536340317|FG001|Overall Study|Pregnancy|2|||
148690662|NCT01463683|536340318|FG002|Overall Study|Pregnancy|1|||
148690663|NCT01463683|536340316|FG000|Overall Study|Withdrawal by Subject|5|||
148690664|NCT01463683|536340317|FG001|Overall Study|Withdrawal by Subject|17|||
148690665|NCT01463683|536340318|FG002|Overall Study|Withdrawal by Subject|2|||
148690666|NCT03111147|536340319|FG000|Overall Study|Lost to Follow-up|2|||
149233149|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
149233150|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
149233151|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
149233152|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
149233153|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
149233154|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
149233155|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
149233156|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
149233157|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
149233158|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
149233159|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
149233160|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
149233161|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
149233162|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
149233163|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
149233164|NCT00570492|538322529|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
149233165|NCT00570492|538322530|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
149233166|NCT00570492|538322531|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
149233167|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Adverse Event|6|||
149233168|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Adverse Event|6|||
149233169|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Death|14|||
149233170|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Death|11|||
149233171|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
149233172|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
149233173|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
149233174|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
149233175|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
149233176|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
149233177|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Disease Progression|1|||
149233178|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Disease Progression|0|||
149233179|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
149233180|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
149233181|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
149233182|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
149233183|NCT04419558|538322532|FG000|DB Period (48 Weeks)|Participant Decision|4|||
149233184|NCT04419558|538322533|FG001|DB Period (48 Weeks)|Participant Decision|3|||
149233185|NCT04419558|538322532|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
149233186|NCT04419558|538322533|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
149233187|NCT04419558|538322532|FG000|OLE Period (48 Weeks)|Death|4|||
149233188|NCT04419558|538322533|FG001|OLE Period (48 Weeks)|Death|6|||
149233189|NCT04419558|538322532|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
149233190|NCT04419558|538322533|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
149233191|NCT04419558|538322532|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
149233192|NCT04419558|538322533|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
149233193|NCT00908375|538322534|FG000|Overall Study|Withdrawal by Subject|2|||
149233194|NCT00908375|538322535|FG001|Overall Study|Withdrawal by Subject|4|||
149233195|NCT00908375|538322534|FG000|Overall Study|Lost to Follow-up|8|||
149233196|NCT00908375|538322535|FG001|Overall Study|Lost to Follow-up|6|||
149233197|NCT00752206|538322536|FG000|Overall Study|Disease progression|8|||
149233198|NCT00752206|538322537|FG001|Overall Study|Disease progression|11|||
149233199|NCT00752206|538322536|FG000|Overall Study|Pregnancy|1|||
149233200|NCT00752206|538322537|FG001|Overall Study|Pregnancy|0|||
149233201|NCT01539512|538322538|FG000|Overall Study|Adverse Event|9|||
149233202|NCT01539512|538322539|FG001|Overall Study|Adverse Event|7|||
149233203|NCT01539512|538322538|FG000|Overall Study|Physician Decision|1|||
149233204|NCT01539512|538322539|FG001|Overall Study|Physician Decision|1|||
149233205|NCT01539512|538322538|FG000|Overall Study|Withdrawal by Subject|12|||
149233206|NCT01539512|538322539|FG001|Overall Study|Withdrawal by Subject|5|||
149233207|NCT01539512|538322538|FG000|Overall Study|Richter's Transformation|1|||
149233208|NCT01539512|538322539|FG001|Overall Study|Richter's Transformation|0|||
149233209|NCT01484691|538322540|FG000|Overall Study|Withdrawal by Subject|1|||
149233210|NCT01484691|538322541|FG001|Overall Study|Withdrawal by Subject|1|||
149233211|NCT01484691|538322542|FG002|Overall Study|Withdrawal by Subject|1|||
149233212|NCT01484691|538322540|FG000|Overall Study|Physician Decision|0|||
149233213|NCT01484691|538322541|FG001|Overall Study|Physician Decision|2|||
149233214|NCT01484691|538322542|FG002|Overall Study|Physician Decision|1|||
149233215|NCT04668157|538322547|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
149233216|NCT04668157|538322548|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
149233217|NCT04668157|538322547|FG000|Treatment Period (52 Weeks)|Other|0|||
149233218|NCT04668157|538322548|FG001|Treatment Period (52 Weeks)|Other|2|||
149233219|NCT03958045|538322549|FG000|Overall Study|Withdrawal by Subject|1|||
149233220|NCT02283411|538322554|FG000|Overall Study|Withdrawal by Subject|3|||
149233221|NCT02283411|538322554|FG000|Overall Study|Screen Failed|28|||
149233222|NCT05437211|538322559|FG000|Overall Study|Patient's decision|1|||
149233223|NCT05437211|538322560|FG001|Overall Study|Patient's decision|1|||
149233224|NCT03282123|538322561|FG000|Overall Study|Withdrawal by Subject|5|||
149233225|NCT03457701|538322562|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
149233226|NCT03457701|538322563|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
149233227|NCT03457701|538322562|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
149233228|NCT03457701|538322563|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
149233229|NCT03329404|538322564|FG000|Overall Study|The study was suspended.|1|||
149233230|NCT03329404|538322565|FG001|Overall Study|The study was suspended.|4|||
149233231|NCT01463631|538322569|FG000|Overall Study|Withdrawal by Subject|0|||
149233232|NCT01463631|538322570|FG001|Overall Study|Withdrawal by Subject|0|||
149233233|NCT01463631|538322571|FG002|Overall Study|Withdrawal by Subject|0|||
149233234|NCT01463631|538322572|FG003|Overall Study|Withdrawal by Subject|1|||
149233235|NCT01463631|538322569|FG000|Overall Study|Death|0|||
149233236|NCT01463631|538322570|FG001|Overall Study|Death|0|||
149233237|NCT01463631|538322571|FG002|Overall Study|Death|1|||
149233238|NCT01463631|538322572|FG003|Overall Study|Death|0|||
149233239|NCT01463631|538322569|FG000|Overall Study|Progressive Disease|0|||
149233240|NCT01463631|538322570|FG001|Overall Study|Progressive Disease|0|||
149233241|NCT01463631|538322571|FG002|Overall Study|Progressive Disease|0|||
149233242|NCT01463631|538322572|FG003|Overall Study|Progressive Disease|5|||
149233243|NCT04095039|538322573|FG000|Overall Study|Withdrawal by Subject|2|||
149233244|NCT04095039|538322574|FG001|Overall Study|Withdrawal by Subject|16|||
149233245|NCT04095039|538322573|FG000|Overall Study|Transplanted|21|||
149233246|NCT04095039|538322574|FG001|Overall Study|Transplanted|24|||
149233247|NCT04095039|538322573|FG000|Overall Study|Transferred to Non-study Facility|47|||
149233248|NCT04095039|538322574|FG001|Overall Study|Transferred to Non-study Facility|44|||
149233249|NCT04095039|538322573|FG000|Overall Study|Withdrawal from internvention target|0|||
149233250|NCT04095039|538322574|FG001|Overall Study|Withdrawal from internvention target|2|||
149233251|NCT04095039|538322573|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
149233252|NCT04095039|538322574|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
149233253|NCT04095039|538322573|FG000|Overall Study|Cacliphylaxis|0|||
149233254|NCT04095039|538322574|FG001|Overall Study|Cacliphylaxis|1|||
149233255|NCT04095039|538322573|FG000|Overall Study|Pregnancy|1|||
149233256|NCT04095039|538322574|FG001|Overall Study|Pregnancy|0|||
149233257|NCT04236986|538322575|FG000|Overall Study|Withdrawal by Subject|3|||
149233258|NCT04236986|538322576|FG001|Overall Study|Withdrawal by Subject|1|||
149233259|NCT01326481|538322577|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
149233260|NCT01078974|538322578|FG000|Overall Study|Adverse Event|3|||
149233261|NCT03039699|538322579|FG000|Overall Study|Incorrect inclusion|5|||
149233262|NCT03039699|538322580|FG001|Overall Study|Incorrect inclusion|4|||
149233263|NCT03039699|538322579|FG000|Overall Study|Lack of data to assess study endpoint|5|||
149233264|NCT03039699|538322580|FG001|Overall Study|Lack of data to assess study endpoint|3|||
149233265|NCT03039699|538322579|FG000|Overall Study|Bacterial infection|12|||
149233266|NCT03039699|538322580|FG001|Overall Study|Bacterial infection|28|||
149233267|NCT01397409|538322581|FG000|Stage 2|Adverse Event|0|||
149233268|NCT01397409|538322582|FG001|Stage 2|Adverse Event|0|||
149233269|NCT01397409|538322583|FG002|Stage 2|Adverse Event|0|||
149233270|NCT01397409|538322584|FG003|Stage 2|Adverse Event|0|||
149233271|NCT01397409|538322585|FG004|Stage 2|Adverse Event|6|||
149233272|NCT01397409|538322586|FG005|Stage 2|Adverse Event|3|||
149233273|NCT01397409|538322587|FG006|Stage 2|Adverse Event|0|||
149233274|NCT01397409|538322588|FG007|Stage 2|Adverse Event|0|||
149233275|NCT01397409|538322589|FG008|Stage 2|Adverse Event|0|||
149233276|NCT01397409|538322590|FG009|Stage 2|Adverse Event|0|||
149233277|NCT01397409|538322581|FG000|Stage 2|Personal Reasons|0|||
149233278|NCT01397409|538322582|FG001|Stage 2|Personal Reasons|0|||
149233279|NCT01397409|538322583|FG002|Stage 2|Personal Reasons|0|||
149233280|NCT01397409|538322584|FG003|Stage 2|Personal Reasons|0|||
149233281|NCT01397409|538322585|FG004|Stage 2|Personal Reasons|1|||
149233282|NCT01397409|538322586|FG005|Stage 2|Personal Reasons|0|||
148690667|NCT03111147|536340320|FG001|Overall Study|Lost to Follow-up|5|||
148690668|NCT03111147|536340319|FG000|Overall Study|Withdrawal by Subject|4|||
149233283|NCT01397409|538322587|FG006|Stage 2|Personal Reasons|0|||
149233284|NCT01397409|538322588|FG007|Stage 2|Personal Reasons|0|||
149233285|NCT01397409|538322589|FG008|Stage 2|Personal Reasons|0|||
149233286|NCT01397409|538322590|FG009|Stage 2|Personal Reasons|0|||
149233287|NCT01397409|538322581|FG000|Stage 2|Other Miscellaneous Reasons|0|||
149233288|NCT01397409|538322582|FG001|Stage 2|Other Miscellaneous Reasons|0|||
149233289|NCT01397409|538322583|FG002|Stage 2|Other Miscellaneous Reasons|0|||
149233290|NCT01397409|538322584|FG003|Stage 2|Other Miscellaneous Reasons|0|||
149233291|NCT01397409|538322585|FG004|Stage 2|Other Miscellaneous Reasons|1|||
149233292|NCT01397409|538322586|FG005|Stage 2|Other Miscellaneous Reasons|1|||
149233293|NCT01397409|538322587|FG006|Stage 2|Other Miscellaneous Reasons|0|||
149233294|NCT01397409|538322588|FG007|Stage 2|Other Miscellaneous Reasons|0|||
149233295|NCT01397409|538322589|FG008|Stage 2|Other Miscellaneous Reasons|0|||
149233296|NCT01397409|538322590|FG009|Stage 2|Other Miscellaneous Reasons|0|||
149233297|NCT01397409|538322581|FG000|Stage 3|Adverse Event|0|||
149233298|NCT01397409|538322582|FG001|Stage 3|Adverse Event|0|||
149233299|NCT01397409|538322583|FG002|Stage 3|Adverse Event|0|||
149233300|NCT01397409|538322584|FG003|Stage 3|Adverse Event|0|||
149233301|NCT01397409|538322585|FG004|Stage 3|Adverse Event|0|||
149233302|NCT01397409|538322586|FG005|Stage 3|Adverse Event|0|||
149233303|NCT01397409|538322587|FG006|Stage 3|Adverse Event|0|||
149233304|NCT01397409|538322588|FG007|Stage 3|Adverse Event|1|||
149233305|NCT01397409|538322589|FG008|Stage 3|Adverse Event|0|||
149233306|NCT01397409|538322590|FG009|Stage 3|Adverse Event|0|||
149233307|NCT01397409|538322581|FG000|Stage 3|Other Miscellaneous Reasons|0|||
149233308|NCT01397409|538322582|FG001|Stage 3|Other Miscellaneous Reasons|0|||
149233309|NCT01397409|538322583|FG002|Stage 3|Other Miscellaneous Reasons|0|||
149233310|NCT01397409|538322584|FG003|Stage 3|Other Miscellaneous Reasons|0|||
149233311|NCT01397409|538322585|FG004|Stage 3|Other Miscellaneous Reasons|0|||
149233312|NCT01397409|538322586|FG005|Stage 3|Other Miscellaneous Reasons|0|||
149233313|NCT01397409|538322587|FG006|Stage 3|Other Miscellaneous Reasons|0|||
149233314|NCT01397409|538322588|FG007|Stage 3|Other Miscellaneous Reasons|1|||
149233315|NCT01397409|538322589|FG008|Stage 3|Other Miscellaneous Reasons|0|||
149233316|NCT01397409|538322590|FG009|Stage 3|Other Miscellaneous Reasons|0|||
149233317|NCT00422227|538322591|FG000|Overall Study|Adverse Event|3|||
149233318|NCT00422227|538322592|FG001|Overall Study|Adverse Event|8|||
149233319|NCT00422227|538322591|FG000|Overall Study|Lost to Follow-up|1|||
149233320|NCT00422227|538322592|FG001|Overall Study|Lost to Follow-up|3|||
149233321|NCT00422227|538322591|FG000|Overall Study|Withdrawal by Subject|0|||
149233322|NCT00422227|538322592|FG001|Overall Study|Withdrawal by Subject|4|||
149233323|NCT00686894|538322594|FG000|Overall Study|Relapse|2|||
149233324|NCT00686894|538322594|FG000|Overall Study|Protocol Violation|4|||
148690669|NCT03111147|536340320|FG001|Overall Study|Withdrawal by Subject|3|||
148690670|NCT03111147|536340319|FG000|Overall Study|Protocol Violation|2|||
148690671|NCT03111147|536340320|FG001|Overall Study|Protocol Violation|1|||
148690672|NCT03111147|536340319|FG000|Overall Study|Death|1|||
148690673|NCT03111147|536340320|FG001|Overall Study|Death|1|||
148690674|NCT02178709|536342331|FG000|Overall Study|Adverse Event|5|||
148690675|NCT02178709|536342331|FG000|Overall Study|Death|2|||
148690676|NCT02178709|536342331|FG000|Overall Study|Withdrawal by Subject|2|||
148690677|NCT02178709|536342331|FG000|Overall Study|Physician Decision|2|||
148690678|NCT02178709|536342331|FG000|Overall Study|Disease Progression|5|||
148690679|NCT02946385|536342332|FG000|Overall Study|Lost to Follow-up|0|||
148690680|NCT02946385|536342333|FG001|Overall Study|Lost to Follow-up|0|||
148690681|NCT02946385|536342334|FG002|Overall Study|Lost to Follow-up|3|||
148690682|NCT02946385|536342335|FG003|Overall Study|Lost to Follow-up|0|||
148690683|NCT02946385|536342336|FG004|Overall Study|Lost to Follow-up|2|||
148690684|NCT02946385|536342337|FG005|Overall Study|Lost to Follow-up|1|||
148690685|NCT01691859|536342340|FG000|Overall Study|Adverse Event|19|||
148690686|NCT01691859|536342340|FG000|Overall Study|Lack of Efficacy|11|||
148690687|NCT01691859|536342340|FG000|Overall Study|Protocol Violation|4|||
148690688|NCT01691859|536342340|FG000|Overall Study|Product commercially available|221|||
148690689|NCT01691859|536342340|FG000|Overall Study|Study closed/terminated|50|||
148690690|NCT01691859|536342340|FG000|Overall Study|Lost to Follow-up|5|||
149233325|NCT01791543|538322595|FG000|Overall Study|Lost to Follow-up|1|||
149233326|NCT01791543|538322595|FG000|Overall Study|Adverse Event|1|||
149233327|NCT01790633|538322600|FG000|Overall Study|Protocol Violation|1|||
149233328|NCT01790633|538322601|FG001|Overall Study|Protocol Violation|2|||
149233329|NCT01790633|538322600|FG000|Overall Study|Did not have serology performed|47|||
149233330|NCT01790633|538322601|FG001|Overall Study|Did not have serology performed|0|||
149233331|NCT01790633|538322600|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
148690691|NCT01691859|536342340|FG000|Overall Study|Physician Decision|6|||
149233332|NCT01790633|538322601|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
149233333|NCT01241591|538324789|FG000|Overall Study|Lack of Efficacy|5|||
149233334|NCT01241591|538324790|FG001|Overall Study|Lack of Efficacy|2|||
149233335|NCT01241591|538324791|FG002|Overall Study|Lack of Efficacy|2|||
149233336|NCT01241591|538324792|FG003|Overall Study|Lack of Efficacy|3|||
149233337|NCT01241591|538324789|FG000|Overall Study|Protocol Violation|5|||
149233338|NCT01241591|538324790|FG001|Overall Study|Protocol Violation|2|||
149233339|NCT01241591|538324791|FG002|Overall Study|Protocol Violation|3|||
149233340|NCT01241591|538324792|FG003|Overall Study|Protocol Violation|0|||
149233341|NCT01241591|538324789|FG000|Overall Study|Lost to Follow-up|1|||
149233342|NCT01241591|538324790|FG001|Overall Study|Lost to Follow-up|2|||
149233343|NCT01241591|538324791|FG002|Overall Study|Lost to Follow-up|2|||
149233344|NCT01241591|538324792|FG003|Overall Study|Lost to Follow-up|2|||
149233345|NCT01241591|538324789|FG000|Overall Study|Screen Failure|3|||
149233346|NCT01241591|538324790|FG001|Overall Study|Screen Failure|2|||
149233347|NCT01241591|538324791|FG002|Overall Study|Screen Failure|1|||
149233348|NCT01241591|538324792|FG003|Overall Study|Screen Failure|0|||
149233349|NCT01241591|538324789|FG000|Overall Study|Withdrawal by Subject|6|||
149233350|NCT01241591|538324790|FG001|Overall Study|Withdrawal by Subject|4|||
149233351|NCT01241591|538324791|FG002|Overall Study|Withdrawal by Subject|2|||
149233352|NCT01241591|538324792|FG003|Overall Study|Withdrawal by Subject|2|||
149233353|NCT01241591|538324789|FG000|Overall Study|Other|0|||
149233354|NCT01241591|538324790|FG001|Overall Study|Other|1|||
149233355|NCT01241591|538324791|FG002|Overall Study|Other|0|||
149233356|NCT01241591|538324792|FG003|Overall Study|Other|1|||
149233357|NCT01241591|538324789|FG000|Overall Study|Adverse Event|3|||
149233358|NCT01241591|538324790|FG001|Overall Study|Adverse Event|11|||
149233359|NCT01241591|538324791|FG002|Overall Study|Adverse Event|12|||
149233360|NCT01241591|538324792|FG003|Overall Study|Adverse Event|4|||
149233361|NCT01945034|538324793|FG000|Overall Study|Medication Error|0|||
149233362|NCT01945034|538324794|FG001|Overall Study|Medication Error|1|||
149233363|NCT01945034|538324795|FG002|Overall Study|Medication Error|0|||
149233364|NCT01945034|538324793|FG000|Overall Study|Withdrawal by Subject|0|||
149233365|NCT01945034|538324794|FG001|Overall Study|Withdrawal by Subject|3|||
149233366|NCT01945034|538324795|FG002|Overall Study|Withdrawal by Subject|1|||
149233367|NCT01945034|538324793|FG000|Overall Study|Other|0|||
149233368|NCT01945034|538324794|FG001|Overall Study|Other|1|||
149233369|NCT01945034|538324795|FG002|Overall Study|Other|3|||
149233370|NCT01945034|538324793|FG000|Overall Study|Lost to Follow-up|0|||
149233371|NCT01945034|538324794|FG001|Overall Study|Lost to Follow-up|0|||
149233372|NCT01945034|538324795|FG002|Overall Study|Lost to Follow-up|2|||
149233373|NCT01945034|538324793|FG000|Overall Study|Protocol Violation|1|||
149233374|NCT01945034|538324794|FG001|Overall Study|Protocol Violation|0|||
149233375|NCT01945034|538324795|FG002|Overall Study|Protocol Violation|1|||
149233376|NCT00726882|538324799|FG000|Overall Study|Withdrawal by Subject|5|||
149233377|NCT00726882|538324799|FG000|Overall Study|Lost to Follow-up|7|||
149233378|NCT00726882|538324799|FG000|Overall Study|Other|10|||
149233379|NCT00594568|538324800|FG000|Initial Treatment|Adverse Event|51|||
149233380|NCT00594568|538324801|FG001|Initial Treatment|Adverse Event|121|||
149233381|NCT00594568|538324802|FG002|Initial Treatment|Adverse Event|144|||
149233382|NCT00594568|538324800|FG000|Initial Treatment|Death|6|||
149233383|NCT00594568|538324801|FG001|Initial Treatment|Death|11|||
149233384|NCT00594568|538324802|FG002|Initial Treatment|Death|15|||
148690692|NCT01691859|536342340|FG000|Overall Study|Withdrawal by Subject|31|||
148690693|NCT02688400|536342343|FG000|Overall Study|Protocol Violation|2|||
148690694|NCT02688400|536342344|FG001|Overall Study|Protocol Violation|5|||
149233385|NCT00594568|538324800|FG000|Initial Treatment|Lost to Follow-up|4|||
149233386|NCT00594568|538324801|FG001|Initial Treatment|Lost to Follow-up|1|||
148690695|NCT02688400|536342343|FG000|Overall Study|Lack of Efficacy|7|||
148690696|NCT02688400|536342344|FG001|Overall Study|Lack of Efficacy|7|||
149233387|NCT00594568|538324802|FG002|Initial Treatment|Lost to Follow-up|4|||
149233388|NCT00594568|538324800|FG000|Initial Treatment|Physician Decision|3|||
149233389|NCT00594568|538324801|FG001|Initial Treatment|Physician Decision|2|||
149233390|NCT00594568|538324802|FG002|Initial Treatment|Physician Decision|4|||
149233391|NCT00594568|538324800|FG000|Initial Treatment|Protocol Violation|2|||
149233392|NCT00594568|538324801|FG001|Initial Treatment|Protocol Violation|2|||
149233393|NCT00594568|538324802|FG002|Initial Treatment|Protocol Violation|5|||
149233394|NCT00594568|538324800|FG000|Initial Treatment|Withdrawal by Subject|25|||
149233395|NCT00594568|538324801|FG001|Initial Treatment|Withdrawal by Subject|31|||
149233396|NCT00594568|538324802|FG002|Initial Treatment|Withdrawal by Subject|46|||
149233397|NCT00594568|538324800|FG000|Initial Treatment|Sponsor decision|193|||
149233398|NCT00594568|538324801|FG001|Initial Treatment|Sponsor decision|142|||
149233399|NCT00594568|538324802|FG002|Initial Treatment|Sponsor decision|147|||
149233400|NCT00594568|538324800|FG000|Initial Treatment|Caregiver decision|21|||
149233401|NCT00594568|538324801|FG001|Initial Treatment|Caregiver decision|36|||
149233402|NCT00594568|538324802|FG002|Initial Treatment|Caregiver decision|36|||
149233403|NCT00594568|538324800|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
149233404|NCT00594568|538324801|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
149233405|NCT00594568|538324802|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
149233406|NCT00594568|538324800|FG000|Initial Treatment|Entry criteria exclusion|0|||
149233407|NCT00594568|538324801|FG001|Initial Treatment|Entry criteria exclusion|1|||
149233408|NCT00594568|538324802|FG002|Initial Treatment|Entry criteria exclusion|1|||
149233409|NCT00594568|538324800|FG000|Delayed Start|Death|0|||
149233410|NCT00594568|538324801|FG001|Delayed Start|Death|0|||
149233411|NCT00594568|538324802|FG002|Delayed Start|Death|1|||
149233412|NCT00594568|538324800|FG000|Delayed Start|Adverse Event|12|||
149233413|NCT00594568|538324801|FG001|Delayed Start|Adverse Event|2|||
149233414|NCT00594568|538324802|FG002|Delayed Start|Adverse Event|2|||
149233415|NCT00594568|538324800|FG000|Delayed Start|Withdrawal by Subject|4|||
149233416|NCT00594568|538324801|FG001|Delayed Start|Withdrawal by Subject|3|||
149233417|NCT00594568|538324802|FG002|Delayed Start|Withdrawal by Subject|0|||
149233418|NCT00594568|538324800|FG000|Delayed Start|Physician Decision|0|||
149233419|NCT00594568|538324801|FG001|Delayed Start|Physician Decision|0|||
149233420|NCT00594568|538324802|FG002|Delayed Start|Physician Decision|1|||
149233421|NCT00594568|538324800|FG000|Delayed Start|Lost to Follow-up|0|||
149233422|NCT00594568|538324801|FG001|Delayed Start|Lost to Follow-up|0|||
149233423|NCT00594568|538324802|FG002|Delayed Start|Lost to Follow-up|1|||
149233424|NCT00594568|538324800|FG000|Delayed Start|Caregiver Decision|5|||
149233425|NCT00594568|538324801|FG001|Delayed Start|Caregiver Decision|6|||
149233426|NCT00594568|538324802|FG002|Delayed Start|Caregiver Decision|2|||
149233427|NCT00594568|538324800|FG000|Delayed Start|Sponsor Decision|77|||
149233428|NCT00594568|538324801|FG001|Delayed Start|Sponsor Decision|66|||
149233429|NCT00594568|538324802|FG002|Delayed Start|Sponsor Decision|59|||
149233430|NCT00594568|538324800|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
149233431|NCT00594568|538324801|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
149233432|NCT00594568|538324802|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
149233433|NCT00594568|538324800|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
149233434|NCT00594568|538324801|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
149233435|NCT00594568|538324802|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
149233436|NCT00594568|538324800|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
149233437|NCT00594568|538324801|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
149233438|NCT00594568|538324802|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
149233439|NCT00594568|538324800|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
149233440|NCT00594568|538324801|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
149233441|NCT00594568|538324802|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
149233442|NCT00594568|538324800|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
149233443|NCT00594568|538324801|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
149233444|NCT00594568|538324802|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
148690697|NCT02688400|536342343|FG000|Overall Study|Adverse Event|21|||
149020372|NCT02268552|537552627|FG001|Part 2|Death|0|||
149020373|NCT02268552|537552628|FG002|Part 2|Death|0|||
149020374|NCT02268552|537552629|FG003|Part 2|Death|0|||
149020375|NCT02268552|537552630|FG004|Part 2|Death|0|||
149020376|NCT02268552|537552631|FG005|Part 2|Death|0|||
149020377|NCT02268552|537552632|FG006|Part 2|Death|2|||
149020378|NCT02268552|537552626|FG000|Part 2|Subject/guardian decision|0|||
149020379|NCT02268552|537552627|FG001|Part 2|Subject/guardian decision|0|||
149020380|NCT02268552|537552628|FG002|Part 2|Subject/guardian decision|0|||
149020381|NCT02268552|537552629|FG003|Part 2|Subject/guardian decision|0|||
149020382|NCT02268552|537552630|FG004|Part 2|Subject/guardian decision|0|||
149020383|NCT02268552|537552631|FG005|Part 2|Subject/guardian decision|0|||
149233445|NCT00594568|538324800|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
149233446|NCT00594568|538324801|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
149233447|NCT00594568|538324802|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
149233448|NCT02526017|538324804|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233449|NCT02526017|538324805|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233450|NCT02526017|538324806|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233451|NCT02526017|538324807|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233452|NCT02526017|538324808|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
149233453|NCT02526017|538324809|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233454|NCT02526017|538324810|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233455|NCT02526017|538324811|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233456|NCT02526017|538324812|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
149233457|NCT01600755|538324814|FG000|Overall Study|Withdrawal by Subject|6|||
149233458|NCT02204449|538324819|FG000|Overall Study|Lost to Follow-up|7|||
149233459|NCT02204449|538324820|FG001|Overall Study|Lost to Follow-up|9|||
149233460|NCT02204449|538324819|FG000|Overall Study|Death|0|||
149233461|NCT02204449|538324820|FG001|Overall Study|Death|1|||
149233462|NCT02204449|538324819|FG000|Overall Study|Withdrawal by Subject|0|||
149233463|NCT02204449|538324820|FG001|Overall Study|Withdrawal by Subject|1|||
149233464|NCT04311411|538324823|FG000|Overall Study|Adverse Event|2|||
149233465|NCT04311411|538324824|FG001|Overall Study|Adverse Event|3|||
149233466|NCT04311411|538324825|FG002|Overall Study|Adverse Event|2|||
149233467|NCT04311411|538324823|FG000|Overall Study|Withdrawal by Subject|3|||
149233468|NCT04311411|538324824|FG001|Overall Study|Withdrawal by Subject|3|||
149233469|NCT04311411|538324825|FG002|Overall Study|Withdrawal by Subject|0|||
149233470|NCT01976663|538324829|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
149233471|NCT01976663|538324829|FG000|Overall Study|Personal Reasons|6|||
149233472|NCT01976663|538324829|FG000|Overall Study|Withdrawal by Subject|4|||
149233473|NCT01976663|538324829|FG000|Overall Study|Screen Failure|3|||
149233474|NCT01976663|538324829|FG000|Overall Study|Adverse Event|2|||
149233475|NCT01976663|538324829|FG000|Overall Study|Lost to Follow-up|3|||
149233476|NCT01982942|538324831|FG000|Overall Study|Adverse Event|10|||
149233477|NCT01982942|538324832|FG001|Overall Study|Adverse Event|5|||
149233478|NCT01982942|538324831|FG000|Overall Study|Lost to Follow-up|4|||
149233479|NCT01982942|538324832|FG001|Overall Study|Lost to Follow-up|3|||
149233480|NCT01982942|538324831|FG000|Overall Study|Multiple sclerosis progression|3|||
149233481|NCT01982942|538324832|FG001|Overall Study|Multiple sclerosis progression|2|||
149233482|NCT01982942|538324831|FG000|Overall Study|Wanted to try therapy not permitted|1|||
149233483|NCT01982942|538324832|FG001|Overall Study|Wanted to try therapy not permitted|0|||
149233484|NCT01982942|538324831|FG000|Overall Study|Subject declined future visits|0|||
149233485|NCT01982942|538324832|FG001|Overall Study|Subject declined future visits|1|||
149233486|NCT01982942|538324831|FG000|Overall Study|Left geographical area|2|||
149233487|NCT01982942|538324832|FG001|Overall Study|Left geographical area|0|||
149233488|NCT01982942|538324831|FG000|Overall Study|Too many pills|1|||
149233489|NCT01982942|538324832|FG001|Overall Study|Too many pills|0|||
149233490|NCT01982942|538324831|FG000|Overall Study|MS Relapse|0|||
149233491|NCT01982942|538324832|FG001|Overall Study|MS Relapse|1|||
149233492|NCT01982942|538324831|FG000|Overall Study|Chose to join a stem cell trial|0|||
149233493|NCT01982942|538324832|FG001|Overall Study|Chose to join a stem cell trial|1|||
149233494|NCT01982942|538324831|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
149233495|NCT01982942|538324832|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
149233496|NCT01151085|538324835|FG000|Overall Study|Lost to Follow-up|31|||
149233497|NCT01151085|538324835|FG000|Overall Study|Protocol Violation|25|||
149233498|NCT00003526|538324841|FG000|Overall Study|Not evaluable|6|||
149233499|NCT04196023|538324842|FG000|Overall Study|Withdrawal by Subject|0|||
149233500|NCT04196023|538324843|FG001|Overall Study|Withdrawal by Subject|1|||
149233501|NCT04196023|538324842|FG000|Overall Study|Adverse Event|3|||
149233502|NCT04196023|538324843|FG001|Overall Study|Adverse Event|1|||
149233503|NCT04196023|538324842|FG000|Overall Study|Lost to Follow-up|0|||
149233504|NCT04196023|538324843|FG001|Overall Study|Lost to Follow-up|1|||
149233505|NCT00489411|538324844|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
149233506|NCT00489411|538324845|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
149233507|NCT00489411|538324844|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
149233508|NCT00489411|538324845|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
149233509|NCT00489411|538324844|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
149233510|NCT00489411|538324845|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
149233511|NCT00489411|538324844|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
149233512|NCT00489411|538324845|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
149020384|NCT02268552|537552632|FG006|Part 2|Subject/guardian decision|1|||
148810698|NCT02178956|536784574|FG001|Overall Study|Sponsor terminated study|58|||
148810699|NCT02178956|536784573|FG000|Overall Study|Withdrawal by Subject|15|||
148810700|NCT02178956|536784574|FG001|Overall Study|Withdrawal by Subject|11|||
148810701|NCT02178956|536784573|FG000|Overall Study|Various Reasons|3|||
148810702|NCT02178956|536784574|FG001|Overall Study|Various Reasons|5|||
148810703|NCT01138046|536784575|FG000|Overall Study|Withdrawal due to death|6|||
148810704|NCT01104766|536784576|FG000|Overall Study|Did not meet inc/exc criteria|1|||
148810705|NCT01104766|536784577|FG001|Overall Study|Did not meet inc/exc criteria|0|||
148810706|NCT01104766|536784578|FG002|Overall Study|Did not meet inc/exc criteria|0|||
148810707|NCT01104766|536784579|FG003|Overall Study|Did not meet inc/exc criteria|0|||
148810708|NCT01104766|536784576|FG000|Overall Study|Adverse Event|17|||
148810709|NCT01104766|536784577|FG001|Overall Study|Adverse Event|15|||
148810710|NCT01104766|536784578|FG002|Overall Study|Adverse Event|20|||
148810711|NCT01104766|536784579|FG003|Overall Study|Adverse Event|14|||
148810712|NCT01104766|536784576|FG000|Overall Study|Lack of Efficacy|20|||
148810713|NCT01104766|536784577|FG001|Overall Study|Lack of Efficacy|15|||
148810714|NCT01104766|536784578|FG002|Overall Study|Lack of Efficacy|14|||
148810715|NCT01104766|536784579|FG003|Overall Study|Lack of Efficacy|8|||
148810716|NCT01104766|536784576|FG000|Overall Study|Protocol Violation|2|||
148810717|NCT01104766|536784577|FG001|Overall Study|Protocol Violation|0|||
148810718|NCT01104766|536784578|FG002|Overall Study|Protocol Violation|0|||
148810719|NCT01104766|536784579|FG003|Overall Study|Protocol Violation|0|||
148810720|NCT01104766|536784576|FG000|Overall Study|Withdrawal by Subject|17|||
148810721|NCT01104766|536784577|FG001|Overall Study|Withdrawal by Subject|19|||
148810722|NCT01104766|536784578|FG002|Overall Study|Withdrawal by Subject|25|||
148810723|NCT01104766|536784579|FG003|Overall Study|Withdrawal by Subject|15|||
148810724|NCT01104766|536784576|FG000|Overall Study|Lost to Follow-up|1|||
148810725|NCT01104766|536784577|FG001|Overall Study|Lost to Follow-up|2|||
148810726|NCT01104766|536784578|FG002|Overall Study|Lost to Follow-up|1|||
148810727|NCT01104766|536784579|FG003|Overall Study|Lost to Follow-up|1|||
148810728|NCT01136915|536784580|FG000|Overall Study|Lost to Follow-up|2|||
148810729|NCT01136915|536784581|FG001|Overall Study|Lost to Follow-up|0|||
148810730|NCT01136915|536784580|FG000|Overall Study|Exclusion criterion met|0|||
148810731|NCT01136915|536784581|FG001|Overall Study|Exclusion criterion met|1|||
149233513|NCT00489411|538324844|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
149233514|NCT00489411|538324845|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
149233515|NCT01748162|538324847|FG000|Overall Study|no additional croup episodes to evaluate|2|||
149233516|NCT01748162|538324848|FG001|Overall Study|no additional croup episodes to evaluate|2|||
149233517|NCT01748162|538324847|FG000|Overall Study|participant consented but did not begin|0|||
149233518|NCT01748162|538324848|FG001|Overall Study|participant consented but did not begin|1|||
149233519|NCT01748162|538324847|FG000|Overall Study|reasons not available|3|||
148810742|NCT02327078|536784586|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
148810743|NCT02327078|536784587|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
148810744|NCT02327078|536784588|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
148810745|NCT02327078|536784589|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
148810746|NCT02327078|536784590|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
148810747|NCT02327078|536784591|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
148810748|NCT02327078|536784592|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
148810749|NCT02327078|536784593|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
148810750|NCT02327078|536784594|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
148810751|NCT02327078|536784586|FG000|Overall Study|Death|2|||
148810752|NCT02327078|536784587|FG001|Overall Study|Death|4|||
149233520|NCT01748162|538324848|FG001|Overall Study|reasons not available|2|||
149233521|NCT03219372|538324849|FG000|Overall Study|Withdrawal by Subject|1|||
149233522|NCT03219372|538324850|FG001|Overall Study|Withdrawal by Subject|0|||
149233523|NCT03841331|538324851|FG000|Overall Study|Withdrawal by Subject|4|||
148690698|NCT02688400|536342344|FG001|Overall Study|Adverse Event|12|||
148690699|NCT02688400|536342343|FG000|Overall Study|Withdrawal by Subject|15|||
148690700|NCT02688400|536342344|FG001|Overall Study|Withdrawal by Subject|13|||
148690701|NCT02688400|536342343|FG000|Overall Study|No study medication intake|1|||
148690702|NCT02688400|536342344|FG001|Overall Study|No study medication intake|4|||
148690703|NCT02688400|536342343|FG000|Overall Study|Lost to Follow-up|0|||
148690704|NCT02688400|536342344|FG001|Overall Study|Lost to Follow-up|3|||
148690705|NCT03519256|536342351|FG000|Overall Study|Disease recurrence|4|||
148690706|NCT03519256|536342352|FG001|Overall Study|Disease recurrence|4|||
148690707|NCT03519256|536342353|FG002|Overall Study|Disease recurrence|5|||
148690708|NCT03519256|536342354|FG003|Overall Study|Disease recurrence|2|||
148690709|NCT03519256|536342351|FG000|Overall Study|Study drug toxicity|0|||
148690710|NCT03519256|536342352|FG001|Overall Study|Study drug toxicity|2|||
148690711|NCT03519256|536342353|FG002|Overall Study|Study drug toxicity|5|||
148690712|NCT03519256|536342354|FG003|Overall Study|Study drug toxicity|2|||
148690713|NCT03519256|536342351|FG000|Overall Study|Adverse event unrelated to study drug|0|||
148690714|NCT03519256|536342352|FG001|Overall Study|Adverse event unrelated to study drug|1|||
148690715|NCT03519256|536342353|FG002|Overall Study|Adverse event unrelated to study drug|1|||
148690716|NCT03519256|536342354|FG003|Overall Study|Adverse event unrelated to study drug|0|||
148690717|NCT03519256|536342351|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149233524|NCT03841331|538324852|FG001|Overall Study|Withdrawal by Subject|9|||
149233525|NCT03841331|538324851|FG000|Overall Study|Lost to Follow-up|5|||
148690718|NCT03519256|536342352|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149233526|NCT03841331|538324852|FG001|Overall Study|Lost to Follow-up|1|||
148690719|NCT03519256|536342353|FG002|Overall Study|Participant request to discontinue study treatment|0|||
149233527|NCT04640168|538324853|FG000|Overall Study|Withdrawal by Subject|8|||
149233528|NCT04640168|538324854|FG001|Overall Study|Withdrawal by Subject|7|||
148690720|NCT03519256|536342354|FG003|Overall Study|Participant request to discontinue study treatment|2|||
148690721|NCT03519256|536342351|FG000|Overall Study|Other reasons|0|||
149233529|NCT04640168|538324853|FG000|Overall Study|Lost to Follow-up|1|||
149233530|NCT04640168|538324854|FG001|Overall Study|Lost to Follow-up|0|||
149233531|NCT04640168|538324853|FG000|Overall Study|Enrolled but not treated|12|||
148690722|NCT03519256|536342352|FG001|Overall Study|Other reasons|0|||
148690723|NCT03519256|536342353|FG002|Overall Study|Other reasons|2|||
149233532|NCT04640168|538324854|FG001|Overall Study|Enrolled but not treated|12|||
149233533|NCT00779857|538324855|FG000|Overall Study|Death|1|||
149233534|NCT00779857|538324855|FG000|Overall Study|Withdrawal by Subject|3|||
149233535|NCT00779857|538324855|FG000|Overall Study|Missed Visit|2|||
149233536|NCT00442572|538324859|FG000|Overall Study|Relapse|8|||
149233537|NCT00442572|538324860|FG001|Overall Study|Relapse|1|||
149233538|NCT00442572|538324859|FG000|Overall Study|Lost to Follow-up|0|||
149233539|NCT00442572|538324860|FG001|Overall Study|Lost to Follow-up|1|||
149233540|NCT00442572|538324859|FG000|Overall Study|Withdrawal by Subject|0|||
149233541|NCT00442572|538324860|FG001|Overall Study|Withdrawal by Subject|1|||
149233542|NCT01023815|538324861|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
149233543|NCT01023815|538324862|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
149233544|NCT01023815|538324863|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
149233545|NCT01023815|538324864|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
149233546|NCT01023815|538324861|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
149233547|NCT01023815|538324862|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
149233548|NCT01023815|538324863|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
149233549|NCT01023815|538324864|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
149233550|NCT01023815|538324861|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
149233551|NCT01023815|538324862|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
148690724|NCT03519256|536342354|FG003|Overall Study|Other reasons|0|||
148690725|NCT03519256|536342351|FG000|Overall Study|Disease progression|6|||
148690726|NCT03519256|536342352|FG001|Overall Study|Disease progression|3|||
148690727|NCT03519256|536342353|FG002|Overall Study|Disease progression|2|||
148690728|NCT03519256|536342354|FG003|Overall Study|Disease progression|1|||
148690729|NCT03519256|536342351|FG000|Overall Study|Lost to Follow-up|0|||
148690730|NCT03519256|536342352|FG001|Overall Study|Lost to Follow-up|1|||
148690731|NCT03519256|536342353|FG002|Overall Study|Lost to Follow-up|0|||
148690732|NCT03519256|536342354|FG003|Overall Study|Lost to Follow-up|0|||
148690733|NCT00275002|536342355|FG000|Overall Study|Death|1|||
149233552|NCT01023815|538324863|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
149233553|NCT01023815|538324864|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
149233554|NCT01023815|538324861|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
149233555|NCT01023815|538324862|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
149233556|NCT01023815|538324863|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
149233557|NCT01023815|538324864|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
149233558|NCT01023815|538324861|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
149233559|NCT01023815|538324862|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
148690734|NCT00275002|536342356|FG001|Overall Study|Death|0|||
148690735|NCT00275002|536342355|FG000|Overall Study|Disease progression|21|||
148690736|NCT00275002|536342356|FG001|Overall Study|Disease progression|15|||
148690737|NCT00275002|536342355|FG000|Overall Study|Adverse Event|0|||
148690738|NCT00275002|536342356|FG001|Overall Study|Adverse Event|1|||
148690739|NCT05456529|536342357|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
148690740|NCT05456529|536342357|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
148690741|NCT05456529|536342357|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
148690742|NCT05456529|536342357|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
148690743|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
148690744|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
149233560|NCT01023815|538324863|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
148690745|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Physician Decision|2|||
148690746|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
148690747|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
148690748|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
148810753|NCT02327078|536784588|FG002|Overall Study|Death|10|||
148810754|NCT02327078|536784589|FG003|Overall Study|Death|6|||
148810755|NCT02327078|536784590|FG004|Overall Study|Death|4|||
148810756|NCT02327078|536784591|FG005|Overall Study|Death|3|||
148810757|NCT02327078|536784592|FG006|Overall Study|Death|2|||
149233561|NCT01023815|538324864|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
149233562|NCT02058849|538324870|FG000|Overall Study|Hospitalization|1|||
149233563|NCT02058849|538324871|FG001|Overall Study|Hospitalization|1|||
149233564|NCT02058849|538324870|FG000|Overall Study|Death|1|||
149233565|NCT02058849|538324871|FG001|Overall Study|Death|0|||
149233566|NCT02058849|538324870|FG000|Overall Study|Lost to Follow-up|1|||
149233567|NCT02058849|538324871|FG001|Overall Study|Lost to Follow-up|0|||
149233568|NCT02058849|538324870|FG000|Overall Study|Withdrawal by Subject|4|||
148810758|NCT02327078|536784593|FG007|Overall Study|Death|51|||
148810759|NCT02327078|536784594|FG008|Overall Study|Death|97|||
148810760|NCT02327078|536784586|FG000|Overall Study|Lost to Follow-up|0|||
148810761|NCT02327078|536784587|FG001|Overall Study|Lost to Follow-up|1|||
148810762|NCT02327078|536784588|FG002|Overall Study|Lost to Follow-up|1|||
148810763|NCT02327078|536784589|FG003|Overall Study|Lost to Follow-up|0|||
148810764|NCT02327078|536784590|FG004|Overall Study|Lost to Follow-up|0|||
148810765|NCT02327078|536784591|FG005|Overall Study|Lost to Follow-up|0|||
148810766|NCT02327078|536784592|FG006|Overall Study|Lost to Follow-up|0|||
148810767|NCT02327078|536784593|FG007|Overall Study|Lost to Follow-up|2|||
148810768|NCT02327078|536784594|FG008|Overall Study|Lost to Follow-up|5|||
148810769|NCT02327078|536784586|FG000|Overall Study|Site Terminated by Sponsor|1|||
148810770|NCT02327078|536784587|FG001|Overall Study|Site Terminated by Sponsor|0|||
148810771|NCT02327078|536784588|FG002|Overall Study|Site Terminated by Sponsor|1|||
148810772|NCT02327078|536784589|FG003|Overall Study|Site Terminated by Sponsor|4|||
148810773|NCT02327078|536784590|FG004|Overall Study|Site Terminated by Sponsor|0|||
148810774|NCT02327078|536784591|FG005|Overall Study|Site Terminated by Sponsor|0|||
148810775|NCT02327078|536784592|FG006|Overall Study|Site Terminated by Sponsor|0|||
148810776|NCT02327078|536784593|FG007|Overall Study|Site Terminated by Sponsor|11|||
148810777|NCT02327078|536784594|FG008|Overall Study|Site Terminated by Sponsor|25|||
149233569|NCT02058849|538324871|FG001|Overall Study|Withdrawal by Subject|0|||
149233570|NCT01694849|538324872|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
148810778|NCT02327078|536784586|FG000|Overall Study|Physician Decision|0|||
148810779|NCT02327078|536784587|FG001|Overall Study|Physician Decision|0|||
148810780|NCT02327078|536784588|FG002|Overall Study|Physician Decision|0|||
148810781|NCT02327078|536784589|FG003|Overall Study|Physician Decision|1|||
148810782|NCT02327078|536784590|FG004|Overall Study|Physician Decision|0|||
148810783|NCT02327078|536784591|FG005|Overall Study|Physician Decision|0|||
148810784|NCT02327078|536784592|FG006|Overall Study|Physician Decision|0|||
148810785|NCT02327078|536784593|FG007|Overall Study|Physician Decision|0|||
148810786|NCT02327078|536784594|FG008|Overall Study|Physician Decision|1|||
149233571|NCT01694849|538324873|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
149233572|NCT01694849|538324874|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
149233573|NCT01694849|538324872|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
149233574|NCT01694849|538324873|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
149233575|NCT01694849|538324874|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
149233576|NCT01694849|538324872|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
149233577|NCT01694849|538324873|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
149233578|NCT01694849|538324874|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
149233579|NCT01694849|538324872|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
149233580|NCT01694849|538324873|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
149233581|NCT01694849|538324874|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
149233582|NCT01694849|538324872|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
148690749|NCT05456529|536342357|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
148690750|NCT02374918|536342358|FG000|Overall Study|Protocol Violation|2|||
148690751|NCT02374918|536342359|FG001|Overall Study|Protocol Violation|0|||
148690752|NCT02374918|536342360|FG002|Overall Study|Protocol Violation|2|||
148690753|NCT02374918|536342361|FG003|Overall Study|Protocol Violation|1|||
148690754|NCT02374918|536342358|FG000|Overall Study|Withdrawal by Subject|1|||
148690755|NCT02374918|536342359|FG001|Overall Study|Withdrawal by Subject|1|||
148690756|NCT02374918|536342360|FG002|Overall Study|Withdrawal by Subject|1|||
148690757|NCT02374918|536342361|FG003|Overall Study|Withdrawal by Subject|0|||
148690758|NCT02374918|536342358|FG000|Overall Study|Lack of Efficacy|0|||
148690759|NCT02374918|536342359|FG001|Overall Study|Lack of Efficacy|0|||
148690760|NCT02374918|536342360|FG002|Overall Study|Lack of Efficacy|1|||
148690761|NCT02374918|536342361|FG003|Overall Study|Lack of Efficacy|1|||
148690762|NCT01506947|536342362|FG000|Overall Study|Lost to Follow-up|7|||
148690763|NCT01506947|536342362|FG000|Overall Study|Adverse Event|5|||
148690764|NCT01506947|536342362|FG000|Overall Study|Death|1|||
148690765|NCT01506947|536342362|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
148810787|NCT02327078|536784586|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
148810788|NCT02327078|536784587|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
148810789|NCT02327078|536784588|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
148810790|NCT02327078|536784589|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
148810791|NCT02327078|536784590|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
148810792|NCT02327078|536784591|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
148810793|NCT02327078|536784592|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
148810794|NCT02327078|536784593|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
148810795|NCT02327078|536784594|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
148810796|NCT02327078|536784586|FG000|Overall Study|Reason not Specified|0|||
148810797|NCT02327078|536784587|FG001|Overall Study|Reason not Specified|0|||
148810798|NCT02327078|536784588|FG002|Overall Study|Reason not Specified|0|||
148810799|NCT02327078|536784589|FG003|Overall Study|Reason not Specified|0|||
148810800|NCT02327078|536784590|FG004|Overall Study|Reason not Specified|0|||
148810801|NCT02327078|536784591|FG005|Overall Study|Reason not Specified|0|||
148810802|NCT02327078|536784592|FG006|Overall Study|Reason not Specified|0|||
148810803|NCT02327078|536784593|FG007|Overall Study|Reason not Specified|5|||
148690766|NCT02752776|536342366|FG000|Overall Study|Adverse Event|15|||
148690767|NCT02752776|536342367|FG001|Overall Study|Adverse Event|23|||
148690768|NCT02752776|536342368|FG002|Overall Study|Adverse Event|11|||
148690769|NCT02752776|536342366|FG000|Overall Study|Lack of Efficacy|2|||
148690770|NCT02752776|536342367|FG001|Overall Study|Lack of Efficacy|6|||
148690771|NCT02752776|536342368|FG002|Overall Study|Lack of Efficacy|14|||
148690772|NCT02752776|536342366|FG000|Overall Study|Lost to Follow-up|11|||
148690773|NCT02752776|536342367|FG001|Overall Study|Lost to Follow-up|12|||
148690774|NCT02752776|536342368|FG002|Overall Study|Lost to Follow-up|4|||
148690775|NCT02752776|536342366|FG000|Overall Study|Non-compliance with study treatment|0|||
148690776|NCT02752776|536342367|FG001|Overall Study|Non-compliance with study treatment|0|||
148690777|NCT02752776|536342368|FG002|Overall Study|Non-compliance with study treatment|1|||
148690778|NCT02752776|536342366|FG000|Overall Study|Physician Decision|2|||
148690779|NCT02752776|536342367|FG001|Overall Study|Physician Decision|6|||
148690780|NCT02752776|536342368|FG002|Overall Study|Physician Decision|2|||
148690781|NCT02752776|536342366|FG000|Overall Study|Pregnancy|1|||
148690782|NCT02752776|536342367|FG001|Overall Study|Pregnancy|6|||
148690783|NCT02752776|536342368|FG002|Overall Study|Pregnancy|3|||
148690784|NCT02752776|536342366|FG000|Overall Study|Protocol Violation|10|||
148690785|NCT02752776|536342367|FG001|Overall Study|Protocol Violation|13|||
148690786|NCT02752776|536342368|FG002|Overall Study|Protocol Violation|6|||
148690787|NCT02752776|536342366|FG000|Overall Study|Subject/guardian decision|8|||
148690788|NCT02752776|536342367|FG001|Overall Study|Subject/guardian decision|6|||
148690789|NCT02752776|536342368|FG002|Overall Study|Subject/guardian decision|4|||
148690790|NCT02752776|536342366|FG000|Overall Study|Death|0|||
148690791|NCT02752776|536342367|FG001|Overall Study|Death|0|||
148690792|NCT02752776|536342368|FG002|Overall Study|Death|1|||
148690793|NCT02752776|536342366|FG000|Overall Study|Withdrawal by Subject|3|||
148690794|NCT02752776|536342367|FG001|Overall Study|Withdrawal by Subject|4|||
148690795|NCT02752776|536342368|FG002|Overall Study|Withdrawal by Subject|2|||
148690796|NCT00266409|536342369|FG000|Overall Study|Lack of Efficacy|2|||
148690797|NCT00266409|536342370|FG001|Overall Study|Lack of Efficacy|6|||
148690798|NCT00266409|536342371|FG002|Overall Study|Lack of Efficacy|1|||
148690799|NCT00266409|536342372|FG003|Overall Study|Lack of Efficacy|2|||
148690800|NCT00266409|536342369|FG000|Overall Study|Adverse Event|7|||
148690801|NCT00266409|536342370|FG001|Overall Study|Adverse Event|2|||
148690802|NCT00266409|536342371|FG002|Overall Study|Adverse Event|1|||
148690803|NCT00266409|536342372|FG003|Overall Study|Adverse Event|1|||
148690804|NCT00266409|536342369|FG000|Overall Study|Lost to Follow-up|18|||
148690805|NCT00266409|536342370|FG001|Overall Study|Lost to Follow-up|21|||
148690806|NCT00266409|536342371|FG002|Overall Study|Lost to Follow-up|6|||
148690807|NCT00266409|536342372|FG003|Overall Study|Lost to Follow-up|8|||
148690808|NCT00266409|536342369|FG000|Overall Study|Withdrawal by Subject|6|||
148690809|NCT00266409|536342370|FG001|Overall Study|Withdrawal by Subject|10|||
148690810|NCT00266409|536342371|FG002|Overall Study|Withdrawal by Subject|3|||
148690811|NCT00266409|536342372|FG003|Overall Study|Withdrawal by Subject|9|||
148810804|NCT02327078|536784594|FG008|Overall Study|Reason not Specified|12|||
148810805|NCT04797169|536784598|FG000|Overall Study|Lost to Follow-up|84|||
148690812|NCT00266409|536342369|FG000|Overall Study|Protocol Violation|5|||
148690813|NCT00266409|536342370|FG001|Overall Study|Protocol Violation|3|||
148690814|NCT00266409|536342371|FG002|Overall Study|Protocol Violation|4|||
148810806|NCT04797169|536784599|FG001|Overall Study|Lost to Follow-up|67|||
148690815|NCT00266409|536342372|FG003|Overall Study|Protocol Violation|2|||
148690816|NCT00266409|536342369|FG000|Overall Study|Other|7|||
148690817|NCT00266409|536342370|FG001|Overall Study|Other|4|||
148690818|NCT00266409|536342371|FG002|Overall Study|Other|2|||
148690819|NCT00266409|536342372|FG003|Overall Study|Other|0|||
148690820|NCT00108732|536342373|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
148690821|NCT00108732|536342373|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
148810807|NCT04797169|536784598|FG000|Overall Study|Pregnancy|1|||
148690822|NCT00108732|536342373|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
148690823|NCT00108732|536342373|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
148690824|NCT00108732|536342373|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
148810808|NCT04797169|536784599|FG001|Overall Study|Pregnancy|3|||
149233583|NCT01694849|538324873|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
149233584|NCT01694849|538324874|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
149233585|NCT01694849|538324872|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
149233586|NCT01694849|538324873|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
149233587|NCT01694849|538324874|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
149233588|NCT01694849|538324872|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
149020385|NCT02268552|537552626|FG000|Part 3 Extension|Death|0|||
149233589|NCT01694849|538324873|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
149233590|NCT01694849|538324874|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
149233591|NCT01694849|538324872|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
149020386|NCT02268552|537552627|FG001|Part 3 Extension|Death|1|||
149020387|NCT02268552|537552628|FG002|Part 3 Extension|Death|1|||
148810809|NCT04797169|536784598|FG000|Overall Study|Withdrawal by Subject|27|||
148810810|NCT04797169|536784599|FG001|Overall Study|Withdrawal by Subject|35|||
148810811|NCT03839641|536784601|FG000|Overall Study|Withdrawal by Subject|1|||
148810812|NCT03839641|536784602|FG001|Overall Study|Withdrawal by Subject|1|||
148810813|NCT04221490|536784604|FG000|At 30 Days Follow-up|Death|7|||
148810814|NCT04221490|536784604|FG000|At 30 Days Follow-up|Missed Visit|4|||
148810815|NCT04221490|536784604|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
148810816|NCT04221490|536784604|FG000|At 6 Months Follow-up|Death|9|||
148810817|NCT04221490|536784604|FG000|At 6 Months Follow-up|Physician Decision|1|||
148810818|NCT04221490|536784604|FG000|At 6 Months Follow-up|Missed Visit|8|||
148810819|NCT04221490|536784604|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
148810820|NCT03188822|536784610|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
148810821|NCT03188822|536784610|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
148810822|NCT04537299|536784611|FG000|Overall Study|Withdrawal by Subject|2|||
149233592|NCT01694849|538324873|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
149233593|NCT01694849|538324874|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
149233594|NCT02279888|538324875|FG000|Overall Study|Death|326|||
149233595|NCT02279888|538324875|FG000|Overall Study|Withdrawal by Subject|38|||
148810823|NCT04537299|536784612|FG001|Overall Study|Withdrawal by Subject|0|||
148810824|NCT04537299|536784611|FG000|Overall Study|Protocol Violation|1|||
148810825|NCT04537299|536784612|FG001|Overall Study|Protocol Violation|1|||
149233596|NCT02279888|538324875|FG000|Overall Study|Lost to Follow-up|21|||
149233597|NCT02279888|538324875|FG000|Overall Study|Physician Decision|62|||
149233598|NCT02279888|538324875|FG000|Overall Study|Subject Non-compliance|43|||
149233599|NCT02279888|538324875|FG000|Overall Study|Not implanted|14|||
149233600|NCT02279888|538324875|FG000|Overall Study|Visit not performed|26|||
149233601|NCT01683565|538324881|FG000|Overall Study|Lost to Follow-up|2|||
149233602|NCT01683565|538324882|FG001|Overall Study|Lost to Follow-up|0|||
149233603|NCT01683565|538324881|FG000|Overall Study|Discontinued Intervention|1|||
148810826|NCT03034967|536784613|FG000|Overall Study|Withdrawal by Subject|9|||
148810827|NCT03034967|536784614|FG001|Overall Study|Withdrawal by Subject|2|||
148810828|NCT03034967|536784615|FG002|Overall Study|Withdrawal by Subject|6|||
149233604|NCT01683565|538324882|FG001|Overall Study|Discontinued Intervention|1|||
149233605|NCT04479358|538324883|FG000|Overall Study|Withdrawal by Subject|0|||
149233606|NCT04479358|538324884|FG001|Overall Study|Withdrawal by Subject|0|||
149233607|NCT04479358|538324885|FG002|Overall Study|Withdrawal by Subject|1|||
149233608|NCT04479358|538324886|FG003|Overall Study|Withdrawal by Subject|0|||
149233609|NCT04479358|538324887|FG004|Overall Study|Withdrawal by Subject|0|||
149233610|NCT04479358|538324888|FG005|Overall Study|Withdrawal by Subject|1|||
149233611|NCT04410991|538324898|FG000|Overall Study|Poor compliance to protocol|5|||
149233612|NCT04410991|538324899|FG001|Overall Study|Poor compliance to protocol|4|||
149233613|NCT04410991|538324898|FG000|Overall Study|Withdrawal by Subject|59|||
149233614|NCT04410991|538324899|FG001|Overall Study|Withdrawal by Subject|55|||
149233615|NCT04410991|538324898|FG000|Overall Study|Other|10|||
149233616|NCT04410991|538324899|FG001|Overall Study|Other|4|||
149233617|NCT00764465|538324900|FG000|Overall Study|Adverse Event|2|||
149233618|NCT00764465|538324901|FG001|Overall Study|Adverse Event|0|||
149233619|NCT00764465|538324902|FG002|Overall Study|Adverse Event|0|||
149233620|NCT00764465|538324903|FG003|Overall Study|Adverse Event|1|||
149233621|NCT00764465|538324904|FG004|Overall Study|Adverse Event|1|||
149233622|NCT00764465|538324905|FG005|Overall Study|Adverse Event|1|||
149233623|NCT00764465|538324900|FG000|Overall Study|Withdrawal by Subject|0|||
149233624|NCT00764465|538324901|FG001|Overall Study|Withdrawal by Subject|1|||
149233625|NCT00764465|538324902|FG002|Overall Study|Withdrawal by Subject|1|||
149233626|NCT00764465|538324903|FG003|Overall Study|Withdrawal by Subject|0|||
149233627|NCT00764465|538324904|FG004|Overall Study|Withdrawal by Subject|0|||
149233628|NCT00764465|538324905|FG005|Overall Study|Withdrawal by Subject|0|||
149233629|NCT01195662|538324906|FG000|Double Blind Treatment Period|Adverse Event|4|||
149233630|NCT01195662|538324907|FG001|Double Blind Treatment Period|Adverse Event|1|||
149233631|NCT01195662|538324908|FG002|Double Blind Treatment Period|Adverse Event|2|||
149233632|NCT01195662|538324906|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
149233633|NCT01195662|538324907|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
149233634|NCT01195662|538324908|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
149233635|NCT01195662|538324906|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
149233636|NCT01195662|538324907|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
148810829|NCT03034967|536784616|FG003|Overall Study|Withdrawal by Subject|6|||
148810830|NCT03034967|536784617|FG004|Overall Study|Withdrawal by Subject|9|||
149233637|NCT01195662|538324908|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
149233638|NCT01195662|538324906|FG000|Double Blind Treatment Period|Administrative reason|2|||
149233639|NCT01195662|538324907|FG001|Double Blind Treatment Period|Administrative reason|1|||
149233640|NCT01195662|538324908|FG002|Double Blind Treatment Period|Administrative reason|1|||
149233641|NCT01195662|538324906|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
149233642|NCT01195662|538324907|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
149233643|NCT01195662|538324908|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
148690825|NCT00108732|536342373|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
148690826|NCT00108732|536342373|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
148690827|NCT01766921|536342375|FG000|Overall Study|Administrative Reason|5|||
148690828|NCT01766921|536342376|FG001|Overall Study|Administrative Reason|5|||
148690829|NCT01766921|536342375|FG000|Overall Study|Death|1|||
148690830|NCT01766921|536342376|FG001|Overall Study|Death|1|||
148690831|NCT01766921|536342375|FG000|Overall Study|Lost to Follow-up|1|||
148690832|NCT01766921|536342376|FG001|Overall Study|Lost to Follow-up|3|||
148690833|NCT01766921|536342375|FG000|Overall Study|Unclassified|2|||
148690834|NCT01766921|536342376|FG001|Overall Study|Unclassified|2|||
148690835|NCT01766921|536342375|FG000|Overall Study|Protocol Violation|1|||
148690836|NCT01766921|536342376|FG001|Overall Study|Protocol Violation|1|||
148690837|NCT01766921|536342375|FG000|Overall Study|Withdrawal by Subject|14|||
148690838|NCT01766921|536342376|FG001|Overall Study|Withdrawal by Subject|5|||
148690839|NCT01946165|536342377|FG000|Overall Study|Physician Decision|2|||
148690840|NCT01946165|536342378|FG001|Overall Study|Physician Decision|0|||
148690841|NCT01946165|536342377|FG000|Overall Study|Withdrawal by Subject|0|||
148690842|NCT01946165|536342378|FG001|Overall Study|Withdrawal by Subject|2|||
148690843|NCT01901055|536342381|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
148690844|NCT01901055|536342382|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
148690845|NCT01901055|536342381|FG000|Randomization But Not Titrated|Physician Decision|0|||
148690846|NCT01901055|536342382|FG001|Randomization But Not Titrated|Physician Decision|1|||
148690847|NCT01901055|536342381|FG000|Started Protocol to Week 6|Physician Decision|2|||
148690848|NCT01901055|536342382|FG001|Started Protocol to Week 6|Physician Decision|1|||
148690849|NCT01901055|536342381|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
148690850|NCT01901055|536342382|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
148690851|NCT01901055|536342381|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
148690852|NCT01901055|536342382|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
148690853|NCT01901055|536342381|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
148690854|NCT01901055|536342382|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
148690855|NCT01901055|536342381|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
148690856|NCT01901055|536342382|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
148690857|NCT01901055|536342381|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
148690858|NCT01901055|536342382|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
148690859|NCT01901055|536342381|FG000|Week 24|Withdrawal by Subject|13|||
148690860|NCT01901055|536342382|FG001|Week 24|Withdrawal by Subject|19|||
148690861|NCT01901055|536342381|FG000|Week 24|Physician Decision|1|||
148690862|NCT01901055|536342382|FG001|Week 24|Physician Decision|0|||
148690863|NCT01901055|536342381|FG000|Week 36|Withdrawal by Subject|0|||
148690864|NCT01901055|536342382|FG001|Week 36|Withdrawal by Subject|5|||
148690865|NCT00708422|536342383|FG000|Overall Study|Adverse Event|3|||
148690866|NCT00708422|536342384|FG001|Overall Study|Adverse Event|1|||
148690867|NCT00708422|536342383|FG000|Overall Study|Withdrawal by Subject|1|||
148690868|NCT00708422|536342384|FG001|Overall Study|Withdrawal by Subject|0|||
148690869|NCT02795104|536342385|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
148690870|NCT02795104|536342386|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
148690871|NCT02795104|536342387|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
148690872|NCT02795104|536342385|FG000|Overall Study|Withdrawal by Subject|0|||
148690873|NCT02795104|536342386|FG001|Overall Study|Withdrawal by Subject|2|||
148690874|NCT02795104|536342387|FG002|Overall Study|Withdrawal by Subject|0|||
148690875|NCT02795104|536342385|FG000|Overall Study|Lost to Follow-up|0|||
148690876|NCT02795104|536342386|FG001|Overall Study|Lost to Follow-up|0|||
148690877|NCT02795104|536342387|FG002|Overall Study|Lost to Follow-up|1|||
148690878|NCT01654380|536342391|FG000|Part B, Period 1|Physician Decision|0|||
149233644|NCT01195662|538324906|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
149233645|NCT01195662|538324907|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
149233646|NCT01195662|538324908|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
149233647|NCT01195662|538324906|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
149233648|NCT01195662|538324907|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
149233649|NCT01195662|538324908|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
149233650|NCT01195662|538324906|FG000|Double Blind Treatment Period|Non-specified|3|||
149233651|NCT01195662|538324907|FG001|Double Blind Treatment Period|Non-specified|0|||
149233652|NCT01195662|538324908|FG002|Double Blind Treatment Period|Non-specified|0|||
149233653|NCT01195662|538324906|FG000|Double Blind Treatment Period|Missing disposition information|0|||
149233654|NCT01195662|538324907|FG001|Double Blind Treatment Period|Missing disposition information|1|||
148690879|NCT01654380|536342392|FG001|Part B, Period 1|Physician Decision|0|||
148690880|NCT01654380|536342393|FG002|Part B, Period 1|Physician Decision|1|||
148690881|NCT01654380|536342394|FG003|Part B, Period 1|Physician Decision|0|||
148690882|NCT04652453|536342397|FG000|Overall Study|Death|8|||
148690883|NCT04652453|536342398|FG001|Overall Study|Death|2|||
148690884|NCT04652453|536342399|FG002|Overall Study|Death|0|||
149233655|NCT01195662|538324908|FG002|Double Blind Treatment Period|Missing disposition information|1|||
149233656|NCT01195662|538324906|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
149233657|NCT01195662|538324907|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
149233658|NCT01195662|538324908|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
149233659|NCT01195662|538324906|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
149233660|NCT01195662|538324907|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
149233661|NCT01195662|538324908|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
149233662|NCT01250418|538324910|FG000|Overall Study|monitor data failure|1|||
149233663|NCT01250418|538324911|FG001|Overall Study|monitor data failure|1|||
149233664|NCT05966129|538324914|FG000|Overall Study|Death|1|||
149233665|NCT05966129|538324915|FG001|Overall Study|Death|2|||
149233666|NCT05966129|538324914|FG000|Overall Study|Lost to Follow-up|63|||
149233667|NCT05966129|538324915|FG001|Overall Study|Lost to Follow-up|66|||
149233668|NCT05966129|538324914|FG000|Overall Study|Protocol Violation|1|||
149233669|NCT05966129|538324915|FG001|Overall Study|Protocol Violation|0|||
149233670|NCT05966129|538324914|FG000|Overall Study|Withdrawal by Subject|26|||
149233671|NCT05966129|538324915|FG001|Overall Study|Withdrawal by Subject|25|||
149233672|NCT05966129|538324914|FG000|Overall Study|Surgery not completed|63|||
149233673|NCT05966129|538324915|FG001|Overall Study|Surgery not completed|69|||
149233674|NCT05966129|538324914|FG000|Overall Study|Surgery logistics issue|2|||
149233675|NCT05966129|538324915|FG001|Overall Study|Surgery logistics issue|1|||
149233676|NCT01298323|538324916|FG000|Overall Study|Adverse Event|2|||
149233677|NCT01298323|538324917|FG001|Overall Study|Adverse Event|4|||
149233678|NCT01298323|538324916|FG000|Overall Study|Death|11|||
149233679|NCT01298323|538324917|FG001|Overall Study|Death|16|||
149233680|NCT01298323|538324916|FG000|Overall Study|Lost to Follow-up|1|||
149233681|NCT01298323|538324917|FG001|Overall Study|Lost to Follow-up|0|||
149233682|NCT01298323|538324916|FG000|Overall Study|Withdrawal by Subject|6|||
149233683|NCT01298323|538324917|FG001|Overall Study|Withdrawal by Subject|3|||
149233684|NCT01298323|538324916|FG000|Overall Study|Protocol Violation|1|||
149233685|NCT01298323|538324917|FG001|Overall Study|Protocol Violation|0|||
149233686|NCT01298323|538324916|FG000|Overall Study|Other|10|||
149233687|NCT01298323|538324917|FG001|Overall Study|Other|9|||
149233688|NCT01298323|538324916|FG000|Overall Study|Ongoing|55|||
149233689|NCT01298323|538324917|FG001|Overall Study|Ongoing|55|||
149233690|NCT01298323|538324916|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149233691|NCT01298323|538324917|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149233692|NCT01761565|538324918|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
148690885|NCT04652453|536342397|FG000|Overall Study|Hospice|5|||
148690886|NCT04652453|536342398|FG001|Overall Study|Hospice|5|||
148690887|NCT04652453|536342399|FG002|Overall Study|Hospice|0|||
148690888|NCT04652453|536342397|FG000|Overall Study|Withdrawal by Subject|2|||
148690889|NCT04652453|536342398|FG001|Overall Study|Withdrawal by Subject|0|||
148690890|NCT04652453|536342399|FG002|Overall Study|Withdrawal by Subject|0|||
148690891|NCT04543136|536342400|FG000|Overall Study|Withdrawal by Subject|0|||
148690892|NCT04543136|536342401|FG001|Overall Study|Withdrawal by Subject|1|||
148690893|NCT04543136|536342402|FG002|Overall Study|Withdrawal by Subject|0|||
148690894|NCT04543136|536342403|FG003|Overall Study|Withdrawal by Subject|1|||
148690895|NCT04543136|536342404|FG004|Overall Study|Withdrawal by Subject|0|||
148690896|NCT04543136|536342405|FG005|Overall Study|Withdrawal by Subject|0|||
148690897|NCT02192099|536342406|FG000|Overall Study|Adverse Event|1|||
148690898|NCT02192099|536342406|FG000|Overall Study|Lost to Follow-up|2|||
148690899|NCT02192099|536342406|FG000|Overall Study|Physician Decision|1|||
148690900|NCT02192099|536342406|FG000|Overall Study|Pregnancy|1|||
148690901|NCT02192099|536342406|FG000|Overall Study|Protocol Violation|8|||
148690902|NCT02192099|536342406|FG000|Overall Study|Study Terminated by Sponsor|32|||
148690903|NCT02192099|536342406|FG000|Overall Study|Withdrawal by Subject|11|||
148690904|NCT02192099|536342406|FG000|Overall Study|Miscellaneous Reasons|5|||
148690905|NCT00386009|536342407|FG000|Overall Study|Adverse Event|0|||
148690906|NCT00386009|536342408|FG001|Overall Study|Adverse Event|2|||
148690907|NCT00386009|536342407|FG000|Overall Study|Death|1|||
148690908|NCT00386009|536342408|FG001|Overall Study|Death|0|||
148690909|NCT00386009|536342407|FG000|Overall Study|Entry Criteria Not Met|0|||
148690910|NCT00386009|536342408|FG001|Overall Study|Entry Criteria Not Met|2|||
148690911|NCT00386009|536342407|FG000|Overall Study|Lost to Follow-up|1|||
148690912|NCT00386009|536342408|FG001|Overall Study|Lost to Follow-up|1|||
148690913|NCT00386009|536342407|FG000|Overall Study|Protocol Violation|1|||
148690914|NCT00386009|536342408|FG001|Overall Study|Protocol Violation|0|||
148690915|NCT00386009|536342407|FG000|Overall Study|Sponsor Decision|1|||
148690916|NCT00386009|536342408|FG001|Overall Study|Sponsor Decision|1|||
148690917|NCT00386009|536342407|FG000|Overall Study|Withdrawal by Subject|5|||
148690918|NCT00386009|536342408|FG001|Overall Study|Withdrawal by Subject|4|||
148690919|NCT04128007|536342417|FG000|Overall Study|Withdrawal by Subject|9|||
149233693|NCT05182840|538324919|FG000|Run-in Period|Not treated|0|||
149233694|NCT05182840|538324920|FG001|Run-in Period|Not treated|1|||
149233695|NCT05182840|538324921|FG002|Run-in Period|Not treated|0|||
149233696|NCT05182840|538324922|FG003|Run-in Period|Not treated|0|||
148690920|NCT04128007|536342418|FG001|Overall Study|Withdrawal by Subject|6|||
148690921|NCT04128007|536342417|FG000|Overall Study|Protocol Violation|1|||
149233697|NCT05182840|538324923|FG004|Run-in Period|Not treated|0|||
149233698|NCT05182840|538324924|FG005|Run-in Period|Not treated|0|||
149233699|NCT05182840|538324925|FG006|Run-in Period|Not treated|0|||
149233700|NCT05182840|538324926|FG007|Run-in Period|Not treated|0|||
149233701|NCT05182840|538324927|FG008|Run-in Period|Not treated|0|||
149233702|NCT05182840|538324928|FG009|Run-in Period|Not treated|0|||
149233703|NCT05182840|538324919|FG000|Run-in Period|Other reason but not sponsor termination|14|||
149233704|NCT05182840|538324920|FG001|Run-in Period|Other reason but not sponsor termination|18|||
148690922|NCT04128007|536342418|FG001|Overall Study|Protocol Violation|0|||
148690923|NCT04128007|536342417|FG000|Overall Study|Lost to Follow-up|8|||
148690924|NCT04128007|536342418|FG001|Overall Study|Lost to Follow-up|7|||
148690925|NCT04128007|536342417|FG000|Overall Study|Adverse Event|5|||
148690926|NCT04128007|536342418|FG001|Overall Study|Adverse Event|2|||
148690927|NCT04128007|536342417|FG000|Overall Study|Not reported|0|||
148690928|NCT04128007|536342418|FG001|Overall Study|Not reported|2|||
148690929|NCT01862328|536342421|FG000|Overall Study|Progressive Disease|3|||
148690930|NCT01862328|536342422|FG001|Overall Study|Progressive Disease|11|||
148690931|NCT01862328|536342423|FG002|Overall Study|Progressive Disease|5|||
148690932|NCT01862328|536342424|FG003|Overall Study|Progressive Disease|6|||
148690933|NCT01862328|536342425|FG004|Overall Study|Progressive Disease|7|||
148690934|NCT01862328|536342426|FG005|Overall Study|Progressive Disease|4|||
149233705|NCT05182840|538324921|FG002|Run-in Period|Other reason but not sponsor termination|0|||
149233706|NCT05182840|538324922|FG003|Run-in Period|Other reason but not sponsor termination|0|||
149233707|NCT05182840|538324923|FG004|Run-in Period|Other reason but not sponsor termination|0|||
149233708|NCT05182840|538324924|FG005|Run-in Period|Other reason but not sponsor termination|0|||
148690935|NCT01862328|536342427|FG006|Overall Study|Progressive Disease|3|||
149233709|NCT05182840|538324925|FG006|Run-in Period|Other reason but not sponsor termination|0|||
149233710|NCT05182840|538324926|FG007|Run-in Period|Other reason but not sponsor termination|0|||
149233711|NCT05182840|538324927|FG008|Run-in Period|Other reason but not sponsor termination|0|||
149233712|NCT05182840|538324928|FG009|Run-in Period|Other reason but not sponsor termination|0|||
149233713|NCT05182840|538324919|FG000|Run-in Period|No reason available|2|||
149233714|NCT05182840|538324920|FG001|Run-in Period|No reason available|2|||
149233715|NCT05182840|538324921|FG002|Run-in Period|No reason available|0|||
149233716|NCT05182840|538324922|FG003|Run-in Period|No reason available|0|||
149233717|NCT05182840|538324923|FG004|Run-in Period|No reason available|0|||
149233718|NCT05182840|538324924|FG005|Run-in Period|No reason available|0|||
149233719|NCT05182840|538324925|FG006|Run-in Period|No reason available|0|||
149233720|NCT05182840|538324926|FG007|Run-in Period|No reason available|0|||
149233721|NCT05182840|538324927|FG008|Run-in Period|No reason available|0|||
149233722|NCT05182840|538324928|FG009|Run-in Period|No reason available|0|||
149233723|NCT05182840|538324919|FG000|Run-in Period|Burden of study procedures|2|||
149233724|NCT05182840|538324920|FG001|Run-in Period|Burden of study procedures|2|||
149233725|NCT05182840|538324921|FG002|Run-in Period|Burden of study procedures|0|||
149233726|NCT05182840|538324922|FG003|Run-in Period|Burden of study procedures|0|||
149233727|NCT05182840|538324923|FG004|Run-in Period|Burden of study procedures|0|||
149233728|NCT05182840|538324924|FG005|Run-in Period|Burden of study procedures|0|||
149233729|NCT05182840|538324925|FG006|Run-in Period|Burden of study procedures|0|||
149233730|NCT05182840|538324926|FG007|Run-in Period|Burden of study procedures|0|||
149233731|NCT05182840|538324927|FG008|Run-in Period|Burden of study procedures|0|||
149233732|NCT05182840|538324928|FG009|Run-in Period|Burden of study procedures|0|||
149233733|NCT05182840|538324919|FG000|Run-in Period|Change of residence|1|||
149233734|NCT05182840|538324920|FG001|Run-in Period|Change of residence|0|||
149233735|NCT05182840|538324921|FG002|Run-in Period|Change of residence|0|||
149233736|NCT05182840|538324922|FG003|Run-in Period|Change of residence|0|||
149233737|NCT05182840|538324923|FG004|Run-in Period|Change of residence|0|||
149233738|NCT05182840|538324924|FG005|Run-in Period|Change of residence|0|||
149233739|NCT05182840|538324925|FG006|Run-in Period|Change of residence|0|||
149233740|NCT05182840|538324926|FG007|Run-in Period|Change of residence|0|||
149233741|NCT05182840|538324927|FG008|Run-in Period|Change of residence|0|||
149233742|NCT05182840|538324928|FG009|Run-in Period|Change of residence|0|||
149233743|NCT05182840|538324919|FG000|Run-in Period|Adverse Event|5|||
149233744|NCT05182840|538324920|FG001|Run-in Period|Adverse Event|5|||
149233745|NCT05182840|538324921|FG002|Run-in Period|Adverse Event|0|||
149233746|NCT05182840|538324922|FG003|Run-in Period|Adverse Event|0|||
149233747|NCT05182840|538324923|FG004|Run-in Period|Adverse Event|0|||
149233748|NCT05182840|538324924|FG005|Run-in Period|Adverse Event|0|||
149233749|NCT05182840|538324925|FG006|Run-in Period|Adverse Event|0|||
149233750|NCT05182840|538324926|FG007|Run-in Period|Adverse Event|0|||
149233751|NCT05182840|538324927|FG008|Run-in Period|Adverse Event|0|||
149233752|NCT05182840|538324928|FG009|Run-in Period|Adverse Event|0|||
148690936|NCT01862328|536342421|FG000|Overall Study|Adverse Event|0|||
148690937|NCT01862328|536342422|FG001|Overall Study|Adverse Event|4|||
148810831|NCT03034967|536784618|FG005|Overall Study|Withdrawal by Subject|2|||
149233753|NCT05182840|538324919|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
149233754|NCT05182840|538324920|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
148690938|NCT01862328|536342423|FG002|Overall Study|Adverse Event|0|||
148690939|NCT01862328|536342424|FG003|Overall Study|Adverse Event|1|||
149233755|NCT05182840|538324921|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
148810832|NCT03034967|536784613|FG000|Overall Study|Physician Decision|1|||
148810833|NCT03034967|536784614|FG001|Overall Study|Physician Decision|0|||
148810834|NCT03034967|536784615|FG002|Overall Study|Physician Decision|1|||
148810835|NCT03034967|536784616|FG003|Overall Study|Physician Decision|1|||
148810836|NCT03034967|536784617|FG004|Overall Study|Physician Decision|1|||
148810837|NCT03034967|536784618|FG005|Overall Study|Physician Decision|0|||
148810838|NCT03034967|536784613|FG000|Overall Study|Lost to Follow-up|0|||
148810839|NCT03034967|536784614|FG001|Overall Study|Lost to Follow-up|0|||
148810840|NCT03034967|536784615|FG002|Overall Study|Lost to Follow-up|0|||
148810841|NCT03034967|536784616|FG003|Overall Study|Lost to Follow-up|1|||
148810842|NCT03034967|536784617|FG004|Overall Study|Lost to Follow-up|0|||
148810843|NCT03034967|536784618|FG005|Overall Study|Lost to Follow-up|2|||
148810844|NCT03034967|536784613|FG000|Overall Study|Liver function test abnormality|0|||
148810845|NCT03034967|536784614|FG001|Overall Study|Liver function test abnormality|0|||
148810846|NCT03034967|536784615|FG002|Overall Study|Liver function test abnormality|1|||
148810847|NCT03034967|536784616|FG003|Overall Study|Liver function test abnormality|0|||
148810848|NCT03034967|536784617|FG004|Overall Study|Liver function test abnormality|0|||
148810849|NCT03034967|536784618|FG005|Overall Study|Liver function test abnormality|0|||
148810850|NCT03034967|536784613|FG000|Overall Study|Protocol Violation|1|||
148810851|NCT03034967|536784614|FG001|Overall Study|Protocol Violation|0|||
148810852|NCT03034967|536784615|FG002|Overall Study|Protocol Violation|0|||
148810853|NCT03034967|536784616|FG003|Overall Study|Protocol Violation|0|||
148810854|NCT03034967|536784617|FG004|Overall Study|Protocol Violation|0|||
148810855|NCT03034967|536784618|FG005|Overall Study|Protocol Violation|2|||
148810856|NCT03034967|536784613|FG000|Overall Study|Lack of Efficacy|0|||
148810857|NCT03034967|536784614|FG001|Overall Study|Lack of Efficacy|1|||
148810858|NCT03034967|536784615|FG002|Overall Study|Lack of Efficacy|2|||
148810859|NCT03034967|536784616|FG003|Overall Study|Lack of Efficacy|1|||
148810860|NCT03034967|536784617|FG004|Overall Study|Lack of Efficacy|1|||
148810861|NCT03034967|536784618|FG005|Overall Study|Lack of Efficacy|0|||
148810862|NCT03034967|536784613|FG000|Overall Study|Adverse Event, non-fatal|3|||
148810863|NCT03034967|536784614|FG001|Overall Study|Adverse Event, non-fatal|1|||
148810864|NCT03034967|536784615|FG002|Overall Study|Adverse Event, non-fatal|2|||
148810865|NCT03034967|536784616|FG003|Overall Study|Adverse Event, non-fatal|0|||
148810866|NCT03034967|536784617|FG004|Overall Study|Adverse Event, non-fatal|2|||
148810867|NCT03034967|536784618|FG005|Overall Study|Adverse Event, non-fatal|8|||
148810868|NCT03034967|536784613|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
148810869|NCT03034967|536784614|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
148810870|NCT03034967|536784615|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
148810871|NCT03034967|536784616|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
148810872|NCT03034967|536784617|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
148810873|NCT03034967|536784618|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
148810874|NCT03806296|536784619|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
148810875|NCT03806296|536784620|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
149233756|NCT05182840|538324922|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149233757|NCT05182840|538324923|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
148810876|NCT03806296|536784621|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
148810877|NCT03806296|536784619|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
148810878|NCT03806296|536784620|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
149233758|NCT05182840|538324924|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149233759|NCT05182840|538324925|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149233760|NCT05182840|538324926|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149233761|NCT05182840|538324927|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149233762|NCT05182840|538324928|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
149233763|NCT05182840|538324919|FG000|Treatment Period|Reason missing|0|||
149233764|NCT05182840|538324920|FG001|Treatment Period|Reason missing|0|||
149233765|NCT05182840|538324921|FG002|Treatment Period|Reason missing|1|||
149233766|NCT05182840|538324922|FG003|Treatment Period|Reason missing|0|||
149233767|NCT05182840|538324923|FG004|Treatment Period|Reason missing|0|||
149233768|NCT05182840|538324924|FG005|Treatment Period|Reason missing|0|||
149233769|NCT05182840|538324925|FG006|Treatment Period|Reason missing|0|||
149233770|NCT05182840|538324926|FG007|Treatment Period|Reason missing|0|||
149233771|NCT05182840|538324927|FG008|Treatment Period|Reason missing|0|||
149233772|NCT05182840|538324928|FG009|Treatment Period|Reason missing|0|||
149233773|NCT05182840|538324919|FG000|Treatment Period|Other but not sponsor termination|0|||
149020388|NCT02268552|537552629|FG003|Part 3 Extension|Death|1|||
148810879|NCT03806296|536784621|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
149020389|NCT02268552|537552630|FG004|Part 3 Extension|Death|1|||
148810880|NCT03806296|536784619|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
148810881|NCT03806296|536784620|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
148810882|NCT03806296|536784621|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
148810883|NCT02763566|536784637|FG000|Overall Study|Lost to Follow-up|1|||
148810884|NCT02763566|536784638|FG001|Overall Study|Lost to Follow-up|4|||
148810885|NCT02763566|536784639|FG002|Overall Study|Lost to Follow-up|0|||
148810886|NCT02763566|536784640|FG003|Overall Study|Lost to Follow-up|1|||
148810887|NCT02763566|536784637|FG000|Overall Study|On study treatment at study conclusion|114|||
148810888|NCT02763566|536784638|FG001|Overall Study|On study treatment at study conclusion|34|||
148810889|NCT02763566|536784639|FG002|Overall Study|On study treatment at study conclusion|54|||
148810890|NCT02763566|536784640|FG003|Overall Study|On study treatment at study conclusion|13|||
148810891|NCT02763566|536784637|FG000|Overall Study|Withdrawal by Subject|3|||
148810892|NCT02763566|536784638|FG001|Overall Study|Withdrawal by Subject|1|||
148810893|NCT02763566|536784639|FG002|Overall Study|Withdrawal by Subject|0|||
148810894|NCT02763566|536784640|FG003|Overall Study|Withdrawal by Subject|0|||
148810895|NCT01925794|536784641|FG000|180 Days|Death|2|||
148810896|NCT01925794|536784641|FG000|180 Days|Withdrawal by Subject|2|||
148810897|NCT01925794|536784641|FG000|270 Days|Death|2|||
148810898|NCT01925794|536784641|FG000|270 Days|Protocol Violation|3|||
148810899|NCT01901562|536784642|FG000|Overall Study|Protocol Violation|5|||
148810900|NCT01901562|536784642|FG000|Overall Study|Excluded intraoperatively|4|||
148810901|NCT00790036|536784643|FG000|Overall Study|Abnormal lab values|3|||
148810902|NCT00790036|536784644|FG001|Overall Study|Abnormal lab values|2|||
148810903|NCT00790036|536784643|FG000|Overall Study|Administrative problems|5|||
148810904|NCT00790036|536784644|FG001|Overall Study|Administrative problems|9|||
148810905|NCT00790036|536784643|FG000|Overall Study|Adverse Event|113|||
148810906|NCT00790036|536784644|FG001|Overall Study|Adverse Event|44|||
148810907|NCT00790036|536784643|FG000|Overall Study|Death|1|||
148810908|NCT00790036|536784644|FG001|Overall Study|Death|0|||
148810909|NCT00790036|536784643|FG000|Overall Study|Disease progression|24|||
148810910|NCT00790036|536784644|FG001|Overall Study|Disease progression|48|||
148810911|NCT00790036|536784643|FG000|Overall Study|Lost to Follow-up|1|||
148810912|NCT00790036|536784644|FG001|Overall Study|Lost to Follow-up|2|||
148810913|NCT00790036|536784643|FG000|Overall Study|Protocol Violation|10|||
148810914|NCT00790036|536784644|FG001|Overall Study|Protocol Violation|2|||
148810915|NCT00790036|536784643|FG000|Overall Study|Withdrawal by Subject|18|||
148810916|NCT00790036|536784644|FG001|Overall Study|Withdrawal by Subject|7|||
148810917|NCT00790036|536784643|FG000|Overall Study|Subject/guardian decision|20|||
148810918|NCT00790036|536784644|FG001|Overall Study|Subject/guardian decision|7|||
148810919|NCT03197129|536784645|FG000|Overall Study|did not answer the VPT: shyness|4|||
148810920|NCT03197129|536784646|FG001|Overall Study|did not answer the VPT: shyness|5|||
148810921|NCT01564407|536784647|FG000|Overall Study|Lost to Follow-up|0|||
148810922|NCT01564407|536784648|FG001|Overall Study|Lost to Follow-up|1|||
148810923|NCT01564407|536784649|FG002|Overall Study|Lost to Follow-up|0|||
148810924|NCT01564407|536784650|FG003|Overall Study|Lost to Follow-up|0|||
148810925|NCT01564407|536784651|FG004|Overall Study|Lost to Follow-up|0|||
148810926|NCT01564407|536784647|FG000|Overall Study|Withdrawal by Subject|0|||
148810927|NCT01564407|536784648|FG001|Overall Study|Withdrawal by Subject|1|||
148810928|NCT01564407|536784649|FG002|Overall Study|Withdrawal by Subject|0|||
148810929|NCT01564407|536784650|FG003|Overall Study|Withdrawal by Subject|0|||
148810930|NCT01564407|536784651|FG004|Overall Study|Withdrawal by Subject|0|||
148810931|NCT01564407|536784647|FG000|Overall Study|funding lost, study ended|0|||
148810932|NCT01564407|536784648|FG001|Overall Study|funding lost, study ended|0|||
148810933|NCT01564407|536784649|FG002|Overall Study|funding lost, study ended|0|||
148810934|NCT01564407|536784650|FG003|Overall Study|funding lost, study ended|1|||
148810935|NCT01564407|536784651|FG004|Overall Study|funding lost, study ended|0|||
148810936|NCT02442349|536784652|FG000|Overall Study|Death|95|||
148810937|NCT02442349|536784652|FG000|Overall Study|Withdrawal by Subject|27|||
148810938|NCT02442349|536784652|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
148810939|NCT02442349|536784652|FG000|Overall Study|Lost to Follow-up|1|||
148810940|NCT01285518|536784653|FG000|Overall Study|Lost to Follow-up|0|||
148810941|NCT01285518|536784654|FG001|Overall Study|Lost to Follow-up|0|||
148810942|NCT01285518|536784655|FG002|Overall Study|Lost to Follow-up|0|||
148810943|NCT01285518|536784656|FG003|Overall Study|Lost to Follow-up|0|||
148810944|NCT01285518|536784657|FG004|Overall Study|Lost to Follow-up|0|||
148810945|NCT01285518|536784658|FG005|Overall Study|Lost to Follow-up|1|||
148810946|NCT01285518|536784659|FG006|Overall Study|Lost to Follow-up|0|||
148810947|NCT01285518|536784660|FG007|Overall Study|Lost to Follow-up|0|||
148810948|NCT00639509|536784661|FG000|Overall Study|Death|1|||
148810949|NCT00294658|536784662|FG000|Overall Study|Death|0|||
148810950|NCT00294658|536784663|FG001|Overall Study|Death|1|||
148954520|NCT02282020|537317112|FG000|Overall Study|Withdrawal by Subject|7|||
148810951|NCT00294658|536784662|FG000|Overall Study|Lost to Follow-up|4|||
148810952|NCT00294658|536784663|FG001|Overall Study|Lost to Follow-up|0|||
148954521|NCT02282020|537317113|FG001|Overall Study|Withdrawal by Subject|10|||
148810953|NCT00294658|536784662|FG000|Overall Study|Physician Decision|1|||
148810954|NCT00294658|536784663|FG001|Overall Study|Physician Decision|2|||
148954522|NCT02282020|537317112|FG000|Overall Study|Miscellaneous|5|||
148690940|NCT01862328|536342425|FG004|Overall Study|Adverse Event|0|||
148690941|NCT01862328|536342426|FG005|Overall Study|Adverse Event|2|||
148690942|NCT01862328|536342427|FG006|Overall Study|Adverse Event|4|||
148690943|NCT01862328|536342421|FG000|Overall Study|Other|0|||
148690944|NCT01862328|536342422|FG001|Overall Study|Other|2|||
148690945|NCT01862328|536342423|FG002|Overall Study|Other|1|||
148690946|NCT01862328|536342424|FG003|Overall Study|Other|0|||
148690947|NCT01862328|536342425|FG004|Overall Study|Other|4|||
148690948|NCT01862328|536342426|FG005|Overall Study|Other|0|||
148690949|NCT01862328|536342427|FG006|Overall Study|Other|1|||
148690950|NCT01862328|536342421|FG000|Overall Study|Withdrawal by Subject|1|||
148690951|NCT01862328|536342422|FG001|Overall Study|Withdrawal by Subject|1|||
148690952|NCT01862328|536342423|FG002|Overall Study|Withdrawal by Subject|0|||
148690953|NCT01862328|536342424|FG003|Overall Study|Withdrawal by Subject|0|||
148690954|NCT01862328|536342425|FG004|Overall Study|Withdrawal by Subject|1|||
148690955|NCT01862328|536342426|FG005|Overall Study|Withdrawal by Subject|1|||
148690956|NCT01862328|536342427|FG006|Overall Study|Withdrawal by Subject|1|||
148690957|NCT01862328|536342421|FG000|Overall Study|Symptomatic Deterioration|0|||
148690958|NCT01862328|536342422|FG001|Overall Study|Symptomatic Deterioration|0|||
148690959|NCT01862328|536342423|FG002|Overall Study|Symptomatic Deterioration|0|||
148690960|NCT01862328|536342424|FG003|Overall Study|Symptomatic Deterioration|0|||
148690961|NCT01862328|536342425|FG004|Overall Study|Symptomatic Deterioration|0|||
148690962|NCT01862328|536342426|FG005|Overall Study|Symptomatic Deterioration|0|||
148690963|NCT01862328|536342427|FG006|Overall Study|Symptomatic Deterioration|1|||
148690964|NCT02482571|536342428|FG000|Overall Study|Adverse Event|1|||
148690965|NCT02482571|536342428|FG000|Overall Study|Scanner or Respiract failure|3|||
148690966|NCT02482571|536342428|FG000|Overall Study|Withdrawal by Subject|4|||
148690967|NCT01498484|536342429|FG000|Overall Study|Death|6|||
148690968|NCT01498484|536342430|FG001|Overall Study|Death|3|||
148690969|NCT01498484|536342431|FG002|Overall Study|Death|1|||
148690970|NCT01498484|536342432|FG003|Overall Study|Death|1|||
148690971|NCT01498484|536342433|FG004|Overall Study|Death|0|||
148690972|NCT01498484|536342434|FG005|Overall Study|Death|0|||
148690973|NCT01498484|536342435|FG006|Overall Study|Death|10|||
148690974|NCT01498484|536342436|FG007|Overall Study|Death|1|||
148690975|NCT01498484|536342437|FG008|Overall Study|Death|0|||
148690976|NCT01498484|536342429|FG000|Overall Study|Physician Decision|3|||
148690977|NCT01498484|536342430|FG001|Overall Study|Physician Decision|2|||
148690978|NCT01498484|536342431|FG002|Overall Study|Physician Decision|1|||
148690979|NCT01498484|536342432|FG003|Overall Study|Physician Decision|1|||
148690980|NCT01498484|536342433|FG004|Overall Study|Physician Decision|0|||
148690981|NCT01498484|536342434|FG005|Overall Study|Physician Decision|0|||
148690982|NCT01498484|536342435|FG006|Overall Study|Physician Decision|8|||
148690983|NCT01498484|536342436|FG007|Overall Study|Physician Decision|13|||
148690984|NCT01498484|536342437|FG008|Overall Study|Physician Decision|1|||
148690985|NCT01498484|536342429|FG000|Overall Study|Adverse Event|0|||
148690986|NCT01498484|536342430|FG001|Overall Study|Adverse Event|0|||
148690987|NCT01498484|536342431|FG002|Overall Study|Adverse Event|0|||
148690988|NCT01498484|536342432|FG003|Overall Study|Adverse Event|0|||
148690989|NCT01498484|536342433|FG004|Overall Study|Adverse Event|0|||
148690990|NCT01498484|536342434|FG005|Overall Study|Adverse Event|1|||
148690991|NCT01498484|536342435|FG006|Overall Study|Adverse Event|0|||
148690992|NCT01498484|536342436|FG007|Overall Study|Adverse Event|0|||
148690993|NCT01498484|536342437|FG008|Overall Study|Adverse Event|0|||
148690994|NCT01498484|536342429|FG000|Overall Study|Withdrawal by Subject|0|||
148690995|NCT01498484|536342430|FG001|Overall Study|Withdrawal by Subject|0|||
148690996|NCT01498484|536342431|FG002|Overall Study|Withdrawal by Subject|0|||
148690997|NCT01498484|536342432|FG003|Overall Study|Withdrawal by Subject|1|||
148690998|NCT01498484|536342433|FG004|Overall Study|Withdrawal by Subject|0|||
148690999|NCT01498484|536342434|FG005|Overall Study|Withdrawal by Subject|0|||
148691000|NCT01498484|536342435|FG006|Overall Study|Withdrawal by Subject|1|||
148691001|NCT01498484|536342436|FG007|Overall Study|Withdrawal by Subject|0|||
148691002|NCT01498484|536342437|FG008|Overall Study|Withdrawal by Subject|0|||
148691003|NCT01498484|536342429|FG000|Overall Study|Other|5|||
148691004|NCT01498484|536342430|FG001|Overall Study|Other|2|||
148691005|NCT01498484|536342431|FG002|Overall Study|Other|0|||
148691006|NCT01498484|536342432|FG003|Overall Study|Other|0|||
148691007|NCT01498484|536342433|FG004|Overall Study|Other|1|||
148691008|NCT01498484|536342434|FG005|Overall Study|Other|0|||
148691009|NCT01498484|536342435|FG006|Overall Study|Other|3|||
148691010|NCT01498484|536342436|FG007|Overall Study|Other|0|||
148691011|NCT01498484|536342437|FG008|Overall Study|Other|1|||
148691012|NCT02486796|536342438|FG000|Overall Study|Withdrawal by Subject|1|||
148691013|NCT02486796|536342439|FG001|Overall Study|Withdrawal by Subject|1|||
148691014|NCT02486796|536342438|FG000|Overall Study|Physician Decision|1|||
148691015|NCT02486796|536342439|FG001|Overall Study|Physician Decision|0|||
148691016|NCT03387098|536342440|FG000|Overall Study|progressive disease|1|||
148691017|NCT03387098|536342440|FG000|Overall Study|Withdrawal by Subject|2|||
148691018|NCT03387098|536342440|FG000|Overall Study|study terminated by sponsor|1|||
148691019|NCT02974153|536342441|FG000|Overall Study|Adverse Event|6|||
148691020|NCT02974153|536342442|FG001|Overall Study|Adverse Event|0|||
149233774|NCT05182840|538324920|FG001|Treatment Period|Other but not sponsor termination|0|||
149233775|NCT05182840|538324921|FG002|Treatment Period|Other but not sponsor termination|8|||
149233776|NCT05182840|538324922|FG003|Treatment Period|Other but not sponsor termination|6|||
149233777|NCT05182840|538324923|FG004|Treatment Period|Other but not sponsor termination|6|||
149233778|NCT05182840|538324924|FG005|Treatment Period|Other but not sponsor termination|7|||
149233779|NCT05182840|538324925|FG006|Treatment Period|Other but not sponsor termination|5|||
149233780|NCT05182840|538324926|FG007|Treatment Period|Other but not sponsor termination|8|||
149233781|NCT05182840|538324927|FG008|Treatment Period|Other but not sponsor termination|7|||
149233782|NCT05182840|538324928|FG009|Treatment Period|Other but not sponsor termination|2|||
149233783|NCT05182840|538324919|FG000|Treatment Period|Protocol deviation|0|||
149233784|NCT05182840|538324920|FG001|Treatment Period|Protocol deviation|0|||
149233785|NCT05182840|538324921|FG002|Treatment Period|Protocol deviation|0|||
149233786|NCT05182840|538324922|FG003|Treatment Period|Protocol deviation|0|||
149233787|NCT05182840|538324923|FG004|Treatment Period|Protocol deviation|0|||
149233788|NCT05182840|538324924|FG005|Treatment Period|Protocol deviation|0|||
149233789|NCT05182840|538324925|FG006|Treatment Period|Protocol deviation|0|||
149233790|NCT05182840|538324926|FG007|Treatment Period|Protocol deviation|0|||
149233791|NCT05182840|538324927|FG008|Treatment Period|Protocol deviation|1|||
149233792|NCT05182840|538324928|FG009|Treatment Period|Protocol deviation|0|||
148954523|NCT02282020|537317113|FG001|Overall Study|Miscellaneous|19|||
148954524|NCT02282020|537317112|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
148954525|NCT02282020|537317113|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
149233793|NCT05182840|538324919|FG000|Treatment Period|No reason available|0|||
148691021|NCT02974153|536342443|FG002|Overall Study|Adverse Event|1|||
148691022|NCT02974153|536342441|FG000|Overall Study|Lack of Efficacy|6|||
148691023|NCT02974153|536342442|FG001|Overall Study|Lack of Efficacy|5|||
148691024|NCT02974153|536342443|FG002|Overall Study|Lack of Efficacy|10|||
148691025|NCT02974153|536342441|FG000|Overall Study|Lost to Follow-up|9|||
148691026|NCT02974153|536342442|FG001|Overall Study|Lost to Follow-up|10|||
148691027|NCT02974153|536342443|FG002|Overall Study|Lost to Follow-up|17|||
148691028|NCT02974153|536342441|FG000|Overall Study|Physician Decision|0|||
148691029|NCT02974153|536342442|FG001|Overall Study|Physician Decision|2|||
148691030|NCT02974153|536342443|FG002|Overall Study|Physician Decision|1|||
148691031|NCT02974153|536342441|FG000|Overall Study|Withdrawal by Subject|9|||
148691032|NCT02974153|536342442|FG001|Overall Study|Withdrawal by Subject|16|||
148691033|NCT02974153|536342443|FG002|Overall Study|Withdrawal by Subject|11|||
148691034|NCT02974153|536342441|FG000|Overall Study|Study Burden|8|||
148691035|NCT02974153|536342442|FG001|Overall Study|Study Burden|7|||
148691036|NCT02974153|536342443|FG002|Overall Study|Study Burden|3|||
148691037|NCT02974153|536342441|FG000|Overall Study|Other|14|||
148691038|NCT02974153|536342442|FG001|Overall Study|Other|8|||
148691039|NCT02974153|536342443|FG002|Overall Study|Other|7|||
148691040|NCT00423800|536342444|FG000|Overall Study|Protocol Violation|0|||
148691041|NCT00423800|536342445|FG001|Overall Study|Protocol Violation|1|||
148691042|NCT00679783|536342447|FG000|Overall Study|Adverse Event|0|||
148691043|NCT00679783|536342448|FG001|Overall Study|Adverse Event|0|||
148691044|NCT00679783|536342449|FG002|Overall Study|Adverse Event|0|||
148691045|NCT00679783|536342450|FG003|Overall Study|Adverse Event|3|||
148691046|NCT00679783|536342451|FG004|Overall Study|Adverse Event|0|||
148691047|NCT00679783|536342452|FG005|Overall Study|Adverse Event|0|||
148691048|NCT00679783|536342453|FG006|Overall Study|Adverse Event|1|||
148691049|NCT00679783|536342447|FG000|Overall Study|Lack of Efficacy|0|||
148691050|NCT00679783|536342448|FG001|Overall Study|Lack of Efficacy|1|||
148691051|NCT00679783|536342449|FG002|Overall Study|Lack of Efficacy|0|||
148691052|NCT00679783|536342450|FG003|Overall Study|Lack of Efficacy|2|||
148691053|NCT00679783|536342451|FG004|Overall Study|Lack of Efficacy|0|||
148691054|NCT00679783|536342452|FG005|Overall Study|Lack of Efficacy|0|||
148691055|NCT00679783|536342453|FG006|Overall Study|Lack of Efficacy|0|||
148691056|NCT00679783|536342447|FG000|Overall Study|Withdrawal by Subject|0|||
148691057|NCT00679783|536342448|FG001|Overall Study|Withdrawal by Subject|0|||
148691058|NCT00679783|536342449|FG002|Overall Study|Withdrawal by Subject|1|||
148691059|NCT00679783|536342450|FG003|Overall Study|Withdrawal by Subject|1|||
148691060|NCT00679783|536342451|FG004|Overall Study|Withdrawal by Subject|0|||
148691061|NCT00679783|536342452|FG005|Overall Study|Withdrawal by Subject|0|||
148691062|NCT00679783|536342453|FG006|Overall Study|Withdrawal by Subject|0|||
148691063|NCT00679783|536342447|FG000|Overall Study|Not Captured|0|||
148691064|NCT00679783|536342448|FG001|Overall Study|Not Captured|0|||
148691065|NCT00679783|536342449|FG002|Overall Study|Not Captured|0|||
148691066|NCT00679783|536342450|FG003|Overall Study|Not Captured|5|||
148691067|NCT00679783|536342451|FG004|Overall Study|Not Captured|0|||
148691068|NCT00679783|536342452|FG005|Overall Study|Not Captured|0|||
148691069|NCT00679783|536342453|FG006|Overall Study|Not Captured|0|||
148691070|NCT00679783|536342447|FG000|Overall Study|Ongoing at data cut-off|2|||
148691071|NCT00679783|536342448|FG001|Overall Study|Ongoing at data cut-off|2|||
148691072|NCT00679783|536342449|FG002|Overall Study|Ongoing at data cut-off|0|||
148691073|NCT00679783|536342450|FG003|Overall Study|Ongoing at data cut-off|9|||
148691074|NCT00679783|536342451|FG004|Overall Study|Ongoing at data cut-off|1|||
148691075|NCT00679783|536342452|FG005|Overall Study|Ongoing at data cut-off|0|||
148691076|NCT00679783|536342453|FG006|Overall Study|Ongoing at data cut-off|0|||
148954526|NCT02282020|537317112|FG000|Overall Study|Developed Discontinuation Criteria|0|||
148691077|NCT00814320|536342454|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
148691078|NCT00814320|536342455|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
148691079|NCT00814320|536342454|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
148691080|NCT00814320|536342455|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
148691081|NCT00814320|536342454|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
148810955|NCT00294658|536784662|FG000|Overall Study|Pregnancy|0|||
148954527|NCT02282020|537317113|FG001|Overall Study|Developed Discontinuation Criteria|2|||
148954528|NCT02282020|537317112|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
148954529|NCT02282020|537317113|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
148954530|NCT01500629|537317114|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
148691082|NCT00814320|536342455|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
148691083|NCT00814320|536342454|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
148691084|NCT00814320|536342455|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
148691085|NCT00814320|536342454|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
148691086|NCT00814320|536342455|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
148691087|NCT00814320|536342454|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
148691088|NCT00814320|536342455|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
148691089|NCT00814320|536342454|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
148691090|NCT00814320|536342455|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
148691091|NCT00814320|536342454|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
148691092|NCT00814320|536342455|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
148691093|NCT00814320|536342454|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
148691094|NCT00814320|536342455|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
148691095|NCT00814320|536342454|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
148691096|NCT00814320|536342455|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
148691097|NCT00491504|536342456|FG000|Overall Study|Adverse Event|0|||
148691098|NCT00491504|536342457|FG001|Overall Study|Adverse Event|1|||
148691099|NCT00491504|536342458|FG002|Overall Study|Adverse Event|0|||
148691100|NCT00491504|536342459|FG003|Overall Study|Adverse Event|0|||
148691101|NCT00491504|536342456|FG000|Overall Study|Withdrawal by Subject|0|||
148691102|NCT00491504|536342457|FG001|Overall Study|Withdrawal by Subject|0|||
148691103|NCT00491504|536342458|FG002|Overall Study|Withdrawal by Subject|1|||
148691104|NCT00491504|536342459|FG003|Overall Study|Withdrawal by Subject|2|||
148691105|NCT00491504|536342456|FG000|Overall Study|Protocol Violation|0|||
148691106|NCT00491504|536342457|FG001|Overall Study|Protocol Violation|0|||
148691107|NCT00491504|536342458|FG002|Overall Study|Protocol Violation|3|||
148691108|NCT00491504|536342459|FG003|Overall Study|Protocol Violation|2|||
148691109|NCT00601484|536342465|FG000|Overall Study|Adverse Event|0|||
148691110|NCT00601484|536342466|FG001|Overall Study|Adverse Event|1|||
148691111|NCT00601484|536342465|FG000|Overall Study|Lost to Follow-up|4|||
148691112|NCT00601484|536342466|FG001|Overall Study|Lost to Follow-up|3|||
148691113|NCT00601484|536342465|FG000|Overall Study|Lack of Efficacy|0|||
148691114|NCT00601484|536342466|FG001|Overall Study|Lack of Efficacy|2|||
148691115|NCT00601484|536342465|FG000|Overall Study|Withdrawal by Subject|1|||
148691116|NCT00601484|536342466|FG001|Overall Study|Withdrawal by Subject|1|||
148691117|NCT00601484|536342465|FG000|Overall Study|Randomized, but not treated|0|||
148691118|NCT00601484|536342466|FG001|Overall Study|Randomized, but not treated|1|||
148810956|NCT00294658|536784663|FG001|Overall Study|Pregnancy|1|||
148810957|NCT00294658|536784662|FG000|Overall Study|Withdrawal by Subject|0|||
148810958|NCT00294658|536784663|FG001|Overall Study|Withdrawal by Subject|4|||
148691119|NCT03504852|536342467|FG000|Overall Study|Withdrawal of informed consent|2|||
148691120|NCT03504852|536342468|FG001|Overall Study|Withdrawal of informed consent|1|||
148810959|NCT00294658|536784662|FG000|Overall Study|Found to have invasive thymoma|1|||
148810960|NCT00294658|536784663|FG001|Overall Study|Found to have invasive thymoma|0|||
148810961|NCT00294658|536784662|FG000|Overall Study|Patient and family were not satisfied|0|||
148691121|NCT03504852|536342469|FG002|Overall Study|Withdrawal of informed consent|0|||
148691122|NCT03504852|536342467|FG000|Overall Study|Withdrawal by Subject|5|||
148691123|NCT03504852|536342468|FG001|Overall Study|Withdrawal by Subject|5|||
148691124|NCT03504852|536342469|FG002|Overall Study|Withdrawal by Subject|1|||
148691125|NCT03504852|536342467|FG000|Overall Study|Lost to Follow-up|4|||
148691126|NCT03504852|536342468|FG001|Overall Study|Lost to Follow-up|1|||
148691127|NCT03504852|536342469|FG002|Overall Study|Lost to Follow-up|0|||
148691128|NCT03504852|536342467|FG000|Overall Study|New therapy for study indication|1|||
148691129|NCT03504852|536342468|FG001|Overall Study|New therapy for study indication|0|||
148691130|NCT03504852|536342469|FG002|Overall Study|New therapy for study indication|0|||
148691131|NCT03504852|536342467|FG000|Overall Study|Lack of Efficacy|1|||
148691132|NCT03504852|536342468|FG001|Overall Study|Lack of Efficacy|2|||
148691133|NCT03504852|536342469|FG002|Overall Study|Lack of Efficacy|0|||
148691134|NCT03504852|536342467|FG000|Overall Study|Death|0|||
148691135|NCT03504852|536342468|FG001|Overall Study|Death|1|||
148691136|NCT03504852|536342469|FG002|Overall Study|Death|0|||
148691137|NCT03504852|536342467|FG000|Overall Study|Adverse Event|4|||
148691138|NCT03504852|536342468|FG001|Overall Study|Adverse Event|8|||
148691139|NCT03504852|536342469|FG002|Overall Study|Adverse Event|2|||
148691140|NCT03850509|536342470|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
148810962|NCT00294658|536784663|FG001|Overall Study|Patient and family were not satisfied|1|||
148691141|NCT03850509|536342471|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
148691142|NCT00969332|536342472|FG000|Overall Study|Physician Decision|8|||
148691143|NCT00969332|536342472|FG000|Overall Study|Withdrawal by Subject|3|||
148691144|NCT02666430|536342473|FG000|Period 1|Lost to Follow-up|1|||
148691145|NCT02666430|536342474|FG001|Period 1|Lost to Follow-up|0|||
148691146|NCT02666430|536342473|FG000|Period 1|Adverse Event|0|||
148691147|NCT02666430|536342474|FG001|Period 1|Adverse Event|1|||
148691148|NCT02666430|536342473|FG000|Period 2|Withdrawal by Subject|1|||
148954531|NCT01500629|537317115|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
148954532|NCT00249444|537317116|FG000|Overall Study|Lost to Follow-up|2|||
148954533|NCT00249444|537317117|FG001|Overall Study|Lost to Follow-up|2|||
148954534|NCT00249444|537317116|FG000|Overall Study|non-compliant|9|||
148954535|NCT00249444|537317117|FG001|Overall Study|non-compliant|11|||
148954536|NCT00249444|537317116|FG000|Overall Study|Adverse Event|1|||
148954537|NCT00249444|537317117|FG001|Overall Study|Adverse Event|1|||
148954538|NCT00249444|537317116|FG000|Overall Study|life event|0|||
148954539|NCT00249444|537317117|FG001|Overall Study|life event|1|||
148954540|NCT01499667|537317118|FG000|Overall Study|administrative problems|4|||
148954541|NCT01499667|537317119|FG001|Overall Study|administrative problems|5|||
148954542|NCT01499667|537317120|FG002|Overall Study|administrative problems|5|||
148954543|NCT01499667|537317118|FG000|Overall Study|Protocol Violation|1|||
148954544|NCT01499667|537317119|FG001|Overall Study|Protocol Violation|3|||
148954545|NCT01499667|537317120|FG002|Overall Study|Protocol Violation|2|||
148954546|NCT01499667|537317118|FG000|Overall Study|Adverse Event|0|||
148954547|NCT01499667|537317119|FG001|Overall Study|Adverse Event|2|||
148954548|NCT01499667|537317120|FG002|Overall Study|Adverse Event|2|||
148954549|NCT01499667|537317118|FG000|Overall Study|Withdrawal by Subject|2|||
148954550|NCT01499667|537317119|FG001|Overall Study|Withdrawal by Subject|1|||
148954551|NCT01499667|537317120|FG002|Overall Study|Withdrawal by Subject|1|||
148954552|NCT01499667|537317118|FG000|Overall Study|Lack of Efficacy|2|||
148954553|NCT01499667|537317119|FG001|Overall Study|Lack of Efficacy|0|||
148691149|NCT02666430|536342474|FG001|Period 2|Withdrawal by Subject|4|||
148691150|NCT02666430|536342473|FG000|Period 3|Lost to Follow-up|1|||
148691151|NCT02666430|536342474|FG001|Period 3|Lost to Follow-up|0|||
148691152|NCT03828461|536342475|FG000|Overall Study|Lost to Follow-up|1|||
148691153|NCT03828461|536342475|FG000|Overall Study|Withdrawal by Subject|3|||
148691154|NCT00576199|536342476|FG000|Overall Study|Adverse Event|12|||
148691155|NCT00576199|536342476|FG000|Overall Study|Insufficient Therapeutic Response|14|||
148691156|NCT00576199|536342476|FG000|Overall Study|Refused Treatment|2|||
148691157|NCT00576199|536342476|FG000|Overall Study|Reason Unspecified|2|||
148691158|NCT01565083|536342478|FG000|Overall Study|Withdrawal by Subject|6|||
148954554|NCT01499667|537317120|FG002|Overall Study|Lack of Efficacy|0|||
148954555|NCT02673489|537317121|FG000|Treatment Period|Lost to Follow-up|3|||
148954556|NCT02673489|537317122|FG001|Treatment Period|Lost to Follow-up|0|||
148954557|NCT02673489|537317121|FG000|Treatment Period|Participant request to discontinue|1|||
148954558|NCT02673489|537317122|FG001|Treatment Period|Participant request to discontinue|1|||
149020390|NCT02268552|537552631|FG005|Part 3 Extension|Death|1|||
149020391|NCT02268552|537552632|FG006|Part 3 Extension|Death|0|||
149020392|NCT02268552|537552626|FG000|Part 3 Extension|Early termination of trial|1|||
149020393|NCT02268552|537552627|FG001|Part 3 Extension|Early termination of trial|0|||
149020394|NCT02268552|537552628|FG002|Part 3 Extension|Early termination of trial|0|||
149020395|NCT02268552|537552629|FG003|Part 3 Extension|Early termination of trial|0|||
149020396|NCT02268552|537552630|FG004|Part 3 Extension|Early termination of trial|2|||
149020397|NCT02268552|537552631|FG005|Part 3 Extension|Early termination of trial|9|||
149020398|NCT02268552|537552632|FG006|Part 3 Extension|Early termination of trial|11|||
149020399|NCT02268552|537552626|FG000|Part 3 Extension|Subject/guardian decision|0|||
149020400|NCT02268552|537552627|FG001|Part 3 Extension|Subject/guardian decision|0|||
149020401|NCT02268552|537552628|FG002|Part 3 Extension|Subject/guardian decision|0|||
148691159|NCT01565083|536342479|FG001|Overall Study|Withdrawal by Subject|4|||
149020402|NCT02268552|537552629|FG003|Part 3 Extension|Subject/guardian decision|0|||
149020403|NCT02268552|537552630|FG004|Part 3 Extension|Subject/guardian decision|0|||
148691160|NCT01565083|536342478|FG000|Overall Study|Lost to Follow-up|2|||
148691161|NCT01565083|536342479|FG001|Overall Study|Lost to Follow-up|7|||
148691162|NCT01565083|536342478|FG000|Overall Study|Death|22|||
148691163|NCT01565083|536342479|FG001|Overall Study|Death|23|||
148691164|NCT01565083|536342478|FG000|Overall Study|Other|3|||
148691165|NCT01565083|536342479|FG001|Overall Study|Other|5|||
148691166|NCT01118728|536342480|FG000|Overall Study|Adverse Event|17|||
148691167|NCT01118728|536342480|FG000|Overall Study|Lack of Efficacy|27|||
148691168|NCT01118728|536342480|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
148691169|NCT01118728|536342480|FG000|Overall Study|Withdrawal by Subject|3|||
148691170|NCT01118728|536342480|FG000|Overall Study|Lost to Follow-up|4|||
148691171|NCT03131999|536342483|FG000|Overall Study|Withdrawal by Subject|0|||
148691172|NCT03131999|536342484|FG001|Overall Study|Withdrawal by Subject|1|||
148691173|NCT03495869|536342487|FG000|Overall Study|Lost to Follow-up|4|||
148691174|NCT03495869|536342488|FG001|Overall Study|Lost to Follow-up|17|||
148691175|NCT03495869|536342489|FG002|Overall Study|Lost to Follow-up|8|||
148691176|NCT03495869|536342490|FG003|Overall Study|Lost to Follow-up|14|||
148691177|NCT03495869|536342487|FG000|Overall Study|Withdrawal by Subject|0|||
148691178|NCT03495869|536342488|FG001|Overall Study|Withdrawal by Subject|3|||
148691179|NCT03495869|536342489|FG002|Overall Study|Withdrawal by Subject|0|||
148691180|NCT03495869|536342490|FG003|Overall Study|Withdrawal by Subject|3|||
148691181|NCT03495869|536342487|FG000|Overall Study|Dropped from study|0|||
148691182|NCT03495869|536342488|FG001|Overall Study|Dropped from study|7|||
148691183|NCT03495869|536342489|FG002|Overall Study|Dropped from study|2|||
148691184|NCT03495869|536342490|FG003|Overall Study|Dropped from study|4|||
148691185|NCT04634409|536342491|FG000|Overall Study|Death|0|||
148691186|NCT04634409|536342492|FG001|Overall Study|Death|0|||
148691187|NCT04634409|536342493|FG002|Overall Study|Death|0|||
148691188|NCT04634409|536342494|FG003|Overall Study|Death|0|||
148691189|NCT04634409|536342495|FG004|Overall Study|Death|0|||
148954559|NCT02673489|537317121|FG000|Treatment Period|Participant moved to another province|1|||
148954560|NCT02673489|537317122|FG001|Treatment Period|Participant moved to another province|0|||
148954561|NCT02673489|537317121|FG000|Treatment Period|Participant was incarcerated|0|||
148954562|NCT02673489|537317122|FG001|Treatment Period|Participant was incarcerated|1|||
148954563|NCT02673489|537317121|FG000|Treatment Period|Adverse Event|0|||
148954564|NCT02673489|537317122|FG001|Treatment Period|Adverse Event|1|||
148954565|NCT02673489|537317121|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
148954566|NCT02673489|537317122|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
148954567|NCT02673489|537317121|FG000|Follow Up Period|Unable to return for follow-up|0|||
148691190|NCT04634409|536342496|FG005|Overall Study|Death|0|||
148691191|NCT04634409|536342497|FG006|Overall Study|Death|0|||
148691192|NCT04634409|536342498|FG007|Overall Study|Death|0|||
148691193|NCT04634409|536342499|FG008|Overall Study|Death|0|||
148691194|NCT04634409|536342500|FG009|Overall Study|Death|0|||
148691195|NCT04634409|536342501|FG010|Overall Study|Death|1|||
148691196|NCT04634409|536342502|FG011|Overall Study|Death|0|||
148691197|NCT04634409|536342503|FG012|Overall Study|Death|1|||
148954568|NCT02673489|537317122|FG001|Follow Up Period|Unable to return for follow-up|1|||
148954569|NCT00759863|537317123|FG000|Overall Study|Death, moved, or lost contact|20|||
148954570|NCT00759863|537317124|FG001|Overall Study|Death, moved, or lost contact|18|||
148954571|NCT01549392|537317125|FG000|Overall Study|Withdrawal by Subject|1|||
148954572|NCT01549392|537317126|FG001|Overall Study|Withdrawal by Subject|0|||
148954573|NCT02743806|537317127|FG000|Overall Study|Adverse Event|9|||
148954574|NCT02743806|537317127|FG000|Overall Study|Lost to Follow-up|8|||
148954575|NCT02743806|537317127|FG000|Overall Study|Voluntary Withdrawal|54|||
148954576|NCT02743806|537317127|FG000|Overall Study|Study Termination|65|||
148954577|NCT02743806|537317127|FG000|Overall Study|Pregnancy|6|||
148954578|NCT02743806|537317127|FG000|Overall Study|No Longer Clinically Benefiting|27|||
148954579|NCT02743806|537317127|FG000|Overall Study|Reason Not Specified|12|||
148954580|NCT00849381|537317128|FG000|Overall Study|Adverse Event|1|||
148954581|NCT00849381|537317128|FG000|Overall Study|Lost to Follow-up|129|||
148954582|NCT00849381|537317128|FG000|Overall Study|Protocol Violation|5|||
148954583|NCT00849381|537317128|FG000|Overall Study|Withdrawal by Subject|6|||
148954584|NCT00849381|537317128|FG000|Overall Study|Other|4|||
148954585|NCT00460031|537317129|FG000|Overall Study|Adverse Event|5|||
148954586|NCT00460031|537317129|FG000|Overall Study|Withdrawal by Subject|5|||
148954587|NCT00460031|537317129|FG000|Overall Study|Death|1|||
148954588|NCT02618434|537317130|FG000|Overall Study|Withdrawal by Subject|0|||
148954589|NCT02618434|537317131|FG001|Overall Study|Withdrawal by Subject|2|||
148954590|NCT02618434|537317132|FG002|Overall Study|Withdrawal by Subject|3|||
148954591|NCT02618434|537317130|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
148691198|NCT04634409|536342504|FG013|Overall Study|Death|0|||
148691199|NCT04634409|536342505|FG014|Overall Study|Death|0|||
148691200|NCT04634409|536342506|FG015|Overall Study|Death|0|||
148691201|NCT04634409|536342507|FG016|Overall Study|Death|0|||
148691202|NCT04634409|536342508|FG017|Overall Study|Death|0|||
148691203|NCT04634409|536342509|FG018|Overall Study|Death|0|||
148691204|NCT04634409|536342510|FG019|Overall Study|Death|0|||
148691205|NCT04634409|536342511|FG020|Overall Study|Death|0|||
148691206|NCT04634409|536342512|FG021|Overall Study|Death|0|||
148691207|NCT04634409|536342513|FG022|Overall Study|Death|0|||
148691208|NCT04634409|536342514|FG023|Overall Study|Death|0|||
148691209|NCT04634409|536342515|FG024|Overall Study|Death|0|||
148691210|NCT04634409|536342516|FG025|Overall Study|Death|0|||
148691211|NCT04634409|536342517|FG026|Overall Study|Death|0|||
148691212|NCT04634409|536342491|FG000|Overall Study|Adverse Event|0|||
148691213|NCT04634409|536342492|FG001|Overall Study|Adverse Event|0|||
148691214|NCT04634409|536342493|FG002|Overall Study|Adverse Event|1|||
148691215|NCT04634409|536342494|FG003|Overall Study|Adverse Event|0|||
148954592|NCT02618434|537317131|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
148954593|NCT02618434|537317132|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
148954594|NCT02618434|537317130|FG000|Overall Study|Lost to Follow-up|3|||
148954595|NCT02618434|537317131|FG001|Overall Study|Lost to Follow-up|1|||
148954596|NCT02618434|537317132|FG002|Overall Study|Lost to Follow-up|3|||
148691216|NCT04634409|536342495|FG004|Overall Study|Adverse Event|0|||
148691217|NCT04634409|536342496|FG005|Overall Study|Adverse Event|1|||
148691218|NCT04634409|536342497|FG006|Overall Study|Adverse Event|0|||
148691219|NCT04634409|536342498|FG007|Overall Study|Adverse Event|0|||
148691220|NCT04634409|536342499|FG008|Overall Study|Adverse Event|0|||
148691221|NCT04634409|536342500|FG009|Overall Study|Adverse Event|0|||
148691222|NCT04634409|536342501|FG010|Overall Study|Adverse Event|0|||
148954597|NCT02618434|537317130|FG000|Overall Study|Adverse Event|1|||
148954598|NCT02618434|537317131|FG001|Overall Study|Adverse Event|0|||
148954599|NCT02618434|537317132|FG002|Overall Study|Adverse Event|12|||
148954600|NCT02618434|537317130|FG000|Overall Study|Physician Decision|0|||
148954601|NCT02618434|537317131|FG001|Overall Study|Physician Decision|1|||
148954602|NCT02618434|537317132|FG002|Overall Study|Physician Decision|0|||
148954603|NCT02618434|537317130|FG000|Overall Study|Protocol Violation|0|||
148954604|NCT02618434|537317131|FG001|Overall Study|Protocol Violation|0|||
148954605|NCT02618434|537317132|FG002|Overall Study|Protocol Violation|1|||
148954606|NCT02618434|537317130|FG000|Overall Study|Other, Multiple categories|1|||
148954607|NCT02618434|537317131|FG001|Overall Study|Other, Multiple categories|1|||
148954608|NCT02618434|537317132|FG002|Overall Study|Other, Multiple categories|1|||
148954609|NCT01988103|537317133|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
148954610|NCT01988103|537317134|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
148954611|NCT01988103|537317135|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
148954612|NCT01988103|537317136|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
148954613|NCT01988103|537317137|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
148954614|NCT01988103|537317133|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
148954615|NCT01988103|537317134|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
148954616|NCT01988103|537317135|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
148954617|NCT01988103|537317136|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
148954618|NCT01988103|537317137|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
148954619|NCT01988103|537317133|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
148954620|NCT01988103|537317134|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
148954621|NCT01988103|537317135|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
148954622|NCT01988103|537317136|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
148954623|NCT01988103|537317137|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
148954624|NCT01988103|537317133|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
148954625|NCT01988103|537317134|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
148954626|NCT01988103|537317135|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
148954627|NCT01988103|537317136|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
148954628|NCT01988103|537317137|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
148954629|NCT01988103|537317133|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
148954630|NCT01988103|537317134|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
148954631|NCT01988103|537317135|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
148954632|NCT01988103|537317136|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
148954633|NCT01988103|537317137|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
148954634|NCT01988103|537317133|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
148954635|NCT01988103|537317134|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
148954636|NCT01988103|537317135|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
148954637|NCT01988103|537317136|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
148954638|NCT01988103|537317137|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
148954639|NCT01988103|537317133|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
148954640|NCT01988103|537317134|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
148954641|NCT01988103|537317135|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
148691223|NCT04634409|536342502|FG011|Overall Study|Adverse Event|0|||
148691224|NCT04634409|536342503|FG012|Overall Study|Adverse Event|0|||
148691225|NCT04634409|536342504|FG013|Overall Study|Adverse Event|0|||
148691226|NCT04634409|536342505|FG014|Overall Study|Adverse Event|0|||
148691227|NCT04634409|536342506|FG015|Overall Study|Adverse Event|0|||
148954642|NCT01988103|537317136|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
148954643|NCT01988103|537317137|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
148954644|NCT02506153|537317138|FG000|Overall Study|Adverse Event|359|||
148954645|NCT02506153|537317139|FG001|Overall Study|Adverse Event|114|||
148954646|NCT02506153|537317138|FG000|Overall Study|Refused unrelated to adverse event|127|||
148954647|NCT02506153|537317139|FG001|Overall Study|Refused unrelated to adverse event|18|||
148954648|NCT02506153|537317138|FG000|Overall Study|Progression/relapse|91|||
148954649|NCT02506153|537317139|FG001|Overall Study|Progression/relapse|136|||
148954650|NCT02506153|537317138|FG000|Overall Study|Death|2|||
148954651|NCT02506153|537317139|FG001|Overall Study|Death|1|||
148954652|NCT02506153|537317138|FG000|Overall Study|Other - not protocol specified|23|||
148954653|NCT02506153|537317139|FG001|Overall Study|Other - not protocol specified|12|||
148954654|NCT00885105|537317140|FG000|Overall Study|Withdrawal by Subject|0|||
148954655|NCT00885105|537317141|FG001|Overall Study|Withdrawal by Subject|8|||
148954656|NCT00885105|537317140|FG000|Overall Study|Adverse Event|1|||
148954657|NCT00885105|537317141|FG001|Overall Study|Adverse Event|0|||
148954658|NCT00885105|537317140|FG000|Overall Study|Protocol Violation|0|||
148954659|NCT00885105|537317141|FG001|Overall Study|Protocol Violation|2|||
148954660|NCT02772081|537317147|FG000|Overall Study|Physician Decision|1|||
148954661|NCT02772081|537317148|FG001|Overall Study|Physician Decision|1|||
148954662|NCT02772081|537317147|FG000|Overall Study|Death|1|||
149020404|NCT02268552|537552631|FG005|Part 3 Extension|Subject/guardian decision|0|||
149020405|NCT02268552|537552632|FG006|Part 3 Extension|Subject/guardian decision|1|||
149020406|NCT02748512|537552636|FG000|Overall Study|Lost to Follow-up|1|||
149020407|NCT02748512|537552637|FG001|Overall Study|Lost to Follow-up|1|||
149020408|NCT00997243|537552638|FG000|Overall Study|Early termination of study by sponsor|7|||
149020409|NCT03415022|537552645|FG000|Overall Study|Withdrawal by Subject|1|||
149020410|NCT03415022|537552646|FG001|Overall Study|Withdrawal by Subject|2|||
149020411|NCT03415022|537552645|FG000|Overall Study|COVID-19 Suspension|2|||
149020412|NCT03415022|537552646|FG001|Overall Study|COVID-19 Suspension|3|||
149020413|NCT03415022|537552645|FG000|Overall Study|Lost to Follow-up|2|||
149020414|NCT03415022|537552646|FG001|Overall Study|Lost to Follow-up|0|||
149020415|NCT03583541|537552652|FG000|Overall Study|Lost to Follow-up|31|||
149020416|NCT03583541|537552653|FG001|Overall Study|Lost to Follow-up|65|||
149020417|NCT00884286|537552654|FG000|Overall Study|Progressive disease|21|||
149020418|NCT00884286|537552655|FG001|Overall Study|Progressive disease|28|||
149020419|NCT00884286|537552654|FG000|Overall Study|Toxicity|4|||
149020420|NCT00884286|537552655|FG001|Overall Study|Toxicity|1|||
149020421|NCT00884286|537552654|FG000|Overall Study|Death|2|||
149020422|NCT00884286|537552655|FG001|Overall Study|Death|2|||
149020423|NCT00884286|537552654|FG000|Overall Study|Physician Decision|1|||
149020424|NCT00884286|537552655|FG001|Overall Study|Physician Decision|0|||
149020425|NCT00884286|537552654|FG000|Overall Study|Septic shock|1|||
149020426|NCT00884286|537552655|FG001|Overall Study|Septic shock|0|||
149020427|NCT00884286|537552654|FG000|Overall Study|Thrombus in right auricle|1|||
149020428|NCT00884286|537552655|FG001|Overall Study|Thrombus in right auricle|0|||
149020429|NCT00884286|537552654|FG000|Overall Study|Not treated|2|||
149020430|NCT00884286|537552655|FG001|Overall Study|Not treated|1|||
149020431|NCT00884286|537552654|FG000|Overall Study|Comprised lung carcinoma|0|||
149020432|NCT00884286|537552655|FG001|Overall Study|Comprised lung carcinoma|1|||
149020433|NCT01196104|537552656|FG000|Overall Study|Lost to Follow-up|1|||
149020434|NCT01196104|537552657|FG001|Overall Study|Lost to Follow-up|0|||
148954663|NCT02772081|537317148|FG001|Overall Study|Death|1|||
148954664|NCT02598076|537317153|FG000|Overall Study|Lost to Follow-up|2|||
149020435|NCT01196104|537552656|FG000|Overall Study|Physician Decision|0|||
149020436|NCT01196104|537552657|FG001|Overall Study|Physician Decision|1|||
149020437|NCT01196104|537552656|FG000|Overall Study|Withdrawal by Subject|3|||
149020438|NCT01196104|537552657|FG001|Overall Study|Withdrawal by Subject|3|||
149020439|NCT01196104|537552656|FG000|Overall Study|Various|0|||
149020440|NCT01196104|537552657|FG001|Overall Study|Various|1|||
149020441|NCT01094171|537552662|FG000|Overall Study|Lost to Follow-up|2|||
149020442|NCT01094171|537552662|FG000|Overall Study|Informed consent withdrawal|4|||
149020443|NCT01094171|537552662|FG000|Overall Study|Migration from the study area|3|||
149020444|NCT01094171|537552662|FG000|Overall Study|Other|1|||
149020445|NCT00594932|537552663|FG000|First 3 Months|Withdrawal by Subject|1|||
148954665|NCT02598076|537317154|FG001|Overall Study|Lost to Follow-up|3|||
148954666|NCT00311623|537317155|FG000|Overall Study|Physician Decision|0|||
148954667|NCT00311623|537317156|FG001|Overall Study|Physician Decision|0|||
148954668|NCT00311623|537317157|FG002|Overall Study|Physician Decision|2|||
149020446|NCT00594932|537552664|FG001|First 3 Months|Withdrawal by Subject|3|||
149020447|NCT00594932|537552663|FG000|Final 3 Months|Withdrawal by Subject|4|||
149020448|NCT00594932|537552664|FG001|Final 3 Months|Withdrawal by Subject|3|||
149020449|NCT01536145|537552665|FG000|Overall Study|Progressive disease|3|||
149020450|NCT01536145|537552666|FG001|Overall Study|Progressive disease|4|||
149020451|NCT01536145|537552667|FG002|Overall Study|Progressive disease|1|||
149020452|NCT01536145|537552668|FG003|Overall Study|Progressive disease|2|||
149020453|NCT01536145|537552669|FG004|Overall Study|Progressive disease|1|||
149020454|NCT01536145|537552670|FG005|Overall Study|Progressive disease|2|||
149020455|NCT01536145|537552671|FG006|Overall Study|Progressive disease|1|||
149020456|NCT01536145|537552672|FG007|Overall Study|Progressive disease|2|||
149020457|NCT01536145|537552673|FG008|Overall Study|Progressive disease|1|||
149020458|NCT01536145|537552674|FG009|Overall Study|Progressive disease|3|||
149020459|NCT01536145|537552675|FG010|Overall Study|Progressive disease|3|||
149020460|NCT01536145|537552665|FG000|Overall Study|Withdrawal by Subject|0|||
149020461|NCT01536145|537552666|FG001|Overall Study|Withdrawal by Subject|0|||
149020462|NCT01536145|537552667|FG002|Overall Study|Withdrawal by Subject|1|||
149020463|NCT01536145|537552668|FG003|Overall Study|Withdrawal by Subject|0|||
149020464|NCT01536145|537552669|FG004|Overall Study|Withdrawal by Subject|0|||
149020465|NCT01536145|537552670|FG005|Overall Study|Withdrawal by Subject|1|||
149020466|NCT01536145|537552671|FG006|Overall Study|Withdrawal by Subject|0|||
149020467|NCT01536145|537552672|FG007|Overall Study|Withdrawal by Subject|0|||
149020468|NCT01536145|537552673|FG008|Overall Study|Withdrawal by Subject|2|||
149020469|NCT01536145|537552674|FG009|Overall Study|Withdrawal by Subject|0|||
149020470|NCT01536145|537552675|FG010|Overall Study|Withdrawal by Subject|2|||
149020471|NCT01536145|537552665|FG000|Overall Study|Other|0|||
149020472|NCT01536145|537552666|FG001|Overall Study|Other|0|||
149020473|NCT01536145|537552667|FG002|Overall Study|Other|0|||
149020474|NCT01536145|537552668|FG003|Overall Study|Other|0|||
149020475|NCT01536145|537552669|FG004|Overall Study|Other|1|||
149020476|NCT01536145|537552670|FG005|Overall Study|Other|0|||
149020477|NCT01536145|537552671|FG006|Overall Study|Other|0|||
149020478|NCT01536145|537552672|FG007|Overall Study|Other|0|||
149020479|NCT01536145|537552673|FG008|Overall Study|Other|0|||
149020480|NCT01536145|537552674|FG009|Overall Study|Other|3|||
149020481|NCT01536145|537552675|FG010|Overall Study|Other|2|||
149020482|NCT01536145|537552665|FG000|Overall Study|Death|0|||
149020483|NCT01536145|537552666|FG001|Overall Study|Death|0|||
149020484|NCT01536145|537552667|FG002|Overall Study|Death|0|||
149020485|NCT01536145|537552668|FG003|Overall Study|Death|0|||
149020486|NCT01536145|537552669|FG004|Overall Study|Death|0|||
149020487|NCT01536145|537552670|FG005|Overall Study|Death|0|||
149020488|NCT01536145|537552671|FG006|Overall Study|Death|1|||
148954669|NCT03454893|537317162|FG000|Overall Study|Study Terminated by the Sponsor|5|||
148954670|NCT03454893|537317162|FG000|Overall Study|Did not pass screening|4|||
148954671|NCT04876274|537317163|FG000|Overall Study|Lost to Follow-up|9|||
148954672|NCT04876274|537317164|FG001|Overall Study|Lost to Follow-up|12|||
148954673|NCT03414424|537317165|FG000|Overall Study|Screened out after consent|0|||
148954674|NCT03414424|537317166|FG001|Overall Study|Screened out after consent|2|||
148954675|NCT03414424|537317165|FG000|Overall Study|Lost to Follow-up|0|||
149020489|NCT01536145|537552672|FG007|Overall Study|Death|0|||
149020490|NCT01536145|537552673|FG008|Overall Study|Death|0|||
149020491|NCT01536145|537552674|FG009|Overall Study|Death|0|||
149020492|NCT01536145|537552675|FG010|Overall Study|Death|0|||
149020493|NCT01536145|537552665|FG000|Overall Study|Adverse Event|0|||
149020494|NCT01536145|537552666|FG001|Overall Study|Adverse Event|0|||
149020495|NCT01536145|537552667|FG002|Overall Study|Adverse Event|0|||
149020496|NCT01536145|537552668|FG003|Overall Study|Adverse Event|0|||
149020497|NCT01536145|537552669|FG004|Overall Study|Adverse Event|0|||
149020498|NCT01536145|537552670|FG005|Overall Study|Adverse Event|0|||
149020499|NCT01536145|537552671|FG006|Overall Study|Adverse Event|0|||
149020500|NCT01536145|537552672|FG007|Overall Study|Adverse Event|2|||
149020501|NCT01536145|537552673|FG008|Overall Study|Adverse Event|0|||
149020502|NCT01536145|537552674|FG009|Overall Study|Adverse Event|0|||
149020503|NCT01536145|537552675|FG010|Overall Study|Adverse Event|3|||
149020504|NCT00088205|537552680|FG000|Overall Study|Adverse Event|4|||
149020505|NCT00088205|537552680|FG000|Overall Study|Progressive Disease|51|||
148691228|NCT04634409|536342507|FG016|Overall Study|Adverse Event|0|||
148954676|NCT03414424|537317166|FG001|Overall Study|Lost to Follow-up|1|||
149020506|NCT00088205|537552680|FG000|Overall Study|Physician Decision|1|||
149020507|NCT00088205|537552680|FG000|Overall Study|Death Due to Study Disease|4|||
149020508|NCT05199233|537552681|FG000|Overall Study|Lack of Efficacy|1|||
149020509|NCT00688259|537552686|FG000|Overall Study|Lost to Follow-up|2|||
149020510|NCT00688259|537552687|FG001|Overall Study|Lost to Follow-up|4|||
149020511|NCT00688259|537552686|FG000|Overall Study|Physician Decision|1|||
148954677|NCT03070782|537317168|FG000|Overall Study|Adverse Event|3|||
148954678|NCT03070782|537317169|FG001|Overall Study|Adverse Event|0|||
148954679|NCT03070782|537317170|FG002|Overall Study|Adverse Event|3|||
148954680|NCT03070782|537317171|FG003|Overall Study|Adverse Event|1|||
148954681|NCT03070782|537317172|FG004|Overall Study|Adverse Event|6|||
148954682|NCT03070782|537317173|FG005|Overall Study|Adverse Event|2|||
148954683|NCT03070782|537317168|FG000|Overall Study|Withdrawal by Subject|2|||
148954684|NCT03070782|537317169|FG001|Overall Study|Withdrawal by Subject|1|||
148954685|NCT03070782|537317170|FG002|Overall Study|Withdrawal by Subject|1|||
148954686|NCT03070782|537317171|FG003|Overall Study|Withdrawal by Subject|0|||
148954687|NCT03070782|537317172|FG004|Overall Study|Withdrawal by Subject|4|||
148954688|NCT03070782|537317173|FG005|Overall Study|Withdrawal by Subject|3|||
148954689|NCT03070782|537317168|FG000|Overall Study|Reason Not Specified|2|||
148954690|NCT03070782|537317169|FG001|Overall Study|Reason Not Specified|0|||
148954691|NCT03070782|537317170|FG002|Overall Study|Reason Not Specified|0|||
148954692|NCT03070782|537317171|FG003|Overall Study|Reason Not Specified|1|||
148954693|NCT03070782|537317172|FG004|Overall Study|Reason Not Specified|2|||
148954694|NCT03070782|537317173|FG005|Overall Study|Reason Not Specified|1|||
148954695|NCT03070782|537317168|FG000|Overall Study|Ineligibility|0|||
148954696|NCT03070782|537317169|FG001|Overall Study|Ineligibility|0|||
148954697|NCT03070782|537317170|FG002|Overall Study|Ineligibility|0|||
148954698|NCT03070782|537317171|FG003|Overall Study|Ineligibility|1|||
148954699|NCT03070782|537317172|FG004|Overall Study|Ineligibility|0|||
148954700|NCT03070782|537317173|FG005|Overall Study|Ineligibility|1|||
148954701|NCT03070782|537317168|FG000|Overall Study|Pregnancy|0|||
148954702|NCT03070782|537317169|FG001|Overall Study|Pregnancy|0|||
148954703|NCT03070782|537317170|FG002|Overall Study|Pregnancy|0|||
148954704|NCT03070782|537317171|FG003|Overall Study|Pregnancy|1|||
148954705|NCT03070782|537317172|FG004|Overall Study|Pregnancy|0|||
148954706|NCT03070782|537317173|FG005|Overall Study|Pregnancy|0|||
148954707|NCT03070782|537317168|FG000|Overall Study|Investigator Judgement|0|||
148954708|NCT03070782|537317169|FG001|Overall Study|Investigator Judgement|0|||
148954709|NCT03070782|537317170|FG002|Overall Study|Investigator Judgement|0|||
148954710|NCT03070782|537317171|FG003|Overall Study|Investigator Judgement|1|||
148954711|NCT03070782|537317172|FG004|Overall Study|Investigator Judgement|0|||
148954712|NCT03070782|537317173|FG005|Overall Study|Investigator Judgement|0|||
148954713|NCT01881776|537317174|FG000|Overall Study|Lost to Follow-up|1|||
148954714|NCT01881776|537317175|FG001|Overall Study|Lost to Follow-up|2|||
148954715|NCT01881776|537317176|FG002|Overall Study|Lost to Follow-up|1|||
148954716|NCT01881776|537317174|FG000|Overall Study|Protocol Violation|0|||
148954717|NCT01881776|537317175|FG001|Overall Study|Protocol Violation|2|||
148954718|NCT01881776|537317176|FG002|Overall Study|Protocol Violation|1|||
148954719|NCT02320149|537317177|FG000|Overall Study|Adverse Event|3|||
148954720|NCT02320149|537317178|FG001|Overall Study|Adverse Event|7|||
148954721|NCT02320149|537317177|FG000|Overall Study|Withdrawal of Consent|28|||
148954722|NCT02320149|537317178|FG001|Overall Study|Withdrawal of Consent|32|||
148954723|NCT02320149|537317177|FG000|Overall Study|Lost to Follow-up|21|||
148954724|NCT02320149|537317178|FG001|Overall Study|Lost to Follow-up|34|||
148954725|NCT02320149|537317177|FG000|Overall Study|Protocol Violation|2|||
148954726|NCT02320149|537317178|FG001|Overall Study|Protocol Violation|1|||
148954727|NCT02320149|537317177|FG000|Overall Study|Noncompliance with Study Treatment|7|||
148954728|NCT02320149|537317178|FG001|Overall Study|Noncompliance with Study Treatment|2|||
148954729|NCT02320149|537317177|FG000|Overall Study|Lack of Efficacy|0|||
148954730|NCT02320149|537317178|FG001|Overall Study|Lack of Efficacy|1|||
149020512|NCT00688259|537552687|FG001|Overall Study|Physician Decision|0|||
149020513|NCT00688259|537552686|FG000|Overall Study|Withdrawal by Subject|2|||
149020514|NCT00688259|537552687|FG001|Overall Study|Withdrawal by Subject|0|||
149020515|NCT00688259|537552686|FG000|Overall Study|Declined Interview|2|||
149020516|NCT00688259|537552687|FG001|Overall Study|Declined Interview|3|||
149020517|NCT00688259|537552686|FG000|Overall Study|Hospitalized at Follow-up|0|||
149020518|NCT00688259|537552687|FG001|Overall Study|Hospitalized at Follow-up|1|||
149020519|NCT00065468|537552695|FG000|Overall Study|Death|172|||
149020520|NCT00065468|537552696|FG001|Overall Study|Death|169|||
149020521|NCT00065468|537552697|FG002|Overall Study|Death|171|||
148954731|NCT02320149|537317177|FG000|Overall Study|Other Miscellaneous Reasons|2|||
148954732|NCT02320149|537317178|FG001|Overall Study|Other Miscellaneous Reasons|3|||
148954733|NCT00022633|537317179|FG000|Overall Study|Adverse Event|11|||
148954734|NCT00022633|537317180|FG001|Overall Study|Adverse Event|1|||
148954735|NCT00022633|537317179|FG000|Overall Study|Refusal unrelated to adverse event|1|||
148954736|NCT00022633|537317180|FG001|Overall Study|Refusal unrelated to adverse event|0|||
148954737|NCT00022633|537317179|FG000|Overall Study|Progression/relapse|9|||
149020522|NCT00065468|537552695|FG000|Overall Study|Withdrawal by Subject|3|||
148954738|NCT00022633|537317180|FG001|Overall Study|Progression/relapse|2|||
148954739|NCT00022633|537317179|FG000|Overall Study|Death|4|||
149020523|NCT00065468|537552696|FG001|Overall Study|Withdrawal by Subject|4|||
149020524|NCT00065468|537552697|FG002|Overall Study|Withdrawal by Subject|5|||
148954740|NCT00022633|537317180|FG001|Overall Study|Death|0|||
148954741|NCT00022633|537317179|FG000|Overall Study|Other - not protocol specified|3|||
148954742|NCT00022633|537317180|FG001|Overall Study|Other - not protocol specified|2|||
148954743|NCT00022633|537317179|FG000|Overall Study|Ineligible|4|||
148954744|NCT00022633|537317180|FG001|Overall Study|Ineligible|0|||
148954745|NCT00333866|537317181|FG000|Overall Study|Adverse Event|23|||
148954746|NCT00333866|537317182|FG001|Overall Study|Adverse Event|37|||
148954747|NCT00333866|537317183|FG002|Overall Study|Adverse Event|38|||
148954748|NCT00333866|537317184|FG003|Overall Study|Adverse Event|47|||
148954749|NCT00333866|537317181|FG000|Overall Study|Other|3|||
148954750|NCT00333866|537317182|FG001|Overall Study|Other|2|||
148954751|NCT00333866|537317183|FG002|Overall Study|Other|2|||
148954752|NCT00333866|537317184|FG003|Overall Study|Other|2|||
148954753|NCT00333866|537317181|FG000|Overall Study|Lack of Efficacy|8|||
148954754|NCT00333866|537317182|FG001|Overall Study|Lack of Efficacy|6|||
149020525|NCT00065468|537552695|FG000|Overall Study|Lost to Follow-up|5|||
149020526|NCT00065468|537552696|FG001|Overall Study|Lost to Follow-up|3|||
149020527|NCT00065468|537552697|FG002|Overall Study|Lost to Follow-up|2|||
149020528|NCT00065468|537552695|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
149020529|NCT00065468|537552696|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
149020530|NCT00065468|537552697|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
149020531|NCT00065468|537552695|FG000|Overall Study|Disease progression|0|||
149020532|NCT00065468|537552696|FG001|Overall Study|Disease progression|0|||
149020533|NCT00065468|537552697|FG002|Overall Study|Disease progression|1|||
149020534|NCT00065468|537552695|FG000|Overall Study|Other|14|||
149020535|NCT00065468|537552696|FG001|Overall Study|Other|24|||
149020536|NCT00065468|537552697|FG002|Overall Study|Other|18|||
149020537|NCT01058863|537552698|FG000|Overall Study|Lost to Follow-up|1|||
149020538|NCT01058863|537552698|FG000|Overall Study|Withdrawal by Subject|1|||
149020539|NCT01058863|537552698|FG000|Overall Study|Sponsor requested withdrawal|1|||
149020540|NCT01058863|537552698|FG000|Overall Study|Randomized in error|1|||
148691229|NCT04634409|536342508|FG017|Overall Study|Adverse Event|0|||
148954755|NCT00333866|537317183|FG002|Overall Study|Lack of Efficacy|3|||
148954756|NCT00333866|537317184|FG003|Overall Study|Lack of Efficacy|5|||
149020541|NCT03653416|537552699|FG000|Overall Study|Protocol Violation|6|||
148954757|NCT00333866|537317181|FG000|Overall Study|Lost to Follow-up|1|||
148954758|NCT00333866|537317182|FG001|Overall Study|Lost to Follow-up|2|||
148954759|NCT00333866|537317183|FG002|Overall Study|Lost to Follow-up|2|||
148954760|NCT00333866|537317184|FG003|Overall Study|Lost to Follow-up|2|||
148954761|NCT00333866|537317181|FG000|Overall Study|Withdrawal by Subject|8|||
149020542|NCT03653416|537552700|FG001|Overall Study|Protocol Violation|1|||
149020543|NCT03050398|537552706|FG000|Overall Study|Study terminated by sponsor|8|||
149020544|NCT03018106|537552707|FG000|Overall Study|Lost to Follow-up|0|||
149020545|NCT03018106|537552708|FG001|Overall Study|Lost to Follow-up|1|||
148810963|NCT01402700|536784664|FG000|Overall Study|Death|3|||
148810964|NCT01402700|536784664|FG000|Overall Study|Withdrawal by Subject|3|||
148810965|NCT01402700|536784664|FG000|Overall Study|Missed Visit|1|||
148810966|NCT03507790|536784665|FG000|Overall Study|Adverse Event|0|||
148810967|NCT03507790|536784666|FG001|Overall Study|Adverse Event|11|||
148810968|NCT03507790|536784667|FG002|Overall Study|Adverse Event|3|||
148810969|NCT03507790|536784665|FG000|Overall Study|Withdrawal by Subject|2|||
148810970|NCT03507790|536784666|FG001|Overall Study|Withdrawal by Subject|0|||
148810971|NCT03507790|536784667|FG002|Overall Study|Withdrawal by Subject|0|||
148810972|NCT03507790|536784665|FG000|Overall Study|Subject moved to another location|1|||
148810973|NCT03507790|536784666|FG001|Overall Study|Subject moved to another location|2|||
148810974|NCT03507790|536784667|FG002|Overall Study|Subject moved to another location|0|||
148810975|NCT03507790|536784665|FG000|Overall Study|Non-compliance with study drug|0|||
148810976|NCT03507790|536784666|FG001|Overall Study|Non-compliance with study drug|0|||
148810977|NCT03507790|536784667|FG002|Overall Study|Non-compliance with study drug|1|||
148810978|NCT03507790|536784665|FG000|Overall Study|COVID 19 Pandemic|0|||
148810979|NCT03507790|536784666|FG001|Overall Study|COVID 19 Pandemic|1|||
148810980|NCT03507790|536784667|FG002|Overall Study|COVID 19 Pandemic|0|||
148810981|NCT03507790|536784665|FG000|Overall Study|Lost to Follow-up|0|||
148810982|NCT03507790|536784666|FG001|Overall Study|Lost to Follow-up|1|||
148810983|NCT03507790|536784667|FG002|Overall Study|Lost to Follow-up|0|||
148810984|NCT03507790|536784665|FG000|Overall Study|Discontinuation of the trial at the site|1|||
148810985|NCT03507790|536784666|FG001|Overall Study|Discontinuation of the trial at the site|1|||
148810986|NCT03507790|536784667|FG002|Overall Study|Discontinuation of the trial at the site|0|||
148810987|NCT03507790|536784665|FG000|Overall Study|Randomized in error|0|||
148810988|NCT03507790|536784666|FG001|Overall Study|Randomized in error|0|||
148810989|NCT03507790|536784667|FG002|Overall Study|Randomized in error|1|||
148810990|NCT00157755|536784669|FG000|Overall Study|Death|2|||
148810991|NCT00157755|536784670|FG001|Overall Study|Death|3|||
148810992|NCT00157755|536784671|FG002|Overall Study|Death|3|||
148810993|NCT00157755|536784672|FG003|Overall Study|Death|2|||
148810994|NCT00157755|536784673|FG004|Overall Study|Death|0|||
148810995|NCT00157755|536784674|FG005|Overall Study|Death|0|||
148810996|NCT00157755|536784669|FG000|Overall Study|Lost to Follow-up|0|||
148810997|NCT00157755|536784670|FG001|Overall Study|Lost to Follow-up|0|||
148810998|NCT00157755|536784671|FG002|Overall Study|Lost to Follow-up|1|||
148810999|NCT00157755|536784672|FG003|Overall Study|Lost to Follow-up|0|||
148811000|NCT00157755|536784673|FG004|Overall Study|Lost to Follow-up|0|||
148811001|NCT00157755|536784674|FG005|Overall Study|Lost to Follow-up|0|||
148811002|NCT00157755|536784669|FG000|Overall Study|Withdrawal by Subject|0|||
148811003|NCT00157755|536784670|FG001|Overall Study|Withdrawal by Subject|0|||
148811004|NCT00157755|536784671|FG002|Overall Study|Withdrawal by Subject|1|||
148811005|NCT00157755|536784672|FG003|Overall Study|Withdrawal by Subject|1|||
148811006|NCT00157755|536784673|FG004|Overall Study|Withdrawal by Subject|1|||
148954762|NCT00333866|537317182|FG001|Overall Study|Withdrawal by Subject|14|||
148954763|NCT00333866|537317183|FG002|Overall Study|Withdrawal by Subject|4|||
148954764|NCT00333866|537317184|FG003|Overall Study|Withdrawal by Subject|9|||
148954765|NCT00333866|537317181|FG000|Overall Study|Randomized but not Treated|5|||
148954766|NCT00333866|537317182|FG001|Overall Study|Randomized but not Treated|3|||
148954767|NCT00333866|537317183|FG002|Overall Study|Randomized but not Treated|2|||
148954768|NCT00333866|537317184|FG003|Overall Study|Randomized but not Treated|1|||
148954769|NCT06073119|537317185|FG000|Overall Study|Adverse Event|1|||
148954770|NCT06073119|537317186|FG001|Overall Study|Adverse Event|3|||
148954771|NCT06073119|537317187|FG002|Overall Study|Adverse Event|0|||
148954772|NCT06073119|537317188|FG003|Overall Study|Adverse Event|0|||
148954773|NCT06073119|537317189|FG004|Overall Study|Adverse Event|1|||
148954774|NCT06073119|537317190|FG005|Overall Study|Adverse Event|0|||
148954775|NCT06073119|537317185|FG000|Overall Study|Non-compliance with study schedule|1|||
148954776|NCT06073119|537317186|FG001|Overall Study|Non-compliance with study schedule|0|||
148954777|NCT06073119|537317187|FG002|Overall Study|Non-compliance with study schedule|0|||
148954778|NCT06073119|537317188|FG003|Overall Study|Non-compliance with study schedule|0|||
148954779|NCT06073119|537317189|FG004|Overall Study|Non-compliance with study schedule|1|||
148954780|NCT06073119|537317190|FG005|Overall Study|Non-compliance with study schedule|0|||
148954781|NCT06073119|537317185|FG000|Overall Study|Withdrawal by Subject|4|||
148954782|NCT06073119|537317186|FG001|Overall Study|Withdrawal by Subject|4|||
148954783|NCT06073119|537317187|FG002|Overall Study|Withdrawal by Subject|3|||
148954784|NCT06073119|537317188|FG003|Overall Study|Withdrawal by Subject|5|||
148954785|NCT06073119|537317189|FG004|Overall Study|Withdrawal by Subject|3|||
148811007|NCT00157755|536784674|FG005|Overall Study|Withdrawal by Subject|2|||
148811008|NCT00157755|536784669|FG000|Overall Study|Explant due to infection|0|||
148811009|NCT00157755|536784670|FG001|Overall Study|Explant due to infection|0|||
148954786|NCT06073119|537317190|FG005|Overall Study|Withdrawal by Subject|1|||
148954787|NCT06073119|537317185|FG000|Overall Study|Other|2|||
148954788|NCT06073119|537317186|FG001|Overall Study|Other|4|||
148954789|NCT06073119|537317187|FG002|Overall Study|Other|1|||
148811010|NCT00157755|536784671|FG002|Overall Study|Explant due to infection|1|||
148954790|NCT06073119|537317188|FG003|Overall Study|Other|0|||
148954791|NCT06073119|537317189|FG004|Overall Study|Other|1|||
148954792|NCT06073119|537317190|FG005|Overall Study|Other|0|||
148954793|NCT01408914|537317200|FG000|Overall Study|Could not complete tx in protocol period|5|||
148954794|NCT01408914|537317201|FG001|Overall Study|Could not complete tx in protocol period|5|||
148954795|NCT01408914|537317202|FG002|Overall Study|Could not complete tx in protocol period|6|||
148954796|NCT01408914|537317200|FG000|Overall Study|Lost to Follow-up|4|||
148954797|NCT01408914|537317201|FG001|Overall Study|Lost to Follow-up|1|||
148811011|NCT00157755|536784672|FG003|Overall Study|Explant due to infection|0|||
148954798|NCT01408914|537317202|FG002|Overall Study|Lost to Follow-up|2|||
148954799|NCT01408914|537317200|FG000|Overall Study|Physician Decision|1|||
148954800|NCT01408914|537317201|FG001|Overall Study|Physician Decision|1|||
148954801|NCT01408914|537317202|FG002|Overall Study|Physician Decision|0|||
148954802|NCT01408914|537317200|FG000|Overall Study|Withdrawal by Subject|1|||
148954803|NCT01408914|537317201|FG001|Overall Study|Withdrawal by Subject|0|||
148954804|NCT01408914|537317202|FG002|Overall Study|Withdrawal by Subject|1|||
148954805|NCT01408914|537317200|FG000|Overall Study|Moved out of study jurisdiction|1|||
148954806|NCT01408914|537317201|FG001|Overall Study|Moved out of study jurisdiction|1|||
148954807|NCT01408914|537317202|FG002|Overall Study|Moved out of study jurisdiction|0|||
148954808|NCT01408914|537317200|FG000|Overall Study|Late exclusion|0|||
148954809|NCT01408914|537317201|FG001|Overall Study|Late exclusion|3|||
148954810|NCT01408914|537317202|FG002|Overall Study|Late exclusion|3|||
148811012|NCT00157755|536784673|FG004|Overall Study|Explant due to infection|0|||
148811013|NCT00157755|536784674|FG005|Overall Study|Explant due to infection|0|||
148811014|NCT00157755|536784669|FG000|Overall Study|Medical reason|0|||
148811015|NCT00157755|536784670|FG001|Overall Study|Medical reason|0|||
148811016|NCT00157755|536784671|FG002|Overall Study|Medical reason|1|||
148811017|NCT00157755|536784672|FG003|Overall Study|Medical reason|1|||
148811018|NCT00157755|536784673|FG004|Overall Study|Medical reason|0|||
148811019|NCT00157755|536784674|FG005|Overall Study|Medical reason|0|||
148811020|NCT00157755|536784669|FG000|Overall Study|Study site closure|0|||
148811021|NCT00157755|536784670|FG001|Overall Study|Study site closure|1|||
148811022|NCT00157755|536784671|FG002|Overall Study|Study site closure|0|||
148811023|NCT00157755|536784672|FG003|Overall Study|Study site closure|0|||
148811024|NCT00157755|536784673|FG004|Overall Study|Study site closure|0|||
148811025|NCT00157755|536784674|FG005|Overall Study|Study site closure|0|||
148811026|NCT00157755|536784669|FG000|Overall Study|Subject non-compliance|0|||
148811027|NCT00157755|536784670|FG001|Overall Study|Subject non-compliance|0|||
148811028|NCT00157755|536784671|FG002|Overall Study|Subject non-compliance|0|||
148811029|NCT00157755|536784672|FG003|Overall Study|Subject non-compliance|0|||
148811030|NCT00157755|536784673|FG004|Overall Study|Subject non-compliance|0|||
148811031|NCT00157755|536784674|FG005|Overall Study|Subject non-compliance|1|||
148811032|NCT00157755|536784669|FG000|Overall Study|Study completion|0|||
148811033|NCT00157755|536784670|FG001|Overall Study|Study completion|0|||
148811034|NCT00157755|536784671|FG002|Overall Study|Study completion|0|||
148811035|NCT00157755|536784672|FG003|Overall Study|Study completion|0|||
148811036|NCT00157755|536784673|FG004|Overall Study|Study completion|1|||
148811037|NCT00157755|536784674|FG005|Overall Study|Study completion|2|||
148811038|NCT05049122|536784682|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
148811039|NCT05049122|536784682|FG000|Overall Study|Participant moved|1|||
148811040|NCT05049122|536784682|FG000|Overall Study|At the direction of the doctor|1|||
148811041|NCT01910441|536784683|FG000|Overall Study|Sponsor decision|0|||
148811042|NCT01910441|536784684|FG001|Overall Study|Sponsor decision|2|||
148811043|NCT01910441|536784683|FG000|Overall Study|Lost to Follow-up|6|||
148811044|NCT01910441|536784684|FG001|Overall Study|Lost to Follow-up|5|||
148811045|NCT01910441|536784683|FG000|Overall Study|Withdrawal by Subject|0|||
148811046|NCT01910441|536784684|FG001|Overall Study|Withdrawal by Subject|1|||
148811047|NCT01910441|536784683|FG000|Overall Study|Non-compliance|0|||
148811048|NCT01910441|536784684|FG001|Overall Study|Non-compliance|1|||
148811049|NCT01910441|536784683|FG000|Overall Study|Adverse Event|1|||
148811050|NCT01910441|536784684|FG001|Overall Study|Adverse Event|0|||
148811051|NCT01910441|536784683|FG000|Overall Study|Physician Decision|0|||
148811052|NCT01910441|536784684|FG001|Overall Study|Physician Decision|1|||
148811053|NCT03636477|536784685|FG000|Overall Study|Adverse Event|0|||
148811054|NCT03636477|536784686|FG001|Overall Study|Adverse Event|0|||
148811055|NCT03636477|536784687|FG002|Overall Study|Adverse Event|1|||
148811056|NCT02382380|536784688|FG000|Overall Study|Withdrawal by Subject|2|||
148811057|NCT02382380|536784689|FG001|Overall Study|Withdrawal by Subject|2|||
148811058|NCT02382380|536784688|FG000|Overall Study|Lost to Follow-up|0|||
148811059|NCT02382380|536784689|FG001|Overall Study|Lost to Follow-up|1|||
148811060|NCT05168800|536784690|FG000|Time 1 Survey|Did not start T1 survey|182|||
148811061|NCT05168800|536784691|FG001|Time 1 Survey|Did not start T1 survey|150|||
148954811|NCT01408914|537317200|FG000|Overall Study|Change in local TB/HIV norms|0|||
148954812|NCT01408914|537317201|FG001|Overall Study|Change in local TB/HIV norms|1|||
148954813|NCT01408914|537317202|FG002|Overall Study|Change in local TB/HIV norms|1|||
148954814|NCT01714635|537317218|FG000|Overall Study|Discontinued|1|||
148954815|NCT01714635|537317219|FG001|Overall Study|Discontinued|0|||
148954816|NCT01714635|537317220|FG002|Overall Study|Discontinued|2|||
148954817|NCT01714635|537317218|FG000|Overall Study|Missed 6-month exam|1|||
148954818|NCT01714635|537317219|FG001|Overall Study|Missed 6-month exam|0|||
148954819|NCT01714635|537317220|FG002|Overall Study|Missed 6-month exam|0|||
148954820|NCT03672747|537317221|FG000|Overall Study|Lost to Follow-up|1|||
148811062|NCT05168800|536784692|FG002|Time 1 Survey|Did not start T1 survey|140|||
148811063|NCT05168800|536784690|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
148811064|NCT05168800|536784691|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
148811065|NCT05168800|536784692|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
148811066|NCT05168800|536784690|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
148811067|NCT05168800|536784691|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
148811068|NCT05168800|536784692|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
148954821|NCT03672747|537317222|FG001|Overall Study|Lost to Follow-up|1|||
148954822|NCT03672747|537317223|FG002|Overall Study|Lost to Follow-up|2|||
148954823|NCT03672747|537317224|FG003|Overall Study|Lost to Follow-up|2|||
148954824|NCT03672747|537317225|FG004|Overall Study|Lost to Follow-up|2|||
148954825|NCT03672747|537317226|FG005|Overall Study|Lost to Follow-up|1|||
148954826|NCT04285879|537317227|FG000|Overall Study|Lost to Follow-up|1|||
148954827|NCT04285879|537317228|FG001|Overall Study|Lost to Follow-up|8|||
148954828|NCT04285879|537317227|FG000|Overall Study|medical/surgical exclusion|16|||
148954829|NCT04285879|537317228|FG001|Overall Study|medical/surgical exclusion|0|||
148954830|NCT00071513|537317231|FG000|Intervention Component|Withdrawal by Subject|2|||
148954831|NCT00071513|537317232|FG001|Intervention Component|Withdrawal by Subject|3|||
148954832|NCT00071513|537317231|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
148954833|NCT00071513|537317232|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
148954834|NCT03667924|537317233|FG000|Baseline Completed|Lost to Follow-up|0|||
148954835|NCT03667924|537317234|FG001|Baseline Completed|Lost to Follow-up|2|||
148954836|NCT03667924|537317235|FG002|Baseline Completed|Lost to Follow-up|0|||
148954837|NCT03667924|537317233|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
148954838|NCT03667924|537317234|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
148954839|NCT03667924|537317235|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
148954840|NCT03667924|537317233|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
148954841|NCT03667924|537317234|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
148954842|NCT03667924|537317235|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
148954843|NCT03667924|537317233|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
148954844|NCT03667924|537317234|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
148954845|NCT03667924|537317235|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
148954846|NCT03667924|537317233|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
148954847|NCT03667924|537317234|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
148954848|NCT03667924|537317235|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
148954849|NCT03667924|537317233|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
148954850|NCT03667924|537317234|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
148954851|NCT03667924|537317235|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
148954852|NCT03667924|537317233|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
148954853|NCT03667924|537317234|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
148954854|NCT03667924|537317235|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
148954855|NCT03358290|537317236|FG000|Overall Study|Study discontinued by Sponsor|0|||
148954856|NCT03358290|537317237|FG001|Overall Study|Study discontinued by Sponsor|1|||
148954857|NCT03358290|537317238|FG002|Overall Study|Study discontinued by Sponsor|1|||
148954858|NCT03358290|537317239|FG003|Overall Study|Study discontinued by Sponsor|0|||
148954859|NCT03358290|537317240|FG004|Overall Study|Study discontinued by Sponsor|0|||
148954860|NCT03358290|537317236|FG000|Overall Study|Adverse Event|0|||
148954861|NCT03358290|537317237|FG001|Overall Study|Adverse Event|0|||
148954862|NCT03358290|537317238|FG002|Overall Study|Adverse Event|1|||
148954863|NCT03358290|537317239|FG003|Overall Study|Adverse Event|2|||
148954864|NCT03358290|537317240|FG004|Overall Study|Adverse Event|0|||
148954865|NCT03358290|537317236|FG000|Overall Study|Withdrawal by Subject|0|||
148954866|NCT03358290|537317237|FG001|Overall Study|Withdrawal by Subject|0|||
148954867|NCT03358290|537317238|FG002|Overall Study|Withdrawal by Subject|0|||
148954868|NCT03358290|537317239|FG003|Overall Study|Withdrawal by Subject|0|||
148954869|NCT03358290|537317240|FG004|Overall Study|Withdrawal by Subject|1|||
148954870|NCT02743871|537317241|FG000|Overall Study|Lost to Follow-up|0|||
148954871|NCT02743871|537317242|FG001|Overall Study|Lost to Follow-up|0|||
148954872|NCT02743871|537317243|FG002|Overall Study|Lost to Follow-up|0|||
148954873|NCT02743871|537317244|FG003|Overall Study|Lost to Follow-up|1|||
148954874|NCT02743871|537317245|FG004|Overall Study|Lost to Follow-up|0|||
148954875|NCT02743871|537317246|FG005|Overall Study|Lost to Follow-up|0|||
148954876|NCT02743871|537317247|FG006|Overall Study|Lost to Follow-up|1|||
148954877|NCT02743871|537317248|FG007|Overall Study|Lost to Follow-up|0|||
148954878|NCT02743871|537317249|FG008|Overall Study|Lost to Follow-up|0|||
148954879|NCT02743871|537317250|FG009|Overall Study|Lost to Follow-up|0|||
148954880|NCT02743871|537317251|FG010|Overall Study|Lost to Follow-up|0|||
148954881|NCT02743871|537317252|FG011|Overall Study|Lost to Follow-up|2|||
148954882|NCT02743871|537317253|FG012|Overall Study|Lost to Follow-up|0|||
148954883|NCT02743871|537317254|FG013|Overall Study|Lost to Follow-up|0|||
148954884|NCT02743871|537317241|FG000|Overall Study|Withdrawal by Subject|0|||
148811069|NCT05168800|536784690|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
148811070|NCT05168800|536784691|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
148811071|NCT05168800|536784692|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
148811072|NCT05168800|536784690|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
148811073|NCT05168800|536784691|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
148811074|NCT05168800|536784692|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
148811075|NCT05168800|536784690|FG000|Time 1 Survey|Withdrawal by Subject|6|||
148954885|NCT02743871|537317242|FG001|Overall Study|Withdrawal by Subject|0|||
148954886|NCT02743871|537317243|FG002|Overall Study|Withdrawal by Subject|0|||
149020546|NCT01991197|537552709|FG000|Overall Study|Lost to Follow-up|1|||
149020547|NCT01991197|537552710|FG001|Overall Study|Lost to Follow-up|1|||
149020548|NCT01991197|537552709|FG000|Overall Study|Physician Decision|0|||
149020549|NCT01991197|537552710|FG001|Overall Study|Physician Decision|2|||
149020550|NCT01991197|537552709|FG000|Overall Study|Withdrawal by Subject|2|||
148954887|NCT02743871|537317244|FG003|Overall Study|Withdrawal by Subject|0|||
148954888|NCT02743871|537317245|FG004|Overall Study|Withdrawal by Subject|0|||
148954889|NCT02743871|537317246|FG005|Overall Study|Withdrawal by Subject|0|||
148954890|NCT02743871|537317247|FG006|Overall Study|Withdrawal by Subject|0|||
148954891|NCT02743871|537317248|FG007|Overall Study|Withdrawal by Subject|0|||
148954892|NCT02743871|537317249|FG008|Overall Study|Withdrawal by Subject|0|||
148954893|NCT02743871|537317250|FG009|Overall Study|Withdrawal by Subject|0|||
148954894|NCT02743871|537317251|FG010|Overall Study|Withdrawal by Subject|1|||
148954895|NCT02743871|537317252|FG011|Overall Study|Withdrawal by Subject|0|||
148954896|NCT02743871|537317253|FG012|Overall Study|Withdrawal by Subject|12|||
148954897|NCT02743871|537317254|FG013|Overall Study|Withdrawal by Subject|6|||
148954898|NCT02743871|537317241|FG000|Overall Study|Adverse Event|1|||
148954899|NCT02743871|537317242|FG001|Overall Study|Adverse Event|0|||
148954900|NCT02743871|537317243|FG002|Overall Study|Adverse Event|0|||
148954901|NCT02743871|537317244|FG003|Overall Study|Adverse Event|0|||
148954902|NCT02743871|537317245|FG004|Overall Study|Adverse Event|0|||
148954903|NCT02743871|537317246|FG005|Overall Study|Adverse Event|0|||
148954904|NCT02743871|537317247|FG006|Overall Study|Adverse Event|0|||
148954905|NCT02743871|537317248|FG007|Overall Study|Adverse Event|0|||
148954906|NCT02743871|537317249|FG008|Overall Study|Adverse Event|0|||
148954907|NCT02743871|537317250|FG009|Overall Study|Adverse Event|0|||
148954908|NCT02743871|537317251|FG010|Overall Study|Adverse Event|0|||
148954909|NCT02743871|537317252|FG011|Overall Study|Adverse Event|0|||
148954910|NCT02743871|537317253|FG012|Overall Study|Adverse Event|0|||
148954911|NCT02743871|537317254|FG013|Overall Study|Adverse Event|0|||
148954912|NCT02743871|537317241|FG000|Overall Study|Other|0|||
148954913|NCT02743871|537317242|FG001|Overall Study|Other|0|||
148954914|NCT02743871|537317243|FG002|Overall Study|Other|0|||
148954915|NCT02743871|537317244|FG003|Overall Study|Other|0|||
149020551|NCT01991197|537552710|FG001|Overall Study|Withdrawal by Subject|0|||
149020552|NCT01010217|537552711|FG000|Overall Study|Lost to Follow-up|4|||
149020553|NCT01010217|537552712|FG001|Overall Study|Lost to Follow-up|5|||
149020554|NCT01010217|537552713|FG002|Overall Study|Lost to Follow-up|1|||
149020555|NCT01010217|537552714|FG003|Overall Study|Lost to Follow-up|0|||
149020556|NCT01010217|537552715|FG004|Overall Study|Lost to Follow-up|0|||
149020557|NCT01010217|537552711|FG000|Overall Study|Withdrawal by Subject|1|||
149020558|NCT01010217|537552712|FG001|Overall Study|Withdrawal by Subject|0|||
149020559|NCT01010217|537552713|FG002|Overall Study|Withdrawal by Subject|0|||
149020560|NCT01010217|537552714|FG003|Overall Study|Withdrawal by Subject|0|||
149020561|NCT01010217|537552715|FG004|Overall Study|Withdrawal by Subject|0|||
149020562|NCT01010217|537552711|FG000|Overall Study|Physician Decision|0|||
149020563|NCT01010217|537552712|FG001|Overall Study|Physician Decision|0|||
149020564|NCT01010217|537552713|FG002|Overall Study|Physician Decision|0|||
149020565|NCT01010217|537552714|FG003|Overall Study|Physician Decision|6|||
149020566|NCT01010217|537552715|FG004|Overall Study|Physician Decision|3|||
148811076|NCT05168800|536784691|FG001|Time 1 Survey|Withdrawal by Subject|3|||
148811077|NCT05168800|536784692|FG002|Time 1 Survey|Withdrawal by Subject|2|||
148811078|NCT05168800|536784690|FG000|Time 2 Survey|Already excluded at Time 1|228|||
148954916|NCT02743871|537317245|FG004|Overall Study|Other|0|||
148954917|NCT02743871|537317246|FG005|Overall Study|Other|0|||
148954918|NCT02743871|537317247|FG006|Overall Study|Other|0|||
148954919|NCT02743871|537317248|FG007|Overall Study|Other|0|||
148954920|NCT02743871|537317249|FG008|Overall Study|Other|0|||
148954921|NCT02743871|537317250|FG009|Overall Study|Other|0|||
148954922|NCT02743871|537317251|FG010|Overall Study|Other|0|||
148954923|NCT02743871|537317252|FG011|Overall Study|Other|1|||
148954924|NCT02743871|537317253|FG012|Overall Study|Other|1|||
148954925|NCT02743871|537317254|FG013|Overall Study|Other|1|||
148954926|NCT02743871|537317241|FG000|Overall Study|Protocol Violation|0|||
149020567|NCT04242875|537552718|FG000|Overall Study|Adverse Event|2|||
149020568|NCT02611830|537552721|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
149020569|NCT02611830|537552722|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
149020570|NCT02611830|537552723|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
149020571|NCT02611830|537552724|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
148811079|NCT05168800|536784691|FG001|Time 2 Survey|Already excluded at Time 1|202|||
148811080|NCT05168800|536784692|FG002|Time 2 Survey|Already excluded at Time 1|173|||
148811081|NCT05168800|536784690|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
148811082|NCT05168800|536784691|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
148811083|NCT05168800|536784692|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
148954927|NCT02743871|537317242|FG001|Overall Study|Protocol Violation|0|||
148954928|NCT02743871|537317243|FG002|Overall Study|Protocol Violation|0|||
148954929|NCT02743871|537317244|FG003|Overall Study|Protocol Violation|0|||
148954930|NCT02743871|537317245|FG004|Overall Study|Protocol Violation|0|||
148954931|NCT02743871|537317246|FG005|Overall Study|Protocol Violation|0|||
148954932|NCT02743871|537317247|FG006|Overall Study|Protocol Violation|0|||
148954933|NCT02743871|537317248|FG007|Overall Study|Protocol Violation|0|||
148954934|NCT02743871|537317249|FG008|Overall Study|Protocol Violation|0|||
148954935|NCT02743871|537317250|FG009|Overall Study|Protocol Violation|0|||
148954936|NCT02743871|537317251|FG010|Overall Study|Protocol Violation|0|||
148954937|NCT02743871|537317252|FG011|Overall Study|Protocol Violation|0|||
148954938|NCT02743871|537317253|FG012|Overall Study|Protocol Violation|2|||
148954939|NCT02743871|537317254|FG013|Overall Study|Protocol Violation|0|||
148954940|NCT01937559|537317255|FG000|Overall Study|Physician Decision|3|||
148954941|NCT01937559|537317256|FG001|Overall Study|Physician Decision|3|||
148954942|NCT01937559|537317257|FG002|Overall Study|Physician Decision|0|||
148954943|NCT01937559|537317255|FG000|Overall Study|Withdrawal by Subject|6|||
148954944|NCT01937559|537317256|FG001|Overall Study|Withdrawal by Subject|4|||
148954945|NCT01937559|537317257|FG002|Overall Study|Withdrawal by Subject|0|||
148954946|NCT01937559|537317255|FG000|Overall Study|screen fail|2|||
148954947|NCT01937559|537317256|FG001|Overall Study|screen fail|4|||
148954948|NCT01937559|537317257|FG002|Overall Study|screen fail|0|||
148954949|NCT00407563|537319177|FG000|Overall Study|Patient continues on treatment|1|||
148954950|NCT05040386|537319178|FG000|Overall Study|Withdrawal by Subject|1|||
148954951|NCT05040386|537319179|FG001|Overall Study|Withdrawal by Subject|0|||
148954952|NCT05040386|537319180|FG002|Overall Study|Withdrawal by Subject|1|||
148954953|NCT05040386|537319181|FG003|Overall Study|Withdrawal by Subject|0|||
148954954|NCT05040386|537319178|FG000|Overall Study|Lost to Follow-up|0|||
148954955|NCT05040386|537319179|FG001|Overall Study|Lost to Follow-up|0|||
148954956|NCT05040386|537319180|FG002|Overall Study|Lost to Follow-up|1|||
148954957|NCT05040386|537319181|FG003|Overall Study|Lost to Follow-up|0|||
148954958|NCT00715078|537319188|FG000|Overall Study|Death|29|||
148954959|NCT00715078|537319189|FG001|Overall Study|Death|36|||
148954960|NCT00715078|537319190|FG002|Overall Study|Death|36|||
148954961|NCT00715078|537319188|FG000|Overall Study|Withdrawal by Subject|1|||
148954962|NCT00715078|537319189|FG001|Overall Study|Withdrawal by Subject|0|||
148691230|NCT04634409|536342509|FG018|Overall Study|Adverse Event|0|||
148691231|NCT04634409|536342510|FG019|Overall Study|Adverse Event|0|||
148691232|NCT04634409|536342511|FG020|Overall Study|Adverse Event|0|||
148691233|NCT04634409|536342512|FG021|Overall Study|Adverse Event|0|||
148691234|NCT04634409|536342513|FG022|Overall Study|Adverse Event|0|||
148691235|NCT04634409|536342514|FG023|Overall Study|Adverse Event|0|||
148691236|NCT04634409|536342515|FG024|Overall Study|Adverse Event|0|||
148691237|NCT04634409|536342516|FG025|Overall Study|Adverse Event|0|||
148691238|NCT04634409|536342517|FG026|Overall Study|Adverse Event|0|||
148691239|NCT04634409|536342491|FG000|Overall Study|Lost to Follow-up|3|||
148691240|NCT04634409|536342492|FG001|Overall Study|Lost to Follow-up|1|||
148691241|NCT04634409|536342493|FG002|Overall Study|Lost to Follow-up|1|||
148691242|NCT04634409|536342494|FG003|Overall Study|Lost to Follow-up|3|||
148691243|NCT04634409|536342495|FG004|Overall Study|Lost to Follow-up|1|||
148691244|NCT04634409|536342496|FG005|Overall Study|Lost to Follow-up|1|||
148691245|NCT04634409|536342497|FG006|Overall Study|Lost to Follow-up|1|||
148691246|NCT04634409|536342498|FG007|Overall Study|Lost to Follow-up|3|||
148691247|NCT04634409|536342499|FG008|Overall Study|Lost to Follow-up|3|||
148691248|NCT04634409|536342500|FG009|Overall Study|Lost to Follow-up|11|||
148691249|NCT04634409|536342501|FG010|Overall Study|Lost to Follow-up|8|||
148691250|NCT04634409|536342502|FG011|Overall Study|Lost to Follow-up|15|||
148691251|NCT04634409|536342503|FG012|Overall Study|Lost to Follow-up|3|||
148691252|NCT04634409|536342504|FG013|Overall Study|Lost to Follow-up|2|||
148691253|NCT04634409|536342505|FG014|Overall Study|Lost to Follow-up|7|||
148691254|NCT04634409|536342506|FG015|Overall Study|Lost to Follow-up|0|||
148691255|NCT04634409|536342507|FG016|Overall Study|Lost to Follow-up|0|||
148691256|NCT04634409|536342508|FG017|Overall Study|Lost to Follow-up|0|||
148691257|NCT04634409|536342509|FG018|Overall Study|Lost to Follow-up|0|||
148811084|NCT05168800|536784690|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
148954963|NCT00715078|537319190|FG002|Overall Study|Withdrawal by Subject|1|||
148954964|NCT00715078|537319188|FG000|Overall Study|Unable to start due to disease prog.|0|||
148954965|NCT00715078|537319189|FG001|Overall Study|Unable to start due to disease prog.|0|||
148691258|NCT04634409|536342510|FG019|Overall Study|Lost to Follow-up|0|||
148691259|NCT04634409|536342511|FG020|Overall Study|Lost to Follow-up|0|||
148691260|NCT04634409|536342512|FG021|Overall Study|Lost to Follow-up|0|||
148954966|NCT00715078|537319190|FG002|Overall Study|Unable to start due to disease prog.|1|||
148954967|NCT01529346|537319191|FG000|Overall Study|Lost to Follow-up|2|||
148691261|NCT04634409|536342513|FG022|Overall Study|Lost to Follow-up|0|||
149020572|NCT02611830|537552721|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
149020573|NCT02611830|537552722|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
149020574|NCT02611830|537552723|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
148691262|NCT04634409|536342514|FG023|Overall Study|Lost to Follow-up|0|||
148691263|NCT04634409|536342515|FG024|Overall Study|Lost to Follow-up|0|||
148691264|NCT04634409|536342516|FG025|Overall Study|Lost to Follow-up|0|||
148691265|NCT04634409|536342517|FG026|Overall Study|Lost to Follow-up|0|||
148691266|NCT04634409|536342491|FG000|Overall Study|Withdrawal by Subject|3|||
148691267|NCT04634409|536342492|FG001|Overall Study|Withdrawal by Subject|1|||
148691268|NCT04634409|536342493|FG002|Overall Study|Withdrawal by Subject|6|||
148691269|NCT04634409|536342494|FG003|Overall Study|Withdrawal by Subject|4|||
148691270|NCT04634409|536342495|FG004|Overall Study|Withdrawal by Subject|2|||
148691271|NCT04634409|536342496|FG005|Overall Study|Withdrawal by Subject|0|||
148691272|NCT04634409|536342497|FG006|Overall Study|Withdrawal by Subject|0|||
148691273|NCT04634409|536342498|FG007|Overall Study|Withdrawal by Subject|2|||
148691274|NCT04634409|536342499|FG008|Overall Study|Withdrawal by Subject|3|||
148691275|NCT04634409|536342500|FG009|Overall Study|Withdrawal by Subject|2|||
148691276|NCT04634409|536342501|FG010|Overall Study|Withdrawal by Subject|3|||
148691277|NCT04634409|536342502|FG011|Overall Study|Withdrawal by Subject|2|||
148691278|NCT04634409|536342503|FG012|Overall Study|Withdrawal by Subject|2|||
148691279|NCT04634409|536342504|FG013|Overall Study|Withdrawal by Subject|1|||
148691280|NCT04634409|536342505|FG014|Overall Study|Withdrawal by Subject|5|||
148691281|NCT04634409|536342506|FG015|Overall Study|Withdrawal by Subject|0|||
148691282|NCT04634409|536342507|FG016|Overall Study|Withdrawal by Subject|0|||
148691283|NCT04634409|536342508|FG017|Overall Study|Withdrawal by Subject|1|||
148691284|NCT04634409|536342509|FG018|Overall Study|Withdrawal by Subject|0|||
148691285|NCT04634409|536342510|FG019|Overall Study|Withdrawal by Subject|0|||
148691286|NCT04634409|536342511|FG020|Overall Study|Withdrawal by Subject|0|||
148691287|NCT04634409|536342512|FG021|Overall Study|Withdrawal by Subject|0|||
148691288|NCT04634409|536342513|FG022|Overall Study|Withdrawal by Subject|0|||
148691289|NCT04634409|536342514|FG023|Overall Study|Withdrawal by Subject|1|||
148691290|NCT04634409|536342515|FG024|Overall Study|Withdrawal by Subject|0|||
148691291|NCT04634409|536342516|FG025|Overall Study|Withdrawal by Subject|0|||
148691292|NCT04634409|536342517|FG026|Overall Study|Withdrawal by Subject|0|||
148691293|NCT04634409|536342491|FG000|Overall Study|Other - As reported by Investigator|1|||
148691294|NCT04634409|536342492|FG001|Overall Study|Other - As reported by Investigator|0|||
148691295|NCT04634409|536342493|FG002|Overall Study|Other - As reported by Investigator|0|||
148691296|NCT04634409|536342494|FG003|Overall Study|Other - As reported by Investigator|0|||
148691297|NCT04634409|536342495|FG004|Overall Study|Other - As reported by Investigator|0|||
148691298|NCT04634409|536342496|FG005|Overall Study|Other - As reported by Investigator|0|||
148691299|NCT04634409|536342497|FG006|Overall Study|Other - As reported by Investigator|0|||
148691300|NCT04634409|536342498|FG007|Overall Study|Other - As reported by Investigator|6|||
148691301|NCT04634409|536342499|FG008|Overall Study|Other - As reported by Investigator|4|||
148691302|NCT04634409|536342500|FG009|Overall Study|Other - As reported by Investigator|0|||
148691303|NCT04634409|536342501|FG010|Overall Study|Other - As reported by Investigator|1|||
148691304|NCT04634409|536342502|FG011|Overall Study|Other - As reported by Investigator|2|||
148691305|NCT04634409|536342503|FG012|Overall Study|Other - As reported by Investigator|2|||
148691306|NCT04634409|536342504|FG013|Overall Study|Other - As reported by Investigator|1|||
148691307|NCT04634409|536342505|FG014|Overall Study|Other - As reported by Investigator|0|||
148691308|NCT04634409|536342506|FG015|Overall Study|Other - As reported by Investigator|0|||
148691309|NCT04634409|536342507|FG016|Overall Study|Other - As reported by Investigator|0|||
148691310|NCT04634409|536342508|FG017|Overall Study|Other - As reported by Investigator|0|||
148691311|NCT04634409|536342509|FG018|Overall Study|Other - As reported by Investigator|0|||
148691312|NCT04634409|536342510|FG019|Overall Study|Other - As reported by Investigator|0|||
148691313|NCT04634409|536342511|FG020|Overall Study|Other - As reported by Investigator|0|||
148691314|NCT04634409|536342512|FG021|Overall Study|Other - As reported by Investigator|0|||
148691315|NCT04634409|536342513|FG022|Overall Study|Other - As reported by Investigator|0|||
148691316|NCT04634409|536342514|FG023|Overall Study|Other - As reported by Investigator|0|||
148691317|NCT04634409|536342515|FG024|Overall Study|Other - As reported by Investigator|0|||
148691318|NCT04634409|536342516|FG025|Overall Study|Other - As reported by Investigator|0|||
148691319|NCT04634409|536342517|FG026|Overall Study|Other - As reported by Investigator|0|||
148691320|NCT05514119|536344123|FG000|Overall Study|Ineligible due to disease progression|1|||
148691321|NCT00278200|536344124|FG000|Overall Study|Death|1|||
148691322|NCT00278200|536344125|FG001|Overall Study|Death|3|||
148691323|NCT00278200|536344124|FG000|Overall Study|Physician Decision|0|||
148691324|NCT00278200|536344125|FG001|Overall Study|Physician Decision|1|||
148691325|NCT02918162|536344127|FG000|Overall Study|Withdrawal by Subject|1|||
148691326|NCT02918162|536344127|FG000|Overall Study|Omental Disease|1|||
149020575|NCT02611830|537552724|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
148691327|NCT00395226|536344128|FG000|Overall Study|Adverse Event|4|||
148691328|NCT00395226|536344129|FG001|Overall Study|Adverse Event|3|||
148691329|NCT00395226|536344128|FG000|Overall Study|Withdrawal by Subject|0|||
148691330|NCT00395226|536344129|FG001|Overall Study|Withdrawal by Subject|1|||
148691331|NCT00395226|536344128|FG000|Overall Study|Lost to Follow-up|0|||
148954968|NCT01529346|537319192|FG001|Overall Study|Lost to Follow-up|0|||
148954969|NCT01529346|537319193|FG002|Overall Study|Lost to Follow-up|1|||
148954970|NCT01529346|537319194|FG003|Overall Study|Lost to Follow-up|0|||
148954971|NCT01529346|537319195|FG004|Overall Study|Lost to Follow-up|0|||
148954972|NCT01529346|537319191|FG000|Overall Study|Other|0|||
148954973|NCT01529346|537319192|FG001|Overall Study|Other|1|||
148954974|NCT01529346|537319193|FG002|Overall Study|Other|1|||
148954975|NCT01529346|537319194|FG003|Overall Study|Other|0|||
148954976|NCT01529346|537319195|FG004|Overall Study|Other|0|||
148954977|NCT02892760|537319196|FG000|Overall Study|Withdrawal by Subject|3|||
148954978|NCT00386776|537319197|FG000|Overall Study|Withdrawal by Subject|8|||
148954979|NCT00588848|537319198|FG000|Overall Study|Physician Decision|0|||
148954980|NCT00588848|537319199|FG001|Overall Study|Physician Decision|3|||
148954981|NCT00412854|537319200|FG000|Overall Study|Withdrawn due to adverse events|1|||
148954982|NCT00412854|537319201|FG001|Overall Study|Withdrawn due to adverse events|5|||
148954983|NCT00412854|537319200|FG000|Overall Study|Withdrawn for other reasons|13|||
148954984|NCT00412854|537319201|FG001|Overall Study|Withdrawn for other reasons|11|||
148954985|NCT01084174|537319202|FG000|Overall Study|gastrointestinal symptoms|1|||
148954986|NCT01084174|537319203|FG001|Overall Study|gastrointestinal symptoms|1|||
148954987|NCT01084174|537319202|FG000|Overall Study|Eosinophilic esophagitis|0|||
148954988|NCT01084174|537319203|FG001|Overall Study|Eosinophilic esophagitis|1|||
148954989|NCT01084174|537319202|FG000|Overall Study|Anaphylaxis|0|||
148954990|NCT01084174|537319203|FG001|Overall Study|Anaphylaxis|1|||
148954991|NCT01084174|537319202|FG000|Overall Study|Participant noncompliance|0|||
148954992|NCT01084174|537319203|FG001|Overall Study|Participant noncompliance|1|||
148954993|NCT01484873|537319204|FG000|Overall Study|Withdrawal by Subject|2|||
148954994|NCT03103919|537319205|FG000|Overall Study|Adverse Event|2|||
148954995|NCT03103919|537319206|FG001|Overall Study|Adverse Event|2|||
148954996|NCT05682326|537319207|FG000|Overall Study|Withdrawal by Subject|1|||
148954997|NCT05682326|537319208|FG001|Overall Study|Withdrawal by Subject|0|||
148954998|NCT03998189|537319209|FG000|Overall Study|Lack of Efficacy|0|||
148954999|NCT03998189|537319210|FG001|Overall Study|Lack of Efficacy|1|||
148955000|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Death|3|||
148955001|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Death|3|||
148955002|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Death|0|||
148955003|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Death|0|||
148955004|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
148955005|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
148955006|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
148955007|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
148955008|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
148955009|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
148955010|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
148955011|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
148955012|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
148955013|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
148955014|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
148955015|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
148955016|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
148955017|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
148955018|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
148955019|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
148955020|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
148955021|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
148955022|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
148955023|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
148955024|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
148955025|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
148955026|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
148955027|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
148955028|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Other|6|||
148955029|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Other|3|||
148955030|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Other|0|||
148955031|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Other|0|||
148955032|NCT02051608|537319211|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
148955033|NCT02051608|537319212|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
148955034|NCT02051608|537319213|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
148955035|NCT02051608|537319214|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
148955036|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Adverse Event|0|||
148955037|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Adverse Event|0|||
148955038|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Adverse Event|6|||
148955039|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Adverse Event|8|||
148955040|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Death|0|||
148955041|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Death|0|||
148955042|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Death|7|||
148955043|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Death|4|||
148955044|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
148955045|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
148955046|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
148955047|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
148955048|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
148955049|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
148955050|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
148955051|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
148955052|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
148955053|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
148955054|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
148955055|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
148955056|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
148955057|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
148955058|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
148955059|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
148955060|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Physician Decision|0|||
148955061|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Physician Decision|0|||
148955062|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Physician Decision|8|||
148955063|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Physician Decision|5|||
148955064|NCT02051608|537319211|FG000|Part 2: Open-label Extension|Other|0|||
148955065|NCT02051608|537319212|FG001|Part 2: Open-label Extension|Other|0|||
148955066|NCT02051608|537319213|FG002|Part 2: Open-label Extension|Other|9|||
148955067|NCT02051608|537319214|FG003|Part 2: Open-label Extension|Other|9|||
148955068|NCT01083576|537319215|FG000|Overall Study|Treatment Failure|6|||
148955069|NCT01083576|537319216|FG001|Overall Study|Treatment Failure|1|||
148955070|NCT01986985|537319217|FG000|Overall Study|Withdrawal by Subject|4|||
148955071|NCT01986985|537319217|FG000|Overall Study|Scan not completed due to malfunction|3|||
148955072|NCT03527966|537319218|FG000|Overall Study|Lost to Follow-up|3|||
148955073|NCT03527966|537319219|FG001|Overall Study|Lost to Follow-up|0|||
148955074|NCT01948050|537319220|FG000|Overall Study|Withdrawal by Subject|0|||
148955075|NCT01948050|537319221|FG001|Overall Study|Withdrawal by Subject|1|||
148955076|NCT02288559|537319222|FG000|Overall Study|Adverse Event|1|||
148955077|NCT02288559|537319223|FG001|Overall Study|Adverse Event|1|||
148955078|NCT02288559|537319224|FG002|Overall Study|Adverse Event|5|||
148955079|NCT02288559|537319225|FG003|Overall Study|Adverse Event|0|||
148955080|NCT02288559|537319222|FG000|Overall Study|Death|0|||
148955081|NCT02288559|537319223|FG001|Overall Study|Death|0|||
148955082|NCT02288559|537319224|FG002|Overall Study|Death|1|||
148955083|NCT02288559|537319225|FG003|Overall Study|Death|0|||
148955084|NCT02288559|537319222|FG000|Overall Study|Lost to Follow-up|0|||
148955085|NCT02288559|537319223|FG001|Overall Study|Lost to Follow-up|0|||
148955086|NCT02288559|537319224|FG002|Overall Study|Lost to Follow-up|0|||
148955087|NCT02288559|537319225|FG003|Overall Study|Lost to Follow-up|1|||
148955088|NCT02288559|537319222|FG000|Overall Study|Withdrawal by Subject|0|||
148955089|NCT02288559|537319223|FG001|Overall Study|Withdrawal by Subject|0|||
148955090|NCT02288559|537319224|FG002|Overall Study|Withdrawal by Subject|2|||
148955091|NCT02288559|537319225|FG003|Overall Study|Withdrawal by Subject|1|||
148955092|NCT02288559|537319222|FG000|Overall Study|Reason Not Specified|0|||
148955093|NCT02288559|537319223|FG001|Overall Study|Reason Not Specified|0|||
148955094|NCT02288559|537319224|FG002|Overall Study|Reason Not Specified|3|||
148691332|NCT00395226|536344129|FG001|Overall Study|Lost to Follow-up|1|||
148691333|NCT00576381|536344133|FG000|Overall Study|Reoperation|3|||
148691334|NCT00576381|536344133|FG000|Overall Study|Adverse Event|4|||
148691335|NCT01031537|536344134|FG000|Overall Study|medical reasons not related to study|3|||
148691336|NCT01031537|536344134|FG000|Overall Study|Lack of Efficacy|1|||
148691337|NCT01031537|536344134|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
148691338|NCT01031537|536344134|FG000|Overall Study|moved, met exclusion criteria|10|||
148691339|NCT01031537|536344134|FG000|Overall Study|Withdrawal by Subject|5|||
148955095|NCT02288559|537319225|FG003|Overall Study|Reason Not Specified|0|||
148955096|NCT00558025|537319226|FG000|Overall Study|Adverse Event|1|||
148955097|NCT00558025|537319227|FG001|Overall Study|Adverse Event|1|||
148955098|NCT00558025|537319226|FG000|Overall Study|Withdrawal by Subject|2|||
148955099|NCT00558025|537319227|FG001|Overall Study|Withdrawal by Subject|2|||
148955100|NCT00558025|537319226|FG000|Overall Study|Protocol Violation|1|||
148955101|NCT00558025|537319227|FG001|Overall Study|Protocol Violation|0|||
148955102|NCT02005445|537319228|FG000|Overall Study|Dual study enrollment|0|||
148955103|NCT02005445|537319229|FG001|Overall Study|Dual study enrollment|1|||
148955104|NCT01314443|537319230|FG000|Overall Study|Withdrawal by Subject|2|||
148955105|NCT01314443|537319231|FG001|Overall Study|Withdrawal by Subject|1|||
148955106|NCT01314443|537319232|FG002|Overall Study|Withdrawal by Subject|1|||
148955107|NCT01314443|537319233|FG003|Overall Study|Withdrawal by Subject|1|||
148955108|NCT01314443|537319230|FG000|Overall Study|Protocol Violation|2|||
148955109|NCT01314443|537319231|FG001|Overall Study|Protocol Violation|2|||
148955110|NCT01314443|537319232|FG002|Overall Study|Protocol Violation|1|||
148955111|NCT01314443|537319233|FG003|Overall Study|Protocol Violation|1|||
148955112|NCT00449540|537319234|FG000|Pretreatment Phase|No migraine experienced|66|||
148955113|NCT00449540|537319235|FG001|Pretreatment Phase|No migraine experienced|0|||
148955114|NCT00449540|537319236|FG002|Pretreatment Phase|No migraine experienced|0|||
148955115|NCT00449540|537319234|FG000|Treatment Phase|did not experience or treat migraine|0|||
148955116|NCT00449540|537319235|FG001|Treatment Phase|did not experience or treat migraine|20|||
148955117|NCT00449540|537319236|FG002|Treatment Phase|did not experience or treat migraine|17|||
148955118|NCT04463719|537319237|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
148955119|NCT04463719|537319238|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
148955120|NCT04463719|537319239|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
148955121|NCT00487747|537319242|FG000|Overall Study|Adverse Event|1|||
148955122|NCT00487747|537319242|FG000|Overall Study|Lost to Follow-up|9|||
148955123|NCT00487747|537319242|FG000|Overall Study|Lack of Efficacy|1|||
148955124|NCT01359449|537319245|FG000|Overall Study|Lost to Follow-up|1|||
148955125|NCT01359449|537319246|FG001|Overall Study|Lost to Follow-up|0|||
148955126|NCT01359449|537319245|FG000|Overall Study|Protocol Violation|0|||
148955127|NCT01359449|537319246|FG001|Overall Study|Protocol Violation|2|||
148955128|NCT01359449|537319245|FG000|Overall Study|Withdrawal by Subject|3|||
148955129|NCT01359449|537319246|FG001|Overall Study|Withdrawal by Subject|2|||
148955130|NCT02036294|537319248|FG000|Overall Study|Death|7|||
148955131|NCT02036294|537319249|FG001|Overall Study|Death|8|||
148955132|NCT02036294|537319248|FG000|Overall Study|Withdrawal by Subject|2|||
148955133|NCT02036294|537319249|FG001|Overall Study|Withdrawal by Subject|3|||
148955134|NCT02393547|537319250|FG000|Overall Study|Adverse Event|2|||
148955135|NCT02393547|537319250|FG000|Overall Study|Withdrawal by Subject|3|||
148955136|NCT02393547|537319250|FG000|Overall Study|Lost to Follow-up|1|||
148955137|NCT02979522|537319251|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
148955138|NCT02979522|537319252|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
148955139|NCT02979522|537319251|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
148955140|NCT02979522|537319252|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
148955141|NCT00429104|537319255|FG000|Overall Study|Protocol Violation|1|||
148955142|NCT01907815|537319256|FG000|Overall Study|Withdrawal by Subject|1|||
148955143|NCT01907815|537319257|FG001|Overall Study|Withdrawal by Subject|0|||
148955144|NCT05185089|537319258|FG000|First Intervention (4 weeks)|Adverse Event|0|||
148955145|NCT05185089|537319259|FG001|First Intervention (4 weeks)|Adverse Event|0|||
148955146|NCT05185089|537319260|FG002|First Intervention (4 weeks)|Adverse Event|0|||
148955147|NCT05185089|537319261|FG003|First Intervention (4 weeks)|Adverse Event|1|||
148955148|NCT05185089|537319258|FG000|Second Intervention (4 weeks)|Death|0|||
148955149|NCT05185089|537319259|FG001|Second Intervention (4 weeks)|Death|1|||
148955150|NCT05185089|537319260|FG002|Second Intervention (4 weeks)|Death|0|||
148955151|NCT05185089|537319261|FG003|Second Intervention (4 weeks)|Death|0|||
148955152|NCT05185089|537319258|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
148955153|NCT05185089|537319259|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
148955154|NCT05185089|537319260|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
148955155|NCT05185089|537319261|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
148955156|NCT04997161|537319262|FG000|Overall Study|Study terminated by sponsor|3|||
148955157|NCT02485574|537319265|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
148955158|NCT00667368|537319267|FG000|Overall Study|Lost to Follow-up|176|||
148955159|NCT00667368|537319268|FG001|Overall Study|Lost to Follow-up|155|||
148955160|NCT00667368|537319267|FG000|Overall Study|Discontinued early|24|||
148955161|NCT00667368|537319268|FG001|Overall Study|Discontinued early|17|||
148955162|NCT00191789|537319269|FG000|Overall Study|Adverse Event|5|||
148955163|NCT00191789|537319269|FG000|Overall Study|Patient: Satisfactory Response|5|||
148955164|NCT00191789|537319269|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
148955165|NCT00191789|537319269|FG000|Overall Study|Withdrawal by Subject|4|||
148955166|NCT00191789|537319269|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
149020576|NCT02611830|537552721|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
148955167|NCT00191789|537319269|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
148955168|NCT00191789|537319269|FG000|Overall Study|Death - Not Study-Drug Related|1|||
148955169|NCT06112756|537319270|FG000|Overall Study|Withdrawal by Subject|0|||
148955170|NCT06112756|537319271|FG001|Overall Study|Withdrawal by Subject|2|||
148955171|NCT06112756|537319270|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
148955172|NCT06112756|537319271|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
149020577|NCT02611830|537552722|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
148955173|NCT06112756|537319270|FG000|Overall Study|Adverse Event|2|||
148955174|NCT06112756|537319271|FG001|Overall Study|Adverse Event|2|||
148955175|NCT04551092|537319272|FG000|Overall Study|Lost to Follow-up|7|||
149020578|NCT02611830|537552723|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
148955176|NCT04551092|537319272|FG000|Overall Study|Withdrawal by Subject|4|||
148955177|NCT01712490|537319273|FG000|Overall Study|Ongoing|601|||
148955178|NCT01712490|537319274|FG001|Overall Study|Ongoing|586|||
148955179|NCT01712490|537319273|FG000|Overall Study|Other|11|||
148955180|NCT01712490|537319274|FG001|Overall Study|Other|11|||
148955181|NCT01712490|537319273|FG000|Overall Study|Withdrawal by Subject|36|||
148955182|NCT01712490|537319274|FG001|Overall Study|Withdrawal by Subject|44|||
148955183|NCT01712490|537319273|FG000|Overall Study|Lost to Follow-up|16|||
148955184|NCT01712490|537319274|FG001|Overall Study|Lost to Follow-up|29|||
148955185|NCT03060629|537319279|FG000|Overall Study|Death|4|||
148955186|NCT03060629|537319280|FG001|Overall Study|Death|5|||
148955187|NCT03060629|537319279|FG000|Overall Study|Withdrawal by Subject|50|||
148955188|NCT03060629|537319280|FG001|Overall Study|Withdrawal by Subject|35|||
148955189|NCT03060629|537319279|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
148955190|NCT03060629|537319280|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
148955191|NCT03060629|537319279|FG000|Overall Study|Participant Relocate|15|||
148955192|NCT03060629|537319280|FG001|Overall Study|Participant Relocate|15|||
148955193|NCT03060629|537319279|FG000|Overall Study|Unable to Contact Participant|34|||
148955194|NCT03060629|537319280|FG001|Overall Study|Unable to Contact Participant|23|||
148955195|NCT03060629|537319279|FG000|Overall Study|Investigator Decision|7|||
148955196|NCT03060629|537319280|FG001|Overall Study|Investigator Decision|7|||
148955197|NCT03060629|537319279|FG000|Overall Study|Study Terminated by Sponsor|1100|||
148955198|NCT03060629|537319280|FG001|Overall Study|Study Terminated by Sponsor|1123|||
148955199|NCT03060629|537319279|FG000|Overall Study|Other|4|||
148955200|NCT03060629|537319280|FG001|Overall Study|Other|4|||
148955201|NCT01862874|537319281|FG000|Overall Study|Randomized not treated|1|||
148955202|NCT01862874|537319282|FG001|Overall Study|Randomized not treated|0|||
148955203|NCT01862874|537319281|FG000|Overall Study|Adverse Event|0|||
148955204|NCT01862874|537319282|FG001|Overall Study|Adverse Event|3|||
148955205|NCT01862874|537319281|FG000|Overall Study|Lost to Follow-up|26|||
148955206|NCT01862874|537319282|FG001|Overall Study|Lost to Follow-up|29|||
148955207|NCT01862874|537319281|FG000|Overall Study|Physician Decision|5|||
148955208|NCT01862874|537319282|FG001|Overall Study|Physician Decision|3|||
148955209|NCT01862874|537319281|FG000|Overall Study|Withdrawn by parent/guardian|1|||
148955210|NCT01862874|537319282|FG001|Overall Study|Withdrawn by parent/guardian|1|||
148955211|NCT01862874|537319281|FG000|Overall Study|Withdrawal by Subject|46|||
148955212|NCT01862874|537319282|FG001|Overall Study|Withdrawal by Subject|40|||
148955213|NCT01862874|537319281|FG000|Overall Study|Death|0|||
148955214|NCT01862874|537319282|FG001|Overall Study|Death|1|||
148955215|NCT01129960|537319286|FG000|Overall Study|Withdrawal by Subject|3|||
148955216|NCT01129960|537319287|FG001|Overall Study|Withdrawal by Subject|0|||
148955217|NCT01129960|537319288|FG002|Overall Study|Withdrawal by Subject|3|||
148955218|NCT01129960|537319289|FG003|Overall Study|Withdrawal by Subject|2|||
148955219|NCT01129960|537319286|FG000|Overall Study|Lack of Efficacy|1|||
148955220|NCT01129960|537319287|FG001|Overall Study|Lack of Efficacy|1|||
148955221|NCT01129960|537319288|FG002|Overall Study|Lack of Efficacy|1|||
148955222|NCT01129960|537319289|FG003|Overall Study|Lack of Efficacy|1|||
148955223|NCT01129960|537319286|FG000|Overall Study|Adverse Event|23|||
148955224|NCT01129960|537319287|FG001|Overall Study|Adverse Event|16|||
148955225|NCT01129960|537319288|FG002|Overall Study|Adverse Event|16|||
148955226|NCT01129960|537319289|FG003|Overall Study|Adverse Event|7|||
148955227|NCT01129960|537319286|FG000|Overall Study|Protocol Violation|1|||
148955228|NCT01129960|537319287|FG001|Overall Study|Protocol Violation|2|||
148955229|NCT01129960|537319288|FG002|Overall Study|Protocol Violation|3|||
148955230|NCT01129960|537319289|FG003|Overall Study|Protocol Violation|0|||
148955231|NCT01129960|537319286|FG000|Overall Study|Lost to Follow-up|0|||
148955232|NCT01129960|537319287|FG001|Overall Study|Lost to Follow-up|2|||
148955233|NCT01129960|537319288|FG002|Overall Study|Lost to Follow-up|3|||
148955234|NCT01129960|537319289|FG003|Overall Study|Lost to Follow-up|3|||
148955235|NCT01129960|537319286|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
148955236|NCT01129960|537319287|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
148955237|NCT01129960|537319288|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
148955238|NCT01129960|537319289|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
148955239|NCT01129960|537319286|FG000|Overall Study|Physician Decision|1|||
148955240|NCT01129960|537319287|FG001|Overall Study|Physician Decision|0|||
148955241|NCT01129960|537319288|FG002|Overall Study|Physician Decision|0|||
148955242|NCT01129960|537319289|FG003|Overall Study|Physician Decision|0|||
148955243|NCT01129960|537319286|FG000|Overall Study|Pregnancy|1|||
148955244|NCT01129960|537319287|FG001|Overall Study|Pregnancy|0|||
148955245|NCT01129960|537319288|FG002|Overall Study|Pregnancy|0|||
148955246|NCT01129960|537319289|FG003|Overall Study|Pregnancy|0|||
148955247|NCT03198234|537319290|FG000|Overall Study|Relapse of primary disease|0|||
148955248|NCT03198234|537319291|FG001|Overall Study|Relapse of primary disease|1|||
148955249|NCT03198234|537319292|FG002|Overall Study|Relapse of primary disease|0|||
148955250|NCT03228537|537319297|FG000|Neoadjuvant|Adverse Event|2|||
148955251|NCT03228537|537319297|FG000|Neoadjuvant|Progression/Relapse|4|||
148955252|NCT03228537|537319297|FG000|Neoadjuvant|Death|1|||
148955253|NCT03228537|537319297|FG000|Surgery|Death|1|||
148955254|NCT03228537|537319297|FG000|Surgery|Other - Not Protocol Specified|2|||
148955255|NCT03228537|537319297|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
148955256|NCT03228537|537319297|FG000|Maintenance|Progression/Relapse|10|||
148955257|NCT01927367|537319298|FG000|Overall Study|Withdrawal by Subject|7|||
148955258|NCT01927367|537319299|FG001|Overall Study|Withdrawal by Subject|4|||
148955259|NCT01927367|537319298|FG000|Overall Study|No baseline data|0|||
148955260|NCT01927367|537319299|FG001|Overall Study|No baseline data|1|||
148955261|NCT02622321|537319302|FG000|Overall Study|Withdrawal by Subject|2|||
148955262|NCT02622321|537319303|FG001|Overall Study|Withdrawal by Subject|0|||
148955263|NCT02622321|537319304|FG002|Overall Study|Withdrawal by Subject|0|||
149020579|NCT02611830|537552724|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
148691340|NCT01031537|536344134|FG000|Overall Study|PI removal, no longer met eligibility|12|||
148691341|NCT02492958|536344145|FG000|Overall Study|Withdrawal by Subject|0|||
148691342|NCT02492958|536344146|FG001|Overall Study|Withdrawal by Subject|0|||
148811085|NCT05168800|536784691|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
148955264|NCT02622321|537319305|FG003|Overall Study|Withdrawal by Subject|0|||
148955265|NCT02622321|537319302|FG000|Overall Study|Death|0|||
148955266|NCT02622321|537319303|FG001|Overall Study|Death|0|||
148955267|NCT02622321|537319304|FG002|Overall Study|Death|1|||
148955268|NCT02622321|537319305|FG003|Overall Study|Death|0|||
148955269|NCT02622321|537319302|FG000|Overall Study|Physician Decision|1|||
148955270|NCT02622321|537319303|FG001|Overall Study|Physician Decision|0|||
148955271|NCT02622321|537319304|FG002|Overall Study|Physician Decision|0|||
148955272|NCT02622321|537319305|FG003|Overall Study|Physician Decision|0|||
148955273|NCT00241280|537319309|FG000|Overall Study|Adverse Event|2|||
148955274|NCT00241280|537319310|FG001|Overall Study|Adverse Event|6|||
148955275|NCT00241280|537319309|FG000|Overall Study|Discomfort|11|||
148955276|NCT00241280|537319310|FG001|Overall Study|Discomfort|16|||
148955277|NCT00241280|537319309|FG000|Overall Study|Pregnancy|1|||
148955278|NCT00241280|537319310|FG001|Overall Study|Pregnancy|5|||
148955279|NCT00241280|537319309|FG000|Overall Study|Lost to Follow-up|5|||
148955280|NCT00241280|537319310|FG001|Overall Study|Lost to Follow-up|8|||
148955281|NCT00241280|537319309|FG000|Overall Study|Withdrawal by Subject|7|||
148955282|NCT00241280|537319310|FG001|Overall Study|Withdrawal by Subject|4|||
148955283|NCT00241280|537319309|FG000|Overall Study|Protocol Violation|4|||
148955284|NCT00241280|537319310|FG001|Overall Study|Protocol Violation|10|||
148955285|NCT00241280|537319309|FG000|Overall Study|Relocation|4|||
148955286|NCT00241280|537319310|FG001|Overall Study|Relocation|4|||
148955287|NCT00241280|537319309|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
148955288|NCT00241280|537319310|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
148955289|NCT00241280|537319309|FG000|Overall Study|Unsatisfactory Visual Response|1|||
148955290|NCT00241280|537319310|FG001|Overall Study|Unsatisfactory Visual Response|1|||
148955291|NCT00241280|537319309|FG000|Overall Study|Diabetic|1|||
148955292|NCT00241280|537319310|FG001|Overall Study|Diabetic|0|||
148955293|NCT00241280|537319309|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
148955294|NCT00241280|537319310|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
148955295|NCT00241280|537319309|FG000|Overall Study|Dispensed incorrect test article|1|||
148955296|NCT00241280|537319310|FG001|Overall Study|Dispensed incorrect test article|2|||
148955297|NCT00241280|537319309|FG000|Overall Study|Unacceptable Fit|0|||
148955298|NCT00241280|537319310|FG001|Overall Study|Unacceptable Fit|1|||
148955299|NCT00241280|537319309|FG000|Overall Study|Scheduling Conflict|0|||
148955300|NCT00241280|537319310|FG001|Overall Study|Scheduling Conflict|2|||
148955301|NCT00241280|537319309|FG000|Overall Study|History of Ocular Surgery|0|||
148955302|NCT00241280|537319310|FG001|Overall Study|History of Ocular Surgery|1|||
148955303|NCT00241280|537319309|FG000|Overall Study|Coating on Lens|1|||
148955304|NCT00241280|537319310|FG001|Overall Study|Coating on Lens|0|||
148955305|NCT00241280|537319309|FG000|Overall Study|Excessive Dryness|0|||
148811086|NCT05168800|536784692|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
148955306|NCT00241280|537319310|FG001|Overall Study|Excessive Dryness|1|||
148955307|NCT00965718|537319311|FG000|Overall Study|Withdrawal by Subject|4|||
148955308|NCT01634360|537319312|FG000|Overall Study|Adverse Event|10|||
148955309|NCT01634360|537319313|FG001|Overall Study|Adverse Event|34|||
148955310|NCT01634360|537319312|FG000|Overall Study|subject withdrew consent|13|||
148955311|NCT01634360|537319313|FG001|Overall Study|subject withdrew consent|23|||
148955312|NCT01634360|537319312|FG000|Overall Study|Protocol Violation|1|||
148955313|NCT01634360|537319313|FG001|Overall Study|Protocol Violation|1|||
148955314|NCT01634360|537319312|FG000|Overall Study|Lack of Efficacy|4|||
148955315|NCT01634360|537319313|FG001|Overall Study|Lack of Efficacy|14|||
148955316|NCT01634360|537319312|FG000|Overall Study|Other|3|||
148691343|NCT02492958|536344147|FG002|Overall Study|Withdrawal by Subject|1|||
148691344|NCT02492958|536344148|FG003|Overall Study|Withdrawal by Subject|0|||
148691345|NCT02492958|536344145|FG000|Overall Study|Adverse Event|1|||
148691346|NCT02492958|536344146|FG001|Overall Study|Adverse Event|0|||
148691347|NCT02492958|536344147|FG002|Overall Study|Adverse Event|1|||
148691348|NCT02492958|536344148|FG003|Overall Study|Adverse Event|0|||
148691349|NCT03522948|536344149|FG000|Overall Study|Lost to Follow-up|1|||
148691350|NCT00712010|536344152|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
148691351|NCT02187042|536344153|FG000|Overall Study|Death|1|||
148691352|NCT02187042|536344154|FG001|Overall Study|Death|1|||
148691353|NCT02187042|536344153|FG000|Overall Study|Toxicity|6|||
148811087|NCT05168800|536784690|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
148811088|NCT05168800|536784691|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
148811089|NCT05168800|536784692|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
148811090|NCT05168800|536784690|FG000|Time 2 Survey|Withdrawal by Subject|1|||
148811091|NCT05168800|536784691|FG001|Time 2 Survey|Withdrawal by Subject|0|||
148811092|NCT05168800|536784692|FG002|Time 2 Survey|Withdrawal by Subject|1|||
148811093|NCT05168800|536784690|FG000|Time 3 Survey|Already excluded at Time 1|228|||
148811094|NCT05168800|536784691|FG001|Time 3 Survey|Already excluded at Time 1|200|||
148811095|NCT05168800|536784692|FG002|Time 3 Survey|Already excluded at Time 1|173|||
148811096|NCT05168800|536784690|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
148811097|NCT05168800|536784691|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
148811098|NCT05168800|536784692|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
148811099|NCT05168800|536784690|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
148811100|NCT05168800|536784691|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
148811101|NCT05168800|536784692|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
148811102|NCT05168800|536784690|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
148811103|NCT05168800|536784691|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
148811104|NCT05168800|536784692|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
149020580|NCT02611830|537552721|FG000|OL Induction Phase|Lack of Efficacy|9|||
149020581|NCT02611830|537552722|FG001|OL Induction Phase|Lack of Efficacy|0|||
148691354|NCT02187042|536344154|FG001|Overall Study|Toxicity|5|||
148691355|NCT02187042|536344153|FG000|Overall Study|Participant choice|1|||
148691356|NCT02187042|536344154|FG001|Overall Study|Participant choice|0|||
148691357|NCT02187042|536344153|FG000|Overall Study|Doctor choice|1|||
148691358|NCT02187042|536344154|FG001|Overall Study|Doctor choice|0|||
148691359|NCT02187042|536344153|FG000|Overall Study|Progressive disease|4|||
148691360|NCT02187042|536344154|FG001|Overall Study|Progressive disease|8|||
148691361|NCT01659567|536344157|FG000|Overall Study|Lack of Efficacy|22|||
148691362|NCT01659567|536344157|FG000|Overall Study|Switched to Pegferon|6|||
149020582|NCT02611830|537552723|FG002|OL Induction Phase|Lack of Efficacy|0|||
149020583|NCT02611830|537552724|FG003|OL Induction Phase|Lack of Efficacy|0|||
149020584|NCT02611830|537552721|FG000|OL Induction Phase|Reason not specified|3|||
149020585|NCT02611830|537552722|FG001|OL Induction Phase|Reason not specified|0|||
149020586|NCT02611830|537552723|FG002|OL Induction Phase|Reason not specified|0|||
149020587|NCT02611830|537552724|FG003|OL Induction Phase|Reason not specified|0|||
149020588|NCT02611830|537552721|FG000|Maintenance Phase|Lack of Efficacy|0|||
149020589|NCT02611830|537552722|FG001|Maintenance Phase|Lack of Efficacy|29|||
149020590|NCT02611830|537552723|FG002|Maintenance Phase|Lack of Efficacy|18|||
149020591|NCT02611830|537552724|FG003|Maintenance Phase|Lack of Efficacy|6|||
149020592|NCT02611830|537552721|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
149020593|NCT02611830|537552722|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
149020594|NCT02611830|537552723|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
149020595|NCT02611830|537552724|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
149020596|NCT02611830|537552721|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
149020597|NCT02611830|537552722|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
149020598|NCT02611830|537552723|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
149020599|NCT02611830|537552724|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
149020600|NCT02611830|537552721|FG000|Maintenance Phase|Lost to Follow-up|0|||
149020601|NCT02611830|537552722|FG001|Maintenance Phase|Lost to Follow-up|0|||
149020602|NCT02611830|537552723|FG002|Maintenance Phase|Lost to Follow-up|0|||
148691363|NCT01659567|536344157|FG000|Overall Study|Adverse Event|12|||
148691364|NCT01659567|536344157|FG000|Overall Study|Good result at early stage of treatment|5|||
148811105|NCT04958707|536784693|FG000|Post Intervention|Withdrawal by Subject|1|||
148811106|NCT04958707|536784694|FG001|Post Intervention|Withdrawal by Subject|0|||
148811107|NCT04958707|536784695|FG002|Post Intervention|Withdrawal by Subject|0|||
148811108|NCT04958707|536784693|FG000|3 Months Follow- up|Lost to Follow-up|0|||
149020603|NCT02611830|537552724|FG003|Maintenance Phase|Lost to Follow-up|1|||
149020604|NCT02611830|537552721|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
149020605|NCT02611830|537552722|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
149020606|NCT02611830|537552723|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
149020607|NCT02611830|537552724|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
148691365|NCT01659567|536344157|FG000|Overall Study|Withdrawal by Subject|64|||
148691366|NCT01659567|536344157|FG000|Overall Study|Progression of the main disease|1|||
149020608|NCT02611830|537552721|FG000|Maintenance Phase|Pregnancy|0|||
149020609|NCT02611830|537552722|FG001|Maintenance Phase|Pregnancy|0|||
149020610|NCT02611830|537552723|FG002|Maintenance Phase|Pregnancy|1|||
149020611|NCT02611830|537552724|FG003|Maintenance Phase|Pregnancy|0|||
149020612|NCT02611830|537552721|FG000|Maintenance Phase|Reason not specified|0|||
149020613|NCT02611830|537552722|FG001|Maintenance Phase|Reason not specified|1|||
149020614|NCT02611830|537552723|FG002|Maintenance Phase|Reason not specified|4|||
149020615|NCT02611830|537552724|FG003|Maintenance Phase|Reason not specified|0|||
149020616|NCT00839917|537554705|FG000|Overall Study|Lost to Follow-up|1|||
149020617|NCT00839917|537554706|FG001|Overall Study|Lost to Follow-up|0|||
149020618|NCT00839917|537554705|FG000|Overall Study|Did not receive vaccine|0|||
149020619|NCT00839917|537554706|FG001|Overall Study|Did not receive vaccine|1|||
149020620|NCT00109928|537554714|FG000|Overall Study|Adverse Event|2|||
149020621|NCT00109928|537554714|FG000|Overall Study|Progression|6|||
149020622|NCT00109928|537554714|FG000|Overall Study|Death|2|||
149020623|NCT00109928|537554714|FG000|Overall Study|not protocol specified|2|||
149020624|NCT00109928|537554714|FG000|Overall Study|not eligible|1|||
149020625|NCT04004208|537554719|FG000|Overall Study|Withdrawal by parent/guardian|1|||
149020626|NCT04004208|537554720|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149020627|NCT04004208|537554719|FG000|Overall Study|Death|3|||
149020628|NCT04004208|537554720|FG001|Overall Study|Death|0|||
149020629|NCT04004208|537554719|FG000|Overall Study|COVID-19 pandemic|1|||
149020630|NCT04004208|537554720|FG001|Overall Study|COVID-19 pandemic|0|||
149020631|NCT04004208|537554719|FG000|Overall Study|Physician Decision|1|||
149020632|NCT04004208|537554720|FG001|Overall Study|Physician Decision|0|||
149020633|NCT04004208|537554719|FG000|Overall Study|Adverse Event|1|||
149020634|NCT04004208|537554720|FG001|Overall Study|Adverse Event|1|||
149020635|NCT01364727|537554722|FG000|Overall Study|Not Eligible|2|||
149020636|NCT01676220|537554724|FG000|Overall Study|Randomized But Not Treated|4|||
149020637|NCT01676220|537554725|FG001|Overall Study|Randomized But Not Treated|1|||
149020638|NCT01676220|537554724|FG000|Overall Study|Adverse Event|10|||
149020639|NCT01676220|537554725|FG001|Overall Study|Adverse Event|8|||
149020640|NCT01676220|537554724|FG000|Overall Study|Lack of Efficacy|2|||
149020641|NCT01676220|537554725|FG001|Overall Study|Lack of Efficacy|5|||
149020642|NCT01676220|537554724|FG000|Overall Study|Protocol Violation|11|||
149020643|NCT01676220|537554725|FG001|Overall Study|Protocol Violation|12|||
149020644|NCT01676220|537554724|FG000|Overall Study|Received Rescue Therapy|14|||
149020645|NCT01676220|537554725|FG001|Overall Study|Received Rescue Therapy|22|||
149020646|NCT01676220|537554724|FG000|Overall Study|Personal Reason|34|||
149020647|NCT01676220|537554725|FG001|Overall Study|Personal Reason|45|||
149020648|NCT01676220|537554724|FG000|Overall Study|Lost to Follow-up|11|||
149020649|NCT01676220|537554725|FG001|Overall Study|Lost to Follow-up|18|||
149020650|NCT01676220|537554724|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
149020651|NCT01676220|537554725|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
149020652|NCT01676220|537554724|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
149020653|NCT01676220|537554725|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
149020654|NCT01676220|537554724|FG000|Overall Study|Perceived Lack of Efficacy|3|||
149020655|NCT01676220|537554725|FG001|Overall Study|Perceived Lack of Efficacy|1|||
149020656|NCT01676220|537554724|FG000|Overall Study|Non Serious Hypoglycemia|2|||
149020657|NCT01676220|537554725|FG001|Overall Study|Non Serious Hypoglycemia|0|||
149020658|NCT01676220|537554724|FG000|Overall Study|No More Need of Insulin|1|||
149020659|NCT01676220|537554725|FG001|Overall Study|No More Need of Insulin|0|||
149020660|NCT02411591|537554726|FG000|Overall Study|Adverse Event|0|||
149020661|NCT02411591|537554727|FG001|Overall Study|Adverse Event|4|||
149020662|NCT02411591|537554728|FG002|Overall Study|Adverse Event|2|||
149020663|NCT02411591|537554726|FG000|Overall Study|Withdrawal by Subject|0|||
149020664|NCT02411591|537554727|FG001|Overall Study|Withdrawal by Subject|3|||
148955317|NCT01634360|537319313|FG001|Overall Study|Other|20|||
148955318|NCT01634360|537319312|FG000|Overall Study|Study termination by sponsor|18|||
148955319|NCT01634360|537319313|FG001|Overall Study|Study termination by sponsor|44|||
148955320|NCT02260921|537319320|FG000|Overall Study|Adverse Event|1|||
148955321|NCT02260921|537319321|FG001|Overall Study|Adverse Event|0|||
148955322|NCT02260921|537319320|FG000|Overall Study|Lost to Follow-up|4|||
148955323|NCT02260921|537319321|FG001|Overall Study|Lost to Follow-up|3|||
148955324|NCT02260921|537319320|FG000|Overall Study|Withdraw Consent|4|||
148955325|NCT02260921|537319321|FG001|Overall Study|Withdraw Consent|1|||
148955326|NCT02260921|537319320|FG000|Overall Study|Death|1|||
148955327|NCT02260921|537319321|FG001|Overall Study|Death|0|||
148955328|NCT02260921|537319320|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
148955329|NCT02260921|537319321|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
148955330|NCT01244425|537319322|FG000|Overall Study|Withdrawal by Subject|2|||
148955331|NCT01244425|537319323|FG001|Overall Study|Withdrawal by Subject|2|||
148955332|NCT01244425|537319322|FG000|Overall Study|Adverse Event|1|||
148955333|NCT01244425|537319323|FG001|Overall Study|Adverse Event|1|||
148955334|NCT02484729|537319324|FG000|Overall Study|Failure of IntelliCap Error|0|||
148955335|NCT02484729|537319325|FG001|Overall Study|Failure of IntelliCap Error|0|||
149020665|NCT02411591|537554728|FG002|Overall Study|Withdrawal by Subject|0|||
149020666|NCT02411591|537554726|FG000|Overall Study|Physician Decision|0|||
149020667|NCT02411591|537554727|FG001|Overall Study|Physician Decision|3|||
149020668|NCT02411591|537554728|FG002|Overall Study|Physician Decision|1|||
149020669|NCT02491892|537554729|FG000|Overall Study|Adverse Event|1|||
148955336|NCT02484729|537319326|FG002|Overall Study|Failure of IntelliCap Error|0|||
148955337|NCT02484729|537319327|FG003|Overall Study|Failure of IntelliCap Error|0|||
148955338|NCT02484729|537319328|FG004|Overall Study|Failure of IntelliCap Error|0|||
148955339|NCT02484729|537319329|FG005|Overall Study|Failure of IntelliCap Error|0|||
148955340|NCT02484729|537319330|FG006|Overall Study|Failure of IntelliCap Error|0|||
148955341|NCT02484729|537319331|FG007|Overall Study|Failure of IntelliCap Error|0|||
148955342|NCT02484729|537319332|FG008|Overall Study|Failure of IntelliCap Error|0|||
148955343|NCT02484729|537319333|FG009|Overall Study|Failure of IntelliCap Error|1|||
148955344|NCT02480114|537319336|FG000|Overall Study|Not completing surveys|3|||
148955345|NCT02480114|537319337|FG001|Overall Study|Not completing surveys|2|||
148955346|NCT02480114|537319336|FG000|Overall Study|Withdrawal by Subject|2|||
148955347|NCT02480114|537319337|FG001|Overall Study|Withdrawal by Subject|4|||
148955348|NCT02480114|537319336|FG000|Overall Study|Disease progression|3|||
148955349|NCT02480114|537319337|FG001|Overall Study|Disease progression|0|||
148955350|NCT02480114|537319336|FG000|Overall Study|Improper completion of survey|1|||
148955351|NCT02480114|537319337|FG001|Overall Study|Improper completion of survey|1|||
148955352|NCT02480114|537319336|FG000|Overall Study|Not eligible|0|||
148955353|NCT02480114|537319337|FG001|Overall Study|Not eligible|1|||
148955354|NCT01535053|537319338|FG000|Overall Study|Ineligible|1|||
148955355|NCT01535053|537319339|FG001|Overall Study|Ineligible|2|||
148955356|NCT01031069|537319340|FG000|Overall Study|Serious Adverse Event|0|||
148955357|NCT01031069|537319341|FG001|Overall Study|Serious Adverse Event|1|||
148955358|NCT01031069|537319342|FG002|Overall Study|Serious Adverse Event|0|||
148955359|NCT01031069|537319343|FG003|Overall Study|Serious Adverse Event|0|||
148955360|NCT01031069|537319340|FG000|Overall Study|Withdrawal by Subject|2|||
148955361|NCT01031069|537319341|FG001|Overall Study|Withdrawal by Subject|3|||
148955362|NCT01031069|537319342|FG002|Overall Study|Withdrawal by Subject|18|||
148955363|NCT01031069|537319343|FG003|Overall Study|Withdrawal by Subject|18|||
148955364|NCT01031069|537319340|FG000|Overall Study|Migrated/moved from study area|1|||
148955365|NCT01031069|537319341|FG001|Overall Study|Migrated/moved from study area|2|||
148955366|NCT01031069|537319342|FG002|Overall Study|Migrated/moved from study area|1|||
148955367|NCT01031069|537319343|FG003|Overall Study|Migrated/moved from study area|1|||
148955368|NCT01031069|537319340|FG000|Overall Study|Lost to Follow-up|9|||
148955369|NCT01031069|537319341|FG001|Overall Study|Lost to Follow-up|5|||
148955370|NCT01031069|537319342|FG002|Overall Study|Lost to Follow-up|21|||
148955371|NCT01031069|537319343|FG003|Overall Study|Lost to Follow-up|15|||
148955372|NCT01031069|537319340|FG000|Overall Study|Other|0|||
148955373|NCT01031069|537319341|FG001|Overall Study|Other|0|||
148955374|NCT01031069|537319342|FG002|Overall Study|Other|1|||
148955375|NCT01031069|537319343|FG003|Overall Study|Other|0|||
148955376|NCT00512707|537319344|FG000|Overall Study|Lost to Follow-up|5|||
148955377|NCT00512707|537319345|FG001|Overall Study|Lost to Follow-up|11|||
148955378|NCT00512707|537319344|FG000|Overall Study|Developed skin irritation|2|||
148955379|NCT00512707|537319345|FG001|Overall Study|Developed skin irritation|1|||
148955380|NCT00512707|537319344|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
148955381|NCT00512707|537319345|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
148955382|NCT00512707|537319344|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
148955383|NCT00512707|537319345|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
148955384|NCT01317160|537319346|FG000|Overall Study|Incorrect inclusion|1|||
148955385|NCT01317160|537319347|FG001|Overall Study|Incorrect inclusion|1|||
148955386|NCT01317160|537319346|FG000|Overall Study|Lost to Follow-up|3|||
148955387|NCT01317160|537319347|FG001|Overall Study|Lost to Follow-up|3|||
148955388|NCT01317160|537319346|FG000|Overall Study|Withdrawal by Subject|0|||
148955389|NCT01317160|537319347|FG001|Overall Study|Withdrawal by Subject|2|||
148955390|NCT03032705|537319349|FG000|Overall Study|Lost to Follow-up|16|||
148955391|NCT03032705|537319350|FG001|Overall Study|Lost to Follow-up|17|||
148955392|NCT03032705|537319349|FG000|Overall Study|did not quality|6|||
148955393|NCT03032705|537319350|FG001|Overall Study|did not quality|6|||
148955394|NCT04405037|537319353|FG000|Overall Study|Withdrawal by Subject|1|||
148955395|NCT04405037|537319354|FG001|Overall Study|Withdrawal by Subject|0|||
148955396|NCT04405037|537319353|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
148955397|NCT04405037|537319354|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
148955398|NCT01853826|537320903|FG000|Overall Study|Patients who switched to commercial drug|11|||
148955399|NCT01853826|537320903|FG000|Overall Study|Patient refused to continue medication|21|||
148955400|NCT01853826|537320903|FG000|Overall Study|Lost to Follow-up|2|||
148955401|NCT01853826|537320903|FG000|Overall Study|Non-compliant with protocol|4|||
148955402|NCT01853826|537320903|FG000|Overall Study|Other adverse events (AE)|62|||
148955403|NCT01853826|537320903|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
148955404|NCT01853826|537320903|FG000|Overall Study|Progressive disease|342|||
148955405|NCT01853826|537320903|FG000|Overall Study|Other than listed|13|||
148955406|NCT01853826|537320903|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
148955407|NCT03653637|537320904|FG000|Overall Study|Death|1|||
148955408|NCT03653637|537320905|FG001|Overall Study|Death|3|||
148955409|NCT03653637|537320904|FG000|Overall Study|Lost to Follow-up|29|||
148955410|NCT03653637|537320905|FG001|Overall Study|Lost to Follow-up|30|||
148955411|NCT03653637|537320904|FG000|Overall Study|Physician Decision|1|||
148955412|NCT03653637|537320905|FG001|Overall Study|Physician Decision|1|||
148955413|NCT03653637|537320904|FG000|Overall Study|Withdrawal by Subject|7|||
148955414|NCT03653637|537320905|FG001|Overall Study|Withdrawal by Subject|4|||
148955415|NCT01134783|537320907|FG000|Overall Study|Pregnancy|16|||
148955416|NCT01134783|537320908|FG001|Overall Study|Pregnancy|8|||
148955417|NCT01134783|537320907|FG000|Overall Study|Withdrawal by Subject|15|||
148955418|NCT01134783|537320908|FG001|Overall Study|Withdrawal by Subject|9|||
148955419|NCT01134783|537320907|FG000|Overall Study|Lost to Follow-up|5|||
148955420|NCT01134783|537320908|FG001|Overall Study|Lost to Follow-up|20|||
148955421|NCT00397982|537320910|FG000|Overall Study|Withdrawal by Subject|1|||
148955422|NCT00397982|537320910|FG000|Overall Study|Adverse Event|1|||
148955423|NCT00397982|537320910|FG000|Overall Study|noncompliance|1|||
148955424|NCT00397982|537320910|FG000|Overall Study|Unrelated health issues|1|||
148955425|NCT02450903|537320911|FG000|Overall Study|Adverse Event|3|||
148955426|NCT02450903|537320911|FG000|Overall Study|Progressive disease|15|||
148955427|NCT02450903|537320911|FG000|Overall Study|Switched to commercial drug|1|||
148955428|NCT02450903|537320911|FG000|Overall Study|Subject/guardian decision|1|||
148955429|NCT00967798|537320912|FG000|Overall Study|Withdrawal by Subject|5|||
148955430|NCT00967798|537320913|FG001|Overall Study|Withdrawal by Subject|2|||
148955431|NCT00967798|537320912|FG000|Overall Study|Lost to Follow-up|4|||
148955432|NCT00967798|537320913|FG001|Overall Study|Lost to Follow-up|1|||
148955433|NCT01409564|537320916|FG000|Overall Study|low medication compliance|4|||
148955434|NCT01409564|537320917|FG001|Overall Study|low medication compliance|3|||
148955435|NCT01409564|537320916|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
148955436|NCT01409564|537320917|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
148955437|NCT00225251|537320918|FG000|Overall Study|Withdrawal by Subject|1|||
148955438|NCT00225251|537320919|FG001|Overall Study|Withdrawal by Subject|1|||
148955439|NCT02664441|537320920|FG000|Randomization|Withdrawal by Subject|0|||
148955440|NCT02664441|537320921|FG001|Randomization|Withdrawal by Subject|1|||
148955441|NCT02664441|537320920|FG000|36-week Randomized Trial|Adverse Event|2|||
148955442|NCT02664441|537320921|FG001|36-week Randomized Trial|Adverse Event|0|||
148955443|NCT02664441|537320920|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
148955444|NCT02664441|537320921|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
148955445|NCT02664441|537320920|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
148955446|NCT02664441|537320921|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
148955447|NCT02664441|537320920|FG000|18-week Open Label Extension|Adverse Event|1|||
148955448|NCT02664441|537320921|FG001|18-week Open Label Extension|Adverse Event|0|||
148955449|NCT02664441|537320920|FG000|18-week Open Label Extension|Physician Decision|1|||
148955450|NCT02664441|537320921|FG001|18-week Open Label Extension|Physician Decision|0|||
148955451|NCT02664441|537320920|FG000|18-week Open Label Extension|Death|1|||
148955452|NCT02664441|537320921|FG001|18-week Open Label Extension|Death|0|||
148955453|NCT02664441|537320920|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
148955454|NCT02664441|537320921|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
149020670|NCT02491892|537554730|FG001|Overall Study|Adverse Event|1|||
148955455|NCT03045328|537320922|FG000|Overall Study|Withdrawal by Subject|2|||
148955456|NCT00592839|537320927|FG000|Overall Study|Withdrawal by Subject|1|||
148955457|NCT00592839|537320928|FG001|Overall Study|Withdrawal by Subject|1|||
148955458|NCT00592839|537320929|FG002|Overall Study|Withdrawal by Subject|3|||
148955459|NCT00592839|537320927|FG000|Overall Study|Protocol Violation|1|||
148955460|NCT00592839|537320928|FG001|Overall Study|Protocol Violation|1|||
148955461|NCT00592839|537320929|FG002|Overall Study|Protocol Violation|2|||
148955462|NCT00592839|537320927|FG000|Overall Study|Adverse Event|0|||
148955463|NCT00592839|537320928|FG001|Overall Study|Adverse Event|1|||
148955464|NCT00592839|537320929|FG002|Overall Study|Adverse Event|0|||
148955465|NCT00592839|537320927|FG000|Overall Study|Lost to Follow-up|0|||
149020671|NCT02491892|537554729|FG000|Overall Study|Death|1|||
148691367|NCT01659567|536344157|FG000|Overall Study|Other|13|||
148691368|NCT03019965|536344158|FG000|Overall Study|Withdrawal by Subject|1|||
148691369|NCT03019965|536344159|FG001|Overall Study|Withdrawal by Subject|0|||
148691370|NCT03019965|536344158|FG000|Overall Study|Protocol Violation|1|||
148691371|NCT03019965|536344159|FG001|Overall Study|Protocol Violation|3|||
148691372|NCT03019965|536344158|FG000|Overall Study|viral or fungal infection|3|||
148691373|NCT03019965|536344159|FG001|Overall Study|viral or fungal infection|4|||
148691374|NCT03019965|536344158|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
148691375|NCT03019965|536344159|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
148691376|NCT03019965|536344158|FG000|Overall Study|Physician Decision|1|||
148691377|NCT03019965|536344159|FG001|Overall Study|Physician Decision|1|||
148691378|NCT01179919|536344162|FG000|Overall Study|Protocol Violation|1|||
148691379|NCT01179919|536344162|FG000|Overall Study|Adverse Event|1|||
148691380|NCT01915732|536344173|FG000|Overall Study|Withdrawal by Subject|18|||
148691381|NCT01915732|536344174|FG001|Overall Study|Withdrawal by Subject|18|||
148955466|NCT00592839|537320928|FG001|Overall Study|Lost to Follow-up|1|||
148955467|NCT00592839|537320929|FG002|Overall Study|Lost to Follow-up|1|||
148955468|NCT01313767|537320930|FG000|Overall Study|Adverse Event|1|||
148955469|NCT01313767|537320931|FG001|Overall Study|Adverse Event|0|||
148955470|NCT01313767|537320930|FG000|Overall Study|Lost to Follow-up|1|||
148955471|NCT01313767|537320931|FG001|Overall Study|Lost to Follow-up|0|||
148955472|NCT01313767|537320930|FG000|Overall Study|Withdrawal by Subject|2|||
148955473|NCT01313767|537320931|FG001|Overall Study|Withdrawal by Subject|1|||
148955474|NCT01313767|537320930|FG000|Overall Study|Protocol Violation|3|||
148691382|NCT01915732|536344173|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
148691383|NCT01915732|536344174|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
148691384|NCT01915732|536344173|FG000|Overall Study|Adverse Event|12|||
148691385|NCT01915732|536344174|FG001|Overall Study|Adverse Event|4|||
148691386|NCT01915732|536344173|FG000|Overall Study|Protocol Violation|5|||
148691387|NCT01915732|536344174|FG001|Overall Study|Protocol Violation|5|||
148955475|NCT01313767|537320931|FG001|Overall Study|Protocol Violation|1|||
148955476|NCT00157950|537320932|FG000|Overall Study|Death|1|||
148955477|NCT00157950|537320933|FG001|Overall Study|Death|0|||
148955478|NCT00082355|537320943|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
148955479|NCT00082355|537320943|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
148955480|NCT00082355|537320943|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
148691388|NCT01915732|536344173|FG000|Overall Study|Lack of Efficacy|6|||
148691389|NCT01915732|536344174|FG001|Overall Study|Lack of Efficacy|11|||
148691390|NCT01915732|536344173|FG000|Overall Study|Lost to Follow-up|22|||
148691391|NCT01915732|536344174|FG001|Overall Study|Lost to Follow-up|26|||
148691392|NCT01915732|536344173|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
148691393|NCT01915732|536344174|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
148691394|NCT01915732|536344173|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
148691395|NCT01915732|536344174|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
148955481|NCT02233309|537320944|FG000|Overall Study|Physician Decision|5|||
148955482|NCT00232817|537320947|FG000|Overall Study|Protocol Violation|2|||
148955483|NCT00232817|537320948|FG001|Overall Study|Protocol Violation|1|||
148955484|NCT00799487|537320949|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
148955485|NCT00799487|537320950|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
148955486|NCT00799487|537320951|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
148691396|NCT01915732|536344173|FG000|Overall Study|Drug Release Error|1|||
148811109|NCT04958707|536784694|FG001|3 Months Follow- up|Lost to Follow-up|3|||
148955487|NCT00799487|537320949|FG000|Dose Adjustment Period|Adverse Event|2|||
148955488|NCT00799487|537320950|FG001|Dose Adjustment Period|Adverse Event|0|||
148691397|NCT01915732|536344174|FG001|Overall Study|Drug Release Error|0|||
148811110|NCT04958707|536784695|FG002|3 Months Follow- up|Lost to Follow-up|0|||
148811111|NCT04958707|536784693|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
148811112|NCT04958707|536784694|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
148811113|NCT04958707|536784695|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
148811114|NCT05722015|536784698|FG000|Overall Study|Death|57|||
148811115|NCT05722015|536784699|FG001|Overall Study|Death|37|||
148811116|NCT05722015|536784698|FG000|Overall Study|Lost to Follow-up|1|||
148811117|NCT05722015|536784699|FG001|Overall Study|Lost to Follow-up|0|||
148811118|NCT05722015|536784698|FG000|Overall Study|Withdrawal by Subject|5|||
148811119|NCT05722015|536784699|FG001|Overall Study|Withdrawal by Subject|1|||
148811120|NCT05722015|536784698|FG000|Overall Study|Participants Ongoing|188|||
148811121|NCT05722015|536784699|FG001|Overall Study|Participants Ongoing|88|||
148811122|NCT05523297|536784700|FG000|Overall Study|Death|7|||
148811123|NCT05523297|536784701|FG001|Overall Study|Death|8|||
148811124|NCT05523297|536784700|FG000|Overall Study|Lost to Follow-up|2|||
148811125|NCT05523297|536784701|FG001|Overall Study|Lost to Follow-up|1|||
148811126|NCT02340949|536784704|FG000|Overall Study|Adverse Event|4|||
148811127|NCT02340949|536784705|FG001|Overall Study|Adverse Event|2|||
148811128|NCT02340949|536784704|FG000|Overall Study|Withdrawal by Subject|2|||
148811129|NCT02340949|536784705|FG001|Overall Study|Withdrawal by Subject|0|||
148811130|NCT02340949|536784704|FG000|Overall Study|Progression disease|6|||
148811131|NCT02340949|536784705|FG001|Overall Study|Progression disease|2|||
148811132|NCT02340949|536784704|FG000|Overall Study|Death|3|||
148811133|NCT02340949|536784705|FG001|Overall Study|Death|0|||
148811134|NCT02340949|536784704|FG000|Overall Study|Physician Decision|1|||
148811135|NCT02340949|536784705|FG001|Overall Study|Physician Decision|0|||
148811136|NCT01192178|536784706|FG000|Overall Study|Withdrawal by Subject|6|||
148811137|NCT01192178|536784707|FG001|Overall Study|Withdrawal by Subject|10|||
148811138|NCT01192178|536784706|FG000|Overall Study|Protocol Violation|10|||
148811139|NCT01192178|536784707|FG001|Overall Study|Protocol Violation|3|||
148811140|NCT01192178|536784706|FG000|Overall Study|Physician Decision|2|||
148811141|NCT01192178|536784707|FG001|Overall Study|Physician Decision|4|||
148811142|NCT01192178|536784706|FG000|Overall Study|Lost to Follow-up|3|||
148811143|NCT01192178|536784707|FG001|Overall Study|Lost to Follow-up|3|||
148811144|NCT01192178|536784706|FG000|Overall Study|Adverse Event|2|||
148811145|NCT01192178|536784707|FG001|Overall Study|Adverse Event|1|||
148811146|NCT01192178|536784706|FG000|Overall Study|Lack of Efficacy|1|||
148811147|NCT01192178|536784707|FG001|Overall Study|Lack of Efficacy|2|||
148811148|NCT00964782|536784710|FG000|Overall Study|Lost to Follow-up|1|||
148811149|NCT00964782|536784711|FG001|Overall Study|Lost to Follow-up|0|||
148811150|NCT02774889|536784714|FG000|Overall Study|Lost to Follow-up|2|||
148811151|NCT02774889|536784715|FG001|Overall Study|Lost to Follow-up|1|||
148811152|NCT00858988|536784716|FG000|Analysis|Lactulose unable to be detected in urine|2|||
148811153|NCT00858988|536784717|FG001|Analysis|Lactulose unable to be detected in urine|1|||
149020672|NCT02491892|537554730|FG001|Overall Study|Death|1|||
148811154|NCT01349595|536784720|FG000|Overall Study|Lack of funding|2|||
148811155|NCT01349595|536784721|FG001|Overall Study|Lack of funding|2|||
148811156|NCT04817410|536787016|FG000|Overall Study|Withdrawal by Subject|5|||
148811157|NCT04817410|536787016|FG000|Overall Study|Physician Decision|3|||
148811158|NCT03595748|536787017|FG000|Overall Study|Death|11|||
148811159|NCT03595748|536787018|FG001|Overall Study|Death|12|||
148811160|NCT03595748|536787017|FG000|Overall Study|Withdrawal by Subject|28|||
149020673|NCT02491892|537554729|FG000|Overall Study|Lack of Efficacy|37|||
148691398|NCT01915732|536344173|FG000|Overall Study|Recovered|1|||
148691399|NCT01915732|536344174|FG001|Overall Study|Recovered|0|||
148691400|NCT01915732|536344173|FG000|Overall Study|Pregnancy|1|||
148691401|NCT01915732|536344174|FG001|Overall Study|Pregnancy|0|||
148691402|NCT01915732|536344173|FG000|Overall Study|Poor Perceived Efficacy|1|||
148691403|NCT01915732|536344174|FG001|Overall Study|Poor Perceived Efficacy|0|||
148691404|NCT01915732|536344173|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
148691405|NCT01915732|536344174|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
148691406|NCT01915732|536344173|FG000|Overall Study|Got Well|0|||
148691407|NCT01915732|536344174|FG001|Overall Study|Got Well|1|||
148691408|NCT01915732|536344173|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
148955489|NCT00799487|537320951|FG002|Dose Adjustment Period|Adverse Event|0|||
148955490|NCT00799487|537320949|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
148955491|NCT00799487|537320950|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
148955492|NCT00799487|537320951|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
148955493|NCT00799487|537320949|FG000|Dose Adjustment Period|Investigator Discretion|2|||
148955494|NCT00799487|537320950|FG001|Dose Adjustment Period|Investigator Discretion|0|||
148955495|NCT00799487|537320951|FG002|Dose Adjustment Period|Investigator Discretion|0|||
148955496|NCT00799487|537320949|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
148955497|NCT00799487|537320950|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
148955498|NCT00799487|537320951|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
148955499|NCT00799487|537320949|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
148955500|NCT00799487|537320950|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
148955501|NCT00799487|537320951|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
148955502|NCT00799487|537320949|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
148955503|NCT00799487|537320950|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
148955504|NCT00799487|537320951|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
148955505|NCT00799487|537320949|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
148955506|NCT00799487|537320950|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
148955507|NCT00799487|537320951|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
148955508|NCT00799487|537320949|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
148955509|NCT00799487|537320950|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
148955510|NCT00799487|537320951|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
148955511|NCT00799487|537320949|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
148955512|NCT00799487|537320950|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
148955513|NCT00799487|537320951|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
148955514|NCT00799487|537320949|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
148955515|NCT00799487|537320950|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
148955516|NCT00799487|537320951|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
148955517|NCT00799487|537320949|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
148955518|NCT00799487|537320950|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
148955519|NCT00799487|537320951|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
148955520|NCT03263442|537320952|FG000|Inpatient Phase|Death|1|||
148955521|NCT03263442|537320953|FG001|Inpatient Phase|Death|0|||
148955522|NCT03263442|537320952|FG000|Inpatient Phase|Withdrawal by Subject|1|||
148955523|NCT03263442|537320953|FG001|Inpatient Phase|Withdrawal by Subject|0|||
148955524|NCT03263442|537320952|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
148955525|NCT03263442|537320953|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
148955526|NCT03263442|537320952|FG000|1-month Follow-Up|Lost to Follow-up|1|||
148955527|NCT03263442|537320953|FG001|1-month Follow-Up|Lost to Follow-up|0|||
148955528|NCT03263442|537320952|FG000|3-month Follow-Up|Lost to Follow-up|1|||
148955529|NCT03263442|537320953|FG001|3-month Follow-Up|Lost to Follow-up|3|||
148955530|NCT03263442|537320952|FG000|6-month Follow-Up|Lost to Follow-up|2|||
148955531|NCT03263442|537320953|FG001|6-month Follow-Up|Lost to Follow-up|2|||
148955532|NCT00708643|537320954|FG000|Overall Study|Adverse Event|0|||
148955533|NCT00708643|537320955|FG001|Overall Study|Adverse Event|1|||
148955534|NCT01594125|537320956|FG000|Overall Study|Withdrawal by Subject|1|||
148955535|NCT01594125|537320957|FG001|Overall Study|Withdrawal by Subject|0|||
148955536|NCT01594125|537320958|FG002|Overall Study|Withdrawal by Subject|0|||
148955537|NCT01594125|537320959|FG003|Overall Study|Withdrawal by Subject|1|||
148955538|NCT01594125|537320960|FG004|Overall Study|Withdrawal by Subject|0|||
149020674|NCT02491892|537554730|FG001|Overall Study|Lack of Efficacy|36|||
148811161|NCT03595748|536787018|FG001|Overall Study|Withdrawal by Subject|29|||
148955539|NCT01594125|537320956|FG000|Overall Study|Progressive Disease|3|||
148955540|NCT01594125|537320957|FG001|Overall Study|Progressive Disease|12|||
148955541|NCT01594125|537320958|FG002|Overall Study|Progressive Disease|3|||
148955542|NCT01594125|537320959|FG003|Overall Study|Progressive Disease|3|||
148955543|NCT01594125|537320960|FG004|Overall Study|Progressive Disease|7|||
148955544|NCT05492942|537320963|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
148955545|NCT05492942|537320964|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
148955546|NCT05492942|537320965|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
148955547|NCT05492942|537320966|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
148955548|NCT01946425|537320968|FG000|Overall Study|Protocol Violation|1|||
148955549|NCT01946425|537320969|FG001|Overall Study|Protocol Violation|0|||
148955550|NCT01946425|537320968|FG000|Overall Study|Withdrawal by Subject|1|||
148955551|NCT01946425|537320969|FG001|Overall Study|Withdrawal by Subject|0|||
148955552|NCT04545866|537320973|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
148955553|NCT04545866|537320974|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
148955554|NCT04545866|537320973|FG000|Overall Study|Withdrawal by Physician|1|||
148955555|NCT04545866|537320974|FG001|Overall Study|Withdrawal by Physician|0|||
148955556|NCT05247866|537320975|FG000|Overall Study|Adverse Event|2|||
148955557|NCT05247866|537320975|FG000|Overall Study|Lack of Efficacy|1|||
148955558|NCT05247866|537320975|FG000|Overall Study|Protocol Violation|1|||
148955559|NCT05247866|537320975|FG000|Overall Study|Withdrawal by Subject|3|||
148955560|NCT05582889|537320977|FG000|Overall Study|Health event|3|||
148955561|NCT05582889|537320978|FG001|Overall Study|Health event|2|||
148955562|NCT05582889|537320977|FG000|Overall Study|Lost to Follow-up|2|||
148955563|NCT05582889|537320978|FG001|Overall Study|Lost to Follow-up|4|||
148955564|NCT01782495|537320979|FG000|Overall Study|Adverse Event|0|||
148955565|NCT01782495|537320980|FG001|Overall Study|Adverse Event|0|||
148955566|NCT01782495|537320981|FG002|Overall Study|Adverse Event|0|||
148955567|NCT01782495|537320982|FG003|Overall Study|Adverse Event|0|||
148955568|NCT01782495|537320983|FG004|Overall Study|Adverse Event|0|||
148955569|NCT01782495|537320984|FG005|Overall Study|Adverse Event|0|||
148955570|NCT01782495|537320985|FG006|Overall Study|Adverse Event|0|||
148955571|NCT01782495|537320986|FG007|Overall Study|Adverse Event|2|||
148955572|NCT01782495|537320987|FG008|Overall Study|Adverse Event|0|||
148955573|NCT01782495|537320988|FG009|Overall Study|Adverse Event|0|||
148955574|NCT01782495|537320989|FG010|Overall Study|Adverse Event|0|||
148691409|NCT01915732|536344174|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
148691410|NCT01915732|536344173|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
148691411|NCT01915732|536344174|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
148691412|NCT01915732|536344173|FG000|Overall Study|Job Transfer|0|||
148691413|NCT01915732|536344174|FG001|Overall Study|Job Transfer|1|||
148691414|NCT01915732|536344173|FG000|Overall Study|Improper Facial Procedure|0|||
148691415|NCT01915732|536344174|FG001|Overall Study|Improper Facial Procedure|1|||
148691416|NCT01915732|536344173|FG000|Overall Study|Poor Conscious Effect|0|||
148691417|NCT01915732|536344174|FG001|Overall Study|Poor Conscious Effect|1|||
148691418|NCT00698685|536344175|FG000|Overall Study|Sister withdrew as donor|1|||
148691419|NCT00698685|536344175|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
148691420|NCT01325207|536344176|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
148691421|NCT01325207|536344177|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
148691422|NCT01325207|536344178|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
148955575|NCT01782495|537320979|FG000|Overall Study|Withdrew Consent|0|||
148955576|NCT01782495|537320980|FG001|Overall Study|Withdrew Consent|1|||
148955577|NCT01782495|537320981|FG002|Overall Study|Withdrew Consent|0|||
148955578|NCT01782495|537320982|FG003|Overall Study|Withdrew Consent|0|||
148955579|NCT01782495|537320983|FG004|Overall Study|Withdrew Consent|0|||
148955580|NCT01782495|537320984|FG005|Overall Study|Withdrew Consent|0|||
148955581|NCT01782495|537320985|FG006|Overall Study|Withdrew Consent|0|||
148955582|NCT01782495|537320986|FG007|Overall Study|Withdrew Consent|1|||
148955583|NCT01782495|537320987|FG008|Overall Study|Withdrew Consent|0|||
148955584|NCT01782495|537320988|FG009|Overall Study|Withdrew Consent|0|||
148955585|NCT01782495|537320989|FG010|Overall Study|Withdrew Consent|0|||
148955586|NCT02999854|537320993|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
148955587|NCT02999854|537320994|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
148955588|NCT02999854|537320993|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
148955589|NCT02999854|537320994|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
148955590|NCT02999854|537320993|FG000|Active Study Phase (up to 18 Months)|Death|7|||
148955591|NCT02999854|537320994|FG001|Active Study Phase (up to 18 Months)|Death|5|||
148955592|NCT02999854|537320993|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
148955593|NCT02999854|537320994|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
148955594|NCT02999854|537320993|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
148955595|NCT02999854|537320994|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
148955596|NCT02999854|537320993|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
148955597|NCT02999854|537320994|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
148955598|NCT02999854|537320993|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
148955599|NCT02999854|537320994|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
149020675|NCT02491892|537554729|FG000|Overall Study|Refused Treatment|1|||
149020676|NCT02491892|537554730|FG001|Overall Study|Refused Treatment|0|||
148955600|NCT02999854|537320993|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
148955601|NCT02999854|537320994|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
148955602|NCT02848651|537320995|FG000|Overall Study|Death|85|||
148955603|NCT02848651|537320995|FG000|Overall Study|Lost to Follow-up|1|||
148955604|NCT02848651|537320995|FG000|Overall Study|Non-Compliance|1|||
148955605|NCT02848651|537320995|FG000|Overall Study|Symptomatic Deterioration|1|||
148955606|NCT02848651|537320995|FG000|Overall Study|Physician Decision|4|||
148955607|NCT02848651|537320995|FG000|Overall Study|Withdrawal by Subject|14|||
149020677|NCT02491892|537554729|FG000|Overall Study|Lost to Follow-up|1|||
149020678|NCT02491892|537554730|FG001|Overall Study|Lost to Follow-up|0|||
149020679|NCT04227340|537554731|FG000|Overall Study|Withdrawal by Subject|3|||
149020680|NCT01734850|537554734|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
149020681|NCT01734850|537554735|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
149020682|NCT01734850|537554736|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
149020683|NCT01734850|537554734|FG000|Overall Study|Not infused due to manufacturing failure|0|||
149020684|NCT01734850|537554735|FG001|Overall Study|Not infused due to manufacturing failure|0|||
149020685|NCT01734850|537554736|FG002|Overall Study|Not infused due to manufacturing failure|1|||
149020686|NCT00750893|537554737|FG000|Overall Study|Adverse Event|5|||
149020687|NCT00750893|537554737|FG000|Overall Study|Withdrawal by Subject|10|||
149020688|NCT00750893|537554737|FG000|Overall Study|Lost to Follow-up|510|||
149020689|NCT00750893|537554737|FG000|Overall Study|Other|17|||
149020690|NCT00661258|537554739|FG000|Overall Study|Death|1|||
149020691|NCT00661258|537554740|FG001|Overall Study|Death|0|||
149020692|NCT00661258|537554739|FG000|Overall Study|caught by police and in detox center|2|||
149020693|NCT00661258|537554740|FG001|Overall Study|caught by police and in detox center|1|||
149020694|NCT04496167|537554741|FG000|Overall Study|Adverse Event|6|||
149020695|NCT04496167|537554742|FG001|Overall Study|Adverse Event|2|||
149020696|NCT04496167|537554741|FG000|Overall Study|Withdrawal by Subject|7|||
149020697|NCT04496167|537554742|FG001|Overall Study|Withdrawal by Subject|6|||
149020698|NCT04496167|537554741|FG000|Overall Study|Lost to Follow-up|3|||
149020699|NCT04496167|537554742|FG001|Overall Study|Lost to Follow-up|5|||
149020700|NCT04496167|537554741|FG000|Overall Study|Not Treated|1|||
149020701|NCT04496167|537554742|FG001|Overall Study|Not Treated|2|||
149020702|NCT04496167|537554741|FG000|Overall Study|Other Than Specified|1|||
148955608|NCT04140292|537320996|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
148955609|NCT04140292|537320997|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
148955610|NCT01013701|537321000|FG000|Overall Study|study prematurely terminated|7|||
148955611|NCT03241342|537321002|FG000|Overall Study|Adverse Event|5|||
148955612|NCT03241342|537321003|FG001|Overall Study|Adverse Event|8|||
148955613|NCT03241342|537321004|FG002|Overall Study|Adverse Event|4|||
148955614|NCT03241342|537321002|FG000|Overall Study|Lack of Efficacy|0|||
148955615|NCT03241342|537321003|FG001|Overall Study|Lack of Efficacy|0|||
148955616|NCT03241342|537321004|FG002|Overall Study|Lack of Efficacy|1|||
148955617|NCT03241342|537321002|FG000|Overall Study|noncompliance with study drug|2|||
148955618|NCT03241342|537321003|FG001|Overall Study|noncompliance with study drug|1|||
148955619|NCT03241342|537321004|FG002|Overall Study|noncompliance with study drug|1|||
148955620|NCT03241342|537321002|FG000|Overall Study|sponsor decision|0|||
148955621|NCT03241342|537321003|FG001|Overall Study|sponsor decision|1|||
148955622|NCT03241342|537321004|FG002|Overall Study|sponsor decision|2|||
148955623|NCT03241342|537321002|FG000|Overall Study|not reported|15|||
148955624|NCT03241342|537321003|FG001|Overall Study|not reported|21|||
148955625|NCT03241342|537321004|FG002|Overall Study|not reported|19|||
148955626|NCT00556712|537321005|FG000|Overall Study|Adverse Event|7|||
148955627|NCT00556712|537321006|FG001|Overall Study|Adverse Event|19|||
148955628|NCT00556712|537321005|FG000|Overall Study|Death|5|||
148955629|NCT00556712|537321006|FG001|Overall Study|Death|10|||
148955630|NCT00556712|537321005|FG000|Overall Study|Progressive Disease|383|||
148955631|NCT00556712|537321006|FG001|Overall Study|Progressive Disease|320|||
148955632|NCT00556712|537321005|FG000|Overall Study|Protocol Violation|3|||
148955633|NCT00556712|537321006|FG001|Overall Study|Protocol Violation|2|||
148955634|NCT00556712|537321005|FG000|Overall Study|Refused Treatment|17|||
148955635|NCT00556712|537321006|FG001|Overall Study|Refused Treatment|16|||
148955636|NCT00556712|537321005|FG000|Overall Study|Failure to Return|2|||
148955637|NCT00556712|537321006|FG001|Overall Study|Failure to Return|3|||
148955638|NCT00556712|537321005|FG000|Overall Study|Other|2|||
148955639|NCT00556712|537321006|FG001|Overall Study|Other|2|||
148955640|NCT00556712|537321005|FG000|Overall Study|Ongoing at Data Cutoff|32|||
148955641|NCT00556712|537321006|FG001|Overall Study|Ongoing at Data Cutoff|66|||
148955642|NCT01059799|537321009|FG000|Overall Study|Adverse Event|2|||
148955643|NCT01059799|537321010|FG001|Overall Study|Adverse Event|3|||
148955644|NCT01059799|537321009|FG000|Overall Study|Lack of Efficacy|1|||
148955645|NCT01059799|537321010|FG001|Overall Study|Lack of Efficacy|0|||
148955646|NCT01059799|537321009|FG000|Overall Study|Protocol Violation|3|||
148955647|NCT01059799|537321010|FG001|Overall Study|Protocol Violation|2|||
148955648|NCT01059799|537321009|FG000|Overall Study|Withdrawal criteria|13|||
148955649|NCT01059799|537321010|FG001|Overall Study|Withdrawal criteria|2|||
148955650|NCT01059799|537321009|FG000|Overall Study|Other|12|||
148955651|NCT01059799|537321010|FG001|Overall Study|Other|3|||
148955652|NCT01962207|537321013|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
148955653|NCT01962207|537321014|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
148955654|NCT01962207|537321015|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
148955655|NCT01962207|537321016|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
148955656|NCT01962207|537321013|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
148955657|NCT01962207|537321014|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
148955658|NCT01962207|537321015|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
148955659|NCT01962207|537321016|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
148955660|NCT01962207|537321013|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
148955661|NCT01962207|537321014|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
148955662|NCT01962207|537321015|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
148955663|NCT01962207|537321016|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
148955664|NCT01962207|537321013|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
148955665|NCT01962207|537321014|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
148955666|NCT01962207|537321015|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
148955667|NCT01962207|537321016|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
148955668|NCT01962207|537321013|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
148955669|NCT01962207|537321014|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
148955670|NCT01962207|537321015|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
148955671|NCT01962207|537321016|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
148955672|NCT01962207|537321013|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
148955673|NCT01962207|537321014|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
148955674|NCT01962207|537321015|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
148955675|NCT01962207|537321016|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
148955676|NCT02671422|537321020|FG000|Overall Study|Lost to Follow-up|1|||
148955677|NCT02671422|537321020|FG000|Overall Study|Adverse Event|68|||
148955678|NCT02671422|537321020|FG000|Overall Study|Lack of Efficacy|1|||
148955679|NCT02671422|537321020|FG000|Overall Study|Lost to Follow-up|4|||
148955680|NCT02671422|537321020|FG000|Overall Study|Withdrawal by Subject|7|||
148955681|NCT02671422|537321020|FG000|Overall Study|Progressive Disease|156|||
148955682|NCT02671422|537321020|FG000|Overall Study|Worsening of Disease|4|||
148955683|NCT02671422|537321020|FG000|Overall Study|Sponsor decision|5|||
148955684|NCT02671422|537321020|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
148955685|NCT02671422|537321020|FG000|Overall Study|Not treated with Vargatef®|3|||
148955686|NCT02671422|537321020|FG000|Overall Study|Other not defined above|3|||
148955687|NCT02289079|537321021|FG000|Overall Study|Physician Decision|2|||
148955688|NCT02289079|537321022|FG001|Overall Study|Physician Decision|0|||
148955689|NCT02289079|537321021|FG000|Overall Study|Lost to Follow-up|0|||
148955690|NCT02289079|537321022|FG001|Overall Study|Lost to Follow-up|1|||
148955691|NCT03036072|537321023|FG000|Overall Study|Death|0|||
148955692|NCT03036072|537321024|FG001|Overall Study|Death|1|||
148955693|NCT03036072|537321023|FG000|Overall Study|Withdrawal by Subject|0|||
148955694|NCT03036072|537321024|FG001|Overall Study|Withdrawal by Subject|1|||
148955695|NCT03036072|537321023|FG000|Overall Study|Physician Decision|0|||
148955696|NCT03036072|537321024|FG001|Overall Study|Physician Decision|1|||
148955697|NCT04772755|537321025|FG000|Overall Study|Withdrawal by Subject|1|||
148955698|NCT04772755|537321026|FG001|Overall Study|Withdrawal by Subject|0|||
148955699|NCT04772755|537321025|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
148955700|NCT04772755|537321026|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
148955701|NCT00662363|537321027|FG000|Overall Study|Withdrawal by Subject|6|||
148955702|NCT00662363|537321028|FG001|Overall Study|Withdrawal by Subject|5|||
148955703|NCT00662363|537321027|FG000|Overall Study|Adverse Event|0|||
148955704|NCT00662363|537321028|FG001|Overall Study|Adverse Event|3|||
148955705|NCT00662363|537321027|FG000|Overall Study|Discharged early from rehab|4|||
148955706|NCT00662363|537321028|FG001|Overall Study|Discharged early from rehab|1|||
148955707|NCT00662363|537321027|FG000|Overall Study|Protocol Violation|1|||
148955708|NCT00662363|537321028|FG001|Overall Study|Protocol Violation|1|||
148955709|NCT05838742|537321029|FG000|Overall Study|Adverse Event|2|||
148955710|NCT05838742|537321030|FG001|Overall Study|Adverse Event|0|||
148955711|NCT05838742|537321031|FG002|Overall Study|Adverse Event|1|||
148955712|NCT05838742|537321032|FG003|Overall Study|Adverse Event|0|||
148955713|NCT05838742|537321033|FG004|Overall Study|Adverse Event|1|||
148955714|NCT05838742|537321029|FG000|Overall Study|Lost to Follow-up|1|||
148955715|NCT05838742|537321030|FG001|Overall Study|Lost to Follow-up|1|||
148955716|NCT05838742|537321031|FG002|Overall Study|Lost to Follow-up|1|||
148955717|NCT05838742|537321032|FG003|Overall Study|Lost to Follow-up|0|||
148955718|NCT05838742|537321033|FG004|Overall Study|Lost to Follow-up|0|||
148955719|NCT05838742|537321029|FG000|Overall Study|Physician Decision|0|||
148955720|NCT05838742|537321030|FG001|Overall Study|Physician Decision|0|||
148955721|NCT05838742|537321031|FG002|Overall Study|Physician Decision|0|||
148955722|NCT05838742|537321032|FG003|Overall Study|Physician Decision|0|||
148955723|NCT05838742|537321033|FG004|Overall Study|Physician Decision|1|||
148955724|NCT05838742|537321029|FG000|Overall Study|Withdrawal by Subject|8|||
148955725|NCT05838742|537321030|FG001|Overall Study|Withdrawal by Subject|3|||
148955726|NCT05838742|537321031|FG002|Overall Study|Withdrawal by Subject|3|||
148955727|NCT05838742|537321032|FG003|Overall Study|Withdrawal by Subject|1|||
148955728|NCT05838742|537321033|FG004|Overall Study|Withdrawal by Subject|4|||
148955729|NCT05838742|537321029|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
148955730|NCT05838742|537321030|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
148955731|NCT05838742|537321031|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
148955732|NCT05838742|537321032|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
148955733|NCT05838742|537321033|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
148955734|NCT05838742|537321029|FG000|Overall Study|Lack of Efficacy|0|||
148955735|NCT05838742|537321030|FG001|Overall Study|Lack of Efficacy|0|||
148955736|NCT05838742|537321031|FG002|Overall Study|Lack of Efficacy|0|||
148955737|NCT05838742|537321032|FG003|Overall Study|Lack of Efficacy|1|||
148955738|NCT05838742|537321033|FG004|Overall Study|Lack of Efficacy|0|||
148955739|NCT05838742|537321029|FG000|Overall Study|Randomized, not treated|2|||
148955740|NCT05838742|537321030|FG001|Overall Study|Randomized, not treated|1|||
148955741|NCT05838742|537321031|FG002|Overall Study|Randomized, not treated|0|||
148955742|NCT05838742|537321032|FG003|Overall Study|Randomized, not treated|1|||
148955743|NCT05838742|537321033|FG004|Overall Study|Randomized, not treated|0|||
148955744|NCT05119569|537321034|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
148955745|NCT05119569|537321035|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
148955746|NCT05119569|537321036|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
148955747|NCT05119569|537321037|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
148955748|NCT05119569|537321034|FG000|Double Blind Treatment Phase|Adverse Event|6|||
148955749|NCT05119569|537321035|FG001|Double Blind Treatment Phase|Adverse Event|0|||
149020703|NCT04496167|537554742|FG001|Overall Study|Other Than Specified|1|||
149020704|NCT00598481|537554745|FG000|Treatment|Physician Decision|1|||
149020705|NCT01083160|537554746|FG000|Overall Study|Adverse Event|1|||
149020706|NCT01951092|537554749|FG000|Overall Study|Lost to Follow-up|10|||
149020707|NCT01951092|537554749|FG000|Overall Study|Incarceration|1|||
149020708|NCT01951092|537554749|FG000|Overall Study|Transfer of Care|1|||
149020709|NCT00918749|537554750|FG000|Overall Study|Adverse Event|1|||
149020710|NCT00918749|537554751|FG001|Overall Study|Adverse Event|0|||
149020711|NCT00918749|537554752|FG002|Overall Study|Adverse Event|1|||
149020712|NCT00918749|537554750|FG000|Overall Study|Lost to Follow-up|0|||
149020713|NCT00918749|537554751|FG001|Overall Study|Lost to Follow-up|0|||
149020714|NCT00918749|537554752|FG002|Overall Study|Lost to Follow-up|1|||
149020715|NCT00918749|537554750|FG000|Overall Study|Withdrawal by Subject|5|||
149020716|NCT00918749|537554751|FG001|Overall Study|Withdrawal by Subject|3|||
149020717|NCT00918749|537554752|FG002|Overall Study|Withdrawal by Subject|5|||
149020718|NCT00918749|537554750|FG000|Overall Study|No Study Medication Taken|1|||
149020719|NCT00918749|537554751|FG001|Overall Study|No Study Medication Taken|0|||
149020720|NCT00918749|537554752|FG002|Overall Study|No Study Medication Taken|0|||
149020721|NCT01712789|537554753|FG000|Overall Study|Lack of Efficacy|2|||
149020722|NCT01712789|537554753|FG000|Overall Study|Lost to Follow-up|1|||
149020723|NCT01712789|537554753|FG000|Overall Study|Progressive Disease|504|||
149020724|NCT01712789|537554753|FG000|Overall Study|Death|57|||
149020725|NCT01712789|537554753|FG000|Overall Study|Adverse Event|52|||
149020726|NCT01712789|537554753|FG000|Overall Study|Miscellaneous|31|||
149020727|NCT01712789|537554753|FG000|Overall Study|Withdrawal by Subject|21|||
149020728|NCT01712789|537554753|FG000|Overall Study|Transition to Commercial Treatment|8|||
149020729|NCT01712789|537554753|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
149020730|NCT01708187|537554754|FG000|Overall Study|Lost to Follow-up|0|||
149020731|NCT01708187|537554755|FG001|Overall Study|Lost to Follow-up|1|||
149020732|NCT00136916|537554756|FG000|Overall Study|Never received study treatment|3|||
149020733|NCT00136916|537554757|FG001|Overall Study|Never received study treatment|5|||
149020734|NCT00136916|537554756|FG000|Overall Study|Death|1|||
149020735|NCT00136916|537554757|FG001|Overall Study|Death|3|||
149020736|NCT00136916|537554756|FG000|Overall Study|Adverse Event|27|||
149020737|NCT00136916|537554757|FG001|Overall Study|Adverse Event|8|||
149020738|NCT00136916|537554756|FG000|Overall Study|Laboratory abnormality|0|||
149020739|NCT00136916|537554757|FG001|Overall Study|Laboratory abnormality|1|||
149020740|NCT00136916|537554756|FG000|Overall Study|Lack of Efficacy|13|||
149020741|NCT00136916|537554757|FG001|Overall Study|Lack of Efficacy|3|||
149020742|NCT00136916|537554756|FG000|Overall Study|Lost to Follow-up|12|||
149020743|NCT00136916|537554757|FG001|Overall Study|Lost to Follow-up|14|||
149020744|NCT00136916|537554756|FG000|Overall Study|Withdrawal by Subject|44|||
149020745|NCT00136916|537554757|FG001|Overall Study|Withdrawal by Subject|46|||
149020746|NCT00136916|537554756|FG000|Overall Study|Other|22|||
149020747|NCT00136916|537554757|FG001|Overall Study|Other|24|||
149020748|NCT00136916|537554756|FG000|Overall Study|Discontinued in follow up period|3|||
149020749|NCT00136916|537554757|FG001|Overall Study|Discontinued in follow up period|0|||
149020750|NCT02408549|537554759|FG000|Overall Study|Adverse Event|15|||
149020751|NCT02408549|537554759|FG000|Overall Study|Death|4|||
149020752|NCT02408549|537554759|FG000|Overall Study|Lack of Efficacy|17|||
149020753|NCT02408549|537554759|FG000|Overall Study|Protocol Violation|4|||
149020754|NCT02408549|537554759|FG000|Overall Study|Lost to Follow-up|6|||
149020755|NCT02408549|537554759|FG000|Overall Study|Consent withdrawn|30|||
149020756|NCT02408549|537554759|FG000|Overall Study|Neurology research program closing at site|1|||
149020757|NCT02408549|537554759|FG000|Overall Study|Site closure|1|||
149020758|NCT02408549|537554759|FG000|Overall Study|Pregnancy|1|||
149020759|NCT02408549|537554759|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
149020760|NCT02408549|537554759|FG000|Overall Study|Subject moved to another place, far from site|1|||
149020761|NCT02408549|537554759|FG000|Overall Study|Study terminated at site|1|||
149020762|NCT02213055|537554760|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
149020763|NCT02213055|537554761|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
149020764|NCT02213055|537554760|FG000|Overall Study|Protocol was not Followed during Study|1|||
149020765|NCT02213055|537554761|FG001|Overall Study|Protocol was not Followed during Study|0|||
149020766|NCT02213055|537554760|FG000|Overall Study|Documentation Issue at Enrollment|1|||
149020767|NCT02213055|537554761|FG001|Overall Study|Documentation Issue at Enrollment|0|||
149020768|NCT02213055|537554760|FG000|Overall Study|Documentation Issue during Study|10|||
149020769|NCT02213055|537554761|FG001|Overall Study|Documentation Issue during Study|0|||
149020770|NCT02213055|537554760|FG000|Overall Study|Did not have Live Lice|8|||
149020771|NCT02213055|537554761|FG001|Overall Study|Did not have Live Lice|0|||
149020772|NCT02213055|537554760|FG000|Overall Study|Had another Treatment during the Study|3|||
149020773|NCT02213055|537554761|FG001|Overall Study|Had another Treatment during the Study|0|||
149020774|NCT02213055|537554760|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
149020775|NCT02213055|537554761|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
149020776|NCT02213055|537554760|FG000|Overall Study|Did not Return to School|5|||
149020777|NCT02213055|537554761|FG001|Overall Study|Did not Return to School|0|||
149020778|NCT00231894|537554762|FG000|Overall Study|Withdrawal by Subject|1|||
148811162|NCT03595748|536787017|FG000|Overall Study|Protocol Violation|0|||
148955750|NCT05119569|537321036|FG002|Double Blind Treatment Phase|Adverse Event|0|||
148955751|NCT05119569|537321037|FG003|Double Blind Treatment Phase|Adverse Event|0|||
148955752|NCT05119569|537321034|FG000|Open Label Extension Phase|Ongoing in the study|0|||
148955753|NCT05119569|537321035|FG001|Open Label Extension Phase|Ongoing in the study|0|||
148955754|NCT05119569|537321036|FG002|Open Label Extension Phase|Ongoing in the study|65|||
148955755|NCT05119569|537321037|FG003|Open Label Extension Phase|Ongoing in the study|34|||
148955756|NCT03700671|537321041|FG000|Overall Study|Lack of Efficacy|1|||
148955757|NCT03700671|537321042|FG001|Overall Study|Lack of Efficacy|2|||
148955758|NCT03578367|537321047|FG000|Overall Study|Adverse Event|0|||
148955759|NCT03578367|537321048|FG001|Overall Study|Adverse Event|3|||
148955760|NCT03578367|537321049|FG002|Overall Study|Adverse Event|0|||
148955761|NCT03578367|537321050|FG003|Overall Study|Adverse Event|5|||
148955762|NCT03578367|537321047|FG000|Overall Study|Withdrawal by Subject|2|||
148955763|NCT03578367|537321048|FG001|Overall Study|Withdrawal by Subject|2|||
148955764|NCT03578367|537321049|FG002|Overall Study|Withdrawal by Subject|1|||
148955765|NCT03578367|537321050|FG003|Overall Study|Withdrawal by Subject|3|||
148955766|NCT03578367|537321047|FG000|Overall Study|Physician Decision|0|||
148955767|NCT03578367|537321048|FG001|Overall Study|Physician Decision|0|||
148955768|NCT03578367|537321049|FG002|Overall Study|Physician Decision|14|||
148955769|NCT03578367|537321050|FG003|Overall Study|Physician Decision|0|||
148955770|NCT03578367|537321047|FG000|Overall Study|Death|1|||
148955771|NCT03578367|537321048|FG001|Overall Study|Death|0|||
148955772|NCT03578367|537321049|FG002|Overall Study|Death|0|||
148955773|NCT03578367|537321050|FG003|Overall Study|Death|0|||
148955774|NCT03578367|537321047|FG000|Overall Study|Not treated|0|||
148955775|NCT03578367|537321048|FG001|Overall Study|Not treated|0|||
148955776|NCT03578367|537321049|FG002|Overall Study|Not treated|1|||
148955777|NCT03578367|537321050|FG003|Overall Study|Not treated|0|||
148955778|NCT05661942|537322747|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
148955779|NCT05661942|537322748|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
148955780|NCT02081690|537322759|FG000|Overall Study|Death|3|||
148955781|NCT02081690|537322759|FG000|Overall Study|Physician Decision|3|||
148955782|NCT02081690|537322759|FG000|Overall Study|Withdrawal by Subject|1|||
148955783|NCT00982488|537322763|FG000|Overall Study|Administrative reason by sponsor|81|||
148955784|NCT00982488|537322764|FG001|Overall Study|Administrative reason by sponsor|3|||
148955785|NCT00982488|537322765|FG002|Overall Study|Administrative reason by sponsor|11|||
148955786|NCT00982488|537322766|FG003|Overall Study|Administrative reason by sponsor|0|||
148955787|NCT00982488|537322767|FG004|Overall Study|Administrative reason by sponsor|0|||
148955788|NCT00982488|537322763|FG000|Overall Study|Adverse event unrelated to study drug|5|||
148955789|NCT00982488|537322764|FG001|Overall Study|Adverse event unrelated to study drug|1|||
148955790|NCT00982488|537322765|FG002|Overall Study|Adverse event unrelated to study drug|0|||
148955791|NCT00982488|537322766|FG003|Overall Study|Adverse event unrelated to study drug|0|||
148955792|NCT00982488|537322767|FG004|Overall Study|Adverse event unrelated to study drug|0|||
148955793|NCT00982488|537322763|FG000|Overall Study|Death|11|||
148955794|NCT00982488|537322764|FG001|Overall Study|Death|0|||
148955795|NCT00982488|537322765|FG002|Overall Study|Death|2|||
148955796|NCT00982488|537322766|FG003|Overall Study|Death|0|||
148955797|NCT00982488|537322767|FG004|Overall Study|Death|0|||
148955798|NCT00982488|537322763|FG000|Overall Study|Disease progression|30|||
148955799|NCT00982488|537322764|FG001|Overall Study|Disease progression|5|||
148955800|NCT00982488|537322765|FG002|Overall Study|Disease progression|10|||
148955801|NCT00982488|537322766|FG003|Overall Study|Disease progression|1|||
148955802|NCT00982488|537322767|FG004|Overall Study|Disease progression|1|||
148955803|NCT00982488|537322763|FG000|Overall Study|Lost to Follow-up|1|||
148955804|NCT00982488|537322764|FG001|Overall Study|Lost to Follow-up|0|||
148955805|NCT00982488|537322765|FG002|Overall Study|Lost to Follow-up|0|||
148955806|NCT00982488|537322766|FG003|Overall Study|Lost to Follow-up|0|||
148955807|NCT00982488|537322767|FG004|Overall Study|Lost to Follow-up|0|||
148955808|NCT00982488|537322763|FG000|Overall Study|Maximum clinical benefit|1|||
148955809|NCT00982488|537322764|FG001|Overall Study|Maximum clinical benefit|1|||
148955810|NCT00982488|537322765|FG002|Overall Study|Maximum clinical benefit|1|||
148955811|NCT00982488|537322766|FG003|Overall Study|Maximum clinical benefit|0|||
148955812|NCT00982488|537322767|FG004|Overall Study|Maximum clinical benefit|0|||
148955813|NCT00982488|537322763|FG000|Overall Study|Other|15|||
148955814|NCT00982488|537322764|FG001|Overall Study|Other|1|||
148955815|NCT00982488|537322765|FG002|Overall Study|Other|3|||
148955816|NCT00982488|537322766|FG003|Overall Study|Other|1|||
148955817|NCT00982488|537322767|FG004|Overall Study|Other|0|||
148955818|NCT00982488|537322763|FG000|Overall Study|Poor compliance/noncompliance|0|||
148955819|NCT00982488|537322764|FG001|Overall Study|Poor compliance/noncompliance|1|||
148955820|NCT00982488|537322765|FG002|Overall Study|Poor compliance/noncompliance|0|||
148955821|NCT00982488|537322766|FG003|Overall Study|Poor compliance/noncompliance|0|||
148955822|NCT00982488|537322767|FG004|Overall Study|Poor compliance/noncompliance|0|||
148955823|NCT00982488|537322763|FG000|Overall Study|Stem cell transplant|2|||
148955824|NCT00982488|537322764|FG001|Overall Study|Stem cell transplant|0|||
148955825|NCT00982488|537322765|FG002|Overall Study|Stem cell transplant|0|||
148955826|NCT00982488|537322766|FG003|Overall Study|Stem cell transplant|1|||
149020779|NCT00231894|537554763|FG001|Overall Study|Withdrawal by Subject|1|||
149020780|NCT02025205|537554765|FG000|Overall Study|Withdrawal by Subject|1|||
149020781|NCT02025205|537554766|FG001|Overall Study|Withdrawal by Subject|1|||
149020782|NCT02025205|537554765|FG000|Overall Study|Protocol Violation|2|||
149020783|NCT02025205|537554766|FG001|Overall Study|Protocol Violation|1|||
149020784|NCT02025205|537554765|FG000|Overall Study|Death|0|||
149020785|NCT02025205|537554766|FG001|Overall Study|Death|1|||
149020786|NCT01232556|537554769|FG000|Overall Study|Withdrawal by Subject|21|||
149020787|NCT01232556|537554770|FG001|Overall Study|Withdrawal by Subject|17|||
149020788|NCT01232556|537554769|FG000|Overall Study|Death|97|||
149020789|NCT01232556|537554770|FG001|Overall Study|Death|97|||
149020790|NCT01232556|537554769|FG000|Overall Study|Lost to Follow-up|0|||
149020791|NCT01232556|537554770|FG001|Overall Study|Lost to Follow-up|2|||
149020792|NCT01232556|537554769|FG000|Overall Study|Terminated by Sponsor|35|||
149020793|NCT01232556|537554770|FG001|Overall Study|Terminated by Sponsor|51|||
149020794|NCT01232556|537554769|FG000|Overall Study|Other|6|||
149020795|NCT01232556|537554770|FG001|Overall Study|Other|4|||
149020796|NCT02448719|537554771|FG000|Overall Study|Withdrawal by Subject|0|||
149020797|NCT02448719|537554772|FG001|Overall Study|Withdrawal by Subject|0|||
149020798|NCT02448719|537554773|FG002|Overall Study|Withdrawal by Subject|0|||
149020799|NCT02448719|537554774|FG003|Overall Study|Withdrawal by Subject|0|||
149020800|NCT02448719|537554775|FG004|Overall Study|Withdrawal by Subject|1|||
149020801|NCT02448719|537554776|FG005|Overall Study|Withdrawal by Subject|0|||
149020802|NCT02448719|537554777|FG006|Overall Study|Withdrawal by Subject|0|||
148691423|NCT01325207|536344179|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
148811163|NCT03595748|536787018|FG001|Overall Study|Protocol Violation|1|||
149020803|NCT02448719|537554778|FG007|Overall Study|Withdrawal by Subject|0|||
149020804|NCT02448719|537554779|FG008|Overall Study|Withdrawal by Subject|0|||
149020805|NCT02448719|537554780|FG009|Overall Study|Withdrawal by Subject|0|||
149020806|NCT02448719|537554781|FG010|Overall Study|Withdrawal by Subject|0|||
149020807|NCT01024751|537554782|FG000|Enrolled Participants|Ineligible at baseline|3|||
149020808|NCT01024751|537554783|FG001|Enrolled Participants|Ineligible at baseline|4|||
149020809|NCT01024751|537554782|FG000|Eligible Participants|Withdrawal by Subject|0|||
149020810|NCT01024751|537554783|FG001|Eligible Participants|Withdrawal by Subject|1|||
148955827|NCT00982488|537322767|FG004|Overall Study|Stem cell transplant|0|||
148955828|NCT00982488|537322763|FG000|Overall Study|Study drug toxicity|34|||
148955829|NCT00982488|537322764|FG001|Overall Study|Study drug toxicity|1|||
148955830|NCT00982488|537322765|FG002|Overall Study|Study drug toxicity|6|||
148955831|NCT00982488|537322766|FG003|Overall Study|Study drug toxicity|0|||
148955832|NCT00982488|537322767|FG004|Overall Study|Study drug toxicity|0|||
148955833|NCT00982488|537322763|FG000|Overall Study|Withdrawal by Subject|5|||
148955834|NCT00982488|537322764|FG001|Overall Study|Withdrawal by Subject|1|||
148955835|NCT00982488|537322765|FG002|Overall Study|Withdrawal by Subject|1|||
148955836|NCT00982488|537322766|FG003|Overall Study|Withdrawal by Subject|0|||
148955837|NCT00982488|537322767|FG004|Overall Study|Withdrawal by Subject|0|||
148955838|NCT04203238|537322768|FG000|Overall Study|Withdrawal by Subject|1|||
148955839|NCT04203238|537322769|FG001|Overall Study|Withdrawal by Subject|1|||
148955840|NCT04203238|537322768|FG000|Overall Study|Covid-19|3|||
148955841|NCT04203238|537322769|FG001|Overall Study|Covid-19|0|||
148955842|NCT00001596|537322770|FG000|Overall Study|Death|1|||
148955843|NCT00001596|537322771|FG001|Overall Study|Death|0|||
148955844|NCT00001596|537322770|FG000|Overall Study|Withdrawal by Subject|3|||
148955845|NCT00001596|537322771|FG001|Overall Study|Withdrawal by Subject|1|||
148955846|NCT00001596|537322770|FG000|Overall Study|Study Termination|12|||
148955847|NCT00001596|537322771|FG001|Overall Study|Study Termination|9|||
148955848|NCT00001596|537322770|FG000|Overall Study|Adverse Event|1|||
148955849|NCT00001596|537322771|FG001|Overall Study|Adverse Event|0|||
148955850|NCT00180414|537322783|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
148955851|NCT00180414|537322784|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
148955852|NCT00463346|537322786|FG000|Overall Study|Withdrawal by Subject|3|||
148955853|NCT00463346|537322787|FG001|Overall Study|Withdrawal by Subject|3|||
148955854|NCT01572909|537322788|FG000|Overall Study|Adverse Event|7|||
148955855|NCT01572909|537322789|FG001|Overall Study|Adverse Event|2|||
148955856|NCT01572909|537322788|FG000|Overall Study|Death|3|||
148955857|NCT01572909|537322789|FG001|Overall Study|Death|1|||
148955858|NCT01572909|537322788|FG000|Overall Study|Lost to Follow-up|8|||
148955859|NCT01572909|537322789|FG001|Overall Study|Lost to Follow-up|7|||
148955860|NCT01572909|537322788|FG000|Overall Study|Physician Decision|1|||
148955861|NCT01572909|537322789|FG001|Overall Study|Physician Decision|1|||
148955862|NCT01572909|537322788|FG000|Overall Study|Technical Issues|1|||
148955863|NCT01572909|537322789|FG001|Overall Study|Technical Issues|0|||
148955864|NCT01572909|537322788|FG000|Overall Study|Withdrawal by Subject|12|||
148955865|NCT01572909|537322789|FG001|Overall Study|Withdrawal by Subject|11|||
148955866|NCT01572909|537322788|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
148955867|NCT01572909|537322789|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
148955868|NCT03641651|537322794|FG000|Overall Study|organizational issues at one study site|1|||
148955869|NCT04779489|537322795|FG000|Overall Study|Physician Decision|1|||
148955870|NCT00951665|537322796|FG000|Phase 1b|Adverse Event|2|||
148955871|NCT00951665|537322797|FG001|Phase 1b|Adverse Event|1|||
148955872|NCT00951665|537322798|FG002|Phase 1b|Adverse Event|0|||
148955873|NCT00951665|537322799|FG003|Phase 1b|Adverse Event|1|||
148955874|NCT00951665|537322800|FG004|Phase 1b|Adverse Event|0|||
148955875|NCT00951665|537322801|FG005|Phase 1b|Adverse Event|0|||
148955876|NCT00951665|537322796|FG000|Phase 1b|Death|1|||
148955877|NCT00951665|537322797|FG001|Phase 1b|Death|0|||
148955878|NCT00951665|537322798|FG002|Phase 1b|Death|2|||
148955879|NCT00951665|537322799|FG003|Phase 1b|Death|0|||
148955880|NCT00951665|537322800|FG004|Phase 1b|Death|0|||
148955881|NCT00951665|537322801|FG005|Phase 1b|Death|0|||
148955882|NCT00951665|537322796|FG000|Phase 1b|Physician Decision|4|||
148955883|NCT00951665|537322797|FG001|Phase 1b|Physician Decision|0|||
148955884|NCT00951665|537322798|FG002|Phase 1b|Physician Decision|1|||
148955885|NCT00951665|537322799|FG003|Phase 1b|Physician Decision|0|||
148955886|NCT00951665|537322800|FG004|Phase 1b|Physician Decision|0|||
148955887|NCT00951665|537322801|FG005|Phase 1b|Physician Decision|0|||
148955888|NCT00951665|537322796|FG000|Phase 1b|Withdrawal by Subject|0|||
148955889|NCT00951665|537322797|FG001|Phase 1b|Withdrawal by Subject|1|||
148955890|NCT00951665|537322798|FG002|Phase 1b|Withdrawal by Subject|0|||
148955891|NCT00951665|537322799|FG003|Phase 1b|Withdrawal by Subject|0|||
148955892|NCT00951665|537322800|FG004|Phase 1b|Withdrawal by Subject|0|||
148955893|NCT00951665|537322801|FG005|Phase 1b|Withdrawal by Subject|0|||
148955894|NCT00951665|537322796|FG000|Phase 1b|Disease Progression|13|||
148955895|NCT00951665|537322797|FG001|Phase 1b|Disease Progression|2|||
148955896|NCT00951665|537322798|FG002|Phase 1b|Disease Progression|14|||
148955897|NCT00951665|537322799|FG003|Phase 1b|Disease Progression|0|||
148955898|NCT00951665|537322800|FG004|Phase 1b|Disease Progression|0|||
148955899|NCT00951665|537322801|FG005|Phase 1b|Disease Progression|0|||
148955900|NCT00951665|537322796|FG000|Phase 1b|Protocol Violation|2|||
148955901|NCT00951665|537322797|FG001|Phase 1b|Protocol Violation|0|||
148955902|NCT00951665|537322798|FG002|Phase 1b|Protocol Violation|0|||
148955903|NCT00951665|537322799|FG003|Phase 1b|Protocol Violation|0|||
148955904|NCT00951665|537322800|FG004|Phase 1b|Protocol Violation|0|||
148955905|NCT00951665|537322801|FG005|Phase 1b|Protocol Violation|0|||
148955906|NCT00951665|537322796|FG000|Phase 2a|Adverse Event|0|||
148955907|NCT00951665|537322797|FG001|Phase 2a|Adverse Event|0|||
148955908|NCT00951665|537322798|FG002|Phase 2a|Adverse Event|0|||
148955909|NCT00951665|537322799|FG003|Phase 2a|Adverse Event|0|||
148955910|NCT00951665|537322800|FG004|Phase 2a|Adverse Event|2|||
148955911|NCT00951665|537322801|FG005|Phase 2a|Adverse Event|0|||
148955912|NCT00951665|537322796|FG000|Phase 2a|Death|0|||
148955913|NCT00951665|537322797|FG001|Phase 2a|Death|0|||
148955914|NCT00951665|537322798|FG002|Phase 2a|Death|0|||
148955915|NCT00951665|537322799|FG003|Phase 2a|Death|0|||
148955916|NCT00951665|537322800|FG004|Phase 2a|Death|1|||
148955917|NCT00951665|537322801|FG005|Phase 2a|Death|1|||
148955918|NCT00951665|537322796|FG000|Phase 2a|Lost to Follow-up|0|||
148955919|NCT00951665|537322797|FG001|Phase 2a|Lost to Follow-up|0|||
148955920|NCT00951665|537322798|FG002|Phase 2a|Lost to Follow-up|0|||
148955921|NCT00951665|537322799|FG003|Phase 2a|Lost to Follow-up|0|||
148955922|NCT00951665|537322800|FG004|Phase 2a|Lost to Follow-up|1|||
148955923|NCT00951665|537322801|FG005|Phase 2a|Lost to Follow-up|0|||
148955924|NCT00951665|537322796|FG000|Phase 2a|Physician Decision|0|||
148955925|NCT00951665|537322797|FG001|Phase 2a|Physician Decision|0|||
148955926|NCT00951665|537322798|FG002|Phase 2a|Physician Decision|0|||
148955927|NCT00951665|537322799|FG003|Phase 2a|Physician Decision|0|||
148955928|NCT00951665|537322800|FG004|Phase 2a|Physician Decision|0|||
148955929|NCT00951665|537322801|FG005|Phase 2a|Physician Decision|1|||
148955930|NCT00951665|537322796|FG000|Phase 2a|Withdrawal by Subject|0|||
148955931|NCT00951665|537322797|FG001|Phase 2a|Withdrawal by Subject|0|||
148955932|NCT00951665|537322798|FG002|Phase 2a|Withdrawal by Subject|0|||
148955933|NCT00951665|537322799|FG003|Phase 2a|Withdrawal by Subject|0|||
148955934|NCT00951665|537322800|FG004|Phase 2a|Withdrawal by Subject|2|||
148955935|NCT00951665|537322801|FG005|Phase 2a|Withdrawal by Subject|0|||
148955936|NCT00951665|537322796|FG000|Phase 2a|Disease Progression|0|||
148955937|NCT00951665|537322797|FG001|Phase 2a|Disease Progression|0|||
148955938|NCT00951665|537322798|FG002|Phase 2a|Disease Progression|0|||
148955939|NCT00951665|537322799|FG003|Phase 2a|Disease Progression|0|||
148955940|NCT00951665|537322800|FG004|Phase 2a|Disease Progression|6|||
148955941|NCT00951665|537322801|FG005|Phase 2a|Disease Progression|5|||
148955942|NCT01199289|537322802|FG000|Overall Study|Ineligibility determined|2|||
148955943|NCT01199289|537322803|FG001|Overall Study|Ineligibility determined|1|||
148955944|NCT01199289|537322804|FG002|Overall Study|Ineligibility determined|0|||
148955945|NCT01199289|537322805|FG003|Overall Study|Ineligibility determined|0|||
148955946|NCT01199289|537322802|FG000|Overall Study|Protocol Violation|1|||
148955947|NCT01199289|537322803|FG001|Overall Study|Protocol Violation|0|||
148955948|NCT01199289|537322804|FG002|Overall Study|Protocol Violation|0|||
148955949|NCT01199289|537322805|FG003|Overall Study|Protocol Violation|1|||
148955950|NCT01199289|537322802|FG000|Overall Study|Noncompliance|1|||
148955951|NCT01199289|537322803|FG001|Overall Study|Noncompliance|0|||
148955952|NCT01199289|537322804|FG002|Overall Study|Noncompliance|2|||
148955953|NCT01199289|537322805|FG003|Overall Study|Noncompliance|0|||
148955954|NCT01199289|537322802|FG000|Overall Study|Adverse Event|0|||
148955955|NCT01199289|537322803|FG001|Overall Study|Adverse Event|3|||
148955956|NCT01199289|537322804|FG002|Overall Study|Adverse Event|1|||
148955957|NCT01199289|537322805|FG003|Overall Study|Adverse Event|4|||
148955958|NCT01199289|537322802|FG000|Overall Study|Full consent withdrawn|2|||
148955959|NCT01199289|537322803|FG001|Overall Study|Full consent withdrawn|2|||
148955960|NCT01199289|537322804|FG002|Overall Study|Full consent withdrawn|2|||
148955961|NCT01199289|537322805|FG003|Overall Study|Full consent withdrawn|3|||
148955962|NCT01199289|537322802|FG000|Overall Study|Administrative decision|0|||
148955963|NCT01199289|537322803|FG001|Overall Study|Administrative decision|0|||
148955964|NCT01199289|537322804|FG002|Overall Study|Administrative decision|0|||
148955965|NCT01199289|537322805|FG003|Overall Study|Administrative decision|1|||
148955966|NCT01199289|537322802|FG000|Overall Study|Lost to Follow-up|0|||
148955967|NCT01199289|537322803|FG001|Overall Study|Lost to Follow-up|0|||
148955968|NCT01199289|537322804|FG002|Overall Study|Lost to Follow-up|0|||
148955969|NCT01199289|537322805|FG003|Overall Study|Lost to Follow-up|1|||
148955970|NCT01199289|537322802|FG000|Overall Study|Protocol-specified criteria|3|||
148955971|NCT01199289|537322803|FG001|Overall Study|Protocol-specified criteria|0|||
148955972|NCT01199289|537322804|FG002|Overall Study|Protocol-specified criteria|0|||
148955973|NCT01199289|537322805|FG003|Overall Study|Protocol-specified criteria|1|||
148955974|NCT01199289|537322802|FG000|Overall Study|Pregnancy|0|||
148955975|NCT01199289|537322803|FG001|Overall Study|Pregnancy|1|||
148955976|NCT01199289|537322804|FG002|Overall Study|Pregnancy|0|||
148955977|NCT01199289|537322805|FG003|Overall Study|Pregnancy|1|||
148955978|NCT02723084|537322808|FG000|Overall Study|Withdrawal by Subject|1|||
148955979|NCT02723084|537322809|FG001|Overall Study|Withdrawal by Subject|1|||
148955980|NCT02723084|537322808|FG000|Overall Study|Lost to Follow-up|3|||
148955981|NCT02723084|537322809|FG001|Overall Study|Lost to Follow-up|0|||
148955982|NCT00415909|537322812|FG000|Overall Study|Withdrawal by Subject|2|||
148955983|NCT00415909|537322812|FG000|Overall Study|Death|1|||
148955984|NCT05024058|537322813|FG000|Treatment|Study terminated by sponsor|5|||
148955985|NCT05024058|537322814|FG001|Treatment|Study terminated by sponsor|6|||
148955986|NCT05024058|537322815|FG002|Treatment|Study terminated by sponsor|4|||
148955987|NCT05024058|537322816|FG003|Treatment|Study terminated by sponsor|2|||
148955988|NCT05024058|537322817|FG004|Treatment|Study terminated by sponsor|3|||
148955989|NCT05024058|537322818|FG005|Treatment|Study terminated by sponsor|3|||
149020811|NCT01024751|537554782|FG000|Eligible Participants|Lost to Follow-up|0|||
149020812|NCT01024751|537554783|FG001|Eligible Participants|Lost to Follow-up|1|||
149020813|NCT01024751|537554782|FG000|Eligible Participants|Ineligible|0|||
149020814|NCT01024751|537554783|FG001|Eligible Participants|Ineligible|1|||
149020815|NCT01603121|537554789|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
149020816|NCT01603121|537554790|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
149020817|NCT00577720|537554793|FG000|Overall Study|Adverse Event|2|||
149020818|NCT00577720|537554794|FG001|Overall Study|Adverse Event|1|||
149020819|NCT00577720|537554795|FG002|Overall Study|Adverse Event|0|||
149020820|NCT00577720|537554796|FG003|Overall Study|Adverse Event|4|||
149020821|NCT00577720|537554793|FG000|Overall Study|Lost to Follow-up|0|||
149020822|NCT00577720|537554794|FG001|Overall Study|Lost to Follow-up|0|||
149020823|NCT00577720|537554795|FG002|Overall Study|Lost to Follow-up|1|||
149020824|NCT00577720|537554796|FG003|Overall Study|Lost to Follow-up|0|||
149020825|NCT00577720|537554793|FG000|Overall Study|Protocol Violation|0|||
149020826|NCT00577720|537554794|FG001|Overall Study|Protocol Violation|0|||
149020827|NCT00577720|537554795|FG002|Overall Study|Protocol Violation|0|||
149020828|NCT00577720|537554796|FG003|Overall Study|Protocol Violation|1|||
149020829|NCT00577720|537554793|FG000|Overall Study|Withdrawal by Subject|2|||
149020830|NCT00577720|537554794|FG001|Overall Study|Withdrawal by Subject|0|||
149020831|NCT00577720|537554795|FG002|Overall Study|Withdrawal by Subject|0|||
149020832|NCT00577720|537554796|FG003|Overall Study|Withdrawal by Subject|2|||
149020833|NCT01628510|537554797|FG000|Overall Study|Withdrawal by Subject|0|||
149020834|NCT01628510|537554798|FG001|Overall Study|Withdrawal by Subject|4|||
149020835|NCT01628510|537554797|FG000|Overall Study|Death|3|||
149020836|NCT01628510|537554798|FG001|Overall Study|Death|1|||
149020837|NCT04707391|537554799|FG000|Overall Study|Adverse Event|5|||
149020838|NCT04707391|537554800|FG001|Overall Study|Adverse Event|8|||
149020839|NCT04707391|537554799|FG000|Overall Study|Lost to Follow-up|44|||
149020840|NCT04707391|537554800|FG001|Overall Study|Lost to Follow-up|31|||
149020841|NCT04707391|537554799|FG000|Overall Study|Protocol Violation|1|||
149020842|NCT04707391|537554800|FG001|Overall Study|Protocol Violation|5|||
149020843|NCT04707391|537554799|FG000|Overall Study|Withdrawal by Subject|27|||
149020844|NCT04707391|537554800|FG001|Overall Study|Withdrawal by Subject|25|||
149020845|NCT04707391|537554799|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
149020846|NCT04707391|537554800|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
149020847|NCT04707391|537554799|FG000|Overall Study|Other|0|||
149020848|NCT04707391|537554800|FG001|Overall Study|Other|2|||
149020849|NCT03246672|537554802|FG000|Overall Study|Lost to Follow-up|2|||
149020850|NCT01932996|537554803|FG000|Overall Study|Protocol Violation|2|||
149020851|NCT01932996|537554804|FG001|Overall Study|Protocol Violation|0|||
149020852|NCT02500316|537554808|FG000|Overall Study|Adverse Event|3|||
149020853|NCT02500316|537554808|FG000|Overall Study|Lost to Follow-up|2|||
149020854|NCT02500316|537554808|FG000|Overall Study|Protocol Violation|1|||
149020855|NCT02500316|537554808|FG000|Overall Study|Withdrawal by Subject|15|||
149020856|NCT02500316|537554808|FG000|Overall Study|Final height achieved|5|||
148955990|NCT05024058|537322819|FG006|Treatment|Study terminated by sponsor|1|||
148955991|NCT05024058|537322820|FG007|Treatment|Study terminated by sponsor|3|||
148955992|NCT05024058|537322821|FG008|Treatment|Study terminated by sponsor|6|||
148955993|NCT05024058|537322822|FG009|Treatment|Study terminated by sponsor|6|||
148955994|NCT05024058|537322813|FG000|Follow-up|Withdrawal by Subject|1|||
148955995|NCT05024058|537322814|FG001|Follow-up|Withdrawal by Subject|0|||
148955996|NCT05024058|537322815|FG002|Follow-up|Withdrawal by Subject|1|||
148955997|NCT05024058|537322816|FG003|Follow-up|Withdrawal by Subject|0|||
148955998|NCT05024058|537322817|FG004|Follow-up|Withdrawal by Subject|0|||
148955999|NCT05024058|537322818|FG005|Follow-up|Withdrawal by Subject|0|||
148956000|NCT05024058|537322819|FG006|Follow-up|Withdrawal by Subject|0|||
148956001|NCT05024058|537322820|FG007|Follow-up|Withdrawal by Subject|1|||
148956002|NCT05024058|537322821|FG008|Follow-up|Withdrawal by Subject|0|||
148956003|NCT05024058|537322822|FG009|Follow-up|Withdrawal by Subject|1|||
148956004|NCT02734810|537322826|FG000|Overall Study|Adverse Event|1|||
148956005|NCT02734810|537322827|FG001|Overall Study|Adverse Event|0|||
148956006|NCT02734810|537322826|FG000|Overall Study|Lack of Efficacy|1|||
148956007|NCT02734810|537322827|FG001|Overall Study|Lack of Efficacy|0|||
148956008|NCT00127712|537322831|FG000|Overall Study|Adverse Event|3|||
148956009|NCT00127712|537322832|FG001|Overall Study|Adverse Event|0|||
148956010|NCT00127712|537322831|FG000|Overall Study|Lack of GI access to continue|2|||
148956011|NCT00127712|537322832|FG001|Overall Study|Lack of GI access to continue|0|||
148956012|NCT03055260|537322833|FG000|Overall Study|Withdrawal by Subject|1|||
148956013|NCT03055260|537322834|FG001|Overall Study|Withdrawal by Subject|0|||
148956014|NCT02507505|537322835|FG000|Overall Study|Withdrawal by Subject|13|||
148956015|NCT02507505|537322836|FG001|Overall Study|Withdrawal by Subject|11|||
148956016|NCT02507505|537322835|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
148956017|NCT02507505|537322836|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
149020857|NCT02500316|537554808|FG000|Overall Study|Due to war activity|1|||
149020858|NCT01406717|537554809|FG000|Overall Study|Subject non-compliance|4|||
149020859|NCT01406717|537554810|FG001|Overall Study|Subject non-compliance|3|||
149020860|NCT01406717|537554809|FG000|Overall Study|Protocol Violation|5|||
149020861|NCT01406717|537554810|FG001|Overall Study|Protocol Violation|1|||
149020862|NCT01406717|537554809|FG000|Overall Study|Lost to Follow-up|14|||
149020863|NCT01406717|537554810|FG001|Overall Study|Lost to Follow-up|8|||
149020864|NCT01406717|537554809|FG000|Overall Study|Withdrawal by Subject|19|||
149020865|NCT01406717|537554810|FG001|Overall Study|Withdrawal by Subject|15|||
149020866|NCT01406717|537554809|FG000|Overall Study|Adverse Event|1|||
149020867|NCT01406717|537554810|FG001|Overall Study|Adverse Event|2|||
149020868|NCT01406717|537554809|FG000|Overall Study|Lack of Efficacy|0|||
149020869|NCT01406717|537554810|FG001|Overall Study|Lack of Efficacy|1|||
149020870|NCT01406717|537554809|FG000|Overall Study|Non-completion of visit activity|0|||
149020871|NCT01406717|537554810|FG001|Overall Study|Non-completion of visit activity|1|||
149020872|NCT03257995|537554811|FG000|Overall Study|Adverse Event|0|||
149020873|NCT03257995|537554812|FG001|Overall Study|Adverse Event|1|||
149020874|NCT03257995|537554813|FG002|Overall Study|Adverse Event|0|||
149020875|NCT03257995|537554814|FG003|Overall Study|Adverse Event|0|||
149020876|NCT03257995|537554815|FG004|Overall Study|Adverse Event|0|||
149020877|NCT03257995|537554816|FG005|Overall Study|Adverse Event|0|||
149020878|NCT03257995|537554811|FG000|Overall Study|Protocol deviation|0|||
149020879|NCT03257995|537554812|FG001|Overall Study|Protocol deviation|0|||
149020880|NCT03257995|537554813|FG002|Overall Study|Protocol deviation|0|||
149020881|NCT03257995|537554814|FG003|Overall Study|Protocol deviation|0|||
149020882|NCT03257995|537554815|FG004|Overall Study|Protocol deviation|0|||
149020883|NCT03257995|537554816|FG005|Overall Study|Protocol deviation|2|||
149020884|NCT02040090|537554817|FG000|Overall Study|Adverse Event|2|||
149020885|NCT02040090|537554818|FG001|Overall Study|Adverse Event|0|||
149020886|NCT02040090|537554817|FG000|Overall Study|Physician Decision|1|||
149020887|NCT02040090|537554818|FG001|Overall Study|Physician Decision|0|||
149020888|NCT02040090|537554817|FG000|Overall Study|Withdrawal by Subject|0|||
149020889|NCT02040090|537554818|FG001|Overall Study|Withdrawal by Subject|1|||
149020890|NCT02040090|537554817|FG000|Overall Study|Lost to Follow-up|0|||
149020891|NCT02040090|537554818|FG001|Overall Study|Lost to Follow-up|1|||
149020892|NCT02584855|537554826|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
149020893|NCT02584855|537554827|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
149020894|NCT02584855|537554828|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
149020895|NCT02584855|537554829|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
149020896|NCT02584855|537554830|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
149020897|NCT02584855|537554831|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
149020898|NCT02584855|537554826|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
149020899|NCT02584855|537554827|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
149020900|NCT02584855|537554828|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
149020901|NCT02584855|537554829|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
149020902|NCT02584855|537554830|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
149020903|NCT02584855|537554831|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
149020904|NCT02584855|537554826|FG000|Open-Label Treatment Period|Adverse Event|14|||
149020905|NCT02584855|537554827|FG001|Open-Label Treatment Period|Adverse Event|0|||
149020906|NCT02584855|537554828|FG002|Open-Label Treatment Period|Adverse Event|0|||
148691424|NCT01325207|536344180|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
148691425|NCT01325207|536344181|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
148691426|NCT01325207|536344176|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
148691427|NCT01325207|536344177|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
148691428|NCT01325207|536344178|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
148956018|NCT02507505|537322835|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
148956019|NCT02507505|537322836|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
148956020|NCT02507505|537322835|FG000|Overall Study|Death before receipt of anesthesia|0|||
148956021|NCT02507505|537322836|FG001|Overall Study|Death before receipt of anesthesia|1|||
148956022|NCT02335489|537322837|FG000|Overall Study|Sponsor terminated study|4|||
148956023|NCT02335489|537322837|FG000|Overall Study|Lost to Follow-up|1|||
148956024|NCT02335489|537322837|FG000|Overall Study|Withdrawal by Subject|2|||
148956025|NCT02335489|537322837|FG000|Overall Study|Physician Decision|2|||
148956026|NCT02335489|537322837|FG000|Overall Study|Lack of Efficacy|1|||
148956027|NCT00531050|537322845|FG000|Part 1: Period 1|Adverse Event|0|||
148956028|NCT00531050|537322846|FG001|Part 1: Period 1|Adverse Event|1|||
148956029|NCT00531050|537322847|FG002|Part 1: Period 1|Adverse Event|0|||
148956030|NCT00531050|537322848|FG003|Part 1: Period 1|Adverse Event|0|||
148956031|NCT00531050|537322849|FG004|Part 1: Period 1|Adverse Event|0|||
148956032|NCT00531050|537322850|FG005|Part 1: Period 1|Adverse Event|0|||
148956033|NCT00531050|537322845|FG000|Part 1: Period 1|Protocol Deviation|0|||
148956034|NCT00531050|537322846|FG001|Part 1: Period 1|Protocol Deviation|0|||
148956035|NCT00531050|537322847|FG002|Part 1: Period 1|Protocol Deviation|0|||
148956036|NCT00531050|537322848|FG003|Part 1: Period 1|Protocol Deviation|1|||
149020907|NCT02584855|537554829|FG003|Open-Label Treatment Period|Adverse Event|0|||
149020908|NCT02584855|537554830|FG004|Open-Label Treatment Period|Adverse Event|0|||
149020909|NCT02584855|537554831|FG005|Open-Label Treatment Period|Adverse Event|0|||
149020910|NCT02584855|537554826|FG000|Open-Label Treatment Period|Death|2|||
149020911|NCT02584855|537554827|FG001|Open-Label Treatment Period|Death|0|||
149020912|NCT02584855|537554828|FG002|Open-Label Treatment Period|Death|0|||
149020913|NCT02584855|537554829|FG003|Open-Label Treatment Period|Death|0|||
149020914|NCT02584855|537554830|FG004|Open-Label Treatment Period|Death|0|||
149020915|NCT02584855|537554831|FG005|Open-Label Treatment Period|Death|0|||
148956037|NCT00531050|537322849|FG004|Part 1: Period 1|Protocol Deviation|0|||
148956038|NCT00531050|537322850|FG005|Part 1: Period 1|Protocol Deviation|0|||
148956039|NCT00531050|537322845|FG000|Part 1: Period 3|Adverse Event|1|||
148956040|NCT00531050|537322846|FG001|Part 1: Period 3|Adverse Event|0|||
148956041|NCT00531050|537322847|FG002|Part 1: Period 3|Adverse Event|0|||
148956042|NCT00531050|537322848|FG003|Part 1: Period 3|Adverse Event|0|||
148956043|NCT00531050|537322849|FG004|Part 1: Period 3|Adverse Event|0|||
148956044|NCT00531050|537322850|FG005|Part 1: Period 3|Adverse Event|0|||
148956045|NCT00531050|537322845|FG000|Part 2: Period 1|Adverse Event|0|||
148956046|NCT00531050|537322846|FG001|Part 2: Period 1|Adverse Event|0|||
148956047|NCT00531050|537322847|FG002|Part 2: Period 1|Adverse Event|0|||
148956048|NCT00531050|537322848|FG003|Part 2: Period 1|Adverse Event|0|||
148956049|NCT00531050|537322849|FG004|Part 2: Period 1|Adverse Event|0|||
148956050|NCT00531050|537322850|FG005|Part 2: Period 1|Adverse Event|1|||
148956051|NCT00531050|537322845|FG000|Part 2: Period 3|Abnormal test procedure|1|||
148956052|NCT00531050|537322846|FG001|Part 2: Period 3|Abnormal test procedure|0|||
148956053|NCT00531050|537322847|FG002|Part 2: Period 3|Abnormal test procedure|0|||
148956054|NCT00531050|537322848|FG003|Part 2: Period 3|Abnormal test procedure|0|||
148956055|NCT00531050|537322849|FG004|Part 2: Period 3|Abnormal test procedure|0|||
148956056|NCT00531050|537322850|FG005|Part 2: Period 3|Abnormal test procedure|1|||
148956057|NCT01034462|537322854|FG000|Overall Study|Adverse Event|7|||
148956058|NCT01034462|537322855|FG001|Overall Study|Adverse Event|17|||
148956059|NCT01034462|537322854|FG000|Overall Study|Lack of Efficacy|4|||
148956060|NCT01034462|537322855|FG001|Overall Study|Lack of Efficacy|4|||
148956061|NCT01034462|537322854|FG000|Overall Study|Protocol Violation|10|||
148956062|NCT01034462|537322855|FG001|Overall Study|Protocol Violation|7|||
149020916|NCT02584855|537554826|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
149020917|NCT02584855|537554827|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
149020918|NCT02584855|537554828|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
149020919|NCT02584855|537554829|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
149020920|NCT02584855|537554830|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
149020921|NCT02584855|537554831|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
149020922|NCT02584855|537554826|FG000|Open-Label Treatment Period|Protocol Violation|1|||
149020923|NCT02584855|537554827|FG001|Open-Label Treatment Period|Protocol Violation|0|||
148691429|NCT01325207|536344179|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
148956063|NCT01034462|537322854|FG000|Overall Study|Withdrawal by Subject|9|||
148956064|NCT01034462|537322855|FG001|Overall Study|Withdrawal by Subject|8|||
148956065|NCT01034462|537322854|FG000|Overall Study|Lost to Follow-up|14|||
148956066|NCT01034462|537322855|FG001|Overall Study|Lost to Follow-up|16|||
148956067|NCT01034462|537322854|FG000|Overall Study|Other reasons|1|||
148956068|NCT01034462|537322855|FG001|Overall Study|Other reasons|2|||
148956069|NCT00227903|537322856|FG000|Overall Study|Withdrawal by Subject|2|||
148956070|NCT00227903|537322857|FG001|Overall Study|Withdrawal by Subject|5|||
148956071|NCT00227903|537322856|FG000|Overall Study|Subject moved out of area|1|||
148956072|NCT00227903|537322857|FG001|Overall Study|Subject moved out of area|2|||
148956073|NCT00227903|537322856|FG000|Overall Study|Lost to Follow-up|1|||
148956074|NCT00227903|537322857|FG001|Overall Study|Lost to Follow-up|3|||
148956075|NCT00227903|537322856|FG000|Overall Study|Miscarriage|1|||
148956076|NCT00227903|537322857|FG001|Overall Study|Miscarriage|0|||
149020924|NCT02584855|537554828|FG002|Open-Label Treatment Period|Protocol Violation|0|||
149020925|NCT02584855|537554829|FG003|Open-Label Treatment Period|Protocol Violation|0|||
149020926|NCT02584855|537554830|FG004|Open-Label Treatment Period|Protocol Violation|0|||
149020927|NCT02584855|537554831|FG005|Open-Label Treatment Period|Protocol Violation|0|||
149020928|NCT02584855|537554826|FG000|Open-Label Treatment Period|No PI Available|2|||
149020929|NCT02584855|537554827|FG001|Open-Label Treatment Period|No PI Available|0|||
149020930|NCT02584855|537554828|FG002|Open-Label Treatment Period|No PI Available|0|||
149020931|NCT02584855|537554829|FG003|Open-Label Treatment Period|No PI Available|0|||
149020932|NCT02584855|537554830|FG004|Open-Label Treatment Period|No PI Available|0|||
149020933|NCT02584855|537554831|FG005|Open-Label Treatment Period|No PI Available|0|||
149020934|NCT02584855|537554826|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
149020935|NCT02584855|537554827|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
149020936|NCT02584855|537554828|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
149020937|NCT02584855|537554829|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
149020938|NCT02584855|537554830|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
149020939|NCT02584855|537554831|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
149020940|NCT02584855|537554826|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
149020941|NCT02584855|537554827|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
149020942|NCT02584855|537554828|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
149020943|NCT02584855|537554829|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
149020944|NCT02584855|537554830|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
149020945|NCT02584855|537554831|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
149020946|NCT02584855|537554826|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
149020947|NCT02584855|537554827|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
149020948|NCT02584855|537554828|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
149020949|NCT02584855|537554829|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
149020950|NCT02584855|537554830|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
149020951|NCT02584855|537554831|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
149020952|NCT02584855|537554826|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
149020953|NCT02584855|537554827|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
149020954|NCT02584855|537554828|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
149020955|NCT02584855|537554829|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
149020956|NCT02584855|537554830|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
149020957|NCT02584855|537554831|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
149020958|NCT02584855|537554826|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
149020959|NCT02584855|537554827|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
149020960|NCT02584855|537554828|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
149020961|NCT02584855|537554829|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
149020962|NCT02584855|537554830|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
149020963|NCT02584855|537554831|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
149020964|NCT02584855|537554826|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
149020965|NCT02584855|537554827|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
149020966|NCT02584855|537554828|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
149020967|NCT02584855|537554829|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
149020968|NCT02584855|537554830|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
149020969|NCT02584855|537554831|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
149020970|NCT02584855|537554826|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
149020971|NCT02584855|537554827|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
149020972|NCT02584855|537554828|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
149020973|NCT02584855|537554829|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
149020974|NCT02584855|537554830|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
149020975|NCT02584855|537554831|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
149020976|NCT02337478|537554832|FG000|Overall Study|Lack of Efficacy|5|||
149020977|NCT00895843|537554833|FG000|Overall Study|Protocol Violation|12|||
149020978|NCT00895843|537554834|FG001|Overall Study|Protocol Violation|12|||
149020979|NCT02906202|537554839|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
149020980|NCT04131907|537554841|FG000|Overall Study|Adverse Event|2|||
149020981|NCT04131907|537554842|FG001|Overall Study|Adverse Event|0|||
149020982|NCT04131907|537554843|FG002|Overall Study|Adverse Event|0|||
149020983|NCT04131907|537554841|FG000|Overall Study|Physician Decision|4|||
149020984|NCT04131907|537554842|FG001|Overall Study|Physician Decision|22|||
149020985|NCT04131907|537554843|FG002|Overall Study|Physician Decision|0|||
149020986|NCT04131907|537554841|FG000|Overall Study|Withdrawal by Subject|2|||
149020987|NCT04131907|537554842|FG001|Overall Study|Withdrawal by Subject|0|||
149020988|NCT04131907|537554843|FG002|Overall Study|Withdrawal by Subject|1|||
149020989|NCT04131907|537554841|FG000|Overall Study|Treatment failure|2|||
149020990|NCT04131907|537554842|FG001|Overall Study|Treatment failure|0|||
149020991|NCT04131907|537554843|FG002|Overall Study|Treatment failure|1|||
149020992|NCT03428815|537554846|FG000|Overall Study|Lost to Follow-up|2|||
149020993|NCT03428815|537554847|FG001|Overall Study|Lost to Follow-up|2|||
149020994|NCT03428815|537554846|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
149020995|NCT03428815|537554847|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
149020996|NCT03428815|537554846|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
149020997|NCT03428815|537554847|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
149020998|NCT02404493|537554848|FG000|Overall Study|Adverse Event|1|||
149020999|NCT02404493|537554849|FG001|Overall Study|Adverse Event|1|||
149021000|NCT01700348|537554850|FG000|Overall Study|Withdrawal by Subject|22|||
149021001|NCT01700348|537554850|FG000|Overall Study|Lost to Follow-up|1|||
149021014|NCT03958630|537554859|FG000|Overall Study|Withdrawal by Subject|0|||
149021015|NCT03958630|537554860|FG001|Overall Study|Withdrawal by Subject|0|||
149021016|NCT03958630|537554861|FG002|Overall Study|Withdrawal by Subject|1|||
149021017|NCT03958630|537554859|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
149021018|NCT03958630|537554860|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
149021019|NCT03958630|537554861|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
149021020|NCT04157686|537554864|FG000|Overall Study|Adverse Event|1|||
149021021|NCT04157686|537554865|FG001|Overall Study|Adverse Event|0|||
149021022|NCT04157686|537554866|FG002|Overall Study|Adverse Event|1|||
149021023|NCT04157686|537554867|FG003|Overall Study|Adverse Event|0|||
149021024|NCT04157686|537554868|FG004|Overall Study|Adverse Event|1|||
149021025|NCT04157686|537554869|FG005|Overall Study|Adverse Event|0|||
149021026|NCT04157686|537554870|FG006|Overall Study|Adverse Event|0|||
149021027|NCT04157686|537554871|FG007|Overall Study|Adverse Event|0|||
149021028|NCT04157686|537554864|FG000|Overall Study|Pregnancy|0|||
149021029|NCT04157686|537554865|FG001|Overall Study|Pregnancy|1|||
149021030|NCT04157686|537554866|FG002|Overall Study|Pregnancy|3|||
149021031|NCT04157686|537554867|FG003|Overall Study|Pregnancy|0|||
149021032|NCT04157686|537554868|FG004|Overall Study|Pregnancy|0|||
149021033|NCT04157686|537554869|FG005|Overall Study|Pregnancy|0|||
149021034|NCT04157686|537554870|FG006|Overall Study|Pregnancy|3|||
149021035|NCT04157686|537554871|FG007|Overall Study|Pregnancy|0|||
149021036|NCT04157686|537554864|FG000|Overall Study|Lost to Follow-up|1|||
149021037|NCT04157686|537554865|FG001|Overall Study|Lost to Follow-up|2|||
149021038|NCT04157686|537554866|FG002|Overall Study|Lost to Follow-up|8|||
149021039|NCT04157686|537554867|FG003|Overall Study|Lost to Follow-up|6|||
149021040|NCT04157686|537554868|FG004|Overall Study|Lost to Follow-up|6|||
149021041|NCT04157686|537554869|FG005|Overall Study|Lost to Follow-up|3|||
149021042|NCT04157686|537554870|FG006|Overall Study|Lost to Follow-up|7|||
149021043|NCT04157686|537554871|FG007|Overall Study|Lost to Follow-up|9|||
149021044|NCT04157686|537554864|FG000|Overall Study|Lack of Efficacy|0|||
149021045|NCT04157686|537554865|FG001|Overall Study|Lack of Efficacy|0|||
149021046|NCT04157686|537554866|FG002|Overall Study|Lack of Efficacy|0|||
149021047|NCT04157686|537554867|FG003|Overall Study|Lack of Efficacy|0|||
148811164|NCT04809974|536787019|FG000|Lead-in Phase|Withdrawal by Subject|3|||
148956077|NCT04273217|537322858|FG000|Overall Study|Lost to Follow-up|0|||
148956078|NCT04273217|537322859|FG001|Overall Study|Lost to Follow-up|0|||
148956079|NCT04273217|537322860|FG002|Overall Study|Lost to Follow-up|0|||
148956080|NCT04273217|537322861|FG003|Overall Study|Lost to Follow-up|0|||
148956081|NCT04273217|537322862|FG004|Overall Study|Lost to Follow-up|0|||
148956082|NCT04273217|537322863|FG005|Overall Study|Lost to Follow-up|1|||
148956083|NCT04273217|537322858|FG000|Overall Study|Participant non-compliance|0|||
148956084|NCT04273217|537322859|FG001|Overall Study|Participant non-compliance|0|||
148956085|NCT04273217|537322860|FG002|Overall Study|Participant non-compliance|0|||
148956086|NCT04273217|537322861|FG003|Overall Study|Participant non-compliance|0|||
148956087|NCT04273217|537322862|FG004|Overall Study|Participant non-compliance|1|||
148956088|NCT04273217|537322863|FG005|Overall Study|Participant non-compliance|0|||
148956089|NCT04273217|537322858|FG000|Overall Study|Positive urine drug screen|1|||
148956090|NCT04273217|537322859|FG001|Overall Study|Positive urine drug screen|0|||
148956091|NCT04273217|537322860|FG002|Overall Study|Positive urine drug screen|1|||
149021048|NCT04157686|537554868|FG004|Overall Study|Lack of Efficacy|0|||
149021049|NCT04157686|537554869|FG005|Overall Study|Lack of Efficacy|2|||
149021050|NCT04157686|537554870|FG006|Overall Study|Lack of Efficacy|0|||
149021051|NCT04157686|537554871|FG007|Overall Study|Lack of Efficacy|1|||
149021052|NCT04157686|537554864|FG000|Overall Study|Withdrawal by Subject|10|||
149021053|NCT04157686|537554865|FG001|Overall Study|Withdrawal by Subject|10|||
149021054|NCT04157686|537554866|FG002|Overall Study|Withdrawal by Subject|12|||
149021055|NCT04157686|537554867|FG003|Overall Study|Withdrawal by Subject|20|||
148956092|NCT04273217|537322861|FG003|Overall Study|Positive urine drug screen|0|||
148956093|NCT04273217|537322862|FG004|Overall Study|Positive urine drug screen|0|||
148956094|NCT04273217|537322863|FG005|Overall Study|Positive urine drug screen|1|||
148956095|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
148956096|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
148956097|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
148956098|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
148956099|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
148956100|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
148956101|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
148956102|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
148956103|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
148956104|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
148956105|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
148956106|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
148956107|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
148956108|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
148956109|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
148956110|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
148956111|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
148956112|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
148956113|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
148956114|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
148956115|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
148956116|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
148956117|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
148956118|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
148956119|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
148956120|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
148956121|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
148956122|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
148956123|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
148956124|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
148956125|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
148956126|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
148956127|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
148956128|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
148956129|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
148956130|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
148956131|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
148956132|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
148956133|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
148956134|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
148956135|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
148956136|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
148956137|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
148956138|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
148956139|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
148956140|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
148956141|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
148956142|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
148956143|NCT03720470|537322866|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
148956144|NCT03720470|537322867|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
148956145|NCT03720470|537322868|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
148956146|NCT03720470|537322869|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
148956147|NCT03720470|537322870|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
148956148|NCT03720470|537322871|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
148956149|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
148956150|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
148956151|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
148956152|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
148956153|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
148956154|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
148956155|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
148956156|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
148956157|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
148956158|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
148956159|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
148956160|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
148956161|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
148956162|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
148956163|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
148956164|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
148956165|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
148956166|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
148956167|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
148956168|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
148956169|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
148956170|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
148956171|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
148956172|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
148956173|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
148956174|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
148956175|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
148956176|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
148956177|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
148956178|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
148956179|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
148956180|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
148956181|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
148956182|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
148956183|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
148956184|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
148956185|NCT03720470|537322866|FG000|Treatment Period: Final 4 Weeks|Other|0|||
148956186|NCT03720470|537322867|FG001|Treatment Period: Final 4 Weeks|Other|1|||
148956187|NCT03720470|537322868|FG002|Treatment Period: Final 4 Weeks|Other|0|||
148956188|NCT03720470|537322869|FG003|Treatment Period: Final 4 Weeks|Other|2|||
148956189|NCT03720470|537322870|FG004|Treatment Period: Final 4 Weeks|Other|1|||
148956190|NCT03720470|537322871|FG005|Treatment Period: Final 4 Weeks|Other|0|||
148956191|NCT02056340|537322875|FG000|Overall Study|Lost to Follow-up|5|||
148956192|NCT02056340|537322876|FG001|Overall Study|Lost to Follow-up|5|||
148956193|NCT02056340|537322875|FG000|Overall Study|Withdrawal by Subject|2|||
148956194|NCT02056340|537322876|FG001|Overall Study|Withdrawal by Subject|6|||
148956195|NCT01414855|537322879|FG000|Overall Study|Death|17|||
148956196|NCT01414855|537322879|FG000|Overall Study|Lost to Follow-up|5|||
148956197|NCT01414855|537322879|FG000|Overall Study|Withdrawal by Subject|7|||
148956198|NCT04851314|537322880|FG000|Overall Study|Unable to complete research set-up procedures|0|||
148956199|NCT04851314|537322881|FG001|Overall Study|Unable to complete research set-up procedures|2|||
148956200|NCT04851314|537322880|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
148956201|NCT04851314|537322881|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
148956202|NCT00867009|537322882|FG000|Induction Period|Nonserious Adverse Event|5|||
148956203|NCT00867009|537322882|FG000|Induction Period|Serious Adverse Event|10|||
148956204|NCT00867009|537322882|FG000|Induction Period|Death due to serious adverse event|6|||
148956205|NCT00867009|537322882|FG000|Induction Period|Death due to Study Disease|4|||
148956206|NCT00867009|537322882|FG000|Induction Period|Protocol Violation|1|||
148956207|NCT00867009|537322882|FG000|Induction Period|Withdrawal by Subject|8|||
148956208|NCT00867009|537322882|FG000|Induction Period|Physician Decision|3|||
148956209|NCT00867009|537322882|FG000|Induction Period|Progressive Disease (PD)|25|||
148956210|NCT00867009|537322882|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
148956211|NCT03266094|537322885|FG000|Overall Study|Lost to Follow-up|1|||
148956212|NCT03266094|537322885|FG000|Overall Study|Withdrawal by Subject|1|||
148956213|NCT03128892|537322886|FG000|Overall Study|Withdrawal by Subject|2|||
148956214|NCT03128892|537322886|FG000|Overall Study|Physician Decision|1|||
148956215|NCT00459667|537322889|FG000|Overall Study|Adverse Event|9|||
148956216|NCT00459667|537322890|FG001|Overall Study|Adverse Event|12|||
148956217|NCT00459667|537322891|FG002|Overall Study|Adverse Event|8|||
148956218|NCT00459667|537322889|FG000|Overall Study|Lost to Follow-up|5|||
148956219|NCT00459667|537322890|FG001|Overall Study|Lost to Follow-up|9|||
148956220|NCT00459667|537322891|FG002|Overall Study|Lost to Follow-up|3|||
148956221|NCT00459667|537322889|FG000|Overall Study|Pregnancy|1|||
148956222|NCT00459667|537322890|FG001|Overall Study|Pregnancy|1|||
148956223|NCT00459667|537322891|FG002|Overall Study|Pregnancy|1|||
148956224|NCT00459667|537322889|FG000|Overall Study|Protocol Violation|1|||
148956225|NCT00459667|537322890|FG001|Overall Study|Protocol Violation|0|||
148956226|NCT00459667|537322891|FG002|Overall Study|Protocol Violation|0|||
148956227|NCT00459667|537322889|FG000|Overall Study|Withdrawal by Subject|3|||
148956228|NCT00459667|537322890|FG001|Overall Study|Withdrawal by Subject|5|||
148956229|NCT00459667|537322891|FG002|Overall Study|Withdrawal by Subject|5|||
148956230|NCT00459667|537322889|FG000|Overall Study|Other disease modifying treatment|1|||
148956231|NCT00459667|537322890|FG001|Overall Study|Other disease modifying treatment|2|||
148956232|NCT00459667|537322891|FG002|Overall Study|Other disease modifying treatment|1|||
148956233|NCT00459667|537322889|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
148956234|NCT00459667|537322890|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
148956235|NCT00459667|537322891|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
148956236|NCT00459667|537322889|FG000|Overall Study|No treatment administered|6|||
148691430|NCT01325207|536344180|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
148956237|NCT00459667|537322890|FG001|Overall Study|No treatment administered|3|||
148956238|NCT00459667|537322891|FG002|Overall Study|No treatment administered|1|||
148956239|NCT00396591|537322892|FG000|Overall Study|Disease Progression|13|||
148956240|NCT00396591|537322892|FG000|Overall Study|Adverse Event|2|||
148956241|NCT00396591|537322892|FG000|Overall Study|Participant request|1|||
148956242|NCT00847704|537322895|FG000|Overall Study|Withdrawal by Subject|1|||
148956243|NCT01905657|537322896|FG000|Overall Study|Adverse Event|23|||
148956244|NCT01905657|537322897|FG001|Overall Study|Adverse Event|17|||
148956245|NCT01905657|537322898|FG002|Overall Study|Adverse Event|18|||
148956246|NCT01905657|537322896|FG000|Overall Study|Clinical Progression|103|||
148956247|NCT01905657|537322897|FG001|Overall Study|Clinical Progression|78|||
148956248|NCT01905657|537322898|FG002|Overall Study|Clinical Progression|59|||
148956249|NCT01905657|537322896|FG000|Overall Study|Death|40|||
148956250|NCT01905657|537322897|FG001|Overall Study|Death|43|||
148956251|NCT01905657|537322898|FG002|Overall Study|Death|47|||
148956252|NCT01905657|537322896|FG000|Overall Study|Excluded Medication|13|||
148956253|NCT01905657|537322897|FG001|Overall Study|Excluded Medication|16|||
148956254|NCT01905657|537322898|FG002|Overall Study|Excluded Medication|9|||
148956255|NCT01905657|537322896|FG000|Overall Study|Lost to Follow-up|1|||
148956256|NCT01905657|537322897|FG001|Overall Study|Lost to Follow-up|2|||
148956257|NCT01905657|537322898|FG002|Overall Study|Lost to Follow-up|1|||
148956258|NCT01905657|537322896|FG000|Overall Study|Physician Decision|5|||
148956259|NCT01905657|537322897|FG001|Overall Study|Physician Decision|8|||
148956260|NCT01905657|537322898|FG002|Overall Study|Physician Decision|12|||
148956261|NCT01905657|537322896|FG000|Overall Study|Protocol Violation|2|||
148956262|NCT01905657|537322897|FG001|Overall Study|Protocol Violation|1|||
148956263|NCT01905657|537322898|FG002|Overall Study|Protocol Violation|1|||
148956264|NCT01905657|537322896|FG000|Overall Study|Screen Failure|0|||
148956265|NCT01905657|537322897|FG001|Overall Study|Screen Failure|1|||
148956266|NCT01905657|537322898|FG002|Overall Study|Screen Failure|0|||
148956267|NCT01905657|537322896|FG000|Overall Study|Withdrawal by Subject|15|||
148956268|NCT01905657|537322897|FG001|Overall Study|Withdrawal by Subject|21|||
148956269|NCT01905657|537322898|FG002|Overall Study|Withdrawal by Subject|53|||
148956270|NCT01905657|537322896|FG000|Overall Study|Sponsor Decision|1|||
148956271|NCT01905657|537322897|FG001|Overall Study|Sponsor Decision|0|||
148956272|NCT01905657|537322898|FG002|Overall Study|Sponsor Decision|0|||
148956273|NCT04080297|537322900|FG000|Overall Study|Adverse Event|1|||
148956274|NCT04080297|537322901|FG001|Overall Study|Adverse Event|3|||
148956275|NCT04080297|537322900|FG000|Overall Study|concurrent illness|1|||
148956276|NCT04080297|537322901|FG001|Overall Study|concurrent illness|0|||
148956277|NCT02744391|537322902|FG000|Overall Study|Lost to Follow-up|9|||
148956278|NCT02744391|537322902|FG000|Overall Study|Physician Decision|2|||
148956279|NCT02744391|537322902|FG000|Overall Study|Withdrawal by Subject|3|||
148956280|NCT04484142|537322907|FG000|Overall Study|Adverse Event|13|||
148956281|NCT04484142|537322907|FG000|Overall Study|Progressive Disease|87|||
148956282|NCT04484142|537322907|FG000|Overall Study|Clinical Progression|10|||
148956283|NCT04484142|537322907|FG000|Overall Study|Withdrawal by Subject|6|||
148956284|NCT04484142|537322907|FG000|Overall Study|Physician Decision|1|||
148956285|NCT03851302|537322908|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
148956286|NCT03851302|537322909|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
148956287|NCT03851302|537322910|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
148956288|NCT03851302|537322911|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
148956289|NCT03851302|537322912|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
148956290|NCT03851302|537322913|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
148956291|NCT03851302|537322908|FG000|Screening (1 Day)|Screened out|0|||
148956292|NCT03851302|537322909|FG001|Screening (1 Day)|Screened out|0|||
148956293|NCT03851302|537322910|FG002|Screening (1 Day)|Screened out|1|||
148956294|NCT03851302|537322911|FG003|Screening (1 Day)|Screened out|1|||
148956295|NCT03851302|537322912|FG004|Screening (1 Day)|Screened out|0|||
148956296|NCT03851302|537322913|FG005|Screening (1 Day)|Screened out|0|||
148956297|NCT03851302|537322908|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
148956298|NCT03851302|537322909|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
148956299|NCT03851302|537322910|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
148691431|NCT01325207|536344181|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
148956300|NCT03851302|537322911|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
148956301|NCT03851302|537322912|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
148956302|NCT03851302|537322913|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
148956303|NCT04434092|537322914|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
149021056|NCT04157686|537554868|FG004|Overall Study|Withdrawal by Subject|12|||
149021057|NCT04157686|537554869|FG005|Overall Study|Withdrawal by Subject|11|||
149021058|NCT04157686|537554870|FG006|Overall Study|Withdrawal by Subject|18|||
149021059|NCT04157686|537554871|FG007|Overall Study|Withdrawal by Subject|24|||
149021060|NCT04157686|537554864|FG000|Overall Study|Physician Decision|0|||
149021061|NCT04157686|537554865|FG001|Overall Study|Physician Decision|0|||
149021062|NCT04157686|537554866|FG002|Overall Study|Physician Decision|1|||
149021063|NCT04157686|537554867|FG003|Overall Study|Physician Decision|0|||
149021064|NCT04157686|537554868|FG004|Overall Study|Physician Decision|1|||
149021065|NCT04157686|537554869|FG005|Overall Study|Physician Decision|0|||
149021066|NCT04157686|537554870|FG006|Overall Study|Physician Decision|3|||
149021067|NCT04157686|537554871|FG007|Overall Study|Physician Decision|0|||
149021068|NCT04157686|537554864|FG000|Overall Study|Death|0|||
149021069|NCT04157686|537554865|FG001|Overall Study|Death|0|||
149021070|NCT04157686|537554866|FG002|Overall Study|Death|0|||
149021071|NCT04157686|537554867|FG003|Overall Study|Death|2|||
149021072|NCT04157686|537554868|FG004|Overall Study|Death|0|||
149021073|NCT04157686|537554869|FG005|Overall Study|Death|0|||
149021074|NCT04157686|537554870|FG006|Overall Study|Death|0|||
149021075|NCT04157686|537554871|FG007|Overall Study|Death|0|||
149021076|NCT04157686|537554864|FG000|Overall Study|Protocol Violation|0|||
149021077|NCT04157686|537554865|FG001|Overall Study|Protocol Violation|0|||
149021078|NCT04157686|537554866|FG002|Overall Study|Protocol Violation|0|||
149021079|NCT04157686|537554867|FG003|Overall Study|Protocol Violation|0|||
149021080|NCT04157686|537554868|FG004|Overall Study|Protocol Violation|1|||
148691432|NCT01325207|536344176|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
148691433|NCT01325207|536344177|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
148956304|NCT04434092|537322915|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
148956305|NCT04434092|537322916|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
148956306|NCT04434092|537322914|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
148956307|NCT04434092|537322915|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
148956308|NCT04434092|537322916|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
148956309|NCT04434092|537322914|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
148956310|NCT04434092|537322915|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
148956311|NCT04434092|537322916|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
148956312|NCT04434092|537322914|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
148956313|NCT04434092|537322915|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
148956314|NCT04434092|537322916|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
148956315|NCT04434092|537322914|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
148956316|NCT04434092|537322915|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
148956317|NCT04434092|537322916|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
148956318|NCT04434092|537322914|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
148956319|NCT04434092|537322915|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
148956320|NCT04434092|537322916|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
148956321|NCT04434092|537322914|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
148956322|NCT04434092|537322915|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
148956323|NCT04434092|537322916|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
148956324|NCT00254540|537324403|FG000|Overall Study|Adverse Event|6|||
148956325|NCT00254540|537324404|FG001|Overall Study|Adverse Event|7|||
148956326|NCT00254540|537324403|FG000|Overall Study|Lack of Efficacy|13|||
148956327|NCT00254540|537324404|FG001|Overall Study|Lack of Efficacy|13|||
148956328|NCT00254540|537324403|FG000|Overall Study|Death|0|||
148956329|NCT00254540|537324404|FG001|Overall Study|Death|1|||
148956330|NCT00254540|537324403|FG000|Overall Study|Laboratory Test Abnormality|0|||
148956331|NCT00254540|537324404|FG001|Overall Study|Laboratory Test Abnormality|1|||
148956332|NCT01287897|537324405|FG000|Overall Study|Adverse Event|5|||
148956333|NCT01287897|537324406|FG001|Overall Study|Adverse Event|3|||
148956334|NCT01287897|537324407|FG002|Overall Study|Adverse Event|6|||
148956335|NCT01287897|537324408|FG003|Overall Study|Adverse Event|4|||
148956336|NCT01287897|537324405|FG000|Overall Study|Lack of Efficacy|2|||
148956337|NCT01287897|537324406|FG001|Overall Study|Lack of Efficacy|0|||
148956338|NCT01287897|537324407|FG002|Overall Study|Lack of Efficacy|0|||
148956339|NCT01287897|537324408|FG003|Overall Study|Lack of Efficacy|0|||
148956340|NCT01287897|537324405|FG000|Overall Study|Protocol Violation|1|||
148956341|NCT01287897|537324406|FG001|Overall Study|Protocol Violation|1|||
148956342|NCT01287897|537324407|FG002|Overall Study|Protocol Violation|0|||
148956343|NCT01287897|537324408|FG003|Overall Study|Protocol Violation|1|||
148956344|NCT01287897|537324405|FG000|Overall Study|Lost to Follow-up|0|||
148956345|NCT01287897|537324406|FG001|Overall Study|Lost to Follow-up|0|||
149021081|NCT04157686|537554869|FG005|Overall Study|Protocol Violation|0|||
149021082|NCT04157686|537554870|FG006|Overall Study|Protocol Violation|0|||
149021083|NCT04157686|537554871|FG007|Overall Study|Protocol Violation|0|||
149021084|NCT04157686|537554864|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
148956346|NCT01287897|537324407|FG002|Overall Study|Lost to Follow-up|2|||
149021085|NCT04157686|537554865|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
149021086|NCT04157686|537554866|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
149021087|NCT04157686|537554867|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
149021088|NCT04157686|537554868|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
149021089|NCT04157686|537554869|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
149021090|NCT04157686|537554870|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
149021091|NCT04157686|537554871|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
149021092|NCT03038672|537557179|FG000|Initial Treatment|Unacceptable chemistry|0|||
149021093|NCT03038672|537557180|FG001|Initial Treatment|Unacceptable chemistry|1|||
149021094|NCT03038672|537557179|FG000|Initial Treatment|Progression prior to treatment|1|||
148956347|NCT01287897|537324408|FG003|Overall Study|Lost to Follow-up|0|||
148956348|NCT01287897|537324405|FG000|Overall Study|Withdrawal by Subject|1|||
148956349|NCT01287897|537324406|FG001|Overall Study|Withdrawal by Subject|5|||
148956350|NCT01287897|537324407|FG002|Overall Study|Withdrawal by Subject|3|||
148956351|NCT01287897|537324408|FG003|Overall Study|Withdrawal by Subject|2|||
148956352|NCT01287897|537324405|FG000|Overall Study|Not consented properly|0|||
148956353|NCT01287897|537324406|FG001|Overall Study|Not consented properly|1|||
148956354|NCT01287897|537324407|FG002|Overall Study|Not consented properly|0|||
148956355|NCT01287897|537324408|FG003|Overall Study|Not consented properly|0|||
148956356|NCT01287897|537324405|FG000|Overall Study|Not meeting entrance criteria|1|||
148956357|NCT01287897|537324406|FG001|Overall Study|Not meeting entrance criteria|1|||
148956358|NCT01287897|537324407|FG002|Overall Study|Not meeting entrance criteria|0|||
148956359|NCT01287897|537324408|FG003|Overall Study|Not meeting entrance criteria|0|||
148956360|NCT01287897|537324405|FG000|Overall Study|Other|1|||
148956361|NCT01287897|537324406|FG001|Overall Study|Other|0|||
148956362|NCT01287897|537324407|FG002|Overall Study|Other|1|||
148956363|NCT01287897|537324408|FG003|Overall Study|Other|0|||
148956364|NCT02902965|537324409|FG000|Overall Study|Withdrawal by Subject|10|||
148956365|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
148956366|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
148956367|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
148956368|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
148956369|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
148956370|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
148956371|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
148956372|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
148956373|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
148956374|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
148956375|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
148956376|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
148956377|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
148956378|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
148956379|NCT00293254|537324410|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
148956380|NCT00293254|537324411|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
148956381|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
148956382|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
148956383|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Death|4|||
148956384|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Death|1|||
148956385|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
148956386|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
148956387|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
148956388|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
148956389|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
148956390|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
148956391|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
148956392|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
148956393|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
148956394|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
148956395|NCT00293254|537324410|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
148956396|NCT00293254|537324411|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
148956397|NCT00293254|537324410|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
148956398|NCT00293254|537324411|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
149021095|NCT03038672|537557180|FG001|Initial Treatment|Progression prior to treatment|0|||
149021096|NCT03038672|537557179|FG000|Initial Treatment|No treatment per protocol|1|||
149021097|NCT03038672|537557180|FG001|Initial Treatment|No treatment per protocol|0|||
149021098|NCT04423393|537557181|FG000|Overall Study|Withdrawal by Subject|0|||
149021099|NCT04423393|537557182|FG001|Overall Study|Withdrawal by Subject|0|||
148956399|NCT00293254|537324410|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
148956400|NCT00293254|537324411|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
149021137|NCT05220501|537557199|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
149021138|NCT05220501|537557200|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
149021139|NCT05220501|537557201|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
149021140|NCT02692235|537557202|FG000|Overall Study|Withdrawal by Subject|2|||
149021141|NCT02692235|537557203|FG001|Overall Study|Withdrawal by Subject|1|||
149021142|NCT02692235|537557202|FG000|Overall Study|Adverse Event|1|||
149021143|NCT02692235|537557203|FG001|Overall Study|Adverse Event|2|||
149021144|NCT01929993|537557205|FG000|Overall Study|Protocol Violation|4|||
149021145|NCT01929993|537557206|FG001|Overall Study|Protocol Violation|6|||
149021146|NCT01929993|537557205|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
149021147|NCT01929993|537557206|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
149021148|NCT00107380|537557207|FG000|Overall Study|Adverse Event|7|||
149021149|NCT00107380|537557207|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
149021150|NCT00107380|537557207|FG000|Overall Study|Progression/relapse|4|||
149021151|NCT00107380|537557207|FG000|Overall Study|Death|3|||
149021152|NCT00107380|537557207|FG000|Overall Study|Other - not protocol specified|7|||
149021153|NCT00107380|537557207|FG000|Overall Study|Ineligible|2|||
149021154|NCT03673098|537557208|FG000|Overall Study|Lost to Follow-up|2|||
149021155|NCT03673098|537557209|FG001|Overall Study|Lost to Follow-up|3|||
149021156|NCT03673098|537557208|FG000|Overall Study|Withdrawal by Subject|6|||
149021157|NCT03673098|537557209|FG001|Overall Study|Withdrawal by Subject|1|||
149021158|NCT03673098|537557208|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
149021159|NCT03673098|537557209|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
149021160|NCT01268059|537557210|FG000|Overall Study|Lost to Follow-up|0|||
149021161|NCT01268059|537557211|FG001|Overall Study|Lost to Follow-up|1|||
149021162|NCT01268059|537557212|FG002|Overall Study|Lost to Follow-up|0|||
149021163|NCT01268059|537557213|FG003|Overall Study|Lost to Follow-up|0|||
149021164|NCT01268059|537557210|FG000|Overall Study|Withdrawal by Subject|7|||
149021165|NCT01268059|537557211|FG001|Overall Study|Withdrawal by Subject|4|||
149021166|NCT01268059|537557212|FG002|Overall Study|Withdrawal by Subject|0|||
149021167|NCT01268059|537557213|FG003|Overall Study|Withdrawal by Subject|0|||
149021168|NCT01268059|537557210|FG000|Overall Study|Death|20|||
149021169|NCT01268059|537557211|FG001|Overall Study|Death|30|||
149021170|NCT01268059|537557212|FG002|Overall Study|Death|3|||
149021171|NCT01268059|537557213|FG003|Overall Study|Death|5|||
149021172|NCT01268059|537557210|FG000|Overall Study|Progression of disease|1|||
149021173|NCT01268059|537557211|FG001|Overall Study|Progression of disease|0|||
149021174|NCT01268059|537557212|FG002|Overall Study|Progression of disease|0|||
149021175|NCT01268059|537557213|FG003|Overall Study|Progression of disease|0|||
149021176|NCT03660943|537557214|FG000|Overall Study|Adverse Event|5|||
149021177|NCT03660943|537557215|FG001|Overall Study|Adverse Event|3|||
149021178|NCT03660943|537557214|FG000|Overall Study|Death|0|||
149021179|NCT03660943|537557215|FG001|Overall Study|Death|2|||
149021180|NCT03660943|537557214|FG000|Overall Study|Lost to Follow-up|7|||
149021181|NCT03660943|537557215|FG001|Overall Study|Lost to Follow-up|3|||
149021182|NCT03660943|537557214|FG000|Overall Study|Protocol Violation|3|||
149021183|NCT03660943|537557215|FG001|Overall Study|Protocol Violation|5|||
149021184|NCT03660943|537557214|FG000|Overall Study|Withdrawal by Subject|8|||
149021185|NCT03660943|537557215|FG001|Overall Study|Withdrawal by Subject|15|||
149021186|NCT03660943|537557214|FG000|Overall Study|Lack of Efficacy|9|||
149021187|NCT03660943|537557215|FG001|Overall Study|Lack of Efficacy|12|||
149021188|NCT03660943|537557214|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
149021189|NCT03660943|537557215|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
149021190|NCT03850444|537557216|FG000|Overall Study|Adverse Event|16|||
149021191|NCT03850444|537557217|FG001|Overall Study|Adverse Event|10|||
149021192|NCT03850444|537557216|FG000|Overall Study|Death|87|||
149021193|NCT03850444|537557217|FG001|Overall Study|Death|107|||
149021194|NCT03850444|537557216|FG000|Overall Study|Lost to Follow-up|1|||
149021195|NCT03850444|537557217|FG001|Overall Study|Lost to Follow-up|1|||
149021196|NCT03850444|537557216|FG000|Overall Study|Withdrawal by Subject|1|||
149021197|NCT03850444|537557217|FG001|Overall Study|Withdrawal by Subject|5|||
149021198|NCT03850444|537557216|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
149021199|NCT03850444|537557217|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
149021200|NCT01021878|537557218|FG000|Overall Study|Lost to Follow-up|4|||
149021201|NCT01021878|537557219|FG001|Overall Study|Lost to Follow-up|3|||
149021202|NCT01021878|537557218|FG000|Overall Study|Death|0|||
149021203|NCT01021878|537557219|FG001|Overall Study|Death|1|||
149021204|NCT01021878|537557218|FG000|Overall Study|Adverse Event|6|||
149021205|NCT01021878|537557219|FG001|Overall Study|Adverse Event|5|||
149021206|NCT01021878|537557218|FG000|Overall Study|Transplantation|6|||
149021207|NCT01021878|537557219|FG001|Overall Study|Transplantation|1|||
149021208|NCT01155726|537557220|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
149021209|NCT01155726|537557221|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
149021210|NCT01155726|537557222|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
149021211|NCT01155726|537557223|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
149021212|NCT05305040|537557224|FG000|Overall Study|Not Dosed|37|||
149021213|NCT05305040|537557225|FG001|Overall Study|Not Dosed|37|||
149021214|NCT05305040|537557224|FG000|Overall Study|Study Closure|34|||
149021215|NCT05305040|537557225|FG001|Overall Study|Study Closure|46|||
149021216|NCT05305040|537557224|FG000|Overall Study|Death|14|||
149021217|NCT05305040|537557225|FG001|Overall Study|Death|13|||
149021218|NCT05305040|537557224|FG000|Overall Study|Withdrawal by Subject|15|||
149021219|NCT05305040|537557225|FG001|Overall Study|Withdrawal by Subject|10|||
149021220|NCT05305040|537557224|FG000|Overall Study|Other|13|||
149021221|NCT05305040|537557225|FG001|Overall Study|Other|10|||
149021222|NCT05305040|537557224|FG000|Overall Study|Primary Malignancy Relapse|3|||
149021223|NCT05305040|537557225|FG001|Overall Study|Primary Malignancy Relapse|4|||
149021224|NCT05305040|537557224|FG000|Overall Study|Adverse Event|3|||
149021225|NCT05305040|537557225|FG001|Overall Study|Adverse Event|3|||
149021226|NCT05305040|537557224|FG000|Overall Study|Lost to Follow-up|2|||
149021227|NCT05305040|537557225|FG001|Overall Study|Lost to Follow-up|1|||
149021228|NCT05305040|537557224|FG000|Overall Study|Graft versus host disease|2|||
149021229|NCT05305040|537557225|FG001|Overall Study|Graft versus host disease|0|||
149021230|NCT05305040|537557224|FG000|Overall Study|Investigator's Decision|1|||
149021231|NCT05305040|537557225|FG001|Overall Study|Investigator's Decision|1|||
149021232|NCT05305040|537557224|FG000|Overall Study|COVID-19 Reasons|1|||
149021233|NCT05305040|537557225|FG001|Overall Study|COVID-19 Reasons|0|||
149021234|NCT01195675|537557229|FG000|Overall Study|Adverse Event|1|||
149021235|NCT01195675|537557229|FG000|Overall Study|Withdrawal by Subject|2|||
149021236|NCT02424344|537557230|FG000|Overall Study|Lack of Efficacy|0|||
149021237|NCT02424344|537557231|FG001|Overall Study|Lack of Efficacy|1|||
149021238|NCT02424344|537557230|FG000|Overall Study|Withdrawal by Subject|2|||
149021239|NCT02424344|537557231|FG001|Overall Study|Withdrawal by Subject|1|||
149021240|NCT02424344|537557230|FG000|Overall Study|Lost to Follow-up|1|||
149021241|NCT02424344|537557231|FG001|Overall Study|Lost to Follow-up|0|||
149021242|NCT02424344|537557230|FG000|Overall Study|Adverse Event|4|||
149021243|NCT02424344|537557231|FG001|Overall Study|Adverse Event|8|||
149021244|NCT01174550|537557232|FG000|Overall Study|Death|75|||
149021245|NCT01174550|537557233|FG001|Overall Study|Death|74|||
149021246|NCT01174550|537557232|FG000|Overall Study|Lost to Follow-up|652|||
149021247|NCT01174550|537557233|FG001|Overall Study|Lost to Follow-up|510|||
149021248|NCT01174550|537557232|FG000|Overall Study|Withdrawal by Subject|543|||
149021249|NCT01174550|537557233|FG001|Overall Study|Withdrawal by Subject|289|||
149021250|NCT01536262|537557234|FG000|Overall Study|Adverse Event|6|||
149021251|NCT01536262|537557235|FG001|Overall Study|Adverse Event|1|||
149021252|NCT01536262|537557236|FG002|Overall Study|Adverse Event|2|||
149021253|NCT01536262|537557234|FG000|Overall Study|Withdrawal by Subject|1|||
149021254|NCT01536262|537557235|FG001|Overall Study|Withdrawal by Subject|1|||
149021255|NCT01536262|537557236|FG002|Overall Study|Withdrawal by Subject|0|||
149021256|NCT01536262|537557234|FG000|Overall Study|Other than stated above|1|||
149021257|NCT01536262|537557235|FG001|Overall Study|Other than stated above|0|||
149021258|NCT01536262|537557236|FG002|Overall Study|Other than stated above|0|||
149021259|NCT05257837|537557240|FG000|Overall Study|Excluded (did not find the guns)|4|||
149021260|NCT05257837|537557241|FG001|Overall Study|Excluded (did not find the guns)|2|||
149021261|NCT05257837|537557242|FG002|Overall Study|Excluded (did not find the guns)|4|||
149021262|NCT05257837|537557243|FG003|Overall Study|Excluded (did not find the guns)|0|||
149021263|NCT01781611|537557244|FG000|Overall Study|Adverse Event|4|||
149021264|NCT01781611|537557245|FG001|Overall Study|Adverse Event|0|||
148811252|NCT01995201|536787050|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
148811253|NCT01995201|536787051|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
148811254|NCT01995201|536787052|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
148811255|NCT01995201|536787053|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
148811256|NCT01995201|536787047|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
148811257|NCT01995201|536787048|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
148811258|NCT01995201|536787049|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
148811259|NCT01995201|536787050|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
148811260|NCT01995201|536787051|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
148811261|NCT01995201|536787052|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
148811262|NCT01995201|536787053|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
148811263|NCT01995201|536787047|FG000|From Baseline Until Week 24|Physician Decision|0|||
148811264|NCT01995201|536787048|FG001|From Baseline Until Week 24|Physician Decision|2|||
148811265|NCT01995201|536787049|FG002|From Baseline Until Week 24|Physician Decision|0|||
148811266|NCT01995201|536787050|FG003|From Baseline Until Week 24|Physician Decision|0|||
149021265|NCT03639675|537557246|FG000|Overall Study|Withdrawal by Subject|1|||
149021266|NCT02459587|537557247|FG000|3-Month Follow-up Assessment|Death|0|||
149021267|NCT02459587|537557248|FG001|3-Month Follow-up Assessment|Death|2|||
149021268|NCT02459587|537557247|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
149021269|NCT02459587|537557248|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
149021270|NCT02459587|537557247|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
149021271|NCT02459587|537557248|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
149021272|NCT02459587|537557247|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
149021273|NCT02459587|537557248|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
149021274|NCT02459587|537557247|FG000|6-month Follow-up Assessment|Death|2|||
149021275|NCT02459587|537557248|FG001|6-month Follow-up Assessment|Death|1|||
149021276|NCT02459587|537557247|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
149021277|NCT02459587|537557248|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
149021278|NCT02459587|537557247|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
149021279|NCT02459587|537557248|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
149021280|NCT02459587|537557247|FG000|12-month Follow-up Assessment|Death|2|||
149021281|NCT02459587|537557248|FG001|12-month Follow-up Assessment|Death|0|||
149021282|NCT02459587|537557247|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
149021283|NCT02459587|537557248|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
149021284|NCT02459587|537557247|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
149021285|NCT02459587|537557248|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
149021286|NCT02459587|537557247|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
149021287|NCT02459587|537557248|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
149021288|NCT05343455|537557251|FG000|Overall Study|Withdrawal by Subject|4|||
149021289|NCT05343455|537557252|FG001|Overall Study|Withdrawal by Subject|9|||
149021290|NCT05343455|537557253|FG002|Overall Study|Withdrawal by Subject|7|||
149021291|NCT05343455|537557251|FG000|Overall Study|Adverse Event|2|||
149021292|NCT05343455|537557252|FG001|Overall Study|Adverse Event|1|||
149021293|NCT05343455|537557253|FG002|Overall Study|Adverse Event|2|||
149021294|NCT05343455|537557251|FG000|Overall Study|Lost to Follow-up|1|||
149021295|NCT05343455|537557252|FG001|Overall Study|Lost to Follow-up|1|||
149021296|NCT05343455|537557253|FG002|Overall Study|Lost to Follow-up|3|||
149021297|NCT05343455|537557251|FG000|Overall Study|Pregnancy|1|||
149021298|NCT05343455|537557252|FG001|Overall Study|Pregnancy|0|||
149021299|NCT05343455|537557253|FG002|Overall Study|Pregnancy|0|||
149021300|NCT05343455|537557251|FG000|Overall Study|Physician Decision|0|||
149021301|NCT05343455|537557252|FG001|Overall Study|Physician Decision|0|||
149021302|NCT05343455|537557253|FG002|Overall Study|Physician Decision|1|||
149021303|NCT05343455|537557251|FG000|Overall Study|Protocol Violation|0|||
149021304|NCT05343455|537557252|FG001|Overall Study|Protocol Violation|1|||
149021305|NCT05343455|537557253|FG002|Overall Study|Protocol Violation|1|||
149021306|NCT03468426|537557254|FG000|Overall Study|Progressive disease|3|||
149021307|NCT03468426|537557255|FG001|Overall Study|Progressive disease|0|||
149021308|NCT03468426|537557256|FG002|Overall Study|Progressive disease|4|||
149021309|NCT03468426|537557257|FG003|Overall Study|Progressive disease|20|||
149021310|NCT03468426|537557258|FG004|Overall Study|Progressive disease|23|||
149021311|NCT03468426|537557259|FG005|Overall Study|Progressive disease|15|||
149021312|NCT03468426|537557260|FG006|Overall Study|Progressive disease|24|||
149021313|NCT03468426|537557261|FG007|Overall Study|Progressive disease|27|||
149021314|NCT03468426|537557262|FG008|Overall Study|Progressive disease|13|||
149021315|NCT03468426|537557263|FG009|Overall Study|Progressive disease|13|||
149021316|NCT03468426|537557264|FG010|Overall Study|Progressive disease|0|||
149021317|NCT03468426|537557254|FG000|Overall Study|Other adverse event or clinical progression|0|||
149021318|NCT03468426|537557255|FG001|Overall Study|Other adverse event or clinical progression|1|||
149021319|NCT03468426|537557256|FG002|Overall Study|Other adverse event or clinical progression|3|||
149021320|NCT03468426|537557257|FG003|Overall Study|Other adverse event or clinical progression|14|||
149021321|NCT03468426|537557258|FG004|Overall Study|Other adverse event or clinical progression|10|||
149021322|NCT03468426|537557259|FG005|Overall Study|Other adverse event or clinical progression|8|||
149021323|NCT03468426|537557260|FG006|Overall Study|Other adverse event or clinical progression|5|||
149021324|NCT03468426|537557261|FG007|Overall Study|Other adverse event or clinical progression|4|||
149021325|NCT03468426|537557262|FG008|Overall Study|Other adverse event or clinical progression|6|||
149021326|NCT03468426|537557263|FG009|Overall Study|Other adverse event or clinical progression|11|||
149021327|NCT03468426|537557264|FG010|Overall Study|Other adverse event or clinical progression|0|||
149021328|NCT03468426|537557254|FG000|Overall Study|Refused to continue taking trial medication|0|||
149021329|NCT03468426|537557255|FG001|Overall Study|Refused to continue taking trial medication|0|||
149021330|NCT03468426|537557256|FG002|Overall Study|Refused to continue taking trial medication|0|||
149021331|NCT03468426|537557257|FG003|Overall Study|Refused to continue taking trial medication|2|||
149021332|NCT03468426|537557258|FG004|Overall Study|Refused to continue taking trial medication|0|||
149021333|NCT03468426|537557259|FG005|Overall Study|Refused to continue taking trial medication|3|||
149021334|NCT03468426|537557260|FG006|Overall Study|Refused to continue taking trial medication|0|||
149021335|NCT03468426|537557261|FG007|Overall Study|Refused to continue taking trial medication|0|||
149021336|NCT03468426|537557262|FG008|Overall Study|Refused to continue taking trial medication|1|||
149021337|NCT03468426|537557263|FG009|Overall Study|Refused to continue taking trial medication|0|||
149021338|NCT03468426|537557264|FG010|Overall Study|Refused to continue taking trial medication|0|||
149021339|NCT03468426|537557254|FG000|Overall Study|Other than listed|0|||
149021340|NCT03468426|537557255|FG001|Overall Study|Other than listed|1|||
149021341|NCT03468426|537557256|FG002|Overall Study|Other than listed|0|||
149021342|NCT03468426|537557257|FG003|Overall Study|Other than listed|0|||
149021343|NCT03468426|537557258|FG004|Overall Study|Other than listed|2|||
149021344|NCT03468426|537557259|FG005|Overall Study|Other than listed|2|||
149021345|NCT03468426|537557260|FG006|Overall Study|Other than listed|0|||
149021346|NCT03468426|537557261|FG007|Overall Study|Other than listed|0|||
149021347|NCT03468426|537557262|FG008|Overall Study|Other than listed|4|||
149021348|NCT03468426|537557263|FG009|Overall Study|Other than listed|4|||
149021349|NCT03468426|537557264|FG010|Overall Study|Other than listed|1|||
149021350|NCT03468426|537557254|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021351|NCT03468426|537557255|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021352|NCT03468426|537557256|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
149021353|NCT03468426|537557257|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021354|NCT03468426|537557258|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021355|NCT03468426|537557259|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021356|NCT03468426|537557260|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021357|NCT03468426|537557261|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021358|NCT03468426|537557262|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021359|NCT03468426|537557263|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021360|NCT03468426|537557264|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149021361|NCT03468426|537557254|FG000|Overall Study|missing reason|0|||
149021362|NCT03468426|537557255|FG001|Overall Study|missing reason|0|||
149021363|NCT03468426|537557256|FG002|Overall Study|missing reason|0|||
149021364|NCT03468426|537557257|FG003|Overall Study|missing reason|0|||
149021365|NCT03468426|537557258|FG004|Overall Study|missing reason|0|||
149021366|NCT03468426|537557259|FG005|Overall Study|missing reason|0|||
149021367|NCT03468426|537557260|FG006|Overall Study|missing reason|0|||
149021368|NCT03468426|537557261|FG007|Overall Study|missing reason|0|||
149021369|NCT03468426|537557262|FG008|Overall Study|missing reason|0|||
149021370|NCT03468426|537557263|FG009|Overall Study|missing reason|1|||
149021371|NCT03468426|537557264|FG010|Overall Study|missing reason|0|||
149021372|NCT02139982|537557265|FG000|Overall Study|Lack of Efficacy|0|||
149021373|NCT02139982|537557266|FG001|Overall Study|Lack of Efficacy|1|||
149021374|NCT02139982|537557267|FG002|Overall Study|Lack of Efficacy|0|||
149021375|NCT02139982|537557268|FG003|Overall Study|Lack of Efficacy|1|||
149021376|NCT02139982|537557269|FG004|Overall Study|Lack of Efficacy|0|||
149021377|NCT02139982|537557270|FG005|Overall Study|Lack of Efficacy|0|||
149021378|NCT02139982|537557271|FG006|Overall Study|Lack of Efficacy|0|||
149021379|NCT02139982|537557272|FG007|Overall Study|Lack of Efficacy|0|||
149021380|NCT02139982|537557273|FG008|Overall Study|Lack of Efficacy|0|||
149021381|NCT02139982|537557274|FG009|Overall Study|Lack of Efficacy|0|||
149021382|NCT04466618|537557275|FG000|Overall Study|Withdrawal by Subject|0|||
149021383|NCT04466618|537557276|FG001|Overall Study|Withdrawal by Subject|1|||
149021384|NCT01152554|537557282|FG000|Overall Study|Withdrawal by Subject|73|||
149021385|NCT01152554|537557283|FG001|Overall Study|Withdrawal by Subject|28|||
149021386|NCT01152554|537557282|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
149021387|NCT01152554|537557283|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
149021388|NCT01152554|537557282|FG000|Overall Study|Adverse Event|67|||
149021389|NCT01152554|537557283|FG001|Overall Study|Adverse Event|14|||
149021390|NCT01152554|537557282|FG000|Overall Study|Severe non-compliance to protocol|36|||
149021391|NCT01152554|537557283|FG001|Overall Study|Severe non-compliance to protocol|14|||
149021392|NCT01152554|537557282|FG000|Overall Study|Condition under investigation worsened|5|||
149021393|NCT01152554|537557283|FG001|Overall Study|Condition under investigation worsened|2|||
149021394|NCT01152554|537557282|FG000|Overall Study|Lack of Efficacy|20|||
149021395|NCT01152554|537557283|FG001|Overall Study|Lack of Efficacy|3|||
149021396|NCT01152554|537557282|FG000|Overall Study|Study-specific withdrawal criteria|17|||
149021397|NCT01152554|537557283|FG001|Overall Study|Study-specific withdrawal criteria|8|||
149021398|NCT01152554|537557282|FG000|Overall Study|Lost to Follow-up|87|||
149021399|NCT01152554|537557283|FG001|Overall Study|Lost to Follow-up|32|||
149021400|NCT01152554|537557282|FG000|Overall Study|Other|28|||
149021401|NCT01152554|537557283|FG001|Overall Study|Other|8|||
149021402|NCT01152554|537557282|FG000|Overall Study|Death|1|||
149021403|NCT01152554|537557283|FG001|Overall Study|Death|1|||
149021404|NCT02117544|537557284|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
149021405|NCT02117544|537557285|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
149021406|NCT03486899|537557286|FG000|Overall Study|Lost to Follow-up|4|||
149021407|NCT03486899|537557287|FG001|Overall Study|Lost to Follow-up|1|||
149021408|NCT03486899|537557288|FG002|Overall Study|Lost to Follow-up|4|||
149021409|NCT03486899|537557289|FG003|Overall Study|Lost to Follow-up|3|||
149021410|NCT03486899|537557286|FG000|Overall Study|Death|1|||
149021411|NCT03486899|537557287|FG001|Overall Study|Death|0|||
149021412|NCT03486899|537557288|FG002|Overall Study|Death|0|||
148811267|NCT01995201|536787051|FG004|From Baseline Until Week 24|Physician Decision|0|||
149021413|NCT03486899|537557289|FG003|Overall Study|Death|1|||
149021414|NCT03486899|537557286|FG000|Overall Study|Adverse Event|0|||
149021415|NCT03486899|537557287|FG001|Overall Study|Adverse Event|2|||
149021416|NCT03486899|537557288|FG002|Overall Study|Adverse Event|0|||
149021417|NCT03486899|537557289|FG003|Overall Study|Adverse Event|2|||
149021418|NCT03486899|537557286|FG000|Overall Study|Withdrawal by Subject|3|||
149021419|NCT03486899|537557287|FG001|Overall Study|Withdrawal by Subject|7|||
149021420|NCT03486899|537557288|FG002|Overall Study|Withdrawal by Subject|4|||
148691447|NCT01325207|536344179|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
148691448|NCT01325207|536344180|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
148691449|NCT01325207|536344181|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
148691450|NCT01325207|536344176|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
148691451|NCT01325207|536344177|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
148691452|NCT01325207|536344178|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
148691453|NCT01325207|536344179|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
148691454|NCT01325207|536344180|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
148691455|NCT01325207|536344181|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
148691456|NCT01325207|536344176|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
148691457|NCT01325207|536344177|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
148691458|NCT01325207|536344178|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
148691459|NCT01325207|536344179|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
148691460|NCT01325207|536344180|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
148691461|NCT01325207|536344181|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
148691462|NCT01254409|536344182|FG000|Overall Study|Adverse Event|0|||
148691463|NCT01254409|536344183|FG001|Overall Study|Adverse Event|1|||
148691464|NCT01254409|536344184|FG002|Overall Study|Adverse Event|0|||
148691465|NCT01254409|536344185|FG003|Overall Study|Adverse Event|0|||
148691466|NCT00337571|536344189|FG000|Overall Study|Lack of Efficacy|3|||
148691467|NCT00337571|536344190|FG001|Overall Study|Lack of Efficacy|0|||
148691468|NCT00337571|536344191|FG002|Overall Study|Lack of Efficacy|0|||
148691469|NCT00337571|536344192|FG003|Overall Study|Lack of Efficacy|0|||
148691470|NCT00337571|536344189|FG000|Overall Study|Adverse Event|4|||
148691471|NCT00337571|536344190|FG001|Overall Study|Adverse Event|5|||
148691472|NCT00337571|536344191|FG002|Overall Study|Adverse Event|8|||
148956509|NCT01506479|537324450|FG001|Overall Study|Withdrawal by Subject|2|||
148956510|NCT01506479|537324451|FG002|Overall Study|Withdrawal by Subject|1|||
148956511|NCT01506479|537324449|FG000|Overall Study|Missing assessment|1|||
148956512|NCT01506479|537324450|FG001|Overall Study|Missing assessment|0|||
148956513|NCT01506479|537324451|FG002|Overall Study|Missing assessment|0|||
148956514|NCT01506479|537324449|FG000|Overall Study|Adverse Event|0|||
148956515|NCT01506479|537324450|FG001|Overall Study|Adverse Event|1|||
148956516|NCT01506479|537324451|FG002|Overall Study|Adverse Event|0|||
148956517|NCT01846507|537324452|FG000|Overall Study|Lost to Follow-up|4|||
148956518|NCT01846507|537324452|FG000|Overall Study|Protocol Violation|1|||
148956519|NCT01846507|537324452|FG000|Overall Study|Missing data|2|||
148956520|NCT01782859|537324453|FG000|Overall Study|Protocol Violation|6|||
148956521|NCT01782859|537324454|FG001|Overall Study|Protocol Violation|6|||
148956522|NCT01782859|537324453|FG000|Overall Study|Withdrawal by Subject|0|||
148691473|NCT00337571|536344192|FG003|Overall Study|Adverse Event|4|||
148691474|NCT00337571|536344189|FG000|Overall Study|Withdrawal by Subject|2|||
148811268|NCT01995201|536787052|FG005|From Baseline Until Week 24|Physician Decision|0|||
148811269|NCT01995201|536787053|FG006|From Baseline Until Week 24|Physician Decision|0|||
148811270|NCT01995201|536787047|FG000|From Baseline Until Week 24|Protocol Violation|0|||
148811271|NCT01995201|536787048|FG001|From Baseline Until Week 24|Protocol Violation|9|||
148811272|NCT01995201|536787049|FG002|From Baseline Until Week 24|Protocol Violation|0|||
148811273|NCT01995201|536787050|FG003|From Baseline Until Week 24|Protocol Violation|0|||
148811274|NCT01995201|536787051|FG004|From Baseline Until Week 24|Protocol Violation|0|||
148811275|NCT01995201|536787052|FG005|From Baseline Until Week 24|Protocol Violation|0|||
148811276|NCT01995201|536787053|FG006|From Baseline Until Week 24|Protocol Violation|0|||
148811277|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Adverse Event|0|||
148811278|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Adverse Event|0|||
148811279|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Adverse Event|2|||
148811280|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Adverse Event|1|||
148811281|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Adverse Event|1|||
148956523|NCT01782859|537324454|FG001|Overall Study|Withdrawal by Subject|1|||
149021421|NCT03486899|537557289|FG003|Overall Study|Withdrawal by Subject|3|||
149021422|NCT03486899|537557286|FG000|Overall Study|Other Reasons|0|||
149021423|NCT03486899|537557287|FG001|Overall Study|Other Reasons|1|||
149021424|NCT03486899|537557288|FG002|Overall Study|Other Reasons|0|||
149021425|NCT03486899|537557289|FG003|Overall Study|Other Reasons|1|||
149021426|NCT01439711|537557290|FG000|Overall Study|Ineligible|13|||
149021427|NCT01439711|537557290|FG000|Overall Study|Cancel|3|||
149021428|NCT01439711|537557290|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
149021429|NCT01439711|537557290|FG000|Overall Study|Adverse Event|5|||
149021430|NCT01439711|537557290|FG000|Overall Study|Withdrawal by Subject|3|||
149021431|NCT01439711|537557290|FG000|Overall Study|Progression During Active Tx|3|||
149021432|NCT01439711|537557290|FG000|Overall Study|Noncompliance|3|||
149021433|NCT01439711|537557290|FG000|Overall Study|No MRI|9|||
149021434|NCT02397460|537557291|FG000|Treatment Period 2|Adverse Event|0|||
149021435|NCT02397460|537557292|FG001|Treatment Period 2|Adverse Event|0|||
149021436|NCT02397460|537557293|FG002|Treatment Period 2|Adverse Event|0|||
148811282|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Adverse Event|3|||
149021437|NCT02397460|537557294|FG003|Treatment Period 2|Adverse Event|0|||
149021438|NCT02397460|537557295|FG004|Treatment Period 2|Adverse Event|0|||
149021439|NCT02397460|537557296|FG005|Treatment Period 2|Adverse Event|0|||
149021440|NCT02397460|537557297|FG006|Treatment Period 2|Adverse Event|0|||
149021441|NCT02397460|537557298|FG007|Treatment Period 2|Adverse Event|1|||
149021442|NCT02397460|537557291|FG000|Treatment Period 4|Adverse Event|0|||
149021443|NCT02397460|537557292|FG001|Treatment Period 4|Adverse Event|1|||
149021444|NCT02397460|537557293|FG002|Treatment Period 4|Adverse Event|0|||
149021445|NCT02397460|537557294|FG003|Treatment Period 4|Adverse Event|0|||
149021446|NCT02397460|537557295|FG004|Treatment Period 4|Adverse Event|0|||
149021447|NCT02397460|537557296|FG005|Treatment Period 4|Adverse Event|0|||
149021448|NCT02397460|537557297|FG006|Treatment Period 4|Adverse Event|0|||
149021449|NCT02397460|537557298|FG007|Treatment Period 4|Adverse Event|0|||
149021450|NCT02397460|537557291|FG000|Treatment Period 4|Physician Decision|0|||
149021451|NCT02397460|537557292|FG001|Treatment Period 4|Physician Decision|0|||
149021452|NCT02397460|537557293|FG002|Treatment Period 4|Physician Decision|0|||
149021453|NCT02397460|537557294|FG003|Treatment Period 4|Physician Decision|0|||
149021454|NCT02397460|537557295|FG004|Treatment Period 4|Physician Decision|1|||
149021455|NCT02397460|537557296|FG005|Treatment Period 4|Physician Decision|0|||
149021456|NCT02397460|537557297|FG006|Treatment Period 4|Physician Decision|0|||
149021457|NCT02397460|537557298|FG007|Treatment Period 4|Physician Decision|0|||
149021458|NCT01767129|537557299|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
149021459|NCT01767129|537557300|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
149021460|NCT01473420|537557304|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
149021461|NCT01473420|537557305|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
149021462|NCT01473420|537557304|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
149021463|NCT01473420|537557305|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
149021464|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
149021465|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
149021466|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
149021467|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
149021468|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
149021469|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
149021470|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
149021471|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
149021472|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
149021473|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
149021474|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
149021475|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
149021476|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
149021477|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
149021478|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
149021479|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
149021480|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
149021481|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
149021482|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
149021483|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
149021484|NCT01473420|537557304|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
149021485|NCT01473420|537557305|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
149021486|NCT00738530|537557306|FG000|Overall Study|Death|220|||
149021487|NCT00738530|537557307|FG001|Overall Study|Death|224|||
149021488|NCT00738530|537557306|FG000|Overall Study|Lost to Follow-up|8|||
149021489|NCT00738530|537557307|FG001|Overall Study|Lost to Follow-up|6|||
149021490|NCT00738530|537557306|FG000|Overall Study|Withdrawal by Subject|6|||
149021491|NCT00738530|537557307|FG001|Overall Study|Withdrawal by Subject|8|||
149021492|NCT01656759|537557308|FG000|Overall Study|Protocol Violation|2|||
149021493|NCT01656759|537557309|FG001|Overall Study|Protocol Violation|3|||
149021494|NCT04963062|537557316|FG000|Overall Study|withdrew by the study team|4|||
149021495|NCT04963062|537557317|FG001|Overall Study|withdrew by the study team|2|||
149021496|NCT01513967|537557328|FG000|Overall Study|Pregnancy|0|||
149021497|NCT01513967|537557329|FG001|Overall Study|Pregnancy|0|||
149021498|NCT01513967|537557330|FG002|Overall Study|Pregnancy|0|||
149021499|NCT01513967|537557331|FG003|Overall Study|Pregnancy|0|||
148811283|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Adverse Event|1|||
148811284|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Death|0|||
148811285|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Death|0|||
148811286|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Death|0|||
148811287|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Death|0|||
148811288|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Death|0|||
148811289|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Death|2|||
148811290|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Death|0|||
148811291|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
148811292|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
148811293|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
149021500|NCT01513967|537557332|FG004|Overall Study|Pregnancy|0|||
149021501|NCT01513967|537557333|FG005|Overall Study|Pregnancy|0|||
149021502|NCT01513967|537557334|FG006|Overall Study|Pregnancy|1|||
148811294|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
148811295|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
149021503|NCT01513967|537557335|FG007|Overall Study|Pregnancy|0|||
149021504|NCT01513967|537557328|FG000|Overall Study|missed a study visit|0|||
149021505|NCT01513967|537557329|FG001|Overall Study|missed a study visit|0|||
149021506|NCT01513967|537557330|FG002|Overall Study|missed a study visit|0|||
149021507|NCT01513967|537557331|FG003|Overall Study|missed a study visit|0|||
149021508|NCT01513967|537557332|FG004|Overall Study|missed a study visit|0|||
149021509|NCT01513967|537557333|FG005|Overall Study|missed a study visit|0|||
149021510|NCT01513967|537557334|FG006|Overall Study|missed a study visit|1|||
149021511|NCT01513967|537557335|FG007|Overall Study|missed a study visit|0|||
149021512|NCT01513967|537557328|FG000|Overall Study|excluded due to positive drug screen|0|||
149021513|NCT01513967|537557329|FG001|Overall Study|excluded due to positive drug screen|0|||
149021514|NCT01513967|537557330|FG002|Overall Study|excluded due to positive drug screen|0|||
149021515|NCT01513967|537557331|FG003|Overall Study|excluded due to positive drug screen|0|||
149021516|NCT01513967|537557332|FG004|Overall Study|excluded due to positive drug screen|0|||
149021517|NCT01513967|537557333|FG005|Overall Study|excluded due to positive drug screen|0|||
149021518|NCT01513967|537557334|FG006|Overall Study|excluded due to positive drug screen|0|||
149021519|NCT01513967|537557335|FG007|Overall Study|excluded due to positive drug screen|2|||
149021520|NCT01513967|537557328|FG000|Overall Study|Physician Decision|0|||
149021521|NCT01513967|537557329|FG001|Overall Study|Physician Decision|0|||
149021522|NCT01513967|537557330|FG002|Overall Study|Physician Decision|0|||
149021523|NCT01513967|537557331|FG003|Overall Study|Physician Decision|0|||
149021524|NCT01513967|537557332|FG004|Overall Study|Physician Decision|0|||
149021525|NCT01513967|537557333|FG005|Overall Study|Physician Decision|1|||
149021526|NCT01513967|537557334|FG006|Overall Study|Physician Decision|0|||
149021527|NCT01513967|537557335|FG007|Overall Study|Physician Decision|0|||
149021528|NCT01987830|537557336|FG000|Overall Study|Never received baseline scan|1|||
149021529|NCT01349660|537557337|FG000|Overall Study|Still Receiving Study Treatment|0|||
149021530|NCT01349660|537557338|FG001|Overall Study|Still Receiving Study Treatment|0|||
149021531|NCT01349660|537557339|FG002|Overall Study|Still Receiving Study Treatment|1|||
149021532|NCT01349660|537557337|FG000|Overall Study|Disease Progression|2|||
149021533|NCT01349660|537557338|FG001|Overall Study|Disease Progression|4|||
149021534|NCT01349660|537557339|FG002|Overall Study|Disease Progression|50|||
149021535|NCT01349660|537557337|FG000|Overall Study|Adverse Event|1|||
149021536|NCT01349660|537557338|FG001|Overall Study|Adverse Event|1|||
149021537|NCT01349660|537557339|FG002|Overall Study|Adverse Event|12|||
149021538|NCT01349660|537557337|FG000|Overall Study|Withdrawal by Subject|2|||
149021539|NCT01349660|537557338|FG001|Overall Study|Withdrawal by Subject|0|||
149021540|NCT01349660|537557339|FG002|Overall Study|Withdrawal by Subject|9|||
149021541|NCT01349660|537557337|FG000|Overall Study|Death|1|||
149021542|NCT01349660|537557338|FG001|Overall Study|Death|1|||
149021543|NCT01349660|537557339|FG002|Overall Study|Death|0|||
149021544|NCT01349660|537557337|FG000|Overall Study|Non-Permitted Interventions|0|||
149021545|NCT01349660|537557338|FG001|Overall Study|Non-Permitted Interventions|0|||
149021546|NCT01349660|537557339|FG002|Overall Study|Non-Permitted Interventions|2|||
149021547|NCT01349660|537557337|FG000|Overall Study|Study Compliance|0|||
149021548|NCT01349660|537557338|FG001|Overall Study|Study Compliance|0|||
149021549|NCT01349660|537557339|FG002|Overall Study|Study Compliance|1|||
149021550|NCT01349660|537557337|FG000|Overall Study|Declining Performance Status|0|||
149021551|NCT01349660|537557338|FG001|Overall Study|Declining Performance Status|0|||
149021552|NCT01349660|537557339|FG002|Overall Study|Declining Performance Status|1|||
149021553|NCT01563978|537557342|FG000|Overall Study|Physician Decision|1|||
149021554|NCT01563978|537557343|FG001|Overall Study|Physician Decision|0|||
149021555|NCT01563978|537557342|FG000|Overall Study|Lost to Follow-up|1|||
149021556|NCT01563978|537557343|FG001|Overall Study|Lost to Follow-up|0|||
149021557|NCT01563978|537557342|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
149021558|NCT01563978|537557343|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
149021559|NCT01563978|537557342|FG000|Overall Study|Adverse Event|1|||
149021560|NCT01563978|537557343|FG001|Overall Study|Adverse Event|2|||
149021561|NCT00057811|537557344|FG000|Overall Study|Lack of Efficacy|1|||
149021562|NCT00057811|537557345|FG001|Overall Study|Lack of Efficacy|4|||
149021563|NCT00057811|537557344|FG000|Overall Study|Physician Decision|1|||
149021564|NCT00057811|537557345|FG001|Overall Study|Physician Decision|0|||
149021565|NCT00057811|537557344|FG000|Overall Study|Withdrawal by Subject|3|||
149021566|NCT00057811|537557345|FG001|Overall Study|Withdrawal by Subject|4|||
149021567|NCT00057811|537557344|FG000|Overall Study|Ineligible|4|||
149021568|NCT00057811|537557345|FG001|Overall Study|Ineligible|2|||
149021569|NCT00057811|537557344|FG000|Overall Study|Inevaluable|1|||
149021570|NCT00057811|537557345|FG001|Overall Study|Inevaluable|2|||
149021571|NCT00556374|537557346|FG000|Overall Study|Withdrawal by Subject|235|||
149021572|NCT00556374|537557347|FG001|Overall Study|Withdrawal by Subject|205|||
149021573|NCT00556374|537557346|FG000|Overall Study|Death|158|||
149021574|NCT00556374|537557347|FG001|Overall Study|Death|127|||
149021575|NCT00556374|537557346|FG000|Overall Study|Lost to Follow-up|24|||
149021576|NCT00556374|537557347|FG001|Overall Study|Lost to Follow-up|17|||
149021577|NCT00556374|537557346|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
149021578|NCT00556374|537557347|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
149021579|NCT00847301|537557348|FG000|Overall Study|Adverse Event|35|||
149021580|NCT00847301|537557348|FG000|Overall Study|Switch to other anticoagulants|16|||
149021581|NCT00847301|537557348|FG000|Overall Study|Lost to Follow-up|1|||
149021582|NCT00847301|537557348|FG000|Overall Study|No prescription after hospital discharge|1|||
149021583|NCT00847301|537557348|FG000|Overall Study|Other reason not defined above|1|||
149021584|NCT00996580|537557349|FG000|Overall Study|Adverse Event|466|||
149021585|NCT00996580|537557349|FG000|Overall Study|Lost to Follow-up|480|||
149021586|NCT00996580|537557349|FG000|Overall Study|Noncompliance with the protocol|137|||
149021587|NCT00996580|537557349|FG000|Overall Study|Physician Decision|5|||
149021588|NCT00996580|537557349|FG000|Overall Study|Pregnancy|68|||
149021589|NCT00996580|537557349|FG000|Overall Study|Protocol Violation|16|||
149021590|NCT00996580|537557349|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
149021591|NCT00996580|537557349|FG000|Overall Study|Withdrawal by Subject|217|||
149021592|NCT00996580|537557349|FG000|Overall Study|Other|29|||
149021593|NCT05708846|537557350|FG000|Overall Study|Death|5|||
149021594|NCT05708846|537557350|FG000|Overall Study|Withdrawal by Subject|20|||
149021595|NCT03621982|537557351|FG000|Overall Study|Withdrawal by Subject|1|||
149021596|NCT03621982|537557352|FG001|Overall Study|Withdrawal by Subject|0|||
149021597|NCT03621982|537557353|FG002|Overall Study|Withdrawal by Subject|0|||
149021598|NCT03621982|537557354|FG003|Overall Study|Withdrawal by Subject|1|||
149021599|NCT03621982|537557355|FG004|Overall Study|Withdrawal by Subject|0|||
149021600|NCT03621982|537557356|FG005|Overall Study|Withdrawal by Subject|1|||
149021601|NCT03621982|537557357|FG006|Overall Study|Withdrawal by Subject|1|||
149021602|NCT03621982|537557358|FG007|Overall Study|Withdrawal by Subject|0|||
149021603|NCT03621982|537557359|FG008|Overall Study|Withdrawal by Subject|1|||
149021604|NCT03621982|537557360|FG009|Overall Study|Withdrawal by Subject|0|||
149021605|NCT03621982|537557361|FG010|Overall Study|Withdrawal by Subject|2|||
149021606|NCT03621982|537557362|FG011|Overall Study|Withdrawal by Subject|1|||
149021607|NCT03621982|537557363|FG012|Overall Study|Withdrawal by Subject|2|||
149021608|NCT03621982|537557364|FG013|Overall Study|Withdrawal by Subject|2|||
149021609|NCT03621982|537557351|FG000|Overall Study|Investigator/Sponsor decision|0|||
149021610|NCT03621982|537557352|FG001|Overall Study|Investigator/Sponsor decision|0|||
149021611|NCT03621982|537557353|FG002|Overall Study|Investigator/Sponsor decision|0|||
149021612|NCT03621982|537557354|FG003|Overall Study|Investigator/Sponsor decision|0|||
149021613|NCT03621982|537557355|FG004|Overall Study|Investigator/Sponsor decision|0|||
149021614|NCT03621982|537557356|FG005|Overall Study|Investigator/Sponsor decision|0|||
149021615|NCT03621982|537557357|FG006|Overall Study|Investigator/Sponsor decision|0|||
149021616|NCT03621982|537557358|FG007|Overall Study|Investigator/Sponsor decision|0|||
149021617|NCT03621982|537557359|FG008|Overall Study|Investigator/Sponsor decision|0|||
149021618|NCT03621982|537557360|FG009|Overall Study|Investigator/Sponsor decision|0|||
149021619|NCT03621982|537557361|FG010|Overall Study|Investigator/Sponsor decision|0|||
149021620|NCT03621982|537557362|FG011|Overall Study|Investigator/Sponsor decision|4|||
149021621|NCT03621982|537557363|FG012|Overall Study|Investigator/Sponsor decision|0|||
149021622|NCT03621982|537557364|FG013|Overall Study|Investigator/Sponsor decision|2|||
149021623|NCT03621982|537557351|FG000|Overall Study|Death|2|||
149021624|NCT03621982|537557352|FG001|Overall Study|Death|4|||
149021625|NCT03621982|537557353|FG002|Overall Study|Death|4|||
149021626|NCT03621982|537557354|FG003|Overall Study|Death|3|||
149021627|NCT03621982|537557355|FG004|Overall Study|Death|8|||
149021628|NCT03621982|537557356|FG005|Overall Study|Death|4|||
149021629|NCT03621982|537557357|FG006|Overall Study|Death|6|||
149021630|NCT03621982|537557358|FG007|Overall Study|Death|3|||
149021631|NCT03621982|537557359|FG008|Overall Study|Death|0|||
149021632|NCT03621982|537557360|FG009|Overall Study|Death|3|||
149021633|NCT03621982|537557361|FG010|Overall Study|Death|8|||
149021634|NCT03621982|537557362|FG011|Overall Study|Death|4|||
149021635|NCT03621982|537557363|FG012|Overall Study|Death|2|||
148691475|NCT00337571|536344190|FG001|Overall Study|Withdrawal by Subject|2|||
148691476|NCT00337571|536344191|FG002|Overall Study|Withdrawal by Subject|1|||
148691477|NCT00337571|536344192|FG003|Overall Study|Withdrawal by Subject|0|||
148691478|NCT00337571|536344189|FG000|Overall Study|Lost to Follow-up|3|||
148691479|NCT00337571|536344190|FG001|Overall Study|Lost to Follow-up|1|||
148691480|NCT00337571|536344191|FG002|Overall Study|Lost to Follow-up|0|||
148691481|NCT00337571|536344192|FG003|Overall Study|Lost to Follow-up|1|||
149021636|NCT03621982|537557364|FG013|Overall Study|Death|2|||
149021637|NCT03621982|537557351|FG000|Overall Study|Lost to Follow-up|0|||
149021638|NCT03621982|537557352|FG001|Overall Study|Lost to Follow-up|0|||
149021639|NCT03621982|537557353|FG002|Overall Study|Lost to Follow-up|1|||
149021640|NCT03621982|537557354|FG003|Overall Study|Lost to Follow-up|0|||
149021641|NCT03621982|537557355|FG004|Overall Study|Lost to Follow-up|0|||
149021642|NCT03621982|537557356|FG005|Overall Study|Lost to Follow-up|0|||
149021643|NCT03621982|537557357|FG006|Overall Study|Lost to Follow-up|1|||
149021644|NCT03621982|537557358|FG007|Overall Study|Lost to Follow-up|0|||
149021645|NCT03621982|537557359|FG008|Overall Study|Lost to Follow-up|0|||
149021646|NCT03621982|537557360|FG009|Overall Study|Lost to Follow-up|1|||
149021647|NCT03621982|537557361|FG010|Overall Study|Lost to Follow-up|0|||
149021648|NCT03621982|537557362|FG011|Overall Study|Lost to Follow-up|0|||
148691482|NCT00337571|536344189|FG000|Overall Study|Poor/noncompliance|1|||
148691483|NCT00337571|536344190|FG001|Overall Study|Poor/noncompliance|1|||
148811296|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
148811297|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
148811298|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
148811299|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
148811300|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
148811301|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
148811302|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
148811303|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
148811304|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
148811305|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
148811306|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
148811307|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
148811308|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
148811309|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
148811310|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
148811311|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
148811312|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Physician Decision|0|||
148811313|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Physician Decision|0|||
148811314|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Physician Decision|0|||
148811315|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Physician Decision|0|||
148811316|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Physician Decision|1|||
148811317|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Physician Decision|0|||
148811318|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Physician Decision|0|||
148811319|NCT01995201|536787047|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
148811320|NCT01995201|536787048|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
148811321|NCT01995201|536787049|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
148811322|NCT01995201|536787050|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
148811323|NCT01995201|536787051|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
148811324|NCT01995201|536787052|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
148811325|NCT01995201|536787053|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
148811326|NCT03329001|536787054|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
148811327|NCT03329001|536787055|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
148811328|NCT03329001|536787056|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
148811329|NCT03329001|536787057|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
148811330|NCT03329001|536787058|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
148811331|NCT03329001|536787059|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
148811332|NCT03329001|536787060|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
148811333|NCT03329001|536787061|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
148811334|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148811335|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148811336|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148811337|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
148811338|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148811339|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148811340|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148956524|NCT04483011|537324457|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
148956525|NCT04483011|537324458|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
148956526|NCT00276159|537324459|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
148956527|NCT02426892|537324462|FG000|Overall Study|Adverse Event|2|||
148956528|NCT02426892|537324462|FG000|Overall Study|Lack of Efficacy|17|||
148956529|NCT02426892|537324462|FG000|Overall Study|Withdrawal by Subject|1|||
148956530|NCT03402386|537324463|FG000|Overall Study|Adverse Event|3|||
148956531|NCT03402386|537324463|FG000|Overall Study|Physician Decision|1|||
148956532|NCT03402386|537324463|FG000|Overall Study|Difficult to control Hb|2|||
149021649|NCT03621982|537557363|FG012|Overall Study|Lost to Follow-up|0|||
149021650|NCT03621982|537557364|FG013|Overall Study|Lost to Follow-up|0|||
149021651|NCT00238420|537557365|FG000|Overall Study|Protocol Violation|1|||
149021652|NCT00238420|537557366|FG001|Overall Study|Protocol Violation|1|||
149021653|NCT00442286|537557367|FG000|Overall Study|Death|2|||
149021654|NCT00442286|537557368|FG001|Overall Study|Death|2|||
149021655|NCT00442286|537557367|FG000|Overall Study|Lost to Follow-up|1|||
149021656|NCT00442286|537557368|FG001|Overall Study|Lost to Follow-up|0|||
149021657|NCT00442286|537557367|FG000|Overall Study|Withdrawal by Subject|2|||
149021658|NCT00442286|537557368|FG001|Overall Study|Withdrawal by Subject|0|||
149021659|NCT00442286|537557367|FG000|Overall Study|System explanted|1|||
149021660|NCT00442286|537557368|FG001|Overall Study|System explanted|0|||
149021661|NCT00442286|537557367|FG000|Overall Study|Patient Injury|1|||
149021662|NCT00442286|537557368|FG001|Overall Study|Patient Injury|0|||
149021663|NCT00641186|537557369|FG000|Overall Study|Adverse Event|3|||
149021664|NCT02218489|537557372|FG000|Overall Study|Withdrawal by Subject|4|||
149021665|NCT02218489|537557373|FG001|Overall Study|Withdrawal by Subject|3|||
149021666|NCT02218489|537557372|FG000|Overall Study|Lost to Follow-up|1|||
149021667|NCT02218489|537557373|FG001|Overall Study|Lost to Follow-up|0|||
149021668|NCT05221749|537557374|FG000|Overall Study|Lost to Follow-up|2|||
149021669|NCT05221749|537557375|FG001|Overall Study|Lost to Follow-up|3|||
149021670|NCT02102464|537557376|FG000|Randomized Study|Withdrawal by Subject|0|||
149021671|NCT02102464|537557377|FG001|Randomized Study|Withdrawal by Subject|1|||
149021672|NCT02102464|537557378|FG002|Randomized Study|Withdrawal by Subject|0|||
149021673|NCT04140890|537557381|FG000|Overall Study|Withdrawal by Subject|0|||
149021674|NCT04140890|537557382|FG001|Overall Study|Withdrawal by Subject|1|||
148811341|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
148811342|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
149021675|NCT02388074|537557383|FG000|Overall Study|Lost in Transit|2|||
149021676|NCT02388074|537557383|FG000|Overall Study|Sample Not Returned|1|||
149021677|NCT01778062|537557386|FG000|Overall Study|Adverse Event|1|||
149021678|NCT01778062|537557387|FG001|Overall Study|Adverse Event|3|||
149021679|NCT01778062|537557386|FG000|Overall Study|Consent Withdrawal|1|||
149021680|NCT01778062|537557387|FG001|Overall Study|Consent Withdrawal|5|||
149021681|NCT01778062|537557386|FG000|Overall Study|major protocol deviation|4|||
149021682|NCT01778062|537557387|FG001|Overall Study|major protocol deviation|3|||
149021683|NCT01254890|537557390|FG000|Overall Study|Ineligible|0|||
149021684|NCT01254890|537557391|FG001|Overall Study|Ineligible|3|||
149021685|NCT01254890|537557390|FG000|Overall Study|Withdrawal by Subject|1|||
149021686|NCT01254890|537557391|FG001|Overall Study|Withdrawal by Subject|2|||
149021687|NCT01254890|537557390|FG000|Overall Study|Disease Progression|0|||
149021688|NCT01254890|537557391|FG001|Overall Study|Disease Progression|5|||
148811343|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
148811344|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
148811345|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
148811346|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
148811347|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
148811348|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
148811349|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
148811350|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811351|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811352|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811353|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
148811354|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811355|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811356|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811357|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
148811358|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
148811359|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
149021689|NCT01824472|537557392|FG000|Overall Study|Lost to Follow-up|0|||
148811360|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
149021690|NCT01824472|537557393|FG001|Overall Study|Lost to Follow-up|0|||
149021691|NCT01824472|537557394|FG002|Overall Study|Lost to Follow-up|1|||
149021692|NCT01824472|537557392|FG000|Overall Study|Withdrawal by Subject|1|||
149021693|NCT01824472|537557393|FG001|Overall Study|Withdrawal by Subject|5|||
149021694|NCT01824472|537557394|FG002|Overall Study|Withdrawal by Subject|3|||
149021695|NCT01824472|537557392|FG000|Overall Study|Ineligible post randomization&screening|0|||
149021696|NCT01824472|537557393|FG001|Overall Study|Ineligible post randomization&screening|2|||
149021697|NCT01824472|537557394|FG002|Overall Study|Ineligible post randomization&screening|0|||
149021698|NCT04039503|537557395|FG000|Overall Study|Adverse Event|3|||
149021699|NCT04039503|537557396|FG001|Overall Study|Adverse Event|0|||
148691484|NCT00337571|536344191|FG002|Overall Study|Poor/noncompliance|1|||
148691485|NCT00337571|536344192|FG003|Overall Study|Poor/noncompliance|1|||
148691486|NCT00337571|536344189|FG000|Overall Study|No longer met study criteria|1|||
148691487|NCT00337571|536344190|FG001|Overall Study|No longer met study criteria|0|||
148691488|NCT00337571|536344191|FG002|Overall Study|No longer met study criteria|0|||
148691489|NCT00337571|536344192|FG003|Overall Study|No longer met study criteria|0|||
148691490|NCT00337571|536344189|FG000|Overall Study|High Potassium level|0|||
148691491|NCT00337571|536344190|FG001|Overall Study|High Potassium level|0|||
148956533|NCT01896531|537324464|FG000|Overall Study|Death|57|||
148956534|NCT01896531|537324465|FG001|Overall Study|Death|59|||
148956535|NCT01896531|537324464|FG000|Overall Study|Lost to Follow-up|3|||
148956536|NCT01896531|537324465|FG001|Overall Study|Lost to Follow-up|0|||
148956537|NCT01896531|537324464|FG000|Overall Study|Non-compliance|0|||
148956538|NCT01896531|537324465|FG001|Overall Study|Non-compliance|1|||
148956539|NCT01896531|537324464|FG000|Overall Study|Study Ended by Sponsor|7|||
148956540|NCT01896531|537324465|FG001|Overall Study|Study Ended by Sponsor|20|||
148956541|NCT01896531|537324464|FG000|Overall Study|Withdrawal by Subject|3|||
148956542|NCT01896531|537324465|FG001|Overall Study|Withdrawal by Subject|2|||
148956543|NCT01896531|537324464|FG000|Overall Study|Death Prior to Treatment|1|||
148956544|NCT01896531|537324465|FG001|Overall Study|Death Prior to Treatment|0|||
148956545|NCT03325075|537324466|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
148956546|NCT03325075|537324467|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
148956547|NCT03325075|537324468|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
148956548|NCT03325075|537324469|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
148956549|NCT03325075|537324466|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
148956550|NCT03325075|537324467|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
148956551|NCT03325075|537324468|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
148956552|NCT03325075|537324469|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
148956553|NCT03325075|537324466|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
148956554|NCT03325075|537324467|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
148956555|NCT03325075|537324468|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
148956556|NCT03325075|537324469|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
148956557|NCT04210310|537324470|FG000|Overall Study|Lost to Follow-up|32|||
148956558|NCT04210310|537324471|FG001|Overall Study|Lost to Follow-up|1|||
148956559|NCT01585194|537324472|FG000|Overall Study|Withdrawal by Subject|1|||
148956560|NCT01585194|537324472|FG000|Overall Study|Physician Decision|2|||
148956561|NCT01585194|537324472|FG000|Overall Study|Lack of insurance|1|||
148956562|NCT01333059|537324473|FG000|Overall Study|Physician Decision|3|||
148956563|NCT01333059|537324474|FG001|Overall Study|Physician Decision|3|||
148956564|NCT01333059|537324473|FG000|Overall Study|Protocol Violation|3|||
148956565|NCT01333059|537324474|FG001|Overall Study|Protocol Violation|0|||
148956566|NCT02457910|537324488|FG000|Overall Study|Withdrawal by Subject|0|||
148956567|NCT02457910|537324489|FG001|Overall Study|Withdrawal by Subject|0|||
148956568|NCT02457910|537324490|FG002|Overall Study|Withdrawal by Subject|0|||
148956569|NCT02457910|537324491|FG003|Overall Study|Withdrawal by Subject|0|||
148956570|NCT02457910|537324492|FG004|Overall Study|Withdrawal by Subject|0|||
148956571|NCT02457910|537324493|FG005|Overall Study|Withdrawal by Subject|1|||
148956572|NCT02457910|537324488|FG000|Overall Study|Adverse Event|0|||
148956573|NCT02457910|537324489|FG001|Overall Study|Adverse Event|2|||
148956574|NCT02457910|537324490|FG002|Overall Study|Adverse Event|1|||
148956575|NCT02457910|537324491|FG003|Overall Study|Adverse Event|1|||
148956576|NCT02457910|537324492|FG004|Overall Study|Adverse Event|1|||
148956577|NCT02457910|537324493|FG005|Overall Study|Adverse Event|3|||
148956578|NCT02457910|537324488|FG000|Overall Study|Disease progression|3|||
148956579|NCT02457910|537324489|FG001|Overall Study|Disease progression|3|||
148956580|NCT02457910|537324490|FG002|Overall Study|Disease progression|1|||
148956581|NCT02457910|537324491|FG003|Overall Study|Disease progression|1|||
148956582|NCT02457910|537324492|FG004|Overall Study|Disease progression|4|||
148956583|NCT02457910|537324493|FG005|Overall Study|Disease progression|6|||
148956584|NCT02457910|537324488|FG000|Overall Study|Other complicating illness|0|||
148956585|NCT02457910|537324489|FG001|Overall Study|Other complicating illness|0|||
148956586|NCT02457910|537324490|FG002|Overall Study|Other complicating illness|0|||
148956587|NCT02457910|537324491|FG003|Overall Study|Other complicating illness|0|||
149021700|NCT04039503|537557397|FG002|Overall Study|Adverse Event|2|||
148691492|NCT00337571|536344191|FG002|Overall Study|High Potassium level|0|||
148691493|NCT00337571|536344192|FG003|Overall Study|High Potassium level|1|||
148691494|NCT01974895|536344199|FG000|Overall Study|Protocol Violation|1|||
148691495|NCT01974895|536344200|FG001|Overall Study|Protocol Violation|0|||
148956588|NCT02457910|537324492|FG004|Overall Study|Other complicating illness|0|||
148956589|NCT02457910|537324493|FG005|Overall Study|Other complicating illness|1|||
148956590|NCT02457910|537324488|FG000|Overall Study|Death|0|||
148956591|NCT02457910|537324489|FG001|Overall Study|Death|0|||
148956592|NCT02457910|537324490|FG002|Overall Study|Death|1|||
148956593|NCT02457910|537324491|FG003|Overall Study|Death|0|||
148956594|NCT02457910|537324492|FG004|Overall Study|Death|0|||
148956595|NCT02457910|537324493|FG005|Overall Study|Death|0|||
149021701|NCT04039503|537557398|FG003|Overall Study|Adverse Event|0|||
149021702|NCT04039503|537557395|FG000|Overall Study|Lost to Follow-up|0|||
149021703|NCT04039503|537557396|FG001|Overall Study|Lost to Follow-up|0|||
149021704|NCT04039503|537557397|FG002|Overall Study|Lost to Follow-up|1|||
149021705|NCT04039503|537557398|FG003|Overall Study|Lost to Follow-up|0|||
149021706|NCT04039503|537557395|FG000|Overall Study|Protocol Violation|0|||
149021707|NCT04039503|537557396|FG001|Overall Study|Protocol Violation|1|||
149021708|NCT04039503|537557397|FG002|Overall Study|Protocol Violation|2|||
149021709|NCT04039503|537557398|FG003|Overall Study|Protocol Violation|1|||
149021710|NCT04039503|537557395|FG000|Overall Study|Withdrawal by Subject|4|||
149021711|NCT04039503|537557396|FG001|Overall Study|Withdrawal by Subject|3|||
149021712|NCT04039503|537557397|FG002|Overall Study|Withdrawal by Subject|5|||
149021713|NCT04039503|537557398|FG003|Overall Study|Withdrawal by Subject|2|||
149021714|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
149021715|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
149021716|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
149021717|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
149021718|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
149021719|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
149021720|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
149021721|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
149021722|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
149021723|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
149021724|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
149021725|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
149021726|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
149021727|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
149021728|NCT01815736|537557399|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
149055919|NCT01369355|537689005|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
148956596|NCT06079320|537324494|FG000|Follow up Phase|Lost to Follow-up|1|||
148956597|NCT06079320|537324495|FG001|Follow up Phase|Lost to Follow-up|0|||
148956598|NCT01405742|537324496|FG000|Overall Study|Lost to Follow-up|1|||
148956599|NCT01405742|537324497|FG001|Overall Study|Lost to Follow-up|0|||
148956600|NCT04900220|537324498|FG000|Overall Study|Lost to Follow-up|1|||
148956601|NCT04900220|537324499|FG001|Overall Study|Lost to Follow-up|1|||
148956602|NCT02196558|537324500|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
148956603|NCT02196558|537324501|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
148956604|NCT02196558|537324502|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
148956605|NCT02196558|537324500|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
148956606|NCT02196558|537324501|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
148956607|NCT02196558|537324502|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
148956608|NCT02196558|537324500|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
148956609|NCT02196558|537324501|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
148956610|NCT02196558|537324502|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
148956611|NCT02196558|537324500|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
148956612|NCT02196558|537324501|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
148956613|NCT02196558|537324502|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
148956614|NCT02196558|537324500|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
148956615|NCT02196558|537324501|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
148956616|NCT02196558|537324502|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
148956617|NCT03428360|537324503|FG000|Overall Study|Informed consent withdrawn|5|||
148956618|NCT03428360|537324503|FG000|Overall Study|Withdrawal by Subject|4|||
148956619|NCT03428360|537324503|FG000|Overall Study|Lost to Follow-up|5|||
148956620|NCT03428360|537324503|FG000|Overall Study|Physician Decision|2|||
148956621|NCT03428360|537324503|FG000|Overall Study|Informed consent withdrawn|5|||
148956622|NCT03428360|537324503|FG000|Overall Study|Study terminated by sponsor|10|||
148956623|NCT03428360|537324503|FG000|Overall Study|Non-compliant with study|1|||
148956624|NCT03428360|537324503|FG000|Overall Study|Non-compliant with study drug|3|||
148956625|NCT03428360|537324503|FG000|Overall Study|Death|3|||
148956626|NCT03428360|537324503|FG000|Overall Study|Adverse Event|1|||
148956627|NCT03428360|537324503|FG000|Overall Study|Not on antiepileptic drug|1|||
148956628|NCT01850524|537324506|FG000|Overall Study|Lost to Follow-up|5|||
148956629|NCT01850524|537324507|FG001|Overall Study|Lost to Follow-up|10|||
148956630|NCT01850524|537324506|FG000|Overall Study|Withdrawal by Subject|24|||
148956631|NCT01850524|537324507|FG001|Overall Study|Withdrawal by Subject|22|||
148956632|NCT01850524|537324506|FG000|Overall Study|Reason not Specified|142|||
148956633|NCT01850524|537324507|FG001|Overall Study|Reason not Specified|141|||
148956634|NCT00368355|537324508|FG000|Overall Study|Adverse Event|1|||
148956635|NCT00368355|537324509|FG001|Overall Study|Adverse Event|0|||
148956636|NCT00368355|537324508|FG000|Overall Study|Death|2|||
148956637|NCT00368355|537324509|FG001|Overall Study|Death|4|||
148956638|NCT00368355|537324508|FG000|Overall Study|Relapse|6|||
149021729|NCT01815736|537557400|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
149021730|NCT01815736|537557399|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
149021731|NCT01815736|537557400|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
149021732|NCT01815736|537557399|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
149021733|NCT01815736|537557400|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
149021734|NCT01815736|537557399|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
149021735|NCT01815736|537557400|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
149021736|NCT01815736|537557399|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
149021737|NCT01815736|537557400|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
149021738|NCT01815736|537557399|FG000|Extension Treatment Phase- After Week 96|Death|1|||
149021739|NCT01815736|537557400|FG001|Extension Treatment Phase- After Week 96|Death|0|||
149021740|NCT03387514|537557402|FG000|Overall Study|Withdrawal by Subject|2|||
149021741|NCT03387514|537557402|FG000|Overall Study|Physician Decision|1|||
149021742|NCT03387514|537557402|FG000|Overall Study|Lost to Follow-up|2|||
149021743|NCT03317379|537557405|FG000|Overall Study|Lost to Follow-up|0|||
149021744|NCT03317379|537557406|FG001|Overall Study|Lost to Follow-up|3|||
149021745|NCT03317379|537557407|FG002|Overall Study|Lost to Follow-up|2|||
149021746|NCT02846558|537557408|FG000|Overall Study|Adverse Event|1|||
149021747|NCT02846558|537557409|FG001|Overall Study|Adverse Event|0|||
149021748|NCT02846558|537557410|FG002|Overall Study|Adverse Event|0|||
149021749|NCT02846558|537557411|FG003|Overall Study|Adverse Event|0|||
149021750|NCT02846558|537557408|FG000|Overall Study|Withdrawal by Subject|5|||
149021751|NCT02846558|537557409|FG001|Overall Study|Withdrawal by Subject|4|||
149021752|NCT02846558|537557410|FG002|Overall Study|Withdrawal by Subject|2|||
149021753|NCT02846558|537557411|FG003|Overall Study|Withdrawal by Subject|2|||
149021754|NCT02846558|537557408|FG000|Overall Study|Lost to Follow-up|2|||
149021755|NCT02846558|537557409|FG001|Overall Study|Lost to Follow-up|0|||
149021756|NCT02846558|537557410|FG002|Overall Study|Lost to Follow-up|0|||
149021757|NCT02846558|537557411|FG003|Overall Study|Lost to Follow-up|0|||
149021758|NCT04445155|537557412|FG000|Overall Study|Lost to Follow-up|11|||
149021759|NCT04445155|537557413|FG001|Overall Study|Lost to Follow-up|2|||
149021760|NCT04445155|537557414|FG002|Overall Study|Lost to Follow-up|3|||
149021761|NCT04445155|537557415|FG003|Overall Study|Lost to Follow-up|0|||
149021762|NCT04445155|537557412|FG000|Overall Study|Withdrawal by Subject|8|||
149021763|NCT04445155|537557413|FG001|Overall Study|Withdrawal by Subject|0|||
149021764|NCT04445155|537557414|FG002|Overall Study|Withdrawal by Subject|0|||
149021765|NCT04445155|537557415|FG003|Overall Study|Withdrawal by Subject|0|||
149055920|NCT01369355|537688997|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
148956639|NCT00368355|537324509|FG001|Overall Study|Relapse|10|||
148956640|NCT00368355|537324508|FG000|Overall Study|Subsequent transplant|0|||
148956641|NCT00368355|537324509|FG001|Overall Study|Subsequent transplant|3|||
148811361|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
148956642|NCT00368355|537324508|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
148811362|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
148956643|NCT00368355|537324509|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
148956644|NCT03473808|537324514|FG000|Overall Study|Withdrawal by Subject|1|||
148956645|NCT03171415|537324517|FG000|Overall Study|Lost to Follow-up|0|||
148888849|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888850|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148956646|NCT03171415|537324518|FG001|Overall Study|Lost to Follow-up|0|||
148888851|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888852|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888853|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888854|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888855|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888856|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148956647|NCT03171415|537324519|FG002|Overall Study|Lost to Follow-up|0|||
148956648|NCT03171415|537324520|FG003|Overall Study|Lost to Follow-up|0|||
148956649|NCT03171415|537324521|FG004|Overall Study|Lost to Follow-up|2|||
148956650|NCT04059094|537324522|FG000|Overall Study|Adverse Event|0|||
148956651|NCT04059094|537324523|FG001|Overall Study|Adverse Event|0|||
148956652|NCT04059094|537324524|FG002|Overall Study|Adverse Event|0|||
148956653|NCT04059094|537324525|FG003|Overall Study|Adverse Event|0|||
148956654|NCT04059094|537324526|FG004|Overall Study|Adverse Event|1|||
148956655|NCT04059094|537324522|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
148956656|NCT04059094|537324523|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
148956657|NCT04059094|537324524|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
148956658|NCT04059094|537324525|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
148956659|NCT04059094|537324526|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
148956660|NCT01339429|537324527|FG000|Overall Study|Withdrawal by Subject|1|||
148956661|NCT01339429|537324527|FG000|Overall Study|Physician Decision|3|||
148956662|NCT01085591|537324536|FG000|Overall Study|Adverse Event|0|||
148956663|NCT01085591|537324537|FG001|Overall Study|Adverse Event|1|||
148956664|NCT01085591|537324538|FG002|Overall Study|Adverse Event|3|||
148956665|NCT01085591|537324536|FG000|Overall Study|Physician Decision|1|||
148956666|NCT01085591|537324537|FG001|Overall Study|Physician Decision|0|||
148956667|NCT01085591|537324538|FG002|Overall Study|Physician Decision|1|||
148956668|NCT01085591|537324536|FG000|Overall Study|Withdrawal by Subject|0|||
148956669|NCT01085591|537324537|FG001|Overall Study|Withdrawal by Subject|2|||
148956670|NCT01085591|537324538|FG002|Overall Study|Withdrawal by Subject|1|||
148956671|NCT01085591|537324536|FG000|Overall Study|Lost to Follow-up|0|||
148956672|NCT01085591|537324537|FG001|Overall Study|Lost to Follow-up|1|||
148956673|NCT01085591|537324538|FG002|Overall Study|Lost to Follow-up|1|||
148956674|NCT01085591|537324536|FG000|Overall Study|Protocol Violation|1|||
148956675|NCT01085591|537324537|FG001|Overall Study|Protocol Violation|1|||
148956676|NCT01085591|537324538|FG002|Overall Study|Protocol Violation|1|||
148956677|NCT01085591|537324536|FG000|Overall Study|Other|0|||
148956678|NCT01085591|537324537|FG001|Overall Study|Other|1|||
148956679|NCT01085591|537324538|FG002|Overall Study|Other|0|||
148956680|NCT01085591|537324536|FG000|Overall Study|Not Properly Consented|1|||
148956681|NCT01085591|537324537|FG001|Overall Study|Not Properly Consented|0|||
148956682|NCT01085591|537324538|FG002|Overall Study|Not Properly Consented|0|||
148956683|NCT01846611|537324542|FG000|Overall Study|Lost to Follow-up|4|||
148956684|NCT01846611|537324543|FG001|Overall Study|Lost to Follow-up|6|||
148956685|NCT01846611|537324542|FG000|Overall Study|Withdrawal by Subject|15|||
148956686|NCT01846611|537324543|FG001|Overall Study|Withdrawal by Subject|19|||
148956687|NCT01846611|537324542|FG000|Overall Study|Other|19|||
148956688|NCT01846611|537324543|FG001|Overall Study|Other|18|||
148956689|NCT00541034|537324544|FG000|Overall Study|Non-Compliance|3|||
148956690|NCT03061331|537324546|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
148956691|NCT03061331|537324547|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
148956692|NCT02623439|537324550|FG000|Overall Study|Withdrawal by Subject|1|||
148956693|NCT02623439|537324550|FG000|Overall Study|Screen Failure|1|||
148956694|NCT05371509|537324551|FG000|Overall Study|Physician Decision|1|||
148811363|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
148811364|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
148811365|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
148811366|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811367|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811368|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
148811369|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811370|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811371|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811372|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811373|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
148811374|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811375|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811376|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
148811377|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811378|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811379|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811380|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811381|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
148811382|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811383|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811384|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
148811385|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811386|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811387|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811388|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811389|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
148811390|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
148811391|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
148811392|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
148811393|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
148811394|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
148811395|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
148811396|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
148811397|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
148811398|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811399|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811400|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
148811401|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811402|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811403|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811404|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811405|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
148811406|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
148811407|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
148811408|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
148811409|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
148811410|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
148811411|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
148811412|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
148811413|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
148811414|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
148811415|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
148811416|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
148956695|NCT05371509|537324552|FG001|Overall Study|Physician Decision|0|||
148956696|NCT02879305|537324555|FG000|Overall Study|Investigator Site Closed|55|||
148956697|NCT02879305|537324556|FG001|Overall Study|Investigator Site Closed|57|||
148956698|NCT02879305|537324555|FG000|Overall Study|Withdrawal by Subject|44|||
148956699|NCT02879305|537324556|FG001|Overall Study|Withdrawal by Subject|42|||
148956700|NCT02879305|537324555|FG000|Overall Study|Lost to Follow-up|17|||
148956701|NCT02879305|537324556|FG001|Overall Study|Lost to Follow-up|12|||
148956702|NCT02879305|537324555|FG000|Overall Study|Other|1|||
148956703|NCT02879305|537324556|FG001|Overall Study|Other|0|||
148956704|NCT03220217|537326479|FG000|Overall Study|Withdrawal by Subject|0|||
148956705|NCT03220217|537326480|FG001|Overall Study|Withdrawal by Subject|1|||
148956706|NCT03220217|537326481|FG002|Overall Study|Withdrawal by Subject|0|||
148956707|NCT03220217|537326479|FG000|Overall Study|Subject Missed Procedure|0|||
148956708|NCT03220217|537326480|FG001|Overall Study|Subject Missed Procedure|0|||
148956709|NCT03220217|537326481|FG002|Overall Study|Subject Missed Procedure|1|||
148956710|NCT00501293|537326482|FG000|Optimization Period|Enrolled in error|1|||
148956711|NCT00501293|537326483|FG001|Optimization Period|Enrolled in error|0|||
148956712|NCT00501293|537326482|FG000|Maintenance Period|Withdrawal by Subject|14|||
148956713|NCT00501293|537326483|FG001|Maintenance Period|Withdrawal by Subject|13|||
148956714|NCT00501293|537326482|FG000|Maintenance Period|Lost to Follow-up|12|||
148956715|NCT00501293|537326483|FG001|Maintenance Period|Lost to Follow-up|7|||
148956716|NCT00501293|537326482|FG000|Maintenance Period|Adverse Event|6|||
148956717|NCT00501293|537326483|FG001|Maintenance Period|Adverse Event|6|||
148956718|NCT00501293|537326482|FG000|Maintenance Period|Protocol Violation|2|||
148956719|NCT00501293|537326483|FG001|Maintenance Period|Protocol Violation|1|||
148956720|NCT00501293|537326482|FG000|Maintenance Period|Lack of Efficacy|4|||
148956721|NCT00501293|537326483|FG001|Maintenance Period|Lack of Efficacy|1|||
148956722|NCT00501293|537326482|FG000|Maintenance Period|Noncompliant with study medication|5|||
148956723|NCT00501293|537326483|FG001|Maintenance Period|Noncompliant with study medication|0|||
148956724|NCT00501293|537326482|FG000|Maintenance Period|Went into rehabilitation|1|||
148956725|NCT00501293|537326483|FG001|Maintenance Period|Went into rehabilitation|0|||
148956726|NCT00501293|537326482|FG000|Maintenance Period|Would not wear patch|1|||
148956727|NCT00501293|537326483|FG001|Maintenance Period|Would not wear patch|0|||
148956728|NCT00501293|537326482|FG000|Maintenance Period|Application site reaction|1|||
148956729|NCT00501293|537326483|FG001|Maintenance Period|Application site reaction|0|||
148956730|NCT00488345|537326484|FG000|Overall Study|Adverse Event|0|||
148956731|NCT00488345|537326485|FG001|Overall Study|Adverse Event|1|||
148956732|NCT00488345|537326486|FG002|Overall Study|Adverse Event|1|||
148956733|NCT00488345|537326484|FG000|Overall Study|Unable to administer antibiotics at home|0|||
148956734|NCT00488345|537326485|FG001|Overall Study|Unable to administer antibiotics at home|1|||
148956735|NCT00488345|537326486|FG002|Overall Study|Unable to administer antibiotics at home|0|||
148956736|NCT00488345|537326484|FG000|Overall Study|Institutional Review Board review|0|||
148956737|NCT00488345|537326485|FG001|Overall Study|Institutional Review Board review|0|||
148956738|NCT00488345|537326486|FG002|Overall Study|Institutional Review Board review|1|||
148956739|NCT00488345|537326484|FG000|Overall Study|Surgical team recommendation|0|||
148956740|NCT00488345|537326485|FG001|Overall Study|Surgical team recommendation|1|||
148956741|NCT00488345|537326486|FG002|Overall Study|Surgical team recommendation|0|||
148956742|NCT00488345|537326484|FG000|Overall Study|Parent/legal guardian request|0|||
148956743|NCT00488345|537326485|FG001|Overall Study|Parent/legal guardian request|1|||
148956744|NCT00488345|537326486|FG002|Overall Study|Parent/legal guardian request|1|||
148956745|NCT00903617|537326489|FG000|Overall Study|Adverse Event|0|||
148956746|NCT00903617|537326490|FG001|Overall Study|Adverse Event|1|||
148956747|NCT00903617|537326491|FG002|Overall Study|Adverse Event|1|||
148956748|NCT00903617|537326492|FG003|Overall Study|Adverse Event|0|||
148956749|NCT00903617|537326489|FG000|Overall Study|Protocol-defined stopping criteria|0|||
148956750|NCT00903617|537326490|FG001|Overall Study|Protocol-defined stopping criteria|2|||
148956751|NCT00903617|537326491|FG002|Overall Study|Protocol-defined stopping criteria|0|||
148956752|NCT00903617|537326492|FG003|Overall Study|Protocol-defined stopping criteria|0|||
148956753|NCT00903617|537326489|FG000|Overall Study|Lost to Follow-up|2|||
148956754|NCT00903617|537326490|FG001|Overall Study|Lost to Follow-up|0|||
148956755|NCT00903617|537326491|FG002|Overall Study|Lost to Follow-up|1|||
148956756|NCT00903617|537326492|FG003|Overall Study|Lost to Follow-up|1|||
148956757|NCT00903617|537326489|FG000|Overall Study|Withdrawal by Subject|1|||
148956758|NCT00903617|537326490|FG001|Overall Study|Withdrawal by Subject|2|||
148956759|NCT00903617|537326491|FG002|Overall Study|Withdrawal by Subject|3|||
148956760|NCT00903617|537326492|FG003|Overall Study|Withdrawal by Subject|0|||
148956761|NCT01104636|537326493|FG000|Overall Study|Lack of Efficacy|43|||
148956762|NCT01104636|537326493|FG000|Overall Study|Lost to Follow-up|24|||
148956763|NCT01104636|537326493|FG000|Overall Study|Withdrawal by Subject|4|||
148956764|NCT01104636|537326493|FG000|Overall Study|Other|43|||
148956765|NCT01104636|537326493|FG000|Overall Study|Study terminated by sponsor|1|||
148956766|NCT01104636|537326493|FG000|Overall Study|Pregnancy|2|||
148956767|NCT01104636|537326493|FG000|Overall Study|Adverse Event|40|||
148956768|NCT01104636|537326493|FG000|Overall Study|Ongoing|21|||
148956769|NCT02259582|537326498|FG000|Overall Study|Physician Decision|0|||
148956770|NCT02259582|537326499|FG001|Overall Study|Physician Decision|1|||
148956771|NCT02259582|537326500|FG002|Overall Study|Physician Decision|0|||
148956772|NCT02259582|537326498|FG000|Overall Study|Death|0|||
148956773|NCT02259582|537326499|FG001|Overall Study|Death|0|||
148956774|NCT02259582|537326500|FG002|Overall Study|Death|1|||
148956775|NCT02259582|537326498|FG000|Overall Study|Adverse Event|1|||
148956776|NCT02259582|537326499|FG001|Overall Study|Adverse Event|0|||
148956777|NCT02259582|537326500|FG002|Overall Study|Adverse Event|1|||
148956778|NCT02259582|537326498|FG000|Overall Study|Withdrawal by Subject|0|||
148956779|NCT02259582|537326499|FG001|Overall Study|Withdrawal by Subject|0|||
148956780|NCT02259582|537326500|FG002|Overall Study|Withdrawal by Subject|1|||
148956781|NCT02259582|537326498|FG000|Overall Study|Disease progression|14|||
148956782|NCT02259582|537326499|FG001|Overall Study|Disease progression|15|||
148956783|NCT02259582|537326500|FG002|Overall Study|Disease progression|17|||
148956784|NCT02259582|537326498|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
148956785|NCT02259582|537326499|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
148956786|NCT02259582|537326500|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
148956787|NCT03518073|537326501|FG000|Overall Study|Adverse Event|2|||
148956788|NCT03518073|537326502|FG001|Overall Study|Adverse Event|4|||
148956789|NCT03518073|537326503|FG002|Overall Study|Adverse Event|2|||
148956790|NCT03518073|537326501|FG000|Overall Study|Death|2|||
148956791|NCT03518073|537326502|FG001|Overall Study|Death|1|||
148956792|NCT03518073|537326503|FG002|Overall Study|Death|3|||
148956793|NCT03518073|537326501|FG000|Overall Study|Lost to Follow-up|1|||
148956794|NCT03518073|537326502|FG001|Overall Study|Lost to Follow-up|0|||
148956795|NCT03518073|537326503|FG002|Overall Study|Lost to Follow-up|1|||
148956796|NCT03518073|537326501|FG000|Overall Study|Physician Decision|5|||
148956797|NCT03518073|537326502|FG001|Overall Study|Physician Decision|0|||
148956798|NCT03518073|537326503|FG002|Overall Study|Physician Decision|2|||
148956799|NCT03518073|537326501|FG000|Overall Study|Progressive disease|1|||
148956800|NCT03518073|537326502|FG001|Overall Study|Progressive disease|1|||
148956801|NCT03518073|537326503|FG002|Overall Study|Progressive disease|1|||
148956802|NCT03518073|537326501|FG000|Overall Study|Protocol Violation|1|||
148956803|NCT03518073|537326502|FG001|Overall Study|Protocol Violation|0|||
148956804|NCT03518073|537326503|FG002|Overall Study|Protocol Violation|0|||
148956805|NCT03518073|537326501|FG000|Overall Study|Withdrawal by Subject|30|||
148956806|NCT03518073|537326502|FG001|Overall Study|Withdrawal by Subject|34|||
148956807|NCT03518073|537326503|FG002|Overall Study|Withdrawal by Subject|29|||
148956808|NCT03518073|537326501|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
148956809|NCT03518073|537326502|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
148956810|NCT03518073|537326503|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
148956811|NCT03518073|537326501|FG000|Overall Study|Covid-19|1|||
148956812|NCT03518073|537326502|FG001|Overall Study|Covid-19|2|||
148956813|NCT03518073|537326503|FG002|Overall Study|Covid-19|1|||
148956814|NCT03045081|537326504|FG000|Overall Study|Withdrawal by Subject|6|||
148956815|NCT03045081|537326505|FG001|Overall Study|Withdrawal by Subject|11|||
148956816|NCT00475176|537326506|FG000|Overall Study|Adverse Event|2|||
148956817|NCT00475176|537326506|FG000|Overall Study|Withdrawal by Subject|1|||
148956818|NCT00475176|537326506|FG000|Overall Study|Protocol Violation|1|||
148956819|NCT01853046|537326507|FG000|Overall Study|Withdrawal by Subject|1|||
148956820|NCT01853046|537326508|FG001|Overall Study|Withdrawal by Subject|1|||
148956821|NCT01853046|537326507|FG000|Overall Study|Adverse Event|4|||
148956822|NCT01853046|537326508|FG001|Overall Study|Adverse Event|2|||
148956823|NCT01853046|537326507|FG000|Overall Study|Disease progression|13|||
148956824|NCT01853046|537326508|FG001|Overall Study|Disease progression|3|||
148956825|NCT01463878|537326512|FG000|Overall Study|no longer met criteria for tube feed|2|||
148956826|NCT01463878|537326513|FG001|Overall Study|no longer met criteria for tube feed|2|||
148956827|NCT03804879|537326514|FG000|Overall Study|Adverse Event|3|||
148956828|NCT03804879|537326515|FG001|Overall Study|Adverse Event|0|||
148956829|NCT03804879|537326514|FG000|Overall Study|Study Terminated By Sponsor|10|||
148956830|NCT03804879|537326515|FG001|Overall Study|Study Terminated By Sponsor|12|||
148956831|NCT03804879|537326514|FG000|Overall Study|Withdrawal by Subject|3|||
149021766|NCT04445155|537557412|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
149021767|NCT04445155|537557413|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
149021768|NCT04445155|537557414|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
149021769|NCT04445155|537557415|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
149021770|NCT04445155|537557412|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
149021771|NCT04445155|537557413|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
149021772|NCT04445155|537557414|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
149021773|NCT04445155|537557415|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
149021774|NCT03363659|537557418|FG000|Overall Study|Adverse Event|1|||
149021775|NCT03363659|537557418|FG000|Overall Study|Screen fail|1|||
149021776|NCT03363659|537557418|FG000|Overall Study|Withdrawal by Subject|1|||
149021777|NCT03872388|537557419|FG000|Overall Study|Disease Progression|0|||
149021778|NCT03872388|537557420|FG001|Overall Study|Disease Progression|0|||
149021779|NCT03872388|537557421|FG002|Overall Study|Disease Progression|0|||
149021780|NCT03872388|537557422|FG003|Overall Study|Disease Progression|0|||
149021781|NCT03872388|537557423|FG004|Overall Study|Disease Progression|0|||
149021782|NCT03872388|537557424|FG005|Overall Study|Disease Progression|0|||
149021783|NCT03872388|537557425|FG006|Overall Study|Disease Progression|1|||
149021784|NCT03872388|537557426|FG007|Overall Study|Disease Progression|1|||
149021785|NCT03531905|537558924|FG000|Overall Study|Withdrawal by Subject|3|||
149021786|NCT03531905|537558925|FG001|Overall Study|Withdrawal by Subject|3|||
149021787|NCT03531905|537558926|FG002|Overall Study|Withdrawal by Subject|2|||
149021788|NCT03531905|537558924|FG000|Overall Study|Lost to Follow-up|2|||
149021789|NCT03531905|537558925|FG001|Overall Study|Lost to Follow-up|2|||
149021790|NCT03531905|537558926|FG002|Overall Study|Lost to Follow-up|1|||
149021791|NCT03531905|537558924|FG000|Overall Study|Participant was out of town|1|||
149021792|NCT03531905|537558925|FG001|Overall Study|Participant was out of town|0|||
149021793|NCT03531905|537558926|FG002|Overall Study|Participant was out of town|0|||
149021794|NCT03531905|537558924|FG000|Overall Study|Could not speak with the participant|1|||
149021795|NCT03531905|537558925|FG001|Overall Study|Could not speak with the participant|0|||
149021796|NCT03531905|537558926|FG002|Overall Study|Could not speak with the participant|0|||
149021797|NCT01036087|537558927|FG000|Overall Study|Adverse Event|2|||
149021798|NCT01036087|537558927|FG000|Overall Study|Lack of Efficacy|1|||
149021799|NCT01625338|537558930|FG000|Overall Study|Enrolled but not Treated|0|||
149021800|NCT01625338|537558931|FG001|Overall Study|Enrolled but not Treated|0|||
149021801|NCT01625338|537558932|FG002|Overall Study|Enrolled but not Treated|1|||
149021802|NCT01625338|537558930|FG000|Overall Study|Efficacy Failure|27|||
149021803|NCT01625338|537558931|FG001|Overall Study|Efficacy Failure|39|||
149021804|NCT01625338|537558932|FG002|Overall Study|Efficacy Failure|31|||
149021805|NCT01625338|537558930|FG000|Overall Study|Lost to Follow-up|3|||
149021806|NCT01625338|537558931|FG001|Overall Study|Lost to Follow-up|3|||
149021807|NCT01625338|537558932|FG002|Overall Study|Lost to Follow-up|2|||
149021808|NCT01625338|537558930|FG000|Overall Study|Investigator Decision|0|||
149021809|NCT01625338|537558931|FG001|Overall Study|Investigator Decision|2|||
149021810|NCT01625338|537558932|FG002|Overall Study|Investigator Decision|1|||
149021811|NCT01625338|537558930|FG000|Overall Study|Subject Withdrew Consent|1|||
149021812|NCT01625338|537558931|FG001|Overall Study|Subject Withdrew Consent|0|||
149021813|NCT01625338|537558932|FG002|Overall Study|Subject Withdrew Consent|2|||
149021814|NCT01625338|537558930|FG000|Overall Study|Adverse Event|1|||
149021815|NCT01625338|537558931|FG001|Overall Study|Adverse Event|0|||
148956832|NCT03804879|537326515|FG001|Overall Study|Withdrawal by Subject|1|||
148956833|NCT02436889|537326516|FG000|Overall Study|No improvement in symptoms|1|||
148956834|NCT02436889|537326517|FG001|Overall Study|No improvement in symptoms|0|||
148956835|NCT02436889|537326516|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
148956836|NCT02436889|537326517|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
148956837|NCT01710033|537326520|FG000|Stage 2|Adverse Event|0|||
148956838|NCT01710033|537326521|FG001|Stage 2|Adverse Event|0|||
148956839|NCT01710033|537326522|FG002|Stage 2|Adverse Event|0|||
149021816|NCT01625338|537558932|FG002|Overall Study|Adverse Event|1|||
149021817|NCT01625338|537558930|FG000|Overall Study|Study Discontinued by Sponsor|0|||
149021818|NCT01625338|537558931|FG001|Overall Study|Study Discontinued by Sponsor|0|||
149021819|NCT01625338|537558932|FG002|Overall Study|Study Discontinued by Sponsor|1|||
149021820|NCT01477749|537558937|FG000|Overall Study|Physician Decision|4|||
149021821|NCT04172987|537558938|FG000|Lead In Period|Adverse Event|1|||
148691496|NCT01974895|536344199|FG000|Overall Study|Lost to Follow-up|4|||
148691497|NCT01974895|536344200|FG001|Overall Study|Lost to Follow-up|6|||
148691498|NCT01974895|536344199|FG000|Overall Study|Withdrawal by Subject|0|||
148691499|NCT01974895|536344200|FG001|Overall Study|Withdrawal by Subject|1|||
148691500|NCT01974895|536344199|FG000|Overall Study|Other (Missed Visit)|1|||
148691501|NCT01974895|536344200|FG001|Overall Study|Other (Missed Visit)|0|||
148691502|NCT01974895|536344199|FG000|Overall Study|Other (Reason unknown)|9|||
148691503|NCT01974895|536344200|FG001|Overall Study|Other (Reason unknown)|8|||
148691504|NCT00635154|536344201|FG000|Overall Study|Alternative Treatment|8|||
148691505|NCT00635154|536344201|FG000|Overall Study|Other|4|||
148691506|NCT00635154|536344201|FG000|Overall Study|Still on treatment|21|||
148691507|NCT01513148|536344202|FG000|Overall Study|Protocol Violation|2|||
148691508|NCT01513148|536344203|FG001|Overall Study|Protocol Violation|2|||
148811417|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
148811418|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
148811419|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
148811420|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
148811421|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
148811422|NCT03329001|536787054|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
148811423|NCT03329001|536787055|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
148811424|NCT03329001|536787056|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
148811425|NCT03329001|536787057|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
148811426|NCT03329001|536787058|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
148811427|NCT03329001|536787059|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
148811428|NCT03329001|536787060|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
148811429|NCT03329001|536787061|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
148811430|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811431|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811432|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811433|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
148811434|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811435|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811436|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811437|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
148811438|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811439|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811440|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811441|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
148811442|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811443|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811444|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811445|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
148811446|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148811447|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148811448|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
148811449|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148811450|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148956840|NCT01710033|537326523|FG003|Stage 2|Adverse Event|0|||
148691509|NCT01399736|536344204|FG000|Overall Study|Withdrawal by Subject|4|||
148691510|NCT01399736|536344205|FG001|Overall Study|Withdrawal by Subject|2|||
148691511|NCT01399736|536344204|FG000|Overall Study|Lost to Follow-up|0|||
148691512|NCT01399736|536344205|FG001|Overall Study|Lost to Follow-up|2|||
148691513|NCT03500484|536344206|FG000|Overall Study|Adverse Event|2|||
148691514|NCT03500484|536344207|FG001|Overall Study|Adverse Event|0|||
148691515|NCT03500484|536344206|FG000|Overall Study|Physician Decision|1|||
148691516|NCT03500484|536344207|FG001|Overall Study|Physician Decision|0|||
148691517|NCT03500484|536344206|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
148691518|NCT03500484|536344207|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
148691519|NCT00948675|536344208|FG000|Overall Study|Lost to Follow-up|1|||
148691520|NCT00948675|536344209|FG001|Overall Study|Lost to Follow-up|0|||
148691521|NCT03552757|536344210|FG000|Overall Study|Withdrawal by Subject|10|||
148691522|NCT03552757|536344211|FG001|Overall Study|Withdrawal by Subject|5|||
148691523|NCT03552757|536344212|FG002|Overall Study|Withdrawal by Subject|12|||
148691524|NCT03552757|536344210|FG000|Overall Study|Lost to Follow-up|2|||
148691525|NCT03552757|536344211|FG001|Overall Study|Lost to Follow-up|7|||
148691526|NCT03552757|536344212|FG002|Overall Study|Lost to Follow-up|7|||
148691527|NCT03552757|536344210|FG000|Overall Study|Death|1|||
148811451|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148811452|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148811453|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
148811454|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
148811455|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
148811456|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
148811457|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
148811458|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
148811459|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
148811460|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
148811461|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
148811462|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811463|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811464|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
148811465|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811466|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811467|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811468|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811469|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
148811470|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
148811471|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
148811472|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
148811473|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
148811474|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
148811475|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
148811476|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
148691528|NCT03552757|536344211|FG001|Overall Study|Death|1|||
148691529|NCT03552757|536344212|FG002|Overall Study|Death|1|||
148691530|NCT00449150|536344213|FG000|Overall Study|Adverse Event|11|||
148691531|NCT00449150|536344214|FG001|Overall Study|Adverse Event|18|||
149021822|NCT04172987|537558938|FG000|Lead In Period|Protocol Violation|1|||
149021823|NCT04172987|537558938|FG000|Period 1|Physician Decision|1|||
149021824|NCT04172987|537558938|FG000|Period 2|Adverse Event|5|||
149021825|NCT04172987|537558938|FG000|Period 2|Dosing Termination by Sponsor|4|||
149021826|NCT04179461|537558946|FG000|Overall Study|Lost to Follow-up|4|||
149021827|NCT03100838|537558947|FG000|Overall Study|Adverse Event|1|||
149021828|NCT03100838|537558948|FG001|Overall Study|Adverse Event|0|||
149021829|NCT03100838|537558949|FG002|Overall Study|Adverse Event|0|||
149021830|NCT03100838|537558950|FG003|Overall Study|Adverse Event|0|||
149021831|NCT03100838|537558947|FG000|Overall Study|Physician Decision|1|||
149021832|NCT03100838|537558948|FG001|Overall Study|Physician Decision|1|||
149021833|NCT03100838|537558949|FG002|Overall Study|Physician Decision|1|||
149021834|NCT03100838|537558950|FG003|Overall Study|Physician Decision|1|||
149021835|NCT03100838|537558947|FG000|Overall Study|Pregnancy|0|||
149021836|NCT03100838|537558948|FG001|Overall Study|Pregnancy|1|||
149021837|NCT03100838|537558949|FG002|Overall Study|Pregnancy|0|||
149021838|NCT03100838|537558950|FG003|Overall Study|Pregnancy|0|||
149021839|NCT03100838|537558947|FG000|Overall Study|Lost to Follow-up|0|||
149021840|NCT03100838|537558948|FG001|Overall Study|Lost to Follow-up|0|||
149021841|NCT03100838|537558949|FG002|Overall Study|Lost to Follow-up|1|||
149021842|NCT03100838|537558950|FG003|Overall Study|Lost to Follow-up|0|||
149021843|NCT00184028|537558951|FG000|Overall Study|Death|1|||
149021844|NCT00184028|537558951|FG000|Overall Study|Lack of Efficacy|4|||
149021845|NCT00184028|537558951|FG000|Overall Study|Adverse Event|2|||
149021846|NCT00184028|537558951|FG000|Overall Study|Withdrawal by Subject|1|||
149021847|NCT00184028|537558951|FG000|Overall Study|Non-compliance|2|||
149021848|NCT01347645|537558952|FG000|Overall Study|Death|1|||
149021849|NCT01347645|537558953|FG001|Overall Study|Death|5|||
149021850|NCT01347645|537558954|FG002|Overall Study|Death|2|||
149021851|NCT01347645|537558955|FG003|Overall Study|Death|7|||
149021852|NCT01347645|537558956|FG004|Overall Study|Death|7|||
149021853|NCT01347645|537558952|FG000|Overall Study|Lost to Follow-up|1|||
149021854|NCT01347645|537558953|FG001|Overall Study|Lost to Follow-up|1|||
149021855|NCT01347645|537558954|FG002|Overall Study|Lost to Follow-up|0|||
149021856|NCT01347645|537558955|FG003|Overall Study|Lost to Follow-up|1|||
149021857|NCT01347645|537558956|FG004|Overall Study|Lost to Follow-up|1|||
149021858|NCT01347645|537558952|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
149021859|NCT01347645|537558953|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
149021860|NCT01347645|537558954|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
148811477|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
149021861|NCT01347645|537558955|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
149021862|NCT01347645|537558956|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
149021863|NCT01347645|537558952|FG000|Overall Study|Other|1|||
149021864|NCT01347645|537558953|FG001|Overall Study|Other|0|||
149021865|NCT01347645|537558954|FG002|Overall Study|Other|0|||
149021866|NCT01347645|537558955|FG003|Overall Study|Other|0|||
149021867|NCT01347645|537558956|FG004|Overall Study|Other|1|||
149021868|NCT01347645|537558952|FG000|Overall Study|Withdrawal by Subject|0|||
149021869|NCT01347645|537558953|FG001|Overall Study|Withdrawal by Subject|0|||
149021870|NCT01347645|537558954|FG002|Overall Study|Withdrawal by Subject|0|||
149021871|NCT01347645|537558955|FG003|Overall Study|Withdrawal by Subject|3|||
149021872|NCT01347645|537558956|FG004|Overall Study|Withdrawal by Subject|3|||
149021873|NCT01347645|537558952|FG000|Overall Study|Physician Decision|0|||
149021874|NCT01347645|537558953|FG001|Overall Study|Physician Decision|0|||
149021875|NCT01347645|537558954|FG002|Overall Study|Physician Decision|0|||
149021876|NCT01347645|537558955|FG003|Overall Study|Physician Decision|0|||
149021877|NCT01347645|537558956|FG004|Overall Study|Physician Decision|1|||
149021878|NCT01347645|537558952|FG000|Overall Study|Adverse Event|0|||
148811478|NCT03329001|536787054|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149021879|NCT01347645|537558953|FG001|Overall Study|Adverse Event|0|||
149021880|NCT01347645|537558954|FG002|Overall Study|Adverse Event|0|||
149021881|NCT01347645|537558955|FG003|Overall Study|Adverse Event|1|||
149021882|NCT01347645|537558956|FG004|Overall Study|Adverse Event|1|||
149021883|NCT01141660|537558957|FG000|Overall Study|Physician Decision|0|||
149021884|NCT01141660|537558958|FG001|Overall Study|Physician Decision|12|||
149021885|NCT00209027|537558960|FG000|Overall Study|study terminated|10|||
149021886|NCT00209027|537558961|FG001|Overall Study|study terminated|0|||
149021887|NCT03785340|537558962|FG000|Overall Study|Lost to Follow-up|2|||
149021888|NCT03785340|537558963|FG001|Overall Study|Lost to Follow-up|0|||
149021889|NCT03785340|537558962|FG000|Overall Study|Adverse Event|1|||
149021890|NCT03785340|537558963|FG001|Overall Study|Adverse Event|0|||
149021891|NCT01848834|537558964|FG000|Overall Study|Adverse Event|3|||
149021892|NCT01848834|537558965|FG001|Overall Study|Adverse Event|11|||
149021893|NCT01848834|537558966|FG002|Overall Study|Adverse Event|3|||
149021894|NCT01848834|537558967|FG003|Overall Study|Adverse Event|5|||
149021895|NCT01848834|537558968|FG004|Overall Study|Adverse Event|9|||
149021896|NCT01848834|537558964|FG000|Overall Study|Death|2|||
149021897|NCT01848834|537558965|FG001|Overall Study|Death|11|||
149021898|NCT01848834|537558966|FG002|Overall Study|Death|1|||
149021899|NCT01848834|537558967|FG003|Overall Study|Death|8|||
149021900|NCT01848834|537558968|FG004|Overall Study|Death|27|||
149021901|NCT01848834|537558964|FG000|Overall Study|Excluded Medication|5|||
149021902|NCT01848834|537558965|FG001|Overall Study|Excluded Medication|4|||
149021903|NCT01848834|537558966|FG002|Overall Study|Excluded Medication|3|||
149021904|NCT01848834|537558967|FG003|Overall Study|Excluded Medication|6|||
149021905|NCT01848834|537558968|FG004|Overall Study|Excluded Medication|6|||
149021906|NCT01848834|537558964|FG000|Overall Study|Lost to Follow-up|5|||
149021907|NCT01848834|537558965|FG001|Overall Study|Lost to Follow-up|5|||
149021908|NCT01848834|537558966|FG002|Overall Study|Lost to Follow-up|3|||
149021909|NCT01848834|537558967|FG003|Overall Study|Lost to Follow-up|0|||
149021910|NCT01848834|537558968|FG004|Overall Study|Lost to Follow-up|3|||
149021911|NCT01848834|537558964|FG000|Overall Study|Physician Decision|1|||
149021912|NCT01848834|537558965|FG001|Overall Study|Physician Decision|3|||
149021913|NCT01848834|537558966|FG002|Overall Study|Physician Decision|4|||
149021914|NCT01848834|537558967|FG003|Overall Study|Physician Decision|0|||
149021915|NCT01848834|537558968|FG004|Overall Study|Physician Decision|11|||
149021916|NCT01848834|537558964|FG000|Overall Study|Protocol Violation|0|||
149021917|NCT01848834|537558965|FG001|Overall Study|Protocol Violation|0|||
149021918|NCT01848834|537558966|FG002|Overall Study|Protocol Violation|0|||
149021919|NCT01848834|537558967|FG003|Overall Study|Protocol Violation|0|||
149021920|NCT01848834|537558968|FG004|Overall Study|Protocol Violation|1|||
149021921|NCT01848834|537558964|FG000|Overall Study|Sponsor Decision|1|||
149021922|NCT01848834|537558965|FG001|Overall Study|Sponsor Decision|1|||
149021923|NCT01848834|537558966|FG002|Overall Study|Sponsor Decision|0|||
149021924|NCT01848834|537558967|FG003|Overall Study|Sponsor Decision|1|||
149021925|NCT01848834|537558968|FG004|Overall Study|Sponsor Decision|1|||
149021926|NCT01848834|537558964|FG000|Overall Study|Withdrawal by Subject|2|||
149021927|NCT01848834|537558965|FG001|Overall Study|Withdrawal by Subject|13|||
149021928|NCT01848834|537558966|FG002|Overall Study|Withdrawal by Subject|10|||
149021929|NCT01848834|537558967|FG003|Overall Study|Withdrawal by Subject|6|||
149021930|NCT01848834|537558968|FG004|Overall Study|Withdrawal by Subject|36|||
149021931|NCT03259373|537558979|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
149021932|NCT03259373|537558980|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
149021933|NCT03259373|537558979|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
149021934|NCT03259373|537558980|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
149021935|NCT03259373|537558979|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
149021936|NCT03259373|537558980|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
149021937|NCT03259373|537558979|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
149021938|NCT03259373|537558980|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
149021939|NCT03259373|537558979|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
149021940|NCT03259373|537558980|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
149021941|NCT03259373|537558979|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
149021942|NCT03259373|537558980|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
149021943|NCT01923428|537558982|FG000|Overall Study|Adverse Event|8|||
149021944|NCT01923428|537558983|FG001|Overall Study|Adverse Event|6|||
149021945|NCT01923428|537558984|FG002|Overall Study|Adverse Event|3|||
149021946|NCT01923428|537558985|FG003|Overall Study|Adverse Event|3|||
149021947|NCT01923428|537558982|FG000|Overall Study|Withdrawal by Subject|5|||
149021948|NCT01923428|537558983|FG001|Overall Study|Withdrawal by Subject|3|||
149021949|NCT01923428|537558984|FG002|Overall Study|Withdrawal by Subject|0|||
149021950|NCT01923428|537558985|FG003|Overall Study|Withdrawal by Subject|4|||
149021951|NCT01923428|537558982|FG000|Overall Study|Lost to Follow-up|2|||
149021952|NCT01923428|537558983|FG001|Overall Study|Lost to Follow-up|1|||
149021953|NCT01923428|537558984|FG002|Overall Study|Lost to Follow-up|5|||
149021954|NCT01923428|537558985|FG003|Overall Study|Lost to Follow-up|0|||
149021955|NCT01923428|537558982|FG000|Overall Study|Protocol Violation|3|||
149021956|NCT01923428|537558983|FG001|Overall Study|Protocol Violation|0|||
149021957|NCT01923428|537558984|FG002|Overall Study|Protocol Violation|2|||
149021958|NCT01923428|537558985|FG003|Overall Study|Protocol Violation|1|||
149021959|NCT01923428|537558982|FG000|Overall Study|Non Compliance to treatment|1|||
149021960|NCT01923428|537558983|FG001|Overall Study|Non Compliance to treatment|2|||
149021961|NCT01923428|537558984|FG002|Overall Study|Non Compliance to treatment|0|||
149021962|NCT01923428|537558985|FG003|Overall Study|Non Compliance to treatment|1|||
149021963|NCT01923428|537558982|FG000|Overall Study|Lack of Efficacy|0|||
149021964|NCT01923428|537558983|FG001|Overall Study|Lack of Efficacy|0|||
149021965|NCT01923428|537558984|FG002|Overall Study|Lack of Efficacy|1|||
149021966|NCT01923428|537558985|FG003|Overall Study|Lack of Efficacy|1|||
149021967|NCT02107443|537558986|FG000|Overall Study|Death|42|||
149021968|NCT02107443|537558987|FG001|Overall Study|Death|30|||
149021969|NCT02107443|537558986|FG000|Overall Study|Study Protocol Violation|3|||
149021970|NCT02107443|537558987|FG001|Overall Study|Study Protocol Violation|1|||
149021971|NCT02107443|537558986|FG000|Overall Study|Registered but Not Eligible|0|||
149021972|NCT02107443|537558987|FG001|Overall Study|Registered but Not Eligible|1|||
149021973|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
149021974|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
149021975|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
149021976|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
149021977|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Changed Mind|2|||
149021978|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Changed Mind|0|||
149021979|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
149021980|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
149021981|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
149021982|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
149021983|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
149021984|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
149021985|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
149021986|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
149021987|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Other Medical|9|||
149021988|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Other Medical|5|||
149021989|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Disease Progression|4|||
149021990|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Disease Progression|2|||
148691532|NCT00449150|536344215|FG002|Overall Study|Adverse Event|9|||
148691533|NCT00449150|536344213|FG000|Overall Study|Lack of Efficacy|1|||
148691534|NCT00449150|536344214|FG001|Overall Study|Lack of Efficacy|2|||
148691535|NCT00449150|536344215|FG002|Overall Study|Lack of Efficacy|2|||
148691536|NCT00449150|536344213|FG000|Overall Study|Other|16|||
148691537|NCT00449150|536344214|FG001|Overall Study|Other|13|||
148691538|NCT00449150|536344215|FG002|Overall Study|Other|14|||
148691539|NCT00449150|536344213|FG000|Overall Study|Withdrawal by Subject|17|||
148691540|NCT00449150|536344214|FG001|Overall Study|Withdrawal by Subject|18|||
148691541|NCT00449150|536344215|FG002|Overall Study|Withdrawal by Subject|21|||
148811479|NCT03329001|536787055|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
149021991|NCT02107443|537558986|FG000|Overall Study|Withdrawal: Personal Issues|0|||
149021992|NCT02107443|537558987|FG001|Overall Study|Withdrawal: Personal Issues|3|||
149021993|NCT00885495|537558988|FG000|Overall Study|Adverse Event|1|||
149021994|NCT00885495|537558989|FG001|Overall Study|Adverse Event|2|||
149021995|NCT00885495|537558988|FG000|Overall Study|Protocol Violation|0|||
149021996|NCT00885495|537558989|FG001|Overall Study|Protocol Violation|1|||
149021997|NCT00885495|537558988|FG000|Overall Study|Withdrawal by Subject|1|||
148691542|NCT00449150|536344213|FG000|Overall Study|Protocol Violation|1|||
148691543|NCT00449150|536344214|FG001|Overall Study|Protocol Violation|2|||
148811480|NCT03329001|536787056|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
148956841|NCT01710033|537326524|FG004|Stage 2|Adverse Event|1|||
148956842|NCT00100815|537326525|FG000|Overall Study|Progression|24|||
148956843|NCT00100815|537326525|FG000|Overall Study|Adverse Event|18|||
148956844|NCT00100815|537326525|FG000|Overall Study|Death|4|||
148956845|NCT00100815|537326525|FG000|Overall Study|Other|3|||
148956846|NCT01525550|537326526|FG000|Overall Study|Lost to Follow-up|8|||
148956847|NCT01525550|537326527|FG001|Overall Study|Lost to Follow-up|2|||
148956848|NCT01525550|537326526|FG000|Overall Study|Death|19|||
148956849|NCT01525550|537326527|FG001|Overall Study|Death|28|||
148956850|NCT01525550|537326526|FG000|Overall Study|Other|0|||
148956851|NCT01525550|537326527|FG001|Overall Study|Other|4|||
149021998|NCT00885495|537558989|FG001|Overall Study|Withdrawal by Subject|0|||
149021999|NCT01400893|537558990|FG000|Overall Study|Death|27|||
149022000|NCT01400893|537558991|FG001|Overall Study|Death|21|||
149022001|NCT01400893|537558990|FG000|Overall Study|Lost to Follow-up|0|||
149022002|NCT01400893|537558991|FG001|Overall Study|Lost to Follow-up|6|||
149022003|NCT00946647|537558992|FG000|Phase 1 Part|Adverse Event|2|||
149022004|NCT00946647|537558993|FG001|Phase 1 Part|Adverse Event|5|||
149022005|NCT00946647|537558994|FG002|Phase 1 Part|Adverse Event|3|||
149022006|NCT00946647|537558995|FG003|Phase 1 Part|Adverse Event|0|||
149022007|NCT00946647|537558996|FG004|Phase 1 Part|Adverse Event|0|||
149022008|NCT00946647|537558992|FG000|Phase 1 Part|Disease progression|3|||
148956852|NCT01525550|537326526|FG000|Overall Study|Sponsor's Decision|30|||
148956853|NCT01525550|537326527|FG001|Overall Study|Sponsor's Decision|11|||
149022009|NCT00946647|537558993|FG001|Phase 1 Part|Disease progression|6|||
149022010|NCT00946647|537558994|FG002|Phase 1 Part|Disease progression|1|||
149022011|NCT00946647|537558995|FG003|Phase 1 Part|Disease progression|0|||
148956854|NCT01525550|537326526|FG000|Overall Study|Withdrawal by Subject|4|||
148956855|NCT01525550|537326527|FG001|Overall Study|Withdrawal by Subject|0|||
149022012|NCT00946647|537558996|FG004|Phase 1 Part|Disease progression|0|||
148956856|NCT01244906|537326528|FG000|Overall Study|Death|2|||
148956857|NCT01244906|537326528|FG000|Overall Study|Progression of disease post treatment|6|||
148956858|NCT02877082|537326529|FG000|Overall Study|Trial was closed early|5|||
148956859|NCT00498602|537326530|FG000|Overall Study|Death|0|||
148956860|NCT00498602|537326531|FG001|Overall Study|Death|0|||
148956861|NCT00498602|537326532|FG002|Overall Study|Death|0|||
148956862|NCT00498602|537326533|FG003|Overall Study|Death|0|||
148956863|NCT00498602|537326534|FG004|Overall Study|Death|0|||
148956864|NCT00498602|537326535|FG005|Overall Study|Death|1|||
148956865|NCT00498602|537326536|FG006|Overall Study|Death|0|||
148956866|NCT00498602|537326530|FG000|Overall Study|Lack of Efficacy|1|||
148956867|NCT00498602|537326531|FG001|Overall Study|Lack of Efficacy|0|||
148956868|NCT00498602|537326532|FG002|Overall Study|Lack of Efficacy|0|||
148956869|NCT00498602|537326533|FG003|Overall Study|Lack of Efficacy|0|||
148956870|NCT00498602|537326534|FG004|Overall Study|Lack of Efficacy|0|||
148956871|NCT00498602|537326535|FG005|Overall Study|Lack of Efficacy|0|||
148956872|NCT00498602|537326536|FG006|Overall Study|Lack of Efficacy|0|||
148956873|NCT00498602|537326530|FG000|Overall Study|Lost to Follow-up|0|||
148956874|NCT00498602|537326531|FG001|Overall Study|Lost to Follow-up|2|||
148956875|NCT00498602|537326532|FG002|Overall Study|Lost to Follow-up|0|||
148956876|NCT00498602|537326533|FG003|Overall Study|Lost to Follow-up|2|||
148956877|NCT00498602|537326534|FG004|Overall Study|Lost to Follow-up|0|||
148956878|NCT00498602|537326535|FG005|Overall Study|Lost to Follow-up|0|||
148956879|NCT00498602|537326536|FG006|Overall Study|Lost to Follow-up|0|||
148956880|NCT00498602|537326530|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
148956881|NCT00498602|537326531|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
148956882|NCT00498602|537326532|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
148956883|NCT00498602|537326533|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
148956884|NCT00498602|537326534|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
148956885|NCT00498602|537326535|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
148956886|NCT00498602|537326536|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
148956887|NCT00498602|537326530|FG000|Overall Study|AE not related to Study Drug|1|||
148956888|NCT00498602|537326531|FG001|Overall Study|AE not related to Study Drug|3|||
148956889|NCT00498602|537326532|FG002|Overall Study|AE not related to Study Drug|0|||
148956890|NCT00498602|537326533|FG003|Overall Study|AE not related to Study Drug|0|||
148956891|NCT00498602|537326534|FG004|Overall Study|AE not related to Study Drug|2|||
148956892|NCT00498602|537326535|FG005|Overall Study|AE not related to Study Drug|2|||
148956893|NCT00498602|537326536|FG006|Overall Study|AE not related to Study Drug|1|||
148956894|NCT00498602|537326530|FG000|Overall Study|Caregiver Request|2|||
148956895|NCT00498602|537326531|FG001|Overall Study|Caregiver Request|2|||
148691544|NCT00449150|536344215|FG002|Overall Study|Protocol Violation|1|||
148956896|NCT00498602|537326532|FG002|Overall Study|Caregiver Request|2|||
148956897|NCT00498602|537326533|FG003|Overall Study|Caregiver Request|0|||
148956898|NCT00498602|537326534|FG004|Overall Study|Caregiver Request|1|||
148956899|NCT00498602|537326535|FG005|Overall Study|Caregiver Request|2|||
148956900|NCT00498602|537326536|FG006|Overall Study|Caregiver Request|0|||
148956901|NCT00498602|537326530|FG000|Overall Study|Investigator Request|0|||
148691545|NCT06331156|536344216|FG000|Overall Study|Adverse Event|1|||
148956902|NCT00498602|537326531|FG001|Overall Study|Investigator Request|0|||
148691546|NCT06331156|536344217|FG001|Overall Study|Adverse Event|0|||
148691547|NCT06331156|536344216|FG000|Overall Study|Lost to Follow-up|1|||
148691548|NCT06331156|536344217|FG001|Overall Study|Lost to Follow-up|0|||
148691549|NCT06331156|536344216|FG000|Overall Study|Migrated / Moved from the study area|4|||
148691550|NCT06331156|536344217|FG001|Overall Study|Migrated / Moved from the study area|3|||
148691551|NCT06331156|536344216|FG000|Overall Study|Other|7|||
148691552|NCT06331156|536344217|FG001|Overall Study|Other|0|||
148691553|NCT06331156|536344216|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
148691554|NCT06331156|536344217|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
148691555|NCT02978326|536344220|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
148691556|NCT02978326|536344221|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
148691557|NCT02978326|536344222|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
148691558|NCT02978326|536344220|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
148691559|NCT02978326|536344221|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
148691560|NCT02978326|536344222|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
148691561|NCT02978326|536344220|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
148691562|NCT02978326|536344221|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
148691563|NCT02978326|536344222|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
148691564|NCT02978326|536344220|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
148691565|NCT02978326|536344221|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
148691566|NCT02978326|536344222|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
148691567|NCT01265784|536344227|FG000|Overall Study|Lost to Follow-up|5|||
148691568|NCT01265784|536344228|FG001|Overall Study|Lost to Follow-up|3|||
148691569|NCT01265784|536344229|FG002|Overall Study|Lost to Follow-up|2|||
148691570|NCT01265784|536344227|FG000|Overall Study|Withdrawal by Subject|0|||
148691571|NCT01265784|536344228|FG001|Overall Study|Withdrawal by Subject|5|||
148691572|NCT01265784|536344229|FG002|Overall Study|Withdrawal by Subject|0|||
148691573|NCT01265784|536344227|FG000|Overall Study|Physician Decision|1|||
148691574|NCT01265784|536344228|FG001|Overall Study|Physician Decision|0|||
148691575|NCT01265784|536344229|FG002|Overall Study|Physician Decision|1|||
148691576|NCT01265784|536344227|FG000|Overall Study|Adverse Event|1|||
148691577|NCT01265784|536344228|FG001|Overall Study|Adverse Event|0|||
148691578|NCT01265784|536344229|FG002|Overall Study|Adverse Event|0|||
148691579|NCT01265784|536344227|FG000|Overall Study|Death|3|||
148691580|NCT01265784|536344228|FG001|Overall Study|Death|0|||
148691581|NCT01265784|536344229|FG002|Overall Study|Death|0|||
148691582|NCT01265784|536344227|FG000|Overall Study|Protocol Violation|2|||
148691583|NCT01265784|536344228|FG001|Overall Study|Protocol Violation|0|||
148691584|NCT01265784|536344229|FG002|Overall Study|Protocol Violation|0|||
148691585|NCT01265784|536344227|FG000|Overall Study|Incorrectly Randomized|0|||
148691586|NCT01265784|536344228|FG001|Overall Study|Incorrectly Randomized|0|||
148691587|NCT01265784|536344229|FG002|Overall Study|Incorrectly Randomized|1|||
148691588|NCT01937364|536344230|FG000|Overall Study|Adverse Event|2|||
148691589|NCT01937364|536344231|FG001|Overall Study|Adverse Event|1|||
148691590|NCT04799158|536344232|FG000|Run-In Period|Adverse Event|6|||
148691591|NCT04799158|536344233|FG001|Run-In Period|Adverse Event|0|||
148691592|NCT04799158|536344234|FG002|Run-In Period|Adverse Event|0|||
148691593|NCT04799158|536344235|FG003|Run-In Period|Adverse Event|0|||
148691594|NCT04799158|536344236|FG004|Run-In Period|Adverse Event|0|||
148691595|NCT04799158|536344232|FG000|Run-In Period|Lost to Follow-up|4|||
148691596|NCT04799158|536344233|FG001|Run-In Period|Lost to Follow-up|0|||
148691597|NCT04799158|536344234|FG002|Run-In Period|Lost to Follow-up|0|||
148691598|NCT04799158|536344235|FG003|Run-In Period|Lost to Follow-up|0|||
148691599|NCT04799158|536344236|FG004|Run-In Period|Lost to Follow-up|0|||
148691600|NCT04799158|536344232|FG000|Run-In Period|Significant Protocol Deviation|1|||
148691601|NCT04799158|536344233|FG001|Run-In Period|Significant Protocol Deviation|0|||
148691602|NCT04799158|536344234|FG002|Run-In Period|Significant Protocol Deviation|0|||
148691603|NCT04799158|536344235|FG003|Run-In Period|Significant Protocol Deviation|0|||
148691604|NCT04799158|536344236|FG004|Run-In Period|Significant Protocol Deviation|0|||
148691605|NCT04799158|536344232|FG000|Run-In Period|Withdrawal by Subject|11|||
148691606|NCT04799158|536344233|FG001|Run-In Period|Withdrawal by Subject|0|||
148691607|NCT04799158|536344234|FG002|Run-In Period|Withdrawal by Subject|0|||
148691608|NCT04799158|536344235|FG003|Run-In Period|Withdrawal by Subject|0|||
148691609|NCT04799158|536344236|FG004|Run-In Period|Withdrawal by Subject|0|||
148691610|NCT04799158|536344232|FG000|Run-In Period|Miscellaneous|3|||
148691611|NCT04799158|536344233|FG001|Run-In Period|Miscellaneous|0|||
148691612|NCT04799158|536344234|FG002|Run-In Period|Miscellaneous|0|||
148691613|NCT04799158|536344235|FG003|Run-In Period|Miscellaneous|0|||
148691614|NCT04799158|536344236|FG004|Run-In Period|Miscellaneous|0|||
148691615|NCT04799158|536344232|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
148691616|NCT04799158|536344233|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
148691617|NCT04799158|536344234|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
148691618|NCT04799158|536344235|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
148691619|NCT04799158|536344236|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
148691620|NCT04799158|536344232|FG000|On-Demand Treatment Period|Adverse Event|0|||
148691621|NCT04799158|536344233|FG001|On-Demand Treatment Period|Adverse Event|1|||
148691622|NCT04799158|536344234|FG002|On-Demand Treatment Period|Adverse Event|0|||
148691623|NCT04799158|536344235|FG003|On-Demand Treatment Period|Adverse Event|0|||
148691624|NCT04799158|536344236|FG004|On-Demand Treatment Period|Adverse Event|1|||
148691625|NCT04799158|536344232|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
148691626|NCT04799158|536344233|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
148691627|NCT04799158|536344234|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
148691628|NCT04799158|536344235|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
148691629|NCT04799158|536344236|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
148691630|NCT04799158|536344232|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
148691631|NCT04799158|536344233|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
148691632|NCT04799158|536344234|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
148956903|NCT00498602|537326532|FG002|Overall Study|Investigator Request|1|||
148956904|NCT00498602|537326533|FG003|Overall Study|Investigator Request|0|||
148956905|NCT00498602|537326534|FG004|Overall Study|Investigator Request|0|||
148956906|NCT00498602|537326535|FG005|Overall Study|Investigator Request|0|||
148956907|NCT00498602|537326536|FG006|Overall Study|Investigator Request|0|||
148956908|NCT00498602|537326530|FG000|Overall Study|Subject Request|3|||
148956909|NCT00498602|537326531|FG001|Overall Study|Subject Request|0|||
148956910|NCT00498602|537326532|FG002|Overall Study|Subject Request|1|||
148956911|NCT00498602|537326533|FG003|Overall Study|Subject Request|1|||
148956912|NCT00498602|537326534|FG004|Overall Study|Subject Request|1|||
148956913|NCT00498602|537326535|FG005|Overall Study|Subject Request|4|||
148956914|NCT00498602|537326536|FG006|Overall Study|Subject Request|1|||
148956915|NCT00498602|537326530|FG000|Overall Study|Other|2|||
148956916|NCT00498602|537326531|FG001|Overall Study|Other|3|||
148956917|NCT00498602|537326532|FG002|Overall Study|Other|1|||
148956918|NCT00498602|537326533|FG003|Overall Study|Other|0|||
148956919|NCT00498602|537326534|FG004|Overall Study|Other|0|||
148956920|NCT00498602|537326535|FG005|Overall Study|Other|3|||
148956921|NCT00498602|537326536|FG006|Overall Study|Other|0|||
148956922|NCT01113801|537326537|FG000|Overall Study|Adverse Event|4|||
148956923|NCT01113801|537326538|FG001|Overall Study|Adverse Event|0|||
148956924|NCT01113801|537326539|FG002|Overall Study|Adverse Event|2|||
148956925|NCT01113801|537326540|FG003|Overall Study|Adverse Event|6|||
148956926|NCT01113801|537326537|FG000|Overall Study|Death|4|||
148956927|NCT01113801|537326538|FG001|Overall Study|Death|5|||
148956928|NCT01113801|537326539|FG002|Overall Study|Death|3|||
148956929|NCT01113801|537326540|FG003|Overall Study|Death|4|||
148956930|NCT01113801|537326537|FG000|Overall Study|Protocol Violation|0|||
148956931|NCT01113801|537326538|FG001|Overall Study|Protocol Violation|1|||
148956932|NCT01113801|537326539|FG002|Overall Study|Protocol Violation|0|||
148956933|NCT01113801|537326540|FG003|Overall Study|Protocol Violation|0|||
148956934|NCT01113801|537326537|FG000|Overall Study|Withdrawal by Subject|9|||
148956935|NCT01113801|537326538|FG001|Overall Study|Withdrawal by Subject|7|||
148956936|NCT01113801|537326539|FG002|Overall Study|Withdrawal by Subject|7|||
148956937|NCT01113801|537326540|FG003|Overall Study|Withdrawal by Subject|8|||
148956938|NCT01113801|537326537|FG000|Overall Study|Physician Decision|2|||
148956939|NCT01113801|537326538|FG001|Overall Study|Physician Decision|2|||
148956940|NCT01113801|537326539|FG002|Overall Study|Physician Decision|3|||
148956941|NCT01113801|537326540|FG003|Overall Study|Physician Decision|3|||
148956942|NCT01113801|537326537|FG000|Overall Study|Sponsor Decision|15|||
148956943|NCT01113801|537326538|FG001|Overall Study|Sponsor Decision|21|||
148956944|NCT01113801|537326539|FG002|Overall Study|Sponsor Decision|20|||
148956945|NCT01113801|537326540|FG003|Overall Study|Sponsor Decision|15|||
148956946|NCT01113801|537326537|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
148956947|NCT01113801|537326538|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
148956948|NCT01113801|537326539|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
148956949|NCT01113801|537326540|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
148956950|NCT02436356|537326541|FG000|Overall Study|Excluded by MRI Screening|0|||
148956951|NCT02436356|537326542|FG001|Overall Study|Excluded by MRI Screening|0|||
148956952|NCT02436356|537326543|FG002|Overall Study|Excluded by MRI Screening|2|||
148956953|NCT02436356|537326541|FG000|Overall Study|Lost to Follow-up|0|||
148956954|NCT02436356|537326542|FG001|Overall Study|Lost to Follow-up|1|||
148956955|NCT02436356|537326543|FG002|Overall Study|Lost to Follow-up|0|||
148691633|NCT04799158|536344235|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
148691634|NCT04799158|536344236|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
148691635|NCT04799158|536344232|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
148691636|NCT04799158|536344233|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
148691637|NCT04799158|536344234|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
148691638|NCT04799158|536344235|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
148956956|NCT02436356|537326541|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
148956957|NCT02436356|537326542|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
148691639|NCT04799158|536344236|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
148956958|NCT02436356|537326543|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
148956959|NCT02436356|537326541|FG000|Overall Study|Excluded due to other medical conditions|3|||
148956960|NCT02436356|537326542|FG001|Overall Study|Excluded due to other medical conditions|0|||
148956961|NCT02436356|537326543|FG002|Overall Study|Excluded due to other medical conditions|0|||
148811481|NCT03329001|536787057|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
148811482|NCT03329001|536787058|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
148811483|NCT03329001|536787059|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
148811484|NCT03329001|536787060|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
148811485|NCT03329001|536787061|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
148811486|NCT03329001|536787054|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811487|NCT03329001|536787055|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811488|NCT03329001|536787056|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811489|NCT03329001|536787057|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811490|NCT03329001|536787058|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811491|NCT03329001|536787059|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
148811492|NCT03329001|536787060|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811493|NCT03329001|536787061|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
148811494|NCT03329001|536787054|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811495|NCT03329001|536787055|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811496|NCT03329001|536787056|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811497|NCT03329001|536787057|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811498|NCT03329001|536787058|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
148811499|NCT03329001|536787059|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811500|NCT03329001|536787060|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811501|NCT03329001|536787061|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
148811502|NCT03329001|536787054|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
148811503|NCT03329001|536787055|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
148811504|NCT03329001|536787056|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
148811505|NCT03329001|536787057|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
148811506|NCT03329001|536787058|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
148811507|NCT03329001|536787059|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
148956962|NCT02436356|537326541|FG000|Overall Study|Withdrawal by Subject|1|||
148956963|NCT02436356|537326542|FG001|Overall Study|Withdrawal by Subject|0|||
148956964|NCT02436356|537326543|FG002|Overall Study|Withdrawal by Subject|0|||
148956965|NCT02746874|537326544|FG000|Overall Study|Withdrawal by Subject|0|||
148956966|NCT02746874|537326545|FG001|Overall Study|Withdrawal by Subject|1|||
148956967|NCT02746874|537326544|FG000|Overall Study|Surgery Date Changed|0|||
148691640|NCT04799158|536344232|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
149022013|NCT00946647|537558992|FG000|Phase 1 Part|Withdrawal by Subject|1|||
149022014|NCT00946647|537558993|FG001|Phase 1 Part|Withdrawal by Subject|4|||
149022015|NCT00946647|537558994|FG002|Phase 1 Part|Withdrawal by Subject|3|||
149022016|NCT00946647|537558995|FG003|Phase 1 Part|Withdrawal by Subject|0|||
149022017|NCT00946647|537558996|FG004|Phase 1 Part|Withdrawal by Subject|0|||
149022018|NCT00946647|537558992|FG000|Phase 1 Part|Abnormal values|0|||
149022019|NCT00946647|537558993|FG001|Phase 1 Part|Abnormal values|2|||
149022020|NCT00946647|537558994|FG002|Phase 1 Part|Abnormal values|0|||
149022021|NCT00946647|537558995|FG003|Phase 1 Part|Abnormal values|0|||
149022022|NCT00946647|537558996|FG004|Phase 1 Part|Abnormal values|0|||
148811508|NCT03329001|536787060|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
148811509|NCT03329001|536787061|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
148811510|NCT03329001|536787054|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148811511|NCT03329001|536787055|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148811512|NCT03329001|536787056|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148956968|NCT02746874|537326545|FG001|Overall Study|Surgery Date Changed|2|||
148956969|NCT03178773|537326546|FG000|Overall Study|Death|0|||
148811513|NCT03329001|536787057|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148811514|NCT03329001|536787058|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
148811515|NCT03329001|536787059|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148811516|NCT03329001|536787060|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148811517|NCT03329001|536787061|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
148811518|NCT03329001|536787054|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
148811519|NCT03329001|536787055|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
148811520|NCT03329001|536787056|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
148811521|NCT03329001|536787057|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
148811522|NCT03329001|536787058|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
148811523|NCT03329001|536787059|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
148811524|NCT03329001|536787060|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
148811525|NCT03329001|536787061|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
148811526|NCT03329001|536787054|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
148811527|NCT03329001|536787055|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
148811528|NCT03329001|536787056|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
148811529|NCT03329001|536787057|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
148811530|NCT03329001|536787058|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
148811531|NCT03329001|536787059|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
148811532|NCT03329001|536787060|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
148811533|NCT03329001|536787061|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
148811534|NCT03329001|536787054|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811535|NCT03329001|536787055|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811536|NCT03329001|536787056|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811537|NCT03329001|536787057|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811538|NCT03329001|536787058|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811539|NCT03329001|536787059|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811540|NCT03329001|536787060|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
148811541|NCT03329001|536787061|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
148811542|NCT03329001|536787054|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
148811543|NCT03329001|536787055|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
148811544|NCT03329001|536787056|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
148811545|NCT03329001|536787057|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
148811546|NCT03329001|536787058|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
148811547|NCT03329001|536787059|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
148811548|NCT03329001|536787060|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
148811549|NCT03329001|536787061|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
148811550|NCT03329001|536787054|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
148811551|NCT03329001|536787055|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
148811552|NCT03329001|536787056|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
148811553|NCT03329001|536787057|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
148811554|NCT03329001|536787058|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
148811555|NCT03329001|536787059|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
148811556|NCT03329001|536787060|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
148811557|NCT03329001|536787061|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
148811558|NCT00963235|536787066|FG000|Overall Study|Withdrawal by Subject|22|||
148811559|NCT00963235|536787066|FG000|Overall Study|Lost to Follow-up|14|||
148811560|NCT00963235|536787066|FG000|Overall Study|Failed to return|9|||
148811561|NCT00963235|536787066|FG000|Overall Study|Protocol Violation|7|||
148811562|NCT00963235|536787066|FG000|Overall Study|Adverse Event|5|||
148811563|NCT00963235|536787066|FG000|Overall Study|Physician Decision|2|||
148811564|NCT00963235|536787066|FG000|Overall Study|Other|1|||
148811565|NCT01756235|536787068|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
148811566|NCT04225832|536787069|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
148811567|NCT04225832|536787070|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
148811568|NCT04225832|536787069|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
148811569|NCT04225832|536787070|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
148811570|NCT03765073|536787071|FG000|Stage 1|Lost to Follow-up|1|||
148811571|NCT03765073|536787072|FG001|Stage 1|Lost to Follow-up|0|||
148811572|NCT03765073|536787073|FG002|Stage 1|Lost to Follow-up|0|||
148811573|NCT03765073|536787074|FG003|Stage 1|Lost to Follow-up|0|||
148811574|NCT03765073|536787075|FG004|Stage 1|Lost to Follow-up|0|||
148811575|NCT03765073|536787076|FG005|Stage 1|Lost to Follow-up|0|||
148811576|NCT03765073|536787077|FG006|Stage 1|Lost to Follow-up|0|||
148811577|NCT03765073|536787078|FG007|Stage 1|Lost to Follow-up|0|||
148811578|NCT03765073|536787079|FG008|Stage 1|Lost to Follow-up|0|||
148811579|NCT03765073|536787080|FG009|Stage 1|Lost to Follow-up|0|||
148811580|NCT03765073|536787081|FG010|Stage 1|Lost to Follow-up|0|||
148811581|NCT03765073|536787082|FG011|Stage 1|Lost to Follow-up|0|||
148811582|NCT03765073|536787083|FG012|Stage 1|Lost to Follow-up|0|||
148811583|NCT03765073|536787084|FG013|Stage 1|Lost to Follow-up|0|||
148811584|NCT03765073|536787085|FG014|Stage 1|Lost to Follow-up|0|||
148811585|NCT03765073|536787086|FG015|Stage 1|Lost to Follow-up|0|||
148811586|NCT03765073|536787087|FG016|Stage 1|Lost to Follow-up|0|||
148811587|NCT03765073|536787088|FG017|Stage 1|Lost to Follow-up|0|||
149022023|NCT00946647|537558992|FG000|Phase 1 Part|Reason missing|0|||
148811588|NCT03765073|536787089|FG018|Stage 1|Lost to Follow-up|0|||
148811589|NCT03765073|536787090|FG019|Stage 1|Lost to Follow-up|0|||
148811590|NCT03765073|536787091|FG020|Stage 1|Lost to Follow-up|0|||
148811591|NCT03765073|536787071|FG000|Stage 1|Withdrawal by participant|0|||
148811592|NCT03765073|536787072|FG001|Stage 1|Withdrawal by participant|1|||
148811593|NCT03765073|536787073|FG002|Stage 1|Withdrawal by participant|0|||
148811594|NCT03765073|536787074|FG003|Stage 1|Withdrawal by participant|0|||
148811595|NCT03765073|536787075|FG004|Stage 1|Withdrawal by participant|0|||
148811596|NCT03765073|536787076|FG005|Stage 1|Withdrawal by participant|0|||
148956970|NCT03178773|537326547|FG001|Overall Study|Death|1|||
148956971|NCT03178773|537326546|FG000|Overall Study|Lost to Follow-up|29|||
148956972|NCT03178773|537326547|FG001|Overall Study|Lost to Follow-up|25|||
148956973|NCT03178773|537326546|FG000|Overall Study|Withdrawal by Subject|10|||
148956974|NCT03178773|537326547|FG001|Overall Study|Withdrawal by Subject|14|||
148956975|NCT01382446|537326548|FG000|Overall Study|Withdrawal by Subject|0|||
148956976|NCT01382446|537326549|FG001|Overall Study|Withdrawal by Subject|1|||
148956977|NCT01382446|537326548|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
148956978|NCT01382446|537326549|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
148956979|NCT00268996|537326555|FG000|Overall Study|Adverse Event|11|||
148956980|NCT00268996|537326556|FG001|Overall Study|Adverse Event|7|||
148956981|NCT00268996|537326555|FG000|Overall Study|Lost to Follow-up|3|||
148956982|NCT00268996|537326556|FG001|Overall Study|Lost to Follow-up|1|||
148956983|NCT00268996|537326555|FG000|Overall Study|Withdrawal by Subject|5|||
148956984|NCT00268996|537326556|FG001|Overall Study|Withdrawal by Subject|11|||
148956985|NCT00268996|537326555|FG000|Overall Study|Non-compliance|1|||
148956986|NCT00268996|537326556|FG001|Overall Study|Non-compliance|0|||
148956987|NCT00268996|537326555|FG000|Overall Study|Other|1|||
148956988|NCT00268996|537326556|FG001|Overall Study|Other|1|||
148956989|NCT02956486|537326557|FG000|Core Phase|Adverse Event|51|||
148956990|NCT02956486|537326558|FG001|Core Phase|Adverse Event|88|||
148956991|NCT02956486|537326559|FG002|Core Phase|Adverse Event|0|||
148956992|NCT02956486|537326557|FG000|Core Phase|Lost to Follow-up|8|||
148956993|NCT02956486|537326558|FG001|Core Phase|Lost to Follow-up|6|||
148956994|NCT02956486|537326559|FG002|Core Phase|Lost to Follow-up|0|||
148956995|NCT02956486|537326557|FG000|Core Phase|Inadequate therapeutic effect|4|||
148956996|NCT02956486|537326558|FG001|Core Phase|Inadequate therapeutic effect|5|||
148956997|NCT02956486|537326559|FG002|Core Phase|Inadequate therapeutic effect|0|||
148956998|NCT02956486|537326557|FG000|Core Phase|Withdrawal by Subject|101|||
148956999|NCT02956486|537326558|FG001|Core Phase|Withdrawal by Subject|104|||
148957000|NCT02956486|537326559|FG002|Core Phase|Withdrawal by Subject|0|||
148957001|NCT02956486|537326557|FG000|Core Phase|Study terminated by sponsor|888|||
148957002|NCT02956486|537326558|FG001|Core Phase|Study terminated by sponsor|848|||
148957003|NCT02956486|537326559|FG002|Core Phase|Study terminated by sponsor|0|||
148957004|NCT02956486|537326557|FG000|Core Phase|Other|27|||
148957005|NCT02956486|537326558|FG001|Core Phase|Other|18|||
148957006|NCT02956486|537326559|FG002|Core Phase|Other|0|||
148957007|NCT02956486|537326557|FG000|Core Phase|Not treated|0|||
148957008|NCT02956486|537326558|FG001|Core Phase|Not treated|3|||
148957009|NCT02956486|537326559|FG002|Core Phase|Not treated|0|||
148957010|NCT02956486|537326557|FG000|Extension Phase|Adverse Event|0|||
148957011|NCT02956486|537326558|FG001|Extension Phase|Adverse Event|0|||
148957012|NCT02956486|537326559|FG002|Extension Phase|Adverse Event|2|||
148957013|NCT02956486|537326557|FG000|Extension Phase|Study terminated by sponsor|0|||
148957014|NCT02956486|537326558|FG001|Extension Phase|Study terminated by sponsor|0|||
148957015|NCT02956486|537326559|FG002|Extension Phase|Study terminated by sponsor|16|||
148957016|NCT02956486|537326557|FG000|Extension Phase|Not Treated|0|||
148957017|NCT02956486|537326558|FG001|Extension Phase|Not Treated|0|||
148957018|NCT02956486|537326559|FG002|Extension Phase|Not Treated|1|||
148957019|NCT00422591|537326562|FG000|Overall Study|Physician Decision|4|||
148957020|NCT00422591|537326562|FG000|Overall Study|Withdrawal by Subject|2|||
148957021|NCT02377466|537326565|FG000|Overall Study|Other: Randomized and not treated|0|||
148957022|NCT02377466|537326566|FG001|Overall Study|Other: Randomized and not treated|2|||
148957023|NCT00330616|537326569|FG000|Overall Study|Adverse Event|13|||
148957024|NCT00330616|537326569|FG000|Overall Study|Lack of Efficacy|1|||
148957025|NCT00330616|537326569|FG000|Overall Study|Lost to Follow-up|2|||
148957026|NCT00330616|537326569|FG000|Overall Study|Withdrawal by Subject|4|||
148957027|NCT00330616|537326569|FG000|Overall Study|Other|1|||
148957028|NCT02617511|537326574|FG000|Overall Study|Withdrawal by Subject|1|||
148957029|NCT02617511|537326575|FG001|Overall Study|Withdrawal by Subject|0|||
148957030|NCT00255047|537326576|FG000|Overall Study|Serious Adverse Events|2|||
148957031|NCT00255047|537326577|FG001|Overall Study|Serious Adverse Events|1|||
148957032|NCT00255047|537326578|FG002|Overall Study|Serious Adverse Events|2|||
148957033|NCT00255047|537326579|FG003|Overall Study|Serious Adverse Events|1|||
148957034|NCT00255047|537326576|FG000|Overall Study|Adverse Event|0|||
148957035|NCT00255047|537326577|FG001|Overall Study|Adverse Event|3|||
148957036|NCT00255047|537326578|FG002|Overall Study|Adverse Event|2|||
148957037|NCT00255047|537326579|FG003|Overall Study|Adverse Event|1|||
148957038|NCT00255047|537326576|FG000|Overall Study|Protocol Violation|13|||
148957039|NCT00255047|537326577|FG001|Overall Study|Protocol Violation|13|||
148957040|NCT00255047|537326578|FG002|Overall Study|Protocol Violation|16|||
148957041|NCT00255047|537326579|FG003|Overall Study|Protocol Violation|20|||
148957042|NCT00255047|537326576|FG000|Overall Study|Lost to Follow-up|9|||
148957043|NCT00255047|537326577|FG001|Overall Study|Lost to Follow-up|8|||
148957044|NCT00255047|537326578|FG002|Overall Study|Lost to Follow-up|5|||
148957045|NCT00255047|537326579|FG003|Overall Study|Lost to Follow-up|6|||
148957046|NCT00255047|537326576|FG000|Overall Study|Withdrawal by Subject|24|||
148957047|NCT00255047|537326577|FG001|Overall Study|Withdrawal by Subject|23|||
148957048|NCT00255047|537326578|FG002|Overall Study|Withdrawal by Subject|25|||
148957049|NCT00255047|537326579|FG003|Overall Study|Withdrawal by Subject|18|||
148957050|NCT00811473|537326580|FG000|Overall Study|Adverse Event|3|||
148957051|NCT00811473|537326581|FG001|Overall Study|Adverse Event|12|||
148957052|NCT00811473|537326580|FG000|Overall Study|Lost to Follow-up|5|||
148957053|NCT00811473|537326581|FG001|Overall Study|Lost to Follow-up|1|||
148957054|NCT00811473|537326580|FG000|Overall Study|Withdrawal by Subject|2|||
148957055|NCT00811473|537326581|FG001|Overall Study|Withdrawal by Subject|4|||
148957056|NCT00811473|537326580|FG000|Overall Study|Severe non-compliance to protocol|2|||
148957057|NCT00811473|537326581|FG001|Overall Study|Severe non-compliance to protocol|4|||
148957058|NCT00811473|537326580|FG000|Overall Study|Lack of therapeutic response|4|||
148957059|NCT00811473|537326581|FG001|Overall Study|Lack of therapeutic response|1|||
148957060|NCT00811473|537326580|FG000|Overall Study|Condition under investigation worsened|1|||
148957061|NCT00811473|537326581|FG001|Overall Study|Condition under investigation worsened|3|||
149022024|NCT00946647|537558993|FG001|Phase 1 Part|Reason missing|1|||
149022025|NCT00946647|537558994|FG002|Phase 1 Part|Reason missing|0|||
149022026|NCT00946647|537558995|FG003|Phase 1 Part|Reason missing|0|||
149022027|NCT00946647|537558996|FG004|Phase 1 Part|Reason missing|0|||
149022028|NCT00946647|537558992|FG000|Phase ll Part|Untreated|0|||
149022029|NCT00946647|537558993|FG001|Phase ll Part|Untreated|0|||
149022030|NCT00946647|537558994|FG002|Phase ll Part|Untreated|0|||
149022031|NCT00946647|537558995|FG003|Phase ll Part|Untreated|0|||
149022032|NCT00946647|537558996|FG004|Phase ll Part|Untreated|2|||
149022033|NCT00946647|537558992|FG000|Phase ll Part|Adverse Event|0|||
149022034|NCT00946647|537558993|FG001|Phase ll Part|Adverse Event|0|||
149022035|NCT00946647|537558994|FG002|Phase ll Part|Adverse Event|0|||
149022036|NCT00946647|537558995|FG003|Phase ll Part|Adverse Event|10|||
149022037|NCT00946647|537558996|FG004|Phase ll Part|Adverse Event|6|||
149022038|NCT00946647|537558992|FG000|Phase ll Part|Withdrawal by Subject|0|||
149022039|NCT00946647|537558993|FG001|Phase ll Part|Withdrawal by Subject|0|||
149022040|NCT00946647|537558994|FG002|Phase ll Part|Withdrawal by Subject|0|||
149022041|NCT00946647|537558995|FG003|Phase ll Part|Withdrawal by Subject|8|||
149022042|NCT00946647|537558996|FG004|Phase ll Part|Withdrawal by Subject|6|||
149022043|NCT00946647|537558992|FG000|Phase ll Part|Administrative problems|0|||
149022044|NCT00946647|537558993|FG001|Phase ll Part|Administrative problems|0|||
149022045|NCT00946647|537558994|FG002|Phase ll Part|Administrative problems|0|||
149022046|NCT00946647|537558995|FG003|Phase ll Part|Administrative problems|3|||
149022047|NCT00946647|537558996|FG004|Phase ll Part|Administrative problems|8|||
149022048|NCT00946647|537558992|FG000|Phase ll Part|Death|0|||
149022049|NCT00946647|537558993|FG001|Phase ll Part|Death|0|||
149022050|NCT00946647|537558994|FG002|Phase ll Part|Death|0|||
149022051|NCT00946647|537558995|FG003|Phase ll Part|Death|7|||
149022052|NCT00946647|537558996|FG004|Phase ll Part|Death|4|||
149022053|NCT00946647|537558992|FG000|Phase ll Part|Disease progression|0|||
149022054|NCT00946647|537558993|FG001|Phase ll Part|Disease progression|0|||
149022055|NCT00946647|537558994|FG002|Phase ll Part|Disease progression|0|||
149022056|NCT00946647|537558995|FG003|Phase ll Part|Disease progression|6|||
149022057|NCT00946647|537558996|FG004|Phase ll Part|Disease progression|14|||
149022058|NCT00946647|537558992|FG000|Phase ll Part|Protocol Violation|0|||
149022059|NCT00946647|537558993|FG001|Phase ll Part|Protocol Violation|0|||
149022060|NCT00946647|537558994|FG002|Phase ll Part|Protocol Violation|0|||
149022061|NCT00946647|537558995|FG003|Phase ll Part|Protocol Violation|4|||
149022062|NCT00946647|537558996|FG004|Phase ll Part|Protocol Violation|2|||
149022063|NCT00946647|537558992|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
148691641|NCT04799158|536344233|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
148691642|NCT04799158|536344234|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
148957062|NCT00811473|537326580|FG000|Overall Study|Other 2|4|||
148957063|NCT00811473|537326581|FG001|Overall Study|Other 2|1|||
148957064|NCT00811473|537326580|FG000|Overall Study|Incorrect Enrollment|1|||
148957065|NCT00811473|537326581|FG001|Overall Study|Incorrect Enrollment|0|||
148957066|NCT00811473|537326580|FG000|Overall Study|Safety Reasons|1|||
148957067|NCT00811473|537326581|FG001|Overall Study|Safety Reasons|0|||
148957068|NCT01119131|537326591|FG000|Overall Study|Adverse Event|1|||
148957069|NCT01119131|537326592|FG001|Overall Study|Adverse Event|1|||
148957070|NCT01119131|537326593|FG002|Overall Study|Adverse Event|1|||
148957071|NCT01119131|537326591|FG000|Overall Study|Non-Compliance|1|||
148957072|NCT01119131|537326592|FG001|Overall Study|Non-Compliance|0|||
148957073|NCT01119131|537326593|FG002|Overall Study|Non-Compliance|4|||
148957074|NCT01119131|537326591|FG000|Overall Study|Physician Decision|0|||
148957075|NCT01119131|537326592|FG001|Overall Study|Physician Decision|0|||
148957076|NCT01119131|537326593|FG002|Overall Study|Physician Decision|1|||
148957077|NCT00732615|537326594|FG000|Overall Study|Withdrawal by Subject|3|||
148957078|NCT00732615|537326595|FG001|Overall Study|Withdrawal by Subject|1|||
148957079|NCT00732615|537326594|FG000|Overall Study|Lost to Follow-up|0|||
148957080|NCT00732615|537326595|FG001|Overall Study|Lost to Follow-up|1|||
148957081|NCT00732615|537326594|FG000|Overall Study|Adverse Event|0|||
148957082|NCT00732615|537326595|FG001|Overall Study|Adverse Event|2|||
148957083|NCT00732615|537326594|FG000|Overall Study|Physician Decision|3|||
148957084|NCT00732615|537326595|FG001|Overall Study|Physician Decision|0|||
148957085|NCT00732615|537326594|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
148957086|NCT00732615|537326595|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
148957087|NCT00993291|537326596|FG000|Overall Study|Withdrawal by Subject|1|||
148957088|NCT00003492|537326597|FG000|Overall Study|Not evaluable|6|||
148957089|NCT03566823|537326598|FG000|Overall Study|Lack of Efficacy|0|||
148957090|NCT03566823|537326599|FG001|Overall Study|Lack of Efficacy|1|||
148957091|NCT03566823|537326600|FG002|Overall Study|Lack of Efficacy|0|||
148957092|NCT03566823|537326598|FG000|Overall Study|Withdrawal by Subject|1|||
148957093|NCT03566823|537326599|FG001|Overall Study|Withdrawal by Subject|2|||
148957094|NCT03566823|537326600|FG002|Overall Study|Withdrawal by Subject|0|||
148957095|NCT03566823|537326598|FG000|Overall Study|Adverse Event|1|||
148957096|NCT03566823|537326599|FG001|Overall Study|Adverse Event|0|||
148957097|NCT03566823|537326600|FG002|Overall Study|Adverse Event|2|||
148957098|NCT04446377|537326601|FG000|Overall Study|Withdrawal by Subject|6|||
148957099|NCT04446377|537326602|FG001|Overall Study|Withdrawal by Subject|1|||
148957100|NCT04446377|537326601|FG000|Overall Study|Physician Decision|1|||
148957101|NCT04446377|537326602|FG001|Overall Study|Physician Decision|1|||
148957102|NCT04446377|537326601|FG000|Overall Study|Lost to Follow-up|0|||
148957103|NCT04446377|537326602|FG001|Overall Study|Lost to Follow-up|2|||
148957104|NCT04446377|537326601|FG000|Overall Study|Not eligible|0|||
148957105|NCT04446377|537326602|FG001|Overall Study|Not eligible|1|||
148957106|NCT01414075|537326603|FG000|Overall Study|Adverse Event|1|||
148957107|NCT01414075|537326604|FG001|Overall Study|Adverse Event|0|||
148957108|NCT01414075|537326605|FG002|Overall Study|Adverse Event|1|||
148957109|NCT01414075|537326606|FG003|Overall Study|Adverse Event|0|||
148957110|NCT01414075|537326603|FG000|Overall Study|Death|1|||
148691643|NCT04799158|536344235|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
148691644|NCT04799158|536344236|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
148957111|NCT01414075|537326604|FG001|Overall Study|Death|0|||
148957112|NCT01414075|537326605|FG002|Overall Study|Death|0|||
148691645|NCT04799158|536344232|FG000|On-Demand Treatment Period|Miscellaneous|0|||
148957113|NCT01414075|537326606|FG003|Overall Study|Death|1|||
148957114|NCT01414075|537326603|FG000|Overall Study|Withdrawal by Subject|0|||
148691646|NCT04799158|536344233|FG001|On-Demand Treatment Period|Miscellaneous|0|||
148957115|NCT01414075|537326604|FG001|Overall Study|Withdrawal by Subject|0|||
148957116|NCT01414075|537326605|FG002|Overall Study|Withdrawal by Subject|0|||
148957117|NCT01414075|537326606|FG003|Overall Study|Withdrawal by Subject|1|||
148957118|NCT01414075|537326603|FG000|Overall Study|Other than specified|1|||
148957119|NCT01414075|537326604|FG001|Overall Study|Other than specified|0|||
148957120|NCT01414075|537326605|FG002|Overall Study|Other than specified|1|||
148957121|NCT01414075|537326606|FG003|Overall Study|Other than specified|0|||
148957122|NCT01187043|537326609|FG000|Overall Study|Adverse Event|0|||
148957123|NCT01187043|537326610|FG001|Overall Study|Adverse Event|0|||
148957124|NCT01187043|537326611|FG002|Overall Study|Adverse Event|0|||
148957125|NCT01187043|537326612|FG003|Overall Study|Adverse Event|0|||
148957126|NCT01187043|537326613|FG004|Overall Study|Adverse Event|1|||
148957127|NCT01187043|537326609|FG000|Overall Study|Unable to make scheduled visits|1|||
148957128|NCT01187043|537326610|FG001|Overall Study|Unable to make scheduled visits|0|||
148957129|NCT01187043|537326611|FG002|Overall Study|Unable to make scheduled visits|4|||
148957130|NCT01187043|537326612|FG003|Overall Study|Unable to make scheduled visits|0|||
148957131|NCT01187043|537326613|FG004|Overall Study|Unable to make scheduled visits|1|||
148957132|NCT04903626|537326614|FG000|Overall Study|Lost to Follow-up|6|||
148957133|NCT04903626|537326614|FG000|Overall Study|Withdrawal by Subject|1|||
148957134|NCT04903626|537326614|FG000|Overall Study|Other, Not Specified|1|||
148957135|NCT00573534|537326615|FG000|Overall Study|oppositional behavior|3|||
148957136|NCT03035409|537326616|FG000|Overall Study|Adverse Event|5|||
148957137|NCT03035409|537326616|FG000|Overall Study|Death|2|||
148957138|NCT03035409|537326616|FG000|Overall Study|Withdrawal by Subject|2|||
148957139|NCT03035409|537326616|FG000|Overall Study|Non compliance|4|||
148957140|NCT03035409|537326616|FG000|Overall Study|Patient was jittery|1|||
148957141|NCT03035409|537326616|FG000|Overall Study|Did not like Questionnaire|1|||
148957142|NCT03035409|537326616|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
148811597|NCT03765073|536787077|FG006|Stage 1|Withdrawal by participant|0|||
148957143|NCT03035409|537326616|FG000|Overall Study|Did not like taking drugs|1|||
148957144|NCT00927784|537326619|FG000|Overall Study|Death|1|||
148811598|NCT03765073|536787078|FG007|Stage 1|Withdrawal by participant|0|||
148957145|NCT00927784|537326620|FG001|Overall Study|Death|0|||
148957146|NCT00927784|537326619|FG000|Overall Study|Withdrawal by Subject|1|||
148957147|NCT00927784|537326620|FG001|Overall Study|Withdrawal by Subject|0|||
148957148|NCT00467259|537326621|FG000|Overall Study|Adverse Event|24|||
148957149|NCT00467259|537326622|FG001|Overall Study|Adverse Event|90|||
148957150|NCT00467259|537326621|FG000|Overall Study|Protocol Violation|1|||
148957151|NCT00467259|537326622|FG001|Overall Study|Protocol Violation|7|||
148957152|NCT00467259|537326621|FG000|Overall Study|Withdrawal by Subject|34|||
148957153|NCT00467259|537326622|FG001|Overall Study|Withdrawal by Subject|108|||
148957154|NCT00467259|537326621|FG000|Overall Study|Physician Decision|0|||
148957155|NCT00467259|537326622|FG001|Overall Study|Physician Decision|2|||
148957156|NCT00467259|537326621|FG000|Overall Study|Lost to Follow-up|14|||
148957157|NCT00467259|537326622|FG001|Overall Study|Lost to Follow-up|34|||
148957158|NCT00467259|537326621|FG000|Overall Study|Site Closed|2|||
148957159|NCT00467259|537326622|FG001|Overall Study|Site Closed|1|||
148957160|NCT02028065|537326623|FG000|Randomization Through Start Treatment|Not treated|1|||
148957161|NCT02028065|537326624|FG001|Randomization Through Start Treatment|Not treated|3|||
148957162|NCT02028065|537326625|FG002|Randomization Through Start Treatment|Not treated|3|||
148957163|NCT02028065|537326623|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
148957164|NCT02028065|537326624|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
148957165|NCT02028065|537326625|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
148957166|NCT02028065|537326623|FG000|Treatment Through Study Completion|Physician Decision|1|||
148957167|NCT02028065|537326624|FG001|Treatment Through Study Completion|Physician Decision|0|||
148957168|NCT02028065|537326625|FG002|Treatment Through Study Completion|Physician Decision|0|||
148957169|NCT02028065|537326623|FG000|Treatment Through Study Completion|Protocol Violation|1|||
148957170|NCT02028065|537326624|FG001|Treatment Through Study Completion|Protocol Violation|4|||
148957171|NCT02028065|537326625|FG002|Treatment Through Study Completion|Protocol Violation|0|||
148957172|NCT02028065|537326623|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
148957173|NCT02028065|537326624|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
148957174|NCT02028065|537326625|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
148957175|NCT02028065|537326623|FG000|Treatment Through Study Completion|Adverse Event|3|||
148957176|NCT02028065|537326624|FG001|Treatment Through Study Completion|Adverse Event|3|||
148957177|NCT02028065|537326625|FG002|Treatment Through Study Completion|Adverse Event|5|||
148957178|NCT02107482|537326629|FG000|Overall Study|inconveinence|2|||
148957179|NCT02107482|537326629|FG000|Overall Study|Lost to Follow-up|1|||
148957180|NCT02107482|537326629|FG000|Overall Study|Lack of Efficacy|1|||
148957181|NCT00576927|537326630|FG000|Clinical Assessment|Lack of Efficacy|24|||
148957182|NCT00576927|537326630|FG000|Clinical Assessment|Death|1|||
148957183|NCT00576927|537326630|FG000|Clinical Assessment|Withdrawal by Subject|10|||
148957184|NCT00576927|537326630|FG000|Clinical Assessment|Physician Decision|1|||
148957185|NCT00576927|537326630|FG000|Baseline|Physician Decision|9|||
148957186|NCT00576927|537326630|FG000|Baseline|Medication Change by PCP of subject|1|||
148957187|NCT00576927|537326630|FG000|Baseline|Withdrawal by Subject|3|||
148957188|NCT00576927|537326630|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
148957189|NCT00576927|537326630|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
148957190|NCT00576927|537326630|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
148957191|NCT00576927|537326630|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
148957192|NCT00576927|537326630|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
148957193|NCT00680043|537326638|FG000|Overall Study|Withdrawal by Subject|1|||
148957194|NCT00680043|537326639|FG001|Overall Study|Withdrawal by Subject|0|||
148957195|NCT00680043|537326640|FG002|Overall Study|Withdrawal by Subject|0|||
148957196|NCT00680043|537326638|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
148957197|NCT00680043|537326639|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
148957198|NCT00680043|537326640|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
148957199|NCT00680043|537326638|FG000|Overall Study|Renal Transplant|1|||
148957200|NCT00680043|537326639|FG001|Overall Study|Renal Transplant|0|||
148957201|NCT00680043|537326640|FG002|Overall Study|Renal Transplant|4|||
148957202|NCT02111850|537326641|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957203|NCT02111850|537326642|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957204|NCT02111850|537326643|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957205|NCT02111850|537326644|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957206|NCT02111850|537326645|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
148957207|NCT02111850|537326646|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957208|NCT02111850|537326647|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957209|NCT02111850|537326648|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957210|NCT02111850|537326649|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957211|NCT02111850|537326650|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957212|NCT02111850|537326651|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
148957213|NCT01980875|537326652|FG000|Overall Study|Withdrew Consent|1|||
148957214|NCT01980875|537326653|FG001|Overall Study|Withdrew Consent|1|||
148957215|NCT01980875|537326654|FG002|Overall Study|Withdrew Consent|1|||
148957216|NCT01980875|537326652|FG000|Overall Study|Study Terminated by Sponsor|7|||
148957217|NCT01980875|537326653|FG001|Overall Study|Study Terminated by Sponsor|24|||
148957218|NCT01980875|537326654|FG002|Overall Study|Study Terminated by Sponsor|22|||
148957219|NCT01980875|537326652|FG000|Overall Study|Lost to Follow-up|0|||
148957220|NCT01980875|537326653|FG001|Overall Study|Lost to Follow-up|0|||
148957221|NCT01980875|537326654|FG002|Overall Study|Lost to Follow-up|1|||
148957222|NCT00513474|537326655|FG000|Overall Study|Death|6|||
148957223|NCT00513474|537326656|FG001|Overall Study|Death|9|||
148957224|NCT00513474|537326655|FG000|Overall Study|Participant Withdrew Consent|1|||
148957225|NCT00513474|537326656|FG001|Overall Study|Participant Withdrew Consent|0|||
148957226|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Adverse Event|82|||
148957227|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Death|6|||
148957228|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
148957229|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
148957230|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
148957231|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
148957232|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
148957233|NCT00195676|537326657|FG000|Period O - Open-label Treatment|Other reasons|68|||
148957234|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
148957235|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
148957236|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
148957237|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
148957238|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
148957239|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
148957240|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
148957241|NCT00195676|537326657|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
148957242|NCT00195676|537326657|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
148957243|NCT00195676|537326657|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
148957244|NCT00195676|537326657|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
148957245|NCT00195676|537326657|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
148957246|NCT00195676|537326657|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
148957247|NCT01189812|537326658|FG000|Overall Study|Withdrawal by Subject|2|||
148957248|NCT01189812|537326659|FG001|Overall Study|Withdrawal by Subject|3|||
148957249|NCT01189812|537326658|FG000|Overall Study|Adverse Event|1|||
148957250|NCT01189812|537326659|FG001|Overall Study|Adverse Event|0|||
148957251|NCT01189812|537326658|FG000|Overall Study|Out of Window|4|||
148957252|NCT01189812|537326659|FG001|Overall Study|Out of Window|3|||
148957253|NCT01189812|537326658|FG000|Overall Study|Moved out of State|1|||
148957254|NCT01189812|537326659|FG001|Overall Study|Moved out of State|2|||
148957255|NCT02200445|537326661|FG000|Overall Study|Lack of Efficacy|1|||
148957256|NCT02200445|537326662|FG001|Overall Study|Lack of Efficacy|2|||
148957257|NCT02200445|537326663|FG002|Overall Study|Lack of Efficacy|2|||
148957258|NCT02200445|537326661|FG000|Overall Study|Adverse Event|0|||
148957259|NCT02200445|537326662|FG001|Overall Study|Adverse Event|2|||
148957260|NCT02200445|537326663|FG002|Overall Study|Adverse Event|0|||
148957261|NCT03334903|537326664|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
148957262|NCT03334903|537326665|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
148957263|NCT03334903|537326664|FG000|Overall Study|Protocol Violation|1|||
148957264|NCT03334903|537326665|FG001|Overall Study|Protocol Violation|3|||
148957265|NCT03334903|537326664|FG000|Overall Study|Surgery postponed|1|||
148957266|NCT03334903|537326665|FG001|Overall Study|Surgery postponed|0|||
148957267|NCT03334903|537326664|FG000|Overall Study|Adverse Event|1|||
148957268|NCT03334903|537326665|FG001|Overall Study|Adverse Event|1|||
148957269|NCT03334903|537326664|FG000|Overall Study|Withdrawal by Subject|0|||
148957270|NCT03334903|537326665|FG001|Overall Study|Withdrawal by Subject|1|||
148957271|NCT00587561|537328271|FG000|Overall Study|Lost to Follow-up|6|||
148957272|NCT00587561|537328272|FG001|Overall Study|Lost to Follow-up|4|||
148957273|NCT03204981|537328274|FG000|Overall Study|Physician Decision|2|||
148957274|NCT03204981|537328274|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
148957275|NCT04244786|537328277|FG000|Overall Study|Adverse Event|0|||
148957276|NCT04244786|537328278|FG001|Overall Study|Adverse Event|0|||
148957277|NCT04244786|537328279|FG002|Overall Study|Adverse Event|2|||
148957278|NCT04244786|537328277|FG000|Overall Study|Withdrawal by Subject|0|||
148957279|NCT04244786|537328278|FG001|Overall Study|Withdrawal by Subject|0|||
148957280|NCT04244786|537328279|FG002|Overall Study|Withdrawal by Subject|5|||
148957281|NCT03274687|537328280|FG000|Overall Study|Protocol Violation|1|||
148957282|NCT03274687|537328281|FG001|Overall Study|Protocol Violation|1|||
148957283|NCT00613938|537328282|FG000|Overall Study|Withdrawal by Subject|2|||
149022064|NCT00946647|537558993|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
149022065|NCT00946647|537558994|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
149022066|NCT00946647|537558995|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
149022067|NCT00946647|537558996|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
149022068|NCT00519636|537558997|FG000|Treatment Period 1|Adverse Event|1|||
149022069|NCT00519636|537558998|FG001|Treatment Period 1|Adverse Event|0|||
149022070|NCT00519636|537558999|FG002|Treatment Period 1|Adverse Event|1|||
149022071|NCT00519636|537559000|FG003|Treatment Period 1|Adverse Event|0|||
149022072|NCT00519636|537558997|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
149022073|NCT00519636|537558998|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
149022074|NCT00519636|537558999|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
149022075|NCT00519636|537559000|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
149022076|NCT00519636|537558997|FG000|Washout Period|Adverse Event|2|||
149022077|NCT00519636|537558998|FG001|Washout Period|Adverse Event|1|||
149022078|NCT00519636|537558999|FG002|Washout Period|Adverse Event|1|||
149022079|NCT00519636|537559000|FG003|Washout Period|Adverse Event|0|||
149022080|NCT00519636|537558997|FG000|Washout Period|Lost to Follow-up|1|||
149022081|NCT00519636|537558998|FG001|Washout Period|Lost to Follow-up|0|||
149022082|NCT00519636|537558999|FG002|Washout Period|Lost to Follow-up|0|||
149022083|NCT00519636|537559000|FG003|Washout Period|Lost to Follow-up|0|||
149022084|NCT00519636|537558997|FG000|Washout Period|Protocol Violation|0|||
149022085|NCT00519636|537558998|FG001|Washout Period|Protocol Violation|0|||
149022086|NCT00519636|537558999|FG002|Washout Period|Protocol Violation|1|||
149022087|NCT00519636|537559000|FG003|Washout Period|Protocol Violation|2|||
149022088|NCT00519636|537558997|FG000|Washout Period|Withdrawal by Subject|1|||
149022089|NCT00519636|537558998|FG001|Washout Period|Withdrawal by Subject|0|||
149022090|NCT00519636|537558999|FG002|Washout Period|Withdrawal by Subject|1|||
149022091|NCT00519636|537559000|FG003|Washout Period|Withdrawal by Subject|0|||
149022092|NCT00519636|537558997|FG000|Washout Period|Failed to meet continuation criteria|14|||
149022093|NCT00519636|537558998|FG001|Washout Period|Failed to meet continuation criteria|11|||
149022094|NCT00519636|537558999|FG002|Washout Period|Failed to meet continuation criteria|9|||
149022095|NCT00519636|537559000|FG003|Washout Period|Failed to meet continuation criteria|3|||
149022096|NCT00519636|537558997|FG000|Washout Period|Out of pollen area > 48 hours|1|||
149022097|NCT00519636|537558998|FG001|Washout Period|Out of pollen area > 48 hours|0|||
149022098|NCT00519636|537558999|FG002|Washout Period|Out of pollen area > 48 hours|0|||
149022099|NCT00519636|537559000|FG003|Washout Period|Out of pollen area > 48 hours|0|||
149022100|NCT00519636|537558997|FG000|Washout Period|Participating in study at another site|1|||
149022101|NCT00519636|537558998|FG001|Washout Period|Participating in study at another site|0|||
149022102|NCT00519636|537558999|FG002|Washout Period|Participating in study at another site|0|||
149022103|NCT00519636|537559000|FG003|Washout Period|Participating in study at another site|0|||
148811599|NCT03765073|536787079|FG008|Stage 1|Withdrawal by participant|0|||
148957284|NCT00613938|537328283|FG001|Overall Study|Withdrawal by Subject|4|||
148957285|NCT00613938|537328284|FG002|Overall Study|Withdrawal by Subject|9|||
148957286|NCT00613938|537328285|FG003|Overall Study|Withdrawal by Subject|9|||
148957287|NCT00613938|537328282|FG000|Overall Study|Adverse Event|1|||
148957288|NCT00613938|537328283|FG001|Overall Study|Adverse Event|4|||
148957289|NCT00613938|537328284|FG002|Overall Study|Adverse Event|8|||
148957290|NCT00613938|537328285|FG003|Overall Study|Adverse Event|5|||
148957291|NCT00613938|537328282|FG000|Overall Study|Lack of Efficacy|16|||
148957292|NCT00613938|537328283|FG001|Overall Study|Lack of Efficacy|18|||
148957293|NCT00613938|537328284|FG002|Overall Study|Lack of Efficacy|5|||
148957294|NCT00613938|537328285|FG003|Overall Study|Lack of Efficacy|9|||
148957295|NCT00613938|537328282|FG000|Overall Study|Other|1|||
148957296|NCT00613938|537328283|FG001|Overall Study|Other|2|||
148957297|NCT00613938|537328284|FG002|Overall Study|Other|1|||
148957298|NCT00613938|537328285|FG003|Overall Study|Other|3|||
148957299|NCT00623727|537328286|FG000|Double Blind (DB)|Adverse Event|1|||
148957300|NCT00623727|537328287|FG001|Double Blind (DB)|Adverse Event|3|||
148957301|NCT00623727|537328286|FG000|Double Blind (DB)|Physician Decision|0|||
148957302|NCT00623727|537328287|FG001|Double Blind (DB)|Physician Decision|1|||
149022104|NCT00519636|537558997|FG000|Washout Period|Non-compliant|0|||
149022105|NCT00519636|537558998|FG001|Washout Period|Non-compliant|1|||
149022106|NCT00519636|537558999|FG002|Washout Period|Non-compliant|0|||
149022107|NCT00519636|537559000|FG003|Washout Period|Non-compliant|0|||
149022108|NCT00519636|537558997|FG000|Washout Period|Per doctors request|0|||
149022109|NCT00519636|537558998|FG001|Washout Period|Per doctors request|1|||
149022110|NCT00519636|537558999|FG002|Washout Period|Per doctors request|0|||
148957303|NCT00623727|537328286|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
148957304|NCT00623727|537328287|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
148957305|NCT00623727|537328286|FG000|Double Blind (DB)|Lack of Efficacy|2|||
149022111|NCT00519636|537559000|FG003|Washout Period|Per doctors request|0|||
149022112|NCT00519636|537558997|FG000|Washout Period|Subject randomized in error|0|||
149022113|NCT00519636|537558998|FG001|Washout Period|Subject randomized in error|0|||
149022114|NCT00519636|537558999|FG002|Washout Period|Subject randomized in error|1|||
148691647|NCT04799158|536344234|FG002|On-Demand Treatment Period|Miscellaneous|0|||
148691648|NCT04799158|536344235|FG003|On-Demand Treatment Period|Miscellaneous|0|||
148691649|NCT04799158|536344236|FG004|On-Demand Treatment Period|Miscellaneous|1|||
148691650|NCT00936975|536344237|FG000|Overall Study|Withdrawal by Subject|1|||
148691651|NCT00936975|536344237|FG000|Overall Study|Disease progression|3|||
148691652|NCT00936975|536344237|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
148691653|NCT03922477|536344238|FG000|Overall Study|Death|9|||
148691654|NCT03922477|536344238|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
149022115|NCT00519636|537559000|FG003|Washout Period|Subject randomized in error|0|||
149022116|NCT00519636|537558997|FG000|Washout Period|Prohibited medications|0|||
148957306|NCT00623727|537328287|FG001|Double Blind (DB)|Lack of Efficacy|2|||
148957307|NCT00623727|537328286|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
148957308|NCT00623727|537328287|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
148957309|NCT00623727|537328286|FG000|Double Blind (DB)|Lost to Follow-up|1|||
148957310|NCT00623727|537328287|FG001|Double Blind (DB)|Lost to Follow-up|1|||
148957311|NCT00623727|537328286|FG000|Double Blind (DB)|Protocol Violation|2|||
148957312|NCT00623727|537328287|FG001|Double Blind (DB)|Protocol Violation|2|||
148957313|NCT00623727|537328286|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
148957314|NCT00623727|537328287|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
148957315|NCT00623727|537328286|FG000|Open Label Follow-up|Study termination|0|||
148957316|NCT00623727|537328287|FG001|Open Label Follow-up|Study termination|6|||
148957317|NCT00623727|537328286|FG000|Open Label Follow-up|Participant convenience|0|||
148957318|NCT00623727|537328287|FG001|Open Label Follow-up|Participant convenience|1|||
148957319|NCT02636868|537328288|FG000|Overall Study|Death|0|||
148957320|NCT02636868|537328289|FG001|Overall Study|Death|1|||
148957321|NCT02636868|537328290|FG002|Overall Study|Death|2|||
148957322|NCT03025542|537328291|FG000|Overall Study|Adverse Event|0|||
148957323|NCT03025542|537328292|FG001|Overall Study|Adverse Event|2|||
148957324|NCT03025542|537328291|FG000|Overall Study|Lost to Follow-up|1|||
148957325|NCT03025542|537328292|FG001|Overall Study|Lost to Follow-up|0|||
148957326|NCT03025542|537328291|FG000|Overall Study|Withdrawal by Subject|1|||
148957327|NCT03025542|537328292|FG001|Overall Study|Withdrawal by Subject|0|||
148957328|NCT03745937|537328293|FG000|Overall Study|Withdrawal by Subject|0|||
148957329|NCT03745937|537328294|FG001|Overall Study|Withdrawal by Subject|0|||
148957330|NCT03745937|537328295|FG002|Overall Study|Withdrawal by Subject|0|||
148957331|NCT03745937|537328296|FG003|Overall Study|Withdrawal by Subject|1|||
148957332|NCT03745937|537328293|FG000|Overall Study|Not-specifed|0|||
148957333|NCT03745937|537328294|FG001|Overall Study|Not-specifed|1|||
148957334|NCT03745937|537328295|FG002|Overall Study|Not-specifed|0|||
148957335|NCT03745937|537328296|FG003|Overall Study|Not-specifed|1|||
148957336|NCT00312494|537328298|FG000|Overall Study|Randomized; not treated with study drug|9|||
148957337|NCT00312494|537328299|FG001|Overall Study|Randomized; not treated with study drug|10|||
148957338|NCT00312494|537328300|FG002|Overall Study|Randomized; not treated with study drug|5|||
148957339|NCT00312494|537328298|FG000|Overall Study|Adverse Event|33|||
148957340|NCT00312494|537328299|FG001|Overall Study|Adverse Event|15|||
148957341|NCT00312494|537328300|FG002|Overall Study|Adverse Event|11|||
148957342|NCT00312494|537328298|FG000|Overall Study|Lack of Efficacy|4|||
148957343|NCT00312494|537328299|FG001|Overall Study|Lack of Efficacy|6|||
148957344|NCT00312494|537328300|FG002|Overall Study|Lack of Efficacy|8|||
148957345|NCT00312494|537328298|FG000|Overall Study|Laboratory abnormality|1|||
148957346|NCT00312494|537328299|FG001|Overall Study|Laboratory abnormality|0|||
148957347|NCT00312494|537328300|FG002|Overall Study|Laboratory abnormality|0|||
148957348|NCT00312494|537328298|FG000|Overall Study|Lost to Follow-up|8|||
148957349|NCT00312494|537328299|FG001|Overall Study|Lost to Follow-up|8|||
148957350|NCT00312494|537328300|FG002|Overall Study|Lost to Follow-up|8|||
148957351|NCT00312494|537328298|FG000|Overall Study|Withdrawal by Subject|6|||
148957352|NCT00312494|537328299|FG001|Overall Study|Withdrawal by Subject|9|||
148957353|NCT00312494|537328300|FG002|Overall Study|Withdrawal by Subject|10|||
148957354|NCT00312494|537328298|FG000|Overall Study|Other|10|||
148957355|NCT00312494|537328299|FG001|Overall Study|Other|10|||
148957356|NCT00312494|537328300|FG002|Overall Study|Other|1|||
148957357|NCT01706003|537328302|FG000|Overall Study|Withdrawal by Subject|2|||
148957358|NCT01706003|537328303|FG001|Overall Study|Withdrawal by Subject|0|||
148957359|NCT01706003|537328302|FG000|Overall Study|Not scheduled|3|||
148957360|NCT01706003|537328303|FG001|Overall Study|Not scheduled|0|||
148957361|NCT01706003|537328302|FG000|Overall Study|Lost to Follow-up|6|||
148957362|NCT01706003|537328303|FG001|Overall Study|Lost to Follow-up|4|||
148957363|NCT03182829|537328306|FG000|Overall Study|Protocol Violation|12|||
148957364|NCT03182829|537328307|FG001|Overall Study|Protocol Violation|12|||
148957365|NCT03182829|537328306|FG000|Overall Study|Other|4|||
148957366|NCT03182829|537328307|FG001|Overall Study|Other|3|||
148957367|NCT03316131|537328308|FG000|Treatment Period 2|Protocol deviation|1|||
148957368|NCT03316131|537328309|FG001|Treatment Period 2|Protocol deviation|0|||
148957369|NCT00708162|537328311|FG000|Randomized Phase|Randomized but Not Treated|7|||
148957370|NCT00708162|537328312|FG001|Randomized Phase|Randomized but Not Treated|5|||
148957371|NCT00708162|537328311|FG000|Randomized Phase|Participant Noncompliance|40|||
148957372|NCT00708162|537328312|FG001|Randomized Phase|Participant Noncompliance|32|||
148957373|NCT00708162|537328311|FG000|Randomized Phase|Lost to Follow-up|34|||
148957374|NCT00708162|537328312|FG001|Randomized Phase|Lost to Follow-up|34|||
148957375|NCT00708162|537328311|FG000|Randomized Phase|Withdrew Consent|31|||
148957376|NCT00708162|537328312|FG001|Randomized Phase|Withdrew Consent|22|||
149022117|NCT00519636|537558998|FG001|Washout Period|Prohibited medications|0|||
149022118|NCT00519636|537558999|FG002|Washout Period|Prohibited medications|1|||
148957377|NCT00708162|537328311|FG000|Randomized Phase|Lack of Efficacy|14|||
148957378|NCT00708162|537328312|FG001|Randomized Phase|Lack of Efficacy|19|||
148957379|NCT00708162|537328311|FG000|Randomized Phase|Protocol Violation|10|||
148957380|NCT00708162|537328312|FG001|Randomized Phase|Protocol Violation|11|||
148691655|NCT03922477|536344238|FG000|Overall Study|Physician Decision|1|||
148691656|NCT03922477|536344238|FG000|Overall Study|Withdrawal by Subject|2|||
148691657|NCT04104646|536344242|FG000|Overall Study|Withdrawal by Subject|1|||
148691658|NCT04104646|536344243|FG001|Overall Study|Withdrawal by Subject|1|||
148691659|NCT04104646|536344242|FG000|Overall Study|Lost to Follow-up|1|||
148691660|NCT04104646|536344243|FG001|Overall Study|Lost to Follow-up|0|||
148691661|NCT04104646|536344242|FG000|Overall Study|Physician Decision|2|||
148691662|NCT04104646|536344243|FG001|Overall Study|Physician Decision|0|||
148691663|NCT01199601|536344244|FG000|Overall Study|Lost to Follow-up|47|||
148691664|NCT01199601|536344245|FG001|Overall Study|Lost to Follow-up|66|||
148691665|NCT01199601|536344244|FG000|Overall Study|Withdrawal by Subject|15|||
148691666|NCT01199601|536344245|FG001|Overall Study|Withdrawal by Subject|3|||
148691667|NCT01199601|536344244|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
148691668|NCT01199601|536344245|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
148691669|NCT02607800|536344246|FG000|Overall Study|Lost to Follow-up|7|||
148691670|NCT02607800|536344247|FG001|Overall Study|Lost to Follow-up|10|||
148691671|NCT02607800|536344246|FG000|Overall Study|Withdrew Consent|2|||
148691672|NCT02607800|536344247|FG001|Overall Study|Withdrew Consent|0|||
148691673|NCT02607800|536344246|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
148691674|NCT02607800|536344247|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
148691675|NCT01656889|536344248|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
148691676|NCT01656889|536344249|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
148691677|NCT01656889|536344248|FG000|Treatment Period, 12 Weeks|Death|0|||
148691678|NCT01656889|536344249|FG001|Treatment Period, 12 Weeks|Death|1|||
148691679|NCT01656889|536344248|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
148691680|NCT01656889|536344249|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
148957381|NCT00708162|537328311|FG000|Randomized Phase|Adverse Event|8|||
148691681|NCT01656889|536344248|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
148691682|NCT01656889|536344249|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
148691683|NCT01656889|536344248|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
148691684|NCT01656889|536344249|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
148957382|NCT00708162|537328312|FG001|Randomized Phase|Adverse Event|12|||
148957383|NCT00708162|537328311|FG000|Randomized Phase|Investigator's Discretion|7|||
148957384|NCT00708162|537328312|FG001|Randomized Phase|Investigator's Discretion|10|||
148957385|NCT00708162|537328311|FG000|Randomized Phase|Death|2|||
148957386|NCT00708162|537328312|FG001|Randomized Phase|Death|9|||
148957387|NCT00708162|537328311|FG000|Randomized Phase|Pregnancy|3|||
148957388|NCT00708162|537328312|FG001|Randomized Phase|Pregnancy|0|||
148957389|NCT00708162|537328311|FG000|Open-Label Phase|Lost to Follow-up|10|||
148957390|NCT00708162|537328312|FG001|Open-Label Phase|Lost to Follow-up|8|||
148957391|NCT00708162|537328311|FG000|Open-Label Phase|Withdrew Consent|12|||
148957392|NCT00708162|537328312|FG001|Open-Label Phase|Withdrew Consent|6|||
148957393|NCT00708162|537328311|FG000|Open-Label Phase|Participant Noncompliance|7|||
148957394|NCT00708162|537328312|FG001|Open-Label Phase|Participant Noncompliance|7|||
148957395|NCT00708162|537328311|FG000|Open-Label Phase|Lack of Efficacy|7|||
148957396|NCT00708162|537328312|FG001|Open-Label Phase|Lack of Efficacy|4|||
148957397|NCT00708162|537328311|FG000|Open-Label Phase|Investigator's Discretion|3|||
148957398|NCT00708162|537328312|FG001|Open-Label Phase|Investigator's Discretion|2|||
148957399|NCT00708162|537328311|FG000|Open-Label Phase|Death|3|||
148957400|NCT00708162|537328312|FG001|Open-Label Phase|Death|1|||
148957401|NCT00708162|537328311|FG000|Open-Label Phase|Adverse Event|1|||
148957402|NCT00708162|537328312|FG001|Open-Label Phase|Adverse Event|2|||
148957403|NCT00708162|537328311|FG000|Open-Label Phase|Other|1|||
148957404|NCT00708162|537328312|FG001|Open-Label Phase|Other|0|||
148957405|NCT00065507|537328314|FG000|Overall Study|Death|16|||
148957406|NCT00065507|537328315|FG001|Overall Study|Death|17|||
148957407|NCT00065507|537328314|FG000|Overall Study|Adverse Event|4|||
148957408|NCT00065507|537328315|FG001|Overall Study|Adverse Event|3|||
148957409|NCT00065507|537328314|FG000|Overall Study|Lack of Efficacy|0|||
148957410|NCT00065507|537328315|FG001|Overall Study|Lack of Efficacy|6|||
148957411|NCT00065507|537328314|FG000|Overall Study|Poor/Non-compliance|3|||
148957412|NCT00065507|537328315|FG001|Overall Study|Poor/Non-compliance|2|||
148957413|NCT00065507|537328314|FG000|Overall Study|Lost to Follow-up|3|||
148957414|NCT00065507|537328315|FG001|Overall Study|Lost to Follow-up|0|||
148957415|NCT00065507|537328314|FG000|Overall Study|Subject Withdrew Consent|2|||
148957416|NCT00065507|537328315|FG001|Overall Study|Subject Withdrew Consent|1|||
148957417|NCT00065507|537328314|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
148957418|NCT00065507|537328315|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
148957419|NCT02169739|537328316|FG000|Overall Study|Lost to Follow-up|0|||
148957420|NCT02169739|537328317|FG001|Overall Study|Lost to Follow-up|4|||
148957421|NCT03635957|537328318|FG000|Run-In Period|Lost to Follow-up|1|||
148957422|NCT03635957|537328318|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
148957423|NCT00350636|537328319|FG000|Overall Study|Adverse Event|19|||
148957424|NCT00350636|537328320|FG001|Overall Study|Adverse Event|13|||
148957425|NCT00350636|537328319|FG000|Overall Study|Protocol Violation|1|||
148957426|NCT00350636|537328320|FG001|Overall Study|Protocol Violation|3|||
148957427|NCT00350636|537328319|FG000|Overall Study|Withdrawal by Subject|13|||
148957428|NCT00350636|537328320|FG001|Overall Study|Withdrawal by Subject|17|||
148957429|NCT00350636|537328319|FG000|Overall Study|Lost to Follow-up|9|||
148957430|NCT00350636|537328320|FG001|Overall Study|Lost to Follow-up|8|||
148957431|NCT00350636|537328319|FG000|Overall Study|Physician Decision|0|||
148957432|NCT00350636|537328320|FG001|Overall Study|Physician Decision|2|||
148957433|NCT00350636|537328319|FG000|Overall Study|Other|1|||
148957434|NCT00350636|537328320|FG001|Overall Study|Other|2|||
149022119|NCT00519636|537559000|FG003|Washout Period|Prohibited medications|0|||
148957435|NCT01647282|537328326|FG000|Overall Study|Physician Decision|7|||
148957436|NCT01647282|537328327|FG001|Overall Study|Physician Decision|5|||
148957437|NCT01042236|537328328|FG000|Treatment Period 1|Adverse Event|0|||
148957438|NCT01042236|537328329|FG001|Treatment Period 1|Adverse Event|1|||
148957439|NCT01042236|537328330|FG002|Treatment Period 1|Adverse Event|0|||
148957440|NCT01042236|537328331|FG003|Treatment Period 1|Adverse Event|0|||
148957441|NCT01042236|537328332|FG004|Treatment Period 1|Adverse Event|1|||
148957442|NCT01042236|537328333|FG005|Treatment Period 1|Adverse Event|0|||
148811600|NCT03765073|536787080|FG009|Stage 1|Withdrawal by participant|0|||
148811601|NCT03765073|536787081|FG010|Stage 1|Withdrawal by participant|0|||
148811602|NCT03765073|536787082|FG011|Stage 1|Withdrawal by participant|0|||
148811603|NCT03765073|536787083|FG012|Stage 1|Withdrawal by participant|0|||
148811604|NCT03765073|536787084|FG013|Stage 1|Withdrawal by participant|0|||
148811605|NCT03765073|536787085|FG014|Stage 1|Withdrawal by participant|0|||
148811606|NCT03765073|536787086|FG015|Stage 1|Withdrawal by participant|0|||
148811607|NCT03765073|536787087|FG016|Stage 1|Withdrawal by participant|0|||
148811608|NCT03765073|536787088|FG017|Stage 1|Withdrawal by participant|0|||
148811609|NCT03765073|536787089|FG018|Stage 1|Withdrawal by participant|0|||
148811610|NCT03765073|536787090|FG019|Stage 1|Withdrawal by participant|0|||
148811611|NCT03765073|536787091|FG020|Stage 1|Withdrawal by participant|0|||
148811612|NCT03765073|536787071|FG000|Stage 2|Death|0|||
148811613|NCT03765073|536787072|FG001|Stage 2|Death|0|||
148811614|NCT03765073|536787073|FG002|Stage 2|Death|0|||
148811615|NCT03765073|536787074|FG003|Stage 2|Death|0|||
148811616|NCT03765073|536787075|FG004|Stage 2|Death|0|||
148811617|NCT03765073|536787076|FG005|Stage 2|Death|0|||
148811618|NCT03765073|536787077|FG006|Stage 2|Death|0|||
148811619|NCT03765073|536787078|FG007|Stage 2|Death|0|||
148811620|NCT03765073|536787079|FG008|Stage 2|Death|0|||
148811621|NCT03765073|536787080|FG009|Stage 2|Death|1|||
148811622|NCT03765073|536787081|FG010|Stage 2|Death|0|||
148811623|NCT03765073|536787082|FG011|Stage 2|Death|1|||
148811624|NCT03765073|536787083|FG012|Stage 2|Death|0|||
148811625|NCT03765073|536787084|FG013|Stage 2|Death|0|||
148811626|NCT03765073|536787085|FG014|Stage 2|Death|0|||
148811627|NCT03765073|536787086|FG015|Stage 2|Death|0|||
148811628|NCT03765073|536787087|FG016|Stage 2|Death|2|||
148811629|NCT03765073|536787088|FG017|Stage 2|Death|0|||
148811630|NCT03765073|536787089|FG018|Stage 2|Death|0|||
148811631|NCT03765073|536787090|FG019|Stage 2|Death|0|||
148811632|NCT03765073|536787091|FG020|Stage 2|Death|0|||
148811633|NCT03765073|536787071|FG000|Stage 2|Lost to Follow-up|0|||
148811634|NCT03765073|536787072|FG001|Stage 2|Lost to Follow-up|0|||
148811635|NCT03765073|536787073|FG002|Stage 2|Lost to Follow-up|0|||
148811636|NCT03765073|536787074|FG003|Stage 2|Lost to Follow-up|5|||
148811637|NCT03765073|536787075|FG004|Stage 2|Lost to Follow-up|1|||
148811638|NCT03765073|536787076|FG005|Stage 2|Lost to Follow-up|0|||
148811639|NCT03765073|536787077|FG006|Stage 2|Lost to Follow-up|3|||
148811640|NCT03765073|536787078|FG007|Stage 2|Lost to Follow-up|3|||
148811641|NCT03765073|536787079|FG008|Stage 2|Lost to Follow-up|1|||
148811642|NCT03765073|536787080|FG009|Stage 2|Lost to Follow-up|6|||
148957443|NCT01042236|537328328|FG000|Treatment Period 3|Adverse Event|0|||
148957444|NCT01042236|537328329|FG001|Treatment Period 3|Adverse Event|0|||
148957445|NCT01042236|537328330|FG002|Treatment Period 3|Adverse Event|0|||
148957446|NCT01042236|537328331|FG003|Treatment Period 3|Adverse Event|1|||
148957447|NCT01042236|537328332|FG004|Treatment Period 3|Adverse Event|0|||
148957448|NCT01042236|537328333|FG005|Treatment Period 3|Adverse Event|0|||
148957449|NCT01042236|537328328|FG000|Treatment Period 3|Protocol Violation|0|||
148957450|NCT01042236|537328329|FG001|Treatment Period 3|Protocol Violation|0|||
148957451|NCT01042236|537328330|FG002|Treatment Period 3|Protocol Violation|0|||
148957452|NCT01042236|537328331|FG003|Treatment Period 3|Protocol Violation|1|||
148957453|NCT01042236|537328332|FG004|Treatment Period 3|Protocol Violation|0|||
148957454|NCT01042236|537328333|FG005|Treatment Period 3|Protocol Violation|0|||
148957455|NCT03480750|537328338|FG000|Overall Study|Withdrawal by Subject|0|||
148957456|NCT03480750|537328339|FG001|Overall Study|Withdrawal by Subject|1|||
148957457|NCT03480750|537328340|FG002|Overall Study|Withdrawal by Subject|0|||
148957458|NCT03480750|537328341|FG003|Overall Study|Withdrawal by Subject|0|||
148957459|NCT03480750|537328342|FG004|Overall Study|Withdrawal by Subject|0|||
148957460|NCT03480750|537328343|FG005|Overall Study|Withdrawal by Subject|0|||
148957461|NCT03480750|537328338|FG000|Overall Study|The interruption in Trientine shippment|0|||
148957462|NCT03480750|537328339|FG001|Overall Study|The interruption in Trientine shippment|0|||
148957463|NCT03480750|537328340|FG002|Overall Study|The interruption in Trientine shippment|0|||
148957464|NCT03480750|537328341|FG003|Overall Study|The interruption in Trientine shippment|0|||
148957465|NCT03480750|537328342|FG004|Overall Study|The interruption in Trientine shippment|0|||
148957466|NCT03480750|537328343|FG005|Overall Study|The interruption in Trientine shippment|1|||
148957467|NCT02411292|537328344|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
148957468|NCT02411292|537328344|FG000|Overall Study|Death|2|||
148957469|NCT02411292|537328344|FG000|Overall Study|Lost to Follow-up|3|||
148957470|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
148957471|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
148957472|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
148957473|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
148957474|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
148957475|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
148957476|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
148957477|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
148957478|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Other|4|||
148811643|NCT03765073|536787081|FG010|Stage 2|Lost to Follow-up|5|||
148957479|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Other|1|||
148957480|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
148957481|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
148957482|NCT00303498|537328347|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
148957483|NCT00303498|537328348|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
148957484|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
148957485|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
148957486|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Death|1|||
148957487|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Death|0|||
148957488|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
148957489|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
148957490|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
148957491|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
148957492|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
148957493|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
148957494|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
148957495|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
148957496|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Other|1|||
148957497|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Other|0|||
148957498|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
148957499|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
148957500|NCT00303498|537328347|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
148957501|NCT00303498|537328348|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
148957502|NCT00453921|537328349|FG000|Overall Study|Withdrawal by Subject|1|||
148957503|NCT00453921|537328350|FG001|Overall Study|Withdrawal by Subject|1|||
148957504|NCT00453921|537328351|FG002|Overall Study|Withdrawal by Subject|1|||
148957505|NCT00453921|537328352|FG003|Overall Study|Withdrawal by Subject|1|||
148957506|NCT00453921|537328349|FG000|Overall Study|Lost to Follow-up|0|||
148957507|NCT00453921|537328350|FG001|Overall Study|Lost to Follow-up|0|||
148957508|NCT00453921|537328351|FG002|Overall Study|Lost to Follow-up|1|||
148957509|NCT00453921|537328352|FG003|Overall Study|Lost to Follow-up|0|||
148957510|NCT00174915|537328353|FG000|Overall Study|Lost to Follow-up|19|||
148957511|NCT00174915|537328354|FG001|Overall Study|Lost to Follow-up|17|||
148957512|NCT00174915|537328355|FG002|Overall Study|Lost to Follow-up|9|||
148957513|NCT00174915|537328356|FG003|Overall Study|Lost to Follow-up|17|||
148957514|NCT00174915|537328357|FG004|Overall Study|Lost to Follow-up|10|||
148957515|NCT00174915|537328353|FG000|Overall Study|Adverse Event|18|||
148957516|NCT00174915|537328354|FG001|Overall Study|Adverse Event|16|||
148957517|NCT00174915|537328355|FG002|Overall Study|Adverse Event|11|||
148957518|NCT00174915|537328356|FG003|Overall Study|Adverse Event|18|||
148957519|NCT00174915|537328357|FG004|Overall Study|Adverse Event|5|||
149022120|NCT00519636|537558997|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
148811644|NCT03765073|536787082|FG011|Stage 2|Lost to Follow-up|1|||
148957520|NCT00174915|537328353|FG000|Overall Study|Personal Reason(s)|16|||
148957521|NCT00174915|537328354|FG001|Overall Study|Personal Reason(s)|16|||
148957522|NCT00174915|537328355|FG002|Overall Study|Personal Reason(s)|9|||
148957523|NCT00174915|537328356|FG003|Overall Study|Personal Reason(s)|9|||
148957524|NCT00174915|537328357|FG004|Overall Study|Personal Reason(s)|9|||
148957525|NCT00174915|537328353|FG000|Overall Study|Other|15|||
148957526|NCT00174915|537328354|FG001|Overall Study|Other|8|||
148957527|NCT00174915|537328355|FG002|Overall Study|Other|6|||
148957528|NCT00174915|537328356|FG003|Overall Study|Other|5|||
148957529|NCT00174915|537328357|FG004|Overall Study|Other|3|||
148957530|NCT00174915|537328353|FG000|Overall Study|Gout Flare|13|||
148957531|NCT00174915|537328354|FG001|Overall Study|Gout Flare|6|||
148957532|NCT00174915|537328355|FG002|Overall Study|Gout Flare|8|||
148957533|NCT00174915|537328356|FG003|Overall Study|Gout Flare|1|||
148957534|NCT00174915|537328357|FG004|Overall Study|Gout Flare|0|||
148957535|NCT00174915|537328353|FG000|Overall Study|Protocol Violation|6|||
148957536|NCT00174915|537328354|FG001|Overall Study|Protocol Violation|3|||
148957537|NCT00174915|537328355|FG002|Overall Study|Protocol Violation|3|||
148957538|NCT00174915|537328356|FG003|Overall Study|Protocol Violation|6|||
148957539|NCT00174915|537328357|FG004|Overall Study|Protocol Violation|3|||
148957540|NCT00174915|537328353|FG000|Overall Study|Therapeutic Failure|6|||
148957541|NCT00174915|537328354|FG001|Overall Study|Therapeutic Failure|3|||
148957542|NCT00174915|537328355|FG002|Overall Study|Therapeutic Failure|2|||
148957543|NCT00174915|537328356|FG003|Overall Study|Therapeutic Failure|1|||
148957544|NCT00174915|537328357|FG004|Overall Study|Therapeutic Failure|3|||
148957545|NCT02232425|537328358|FG000|Overall Study|Lost to Follow-up|6|||
148957546|NCT02232425|537328359|FG001|Overall Study|Lost to Follow-up|2|||
148957547|NCT02232425|537328358|FG000|Overall Study|Adverse Event|2|||
148957548|NCT02232425|537328359|FG001|Overall Study|Adverse Event|0|||
148957549|NCT02232425|537328358|FG000|Overall Study|Withdrawal by Subject|5|||
148957550|NCT02232425|537328359|FG001|Overall Study|Withdrawal by Subject|6|||
148957551|NCT02232425|537328358|FG000|Overall Study|Lack of Efficacy|1|||
148957552|NCT02232425|537328359|FG001|Overall Study|Lack of Efficacy|0|||
148957553|NCT03060447|537328360|FG000|Overall Study|Withdrawal by Subject|2|||
148957554|NCT03060447|537328361|FG001|Overall Study|Withdrawal by Subject|0|||
148957555|NCT04984993|537328362|FG000|Overall Study|Withdrawal by Subject|8|||
148957556|NCT04984993|537328363|FG001|Overall Study|Withdrawal by Subject|2|||
148957557|NCT04984993|537328362|FG000|Overall Study|Lost to Follow-up|2|||
148957558|NCT04984993|537328363|FG001|Overall Study|Lost to Follow-up|2|||
148957559|NCT04984993|537328362|FG000|Overall Study|Both patients moved to another country|4|||
148957560|NCT04984993|537328363|FG001|Overall Study|Both patients moved to another country|0|||
148957561|NCT03318315|537328364|FG000|Overall Study|Lost to Follow-up|3|||
148957562|NCT03318315|537328365|FG001|Overall Study|Lost to Follow-up|2|||
148957563|NCT03318315|537328366|FG002|Overall Study|Lost to Follow-up|1|||
148957564|NCT03318315|537328364|FG000|Overall Study|Protocol Violation|1|||
148957565|NCT03318315|537328365|FG001|Overall Study|Protocol Violation|1|||
148957566|NCT03318315|537328366|FG002|Overall Study|Protocol Violation|1|||
148957567|NCT03318315|537328364|FG000|Overall Study|Withdrawal by Subject|0|||
148957568|NCT03318315|537328365|FG001|Overall Study|Withdrawal by Subject|0|||
148957569|NCT03318315|537328366|FG002|Overall Study|Withdrawal by Subject|2|||
148957570|NCT04577118|537328371|FG000|Overall Study|Withdrawal by Subject|4|||
148957571|NCT02611778|537328372|FG000|Overall Study|Withdrawal by Subject|2|||
148957572|NCT02611778|537328373|FG001|Overall Study|Withdrawal by Subject|8|||
149022121|NCT00519636|537558998|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
148957573|NCT02611778|537328372|FG000|Overall Study|Adverse Event|1|||
148957574|NCT02611778|537328373|FG001|Overall Study|Adverse Event|2|||
148957575|NCT02611778|537328372|FG000|Overall Study|Death|2|||
148957576|NCT02611778|537328373|FG001|Overall Study|Death|1|||
148957577|NCT02611778|537328372|FG000|Overall Study|Protocol Violation|1|||
148957578|NCT02611778|537328373|FG001|Overall Study|Protocol Violation|0|||
148957579|NCT02611778|537328372|FG000|Overall Study|Lost to Follow-up|3|||
148957580|NCT02611778|537328373|FG001|Overall Study|Lost to Follow-up|1|||
148957581|NCT02611778|537328372|FG000|Overall Study|Need for alternative treatment|1|||
148957582|NCT02611778|537328373|FG001|Overall Study|Need for alternative treatment|0|||
148957583|NCT02611778|537328372|FG000|Overall Study|Other Reason|2|||
148957584|NCT02611778|537328373|FG001|Overall Study|Other Reason|1|||
148957585|NCT00810407|537328374|FG000|Overall Study|Protocol Violation|3|||
148957586|NCT00810407|537328374|FG000|Overall Study|No Visit After First Day of Treatment|3|||
148957587|NCT02968563|537328375|FG000|Overall Study|Adverse Event|0|||
148957588|NCT02968563|537328376|FG001|Overall Study|Adverse Event|6|||
148957589|NCT02968563|537328375|FG000|Overall Study|Death|1|||
148957590|NCT02968563|537328376|FG001|Overall Study|Death|1|||
148957591|NCT02968563|537328375|FG000|Overall Study|Lost to Follow-up|0|||
148957592|NCT02968563|537328376|FG001|Overall Study|Lost to Follow-up|1|||
148957593|NCT03287804|537328377|FG000|Overall Study|Death|1|||
148957594|NCT03287804|537328377|FG000|Overall Study|Physician Decision|2|||
148957595|NCT03287804|537328377|FG000|Overall Study|Progressive disease|8|||
148957596|NCT04008030|537328380|FG000|Pre-Treatment|Withdrawal by Subject|0|||
148957597|NCT04008030|537328381|FG001|Pre-Treatment|Withdrawal by Subject|0|||
148957598|NCT04008030|537328382|FG002|Pre-Treatment|Withdrawal by Subject|9|||
148957599|NCT04008030|537328380|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
148957600|NCT04008030|537328381|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
148957601|NCT04008030|537328382|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
148957602|NCT04008030|537328380|FG000|Pre-Treatment|Other reasons|0|||
148957603|NCT04008030|537328381|FG001|Pre-Treatment|Other reasons|1|||
148957604|NCT04008030|537328382|FG002|Pre-Treatment|Other reasons|6|||
148957605|NCT04008030|537328380|FG000|Treatment|Withdrawal by Subject|1|||
148957606|NCT04008030|537328381|FG001|Treatment|Withdrawal by Subject|1|||
148957607|NCT04008030|537328382|FG002|Treatment|Withdrawal by Subject|1|||
148957608|NCT04008030|537328380|FG000|Treatment|Death|2|||
148957609|NCT04008030|537328381|FG001|Treatment|Death|4|||
148957610|NCT04008030|537328382|FG002|Treatment|Death|0|||
148957611|NCT04008030|537328380|FG000|Treatment|Pregnancy|0|||
148957612|NCT04008030|537328381|FG001|Treatment|Pregnancy|1|||
148957613|NCT04008030|537328382|FG002|Treatment|Pregnancy|0|||
148957614|NCT04008030|537328380|FG000|Treatment|Participant no longer meets study criteria|0|||
148957615|NCT04008030|537328381|FG001|Treatment|Participant no longer meets study criteria|1|||
148957616|NCT04008030|537328382|FG002|Treatment|Participant no longer meets study criteria|0|||
148957617|NCT04008030|537328380|FG000|Treatment|Other reasons|5|||
148957618|NCT04008030|537328381|FG001|Treatment|Other reasons|13|||
148957619|NCT04008030|537328382|FG002|Treatment|Other reasons|6|||
148957620|NCT04008030|537328380|FG000|Treatment|Disease Progression|137|||
148957621|NCT04008030|537328381|FG001|Treatment|Disease Progression|82|||
148957622|NCT04008030|537328382|FG002|Treatment|Disease Progression|85|||
148957623|NCT04008030|537328380|FG000|Treatment|Study drug toxicity|28|||
148957624|NCT04008030|537328381|FG001|Treatment|Study drug toxicity|48|||
148957625|NCT04008030|537328382|FG002|Treatment|Study drug toxicity|8|||
148957626|NCT04008030|537328380|FG000|Treatment|Adverse Event unrelated to study drug|28|||
148957627|NCT04008030|537328381|FG001|Treatment|Adverse Event unrelated to study drug|22|||
148957628|NCT04008030|537328382|FG002|Treatment|Adverse Event unrelated to study drug|6|||
148957629|NCT04008030|537328380|FG000|Treatment|Maximum Clinical Benefit|0|||
148957630|NCT04008030|537328381|FG001|Treatment|Maximum Clinical Benefit|1|||
148957631|NCT04008030|537328382|FG002|Treatment|Maximum Clinical Benefit|9|||
148957632|NCT04008030|537328380|FG000|Treatment|On-going treatment|13|||
149022122|NCT00519636|537558999|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
148957633|NCT04008030|537328381|FG001|Treatment|On-going treatment|20|||
148957634|NCT04008030|537328382|FG002|Treatment|On-going treatment|0|||
148957635|NCT03108027|537328395|FG000|Period 1|Subject/Guardian Decision|0|||
148957636|NCT03108027|537328396|FG001|Period 1|Subject/Guardian Decision|0|||
149022123|NCT00519636|537559000|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
148957637|NCT03108027|537328397|FG002|Period 1|Subject/Guardian Decision|0|||
148957638|NCT03108027|537328398|FG003|Period 1|Subject/Guardian Decision|2|||
148957639|NCT03108027|537328399|FG004|Period 1|Subject/Guardian Decision|0|||
148957640|NCT03108027|537328400|FG005|Period 1|Subject/Guardian Decision|0|||
148957641|NCT03108027|537328395|FG000|Period 3|Adverse Event|0|||
148957642|NCT03108027|537328396|FG001|Period 3|Adverse Event|1|||
148957643|NCT03108027|537328397|FG002|Period 3|Adverse Event|0|||
148957644|NCT03108027|537328398|FG003|Period 3|Adverse Event|0|||
148957645|NCT03108027|537328399|FG004|Period 3|Adverse Event|0|||
148691685|NCT01656889|536344248|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
148691686|NCT01656889|536344249|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
148691687|NCT01656889|536344248|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
148691688|NCT01656889|536344249|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
148691689|NCT01656889|536344248|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
148691690|NCT01656889|536344249|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
148691691|NCT01656889|536344248|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
148691692|NCT01656889|536344249|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
148691693|NCT01656889|536344248|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
148691694|NCT01656889|536344249|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
148691695|NCT02521948|536344250|FG000|Overall Study|Adverse Event|2|||
148691696|NCT02521948|536344250|FG000|Overall Study|Death|4|||
148691697|NCT02521948|536344250|FG000|Overall Study|Lost to Follow-up|1|||
148691698|NCT02521948|536344250|FG000|Overall Study|Did not attend one or both follow-ups|6|||
148691699|NCT02568384|536344254|FG000|Overall Study|Mobile devices incompatible with App|2|||
148691700|NCT01485536|536344255|FG000|Overall Study|Withdrawal by Subject|3|||
148691701|NCT01485536|536344255|FG000|Overall Study|Adverse Event|1|||
148691702|NCT00329602|536344256|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
148691703|NCT00329602|536344257|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
148691704|NCT00329602|536344258|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
148691705|NCT00329602|536344256|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
148691706|NCT00329602|536344257|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
148691707|NCT00329602|536344258|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
148691708|NCT00329602|536344256|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
148691709|NCT00329602|536344257|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
148691710|NCT00329602|536344258|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
148691711|NCT00329602|536344256|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
148691712|NCT00329602|536344257|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
148691713|NCT00329602|536344258|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
148691714|NCT00329602|536344256|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
148691715|NCT00329602|536344257|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
148691716|NCT00329602|536344258|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
148691717|NCT00329602|536344256|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
148691718|NCT00329602|536344257|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
148691719|NCT00329602|536344258|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
148691720|NCT00510510|536344259|FG000|Overall Study|Adverse Event|4|||
148691721|NCT00510510|536344260|FG001|Overall Study|Adverse Event|3|||
148691722|NCT00510510|536344261|FG002|Overall Study|Adverse Event|6|||
148691723|NCT00510510|536344259|FG000|Overall Study|Lack of Efficacy|0|||
148691724|NCT00510510|536344260|FG001|Overall Study|Lack of Efficacy|1|||
148691725|NCT00510510|536344261|FG002|Overall Study|Lack of Efficacy|1|||
148691726|NCT00510510|536344259|FG000|Overall Study|Subjects no longer requires study drug|0|||
148691727|NCT00510510|536344260|FG001|Overall Study|Subjects no longer requires study drug|0|||
148691728|NCT00510510|536344261|FG002|Overall Study|Subjects no longer requires study drug|2|||
148691729|NCT00510510|536344259|FG000|Overall Study|Withdrawal by Subject|1|||
148691730|NCT00510510|536344260|FG001|Overall Study|Withdrawal by Subject|2|||
148691731|NCT00510510|536344261|FG002|Overall Study|Withdrawal by Subject|3|||
148691732|NCT00510510|536344259|FG000|Overall Study|Lost to Follow-up|0|||
148691733|NCT00510510|536344260|FG001|Overall Study|Lost to Follow-up|0|||
148691734|NCT00510510|536344261|FG002|Overall Study|Lost to Follow-up|1|||
148957646|NCT03108027|537328400|FG005|Period 3|Adverse Event|0|||
148957647|NCT02574247|537328401|FG000|Overall Study|Withdrawal by Subject|1|||
148957648|NCT02574247|537328402|FG001|Overall Study|Withdrawal by Subject|0|||
148957649|NCT02574247|537328403|FG002|Overall Study|Withdrawal by Subject|0|||
148957650|NCT02574247|537328401|FG000|Overall Study|Did not meet inclusion criteria|4|||
148957651|NCT02574247|537328402|FG001|Overall Study|Did not meet inclusion criteria|3|||
148957652|NCT02574247|537328403|FG002|Overall Study|Did not meet inclusion criteria|5|||
148957653|NCT00770289|537328408|FG000|Overall Study|Other|6|||
148957654|NCT02733991|537328409|FG000|Overall Study|Adverse Event|1|||
148957655|NCT02733991|537328410|FG001|Overall Study|Adverse Event|0|||
148957656|NCT02733991|537328409|FG000|Overall Study|Withdrawal by Subject|0|||
148957657|NCT02733991|537328410|FG001|Overall Study|Withdrawal by Subject|5|||
148957658|NCT02659631|537328413|FG000|Overall Study|Lost to Follow-up|0|||
148957659|NCT02659631|537328414|FG001|Overall Study|Lost to Follow-up|0|||
148957660|NCT02659631|537328415|FG002|Overall Study|Lost to Follow-up|2|||
148957661|NCT02659631|537328416|FG003|Overall Study|Lost to Follow-up|0|||
148957662|NCT02659631|537328417|FG004|Overall Study|Lost to Follow-up|0|||
148957663|NCT02659631|537328418|FG005|Overall Study|Lost to Follow-up|1|||
148957664|NCT02659631|537328419|FG006|Overall Study|Lost to Follow-up|0|||
148957665|NCT02659631|537328420|FG007|Overall Study|Lost to Follow-up|0|||
148957666|NCT02659631|537328421|FG008|Overall Study|Lost to Follow-up|0|||
148957667|NCT02659631|537328422|FG009|Overall Study|Lost to Follow-up|0|||
148957668|NCT02659631|537328413|FG000|Overall Study|Withdrawal prior to treatment|0|||
148957669|NCT02659631|537328414|FG001|Overall Study|Withdrawal prior to treatment|0|||
149022124|NCT00519636|537558997|FG000|Treatment Period 2|Subject randomized in error|0|||
149022125|NCT00519636|537558998|FG001|Treatment Period 2|Subject randomized in error|1|||
148957670|NCT02659631|537328415|FG002|Overall Study|Withdrawal prior to treatment|0|||
148957671|NCT02659631|537328416|FG003|Overall Study|Withdrawal prior to treatment|0|||
148957672|NCT02659631|537328417|FG004|Overall Study|Withdrawal prior to treatment|1|||
148957673|NCT02659631|537328418|FG005|Overall Study|Withdrawal prior to treatment|0|||
148957674|NCT02659631|537328419|FG006|Overall Study|Withdrawal prior to treatment|0|||
149022126|NCT00519636|537558999|FG002|Treatment Period 2|Subject randomized in error|0|||
148957675|NCT02659631|537328420|FG007|Overall Study|Withdrawal prior to treatment|0|||
148957676|NCT02659631|537328421|FG008|Overall Study|Withdrawal prior to treatment|0|||
148957677|NCT02659631|537328422|FG009|Overall Study|Withdrawal prior to treatment|0|||
148691735|NCT00510510|536344259|FG000|Overall Study|Protocol Violation|0|||
148691736|NCT00510510|536344260|FG001|Overall Study|Protocol Violation|3|||
148691737|NCT00510510|536344261|FG002|Overall Study|Protocol Violation|4|||
148691738|NCT01066052|536344262|FG000|Overall Study|Enrolled But Not Treated|3|||
148691739|NCT01066052|536344263|FG001|Overall Study|Enrolled But Not Treated|0|||
148691740|NCT01497938|536344264|FG000|Overall Study|Adverse Event|0|||
148691741|NCT01497938|536344265|FG001|Overall Study|Adverse Event|1|||
148691742|NCT01497938|536344264|FG000|Overall Study|Physician Decision|0|||
148691743|NCT01497938|536344265|FG001|Overall Study|Physician Decision|1|||
148691744|NCT01497938|536344264|FG000|Overall Study|Withdrawal by Subject|4|||
148691745|NCT01497938|536344265|FG001|Overall Study|Withdrawal by Subject|0|||
148691746|NCT01497938|536344264|FG000|Overall Study|Device Violation|1|||
148691747|NCT01497938|536344265|FG001|Overall Study|Device Violation|0|||
148691748|NCT00365352|536344266|FG000|Overall Study|Adverse Event|6|||
148691749|NCT00365352|536344267|FG001|Overall Study|Adverse Event|7|||
148691750|NCT00365352|536344268|FG002|Overall Study|Adverse Event|8|||
148691751|NCT00365352|536344266|FG000|Overall Study|Participant Withdrew Consent|8|||
148691752|NCT00365352|536344267|FG001|Overall Study|Participant Withdrew Consent|3|||
148811645|NCT03765073|536787083|FG012|Stage 2|Lost to Follow-up|1|||
148811646|NCT03765073|536787084|FG013|Stage 2|Lost to Follow-up|3|||
148811647|NCT03765073|536787085|FG014|Stage 2|Lost to Follow-up|3|||
148691753|NCT00365352|536344268|FG002|Overall Study|Participant Withdrew Consent|4|||
148691754|NCT00365352|536344266|FG000|Overall Study|Lack of Efficacy|3|||
148691755|NCT00365352|536344267|FG001|Overall Study|Lack of Efficacy|0|||
148691756|NCT00365352|536344268|FG002|Overall Study|Lack of Efficacy|0|||
148691757|NCT00365352|536344266|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
148691758|NCT00365352|536344267|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
148811648|NCT03765073|536787086|FG015|Stage 2|Lost to Follow-up|1|||
148811649|NCT03765073|536787087|FG016|Stage 2|Lost to Follow-up|6|||
148957678|NCT02659631|537328413|FG000|Overall Study|Participant refused further follow-up|0|||
148957679|NCT02659631|537328414|FG001|Overall Study|Participant refused further follow-up|0|||
148957680|NCT02659631|537328415|FG002|Overall Study|Participant refused further follow-up|0|||
148957681|NCT02659631|537328416|FG003|Overall Study|Participant refused further follow-up|1|||
148957682|NCT02659631|537328417|FG004|Overall Study|Participant refused further follow-up|0|||
148957683|NCT02659631|537328418|FG005|Overall Study|Participant refused further follow-up|0|||
148957684|NCT02659631|537328419|FG006|Overall Study|Participant refused further follow-up|0|||
148691759|NCT00365352|536344268|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
148957685|NCT02659631|537328420|FG007|Overall Study|Participant refused further follow-up|0|||
148957686|NCT02659631|537328421|FG008|Overall Study|Participant refused further follow-up|1|||
148957687|NCT02659631|537328422|FG009|Overall Study|Participant refused further follow-up|0|||
148957688|NCT02659631|537328413|FG000|Overall Study|Death (follow-up phase)|1|||
148957689|NCT02659631|537328414|FG001|Overall Study|Death (follow-up phase)|2|||
148811650|NCT03765073|536787088|FG017|Stage 2|Lost to Follow-up|0|||
148957690|NCT02659631|537328415|FG002|Overall Study|Death (follow-up phase)|1|||
148957691|NCT02659631|537328416|FG003|Overall Study|Death (follow-up phase)|1|||
148957692|NCT02659631|537328417|FG004|Overall Study|Death (follow-up phase)|3|||
148957693|NCT02659631|537328418|FG005|Overall Study|Death (follow-up phase)|2|||
148957694|NCT02659631|537328419|FG006|Overall Study|Death (follow-up phase)|0|||
148957695|NCT02659631|537328420|FG007|Overall Study|Death (follow-up phase)|3|||
148957696|NCT02659631|537328421|FG008|Overall Study|Death (follow-up phase)|1|||
148957697|NCT02659631|537328422|FG009|Overall Study|Death (follow-up phase)|0|||
148957698|NCT02659631|537328413|FG000|Overall Study|Death (treatment phase)|0|||
148957699|NCT02659631|537328414|FG001|Overall Study|Death (treatment phase)|0|||
148957700|NCT02659631|537328415|FG002|Overall Study|Death (treatment phase)|0|||
148957701|NCT02659631|537328416|FG003|Overall Study|Death (treatment phase)|0|||
148957702|NCT02659631|537328417|FG004|Overall Study|Death (treatment phase)|1|||
148957703|NCT02659631|537328418|FG005|Overall Study|Death (treatment phase)|0|||
148957704|NCT02659631|537328419|FG006|Overall Study|Death (treatment phase)|1|||
148957705|NCT02659631|537328420|FG007|Overall Study|Death (treatment phase)|0|||
148957706|NCT02659631|537328421|FG008|Overall Study|Death (treatment phase)|0|||
148957707|NCT02659631|537328422|FG009|Overall Study|Death (treatment phase)|0|||
148957708|NCT00495170|537328423|FG000|Overall Study|Lost to Follow-up|9|||
148957709|NCT00495170|537328423|FG000|Overall Study|Withdrawal by Subject|3|||
148957710|NCT00495170|537328423|FG000|Overall Study|Inappropriate staging|8|||
148957711|NCT04191499|537328424|FG000|Overall Study|Adverse Event|1|||
148957712|NCT04191499|537328425|FG001|Overall Study|Adverse Event|0|||
148957713|NCT04191499|537328424|FG000|Overall Study|Death|42|||
148957714|NCT04191499|537328425|FG001|Overall Study|Death|55|||
148957715|NCT04191499|537328424|FG000|Overall Study|Lost to Follow-up|4|||
148957716|NCT04191499|537328425|FG001|Overall Study|Lost to Follow-up|1|||
148957717|NCT04191499|537328424|FG000|Overall Study|Physician Decision|1|||
148957718|NCT04191499|537328425|FG001|Overall Study|Physician Decision|0|||
148957719|NCT04191499|537328424|FG000|Overall Study|Progressive Disease|1|||
148957720|NCT04191499|537328425|FG001|Overall Study|Progressive Disease|0|||
148957721|NCT04191499|537328424|FG000|Overall Study|Symptomatic Deterioration|1|||
148957722|NCT04191499|537328425|FG001|Overall Study|Symptomatic Deterioration|0|||
148957723|NCT04191499|537328424|FG000|Overall Study|Withdrawal by Subject|7|||
148957724|NCT04191499|537328425|FG001|Overall Study|Withdrawal by Subject|11|||
149022127|NCT00519636|537559000|FG003|Treatment Period 2|Subject randomized in error|0|||
148957725|NCT04191499|537328424|FG000|Overall Study|Ongoing in the study|104|||
148957726|NCT04191499|537328425|FG001|Overall Study|Ongoing in the study|97|||
148957727|NCT00680745|537328426|FG000|Overall Study|Withdrawal by Subject|8|||
149022128|NCT00519636|537558997|FG000|Treatment Period 2|Per doctors request|0|||
149022129|NCT00519636|537558998|FG001|Treatment Period 2|Per doctors request|0|||
148957728|NCT00680745|537328427|FG001|Overall Study|Withdrawal by Subject|3|||
148957729|NCT00680745|537328428|FG002|Overall Study|Withdrawal by Subject|2|||
148957730|NCT00680745|537328429|FG003|Overall Study|Withdrawal by Subject|8|||
149022130|NCT00519636|537558999|FG002|Treatment Period 2|Per doctors request|1|||
148957731|NCT00680745|537328426|FG000|Overall Study|Lost to Follow-up|0|||
148957732|NCT00680745|537328427|FG001|Overall Study|Lost to Follow-up|1|||
148957733|NCT00680745|537328428|FG002|Overall Study|Lost to Follow-up|1|||
148957734|NCT00680745|537328429|FG003|Overall Study|Lost to Follow-up|0|||
148957735|NCT00680745|537328426|FG000|Overall Study|Death|1|||
148957736|NCT00680745|537328427|FG001|Overall Study|Death|0|||
148957737|NCT00680745|537328428|FG002|Overall Study|Death|1|||
148957738|NCT00680745|537328429|FG003|Overall Study|Death|0|||
148957739|NCT00680745|537328426|FG000|Overall Study|Adverse Event|5|||
148957740|NCT00680745|537328427|FG001|Overall Study|Adverse Event|3|||
148957741|NCT00680745|537328428|FG002|Overall Study|Adverse Event|3|||
148957742|NCT00680745|537328429|FG003|Overall Study|Adverse Event|3|||
148957743|NCT00680745|537328426|FG000|Overall Study|Poor/Non-compliance|0|||
148957744|NCT00680745|537328427|FG001|Overall Study|Poor/Non-compliance|3|||
148957745|NCT00680745|537328428|FG002|Overall Study|Poor/Non-compliance|0|||
148957746|NCT00680745|537328429|FG003|Overall Study|Poor/Non-compliance|0|||
148957747|NCT00680745|537328426|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
148957748|NCT00680745|537328427|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
148957749|NCT00680745|537328428|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
148957750|NCT00680745|537328429|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
148957751|NCT00680745|537328426|FG000|Overall Study|False Treatment|0|||
148957752|NCT00680745|537328427|FG001|Overall Study|False Treatment|1|||
148957753|NCT00680745|537328428|FG002|Overall Study|False Treatment|3|||
148957754|NCT00680745|537328429|FG003|Overall Study|False Treatment|0|||
148957755|NCT01928329|537328430|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
148957756|NCT01928329|537328431|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
148957757|NCT01928329|537328430|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
148957758|NCT01928329|537328431|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
148957759|NCT01928329|537328430|FG000|Overall Study|Adverse Event|5|||
148957760|NCT01928329|537328431|FG001|Overall Study|Adverse Event|3|||
148957761|NCT01928329|537328430|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
148957762|NCT01928329|537328431|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
148957763|NCT01928329|537328430|FG000|Overall Study|Withdrawal by Subject|1|||
148957764|NCT01928329|537328431|FG001|Overall Study|Withdrawal by Subject|5|||
148957765|NCT01928329|537328430|FG000|Overall Study|Physician Decision|1|||
148957766|NCT01928329|537328431|FG001|Overall Study|Physician Decision|1|||
148957767|NCT05608005|537331126|FG000|Overall Study|Adverse Event|2|||
148957768|NCT05608005|537331127|FG001|Overall Study|Adverse Event|1|||
148957769|NCT05608005|537331128|FG002|Overall Study|Adverse Event|3|||
148957770|NCT05608005|537331126|FG000|Overall Study|Protocol Violation|2|||
148957771|NCT05608005|537331127|FG001|Overall Study|Protocol Violation|3|||
148957772|NCT05608005|537331128|FG002|Overall Study|Protocol Violation|0|||
148957773|NCT05608005|537331126|FG000|Overall Study|Withdrawal by Subject|10|||
148957774|NCT05608005|537331127|FG001|Overall Study|Withdrawal by Subject|12|||
148957775|NCT05608005|537331128|FG002|Overall Study|Withdrawal by Subject|4|||
148957776|NCT05608005|537331126|FG000|Overall Study|Lost to Follow-up|25|||
148957777|NCT05608005|537331127|FG001|Overall Study|Lost to Follow-up|27|||
148957778|NCT05608005|537331128|FG002|Overall Study|Lost to Follow-up|15|||
148957779|NCT05608005|537331126|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
148957780|NCT05608005|537331127|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
148957781|NCT05608005|537331128|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
148957782|NCT03020407|537331132|FG000|Overall Study|Withdrawal by Subject|2|||
148957783|NCT03020407|537331133|FG001|Overall Study|Withdrawal by Subject|1|||
148957784|NCT03020407|537331132|FG000|Overall Study|Lost to Follow-up|2|||
148957785|NCT03020407|537331133|FG001|Overall Study|Lost to Follow-up|3|||
148957786|NCT03020407|537331132|FG000|Overall Study|Protocol Violation|0|||
148957787|NCT03020407|537331133|FG001|Overall Study|Protocol Violation|1|||
148957788|NCT01585428|537331134|FG000|Overall Study|Death during treatment|1|||
148957789|NCT01585428|537331135|FG001|Overall Study|Death during treatment|0|||
148957790|NCT02699554|537331136|FG000|Overall Study|Lost to Follow-up|9|||
148957791|NCT00788151|537331137|FG000|Overall Study|Other adverse event|0|||
148957792|NCT00788151|537331138|FG001|Overall Study|Other adverse event|2|||
148957793|NCT00788151|537331137|FG000|Overall Study|Protocol Violation|0|||
148957794|NCT00788151|537331138|FG001|Overall Study|Protocol Violation|1|||
148957795|NCT00788151|537331137|FG000|Overall Study|Withdrawal by Subject|13|||
148957796|NCT00788151|537331138|FG001|Overall Study|Withdrawal by Subject|6|||
148957797|NCT00788151|537331137|FG000|Overall Study|Enrolled but not treated|1|||
148957798|NCT00788151|537331138|FG001|Overall Study|Enrolled but not treated|1|||
148957799|NCT00503009|537331139|FG000|Overall Study|Protocol Violation|1|||
148957800|NCT00503009|537331140|FG001|Overall Study|Protocol Violation|0|||
148957801|NCT00503009|537331141|FG002|Overall Study|Protocol Violation|1|||
148957802|NCT00503009|537331139|FG000|Overall Study|Withdrawal by Subject|0|||
148957803|NCT00503009|537331140|FG001|Overall Study|Withdrawal by Subject|1|||
148957804|NCT00503009|537331141|FG002|Overall Study|Withdrawal by Subject|1|||
148957805|NCT00503009|537331139|FG000|Overall Study|Physician Decision|0|||
148957806|NCT00503009|537331140|FG001|Overall Study|Physician Decision|1|||
148957807|NCT00503009|537331141|FG002|Overall Study|Physician Decision|1|||
148957808|NCT01349803|537331145|FG000|Overall Study|Adverse Event|0|||
148957809|NCT01349803|537331146|FG001|Overall Study|Adverse Event|0|||
148957810|NCT01349803|537331147|FG002|Overall Study|Adverse Event|0|||
148957811|NCT01349803|537331148|FG003|Overall Study|Adverse Event|2|||
148957812|NCT01349803|537331145|FG000|Overall Study|Withdrawal by Subject|1|||
148957813|NCT01349803|537331146|FG001|Overall Study|Withdrawal by Subject|0|||
148957814|NCT01349803|537331147|FG002|Overall Study|Withdrawal by Subject|0|||
148957815|NCT01349803|537331148|FG003|Overall Study|Withdrawal by Subject|0|||
148957816|NCT01349803|537331145|FG000|Overall Study|Protocol-specified criteria|0|||
148957817|NCT01349803|537331146|FG001|Overall Study|Protocol-specified criteria|1|||
148957818|NCT01349803|537331147|FG002|Overall Study|Protocol-specified criteria|3|||
148957819|NCT01349803|537331148|FG003|Overall Study|Protocol-specified criteria|0|||
148957820|NCT03232281|537331149|FG000|Overall Study|Adverse Event|1|||
148957821|NCT03232281|537331150|FG001|Overall Study|Adverse Event|1|||
148957822|NCT03232281|537331149|FG000|Overall Study|Withdrawal by Subject|5|||
148957823|NCT03232281|537331150|FG001|Overall Study|Withdrawal by Subject|4|||
148957824|NCT03232281|537331149|FG000|Overall Study|Protocol Deviation|1|||
148957825|NCT03232281|537331150|FG001|Overall Study|Protocol Deviation|1|||
148957826|NCT02522286|537331151|FG000|Overall Study|Withdrawal by Subject|3|||
148957827|NCT02522286|537331152|FG001|Overall Study|Withdrawal by Subject|0|||
148957828|NCT02522286|537331153|FG002|Overall Study|Withdrawal by Subject|0|||
148957829|NCT02522286|537331154|FG003|Overall Study|Withdrawal by Subject|3|||
148957830|NCT03683758|537331159|FG000|Overall Study|Non-study commitment conflict|1|||
148957831|NCT03683758|537331160|FG001|Overall Study|Non-study commitment conflict|3|||
148957832|NCT03683758|537331159|FG000|Overall Study|Illness preventing participation|1|||
148957833|NCT03683758|537331160|FG001|Overall Study|Illness preventing participation|0|||
148957834|NCT03683758|537331159|FG000|Overall Study|Adverse Event|1|||
148957835|NCT03683758|537331160|FG001|Overall Study|Adverse Event|0|||
148957836|NCT01172847|537331163|FG000|Overall Study|Withdrawal by Subject|3|||
148957837|NCT01163279|537331164|FG000|Overall Study|Withdrawal by Subject|2|||
148957838|NCT01163279|537331165|FG001|Overall Study|Withdrawal by Subject|0|||
148957839|NCT01601626|537331171|FG000|Overall Study|Death|1|||
148957840|NCT01601626|537331172|FG001|Overall Study|Death|1|||
148957841|NCT01601626|537331173|FG002|Overall Study|Death|1|||
148957842|NCT01601626|537331171|FG000|Overall Study|Lost to Follow-up|1|||
148957843|NCT01601626|537331172|FG001|Overall Study|Lost to Follow-up|2|||
148957844|NCT01601626|537331173|FG002|Overall Study|Lost to Follow-up|0|||
148957845|NCT01601626|537331171|FG000|Overall Study|Unable to Get to Clinic|0|||
148691760|NCT00365352|536344266|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
148691761|NCT00365352|536344267|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
148691762|NCT00365352|536344268|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
148691763|NCT00365352|536344266|FG000|Overall Study|Lost to Follow-up|1|||
148691764|NCT00365352|536344267|FG001|Overall Study|Lost to Follow-up|1|||
148691765|NCT00365352|536344268|FG002|Overall Study|Lost to Follow-up|0|||
148691766|NCT00365352|536344266|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
148691767|NCT00365352|536344267|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
148691768|NCT00365352|536344268|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
148691769|NCT02683187|536344276|FG000|Overall Study|Failed IV access|3|||
148691770|NCT02683187|536344276|FG000|Overall Study|Withdrawal by Subject|5|||
148957846|NCT01601626|537331172|FG001|Overall Study|Unable to Get to Clinic|1|||
148957847|NCT01601626|537331173|FG002|Overall Study|Unable to Get to Clinic|0|||
148957848|NCT01601626|537331171|FG000|Overall Study|Withdrawal by Subject|0|||
148957849|NCT01601626|537331172|FG001|Overall Study|Withdrawal by Subject|1|||
148957850|NCT01601626|537331173|FG002|Overall Study|Withdrawal by Subject|1|||
148691771|NCT01290263|536345893|FG000|Overall Study|Adverse Event|0|||
148691772|NCT01290263|536345894|FG001|Overall Study|Adverse Event|0|||
148691773|NCT01290263|536345895|FG002|Overall Study|Adverse Event|0|||
148811651|NCT03765073|536787089|FG018|Stage 2|Lost to Follow-up|0|||
148811652|NCT03765073|536787090|FG019|Stage 2|Lost to Follow-up|0|||
148811653|NCT03765073|536787091|FG020|Stage 2|Lost to Follow-up|0|||
148811654|NCT03765073|536787071|FG000|Stage 2|Other|0|||
148811655|NCT03765073|536787072|FG001|Stage 2|Other|0|||
148811656|NCT03765073|536787073|FG002|Stage 2|Other|0|||
148811657|NCT03765073|536787074|FG003|Stage 2|Other|0|||
148811658|NCT03765073|536787075|FG004|Stage 2|Other|0|||
148811659|NCT03765073|536787076|FG005|Stage 2|Other|0|||
148811660|NCT03765073|536787077|FG006|Stage 2|Other|0|||
148811661|NCT03765073|536787078|FG007|Stage 2|Other|1|||
148811662|NCT03765073|536787079|FG008|Stage 2|Other|1|||
148811663|NCT03765073|536787080|FG009|Stage 2|Other|3|||
148811664|NCT03765073|536787081|FG010|Stage 2|Other|0|||
148811665|NCT03765073|536787082|FG011|Stage 2|Other|0|||
148811666|NCT03765073|536787083|FG012|Stage 2|Other|0|||
148811667|NCT03765073|536787084|FG013|Stage 2|Other|0|||
148811668|NCT03765073|536787085|FG014|Stage 2|Other|0|||
148811669|NCT03765073|536787086|FG015|Stage 2|Other|1|||
148811670|NCT03765073|536787087|FG016|Stage 2|Other|2|||
149022131|NCT00519636|537559000|FG003|Treatment Period 2|Per doctors request|0|||
149022132|NCT00519636|537558997|FG000|Treatment Period 2|Subject misrandomized|0|||
149022133|NCT00519636|537558998|FG001|Treatment Period 2|Subject misrandomized|0|||
149022134|NCT00519636|537558999|FG002|Treatment Period 2|Subject misrandomized|0|||
149022135|NCT00519636|537559000|FG003|Treatment Period 2|Subject misrandomized|1|||
149022136|NCT00519636|537558997|FG000|Post Study Period|Subject randomized in error|0|||
149022137|NCT00519636|537558998|FG001|Post Study Period|Subject randomized in error|0|||
149022138|NCT00519636|537558999|FG002|Post Study Period|Subject randomized in error|0|||
149022139|NCT00519636|537559000|FG003|Post Study Period|Subject randomized in error|1|||
149022140|NCT04504916|537559001|FG000|Overall Study|Study terminated|7|||
149022141|NCT04504916|537559002|FG001|Overall Study|Study terminated|8|||
149022142|NCT04504916|537559001|FG000|Overall Study|Death|54|||
149022143|NCT04504916|537559002|FG001|Overall Study|Death|18|||
149022144|NCT04504916|537559001|FG000|Overall Study|Lost to Follow-up|1|||
149022145|NCT04504916|537559002|FG001|Overall Study|Lost to Follow-up|1|||
149022146|NCT04504916|537559001|FG000|Overall Study|Withdrawal by Subject|8|||
149022147|NCT04504916|537559002|FG001|Overall Study|Withdrawal by Subject|4|||
149022148|NCT04504916|537559001|FG000|Overall Study|Did not agree to follow-up|0|||
149022149|NCT04504916|537559002|FG001|Overall Study|Did not agree to follow-up|1|||
149022150|NCT01368211|537559003|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
149022151|NCT01368211|537559004|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
149022152|NCT03057834|537559005|FG000|Overall Study|Withdrawal by Subject|25|||
149022153|NCT03057834|537559006|FG001|Overall Study|Withdrawal by Subject|29|||
149022154|NCT03990363|537559011|FG000|Overall Study|Withdrawal by Subject|10|||
149022155|NCT03990363|537559012|FG001|Overall Study|Withdrawal by Subject|9|||
148691774|NCT01290263|536345896|FG003|Overall Study|Adverse Event|1|||
148691775|NCT01290263|536345897|FG004|Overall Study|Adverse Event|1|||
148691776|NCT01290263|536345893|FG000|Overall Study|Lack of Efficacy|8|||
148691777|NCT01290263|536345894|FG001|Overall Study|Lack of Efficacy|2|||
148691778|NCT01290263|536345895|FG002|Overall Study|Lack of Efficacy|7|||
148691779|NCT01290263|536345896|FG003|Overall Study|Lack of Efficacy|24|||
148691780|NCT01290263|536345897|FG004|Overall Study|Lack of Efficacy|33|||
148691781|NCT01290263|536345893|FG000|Overall Study|Withdrawal by Subject|3|||
148691782|NCT01290263|536345894|FG001|Overall Study|Withdrawal by Subject|1|||
148691783|NCT01290263|536345895|FG002|Overall Study|Withdrawal by Subject|0|||
148691784|NCT01290263|536345896|FG003|Overall Study|Withdrawal by Subject|1|||
148691785|NCT01290263|536345897|FG004|Overall Study|Withdrawal by Subject|2|||
148691786|NCT01290263|536345893|FG000|Overall Study|Participant Non-Compliance|0|||
148691787|NCT01290263|536345894|FG001|Overall Study|Participant Non-Compliance|0|||
148691788|NCT01290263|536345895|FG002|Overall Study|Participant Non-Compliance|0|||
148691789|NCT01290263|536345896|FG003|Overall Study|Participant Non-Compliance|1|||
148691790|NCT01290263|536345897|FG004|Overall Study|Participant Non-Compliance|1|||
148691791|NCT01521559|536345898|FG000|Overall Study|Adverse Event|0|||
148691792|NCT01521559|536345899|FG001|Overall Study|Adverse Event|4|||
148691793|NCT01521559|536345898|FG000|Overall Study|Death|1|||
148691794|NCT01521559|536345899|FG001|Overall Study|Death|0|||
148691795|NCT01521559|536345898|FG000|Overall Study|Withdrawal by Subject|9|||
148691796|NCT01521559|536345899|FG001|Overall Study|Withdrawal by Subject|11|||
148691797|NCT01521559|536345898|FG000|Overall Study|Lost to Follow-up|3|||
148691798|NCT01521559|536345899|FG001|Overall Study|Lost to Follow-up|1|||
148691799|NCT01521559|536345898|FG000|Overall Study|Protocol Violation|1|||
148691800|NCT01521559|536345899|FG001|Overall Study|Protocol Violation|0|||
148691801|NCT01521559|536345898|FG000|Overall Study|Other|1|||
148691802|NCT01521559|536345899|FG001|Overall Study|Other|2|||
148691803|NCT02228382|536345900|FG000|Overall Study|Death|5|||
148691804|NCT02228382|536345901|FG001|Overall Study|Death|7|||
148691805|NCT02228382|536345902|FG002|Overall Study|Death|5|||
148691806|NCT02228382|536345903|FG003|Overall Study|Death|0|||
148691807|NCT02228382|536345904|FG004|Overall Study|Death|2|||
148691808|NCT02228382|536345900|FG000|Overall Study|Participant refused further follow-up|0|||
148691809|NCT02228382|536345901|FG001|Overall Study|Participant refused further follow-up|0|||
148691810|NCT02228382|536345902|FG002|Overall Study|Participant refused further follow-up|1|||
148691811|NCT02228382|536345903|FG003|Overall Study|Participant refused further follow-up|0|||
148691812|NCT02228382|536345904|FG004|Overall Study|Participant refused further follow-up|0|||
148691813|NCT02228382|536345900|FG000|Overall Study|Study terminated by sponsor|3|||
148691814|NCT02228382|536345901|FG001|Overall Study|Study terminated by sponsor|5|||
148691815|NCT02228382|536345902|FG002|Overall Study|Study terminated by sponsor|7|||
148691816|NCT02228382|536345903|FG003|Overall Study|Study terminated by sponsor|0|||
148957851|NCT01601626|537331171|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
148691817|NCT02228382|536345904|FG004|Overall Study|Study terminated by sponsor|0|||
148691818|NCT02228382|536345900|FG000|Overall Study|Lost to Follow-up|0|||
148691819|NCT02228382|536345901|FG001|Overall Study|Lost to Follow-up|0|||
148691820|NCT02228382|536345902|FG002|Overall Study|Lost to Follow-up|3|||
148691821|NCT02228382|536345903|FG003|Overall Study|Lost to Follow-up|1|||
149022156|NCT03990363|537559013|FG002|Overall Study|Withdrawal by Subject|18|||
149022157|NCT03990363|537559014|FG003|Overall Study|Withdrawal by Subject|11|||
149022158|NCT03990363|537559015|FG004|Overall Study|Withdrawal by Subject|9|||
149022159|NCT03990363|537559011|FG000|Overall Study|Physician Decision|1|||
149022160|NCT03990363|537559012|FG001|Overall Study|Physician Decision|0|||
149022161|NCT03990363|537559013|FG002|Overall Study|Physician Decision|0|||
149022162|NCT03990363|537559014|FG003|Overall Study|Physician Decision|0|||
149022163|NCT03990363|537559015|FG004|Overall Study|Physician Decision|0|||
149022164|NCT03990363|537559011|FG000|Overall Study|Adverse Event|1|||
149022165|NCT03990363|537559012|FG001|Overall Study|Adverse Event|3|||
149022166|NCT03990363|537559013|FG002|Overall Study|Adverse Event|2|||
149022167|NCT03990363|537559014|FG003|Overall Study|Adverse Event|2|||
149022168|NCT03990363|537559015|FG004|Overall Study|Adverse Event|0|||
149022169|NCT03990363|537559011|FG000|Overall Study|Death|14|||
149022170|NCT03990363|537559012|FG001|Overall Study|Death|8|||
149022171|NCT03990363|537559013|FG002|Overall Study|Death|14|||
149022172|NCT03990363|537559014|FG003|Overall Study|Death|10|||
149022173|NCT03990363|537559015|FG004|Overall Study|Death|11|||
149022174|NCT03990363|537559011|FG000|Overall Study|Failure to meet randomization criteria|0|||
149022175|NCT03990363|537559012|FG001|Overall Study|Failure to meet randomization criteria|1|||
149022176|NCT03990363|537559013|FG002|Overall Study|Failure to meet randomization criteria|1|||
148691822|NCT02228382|536345904|FG004|Overall Study|Lost to Follow-up|0|||
148691823|NCT02228382|536345900|FG000|Overall Study|Withdrawal by Subject|0|||
148691824|NCT02228382|536345901|FG001|Overall Study|Withdrawal by Subject|3|||
148691825|NCT02228382|536345902|FG002|Overall Study|Withdrawal by Subject|2|||
148691826|NCT02228382|536345903|FG003|Overall Study|Withdrawal by Subject|1|||
148691827|NCT02228382|536345904|FG004|Overall Study|Withdrawal by Subject|0|||
148691828|NCT02228382|536345900|FG000|Overall Study|Other|2|||
148691829|NCT02228382|536345901|FG001|Overall Study|Other|3|||
148691830|NCT02228382|536345902|FG002|Overall Study|Other|3|||
148691831|NCT02228382|536345903|FG003|Overall Study|Other|0|||
148691832|NCT02228382|536345904|FG004|Overall Study|Other|0|||
148691833|NCT01802879|536345905|FG000|Overall Study|Administrative problems|2|||
148691834|NCT01802879|536345905|FG000|Overall Study|Disease progression|6|||
148811671|NCT03765073|536787088|FG017|Stage 2|Other|0|||
148811672|NCT03765073|536787089|FG018|Stage 2|Other|0|||
148957852|NCT01601626|537331172|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
148957853|NCT01601626|537331173|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
148957854|NCT03045887|537331175|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
148957855|NCT03045887|537331176|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957856|NCT03045887|537331177|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957857|NCT03045887|537331178|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957858|NCT03045887|537331179|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957859|NCT03045887|537331180|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957860|NCT03045887|537331181|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957861|NCT03045887|537331182|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957862|NCT03045887|537331183|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957863|NCT03045887|537331184|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
148957864|NCT03045887|537331175|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957865|NCT03045887|537331176|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957866|NCT03045887|537331177|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957867|NCT03045887|537331178|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
148957868|NCT03045887|537331179|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957869|NCT03045887|537331180|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957870|NCT03045887|537331181|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957871|NCT03045887|537331182|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957872|NCT03045887|537331183|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957873|NCT03045887|537331184|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
148957874|NCT03045887|537331175|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
148957875|NCT03045887|537331176|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957876|NCT03045887|537331177|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957877|NCT03045887|537331178|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957878|NCT03045887|537331179|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957879|NCT03045887|537331180|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957880|NCT03045887|537331181|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957881|NCT03045887|537331182|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957882|NCT03045887|537331183|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957883|NCT03045887|537331184|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
148957884|NCT03045887|537331175|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957885|NCT03045887|537331176|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957886|NCT03045887|537331177|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
148957887|NCT03045887|537331178|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
148957888|NCT03045887|537331179|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957889|NCT03045887|537331180|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957890|NCT03045887|537331181|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957891|NCT03045887|537331182|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
149022177|NCT03990363|537559014|FG003|Overall Study|Failure to meet randomization criteria|0|||
148691835|NCT02246478|536345908|FG000|Multiple-dose Phase|Protocol Violation|1|||
148691836|NCT02246478|536345909|FG001|Multiple-dose Phase|Protocol Violation|0|||
148691837|NCT02246478|536345910|FG002|Multiple-dose Phase|Protocol Violation|0|||
148691838|NCT02246478|536345911|FG003|Multiple-dose Phase|Protocol Violation|1|||
148691839|NCT00865709|536345924|FG000|Treatment|Adverse Event|9|||
148691840|NCT00865709|536345925|FG001|Treatment|Adverse Event|6|||
148691841|NCT00865709|536345924|FG000|Treatment|Withdrawal by Subject|10|||
148691842|NCT00865709|536345925|FG001|Treatment|Withdrawal by Subject|7|||
148691843|NCT00865709|536345924|FG000|Treatment|Physician Decision|3|||
148811673|NCT03765073|536787090|FG019|Stage 2|Other|0|||
148691844|NCT00865709|536345925|FG001|Treatment|Physician Decision|2|||
148691845|NCT00865709|536345924|FG000|Treatment|Surgery|8|||
148691846|NCT00865709|536345925|FG001|Treatment|Surgery|3|||
148691847|NCT00429923|536345926|FG000|Overall Study|Adverse Event|0|||
148691848|NCT00429923|536345927|FG001|Overall Study|Adverse Event|2|||
148811674|NCT03765073|536787091|FG020|Stage 2|Other|0|||
148691849|NCT00429923|536345928|FG002|Overall Study|Adverse Event|3|||
148691850|NCT00429923|536345926|FG000|Overall Study|Lack of Efficacy|4|||
148691851|NCT00429923|536345927|FG001|Overall Study|Lack of Efficacy|1|||
148691852|NCT00429923|536345928|FG002|Overall Study|Lack of Efficacy|33|||
148811675|NCT03765073|536787071|FG000|Stage 2|Withdrawal by parent/guardian|0|||
148957892|NCT03045887|537331183|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957893|NCT03045887|537331184|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
148957894|NCT03045887|537331175|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957895|NCT03045887|537331176|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957896|NCT03045887|537331177|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957897|NCT03045887|537331178|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
148957898|NCT03045887|537331179|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957899|NCT03045887|537331180|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957900|NCT03045887|537331181|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957901|NCT03045887|537331182|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957902|NCT03045887|537331183|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957903|NCT03045887|537331184|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
148957904|NCT02632552|537331185|FG000|Overall Study|Lost to Follow-up|14|||
148957905|NCT02632552|537331186|FG001|Overall Study|Lost to Follow-up|8|||
148957906|NCT02632552|537331185|FG000|Overall Study|Withdrawal by Subject|2|||
148957907|NCT02632552|537331186|FG001|Overall Study|Withdrawal by Subject|0|||
148957908|NCT02632552|537331185|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
148957909|NCT02632552|537331186|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
148957910|NCT02132767|537331187|FG000|Overall Study|Death|3|||
148957911|NCT02132767|537331188|FG001|Overall Study|Death|2|||
148957912|NCT02132767|537331187|FG000|Overall Study|Withdrawal by Subject|10|||
148957913|NCT02132767|537331188|FG001|Overall Study|Withdrawal by Subject|9|||
148957914|NCT02132767|537331187|FG000|Overall Study|Lost to Follow-up|4|||
148957915|NCT02132767|537331188|FG001|Overall Study|Lost to Follow-up|4|||
148957916|NCT00778700|537331191|FG000|Overall Study|Adverse Event|6|||
148957917|NCT00778700|537331192|FG001|Overall Study|Adverse Event|1|||
148957918|NCT00778700|537331193|FG002|Overall Study|Adverse Event|3|||
148957919|NCT00778700|537331194|FG003|Overall Study|Adverse Event|5|||
148957920|NCT00778700|537331191|FG000|Overall Study|Protocol Violation|1|||
148957921|NCT00778700|537331192|FG001|Overall Study|Protocol Violation|1|||
148957922|NCT00778700|537331193|FG002|Overall Study|Protocol Violation|0|||
148957923|NCT00778700|537331194|FG003|Overall Study|Protocol Violation|0|||
148957924|NCT00778700|537331191|FG000|Overall Study|Subject Withdrew Consent|6|||
148957925|NCT00778700|537331192|FG001|Overall Study|Subject Withdrew Consent|4|||
148957926|NCT00778700|537331193|FG002|Overall Study|Subject Withdrew Consent|1|||
148957927|NCT00778700|537331194|FG003|Overall Study|Subject Withdrew Consent|4|||
148957928|NCT00778700|537331191|FG000|Overall Study|Lost to Follow-up|3|||
148957929|NCT00778700|537331192|FG001|Overall Study|Lost to Follow-up|1|||
148957930|NCT00778700|537331193|FG002|Overall Study|Lost to Follow-up|0|||
148957931|NCT00778700|537331194|FG003|Overall Study|Lost to Follow-up|1|||
148957932|NCT00778700|537331191|FG000|Overall Study|Reason not Specified|2|||
148957933|NCT00778700|537331192|FG001|Overall Study|Reason not Specified|0|||
148957934|NCT00778700|537331193|FG002|Overall Study|Reason not Specified|1|||
148957935|NCT00778700|537331194|FG003|Overall Study|Reason not Specified|3|||
148957936|NCT00778700|537331191|FG000|Overall Study|Other|0|||
148957937|NCT00778700|537331192|FG001|Overall Study|Other|0|||
148957938|NCT00778700|537331193|FG002|Overall Study|Other|1|||
148957939|NCT00778700|537331194|FG003|Overall Study|Other|0|||
148957940|NCT03227029|537331197|FG000|Overall Study|Child Wheezed (no treatment)|0|||
148957941|NCT03227029|537331198|FG001|Overall Study|Child Wheezed (no treatment)|1|||
148957942|NCT03227029|537331199|FG002|Overall Study|Child Wheezed (no treatment)|0|||
148957943|NCT03227029|537331197|FG000|Overall Study|No post RSV season visit due to COVID|3|||
148957944|NCT03227029|537331198|FG001|Overall Study|No post RSV season visit due to COVID|3|||
148957945|NCT03227029|537331199|FG002|Overall Study|No post RSV season visit due to COVID|2|||
148957946|NCT03227029|537331197|FG000|Overall Study|Not able to get to clinic|0|||
149022178|NCT03990363|537559015|FG004|Overall Study|Failure to meet randomization criteria|0|||
149022179|NCT03990363|537559011|FG000|Overall Study|Lost to Follow-up|0|||
149022180|NCT03990363|537559012|FG001|Overall Study|Lost to Follow-up|0|||
148957947|NCT03227029|537331198|FG001|Overall Study|Not able to get to clinic|0|||
148957948|NCT03227029|537331199|FG002|Overall Study|Not able to get to clinic|1|||
148957949|NCT03227029|537331197|FG000|Overall Study|Withdrawal by Subject|1|||
148957950|NCT03227029|537331198|FG001|Overall Study|Withdrawal by Subject|0|||
149022181|NCT03990363|537559013|FG002|Overall Study|Lost to Follow-up|0|||
149022182|NCT03990363|537559014|FG003|Overall Study|Lost to Follow-up|1|||
148691853|NCT00429923|536345926|FG000|Overall Study|Lost to Follow-up|0|||
148691854|NCT00429923|536345927|FG001|Overall Study|Lost to Follow-up|0|||
148691855|NCT00429923|536345928|FG002|Overall Study|Lost to Follow-up|2|||
148691856|NCT00429923|536345926|FG000|Overall Study|Withdrew Consent|1|||
148691857|NCT00429923|536345927|FG001|Overall Study|Withdrew Consent|0|||
148691858|NCT00429923|536345928|FG002|Overall Study|Withdrew Consent|1|||
148691859|NCT00429923|536345926|FG000|Overall Study|Early Termination|0|||
149022183|NCT03990363|537559015|FG004|Overall Study|Lost to Follow-up|2|||
148691860|NCT00429923|536345927|FG001|Overall Study|Early Termination|1|||
148691861|NCT00429923|536345928|FG002|Overall Study|Early Termination|0|||
148957951|NCT03227029|537331199|FG002|Overall Study|Withdrawal by Subject|0|||
148957952|NCT03227029|537331197|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
148957953|NCT03227029|537331198|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
148691862|NCT03276975|536345929|FG000|Overall Study|Withdrawal by Subject|1|||
148957954|NCT03227029|537331199|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
148957955|NCT03274440|537331200|FG000|Overall Study|Time commitment too great|1|||
148957956|NCT03274440|537331201|FG001|Overall Study|Time commitment too great|0|||
148691863|NCT03276975|536345930|FG001|Overall Study|Withdrawal by Subject|0|||
148691864|NCT00662129|536345931|FG000|Overall Study|Protocol Violation|1|||
148691865|NCT00662129|536345931|FG000|Overall Study|Cancel prior to beginning treatment|1|||
148691866|NCT00662129|536345931|FG000|Overall Study|Ineligible|1|||
148691867|NCT02153736|536345936|FG000|Overall Study|Lost to Follow-up|1|||
148691868|NCT02153736|536345937|FG001|Overall Study|Lost to Follow-up|0|||
148691869|NCT02153736|536345936|FG000|Overall Study|Medical status change made ineligible|1|||
148691870|NCT02153736|536345937|FG001|Overall Study|Medical status change made ineligible|0|||
148811676|NCT03765073|536787072|FG001|Stage 2|Withdrawal by parent/guardian|0|||
148811677|NCT03765073|536787073|FG002|Stage 2|Withdrawal by parent/guardian|0|||
148811678|NCT03765073|536787074|FG003|Stage 2|Withdrawal by parent/guardian|0|||
148811679|NCT03765073|536787075|FG004|Stage 2|Withdrawal by parent/guardian|0|||
149022184|NCT03990363|537559011|FG000|Overall Study|Non-compliance with study drug|2|||
148691871|NCT02153736|536345936|FG000|Overall Study|Death|0|||
148691872|NCT02153736|536345937|FG001|Overall Study|Death|1|||
149022185|NCT03990363|537559012|FG001|Overall Study|Non-compliance with study drug|1|||
148691873|NCT02153736|536345936|FG000|Overall Study|Withdrawal by Subject|0|||
148691874|NCT02153736|536345937|FG001|Overall Study|Withdrawal by Subject|1|||
149022186|NCT03990363|537559013|FG002|Overall Study|Non-compliance with study drug|2|||
149022187|NCT03990363|537559014|FG003|Overall Study|Non-compliance with study drug|0|||
148691875|NCT00796510|536345946|FG000|Overall Study|Death|1|||
148957957|NCT03274440|537331202|FG002|Overall Study|Time commitment too great|0|||
148957958|NCT03274440|537331203|FG003|Overall Study|Time commitment too great|1|||
148691876|NCT00796510|536345947|FG001|Overall Study|Death|0|||
148691877|NCT00796510|536345946|FG000|Overall Study|Study Terminated|2|||
148691878|NCT00796510|536345947|FG001|Overall Study|Study Terminated|0|||
148691879|NCT01734772|536345948|FG000|Overall Study|Adverse Event|1|||
148691880|NCT01734772|536345949|FG001|Overall Study|Adverse Event|2|||
148957959|NCT03274440|537331204|FG004|Overall Study|Time commitment too great|0|||
148957960|NCT03274440|537331205|FG005|Overall Study|Time commitment too great|0|||
148957961|NCT01291173|537331206|FG000|Overall Study|Adverse Event|0|||
148957962|NCT01291173|537331207|FG001|Overall Study|Adverse Event|3|||
148957963|NCT01291173|537331208|FG002|Overall Study|Adverse Event|1|||
148957964|NCT01291173|537331209|FG003|Overall Study|Adverse Event|3|||
148957965|NCT01291173|537331206|FG000|Overall Study|Protocol Violation|7|||
148957966|NCT01291173|537331207|FG001|Overall Study|Protocol Violation|2|||
148957967|NCT01291173|537331208|FG002|Overall Study|Protocol Violation|2|||
148957968|NCT01291173|537331209|FG003|Overall Study|Protocol Violation|5|||
148957969|NCT01291173|537331206|FG000|Overall Study|Withdrawal by Subject|6|||
148957970|NCT01291173|537331207|FG001|Overall Study|Withdrawal by Subject|4|||
148957971|NCT01291173|537331208|FG002|Overall Study|Withdrawal by Subject|4|||
148957972|NCT01291173|537331209|FG003|Overall Study|Withdrawal by Subject|2|||
148957973|NCT01291173|537331206|FG000|Overall Study|Lost to Follow-up|4|||
148957974|NCT01291173|537331207|FG001|Overall Study|Lost to Follow-up|6|||
148957975|NCT01291173|537331208|FG002|Overall Study|Lost to Follow-up|3|||
148957976|NCT01291173|537331209|FG003|Overall Study|Lost to Follow-up|2|||
148811680|NCT03765073|536787076|FG005|Stage 2|Withdrawal by parent/guardian|0|||
148957977|NCT01291173|537331206|FG000|Overall Study|Unable to meet visit schedule|0|||
148957978|NCT01291173|537331207|FG001|Overall Study|Unable to meet visit schedule|0|||
148957979|NCT01291173|537331208|FG002|Overall Study|Unable to meet visit schedule|1|||
148957980|NCT01291173|537331209|FG003|Overall Study|Unable to meet visit schedule|0|||
148957981|NCT01291173|537331206|FG000|Overall Study|Lack of compliance|0|||
148957982|NCT01291173|537331207|FG001|Overall Study|Lack of compliance|0|||
148957983|NCT01291173|537331208|FG002|Overall Study|Lack of compliance|0|||
148957984|NCT01291173|537331209|FG003|Overall Study|Lack of compliance|1|||
148691881|NCT01734772|536345948|FG000|Overall Study|Withdrawal by Subject|0|||
148691882|NCT01734772|536345949|FG001|Overall Study|Withdrawal by Subject|1|||
148691883|NCT05030753|536345950|FG000|9-week|Lost to Follow-up|10|||
149022188|NCT03990363|537559015|FG004|Overall Study|Non-compliance with study drug|0|||
149022189|NCT03990363|537559011|FG000|Overall Study|Study terminated by sponsor|0|||
149022190|NCT03990363|537559012|FG001|Overall Study|Study terminated by sponsor|1|||
148811681|NCT03765073|536787077|FG006|Stage 2|Withdrawal by parent/guardian|0|||
148957985|NCT01291173|537331206|FG000|Overall Study|Subject was unblinded|0|||
148957986|NCT01291173|537331207|FG001|Overall Study|Subject was unblinded|0|||
148957987|NCT01291173|537331208|FG002|Overall Study|Subject was unblinded|1|||
148957988|NCT01291173|537331209|FG003|Overall Study|Subject was unblinded|0|||
148957989|NCT01291173|537331206|FG000|Overall Study|Excluded therapy|0|||
148957990|NCT01291173|537331207|FG001|Overall Study|Excluded therapy|0|||
148957991|NCT01291173|537331208|FG002|Overall Study|Excluded therapy|1|||
148957992|NCT01291173|537331209|FG003|Overall Study|Excluded therapy|0|||
148957993|NCT02141997|537331213|FG000|Overall Study|Adverse Event|0|||
148957994|NCT02141997|537331214|FG001|Overall Study|Adverse Event|2|||
148957995|NCT02141997|537331215|FG002|Overall Study|Adverse Event|0|||
148957996|NCT02141997|537331216|FG003|Overall Study|Adverse Event|1|||
148957997|NCT02141997|537331213|FG000|Overall Study|Participant noncompliance|1|||
148957998|NCT02141997|537331214|FG001|Overall Study|Participant noncompliance|0|||
148957999|NCT02141997|537331215|FG002|Overall Study|Participant noncompliance|0|||
148958000|NCT02141997|537331216|FG003|Overall Study|Participant noncompliance|0|||
148958001|NCT02141997|537331213|FG000|Overall Study|Withdrew consent|1|||
148958002|NCT02141997|537331214|FG001|Overall Study|Withdrew consent|0|||
148958003|NCT02141997|537331215|FG002|Overall Study|Withdrew consent|3|||
148958004|NCT02141997|537331216|FG003|Overall Study|Withdrew consent|0|||
148958005|NCT02141997|537331213|FG000|Overall Study|Other|1|||
148958006|NCT02141997|537331214|FG001|Overall Study|Other|4|||
148958007|NCT02141997|537331215|FG002|Overall Study|Other|0|||
148958008|NCT02141997|537331216|FG003|Overall Study|Other|0|||
148958009|NCT01496313|537331217|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
148958010|NCT01496313|537331218|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
148958011|NCT01496313|537331219|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
149022191|NCT03990363|537559013|FG002|Overall Study|Study terminated by sponsor|0|||
149022192|NCT03990363|537559014|FG003|Overall Study|Study terminated by sponsor|0|||
149022193|NCT03990363|537559015|FG004|Overall Study|Study terminated by sponsor|0|||
148811682|NCT03765073|536787078|FG007|Stage 2|Withdrawal by parent/guardian|0|||
149022194|NCT03990363|537559011|FG000|Overall Study|Site terminated by sponsor|2|||
148958012|NCT01496313|537331220|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
149022195|NCT03990363|537559012|FG001|Overall Study|Site terminated by sponsor|1|||
148958013|NCT01496313|537331221|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
148958014|NCT01496313|537331222|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
148958015|NCT01496313|537331217|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
148958016|NCT01496313|537331218|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
148958017|NCT01496313|537331219|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
148691884|NCT05030753|536345951|FG001|9-week|Lost to Follow-up|7|||
148691885|NCT05030753|536345950|FG000|9-week|Withdrawal by Subject|1|||
148691886|NCT05030753|536345951|FG001|9-week|Withdrawal by Subject|0|||
148691887|NCT05030753|536345950|FG000|9-week|Excluded from analysis due to missing covariates|2|||
148691888|NCT05030753|536345951|FG001|9-week|Excluded from analysis due to missing covariates|1|||
148958018|NCT01496313|537331220|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
148958019|NCT01496313|537331221|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
148958020|NCT01496313|537331222|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
148958021|NCT01496313|537331217|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
148691889|NCT05030753|536345950|FG000|6-month post intervention|Lost to Follow-up|5|||
148958022|NCT01496313|537331218|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
148958023|NCT01496313|537331219|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
148958024|NCT01496313|537331220|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
148958025|NCT01496313|537331221|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
148958026|NCT01496313|537331222|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
148958027|NCT01496313|537331217|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
148958028|NCT01496313|537331218|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
148958029|NCT01496313|537331219|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
148958030|NCT01496313|537331220|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
148958031|NCT01496313|537331221|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
148958032|NCT01496313|537331222|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
148958033|NCT01496313|537331217|FG000|Randomized Period (up to 14 Months)|Other|1|||
148958034|NCT01496313|537331218|FG001|Randomized Period (up to 14 Months)|Other|2|||
148958035|NCT01496313|537331219|FG002|Randomized Period (up to 14 Months)|Other|0|||
148958036|NCT01496313|537331220|FG003|Randomized Period (up to 14 Months)|Other|0|||
148958037|NCT01496313|537331221|FG004|Randomized Period (up to 14 Months)|Other|0|||
148958038|NCT01496313|537331222|FG005|Randomized Period (up to 14 Months)|Other|0|||
148958039|NCT01496313|537331217|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
148958040|NCT01496313|537331218|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
148958041|NCT01496313|537331219|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
148958042|NCT01496313|537331220|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
148958043|NCT01496313|537331221|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
148958044|NCT01496313|537331222|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
148958045|NCT01496313|537331217|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
148958046|NCT01496313|537331218|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
148958047|NCT01496313|537331219|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
148958048|NCT01496313|537331220|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
148958049|NCT01496313|537331221|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
148958050|NCT01496313|537331222|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
148958051|NCT01496313|537331217|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
148958052|NCT01496313|537331218|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
148958053|NCT01496313|537331219|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
148958054|NCT01496313|537331220|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
148958055|NCT01496313|537331221|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
148958056|NCT01496313|537331222|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
148958057|NCT00451321|537331224|FG000|Overall Study|Lost to Follow-up|3|||
148958058|NCT00451321|537331225|FG001|Overall Study|Lost to Follow-up|3|||
148958059|NCT00451321|537331226|FG002|Overall Study|Lost to Follow-up|1|||
148958060|NCT00451321|537331227|FG003|Overall Study|Lost to Follow-up|3|||
148958061|NCT00451321|537331228|FG004|Overall Study|Lost to Follow-up|0|||
148958062|NCT00451321|537331229|FG005|Overall Study|Lost to Follow-up|1|||
148958063|NCT00451321|537331230|FG006|Overall Study|Lost to Follow-up|0|||
148958064|NCT00451321|537331231|FG007|Overall Study|Lost to Follow-up|0|||
148958065|NCT00451321|537331224|FG000|Overall Study|Withdrawal by Subject|3|||
148958066|NCT00451321|537331225|FG001|Overall Study|Withdrawal by Subject|1|||
148958067|NCT00451321|537331226|FG002|Overall Study|Withdrawal by Subject|0|||
148958068|NCT00451321|537331227|FG003|Overall Study|Withdrawal by Subject|4|||
148958069|NCT00451321|537331228|FG004|Overall Study|Withdrawal by Subject|0|||
148958070|NCT00451321|537331229|FG005|Overall Study|Withdrawal by Subject|0|||
148958071|NCT00451321|537331230|FG006|Overall Study|Withdrawal by Subject|0|||
148958072|NCT00451321|537331231|FG007|Overall Study|Withdrawal by Subject|0|||
148958073|NCT00451321|537331224|FG000|Overall Study|Study closed/terminated|1|||
148958074|NCT00451321|537331225|FG001|Overall Study|Study closed/terminated|1|||
148958075|NCT00451321|537331226|FG002|Overall Study|Study closed/terminated|17|||
148958076|NCT00451321|537331227|FG003|Overall Study|Study closed/terminated|5|||
148958077|NCT00451321|537331228|FG004|Overall Study|Study closed/terminated|7|||
148958078|NCT00451321|537331229|FG005|Overall Study|Study closed/terminated|7|||
148958079|NCT00451321|537331230|FG006|Overall Study|Study closed/terminated|5|||
148958080|NCT00451321|537331231|FG007|Overall Study|Study closed/terminated|3|||
148958081|NCT00451321|537331224|FG000|Overall Study|Sponsor decision to amend protocol|0|||
148958082|NCT00451321|537331225|FG001|Overall Study|Sponsor decision to amend protocol|0|||
148958083|NCT00451321|537331226|FG002|Overall Study|Sponsor decision to amend protocol|0|||
148958084|NCT00451321|537331227|FG003|Overall Study|Sponsor decision to amend protocol|0|||
148958085|NCT00451321|537331228|FG004|Overall Study|Sponsor decision to amend protocol|0|||
148958086|NCT00451321|537331229|FG005|Overall Study|Sponsor decision to amend protocol|1|||
148958087|NCT00451321|537331230|FG006|Overall Study|Sponsor decision to amend protocol|1|||
148958088|NCT00451321|537331231|FG007|Overall Study|Sponsor decision to amend protocol|3|||
148958089|NCT00909389|537331235|FG000|Overall Study|Adverse Event|6|||
148958090|NCT00909389|537331235|FG000|Overall Study|Death|4|||
148958091|NCT00909389|537331235|FG000|Overall Study|Poor Compliance|16|||
148958092|NCT00909389|537331235|FG000|Overall Study|Lost to Follow-up|4|||
148958093|NCT00909389|537331235|FG000|Overall Study|No Information|103|||
148958094|NCT01528254|537331236|FG000|Overall Study|Administrative problems|96|||
148958095|NCT01528254|537331237|FG001|Overall Study|Administrative problems|94|||
148958096|NCT01528254|537331236|FG000|Overall Study|Adverse Event|28|||
148958097|NCT01528254|537331237|FG001|Overall Study|Adverse Event|44|||
148958098|NCT01528254|537331236|FG000|Overall Study|Lost to Follow-up|17|||
148958099|NCT01528254|537331237|FG001|Overall Study|Lost to Follow-up|24|||
148958100|NCT01528254|537331236|FG000|Overall Study|Death|13|||
148958101|NCT01528254|537331237|FG001|Overall Study|Death|9|||
148958102|NCT01528254|537331236|FG000|Overall Study|Protocol deviation|9|||
148958103|NCT01528254|537331237|FG001|Overall Study|Protocol deviation|19|||
148958104|NCT01528254|537331236|FG000|Overall Study|New therapy for study indication|8|||
148958105|NCT01528254|537331237|FG001|Overall Study|New therapy for study indication|6|||
148958106|NCT01528254|537331236|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
148958107|NCT01528254|537331237|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
148958108|NCT01528254|537331236|FG000|Overall Study|Withdrawal by Subject|5|||
148958109|NCT01528254|537331237|FG001|Overall Study|Withdrawal by Subject|4|||
148958110|NCT01528254|537331236|FG000|Overall Study|Abnormal laboratory value(s)|3|||
148958111|NCT01528254|537331237|FG001|Overall Study|Abnormal laboratory value(s)|7|||
148958112|NCT01528254|537331236|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148958113|NCT01528254|537331237|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148958114|NCT01528254|537331236|FG000|Overall Study|No longer requires study drug|1|||
148958115|NCT01528254|537331237|FG001|Overall Study|No longer requires study drug|1|||
148958116|NCT00737282|537331238|FG000|Overall Study|Study prematurely terminated|175|||
148958117|NCT02763189|537331239|FG000|Overall Study|Device failure|0|||
148958118|NCT02763189|537331240|FG001|Overall Study|Device failure|2|||
148958119|NCT02049957|537331241|FG000|Overall Study|Progressive Disease|5|||
148958120|NCT02049957|537331242|FG001|Overall Study|Progressive Disease|4|||
148958121|NCT02049957|537331243|FG002|Overall Study|Progressive Disease|2|||
148958122|NCT02049957|537331244|FG003|Overall Study|Progressive Disease|2|||
148958123|NCT02049957|537331245|FG004|Overall Study|Progressive Disease|6|||
148958124|NCT02049957|537331246|FG005|Overall Study|Progressive Disease|35|||
148958125|NCT02049957|537331247|FG006|Overall Study|Progressive Disease|7|||
148958126|NCT02049957|537331248|FG007|Overall Study|Progressive Disease|26|||
148958127|NCT02049957|537331249|FG008|Overall Study|Progressive Disease|6|||
148958128|NCT02049957|537331241|FG000|Overall Study|Adverse Event|1|||
148958129|NCT02049957|537331242|FG001|Overall Study|Adverse Event|1|||
148958130|NCT02049957|537331243|FG002|Overall Study|Adverse Event|1|||
148958131|NCT02049957|537331244|FG003|Overall Study|Adverse Event|0|||
148958132|NCT02049957|537331245|FG004|Overall Study|Adverse Event|0|||
148958133|NCT02049957|537331246|FG005|Overall Study|Adverse Event|5|||
148958134|NCT02049957|537331247|FG006|Overall Study|Adverse Event|0|||
148958135|NCT02049957|537331248|FG007|Overall Study|Adverse Event|6|||
148958136|NCT02049957|537331249|FG008|Overall Study|Adverse Event|1|||
148958137|NCT02049957|537331241|FG000|Overall Study|Study Terminated by Sponsor|0|||
148958138|NCT02049957|537331242|FG001|Overall Study|Study Terminated by Sponsor|1|||
148958139|NCT02049957|537331243|FG002|Overall Study|Study Terminated by Sponsor|0|||
148958140|NCT02049957|537331244|FG003|Overall Study|Study Terminated by Sponsor|0|||
148958141|NCT02049957|537331245|FG004|Overall Study|Study Terminated by Sponsor|0|||
148958142|NCT02049957|537331246|FG005|Overall Study|Study Terminated by Sponsor|0|||
148958143|NCT02049957|537331247|FG006|Overall Study|Study Terminated by Sponsor|1|||
148958144|NCT02049957|537331248|FG007|Overall Study|Study Terminated by Sponsor|0|||
148958145|NCT02049957|537331249|FG008|Overall Study|Study Terminated by Sponsor|0|||
148958146|NCT02049957|537331241|FG000|Overall Study|Withdrawal by Subject|0|||
148958147|NCT02049957|537331242|FG001|Overall Study|Withdrawal by Subject|0|||
148691890|NCT05030753|536345951|FG001|6-month post intervention|Lost to Follow-up|4|||
148958148|NCT02049957|537331243|FG002|Overall Study|Withdrawal by Subject|0|||
148958149|NCT02049957|537331244|FG003|Overall Study|Withdrawal by Subject|1|||
148958150|NCT02049957|537331245|FG004|Overall Study|Withdrawal by Subject|0|||
148958151|NCT02049957|537331246|FG005|Overall Study|Withdrawal by Subject|2|||
148958152|NCT02049957|537331247|FG006|Overall Study|Withdrawal by Subject|0|||
149022196|NCT03990363|537559013|FG002|Overall Study|Site terminated by sponsor|2|||
148958153|NCT02049957|537331248|FG007|Overall Study|Withdrawal by Subject|3|||
148958154|NCT02049957|537331249|FG008|Overall Study|Withdrawal by Subject|1|||
148958155|NCT02049957|537331241|FG000|Overall Study|Physician Decision|0|||
148958156|NCT02049957|537331242|FG001|Overall Study|Physician Decision|0|||
148958157|NCT02049957|537331243|FG002|Overall Study|Physician Decision|0|||
148958158|NCT02049957|537331244|FG003|Overall Study|Physician Decision|0|||
148958159|NCT02049957|537331245|FG004|Overall Study|Physician Decision|0|||
148691891|NCT05030753|536345950|FG000|6-month post intervention|Withdrawal by Subject|4|||
148691892|NCT05030753|536345951|FG001|6-month post intervention|Withdrawal by Subject|0|||
148691893|NCT05030753|536345950|FG000|18-month post intervention|Lost to Follow-up|3|||
148691894|NCT05030753|536345951|FG001|18-month post intervention|Lost to Follow-up|1|||
148691895|NCT00720122|536345960|FG000|Overall Study|Lost to Follow-up|1|||
148691896|NCT00720122|536345960|FG000|Overall Study|Physician Decision|1|||
148691897|NCT00720122|536345960|FG000|Overall Study|Withdrawal by Subject|7|||
148691898|NCT03072459|536345961|FG000|Overall Study|Device revised/removed|1|||
148691899|NCT03072459|536345961|FG000|Overall Study|Subject not able to return|1|||
148691900|NCT02275364|536345962|FG000|Period 1|Withdrawal by Subject|1|||
148691901|NCT02275364|536345963|FG001|Period 1|Withdrawal by Subject|0|||
148691902|NCT02275364|536345962|FG000|Period 1|Other reason|1|||
148958160|NCT02049957|537331246|FG005|Overall Study|Physician Decision|1|||
148958161|NCT02049957|537331247|FG006|Overall Study|Physician Decision|0|||
148958162|NCT02049957|537331248|FG007|Overall Study|Physician Decision|0|||
148958163|NCT02049957|537331249|FG008|Overall Study|Physician Decision|0|||
148958164|NCT03557151|537331250|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
148958165|NCT03557151|537331251|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
148958166|NCT03557151|537331250|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
148958167|NCT03557151|537331251|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
148958168|NCT03557151|537331250|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
148958169|NCT03557151|537331251|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
148958170|NCT02810392|537331252|FG000|Overall Study|Subject too ill to continue|1|||
148958171|NCT02810392|537331253|FG001|Overall Study|Subject too ill to continue|0|||
148958172|NCT02810392|537331252|FG000|Overall Study|COVID 19 research restrictions|0|||
148958173|NCT02810392|537331253|FG001|Overall Study|COVID 19 research restrictions|1|||
148958174|NCT00840294|537331254|FG000|Overall Study|Withdrawal by Subject|2|||
148958175|NCT00840294|537331255|FG001|Overall Study|Withdrawal by Subject|1|||
148958176|NCT00840294|537331254|FG000|Overall Study|Protocol Violation|1|||
148958177|NCT00840294|537331255|FG001|Overall Study|Protocol Violation|3|||
148958178|NCT00840294|537331254|FG000|Overall Study|Illness|0|||
148958179|NCT00840294|537331255|FG001|Overall Study|Illness|1|||
148958180|NCT04868890|537331265|FG000|Overall Study|Death|2|||
148958181|NCT04868890|537331266|FG001|Overall Study|Death|1|||
148958182|NCT04868890|537331265|FG000|Overall Study|Withdrawal by Subject|1|||
148958183|NCT04868890|537331266|FG001|Overall Study|Withdrawal by Subject|5|||
148958184|NCT02669433|537331269|FG000|Overall Study|Protocol Violation|0|||
148958185|NCT02669433|537331270|FG001|Overall Study|Protocol Violation|4|||
148958186|NCT02669433|537331271|FG002|Overall Study|Protocol Violation|1|||
148958187|NCT02669433|537331269|FG000|Overall Study|Disease Progression|1|||
148958188|NCT02669433|537331270|FG001|Overall Study|Disease Progression|0|||
148958189|NCT02669433|537331271|FG002|Overall Study|Disease Progression|0|||
148958190|NCT02669433|537331269|FG000|Overall Study|Physician Decision|1|||
148958191|NCT02669433|537331270|FG001|Overall Study|Physician Decision|1|||
148958192|NCT02669433|537331271|FG002|Overall Study|Physician Decision|0|||
148958193|NCT02669433|537331269|FG000|Overall Study|Adverse Event|6|||
148958194|NCT02669433|537331270|FG001|Overall Study|Adverse Event|7|||
148958195|NCT02669433|537331271|FG002|Overall Study|Adverse Event|10|||
148958196|NCT02669433|537331269|FG000|Overall Study|Sponsor Termination|1|||
148958197|NCT02669433|537331270|FG001|Overall Study|Sponsor Termination|0|||
148958198|NCT02669433|537331271|FG002|Overall Study|Sponsor Termination|1|||
148958199|NCT02669433|537331269|FG000|Overall Study|Withdrawal by Subject|5|||
148958200|NCT02669433|537331270|FG001|Overall Study|Withdrawal by Subject|1|||
148958201|NCT02669433|537331271|FG002|Overall Study|Withdrawal by Subject|0|||
148958202|NCT02669433|537331269|FG000|Overall Study|Withdrawal by Caregiver|1|||
148958203|NCT02669433|537331270|FG001|Overall Study|Withdrawal by Caregiver|0|||
148958204|NCT02669433|537331271|FG002|Overall Study|Withdrawal by Caregiver|2|||
148958205|NCT02669433|537331269|FG000|Overall Study|Death|0|||
148958206|NCT02669433|537331270|FG001|Overall Study|Death|1|||
148958207|NCT02669433|537331271|FG002|Overall Study|Death|1|||
148958208|NCT02157298|537331279|FG000|Overall Study|Adverse Event|1|||
148958209|NCT02157298|537331280|FG001|Overall Study|Adverse Event|0|||
148958210|NCT02157298|537331279|FG000|Overall Study|Subject no longer meets study criteria|1|||
148958211|NCT02157298|537331280|FG001|Overall Study|Subject no longer meets study criteria|2|||
148958212|NCT02157298|537331279|FG000|Overall Study|Poor/Non-compliance|1|||
148958213|NCT02157298|537331280|FG001|Overall Study|Poor/Non-compliance|0|||
148958214|NCT02157298|537331279|FG000|Overall Study|Withdrawal by Subject|1|||
148958215|NCT02157298|537331280|FG001|Overall Study|Withdrawal by Subject|0|||
148958216|NCT00883116|537331285|FG000|Overall Study|Adverse event unrelated to study drug|5|||
148958217|NCT00883116|537331286|FG001|Overall Study|Adverse event unrelated to study drug|10|||
148958218|NCT00883116|537331285|FG000|Overall Study|Death|6|||
148958219|NCT00883116|537331286|FG001|Overall Study|Death|2|||
148691903|NCT02275364|536345963|FG001|Period 1|Other reason|0|||
148691904|NCT03595657|536345968|FG000|Overall Study|Adverse Event|14|||
148958220|NCT00883116|537331285|FG000|Overall Study|Disease progression|130|||
148958221|NCT00883116|537331286|FG001|Overall Study|Disease progression|128|||
148958222|NCT00883116|537331285|FG000|Overall Study|Lost to Follow-up|0|||
148958223|NCT00883116|537331286|FG001|Overall Study|Lost to Follow-up|1|||
148958224|NCT00883116|537331285|FG000|Overall Study|Maximum clinical benefit|13|||
148958225|NCT00883116|537331286|FG001|Overall Study|Maximum clinical benefit|46|||
148958226|NCT00883116|537331285|FG000|Overall Study|Not identified|3|||
148958227|NCT00883116|537331286|FG001|Overall Study|Not identified|6|||
148691905|NCT03595657|536345968|FG000|Overall Study|Death|1|||
148691906|NCT03595657|536345968|FG000|Overall Study|Lack of Efficacy|40|||
148958228|NCT00883116|537331285|FG000|Overall Study|Study drug toxicity|36|||
148958229|NCT00883116|537331286|FG001|Overall Study|Study drug toxicity|16|||
148958230|NCT00883116|537331285|FG000|Overall Study|Withdrawal by Subject|14|||
148958231|NCT00883116|537331286|FG001|Overall Study|Withdrawal by Subject|8|||
149022197|NCT03990363|537559014|FG003|Overall Study|Site terminated by sponsor|0|||
149022198|NCT03990363|537559015|FG004|Overall Study|Site terminated by sponsor|2|||
149022199|NCT03990363|537559011|FG000|Overall Study|Not categorized|5|||
149022200|NCT03990363|537559012|FG001|Overall Study|Not categorized|5|||
149022201|NCT03990363|537559013|FG002|Overall Study|Not categorized|3|||
149022202|NCT03990363|537559014|FG003|Overall Study|Not categorized|2|||
149022203|NCT03990363|537559015|FG004|Overall Study|Not categorized|2|||
149022204|NCT05764239|537559022|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
149022205|NCT05764239|537559022|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
149022206|NCT05764239|537559022|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
149022207|NCT05764239|537559022|FG000|DEP (Part 1)|Adverse Event|1|||
149022208|NCT05764239|537559022|FG000|DEP (Part 1)|Lost to Follow-up|1|||
149022209|NCT05764239|537559022|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
149022210|NCT05764239|537559022|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
149022211|NCT05764239|537559022|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
149022212|NCT05764239|537559022|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
149022213|NCT04630756|537559025|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
149022214|NCT04630756|537559026|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
149022215|NCT04630756|537559027|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
149022216|NCT05593211|537559029|FG000|Overall Study|Withdrawal by Subject|1|||
149022217|NCT03077620|537559033|FG000|Overall Study|Unable to place lumbar catheter|1|||
149022218|NCT03077620|537559034|FG001|Overall Study|Unable to place lumbar catheter|0|||
149022219|NCT03077620|537559035|FG002|Overall Study|Unable to place lumbar catheter|1|||
149022220|NCT03077620|537559036|FG003|Overall Study|Unable to place lumbar catheter|0|||
149022221|NCT03077620|537559033|FG000|Overall Study|Withdrawal by Subject|0|||
149022222|NCT03077620|537559034|FG001|Overall Study|Withdrawal by Subject|1|||
149022223|NCT03077620|537559035|FG002|Overall Study|Withdrawal by Subject|0|||
149022224|NCT03077620|537559036|FG003|Overall Study|Withdrawal by Subject|0|||
149022225|NCT03077620|537559033|FG000|Overall Study|Physician Decision|0|||
149022226|NCT03077620|537559034|FG001|Overall Study|Physician Decision|0|||
149022227|NCT03077620|537559035|FG002|Overall Study|Physician Decision|1|||
149022228|NCT03077620|537559036|FG003|Overall Study|Physician Decision|0|||
149022229|NCT03225846|537559037|FG000|Overall Study|Adverse Event|0|||
149022230|NCT03225846|537559038|FG001|Overall Study|Adverse Event|0|||
149022231|NCT03225846|537559039|FG002|Overall Study|Adverse Event|0|||
149022232|NCT03225846|537559040|FG003|Overall Study|Adverse Event|0|||
149022233|NCT03225846|537559041|FG004|Overall Study|Adverse Event|0|||
149022234|NCT03225846|537559042|FG005|Overall Study|Adverse Event|0|||
149022235|NCT03225846|537559043|FG006|Overall Study|Adverse Event|6|||
149022236|NCT03225846|537559037|FG000|Overall Study|Withdrawal by Subject|0|||
149022237|NCT03225846|537559038|FG001|Overall Study|Withdrawal by Subject|1|||
149022238|NCT03225846|537559039|FG002|Overall Study|Withdrawal by Subject|0|||
149022239|NCT03225846|537559040|FG003|Overall Study|Withdrawal by Subject|0|||
149022240|NCT03225846|537559041|FG004|Overall Study|Withdrawal by Subject|0|||
149022241|NCT03225846|537559042|FG005|Overall Study|Withdrawal by Subject|0|||
149022242|NCT03225846|537559043|FG006|Overall Study|Withdrawal by Subject|0|||
149022243|NCT03225846|537559037|FG000|Overall Study|Death|0|||
149022244|NCT03225846|537559038|FG001|Overall Study|Death|1|||
149022245|NCT03225846|537559039|FG002|Overall Study|Death|0|||
149022246|NCT03225846|537559040|FG003|Overall Study|Death|0|||
148958232|NCT00883116|537331285|FG000|Overall Study|No longer meets study criteria|2|||
148958233|NCT00883116|537331286|FG001|Overall Study|No longer meets study criteria|2|||
148958234|NCT03715764|537331287|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
148958235|NCT03715764|537331288|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
148958236|NCT03715764|537331287|FG000|3 Month Follow-up|Lost to Follow-up|2|||
148958237|NCT03715764|537331288|FG001|3 Month Follow-up|Lost to Follow-up|2|||
148958238|NCT03715764|537331287|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
148958239|NCT03715764|537331288|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
148811683|NCT03765073|536787079|FG008|Stage 2|Withdrawal by parent/guardian|0|||
148958240|NCT03715764|537331287|FG000|6 Month Follow-up|Lost to Follow-up|3|||
148958241|NCT03715764|537331288|FG001|6 Month Follow-up|Lost to Follow-up|0|||
148958242|NCT03715764|537331287|FG000|12 Month Follow-up|Lost to Follow-up|2|||
148958243|NCT03715764|537331288|FG001|12 Month Follow-up|Lost to Follow-up|3|||
148958244|NCT03715764|537331287|FG000|12 Month Follow-up|Pregnancy|0|||
148958245|NCT03715764|537331288|FG001|12 Month Follow-up|Pregnancy|1|||
149022247|NCT03225846|537559041|FG004|Overall Study|Death|0|||
149022248|NCT03225846|537559042|FG005|Overall Study|Death|0|||
149022249|NCT03225846|537559043|FG006|Overall Study|Death|0|||
149022250|NCT03225846|537559037|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
148958246|NCT03715764|537331287|FG000|12 Month Follow-up|Surgery|2|||
149022251|NCT03225846|537559038|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
149022252|NCT03225846|537559039|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
149022253|NCT03225846|537559040|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
148811684|NCT03765073|536787080|FG009|Stage 2|Withdrawal by parent/guardian|0|||
148958247|NCT03715764|537331288|FG001|12 Month Follow-up|Surgery|0|||
148958248|NCT03715764|537331287|FG000|12 Month Follow-up|Wrong address|1|||
148958249|NCT03715764|537331288|FG001|12 Month Follow-up|Wrong address|0|||
148958250|NCT03715764|537331287|FG000|12 Month Follow-up|No symptoms|1|||
148958251|NCT03715764|537331288|FG001|12 Month Follow-up|No symptoms|0|||
148958252|NCT03715764|537331287|FG000|12 Month Follow-up|Changed primary care centre|0|||
148958253|NCT03715764|537331288|FG001|12 Month Follow-up|Changed primary care centre|1|||
148958254|NCT01361464|537331291|FG000|Overall Study|Death|1|||
148958255|NCT01361464|537331291|FG000|Overall Study|Withdrawal by Subject|2|||
148958256|NCT01722071|537331292|FG000|Overall Study|Protocol Violation|1|||
148958257|NCT01722071|537331293|FG001|Overall Study|Protocol Violation|0|||
148958258|NCT00818662|537331294|FG000|Overall Study|Adverse Event|5|||
148958259|NCT00818662|537331295|FG001|Overall Study|Adverse Event|14|||
148958260|NCT00818662|537331296|FG002|Overall Study|Adverse Event|4|||
148958261|NCT00818662|537331297|FG003|Overall Study|Adverse Event|3|||
148958262|NCT00818662|537331294|FG000|Overall Study|Withdrawal by Subject|5|||
148958263|NCT00818662|537331295|FG001|Overall Study|Withdrawal by Subject|4|||
148958264|NCT00818662|537331296|FG002|Overall Study|Withdrawal by Subject|2|||
148958265|NCT00818662|537331297|FG003|Overall Study|Withdrawal by Subject|2|||
148958266|NCT00818662|537331294|FG000|Overall Study|Death|1|||
148958267|NCT00818662|537331295|FG001|Overall Study|Death|3|||
148958268|NCT00818662|537331296|FG002|Overall Study|Death|0|||
148958269|NCT00818662|537331297|FG003|Overall Study|Death|0|||
148958270|NCT00818662|537331294|FG000|Overall Study|Physician Decision|1|||
148958271|NCT00818662|537331295|FG001|Overall Study|Physician Decision|0|||
148958272|NCT00818662|537331296|FG002|Overall Study|Physician Decision|0|||
148958273|NCT00818662|537331297|FG003|Overall Study|Physician Decision|0|||
148958274|NCT00818662|537331294|FG000|Overall Study|Lost to Follow-up|0|||
148958275|NCT00818662|537331295|FG001|Overall Study|Lost to Follow-up|0|||
148958276|NCT00818662|537331296|FG002|Overall Study|Lost to Follow-up|0|||
148958277|NCT00818662|537331297|FG003|Overall Study|Lost to Follow-up|1|||
148958278|NCT00818662|537331294|FG000|Overall Study|Unwilling or Unable to Participate|4|||
148958279|NCT00818662|537331295|FG001|Overall Study|Unwilling or Unable to Participate|6|||
148958280|NCT00818662|537331296|FG002|Overall Study|Unwilling or Unable to Participate|2|||
148958281|NCT00818662|537331297|FG003|Overall Study|Unwilling or Unable to Participate|4|||
148958282|NCT00818662|537331294|FG000|Overall Study|Protocol Violation|1|||
148958283|NCT00818662|537331295|FG001|Overall Study|Protocol Violation|1|||
148958284|NCT00818662|537331296|FG002|Overall Study|Protocol Violation|0|||
148958285|NCT00818662|537331297|FG003|Overall Study|Protocol Violation|0|||
148958286|NCT00818662|537331294|FG000|Overall Study|Requires a Prohibited Medication|1|||
148958287|NCT00818662|537331295|FG001|Overall Study|Requires a Prohibited Medication|0|||
148958288|NCT00818662|537331296|FG002|Overall Study|Requires a Prohibited Medication|0|||
148958289|NCT00818662|537331297|FG003|Overall Study|Requires a Prohibited Medication|0|||
148958290|NCT00818662|537331294|FG000|Overall Study|Safety Risk|1|||
148958291|NCT00818662|537331295|FG001|Overall Study|Safety Risk|1|||
148958292|NCT00818662|537331296|FG002|Overall Study|Safety Risk|0|||
148958293|NCT00818662|537331297|FG003|Overall Study|Safety Risk|1|||
148958294|NCT00818662|537331294|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
148958295|NCT00818662|537331295|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
148958296|NCT00818662|537331296|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
148958297|NCT00818662|537331297|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
148958298|NCT00818662|537331294|FG000|Overall Study|Participant's health declined|0|||
148958299|NCT00818662|537331295|FG001|Overall Study|Participant's health declined|0|||
148958300|NCT00818662|537331296|FG002|Overall Study|Participant's health declined|0|||
148958301|NCT00818662|537331297|FG003|Overall Study|Participant's health declined|1|||
148958302|NCT00818662|537331294|FG000|Overall Study|Caregiver to pursue other treatment|0|||
148958303|NCT00818662|537331295|FG001|Overall Study|Caregiver to pursue other treatment|1|||
148958304|NCT00818662|537331296|FG002|Overall Study|Caregiver to pursue other treatment|0|||
148958305|NCT00818662|537331297|FG003|Overall Study|Caregiver to pursue other treatment|0|||
148958306|NCT00818662|537331294|FG000|Overall Study|Moving out of state|0|||
148958307|NCT00818662|537331295|FG001|Overall Study|Moving out of state|0|||
148958308|NCT00818662|537331296|FG002|Overall Study|Moving out of state|0|||
148958309|NCT00818662|537331297|FG003|Overall Study|Moving out of state|1|||
148958310|NCT00818662|537331294|FG000|Overall Study|Declined move to another study site|1|||
148958311|NCT00818662|537331295|FG001|Overall Study|Declined move to another study site|0|||
148958312|NCT00818662|537331296|FG002|Overall Study|Declined move to another study site|0|||
148958313|NCT00818662|537331297|FG003|Overall Study|Declined move to another study site|0|||
148958314|NCT00818662|537331294|FG000|Overall Study|Change in living situation|0|||
148958315|NCT00818662|537331295|FG001|Overall Study|Change in living situation|0|||
148958316|NCT00818662|537331296|FG002|Overall Study|Change in living situation|0|||
148958317|NCT00818662|537331297|FG003|Overall Study|Change in living situation|1|||
148958318|NCT00818662|537331294|FG000|Overall Study|Study partner decision|0|||
148958319|NCT00818662|537331295|FG001|Overall Study|Study partner decision|0|||
148958320|NCT00818662|537331296|FG002|Overall Study|Study partner decision|0|||
148958321|NCT00818662|537331297|FG003|Overall Study|Study partner decision|1|||
148958322|NCT00818662|537331294|FG000|Overall Study|Admitted to long term nursing care|0|||
148958323|NCT00818662|537331295|FG001|Overall Study|Admitted to long term nursing care|1|||
148958324|NCT00818662|537331296|FG002|Overall Study|Admitted to long term nursing care|0|||
148958325|NCT00818662|537331297|FG003|Overall Study|Admitted to long term nursing care|0|||
148958326|NCT03021265|537331298|FG000|Overall Study|Adverse Event|29|||
148958327|NCT03021265|537331298|FG000|Overall Study|Lack of Efficacy|3|||
148958328|NCT03021265|537331298|FG000|Overall Study|Improved|17|||
148958329|NCT03021265|537331298|FG000|Overall Study|Lost to Follow-up|67|||
148958330|NCT03021265|537331298|FG000|Overall Study|No reason given|2|||
148958331|NCT03021265|537331298|FG000|Overall Study|No visit since the first visit|4|||
148958332|NCT01106898|537331299|FG000|Overall Study|Adverse Event|6|||
148958333|NCT01338493|537331300|FG000|Enrolled|Withdrawal by Subject|1|||
148958334|NCT01338493|537331300|FG000|Enrolled|Patient not implanted|4|||
148958335|NCT01338493|537331300|FG000|Discharge|Death|1|||
148958336|NCT01338493|537331300|FG000|Discharge|Missed visit|1|||
148958337|NCT01338493|537331300|FG000|6 Months Follow up|Lost to Follow-up|11|||
148958338|NCT01338493|537331300|FG000|6 Months Follow up|Missed visit|8|||
148958339|NCT01338493|537331300|FG000|12 Months Follow up|Lost to Follow-up|9|||
148958340|NCT01472081|537331301|FG000|Overall Study|Continuing treatment at time of analysis|1|||
148958341|NCT01472081|537331302|FG001|Overall Study|Continuing treatment at time of analysis|4|||
148958342|NCT01472081|537331303|FG002|Overall Study|Continuing treatment at time of analysis|1|||
148958343|NCT01472081|537331304|FG003|Overall Study|Continuing treatment at time of analysis|8|||
148958344|NCT01472081|537331305|FG004|Overall Study|Continuing treatment at time of analysis|9|||
148958345|NCT01472081|537331306|FG005|Overall Study|Continuing treatment at time of analysis|0|||
148958346|NCT01472081|537331301|FG000|Overall Study|Disease Progression|4|||
148958347|NCT01472081|537331302|FG001|Overall Study|Disease Progression|10|||
148958348|NCT01472081|537331303|FG002|Overall Study|Disease Progression|12|||
148958349|NCT01472081|537331304|FG003|Overall Study|Disease Progression|31|||
148958350|NCT01472081|537331305|FG004|Overall Study|Disease Progression|22|||
148958351|NCT01472081|537331306|FG005|Overall Study|Disease Progression|3|||
148958352|NCT01472081|537331301|FG000|Overall Study|Study drug toxicity|2|||
148958353|NCT01472081|537331302|FG001|Overall Study|Study drug toxicity|9|||
148958354|NCT01472081|537331303|FG002|Overall Study|Study drug toxicity|4|||
148958355|NCT01472081|537331304|FG003|Overall Study|Study drug toxicity|6|||
148958356|NCT01472081|537331305|FG004|Overall Study|Study drug toxicity|13|||
148958357|NCT01472081|537331306|FG005|Overall Study|Study drug toxicity|2|||
148958358|NCT01472081|537331301|FG000|Overall Study|Death|0|||
148958359|NCT01472081|537331302|FG001|Overall Study|Death|0|||
148958360|NCT01472081|537331303|FG002|Overall Study|Death|0|||
148958361|NCT01472081|537331304|FG003|Overall Study|Death|0|||
148958362|NCT01472081|537331305|FG004|Overall Study|Death|1|||
148958363|NCT01472081|537331306|FG005|Overall Study|Death|0|||
148958364|NCT01472081|537331301|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
148958365|NCT01472081|537331302|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
148958366|NCT01472081|537331303|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
148958367|NCT01472081|537331304|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
148958368|NCT01472081|537331305|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
148958369|NCT01472081|537331306|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
148958370|NCT01472081|537331301|FG000|Overall Study|Withdrawal by Subject|0|||
148958371|NCT01472081|537331302|FG001|Overall Study|Withdrawal by Subject|0|||
148958372|NCT01472081|537331303|FG002|Overall Study|Withdrawal by Subject|0|||
148958373|NCT01472081|537331304|FG003|Overall Study|Withdrawal by Subject|0|||
148958374|NCT01472081|537331305|FG004|Overall Study|Withdrawal by Subject|0|||
148958375|NCT01472081|537331306|FG005|Overall Study|Withdrawal by Subject|1|||
148958376|NCT01472081|537331301|FG000|Overall Study|Poor/non-compliance|0|||
148958377|NCT01472081|537331302|FG001|Overall Study|Poor/non-compliance|0|||
148958378|NCT01472081|537331303|FG002|Overall Study|Poor/non-compliance|1|||
148958379|NCT01472081|537331304|FG003|Overall Study|Poor/non-compliance|0|||
149022254|NCT03225846|537559041|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
149022255|NCT03225846|537559042|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
149022256|NCT03225846|537559043|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
148958380|NCT01472081|537331305|FG004|Overall Study|Poor/non-compliance|1|||
148958381|NCT01472081|537331306|FG005|Overall Study|Poor/non-compliance|0|||
148958382|NCT01472081|537331301|FG000|Overall Study|No longer meets study criteria|0|||
148958383|NCT01472081|537331302|FG001|Overall Study|No longer meets study criteria|0|||
148958384|NCT01472081|537331303|FG002|Overall Study|No longer meets study criteria|1|||
148958385|NCT01472081|537331304|FG003|Overall Study|No longer meets study criteria|0|||
148691907|NCT03595657|536345968|FG000|Overall Study|Withdrawal by Subject|10|||
148691908|NCT03595657|536345968|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
148691909|NCT03595657|536345968|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
148691910|NCT01200394|536345969|FG000|Overall Study|Adverse Event|0|||
148691911|NCT01200394|536345970|FG001|Overall Study|Adverse Event|14|||
148691912|NCT01200394|536345969|FG000|Overall Study|Death|1|||
148691913|NCT01200394|536345970|FG001|Overall Study|Death|0|||
148691914|NCT01200394|536345969|FG000|Overall Study|Lost to Follow-up|0|||
148691915|NCT01200394|536345970|FG001|Overall Study|Lost to Follow-up|1|||
148691916|NCT01200394|536345969|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
148691917|NCT01200394|536345970|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
148691918|NCT01200394|536345969|FG000|Overall Study|Protocol Violation|0|||
148691919|NCT01200394|536345970|FG001|Overall Study|Protocol Violation|3|||
148691920|NCT01200394|536345969|FG000|Overall Study|Withdrawal by Subject|0|||
148691921|NCT01200394|536345970|FG001|Overall Study|Withdrawal by Subject|5|||
148691922|NCT01200394|536345969|FG000|Overall Study|Other|0|||
148691923|NCT01200394|536345970|FG001|Overall Study|Other|1|||
148691924|NCT00663871|536345973|FG000|Overall Study|Lost to Follow-up|5|||
148691925|NCT00663871|536345974|FG001|Overall Study|Lost to Follow-up|5|||
148691926|NCT00663871|536345973|FG000|Overall Study|Withdrawal by Subject|5|||
148691927|NCT00663871|536345974|FG001|Overall Study|Withdrawal by Subject|2|||
148691928|NCT02729896|536345977|FG000|Overall Study|Death|0|||
148691929|NCT02729896|536345978|FG001|Overall Study|Death|2|||
148691930|NCT02729896|536345979|FG002|Overall Study|Death|13|||
148691931|NCT02729896|536345977|FG000|Overall Study|Lost to Follow-up|0|||
148691932|NCT02729896|536345978|FG001|Overall Study|Lost to Follow-up|2|||
148691933|NCT02729896|536345979|FG002|Overall Study|Lost to Follow-up|3|||
148691934|NCT02729896|536345977|FG000|Overall Study|Other|0|||
148691935|NCT02729896|536345978|FG001|Overall Study|Other|2|||
148691936|NCT02729896|536345979|FG002|Overall Study|Other|0|||
148691937|NCT02729896|536345977|FG000|Overall Study|Physician Decision|1|||
148691938|NCT02729896|536345978|FG001|Overall Study|Physician Decision|2|||
148691939|NCT02729896|536345979|FG002|Overall Study|Physician Decision|3|||
148691940|NCT02729896|536345977|FG000|Overall Study|Progressive Disease|0|||
148691941|NCT02729896|536345978|FG001|Overall Study|Progressive Disease|1|||
148691942|NCT02729896|536345979|FG002|Overall Study|Progressive Disease|0|||
148691943|NCT02729896|536345977|FG000|Overall Study|Withdrawal by Subject|1|||
148691944|NCT02729896|536345978|FG001|Overall Study|Withdrawal by Subject|0|||
148691945|NCT02729896|536345979|FG002|Overall Study|Withdrawal by Subject|3|||
148691946|NCT01835145|536345980|FG000|Overall Study|Ineligible prior to treatment|1|||
148691947|NCT01835145|536345981|FG001|Overall Study|Ineligible prior to treatment|0|||
148691948|NCT00582309|536345982|FG000|Overall Study|Protocol Violation|0|||
148691949|NCT00582309|536345983|FG001|Overall Study|Protocol Violation|0|||
148691950|NCT00582309|536345984|FG002|Overall Study|Protocol Violation|2|||
148691951|NCT04094870|536345988|FG000|Overall Study|Lost to Follow-up|1|||
148691952|NCT04094870|536345989|FG001|Overall Study|Lost to Follow-up|1|||
148691953|NCT03384745|536345991|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
148691954|NCT03384745|536345992|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
148691955|NCT03384745|536345993|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
148691956|NCT03384745|536345994|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
148691957|NCT03384745|536345995|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
148691958|NCT03384745|536345996|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
148691959|NCT03384745|536345991|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
148691960|NCT03384745|536345992|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
148691961|NCT03384745|536345993|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
148691962|NCT03384745|536345994|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
148691963|NCT03384745|536345995|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
148691964|NCT03384745|536345996|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
148691965|NCT03384745|536345991|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
148691966|NCT03384745|536345992|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
148691967|NCT03384745|536345993|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
148691968|NCT03384745|536345994|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
148691969|NCT03384745|536345995|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
148691970|NCT03384745|536345996|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
148691971|NCT03384745|536345991|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
148691972|NCT03384745|536345992|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
148691973|NCT03384745|536345993|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
148691974|NCT03384745|536345994|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
148691975|NCT03384745|536345995|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
148691976|NCT03384745|536345996|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
148691977|NCT03384745|536345991|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
148691978|NCT03384745|536345992|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
148691979|NCT03384745|536345993|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
149022257|NCT03225846|537559037|FG000|Overall Study|Patient decision|0|||
149022258|NCT03225846|537559038|FG001|Overall Study|Patient decision|0|||
149022259|NCT03225846|537559039|FG002|Overall Study|Patient decision|0|||
149022260|NCT03225846|537559040|FG003|Overall Study|Patient decision|0|||
149022261|NCT03225846|537559041|FG004|Overall Study|Patient decision|0|||
149022262|NCT03225846|537559042|FG005|Overall Study|Patient decision|0|||
149022263|NCT03225846|537559043|FG006|Overall Study|Patient decision|1|||
149022264|NCT04248465|537559044|FG000|Randomized-Controlled Period|Death|12|||
149022265|NCT04248465|537559045|FG001|Randomized-Controlled Period|Death|5|||
149022266|NCT04248465|537559044|FG000|Randomized-Controlled Period|Adverse Event|2|||
149022267|NCT04248465|537559045|FG001|Randomized-Controlled Period|Adverse Event|0|||
149022268|NCT04248465|537559044|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
149022269|NCT04248465|537559045|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
149022270|NCT04248465|537559044|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
149022271|NCT04248465|537559045|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
149022272|NCT04248465|537559044|FG000|Randomized-Controlled Period|Physician Decision|1|||
149022273|NCT04248465|537559045|FG001|Randomized-Controlled Period|Physician Decision|1|||
149022274|NCT04248465|537559044|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
149022275|NCT04248465|537559045|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
149022276|NCT04248465|537559044|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
149022277|NCT04248465|537559045|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
149022278|NCT04248465|537559044|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
149022279|NCT04248465|537559045|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
149022280|NCT00245011|537559056|FG000|Overall Study|Lack of Efficacy|1|||
149022281|NCT03040687|537559059|FG000|Overall Study|Withdrawal by Subject|1|||
149022282|NCT03040687|537559060|FG001|Overall Study|Withdrawal by Subject|0|||
149022283|NCT03040687|537559061|FG002|Overall Study|Withdrawal by Subject|0|||
149022284|NCT00550173|537559062|FG000|Overall Study|Death|45|||
149022285|NCT00550173|537559063|FG001|Overall Study|Death|38|||
149022286|NCT00550173|537559064|FG002|Overall Study|Death|50|||
149022287|NCT00550173|537559062|FG000|Overall Study|Physician Decision|1|||
149022288|NCT00550173|537559063|FG001|Overall Study|Physician Decision|2|||
149022289|NCT00550173|537559064|FG002|Overall Study|Physician Decision|2|||
149022290|NCT00550173|537559062|FG000|Overall Study|Withdrawal by Subject|9|||
149022291|NCT00550173|537559063|FG001|Overall Study|Withdrawal by Subject|12|||
149022292|NCT00550173|537559064|FG002|Overall Study|Withdrawal by Subject|17|||
149022293|NCT00550173|537559062|FG000|Overall Study|Sponsor Decision|13|||
149022294|NCT00550173|537559063|FG001|Overall Study|Sponsor Decision|7|||
149022295|NCT00550173|537559064|FG002|Overall Study|Sponsor Decision|1|||
149022296|NCT00550173|537559062|FG000|Overall Study|Lost to Follow-up|4|||
149022297|NCT00550173|537559063|FG001|Overall Study|Lost to Follow-up|4|||
149022298|NCT00550173|537559064|FG002|Overall Study|Lost to Follow-up|3|||
149022299|NCT01388543|537559072|FG000|Day 14|Adverse Event|1|||
149022300|NCT01388543|537559073|FG001|Day 14|Adverse Event|4|||
149022301|NCT02325713|537559076|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022302|NCT02325713|537559077|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022303|NCT02325713|537559078|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022304|NCT02325713|537559079|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022305|NCT02325713|537559080|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022306|NCT02325713|537559081|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022307|NCT02325713|537559082|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022308|NCT02325713|537559083|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022309|NCT02325713|537559084|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022310|NCT02325713|537559085|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022311|NCT02325713|537559086|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
149022312|NCT02325713|537559087|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022313|NCT02325713|537559088|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022314|NCT02325713|537559089|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022315|NCT02325713|537559090|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022316|NCT02325713|537559091|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
149022317|NCT02325713|537559076|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
148811685|NCT03765073|536787081|FG010|Stage 2|Withdrawal by parent/guardian|3|||
149022318|NCT02325713|537559077|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
148811686|NCT03765073|536787082|FG011|Stage 2|Withdrawal by parent/guardian|3|||
148811687|NCT03765073|536787083|FG012|Stage 2|Withdrawal by parent/guardian|3|||
149022319|NCT02325713|537559078|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022320|NCT02325713|537559079|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022321|NCT02325713|537559080|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022322|NCT02325713|537559081|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022323|NCT02325713|537559082|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022324|NCT02325713|537559083|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
148958386|NCT01472081|537331305|FG004|Overall Study|No longer meets study criteria|0|||
148958387|NCT01472081|537331306|FG005|Overall Study|No longer meets study criteria|0|||
148958388|NCT01472081|537331301|FG000|Overall Study|Subject request to discontinue treatment|0|||
148958389|NCT01472081|537331302|FG001|Overall Study|Subject request to discontinue treatment|3|||
148958390|NCT01472081|537331303|FG002|Overall Study|Subject request to discontinue treatment|1|||
148958391|NCT01472081|537331304|FG003|Overall Study|Subject request to discontinue treatment|1|||
148958392|NCT01472081|537331305|FG004|Overall Study|Subject request to discontinue treatment|0|||
148958393|NCT01472081|537331306|FG005|Overall Study|Subject request to discontinue treatment|0|||
148958394|NCT01698801|537331307|FG000|Treatment Phase|Adverse Event|4|||
149022325|NCT02325713|537559084|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022326|NCT02325713|537559085|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022327|NCT02325713|537559086|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022328|NCT02325713|537559087|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022329|NCT02325713|537559088|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022330|NCT02325713|537559089|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022331|NCT02325713|537559090|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022332|NCT02325713|537559091|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
149022333|NCT02325713|537559076|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022334|NCT02325713|537559077|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022335|NCT02325713|537559078|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022336|NCT02325713|537559079|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022337|NCT02325713|537559080|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022338|NCT02325713|537559081|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022339|NCT02325713|537559082|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022340|NCT02325713|537559083|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022341|NCT02325713|537559084|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022342|NCT02325713|537559085|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
149022343|NCT02325713|537559086|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022344|NCT02325713|537559087|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022345|NCT02325713|537559088|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022346|NCT02325713|537559089|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022347|NCT02325713|537559090|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022348|NCT02325713|537559091|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
149022349|NCT01213173|537559093|FG000|Overall Study|Protocol Violation|2|||
149022350|NCT01213173|537559094|FG001|Overall Study|Protocol Violation|0|||
149022351|NCT01213173|537559093|FG000|Overall Study|Adverse Event|4|||
149022352|NCT01213173|537559094|FG001|Overall Study|Adverse Event|8|||
149022353|NCT01213173|537559093|FG000|Overall Study|Withdrawal by Subject|5|||
149022354|NCT01213173|537559094|FG001|Overall Study|Withdrawal by Subject|5|||
149022355|NCT01213173|537559093|FG000|Overall Study|Incorrect Enrollment|1|||
149022356|NCT01213173|537559094|FG001|Overall Study|Incorrect Enrollment|3|||
149022357|NCT02253316|537559095|FG000|Consolidation|Progression|4|||
149022358|NCT02253316|537559096|FG001|Consolidation|Progression|0|||
149022359|NCT02253316|537559097|FG002|Consolidation|Progression|0|||
149022360|NCT02253316|537559095|FG000|Consolidation|Non-Compliance|1|||
149022361|NCT02253316|537559096|FG001|Consolidation|Non-Compliance|0|||
149022362|NCT02253316|537559097|FG002|Consolidation|Non-Compliance|0|||
149022363|NCT02253316|537559095|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
149022364|NCT02253316|537559096|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
149022365|NCT02253316|537559097|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
149022366|NCT02253316|537559095|FG000|Consolidation|Secondary Malignancy|2|||
149022367|NCT02253316|537559096|FG001|Consolidation|Secondary Malignancy|0|||
149022368|NCT02253316|537559097|FG002|Consolidation|Secondary Malignancy|0|||
149022369|NCT02253316|537559095|FG000|Consolidation|Adverse Event|7|||
149022370|NCT02253316|537559096|FG001|Consolidation|Adverse Event|0|||
149022371|NCT02253316|537559097|FG002|Consolidation|Adverse Event|0|||
149022372|NCT02253316|537559095|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
149022373|NCT02253316|537559096|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
149022374|NCT02253316|537559097|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
149022375|NCT02253316|537559095|FG000|Maintenance|Physician Decision|0|||
149022376|NCT02253316|537559096|FG001|Maintenance|Physician Decision|7|||
149022377|NCT02253316|537559097|FG002|Maintenance|Physician Decision|16|||
149022378|NCT02253316|537559095|FG000|Maintenance|Non-Compliance|0|||
149022379|NCT02253316|537559096|FG001|Maintenance|Non-Compliance|1|||
149022380|NCT02253316|537559097|FG002|Maintenance|Non-Compliance|1|||
149022381|NCT02253316|537559095|FG000|Maintenance|Secondary Malignancy|0|||
148811688|NCT03765073|536787084|FG013|Stage 2|Withdrawal by parent/guardian|1|||
148811689|NCT03765073|536787085|FG014|Stage 2|Withdrawal by parent/guardian|1|||
148811690|NCT03765073|536787086|FG015|Stage 2|Withdrawal by parent/guardian|0|||
149022382|NCT02253316|537559096|FG001|Maintenance|Secondary Malignancy|2|||
149022383|NCT02253316|537559097|FG002|Maintenance|Secondary Malignancy|6|||
149022384|NCT02253316|537559095|FG000|Maintenance|Adverse Event|0|||
149022385|NCT02253316|537559096|FG001|Maintenance|Adverse Event|8|||
149022386|NCT02253316|537559097|FG002|Maintenance|Adverse Event|12|||
149022387|NCT02253316|537559095|FG000|Maintenance|Still receiving active treatment|0|||
149022388|NCT02253316|537559096|FG001|Maintenance|Still receiving active treatment|4|||
149022389|NCT02253316|537559097|FG002|Maintenance|Still receiving active treatment|0|||
149022390|NCT02353832|537559098|FG000|Overall Study|Ineligible after enrollment|1|||
149022391|NCT02353832|537559098|FG000|Overall Study|Lost to Follow-up|1|||
149022416|NCT05567952|537560548|FG000|Overall Study|Lost to Follow-up|3|||
149022417|NCT05567952|537560549|FG001|Overall Study|Lost to Follow-up|2|||
149022418|NCT05567952|537560548|FG000|Overall Study|Withdrawal by Subject|6|||
149022419|NCT05567952|537560549|FG001|Overall Study|Withdrawal by Subject|3|||
149022420|NCT05567952|537560548|FG000|Overall Study|Other|3|||
149022421|NCT05567952|537560549|FG001|Overall Study|Other|1|||
149022422|NCT03280563|537560551|FG000|Stage 1|Death|2|||
149022423|NCT03280563|537560552|FG001|Stage 1|Death|1|||
149022424|NCT03280563|537560553|FG002|Stage 1|Death|0|||
149022425|NCT03280563|537560554|FG003|Stage 1|Death|0|||
149022426|NCT03280563|537560555|FG004|Stage 1|Death|0|||
149022427|NCT03280563|537560556|FG005|Stage 1|Death|3|||
149022428|NCT03280563|537560557|FG006|Stage 1|Death|0|||
149022429|NCT03280563|537560558|FG007|Stage 1|Death|0|||
149022430|NCT03280563|537560559|FG008|Stage 1|Death|0|||
149022431|NCT03280563|537560551|FG000|Stage 1|Study Ended by Sponsor|0|||
149022432|NCT03280563|537560552|FG001|Stage 1|Study Ended by Sponsor|0|||
149022433|NCT03280563|537560553|FG002|Stage 1|Study Ended by Sponsor|1|||
149022434|NCT03280563|537560554|FG003|Stage 1|Study Ended by Sponsor|0|||
149022435|NCT03280563|537560555|FG004|Stage 1|Study Ended by Sponsor|0|||
149022436|NCT03280563|537560556|FG005|Stage 1|Study Ended by Sponsor|1|||
149022437|NCT03280563|537560557|FG006|Stage 1|Study Ended by Sponsor|0|||
149022438|NCT03280563|537560558|FG007|Stage 1|Study Ended by Sponsor|0|||
149022439|NCT03280563|537560559|FG008|Stage 1|Study Ended by Sponsor|0|||
149022440|NCT03280563|537560551|FG000|Stage 1|Withdrawal by Subject|5|||
149022441|NCT03280563|537560552|FG001|Stage 1|Withdrawal by Subject|1|||
149022442|NCT03280563|537560553|FG002|Stage 1|Withdrawal by Subject|2|||
149022443|NCT03280563|537560554|FG003|Stage 1|Withdrawal by Subject|0|||
149022444|NCT03280563|537560555|FG004|Stage 1|Withdrawal by Subject|0|||
149022445|NCT03280563|537560556|FG005|Stage 1|Withdrawal by Subject|2|||
149022446|NCT03280563|537560557|FG006|Stage 1|Withdrawal by Subject|0|||
149022447|NCT03280563|537560558|FG007|Stage 1|Withdrawal by Subject|0|||
149022448|NCT03280563|537560559|FG008|Stage 1|Withdrawal by Subject|0|||
149022449|NCT03280563|537560551|FG000|Stage 1|Reason Not Specified|0|||
149022450|NCT03280563|537560552|FG001|Stage 1|Reason Not Specified|0|||
149022451|NCT03280563|537560553|FG002|Stage 1|Reason Not Specified|0|||
149022452|NCT03280563|537560554|FG003|Stage 1|Reason Not Specified|0|||
149022453|NCT03280563|537560555|FG004|Stage 1|Reason Not Specified|0|||
149022454|NCT03280563|537560556|FG005|Stage 1|Reason Not Specified|1|||
149022455|NCT03280563|537560557|FG006|Stage 1|Reason Not Specified|0|||
149022456|NCT03280563|537560558|FG007|Stage 1|Reason Not Specified|0|||
149022457|NCT03280563|537560559|FG008|Stage 1|Reason Not Specified|0|||
149022458|NCT03280563|537560551|FG000|Stage 1|Physician Decision|0|||
149022459|NCT03280563|537560552|FG001|Stage 1|Physician Decision|1|||
149022460|NCT03280563|537560553|FG002|Stage 1|Physician Decision|0|||
149022461|NCT03280563|537560554|FG003|Stage 1|Physician Decision|0|||
149022462|NCT03280563|537560555|FG004|Stage 1|Physician Decision|0|||
149022463|NCT03280563|537560556|FG005|Stage 1|Physician Decision|0|||
149022464|NCT03280563|537560557|FG006|Stage 1|Physician Decision|0|||
149022465|NCT03280563|537560558|FG007|Stage 1|Physician Decision|0|||
149022466|NCT03280563|537560559|FG008|Stage 1|Physician Decision|0|||
149022467|NCT03280563|537560551|FG000|Stage 2|Death|0|||
149022468|NCT03280563|537560552|FG001|Stage 2|Death|0|||
149022469|NCT03280563|537560553|FG002|Stage 2|Death|0|||
149022470|NCT03280563|537560554|FG003|Stage 2|Death|0|||
149022471|NCT03280563|537560555|FG004|Stage 2|Death|0|||
149022472|NCT03280563|537560556|FG005|Stage 2|Death|0|||
149022473|NCT03280563|537560557|FG006|Stage 2|Death|0|||
149022474|NCT03280563|537560558|FG007|Stage 2|Death|1|||
149022475|NCT03280563|537560559|FG008|Stage 2|Death|0|||
149022476|NCT03280563|537560551|FG000|Stage 2|Progressive Disease|0|||
149022477|NCT03280563|537560552|FG001|Stage 2|Progressive Disease|0|||
149022478|NCT03280563|537560553|FG002|Stage 2|Progressive Disease|0|||
148691980|NCT03384745|536345994|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
148691981|NCT03384745|536345995|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
148958395|NCT01698801|537331307|FG000|Treatment Phase|Protocol Violation|1|||
148958396|NCT01698801|537331307|FG000|Treatment Phase|Other|4|||
148958397|NCT01698801|537331307|FG000|Treatment Phase|Withdrawal by Subject|1|||
148958398|NCT01698801|537331307|FG000|Treatment Phase|Disease progression|1|||
148958399|NCT01698801|537331307|FG000|Follow Up Phase|Withdrawal by Subject|1|||
148958400|NCT01698801|537331307|FG000|Follow Up Phase|Death|4|||
148958401|NCT02625259|537331310|FG000|First Intervention (Day 1)|Other|0|||
148958402|NCT02625259|537331311|FG001|First Intervention (Day 1)|Other|0|||
148958403|NCT02625259|537331312|FG002|First Intervention (Day 1)|Other|1|||
148958404|NCT02625259|537331313|FG003|First Intervention (Day 1)|Other|0|||
148958405|NCT02625259|537331314|FG004|First Intervention (Day 1)|Other|0|||
148958406|NCT02625259|537331310|FG000|First Intervention (Day 1)|Adverse Event|2|||
148958407|NCT02625259|537331311|FG001|First Intervention (Day 1)|Adverse Event|1|||
148958408|NCT02625259|537331312|FG002|First Intervention (Day 1)|Adverse Event|0|||
148958409|NCT02625259|537331313|FG003|First Intervention (Day 1)|Adverse Event|0|||
148958410|NCT02625259|537331314|FG004|First Intervention (Day 1)|Adverse Event|0|||
148958411|NCT02625259|537331310|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
148958412|NCT02625259|537331311|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
148958413|NCT02625259|537331312|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
148958414|NCT02625259|537331313|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
148958415|NCT02625259|537331314|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
148958416|NCT02998840|537331318|FG000|Overall Study|Lost to Follow-up|1|||
148958417|NCT02998840|537331319|FG001|Overall Study|Lost to Follow-up|1|||
148958418|NCT02998840|537331320|FG002|Overall Study|Lost to Follow-up|2|||
148958419|NCT02998840|537331321|FG003|Overall Study|Lost to Follow-up|3|||
148958420|NCT02998840|537331318|FG000|Overall Study|Withdrawal by Subject|1|||
148958421|NCT02998840|537331319|FG001|Overall Study|Withdrawal by Subject|1|||
148958422|NCT02998840|537331320|FG002|Overall Study|Withdrawal by Subject|0|||
148958423|NCT02998840|537331321|FG003|Overall Study|Withdrawal by Subject|1|||
148958424|NCT02998840|537331318|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
148958425|NCT02998840|537331319|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
148958426|NCT02998840|537331320|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
148958427|NCT02998840|537331321|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
148958428|NCT00665847|537331322|FG000|Overall Study|Adverse Event|8|||
148958429|NCT00665847|537331322|FG000|Overall Study|Withdrawal by Subject|2|||
148958430|NCT00665847|537331322|FG000|Overall Study|Subject non-compliant|8|||
148958431|NCT00665847|537331322|FG000|Overall Study|Subject reached a virologic endpoint|4|||
148958432|NCT00665847|537331322|FG000|Overall Study|Resistance to TMC125|1|||
148958433|NCT00665847|537331322|FG000|Overall Study|Subject ineligible to continue the trial|1|||
148958434|NCT00665847|537331322|FG000|Overall Study|Switch to Commercial Medication|1|||
148958435|NCT01686633|537331323|FG000|Overall Study|Lack of Efficacy|33|||
148958436|NCT01686633|537331324|FG001|Overall Study|Lack of Efficacy|13|||
148958437|NCT01686633|537331325|FG002|Overall Study|Lack of Efficacy|11|||
148958438|NCT01686633|537331323|FG000|Overall Study|Withdrawal by Subject|8|||
148958439|NCT01686633|537331324|FG001|Overall Study|Withdrawal by Subject|8|||
149022479|NCT03280563|537560554|FG003|Stage 2|Progressive Disease|0|||
149022480|NCT03280563|537560555|FG004|Stage 2|Progressive Disease|0|||
149022481|NCT03280563|537560556|FG005|Stage 2|Progressive Disease|0|||
148958440|NCT01686633|537331325|FG002|Overall Study|Withdrawal by Subject|5|||
148958441|NCT01686633|537331323|FG000|Overall Study|Physician Decision|3|||
148958442|NCT01686633|537331324|FG001|Overall Study|Physician Decision|4|||
148958443|NCT01686633|537331325|FG002|Overall Study|Physician Decision|4|||
148958444|NCT01686633|537331323|FG000|Overall Study|Adverse Event|4|||
148958445|NCT01686633|537331324|FG001|Overall Study|Adverse Event|3|||
148958446|NCT01686633|537331325|FG002|Overall Study|Adverse Event|3|||
149022482|NCT03280563|537560557|FG006|Stage 2|Progressive Disease|2|||
149022483|NCT03280563|537560558|FG007|Stage 2|Progressive Disease|0|||
149022484|NCT03280563|537560559|FG008|Stage 2|Progressive Disease|0|||
149022485|NCT03280563|537560551|FG000|Long-term Survival Follow-up|Death|10|||
149022486|NCT03280563|537560552|FG001|Long-term Survival Follow-up|Death|14|||
149022487|NCT03280563|537560553|FG002|Long-term Survival Follow-up|Death|15|||
149022488|NCT03280563|537560554|FG003|Long-term Survival Follow-up|Death|3|||
149022489|NCT03280563|537560555|FG004|Long-term Survival Follow-up|Death|6|||
149022490|NCT03280563|537560556|FG005|Long-term Survival Follow-up|Death|18|||
149022491|NCT03280563|537560557|FG006|Long-term Survival Follow-up|Death|11|||
149022492|NCT03280563|537560558|FG007|Long-term Survival Follow-up|Death|1|||
149022493|NCT03280563|537560559|FG008|Long-term Survival Follow-up|Death|3|||
149022494|NCT03280563|537560551|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
149022495|NCT03280563|537560552|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
149022496|NCT03280563|537560553|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
149022497|NCT03280563|537560554|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
149022498|NCT03280563|537560555|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
149022499|NCT03280563|537560556|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
149022500|NCT03280563|537560557|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
149022501|NCT03280563|537560558|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
149022502|NCT03280563|537560559|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
149022503|NCT03280563|537560551|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
149022504|NCT03280563|537560552|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
149022505|NCT03280563|537560553|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
149022506|NCT03280563|537560554|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
149022507|NCT03280563|537560555|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
149022508|NCT03280563|537560556|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
149022509|NCT03280563|537560557|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
149022510|NCT03280563|537560558|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
149022511|NCT03280563|537560559|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
149022512|NCT03280563|537560551|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
149022513|NCT03280563|537560552|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
149022514|NCT03280563|537560553|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
149022515|NCT03280563|537560554|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
149022516|NCT03280563|537560555|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
149022517|NCT03280563|537560556|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
149022518|NCT03280563|537560557|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
149022519|NCT03280563|537560558|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
149022520|NCT03280563|537560559|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
149022521|NCT04213846|537560560|FG000|Overall Study|Withdrawal by Subject|7|||
149022522|NCT04213846|537560561|FG001|Overall Study|Withdrawal by Subject|6|||
149022523|NCT04213846|537560560|FG000|Overall Study|Lost to Follow-up|15|||
149022524|NCT04213846|537560561|FG001|Overall Study|Lost to Follow-up|21|||
149022525|NCT00802841|537560564|FG000|Overall Study|Administrative problems|1|||
148691982|NCT03384745|536345996|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
148691983|NCT03384745|536345991|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
148691984|NCT03384745|536345992|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
148691985|NCT03384745|536345993|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
148691986|NCT03384745|536345994|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
148691987|NCT03384745|536345995|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
148691988|NCT03384745|536345996|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
148691989|NCT03384745|536345991|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
148958447|NCT01686633|537331323|FG000|Overall Study|Protocol Violation|2|||
148958448|NCT01686633|537331324|FG001|Overall Study|Protocol Violation|3|||
148958449|NCT01686633|537331325|FG002|Overall Study|Protocol Violation|0|||
148958450|NCT01686633|537331323|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
148958451|NCT01686633|537331324|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
149022526|NCT00802841|537560565|FG001|Overall Study|Administrative problems|0|||
149022527|NCT00802841|537560564|FG000|Overall Study|Lost to Follow-up|2|||
149022528|NCT00802841|537560565|FG001|Overall Study|Lost to Follow-up|1|||
148691990|NCT03384745|536345992|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
148811691|NCT03765073|536787087|FG016|Stage 2|Withdrawal by parent/guardian|3|||
148811692|NCT03765073|536787088|FG017|Stage 2|Withdrawal by parent/guardian|0|||
148811693|NCT03765073|536787089|FG018|Stage 2|Withdrawal by parent/guardian|0|||
148958452|NCT01686633|537331325|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
149022529|NCT00802841|537560564|FG000|Overall Study|Death|1|||
149022530|NCT00802841|537560565|FG001|Overall Study|Death|2|||
149022531|NCT00802841|537560564|FG000|Overall Study|Adverse Event|8|||
149022532|NCT00802841|537560565|FG001|Overall Study|Adverse Event|2|||
148958453|NCT01686633|537331323|FG000|Overall Study|Lost to Follow-up|0|||
148958454|NCT01686633|537331324|FG001|Overall Study|Lost to Follow-up|1|||
148958455|NCT01686633|537331325|FG002|Overall Study|Lost to Follow-up|1|||
148691991|NCT03384745|536345993|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
148691992|NCT03384745|536345994|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
148691993|NCT03384745|536345995|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
148691994|NCT03384745|536345996|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
148691995|NCT03384745|536345991|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
148691996|NCT03384745|536345992|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
148691997|NCT03384745|536345993|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
148691998|NCT03384745|536345994|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
148691999|NCT03384745|536345995|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
148692000|NCT03384745|536345996|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
148692001|NCT03384745|536345991|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
148692002|NCT03384745|536345992|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
148692003|NCT03384745|536345993|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
148692004|NCT03384745|536345994|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
148692005|NCT03384745|536345995|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
148692006|NCT03384745|536345996|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
148692007|NCT03384745|536345991|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
148692008|NCT03384745|536345992|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
148692009|NCT03384745|536345993|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
148692010|NCT03384745|536345994|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
148692011|NCT03384745|536345995|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
148692012|NCT03384745|536345996|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
148692013|NCT03384745|536345991|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
148692014|NCT03384745|536345992|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
148692015|NCT03384745|536345993|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
148692016|NCT03384745|536345994|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
148692017|NCT03384745|536345995|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
148692018|NCT03384745|536345996|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
148692019|NCT02708277|536345999|FG000|Overall Study|Lost to Follow-up|7|||
148692020|NCT02708277|536346000|FG001|Overall Study|Lost to Follow-up|4|||
148692021|NCT01058421|536346001|FG000|1 Month Outcomes|Death|10|||
148692022|NCT01058421|536346002|FG001|1 Month Outcomes|Death|6|||
148692023|NCT01058421|536346001|FG000|1 Month Outcomes|Lost to Follow-up|8|||
148692024|NCT01058421|536346002|FG001|1 Month Outcomes|Lost to Follow-up|7|||
148692025|NCT01058421|536346001|FG000|1 Month Outcomes|Remained in Hospital|5|||
148692026|NCT01058421|536346002|FG001|1 Month Outcomes|Remained in Hospital|12|||
148692027|NCT01058421|536346001|FG000|1 Month Outcomes|Remained in Other Facility|16|||
148692028|NCT01058421|536346002|FG001|1 Month Outcomes|Remained in Other Facility|17|||
148692029|NCT01058421|536346001|FG000|3 Month Outcomes|Death|3|||
148958456|NCT00511667|537331331|FG000|Overall Study|Adverse Event|1|||
148958457|NCT00511667|537331332|FG001|Overall Study|Adverse Event|0|||
148958458|NCT00511667|537331331|FG000|Overall Study|Protocol Violation|1|||
148958459|NCT00511667|537331332|FG001|Overall Study|Protocol Violation|1|||
148958460|NCT00511667|537331331|FG000|Overall Study|Withdrawal by Subject|2|||
148958461|NCT00511667|537331332|FG001|Overall Study|Withdrawal by Subject|0|||
148958462|NCT00511667|537331331|FG000|Overall Study|Site terminated|6|||
148958463|NCT00511667|537331332|FG001|Overall Study|Site terminated|1|||
148958464|NCT00511667|537331331|FG000|Overall Study|Other|2|||
148958465|NCT00511667|537331332|FG001|Overall Study|Other|1|||
148958466|NCT03605303|537331333|FG000|Period 1|Study Terminated|2|||
148958467|NCT03605303|537331334|FG001|Period 1|Study Terminated|1|||
148958468|NCT04702997|537331335|FG000|Overall Study|Withdrawal by Subject|1|||
148958469|NCT04702997|537331336|FG001|Overall Study|Withdrawal by Subject|1|||
148958470|NCT01386554|537331337|FG000|Overall Study|Lost to Follow-up|0|||
148958471|NCT01386554|537331338|FG001|Overall Study|Lost to Follow-up|0|||
148958472|NCT01386554|537331339|FG002|Overall Study|Lost to Follow-up|1|||
148958473|NCT01386554|537331337|FG000|Overall Study|Adverse Event|2|||
148958474|NCT01386554|537331338|FG001|Overall Study|Adverse Event|5|||
148958475|NCT01386554|537331339|FG002|Overall Study|Adverse Event|2|||
148958476|NCT01386554|537331337|FG000|Overall Study|Progressive disease|1|||
148958477|NCT01386554|537331338|FG001|Overall Study|Progressive disease|2|||
148958478|NCT01386554|537331339|FG002|Overall Study|Progressive disease|2|||
148958479|NCT01386554|537331337|FG000|Overall Study|Administration of live vaccines|0|||
148958480|NCT01386554|537331338|FG001|Overall Study|Administration of live vaccines|1|||
148958481|NCT01386554|537331339|FG002|Overall Study|Administration of live vaccines|0|||
148958482|NCT01386554|537331337|FG000|Overall Study|Investigator discretion|0|||
148958483|NCT01386554|537331338|FG001|Overall Study|Investigator discretion|0|||
148958484|NCT01386554|537331339|FG002|Overall Study|Investigator discretion|1|||
148958485|NCT01386554|537331337|FG000|Overall Study|Reason not collected|0|||
148958486|NCT01386554|537331338|FG001|Overall Study|Reason not collected|1|||
148958487|NCT01386554|537331339|FG002|Overall Study|Reason not collected|0|||
148958488|NCT02759471|537331340|FG000|Overall Study|discomfort|2|||
148958489|NCT02554812|537331341|FG000|Overall Study|Adverse Event|2|||
148958490|NCT02554812|537331342|FG001|Overall Study|Adverse Event|5|||
148692030|NCT01058421|536346002|FG001|3 Month Outcomes|Death|5|||
148692031|NCT01058421|536346001|FG000|3 Month Outcomes|Lost to Follow-up|12|||
148692032|NCT01058421|536346002|FG001|3 Month Outcomes|Lost to Follow-up|11|||
148692033|NCT01058421|536346001|FG000|3 Month Outcomes|Remained in Hospital|0|||
148692034|NCT01058421|536346002|FG001|3 Month Outcomes|Remained in Hospital|2|||
148692035|NCT01058421|536346001|FG000|3 Month Outcomes|Remained in Other Facility|5|||
148692036|NCT01058421|536346002|FG001|3 Month Outcomes|Remained in Other Facility|8|||
148692037|NCT01058421|536346001|FG000|6 Month Outcomes|Death|2|||
148692038|NCT01058421|536346002|FG001|6 Month Outcomes|Death|2|||
148692039|NCT01058421|536346001|FG000|6 Month Outcomes|Lost to Follow-up|16|||
148692040|NCT01058421|536346002|FG001|6 Month Outcomes|Lost to Follow-up|21|||
148692041|NCT01058421|536346001|FG000|6 Month Outcomes|Remained in Other Facility|1|||
148692042|NCT01058421|536346002|FG001|6 Month Outcomes|Remained in Other Facility|3|||
148692043|NCT02984683|536346005|FG000|Overall Study|Adverse Event|3|||
148692044|NCT02984683|536346006|FG001|Overall Study|Adverse Event|3|||
148692045|NCT02984683|536346005|FG000|Overall Study|Withdrawal by Subject|1|||
148692046|NCT02984683|536346006|FG001|Overall Study|Withdrawal by Subject|0|||
148692047|NCT02984683|536346005|FG000|Overall Study|Disease progression|7|||
148692048|NCT02984683|536346006|FG001|Overall Study|Disease progression|9|||
148692049|NCT01592370|536346007|FG000|Overall Study|Disease Progression|62|||
148692050|NCT01592370|536346008|FG001|Overall Study|Disease Progression|16|||
148692051|NCT01592370|536346009|FG002|Overall Study|Disease Progression|52|||
148692052|NCT01592370|536346010|FG003|Overall Study|Disease Progression|3|||
148692053|NCT01592370|536346011|FG004|Overall Study|Disease Progression|3|||
148692054|NCT01592370|536346012|FG005|Overall Study|Disease Progression|31|||
148692055|NCT01592370|536346013|FG006|Overall Study|Disease Progression|14|||
148692056|NCT01592370|536346007|FG000|Overall Study|Study Drug Toxicity|14|||
148692057|NCT01592370|536346008|FG001|Overall Study|Study Drug Toxicity|3|||
148692058|NCT01592370|536346009|FG002|Overall Study|Study Drug Toxicity|0|||
148692059|NCT01592370|536346010|FG003|Overall Study|Study Drug Toxicity|0|||
148692060|NCT01592370|536346011|FG004|Overall Study|Study Drug Toxicity|0|||
148692061|NCT01592370|536346012|FG005|Overall Study|Study Drug Toxicity|0|||
148692062|NCT01592370|536346013|FG006|Overall Study|Study Drug Toxicity|1|||
148692063|NCT01592370|536346007|FG000|Overall Study|AE unrelated to study drug|4|||
148692064|NCT01592370|536346008|FG001|Overall Study|AE unrelated to study drug|3|||
148692065|NCT01592370|536346009|FG002|Overall Study|AE unrelated to study drug|0|||
148692066|NCT01592370|536346010|FG003|Overall Study|AE unrelated to study drug|0|||
148692067|NCT01592370|536346011|FG004|Overall Study|AE unrelated to study drug|0|||
148692068|NCT01592370|536346012|FG005|Overall Study|AE unrelated to study drug|0|||
148692069|NCT01592370|536346013|FG006|Overall Study|AE unrelated to study drug|1|||
148692070|NCT01592370|536346007|FG000|Overall Study|Request to discontinue study treatment|5|||
148692071|NCT01592370|536346008|FG001|Overall Study|Request to discontinue study treatment|0|||
148692072|NCT01592370|536346009|FG002|Overall Study|Request to discontinue study treatment|2|||
148692073|NCT01592370|536346010|FG003|Overall Study|Request to discontinue study treatment|0|||
148692074|NCT01592370|536346011|FG004|Overall Study|Request to discontinue study treatment|1|||
148692075|NCT01592370|536346012|FG005|Overall Study|Request to discontinue study treatment|2|||
148692076|NCT01592370|536346013|FG006|Overall Study|Request to discontinue study treatment|0|||
148692077|NCT01592370|536346007|FG000|Overall Study|Withdrew consent|1|||
148692078|NCT01592370|536346008|FG001|Overall Study|Withdrew consent|2|||
148958491|NCT02554812|537331343|FG002|Overall Study|Adverse Event|3|||
148958492|NCT02554812|537331344|FG003|Overall Study|Adverse Event|0|||
148958493|NCT02554812|537331345|FG004|Overall Study|Adverse Event|5|||
148958494|NCT02554812|537331346|FG005|Overall Study|Adverse Event|0|||
148958495|NCT02554812|537331347|FG006|Overall Study|Adverse Event|1|||
148958496|NCT02554812|537331348|FG007|Overall Study|Adverse Event|6|||
148958497|NCT02554812|537331349|FG008|Overall Study|Adverse Event|2|||
148958498|NCT02554812|537331350|FG009|Overall Study|Adverse Event|2|||
148958499|NCT02554812|537331351|FG010|Overall Study|Adverse Event|1|||
148958500|NCT02554812|537331352|FG011|Overall Study|Adverse Event|2|||
148958501|NCT02554812|537331353|FG012|Overall Study|Adverse Event|0|||
148958502|NCT02554812|537331354|FG013|Overall Study|Adverse Event|3|||
148958503|NCT02554812|537331355|FG014|Overall Study|Adverse Event|2|||
148958504|NCT02554812|537331356|FG015|Overall Study|Adverse Event|1|||
148958505|NCT02554812|537331357|FG016|Overall Study|Adverse Event|0|||
148692079|NCT01592370|536346009|FG002|Overall Study|Withdrew consent|1|||
148692080|NCT01592370|536346010|FG003|Overall Study|Withdrew consent|1|||
148692081|NCT01592370|536346011|FG004|Overall Study|Withdrew consent|0|||
148692082|NCT01592370|536346012|FG005|Overall Study|Withdrew consent|0|||
148692083|NCT01592370|536346013|FG006|Overall Study|Withdrew consent|0|||
148692084|NCT01592370|536346007|FG000|Overall Study|Maximum clinical benefit|11|||
148692085|NCT01592370|536346008|FG001|Overall Study|Maximum clinical benefit|1|||
148692086|NCT01592370|536346009|FG002|Overall Study|Maximum clinical benefit|7|||
148692087|NCT01592370|536346010|FG003|Overall Study|Maximum clinical benefit|1|||
148692088|NCT01592370|536346011|FG004|Overall Study|Maximum clinical benefit|0|||
148958506|NCT02554812|537331358|FG017|Overall Study|Adverse Event|1|||
148958507|NCT02554812|537331359|FG018|Overall Study|Adverse Event|0|||
148958508|NCT02554812|537331360|FG019|Overall Study|Adverse Event|0|||
148958509|NCT02554812|537331361|FG020|Overall Study|Adverse Event|0|||
148958510|NCT02554812|537331362|FG021|Overall Study|Adverse Event|2|||
148958511|NCT02554812|537331363|FG022|Overall Study|Adverse Event|1|||
148958512|NCT02554812|537331364|FG023|Overall Study|Adverse Event|1|||
148958513|NCT02554812|537331365|FG024|Overall Study|Adverse Event|1|||
148958514|NCT02554812|537331366|FG025|Overall Study|Adverse Event|2|||
148958515|NCT02554812|537331367|FG026|Overall Study|Adverse Event|1|||
148958516|NCT02554812|537331341|FG000|Overall Study|Death|1|||
148958517|NCT02554812|537331342|FG001|Overall Study|Death|2|||
148958518|NCT02554812|537331343|FG002|Overall Study|Death|2|||
148958519|NCT02554812|537331344|FG003|Overall Study|Death|2|||
148958520|NCT02554812|537331345|FG004|Overall Study|Death|0|||
148958521|NCT02554812|537331346|FG005|Overall Study|Death|1|||
148958522|NCT02554812|537331347|FG006|Overall Study|Death|1|||
148958523|NCT02554812|537331348|FG007|Overall Study|Death|1|||
148958524|NCT02554812|537331349|FG008|Overall Study|Death|0|||
148958525|NCT02554812|537331350|FG009|Overall Study|Death|0|||
148958526|NCT02554812|537331351|FG010|Overall Study|Death|0|||
148958527|NCT02554812|537331352|FG011|Overall Study|Death|0|||
148958528|NCT02554812|537331353|FG012|Overall Study|Death|0|||
148958529|NCT02554812|537331354|FG013|Overall Study|Death|0|||
148958530|NCT02554812|537331355|FG014|Overall Study|Death|1|||
148958531|NCT02554812|537331356|FG015|Overall Study|Death|1|||
148958532|NCT02554812|537331357|FG016|Overall Study|Death|1|||
148958533|NCT02554812|537331358|FG017|Overall Study|Death|0|||
148958534|NCT02554812|537331359|FG018|Overall Study|Death|1|||
148958535|NCT02554812|537331360|FG019|Overall Study|Death|2|||
148958536|NCT02554812|537331361|FG020|Overall Study|Death|0|||
148958537|NCT02554812|537331362|FG021|Overall Study|Death|1|||
148958538|NCT02554812|537331363|FG022|Overall Study|Death|1|||
148958539|NCT02554812|537331364|FG023|Overall Study|Death|0|||
148958540|NCT02554812|537331365|FG024|Overall Study|Death|0|||
148958541|NCT02554812|537331366|FG025|Overall Study|Death|0|||
148958542|NCT02554812|537331367|FG026|Overall Study|Death|0|||
148958543|NCT02554812|537331341|FG000|Overall Study|Lost to Follow-up|0|||
148958544|NCT02554812|537331342|FG001|Overall Study|Lost to Follow-up|1|||
148958545|NCT02554812|537331343|FG002|Overall Study|Lost to Follow-up|0|||
148958546|NCT02554812|537331344|FG003|Overall Study|Lost to Follow-up|0|||
148958547|NCT02554812|537331345|FG004|Overall Study|Lost to Follow-up|0|||
148958548|NCT02554812|537331346|FG005|Overall Study|Lost to Follow-up|0|||
148958549|NCT02554812|537331347|FG006|Overall Study|Lost to Follow-up|0|||
148958550|NCT02554812|537331348|FG007|Overall Study|Lost to Follow-up|0|||
148958551|NCT02554812|537331349|FG008|Overall Study|Lost to Follow-up|0|||
148958552|NCT02554812|537331350|FG009|Overall Study|Lost to Follow-up|0|||
148958553|NCT02554812|537331351|FG010|Overall Study|Lost to Follow-up|0|||
148958554|NCT02554812|537331352|FG011|Overall Study|Lost to Follow-up|0|||
148958555|NCT02554812|537331353|FG012|Overall Study|Lost to Follow-up|0|||
148958556|NCT02554812|537331354|FG013|Overall Study|Lost to Follow-up|0|||
148958557|NCT02554812|537331355|FG014|Overall Study|Lost to Follow-up|0|||
148958558|NCT02554812|537331356|FG015|Overall Study|Lost to Follow-up|0|||
148958559|NCT02554812|537331357|FG016|Overall Study|Lost to Follow-up|0|||
148958560|NCT02554812|537331358|FG017|Overall Study|Lost to Follow-up|0|||
148958561|NCT02554812|537331359|FG018|Overall Study|Lost to Follow-up|0|||
148958562|NCT02554812|537331360|FG019|Overall Study|Lost to Follow-up|0|||
148958563|NCT02554812|537331361|FG020|Overall Study|Lost to Follow-up|0|||
148958564|NCT02554812|537331362|FG021|Overall Study|Lost to Follow-up|0|||
148958565|NCT02554812|537331363|FG022|Overall Study|Lost to Follow-up|0|||
148958566|NCT02554812|537331364|FG023|Overall Study|Lost to Follow-up|0|||
148958567|NCT02554812|537331365|FG024|Overall Study|Lost to Follow-up|0|||
148958568|NCT02554812|537331366|FG025|Overall Study|Lost to Follow-up|0|||
148958569|NCT02554812|537331367|FG026|Overall Study|Lost to Follow-up|0|||
148958570|NCT02554812|537331341|FG000|Overall Study|Global deterioration of health status|4|||
148958571|NCT02554812|537331342|FG001|Overall Study|Global deterioration of health status|3|||
148958572|NCT02554812|537331343|FG002|Overall Study|Global deterioration of health status|3|||
148958573|NCT02554812|537331344|FG003|Overall Study|Global deterioration of health status|2|||
148958574|NCT02554812|537331345|FG004|Overall Study|Global deterioration of health status|5|||
148958575|NCT02554812|537331346|FG005|Overall Study|Global deterioration of health status|0|||
148958576|NCT02554812|537331347|FG006|Overall Study|Global deterioration of health status|2|||
148958577|NCT02554812|537331348|FG007|Overall Study|Global deterioration of health status|1|||
148958578|NCT02554812|537331349|FG008|Overall Study|Global deterioration of health status|1|||
148811694|NCT03765073|536787090|FG019|Stage 2|Withdrawal by parent/guardian|0|||
148958579|NCT02554812|537331350|FG009|Overall Study|Global deterioration of health status|1|||
148958580|NCT02554812|537331351|FG010|Overall Study|Global deterioration of health status|2|||
148958581|NCT02554812|537331352|FG011|Overall Study|Global deterioration of health status|1|||
148958582|NCT02554812|537331353|FG012|Overall Study|Global deterioration of health status|0|||
148958583|NCT02554812|537331354|FG013|Overall Study|Global deterioration of health status|0|||
148811695|NCT03765073|536787091|FG020|Stage 2|Withdrawal by parent/guardian|0|||
148958584|NCT02554812|537331355|FG014|Overall Study|Global deterioration of health status|0|||
148958585|NCT02554812|537331356|FG015|Overall Study|Global deterioration of health status|1|||
148958586|NCT02554812|537331357|FG016|Overall Study|Global deterioration of health status|0|||
149022533|NCT00802841|537560564|FG000|Overall Study|Disease progression|7|||
149022534|NCT00802841|537560565|FG001|Overall Study|Disease progression|3|||
149022535|NCT00802841|537560564|FG000|Overall Study|Withdrawal by Subject|9|||
149022536|NCT00802841|537560565|FG001|Overall Study|Withdrawal by Subject|5|||
149022537|NCT00802841|537560564|FG000|Overall Study|Protocol deviation|2|||
149022538|NCT00802841|537560565|FG001|Overall Study|Protocol deviation|6|||
149022539|NCT00802841|537560564|FG000|Overall Study|Treatment duration completed|66|||
149022540|NCT00802841|537560565|FG001|Overall Study|Treatment duration completed|76|||
149022541|NCT04096365|537560568|FG000|Overall Study|Adverse Event|1|||
149022542|NCT05310084|537560571|FG000|Overall Study|Withdrawal by Subject|2|||
149022543|NCT05310084|537560572|FG001|Overall Study|Withdrawal by Subject|3|||
149022544|NCT05310084|537560571|FG000|Overall Study|Participant availability|0|||
149022545|NCT05310084|537560572|FG001|Overall Study|Participant availability|4|||
149022546|NCT05310084|537560571|FG000|Overall Study|Lost to Follow-up|1|||
149022547|NCT05310084|537560572|FG001|Overall Study|Lost to Follow-up|1|||
149022548|NCT05310084|537560571|FG000|Overall Study|Adverse Event|1|||
149022549|NCT05310084|537560572|FG001|Overall Study|Adverse Event|1|||
149022550|NCT05310084|537560571|FG000|Overall Study|Randomized but not vaccinated|4|||
149022551|NCT05310084|537560572|FG001|Overall Study|Randomized but not vaccinated|2|||
149022552|NCT02065245|537560574|FG000|Infusion 1|Lost to Follow-up|0|||
149022553|NCT02065245|537560575|FG001|Infusion 1|Lost to Follow-up|0|||
149022554|NCT02065245|537560576|FG002|Infusion 1|Lost to Follow-up|0|||
149022555|NCT02065245|537560577|FG003|Infusion 1|Lost to Follow-up|0|||
149022556|NCT02065245|537560578|FG004|Infusion 1|Lost to Follow-up|0|||
149022557|NCT02065245|537560579|FG005|Infusion 1|Lost to Follow-up|0|||
149022558|NCT02065245|537560580|FG006|Infusion 1|Lost to Follow-up|1|||
149022559|NCT02065245|537560574|FG000|Infusion 1|Death|0|||
149022560|NCT02065245|537560575|FG001|Infusion 1|Death|0|||
149022561|NCT02065245|537560576|FG002|Infusion 1|Death|1|||
149022562|NCT02065245|537560577|FG003|Infusion 1|Death|0|||
149022563|NCT02065245|537560578|FG004|Infusion 1|Death|1|||
149022564|NCT02065245|537560579|FG005|Infusion 1|Death|0|||
149022565|NCT02065245|537560580|FG006|Infusion 1|Death|0|||
149022566|NCT02065245|537560574|FG000|Infusion 2|Death|0|||
149022567|NCT02065245|537560575|FG001|Infusion 2|Death|0|||
149022568|NCT02065245|537560576|FG002|Infusion 2|Death|0|||
149022569|NCT02065245|537560577|FG003|Infusion 2|Death|0|||
149022570|NCT02065245|537560578|FG004|Infusion 2|Death|0|||
149022571|NCT02065245|537560579|FG005|Infusion 2|Death|0|||
149022572|NCT02065245|537560580|FG006|Infusion 2|Death|1|||
149022573|NCT02065245|537560574|FG000|Infusion 3|Lost to Follow-up|1|||
149022574|NCT02065245|537560575|FG001|Infusion 3|Lost to Follow-up|1|||
149022575|NCT02065245|537560576|FG002|Infusion 3|Lost to Follow-up|0|||
149022576|NCT02065245|537560577|FG003|Infusion 3|Lost to Follow-up|0|||
149022577|NCT02065245|537560578|FG004|Infusion 3|Lost to Follow-up|0|||
149022578|NCT02065245|537560579|FG005|Infusion 3|Lost to Follow-up|0|||
149022579|NCT02065245|537560580|FG006|Infusion 3|Lost to Follow-up|0|||
149022580|NCT01518257|537560581|FG000|Overall Study|Lost to Follow-up|1|||
149022581|NCT01518257|537560582|FG001|Overall Study|Lost to Follow-up|0|||
149022582|NCT01518257|537560581|FG000|Overall Study|Other Miscellaneous Reason|1|||
149022583|NCT01518257|537560582|FG001|Overall Study|Other Miscellaneous Reason|0|||
149022584|NCT02107274|537560583|FG000|Treatment vs. Placebo|Adverse Event|3|||
149022585|NCT02107274|537560584|FG001|Treatment vs. Placebo|Adverse Event|0|||
149022586|NCT02107274|537560583|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
149022587|NCT02107274|537560584|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
149022588|NCT02107274|537560583|FG000|Control Phase|Lost to Follow-up|1|||
149022589|NCT02107274|537560584|FG001|Control Phase|Lost to Follow-up|1|||
149022590|NCT02107274|537560583|FG000|Control Phase|Death|2|||
149022591|NCT02107274|537560584|FG001|Control Phase|Death|0|||
149022592|NCT02107274|537560583|FG000|Control Phase|Adverse Event|0|||
149022593|NCT02107274|537560584|FG001|Control Phase|Adverse Event|1|||
149022594|NCT03158948|537560588|FG000|Overall Study|Death|1|||
149022595|NCT03158948|537560589|FG001|Overall Study|Death|1|||
149022596|NCT03158948|537560590|FG002|Overall Study|Death|3|||
149022597|NCT03158948|537560591|FG003|Overall Study|Death|2|||
148692089|NCT01592370|536346012|FG005|Overall Study|Maximum clinical benefit|0|||
149022598|NCT03158948|537560588|FG000|Overall Study|Physician Decision|0|||
149022599|NCT03158948|537560589|FG001|Overall Study|Physician Decision|0|||
149022600|NCT03158948|537560590|FG002|Overall Study|Physician Decision|0|||
149022601|NCT03158948|537560591|FG003|Overall Study|Physician Decision|1|||
149022602|NCT04730947|537560592|FG000|Overall Study|Withdrawal by Subject|0|||
149022603|NCT04730947|537560593|FG001|Overall Study|Withdrawal by Subject|1|||
149022604|NCT01033643|537560594|FG000|Overall Study|Withdrew Consent|0|||
149022605|NCT01033643|537560595|FG001|Overall Study|Withdrew Consent|3|||
149022606|NCT01033643|537560596|FG002|Overall Study|Withdrew Consent|0|||
149022607|NCT01033643|537560597|FG003|Overall Study|Withdrew Consent|0|||
149022608|NCT01033643|537560598|FG004|Overall Study|Withdrew Consent|0|||
149022609|NCT01033643|537560599|FG005|Overall Study|Withdrew Consent|1|||
149022610|NCT00354029|537560602|FG000|Overall Study|Protocol Violation|4|||
149022611|NCT00354029|537560603|FG001|Overall Study|Protocol Violation|2|||
149022612|NCT01021332|537560604|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
149022613|NCT01021332|537560604|FG000|Overall Study|Adverse Event|43|||
148692090|NCT01592370|536346013|FG006|Overall Study|Maximum clinical benefit|0|||
148692091|NCT01592370|536346007|FG000|Overall Study|No longer meets study criteria|1|||
148692092|NCT01592370|536346008|FG001|Overall Study|No longer meets study criteria|0|||
148692093|NCT01592370|536346009|FG002|Overall Study|No longer meets study criteria|0|||
148692094|NCT01592370|536346010|FG003|Overall Study|No longer meets study criteria|0|||
148692095|NCT01592370|536346011|FG004|Overall Study|No longer meets study criteria|0|||
148692096|NCT01592370|536346012|FG005|Overall Study|No longer meets study criteria|0|||
148692097|NCT01592370|536346013|FG006|Overall Study|No longer meets study criteria|0|||
148692098|NCT01592370|536346007|FG000|Overall Study|Other Reasons|6|||
148692099|NCT01592370|536346008|FG001|Overall Study|Other Reasons|0|||
148692100|NCT01592370|536346009|FG002|Overall Study|Other Reasons|10|||
148692101|NCT01592370|536346010|FG003|Overall Study|Other Reasons|0|||
148692102|NCT01592370|536346011|FG004|Overall Study|Other Reasons|0|||
148692103|NCT01592370|536346012|FG005|Overall Study|Other Reasons|1|||
148692104|NCT01592370|536346013|FG006|Overall Study|Other Reasons|0|||
148692105|NCT01592370|536346007|FG000|Overall Study|Not Treated|0|||
148811696|NCT03765073|536787071|FG000|Stage 2|Withdrawal by Subject|0|||
148811697|NCT03765073|536787072|FG001|Stage 2|Withdrawal by Subject|0|||
148811698|NCT03765073|536787073|FG002|Stage 2|Withdrawal by Subject|0|||
148811699|NCT03765073|536787074|FG003|Stage 2|Withdrawal by Subject|3|||
148811700|NCT03765073|536787075|FG004|Stage 2|Withdrawal by Subject|3|||
148811701|NCT03765073|536787076|FG005|Stage 2|Withdrawal by Subject|3|||
148811702|NCT03765073|536787077|FG006|Stage 2|Withdrawal by Subject|0|||
148811703|NCT03765073|536787078|FG007|Stage 2|Withdrawal by Subject|1|||
148958587|NCT02554812|537331358|FG017|Overall Study|Global deterioration of health status|0|||
148958588|NCT02554812|537331359|FG018|Overall Study|Global deterioration of health status|0|||
148958589|NCT02554812|537331360|FG019|Overall Study|Global deterioration of health status|0|||
148958590|NCT02554812|537331361|FG020|Overall Study|Global deterioration of health status|0|||
148958591|NCT02554812|537331362|FG021|Overall Study|Global deterioration of health status|0|||
148958592|NCT02554812|537331363|FG022|Overall Study|Global deterioration of health status|0|||
148958593|NCT02554812|537331364|FG023|Overall Study|Global deterioration of health status|0|||
148958594|NCT02554812|537331365|FG024|Overall Study|Global deterioration of health status|0|||
148958595|NCT02554812|537331366|FG025|Overall Study|Global deterioration of health status|0|||
148958596|NCT02554812|537331367|FG026|Overall Study|Global deterioration of health status|0|||
148958597|NCT02554812|537331341|FG000|Overall Study|Progressive disease|20|||
148958598|NCT02554812|537331342|FG001|Overall Study|Progressive disease|16|||
148958599|NCT02554812|537331343|FG002|Overall Study|Progressive disease|19|||
148958600|NCT02554812|537331344|FG003|Overall Study|Progressive disease|18|||
148958601|NCT02554812|537331345|FG004|Overall Study|Progressive disease|21|||
148958602|NCT02554812|537331346|FG005|Overall Study|Progressive disease|15|||
148958603|NCT02554812|537331347|FG006|Overall Study|Progressive disease|6|||
148958604|NCT02554812|537331348|FG007|Overall Study|Progressive disease|13|||
148958605|NCT02554812|537331349|FG008|Overall Study|Progressive disease|6|||
148958606|NCT02554812|537331350|FG009|Overall Study|Progressive disease|6|||
148958607|NCT02554812|537331351|FG010|Overall Study|Progressive disease|8|||
148958608|NCT02554812|537331352|FG011|Overall Study|Progressive disease|8|||
148958609|NCT02554812|537331353|FG012|Overall Study|Progressive disease|6|||
148958610|NCT02554812|537331354|FG013|Overall Study|Progressive disease|10|||
148958611|NCT02554812|537331355|FG014|Overall Study|Progressive disease|20|||
148958612|NCT02554812|537331356|FG015|Overall Study|Progressive disease|6|||
148958613|NCT02554812|537331357|FG016|Overall Study|Progressive disease|3|||
148958614|NCT02554812|537331358|FG017|Overall Study|Progressive disease|3|||
148958615|NCT02554812|537331359|FG018|Overall Study|Progressive disease|11|||
148958616|NCT02554812|537331360|FG019|Overall Study|Progressive disease|7|||
148958617|NCT02554812|537331361|FG020|Overall Study|Progressive disease|11|||
148958618|NCT02554812|537331362|FG021|Overall Study|Progressive disease|6|||
148958619|NCT02554812|537331363|FG022|Overall Study|Progressive disease|9|||
148958620|NCT02554812|537331364|FG023|Overall Study|Progressive disease|9|||
148958621|NCT02554812|537331365|FG024|Overall Study|Progressive disease|4|||
148958622|NCT02554812|537331366|FG025|Overall Study|Progressive disease|5|||
148958623|NCT02554812|537331367|FG026|Overall Study|Progressive disease|5|||
148958624|NCT02554812|537331341|FG000|Overall Study|Other|0|||
148958625|NCT02554812|537331342|FG001|Overall Study|Other|0|||
148958626|NCT02554812|537331343|FG002|Overall Study|Other|2|||
148958627|NCT02554812|537331344|FG003|Overall Study|Other|3|||
148692106|NCT01592370|536346008|FG001|Overall Study|Not Treated|0|||
148958628|NCT02554812|537331345|FG004|Overall Study|Other|2|||
148958629|NCT02554812|537331346|FG005|Overall Study|Other|1|||
148692107|NCT01592370|536346009|FG002|Overall Study|Not Treated|0|||
148692108|NCT01592370|536346010|FG003|Overall Study|Not Treated|0|||
148811704|NCT03765073|536787079|FG008|Stage 2|Withdrawal by Subject|0|||
148958630|NCT02554812|537331347|FG006|Overall Study|Other|0|||
148958631|NCT02554812|537331348|FG007|Overall Study|Other|0|||
148958632|NCT02554812|537331349|FG008|Overall Study|Other|1|||
148692109|NCT01592370|536346011|FG004|Overall Study|Not Treated|2|||
148811705|NCT03765073|536787080|FG009|Stage 2|Withdrawal by Subject|5|||
148958633|NCT02554812|537331350|FG009|Overall Study|Other|1|||
148958634|NCT02554812|537331351|FG010|Overall Study|Other|0|||
148958635|NCT02554812|537331352|FG011|Overall Study|Other|0|||
148692110|NCT01592370|536346012|FG005|Overall Study|Not Treated|2|||
148692111|NCT01592370|536346013|FG006|Overall Study|Not Treated|0|||
148692112|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
148692113|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
148692114|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
148692115|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
148692116|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
148692117|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
148692118|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
148692119|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
148692120|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
148692121|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
148692122|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
148692123|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
148692124|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
148692125|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
148692126|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
148692127|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
148692128|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
148692129|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
148692130|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
148692131|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
148692132|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
148692133|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
148692134|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
148692135|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
148692136|NCT00455533|536346016|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
148692137|NCT00455533|536346017|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
148692138|NCT00455533|536346018|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
148692139|NCT00455533|536346016|FG000|Period Two: Randomized Period|Death|0|||
148692140|NCT00455533|536346017|FG001|Period Two: Randomized Period|Death|0|||
148692141|NCT00455533|536346018|FG002|Period Two: Randomized Period|Death|3|||
148692142|NCT00455533|536346016|FG000|Period Two: Randomized Period|Disease Progression|0|||
148692143|NCT00455533|536346017|FG001|Period Two: Randomized Period|Disease Progression|1|||
148692144|NCT00455533|536346018|FG002|Period Two: Randomized Period|Disease Progression|1|||
148692145|NCT00455533|536346016|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
148692146|NCT00455533|536346017|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
148692147|NCT00455533|536346018|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
148692148|NCT00455533|536346016|FG000|Period Two: Randomized Period|Other - need reasons|0|||
148692149|NCT00455533|536346017|FG001|Period Two: Randomized Period|Other - need reasons|1|||
148692150|NCT00455533|536346018|FG002|Period Two: Randomized Period|Other - need reasons|0|||
148692151|NCT00455533|536346016|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
148692152|NCT00455533|536346017|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
148692153|NCT00455533|536346018|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
148692154|NCT00455533|536346016|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
148692155|NCT00455533|536346017|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
148692156|NCT00455533|536346018|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
148692157|NCT02415959|536346023|FG000|Overall Study|Adverse Event|0|||
148692158|NCT02415959|536346024|FG001|Overall Study|Adverse Event|1|||
148692159|NCT02415959|536346025|FG002|Overall Study|Adverse Event|0|||
148692160|NCT02415959|536346026|FG003|Overall Study|Adverse Event|0|||
148692161|NCT02415959|536346027|FG004|Overall Study|Adverse Event|0|||
148692162|NCT02415959|536346023|FG000|Overall Study|Protocol Violation|0|||
148692163|NCT02415959|536346024|FG001|Overall Study|Protocol Violation|0|||
148692164|NCT02415959|536346025|FG002|Overall Study|Protocol Violation|0|||
148692165|NCT02415959|536346026|FG003|Overall Study|Protocol Violation|1|||
148692166|NCT02415959|536346027|FG004|Overall Study|Protocol Violation|0|||
148958636|NCT02554812|537331353|FG012|Overall Study|Other|1|||
148958637|NCT02554812|537331354|FG013|Overall Study|Other|0|||
148958638|NCT02554812|537331355|FG014|Overall Study|Other|1|||
148958639|NCT02554812|537331356|FG015|Overall Study|Other|0|||
148958640|NCT02554812|537331357|FG016|Overall Study|Other|0|||
148958641|NCT02554812|537331358|FG017|Overall Study|Other|0|||
148958642|NCT02554812|537331359|FG018|Overall Study|Other|0|||
148811706|NCT03765073|536787081|FG010|Stage 2|Withdrawal by Subject|0|||
148692167|NCT01048333|536346028|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
148811707|NCT03765073|536787082|FG011|Stage 2|Withdrawal by Subject|0|||
148811708|NCT03765073|536787083|FG012|Stage 2|Withdrawal by Subject|0|||
148958643|NCT02554812|537331360|FG019|Overall Study|Other|0|||
148958644|NCT02554812|537331361|FG020|Overall Study|Other|0|||
148958645|NCT02554812|537331362|FG021|Overall Study|Other|2|||
149022614|NCT01021332|537560604|FG000|Overall Study|Lack of Efficacy|19|||
149022615|NCT01021332|537560604|FG000|Overall Study|Withdrawal of Consent|23|||
149022616|NCT01021332|537560604|FG000|Overall Study|Lost to Follow-up|4|||
149022617|NCT01021332|537560604|FG000|Overall Study|Protocol Violation|9|||
149022618|NCT01021332|537560604|FG000|Overall Study|Miscellaneous|3|||
149022619|NCT01349907|537560615|FG000|Overall Study|Adverse Event|37|||
149022620|NCT01349907|537560616|FG001|Overall Study|Adverse Event|11|||
149022621|NCT01349907|537560615|FG000|Overall Study|Treatment failure|13|||
149022622|NCT01349907|537560616|FG001|Overall Study|Treatment failure|4|||
149022623|NCT01349907|537560615|FG000|Overall Study|Lost to Follow-up|25|||
149022624|NCT01349907|537560616|FG001|Overall Study|Lost to Follow-up|6|||
149022625|NCT01349907|537560615|FG000|Overall Study|Withdrawal by Subject|30|||
149022626|NCT01349907|537560616|FG001|Overall Study|Withdrawal by Subject|8|||
149022627|NCT01349907|537560615|FG000|Overall Study|Protocol Violation|33|||
149022628|NCT01349907|537560616|FG001|Overall Study|Protocol Violation|13|||
149022629|NCT01349907|537560615|FG000|Overall Study|Administrative|1|||
149022630|NCT01349907|537560616|FG001|Overall Study|Administrative|1|||
148692168|NCT01048333|536346029|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
148692169|NCT01048333|536346030|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
148692170|NCT01048333|536346031|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
148692171|NCT01048333|536346032|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
148958646|NCT02554812|537331363|FG022|Overall Study|Other|0|||
148958647|NCT02554812|537331364|FG023|Overall Study|Other|0|||
148958648|NCT02554812|537331365|FG024|Overall Study|Other|0|||
148958649|NCT02554812|537331366|FG025|Overall Study|Other|0|||
148958650|NCT02554812|537331367|FG026|Overall Study|Other|0|||
148958651|NCT02554812|537331341|FG000|Overall Study|Withdrawal by Subject|1|||
148958652|NCT02554812|537331342|FG001|Overall Study|Withdrawal by Subject|0|||
148958653|NCT02554812|537331343|FG002|Overall Study|Withdrawal by Subject|0|||
148958654|NCT02554812|537331344|FG003|Overall Study|Withdrawal by Subject|2|||
148958655|NCT02554812|537331345|FG004|Overall Study|Withdrawal by Subject|2|||
148958656|NCT02554812|537331346|FG005|Overall Study|Withdrawal by Subject|3|||
148958657|NCT02554812|537331347|FG006|Overall Study|Withdrawal by Subject|0|||
148958658|NCT02554812|537331348|FG007|Overall Study|Withdrawal by Subject|0|||
148958659|NCT02554812|537331349|FG008|Overall Study|Withdrawal by Subject|1|||
148958660|NCT02554812|537331350|FG009|Overall Study|Withdrawal by Subject|1|||
148958661|NCT02554812|537331351|FG010|Overall Study|Withdrawal by Subject|0|||
148958662|NCT02554812|537331352|FG011|Overall Study|Withdrawal by Subject|1|||
148958663|NCT02554812|537331353|FG012|Overall Study|Withdrawal by Subject|1|||
148958664|NCT02554812|537331354|FG013|Overall Study|Withdrawal by Subject|1|||
148958665|NCT02554812|537331355|FG014|Overall Study|Withdrawal by Subject|1|||
148958666|NCT02554812|537331356|FG015|Overall Study|Withdrawal by Subject|1|||
148958667|NCT02554812|537331357|FG016|Overall Study|Withdrawal by Subject|3|||
148958668|NCT02554812|537331358|FG017|Overall Study|Withdrawal by Subject|1|||
148958669|NCT02554812|537331359|FG018|Overall Study|Withdrawal by Subject|0|||
148958670|NCT02554812|537331360|FG019|Overall Study|Withdrawal by Subject|2|||
148958671|NCT02554812|537331361|FG020|Overall Study|Withdrawal by Subject|0|||
148958672|NCT02554812|537331362|FG021|Overall Study|Withdrawal by Subject|1|||
148958673|NCT02554812|537331363|FG022|Overall Study|Withdrawal by Subject|0|||
148958674|NCT02554812|537331364|FG023|Overall Study|Withdrawal by Subject|1|||
148958675|NCT02554812|537331365|FG024|Overall Study|Withdrawal by Subject|0|||
148958676|NCT02554812|537331366|FG025|Overall Study|Withdrawal by Subject|0|||
148958677|NCT02554812|537331367|FG026|Overall Study|Withdrawal by Subject|1|||
148958678|NCT02554812|537331341|FG000|Overall Study|Physician Decision|1|||
148958679|NCT02554812|537331342|FG001|Overall Study|Physician Decision|0|||
148958680|NCT02554812|537331343|FG002|Overall Study|Physician Decision|0|||
148958681|NCT02554812|537331344|FG003|Overall Study|Physician Decision|1|||
148958682|NCT02554812|537331345|FG004|Overall Study|Physician Decision|0|||
148958683|NCT02554812|537331346|FG005|Overall Study|Physician Decision|1|||
148958684|NCT02554812|537331347|FG006|Overall Study|Physician Decision|0|||
148958685|NCT02554812|537331348|FG007|Overall Study|Physician Decision|0|||
148958686|NCT02554812|537331349|FG008|Overall Study|Physician Decision|0|||
148958687|NCT02554812|537331350|FG009|Overall Study|Physician Decision|0|||
148958688|NCT02554812|537331351|FG010|Overall Study|Physician Decision|1|||
148958689|NCT02554812|537331352|FG011|Overall Study|Physician Decision|0|||
148958690|NCT02554812|537331353|FG012|Overall Study|Physician Decision|0|||
148958691|NCT02554812|537331354|FG013|Overall Study|Physician Decision|0|||
148958692|NCT02554812|537331355|FG014|Overall Study|Physician Decision|0|||
149022631|NCT01310868|537560619|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
149022632|NCT01628874|537560626|FG000|Overall Study|Physician Decision|1|||
149022633|NCT01628874|537560627|FG001|Overall Study|Physician Decision|1|||
149022634|NCT01628874|537560626|FG000|Overall Study|Age >4 months|4|||
148958693|NCT02554812|537331356|FG015|Overall Study|Physician Decision|0|||
148958694|NCT02554812|537331357|FG016|Overall Study|Physician Decision|1|||
148958695|NCT02554812|537331358|FG017|Overall Study|Physician Decision|1|||
148958696|NCT02554812|537331359|FG018|Overall Study|Physician Decision|0|||
148958697|NCT02554812|537331360|FG019|Overall Study|Physician Decision|1|||
148958698|NCT02554812|537331361|FG020|Overall Study|Physician Decision|1|||
149022635|NCT01628874|537560627|FG001|Overall Study|Age >4 months|2|||
149022636|NCT00873093|537560628|FG000|Overall Study|Adverse Event|0|||
149022637|NCT00873093|537560629|FG001|Overall Study|Adverse Event|2|||
149022638|NCT00873093|537560630|FG002|Overall Study|Adverse Event|0|||
149022639|NCT00873093|537560631|FG003|Overall Study|Adverse Event|0|||
149022640|NCT00873093|537560632|FG004|Overall Study|Adverse Event|0|||
149022641|NCT00873093|537560628|FG000|Overall Study|Death|0|||
149022642|NCT00873093|537560629|FG001|Overall Study|Death|3|||
149022643|NCT00873093|537560630|FG002|Overall Study|Death|2|||
149022644|NCT00873093|537560631|FG003|Overall Study|Death|0|||
149022645|NCT00873093|537560632|FG004|Overall Study|Death|0|||
149022646|NCT00873093|537560628|FG000|Overall Study|Physician Decision|0|||
149022647|NCT00873093|537560629|FG001|Overall Study|Physician Decision|17|||
149022648|NCT00873093|537560630|FG002|Overall Study|Physician Decision|10|||
149022649|NCT00873093|537560631|FG003|Overall Study|Physician Decision|10|||
149022650|NCT00873093|537560632|FG004|Overall Study|Physician Decision|2|||
149022651|NCT00873093|537560628|FG000|Overall Study|Withdrawal by Subject|1|||
149022652|NCT00873093|537560629|FG001|Overall Study|Withdrawal by Subject|4|||
149022653|NCT00873093|537560630|FG002|Overall Study|Withdrawal by Subject|4|||
149022654|NCT00873093|537560631|FG003|Overall Study|Withdrawal by Subject|0|||
149022655|NCT00873093|537560632|FG004|Overall Study|Withdrawal by Subject|0|||
149022656|NCT00873093|537560628|FG000|Overall Study|Ineligible|0|||
149022657|NCT00873093|537560629|FG001|Overall Study|Ineligible|1|||
149022658|NCT00873093|537560630|FG002|Overall Study|Ineligible|0|||
149022659|NCT00873093|537560631|FG003|Overall Study|Ineligible|1|||
149022660|NCT00873093|537560632|FG004|Overall Study|Ineligible|0|||
149022661|NCT00146640|537560635|FG000|Overall Study|Adverse Event|12|||
149022662|NCT00146640|537560636|FG001|Overall Study|Adverse Event|10|||
149022663|NCT00146640|537560635|FG000|Overall Study|Medical Reasons|3|||
149022664|NCT00146640|537560636|FG001|Overall Study|Medical Reasons|0|||
149022665|NCT00146640|537560635|FG000|Overall Study|Non-Medical Reasons|8|||
149022666|NCT00146640|537560636|FG001|Overall Study|Non-Medical Reasons|4|||
149022667|NCT02059161|537560637|FG000|Overall Study|Pregnancy|0|||
149022668|NCT02059161|537560638|FG001|Overall Study|Pregnancy|2|||
149022669|NCT02059161|537560637|FG000|Overall Study|Adverse Event|2|||
149022670|NCT02059161|537560638|FG001|Overall Study|Adverse Event|6|||
149022671|NCT02059161|537560637|FG000|Overall Study|Lost to Follow-up|20|||
149022672|NCT02059161|537560638|FG001|Overall Study|Lost to Follow-up|12|||
149022673|NCT02059161|537560637|FG000|Overall Study|Physician Decision|4|||
149022674|NCT02059161|537560638|FG001|Overall Study|Physician Decision|4|||
149022675|NCT02059161|537560637|FG000|Overall Study|Protocol Violation|1|||
149022676|NCT02059161|537560638|FG001|Overall Study|Protocol Violation|1|||
149022677|NCT02059161|537560637|FG000|Overall Study|Withdrawal by Subject|16|||
149022678|NCT02059161|537560638|FG001|Overall Study|Withdrawal by Subject|13|||
149022679|NCT02059161|537560637|FG000|Overall Study|Randomized in error, no study drug|0|||
149022680|NCT02059161|537560638|FG001|Overall Study|Randomized in error, no study drug|1|||
149022681|NCT02059161|537560637|FG000|Overall Study|Non-compliance with study drug|6|||
149022682|NCT02059161|537560638|FG001|Overall Study|Non-compliance with study drug|2|||
149022683|NCT01723826|537560642|FG000|Overall Study|Adverse Event|4|||
149022684|NCT01723826|537560643|FG001|Overall Study|Adverse Event|1|||
149022685|NCT01723826|537560644|FG002|Overall Study|Adverse Event|4|||
149022686|NCT01723826|537560645|FG003|Overall Study|Adverse Event|5|||
149022687|NCT01723826|537560642|FG000|Overall Study|Death according to AE eCRF|2|||
149022688|NCT01723826|537560643|FG001|Overall Study|Death according to AE eCRF|3|||
149022689|NCT01723826|537560644|FG002|Overall Study|Death according to AE eCRF|3|||
149022690|NCT01723826|537560645|FG003|Overall Study|Death according to AE eCRF|7|||
149022691|NCT01723826|537560642|FG000|Overall Study|Lost to Follow-up|1|||
149022692|NCT01723826|537560643|FG001|Overall Study|Lost to Follow-up|3|||
149022693|NCT01723826|537560644|FG002|Overall Study|Lost to Follow-up|1|||
149022694|NCT01723826|537560645|FG003|Overall Study|Lost to Follow-up|1|||
149022695|NCT01723826|537560642|FG000|Overall Study|Non-compliance|0|||
149022696|NCT01723826|537560643|FG001|Overall Study|Non-compliance|1|||
149022697|NCT01723826|537560644|FG002|Overall Study|Non-compliance|3|||
149022698|NCT01723826|537560645|FG003|Overall Study|Non-compliance|3|||
149022699|NCT01723826|537560642|FG000|Overall Study|Non-compliance With Study Drug|0|||
149022700|NCT01723826|537560643|FG001|Overall Study|Non-compliance With Study Drug|1|||
149022701|NCT01723826|537560644|FG002|Overall Study|Non-compliance With Study Drug|0|||
149022702|NCT01723826|537560645|FG003|Overall Study|Non-compliance With Study Drug|0|||
149022703|NCT01723826|537560642|FG000|Overall Study|Other Reason|8|||
149022704|NCT01723826|537560643|FG001|Overall Study|Other Reason|6|||
149022705|NCT01723826|537560644|FG002|Overall Study|Other Reason|12|||
149022706|NCT01723826|537560645|FG003|Overall Study|Other Reason|14|||
148811709|NCT03765073|536787084|FG013|Stage 2|Withdrawal by Subject|0|||
149022707|NCT01723826|537560642|FG000|Overall Study|Physician Decision|1|||
149022708|NCT01723826|537560643|FG001|Overall Study|Physician Decision|3|||
149022709|NCT01723826|537560644|FG002|Overall Study|Physician Decision|4|||
149022710|NCT01723826|537560645|FG003|Overall Study|Physician Decision|11|||
149022711|NCT01723826|537560642|FG000|Overall Study|Protocol Violation|1|||
149022712|NCT01723826|537560643|FG001|Overall Study|Protocol Violation|1|||
149022713|NCT01723826|537560644|FG002|Overall Study|Protocol Violation|3|||
148958699|NCT02554812|537331362|FG021|Overall Study|Physician Decision|0|||
148958700|NCT02554812|537331363|FG022|Overall Study|Physician Decision|1|||
148958701|NCT02554812|537331364|FG023|Overall Study|Physician Decision|0|||
148958702|NCT02554812|537331365|FG024|Overall Study|Physician Decision|0|||
148958703|NCT02554812|537331366|FG025|Overall Study|Physician Decision|0|||
148958704|NCT02554812|537331367|FG026|Overall Study|Physician Decision|0|||
148958705|NCT02554812|537331341|FG000|Overall Study|Study terminated by sponsor|0|||
148958706|NCT02554812|537331342|FG001|Overall Study|Study terminated by sponsor|0|||
148958707|NCT02554812|537331343|FG002|Overall Study|Study terminated by sponsor|0|||
148958708|NCT02554812|537331344|FG003|Overall Study|Study terminated by sponsor|0|||
148958709|NCT02554812|537331345|FG004|Overall Study|Study terminated by sponsor|0|||
148958710|NCT02554812|537331346|FG005|Overall Study|Study terminated by sponsor|0|||
148958711|NCT02554812|537331347|FG006|Overall Study|Study terminated by sponsor|0|||
148958712|NCT02554812|537331348|FG007|Overall Study|Study terminated by sponsor|0|||
148958713|NCT02554812|537331349|FG008|Overall Study|Study terminated by sponsor|0|||
148958714|NCT02554812|537331350|FG009|Overall Study|Study terminated by sponsor|0|||
148958715|NCT02554812|537331351|FG010|Overall Study|Study terminated by sponsor|0|||
148958716|NCT02554812|537331352|FG011|Overall Study|Study terminated by sponsor|0|||
148958717|NCT02554812|537331353|FG012|Overall Study|Study terminated by sponsor|0|||
148958718|NCT02554812|537331354|FG013|Overall Study|Study terminated by sponsor|0|||
148958719|NCT02554812|537331355|FG014|Overall Study|Study terminated by sponsor|0|||
148958720|NCT02554812|537331356|FG015|Overall Study|Study terminated by sponsor|0|||
148958721|NCT02554812|537331357|FG016|Overall Study|Study terminated by sponsor|0|||
148958722|NCT02554812|537331358|FG017|Overall Study|Study terminated by sponsor|0|||
148958723|NCT02554812|537331359|FG018|Overall Study|Study terminated by sponsor|0|||
148958724|NCT02554812|537331360|FG019|Overall Study|Study terminated by sponsor|0|||
148958725|NCT02554812|537331361|FG020|Overall Study|Study terminated by sponsor|0|||
148958726|NCT02554812|537331362|FG021|Overall Study|Study terminated by sponsor|0|||
148958727|NCT02554812|537331363|FG022|Overall Study|Study terminated by sponsor|0|||
148958728|NCT02554812|537331364|FG023|Overall Study|Study terminated by sponsor|0|||
148958729|NCT02554812|537331365|FG024|Overall Study|Study terminated by sponsor|1|||
148958730|NCT02554812|537331366|FG025|Overall Study|Study terminated by sponsor|0|||
148958731|NCT02554812|537331367|FG026|Overall Study|Study terminated by sponsor|0|||
148958732|NCT02554812|537331341|FG000|Overall Study|No longer meets eligibility criteria|0|||
148958733|NCT02554812|537331342|FG001|Overall Study|No longer meets eligibility criteria|1|||
148958734|NCT02554812|537331343|FG002|Overall Study|No longer meets eligibility criteria|0|||
148958735|NCT02554812|537331344|FG003|Overall Study|No longer meets eligibility criteria|0|||
148958736|NCT02554812|537331345|FG004|Overall Study|No longer meets eligibility criteria|0|||
148958737|NCT02554812|537331346|FG005|Overall Study|No longer meets eligibility criteria|0|||
148958738|NCT02554812|537331347|FG006|Overall Study|No longer meets eligibility criteria|0|||
148958739|NCT02554812|537331348|FG007|Overall Study|No longer meets eligibility criteria|0|||
148958740|NCT02554812|537331349|FG008|Overall Study|No longer meets eligibility criteria|0|||
148958741|NCT02554812|537331350|FG009|Overall Study|No longer meets eligibility criteria|0|||
148958742|NCT02554812|537331351|FG010|Overall Study|No longer meets eligibility criteria|0|||
148958743|NCT02554812|537331352|FG011|Overall Study|No longer meets eligibility criteria|0|||
148958744|NCT02554812|537331353|FG012|Overall Study|No longer meets eligibility criteria|0|||
148958745|NCT02554812|537331354|FG013|Overall Study|No longer meets eligibility criteria|0|||
148958746|NCT02554812|537331355|FG014|Overall Study|No longer meets eligibility criteria|0|||
148958747|NCT02554812|537331356|FG015|Overall Study|No longer meets eligibility criteria|0|||
148958748|NCT02554812|537331357|FG016|Overall Study|No longer meets eligibility criteria|0|||
148958749|NCT02554812|537331358|FG017|Overall Study|No longer meets eligibility criteria|0|||
148958750|NCT02554812|537331359|FG018|Overall Study|No longer meets eligibility criteria|0|||
148958751|NCT02554812|537331360|FG019|Overall Study|No longer meets eligibility criteria|0|||
148958752|NCT02554812|537331361|FG020|Overall Study|No longer meets eligibility criteria|0|||
148958753|NCT02554812|537331362|FG021|Overall Study|No longer meets eligibility criteria|0|||
148958754|NCT02554812|537331363|FG022|Overall Study|No longer meets eligibility criteria|0|||
148958755|NCT02554812|537331364|FG023|Overall Study|No longer meets eligibility criteria|0|||
148958756|NCT02554812|537331365|FG024|Overall Study|No longer meets eligibility criteria|0|||
148958757|NCT02554812|537331366|FG025|Overall Study|No longer meets eligibility criteria|0|||
148958758|NCT02554812|537331367|FG026|Overall Study|No longer meets eligibility criteria|0|||
148958759|NCT01103284|537331368|FG000|Overall Study|Death|2|||
148958760|NCT01103284|537331369|FG001|Overall Study|Death|0|||
148958761|NCT01103284|537331368|FG000|Overall Study|Lost to Follow-up|9|||
148958762|NCT01103284|537331369|FG001|Overall Study|Lost to Follow-up|10|||
148958763|NCT01103284|537331368|FG000|Overall Study|Pregnancy|3|||
148958764|NCT01103284|537331369|FG001|Overall Study|Pregnancy|1|||
148958765|NCT01103284|537331368|FG000|Overall Study|Protocol Violation|12|||
148958766|NCT01103284|537331369|FG001|Overall Study|Protocol Violation|5|||
148958767|NCT01103284|537331368|FG000|Overall Study|Adverse Event|0|||
148958768|NCT01103284|537331369|FG001|Overall Study|Adverse Event|5|||
148958769|NCT01103284|537331368|FG000|Overall Study|Withdrawal by Subject|14|||
148958770|NCT01103284|537331369|FG001|Overall Study|Withdrawal by Subject|18|||
148958771|NCT01103284|537331368|FG000|Overall Study|Dermal Hypersensitivity|0|||
148692172|NCT01048333|536346033|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
148692173|NCT03008460|536346038|FG000|Overall Study|Protocol deviation|0|||
148692174|NCT03008460|536346039|FG001|Overall Study|Protocol deviation|2|||
148692175|NCT03008460|536346038|FG000|Overall Study|Study drug not dispensed|0|||
148692176|NCT03008460|536346039|FG001|Overall Study|Study drug not dispensed|1|||
148692177|NCT03008460|536346038|FG000|Overall Study|Adverse Event|0|||
148692178|NCT03008460|536346039|FG001|Overall Study|Adverse Event|1|||
148692179|NCT03008460|536346038|FG000|Overall Study|Withdrawal by Subject|5|||
148692180|NCT03008460|536346039|FG001|Overall Study|Withdrawal by Subject|6|||
148692181|NCT03008460|536346038|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
148692182|NCT03008460|536346039|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
148692183|NCT03008460|536346038|FG000|Overall Study|End of study visit outside permitted time window|0|||
148692184|NCT03008460|536346039|FG001|Overall Study|End of study visit outside permitted time window|1|||
148692185|NCT03008460|536346038|FG000|Overall Study|Lost to Follow-up|1|||
149022714|NCT01723826|537560645|FG003|Overall Study|Protocol Violation|1|||
149022715|NCT01723826|537560642|FG000|Overall Study|Withdrawal by Subject|10|||
149022716|NCT01723826|537560643|FG001|Overall Study|Withdrawal by Subject|17|||
149022717|NCT01723826|537560644|FG002|Overall Study|Withdrawal by Subject|27|||
149022718|NCT01723826|537560645|FG003|Overall Study|Withdrawal by Subject|48|||
149022719|NCT02013687|537560646|FG000|Overall Study|Lost to Follow-up|0|||
148692186|NCT03008460|536346039|FG001|Overall Study|Lost to Follow-up|3|||
148692187|NCT02260492|536346042|FG000|Overall Study|Adverse Event|6|||
148692188|NCT02260492|536346043|FG001|Overall Study|Adverse Event|1|||
148692189|NCT02260492|536346044|FG002|Overall Study|Adverse Event|2|||
148692190|NCT02260492|536346042|FG000|Overall Study|Death|0|||
148692191|NCT02260492|536346043|FG001|Overall Study|Death|1|||
148692192|NCT02260492|536346044|FG002|Overall Study|Death|0|||
148692193|NCT02260492|536346042|FG000|Overall Study|Lost to Follow-up|12|||
148692194|NCT02260492|536346043|FG001|Overall Study|Lost to Follow-up|9|||
148692195|NCT02260492|536346044|FG002|Overall Study|Lost to Follow-up|0|||
148692196|NCT02260492|536346042|FG000|Overall Study|Physician Decision|2|||
149022720|NCT02013687|537560647|FG001|Overall Study|Lost to Follow-up|0|||
149022721|NCT02013687|537560648|FG002|Overall Study|Lost to Follow-up|1|||
149022722|NCT02013687|537560649|FG003|Overall Study|Lost to Follow-up|0|||
149022723|NCT02013687|537560646|FG000|Overall Study|Protocol Violation|0|||
149022724|NCT02013687|537560647|FG001|Overall Study|Protocol Violation|0|||
149022725|NCT02013687|537560648|FG002|Overall Study|Protocol Violation|0|||
149022726|NCT02013687|537560649|FG003|Overall Study|Protocol Violation|1|||
149022727|NCT02013687|537560646|FG000|Overall Study|Withdrawal by Subject|0|||
149022728|NCT02013687|537560647|FG001|Overall Study|Withdrawal by Subject|0|||
149022729|NCT02013687|537560648|FG002|Overall Study|Withdrawal by Subject|0|||
149022730|NCT02013687|537560649|FG003|Overall Study|Withdrawal by Subject|1|||
149022731|NCT02013687|537560646|FG000|Overall Study|Missed visits due to patient travel|0|||
149022732|NCT02013687|537560647|FG001|Overall Study|Missed visits due to patient travel|0|||
149022733|NCT02013687|537560648|FG002|Overall Study|Missed visits due to patient travel|1|||
149022734|NCT02013687|537560649|FG003|Overall Study|Missed visits due to patient travel|0|||
149022735|NCT01782326|537560650|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
149022736|NCT01782326|537560651|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
149022737|NCT01782326|537560650|FG000|Planned Treatment Epoch|Death|29|||
149022738|NCT01782326|537560651|FG001|Planned Treatment Epoch|Death|30|||
149022739|NCT01782326|537560650|FG000|Planned Treatment Epoch|Physician Decision|18|||
149022740|NCT01782326|537560651|FG001|Planned Treatment Epoch|Physician Decision|16|||
149022741|NCT01782326|537560650|FG000|Planned Treatment Epoch|Protocol deviation|2|||
149022742|NCT01782326|537560651|FG001|Planned Treatment Epoch|Protocol deviation|3|||
149022743|NCT01782326|537560650|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
149022744|NCT01782326|537560651|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
149022745|NCT01782326|537560650|FG000|Planned Treatment Epoch|Technical problems|0|||
148692197|NCT02260492|536346043|FG001|Overall Study|Physician Decision|0|||
148692198|NCT02260492|536346044|FG002|Overall Study|Physician Decision|1|||
148692199|NCT02260492|536346042|FG000|Overall Study|Withdrawal by Subject|3|||
148692200|NCT02260492|536346043|FG001|Overall Study|Withdrawal by Subject|2|||
148692201|NCT02260492|536346044|FG002|Overall Study|Withdrawal by Subject|2|||
148692202|NCT00996736|536346045|FG000|Overall Study|Death|1|||
148692203|NCT00996736|536346046|FG001|Overall Study|Death|1|||
148692204|NCT00996736|536346045|FG000|Overall Study|Lost to Follow-up|15|||
148692205|NCT00996736|536346046|FG001|Overall Study|Lost to Follow-up|14|||
148692206|NCT00996736|536346045|FG000|Overall Study|Visit not within 3-month window|5|||
148692207|NCT00996736|536346046|FG001|Overall Study|Visit not within 3-month window|3|||
148692208|NCT02346201|536346048|FG000|Overall Study|Adverse Event|3|||
148692209|NCT02346201|536346049|FG001|Overall Study|Adverse Event|2|||
149022746|NCT01782326|537560651|FG001|Planned Treatment Epoch|Technical problems|4|||
149022747|NCT01782326|537560650|FG000|Double-blind Treatment|Adverse Event|129|||
149022748|NCT01782326|537560651|FG001|Double-blind Treatment|Adverse Event|145|||
149022749|NCT01782326|537560650|FG000|Double-blind Treatment|Subject/guardian decision|111|||
149022750|NCT01782326|537560651|FG001|Double-blind Treatment|Subject/guardian decision|125|||
149022751|NCT01782326|537560650|FG000|Double-blind Treatment|Lack of Efficacy|17|||
148692210|NCT02346201|536346048|FG000|Overall Study|Lost to Follow-up|1|||
148692211|NCT02346201|536346049|FG001|Overall Study|Lost to Follow-up|0|||
148692212|NCT02346201|536346048|FG000|Overall Study|Withdrawal by Subject|6|||
148692213|NCT02346201|536346049|FG001|Overall Study|Withdrawal by Subject|3|||
148692214|NCT02346201|536346048|FG000|Overall Study|Unavailable for future follow-up|0|||
148692215|NCT02346201|536346049|FG001|Overall Study|Unavailable for future follow-up|1|||
148692216|NCT02346201|536346048|FG000|Overall Study|Physician Decision|0|||
148692217|NCT02346201|536346049|FG001|Overall Study|Physician Decision|1|||
148692218|NCT02346201|536346048|FG000|Overall Study|Missed final visit|0|||
148692219|NCT02346201|536346049|FG001|Overall Study|Missed final visit|2|||
148692220|NCT03708211|536346050|FG000|Overall Study|Progressive Disease|10|||
148692221|NCT03708211|536346051|FG001|Overall Study|Progressive Disease|7|||
148692222|NCT03708211|536346050|FG000|Overall Study|Withdrawal by Subject|0|||
148692223|NCT03708211|536346051|FG001|Overall Study|Withdrawal by Subject|1|||
148692224|NCT03708211|536346050|FG000|Overall Study|Other|2|||
148692225|NCT03708211|536346051|FG001|Overall Study|Other|0|||
148692226|NCT00462982|536346052|FG000|Overall Study|Adverse Event|1|||
148692227|NCT00462982|536346052|FG000|Overall Study|Patient Not Treated|2|||
148692228|NCT05200858|536346053|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
148692229|NCT05200858|536346054|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
148692230|NCT05200858|536346055|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
148692231|NCT05200858|536346056|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
148692232|NCT02109133|536346057|FG000|Overall Study|Lost to Follow-up|1|||
148692233|NCT02109133|536346058|FG001|Overall Study|Lost to Follow-up|0|||
148692234|NCT00409578|536346061|FG000|Overall Study|Adverse Event|27|||
148692235|NCT00409578|536346062|FG001|Overall Study|Adverse Event|37|||
148692236|NCT00409578|536346063|FG002|Overall Study|Adverse Event|25|||
148811710|NCT03765073|536787085|FG014|Stage 2|Withdrawal by Subject|0|||
148811711|NCT03765073|536787086|FG015|Stage 2|Withdrawal by Subject|0|||
148811712|NCT03765073|536787087|FG016|Stage 2|Withdrawal by Subject|0|||
148958772|NCT01103284|537331369|FG001|Overall Study|Dermal Hypersensitivity|1|||
148958773|NCT01103284|537331368|FG000|Overall Study|Termination by the Sponsor|0|||
148958774|NCT01103284|537331369|FG001|Overall Study|Termination by the Sponsor|1|||
148958775|NCT01103284|537331368|FG000|Overall Study|Not described|2|||
148958776|NCT01103284|537331369|FG001|Overall Study|Not described|1|||
148958777|NCT01103284|537331368|FG000|Overall Study|Missing CRF entries for study completion|0|||
148958778|NCT01103284|537331369|FG001|Overall Study|Missing CRF entries for study completion|2|||
148958779|NCT00936910|537332632|FG000|Overall Study|Lack of Efficacy|3|||
148958780|NCT02057198|537332633|FG000|Overall Study|Death|0|||
148958781|NCT02057198|537332634|FG001|Overall Study|Death|0|||
148958782|NCT02057198|537332635|FG002|Overall Study|Death|1|||
148958783|NCT02057198|537332633|FG000|Overall Study|Discharged early; lost to followup|0|||
148958784|NCT02057198|537332634|FG001|Overall Study|Discharged early; lost to followup|1|||
148958785|NCT02057198|537332635|FG002|Overall Study|Discharged early; lost to followup|0|||
148958786|NCT02355691|537332636|FG000|Overall Study|Loss of Research Personnel|7|||
148958787|NCT02355691|537332637|FG001|Overall Study|Loss of Research Personnel|9|||
148958788|NCT02345811|537332640|FG000|First Intervention|Withdrawal by Subject|1|||
148958789|NCT02345811|537332641|FG001|First Intervention|Withdrawal by Subject|1|||
148958790|NCT00665353|537332642|FG000|Study Step 1|Adverse Event|1|||
148958791|NCT00665353|537332642|FG000|Study Step 1|Withdrawal by Subject|2|||
148958792|NCT00665353|537332642|FG000|Study Step 2|Lost to Follow-up|2|||
148958793|NCT00665353|537332642|FG000|Study Step 2|Lack of Efficacy|12|||
148958800|NCT00546637|537332648|FG000|Overall Study|Adverse Event|46|||
148958801|NCT00546637|537332649|FG001|Overall Study|Adverse Event|20|||
148958802|NCT00546637|537332648|FG000|Overall Study|Lack of Efficacy|5|||
148958803|NCT00546637|537332649|FG001|Overall Study|Lack of Efficacy|5|||
148958804|NCT00546637|537332648|FG000|Overall Study|Lost to Follow-up|2|||
148958805|NCT00546637|537332649|FG001|Overall Study|Lost to Follow-up|2|||
148958806|NCT00546637|537332648|FG000|Overall Study|Other|10|||
148958807|NCT00546637|537332649|FG001|Overall Study|Other|12|||
148958808|NCT00546637|537332648|FG000|Overall Study|Withdrawal by Subject|7|||
148958809|NCT00546637|537332649|FG001|Overall Study|Withdrawal by Subject|9|||
148958810|NCT00546637|537332648|FG000|Overall Study|Randomized, but not treated|3|||
148958811|NCT00546637|537332649|FG001|Overall Study|Randomized, but not treated|1|||
148692237|NCT00409578|536346064|FG003|Overall Study|Adverse Event|33|||
148692238|NCT00409578|536346061|FG000|Overall Study|Abnormal laboratory value(s)|2|||
148692239|NCT00409578|536346062|FG001|Overall Study|Abnormal laboratory value(s)|2|||
148692240|NCT00409578|536346063|FG002|Overall Study|Abnormal laboratory value(s)|2|||
148692241|NCT00409578|536346064|FG003|Overall Study|Abnormal laboratory value(s)|4|||
148692242|NCT00409578|536346061|FG000|Overall Study|Lack of Efficacy|0|||
148692243|NCT00409578|536346062|FG001|Overall Study|Lack of Efficacy|0|||
148958812|NCT00390858|537332650|FG000|Overall Study|Adverse Event|6|||
148692244|NCT00409578|536346063|FG002|Overall Study|Lack of Efficacy|0|||
148692245|NCT00409578|536346064|FG003|Overall Study|Lack of Efficacy|2|||
148692246|NCT00409578|536346061|FG000|Overall Study|Subject no longer requires study drug|0|||
148692247|NCT00409578|536346062|FG001|Overall Study|Subject no longer requires study drug|0|||
148692248|NCT00409578|536346063|FG002|Overall Study|Subject no longer requires study drug|0|||
148692249|NCT00409578|536346064|FG003|Overall Study|Subject no longer requires study drug|1|||
148692250|NCT00409578|536346061|FG000|Overall Study|Withdrawal by Subject|8|||
148692251|NCT00409578|536346062|FG001|Overall Study|Withdrawal by Subject|15|||
148692252|NCT00409578|536346063|FG002|Overall Study|Withdrawal by Subject|16|||
148692253|NCT00409578|536346064|FG003|Overall Study|Withdrawal by Subject|17|||
148692254|NCT00409578|536346061|FG000|Overall Study|Lost to Follow-up|2|||
148692255|NCT00409578|536346062|FG001|Overall Study|Lost to Follow-up|0|||
148692256|NCT00409578|536346063|FG002|Overall Study|Lost to Follow-up|2|||
148692257|NCT00409578|536346064|FG003|Overall Study|Lost to Follow-up|2|||
148692258|NCT00409578|536346061|FG000|Overall Study|Administrative problems|8|||
148692259|NCT00409578|536346062|FG001|Overall Study|Administrative problems|9|||
148811713|NCT03765073|536787088|FG017|Stage 2|Withdrawal by Subject|0|||
148958813|NCT00390858|537332651|FG001|Overall Study|Adverse Event|2|||
148958814|NCT00390858|537332650|FG000|Overall Study|Lack of Efficacy|0|||
148958815|NCT00390858|537332651|FG001|Overall Study|Lack of Efficacy|1|||
148958816|NCT00390858|537332650|FG000|Overall Study|Withdrawal by Subject|3|||
148958817|NCT00390858|537332651|FG001|Overall Study|Withdrawal by Subject|4|||
148958818|NCT00450450|537332655|FG000|Overall Study|Death|1|||
148958819|NCT00450450|537332656|FG001|Overall Study|Death|3|||
148958820|NCT00450450|537332655|FG000|Overall Study|Relapse|2|||
148958821|NCT00450450|537332656|FG001|Overall Study|Relapse|0|||
148958822|NCT00450450|537332655|FG000|Overall Study|Missing Data|2|||
148958823|NCT00450450|537332656|FG001|Overall Study|Missing Data|0|||
148958824|NCT02024867|537332659|FG000|Overall Study|Protocol Violation|3|||
148958825|NCT02024867|537332660|FG001|Overall Study|Protocol Violation|3|||
148958826|NCT02024867|537332659|FG000|Overall Study|Lost to Follow-up|6|||
148958827|NCT02024867|537332660|FG001|Overall Study|Lost to Follow-up|4|||
148958828|NCT02865187|537332661|FG000|Overall Study|Lost to Follow-up|12|||
148958829|NCT02865187|537332662|FG001|Overall Study|Lost to Follow-up|7|||
148958830|NCT02865187|537332661|FG000|Overall Study|Adverse Event|1|||
148958831|NCT02865187|537332662|FG001|Overall Study|Adverse Event|0|||
148958832|NCT04267133|537332663|FG000|Overall Study|Withdrawal by Subject|1|||
148958833|NCT04267133|537332663|FG000|Overall Study|Adverse Event|4|||
148958834|NCT01110707|537332664|FG000|Overall Study|Protocol Violation|0|||
148958835|NCT01110707|537332665|FG001|Overall Study|Protocol Violation|3|||
148958836|NCT00003901|537332671|FG000|Overall Study|Adverse Event|1|||
148958837|NCT00003901|537332671|FG000|Overall Study|Withdrawal by Subject|1|||
148958838|NCT00003901|537332671|FG000|Overall Study|Ineligible|6|||
148958839|NCT00003901|537332671|FG000|Overall Study|CT Scan not within protocol requirement|2|||
148958840|NCT00003901|537332671|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
148958841|NCT00003901|537332671|FG000|Overall Study|Medical problems|6|||
148958842|NCT02268864|537332673|FG000|Overall Study|Withdrawal by Subject|2|||
148958843|NCT02268864|537332674|FG001|Overall Study|Withdrawal by Subject|0|||
148958844|NCT02268864|537332675|FG002|Overall Study|Withdrawal by Subject|0|||
148958845|NCT02268864|537332673|FG000|Overall Study|Death|0|||
148958846|NCT02268864|537332674|FG001|Overall Study|Death|1|||
148958847|NCT02268864|537332675|FG002|Overall Study|Death|0|||
148958848|NCT02612428|537332678|FG000|VTL-308|Death|14|||
148958849|NCT02612428|537332679|FG001|VTL-308|Death|16|||
148958850|NCT02612428|537332678|FG000|VTL-308|Withdrawal by Subject|0|||
148958851|NCT02612428|537332679|FG001|VTL-308|Withdrawal by Subject|1|||
148958852|NCT02612428|537332678|FG000|VTL-308E|Death|9|||
148958853|NCT02612428|537332679|FG001|VTL-308E|Death|7|||
148958854|NCT02612428|537332678|FG000|VTL-308E|Lost to Follow-up|2|||
148958855|NCT02612428|537332679|FG001|VTL-308E|Lost to Follow-up|0|||
148958856|NCT02064166|537332684|FG000|Overall Study|Adverse Event|1|||
148958857|NCT02064166|537332685|FG001|Overall Study|Adverse Event|0|||
148958858|NCT00383149|537332697|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
148958859|NCT00383149|537332697|FG000|Overall Study|Death|2|||
148958860|NCT00383149|537332697|FG000|Overall Study|Disease Progression|38|||
148958861|NCT00383149|537332697|FG000|Overall Study|Lost to Follow-up|1|||
148958862|NCT00383149|537332697|FG000|Overall Study|Other|1|||
148958863|NCT00383149|537332697|FG000|Overall Study|Study Drug Toxicity|4|||
148958864|NCT00383149|537332697|FG000|Overall Study|Request to Discontinue Treatment|4|||
148958865|NCT00383149|537332697|FG000|Overall Study|Participant Withdrew Consent|1|||
148958866|NCT03721276|537332698|FG000|Overall Study|Lost to Follow-up|5|||
148958867|NCT03721276|537332699|FG001|Overall Study|Lost to Follow-up|3|||
148958868|NCT03721276|537332698|FG000|Overall Study|Adverse Event|0|||
149022752|NCT01782326|537560651|FG001|Double-blind Treatment|Lack of Efficacy|22|||
149022753|NCT01782326|537560650|FG000|Double-blind Treatment|Physician Decision|13|||
148692260|NCT00409578|536346063|FG002|Overall Study|Administrative problems|2|||
148692261|NCT00409578|536346064|FG003|Overall Study|Administrative problems|4|||
148958869|NCT03721276|537332699|FG001|Overall Study|Adverse Event|1|||
148958870|NCT01340898|537332702|FG000|Primary Phase|Serious Adverse Events|0|||
148692262|NCT00409578|536346061|FG000|Overall Study|Death|2|||
148958871|NCT01340898|537332703|FG001|Primary Phase|Serious Adverse Events|0|||
148958872|NCT01340898|537332704|FG002|Primary Phase|Serious Adverse Events|1|||
148958873|NCT01340898|537332702|FG000|Primary Phase|Withdrawal by Subject|8|||
148958874|NCT01340898|537332703|FG001|Primary Phase|Withdrawal by Subject|7|||
148958875|NCT01340898|537332704|FG002|Primary Phase|Withdrawal by Subject|5|||
148958876|NCT01340898|537332702|FG000|Primary Phase|Migrated/moved from study area|4|||
148958877|NCT01340898|537332703|FG001|Primary Phase|Migrated/moved from study area|1|||
148958878|NCT01340898|537332704|FG002|Primary Phase|Migrated/moved from study area|0|||
148958879|NCT01340898|537332702|FG000|Primary Phase|Lost to Follow-up|4|||
148958880|NCT01340898|537332703|FG001|Primary Phase|Lost to Follow-up|1|||
148958881|NCT01340898|537332704|FG002|Primary Phase|Lost to Follow-up|0|||
148958882|NCT01340898|537332702|FG000|Booster Phase|Withdrawal by Subject|3|||
148958883|NCT01340898|537332703|FG001|Booster Phase|Withdrawal by Subject|0|||
148958884|NCT01340898|537332704|FG002|Booster Phase|Withdrawal by Subject|4|||
148958885|NCT01340898|537332702|FG000|Booster Phase|Migrated/moved from study area|3|||
148958886|NCT01340898|537332703|FG001|Booster Phase|Migrated/moved from study area|0|||
148958887|NCT01340898|537332704|FG002|Booster Phase|Migrated/moved from study area|0|||
148958888|NCT01340898|537332702|FG000|Booster Phase|Lost to Follow-up|4|||
148958889|NCT01340898|537332703|FG001|Booster Phase|Lost to Follow-up|2|||
148958890|NCT01340898|537332704|FG002|Booster Phase|Lost to Follow-up|3|||
148958891|NCT02375113|537332706|FG000|Overall Study|Undisclosed Reason(s).|1|||
148958892|NCT02375113|537332707|FG001|Overall Study|Undisclosed Reason(s).|1|||
148958893|NCT02375113|537332706|FG000|Overall Study|Poor adherence (<70%).|1|||
148958894|NCT02375113|537332707|FG001|Overall Study|Poor adherence (<70%).|0|||
148958895|NCT02375113|537332706|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
148958896|NCT02375113|537332707|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
148958897|NCT01214629|537332708|FG000|Overall Study|Progressive Disease|1|||
148958898|NCT01214629|537332709|FG001|Overall Study|Progressive Disease|1|||
148958899|NCT01214629|537332710|FG002|Overall Study|Progressive Disease|0|||
148958900|NCT01214629|537332711|FG003|Overall Study|Progressive Disease|1|||
148958901|NCT01214629|537332712|FG004|Overall Study|Progressive Disease|2|||
148958902|NCT01214629|537332713|FG005|Overall Study|Progressive Disease|3|||
148958903|NCT01214629|537332714|FG006|Overall Study|Progressive Disease|1|||
148958904|NCT01214629|537332715|FG007|Overall Study|Progressive Disease|1|||
148958905|NCT01214629|537332716|FG008|Overall Study|Progressive Disease|1|||
148958906|NCT01214629|537332717|FG009|Overall Study|Progressive Disease|5|||
148958907|NCT01214629|537332718|FG010|Overall Study|Progressive Disease|1|||
148958908|NCT01214629|537332708|FG000|Overall Study|Adverse Event|0|||
148958909|NCT01214629|537332709|FG001|Overall Study|Adverse Event|0|||
148958910|NCT01214629|537332710|FG002|Overall Study|Adverse Event|0|||
148958911|NCT01214629|537332711|FG003|Overall Study|Adverse Event|1|||
148958912|NCT01214629|537332712|FG004|Overall Study|Adverse Event|0|||
148958913|NCT01214629|537332713|FG005|Overall Study|Adverse Event|1|||
148958914|NCT01214629|537332714|FG006|Overall Study|Adverse Event|0|||
148958915|NCT01214629|537332715|FG007|Overall Study|Adverse Event|0|||
148958916|NCT01214629|537332716|FG008|Overall Study|Adverse Event|0|||
148958917|NCT01214629|537332717|FG009|Overall Study|Adverse Event|1|||
148958918|NCT01214629|537332718|FG010|Overall Study|Adverse Event|0|||
148958919|NCT01214629|537332708|FG000|Overall Study|Physician Decision|0|||
148958920|NCT01214629|537332709|FG001|Overall Study|Physician Decision|0|||
148958921|NCT01214629|537332710|FG002|Overall Study|Physician Decision|0|||
148958922|NCT01214629|537332711|FG003|Overall Study|Physician Decision|0|||
148958923|NCT01214629|537332712|FG004|Overall Study|Physician Decision|0|||
148958924|NCT01214629|537332713|FG005|Overall Study|Physician Decision|0|||
148958925|NCT01214629|537332714|FG006|Overall Study|Physician Decision|0|||
148958926|NCT01214629|537332715|FG007|Overall Study|Physician Decision|0|||
148958927|NCT01214629|537332716|FG008|Overall Study|Physician Decision|0|||
148958928|NCT01214629|537332717|FG009|Overall Study|Physician Decision|0|||
148958929|NCT01214629|537332718|FG010|Overall Study|Physician Decision|1|||
148958930|NCT01214629|537332708|FG000|Overall Study|Withdrawal by Subject|0|||
148958931|NCT01214629|537332709|FG001|Overall Study|Withdrawal by Subject|0|||
148958932|NCT01214629|537332710|FG002|Overall Study|Withdrawal by Subject|0|||
148958933|NCT01214629|537332711|FG003|Overall Study|Withdrawal by Subject|0|||
148958934|NCT01214629|537332712|FG004|Overall Study|Withdrawal by Subject|0|||
148958935|NCT01214629|537332713|FG005|Overall Study|Withdrawal by Subject|0|||
148958936|NCT01214629|537332714|FG006|Overall Study|Withdrawal by Subject|0|||
148958937|NCT01214629|537332715|FG007|Overall Study|Withdrawal by Subject|0|||
148958938|NCT01214629|537332716|FG008|Overall Study|Withdrawal by Subject|0|||
148958939|NCT01214629|537332717|FG009|Overall Study|Withdrawal by Subject|1|||
148958940|NCT01214629|537332718|FG010|Overall Study|Withdrawal by Subject|0|||
148958941|NCT00877383|537332721|FG000|Overall Study|Adverse Event|13|||
148958942|NCT00877383|537332722|FG001|Overall Study|Adverse Event|14|||
148958943|NCT00877383|537332721|FG000|Overall Study|Lost to Follow-up|5|||
148958944|NCT00877383|537332722|FG001|Overall Study|Lost to Follow-up|3|||
148958945|NCT00877383|537332721|FG000|Overall Study|Subject withdrew consent|3|||
148958946|NCT00877383|537332722|FG001|Overall Study|Subject withdrew consent|12|||
148958947|NCT00877383|537332721|FG000|Overall Study|Subject no longer requires study drug|2|||
148692263|NCT00409578|536346062|FG001|Overall Study|Death|4|||
148692264|NCT00409578|536346063|FG002|Overall Study|Death|4|||
148692265|NCT00409578|536346064|FG003|Overall Study|Death|2|||
148692266|NCT00409578|536346061|FG000|Overall Study|Protocol Violation|3|||
148692267|NCT00409578|536346062|FG001|Overall Study|Protocol Violation|2|||
148692268|NCT00409578|536346063|FG002|Overall Study|Protocol Violation|3|||
148692269|NCT00409578|536346064|FG003|Overall Study|Protocol Violation|1|||
148692270|NCT00409578|536346061|FG000|Overall Study|Missing|0|||
148692271|NCT00409578|536346062|FG001|Overall Study|Missing|1|||
148692272|NCT00409578|536346063|FG002|Overall Study|Missing|0|||
148692273|NCT00409578|536346064|FG003|Overall Study|Missing|1|||
148692274|NCT02448771|536346065|FG000|Overall Study|Disease Progression|30|||
148692275|NCT02448771|536346065|FG000|Overall Study|Unacceptable Toxicity|1|||
148692276|NCT02448771|536346065|FG000|Overall Study|Physician Decision|3|||
148692277|NCT02448771|536346065|FG000|Overall Study|Started new therapy|2|||
148692278|NCT00770315|536346066|FG000|Overall Study|Adverse Event|11|||
148692279|NCT00770315|536346067|FG001|Overall Study|Adverse Event|17|||
148692280|NCT00770315|536346068|FG002|Overall Study|Adverse Event|16|||
148692281|NCT00770315|536346069|FG003|Overall Study|Adverse Event|6|||
148692282|NCT00770315|536346066|FG000|Overall Study|Lost to Follow-up|9|||
148692283|NCT00770315|536346067|FG001|Overall Study|Lost to Follow-up|5|||
148692284|NCT00770315|536346068|FG002|Overall Study|Lost to Follow-up|10|||
148692285|NCT00770315|536346069|FG003|Overall Study|Lost to Follow-up|3|||
148692286|NCT00770315|536346066|FG000|Overall Study|Withdrawal by Subject|13|||
148692287|NCT00770315|536346067|FG001|Overall Study|Withdrawal by Subject|17|||
148692288|NCT00770315|536346068|FG002|Overall Study|Withdrawal by Subject|24|||
148692289|NCT00770315|536346069|FG003|Overall Study|Withdrawal by Subject|20|||
148692290|NCT00770315|536346066|FG000|Overall Study|Noncompliance with Protocol|7|||
148692291|NCT00770315|536346067|FG001|Overall Study|Noncompliance with Protocol|4|||
148811714|NCT03765073|536787089|FG018|Stage 2|Withdrawal by Subject|0|||
148958948|NCT00877383|537332722|FG001|Overall Study|Subject no longer requires study drug|0|||
148958949|NCT00877383|537332721|FG000|Overall Study|Administrative problems|2|||
148958950|NCT00877383|537332722|FG001|Overall Study|Administrative problems|0|||
148958951|NCT00877383|537332721|FG000|Overall Study|Protocol deviation|2|||
148958952|NCT00877383|537332722|FG001|Overall Study|Protocol deviation|6|||
148958953|NCT00877383|537332721|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148958954|NCT00877383|537332722|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148958955|NCT00877383|537332721|FG000|Overall Study|Death|1|||
148958956|NCT00877383|537332722|FG001|Overall Study|Death|2|||
148958957|NCT01705652|537332724|FG000|Overall Study|Adverse Event|1|||
148958958|NCT01705652|537332725|FG001|Overall Study|Adverse Event|0|||
148958959|NCT01705652|537332724|FG000|Overall Study|Withdrawal by Subject|1|||
148958960|NCT01705652|537332725|FG001|Overall Study|Withdrawal by Subject|2|||
148958961|NCT01705652|537332724|FG000|Overall Study|non-compliance|1|||
148958962|NCT01705652|537332725|FG001|Overall Study|non-compliance|1|||
148958963|NCT00656474|537332726|FG000|Overall Study|Other Reason|1|||
148958964|NCT01614067|537332727|FG000|Overall Study|Pregnancy|1|||
148958965|NCT01614067|537332728|FG001|Overall Study|Pregnancy|0|||
148958966|NCT01614067|537332727|FG000|Overall Study|Physician Decision|6|||
148958967|NCT01614067|537332728|FG001|Overall Study|Physician Decision|5|||
148958968|NCT01614067|537332727|FG000|Overall Study|Withdrawal by Subject|0|||
148958969|NCT01614067|537332728|FG001|Overall Study|Withdrawal by Subject|1|||
148958970|NCT01614067|537332727|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
148958971|NCT01614067|537332728|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
148958972|NCT01505868|537332729|FG000|Overall Study|Withdrawal by Subject|1|||
148958973|NCT01505868|537332730|FG001|Overall Study|Withdrawal by Subject|0|||
148958974|NCT01505868|537332731|FG002|Overall Study|Withdrawal by Subject|0|||
148958975|NCT01505868|537332732|FG003|Overall Study|Withdrawal by Subject|0|||
148958976|NCT01505868|537332733|FG004|Overall Study|Withdrawal by Subject|0|||
148958977|NCT02062879|537332734|FG000|Overall Study|Withdrawal by Subject|4|||
148958978|NCT02062879|537332735|FG001|Overall Study|Withdrawal by Subject|1|||
148958979|NCT00056407|537332736|FG000|Overall Study|Adverse Event|282|||
148958980|NCT00056407|537332737|FG001|Overall Study|Adverse Event|364|||
148958981|NCT00056407|537332736|FG000|Overall Study|Withdrawal by Subject|377|||
148958982|NCT00056407|537332737|FG001|Overall Study|Withdrawal by Subject|361|||
148958983|NCT00056407|537332736|FG000|Overall Study|Lost to Follow-up|123|||
148692292|NCT00770315|536346068|FG002|Overall Study|Noncompliance with Protocol|7|||
148692293|NCT00770315|536346069|FG003|Overall Study|Noncompliance with Protocol|9|||
148692294|NCT04256421|536346070|FG000|Overall Study|Death|171|||
148692295|NCT04256421|536346071|FG001|Overall Study|Death|180|||
148692296|NCT04256421|536346070|FG000|Overall Study|Lost to Follow-up|1|||
148692297|NCT04256421|536346071|FG001|Overall Study|Lost to Follow-up|1|||
148958984|NCT00056407|537332737|FG001|Overall Study|Lost to Follow-up|113|||
148958985|NCT00056407|537332736|FG000|Overall Study|Protocol Violation|104|||
148958986|NCT00056407|537332737|FG001|Overall Study|Protocol Violation|95|||
148958987|NCT00056407|537332736|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
148958988|NCT00056407|537332737|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
148958989|NCT00056407|537332736|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
148692298|NCT04256421|536346070|FG000|Overall Study|Withdrawal by Subject|9|||
148692299|NCT04256421|536346071|FG001|Overall Study|Withdrawal by Subject|10|||
148692300|NCT04256421|536346070|FG000|Overall Study|Ongoing in Study|66|||
148692301|NCT04256421|536346071|FG001|Overall Study|Ongoing in Study|52|||
148692302|NCT02785913|536347715|FG000|Overall Study|Adverse Event|5|||
148692303|NCT02785913|536347715|FG000|Overall Study|Death|2|||
148692304|NCT02785913|536347715|FG000|Overall Study|Progression|18|||
148692305|NCT02785913|536347715|FG000|Overall Study|Not protocol specified|1|||
148692306|NCT02841709|536347716|FG000|5th Intervention|Adverse Event|2|||
148692307|NCT02841709|536347717|FG001|5th Intervention|Adverse Event|0|||
148692308|NCT02841709|536347718|FG002|5th Intervention|Adverse Event|0|||
148692309|NCT02841709|536347719|FG003|5th Intervention|Adverse Event|0|||
148692310|NCT02841709|536347720|FG004|5th Intervention|Adverse Event|2|||
148692311|NCT01929109|536347721|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
148692312|NCT01929109|536347722|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
148692313|NCT01929109|536347723|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
148692314|NCT01929109|536347724|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
148692315|NCT01929109|536347725|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
148692316|NCT01052116|536347726|FG000|Overall Study|Lost to Follow-up|11|||
148692317|NCT01052116|536347727|FG001|Overall Study|Lost to Follow-up|17|||
148692318|NCT01052116|536347726|FG000|Overall Study|Withdrawal by Subject|3|||
148692319|NCT01052116|536347727|FG001|Overall Study|Withdrawal by Subject|6|||
148692320|NCT01052116|536347726|FG000|Overall Study|Spirometry not performed|0|||
148692321|NCT01052116|536347727|FG001|Overall Study|Spirometry not performed|4|||
148692322|NCT01402908|536347728|FG000|Overall Study|Withdrawal by Subject|30|||
148692323|NCT01402908|536347729|FG001|Overall Study|Withdrawal by Subject|17|||
148692324|NCT01402908|536347728|FG000|Overall Study|Lost to Follow-up|3|||
148811715|NCT03765073|536787090|FG019|Stage 2|Withdrawal by Subject|0|||
148811716|NCT03765073|536787091|FG020|Stage 2|Withdrawal by Subject|0|||
148958990|NCT00056407|537332737|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
148958991|NCT00056407|537332736|FG000|Overall Study|Missing|25|||
148958992|NCT00056407|537332737|FG001|Overall Study|Missing|34|||
148958993|NCT00616655|537332738|FG000|Overall Study|Adverse Event|10|||
148958994|NCT00616655|537332739|FG001|Overall Study|Adverse Event|7|||
148958995|NCT00616655|537332740|FG002|Overall Study|Adverse Event|12|||
148958996|NCT00616655|537332738|FG000|Overall Study|Lack of Efficacy|5|||
148958997|NCT00616655|537332739|FG001|Overall Study|Lack of Efficacy|5|||
148958998|NCT00616655|537332740|FG002|Overall Study|Lack of Efficacy|5|||
148958999|NCT00616655|537332738|FG000|Overall Study|Lost to Follow-up|3|||
148959000|NCT00616655|537332739|FG001|Overall Study|Lost to Follow-up|12|||
148959001|NCT00616655|537332740|FG002|Overall Study|Lost to Follow-up|10|||
148959002|NCT00616655|537332738|FG000|Overall Study|Protocol Violation|2|||
148959003|NCT00616655|537332739|FG001|Overall Study|Protocol Violation|4|||
148959004|NCT00616655|537332740|FG002|Overall Study|Protocol Violation|3|||
148959005|NCT00616655|537332738|FG000|Overall Study|Withdrawal by Subject|9|||
148959006|NCT00616655|537332739|FG001|Overall Study|Withdrawal by Subject|7|||
148959007|NCT00616655|537332740|FG002|Overall Study|Withdrawal by Subject|11|||
148959008|NCT00616655|537332738|FG000|Overall Study|Does not meet in/ex criteria|0|||
148959009|NCT00616655|537332739|FG001|Overall Study|Does not meet in/ex criteria|0|||
148959010|NCT00616655|537332740|FG002|Overall Study|Does not meet in/ex criteria|2|||
148959011|NCT00616655|537332738|FG000|Overall Study|Other|6|||
148959012|NCT00616655|537332739|FG001|Overall Study|Other|6|||
148959013|NCT00616655|537332740|FG002|Overall Study|Other|5|||
148959014|NCT03761147|537332741|FG000|Overall Study|Withdrawal by Subject|6|||
148959015|NCT03761147|537332742|FG001|Overall Study|Withdrawal by Subject|1|||
148959016|NCT03761147|537332741|FG000|Overall Study|Adverse Event|1|||
148959017|NCT03761147|537332742|FG001|Overall Study|Adverse Event|3|||
148959018|NCT00309842|537332743|FG000|Overall Study|Lost to Follow-up|1|||
148959019|NCT03564145|537332744|FG000|Overall Study|Adverse Event|4|||
148959020|NCT03564145|537332744|FG000|Overall Study|Lost to Follow-up|21|||
148959021|NCT03564145|537332744|FG000|Overall Study|Protocol Violation|2|||
148959022|NCT03564145|537332744|FG000|Overall Study|Withdrawal by Subject|48|||
148959023|NCT03564145|537332744|FG000|Overall Study|Study Terminated by Sponsor|146|||
149022754|NCT01782326|537560651|FG001|Double-blind Treatment|Physician Decision|16|||
148692325|NCT01402908|536347729|FG001|Overall Study|Lost to Follow-up|1|||
148692326|NCT01402908|536347728|FG000|Overall Study|Physician Decision|1|||
148692327|NCT01402908|536347729|FG001|Overall Study|Physician Decision|0|||
148692328|NCT01739790|536347730|FG000|Overall Study|Early Trial Termination|2|||
148692329|NCT01739790|536347731|FG001|Overall Study|Early Trial Termination|4|||
148692330|NCT02581345|536347732|FG000|Part 1: up to Week 16|Adverse Event|3|||
148692331|NCT02581345|536347733|FG001|Part 1: up to Week 16|Adverse Event|8|||
148692332|NCT02581345|536347734|FG002|Part 1: up to Week 16|Adverse Event|0|||
148692333|NCT02581345|536347735|FG003|Part 1: up to Week 16|Adverse Event|0|||
148811717|NCT03765073|536787071|FG000|Stage 3|Adverse Event|0|||
148959024|NCT03564145|537332744|FG000|Overall Study|Physician Decision|1|||
148959025|NCT03564145|537332744|FG000|Overall Study|Other Than Specified|1|||
148959026|NCT03564145|537332744|FG000|Overall Study|Pregnancy|1|||
148959027|NCT00353262|537332747|FG000|Overall Study|Adverse Event|8|||
149022755|NCT01782326|537560650|FG000|Double-blind Treatment|Protocol deviation|8|||
149022756|NCT01782326|537560651|FG001|Double-blind Treatment|Protocol deviation|7|||
149022757|NCT01782326|537560650|FG000|Double-blind Treatment|Technical problems|0|||
149022758|NCT01782326|537560651|FG001|Double-blind Treatment|Technical problems|5|||
149022759|NCT04894903|537560652|FG000|Overall Study|Death|1|||
149022760|NCT04894903|537560653|FG001|Overall Study|Death|0|||
149022761|NCT04894903|537560652|FG000|Overall Study|Pregnancy|1|||
149022762|NCT04894903|537560653|FG001|Overall Study|Pregnancy|0|||
149022763|NCT04894903|537560652|FG000|Overall Study|Withdrawal by Subject|1|||
149022764|NCT04894903|537560653|FG001|Overall Study|Withdrawal by Subject|1|||
149022765|NCT04894903|537560652|FG000|Overall Study|moved or exited health system|1|||
149022766|NCT04894903|537560653|FG001|Overall Study|moved or exited health system|3|||
149022767|NCT01822353|537560655|FG000|Overall Study|Adverse Event|1|||
149022768|NCT01822353|537560656|FG001|Overall Study|Adverse Event|3|||
149022769|NCT01822353|537560657|FG002|Overall Study|Adverse Event|1|||
149022770|NCT01822353|537560655|FG000|Overall Study|Pregnancy|0|||
149022771|NCT01822353|537560656|FG001|Overall Study|Pregnancy|1|||
149022772|NCT01822353|537560657|FG002|Overall Study|Pregnancy|0|||
149022773|NCT01822353|537560655|FG000|Overall Study|Withdrawal by Subject|3|||
149022774|NCT01822353|537560656|FG001|Overall Study|Withdrawal by Subject|1|||
149022775|NCT01822353|537560657|FG002|Overall Study|Withdrawal by Subject|0|||
149022776|NCT02550873|537560658|FG000|Randomized Double Blind|Adverse Event|3|||
149022777|NCT02550873|537560659|FG001|Randomized Double Blind|Adverse Event|1|||
149022778|NCT02550873|537560660|FG002|Randomized Double Blind|Adverse Event|0|||
149022779|NCT02550873|537560658|FG000|Randomized Double Blind|Disease progression|1|||
149022780|NCT02550873|537560659|FG001|Randomized Double Blind|Disease progression|1|||
149022781|NCT02550873|537560660|FG002|Randomized Double Blind|Disease progression|0|||
149022782|NCT02550873|537560658|FG000|Open Label Extension|Study ongoing|0|||
149022783|NCT02550873|537560659|FG001|Open Label Extension|Study ongoing|0|||
149022784|NCT02550873|537560660|FG002|Open Label Extension|Study ongoing|111|||
149022785|NCT04320615|537560661|FG000|Overall Study|Withdrawal by Subject|4|||
149022786|NCT04320615|537560662|FG001|Overall Study|Withdrawal by Subject|10|||
149022787|NCT04320615|537560661|FG000|Overall Study|Physician Decision|2|||
149022788|NCT04320615|537560662|FG001|Overall Study|Physician Decision|0|||
149022789|NCT04320615|537560661|FG000|Overall Study|Other|2|||
149022790|NCT04320615|537560662|FG001|Overall Study|Other|0|||
149022791|NCT04320615|537560661|FG000|Overall Study|Lost to Follow-up|5|||
149022792|NCT04320615|537560662|FG001|Overall Study|Lost to Follow-up|23|||
149022793|NCT04320615|537560661|FG000|Overall Study|Death|35|||
149022794|NCT04320615|537560662|FG001|Overall Study|Death|71|||
149022795|NCT00003509|537560664|FG000|Overall Study|Not evaluable|5|||
149022796|NCT00810641|537560665|FG000|Overall Study|Withdrawal by Subject|0|||
149022797|NCT00810641|537560666|FG001|Overall Study|Withdrawal by Subject|1|||
149022798|NCT00810641|537560667|FG002|Overall Study|Withdrawal by Subject|2|||
149022799|NCT01556243|537560668|FG000|Overall Study|Ineligible|34|||
149022800|NCT01556243|537560668|FG000|Overall Study|Converted to mastectomy|14|||
149022801|NCT01556243|537560668|FG000|Overall Study|Unable to achieve negative margins|2|||
149022802|NCT01556243|537560668|FG000|Overall Study|Withdrawal by Subject|16|||
148811718|NCT03765073|536787072|FG001|Stage 3|Adverse Event|0|||
149022803|NCT02684903|537560669|FG000|Overall Study|COVID-19 shutdown of lab|4|||
149022804|NCT02684903|537560670|FG001|Overall Study|COVID-19 shutdown of lab|6|||
149022805|NCT02684903|537560669|FG000|Overall Study|Lost to Follow-up|31|||
149022806|NCT02684903|537560670|FG001|Overall Study|Lost to Follow-up|41|||
149022807|NCT00904150|537560671|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
149022808|NCT00904150|537560672|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
149022809|NCT00904150|537560671|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
149022810|NCT00904150|537560672|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
149022811|NCT00432159|537562558|FG000|Overall Study|Death|0|||
149022812|NCT00432159|537562559|FG001|Overall Study|Death|1|||
149022813|NCT00432159|537562560|FG002|Overall Study|Death|0|||
149022814|NCT00432159|537562561|FG003|Overall Study|Death|0|||
149022815|NCT00432159|537562562|FG004|Overall Study|Death|0|||
149022816|NCT00432159|537562558|FG000|Overall Study|Failure|9|||
149022817|NCT00432159|537562559|FG001|Overall Study|Failure|5|||
149022818|NCT00432159|537562560|FG002|Overall Study|Failure|3|||
149022819|NCT00432159|537562561|FG003|Overall Study|Failure|2|||
149022820|NCT00432159|537562562|FG004|Overall Study|Failure|3|||
149022821|NCT00432159|537562558|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
149022822|NCT00432159|537562559|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
149022823|NCT00432159|537562560|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
149022824|NCT00432159|537562561|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
149022825|NCT00432159|537562562|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
149022826|NCT01939158|537562564|FG000|Overall Study|Adverse Event|1|||
149022827|NCT01939158|537562565|FG001|Overall Study|Adverse Event|0|||
149022828|NCT01939158|537562566|FG002|Overall Study|Adverse Event|0|||
149022829|NCT01939158|537562567|FG003|Overall Study|Adverse Event|0|||
149022830|NCT01939158|537562564|FG000|Overall Study|Withdrawal by Subject|22|||
149022831|NCT01939158|537562565|FG001|Overall Study|Withdrawal by Subject|25|||
149022832|NCT01939158|537562566|FG002|Overall Study|Withdrawal by Subject|15|||
149022833|NCT01939158|537562567|FG003|Overall Study|Withdrawal by Subject|17|||
149022834|NCT01939158|537562564|FG000|Overall Study|Migrated/moved from study area|5|||
149022835|NCT01939158|537562565|FG001|Overall Study|Migrated/moved from study area|7|||
149022836|NCT01939158|537562566|FG002|Overall Study|Migrated/moved from study area|3|||
149022837|NCT01939158|537562567|FG003|Overall Study|Migrated/moved from study area|6|||
149022838|NCT01939158|537562564|FG000|Overall Study|Lost to Follow-up|18|||
149022839|NCT01939158|537562565|FG001|Overall Study|Lost to Follow-up|17|||
149022840|NCT01939158|537562566|FG002|Overall Study|Lost to Follow-up|17|||
149022841|NCT01939158|537562567|FG003|Overall Study|Lost to Follow-up|17|||
149022842|NCT01939158|537562564|FG000|Overall Study|Death|0|||
149022843|NCT01939158|537562565|FG001|Overall Study|Death|0|||
149022844|NCT01939158|537562566|FG002|Overall Study|Death|1|||
149022845|NCT01939158|537562567|FG003|Overall Study|Death|1|||
149022846|NCT01939158|537562564|FG000|Overall Study|No longer meets eligibility criteria|0|||
149022847|NCT01939158|537562565|FG001|Overall Study|No longer meets eligibility criteria|0|||
149022848|NCT01939158|537562566|FG002|Overall Study|No longer meets eligibility criteria|1|||
149022849|NCT01939158|537562567|FG003|Overall Study|No longer meets eligibility criteria|0|||
149022850|NCT01939158|537562564|FG000|Overall Study|Other|1|||
149022851|NCT01939158|537562565|FG001|Overall Study|Other|3|||
149022852|NCT01939158|537562566|FG002|Overall Study|Other|4|||
149022853|NCT01939158|537562567|FG003|Overall Study|Other|3|||
149022854|NCT02123966|537562568|FG000|Overall Study|Intercurrent Illness|1|||
149022855|NCT01460381|537562569|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
149022856|NCT01460381|537562570|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
149022857|NCT01097655|537562571|FG000|Overall Study|Withdrawal by Subject|1|||
149022858|NCT01097655|537562571|FG000|Overall Study|Subject Documented Twice|1|||
149022859|NCT01097655|537562571|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
149022860|NCT03527277|537562573|FG000|Overall Study|Withdrawal by Subject|5|||
149022861|NCT03527277|537562574|FG001|Overall Study|Withdrawal by Subject|0|||
149022862|NCT03527277|537562573|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
149022863|NCT03527277|537562574|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
149022864|NCT03527277|537562573|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
148959028|NCT00353262|537332747|FG000|Overall Study|Withdrawal by Subject|2|||
148959029|NCT00353262|537332747|FG000|Overall Study|Insufficient Therapeutic Response|13|||
148959030|NCT00353262|537332747|FG000|Overall Study|Progression|1|||
148959031|NCT00353262|537332747|FG000|Overall Study|Surgery|4|||
148959032|NCT00353262|537332747|FG000|Overall Study|Break from Chemotherapy|1|||
148959033|NCT00670800|537334057|FG000|Overall Study|2 controls were insulin resistant|0|||
148959034|NCT00670800|537334058|FG001|Overall Study|2 controls were insulin resistant|2|||
148959035|NCT01786629|537334059|FG000|Overall Study|Lack of Efficacy|0|||
148959036|NCT01786629|537334060|FG001|Overall Study|Lack of Efficacy|4|||
148959037|NCT01786629|537334059|FG000|Overall Study|Adverse Event|0|||
148959038|NCT01786629|537334060|FG001|Overall Study|Adverse Event|1|||
148959039|NCT00410761|537334061|FG000|Randomized Treatment Period|Adverse Event|34|||
148959040|NCT00410761|537334062|FG001|Randomized Treatment Period|Adverse Event|3|||
149022865|NCT03527277|537562574|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
149022866|NCT02652130|537562579|FG000|Overall Study|Death|1|||
149022867|NCT03930186|537562580|FG000|Weeks 0 to 16|Adverse Event|6|||
149022868|NCT03930186|537562580|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
149022869|NCT03930186|537562580|FG000|Weeks 16 to 32|Adverse Event|1|||
149022870|NCT03930186|537562580|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
149022871|NCT05968482|537562586|FG000|First Crossover Period|Withdrawal by Subject|0|||
149022872|NCT05968482|537562587|FG001|First Crossover Period|Withdrawal by Subject|0|||
148811719|NCT03765073|536787073|FG002|Stage 3|Adverse Event|0|||
148959041|NCT00410761|537334061|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
148959042|NCT00410761|537334062|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
148959043|NCT00410761|537334061|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
148811720|NCT03765073|536787074|FG003|Stage 3|Adverse Event|0|||
148959044|NCT00410761|537334062|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
148959045|NCT00410761|537334061|FG000|Randomized Treatment Period|Other|69|||
148959046|NCT00410761|537334062|FG001|Randomized Treatment Period|Other|21|||
148959047|NCT00410761|537334061|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
148959048|NCT00410761|537334062|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
148959049|NCT00410761|537334061|FG000|Open-Label Treatment Period|Adverse Event|13|||
148959050|NCT00410761|537334062|FG001|Open-Label Treatment Period|Adverse Event|15|||
148692334|NCT02581345|536347732|FG000|Part 1: up to Week 16|Physician Decision|2|||
148692335|NCT02581345|536347733|FG001|Part 1: up to Week 16|Physician Decision|4|||
148692336|NCT02581345|536347734|FG002|Part 1: up to Week 16|Physician Decision|0|||
148692337|NCT02581345|536347735|FG003|Part 1: up to Week 16|Physician Decision|0|||
148692338|NCT02581345|536347732|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
148692339|NCT02581345|536347733|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
148692340|NCT02581345|536347734|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
148692341|NCT02581345|536347735|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
148692342|NCT02581345|536347732|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
148692343|NCT02581345|536347733|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
148959051|NCT00410761|537334061|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
148692344|NCT02581345|536347734|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
148692345|NCT02581345|536347735|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
148692346|NCT02581345|536347732|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
148692347|NCT02581345|536347733|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
148692348|NCT02581345|536347734|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
148692349|NCT02581345|536347735|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
148692350|NCT02581345|536347732|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
148692351|NCT02581345|536347733|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
148692352|NCT02581345|536347734|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
148692353|NCT02581345|536347735|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
148692354|NCT02581345|536347732|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
148692355|NCT02581345|536347733|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
148692356|NCT02581345|536347734|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
148692357|NCT02581345|536347735|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
148692358|NCT02581345|536347732|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
148692359|NCT02581345|536347733|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
148692360|NCT02581345|536347734|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
148692361|NCT02581345|536347735|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
148692362|NCT02581345|536347732|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
148692363|NCT02581345|536347733|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
148692364|NCT02581345|536347734|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
148692365|NCT02581345|536347735|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
148692366|NCT02581345|536347732|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
148692367|NCT02581345|536347733|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
148959052|NCT00410761|537334062|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
148959053|NCT00410761|537334061|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
148959054|NCT00410761|537334062|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
148959055|NCT00410761|537334061|FG000|Open-Label Treatment Period|Other|18|||
148959056|NCT00410761|537334062|FG001|Open-Label Treatment Period|Other|9|||
148959057|NCT01852942|537334064|FG000|Overall Study|Physician Decision|1|||
148959058|NCT01852942|537334065|FG001|Overall Study|Physician Decision|0|||
148959059|NCT01852942|537334064|FG000|Overall Study|Death|1|||
148959060|NCT01852942|537334065|FG001|Overall Study|Death|1|||
148959061|NCT01852942|537334064|FG000|Overall Study|Withdrawal by Subject|2|||
148959062|NCT01852942|537334065|FG001|Overall Study|Withdrawal by Subject|3|||
148959063|NCT01852942|537334064|FG000|Overall Study|Lost to Follow-up|1|||
148959064|NCT01852942|537334065|FG001|Overall Study|Lost to Follow-up|2|||
148959065|NCT00696696|537334066|FG000|Overall Study|Adverse Event|5|||
148959066|NCT00696696|537334066|FG000|Overall Study|Withdrawal by Subject|8|||
148959067|NCT00696696|537334066|FG000|Overall Study|Physician Decision|2|||
148959068|NCT00696696|537334066|FG000|Overall Study|Death|3|||
148959069|NCT02642614|537334067|FG000|Overall Study|Adverse Event|1|||
148959070|NCT02642614|537334068|FG001|Overall Study|Adverse Event|1|||
148959071|NCT02642614|537334069|FG002|Overall Study|Adverse Event|2|||
148959072|NCT02642614|537334070|FG003|Overall Study|Adverse Event|2|||
148692368|NCT02581345|536347734|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
148692369|NCT02581345|536347735|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
148692370|NCT02581345|536347732|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
148692371|NCT02581345|536347733|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
148811721|NCT03765073|536787075|FG004|Stage 3|Adverse Event|0|||
148959073|NCT02642614|537334067|FG000|Overall Study|Lost to Follow-up|1|||
148959074|NCT02642614|537334068|FG001|Overall Study|Lost to Follow-up|0|||
148959075|NCT02642614|537334069|FG002|Overall Study|Lost to Follow-up|0|||
148959076|NCT02642614|537334070|FG003|Overall Study|Lost to Follow-up|0|||
148959077|NCT02642614|537334067|FG000|Overall Study|Withdrawal by Subject|1|||
148959078|NCT02642614|537334068|FG001|Overall Study|Withdrawal by Subject|1|||
148959079|NCT02642614|537334069|FG002|Overall Study|Withdrawal by Subject|0|||
148959080|NCT02642614|537334070|FG003|Overall Study|Withdrawal by Subject|0|||
148959081|NCT01485640|537334071|FG000|Overall Study|Adverse Event|10|||
148959082|NCT01485640|537334071|FG000|Overall Study|Lack of Efficacy|2|||
148959083|NCT01485640|537334071|FG000|Overall Study|Protocol Violation|1|||
148959084|NCT01485640|537334071|FG000|Overall Study|Withdrawal by Subject|14|||
148959085|NCT01485640|537334071|FG000|Overall Study|Terminated by Sponsor|95|||
148959086|NCT02489344|537334075|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
148959087|NCT02489344|537334075|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
148692372|NCT02581345|536347734|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
148959088|NCT02489344|537334075|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
148959089|NCT02489344|537334075|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
148959090|NCT00605813|537334076|FG000|Overall Study|Protocol Violation|25|||
148959091|NCT00573755|537334081|FG000|Overall Study|Still receiving treatment|1|||
148692373|NCT02581345|536347735|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
148692374|NCT02581345|536347732|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
148692375|NCT02581345|536347733|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
148692376|NCT02581345|536347734|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
148692377|NCT02581345|536347735|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
148692378|NCT03471078|536347743|FG000|Overall Study|Withdrawal by Subject|9|||
148692379|NCT03471078|536347744|FG001|Overall Study|Withdrawal by Subject|1|||
148692380|NCT03471078|536347743|FG000|Overall Study|Adverse Event|4|||
148692381|NCT03471078|536347744|FG001|Overall Study|Adverse Event|1|||
148692382|NCT03471078|536347743|FG000|Overall Study|Physician Decision|3|||
148692383|NCT03471078|536347744|FG001|Overall Study|Physician Decision|2|||
148692384|NCT03471078|536347743|FG000|Overall Study|Death|2|||
148692385|NCT03471078|536347744|FG001|Overall Study|Death|0|||
148692386|NCT03471078|536347743|FG000|Overall Study|Other|3|||
148692387|NCT03471078|536347744|FG001|Overall Study|Other|2|||
148692388|NCT00862979|536347750|FG000|Overall Study|Adverse Event|6|||
148692389|NCT00862979|536347751|FG001|Overall Study|Adverse Event|3|||
148692390|NCT00862979|536347750|FG000|Overall Study|Protocol Violation|0|||
148692391|NCT00862979|536347751|FG001|Overall Study|Protocol Violation|1|||
148692392|NCT00862979|536347750|FG000|Overall Study|Patient withdrew consent|2|||
148692393|NCT00862979|536347751|FG001|Overall Study|Patient withdrew consent|1|||
148692394|NCT00862979|536347750|FG000|Overall Study|Administrative problems|0|||
148692395|NCT00862979|536347751|FG001|Overall Study|Administrative problems|1|||
148692396|NCT00862979|536347750|FG000|Overall Study|Death|0|||
148692397|NCT00862979|536347751|FG001|Overall Study|Death|1|||
148692398|NCT05568225|536347752|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
148692399|NCT05568225|536347753|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
148692400|NCT05568225|536347754|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
148692401|NCT05568225|536347752|FG000|Primary Treatment Period|Physician Decision|0|||
148692402|NCT05568225|536347753|FG001|Primary Treatment Period|Physician Decision|1|||
148692403|NCT05568225|536347754|FG002|Primary Treatment Period|Physician Decision|0|||
148692404|NCT05568225|536347752|FG000|Primary Treatment Period|Disease progression|0|||
148692405|NCT05568225|536347753|FG001|Primary Treatment Period|Disease progression|1|||
148692406|NCT05568225|536347754|FG002|Primary Treatment Period|Disease progression|0|||
148692407|NCT05568225|536347752|FG000|Primary Treatment Period|Lack of Efficacy|0|||
148692408|NCT05568225|536347753|FG001|Primary Treatment Period|Lack of Efficacy|1|||
148692409|NCT05568225|536347754|FG002|Primary Treatment Period|Lack of Efficacy|0|||
148692410|NCT05568225|536347752|FG000|Primary Treatment Period|Withdrawal of conset|1|||
148692411|NCT05568225|536347753|FG001|Primary Treatment Period|Withdrawal of conset|0|||
148692412|NCT05568225|536347754|FG002|Primary Treatment Period|Withdrawal of conset|4|||
148692413|NCT05568225|536347752|FG000|Primary Treatment Period|Adverse Event|1|||
148692414|NCT05568225|536347753|FG001|Primary Treatment Period|Adverse Event|0|||
148692415|NCT05568225|536347754|FG002|Primary Treatment Period|Adverse Event|0|||
148692416|NCT05568225|536347752|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
148692417|NCT05568225|536347753|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
148692418|NCT05568225|536347754|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
148692419|NCT05568225|536347752|FG000|Extension Treatment Period|Protocol Violation|0|||
148692420|NCT05568225|536347753|FG001|Extension Treatment Period|Protocol Violation|0|||
148692421|NCT05568225|536347754|FG002|Extension Treatment Period|Protocol Violation|1|||
148811722|NCT03765073|536787076|FG005|Stage 3|Adverse Event|0|||
148959092|NCT00573755|537334082|FG001|Overall Study|Still receiving treatment|0|||
148959093|NCT01870583|537334087|FG000|Overall Study|Protocol Violation|0|||
148692422|NCT05568225|536347752|FG000|Extension Treatment Period|Lack of Efficacy|0|||
148692423|NCT05568225|536347753|FG001|Extension Treatment Period|Lack of Efficacy|0|||
148692424|NCT05568225|536347754|FG002|Extension Treatment Period|Lack of Efficacy|1|||
148692425|NCT01027143|536347757|FG000|Overall Study|Lost to Follow-up|9|||
148692426|NCT01027143|536347758|FG001|Overall Study|Lost to Follow-up|4|||
148692427|NCT02309099|536347769|FG000|Overall Study|Adverse Event|2|||
148692428|NCT02309099|536347770|FG001|Overall Study|Adverse Event|0|||
148692429|NCT02819362|536347772|FG000|Overall Study|On-site MRI could not be performed|70|||
148692430|NCT05301751|536347773|FG000|Overall Study|Withdrawal by Subject|0|||
148959094|NCT01870583|537334088|FG001|Overall Study|Protocol Violation|5|||
148692431|NCT05301751|536347774|FG001|Overall Study|Withdrawal by Subject|0|||
148692432|NCT05301751|536347775|FG002|Overall Study|Withdrawal by Subject|1|||
148692433|NCT05301751|536347776|FG003|Overall Study|Withdrawal by Subject|0|||
148692434|NCT00797108|536347780|FG000|Overall Study|Adverse Event|1|||
148692435|NCT00797108|536347781|FG001|Overall Study|Adverse Event|0|||
148692436|NCT00797108|536347782|FG002|Overall Study|Adverse Event|3|||
148692437|NCT00797108|536347780|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
148692438|NCT00797108|536347781|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
148692439|NCT00797108|536347782|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
148692440|NCT00797108|536347780|FG000|Overall Study|Global Deterioration of Health Status|0|||
148692441|NCT00797108|536347781|FG001|Overall Study|Global Deterioration of Health Status|1|||
148692442|NCT00797108|536347782|FG002|Overall Study|Global Deterioration of Health Status|0|||
148692443|NCT00797108|536347780|FG000|Overall Study|Lack of Efficacy|1|||
148692444|NCT00797108|536347781|FG001|Overall Study|Lack of Efficacy|0|||
148692445|NCT00797108|536347782|FG002|Overall Study|Lack of Efficacy|1|||
148692446|NCT00797108|536347780|FG000|Overall Study|Other|0|||
148692447|NCT00797108|536347781|FG001|Overall Study|Other|0|||
148692448|NCT00797108|536347782|FG002|Overall Study|Other|2|||
148692449|NCT00797108|536347780|FG000|Overall Study|Randomized but not Treated|2|||
148692450|NCT00797108|536347781|FG001|Overall Study|Randomized but not Treated|0|||
148692451|NCT00797108|536347782|FG002|Overall Study|Randomized but not Treated|0|||
148692452|NCT02518113|536347783|FG000|Overall Study|Adverse Event|1|||
148692453|NCT02518113|536347784|FG001|Overall Study|Adverse Event|0|||
148692454|NCT02518113|536347785|FG002|Overall Study|Adverse Event|1|||
148692455|NCT02518113|536347786|FG003|Overall Study|Adverse Event|0|||
148692456|NCT02518113|536347783|FG000|Overall Study|Death|1|||
148692457|NCT02518113|536347784|FG001|Overall Study|Death|2|||
148959095|NCT01870583|537334089|FG002|Overall Study|Protocol Violation|3|||
148692458|NCT02518113|536347785|FG002|Overall Study|Death|0|||
148692459|NCT02518113|536347786|FG003|Overall Study|Death|0|||
148692460|NCT02518113|536347783|FG000|Overall Study|Physician Decision|0|||
148692461|NCT02518113|536347784|FG001|Overall Study|Physician Decision|1|||
148692462|NCT02518113|536347785|FG002|Overall Study|Physician Decision|0|||
148692463|NCT02518113|536347786|FG003|Overall Study|Physician Decision|0|||
148692464|NCT02518113|536347783|FG000|Overall Study|Progressive Disease|1|||
148692465|NCT02518113|536347784|FG001|Overall Study|Progressive Disease|2|||
148692466|NCT02518113|536347785|FG002|Overall Study|Progressive Disease|3|||
148959096|NCT01870583|537334087|FG000|Overall Study|Lost to Follow-up|11|||
148959097|NCT01870583|537334088|FG001|Overall Study|Lost to Follow-up|13|||
148692467|NCT02518113|536347786|FG003|Overall Study|Progressive Disease|0|||
148692468|NCT00287118|536347787|FG000|Overall Study|Adverse Event|30|||
148692469|NCT00287118|536347787|FG000|Overall Study|Death|1|||
148692470|NCT00287118|536347787|FG000|Overall Study|Lack of Efficacy|11|||
148959098|NCT01870583|537334089|FG002|Overall Study|Lost to Follow-up|5|||
148959099|NCT02369341|537334094|FG000|Overall Study|Migrated/moved from study area|1|||
148959100|NCT02369341|537334095|FG001|Overall Study|Migrated/moved from study area|0|||
148959101|NCT00674661|537334097|FG000|Overall Study|Other|5|||
148959102|NCT00674661|537334098|FG001|Overall Study|Other|7|||
148959103|NCT00674661|537334097|FG000|Overall Study|Lost to Follow-up|6|||
148959104|NCT00674661|537334098|FG001|Overall Study|Lost to Follow-up|3|||
148959105|NCT00674661|537334097|FG000|Overall Study|Withdrawal by Subject|0|||
148692471|NCT00287118|536347787|FG000|Overall Study|Lost to Follow-up|1|||
148692472|NCT00287118|536347787|FG000|Overall Study|Protocol Violation|2|||
148692473|NCT00287118|536347787|FG000|Overall Study|Other|7|||
148692474|NCT02324465|536347788|FG000|Overall Study|device failure|0|||
148692475|NCT02324465|536347789|FG001|Overall Study|device failure|1|||
148692476|NCT01631864|536347790|FG000|Overall Study|Withdrawal by Subject|0|||
148692477|NCT01631864|536347791|FG001|Overall Study|Withdrawal by Subject|1|||
148692478|NCT01631864|536347790|FG000|Overall Study|Adverse Event|2|||
148692479|NCT01631864|536347791|FG001|Overall Study|Adverse Event|3|||
148692480|NCT02132247|536347792|FG000|Overall Study|Protocol Violation|1|||
148692481|NCT02132247|536347793|FG001|Overall Study|Protocol Violation|0|||
148692482|NCT01860976|536347794|FG000|Blinded Treatment|Adverse Event|1|||
148692483|NCT01860976|536347795|FG001|Blinded Treatment|Adverse Event|3|||
148692484|NCT01860976|536347794|FG000|Blinded Treatment|Lack of Efficacy|5|||
148692485|NCT01860976|536347795|FG001|Blinded Treatment|Lack of Efficacy|12|||
148692486|NCT01860976|536347794|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
148692487|NCT01860976|536347795|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
148692488|NCT01860976|536347794|FG000|Blinded Treatment|Withdrawal by Subject|3|||
148692489|NCT01860976|536347795|FG001|Blinded Treatment|Withdrawal by Subject|5|||
148692490|NCT01860976|536347794|FG000|Blinded Treatment|Subject no longer met criteria|1|||
148692491|NCT01860976|536347795|FG001|Blinded Treatment|Subject no longer met criteria|0|||
148692492|NCT01860976|536347794|FG000|Blinded Treatment|Entered Open-Label in error|0|||
148692493|NCT01860976|536347795|FG001|Blinded Treatment|Entered Open-Label in error|1|||
148692494|NCT01860976|536347794|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
148692495|NCT01860976|536347795|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
148692496|NCT01860976|536347794|FG000|Open-Label|Adverse Event|2|||
148692497|NCT01860976|536347795|FG001|Open-Label|Adverse Event|4|||
148692498|NCT01860976|536347794|FG000|Open-Label|Lack of Efficacy|16|||
148692499|NCT01860976|536347795|FG001|Open-Label|Lack of Efficacy|8|||
148692500|NCT01860976|536347794|FG000|Open-Label|Lost to Follow-up|1|||
148692501|NCT01860976|536347795|FG001|Open-Label|Lost to Follow-up|2|||
148692502|NCT01860976|536347794|FG000|Open-Label|Subject request discontinue treatment|4|||
148692503|NCT01860976|536347795|FG001|Open-Label|Subject request discontinue treatment|3|||
148692504|NCT01860976|536347794|FG000|Open-Label|Withdrawal by Subject|4|||
148692505|NCT01860976|536347795|FG001|Open-Label|Withdrawal by Subject|1|||
148692506|NCT01860976|536347794|FG000|Open-Label|Other Reasons|1|||
148692507|NCT01860976|536347795|FG001|Open-Label|Other Reasons|1|||
148692508|NCT01860976|536347794|FG000|Long Term Extension|Adverse Event|4|||
148692509|NCT01860976|536347795|FG001|Long Term Extension|Adverse Event|0|||
148692510|NCT01860976|536347794|FG000|Long Term Extension|Lack of Efficacy|2|||
148692511|NCT01860976|536347795|FG001|Long Term Extension|Lack of Efficacy|0|||
148692512|NCT01860976|536347794|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
148692513|NCT01860976|536347795|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
148692514|NCT01860976|536347794|FG000|Long Term Extension|Lost to Follow-up|2|||
148692515|NCT01860976|536347795|FG001|Long Term Extension|Lost to Follow-up|0|||
148692516|NCT01860976|536347794|FG000|Long Term Extension|subject withdrew consent|7|||
148692517|NCT01860976|536347795|FG001|Long Term Extension|subject withdrew consent|0|||
148692518|NCT02153398|536347798|FG000|Overall Study|Withdrawal by Subject|1|||
148692519|NCT02153398|536347799|FG001|Overall Study|Withdrawal by Subject|0|||
148692520|NCT02153398|536347800|FG002|Overall Study|Withdrawal by Subject|0|||
148692521|NCT02153398|536347801|FG003|Overall Study|Withdrawal by Subject|0|||
148692522|NCT02153398|536347802|FG004|Overall Study|Withdrawal by Subject|0|||
148692523|NCT02153398|536347798|FG000|Overall Study|Adverse Event|0|||
148692524|NCT02153398|536347799|FG001|Overall Study|Adverse Event|0|||
148692525|NCT02153398|536347800|FG002|Overall Study|Adverse Event|1|||
148692526|NCT02153398|536347801|FG003|Overall Study|Adverse Event|1|||
148692527|NCT02153398|536347802|FG004|Overall Study|Adverse Event|0|||
148692528|NCT02204371|536347803|FG000|Overall Study|Adverse Event|1|||
148692529|NCT03803943|536347809|FG000|Overall Study|Withdrawal by Subject|2|||
148692530|NCT03803943|536347810|FG001|Overall Study|Withdrawal by Subject|2|||
148692531|NCT03803943|536347811|FG002|Overall Study|Withdrawal by Subject|2|||
148692532|NCT03803943|536347812|FG003|Overall Study|Withdrawal by Subject|2|||
148692533|NCT01574248|536347813|FG000|Overall Study|Withdrawal by Subject|2|||
148692534|NCT01574248|536347814|FG001|Overall Study|Withdrawal by Subject|0|||
148692535|NCT01574248|536347813|FG000|Overall Study|Missing primary endpoint data|1|||
148692536|NCT01574248|536347814|FG001|Overall Study|Missing primary endpoint data|0|||
148692537|NCT01781286|536347817|FG000|Overall Study|Lost to Follow-up|0|||
148692538|NCT01781286|536347818|FG001|Overall Study|Lost to Follow-up|0|||
148692539|NCT01781286|536347819|FG002|Overall Study|Lost to Follow-up|0|||
148692540|NCT01781286|536347820|FG003|Overall Study|Lost to Follow-up|0|||
148692541|NCT01781286|536347821|FG004|Overall Study|Lost to Follow-up|0|||
148692542|NCT01781286|536347822|FG005|Overall Study|Lost to Follow-up|1|||
148692543|NCT01781286|536347817|FG000|Overall Study|Time Constraints|2|||
148692544|NCT01781286|536347818|FG001|Overall Study|Time Constraints|0|||
148692545|NCT01781286|536347819|FG002|Overall Study|Time Constraints|2|||
148692546|NCT01781286|536347820|FG003|Overall Study|Time Constraints|0|||
148692547|NCT01781286|536347821|FG004|Overall Study|Time Constraints|0|||
148692548|NCT01781286|536347822|FG005|Overall Study|Time Constraints|0|||
148692549|NCT01781286|536347817|FG000|Overall Study|Noncompliance|0|||
148692550|NCT01781286|536347818|FG001|Overall Study|Noncompliance|0|||
148692551|NCT01781286|536347819|FG002|Overall Study|Noncompliance|0|||
148692552|NCT01781286|536347820|FG003|Overall Study|Noncompliance|1|||
148692553|NCT01781286|536347821|FG004|Overall Study|Noncompliance|0|||
148692554|NCT01781286|536347822|FG005|Overall Study|Noncompliance|0|||
148692555|NCT00995410|536347823|FG000|Overall Study|Adverse Event|51|||
148692556|NCT00995410|536347823|FG000|Overall Study|Withdrawal by Subject|7|||
148959106|NCT00674661|537334098|FG001|Overall Study|Withdrawal by Subject|5|||
148959107|NCT00597766|537334105|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
148959108|NCT00597766|537334106|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
148692557|NCT00995410|536347823|FG000|Overall Study|Lost to Follow-up|2|||
148692558|NCT00995410|536347823|FG000|Overall Study|Misc|28|||
148692559|NCT03594123|536347824|FG000|Overall Study|Lost to Follow-up|0|||
148692560|NCT03594123|536347825|FG001|Overall Study|Lost to Follow-up|1|||
148692561|NCT03594123|536347824|FG000|Overall Study|Adverse Event|8|||
148692562|NCT03594123|536347825|FG001|Overall Study|Adverse Event|5|||
148692563|NCT03594123|536347824|FG000|Overall Study|Site Terminated by Sponsor|4|||
148692564|NCT03594123|536347825|FG001|Overall Study|Site Terminated by Sponsor|1|||
148692565|NCT03594123|536347824|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
148692566|NCT03594123|536347825|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
148692567|NCT03594123|536347824|FG000|Overall Study|Lack of Efficacy|1|||
148692568|NCT03594123|536347825|FG001|Overall Study|Lack of Efficacy|0|||
149022873|NCT05968482|537562588|FG002|First Crossover Period|Withdrawal by Subject|1|||
148692569|NCT03594123|536347824|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
148692570|NCT03594123|536347825|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
148692571|NCT02483975|536347826|FG000|Overall Study|Adverse Event|0|||
148692572|NCT02483975|536347827|FG001|Overall Study|Adverse Event|1|||
149022874|NCT05968482|537562589|FG003|First Crossover Period|Withdrawal by Subject|0|||
149022875|NCT05968482|537562590|FG004|First Crossover Period|Withdrawal by Subject|0|||
149022876|NCT05968482|537562591|FG005|First Crossover Period|Withdrawal by Subject|0|||
149022877|NCT05968482|537562586|FG000|First Crossover Period|Adverse Event|0|||
149022878|NCT05968482|537562587|FG001|First Crossover Period|Adverse Event|0|||
149022879|NCT05968482|537562588|FG002|First Crossover Period|Adverse Event|0|||
149022880|NCT05968482|537562589|FG003|First Crossover Period|Adverse Event|0|||
149022881|NCT05968482|537562590|FG004|First Crossover Period|Adverse Event|0|||
148811723|NCT03765073|536787077|FG006|Stage 3|Adverse Event|0|||
149022882|NCT05968482|537562591|FG005|First Crossover Period|Adverse Event|1|||
148959109|NCT00597766|537334107|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
148959110|NCT00597766|537334105|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
148959111|NCT00597766|537334106|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
148959112|NCT00597766|537334107|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
148959113|NCT01166763|537334109|FG000|Overall Study|Withdrawal by Subject|3|||
148959114|NCT04339296|537334110|FG000|Overall Study|Refuse to participate after allocation|1|||
148811724|NCT03765073|536787078|FG007|Stage 3|Adverse Event|0|||
148811725|NCT03765073|536787079|FG008|Stage 3|Adverse Event|0|||
148811726|NCT03765073|536787080|FG009|Stage 3|Adverse Event|0|||
148959115|NCT04339296|537334111|FG001|Overall Study|Refuse to participate after allocation|1|||
148959116|NCT04339296|537334110|FG000|Overall Study|Withdrew after completion of baseline|2|||
148959117|NCT04339296|537334111|FG001|Overall Study|Withdrew after completion of baseline|1|||
148959118|NCT04339296|537334110|FG000|Overall Study|Lost to Follow-up|0|||
148959119|NCT04339296|537334111|FG001|Overall Study|Lost to Follow-up|4|||
148959120|NCT04339296|537334110|FG000|Overall Study|Discontinued intervention|5|||
148959121|NCT04339296|537334111|FG001|Overall Study|Discontinued intervention|3|||
148959122|NCT01909479|537334112|FG000|From Baseline to Week 26|Adverse Event|3|||
148959123|NCT01909479|537334113|FG001|From Baseline to Week 26|Adverse Event|2|||
148959124|NCT01909479|537334112|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
148959125|NCT01909479|537334113|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
148959126|NCT01909479|537334112|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
148959127|NCT01909479|537334113|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
148692573|NCT02483975|536347826|FG000|Overall Study|Lost to Follow-up|0|||
148959128|NCT01909479|537334112|FG000|26 - 52 Weeks|Adverse Event|0|||
148959129|NCT01909479|537334113|FG001|26 - 52 Weeks|Adverse Event|1|||
148959130|NCT01909479|537334112|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
148959131|NCT01909479|537334113|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
148959132|NCT01909479|537334112|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
148811727|NCT03765073|536787081|FG010|Stage 3|Adverse Event|0|||
148811728|NCT03765073|536787082|FG011|Stage 3|Adverse Event|0|||
148811729|NCT03765073|536787083|FG012|Stage 3|Adverse Event|0|||
148959133|NCT01909479|537334113|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
148959134|NCT01909479|537334112|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
148959135|NCT01909479|537334113|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
148959136|NCT01909479|537334112|FG000|52 Weeks to End of Study|Adverse Event|2|||
148959137|NCT01909479|537334113|FG001|52 Weeks to End of Study|Adverse Event|1|||
148959138|NCT01909479|537334112|FG000|52 Weeks to End of Study|Death|0|||
148692574|NCT02483975|536347827|FG001|Overall Study|Lost to Follow-up|1|||
148692575|NCT02483975|536347826|FG000|Overall Study|Physician Decision|2|||
148692576|NCT02483975|536347827|FG001|Overall Study|Physician Decision|0|||
148692577|NCT03365375|536347828|FG000|Overall Study|Withdrawal by Subject|0|||
148692578|NCT03365375|536347829|FG001|Overall Study|Withdrawal by Subject|1|||
148692579|NCT03365375|536347828|FG000|Overall Study|Lost to Follow-up|0|||
148692580|NCT03365375|536347829|FG001|Overall Study|Lost to Follow-up|4|||
148692581|NCT00818883|536347830|FG000|Overall Study|Adverse Event|28|||
148692582|NCT00818883|536347831|FG001|Overall Study|Adverse Event|19|||
148692583|NCT00818883|536347830|FG000|Overall Study|Protocol Violation|2|||
148692584|NCT00818883|536347831|FG001|Overall Study|Protocol Violation|2|||
148692585|NCT00818883|536347830|FG000|Overall Study|Lost to Follow-up|3|||
148692586|NCT00818883|536347831|FG001|Overall Study|Lost to Follow-up|2|||
148692587|NCT00818883|536347830|FG000|Overall Study|Withdrawal by Subject|16|||
148692588|NCT00818883|536347831|FG001|Overall Study|Withdrawal by Subject|14|||
148692589|NCT00818883|536347830|FG000|Overall Study|Lack of Efficacy|0|||
148692590|NCT00818883|536347831|FG001|Overall Study|Lack of Efficacy|2|||
148692591|NCT00818883|536347830|FG000|Overall Study|Other|2|||
148692592|NCT00818883|536347831|FG001|Overall Study|Other|7|||
148692593|NCT02166697|536347832|FG000|Overall Study|Protocol Violation|347|||
148692594|NCT01505530|536347836|FG000|Overall Study|Progressive Disease|19|||
148811730|NCT03765073|536787084|FG013|Stage 3|Adverse Event|0|||
148692595|NCT01505530|536347837|FG001|Overall Study|Progressive Disease|17|||
148692596|NCT01505530|536347838|FG002|Overall Study|Progressive Disease|18|||
148692597|NCT01505530|536347836|FG000|Overall Study|Adverse Event|1|||
148811731|NCT03765073|536787085|FG014|Stage 3|Adverse Event|0|||
148811732|NCT03765073|536787086|FG015|Stage 3|Adverse Event|0|||
148959139|NCT01909479|537334113|FG001|52 Weeks to End of Study|Death|1|||
148692598|NCT01505530|536347837|FG001|Overall Study|Adverse Event|1|||
148692599|NCT01505530|536347838|FG002|Overall Study|Adverse Event|0|||
148692600|NCT01505530|536347836|FG000|Overall Study|Withdrawal by Subject|7|||
148692601|NCT01505530|536347837|FG001|Overall Study|Withdrawal by Subject|8|||
148692602|NCT01505530|536347838|FG002|Overall Study|Withdrawal by Subject|6|||
148692603|NCT01505530|536347836|FG000|Overall Study|Physician Decision|6|||
148692604|NCT01505530|536347837|FG001|Overall Study|Physician Decision|2|||
148692605|NCT01505530|536347838|FG002|Overall Study|Physician Decision|5|||
148692606|NCT01505530|536347836|FG000|Overall Study|Sponsor Decision|1|||
148692607|NCT01505530|536347837|FG001|Overall Study|Sponsor Decision|8|||
148692608|NCT01505530|536347838|FG002|Overall Study|Sponsor Decision|7|||
148692609|NCT01505530|536347836|FG000|Overall Study|Death|7|||
148692610|NCT01505530|536347837|FG001|Overall Study|Death|6|||
148692611|NCT01505530|536347838|FG002|Overall Study|Death|5|||
148692612|NCT01505530|536347836|FG000|Overall Study|entry criteria not met|0|||
148692613|NCT01505530|536347837|FG001|Overall Study|entry criteria not met|1|||
148692614|NCT01505530|536347838|FG002|Overall Study|entry criteria not met|0|||
148692615|NCT01618266|536347848|FG000|Overall Study|Lost to Follow-up|9|||
148692616|NCT01618266|536347848|FG000|Overall Study|Treatment satisfaction|10|||
148692617|NCT01618266|536347848|FG000|Overall Study|Other reasons|11|||
148692618|NCT01618266|536347848|FG000|Overall Study|Lack of Efficacy|23|||
148692619|NCT01618266|536347848|FG000|Overall Study|Protocol Violation|43|||
148692620|NCT00625807|536347849|FG000|Overall Study|schedule conflict|2|||
148692621|NCT00625807|536347850|FG001|Overall Study|schedule conflict|8|||
148692622|NCT01966042|536347851|FG000|Overall Study|Death|2|||
148692623|NCT03267264|536347852|FG000|Overall Study|Withdrawal by Subject|1|||
148692624|NCT03267264|536347853|FG001|Overall Study|Withdrawal by Subject|0|||
148692625|NCT03267264|536347854|FG002|Overall Study|Withdrawal by Subject|2|||
148692626|NCT03267264|536347855|FG003|Overall Study|Withdrawal by Subject|4|||
148692627|NCT02224391|536347856|FG000|Overall Study|Lost to Follow-up|26|||
148692628|NCT02224391|536347857|FG001|Overall Study|Lost to Follow-up|19|||
148692629|NCT02224391|536347856|FG000|Overall Study|Withdrawal by Subject|6|||
148692630|NCT02224391|536347857|FG001|Overall Study|Withdrawal by Subject|5|||
148692631|NCT00084084|536347858|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
148692632|NCT00084084|536347858|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
148692633|NCT00454636|536347859|FG000|Overall Study|Adverse Event|10|||
148811733|NCT03765073|536787087|FG016|Stage 3|Adverse Event|0|||
148811734|NCT03765073|536787088|FG017|Stage 3|Adverse Event|0|||
148692634|NCT00454636|536347860|FG001|Overall Study|Adverse Event|6|||
148692635|NCT00454636|536347861|FG002|Overall Study|Adverse Event|9|||
148692636|NCT00454636|536347862|FG003|Overall Study|Adverse Event|15|||
148692637|NCT00454636|536347859|FG000|Overall Study|Disease Progression|11|||
148692638|NCT00454636|536347860|FG001|Overall Study|Disease Progression|12|||
148692639|NCT00454636|536347861|FG002|Overall Study|Disease Progression|4|||
148692640|NCT00454636|536347862|FG003|Overall Study|Disease Progression|11|||
148959140|NCT01909479|537334112|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
148959141|NCT01909479|537334113|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
148959142|NCT01909479|537334112|FG000|52 Weeks to End of Study|Protocol Violation|1|||
148959143|NCT01909479|537334113|FG001|52 Weeks to End of Study|Protocol Violation|0|||
148959144|NCT01909479|537334112|FG000|52 Weeks to End of Study|Progressive disease|1|||
148959145|NCT01909479|537334113|FG001|52 Weeks to End of Study|Progressive disease|1|||
149022883|NCT05968482|537562586|FG000|Second Crossover Period|Withdrawal by Subject|0|||
148959146|NCT01909479|537334112|FG000|52 Weeks to End of Study|Personal reasons|2|||
148959147|NCT01909479|537334113|FG001|52 Weeks to End of Study|Personal reasons|1|||
148959148|NCT01909479|537334112|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
148959149|NCT01909479|537334113|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
148959150|NCT01909479|537334112|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
148811735|NCT03765073|536787089|FG018|Stage 3|Adverse Event|1|||
148959151|NCT01909479|537334113|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
148959152|NCT01909479|537334112|FG000|52 Weeks to End of Study|Lack of contact|1|||
148959153|NCT01909479|537334113|FG001|52 Weeks to End of Study|Lack of contact|0|||
148959154|NCT01909479|537334112|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
148959155|NCT01909479|537334113|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
148959156|NCT01909479|537334112|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
148959157|NCT01909479|537334113|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
148959158|NCT00459108|537334116|FG000|Overall Study|Withdrawal by Subject|5|||
148959159|NCT00459108|537334116|FG000|Overall Study|Adverse Event|3|||
148959160|NCT00459108|537334116|FG000|Overall Study|Death|2|||
148959161|NCT00459108|537334116|FG000|Overall Study|Progression|1|||
148959162|NCT00416078|537334122|FG000|Overall Study|Death|3|||
148959163|NCT00416078|537334123|FG001|Overall Study|Death|4|||
148692641|NCT00454636|536347859|FG000|Overall Study|Protocol Violation|3|||
148692642|NCT00454636|536347860|FG001|Overall Study|Protocol Violation|2|||
148959164|NCT00416078|537334122|FG000|Overall Study|Withdrawal by Subject|3|||
148959165|NCT00416078|537334123|FG001|Overall Study|Withdrawal by Subject|2|||
148692643|NCT00454636|536347861|FG002|Overall Study|Protocol Violation|3|||
148692644|NCT00454636|536347862|FG003|Overall Study|Protocol Violation|3|||
148692645|NCT00454636|536347859|FG000|Overall Study|Death|6|||
148692646|NCT00454636|536347860|FG001|Overall Study|Death|1|||
148692647|NCT00454636|536347861|FG002|Overall Study|Death|1|||
148959166|NCT00416078|537334122|FG000|Overall Study|Physician Decision|1|||
148959167|NCT00416078|537334123|FG001|Overall Study|Physician Decision|0|||
148959168|NCT00416078|537334122|FG000|Overall Study|Lost to Follow-up|4|||
148959169|NCT00416078|537334123|FG001|Overall Study|Lost to Follow-up|2|||
148959170|NCT04501666|537334130|FG000|Overall Study|Physician Decision|0|||
148692648|NCT00454636|536347862|FG003|Overall Study|Death|1|||
149022884|NCT05968482|537562587|FG001|Second Crossover Period|Withdrawal by Subject|0|||
149022885|NCT05968482|537562588|FG002|Second Crossover Period|Withdrawal by Subject|0|||
149022886|NCT05968482|537562589|FG003|Second Crossover Period|Withdrawal by Subject|0|||
149022887|NCT05968482|537562590|FG004|Second Crossover Period|Withdrawal by Subject|1|||
148692649|NCT00454636|536347859|FG000|Overall Study|Patient refusal|1|||
148692650|NCT00454636|536347860|FG001|Overall Study|Patient refusal|1|||
148692651|NCT00454636|536347861|FG002|Overall Study|Patient refusal|3|||
148959171|NCT04501666|537334131|FG001|Overall Study|Physician Decision|1|||
148959172|NCT04501666|537334130|FG000|Overall Study|Adverse Event|12|||
148692652|NCT00454636|536347862|FG003|Overall Study|Patient refusal|2|||
148692653|NCT00454636|536347859|FG000|Overall Study|Lost to Follow-up|0|||
148692654|NCT00454636|536347860|FG001|Overall Study|Lost to Follow-up|1|||
148692655|NCT00454636|536347861|FG002|Overall Study|Lost to Follow-up|0|||
148692656|NCT00454636|536347862|FG003|Overall Study|Lost to Follow-up|0|||
148692657|NCT01400113|536347863|FG000|Overall Study|Withdrawal by Subject|1|||
148692658|NCT01400113|536347864|FG001|Overall Study|Withdrawal by Subject|1|||
148692659|NCT02114697|536347865|FG000|Overall Study|Study terminated|5|||
148692660|NCT02114697|536347866|FG001|Overall Study|Study terminated|4|||
148692661|NCT01984242|536347867|FG000|Overall Study|Death|52|||
148692662|NCT01984242|536347868|FG001|Overall Study|Death|50|||
148692663|NCT01984242|536347869|FG002|Overall Study|Death|52|||
148692664|NCT01984242|536347867|FG000|Overall Study|Withdrawal by Subject|5|||
148692665|NCT01984242|536347868|FG001|Overall Study|Withdrawal by Subject|3|||
148692666|NCT01984242|536347869|FG002|Overall Study|Withdrawal by Subject|10|||
148692667|NCT01984242|536347867|FG000|Overall Study|Physician Decision|0|||
148959173|NCT04501666|537334131|FG001|Overall Study|Adverse Event|4|||
148959174|NCT04501666|537334130|FG000|Overall Study|Subject's request|10|||
148692668|NCT01984242|536347868|FG001|Overall Study|Physician Decision|0|||
148692669|NCT01984242|536347869|FG002|Overall Study|Physician Decision|1|||
148692670|NCT01984242|536347867|FG000|Overall Study|Lost to Follow-up|4|||
148959175|NCT04501666|537334131|FG001|Overall Study|Subject's request|6|||
148959176|NCT04501666|537334130|FG000|Overall Study|Protocol Deviation|2|||
148692671|NCT01984242|536347868|FG001|Overall Study|Lost to Follow-up|0|||
148959177|NCT04501666|537334131|FG001|Overall Study|Protocol Deviation|1|||
148959178|NCT04501666|537334130|FG000|Overall Study|Other-- site permanently closing|0|||
148959179|NCT04501666|537334131|FG001|Overall Study|Other-- site permanently closing|1|||
148959180|NCT04128267|537334132|FG000|Overall Study|Withdrawal by Subject|6|||
148692672|NCT01984242|536347869|FG002|Overall Study|Lost to Follow-up|3|||
148692673|NCT01984242|536347867|FG000|Overall Study|Sponsor Decision|1|||
148692674|NCT01984242|536347868|FG001|Overall Study|Sponsor Decision|0|||
148692675|NCT01984242|536347869|FG002|Overall Study|Sponsor Decision|0|||
148811736|NCT03765073|536787090|FG019|Stage 3|Adverse Event|0|||
148811737|NCT03765073|536787091|FG020|Stage 3|Adverse Event|0|||
148811738|NCT03765073|536787071|FG000|Stage 3|Death|0|||
148811739|NCT03765073|536787072|FG001|Stage 3|Death|0|||
148811740|NCT03765073|536787073|FG002|Stage 3|Death|0|||
148959181|NCT04128267|537334132|FG000|Overall Study|Death|2|||
148811741|NCT03765073|536787074|FG003|Stage 3|Death|0|||
148959182|NCT04128267|537334132|FG000|Overall Study|Disease progression|1|||
148959183|NCT04128267|537334132|FG000|Overall Study|Participant had other medical issues|4|||
148959184|NCT04128267|537334132|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
148959185|NCT01026792|537334136|FG000|Overall Study|Protocol Violation|1|||
148959186|NCT02626520|537334140|FG000|Overall Study|Physician Decision|1|||
148959187|NCT02626520|537334141|FG001|Overall Study|Physician Decision|1|||
148959188|NCT02626520|537334140|FG000|Overall Study|Adverse Event|0|||
148959189|NCT02626520|537334141|FG001|Overall Study|Adverse Event|4|||
148959190|NCT02626520|537334140|FG000|Overall Study|Lack of Efficacy|0|||
148959191|NCT02626520|537334141|FG001|Overall Study|Lack of Efficacy|2|||
148959192|NCT02626520|537334140|FG000|Overall Study|Did not start protocol therapy|0|||
148959193|NCT02626520|537334141|FG001|Overall Study|Did not start protocol therapy|2|||
149022888|NCT05968482|537562591|FG005|Second Crossover Period|Withdrawal by Subject|0|||
149022889|NCT05968482|537562586|FG000|Third Crossover Period|Adverse Event|0|||
149022890|NCT05968482|537562587|FG001|Third Crossover Period|Adverse Event|0|||
149022891|NCT05968482|537562588|FG002|Third Crossover Period|Adverse Event|0|||
149022892|NCT05968482|537562589|FG003|Third Crossover Period|Adverse Event|0|||
149022893|NCT05968482|537562590|FG004|Third Crossover Period|Adverse Event|1|||
149022894|NCT05968482|537562591|FG005|Third Crossover Period|Adverse Event|0|||
149022895|NCT05968482|537562586|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
149022896|NCT05968482|537562587|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
148959194|NCT02626520|537334140|FG000|Overall Study|Study terminated|0|||
148959195|NCT02626520|537334141|FG001|Overall Study|Study terminated|1|||
148959196|NCT00535223|537334142|FG000|Overall Study|Withdrawal by Subject|4|||
148959197|NCT00535223|537334143|FG001|Overall Study|Withdrawal by Subject|1|||
148959198|NCT00492115|537334144|FG000|Overall Study|Withdrawal by Subject|3|||
148959199|NCT00492115|537334145|FG001|Overall Study|Withdrawal by Subject|4|||
148959200|NCT02045797|537334148|FG000|Overall Study|Adverse Event|3|||
148959201|NCT02045797|537334149|FG001|Overall Study|Adverse Event|1|||
148959202|NCT02045797|537334150|FG002|Overall Study|Adverse Event|0|||
148959203|NCT02045797|537334148|FG000|Overall Study|Lack of Efficacy|1|||
149022897|NCT05968482|537562588|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
149022898|NCT05968482|537562589|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
149022899|NCT05968482|537562590|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
149022900|NCT05968482|537562591|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
149022901|NCT02559817|537562592|FG000|Treatment Period|Adverse Event|1|||
148959204|NCT02045797|537334149|FG001|Overall Study|Lack of Efficacy|0|||
148959205|NCT02045797|537334150|FG002|Overall Study|Lack of Efficacy|0|||
148959206|NCT02045797|537334148|FG000|Overall Study|Lost to Follow-up|2|||
149022902|NCT02559817|537562593|FG001|Treatment Period|Adverse Event|0|||
148692676|NCT01984242|536347867|FG000|Overall Study|Non-Compliance|1|||
148692677|NCT01984242|536347868|FG001|Overall Study|Non-Compliance|0|||
148692678|NCT01984242|536347869|FG002|Overall Study|Non-Compliance|0|||
149022903|NCT02559817|537562594|FG002|Treatment Period|Adverse Event|1|||
148959207|NCT02045797|537334149|FG001|Overall Study|Lost to Follow-up|3|||
148959208|NCT02045797|537334150|FG002|Overall Study|Lost to Follow-up|1|||
148959209|NCT02045797|537334148|FG000|Overall Study|Physician Decision|0|||
148692679|NCT01984242|536347867|FG000|Overall Study|Study terminated by Sponsor|38|||
148692680|NCT01984242|536347868|FG001|Overall Study|Study terminated by Sponsor|50|||
148692681|NCT01984242|536347869|FG002|Overall Study|Study terminated by Sponsor|34|||
148692682|NCT01984242|536347867|FG000|Overall Study|Disease Progression|0|||
148692683|NCT01984242|536347868|FG001|Overall Study|Disease Progression|0|||
148692684|NCT01984242|536347869|FG002|Overall Study|Disease Progression|1|||
148692685|NCT00319449|536347873|FG000|Overall Study|Subject did not wish to continue|1|||
148692686|NCT00319449|536347874|FG001|Overall Study|Subject did not wish to continue|0|||
148692687|NCT00319449|536347873|FG000|Overall Study|Noncompliance with the protocol|1|||
148692688|NCT00319449|536347874|FG001|Overall Study|Noncompliance with the protocol|0|||
148692689|NCT02739984|536347875|FG000|Overall Study|Sponsor Decision|1|||
148692690|NCT02739984|536347876|FG001|Overall Study|Sponsor Decision|0|||
148692691|NCT02739984|536347875|FG000|Overall Study|Withdrawal by Subject|1|||
148692692|NCT02739984|536347876|FG001|Overall Study|Withdrawal by Subject|1|||
148692693|NCT02739984|536347875|FG000|Overall Study|Death|0|||
148692694|NCT02739984|536347876|FG001|Overall Study|Death|1|||
148692695|NCT02739984|536347875|FG000|Overall Study|Lost to Follow-up|3|||
148692696|NCT02739984|536347876|FG001|Overall Study|Lost to Follow-up|0|||
148692697|NCT00979628|536347877|FG000|Overall Study|received regimen < 24 hours|7|||
148811742|NCT03765073|536787075|FG004|Stage 3|Death|0|||
148811743|NCT03765073|536787076|FG005|Stage 3|Death|0|||
148811744|NCT03765073|536787077|FG006|Stage 3|Death|0|||
148959210|NCT02045797|537334149|FG001|Overall Study|Physician Decision|1|||
148811745|NCT03765073|536787078|FG007|Stage 3|Death|0|||
148811746|NCT03765073|536787079|FG008|Stage 3|Death|0|||
148811747|NCT03765073|536787080|FG009|Stage 3|Death|0|||
148811748|NCT03765073|536787081|FG010|Stage 3|Death|0|||
148959211|NCT02045797|537334150|FG002|Overall Study|Physician Decision|0|||
148959212|NCT02045797|537334148|FG000|Overall Study|Withdrawal by Subject|1|||
148692698|NCT00979628|536347878|FG001|Overall Study|received regimen < 24 hours|6|||
148692699|NCT00979628|536347879|FG002|Overall Study|received regimen < 24 hours|5|||
148692700|NCT00979628|536347877|FG000|Overall Study|received steroids|1|||
148692701|NCT00979628|536347878|FG001|Overall Study|received steroids|1|||
148811749|NCT03765073|536787082|FG011|Stage 3|Death|0|||
148811750|NCT03765073|536787083|FG012|Stage 3|Death|0|||
148811751|NCT03765073|536787084|FG013|Stage 3|Death|0|||
148959213|NCT02045797|537334149|FG001|Overall Study|Withdrawal by Subject|2|||
148959214|NCT02045797|537334150|FG002|Overall Study|Withdrawal by Subject|0|||
148959215|NCT05286307|537334154|FG000|Overall Study|Incomplete outcome assessments|2|||
148959216|NCT05286307|537334155|FG001|Overall Study|Incomplete outcome assessments|1|||
148959217|NCT05286307|537334154|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
148959218|NCT05286307|537334155|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
148959219|NCT05286307|537334154|FG000|Overall Study|Lost to follow up at 6 months|25|||
148959220|NCT05286307|537334155|FG001|Overall Study|Lost to follow up at 6 months|35|||
148959221|NCT05286307|537334154|FG000|Overall Study|Study medication not available|1|||
148959222|NCT05286307|537334155|FG001|Overall Study|Study medication not available|1|||
148959223|NCT04219891|537334158|FG000|Overall Study|Lost to Follow-up|3|||
148959224|NCT04219891|537334158|FG000|Overall Study|Withdrawal by Subject|2|||
148959225|NCT00597012|537334159|FG000|Overall Study|Death|1|||
148959226|NCT00597012|537334160|FG001|Overall Study|Death|1|||
148959227|NCT00597012|537334159|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
148959228|NCT00597012|537334160|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
148959229|NCT00597012|537334159|FG000|Overall Study|Withdrawal by Subject|7|||
148959230|NCT00597012|537334160|FG001|Overall Study|Withdrawal by Subject|4|||
148959231|NCT00597012|537334159|FG000|Overall Study|Ineligible|2|||
148959232|NCT00597012|537334160|FG001|Overall Study|Ineligible|0|||
148959233|NCT00597012|537334159|FG000|Overall Study|Lost to Follow-up|0|||
148959234|NCT00597012|537334160|FG001|Overall Study|Lost to Follow-up|2|||
148959235|NCT03712904|537335598|FG000|Overall Study|Death|0|||
148959236|NCT03712904|537335599|FG001|Overall Study|Death|1|||
148959237|NCT03712904|537335598|FG000|Overall Study|Withdrawal by Subject|0|||
148959238|NCT03712904|537335599|FG001|Overall Study|Withdrawal by Subject|1|||
148959239|NCT03712904|537335598|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
148959240|NCT03712904|537335599|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
148959241|NCT01851720|537335605|FG000|Overall Study|Lost to Follow-up|0|||
148959242|NCT01851720|537335606|FG001|Overall Study|Lost to Follow-up|1|||
148959243|NCT02389998|537335607|FG000|Overall Study|car accident|1|||
148959244|NCT02389998|537335608|FG001|Overall Study|car accident|0|||
148959245|NCT03525574|537335609|FG000|Overall Study|Adverse Event|15|||
148959246|NCT03525574|537335610|FG001|Overall Study|Adverse Event|0|||
148959247|NCT03525574|537335609|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
148959248|NCT03525574|537335610|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
148959249|NCT03525574|537335609|FG000|Overall Study|Lost to Follow-up|4|||
148959250|NCT03525574|537335610|FG001|Overall Study|Lost to Follow-up|0|||
148959251|NCT03525574|537335609|FG000|Overall Study|Commercial drug is Available for participant|48|||
148959252|NCT03525574|537335610|FG001|Overall Study|Commercial drug is Available for participant|0|||
148959253|NCT03525574|537335609|FG000|Overall Study|Death|1|||
148959254|NCT03525574|537335610|FG001|Overall Study|Death|0|||
148959255|NCT03525574|537335609|FG000|Overall Study|Other non-compliance|2|||
148959256|NCT03525574|537335610|FG001|Overall Study|Other non-compliance|0|||
148959257|NCT03525574|537335609|FG000|Overall Study|Physician Decision|6|||
148959258|NCT03525574|537335610|FG001|Overall Study|Physician Decision|0|||
148959259|NCT03525574|537335609|FG000|Overall Study|Other|58|||
148959260|NCT03525574|537335610|FG001|Overall Study|Other|0|||
148959261|NCT03525574|537335609|FG000|Overall Study|Enrolled but never dosed|1|||
148959262|NCT03525574|537335610|FG001|Overall Study|Enrolled but never dosed|0|||
148959263|NCT03525574|537335609|FG000|Overall Study|Not enrolled in 105 study|0|||
148959264|NCT03525574|537335610|FG001|Overall Study|Not enrolled in 105 study|3|||
148959265|NCT01770379|537335613|FG000|Overall Study|Technical issues|1|||
148959266|NCT01770379|537335614|FG001|Overall Study|Technical issues|0|||
148959267|NCT01770379|537335615|FG002|Overall Study|Technical issues|0|||
148959268|NCT01770379|537335613|FG000|Overall Study|Withdrawal by Subject|7|||
148959269|NCT01770379|537335614|FG001|Overall Study|Withdrawal by Subject|10|||
148692702|NCT00979628|536347879|FG002|Overall Study|received steroids|0|||
148692703|NCT00979628|536347877|FG000|Overall Study|transferred to ICU|1|||
148692704|NCT00979628|536347878|FG001|Overall Study|transferred to ICU|2|||
148692705|NCT00979628|536347879|FG002|Overall Study|transferred to ICU|1|||
148692706|NCT00911859|536347880|FG000|Treatment Period|Adverse Event|3|||
148692707|NCT00911859|536347881|FG001|Treatment Period|Adverse Event|3|||
148692708|NCT00911859|536347882|FG002|Treatment Period|Adverse Event|7|||
148692709|NCT00911859|536347880|FG000|Treatment Period|Death|1|||
148692710|NCT00911859|536347881|FG001|Treatment Period|Death|3|||
148692711|NCT00911859|536347882|FG002|Treatment Period|Death|5|||
148692712|NCT00911859|536347880|FG000|Treatment Period|Lack of Efficacy|1|||
148692713|NCT00911859|536347881|FG001|Treatment Period|Lack of Efficacy|7|||
148692714|NCT00911859|536347882|FG002|Treatment Period|Lack of Efficacy|5|||
148692715|NCT00911859|536347880|FG000|Treatment Period|Physician Decision|3|||
148692716|NCT00911859|536347881|FG001|Treatment Period|Physician Decision|3|||
148692717|NCT00911859|536347882|FG002|Treatment Period|Physician Decision|3|||
148692718|NCT00911859|536347880|FG000|Treatment Period|Withdrawal by Subject|0|||
148692719|NCT00911859|536347881|FG001|Treatment Period|Withdrawal by Subject|4|||
148692720|NCT00911859|536347882|FG002|Treatment Period|Withdrawal by Subject|5|||
148692721|NCT00911859|536347880|FG000|Treatment Period|Did not receive study treatment|0|||
148692722|NCT00911859|536347881|FG001|Treatment Period|Did not receive study treatment|1|||
148692723|NCT00911859|536347882|FG002|Treatment Period|Did not receive study treatment|0|||
148692724|NCT00911859|536347880|FG000|Maintainance Period|Lack of Efficacy|0|||
148692725|NCT00911859|536347881|FG001|Maintainance Period|Lack of Efficacy|0|||
148692726|NCT00911859|536347882|FG002|Maintainance Period|Lack of Efficacy|9|||
148692727|NCT00911859|536347880|FG000|Maintainance Period|Physician Decision|0|||
148692728|NCT00911859|536347881|FG001|Maintainance Period|Physician Decision|0|||
148692729|NCT00911859|536347882|FG002|Maintainance Period|Physician Decision|9|||
148692730|NCT00911859|536347880|FG000|Maintainance Period|Withdrawal by Subject|0|||
148692731|NCT00911859|536347881|FG001|Maintainance Period|Withdrawal by Subject|0|||
148692732|NCT00911859|536347882|FG002|Maintainance Period|Withdrawal by Subject|3|||
148692733|NCT00911859|536347880|FG000|Follow-up Period|Death|5|||
148692734|NCT00911859|536347881|FG001|Follow-up Period|Death|8|||
148692735|NCT00911859|536347882|FG002|Follow-up Period|Death|10|||
148692736|NCT00911859|536347880|FG000|Follow-up Period|Lost to Follow-up|1|||
148692737|NCT00911859|536347881|FG001|Follow-up Period|Lost to Follow-up|1|||
148692738|NCT00911859|536347882|FG002|Follow-up Period|Lost to Follow-up|0|||
148692739|NCT00911859|536347880|FG000|Follow-up Period|Withdrawal by Subject|0|||
148692740|NCT00911859|536347881|FG001|Follow-up Period|Withdrawal by Subject|4|||
148692741|NCT00911859|536347882|FG002|Follow-up Period|Withdrawal by Subject|4|||
148692742|NCT00911859|536347880|FG000|Follow-up Period|Study terminated by sponsor|5|||
148692743|NCT00911859|536347881|FG001|Follow-up Period|Study terminated by sponsor|33|||
148692744|NCT00911859|536347882|FG002|Follow-up Period|Study terminated by sponsor|27|||
148811752|NCT03765073|536787085|FG014|Stage 3|Death|0|||
148692745|NCT00767325|536347884|FG000|Overall Study|Lack of Efficacy|2|||
148692746|NCT00767325|536347884|FG000|Overall Study|Adverse Event|7|||
148692747|NCT00767325|536347884|FG000|Overall Study|Lost to Follow-up|3|||
148692748|NCT00767325|536347884|FG000|Overall Study|No longer met study criteria|2|||
148692749|NCT00767325|536347884|FG000|Overall Study|Missed visit due to family reasons|1|||
148692750|NCT03538756|536347885|FG000|Long-Term Follow-up|Adverse Event|0|||
148692751|NCT03538756|536347886|FG001|Long-Term Follow-up|Adverse Event|0|||
148692752|NCT03538756|536347887|FG002|Long-Term Follow-up|Adverse Event|6|||
148692753|NCT03538756|536347885|FG000|Long-Term Follow-up|Death|0|||
148692754|NCT03538756|536347886|FG001|Long-Term Follow-up|Death|0|||
148692755|NCT03538756|536347887|FG002|Long-Term Follow-up|Death|1|||
148692756|NCT03538756|536347885|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
148692757|NCT03538756|536347886|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
148692758|NCT03538756|536347887|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
148692759|NCT03538756|536347885|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
148692760|NCT03538756|536347886|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
148692761|NCT03538756|536347887|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
148692762|NCT03538756|536347885|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
148692763|NCT03538756|536347886|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
148692764|NCT03538756|536347887|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
148692765|NCT00752856|536347888|FG000|Overall Study|randomized but did not do viral kinetics|0|||
148692766|NCT00752856|536347889|FG001|Overall Study|randomized but did not do viral kinetics|1|||
148692767|NCT02688608|536347890|FG000|Overall Study|Lost to Follow-up|1|||
148692768|NCT00502775|536350204|FG000|Overall Study|Adverse Event|1|||
148692769|NCT00502775|536350205|FG001|Overall Study|Adverse Event|2|||
148692770|NCT00502775|536350206|FG002|Overall Study|Adverse Event|1|||
148692771|NCT00502775|536350204|FG000|Overall Study|Protocol Violation|1|||
148692772|NCT00502775|536350205|FG001|Overall Study|Protocol Violation|5|||
148692773|NCT00502775|536350206|FG002|Overall Study|Protocol Violation|2|||
148692774|NCT00502775|536350204|FG000|Overall Study|Withdrawal by Subject|1|||
148692775|NCT00502775|536350205|FG001|Overall Study|Withdrawal by Subject|1|||
148692776|NCT00502775|536350206|FG002|Overall Study|Withdrawal by Subject|2|||
148692777|NCT00502775|536350204|FG000|Overall Study|Sponsor Terminated Study|1|||
148692778|NCT00502775|536350205|FG001|Overall Study|Sponsor Terminated Study|0|||
148692779|NCT00502775|536350206|FG002|Overall Study|Sponsor Terminated Study|1|||
148692780|NCT00502775|536350204|FG000|Overall Study|Non-compliance with eDiary|4|||
148692781|NCT00502775|536350205|FG001|Overall Study|Non-compliance with eDiary|1|||
148692782|NCT00502775|536350206|FG002|Overall Study|Non-compliance with eDiary|1|||
148692783|NCT00502775|536350204|FG000|Overall Study|Subject unable to swallow capsule|1|||
148692784|NCT00502775|536350205|FG001|Overall Study|Subject unable to swallow capsule|0|||
148692785|NCT00502775|536350206|FG002|Overall Study|Subject unable to swallow capsule|1|||
148692786|NCT00502775|536350204|FG000|Overall Study|Logpad compliance <80%|1|||
148692787|NCT00502775|536350205|FG001|Overall Study|Logpad compliance <80%|0|||
148692788|NCT00502775|536350206|FG002|Overall Study|Logpad compliance <80%|0|||
148692789|NCT00502775|536350204|FG000|Overall Study|Randomized in error|0|||
148692790|NCT00502775|536350205|FG001|Overall Study|Randomized in error|1|||
148692791|NCT00502775|536350206|FG002|Overall Study|Randomized in error|1|||
148692792|NCT00502775|536350204|FG000|Overall Study|Non-compliance|0|||
148692793|NCT00502775|536350205|FG001|Overall Study|Non-compliance|2|||
148692794|NCT00502775|536350206|FG002|Overall Study|Non-compliance|2|||
148692795|NCT00502775|536350204|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
148811753|NCT03765073|536787086|FG015|Stage 3|Death|0|||
148811754|NCT03765073|536787087|FG016|Stage 3|Death|0|||
148692796|NCT00502775|536350205|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
148692797|NCT00502775|536350206|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
148692798|NCT00502775|536350204|FG000|Overall Study|Declining pollen counts|0|||
148692799|NCT00502775|536350205|FG001|Overall Study|Declining pollen counts|1|||
148692800|NCT00502775|536350206|FG002|Overall Study|Declining pollen counts|1|||
148692801|NCT00502775|536350204|FG000|Overall Study|Subject in jail|0|||
148692802|NCT00502775|536350205|FG001|Overall Study|Subject in jail|1|||
148692803|NCT00502775|536350206|FG002|Overall Study|Subject in jail|0|||
148692804|NCT00502775|536350204|FG000|Overall Study|Subject took disallowed drug|0|||
148692805|NCT00502775|536350205|FG001|Overall Study|Subject took disallowed drug|0|||
148811755|NCT03765073|536787088|FG017|Stage 3|Death|0|||
148959270|NCT01770379|537335615|FG002|Overall Study|Withdrawal by Subject|7|||
148959271|NCT01770379|537335613|FG000|Overall Study|study terminated by sponsor|22|||
148692806|NCT00502775|536350206|FG002|Overall Study|Subject took disallowed drug|1|||
148692807|NCT04471207|536350213|FG000|Overall Study|Lost to Follow-up|4|||
148692808|NCT04471207|536350214|FG001|Overall Study|Lost to Follow-up|1|||
148692809|NCT04471207|536350213|FG000|Overall Study|Medication Contraindication|0|||
148692810|NCT04471207|536350214|FG001|Overall Study|Medication Contraindication|1|||
148692811|NCT04471207|536350213|FG000|Overall Study|Loss of Interest|2|||
148692812|NCT04471207|536350214|FG001|Overall Study|Loss of Interest|1|||
148692813|NCT04471207|536350213|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
148692814|NCT04471207|536350214|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
148692815|NCT04471207|536350213|FG000|Overall Study|Scheduling Conflicts|3|||
148692816|NCT04471207|536350214|FG001|Overall Study|Scheduling Conflicts|1|||
148692817|NCT04471207|536350213|FG000|Overall Study|Physician Decision|1|||
148692818|NCT04471207|536350214|FG001|Overall Study|Physician Decision|0|||
148692819|NCT04471207|536350213|FG000|Overall Study|Unwilling to Use System|0|||
148692820|NCT04471207|536350214|FG001|Overall Study|Unwilling to Use System|1|||
148692821|NCT00561730|536350219|FG000|Overall Study|Adverse Event|2|||
148692822|NCT00561730|536350219|FG000|Overall Study|Handling of the drug|1|||
148692823|NCT00561730|536350219|FG000|Overall Study|Lost to Follow-up|5|||
148692824|NCT00561730|536350219|FG000|Overall Study|Not specified reasons|1|||
148692825|NCT00520741|536350240|FG000|Overall Study|Adverse Event|16|||
148692826|NCT00520741|536350241|FG001|Overall Study|Adverse Event|56|||
148692827|NCT00520741|536350240|FG000|Overall Study|Lack of Efficacy|11|||
148692828|NCT00520741|536350241|FG001|Overall Study|Lack of Efficacy|30|||
148692829|NCT00520741|536350240|FG000|Overall Study|Withdrawal by Subject|0|||
148692830|NCT00520741|536350241|FG001|Overall Study|Withdrawal by Subject|11|||
148692831|NCT00520741|536350240|FG000|Overall Study|Protocol Violation|2|||
148692832|NCT00520741|536350241|FG001|Overall Study|Protocol Violation|15|||
148692833|NCT00520741|536350240|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
148692834|NCT00520741|536350241|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
148692835|NCT00520741|536350240|FG000|Overall Study|Lost to Follow-up|4|||
148692836|NCT00520741|536350241|FG001|Overall Study|Lost to Follow-up|4|||
148692837|NCT00520741|536350240|FG000|Overall Study|Other reasons for premature termination|0|||
148692838|NCT00520741|536350241|FG001|Overall Study|Other reasons for premature termination|6|||
148692839|NCT04373434|536350242|FG000|Overall Study|Lost to Follow-up|37|||
148692840|NCT04373434|536350243|FG001|Overall Study|Lost to Follow-up|32|||
148692841|NCT04373434|536350242|FG000|Overall Study|Refused at 9 months|1|||
148692842|NCT04373434|536350243|FG001|Overall Study|Refused at 9 months|2|||
148692843|NCT04373434|536350242|FG000|Overall Study|Refused at 4 months|7|||
148692844|NCT04373434|536350243|FG001|Overall Study|Refused at 4 months|3|||
148959272|NCT01770379|537335614|FG001|Overall Study|study terminated by sponsor|23|||
148959273|NCT01770379|537335615|FG002|Overall Study|study terminated by sponsor|22|||
148959274|NCT01770379|537335613|FG000|Overall Study|Protocol Violation|0|||
148692845|NCT04373434|536350242|FG000|Overall Study|Excluded|2|||
148692846|NCT04373434|536350243|FG001|Overall Study|Excluded|0|||
148692847|NCT03702621|536350244|FG000|Overall Study|Physician Decision|6|||
148692848|NCT03702621|536350245|FG001|Overall Study|Physician Decision|6|||
148692849|NCT00527423|536350246|FG000|Overall Study|Protocol Violation|1|||
148692850|NCT00527423|536350246|FG000|Overall Study|Adverse Event|5|||
148959275|NCT01770379|537335614|FG001|Overall Study|Protocol Violation|1|||
148692851|NCT00527423|536350246|FG000|Overall Study|Physician Decision|4|||
148692852|NCT00527423|536350246|FG000|Overall Study|Withdrawal by Subject|10|||
148692853|NCT00527423|536350246|FG000|Overall Study|Lost to Follow-up|4|||
148959276|NCT01770379|537335615|FG002|Overall Study|Protocol Violation|1|||
148692854|NCT00527423|536350246|FG000|Overall Study|OTHER|4|||
148692855|NCT00527423|536350246|FG000|Overall Study|Death|9|||
148811756|NCT03765073|536787089|FG018|Stage 3|Death|0|||
148811757|NCT03765073|536787090|FG019|Stage 3|Death|3|||
148811758|NCT03765073|536787091|FG020|Stage 3|Death|2|||
148811759|NCT03765073|536787071|FG000|Stage 3|Lost to Follow-up|0|||
148811760|NCT03765073|536787072|FG001|Stage 3|Lost to Follow-up|0|||
148811761|NCT03765073|536787073|FG002|Stage 3|Lost to Follow-up|0|||
148811762|NCT03765073|536787074|FG003|Stage 3|Lost to Follow-up|0|||
148811763|NCT03765073|536787075|FG004|Stage 3|Lost to Follow-up|0|||
148811764|NCT03765073|536787076|FG005|Stage 3|Lost to Follow-up|0|||
148811765|NCT03765073|536787077|FG006|Stage 3|Lost to Follow-up|0|||
148811766|NCT03765073|536787078|FG007|Stage 3|Lost to Follow-up|0|||
148959277|NCT01770379|537335613|FG000|Overall Study|Physician Decision|0|||
148959278|NCT01770379|537335614|FG001|Overall Study|Physician Decision|1|||
148959279|NCT01770379|537335615|FG002|Overall Study|Physician Decision|2|||
148811767|NCT03765073|536787079|FG008|Stage 3|Lost to Follow-up|0|||
148811768|NCT03765073|536787080|FG009|Stage 3|Lost to Follow-up|0|||
148811769|NCT03765073|536787081|FG010|Stage 3|Lost to Follow-up|0|||
148959280|NCT01770379|537335613|FG000|Overall Study|Lost to Follow-up|0|||
148692856|NCT03194464|536350250|FG000|Overall Study|data not usable|2|||
148692857|NCT03444038|536350257|FG000|Overall Study|Adverse Event|12|||
148692858|NCT03444038|536350257|FG000|Overall Study|Withdrawal by Subject|7|||
148692859|NCT03444038|536350257|FG000|Overall Study|Lost to Follow-up|1|||
148692860|NCT03444038|536350257|FG000|Overall Study|Physician Decision|2|||
148692861|NCT03444038|536350257|FG000|Overall Study|Lack of Efficacy|7|||
148692862|NCT02354586|536350258|FG000|Overall Study|Death|230|||
148692863|NCT02354586|536350258|FG000|Overall Study|Withdrawal by Subject|59|||
148692864|NCT02354586|536350258|FG000|Overall Study|Lost to Follow-up|11|||
148692865|NCT02354586|536350258|FG000|Overall Study|Sponsor decision|51|||
149022904|NCT02559817|537562595|FG003|Treatment Period|Adverse Event|0|||
148692866|NCT02354586|536350258|FG000|Overall Study|Site closure|2|||
148692867|NCT02354586|536350258|FG000|Overall Study|Intercurrent illness|1|||
148692868|NCT02354586|536350258|FG000|Overall Study|Protocol Violation|3|||
148692869|NCT02354586|536350258|FG000|Overall Study|Physician Decision|13|||
148811770|NCT03765073|536787082|FG011|Stage 3|Lost to Follow-up|0|||
148811771|NCT03765073|536787083|FG012|Stage 3|Lost to Follow-up|0|||
148811772|NCT03765073|536787084|FG013|Stage 3|Lost to Follow-up|0|||
148959281|NCT01770379|537335614|FG001|Overall Study|Lost to Follow-up|0|||
148959282|NCT01770379|537335615|FG002|Overall Study|Lost to Follow-up|2|||
148959283|NCT01770379|537335613|FG000|Overall Study|Lack of Efficacy|8|||
148959284|NCT01770379|537335614|FG001|Overall Study|Lack of Efficacy|6|||
148959285|NCT01770379|537335615|FG002|Overall Study|Lack of Efficacy|6|||
148959286|NCT01770379|537335613|FG000|Overall Study|Adverse Event|1|||
148959287|NCT01770379|537335614|FG001|Overall Study|Adverse Event|3|||
148959288|NCT01770379|537335615|FG002|Overall Study|Adverse Event|2|||
148959289|NCT01074450|537335624|FG000|First Intervention|Emesis in Dosing Interval|0|||
148959290|NCT01074450|537335625|FG001|First Intervention|Emesis in Dosing Interval|2|||
148692870|NCT02354586|536350258|FG000|Overall Study|Lack of Efficacy|86|||
148959291|NCT01074450|537335624|FG000|Second Intervention|Protocol Violation|1|||
148959292|NCT01074450|537335625|FG001|Second Intervention|Protocol Violation|0|||
148692871|NCT02354586|536350258|FG000|Overall Study|Adverse Event|7|||
148692872|NCT00721409|536350261|FG000|Overall Study|Global deterioration of health status|2|||
148692873|NCT00721409|536350262|FG001|Overall Study|Global deterioration of health status|6|||
148692874|NCT00721409|536350263|FG002|Overall Study|Global deterioration of health status|3|||
148692875|NCT00721409|536350261|FG000|Overall Study|Death|0|||
148692876|NCT00721409|536350262|FG001|Overall Study|Death|1|||
148692877|NCT00721409|536350263|FG002|Overall Study|Death|0|||
148692878|NCT00721409|536350261|FG000|Overall Study|Randomized not Treated|0|||
148692879|NCT00721409|536350262|FG001|Overall Study|Randomized not Treated|1|||
148692880|NCT00721409|536350263|FG002|Overall Study|Randomized not Treated|4|||
148692881|NCT00721409|536350261|FG000|Overall Study|Reason not specified|1|||
148692882|NCT00721409|536350262|FG001|Overall Study|Reason not specified|0|||
148692883|NCT00721409|536350263|FG002|Overall Study|Reason not specified|2|||
148692884|NCT00721409|536350261|FG000|Overall Study|Adverse Event|0|||
148692885|NCT00721409|536350262|FG001|Overall Study|Adverse Event|13|||
148692886|NCT00721409|536350263|FG002|Overall Study|Adverse Event|2|||
148692887|NCT00721409|536350261|FG000|Overall Study|Lost to Follow-up|0|||
148692888|NCT00721409|536350262|FG001|Overall Study|Lost to Follow-up|0|||
148692889|NCT00721409|536350263|FG002|Overall Study|Lost to Follow-up|1|||
148692890|NCT00721409|536350261|FG000|Overall Study|Withdrawal by Subject|1|||
148692891|NCT00721409|536350262|FG001|Overall Study|Withdrawal by Subject|6|||
148692892|NCT00721409|536350263|FG002|Overall Study|Withdrawal by Subject|5|||
148692893|NCT00721409|536350261|FG000|Overall Study|Objective progression or relapse|8|||
148692894|NCT00721409|536350262|FG001|Overall Study|Objective progression or relapse|55|||
148692895|NCT00721409|536350263|FG002|Overall Study|Objective progression or relapse|62|||
148692896|NCT02402166|536350264|FG000|Overall Study|Adverse Event|2|||
148692897|NCT02402166|536350264|FG000|Overall Study|Withdrawal by Subject|2|||
148692898|NCT02402166|536350264|FG000|Overall Study|Lost to Follow-up|1|||
148692899|NCT01400425|536350266|FG000|Overall Study|Withdrawal by Subject|10|||
148692900|NCT02720510|536350274|FG000|Overall Study|Study Terminated by the sponsor|2|||
148692901|NCT02720510|536350275|FG001|Overall Study|Study Terminated by the sponsor|0|||
148692902|NCT02720510|536350274|FG000|Overall Study|Adverse Event|0|||
148692903|NCT02720510|536350275|FG001|Overall Study|Adverse Event|1|||
148692904|NCT02720510|536350274|FG000|Overall Study|Physician Decision|1|||
148692905|NCT02720510|536350275|FG001|Overall Study|Physician Decision|2|||
148692906|NCT01153984|536350276|FG000|Overall Study|Withdrawal by Subject|1|||
148692907|NCT01153984|536350276|FG000|Overall Study|Adverse Event|1|||
148692908|NCT00973700|536350277|FG000|Overall Study|Withdrawal by Subject|2|||
148692909|NCT00973700|536350278|FG001|Overall Study|Withdrawal by Subject|2|||
148959293|NCT01074450|537335624|FG000|Second Intervention|Physician Decision|0|||
148959294|NCT01074450|537335625|FG001|Second Intervention|Physician Decision|1|||
148692910|NCT00973700|536350279|FG002|Overall Study|Withdrawal by Subject|8|||
148692911|NCT00973700|536350280|FG003|Overall Study|Withdrawal by Subject|4|||
148692912|NCT00973700|536350281|FG004|Overall Study|Withdrawal by Subject|4|||
148692913|NCT00973700|536350277|FG000|Overall Study|Lost to Follow-up|5|||
148692914|NCT00973700|536350278|FG001|Overall Study|Lost to Follow-up|0|||
148692915|NCT00973700|536350279|FG002|Overall Study|Lost to Follow-up|1|||
148692916|NCT00973700|536350280|FG003|Overall Study|Lost to Follow-up|8|||
148692917|NCT00973700|536350281|FG004|Overall Study|Lost to Follow-up|5|||
148692918|NCT00973700|536350277|FG000|Overall Study|Inappropriate enrolment|0|||
148692919|NCT00973700|536350278|FG001|Overall Study|Inappropriate enrolment|0|||
148692920|NCT00973700|536350279|FG002|Overall Study|Inappropriate enrolment|0|||
148692921|NCT00973700|536350280|FG003|Overall Study|Inappropriate enrolment|4|||
148692922|NCT00973700|536350281|FG004|Overall Study|Inappropriate enrolment|0|||
148692923|NCT00973700|536350277|FG000|Overall Study|Unable to Classify|0|||
148959295|NCT02728895|537335626|FG000|Overall Study|Other|1|||
148959296|NCT02728895|537335627|FG001|Overall Study|Other|2|||
148959297|NCT02728895|537335626|FG000|Overall Study|Withdrawal by Subject|0|||
148959298|NCT02728895|537335627|FG001|Overall Study|Withdrawal by Subject|3|||
148959299|NCT02769247|537335628|FG000|Overall Study|Withdrawal by Subject|1|||
148959300|NCT02769247|537335629|FG001|Overall Study|Withdrawal by Subject|0|||
148959301|NCT02769247|537335630|FG002|Overall Study|Withdrawal by Subject|0|||
148959302|NCT02769247|537335631|FG003|Overall Study|Withdrawal by Subject|1|||
148959303|NCT02769247|537335628|FG000|Overall Study|Protocol Violation|0|||
148959304|NCT02769247|537335629|FG001|Overall Study|Protocol Violation|0|||
148692924|NCT00973700|536350278|FG001|Overall Study|Unable to Classify|0|||
148692925|NCT00973700|536350279|FG002|Overall Study|Unable to Classify|1|||
148692926|NCT00973700|536350280|FG003|Overall Study|Unable to Classify|2|||
148692927|NCT00973700|536350281|FG004|Overall Study|Unable to Classify|1|||
148692928|NCT03499964|536350284|FG000|Overall Study|Lack of Efficacy|6|||
148692929|NCT03499964|536350285|FG001|Overall Study|Lack of Efficacy|26|||
148692930|NCT03499964|536350284|FG000|Overall Study|Adverse Event|1|||
148692931|NCT03499964|536350285|FG001|Overall Study|Adverse Event|0|||
148692932|NCT03499964|536350284|FG000|Overall Study|Death|1|||
149022905|NCT02559817|537562596|FG004|Treatment Period|Adverse Event|0|||
148959305|NCT02769247|537335630|FG002|Overall Study|Protocol Violation|1|||
148959306|NCT02769247|537335631|FG003|Overall Study|Protocol Violation|0|||
148959307|NCT02769247|537335628|FG000|Overall Study|Physician Decision|1|||
148959308|NCT02769247|537335629|FG001|Overall Study|Physician Decision|0|||
148959309|NCT02769247|537335630|FG002|Overall Study|Physician Decision|0|||
148959310|NCT02769247|537335631|FG003|Overall Study|Physician Decision|0|||
148959311|NCT02150954|537335635|FG000|Overall Study|Protocol Violation|1|||
148959312|NCT02150954|537335636|FG001|Overall Study|Protocol Violation|0|||
148959313|NCT05407675|537335649|FG000|Overall Study|Withdrawal by Subject|0|||
148959314|NCT05407675|537335650|FG001|Overall Study|Withdrawal by Subject|2|||
148959315|NCT05407675|537335651|FG002|Overall Study|Withdrawal by Subject|3|||
148959316|NCT05407675|537335652|FG003|Overall Study|Withdrawal by Subject|5|||
148959317|NCT05407675|537335653|FG004|Overall Study|Withdrawal by Subject|0|||
148959318|NCT05407675|537335654|FG005|Overall Study|Withdrawal by Subject|2|||
148959319|NCT05407675|537335655|FG006|Overall Study|Withdrawal by Subject|0|||
148959320|NCT05407675|537335656|FG007|Overall Study|Withdrawal by Subject|0|||
148959321|NCT05407675|537335657|FG008|Overall Study|Withdrawal by Subject|2|||
148959322|NCT05407675|537335658|FG009|Overall Study|Withdrawal by Subject|0|||
148959323|NCT05407675|537335659|FG010|Overall Study|Withdrawal by Subject|1|||
148959324|NCT05407675|537335660|FG011|Overall Study|Withdrawal by Subject|0|||
148959325|NCT05407675|537335661|FG012|Overall Study|Withdrawal by Subject|0|||
148959326|NCT05407675|537335649|FG000|Overall Study|Site terminated by sponsor|0|||
148959327|NCT05407675|537335650|FG001|Overall Study|Site terminated by sponsor|0|||
148692933|NCT03499964|536350285|FG001|Overall Study|Death|0|||
148959328|NCT05407675|537335651|FG002|Overall Study|Site terminated by sponsor|1|||
148959329|NCT05407675|537335652|FG003|Overall Study|Site terminated by sponsor|0|||
148959330|NCT05407675|537335653|FG004|Overall Study|Site terminated by sponsor|2|||
148959331|NCT05407675|537335654|FG005|Overall Study|Site terminated by sponsor|0|||
148959332|NCT05407675|537335655|FG006|Overall Study|Site terminated by sponsor|1|||
148959333|NCT05407675|537335656|FG007|Overall Study|Site terminated by sponsor|0|||
148959334|NCT05407675|537335657|FG008|Overall Study|Site terminated by sponsor|0|||
148959335|NCT05407675|537335658|FG009|Overall Study|Site terminated by sponsor|2|||
148959336|NCT05407675|537335659|FG010|Overall Study|Site terminated by sponsor|2|||
148959337|NCT05407675|537335660|FG011|Overall Study|Site terminated by sponsor|2|||
149022906|NCT02559817|537562592|FG000|Treatment Period|Lack of Efficacy|0|||
149022907|NCT02559817|537562593|FG001|Treatment Period|Lack of Efficacy|1|||
149022908|NCT02559817|537562594|FG002|Treatment Period|Lack of Efficacy|0|||
149022909|NCT02559817|537562595|FG003|Treatment Period|Lack of Efficacy|0|||
149022910|NCT02559817|537562596|FG004|Treatment Period|Lack of Efficacy|0|||
149022911|NCT02559817|537562592|FG000|Treatment Period|Lost to Follow-up|0|||
149022912|NCT02559817|537562593|FG001|Treatment Period|Lost to Follow-up|1|||
149022913|NCT02559817|537562594|FG002|Treatment Period|Lost to Follow-up|0|||
149022914|NCT02559817|537562595|FG003|Treatment Period|Lost to Follow-up|1|||
149022915|NCT02559817|537562596|FG004|Treatment Period|Lost to Follow-up|0|||
149022916|NCT02559817|537562592|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
149022917|NCT02559817|537562593|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
149022918|NCT02559817|537562594|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
149022919|NCT02559817|537562595|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
149022920|NCT02559817|537562596|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
148959338|NCT05407675|537335661|FG012|Overall Study|Site terminated by sponsor|1|||
148959339|NCT05407675|537335649|FG000|Overall Study|Disease Progression|0|||
148959340|NCT05407675|537335650|FG001|Overall Study|Disease Progression|0|||
148959341|NCT05407675|537335651|FG002|Overall Study|Disease Progression|0|||
148959342|NCT05407675|537335652|FG003|Overall Study|Disease Progression|0|||
148959343|NCT05407675|537335653|FG004|Overall Study|Disease Progression|0|||
148959344|NCT05407675|537335654|FG005|Overall Study|Disease Progression|0|||
149022921|NCT02559817|537562592|FG000|Treatment Period|Protocol Violation|0|||
149022922|NCT02559817|537562593|FG001|Treatment Period|Protocol Violation|0|||
149022923|NCT02559817|537562594|FG002|Treatment Period|Protocol Violation|0|||
149022924|NCT02559817|537562595|FG003|Treatment Period|Protocol Violation|1|||
149022925|NCT02559817|537562596|FG004|Treatment Period|Protocol Violation|0|||
149022926|NCT03389893|537562597|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
149022927|NCT03389893|537562598|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
149022928|NCT03389893|537562599|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
149022929|NCT03389893|537562600|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
149022930|NCT03389893|537562597|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
149022931|NCT03389893|537562598|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
149022932|NCT03389893|537562599|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
149022933|NCT03389893|537562600|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
149022934|NCT03389893|537562597|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
149022935|NCT03389893|537562598|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
149022936|NCT03389893|537562599|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
149022937|NCT03389893|537562600|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
149022938|NCT03389893|537562597|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
149022939|NCT03389893|537562598|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
149022940|NCT03389893|537562599|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
149022941|NCT03389893|537562600|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
149022942|NCT01925170|537562602|FG000|Overall Study|Unverified cancer status|53|||
149022943|NCT02034435|537562603|FG000|Overall Study|Withdrawal by Subject|1|||
149022944|NCT02034435|537562604|FG001|Overall Study|Withdrawal by Subject|0|||
149022945|NCT02034435|537562605|FG002|Overall Study|Withdrawal by Subject|0|||
149022946|NCT02034435|537562606|FG003|Overall Study|Withdrawal by Subject|0|||
149022947|NCT02034435|537562603|FG000|Overall Study|Illness|0|||
149022948|NCT02034435|537562604|FG001|Overall Study|Illness|2|||
149022949|NCT02034435|537562605|FG002|Overall Study|Illness|0|||
149022950|NCT02034435|537562606|FG003|Overall Study|Illness|0|||
149022951|NCT02034435|537562603|FG000|Overall Study|Inadequate IV access|1|||
149022952|NCT02034435|537562604|FG001|Overall Study|Inadequate IV access|0|||
149022953|NCT02034435|537562605|FG002|Overall Study|Inadequate IV access|0|||
148811773|NCT03765073|536787085|FG014|Stage 3|Lost to Follow-up|0|||
148959345|NCT05407675|537335655|FG006|Overall Study|Disease Progression|0|||
148959346|NCT05407675|537335656|FG007|Overall Study|Disease Progression|0|||
149022954|NCT02034435|537562606|FG003|Overall Study|Inadequate IV access|1|||
149022955|NCT00801242|537562609|FG000|Overall Study|Adverse Event|10|||
149022956|NCT00801242|537562609|FG000|Overall Study|Withdrawal by Subject|13|||
149022957|NCT00801242|537562609|FG000|Overall Study|Protocol Violation|5|||
149022958|NCT00801242|537562609|FG000|Overall Study|Physician Decision|3|||
149022959|NCT00801242|537562609|FG000|Overall Study|Lost to Follow-up|1|||
149022960|NCT00801242|537562609|FG000|Overall Study|Miscellaneous reasons|20|||
148811774|NCT03765073|536787086|FG015|Stage 3|Lost to Follow-up|0|||
148959347|NCT05407675|537335657|FG008|Overall Study|Disease Progression|0|||
148959348|NCT05407675|537335658|FG009|Overall Study|Disease Progression|0|||
149022961|NCT02554513|537562610|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
149022962|NCT02554513|537562611|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
149022963|NCT00388362|537562614|FG000|Enrolled|Ineligible|1|||
149022964|NCT00388362|537562614|FG000|Enrolled|Adverse Event|9|||
149022965|NCT00388362|537562614|FG000|Enrolled|Death|1|||
149022966|NCT00388362|537562614|FG000|Enrolled|Loss insurance|1|||
149022967|NCT00388362|537562614|FG000|Enrolled|Withdrawal by Subject|1|||
149022968|NCT00388362|537562614|FG000|Remained on Study Median of 514 Days|Death|2|||
149022969|NCT02335268|537562617|FG000|Overall Study|Physician Decision|5|||
149022970|NCT02335268|537562618|FG001|Overall Study|Physician Decision|1|||
149022971|NCT02335268|537562617|FG000|Overall Study|Lack of Efficacy|2|||
149022972|NCT02335268|537562618|FG001|Overall Study|Lack of Efficacy|1|||
149022973|NCT02335268|537562617|FG000|Overall Study|Adverse Event|5|||
149022974|NCT02335268|537562618|FG001|Overall Study|Adverse Event|2|||
149022975|NCT02335268|537562617|FG000|Overall Study|increase blasts|2|||
149022976|NCT02335268|537562618|FG001|Overall Study|increase blasts|0|||
149022977|NCT02335268|537562617|FG000|Overall Study|Withdrawal by Subject|3|||
149022978|NCT02335268|537562618|FG001|Overall Study|Withdrawal by Subject|2|||
149022979|NCT03160079|537562627|FG000|Overall Study|Adverse Event|2|||
149022980|NCT03160079|537562628|FG001|Overall Study|Adverse Event|0|||
149022981|NCT03160079|537562627|FG000|Overall Study|Disease Progression|1|||
149022982|NCT03160079|537562628|FG001|Overall Study|Disease Progression|0|||
149022983|NCT03160079|537562627|FG000|Overall Study|Physician Decision|1|||
149022984|NCT03160079|537562628|FG001|Overall Study|Physician Decision|0|||
149022985|NCT05893797|537562634|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
149022986|NCT05893797|537562634|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
149022987|NCT05893797|537562634|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
149022988|NCT05893797|537562634|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
149022989|NCT04770220|537562635|FG000|Overall Study|Adverse Event|2|||
149022990|NCT04770220|537562636|FG001|Overall Study|Adverse Event|11|||
149022991|NCT04770220|537562635|FG000|Overall Study|Withdrawal by Subject|5|||
149022992|NCT04770220|537562636|FG001|Overall Study|Withdrawal by Subject|11|||
149022993|NCT04770220|537562635|FG000|Overall Study|Lost to Follow-up|4|||
149022994|NCT04770220|537562636|FG001|Overall Study|Lost to Follow-up|3|||
149022995|NCT04770220|537562635|FG000|Overall Study|not otherwise specified|2|||
149022996|NCT04770220|537562636|FG001|Overall Study|not otherwise specified|3|||
149022997|NCT04770220|537562635|FG000|Overall Study|Physician Decision|1|||
149022998|NCT04770220|537562636|FG001|Overall Study|Physician Decision|3|||
149022999|NCT01670500|537562637|FG000|Overall Study|Withdrawal by Subject|1|||
149023000|NCT01670500|537562638|FG001|Overall Study|Withdrawal by Subject|0|||
149023001|NCT04955626|537562639|FG000|Blinded Period|Lost to Follow-up|28|||
149023002|NCT04955626|537562640|FG001|Blinded Period|Lost to Follow-up|28|||
149023003|NCT04955626|537562641|FG002|Blinded Period|Lost to Follow-up|7|||
149023004|NCT04955626|537562642|FG003|Blinded Period|Lost to Follow-up|14|||
149023005|NCT04955626|537562643|FG004|Blinded Period|Lost to Follow-up|3|||
149023006|NCT04955626|537562644|FG005|Blinded Period|Lost to Follow-up|2|||
149023007|NCT04955626|537562645|FG006|Blinded Period|Lost to Follow-up|6|||
149023008|NCT04955626|537562646|FG007|Blinded Period|Lost to Follow-up|4|||
149023009|NCT04955626|537562647|FG008|Blinded Period|Lost to Follow-up|5|||
149023010|NCT04955626|537562648|FG009|Blinded Period|Lost to Follow-up|8|||
149023011|NCT04955626|537562649|FG010|Blinded Period|Lost to Follow-up|10|||
149023012|NCT04955626|537562650|FG011|Blinded Period|Lost to Follow-up|32|||
149023013|NCT04955626|537562651|FG012|Blinded Period|Lost to Follow-up|0|||
149023014|NCT04955626|537562652|FG013|Blinded Period|Lost to Follow-up|0|||
149023015|NCT04955626|537562653|FG014|Blinded Period|Lost to Follow-up|0|||
149023016|NCT04955626|537562654|FG015|Blinded Period|Lost to Follow-up|12|||
149023017|NCT04955626|537562655|FG016|Blinded Period|Lost to Follow-up|2|||
149023018|NCT04955626|537562656|FG017|Blinded Period|Lost to Follow-up|5|||
149023019|NCT04955626|537562657|FG018|Blinded Period|Lost to Follow-up|0|||
149023020|NCT04955626|537562658|FG019|Blinded Period|Lost to Follow-up|0|||
149023021|NCT04955626|537562659|FG020|Blinded Period|Lost to Follow-up|0|||
149023022|NCT04955626|537562660|FG021|Blinded Period|Lost to Follow-up|0|||
149023023|NCT04955626|537562661|FG022|Blinded Period|Lost to Follow-up|0|||
149023024|NCT04955626|537562662|FG023|Blinded Period|Lost to Follow-up|0|||
149023025|NCT04955626|537562663|FG024|Blinded Period|Lost to Follow-up|3|||
149023026|NCT04955626|537562664|FG025|Blinded Period|Lost to Follow-up|1|||
149023027|NCT04955626|537562665|FG026|Blinded Period|Lost to Follow-up|2|||
149023028|NCT04955626|537562666|FG027|Blinded Period|Lost to Follow-up|2|||
149023029|NCT04955626|537562667|FG028|Blinded Period|Lost to Follow-up|2|||
149023030|NCT04955626|537562668|FG029|Blinded Period|Lost to Follow-up|0|||
149023031|NCT04955626|537562669|FG030|Blinded Period|Lost to Follow-up|0|||
149023032|NCT04955626|537562670|FG031|Blinded Period|Lost to Follow-up|0|||
149023033|NCT04955626|537562671|FG032|Blinded Period|Lost to Follow-up|0|||
149023034|NCT04955626|537562672|FG033|Blinded Period|Lost to Follow-up|0|||
149023035|NCT04955626|537562673|FG034|Blinded Period|Lost to Follow-up|0|||
149023036|NCT04955626|537562674|FG035|Blinded Period|Lost to Follow-up|0|||
149023037|NCT04955626|537562639|FG000|Blinded Period|Protocol Violation|5|||
149023038|NCT04955626|537562640|FG001|Blinded Period|Protocol Violation|14|||
149023039|NCT04955626|537562641|FG002|Blinded Period|Protocol Violation|0|||
149023040|NCT04955626|537562642|FG003|Blinded Period|Protocol Violation|1|||
148959349|NCT05407675|537335659|FG010|Overall Study|Disease Progression|1|||
148959350|NCT05407675|537335660|FG011|Overall Study|Disease Progression|0|||
148959351|NCT05407675|537335661|FG012|Overall Study|Disease Progression|0|||
148959352|NCT05407675|537335649|FG000|Overall Study|Physician Decision|0|||
148959353|NCT05407675|537335650|FG001|Overall Study|Physician Decision|0|||
148959354|NCT05407675|537335651|FG002|Overall Study|Physician Decision|0|||
148959355|NCT05407675|537335652|FG003|Overall Study|Physician Decision|0|||
148959356|NCT05407675|537335653|FG004|Overall Study|Physician Decision|0|||
148959357|NCT05407675|537335654|FG005|Overall Study|Physician Decision|0|||
148959358|NCT05407675|537335655|FG006|Overall Study|Physician Decision|0|||
148959359|NCT05407675|537335656|FG007|Overall Study|Physician Decision|0|||
148959360|NCT05407675|537335657|FG008|Overall Study|Physician Decision|0|||
148959361|NCT05407675|537335658|FG009|Overall Study|Physician Decision|0|||
148959362|NCT05407675|537335659|FG010|Overall Study|Physician Decision|1|||
148959363|NCT05407675|537335660|FG011|Overall Study|Physician Decision|0|||
148959364|NCT05407675|537335661|FG012|Overall Study|Physician Decision|0|||
148959365|NCT05407675|537335649|FG000|Overall Study|Other reasons|0|||
148959366|NCT05407675|537335650|FG001|Overall Study|Other reasons|0|||
148959367|NCT05407675|537335651|FG002|Overall Study|Other reasons|0|||
148959368|NCT05407675|537335652|FG003|Overall Study|Other reasons|0|||
148959369|NCT05407675|537335653|FG004|Overall Study|Other reasons|0|||
148959370|NCT05407675|537335654|FG005|Overall Study|Other reasons|0|||
148959371|NCT05407675|537335655|FG006|Overall Study|Other reasons|0|||
148959372|NCT05407675|537335656|FG007|Overall Study|Other reasons|0|||
148959373|NCT05407675|537335657|FG008|Overall Study|Other reasons|1|||
148959374|NCT05407675|537335658|FG009|Overall Study|Other reasons|1|||
148959375|NCT05407675|537335659|FG010|Overall Study|Other reasons|1|||
148959376|NCT05407675|537335660|FG011|Overall Study|Other reasons|1|||
148959377|NCT05407675|537335661|FG012|Overall Study|Other reasons|0|||
148959378|NCT05407675|537335649|FG000|Overall Study|Death|3|||
148959379|NCT05407675|537335650|FG001|Overall Study|Death|4|||
148959380|NCT05407675|537335651|FG002|Overall Study|Death|3|||
148959381|NCT05407675|537335652|FG003|Overall Study|Death|6|||
148959382|NCT05407675|537335653|FG004|Overall Study|Death|0|||
148959383|NCT05407675|537335654|FG005|Overall Study|Death|2|||
148959384|NCT05407675|537335655|FG006|Overall Study|Death|4|||
148959385|NCT05407675|537335656|FG007|Overall Study|Death|2|||
148959386|NCT05407675|537335657|FG008|Overall Study|Death|2|||
148959387|NCT05407675|537335658|FG009|Overall Study|Death|4|||
148959388|NCT05407675|537335659|FG010|Overall Study|Death|2|||
148959389|NCT05407675|537335660|FG011|Overall Study|Death|1|||
148959390|NCT05407675|537335661|FG012|Overall Study|Death|0|||
148959391|NCT05407675|537335649|FG000|Overall Study|Adverse Event|0|||
148959392|NCT05407675|537335650|FG001|Overall Study|Adverse Event|0|||
148959393|NCT05407675|537335651|FG002|Overall Study|Adverse Event|0|||
148959394|NCT05407675|537335652|FG003|Overall Study|Adverse Event|0|||
148959395|NCT05407675|537335653|FG004|Overall Study|Adverse Event|1|||
148959396|NCT05407675|537335654|FG005|Overall Study|Adverse Event|0|||
148959397|NCT05407675|537335655|FG006|Overall Study|Adverse Event|0|||
148959398|NCT05407675|537335656|FG007|Overall Study|Adverse Event|0|||
148959399|NCT05407675|537335657|FG008|Overall Study|Adverse Event|0|||
148959400|NCT05407675|537335658|FG009|Overall Study|Adverse Event|0|||
148959401|NCT05407675|537335659|FG010|Overall Study|Adverse Event|0|||
148959402|NCT05407675|537335660|FG011|Overall Study|Adverse Event|1|||
148959403|NCT05407675|537335661|FG012|Overall Study|Adverse Event|0|||
148959404|NCT05407675|537335649|FG000|Overall Study|Ongoing Treatment|0|||
148959405|NCT05407675|537335650|FG001|Overall Study|Ongoing Treatment|0|||
148959406|NCT05407675|537335651|FG002|Overall Study|Ongoing Treatment|0|||
148959407|NCT05407675|537335652|FG003|Overall Study|Ongoing Treatment|0|||
148959408|NCT05407675|537335653|FG004|Overall Study|Ongoing Treatment|0|||
148959409|NCT05407675|537335654|FG005|Overall Study|Ongoing Treatment|0|||
148959410|NCT05407675|537335655|FG006|Overall Study|Ongoing Treatment|0|||
148959411|NCT05407675|537335656|FG007|Overall Study|Ongoing Treatment|0|||
148959412|NCT05407675|537335657|FG008|Overall Study|Ongoing Treatment|1|||
148959413|NCT05407675|537335658|FG009|Overall Study|Ongoing Treatment|0|||
148959414|NCT05407675|537335659|FG010|Overall Study|Ongoing Treatment|0|||
148959415|NCT05407675|537335660|FG011|Overall Study|Ongoing Treatment|0|||
148959416|NCT05407675|537335661|FG012|Overall Study|Ongoing Treatment|0|||
148959417|NCT00857220|537335662|FG000|Overall Study|Adverse Event|35|||
148959418|NCT00857220|537335662|FG000|Overall Study|Death|1|||
148959419|NCT00857220|537335662|FG000|Overall Study|Lack of Efficacy|11|||
148959420|NCT00857220|537335662|FG000|Overall Study|Lost to Follow-up|30|||
148959421|NCT00857220|537335662|FG000|Overall Study|Physician Decision|4|||
148959422|NCT00857220|537335662|FG000|Overall Study|Protocol Violation|16|||
148959423|NCT00857220|537335662|FG000|Overall Study|Withdrawal by Subject|67|||
148959424|NCT00857220|537335662|FG000|Overall Study|Clinical Hold|6|||
148959425|NCT00857220|537335662|FG000|Overall Study|Site Closed|5|||
148959426|NCT00857220|537335662|FG000|Overall Study|Miscellaneous|8|||
148692934|NCT03499964|536350284|FG000|Overall Study|Withdrawal by Subject|2|||
148959427|NCT00742001|537335663|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
148959428|NCT00742001|537335664|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
148959429|NCT00742001|537335665|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
148959430|NCT00137423|537335666|FG000|Overall Study|Adverse Event|7|||
148959431|NCT00137423|537335667|FG001|Overall Study|Adverse Event|9|||
148959432|NCT00137423|537335666|FG000|Overall Study|consent withdrawn|1|||
148959433|NCT00137423|537335667|FG001|Overall Study|consent withdrawn|1|||
148959434|NCT00137423|537335666|FG000|Overall Study|Lack of Efficacy|31|||
148959435|NCT00137423|537335667|FG001|Overall Study|Lack of Efficacy|33|||
148959436|NCT00137423|537335666|FG000|Overall Study|Death|0|||
148959437|NCT00137423|537335667|FG001|Overall Study|Death|1|||
148959438|NCT03187262|537335668|FG000|Induction|Lack of Efficacy|2|||
148959439|NCT03187262|537335668|FG000|Induction|Progressive Disease|4|||
148959440|NCT03187262|537335668|FG000|Consolidation|Progressive Disease|5|||
148959441|NCT04105998|537335670|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
148959442|NCT04105998|537335671|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
148959443|NCT01050257|537335672|FG000|Overall Study|Adverse Event|4|||
148959444|NCT01050257|537335673|FG001|Overall Study|Adverse Event|4|||
148959445|NCT01050257|537335674|FG002|Overall Study|Adverse Event|2|||
148959446|NCT01050257|537335672|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
148959447|NCT01050257|537335673|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
148959448|NCT01050257|537335674|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
148959449|NCT01050257|537335672|FG000|Overall Study|Withdrawal by Subject|0|||
148959450|NCT01050257|537335673|FG001|Overall Study|Withdrawal by Subject|3|||
148959451|NCT01050257|537335674|FG002|Overall Study|Withdrawal by Subject|0|||
148959452|NCT01050257|537335672|FG000|Overall Study|No reason specified|0|||
149023041|NCT04955626|537562643|FG004|Blinded Period|Protocol Violation|2|||
148959453|NCT01050257|537335673|FG001|Overall Study|No reason specified|0|||
148959454|NCT01050257|537335674|FG002|Overall Study|No reason specified|2|||
149023042|NCT04955626|537562644|FG005|Blinded Period|Protocol Violation|2|||
148959455|NCT01050257|537335672|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
148959456|NCT01050257|537335673|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
148959457|NCT01050257|537335674|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
148959458|NCT01050257|537335672|FG000|Overall Study|Violation criteria|0|||
148959459|NCT01050257|537335673|FG001|Overall Study|Violation criteria|1|||
148959460|NCT01050257|537335674|FG002|Overall Study|Violation criteria|0|||
148959461|NCT01050257|537335672|FG000|Overall Study|Failure to return|0|||
148959462|NCT01050257|537335673|FG001|Overall Study|Failure to return|2|||
148959463|NCT01050257|537335674|FG002|Overall Study|Failure to return|0|||
148959464|NCT01050257|537335672|FG000|Overall Study|Death|0|||
148959465|NCT01050257|537335673|FG001|Overall Study|Death|0|||
148959466|NCT01050257|537335674|FG002|Overall Study|Death|1|||
148959467|NCT00171223|537335675|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
148959468|NCT00171223|537335676|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
148959469|NCT00171223|537335677|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
148692935|NCT03499964|536350285|FG001|Overall Study|Withdrawal by Subject|1|||
148959470|NCT00171223|537335675|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
148959471|NCT00171223|537335676|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
148959472|NCT00171223|537335677|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
148959473|NCT00171223|537335675|FG000|Overall Study|Abnormal Procedure|1|||
148959474|NCT00171223|537335676|FG001|Overall Study|Abnormal Procedure|0|||
148959475|NCT00171223|537335677|FG002|Overall Study|Abnormal Procedure|0|||
148959476|NCT00171223|537335675|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
148959477|NCT00171223|537335676|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
148959478|NCT00171223|537335677|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
148959479|NCT00171223|537335675|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
148959480|NCT00171223|537335676|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
148959481|NCT00171223|537335677|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
148959482|NCT00171223|537335675|FG000|Overall Study|Protocol Violation|2|||
148959483|NCT00171223|537335676|FG001|Overall Study|Protocol Violation|2|||
148959484|NCT00171223|537335677|FG002|Overall Study|Protocol Violation|3|||
148959485|NCT00171223|537335675|FG000|Overall Study|Participant Withdrew Consent|12|||
148959486|NCT00171223|537335676|FG001|Overall Study|Participant Withdrew Consent|21|||
148959487|NCT00171223|537335677|FG002|Overall Study|Participant Withdrew Consent|15|||
148959488|NCT00171223|537335675|FG000|Overall Study|Lost to Follow-up|5|||
148959489|NCT00171223|537335676|FG001|Overall Study|Lost to Follow-up|2|||
148959490|NCT00171223|537335677|FG002|Overall Study|Lost to Follow-up|3|||
148959491|NCT00171223|537335675|FG000|Overall Study|Administrative Problems|4|||
148959492|NCT00171223|537335676|FG001|Overall Study|Administrative Problems|7|||
148959493|NCT00171223|537335677|FG002|Overall Study|Administrative Problems|6|||
148959494|NCT00171223|537335675|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
148959495|NCT00171223|537335676|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
148959496|NCT00171223|537335677|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
148959497|NCT00171223|537335675|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
148959498|NCT00171223|537335676|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
148959499|NCT00171223|537335677|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
148959500|NCT02604212|537335679|FG000|Overall Study|Study Terminated by Sponsor|2|||
148959501|NCT02604212|537335680|FG001|Overall Study|Study Terminated by Sponsor|1|||
148959502|NCT02604212|537335681|FG002|Overall Study|Study Terminated by Sponsor|3|||
148959503|NCT02604212|537335682|FG003|Overall Study|Study Terminated by Sponsor|3|||
148959504|NCT02604212|537335679|FG000|Overall Study|Withdrawal by Subject|0|||
148959505|NCT02604212|537335680|FG001|Overall Study|Withdrawal by Subject|0|||
148959506|NCT02604212|537335681|FG002|Overall Study|Withdrawal by Subject|1|||
148959507|NCT02604212|537335682|FG003|Overall Study|Withdrawal by Subject|0|||
148959508|NCT00278109|537335683|FG000|Overall Study|Adverse Event|3|||
148959509|NCT00278109|537335683|FG000|Overall Study|social circumstances|1|||
148959510|NCT02580357|537335684|FG000|Overall Study|Lost to Follow-up|2|||
148959511|NCT02580357|537335685|FG001|Overall Study|Lost to Follow-up|0|||
148959512|NCT02580357|537335686|FG002|Overall Study|Lost to Follow-up|0|||
148959513|NCT02580357|537335684|FG000|Overall Study|Protocol Violation|1|||
148959514|NCT02580357|537335685|FG001|Overall Study|Protocol Violation|0|||
148959515|NCT02580357|537335686|FG002|Overall Study|Protocol Violation|0|||
148959516|NCT00450333|537335687|FG000|Overall Study|Study terminated|47|||
148959517|NCT00450333|537335688|FG001|Overall Study|Study terminated|54|||
148959518|NCT00450333|537335689|FG002|Overall Study|Study terminated|16|||
148959519|NCT00450333|537335690|FG003|Overall Study|Study terminated|21|||
148959520|NCT00450333|537335687|FG000|Overall Study|Adverse Event|1|||
148959521|NCT00450333|537335688|FG001|Overall Study|Adverse Event|7|||
148959522|NCT00450333|537335689|FG002|Overall Study|Adverse Event|2|||
148959523|NCT00450333|537335690|FG003|Overall Study|Adverse Event|2|||
148959524|NCT00450333|537335687|FG000|Overall Study|Protocol Violation|1|||
148959525|NCT00450333|537335688|FG001|Overall Study|Protocol Violation|0|||
148959526|NCT00450333|537335689|FG002|Overall Study|Protocol Violation|1|||
148959527|NCT00450333|537335690|FG003|Overall Study|Protocol Violation|0|||
148959528|NCT00450333|537335687|FG000|Overall Study|Withdrawal by Subject|1|||
148959529|NCT00450333|537335688|FG001|Overall Study|Withdrawal by Subject|0|||
148959530|NCT00450333|537335689|FG002|Overall Study|Withdrawal by Subject|3|||
148959531|NCT00450333|537335690|FG003|Overall Study|Withdrawal by Subject|0|||
148959532|NCT00450333|537335687|FG000|Overall Study|Kidney transplant|1|||
148959533|NCT00450333|537335688|FG001|Overall Study|Kidney transplant|0|||
148959534|NCT00450333|537335689|FG002|Overall Study|Kidney transplant|1|||
148959535|NCT00450333|537335690|FG003|Overall Study|Kidney transplant|3|||
148959536|NCT00450333|537335687|FG000|Overall Study|Death|3|||
148959537|NCT00450333|537335688|FG001|Overall Study|Death|2|||
148959538|NCT00450333|537335689|FG002|Overall Study|Death|2|||
148959539|NCT00450333|537335690|FG003|Overall Study|Death|2|||
148959540|NCT01829230|537335699|FG000|Overall Study|Protocol Violation|0|||
148959541|NCT01829230|537335700|FG001|Overall Study|Protocol Violation|2|||
148811775|NCT03765073|536787087|FG016|Stage 3|Lost to Follow-up|0|||
148811776|NCT03765073|536787088|FG017|Stage 3|Lost to Follow-up|8|||
148811777|NCT03765073|536787089|FG018|Stage 3|Lost to Follow-up|5|||
148959542|NCT01829230|537335699|FG000|Overall Study|Withdrawal by Subject|0|||
148959543|NCT01829230|537335700|FG001|Overall Study|Withdrawal by Subject|1|||
148959544|NCT01829230|537335699|FG000|Overall Study|Lost to Follow-up|1|||
148959545|NCT01829230|537335700|FG001|Overall Study|Lost to Follow-up|1|||
148959546|NCT03855280|537335701|FG000|Treatment Phase|Adverse Event|1|||
148959547|NCT03855280|537335701|FG000|Treatment Phase|Withdrawal by Subject|1|||
148959548|NCT03855280|537335701|FG000|Continuation Phase|Protocol Violation|1|||
148959549|NCT03855280|537335701|FG000|Continuation Phase|Adverse Event|1|||
148959550|NCT03855280|537335701|FG000|Continuation Phase|Sponsor Concluded Study|1|||
148959551|NCT00969150|537335705|FG000|Overall Study|Adverse Event|4|||
148959552|NCT00969150|537335706|FG001|Overall Study|Adverse Event|14|||
148959553|NCT00969150|537335705|FG000|Overall Study|Lack of Efficacy|1|||
148959554|NCT00969150|537335706|FG001|Overall Study|Lack of Efficacy|1|||
148959555|NCT00969150|537335705|FG000|Overall Study|Protocol Violation|9|||
148959556|NCT00969150|537335706|FG001|Overall Study|Protocol Violation|12|||
148959557|NCT00969150|537335705|FG000|Overall Study|Withdrawal by Subject|13|||
148959558|NCT00969150|537335706|FG001|Overall Study|Withdrawal by Subject|9|||
148959559|NCT00969150|537335705|FG000|Overall Study|Lost to Follow-up|5|||
148959560|NCT00969150|537335706|FG001|Overall Study|Lost to Follow-up|4|||
148959561|NCT00969150|537335705|FG000|Overall Study|Other reasons|1|||
148959562|NCT00969150|537335706|FG001|Overall Study|Other reasons|0|||
148959563|NCT00461682|537335707|FG000|Overall Study|Protocol Violation|1|||
148959564|NCT00553150|537335708|FG000|Overall Study|Withdrawal by Subject|0|||
148959565|NCT00553150|537335709|FG001|Overall Study|Withdrawal by Subject|0|||
148959566|NCT00553150|537335710|FG002|Overall Study|Withdrawal by Subject|0|||
148959567|NCT00553150|537335711|FG003|Overall Study|Withdrawal by Subject|2|||
148959568|NCT00553150|537335708|FG000|Overall Study|Protocol Violation|0|||
148811778|NCT03765073|536787090|FG019|Stage 3|Lost to Follow-up|7|||
148959569|NCT00553150|537335709|FG001|Overall Study|Protocol Violation|0|||
148959570|NCT00553150|537335710|FG002|Overall Study|Protocol Violation|0|||
148959571|NCT00553150|537335711|FG003|Overall Study|Protocol Violation|1|||
148959572|NCT00553150|537335708|FG000|Overall Study|Ineligible|0|||
148959573|NCT00553150|537335709|FG001|Overall Study|Ineligible|0|||
148959574|NCT00553150|537335710|FG002|Overall Study|Ineligible|0|||
148959575|NCT00553150|537335711|FG003|Overall Study|Ineligible|1|||
148959576|NCT01165554|537335712|FG000|Overall Study|Withdrawal by Subject|23|||
149023043|NCT04955626|537562645|FG006|Blinded Period|Protocol Violation|0|||
149023044|NCT04955626|537562646|FG007|Blinded Period|Protocol Violation|0|||
149023045|NCT04955626|537562647|FG008|Blinded Period|Protocol Violation|0|||
149023046|NCT04955626|537562648|FG009|Blinded Period|Protocol Violation|4|||
149023047|NCT04955626|537562649|FG010|Blinded Period|Protocol Violation|6|||
149023048|NCT04955626|537562650|FG011|Blinded Period|Protocol Violation|1|||
149023049|NCT04955626|537562651|FG012|Blinded Period|Protocol Violation|0|||
149023050|NCT04955626|537562652|FG013|Blinded Period|Protocol Violation|0|||
149023051|NCT04955626|537562653|FG014|Blinded Period|Protocol Violation|2|||
149023052|NCT04955626|537562654|FG015|Blinded Period|Protocol Violation|6|||
149023053|NCT04955626|537562655|FG016|Blinded Period|Protocol Violation|4|||
149023054|NCT04955626|537562656|FG017|Blinded Period|Protocol Violation|6|||
149023055|NCT04955626|537562657|FG018|Blinded Period|Protocol Violation|0|||
149023056|NCT04955626|537562658|FG019|Blinded Period|Protocol Violation|1|||
149023057|NCT04955626|537562659|FG020|Blinded Period|Protocol Violation|0|||
149023058|NCT04955626|537562660|FG021|Blinded Period|Protocol Violation|1|||
149023059|NCT04955626|537562661|FG022|Blinded Period|Protocol Violation|0|||
149023060|NCT04955626|537562662|FG023|Blinded Period|Protocol Violation|0|||
149023061|NCT04955626|537562663|FG024|Blinded Period|Protocol Violation|4|||
149023062|NCT04955626|537562664|FG025|Blinded Period|Protocol Violation|6|||
149023063|NCT04955626|537562665|FG026|Blinded Period|Protocol Violation|5|||
149023064|NCT04955626|537562666|FG027|Blinded Period|Protocol Violation|3|||
149023065|NCT04955626|537562667|FG028|Blinded Period|Protocol Violation|4|||
148692936|NCT03499964|536350284|FG000|Overall Study|Lost to Follow-up|1|||
149023066|NCT04955626|537562668|FG029|Blinded Period|Protocol Violation|3|||
149023067|NCT04955626|537562669|FG030|Blinded Period|Protocol Violation|0|||
149023068|NCT04955626|537562670|FG031|Blinded Period|Protocol Violation|0|||
149023069|NCT04955626|537562671|FG032|Blinded Period|Protocol Violation|0|||
149023070|NCT04955626|537562672|FG033|Blinded Period|Protocol Violation|0|||
149023071|NCT04955626|537562673|FG034|Blinded Period|Protocol Violation|0|||
149023072|NCT04955626|537562674|FG035|Blinded Period|Protocol Violation|0|||
149023073|NCT04955626|537562639|FG000|Blinded Period|Death|0|||
149023074|NCT04955626|537562640|FG001|Blinded Period|Death|2|||
149023075|NCT04955626|537562641|FG002|Blinded Period|Death|0|||
149023076|NCT04955626|537562642|FG003|Blinded Period|Death|0|||
149023077|NCT04955626|537562643|FG004|Blinded Period|Death|0|||
149023078|NCT04955626|537562644|FG005|Blinded Period|Death|0|||
149023079|NCT04955626|537562645|FG006|Blinded Period|Death|0|||
149023080|NCT04955626|537562646|FG007|Blinded Period|Death|2|||
149023081|NCT04955626|537562647|FG008|Blinded Period|Death|1|||
149023082|NCT04955626|537562648|FG009|Blinded Period|Death|1|||
149023083|NCT04955626|537562649|FG010|Blinded Period|Death|0|||
149023084|NCT04955626|537562650|FG011|Blinded Period|Death|2|||
149023085|NCT04955626|537562651|FG012|Blinded Period|Death|0|||
149023086|NCT04955626|537562652|FG013|Blinded Period|Death|0|||
149023087|NCT04955626|537562653|FG014|Blinded Period|Death|0|||
149023088|NCT04955626|537562654|FG015|Blinded Period|Death|0|||
149023089|NCT04955626|537562655|FG016|Blinded Period|Death|0|||
149023090|NCT04955626|537562656|FG017|Blinded Period|Death|0|||
149023091|NCT04955626|537562657|FG018|Blinded Period|Death|0|||
149023092|NCT04955626|537562658|FG019|Blinded Period|Death|0|||
149023093|NCT04955626|537562659|FG020|Blinded Period|Death|0|||
149023094|NCT04955626|537562660|FG021|Blinded Period|Death|0|||
149023095|NCT04955626|537562661|FG022|Blinded Period|Death|0|||
149023096|NCT04955626|537562662|FG023|Blinded Period|Death|1|||
149023097|NCT04955626|537562663|FG024|Blinded Period|Death|0|||
149023098|NCT04955626|537562664|FG025|Blinded Period|Death|0|||
149023099|NCT04955626|537562665|FG026|Blinded Period|Death|1|||
149023100|NCT04955626|537562666|FG027|Blinded Period|Death|1|||
149023101|NCT04955626|537562667|FG028|Blinded Period|Death|0|||
149023102|NCT04955626|537562668|FG029|Blinded Period|Death|1|||
149023103|NCT04955626|537562669|FG030|Blinded Period|Death|0|||
149023104|NCT04955626|537562670|FG031|Blinded Period|Death|0|||
149023105|NCT04955626|537562671|FG032|Blinded Period|Death|0|||
149023106|NCT04955626|537562672|FG033|Blinded Period|Death|0|||
149023107|NCT04955626|537562673|FG034|Blinded Period|Death|0|||
149023108|NCT04955626|537562674|FG035|Blinded Period|Death|0|||
149023109|NCT04955626|537562639|FG000|Blinded Period|Adverse Event|0|||
149023110|NCT04955626|537562640|FG001|Blinded Period|Adverse Event|1|||
149023111|NCT04955626|537562641|FG002|Blinded Period|Adverse Event|1|||
149023112|NCT04955626|537562642|FG003|Blinded Period|Adverse Event|1|||
149023113|NCT04955626|537562643|FG004|Blinded Period|Adverse Event|0|||
149023114|NCT04955626|537562644|FG005|Blinded Period|Adverse Event|0|||
149023115|NCT04955626|537562645|FG006|Blinded Period|Adverse Event|0|||
149023116|NCT04955626|537562646|FG007|Blinded Period|Adverse Event|0|||
149023117|NCT04955626|537562647|FG008|Blinded Period|Adverse Event|0|||
149023118|NCT04955626|537562648|FG009|Blinded Period|Adverse Event|1|||
149023119|NCT04955626|537562649|FG010|Blinded Period|Adverse Event|1|||
149023120|NCT04955626|537562650|FG011|Blinded Period|Adverse Event|0|||
149023121|NCT04955626|537562651|FG012|Blinded Period|Adverse Event|0|||
149023122|NCT04955626|537562652|FG013|Blinded Period|Adverse Event|0|||
149023123|NCT04955626|537562653|FG014|Blinded Period|Adverse Event|0|||
149023124|NCT04955626|537562654|FG015|Blinded Period|Adverse Event|0|||
149023125|NCT04955626|537562655|FG016|Blinded Period|Adverse Event|0|||
149023126|NCT04955626|537562656|FG017|Blinded Period|Adverse Event|0|||
149023127|NCT04955626|537562657|FG018|Blinded Period|Adverse Event|1|||
149023128|NCT04955626|537562658|FG019|Blinded Period|Adverse Event|0|||
149023129|NCT04955626|537562659|FG020|Blinded Period|Adverse Event|0|||
149023130|NCT04955626|537562660|FG021|Blinded Period|Adverse Event|0|||
149023131|NCT04955626|537562661|FG022|Blinded Period|Adverse Event|0|||
149023132|NCT04955626|537562662|FG023|Blinded Period|Adverse Event|0|||
149023133|NCT04955626|537562663|FG024|Blinded Period|Adverse Event|0|||
149023134|NCT04955626|537562664|FG025|Blinded Period|Adverse Event|0|||
149023135|NCT04955626|537562665|FG026|Blinded Period|Adverse Event|1|||
149023136|NCT04955626|537562666|FG027|Blinded Period|Adverse Event|0|||
149023137|NCT04955626|537562667|FG028|Blinded Period|Adverse Event|0|||
149023138|NCT04955626|537562668|FG029|Blinded Period|Adverse Event|0|||
149023139|NCT04955626|537562669|FG030|Blinded Period|Adverse Event|0|||
149023140|NCT04955626|537562670|FG031|Blinded Period|Adverse Event|0|||
149023141|NCT04955626|537562671|FG032|Blinded Period|Adverse Event|0|||
149023142|NCT04955626|537562672|FG033|Blinded Period|Adverse Event|0|||
148959577|NCT00101907|537335714|FG000|Overall Study|Adverse Event|1|||
148959578|NCT00101907|537335715|FG001|Overall Study|Adverse Event|0|||
148959579|NCT00101907|537335716|FG002|Overall Study|Adverse Event|0|||
148959580|NCT00101907|537335717|FG003|Overall Study|Adverse Event|0|||
148959581|NCT00101907|537335718|FG004|Overall Study|Adverse Event|0|||
148959582|NCT00101907|537335719|FG005|Overall Study|Adverse Event|0|||
148959583|NCT00101907|537335714|FG000|Overall Study|Death|0|||
148959584|NCT00101907|537335715|FG001|Overall Study|Death|1|||
148959585|NCT00101907|537335716|FG002|Overall Study|Death|0|||
148959586|NCT00101907|537335717|FG003|Overall Study|Death|0|||
149023143|NCT04955626|537562673|FG034|Blinded Period|Adverse Event|0|||
149023144|NCT04955626|537562674|FG035|Blinded Period|Adverse Event|0|||
149023145|NCT04955626|537562639|FG000|Blinded Period|No longer meets eligibility criteria|1|||
149023146|NCT04955626|537562640|FG001|Blinded Period|No longer meets eligibility criteria|2|||
149023147|NCT04955626|537562641|FG002|Blinded Period|No longer meets eligibility criteria|0|||
149023148|NCT04955626|537562642|FG003|Blinded Period|No longer meets eligibility criteria|1|||
149023149|NCT04955626|537562643|FG004|Blinded Period|No longer meets eligibility criteria|0|||
149023150|NCT04955626|537562644|FG005|Blinded Period|No longer meets eligibility criteria|0|||
148959587|NCT00101907|537335718|FG004|Overall Study|Death|3|||
148959588|NCT00101907|537335719|FG005|Overall Study|Death|0|||
148959589|NCT00101907|537335714|FG000|Overall Study|Physician Decision|0|||
148959590|NCT00101907|537335715|FG001|Overall Study|Physician Decision|0|||
148811779|NCT03765073|536787091|FG020|Stage 3|Lost to Follow-up|4|||
148959591|NCT00101907|537335716|FG002|Overall Study|Physician Decision|0|||
148959592|NCT00101907|537335717|FG003|Overall Study|Physician Decision|1|||
148959593|NCT00101907|537335718|FG004|Overall Study|Physician Decision|1|||
148959594|NCT00101907|537335719|FG005|Overall Study|Physician Decision|0|||
148959595|NCT00101907|537335714|FG000|Overall Study|Withdrawal by Subject|1|||
148959596|NCT00101907|537335715|FG001|Overall Study|Withdrawal by Subject|0|||
148959597|NCT00101907|537335716|FG002|Overall Study|Withdrawal by Subject|1|||
148959598|NCT00101907|537335717|FG003|Overall Study|Withdrawal by Subject|0|||
148959599|NCT00101907|537335718|FG004|Overall Study|Withdrawal by Subject|1|||
148959600|NCT00101907|537335719|FG005|Overall Study|Withdrawal by Subject|0|||
148959601|NCT01765153|537335720|FG000|Training Phase 1|Format of intervention differed|1|||
148959602|NCT01765153|537335721|FG001|Training Phase 1|Format of intervention differed|0|||
148959603|NCT01765153|537335720|FG000|Training Phase 1|Poor participation in intervention|0|||
148959604|NCT01765153|537335721|FG001|Training Phase 1|Poor participation in intervention|1|||
148959605|NCT01765153|537335720|FG000|Rest Phase 1|Withdrawal by Subject|0|||
148959606|NCT01765153|537335721|FG001|Rest Phase 1|Withdrawal by Subject|1|||
148959607|NCT01765153|537335720|FG000|Training Phase 2|Withdrawal by Subject|0|||
148959608|NCT01765153|537335721|FG001|Training Phase 2|Withdrawal by Subject|1|||
148959609|NCT01765153|537335720|FG000|Rest Phase 2|Lost to Follow-up|2|||
148959610|NCT01765153|537335721|FG001|Rest Phase 2|Lost to Follow-up|1|||
148959611|NCT03915496|537335724|FG000|Overall Study|Adverse Event|2|||
148959612|NCT03915496|537335725|FG001|Overall Study|Adverse Event|1|||
148959613|NCT03915496|537335726|FG002|Overall Study|Adverse Event|2|||
148692937|NCT03499964|536350285|FG001|Overall Study|Lost to Follow-up|0|||
148959614|NCT02663674|537335727|FG000|Overall Study|Lost to Follow-up|5|||
148692938|NCT01047345|536350291|FG000|Base Study|Adverse Event|3|||
148692939|NCT01047345|536350292|FG001|Base Study|Adverse Event|0|||
148692940|NCT01047345|536350293|FG002|Base Study|Adverse Event|0|||
148959615|NCT02663674|537335728|FG001|Overall Study|Lost to Follow-up|4|||
148959616|NCT02663674|537335727|FG000|Overall Study|Withdrawal by Subject|1|||
148959617|NCT02663674|537335728|FG001|Overall Study|Withdrawal by Subject|4|||
148959618|NCT02663674|537335727|FG000|Overall Study|Physician Decision|1|||
148959619|NCT02663674|537335728|FG001|Overall Study|Physician Decision|1|||
148959620|NCT02663674|537335727|FG000|Overall Study|Other Event (Health Related)|0|||
148959621|NCT02663674|537335728|FG001|Overall Study|Other Event (Health Related)|1|||
148959622|NCT02472795|537335729|FG000|Overall Study|Adverse Event|0|||
149023151|NCT04955626|537562645|FG006|Blinded Period|No longer meets eligibility criteria|0|||
149023152|NCT04955626|537562646|FG007|Blinded Period|No longer meets eligibility criteria|0|||
149023153|NCT04955626|537562647|FG008|Blinded Period|No longer meets eligibility criteria|1|||
149023154|NCT04955626|537562648|FG009|Blinded Period|No longer meets eligibility criteria|0|||
149023155|NCT04955626|537562649|FG010|Blinded Period|No longer meets eligibility criteria|1|||
149023156|NCT04955626|537562650|FG011|Blinded Period|No longer meets eligibility criteria|1|||
149023157|NCT04955626|537562651|FG012|Blinded Period|No longer meets eligibility criteria|0|||
149023158|NCT04955626|537562652|FG013|Blinded Period|No longer meets eligibility criteria|0|||
149023159|NCT04955626|537562653|FG014|Blinded Period|No longer meets eligibility criteria|0|||
149023160|NCT04955626|537562654|FG015|Blinded Period|No longer meets eligibility criteria|3|||
149023161|NCT04955626|537562655|FG016|Blinded Period|No longer meets eligibility criteria|0|||
149023162|NCT04955626|537562656|FG017|Blinded Period|No longer meets eligibility criteria|2|||
149023163|NCT04955626|537562657|FG018|Blinded Period|No longer meets eligibility criteria|0|||
149023164|NCT04955626|537562658|FG019|Blinded Period|No longer meets eligibility criteria|0|||
149023165|NCT04955626|537562659|FG020|Blinded Period|No longer meets eligibility criteria|0|||
148959623|NCT02472795|537335730|FG001|Overall Study|Adverse Event|1|||
148959624|NCT02472795|537335731|FG002|Overall Study|Adverse Event|0|||
148959625|NCT02472795|537335732|FG003|Overall Study|Adverse Event|0|||
148959626|NCT02472795|537335733|FG004|Overall Study|Adverse Event|2|||
148959627|NCT02472795|537335729|FG000|Overall Study|Withdrawal by Subject|0|||
148959628|NCT02472795|537335730|FG001|Overall Study|Withdrawal by Subject|0|||
148959629|NCT02472795|537335731|FG002|Overall Study|Withdrawal by Subject|0|||
148959630|NCT02472795|537335732|FG003|Overall Study|Withdrawal by Subject|0|||
148959631|NCT02472795|537335733|FG004|Overall Study|Withdrawal by Subject|1|||
148959632|NCT04166513|537335734|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
148959633|NCT04166513|537335735|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
148959634|NCT04166513|537335736|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
148692941|NCT01047345|536350291|FG000|Base Study|Lost to Follow-up|4|||
148692942|NCT01047345|536350292|FG001|Base Study|Lost to Follow-up|1|||
148959635|NCT04166513|537335737|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
148959636|NCT04166513|537335734|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
149023166|NCT04955626|537562660|FG021|Blinded Period|No longer meets eligibility criteria|0|||
149023167|NCT04955626|537562661|FG022|Blinded Period|No longer meets eligibility criteria|0|||
149023168|NCT04955626|537562662|FG023|Blinded Period|No longer meets eligibility criteria|0|||
149023169|NCT04955626|537562663|FG024|Blinded Period|No longer meets eligibility criteria|1|||
149023170|NCT04955626|537562664|FG025|Blinded Period|No longer meets eligibility criteria|0|||
149023171|NCT04955626|537562665|FG026|Blinded Period|No longer meets eligibility criteria|0|||
149023172|NCT04955626|537562666|FG027|Blinded Period|No longer meets eligibility criteria|1|||
149023173|NCT04955626|537562667|FG028|Blinded Period|No longer meets eligibility criteria|0|||
149023174|NCT04955626|537562668|FG029|Blinded Period|No longer meets eligibility criteria|0|||
149023175|NCT04955626|537562669|FG030|Blinded Period|No longer meets eligibility criteria|0|||
149023176|NCT04955626|537562670|FG031|Blinded Period|No longer meets eligibility criteria|0|||
149023177|NCT04955626|537562671|FG032|Blinded Period|No longer meets eligibility criteria|0|||
149023178|NCT04955626|537562672|FG033|Blinded Period|No longer meets eligibility criteria|0|||
149023179|NCT04955626|537562673|FG034|Blinded Period|No longer meets eligibility criteria|0|||
149023180|NCT04955626|537562674|FG035|Blinded Period|No longer meets eligibility criteria|0|||
149023181|NCT04955626|537562639|FG000|Blinded Period|Other|54|||
149023182|NCT04955626|537562640|FG001|Blinded Period|Other|3|||
149023183|NCT04955626|537562641|FG002|Blinded Period|Other|4|||
149023184|NCT04955626|537562642|FG003|Blinded Period|Other|2|||
149023185|NCT04955626|537562643|FG004|Blinded Period|Other|0|||
149023186|NCT04955626|537562644|FG005|Blinded Period|Other|0|||
149023187|NCT04955626|537562645|FG006|Blinded Period|Other|2|||
149023188|NCT04955626|537562646|FG007|Blinded Period|Other|2|||
149023189|NCT04955626|537562647|FG008|Blinded Period|Other|1|||
149023190|NCT04955626|537562648|FG009|Blinded Period|Other|0|||
148692943|NCT01047345|536350293|FG002|Base Study|Lost to Follow-up|0|||
148959637|NCT04166513|537335735|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
148959638|NCT04166513|537335736|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
148959639|NCT04166513|537335737|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
148959640|NCT04166513|537335734|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
148959641|NCT04166513|537335735|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
148959642|NCT04166513|537335736|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
148959643|NCT04166513|537335737|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
148959644|NCT04166513|537335734|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
148959645|NCT04166513|537335735|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
148959646|NCT04166513|537335736|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
148959647|NCT04166513|537335737|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
149023191|NCT04955626|537562649|FG010|Blinded Period|Other|1|||
149023192|NCT04955626|537562650|FG011|Blinded Period|Other|1|||
149023193|NCT04955626|537562651|FG012|Blinded Period|Other|0|||
149023194|NCT04955626|537562652|FG013|Blinded Period|Other|0|||
149023195|NCT04955626|537562653|FG014|Blinded Period|Other|0|||
148959648|NCT04166513|537335734|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
148959649|NCT04166513|537335735|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
149023196|NCT04955626|537562654|FG015|Blinded Period|Other|0|||
149023197|NCT04955626|537562655|FG016|Blinded Period|Other|0|||
149023198|NCT04955626|537562656|FG017|Blinded Period|Other|1|||
149023199|NCT04955626|537562657|FG018|Blinded Period|Other|0|||
149023200|NCT04955626|537562658|FG019|Blinded Period|Other|0|||
149023201|NCT04955626|537562659|FG020|Blinded Period|Other|0|||
149023202|NCT04955626|537562660|FG021|Blinded Period|Other|0|||
149023203|NCT04955626|537562661|FG022|Blinded Period|Other|0|||
149023204|NCT04955626|537562662|FG023|Blinded Period|Other|0|||
148959650|NCT04166513|537335736|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
148959651|NCT04166513|537335737|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
148959652|NCT04568590|537337223|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
148959653|NCT04708886|537337227|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
148959654|NCT04708886|537337227|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
148959655|NCT00202644|537337228|FG000|Overall Study|Adverse Event|12|||
148959656|NCT00202644|537337229|FG001|Overall Study|Adverse Event|13|||
148959657|NCT00202644|537337228|FG000|Overall Study|Withdrawal by Subject|8|||
148959658|NCT00202644|537337229|FG001|Overall Study|Withdrawal by Subject|6|||
148959659|NCT00202644|537337228|FG000|Overall Study|Lack of Efficacy|6|||
148959660|NCT00202644|537337229|FG001|Overall Study|Lack of Efficacy|6|||
148959661|NCT00202644|537337228|FG000|Overall Study|Lost to Follow-up|0|||
148959662|NCT00202644|537337229|FG001|Overall Study|Lost to Follow-up|1|||
148959663|NCT00202644|537337228|FG000|Overall Study|Other|9|||
148959664|NCT00202644|537337229|FG001|Overall Study|Other|1|||
148959665|NCT02750592|537337230|FG000|Overall Study|Adverse Event|3|||
148959666|NCT02750592|537337230|FG000|Overall Study|Lack of Efficacy|2|||
148959667|NCT02981342|537337233|FG000|Overall Study|Adverse Event|0|||
148959668|NCT02981342|537337234|FG001|Overall Study|Adverse Event|0|||
148959669|NCT02981342|537337235|FG002|Overall Study|Adverse Event|0|||
148959670|NCT02981342|537337236|FG003|Overall Study|Adverse Event|1|||
148959671|NCT02981342|537337233|FG000|Overall Study|Death|0|||
148959672|NCT02981342|537337234|FG001|Overall Study|Death|9|||
148959673|NCT02981342|537337235|FG002|Overall Study|Death|9|||
148959674|NCT02981342|537337236|FG003|Overall Study|Death|4|||
148959675|NCT02981342|537337233|FG000|Overall Study|Withdrawal by Subject|0|||
148959676|NCT02981342|537337234|FG001|Overall Study|Withdrawal by Subject|0|||
148959677|NCT02981342|537337235|FG002|Overall Study|Withdrawal by Subject|3|||
148959678|NCT02981342|537337236|FG003|Overall Study|Withdrawal by Subject|1|||
148959679|NCT02981342|537337233|FG000|Overall Study|Study closed by sponsor|0|||
148959680|NCT02981342|537337234|FG001|Overall Study|Study closed by sponsor|0|||
148959681|NCT02981342|537337235|FG002|Overall Study|Study closed by sponsor|1|||
148959682|NCT02981342|537337236|FG003|Overall Study|Study closed by sponsor|1|||
148959683|NCT02981342|537337233|FG000|Overall Study|Randomized, Never Treated|0|||
148959684|NCT02981342|537337234|FG001|Overall Study|Randomized, Never Treated|1|||
149023205|NCT04955626|537562663|FG024|Blinded Period|Other|0|||
149023206|NCT04955626|537562664|FG025|Blinded Period|Other|0|||
149023207|NCT04955626|537562665|FG026|Blinded Period|Other|2|||
149023208|NCT04955626|537562666|FG027|Blinded Period|Other|0|||
149023209|NCT04955626|537562667|FG028|Blinded Period|Other|0|||
149023210|NCT04955626|537562668|FG029|Blinded Period|Other|0|||
149023211|NCT04955626|537562669|FG030|Blinded Period|Other|0|||
149023212|NCT04955626|537562670|FG031|Blinded Period|Other|0|||
149023213|NCT04955626|537562671|FG032|Blinded Period|Other|0|||
149023214|NCT04955626|537562672|FG033|Blinded Period|Other|0|||
149023215|NCT04955626|537562673|FG034|Blinded Period|Other|0|||
149023216|NCT04955626|537562674|FG035|Blinded Period|Other|0|||
149023217|NCT04955626|537562639|FG000|Blinded Period|Physician Decision|1|||
149023218|NCT04955626|537562640|FG001|Blinded Period|Physician Decision|1|||
149023219|NCT04955626|537562641|FG002|Blinded Period|Physician Decision|0|||
149023220|NCT04955626|537562642|FG003|Blinded Period|Physician Decision|3|||
149023221|NCT04955626|537562643|FG004|Blinded Period|Physician Decision|0|||
149023222|NCT04955626|537562644|FG005|Blinded Period|Physician Decision|0|||
149023223|NCT04955626|537562645|FG006|Blinded Period|Physician Decision|1|||
148692944|NCT01047345|536350291|FG000|Base Study|Protocol Violation|3|||
149023224|NCT04955626|537562646|FG007|Blinded Period|Physician Decision|1|||
149023225|NCT04955626|537562647|FG008|Blinded Period|Physician Decision|0|||
149023226|NCT04955626|537562648|FG009|Blinded Period|Physician Decision|0|||
149023227|NCT04955626|537562649|FG010|Blinded Period|Physician Decision|0|||
149023228|NCT04955626|537562650|FG011|Blinded Period|Physician Decision|5|||
149023229|NCT04955626|537562651|FG012|Blinded Period|Physician Decision|0|||
149023230|NCT04955626|537562652|FG013|Blinded Period|Physician Decision|0|||
149023231|NCT04955626|537562653|FG014|Blinded Period|Physician Decision|0|||
149023232|NCT04955626|537562654|FG015|Blinded Period|Physician Decision|0|||
149023233|NCT04955626|537562655|FG016|Blinded Period|Physician Decision|0|||
149023234|NCT04955626|537562656|FG017|Blinded Period|Physician Decision|0|||
149023235|NCT04955626|537562657|FG018|Blinded Period|Physician Decision|0|||
149023236|NCT04955626|537562658|FG019|Blinded Period|Physician Decision|0|||
149023237|NCT04955626|537562659|FG020|Blinded Period|Physician Decision|0|||
149023238|NCT04955626|537562660|FG021|Blinded Period|Physician Decision|0|||
149023239|NCT04955626|537562661|FG022|Blinded Period|Physician Decision|0|||
149023240|NCT04955626|537562662|FG023|Blinded Period|Physician Decision|0|||
148692945|NCT01047345|536350292|FG001|Base Study|Protocol Violation|1|||
149023241|NCT04955626|537562663|FG024|Blinded Period|Physician Decision|0|||
148692946|NCT01047345|536350293|FG002|Base Study|Protocol Violation|0|||
149023242|NCT04955626|537562664|FG025|Blinded Period|Physician Decision|0|||
149023243|NCT04955626|537562665|FG026|Blinded Period|Physician Decision|0|||
149023244|NCT04955626|537562666|FG027|Blinded Period|Physician Decision|0|||
149023245|NCT04955626|537562667|FG028|Blinded Period|Physician Decision|0|||
149023246|NCT04955626|537562668|FG029|Blinded Period|Physician Decision|0|||
149023247|NCT04955626|537562669|FG030|Blinded Period|Physician Decision|0|||
149023248|NCT04955626|537562670|FG031|Blinded Period|Physician Decision|0|||
149023249|NCT04955626|537562671|FG032|Blinded Period|Physician Decision|0|||
149023250|NCT04955626|537562672|FG033|Blinded Period|Physician Decision|0|||
149023251|NCT04955626|537562673|FG034|Blinded Period|Physician Decision|0|||
149023252|NCT04955626|537562674|FG035|Blinded Period|Physician Decision|0|||
149023253|NCT04955626|537562639|FG000|Blinded Period|Withdrawal by Subject|26|||
149023254|NCT04955626|537562640|FG001|Blinded Period|Withdrawal by Subject|62|||
149023255|NCT04955626|537562641|FG002|Blinded Period|Withdrawal by Subject|14|||
149023256|NCT04955626|537562642|FG003|Blinded Period|Withdrawal by Subject|16|||
149023257|NCT04955626|537562643|FG004|Blinded Period|Withdrawal by Subject|1|||
149023258|NCT04955626|537562644|FG005|Blinded Period|Withdrawal by Subject|2|||
149023259|NCT04955626|537562645|FG006|Blinded Period|Withdrawal by Subject|9|||
149023260|NCT04955626|537562646|FG007|Blinded Period|Withdrawal by Subject|5|||
149023261|NCT04955626|537562647|FG008|Blinded Period|Withdrawal by Subject|3|||
149023262|NCT04955626|537562648|FG009|Blinded Period|Withdrawal by Subject|15|||
149023263|NCT04955626|537562649|FG010|Blinded Period|Withdrawal by Subject|11|||
149023264|NCT04955626|537562650|FG011|Blinded Period|Withdrawal by Subject|7|||
149023265|NCT04955626|537562651|FG012|Blinded Period|Withdrawal by Subject|2|||
149023266|NCT04955626|537562652|FG013|Blinded Period|Withdrawal by Subject|0|||
149023267|NCT04955626|537562653|FG014|Blinded Period|Withdrawal by Subject|1|||
149023268|NCT04955626|537562654|FG015|Blinded Period|Withdrawal by Subject|11|||
149023269|NCT04955626|537562655|FG016|Blinded Period|Withdrawal by Subject|2|||
148959685|NCT02981342|537337235|FG002|Overall Study|Randomized, Never Treated|0|||
148959686|NCT02981342|537337236|FG003|Overall Study|Randomized, Never Treated|7|||
148959687|NCT02981342|537337233|FG000|Overall Study|Lost to Follow-up|0|||
148959688|NCT02981342|537337234|FG001|Overall Study|Lost to Follow-up|1|||
148959689|NCT02981342|537337235|FG002|Overall Study|Lost to Follow-up|0|||
148959690|NCT02981342|537337236|FG003|Overall Study|Lost to Follow-up|0|||
148959691|NCT01372501|537337237|FG000|Overall Study|Adverse Event|4|||
148959692|NCT01372501|537337237|FG000|Overall Study|Device migration|1|||
148959693|NCT01132482|537337238|FG000|Overall Study|Adverse Event|1|||
148959694|NCT01132482|537337239|FG001|Overall Study|Adverse Event|0|||
148959695|NCT05333900|537337240|FG000|Overall Study|Protocol Violation|0|||
148959696|NCT05333900|537337241|FG001|Overall Study|Protocol Violation|1|||
148959697|NCT05333900|537337240|FG000|Overall Study|Withdrawal by Subject|0|||
148959698|NCT05333900|537337241|FG001|Overall Study|Withdrawal by Subject|1|||
148959699|NCT05333900|537337240|FG000|Overall Study|COVID-19 Pandemic|1|||
148959700|NCT05333900|537337241|FG001|Overall Study|COVID-19 Pandemic|1|||
148959701|NCT01277523|537337244|FG000|Overall Study|Adverse Event|1|||
148959702|NCT01277523|537337245|FG001|Overall Study|Adverse Event|0|||
148959703|NCT01277523|537337246|FG002|Overall Study|Adverse Event|0|||
148959704|NCT01277523|537337244|FG000|Overall Study|Protocol Violation|2|||
148959705|NCT01277523|537337245|FG001|Overall Study|Protocol Violation|0|||
148959706|NCT01277523|537337246|FG002|Overall Study|Protocol Violation|0|||
148959707|NCT01277523|537337244|FG000|Overall Study|Other Reason not Defined|0|||
148959708|NCT01277523|537337245|FG001|Overall Study|Other Reason not Defined|1|||
148959709|NCT01277523|537337246|FG002|Overall Study|Other Reason not Defined|0|||
148959710|NCT03724812|537337247|FG000|Overall Study|Missed Visit|1|||
148959711|NCT03724812|537337247|FG000|Overall Study|Death|2|||
148959712|NCT03724812|537337247|FG000|Overall Study|Withdrawal by Subject|1|||
148959713|NCT01394523|537337248|FG000|Overall Study|Unable to place block|1|||
148959714|NCT01394523|537337249|FG001|Overall Study|Unable to place block|0|||
148959715|NCT01394523|537337250|FG002|Overall Study|Unable to place block|0|||
148959716|NCT04788953|537337251|FG000|Overall Study|Adverse Event|1|||
148959717|NCT04788953|537337252|FG001|Overall Study|Adverse Event|1|||
148959718|NCT04788953|537337251|FG000|Overall Study|Withdrawal by Subject|1|||
148959719|NCT04788953|537337252|FG001|Overall Study|Withdrawal by Subject|0|||
148959720|NCT04788953|537337251|FG000|Overall Study|Protocol Violation|0|||
148959721|NCT04788953|537337252|FG001|Overall Study|Protocol Violation|1|||
148959722|NCT00469092|537337253|FG000|Overall Study|Adverse Event|5|||
148959723|NCT00469092|537337254|FG001|Overall Study|Adverse Event|4|||
148959724|NCT00469092|537337253|FG000|Overall Study|Lack of Efficacy|1|||
148959725|NCT00469092|537337254|FG001|Overall Study|Lack of Efficacy|0|||
148959726|NCT00469092|537337253|FG000|Overall Study|Lost to Follow-up|1|||
148959727|NCT00469092|537337254|FG001|Overall Study|Lost to Follow-up|2|||
148959728|NCT00469092|537337253|FG000|Overall Study|Protocol Violation|3|||
148959729|NCT00469092|537337254|FG001|Overall Study|Protocol Violation|3|||
148959730|NCT00469092|537337253|FG000|Overall Study|Withdrawal by Subject|4|||
148959731|NCT00469092|537337254|FG001|Overall Study|Withdrawal by Subject|4|||
148959732|NCT00469092|537337253|FG000|Overall Study|Withdrawal Criteria|3|||
148959733|NCT00469092|537337254|FG001|Overall Study|Withdrawal Criteria|4|||
148959734|NCT00469092|537337253|FG000|Overall Study|Incorrectly Randomised|4|||
148959735|NCT00469092|537337254|FG001|Overall Study|Incorrectly Randomised|3|||
148959736|NCT00469092|537337253|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
148959737|NCT00469092|537337254|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
148959738|NCT00469092|537337253|FG000|Overall Study|Use of lipid lowering drug|1|||
148959739|NCT00469092|537337254|FG001|Overall Study|Use of lipid lowering drug|0|||
148959740|NCT00469092|537337253|FG000|Overall Study|Hypoglycaemic Episodes|1|||
148959741|NCT00469092|537337254|FG001|Overall Study|Hypoglycaemic Episodes|1|||
148692947|NCT01047345|536350291|FG000|Base Study|Withdrawal by Subject|12|||
148959742|NCT00469092|537337253|FG000|Overall Study|Abnormal lab value|1|||
148959743|NCT00469092|537337254|FG001|Overall Study|Abnormal lab value|0|||
148959744|NCT00469092|537337253|FG000|Overall Study|Use of Corticosteroid|1|||
148959745|NCT00469092|537337254|FG001|Overall Study|Use of Corticosteroid|0|||
148959746|NCT01086540|537337256|FG000|Overall Study|Death|3|||
148959747|NCT01086540|537337257|FG001|Overall Study|Death|1|||
148692948|NCT01047345|536350292|FG001|Base Study|Withdrawal by Subject|4|||
148692949|NCT01047345|536350293|FG002|Base Study|Withdrawal by Subject|0|||
148959748|NCT01086540|537337256|FG000|Overall Study|Physician Decision|2|||
148959749|NCT01086540|537337257|FG001|Overall Study|Physician Decision|1|||
148959750|NCT01086540|537337256|FG000|Overall Study|Addition of new therapy for PAH|1|||
148959751|NCT01086540|537337257|FG001|Overall Study|Addition of new therapy for PAH|0|||
148959752|NCT03164928|537337258|FG000|Overall Study|Lost to Follow-up|1|||
148959753|NCT03164928|537337259|FG001|Overall Study|Lost to Follow-up|0|||
148959754|NCT01998737|537337260|FG000|Overall Study|Corrupted database|23|||
148959755|NCT01998737|537337261|FG001|Overall Study|Corrupted database|0|||
148959756|NCT00326950|537337265|FG000|Overall Study|Progressive Disease|1|||
148959757|NCT02092662|537337266|FG000|Overall Study|Lost to Follow-up|13|||
148959758|NCT02092662|537337267|FG001|Overall Study|Lost to Follow-up|0|||
148959759|NCT05811234|537337271|FG000|Overall Study|Loss of Effectiveness|2|||
148959760|NCT05811234|537337271|FG000|Overall Study|Adverse Event|4|||
148959761|NCT05811234|537337271|FG000|Overall Study|Pregnancy|1|||
148959762|NCT05811234|537337271|FG000|Overall Study|Disease progression|1|||
148959763|NCT05811234|537337271|FG000|Overall Study|Withdrawal by Subject|4|||
148959764|NCT05811234|537337271|FG000|Overall Study|Lost to Follow-up|13|||
148959765|NCT05811234|537337271|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
148959766|NCT04499781|537337272|FG000|Overall Study|Lost to Follow-up|2|||
148959767|NCT04499781|537337273|FG001|Overall Study|Lost to Follow-up|3|||
148959768|NCT04499781|537337272|FG000|Overall Study|Withdrawal by Subject|2|||
148959769|NCT04499781|537337273|FG001|Overall Study|Withdrawal by Subject|0|||
148959770|NCT00227305|537337274|FG000|Overall Study|Adverse Event|40|||
148959771|NCT00227305|537337274|FG000|Overall Study|Withdrawal by Subject|42|||
148959772|NCT00227305|537337274|FG000|Overall Study|Lost to Follow-up|33|||
149023270|NCT04955626|537562656|FG017|Blinded Period|Withdrawal by Subject|5|||
149023271|NCT04955626|537562657|FG018|Blinded Period|Withdrawal by Subject|0|||
149023272|NCT04955626|537562658|FG019|Blinded Period|Withdrawal by Subject|0|||
149023273|NCT04955626|537562659|FG020|Blinded Period|Withdrawal by Subject|1|||
149023274|NCT04955626|537562660|FG021|Blinded Period|Withdrawal by Subject|0|||
149023275|NCT04955626|537562661|FG022|Blinded Period|Withdrawal by Subject|0|||
149023276|NCT04955626|537562662|FG023|Blinded Period|Withdrawal by Subject|0|||
149023277|NCT04955626|537562663|FG024|Blinded Period|Withdrawal by Subject|5|||
149023278|NCT04955626|537562664|FG025|Blinded Period|Withdrawal by Subject|1|||
149023279|NCT04955626|537562665|FG026|Blinded Period|Withdrawal by Subject|5|||
149023280|NCT04955626|537562666|FG027|Blinded Period|Withdrawal by Subject|1|||
149023281|NCT04955626|537562667|FG028|Blinded Period|Withdrawal by Subject|4|||
149023282|NCT04955626|537562668|FG029|Blinded Period|Withdrawal by Subject|2|||
149023283|NCT04955626|537562669|FG030|Blinded Period|Withdrawal by Subject|0|||
149023284|NCT04955626|537562670|FG031|Blinded Period|Withdrawal by Subject|0|||
149023285|NCT04955626|537562671|FG032|Blinded Period|Withdrawal by Subject|0|||
149023286|NCT04955626|537562672|FG033|Blinded Period|Withdrawal by Subject|0|||
149023287|NCT04955626|537562673|FG034|Blinded Period|Withdrawal by Subject|0|||
149023288|NCT04955626|537562674|FG035|Blinded Period|Withdrawal by Subject|0|||
149023289|NCT04955626|537562639|FG000|Blinded Period|Refused further study procedures|0|||
149023290|NCT04955626|537562640|FG001|Blinded Period|Refused further study procedures|0|||
149023291|NCT04955626|537562641|FG002|Blinded Period|Refused further study procedures|0|||
149023292|NCT04955626|537562642|FG003|Blinded Period|Refused further study procedures|0|||
149023293|NCT04955626|537562643|FG004|Blinded Period|Refused further study procedures|0|||
149023294|NCT04955626|537562644|FG005|Blinded Period|Refused further study procedures|0|||
149023295|NCT04955626|537562645|FG006|Blinded Period|Refused further study procedures|1|||
149023296|NCT04955626|537562646|FG007|Blinded Period|Refused further study procedures|0|||
149023297|NCT04955626|537562647|FG008|Blinded Period|Refused further study procedures|0|||
149023298|NCT04955626|537562648|FG009|Blinded Period|Refused further study procedures|0|||
149023299|NCT04955626|537562649|FG010|Blinded Period|Refused further study procedures|0|||
149023300|NCT04955626|537562650|FG011|Blinded Period|Refused further study procedures|2|||
149023301|NCT04955626|537562651|FG012|Blinded Period|Refused further study procedures|0|||
149023302|NCT04955626|537562652|FG013|Blinded Period|Refused further study procedures|0|||
149023303|NCT04955626|537562653|FG014|Blinded Period|Refused further study procedures|0|||
149023304|NCT04955626|537562654|FG015|Blinded Period|Refused further study procedures|0|||
149023305|NCT04955626|537562655|FG016|Blinded Period|Refused further study procedures|0|||
149023306|NCT04955626|537562656|FG017|Blinded Period|Refused further study procedures|0|||
149023307|NCT04955626|537562657|FG018|Blinded Period|Refused further study procedures|0|||
149023308|NCT04955626|537562658|FG019|Blinded Period|Refused further study procedures|0|||
149023309|NCT04955626|537562659|FG020|Blinded Period|Refused further study procedures|0|||
149023310|NCT04955626|537562660|FG021|Blinded Period|Refused further study procedures|0|||
149023311|NCT04955626|537562661|FG022|Blinded Period|Refused further study procedures|0|||
149023312|NCT04955626|537562662|FG023|Blinded Period|Refused further study procedures|0|||
149023313|NCT04955626|537562663|FG024|Blinded Period|Refused further study procedures|0|||
149023314|NCT04955626|537562664|FG025|Blinded Period|Refused further study procedures|0|||
149023315|NCT04955626|537562665|FG026|Blinded Period|Refused further study procedures|0|||
149023316|NCT04955626|537562666|FG027|Blinded Period|Refused further study procedures|0|||
149023317|NCT04955626|537562667|FG028|Blinded Period|Refused further study procedures|0|||
149023318|NCT04955626|537562668|FG029|Blinded Period|Refused further study procedures|0|||
149023319|NCT04955626|537562669|FG030|Blinded Period|Refused further study procedures|0|||
149023320|NCT04955626|537562670|FG031|Blinded Period|Refused further study procedures|0|||
149023321|NCT04955626|537562671|FG032|Blinded Period|Refused further study procedures|0|||
149023322|NCT04955626|537562672|FG033|Blinded Period|Refused further study procedures|0|||
149023323|NCT04955626|537562673|FG034|Blinded Period|Refused further study procedures|0|||
149023324|NCT04955626|537562674|FG035|Blinded Period|Refused further study procedures|0|||
149023325|NCT04955626|537562639|FG000|Blinded Period|Participants entered open label period|4544|||
149023326|NCT04955626|537562640|FG001|Blinded Period|Participants entered open label period|4906|||
148692950|NCT01047345|536350291|FG000|Extension|Withdrawal by Subject|0|||
148692951|NCT01047345|536350292|FG001|Extension|Withdrawal by Subject|0|||
148692952|NCT01047345|536350293|FG002|Extension|Withdrawal by Subject|1|||
149023327|NCT04955626|537562641|FG002|Blinded Period|Participants entered open label period|0|||
149023328|NCT04955626|537562642|FG003|Blinded Period|Participants entered open label period|0|||
149023329|NCT04955626|537562643|FG004|Blinded Period|Participants entered open label period|0|||
149023330|NCT04955626|537562644|FG005|Blinded Period|Participants entered open label period|0|||
149023331|NCT04955626|537562645|FG006|Blinded Period|Participants entered open label period|0|||
149023332|NCT04955626|537562646|FG007|Blinded Period|Participants entered open label period|0|||
149023333|NCT04955626|537562647|FG008|Blinded Period|Participants entered open label period|0|||
149023334|NCT04955626|537562648|FG009|Blinded Period|Participants entered open label period|0|||
149023335|NCT04955626|537562649|FG010|Blinded Period|Participants entered open label period|0|||
148692953|NCT01047345|536350291|FG000|Extension|Lost to Follow-up|0|||
148692954|NCT01047345|536350292|FG001|Extension|Lost to Follow-up|0|||
148692955|NCT01047345|536350293|FG002|Extension|Lost to Follow-up|5|||
148692956|NCT00806156|536350294|FG000|Overall Study|Death|35|||
148692957|NCT00806156|536350295|FG001|Overall Study|Death|95|||
148692958|NCT00806156|536350294|FG000|Overall Study|Did not meet eligibility criteria|1|||
148692959|NCT00806156|536350295|FG001|Overall Study|Did not meet eligibility criteria|0|||
148692960|NCT00806156|536350294|FG000|Overall Study|Study terminated by Sponsor|2|||
148692961|NCT00806156|536350295|FG001|Overall Study|Study terminated by Sponsor|40|||
148692962|NCT00806156|536350294|FG000|Overall Study|Consent withdrawn by subject|1|||
148692963|NCT00806156|536350295|FG001|Overall Study|Consent withdrawn by subject|3|||
148692964|NCT00806156|536350294|FG000|Overall Study|Lost to Follow-up|0|||
148692965|NCT00806156|536350295|FG001|Overall Study|Lost to Follow-up|1|||
148959773|NCT00227305|537337274|FG000|Overall Study|Study specific discontinuation|13|||
148959774|NCT00227305|537337274|FG000|Overall Study|MOVED OUT OF AREA|3|||
148959775|NCT00227305|537337274|FG000|Overall Study|Lack of Efficacy|7|||
148959776|NCT00227305|537337274|FG000|Overall Study|Physician Decision|3|||
148959777|NCT00227305|537337274|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
148959778|NCT00227305|537337274|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
148959779|NCT00227305|537337274|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
148959780|NCT02707991|537337275|FG000|Overall Study|Protocol Violation|1|||
148959781|NCT02707991|537337276|FG001|Overall Study|Protocol Violation|0|||
148959782|NCT02707991|537337275|FG000|Overall Study|Became ineligible|0|||
148959783|NCT02707991|537337276|FG001|Overall Study|Became ineligible|1|||
148959784|NCT04519645|537337281|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
148959785|NCT04519645|537337282|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
148959786|NCT04519645|537337283|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
148959787|NCT04519645|537337281|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
148959788|NCT04519645|537337282|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
148959789|NCT04519645|537337283|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
148959790|NCT04519645|537337281|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
148959791|NCT04519645|537337282|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
148959792|NCT04519645|537337283|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
148959793|NCT04519645|537337281|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
149023336|NCT04955626|537562650|FG011|Blinded Period|Participants entered open label period|0|||
149023337|NCT04955626|537562651|FG012|Blinded Period|Participants entered open label period|0|||
148692966|NCT00282256|536350296|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
148959794|NCT04519645|537337282|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
148959795|NCT04519645|537337283|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
148959796|NCT00453544|537337294|FG000|Overall Study|Withdrawal by Subject|1|||
148959797|NCT00453544|537337295|FG001|Overall Study|Withdrawal by Subject|0|||
148959798|NCT00453544|537337296|FG002|Overall Study|Withdrawal by Subject|0|||
148959799|NCT00453544|537337297|FG003|Overall Study|Withdrawal by Subject|0|||
148959800|NCT00453544|537337294|FG000|Overall Study|Primary outcome measure not completed|1|||
148959801|NCT00453544|537337295|FG001|Overall Study|Primary outcome measure not completed|1|||
148959802|NCT00453544|537337296|FG002|Overall Study|Primary outcome measure not completed|0|||
148959803|NCT00453544|537337297|FG003|Overall Study|Primary outcome measure not completed|1|||
148959804|NCT00619801|537337300|FG000|Overall Study|Lack of Efficacy|0|||
148959805|NCT00619801|537337301|FG001|Overall Study|Lack of Efficacy|1|||
148959806|NCT00619801|537337300|FG000|Overall Study|Withdrawal by Subject|1|||
148959807|NCT00619801|537337301|FG001|Overall Study|Withdrawal by Subject|1|||
148959808|NCT00619801|537337300|FG000|Overall Study|Loss of efficacy|0|||
148959809|NCT00619801|537337301|FG001|Overall Study|Loss of efficacy|1|||
148959810|NCT00642941|537337308|FG000|Overall Study|Physician Decision|3|||
148959811|NCT00642941|537337309|FG001|Overall Study|Physician Decision|1|||
148959812|NCT00642941|537337310|FG002|Overall Study|Physician Decision|0|||
148959813|NCT00642941|537337311|FG003|Overall Study|Physician Decision|0|||
148959814|NCT00642941|537337312|FG004|Overall Study|Physician Decision|0|||
148959815|NCT00642941|537337313|FG005|Overall Study|Physician Decision|0|||
148959816|NCT00642941|537337314|FG006|Overall Study|Physician Decision|1|||
148959817|NCT00642941|537337315|FG007|Overall Study|Physician Decision|0|||
148959818|NCT00642941|537337316|FG008|Overall Study|Physician Decision|0|||
148959819|NCT00642941|537337317|FG009|Overall Study|Physician Decision|1|||
148959820|NCT00642941|537337318|FG010|Overall Study|Physician Decision|0|||
148959821|NCT00642941|537337319|FG011|Overall Study|Physician Decision|1|||
148959822|NCT00642941|537337308|FG000|Overall Study|Death|4|||
148959823|NCT00642941|537337309|FG001|Overall Study|Death|0|||
148959824|NCT00642941|537337310|FG002|Overall Study|Death|1|||
148959825|NCT00642941|537337311|FG003|Overall Study|Death|1|||
148959826|NCT00642941|537337312|FG004|Overall Study|Death|2|||
148959827|NCT00642941|537337313|FG005|Overall Study|Death|1|||
148959828|NCT00642941|537337314|FG006|Overall Study|Death|0|||
148959829|NCT00642941|537337315|FG007|Overall Study|Death|0|||
148959830|NCT00642941|537337316|FG008|Overall Study|Death|0|||
148959831|NCT00642941|537337317|FG009|Overall Study|Death|0|||
148959832|NCT00642941|537337318|FG010|Overall Study|Death|0|||
148959833|NCT00642941|537337319|FG011|Overall Study|Death|1|||
148959834|NCT00642941|537337308|FG000|Overall Study|Study closed by Sponsor|0|||
148959835|NCT00642941|537337309|FG001|Overall Study|Study closed by Sponsor|1|||
148959836|NCT00642941|537337310|FG002|Overall Study|Study closed by Sponsor|0|||
148959837|NCT00642941|537337311|FG003|Overall Study|Study closed by Sponsor|0|||
148959838|NCT00642941|537337312|FG004|Overall Study|Study closed by Sponsor|0|||
148959839|NCT00642941|537337313|FG005|Overall Study|Study closed by Sponsor|0|||
148959840|NCT00642941|537337314|FG006|Overall Study|Study closed by Sponsor|0|||
148959841|NCT00642941|537337315|FG007|Overall Study|Study closed by Sponsor|0|||
148959842|NCT00642941|537337316|FG008|Overall Study|Study closed by Sponsor|0|||
148959843|NCT00642941|537337317|FG009|Overall Study|Study closed by Sponsor|0|||
148959844|NCT00642941|537337318|FG010|Overall Study|Study closed by Sponsor|0|||
148959845|NCT00642941|537337319|FG011|Overall Study|Study closed by Sponsor|0|||
148959846|NCT00642941|537337308|FG000|Overall Study|Withdrawal by Subject|1|||
148959847|NCT00642941|537337309|FG001|Overall Study|Withdrawal by Subject|0|||
148959848|NCT00642941|537337310|FG002|Overall Study|Withdrawal by Subject|0|||
148959849|NCT00642941|537337311|FG003|Overall Study|Withdrawal by Subject|2|||
148959850|NCT00642941|537337312|FG004|Overall Study|Withdrawal by Subject|0|||
148959851|NCT00642941|537337313|FG005|Overall Study|Withdrawal by Subject|0|||
148959852|NCT00642941|537337314|FG006|Overall Study|Withdrawal by Subject|2|||
148959853|NCT00642941|537337315|FG007|Overall Study|Withdrawal by Subject|0|||
148959854|NCT00642941|537337316|FG008|Overall Study|Withdrawal by Subject|1|||
148959855|NCT00642941|537337317|FG009|Overall Study|Withdrawal by Subject|0|||
148959856|NCT00642941|537337318|FG010|Overall Study|Withdrawal by Subject|0|||
148959857|NCT00642941|537337319|FG011|Overall Study|Withdrawal by Subject|1|||
148959858|NCT00642941|537337308|FG000|Overall Study|Protocol Violation|0|||
148959859|NCT00642941|537337309|FG001|Overall Study|Protocol Violation|0|||
148959860|NCT00642941|537337310|FG002|Overall Study|Protocol Violation|0|||
148959861|NCT00642941|537337311|FG003|Overall Study|Protocol Violation|0|||
149023338|NCT04955626|537562652|FG013|Blinded Period|Participants entered open label period|0|||
149023339|NCT04955626|537562653|FG014|Blinded Period|Participants entered open label period|0|||
148959862|NCT00642941|537337312|FG004|Overall Study|Protocol Violation|0|||
148959863|NCT00642941|537337313|FG005|Overall Study|Protocol Violation|0|||
148959864|NCT00642941|537337314|FG006|Overall Study|Protocol Violation|1|||
148959865|NCT00642941|537337315|FG007|Overall Study|Protocol Violation|0|||
148959866|NCT00642941|537337316|FG008|Overall Study|Protocol Violation|0|||
148959867|NCT00642941|537337317|FG009|Overall Study|Protocol Violation|0|||
149023340|NCT04955626|537562654|FG015|Blinded Period|Participants entered open label period|0|||
149023341|NCT04955626|537562655|FG016|Blinded Period|Participants entered open label period|0|||
149023342|NCT04955626|537562656|FG017|Blinded Period|Participants entered open label period|0|||
149023343|NCT04955626|537562657|FG018|Blinded Period|Participants entered open label period|0|||
149023344|NCT04955626|537562658|FG019|Blinded Period|Participants entered open label period|0|||
149023345|NCT04955626|537562659|FG020|Blinded Period|Participants entered open label period|0|||
149023346|NCT04955626|537562660|FG021|Blinded Period|Participants entered open label period|0|||
149023347|NCT04955626|537562661|FG022|Blinded Period|Participants entered open label period|0|||
149023348|NCT04955626|537562662|FG023|Blinded Period|Participants entered open label period|0|||
149023349|NCT04955626|537562663|FG024|Blinded Period|Participants entered open label period|0|||
149023350|NCT04955626|537562664|FG025|Blinded Period|Participants entered open label period|0|||
149023351|NCT04955626|537562665|FG026|Blinded Period|Participants entered open label period|0|||
149023352|NCT04955626|537562666|FG027|Blinded Period|Participants entered open label period|0|||
149023353|NCT04955626|537562667|FG028|Blinded Period|Participants entered open label period|0|||
149023354|NCT04955626|537562668|FG029|Blinded Period|Participants entered open label period|0|||
149023355|NCT04955626|537562669|FG030|Blinded Period|Participants entered open label period|0|||
149023356|NCT04955626|537562670|FG031|Blinded Period|Participants entered open label period|0|||
149023357|NCT04955626|537562671|FG032|Blinded Period|Participants entered open label period|0|||
149023358|NCT04955626|537562672|FG033|Blinded Period|Participants entered open label period|0|||
149023359|NCT04955626|537562673|FG034|Blinded Period|Participants entered open label period|0|||
149023360|NCT04955626|537562674|FG035|Blinded Period|Participants entered open label period|0|||
149023361|NCT04955626|537562639|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
149023362|NCT04955626|537562640|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
149023363|NCT04955626|537562641|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
149023364|NCT04955626|537562642|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
148692967|NCT00282256|536350296|FG000|Extension Treatment Period|Adverse Event|2|||
148959868|NCT00642941|537337318|FG010|Overall Study|Protocol Violation|0|||
148959869|NCT00642941|537337319|FG011|Overall Study|Protocol Violation|0|||
149023365|NCT04955626|537562643|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
148959870|NCT00642941|537337308|FG000|Overall Study|Adverse Event|1|||
148959871|NCT00642941|537337309|FG001|Overall Study|Adverse Event|1|||
148959872|NCT00642941|537337310|FG002|Overall Study|Adverse Event|0|||
148959873|NCT00642941|537337311|FG003|Overall Study|Adverse Event|0|||
148959874|NCT00642941|537337312|FG004|Overall Study|Adverse Event|0|||
148959875|NCT00642941|537337313|FG005|Overall Study|Adverse Event|0|||
148959876|NCT00642941|537337314|FG006|Overall Study|Adverse Event|1|||
148959877|NCT00642941|537337315|FG007|Overall Study|Adverse Event|1|||
148959878|NCT00642941|537337316|FG008|Overall Study|Adverse Event|0|||
148959879|NCT00642941|537337317|FG009|Overall Study|Adverse Event|1|||
148959880|NCT00642941|537337318|FG010|Overall Study|Adverse Event|0|||
148959881|NCT00642941|537337319|FG011|Overall Study|Adverse Event|0|||
148959882|NCT00642941|537337308|FG000|Overall Study|Other|1|||
148959883|NCT00642941|537337309|FG001|Overall Study|Other|1|||
148959884|NCT00642941|537337310|FG002|Overall Study|Other|1|||
148959885|NCT00642941|537337311|FG003|Overall Study|Other|1|||
148959886|NCT00642941|537337312|FG004|Overall Study|Other|0|||
148959887|NCT00642941|537337313|FG005|Overall Study|Other|1|||
148959888|NCT00642941|537337314|FG006|Overall Study|Other|0|||
148959889|NCT00642941|537337315|FG007|Overall Study|Other|1|||
148959890|NCT00642941|537337316|FG008|Overall Study|Other|0|||
148959891|NCT00642941|537337317|FG009|Overall Study|Other|0|||
148959892|NCT00642941|537337318|FG010|Overall Study|Other|0|||
148959893|NCT00642941|537337319|FG011|Overall Study|Other|1|||
148959894|NCT00642941|537337308|FG000|Overall Study|Disease progression|60|||
148959895|NCT00642941|537337309|FG001|Overall Study|Disease progression|50|||
148959896|NCT00642941|537337310|FG002|Overall Study|Disease progression|5|||
148959897|NCT00642941|537337311|FG003|Overall Study|Disease progression|36|||
148959898|NCT00642941|537337312|FG004|Overall Study|Disease progression|23|||
148959899|NCT00642941|537337313|FG005|Overall Study|Disease progression|39|||
148959900|NCT00642941|537337314|FG006|Overall Study|Disease progression|18|||
148959901|NCT00642941|537337315|FG007|Overall Study|Disease progression|12|||
148959902|NCT00642941|537337316|FG008|Overall Study|Disease progression|10|||
148959903|NCT00642941|537337317|FG009|Overall Study|Disease progression|7|||
148959904|NCT00642941|537337318|FG010|Overall Study|Disease progression|12|||
148959905|NCT00642941|537337319|FG011|Overall Study|Disease progression|7|||
148959906|NCT03559257|537337322|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
148959907|NCT03559257|537337323|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
148959908|NCT03559257|537337322|FG000|Double Blind Treatment Period|Protocol Violation|1|||
148959909|NCT03559257|537337323|FG001|Double Blind Treatment Period|Protocol Violation|4|||
148959910|NCT03559257|537337322|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
148959911|NCT03559257|537337323|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
148959912|NCT03559257|537337322|FG000|Double Blind Treatment Period|Adverse Event|0|||
148959913|NCT03559257|537337323|FG001|Double Blind Treatment Period|Adverse Event|1|||
148959914|NCT03559257|537337322|FG000|Double Blind Treatment Period|Screen Failure|0|||
148959915|NCT03559257|537337323|FG001|Double Blind Treatment Period|Screen Failure|1|||
148959916|NCT03559257|537337322|FG000|Open-label Treatment Period|Adverse Event|1|||
148959917|NCT03559257|537337323|FG001|Open-label Treatment Period|Adverse Event|4|||
148959918|NCT03559257|537337322|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
148959919|NCT03559257|537337323|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
148959920|NCT03559257|537337322|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
148959921|NCT03559257|537337323|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
148959922|NCT03559257|537337322|FG000|Open-label Treatment Period|Protocol Violation|2|||
148959923|NCT03559257|537337323|FG001|Open-label Treatment Period|Protocol Violation|0|||
148959924|NCT03559257|537337322|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
148959925|NCT03559257|537337323|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
148959926|NCT03559257|537337322|FG000|Open-label Treatment Period|Physician Decision|0|||
148959927|NCT03559257|537337323|FG001|Open-label Treatment Period|Physician Decision|1|||
148959928|NCT03204305|537337324|FG000|Overall Study|Lost to Follow-up|6|||
148959929|NCT03204305|537337325|FG001|Overall Study|Lost to Follow-up|4|||
148959930|NCT03204305|537337326|FG002|Overall Study|Lost to Follow-up|0|||
148959931|NCT03204305|537337327|FG003|Overall Study|Lost to Follow-up|0|||
148959932|NCT03204305|537337324|FG000|Overall Study|Physician Decision|1|||
148959933|NCT03204305|537337325|FG001|Overall Study|Physician Decision|0|||
148959934|NCT03204305|537337326|FG002|Overall Study|Physician Decision|0|||
148959935|NCT03204305|537337327|FG003|Overall Study|Physician Decision|0|||
148959936|NCT03204305|537337324|FG000|Overall Study|failure to place arterial line|2|||
148692968|NCT01890915|536350304|FG000|Overall Study|Adverse Event|1|||
148692969|NCT01890915|536350305|FG001|Overall Study|Adverse Event|0|||
148692970|NCT01890915|536350304|FG000|Overall Study|Protocol Violation|2|||
148959937|NCT03204305|537337325|FG001|Overall Study|failure to place arterial line|1|||
148959938|NCT03204305|537337326|FG002|Overall Study|failure to place arterial line|0|||
148959939|NCT03204305|537337327|FG003|Overall Study|failure to place arterial line|0|||
148959940|NCT03204305|537337324|FG000|Overall Study|Withdrawal by Subject|2|||
148959941|NCT03204305|537337325|FG001|Overall Study|Withdrawal by Subject|0|||
148959942|NCT03204305|537337326|FG002|Overall Study|Withdrawal by Subject|0|||
148959943|NCT03204305|537337327|FG003|Overall Study|Withdrawal by Subject|0|||
148959944|NCT00455429|537337328|FG000|Overall Study|Study Terminated by Sponsor|0|||
148959945|NCT00455429|537337329|FG001|Overall Study|Study Terminated by Sponsor|0|||
148959946|NCT00455429|537337330|FG002|Overall Study|Study Terminated by Sponsor|0|||
148959947|NCT00455429|537337331|FG003|Overall Study|Study Terminated by Sponsor|3|||
148959948|NCT00455429|537337328|FG000|Overall Study|Lost to Follow-up|1|||
148959949|NCT00455429|537337329|FG001|Overall Study|Lost to Follow-up|0|||
148959950|NCT00455429|537337330|FG002|Overall Study|Lost to Follow-up|0|||
148959951|NCT00455429|537337331|FG003|Overall Study|Lost to Follow-up|3|||
148959952|NCT00455429|537337328|FG000|Overall Study|Withdrawal by Subject|0|||
148959953|NCT00455429|537337329|FG001|Overall Study|Withdrawal by Subject|1|||
148959954|NCT00455429|537337330|FG002|Overall Study|Withdrawal by Subject|1|||
148959955|NCT00455429|537337331|FG003|Overall Study|Withdrawal by Subject|0|||
148959956|NCT00455429|537337328|FG000|Overall Study|Lack of Efficacy|0|||
148959957|NCT00455429|537337329|FG001|Overall Study|Lack of Efficacy|1|||
148959958|NCT00455429|537337330|FG002|Overall Study|Lack of Efficacy|0|||
148959959|NCT00455429|537337331|FG003|Overall Study|Lack of Efficacy|1|||
148959960|NCT00455429|537337328|FG000|Overall Study|Adverse Event|0|||
148959961|NCT00455429|537337329|FG001|Overall Study|Adverse Event|1|||
148959962|NCT00455429|537337330|FG002|Overall Study|Adverse Event|0|||
148959963|NCT00455429|537337331|FG003|Overall Study|Adverse Event|3|||
149023366|NCT04955626|537562644|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
149023367|NCT04955626|537562645|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
149023368|NCT04955626|537562646|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
149023369|NCT04955626|537562647|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
149023370|NCT04955626|537562648|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
149023371|NCT04955626|537562649|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
149023372|NCT04955626|537562650|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
149023373|NCT04955626|537562651|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
149023374|NCT04955626|537562652|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
149023375|NCT04955626|537562653|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
149023376|NCT04955626|537562654|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
149023377|NCT04955626|537562655|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
149023378|NCT04955626|537562656|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
149023379|NCT04955626|537562657|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
149023380|NCT04955626|537562658|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
149023381|NCT04955626|537562659|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
149023382|NCT04955626|537562660|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
149023383|NCT04955626|537562661|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
149023384|NCT04955626|537562662|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
149023385|NCT04955626|537562663|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
149023386|NCT04955626|537562664|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
149023387|NCT04955626|537562665|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
149023388|NCT04955626|537562666|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
149023389|NCT04955626|537562667|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
149023390|NCT04955626|537562668|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
149023391|NCT04955626|537562669|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
149023392|NCT04955626|537562670|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
149023393|NCT04955626|537562671|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
149023394|NCT04955626|537562672|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
149023395|NCT04955626|537562673|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
149023396|NCT04955626|537562674|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
149023397|NCT04955626|537562639|FG000|Blinded Period|Medication error|0|||
149023398|NCT04955626|537562640|FG001|Blinded Period|Medication error|0|||
149023399|NCT04955626|537562641|FG002|Blinded Period|Medication error|0|||
149023400|NCT04955626|537562642|FG003|Blinded Period|Medication error|0|||
149023401|NCT04955626|537562643|FG004|Blinded Period|Medication error|0|||
149023402|NCT04955626|537562644|FG005|Blinded Period|Medication error|0|||
149023403|NCT04955626|537562645|FG006|Blinded Period|Medication error|0|||
149023404|NCT04955626|537562646|FG007|Blinded Period|Medication error|0|||
149023405|NCT04955626|537562647|FG008|Blinded Period|Medication error|0|||
149023406|NCT04955626|537562648|FG009|Blinded Period|Medication error|0|||
149023407|NCT04955626|537562649|FG010|Blinded Period|Medication error|2|||
149023408|NCT04955626|537562650|FG011|Blinded Period|Medication error|0|||
149023409|NCT04955626|537562651|FG012|Blinded Period|Medication error|0|||
149023410|NCT04955626|537562652|FG013|Blinded Period|Medication error|0|||
149023411|NCT04955626|537562653|FG014|Blinded Period|Medication error|0|||
149023412|NCT04955626|537562654|FG015|Blinded Period|Medication error|0|||
149023413|NCT04955626|537562655|FG016|Blinded Period|Medication error|0|||
149023414|NCT04955626|537562656|FG017|Blinded Period|Medication error|0|||
149023415|NCT04955626|537562657|FG018|Blinded Period|Medication error|0|||
148959964|NCT00455429|537337328|FG000|Overall Study|Randomly assigned but not treated|0|||
148959965|NCT00455429|537337329|FG001|Overall Study|Randomly assigned but not treated|0|||
148959966|NCT00455429|537337330|FG002|Overall Study|Randomly assigned but not treated|0|||
148959967|NCT00455429|537337331|FG003|Overall Study|Randomly assigned but not treated|2|||
148959968|NCT00455429|537337328|FG000|Overall Study|Personal Reason|1|||
148959969|NCT00455429|537337329|FG001|Overall Study|Personal Reason|0|||
148959970|NCT00455429|537337330|FG002|Overall Study|Personal Reason|0|||
148959971|NCT00455429|537337331|FG003|Overall Study|Personal Reason|0|||
148959972|NCT00455429|537337328|FG000|Overall Study|Non-compliance|0|||
148959973|NCT00455429|537337329|FG001|Overall Study|Non-compliance|0|||
148959974|NCT00455429|537337330|FG002|Overall Study|Non-compliance|0|||
148959975|NCT00455429|537337331|FG003|Overall Study|Non-compliance|1|||
148959976|NCT00455429|537337328|FG000|Overall Study|Other|0|||
148959977|NCT00455429|537337329|FG001|Overall Study|Other|2|||
149023416|NCT04955626|537562658|FG019|Blinded Period|Medication error|0|||
149023417|NCT04955626|537562659|FG020|Blinded Period|Medication error|0|||
149023418|NCT04955626|537562660|FG021|Blinded Period|Medication error|0|||
149023419|NCT04955626|537562661|FG022|Blinded Period|Medication error|0|||
149023420|NCT04955626|537562662|FG023|Blinded Period|Medication error|0|||
149023421|NCT04955626|537562663|FG024|Blinded Period|Medication error|0|||
149023422|NCT04955626|537562664|FG025|Blinded Period|Medication error|0|||
148959978|NCT00455429|537337330|FG002|Overall Study|Other|0|||
149023423|NCT04955626|537562665|FG026|Blinded Period|Medication error|0|||
149023424|NCT04955626|537562666|FG027|Blinded Period|Medication error|0|||
149023425|NCT04955626|537562667|FG028|Blinded Period|Medication error|4|||
148959979|NCT00455429|537337331|FG003|Overall Study|Other|1|||
149023426|NCT04955626|537562668|FG029|Blinded Period|Medication error|0|||
149023427|NCT04955626|537562669|FG030|Blinded Period|Medication error|0|||
149023428|NCT04955626|537562670|FG031|Blinded Period|Medication error|0|||
149023429|NCT04955626|537562671|FG032|Blinded Period|Medication error|0|||
149023430|NCT04955626|537562672|FG033|Blinded Period|Medication error|0|||
149023431|NCT04955626|537562673|FG034|Blinded Period|Medication error|0|||
149023432|NCT04955626|537562674|FG035|Blinded Period|Medication error|0|||
149023433|NCT04955626|537562639|FG000|Open-Label Period|Lost to Follow-up|109|||
149023434|NCT04955626|537562640|FG001|Open-Label Period|Lost to Follow-up|41|||
149023435|NCT04955626|537562641|FG002|Open-Label Period|Lost to Follow-up|0|||
149023436|NCT04955626|537562642|FG003|Open-Label Period|Lost to Follow-up|0|||
149023437|NCT04955626|537562643|FG004|Open-Label Period|Lost to Follow-up|0|||
149023438|NCT04955626|537562644|FG005|Open-Label Period|Lost to Follow-up|0|||
149023439|NCT04955626|537562645|FG006|Open-Label Period|Lost to Follow-up|0|||
149023440|NCT04955626|537562646|FG007|Open-Label Period|Lost to Follow-up|0|||
149023441|NCT04955626|537562647|FG008|Open-Label Period|Lost to Follow-up|0|||
149023442|NCT04955626|537562648|FG009|Open-Label Period|Lost to Follow-up|0|||
149023443|NCT04955626|537562649|FG010|Open-Label Period|Lost to Follow-up|0|||
149023444|NCT04955626|537562650|FG011|Open-Label Period|Lost to Follow-up|0|||
149023445|NCT04955626|537562651|FG012|Open-Label Period|Lost to Follow-up|0|||
149023446|NCT04955626|537562652|FG013|Open-Label Period|Lost to Follow-up|0|||
149023447|NCT04955626|537562653|FG014|Open-Label Period|Lost to Follow-up|0|||
149023448|NCT04955626|537562654|FG015|Open-Label Period|Lost to Follow-up|0|||
149023449|NCT04955626|537562655|FG016|Open-Label Period|Lost to Follow-up|0|||
149023450|NCT04955626|537562656|FG017|Open-Label Period|Lost to Follow-up|0|||
149023451|NCT04955626|537562657|FG018|Open-Label Period|Lost to Follow-up|0|||
149023452|NCT04955626|537562658|FG019|Open-Label Period|Lost to Follow-up|0|||
149023453|NCT04955626|537562659|FG020|Open-Label Period|Lost to Follow-up|0|||
149023454|NCT04955626|537562660|FG021|Open-Label Period|Lost to Follow-up|0|||
149023455|NCT04955626|537562661|FG022|Open-Label Period|Lost to Follow-up|0|||
149023456|NCT04955626|537562662|FG023|Open-Label Period|Lost to Follow-up|0|||
149023457|NCT04955626|537562663|FG024|Open-Label Period|Lost to Follow-up|0|||
149023458|NCT04955626|537562664|FG025|Open-Label Period|Lost to Follow-up|0|||
149023459|NCT04955626|537562665|FG026|Open-Label Period|Lost to Follow-up|0|||
149023460|NCT04955626|537562666|FG027|Open-Label Period|Lost to Follow-up|0|||
149023461|NCT04955626|537562667|FG028|Open-Label Period|Lost to Follow-up|0|||
149023462|NCT04955626|537562668|FG029|Open-Label Period|Lost to Follow-up|0|||
149023463|NCT04955626|537562669|FG030|Open-Label Period|Lost to Follow-up|0|||
149023464|NCT04955626|537562670|FG031|Open-Label Period|Lost to Follow-up|0|||
149023465|NCT04955626|537562671|FG032|Open-Label Period|Lost to Follow-up|0|||
149023466|NCT04955626|537562672|FG033|Open-Label Period|Lost to Follow-up|0|||
149023467|NCT04955626|537562673|FG034|Open-Label Period|Lost to Follow-up|0|||
149023468|NCT04955626|537562674|FG035|Open-Label Period|Lost to Follow-up|0|||
149023469|NCT04955626|537562639|FG000|Open-Label Period|Protocol Violation|377|||
149023470|NCT04955626|537562640|FG001|Open-Label Period|Protocol Violation|48|||
149023471|NCT04955626|537562641|FG002|Open-Label Period|Protocol Violation|0|||
149023472|NCT04955626|537562642|FG003|Open-Label Period|Protocol Violation|0|||
149023473|NCT04955626|537562643|FG004|Open-Label Period|Protocol Violation|0|||
149023474|NCT04955626|537562644|FG005|Open-Label Period|Protocol Violation|0|||
149023475|NCT04955626|537562645|FG006|Open-Label Period|Protocol Violation|0|||
149023476|NCT04955626|537562646|FG007|Open-Label Period|Protocol Violation|0|||
149023477|NCT04955626|537562647|FG008|Open-Label Period|Protocol Violation|0|||
149023478|NCT04955626|537562648|FG009|Open-Label Period|Protocol Violation|0|||
149023479|NCT04955626|537562649|FG010|Open-Label Period|Protocol Violation|0|||
149023480|NCT04955626|537562650|FG011|Open-Label Period|Protocol Violation|0|||
149023481|NCT04955626|537562651|FG012|Open-Label Period|Protocol Violation|0|||
149023482|NCT04955626|537562652|FG013|Open-Label Period|Protocol Violation|0|||
149023483|NCT04955626|537562653|FG014|Open-Label Period|Protocol Violation|0|||
149023484|NCT04955626|537562654|FG015|Open-Label Period|Protocol Violation|0|||
149023485|NCT04955626|537562655|FG016|Open-Label Period|Protocol Violation|0|||
149023486|NCT04955626|537562656|FG017|Open-Label Period|Protocol Violation|0|||
149023487|NCT04955626|537562657|FG018|Open-Label Period|Protocol Violation|0|||
149023488|NCT04955626|537562658|FG019|Open-Label Period|Protocol Violation|0|||
149023489|NCT04955626|537562659|FG020|Open-Label Period|Protocol Violation|0|||
149023490|NCT04955626|537562660|FG021|Open-Label Period|Protocol Violation|0|||
149023491|NCT04955626|537562661|FG022|Open-Label Period|Protocol Violation|0|||
149023492|NCT04955626|537562662|FG023|Open-Label Period|Protocol Violation|0|||
149023493|NCT04955626|537562663|FG024|Open-Label Period|Protocol Violation|0|||
149023494|NCT04955626|537562664|FG025|Open-Label Period|Protocol Violation|0|||
149023495|NCT04955626|537562665|FG026|Open-Label Period|Protocol Violation|0|||
149023496|NCT04955626|537562666|FG027|Open-Label Period|Protocol Violation|0|||
149023497|NCT04955626|537562667|FG028|Open-Label Period|Protocol Violation|0|||
149023498|NCT04955626|537562668|FG029|Open-Label Period|Protocol Violation|0|||
149023499|NCT04955626|537562669|FG030|Open-Label Period|Protocol Violation|0|||
149023500|NCT04955626|537562670|FG031|Open-Label Period|Protocol Violation|0|||
149023501|NCT04955626|537562671|FG032|Open-Label Period|Protocol Violation|0|||
148959980|NCT01603459|537337340|FG000|Overall Study|Adverse Event|5|||
149023502|NCT04955626|537562672|FG033|Open-Label Period|Protocol Violation|0|||
149023503|NCT04955626|537562673|FG034|Open-Label Period|Protocol Violation|0|||
149023504|NCT04955626|537562674|FG035|Open-Label Period|Protocol Violation|0|||
149023505|NCT04955626|537562639|FG000|Open-Label Period|Death|5|||
149023506|NCT04955626|537562640|FG001|Open-Label Period|Death|5|||
149023507|NCT04955626|537562641|FG002|Open-Label Period|Death|0|||
149023508|NCT04955626|537562642|FG003|Open-Label Period|Death|0|||
149023509|NCT04955626|537562643|FG004|Open-Label Period|Death|0|||
149023510|NCT04955626|537562644|FG005|Open-Label Period|Death|0|||
149023511|NCT04955626|537562645|FG006|Open-Label Period|Death|0|||
148959981|NCT01603459|537337340|FG000|Overall Study|Withdrawal by Subject|5|||
148959982|NCT01603459|537337340|FG000|Overall Study|Lost to Follow-up|3|||
148959983|NCT01603459|537337340|FG000|Overall Study|Predefined discontinuation criteria|3|||
148959984|NCT01603459|537337340|FG000|Overall Study|Non-compliance|1|||
148959985|NCT01603459|537337340|FG000|Overall Study|Administrative reason|1|||
148959986|NCT00399360|537337341|FG000|Overall Study|Lost to Follow-up|2|||
148959987|NCT00399360|537337342|FG001|Overall Study|Lost to Follow-up|1|||
148959988|NCT00399360|537337343|FG002|Overall Study|Lost to Follow-up|2|||
148959989|NCT00399360|537337344|FG003|Overall Study|Lost to Follow-up|4|||
148959990|NCT00399360|537337341|FG000|Overall Study|Adverse Event|0|||
148959991|NCT00399360|537337342|FG001|Overall Study|Adverse Event|0|||
148959992|NCT00399360|537337343|FG002|Overall Study|Adverse Event|1|||
148959993|NCT00399360|537337344|FG003|Overall Study|Adverse Event|0|||
148959994|NCT00399360|537337341|FG000|Overall Study|Withdrawal by Subject|0|||
148959995|NCT00399360|537337342|FG001|Overall Study|Withdrawal by Subject|2|||
148959996|NCT00399360|537337343|FG002|Overall Study|Withdrawal by Subject|0|||
148959997|NCT00399360|537337344|FG003|Overall Study|Withdrawal by Subject|2|||
148959998|NCT02953314|537337348|FG000|Overall Study|Adverse Event|0|||
148959999|NCT02953314|537337349|FG001|Overall Study|Adverse Event|1|||
148960000|NCT02953314|537337348|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
148960001|NCT02953314|537337349|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
148960002|NCT01729754|537339177|FG000|Part 1|Adverse Event|2|||
148960003|NCT01729754|537339178|FG001|Part 1|Adverse Event|0|||
148960004|NCT01729754|537339179|FG002|Part 1|Adverse Event|0|||
148960005|NCT01729754|537339180|FG003|Part 1|Adverse Event|1|||
148960006|NCT01729754|537339181|FG004|Part 1|Adverse Event|0|||
148960007|NCT01729754|537339182|FG005|Part 1|Adverse Event|0|||
148960008|NCT01729754|537339183|FG006|Part 1|Adverse Event|2|||
148960009|NCT01729754|537339184|FG007|Part 1|Adverse Event|0|||
148960010|NCT01729754|537339185|FG008|Part 1|Adverse Event|0|||
148960011|NCT01729754|537339186|FG009|Part 1|Adverse Event|5|||
148960012|NCT01729754|537339177|FG000|Part 1|Lack of Efficacy|1|||
148960013|NCT01729754|537339178|FG001|Part 1|Lack of Efficacy|0|||
148960014|NCT01729754|537339179|FG002|Part 1|Lack of Efficacy|0|||
148960015|NCT01729754|537339180|FG003|Part 1|Lack of Efficacy|0|||
148960016|NCT01729754|537339181|FG004|Part 1|Lack of Efficacy|0|||
148960017|NCT01729754|537339182|FG005|Part 1|Lack of Efficacy|0|||
148960018|NCT01729754|537339183|FG006|Part 1|Lack of Efficacy|2|||
148960019|NCT01729754|537339184|FG007|Part 1|Lack of Efficacy|0|||
148960020|NCT01729754|537339185|FG008|Part 1|Lack of Efficacy|0|||
148960021|NCT01729754|537339186|FG009|Part 1|Lack of Efficacy|0|||
148960022|NCT01729754|537339177|FG000|Part 1|Lost to Follow-up|1|||
148960023|NCT01729754|537339178|FG001|Part 1|Lost to Follow-up|0|||
148960024|NCT01729754|537339179|FG002|Part 1|Lost to Follow-up|0|||
149023512|NCT04955626|537562646|FG007|Open-Label Period|Death|0|||
149023513|NCT04955626|537562647|FG008|Open-Label Period|Death|0|||
149023514|NCT04955626|537562648|FG009|Open-Label Period|Death|0|||
148960025|NCT01729754|537339180|FG003|Part 1|Lost to Follow-up|2|||
148960026|NCT01729754|537339181|FG004|Part 1|Lost to Follow-up|0|||
148960027|NCT01729754|537339182|FG005|Part 1|Lost to Follow-up|0|||
148960028|NCT01729754|537339183|FG006|Part 1|Lost to Follow-up|3|||
148960029|NCT01729754|537339184|FG007|Part 1|Lost to Follow-up|0|||
148960030|NCT01729754|537339185|FG008|Part 1|Lost to Follow-up|0|||
148960031|NCT01729754|537339186|FG009|Part 1|Lost to Follow-up|3|||
148960032|NCT01729754|537339177|FG000|Part 1|Non-compliance with Study Drug|1|||
148960033|NCT01729754|537339178|FG001|Part 1|Non-compliance with Study Drug|0|||
148960034|NCT01729754|537339179|FG002|Part 1|Non-compliance with Study Drug|0|||
148960035|NCT01729754|537339180|FG003|Part 1|Non-compliance with Study Drug|0|||
148960036|NCT01729754|537339181|FG004|Part 1|Non-compliance with Study Drug|0|||
148960037|NCT01729754|537339182|FG005|Part 1|Non-compliance with Study Drug|0|||
148960038|NCT01729754|537339183|FG006|Part 1|Non-compliance with Study Drug|0|||
148960039|NCT01729754|537339184|FG007|Part 1|Non-compliance with Study Drug|0|||
149023515|NCT04955626|537562649|FG010|Open-Label Period|Death|0|||
149023516|NCT04955626|537562650|FG011|Open-Label Period|Death|0|||
149023517|NCT04955626|537562651|FG012|Open-Label Period|Death|0|||
149023518|NCT04955626|537562652|FG013|Open-Label Period|Death|0|||
149023519|NCT04955626|537562653|FG014|Open-Label Period|Death|0|||
149023520|NCT04955626|537562654|FG015|Open-Label Period|Death|0|||
149023521|NCT04955626|537562655|FG016|Open-Label Period|Death|0|||
149023522|NCT04955626|537562656|FG017|Open-Label Period|Death|0|||
149023523|NCT04955626|537562657|FG018|Open-Label Period|Death|0|||
149023524|NCT04955626|537562658|FG019|Open-Label Period|Death|0|||
149023525|NCT04955626|537562659|FG020|Open-Label Period|Death|0|||
149023526|NCT04955626|537562660|FG021|Open-Label Period|Death|0|||
149023527|NCT04955626|537562661|FG022|Open-Label Period|Death|0|||
149023528|NCT04955626|537562662|FG023|Open-Label Period|Death|0|||
149023529|NCT04955626|537562663|FG024|Open-Label Period|Death|0|||
149023530|NCT04955626|537562664|FG025|Open-Label Period|Death|0|||
149023531|NCT04955626|537562665|FG026|Open-Label Period|Death|0|||
149023532|NCT04955626|537562666|FG027|Open-Label Period|Death|0|||
149023533|NCT04955626|537562667|FG028|Open-Label Period|Death|0|||
149023534|NCT04955626|537562668|FG029|Open-Label Period|Death|0|||
149023535|NCT04955626|537562669|FG030|Open-Label Period|Death|0|||
149023536|NCT04955626|537562670|FG031|Open-Label Period|Death|0|||
149023537|NCT04955626|537562671|FG032|Open-Label Period|Death|0|||
149023538|NCT04955626|537562672|FG033|Open-Label Period|Death|0|||
149023539|NCT04955626|537562673|FG034|Open-Label Period|Death|0|||
149023540|NCT04955626|537562674|FG035|Open-Label Period|Death|0|||
149023541|NCT04955626|537562639|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
149023542|NCT04955626|537562640|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
149023543|NCT04955626|537562641|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
149023544|NCT04955626|537562642|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
149023545|NCT04955626|537562643|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
149023546|NCT04955626|537562644|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
149023547|NCT04955626|537562645|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
149023548|NCT04955626|537562646|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
149023549|NCT04955626|537562647|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
149023550|NCT04955626|537562648|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
149023551|NCT04955626|537562649|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
149023552|NCT04955626|537562650|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
149023553|NCT04955626|537562651|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
149023554|NCT04955626|537562652|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
149023555|NCT04955626|537562653|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
149023556|NCT04955626|537562654|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
149023557|NCT04955626|537562655|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
149023558|NCT04955626|537562656|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
149023559|NCT04955626|537562657|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
149023560|NCT04955626|537562658|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
149023561|NCT04955626|537562659|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
149023562|NCT04955626|537562660|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
149023563|NCT04955626|537562661|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
149023564|NCT04955626|537562662|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
149023565|NCT04955626|537562663|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
149023566|NCT04955626|537562664|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
149023567|NCT04955626|537562665|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
149023568|NCT04955626|537562666|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
148811780|NCT03765073|536787071|FG000|Stage 3|No longer meets eligibility criteria|0|||
148960040|NCT01729754|537339185|FG008|Part 1|Non-compliance with Study Drug|0|||
148960041|NCT01729754|537339186|FG009|Part 1|Non-compliance with Study Drug|0|||
149023569|NCT04955626|537562667|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
148692971|NCT01890915|536350305|FG001|Overall Study|Protocol Violation|0|||
148960042|NCT01729754|537339177|FG000|Part 1|Physician Decision|0|||
148960043|NCT01729754|537339178|FG001|Part 1|Physician Decision|0|||
149023570|NCT04955626|537562668|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
149023571|NCT04955626|537562669|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
149023572|NCT04955626|537562670|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
149023573|NCT04955626|537562671|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
149023574|NCT04955626|537562672|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
149023575|NCT04955626|537562673|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
149023576|NCT04955626|537562674|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
149023577|NCT04955626|537562639|FG000|Open-Label Period|Other|621|||
149023578|NCT04955626|537562640|FG001|Open-Label Period|Other|429|||
149023579|NCT04955626|537562641|FG002|Open-Label Period|Other|0|||
149023580|NCT04955626|537562642|FG003|Open-Label Period|Other|0|||
149023581|NCT04955626|537562643|FG004|Open-Label Period|Other|0|||
149023582|NCT04955626|537562644|FG005|Open-Label Period|Other|0|||
149023583|NCT04955626|537562645|FG006|Open-Label Period|Other|0|||
149023584|NCT04955626|537562646|FG007|Open-Label Period|Other|0|||
149023585|NCT04955626|537562647|FG008|Open-Label Period|Other|0|||
149023586|NCT04955626|537562648|FG009|Open-Label Period|Other|0|||
149023587|NCT04955626|537562649|FG010|Open-Label Period|Other|0|||
149023588|NCT04955626|537562650|FG011|Open-Label Period|Other|0|||
149023589|NCT04955626|537562651|FG012|Open-Label Period|Other|0|||
149023590|NCT04955626|537562652|FG013|Open-Label Period|Other|0|||
149023591|NCT04955626|537562653|FG014|Open-Label Period|Other|0|||
149023592|NCT04955626|537562654|FG015|Open-Label Period|Other|0|||
149023593|NCT04955626|537562655|FG016|Open-Label Period|Other|0|||
149023594|NCT04955626|537562656|FG017|Open-Label Period|Other|0|||
149023595|NCT04955626|537562657|FG018|Open-Label Period|Other|0|||
149023596|NCT04955626|537562658|FG019|Open-Label Period|Other|0|||
149023597|NCT04955626|537562659|FG020|Open-Label Period|Other|0|||
149023598|NCT04955626|537562660|FG021|Open-Label Period|Other|0|||
149023599|NCT04955626|537562661|FG022|Open-Label Period|Other|0|||
149023600|NCT04955626|537562662|FG023|Open-Label Period|Other|0|||
149023601|NCT04955626|537562663|FG024|Open-Label Period|Other|0|||
149023602|NCT04955626|537562664|FG025|Open-Label Period|Other|0|||
149023603|NCT04955626|537562665|FG026|Open-Label Period|Other|0|||
149023604|NCT04955626|537562666|FG027|Open-Label Period|Other|0|||
149023605|NCT04955626|537562667|FG028|Open-Label Period|Other|0|||
149023606|NCT04955626|537562668|FG029|Open-Label Period|Other|0|||
149023607|NCT04955626|537562669|FG030|Open-Label Period|Other|0|||
149023608|NCT04955626|537562670|FG031|Open-Label Period|Other|0|||
149023609|NCT04955626|537562671|FG032|Open-Label Period|Other|0|||
149023610|NCT04955626|537562672|FG033|Open-Label Period|Other|0|||
149023611|NCT04955626|537562673|FG034|Open-Label Period|Other|0|||
149023612|NCT04955626|537562674|FG035|Open-Label Period|Other|0|||
148960044|NCT01729754|537339179|FG002|Part 1|Physician Decision|0|||
148960045|NCT01729754|537339180|FG003|Part 1|Physician Decision|0|||
148960046|NCT01729754|537339181|FG004|Part 1|Physician Decision|0|||
148960047|NCT01729754|537339182|FG005|Part 1|Physician Decision|0|||
148960048|NCT01729754|537339183|FG006|Part 1|Physician Decision|0|||
148960049|NCT01729754|537339184|FG007|Part 1|Physician Decision|0|||
148960050|NCT01729754|537339185|FG008|Part 1|Physician Decision|0|||
148960051|NCT01729754|537339186|FG009|Part 1|Physician Decision|4|||
148960052|NCT01729754|537339177|FG000|Part 1|Pregnancy|0|||
148960053|NCT01729754|537339178|FG001|Part 1|Pregnancy|0|||
148960054|NCT01729754|537339179|FG002|Part 1|Pregnancy|0|||
148960055|NCT01729754|537339180|FG003|Part 1|Pregnancy|1|||
148960056|NCT01729754|537339181|FG004|Part 1|Pregnancy|0|||
148960057|NCT01729754|537339182|FG005|Part 1|Pregnancy|0|||
148960058|NCT01729754|537339183|FG006|Part 1|Pregnancy|0|||
148960059|NCT01729754|537339184|FG007|Part 1|Pregnancy|0|||
148960060|NCT01729754|537339185|FG008|Part 1|Pregnancy|0|||
148960061|NCT01729754|537339186|FG009|Part 1|Pregnancy|1|||
148960062|NCT01729754|537339177|FG000|Part 1|Progressive Disease|0|||
148960063|NCT01729754|537339178|FG001|Part 1|Progressive Disease|0|||
148960064|NCT01729754|537339179|FG002|Part 1|Progressive Disease|0|||
148960065|NCT01729754|537339180|FG003|Part 1|Progressive Disease|0|||
148960066|NCT01729754|537339181|FG004|Part 1|Progressive Disease|0|||
148960067|NCT01729754|537339182|FG005|Part 1|Progressive Disease|0|||
148960068|NCT01729754|537339183|FG006|Part 1|Progressive Disease|0|||
148960069|NCT01729754|537339184|FG007|Part 1|Progressive Disease|0|||
148960070|NCT01729754|537339185|FG008|Part 1|Progressive Disease|0|||
148960071|NCT01729754|537339186|FG009|Part 1|Progressive Disease|1|||
148960072|NCT01729754|537339177|FG000|Part 1|Protocol Violation|2|||
148960073|NCT01729754|537339178|FG001|Part 1|Protocol Violation|0|||
148960074|NCT01729754|537339179|FG002|Part 1|Protocol Violation|0|||
148960075|NCT01729754|537339180|FG003|Part 1|Protocol Violation|1|||
148960076|NCT01729754|537339181|FG004|Part 1|Protocol Violation|0|||
148960077|NCT01729754|537339182|FG005|Part 1|Protocol Violation|0|||
148960078|NCT01729754|537339183|FG006|Part 1|Protocol Violation|1|||
148960079|NCT01729754|537339184|FG007|Part 1|Protocol Violation|0|||
148960080|NCT01729754|537339185|FG008|Part 1|Protocol Violation|0|||
148960081|NCT01729754|537339186|FG009|Part 1|Protocol Violation|0|||
148960082|NCT01729754|537339177|FG000|Part 1|Withdrawal by Subject|5|||
148960083|NCT01729754|537339178|FG001|Part 1|Withdrawal by Subject|0|||
148960084|NCT01729754|537339179|FG002|Part 1|Withdrawal by Subject|0|||
148960085|NCT01729754|537339180|FG003|Part 1|Withdrawal by Subject|7|||
148960086|NCT01729754|537339181|FG004|Part 1|Withdrawal by Subject|0|||
148960087|NCT01729754|537339182|FG005|Part 1|Withdrawal by Subject|0|||
148960088|NCT01729754|537339183|FG006|Part 1|Withdrawal by Subject|5|||
148960089|NCT01729754|537339184|FG007|Part 1|Withdrawal by Subject|0|||
148960090|NCT01729754|537339185|FG008|Part 1|Withdrawal by Subject|0|||
148960091|NCT01729754|537339186|FG009|Part 1|Withdrawal by Subject|6|||
148960092|NCT01729754|537339177|FG000|Part 1|Other Protocol Specified Criteria|2|||
148960093|NCT01729754|537339178|FG001|Part 1|Other Protocol Specified Criteria|0|||
148960094|NCT01729754|537339179|FG002|Part 1|Other Protocol Specified Criteria|0|||
148960095|NCT01729754|537339180|FG003|Part 1|Other Protocol Specified Criteria|0|||
148960096|NCT01729754|537339181|FG004|Part 1|Other Protocol Specified Criteria|0|||
148960097|NCT01729754|537339182|FG005|Part 1|Other Protocol Specified Criteria|0|||
148960098|NCT01729754|537339183|FG006|Part 1|Other Protocol Specified Criteria|1|||
148960099|NCT01729754|537339184|FG007|Part 1|Other Protocol Specified Criteria|0|||
148960100|NCT01729754|537339185|FG008|Part 1|Other Protocol Specified Criteria|0|||
148960101|NCT01729754|537339186|FG009|Part 1|Other Protocol Specified Criteria|4|||
148960102|NCT01729754|537339177|FG000|Part 2|Adverse Event|2|||
148960103|NCT01729754|537339178|FG001|Part 2|Adverse Event|0|||
148960104|NCT01729754|537339179|FG002|Part 2|Adverse Event|0|||
148960105|NCT01729754|537339180|FG003|Part 2|Adverse Event|0|||
148960106|NCT01729754|537339181|FG004|Part 2|Adverse Event|0|||
148960107|NCT01729754|537339182|FG005|Part 2|Adverse Event|0|||
148960108|NCT01729754|537339183|FG006|Part 2|Adverse Event|0|||
148960109|NCT01729754|537339184|FG007|Part 2|Adverse Event|0|||
148960110|NCT01729754|537339185|FG008|Part 2|Adverse Event|1|||
148960111|NCT01729754|537339186|FG009|Part 2|Adverse Event|2|||
148960112|NCT01729754|537339177|FG000|Part 2|Lack of Efficacy|0|||
148960113|NCT01729754|537339178|FG001|Part 2|Lack of Efficacy|0|||
148960114|NCT01729754|537339179|FG002|Part 2|Lack of Efficacy|0|||
148960115|NCT01729754|537339180|FG003|Part 2|Lack of Efficacy|0|||
148960116|NCT01729754|537339181|FG004|Part 2|Lack of Efficacy|0|||
148960117|NCT01729754|537339182|FG005|Part 2|Lack of Efficacy|0|||
148960118|NCT01729754|537339183|FG006|Part 2|Lack of Efficacy|0|||
148960119|NCT01729754|537339184|FG007|Part 2|Lack of Efficacy|0|||
148960120|NCT01729754|537339185|FG008|Part 2|Lack of Efficacy|2|||
148960121|NCT01729754|537339186|FG009|Part 2|Lack of Efficacy|2|||
148960122|NCT01729754|537339177|FG000|Part 2|Lost to Follow-up|0|||
148960123|NCT01729754|537339178|FG001|Part 2|Lost to Follow-up|0|||
148960124|NCT01729754|537339179|FG002|Part 2|Lost to Follow-up|0|||
148960125|NCT01729754|537339180|FG003|Part 2|Lost to Follow-up|2|||
148960126|NCT01729754|537339181|FG004|Part 2|Lost to Follow-up|0|||
148960127|NCT01729754|537339182|FG005|Part 2|Lost to Follow-up|0|||
148960128|NCT01729754|537339183|FG006|Part 2|Lost to Follow-up|0|||
148960129|NCT01729754|537339184|FG007|Part 2|Lost to Follow-up|1|||
148960130|NCT01729754|537339185|FG008|Part 2|Lost to Follow-up|0|||
148960131|NCT01729754|537339186|FG009|Part 2|Lost to Follow-up|2|||
148960132|NCT01729754|537339177|FG000|Part 2|Non-Compliance with Study Drug|0|||
148960133|NCT01729754|537339178|FG001|Part 2|Non-Compliance with Study Drug|0|||
148960134|NCT01729754|537339179|FG002|Part 2|Non-Compliance with Study Drug|0|||
148960135|NCT01729754|537339180|FG003|Part 2|Non-Compliance with Study Drug|0|||
148960136|NCT01729754|537339181|FG004|Part 2|Non-Compliance with Study Drug|0|||
148960137|NCT01729754|537339182|FG005|Part 2|Non-Compliance with Study Drug|0|||
148960138|NCT01729754|537339183|FG006|Part 2|Non-Compliance with Study Drug|0|||
148960139|NCT01729754|537339184|FG007|Part 2|Non-Compliance with Study Drug|0|||
148960140|NCT01729754|537339185|FG008|Part 2|Non-Compliance with Study Drug|0|||
148960141|NCT01729754|537339186|FG009|Part 2|Non-Compliance with Study Drug|1|||
148960142|NCT01729754|537339177|FG000|Part 2|Pregnancy|0|||
148960143|NCT01729754|537339178|FG001|Part 2|Pregnancy|0|||
148960144|NCT01729754|537339179|FG002|Part 2|Pregnancy|0|||
148960145|NCT01729754|537339180|FG003|Part 2|Pregnancy|1|||
148960146|NCT01729754|537339181|FG004|Part 2|Pregnancy|0|||
148960147|NCT01729754|537339182|FG005|Part 2|Pregnancy|0|||
148960148|NCT01729754|537339183|FG006|Part 2|Pregnancy|0|||
148960149|NCT01729754|537339184|FG007|Part 2|Pregnancy|0|||
148960150|NCT01729754|537339185|FG008|Part 2|Pregnancy|0|||
148960151|NCT01729754|537339186|FG009|Part 2|Pregnancy|1|||
148960152|NCT01729754|537339177|FG000|Part 2|Withdrawal by Subject|3|||
148960153|NCT01729754|537339178|FG001|Part 2|Withdrawal by Subject|0|||
148960154|NCT01729754|537339179|FG002|Part 2|Withdrawal by Subject|0|||
149023613|NCT04955626|537562639|FG000|Open-Label Period|Physician Decision|2|||
148960155|NCT01729754|537339180|FG003|Part 2|Withdrawal by Subject|2|||
148960156|NCT01729754|537339181|FG004|Part 2|Withdrawal by Subject|0|||
148960157|NCT01729754|537339182|FG005|Part 2|Withdrawal by Subject|0|||
148960158|NCT01729754|537339183|FG006|Part 2|Withdrawal by Subject|0|||
148960159|NCT01729754|537339184|FG007|Part 2|Withdrawal by Subject|1|||
148960160|NCT01729754|537339185|FG008|Part 2|Withdrawal by Subject|1|||
148960161|NCT01729754|537339186|FG009|Part 2|Withdrawal by Subject|4|||
148960162|NCT01729754|537339177|FG000|Part 2|Other Protocol Specified Criteria|1|||
148960163|NCT01729754|537339178|FG001|Part 2|Other Protocol Specified Criteria|0|||
148960164|NCT01729754|537339179|FG002|Part 2|Other Protocol Specified Criteria|0|||
148692972|NCT01890915|536350304|FG000|Overall Study|Equipment Malfunction|0|||
148960165|NCT01729754|537339180|FG003|Part 2|Other Protocol Specified Criteria|0|||
148960166|NCT01729754|537339181|FG004|Part 2|Other Protocol Specified Criteria|0|||
148960167|NCT01729754|537339182|FG005|Part 2|Other Protocol Specified Criteria|0|||
148960168|NCT01729754|537339183|FG006|Part 2|Other Protocol Specified Criteria|0|||
148960169|NCT01729754|537339184|FG007|Part 2|Other Protocol Specified Criteria|1|||
148960170|NCT01729754|537339185|FG008|Part 2|Other Protocol Specified Criteria|0|||
148960171|NCT01729754|537339186|FG009|Part 2|Other Protocol Specified Criteria|0|||
148960172|NCT01729754|537339177|FG000|Part 3|Adverse Event|0|||
148960173|NCT01729754|537339178|FG001|Part 3|Adverse Event|0|||
148960174|NCT01729754|537339179|FG002|Part 3|Adverse Event|1|||
148960175|NCT01729754|537339180|FG003|Part 3|Adverse Event|0|||
148960176|NCT01729754|537339181|FG004|Part 3|Adverse Event|0|||
148960177|NCT01729754|537339182|FG005|Part 3|Adverse Event|5|||
148960178|NCT01729754|537339183|FG006|Part 3|Adverse Event|0|||
148960179|NCT01729754|537339184|FG007|Part 3|Adverse Event|0|||
148960180|NCT01729754|537339185|FG008|Part 3|Adverse Event|0|||
148960181|NCT01729754|537339186|FG009|Part 3|Adverse Event|3|||
148960182|NCT01729754|537339177|FG000|Part 3|Death|0|||
148960183|NCT01729754|537339178|FG001|Part 3|Death|0|||
148960184|NCT01729754|537339179|FG002|Part 3|Death|0|||
148960185|NCT01729754|537339180|FG003|Part 3|Death|0|||
148960186|NCT01729754|537339181|FG004|Part 3|Death|0|||
148960187|NCT01729754|537339182|FG005|Part 3|Death|2|||
148960188|NCT01729754|537339183|FG006|Part 3|Death|0|||
148960189|NCT01729754|537339184|FG007|Part 3|Death|0|||
148960190|NCT01729754|537339185|FG008|Part 3|Death|0|||
148960191|NCT01729754|537339186|FG009|Part 3|Death|0|||
148960192|NCT01729754|537339177|FG000|Part 3|Lack of Efficacy|0|||
148960193|NCT01729754|537339178|FG001|Part 3|Lack of Efficacy|0|||
148960194|NCT01729754|537339179|FG002|Part 3|Lack of Efficacy|0|||
148960195|NCT01729754|537339180|FG003|Part 3|Lack of Efficacy|0|||
148960196|NCT01729754|537339181|FG004|Part 3|Lack of Efficacy|2|||
148960197|NCT01729754|537339182|FG005|Part 3|Lack of Efficacy|0|||
148960198|NCT01729754|537339183|FG006|Part 3|Lack of Efficacy|0|||
149023614|NCT04955626|537562640|FG001|Open-Label Period|Physician Decision|0|||
149023615|NCT04955626|537562641|FG002|Open-Label Period|Physician Decision|0|||
148960199|NCT01729754|537339184|FG007|Part 3|Lack of Efficacy|0|||
149023616|NCT04955626|537562642|FG003|Open-Label Period|Physician Decision|0|||
148960200|NCT01729754|537339185|FG008|Part 3|Lack of Efficacy|0|||
148960201|NCT01729754|537339186|FG009|Part 3|Lack of Efficacy|4|||
149023617|NCT04955626|537562643|FG004|Open-Label Period|Physician Decision|0|||
148960202|NCT01729754|537339177|FG000|Part 3|Lost to Follow-up|0|||
148960203|NCT01729754|537339178|FG001|Part 3|Lost to Follow-up|1|||
148960204|NCT01729754|537339179|FG002|Part 3|Lost to Follow-up|2|||
148960205|NCT01729754|537339180|FG003|Part 3|Lost to Follow-up|0|||
148960206|NCT01729754|537339181|FG004|Part 3|Lost to Follow-up|0|||
148960207|NCT01729754|537339182|FG005|Part 3|Lost to Follow-up|3|||
148960208|NCT01729754|537339183|FG006|Part 3|Lost to Follow-up|0|||
148960209|NCT01729754|537339184|FG007|Part 3|Lost to Follow-up|0|||
148960210|NCT01729754|537339185|FG008|Part 3|Lost to Follow-up|1|||
149023618|NCT04955626|537562644|FG005|Open-Label Period|Physician Decision|0|||
149023619|NCT04955626|537562645|FG006|Open-Label Period|Physician Decision|0|||
149023620|NCT04955626|537562646|FG007|Open-Label Period|Physician Decision|0|||
148960211|NCT01729754|537339186|FG009|Part 3|Lost to Follow-up|0|||
148960212|NCT01729754|537339177|FG000|Part 3|Physician Decision|0|||
148960213|NCT01729754|537339178|FG001|Part 3|Physician Decision|0|||
149023621|NCT04955626|537562647|FG008|Open-Label Period|Physician Decision|0|||
148960214|NCT01729754|537339179|FG002|Part 3|Physician Decision|1|||
148960215|NCT01729754|537339180|FG003|Part 3|Physician Decision|0|||
148960216|NCT01729754|537339181|FG004|Part 3|Physician Decision|0|||
148960217|NCT01729754|537339182|FG005|Part 3|Physician Decision|0|||
149023622|NCT04955626|537562648|FG009|Open-Label Period|Physician Decision|0|||
149023623|NCT04955626|537562649|FG010|Open-Label Period|Physician Decision|0|||
149023624|NCT04955626|537562650|FG011|Open-Label Period|Physician Decision|0|||
149023625|NCT04955626|537562651|FG012|Open-Label Period|Physician Decision|0|||
149023626|NCT04955626|537562652|FG013|Open-Label Period|Physician Decision|0|||
149023627|NCT04955626|537562653|FG014|Open-Label Period|Physician Decision|0|||
149023628|NCT04955626|537562654|FG015|Open-Label Period|Physician Decision|0|||
149023629|NCT04955626|537562655|FG016|Open-Label Period|Physician Decision|0|||
149023630|NCT04955626|537562656|FG017|Open-Label Period|Physician Decision|0|||
149023631|NCT04955626|537562657|FG018|Open-Label Period|Physician Decision|0|||
149023632|NCT04955626|537562658|FG019|Open-Label Period|Physician Decision|0|||
149023633|NCT04955626|537562659|FG020|Open-Label Period|Physician Decision|0|||
149023634|NCT04955626|537562660|FG021|Open-Label Period|Physician Decision|0|||
149023635|NCT04955626|537562661|FG022|Open-Label Period|Physician Decision|0|||
149023636|NCT04955626|537562662|FG023|Open-Label Period|Physician Decision|0|||
149023637|NCT04955626|537562663|FG024|Open-Label Period|Physician Decision|0|||
149023638|NCT04955626|537562664|FG025|Open-Label Period|Physician Decision|0|||
149023639|NCT04955626|537562665|FG026|Open-Label Period|Physician Decision|0|||
149023640|NCT04955626|537562666|FG027|Open-Label Period|Physician Decision|0|||
149023641|NCT04955626|537562667|FG028|Open-Label Period|Physician Decision|0|||
149023642|NCT04955626|537562668|FG029|Open-Label Period|Physician Decision|0|||
149023643|NCT04955626|537562669|FG030|Open-Label Period|Physician Decision|0|||
149023644|NCT04955626|537562670|FG031|Open-Label Period|Physician Decision|0|||
149023645|NCT04955626|537562671|FG032|Open-Label Period|Physician Decision|0|||
149023646|NCT04955626|537562672|FG033|Open-Label Period|Physician Decision|0|||
149023647|NCT04955626|537562673|FG034|Open-Label Period|Physician Decision|0|||
149023648|NCT04955626|537562674|FG035|Open-Label Period|Physician Decision|0|||
149023649|NCT04955626|537562639|FG000|Open-Label Period|Withdrawal by Subject|135|||
149023650|NCT04955626|537562640|FG001|Open-Label Period|Withdrawal by Subject|25|||
149023651|NCT04955626|537562641|FG002|Open-Label Period|Withdrawal by Subject|0|||
149023652|NCT04955626|537562642|FG003|Open-Label Period|Withdrawal by Subject|0|||
149023653|NCT04955626|537562643|FG004|Open-Label Period|Withdrawal by Subject|0|||
149023654|NCT04955626|537562644|FG005|Open-Label Period|Withdrawal by Subject|0|||
149023655|NCT04955626|537562645|FG006|Open-Label Period|Withdrawal by Subject|0|||
148811781|NCT03765073|536787072|FG001|Stage 3|No longer meets eligibility criteria|0|||
148811782|NCT03765073|536787073|FG002|Stage 3|No longer meets eligibility criteria|0|||
148811783|NCT03765073|536787074|FG003|Stage 3|No longer meets eligibility criteria|0|||
148811784|NCT03765073|536787075|FG004|Stage 3|No longer meets eligibility criteria|0|||
148811785|NCT03765073|536787076|FG005|Stage 3|No longer meets eligibility criteria|0|||
148811786|NCT03765073|536787077|FG006|Stage 3|No longer meets eligibility criteria|0|||
148811787|NCT03765073|536787078|FG007|Stage 3|No longer meets eligibility criteria|0|||
148811788|NCT03765073|536787079|FG008|Stage 3|No longer meets eligibility criteria|0|||
148811789|NCT03765073|536787080|FG009|Stage 3|No longer meets eligibility criteria|0|||
148811790|NCT03765073|536787081|FG010|Stage 3|No longer meets eligibility criteria|0|||
148811791|NCT03765073|536787082|FG011|Stage 3|No longer meets eligibility criteria|0|||
148811792|NCT03765073|536787083|FG012|Stage 3|No longer meets eligibility criteria|0|||
148811793|NCT03765073|536787084|FG013|Stage 3|No longer meets eligibility criteria|0|||
148960218|NCT01729754|537339183|FG006|Part 3|Physician Decision|0|||
148960219|NCT01729754|537339184|FG007|Part 3|Physician Decision|0|||
148960220|NCT01729754|537339185|FG008|Part 3|Physician Decision|0|||
148960221|NCT01729754|537339186|FG009|Part 3|Physician Decision|0|||
148811794|NCT03765073|536787085|FG014|Stage 3|No longer meets eligibility criteria|0|||
148811795|NCT03765073|536787086|FG015|Stage 3|No longer meets eligibility criteria|0|||
148811796|NCT03765073|536787087|FG016|Stage 3|No longer meets eligibility criteria|0|||
148960222|NCT01729754|537339177|FG000|Part 3|Withdrawal by Subject|0|||
148960223|NCT01729754|537339178|FG001|Part 3|Withdrawal by Subject|4|||
148960224|NCT01729754|537339179|FG002|Part 3|Withdrawal by Subject|1|||
148960225|NCT01729754|537339180|FG003|Part 3|Withdrawal by Subject|0|||
148960226|NCT01729754|537339181|FG004|Part 3|Withdrawal by Subject|2|||
148960227|NCT01729754|537339182|FG005|Part 3|Withdrawal by Subject|1|||
148960228|NCT01729754|537339183|FG006|Part 3|Withdrawal by Subject|0|||
148960229|NCT01729754|537339184|FG007|Part 3|Withdrawal by Subject|2|||
148811797|NCT03765073|536787088|FG017|Stage 3|No longer meets eligibility criteria|0|||
148811798|NCT03765073|536787089|FG018|Stage 3|No longer meets eligibility criteria|1|||
148811799|NCT03765073|536787090|FG019|Stage 3|No longer meets eligibility criteria|0|||
148811800|NCT03765073|536787091|FG020|Stage 3|No longer meets eligibility criteria|1|||
148811801|NCT03765073|536787071|FG000|Stage 3|Other|0|||
148811802|NCT03765073|536787072|FG001|Stage 3|Other|0|||
148811803|NCT03765073|536787073|FG002|Stage 3|Other|0|||
148960230|NCT01729754|537339185|FG008|Part 3|Withdrawal by Subject|0|||
148960231|NCT01729754|537339186|FG009|Part 3|Withdrawal by Subject|0|||
148960232|NCT01729754|537339177|FG000|Part 3|Other Protocol Specified Criteria|0|||
148960233|NCT01729754|537339178|FG001|Part 3|Other Protocol Specified Criteria|0|||
148960234|NCT01729754|537339179|FG002|Part 3|Other Protocol Specified Criteria|0|||
148960235|NCT01729754|537339180|FG003|Part 3|Other Protocol Specified Criteria|0|||
148960236|NCT01729754|537339181|FG004|Part 3|Other Protocol Specified Criteria|0|||
148960237|NCT01729754|537339182|FG005|Part 3|Other Protocol Specified Criteria|2|||
148960238|NCT01729754|537339183|FG006|Part 3|Other Protocol Specified Criteria|0|||
148960239|NCT01729754|537339184|FG007|Part 3|Other Protocol Specified Criteria|1|||
148960240|NCT01729754|537339185|FG008|Part 3|Other Protocol Specified Criteria|0|||
148811804|NCT03765073|536787074|FG003|Stage 3|Other|0|||
148811805|NCT03765073|536787075|FG004|Stage 3|Other|0|||
148811806|NCT03765073|536787076|FG005|Stage 3|Other|0|||
148960241|NCT01729754|537339186|FG009|Part 3|Other Protocol Specified Criteria|0|||
148960242|NCT04741074|537339187|FG000|Overall Study|Withdrawal by Subject|1|||
148811807|NCT03765073|536787077|FG006|Stage 3|Other|0|||
148811808|NCT03765073|536787078|FG007|Stage 3|Other|0|||
148811809|NCT03765073|536787079|FG008|Stage 3|Other|0|||
149023656|NCT04955626|537562646|FG007|Open-Label Period|Withdrawal by Subject|0|||
149023657|NCT04955626|537562647|FG008|Open-Label Period|Withdrawal by Subject|0|||
149023658|NCT04955626|537562648|FG009|Open-Label Period|Withdrawal by Subject|0|||
149023659|NCT04955626|537562649|FG010|Open-Label Period|Withdrawal by Subject|0|||
149023660|NCT04955626|537562650|FG011|Open-Label Period|Withdrawal by Subject|0|||
149023661|NCT04955626|537562651|FG012|Open-Label Period|Withdrawal by Subject|0|||
149023662|NCT04955626|537562652|FG013|Open-Label Period|Withdrawal by Subject|0|||
149023663|NCT04955626|537562653|FG014|Open-Label Period|Withdrawal by Subject|0|||
149023664|NCT04955626|537562654|FG015|Open-Label Period|Withdrawal by Subject|0|||
149023665|NCT04955626|537562655|FG016|Open-Label Period|Withdrawal by Subject|0|||
149023666|NCT04955626|537562656|FG017|Open-Label Period|Withdrawal by Subject|0|||
149023667|NCT04955626|537562657|FG018|Open-Label Period|Withdrawal by Subject|0|||
149023668|NCT04955626|537562658|FG019|Open-Label Period|Withdrawal by Subject|0|||
149023669|NCT04955626|537562659|FG020|Open-Label Period|Withdrawal by Subject|0|||
149023670|NCT04955626|537562660|FG021|Open-Label Period|Withdrawal by Subject|0|||
149023671|NCT04955626|537562661|FG022|Open-Label Period|Withdrawal by Subject|0|||
149023672|NCT04955626|537562662|FG023|Open-Label Period|Withdrawal by Subject|0|||
149023673|NCT04955626|537562663|FG024|Open-Label Period|Withdrawal by Subject|0|||
149023674|NCT04955626|537562664|FG025|Open-Label Period|Withdrawal by Subject|0|||
149023675|NCT04955626|537562665|FG026|Open-Label Period|Withdrawal by Subject|0|||
149023676|NCT04955626|537562666|FG027|Open-Label Period|Withdrawal by Subject|0|||
149023677|NCT04955626|537562667|FG028|Open-Label Period|Withdrawal by Subject|0|||
149023678|NCT04955626|537562668|FG029|Open-Label Period|Withdrawal by Subject|0|||
149023679|NCT04955626|537562669|FG030|Open-Label Period|Withdrawal by Subject|0|||
149023680|NCT04955626|537562670|FG031|Open-Label Period|Withdrawal by Subject|0|||
149023681|NCT04955626|537562671|FG032|Open-Label Period|Withdrawal by Subject|0|||
149023682|NCT04955626|537562672|FG033|Open-Label Period|Withdrawal by Subject|0|||
148960243|NCT04741074|537339188|FG001|Overall Study|Withdrawal by Subject|1|||
148960244|NCT04741074|537339187|FG000|Overall Study|Study terminated prematurely|1|||
148960245|NCT04741074|537339188|FG001|Overall Study|Study terminated prematurely|0|||
148960246|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Death|3|||
148960247|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Death|2|||
148960248|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Death|4|||
148960249|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Death|3|||
148960250|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Death|0|||
148960251|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Death|0|||
148960252|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
148960253|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
148960254|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
149023683|NCT04955626|537562673|FG034|Open-Label Period|Withdrawal by Subject|0|||
149023684|NCT04955626|537562674|FG035|Open-Label Period|Withdrawal by Subject|0|||
149023685|NCT04955626|537562639|FG000|Open-Label Period|Refused further study procedures|1|||
149023686|NCT04955626|537562640|FG001|Open-Label Period|Refused further study procedures|0|||
149023687|NCT04955626|537562641|FG002|Open-Label Period|Refused further study procedures|0|||
148960255|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
149023688|NCT04955626|537562642|FG003|Open-Label Period|Refused further study procedures|0|||
149023689|NCT04955626|537562643|FG004|Open-Label Period|Refused further study procedures|0|||
149023690|NCT04955626|537562644|FG005|Open-Label Period|Refused further study procedures|0|||
149023691|NCT04955626|537562645|FG006|Open-Label Period|Refused further study procedures|0|||
149023692|NCT04955626|537562646|FG007|Open-Label Period|Refused further study procedures|0|||
149023693|NCT04955626|537562647|FG008|Open-Label Period|Refused further study procedures|0|||
149023694|NCT04955626|537562648|FG009|Open-Label Period|Refused further study procedures|0|||
149023695|NCT04955626|537562649|FG010|Open-Label Period|Refused further study procedures|0|||
149023696|NCT04955626|537562650|FG011|Open-Label Period|Refused further study procedures|0|||
149023697|NCT04955626|537562651|FG012|Open-Label Period|Refused further study procedures|0|||
149023698|NCT04955626|537562652|FG013|Open-Label Period|Refused further study procedures|0|||
149023699|NCT04955626|537562653|FG014|Open-Label Period|Refused further study procedures|0|||
149023700|NCT04955626|537562654|FG015|Open-Label Period|Refused further study procedures|0|||
149023701|NCT04955626|537562655|FG016|Open-Label Period|Refused further study procedures|0|||
149023702|NCT04955626|537562656|FG017|Open-Label Period|Refused further study procedures|0|||
149023703|NCT04955626|537562657|FG018|Open-Label Period|Refused further study procedures|0|||
149023704|NCT04955626|537562658|FG019|Open-Label Period|Refused further study procedures|0|||
149023705|NCT04955626|537562659|FG020|Open-Label Period|Refused further study procedures|0|||
149023706|NCT04955626|537562660|FG021|Open-Label Period|Refused further study procedures|0|||
149023707|NCT04955626|537562661|FG022|Open-Label Period|Refused further study procedures|0|||
149023708|NCT04955626|537562662|FG023|Open-Label Period|Refused further study procedures|0|||
149023709|NCT04955626|537562663|FG024|Open-Label Period|Refused further study procedures|0|||
148960256|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
149023710|NCT04955626|537562664|FG025|Open-Label Period|Refused further study procedures|0|||
149023711|NCT04955626|537562665|FG026|Open-Label Period|Refused further study procedures|0|||
149023712|NCT04955626|537562666|FG027|Open-Label Period|Refused further study procedures|0|||
149023713|NCT04955626|537562667|FG028|Open-Label Period|Refused further study procedures|0|||
149023714|NCT04955626|537562668|FG029|Open-Label Period|Refused further study procedures|0|||
149023715|NCT04955626|537562669|FG030|Open-Label Period|Refused further study procedures|0|||
149023716|NCT04955626|537562670|FG031|Open-Label Period|Refused further study procedures|0|||
149023717|NCT04955626|537562671|FG032|Open-Label Period|Refused further study procedures|0|||
149023718|NCT04955626|537562672|FG033|Open-Label Period|Refused further study procedures|0|||
149023719|NCT04955626|537562673|FG034|Open-Label Period|Refused further study procedures|0|||
149023720|NCT04955626|537562674|FG035|Open-Label Period|Refused further study procedures|0|||
149023721|NCT04955626|537562639|FG000|Open-Label Period|Adverse Event|1|||
149023722|NCT04955626|537562640|FG001|Open-Label Period|Adverse Event|0|||
149023723|NCT04955626|537562641|FG002|Open-Label Period|Adverse Event|0|||
149023724|NCT04955626|537562642|FG003|Open-Label Period|Adverse Event|0|||
149023725|NCT04955626|537562643|FG004|Open-Label Period|Adverse Event|0|||
149023726|NCT04955626|537562644|FG005|Open-Label Period|Adverse Event|0|||
149023727|NCT04955626|537562645|FG006|Open-Label Period|Adverse Event|0|||
149023728|NCT04955626|537562646|FG007|Open-Label Period|Adverse Event|0|||
149023729|NCT04955626|537562647|FG008|Open-Label Period|Adverse Event|0|||
149023730|NCT04955626|537562648|FG009|Open-Label Period|Adverse Event|0|||
149023731|NCT04955626|537562649|FG010|Open-Label Period|Adverse Event|0|||
149023732|NCT04955626|537562650|FG011|Open-Label Period|Adverse Event|0|||
149023733|NCT04955626|537562651|FG012|Open-Label Period|Adverse Event|0|||
149023734|NCT04955626|537562652|FG013|Open-Label Period|Adverse Event|0|||
149023735|NCT04955626|537562653|FG014|Open-Label Period|Adverse Event|0|||
149023736|NCT04955626|537562654|FG015|Open-Label Period|Adverse Event|0|||
149023737|NCT04955626|537562655|FG016|Open-Label Period|Adverse Event|0|||
149023738|NCT04955626|537562656|FG017|Open-Label Period|Adverse Event|0|||
149023739|NCT04955626|537562657|FG018|Open-Label Period|Adverse Event|0|||
149023740|NCT04955626|537562658|FG019|Open-Label Period|Adverse Event|0|||
149023741|NCT04955626|537562659|FG020|Open-Label Period|Adverse Event|0|||
149023742|NCT04955626|537562660|FG021|Open-Label Period|Adverse Event|0|||
149023743|NCT04955626|537562661|FG022|Open-Label Period|Adverse Event|0|||
149023744|NCT04955626|537562662|FG023|Open-Label Period|Adverse Event|0|||
149023745|NCT04955626|537562663|FG024|Open-Label Period|Adverse Event|0|||
149023746|NCT04955626|537562664|FG025|Open-Label Period|Adverse Event|0|||
149023747|NCT04955626|537562665|FG026|Open-Label Period|Adverse Event|0|||
149023748|NCT04955626|537562666|FG027|Open-Label Period|Adverse Event|0|||
149023749|NCT04955626|537562667|FG028|Open-Label Period|Adverse Event|0|||
149023750|NCT04955626|537562668|FG029|Open-Label Period|Adverse Event|0|||
149023751|NCT04955626|537562669|FG030|Open-Label Period|Adverse Event|0|||
149023752|NCT04955626|537562670|FG031|Open-Label Period|Adverse Event|0|||
149023753|NCT04955626|537562671|FG032|Open-Label Period|Adverse Event|0|||
149023754|NCT04955626|537562672|FG033|Open-Label Period|Adverse Event|0|||
149023755|NCT04955626|537562673|FG034|Open-Label Period|Adverse Event|0|||
149023756|NCT04955626|537562674|FG035|Open-Label Period|Adverse Event|0|||
149023757|NCT04955626|537562639|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
149023758|NCT04955626|537562640|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
149023759|NCT04955626|537562641|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
149023760|NCT04955626|537562642|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
149023761|NCT04955626|537562643|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
149023762|NCT04955626|537562644|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
149023763|NCT04955626|537562645|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
149023764|NCT04955626|537562646|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
149023765|NCT04955626|537562647|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
149023766|NCT04955626|537562648|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
149023767|NCT04955626|537562649|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
149023768|NCT04955626|537562650|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
149023769|NCT04955626|537562651|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
149023770|NCT04955626|537562652|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
149023771|NCT04955626|537562653|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
149023772|NCT04955626|537562654|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
149023773|NCT04955626|537562655|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
149023774|NCT04955626|537562656|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
149023775|NCT04955626|537562657|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
149023776|NCT04955626|537562658|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
149023777|NCT04955626|537562659|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
149023778|NCT04955626|537562660|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
149023779|NCT04955626|537562661|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
149023780|NCT04955626|537562662|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
149023781|NCT04955626|537562663|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
149023782|NCT04955626|537562664|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
149023783|NCT04955626|537562665|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
149023784|NCT04955626|537562666|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
149023785|NCT04955626|537562667|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
149023786|NCT04955626|537562668|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
149023787|NCT04955626|537562669|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
149023788|NCT04955626|537562670|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
149023789|NCT04955626|537562671|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
149023790|NCT04955626|537562672|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
149023791|NCT04955626|537562673|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
149023792|NCT04955626|537562674|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
149023793|NCT04955626|537562639|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023794|NCT04955626|537562640|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
149023795|NCT04955626|537562641|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023796|NCT04955626|537562642|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023797|NCT04955626|537562643|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148692973|NCT01890915|536350305|FG001|Overall Study|Equipment Malfunction|1|||
148692974|NCT00424489|536350306|FG000|Overall Study|Death|3|||
148692975|NCT00536575|536350311|FG000|Overall Study|Withdrawal by Subject|1|||
148692976|NCT00536575|536350311|FG000|Overall Study|Death|1|||
148692977|NCT01089647|536350312|FG000|Overall Study|Lost to Follow-up|2|||
148692978|NCT01089647|536350313|FG001|Overall Study|Lost to Follow-up|2|||
148692979|NCT01089647|536350312|FG000|Overall Study|Withdrawal by Subject|2|||
148692980|NCT01089647|536350313|FG001|Overall Study|Withdrawal by Subject|1|||
148692981|NCT01089647|536350312|FG000|Overall Study|Adverse Event|0|||
148692982|NCT01089647|536350313|FG001|Overall Study|Adverse Event|1|||
148692983|NCT00198029|536350314|FG000|Overall Study|Withdrawal by Subject|4|||
148692984|NCT01626079|536350316|FG000|Overall Study|Death|167|||
148692985|NCT01626079|536350317|FG001|Overall Study|Death|192|||
148692986|NCT01626079|536350318|FG002|Overall Study|Death|39|||
148692987|NCT01626079|536350316|FG000|Overall Study|Withdrawal by Subject|23|||
148692988|NCT01626079|536350317|FG001|Overall Study|Withdrawal by Subject|37|||
148692989|NCT01626079|536350318|FG002|Overall Study|Withdrawal by Subject|5|||
148692990|NCT01626079|536350316|FG000|Overall Study|Lost to Follow-up|7|||
148692991|NCT01626079|536350317|FG001|Overall Study|Lost to Follow-up|4|||
148692992|NCT01626079|536350318|FG002|Overall Study|Lost to Follow-up|2|||
148692993|NCT01626079|536350316|FG000|Overall Study|Missed Visits|1|||
148692994|NCT01626079|536350317|FG001|Overall Study|Missed Visits|4|||
148692995|NCT01626079|536350318|FG002|Overall Study|Missed Visits|6|||
148692996|NCT01457053|536350319|FG000|Overall Study|Unable to undergo selected treatment|1|||
148692997|NCT01457053|536350320|FG001|Overall Study|Unable to undergo selected treatment|1|||
148692998|NCT02780687|536350322|FG000|Overall Study|Adverse Event|1|||
148692999|NCT02780687|536350323|FG001|Overall Study|Adverse Event|1|||
148693000|NCT02780687|536350322|FG000|Overall Study|Withdrawal by Subject|2|||
148693001|NCT02780687|536350323|FG001|Overall Study|Withdrawal by Subject|1|||
148693002|NCT02780687|536350322|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
148693003|NCT02780687|536350323|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
148693004|NCT02780687|536350322|FG000|Overall Study|progressive disease|29|||
148693005|NCT02780687|536350323|FG001|Overall Study|progressive disease|6|||
148693006|NCT02430870|536350324|FG000|Part 2|Voluntary Withdrawal|0|||
148693007|NCT02430870|536350325|FG001|Part 2|Voluntary Withdrawal|0|||
148693008|NCT02430870|536350326|FG002|Part 2|Voluntary Withdrawal|0|||
148693009|NCT02430870|536350327|FG003|Part 2|Voluntary Withdrawal|0|||
148693010|NCT02430870|536350328|FG004|Part 2|Voluntary Withdrawal|0|||
148693011|NCT02430870|536350329|FG005|Part 2|Voluntary Withdrawal|0|||
148693012|NCT02430870|536350330|FG006|Part 2|Voluntary Withdrawal|1|||
148693013|NCT02430870|536350331|FG007|Part 2|Voluntary Withdrawal|0|||
148693014|NCT02430870|536350324|FG000|Part 2|Other Reason Not Specified|0|||
148693015|NCT02430870|536350325|FG001|Part 2|Other Reason Not Specified|0|||
148693016|NCT02430870|536350326|FG002|Part 2|Other Reason Not Specified|0|||
149023798|NCT04955626|537562644|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148693017|NCT02430870|536350327|FG003|Part 2|Other Reason Not Specified|0|||
148693018|NCT02430870|536350328|FG004|Part 2|Other Reason Not Specified|0|||
148693019|NCT02430870|536350329|FG005|Part 2|Other Reason Not Specified|0|||
148693020|NCT02430870|536350330|FG006|Part 2|Other Reason Not Specified|0|||
148693021|NCT02430870|536350331|FG007|Part 2|Other Reason Not Specified|1|||
148693022|NCT03982433|536350332|FG000|Overall Study|Lost to Follow-up|1|||
148693023|NCT04257929|536350333|FG000|Overall Study|Adverse Event|1|||
148693024|NCT04257929|536350334|FG001|Overall Study|Adverse Event|0|||
148693025|NCT04257929|536350335|FG002|Overall Study|Adverse Event|1|||
148693026|NCT04257929|536350333|FG000|Overall Study|Withdrawal by Subject|1|||
148693027|NCT04257929|536350334|FG001|Overall Study|Withdrawal by Subject|0|||
148960257|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
148960258|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
148960259|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
148960260|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
148811810|NCT03765073|536787080|FG009|Stage 3|Other|0|||
148811811|NCT03765073|536787081|FG010|Stage 3|Other|0|||
148811812|NCT03765073|536787082|FG011|Stage 3|Other|0|||
148811813|NCT03765073|536787083|FG012|Stage 3|Other|0|||
148811814|NCT03765073|536787084|FG013|Stage 3|Other|0|||
148811815|NCT03765073|536787085|FG014|Stage 3|Other|0|||
148811816|NCT03765073|536787086|FG015|Stage 3|Other|0|||
148811817|NCT03765073|536787087|FG016|Stage 3|Other|0|||
148811818|NCT03765073|536787088|FG017|Stage 3|Other|1|||
148811819|NCT03765073|536787089|FG018|Stage 3|Other|2|||
148811820|NCT03765073|536787090|FG019|Stage 3|Other|2|||
148811821|NCT03765073|536787091|FG020|Stage 3|Other|2|||
148693028|NCT04257929|536350335|FG002|Overall Study|Withdrawal by Subject|0|||
148693029|NCT04257929|536350333|FG000|Overall Study|COVID-19|0|||
148693030|NCT04257929|536350334|FG001|Overall Study|COVID-19|1|||
148693031|NCT04257929|536350335|FG002|Overall Study|COVID-19|1|||
148693032|NCT04257929|536350333|FG000|Overall Study|Lost to Follow-up|0|||
148693033|NCT04257929|536350334|FG001|Overall Study|Lost to Follow-up|0|||
148693034|NCT04257929|536350335|FG002|Overall Study|Lost to Follow-up|1|||
148693035|NCT04333095|536350338|FG000|Overall Study|Protocol Violation|4|||
148693036|NCT04333095|536350339|FG001|Overall Study|Protocol Violation|0|||
148693037|NCT04333095|536350338|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
148811822|NCT03765073|536787071|FG000|Stage 3|Withdrawal by parent/guardian|0|||
148811823|NCT03765073|536787072|FG001|Stage 3|Withdrawal by parent/guardian|0|||
148960261|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
148960262|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
148693038|NCT04333095|536350339|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
148811824|NCT03765073|536787073|FG002|Stage 3|Withdrawal by parent/guardian|0|||
148693039|NCT04333095|536350338|FG000|Overall Study|Mini Sternotomy|4|||
148693040|NCT04333095|536350339|FG001|Overall Study|Mini Sternotomy|5|||
148960263|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
148960264|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
148960265|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
148960266|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
148960267|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
148811825|NCT03765073|536787074|FG003|Stage 3|Withdrawal by parent/guardian|0|||
148811826|NCT03765073|536787075|FG004|Stage 3|Withdrawal by parent/guardian|0|||
148811827|NCT03765073|536787076|FG005|Stage 3|Withdrawal by parent/guardian|0|||
148811828|NCT03765073|536787077|FG006|Stage 3|Withdrawal by parent/guardian|0|||
148811829|NCT03765073|536787078|FG007|Stage 3|Withdrawal by parent/guardian|0|||
148811830|NCT03765073|536787079|FG008|Stage 3|Withdrawal by parent/guardian|0|||
148811831|NCT03765073|536787080|FG009|Stage 3|Withdrawal by parent/guardian|0|||
148811832|NCT03765073|536787081|FG010|Stage 3|Withdrawal by parent/guardian|0|||
148811833|NCT03765073|536787082|FG011|Stage 3|Withdrawal by parent/guardian|0|||
148811834|NCT03765073|536787083|FG012|Stage 3|Withdrawal by parent/guardian|0|||
148811835|NCT03765073|536787084|FG013|Stage 3|Withdrawal by parent/guardian|0|||
149023799|NCT04955626|537562645|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148811836|NCT03765073|536787085|FG014|Stage 3|Withdrawal by parent/guardian|0|||
148811837|NCT03765073|536787086|FG015|Stage 3|Withdrawal by parent/guardian|0|||
148811838|NCT03765073|536787087|FG016|Stage 3|Withdrawal by parent/guardian|0|||
148811839|NCT03765073|536787088|FG017|Stage 3|Withdrawal by parent/guardian|0|||
148811840|NCT03765073|536787089|FG018|Stage 3|Withdrawal by parent/guardian|0|||
148811841|NCT03765073|536787090|FG019|Stage 3|Withdrawal by parent/guardian|6|||
148811842|NCT03765073|536787091|FG020|Stage 3|Withdrawal by parent/guardian|9|||
148811843|NCT03765073|536787071|FG000|Stage 3|Withdrawal by Subject|0|||
148811844|NCT03765073|536787072|FG001|Stage 3|Withdrawal by Subject|0|||
148811845|NCT03765073|536787073|FG002|Stage 3|Withdrawal by Subject|0|||
148811846|NCT03765073|536787074|FG003|Stage 3|Withdrawal by Subject|0|||
149023800|NCT04955626|537562646|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148811847|NCT03765073|536787075|FG004|Stage 3|Withdrawal by Subject|0|||
148811848|NCT03765073|536787076|FG005|Stage 3|Withdrawal by Subject|0|||
148811849|NCT03765073|536787077|FG006|Stage 3|Withdrawal by Subject|0|||
148811850|NCT03765073|536787078|FG007|Stage 3|Withdrawal by Subject|0|||
148811851|NCT03765073|536787079|FG008|Stage 3|Withdrawal by Subject|0|||
148811852|NCT03765073|536787080|FG009|Stage 3|Withdrawal by Subject|0|||
148811853|NCT03765073|536787081|FG010|Stage 3|Withdrawal by Subject|0|||
148811854|NCT03765073|536787082|FG011|Stage 3|Withdrawal by Subject|0|||
148811855|NCT03765073|536787083|FG012|Stage 3|Withdrawal by Subject|0|||
148960268|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
149023801|NCT04955626|537562647|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023802|NCT04955626|537562648|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023803|NCT04955626|537562649|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023804|NCT04955626|537562650|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148811856|NCT03765073|536787084|FG013|Stage 3|Withdrawal by Subject|0|||
148811857|NCT03765073|536787085|FG014|Stage 3|Withdrawal by Subject|0|||
148811858|NCT03765073|536787086|FG015|Stage 3|Withdrawal by Subject|0|||
148960269|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
148960270|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
148811859|NCT03765073|536787087|FG016|Stage 3|Withdrawal by Subject|0|||
148960271|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
148960272|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
148960273|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
148960274|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
148960275|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
148811860|NCT03765073|536787088|FG017|Stage 3|Withdrawal by Subject|8|||
148811861|NCT03765073|536787089|FG018|Stage 3|Withdrawal by Subject|11|||
148811862|NCT03765073|536787090|FG019|Stage 3|Withdrawal by Subject|0|||
148811863|NCT03765073|536787091|FG020|Stage 3|Withdrawal by Subject|0|||
148960276|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
148811864|NCT02550795|536787099|FG000|Overall Study|Physician Decision|0|||
148960277|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
148960278|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
148811865|NCT02550795|536787100|FG001|Overall Study|Physician Decision|1|||
148960279|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
148960280|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
148960281|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
148960282|NCT02432846|537339189|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
148960283|NCT02432846|537339190|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
148960284|NCT02432846|537339191|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
148960285|NCT02432846|537339192|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
148960286|NCT02432846|537339193|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
148960287|NCT02432846|537339194|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
148960288|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
148960289|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
148960290|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
148960291|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
148960292|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
148960293|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
148693041|NCT00984295|536350340|FG000|Overall Study|Lost to Follow-up|31|||
148960294|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
149023805|NCT04955626|537562651|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148693042|NCT00984295|536350341|FG001|Overall Study|Lost to Follow-up|12|||
148811866|NCT02550795|536787101|FG002|Overall Study|Physician Decision|0|||
148811867|NCT02802228|536787102|FG000|Overall Study|Withdrawal by Subject|2|||
148811868|NCT02802228|536787103|FG001|Overall Study|Withdrawal by Subject|0|||
148811869|NCT02802228|536787102|FG000|Overall Study|Lost to Follow-up|1|||
148811870|NCT02802228|536787103|FG001|Overall Study|Lost to Follow-up|0|||
148811871|NCT02802228|536787102|FG000|Overall Study|Adverse Event|1|||
148811872|NCT02802228|536787103|FG001|Overall Study|Adverse Event|0|||
148811873|NCT02802228|536787102|FG000|Overall Study|Physician Decision|1|||
148811874|NCT02802228|536787103|FG001|Overall Study|Physician Decision|0|||
148811875|NCT00695019|536787106|FG000|Overall Study|Withdrawal by Subject|8|||
148811876|NCT00695019|536787107|FG001|Overall Study|Withdrawal by Subject|6|||
148811877|NCT00695019|536787108|FG002|Overall Study|Withdrawal by Subject|4|||
148811878|NCT00695019|536787106|FG000|Overall Study|Protocol Violation|1|||
148811879|NCT00695019|536787107|FG001|Overall Study|Protocol Violation|3|||
148811880|NCT00695019|536787108|FG002|Overall Study|Protocol Violation|1|||
148811881|NCT00695019|536787106|FG000|Overall Study|Lack of Efficacy|0|||
148811882|NCT00695019|536787107|FG001|Overall Study|Lack of Efficacy|0|||
148811883|NCT00695019|536787108|FG002|Overall Study|Lack of Efficacy|1|||
148811884|NCT00695019|536787106|FG000|Overall Study|Various|4|||
148811885|NCT00695019|536787107|FG001|Overall Study|Various|5|||
148811886|NCT00695019|536787108|FG002|Overall Study|Various|4|||
148811887|NCT02225587|536787109|FG000|Overall Study|Adverse Event|5|||
148811888|NCT02225587|536787110|FG001|Overall Study|Adverse Event|5|||
148811889|NCT02225587|536787109|FG000|Overall Study|Lost to Follow-up|5|||
148811890|NCT02225587|536787110|FG001|Overall Study|Lost to Follow-up|5|||
148811891|NCT02225587|536787109|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148693043|NCT00984295|536350342|FG002|Overall Study|Lost to Follow-up|13|||
148693044|NCT00984295|536350340|FG000|Overall Study|Protocol Violation|2|||
148960295|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
148960296|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
148960297|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
148960298|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
148960299|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
148960300|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
148960301|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
148960302|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
148693045|NCT00984295|536350341|FG001|Overall Study|Protocol Violation|1|||
149023806|NCT04955626|537562652|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148693046|NCT00984295|536350342|FG002|Overall Study|Protocol Violation|4|||
149023807|NCT04955626|537562653|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148960303|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
148960304|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
148960305|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
148960306|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
149023808|NCT04955626|537562654|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023809|NCT04955626|537562655|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023810|NCT04955626|537562656|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023811|NCT04955626|537562657|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023812|NCT04955626|537562658|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023813|NCT04955626|537562659|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023814|NCT04955626|537562660|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
148960307|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
148960308|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
148960309|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
148960310|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
148693047|NCT00984295|536350340|FG000|Overall Study|Withdrawal by Subject|18|||
148693048|NCT00984295|536350341|FG001|Overall Study|Withdrawal by Subject|9|||
148693049|NCT00984295|536350342|FG002|Overall Study|Withdrawal by Subject|12|||
148693050|NCT00984295|536350340|FG000|Overall Study|CAE - discontinued test vaccine|0|||
148693051|NCT00984295|536350341|FG001|Overall Study|CAE - discontinued test vaccine|1|||
148693052|NCT00984295|536350342|FG002|Overall Study|CAE - discontinued test vaccine|3|||
148693053|NCT00984295|536350340|FG000|Overall Study|Missed one or more blood samplings|3|||
148693054|NCT00984295|536350341|FG001|Overall Study|Missed one or more blood samplings|7|||
148693055|NCT00984295|536350342|FG002|Overall Study|Missed one or more blood samplings|2|||
148693056|NCT00984295|536350340|FG000|Overall Study|Incomplete safety follow-up|11|||
148693057|NCT00984295|536350341|FG001|Overall Study|Incomplete safety follow-up|2|||
148693058|NCT00984295|536350342|FG002|Overall Study|Incomplete safety follow-up|3|||
148693059|NCT03740165|536350343|FG000|Overall Study|Death|232|||
148693060|NCT03740165|536350344|FG001|Overall Study|Death|242|||
148693061|NCT03740165|536350345|FG002|Overall Study|Death|229|||
148693062|NCT03740165|536350343|FG000|Overall Study|Lost to Follow-up|0|||
148693063|NCT03740165|536350344|FG001|Overall Study|Lost to Follow-up|0|||
148693064|NCT03740165|536350345|FG002|Overall Study|Lost to Follow-up|1|||
148693065|NCT03740165|536350343|FG000|Overall Study|Withdrawal by Subject|7|||
148960311|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
148960312|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
148960313|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
148960314|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
148960315|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
148960316|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
148960317|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
148960318|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
148960319|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
148960320|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
148960321|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
148960322|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
148960323|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
148960324|NCT02432846|537339189|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
148960325|NCT02432846|537339190|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
148960326|NCT02432846|537339191|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
148693066|NCT03740165|536350344|FG001|Overall Study|Withdrawal by Subject|4|||
148960327|NCT02432846|537339192|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
148960328|NCT02432846|537339193|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
148693067|NCT03740165|536350345|FG002|Overall Study|Withdrawal by Subject|3|||
148693068|NCT03740165|536350343|FG000|Overall Study|Ongoing in Study|216|||
148693069|NCT03740165|536350344|FG001|Overall Study|Ongoing in Study|212|||
148693070|NCT03740165|536350345|FG002|Overall Study|Ongoing in Study|221|||
148693071|NCT03049618|536350346|FG000|Overall Study|Death|1|||
148693072|NCT03049618|536350347|FG001|Overall Study|Death|0|||
148693073|NCT03049618|536350346|FG000|Overall Study|Lack of Efficacy|1|||
148693074|NCT03049618|536350347|FG001|Overall Study|Lack of Efficacy|2|||
148693075|NCT04582539|536350348|FG000|Overall Study|Death|1|||
148693076|NCT04582539|536350349|FG001|Overall Study|Death|1|||
148693077|NCT04582539|536350350|FG002|Overall Study|Death|0|||
148693078|NCT04582539|536350351|FG003|Overall Study|Death|1|||
148693079|NCT04582539|536350352|FG004|Overall Study|Death|0|||
148693080|NCT04582539|536350348|FG000|Overall Study|Lost to Follow-up|1|||
148693081|NCT04582539|536350349|FG001|Overall Study|Lost to Follow-up|0|||
148693082|NCT04582539|536350350|FG002|Overall Study|Lost to Follow-up|0|||
148960329|NCT02432846|537339194|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
148960330|NCT01912287|537339199|FG000|Overall Study|Ineligible|1|||
148960331|NCT01912287|537339200|FG001|Overall Study|Ineligible|0|||
148960332|NCT01912287|537339201|FG002|Overall Study|Ineligible|1|||
148960333|NCT01912287|537339199|FG000|Overall Study|No-show|0|||
148960334|NCT01912287|537339200|FG001|Overall Study|No-show|0|||
148960335|NCT01912287|537339201|FG002|Overall Study|No-show|1|||
148960336|NCT01912287|537339199|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
148960337|NCT01912287|537339200|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
148960338|NCT01912287|537339201|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
148960339|NCT01912287|537339199|FG000|Overall Study|Felt treatment no longer needed|0|||
148960340|NCT01912287|537339200|FG001|Overall Study|Felt treatment no longer needed|1|||
148960341|NCT01912287|537339201|FG002|Overall Study|Felt treatment no longer needed|0|||
148960342|NCT01912287|537339199|FG000|Overall Study|Life circumstances|4|||
148960343|NCT01912287|537339200|FG001|Overall Study|Life circumstances|2|||
148960344|NCT01912287|537339201|FG002|Overall Study|Life circumstances|0|||
148960345|NCT01912287|537339199|FG000|Overall Study|Lost Interest|1|||
148960346|NCT01912287|537339200|FG001|Overall Study|Lost Interest|0|||
148693083|NCT04582539|536350351|FG003|Overall Study|Lost to Follow-up|0|||
148693084|NCT04582539|536350352|FG004|Overall Study|Lost to Follow-up|0|||
148693085|NCT04582539|536350348|FG000|Overall Study|Study Terminated by Sponsor|1|||
148693086|NCT04582539|536350349|FG001|Overall Study|Study Terminated by Sponsor|3|||
148693087|NCT04582539|536350350|FG002|Overall Study|Study Terminated by Sponsor|2|||
148960347|NCT01912287|537339201|FG002|Overall Study|Lost Interest|0|||
148960348|NCT01912287|537339199|FG000|Overall Study|Uknown reason - subject drop out|5|||
148960349|NCT01912287|537339200|FG001|Overall Study|Uknown reason - subject drop out|7|||
148960350|NCT01912287|537339201|FG002|Overall Study|Uknown reason - subject drop out|3|||
148693088|NCT04582539|536350351|FG003|Overall Study|Study Terminated by Sponsor|2|||
148693089|NCT04582539|536350352|FG004|Overall Study|Study Terminated by Sponsor|3|||
148960351|NCT01912287|537339199|FG000|Overall Study|Missed Assesment|1|||
148960352|NCT01912287|537339200|FG001|Overall Study|Missed Assesment|1|||
148960353|NCT01912287|537339201|FG002|Overall Study|Missed Assesment|1|||
148960354|NCT01912287|537339199|FG000|Overall Study|Scheduling/change in availability|17|||
148960355|NCT01912287|537339200|FG001|Overall Study|Scheduling/change in availability|10|||
148960356|NCT01912287|537339201|FG002|Overall Study|Scheduling/change in availability|8|||
148960357|NCT03226392|537339202|FG000|Overall Study|Protocol Deviation|1|||
148960358|NCT03226392|537339203|FG001|Overall Study|Protocol Deviation|0|||
148960359|NCT03226392|537339202|FG000|Overall Study|Physician Decision|1|||
148960360|NCT03226392|537339203|FG001|Overall Study|Physician Decision|0|||
148960361|NCT03226392|537339202|FG000|Overall Study|Lost to Follow-up|1|||
148960362|NCT03226392|537339203|FG001|Overall Study|Lost to Follow-up|0|||
148960363|NCT03226392|537339202|FG000|Overall Study|Adverse Event|1|||
148960364|NCT03226392|537339203|FG001|Overall Study|Adverse Event|0|||
148960365|NCT03226392|537339202|FG000|Overall Study|Technical Problems|0|||
148960366|NCT03226392|537339203|FG001|Overall Study|Technical Problems|2|||
148693090|NCT04582539|536350348|FG000|Overall Study|Physician Decision|0|||
148693091|NCT04582539|536350349|FG001|Overall Study|Physician Decision|1|||
148960367|NCT03226392|537339202|FG000|Overall Study|Subject/Guardian Decision|7|||
148693092|NCT04582539|536350350|FG002|Overall Study|Physician Decision|0|||
148693093|NCT04582539|536350351|FG003|Overall Study|Physician Decision|0|||
149023815|NCT04955626|537562661|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023816|NCT04955626|537562662|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023817|NCT04955626|537562663|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023818|NCT04955626|537562664|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023819|NCT04955626|537562665|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023820|NCT04955626|537562666|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023821|NCT04955626|537562667|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023822|NCT04955626|537562668|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023823|NCT04955626|537562669|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023824|NCT04955626|537562670|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023825|NCT04955626|537562671|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023826|NCT04955626|537562672|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023827|NCT04955626|537562673|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023828|NCT04955626|537562674|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
149023829|NCT03873246|537562675|FG000|Overall Study|Adverse Event|1|||
148960368|NCT03226392|537339203|FG001|Overall Study|Subject/Guardian Decision|6|||
148960369|NCT00937157|537339204|FG000|Overall Study|Pregnancy|1|||
148960370|NCT00937157|537339204|FG000|Overall Study|Lost to Follow-up|3|||
148960371|NCT02278263|537339205|FG000|Overall Study|Protocol Violation|7|||
148960372|NCT02278263|537339206|FG001|Overall Study|Protocol Violation|0|||
148960373|NCT02278263|537339207|FG002|Overall Study|Protocol Violation|9|||
148960374|NCT01514760|537339209|FG000|Overall Study|Lost to Follow-up|2|||
148960375|NCT01132547|537339210|FG000|Overall Study|Withdrawal by Subject|3|||
148960376|NCT01132547|537339211|FG001|Overall Study|Withdrawal by Subject|1|||
148960377|NCT01132547|537339210|FG000|Overall Study|Death|1|||
149023830|NCT03873246|537562676|FG001|Overall Study|Adverse Event|3|||
149023831|NCT03873246|537562677|FG002|Overall Study|Adverse Event|3|||
149023832|NCT03873246|537562675|FG000|Overall Study|Lost to Follow-up|4|||
148960378|NCT01132547|537339211|FG001|Overall Study|Death|0|||
148960379|NCT02710045|537339212|FG000|Overall Study|Death|1|||
148960380|NCT02710045|537339213|FG001|Overall Study|Death|2|||
148960381|NCT02710045|537339214|FG002|Overall Study|Death|0|||
148811892|NCT02225587|536787110|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148960382|NCT02710045|537339212|FG000|Overall Study|Withdrawal by Subject|6|||
148960383|NCT02710045|537339213|FG001|Overall Study|Withdrawal by Subject|6|||
148960384|NCT02710045|537339214|FG002|Overall Study|Withdrawal by Subject|2|||
148960385|NCT02710045|537339212|FG000|Overall Study|Protocol Violation|1|||
148960386|NCT02710045|537339213|FG001|Overall Study|Protocol Violation|2|||
148811893|NCT02225587|536787109|FG000|Overall Study|Physician Decision|2|||
148960387|NCT02710045|537339214|FG002|Overall Study|Protocol Violation|3|||
148693094|NCT04582539|536350352|FG004|Overall Study|Physician Decision|0|||
148960388|NCT02710045|537339212|FG000|Overall Study|Lost to Follow-up|3|||
148811894|NCT02225587|536787110|FG001|Overall Study|Physician Decision|0|||
148811895|NCT02225587|536787109|FG000|Overall Study|Protocol Violation|1|||
148811896|NCT02225587|536787110|FG001|Overall Study|Protocol Violation|0|||
148960389|NCT02710045|537339213|FG001|Overall Study|Lost to Follow-up|6|||
148960390|NCT02710045|537339214|FG002|Overall Study|Lost to Follow-up|7|||
148960391|NCT02710045|537339212|FG000|Overall Study|Physician Decision|0|||
148811897|NCT02225587|536787109|FG000|Overall Study|Participant Moved|1|||
148811898|NCT02225587|536787110|FG001|Overall Study|Participant Moved|0|||
148811899|NCT02225587|536787109|FG000|Overall Study|Withdrawal by Subject|13|||
148811900|NCT02225587|536787110|FG001|Overall Study|Withdrawal by Subject|28|||
148811901|NCT04896385|536787111|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
148811902|NCT04896385|536787112|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
148960392|NCT02710045|537339213|FG001|Overall Study|Physician Decision|0|||
148693095|NCT04582539|536350348|FG000|Overall Study|Withdrawal by Subject|1|||
148693096|NCT04582539|536350349|FG001|Overall Study|Withdrawal by Subject|0|||
148693097|NCT04582539|536350350|FG002|Overall Study|Withdrawal by Subject|2|||
148693098|NCT04582539|536350351|FG003|Overall Study|Withdrawal by Subject|1|||
148960393|NCT02710045|537339214|FG002|Overall Study|Physician Decision|1|||
148811903|NCT04896385|536787113|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
148811904|NCT04896385|536787114|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
148960394|NCT02710045|537339212|FG000|Overall Study|Poor Attendance|0|||
148960395|NCT02710045|537339213|FG001|Overall Study|Poor Attendance|1|||
148960396|NCT02710045|537339214|FG002|Overall Study|Poor Attendance|0|||
148960397|NCT01275833|537339215|FG000|Overall Study|Study terminated|1|||
148960398|NCT01275833|537339216|FG001|Overall Study|Study terminated|1|||
148960399|NCT02118012|537339217|FG000|Overall Study|Adverse Event|0|||
148960400|NCT02118012|537339218|FG001|Overall Study|Adverse Event|1|||
148960401|NCT02118012|537339217|FG000|Overall Study|Physician Decision|0|||
148960402|NCT02118012|537339218|FG001|Overall Study|Physician Decision|1|||
148960403|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
148811905|NCT04896385|536787111|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
148811906|NCT04896385|536787112|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
148811907|NCT04896385|536787113|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
148811908|NCT04896385|536787114|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
148811909|NCT04896385|536787111|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
148811910|NCT04896385|536787112|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
148811911|NCT04896385|536787113|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
148811912|NCT04896385|536787114|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
148811913|NCT04896385|536787111|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
148811914|NCT04896385|536787112|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
148811915|NCT04896385|536787113|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
148811916|NCT04896385|536787114|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
148811917|NCT04896385|536787111|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
148811918|NCT04896385|536787112|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
148811919|NCT04896385|536787113|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
148811920|NCT04896385|536787114|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
148811921|NCT04896385|536787111|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
148811922|NCT04896385|536787112|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
148811923|NCT04896385|536787113|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
148811924|NCT04896385|536787114|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
148811925|NCT05291689|536787118|FG000|Overall Study|Adverse Event|3|||
148811926|NCT05291689|536787118|FG000|Overall Study|Lack of Efficacy|10|||
148811927|NCT05291689|536787118|FG000|Overall Study|Withdrawal by Subject|4|||
148811928|NCT02278354|536787119|FG000|Overall Study|Lost to Follow-up|2|||
148811929|NCT02278354|536787120|FG001|Overall Study|Lost to Follow-up|2|||
148811930|NCT02278354|536787119|FG000|Overall Study|Withdrawal by Subject|0|||
148811931|NCT02278354|536787120|FG001|Overall Study|Withdrawal by Subject|1|||
148811932|NCT02278354|536787119|FG000|Overall Study|<10 professional fights|2|||
148811933|NCT02278354|536787120|FG001|Overall Study|<10 professional fights|0|||
148811934|NCT02612155|536787122|FG000|Overall Study|Death|1|||
148811935|NCT02612155|536787123|FG001|Overall Study|Death|1|||
148811936|NCT02612155|536787122|FG000|Overall Study|Lost to Follow-up|2|||
148811937|NCT02612155|536787123|FG001|Overall Study|Lost to Follow-up|2|||
148811938|NCT03126110|536787130|FG000|Phase 1|Death|2|||
148811939|NCT03126110|536787131|FG001|Phase 1|Death|2|||
148811940|NCT03126110|536787132|FG002|Phase 1|Death|4|||
148811941|NCT03126110|536787133|FG003|Phase 1|Death|3|||
148811942|NCT03126110|536787134|FG004|Phase 1|Death|4|||
148811943|NCT03126110|536787135|FG005|Phase 1|Death|4|||
148811944|NCT03126110|536787136|FG006|Phase 1|Death|3|||
148811945|NCT03126110|536787137|FG007|Phase 1|Death|4|||
148811946|NCT03126110|536787138|FG008|Phase 1|Death|5|||
148811947|NCT03126110|536787139|FG009|Phase 1|Death|2|||
148811948|NCT03126110|536787140|FG010|Phase 1|Death|6|||
148811949|NCT03126110|536787141|FG011|Phase 1|Death|0|||
148811950|NCT03126110|536787142|FG012|Phase 1|Death|0|||
148811951|NCT03126110|536787143|FG013|Phase 1|Death|0|||
148960404|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
148960405|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
148960406|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
148960407|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
148960408|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
148960409|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
148960410|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
148960411|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
148960412|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
148960413|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
148960414|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
148960415|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
148960416|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
148960417|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
148960418|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
148960419|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
148811952|NCT03126110|536787144|FG014|Phase 1|Death|0|||
148811953|NCT03126110|536787145|FG015|Phase 1|Death|0|||
148960420|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
148960421|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
148960422|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
149023833|NCT03873246|537562676|FG001|Overall Study|Lost to Follow-up|4|||
148811954|NCT03126110|536787146|FG016|Phase 1|Death|0|||
148811955|NCT03126110|536787130|FG000|Phase 1|Lost to Follow-up|0|||
148811956|NCT03126110|536787131|FG001|Phase 1|Lost to Follow-up|1|||
148811957|NCT03126110|536787132|FG002|Phase 1|Lost to Follow-up|0|||
148811958|NCT03126110|536787133|FG003|Phase 1|Lost to Follow-up|0|||
148811959|NCT03126110|536787134|FG004|Phase 1|Lost to Follow-up|0|||
148811960|NCT03126110|536787135|FG005|Phase 1|Lost to Follow-up|0|||
148811961|NCT03126110|536787136|FG006|Phase 1|Lost to Follow-up|0|||
148811962|NCT03126110|536787137|FG007|Phase 1|Lost to Follow-up|0|||
148811963|NCT03126110|536787138|FG008|Phase 1|Lost to Follow-up|1|||
148811964|NCT03126110|536787139|FG009|Phase 1|Lost to Follow-up|0|||
148811965|NCT03126110|536787140|FG010|Phase 1|Lost to Follow-up|0|||
148960423|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
148960424|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
148960425|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
148960426|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
148960427|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
148960428|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
148960429|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
148960430|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
148960431|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
148960432|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
148960433|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
149023834|NCT03873246|537562677|FG002|Overall Study|Lost to Follow-up|5|||
148960434|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
148960435|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
148960436|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
148960437|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
148960438|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
148960439|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
148960440|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
148960441|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
148960442|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
148960443|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
148960444|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
148960445|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
148960446|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
148960447|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
148960448|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
148960449|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
148960450|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
148960451|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
148693099|NCT04582539|536350352|FG004|Overall Study|Withdrawal by Subject|0|||
148960452|NCT03742037|537339230|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
148960453|NCT03742037|537339231|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
148960454|NCT03742037|537339232|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
148960455|NCT03742037|537339233|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
148960456|NCT03742037|537339234|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
148960457|NCT03742037|537339235|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
148960458|NCT03742037|537339236|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
148960459|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
148960460|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
148960461|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
148960462|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
148811966|NCT03126110|536787141|FG011|Phase 1|Lost to Follow-up|0|||
148960463|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
148960464|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
148960465|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
148960466|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
148960467|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
149023835|NCT03873246|537562675|FG000|Overall Study|Protocol Violation|0|||
148693100|NCT04582539|536350348|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
148960468|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
148960469|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
148960470|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
148960471|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
148960472|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
148960473|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
148960474|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
148960475|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
148960476|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
148960477|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
148960478|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
148960479|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
148960480|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
148960481|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
148960482|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
148960483|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
148960484|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
148960485|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
148960486|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
148960487|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
148960488|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
148960489|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
148960490|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
148960491|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
148960492|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
148960493|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
148811967|NCT03126110|536787142|FG012|Phase 1|Lost to Follow-up|0|||
148811968|NCT03126110|536787143|FG013|Phase 1|Lost to Follow-up|0|||
148960494|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
148960495|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
148960496|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
148960497|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
148960498|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
148960499|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
148960500|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
148960501|NCT03742037|537339230|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
148960502|NCT03742037|537339231|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
148960503|NCT03742037|537339232|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
148960504|NCT03742037|537339233|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
148960505|NCT03742037|537339234|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
148960506|NCT03742037|537339235|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
148960507|NCT03742037|537339236|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
148960508|NCT04447755|537339237|FG000|Overall Study|Death|9|||
148960509|NCT04447755|537339238|FG001|Overall Study|Death|16|||
148960510|NCT04447755|537339239|FG002|Overall Study|Death|8|||
148960511|NCT04447755|537339240|FG003|Overall Study|Death|9|||
148960512|NCT04447755|537339241|FG004|Overall Study|Death|8|||
148960513|NCT04447755|537339242|FG005|Overall Study|Death|9|||
148960514|NCT04447755|537339243|FG006|Overall Study|Death|55|||
148960515|NCT04447755|537339237|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148960516|NCT04447755|537339238|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
148960517|NCT04447755|537339239|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
148960518|NCT04447755|537339240|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
148811969|NCT03126110|536787144|FG014|Phase 1|Lost to Follow-up|0|||
148693101|NCT04582539|536350349|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
148693102|NCT04582539|536350350|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
148693103|NCT04582539|536350351|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
148693104|NCT04582539|536350352|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
148693105|NCT00788957|536350361|FG000|Part 1|Death|8|||
148693106|NCT00788957|536350362|FG001|Part 1|Death|0|||
148693107|NCT00788957|536350363|FG002|Part 1|Death|0|||
148693108|NCT00788957|536350364|FG003|Part 1|Death|0|||
148811970|NCT03126110|536787145|FG015|Phase 1|Lost to Follow-up|0|||
148693109|NCT00788957|536350365|FG004|Part 1|Death|0|||
148693110|NCT00788957|536350366|FG005|Part 1|Death|0|||
148811971|NCT03126110|536787146|FG016|Phase 1|Lost to Follow-up|0|||
148693111|NCT00788957|536350361|FG000|Part 1|Lost to Follow-up|1|||
148693112|NCT00788957|536350362|FG001|Part 1|Lost to Follow-up|0|||
148693113|NCT00788957|536350363|FG002|Part 1|Lost to Follow-up|0|||
148693114|NCT00788957|536350364|FG003|Part 1|Lost to Follow-up|0|||
148693115|NCT00788957|536350365|FG004|Part 1|Lost to Follow-up|0|||
148693116|NCT00788957|536350366|FG005|Part 1|Lost to Follow-up|0|||
148693117|NCT00788957|536350361|FG000|Part 2|Withdrawal by Subject|0|||
148960519|NCT04447755|537339241|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
148960520|NCT04447755|537339242|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
148960521|NCT04447755|537339243|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
148960522|NCT04447755|537339237|FG000|Overall Study|Sponsor Decision|0|||
148960523|NCT04447755|537339238|FG001|Overall Study|Sponsor Decision|0|||
148960524|NCT04447755|537339239|FG002|Overall Study|Sponsor Decision|0|||
148960525|NCT04447755|537339240|FG003|Overall Study|Sponsor Decision|0|||
148960526|NCT04447755|537339241|FG004|Overall Study|Sponsor Decision|1|||
148960527|NCT04447755|537339242|FG005|Overall Study|Sponsor Decision|0|||
148960528|NCT04447755|537339243|FG006|Overall Study|Sponsor Decision|10|||
148960529|NCT04447755|537339237|FG000|Overall Study|Lost to Follow-up|0|||
148960530|NCT04447755|537339238|FG001|Overall Study|Lost to Follow-up|0|||
148960531|NCT04447755|537339239|FG002|Overall Study|Lost to Follow-up|0|||
148960532|NCT04447755|537339240|FG003|Overall Study|Lost to Follow-up|0|||
148960533|NCT04447755|537339241|FG004|Overall Study|Lost to Follow-up|0|||
148960534|NCT04447755|537339242|FG005|Overall Study|Lost to Follow-up|0|||
148960535|NCT04447755|537339243|FG006|Overall Study|Lost to Follow-up|1|||
149023836|NCT03873246|537562676|FG001|Overall Study|Protocol Violation|1|||
148693118|NCT00788957|536350362|FG001|Part 2|Withdrawal by Subject|9|||
148693119|NCT00788957|536350363|FG002|Part 2|Withdrawal by Subject|5|||
148693120|NCT00788957|536350364|FG003|Part 2|Withdrawal by Subject|3|||
148693121|NCT00788957|536350365|FG004|Part 2|Withdrawal by Subject|0|||
148693122|NCT00788957|536350366|FG005|Part 2|Withdrawal by Subject|0|||
148693123|NCT00788957|536350361|FG000|Part 2|Death|0|||
148693124|NCT00788957|536350362|FG001|Part 2|Death|32|||
148693125|NCT00788957|536350363|FG002|Part 2|Death|35|||
148693126|NCT00788957|536350364|FG003|Part 2|Death|37|||
148960536|NCT03424265|537339246|FG000|Overall Study|screening failure|1|||
148960537|NCT03424265|537339247|FG001|Overall Study|screening failure|0|||
148960538|NCT03424265|537339246|FG000|Overall Study|Withdrawal by Subject|0|||
148960539|NCT03424265|537339247|FG001|Overall Study|Withdrawal by Subject|2|||
148693127|NCT00788957|536350365|FG004|Part 2|Death|0|||
148693128|NCT00788957|536350366|FG005|Part 2|Death|0|||
148693129|NCT00788957|536350361|FG000|Part 2|Lost to Follow-up|0|||
148693130|NCT00788957|536350362|FG001|Part 2|Lost to Follow-up|0|||
148811972|NCT03126110|536787130|FG000|Phase 1|Withdrawal by Subject|1|||
148693131|NCT00788957|536350363|FG002|Part 2|Lost to Follow-up|3|||
148811973|NCT03126110|536787131|FG001|Phase 1|Withdrawal by Subject|0|||
148811974|NCT03126110|536787132|FG002|Phase 1|Withdrawal by Subject|0|||
148960540|NCT03051607|537339251|FG000|Overall Study|Adverse Event|66|||
148960541|NCT03338855|537339253|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
148693132|NCT00788957|536350364|FG003|Part 2|Lost to Follow-up|0|||
148693133|NCT00788957|536350365|FG004|Part 2|Lost to Follow-up|0|||
148960542|NCT03338855|537339254|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
148693134|NCT00788957|536350366|FG005|Part 2|Lost to Follow-up|0|||
148811975|NCT03126110|536787133|FG003|Phase 1|Withdrawal by Subject|1|||
148693135|NCT00788957|536350361|FG000|Part 2|On-study at time of data cut-off|0|||
148693136|NCT00788957|536350362|FG001|Part 2|On-study at time of data cut-off|1|||
148693137|NCT00788957|536350363|FG002|Part 2|On-study at time of data cut-off|1|||
148693138|NCT00788957|536350364|FG003|Part 2|On-study at time of data cut-off|1|||
148811976|NCT03126110|536787134|FG004|Phase 1|Withdrawal by Subject|1|||
148693139|NCT00788957|536350365|FG004|Part 2|On-study at time of data cut-off|0|||
148693140|NCT00788957|536350366|FG005|Part 2|On-study at time of data cut-off|0|||
148693141|NCT00788957|536350361|FG000|Part 3|Withdrawal by Subject|0|||
148693142|NCT00788957|536350362|FG001|Part 3|Withdrawal by Subject|0|||
148693143|NCT00788957|536350363|FG002|Part 3|Withdrawal by Subject|0|||
148693144|NCT00788957|536350364|FG003|Part 3|Withdrawal by Subject|0|||
149023837|NCT03873246|537562677|FG002|Overall Study|Protocol Violation|0|||
149023838|NCT03873246|537562675|FG000|Overall Study|Withdrawal by Subject|0|||
148693145|NCT00788957|536350365|FG004|Part 3|Withdrawal by Subject|0|||
148693146|NCT00788957|536350366|FG005|Part 3|Withdrawal by Subject|2|||
149023839|NCT03873246|537562676|FG001|Overall Study|Withdrawal by Subject|4|||
149023840|NCT03873246|537562677|FG002|Overall Study|Withdrawal by Subject|1|||
148960543|NCT02738450|537339255|FG000|Overall Study|Withdrawal by Subject|0|||
148960544|NCT02738450|537339256|FG001|Overall Study|Withdrawal by Subject|2|||
148693147|NCT00788957|536350361|FG000|Part 3|Death|0|||
148693148|NCT00788957|536350362|FG001|Part 3|Death|0|||
148811977|NCT03126110|536787135|FG005|Phase 1|Withdrawal by Subject|0|||
148811978|NCT03126110|536787136|FG006|Phase 1|Withdrawal by Subject|0|||
148811979|NCT03126110|536787137|FG007|Phase 1|Withdrawal by Subject|0|||
148811980|NCT03126110|536787138|FG008|Phase 1|Withdrawal by Subject|2|||
148811981|NCT03126110|536787139|FG009|Phase 1|Withdrawal by Subject|1|||
148811982|NCT03126110|536787140|FG010|Phase 1|Withdrawal by Subject|0|||
148811983|NCT03126110|536787141|FG011|Phase 1|Withdrawal by Subject|0|||
148811984|NCT03126110|536787142|FG012|Phase 1|Withdrawal by Subject|0|||
148811985|NCT03126110|536787143|FG013|Phase 1|Withdrawal by Subject|0|||
148811986|NCT03126110|536787144|FG014|Phase 1|Withdrawal by Subject|0|||
148811987|NCT03126110|536787145|FG015|Phase 1|Withdrawal by Subject|0|||
148811988|NCT03126110|536787146|FG016|Phase 1|Withdrawal by Subject|0|||
148811989|NCT03126110|536787130|FG000|Phase 1|Safety follow-up no longer necessary|1|||
148811990|NCT03126110|536787131|FG001|Phase 1|Safety follow-up no longer necessary|0|||
148811991|NCT03126110|536787132|FG002|Phase 1|Safety follow-up no longer necessary|0|||
148811992|NCT03126110|536787133|FG003|Phase 1|Safety follow-up no longer necessary|0|||
148811993|NCT03126110|536787134|FG004|Phase 1|Safety follow-up no longer necessary|0|||
148811994|NCT03126110|536787135|FG005|Phase 1|Safety follow-up no longer necessary|0|||
148811995|NCT03126110|536787136|FG006|Phase 1|Safety follow-up no longer necessary|0|||
148811996|NCT03126110|536787137|FG007|Phase 1|Safety follow-up no longer necessary|0|||
148811997|NCT03126110|536787138|FG008|Phase 1|Safety follow-up no longer necessary|0|||
148811998|NCT03126110|536787139|FG009|Phase 1|Safety follow-up no longer necessary|0|||
148811999|NCT03126110|536787140|FG010|Phase 1|Safety follow-up no longer necessary|0|||
148812000|NCT03126110|536787141|FG011|Phase 1|Safety follow-up no longer necessary|0|||
148812001|NCT03126110|536787142|FG012|Phase 1|Safety follow-up no longer necessary|0|||
148812002|NCT03126110|536787143|FG013|Phase 1|Safety follow-up no longer necessary|0|||
148812003|NCT03126110|536787144|FG014|Phase 1|Safety follow-up no longer necessary|0|||
148812004|NCT03126110|536787145|FG015|Phase 1|Safety follow-up no longer necessary|0|||
148812005|NCT03126110|536787146|FG016|Phase 1|Safety follow-up no longer necessary|0|||
148812006|NCT03126110|536787130|FG000|Phase 1|Survival follow-up no longer necessary|0|||
148812007|NCT03126110|536787131|FG001|Phase 1|Survival follow-up no longer necessary|0|||
148812008|NCT03126110|536787132|FG002|Phase 1|Survival follow-up no longer necessary|1|||
148812009|NCT03126110|536787133|FG003|Phase 1|Survival follow-up no longer necessary|0|||
148812010|NCT03126110|536787134|FG004|Phase 1|Survival follow-up no longer necessary|0|||
148812011|NCT03126110|536787135|FG005|Phase 1|Survival follow-up no longer necessary|0|||
148812012|NCT03126110|536787136|FG006|Phase 1|Survival follow-up no longer necessary|0|||
148812013|NCT03126110|536787137|FG007|Phase 1|Survival follow-up no longer necessary|0|||
148812014|NCT03126110|536787138|FG008|Phase 1|Survival follow-up no longer necessary|0|||
149023841|NCT01857323|537562678|FG000|Overall Study|Adverse Event|1|||
148812015|NCT03126110|536787139|FG009|Phase 1|Survival follow-up no longer necessary|0|||
148960545|NCT02738450|537339257|FG002|Overall Study|Withdrawal by Subject|0|||
148960546|NCT03251079|537339259|FG000|Overall Study|Withdrawal by Subject|1|||
148960547|NCT01387347|537339260|FG000|Overall Study|Lost to Follow-up|2|||
148960548|NCT01387347|537339261|FG001|Overall Study|Lost to Follow-up|1|||
148960549|NCT00423150|537339270|FG000|Overall Study|Adverse Event|11|||
148812016|NCT03126110|536787140|FG010|Phase 1|Survival follow-up no longer necessary|0|||
148960550|NCT00423150|537339270|FG000|Overall Study|Progression of disease being studied|69|||
148960551|NCT00423150|537339270|FG000|Overall Study|Withdrawal by Subject|1|||
148960552|NCT00423150|537339270|FG000|Overall Study|Non-compliance with protocol|1|||
148960553|NCT00423150|537339270|FG000|Overall Study|Administrative|4|||
148960554|NCT02335099|537339271|FG000|Treatment|Withdrawal by Subject|1|||
148960555|NCT02335099|537339272|FG001|Treatment|Withdrawal by Subject|3|||
148960556|NCT02335099|537339271|FG000|Treatment|Lost to Follow-up|2|||
148960557|NCT02335099|537339272|FG001|Treatment|Lost to Follow-up|0|||
149023842|NCT01857323|537562678|FG000|Overall Study|Withdrawal by Subject|3|||
149023843|NCT01857323|537562678|FG000|Overall Study|Non-compliance|1|||
148693149|NCT00788957|536350363|FG002|Part 3|Death|0|||
148693150|NCT00788957|536350364|FG003|Part 3|Death|0|||
148693151|NCT00788957|536350365|FG004|Part 3|Death|8|||
148693152|NCT00788957|536350366|FG005|Part 3|Death|8|||
148812017|NCT03126110|536787141|FG011|Phase 1|Survival follow-up no longer necessary|0|||
149023844|NCT01857323|537562678|FG000|Overall Study|Protocol Violation|6|||
148812018|NCT03126110|536787142|FG012|Phase 1|Survival follow-up no longer necessary|0|||
149023845|NCT01857323|537562678|FG000|Overall Study|Lost to Follow-up|1|||
149023846|NCT01857323|537562678|FG000|Overall Study|Other|4|||
149023847|NCT01857323|537562678|FG000|Overall Study|Did not complete 180 doses|48|||
149023848|NCT04209790|537562679|FG000|Overall Study|Physician Decision|1|||
149023849|NCT04060680|537562681|FG000|Overall Study|Unsuccessful implant|17|||
149023850|NCT04060680|537562682|FG001|Overall Study|Unsuccessful implant|2|||
149023851|NCT04060680|537562681|FG000|Overall Study|Adverse Event|3|||
149023852|NCT04060680|537562682|FG001|Overall Study|Adverse Event|0|||
149023853|NCT04060680|537562681|FG000|Overall Study|Death|2|||
149023854|NCT04060680|537562682|FG001|Overall Study|Death|0|||
149023855|NCT04060680|537562681|FG000|Overall Study|Study product no longer in use|1|||
149023856|NCT04060680|537562682|FG001|Overall Study|Study product no longer in use|0|||
149023857|NCT04060680|537562681|FG000|Overall Study|Withdrawal by Subject|1|||
149023858|NCT04060680|537562682|FG001|Overall Study|Withdrawal by Subject|0|||
149023859|NCT05617040|537562683|FG000|Overall Study|Adverse Event|0|||
149023860|NCT05617040|537562684|FG001|Overall Study|Adverse Event|1|||
149023861|NCT05617040|537562685|FG002|Overall Study|Adverse Event|0|||
149023862|NCT05617040|537562683|FG000|Overall Study|Death|0|||
149023863|NCT05617040|537562684|FG001|Overall Study|Death|0|||
148812019|NCT03126110|536787143|FG013|Phase 1|Survival follow-up no longer necessary|0|||
149023864|NCT05617040|537562685|FG002|Overall Study|Death|1|||
148812020|NCT03126110|536787144|FG014|Phase 1|Survival follow-up no longer necessary|0|||
148812021|NCT03126110|536787145|FG015|Phase 1|Survival follow-up no longer necessary|0|||
148812022|NCT03126110|536787146|FG016|Phase 1|Survival follow-up no longer necessary|0|||
148812023|NCT03126110|536787130|FG000|Phase 2|Study terminated by the sponsor|0|||
148812024|NCT03126110|536787131|FG001|Phase 2|Study terminated by the sponsor|0|||
148812025|NCT03126110|536787132|FG002|Phase 2|Study terminated by the sponsor|0|||
149023865|NCT02711826|537562686|FG000|Overall Study|Physician Decision|0|||
149023866|NCT02711826|537562687|FG001|Overall Study|Physician Decision|0|||
149023867|NCT02711826|537562688|FG002|Overall Study|Physician Decision|0|||
149023868|NCT02711826|537562689|FG003|Overall Study|Physician Decision|1|||
149023869|NCT02711826|537562690|FG004|Overall Study|Physician Decision|0|||
148960558|NCT02335099|537339271|FG000|Treatment|Death|1|||
148960559|NCT02335099|537339272|FG001|Treatment|Death|0|||
148960560|NCT02335099|537339271|FG000|Treatment|Adverse Event|1|||
148960561|NCT02335099|537339272|FG001|Treatment|Adverse Event|2|||
148960562|NCT02335099|537339271|FG000|Follow-up|Death|0|||
148960563|NCT02335099|537339272|FG001|Follow-up|Death|1|||
148960564|NCT01641692|537339275|FG000|Treatment Period 1|Adverse Event|1|||
148960565|NCT01641692|537339276|FG001|Treatment Period 1|Adverse Event|0|||
148960566|NCT01641692|537339277|FG002|Treatment Period 1|Adverse Event|0|||
148960567|NCT01641692|537339278|FG003|Treatment Period 1|Adverse Event|0|||
148960568|NCT01641692|537339279|FG004|Treatment Period 1|Adverse Event|0|||
148960569|NCT01641692|537339280|FG005|Treatment Period 1|Adverse Event|0|||
149023870|NCT02711826|537562686|FG000|Overall Study|Withdrawal by Subject|0|||
149023871|NCT02711826|537562687|FG001|Overall Study|Withdrawal by Subject|1|||
149023872|NCT02711826|537562688|FG002|Overall Study|Withdrawal by Subject|0|||
148960570|NCT01641692|537339281|FG006|Treatment Period 1|Adverse Event|0|||
148960571|NCT01641692|537339282|FG007|Treatment Period 1|Adverse Event|0|||
148960572|NCT01641692|537339275|FG000|Treatment Period 1|Lack of Efficacy|0|||
148960573|NCT01641692|537339276|FG001|Treatment Period 1|Lack of Efficacy|0|||
148960574|NCT01641692|537339277|FG002|Treatment Period 1|Lack of Efficacy|0|||
148960575|NCT01641692|537339278|FG003|Treatment Period 1|Lack of Efficacy|0|||
148960576|NCT01641692|537339279|FG004|Treatment Period 1|Lack of Efficacy|0|||
148960577|NCT01641692|537339280|FG005|Treatment Period 1|Lack of Efficacy|0|||
148960578|NCT01641692|537339281|FG006|Treatment Period 1|Lack of Efficacy|0|||
148960579|NCT01641692|537339282|FG007|Treatment Period 1|Lack of Efficacy|1|||
148960580|NCT01641692|537339275|FG000|Treatment Period 1|Protocol Violation|1|||
148693153|NCT00788957|536350361|FG000|Part 3|On-study at time of data cut-off|0|||
148693154|NCT00788957|536350362|FG001|Part 3|On-study at time of data cut-off|0|||
148693155|NCT00788957|536350363|FG002|Part 3|On-study at time of data cut-off|0|||
148693156|NCT00788957|536350364|FG003|Part 3|On-study at time of data cut-off|0|||
148960581|NCT01641692|537339276|FG001|Treatment Period 1|Protocol Violation|0|||
148693157|NCT00788957|536350365|FG004|Part 3|On-study at time of data cut-off|1|||
148960582|NCT01641692|537339277|FG002|Treatment Period 1|Protocol Violation|0|||
148960583|NCT01641692|537339278|FG003|Treatment Period 1|Protocol Violation|0|||
148960584|NCT01641692|537339279|FG004|Treatment Period 1|Protocol Violation|2|||
148960585|NCT01641692|537339280|FG005|Treatment Period 1|Protocol Violation|0|||
148960586|NCT01641692|537339281|FG006|Treatment Period 1|Protocol Violation|0|||
148960587|NCT01641692|537339282|FG007|Treatment Period 1|Protocol Violation|0|||
148960588|NCT01641692|537339275|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
148960589|NCT01641692|537339276|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
148960590|NCT01641692|537339277|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
148693158|NCT00788957|536350366|FG005|Part 3|On-study at time of data cut-off|0|||
148693159|NCT02579096|536350369|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
148693160|NCT02579096|536350370|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
148693161|NCT02579096|536350369|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
148693162|NCT02579096|536350370|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
148693163|NCT02579096|536350369|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
148693164|NCT02579096|536350370|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
148693165|NCT02579096|536350369|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
148693166|NCT02579096|536350370|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
148693167|NCT02579096|536350369|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
148693168|NCT02579096|536350370|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
148693169|NCT02579096|536350369|FG000|Phase 2, Weeks 25 - 48|Death|2|||
148693170|NCT02579096|536350370|FG001|Phase 2, Weeks 25 - 48|Death|4|||
148960591|NCT01641692|537339278|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
148960592|NCT01641692|537339279|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
148693171|NCT02579096|536350369|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
148693172|NCT02579096|536350370|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
148693173|NCT02579096|536350369|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
148960593|NCT01641692|537339280|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
149023873|NCT02711826|537562689|FG003|Overall Study|Withdrawal by Subject|4|||
148960594|NCT01641692|537339281|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
148960595|NCT01641692|537339282|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
148960596|NCT01641692|537339275|FG000|Treatment Period 1|Lost to Follow-up|0|||
148960597|NCT01641692|537339276|FG001|Treatment Period 1|Lost to Follow-up|0|||
148960598|NCT01641692|537339277|FG002|Treatment Period 1|Lost to Follow-up|1|||
148693174|NCT02579096|536350370|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
148693175|NCT02579096|536350369|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
148693176|NCT02579096|536350370|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
148693177|NCT02579096|536350369|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
148693178|NCT02579096|536350370|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
148693179|NCT02579096|536350369|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
148693180|NCT02579096|536350370|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
148693181|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Death|3|||
148693182|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Death|2|||
148693183|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
148693184|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
148693185|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
148693186|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
148693187|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
148693188|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
148693189|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
148693190|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
148693191|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
148693192|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
148693193|NCT02579096|536350369|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
148693194|NCT02579096|536350370|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
148693195|NCT02097121|536350371|FG000|Overall Study|Other, not specified|4|||
148693196|NCT02097121|536350372|FG001|Overall Study|Other, not specified|2|||
148693197|NCT02097121|536350373|FG002|Overall Study|Other, not specified|3|||
148693198|NCT02097121|536350371|FG000|Overall Study|Lack of Efficacy|2|||
148693199|NCT02097121|536350372|FG001|Overall Study|Lack of Efficacy|1|||
148693200|NCT02097121|536350373|FG002|Overall Study|Lack of Efficacy|3|||
148693201|NCT02097121|536350371|FG000|Overall Study|Withdrawal by Subject|0|||
148693202|NCT02097121|536350372|FG001|Overall Study|Withdrawal by Subject|1|||
148693203|NCT02097121|536350373|FG002|Overall Study|Withdrawal by Subject|2|||
148693204|NCT02097121|536350371|FG000|Overall Study|Adverse Event|0|||
148693205|NCT02097121|536350372|FG001|Overall Study|Adverse Event|1|||
148693206|NCT02097121|536350373|FG002|Overall Study|Adverse Event|0|||
148693207|NCT02097121|536350371|FG000|Overall Study|Lost to Follow-up|1|||
148693208|NCT02097121|536350372|FG001|Overall Study|Lost to Follow-up|1|||
148693209|NCT02097121|536350373|FG002|Overall Study|Lost to Follow-up|2|||
148693210|NCT03968224|536350374|FG000|Overall Study|Lost to Follow-up|11|||
148693211|NCT03968224|536350375|FG001|Overall Study|Lost to Follow-up|18|||
148693212|NCT05665595|536352169|FG000|Overall Study|Ongoing|692|||
148693213|NCT05665595|536352170|FG001|Overall Study|Ongoing|698|||
148693214|NCT05665595|536352169|FG000|Overall Study|Withdrawal by Subject|2|||
148693215|NCT05665595|536352170|FG001|Overall Study|Withdrawal by Subject|2|||
148693216|NCT05665595|536352169|FG000|Overall Study|Lost to Follow-up|1|||
148693217|NCT05665595|536352170|FG001|Overall Study|Lost to Follow-up|0|||
148693218|NCT05665595|536352169|FG000|Overall Study|Death|6|||
148693219|NCT05665595|536352170|FG001|Overall Study|Death|1|||
148693220|NCT05771428|536352171|FG000|Overall Study|Adverse Event|0|||
148693221|NCT05771428|536352172|FG001|Overall Study|Adverse Event|1|||
148693222|NCT05771428|536352173|FG002|Overall Study|Adverse Event|1|||
148693223|NCT05771428|536352174|FG003|Overall Study|Adverse Event|1|||
148693224|NCT05771428|536352171|FG000|Overall Study|Withdrawal by Subject|3|||
148693225|NCT05771428|536352172|FG001|Overall Study|Withdrawal by Subject|2|||
148693226|NCT05771428|536352173|FG002|Overall Study|Withdrawal by Subject|1|||
148960599|NCT01641692|537339278|FG003|Treatment Period 1|Lost to Follow-up|0|||
148960600|NCT01641692|537339279|FG004|Treatment Period 1|Lost to Follow-up|0|||
148693227|NCT05771428|536352174|FG003|Overall Study|Withdrawal by Subject|4|||
148960601|NCT01641692|537339280|FG005|Treatment Period 1|Lost to Follow-up|0|||
148960602|NCT01641692|537339281|FG006|Treatment Period 1|Lost to Follow-up|0|||
148693228|NCT05771428|536352171|FG000|Overall Study|Other|0|||
148693229|NCT05771428|536352172|FG001|Overall Study|Other|1|||
148693230|NCT05771428|536352173|FG002|Overall Study|Other|2|||
148693231|NCT05771428|536352174|FG003|Overall Study|Other|1|||
148693232|NCT05771428|536352171|FG000|Overall Study|Randomized but Not Treated|0|||
148693233|NCT05771428|536352172|FG001|Overall Study|Randomized but Not Treated|0|||
148693234|NCT05771428|536352173|FG002|Overall Study|Randomized but Not Treated|1|||
149023874|NCT02711826|537562690|FG004|Overall Study|Withdrawal by Subject|0|||
149023875|NCT02711826|537562686|FG000|Overall Study|Failure to manufacture cellular product|0|||
149023876|NCT02711826|537562687|FG001|Overall Study|Failure to manufacture cellular product|0|||
148960603|NCT01641692|537339282|FG007|Treatment Period 1|Lost to Follow-up|0|||
148960604|NCT01641692|537339275|FG000|Treatment Period 1|Physician Decision|0|||
148960605|NCT01641692|537339276|FG001|Treatment Period 1|Physician Decision|0|||
148693235|NCT05771428|536352174|FG003|Overall Study|Randomized but Not Treated|0|||
148960606|NCT01641692|537339277|FG002|Treatment Period 1|Physician Decision|0|||
148960607|NCT01641692|537339278|FG003|Treatment Period 1|Physician Decision|0|||
148693236|NCT04025229|536352175|FG000|Overall Study|Adverse Event|1|||
148693237|NCT04025229|536352176|FG001|Overall Study|Adverse Event|0|||
148693238|NCT04025229|536352175|FG000|Overall Study|Withdrawal by Subject|0|||
148960608|NCT01641692|537339279|FG004|Treatment Period 1|Physician Decision|1|||
148960609|NCT01641692|537339280|FG005|Treatment Period 1|Physician Decision|0|||
148960610|NCT01641692|537339281|FG006|Treatment Period 1|Physician Decision|0|||
148960611|NCT01641692|537339282|FG007|Treatment Period 1|Physician Decision|0|||
148960612|NCT01641692|537339275|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148960613|NCT01641692|537339276|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148960614|NCT01641692|537339277|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148960615|NCT01641692|537339278|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148960616|NCT01641692|537339279|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148960617|NCT01641692|537339280|FG005|Treatment Period 1|Withdrawal by Subject|2|||
148960618|NCT01641692|537339281|FG006|Treatment Period 1|Withdrawal by Subject|0|||
148960619|NCT01641692|537339282|FG007|Treatment Period 1|Withdrawal by Subject|1|||
148960620|NCT01641692|537339275|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
148960621|NCT01641692|537339276|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960622|NCT01641692|537339277|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960623|NCT01641692|537339278|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960624|NCT01641692|537339279|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960625|NCT01641692|537339280|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960626|NCT01641692|537339281|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960627|NCT01641692|537339282|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
148960628|NCT01641692|537339275|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960629|NCT01641692|537339276|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960630|NCT01641692|537339277|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960631|NCT01641692|537339278|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960632|NCT01641692|537339279|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960633|NCT01641692|537339280|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960634|NCT01641692|537339281|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
148960635|NCT01641692|537339282|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148960636|NCT01641692|537339275|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
148960637|NCT01641692|537339276|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960638|NCT01641692|537339277|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
148960639|NCT01641692|537339278|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
148960640|NCT01641692|537339279|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
148960641|NCT01641692|537339280|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960642|NCT01641692|537339281|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960643|NCT01641692|537339282|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
148960644|NCT01641692|537339275|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
148960645|NCT01641692|537339276|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
148960646|NCT01641692|537339277|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148960647|NCT01641692|537339278|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
148960648|NCT01641692|537339279|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
148960649|NCT01641692|537339280|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148693239|NCT04025229|536352176|FG001|Overall Study|Withdrawal by Subject|2|||
148693240|NCT04025229|536352175|FG000|Overall Study|Death|0|||
148693241|NCT04025229|536352176|FG001|Overall Study|Death|1|||
148693242|NCT04025229|536352175|FG000|Overall Study|Physician Decision|0|||
148693243|NCT04025229|536352176|FG001|Overall Study|Physician Decision|1|||
148693244|NCT02207231|536352177|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
148693245|NCT02207231|536352178|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
148693246|NCT02207231|536352179|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
148693247|NCT02207231|536352180|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
148693248|NCT02207231|536352177|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
148693249|NCT02207231|536352178|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
148693250|NCT02207231|536352179|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
148693251|NCT02207231|536352180|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
148812026|NCT03126110|536787133|FG003|Phase 2|Study terminated by the sponsor|0|||
148812027|NCT03126110|536787134|FG004|Phase 2|Study terminated by the sponsor|0|||
148693252|NCT02207231|536352177|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
148960650|NCT01641692|537339281|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
148693253|NCT02207231|536352178|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
148693254|NCT02207231|536352179|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
148693255|NCT02207231|536352180|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
148693256|NCT02207231|536352177|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
148693257|NCT02207231|536352178|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
148693258|NCT02207231|536352179|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
148693259|NCT02207231|536352180|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
148693260|NCT02207231|536352177|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
148693261|NCT02207231|536352178|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
148693262|NCT02207231|536352179|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
148693263|NCT02207231|536352180|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
148693264|NCT02207231|536352177|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
148693265|NCT02207231|536352178|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
148960651|NCT01641692|537339282|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148960652|NCT01641692|537339275|FG000|Treatment Period 2|Lack of Efficacy|1|||
148960653|NCT01641692|537339276|FG001|Treatment Period 2|Lack of Efficacy|0|||
148960654|NCT01641692|537339277|FG002|Treatment Period 2|Lack of Efficacy|0|||
148960655|NCT01641692|537339278|FG003|Treatment Period 2|Lack of Efficacy|0|||
148960656|NCT01641692|537339279|FG004|Treatment Period 2|Lack of Efficacy|0|||
148960657|NCT01641692|537339280|FG005|Treatment Period 2|Lack of Efficacy|0|||
148960658|NCT01641692|537339281|FG006|Treatment Period 2|Lack of Efficacy|0|||
148960659|NCT01641692|537339282|FG007|Treatment Period 2|Lack of Efficacy|0|||
148693266|NCT02207231|536352179|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
148693267|NCT02207231|536352180|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
148693268|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
148693269|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
148693270|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
148960660|NCT01641692|537339275|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
148960661|NCT01641692|537339276|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148960662|NCT01641692|537339277|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
149023877|NCT02711826|537562688|FG002|Overall Study|Failure to manufacture cellular product|5|||
149023878|NCT02711826|537562689|FG003|Overall Study|Failure to manufacture cellular product|0|||
149023879|NCT02711826|537562690|FG004|Overall Study|Failure to manufacture cellular product|0|||
148693271|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
148693272|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
148693273|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
148960663|NCT01641692|537339278|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148960664|NCT01641692|537339279|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148960665|NCT01641692|537339280|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148960666|NCT01641692|537339281|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148960667|NCT01641692|537339282|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148960668|NCT01641692|537339275|FG000|Treatment Period 2|Lost to Follow-up|0|||
148960669|NCT01641692|537339276|FG001|Treatment Period 2|Lost to Follow-up|0|||
148960670|NCT01641692|537339277|FG002|Treatment Period 2|Lost to Follow-up|0|||
148960671|NCT01641692|537339278|FG003|Treatment Period 2|Lost to Follow-up|0|||
148960672|NCT01641692|537339279|FG004|Treatment Period 2|Lost to Follow-up|0|||
148960673|NCT01641692|537339280|FG005|Treatment Period 2|Lost to Follow-up|1|||
148960674|NCT01641692|537339281|FG006|Treatment Period 2|Lost to Follow-up|0|||
148960675|NCT01641692|537339282|FG007|Treatment Period 2|Lost to Follow-up|0|||
148960676|NCT01641692|537339275|FG000|Treatment Period 2|Withdrawal by Subject|1|||
148960677|NCT01641692|537339276|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148960678|NCT01641692|537339277|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148960679|NCT01641692|537339278|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148960680|NCT01641692|537339279|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148960681|NCT01641692|537339280|FG005|Treatment Period 2|Withdrawal by Subject|1|||
148960682|NCT01641692|537339281|FG006|Treatment Period 2|Withdrawal by Subject|0|||
148960683|NCT01641692|537339282|FG007|Treatment Period 2|Withdrawal by Subject|1|||
149023880|NCT02711826|537562686|FG000|Overall Study|Infusion canceled for active infection|0|||
148960684|NCT01641692|537339275|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
149023881|NCT02711826|537562687|FG001|Overall Study|Infusion canceled for active infection|1|||
148693274|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
148693275|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
148693276|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
148693277|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
148693278|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
148693279|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
148693280|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
148693281|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
148693282|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
148693283|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
148693284|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
148693285|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
148693286|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
148693287|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
148693288|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
148693289|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
148693290|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
148693291|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
148960685|NCT01641692|537339276|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960686|NCT01641692|537339277|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960687|NCT01641692|537339278|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960688|NCT01641692|537339279|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
148960689|NCT01641692|537339280|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960690|NCT01641692|537339281|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
148960691|NCT01641692|537339282|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
148960692|NCT01641692|537339275|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148960693|NCT01641692|537339276|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
149023882|NCT02711826|537562688|FG002|Overall Study|Infusion canceled for active infection|0|||
148693292|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
149023883|NCT02711826|537562689|FG003|Overall Study|Infusion canceled for active infection|0|||
148693293|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
149023884|NCT02711826|537562690|FG004|Overall Study|Infusion canceled for active infection|0|||
148960694|NCT01641692|537339277|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
148960695|NCT01641692|537339278|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148960696|NCT01641692|537339279|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148960697|NCT01641692|537339280|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
148960698|NCT01641692|537339281|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148960699|NCT01641692|537339282|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
148960700|NCT01641692|537339275|FG000|Treatment Period 3|Adverse Event|0|||
148960701|NCT01641692|537339276|FG001|Treatment Period 3|Adverse Event|0|||
148960702|NCT01641692|537339277|FG002|Treatment Period 3|Adverse Event|0|||
149023885|NCT02711826|537562686|FG000|Overall Study|Screen failures|0|||
149023886|NCT02711826|537562687|FG001|Overall Study|Screen failures|0|||
148960703|NCT01641692|537339278|FG003|Treatment Period 3|Adverse Event|0|||
148960704|NCT01641692|537339279|FG004|Treatment Period 3|Adverse Event|0|||
149023887|NCT02711826|537562688|FG002|Overall Study|Screen failures|0|||
148693294|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
148693295|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
148693296|NCT02207231|536352177|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
148693297|NCT02207231|536352178|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
148693298|NCT02207231|536352179|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
149023888|NCT02711826|537562689|FG003|Overall Study|Screen failures|4|||
148693299|NCT02207231|536352180|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
148960705|NCT01641692|537339280|FG005|Treatment Period 3|Adverse Event|0|||
148960706|NCT01641692|537339281|FG006|Treatment Period 3|Adverse Event|1|||
148960707|NCT01641692|537339282|FG007|Treatment Period 3|Adverse Event|0|||
148960708|NCT01641692|537339275|FG000|Treatment Period 3|Protocol Violation|0|||
148960709|NCT01641692|537339276|FG001|Treatment Period 3|Protocol Violation|0|||
148960710|NCT01641692|537339277|FG002|Treatment Period 3|Protocol Violation|1|||
148960711|NCT01641692|537339278|FG003|Treatment Period 3|Protocol Violation|0|||
148960712|NCT01641692|537339279|FG004|Treatment Period 3|Protocol Violation|0|||
148960713|NCT01641692|537339280|FG005|Treatment Period 3|Protocol Violation|0|||
148960714|NCT01641692|537339281|FG006|Treatment Period 3|Protocol Violation|0|||
148960715|NCT01641692|537339282|FG007|Treatment Period 3|Protocol Violation|0|||
148960716|NCT01641692|537339275|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960717|NCT01641692|537339276|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960718|NCT01641692|537339277|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960719|NCT01641692|537339278|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960720|NCT01641692|537339279|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960721|NCT01641692|537339280|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960722|NCT01641692|537339281|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
148960723|NCT01641692|537339282|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148960724|NCT01641692|537339275|FG000|Treatment Period 3|Lost to Follow-up|0|||
148960725|NCT01641692|537339276|FG001|Treatment Period 3|Lost to Follow-up|1|||
148960726|NCT01641692|537339277|FG002|Treatment Period 3|Lost to Follow-up|0|||
148693300|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
148693301|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
148693302|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
148960727|NCT01641692|537339278|FG003|Treatment Period 3|Lost to Follow-up|0|||
148960728|NCT01641692|537339279|FG004|Treatment Period 3|Lost to Follow-up|0|||
148960729|NCT01641692|537339280|FG005|Treatment Period 3|Lost to Follow-up|0|||
148693303|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
148960730|NCT01641692|537339281|FG006|Treatment Period 3|Lost to Follow-up|0|||
148960731|NCT01641692|537339282|FG007|Treatment Period 3|Lost to Follow-up|0|||
148960732|NCT01641692|537339275|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960733|NCT01641692|537339276|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960734|NCT01641692|537339277|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960735|NCT01641692|537339278|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960736|NCT01641692|537339279|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960737|NCT01641692|537339280|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
148960738|NCT01641692|537339281|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960739|NCT01641692|537339282|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
148960740|NCT01641692|537339275|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
148960741|NCT01641692|537339276|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
149023889|NCT02711826|537562690|FG004|Overall Study|Screen failures|0|||
148960742|NCT01641692|537339277|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
149023890|NCT00729690|537562692|FG000|Overall Study|IT Catheter Malfunction|0|||
148960743|NCT01641692|537339278|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
148960744|NCT01641692|537339279|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
148960745|NCT01641692|537339280|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
148960746|NCT01641692|537339281|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
148960747|NCT01641692|537339282|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
148960748|NCT04948450|537339285|FG000|Overall Study|Return home|1|||
148960749|NCT04948450|537339286|FG001|Overall Study|Return home|3|||
148960750|NCT00529542|537339288|FG000|Overall Study|Withdrawal by Subject|1|||
148960751|NCT00529542|537339289|FG001|Overall Study|Withdrawal by Subject|0|||
148960752|NCT00529542|537339288|FG000|Overall Study|Lost to Follow-up|0|||
148960753|NCT00529542|537339289|FG001|Overall Study|Lost to Follow-up|1|||
148960754|NCT01474876|537339296|FG000|Overall Study|Adverse Event|11|||
148960755|NCT01474876|537339297|FG001|Overall Study|Adverse Event|5|||
148960756|NCT01474876|537339298|FG002|Overall Study|Adverse Event|0|||
148960757|NCT01474876|537339296|FG000|Overall Study|Serious Adverse Event|2|||
148960758|NCT01474876|537339297|FG001|Overall Study|Serious Adverse Event|3|||
148960759|NCT01474876|537339298|FG002|Overall Study|Serious Adverse Event|0|||
148960760|NCT01474876|537339296|FG000|Overall Study|Lost to Follow-up|5|||
148960761|NCT01474876|537339297|FG001|Overall Study|Lost to Follow-up|4|||
148960762|NCT01474876|537339298|FG002|Overall Study|Lost to Follow-up|0|||
148960763|NCT01474876|537339296|FG000|Overall Study|Investigator's decision|28|||
148960764|NCT01474876|537339297|FG001|Overall Study|Investigator's decision|6|||
148960765|NCT01474876|537339298|FG002|Overall Study|Investigator's decision|0|||
148960766|NCT01474876|537339296|FG000|Overall Study|Patient's request|19|||
148960767|NCT01474876|537339297|FG001|Overall Study|Patient's request|5|||
148960768|NCT01474876|537339298|FG002|Overall Study|Patient's request|0|||
148960769|NCT01474876|537339296|FG000|Overall Study|Investigator's decision and pt request|1|||
148960770|NCT01474876|537339297|FG001|Overall Study|Investigator's decision and pt request|0|||
148960771|NCT01474876|537339298|FG002|Overall Study|Investigator's decision and pt request|0|||
148693304|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
148960772|NCT02291055|537339299|FG000|Overall Study|Death|2|||
148960773|NCT02291055|537339300|FG001|Overall Study|Death|2|||
148960774|NCT02291055|537339301|FG002|Overall Study|Death|5|||
148960775|NCT02291055|537339302|FG003|Overall Study|Death|8|||
148960776|NCT02291055|537339303|FG004|Overall Study|Death|12|||
148960777|NCT02291055|537339299|FG000|Overall Study|Lost to Follow-up|0|||
148960778|NCT02291055|537339300|FG001|Overall Study|Lost to Follow-up|0|||
148693305|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
148960779|NCT02291055|537339301|FG002|Overall Study|Lost to Follow-up|0|||
149023891|NCT00729690|537562693|FG001|Overall Study|IT Catheter Malfunction|2|||
148960780|NCT02291055|537339302|FG003|Overall Study|Lost to Follow-up|1|||
148960781|NCT02291055|537339303|FG004|Overall Study|Lost to Follow-up|2|||
148812028|NCT03126110|536787135|FG005|Phase 2|Study terminated by the sponsor|0|||
148812029|NCT03126110|536787136|FG006|Phase 2|Study terminated by the sponsor|0|||
148960782|NCT02291055|537339299|FG000|Overall Study|Withdrawal by Subject|3|||
148960783|NCT02291055|537339300|FG001|Overall Study|Withdrawal by Subject|1|||
148960784|NCT02291055|537339301|FG002|Overall Study|Withdrawal by Subject|1|||
148960785|NCT02291055|537339302|FG003|Overall Study|Withdrawal by Subject|5|||
148960786|NCT02291055|537339303|FG004|Overall Study|Withdrawal by Subject|10|||
148960787|NCT02291055|537339299|FG000|Overall Study|Progressive Disease|0|||
148960788|NCT02291055|537339300|FG001|Overall Study|Progressive Disease|0|||
148960789|NCT02291055|537339301|FG002|Overall Study|Progressive Disease|1|||
148960790|NCT02291055|537339302|FG003|Overall Study|Progressive Disease|4|||
148960791|NCT02291055|537339303|FG004|Overall Study|Progressive Disease|2|||
148960792|NCT02291055|537339299|FG000|Overall Study|Study Terminated by Sponsor|0|||
148960793|NCT02291055|537339300|FG001|Overall Study|Study Terminated by Sponsor|0|||
148960794|NCT02291055|537339301|FG002|Overall Study|Study Terminated by Sponsor|0|||
148960795|NCT02291055|537339302|FG003|Overall Study|Study Terminated by Sponsor|5|||
148960796|NCT02291055|537339303|FG004|Overall Study|Study Terminated by Sponsor|1|||
148960797|NCT02291055|537339299|FG000|Overall Study|Other|0|||
148960798|NCT02291055|537339300|FG001|Overall Study|Other|2|||
148960799|NCT02291055|537339301|FG002|Overall Study|Other|1|||
148960800|NCT02291055|537339302|FG003|Overall Study|Other|4|||
148960801|NCT02291055|537339303|FG004|Overall Study|Other|0|||
148960802|NCT01523886|537339307|FG000|Overall Study|surgery cancelled|0|||
148812030|NCT03126110|536787137|FG007|Phase 2|Study terminated by the sponsor|0|||
148960803|NCT01523886|537339308|FG001|Overall Study|surgery cancelled|1|||
148960804|NCT00733746|537339312|FG000|Overall Study|Ineligible|5|||
148960805|NCT01367158|537339313|FG000|Overall Study|Withdrew consent|0|||
148960806|NCT01367158|537339314|FG001|Overall Study|Withdrew consent|2|||
148960807|NCT01367158|537339315|FG002|Overall Study|Withdrew consent|1|||
148693306|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
148693307|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
148693308|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
148693309|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
148693310|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
148693311|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
148693312|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
148693313|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
148693314|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
148693315|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
148693316|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
148693317|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
148693318|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
148693319|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
148693320|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
148693321|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
148693322|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
148693323|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
148693324|NCT02207231|536352177|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
148693325|NCT02207231|536352178|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
148693326|NCT02207231|536352179|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
148693327|NCT02207231|536352180|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
148693328|NCT02016300|536352185|FG000|Overall Study|Lost to Follow-up|0|||
148693329|NCT02016300|536352186|FG001|Overall Study|Lost to Follow-up|3|||
148693330|NCT06165744|536352193|FG000|Overall Study|Non device-related adverse event|1|||
148693331|NCT01545076|536352194|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
148693332|NCT01545076|536352195|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
148960808|NCT01367158|537339316|FG003|Overall Study|Withdrew consent|0|||
148960809|NCT01367158|537339317|FG004|Overall Study|Withdrew consent|2|||
148693333|NCT01545076|536352196|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
148693334|NCT01545076|536352197|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
148693335|NCT01545076|536352198|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
148693336|NCT01545076|536352194|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
148960810|NCT01367158|537339318|FG005|Overall Study|Withdrew consent|0|||
148812031|NCT03126110|536787138|FG008|Phase 2|Study terminated by the sponsor|0|||
148960811|NCT01367158|537339319|FG006|Overall Study|Withdrew consent|0|||
148960812|NCT01367158|537339320|FG007|Overall Study|Withdrew consent|1|||
148960813|NCT01367158|537339321|FG008|Overall Study|Withdrew consent|0|||
148960814|NCT01367158|537339322|FG009|Overall Study|Withdrew consent|0|||
148960815|NCT01367158|537339323|FG010|Overall Study|Withdrew consent|0|||
148960816|NCT01367158|537339313|FG000|Overall Study|Lost to Follow-up|0|||
148693337|NCT01545076|536352195|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
148693338|NCT01545076|536352196|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
148693339|NCT01545076|536352197|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
148693340|NCT01545076|536352198|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
148693341|NCT01545076|536352194|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
148693342|NCT01545076|536352195|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
148693343|NCT01545076|536352196|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
148693344|NCT01545076|536352197|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
148693345|NCT01545076|536352198|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
148693346|NCT01545076|536352194|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
148960817|NCT01367158|537339314|FG001|Overall Study|Lost to Follow-up|0|||
148960818|NCT01367158|537339315|FG002|Overall Study|Lost to Follow-up|0|||
148960819|NCT01367158|537339316|FG003|Overall Study|Lost to Follow-up|1|||
148693347|NCT01545076|536352195|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
148693348|NCT01545076|536352196|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
148693349|NCT01545076|536352197|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
148693350|NCT01545076|536352198|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
148960820|NCT01367158|537339317|FG004|Overall Study|Lost to Follow-up|0|||
148693351|NCT01545076|536352194|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
148693352|NCT01545076|536352195|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
148693353|NCT01545076|536352196|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
148693354|NCT01545076|536352197|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
148960821|NCT01367158|537339318|FG005|Overall Study|Lost to Follow-up|2|||
148960822|NCT01367158|537339319|FG006|Overall Study|Lost to Follow-up|0|||
148960823|NCT01367158|537339320|FG007|Overall Study|Lost to Follow-up|1|||
148960824|NCT01367158|537339321|FG008|Overall Study|Lost to Follow-up|0|||
148960825|NCT01367158|537339322|FG009|Overall Study|Lost to Follow-up|0|||
148960826|NCT01367158|537339323|FG010|Overall Study|Lost to Follow-up|1|||
148960827|NCT01367158|537339313|FG000|Overall Study|Protocol Violation|0|||
148960828|NCT01367158|537339314|FG001|Overall Study|Protocol Violation|1|||
148960829|NCT01367158|537339315|FG002|Overall Study|Protocol Violation|0|||
148693355|NCT01545076|536352198|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
148960830|NCT01367158|537339316|FG003|Overall Study|Protocol Violation|0|||
148960831|NCT01367158|537339317|FG004|Overall Study|Protocol Violation|0|||
148960832|NCT01367158|537339318|FG005|Overall Study|Protocol Violation|0|||
148960833|NCT01367158|537339319|FG006|Overall Study|Protocol Violation|0|||
148960834|NCT01367158|537339320|FG007|Overall Study|Protocol Violation|0|||
148960835|NCT01367158|537339321|FG008|Overall Study|Protocol Violation|0|||
148812032|NCT03126110|536787139|FG009|Phase 2|Study terminated by the sponsor|0|||
148812033|NCT03126110|536787140|FG010|Phase 2|Study terminated by the sponsor|0|||
148812034|NCT03126110|536787141|FG011|Phase 2|Study terminated by the sponsor|0|||
148812035|NCT03126110|536787142|FG012|Phase 2|Study terminated by the sponsor|0|||
148812036|NCT03126110|536787143|FG013|Phase 2|Study terminated by the sponsor|4|||
148812037|NCT03126110|536787144|FG014|Phase 2|Study terminated by the sponsor|0|||
148812038|NCT03126110|536787145|FG015|Phase 2|Study terminated by the sponsor|0|||
148812039|NCT03126110|536787146|FG016|Phase 2|Study terminated by the sponsor|0|||
148812040|NCT03126110|536787130|FG000|Phase 2|Withdrawal by Subject|0|||
148812041|NCT03126110|536787131|FG001|Phase 2|Withdrawal by Subject|0|||
148812042|NCT03126110|536787132|FG002|Phase 2|Withdrawal by Subject|0|||
148812043|NCT03126110|536787133|FG003|Phase 2|Withdrawal by Subject|0|||
148812044|NCT03126110|536787134|FG004|Phase 2|Withdrawal by Subject|0|||
148812045|NCT03126110|536787135|FG005|Phase 2|Withdrawal by Subject|0|||
148812046|NCT03126110|536787136|FG006|Phase 2|Withdrawal by Subject|0|||
148812047|NCT03126110|536787137|FG007|Phase 2|Withdrawal by Subject|0|||
148812048|NCT03126110|536787138|FG008|Phase 2|Withdrawal by Subject|0|||
148812049|NCT03126110|536787139|FG009|Phase 2|Withdrawal by Subject|0|||
148812050|NCT03126110|536787140|FG010|Phase 2|Withdrawal by Subject|0|||
148812051|NCT03126110|536787141|FG011|Phase 2|Withdrawal by Subject|1|||
148960836|NCT01367158|537339322|FG009|Overall Study|Protocol Violation|0|||
148960837|NCT01367158|537339323|FG010|Overall Study|Protocol Violation|0|||
148960838|NCT03658538|537339324|FG000|Overall Study|Death|2|||
148812052|NCT03126110|536787142|FG012|Phase 2|Withdrawal by Subject|3|||
148812053|NCT03126110|536787143|FG013|Phase 2|Withdrawal by Subject|3|||
148812054|NCT03126110|536787144|FG014|Phase 2|Withdrawal by Subject|2|||
148812055|NCT03126110|536787145|FG015|Phase 2|Withdrawal by Subject|1|||
148812056|NCT03126110|536787146|FG016|Phase 2|Withdrawal by Subject|0|||
148812057|NCT03126110|536787130|FG000|Phase 2|Lost to Follow-up|0|||
148812058|NCT03126110|536787131|FG001|Phase 2|Lost to Follow-up|0|||
148812059|NCT03126110|536787132|FG002|Phase 2|Lost to Follow-up|0|||
148960839|NCT03658538|537339325|FG001|Overall Study|Death|1|||
148960840|NCT03658538|537339324|FG000|Overall Study|Cancer diagnosis|1|||
148812060|NCT03126110|536787133|FG003|Phase 2|Lost to Follow-up|0|||
148812061|NCT03126110|536787134|FG004|Phase 2|Lost to Follow-up|0|||
148812062|NCT03126110|536787135|FG005|Phase 2|Lost to Follow-up|0|||
148812063|NCT03126110|536787136|FG006|Phase 2|Lost to Follow-up|0|||
148960841|NCT03658538|537339325|FG001|Overall Study|Cancer diagnosis|0|||
148812064|NCT03126110|536787137|FG007|Phase 2|Lost to Follow-up|0|||
148812065|NCT03126110|536787138|FG008|Phase 2|Lost to Follow-up|0|||
148812066|NCT03126110|536787139|FG009|Phase 2|Lost to Follow-up|0|||
148812067|NCT03126110|536787140|FG010|Phase 2|Lost to Follow-up|0|||
148812068|NCT03126110|536787141|FG011|Phase 2|Lost to Follow-up|1|||
148812069|NCT03126110|536787142|FG012|Phase 2|Lost to Follow-up|1|||
148812070|NCT03126110|536787143|FG013|Phase 2|Lost to Follow-up|1|||
148960842|NCT03658538|537339324|FG000|Overall Study|Change residence|1|||
148812071|NCT03126110|536787144|FG014|Phase 2|Lost to Follow-up|2|||
148812072|NCT03126110|536787145|FG015|Phase 2|Lost to Follow-up|0|||
148812073|NCT03126110|536787146|FG016|Phase 2|Lost to Follow-up|0|||
148812074|NCT03126110|536787130|FG000|Phase 2|Death|0|||
148812075|NCT03126110|536787131|FG001|Phase 2|Death|0|||
148960843|NCT03658538|537339325|FG001|Overall Study|Change residence|2|||
148960844|NCT03658538|537339324|FG000|Overall Study|Lost to Follow-up|3|||
148960845|NCT03658538|537339325|FG001|Overall Study|Lost to Follow-up|3|||
148693356|NCT01545076|536352194|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
148960846|NCT03658538|537339324|FG000|Overall Study|Unblinded|2|||
148960847|NCT03658538|537339325|FG001|Overall Study|Unblinded|3|||
148960848|NCT03658538|537339324|FG000|Overall Study|Physician Decision|0|||
149023892|NCT00729690|537562694|FG002|Overall Study|IT Catheter Malfunction|2|||
149023893|NCT02169219|537562695|FG000|Overall Study|Lack of Efficacy|6|||
149023894|NCT02886936|537562696|FG000|Overall Study|Lost to Follow-up|4|||
149023895|NCT02886936|537562697|FG001|Overall Study|Lost to Follow-up|3|||
149023896|NCT02886936|537562698|FG002|Overall Study|Lost to Follow-up|0|||
149023897|NCT02507219|537562699|FG000|Overall Study|Physician Decision|1|||
149023898|NCT02507219|537562700|FG001|Overall Study|Physician Decision|0|||
149023899|NCT02507219|537562701|FG002|Overall Study|Physician Decision|0|||
149023900|NCT02507219|537562702|FG003|Overall Study|Physician Decision|0|||
149023901|NCT02507219|537562703|FG004|Overall Study|Physician Decision|0|||
149023902|NCT02507219|537562704|FG005|Overall Study|Physician Decision|0|||
149023903|NCT02507219|537562699|FG000|Overall Study|Withdrawal by Subject|0|||
149023904|NCT02507219|537562700|FG001|Overall Study|Withdrawal by Subject|0|||
149023905|NCT02507219|537562701|FG002|Overall Study|Withdrawal by Subject|0|||
149023906|NCT02507219|537562702|FG003|Overall Study|Withdrawal by Subject|0|||
149023907|NCT02507219|537562703|FG004|Overall Study|Withdrawal by Subject|1|||
149023908|NCT02507219|537562704|FG005|Overall Study|Withdrawal by Subject|0|||
148812076|NCT03126110|536787132|FG002|Phase 2|Death|0|||
149023909|NCT04562779|537562705|FG000|Overall Study|Lost to Follow-up|7|||
148693357|NCT01545076|536352195|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
148812077|NCT03126110|536787133|FG003|Phase 2|Death|0|||
149023910|NCT04562779|537562706|FG001|Overall Study|Lost to Follow-up|5|||
148812078|NCT03126110|536787134|FG004|Phase 2|Death|0|||
148812079|NCT03126110|536787135|FG005|Phase 2|Death|0|||
149023911|NCT04562779|537562707|FG002|Overall Study|Lost to Follow-up|10|||
149023912|NCT04562779|537562705|FG000|Overall Study|Protocol Violation|2|||
148960849|NCT03658538|537339325|FG001|Overall Study|Physician Decision|1|||
149005471|NCT03217747|537497904|FG012|Overall Study|Withdrawal by Subject|0|||
149023913|NCT04562779|537562706|FG001|Overall Study|Protocol Violation|2|||
149023914|NCT04562779|537562707|FG002|Overall Study|Protocol Violation|0|||
149023915|NCT02320721|537562708|FG000|Overall Study|Adverse Event|6|||
148693358|NCT01545076|536352196|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
148693359|NCT01545076|536352197|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
148960850|NCT03658538|537339324|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
148960851|NCT03658538|537339325|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
148693360|NCT01545076|536352198|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
148693361|NCT01545076|536352194|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
148693362|NCT01545076|536352195|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
148693363|NCT01545076|536352196|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
148693364|NCT01545076|536352197|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
148693365|NCT01545076|536352198|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
148693366|NCT01545076|536352194|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
148693367|NCT01545076|536352195|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
148693368|NCT01545076|536352196|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
148693369|NCT01545076|536352197|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
148693370|NCT01545076|536352198|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
148693371|NCT01545076|536352194|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
148693372|NCT01545076|536352195|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
148693373|NCT01545076|536352196|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
148693374|NCT01545076|536352197|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
148693375|NCT01545076|536352198|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
148693376|NCT01546987|536352199|FG000|Overall Study|Protocol Violation|3|||
148693377|NCT01546987|536352200|FG001|Overall Study|Protocol Violation|4|||
148812080|NCT03126110|536787136|FG006|Phase 2|Death|0|||
148693378|NCT02270736|536352201|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
148693379|NCT02270736|536352202|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
148812081|NCT03126110|536787137|FG007|Phase 2|Death|0|||
148960852|NCT03658538|537339324|FG000|Overall Study|Evicted from home|1|||
148960853|NCT03658538|537339325|FG001|Overall Study|Evicted from home|0|||
148960854|NCT02921776|537339326|FG000|Overall Study|patient deterioration, fatigue|2|||
148960855|NCT02921776|537339327|FG001|Overall Study|patient deterioration, fatigue|6|||
148960856|NCT02921776|537339328|FG002|Overall Study|patient deterioration, fatigue|0|||
148960857|NCT02921776|537339329|FG003|Overall Study|patient deterioration, fatigue|0|||
148960858|NCT02921776|537339330|FG004|Overall Study|patient deterioration, fatigue|0|||
148960859|NCT02921776|537339331|FG005|Overall Study|patient deterioration, fatigue|0|||
149023916|NCT02320721|537562709|FG001|Overall Study|Adverse Event|6|||
148693380|NCT02270736|536352203|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
148693381|NCT02270736|536352204|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
148693382|NCT02270736|536352205|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
148960860|NCT02921776|537339332|FG006|Overall Study|patient deterioration, fatigue|0|||
148960861|NCT02921776|537339333|FG007|Overall Study|patient deterioration, fatigue|0|||
148960862|NCT02921776|537339326|FG000|Overall Study|Withdrawal by Subject|0|||
148960863|NCT02921776|537339327|FG001|Overall Study|Withdrawal by Subject|2|||
148960864|NCT02921776|537339328|FG002|Overall Study|Withdrawal by Subject|0|||
148960865|NCT02921776|537339329|FG003|Overall Study|Withdrawal by Subject|1|||
148693383|NCT02270736|536352201|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
148812082|NCT03126110|536787138|FG008|Phase 2|Death|0|||
149023917|NCT02320721|537562708|FG000|Overall Study|Lack of Efficacy|2|||
148812083|NCT03126110|536787139|FG009|Phase 2|Death|0|||
148693384|NCT02270736|536352202|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
148693385|NCT02270736|536352203|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
148693386|NCT02270736|536352204|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
148693387|NCT02270736|536352205|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
148693388|NCT02270736|536352201|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
148693389|NCT02270736|536352202|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
148693390|NCT02270736|536352203|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
148693391|NCT02270736|536352204|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
148812084|NCT03126110|536787140|FG010|Phase 2|Death|0|||
148812085|NCT03126110|536787141|FG011|Phase 2|Death|6|||
148812086|NCT03126110|536787142|FG012|Phase 2|Death|12|||
148693392|NCT02270736|536352205|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
148693393|NCT02270736|536352201|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
148693394|NCT02270736|536352202|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
148693395|NCT02270736|536352203|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
148693396|NCT02270736|536352204|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
148693397|NCT02270736|536352205|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
148693398|NCT02270736|536352201|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
148693399|NCT02270736|536352202|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
148693400|NCT02270736|536352203|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
148960866|NCT02921776|537339330|FG004|Overall Study|Withdrawal by Subject|1|||
148960867|NCT02921776|537339331|FG005|Overall Study|Withdrawal by Subject|0|||
148960868|NCT02921776|537339332|FG006|Overall Study|Withdrawal by Subject|8|||
148960869|NCT02921776|537339333|FG007|Overall Study|Withdrawal by Subject|1|||
148960870|NCT02921776|537339326|FG000|Overall Study|Death|0|||
148812087|NCT03126110|536787143|FG013|Phase 2|Death|25|||
148960871|NCT02921776|537339327|FG001|Overall Study|Death|0|||
148812088|NCT03126110|536787144|FG014|Phase 2|Death|11|||
149023918|NCT02320721|537562709|FG001|Overall Study|Lack of Efficacy|0|||
148960872|NCT02921776|537339328|FG002|Overall Study|Death|0|||
148960873|NCT02921776|537339329|FG003|Overall Study|Death|2|||
148812089|NCT03126110|536787145|FG015|Phase 2|Death|3|||
148960874|NCT02921776|537339330|FG004|Overall Study|Death|0|||
148960875|NCT02921776|537339331|FG005|Overall Study|Death|0|||
148960876|NCT02921776|537339332|FG006|Overall Study|Death|0|||
148960877|NCT02921776|537339333|FG007|Overall Study|Death|0|||
148960878|NCT02921776|537339326|FG000|Overall Study|extubation or early discharge|0|||
148960879|NCT02921776|537339327|FG001|Overall Study|extubation or early discharge|0|||
148960880|NCT02921776|537339328|FG002|Overall Study|extubation or early discharge|0|||
148960881|NCT02921776|537339329|FG003|Overall Study|extubation or early discharge|5|||
148960882|NCT02921776|537339330|FG004|Overall Study|extubation or early discharge|5|||
148812090|NCT03126110|536787146|FG016|Phase 2|Death|2|||
148812091|NCT03126110|536787130|FG000|Phase 2|Progressive Disease|0|||
148812092|NCT03126110|536787131|FG001|Phase 2|Progressive Disease|0|||
148812093|NCT03126110|536787132|FG002|Phase 2|Progressive Disease|0|||
148812094|NCT03126110|536787133|FG003|Phase 2|Progressive Disease|0|||
148812095|NCT03126110|536787134|FG004|Phase 2|Progressive Disease|0|||
148812096|NCT03126110|536787135|FG005|Phase 2|Progressive Disease|0|||
148812097|NCT03126110|536787136|FG006|Phase 2|Progressive Disease|0|||
148812098|NCT03126110|536787137|FG007|Phase 2|Progressive Disease|0|||
148812099|NCT03126110|536787138|FG008|Phase 2|Progressive Disease|0|||
148812100|NCT03126110|536787139|FG009|Phase 2|Progressive Disease|0|||
148812101|NCT03126110|536787140|FG010|Phase 2|Progressive Disease|0|||
148812102|NCT03126110|536787141|FG011|Phase 2|Progressive Disease|0|||
148812103|NCT03126110|536787142|FG012|Phase 2|Progressive Disease|0|||
148812104|NCT03126110|536787143|FG013|Phase 2|Progressive Disease|1|||
148812105|NCT03126110|536787144|FG014|Phase 2|Progressive Disease|0|||
148812106|NCT03126110|536787145|FG015|Phase 2|Progressive Disease|0|||
148812107|NCT03126110|536787146|FG016|Phase 2|Progressive Disease|0|||
148812108|NCT03126110|536787130|FG000|Phase 2|Started new treatment|0|||
148812109|NCT03126110|536787131|FG001|Phase 2|Started new treatment|0|||
148812110|NCT03126110|536787132|FG002|Phase 2|Started new treatment|0|||
148812111|NCT03126110|536787133|FG003|Phase 2|Started new treatment|0|||
148812112|NCT03126110|536787134|FG004|Phase 2|Started new treatment|0|||
148812113|NCT03126110|536787135|FG005|Phase 2|Started new treatment|0|||
148812114|NCT03126110|536787136|FG006|Phase 2|Started new treatment|0|||
148812115|NCT03126110|536787137|FG007|Phase 2|Started new treatment|0|||
148812116|NCT03126110|536787138|FG008|Phase 2|Started new treatment|0|||
148812117|NCT03126110|536787139|FG009|Phase 2|Started new treatment|0|||
148812118|NCT03126110|536787140|FG010|Phase 2|Started new treatment|0|||
148812119|NCT03126110|536787141|FG011|Phase 2|Started new treatment|0|||
148812120|NCT03126110|536787142|FG012|Phase 2|Started new treatment|0|||
148812121|NCT03126110|536787143|FG013|Phase 2|Started new treatment|0|||
148812122|NCT03126110|536787144|FG014|Phase 2|Started new treatment|1|||
148812123|NCT03126110|536787145|FG015|Phase 2|Started new treatment|0|||
148812124|NCT03126110|536787146|FG016|Phase 2|Started new treatment|0|||
148812125|NCT00580840|536787147|FG000|Run-in|Adverse Event|17|||
148812126|NCT00580840|536787148|FG001|Run-in|Adverse Event|0|||
148812127|NCT00580840|536787149|FG002|Run-in|Adverse Event|0|||
148812128|NCT00580840|536787150|FG003|Run-in|Adverse Event|0|||
148812129|NCT00580840|536787147|FG000|Run-in|Lack of Efficacy|93|||
148812130|NCT00580840|536787148|FG001|Run-in|Lack of Efficacy|0|||
148812131|NCT00580840|536787149|FG002|Run-in|Lack of Efficacy|0|||
148812132|NCT00580840|536787150|FG003|Run-in|Lack of Efficacy|0|||
148812133|NCT00580840|536787147|FG000|Run-in|Loss of Efficacy|1|||
148812134|NCT00580840|536787148|FG001|Run-in|Loss of Efficacy|0|||
148812135|NCT00580840|536787149|FG002|Run-in|Loss of Efficacy|0|||
148812136|NCT00580840|536787150|FG003|Run-in|Loss of Efficacy|0|||
148812137|NCT00580840|536787147|FG000|Run-in|Lost to Follow-up|4|||
148812138|NCT00580840|536787148|FG001|Run-in|Lost to Follow-up|0|||
148812139|NCT00580840|536787149|FG002|Run-in|Lost to Follow-up|0|||
148812140|NCT00580840|536787150|FG003|Run-in|Lost to Follow-up|0|||
148812141|NCT00580840|536787147|FG000|Run-in|Withdrawal by Subject|5|||
149023919|NCT02320721|537562708|FG000|Overall Study|Poor compliance to protocol|3|||
149023920|NCT02320721|537562709|FG001|Overall Study|Poor compliance to protocol|7|||
149023921|NCT02320721|537562708|FG000|Overall Study|Randomized but not treated|0|||
148960883|NCT02921776|537339331|FG005|Overall Study|extubation or early discharge|0|||
148960884|NCT02921776|537339332|FG006|Overall Study|extubation or early discharge|0|||
148960885|NCT02921776|537339333|FG007|Overall Study|extubation or early discharge|0|||
148960886|NCT02921776|537339326|FG000|Overall Study|Lost to Follow-up|0|||
148960887|NCT02921776|537339327|FG001|Overall Study|Lost to Follow-up|0|||
148960888|NCT02921776|537339328|FG002|Overall Study|Lost to Follow-up|0|||
148960889|NCT02921776|537339329|FG003|Overall Study|Lost to Follow-up|0|||
148960890|NCT02921776|537339330|FG004|Overall Study|Lost to Follow-up|0|||
148960891|NCT02921776|537339331|FG005|Overall Study|Lost to Follow-up|2|||
148960892|NCT02921776|537339332|FG006|Overall Study|Lost to Follow-up|3|||
148960893|NCT02921776|537339333|FG007|Overall Study|Lost to Follow-up|6|||
148960894|NCT06308822|537341467|FG000|Overall Study|Mutation Status Not Confirmed|17|||
148960895|NCT06308822|537341467|FG000|Overall Study|Adverse Event|1|||
148960896|NCT06308822|537341467|FG000|Overall Study|Death|5|||
148960897|NCT06308822|537341467|FG000|Overall Study|Disease progression|8|||
148960898|NCT06308822|537341467|FG000|Overall Study|Withdrawal by Subject|1|||
148960899|NCT06308822|537341467|FG000|Overall Study|Physician Decision|3|||
148960900|NCT01998633|537341468|FG000|Overall Study|Death|1|||
148960901|NCT02631850|537341469|FG000|Treatment Period|Lost to Follow-up|0|||
148960902|NCT02631850|537341470|FG001|Treatment Period|Lost to Follow-up|1|||
148960903|NCT02631850|537341471|FG002|Treatment Period|Lost to Follow-up|0|||
148960904|NCT02631850|537341472|FG003|Treatment Period|Lost to Follow-up|0|||
148960905|NCT02631850|537341469|FG000|Treatment Period|Protocol Violation|1|||
148693401|NCT02270736|536352204|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
148693402|NCT02270736|536352205|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
148693403|NCT02270736|536352201|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
148693404|NCT02270736|536352202|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
148693405|NCT02270736|536352203|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
148693406|NCT02270736|536352204|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
148693407|NCT02270736|536352205|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
148693408|NCT02270736|536352201|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
148693409|NCT02270736|536352202|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
148693410|NCT02270736|536352203|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
148693411|NCT02270736|536352204|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
148693412|NCT02270736|536352205|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
148693413|NCT02270736|536352201|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
148693414|NCT02270736|536352202|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
148693415|NCT02270736|536352203|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
148693416|NCT02270736|536352204|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
148693417|NCT02270736|536352205|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
148693418|NCT02270736|536352201|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
148693419|NCT02270736|536352202|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
148693420|NCT02270736|536352203|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
148693421|NCT02270736|536352204|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
148693422|NCT02270736|536352205|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
148693423|NCT00262600|536352206|FG000|Overall Study|Lost to Follow-up|17|||
148693424|NCT00262600|536352207|FG001|Overall Study|Lost to Follow-up|31|||
148693425|NCT00262600|536352208|FG002|Overall Study|Lost to Follow-up|41|||
148693426|NCT00262600|536352206|FG000|Overall Study|Withdrawal by Subject|128|||
148693427|NCT00262600|536352207|FG001|Overall Study|Withdrawal by Subject|145|||
148693428|NCT00262600|536352208|FG002|Overall Study|Withdrawal by Subject|139|||
148693429|NCT00262600|536352206|FG000|Overall Study|Not Treated|32|||
148693430|NCT00262600|536352207|FG001|Overall Study|Not Treated|17|||
148693431|NCT00262600|536352208|FG002|Overall Study|Not Treated|24|||
148693432|NCT00262600|536352206|FG000|Overall Study|Other|58|||
148693433|NCT00262600|536352207|FG001|Overall Study|Other|59|||
148693434|NCT00262600|536352208|FG002|Overall Study|Other|62|||
148693435|NCT02710123|536352209|FG000|Overall Study|Lost to Follow-up|3|||
148960906|NCT02631850|537341470|FG001|Treatment Period|Protocol Violation|0|||
148960907|NCT02631850|537341471|FG002|Treatment Period|Protocol Violation|0|||
148693436|NCT02710123|536352210|FG001|Overall Study|Lost to Follow-up|4|||
148693437|NCT02710123|536352209|FG000|Overall Study|Withdrawal by Subject|1|||
148693438|NCT02710123|536352210|FG001|Overall Study|Withdrawal by Subject|1|||
148693439|NCT02710123|536352209|FG000|Overall Study|Illness unrelated to study intervention|1|||
148693440|NCT02710123|536352210|FG001|Overall Study|Illness unrelated to study intervention|0|||
148693441|NCT05381948|536352211|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
148693442|NCT05381948|536352212|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
148693443|NCT05381948|536352213|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
148693444|NCT05381948|536352211|FG000|Overall Study|Adverse Event: Non-ocular|0|||
148693445|NCT05381948|536352212|FG001|Overall Study|Adverse Event: Non-ocular|1|||
148693446|NCT05381948|536352213|FG002|Overall Study|Adverse Event: Non-ocular|0|||
148693447|NCT05381948|536352211|FG000|Overall Study|Lost to Follow-up|1|||
148693448|NCT05381948|536352212|FG001|Overall Study|Lost to Follow-up|0|||
148693449|NCT05381948|536352213|FG002|Overall Study|Lost to Follow-up|0|||
148693450|NCT05381948|536352211|FG000|Overall Study|Protocol Deviation|0|||
148693451|NCT05381948|536352212|FG001|Overall Study|Protocol Deviation|2|||
148693452|NCT05381948|536352213|FG002|Overall Study|Protocol Deviation|0|||
148960908|NCT02631850|537341472|FG003|Treatment Period|Protocol Violation|0|||
148693453|NCT05381948|536352211|FG000|Overall Study|Withdrawal by Subject|1|||
148693454|NCT05381948|536352212|FG001|Overall Study|Withdrawal by Subject|0|||
148693455|NCT05381948|536352213|FG002|Overall Study|Withdrawal by Subject|1|||
148693456|NCT05381948|536352211|FG000|Overall Study|Death|0|||
148693457|NCT05381948|536352212|FG001|Overall Study|Death|2|||
148693458|NCT05381948|536352213|FG002|Overall Study|Death|0|||
148693459|NCT05381948|536352211|FG000|Overall Study|Discontinued study without receiving study drug|0|||
148693460|NCT05381948|536352212|FG001|Overall Study|Discontinued study without receiving study drug|0|||
148693461|NCT05381948|536352213|FG002|Overall Study|Discontinued study without receiving study drug|1|||
148693462|NCT02446132|536352216|FG000|Overall Study|Adverse Event|10|||
148693463|NCT02446132|536352217|FG001|Overall Study|Adverse Event|27|||
148693464|NCT02446132|536352218|FG002|Overall Study|Adverse Event|27|||
148812142|NCT00580840|536787148|FG001|Run-in|Withdrawal by Subject|0|||
148693465|NCT02446132|536352216|FG000|Overall Study|Death|2|||
148693466|NCT02446132|536352217|FG001|Overall Study|Death|13|||
148693467|NCT02446132|536352218|FG002|Overall Study|Death|10|||
148693468|NCT02446132|536352216|FG000|Overall Study|Lack of Efficacy|1|||
148693469|NCT02446132|536352217|FG001|Overall Study|Lack of Efficacy|10|||
148693470|NCT02446132|536352218|FG002|Overall Study|Lack of Efficacy|6|||
148693471|NCT02446132|536352216|FG000|Overall Study|Lost to Follow-up|2|||
148693472|NCT02446132|536352217|FG001|Overall Study|Lost to Follow-up|4|||
148693473|NCT02446132|536352218|FG002|Overall Study|Lost to Follow-up|5|||
148812143|NCT00580840|536787149|FG002|Run-in|Withdrawal by Subject|0|||
148693474|NCT02446132|536352216|FG000|Overall Study|Non-compliance With Study Drug|2|||
148812144|NCT00580840|536787150|FG003|Run-in|Withdrawal by Subject|0|||
148812145|NCT00580840|536787147|FG000|Run-in|Other: Per Sponsor Request|2|||
148812146|NCT00580840|536787148|FG001|Run-in|Other: Per Sponsor Request|0|||
148812147|NCT00580840|536787149|FG002|Run-in|Other: Per Sponsor Request|0|||
148812148|NCT00580840|536787150|FG003|Run-in|Other: Per Sponsor Request|0|||
148812149|NCT00580840|536787147|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
148812150|NCT00580840|536787148|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
148812151|NCT00580840|536787149|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
148812152|NCT00580840|536787150|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
148812153|NCT00580840|536787147|FG000|Run-in|Other: Exclusionary Lab Value|1|||
148812154|NCT00580840|536787148|FG001|Run-in|Other: Exclusionary Lab Value|0|||
148812155|NCT00580840|536787149|FG002|Run-in|Other: Exclusionary Lab Value|0|||
148812156|NCT00580840|536787150|FG003|Run-in|Other: Exclusionary Lab Value|0|||
148812157|NCT00580840|536787147|FG000|Double-Blind|Adverse Event|0|||
148812158|NCT00580840|536787148|FG001|Double-Blind|Adverse Event|3|||
148812159|NCT00580840|536787149|FG002|Double-Blind|Adverse Event|4|||
148812160|NCT00580840|536787150|FG003|Double-Blind|Adverse Event|1|||
148812161|NCT00580840|536787147|FG000|Double-Blind|Loss of Efficacy|0|||
148812162|NCT00580840|536787148|FG001|Double-Blind|Loss of Efficacy|1|||
148812163|NCT00580840|536787149|FG002|Double-Blind|Loss of Efficacy|2|||
148812164|NCT00580840|536787150|FG003|Double-Blind|Loss of Efficacy|10|||
148812165|NCT00580840|536787147|FG000|Double-Blind|Lost to Follow-up|0|||
148812166|NCT00580840|536787148|FG001|Double-Blind|Lost to Follow-up|1|||
148812167|NCT00580840|536787149|FG002|Double-Blind|Lost to Follow-up|0|||
148812168|NCT00580840|536787150|FG003|Double-Blind|Lost to Follow-up|2|||
148812169|NCT00580840|536787147|FG000|Double-Blind|Withdrawal by Subject|0|||
148812170|NCT00580840|536787148|FG001|Double-Blind|Withdrawal by Subject|1|||
148812171|NCT00580840|536787149|FG002|Double-Blind|Withdrawal by Subject|2|||
148812172|NCT00580840|536787150|FG003|Double-Blind|Withdrawal by Subject|2|||
148812173|NCT00580840|536787147|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
148812174|NCT00580840|536787148|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
148812175|NCT00580840|536787149|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
148812176|NCT00580840|536787150|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
148812177|NCT00580840|536787147|FG000|Double-Blind|Other: Forbidden Medication|0|||
148812178|NCT00580840|536787148|FG001|Double-Blind|Other: Forbidden Medication|0|||
148812179|NCT00580840|536787149|FG002|Double-Blind|Other: Forbidden Medication|1|||
148812180|NCT00580840|536787150|FG003|Double-Blind|Other: Forbidden Medication|0|||
148812181|NCT00976027|536787152|FG000|Overall Study|Serious Adverse Event|36|||
148812182|NCT00976027|536787153|FG001|Overall Study|Serious Adverse Event|17|||
148812183|NCT00976027|536787152|FG000|Overall Study|Adverse Event|0|||
148812184|NCT00976027|536787153|FG001|Overall Study|Adverse Event|2|||
148812185|NCT00976027|536787152|FG000|Overall Study|Protocol Violation|60|||
148812186|NCT00976027|536787153|FG001|Overall Study|Protocol Violation|27|||
148812187|NCT00976027|536787152|FG000|Overall Study|Lost to Follow-up|208|||
148812188|NCT00976027|536787153|FG001|Overall Study|Lost to Follow-up|103|||
148812189|NCT00976027|536787152|FG000|Overall Study|Withdrawal by Subject|107|||
148693475|NCT02446132|536352217|FG001|Overall Study|Non-compliance With Study Drug|2|||
148693476|NCT02446132|536352218|FG002|Overall Study|Non-compliance With Study Drug|3|||
148693477|NCT02446132|536352216|FG000|Overall Study|Physician Decision|1|||
148693478|NCT02446132|536352217|FG001|Overall Study|Physician Decision|8|||
148693479|NCT02446132|536352218|FG002|Overall Study|Physician Decision|13|||
148693480|NCT02446132|536352216|FG000|Overall Study|Protocol Deviation|0|||
148693481|NCT02446132|536352217|FG001|Overall Study|Protocol Deviation|0|||
149023922|NCT02320721|537562709|FG001|Overall Study|Randomized but not treated|1|||
149023923|NCT02320721|537562708|FG000|Overall Study|Hypoglycemia|1|||
149023924|NCT02320721|537562709|FG001|Overall Study|Hypoglycemia|0|||
149023925|NCT02320721|537562708|FG000|Overall Study|Other than specified above|15|||
149023926|NCT02320721|537562709|FG001|Overall Study|Other than specified above|20|||
149023927|NCT03173248|537562710|FG000|Overall Study|Death|28|||
149023928|NCT03173248|537562711|FG001|Overall Study|Death|46|||
149023929|NCT03173248|537562710|FG000|Overall Study|Lost to Follow-up|0|||
148693482|NCT02446132|536352218|FG002|Overall Study|Protocol Deviation|1|||
148693483|NCT02446132|536352216|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
149023930|NCT03173248|537562711|FG001|Overall Study|Lost to Follow-up|1|||
148693484|NCT02446132|536352217|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
148693485|NCT02446132|536352218|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
148693486|NCT02446132|536352216|FG000|Overall Study|Study Terminated by Sponsor|4|||
148693487|NCT02446132|536352217|FG001|Overall Study|Study Terminated by Sponsor|35|||
148693488|NCT02446132|536352218|FG002|Overall Study|Study Terminated by Sponsor|58|||
148693489|NCT02446132|536352216|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
148693490|NCT02446132|536352217|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
149023931|NCT03173248|537562710|FG000|Overall Study|Withdrawal by Subject|6|||
148960909|NCT02631850|537341469|FG000|Treatment Period|Withdrawal by Subject|0|||
148693491|NCT02446132|536352218|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
148693492|NCT02446132|536352216|FG000|Overall Study|Withdrawal by Subject|11|||
148693493|NCT02446132|536352217|FG001|Overall Study|Withdrawal by Subject|29|||
148693494|NCT02446132|536352218|FG002|Overall Study|Withdrawal by Subject|25|||
148693495|NCT02446132|536352216|FG000|Overall Study|Reason not Specified|4|||
148693496|NCT02446132|536352217|FG001|Overall Study|Reason not Specified|16|||
149023932|NCT03173248|537562711|FG001|Overall Study|Withdrawal by Subject|4|||
148693497|NCT02446132|536352218|FG002|Overall Study|Reason not Specified|10|||
148693498|NCT02446132|536352216|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
148693499|NCT02446132|536352217|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
148693500|NCT02446132|536352218|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
148693501|NCT05526248|536352219|FG000|Overall Study|Lost to Follow-up|1|||
148693502|NCT05526248|536352219|FG000|Overall Study|Adverse Event|2|||
148693503|NCT05526248|536352219|FG000|Overall Study|Withdrawal by Subject|1|||
148693504|NCT01957488|536352221|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
148693505|NCT01957488|536352222|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
149023933|NCT03173248|537562710|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
148693506|NCT01957488|536352223|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
148693507|NCT01957488|536352224|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
148693508|NCT01957488|536352225|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
148693509|NCT01957488|536352226|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
148693510|NCT01957488|536352221|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
148693511|NCT01957488|536352222|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
148693512|NCT01957488|536352223|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
148693513|NCT01957488|536352224|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
148693514|NCT01957488|536352225|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
148693515|NCT01957488|536352226|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
148693516|NCT01957488|536352221|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
148693517|NCT01957488|536352222|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
148693518|NCT01957488|536352223|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
148693519|NCT01957488|536352224|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
148693520|NCT01957488|536352225|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
148693521|NCT01957488|536352226|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
148693522|NCT01957488|536352221|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
148693523|NCT01957488|536352222|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
148693524|NCT01957488|536352223|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
148693525|NCT01957488|536352224|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
148693526|NCT01957488|536352225|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
148693527|NCT01957488|536352226|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
148693528|NCT01957488|536352221|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
148693529|NCT01957488|536352222|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
148693530|NCT01957488|536352223|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
148693531|NCT01957488|536352224|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
148693532|NCT01957488|536352225|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
148693533|NCT01957488|536352226|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
148693534|NCT01957488|536352221|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
148693535|NCT01957488|536352222|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
148693536|NCT01957488|536352223|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
148693537|NCT01957488|536352224|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
148693538|NCT01957488|536352225|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
148693539|NCT01957488|536352226|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
148693540|NCT01957488|536352221|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
148693541|NCT01957488|536352222|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
148693542|NCT01957488|536352223|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
148693543|NCT01957488|536352224|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
148693544|NCT01957488|536352225|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
148693545|NCT01957488|536352226|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
148693546|NCT01957488|536352221|FG000|Test Period 2 (2 Weeks)|Other|1|||
148693547|NCT01957488|536352222|FG001|Test Period 2 (2 Weeks)|Other|0|||
148693548|NCT01957488|536352223|FG002|Test Period 2 (2 Weeks)|Other|0|||
148693549|NCT01957488|536352224|FG003|Test Period 2 (2 Weeks)|Other|0|||
148693550|NCT01957488|536352225|FG004|Test Period 2 (2 Weeks)|Other|0|||
148693551|NCT01957488|536352226|FG005|Test Period 2 (2 Weeks)|Other|0|||
148693552|NCT01957488|536352221|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
148693553|NCT01957488|536352222|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
148693554|NCT01957488|536352223|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
148693555|NCT01957488|536352224|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
148693556|NCT01957488|536352225|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
148693557|NCT01957488|536352226|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
148693558|NCT01957488|536352221|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
148693559|NCT01957488|536352222|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
148693560|NCT01957488|536352223|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
148693561|NCT01957488|536352224|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
148960910|NCT02631850|537341470|FG001|Treatment Period|Withdrawal by Subject|5|||
148960911|NCT02631850|537341471|FG002|Treatment Period|Withdrawal by Subject|2|||
148960912|NCT02631850|537341472|FG003|Treatment Period|Withdrawal by Subject|2|||
148812190|NCT00976027|536787153|FG001|Overall Study|Withdrawal by Subject|66|||
148812191|NCT05845619|536787154|FG000|Overall Study|duplicate enrollment|2|||
148812192|NCT05845619|536787155|FG001|Overall Study|duplicate enrollment|2|||
148812193|NCT05845619|536787156|FG002|Overall Study|duplicate enrollment|1|||
148812194|NCT02864992|536787157|FG000|Overall Study|still on treatment|15|||
148812195|NCT02864992|536787158|FG001|Overall Study|still on treatment|1|||
148812196|NCT02864992|536787159|FG002|Overall Study|still on treatment|33|||
148812197|NCT04967222|536787160|FG000|Randomized|Lost to Follow-up|0|||
148812198|NCT04967222|536787161|FG001|Randomized|Lost to Follow-up|1|||
148812199|NCT04967222|536787162|FG002|Randomized|Lost to Follow-up|1|||
148812200|NCT04967222|536787160|FG000|Randomized|Physician Decision|0|||
148812201|NCT04967222|536787161|FG001|Randomized|Physician Decision|0|||
149023934|NCT03173248|537562711|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
149023935|NCT01544582|537562712|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
148693562|NCT01957488|536352225|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
148693563|NCT01957488|536352226|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
148693564|NCT01957488|536352221|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
148693565|NCT01957488|536352222|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
148693566|NCT01957488|536352223|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
148693567|NCT01957488|536352224|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
148693568|NCT01957488|536352225|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
149023936|NCT01544582|537562713|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
148812202|NCT04967222|536787162|FG002|Randomized|Physician Decision|1|||
148812203|NCT04967222|536787160|FG000|Randomized|Withdrawal by Subject|0|||
148812204|NCT04967222|536787161|FG001|Randomized|Withdrawal by Subject|0|||
148812205|NCT04967222|536787162|FG002|Randomized|Withdrawal by Subject|2|||
148693569|NCT01957488|536352226|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
148693570|NCT01957488|536352221|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
148693571|NCT01957488|536352222|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
148693572|NCT01957488|536352223|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
148693573|NCT01957488|536352224|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
148812206|NCT04967222|536787160|FG000|Randomized|abnormal finding in MRI|0|||
148812207|NCT04967222|536787161|FG001|Randomized|abnormal finding in MRI|2|||
149023937|NCT01544582|537562714|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
148812208|NCT04967222|536787162|FG002|Randomized|abnormal finding in MRI|0|||
148812209|NCT01295944|536787163|FG000|Overall Study|Switched to alternative treatment|1|||
148693574|NCT01957488|536352225|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
148693575|NCT01957488|536352226|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
148693576|NCT01957488|536352221|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
148693577|NCT01957488|536352222|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
148693578|NCT01957488|536352223|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
148693579|NCT01957488|536352224|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
148693580|NCT01957488|536352225|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
148693581|NCT01957488|536352226|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
148693582|NCT00810368|536352227|FG000|Overall Study|Lost to Follow-up|4|||
148693583|NCT00810368|536352228|FG001|Overall Study|Lost to Follow-up|2|||
148693584|NCT00810368|536352227|FG000|Overall Study|Lack of Efficacy|2|||
148693585|NCT00810368|536352228|FG001|Overall Study|Lack of Efficacy|0|||
148693586|NCT00623103|536352229|FG000|Overall Study|Adverse Event|70|||
148693587|NCT00623103|536352230|FG001|Overall Study|Adverse Event|60|||
148693588|NCT00623103|536352229|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
148693589|NCT00623103|536352230|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
148693590|NCT00623103|536352229|FG000|Overall Study|Withdrawal by Subject|18|||
148693591|NCT00623103|536352230|FG001|Overall Study|Withdrawal by Subject|24|||
148693592|NCT00623103|536352229|FG000|Overall Study|Lost to Follow-up|4|||
148693593|NCT00623103|536352230|FG001|Overall Study|Lost to Follow-up|1|||
148693594|NCT00623103|536352229|FG000|Overall Study|Administrative problems|2|||
148693595|NCT00623103|536352230|FG001|Overall Study|Administrative problems|4|||
148693596|NCT00623103|536352229|FG000|Overall Study|Death|11|||
148693597|NCT00623103|536352230|FG001|Overall Study|Death|11|||
148693598|NCT00623103|536352229|FG000|Overall Study|Protocol deviation|2|||
148693599|NCT00623103|536352230|FG001|Overall Study|Protocol deviation|1|||
148693600|NCT01424722|536352234|FG000|Overall Study|Sponsor terminated investigation|2258|||
148693601|NCT01025037|536352235|FG000|Overall Study|Adverse Event|3|||
148693602|NCT01025037|536352235|FG000|Overall Study|Lost to Follow-up|7|||
148693603|NCT01025037|536352235|FG000|Overall Study|Withdrawal by Subject|1|||
148693604|NCT02674334|536352238|FG000|Overall Study|Lost to Follow-up|5|||
148693605|NCT02674334|536352239|FG001|Overall Study|Lost to Follow-up|3|||
148693606|NCT02674334|536352238|FG000|Overall Study|participant difficulty breathing|1|||
148693607|NCT02674334|536352239|FG001|Overall Study|participant difficulty breathing|0|||
148693608|NCT02674334|536352238|FG000|Overall Study|NIRS not recording|1|||
148693609|NCT02674334|536352239|FG001|Overall Study|NIRS not recording|0|||
148693610|NCT02660242|536352245|FG000|Glucose Tabs|Lost to Follow-up|1|||
148693611|NCT02660242|536352245|FG000|Glucagon Injection|Lost to Follow-up|1|||
148693612|NCT00770510|536352246|FG000|Overall Study|Lost to Follow-up|2|||
148693613|NCT00770510|536352246|FG000|Overall Study|Pregnancy|1|||
148693614|NCT00770510|536352246|FG000|Overall Study|Withdrawal by Subject|2|||
148693615|NCT02796664|536352250|FG000|Overall Study|Withdrawal by Subject|0|||
148693616|NCT02796664|536352251|FG001|Overall Study|Withdrawal by Subject|3|||
148693617|NCT02796664|536352250|FG000|Overall Study|Noncompliance|1|||
148693618|NCT02796664|536352251|FG001|Overall Study|Noncompliance|1|||
148693619|NCT02796664|536352250|FG000|Overall Study|Death|0|||
148693620|NCT02796664|536352251|FG001|Overall Study|Death|1|||
148693621|NCT01531205|536352255|FG000|Overall Study|Did not proceed to surgery|1|||
148693622|NCT00995553|536352256|FG000|Overall Study|Withdrawal by Subject|2|||
148693623|NCT00995553|536352257|FG001|Overall Study|Withdrawal by Subject|6|||
148693624|NCT00927810|536352258|FG000|Overall Study|Withdrawal by Subject|0|||
148693625|NCT00927810|536352259|FG001|Overall Study|Withdrawal by Subject|3|||
148693626|NCT00927810|536352260|FG002|Overall Study|Withdrawal by Subject|0|||
148693627|NCT00927810|536352261|FG003|Overall Study|Withdrawal by Subject|1|||
148693628|NCT00927810|536352258|FG000|Overall Study|Lost to Follow-up|0|||
148693629|NCT00927810|536352259|FG001|Overall Study|Lost to Follow-up|2|||
148693630|NCT00927810|536352260|FG002|Overall Study|Lost to Follow-up|1|||
148693631|NCT00927810|536352261|FG003|Overall Study|Lost to Follow-up|1|||
148693632|NCT00927810|536352258|FG000|Overall Study|Death|0|||
148693633|NCT00927810|536352259|FG001|Overall Study|Death|2|||
148693634|NCT00927810|536352260|FG002|Overall Study|Death|0|||
148693635|NCT00927810|536352261|FG003|Overall Study|Death|0|||
148693636|NCT00927810|536352258|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148693637|NCT00927810|536352259|FG001|Overall Study|Abnormal laboratory value(s)|1|||
148693638|NCT00927810|536352260|FG002|Overall Study|Abnormal laboratory value(s)|0|||
148693639|NCT00927810|536352261|FG003|Overall Study|Abnormal laboratory value(s)|0|||
148693640|NCT02465567|536352264|FG000|Overall Study|Adverse Event|118|||
148693641|NCT02465567|536352265|FG001|Overall Study|Adverse Event|113|||
148693642|NCT02465567|536352266|FG002|Overall Study|Adverse Event|147|||
148812210|NCT01295944|536787163|FG000|Overall Study|Ineligible|9|||
148812211|NCT01295944|536787163|FG000|Overall Study|Withdrawal by Subject|1|||
149023938|NCT01544582|537562715|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
149023939|NCT01544582|537562712|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
149023940|NCT01544582|537562713|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
149023941|NCT01544582|537562714|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
149023942|NCT01544582|537562715|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
148693643|NCT02465567|536352267|FG003|Overall Study|Adverse Event|138|||
148693644|NCT02465567|536352264|FG000|Overall Study|Lack of Efficacy|103|||
148812212|NCT01295944|536787163|FG000|Overall Study|Participant chose to be treated in Peru|1|||
148693645|NCT02465567|536352265|FG001|Overall Study|Lack of Efficacy|102|||
148693646|NCT02465567|536352266|FG002|Overall Study|Lack of Efficacy|171|||
148693647|NCT02465567|536352267|FG003|Overall Study|Lack of Efficacy|135|||
148693648|NCT02465567|536352264|FG000|Overall Study|Withdrawal by Subject|104|||
148693649|NCT02465567|536352265|FG001|Overall Study|Withdrawal by Subject|94|||
148693650|NCT02465567|536352266|FG002|Overall Study|Withdrawal by Subject|123|||
148693651|NCT02465567|536352267|FG003|Overall Study|Withdrawal by Subject|130|||
148693652|NCT02465567|536352264|FG000|Overall Study|Physician Decision|23|||
148693653|NCT02465567|536352265|FG001|Overall Study|Physician Decision|33|||
148693654|NCT02465567|536352266|FG002|Overall Study|Physician Decision|38|||
148693655|NCT02465567|536352267|FG003|Overall Study|Physician Decision|28|||
148693656|NCT02465567|536352264|FG000|Overall Study|Major Protocol Deviation|24|||
148693657|NCT02465567|536352265|FG001|Overall Study|Major Protocol Deviation|26|||
148693658|NCT02465567|536352266|FG002|Overall Study|Major Protocol Deviation|22|||
148693659|NCT02465567|536352267|FG003|Overall Study|Major Protocol Deviation|25|||
148693660|NCT02465567|536352264|FG000|Overall Study|Lost to Follow-up|25|||
148693661|NCT02465567|536352265|FG001|Overall Study|Lost to Follow-up|21|||
148693662|NCT02465567|536352266|FG002|Overall Study|Lost to Follow-up|19|||
148693663|NCT02465567|536352267|FG003|Overall Study|Lost to Follow-up|15|||
148693664|NCT02465567|536352264|FG000|Overall Study|Protocol Specified Criteria|20|||
148693665|NCT02465567|536352265|FG001|Overall Study|Protocol Specified Criteria|10|||
148960913|NCT02631850|537341469|FG000|Treatment Period|Adverse Event|1|||
148693666|NCT02465567|536352266|FG002|Overall Study|Protocol Specified Criteria|9|||
148693667|NCT02465567|536352267|FG003|Overall Study|Protocol Specified Criteria|12|||
148693668|NCT02465567|536352264|FG000|Overall Study|Administrative Reasons|12|||
148960914|NCT02631850|537341470|FG001|Treatment Period|Adverse Event|0|||
148960915|NCT02631850|537341471|FG002|Treatment Period|Adverse Event|2|||
148960916|NCT02631850|537341472|FG003|Treatment Period|Adverse Event|3|||
148960917|NCT02631850|537341469|FG000|Treatment Period|Family medical issue|1|||
148960918|NCT02631850|537341470|FG001|Treatment Period|Family medical issue|0|||
148960919|NCT02631850|537341471|FG002|Treatment Period|Family medical issue|0|||
148960920|NCT02631850|537341472|FG003|Treatment Period|Family medical issue|0|||
149023943|NCT01544582|537562712|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
149023944|NCT01544582|537562713|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
148693669|NCT02465567|536352265|FG001|Overall Study|Administrative Reasons|9|||
148693670|NCT02465567|536352266|FG002|Overall Study|Administrative Reasons|11|||
148693671|NCT02465567|536352267|FG003|Overall Study|Administrative Reasons|5|||
148693672|NCT02465567|536352264|FG000|Overall Study|Randomized but not treated|1|||
148693673|NCT02465567|536352265|FG001|Overall Study|Randomized but not treated|5|||
148693674|NCT02465567|536352266|FG002|Overall Study|Randomized but not treated|4|||
148693675|NCT02465567|536352267|FG003|Overall Study|Randomized but not treated|5|||
148693676|NCT02465567|536352264|FG000|Overall Study|enrolled in >1 studies|18|||
148693677|NCT02465567|536352265|FG001|Overall Study|enrolled in >1 studies|11|||
148812213|NCT01295944|536787163|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
148812214|NCT01295944|536787163|FG000|Overall Study|Physician Decision|1|||
148812215|NCT01295944|536787163|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
148812216|NCT01295944|536787163|FG000|Overall Study|Disease progression|4|||
148812217|NCT01295944|536787163|FG000|Overall Study|Transferred care before starting new treatment|1|||
148812218|NCT04279522|536787164|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
148812219|NCT04279522|536787165|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
148812220|NCT04279522|536787164|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
148812221|NCT04279522|536787165|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
148693678|NCT02465567|536352266|FG002|Overall Study|enrolled in >1 studies|19|||
148693679|NCT02465567|536352267|FG003|Overall Study|enrolled in >1 studies|15|||
148812222|NCT04279522|536787164|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
148812223|NCT04279522|536787165|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
148812224|NCT04279522|536787164|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
148812225|NCT04279522|536787165|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
148812226|NCT04279522|536787164|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
148812227|NCT04279522|536787165|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
148812228|NCT04279522|536787164|FG000|Period 2: Open Label Phase|Physician Decision|0|||
148812229|NCT04279522|536787165|FG001|Period 2: Open Label Phase|Physician Decision|3|||
148812230|NCT04279522|536787164|FG000|Period 2: Open Label Phase|Adverse Event|0|||
148812231|NCT04279522|536787165|FG001|Period 2: Open Label Phase|Adverse Event|1|||
148693680|NCT02465567|536352264|FG000|Overall Study|missing PI Signature|1|||
148693681|NCT02465567|536352265|FG001|Overall Study|missing PI Signature|0|||
148693682|NCT02465567|536352266|FG002|Overall Study|missing PI Signature|0|||
148693683|NCT02465567|536352267|FG003|Overall Study|missing PI Signature|0|||
148693684|NCT02001558|536352268|FG000|Overall Study|Lost to Follow-up|8|||
148693685|NCT02001558|536352269|FG001|Overall Study|Lost to Follow-up|14|||
148693686|NCT04117607|536352270|FG000|Overall Study|Early Termination|0|||
148693687|NCT04117607|536352271|FG001|Overall Study|Early Termination|1|||
148693688|NCT04117607|536352272|FG002|Overall Study|Early Termination|0|||
148693689|NCT04117607|536352273|FG003|Overall Study|Early Termination|0|||
148693690|NCT04117607|536352274|FG004|Overall Study|Early Termination|0|||
148812232|NCT04279522|536787164|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
148812233|NCT04279522|536787165|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
148812234|NCT02629159|536787166|FG000|Overall Study|Adverse Event|17|||
148812235|NCT02629159|536787167|FG001|Overall Study|Adverse Event|20|||
148693691|NCT04117607|536352275|FG005|Overall Study|Early Termination|0|||
148693692|NCT04117607|536352276|FG006|Overall Study|Early Termination|1|||
148693693|NCT04117607|536352277|FG007|Overall Study|Early Termination|0|||
148693694|NCT04117607|536352278|FG008|Overall Study|Early Termination|0|||
148693695|NCT04117607|536352279|FG009|Overall Study|Early Termination|0|||
148812236|NCT02629159|536787168|FG002|Overall Study|Adverse Event|22|||
148693696|NCT04117607|536352280|FG010|Overall Study|Early Termination|0|||
148693697|NCT04117607|536352281|FG011|Overall Study|Early Termination|0|||
148693698|NCT04117607|536352282|FG012|Overall Study|Early Termination|0|||
148693699|NCT04117607|536352283|FG013|Overall Study|Early Termination|0|||
148693700|NCT00950807|536352286|FG000|Treatment Period 1|Lack of Efficacy|1|||
148693701|NCT00950807|536352287|FG001|Treatment Period 1|Lack of Efficacy|0|||
148693702|NCT00950807|536352288|FG002|Treatment Period 1|Lack of Efficacy|0|||
148693703|NCT00950807|536352289|FG003|Treatment Period 1|Lack of Efficacy|0|||
148693704|NCT00950807|536352290|FG004|Treatment Period 1|Lack of Efficacy|0|||
148693705|NCT00950807|536352291|FG005|Treatment Period 1|Lack of Efficacy|1|||
148693706|NCT00950807|536352292|FG006|Treatment Period 1|Lack of Efficacy|0|||
148693707|NCT00950807|536352293|FG007|Treatment Period 1|Lack of Efficacy|0|||
148693708|NCT00950807|536352294|FG008|Treatment Period 1|Lack of Efficacy|0|||
148693709|NCT00950807|536352295|FG009|Treatment Period 1|Lack of Efficacy|0|||
148693710|NCT00950807|536352286|FG000|Treatment Period 1|Protocol Violation|1|||
148693711|NCT00950807|536352287|FG001|Treatment Period 1|Protocol Violation|0|||
148693712|NCT00950807|536352288|FG002|Treatment Period 1|Protocol Violation|0|||
148693713|NCT00950807|536352289|FG003|Treatment Period 1|Protocol Violation|0|||
148693714|NCT00950807|536352290|FG004|Treatment Period 1|Protocol Violation|0|||
148812237|NCT02629159|536787166|FG000|Overall Study|Withdrawal by Subject|22|||
148693715|NCT00950807|536352291|FG005|Treatment Period 1|Protocol Violation|0|||
148693716|NCT00950807|536352292|FG006|Treatment Period 1|Protocol Violation|0|||
148693717|NCT00950807|536352293|FG007|Treatment Period 1|Protocol Violation|0|||
148693718|NCT00950807|536352294|FG008|Treatment Period 1|Protocol Violation|0|||
148812238|NCT02629159|536787167|FG001|Overall Study|Withdrawal by Subject|11|||
148693719|NCT00950807|536352295|FG009|Treatment Period 1|Protocol Violation|0|||
148812239|NCT02629159|536787168|FG002|Overall Study|Withdrawal by Subject|15|||
148812240|NCT02629159|536787166|FG000|Overall Study|Lost to Follow-up|7|||
148812241|NCT02629159|536787167|FG001|Overall Study|Lost to Follow-up|4|||
148812242|NCT02629159|536787168|FG002|Overall Study|Lost to Follow-up|5|||
148812243|NCT02629159|536787166|FG000|Overall Study|Lack of Efficacy|4|||
148812244|NCT02629159|536787167|FG001|Overall Study|Lack of Efficacy|0|||
148812245|NCT02629159|536787168|FG002|Overall Study|Lack of Efficacy|1|||
148812246|NCT02629159|536787166|FG000|Overall Study|Other|6|||
148812247|NCT02629159|536787167|FG001|Overall Study|Other|4|||
148812248|NCT02629159|536787168|FG002|Overall Study|Other|8|||
148812249|NCT00831844|536787175|FG000|Overall Study|Adverse Event|2|||
148812250|NCT00831844|536787176|FG001|Overall Study|Adverse Event|0|||
148812251|NCT00831844|536787177|FG002|Overall Study|Adverse Event|0|||
148812252|NCT00831844|536787178|FG003|Overall Study|Adverse Event|0|||
148812253|NCT00831844|536787179|FG004|Overall Study|Adverse Event|1|||
148812254|NCT00831844|536787180|FG005|Overall Study|Adverse Event|1|||
148812255|NCT00831844|536787181|FG006|Overall Study|Adverse Event|2|||
148812256|NCT00831844|536787182|FG007|Overall Study|Adverse Event|0|||
148812257|NCT00831844|536787183|FG008|Overall Study|Adverse Event|0|||
148812258|NCT00831844|536787184|FG009|Overall Study|Adverse Event|0|||
148812259|NCT00831844|536787175|FG000|Overall Study|Death|0|||
148812260|NCT00831844|536787176|FG001|Overall Study|Death|0|||
148812261|NCT00831844|536787177|FG002|Overall Study|Death|0|||
148812262|NCT00831844|536787178|FG003|Overall Study|Death|1|||
148812263|NCT00831844|536787179|FG004|Overall Study|Death|0|||
148812264|NCT00831844|536787180|FG005|Overall Study|Death|0|||
148812265|NCT00831844|536787181|FG006|Overall Study|Death|0|||
148812266|NCT00831844|536787182|FG007|Overall Study|Death|0|||
148812267|NCT00831844|536787183|FG008|Overall Study|Death|0|||
148812268|NCT00831844|536787184|FG009|Overall Study|Death|0|||
148812269|NCT00831844|536787175|FG000|Overall Study|Lack of Efficacy|8|||
148812270|NCT00831844|536787176|FG001|Overall Study|Lack of Efficacy|10|||
148812271|NCT00831844|536787177|FG002|Overall Study|Lack of Efficacy|15|||
148812272|NCT00831844|536787178|FG003|Overall Study|Lack of Efficacy|8|||
148812273|NCT00831844|536787179|FG004|Overall Study|Lack of Efficacy|11|||
148812274|NCT00831844|536787180|FG005|Overall Study|Lack of Efficacy|17|||
148812275|NCT00831844|536787181|FG006|Overall Study|Lack of Efficacy|8|||
148812276|NCT00831844|536787182|FG007|Overall Study|Lack of Efficacy|9|||
148812277|NCT00831844|536787183|FG008|Overall Study|Lack of Efficacy|7|||
148812278|NCT00831844|536787184|FG009|Overall Study|Lack of Efficacy|0|||
148812279|NCT00831844|536787175|FG000|Overall Study|Physician Decision|0|||
148812280|NCT00831844|536787176|FG001|Overall Study|Physician Decision|1|||
148812281|NCT00831844|536787177|FG002|Overall Study|Physician Decision|3|||
148812282|NCT00831844|536787178|FG003|Overall Study|Physician Decision|1|||
148812283|NCT00831844|536787179|FG004|Overall Study|Physician Decision|1|||
148812284|NCT00831844|536787180|FG005|Overall Study|Physician Decision|1|||
148812285|NCT00831844|536787181|FG006|Overall Study|Physician Decision|0|||
148812286|NCT00831844|536787182|FG007|Overall Study|Physician Decision|0|||
148812287|NCT00831844|536787183|FG008|Overall Study|Physician Decision|1|||
148812288|NCT00831844|536787184|FG009|Overall Study|Physician Decision|0|||
148812289|NCT00831844|536787175|FG000|Overall Study|Withdrawal by Subject|0|||
148812290|NCT00831844|536787176|FG001|Overall Study|Withdrawal by Subject|0|||
148812291|NCT00831844|536787177|FG002|Overall Study|Withdrawal by Subject|1|||
148812292|NCT00831844|536787178|FG003|Overall Study|Withdrawal by Subject|0|||
148812293|NCT00831844|536787179|FG004|Overall Study|Withdrawal by Subject|0|||
148812294|NCT00831844|536787180|FG005|Overall Study|Withdrawal by Subject|0|||
148812295|NCT00831844|536787181|FG006|Overall Study|Withdrawal by Subject|0|||
148812296|NCT00831844|536787182|FG007|Overall Study|Withdrawal by Subject|1|||
148812297|NCT00831844|536787183|FG008|Overall Study|Withdrawal by Subject|1|||
148812298|NCT00831844|536787184|FG009|Overall Study|Withdrawal by Subject|0|||
148812299|NCT00831844|536787175|FG000|Overall Study|Ineligible|0|||
148812300|NCT00831844|536787176|FG001|Overall Study|Ineligible|1|||
148812301|NCT00831844|536787177|FG002|Overall Study|Ineligible|1|||
148812302|NCT00831844|536787178|FG003|Overall Study|Ineligible|0|||
148812303|NCT00831844|536787179|FG004|Overall Study|Ineligible|1|||
148812304|NCT00831844|536787180|FG005|Overall Study|Ineligible|0|||
148812305|NCT00831844|536787181|FG006|Overall Study|Ineligible|0|||
148812306|NCT00831844|536787182|FG007|Overall Study|Ineligible|0|||
148812307|NCT00831844|536787183|FG008|Overall Study|Ineligible|0|||
148812308|NCT00831844|536787184|FG009|Overall Study|Ineligible|0|||
148812309|NCT00830765|536787185|FG000|Overall Study|Protocol Violation|3|||
148812310|NCT00830765|536787186|FG001|Overall Study|Protocol Violation|2|||
148812311|NCT00315445|536787187|FG000|Overall Study|Adverse Event|7|||
148812312|NCT00315445|536787188|FG001|Overall Study|Adverse Event|12|||
148812313|NCT00315445|536787189|FG002|Overall Study|Adverse Event|15|||
148812314|NCT00315445|536787187|FG000|Overall Study|Lack of Efficacy|16|||
148812315|NCT00315445|536787188|FG001|Overall Study|Lack of Efficacy|1|||
149023945|NCT01544582|537562714|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
149023946|NCT01544582|537562715|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
148693720|NCT00950807|536352286|FG000|Treatment Period 1|Lost to Follow-up|0|||
148812316|NCT00315445|536787189|FG002|Overall Study|Lack of Efficacy|7|||
148812317|NCT00315445|536787187|FG000|Overall Study|Lost to Follow-up|1|||
148812318|NCT00315445|536787188|FG001|Overall Study|Lost to Follow-up|0|||
148812319|NCT00315445|536787189|FG002|Overall Study|Lost to Follow-up|1|||
148812320|NCT00315445|536787187|FG000|Overall Study|Protocol Violation|2|||
148812321|NCT00315445|536787188|FG001|Overall Study|Protocol Violation|0|||
148812322|NCT00315445|536787189|FG002|Overall Study|Protocol Violation|1|||
148812323|NCT00315445|536787187|FG000|Overall Study|Other|1|||
148812324|NCT00315445|536787188|FG001|Overall Study|Other|3|||
148812325|NCT00315445|536787189|FG002|Overall Study|Other|0|||
148812326|NCT01299909|536787190|FG000|Overall Study|Lost to Follow-up|22|||
148812327|NCT01299909|536787191|FG001|Overall Study|Lost to Follow-up|18|||
148812328|NCT01299909|536787192|FG002|Overall Study|Lost to Follow-up|17|||
148812329|NCT02460289|536787193|FG000|Overall Study|Adverse Event|1|||
148812330|NCT02460289|536787193|FG000|Overall Study|Withdrawal by Subject|8|||
148812331|NCT02460289|536787193|FG000|Overall Study|Lost to Follow-up|1|||
148812332|NCT01155570|536787194|FG000|Overall Study|Adverse Event|39|||
148812333|NCT01155570|536787194|FG000|Overall Study|Lack of Efficacy|46|||
148812334|NCT01155570|536787194|FG000|Overall Study|Participant's Economic Reasons|17|||
148812335|NCT01155570|536787194|FG000|Overall Study|No Hospital Visits|7|||
148693721|NCT00950807|536352287|FG001|Treatment Period 1|Lost to Follow-up|0|||
148693722|NCT00950807|536352288|FG002|Treatment Period 1|Lost to Follow-up|1|||
148693723|NCT00950807|536352289|FG003|Treatment Period 1|Lost to Follow-up|0|||
148693724|NCT00950807|536352290|FG004|Treatment Period 1|Lost to Follow-up|0|||
149023947|NCT01544582|537562712|FG000|Analysis Population|Physician Decision|0|||
149023948|NCT01544582|537562713|FG001|Analysis Population|Physician Decision|13|||
149023949|NCT01544582|537562714|FG002|Analysis Population|Physician Decision|10|||
149023950|NCT01544582|537562715|FG003|Analysis Population|Physician Decision|9|||
149023951|NCT01544582|537562712|FG000|Analysis Population|Safety Reason|0|||
149023952|NCT01544582|537562713|FG001|Analysis Population|Safety Reason|33|||
149023953|NCT01544582|537562714|FG002|Analysis Population|Safety Reason|31|||
149023954|NCT01544582|537562715|FG003|Analysis Population|Safety Reason|8|||
149023955|NCT01544582|537562712|FG000|Analysis Population|Effectiveness Reason|0|||
149023956|NCT01544582|537562713|FG001|Analysis Population|Effectiveness Reason|48|||
149023957|NCT01544582|537562714|FG002|Analysis Population|Effectiveness Reason|29|||
149023958|NCT01544582|537562715|FG003|Analysis Population|Effectiveness Reason|12|||
149023959|NCT01544582|537562712|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
149023960|NCT01544582|537562713|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
149023961|NCT01544582|537562714|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
149023962|NCT01544582|537562715|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
149023963|NCT01544582|537562712|FG000|Analysis Population|Lost to Follow-up|0|||
149023964|NCT01544582|537562713|FG001|Analysis Population|Lost to Follow-up|6|||
148693725|NCT00950807|536352291|FG005|Treatment Period 1|Lost to Follow-up|0|||
148693726|NCT00950807|536352292|FG006|Treatment Period 1|Lost to Follow-up|0|||
149023965|NCT01544582|537562714|FG002|Analysis Population|Lost to Follow-up|6|||
149023966|NCT01544582|537562715|FG003|Analysis Population|Lost to Follow-up|5|||
149023967|NCT01544582|537562712|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
149023968|NCT01544582|537562713|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
149023969|NCT01544582|537562714|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
148693727|NCT00950807|536352293|FG007|Treatment Period 1|Lost to Follow-up|0|||
148693728|NCT00950807|536352294|FG008|Treatment Period 1|Lost to Follow-up|0|||
148693729|NCT00950807|536352295|FG009|Treatment Period 1|Lost to Follow-up|0|||
148693730|NCT00950807|536352286|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148693731|NCT00950807|536352287|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148693732|NCT00950807|536352288|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148693733|NCT00950807|536352289|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148693734|NCT00950807|536352290|FG004|Treatment Period 1|Withdrawal by Subject|1|||
148693735|NCT00950807|536352291|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148693736|NCT00950807|536352292|FG006|Treatment Period 1|Withdrawal by Subject|0|||
148693737|NCT00950807|536352293|FG007|Treatment Period 1|Withdrawal by Subject|0|||
148693738|NCT00950807|536352294|FG008|Treatment Period 1|Withdrawal by Subject|1|||
148693739|NCT00950807|536352295|FG009|Treatment Period 1|Withdrawal by Subject|0|||
148693740|NCT00950807|536352286|FG000|Treatment Period 1|Adverse Event|0|||
148693741|NCT00950807|536352287|FG001|Treatment Period 1|Adverse Event|0|||
148693742|NCT00950807|536352288|FG002|Treatment Period 1|Adverse Event|0|||
148693743|NCT00950807|536352289|FG003|Treatment Period 1|Adverse Event|0|||
148693744|NCT00950807|536352290|FG004|Treatment Period 1|Adverse Event|0|||
148693745|NCT00950807|536352291|FG005|Treatment Period 1|Adverse Event|1|||
148693746|NCT00950807|536352292|FG006|Treatment Period 1|Adverse Event|0|||
148693747|NCT00950807|536352293|FG007|Treatment Period 1|Adverse Event|0|||
148693748|NCT00950807|536352294|FG008|Treatment Period 1|Adverse Event|0|||
148693749|NCT00950807|536352295|FG009|Treatment Period 1|Adverse Event|0|||
148693750|NCT00950807|536352286|FG000|Washout Period 1|Lack of Efficacy|0|||
148693751|NCT00950807|536352287|FG001|Washout Period 1|Lack of Efficacy|0|||
148693752|NCT00950807|536352288|FG002|Washout Period 1|Lack of Efficacy|0|||
148693753|NCT00950807|536352289|FG003|Washout Period 1|Lack of Efficacy|0|||
148693754|NCT00950807|536352290|FG004|Washout Period 1|Lack of Efficacy|0|||
148693755|NCT00950807|536352291|FG005|Washout Period 1|Lack of Efficacy|0|||
148693756|NCT00950807|536352292|FG006|Washout Period 1|Lack of Efficacy|1|||
148693757|NCT00950807|536352293|FG007|Washout Period 1|Lack of Efficacy|0|||
148960921|NCT02631850|537341469|FG000|6 Month Follow up|Lost to Follow-up|5|||
148960922|NCT02631850|537341470|FG001|6 Month Follow up|Lost to Follow-up|8|||
148960923|NCT02631850|537341471|FG002|6 Month Follow up|Lost to Follow-up|3|||
148960924|NCT02631850|537341472|FG003|6 Month Follow up|Lost to Follow-up|5|||
148960925|NCT02631850|537341469|FG000|6 Month Follow up|Withdrawal by Subject|1|||
148960926|NCT02631850|537341470|FG001|6 Month Follow up|Withdrawal by Subject|0|||
148960927|NCT02631850|537341471|FG002|6 Month Follow up|Withdrawal by Subject|0|||
148960928|NCT02631850|537341472|FG003|6 Month Follow up|Withdrawal by Subject|2|||
148960929|NCT02631850|537341469|FG000|6 Month Follow up|Adverse Event|1|||
148960930|NCT02631850|537341470|FG001|6 Month Follow up|Adverse Event|4|||
148960931|NCT02631850|537341471|FG002|6 Month Follow up|Adverse Event|1|||
148960932|NCT02631850|537341472|FG003|6 Month Follow up|Adverse Event|3|||
148960933|NCT02631850|537341469|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
148960934|NCT02631850|537341470|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
148960935|NCT02631850|537341471|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
148960936|NCT02631850|537341472|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
148693758|NCT00950807|536352294|FG008|Washout Period 1|Lack of Efficacy|0|||
148693759|NCT00950807|536352295|FG009|Washout Period 1|Lack of Efficacy|0|||
148693760|NCT00950807|536352286|FG000|Washout Period 1|Withdrawal by Subject|0|||
148693761|NCT00950807|536352287|FG001|Washout Period 1|Withdrawal by Subject|0|||
148693762|NCT00950807|536352288|FG002|Washout Period 1|Withdrawal by Subject|0|||
148693763|NCT00950807|536352289|FG003|Washout Period 1|Withdrawal by Subject|0|||
148693764|NCT00950807|536352290|FG004|Washout Period 1|Withdrawal by Subject|0|||
148693765|NCT00950807|536352291|FG005|Washout Period 1|Withdrawal by Subject|0|||
148693766|NCT00950807|536352292|FG006|Washout Period 1|Withdrawal by Subject|0|||
148693767|NCT00950807|536352293|FG007|Washout Period 1|Withdrawal by Subject|0|||
148693768|NCT00950807|536352294|FG008|Washout Period 1|Withdrawal by Subject|1|||
148693769|NCT00950807|536352295|FG009|Washout Period 1|Withdrawal by Subject|0|||
148693770|NCT00950807|536352286|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
148693771|NCT00950807|536352287|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148693772|NCT00950807|536352288|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148693773|NCT00950807|536352289|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148960937|NCT01462084|537341474|FG000|Overall Study|Withdrawal by Subject|1|||
148960938|NCT01462084|537341475|FG001|Overall Study|Withdrawal by Subject|0|||
148693774|NCT00950807|536352290|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148693775|NCT00950807|536352291|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148693776|NCT00950807|536352292|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
148693777|NCT00950807|536352293|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
148693778|NCT00950807|536352294|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148693779|NCT00950807|536352295|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
148693780|NCT00950807|536352286|FG000|Washout Period 1|Adverse Event|2|||
148693781|NCT00950807|536352287|FG001|Washout Period 1|Adverse Event|0|||
148693782|NCT00950807|536352288|FG002|Washout Period 1|Adverse Event|0|||
148693783|NCT00950807|536352289|FG003|Washout Period 1|Adverse Event|1|||
148693784|NCT00950807|536352290|FG004|Washout Period 1|Adverse Event|1|||
148693785|NCT00950807|536352291|FG005|Washout Period 1|Adverse Event|0|||
148693786|NCT00950807|536352292|FG006|Washout Period 1|Adverse Event|0|||
148693787|NCT00950807|536352293|FG007|Washout Period 1|Adverse Event|0|||
148693788|NCT00950807|536352294|FG008|Washout Period 1|Adverse Event|0|||
148693789|NCT00950807|536352295|FG009|Washout Period 1|Adverse Event|0|||
148693790|NCT00950807|536352286|FG000|Treatment Period 2|Lack of Efficacy|1|||
148693791|NCT00950807|536352287|FG001|Treatment Period 2|Lack of Efficacy|0|||
148693792|NCT00950807|536352288|FG002|Treatment Period 2|Lack of Efficacy|0|||
148693793|NCT00950807|536352289|FG003|Treatment Period 2|Lack of Efficacy|0|||
148693794|NCT00950807|536352290|FG004|Treatment Period 2|Lack of Efficacy|0|||
148693795|NCT00950807|536352291|FG005|Treatment Period 2|Lack of Efficacy|0|||
148693796|NCT00950807|536352292|FG006|Treatment Period 2|Lack of Efficacy|0|||
148693797|NCT00950807|536352293|FG007|Treatment Period 2|Lack of Efficacy|0|||
148693798|NCT00950807|536352294|FG008|Treatment Period 2|Lack of Efficacy|0|||
148693799|NCT00950807|536352295|FG009|Treatment Period 2|Lack of Efficacy|0|||
148693800|NCT00950807|536352286|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148693801|NCT00950807|536352287|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148693802|NCT00950807|536352288|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148693803|NCT00950807|536352289|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148693804|NCT00950807|536352290|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148693805|NCT00950807|536352291|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148693806|NCT00950807|536352292|FG006|Treatment Period 2|Withdrawal by Subject|1|||
148693807|NCT00950807|536352293|FG007|Treatment Period 2|Withdrawal by Subject|2|||
148693808|NCT00950807|536352294|FG008|Treatment Period 2|Withdrawal by Subject|0|||
148693809|NCT00950807|536352295|FG009|Treatment Period 2|Withdrawal by Subject|0|||
148693810|NCT00950807|536352286|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
148693811|NCT00950807|536352287|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693812|NCT00950807|536352288|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693813|NCT00950807|536352289|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693814|NCT00950807|536352290|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693815|NCT00950807|536352291|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693816|NCT00950807|536352292|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693817|NCT00950807|536352293|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693818|NCT00950807|536352294|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693819|NCT00950807|536352295|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
148693820|NCT00950807|536352286|FG000|Treatment Period 2|Adverse Event|0|||
148693821|NCT00950807|536352287|FG001|Treatment Period 2|Adverse Event|1|||
148693822|NCT00950807|536352288|FG002|Treatment Period 2|Adverse Event|0|||
148693823|NCT00950807|536352289|FG003|Treatment Period 2|Adverse Event|1|||
148693824|NCT00950807|536352290|FG004|Treatment Period 2|Adverse Event|0|||
148693825|NCT00950807|536352291|FG005|Treatment Period 2|Adverse Event|1|||
148693826|NCT00950807|536352292|FG006|Treatment Period 2|Adverse Event|0|||
148812336|NCT01155570|536787194|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
148812337|NCT01155570|536787194|FG000|Overall Study|Adverse Event + Other Reasons|7|||
148812338|NCT01155570|536787194|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
148812339|NCT01155570|536787194|FG000|Overall Study|Other Reasons|23|||
148812340|NCT01706328|536787204|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
148812341|NCT01706328|536787205|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148812342|NCT01706328|536787206|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148812343|NCT01706328|536787204|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
148812344|NCT01706328|536787205|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
148812345|NCT01706328|536787206|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
148812346|NCT01706328|536787204|FG000|2-week Run-in Period|Physician Decision|4|||
148812347|NCT01706328|536787205|FG001|2-week Run-in Period|Physician Decision|0|||
148812348|NCT01706328|536787206|FG002|2-week Run-in Period|Physician Decision|0|||
148812349|NCT01706328|536787204|FG000|2-week Run-in Period|Adverse Event|4|||
148812350|NCT01706328|536787205|FG001|2-week Run-in Period|Adverse Event|0|||
148812351|NCT01706328|536787206|FG002|2-week Run-in Period|Adverse Event|0|||
148812352|NCT01706328|536787204|FG000|2-week Run-in Period|Lost to Follow-up|2|||
148812353|NCT01706328|536787205|FG001|2-week Run-in Period|Lost to Follow-up|0|||
148812354|NCT01706328|536787206|FG002|2-week Run-in Period|Lost to Follow-up|0|||
148812355|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
148812356|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
148812357|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
148812358|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
148812359|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
148812360|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
148812361|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
148812362|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
148812363|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
148812364|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
148812365|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
148812366|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
148812367|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
148812368|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
148812369|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
148812370|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
148812371|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
148812372|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
148812373|NCT01706328|536787204|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
148812374|NCT01706328|536787205|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
148812375|NCT01706328|536787206|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
148812376|NCT06481579|536787207|FG000|Overall Study|Death|1|||
148812377|NCT06481579|536787208|FG001|Overall Study|Death|0|||
148812378|NCT06481579|536787207|FG000|Overall Study|Withdrawal by Subject|3|||
148812379|NCT06481579|536787208|FG001|Overall Study|Withdrawal by Subject|0|||
148812380|NCT06481579|536787207|FG000|Overall Study|Other|1|||
148812381|NCT06481579|536787208|FG001|Overall Study|Other|1|||
148812382|NCT00770809|536789098|FG000|Overall Study|Adverse Event|9|||
148812383|NCT00770809|536789099|FG001|Overall Study|Adverse Event|1|||
148812384|NCT00770809|536789100|FG002|Overall Study|Adverse Event|12|||
148812385|NCT00770809|536789098|FG000|Overall Study|Death|1|||
148812386|NCT00770809|536789099|FG001|Overall Study|Death|0|||
148812387|NCT00770809|536789100|FG002|Overall Study|Death|0|||
148812388|NCT00770809|536789098|FG000|Overall Study|Withdrawal by Subject|3|||
148812389|NCT00770809|536789099|FG001|Overall Study|Withdrawal by Subject|3|||
148812390|NCT00770809|536789100|FG002|Overall Study|Withdrawal by Subject|7|||
148812391|NCT00770809|536789098|FG000|Overall Study|Progression|2|||
148812392|NCT00770809|536789099|FG001|Overall Study|Progression|2|||
148812393|NCT00770809|536789100|FG002|Overall Study|Progression|0|||
148812394|NCT00770809|536789098|FG000|Overall Study|Complicating illness|0|||
148812395|NCT00770809|536789099|FG001|Overall Study|Complicating illness|0|||
148812396|NCT00770809|536789100|FG002|Overall Study|Complicating illness|1|||
148812397|NCT00770809|536789098|FG000|Overall Study|Other Medical Reasons|2|||
148812398|NCT00770809|536789099|FG001|Overall Study|Other Medical Reasons|4|||
148812399|NCT00770809|536789100|FG002|Overall Study|Other Medical Reasons|3|||
148812400|NCT01240746|536789102|FG000|Overall Study|Adverse Event|2|||
148812401|NCT01240746|536789103|FG001|Overall Study|Adverse Event|0|||
148812402|NCT01240746|536789104|FG002|Overall Study|Adverse Event|10|||
148812403|NCT01240746|536789102|FG000|Overall Study|Lost to Follow-up|23|||
148812404|NCT01240746|536789103|FG001|Overall Study|Lost to Follow-up|20|||
148812405|NCT01240746|536789104|FG002|Overall Study|Lost to Follow-up|102|||
148693827|NCT00950807|536352293|FG007|Treatment Period 2|Adverse Event|1|||
148693828|NCT00950807|536352294|FG008|Treatment Period 2|Adverse Event|0|||
148693829|NCT00950807|536352295|FG009|Treatment Period 2|Adverse Event|0|||
148693830|NCT00950807|536352286|FG000|Washout Period 2|Lack of Efficacy|1|||
148693831|NCT00950807|536352287|FG001|Washout Period 2|Lack of Efficacy|0|||
148693832|NCT00950807|536352288|FG002|Washout Period 2|Lack of Efficacy|0|||
148693833|NCT00950807|536352289|FG003|Washout Period 2|Lack of Efficacy|0|||
148693834|NCT00950807|536352290|FG004|Washout Period 2|Lack of Efficacy|0|||
148693835|NCT00950807|536352291|FG005|Washout Period 2|Lack of Efficacy|0|||
148693836|NCT00950807|536352292|FG006|Washout Period 2|Lack of Efficacy|0|||
148693837|NCT00950807|536352293|FG007|Washout Period 2|Lack of Efficacy|0|||
148693838|NCT00950807|536352294|FG008|Washout Period 2|Lack of Efficacy|0|||
148693839|NCT00950807|536352295|FG009|Washout Period 2|Lack of Efficacy|0|||
148693840|NCT00950807|536352286|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
148693841|NCT00950807|536352287|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
148693842|NCT00950807|536352288|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
148693843|NCT00950807|536352289|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
148693844|NCT00950807|536352290|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
148693845|NCT00950807|536352291|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
148693846|NCT00950807|536352292|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
148693847|NCT00950807|536352293|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
148693848|NCT00950807|536352294|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
148693849|NCT00950807|536352295|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
148693850|NCT00950807|536352286|FG000|Washout Period 2|Adverse Event|3|||
148693851|NCT00950807|536352287|FG001|Washout Period 2|Adverse Event|0|||
148693852|NCT00950807|536352288|FG002|Washout Period 2|Adverse Event|0|||
148693853|NCT00950807|536352289|FG003|Washout Period 2|Adverse Event|1|||
148693854|NCT00950807|536352290|FG004|Washout Period 2|Adverse Event|0|||
148960939|NCT01462084|537341474|FG000|Overall Study|Protocol Violation|1|||
148960940|NCT01462084|537341475|FG001|Overall Study|Protocol Violation|1|||
148960941|NCT03992781|537341476|FG000|Overall Study|Lost to Follow-up|5|||
148960942|NCT03992781|537341476|FG000|Overall Study|Adverse Event|1|||
148693855|NCT00950807|536352291|FG005|Washout Period 2|Adverse Event|0|||
148693856|NCT00950807|536352292|FG006|Washout Period 2|Adverse Event|0|||
148693857|NCT00950807|536352293|FG007|Washout Period 2|Adverse Event|0|||
148693858|NCT00950807|536352294|FG008|Washout Period 2|Adverse Event|0|||
148693859|NCT00950807|536352295|FG009|Washout Period 2|Adverse Event|0|||
148693860|NCT00950807|536352286|FG000|Treatment Period 3|Withdrawal by Subject|0|||
148693861|NCT00950807|536352287|FG001|Treatment Period 3|Withdrawal by Subject|0|||
148693862|NCT00950807|536352288|FG002|Treatment Period 3|Withdrawal by Subject|0|||
148693863|NCT00950807|536352289|FG003|Treatment Period 3|Withdrawal by Subject|0|||
148693864|NCT00950807|536352290|FG004|Treatment Period 3|Withdrawal by Subject|0|||
148693865|NCT00950807|536352291|FG005|Treatment Period 3|Withdrawal by Subject|0|||
148693866|NCT00950807|536352292|FG006|Treatment Period 3|Withdrawal by Subject|0|||
148693867|NCT00950807|536352293|FG007|Treatment Period 3|Withdrawal by Subject|0|||
148693868|NCT00950807|536352294|FG008|Treatment Period 3|Withdrawal by Subject|0|||
148693869|NCT00950807|536352295|FG009|Treatment Period 3|Withdrawal by Subject|1|||
148693870|NCT00950807|536352286|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
148693871|NCT00950807|536352287|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148693872|NCT00950807|536352288|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148693873|NCT00950807|536352289|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148693874|NCT00950807|536352290|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148693875|NCT00950807|536352291|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148693876|NCT00950807|536352292|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148693877|NCT00950807|536352293|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
148693878|NCT00950807|536352294|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
148812406|NCT01240746|536789102|FG000|Overall Study|Protocol Violation|24|||
148812407|NCT01240746|536789103|FG001|Overall Study|Protocol Violation|15|||
148812408|NCT01240746|536789104|FG002|Overall Study|Protocol Violation|72|||
148693879|NCT00950807|536352295|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
149023970|NCT01544582|537562715|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
149023971|NCT01544582|537562712|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
149023972|NCT01544582|537562713|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
148693880|NCT00950807|536352286|FG000|Treatment Period 3|Adverse Event|0|||
148812409|NCT01240746|536789102|FG000|Overall Study|Withdrawal by Subject|10|||
148812410|NCT01240746|536789103|FG001|Overall Study|Withdrawal by Subject|13|||
148812411|NCT01240746|536789104|FG002|Overall Study|Withdrawal by Subject|59|||
148812412|NCT01126424|536789109|FG000|Overall Study|Adverse Event|0|||
148812413|NCT01126424|536789110|FG001|Overall Study|Adverse Event|0|||
148812414|NCT01126424|536789111|FG002|Overall Study|Adverse Event|0|||
148812415|NCT01126424|536789112|FG003|Overall Study|Adverse Event|0|||
148812416|NCT01126424|536789113|FG004|Overall Study|Adverse Event|1|||
148812417|NCT01126424|536789114|FG005|Overall Study|Adverse Event|0|||
148812418|NCT01126424|536789109|FG000|Overall Study|Withdrawal by Subject|0|||
148812419|NCT01126424|536789110|FG001|Overall Study|Withdrawal by Subject|0|||
148812420|NCT01126424|536789111|FG002|Overall Study|Withdrawal by Subject|1|||
148960943|NCT03992781|537341476|FG000|Overall Study|Lack of Efficacy|5|||
148693881|NCT00950807|536352287|FG001|Treatment Period 3|Adverse Event|0|||
148693882|NCT00950807|536352288|FG002|Treatment Period 3|Adverse Event|0|||
148693883|NCT00950807|536352289|FG003|Treatment Period 3|Adverse Event|0|||
148693884|NCT00950807|536352290|FG004|Treatment Period 3|Adverse Event|0|||
148693885|NCT00950807|536352291|FG005|Treatment Period 3|Adverse Event|0|||
148693886|NCT00950807|536352292|FG006|Treatment Period 3|Adverse Event|1|||
148693887|NCT00950807|536352293|FG007|Treatment Period 3|Adverse Event|0|||
148693888|NCT00950807|536352294|FG008|Treatment Period 3|Adverse Event|0|||
148693889|NCT00950807|536352295|FG009|Treatment Period 3|Adverse Event|0|||
148693890|NCT00337077|536352296|FG000|Overall Study|Progressive disease|25|||
148693891|NCT00337077|536352297|FG001|Overall Study|Progressive disease|37|||
148693892|NCT00337077|536352298|FG002|Overall Study|Progressive disease|19|||
148693893|NCT00337077|536352296|FG000|Overall Study|Adverse Event|7|||
148693894|NCT00337077|536352297|FG001|Overall Study|Adverse Event|7|||
148693895|NCT00337077|536352298|FG002|Overall Study|Adverse Event|1|||
148693896|NCT00337077|536352296|FG000|Overall Study|Death|0|||
148693897|NCT00337077|536352297|FG001|Overall Study|Death|1|||
148693898|NCT00337077|536352298|FG002|Overall Study|Death|0|||
148693899|NCT00337077|536352296|FG000|Overall Study|Withdrawal by Subject|7|||
148693900|NCT00337077|536352297|FG001|Overall Study|Withdrawal by Subject|2|||
148693901|NCT00337077|536352298|FG002|Overall Study|Withdrawal by Subject|2|||
148693902|NCT00337077|536352296|FG000|Overall Study|Alternative therapy|1|||
148693903|NCT00337077|536352297|FG001|Overall Study|Alternative therapy|0|||
148693904|NCT00337077|536352298|FG002|Overall Study|Alternative therapy|0|||
148693905|NCT00337077|536352296|FG000|Overall Study|Physician Decision|1|||
148693906|NCT00337077|536352297|FG001|Overall Study|Physician Decision|4|||
148693907|NCT00337077|536352298|FG002|Overall Study|Physician Decision|2|||
148693908|NCT00337077|536352296|FG000|Overall Study|Never started treatment|1|||
148693909|NCT00337077|536352297|FG001|Overall Study|Never started treatment|1|||
148693910|NCT00337077|536352298|FG002|Overall Study|Never started treatment|0|||
148693911|NCT00337077|536352296|FG000|Overall Study|Ineligible|1|||
148693912|NCT00337077|536352297|FG001|Overall Study|Ineligible|1|||
148693913|NCT00337077|536352298|FG002|Overall Study|Ineligible|1|||
148693914|NCT00814463|536352299|FG000|Overall Study|Lost to Follow-up|1|||
148693915|NCT05014412|536352302|FG000|Overall Study|Death|11|||
148693916|NCT05014412|536352303|FG001|Overall Study|Death|7|||
149023973|NCT01544582|537562714|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
148693917|NCT05014412|536352304|FG002|Overall Study|Death|4|||
148693918|NCT05014412|536352305|FG003|Overall Study|Death|7|||
148693919|NCT05014412|536352302|FG000|Overall Study|Withdrawal by Subject|1|||
148693920|NCT05014412|536352303|FG001|Overall Study|Withdrawal by Subject|1|||
148812421|NCT01126424|536789112|FG003|Overall Study|Withdrawal by Subject|3|||
148812422|NCT01126424|536789113|FG004|Overall Study|Withdrawal by Subject|1|||
148812423|NCT01126424|536789114|FG005|Overall Study|Withdrawal by Subject|0|||
148812424|NCT02127671|536789115|FG000|Overall Study|Death|2|||
148812425|NCT02127671|536789116|FG001|Overall Study|Death|2|||
148812426|NCT02127671|536789115|FG000|Overall Study|Lost to Follow-up|4|||
148812427|NCT02127671|536789116|FG001|Overall Study|Lost to Follow-up|2|||
148812428|NCT02127671|536789115|FG000|Overall Study|Physician Decision|1|||
148812429|NCT02127671|536789116|FG001|Overall Study|Physician Decision|0|||
148812430|NCT02127671|536789115|FG000|Overall Study|incarceration|0|||
148812431|NCT02127671|536789116|FG001|Overall Study|incarceration|1|||
148812432|NCT02127671|536789115|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
148812433|NCT02127671|536789116|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
148812434|NCT00764517|536789120|FG000|Overall Study|Adverse Event|9|||
148812435|NCT00764517|536789121|FG001|Overall Study|Adverse Event|3|||
148812436|NCT00764517|536789120|FG000|Overall Study|Death|3|||
148812437|NCT00764517|536789121|FG001|Overall Study|Death|11|||
148812438|NCT00764517|536789120|FG000|Overall Study|Physician Decision|3|||
148812439|NCT00764517|536789121|FG001|Overall Study|Physician Decision|0|||
148812440|NCT02239328|536789127|FG000|Overall Study|Benign disease noted at time of surgery|6|||
148812441|NCT02239328|536789127|FG000|Overall Study|Equipment or website malfunction|2|||
148812442|NCT00460798|536789128|FG000|Overall Study|Death|59|||
148812443|NCT00460798|536789128|FG000|Overall Study|Adverse Event|27|||
148812444|NCT00460798|536789128|FG000|Overall Study|Lost to Follow-up|19|||
148812445|NCT00460798|536789128|FG000|Overall Study|Progressive Disease|99|||
148812446|NCT00460798|536789128|FG000|Overall Study|Other|27|||
148812447|NCT00460798|536789128|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
148812448|NCT00460798|536789128|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
148812449|NCT04115059|536789129|FG000|Overall Study|Withdrawal by Subject|1|||
148812450|NCT04115059|536789129|FG000|Overall Study|Lack of Efficacy|2|||
148812451|NCT03517137|536789140|FG000|Overall Study|Lack of Efficacy|1|||
148812452|NCT03517137|536789140|FG000|Overall Study|Adverse Event|2|||
148812453|NCT03517137|536789140|FG000|Overall Study|Withdrawal by Subject|2|||
148812454|NCT03517137|536789140|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
148812455|NCT03575364|536789141|FG000|Overall Study|Death|45|||
148812456|NCT03575364|536789141|FG000|Overall Study|Lost to Follow-up|114|||
148812457|NCT03575364|536789141|FG000|Overall Study|Withdrawal by Subject|21|||
148812458|NCT03575364|536789141|FG000|Overall Study|Physician Decision|11|||
148812459|NCT03575364|536789141|FG000|Overall Study|Subject Refused Follow-up|13|||
148812460|NCT03575364|536789141|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
148812461|NCT03575364|536789141|FG000|Overall Study|Patient moved out of the state|1|||
148812462|NCT03575364|536789141|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
148812463|NCT03575364|536789141|FG000|Overall Study|Patient is lost to follow up|1|||
148812464|NCT03575364|536789141|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
148812465|NCT05522751|536789143|FG000|Overall Study|Adverse Event|1|||
148812466|NCT06420232|536789144|FG000|Overall Study|Withdrawal by Subject|3|||
148812467|NCT01369433|536789150|FG000|Overall Study|Adverse Event|31|||
148812468|NCT01369433|536789151|FG001|Overall Study|Adverse Event|1|||
148812469|NCT01369433|536789150|FG000|Overall Study|Required significant surgical procedure|1|||
148812470|NCT01369433|536789151|FG001|Overall Study|Required significant surgical procedure|0|||
148812471|NCT01369433|536789150|FG000|Overall Study|Non-compliance|1|||
148812472|NCT01369433|536789151|FG001|Overall Study|Non-compliance|0|||
148812473|NCT01369433|536789150|FG000|Overall Study|Withdrawal by Subject|5|||
148812474|NCT01369433|536789151|FG001|Overall Study|Withdrawal by Subject|2|||
148812475|NCT01369433|536789150|FG000|Overall Study|Study terminated by Sponsor|67|||
148812476|NCT01369433|536789151|FG001|Overall Study|Study terminated by Sponsor|0|||
148812477|NCT01369433|536789150|FG000|Overall Study|Lost to Follow-up|1|||
148812478|NCT01369433|536789151|FG001|Overall Study|Lost to Follow-up|0|||
148812479|NCT01369433|536789150|FG000|Overall Study|Death|5|||
148812480|NCT01369433|536789151|FG001|Overall Study|Death|0|||
148812481|NCT01369433|536789150|FG000|Overall Study|Investigator discretion|6|||
148812482|NCT01369433|536789151|FG001|Overall Study|Investigator discretion|1|||
148812483|NCT01369433|536789150|FG000|Overall Study|Progressive Disease|92|||
148812484|NCT01369433|536789151|FG001|Overall Study|Progressive Disease|12|||
148812485|NCT00689936|536789154|FG000|Active Treatment Phase|Adverse Event|68|||
148812486|NCT00689936|536789155|FG001|Active Treatment Phase|Adverse Event|71|||
148812487|NCT00689936|536789156|FG002|Active Treatment Phase|Adverse Event|76|||
148812488|NCT00689936|536789154|FG000|Active Treatment Phase|Disease Progression|273|||
148812489|NCT00689936|536789155|FG001|Active Treatment Phase|Disease Progression|362|||
148812490|NCT00689936|536789156|FG002|Active Treatment Phase|Disease Progression|339|||
148812491|NCT00689936|536789154|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
148812492|NCT00689936|536789155|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
148812493|NCT00689936|536789156|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
148812494|NCT00689936|536789154|FG000|Active Treatment Phase|Death|60|||
148812495|NCT00689936|536789155|FG001|Active Treatment Phase|Death|28|||
148812496|NCT00689936|536789156|FG002|Active Treatment Phase|Death|37|||
148812497|NCT00689936|536789154|FG000|Active Treatment Phase|Lost to Follow-up|0|||
148812498|NCT00689936|536789155|FG001|Active Treatment Phase|Lost to Follow-up|2|||
148812499|NCT00689936|536789156|FG002|Active Treatment Phase|Lost to Follow-up|2|||
148812500|NCT00689936|536789154|FG000|Active Treatment Phase|Protocol Violation|2|||
148812501|NCT00689936|536789155|FG001|Active Treatment Phase|Protocol Violation|2|||
148812502|NCT00689936|536789156|FG002|Active Treatment Phase|Protocol Violation|4|||
148812503|NCT00689936|536789154|FG000|Active Treatment Phase|Study Close Out|64|||
148812504|NCT00689936|536789155|FG001|Active Treatment Phase|Study Close Out|26|||
148812505|NCT00689936|536789156|FG002|Active Treatment Phase|Study Close Out|21|||
148812506|NCT00689936|536789154|FG000|Active Treatment Phase|Miscellaneous|52|||
148812507|NCT00689936|536789155|FG001|Active Treatment Phase|Miscellaneous|34|||
148812508|NCT00689936|536789156|FG002|Active Treatment Phase|Miscellaneous|47|||
148812509|NCT00689936|536789154|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
148812510|NCT00689936|536789155|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
148812511|NCT00689936|536789156|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
148812512|NCT01682031|536789157|FG000|Overall Study|Withdrawal by Subject|0|||
148812513|NCT01682031|536789158|FG001|Overall Study|Withdrawal by Subject|1|||
148812514|NCT01682031|536789157|FG000|Overall Study|Adverse Event|0|||
148812515|NCT01682031|536789158|FG001|Overall Study|Adverse Event|2|||
148812516|NCT01682031|536789157|FG000|Overall Study|MRI results indicate increased nodul|0|||
148812517|NCT01682031|536789158|FG001|Overall Study|MRI results indicate increased nodul|1|||
148812518|NCT01682031|536789157|FG000|Overall Study|Patient could not swallow tablets|1|||
148812519|NCT01682031|536789158|FG001|Overall Study|Patient could not swallow tablets|0|||
148812520|NCT01682031|536789157|FG000|Overall Study|Patient stopped selenium on his own|0|||
148812521|NCT01682031|536789158|FG001|Overall Study|Patient stopped selenium on his own|1|||
148693921|NCT05014412|536352304|FG002|Overall Study|Withdrawal by Subject|1|||
148693922|NCT05014412|536352305|FG003|Overall Study|Withdrawal by Subject|2|||
148693923|NCT05014412|536352302|FG000|Overall Study|Ongoing|21|||
148693924|NCT05014412|536352303|FG001|Overall Study|Ongoing|4|||
148693925|NCT05014412|536352304|FG002|Overall Study|Ongoing|6|||
148693926|NCT05014412|536352305|FG003|Overall Study|Ongoing|20|||
148693927|NCT02353169|536352306|FG000|Overall Study|QTc > 450 msec|1|||
148693928|NCT02353169|536352307|FG001|Overall Study|QTc > 450 msec|1|||
148693929|NCT02353169|536352308|FG002|Overall Study|QTc > 450 msec|1|||
148960944|NCT01996826|537341477|FG000|Overall Study|Lost to Follow-up|6|||
148960945|NCT01996826|537341478|FG001|Overall Study|Lost to Follow-up|2|||
148960946|NCT01996826|537341477|FG000|Overall Study|Physician Decision|1|||
148960947|NCT01996826|537341478|FG001|Overall Study|Physician Decision|1|||
148960948|NCT00695396|537341479|FG000|Overall Study|Study Closed Prematurely|5|||
148960949|NCT00695396|537341480|FG001|Overall Study|Study Closed Prematurely|6|||
148960950|NCT00695396|537341481|FG002|Overall Study|Study Closed Prematurely|8|||
148960951|NCT00695396|537341479|FG000|Overall Study|Withdrawal by Subject|2|||
148960952|NCT00695396|537341480|FG001|Overall Study|Withdrawal by Subject|2|||
148960953|NCT00695396|537341481|FG002|Overall Study|Withdrawal by Subject|0|||
148960954|NCT00518323|537341483|FG000|Overall Study|Lack of Efficacy|14|||
148960955|NCT00518323|537341484|FG001|Overall Study|Lack of Efficacy|2|||
148960956|NCT00518323|537341485|FG002|Overall Study|Lack of Efficacy|4|||
148960957|NCT00518323|537341486|FG003|Overall Study|Lack of Efficacy|20|||
148960958|NCT00518323|537341483|FG000|Overall Study|Withdrawal by Subject|1|||
148960959|NCT00518323|537341484|FG001|Overall Study|Withdrawal by Subject|2|||
148960960|NCT00518323|537341485|FG002|Overall Study|Withdrawal by Subject|4|||
148960961|NCT00518323|537341486|FG003|Overall Study|Withdrawal by Subject|2|||
148960962|NCT00518323|537341483|FG000|Overall Study|Lost to Follow-up|0|||
148960963|NCT00518323|537341484|FG001|Overall Study|Lost to Follow-up|2|||
148960964|NCT00518323|537341485|FG002|Overall Study|Lost to Follow-up|1|||
148960965|NCT00518323|537341486|FG003|Overall Study|Lost to Follow-up|3|||
148960966|NCT00518323|537341483|FG000|Overall Study|Adverse Event|1|||
148960967|NCT00518323|537341484|FG001|Overall Study|Adverse Event|1|||
148960968|NCT00518323|537341485|FG002|Overall Study|Adverse Event|1|||
148960969|NCT00518323|537341486|FG003|Overall Study|Adverse Event|0|||
148960970|NCT00518323|537341483|FG000|Overall Study|Prohibited medication and others|3|||
148960971|NCT00518323|537341484|FG001|Overall Study|Prohibited medication and others|1|||
148960972|NCT00518323|537341485|FG002|Overall Study|Prohibited medication and others|1|||
148960973|NCT00518323|537341486|FG003|Overall Study|Prohibited medication and others|0|||
148960974|NCT03329690|537341487|FG000|Overall Study|Progressive disease per RECIST|85|||
148960975|NCT03329690|537341488|FG001|Overall Study|Progressive disease per RECIST|44|||
148693930|NCT02353169|536352309|FG003|Overall Study|QTc > 450 msec|1|||
148693931|NCT02353169|536352306|FG000|Overall Study|OR team declined|2|||
148693932|NCT02353169|536352307|FG001|Overall Study|OR team declined|0|||
148693933|NCT02353169|536352308|FG002|Overall Study|OR team declined|0|||
148960976|NCT03329690|537341489|FG002|Overall Study|Progressive disease per RECIST|6|||
148960977|NCT03329690|537341490|FG003|Overall Study|Progressive disease per RECIST|16|||
148960978|NCT03329690|537341491|FG004|Overall Study|Progressive disease per RECIST|20|||
148960979|NCT03329690|537341487|FG000|Overall Study|Clinical progression|7|||
148960980|NCT03329690|537341488|FG001|Overall Study|Clinical progression|4|||
148960981|NCT03329690|537341489|FG002|Overall Study|Clinical progression|1|||
148960982|NCT03329690|537341490|FG003|Overall Study|Clinical progression|1|||
148960983|NCT03329690|537341491|FG004|Overall Study|Clinical progression|1|||
148960984|NCT03329690|537341487|FG000|Overall Study|Adverse Event|22|||
148960985|NCT03329690|537341488|FG001|Overall Study|Adverse Event|4|||
148960986|NCT03329690|537341489|FG002|Overall Study|Adverse Event|0|||
148960987|NCT03329690|537341490|FG003|Overall Study|Adverse Event|1|||
148960988|NCT03329690|537341491|FG004|Overall Study|Adverse Event|2|||
148693934|NCT02353169|536352309|FG003|Overall Study|OR team declined|0|||
148693935|NCT02353169|536352306|FG000|Overall Study|Inhalational induction|0|||
148960989|NCT03329690|537341487|FG000|Overall Study|Death|2|||
148960990|NCT03329690|537341488|FG001|Overall Study|Death|0|||
148960991|NCT03329690|537341489|FG002|Overall Study|Death|0|||
148960992|NCT03329690|537341490|FG003|Overall Study|Death|1|||
148960993|NCT03329690|537341491|FG004|Overall Study|Death|0|||
148960994|NCT03329690|537341487|FG000|Overall Study|Withdrawal by Subject|2|||
148960995|NCT03329690|537341488|FG001|Overall Study|Withdrawal by Subject|3|||
148960996|NCT03329690|537341489|FG002|Overall Study|Withdrawal by Subject|0|||
148960997|NCT03329690|537341490|FG003|Overall Study|Withdrawal by Subject|1|||
148960998|NCT03329690|537341491|FG004|Overall Study|Withdrawal by Subject|0|||
149023974|NCT01544582|537562715|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
149023975|NCT01544582|537562712|FG000|Analysis Population|Intolerance|0|||
149023976|NCT01544582|537562713|FG001|Analysis Population|Intolerance|1|||
148960999|NCT03329690|537341487|FG000|Overall Study|Physician Decision|1|||
148961000|NCT03329690|537341488|FG001|Overall Study|Physician Decision|0|||
148693936|NCT02353169|536352307|FG001|Overall Study|Inhalational induction|2|||
148693937|NCT02353169|536352308|FG002|Overall Study|Inhalational induction|0|||
148693938|NCT02353169|536352309|FG003|Overall Study|Inhalational induction|0|||
148693939|NCT02353169|536352306|FG000|Overall Study|ECG data error|0|||
148693940|NCT02353169|536352307|FG001|Overall Study|ECG data error|3|||
148693941|NCT02353169|536352308|FG002|Overall Study|ECG data error|2|||
148693942|NCT02353169|536352309|FG003|Overall Study|ECG data error|2|||
148693943|NCT02353169|536352306|FG000|Overall Study|Pre-op medication|0|||
148693944|NCT02353169|536352307|FG001|Overall Study|Pre-op medication|0|||
148693945|NCT02353169|536352308|FG002|Overall Study|Pre-op medication|1|||
148693946|NCT02353169|536352309|FG003|Overall Study|Pre-op medication|0|||
148693947|NCT05049460|536352312|FG000|Overall Study|Withdrawal by Subject|2|||
148693948|NCT05049460|536352313|FG001|Overall Study|Withdrawal by Subject|2|||
148693949|NCT05049460|536352312|FG000|Overall Study|Lost to Follow-up|2|||
148693950|NCT05049460|536352313|FG001|Overall Study|Lost to Follow-up|2|||
148693951|NCT00661999|536352318|FG000|Overall Study|Adverse Event|11|||
148693952|NCT00661999|536352319|FG001|Overall Study|Adverse Event|5|||
148693953|NCT00661999|536352320|FG002|Overall Study|Adverse Event|8|||
148693954|NCT00661999|536352318|FG000|Overall Study|Death|8|||
148693955|NCT00661999|536352319|FG001|Overall Study|Death|6|||
148693956|NCT00661999|536352320|FG002|Overall Study|Death|3|||
148693957|NCT00661999|536352318|FG000|Overall Study|Other Reasons|5|||
148693958|NCT00661999|536352319|FG001|Overall Study|Other Reasons|12|||
148693959|NCT00661999|536352320|FG002|Overall Study|Other Reasons|23|||
148961001|NCT03329690|537341489|FG002|Overall Study|Physician Decision|0|||
148693960|NCT00661999|536352318|FG000|Overall Study|Withdrawal by Subject|30|||
148693961|NCT00661999|536352319|FG001|Overall Study|Withdrawal by Subject|23|||
148693962|NCT00661999|536352320|FG002|Overall Study|Withdrawal by Subject|14|||
148693963|NCT00661999|536352318|FG000|Overall Study|Alternative Treatment|1|||
148961002|NCT03329690|537341490|FG003|Overall Study|Physician Decision|0|||
148693964|NCT00661999|536352319|FG001|Overall Study|Alternative Treatment|0|||
148693965|NCT00661999|536352320|FG002|Overall Study|Alternative Treatment|0|||
148693966|NCT00661999|536352318|FG000|Overall Study|Other Medical Problems|4|||
148693967|NCT00661999|536352319|FG001|Overall Study|Other Medical Problems|4|||
148693968|NCT00661999|536352320|FG002|Overall Study|Other Medical Problems|9|||
148693969|NCT03066999|536352321|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
148693970|NCT03066999|536352322|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
148693971|NCT01790568|536352325|FG000|Overall Study|Progression prior to transplant|0|||
148693972|NCT01790568|536352326|FG001|Overall Study|Progression prior to transplant|1|||
148693973|NCT01361126|536352327|FG000|Overall Study|Sponsor decision|0|||
148693974|NCT01361126|536352328|FG001|Overall Study|Sponsor decision|2|||
148693975|NCT02994056|536352329|FG000|Overall Study|Death|8|||
148693976|NCT02994056|536352329|FG000|Overall Study|Withdrew Consent|1|||
148693977|NCT02742181|536352331|FG000|Overall Study|Physician Decision|1|||
148693978|NCT02742181|536352332|FG001|Overall Study|Physician Decision|0|||
148693979|NCT01346410|536352333|FG000|Overall Study|Death|1|||
148693980|NCT02576990|536352334|FG000|Overall Study|Death|29|||
148693981|NCT02576990|536352335|FG001|Overall Study|Death|18|||
148693982|NCT02576990|536352334|FG000|Overall Study|Physician Decision|1|||
148693983|NCT02576990|536352335|FG001|Overall Study|Physician Decision|0|||
148693984|NCT02576990|536352334|FG000|Overall Study|Screen failure|2|||
148693985|NCT02576990|536352335|FG001|Overall Study|Screen failure|0|||
148693986|NCT02576990|536352334|FG000|Overall Study|Sponsor's decision|24|||
148693987|NCT02576990|536352335|FG001|Overall Study|Sponsor's decision|4|||
148693988|NCT02576990|536352334|FG000|Overall Study|Withdrawal by Subject|0|||
148693989|NCT02576990|536352335|FG001|Overall Study|Withdrawal by Subject|2|||
148693990|NCT05905783|536352336|FG000|Overall Study|Lost to Follow-up|12|||
148693991|NCT05905783|536352337|FG001|Overall Study|Lost to Follow-up|18|||
148693992|NCT05905783|536352336|FG000|Overall Study|Withdrawal by Subject|29|||
148693993|NCT05905783|536352337|FG001|Overall Study|Withdrawal by Subject|37|||
148693994|NCT05905783|536352336|FG000|Overall Study|Decision by sponsor|69|||
148693995|NCT05905783|536352337|FG001|Overall Study|Decision by sponsor|65|||
148693996|NCT01575054|536352338|FG000|Overall Study|Other Reasons|5|||
148693997|NCT01575054|536352339|FG001|Overall Study|Other Reasons|3|||
148693998|NCT01575054|536352338|FG000|Overall Study|Protocol Violation|2|||
148961003|NCT03329690|537341491|FG004|Overall Study|Physician Decision|1|||
148961004|NCT03329690|537341487|FG000|Overall Study|Miscellaneous|6|||
148693999|NCT01575054|536352339|FG001|Overall Study|Protocol Violation|1|||
148694000|NCT01575054|536352338|FG000|Overall Study|Personal Reasons|10|||
148694001|NCT01575054|536352339|FG001|Overall Study|Personal Reasons|11|||
148694002|NCT01575054|536352338|FG000|Overall Study|Lost to Follow-up|3|||
148961005|NCT03329690|537341488|FG001|Overall Study|Miscellaneous|0|||
148961006|NCT03329690|537341489|FG002|Overall Study|Miscellaneous|0|||
148694003|NCT01575054|536352339|FG001|Overall Study|Lost to Follow-up|3|||
148961007|NCT03329690|537341490|FG003|Overall Study|Miscellaneous|0|||
148961008|NCT03329690|537341491|FG004|Overall Study|Miscellaneous|0|||
148961009|NCT03329690|537341487|FG000|Overall Study|Did not receive treatment|1|||
148812522|NCT05376358|536789165|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
148812523|NCT05376358|536789166|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
148812524|NCT05376358|536789165|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
148812525|NCT05376358|536789166|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
148812526|NCT05376358|536789165|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
148812527|NCT05376358|536789166|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
148812528|NCT05376358|536789165|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
148812529|NCT05376358|536789166|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
148888857|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148812530|NCT05376358|536789165|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
148812531|NCT05376358|536789166|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
148812532|NCT05376358|536789165|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
148812533|NCT05376358|536789166|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
148812534|NCT00311168|536789167|FG000|First Intervention|Withdrawal by Subject|2|||
148812535|NCT00311168|536789168|FG001|First Intervention|Withdrawal by Subject|2|||
148812536|NCT00311168|536789167|FG000|First Intervention|Lost to Follow-up|1|||
148812537|NCT00311168|536789168|FG001|First Intervention|Lost to Follow-up|1|||
148812538|NCT00311168|536789167|FG000|First Intervention|Protocol Violation|1|||
148812539|NCT00311168|536789168|FG001|First Intervention|Protocol Violation|1|||
148812540|NCT00311168|536789167|FG000|First Intervention|Adverse Event|1|||
148812541|NCT00311168|536789168|FG001|First Intervention|Adverse Event|0|||
148812542|NCT00311168|536789167|FG000|First Intervention|Other|2|||
148812543|NCT00311168|536789168|FG001|First Intervention|Other|2|||
148812544|NCT00311168|536789167|FG000|Second Intervention|Lost to Follow-up|9|||
148812545|NCT00311168|536789168|FG001|Second Intervention|Lost to Follow-up|2|||
148812546|NCT00311168|536789167|FG000|Second Intervention|Withdrawal by Subject|0|||
148812547|NCT00311168|536789168|FG001|Second Intervention|Withdrawal by Subject|1|||
148812548|NCT00311168|536789167|FG000|Second Intervention|Other|1|||
148812549|NCT00311168|536789168|FG001|Second Intervention|Other|1|||
148812550|NCT03965923|536789171|FG000|Overall Study|Withdrawal by Subject|1|||
148812551|NCT03965923|536789172|FG001|Overall Study|Withdrawal by Subject|2|||
148812552|NCT03965923|536789173|FG002|Overall Study|Withdrawal by Subject|3|||
148812553|NCT03965923|536789174|FG003|Overall Study|Withdrawal by Subject|1|||
148812554|NCT03965923|536789175|FG004|Overall Study|Withdrawal by Subject|2|||
148812555|NCT03965923|536789176|FG005|Overall Study|Withdrawal by Subject|0|||
148812556|NCT03965923|536789177|FG006|Overall Study|Withdrawal by Subject|4|||
148812557|NCT03965923|536789178|FG007|Overall Study|Withdrawal by Subject|3|||
148812558|NCT03965923|536789179|FG008|Overall Study|Withdrawal by Subject|4|||
148812559|NCT03965923|536789180|FG009|Overall Study|Withdrawal by Subject|0|||
148812560|NCT03965923|536789181|FG010|Overall Study|Withdrawal by Subject|2|||
148812561|NCT03965923|536789182|FG011|Overall Study|Withdrawal by Subject|0|||
148812562|NCT03965923|536789171|FG000|Overall Study|Lost to Follow-up|2|||
148812563|NCT03965923|536789172|FG001|Overall Study|Lost to Follow-up|1|||
148812564|NCT03965923|536789173|FG002|Overall Study|Lost to Follow-up|1|||
148812565|NCT03965923|536789174|FG003|Overall Study|Lost to Follow-up|0|||
148812566|NCT03965923|536789175|FG004|Overall Study|Lost to Follow-up|2|||
148812567|NCT03965923|536789176|FG005|Overall Study|Lost to Follow-up|1|||
148812568|NCT03965923|536789177|FG006|Overall Study|Lost to Follow-up|2|||
148812569|NCT03965923|536789178|FG007|Overall Study|Lost to Follow-up|1|||
148812570|NCT03965923|536789179|FG008|Overall Study|Lost to Follow-up|0|||
148812571|NCT03965923|536789180|FG009|Overall Study|Lost to Follow-up|2|||
148812572|NCT03965923|536789181|FG010|Overall Study|Lost to Follow-up|0|||
149023977|NCT01544582|537562714|FG002|Analysis Population|Intolerance|0|||
149023978|NCT01544582|537562715|FG003|Analysis Population|Intolerance|0|||
148812573|NCT03965923|536789182|FG011|Overall Study|Lost to Follow-up|0|||
148812574|NCT03965923|536789171|FG000|Overall Study|Death|0|||
148812575|NCT03965923|536789172|FG001|Overall Study|Death|0|||
148812576|NCT03965923|536789173|FG002|Overall Study|Death|0|||
148812577|NCT03965923|536789174|FG003|Overall Study|Death|0|||
148812578|NCT03965923|536789175|FG004|Overall Study|Death|0|||
148812579|NCT03965923|536789176|FG005|Overall Study|Death|0|||
148812580|NCT03965923|536789177|FG006|Overall Study|Death|0|||
148812581|NCT03965923|536789178|FG007|Overall Study|Death|1|||
148812582|NCT03965923|536789179|FG008|Overall Study|Death|4|||
148812583|NCT03965923|536789180|FG009|Overall Study|Death|0|||
148812584|NCT03965923|536789181|FG010|Overall Study|Death|4|||
148812585|NCT03965923|536789182|FG011|Overall Study|Death|0|||
148812586|NCT03965923|536789171|FG000|Overall Study|Other reason|0|||
148812587|NCT03965923|536789172|FG001|Overall Study|Other reason|0|||
148812588|NCT03965923|536789173|FG002|Overall Study|Other reason|0|||
148812589|NCT03965923|536789174|FG003|Overall Study|Other reason|1|||
148812590|NCT03965923|536789175|FG004|Overall Study|Other reason|0|||
148812591|NCT03965923|536789176|FG005|Overall Study|Other reason|0|||
148812592|NCT03965923|536789177|FG006|Overall Study|Other reason|0|||
148812593|NCT03965923|536789178|FG007|Overall Study|Other reason|0|||
148812594|NCT03965923|536789179|FG008|Overall Study|Other reason|0|||
148812595|NCT03965923|536789180|FG009|Overall Study|Other reason|0|||
148812596|NCT03965923|536789181|FG010|Overall Study|Other reason|2|||
148812597|NCT03965923|536789182|FG011|Overall Study|Other reason|0|||
148812598|NCT02452190|536789183|FG000|Overall Study|Withdrawal by Sponsor|1|||
148812599|NCT02452190|536789184|FG001|Overall Study|Withdrawal by Sponsor|3|||
148812600|NCT02452190|536789183|FG000|Overall Study|Pregnancy|1|||
148812601|NCT02452190|536789184|FG001|Overall Study|Pregnancy|0|||
148812602|NCT02452190|536789183|FG000|Overall Study|Investigator's Decision|2|||
148812603|NCT02452190|536789184|FG001|Overall Study|Investigator's Decision|0|||
148812604|NCT02452190|536789183|FG000|Overall Study|Lack of Efficacy|3|||
148812605|NCT02452190|536789184|FG001|Overall Study|Lack of Efficacy|1|||
148812606|NCT02452190|536789183|FG000|Overall Study|Lost to Follow-up|4|||
148812607|NCT02452190|536789184|FG001|Overall Study|Lost to Follow-up|3|||
148812608|NCT02452190|536789183|FG000|Overall Study|Adverse Event|2|||
148812609|NCT02452190|536789184|FG001|Overall Study|Adverse Event|5|||
148812610|NCT02452190|536789183|FG000|Overall Study|Withdrawal by Subject|20|||
148812611|NCT02452190|536789184|FG001|Overall Study|Withdrawal by Subject|11|||
148812612|NCT02452190|536789183|FG000|Overall Study|Noncompliance with study drug|1|||
148961010|NCT03329690|537341488|FG001|Overall Study|Did not receive treatment|0|||
148961011|NCT03329690|537341489|FG002|Overall Study|Did not receive treatment|0|||
148961012|NCT03329690|537341490|FG003|Overall Study|Did not receive treatment|1|||
148961013|NCT03329690|537341491|FG004|Overall Study|Did not receive treatment|0|||
148961014|NCT01817725|537341492|FG000|Overall Study|Withdrawal by Subject|1|||
148961015|NCT01179477|537341495|FG000|Overall Study|Death|542|||
148961016|NCT01179477|537341495|FG000|Overall Study|Unsuccessful implant|80|||
148961017|NCT01179477|537341495|FG000|Overall Study|Non-death withdrawal|438|||
148961018|NCT01179477|537341495|FG000|Overall Study|Did not complete final visit|27|||
148961019|NCT04327388|537341497|FG000|Overall Study|Adverse Event|17|||
148812613|NCT02452190|536789184|FG001|Overall Study|Noncompliance with study drug|0|||
148812614|NCT02452190|536789183|FG000|Overall Study|Participant traveled abroad|1|||
148812615|NCT02452190|536789184|FG001|Overall Study|Participant traveled abroad|0|||
148812616|NCT02452190|536789183|FG000|Overall Study|Death|0|||
148812617|NCT02452190|536789184|FG001|Overall Study|Death|1|||
148812618|NCT06001021|536789187|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
148812619|NCT06001021|536789188|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
148961020|NCT04327388|537341498|FG001|Overall Study|Adverse Event|18|||
148961021|NCT04327388|537341499|FG002|Overall Study|Adverse Event|9|||
148961022|NCT04327388|537341497|FG000|Overall Study|Other|1|||
148812620|NCT06001021|536789189|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
149023979|NCT01544582|537562712|FG000|Analysis Population|Liver Transplantation|0|||
149023980|NCT01544582|537562713|FG001|Analysis Population|Liver Transplantation|0|||
149023981|NCT01544582|537562714|FG002|Analysis Population|Liver Transplantation|1|||
149023982|NCT01544582|537562715|FG003|Analysis Population|Liver Transplantation|0|||
149023983|NCT01544582|537562712|FG000|Analysis Population|No Social Insurance|0|||
148694004|NCT01575054|536352338|FG000|Overall Study|Adverse Event|9|||
148694005|NCT01575054|536352339|FG001|Overall Study|Adverse Event|8|||
148694006|NCT01508936|536352341|FG000|Overall Study|Adverse Event|11|||
148694007|NCT01508936|536352342|FG001|Overall Study|Adverse Event|32|||
148694008|NCT01508936|536352341|FG000|Overall Study|Lack of Efficacy|0|||
148694009|NCT01508936|536352342|FG001|Overall Study|Lack of Efficacy|1|||
148694010|NCT01508936|536352341|FG000|Overall Study|Withdrawal by Subject|4|||
148694011|NCT01508936|536352342|FG001|Overall Study|Withdrawal by Subject|18|||
148694012|NCT01508936|536352341|FG000|Overall Study|Protocol Violation|2|||
148694013|NCT01508936|536352342|FG001|Overall Study|Protocol Violation|3|||
148694014|NCT01508936|536352341|FG000|Overall Study|Lost to Follow-up|2|||
148694015|NCT01508936|536352342|FG001|Overall Study|Lost to Follow-up|9|||
148694016|NCT01508936|536352341|FG000|Overall Study|Other|0|||
148694017|NCT01508936|536352342|FG001|Overall Study|Other|5|||
148694018|NCT01508936|536352341|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
148694019|NCT01508936|536352342|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
148812621|NCT06001021|536789190|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
148812622|NCT06001021|536789191|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
148694020|NCT00679367|536352343|FG000|Overall Study|Adverse Event|7|||
148694021|NCT00679367|536352343|FG000|Overall Study|inability to swallow oral drugs|1|||
148812623|NCT06001021|536789192|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
148812624|NCT06001021|536789193|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
148694022|NCT00679367|536352343|FG000|Overall Study|Lack of Efficacy|3|||
148961023|NCT04327388|537341498|FG001|Overall Study|Other|2|||
148961024|NCT04327388|537341499|FG002|Overall Study|Other|0|||
148961025|NCT04327388|537341497|FG000|Overall Study|Randomized and not treated|2|||
148961026|NCT04327388|537341498|FG001|Overall Study|Randomized and not treated|0|||
148961027|NCT04327388|537341499|FG002|Overall Study|Randomized and not treated|2|||
148961028|NCT04829318|537341500|FG000|Overall Study|Adverse Event|6|||
148694023|NCT00679367|536352343|FG000|Overall Study|Withdrawal by Subject|1|||
148694024|NCT03365947|536352344|FG000|Overall Study|Lost to Follow-up|0|||
148694025|NCT03365947|536352345|FG001|Overall Study|Lost to Follow-up|0|||
148694026|NCT03365947|536352346|FG002|Overall Study|Lost to Follow-up|0|||
148694027|NCT03365947|536352347|FG003|Overall Study|Lost to Follow-up|0|||
148694028|NCT03365947|536352348|FG004|Overall Study|Lost to Follow-up|0|||
148694029|NCT03365947|536352349|FG005|Overall Study|Lost to Follow-up|1|||
148694030|NCT03365947|536352350|FG006|Overall Study|Lost to Follow-up|0|||
148694031|NCT03365947|536352351|FG007|Overall Study|Lost to Follow-up|0|||
148694032|NCT03365947|536352352|FG008|Overall Study|Lost to Follow-up|0|||
148694033|NCT03365947|536352353|FG009|Overall Study|Lost to Follow-up|0|||
148694034|NCT03365947|536352354|FG010|Overall Study|Lost to Follow-up|0|||
148694035|NCT03365947|536352355|FG011|Overall Study|Lost to Follow-up|0|||
148694036|NCT03365947|536352356|FG012|Overall Study|Lost to Follow-up|0|||
148694037|NCT03365947|536352357|FG013|Overall Study|Lost to Follow-up|0|||
148694038|NCT03365947|536352358|FG014|Overall Study|Lost to Follow-up|0|||
148694039|NCT03365947|536352359|FG015|Overall Study|Lost to Follow-up|0|||
148694040|NCT03365947|536352360|FG016|Overall Study|Lost to Follow-up|0|||
148694041|NCT03365947|536352361|FG017|Overall Study|Lost to Follow-up|0|||
148694042|NCT03365947|536352362|FG018|Overall Study|Lost to Follow-up|0|||
148694043|NCT02518685|536352363|FG000|Overall Study|Adverse Event|29|||
148694044|NCT02518685|536352364|FG001|Overall Study|Adverse Event|1|||
148694045|NCT02518685|536352363|FG000|Overall Study|Withdrawal by Subject|10|||
148961029|NCT04829318|537341500|FG000|Overall Study|Death|1|||
148961030|NCT04829318|537341500|FG000|Overall Study|Lost to Follow-up|1|||
148812625|NCT06001021|536789187|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
148812626|NCT06001021|536789188|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
148812627|NCT06001021|536789189|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
148812628|NCT06001021|536789190|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
148812629|NCT06001021|536789191|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
148812630|NCT06001021|536789192|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
148812631|NCT06001021|536789193|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
148812632|NCT06001866|536789194|FG000|Overall Study|Withdrawal by Subject|0|||
148812633|NCT06001866|536789195|FG001|Overall Study|Withdrawal by Subject|2|||
148812634|NCT06001866|536789194|FG000|Overall Study|Protocol Violation|0|||
148812635|NCT06001866|536789195|FG001|Overall Study|Protocol Violation|2|||
148812636|NCT00207740|536789196|FG000|Overall Study|Adverse Event|4|||
148961031|NCT04829318|537341500|FG000|Overall Study|Physician Decision|1|||
149023984|NCT01544582|537562713|FG001|Analysis Population|No Social Insurance|0|||
149023985|NCT01544582|537562714|FG002|Analysis Population|No Social Insurance|1|||
149023986|NCT01544582|537562715|FG003|Analysis Population|No Social Insurance|0|||
149023987|NCT01544582|537562712|FG000|Analysis Population|Poor Adherence|0|||
149023988|NCT01544582|537562713|FG001|Analysis Population|Poor Adherence|0|||
149023989|NCT01544582|537562714|FG002|Analysis Population|Poor Adherence|1|||
149023990|NCT01544582|537562715|FG003|Analysis Population|Poor Adherence|0|||
149023991|NCT01544582|537562712|FG000|Analysis Population|Poor Participant Compliance|0|||
149023992|NCT01544582|537562713|FG001|Analysis Population|Poor Participant Compliance|1|||
149023993|NCT01544582|537562714|FG002|Analysis Population|Poor Participant Compliance|0|||
148694046|NCT02518685|536352364|FG001|Overall Study|Withdrawal by Subject|3|||
148694047|NCT02518685|536352363|FG000|Overall Study|relocation, study fatigue|7|||
148812637|NCT00207740|536789197|FG001|Overall Study|Adverse Event|14|||
148961032|NCT04829318|537341500|FG000|Overall Study|Withdrawal by Subject|19|||
148961033|NCT04829318|537341500|FG000|Overall Study|Site terminated by sponsor|1|||
148961034|NCT04829318|537341500|FG000|Overall Study|Sponsor decision|5|||
148961035|NCT04829318|537341500|FG000|Overall Study|Other|1|||
148961036|NCT00728130|537341501|FG000|Overall Study|Withdrawal by Subject|1|||
148961037|NCT00728130|537341501|FG000|Overall Study|Paperwork not completed in time|1|||
148961038|NCT00728130|537341501|FG000|Overall Study|Physician Decision|1|||
148961039|NCT00071760|537341502|FG000|Overall Study|Adverse Event|2|||
148961040|NCT00071760|537341503|FG001|Overall Study|Adverse Event|1|||
148961041|NCT00071760|537341502|FG000|Overall Study|Lost to Follow-up|0|||
148961042|NCT00071760|537341503|FG001|Overall Study|Lost to Follow-up|3|||
148961043|NCT00071760|537341502|FG000|Overall Study|Protocol Violation|1|||
148961044|NCT00071760|537341503|FG001|Overall Study|Protocol Violation|0|||
148961045|NCT00071760|537341502|FG000|Overall Study|Withdrawal by Subject|0|||
148961046|NCT00071760|537341503|FG001|Overall Study|Withdrawal by Subject|1|||
148961047|NCT00071760|537341502|FG000|Overall Study|Insufficient Viral Load Response|1|||
148961048|NCT00071760|537341503|FG001|Overall Study|Insufficient Viral Load Response|1|||
148961049|NCT00071760|537341502|FG000|Overall Study|Lack of availability of RTV|1|||
148961050|NCT00071760|537341503|FG001|Overall Study|Lack of availability of RTV|0|||
148961051|NCT00071760|537341502|FG000|Overall Study|Physician Decision|2|||
148961052|NCT00071760|537341503|FG001|Overall Study|Physician Decision|1|||
148961053|NCT00071760|537341502|FG000|Overall Study|Relocation|0|||
148961054|NCT00071760|537341503|FG001|Overall Study|Relocation|1|||
148961055|NCT01994629|537341504|FG000|Overall Study|Withdrawal by Subject|1|||
148961056|NCT01994629|537341505|FG001|Overall Study|Withdrawal by Subject|0|||
148961057|NCT01994629|537341504|FG000|Overall Study|Lost to Follow-up|0|||
148961058|NCT01994629|537341505|FG001|Overall Study|Lost to Follow-up|3|||
148961059|NCT03338062|537341506|FG000|Overall Study|Alternative Therapy|1|||
148961060|NCT03338062|537341507|FG001|Overall Study|Alternative Therapy|0|||
148961061|NCT00391274|537341514|FG000|Overall Study|Death Due to Study Disease|55|||
148961062|NCT00391274|537341515|FG001|Overall Study|Death Due to Study Disease|45|||
148961063|NCT00391274|537341514|FG000|Overall Study|Lost to Follow-up|0|||
148812638|NCT00207740|536789198|FG002|Overall Study|Adverse Event|14|||
148812639|NCT00207740|536789199|FG003|Overall Study|Adverse Event|11|||
148812640|NCT00207740|536789196|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148812641|NCT00207740|536789197|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148812642|NCT00207740|536789198|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
148812643|NCT00207740|536789199|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
148812644|NCT00207740|536789196|FG000|Overall Study|Lost to Follow-up|0|||
148961064|NCT00391274|537341515|FG001|Overall Study|Lost to Follow-up|3|||
148961065|NCT00391274|537341514|FG000|Overall Study|Physician Decision|4|||
148961066|NCT00391274|537341515|FG001|Overall Study|Physician Decision|2|||
148961067|NCT00391274|537341514|FG000|Overall Study|Withdrawal by Subject|0|||
148961068|NCT00391274|537341515|FG001|Overall Study|Withdrawal by Subject|3|||
148961069|NCT00391274|537341514|FG000|Overall Study|Death Due to Adverse Event|1|||
149023994|NCT01544582|537562715|FG003|Analysis Population|Poor Participant Compliance|0|||
148961070|NCT00391274|537341515|FG001|Overall Study|Death Due to Adverse Event|3|||
148961071|NCT00391274|537341514|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
148961072|NCT00391274|537341515|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
148961073|NCT00391274|537341514|FG000|Overall Study|Death Not Study Related|0|||
148961074|NCT00391274|537341515|FG001|Overall Study|Death Not Study Related|1|||
148961075|NCT00894322|537341519|FG000|Overall Study|Withdrawal by Subject|1|||
148961076|NCT00894322|537341520|FG001|Overall Study|Withdrawal by Subject|0|||
148961077|NCT00894322|537341521|FG002|Overall Study|Withdrawal by Subject|0|||
148961078|NCT00975481|537341530|FG000|Second Intervention Period|Adverse Event|2|||
148961079|NCT00975481|537341531|FG001|Second Intervention Period|Adverse Event|1|||
148961080|NCT00975481|537341532|FG002|Second Intervention Period|Adverse Event|0|||
148961081|NCT00975481|537341533|FG003|Second Intervention Period|Adverse Event|0|||
148961082|NCT00975481|537341534|FG004|Second Intervention Period|Adverse Event|0|||
148961083|NCT00975481|537341535|FG005|Second Intervention Period|Adverse Event|0|||
149023995|NCT01544582|537562712|FG000|Analysis Population|Programmed Surgery|0|||
149023996|NCT01544582|537562713|FG001|Analysis Population|Programmed Surgery|1|||
148694048|NCT02518685|536352364|FG001|Overall Study|relocation, study fatigue|2|||
148694049|NCT02518685|536352363|FG000|Overall Study|Pregnancy|1|||
148694050|NCT02518685|536352364|FG001|Overall Study|Pregnancy|0|||
148694051|NCT02518685|536352363|FG000|Overall Study|Physician Decision|1|||
148694052|NCT02518685|536352364|FG001|Overall Study|Physician Decision|0|||
148694053|NCT02518685|536352363|FG000|Overall Study|Lost to Follow-up|1|||
149023997|NCT01544582|537562714|FG002|Analysis Population|Programmed Surgery|0|||
148961084|NCT00975481|537341530|FG000|Second Intervention Period|Withdrawal by Subject|0|||
148961085|NCT00975481|537341531|FG001|Second Intervention Period|Withdrawal by Subject|0|||
148961086|NCT00975481|537341532|FG002|Second Intervention Period|Withdrawal by Subject|1|||
148961087|NCT00975481|537341533|FG003|Second Intervention Period|Withdrawal by Subject|0|||
148961088|NCT00975481|537341534|FG004|Second Intervention Period|Withdrawal by Subject|0|||
148961089|NCT00975481|537341535|FG005|Second Intervention Period|Withdrawal by Subject|0|||
148961090|NCT00975481|537341530|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
148961091|NCT00975481|537341531|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
148961092|NCT00975481|537341532|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
148961093|NCT00975481|537341533|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
148961094|NCT00975481|537341534|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
148961095|NCT00975481|537341535|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
148961096|NCT00975481|537341530|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
148961097|NCT00975481|537341531|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
148812645|NCT00207740|536789197|FG001|Overall Study|Lost to Follow-up|2|||
148812646|NCT00207740|536789198|FG002|Overall Study|Lost to Follow-up|1|||
148812647|NCT00207740|536789199|FG003|Overall Study|Lost to Follow-up|1|||
148812648|NCT00207740|536789196|FG000|Overall Study|Death|0|||
148812649|NCT00207740|536789197|FG001|Overall Study|Death|0|||
148812650|NCT00207740|536789198|FG002|Overall Study|Death|0|||
148812651|NCT00207740|536789199|FG003|Overall Study|Death|1|||
148812652|NCT00207740|536789196|FG000|Overall Study|Sponsor Directive|22|||
149023998|NCT01544582|537562715|FG003|Analysis Population|Programmed Surgery|0|||
148812653|NCT00207740|536789197|FG001|Overall Study|Sponsor Directive|15|||
148812654|NCT00207740|536789198|FG002|Overall Study|Sponsor Directive|16|||
148812655|NCT00207740|536789199|FG003|Overall Study|Sponsor Directive|21|||
148812656|NCT00207740|536789196|FG000|Overall Study|Other|2|||
148812657|NCT00207740|536789197|FG001|Overall Study|Other|10|||
148812658|NCT00207740|536789198|FG002|Overall Study|Other|7|||
148812659|NCT00207740|536789199|FG003|Overall Study|Other|5|||
148961098|NCT00975481|537341532|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
148961099|NCT00975481|537341533|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
148961100|NCT00975481|537341534|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
148961101|NCT00975481|537341535|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
148961102|NCT03447990|537341536|FG000|Overall Study|Withdrawal by Subject|0|||
148961103|NCT03447990|537341537|FG001|Overall Study|Withdrawal by Subject|0|||
148961104|NCT03447990|537341538|FG002|Overall Study|Withdrawal by Subject|0|||
148961105|NCT03447990|537341539|FG003|Overall Study|Withdrawal by Subject|0|||
148961106|NCT03447990|537341540|FG004|Overall Study|Withdrawal by Subject|0|||
148961107|NCT03447990|537341541|FG005|Overall Study|Withdrawal by Subject|0|||
148961108|NCT03447990|537341542|FG006|Overall Study|Withdrawal by Subject|1|||
148961109|NCT03630120|537341543|FG000|Overall Study|Disease progression|0|||
148961110|NCT03630120|537341544|FG001|Overall Study|Disease progression|1|||
148961111|NCT03630120|537341545|FG002|Overall Study|Disease progression|1|||
148961112|NCT03630120|537341546|FG003|Overall Study|Disease progression|1|||
148961113|NCT01519960|537341547|FG000|Overall Study|Withdrawal from the study|26|||
148961114|NCT01519960|537341548|FG001|Overall Study|Withdrawal from the study|22|||
148961115|NCT01519960|537341549|FG002|Overall Study|Withdrawal from the study|5|||
148961116|NCT01288287|537341550|FG000|Overall Study|Lost to Follow-up|8|||
148961117|NCT01288287|537341550|FG000|Overall Study|Withdrawal by Subject|4|||
148961118|NCT01288287|537341550|FG000|Overall Study|Lack of Efficacy|13|||
148961119|NCT01288287|537341550|FG000|Overall Study|Other Reason|13|||
148961120|NCT01288287|537341550|FG000|Overall Study|Unknown Reason|1|||
148961121|NCT01288287|537341550|FG000|Overall Study|Unknown Status|7|||
148961122|NCT03519347|537341551|FG000|Interventional Crossover Period 1|Death|0|||
148961123|NCT03519347|537341552|FG001|Interventional Crossover Period 1|Death|0|||
148961124|NCT03519347|537341553|FG002|Interventional Crossover Period 1|Death|0|||
148961125|NCT03519347|537341554|FG003|Interventional Crossover Period 1|Death|1|||
148961126|NCT02515045|537341561|FG000|Overall Study|Adverse Event|0|||
148961127|NCT02515045|537341562|FG001|Overall Study|Adverse Event|3|||
148961128|NCT02515045|537341563|FG002|Overall Study|Adverse Event|3|||
148961129|NCT02515045|537341561|FG000|Overall Study|Lost to Follow-up|0|||
148961130|NCT02515045|537341562|FG001|Overall Study|Lost to Follow-up|1|||
148961131|NCT02515045|537341563|FG002|Overall Study|Lost to Follow-up|1|||
148961132|NCT01412021|537341564|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
148961133|NCT01412021|537341564|FG000|Overall Study|Treatment Prior to Approval|3|||
148961134|NCT01412021|537341564|FG000|Overall Study|Transferred to Other Hospital|9|||
148961135|NCT00238121|537341565|FG000|Overall Study|Withdrawal by Subject|1|||
148961136|NCT00238121|537341566|FG001|Overall Study|Withdrawal by Subject|1|||
148961137|NCT00238121|537341565|FG000|Overall Study|Adverse Event|2|||
148961138|NCT00238121|537341566|FG001|Overall Study|Adverse Event|1|||
148961139|NCT02221284|537341567|FG000|Overall Study|Case Report Forms Uncollected|56|||
148961140|NCT02221284|537341567|FG000|Overall Study|Protocol Deviation|5|||
148961141|NCT01166178|537341568|FG000|Overall Study|Withdrawal by Subject|1|||
148961142|NCT01166178|537341569|FG001|Overall Study|Withdrawal by Subject|0|||
148961143|NCT01166178|537341568|FG000|Overall Study|Study was terminated|20|||
148961144|NCT01166178|537341569|FG001|Overall Study|Study was terminated|8|||
148961145|NCT00484939|537341570|FG000|Overall Study|Death|9|||
148961146|NCT00484939|537341571|FG001|Overall Study|Death|13|||
148694054|NCT02518685|536352364|FG001|Overall Study|Lost to Follow-up|4|||
148961147|NCT00484939|537341570|FG000|Overall Study|Adverse Event|22|||
148961148|NCT00484939|537341571|FG001|Overall Study|Adverse Event|12|||
148961149|NCT00484939|537341570|FG000|Overall Study|Patient Withdrew Consent|19|||
148961150|NCT00484939|537341571|FG001|Overall Study|Patient Withdrew Consent|10|||
148961151|NCT00484939|537341570|FG000|Overall Study|Protocol Violation|3|||
148812660|NCT03916926|536789200|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
148812661|NCT03916926|536789201|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
148812662|NCT03916926|536789200|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
148812663|NCT03916926|536789201|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
148812664|NCT03916926|536789200|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
148812665|NCT03916926|536789201|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
148812666|NCT03916926|536789200|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
148812667|NCT03916926|536789201|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
148812668|NCT04725188|536789202|FG000|Overall Study|Death|72|||
148812669|NCT04725188|536789203|FG001|Overall Study|Death|69|||
148812670|NCT04725188|536789204|FG002|Overall Study|Death|76|||
148812671|NCT04725188|536789202|FG000|Overall Study|Lost to Follow-up|1|||
148812672|NCT04725188|536789203|FG001|Overall Study|Lost to Follow-up|0|||
148812673|NCT04725188|536789204|FG002|Overall Study|Lost to Follow-up|1|||
148812674|NCT04725188|536789202|FG000|Overall Study|Withdrawal by Subject|2|||
148812675|NCT04725188|536789203|FG001|Overall Study|Withdrawal by Subject|2|||
148812676|NCT04725188|536789204|FG002|Overall Study|Withdrawal by Subject|1|||
148812677|NCT04725188|536789202|FG000|Overall Study|Sponsor Decision|12|||
148812678|NCT04725188|536789203|FG001|Overall Study|Sponsor Decision|12|||
148812679|NCT04725188|536789204|FG002|Overall Study|Sponsor Decision|7|||
148812680|NCT00390013|536789205|FG000|Phase 1|tired|0|||
148961152|NCT00484939|537341571|FG001|Overall Study|Protocol Violation|3|||
148961153|NCT00484939|537341570|FG000|Overall Study|Lost to Follow-up|0|||
148961154|NCT00484939|537341571|FG001|Overall Study|Lost to Follow-up|3|||
148812681|NCT00390013|536789206|FG001|Phase 1|tired|0|||
148812682|NCT00390013|536789207|FG002|Phase 1|tired|0|||
148812683|NCT00390013|536789208|FG003|Phase 1|tired|1|||
148812684|NCT00390013|536789205|FG000|Phase 2 First Treatment|tired|1|||
148812685|NCT00390013|536789206|FG001|Phase 2 First Treatment|tired|0|||
148812686|NCT00390013|536789207|FG002|Phase 2 First Treatment|tired|0|||
148812687|NCT00390013|536789208|FG003|Phase 2 First Treatment|tired|0|||
148812688|NCT00390013|536789205|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
148812689|NCT00390013|536789206|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
148812690|NCT00390013|536789207|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
148812691|NCT00390013|536789208|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
148812692|NCT00924898|536789209|FG000|Overall Study|Withdrawal by Subject|2|||
148961155|NCT00484939|537341570|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
148961156|NCT00484939|537341571|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
148961157|NCT00484939|537341570|FG000|Overall Study|Disease progression|67|||
148961158|NCT00484939|537341571|FG001|Overall Study|Disease progression|88|||
148961159|NCT00484939|537341570|FG000|Overall Study|Screen Failure|2|||
148961160|NCT00484939|537341571|FG001|Overall Study|Screen Failure|2|||
148961161|NCT00484939|537341570|FG000|Overall Study|Reason Not Specified|11|||
148961162|NCT00484939|537341571|FG001|Overall Study|Reason Not Specified|6|||
148961163|NCT00624052|537341572|FG000|Overall Study|Adverse Event|7|||
148961164|NCT00624052|537341573|FG001|Overall Study|Adverse Event|6|||
148961165|NCT00624052|537341574|FG002|Overall Study|Adverse Event|0|||
148961166|NCT00624052|537341575|FG003|Overall Study|Adverse Event|3|||
148961167|NCT00624052|537341572|FG000|Overall Study|Lack of Efficacy|1|||
148694055|NCT00336024|536352365|FG000|Overall Study|Death|2|||
148694056|NCT00336024|536352366|FG001|Overall Study|Death|1|||
148961168|NCT00624052|537341573|FG001|Overall Study|Lack of Efficacy|1|||
148961169|NCT00624052|537341574|FG002|Overall Study|Lack of Efficacy|0|||
148961170|NCT00624052|537341575|FG003|Overall Study|Lack of Efficacy|0|||
148961171|NCT00624052|537341572|FG000|Overall Study|Lost to Follow-up|2|||
148961172|NCT00624052|537341573|FG001|Overall Study|Lost to Follow-up|3|||
148961173|NCT00624052|537341574|FG002|Overall Study|Lost to Follow-up|1|||
148961174|NCT00624052|537341575|FG003|Overall Study|Lost to Follow-up|0|||
148961175|NCT00624052|537341572|FG000|Overall Study|Non compliant with the protocol|2|||
148961176|NCT00624052|537341573|FG001|Overall Study|Non compliant with the protocol|1|||
148961177|NCT00624052|537341574|FG002|Overall Study|Non compliant with the protocol|1|||
148961178|NCT00624052|537341575|FG003|Overall Study|Non compliant with the protocol|1|||
148961179|NCT00624052|537341572|FG000|Overall Study|Consent withdrawn|3|||
148694057|NCT00336024|536352365|FG000|Overall Study|Physician Decision|4|||
148694058|NCT00336024|536352366|FG001|Overall Study|Physician Decision|1|||
148694059|NCT00336024|536352365|FG000|Overall Study|Protocol Violation|1|||
148694060|NCT00336024|536352366|FG001|Overall Study|Protocol Violation|0|||
148694061|NCT00336024|536352365|FG000|Overall Study|Withdrawal by Subject|1|||
148694062|NCT00336024|536352366|FG001|Overall Study|Withdrawal by Subject|2|||
148694063|NCT00336024|536352365|FG000|Overall Study|Failure to fulfill consolidation|1|||
148694064|NCT00336024|536352366|FG001|Overall Study|Failure to fulfill consolidation|1|||
148694065|NCT00336024|536352365|FG000|Overall Study|Progressive Disease|4|||
148694066|NCT00336024|536352366|FG001|Overall Study|Progressive Disease|7|||
148694067|NCT00336024|536352365|FG000|Overall Study|Ineligible|7|||
148694068|NCT00336024|536352366|FG001|Overall Study|Ineligible|7|||
148694069|NCT03815942|536354154|FG000|Overall Study|Withdrawal by Subject|0|||
148694070|NCT03815942|536354155|FG001|Overall Study|Withdrawal by Subject|17|||
148694071|NCT03717064|536354156|FG000|Period 2|Adverse Event|1|||
148694072|NCT01298570|536354157|FG000|Overall Study|Disease progression, relapse during acti|64|||
148694073|NCT01298570|536354158|FG001|Overall Study|Disease progression, relapse during acti|40|||
148694074|NCT01298570|536354157|FG000|Overall Study|Adverse Event|20|||
148694075|NCT01298570|536354158|FG001|Overall Study|Adverse Event|2|||
148694076|NCT01298570|536354157|FG000|Overall Study|Withdrawal by Subject|21|||
148694077|NCT01298570|536354158|FG001|Overall Study|Withdrawal by Subject|6|||
148694078|NCT01298570|536354157|FG000|Overall Study|Treatment delay > 4 weeks|4|||
148694079|NCT01298570|536354158|FG001|Overall Study|Treatment delay > 4 weeks|5|||
148694080|NCT01298570|536354157|FG000|Overall Study|Physician Decision|4|||
148694081|NCT01298570|536354158|FG001|Overall Study|Physician Decision|2|||
148694082|NCT01298570|536354157|FG000|Overall Study|Other complicating disease|2|||
148694083|NCT01298570|536354158|FG001|Overall Study|Other complicating disease|1|||
148694084|NCT01298570|536354157|FG000|Overall Study|Surgery|2|||
148694085|NCT01298570|536354158|FG001|Overall Study|Surgery|1|||
148694086|NCT01298570|536354157|FG000|Overall Study|Symptomatic progression/deterioration|3|||
148694087|NCT01298570|536354158|FG001|Overall Study|Symptomatic progression/deterioration|2|||
148694088|NCT01298570|536354157|FG000|Overall Study|Death|0|||
148694089|NCT01298570|536354158|FG001|Overall Study|Death|1|||
148694090|NCT01298570|536354157|FG000|Overall Study|Ineligibility|0|||
148694091|NCT01298570|536354158|FG001|Overall Study|Ineligibility|1|||
148694092|NCT00076102|536354159|FG000|Overall Study|Clinical progression|1|||
148694093|NCT00076102|536354159|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
148694094|NCT00076102|536354159|FG000|Overall Study|plexiform neurofibroma surgery|1|||
148694095|NCT00076102|536354159|FG000|Overall Study|refusal of further therapy|2|||
148694096|NCT04720664|536354166|FG000|Overall Study|Adverse Event|2|||
148694097|NCT04720664|536354166|FG000|Overall Study|Lack of Efficacy|9|||
148812693|NCT01931098|536789212|FG000|Overall Study|Withdrawal by Subject|0|||
148812694|NCT01931098|536789213|FG001|Overall Study|Withdrawal by Subject|1|||
148812695|NCT01931098|536789212|FG000|Overall Study|Enrolled in different protocol|0|||
148812696|NCT01931098|536789213|FG001|Overall Study|Enrolled in different protocol|1|||
148812697|NCT01931098|536789212|FG000|Overall Study|Unable to begin trmt:active infection|0|||
148812698|NCT01931098|536789213|FG001|Overall Study|Unable to begin trmt:active infection|1|||
148812699|NCT01931098|536789212|FG000|Overall Study|Refused further treatment|0|||
148694098|NCT02322047|536354167|FG000|Overall Study|Physician Decision|1|||
148694099|NCT02322047|536354168|FG001|Overall Study|Physician Decision|0|||
148812700|NCT01931098|536789213|FG001|Overall Study|Refused further treatment|1|||
148812701|NCT02879695|536789217|FG000|Overall Study|Did not start study treatment|2|||
148812702|NCT02879695|536789218|FG001|Overall Study|Did not start study treatment|0|||
148812703|NCT02879695|536789219|FG002|Overall Study|Did not start study treatment|3|||
148694100|NCT02322047|536354169|FG002|Overall Study|Physician Decision|0|||
148694101|NCT02322047|536354170|FG003|Overall Study|Physician Decision|0|||
148694102|NCT02322047|536354167|FG000|Overall Study|Withdrawal by Subject|1|||
149023999|NCT01544582|537562712|FG000|Analysis Population|Participant in Jail|0|||
149024000|NCT01544582|537562713|FG001|Analysis Population|Participant in Jail|0|||
149024001|NCT01544582|537562714|FG002|Analysis Population|Participant in Jail|1|||
149024002|NCT01544582|537562715|FG003|Analysis Population|Participant in Jail|0|||
149024003|NCT02419755|537562718|FG000|Overall Study|Death|1|||
149024004|NCT02419755|537562719|FG001|Overall Study|Death|3|||
149024005|NCT02419755|537562718|FG000|Overall Study|Relapse|0|||
149024006|NCT02419755|537562719|FG001|Overall Study|Relapse|1|||
149024007|NCT02419755|537562718|FG000|Overall Study|Ineligible|1|||
149024008|NCT02419755|537562719|FG001|Overall Study|Ineligible|0|||
149024009|NCT02419755|537562718|FG000|Overall Study|Withdrawal by Subject|1|||
149024010|NCT02419755|537562719|FG001|Overall Study|Withdrawal by Subject|0|||
149024011|NCT05397470|537562722|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
149024012|NCT05397470|537562723|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
149024013|NCT05397470|537562724|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
148694103|NCT02322047|536354168|FG001|Overall Study|Withdrawal by Subject|0|||
148694104|NCT02322047|536354169|FG002|Overall Study|Withdrawal by Subject|0|||
148694105|NCT02322047|536354170|FG003|Overall Study|Withdrawal by Subject|1|||
148694106|NCT02322047|536354167|FG000|Overall Study|Adverse Event|0|||
148812704|NCT02879695|536789220|FG003|Overall Study|Did not start study treatment|0|||
148694107|NCT02322047|536354168|FG001|Overall Study|Adverse Event|1|||
148694108|NCT02322047|536354169|FG002|Overall Study|Adverse Event|0|||
148694109|NCT02322047|536354170|FG003|Overall Study|Adverse Event|0|||
148694110|NCT02322047|536354167|FG000|Overall Study|Lost to Follow-up|0|||
148694111|NCT02322047|536354168|FG001|Overall Study|Lost to Follow-up|0|||
148694112|NCT02322047|536354169|FG002|Overall Study|Lost to Follow-up|1|||
148694113|NCT02322047|536354170|FG003|Overall Study|Lost to Follow-up|1|||
148694114|NCT03311646|536354171|FG000|Overall Study|Physician Decision|1|||
148694115|NCT03311646|536354171|FG000|Overall Study|Withdrawal by Subject|5|||
148694116|NCT03311646|536354171|FG000|Overall Study|Lost to Follow-up|5|||
148694117|NCT03311646|536354171|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
148694118|NCT03103100|536354172|FG000|Overall Study|Adverse Event|1|||
148694119|NCT03103100|536354173|FG001|Overall Study|Adverse Event|0|||
148694120|NCT03103100|536354174|FG002|Overall Study|Adverse Event|0|||
148694121|NCT03103100|536354172|FG000|Overall Study|Physician Decision|1|||
148694122|NCT03103100|536354173|FG001|Overall Study|Physician Decision|0|||
148694123|NCT03103100|536354174|FG002|Overall Study|Physician Decision|2|||
148694124|NCT00531206|536354175|FG000|Overall Study|Adverse Event related|5|||
148694125|NCT00531206|536354175|FG000|Overall Study|Lack of Efficacy|2|||
148694126|NCT00531206|536354175|FG000|Overall Study|Lost to Follow-up|5|||
148694127|NCT00531206|536354175|FG000|Overall Study|including non-related adverse events|8|||
148694128|NCT02906709|536354176|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
148694129|NCT02906709|536354177|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
148694130|NCT02906709|536354176|FG000|Phase A (Week 0 to Week 16)|Death|0|||
148694131|NCT02906709|536354177|FG001|Phase A (Week 0 to Week 16)|Death|1|||
148694132|NCT02906709|536354176|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
148694133|NCT02906709|536354177|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
148694134|NCT02906709|536354176|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
148694135|NCT02906709|536354177|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
148694136|NCT00977106|536354179|FG000|Overall Study|Adverse Event|5|||
148694137|NCT00977106|536354180|FG001|Overall Study|Adverse Event|6|||
148694138|NCT00977106|536354179|FG000|Overall Study|Withdrawal by Subject|2|||
148694139|NCT00977106|536354180|FG001|Overall Study|Withdrawal by Subject|2|||
148694140|NCT00977106|536354179|FG000|Overall Study|Lack of Efficacy|2|||
148694141|NCT00977106|536354180|FG001|Overall Study|Lack of Efficacy|2|||
148694142|NCT00977106|536354179|FG000|Overall Study|Protocol Violation|0|||
148694143|NCT00977106|536354180|FG001|Overall Study|Protocol Violation|1|||
148694144|NCT00977106|536354179|FG000|Overall Study|Other|1|||
148694145|NCT00977106|536354180|FG001|Overall Study|Other|0|||
148961180|NCT00624052|537341573|FG001|Overall Study|Consent withdrawn|1|||
148961181|NCT00624052|537341574|FG002|Overall Study|Consent withdrawn|1|||
148961182|NCT00624052|537341575|FG003|Overall Study|Consent withdrawn|0|||
148694146|NCT02419313|536354181|FG000|First Intervention|Lost to Follow-up|2|||
148694147|NCT02419313|536354182|FG001|First Intervention|Lost to Follow-up|0|||
148694148|NCT02419313|536354181|FG000|Second Intervention|Lost to Follow-up|1|||
148694149|NCT02419313|536354182|FG001|Second Intervention|Lost to Follow-up|0|||
148694150|NCT00442936|536354186|FG000|Overall Study|Protocol Violation|1|||
148694151|NCT00442936|536354187|FG001|Overall Study|Protocol Violation|0|||
148694152|NCT00442936|536354188|FG002|Overall Study|Protocol Violation|1|||
148694153|NCT00442936|536354189|FG003|Overall Study|Protocol Violation|1|||
148694154|NCT00524459|536354191|FG000|Overall Study|Withdrawal by Subject|1|||
148694155|NCT00524459|536354191|FG000|Overall Study|Other|1|||
148694156|NCT02428699|536354192|FG000|Washout Period 1|Screen Failure|1|||
148694157|NCT02428699|536354193|FG001|Washout Period 1|Screen Failure|2|||
148694158|NCT02433678|536354194|FG000|Overall Study|Lost to Follow-up|1|||
148694159|NCT02433678|536354195|FG001|Overall Study|Lost to Follow-up|2|||
148961183|NCT00624052|537341572|FG000|Overall Study|Changed job/ran out if meds|0|||
148961184|NCT00624052|537341573|FG001|Overall Study|Changed job/ran out if meds|2|||
148961185|NCT00624052|537341574|FG002|Overall Study|Changed job/ran out if meds|0|||
148961186|NCT00624052|537341575|FG003|Overall Study|Changed job/ran out if meds|0|||
148961187|NCT01173718|537341584|FG000|Overall Study|Death|17|||
148961188|NCT01173718|537341584|FG000|Overall Study|Abandonment of study graft|27|||
148961189|NCT01499563|537341587|FG000|Overall Study|Withdrawal by Subject|10|||
148961190|NCT01499563|537341588|FG001|Overall Study|Withdrawal by Subject|11|||
148961191|NCT01499563|537341589|FG002|Overall Study|Withdrawal by Subject|7|||
148961192|NCT01499563|537341590|FG003|Overall Study|Withdrawal by Subject|8|||
148961193|NCT01499563|537341587|FG000|Overall Study|Physician Decision|2|||
148961194|NCT01499563|537341588|FG001|Overall Study|Physician Decision|1|||
148961195|NCT01499563|537341589|FG002|Overall Study|Physician Decision|3|||
148961196|NCT01499563|537341590|FG003|Overall Study|Physician Decision|0|||
148961197|NCT01499563|537341587|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
148961198|NCT01499563|537341588|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
148961199|NCT01499563|537341589|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
148961200|NCT01499563|537341590|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
148961201|NCT01499563|537341587|FG000|Overall Study|Adverse Event|2|||
148961202|NCT01499563|537341588|FG001|Overall Study|Adverse Event|0|||
148961203|NCT01499563|537341589|FG002|Overall Study|Adverse Event|1|||
148961204|NCT01499563|537341590|FG003|Overall Study|Adverse Event|3|||
148961205|NCT01499563|537341587|FG000|Overall Study|Lack of Efficacy|0|||
148961206|NCT01499563|537341588|FG001|Overall Study|Lack of Efficacy|1|||
148961207|NCT01499563|537341589|FG002|Overall Study|Lack of Efficacy|6|||
148961208|NCT01499563|537341590|FG003|Overall Study|Lack of Efficacy|3|||
148961209|NCT01499563|537341587|FG000|Overall Study|Other|8|||
148961210|NCT01499563|537341588|FG001|Overall Study|Other|6|||
148961211|NCT01499563|537341589|FG002|Overall Study|Other|6|||
148961212|NCT01499563|537341590|FG003|Overall Study|Other|4|||
148961213|NCT03279692|537341593|FG000|Overall Study|Withdrawal by Subject|1|||
148961214|NCT05198843|537341594|FG000|Overall Study|Lack of Efficacy|1|||
148961215|NCT02588833|537341596|FG000|Part 1|Withdrawal by Subject|1|||
148961216|NCT02588833|537341597|FG001|Part 1|Withdrawal by Subject|0|||
148961217|NCT02588833|537341596|FG000|Part 2A|Physician Decision|0|||
148961218|NCT02588833|537341597|FG001|Part 2A|Physician Decision|1|||
148961219|NCT02588833|537341596|FG000|Part 2A|Withdrawal by Subject|0|||
148961220|NCT02588833|537341597|FG001|Part 2A|Withdrawal by Subject|1|||
148961221|NCT02588833|537341596|FG000|Part 2B|Adverse Event|0|||
148961222|NCT02588833|537341597|FG001|Part 2B|Adverse Event|1|||
148961223|NCT02588833|537341596|FG000|Part 2C|Adverse Event|0|||
148961224|NCT02588833|537341597|FG001|Part 2C|Adverse Event|1|||
148961225|NCT02588833|537341596|FG000|Part 2C|Withdrawal by Subject|0|||
148961226|NCT02588833|537341597|FG001|Part 2C|Withdrawal by Subject|1|||
148961227|NCT02588833|537341596|FG000|Part 3 (Safety Follow-up)|Other|0|||
148961228|NCT02588833|537341597|FG001|Part 3 (Safety Follow-up)|Other|2|||
148961229|NCT03333044|537341600|FG000|Overall Study|Pregnancy|1|||
149024014|NCT05397470|537562722|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
149024015|NCT05397470|537562723|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
149024016|NCT05397470|537562724|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
149024017|NCT05397470|537562722|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
149024018|NCT05397470|537562723|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
148961230|NCT03333044|537341601|FG001|Overall Study|Pregnancy|0|||
148961231|NCT03333044|537341602|FG002|Overall Study|Pregnancy|0|||
148961232|NCT03333044|537341600|FG000|Overall Study|Lost to Follow-up|0|||
148961233|NCT03333044|537341601|FG001|Overall Study|Lost to Follow-up|14|||
148961234|NCT03333044|537341602|FG002|Overall Study|Lost to Follow-up|6|||
148961235|NCT03649711|537341605|FG000|Overall Study|Adverse Event|0|||
148961236|NCT03649711|537341606|FG001|Overall Study|Adverse Event|1|||
148961237|NCT03649711|537341607|FG002|Overall Study|Adverse Event|0|||
148961238|NCT03649711|537341605|FG000|Overall Study|Kidney Transplant|1|||
148961239|NCT03649711|537341606|FG001|Overall Study|Kidney Transplant|0|||
148961240|NCT03649711|537341607|FG002|Overall Study|Kidney Transplant|0|||
148961241|NCT04537234|537341609|FG000|Overall Study|Withdrawal by Subject|2|||
148694160|NCT04424407|536354196|FG000|Overall Study|Withdrawal by Subject|2|||
148694161|NCT04424407|536354196|FG000|Overall Study|Lost to Follow-up|1|||
148961242|NCT04537234|537341610|FG001|Overall Study|Withdrawal by Subject|0|||
148961243|NCT00296374|537341611|FG000|Overall Study|Adverse Event|14|||
148961244|NCT00296374|537341612|FG001|Overall Study|Adverse Event|10|||
148961245|NCT00296374|537341613|FG002|Overall Study|Adverse Event|7|||
148961246|NCT00296374|537341611|FG000|Overall Study|Withdrawal by Subject|3|||
148961247|NCT00296374|537341612|FG001|Overall Study|Withdrawal by Subject|5|||
148961248|NCT00296374|537341613|FG002|Overall Study|Withdrawal by Subject|11|||
148812705|NCT04235374|536789221|FG000|Overall Study|Death|91|||
148812706|NCT04235374|536789222|FG001|Overall Study|Death|91|||
148812707|NCT04235374|536789221|FG000|Overall Study|Refused|2|||
148812708|NCT04235374|536789222|FG001|Overall Study|Refused|2|||
148812709|NCT04235374|536789221|FG000|Overall Study|Unavailable|12|||
148812710|NCT04235374|536789222|FG001|Overall Study|Unavailable|3|||
148694162|NCT02684578|536354197|FG000|Overall Study|Withdrawal by Subject|10|||
148694163|NCT02684578|536354198|FG001|Overall Study|Withdrawal by Subject|7|||
148694164|NCT02684578|536354197|FG000|Overall Study|Lost to Follow-up|0|||
148694165|NCT02684578|536354198|FG001|Overall Study|Lost to Follow-up|3|||
148694166|NCT02684578|536354197|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
148694167|NCT02684578|536354198|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
148694168|NCT02684578|536354197|FG000|Overall Study|Missing follow-up data|0|||
148694169|NCT02684578|536354198|FG001|Overall Study|Missing follow-up data|1|||
148694170|NCT02460159|536354199|FG000|Overall Study|Adverse Event|4|||
148694171|NCT02460159|536354200|FG001|Overall Study|Adverse Event|1|||
148694172|NCT02460159|536354199|FG000|Overall Study|Withdrawal by Subject|2|||
148694173|NCT02460159|536354200|FG001|Overall Study|Withdrawal by Subject|0|||
148694174|NCT01193608|536354201|FG000|Overall Study|Other|0|||
148694175|NCT01193608|536354202|FG001|Overall Study|Other|1|||
148694176|NCT01193608|536354203|FG002|Overall Study|Other|0|||
148694177|NCT01193608|536354204|FG003|Overall Study|Other|0|||
148694178|NCT01193608|536354205|FG004|Overall Study|Other|0|||
148694179|NCT01193608|536354206|FG005|Overall Study|Other|0|||
148694180|NCT01193608|536354201|FG000|Overall Study|Withdrawal by Subject|0|||
148694181|NCT01193608|536354202|FG001|Overall Study|Withdrawal by Subject|1|||
148694182|NCT01193608|536354203|FG002|Overall Study|Withdrawal by Subject|2|||
148694183|NCT01193608|536354204|FG003|Overall Study|Withdrawal by Subject|3|||
148694184|NCT01193608|536354205|FG004|Overall Study|Withdrawal by Subject|3|||
148694185|NCT01193608|536354206|FG005|Overall Study|Withdrawal by Subject|0|||
148694186|NCT01193608|536354201|FG000|Overall Study|Lost to Follow-up|0|||
148694187|NCT01193608|536354202|FG001|Overall Study|Lost to Follow-up|0|||
148694188|NCT01193608|536354203|FG002|Overall Study|Lost to Follow-up|0|||
148694189|NCT01193608|536354204|FG003|Overall Study|Lost to Follow-up|0|||
148694190|NCT01193608|536354205|FG004|Overall Study|Lost to Follow-up|1|||
148694191|NCT01193608|536354206|FG005|Overall Study|Lost to Follow-up|2|||
148694192|NCT01193608|536354201|FG000|Overall Study|Adverse Event|0|||
148694193|NCT01193608|536354202|FG001|Overall Study|Adverse Event|0|||
148694194|NCT01193608|536354203|FG002|Overall Study|Adverse Event|0|||
148694195|NCT01193608|536354204|FG003|Overall Study|Adverse Event|0|||
148694196|NCT01193608|536354205|FG004|Overall Study|Adverse Event|1|||
148694197|NCT01193608|536354206|FG005|Overall Study|Adverse Event|0|||
148694198|NCT01492400|536354214|FG000|Overall Study|Miscellaneous Reasons|2|||
148694199|NCT01492400|536354215|FG001|Overall Study|Miscellaneous Reasons|3|||
148694200|NCT01492400|536354214|FG000|Overall Study|Personal Reasons|0|||
148694201|NCT01492400|536354215|FG001|Overall Study|Personal Reasons|5|||
148694202|NCT01492400|536354214|FG000|Overall Study|Lost to Follow-up|3|||
148694203|NCT01492400|536354215|FG001|Overall Study|Lost to Follow-up|1|||
148694204|NCT01492400|536354214|FG000|Overall Study|Pregnancy|0|||
148694205|NCT01492400|536354215|FG001|Overall Study|Pregnancy|1|||
148694206|NCT01492400|536354214|FG000|Overall Study|Lack of Efficacy|1|||
148694207|NCT01492400|536354215|FG001|Overall Study|Lack of Efficacy|1|||
148694208|NCT01492400|536354214|FG000|Overall Study|Adverse Event|10|||
148694209|NCT01492400|536354215|FG001|Overall Study|Adverse Event|5|||
148694210|NCT00659607|536354217|FG000|Overall Study|No blood pressure recorded|147|||
148694211|NCT00659607|536354217|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
148694212|NCT00659607|536354217|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
148694213|NCT00659607|536354217|FG000|Overall Study|No recorded efficacy data|15|||
148694214|NCT00659607|536354217|FG000|Overall Study|Inconsistent BP measuring date|2|||
148694215|NCT02899338|536354218|FG000|Overall Study|Adverse Event|1|||
148694216|NCT02899338|536354219|FG001|Overall Study|Adverse Event|2|||
148694217|NCT02899338|536354218|FG000|Overall Study|Withdrawal by Subject|2|||
148694218|NCT02899338|536354219|FG001|Overall Study|Withdrawal by Subject|0|||
148694219|NCT06179108|536354220|FG000|Overall Study|Withdrawal by Subject|16|||
148694220|NCT06179108|536354221|FG001|Overall Study|Withdrawal by Subject|19|||
148694221|NCT06179108|536354222|FG002|Overall Study|Withdrawal by Subject|10|||
148694222|NCT06179108|536354223|FG003|Overall Study|Withdrawal by Subject|11|||
148694223|NCT06179108|536354220|FG000|Overall Study|Lost to Follow-up|12|||
148694224|NCT06179108|536354221|FG001|Overall Study|Lost to Follow-up|4|||
148694225|NCT06179108|536354222|FG002|Overall Study|Lost to Follow-up|1|||
148694226|NCT06179108|536354223|FG003|Overall Study|Lost to Follow-up|9|||
148694227|NCT06179108|536354220|FG000|Overall Study|Adverse Event|2|||
148694228|NCT06179108|536354221|FG001|Overall Study|Adverse Event|3|||
148694229|NCT06179108|536354222|FG002|Overall Study|Adverse Event|3|||
148694230|NCT06179108|536354223|FG003|Overall Study|Adverse Event|2|||
148694231|NCT06179108|536354220|FG000|Overall Study|Protocol Violation|0|||
148694232|NCT06179108|536354221|FG001|Overall Study|Protocol Violation|1|||
148694233|NCT06179108|536354222|FG002|Overall Study|Protocol Violation|0|||
148694234|NCT06179108|536354223|FG003|Overall Study|Protocol Violation|1|||
148694235|NCT06179108|536354220|FG000|Overall Study|Physician Decision|1|||
148694236|NCT06179108|536354221|FG001|Overall Study|Physician Decision|1|||
148694237|NCT06179108|536354222|FG002|Overall Study|Physician Decision|0|||
148694238|NCT06179108|536354223|FG003|Overall Study|Physician Decision|0|||
148694239|NCT06179108|536354220|FG000|Overall Study|Lack of Efficacy|0|||
148694240|NCT06179108|536354221|FG001|Overall Study|Lack of Efficacy|0|||
148694241|NCT06179108|536354222|FG002|Overall Study|Lack of Efficacy|0|||
148694242|NCT06179108|536354223|FG003|Overall Study|Lack of Efficacy|1|||
148694243|NCT06179108|536354220|FG000|Overall Study|Death|0|||
148694244|NCT06179108|536354221|FG001|Overall Study|Death|0|||
148694245|NCT06179108|536354222|FG002|Overall Study|Death|0|||
148694246|NCT06179108|536354223|FG003|Overall Study|Death|1|||
148694247|NCT01370408|536354224|FG000|Overall Study|treatment failure|9|||
148961249|NCT00296374|537341611|FG000|Overall Study|Incorrect enrollment|3|||
149024019|NCT05397470|537562724|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
149024020|NCT05397470|537562722|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
149024021|NCT05397470|537562723|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
149024022|NCT05397470|537562724|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
149024023|NCT05397470|537562722|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
149024024|NCT05397470|537562723|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
149024025|NCT05397470|537562724|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
149024026|NCT05397470|537562722|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
149024027|NCT05397470|537562723|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
149024028|NCT05397470|537562724|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
149024029|NCT05397470|537562722|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
149024030|NCT05397470|537562723|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
149024031|NCT05397470|537562724|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
149024032|NCT06403605|537562729|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
148694248|NCT00486837|536354225|FG000|Overall Study|Withdrawal by Subject|1|||
148694249|NCT00486837|536354226|FG001|Overall Study|Withdrawal by Subject|0|||
148694250|NCT00486837|536354225|FG000|Overall Study|Adverse Event|1|||
148694251|NCT00486837|536354226|FG001|Overall Study|Adverse Event|1|||
148694252|NCT00486837|536354225|FG000|Overall Study|Protocol Violation|4|||
148694253|NCT00486837|536354226|FG001|Overall Study|Protocol Violation|2|||
148694254|NCT00486837|536354225|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
148694255|NCT00486837|536354226|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
148694256|NCT05694013|536354227|FG000|Overall Study|Death|6|||
148694257|NCT05694013|536354228|FG001|Overall Study|Death|2|||
148812711|NCT04235374|536789221|FG000|Overall Study|Withdrawal by Subject|0|||
148812712|NCT04235374|536789222|FG001|Overall Study|Withdrawal by Subject|1|||
148812713|NCT04235374|536789221|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
148961250|NCT00296374|537341612|FG001|Overall Study|Incorrect enrollment|3|||
148961251|NCT00296374|537341613|FG002|Overall Study|Incorrect enrollment|4|||
148961252|NCT00296374|537341611|FG000|Overall Study|Protocol Violation|1|||
148961253|NCT00296374|537341612|FG001|Overall Study|Protocol Violation|2|||
148961254|NCT00296374|537341613|FG002|Overall Study|Protocol Violation|3|||
148961255|NCT00296374|537341611|FG000|Overall Study|Lost to Follow-up|3|||
148961256|NCT00296374|537341612|FG001|Overall Study|Lost to Follow-up|1|||
148961257|NCT00296374|537341613|FG002|Overall Study|Lost to Follow-up|1|||
148961258|NCT00296374|537341611|FG000|Overall Study|Relocated to another state|1|||
148961259|NCT00296374|537341612|FG001|Overall Study|Relocated to another state|0|||
148961260|NCT00296374|537341613|FG002|Overall Study|Relocated to another state|0|||
149024033|NCT06403605|537562730|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
148812714|NCT04235374|536789222|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
148694258|NCT05694013|536354227|FG000|Overall Study|Participant Decision|0|||
148694259|NCT05694013|536354228|FG001|Overall Study|Participant Decision|1|||
148812715|NCT00314145|536789223|FG000|Overall Study|Withdrawal by Subject|8|||
148961261|NCT00296374|537341611|FG000|Overall Study|Stopped drug before end of study visit|0|||
149024034|NCT06403605|537562729|FG000|Follow-up|Adverse Event|4|||
149024035|NCT06403605|537562730|FG001|Follow-up|Adverse Event|2|||
148961262|NCT00296374|537341612|FG001|Overall Study|Stopped drug before end of study visit|1|||
148961263|NCT00296374|537341613|FG002|Overall Study|Stopped drug before end of study visit|0|||
148961264|NCT00296374|537341611|FG000|Overall Study|Nephrologist introduced ACE|0|||
148961265|NCT00296374|537341612|FG001|Overall Study|Nephrologist introduced ACE|1|||
148961266|NCT00296374|537341613|FG002|Overall Study|Nephrologist introduced ACE|0|||
148961267|NCT00296374|537341611|FG000|Overall Study|Pregnancy|0|||
148961268|NCT00296374|537341612|FG001|Overall Study|Pregnancy|0|||
148961269|NCT00296374|537341613|FG002|Overall Study|Pregnancy|2|||
148961270|NCT00296374|537341611|FG000|Overall Study|Other|0|||
148961271|NCT00296374|537341612|FG001|Overall Study|Other|0|||
148961272|NCT00296374|537341613|FG002|Overall Study|Other|1|||
148961273|NCT01721330|537341614|FG000|Overall Study|Withdrawal by Subject|0|||
148961274|NCT01721330|537341615|FG001|Overall Study|Withdrawal by Subject|1|||
148961275|NCT04318080|537343222|FG000|Overall Study|Study closed by sponsor|10|||
148961276|NCT04318080|537343223|FG001|Overall Study|Study closed by sponsor|22|||
148961277|NCT04318080|537343222|FG000|Overall Study|Death|3|||
148961278|NCT04318080|537343223|FG001|Overall Study|Death|9|||
148961279|NCT04318080|537343222|FG000|Overall Study|Withdrawal by Subject|1|||
148961280|NCT04318080|537343223|FG001|Overall Study|Withdrawal by Subject|0|||
148961281|NCT04318080|537343222|FG000|Overall Study|Protocol Deviation|1|||
148961282|NCT04318080|537343223|FG001|Overall Study|Protocol Deviation|0|||
148961283|NCT04734652|537343229|FG000|Overall Study|Withdrawal by Subject|2|||
148961284|NCT04734652|537343230|FG001|Overall Study|Withdrawal by Subject|0|||
148961285|NCT04734652|537343229|FG000|Overall Study|Death|0|||
148961286|NCT04734652|537343230|FG001|Overall Study|Death|1|||
148961287|NCT01921179|537343234|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
148961288|NCT01921179|537343235|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
148961289|NCT01921179|537343234|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
148961290|NCT01921179|537343235|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
148961291|NCT01190254|537343238|FG000|Overall Study|Adverse Event|3|||
148961292|NCT01190254|537343239|FG001|Overall Study|Adverse Event|6|||
148961293|NCT01190254|537343240|FG002|Overall Study|Adverse Event|8|||
148961294|NCT01190254|537343238|FG000|Overall Study|Lack of Efficacy|7|||
148961295|NCT01190254|537343239|FG001|Overall Study|Lack of Efficacy|4|||
148961296|NCT01190254|537343240|FG002|Overall Study|Lack of Efficacy|5|||
148961297|NCT01190254|537343238|FG000|Overall Study|Lost to Follow-up|4|||
148961298|NCT01190254|537343239|FG001|Overall Study|Lost to Follow-up|2|||
148961299|NCT01190254|537343240|FG002|Overall Study|Lost to Follow-up|0|||
148694260|NCT05694013|536354227|FG000|Overall Study|Physician Decision|1|||
148694261|NCT05694013|536354228|FG001|Overall Study|Physician Decision|0|||
148694262|NCT05694013|536354227|FG000|Overall Study|Progressive Disease|0|||
148694263|NCT05694013|536354228|FG001|Overall Study|Progressive Disease|1|||
148694264|NCT05694013|536354227|FG000|Overall Study|Study Terminated by Sponsor|12|||
148694265|NCT05694013|536354228|FG001|Overall Study|Study Terminated by Sponsor|17|||
148694266|NCT05694013|536354227|FG000|Overall Study|Withdrawal by Subject|3|||
148694267|NCT05694013|536354228|FG001|Overall Study|Withdrawal by Subject|0|||
148694268|NCT04817891|536354229|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
148694269|NCT04817891|536354229|FG000|Overall Study|Adverse Event|1|||
148694270|NCT04817891|536354229|FG000|Overall Study|Withdrawal by Subject|1|||
148694271|NCT04534283|536354230|FG000|Overall Study|Physician Decision|2|||
148694272|NCT04534283|536354230|FG000|Overall Study|Withdrawal by Subject|1|||
148694273|NCT04534283|536354230|FG000|Overall Study|Disease Progression|12|||
148694274|NCT04534283|536354230|FG000|Overall Study|Adverse Event|1|||
148694275|NCT03257462|536354231|FG000|Cohort A|Lost to Follow-up|1|||
148694276|NCT03257462|536354232|FG001|Cohort A|Lost to Follow-up|0|||
148961300|NCT01190254|537343238|FG000|Overall Study|Withdrawal by Subject|4|||
148961301|NCT01190254|537343239|FG001|Overall Study|Withdrawal by Subject|5|||
148961302|NCT01190254|537343240|FG002|Overall Study|Withdrawal by Subject|7|||
148694277|NCT03257462|536354233|FG002|Cohort A|Lost to Follow-up|0|||
148694278|NCT03257462|536354234|FG003|Cohort A|Lost to Follow-up|0|||
148961303|NCT01190254|537343238|FG000|Overall Study|Protocol Violation|2|||
148961304|NCT01190254|537343239|FG001|Overall Study|Protocol Violation|0|||
148694279|NCT03257462|536354231|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
148694280|NCT03257462|536354232|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
148961305|NCT01190254|537343240|FG002|Overall Study|Protocol Violation|2|||
149024036|NCT06403605|537562729|FG000|Follow-up|Withdrawal by Subject|2|||
148961306|NCT01190254|537343238|FG000|Overall Study|Did not meet protocol eligibility|1|||
148961307|NCT01190254|537343239|FG001|Overall Study|Did not meet protocol eligibility|0|||
148961308|NCT01190254|537343240|FG002|Overall Study|Did not meet protocol eligibility|0|||
148961309|NCT04146545|537343241|FG000|Overall Study|deemed ineligible after randomization|1|||
148961310|NCT04146545|537343242|FG001|Overall Study|deemed ineligible after randomization|0|||
148961311|NCT00773292|537343243|FG000|Treatment 48 Weeks|Adverse Event|1|||
148961312|NCT00773292|537343243|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
148961313|NCT04729127|537343244|FG000|Overall Study|Suspended/Terminated EI Services|4|||
148961314|NCT04729127|537343245|FG001|Overall Study|Suspended/Terminated EI Services|0|||
148961315|NCT04729127|537343246|FG002|Overall Study|Suspended/Terminated EI Services|4|||
148961316|NCT04729127|537343247|FG003|Overall Study|Suspended/Terminated EI Services|6|||
148961317|NCT04729127|537343248|FG004|Overall Study|Suspended/Terminated EI Services|0|||
148961318|NCT04729127|537343249|FG005|Overall Study|Suspended/Terminated EI Services|6|||
148961319|NCT04729127|537343250|FG006|Overall Study|Suspended/Terminated EI Services|2|||
148961320|NCT04729127|537343251|FG007|Overall Study|Suspended/Terminated EI Services|0|||
148961321|NCT04729127|537343252|FG008|Overall Study|Suspended/Terminated EI Services|2|||
148961322|NCT04729127|537343244|FG000|Overall Study|Withdrawal by Subject|1|||
148961323|NCT04729127|537343245|FG001|Overall Study|Withdrawal by Subject|0|||
148961324|NCT04729127|537343246|FG002|Overall Study|Withdrawal by Subject|1|||
148961325|NCT04729127|537343247|FG003|Overall Study|Withdrawal by Subject|0|||
148961326|NCT04729127|537343248|FG004|Overall Study|Withdrawal by Subject|0|||
148961327|NCT04729127|537343249|FG005|Overall Study|Withdrawal by Subject|0|||
148961328|NCT04729127|537343250|FG006|Overall Study|Withdrawal by Subject|0|||
148961329|NCT04729127|537343251|FG007|Overall Study|Withdrawal by Subject|0|||
148961330|NCT04729127|537343252|FG008|Overall Study|Withdrawal by Subject|0|||
148961331|NCT04729127|537343244|FG000|Overall Study|Switched Agency/Setting|1|||
148961332|NCT04729127|537343245|FG001|Overall Study|Switched Agency/Setting|0|||
149024037|NCT06403605|537562730|FG001|Follow-up|Withdrawal by Subject|3|||
148961333|NCT04729127|537343246|FG002|Overall Study|Switched Agency/Setting|1|||
148961334|NCT04729127|537343247|FG003|Overall Study|Switched Agency/Setting|1|||
148961335|NCT04729127|537343248|FG004|Overall Study|Switched Agency/Setting|0|||
148961336|NCT04729127|537343249|FG005|Overall Study|Switched Agency/Setting|1|||
148961337|NCT04729127|537343250|FG006|Overall Study|Switched Agency/Setting|1|||
148961338|NCT04729127|537343251|FG007|Overall Study|Switched Agency/Setting|0|||
148961339|NCT04729127|537343252|FG008|Overall Study|Switched Agency/Setting|1|||
148961340|NCT00542919|537343255|FG000|Overall Study|Adverse Event|1|||
148961341|NCT00542919|537343256|FG001|Overall Study|Adverse Event|5|||
148961342|NCT00542919|537343257|FG002|Overall Study|Adverse Event|1|||
148961343|NCT00542919|537343255|FG000|Overall Study|Withdrawal by Subject|1|||
148961344|NCT00542919|537343256|FG001|Overall Study|Withdrawal by Subject|0|||
148961345|NCT00542919|537343257|FG002|Overall Study|Withdrawal by Subject|3|||
148961346|NCT00542919|537343255|FG000|Overall Study|Physician Decision|2|||
148961347|NCT00542919|537343256|FG001|Overall Study|Physician Decision|2|||
148961348|NCT00542919|537343257|FG002|Overall Study|Physician Decision|1|||
148961349|NCT00542919|537343255|FG000|Overall Study|Sponsor Decision|1|||
148961350|NCT00542919|537343256|FG001|Overall Study|Sponsor Decision|0|||
148961351|NCT00542919|537343257|FG002|Overall Study|Sponsor Decision|0|||
148961352|NCT00542919|537343255|FG000|Overall Study|Lost to Follow-up|2|||
148961353|NCT00542919|537343256|FG001|Overall Study|Lost to Follow-up|0|||
148961354|NCT00542919|537343257|FG002|Overall Study|Lost to Follow-up|1|||
148961355|NCT03388138|537343268|FG000|Overall Study|Protocol Violation|1|||
148961356|NCT03388138|537343269|FG001|Overall Study|Protocol Violation|0|||
148961357|NCT01528072|537343270|FG000|Overall Study|Withdrawal by Subject|5|||
148961358|NCT01528072|537343270|FG000|Overall Study|Physician Decision|1|||
148961359|NCT01528072|537343270|FG000|Overall Study|Determined not eligible by AEAC|1|||
148961360|NCT01528072|537343270|FG000|Overall Study|Missed Visit|2|||
148961361|NCT01528072|537343270|FG000|Overall Study|Lost to Follow-up|5|||
148961362|NCT01528072|537343270|FG000|Overall Study|Explanted|2|||
148961363|NCT01528072|537343270|FG000|Overall Study|Site Closure|4|||
148961364|NCT01528072|537343270|FG000|Overall Study|Death|2|||
148961365|NCT01528072|537343270|FG000|Overall Study|Early Termination of Study|52|||
148961366|NCT04014075|537343272|FG000|Overall Study|Progressive Disease|53|||
148961367|NCT04014075|537343272|FG000|Overall Study|Adverse Event|15|||
148961368|NCT04014075|537343272|FG000|Overall Study|Clinical Progression|4|||
148961369|NCT04014075|537343272|FG000|Overall Study|Death|2|||
148961370|NCT04014075|537343272|FG000|Overall Study|Withdrawal by Subject|2|||
148961371|NCT04014075|537343272|FG000|Overall Study|Miscellaneous|2|||
148961372|NCT04014075|537343272|FG000|Overall Study|Physician Decision|1|||
148961373|NCT00483379|537343277|FG000|Treatment Period|Adverse Event|1|||
148961374|NCT00483379|537343278|FG001|Treatment Period|Adverse Event|0|||
148961375|NCT00483379|537343277|FG000|Treatment Period|Withdrawal by Subject|1|||
148961376|NCT00483379|537343278|FG001|Treatment Period|Withdrawal by Subject|0|||
148961377|NCT00536107|537343280|FG000|Overall Study|Death|5|||
148961378|NCT00536107|537343281|FG001|Overall Study|Death|1|||
148961379|NCT00536107|537343280|FG000|Overall Study|Incorrect enrolment|1|||
148961380|NCT00536107|537343281|FG001|Overall Study|Incorrect enrolment|0|||
148961381|NCT00536107|537343280|FG000|Overall Study|Withdrawal by Subject|0|||
148961382|NCT00536107|537343281|FG001|Overall Study|Withdrawal by Subject|1|||
148694281|NCT03257462|536354233|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
148694282|NCT03257462|536354234|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
148694283|NCT00368277|536354235|FG000|Overall Study|Adverse Event|33|||
148694284|NCT00368277|536354236|FG001|Overall Study|Adverse Event|49|||
148694285|NCT00368277|536354235|FG000|Overall Study|Death|2|||
148694286|NCT00368277|536354236|FG001|Overall Study|Death|1|||
148694287|NCT00368277|536354235|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
148694288|NCT00368277|536354236|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
148694289|NCT00368277|536354235|FG000|Overall Study|Protocol deviation|7|||
148694290|NCT00368277|536354236|FG001|Overall Study|Protocol deviation|0|||
148694291|NCT00368277|536354235|FG000|Overall Study|Patient withdrew consent|32|||
148694292|NCT00368277|536354236|FG001|Overall Study|Patient withdrew consent|28|||
148694293|NCT00368277|536354235|FG000|Overall Study|Lost to Follow-up|8|||
148694294|NCT00368277|536354236|FG001|Overall Study|Lost to Follow-up|6|||
148694295|NCT03978624|536354237|FG000|Overall Study|Protocol Violation|1|||
148694296|NCT03978624|536354238|FG001|Overall Study|Protocol Violation|0|||
148694297|NCT04347239|536354239|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
148694298|NCT04347239|536354240|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
148694299|NCT04347239|536354241|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
148694300|NCT04347239|536354239|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
148694301|NCT04347239|536354240|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
148694302|NCT04347239|536354241|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
148694303|NCT05097989|536354243|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694304|NCT05097989|536354244|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694305|NCT05097989|536354245|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694306|NCT05097989|536354246|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694307|NCT05097989|536354247|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694308|NCT05097989|536354248|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
148694309|NCT05097989|536354249|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694310|NCT05097989|536354250|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694311|NCT05097989|536354251|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
148694312|NCT05097989|536354243|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
148694313|NCT05097989|536354244|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
148961383|NCT00536107|537343280|FG000|Overall Study|Study Termination|2|||
148961384|NCT00536107|537343281|FG001|Overall Study|Study Termination|4|||
148961385|NCT00371254|537343282|FG000|Overall Study|Disease progression|13|||
148961386|NCT00371254|537343283|FG001|Overall Study|Disease progression|13|||
148961387|NCT00371254|537343282|FG000|Overall Study|Study drug toxicity|3|||
148961388|NCT00371254|537343283|FG001|Overall Study|Study drug toxicity|5|||
148961389|NCT00371254|537343282|FG000|Overall Study|Subject request|5|||
148961390|NCT00371254|537343283|FG001|Overall Study|Subject request|0|||
148961391|NCT00371254|537343282|FG000|Overall Study|Investigator Decision|2|||
148961392|NCT00371254|537343283|FG001|Overall Study|Investigator Decision|0|||
148961393|NCT00371254|537343282|FG000|Overall Study|Adverse event unrelated to study drug|0|||
148961394|NCT00371254|537343283|FG001|Overall Study|Adverse event unrelated to study drug|1|||
148961395|NCT00371254|537343282|FG000|Overall Study|Lost to Follow-up|0|||
148961396|NCT00371254|537343283|FG001|Overall Study|Lost to Follow-up|1|||
148961397|NCT00371254|537343282|FG000|Overall Study|Withdrawal by Subject|0|||
148961398|NCT00371254|537343283|FG001|Overall Study|Withdrawal by Subject|1|||
148961399|NCT02337907|537343286|FG000|Overall Study|Other than listed|1|||
148961400|NCT02337907|537343287|FG001|Overall Study|Other than listed|0|||
148961401|NCT02337907|537343288|FG002|Overall Study|Other than listed|0|||
148961402|NCT02337907|537343289|FG003|Overall Study|Other than listed|1|||
148961403|NCT02337907|537343290|FG004|Overall Study|Other than listed|1|||
148961404|NCT02337907|537343291|FG005|Overall Study|Other than listed|0|||
148961405|NCT02337907|537343286|FG000|Overall Study|Withdrawal by Subject|2|||
148961406|NCT02337907|537343287|FG001|Overall Study|Withdrawal by Subject|3|||
148961407|NCT02337907|537343288|FG002|Overall Study|Withdrawal by Subject|0|||
148961408|NCT02337907|537343289|FG003|Overall Study|Withdrawal by Subject|2|||
148961409|NCT02337907|537343290|FG004|Overall Study|Withdrawal by Subject|5|||
148961410|NCT02337907|537343291|FG005|Overall Study|Withdrawal by Subject|0|||
148961411|NCT02337907|537343286|FG000|Overall Study|Lost to Follow-up|0|||
148961412|NCT02337907|537343287|FG001|Overall Study|Lost to Follow-up|0|||
148961413|NCT02337907|537343288|FG002|Overall Study|Lost to Follow-up|0|||
148961414|NCT02337907|537343289|FG003|Overall Study|Lost to Follow-up|0|||
148961415|NCT02337907|537343290|FG004|Overall Study|Lost to Follow-up|0|||
148961416|NCT02337907|537343291|FG005|Overall Study|Lost to Follow-up|1|||
148694314|NCT05097989|536354245|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
148961417|NCT02337907|537343286|FG000|Overall Study|Adverse Event|1|||
148961418|NCT02337907|537343287|FG001|Overall Study|Adverse Event|1|||
148961419|NCT02337907|537343288|FG002|Overall Study|Adverse Event|1|||
148961420|NCT02337907|537343289|FG003|Overall Study|Adverse Event|1|||
149024038|NCT06403605|537562729|FG000|Follow-up|Lost to Follow-up|1|||
149024039|NCT06403605|537562730|FG001|Follow-up|Lost to Follow-up|0|||
148961421|NCT02337907|537343290|FG004|Overall Study|Adverse Event|4|||
148961422|NCT02337907|537343291|FG005|Overall Study|Adverse Event|0|||
148961423|NCT03311659|537343299|FG000|Overall Study|Protocol Violation|1|||
148961424|NCT00613015|537343302|FG000|Overall Study|Lost to Follow-up|0|||
148961425|NCT00613015|537343303|FG001|Overall Study|Lost to Follow-up|1|||
148961426|NCT00613015|537343304|FG002|Overall Study|Lost to Follow-up|3|||
148961427|NCT00613015|537343305|FG003|Overall Study|Lost to Follow-up|3|||
148961428|NCT00613015|537343306|FG004|Overall Study|Lost to Follow-up|2|||
148961429|NCT00613015|537343307|FG005|Overall Study|Lost to Follow-up|3|||
148961430|NCT04053023|537343312|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
148961431|NCT04053023|537343313|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
148961432|NCT02073279|537343314|FG000|Double-blind Period|Adverse Event|1|||
148961433|NCT02073279|537343315|FG001|Double-blind Period|Adverse Event|1|||
148961434|NCT02073279|537343314|FG000|Double-blind Period|Switched to another treatment|1|||
148961435|NCT02073279|537343315|FG001|Double-blind Period|Switched to another treatment|2|||
148961436|NCT02073279|537343314|FG000|Double-blind Period|Protocol Violation|0|||
148961437|NCT02073279|537343315|FG001|Double-blind Period|Protocol Violation|1|||
148961438|NCT02073279|537343314|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
148961439|NCT02073279|537343315|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
148961440|NCT02073279|537343314|FG000|Double-blind Period|Withdrawal by Subject|2|||
148961441|NCT02073279|537343315|FG001|Double-blind Period|Withdrawal by Subject|2|||
148961442|NCT02073279|537343314|FG000|Open-label Extension Period|Adverse Event|1|||
148961443|NCT02073279|537343315|FG001|Open-label Extension Period|Adverse Event|0|||
148961444|NCT02073279|537343314|FG000|Open-label Extension Period|Lack of Efficacy|1|||
148961445|NCT02073279|537343315|FG001|Open-label Extension Period|Lack of Efficacy|0|||
148961446|NCT02073279|537343314|FG000|Open-label Extension Period|Lost to Follow-up|0|||
148961447|NCT02073279|537343315|FG001|Open-label Extension Period|Lost to Follow-up|4|||
148961448|NCT02073279|537343314|FG000|Open-label Extension Period|Switched to another treatment|1|||
148961449|NCT02073279|537343315|FG001|Open-label Extension Period|Switched to another treatment|4|||
148961450|NCT02073279|537343314|FG000|Open-label Extension Period|Protocol Violation|0|||
148961451|NCT02073279|537343315|FG001|Open-label Extension Period|Protocol Violation|1|||
148961452|NCT02073279|537343314|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
148961453|NCT02073279|537343315|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
148961454|NCT02073279|537343314|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
148961455|NCT02073279|537343315|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
148961456|NCT01558752|537343319|FG000|Overall Study|Physician Decision|2|||
149024040|NCT06403605|537562729|FG000|Follow-up|Death|1|||
148694315|NCT05097989|536354246|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
148694316|NCT05097989|536354247|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
148694317|NCT05097989|536354248|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
148694318|NCT05097989|536354249|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
148694319|NCT05097989|536354250|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
148694320|NCT05097989|536354251|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
148694321|NCT05097989|536354243|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
148694322|NCT05097989|536354244|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
148694323|NCT05097989|536354245|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
148694324|NCT05097989|536354246|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
148694325|NCT05097989|536354247|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
148694326|NCT05097989|536354248|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
148961457|NCT01558752|537343320|FG001|Overall Study|Physician Decision|0|||
148961458|NCT04340362|537343323|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
148961459|NCT04387435|537343328|FG000|Overall Study|Physician Decision|1|||
148961460|NCT00561080|537343329|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
148961461|NCT00561080|537343330|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
148961462|NCT00561080|537343331|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
149024041|NCT06403605|537562730|FG001|Follow-up|Death|0|||
148694327|NCT05097989|536354249|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
148694328|NCT05097989|536354250|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
148694329|NCT05097989|536354251|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
148694330|NCT05097989|536354243|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
148694331|NCT05097989|536354244|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
148694332|NCT05097989|536354245|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
148694333|NCT05097989|536354246|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
148694334|NCT05097989|536354247|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
148694335|NCT05097989|536354248|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
148694336|NCT05097989|536354249|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
148694337|NCT05097989|536354250|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
148694338|NCT05097989|536354251|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
148694339|NCT05097989|536354243|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694340|NCT05097989|536354244|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694341|NCT05097989|536354245|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
148694342|NCT05097989|536354246|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694343|NCT05097989|536354247|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694344|NCT05097989|536354248|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694345|NCT05097989|536354249|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694346|NCT05097989|536354250|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694347|NCT05097989|536354251|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
148694348|NCT05097989|536354243|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694349|NCT05097989|536354244|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
148694350|NCT05097989|536354245|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148961463|NCT00561080|537343329|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
148961464|NCT00561080|537343330|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
148961465|NCT00561080|537343331|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
148961466|NCT00561080|537343329|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
148961467|NCT00561080|537343330|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
148961468|NCT00561080|537343331|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
148961469|NCT00561080|537343329|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
148961470|NCT00561080|537343330|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
148961471|NCT00561080|537343331|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
148961472|NCT00561080|537343329|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
148961473|NCT00561080|537343330|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
148961474|NCT00561080|537343331|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
148961475|NCT00561080|537343329|FG000|Vaccination Period (up to Month 4)|Other|0|||
148961476|NCT00561080|537343330|FG001|Vaccination Period (up to Month 4)|Other|2|||
148961477|NCT00561080|537343331|FG002|Vaccination Period (up to Month 4)|Other|1|||
148961478|NCT00561080|537343329|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
148961479|NCT00561080|537343330|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
148961480|NCT00561080|537343331|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
148961481|NCT00561080|537343329|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
148961482|NCT00561080|537343330|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
148961483|NCT00561080|537343331|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
148961484|NCT00561080|537343329|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
148961485|NCT00561080|537343330|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
148961486|NCT00561080|537343331|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
148961487|NCT00561080|537343329|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
148961488|NCT00561080|537343330|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
148694351|NCT05097989|536354246|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694352|NCT05097989|536354247|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694353|NCT05097989|536354248|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694354|NCT05097989|536354249|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694355|NCT05097989|536354250|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694356|NCT05097989|536354251|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
148694357|NCT05097989|536354243|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148961489|NCT00561080|537343331|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
148961490|NCT02951156|537343332|FG000|Overall Study|Death|3|||
148961491|NCT02951156|537343333|FG001|Overall Study|Death|8|||
148961492|NCT02951156|537343334|FG002|Overall Study|Death|5|||
148961493|NCT02951156|537343332|FG000|Overall Study|Progressive disease|1|||
148961494|NCT02951156|537343333|FG001|Overall Study|Progressive disease|0|||
148961495|NCT02951156|537343334|FG002|Overall Study|Progressive disease|1|||
148961496|NCT02951156|537343332|FG000|Overall Study|Withdrawal by Subject|0|||
148961497|NCT02951156|537343333|FG001|Overall Study|Withdrawal by Subject|0|||
148961498|NCT02951156|537343334|FG002|Overall Study|Withdrawal by Subject|1|||
148961499|NCT02951156|537343332|FG000|Overall Study|Study terminated by sponsor|0|||
148961500|NCT02951156|537343333|FG001|Overall Study|Study terminated by sponsor|0|||
148961501|NCT02951156|537343334|FG002|Overall Study|Study terminated by sponsor|1|||
148961502|NCT02951156|537343332|FG000|Overall Study|Other|5|||
148961503|NCT02951156|537343333|FG001|Overall Study|Other|1|||
148961504|NCT02951156|537343334|FG002|Overall Study|Other|2|||
148961505|NCT01092182|537343335|FG000|Overall Study|Death|0|||
148961506|NCT01092182|537343336|FG001|Overall Study|Death|5|||
148961507|NCT01092182|537343337|FG002|Overall Study|Death|3|||
148961508|NCT01092182|537343335|FG000|Overall Study|participant safety|1|||
148961509|NCT01092182|537343336|FG001|Overall Study|participant safety|2|||
148961510|NCT01092182|537343337|FG002|Overall Study|participant safety|0|||
148961511|NCT01092182|537343335|FG000|Overall Study|Physician Decision|0|||
148961512|NCT01092182|537343336|FG001|Overall Study|Physician Decision|6|||
148961513|NCT01092182|537343337|FG002|Overall Study|Physician Decision|0|||
148961514|NCT01092182|537343335|FG000|Overall Study|Did not meet criteria|0|||
148961515|NCT01092182|537343336|FG001|Overall Study|Did not meet criteria|0|||
148961516|NCT01092182|537343337|FG002|Overall Study|Did not meet criteria|25|||
148961517|NCT01092182|537343335|FG000|Overall Study|Non-compliance|0|||
148961518|NCT01092182|537343336|FG001|Overall Study|Non-compliance|3|||
148961519|NCT01092182|537343337|FG002|Overall Study|Non-compliance|0|||
148961520|NCT01092182|537343335|FG000|Overall Study|Participant refused follow-up|0|||
148961521|NCT01092182|537343336|FG001|Overall Study|Participant refused follow-up|2|||
148961522|NCT01092182|537343337|FG002|Overall Study|Participant refused follow-up|0|||
148961523|NCT03255382|537343338|FG000|Overall Study|Adverse Event|3|||
148961524|NCT03255382|537343339|FG001|Overall Study|Adverse Event|0|||
148961525|NCT03255382|537343338|FG000|Overall Study|Lost to Follow-up|2|||
148961526|NCT03255382|537343339|FG001|Overall Study|Lost to Follow-up|0|||
148961527|NCT03255382|537343338|FG000|Overall Study|Withdrawal by Subject|2|||
148694358|NCT05097989|536354244|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148694359|NCT05097989|536354245|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148961528|NCT03255382|537343339|FG001|Overall Study|Withdrawal by Subject|0|||
148961529|NCT03255382|537343338|FG000|Overall Study|Other|6|||
148961530|NCT03255382|537343339|FG001|Overall Study|Other|0|||
148961531|NCT02466555|537343342|FG000|Overall Study|Lost to Follow-up|2|||
148961532|NCT00449644|537343345|FG000|Overall Study|Adverse Event|0|||
148694360|NCT05097989|536354246|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148694361|NCT05097989|536354247|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
148694362|NCT05097989|536354248|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148694363|NCT05097989|536354249|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148694364|NCT05097989|536354250|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148694365|NCT05097989|536354251|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148694366|NCT05097989|536354243|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694367|NCT05097989|536354244|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694368|NCT05097989|536354245|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694369|NCT05097989|536354246|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694370|NCT05097989|536354247|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
148694371|NCT05097989|536354248|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148812716|NCT00314145|536789224|FG001|Overall Study|Withdrawal by Subject|10|||
148812717|NCT00314145|536789223|FG000|Overall Study|Lost to Follow-up|5|||
148961533|NCT00449644|537343346|FG001|Overall Study|Adverse Event|0|||
148961534|NCT00449644|537343347|FG002|Overall Study|Adverse Event|3|||
148961535|NCT00449644|537343348|FG003|Overall Study|Adverse Event|5|||
148961536|NCT00449644|537343345|FG000|Overall Study|Death|1|||
148961537|NCT00449644|537343346|FG001|Overall Study|Death|0|||
148961538|NCT00449644|537343347|FG002|Overall Study|Death|6|||
148961539|NCT00449644|537343348|FG003|Overall Study|Death|1|||
148961540|NCT00449644|537343345|FG000|Overall Study|Lost to Follow-up|1|||
148961541|NCT00449644|537343346|FG001|Overall Study|Lost to Follow-up|1|||
148961542|NCT00449644|537343347|FG002|Overall Study|Lost to Follow-up|5|||
148961543|NCT00449644|537343348|FG003|Overall Study|Lost to Follow-up|3|||
148961544|NCT00449644|537343345|FG000|Overall Study|Pregnancy|0|||
148961545|NCT00449644|537343346|FG001|Overall Study|Pregnancy|0|||
148961546|NCT00449644|537343347|FG002|Overall Study|Pregnancy|3|||
148961547|NCT00449644|537343348|FG003|Overall Study|Pregnancy|2|||
148961548|NCT00449644|537343345|FG000|Overall Study|Protocol Violation|4|||
148961549|NCT00449644|537343346|FG001|Overall Study|Protocol Violation|4|||
148961550|NCT00449644|537343347|FG002|Overall Study|Protocol Violation|3|||
148961551|NCT00449644|537343348|FG003|Overall Study|Protocol Violation|7|||
148961552|NCT00449644|537343345|FG000|Overall Study|Withdrawal by Subject|3|||
148961553|NCT00449644|537343346|FG001|Overall Study|Withdrawal by Subject|4|||
148961554|NCT00449644|537343347|FG002|Overall Study|Withdrawal by Subject|6|||
148961555|NCT00449644|537343348|FG003|Overall Study|Withdrawal by Subject|7|||
148961556|NCT00449644|537343345|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
148961557|NCT00449644|537343346|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
148961558|NCT00449644|537343347|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
148961559|NCT00449644|537343348|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
148961560|NCT00449644|537343345|FG000|Overall Study|Other|1|||
148961561|NCT00449644|537343346|FG001|Overall Study|Other|4|||
148961562|NCT00449644|537343347|FG002|Overall Study|Other|1|||
148961563|NCT00449644|537343348|FG003|Overall Study|Other|0|||
148961564|NCT00449644|537343345|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
148961565|NCT00449644|537343346|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
148961566|NCT00449644|537343347|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
148961567|NCT00449644|537343348|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
148961568|NCT03839212|537343349|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
148961569|NCT02113956|537343355|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
148961570|NCT02113956|537343356|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
148961571|NCT02113956|537343355|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
148961572|NCT02113956|537343356|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
148694372|NCT05097989|536354249|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694373|NCT05097989|536354250|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694374|NCT05097989|536354251|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
148694375|NCT05097989|536354243|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148694376|NCT05097989|536354244|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
148694377|NCT05097989|536354245|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148812718|NCT00314145|536789224|FG001|Overall Study|Lost to Follow-up|12|||
148812719|NCT00314145|536789223|FG000|Overall Study|Physician Decision|3|||
148812720|NCT00314145|536789224|FG001|Overall Study|Physician Decision|4|||
148812721|NCT00314145|536789223|FG000|Overall Study|Adverse Event|0|||
148812722|NCT00314145|536789224|FG001|Overall Study|Adverse Event|3|||
148961573|NCT02113956|537343355|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
148961574|NCT02113956|537343356|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
148961575|NCT01498458|537343357|FG000|Overall Study|Adverse Event|4|||
148694378|NCT05097989|536354246|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
148812723|NCT00314145|536789223|FG000|Overall Study|Protocol Violation|3|||
148961576|NCT01498458|537343357|FG000|Overall Study|Physician Decision|3|||
148961577|NCT02226003|537343358|FG000|Overall Study|Lost to Follow-up|2|||
148961578|NCT02226003|537343359|FG001|Overall Study|Lost to Follow-up|1|||
148694379|NCT05097989|536354247|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148694380|NCT05097989|536354248|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148694381|NCT05097989|536354249|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148694382|NCT05097989|536354250|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148694383|NCT05097989|536354251|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148694384|NCT05097989|536354243|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
148694385|NCT05097989|536354244|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
148694386|NCT05097989|536354245|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
148694387|NCT05097989|536354246|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
148694388|NCT05097989|536354247|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
148694389|NCT05097989|536354248|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
148694390|NCT05097989|536354249|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
148694391|NCT05097989|536354250|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
148694392|NCT05097989|536354251|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
148694393|NCT05097989|536354243|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
148694394|NCT05097989|536354244|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
148694395|NCT05097989|536354245|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
148694396|NCT05097989|536354246|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
148694397|NCT05097989|536354247|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
148694398|NCT05097989|536354248|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
148694399|NCT05097989|536354249|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
148694400|NCT05097989|536354250|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
148694401|NCT05097989|536354251|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
148694402|NCT05097989|536354243|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694403|NCT05097989|536354244|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694404|NCT05097989|536354245|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694405|NCT05097989|536354246|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694406|NCT05097989|536354247|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
148694407|NCT05097989|536354248|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694408|NCT05097989|536354249|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694409|NCT05097989|536354250|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694410|NCT05097989|536354251|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
148694411|NCT05097989|536354243|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
148694412|NCT05097989|536354244|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
148694413|NCT05097989|536354245|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694414|NCT05097989|536354246|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694415|NCT05097989|536354247|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694416|NCT05097989|536354248|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694417|NCT05097989|536354249|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694418|NCT05097989|536354250|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694419|NCT05097989|536354251|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
148694420|NCT05097989|536354243|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
148694421|NCT05097989|536354244|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
148694422|NCT05097989|536354245|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
148694423|NCT05097989|536354246|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
148694424|NCT05097989|536354247|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
148694425|NCT05097989|536354248|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
148694426|NCT05097989|536354249|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
148694427|NCT05097989|536354250|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
148694428|NCT05097989|536354251|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
148694429|NCT00918567|536354259|FG000|Overall Study|Lack of Efficacy|3|||
148961579|NCT02226003|537343360|FG002|Overall Study|Lost to Follow-up|3|||
148961580|NCT02226003|537343358|FG000|Overall Study|Withdrawal by Subject|0|||
148961581|NCT02226003|537343359|FG001|Overall Study|Withdrawal by Subject|0|||
148961582|NCT02226003|537343360|FG002|Overall Study|Withdrawal by Subject|3|||
148961583|NCT07114198|537343363|FG000|Overall Study|Protocol Violation|1|||
148961584|NCT07114198|537343364|FG001|Overall Study|Protocol Violation|1|||
148961585|NCT02926924|537344734|FG000|Overall Study|withdrawal - reason unknown|0|||
148961586|NCT02926924|537344735|FG001|Overall Study|withdrawal - reason unknown|1|||
148961587|NCT03970733|537344738|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
148961588|NCT03970733|537344739|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
148961589|NCT03970733|537344740|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
148961590|NCT03970733|537344741|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
148961591|NCT03970733|537344742|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
148961592|NCT03970733|537344738|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
148961593|NCT03970733|537344739|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
148961594|NCT03970733|537344740|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
148961595|NCT03970733|537344741|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
148961596|NCT03970733|537344742|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
148961597|NCT03970733|537344738|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
148961598|NCT03970733|537344739|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
148961599|NCT03970733|537344740|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
148961600|NCT03970733|537344741|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
148961601|NCT03970733|537344742|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
148961602|NCT03970733|537344738|FG000|Main Study Phase (18 Months)|Other|1|||
148961603|NCT03970733|537344739|FG001|Main Study Phase (18 Months)|Other|1|||
148961604|NCT03970733|537344740|FG002|Main Study Phase (18 Months)|Other|0|||
148961605|NCT03970733|537344741|FG003|Main Study Phase (18 Months)|Other|0|||
148961606|NCT03970733|537344742|FG004|Main Study Phase (18 Months)|Other|0|||
148961607|NCT03970733|537344738|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
148961608|NCT03970733|537344739|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
148961609|NCT03970733|537344740|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
148961610|NCT03970733|537344741|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
148961611|NCT03970733|537344742|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
148961612|NCT01139450|537344746|FG000|Overall Study|Withdrawal by Subject|7|||
148961613|NCT01139450|537344747|FG001|Overall Study|Withdrawal by Subject|10|||
148961614|NCT01139450|537344748|FG002|Overall Study|Withdrawal by Subject|13|||
148961615|NCT01139450|537344746|FG000|Overall Study|Lack of Efficacy|3|||
148961616|NCT01139450|537344747|FG001|Overall Study|Lack of Efficacy|1|||
148961617|NCT01139450|537344748|FG002|Overall Study|Lack of Efficacy|8|||
148961618|NCT01139450|537344746|FG000|Overall Study|Protocol Violation|6|||
148961619|NCT01139450|537344747|FG001|Overall Study|Protocol Violation|5|||
148961620|NCT01139450|537344748|FG002|Overall Study|Protocol Violation|2|||
148961621|NCT01139450|537344746|FG000|Overall Study|Lost to Follow-up|9|||
148961622|NCT01139450|537344747|FG001|Overall Study|Lost to Follow-up|7|||
148961623|NCT01139450|537344748|FG002|Overall Study|Lost to Follow-up|11|||
148961624|NCT01139450|537344746|FG000|Overall Study|Administrative|0|||
148961625|NCT01139450|537344747|FG001|Overall Study|Administrative|0|||
148961626|NCT01139450|537344748|FG002|Overall Study|Administrative|1|||
148961627|NCT01139450|537344746|FG000|Overall Study|Adverse Event|2|||
148961628|NCT01139450|537344747|FG001|Overall Study|Adverse Event|2|||
148961629|NCT01139450|537344748|FG002|Overall Study|Adverse Event|3|||
148961630|NCT02385266|537344755|FG000|Overall Study|Withdrawal by Subject|1|||
148961631|NCT02385266|537344756|FG001|Overall Study|Withdrawal by Subject|3|||
149024042|NCT06403605|537562729|FG000|Follow-up|Other reasons|0|||
149024043|NCT06403605|537562730|FG001|Follow-up|Other reasons|4|||
149024044|NCT00394095|537564157|FG000|Screening|Withdrawal by Subject|1|||
149024045|NCT00394095|537564158|FG001|Screening|Withdrawal by Subject|0|||
149024046|NCT00394095|537564157|FG000|Randomized|Withdrawal by Subject|5|||
149024047|NCT00394095|537564158|FG001|Randomized|Withdrawal by Subject|1|||
149024048|NCT00394095|537564157|FG000|Randomized|Adverse Event|1|||
149024049|NCT00394095|537564158|FG001|Randomized|Adverse Event|1|||
149024050|NCT00394095|537564157|FG000|Randomized|Overdose|1|||
148694430|NCT00918567|536354260|FG001|Overall Study|Lack of Efficacy|1|||
148694431|NCT00918567|536354259|FG000|Overall Study|Withdrawal by Subject|1|||
148694432|NCT00918567|536354260|FG001|Overall Study|Withdrawal by Subject|1|||
148694433|NCT00918567|536354259|FG000|Overall Study|Adverse Event|1|||
148694434|NCT00918567|536354260|FG001|Overall Study|Adverse Event|0|||
148694435|NCT01867242|536354261|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
148694436|NCT01867242|536354262|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
148694437|NCT01867242|536354263|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
148694438|NCT04803357|536354268|FG000|Overall Study|Withdrawal by Subject|31|||
148694439|NCT04803357|536354269|FG001|Overall Study|Withdrawal by Subject|5|||
148961632|NCT02535741|537344757|FG000|Overall Study|Adverse Event|3|||
148961633|NCT02535741|537344757|FG000|Overall Study|Withdrawal by Subject|9|||
148961634|NCT02535741|537344757|FG000|Overall Study|Lost to Follow-up|10|||
148961635|NCT02535741|537344757|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
148961636|NCT02535741|537344757|FG000|Overall Study|Missing data|6|||
148961637|NCT01030523|537344758|FG000|Initial Study (5 Years)|Death|1|||
148961638|NCT01030523|537344759|FG001|Initial Study (5 Years)|Death|0|||
148961639|NCT01030523|537344758|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
148961640|NCT01030523|537344759|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
148961641|NCT01030523|537344758|FG000|Initial Study (5 Years)|Implant failure|1|||
148961642|NCT01030523|537344759|FG001|Initial Study (5 Years)|Implant failure|0|||
148961643|NCT01030523|537344758|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
148961644|NCT01030523|537344759|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
148961645|NCT01030523|537344758|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
148961646|NCT01030523|537344759|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
148961647|NCT01030523|537344758|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
148961648|NCT01030523|537344759|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
148961649|NCT03662542|537344764|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
148961650|NCT03662542|537344765|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961651|NCT03662542|537344766|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961652|NCT03662542|537344767|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961653|NCT03662542|537344768|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961654|NCT03662542|537344769|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961655|NCT03662542|537344770|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961656|NCT03662542|537344771|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961657|NCT03662542|537344772|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
148961658|NCT03662542|537344764|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961659|NCT03662542|537344765|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
148961660|NCT03662542|537344766|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961661|NCT03662542|537344767|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961662|NCT03662542|537344768|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961663|NCT03662542|537344769|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961664|NCT03662542|537344770|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961665|NCT03662542|537344771|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148961666|NCT03662542|537344772|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
148694440|NCT02879643|536354270|FG000|Overall Study|Adverse Event|0|||
148694441|NCT02879643|536354271|FG001|Overall Study|Adverse Event|0|||
148694442|NCT02879643|536354272|FG002|Overall Study|Adverse Event|1|||
148694443|NCT02879643|536354273|FG003|Overall Study|Adverse Event|1|||
148694444|NCT02879643|536354274|FG004|Overall Study|Adverse Event|0|||
148694445|NCT00182091|536354275|FG000|Overall Study|Withdrawal by Subject|1|||
148694446|NCT00182091|536354276|FG001|Overall Study|Withdrawal by Subject|0|||
148694447|NCT00182091|536354277|FG002|Overall Study|Withdrawal by Subject|0|||
148961667|NCT03662542|537344764|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
148961668|NCT03662542|537344765|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
148694448|NCT00182091|536354278|FG003|Overall Study|Withdrawal by Subject|0|||
148961669|NCT03662542|537344766|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
148961670|NCT03662542|537344767|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
149024051|NCT00394095|537564158|FG001|Randomized|Overdose|0|||
149024052|NCT00394095|537564157|FG000|Randomized|Lost to Follow-up|1|||
149024053|NCT00394095|537564158|FG001|Randomized|Lost to Follow-up|2|||
149024054|NCT05194735|537564159|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
148694449|NCT02199509|536354279|FG000|Overall Study|Suicidal Ideation|0|||
148961671|NCT03662542|537344768|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
148961672|NCT03662542|537344769|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
148961673|NCT03662542|537344770|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
148694450|NCT02199509|536354280|FG001|Overall Study|Suicidal Ideation|1|||
148694451|NCT02199509|536354279|FG000|Overall Study|Misunderstood titration schedule|1|||
148694452|NCT02199509|536354280|FG001|Overall Study|Misunderstood titration schedule|0|||
148694453|NCT01658943|536354282|FG000|Overall Study|Adverse Event|6|||
148694454|NCT01658943|536354283|FG001|Overall Study|Adverse Event|13|||
148694455|NCT01658943|536354282|FG000|Overall Study|Withdrawal by Subject|9|||
148694456|NCT01658943|536354283|FG001|Overall Study|Withdrawal by Subject|2|||
148694457|NCT01658943|536354282|FG000|Overall Study|Progression/Relapse|39|||
148694458|NCT01658943|536354283|FG001|Overall Study|Progression/Relapse|40|||
148694459|NCT01658943|536354282|FG000|Overall Study|Death|4|||
148694460|NCT01658943|536354283|FG001|Overall Study|Death|2|||
148694461|NCT01658943|536354282|FG000|Overall Study|not protocol specified|4|||
148694462|NCT01658943|536354283|FG001|Overall Study|not protocol specified|1|||
148694463|NCT01658943|536354282|FG000|Overall Study|Not eligible|7|||
148694464|NCT01658943|536354283|FG001|Overall Study|Not eligible|9|||
148694465|NCT01658943|536354282|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
148694466|NCT01658943|536354283|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
148694467|NCT02093689|536354285|FG000|Overall Study|Physician Decision|4|||
148694468|NCT02093689|536354286|FG001|Overall Study|Physician Decision|0|||
148694469|NCT02093689|536354287|FG002|Overall Study|Physician Decision|0|||
148694470|NCT04947579|536354293|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
148694471|NCT04947579|536354294|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
148694472|NCT04947579|536354295|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
148694473|NCT04947579|536354296|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
148694474|NCT04947579|536354297|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
148694475|NCT04947579|536354298|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
148694476|NCT04947579|536354293|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
148694477|NCT04947579|536354294|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
148694478|NCT04947579|536354295|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
148694479|NCT04947579|536354296|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
148694480|NCT04947579|536354297|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
148694481|NCT04947579|536354298|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
148694482|NCT04947579|536354293|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
148694483|NCT04947579|536354294|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
148694484|NCT04947579|536354295|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
148694485|NCT04947579|536354296|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
148694486|NCT04947579|536354297|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
148694487|NCT04947579|536354298|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
148812724|NCT00314145|536789224|FG001|Overall Study|Protocol Violation|0|||
149055921|NCT01369355|537688998|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
148961674|NCT03662542|537344771|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
148961675|NCT03662542|537344772|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
148961676|NCT03662542|537344764|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
148961677|NCT03662542|537344765|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148961678|NCT03662542|537344766|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148961679|NCT03662542|537344767|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148961680|NCT03662542|537344768|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148694488|NCT04947579|536354293|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
148694489|NCT04947579|536354294|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
148694490|NCT04947579|536354295|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
148694491|NCT04947579|536354296|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
148961681|NCT03662542|537344769|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148961682|NCT03662542|537344770|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148694492|NCT04947579|536354297|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
148694493|NCT04947579|536354298|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
148694494|NCT04947579|536354293|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
148694495|NCT04947579|536354294|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
148694496|NCT04947579|536354295|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
148694497|NCT04947579|536354296|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
148812725|NCT00314145|536789223|FG000|Overall Study|Sponsor Decision|2|||
148812726|NCT00314145|536789224|FG001|Overall Study|Sponsor Decision|0|||
148812727|NCT02572167|536789227|FG000|Overall Study|Withdrawal by Subject|0|||
148812728|NCT02572167|536789228|FG001|Overall Study|Withdrawal by Subject|3|||
148812729|NCT02572167|536789229|FG002|Overall Study|Withdrawal by Subject|0|||
148812730|NCT02572167|536789227|FG000|Overall Study|Lost to Follow-up|2|||
148812731|NCT02572167|536789228|FG001|Overall Study|Lost to Follow-up|5|||
148812732|NCT02572167|536789229|FG002|Overall Study|Lost to Follow-up|3|||
148812733|NCT02572167|536789227|FG000|Overall Study|Death|0|||
148812734|NCT02572167|536789228|FG001|Overall Study|Death|8|||
148812735|NCT02572167|536789229|FG002|Overall Study|Death|3|||
148812736|NCT02572167|536789227|FG000|Overall Study|Did not meet inclusion criteria|0|||
148812737|NCT02572167|536789228|FG001|Overall Study|Did not meet inclusion criteria|0|||
148812738|NCT02572167|536789229|FG002|Overall Study|Did not meet inclusion criteria|1|||
148812739|NCT02572167|536789227|FG000|Overall Study|Study closure by Sponsor|4|||
148812740|NCT02572167|536789228|FG001|Overall Study|Study closure by Sponsor|40|||
148812741|NCT02572167|536789229|FG002|Overall Study|Study closure by Sponsor|24|||
148812742|NCT04435626|536789232|FG000|Overall Study|Lost to Follow-up|1|||
148812743|NCT04435626|536789233|FG001|Overall Study|Lost to Follow-up|5|||
148812744|NCT04435626|536789232|FG000|Overall Study|Withdrawal by Subject|6|||
148812745|NCT04435626|536789233|FG001|Overall Study|Withdrawal by Subject|7|||
148812746|NCT04435626|536789232|FG000|Overall Study|major GCP violations|8|||
148812747|NCT04435626|536789233|FG001|Overall Study|major GCP violations|7|||
148812748|NCT01771107|536789241|FG000|Overall Study|Adverse Event|1|||
148812749|NCT01771107|536789242|FG001|Overall Study|Adverse Event|3|||
148961683|NCT03662542|537344771|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148961684|NCT03662542|537344772|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
148812750|NCT01771107|536789241|FG000|Overall Study|Withdrawal by Subject|0|||
148812751|NCT01771107|536789242|FG001|Overall Study|Withdrawal by Subject|2|||
148812752|NCT01771107|536789241|FG000|Overall Study|Lost to Follow-up|0|||
148812753|NCT01771107|536789242|FG001|Overall Study|Lost to Follow-up|1|||
148961685|NCT03662542|537344764|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148694498|NCT04947579|536354297|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
148961686|NCT03662542|537344765|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961687|NCT03662542|537344766|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961688|NCT03662542|537344767|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961689|NCT03662542|537344768|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961690|NCT03662542|537344769|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
148961691|NCT03662542|537344770|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961692|NCT03662542|537344771|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961693|NCT03662542|537344772|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
148961694|NCT03662542|537344764|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961695|NCT03662542|537344765|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961696|NCT03662542|537344766|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961697|NCT03662542|537344767|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
148961698|NCT03662542|537344768|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
148961699|NCT03662542|537344769|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961700|NCT03662542|537344770|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961701|NCT03662542|537344771|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961702|NCT03662542|537344772|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
148961703|NCT03662542|537344764|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
148961704|NCT03662542|537344765|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
148961705|NCT03662542|537344766|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
148961706|NCT03662542|537344767|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
148961707|NCT03662542|537344768|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
148961708|NCT03662542|537344769|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
148961709|NCT03662542|537344770|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
148961710|NCT03662542|537344771|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
148961711|NCT03662542|537344772|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
148961712|NCT03662542|537344764|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961713|NCT03662542|537344765|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961714|NCT03662542|537344766|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961715|NCT03662542|537344767|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961716|NCT03662542|537344768|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
148961717|NCT03662542|537344769|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
148961718|NCT03662542|537344770|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961719|NCT03662542|537344771|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961720|NCT03662542|537344772|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
148961721|NCT03662542|537344764|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961722|NCT03662542|537344765|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961723|NCT03662542|537344766|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961724|NCT03662542|537344767|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961725|NCT03662542|537344768|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961726|NCT03662542|537344769|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
148961727|NCT03662542|537344770|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961728|NCT03662542|537344771|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961729|NCT03662542|537344772|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
148961730|NCT03662542|537344764|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961731|NCT03662542|537344765|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961732|NCT03662542|537344766|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961733|NCT03662542|537344767|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961734|NCT03662542|537344768|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961735|NCT03662542|537344769|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961736|NCT03662542|537344770|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961737|NCT03662542|537344771|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
148961738|NCT03662542|537344772|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
148961739|NCT03662542|537344764|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961740|NCT03662542|537344765|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961741|NCT03662542|537344766|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961742|NCT03662542|537344767|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961743|NCT03662542|537344768|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961744|NCT03662542|537344769|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961745|NCT03662542|537344770|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
148961746|NCT03662542|537344771|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
148961747|NCT03662542|537344772|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
148961748|NCT03662542|537344764|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961749|NCT03662542|537344765|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961750|NCT03662542|537344766|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961751|NCT03662542|537344767|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961752|NCT03662542|537344768|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961753|NCT03662542|537344769|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961754|NCT03662542|537344770|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
148961755|NCT03662542|537344771|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
148961756|NCT03662542|537344772|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
148961757|NCT03662542|537344764|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
148961758|NCT03662542|537344765|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
148961759|NCT03662542|537344766|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
148961760|NCT03662542|537344767|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
148961761|NCT03662542|537344768|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
148961762|NCT03662542|537344769|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
148961763|NCT03662542|537344770|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
148961764|NCT03662542|537344771|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
148961765|NCT03662542|537344772|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
148961766|NCT01217060|537344773|FG000|Overall Study|Withdrawal by Subject|1|||
148961767|NCT01859494|537344782|FG000|Overall Study|Adverse Event|1|||
148961768|NCT02357901|537344787|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
148961769|NCT02357901|537344788|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
148961770|NCT02357901|537344789|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
148961771|NCT02357901|537344790|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
148961772|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
148961773|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
148961774|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
148961775|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
148961776|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
148961777|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
148961778|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
148961779|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
148961780|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
148694499|NCT04947579|536354298|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
148961781|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
148961782|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
148694500|NCT04947579|536354293|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
148961783|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
148961784|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
148694501|NCT04947579|536354294|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
148694502|NCT04947579|536354295|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
148961785|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
148961786|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
148961787|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
148961788|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
148961789|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
148961790|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
148961791|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
148961792|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
148961793|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
148961794|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
148961795|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
148961796|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
148961797|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
148961798|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
148961799|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
148694503|NCT04947579|536354296|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
148694504|NCT04947579|536354297|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
148694505|NCT04947579|536354298|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
148694506|NCT04947579|536354293|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
148694507|NCT04947579|536354294|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
148694508|NCT04947579|536354295|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
148961800|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
148961801|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
148961802|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
148961803|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
148961804|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
148961805|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
148961806|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
148961807|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
148961808|NCT02357901|537344787|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
148961809|NCT02357901|537344788|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
148961810|NCT02357901|537344789|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
148961811|NCT02357901|537344790|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
148961812|NCT00491387|537344799|FG000|Overall Study|study terminated|20|||
148961813|NCT00413192|537344802|FG000|Overall Study|Disease progression|26|||
148961814|NCT00413192|537344803|FG001|Overall Study|Disease progression|31|||
148961815|NCT00413192|537344804|FG002|Overall Study|Disease progression|16|||
148961816|NCT00413192|537344805|FG003|Overall Study|Disease progression|25|||
148961817|NCT00413192|537344802|FG000|Overall Study|Toxicity|3|||
148961818|NCT00413192|537344803|FG001|Overall Study|Toxicity|2|||
148961819|NCT00413192|537344804|FG002|Overall Study|Toxicity|2|||
148961820|NCT00413192|537344805|FG003|Overall Study|Toxicity|2|||
148961821|NCT00413192|537344802|FG000|Overall Study|Withdrawal by Subject|3|||
148961822|NCT00413192|537344803|FG001|Overall Study|Withdrawal by Subject|5|||
148961823|NCT00413192|537344804|FG002|Overall Study|Withdrawal by Subject|0|||
148961824|NCT00413192|537344805|FG003|Overall Study|Withdrawal by Subject|1|||
148961825|NCT00413192|537344802|FG000|Overall Study|Intercurrent illness|0|||
148961826|NCT00413192|537344803|FG001|Overall Study|Intercurrent illness|0|||
148961827|NCT00413192|537344804|FG002|Overall Study|Intercurrent illness|0|||
148961828|NCT00413192|537344805|FG003|Overall Study|Intercurrent illness|1|||
148961829|NCT00413192|537344802|FG000|Overall Study|Intercurrent death|0|||
148961830|NCT00413192|537344803|FG001|Overall Study|Intercurrent death|1|||
148961831|NCT00413192|537344804|FG002|Overall Study|Intercurrent death|0|||
148961832|NCT00413192|537344805|FG003|Overall Study|Intercurrent death|0|||
148961833|NCT00413192|537344802|FG000|Overall Study|Other|5|||
148961834|NCT00413192|537344803|FG001|Overall Study|Other|1|||
148961835|NCT00413192|537344804|FG002|Overall Study|Other|1|||
148961836|NCT00413192|537344805|FG003|Overall Study|Other|2|||
148961837|NCT00413192|537344802|FG000|Overall Study|Not treated|0|||
148961838|NCT00413192|537344803|FG001|Overall Study|Not treated|0|||
148961839|NCT00413192|537344804|FG002|Overall Study|Not treated|0|||
148961840|NCT00413192|537344805|FG003|Overall Study|Not treated|1|||
148961841|NCT03814746|537344806|FG000|Overall Study|Participant decision|9|||
148961842|NCT03814746|537344807|FG001|Overall Study|Participant decision|6|||
148961843|NCT03814746|537344808|FG002|Overall Study|Participant decision|15|||
148961844|NCT03814746|537344806|FG000|Overall Study|Physician Decision|2|||
148961845|NCT03814746|537344807|FG001|Overall Study|Physician Decision|2|||
148961846|NCT03814746|537344808|FG002|Overall Study|Physician Decision|4|||
148961847|NCT03814746|537344806|FG000|Overall Study|Death|2|||
148961848|NCT03814746|537344807|FG001|Overall Study|Death|2|||
148961849|NCT03814746|537344808|FG002|Overall Study|Death|2|||
148961850|NCT03814746|537344806|FG000|Overall Study|Adverse Event|2|||
148961851|NCT03814746|537344807|FG001|Overall Study|Adverse Event|2|||
148961852|NCT03814746|537344808|FG002|Overall Study|Adverse Event|1|||
148961853|NCT03814746|537344806|FG000|Overall Study|Lost to Follow-up|2|||
148812754|NCT01771107|536789241|FG000|Overall Study|participant moved|0|||
148961854|NCT03814746|537344807|FG001|Overall Study|Lost to Follow-up|1|||
148961855|NCT03814746|537344808|FG002|Overall Study|Lost to Follow-up|2|||
148961856|NCT03814746|537344806|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148961857|NCT03814746|537344807|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148961858|NCT03814746|537344808|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
148961859|NCT03814746|537344806|FG000|Overall Study|Pregnancy|0|||
148961860|NCT03814746|537344807|FG001|Overall Study|Pregnancy|1|||
149024055|NCT05194735|537564160|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
149055922|NCT01369355|537688999|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
148961861|NCT03814746|537344808|FG002|Overall Study|Pregnancy|1|||
148961862|NCT03814746|537344806|FG000|Overall Study|Protocol Violation|1|||
148961863|NCT03814746|537344807|FG001|Overall Study|Protocol Violation|0|||
148961864|NCT03814746|537344808|FG002|Overall Study|Protocol Violation|0|||
148961865|NCT05089682|537344809|FG000|Overall Study|Withdrawal by Subject|2|||
148961866|NCT00772707|537344814|FG000|Overall Study|Withdrawn|3|||
148961867|NCT01266460|537344815|FG000|Overall Study|Adverse Event|3|||
148961868|NCT01266460|537344815|FG000|Overall Study|Withdrawal by Subject|5|||
148961869|NCT01266460|537344815|FG000|Overall Study|Disease Progression|18|||
148961870|NCT01266460|537344815|FG000|Overall Study|Not otherwise specified|8|||
148961871|NCT00909779|537344821|FG000|Overall Study|Adverse Event|53|||
148961872|NCT00909779|537344822|FG001|Overall Study|Adverse Event|55|||
148961873|NCT00909779|537344821|FG000|Overall Study|Lack of Efficacy|7|||
148961874|NCT00909779|537344822|FG001|Overall Study|Lack of Efficacy|4|||
148961875|NCT00909779|537344821|FG000|Overall Study|Lost to Follow-up|19|||
148961876|NCT00909779|537344822|FG001|Overall Study|Lost to Follow-up|15|||
148961877|NCT00909779|537344821|FG000|Overall Study|Physician Decision|8|||
148961878|NCT00909779|537344822|FG001|Overall Study|Physician Decision|2|||
148961879|NCT00909779|537344821|FG000|Overall Study|Protocol Violation|2|||
148961880|NCT00909779|537344822|FG001|Overall Study|Protocol Violation|5|||
148961881|NCT00909779|537344821|FG000|Overall Study|Withdrawal by Subject|116|||
148961882|NCT00909779|537344822|FG001|Overall Study|Withdrawal by Subject|80|||
148961883|NCT00909779|537344821|FG000|Overall Study|Site Ceasing Operation|2|||
148961884|NCT00909779|537344822|FG001|Overall Study|Site Ceasing Operation|2|||
148961885|NCT00909779|537344821|FG000|Overall Study|Medical Monitor Decision|1|||
148961886|NCT00909779|537344822|FG001|Overall Study|Medical Monitor Decision|0|||
148961887|NCT00909779|537344821|FG000|Overall Study|Noncompliance|1|||
148961888|NCT00909779|537344822|FG001|Overall Study|Noncompliance|1|||
148961889|NCT00909779|537344821|FG000|Overall Study|Randomized in error|1|||
148961890|NCT00909779|537344822|FG001|Overall Study|Randomized in error|1|||
148961891|NCT01592344|537344823|FG000|Overall Study|Adverse Event|1|||
148961892|NCT01592344|537344824|FG001|Overall Study|Adverse Event|1|||
148961893|NCT01592344|537344823|FG000|Overall Study|Lack of Efficacy|1|||
148961894|NCT01592344|537344824|FG001|Overall Study|Lack of Efficacy|0|||
148961895|NCT01592344|537344823|FG000|Overall Study|not available at primary outcome visit|2|||
148961896|NCT01592344|537344824|FG001|Overall Study|not available at primary outcome visit|4|||
148961897|NCT03165110|537344826|FG000|Overall Study|Anroid phone software incompatibility|1|||
148961898|NCT00730912|537344831|FG000|Overall Study|Discontinued|0|||
148961899|NCT00730912|537344832|FG001|Overall Study|Discontinued|0|||
148961900|NCT00730912|537344833|FG002|Overall Study|Discontinued|1|||
148961901|NCT04351087|537344837|FG000|Overall Study|Lost to Follow-up|7|||
148961902|NCT04351087|537344838|FG001|Overall Study|Lost to Follow-up|3|||
148961903|NCT04351087|537344837|FG000|Overall Study|Withdrawal by Subject|3|||
148961904|NCT04351087|537344838|FG001|Overall Study|Withdrawal by Subject|4|||
148961905|NCT04351087|537344837|FG000|Overall Study|Lack of Efficacy|3|||
148961906|NCT04351087|537344838|FG001|Overall Study|Lack of Efficacy|2|||
148961907|NCT00679263|537344842|FG000|Visit 2/Dose 1|Adverse Event|1|||
148961908|NCT00679263|537344843|FG001|Visit 2/Dose 1|Adverse Event|0|||
148961909|NCT00679263|537344844|FG002|Visit 2/Dose 1|Adverse Event|0|||
148961910|NCT00679263|537344842|FG000|Visit 2/Dose 1|subject not compliance|1|||
148961911|NCT00679263|537344843|FG001|Visit 2/Dose 1|subject not compliance|1|||
148961912|NCT00679263|537344844|FG002|Visit 2/Dose 1|subject not compliance|0|||
148961913|NCT05104567|537344845|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
148961914|NCT05104567|537344846|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
148961915|NCT05104567|537344847|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
148961916|NCT05104567|537344848|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
148961917|NCT05104567|537344849|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
148961918|NCT05104567|537344850|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
148961919|NCT05104567|537344851|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
148961920|NCT05104567|537344845|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
148961921|NCT05104567|537344846|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
148961922|NCT05104567|537344847|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
148961923|NCT05104567|537344848|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
148961924|NCT05104567|537344849|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
148961925|NCT05104567|537344850|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
148961926|NCT05104567|537344851|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
148961927|NCT05104567|537344845|FG000|Overall Study|Progressive disease|3|||
148961928|NCT05104567|537344846|FG001|Overall Study|Progressive disease|13|||
148694509|NCT04947579|536354296|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
148694510|NCT04947579|536354297|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
148694511|NCT04947579|536354298|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
148694512|NCT04947579|536354293|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
148694513|NCT04947579|536354294|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
148694514|NCT04947579|536354295|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
148694515|NCT04947579|536354296|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
148694516|NCT04947579|536354297|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
148694517|NCT04947579|536354298|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
148694518|NCT04947579|536354293|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
148694519|NCT04947579|536354294|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
148694520|NCT04947579|536354295|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
148812755|NCT01771107|536789242|FG001|Overall Study|participant moved|1|||
148812756|NCT01771107|536789241|FG000|Overall Study|Other|0|||
148812757|NCT01771107|536789242|FG001|Overall Study|Other|1|||
148812758|NCT02296125|536789247|FG000|Overall Study|Withdrawal by Subject|18|||
148812759|NCT02296125|536789248|FG001|Overall Study|Withdrawal by Subject|8|||
148812760|NCT02296125|536789249|FG002|Overall Study|Withdrawal by Subject|6|||
148812761|NCT02296125|536789250|FG003|Overall Study|Withdrawal by Subject|2|||
148812762|NCT02296125|536789247|FG000|Overall Study|Adverse Event|41|||
148812763|NCT02296125|536789248|FG001|Overall Study|Adverse Event|52|||
148812764|NCT02296125|536789249|FG002|Overall Study|Adverse Event|9|||
148812765|NCT02296125|536789250|FG003|Overall Study|Adverse Event|4|||
148812766|NCT02296125|536789247|FG000|Overall Study|Severe non-compliance to protocol|0|||
148812767|NCT02296125|536789248|FG001|Overall Study|Severe non-compliance to protocol|1|||
148812768|NCT02296125|536789249|FG002|Overall Study|Severe non-compliance to protocol|0|||
148812769|NCT02296125|536789250|FG003|Overall Study|Severe non-compliance to protocol|0|||
148812770|NCT02296125|536789247|FG000|Overall Study|Condition under investigation worsened|153|||
148812771|NCT02296125|536789248|FG001|Overall Study|Condition under investigation worsened|199|||
148812772|NCT02296125|536789249|FG002|Overall Study|Condition under investigation worsened|39|||
148812773|NCT02296125|536789250|FG003|Overall Study|Condition under investigation worsened|56|||
148812774|NCT02296125|536789247|FG000|Overall Study|Any reason not specifically recorded|6|||
148812775|NCT02296125|536789248|FG001|Overall Study|Any reason not specifically recorded|4|||
148812776|NCT02296125|536789249|FG002|Overall Study|Any reason not specifically recorded|2|||
148812777|NCT02296125|536789250|FG003|Overall Study|Any reason not specifically recorded|0|||
148812778|NCT01160614|536789251|FG000|Overall Study|Withdrawal by Subject|0|||
148812779|NCT01160614|536789252|FG001|Overall Study|Withdrawal by Subject|2|||
148812780|NCT03805841|536789253|FG000|Overall Study|Clinical Progression|2|||
148812781|NCT03805841|536789254|FG001|Overall Study|Clinical Progression|0|||
148812782|NCT03805841|536789255|FG002|Overall Study|Clinical Progression|0|||
148812783|NCT03805841|536789253|FG000|Overall Study|Death|0|||
148812784|NCT03805841|536789254|FG001|Overall Study|Death|3|||
148812785|NCT03805841|536789255|FG002|Overall Study|Death|1|||
148812786|NCT03805841|536789253|FG000|Overall Study|Lost to Follow-up|0|||
148812787|NCT03805841|536789254|FG001|Overall Study|Lost to Follow-up|0|||
148812788|NCT03805841|536789255|FG002|Overall Study|Lost to Follow-up|1|||
148812789|NCT03805841|536789253|FG000|Overall Study|Withdrawal by Subject|2|||
148812790|NCT03805841|536789254|FG001|Overall Study|Withdrawal by Subject|3|||
148812791|NCT03805841|536789255|FG002|Overall Study|Withdrawal by Subject|0|||
148812792|NCT03805841|536789253|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
148812793|NCT03805841|536789254|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
148812794|NCT03805841|536789255|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
148812795|NCT05248386|536789257|FG000|Overall Study|Technical problems|0|||
148812796|NCT05248386|536789258|FG001|Overall Study|Technical problems|1|||
148694521|NCT04947579|536354296|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
148694522|NCT04947579|536354297|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
148694523|NCT04947579|536354298|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
148694524|NCT04947579|536354293|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
148694525|NCT04947579|536354294|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
148694526|NCT04947579|536354295|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
148694527|NCT04947579|536354296|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
148961929|NCT05104567|537344847|FG002|Overall Study|Progressive disease|13|||
148961930|NCT05104567|537344848|FG003|Overall Study|Progressive disease|17|||
148961931|NCT05104567|537344849|FG004|Overall Study|Progressive disease|17|||
148961932|NCT05104567|537344850|FG005|Overall Study|Progressive disease|28|||
148961933|NCT05104567|537344851|FG006|Overall Study|Progressive disease|24|||
148961934|NCT05104567|537344845|FG000|Overall Study|Withdrawal by Subject|1|||
148961935|NCT05104567|537344846|FG001|Overall Study|Withdrawal by Subject|1|||
148961936|NCT05104567|537344847|FG002|Overall Study|Withdrawal by Subject|2|||
148961937|NCT05104567|537344848|FG003|Overall Study|Withdrawal by Subject|0|||
148961938|NCT05104567|537344849|FG004|Overall Study|Withdrawal by Subject|0|||
148961939|NCT05104567|537344850|FG005|Overall Study|Withdrawal by Subject|0|||
148961940|NCT05104567|537344851|FG006|Overall Study|Withdrawal by Subject|0|||
148961941|NCT05104567|537344845|FG000|Overall Study|Other|1|||
148961942|NCT05104567|537344846|FG001|Overall Study|Other|1|||
148961943|NCT05104567|537344847|FG002|Overall Study|Other|1|||
148961944|NCT05104567|537344848|FG003|Overall Study|Other|0|||
148961945|NCT05104567|537344849|FG004|Overall Study|Other|0|||
148961946|NCT05104567|537344850|FG005|Overall Study|Other|0|||
148961947|NCT05104567|537344851|FG006|Overall Study|Other|0|||
148961948|NCT02295995|537344855|FG000|Overall Study|Lost to Follow-up|5|||
148961949|NCT02295995|537344856|FG001|Overall Study|Lost to Follow-up|1|||
148961950|NCT02446990|537344858|FG000|Overall Study|Death|485|||
148961951|NCT02446990|537344859|FG001|Overall Study|Death|458|||
148961952|NCT02446990|537344858|FG000|Overall Study|Lost to Follow-up|3|||
148961953|NCT02446990|537344859|FG001|Overall Study|Lost to Follow-up|1|||
148961954|NCT02446990|537344858|FG000|Overall Study|Physician Decision|1|||
148961955|NCT02446990|537344859|FG001|Overall Study|Physician Decision|0|||
148961956|NCT02446990|537344858|FG000|Overall Study|Withdrawal by Subject|231|||
148961957|NCT02446990|537344859|FG001|Overall Study|Withdrawal by Subject|199|||
148961958|NCT01064401|537344860|FG000|Overall Study|Adverse Event|47|||
148961959|NCT01064401|537344861|FG001|Overall Study|Adverse Event|56|||
148961960|NCT01064401|537344860|FG000|Overall Study|Lack of Efficacy|46|||
148961961|NCT01064401|537344861|FG001|Overall Study|Lack of Efficacy|23|||
148961962|NCT01064401|537344860|FG000|Overall Study|Lost to Follow-up|12|||
148961963|NCT01064401|537344861|FG001|Overall Study|Lost to Follow-up|9|||
148961964|NCT01064401|537344860|FG000|Overall Study|Consent Withdrawn|98|||
148961965|NCT01064401|537344861|FG001|Overall Study|Consent Withdrawn|80|||
148961966|NCT01064401|537344860|FG000|Overall Study|Investigator Decision|4|||
148961967|NCT01064401|537344861|FG001|Overall Study|Investigator Decision|6|||
148961968|NCT01064401|537344860|FG000|Overall Study|Death|4|||
148961969|NCT01064401|537344861|FG001|Overall Study|Death|0|||
148961970|NCT01064401|537344860|FG000|Overall Study|Pregnancy|4|||
148961971|NCT01064401|537344861|FG001|Overall Study|Pregnancy|7|||
148961972|NCT01064401|537344860|FG000|Overall Study|Noncompliance|7|||
148961973|NCT01064401|537344861|FG001|Overall Study|Noncompliance|8|||
148961974|NCT01064401|537344860|FG000|Overall Study|Site Closure|4|||
148961975|NCT01064401|537344861|FG001|Overall Study|Site Closure|5|||
148961976|NCT01064401|537344860|FG000|Overall Study|Other|2|||
148961977|NCT01064401|537344861|FG001|Overall Study|Other|1|||
148961978|NCT03158051|537344862|FG000|Overall Study|Lost to Follow-up|41|||
148961979|NCT03158051|537344863|FG001|Overall Study|Lost to Follow-up|47|||
148961980|NCT03158051|537344862|FG000|Overall Study|Physician Decision|6|||
148961981|NCT03158051|537344863|FG001|Overall Study|Physician Decision|7|||
148961982|NCT03158051|537344862|FG000|Overall Study|Withdrawal by Subject|24|||
148961983|NCT03158051|537344863|FG001|Overall Study|Withdrawal by Subject|15|||
148961984|NCT03158051|537344862|FG000|Overall Study|Death|0|||
148961985|NCT03158051|537344863|FG001|Overall Study|Death|1|||
148961986|NCT02738151|537344864|FG000|Overall Study|Randomized but not treated|4|||
148961987|NCT02738151|537344865|FG001|Overall Study|Randomized but not treated|1|||
148961988|NCT02738151|537344864|FG000|Overall Study|Adverse Event|4|||
148961989|NCT02738151|537344865|FG001|Overall Study|Adverse Event|5|||
148961990|NCT02738151|537344864|FG000|Overall Study|Hypoglycemia|0|||
148961991|NCT02738151|537344865|FG001|Overall Study|Hypoglycemia|1|||
148961992|NCT02738151|537344864|FG000|Overall Study|Poor Compliance to Protocol|4|||
148961993|NCT02738151|537344865|FG001|Overall Study|Poor Compliance to Protocol|3|||
148961994|NCT02738151|537344864|FG000|Overall Study|Other than specified above|11|||
148961995|NCT02738151|537344865|FG001|Overall Study|Other than specified above|21|||
148961996|NCT02070744|537344881|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
148961997|NCT02070744|537344882|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
148961998|NCT02070744|537344883|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
148961999|NCT02070744|537344884|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
148962000|NCT02070744|537344885|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
148962001|NCT02070744|537344881|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
148962002|NCT02070744|537344882|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
148962003|NCT02070744|537344883|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
148962004|NCT02070744|537344884|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
148962005|NCT02070744|537344885|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
148962006|NCT02070744|537344881|FG000|OLE Phase (48 Weeks)|Other|0|||
148962007|NCT02070744|537344882|FG001|OLE Phase (48 Weeks)|Other|0|||
148962008|NCT02070744|537344883|FG002|OLE Phase (48 Weeks)|Other|0|||
148962009|NCT02070744|537344884|FG003|OLE Phase (48 Weeks)|Other|0|||
148962010|NCT02070744|537344885|FG004|OLE Phase (48 Weeks)|Other|1|||
148962011|NCT03795298|537344889|FG000|Overall Study|Death|34|||
148962012|NCT03795298|537344890|FG001|Overall Study|Death|29|||
148962013|NCT03795298|537344889|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
148962014|NCT03795298|537344890|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
148962015|NCT03795298|537344889|FG000|Overall Study|Lost to Follow-up|28|||
148962016|NCT03795298|537344890|FG001|Overall Study|Lost to Follow-up|17|||
148962017|NCT03795298|537344889|FG000|Overall Study|Physician Decision|5|||
148962018|NCT03795298|537344890|FG001|Overall Study|Physician Decision|4|||
148962019|NCT03795298|537344889|FG000|Overall Study|Withdrawal by Subject|43|||
148694528|NCT04947579|536354297|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
148694529|NCT04947579|536354298|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
148694530|NCT04947579|536354293|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
148694531|NCT04947579|536354294|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
148694532|NCT04947579|536354295|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
148694533|NCT04947579|536354296|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
148694534|NCT04947579|536354297|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
148694535|NCT04947579|536354298|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
148694536|NCT00634179|536354299|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
148694537|NCT04272801|536354300|FG000|Overall Study|Withdrawal by Subject|4|||
148694538|NCT04272801|536354300|FG000|Overall Study|Lost to Follow-up|4|||
148694539|NCT04272801|536354300|FG000|Overall Study|Ineligible|1|||
148694540|NCT03481309|536354301|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
148694541|NCT03481309|536354302|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
148694542|NCT03481309|536354303|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
148694543|NCT03481309|536354304|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
148694544|NCT03481309|536354305|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
148962020|NCT03795298|537344890|FG001|Overall Study|Withdrawal by Subject|28|||
148962021|NCT03795298|537344889|FG000|Overall Study|Reason not reported|7|||
148962022|NCT03795298|537344890|FG001|Overall Study|Reason not reported|9|||
148962023|NCT01252940|537344891|FG000|Main Study Phase|Randomized but not treated|4|||
148962024|NCT01252940|537344892|FG001|Main Study Phase|Randomized but not treated|2|||
148962025|NCT01252940|537344891|FG000|Main Study Phase|Adverse Event|3|||
148962026|NCT01252940|537344892|FG001|Main Study Phase|Adverse Event|1|||
148694545|NCT03481309|536354306|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
148694546|NCT02130466|536354307|FG000|Overall Study|Death|4|||
148694547|NCT02130466|536354308|FG001|Overall Study|Death|1|||
148694548|NCT02130466|536354309|FG002|Overall Study|Death|1|||
148694549|NCT02130466|536354310|FG003|Overall Study|Death|3|||
148694550|NCT02130466|536354311|FG004|Overall Study|Death|2|||
148694551|NCT02130466|536354312|FG005|Overall Study|Death|30|||
148694552|NCT02130466|536354313|FG006|Overall Study|Death|45|||
148694553|NCT02130466|536354314|FG007|Overall Study|Death|2|||
148694554|NCT02130466|536354315|FG008|Overall Study|Death|3|||
148694555|NCT02130466|536354316|FG009|Overall Study|Death|4|||
148694556|NCT02130466|536354317|FG010|Overall Study|Death|5|||
148694557|NCT02130466|536354318|FG011|Overall Study|Death|3|||
148962027|NCT01252940|537344891|FG000|Main Study Phase|Lack of Efficacy|1|||
148694558|NCT02130466|536354319|FG012|Overall Study|Death|11|||
148694559|NCT02130466|536354320|FG013|Overall Study|Death|7|||
148694560|NCT02130466|536354307|FG000|Overall Study|Lost to Follow-up|1|||
148694561|NCT02130466|536354308|FG001|Overall Study|Lost to Follow-up|0|||
148694562|NCT02130466|536354309|FG002|Overall Study|Lost to Follow-up|0|||
148694563|NCT02130466|536354310|FG003|Overall Study|Lost to Follow-up|0|||
148694564|NCT02130466|536354311|FG004|Overall Study|Lost to Follow-up|0|||
148962028|NCT01252940|537344892|FG001|Main Study Phase|Lack of Efficacy|0|||
148962029|NCT01252940|537344891|FG000|Main Study Phase|Lost to Follow-up|6|||
148694565|NCT02130466|536354312|FG005|Overall Study|Lost to Follow-up|1|||
148694566|NCT02130466|536354313|FG006|Overall Study|Lost to Follow-up|0|||
148694567|NCT02130466|536354314|FG007|Overall Study|Lost to Follow-up|0|||
148694568|NCT02130466|536354315|FG008|Overall Study|Lost to Follow-up|0|||
148694569|NCT02130466|536354316|FG009|Overall Study|Lost to Follow-up|0|||
148694570|NCT02130466|536354317|FG010|Overall Study|Lost to Follow-up|0|||
148812797|NCT05248386|536789257|FG000|Overall Study|Withdrawal by Subject|15|||
148962030|NCT01252940|537344892|FG001|Main Study Phase|Lost to Follow-up|1|||
148962031|NCT01252940|537344891|FG000|Main Study Phase|Physician Decision|1|||
148694571|NCT02130466|536354318|FG011|Overall Study|Lost to Follow-up|0|||
148694572|NCT02130466|536354319|FG012|Overall Study|Lost to Follow-up|1|||
148694573|NCT02130466|536354320|FG013|Overall Study|Lost to Follow-up|0|||
148694574|NCT02130466|536354307|FG000|Overall Study|Physician Decision|0|||
148694575|NCT02130466|536354308|FG001|Overall Study|Physician Decision|0|||
148962032|NCT01252940|537344892|FG001|Main Study Phase|Physician Decision|0|||
148694576|NCT02130466|536354309|FG002|Overall Study|Physician Decision|0|||
148694577|NCT02130466|536354310|FG003|Overall Study|Physician Decision|0|||
148962033|NCT01252940|537344891|FG000|Main Study Phase|Protocol Violation|4|||
148962034|NCT01252940|537344892|FG001|Main Study Phase|Protocol Violation|2|||
148694578|NCT02130466|536354311|FG004|Overall Study|Physician Decision|0|||
148694579|NCT02130466|536354312|FG005|Overall Study|Physician Decision|1|||
148694580|NCT02130466|536354313|FG006|Overall Study|Physician Decision|1|||
148694581|NCT02130466|536354314|FG007|Overall Study|Physician Decision|0|||
148694582|NCT02130466|536354315|FG008|Overall Study|Physician Decision|0|||
148694583|NCT02130466|536354316|FG009|Overall Study|Physician Decision|0|||
148694584|NCT02130466|536354317|FG010|Overall Study|Physician Decision|0|||
148694585|NCT02130466|536354318|FG011|Overall Study|Physician Decision|0|||
148694586|NCT02130466|536354319|FG012|Overall Study|Physician Decision|0|||
148694587|NCT02130466|536354320|FG013|Overall Study|Physician Decision|0|||
148694588|NCT02130466|536354307|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
148694589|NCT02130466|536354308|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
148694590|NCT02130466|536354309|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
148694591|NCT02130466|536354310|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
148694592|NCT02130466|536354311|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
148694593|NCT02130466|536354312|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
148694594|NCT02130466|536354313|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
148694595|NCT02130466|536354314|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
148694596|NCT02130466|536354315|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
148694597|NCT02130466|536354316|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
148694598|NCT02130466|536354317|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
148694599|NCT02130466|536354318|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
148694600|NCT02130466|536354319|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
148694601|NCT02130466|536354320|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
148694602|NCT02130466|536354307|FG000|Overall Study|Withdrawal by Subject|1|||
148694603|NCT02130466|536354308|FG001|Overall Study|Withdrawal by Subject|0|||
148694604|NCT02130466|536354309|FG002|Overall Study|Withdrawal by Subject|0|||
148694605|NCT02130466|536354310|FG003|Overall Study|Withdrawal by Subject|0|||
148694606|NCT02130466|536354311|FG004|Overall Study|Withdrawal by Subject|0|||
148694607|NCT02130466|536354312|FG005|Overall Study|Withdrawal by Subject|1|||
148694608|NCT02130466|536354313|FG006|Overall Study|Withdrawal by Subject|0|||
148694609|NCT02130466|536354314|FG007|Overall Study|Withdrawal by Subject|0|||
148694610|NCT02130466|536354315|FG008|Overall Study|Withdrawal by Subject|1|||
148694611|NCT02130466|536354316|FG009|Overall Study|Withdrawal by Subject|0|||
148694612|NCT02130466|536354317|FG010|Overall Study|Withdrawal by Subject|0|||
148694613|NCT02130466|536354318|FG011|Overall Study|Withdrawal by Subject|0|||
148694614|NCT02130466|536354319|FG012|Overall Study|Withdrawal by Subject|0|||
148694615|NCT02130466|536354320|FG013|Overall Study|Withdrawal by Subject|0|||
148694616|NCT04529109|536354321|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
148694617|NCT04529109|536354322|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
148694618|NCT04603937|536354323|FG000|Overall Study|Adverse Event|9|||
148694619|NCT04603937|536354324|FG001|Overall Study|Adverse Event|10|||
148694620|NCT04603937|536354323|FG000|Overall Study|Withdrawal by Subject|7|||
148694621|NCT04603937|536354324|FG001|Overall Study|Withdrawal by Subject|6|||
148694622|NCT04603937|536354323|FG000|Overall Study|Lost to Follow-up|5|||
148694623|NCT04603937|536354324|FG001|Overall Study|Lost to Follow-up|6|||
148694624|NCT04603937|536354323|FG000|Overall Study|Physician Decision|0|||
148694625|NCT04603937|536354324|FG001|Overall Study|Physician Decision|1|||
148694626|NCT04603937|536354323|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
148694627|NCT04603937|536354324|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
148694628|NCT05109234|536354325|FG000|Overall Study|Adverse Event|2|||
148694629|NCT05109234|536354326|FG001|Overall Study|Adverse Event|2|||
148694630|NCT05109234|536354325|FG000|Overall Study|Lack of Efficacy|5|||
148694631|NCT05109234|536354326|FG001|Overall Study|Lack of Efficacy|0|||
148694632|NCT05109234|536354325|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
148694633|NCT05109234|536354326|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
149024056|NCT05194735|537564161|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
149024057|NCT05194735|537564159|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
149024058|NCT05194735|537564160|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
149024059|NCT05194735|537564161|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
149024060|NCT05194735|537564159|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
149024061|NCT05194735|537564160|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
149024062|NCT05194735|537564161|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
149024063|NCT05194735|537564159|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
149024064|NCT05194735|537564160|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
149024065|NCT05194735|537564161|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
149024066|NCT00731042|537564162|FG000|Second Intervention|Did not meet inclusion criteria|0|||
149024067|NCT00731042|537564163|FG001|Second Intervention|Did not meet inclusion criteria|2|||
149024068|NCT01256476|537564165|FG000|Overall Study|Adverse Event|2|||
149024069|NCT01256476|537564166|FG001|Overall Study|Adverse Event|1|||
149024070|NCT01256476|537564165|FG000|Overall Study|Withdrawal by Subject|2|||
149024071|NCT01256476|537564166|FG001|Overall Study|Withdrawal by Subject|1|||
149024072|NCT01256476|537564165|FG000|Overall Study|Lost to Follow-up|1|||
149024073|NCT01256476|537564166|FG001|Overall Study|Lost to Follow-up|2|||
149024074|NCT01256476|537564165|FG000|Overall Study|Persistent ALT or AST elevation|1|||
149024075|NCT01256476|537564166|FG001|Overall Study|Persistent ALT or AST elevation|0|||
149024076|NCT01256476|537564165|FG000|Overall Study|Physician Decision|0|||
149024077|NCT01256476|537564166|FG001|Overall Study|Physician Decision|1|||
148694634|NCT05109234|536354325|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
148694635|NCT05109234|536354326|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
148694636|NCT05109234|536354325|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
148694637|NCT05109234|536354326|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
148694638|NCT05109234|536354325|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
148694639|NCT05109234|536354326|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
148694640|NCT00993616|536354327|FG000|Overall Study|No tumor at entry|1|||
148694641|NCT00993616|536354327|FG000|Overall Study|Never treated|1|||
148694642|NCT02585258|536354329|FG000|Overall Study|Adverse Event|28|||
148694643|NCT02585258|536354330|FG001|Overall Study|Adverse Event|29|||
148962035|NCT01252940|537344891|FG000|Main Study Phase|Withdrawal by Subject|6|||
148962036|NCT01252940|537344892|FG001|Main Study Phase|Withdrawal by Subject|5|||
148962037|NCT01252940|537344891|FG000|Main Study Phase|Subject Non-compliance|1|||
148962038|NCT01252940|537344892|FG001|Main Study Phase|Subject Non-compliance|1|||
148962039|NCT01252940|537344891|FG000|Extension Phase|Adverse Event|2|||
148962040|NCT01252940|537344892|FG001|Extension Phase|Adverse Event|1|||
148962041|NCT01252940|537344891|FG000|Extension Phase|Lack of Efficacy|1|||
148962042|NCT01252940|537344892|FG001|Extension Phase|Lack of Efficacy|0|||
148962043|NCT01252940|537344891|FG000|Extension Phase|Lost to Follow-up|5|||
148962044|NCT01252940|537344892|FG001|Extension Phase|Lost to Follow-up|0|||
148962045|NCT01252940|537344891|FG000|Extension Phase|Physician Decision|0|||
148694644|NCT02585258|536354329|FG000|Overall Study|Death|3|||
148962046|NCT01252940|537344892|FG001|Extension Phase|Physician Decision|1|||
148962047|NCT01252940|537344891|FG000|Extension Phase|Subject Non-compliance|1|||
148962048|NCT01252940|537344892|FG001|Extension Phase|Subject Non-compliance|0|||
148694645|NCT02585258|536354330|FG001|Overall Study|Death|2|||
148694646|NCT02585258|536354329|FG000|Overall Study|Lack of Efficacy|7|||
148694647|NCT02585258|536354330|FG001|Overall Study|Lack of Efficacy|9|||
148694648|NCT02585258|536354329|FG000|Overall Study|includes covid-related access problems|42|||
148694649|NCT02585258|536354330|FG001|Overall Study|includes covid-related access problems|46|||
148694650|NCT02585258|536354329|FG000|Overall Study|Lost to Follow-up|5|||
148694651|NCT02585258|536354330|FG001|Overall Study|Lost to Follow-up|2|||
148694652|NCT05125952|536354331|FG000|Overall Study|Physician Decision|1|||
148694653|NCT03946449|536354332|FG000|Treatment Extension II|Rolled over to another study|0|||
148694654|NCT03946449|536354333|FG001|Treatment Extension II|Rolled over to another study|0|||
148694655|NCT03946449|536354334|FG002|Treatment Extension II|Rolled over to another study|2|||
148694656|NCT03946449|536354332|FG000|Treatment Extension II|Withdrawal by Subject|0|||
148694657|NCT03946449|536354333|FG001|Treatment Extension II|Withdrawal by Subject|0|||
148962049|NCT01252940|537344891|FG000|Extension Phase|Withdrawal by Subject|1|||
148962050|NCT01252940|537344892|FG001|Extension Phase|Withdrawal by Subject|1|||
148962051|NCT04199117|537344893|FG000|Overall Study|Withdrawal by Subject|3|||
148962052|NCT04199117|537344894|FG001|Overall Study|Withdrawal by Subject|0|||
148962053|NCT04199117|537344895|FG002|Overall Study|Withdrawal by Subject|0|||
148962054|NCT04199117|537344896|FG003|Overall Study|Withdrawal by Subject|1|||
148962055|NCT04199117|537344897|FG004|Overall Study|Withdrawal by Subject|1|||
148962056|NCT04199117|537344898|FG005|Overall Study|Withdrawal by Subject|0|||
148962057|NCT04199117|537344899|FG006|Overall Study|Withdrawal by Subject|0|||
148962058|NCT04199117|537344900|FG007|Overall Study|Withdrawal by Subject|2|||
148694658|NCT03946449|536354334|FG002|Treatment Extension II|Withdrawal by Subject|1|||
148694659|NCT05067504|536354336|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
148694660|NCT05067504|536354337|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
148694661|NCT05067504|536354336|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
148694662|NCT05067504|536354337|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
148694663|NCT05067504|536354336|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
148694664|NCT05067504|536354337|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
148694665|NCT01619800|536356018|FG000|Overall Study|study terminated|2|||
148694666|NCT01619800|536356019|FG001|Overall Study|study terminated|0|||
148694667|NCT02848326|536356020|FG000|Treatment Period|Adverse Event|5|||
148962059|NCT04199117|537344901|FG008|Overall Study|Withdrawal by Subject|0|||
148694668|NCT02848326|536356021|FG001|Treatment Period|Adverse Event|4|||
148962060|NCT04199117|537344902|FG009|Overall Study|Withdrawal by Subject|0|||
148962061|NCT04199117|537344903|FG010|Overall Study|Withdrawal by Subject|1|||
148962062|NCT04199117|537344904|FG011|Overall Study|Withdrawal by Subject|1|||
148694669|NCT02848326|536356022|FG002|Treatment Period|Adverse Event|11|||
148694670|NCT02848326|536356023|FG003|Treatment Period|Adverse Event|6|||
148694671|NCT02848326|536356024|FG004|Treatment Period|Adverse Event|5|||
148694672|NCT02848326|536356025|FG005|Treatment Period|Adverse Event|7|||
148962063|NCT04199117|537344905|FG012|Overall Study|Withdrawal by Subject|2|||
148694673|NCT02848326|536356020|FG000|Treatment Period|Withdrawal of Consent|20|||
148694674|NCT02848326|536356021|FG001|Treatment Period|Withdrawal of Consent|6|||
148694675|NCT02848326|536356022|FG002|Treatment Period|Withdrawal of Consent|9|||
148694676|NCT02848326|536356023|FG003|Treatment Period|Withdrawal of Consent|6|||
148694677|NCT02848326|536356024|FG004|Treatment Period|Withdrawal of Consent|9|||
148694678|NCT02848326|536356025|FG005|Treatment Period|Withdrawal of Consent|6|||
148694679|NCT02848326|536356020|FG000|Treatment Period|Lost to Follow-up|5|||
148694680|NCT02848326|536356021|FG001|Treatment Period|Lost to Follow-up|1|||
148694681|NCT02848326|536356022|FG002|Treatment Period|Lost to Follow-up|11|||
148694682|NCT02848326|536356023|FG003|Treatment Period|Lost to Follow-up|7|||
148694683|NCT02848326|536356024|FG004|Treatment Period|Lost to Follow-up|2|||
148694684|NCT02848326|536356025|FG005|Treatment Period|Lost to Follow-up|3|||
148694685|NCT02848326|536356020|FG000|Treatment Period|Pregnancy|0|||
148694686|NCT02848326|536356021|FG001|Treatment Period|Pregnancy|0|||
148694687|NCT02848326|536356022|FG002|Treatment Period|Pregnancy|1|||
148694688|NCT02848326|536356023|FG003|Treatment Period|Pregnancy|1|||
148694689|NCT02848326|536356024|FG004|Treatment Period|Pregnancy|0|||
148694690|NCT02848326|536356025|FG005|Treatment Period|Pregnancy|1|||
148694691|NCT02848326|536356020|FG000|Treatment Period|Protocol Violation|4|||
148694692|NCT02848326|536356021|FG001|Treatment Period|Protocol Violation|3|||
148694693|NCT02848326|536356022|FG002|Treatment Period|Protocol Violation|4|||
148694694|NCT02848326|536356023|FG003|Treatment Period|Protocol Violation|2|||
148694695|NCT02848326|536356024|FG004|Treatment Period|Protocol Violation|3|||
148694696|NCT02848326|536356025|FG005|Treatment Period|Protocol Violation|3|||
148694697|NCT02848326|536356020|FG000|Treatment Period|Non-compliance with Study Drug|4|||
148694698|NCT02848326|536356021|FG001|Treatment Period|Non-compliance with Study Drug|0|||
148694699|NCT02848326|536356022|FG002|Treatment Period|Non-compliance with Study Drug|0|||
148694700|NCT02848326|536356023|FG003|Treatment Period|Non-compliance with Study Drug|1|||
148694701|NCT02848326|536356024|FG004|Treatment Period|Non-compliance with Study Drug|0|||
148694702|NCT02848326|536356025|FG005|Treatment Period|Non-compliance with Study Drug|0|||
148694703|NCT02848326|536356020|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
148694704|NCT02848326|536356021|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
148694705|NCT02848326|536356022|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
148694706|NCT02848326|536356023|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
148694707|NCT02848326|536356024|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
148694708|NCT02848326|536356025|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
148694709|NCT02848326|536356020|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
148694710|NCT02848326|536356021|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
148694711|NCT02848326|536356022|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
148694712|NCT02848326|536356023|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
148694713|NCT02848326|536356024|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
148694714|NCT02848326|536356025|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
148694715|NCT02684344|536356027|FG000|Overall Study|Withdrawal by Subject|0|||
148694716|NCT02684344|536356028|FG001|Overall Study|Withdrawal by Subject|1|||
148694717|NCT00863746|536356031|FG000|Treatment|Not treated|4|||
148962064|NCT04199117|537344906|FG013|Overall Study|Withdrawal by Subject|1|||
148962065|NCT04199117|537344907|FG014|Overall Study|Withdrawal by Subject|1|||
148962066|NCT04199117|537344908|FG015|Overall Study|Withdrawal by Subject|1|||
148962067|NCT04199117|537344893|FG000|Overall Study|Death|1|||
148962068|NCT04199117|537344894|FG001|Overall Study|Death|1|||
148962069|NCT04199117|537344895|FG002|Overall Study|Death|0|||
148962070|NCT04199117|537344896|FG003|Overall Study|Death|0|||
148694718|NCT00863746|536356032|FG001|Treatment|Not treated|2|||
148694719|NCT00863746|536356031|FG000|Treatment|Adverse Event|41|||
148694720|NCT00863746|536356032|FG001|Treatment|Adverse Event|16|||
148694721|NCT00863746|536356031|FG000|Treatment|non-compliant with study medication|4|||
148694722|NCT00863746|536356032|FG001|Treatment|non-compliant with study medication|0|||
148694723|NCT00863746|536356031|FG000|Treatment|Consent withdrawn|15|||
148694724|NCT00863746|536356032|FG001|Treatment|Consent withdrawn|14|||
148694725|NCT00863746|536356031|FG000|Treatment|Lost to Follow-up|1|||
148694726|NCT00863746|536356032|FG001|Treatment|Lost to Follow-up|0|||
148694727|NCT00863746|536356031|FG000|Treatment|Protocol Violation|5|||
148694728|NCT00863746|536356032|FG001|Treatment|Protocol Violation|3|||
148962071|NCT04199117|537344897|FG004|Overall Study|Death|0|||
148694729|NCT00863746|536356031|FG000|Treatment|Other|1|||
148694730|NCT00863746|536356032|FG001|Treatment|Other|0|||
148694731|NCT00863746|536356031|FG000|Survival Follow up|Death|244|||
148962072|NCT04199117|537344898|FG005|Overall Study|Death|0|||
148962073|NCT04199117|537344899|FG006|Overall Study|Death|0|||
148962074|NCT04199117|537344900|FG007|Overall Study|Death|0|||
148694732|NCT00863746|536356032|FG001|Survival Follow up|Death|271|||
148962075|NCT04199117|537344901|FG008|Overall Study|Death|0|||
148962076|NCT04199117|537344902|FG009|Overall Study|Death|0|||
148962077|NCT04199117|537344903|FG010|Overall Study|Death|0|||
148962078|NCT04199117|537344904|FG011|Overall Study|Death|1|||
148962079|NCT04199117|537344905|FG012|Overall Study|Death|0|||
148962080|NCT04199117|537344906|FG013|Overall Study|Death|1|||
148962081|NCT04199117|537344907|FG014|Overall Study|Death|0|||
148962082|NCT04199117|537344908|FG015|Overall Study|Death|0|||
148962083|NCT04199117|537344893|FG000|Overall Study|Withdrawal by PI|0|||
148962084|NCT04199117|537344894|FG001|Overall Study|Withdrawal by PI|0|||
148694733|NCT00863746|536356031|FG000|Survival Follow up|Lost to Follow-up|2|||
148694734|NCT00863746|536356032|FG001|Survival Follow up|Lost to Follow-up|1|||
148694735|NCT00863746|536356031|FG000|Survival Follow up|Consent Withdrawn|7|||
148694736|NCT00863746|536356032|FG001|Survival Follow up|Consent Withdrawn|8|||
148694737|NCT03292653|536356035|FG000|Overall Study|Adverse Event|0|||
148694738|NCT03292653|536356036|FG001|Overall Study|Adverse Event|0|||
148694739|NCT03292653|536356037|FG002|Overall Study|Adverse Event|1|||
148694740|NCT03292653|536356035|FG000|Overall Study|Did not Receive Treatment|1|||
148694741|NCT03292653|536356036|FG001|Overall Study|Did not Receive Treatment|0|||
148694742|NCT03292653|536356037|FG002|Overall Study|Did not Receive Treatment|0|||
148694743|NCT05037097|536356038|FG000|Overall Study|Withdrawal by Subject|0|||
148694744|NCT05037097|536356039|FG001|Overall Study|Withdrawal by Subject|1|||
148694745|NCT05037097|536356040|FG002|Overall Study|Withdrawal by Subject|0|||
148694746|NCT05037097|536356041|FG003|Overall Study|Withdrawal by Subject|1|||
148694747|NCT05037097|536356042|FG004|Overall Study|Withdrawal by Subject|0|||
148694748|NCT05037097|536356043|FG005|Overall Study|Withdrawal by Subject|2|||
148694749|NCT05037097|536356044|FG006|Overall Study|Withdrawal by Subject|0|||
148694750|NCT05037097|536356045|FG007|Overall Study|Withdrawal by Subject|0|||
148694751|NCT05037097|536356038|FG000|Overall Study|Lost to Follow-up|0|||
148694752|NCT05037097|536356039|FG001|Overall Study|Lost to Follow-up|1|||
148694753|NCT05037097|536356040|FG002|Overall Study|Lost to Follow-up|0|||
148694754|NCT05037097|536356041|FG003|Overall Study|Lost to Follow-up|0|||
148694755|NCT05037097|536356042|FG004|Overall Study|Lost to Follow-up|1|||
148694756|NCT05037097|536356043|FG005|Overall Study|Lost to Follow-up|1|||
148694757|NCT05037097|536356044|FG006|Overall Study|Lost to Follow-up|0|||
148694758|NCT05037097|536356045|FG007|Overall Study|Lost to Follow-up|0|||
148694759|NCT00376220|536356050|FG000|Overall Study|Lost to Follow-up|7|||
148694760|NCT00376220|536356051|FG001|Overall Study|Lost to Follow-up|10|||
148694761|NCT00376220|536356050|FG000|Overall Study|Withdrawal by Subject|3|||
148694762|NCT00376220|536356051|FG001|Overall Study|Withdrawal by Subject|2|||
148694763|NCT00436007|536356058|FG000|Overall Study|Withdrawal by Subject|5|||
148694764|NCT00436007|536356059|FG001|Overall Study|Withdrawal by Subject|3|||
148694765|NCT00436007|536356060|FG002|Overall Study|Withdrawal by Subject|4|||
148694766|NCT00436007|536356058|FG000|Overall Study|Lost to Follow-up|14|||
148694767|NCT00436007|536356059|FG001|Overall Study|Lost to Follow-up|10|||
148694768|NCT00436007|536356060|FG002|Overall Study|Lost to Follow-up|13|||
148694769|NCT00436007|536356058|FG000|Overall Study|Physician Decision|0|||
148694770|NCT00436007|536356059|FG001|Overall Study|Physician Decision|0|||
148694771|NCT00436007|536356060|FG002|Overall Study|Physician Decision|2|||
148694772|NCT00436007|536356058|FG000|Overall Study|Death|0|||
148694773|NCT00436007|536356059|FG001|Overall Study|Death|1|||
148694774|NCT00436007|536356060|FG002|Overall Study|Death|3|||
148962085|NCT04199117|537344895|FG002|Overall Study|Withdrawal by PI|0|||
148962086|NCT04199117|537344896|FG003|Overall Study|Withdrawal by PI|0|||
148962087|NCT04199117|537344897|FG004|Overall Study|Withdrawal by PI|0|||
148962088|NCT04199117|537344898|FG005|Overall Study|Withdrawal by PI|0|||
148962089|NCT04199117|537344899|FG006|Overall Study|Withdrawal by PI|0|||
148962090|NCT04199117|537344900|FG007|Overall Study|Withdrawal by PI|0|||
148694775|NCT00436007|536356058|FG000|Overall Study|Other|0|||
148694776|NCT00436007|536356059|FG001|Overall Study|Other|0|||
148694777|NCT00436007|536356060|FG002|Overall Study|Other|1|||
148962091|NCT04199117|537344901|FG008|Overall Study|Withdrawal by PI|0|||
148694778|NCT03331042|536356061|FG000|Overall Study|Protocol Violation|1|||
148962092|NCT04199117|537344902|FG009|Overall Study|Withdrawal by PI|0|||
148962093|NCT04199117|537344903|FG010|Overall Study|Withdrawal by PI|0|||
148694779|NCT03331042|536356062|FG001|Overall Study|Protocol Violation|0|||
148962094|NCT04199117|537344904|FG011|Overall Study|Withdrawal by PI|0|||
148694780|NCT03331042|536356063|FG002|Overall Study|Protocol Violation|0|||
148694781|NCT03331042|536356064|FG003|Overall Study|Protocol Violation|0|||
148962095|NCT04199117|537344905|FG012|Overall Study|Withdrawal by PI|1|||
148962096|NCT04199117|537344906|FG013|Overall Study|Withdrawal by PI|0|||
148962097|NCT04199117|537344907|FG014|Overall Study|Withdrawal by PI|0|||
148962098|NCT04199117|537344908|FG015|Overall Study|Withdrawal by PI|0|||
148962099|NCT04383743|537344909|FG000|Overall Study|Withdrawal by Subject|1|||
148962100|NCT04383743|537344909|FG000|Overall Study|Adverse Event|1|||
148962101|NCT01239368|537347085|FG000|Overall Study|Principal investigator discretion|1|||
148962102|NCT01239368|537347086|FG001|Overall Study|Principal investigator discretion|0|||
148962103|NCT01239368|537347087|FG002|Overall Study|Principal investigator discretion|0|||
148962104|NCT01239368|537347088|FG003|Overall Study|Principal investigator discretion|0|||
148962105|NCT01239368|537347089|FG004|Overall Study|Principal investigator discretion|1|||
148962106|NCT01239368|537347090|FG005|Overall Study|Principal investigator discretion|2|||
148694782|NCT03331042|536356061|FG000|Overall Study|Physician Decision|0|||
148962107|NCT01239368|537347091|FG006|Overall Study|Principal investigator discretion|0|||
148962108|NCT01239368|537347092|FG007|Overall Study|Principal investigator discretion|0|||
148694783|NCT03331042|536356062|FG001|Overall Study|Physician Decision|0|||
148694784|NCT03331042|536356063|FG002|Overall Study|Physician Decision|1|||
148694785|NCT03331042|536356064|FG003|Overall Study|Physician Decision|0|||
148694786|NCT03331042|536356061|FG000|Overall Study|Lost to Follow-up|0|||
148694787|NCT03331042|536356062|FG001|Overall Study|Lost to Follow-up|0|||
148694788|NCT03331042|536356063|FG002|Overall Study|Lost to Follow-up|0|||
148694789|NCT03331042|536356064|FG003|Overall Study|Lost to Follow-up|1|||
148694790|NCT00688064|536356067|FG000|Overall Study|Protocol Violation|0|||
148694791|NCT00688064|536356068|FG001|Overall Study|Protocol Violation|1|||
148694792|NCT00688064|536356067|FG000|Overall Study|Adverse Event|2|||
148694793|NCT00688064|536356068|FG001|Overall Study|Adverse Event|4|||
148694794|NCT00688064|536356067|FG000|Overall Study|Withdrawal by Subject|7|||
148694795|NCT00688064|536356068|FG001|Overall Study|Withdrawal by Subject|7|||
148694796|NCT00688064|536356067|FG000|Overall Study|Lost to Follow-up|10|||
148694797|NCT00688064|536356068|FG001|Overall Study|Lost to Follow-up|10|||
148694798|NCT00688064|536356067|FG000|Overall Study|Lack of Efficacy|0|||
148694799|NCT00688064|536356068|FG001|Overall Study|Lack of Efficacy|1|||
148694800|NCT00688064|536356067|FG000|Overall Study|Pregnancy|1|||
148694801|NCT00688064|536356068|FG001|Overall Study|Pregnancy|0|||
148694802|NCT00688064|536356067|FG000|Overall Study|Any other reasons|1|||
148694803|NCT00688064|536356068|FG001|Overall Study|Any other reasons|3|||
148694804|NCT05518487|536356069|FG000|Overall Study|Withdrawal by Subject|3|||
148694805|NCT02194998|536356072|FG000|On-HCV Treatment|Did not pick up study medication|0|||
148694806|NCT02194998|536356073|FG001|On-HCV Treatment|Did not pick up study medication|1|||
148694807|NCT02194998|536356074|FG002|On-HCV Treatment|Did not pick up study medication|0|||
148694808|NCT02194998|536356075|FG003|On-HCV Treatment|Did not pick up study medication|0|||
148694809|NCT02194998|536356072|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
148694810|NCT02194998|536356073|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
148694811|NCT02194998|536356074|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
148694812|NCT02194998|536356075|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
148694813|NCT01458405|536356078|FG000|Phase 1 (up to 12 Months)|Other|0|||
148694814|NCT01458405|536356079|FG001|Phase 1 (up to 12 Months)|Other|1|||
148694815|NCT01458405|536356080|FG002|Phase 1 (up to 12 Months)|Other|0|||
148694816|NCT01458405|536356081|FG003|Phase 1 (up to 12 Months)|Other|0|||
148694817|NCT01458405|536356078|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
148962109|NCT01239368|537347093|FG008|Overall Study|Principal investigator discretion|0|||
148694818|NCT01458405|536356079|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
148694819|NCT01458405|536356080|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
148812798|NCT05248386|536789258|FG001|Overall Study|Withdrawal by Subject|10|||
148812799|NCT05248386|536789257|FG000|Overall Study|Physician Decision|0|||
148812800|NCT05248386|536789258|FG001|Overall Study|Physician Decision|1|||
148812801|NCT05248386|536789257|FG000|Overall Study|Adverse Event|2|||
148694820|NCT01458405|536356081|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
148694821|NCT01458405|536356078|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
148694822|NCT01458405|536356079|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
148694823|NCT01458405|536356080|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
148694824|NCT01458405|536356081|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
148694825|NCT01458405|536356078|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
148694826|NCT01458405|536356079|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
148694827|NCT01458405|536356080|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
148694828|NCT01458405|536356081|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
148694829|NCT02497781|536356082|FG000|Overall Study|Withdrawal by Subject|2|||
148694830|NCT02497781|536356083|FG001|Overall Study|Withdrawal by Subject|0|||
148694831|NCT02497781|536356082|FG000|Overall Study|Lack of Efficacy|0|||
148694832|NCT02497781|536356083|FG001|Overall Study|Lack of Efficacy|1|||
148694833|NCT02497781|536356082|FG000|Overall Study|Randomised but not treated|1|||
148694834|NCT02497781|536356083|FG001|Overall Study|Randomised but not treated|1|||
148694835|NCT02497781|536356082|FG000|Overall Study|Lost to Follow-up|1|||
148694836|NCT02497781|536356083|FG001|Overall Study|Lost to Follow-up|1|||
148694837|NCT02236130|536356084|FG000|Overall Study|Lost to Follow-up|7|||
148694838|NCT02236130|536356085|FG001|Overall Study|Lost to Follow-up|12|||
148694839|NCT00525590|536356086|FG000|Overall Study|Adverse Event|3|||
148694840|NCT00525590|536356086|FG000|Overall Study|Physician Decision|3|||
148694841|NCT00525590|536356086|FG000|Overall Study|Withdrawal by Subject|16|||
148694842|NCT00525590|536356086|FG000|Overall Study|Lost to Follow-up|1|||
148694843|NCT00525590|536356086|FG000|Overall Study|Death|9|||
148694844|NCT00525590|536356086|FG000|Overall Study|Other|13|||
148694845|NCT00320112|536356087|FG000|Overall Study|Lost to Follow-up|3|||
148694846|NCT00320112|536356088|FG001|Overall Study|Lost to Follow-up|4|||
148694847|NCT00320112|536356087|FG000|Overall Study|Withdrawal by Subject|3|||
148694848|NCT00320112|536356088|FG001|Overall Study|Withdrawal by Subject|0|||
148694849|NCT00320112|536356087|FG000|Overall Study|Death|2|||
148694850|NCT00320112|536356088|FG001|Overall Study|Death|1|||
148694851|NCT02073643|536356089|FG000|Overall Study|Lost to Follow-up|24|||
148694852|NCT02468778|536356096|FG000|Overall Study|Death|2|||
148694853|NCT02468778|536356097|FG001|Overall Study|Death|1|||
148694854|NCT02468778|536356098|FG002|Overall Study|Death|0|||
148694855|NCT02468778|536356096|FG000|Overall Study|Lost to Follow-up|1|||
148694856|NCT02468778|536356097|FG001|Overall Study|Lost to Follow-up|2|||
148694857|NCT02468778|536356098|FG002|Overall Study|Lost to Follow-up|2|||
148694858|NCT02468778|536356096|FG000|Overall Study|Withdrawal by Subject|0|||
148694859|NCT02468778|536356097|FG001|Overall Study|Withdrawal by Subject|1|||
148694860|NCT02468778|536356098|FG002|Overall Study|Withdrawal by Subject|1|||
148694861|NCT00414765|536356099|FG000|Overall Study|Adverse Event|5|||
148694862|NCT00414765|536356100|FG001|Overall Study|Adverse Event|9|||
148694863|NCT00414765|536356099|FG000|Overall Study|Withdrawal by Subject|1|||
148694864|NCT00414765|536356100|FG001|Overall Study|Withdrawal by Subject|1|||
148694865|NCT00414765|536356099|FG000|Overall Study|Disease Progression|0|||
148694866|NCT00414765|536356100|FG001|Overall Study|Disease Progression|1|||
148694867|NCT05295953|536356102|FG000|Overall Study|Withdrawal by Subject|0|||
148694868|NCT05295953|536356103|FG001|Overall Study|Withdrawal by Subject|1|||
148694869|NCT01199861|536356105|FG000|Overall Study|Administrative problems|1|||
148694870|NCT01199861|536356106|FG001|Overall Study|Administrative problems|0|||
148694871|NCT01199861|536356105|FG000|Overall Study|Adverse Event|1|||
148694872|NCT01199861|536356106|FG001|Overall Study|Adverse Event|0|||
148694873|NCT04981912|536356107|FG000|Overall Study|Physician Decision|2|||
148694874|NCT00661505|536356108|FG000|Overall Study|Adverse Event|3|||
148694875|NCT00661505|536356108|FG000|Overall Study|Protocol Violation|14|||
148694876|NCT00661505|536356108|FG000|Overall Study|Withdrawal by Subject|8|||
148694877|NCT00661505|536356108|FG000|Overall Study|Lost to Follow-up|3|||
148962110|NCT01239368|537347094|FG009|Overall Study|Principal investigator discretion|1|||
148694878|NCT00661505|536356108|FG000|Overall Study|Other|2|||
148694879|NCT05630547|536356109|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
148694880|NCT05630547|536356110|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
148694881|NCT05630547|536356111|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
148694882|NCT05630547|536356112|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
148962111|NCT01239368|537347085|FG000|Overall Study|Disease progression on study|1|||
148694883|NCT05630547|536356109|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
148694884|NCT05630547|536356110|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
148694885|NCT05630547|536356111|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
148694886|NCT05630547|536356112|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
148694887|NCT05630547|536356109|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
148694888|NCT05630547|536356110|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
148694889|NCT05630547|536356111|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
148694890|NCT05630547|536356112|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
148694891|NCT05630547|536356109|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
148694892|NCT05630547|536356110|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
148694893|NCT05630547|536356111|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
148694894|NCT05630547|536356112|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
148694895|NCT05630547|536356109|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
148694896|NCT05630547|536356110|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
148694897|NCT05630547|536356111|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
148694898|NCT05630547|536356112|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
148694899|NCT05630547|536356109|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
148694900|NCT05630547|536356110|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
148694901|NCT05630547|536356111|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
148694902|NCT05630547|536356112|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
148694903|NCT05630547|536356109|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
148962112|NCT01239368|537347086|FG001|Overall Study|Disease progression on study|1|||
148962113|NCT01239368|537347087|FG002|Overall Study|Disease progression on study|1|||
148812802|NCT05248386|536789258|FG001|Overall Study|Adverse Event|4|||
148812803|NCT05248386|536789257|FG000|Overall Study|Other|1|||
148694904|NCT05630547|536356110|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
148694905|NCT05630547|536356111|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
148694906|NCT05630547|536356112|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
148694907|NCT05630547|536356109|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
148694908|NCT05630547|536356110|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
148694909|NCT05630547|536356111|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
148694910|NCT05630547|536356112|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
148694911|NCT05630547|536356109|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
148694912|NCT05630547|536356110|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
148694913|NCT05630547|536356111|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
148694914|NCT05630547|536356112|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
148694915|NCT05630547|536356109|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
148694916|NCT05630547|536356110|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
148694917|NCT05630547|536356111|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
148694918|NCT05630547|536356112|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
148694919|NCT00977470|536356113|FG000|Overall Study|Lack of Efficacy|32|||
148694920|NCT00977470|536356114|FG001|Overall Study|Lack of Efficacy|30|||
148694921|NCT00977470|536356113|FG000|Overall Study|Physician Decision|2|||
148694922|NCT00977470|536356114|FG001|Overall Study|Physician Decision|0|||
148694923|NCT00977470|536356113|FG000|Overall Study|Adverse Event|1|||
148694924|NCT00977470|536356114|FG001|Overall Study|Adverse Event|2|||
148694925|NCT00977470|536356113|FG000|Overall Study|Protocol Violation|1|||
148962114|NCT01239368|537347088|FG003|Overall Study|Disease progression on study|1|||
148962115|NCT01239368|537347089|FG004|Overall Study|Disease progression on study|4|||
148962116|NCT01239368|537347090|FG005|Overall Study|Disease progression on study|2|||
148962117|NCT01239368|537347091|FG006|Overall Study|Disease progression on study|5|||
148962118|NCT01239368|537347092|FG007|Overall Study|Disease progression on study|0|||
148962119|NCT01239368|537347093|FG008|Overall Study|Disease progression on study|0|||
148962120|NCT01239368|537347094|FG009|Overall Study|Disease progression on study|2|||
148962121|NCT01239368|537347085|FG000|Overall Study|Refused further treatment|0|||
148962122|NCT01239368|537347086|FG001|Overall Study|Refused further treatment|0|||
148962123|NCT01239368|537347087|FG002|Overall Study|Refused further treatment|0|||
148962124|NCT01239368|537347088|FG003|Overall Study|Refused further treatment|0|||
148962125|NCT01239368|537347089|FG004|Overall Study|Refused further treatment|0|||
148962126|NCT01239368|537347090|FG005|Overall Study|Refused further treatment|0|||
148962127|NCT01239368|537347091|FG006|Overall Study|Refused further treatment|0|||
148962128|NCT01239368|537347092|FG007|Overall Study|Refused further treatment|0|||
148962129|NCT01239368|537347093|FG008|Overall Study|Refused further treatment|0|||
148962130|NCT01239368|537347094|FG009|Overall Study|Refused further treatment|1|||
148962131|NCT01239368|537347085|FG000|Overall Study|Death|0|||
148962132|NCT01239368|537347086|FG001|Overall Study|Death|0|||
148962133|NCT01239368|537347087|FG002|Overall Study|Death|0|||
148962134|NCT01239368|537347088|FG003|Overall Study|Death|0|||
148962135|NCT01239368|537347089|FG004|Overall Study|Death|0|||
148962136|NCT01239368|537347090|FG005|Overall Study|Death|0|||
148962137|NCT01239368|537347091|FG006|Overall Study|Death|1|||
148962138|NCT01239368|537347092|FG007|Overall Study|Death|0|||
148962139|NCT01239368|537347093|FG008|Overall Study|Death|0|||
148962140|NCT01239368|537347094|FG009|Overall Study|Death|0|||
148962141|NCT04709575|537347095|FG000|Overall Study|Withdrawal by Subject|6|||
148962142|NCT04709575|537347096|FG001|Overall Study|Withdrawal by Subject|2|||
148962143|NCT04709575|537347095|FG000|Overall Study|Lost to Follow-up|2|||
148962144|NCT04709575|537347096|FG001|Overall Study|Lost to Follow-up|2|||
148962145|NCT04709575|537347095|FG000|Overall Study|Adverse Event|1|||
148962146|NCT04709575|537347096|FG001|Overall Study|Adverse Event|0|||
148962147|NCT04709575|537347095|FG000|Overall Study|Protocol Violation|1|||
148962148|NCT04709575|537347096|FG001|Overall Study|Protocol Violation|1|||
148962149|NCT03181399|537347098|FG000|6 Months on Treatment|Protocol non-compliance|7|||
148962150|NCT03181399|537347098|FG000|6 Months on Treatment|Adverse Event|4|||
148962151|NCT03181399|537347098|FG000|6 Months on Treatment|Tried alternative treatment|2|||
148962152|NCT03181399|537347098|FG000|6 Months on Treatment|Lost to Follow-up|2|||
148962153|NCT03181399|537347098|FG000|6 Months on Treatment|Personal reasons|1|||
148962154|NCT03181399|537347098|FG000|3 Months Off-treatment|Parent unable to travel|1|||
148962155|NCT01536379|537347099|FG000|Overall Study|Adverse Event|1|||
148962156|NCT01536379|537347100|FG001|Overall Study|Adverse Event|2|||
148962157|NCT01536379|537347099|FG000|Overall Study|Withdrawal by Subject|1|||
148962158|NCT01536379|537347100|FG001|Overall Study|Withdrawal by Subject|1|||
148962159|NCT04439253|537347106|FG000|Overall Study|Adverse Event|1|||
148962160|NCT04439253|537347106|FG000|Overall Study|Disease progression|2|||
148962161|NCT04439253|537347106|FG000|Overall Study|Complicating disease|1|||
148962162|NCT00939809|537347107|FG000|Overall Study|Adverse Event|2|||
148962163|NCT00939809|537347107|FG000|Overall Study|Death|1|||
148962164|NCT00702403|537347108|FG000|From Consent to Engraftment|Progressive leukemia|6|||
148962165|NCT00702403|537347108|FG000|From Consent to Engraftment|Critically ill|2|||
148962166|NCT00702403|537347108|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
148962167|NCT00702403|537347108|FG000|From Consent to Engraftment|Myocardial infarction|1|||
148962168|NCT00702403|537347108|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
148962169|NCT00702403|537347108|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
148962170|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
148962171|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
148962172|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Non-compliance|2|||
148962173|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
148962174|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
148962175|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Suicide|1|||
148962176|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
148962177|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
148962178|NCT00702403|537347108|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
148962179|NCT02155738|537347111|FG000|Overall Study|Missing critical information|1|||
148962180|NCT02155738|537347112|FG001|Overall Study|Missing critical information|0|||
148812804|NCT05248386|536789258|FG001|Overall Study|Other|0|||
148812805|NCT05248386|536789257|FG000|Overall Study|Lack of Efficacy|14|||
148812806|NCT05248386|536789258|FG001|Overall Study|Lack of Efficacy|12|||
148812807|NCT01802281|536789260|FG000|Overall Study|Death|1|||
148812808|NCT01802281|536789261|FG001|Overall Study|Death|2|||
148812809|NCT01802281|536789260|FG000|Overall Study|Withdrawal by Subject|2|||
148812810|NCT01802281|536789261|FG001|Overall Study|Withdrawal by Subject|1|||
148812811|NCT01802281|536789260|FG000|Overall Study|Ineligible|5|||
148812812|NCT01802281|536789261|FG001|Overall Study|Ineligible|3|||
148962181|NCT02155738|537347113|FG002|Overall Study|Missing critical information|0|||
148962182|NCT02155738|537347114|FG003|Overall Study|Missing critical information|1|||
148962183|NCT02016625|537347115|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
148962184|NCT02016625|537347116|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
148962185|NCT02016625|537347115|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
148962186|NCT02016625|537347116|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
148962187|NCT02016625|537347115|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
148694926|NCT00977470|536356114|FG001|Overall Study|Protocol Violation|0|||
148962188|NCT02016625|537347116|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
148694927|NCT00977470|536356113|FG000|Overall Study|Withdrawal by Subject|0|||
148962189|NCT02356783|537347118|FG000|Overall Study|Lost to Follow-up|1|||
148962190|NCT02356783|537347119|FG001|Overall Study|Lost to Follow-up|3|||
148962191|NCT02603809|537347120|FG000|Overall Study|Withdrawal by Subject|4|||
148962192|NCT02603809|537347121|FG001|Overall Study|Withdrawal by Subject|1|||
148962193|NCT02603809|537347122|FG002|Overall Study|Withdrawal by Subject|2|||
148962194|NCT02603809|537347123|FG003|Overall Study|Withdrawal by Subject|3|||
148962195|NCT02603809|537347124|FG004|Overall Study|Withdrawal by Subject|3|||
148962196|NCT02603809|537347125|FG005|Overall Study|Withdrawal by Subject|4|||
148694928|NCT00977470|536356114|FG001|Overall Study|Withdrawal by Subject|2|||
148962197|NCT02603809|537347120|FG000|Overall Study|Lost to Follow-up|2|||
148694929|NCT00977470|536356113|FG000|Overall Study|Death|0|||
148812813|NCT02685735|536789262|FG000|Overall Study|Surgery Cancelled|4|||
148812814|NCT02685735|536789263|FG001|Overall Study|Surgery Cancelled|9|||
148812815|NCT02685735|536789262|FG000|Overall Study|Adverse Event|10|||
148694930|NCT00977470|536356114|FG001|Overall Study|Death|2|||
148694931|NCT00977470|536356113|FG000|Overall Study|clinical decline|0|||
148694932|NCT00977470|536356114|FG001|Overall Study|clinical decline|1|||
148694933|NCT00977470|536356113|FG000|Overall Study|prolonged recovery post-surgery|0|||
148694934|NCT00977470|536356114|FG001|Overall Study|prolonged recovery post-surgery|1|||
148694935|NCT00977470|536356113|FG000|Overall Study|Still on-study|2|||
148694936|NCT00977470|536356114|FG001|Overall Study|Still on-study|0|||
148694937|NCT00796822|536356115|FG000|Overall Study|Lost to Follow-up|2|||
148694938|NCT00796822|536356116|FG001|Overall Study|Lost to Follow-up|0|||
148694939|NCT00796822|536356115|FG000|Overall Study|Adverse Event|1|||
148962198|NCT02603809|537347121|FG001|Overall Study|Lost to Follow-up|3|||
148962199|NCT02603809|537347122|FG002|Overall Study|Lost to Follow-up|1|||
148962200|NCT02603809|537347123|FG003|Overall Study|Lost to Follow-up|4|||
148962201|NCT02603809|537347124|FG004|Overall Study|Lost to Follow-up|2|||
148962202|NCT02603809|537347125|FG005|Overall Study|Lost to Follow-up|2|||
148962203|NCT02603809|537347120|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
148962204|NCT02603809|537347121|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
148694940|NCT00796822|536356116|FG001|Overall Study|Adverse Event|0|||
148962205|NCT02603809|537347122|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
148962206|NCT02603809|537347123|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
148962207|NCT02603809|537347124|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
148962208|NCT02603809|537347125|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
148962209|NCT02603809|537347120|FG000|Overall Study|Physician Decision|0|||
148962210|NCT02603809|537347121|FG001|Overall Study|Physician Decision|0|||
148962211|NCT02603809|537347122|FG002|Overall Study|Physician Decision|0|||
148962212|NCT02603809|537347123|FG003|Overall Study|Physician Decision|1|||
148962213|NCT02603809|537347124|FG004|Overall Study|Physician Decision|2|||
148962214|NCT02603809|537347125|FG005|Overall Study|Physician Decision|1|||
148962215|NCT02603809|537347120|FG000|Overall Study|Adverse Event|3|||
148962216|NCT02603809|537347121|FG001|Overall Study|Adverse Event|0|||
148962217|NCT02603809|537347122|FG002|Overall Study|Adverse Event|2|||
148962218|NCT02603809|537347123|FG003|Overall Study|Adverse Event|2|||
148962219|NCT02603809|537347124|FG004|Overall Study|Adverse Event|1|||
148962220|NCT02603809|537347125|FG005|Overall Study|Adverse Event|1|||
148962221|NCT02603809|537347120|FG000|Overall Study|Lack of Efficacy|0|||
148962222|NCT02603809|537347121|FG001|Overall Study|Lack of Efficacy|1|||
148962223|NCT02603809|537347122|FG002|Overall Study|Lack of Efficacy|0|||
148962224|NCT02603809|537347123|FG003|Overall Study|Lack of Efficacy|0|||
148962225|NCT02603809|537347124|FG004|Overall Study|Lack of Efficacy|0|||
148962226|NCT02603809|537347125|FG005|Overall Study|Lack of Efficacy|1|||
148962227|NCT05123222|537347127|FG000|Overall Study|Lost to Follow-up|2|||
148962228|NCT05123222|537347128|FG001|Overall Study|Lost to Follow-up|0|||
148962229|NCT05123222|537347129|FG002|Overall Study|Lost to Follow-up|0|||
148962230|NCT05123222|537347130|FG003|Overall Study|Lost to Follow-up|0|||
148962231|NCT05123222|537347127|FG000|Overall Study|Protocol Violation|0|||
148962232|NCT05123222|537347128|FG001|Overall Study|Protocol Violation|0|||
148962233|NCT05123222|537347129|FG002|Overall Study|Protocol Violation|1|||
148962234|NCT05123222|537347130|FG003|Overall Study|Protocol Violation|0|||
148962235|NCT00112502|537347131|FG000|Overall Study|Withdrawal by Subject|0|||
148962236|NCT00112502|537347132|FG001|Overall Study|Withdrawal by Subject|1|||
148962237|NCT00112502|537347133|FG002|Overall Study|Withdrawal by Subject|1|||
148962238|NCT00112502|537347134|FG003|Overall Study|Withdrawal by Subject|4|||
148962239|NCT00112502|537347135|FG004|Overall Study|Withdrawal by Subject|2|||
148962240|NCT00112502|537347136|FG005|Overall Study|Withdrawal by Subject|5|||
148962241|NCT00112502|537347137|FG006|Overall Study|Withdrawal by Subject|3|||
148962242|NCT00112502|537347138|FG007|Overall Study|Withdrawal by Subject|7|||
148962243|NCT05129488|537347139|FG000|Overall Study|Protocol Violation|3|||
148962244|NCT02608268|537347140|FG000|Overall Study|Adverse Event|0|||
148962245|NCT02608268|537347141|FG001|Overall Study|Adverse Event|0|||
148962246|NCT02608268|537347142|FG002|Overall Study|Adverse Event|1|||
148962247|NCT02608268|537347143|FG003|Overall Study|Adverse Event|0|||
148962248|NCT02608268|537347144|FG004|Overall Study|Adverse Event|0|||
148962249|NCT02608268|537347145|FG005|Overall Study|Adverse Event|0|||
148962250|NCT02608268|537347146|FG006|Overall Study|Adverse Event|0|||
148962251|NCT02608268|537347147|FG007|Overall Study|Adverse Event|0|||
148962252|NCT02608268|537347148|FG008|Overall Study|Adverse Event|0|||
148962253|NCT02608268|537347149|FG009|Overall Study|Adverse Event|0|||
148962254|NCT02608268|537347150|FG010|Overall Study|Adverse Event|0|||
148962255|NCT02608268|537347151|FG011|Overall Study|Adverse Event|0|||
148962256|NCT02608268|537347152|FG012|Overall Study|Adverse Event|2|||
148962257|NCT02608268|537347153|FG013|Overall Study|Adverse Event|0|||
148962258|NCT02608268|537347154|FG014|Overall Study|Adverse Event|0|||
148962259|NCT02608268|537347155|FG015|Overall Study|Adverse Event|0|||
148962260|NCT02608268|537347156|FG016|Overall Study|Adverse Event|0|||
148962261|NCT02608268|537347157|FG017|Overall Study|Adverse Event|0|||
148962262|NCT02608268|537347158|FG018|Overall Study|Adverse Event|0|||
148962263|NCT02608268|537347159|FG019|Overall Study|Adverse Event|0|||
148962264|NCT02608268|537347160|FG020|Overall Study|Adverse Event|1|||
148962265|NCT02608268|537347161|FG021|Overall Study|Adverse Event|1|||
148962266|NCT02608268|537347162|FG022|Overall Study|Adverse Event|0|||
148962267|NCT02608268|537347163|FG023|Overall Study|Adverse Event|0|||
148962268|NCT02608268|537347164|FG024|Overall Study|Adverse Event|1|||
148962269|NCT02608268|537347165|FG025|Overall Study|Adverse Event|0|||
148962270|NCT02608268|537347166|FG026|Overall Study|Adverse Event|0|||
148962271|NCT02608268|537347167|FG027|Overall Study|Adverse Event|0|||
148962272|NCT02608268|537347168|FG028|Overall Study|Adverse Event|1|||
148962273|NCT02608268|537347169|FG029|Overall Study|Adverse Event|0|||
148962274|NCT02608268|537347140|FG000|Overall Study|Death|1|||
148962275|NCT02608268|537347141|FG001|Overall Study|Death|0|||
148962276|NCT02608268|537347142|FG002|Overall Study|Death|0|||
148962277|NCT02608268|537347143|FG003|Overall Study|Death|0|||
148962278|NCT02608268|537347144|FG004|Overall Study|Death|0|||
148962279|NCT02608268|537347145|FG005|Overall Study|Death|0|||
148962280|NCT02608268|537347146|FG006|Overall Study|Death|0|||
148962281|NCT02608268|537347147|FG007|Overall Study|Death|0|||
148962282|NCT02608268|537347148|FG008|Overall Study|Death|1|||
148962283|NCT02608268|537347149|FG009|Overall Study|Death|1|||
148962284|NCT02608268|537347150|FG010|Overall Study|Death|0|||
148962285|NCT02608268|537347151|FG011|Overall Study|Death|0|||
148962286|NCT02608268|537347152|FG012|Overall Study|Death|0|||
148962287|NCT02608268|537347153|FG013|Overall Study|Death|0|||
148962288|NCT02608268|537347154|FG014|Overall Study|Death|0|||
148962289|NCT02608268|537347155|FG015|Overall Study|Death|1|||
148962290|NCT02608268|537347156|FG016|Overall Study|Death|0|||
148962291|NCT02608268|537347157|FG017|Overall Study|Death|1|||
148962292|NCT02608268|537347158|FG018|Overall Study|Death|0|||
148962293|NCT02608268|537347159|FG019|Overall Study|Death|1|||
148962294|NCT02608268|537347160|FG020|Overall Study|Death|1|||
148962295|NCT02608268|537347161|FG021|Overall Study|Death|0|||
148962296|NCT02608268|537347162|FG022|Overall Study|Death|0|||
148962297|NCT02608268|537347163|FG023|Overall Study|Death|0|||
148962298|NCT02608268|537347164|FG024|Overall Study|Death|1|||
148962299|NCT02608268|537347165|FG025|Overall Study|Death|2|||
148812816|NCT02685735|536789263|FG001|Overall Study|Adverse Event|3|||
148812817|NCT02685735|536789262|FG000|Overall Study|Preop testing found to be incomplete|2|||
148812818|NCT02685735|536789263|FG001|Overall Study|Preop testing found to be incomplete|2|||
148812819|NCT02685735|536789262|FG000|Overall Study|Withdrawal by Subject|1|||
148812820|NCT02685735|536789263|FG001|Overall Study|Withdrawal by Subject|2|||
148812821|NCT02685735|536789262|FG000|Overall Study|Death|1|||
148812822|NCT02685735|536789263|FG001|Overall Study|Death|0|||
148812823|NCT02401230|536789264|FG000|Overall Study|Adverse Event|3|||
148812824|NCT02401230|536789265|FG001|Overall Study|Adverse Event|2|||
148812825|NCT02401230|536789266|FG002|Overall Study|Adverse Event|0|||
148812826|NCT02401230|536789264|FG000|Overall Study|Withdrawal by Subject|2|||
148812827|NCT02401230|536789265|FG001|Overall Study|Withdrawal by Subject|1|||
148812828|NCT02401230|536789266|FG002|Overall Study|Withdrawal by Subject|1|||
148812829|NCT02401230|536789264|FG000|Overall Study|Lost to Follow-up|1|||
148812830|NCT02401230|536789265|FG001|Overall Study|Lost to Follow-up|3|||
148812831|NCT02401230|536789266|FG002|Overall Study|Lost to Follow-up|3|||
148812832|NCT04133909|536789272|FG000|Overall Study|Death|11|||
148812833|NCT04133909|536789273|FG001|Overall Study|Death|11|||
148812834|NCT04133909|536789272|FG000|Overall Study|Adverse Event|4|||
148812835|NCT04133909|536789273|FG001|Overall Study|Adverse Event|5|||
148812836|NCT04133909|536789272|FG000|Overall Study|Lost to Follow-up|3|||
148812837|NCT04133909|536789273|FG001|Overall Study|Lost to Follow-up|5|||
148962300|NCT02608268|537347166|FG026|Overall Study|Death|0|||
148962301|NCT02608268|537347167|FG027|Overall Study|Death|1|||
148694941|NCT02364557|536356117|FG000|Overall Study|Protocol Violation|3|||
148694942|NCT02364557|536356118|FG001|Overall Study|Protocol Violation|1|||
148694943|NCT03283709|536356128|FG000|Overall Study|trial terminated|0|||
148694944|NCT03283709|536356129|FG001|Overall Study|trial terminated|1|||
148694945|NCT00117949|536356130|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
148694946|NCT00117949|536356131|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
148694947|NCT00117949|536356132|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
148694948|NCT00117949|536356133|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
148694949|NCT00117949|536356130|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
148694950|NCT00117949|536356131|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
148962302|NCT02608268|537347168|FG028|Overall Study|Death|4|||
148962303|NCT02608268|537347169|FG029|Overall Study|Death|0|||
148962304|NCT02608268|537347140|FG000|Overall Study|Physician Decision|0|||
148694951|NCT00117949|536356132|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
148694952|NCT00117949|536356133|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
148812838|NCT04133909|536789272|FG000|Overall Study|Physician Decision|4|||
148812839|NCT04133909|536789273|FG001|Overall Study|Physician Decision|7|||
148812840|NCT04133909|536789272|FG000|Overall Study|Withdrawal by Subject|40|||
148812841|NCT04133909|536789273|FG001|Overall Study|Withdrawal by Subject|35|||
148694953|NCT00117949|536356130|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
148694954|NCT00117949|536356131|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
148694955|NCT00117949|536356132|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
148694956|NCT00117949|536356133|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
148694957|NCT00117949|536356130|FG000|Overall Study|PSA increase >=10ng/mL|0|||
148694958|NCT00117949|536356131|FG001|Overall Study|PSA increase >=10ng/mL|1|||
148694959|NCT00117949|536356132|FG002|Overall Study|PSA increase >=10ng/mL|1|||
148694960|NCT00117949|536356133|FG003|Overall Study|PSA increase >=10ng/mL|0|||
148694961|NCT00117949|536356130|FG000|Overall Study|PSA reduction <=50%|0|||
148694962|NCT00117949|536356131|FG001|Overall Study|PSA reduction <=50%|2|||
148694963|NCT00117949|536356132|FG002|Overall Study|PSA reduction <=50%|2|||
148694964|NCT00117949|536356133|FG003|Overall Study|PSA reduction <=50%|4|||
148694965|NCT00117949|536356130|FG000|Overall Study|Hepatic abnormalities|0|||
148694966|NCT00117949|536356131|FG001|Overall Study|Hepatic abnormalities|1|||
148694967|NCT00117949|536356132|FG002|Overall Study|Hepatic abnormalities|0|||
148694968|NCT00117949|536356133|FG003|Overall Study|Hepatic abnormalities|1|||
148694969|NCT05275998|536356134|FG000|Overall Study|Adverse Event|0|||
148694970|NCT05275998|536356135|FG001|Overall Study|Adverse Event|0|||
148694971|NCT05275998|536356136|FG002|Overall Study|Adverse Event|0|||
148694972|NCT05275998|536356137|FG003|Overall Study|Adverse Event|1|||
148694973|NCT05275998|536356134|FG000|Overall Study|Withdrawal by Subject|0|||
148694974|NCT05275998|536356135|FG001|Overall Study|Withdrawal by Subject|0|||
148694975|NCT05275998|536356136|FG002|Overall Study|Withdrawal by Subject|0|||
148694976|NCT05275998|536356137|FG003|Overall Study|Withdrawal by Subject|1|||
148694977|NCT05275998|536356134|FG000|Overall Study|Physician Decision|0|||
148694978|NCT05275998|536356135|FG001|Overall Study|Physician Decision|0|||
148694979|NCT05275998|536356136|FG002|Overall Study|Physician Decision|0|||
148694980|NCT05275998|536356137|FG003|Overall Study|Physician Decision|1|||
148694981|NCT05275998|536356134|FG000|Overall Study|Protocol Violation|0|||
148694982|NCT05275998|536356135|FG001|Overall Study|Protocol Violation|0|||
148694983|NCT05275998|536356136|FG002|Overall Study|Protocol Violation|1|||
148694984|NCT05275998|536356137|FG003|Overall Study|Protocol Violation|0|||
148694985|NCT01139164|536356140|FG000|Overall Study|Withdrawn prior to study start|0|||
148694986|NCT01139164|536356141|FG001|Overall Study|Withdrawn prior to study start|2|||
148694987|NCT01139164|536356142|FG002|Overall Study|Withdrawn prior to study start|0|||
148694988|NCT00406848|536356143|FG000|Overall Study|Withdrawal by Subject|27|||
148694989|NCT00406848|536356144|FG001|Overall Study|Withdrawal by Subject|22|||
148694990|NCT00406848|536356143|FG000|Overall Study|Adverse Event|38|||
148694991|NCT00406848|536356144|FG001|Overall Study|Adverse Event|7|||
148694992|NCT00406848|536356143|FG000|Overall Study|Lack of Efficacy|9|||
148694993|NCT00406848|536356144|FG001|Overall Study|Lack of Efficacy|14|||
148694994|NCT00406848|536356143|FG000|Overall Study|Protocol Violation|10|||
148694995|NCT00406848|536356144|FG001|Overall Study|Protocol Violation|6|||
148694996|NCT00406848|536356143|FG000|Overall Study|Lost to Follow-up|6|||
148694997|NCT00406848|536356144|FG001|Overall Study|Lost to Follow-up|2|||
148694998|NCT00406848|536356143|FG000|Overall Study|Physician Decision|2|||
148694999|NCT00406848|536356144|FG001|Overall Study|Physician Decision|2|||
148695000|NCT00406848|536356143|FG000|Overall Study|Sponsor Decision|1|||
148695001|NCT00406848|536356144|FG001|Overall Study|Sponsor Decision|1|||
148695002|NCT01355081|536356145|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
148695003|NCT01355081|536356146|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
148695004|NCT01355081|536356147|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
148695005|NCT01355081|536356145|FG000|Overall Study|Major Protocol Deviation|0|||
148695006|NCT01355081|536356146|FG001|Overall Study|Major Protocol Deviation|1|||
148695007|NCT01355081|536356147|FG002|Overall Study|Major Protocol Deviation|0|||
148812842|NCT04133909|536789272|FG000|Overall Study|Lack of Efficacy|2|||
148812843|NCT04133909|536789273|FG001|Overall Study|Lack of Efficacy|7|||
148695008|NCT01355081|536356145|FG000|Overall Study|Lost to Follow-up|0|||
148695009|NCT01355081|536356146|FG001|Overall Study|Lost to Follow-up|0|||
148695010|NCT01355081|536356147|FG002|Overall Study|Lost to Follow-up|1|||
148695011|NCT01355081|536356145|FG000|Overall Study|Withdrawal of Consent|2|||
148812844|NCT04133909|536789272|FG000|Overall Study|Randomized in error|1|||
148695012|NCT01355081|536356146|FG001|Overall Study|Withdrawal of Consent|3|||
148695013|NCT01355081|536356147|FG002|Overall Study|Withdrawal of Consent|3|||
148962305|NCT02608268|537347141|FG001|Overall Study|Physician Decision|0|||
148695014|NCT01355081|536356145|FG000|Overall Study|Lack of Efficacy|2|||
148695015|NCT01355081|536356146|FG001|Overall Study|Lack of Efficacy|1|||
148962306|NCT02608268|537347142|FG002|Overall Study|Physician Decision|0|||
148962307|NCT02608268|537347143|FG003|Overall Study|Physician Decision|0|||
148962308|NCT02608268|537347144|FG004|Overall Study|Physician Decision|0|||
148962309|NCT02608268|537347145|FG005|Overall Study|Physician Decision|0|||
148962310|NCT02608268|537347146|FG006|Overall Study|Physician Decision|0|||
148962311|NCT02608268|537347147|FG007|Overall Study|Physician Decision|0|||
148962312|NCT02608268|537347148|FG008|Overall Study|Physician Decision|0|||
148962313|NCT02608268|537347149|FG009|Overall Study|Physician Decision|0|||
148962314|NCT02608268|537347150|FG010|Overall Study|Physician Decision|1|||
148962315|NCT02608268|537347151|FG011|Overall Study|Physician Decision|0|||
148962316|NCT02608268|537347152|FG012|Overall Study|Physician Decision|0|||
148962317|NCT02608268|537347153|FG013|Overall Study|Physician Decision|1|||
148962318|NCT02608268|537347154|FG014|Overall Study|Physician Decision|0|||
148962319|NCT02608268|537347155|FG015|Overall Study|Physician Decision|0|||
148962320|NCT02608268|537347156|FG016|Overall Study|Physician Decision|0|||
148962321|NCT02608268|537347157|FG017|Overall Study|Physician Decision|0|||
148962322|NCT02608268|537347158|FG018|Overall Study|Physician Decision|0|||
148962323|NCT02608268|537347159|FG019|Overall Study|Physician Decision|0|||
148962324|NCT02608268|537347160|FG020|Overall Study|Physician Decision|0|||
148962325|NCT02608268|537347161|FG021|Overall Study|Physician Decision|0|||
148962326|NCT02608268|537347162|FG022|Overall Study|Physician Decision|1|||
148962327|NCT02608268|537347163|FG023|Overall Study|Physician Decision|1|||
148962328|NCT02608268|537347164|FG024|Overall Study|Physician Decision|1|||
148962329|NCT02608268|537347165|FG025|Overall Study|Physician Decision|0|||
148962330|NCT02608268|537347166|FG026|Overall Study|Physician Decision|0|||
148962331|NCT02608268|537347167|FG027|Overall Study|Physician Decision|2|||
148962332|NCT02608268|537347168|FG028|Overall Study|Physician Decision|1|||
148962333|NCT02608268|537347169|FG029|Overall Study|Physician Decision|1|||
148962334|NCT02608268|537347140|FG000|Overall Study|Progressive disease|12|||
148962335|NCT02608268|537347141|FG001|Overall Study|Progressive disease|8|||
148962336|NCT02608268|537347142|FG002|Overall Study|Progressive disease|13|||
148962337|NCT02608268|537347143|FG003|Overall Study|Progressive disease|5|||
148962338|NCT02608268|537347144|FG004|Overall Study|Progressive disease|2|||
148962339|NCT02608268|537347145|FG005|Overall Study|Progressive disease|4|||
148962340|NCT02608268|537347146|FG006|Overall Study|Progressive disease|6|||
148962341|NCT02608268|537347147|FG007|Overall Study|Progressive disease|2|||
148962342|NCT02608268|537347148|FG008|Overall Study|Progressive disease|5|||
148962343|NCT02608268|537347149|FG009|Overall Study|Progressive disease|6|||
148962344|NCT02608268|537347150|FG010|Overall Study|Progressive disease|5|||
148962345|NCT02608268|537347151|FG011|Overall Study|Progressive disease|5|||
148962346|NCT02608268|537347152|FG012|Overall Study|Progressive disease|4|||
148812845|NCT04133909|536789273|FG001|Overall Study|Randomized in error|1|||
148812846|NCT05020743|536789278|FG000|Overall Study|Enrollment in Interventional Study|2|||
148812847|NCT05020743|536789279|FG001|Overall Study|Enrollment in Interventional Study|9|||
148812848|NCT05020743|536789280|FG002|Overall Study|Enrollment in Interventional Study|0|||
148812849|NCT05020743|536789278|FG000|Overall Study|Withdrawal by Subject|0|||
148812850|NCT05020743|536789279|FG001|Overall Study|Withdrawal by Subject|3|||
148812851|NCT05020743|536789280|FG002|Overall Study|Withdrawal by Subject|1|||
148812852|NCT05020743|536789278|FG000|Overall Study|Lost to Follow-up|1|||
148812853|NCT05020743|536789279|FG001|Overall Study|Lost to Follow-up|0|||
148812854|NCT05020743|536789280|FG002|Overall Study|Lost to Follow-up|0|||
148812855|NCT05020743|536789278|FG000|Overall Study|Study Termination by Sponsor|10|||
148812856|NCT05020743|536789279|FG001|Overall Study|Study Termination by Sponsor|11|||
148812857|NCT05020743|536789280|FG002|Overall Study|Study Termination by Sponsor|10|||
148812858|NCT02390284|536789281|FG000|Overall Study|Physician Decision|0|||
148812859|NCT02390284|536789282|FG001|Overall Study|Physician Decision|0|||
148812860|NCT02390284|536789283|FG002|Overall Study|Physician Decision|9|||
148812861|NCT00724945|536789284|FG000|Period 1|non-compliance|1|||
148812862|NCT00724945|536789285|FG001|Period 1|non-compliance|0|||
148812863|NCT00724945|536789284|FG000|Period 1|Adverse Event|1|||
148812864|NCT00724945|536789285|FG001|Period 1|Adverse Event|1|||
148812865|NCT00724945|536789284|FG000|Period 1|Lost to Follow-up|1|||
148812866|NCT00724945|536789285|FG001|Period 1|Lost to Follow-up|0|||
148812867|NCT00724945|536789284|FG000|Period 2|lens comfort issue|3|||
148812868|NCT00724945|536789285|FG001|Period 2|lens comfort issue|0|||
148812869|NCT00724945|536789284|FG000|Period 2|lens physiology issue|1|||
148812870|NCT00724945|536789285|FG001|Period 2|lens physiology issue|0|||
148812871|NCT05166876|536789286|FG000|Overall Study|Withdrawal by Subject|1|||
148962347|NCT02608268|537347153|FG013|Overall Study|Progressive disease|11|||
148962348|NCT02608268|537347154|FG014|Overall Study|Progressive disease|6|||
148962349|NCT02608268|537347155|FG015|Overall Study|Progressive disease|3|||
148962350|NCT02608268|537347156|FG016|Overall Study|Progressive disease|5|||
148962351|NCT02608268|537347157|FG017|Overall Study|Progressive disease|5|||
148962352|NCT02608268|537347158|FG018|Overall Study|Progressive disease|5|||
148812872|NCT05166876|536789287|FG001|Overall Study|Withdrawal by Subject|0|||
148812873|NCT05166876|536789288|FG002|Overall Study|Withdrawal by Subject|0|||
148812874|NCT04409002|536789289|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
148812875|NCT02924376|536789290|FG000|Overall Study|Progressive Disease|4|||
148812876|NCT02924376|536789291|FG001|Overall Study|Progressive Disease|0|||
148812877|NCT02924376|536789292|FG002|Overall Study|Progressive Disease|1|||
148812878|NCT02924376|536789293|FG003|Overall Study|Progressive Disease|0|||
148962353|NCT02608268|537347159|FG019|Overall Study|Progressive disease|2|||
148812879|NCT02924376|536789290|FG000|Overall Study|Death|73|||
148812880|NCT02924376|536789291|FG001|Overall Study|Death|18|||
148812881|NCT02924376|536789292|FG002|Overall Study|Death|15|||
148695016|NCT01355081|536356147|FG002|Overall Study|Lack of Efficacy|1|||
148695017|NCT01355081|536356145|FG000|Overall Study|Non Compliance with Study Medication|0|||
148695018|NCT01355081|536356146|FG001|Overall Study|Non Compliance with Study Medication|1|||
148695019|NCT01355081|536356147|FG002|Overall Study|Non Compliance with Study Medication|0|||
148695020|NCT02719522|536356148|FG000|Overall Study|Implant Failure|4|||
148695021|NCT02719522|536356148|FG000|Overall Study|Death|2|||
148695022|NCT02719522|536356148|FG000|Overall Study|Lost to Follow-up|5|||
148695023|NCT03184441|536356149|FG000|Overall Study|Withdrawal by Subject|1|||
148695024|NCT00264810|536356150|FG000|Baseline|Withdrawal by Subject|10|||
148695025|NCT00264810|536356151|FG001|Baseline|Withdrawal by Subject|10|||
148695026|NCT00264810|536356150|FG000|Baseline|Physician Decision|7|||
148695027|NCT00264810|536356151|FG001|Baseline|Physician Decision|8|||
148695028|NCT00264810|536356150|FG000|Baseline|Subject Compliance Failure|3|||
148695029|NCT00264810|536356151|FG001|Baseline|Subject Compliance Failure|3|||
148695030|NCT00264810|536356150|FG000|Baseline|Insufficient Seizure Frequency|2|||
148962354|NCT02608268|537347160|FG020|Overall Study|Progressive disease|10|||
148695031|NCT00264810|536356151|FG001|Baseline|Insufficient Seizure Frequency|2|||
148962355|NCT02608268|537347161|FG021|Overall Study|Progressive disease|4|||
148962356|NCT02608268|537347162|FG022|Overall Study|Progressive disease|5|||
148962357|NCT02608268|537347163|FG023|Overall Study|Progressive disease|5|||
148695032|NCT00264810|536356150|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
148962358|NCT02608268|537347164|FG024|Overall Study|Progressive disease|3|||
148695033|NCT00264810|536356151|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
148695034|NCT00264810|536356150|FG000|Baseline|Other|0|||
148695035|NCT00264810|536356151|FG001|Baseline|Other|1|||
148695036|NCT00264810|536356150|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
148695037|NCT00264810|536356151|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
148695038|NCT00264810|536356150|FG000|Stimulation Optimization Period|Death|0|||
148695039|NCT00264810|536356151|FG001|Stimulation Optimization Period|Death|1|||
148695040|NCT00264810|536356150|FG000|Blinded Evaluation Period|Explant due to infection|1|||
148695041|NCT00264810|536356151|FG001|Blinded Evaluation Period|Explant due to infection|1|||
148695042|NCT00264810|536356150|FG000|Open Label Evaluation Period|Explant due to infection|1|||
148695043|NCT00264810|536356151|FG001|Open Label Evaluation Period|Explant due to infection|1|||
148695044|NCT00264810|536356150|FG000|Open Label Evaluation Period|Death|3|||
148695045|NCT00264810|536356151|FG001|Open Label Evaluation Period|Death|2|||
148695046|NCT00264810|536356150|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
148695047|NCT00264810|536356151|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
148695048|NCT00936390|536356153|FG000|Overall Study|Protocol Violation|21|||
148695049|NCT00936390|536356154|FG001|Overall Study|Protocol Violation|25|||
148695050|NCT00475020|536356155|FG000|Overall Study|Physician Decision|3|||
148695051|NCT00475020|536356155|FG000|Overall Study|Insurance Denial|1|||
148695052|NCT00475020|536356155|FG000|Overall Study|Donor not able to donate the last minute|1|||
148695053|NCT02456909|536356156|FG000|Overall Study|Did not receive allocated intervention|24|||
148695054|NCT02456909|536356157|FG001|Overall Study|Did not receive allocated intervention|26|||
148695055|NCT02456909|536356156|FG000|Overall Study|Did not complete the primary outcome|0|||
148695056|NCT02456909|536356157|FG001|Overall Study|Did not complete the primary outcome|1|||
148695057|NCT03309956|536356160|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
148695058|NCT02768298|536356161|FG000|Overall Study|Adverse Event|1|||
148695059|NCT02768298|536356162|FG001|Overall Study|Adverse Event|4|||
148695060|NCT02768298|536356161|FG000|Overall Study|Death|2|||
148695061|NCT02768298|536356162|FG001|Overall Study|Death|1|||
148695062|NCT02768298|536356161|FG000|Overall Study|Non-compliance with study treatment|0|||
148695063|NCT02768298|536356162|FG001|Overall Study|Non-compliance with study treatment|1|||
148695064|NCT02768298|536356161|FG000|Overall Study|Subject/guardian decision|1|||
148695065|NCT02768298|536356162|FG001|Overall Study|Subject/guardian decision|0|||
148695066|NCT02768298|536356161|FG000|Overall Study|Withdrawal of informed consent|0|||
148695067|NCT02768298|536356162|FG001|Overall Study|Withdrawal of informed consent|1|||
148695068|NCT01611090|536356163|FG000|Randomized Period|Lost to Follow-up|8|||
148695069|NCT01611090|536356164|FG001|Randomized Period|Lost to Follow-up|3|||
148695070|NCT01611090|536356165|FG002|Randomized Period|Lost to Follow-up|0|||
148695071|NCT01611090|536356163|FG000|Randomized Period|Withdrawal by Subject|22|||
148695072|NCT01611090|536356164|FG001|Randomized Period|Withdrawal by Subject|26|||
148695073|NCT01611090|536356165|FG002|Randomized Period|Withdrawal by Subject|0|||
148695074|NCT01611090|536356163|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
148695075|NCT01611090|536356164|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
148695076|NCT01611090|536356165|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
148695077|NCT01611090|536356163|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
148695078|NCT01611090|536356164|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
148695079|NCT01611090|536356165|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
148695080|NCT01922349|536356166|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
148695081|NCT01922349|536356167|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
148962359|NCT02608268|537347165|FG025|Overall Study|Progressive disease|11|||
148695082|NCT01922349|536356168|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
148695083|NCT01922349|536356169|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
148695084|NCT00922779|536356170|FG000|Overall Study|Adverse Event|67|||
148695085|NCT00922779|536356170|FG000|Overall Study|Pregnancy|7|||
148695086|NCT00922779|536356170|FG000|Overall Study|Withdrawal by Subject|308|||
148695087|NCT00922779|536356170|FG000|Overall Study|Lost to Follow-up|44|||
148695088|NCT00922779|536356170|FG000|Overall Study|Other|27|||
148695089|NCT00922779|536356170|FG000|Overall Study|Missing|1874|||
148812882|NCT02924376|536789293|FG003|Overall Study|Death|2|||
148812883|NCT02924376|536789290|FG000|Overall Study|Lost to Follow-up|3|||
148812884|NCT02924376|536789291|FG001|Overall Study|Lost to Follow-up|0|||
148812885|NCT02924376|536789292|FG002|Overall Study|Lost to Follow-up|0|||
148812886|NCT02924376|536789293|FG003|Overall Study|Lost to Follow-up|0|||
148812887|NCT02924376|536789290|FG000|Overall Study|Study Terminated by Sponsor|19|||
148812888|NCT02924376|536789291|FG001|Overall Study|Study Terminated by Sponsor|0|||
148812889|NCT02924376|536789292|FG002|Overall Study|Study Terminated by Sponsor|0|||
148812890|NCT02924376|536789293|FG003|Overall Study|Study Terminated by Sponsor|0|||
148812891|NCT02924376|536789290|FG000|Overall Study|Physician Decision|1|||
148812892|NCT02924376|536789291|FG001|Overall Study|Physician Decision|0|||
148812893|NCT02924376|536789292|FG002|Overall Study|Physician Decision|0|||
148812894|NCT02924376|536789293|FG003|Overall Study|Physician Decision|0|||
148812895|NCT02924376|536789290|FG000|Overall Study|Withdrawal by Subject|7|||
148812896|NCT02924376|536789291|FG001|Overall Study|Withdrawal by Subject|2|||
148812897|NCT02924376|536789292|FG002|Overall Study|Withdrawal by Subject|1|||
148812898|NCT02924376|536789293|FG003|Overall Study|Withdrawal by Subject|0|||
148812899|NCT02924376|536789290|FG000|Overall Study|Rolled Over to Another Study|1|||
148812900|NCT02924376|536789291|FG001|Overall Study|Rolled Over to Another Study|0|||
148812901|NCT02924376|536789292|FG002|Overall Study|Rolled Over to Another Study|0|||
148812902|NCT02924376|536789293|FG003|Overall Study|Rolled Over to Another Study|0|||
148812903|NCT01787838|536790486|FG000|Overall Study|refused|1413|||
148812904|NCT01582451|536790491|FG000|Overall Study|Adverse Event|1|||
148812905|NCT01582451|536790492|FG001|Overall Study|Adverse Event|3|||
148812906|NCT01582451|536790491|FG000|Overall Study|Death|3|||
148812907|NCT01582451|536790492|FG001|Overall Study|Death|3|||
148812908|NCT01582451|536790491|FG000|Overall Study|Lost to Follow-up|0|||
148812909|NCT01582451|536790492|FG001|Overall Study|Lost to Follow-up|2|||
148812910|NCT01582451|536790491|FG000|Overall Study|Protocol Violation|11|||
148812911|NCT01582451|536790492|FG001|Overall Study|Protocol Violation|3|||
148812912|NCT01582451|536790491|FG000|Overall Study|Withdrawal by Subject|13|||
148812913|NCT01582451|536790492|FG001|Overall Study|Withdrawal by Subject|9|||
148812914|NCT01582451|536790491|FG000|Overall Study|Physician Decision|3|||
148812915|NCT01582451|536790492|FG001|Overall Study|Physician Decision|0|||
148695090|NCT01210001|536357543|FG000|Overall Study|Not treated|1|||
148695091|NCT01210001|536357544|FG001|Overall Study|Not treated|0|||
148695092|NCT01210001|536357545|FG002|Overall Study|Not treated|0|||
148695093|NCT01210001|536357543|FG000|Overall Study|Adverse Event|4|||
148695094|NCT01210001|536357544|FG001|Overall Study|Adverse Event|2|||
148695095|NCT01210001|536357545|FG002|Overall Study|Adverse Event|5|||
148695096|NCT01210001|536357543|FG000|Overall Study|Non compliant with protocol|2|||
148695097|NCT01210001|536357544|FG001|Overall Study|Non compliant with protocol|2|||
148695098|NCT01210001|536357545|FG002|Overall Study|Non compliant with protocol|3|||
148695099|NCT01210001|536357543|FG000|Overall Study|Lost to Follow-up|4|||
148695100|NCT01210001|536357544|FG001|Overall Study|Lost to Follow-up|3|||
148695101|NCT01210001|536357545|FG002|Overall Study|Lost to Follow-up|2|||
148695102|NCT01210001|536357543|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
148695103|NCT01210001|536357544|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
148695104|NCT01210001|536357545|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
148695105|NCT01210001|536357543|FG000|Overall Study|Other reason not defined above|2|||
148695106|NCT01210001|536357544|FG001|Overall Study|Other reason not defined above|2|||
148695107|NCT01210001|536357545|FG002|Overall Study|Other reason not defined above|1|||
148695108|NCT00788125|536357546|FG000|Overall Study|Death|6|||
148695109|NCT02180711|536357553|FG000|Overall Study|Death|0|||
148695110|NCT02180711|536357554|FG001|Overall Study|Death|1|||
148695111|NCT02180711|536357555|FG002|Overall Study|Death|0|||
148695112|NCT02180711|536357556|FG003|Overall Study|Death|0|||
148695113|NCT02180711|536357557|FG004|Overall Study|Death|7|||
148695114|NCT02180711|536357558|FG005|Overall Study|Death|0|||
148695115|NCT02180711|536357559|FG006|Overall Study|Death|1|||
148695116|NCT02180711|536357560|FG007|Overall Study|Death|3|||
148695117|NCT02180711|536357553|FG000|Overall Study|Lost to Follow-up|0|||
148695118|NCT02180711|536357554|FG001|Overall Study|Lost to Follow-up|1|||
148695119|NCT02180711|536357555|FG002|Overall Study|Lost to Follow-up|0|||
148695120|NCT02180711|536357556|FG003|Overall Study|Lost to Follow-up|0|||
148695121|NCT02180711|536357557|FG004|Overall Study|Lost to Follow-up|1|||
148695122|NCT02180711|536357558|FG005|Overall Study|Lost to Follow-up|1|||
148695123|NCT02180711|536357559|FG006|Overall Study|Lost to Follow-up|0|||
148695124|NCT02180711|536357560|FG007|Overall Study|Lost to Follow-up|3|||
148695125|NCT02180711|536357553|FG000|Overall Study|Withdrawal by Subject|2|||
148695126|NCT02180711|536357554|FG001|Overall Study|Withdrawal by Subject|1|||
148695127|NCT02180711|536357555|FG002|Overall Study|Withdrawal by Subject|0|||
148695128|NCT02180711|536357556|FG003|Overall Study|Withdrawal by Subject|4|||
148695129|NCT02180711|536357557|FG004|Overall Study|Withdrawal by Subject|3|||
148695130|NCT02180711|536357558|FG005|Overall Study|Withdrawal by Subject|0|||
148695131|NCT02180711|536357559|FG006|Overall Study|Withdrawal by Subject|3|||
148695132|NCT02180711|536357560|FG007|Overall Study|Withdrawal by Subject|2|||
148695133|NCT02180711|536357553|FG000|Overall Study|- Disease Progression|0|||
148695134|NCT02180711|536357554|FG001|Overall Study|- Disease Progression|1|||
148695135|NCT02180711|536357555|FG002|Overall Study|- Disease Progression|0|||
148695136|NCT02180711|536357556|FG003|Overall Study|- Disease Progression|0|||
148695137|NCT02180711|536357557|FG004|Overall Study|- Disease Progression|0|||
148695138|NCT02180711|536357558|FG005|Overall Study|- Disease Progression|0|||
148695139|NCT02180711|536357559|FG006|Overall Study|- Disease Progression|0|||
148695140|NCT02180711|536357560|FG007|Overall Study|- Disease Progression|0|||
148695141|NCT02180711|536357553|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
148695142|NCT02180711|536357554|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
148695143|NCT02180711|536357555|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
148695144|NCT02180711|536357556|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
148695145|NCT02180711|536357557|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
148695146|NCT02180711|536357558|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
148695147|NCT02180711|536357559|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
148695148|NCT02180711|536357560|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
148695149|NCT02180711|536357553|FG000|Overall Study|- Study Terminated by Sponsor|2|||
148962360|NCT02608268|537347166|FG026|Overall Study|Progressive disease|16|||
148962361|NCT02608268|537347167|FG027|Overall Study|Progressive disease|11|||
148962362|NCT02608268|537347168|FG028|Overall Study|Progressive disease|10|||
148962363|NCT02608268|537347169|FG029|Overall Study|Progressive disease|15|||
148962364|NCT02608268|537347140|FG000|Overall Study|Subject/guardian decision|1|||
148962365|NCT02608268|537347141|FG001|Overall Study|Subject/guardian decision|1|||
148962366|NCT02608268|537347142|FG002|Overall Study|Subject/guardian decision|2|||
148962367|NCT02608268|537347143|FG003|Overall Study|Subject/guardian decision|0|||
148962368|NCT02608268|537347144|FG004|Overall Study|Subject/guardian decision|0|||
148962369|NCT02608268|537347145|FG005|Overall Study|Subject/guardian decision|0|||
148962370|NCT02608268|537347146|FG006|Overall Study|Subject/guardian decision|0|||
148962371|NCT02608268|537347147|FG007|Overall Study|Subject/guardian decision|0|||
148962372|NCT02608268|537347148|FG008|Overall Study|Subject/guardian decision|2|||
148962373|NCT02608268|537347149|FG009|Overall Study|Subject/guardian decision|2|||
148962374|NCT02608268|537347150|FG010|Overall Study|Subject/guardian decision|0|||
148962375|NCT02608268|537347151|FG011|Overall Study|Subject/guardian decision|1|||
148962376|NCT02608268|537347152|FG012|Overall Study|Subject/guardian decision|0|||
148962377|NCT02608268|537347153|FG013|Overall Study|Subject/guardian decision|1|||
148962378|NCT02608268|537347154|FG014|Overall Study|Subject/guardian decision|0|||
148962379|NCT02608268|537347155|FG015|Overall Study|Subject/guardian decision|1|||
148962380|NCT02608268|537347156|FG016|Overall Study|Subject/guardian decision|0|||
148695150|NCT02180711|536357554|FG001|Overall Study|- Study Terminated by Sponsor|3|||
148695151|NCT02180711|536357555|FG002|Overall Study|- Study Terminated by Sponsor|0|||
148695152|NCT02180711|536357556|FG003|Overall Study|- Study Terminated by Sponsor|5|||
148695153|NCT02180711|536357557|FG004|Overall Study|- Study Terminated by Sponsor|32|||
148695154|NCT02180711|536357558|FG005|Overall Study|- Study Terminated by Sponsor|0|||
148695155|NCT02180711|536357559|FG006|Overall Study|- Study Terminated by Sponsor|4|||
148695156|NCT02180711|536357560|FG007|Overall Study|- Study Terminated by Sponsor|13|||
148812916|NCT01582451|536790491|FG000|Overall Study|Sponsor Decision|1|||
148695157|NCT02180711|536357553|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
148695158|NCT02180711|536357554|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
148695159|NCT02180711|536357555|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
148695160|NCT02180711|536357556|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
148695161|NCT02180711|536357557|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
148695162|NCT02180711|536357558|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
148695163|NCT02180711|536357559|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
148695164|NCT02180711|536357560|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
148695165|NCT02180711|536357553|FG000|Overall Study|- Other|1|||
148962381|NCT02608268|537347157|FG017|Overall Study|Subject/guardian decision|0|||
148962382|NCT02608268|537347158|FG018|Overall Study|Subject/guardian decision|1|||
148962383|NCT02608268|537347159|FG019|Overall Study|Subject/guardian decision|0|||
148962384|NCT02608268|537347160|FG020|Overall Study|Subject/guardian decision|0|||
148962385|NCT02608268|537347161|FG021|Overall Study|Subject/guardian decision|0|||
148962386|NCT02608268|537347162|FG022|Overall Study|Subject/guardian decision|1|||
148962387|NCT02608268|537347163|FG023|Overall Study|Subject/guardian decision|0|||
148962388|NCT02608268|537347164|FG024|Overall Study|Subject/guardian decision|0|||
148962389|NCT02608268|537347165|FG025|Overall Study|Subject/guardian decision|1|||
148695166|NCT02180711|536357554|FG001|Overall Study|- Other|0|||
148695167|NCT02180711|536357555|FG002|Overall Study|- Other|0|||
148695168|NCT02180711|536357556|FG003|Overall Study|- Other|1|||
148962390|NCT02608268|537347166|FG026|Overall Study|Subject/guardian decision|1|||
148962391|NCT02608268|537347167|FG027|Overall Study|Subject/guardian decision|1|||
148962392|NCT02608268|537347168|FG028|Overall Study|Subject/guardian decision|1|||
148962393|NCT02608268|537347169|FG029|Overall Study|Subject/guardian decision|0|||
148962394|NCT00265343|537347170|FG000|Overall Study|Adverse Event|10|||
148962395|NCT00265343|537347171|FG001|Overall Study|Adverse Event|7|||
148962396|NCT00265343|537347170|FG000|Overall Study|Withdrawal by Subject|3|||
148962397|NCT00265343|537347171|FG001|Overall Study|Withdrawal by Subject|9|||
148962398|NCT00265343|537347170|FG000|Overall Study|Other|8|||
148695169|NCT02180711|536357557|FG004|Overall Study|- Other|0|||
148695170|NCT02180711|536357558|FG005|Overall Study|- Other|0|||
148695171|NCT02180711|536357559|FG006|Overall Study|- Other|0|||
148695172|NCT02180711|536357560|FG007|Overall Study|- Other|0|||
148695173|NCT00444145|536357564|FG000|Overall Study|Withdrawal by Subject|2|||
148695174|NCT00444145|536357564|FG000|Overall Study|Lost to Follow-up|1|||
148695175|NCT00444145|536357564|FG000|Overall Study|non-compliant|11|||
148695176|NCT00444145|536357564|FG000|Overall Study|Screen Failures|5|||
148695177|NCT03805438|536357565|FG000|Overall Study|Lack of Efficacy|1|||
148695178|NCT03805438|536357565|FG000|Overall Study|Protocol Violation|1|||
148695179|NCT01374919|536357566|FG000|Overall Study|Withdrawal by Subject|2|||
148962399|NCT00265343|537347171|FG001|Overall Study|Other|3|||
148962400|NCT00706641|537347177|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
148695180|NCT00366899|536357567|FG000|Infant Series|Withdrawal by Subject|4|||
148695181|NCT00366899|536357568|FG001|Infant Series|Withdrawal by Subject|7|||
148695182|NCT00366899|536357567|FG000|Infant Series|Protocol Violation|2|||
148962401|NCT00706641|537347177|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
148962402|NCT00706641|537347177|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
148695183|NCT00366899|536357568|FG001|Infant Series|Protocol Violation|1|||
148695184|NCT00366899|536357567|FG000|Infant Series|Failed to return|1|||
148695185|NCT00366899|536357568|FG001|Infant Series|Failed to return|1|||
148695186|NCT00366899|536357567|FG000|Infant Series|Lost to Follow-up|0|||
148695187|NCT00366899|536357568|FG001|Infant Series|Lost to Follow-up|2|||
148695188|NCT00366899|536357567|FG000|Infant Series|Adverse Event|0|||
148695189|NCT00366899|536357568|FG001|Infant Series|Adverse Event|1|||
148695190|NCT00366899|536357567|FG000|Infant Series|Physician Decision|1|||
148962403|NCT04782856|537347180|FG000|Overall Study|Withdrawal by Subject|0|||
148962404|NCT04782856|537347181|FG001|Overall Study|Withdrawal by Subject|1|||
148962405|NCT00798369|537347182|FG000|Overall Study|Subject withdrew consent|0|||
148962406|NCT00798369|537347183|FG001|Overall Study|Subject withdrew consent|0|||
148962407|NCT00798369|537347184|FG002|Overall Study|Subject withdrew consent|1|||
148962408|NCT00798369|537347185|FG003|Overall Study|Subject withdrew consent|1|||
148962409|NCT00798369|537347186|FG004|Overall Study|Subject withdrew consent|0|||
148962410|NCT00798369|537347187|FG005|Overall Study|Subject withdrew consent|2|||
148962411|NCT00798369|537347182|FG000|Overall Study|Lost to Follow-up|1|||
148962412|NCT00798369|537347183|FG001|Overall Study|Lost to Follow-up|1|||
148962413|NCT00798369|537347184|FG002|Overall Study|Lost to Follow-up|1|||
148962414|NCT00798369|537347185|FG003|Overall Study|Lost to Follow-up|0|||
148962415|NCT00798369|537347186|FG004|Overall Study|Lost to Follow-up|1|||
148962416|NCT00798369|537347187|FG005|Overall Study|Lost to Follow-up|0|||
148962417|NCT00798369|537347182|FG000|Overall Study|Adminstrative problems|0|||
148962418|NCT00798369|537347183|FG001|Overall Study|Adminstrative problems|0|||
148962419|NCT00798369|537347184|FG002|Overall Study|Adminstrative problems|0|||
148962420|NCT00798369|537347185|FG003|Overall Study|Adminstrative problems|0|||
148962421|NCT00798369|537347186|FG004|Overall Study|Adminstrative problems|0|||
148962422|NCT00798369|537347187|FG005|Overall Study|Adminstrative problems|1|||
148962423|NCT00588822|537347188|FG000|Overall Study|progression of disease|8|||
148962424|NCT00099437|537347189|FG000|Overall Study|Lost to Follow-up|30|||
148962425|NCT00099437|537347190|FG001|Overall Study|Lost to Follow-up|33|||
148962426|NCT00099437|537347189|FG000|Overall Study|Death|293|||
148962427|NCT00099437|537347190|FG001|Overall Study|Death|261|||
148962428|NCT00099437|537347189|FG000|Overall Study|Withdrawal by Subject|6|||
148962429|NCT00099437|537347190|FG001|Overall Study|Withdrawal by Subject|10|||
148962430|NCT00099437|537347189|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
148962431|NCT00099437|537347190|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
148962432|NCT02410954|537347191|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
148962433|NCT02410954|537347192|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
148962434|NCT02410954|537347191|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
148962435|NCT02410954|537347192|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
148962436|NCT02738333|537347193|FG000|Overall Study|Death|1|||
148962437|NCT02738333|537347194|FG001|Overall Study|Death|0|||
148962438|NCT02738333|537347195|FG002|Overall Study|Death|0|||
148962439|NCT02738333|537347193|FG000|Overall Study|Lost to Follow-up|1|||
148962440|NCT02738333|537347194|FG001|Overall Study|Lost to Follow-up|0|||
148962441|NCT02738333|537347195|FG002|Overall Study|Lost to Follow-up|0|||
148962442|NCT05413369|537347196|FG000|Overall Study|Adverse Event|1|||
148962443|NCT05413369|537347197|FG001|Overall Study|Adverse Event|1|||
148962444|NCT05413369|537347196|FG000|Overall Study|Withdrawal by Subject|13|||
148962445|NCT05413369|537347197|FG001|Overall Study|Withdrawal by Subject|4|||
148962446|NCT05413369|537347196|FG000|Overall Study|Non-compliance with study schedule|2|||
148962447|NCT05413369|537347197|FG001|Overall Study|Non-compliance with study schedule|1|||
148962448|NCT05413369|537347196|FG000|Overall Study|Other|1|||
148962449|NCT05413369|537347197|FG001|Overall Study|Other|1|||
148962450|NCT02809677|537347198|FG000|Overall Study|Withdrawal by Subject|8|||
148962451|NCT01679002|537347203|FG000|Overall Study|Adverse Event|1|||
148962452|NCT01679002|537347204|FG001|Overall Study|Adverse Event|1|||
148962453|NCT01679002|537347205|FG002|Overall Study|Adverse Event|0|||
148962454|NCT05172544|537347206|FG000|Overall Study|Withdrawal by Subject|1|||
148962455|NCT05172544|537347207|FG001|Overall Study|Withdrawal by Subject|0|||
148962456|NCT05172544|537347208|FG002|Overall Study|Withdrawal by Subject|0|||
148962457|NCT05172544|537347206|FG000|Overall Study|Physician Decision|0|||
148962458|NCT05172544|537347207|FG001|Overall Study|Physician Decision|0|||
148962459|NCT05172544|537347208|FG002|Overall Study|Physician Decision|1|||
148962460|NCT05517382|537347209|FG000|Overall Study|Lost to Follow-up|0|||
148962461|NCT05517382|537347210|FG001|Overall Study|Lost to Follow-up|1|||
148962462|NCT01374087|537347218|FG000|Overall Study|Adverse Event|1|||
148962463|NCT01374087|537347219|FG001|Overall Study|Adverse Event|0|||
148962464|NCT01374087|537347218|FG000|Overall Study|Disease progression|2|||
148962465|NCT01374087|537347219|FG001|Overall Study|Disease progression|2|||
148962466|NCT01374087|537347218|FG000|Overall Study|Study discontinued|13|||
148695191|NCT00366899|536357568|FG001|Infant Series|Physician Decision|0|||
148962467|NCT01374087|537347219|FG001|Overall Study|Study discontinued|13|||
148962468|NCT00271947|537347222|FG000|Overall Study|Lost to Follow-up|1|||
148962469|NCT01522365|537347225|FG000|Overall Study|Withdrawal by Subject|1|||
148962470|NCT01522365|537347226|FG001|Overall Study|Withdrawal by Subject|1|||
148962471|NCT01522365|537347225|FG000|Overall Study|Lost to Follow-up|1|||
148962472|NCT01522365|537347226|FG001|Overall Study|Lost to Follow-up|1|||
148962473|NCT00651755|537347227|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
148962474|NCT00651755|537347228|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
148962475|NCT00651755|537347227|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
148962476|NCT00651755|537347228|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
148962477|NCT04170348|537347229|FG000|Overall Study|Lost to Follow-up|2|||
148962478|NCT04170348|537347230|FG001|Overall Study|Lost to Follow-up|2|||
148695192|NCT00366899|536357567|FG000|Infant Series|Randomized but not consented|1|||
148695193|NCT00366899|536357568|FG001|Infant Series|Randomized but not consented|0|||
148695194|NCT00366899|536357567|FG000|After Infant Series|Lost to Follow-up|4|||
148695195|NCT00366899|536357568|FG001|After Infant Series|Lost to Follow-up|3|||
148695196|NCT00366899|536357567|FG000|After Infant Series|Withdrawal by Subject|1|||
148695197|NCT00366899|536357568|FG001|After Infant Series|Withdrawal by Subject|4|||
148962479|NCT04170348|537347229|FG000|Overall Study|Withdrawal by Subject|1|||
148962480|NCT04170348|537347230|FG001|Overall Study|Withdrawal by Subject|5|||
148962481|NCT04170348|537347229|FG000|Overall Study|Non-adherence|1|||
148962482|NCT04170348|537347230|FG001|Overall Study|Non-adherence|1|||
148962483|NCT04170348|537347229|FG000|Overall Study|Adverse Event|1|||
148962484|NCT04170348|537347230|FG001|Overall Study|Adverse Event|0|||
148962485|NCT01120756|537347231|FG000|Overall Study|Withdrawal by Subject|1|||
148962486|NCT01120756|537347232|FG001|Overall Study|Withdrawal by Subject|1|||
148962487|NCT01464346|537347238|FG000|Overall Study|Withdrawal by Subject|0|||
148962488|NCT01464346|537347239|FG001|Overall Study|Withdrawal by Subject|0|||
148962489|NCT01464346|537347240|FG002|Overall Study|Withdrawal by Subject|1|||
148962490|NCT02005250|537347241|FG000|Overall Study|Lost to Follow-up|15|||
148962491|NCT02005250|537347242|FG001|Overall Study|Lost to Follow-up|5|||
148962492|NCT04007094|537347243|FG000|Overall Study|Lost to Follow-up|1|||
148962493|NCT04007094|537347244|FG001|Overall Study|Lost to Follow-up|1|||
148962494|NCT04350788|537347250|FG000|Overall Study|Lost to Follow-up|6|||
148962495|NCT04350788|537347251|FG001|Overall Study|Lost to Follow-up|2|||
148962496|NCT04350788|537347250|FG000|Overall Study|Withdrawal by Subject|2|||
148962497|NCT04350788|537347251|FG001|Overall Study|Withdrawal by Subject|4|||
148962498|NCT04350788|537347250|FG000|Overall Study|Protocol Violation|4|||
148962499|NCT04350788|537347251|FG001|Overall Study|Protocol Violation|0|||
148695198|NCT00366899|536357567|FG000|After Infant Series|Adverse Event|1|||
148962500|NCT01581307|537347252|FG000|Overall Study|Withdrawal by Subject|1|||
148962501|NCT00378209|537347255|FG000|Overall Study|Progressive disease|11|||
148962502|NCT00378209|537347255|FG000|Overall Study|Adverse Event|3|||
148962503|NCT00378209|537347255|FG000|Overall Study|Initiation of non-protocol therapy|3|||
148962504|NCT00378209|537347255|FG000|Overall Study|Physician Decision|3|||
148962505|NCT00378209|537347255|FG000|Overall Study|Death|1|||
148962506|NCT00378209|537347255|FG000|Overall Study|Treatment delay|1|||
148962507|NCT01894581|537347258|FG000|Overall Study|Withdrawal by Subject|2|||
148962508|NCT01894581|537347259|FG001|Overall Study|Withdrawal by Subject|3|||
148962509|NCT01894581|537347258|FG000|Overall Study|Screen Failure|3|||
148962510|NCT01894581|537347259|FG001|Overall Study|Screen Failure|4|||
148962511|NCT05478252|537347260|FG000|Overall Study|Withdrawal by Subject|2|||
148812917|NCT01582451|536790492|FG001|Overall Study|Sponsor Decision|0|||
148812918|NCT01838876|536790493|FG000|Overall Study|Adverse Event|49|||
148812919|NCT01838876|536790493|FG000|Overall Study|Insufficient Therapeutic Response|10|||
148812920|NCT01838876|536790493|FG000|Overall Study|Protocol Violation|34|||
148812921|NCT01838876|536790493|FG000|Overall Study|Withdrawal of Consent|33|||
148812922|NCT01838876|536790493|FG000|Overall Study|Lost to Follow-up|21|||
148812923|NCT01838876|536790493|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
148812924|NCT01838876|536790493|FG000|Overall Study|Reason not Specified|7|||
148812925|NCT01838876|536790493|FG000|Overall Study|Did not meet eligibility criteria|78|||
148812926|NCT00933933|536790494|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
148812927|NCT00933933|536790495|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
148812928|NCT00933933|536790496|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
148812929|NCT00933933|536790494|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
148812930|NCT00933933|536790495|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
148812931|NCT00933933|536790496|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
148812932|NCT01341470|536790497|FG000|Overall Study|Sponsor decision|0|||
148812933|NCT01341470|536790498|FG001|Overall Study|Sponsor decision|0|||
148812934|NCT01341470|536790499|FG002|Overall Study|Sponsor decision|1|||
148812935|NCT01341470|536790500|FG003|Overall Study|Sponsor decision|1|||
148812936|NCT01341470|536790501|FG004|Overall Study|Sponsor decision|0|||
148812937|NCT01341470|536790502|FG005|Overall Study|Sponsor decision|1|||
148812938|NCT03112603|536790508|FG000|End of Randomization Period|Lost to Follow-up|3|||
148812939|NCT03112603|536790509|FG001|End of Randomization Period|Lost to Follow-up|0|||
148812940|NCT03112603|536790510|FG002|End of Randomization Period|Lost to Follow-up|0|||
148812941|NCT03112603|536790508|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
148812942|NCT03112603|536790509|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
148812943|NCT03112603|536790510|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
148812944|NCT03112603|536790508|FG000|End of Randomization Period|Physician Decision|43|||
148812945|NCT03112603|536790509|FG001|End of Randomization Period|Physician Decision|18|||
148812946|NCT03112603|536790510|FG002|End of Randomization Period|Physician Decision|0|||
148812947|NCT03112603|536790508|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
148812948|NCT03112603|536790509|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
148812949|NCT03112603|536790510|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
148812950|NCT03112603|536790508|FG000|End of Randomization Period|Death|10|||
148812951|NCT03112603|536790509|FG001|End of Randomization Period|Death|7|||
148812952|NCT03112603|536790510|FG002|End of Randomization Period|Death|0|||
148812953|NCT03112603|536790508|FG000|End of Randomization Period|Disease Relapse|12|||
148812954|NCT03112603|536790509|FG001|End of Randomization Period|Disease Relapse|7|||
148812955|NCT03112603|536790510|FG002|End of Randomization Period|Disease Relapse|0|||
148812956|NCT03112603|536790508|FG000|End of Randomization Period|Lack of Efficacy|25|||
148812957|NCT03112603|536790509|FG001|End of Randomization Period|Lack of Efficacy|77|||
148812958|NCT03112603|536790510|FG002|End of Randomization Period|Lack of Efficacy|0|||
148812959|NCT03112603|536790508|FG000|End of Randomization Period|Adverse Event|32|||
148812960|NCT03112603|536790509|FG001|End of Randomization Period|Adverse Event|12|||
148812961|NCT03112603|536790510|FG002|End of Randomization Period|Adverse Event|0|||
148812962|NCT03112603|536790508|FG000|End of Cross Over Period|Death|0|||
148812963|NCT03112603|536790509|FG001|End of Cross Over Period|Death|0|||
148812964|NCT03112603|536790510|FG002|End of Cross Over Period|Death|2|||
148812965|NCT03112603|536790508|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
148812966|NCT03112603|536790509|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
148812967|NCT03112603|536790510|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
148812968|NCT03112603|536790508|FG000|End of Cross Over Period|Physician Decision|0|||
148812969|NCT03112603|536790509|FG001|End of Cross Over Period|Physician Decision|0|||
148812970|NCT03112603|536790510|FG002|End of Cross Over Period|Physician Decision|29|||
148812971|NCT03112603|536790508|FG000|End of Cross Over Period|Lack of Efficacy|0|||
148812972|NCT03112603|536790509|FG001|End of Cross Over Period|Lack of Efficacy|0|||
148812973|NCT03112603|536790510|FG002|End of Cross Over Period|Lack of Efficacy|8|||
148812974|NCT03112603|536790508|FG000|End of Cross Over Period|Adverse Event|0|||
148812975|NCT03112603|536790509|FG001|End of Cross Over Period|Adverse Event|0|||
148812976|NCT03112603|536790510|FG002|End of Cross Over Period|Adverse Event|6|||
148812977|NCT03112603|536790508|FG000|End of Cross Over Period|Disease Relapse|0|||
148812978|NCT03112603|536790509|FG001|End of Cross Over Period|Disease Relapse|0|||
148812979|NCT03112603|536790510|FG002|End of Cross Over Period|Disease Relapse|2|||
148812980|NCT03621592|536790517|FG000|Overall Study|Lost to Follow-up|1|||
148812981|NCT03621592|536790518|FG001|Overall Study|Lost to Follow-up|0|||
148812982|NCT03621592|536790517|FG000|Overall Study|Lack of Improvement|1|||
148812983|NCT03621592|536790518|FG001|Overall Study|Lack of Improvement|0|||
148812984|NCT03621592|536790517|FG000|Overall Study|Preference to receive wound care closer to home|1|||
148812985|NCT03621592|536790518|FG001|Overall Study|Preference to receive wound care closer to home|0|||
148695199|NCT00366899|536357568|FG001|After Infant Series|Adverse Event|2|||
148695200|NCT00366899|536357567|FG000|After Infant Series|Protocol Violation|1|||
148695201|NCT00366899|536357568|FG001|After Infant Series|Protocol Violation|0|||
148695202|NCT00366899|536357567|FG000|Toddler Dose|Withdrawal by Subject|1|||
148695203|NCT00366899|536357568|FG001|Toddler Dose|Withdrawal by Subject|1|||
148695204|NCT00366899|536357567|FG000|Toddler Dose|Protocol Violation|1|||
148695205|NCT00366899|536357568|FG001|Toddler Dose|Protocol Violation|0|||
148695206|NCT00419770|536357569|FG000|Overall Study|Withdrawal by Subject|5|||
148695207|NCT00419770|536357570|FG001|Overall Study|Withdrawal by Subject|1|||
148695208|NCT00414466|536357572|FG000|Overall Study|Adverse Event|0|||
148695209|NCT00414466|536357573|FG001|Overall Study|Adverse Event|0|||
148695210|NCT00414466|536357574|FG002|Overall Study|Adverse Event|1|||
148695211|NCT00414466|536357575|FG003|Overall Study|Adverse Event|1|||
148695212|NCT00414466|536357572|FG000|Overall Study|Lack of Efficacy|1|||
148695213|NCT00414466|536357573|FG001|Overall Study|Lack of Efficacy|0|||
148695214|NCT00414466|536357574|FG002|Overall Study|Lack of Efficacy|0|||
148695215|NCT00414466|536357575|FG003|Overall Study|Lack of Efficacy|0|||
148695216|NCT00414466|536357572|FG000|Overall Study|Withdrawn by Sponsor|1|||
148695217|NCT00414466|536357573|FG001|Overall Study|Withdrawn by Sponsor|0|||
148695218|NCT00414466|536357574|FG002|Overall Study|Withdrawn by Sponsor|0|||
148695219|NCT00414466|536357575|FG003|Overall Study|Withdrawn by Sponsor|0|||
148695220|NCT01781637|536357576|FG000|Overall Study|Adverse Event|1|||
148695221|NCT01781637|536357577|FG001|Overall Study|Adverse Event|0|||
148695222|NCT01781637|536357576|FG000|Overall Study|Lack of Efficacy|2|||
148695223|NCT01781637|536357577|FG001|Overall Study|Lack of Efficacy|6|||
148695224|NCT01781637|536357576|FG000|Overall Study|Withdrawal by Subject|1|||
148695225|NCT01781637|536357577|FG001|Overall Study|Withdrawal by Subject|0|||
148695226|NCT02637232|536357578|FG000|Overall Study|Lost to Follow-up|42|||
148695227|NCT02637232|536357578|FG000|Overall Study|Adverse Event|11|||
148695228|NCT02637232|536357578|FG000|Overall Study|patient 's decision|2|||
148695229|NCT02999178|536357579|FG000|Overall Study|Adverse Event|85|||
148695230|NCT02999178|536357580|FG001|Overall Study|Adverse Event|62|||
148695231|NCT02999178|536357579|FG000|Overall Study|Protocol Violation|1|||
148695232|NCT02999178|536357580|FG001|Overall Study|Protocol Violation|2|||
148695233|NCT02999178|536357579|FG000|Overall Study|Lost to Follow-up|0|||
148695234|NCT02999178|536357580|FG001|Overall Study|Lost to Follow-up|2|||
148695235|NCT02999178|536357579|FG000|Overall Study|Withdrawal by Subject|21|||
148695236|NCT02999178|536357580|FG001|Overall Study|Withdrawal by Subject|21|||
148695237|NCT02999178|536357579|FG000|Overall Study|Other reason not defined above|7|||
148695238|NCT02999178|536357580|FG001|Overall Study|Other reason not defined above|13|||
148695239|NCT00090857|536357581|FG000|Overall Study|Lost to Follow-up|0|||
148695240|NCT00090857|536357582|FG001|Overall Study|Lost to Follow-up|1|||
148695241|NCT00090857|536357581|FG000|Overall Study|Withdrawal by Subject|2|||
148695242|NCT00090857|536357582|FG001|Overall Study|Withdrawal by Subject|0|||
148695243|NCT00090857|536357581|FG000|Overall Study|Adverse Event|2|||
148695244|NCT00090857|536357582|FG001|Overall Study|Adverse Event|2|||
148695245|NCT05097326|536357583|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
148695246|NCT05097326|536357584|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
148695247|NCT03480425|536357586|FG000|Overall Study|Force transducer technical failure|1|||
148695248|NCT01244126|536357587|FG000|Overall Study|Protocol Violation|3|||
148695249|NCT01244126|536357588|FG001|Overall Study|Protocol Violation|3|||
148812986|NCT03621592|536790517|FG000|Overall Study|Lack of healing|0|||
148695250|NCT01244126|536357589|FG002|Overall Study|Protocol Violation|9|||
148695251|NCT01451762|536357592|FG000|Overall Study|Lost to Follow-up|3|||
148695252|NCT01451762|536357593|FG001|Overall Study|Lost to Follow-up|6|||
148695253|NCT01451762|536357594|FG002|Overall Study|Lost to Follow-up|6|||
148695254|NCT02424188|536357600|FG000|Overall Study|Death|2|||
148695255|NCT02424188|536357601|FG001|Overall Study|Death|2|||
148695256|NCT02424188|536357600|FG000|Overall Study|Lost to Follow-up|1|||
148695257|NCT02424188|536357601|FG001|Overall Study|Lost to Follow-up|3|||
148695258|NCT02424188|536357600|FG000|Overall Study|Incarceration|1|||
148695259|NCT02424188|536357601|FG001|Overall Study|Incarceration|0|||
148695260|NCT00630305|536357602|FG000|Overall Study|Withdrawal by Subject|1|||
148962512|NCT05478252|537347261|FG001|Overall Study|Withdrawal by Subject|3|||
148962513|NCT05478252|537347260|FG000|Overall Study|Lost to Follow-up|4|||
148695261|NCT00630305|536357602|FG000|Overall Study|Inability to insert contact lens|1|||
148695262|NCT01085045|536357603|FG000|Part A|Withdrawal by Subject|4|||
148695263|NCT01085045|536357603|FG000|Part A|Adverse Event|6|||
148695264|NCT01085045|536357603|FG000|Part A|Protocol Violation|1|||
148695265|NCT01085045|536357603|FG000|Part A|Protocol Specified Criteria|7|||
148695266|NCT01085045|536357603|FG000|Part B|Withdrawal by Subject|2|||
148695267|NCT01085045|536357603|FG000|Part B|Protocol Specified Criteria|6|||
148695268|NCT01085045|536357603|FG000|Part B|Lost to Follow-up|1|||
148695269|NCT01085045|536357603|FG000|Part B|Adverse Event|6|||
148695270|NCT01494506|536357606|FG000|Overall Study|Lack of Efficacy|77|||
148695271|NCT01494506|536357607|FG001|Overall Study|Lack of Efficacy|83|||
148695272|NCT01494506|536357608|FG002|Overall Study|Lack of Efficacy|57|||
148695273|NCT01494506|536357606|FG000|Overall Study|Adverse Event|17|||
148695274|NCT01494506|536357607|FG001|Overall Study|Adverse Event|10|||
148695275|NCT01494506|536357608|FG002|Overall Study|Adverse Event|11|||
148695276|NCT01494506|536357606|FG000|Overall Study|Death|9|||
148695277|NCT01494506|536357607|FG001|Overall Study|Death|5|||
148962514|NCT05478252|537347261|FG001|Overall Study|Lost to Follow-up|2|||
148962515|NCT05478252|537347260|FG000|Overall Study|Physician Decision|1|||
148962516|NCT05478252|537347261|FG001|Overall Study|Physician Decision|1|||
148962517|NCT05478252|537347260|FG000|Overall Study|Death|1|||
148962518|NCT05478252|537347261|FG001|Overall Study|Death|0|||
148962519|NCT03482791|537347266|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
148962520|NCT03482791|537347267|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
148962521|NCT01816893|537347269|FG000|Washout Period|Withdrawal by Subject|2|||
148962522|NCT01816893|537347270|FG001|Washout Period|Withdrawal by Subject|0|||
148962523|NCT03971695|537349288|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962524|NCT03971695|537349289|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962525|NCT03971695|537349290|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962526|NCT03971695|537349291|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
148962527|NCT03971695|537349292|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
148962528|NCT03971695|537349293|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962529|NCT03971695|537349294|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962530|NCT03971695|537349295|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962531|NCT03971695|537349296|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
148962532|NCT03971695|537349297|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
148962533|NCT03971695|537349298|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
148962534|NCT03971695|537349299|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
148962535|NCT03971695|537349300|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
148962536|NCT04447417|537349301|FG000|Overall Study|Withdrawal by Subject|1|||
148962537|NCT04447417|537349302|FG001|Overall Study|Withdrawal by Subject|0|||
148962538|NCT04447417|537349301|FG000|Overall Study|Failure to meet inclusion criteria|1|||
148962539|NCT04447417|537349302|FG001|Overall Study|Failure to meet inclusion criteria|0|||
148962540|NCT04447417|537349301|FG000|Overall Study|Lost to Follow-up|1|||
148962541|NCT04447417|537349302|FG001|Overall Study|Lost to Follow-up|0|||
148962542|NCT00858442|537349307|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
148695278|NCT01494506|536357608|FG002|Overall Study|Death|2|||
148695279|NCT01494506|536357606|FG000|Overall Study|Physician Decision|7|||
148695280|NCT01494506|536357607|FG001|Overall Study|Physician Decision|5|||
148695281|NCT01494506|536357608|FG002|Overall Study|Physician Decision|4|||
148695282|NCT01494506|536357606|FG000|Overall Study|Withdrawal by Subject|17|||
148695283|NCT01494506|536357607|FG001|Overall Study|Withdrawal by Subject|20|||
148695284|NCT01494506|536357608|FG002|Overall Study|Withdrawal by Subject|14|||
148695285|NCT01494506|536357606|FG000|Overall Study|Clinical Deterioration|21|||
148695286|NCT01494506|536357607|FG001|Overall Study|Clinical Deterioration|17|||
148695287|NCT01494506|536357608|FG002|Overall Study|Clinical Deterioration|13|||
148962543|NCT00858442|537349308|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
148962544|NCT00380978|537349309|FG000|Overall Study|Refused allocated intervention|0|||
148962545|NCT00380978|537349310|FG001|Overall Study|Refused allocated intervention|6|||
148962546|NCT00380978|537349309|FG000|Overall Study|Wrong study envelope|0|||
148962547|NCT00380978|537349310|FG001|Overall Study|Wrong study envelope|2|||
148962548|NCT00380978|537349309|FG000|Overall Study|Allocation prior to analgesia request|1|||
148695288|NCT01494506|536357606|FG000|Overall Study|Sponsor Decision|0|||
148812987|NCT03621592|536790518|FG001|Overall Study|Lack of healing|2|||
148695289|NCT01494506|536357607|FG001|Overall Study|Sponsor Decision|0|||
148695290|NCT01494506|536357608|FG002|Overall Study|Sponsor Decision|1|||
148695291|NCT01494506|536357606|FG000|Overall Study|Other|0|||
148695292|NCT01494506|536357607|FG001|Overall Study|Other|3|||
148695293|NCT01494506|536357608|FG002|Overall Study|Other|1|||
148695294|NCT02395822|536357617|FG000|Overall Study|Withdrawal by Subject|1|||
148695295|NCT02395822|536357617|FG000|Overall Study|Death|1|||
148695296|NCT02127281|536357618|FG000|Overall Study|Lost to Follow-up|1|||
148695297|NCT02127281|536357619|FG001|Overall Study|Lost to Follow-up|0|||
148695298|NCT04510857|536357620|FG000|Overall Study|Withdrawal by Subject|1|||
148695299|NCT04510857|536357621|FG001|Overall Study|Withdrawal by Subject|2|||
148695300|NCT02564263|536357624|FG000|Overall Study|Adverse Event|31|||
148962549|NCT00380978|537349310|FG001|Overall Study|Allocation prior to analgesia request|2|||
148962550|NCT00380978|537349309|FG000|Overall Study|Parous patient|1|||
148962551|NCT00380978|537349310|FG001|Overall Study|Parous patient|0|||
148962552|NCT01254227|537349311|FG000|Overall Study|Withdrawal by Subject|6|||
148962553|NCT01254227|537349311|FG000|Overall Study|Lost to Follow-up|6|||
148962554|NCT01254227|537349311|FG000|Overall Study|Adverse Event|5|||
148962555|NCT01254227|537349311|FG000|Overall Study|Abnormal test procedure result|5|||
148962556|NCT01254227|537349311|FG000|Overall Study|Administrative problems|2|||
148962557|NCT01254227|537349311|FG000|Overall Study|Death|1|||
148962558|NCT01254227|537349311|FG000|Overall Study|Protocol deviation|1|||
148962559|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
148962560|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
148962561|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
148962562|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
148962563|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
148962564|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
148962565|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
148962566|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
148962567|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
148962568|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
148962569|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
148962570|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
148962571|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
148962572|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
148962573|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
148962574|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
148962575|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
148962576|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
148962577|NCT00887354|537349312|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
148962578|NCT00887354|537349313|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
148962579|NCT00887354|537349312|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
148962580|NCT00887354|537349313|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
148962581|NCT00887354|537349312|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
148962582|NCT00887354|537349313|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
148962583|NCT00887354|537349312|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
148962584|NCT00887354|537349313|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
148962585|NCT00887354|537349312|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
148962586|NCT00887354|537349313|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
148962587|NCT00887354|537349312|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
148962588|NCT00887354|537349313|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
148962589|NCT01466348|537349316|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
148962590|NCT01466348|537349317|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
148962591|NCT00192504|537349320|FG000|Overall Study|Lost to Follow-up|1|||
148962592|NCT00192504|537349321|FG001|Overall Study|Lost to Follow-up|0|||
148962593|NCT00192504|537349322|FG002|Overall Study|Lost to Follow-up|0|||
148695301|NCT02564263|536357625|FG001|Overall Study|Adverse Event|29|||
148695302|NCT02564263|536357624|FG000|Overall Study|Death|270|||
148695303|NCT02564263|536357625|FG001|Overall Study|Death|262|||
148695304|NCT02564263|536357624|FG000|Overall Study|Withdrawal by Subject|4|||
148695305|NCT02564263|536357625|FG001|Overall Study|Withdrawal by Subject|19|||
148695306|NCT02564263|536357624|FG000|Overall Study|Sponsor's decision|9|||
148695307|NCT02564263|536357625|FG001|Overall Study|Sponsor's decision|4|||
148695308|NCT00920140|536357626|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
148962594|NCT00192504|537349323|FG003|Overall Study|Lost to Follow-up|0|||
148962595|NCT00192504|537349320|FG000|Overall Study|Dosing window missed|0|||
148962596|NCT00192504|537349321|FG001|Overall Study|Dosing window missed|0|||
148962597|NCT00192504|537349322|FG002|Overall Study|Dosing window missed|1|||
148962598|NCT00192504|537349323|FG003|Overall Study|Dosing window missed|0|||
148962599|NCT03989440|537349324|FG000|Overall Study|COVID-19 travel restrictions|0|||
148962600|NCT03989440|537349325|FG001|Overall Study|COVID-19 travel restrictions|0|||
148962601|NCT03989440|537349326|FG002|Overall Study|COVID-19 travel restrictions|1|||
148962602|NCT03989440|537349327|FG003|Overall Study|COVID-19 travel restrictions|0|||
148962603|NCT03989440|537349328|FG004|Overall Study|COVID-19 travel restrictions|0|||
148962604|NCT03989440|537349329|FG005|Overall Study|COVID-19 travel restrictions|0|||
148962605|NCT03989440|537349324|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
148962606|NCT03989440|537349325|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
148962607|NCT03989440|537349326|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
148962608|NCT03989440|537349327|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
148962609|NCT03989440|537349328|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
148962610|NCT03989440|537349329|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
148962611|NCT02189473|537349332|FG000|Overall Study|Death|22|||
148962612|NCT02189473|537349333|FG001|Overall Study|Death|23|||
148962613|NCT02189473|537349332|FG000|Overall Study|Lost to Follow-up|1|||
148962614|NCT02189473|537349333|FG001|Overall Study|Lost to Follow-up|2|||
148962615|NCT01955161|537349334|FG000|Overall Study|Withdrawal before treatment|2|||
148962616|NCT01955161|537349335|FG001|Overall Study|Withdrawal before treatment|0|||
148962617|NCT01955161|537349336|FG002|Overall Study|Withdrawal before treatment|1|||
148962618|NCT01955161|537349334|FG000|Overall Study|Adverse Event|10|||
148962619|NCT01955161|537349335|FG001|Overall Study|Adverse Event|14|||
148962620|NCT01955161|537349336|FG002|Overall Study|Adverse Event|15|||
148962621|NCT01955161|537349334|FG000|Overall Study|Death|1|||
148962622|NCT01955161|537349335|FG001|Overall Study|Death|1|||
148962623|NCT01955161|537349336|FG002|Overall Study|Death|3|||
148962624|NCT01955161|537349334|FG000|Overall Study|Withdrawal by Subject|9|||
148962625|NCT01955161|537349335|FG001|Overall Study|Withdrawal by Subject|8|||
148962626|NCT01955161|537349336|FG002|Overall Study|Withdrawal by Subject|12|||
148962627|NCT01955161|537349334|FG000|Overall Study|Protocol Violation|2|||
148962628|NCT01955161|537349335|FG001|Overall Study|Protocol Violation|0|||
148962629|NCT01955161|537349336|FG002|Overall Study|Protocol Violation|0|||
148962630|NCT01955161|537349334|FG000|Overall Study|Other reason: physician decision|0|||
148962631|NCT01955161|537349335|FG001|Overall Study|Other reason: physician decision|1|||
148962632|NCT01955161|537349336|FG002|Overall Study|Other reason: physician decision|1|||
148962633|NCT01955161|537349334|FG000|Overall Study|Other reason: disallowed medication|1|||
148962634|NCT01955161|537349335|FG001|Overall Study|Other reason: disallowed medication|0|||
148695309|NCT00920140|536357627|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
148962635|NCT01955161|537349336|FG002|Overall Study|Other reason: disallowed medication|1|||
148962636|NCT01955161|537349334|FG000|Overall Study|Other reason: caregiver unavailable|1|||
148812988|NCT03785366|536790526|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
148812989|NCT03785366|536790527|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
148812990|NCT03785366|536790526|FG000|Overall Study|Lost to Follow-up|1|||
148812991|NCT03785366|536790527|FG001|Overall Study|Lost to Follow-up|0|||
148812992|NCT03785366|536790526|FG000|Overall Study|Partial IUD Expulsion|0|||
148812993|NCT03785366|536790527|FG001|Overall Study|Partial IUD Expulsion|2|||
148812994|NCT03785366|536790526|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
148812995|NCT03785366|536790527|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
148812996|NCT03240874|536790528|FG000|Overall Study|Lost to Follow-up|0|||
148812997|NCT03240874|536790529|FG001|Overall Study|Lost to Follow-up|2|||
148812998|NCT03240874|536790530|FG002|Overall Study|Lost to Follow-up|4|||
148812999|NCT03240874|536790531|FG003|Overall Study|Lost to Follow-up|1|||
148813000|NCT04153864|536790532|FG000|Overall Study|Withdrawal by Subject|21|||
148813001|NCT04153864|536790533|FG001|Overall Study|Withdrawal by Subject|7|||
148813002|NCT04153864|536790534|FG002|Overall Study|Withdrawal by Subject|23|||
148813003|NCT04153864|536790535|FG003|Overall Study|Withdrawal by Subject|2|||
148813004|NCT04153864|536790532|FG000|Overall Study|Lost to Follow-up|4|||
148813005|NCT04153864|536790533|FG001|Overall Study|Lost to Follow-up|0|||
148813006|NCT04153864|536790534|FG002|Overall Study|Lost to Follow-up|3|||
148813007|NCT04153864|536790535|FG003|Overall Study|Lost to Follow-up|0|||
148813008|NCT04153864|536790532|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
148813009|NCT04153864|536790533|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
148813010|NCT04153864|536790534|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
148813011|NCT04153864|536790535|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
148813012|NCT03036254|536790537|FG000|Overall Study|Adverse Event|6|||
148813013|NCT03036254|536790538|FG001|Overall Study|Adverse Event|4|||
148813014|NCT03036254|536790537|FG000|Overall Study|Death|3|||
148813015|NCT03036254|536790538|FG001|Overall Study|Death|1|||
148813016|NCT03036254|536790537|FG000|Overall Study|Lack of Efficacy|5|||
148813017|NCT03036254|536790538|FG001|Overall Study|Lack of Efficacy|1|||
148813018|NCT03036254|536790537|FG000|Overall Study|Withdrawal by Subject|3|||
148813019|NCT03036254|536790538|FG001|Overall Study|Withdrawal by Subject|5|||
148813020|NCT02783274|536790539|FG000|Overall Study|Withdrawal by Subject|16|||
148813021|NCT02783274|536790539|FG000|Overall Study|Physician Decision|6|||
148813022|NCT02783274|536790539|FG000|Overall Study|Death|9|||
148813023|NCT02783274|536790539|FG000|Overall Study|Lost to Follow-up|22|||
148813024|NCT02783274|536790539|FG000|Overall Study|Other|22|||
148813025|NCT06354257|536790541|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148813026|NCT06354257|536790541|FG000|Treatment Period 2|Adverse Event|1|||
148813027|NCT04132050|536790542|FG000|Period I (Double-blind Period)|Adverse Event|3|||
148813028|NCT04132050|536790543|FG001|Period I (Double-blind Period)|Adverse Event|0|||
148813029|NCT04132050|536790542|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
148813030|NCT04132050|536790543|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
148813031|NCT04132050|536790542|FG000|R788 Treatment Period|Adverse Event|5|||
148813032|NCT04132050|536790543|FG001|R788 Treatment Period|Adverse Event|0|||
148813033|NCT04132050|536790542|FG000|R788 Treatment Period|Lack of Efficacy|5|||
148813034|NCT04132050|536790543|FG001|R788 Treatment Period|Lack of Efficacy|0|||
148813035|NCT04132050|536790542|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
148813036|NCT04132050|536790543|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
148813037|NCT01063114|536790544|FG000|Overall Study|Lost to Follow-up|1|||
148813038|NCT04635423|536790557|FG000|Overall Study|Ongoing|493|||
148813039|NCT04635423|536790558|FG001|Overall Study|Ongoing|501|||
148813040|NCT04635423|536790557|FG000|Overall Study|Withdrawal by Subject|36|||
148962637|NCT01955161|537349335|FG001|Overall Study|Other reason: caregiver unavailable|0|||
148962638|NCT01955161|537349336|FG002|Overall Study|Other reason: caregiver unavailable|0|||
148962639|NCT01955161|537349334|FG000|Overall Study|Other reason: moved to nursing home|0|||
148962640|NCT01955161|537349335|FG001|Overall Study|Other reason: moved to nursing home|1|||
148962641|NCT01955161|537349336|FG002|Overall Study|Other reason: moved to nursing home|0|||
148962642|NCT01955161|537349334|FG000|Overall Study|Other reason: insufficient compliance|0|||
148962643|NCT01955161|537349335|FG001|Overall Study|Other reason: insufficient compliance|0|||
148962644|NCT01955161|537349336|FG002|Overall Study|Other reason: insufficient compliance|1|||
148962645|NCT01955161|537349334|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
148962646|NCT01955161|537349335|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
148962647|NCT01955161|537349336|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
148962648|NCT01955161|537349334|FG000|Overall Study|Other reason: patient's will|0|||
148962649|NCT01955161|537349335|FG001|Overall Study|Other reason: patient's will|0|||
148962650|NCT01955161|537349336|FG002|Overall Study|Other reason: patient's will|1|||
148962651|NCT02784821|537349337|FG000|Overall Study|Death|0|||
148962652|NCT02784821|537349338|FG001|Overall Study|Death|5|||
148962653|NCT02784821|537349339|FG002|Overall Study|Death|4|||
148962654|NCT02784821|537349340|FG003|Overall Study|Death|5|||
148962655|NCT02794103|537349341|FG000|Overall Study|Loss to follow up due to high sedation|3|||
148962656|NCT04608500|537349342|FG000|Overall Study|Adverse Event|2|||
148962657|NCT04608500|537349343|FG001|Overall Study|Adverse Event|0|||
148962658|NCT04608500|537349342|FG000|Overall Study|Lost to Follow-up|15|||
148962659|NCT04608500|537349343|FG001|Overall Study|Lost to Follow-up|9|||
148962660|NCT04608500|537349342|FG000|Overall Study|Participant request|11|||
148962661|NCT04608500|537349343|FG001|Overall Study|Participant request|7|||
148962662|NCT04608500|537349342|FG000|Overall Study|Protocol Violation|1|||
148962663|NCT04608500|537349343|FG001|Overall Study|Protocol Violation|0|||
148962664|NCT04608500|537349342|FG000|Overall Study|Other|6|||
148962665|NCT04608500|537349343|FG001|Overall Study|Other|2|||
148962666|NCT01881230|537349349|FG000|Overall Study|Death|2|||
148962667|NCT01881230|537349350|FG001|Overall Study|Death|0|||
148962668|NCT01881230|537349351|FG002|Overall Study|Death|1|||
148962669|NCT01881230|537349349|FG000|Overall Study|Adverse Event|9|||
148962670|NCT01881230|537349350|FG001|Overall Study|Adverse Event|13|||
148962671|NCT01881230|537349351|FG002|Overall Study|Adverse Event|12|||
148962672|NCT01881230|537349349|FG000|Overall Study|Progressive Disease|31|||
148962673|NCT01881230|537349350|FG001|Overall Study|Progressive Disease|35|||
148962674|NCT01881230|537349351|FG002|Overall Study|Progressive Disease|36|||
148962675|NCT01881230|537349349|FG000|Overall Study|Symptomatic Deterioration|3|||
148962676|NCT01881230|537349350|FG001|Overall Study|Symptomatic Deterioration|3|||
148962677|NCT01881230|537349351|FG002|Overall Study|Symptomatic Deterioration|1|||
148962678|NCT01881230|537349349|FG000|Overall Study|Withdrawal by Subject|6|||
148962679|NCT01881230|537349350|FG001|Overall Study|Withdrawal by Subject|4|||
148962680|NCT01881230|537349351|FG002|Overall Study|Withdrawal by Subject|6|||
148962681|NCT01881230|537349349|FG000|Overall Study|Physician Decision|4|||
148962682|NCT01881230|537349350|FG001|Overall Study|Physician Decision|3|||
148962683|NCT01881230|537349351|FG002|Overall Study|Physician Decision|6|||
148962684|NCT01881230|537349349|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148962685|NCT01881230|537349350|FG001|Overall Study|Non-Compliance with Study Drug|2|||
148962686|NCT01881230|537349351|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148962687|NCT01881230|537349349|FG000|Overall Study|Given Commercially Available Drug|0|||
148962688|NCT01881230|537349350|FG001|Overall Study|Given Commercially Available Drug|0|||
148962689|NCT01881230|537349351|FG002|Overall Study|Given Commercially Available Drug|2|||
148962690|NCT01881230|537349349|FG000|Overall Study|Protocol Violation|1|||
148962691|NCT01881230|537349350|FG001|Overall Study|Protocol Violation|1|||
148962692|NCT01881230|537349351|FG002|Overall Study|Protocol Violation|0|||
148962693|NCT01881230|537349349|FG000|Overall Study|Miscellaneous|3|||
148962694|NCT01881230|537349350|FG001|Overall Study|Miscellaneous|3|||
148962695|NCT01881230|537349351|FG002|Overall Study|Miscellaneous|0|||
148962696|NCT01881230|537349349|FG000|Overall Study|Untreated: Other|0|||
148962697|NCT01881230|537349350|FG001|Overall Study|Untreated: Other|0|||
148962698|NCT01881230|537349351|FG002|Overall Study|Untreated: Other|1|||
148962699|NCT01881230|537349349|FG000|Overall Study|Untreated: Death|0|||
148962700|NCT01881230|537349350|FG001|Overall Study|Untreated: Death|0|||
148962701|NCT01881230|537349351|FG002|Overall Study|Untreated: Death|1|||
148962702|NCT01881230|537349349|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
148962703|NCT01881230|537349350|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
148962704|NCT01881230|537349351|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
148962705|NCT00914810|537349354|FG000|Overall Study|Withdrawal by Subject|1|||
148962706|NCT00914810|537349355|FG001|Overall Study|Withdrawal by Subject|0|||
148962707|NCT00914810|537349354|FG000|Overall Study|Relocated out of state|1|||
148962708|NCT00914810|537349355|FG001|Overall Study|Relocated out of state|0|||
148962709|NCT00914810|537349354|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
148962710|NCT00914810|537349355|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
148962711|NCT02747420|537349356|FG000|Overall Study|Lost to Follow-up|4|||
148962712|NCT02747420|537349357|FG001|Overall Study|Lost to Follow-up|2|||
148962713|NCT02747420|537349356|FG000|Overall Study|Withdrawal by Subject|3|||
148962714|NCT02747420|537349357|FG001|Overall Study|Withdrawal by Subject|2|||
148962715|NCT03739112|537349359|FG000|Overall Study|Adverse Event|2|||
148962716|NCT03739112|537349360|FG001|Overall Study|Adverse Event|2|||
148962717|NCT03739112|537349359|FG000|Overall Study|Withdrawal by Subject|38|||
148962718|NCT03739112|537349360|FG001|Overall Study|Withdrawal by Subject|19|||
148962719|NCT03739112|537349359|FG000|Overall Study|Lost to Follow-up|31|||
148695310|NCT00920140|536357628|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
148695311|NCT00920140|536357629|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
148695312|NCT00920140|536357630|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
148695313|NCT00920140|536357626|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
148695314|NCT00920140|536357627|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
148695315|NCT00920140|536357628|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
148695316|NCT00920140|536357629|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
148695317|NCT00920140|536357630|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
148695318|NCT00920140|536357626|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
148695319|NCT00920140|536357627|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
148695320|NCT00920140|536357628|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
148695321|NCT00920140|536357629|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
148695322|NCT00920140|536357630|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
148695323|NCT00920140|536357626|FG000|Phase 2|Adverse Event|0|||
148695324|NCT00920140|536357627|FG001|Phase 2|Adverse Event|0|||
148695325|NCT00920140|536357628|FG002|Phase 2|Adverse Event|14|||
148695326|NCT00920140|536357629|FG003|Phase 2|Adverse Event|2|||
148695327|NCT00920140|536357630|FG004|Phase 2|Adverse Event|3|||
148695328|NCT00920140|536357626|FG000|Phase 2|Lack of Efficacy|0|||
148695329|NCT00920140|536357627|FG001|Phase 2|Lack of Efficacy|0|||
148695330|NCT00920140|536357628|FG002|Phase 2|Lack of Efficacy|29|||
148695331|NCT00920140|536357629|FG003|Phase 2|Lack of Efficacy|14|||
148695332|NCT00920140|536357630|FG004|Phase 2|Lack of Efficacy|5|||
148695333|NCT00920140|536357626|FG000|Phase 2|Lost to Follow-up|0|||
148695334|NCT00920140|536357627|FG001|Phase 2|Lost to Follow-up|0|||
148695335|NCT00920140|536357628|FG002|Phase 2|Lost to Follow-up|0|||
148695336|NCT00920140|536357629|FG003|Phase 2|Lost to Follow-up|1|||
148695337|NCT00920140|536357630|FG004|Phase 2|Lost to Follow-up|0|||
148695338|NCT00920140|536357626|FG000|Phase 2|Physician Decision|0|||
148695339|NCT00920140|536357627|FG001|Phase 2|Physician Decision|0|||
148695340|NCT00920140|536357628|FG002|Phase 2|Physician Decision|3|||
148695341|NCT00920140|536357629|FG003|Phase 2|Physician Decision|3|||
148695342|NCT00920140|536357630|FG004|Phase 2|Physician Decision|2|||
148695343|NCT00920140|536357626|FG000|Phase 2|Withdrawal by Subject|0|||
148695344|NCT00920140|536357627|FG001|Phase 2|Withdrawal by Subject|0|||
148695345|NCT00920140|536357628|FG002|Phase 2|Withdrawal by Subject|4|||
148695346|NCT00920140|536357629|FG003|Phase 2|Withdrawal by Subject|2|||
148695347|NCT00920140|536357630|FG004|Phase 2|Withdrawal by Subject|1|||
148695348|NCT01124149|536357631|FG000|Acute Phase|Withdrawal by Subject|22|||
148695349|NCT01124149|536357631|FG000|Acute Phase|Adverse Event|21|||
148695350|NCT01124149|536357631|FG000|Acute Phase|Lack of Efficacy|17|||
148695351|NCT01124149|536357631|FG000|Acute Phase|Protocol Violation|14|||
148695352|NCT01124149|536357631|FG000|Acute Phase|Lost to Follow-up|2|||
148695353|NCT01124149|536357631|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
148695354|NCT01124149|536357631|FG000|Acute Phase|Sponsor request|1|||
148695355|NCT01124149|536357631|FG000|Acute Phase|UC symptoms not ameliorated|1|||
148695356|NCT01124149|536357631|FG000|Acute Phase|Non-compliance|1|||
148695357|NCT01124149|536357631|FG000|Acute Phase|Low hemoglobin|1|||
148695358|NCT01124149|536357631|FG000|Acute Phase|Travelling to another country|1|||
148695359|NCT01124149|536357631|FG000|Acute Phase|Sponsor decision|1|||
148695360|NCT01124149|536357631|FG000|Maintenance Phase|Lack of Efficacy|40|||
148695361|NCT01124149|536357631|FG000|Maintenance Phase|Adverse Event|24|||
148695362|NCT01124149|536357631|FG000|Maintenance Phase|Lost to Follow-up|15|||
148695363|NCT01124149|536357631|FG000|Maintenance Phase|Withdrawal by Subject|10|||
148695364|NCT01124149|536357631|FG000|Maintenance Phase|Protocol Violation|5|||
148695365|NCT01124149|536357631|FG000|Maintenance Phase|Coordinator error|1|||
148695366|NCT01124149|536357631|FG000|Maintenance Phase|Non-compliance|1|||
148695367|NCT01644500|536357632|FG000|Overall Study|Adverse Event|6|||
148695368|NCT01644500|536357633|FG001|Overall Study|Adverse Event|1|||
148695369|NCT01644500|536357634|FG002|Overall Study|Adverse Event|2|||
148813041|NCT04635423|536790558|FG001|Overall Study|Withdrawal by Subject|29|||
148695370|NCT01644500|536357632|FG000|Overall Study|Death|0|||
148695371|NCT01644500|536357633|FG001|Overall Study|Death|1|||
148695372|NCT01644500|536357634|FG002|Overall Study|Death|0|||
148962720|NCT03739112|537349360|FG001|Overall Study|Lost to Follow-up|33|||
148962721|NCT03739112|537349359|FG000|Overall Study|Protocol Deviation|12|||
148962722|NCT03739112|537349360|FG001|Overall Study|Protocol Deviation|9|||
148962723|NCT03739112|537349359|FG000|Overall Study|Physician Decision|1|||
148962724|NCT03739112|537349360|FG001|Overall Study|Physician Decision|0|||
148962725|NCT03739112|537349359|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
148962726|NCT03739112|537349360|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
148962727|NCT03739112|537349359|FG000|Overall Study|Site went on hold|65|||
148962728|NCT03739112|537349360|FG001|Overall Study|Site went on hold|67|||
148962729|NCT03739112|537349359|FG000|Overall Study|Other than specified|8|||
148962730|NCT03739112|537349360|FG001|Overall Study|Other than specified|5|||
148962731|NCT03739112|537349359|FG000|Overall Study|Randomized but not vaccinated|31|||
148962732|NCT03739112|537349360|FG001|Overall Study|Randomized but not vaccinated|25|||
148962733|NCT02436759|537349363|FG000|Overall Study|Adverse Event|3|||
148962734|NCT02436759|537349364|FG001|Overall Study|Adverse Event|0|||
148962735|NCT02436759|537349363|FG000|Overall Study|Protocol Violation|1|||
148962736|NCT02436759|537349364|FG001|Overall Study|Protocol Violation|0|||
148962737|NCT02436759|537349363|FG000|Overall Study|Withdrawal by Subject|0|||
148962738|NCT02436759|537349364|FG001|Overall Study|Withdrawal by Subject|1|||
148962739|NCT02584504|537349365|FG000|Double-blind Treatment|Participant withdrew consent|0|||
148962740|NCT02584504|537349366|FG001|Double-blind Treatment|Participant withdrew consent|0|||
148962741|NCT02584504|537349367|FG002|Double-blind Treatment|Participant withdrew consent|1|||
148962742|NCT02584504|537349365|FG000|Double-blind Treatment|Adverse Event|0|||
148962743|NCT02584504|537349366|FG001|Double-blind Treatment|Adverse Event|1|||
148962744|NCT02584504|537349367|FG002|Double-blind Treatment|Adverse Event|0|||
148962745|NCT02584504|537349365|FG000|Double-blind Treatment|Family Matter|0|||
148962746|NCT02584504|537349366|FG001|Double-blind Treatment|Family Matter|1|||
148962747|NCT02584504|537349367|FG002|Double-blind Treatment|Family Matter|0|||
148962748|NCT02584504|537349365|FG000|Open-label Treatment|Participant withdrew consent|0|||
148962749|NCT02584504|537349366|FG001|Open-label Treatment|Participant withdrew consent|0|||
148962750|NCT02584504|537349367|FG002|Open-label Treatment|Participant withdrew consent|4|||
148962751|NCT02584504|537349365|FG000|Open-label Treatment|Adverse Event|2|||
148962752|NCT02584504|537349366|FG001|Open-label Treatment|Adverse Event|2|||
148962753|NCT02584504|537349367|FG002|Open-label Treatment|Adverse Event|3|||
148962754|NCT02584504|537349365|FG000|Open-label Treatment|Physician Decision|0|||
148962755|NCT02584504|537349366|FG001|Open-label Treatment|Physician Decision|1|||
148962756|NCT02584504|537349367|FG002|Open-label Treatment|Physician Decision|0|||
148962757|NCT02584504|537349365|FG000|Open-label Treatment|Entered but not treated|0|||
148962758|NCT02584504|537349366|FG001|Open-label Treatment|Entered but not treated|1|||
148962759|NCT02584504|537349367|FG002|Open-label Treatment|Entered but not treated|1|||
148962760|NCT01290666|537349369|FG000|Overall Study|Lost to Follow-up|11|||
148962761|NCT01290666|537349369|FG000|Overall Study|Withdrawal by Subject|23|||
148962762|NCT01290666|537349369|FG000|Overall Study|Early Termination of Study|4|||
148962763|NCT01652664|537349372|FG000|Overall Study|Treatment Failure|5|||
148962764|NCT01652664|537349373|FG001|Overall Study|Treatment Failure|1|||
148962765|NCT01652664|537349372|FG000|Overall Study|Inadequate IOP control|1|||
148962766|NCT01652664|537349373|FG001|Overall Study|Inadequate IOP control|0|||
148962767|NCT00297037|537349374|FG000|Overall Study|Withdrawal by Subject|2|||
148962768|NCT00297037|537349375|FG001|Overall Study|Withdrawal by Subject|0|||
148962769|NCT00581776|537349376|FG000|Overall Study|Disease progression or no response|3|||
148962770|NCT01413360|537349377|FG000|Overall Study|Lost to Follow-up|2|||
148962771|NCT01413360|537349377|FG000|Overall Study|Adverse Event|1|||
148962772|NCT02246673|537349380|FG000|Overall Study|Sponsor Decision|1|||
148962773|NCT02246673|537349381|FG001|Overall Study|Sponsor Decision|0|||
148962774|NCT02246673|537349382|FG002|Overall Study|Sponsor Decision|0|||
148962775|NCT02246673|537349383|FG003|Overall Study|Sponsor Decision|0|||
148695373|NCT01644500|536357632|FG000|Overall Study|Lost to Follow-up|3|||
148695374|NCT01644500|536357633|FG001|Overall Study|Lost to Follow-up|8|||
148695375|NCT01644500|536357634|FG002|Overall Study|Lost to Follow-up|0|||
148695376|NCT01644500|536357632|FG000|Overall Study|Protocol Violation|1|||
148695377|NCT01644500|536357633|FG001|Overall Study|Protocol Violation|1|||
148695378|NCT01644500|536357634|FG002|Overall Study|Protocol Violation|0|||
148695379|NCT01644500|536357632|FG000|Overall Study|Withdrawal by Subject|11|||
148695380|NCT01644500|536357633|FG001|Overall Study|Withdrawal by Subject|12|||
148962776|NCT02246673|537349384|FG004|Overall Study|Sponsor Decision|0|||
148962777|NCT02246673|537349380|FG000|Overall Study|Withdrawal by Subject|0|||
148695381|NCT01644500|536357634|FG002|Overall Study|Withdrawal by Subject|12|||
148962778|NCT02246673|537349381|FG001|Overall Study|Withdrawal by Subject|0|||
148962779|NCT02246673|537349382|FG002|Overall Study|Withdrawal by Subject|0|||
148962780|NCT02246673|537349383|FG003|Overall Study|Withdrawal by Subject|0|||
148962781|NCT02246673|537349384|FG004|Overall Study|Withdrawal by Subject|1|||
148695382|NCT01644500|536357632|FG000|Overall Study|Physician Decision|1|||
148695383|NCT01644500|536357633|FG001|Overall Study|Physician Decision|1|||
148695384|NCT01644500|536357634|FG002|Overall Study|Physician Decision|1|||
148695385|NCT01439165|536357635|FG000|Overall Study|Protocol Violation|3|||
148695386|NCT01439165|536357636|FG001|Overall Study|Protocol Violation|0|||
148695387|NCT01439165|536357635|FG000|Overall Study|Lost to Follow-up|11|||
148695388|NCT01439165|536357636|FG001|Overall Study|Lost to Follow-up|1|||
148695389|NCT01439165|536357635|FG000|Overall Study|Withdrawal by Subject|7|||
148695390|NCT01439165|536357636|FG001|Overall Study|Withdrawal by Subject|1|||
148695391|NCT00322491|536357644|FG000|Overall Study|Adverse Event|1|||
148695392|NCT00322491|536357645|FG001|Overall Study|Adverse Event|0|||
148695393|NCT00322491|536357644|FG000|Overall Study|Death|1|||
148695394|NCT00322491|536357645|FG001|Overall Study|Death|2|||
148695395|NCT03992196|536357648|FG000|Enrollment|lost to follow-up prior dosing|1|||
148695396|NCT03992196|536357649|FG001|Enrollment|lost to follow-up prior dosing|0|||
148695397|NCT03992196|536357650|FG002|Enrollment|lost to follow-up prior dosing|0|||
148695398|NCT03992196|536357648|FG000|Treatment|Protocol Violation|0|||
148695399|NCT03992196|536357649|FG001|Treatment|Protocol Violation|0|||
148695400|NCT03992196|536357650|FG002|Treatment|Protocol Violation|1|||
148695401|NCT03992196|536357648|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
148695402|NCT03992196|536357649|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
148695403|NCT03992196|536357650|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
148695404|NCT03992196|536357648|FG000|Treatment|Withdrawal due to non-compliance|0|||
148695405|NCT03992196|536357649|FG001|Treatment|Withdrawal due to non-compliance|0|||
148695406|NCT03992196|536357650|FG002|Treatment|Withdrawal due to non-compliance|1|||
148695407|NCT03992196|536357648|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
148695408|NCT03992196|536357649|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
148695409|NCT03992196|536357650|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
148695410|NCT03992196|536357648|FG000|Treatment|Withdrawal by parent/guardian|0|||
148695411|NCT03992196|536357649|FG001|Treatment|Withdrawal by parent/guardian|0|||
148695412|NCT03992196|536357650|FG002|Treatment|Withdrawal by parent/guardian|2|||
148695413|NCT00048048|536357651|FG000|Core Treatment|Withdrawal by Subject|0|||
148962782|NCT02246673|537349380|FG000|Overall Study|Lost to Follow-up|0|||
148962783|NCT02246673|537349381|FG001|Overall Study|Lost to Follow-up|0|||
148962784|NCT02246673|537349382|FG002|Overall Study|Lost to Follow-up|0|||
148962785|NCT02246673|537349383|FG003|Overall Study|Lost to Follow-up|1|||
148962786|NCT02246673|537349384|FG004|Overall Study|Lost to Follow-up|0|||
148962787|NCT02246673|537349380|FG000|Overall Study|Protocol Violation|0|||
148962788|NCT02246673|537349381|FG001|Overall Study|Protocol Violation|0|||
148962789|NCT02246673|537349382|FG002|Overall Study|Protocol Violation|0|||
148962790|NCT02246673|537349383|FG003|Overall Study|Protocol Violation|1|||
148962791|NCT02246673|537349384|FG004|Overall Study|Protocol Violation|0|||
148962792|NCT02418468|537349386|FG000|Overall Study|Adverse Event|1|||
148962793|NCT02418468|537349387|FG001|Overall Study|Adverse Event|0|||
148962794|NCT02418468|537349386|FG000|Overall Study|Withdrawal of informed consent|1|||
148962795|NCT02418468|537349387|FG001|Overall Study|Withdrawal of informed consent|1|||
148962796|NCT02914769|537349388|FG000|Overall Study|Protocol Violation|3|||
148962797|NCT02914769|537349389|FG001|Overall Study|Protocol Violation|2|||
148962798|NCT02914769|537349388|FG000|Overall Study|Withdrawal by Subject|0|||
148962799|NCT02914769|537349389|FG001|Overall Study|Withdrawal by Subject|1|||
148962800|NCT04356963|537349393|FG000|First Session|Withdrawal by Subject|1|||
148962801|NCT04356963|537349393|FG000|Second Session|Withdrawal by Subject|3|||
148962802|NCT04356963|537349393|FG000|Second Session|Lost to Follow-up|1|||
148962803|NCT04356963|537349393|FG000|Third Session|Lost to Follow-up|6|||
148695414|NCT00048048|536357652|FG001|Core Treatment|Withdrawal by Subject|0|||
148695415|NCT00048048|536357653|FG002|Core Treatment|Withdrawal by Subject|1|||
148695416|NCT00048048|536357654|FG003|Core Treatment|Withdrawal by Subject|0|||
148695417|NCT00048048|536357655|FG004|Core Treatment|Withdrawal by Subject|0|||
148695418|NCT00048048|536357656|FG005|Core Treatment|Withdrawal by Subject|0|||
148695419|NCT00048048|536357657|FG006|Core Treatment|Withdrawal by Subject|0|||
148962804|NCT04356963|537349393|FG000|Third Session|Withdrawal by Subject|1|||
148962805|NCT00720057|537349400|FG000|Overall Study|Lost to Follow-up|0|||
148962806|NCT00720057|537349401|FG001|Overall Study|Lost to Follow-up|2|||
148695420|NCT00048048|536357658|FG007|Core Treatment|Withdrawal by Subject|0|||
148695421|NCT00048048|536357659|FG008|Core Treatment|Withdrawal by Subject|0|||
148695422|NCT00048048|536357660|FG009|Core Treatment|Withdrawal by Subject|0|||
148695423|NCT00048048|536357661|FG010|Core Treatment|Withdrawal by Subject|0|||
148695424|NCT00048048|536357662|FG011|Core Treatment|Withdrawal by Subject|0|||
148695425|NCT00048048|536357651|FG000|Core Treatment|Adverse Event|0|||
148695426|NCT00048048|536357652|FG001|Core Treatment|Adverse Event|0|||
148695427|NCT00048048|536357653|FG002|Core Treatment|Adverse Event|0|||
148695428|NCT00048048|536357654|FG003|Core Treatment|Adverse Event|0|||
148695429|NCT00048048|536357655|FG004|Core Treatment|Adverse Event|0|||
148695430|NCT00048048|536357656|FG005|Core Treatment|Adverse Event|0|||
148695431|NCT00048048|536357657|FG006|Core Treatment|Adverse Event|0|||
148695432|NCT00048048|536357658|FG007|Core Treatment|Adverse Event|1|||
148695433|NCT00048048|536357659|FG008|Core Treatment|Adverse Event|0|||
148695434|NCT00048048|536357660|FG009|Core Treatment|Adverse Event|0|||
148695435|NCT00048048|536357661|FG010|Core Treatment|Adverse Event|0|||
148695436|NCT00048048|536357662|FG011|Core Treatment|Adverse Event|0|||
148695437|NCT00048048|536357651|FG000|Extension Year 1|Early withdrawals|0|||
148695438|NCT00048048|536357652|FG001|Extension Year 1|Early withdrawals|0|||
148695439|NCT00048048|536357653|FG002|Extension Year 1|Early withdrawals|0|||
148695440|NCT00048048|536357654|FG003|Extension Year 1|Early withdrawals|0|||
148695441|NCT00048048|536357655|FG004|Extension Year 1|Early withdrawals|0|||
148695442|NCT00048048|536357656|FG005|Extension Year 1|Early withdrawals|0|||
148695443|NCT00048048|536357657|FG006|Extension Year 1|Early withdrawals|0|||
148695444|NCT00048048|536357658|FG007|Extension Year 1|Early withdrawals|0|||
148695445|NCT00048048|536357659|FG008|Extension Year 1|Early withdrawals|0|||
148695446|NCT00048048|536357660|FG009|Extension Year 1|Early withdrawals|2|||
148695447|NCT00048048|536357661|FG010|Extension Year 1|Early withdrawals|2|||
148695448|NCT00048048|536357662|FG011|Extension Year 1|Early withdrawals|4|||
148813042|NCT03488524|536790564|FG000|Overall Study|Withdrawal by Subject|51|||
148813043|NCT03488524|536790564|FG000|Overall Study|Death|19|||
148813044|NCT03488524|536790564|FG000|Overall Study|Study Sponsor|11|||
148695449|NCT00048048|536357651|FG000|Extension Year 2|Early withdrawals|0|||
148695450|NCT00048048|536357652|FG001|Extension Year 2|Early withdrawals|0|||
148695451|NCT00048048|536357653|FG002|Extension Year 2|Early withdrawals|0|||
148695452|NCT00048048|536357654|FG003|Extension Year 2|Early withdrawals|0|||
148695453|NCT00048048|536357655|FG004|Extension Year 2|Early withdrawals|0|||
148695454|NCT00048048|536357656|FG005|Extension Year 2|Early withdrawals|0|||
148695455|NCT00048048|536357657|FG006|Extension Year 2|Early withdrawals|0|||
148813045|NCT03488524|536790564|FG000|Overall Study|Physician Decision|4|||
148962807|NCT00720057|537349400|FG000|Overall Study|Protocol Violation|1|||
148962808|NCT00720057|537349401|FG001|Overall Study|Protocol Violation|0|||
148962809|NCT00720057|537349400|FG000|Overall Study|Withdrawal by Subject|0|||
148962810|NCT00720057|537349401|FG001|Overall Study|Withdrawal by Subject|1|||
148962811|NCT02205333|537349404|FG000|Overall Study|Death|5|||
148962812|NCT02205333|537349405|FG001|Overall Study|Death|6|||
148962813|NCT02205333|537349406|FG002|Overall Study|Death|2|||
148962814|NCT02205333|537349407|FG003|Overall Study|Death|6|||
148962815|NCT02205333|537349408|FG004|Overall Study|Death|5|||
148962816|NCT02205333|537349409|FG005|Overall Study|Death|3|||
148962817|NCT02205333|537349410|FG006|Overall Study|Death|3|||
148962818|NCT02205333|537349411|FG007|Overall Study|Death|2|||
148962819|NCT02205333|537349412|FG008|Overall Study|Death|0|||
148962820|NCT02205333|537349404|FG000|Overall Study|Withdrawal by Subject|1|||
148962821|NCT02205333|537349405|FG001|Overall Study|Withdrawal by Subject|0|||
148962822|NCT02205333|537349406|FG002|Overall Study|Withdrawal by Subject|0|||
148962823|NCT02205333|537349407|FG003|Overall Study|Withdrawal by Subject|1|||
148962824|NCT02205333|537349408|FG004|Overall Study|Withdrawal by Subject|0|||
148962825|NCT02205333|537349409|FG005|Overall Study|Withdrawal by Subject|0|||
148962826|NCT02205333|537349410|FG006|Overall Study|Withdrawal by Subject|2|||
148962827|NCT02205333|537349411|FG007|Overall Study|Withdrawal by Subject|0|||
148962828|NCT02205333|537349412|FG008|Overall Study|Withdrawal by Subject|0|||
148962829|NCT00454987|537349413|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
148962830|NCT00454987|537349414|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
148962831|NCT00454987|537349415|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
148962832|NCT00454987|537349413|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
148962833|NCT00454987|537349414|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
148962834|NCT00454987|537349415|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
148962835|NCT00454987|537349413|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
148962836|NCT00454987|537349414|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
148962837|NCT00454987|537349415|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
148962838|NCT02009046|537349417|FG000|Overall Study|Lost to Follow-up|256|||
148962839|NCT02009046|537349418|FG001|Overall Study|Lost to Follow-up|206|||
148962840|NCT01176266|537349419|FG000|Overall Study|Death|6|||
148962841|NCT01176266|537349419|FG000|Overall Study|Withdrawal by Subject|3|||
148962842|NCT01675128|537349421|FG000|Overall Study|Disease progression on study|1|||
148962843|NCT01675128|537349422|FG001|Overall Study|Disease progression on study|1|||
148962844|NCT01675128|537349423|FG002|Overall Study|Disease progression on study|1|||
148962845|NCT01675128|537349421|FG000|Overall Study|Refused further treatment|1|||
148962846|NCT01675128|537349422|FG001|Overall Study|Refused further treatment|0|||
148962847|NCT01675128|537349423|FG002|Overall Study|Refused further treatment|0|||
148962848|NCT01675128|537349421|FG000|Overall Study|Pulmonary complication; off study|0|||
148962849|NCT01675128|537349422|FG001|Overall Study|Pulmonary complication; off study|1|||
148962850|NCT01675128|537349423|FG002|Overall Study|Pulmonary complication; off study|0|||
148962851|NCT03526458|537349424|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
148962852|NCT03526458|537349425|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
148813046|NCT03488524|536790564|FG000|Overall Study|Lost to Follow-up|3|||
148962853|NCT03526458|537349424|FG000|Overall Study|Stone passed, surgery cancelled|2|||
148962854|NCT03526458|537349425|FG001|Overall Study|Stone passed, surgery cancelled|1|||
148813047|NCT01811238|536790565|FG000|Overall Study|Withdrawal by Subject|42|||
148962855|NCT03526458|537349424|FG000|Overall Study|Withdrawal by Subject|1|||
148962856|NCT03526458|537349425|FG001|Overall Study|Withdrawal by Subject|0|||
148962857|NCT03526458|537349424|FG000|Overall Study|Physician Decision|2|||
148962858|NCT03526458|537349425|FG001|Overall Study|Physician Decision|1|||
148962859|NCT03526458|537349424|FG000|Overall Study|Lack of equipment|1|||
148962860|NCT03526458|537349425|FG001|Overall Study|Lack of equipment|1|||
148962861|NCT03011307|537349426|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
148962862|NCT03011307|537349427|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
148962863|NCT03011307|537349426|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
148962864|NCT03011307|537349427|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
148962865|NCT03011307|537349426|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
148962866|NCT03011307|537349427|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
148962867|NCT01782664|537349428|FG000|Overall Study|Adverse Event|2|||
148962868|NCT01782664|537349429|FG001|Overall Study|Adverse Event|2|||
148962869|NCT01782664|537349430|FG002|Overall Study|Adverse Event|2|||
148962870|NCT01782664|537349431|FG003|Overall Study|Adverse Event|2|||
148962871|NCT01782664|537349432|FG004|Overall Study|Adverse Event|0|||
148962872|NCT01782664|537349433|FG005|Overall Study|Adverse Event|0|||
148962873|NCT01782664|537349428|FG000|Overall Study|Lack of Efficacy|2|||
148962874|NCT01782664|537349429|FG001|Overall Study|Lack of Efficacy|0|||
148962875|NCT01782664|537349430|FG002|Overall Study|Lack of Efficacy|2|||
148962876|NCT01782664|537349431|FG003|Overall Study|Lack of Efficacy|2|||
148962877|NCT01782664|537349432|FG004|Overall Study|Lack of Efficacy|0|||
148962878|NCT01782664|537349433|FG005|Overall Study|Lack of Efficacy|0|||
148962879|NCT01782664|537349428|FG000|Overall Study|Protocol Violation|0|||
148962880|NCT01782664|537349429|FG001|Overall Study|Protocol Violation|1|||
148962881|NCT01782664|537349430|FG002|Overall Study|Protocol Violation|0|||
148962882|NCT01782664|537349431|FG003|Overall Study|Protocol Violation|1|||
148962883|NCT01782664|537349432|FG004|Overall Study|Protocol Violation|0|||
148962884|NCT01782664|537349433|FG005|Overall Study|Protocol Violation|0|||
148962885|NCT01782664|537349428|FG000|Overall Study|Withdrawal by Subject|2|||
148962886|NCT01782664|537349429|FG001|Overall Study|Withdrawal by Subject|2|||
148962887|NCT01782664|537349430|FG002|Overall Study|Withdrawal by Subject|0|||
148962888|NCT01782664|537349431|FG003|Overall Study|Withdrawal by Subject|0|||
148962889|NCT01782664|537349432|FG004|Overall Study|Withdrawal by Subject|0|||
148962890|NCT01782664|537349433|FG005|Overall Study|Withdrawal by Subject|0|||
148962891|NCT00698581|537349436|FG000|Overall Study|Lack of Efficacy|23|||
148962892|NCT00698581|537349437|FG001|Overall Study|Lack of Efficacy|11|||
148962893|NCT00698581|537349436|FG000|Overall Study|Withdrawal by Subject|6|||
148962894|NCT00698581|537349437|FG001|Overall Study|Withdrawal by Subject|0|||
148962895|NCT00698581|537349436|FG000|Overall Study|Other reason|9|||
148962896|NCT00698581|537349437|FG001|Overall Study|Other reason|1|||
148962897|NCT00698581|537349436|FG000|Overall Study|SAE, non-fatal|1|||
148962898|NCT00698581|537349437|FG001|Overall Study|SAE, non-fatal|0|||
148962899|NCT00698581|537349436|FG000|Overall Study|AE, non-serious non-fatal|4|||
148962900|NCT00698581|537349437|FG001|Overall Study|AE, non-serious non-fatal|0|||
148962901|NCT00698581|537349436|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148962902|NCT00698581|537349437|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
148962903|NCT00698581|537349436|FG000|Overall Study|AE of unknown type|1|||
148962904|NCT00698581|537349437|FG001|Overall Study|AE of unknown type|0|||
148962905|NCT03760146|537349438|FG000|Overall Study|Adverse Event|11|||
148962906|NCT03760146|537349439|FG001|Overall Study|Adverse Event|8|||
148962907|NCT03760146|537349440|FG002|Overall Study|Adverse Event|0|||
148962908|NCT03760146|537349441|FG003|Overall Study|Adverse Event|0|||
148962909|NCT03760146|537349442|FG004|Overall Study|Adverse Event|0|||
148962910|NCT03760146|537349443|FG005|Overall Study|Adverse Event|0|||
148962911|NCT03760146|537349438|FG000|Overall Study|Death|1|||
148962912|NCT03760146|537349439|FG001|Overall Study|Death|0|||
148962913|NCT03760146|537349440|FG002|Overall Study|Death|0|||
148962914|NCT03760146|537349441|FG003|Overall Study|Death|0|||
148962915|NCT03760146|537349442|FG004|Overall Study|Death|0|||
148962916|NCT03760146|537349443|FG005|Overall Study|Death|0|||
148962917|NCT03760146|537349438|FG000|Overall Study|Lost to Follow-up|41|||
148962918|NCT03760146|537349439|FG001|Overall Study|Lost to Follow-up|28|||
148962919|NCT03760146|537349440|FG002|Overall Study|Lost to Follow-up|9|||
148962920|NCT03760146|537349441|FG003|Overall Study|Lost to Follow-up|2|||
148962921|NCT03760146|537349442|FG004|Overall Study|Lost to Follow-up|14|||
148962922|NCT03760146|537349443|FG005|Overall Study|Lost to Follow-up|8|||
148962923|NCT03760146|537349438|FG000|Overall Study|No longer met eligibility criteria|3|||
148962924|NCT03760146|537349439|FG001|Overall Study|No longer met eligibility criteria|9|||
148962925|NCT03760146|537349440|FG002|Overall Study|No longer met eligibility criteria|0|||
148962926|NCT03760146|537349441|FG003|Overall Study|No longer met eligibility criteria|0|||
148962927|NCT03760146|537349442|FG004|Overall Study|No longer met eligibility criteria|1|||
148962928|NCT03760146|537349443|FG005|Overall Study|No longer met eligibility criteria|0|||
148962929|NCT03760146|537349438|FG000|Overall Study|Protocol Violation|21|||
148695456|NCT00048048|536357658|FG007|Extension Year 2|Early withdrawals|0|||
148962930|NCT03760146|537349439|FG001|Overall Study|Protocol Violation|13|||
148962931|NCT03760146|537349440|FG002|Overall Study|Protocol Violation|1|||
148962932|NCT03760146|537349441|FG003|Overall Study|Protocol Violation|0|||
148962933|NCT03760146|537349442|FG004|Overall Study|Protocol Violation|1|||
148962934|NCT03760146|537349443|FG005|Overall Study|Protocol Violation|0|||
148962935|NCT03760146|537349438|FG000|Overall Study|Withdrawal by Subject|19|||
148962936|NCT03760146|537349439|FG001|Overall Study|Withdrawal by Subject|20|||
148962937|NCT03760146|537349440|FG002|Overall Study|Withdrawal by Subject|1|||
148962938|NCT03760146|537349441|FG003|Overall Study|Withdrawal by Subject|0|||
148962939|NCT03760146|537349442|FG004|Overall Study|Withdrawal by Subject|1|||
148962940|NCT03760146|537349443|FG005|Overall Study|Withdrawal by Subject|0|||
148962941|NCT01082965|537349444|FG000|Overall Study|Protocol Violation|0|||
148962942|NCT01082965|537349445|FG001|Overall Study|Protocol Violation|1|||
148962943|NCT01082965|537349444|FG000|Overall Study|Other|1|||
148962944|NCT01082965|537349445|FG001|Overall Study|Other|1|||
148962945|NCT03642717|537349446|FG000|Overall Study|Lost to Follow-up|2|||
148962946|NCT03642717|537349446|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
148962947|NCT03642717|537349446|FG000|Overall Study|Taken study drug prior to contract date|3|||
148962948|NCT02587065|537349447|FG000|Overall Study|Adverse Event|14|||
148962949|NCT02587065|537349447|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
148962950|NCT02587065|537349447|FG000|Overall Study|Non-adherence to the Protocol|3|||
148962951|NCT02587065|537349447|FG000|Overall Study|Discontinuation of Study Medication|2|||
148962952|NCT02587065|537349447|FG000|Overall Study|Reason not Specified|3|||
148962953|NCT02642432|537349449|FG000|Overall Study|Adverse Event|2|||
148962954|NCT02642432|537349449|FG000|Overall Study|Withdrew Consent|1|||
148962955|NCT02642432|537349449|FG000|Overall Study|Lost to Follow-up|2|||
148813048|NCT01811238|536790565|FG000|Overall Study|Adverse Event|25|||
148813049|NCT01811238|536790565|FG000|Overall Study|Protocol Violation|4|||
148813050|NCT01811238|536790565|FG000|Overall Study|Lack of Efficacy|4|||
148813051|NCT01811238|536790565|FG000|Overall Study|subject refused study medication|6|||
148813052|NCT03980223|536790566|FG000|Overall Study|Lost to Follow-up|3|||
148813053|NCT03980223|536790567|FG001|Overall Study|Lost to Follow-up|7|||
148813054|NCT03980223|536790568|FG002|Overall Study|Lost to Follow-up|10|||
148813055|NCT03980223|536790569|FG003|Overall Study|Lost to Follow-up|8|||
148813056|NCT03980223|536790566|FG000|Overall Study|Withdrawal by Subject|0|||
148813057|NCT03980223|536790567|FG001|Overall Study|Withdrawal by Subject|0|||
148813058|NCT03980223|536790568|FG002|Overall Study|Withdrawal by Subject|1|||
148813059|NCT03980223|536790569|FG003|Overall Study|Withdrawal by Subject|2|||
148962956|NCT02642432|537349449|FG000|Overall Study|Other|3|||
148962957|NCT03999892|537349450|FG000|Overall Study|Lost to Follow-up|1|||
148962958|NCT01848756|537349451|FG000|Overall Study|Adverse Event|1|||
148962959|NCT01848756|537349451|FG000|Overall Study|Withdrawal by Subject|1|||
148962960|NCT01848756|537349451|FG000|Overall Study|Enrolled in Error|1|||
148962961|NCT03245008|537349452|FG000|Overall Study|Adverse Event|15|||
148962962|NCT03245008|537349453|FG001|Overall Study|Adverse Event|18|||
148962963|NCT03245008|537349454|FG002|Overall Study|Adverse Event|15|||
148813060|NCT03980223|536790566|FG000|Overall Study|Physician Decision|0|||
148813061|NCT03980223|536790567|FG001|Overall Study|Physician Decision|0|||
148962964|NCT03245008|537349455|FG003|Overall Study|Adverse Event|0|||
148962965|NCT03245008|537349456|FG004|Overall Study|Adverse Event|1|||
148962966|NCT03245008|537349452|FG000|Overall Study|Lack of Efficacy|0|||
148962967|NCT03245008|537349453|FG001|Overall Study|Lack of Efficacy|1|||
148962968|NCT03245008|537349454|FG002|Overall Study|Lack of Efficacy|0|||
148813062|NCT03980223|536790568|FG002|Overall Study|Physician Decision|1|||
148962969|NCT03245008|537349455|FG003|Overall Study|Lack of Efficacy|0|||
148962970|NCT03245008|537349456|FG004|Overall Study|Lack of Efficacy|0|||
148962971|NCT03245008|537349452|FG000|Overall Study|Lost to Follow-up|4|||
148962972|NCT03245008|537349453|FG001|Overall Study|Lost to Follow-up|1|||
148695457|NCT00048048|536357659|FG008|Extension Year 2|Early withdrawals|0|||
148695458|NCT00048048|536357660|FG009|Extension Year 2|Early withdrawals|0|||
148695459|NCT00048048|536357661|FG010|Extension Year 2|Early withdrawals|4|||
148695460|NCT00048048|536357662|FG011|Extension Year 2|Early withdrawals|2|||
148695461|NCT02388763|536357665|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
148695462|NCT02388763|536357666|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
148695463|NCT02388763|536357665|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
148695464|NCT02388763|536357666|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
148695465|NCT01345019|536357675|FG000|Blinded Treatment Phase|Death|147|||
148695466|NCT01345019|536357676|FG001|Blinded Treatment Phase|Death|137|||
148695467|NCT01345019|536357675|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
148813063|NCT03980223|536790569|FG003|Overall Study|Physician Decision|0|||
148962973|NCT03245008|537349454|FG002|Overall Study|Lost to Follow-up|0|||
148962974|NCT03245008|537349455|FG003|Overall Study|Lost to Follow-up|0|||
148962975|NCT03245008|537349456|FG004|Overall Study|Lost to Follow-up|1|||
148962976|NCT03245008|537349452|FG000|Overall Study|Physician Decision|1|||
148962977|NCT03245008|537349453|FG001|Overall Study|Physician Decision|3|||
148962978|NCT03245008|537349454|FG002|Overall Study|Physician Decision|4|||
148962979|NCT03245008|537349455|FG003|Overall Study|Physician Decision|0|||
148962980|NCT03245008|537349456|FG004|Overall Study|Physician Decision|0|||
148962981|NCT03245008|537349452|FG000|Overall Study|Protocol Violation|0|||
148962982|NCT03245008|537349453|FG001|Overall Study|Protocol Violation|1|||
148962983|NCT03245008|537349454|FG002|Overall Study|Protocol Violation|0|||
148962984|NCT03245008|537349455|FG003|Overall Study|Protocol Violation|0|||
148962985|NCT03245008|537349456|FG004|Overall Study|Protocol Violation|0|||
148962986|NCT03245008|537349452|FG000|Overall Study|Withdrawal by Subject|20|||
148962987|NCT03245008|537349453|FG001|Overall Study|Withdrawal by Subject|19|||
148695468|NCT01345019|536357676|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
148695469|NCT01345019|536357675|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
148962988|NCT03245008|537349454|FG002|Overall Study|Withdrawal by Subject|11|||
148962989|NCT03245008|537349455|FG003|Overall Study|Withdrawal by Subject|0|||
148962990|NCT03245008|537349456|FG004|Overall Study|Withdrawal by Subject|0|||
148962991|NCT03245008|537349452|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
148813064|NCT03980223|536790566|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
148813065|NCT03980223|536790567|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
148813066|NCT03980223|536790568|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
148813067|NCT03980223|536790569|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
148813068|NCT01922934|536790576|FG000|Eligible Patients|Death|0|||
148813069|NCT01922934|536790577|FG001|Eligible Patients|Death|7|||
148813070|NCT01922934|536790576|FG000|Eligible Patients|Physician Decision|17|||
148813071|NCT01922934|536790577|FG001|Eligible Patients|Physician Decision|0|||
148813072|NCT01922934|536790576|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
148813073|NCT01922934|536790577|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
148813074|NCT01922934|536790576|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
148813075|NCT01922934|536790577|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
148813076|NCT01922934|536790576|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
148813077|NCT01922934|536790577|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
148813078|NCT01922934|536790576|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
148813079|NCT01922934|536790577|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
148813080|NCT02916927|536790578|FG000|Overall Study|Discharged prior to study drug receipt|0|||
148813081|NCT02916927|536790579|FG001|Overall Study|Discharged prior to study drug receipt|2|||
148813082|NCT02916927|536790578|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
148813083|NCT02916927|536790579|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
148813084|NCT02916927|536790578|FG000|Overall Study|Withdrawal before first time point|1|||
148813085|NCT02916927|536790579|FG001|Overall Study|Withdrawal before first time point|0|||
148813086|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
148813087|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
148813088|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
148813089|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
148813090|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
148813091|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
148813092|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
148813093|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
148813094|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
148813095|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
148813096|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
148813097|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
148813098|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
148813099|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
148813100|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
148962992|NCT03245008|537349453|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
148962993|NCT03245008|537349454|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
148962994|NCT03245008|537349455|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
148962995|NCT03245008|537349456|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
148962996|NCT03245008|537349452|FG000|Overall Study|Failure to meet randomization criteria|0|||
148962997|NCT03245008|537349453|FG001|Overall Study|Failure to meet randomization criteria|1|||
148962998|NCT03245008|537349454|FG002|Overall Study|Failure to meet randomization criteria|0|||
148962999|NCT03245008|537349455|FG003|Overall Study|Failure to meet randomization criteria|1|||
148963000|NCT03245008|537349456|FG004|Overall Study|Failure to meet randomization criteria|0|||
148963001|NCT02075658|537349457|FG000|Overall Study|Physician Decision|2|||
148963002|NCT02075658|537349458|FG001|Overall Study|Physician Decision|2|||
148963003|NCT01286012|537349459|FG000|Overall Study|Adverse Event|3|||
148963004|NCT01286012|537349460|FG001|Overall Study|Adverse Event|3|||
148963005|NCT01286012|537349459|FG000|Overall Study|Death|2|||
148963006|NCT01286012|537349460|FG001|Overall Study|Death|3|||
148963007|NCT01286012|537349459|FG000|Overall Study|Protocol Violation|1|||
148963008|NCT01286012|537349460|FG001|Overall Study|Protocol Violation|1|||
148963009|NCT01286012|537349459|FG000|Overall Study|Withdrawal by Subject|4|||
148963010|NCT01286012|537349460|FG001|Overall Study|Withdrawal by Subject|4|||
148963011|NCT01286012|537349459|FG000|Overall Study|Physician Decision|2|||
148963012|NCT01286012|537349460|FG001|Overall Study|Physician Decision|0|||
148963013|NCT01286012|537349459|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
148963014|NCT01286012|537349460|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
148963015|NCT04056195|537349463|FG000|Overall Study|Adverse Event|1|||
148963016|NCT04056195|537349464|FG001|Overall Study|Adverse Event|0|||
148963017|NCT04056195|537349465|FG002|Overall Study|Adverse Event|0|||
148963018|NCT04056195|537349463|FG000|Overall Study|Withdrawal by Subject|0|||
148963019|NCT04056195|537349464|FG001|Overall Study|Withdrawal by Subject|1|||
148963020|NCT04056195|537349465|FG002|Overall Study|Withdrawal by Subject|1|||
148963021|NCT04056195|537349463|FG000|Overall Study|Physician Decision|1|||
148963022|NCT04056195|537349464|FG001|Overall Study|Physician Decision|1|||
148963023|NCT04056195|537349465|FG002|Overall Study|Physician Decision|1|||
148963024|NCT02406651|537349466|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
148963025|NCT01602380|537349470|FG000|Overall Study|Death|147|||
148963026|NCT01602380|537349471|FG001|Overall Study|Death|145|||
148963027|NCT01602380|537349470|FG000|Overall Study|Withdrawal by Subject|39|||
148963028|NCT01602380|537349471|FG001|Overall Study|Withdrawal by Subject|41|||
148695470|NCT01345019|536357676|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
148695471|NCT01345019|536357675|FG000|Blinded Treatment Phase|Disease Progression|12|||
148695472|NCT01345019|536357676|FG001|Blinded Treatment Phase|Disease Progression|10|||
148695473|NCT01345019|536357675|FG000|Blinded Treatment Phase|Adverse Event|6|||
148695474|NCT01345019|536357676|FG001|Blinded Treatment Phase|Adverse Event|13|||
148695475|NCT01345019|536357675|FG000|Blinded Treatment Phase|Administrative Decision|10|||
148963029|NCT01602380|537349470|FG000|Overall Study|Lost to Follow-up|15|||
148963030|NCT01602380|537349471|FG001|Overall Study|Lost to Follow-up|12|||
148963031|NCT01602380|537349470|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
148963032|NCT01602380|537349471|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
148963033|NCT01602380|537349470|FG000|Overall Study|Other|2|||
148963034|NCT01602380|537349471|FG001|Overall Study|Other|0|||
148963035|NCT04475588|537350868|FG000|Overall Study|Adverse Event|2|||
148963036|NCT04475588|537350869|FG001|Overall Study|Adverse Event|0|||
148695476|NCT01345019|536357676|FG001|Blinded Treatment Phase|Administrative Decision|8|||
148695477|NCT01345019|536357675|FG000|Blinded Treatment Phase|Noncompliance|5|||
148695478|NCT01345019|536357676|FG001|Blinded Treatment Phase|Noncompliance|3|||
148695479|NCT01345019|536357675|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
148695480|NCT01345019|536357676|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
148695481|NCT01345019|536357675|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
148695482|NCT01345019|536357676|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
148695483|NCT01345019|536357675|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
148695484|NCT01345019|536357676|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
148695485|NCT01345019|536357675|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
148695486|NCT01345019|536357676|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
148695487|NCT01345019|536357675|FG000|Open Label Treatment Phase|Death|49|||
148695488|NCT01345019|536357676|FG001|Open Label Treatment Phase|Death|48|||
148695489|NCT01345019|536357675|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
148695490|NCT01345019|536357676|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
148695491|NCT01345019|536357675|FG000|Open Label Treatment Phase|Adverse Event|30|||
148695492|NCT01345019|536357676|FG001|Open Label Treatment Phase|Adverse Event|51|||
148695493|NCT01345019|536357675|FG000|Open Label Treatment Phase|Administrative Decision|30|||
148695494|NCT01345019|536357676|FG001|Open Label Treatment Phase|Administrative Decision|15|||
148695495|NCT01345019|536357675|FG000|Open Label Treatment Phase|Disease Progression|17|||
148695496|NCT01345019|536357676|FG001|Open Label Treatment Phase|Disease Progression|18|||
148695497|NCT01345019|536357675|FG000|Open Label Treatment Phase|Noncompliance|5|||
148695498|NCT01345019|536357676|FG001|Open Label Treatment Phase|Noncompliance|4|||
148695499|NCT01345019|536357675|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
148695500|NCT01345019|536357676|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
148695501|NCT01345019|536357675|FG000|Open Label Treatment Phase|Pregnancy|1|||
148695502|NCT01345019|536357676|FG001|Open Label Treatment Phase|Pregnancy|0|||
148695503|NCT01345019|536357675|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
148695504|NCT01345019|536357676|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
148695505|NCT01345019|536357675|FG000|Open Label Treatment Phase|Protocol Violation|0|||
148695506|NCT01345019|536357676|FG001|Open Label Treatment Phase|Protocol Violation|1|||
148695507|NCT03830164|536357677|FG000|Overall Study|Adverse Event|0|||
148695508|NCT03830164|536357678|FG001|Overall Study|Adverse Event|2|||
148813101|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
148963037|NCT01327300|537350870|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
148963038|NCT01327300|537350871|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
148963039|NCT03020823|537350872|FG000|Overall Study|Physician Decision|4|||
148695509|NCT03830164|536357679|FG002|Overall Study|Adverse Event|0|||
148695510|NCT03830164|536357677|FG000|Overall Study|Lack of Efficacy|1|||
148695511|NCT03830164|536357678|FG001|Overall Study|Lack of Efficacy|5|||
148695512|NCT03830164|536357679|FG002|Overall Study|Lack of Efficacy|0|||
148695513|NCT03830164|536357677|FG000|Overall Study|Lost to Follow-up|0|||
148963040|NCT03020823|537350872|FG000|Overall Study|Lack of Efficacy|4|||
148963041|NCT03020823|537350872|FG000|Overall Study|Adverse Event|2|||
148963042|NCT02082210|537350873|FG000|Overall Study|Death|0|||
148695514|NCT03830164|536357678|FG001|Overall Study|Lost to Follow-up|1|||
148695515|NCT03830164|536357679|FG002|Overall Study|Lost to Follow-up|0|||
148695516|NCT03830164|536357677|FG000|Overall Study|Withdrawal by Subject|1|||
148695517|NCT03830164|536357678|FG001|Overall Study|Withdrawal by Subject|0|||
148695518|NCT03830164|536357679|FG002|Overall Study|Withdrawal by Subject|0|||
148695519|NCT00860405|536357680|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
148695520|NCT00860405|536357681|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
148695521|NCT00497796|536357683|FG000|Overall Study|Adverse event (not related)|9|||
148695522|NCT00497796|536357684|FG001|Overall Study|Adverse event (not related)|9|||
148695523|NCT00497796|536357683|FG000|Overall Study|Adverse event (related)|5|||
148695524|NCT00497796|536357684|FG001|Overall Study|Adverse event (related)|4|||
148695525|NCT00497796|536357683|FG000|Overall Study|CMV infection or disease treatment|30|||
148695526|NCT00497796|536357684|FG001|Overall Study|CMV infection or disease treatment|4|||
148695527|NCT00497796|536357683|FG000|Overall Study|Consent withdrawn|10|||
148695528|NCT00497796|536357684|FG001|Overall Study|Consent withdrawn|3|||
148695529|NCT00497796|536357683|FG000|Overall Study|Investigator/sponsor discretion|31|||
148695530|NCT00497796|536357684|FG001|Overall Study|Investigator/sponsor discretion|34|||
148695531|NCT00497796|536357683|FG000|Overall Study|Lost to Follow-up|0|||
148695532|NCT00497796|536357684|FG001|Overall Study|Lost to Follow-up|1|||
148695533|NCT00497796|536357683|FG000|Overall Study|Not applicable (randomized not treated)|0|||
148695534|NCT00497796|536357684|FG001|Overall Study|Not applicable (randomized not treated)|4|||
148695535|NCT01074554|536357685|FG000|Overall Study|Adverse Event|3|||
148695536|NCT01074554|536357686|FG001|Overall Study|Adverse Event|3|||
148695537|NCT01074554|536357685|FG000|Overall Study|Lost to Follow-up|0|||
148695538|NCT01074554|536357686|FG001|Overall Study|Lost to Follow-up|1|||
148695539|NCT04276883|536357687|FG000|Overall Study|Withdrawal by Subject|2|||
148695540|NCT04276883|536357688|FG001|Overall Study|Withdrawal by Subject|3|||
148695541|NCT04276883|536357689|FG002|Overall Study|Withdrawal by Subject|6|||
148695542|NCT04276883|536357687|FG000|Overall Study|Lost to Follow-up|1|||
148695543|NCT04276883|536357688|FG001|Overall Study|Lost to Follow-up|3|||
148695544|NCT04276883|536357689|FG002|Overall Study|Lost to Follow-up|0|||
148695545|NCT04276883|536357687|FG000|Overall Study|Adverse Event|0|||
148695546|NCT04276883|536357688|FG001|Overall Study|Adverse Event|1|||
148963043|NCT02082210|537350874|FG001|Overall Study|Death|0|||
148963044|NCT02082210|537350875|FG002|Overall Study|Death|1|||
148963045|NCT02082210|537350876|FG003|Overall Study|Death|1|||
148963046|NCT02082210|537350877|FG004|Overall Study|Death|1|||
148963047|NCT02082210|537350878|FG005|Overall Study|Death|0|||
148963048|NCT02082210|537350873|FG000|Overall Study|Withdrawal by Subject|0|||
148963049|NCT02082210|537350874|FG001|Overall Study|Withdrawal by Subject|0|||
148963050|NCT02082210|537350875|FG002|Overall Study|Withdrawal by Subject|0|||
148963051|NCT02082210|537350876|FG003|Overall Study|Withdrawal by Subject|1|||
148963052|NCT02082210|537350877|FG004|Overall Study|Withdrawal by Subject|2|||
148963053|NCT02082210|537350878|FG005|Overall Study|Withdrawal by Subject|2|||
148963054|NCT02082210|537350873|FG000|Overall Study|Clinical Progression|0|||
148963055|NCT02082210|537350874|FG001|Overall Study|Clinical Progression|0|||
148963056|NCT02082210|537350875|FG002|Overall Study|Clinical Progression|0|||
148963057|NCT02082210|537350876|FG003|Overall Study|Clinical Progression|1|||
148963058|NCT02082210|537350877|FG004|Overall Study|Clinical Progression|0|||
148963059|NCT02082210|537350878|FG005|Overall Study|Clinical Progression|0|||
148963060|NCT02082210|537350873|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
148963061|NCT02082210|537350874|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
148963062|NCT02082210|537350875|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
148963063|NCT02082210|537350876|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
148963064|NCT02082210|537350877|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
148963065|NCT02082210|537350878|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
148963066|NCT02082210|537350873|FG000|Overall Study|Physician Decision|0|||
148963067|NCT02082210|537350874|FG001|Overall Study|Physician Decision|0|||
148963068|NCT02082210|537350875|FG002|Overall Study|Physician Decision|1|||
148963069|NCT02082210|537350876|FG003|Overall Study|Physician Decision|1|||
148695547|NCT04276883|536357689|FG002|Overall Study|Adverse Event|0|||
148695548|NCT04276883|536357687|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
148695549|NCT04276883|536357688|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
148695550|NCT04276883|536357689|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
148695551|NCT04526210|536359278|FG000|Overall Study|Sponsor decision|7|||
148695552|NCT04526210|536359279|FG001|Overall Study|Sponsor decision|5|||
148695553|NCT04526210|536359278|FG000|Overall Study|Withdrawal by Subject|3|||
148695554|NCT04526210|536359279|FG001|Overall Study|Withdrawal by Subject|2|||
148695555|NCT02924038|536359280|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
148695556|NCT02924038|536359281|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
148695557|NCT02473640|536359284|FG000|Treatment Period 1|Adverse Event|1|||
148695558|NCT02777528|536359287|FG000|Overall Study|Still in study|24|||
148963070|NCT02082210|537350877|FG004|Overall Study|Physician Decision|0|||
148963071|NCT02082210|537350878|FG005|Overall Study|Physician Decision|0|||
148963072|NCT04762680|537350879|FG000|Phase 2|Adverse Event|0|||
148695559|NCT02777528|536359288|FG001|Overall Study|Still in study|10|||
148695560|NCT02777528|536359289|FG002|Overall Study|Still in study|1|||
148695561|NCT02777528|536359287|FG000|Overall Study|Study Device Explanted|1|||
148695562|NCT02777528|536359288|FG001|Overall Study|Study Device Explanted|0|||
148695563|NCT02777528|536359289|FG002|Overall Study|Study Device Explanted|0|||
148695564|NCT02777528|536359287|FG000|Overall Study|Death|14|||
148695565|NCT02777528|536359288|FG001|Overall Study|Death|7|||
148695566|NCT02777528|536359289|FG002|Overall Study|Death|1|||
148813102|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
148963073|NCT04762680|537350880|FG001|Phase 2|Adverse Event|1|||
148963074|NCT04762680|537350881|FG002|Phase 2|Adverse Event|0|||
148963075|NCT04762680|537350882|FG003|Phase 2|Adverse Event|0|||
148963076|NCT04762680|537350883|FG004|Phase 2|Adverse Event|0|||
148963077|NCT04762680|537350884|FG005|Phase 2|Adverse Event|0|||
148963078|NCT04762680|537350885|FG006|Phase 2|Adverse Event|0|||
148963079|NCT04762680|537350886|FG007|Phase 2|Adverse Event|0|||
148963080|NCT04762680|537350887|FG008|Phase 2|Adverse Event|0|||
148963081|NCT04762680|537350888|FG009|Phase 2|Adverse Event|0|||
148963082|NCT04762680|537350889|FG010|Phase 2|Adverse Event|0|||
148963083|NCT04762680|537350890|FG011|Phase 2|Adverse Event|0|||
148963084|NCT04762680|537350891|FG012|Phase 2|Adverse Event|0|||
148963085|NCT04762680|537350892|FG013|Phase 2|Adverse Event|0|||
148963086|NCT04762680|537350893|FG014|Phase 2|Adverse Event|0|||
148963087|NCT04762680|537350894|FG015|Phase 2|Adverse Event|0|||
148963088|NCT04762680|537350895|FG016|Phase 2|Adverse Event|0|||
148963089|NCT04762680|537350896|FG017|Phase 2|Adverse Event|0|||
148963090|NCT04762680|537350897|FG018|Phase 2|Adverse Event|0|||
148963091|NCT04762680|537350898|FG019|Phase 2|Adverse Event|0|||
148963092|NCT04762680|537350899|FG020|Phase 2|Adverse Event|0|||
148963093|NCT04762680|537350900|FG021|Phase 2|Adverse Event|0|||
148963094|NCT04762680|537350879|FG000|Phase 2|Protocol Violation|5|||
148963095|NCT04762680|537350880|FG001|Phase 2|Protocol Violation|5|||
148963096|NCT04762680|537350881|FG002|Phase 2|Protocol Violation|1|||
148963097|NCT04762680|537350882|FG003|Phase 2|Protocol Violation|0|||
148963098|NCT04762680|537350883|FG004|Phase 2|Protocol Violation|0|||
148963099|NCT04762680|537350884|FG005|Phase 2|Protocol Violation|0|||
148963100|NCT04762680|537350885|FG006|Phase 2|Protocol Violation|0|||
148963101|NCT04762680|537350886|FG007|Phase 2|Protocol Violation|0|||
148963102|NCT04762680|537350887|FG008|Phase 2|Protocol Violation|0|||
148963103|NCT04762680|537350888|FG009|Phase 2|Protocol Violation|0|||
148963104|NCT04762680|537350889|FG010|Phase 2|Protocol Violation|0|||
148963105|NCT04762680|537350890|FG011|Phase 2|Protocol Violation|0|||
148963106|NCT04762680|537350891|FG012|Phase 2|Protocol Violation|0|||
148963107|NCT04762680|537350892|FG013|Phase 2|Protocol Violation|0|||
148963108|NCT04762680|537350893|FG014|Phase 2|Protocol Violation|0|||
148963109|NCT04762680|537350894|FG015|Phase 2|Protocol Violation|0|||
148963110|NCT04762680|537350895|FG016|Phase 2|Protocol Violation|0|||
148963111|NCT04762680|537350896|FG017|Phase 2|Protocol Violation|0|||
148963112|NCT04762680|537350897|FG018|Phase 2|Protocol Violation|0|||
148963113|NCT04762680|537350898|FG019|Phase 2|Protocol Violation|0|||
148963114|NCT04762680|537350899|FG020|Phase 2|Protocol Violation|0|||
148963115|NCT04762680|537350900|FG021|Phase 2|Protocol Violation|0|||
148963116|NCT04762680|537350879|FG000|Phase 2|Withdrawal by Subject|23|||
148963117|NCT04762680|537350880|FG001|Phase 2|Withdrawal by Subject|21|||
148963118|NCT04762680|537350881|FG002|Phase 2|Withdrawal by Subject|28|||
148963119|NCT04762680|537350882|FG003|Phase 2|Withdrawal by Subject|0|||
148695567|NCT02777528|536359287|FG000|Overall Study|Withdrawal by Subject|2|||
148695568|NCT02777528|536359288|FG001|Overall Study|Withdrawal by Subject|2|||
148963120|NCT04762680|537350883|FG004|Phase 2|Withdrawal by Subject|0|||
148963121|NCT04762680|537350884|FG005|Phase 2|Withdrawal by Subject|0|||
148963122|NCT04762680|537350885|FG006|Phase 2|Withdrawal by Subject|0|||
148963123|NCT04762680|537350886|FG007|Phase 2|Withdrawal by Subject|0|||
148963124|NCT04762680|537350887|FG008|Phase 2|Withdrawal by Subject|0|||
148963125|NCT04762680|537350888|FG009|Phase 2|Withdrawal by Subject|0|||
148963126|NCT04762680|537350889|FG010|Phase 2|Withdrawal by Subject|0|||
148963127|NCT04762680|537350890|FG011|Phase 2|Withdrawal by Subject|0|||
148963128|NCT04762680|537350891|FG012|Phase 2|Withdrawal by Subject|0|||
148963129|NCT04762680|537350892|FG013|Phase 2|Withdrawal by Subject|0|||
148813103|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
148813104|NCT01069939|536790584|FG000|Randomised and Included in the Analyses|Removal|1|||
148963130|NCT04762680|537350893|FG014|Phase 2|Withdrawal by Subject|0|||
148963131|NCT04762680|537350894|FG015|Phase 2|Withdrawal by Subject|0|||
148963132|NCT04762680|537350895|FG016|Phase 2|Withdrawal by Subject|0|||
148963133|NCT04762680|537350896|FG017|Phase 2|Withdrawal by Subject|0|||
148963134|NCT04762680|537350897|FG018|Phase 2|Withdrawal by Subject|0|||
148963135|NCT04762680|537350898|FG019|Phase 2|Withdrawal by Subject|0|||
148963136|NCT04762680|537350899|FG020|Phase 2|Withdrawal by Subject|0|||
148963137|NCT04762680|537350900|FG021|Phase 2|Withdrawal by Subject|0|||
148963138|NCT04762680|537350879|FG000|Phase 2|Lost to Follow-up|14|||
148963139|NCT04762680|537350880|FG001|Phase 2|Lost to Follow-up|8|||
148963140|NCT04762680|537350881|FG002|Phase 2|Lost to Follow-up|9|||
148963141|NCT04762680|537350882|FG003|Phase 2|Lost to Follow-up|0|||
148963142|NCT04762680|537350883|FG004|Phase 2|Lost to Follow-up|0|||
148963143|NCT04762680|537350884|FG005|Phase 2|Lost to Follow-up|0|||
148963144|NCT04762680|537350885|FG006|Phase 2|Lost to Follow-up|0|||
148963145|NCT04762680|537350886|FG007|Phase 2|Lost to Follow-up|0|||
148963146|NCT04762680|537350887|FG008|Phase 2|Lost to Follow-up|0|||
148963147|NCT04762680|537350888|FG009|Phase 2|Lost to Follow-up|0|||
148963148|NCT04762680|537350889|FG010|Phase 2|Lost to Follow-up|0|||
148963149|NCT04762680|537350890|FG011|Phase 2|Lost to Follow-up|0|||
148963150|NCT04762680|537350891|FG012|Phase 2|Lost to Follow-up|0|||
148963151|NCT04762680|537350892|FG013|Phase 2|Lost to Follow-up|0|||
148963152|NCT04762680|537350893|FG014|Phase 2|Lost to Follow-up|0|||
148963153|NCT04762680|537350894|FG015|Phase 2|Lost to Follow-up|0|||
148963154|NCT04762680|537350895|FG016|Phase 2|Lost to Follow-up|0|||
148963155|NCT04762680|537350896|FG017|Phase 2|Lost to Follow-up|0|||
148963156|NCT04762680|537350897|FG018|Phase 2|Lost to Follow-up|0|||
148963157|NCT04762680|537350898|FG019|Phase 2|Lost to Follow-up|0|||
148963158|NCT04762680|537350899|FG020|Phase 2|Lost to Follow-up|0|||
148963159|NCT04762680|537350900|FG021|Phase 2|Lost to Follow-up|0|||
148963160|NCT04762680|537350879|FG000|Phase 3|Adverse Event|0|||
148963161|NCT04762680|537350880|FG001|Phase 3|Adverse Event|0|||
148963162|NCT04762680|537350881|FG002|Phase 3|Adverse Event|0|||
148963163|NCT04762680|537350882|FG003|Phase 3|Adverse Event|1|||
148963164|NCT04762680|537350883|FG004|Phase 3|Adverse Event|0|||
148963165|NCT04762680|537350884|FG005|Phase 3|Adverse Event|0|||
148963166|NCT04762680|537350885|FG006|Phase 3|Adverse Event|0|||
148963167|NCT04762680|537350886|FG007|Phase 3|Adverse Event|0|||
148963168|NCT04762680|537350887|FG008|Phase 3|Adverse Event|0|||
148963169|NCT04762680|537350888|FG009|Phase 3|Adverse Event|0|||
148963170|NCT04762680|537350889|FG010|Phase 3|Adverse Event|0|||
148963171|NCT04762680|537350890|FG011|Phase 3|Adverse Event|0|||
148963172|NCT04762680|537350891|FG012|Phase 3|Adverse Event|0|||
148963173|NCT04762680|537350892|FG013|Phase 3|Adverse Event|0|||
148963174|NCT04762680|537350893|FG014|Phase 3|Adverse Event|0|||
148963175|NCT04762680|537350894|FG015|Phase 3|Adverse Event|0|||
148963176|NCT04762680|537350895|FG016|Phase 3|Adverse Event|0|||
148963177|NCT04762680|537350896|FG017|Phase 3|Adverse Event|3|||
148963178|NCT04762680|537350897|FG018|Phase 3|Adverse Event|0|||
148963179|NCT04762680|537350898|FG019|Phase 3|Adverse Event|0|||
148963180|NCT04762680|537350899|FG020|Phase 3|Adverse Event|0|||
148963181|NCT04762680|537350900|FG021|Phase 3|Adverse Event|0|||
148963182|NCT04762680|537350879|FG000|Phase 3|Protocol Violation|0|||
148963183|NCT04762680|537350880|FG001|Phase 3|Protocol Violation|0|||
148963184|NCT04762680|537350881|FG002|Phase 3|Protocol Violation|0|||
148963185|NCT04762680|537350882|FG003|Phase 3|Protocol Violation|4|||
148963186|NCT04762680|537350883|FG004|Phase 3|Protocol Violation|1|||
148963187|NCT04762680|537350884|FG005|Phase 3|Protocol Violation|5|||
148963188|NCT04762680|537350885|FG006|Phase 3|Protocol Violation|1|||
148963189|NCT04762680|537350886|FG007|Phase 3|Protocol Violation|0|||
148963190|NCT04762680|537350887|FG008|Phase 3|Protocol Violation|0|||
148963191|NCT04762680|537350888|FG009|Phase 3|Protocol Violation|0|||
148963192|NCT04762680|537350889|FG010|Phase 3|Protocol Violation|0|||
148963193|NCT04762680|537350890|FG011|Phase 3|Protocol Violation|2|||
148963194|NCT04762680|537350891|FG012|Phase 3|Protocol Violation|3|||
148963195|NCT04762680|537350892|FG013|Phase 3|Protocol Violation|0|||
148963196|NCT04762680|537350893|FG014|Phase 3|Protocol Violation|0|||
148963197|NCT04762680|537350894|FG015|Phase 3|Protocol Violation|1|||
148963198|NCT04762680|537350895|FG016|Phase 3|Protocol Violation|0|||
148963199|NCT04762680|537350896|FG017|Phase 3|Protocol Violation|10|||
148963200|NCT04762680|537350897|FG018|Phase 3|Protocol Violation|0|||
148963201|NCT04762680|537350898|FG019|Phase 3|Protocol Violation|0|||
148963202|NCT04762680|537350899|FG020|Phase 3|Protocol Violation|0|||
148963203|NCT04762680|537350900|FG021|Phase 3|Protocol Violation|0|||
148963204|NCT04762680|537350879|FG000|Phase 3|Withdrawal by Subject|0|||
148963205|NCT04762680|537350880|FG001|Phase 3|Withdrawal by Subject|0|||
148963206|NCT04762680|537350881|FG002|Phase 3|Withdrawal by Subject|0|||
148963207|NCT04762680|537350882|FG003|Phase 3|Withdrawal by Subject|13|||
148963208|NCT04762680|537350883|FG004|Phase 3|Withdrawal by Subject|17|||
148963209|NCT04762680|537350884|FG005|Phase 3|Withdrawal by Subject|12|||
148963210|NCT04762680|537350885|FG006|Phase 3|Withdrawal by Subject|8|||
148963211|NCT04762680|537350886|FG007|Phase 3|Withdrawal by Subject|3|||
148963212|NCT04762680|537350887|FG008|Phase 3|Withdrawal by Subject|2|||
148963213|NCT04762680|537350888|FG009|Phase 3|Withdrawal by Subject|4|||
148963214|NCT04762680|537350889|FG010|Phase 3|Withdrawal by Subject|3|||
148963215|NCT04762680|537350890|FG011|Phase 3|Withdrawal by Subject|1|||
148963216|NCT04762680|537350891|FG012|Phase 3|Withdrawal by Subject|3|||
148963217|NCT04762680|537350892|FG013|Phase 3|Withdrawal by Subject|2|||
148963218|NCT04762680|537350893|FG014|Phase 3|Withdrawal by Subject|1|||
148963219|NCT04762680|537350894|FG015|Phase 3|Withdrawal by Subject|4|||
148963220|NCT04762680|537350895|FG016|Phase 3|Withdrawal by Subject|6|||
148963221|NCT04762680|537350896|FG017|Phase 3|Withdrawal by Subject|32|||
148963222|NCT04762680|537350897|FG018|Phase 3|Withdrawal by Subject|0|||
148963223|NCT04762680|537350898|FG019|Phase 3|Withdrawal by Subject|0|||
148963224|NCT04762680|537350899|FG020|Phase 3|Withdrawal by Subject|0|||
148963225|NCT04762680|537350900|FG021|Phase 3|Withdrawal by Subject|0|||
148963226|NCT04762680|537350879|FG000|Phase 3|Lost to Follow-up|0|||
148963227|NCT04762680|537350880|FG001|Phase 3|Lost to Follow-up|0|||
148963228|NCT04762680|537350881|FG002|Phase 3|Lost to Follow-up|0|||
148963229|NCT04762680|537350882|FG003|Phase 3|Lost to Follow-up|9|||
148963230|NCT04762680|537350883|FG004|Phase 3|Lost to Follow-up|22|||
148963231|NCT04762680|537350884|FG005|Phase 3|Lost to Follow-up|24|||
148963232|NCT04762680|537350885|FG006|Phase 3|Lost to Follow-up|2|||
148963233|NCT04762680|537350886|FG007|Phase 3|Lost to Follow-up|4|||
148963234|NCT04762680|537350887|FG008|Phase 3|Lost to Follow-up|6|||
148963235|NCT04762680|537350888|FG009|Phase 3|Lost to Follow-up|4|||
148963236|NCT04762680|537350889|FG010|Phase 3|Lost to Follow-up|3|||
148963237|NCT04762680|537350890|FG011|Phase 3|Lost to Follow-up|0|||
148963238|NCT04762680|537350891|FG012|Phase 3|Lost to Follow-up|5|||
148963239|NCT04762680|537350892|FG013|Phase 3|Lost to Follow-up|4|||
148963240|NCT04762680|537350893|FG014|Phase 3|Lost to Follow-up|6|||
148963241|NCT04762680|537350894|FG015|Phase 3|Lost to Follow-up|1|||
148963242|NCT04762680|537350895|FG016|Phase 3|Lost to Follow-up|1|||
148963243|NCT04762680|537350896|FG017|Phase 3|Lost to Follow-up|66|||
148963244|NCT04762680|537350897|FG018|Phase 3|Lost to Follow-up|0|||
148963245|NCT04762680|537350898|FG019|Phase 3|Lost to Follow-up|0|||
148963246|NCT04762680|537350899|FG020|Phase 3|Lost to Follow-up|0|||
148963247|NCT04762680|537350900|FG021|Phase 3|Lost to Follow-up|0|||
148963248|NCT04762680|537350879|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963249|NCT04762680|537350880|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963250|NCT04762680|537350881|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963251|NCT04762680|537350882|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963252|NCT04762680|537350883|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963253|NCT04762680|537350884|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963254|NCT04762680|537350885|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963255|NCT04762680|537350886|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963256|NCT04762680|537350887|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963257|NCT04762680|537350888|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963258|NCT04762680|537350889|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963259|NCT04762680|537350890|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963260|NCT04762680|537350891|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963261|NCT04762680|537350892|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963262|NCT04762680|537350893|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963263|NCT04762680|537350894|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963264|NCT04762680|537350895|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963265|NCT04762680|537350896|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963266|NCT04762680|537350897|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963267|NCT04762680|537350898|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963268|NCT04762680|537350899|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
148963269|NCT04762680|537350900|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
148963270|NCT04762680|537350879|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963271|NCT04762680|537350880|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963272|NCT04762680|537350881|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963273|NCT04762680|537350882|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963274|NCT04762680|537350883|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963275|NCT04762680|537350884|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963276|NCT04762680|537350885|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963277|NCT04762680|537350886|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963278|NCT04762680|537350887|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963279|NCT04762680|537350888|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963280|NCT04762680|537350889|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963281|NCT04762680|537350890|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963282|NCT04762680|537350891|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963283|NCT04762680|537350892|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963284|NCT04762680|537350893|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963285|NCT04762680|537350894|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963286|NCT04762680|537350895|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963287|NCT04762680|537350896|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963288|NCT04762680|537350897|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963289|NCT04762680|537350898|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
148963290|NCT04762680|537350899|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963291|NCT04762680|537350900|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
148963292|NCT04307446|537350907|FG000|Overall Study|Lost to Follow-up|2|||
148963293|NCT04307446|537350908|FG001|Overall Study|Lost to Follow-up|0|||
148963294|NCT01063764|537350912|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
148963295|NCT01063764|537350912|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
148963296|NCT01063764|537350912|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
148963297|NCT01063764|537350912|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
148963298|NCT01063764|537350912|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
148963299|NCT01063764|537350912|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
148963300|NCT01063764|537350912|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
148963301|NCT00697515|537350913|FG000|Dose Optimization Period|Adverse Event|4|||
148963302|NCT00697515|537350914|FG001|Dose Optimization Period|Adverse Event|0|||
148963303|NCT00697515|537350913|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
148963304|NCT00697515|537350914|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
148963305|NCT00697515|537350913|FG000|Dose Optimization Period|Lost to Follow-up|2|||
148963306|NCT00697515|537350914|FG001|Dose Optimization Period|Lost to Follow-up|0|||
148963307|NCT00697515|537350913|FG000|Dose Optimization Period|sponsor request|2|||
148963308|NCT00697515|537350914|FG001|Dose Optimization Period|sponsor request|0|||
148963309|NCT00697515|537350913|FG000|Dose Optimization Period|called to active duty|1|||
148963310|NCT00697515|537350914|FG001|Dose Optimization Period|called to active duty|0|||
148963311|NCT00697515|537350913|FG000|Dose Optimization Period|elevated QTc|1|||
148963312|NCT00697515|537350914|FG001|Dose Optimization Period|elevated QTc|0|||
148963313|NCT00697515|537350913|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
148963314|NCT00697515|537350914|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
148963315|NCT00697515|537350913|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
148963316|NCT00697515|537350914|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
148963317|NCT00697515|537350913|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
148963318|NCT00697515|537350914|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
148963319|NCT00697515|537350913|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
148963320|NCT00697515|537350914|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
148963321|NCT01727141|537350915|FG000|Overall Study|Physician Decision|0|||
148963322|NCT01727141|537350916|FG001|Overall Study|Physician Decision|1|||
148963323|NCT01727141|537350917|FG002|Overall Study|Physician Decision|0|||
148963324|NCT01727141|537350918|FG003|Overall Study|Physician Decision|2|||
148963325|NCT01727141|537350915|FG000|Overall Study|Lost to Follow-up|0|||
148963326|NCT01727141|537350916|FG001|Overall Study|Lost to Follow-up|2|||
148963327|NCT01727141|537350917|FG002|Overall Study|Lost to Follow-up|0|||
148963328|NCT01727141|537350918|FG003|Overall Study|Lost to Follow-up|0|||
148963329|NCT01727141|537350915|FG000|Overall Study|Death|0|||
148963330|NCT01727141|537350916|FG001|Overall Study|Death|1|||
148963331|NCT01727141|537350917|FG002|Overall Study|Death|1|||
148963332|NCT01727141|537350918|FG003|Overall Study|Death|1|||
148963333|NCT01727141|537350915|FG000|Overall Study|Protocol deviation|1|||
148963334|NCT01727141|537350916|FG001|Overall Study|Protocol deviation|1|||
148963335|NCT01727141|537350917|FG002|Overall Study|Protocol deviation|0|||
148963336|NCT01727141|537350918|FG003|Overall Study|Protocol deviation|1|||
148963337|NCT01727141|537350915|FG000|Overall Study|Withdrawal by Subject|4|||
148963338|NCT01727141|537350916|FG001|Overall Study|Withdrawal by Subject|4|||
148963339|NCT01727141|537350917|FG002|Overall Study|Withdrawal by Subject|2|||
148963340|NCT01727141|537350918|FG003|Overall Study|Withdrawal by Subject|11|||
148963341|NCT03538158|537350919|FG000|Overall Study|Lost to Follow-up|13|||
148963342|NCT03538158|537350920|FG001|Overall Study|Lost to Follow-up|7|||
148963343|NCT03538158|537350919|FG000|Overall Study|Withdrawal by Subject|2|||
148963344|NCT03538158|537350920|FG001|Overall Study|Withdrawal by Subject|1|||
148963345|NCT03425331|537350921|FG000|Overall Study|Withdrawal by Subject|1|||
148963346|NCT03425331|537350921|FG000|Overall Study|Death|1|||
148963347|NCT03425331|537350921|FG000|Overall Study|Adverse Event|1|||
148963348|NCT03425331|537350921|FG000|Overall Study|Disease Progression|2|||
148963349|NCT01454570|537350924|FG000|Overall Study|Withdrawal by Subject|2|||
149024078|NCT01256476|537564165|FG000|Overall Study|Subject non-compliance|0|||
148963350|NCT01454570|537350924|FG000|Overall Study|Screen Failure|7|||
148963351|NCT00791518|537350925|FG000|Overall Study|Protocol Violation|93|||
148963352|NCT02488681|537350926|FG000|Overall Study|Implant unsuccessful|7|||
148963353|NCT04969224|537350929|FG000|Overall Study|Adverse Event|1|||
148963354|NCT04969224|537350929|FG000|Overall Study|Enrolled but never dosed|1|||
148963355|NCT01498952|537350930|FG000|Overall Study|Death|2|||
148963356|NCT01498952|537350931|FG001|Overall Study|Death|2|||
148963357|NCT01498952|537350932|FG002|Overall Study|Death|0|||
148963358|NCT01498952|537350933|FG003|Overall Study|Death|0|||
148963359|NCT01498952|537350934|FG004|Overall Study|Death|0|||
148963360|NCT02726074|537350935|FG000|Overall Study|Withdrawal by Subject|4|||
148963361|NCT02726074|537350935|FG000|Overall Study|Adverse Event|14|||
148963362|NCT02726074|537350935|FG000|Overall Study|Protocol Violation|3|||
148963363|NCT02726074|537350935|FG000|Overall Study|Lost to Follow-up|2|||
148963364|NCT02726074|537350935|FG000|Overall Study|Others|3|||
148963365|NCT00579826|537350936|FG000|Overall Study|Withdrawal by Subject|5|||
148963366|NCT00579826|537350937|FG001|Overall Study|Withdrawal by Subject|3|||
148963367|NCT01170091|537350938|FG000|Overall Study|Missing efficacy evaluation|3|||
148963368|NCT01170091|537350938|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
148963369|NCT03194321|537350939|FG000|Overall Study|Withdrawal by Subject|1|||
148963370|NCT03194321|537350939|FG000|Overall Study|Lost to Follow-up|1|||
148963371|NCT03194321|537350939|FG000|Overall Study|Travel for Follow-up|1|||
148963372|NCT02188589|537350940|FG000|Overall Study|Withdrawal by Subject|5|||
148963373|NCT00643682|537350943|FG000|Overall Study|did not keep appointment|522|||
148963374|NCT00643682|537350944|FG001|Overall Study|did not keep appointment|509|||
148963375|NCT03755414|537350946|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
148963376|NCT03755414|537350947|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
148963377|NCT03755414|537350948|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
148963378|NCT03755414|537350946|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
148963379|NCT03755414|537350947|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
148963380|NCT03755414|537350948|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
148963381|NCT03755414|537350946|FG000|Overall Study|Non-compliance|0|||
148963382|NCT03755414|537350947|FG001|Overall Study|Non-compliance|1|||
148963383|NCT03755414|537350948|FG002|Overall Study|Non-compliance|0|||
148963384|NCT05778786|537350949|FG000|Period 1|COVID-19 Related|3|||
148963385|NCT05778786|537350950|FG001|Period 1|COVID-19 Related|3|||
148963386|NCT05778786|537350949|FG000|Period 1|Withdrew Consent during Study|1|||
148963387|NCT05778786|537350950|FG001|Period 1|Withdrew Consent during Study|0|||
148963388|NCT05778786|537350949|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
148963389|NCT05778786|537350950|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
148963390|NCT05778786|537350949|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
148963391|NCT05778786|537350950|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
148963392|NCT00718328|537350955|FG000|Overall Study|Lost to Follow-up|1|||
148963393|NCT00718328|537350956|FG001|Overall Study|Lost to Follow-up|0|||
148963394|NCT02865915|537350957|FG000|Overall Study|Pregnancy|1|||
148963395|NCT02865915|537350958|FG001|Overall Study|Pregnancy|0|||
148963396|NCT02865915|537350957|FG000|Overall Study|Withdrawal by Subject|1|||
148963397|NCT02865915|537350958|FG001|Overall Study|Withdrawal by Subject|1|||
148963398|NCT02865915|537350957|FG000|Overall Study|Adverse Event|0|||
148963399|NCT02865915|537350958|FG001|Overall Study|Adverse Event|4|||
148963400|NCT02865915|537350957|FG000|Overall Study|Lost to Follow-up|0|||
148963401|NCT02865915|537350958|FG001|Overall Study|Lost to Follow-up|1|||
148963402|NCT02865915|537350957|FG000|Overall Study|Protocol Violation|0|||
148963403|NCT02865915|537350958|FG001|Overall Study|Protocol Violation|1|||
148963404|NCT02865915|537350957|FG000|Overall Study|Study terminated by sponsor|23|||
148695569|NCT02777528|536359289|FG002|Overall Study|Withdrawal by Subject|1|||
148695570|NCT02777528|536359287|FG000|Overall Study|Physician Decision|2|||
148695571|NCT02777528|536359288|FG001|Overall Study|Physician Decision|1|||
148695572|NCT02777528|536359289|FG002|Overall Study|Physician Decision|0|||
148695573|NCT02777528|536359287|FG000|Overall Study|Lost to Follow-up|2|||
148695574|NCT02777528|536359288|FG001|Overall Study|Lost to Follow-up|0|||
148695575|NCT02777528|536359289|FG002|Overall Study|Lost to Follow-up|0|||
148695576|NCT02777528|536359287|FG000|Overall Study|Discontinued due to Other|1|||
148695577|NCT02777528|536359288|FG001|Overall Study|Discontinued due to Other|0|||
148695578|NCT02777528|536359289|FG002|Overall Study|Discontinued due to Other|0|||
148695579|NCT00453362|536359292|FG000|Overall Study|Adverse Event|5|||
148695580|NCT00453362|536359292|FG000|Overall Study|Death|7|||
148695581|NCT00453362|536359292|FG000|Overall Study|Physician Decision|2|||
148695582|NCT00453362|536359292|FG000|Overall Study|Withdrawal by Subject|3|||
148695583|NCT00453362|536359292|FG000|Overall Study|Progression of disease|56|||
148695584|NCT00453362|536359292|FG000|Overall Study|Screening Failure|14|||
148963405|NCT02865915|537350958|FG001|Overall Study|Study terminated by sponsor|18|||
148963406|NCT02865915|537350957|FG000|Overall Study|Dosing group discontinued|0|||
148963407|NCT02865915|537350958|FG001|Overall Study|Dosing group discontinued|5|||
148963408|NCT00663052|537350961|FG000|Overall Study|Adverse Event|6|||
148963409|NCT00663052|537350962|FG001|Overall Study|Adverse Event|3|||
148963410|NCT00663052|537350961|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
148963411|NCT00663052|537350962|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
148963412|NCT00663052|537350961|FG000|Overall Study|Protocol Violation|1|||
148963413|NCT00663052|537350962|FG001|Overall Study|Protocol Violation|0|||
148963414|NCT00663052|537350961|FG000|Overall Study|Withdrawal by Subject|2|||
148963415|NCT00663052|537350962|FG001|Overall Study|Withdrawal by Subject|5|||
148963416|NCT00663052|537350961|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
148963417|NCT00663052|537350962|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
148963418|NCT00663052|537350961|FG000|Overall Study|Other|0|||
148963419|NCT00663052|537350962|FG001|Overall Study|Other|1|||
148963420|NCT05497284|537350965|FG000|Overall Study|Adverse Event|1|||
148963421|NCT05497284|537350966|FG001|Overall Study|Adverse Event|0|||
148963422|NCT05497284|537350965|FG000|Overall Study|Physician Decision|0|||
148963423|NCT05497284|537350966|FG001|Overall Study|Physician Decision|1|||
148963424|NCT05497284|537350965|FG000|Overall Study|Study terminated by sponsor|7|||
148963425|NCT05497284|537350966|FG001|Overall Study|Study terminated by sponsor|4|||
148963426|NCT05497284|537350965|FG000|Overall Study|Subject Decision|0|||
148963427|NCT05497284|537350966|FG001|Overall Study|Subject Decision|1|||
148963428|NCT05760300|537350967|FG000|Overall Study|Adverse Event|0|||
148963429|NCT05760300|537350968|FG001|Overall Study|Adverse Event|0|||
148963430|NCT05760300|537350969|FG002|Overall Study|Adverse Event|1|||
148963431|NCT05760300|537350970|FG003|Overall Study|Adverse Event|0|||
148963432|NCT05760300|537350967|FG000|Overall Study|Participant Decision|1|||
148963433|NCT05760300|537350968|FG001|Overall Study|Participant Decision|0|||
148963434|NCT05760300|537350969|FG002|Overall Study|Participant Decision|0|||
148963435|NCT05760300|537350970|FG003|Overall Study|Participant Decision|0|||
148963436|NCT03878446|537350974|FG000|Overall Study|Withdrawn by parent or guardian|1|||
148963437|NCT03878446|537350975|FG001|Overall Study|Withdrawn by parent or guardian|0|||
148963438|NCT03878446|537350976|FG002|Overall Study|Withdrawn by parent or guardian|0|||
148963439|NCT03878446|537350977|FG003|Overall Study|Withdrawn by parent or guardian|0|||
148963440|NCT03878446|537350978|FG004|Overall Study|Withdrawn by parent or guardian|0|||
148963441|NCT03188094|537350981|FG000|Overall Study|Screen failure|1|||
148963442|NCT03188094|537350982|FG001|Overall Study|Screen failure|0|||
148963443|NCT03188094|537350983|FG002|Overall Study|Screen failure|0|||
148963444|NCT03188094|537350981|FG000|Overall Study|Pregnancy|3|||
148963445|NCT03188094|537350982|FG001|Overall Study|Pregnancy|0|||
148963446|NCT03188094|537350983|FG002|Overall Study|Pregnancy|0|||
148963447|NCT03188094|537350981|FG000|Overall Study|Ineligible|1|||
148963448|NCT03188094|537350982|FG001|Overall Study|Ineligible|0|||
148963449|NCT03188094|537350983|FG002|Overall Study|Ineligible|0|||
148963450|NCT03188094|537350981|FG000|Overall Study|Lost to Follow-up|0|||
149024079|NCT01256476|537564166|FG001|Overall Study|Subject non-compliance|1|||
149024080|NCT01256476|537564165|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
149024081|NCT01256476|537564166|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
148695585|NCT04885296|536359293|FG000|Period 1|Covid-19 Related|1|||
148963451|NCT03188094|537350982|FG001|Overall Study|Lost to Follow-up|0|||
148963452|NCT03188094|537350983|FG002|Overall Study|Lost to Follow-up|17|||
149024082|NCT02401529|537564169|FG000|Overall Study|Lost to Follow-up|2|||
148695586|NCT04885296|536359294|FG001|Period 1|Covid-19 Related|0|||
148695587|NCT04885296|536359293|FG000|Period 1|Adverse Event|0|||
148695588|NCT04885296|536359294|FG001|Period 1|Adverse Event|1|||
148963453|NCT03615105|537350984|FG000|Overall Study|Protocol Violation|1|||
148963454|NCT03615105|537350985|FG001|Overall Study|Protocol Violation|0|||
148963455|NCT03615105|537350986|FG002|Overall Study|Protocol Violation|0|||
148963456|NCT03615105|537350984|FG000|Overall Study|Death|0|||
148695589|NCT04885296|536359293|FG000|Period 1|Withdrawal by Subject|1|||
148963457|NCT03615105|537350985|FG001|Overall Study|Death|2|||
148963458|NCT03615105|537350986|FG002|Overall Study|Death|0|||
148695590|NCT04885296|536359294|FG001|Period 1|Withdrawal by Subject|1|||
148695591|NCT04885296|536359293|FG000|Period 1|Test Article No Longer Available|1|||
148695592|NCT04885296|536359294|FG001|Period 1|Test Article No Longer Available|0|||
148695593|NCT04885296|536359293|FG000|Period 1|Dispensed Study lens in Error|1|||
148695594|NCT04885296|536359294|FG001|Period 1|Dispensed Study lens in Error|0|||
148695595|NCT04885296|536359293|FG000|Period 1|Lost to Follow-up|1|||
148695596|NCT04885296|536359294|FG001|Period 1|Lost to Follow-up|0|||
148695597|NCT04885296|536359293|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
148695598|NCT04885296|536359294|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
148695599|NCT00433147|536359296|FG000|Overall Study|Adverse Event|0|||
148695600|NCT00433147|536359297|FG001|Overall Study|Adverse Event|1|||
148695601|NCT00433147|536359298|FG002|Overall Study|Adverse Event|0|||
148695602|NCT00433147|536359299|FG003|Overall Study|Adverse Event|0|||
148695603|NCT01882647|536359300|FG000|Overall Study|Lost to Follow-up|2|||
148695604|NCT01882647|536359301|FG001|Overall Study|Lost to Follow-up|2|||
148695605|NCT01882647|536359300|FG000|Overall Study|Withdrawal by Subject|0|||
148695606|NCT01882647|536359301|FG001|Overall Study|Withdrawal by Subject|4|||
148695607|NCT02937701|536359302|FG000|Day 1 to Week 22|Adverse Event|11|||
148695608|NCT02937701|536359303|FG001|Day 1 to Week 22|Adverse Event|14|||
148695609|NCT02937701|536359304|FG002|Day 1 to Week 22|Adverse Event|0|||
148695610|NCT02937701|536359305|FG003|Day 1 to Week 22|Adverse Event|0|||
148695611|NCT02937701|536359306|FG004|Day 1 to Week 22|Adverse Event|0|||
148695612|NCT02937701|536359302|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
148695613|NCT02937701|536359303|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
148695614|NCT02937701|536359304|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
148695615|NCT02937701|536359305|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
148695616|NCT02937701|536359306|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
148695617|NCT02937701|536359302|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
148695618|NCT02937701|536359303|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
148695619|NCT02937701|536359304|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
148695620|NCT02937701|536359305|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
148695621|NCT02937701|536359306|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
148695622|NCT02937701|536359302|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
148695623|NCT02937701|536359303|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
148695624|NCT02937701|536359304|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
148695625|NCT02937701|536359305|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
148695626|NCT02937701|536359306|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
148695627|NCT02937701|536359302|FG000|Day 1 to Week 22|Death|1|||
148695628|NCT02937701|536359303|FG001|Day 1 to Week 22|Death|1|||
148695629|NCT02937701|536359304|FG002|Day 1 to Week 22|Death|0|||
148695630|NCT02937701|536359305|FG003|Day 1 to Week 22|Death|0|||
148695631|NCT02937701|536359306|FG004|Day 1 to Week 22|Death|0|||
148695632|NCT02937701|536359302|FG000|Day 1 to Week 22|Protocol Violation|1|||
148695633|NCT02937701|536359303|FG001|Day 1 to Week 22|Protocol Violation|1|||
148695634|NCT02937701|536359304|FG002|Day 1 to Week 22|Protocol Violation|0|||
148695635|NCT02937701|536359305|FG003|Day 1 to Week 22|Protocol Violation|0|||
148695636|NCT02937701|536359306|FG004|Day 1 to Week 22|Protocol Violation|0|||
148695637|NCT02937701|536359302|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
148695638|NCT02937701|536359303|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
148963459|NCT05041322|537350987|FG000|Baseline|Withdrawal by Subject|1|||
148963460|NCT05041322|537350988|FG001|Baseline|Withdrawal by Subject|0|||
148963461|NCT05041322|537350987|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
148963462|NCT05041322|537350988|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
148963463|NCT05041322|537350987|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
148963464|NCT05041322|537350988|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
148963465|NCT03313804|537350989|FG000|Treatment|Death|5|||
148963466|NCT03313804|537350989|FG000|Treatment|still on treatment|2|||
148963467|NCT03313804|537350989|FG000|Follow Up|still on follow up|3|||
148963468|NCT01502423|537350990|FG000|Overall Study|Withdrawal by Subject|0|||
148963469|NCT01502423|537350991|FG001|Overall Study|Withdrawal by Subject|1|||
148963470|NCT00567892|537350992|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
148963471|NCT00567892|537350993|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
148963472|NCT00567892|537350994|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
148695639|NCT02937701|536359304|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
148695640|NCT02937701|536359305|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
148695641|NCT02937701|536359306|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
148695642|NCT02937701|536359302|FG000|Day 1 to Week 22|Physician Decision|2|||
148695643|NCT02937701|536359303|FG001|Day 1 to Week 22|Physician Decision|0|||
148695644|NCT02937701|536359304|FG002|Day 1 to Week 22|Physician Decision|0|||
148695645|NCT02937701|536359305|FG003|Day 1 to Week 22|Physician Decision|0|||
148695646|NCT02937701|536359306|FG004|Day 1 to Week 22|Physician Decision|0|||
148695647|NCT02937701|536359302|FG000|Day 1 to Week 22|Other|1|||
148963473|NCT00567892|537350995|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
148963474|NCT00567892|537350992|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
148695648|NCT02937701|536359303|FG001|Day 1 to Week 22|Other|0|||
148963475|NCT00567892|537350993|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
148963476|NCT00567892|537350994|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
148963477|NCT00567892|537350995|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
148963478|NCT04814433|537350996|FG000|Overall Study|Survey not returned|4|||
148963479|NCT04814433|537350997|FG001|Overall Study|Survey not returned|8|||
148963480|NCT04814433|537350998|FG002|Overall Study|Survey not returned|4|||
148963481|NCT04814433|537350999|FG003|Overall Study|Survey not returned|5|||
148963482|NCT02967692|537352826|FG000|Overall Study|Progressive disease|3|||
148963483|NCT02967692|537352827|FG001|Overall Study|Progressive disease|15|||
148963484|NCT02967692|537352828|FG002|Overall Study|Progressive disease|114|||
148963485|NCT02967692|537352829|FG003|Overall Study|Progressive disease|151|||
148963486|NCT02967692|537352826|FG000|Overall Study|Subject/guardian decision|1|||
148963487|NCT02967692|537352827|FG001|Overall Study|Subject/guardian decision|1|||
148963488|NCT02967692|537352828|FG002|Overall Study|Subject/guardian decision|14|||
148963489|NCT02967692|537352829|FG003|Overall Study|Subject/guardian decision|22|||
148963490|NCT02967692|537352826|FG000|Overall Study|Death|0|||
148963491|NCT02967692|537352827|FG001|Overall Study|Death|1|||
148963492|NCT02967692|537352828|FG002|Overall Study|Death|13|||
148963493|NCT02967692|537352829|FG003|Overall Study|Death|13|||
148963494|NCT02967692|537352826|FG000|Overall Study|Protocol deviation|1|||
148963495|NCT02967692|537352827|FG001|Overall Study|Protocol deviation|0|||
148963496|NCT02967692|537352828|FG002|Overall Study|Protocol deviation|1|||
148963497|NCT02967692|537352829|FG003|Overall Study|Protocol deviation|1|||
148963498|NCT02967692|537352826|FG000|Overall Study|Lost to Follow-up|0|||
148963499|NCT02967692|537352827|FG001|Overall Study|Lost to Follow-up|0|||
148963500|NCT02967692|537352828|FG002|Overall Study|Lost to Follow-up|1|||
148963501|NCT02967692|537352829|FG003|Overall Study|Lost to Follow-up|0|||
148963502|NCT02967692|537352826|FG000|Overall Study|Physician Decision|0|||
148963503|NCT02967692|537352827|FG001|Overall Study|Physician Decision|0|||
148963504|NCT02967692|537352828|FG002|Overall Study|Physician Decision|22|||
148963505|NCT02967692|537352829|FG003|Overall Study|Physician Decision|13|||
148963506|NCT02967692|537352826|FG000|Overall Study|Adverse Event|2|||
148963507|NCT02967692|537352827|FG001|Overall Study|Adverse Event|9|||
148963508|NCT02967692|537352828|FG002|Overall Study|Adverse Event|60|||
148963509|NCT02967692|537352829|FG003|Overall Study|Adverse Event|28|||
148963510|NCT02967692|537352826|FG000|Overall Study|Study terminated by sponsor|2|||
148963511|NCT02967692|537352827|FG001|Overall Study|Study terminated by sponsor|1|||
148963512|NCT02967692|537352828|FG002|Overall Study|Study terminated by sponsor|42|||
148963513|NCT02967692|537352829|FG003|Overall Study|Study terminated by sponsor|37|||
148963514|NCT00066066|537352832|FG000|Overall Study|Lost to Follow-up|6|||
148963515|NCT00066066|537352833|FG001|Overall Study|Lost to Follow-up|4|||
148963516|NCT00066066|537352834|FG002|Overall Study|Lost to Follow-up|7|||
148963517|NCT00066066|537352835|FG003|Overall Study|Lost to Follow-up|4|||
148963518|NCT00066066|537352836|FG004|Overall Study|Lost to Follow-up|3|||
148963519|NCT00066066|537352837|FG005|Overall Study|Lost to Follow-up|5|||
148963520|NCT02603432|537352844|FG000|Overall Study|Adverse Event|1|||
148963521|NCT02603432|537352845|FG001|Overall Study|Adverse Event|0|||
148963522|NCT02603432|537352844|FG000|Overall Study|Death|221|||
148963523|NCT02603432|537352845|FG001|Overall Study|Death|242|||
148963524|NCT02603432|537352844|FG000|Overall Study|Lost to Follow-up|3|||
148963525|NCT02603432|537352845|FG001|Overall Study|Lost to Follow-up|9|||
148963526|NCT02603432|537352844|FG000|Overall Study|Progressive Disease|7|||
148963527|NCT02603432|537352845|FG001|Overall Study|Progressive Disease|5|||
148963528|NCT02603432|537352844|FG000|Overall Study|Withdrawal by Subject|12|||
148963529|NCT02603432|537352845|FG001|Overall Study|Withdrawal by Subject|18|||
148963530|NCT02603432|537352844|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
148963531|NCT02603432|537352845|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148963532|NCT02603432|537352844|FG000|Overall Study|Study terminated by sponsor|74|||
148963533|NCT02603432|537352845|FG001|Overall Study|Study terminated by sponsor|75|||
148963534|NCT02603432|537352844|FG000|Overall Study|Other|13|||
148963535|NCT02603432|537352845|FG001|Overall Study|Other|0|||
148963536|NCT02759120|537352852|FG000|Overall Study|Death|34|||
148963537|NCT02759120|537352853|FG001|Overall Study|Death|36|||
148963538|NCT02759120|537352852|FG000|Overall Study|Lost to Follow-up|4|||
148963539|NCT02759120|537352853|FG001|Overall Study|Lost to Follow-up|7|||
149024083|NCT02401529|537564170|FG001|Overall Study|Lost to Follow-up|1|||
148963540|NCT02759120|537352852|FG000|Overall Study|Physician Decision|3|||
148963541|NCT02759120|537352853|FG001|Overall Study|Physician Decision|0|||
148963542|NCT02759120|537352852|FG000|Overall Study|Withdrawal by Subject|28|||
148963543|NCT02759120|537352853|FG001|Overall Study|Withdrawal by Subject|15|||
148963544|NCT02759120|537352852|FG000|Overall Study|Moved out of area|3|||
148963545|NCT02759120|537352853|FG001|Overall Study|Moved out of area|4|||
148963546|NCT02759120|537352852|FG000|Overall Study|Lung transplant|3|||
148963547|NCT02759120|537352853|FG001|Overall Study|Lung transplant|5|||
148963548|NCT02759120|537352852|FG000|Overall Study|Other reason not completed|10|||
148963549|NCT02759120|537352853|FG001|Overall Study|Other reason not completed|12|||
148695649|NCT02937701|536359304|FG002|Day 1 to Week 22|Other|0|||
148695650|NCT02937701|536359305|FG003|Day 1 to Week 22|Other|0|||
148695651|NCT02937701|536359306|FG004|Day 1 to Week 22|Other|0|||
148695652|NCT02937701|536359302|FG000|Week 22 to Week 50|Adverse Event|0|||
148695653|NCT02937701|536359303|FG001|Week 22 to Week 50|Adverse Event|0|||
148695654|NCT02937701|536359304|FG002|Week 22 to Week 50|Adverse Event|10|||
148695655|NCT02937701|536359305|FG003|Week 22 to Week 50|Adverse Event|3|||
148695656|NCT02937701|536359306|FG004|Week 22 to Week 50|Adverse Event|3|||
148695657|NCT02937701|536359302|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
148695658|NCT02937701|536359303|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
148963550|NCT02063854|537352855|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
148963551|NCT02063854|537352856|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
148963552|NCT02063854|537352857|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
148963553|NCT02063854|537352858|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
148963554|NCT02063854|537352859|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
148963555|NCT02063854|537352860|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
148963556|NCT02063854|537352861|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
148963557|NCT02063854|537352855|FG000|Overall Study|Major Protocol Deviation|0|||
148963558|NCT02063854|537352856|FG001|Overall Study|Major Protocol Deviation|0|||
148963559|NCT02063854|537352857|FG002|Overall Study|Major Protocol Deviation|3|||
148963560|NCT02063854|537352858|FG003|Overall Study|Major Protocol Deviation|0|||
148963561|NCT02063854|537352859|FG004|Overall Study|Major Protocol Deviation|0|||
148963562|NCT02063854|537352860|FG005|Overall Study|Major Protocol Deviation|0|||
148963563|NCT02063854|537352861|FG006|Overall Study|Major Protocol Deviation|0|||
148963564|NCT02063854|537352855|FG000|Overall Study|Voluntary Withdrawal|2|||
148963565|NCT02063854|537352856|FG001|Overall Study|Voluntary Withdrawal|0|||
148963566|NCT02063854|537352857|FG002|Overall Study|Voluntary Withdrawal|8|||
148963567|NCT02063854|537352858|FG003|Overall Study|Voluntary Withdrawal|1|||
148963568|NCT02063854|537352859|FG004|Overall Study|Voluntary Withdrawal|3|||
148963569|NCT02063854|537352860|FG005|Overall Study|Voluntary Withdrawal|6|||
148963570|NCT02063854|537352861|FG006|Overall Study|Voluntary Withdrawal|1|||
148963571|NCT02063854|537352855|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
148963572|NCT02063854|537352856|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
148963573|NCT02063854|537352857|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
148963574|NCT02063854|537352858|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
148963575|NCT02063854|537352859|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
148963576|NCT02063854|537352860|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
148963577|NCT02063854|537352861|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
148963578|NCT02063854|537352855|FG000|Overall Study|Reason Not Specified|1|||
148963579|NCT02063854|537352856|FG001|Overall Study|Reason Not Specified|0|||
148963580|NCT02063854|537352857|FG002|Overall Study|Reason Not Specified|0|||
148963581|NCT02063854|537352858|FG003|Overall Study|Reason Not Specified|0|||
148963582|NCT02063854|537352859|FG004|Overall Study|Reason Not Specified|0|||
148963583|NCT02063854|537352860|FG005|Overall Study|Reason Not Specified|0|||
148963584|NCT02063854|537352861|FG006|Overall Study|Reason Not Specified|0|||
148963585|NCT02063854|537352855|FG000|Overall Study|Did Not Receive Study Drug|0|||
148963586|NCT02063854|537352856|FG001|Overall Study|Did Not Receive Study Drug|0|||
148963587|NCT02063854|537352857|FG002|Overall Study|Did Not Receive Study Drug|0|||
148963588|NCT02063854|537352858|FG003|Overall Study|Did Not Receive Study Drug|0|||
148963589|NCT02063854|537352859|FG004|Overall Study|Did Not Receive Study Drug|0|||
148963590|NCT02063854|537352860|FG005|Overall Study|Did Not Receive Study Drug|1|||
148963591|NCT02063854|537352861|FG006|Overall Study|Did Not Receive Study Drug|0|||
148963592|NCT02255981|537352864|FG000|Overall Study|Lost to Follow-up|3|||
148963593|NCT02255981|537352864|FG000|Overall Study|Withdrawal by Subject|1|||
148963594|NCT01046682|537352865|FG000|Overall Study|Adverse Event|2|||
148963595|NCT01046682|537352866|FG001|Overall Study|Adverse Event|0|||
148695659|NCT02937701|536359304|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
148813105|NCT01069939|536790585|FG001|Randomised and Included in the Analyses|Removal|0|||
148963596|NCT00949325|537352873|FG000|Overall Study|Adverse Event|0|||
148963597|NCT00949325|537352874|FG001|Overall Study|Adverse Event|2|||
148963598|NCT00949325|537352875|FG002|Overall Study|Adverse Event|0|||
148963599|NCT05533632|537352876|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
148963600|NCT05533632|537352876|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
148963601|NCT05533632|537352876|FG000|Overall Study|Lost to Follow-up|1|||
149024084|NCT02401529|537564169|FG000|Overall Study|Physician Decision|2|||
148963602|NCT05533632|537352876|FG000|Overall Study|Withdrawal by Subject|4|||
148963603|NCT05533632|537352876|FG000|Overall Study|Adverse Event|4|||
148963604|NCT03054870|537352880|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
148963605|NCT03054870|537352880|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
148963606|NCT00304356|537352882|FG000|Nitazoxanide|Physician Decision|5|||
148695660|NCT02937701|536359305|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
148695661|NCT02937701|536359306|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
148695662|NCT02937701|536359302|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
148813106|NCT00658528|536790586|FG000|Overall Study|Adverse Event|5|||
148813107|NCT00658528|536790587|FG001|Overall Study|Adverse Event|7|||
148813108|NCT00658528|536790586|FG000|Overall Study|Lost to Follow-up|14|||
148963607|NCT00304356|537352882|FG000|Nitazoxanide|Physician Decision|1|||
148813109|NCT00658528|536790587|FG001|Overall Study|Lost to Follow-up|22|||
148813110|NCT00658528|536790586|FG000|Overall Study|Withdrawal by Subject|8|||
148963608|NCT00304356|537352882|FG000|Nitazoxanide|number is 0|1|||
148963609|NCT00304356|537352882|FG000|Nitazoxanide|Physician Decision|1|||
148963610|NCT00304356|537352882|FG000|Nitazoxanide|Physician Decision|1|||
148963611|NCT00304356|537352882|FG000|Nitazoxanide|Physician Decision|1|||
148963612|NCT04120974|537352886|FG000|Overall Study|Death|1|||
148963613|NCT04120974|537352886|FG000|Overall Study|Physician Decision|1|||
148963614|NCT04120974|537352886|FG000|Overall Study|Lost to Follow-up|6|||
148963615|NCT00973479|537352889|FG000|Overall Study|Lost to Follow-up|0|||
148963616|NCT00973479|537352890|FG001|Overall Study|Lost to Follow-up|3|||
148963617|NCT00973479|537352889|FG000|Overall Study|Death|2|||
148963618|NCT00973479|537352890|FG001|Overall Study|Death|2|||
148963619|NCT00973479|537352889|FG000|Overall Study|Withdrawal by Subject|15|||
148963620|NCT00973479|537352890|FG001|Overall Study|Withdrawal by Subject|16|||
148963621|NCT00973479|537352889|FG000|Overall Study|Lack of Efficacy|5|||
148963622|NCT00973479|537352890|FG001|Overall Study|Lack of Efficacy|7|||
148963623|NCT00973479|537352889|FG000|Overall Study|Adverse Event|12|||
148963624|NCT00973479|537352890|FG001|Overall Study|Adverse Event|32|||
148813111|NCT00658528|536790587|FG001|Overall Study|Withdrawal by Subject|6|||
148813112|NCT00658528|536790586|FG000|Overall Study|Withdrawal of consent|5|||
148963625|NCT00973479|537352889|FG000|Overall Study|Protocol Violation|2|||
148813113|NCT00658528|536790587|FG001|Overall Study|Withdrawal of consent|6|||
148813114|NCT00658528|536790586|FG000|Overall Study|Other|8|||
148813115|NCT00658528|536790587|FG001|Overall Study|Other|4|||
148813116|NCT01147458|536790589|FG000|First Intervention|Study terminated by sponsor|8|||
148813117|NCT01147458|536790590|FG001|First Intervention|Study terminated by sponsor|8|||
148813118|NCT01147458|536790591|FG002|First Intervention|Study terminated by sponsor|7|||
148813119|NCT01147458|536790592|FG003|First Intervention|Study terminated by sponsor|8|||
148813120|NCT01147458|536790589|FG000|First Intervention|Protocol Violation|2|||
148813121|NCT01147458|536790590|FG001|First Intervention|Protocol Violation|3|||
148813122|NCT01147458|536790591|FG002|First Intervention|Protocol Violation|2|||
148813123|NCT01147458|536790592|FG003|First Intervention|Protocol Violation|3|||
148813124|NCT01147458|536790589|FG000|First Intervention|Withdrawal by Subject|3|||
148813125|NCT01147458|536790590|FG001|First Intervention|Withdrawal by Subject|0|||
148813126|NCT01147458|536790591|FG002|First Intervention|Withdrawal by Subject|1|||
148813127|NCT01147458|536790592|FG003|First Intervention|Withdrawal by Subject|0|||
149024085|NCT02401529|537564170|FG001|Overall Study|Physician Decision|6|||
148813128|NCT01147458|536790589|FG000|First Intervention|Adverse Event|0|||
148813129|NCT01147458|536790590|FG001|First Intervention|Adverse Event|3|||
148813130|NCT01147458|536790591|FG002|First Intervention|Adverse Event|2|||
148813131|NCT01147458|536790592|FG003|First Intervention|Adverse Event|3|||
148813132|NCT01147458|536790589|FG000|First Intervention|Other|1|||
148813133|NCT01147458|536790590|FG001|First Intervention|Other|2|||
148813134|NCT01147458|536790591|FG002|First Intervention|Other|0|||
148963626|NCT00973479|537352890|FG001|Overall Study|Protocol Violation|2|||
148963627|NCT00973479|537352889|FG000|Overall Study|Other|1|||
148963628|NCT00973479|537352890|FG001|Overall Study|Other|7|||
148963629|NCT05075850|537352891|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
148963630|NCT04256785|537352892|FG000|Overall Study|Adverse Event|8|||
148963631|NCT04256785|537352893|FG001|Overall Study|Adverse Event|6|||
148963632|NCT04256785|537352892|FG000|Overall Study|Lack of Efficacy|3|||
148963633|NCT04256785|537352893|FG001|Overall Study|Lack of Efficacy|4|||
148963634|NCT04256785|537352892|FG000|Overall Study|Lost to Follow-up|7|||
148963635|NCT04256785|537352893|FG001|Overall Study|Lost to Follow-up|7|||
148963636|NCT04256785|537352892|FG000|Overall Study|Protocol Violation|1|||
148963637|NCT04256785|537352893|FG001|Overall Study|Protocol Violation|0|||
148963638|NCT04256785|537352892|FG000|Overall Study|Withdrawal by Subject|4|||
148963639|NCT04256785|537352893|FG001|Overall Study|Withdrawal by Subject|1|||
148963640|NCT04256785|537352892|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
148963641|NCT04256785|537352893|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
148963642|NCT01154218|537352894|FG000|Third Intervention Period|Adverse Event|0|||
148963643|NCT01154218|537352895|FG001|Third Intervention Period|Adverse Event|1|||
148963644|NCT01154218|537352896|FG002|Third Intervention Period|Adverse Event|0|||
148963645|NCT01154218|537352897|FG003|Third Intervention Period|Adverse Event|0|||
148963646|NCT01154218|537352894|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148963647|NCT01154218|537352895|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148963648|NCT01154218|537352896|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148963649|NCT01154218|537352897|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
148963650|NCT01154218|537352894|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
148963651|NCT01154218|537352895|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
148963652|NCT01154218|537352896|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
148963653|NCT01154218|537352897|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
148695663|NCT02937701|536359303|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
148695664|NCT02937701|536359304|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
148695665|NCT02937701|536359305|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
148695666|NCT02937701|536359306|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
148695667|NCT02937701|536359302|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
148695668|NCT02937701|536359303|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
148963654|NCT01265849|537352898|FG000|Overall Study|Randomized//Treatment not initiated|1|||
148963655|NCT01265849|537352899|FG001|Overall Study|Randomized//Treatment not initiated|4|||
148963656|NCT01265849|537352900|FG002|Overall Study|Randomized//Treatment not initiated|0|||
148963657|NCT01265849|537352898|FG000|Overall Study|Physician Decision|1|||
148695669|NCT02937701|536359304|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
148695670|NCT02937701|536359305|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
148695671|NCT02937701|536359306|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
148695672|NCT02937701|536359302|FG000|Week 22 to Week 50|Physician Decision|0|||
148695673|NCT02937701|536359303|FG001|Week 22 to Week 50|Physician Decision|0|||
148695674|NCT02937701|536359304|FG002|Week 22 to Week 50|Physician Decision|2|||
148695675|NCT02937701|536359305|FG003|Week 22 to Week 50|Physician Decision|0|||
148695676|NCT02937701|536359306|FG004|Week 22 to Week 50|Physician Decision|1|||
148695677|NCT02937701|536359302|FG000|Week 22 to Week 50|Other|0|||
148695678|NCT02937701|536359303|FG001|Week 22 to Week 50|Other|0|||
148695679|NCT02937701|536359304|FG002|Week 22 to Week 50|Other|0|||
148695680|NCT02937701|536359305|FG003|Week 22 to Week 50|Other|0|||
148695681|NCT02937701|536359306|FG004|Week 22 to Week 50|Other|1|||
148695682|NCT00720096|536359307|FG000|Overall Study|Withdrawal by Subject|0|||
148695683|NCT00720096|536359308|FG001|Overall Study|Withdrawal by Subject|2|||
148695684|NCT04557124|536359309|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
148695685|NCT04557124|536359310|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
148695686|NCT04557124|536359309|FG000|Mid-point (1 Month)|Missed testing|5|||
148695687|NCT04557124|536359310|FG001|Mid-point (1 Month)|Missed testing|4|||
148695688|NCT04557124|536359309|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
148695689|NCT04557124|536359310|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
148695690|NCT04557124|536359309|FG000|Post-testing (2 Months)|Missed testing|1|||
148695691|NCT04557124|536359310|FG001|Post-testing (2 Months)|Missed testing|5|||
148695692|NCT04557124|536359309|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
148695693|NCT04557124|536359310|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
148695694|NCT04557124|536359309|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
148695695|NCT04557124|536359310|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
148695696|NCT00001849|536359311|FG000|Overall Study|Death|4|||
148695697|NCT00001849|536359311|FG000|Overall Study|Lost to Follow-up|2|||
148695698|NCT00001849|536359311|FG000|Overall Study|Withdrawal by Subject|2|||
148695699|NCT00001849|536359311|FG000|Overall Study|tumor remained occult|6|||
148695700|NCT03127137|536359315|FG000|Overall Study|Requested sedation after consent|1|||
148695701|NCT03127137|536359316|FG001|Overall Study|Requested sedation after consent|0|||
148695702|NCT03127137|536359315|FG000|Overall Study|Malfunction in electronic data collection|1|||
148695703|NCT03127137|536359316|FG001|Overall Study|Malfunction in electronic data collection|0|||
148695704|NCT03127137|536359315|FG000|Overall Study|Post procedure testing could not be obtained|0|||
148695705|NCT03127137|536359316|FG001|Overall Study|Post procedure testing could not be obtained|1|||
148695706|NCT02319148|536359318|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
148695707|NCT02319148|536359319|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
148695708|NCT02319148|536359320|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
148695709|NCT02319148|536359321|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
148695710|NCT02319148|536359318|FG000|Second Intervention Period|No longer willing to participate|0|||
148695711|NCT02319148|536359319|FG001|Second Intervention Period|No longer willing to participate|1|||
148695712|NCT02319148|536359320|FG002|Second Intervention Period|No longer willing to participate|0|||
148695713|NCT02319148|536359321|FG003|Second Intervention Period|No longer willing to participate|0|||
148695714|NCT02319148|536359318|FG000|Second Intervention Period|Other|0|||
148695715|NCT02319148|536359319|FG001|Second Intervention Period|Other|0|||
148695716|NCT02319148|536359320|FG002|Second Intervention Period|Other|0|||
148695717|NCT02319148|536359321|FG003|Second Intervention Period|Other|1|||
148695718|NCT00264797|536359323|FG000|Overall Study|Withdrawal by Subject|11|||
148695719|NCT00264797|536359324|FG001|Overall Study|Withdrawal by Subject|11|||
148695720|NCT00264797|536359323|FG000|Overall Study|Lost to Follow-up|9|||
148695721|NCT00264797|536359324|FG001|Overall Study|Lost to Follow-up|17|||
148695722|NCT00264797|536359323|FG000|Overall Study|Moved from area|3|||
148695723|NCT00264797|536359324|FG001|Overall Study|Moved from area|1|||
148695724|NCT00264797|536359323|FG000|Overall Study|Practical Problems|2|||
148695725|NCT00264797|536359324|FG001|Overall Study|Practical Problems|3|||
148695726|NCT00264797|536359323|FG000|Overall Study|Incarceration|4|||
148695727|NCT00264797|536359324|FG001|Overall Study|Incarceration|5|||
148695728|NCT00264797|536359323|FG000|Overall Study|Pressure/advice from Outsiders|1|||
148695729|NCT00264797|536359324|FG001|Overall Study|Pressure/advice from Outsiders|1|||
148695730|NCT00264797|536359323|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
148695731|NCT00264797|536359324|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
148695732|NCT00264797|536359323|FG000|Overall Study|Other|3|||
148695733|NCT00264797|536359324|FG001|Overall Study|Other|4|||
148695734|NCT00755196|536359326|FG000|Overall Study|Lost to Follow-up|1|||
148695735|NCT00755196|536359326|FG000|Overall Study|Lack of Efficiency|1|||
148695736|NCT01604850|536359327|FG000|Overall Study|Enrolled but never treated|0|||
148695737|NCT01604850|536359328|FG001|Overall Study|Enrolled but never treated|1|||
148695738|NCT01604850|536359327|FG000|Overall Study|Efficacy Failure|50|||
148695739|NCT01604850|536359328|FG001|Overall Study|Efficacy Failure|29|||
148695740|NCT01604850|536359327|FG000|Overall Study|Lost to Follow-up|1|||
148695741|NCT01604850|536359328|FG001|Overall Study|Lost to Follow-up|0|||
148695742|NCT01604850|536359327|FG000|Overall Study|Subject withdrew consent|1|||
148695743|NCT01604850|536359328|FG001|Overall Study|Subject withdrew consent|0|||
148695744|NCT01703832|536359329|FG000|Overall Study|Withdrawal by Subject|1|||
148695745|NCT01703832|536359330|FG001|Overall Study|Withdrawal by Subject|0|||
148963658|NCT01265849|537352899|FG001|Overall Study|Physician Decision|2|||
148963659|NCT01265849|537352900|FG002|Overall Study|Physician Decision|0|||
148963660|NCT01265849|537352898|FG000|Overall Study|Lost to Follow-up|18|||
148963661|NCT01265849|537352899|FG001|Overall Study|Lost to Follow-up|15|||
148963662|NCT01265849|537352900|FG002|Overall Study|Lost to Follow-up|5|||
148963663|NCT01265849|537352898|FG000|Overall Study|Not otherwise specified|1|||
148963664|NCT01265849|537352899|FG001|Overall Study|Not otherwise specified|6|||
148963665|NCT01265849|537352900|FG002|Overall Study|Not otherwise specified|1|||
148963666|NCT01265849|537352898|FG000|Overall Study|Withdrawal by Subject|25|||
148963667|NCT01265849|537352899|FG001|Overall Study|Withdrawal by Subject|34|||
148963668|NCT01265849|537352900|FG002|Overall Study|Withdrawal by Subject|13|||
148963669|NCT00362115|537352901|FG000|Overall Study|Adverse Event|0|||
148963670|NCT00362115|537352902|FG001|Overall Study|Adverse Event|1|||
148963671|NCT00362115|537352903|FG002|Overall Study|Adverse Event|1|||
148963672|NCT00362115|537352904|FG003|Overall Study|Adverse Event|1|||
148963673|NCT00362115|537352905|FG004|Overall Study|Adverse Event|2|||
148963674|NCT00362115|537352906|FG005|Overall Study|Adverse Event|2|||
148963675|NCT00362115|537352907|FG006|Overall Study|Adverse Event|1|||
148963676|NCT00362115|537352901|FG000|Overall Study|Protocol Violation|0|||
148963677|NCT00362115|537352902|FG001|Overall Study|Protocol Violation|0|||
148963678|NCT00362115|537352903|FG002|Overall Study|Protocol Violation|0|||
148963679|NCT00362115|537352904|FG003|Overall Study|Protocol Violation|0|||
148963680|NCT00362115|537352905|FG004|Overall Study|Protocol Violation|0|||
148963681|NCT00362115|537352906|FG005|Overall Study|Protocol Violation|1|||
148963682|NCT00362115|537352907|FG006|Overall Study|Protocol Violation|0|||
148963683|NCT00362115|537352901|FG000|Overall Study|Lost to Follow-up|0|||
148963684|NCT00362115|537352902|FG001|Overall Study|Lost to Follow-up|1|||
148963685|NCT00362115|537352903|FG002|Overall Study|Lost to Follow-up|0|||
148963686|NCT00362115|537352904|FG003|Overall Study|Lost to Follow-up|0|||
148963687|NCT00362115|537352905|FG004|Overall Study|Lost to Follow-up|2|||
148963688|NCT00362115|537352906|FG005|Overall Study|Lost to Follow-up|0|||
148963689|NCT00362115|537352907|FG006|Overall Study|Lost to Follow-up|1|||
148963690|NCT00362115|537352901|FG000|Overall Study|Withdrawal by Subject|1|||
148963691|NCT00362115|537352902|FG001|Overall Study|Withdrawal by Subject|3|||
148963692|NCT00362115|537352903|FG002|Overall Study|Withdrawal by Subject|1|||
148963693|NCT00362115|537352904|FG003|Overall Study|Withdrawal by Subject|0|||
148963694|NCT00362115|537352905|FG004|Overall Study|Withdrawal by Subject|1|||
148963695|NCT00362115|537352906|FG005|Overall Study|Withdrawal by Subject|3|||
148963696|NCT00362115|537352907|FG006|Overall Study|Withdrawal by Subject|4|||
148963697|NCT00362115|537352901|FG000|Overall Study|Lack of Efficacy|1|||
148963698|NCT00362115|537352902|FG001|Overall Study|Lack of Efficacy|0|||
148963699|NCT00362115|537352903|FG002|Overall Study|Lack of Efficacy|5|||
148963700|NCT00362115|537352904|FG003|Overall Study|Lack of Efficacy|2|||
148963701|NCT00362115|537352905|FG004|Overall Study|Lack of Efficacy|2|||
148963702|NCT00362115|537352906|FG005|Overall Study|Lack of Efficacy|0|||
148963703|NCT00362115|537352907|FG006|Overall Study|Lack of Efficacy|3|||
148963704|NCT00362115|537352901|FG000|Overall Study|Physician Decision|0|||
148963705|NCT00362115|537352902|FG001|Overall Study|Physician Decision|0|||
148963706|NCT00362115|537352903|FG002|Overall Study|Physician Decision|0|||
148963707|NCT00362115|537352904|FG003|Overall Study|Physician Decision|0|||
148963708|NCT00362115|537352905|FG004|Overall Study|Physician Decision|0|||
148963709|NCT00362115|537352906|FG005|Overall Study|Physician Decision|0|||
148963710|NCT00362115|537352907|FG006|Overall Study|Physician Decision|3|||
148963711|NCT00362115|537352901|FG000|Overall Study|Other|0|||
148963712|NCT00362115|537352902|FG001|Overall Study|Other|1|||
148963713|NCT00362115|537352903|FG002|Overall Study|Other|0|||
148695746|NCT00243932|536359331|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
148963714|NCT00362115|537352904|FG003|Overall Study|Other|1|||
148963715|NCT00362115|537352905|FG004|Overall Study|Other|0|||
148695747|NCT00243932|536359332|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
148695748|NCT00243932|536359333|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
148695749|NCT00543309|536359334|FG000|Overall Study|Physician Decision|0|||
148695750|NCT00543309|536359335|FG001|Overall Study|Physician Decision|1|||
148695751|NCT00543309|536359336|FG002|Overall Study|Physician Decision|0|||
148695752|NCT01249664|536359344|FG000|Overall Study|Withdrawal by Subject|5|||
148695753|NCT01249664|536359345|FG001|Overall Study|Withdrawal by Subject|0|||
148695754|NCT01249664|536359344|FG000|Overall Study|Adverse Event|1|||
148695755|NCT01249664|536359345|FG001|Overall Study|Adverse Event|0|||
148695756|NCT00762086|536359348|FG000|Overall Study|Adverse Event|2|||
148695757|NCT00762086|536359349|FG001|Overall Study|Adverse Event|0|||
148695758|NCT00762086|536359348|FG000|Overall Study|Lost to Follow-up|0|||
148695759|NCT00762086|536359349|FG001|Overall Study|Lost to Follow-up|2|||
148695760|NCT00762086|536359348|FG000|Overall Study|Non compliance|1|||
148695761|NCT00762086|536359349|FG001|Overall Study|Non compliance|0|||
148695762|NCT00762086|536359348|FG000|Overall Study|Withdrawal by Subject|2|||
148695763|NCT00762086|536359349|FG001|Overall Study|Withdrawal by Subject|2|||
148695764|NCT00762086|536359348|FG000|Overall Study|Ineligible to participate in the study|1|||
148695765|NCT00762086|536359349|FG001|Overall Study|Ineligible to participate in the study|0|||
148695766|NCT01682083|536359354|FG000|Overall Study|Lost to Follow-up|11|||
148695767|NCT01682083|536359355|FG001|Overall Study|Lost to Follow-up|18|||
148695768|NCT01682083|536359354|FG000|Overall Study|Withdrawal by Subject|31|||
148695769|NCT01682083|536359355|FG001|Overall Study|Withdrawal by Subject|40|||
148695770|NCT01682083|536359354|FG000|Overall Study|Death|60|||
148695771|NCT01682083|536359355|FG001|Overall Study|Death|93|||
148695772|NCT01682083|536359354|FG000|Overall Study|Physician Decision|5|||
148695773|NCT01682083|536359355|FG001|Overall Study|Physician Decision|4|||
148695774|NCT00864097|536359356|FG000|Overall Study|Death|0|||
148695775|NCT00864097|536359357|FG001|Overall Study|Death|1|||
148695776|NCT00864097|536359358|FG002|Overall Study|Death|0|||
148695777|NCT00864097|536359359|FG003|Overall Study|Death|0|||
148695778|NCT00864097|536359356|FG000|Overall Study|Adverse Event|6|||
148695779|NCT00864097|536359357|FG001|Overall Study|Adverse Event|8|||
148695780|NCT00864097|536359358|FG002|Overall Study|Adverse Event|11|||
148695781|NCT00864097|536359359|FG003|Overall Study|Adverse Event|9|||
148695782|NCT00864097|536359356|FG000|Overall Study|Lack of Efficacy|9|||
148695783|NCT00864097|536359357|FG001|Overall Study|Lack of Efficacy|3|||
148695784|NCT00864097|536359358|FG002|Overall Study|Lack of Efficacy|7|||
148695785|NCT00864097|536359359|FG003|Overall Study|Lack of Efficacy|2|||
148695786|NCT00864097|536359356|FG000|Overall Study|Lost to Follow-up|0|||
148695787|NCT00864097|536359357|FG001|Overall Study|Lost to Follow-up|1|||
148695788|NCT00864097|536359358|FG002|Overall Study|Lost to Follow-up|0|||
148695789|NCT00864097|536359359|FG003|Overall Study|Lost to Follow-up|1|||
148695790|NCT00864097|536359356|FG000|Overall Study|Withdrawal by Subject|15|||
148695791|NCT00864097|536359357|FG001|Overall Study|Withdrawal by Subject|11|||
148813135|NCT01147458|536790592|FG003|First Intervention|Other|0|||
148695792|NCT00864097|536359358|FG002|Overall Study|Withdrawal by Subject|11|||
148695793|NCT00864097|536359359|FG003|Overall Study|Withdrawal by Subject|12|||
148695794|NCT00864097|536359356|FG000|Overall Study|Protocol Violation|2|||
148695795|NCT00864097|536359357|FG001|Overall Study|Protocol Violation|1|||
148695796|NCT00864097|536359358|FG002|Overall Study|Protocol Violation|0|||
148695797|NCT00864097|536359359|FG003|Overall Study|Protocol Violation|1|||
148695798|NCT00864097|536359356|FG000|Overall Study|Terminated by sponsor|105|||
148695799|NCT00864097|536359357|FG001|Overall Study|Terminated by sponsor|112|||
148813136|NCT01147458|536790589|FG000|Second Intervention|Study terminated by sponsor|7|||
148813137|NCT01147458|536790590|FG001|Second Intervention|Study terminated by sponsor|5|||
148813138|NCT01147458|536790591|FG002|Second Intervention|Study terminated by sponsor|5|||
148813139|NCT01147458|536790592|FG003|Second Intervention|Study terminated by sponsor|3|||
148695800|NCT00864097|536359358|FG002|Overall Study|Terminated by sponsor|102|||
148695801|NCT00864097|536359359|FG003|Overall Study|Terminated by sponsor|99|||
148695802|NCT00864097|536359356|FG000|Overall Study|Randomized but not treated|2|||
148813140|NCT01147458|536790589|FG000|Second Intervention|Protocol Violation|0|||
148695803|NCT00864097|536359357|FG001|Overall Study|Randomized but not treated|0|||
148695804|NCT00864097|536359358|FG002|Overall Study|Randomized but not treated|1|||
148695805|NCT00864097|536359359|FG003|Overall Study|Randomized but not treated|0|||
148695806|NCT00864097|536359356|FG000|Overall Study|Other|0|||
148695807|NCT00864097|536359357|FG001|Overall Study|Other|0|||
148695808|NCT00864097|536359358|FG002|Overall Study|Other|0|||
148695809|NCT00864097|536359359|FG003|Overall Study|Other|1|||
148695810|NCT01225146|536359366|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
148695811|NCT01225146|536359367|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
148695812|NCT03661528|536359372|FG000|Overall Study|Death|1|||
148695813|NCT03661528|536359373|FG001|Overall Study|Death|0|||
148695814|NCT03661528|536359372|FG000|Overall Study|Physician Decision|3|||
148695815|NCT03661528|536359373|FG001|Overall Study|Physician Decision|1|||
148695816|NCT03661528|536359372|FG000|Overall Study|Other than Specified|5|||
148695817|NCT03661528|536359373|FG001|Overall Study|Other than Specified|2|||
148695818|NCT03661528|536359372|FG000|Overall Study|Withdrawal by Subject|5|||
148695819|NCT03661528|536359373|FG001|Overall Study|Withdrawal by Subject|3|||
148695820|NCT03661528|536359372|FG000|Overall Study|Disease Progression|8|||
148963716|NCT00362115|537352906|FG005|Overall Study|Other|1|||
148963717|NCT00362115|537352907|FG006|Overall Study|Other|0|||
148963718|NCT00271609|537352908|FG000|Overall Study|Adverse Event|11|||
148963719|NCT00271609|537352909|FG001|Overall Study|Adverse Event|3|||
149024086|NCT02401529|537564169|FG000|Overall Study|Protocol Violation|5|||
149024087|NCT02401529|537564170|FG001|Overall Study|Protocol Violation|0|||
149024088|NCT02491411|537564173|FG000|Overall Study|Physician Decision|4|||
148963720|NCT00271609|537352908|FG000|Overall Study|Withdrawal by Subject|2|||
148963721|NCT00271609|537352909|FG001|Overall Study|Withdrawal by Subject|0|||
148963722|NCT03341533|537352910|FG000|Overall Study|Withdrawal by Subject|1|||
148963723|NCT03341533|537352911|FG001|Overall Study|Withdrawal by Subject|1|||
148963724|NCT03341533|537352910|FG000|Overall Study|Not eligible after randomization|2|||
148963725|NCT03341533|537352911|FG001|Overall Study|Not eligible after randomization|1|||
148963726|NCT02153112|537352912|FG000|Overall Study|Adverse Event|0|||
148963727|NCT02153112|537352913|FG001|Overall Study|Adverse Event|0|||
148963728|NCT02153112|537352914|FG002|Overall Study|Adverse Event|1|||
148963729|NCT02153112|537352915|FG003|Overall Study|Adverse Event|0|||
148963730|NCT02153112|537352916|FG004|Overall Study|Adverse Event|0|||
148963731|NCT02153112|537352917|FG005|Overall Study|Adverse Event|0|||
148963732|NCT02153112|537352918|FG006|Overall Study|Adverse Event|0|||
148963733|NCT02153112|537352919|FG007|Overall Study|Adverse Event|0|||
148963734|NCT02153112|537352920|FG008|Overall Study|Adverse Event|0|||
148695821|NCT03661528|536359373|FG001|Overall Study|Disease Progression|13|||
148963735|NCT02153112|537352921|FG009|Overall Study|Adverse Event|0|||
148963736|NCT02153112|537352912|FG000|Overall Study|Lost to Follow-up|1|||
148963737|NCT02153112|537352913|FG001|Overall Study|Lost to Follow-up|1|||
149024089|NCT04034238|537564174|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
148695822|NCT03661528|536359372|FG000|Overall Study|Adverse Event|61|||
148963738|NCT02153112|537352914|FG002|Overall Study|Lost to Follow-up|0|||
148963739|NCT02153112|537352915|FG003|Overall Study|Lost to Follow-up|0|||
148963740|NCT02153112|537352916|FG004|Overall Study|Lost to Follow-up|2|||
148963741|NCT02153112|537352917|FG005|Overall Study|Lost to Follow-up|1|||
148963742|NCT02153112|537352918|FG006|Overall Study|Lost to Follow-up|1|||
148963743|NCT02153112|537352919|FG007|Overall Study|Lost to Follow-up|0|||
148963744|NCT02153112|537352920|FG008|Overall Study|Lost to Follow-up|1|||
148963745|NCT02153112|537352921|FG009|Overall Study|Lost to Follow-up|1|||
148963746|NCT02153112|537352912|FG000|Overall Study|Withdrawal by Subject|3|||
148963747|NCT02153112|537352913|FG001|Overall Study|Withdrawal by Subject|1|||
148963748|NCT02153112|537352914|FG002|Overall Study|Withdrawal by Subject|2|||
148963749|NCT02153112|537352915|FG003|Overall Study|Withdrawal by Subject|2|||
148963750|NCT02153112|537352916|FG004|Overall Study|Withdrawal by Subject|1|||
148963751|NCT02153112|537352917|FG005|Overall Study|Withdrawal by Subject|1|||
148963752|NCT02153112|537352918|FG006|Overall Study|Withdrawal by Subject|7|||
148963753|NCT02153112|537352919|FG007|Overall Study|Withdrawal by Subject|2|||
148963754|NCT02153112|537352920|FG008|Overall Study|Withdrawal by Subject|13|||
148963755|NCT02153112|537352921|FG009|Overall Study|Withdrawal by Subject|12|||
148963756|NCT02153112|537352912|FG000|Overall Study|Reason not Specified|0|||
148963757|NCT02153112|537352913|FG001|Overall Study|Reason not Specified|0|||
148963758|NCT02153112|537352914|FG002|Overall Study|Reason not Specified|0|||
148963759|NCT02153112|537352915|FG003|Overall Study|Reason not Specified|0|||
148963760|NCT02153112|537352916|FG004|Overall Study|Reason not Specified|0|||
148963761|NCT02153112|537352917|FG005|Overall Study|Reason not Specified|0|||
148963762|NCT02153112|537352918|FG006|Overall Study|Reason not Specified|0|||
148963763|NCT02153112|537352919|FG007|Overall Study|Reason not Specified|0|||
148963764|NCT02153112|537352920|FG008|Overall Study|Reason not Specified|1|||
148963765|NCT02153112|537352921|FG009|Overall Study|Reason not Specified|1|||
148963766|NCT00003641|537352927|FG000|Overall Study|Withdrawal by Subject|0|||
148963767|NCT00003641|537352928|FG001|Overall Study|Withdrawal by Subject|100|||
148963768|NCT00003641|537352927|FG000|Overall Study|Adverse Event|0|||
148963769|NCT00003641|537352928|FG001|Overall Study|Adverse Event|38|||
148963770|NCT00003641|537352927|FG000|Overall Study|Disease progression|0|||
148695823|NCT03661528|536359373|FG001|Overall Study|Adverse Event|55|||
148695824|NCT02732210|536359374|FG000|Overall Study|Site Closed|0|||
148695825|NCT02732210|536359375|FG001|Overall Study|Site Closed|11|||
148963771|NCT00003641|537352928|FG001|Overall Study|Disease progression|2|||
148963772|NCT00003641|537352927|FG000|Overall Study|Unknown/missing|0|||
148963773|NCT00003641|537352928|FG001|Overall Study|Unknown/missing|22|||
148963774|NCT00003641|537352927|FG000|Overall Study|Should not receive interferon therapy|2|||
148813141|NCT01147458|536790590|FG001|Second Intervention|Protocol Violation|1|||
148813142|NCT01147458|536790591|FG002|Second Intervention|Protocol Violation|1|||
148813143|NCT01147458|536790592|FG003|Second Intervention|Protocol Violation|0|||
148813144|NCT01147458|536790589|FG000|Second Intervention|Withdrawal by Subject|0|||
148813145|NCT01147458|536790590|FG001|Second Intervention|Withdrawal by Subject|1|||
148813146|NCT01147458|536790591|FG002|Second Intervention|Withdrawal by Subject|0|||
148813147|NCT01147458|536790592|FG003|Second Intervention|Withdrawal by Subject|0|||
148813148|NCT01147458|536790589|FG000|Second Intervention|Adverse Event|2|||
148813149|NCT01147458|536790590|FG001|Second Intervention|Adverse Event|0|||
148813150|NCT01147458|536790591|FG002|Second Intervention|Adverse Event|1|||
148813151|NCT01147458|536790592|FG003|Second Intervention|Adverse Event|1|||
148813152|NCT01147458|536790589|FG000|Second Intervention|Other|0|||
148813153|NCT01147458|536790590|FG001|Second Intervention|Other|0|||
148813154|NCT01147458|536790591|FG002|Second Intervention|Other|1|||
148813155|NCT01147458|536790592|FG003|Second Intervention|Other|0|||
148813156|NCT00832975|536790600|FG000|Overall Study|Lost to Follow-up|7|||
148813157|NCT00832975|536790600|FG000|Overall Study|Protocol Violation|6|||
148813158|NCT00832975|536790600|FG000|Overall Study|Death|5|||
148813159|NCT00832975|536790600|FG000|Overall Study|Physician Decision|4|||
148813160|NCT00832975|536790600|FG000|Overall Study|Withdrawal by Subject|3|||
148813161|NCT00832975|536790600|FG000|Overall Study|Other reasons|14|||
148813162|NCT02811159|536790606|FG000|Treatment Course 1|Lost to Follow-up|1|||
148813163|NCT04603066|536790608|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
148813164|NCT04603066|536790609|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
148813165|NCT01525589|536790610|FG000|Overall Study|Non-treatment-related AE|1|||
148813166|NCT01525589|536790611|FG001|Overall Study|Non-treatment-related AE|0|||
148813167|NCT01525589|536790612|FG002|Overall Study|Non-treatment-related AE|0|||
148813168|NCT01525589|536790610|FG000|Overall Study|Progressive disease|48|||
148813169|NCT01525589|536790611|FG001|Overall Study|Progressive disease|15|||
148813170|NCT01525589|536790612|FG002|Overall Study|Progressive disease|29|||
148813171|NCT01525589|536790610|FG000|Overall Study|Never treated|2|||
148813172|NCT01525589|536790611|FG001|Overall Study|Never treated|0|||
148813173|NCT01525589|536790612|FG002|Overall Study|Never treated|0|||
148813174|NCT01525589|536790610|FG000|Overall Study|Physician Decision|4|||
148963775|NCT00003641|537352928|FG001|Overall Study|Should not receive interferon therapy|0|||
148963776|NCT00003641|537352927|FG000|Overall Study|Never started interferon|567|||
148963777|NCT00003641|537352928|FG001|Overall Study|Never started interferon|12|||
148963778|NCT02154581|537352932|FG000|Overall Study|Lost to Follow-up|7|||
148813175|NCT01525589|536790611|FG001|Overall Study|Physician Decision|2|||
148813176|NCT01525589|536790612|FG002|Overall Study|Physician Decision|2|||
148813177|NCT01525589|536790610|FG000|Overall Study|Death|0|||
148813178|NCT01525589|536790611|FG001|Overall Study|Death|0|||
148813179|NCT01525589|536790612|FG002|Overall Study|Death|2|||
148813180|NCT01525589|536790610|FG000|Overall Study|Treatment-related AE|1|||
148813181|NCT01525589|536790611|FG001|Overall Study|Treatment-related AE|1|||
148963779|NCT02154581|537352933|FG001|Overall Study|Lost to Follow-up|8|||
148963780|NCT00878709|537352934|FG000|Overall Study|Withdrawal by Subject|197|||
148963781|NCT00878709|537352935|FG001|Overall Study|Withdrawal by Subject|120|||
148963782|NCT00878709|537352934|FG000|Overall Study|Lost to Follow-up|35|||
148963783|NCT00878709|537352935|FG001|Overall Study|Lost to Follow-up|33|||
148963784|NCT00878709|537352934|FG000|Overall Study|Other Reasons|93|||
148963785|NCT00878709|537352935|FG001|Overall Study|Other Reasons|84|||
148963786|NCT02225743|537352936|FG000|Overall Study|Withdrawal by Subject|18|||
148963787|NCT03886220|537352941|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
148963788|NCT03886220|537352942|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
148963789|NCT03886220|537352941|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
148963790|NCT03886220|537352942|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148963791|NCT03886220|537352941|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
148963792|NCT03886220|537352942|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
148963793|NCT00768300|537352943|FG000|Overall Study|Randomized but not treated|1|||
148963794|NCT00768300|537352944|FG001|Overall Study|Randomized but not treated|1|||
148963795|NCT00768300|537352943|FG000|Overall Study|Adverse Event|10|||
148963796|NCT00768300|537352944|FG001|Overall Study|Adverse Event|2|||
148963797|NCT00768300|537352943|FG000|Overall Study|Protocol Violation|6|||
148963798|NCT00768300|537352944|FG001|Overall Study|Protocol Violation|1|||
148963799|NCT00768300|537352943|FG000|Overall Study|Withdrawal by Subject|13|||
148963800|NCT00768300|537352944|FG001|Overall Study|Withdrawal by Subject|7|||
148963801|NCT00768300|537352943|FG000|Overall Study|Physician Decision|2|||
148963802|NCT00768300|537352944|FG001|Overall Study|Physician Decision|3|||
148963803|NCT00768300|537352943|FG000|Overall Study|Study discontinued by Sponsor|271|||
148963804|NCT00768300|537352944|FG001|Overall Study|Study discontinued by Sponsor|140|||
148695826|NCT02732210|536359374|FG000|Overall Study|Study Ended|13|||
148695827|NCT02732210|536359375|FG001|Overall Study|Study Ended|13|||
148695828|NCT02732210|536359374|FG000|Overall Study|Withdrawal by Subject|28|||
148695829|NCT02732210|536359375|FG001|Overall Study|Withdrawal by Subject|87|||
148695830|NCT02732210|536359374|FG000|Overall Study|Lost to Follow-up|5|||
148695831|NCT02732210|536359375|FG001|Overall Study|Lost to Follow-up|57|||
148695832|NCT02732210|536359374|FG000|Overall Study|Death|4|||
148695833|NCT02732210|536359375|FG001|Overall Study|Death|15|||
148695834|NCT02732210|536359374|FG000|Overall Study|Other|35|||
148695835|NCT02732210|536359375|FG001|Overall Study|Other|103|||
148695836|NCT02732210|536359374|FG000|Overall Study|Missing|0|||
148695837|NCT02732210|536359375|FG001|Overall Study|Missing|8|||
148963805|NCT00768300|537352943|FG000|Overall Study|Death|21|||
148963806|NCT00768300|537352944|FG001|Overall Study|Death|5|||
148963807|NCT00768300|537352943|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
148695838|NCT03561883|536359383|FG000|Overall Study|Adverse Event|10|||
148963808|NCT00768300|537352944|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
148963809|NCT00768300|537352943|FG000|Overall Study|Screen failure following randomization|1|||
148963810|NCT00768300|537352944|FG001|Overall Study|Screen failure following randomization|0|||
148963811|NCT00768300|537352943|FG000|Overall Study|Received lung transplant|1|||
148963812|NCT00768300|537352944|FG001|Overall Study|Received lung transplant|1|||
148963813|NCT00768300|537352943|FG000|Overall Study|Lost to Follow-up|0|||
148963814|NCT00768300|537352944|FG001|Overall Study|Lost to Follow-up|1|||
148963815|NCT00768300|537352943|FG000|Overall Study|Began prohibited concomitant medication|0|||
148963816|NCT00768300|537352944|FG001|Overall Study|Began prohibited concomitant medication|1|||
148963817|NCT00768300|537352943|FG000|Overall Study|Treated but never dosed with Study drug|1|||
148963818|NCT00768300|537352944|FG001|Overall Study|Treated but never dosed with Study drug|0|||
148963819|NCT00768300|537352943|FG000|Overall Study|Missing data|1|||
148963820|NCT00768300|537352944|FG001|Overall Study|Missing data|0|||
148963821|NCT02068222|537352947|FG000|Overall Study|Lost to Follow-up|1|||
148963822|NCT03082599|537352948|FG000|Overall Study|Lost to Follow-up|1|||
148963823|NCT03082599|537352949|FG001|Overall Study|Lost to Follow-up|0|||
148963824|NCT00281684|537352952|FG000|Overall Study|Lost to Follow-up|0|||
148963825|NCT00281684|537352953|FG001|Overall Study|Lost to Follow-up|0|||
148963826|NCT00281684|537352954|FG002|Overall Study|Lost to Follow-up|1|||
148963827|NCT00281684|537352955|FG003|Overall Study|Lost to Follow-up|0|||
148963828|NCT00281684|537352952|FG000|Overall Study|Withdrawal by Subject|1|||
148963829|NCT00281684|537352953|FG001|Overall Study|Withdrawal by Subject|0|||
148963830|NCT00281684|537352954|FG002|Overall Study|Withdrawal by Subject|0|||
148963831|NCT00281684|537352955|FG003|Overall Study|Withdrawal by Subject|0|||
148963832|NCT01559012|537352958|FG000|Overall Study|Withdrawal by Subject|0|||
148963833|NCT01559012|537352959|FG001|Overall Study|Withdrawal by Subject|1|||
148963834|NCT00946712|537352960|FG000|Overall Study|Adverse Event|118|||
148963835|NCT00946712|537352961|FG001|Overall Study|Adverse Event|124|||
148963836|NCT00946712|537352960|FG000|Overall Study|Disease progression|308|||
148963837|NCT00946712|537352961|FG001|Overall Study|Disease progression|404|||
148963838|NCT00946712|537352960|FG000|Overall Study|Death|21|||
148963839|NCT00946712|537352961|FG001|Overall Study|Death|22|||
148963840|NCT00946712|537352960|FG000|Overall Study|No treatment given|25|||
148963841|NCT00946712|537352961|FG001|Overall Study|No treatment given|29|||
148963842|NCT00946712|537352960|FG000|Overall Study|Other reasons|61|||
148963843|NCT00946712|537352961|FG001|Overall Study|Other reasons|73|||
148963844|NCT00946712|537352960|FG000|Overall Study|On Treatment|0|||
148963845|NCT00946712|537352961|FG001|Overall Study|On Treatment|4|||
148963846|NCT00946712|537352960|FG000|Overall Study|Ineligible|14|||
148963847|NCT00946712|537352961|FG001|Overall Study|Ineligible|6|||
148963848|NCT00302458|537352962|FG000|Overall Study|Lost to Follow-up|1|||
148963849|NCT00302458|537352962|FG000|Overall Study|Ineligible after screening|1|||
148963850|NCT00302458|537352962|FG000|Overall Study|Withdrawal by Subject|1|||
149024090|NCT04034238|537564175|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
149024091|NCT04034238|537564176|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
149024092|NCT04034238|537564177|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
149024093|NCT04034238|537564174|FG000|Dose Escalation Phase|Screen failures|0|||
149024094|NCT04034238|537564175|FG001|Dose Escalation Phase|Screen failures|0|||
149024095|NCT04034238|537564176|FG002|Dose Escalation Phase|Screen failures|0|||
149024096|NCT04034238|537564177|FG003|Dose Escalation Phase|Screen failures|2|||
149024097|NCT04034238|537564174|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
149024098|NCT04034238|537564175|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
149024099|NCT04034238|537564176|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
149024100|NCT04034238|537564177|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
149024101|NCT04034238|537564174|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
149024102|NCT04034238|537564175|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
149024103|NCT04034238|537564176|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
149024104|NCT04034238|537564177|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
149024105|NCT01598987|537564178|FG000|Baseline to Month 12|Administrative problems|2|||
149024106|NCT01598987|537564178|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
149024107|NCT01598987|537564178|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
149024108|NCT01598987|537564178|FG000|Baseline to 24 Month|Administrative problems|2|||
149024109|NCT01598987|537564178|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
149024110|NCT00924664|537564179|FG000|Overall Study|Adverse Event|23|||
148963851|NCT00853723|537352965|FG000|Overall Study|Adverse Event|3|||
148963852|NCT00853723|537352966|FG001|Overall Study|Adverse Event|4|||
148963853|NCT00853723|537352967|FG002|Overall Study|Adverse Event|1|||
148963854|NCT00853723|537352965|FG000|Overall Study|Withdrawal by Subject|2|||
148963855|NCT00853723|537352966|FG001|Overall Study|Withdrawal by Subject|1|||
148963856|NCT00853723|537352967|FG002|Overall Study|Withdrawal by Subject|0|||
148963857|NCT00853723|537352965|FG000|Overall Study|Protocol Violation|1|||
148963858|NCT00853723|537352966|FG001|Overall Study|Protocol Violation|2|||
148963859|NCT00853723|537352967|FG002|Overall Study|Protocol Violation|1|||
148963860|NCT00445965|537352968|FG000|Overall Study|Adverse Event|2|||
148963861|NCT00445965|537352968|FG000|Overall Study|Physician Decision|1|||
148963862|NCT00445965|537352968|FG000|Overall Study|Enrolled but not treated|1|||
148963863|NCT00445965|537352968|FG000|Overall Study|Removed due to progressive disease|29|||
148963864|NCT02447081|537352969|FG000|Overall Study|Death|161|||
148963865|NCT02447081|537352969|FG000|Overall Study|Lost to Follow-up|36|||
148963866|NCT02447081|537352969|FG000|Overall Study|Visit not completed|17|||
148963867|NCT02447081|537352969|FG000|Overall Study|unsuccessful implant procedure|10|||
148963868|NCT02867709|537352972|FG000|Treatment Period|Adverse Event|1|||
148963869|NCT02867709|537352973|FG001|Treatment Period|Adverse Event|1|||
148963870|NCT02867709|537352974|FG002|Treatment Period|Adverse Event|2|||
148963871|NCT02867709|537352972|FG000|Treatment Period|Withdrawal of Consent|7|||
148963872|NCT02867709|537352973|FG001|Treatment Period|Withdrawal of Consent|9|||
148963873|NCT02867709|537352974|FG002|Treatment Period|Withdrawal of Consent|8|||
148963874|NCT02867709|537352972|FG000|Treatment Period|Lost to Follow-up|17|||
148963875|NCT02867709|537352973|FG001|Treatment Period|Lost to Follow-up|20|||
148963876|NCT02867709|537352974|FG002|Treatment Period|Lost to Follow-up|20|||
148963877|NCT02867709|537352972|FG000|Treatment Period|Lack of Qualifying Event|42|||
148963878|NCT02867709|537352973|FG001|Treatment Period|Lack of Qualifying Event|55|||
148963879|NCT02867709|537352974|FG002|Treatment Period|Lack of Qualifying Event|42|||
148963880|NCT02867709|537352972|FG000|Treatment Period|Protocol Violation|3|||
148963881|NCT02867709|537352973|FG001|Treatment Period|Protocol Violation|2|||
148963882|NCT02867709|537352974|FG002|Treatment Period|Protocol Violation|3|||
148963883|NCT02867709|537352972|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
148963884|NCT02867709|537352973|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
148963885|NCT02867709|537352974|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
149024111|NCT00924664|537564180|FG001|Overall Study|Adverse Event|39|||
149024112|NCT00924664|537564179|FG000|Overall Study|Lack of Efficacy|10|||
149024113|NCT00924664|537564180|FG001|Overall Study|Lack of Efficacy|15|||
148813182|NCT01525589|536790612|FG002|Overall Study|Treatment-related AE|2|||
149024114|NCT00924664|537564179|FG000|Overall Study|Lost to Follow-up|10|||
149024115|NCT00924664|537564180|FG001|Overall Study|Lost to Follow-up|12|||
149024116|NCT00924664|537564179|FG000|Overall Study|Withdrawal by Subject|47|||
148963886|NCT02867709|537352972|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
148963887|NCT02867709|537352973|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
148963888|NCT02867709|537352974|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
148963889|NCT02867709|537352972|FG000|Safety Follow-up Period|Pregnancy|0|||
148963890|NCT02867709|537352973|FG001|Safety Follow-up Period|Pregnancy|1|||
148963891|NCT02867709|537352974|FG002|Safety Follow-up Period|Pregnancy|0|||
148963892|NCT02867709|537352972|FG000|Safety Follow-up Period|Protocol Violation|0|||
149024117|NCT00924664|537564180|FG001|Overall Study|Withdrawal by Subject|71|||
148963893|NCT02867709|537352973|FG001|Safety Follow-up Period|Protocol Violation|1|||
148963894|NCT02867709|537352974|FG002|Safety Follow-up Period|Protocol Violation|1|||
148963895|NCT01400516|537352975|FG000|Primary Trial|Withdrawal by Subject|0|||
148963896|NCT01400516|537352976|FG001|Primary Trial|Withdrawal by Subject|2|||
148963897|NCT01344161|537352977|FG000|Overall Study|Lost to Follow-up|4|||
148963898|NCT01344161|537352978|FG001|Overall Study|Lost to Follow-up|1|||
148963899|NCT01344161|537352977|FG000|Overall Study|Pregnancy|0|||
148963900|NCT01344161|537352978|FG001|Overall Study|Pregnancy|1|||
148963901|NCT01344161|537352977|FG000|Overall Study|Protocol Violation|1|||
148963902|NCT01344161|537352978|FG001|Overall Study|Protocol Violation|1|||
148963903|NCT04690751|537352979|FG000|Overall Study|Protocol Violation|0|||
148963904|NCT04690751|537352980|FG001|Overall Study|Protocol Violation|1|||
148963905|NCT04690751|537352981|FG002|Overall Study|Protocol Violation|0|||
148963906|NCT04690751|537352982|FG003|Overall Study|Protocol Violation|1|||
148963907|NCT04690751|537352983|FG004|Overall Study|Protocol Violation|2|||
148963908|NCT04690751|537352984|FG005|Overall Study|Protocol Violation|0|||
148963909|NCT04690751|537352979|FG000|Overall Study|Adverse Event|0|||
148963910|NCT04690751|537352980|FG001|Overall Study|Adverse Event|0|||
148963911|NCT04690751|537352981|FG002|Overall Study|Adverse Event|1|||
148963912|NCT04690751|537352982|FG003|Overall Study|Adverse Event|0|||
148963913|NCT04690751|537352983|FG004|Overall Study|Adverse Event|0|||
148963914|NCT04690751|537352984|FG005|Overall Study|Adverse Event|0|||
148963915|NCT04690751|537352979|FG000|Overall Study|Positive urine drug screen test|0|||
148963916|NCT04690751|537352980|FG001|Overall Study|Positive urine drug screen test|0|||
148963917|NCT04690751|537352981|FG002|Overall Study|Positive urine drug screen test|0|||
148963918|NCT04690751|537352982|FG003|Overall Study|Positive urine drug screen test|0|||
148963919|NCT04690751|537352983|FG004|Overall Study|Positive urine drug screen test|1|||
148963920|NCT04690751|537352984|FG005|Overall Study|Positive urine drug screen test|0|||
148963921|NCT01545817|537354490|FG000|Pazopanib|Disease progression|51|||
148963922|NCT01545817|537354491|FG001|Pazopanib|Disease progression|0|||
148963923|NCT01545817|537354490|FG000|Pazopanib|Adverse Event|19|||
148963924|NCT01545817|537354491|FG001|Pazopanib|Adverse Event|0|||
148963925|NCT01545817|537354490|FG000|Pazopanib|Other reason|4|||
148963926|NCT01545817|537354491|FG001|Pazopanib|Other reason|0|||
148963927|NCT01545817|537354490|FG000|Everolimus|Other reason|0|||
148963928|NCT01545817|537354491|FG001|Everolimus|Other reason|7|||
148963929|NCT01545817|537354490|FG000|Everolimus|Disease progression|0|||
148963930|NCT01545817|537354491|FG001|Everolimus|Disease progression|25|||
148963931|NCT01545817|537354490|FG000|Everolimus|Adverse Event|0|||
148963932|NCT01545817|537354491|FG001|Everolimus|Adverse Event|6|||
148963933|NCT01012622|537354496|FG000|Overall Study|Withdrawal by Subject|6|||
148963934|NCT01012622|537354496|FG000|Overall Study|Lost to Follow-up|5|||
148963935|NCT01012622|537354496|FG000|Overall Study|Adverse Event|7|||
148963936|NCT01012622|537354496|FG000|Overall Study|non-compliance with the drug|9|||
148963937|NCT01012622|537354496|FG000|Overall Study|Other|1|||
148963938|NCT01012622|537354496|FG000|Overall Study|screening failure|1|||
148963939|NCT01012622|537354496|FG000|Overall Study|withdrawal of consent by a parent|2|||
148963940|NCT02515942|537354497|FG000|Overall Study|Adverse Event|5|||
148963941|NCT02515942|537354498|FG001|Overall Study|Adverse Event|0|||
148963942|NCT02515942|537354499|FG002|Overall Study|Adverse Event|0|||
148963943|NCT02515942|537354497|FG000|Overall Study|Death|0|||
148963944|NCT02515942|537354498|FG001|Overall Study|Death|0|||
148963945|NCT02515942|537354499|FG002|Overall Study|Death|1|||
148963946|NCT02515942|537354497|FG000|Overall Study|Lack of Efficacy|0|||
148963947|NCT02515942|537354498|FG001|Overall Study|Lack of Efficacy|0|||
148963948|NCT02515942|537354499|FG002|Overall Study|Lack of Efficacy|1|||
148963949|NCT02515942|537354497|FG000|Overall Study|Lost to Follow-up|2|||
148963950|NCT02515942|537354498|FG001|Overall Study|Lost to Follow-up|0|||
148963951|NCT02515942|537354499|FG002|Overall Study|Lost to Follow-up|0|||
148963952|NCT02515942|537354497|FG000|Overall Study|Withdrawal by Subject|0|||
148963953|NCT02515942|537354498|FG001|Overall Study|Withdrawal by Subject|3|||
148963954|NCT02515942|537354499|FG002|Overall Study|Withdrawal by Subject|2|||
148963955|NCT03257631|537354500|FG000|Overall Study|Death|1|||
148963956|NCT03257631|537354501|FG001|Overall Study|Death|0|||
148963957|NCT03257631|537354502|FG002|Overall Study|Death|1|||
148963958|NCT03257631|537354503|FG003|Overall Study|Death|1|||
148963959|NCT03257631|537354500|FG000|Overall Study|Progressive Disease|10|||
148963960|NCT03257631|537354501|FG001|Overall Study|Progressive Disease|9|||
148963961|NCT03257631|537354502|FG002|Overall Study|Progressive Disease|17|||
148963962|NCT03257631|537354503|FG003|Overall Study|Progressive Disease|8|||
148963963|NCT03257631|537354500|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148963964|NCT03257631|537354501|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148813183|NCT01525589|536790610|FG000|Overall Study|Other reasons|0|||
148963965|NCT03257631|537354502|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
148963966|NCT03257631|537354503|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
148963967|NCT03257631|537354500|FG000|Overall Study|Adverse Event|0|||
148963968|NCT03257631|537354501|FG001|Overall Study|Adverse Event|0|||
148963969|NCT03257631|537354502|FG002|Overall Study|Adverse Event|2|||
148963970|NCT03257631|537354503|FG003|Overall Study|Adverse Event|0|||
148963971|NCT00666757|537354506|FG000|Overall Study|Lost to Follow-up|39|||
148963972|NCT00666757|537354507|FG001|Overall Study|Lost to Follow-up|35|||
148963973|NCT00666757|537354506|FG000|Overall Study|Protocol Violation|23|||
148963974|NCT00666757|537354507|FG001|Overall Study|Protocol Violation|24|||
148963975|NCT00666757|537354506|FG000|Overall Study|Adverse Event|22|||
148963976|NCT00666757|537354507|FG001|Overall Study|Adverse Event|12|||
148963977|NCT00666757|537354506|FG000|Overall Study|Withdrawal by Subject|13|||
148963978|NCT00666757|537354507|FG001|Overall Study|Withdrawal by Subject|17|||
148963979|NCT00666757|537354506|FG000|Overall Study|Lack of Efficacy|3|||
148963980|NCT00666757|537354507|FG001|Overall Study|Lack of Efficacy|6|||
148963981|NCT00666757|537354506|FG000|Overall Study|Physician Decision|0|||
148963982|NCT00666757|537354507|FG001|Overall Study|Physician Decision|2|||
148963983|NCT00666757|537354506|FG000|Overall Study|Sponsor decision|0|||
148963984|NCT00666757|537354507|FG001|Overall Study|Sponsor decision|1|||
148963985|NCT02529137|537354508|FG000|Overall Study|Discontinuation for different reasons|8|||
148963986|NCT01723163|537354511|FG000|Treatment Phase|Withdrawal by Subject|14|||
148963987|NCT01723163|537354512|FG001|Treatment Phase|Withdrawal by Subject|6|||
148963988|NCT01723163|537354511|FG000|Treatment Phase|Withdrawal by PI|5|||
148963989|NCT01723163|537354512|FG001|Treatment Phase|Withdrawal by PI|1|||
148963990|NCT01723163|537354511|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
148963991|NCT01723163|537354512|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
148963992|NCT01723163|537354511|FG000|3-Month Follow-up|Unable to Contact|12|||
148963993|NCT01723163|537354512|FG001|3-Month Follow-up|Unable to Contact|19|||
148963994|NCT01723163|537354511|FG000|6-Month Follow-up|Death|1|||
148963995|NCT01723163|537354512|FG001|6-Month Follow-up|Death|0|||
148963996|NCT01723163|537354511|FG000|6-Month Follow-up|Unable to Contact|17|||
148963997|NCT01723163|537354512|FG001|6-Month Follow-up|Unable to Contact|15|||
148963998|NCT01723163|537354511|FG000|12-Month Follow-up|Death|1|||
148963999|NCT01723163|537354512|FG001|12-Month Follow-up|Death|0|||
148964000|NCT01723163|537354511|FG000|12-Month Follow-up|Unable to Contact|23|||
148964001|NCT01723163|537354512|FG001|12-Month Follow-up|Unable to Contact|28|||
148964002|NCT02510794|537354513|FG000|Overall Study|Adverse Event|0|||
148964003|NCT02510794|537354514|FG001|Overall Study|Adverse Event|1|||
148964004|NCT02510794|537354515|FG002|Overall Study|Adverse Event|0|||
148964005|NCT02510794|537354516|FG003|Overall Study|Adverse Event|0|||
148964006|NCT02510794|537354513|FG000|Overall Study|Death|1|||
148964007|NCT02510794|537354514|FG001|Overall Study|Death|2|||
148964008|NCT02510794|537354515|FG002|Overall Study|Death|1|||
148964009|NCT02510794|537354516|FG003|Overall Study|Death|1|||
148964010|NCT02510794|537354513|FG000|Overall Study|Lack of Efficacy|3|||
148964011|NCT02510794|537354514|FG001|Overall Study|Lack of Efficacy|1|||
148964012|NCT02510794|537354515|FG002|Overall Study|Lack of Efficacy|1|||
148964013|NCT02510794|537354516|FG003|Overall Study|Lack of Efficacy|0|||
148964014|NCT02510794|537354513|FG000|Overall Study|Participant moved out of the area|0|||
148964015|NCT02510794|537354514|FG001|Overall Study|Participant moved out of the area|0|||
148964016|NCT02510794|537354515|FG002|Overall Study|Participant moved out of the area|0|||
148964017|NCT02510794|537354516|FG003|Overall Study|Participant moved out of the area|1|||
148964018|NCT02510794|537354513|FG000|Overall Study|Physician Decision|3|||
148964019|NCT02510794|537354514|FG001|Overall Study|Physician Decision|0|||
148964020|NCT02510794|537354515|FG002|Overall Study|Physician Decision|0|||
148964021|NCT02510794|537354516|FG003|Overall Study|Physician Decision|0|||
148964022|NCT02510794|537354513|FG000|Overall Study|Protocol Violation|0|||
148964023|NCT02510794|537354514|FG001|Overall Study|Protocol Violation|0|||
148964024|NCT02510794|537354515|FG002|Overall Study|Protocol Violation|1|||
149024118|NCT00924664|537564179|FG000|Overall Study|Protocol Violation|2|||
148964025|NCT02510794|537354516|FG003|Overall Study|Protocol Violation|0|||
148964026|NCT02510794|537354513|FG000|Overall Study|Withdrawal by Subject|1|||
148964027|NCT02510794|537354514|FG001|Overall Study|Withdrawal by Subject|2|||
148964028|NCT02510794|537354515|FG002|Overall Study|Withdrawal by Subject|4|||
148964029|NCT02510794|537354516|FG003|Overall Study|Withdrawal by Subject|3|||
148964030|NCT01649375|537354517|FG000|Up to Week 16|Adverse Event|2|||
148813184|NCT01525589|536790611|FG001|Overall Study|Other reasons|1|||
148813185|NCT01525589|536790612|FG002|Overall Study|Other reasons|0|||
148813186|NCT01525589|536790610|FG000|Overall Study|Withdrawal by Subject|0|||
148813187|NCT01525589|536790611|FG001|Overall Study|Withdrawal by Subject|1|||
148964031|NCT01649375|537354518|FG001|Up to Week 16|Adverse Event|5|||
148964032|NCT01649375|537354519|FG002|Up to Week 16|Adverse Event|4|||
148964033|NCT01649375|537354520|FG003|Up to Week 16|Adverse Event|0|||
148964034|NCT01649375|537354521|FG004|Up to Week 16|Adverse Event|0|||
148964035|NCT01649375|537354517|FG000|Up to Week 16|Lack of Efficacy|0|||
148964036|NCT01649375|537354518|FG001|Up to Week 16|Lack of Efficacy|0|||
148964037|NCT01649375|537354519|FG002|Up to Week 16|Lack of Efficacy|1|||
148964038|NCT01649375|537354520|FG003|Up to Week 16|Lack of Efficacy|0|||
148964039|NCT01649375|537354521|FG004|Up to Week 16|Lack of Efficacy|0|||
148964040|NCT01649375|537354517|FG000|Up to Week 16|Physician Decision|0|||
148964041|NCT01649375|537354518|FG001|Up to Week 16|Physician Decision|0|||
148964042|NCT01649375|537354519|FG002|Up to Week 16|Physician Decision|1|||
148964043|NCT01649375|537354520|FG003|Up to Week 16|Physician Decision|0|||
148964044|NCT01649375|537354521|FG004|Up to Week 16|Physician Decision|0|||
148964045|NCT01649375|537354517|FG000|Up to Week 16|Withdrawal by Subject|2|||
148964046|NCT01649375|537354518|FG001|Up to Week 16|Withdrawal by Subject|1|||
148964047|NCT01649375|537354519|FG002|Up to Week 16|Withdrawal by Subject|2|||
148964048|NCT01649375|537354520|FG003|Up to Week 16|Withdrawal by Subject|0|||
148964049|NCT01649375|537354521|FG004|Up to Week 16|Withdrawal by Subject|0|||
148964050|NCT01649375|537354517|FG000|Up to Week 16|Death|1|||
148964051|NCT01649375|537354518|FG001|Up to Week 16|Death|0|||
148964052|NCT01649375|537354519|FG002|Up to Week 16|Death|0|||
148964053|NCT01649375|537354520|FG003|Up to Week 16|Death|0|||
148964054|NCT01649375|537354521|FG004|Up to Week 16|Death|0|||
148964055|NCT01649375|537354517|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
148964056|NCT01649375|537354518|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
148964057|NCT01649375|537354519|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
148964058|NCT01649375|537354520|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
148964059|NCT01649375|537354521|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
148964060|NCT01649375|537354517|FG000|Week 16 up to Week 260|Non-compliance|0|||
148964061|NCT01649375|537354518|FG001|Week 16 up to Week 260|Non-compliance|1|||
148964062|NCT01649375|537354519|FG002|Week 16 up to Week 260|Non-compliance|0|||
148964063|NCT01649375|537354520|FG003|Week 16 up to Week 260|Non-compliance|1|||
148964064|NCT01649375|537354521|FG004|Week 16 up to Week 260|Non-compliance|0|||
148964065|NCT01649375|537354517|FG000|Week 16 up to Week 260|Physician Decision|0|||
148964066|NCT01649375|537354518|FG001|Week 16 up to Week 260|Physician Decision|2|||
148964067|NCT01649375|537354519|FG002|Week 16 up to Week 260|Physician Decision|0|||
148964068|NCT01649375|537354520|FG003|Week 16 up to Week 260|Physician Decision|0|||
148964069|NCT01649375|537354521|FG004|Week 16 up to Week 260|Physician Decision|0|||
148964070|NCT01649375|537354517|FG000|Week 16 up to Week 260|Technical issues|0|||
148964071|NCT01649375|537354518|FG001|Week 16 up to Week 260|Technical issues|1|||
148964072|NCT01649375|537354519|FG002|Week 16 up to Week 260|Technical issues|0|||
148964073|NCT01649375|537354520|FG003|Week 16 up to Week 260|Technical issues|1|||
148964074|NCT01649375|537354521|FG004|Week 16 up to Week 260|Technical issues|0|||
148964075|NCT01649375|537354517|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
148964076|NCT01649375|537354518|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
148964077|NCT01649375|537354519|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
148695839|NCT03561883|536359384|FG001|Overall Study|Adverse Event|13|||
148695840|NCT03561883|536359383|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148695841|NCT03561883|536359384|FG001|Overall Study|Non-Compliance With Study Drug|2|||
148695842|NCT03561883|536359383|FG000|Overall Study|Protocol Violation|2|||
148964078|NCT01649375|537354520|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
148964079|NCT01649375|537354521|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
148964080|NCT01649375|537354517|FG000|Week 16 up to Week 260|Death|1|||
148964081|NCT01649375|537354518|FG001|Week 16 up to Week 260|Death|1|||
148964082|NCT01649375|537354519|FG002|Week 16 up to Week 260|Death|0|||
148964083|NCT01649375|537354520|FG003|Week 16 up to Week 260|Death|0|||
148964084|NCT01649375|537354521|FG004|Week 16 up to Week 260|Death|0|||
148964085|NCT01649375|537354517|FG000|Week 16 up to Week 260|Adverse Event|5|||
148964086|NCT01649375|537354518|FG001|Week 16 up to Week 260|Adverse Event|2|||
148964087|NCT01649375|537354519|FG002|Week 16 up to Week 260|Adverse Event|0|||
148964088|NCT01649375|537354520|FG003|Week 16 up to Week 260|Adverse Event|3|||
148964089|NCT01649375|537354521|FG004|Week 16 up to Week 260|Adverse Event|2|||
148964090|NCT02066467|537354526|FG000|Overall Study|Did not undergo implant procedure|24|||
148964091|NCT02066467|537354526|FG000|Overall Study|Attempted to implant withoput success|43|||
148964092|NCT02066467|537354526|FG000|Overall Study|Consent ineligible|1|||
148964093|NCT02066467|537354526|FG000|Overall Study|Death|54|||
148964094|NCT02066467|537354526|FG000|Overall Study|Lost to Follow-up|51|||
148964095|NCT02066467|537354526|FG000|Overall Study|Adverse Event|20|||
148964096|NCT02066467|537354526|FG000|Overall Study|Withdrawal by Subject|16|||
148964097|NCT02066467|537354526|FG000|Overall Study|Physician Decision|2|||
148964098|NCT02066467|537354526|FG000|Overall Study|Not defined|4|||
148964099|NCT00456521|537354527|FG000|Overall Study|Adverse Event|150|||
148964100|NCT00456521|537354528|FG001|Overall Study|Adverse Event|25|||
148964101|NCT00456521|537354527|FG000|Overall Study|Withdrawal by Subject|43|||
148964102|NCT00456521|537354528|FG001|Overall Study|Withdrawal by Subject|24|||
148964103|NCT00456521|537354527|FG000|Overall Study|Lost to Follow-up|22|||
148964104|NCT00456521|537354528|FG001|Overall Study|Lost to Follow-up|17|||
148964105|NCT00456521|537354527|FG000|Overall Study|Lack of Efficacy|3|||
148695843|NCT03561883|536359384|FG001|Overall Study|Protocol Violation|3|||
148695844|NCT03561883|536359383|FG000|Overall Study|Withdrawal by Subject|14|||
148695845|NCT03561883|536359384|FG001|Overall Study|Withdrawal by Subject|6|||
148695846|NCT03561883|536359383|FG000|Overall Study|Lost to Follow-up|2|||
148695847|NCT03561883|536359384|FG001|Overall Study|Lost to Follow-up|6|||
148695848|NCT03561883|536359383|FG000|Overall Study|Study Terminated by Sponsor|12|||
148695849|NCT03561883|536359384|FG001|Overall Study|Study Terminated by Sponsor|11|||
148695850|NCT03561883|536359383|FG000|Overall Study|Physician Decision|1|||
148695851|NCT03561883|536359384|FG001|Overall Study|Physician Decision|0|||
148695852|NCT03561883|536359383|FG000|Overall Study|Randomized by Mistake|1|||
148695853|NCT03561883|536359384|FG001|Overall Study|Randomized by Mistake|0|||
148695854|NCT03561883|536359383|FG000|Overall Study|Other, Not Specified|3|||
148695855|NCT03561883|536359384|FG001|Overall Study|Other, Not Specified|2|||
148695856|NCT05956665|536359385|FG000|Overall Study|Death|1|||
148695857|NCT05956665|536359385|FG000|Overall Study|Withdrawal by Subject|1|||
148695858|NCT01939197|536359389|FG000|Overall Study|Withdrawal by Subject|1|||
148695859|NCT01939197|536359390|FG001|Overall Study|Withdrawal by Subject|0|||
148695860|NCT01939197|536359391|FG002|Overall Study|Withdrawal by Subject|0|||
148695861|NCT01939197|536359392|FG003|Overall Study|Withdrawal by Subject|0|||
149024119|NCT00924664|537564180|FG001|Overall Study|Protocol Violation|5|||
149024120|NCT00924664|537564179|FG000|Overall Study|Pregnancy|1|||
148695862|NCT01939197|536359393|FG004|Overall Study|Withdrawal by Subject|1|||
148695863|NCT01939197|536359394|FG005|Overall Study|Withdrawal by Subject|0|||
148695864|NCT01939197|536359395|FG006|Overall Study|Withdrawal by Subject|0|||
148695865|NCT01939197|536359389|FG000|Overall Study|Lost to Follow-up|0|||
149024121|NCT00924664|537564180|FG001|Overall Study|Pregnancy|1|||
148695866|NCT01939197|536359390|FG001|Overall Study|Lost to Follow-up|1|||
148695867|NCT01939197|536359391|FG002|Overall Study|Lost to Follow-up|0|||
148695868|NCT01939197|536359392|FG003|Overall Study|Lost to Follow-up|1|||
148964106|NCT00456521|537354528|FG001|Overall Study|Lack of Efficacy|6|||
148964107|NCT00456521|537354527|FG000|Overall Study|Protocol Violation|4|||
148964108|NCT00456521|537354528|FG001|Overall Study|Protocol Violation|0|||
148964109|NCT00456521|537354527|FG000|Overall Study|Pregnancy|1|||
148964110|NCT00456521|537354528|FG001|Overall Study|Pregnancy|1|||
149024122|NCT00924664|537564179|FG000|Overall Study|Death|0|||
148695869|NCT01939197|536359393|FG004|Overall Study|Lost to Follow-up|3|||
148695870|NCT01939197|536359394|FG005|Overall Study|Lost to Follow-up|1|||
148695871|NCT01939197|536359395|FG006|Overall Study|Lost to Follow-up|2|||
148695872|NCT04028843|536359403|FG000|Overall Study|Lost to Follow-up|32|||
148695873|NCT04028843|536359404|FG001|Overall Study|Lost to Follow-up|39|||
148695874|NCT04028843|536359403|FG000|Overall Study|Adverse Event|1|||
148964111|NCT00456521|537354527|FG000|Overall Study|Drug non-compliance, moved, other|26|||
148964112|NCT00456521|537354528|FG001|Overall Study|Drug non-compliance, moved, other|11|||
148964113|NCT01316276|537354529|FG000|Overall Study|Death|1|||
148964114|NCT01316276|537354529|FG000|Overall Study|Adverse Event|19|||
148964115|NCT01316276|537354529|FG000|Overall Study|Withdrawal of consent|24|||
148964116|NCT01316276|537354529|FG000|Overall Study|Lost to Follow-up|1|||
148964117|NCT01316276|537354529|FG000|Overall Study|Other|22|||
148964118|NCT00076011|537354533|FG000|Overall Study|Death|1|||
148964119|NCT00076011|537354533|FG000|Overall Study|Adverse Event|10|||
148964120|NCT00076011|537354533|FG000|Overall Study|Lack of Efficacy|25|||
148964121|NCT00076011|537354533|FG000|Overall Study|Withdrawal by Subject|1|||
148964122|NCT00076011|537354533|FG000|Overall Study|Study terminated by sponsor|3|||
148964123|NCT00076011|537354533|FG000|Overall Study|Other|11|||
148964124|NCT00076011|537354533|FG000|Overall Study|Ongoing|1|||
148964125|NCT03056755|537354539|FG000|Treatment- Core Phase|Progressive disease|89|||
148964126|NCT03056755|537354540|FG001|Treatment- Core Phase|Progressive disease|88|||
148964127|NCT03056755|537354541|FG002|Treatment- Core Phase|Progressive disease|90|||
148964128|NCT03056755|537354539|FG000|Treatment- Core Phase|Adverse Event|20|||
148964129|NCT03056755|537354540|FG001|Treatment- Core Phase|Adverse Event|14|||
148695875|NCT04028843|536359404|FG001|Overall Study|Adverse Event|0|||
148695876|NCT04028843|536359403|FG000|Overall Study|Non-viable Pregnancy|0|||
148964130|NCT03056755|537354541|FG002|Treatment- Core Phase|Adverse Event|13|||
148695877|NCT04028843|536359404|FG001|Overall Study|Non-viable Pregnancy|1|||
148964131|NCT03056755|537354539|FG000|Treatment- Core Phase|Physician Decision|7|||
148964132|NCT03056755|537354540|FG001|Treatment- Core Phase|Physician Decision|13|||
148964133|NCT03056755|537354541|FG002|Treatment- Core Phase|Physician Decision|5|||
148964134|NCT03056755|537354539|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
148964135|NCT03056755|537354540|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
148964136|NCT03056755|537354541|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
148964137|NCT03056755|537354539|FG000|Treatment- Core Phase|Death|3|||
148964138|NCT03056755|537354540|FG001|Treatment- Core Phase|Death|2|||
148964139|NCT03056755|537354541|FG002|Treatment- Core Phase|Death|4|||
148964140|NCT03056755|537354539|FG000|Treatment- Core Phase|Protocol deviation|1|||
148964141|NCT03056755|537354540|FG001|Treatment- Core Phase|Protocol deviation|1|||
148964142|NCT03056755|537354541|FG002|Treatment- Core Phase|Protocol deviation|0|||
148964143|NCT03056755|537354539|FG000|Treatment- Core Phase|Technical problems|1|||
148964144|NCT03056755|537354540|FG001|Treatment- Core Phase|Technical problems|0|||
148964145|NCT03056755|537354541|FG002|Treatment- Core Phase|Technical problems|0|||
148964146|NCT03056755|537354539|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
148964147|NCT03056755|537354540|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
148964148|NCT03056755|537354541|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
148964149|NCT03056755|537354539|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
148964150|NCT03056755|537354540|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
148964151|NCT03056755|537354541|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
148964152|NCT03056755|537354539|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
148964153|NCT03056755|537354540|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
148964154|NCT03056755|537354541|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
148964155|NCT03056755|537354539|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
148964156|NCT03056755|537354540|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
148964157|NCT03056755|537354541|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
148964158|NCT04461015|537354544|FG000|Overall Study|IV access lost during the study|0|||
148964159|NCT04461015|537354545|FG001|Overall Study|IV access lost during the study|1|||
148964160|NCT04461015|537354544|FG000|Overall Study|Withdrawal by Subject|0|||
148964161|NCT04461015|537354545|FG001|Overall Study|Withdrawal by Subject|1|||
148964162|NCT00464568|537354546|FG000|Overall Study|Adverse Event|2|||
148964163|NCT00405587|537354551|FG000|Overall Study|Death|0|||
148964164|NCT00405587|537354552|FG001|Overall Study|Death|0|||
148964165|NCT00405587|537354553|FG002|Overall Study|Death|0|||
148964166|NCT00405587|537354554|FG003|Overall Study|Death|1|||
148964167|NCT00405587|537354551|FG000|Overall Study|Disease Progression|22|||
148964168|NCT00405587|537354552|FG001|Overall Study|Disease Progression|23|||
148964169|NCT00405587|537354553|FG002|Overall Study|Disease Progression|21|||
148964170|NCT00405587|537354554|FG003|Overall Study|Disease Progression|17|||
148964171|NCT00405587|537354551|FG000|Overall Study|Physician Decision|3|||
148964172|NCT00405587|537354552|FG001|Overall Study|Physician Decision|2|||
148964173|NCT00405587|537354553|FG002|Overall Study|Physician Decision|0|||
148964174|NCT00405587|537354554|FG003|Overall Study|Physician Decision|0|||
148964175|NCT00405587|537354551|FG000|Overall Study|Adverse Event|1|||
148964176|NCT00405587|537354552|FG001|Overall Study|Adverse Event|0|||
148964177|NCT00405587|537354553|FG002|Overall Study|Adverse Event|0|||
148964178|NCT00405587|537354554|FG003|Overall Study|Adverse Event|0|||
148964179|NCT00405587|537354551|FG000|Overall Study|Lost to Follow-up|0|||
148964180|NCT00405587|537354552|FG001|Overall Study|Lost to Follow-up|1|||
148964181|NCT00405587|537354553|FG002|Overall Study|Lost to Follow-up|1|||
148964182|NCT00405587|537354554|FG003|Overall Study|Lost to Follow-up|0|||
148964183|NCT00405587|537354551|FG000|Overall Study|Radiation induced necrosis|0|||
148964184|NCT00405587|537354552|FG001|Overall Study|Radiation induced necrosis|1|||
148964185|NCT00405587|537354553|FG002|Overall Study|Radiation induced necrosis|0|||
148964186|NCT00405587|537354554|FG003|Overall Study|Radiation induced necrosis|0|||
148964187|NCT00405587|537354551|FG000|Overall Study|Withdrawal by Subject|0|||
148964188|NCT00405587|537354552|FG001|Overall Study|Withdrawal by Subject|0|||
148964189|NCT00405587|537354553|FG002|Overall Study|Withdrawal by Subject|0|||
148964190|NCT00405587|537354554|FG003|Overall Study|Withdrawal by Subject|2|||
148964191|NCT00405587|537354551|FG000|Overall Study|Participant not dosed|0|||
148964192|NCT00405587|537354552|FG001|Overall Study|Participant not dosed|1|||
148964193|NCT00405587|537354553|FG002|Overall Study|Participant not dosed|0|||
148964194|NCT00405587|537354554|FG003|Overall Study|Participant not dosed|0|||
148964195|NCT03406858|537354555|FG000|Overall Study|Failure to receive treatment drug.|1|||
148964196|NCT03406858|537354555|FG000|Overall Study|ineligible|1|||
148964197|NCT02419742|537354556|FG000|Overall Study|Adverse Event|2|||
148964198|NCT02419742|537354557|FG001|Overall Study|Adverse Event|0|||
148964199|NCT02419742|537354556|FG000|Overall Study|Disease Progression|0|||
148964200|NCT02419742|537354557|FG001|Overall Study|Disease Progression|1|||
148964201|NCT02419742|537354556|FG000|Overall Study|Withdrew Consent|2|||
148964202|NCT02419742|537354557|FG001|Overall Study|Withdrew Consent|1|||
148964203|NCT02419742|537354556|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
148695878|NCT04028843|536359403|FG000|Overall Study|Withdrawal by Subject|4|||
148695879|NCT04028843|536359404|FG001|Overall Study|Withdrawal by Subject|2|||
148695880|NCT03298451|536359405|FG000|Overall Study|Death|275|||
148695881|NCT03298451|536359406|FG001|Overall Study|Death|260|||
148695882|NCT03298451|536359407|FG002|Overall Study|Death|122|||
148964204|NCT02419742|537354557|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
148964205|NCT00507442|537354562|FG000|Overall Study|Adverse Event|8|||
149024123|NCT00924664|537564180|FG001|Overall Study|Death|2|||
148695883|NCT03298451|536359408|FG003|Overall Study|Death|280|||
148695884|NCT03298451|536359405|FG000|Overall Study|Lost to Follow-up|1|||
148695885|NCT03298451|536359406|FG001|Overall Study|Lost to Follow-up|1|||
148964206|NCT00507442|537354563|FG001|Overall Study|Adverse Event|11|||
148964207|NCT00507442|537354564|FG002|Overall Study|Adverse Event|4|||
148964208|NCT00507442|537354565|FG003|Overall Study|Adverse Event|1|||
148964209|NCT00507442|537354562|FG000|Overall Study|Protocol Violation|0|||
148964210|NCT00507442|537354563|FG001|Overall Study|Protocol Violation|1|||
148964211|NCT00507442|537354564|FG002|Overall Study|Protocol Violation|0|||
148964212|NCT00507442|537354565|FG003|Overall Study|Protocol Violation|0|||
148964213|NCT00507442|537354562|FG000|Overall Study|Lost to Follow-up|0|||
148964214|NCT00507442|537354563|FG001|Overall Study|Lost to Follow-up|0|||
148964215|NCT00507442|537354564|FG002|Overall Study|Lost to Follow-up|1|||
148964216|NCT00507442|537354565|FG003|Overall Study|Lost to Follow-up|0|||
148964217|NCT00507442|537354562|FG000|Overall Study|Physician Decision|0|||
148964218|NCT00507442|537354563|FG001|Overall Study|Physician Decision|2|||
148964219|NCT00507442|537354564|FG002|Overall Study|Physician Decision|4|||
148964220|NCT00507442|537354565|FG003|Overall Study|Physician Decision|1|||
148964221|NCT00507442|537354562|FG000|Overall Study|Progressive Disease|2|||
148964222|NCT00507442|537354563|FG001|Overall Study|Progressive Disease|4|||
148964223|NCT00507442|537354564|FG002|Overall Study|Progressive Disease|2|||
148964224|NCT00507442|537354565|FG003|Overall Study|Progressive Disease|0|||
148964225|NCT00507442|537354562|FG000|Overall Study|Withdrawal by Subject|4|||
148964226|NCT00507442|537354563|FG001|Overall Study|Withdrawal by Subject|4|||
148964227|NCT00507442|537354564|FG002|Overall Study|Withdrawal by Subject|2|||
148964228|NCT00507442|537354565|FG003|Overall Study|Withdrawal by Subject|1|||
148964229|NCT00507442|537354562|FG000|Overall Study|Other|2|||
148964230|NCT00507442|537354563|FG001|Overall Study|Other|5|||
148964231|NCT00507442|537354564|FG002|Overall Study|Other|2|||
148964232|NCT00507442|537354565|FG003|Overall Study|Other|2|||
148964233|NCT00930579|537354566|FG000|Overall Study|Withdrawal by Subject|1|||
148964234|NCT00930579|537354566|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
148964235|NCT02672423|537354568|FG000|Period 1|Adverse Event|0|||
148964236|NCT02672423|537354569|FG001|Period 1|Adverse Event|0|||
148964237|NCT02672423|537354570|FG002|Period 1|Adverse Event|0|||
148964238|NCT02672423|537354571|FG003|Period 1|Adverse Event|0|||
148964239|NCT02672423|537354572|FG004|Period 1|Adverse Event|1|||
148964240|NCT02672423|537354573|FG005|Period 1|Adverse Event|0|||
148964241|NCT02672423|537354574|FG006|Period 1|Adverse Event|0|||
148964242|NCT02672423|537354575|FG007|Period 1|Adverse Event|0|||
148964243|NCT02672423|537354576|FG008|Period 1|Adverse Event|0|||
148964244|NCT02672423|537354577|FG009|Period 1|Adverse Event|0|||
148964245|NCT02672423|537354568|FG000|Period 2|Withdrawal by Subject|0|||
148964246|NCT02672423|537354569|FG001|Period 2|Withdrawal by Subject|0|||
148964247|NCT02672423|537354570|FG002|Period 2|Withdrawal by Subject|1|||
148964248|NCT02672423|537354571|FG003|Period 2|Withdrawal by Subject|0|||
148964249|NCT02672423|537354572|FG004|Period 2|Withdrawal by Subject|0|||
148964250|NCT02672423|537354573|FG005|Period 2|Withdrawal by Subject|0|||
148964251|NCT02672423|537354574|FG006|Period 2|Withdrawal by Subject|0|||
148964252|NCT02672423|537354575|FG007|Period 2|Withdrawal by Subject|0|||
148964253|NCT02672423|537354576|FG008|Period 2|Withdrawal by Subject|0|||
148964254|NCT02672423|537354577|FG009|Period 2|Withdrawal by Subject|0|||
148964255|NCT02672423|537354568|FG000|Period 3|Withdrawal by Subject|0|||
148964256|NCT02672423|537354569|FG001|Period 3|Withdrawal by Subject|0|||
148964257|NCT02672423|537354570|FG002|Period 3|Withdrawal by Subject|0|||
148964258|NCT02672423|537354571|FG003|Period 3|Withdrawal by Subject|0|||
148964259|NCT02672423|537354572|FG004|Period 3|Withdrawal by Subject|0|||
148964260|NCT02672423|537354573|FG005|Period 3|Withdrawal by Subject|0|||
148964261|NCT02672423|537354574|FG006|Period 3|Withdrawal by Subject|0|||
148964262|NCT02672423|537354575|FG007|Period 3|Withdrawal by Subject|1|||
148964263|NCT02672423|537354576|FG008|Period 3|Withdrawal by Subject|0|||
148964264|NCT02672423|537354577|FG009|Period 3|Withdrawal by Subject|0|||
148964265|NCT02672423|537354568|FG000|Period 3|Physician Decision|0|||
149024124|NCT00924664|537564179|FG000|Overall Study|Study terminated by sponsor|199|||
149024125|NCT00924664|537564180|FG001|Overall Study|Study terminated by sponsor|330|||
149024126|NCT00924664|537564179|FG000|Overall Study|Other|29|||
149024127|NCT00924664|537564180|FG001|Overall Study|Other|52|||
148964266|NCT02672423|537354569|FG001|Period 3|Physician Decision|0|||
148964267|NCT02672423|537354570|FG002|Period 3|Physician Decision|0|||
149024128|NCT00924664|537564179|FG000|Overall Study|Randomized but not Treated|1|||
148964268|NCT02672423|537354571|FG003|Period 3|Physician Decision|0|||
148964269|NCT02672423|537354572|FG004|Period 3|Physician Decision|0|||
148964270|NCT02672423|537354573|FG005|Period 3|Physician Decision|1|||
148964271|NCT02672423|537354574|FG006|Period 3|Physician Decision|0|||
148964272|NCT02672423|537354575|FG007|Period 3|Physician Decision|0|||
148964273|NCT02672423|537354576|FG008|Period 3|Physician Decision|0|||
148964274|NCT02672423|537354577|FG009|Period 3|Physician Decision|0|||
148964275|NCT02864251|537354589|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
148964276|NCT02864251|537354590|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
148964277|NCT02864251|537354591|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
148964278|NCT02864251|537354589|FG000|Pre-Treatment|Withdrawal by Participant|0|||
148964279|NCT02864251|537354590|FG001|Pre-Treatment|Withdrawal by Participant|0|||
148964280|NCT02864251|537354591|FG002|Pre-Treatment|Withdrawal by Participant|4|||
149024129|NCT00924664|537564180|FG001|Overall Study|Randomized but not Treated|0|||
149024130|NCT01616563|537564183|FG000|Overall Study|Lost to Follow-up|40|||
149024131|NCT01106287|537564184|FG000|Overall Study|Adverse Event|1|||
149024132|NCT01106287|537564185|FG001|Overall Study|Adverse Event|0|||
149024133|NCT01106287|537564186|FG002|Overall Study|Adverse Event|0|||
149024134|NCT01106287|537564187|FG003|Overall Study|Adverse Event|0|||
149024135|NCT00072475|537564188|FG000|Overall Study|Adverse Event|44|||
149024136|NCT00072475|537564188|FG000|Overall Study|Death|3|||
149024137|NCT00072475|537564188|FG000|Overall Study|Withdrawal by Subject|46|||
149024138|NCT00072475|537564188|FG000|Overall Study|Patient/Investigator Decision|4|||
149024139|NCT01450943|537564193|FG000|Overall Study|Screen failure, loss to follow-up|2|||
149024140|NCT01450943|537564194|FG001|Overall Study|Screen failure, loss to follow-up|7|||
149024141|NCT01450943|537564195|FG002|Overall Study|Screen failure, loss to follow-up|6|||
149024142|NCT03303105|537564196|FG000|Overall Study|Adverse Event|0|||
149024143|NCT03303105|537564197|FG001|Overall Study|Adverse Event|2|||
149024144|NCT03303105|537564196|FG000|Overall Study|Lack of Efficacy|1|||
148813188|NCT01525589|536790612|FG002|Overall Study|Withdrawal by Subject|0|||
149024145|NCT03303105|537564197|FG001|Overall Study|Lack of Efficacy|0|||
148813189|NCT05759338|536790613|FG000|Overall Study|Withdrawal by Subject|3|||
149024146|NCT03303105|537564196|FG000|Overall Study|Protocol Violation|1|||
148964281|NCT02864251|537354589|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
148964282|NCT02864251|537354590|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
148964283|NCT02864251|537354591|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
148964284|NCT02864251|537354589|FG000|Pre-Treatment|Other Reasons|0|||
148964285|NCT02864251|537354590|FG001|Pre-Treatment|Other Reasons|1|||
148964286|NCT02864251|537354591|FG002|Pre-Treatment|Other Reasons|1|||
148964287|NCT02864251|537354589|FG000|Treatment|Disease Progression|109|||
148964288|NCT02864251|537354590|FG001|Treatment|Disease Progression|52|||
148964289|NCT02864251|537354591|FG002|Treatment|Disease Progression|101|||
148964290|NCT02864251|537354589|FG000|Treatment|Study Drug Toxicity|9|||
148964291|NCT02864251|537354590|FG001|Treatment|Study Drug Toxicity|4|||
148964292|NCT02864251|537354591|FG002|Treatment|Study Drug Toxicity|10|||
148964293|NCT02864251|537354589|FG000|Treatment|Death|0|||
148964294|NCT02864251|537354590|FG001|Treatment|Death|2|||
148964295|NCT02864251|537354591|FG002|Treatment|Death|3|||
148964296|NCT02864251|537354589|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
148964297|NCT02864251|537354590|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
148964298|NCT02864251|537354591|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
148964299|NCT02864251|537354589|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
148964300|NCT02864251|537354590|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
148964301|NCT02864251|537354591|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
148964302|NCT02864251|537354589|FG000|Treatment|Withdrawal by Participant|8|||
148964303|NCT02864251|537354590|FG001|Treatment|Withdrawal by Participant|5|||
148964304|NCT02864251|537354591|FG002|Treatment|Withdrawal by Participant|13|||
148964305|NCT02864251|537354589|FG000|Treatment|Maximum Clinical Benefit|1|||
148964306|NCT02864251|537354590|FG001|Treatment|Maximum Clinical Benefit|0|||
148964307|NCT02864251|537354591|FG002|Treatment|Maximum Clinical Benefit|1|||
148964308|NCT02864251|537354589|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
148964309|NCT02864251|537354590|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
148964310|NCT02864251|537354591|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
148964311|NCT02864251|537354589|FG000|Treatment|Other Reasons|1|||
148964312|NCT02864251|537354590|FG001|Treatment|Other Reasons|1|||
148813190|NCT04835441|536790615|FG000|Overall Study|Physician Decision|4|||
148813191|NCT04835441|536790616|FG001|Overall Study|Physician Decision|4|||
148964313|NCT02864251|537354591|FG002|Treatment|Other Reasons|4|||
148964314|NCT02864251|537354589|FG000|Treatment|Administrative Reason by Sponsor|1|||
148964315|NCT02864251|537354590|FG001|Treatment|Administrative Reason by Sponsor|0|||
148964316|NCT02864251|537354591|FG002|Treatment|Administrative Reason by Sponsor|0|||
148964317|NCT03506373|537354592|FG000|Overall Study|Adverse Event|6|||
148695886|NCT03298451|536359407|FG002|Overall Study|Lost to Follow-up|0|||
148695887|NCT03298451|536359408|FG003|Overall Study|Lost to Follow-up|7|||
148695888|NCT03298451|536359405|FG000|Overall Study|Withdrawal by Subject|9|||
148695889|NCT03298451|536359406|FG001|Overall Study|Withdrawal by Subject|7|||
148695890|NCT03298451|536359407|FG002|Overall Study|Withdrawal by Subject|1|||
148695891|NCT03298451|536359408|FG003|Overall Study|Withdrawal by Subject|20|||
148695892|NCT01347710|536359409|FG000|Overall Study|Withdrawal by Subject|2|||
148695893|NCT01347710|536359409|FG000|Overall Study|Adverse Event|4|||
148695894|NCT01347710|536359409|FG000|Overall Study|Angio or SPECT not completed|18|||
148813192|NCT04835441|536790615|FG000|Overall Study|Other|1|||
148813193|NCT04835441|536790616|FG001|Overall Study|Other|1|||
148695895|NCT01347710|536359409|FG000|Overall Study|issue with vitals prior to dosing|1|||
148813194|NCT04835441|536790615|FG000|Overall Study|Lost to Follow-up|0|||
148695896|NCT01347710|536359409|FG000|Overall Study|Lost to Follow-up|1|||
148695897|NCT01347710|536359409|FG000|Overall Study|Physician Decision|2|||
148695898|NCT01347710|536359409|FG000|Overall Study|Other|3|||
148695899|NCT04591626|536359411|FG000|Overall Study|Adverse Event|4|||
148695900|NCT04591626|536359412|FG001|Overall Study|Adverse Event|0|||
148695901|NCT04591626|536359411|FG000|Overall Study|Withdrawal by Subject|5|||
148695902|NCT04591626|536359412|FG001|Overall Study|Withdrawal by Subject|3|||
148695903|NCT04591626|536359411|FG000|Overall Study|Physician Decision|0|||
148695904|NCT04591626|536359412|FG001|Overall Study|Physician Decision|1|||
148695905|NCT04591626|536359411|FG000|Overall Study|Death|0|||
148695906|NCT04591626|536359412|FG001|Overall Study|Death|1|||
148695907|NCT04591626|536359411|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148695908|NCT04591626|536359412|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148695909|NCT01004172|536359416|FG000|Overall Study|Progressive Disease in CNS Only|16|||
148695910|NCT01004172|536359416|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
148695911|NCT01004172|536359416|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
148695912|NCT01004172|536359416|FG000|Overall Study|Adverse Event|1|||
148695913|NCT01004172|536359416|FG000|Overall Study|Physician Decision|1|||
148695914|NCT01004172|536359416|FG000|Overall Study|Symptomatic Deterioration|2|||
148695915|NCT00878995|536359420|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
148695916|NCT00878995|536359421|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
148695917|NCT02480764|536359424|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
148695918|NCT02480764|536359425|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
148695919|NCT02480764|536359426|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
148695920|NCT02480764|536359424|FG000|Overall Study|Major Protocol Deviation|1|||
148695921|NCT02480764|536359425|FG001|Overall Study|Major Protocol Deviation|4|||
148695922|NCT02480764|536359426|FG002|Overall Study|Major Protocol Deviation|3|||
148695923|NCT02480764|536359424|FG000|Overall Study|Lost to Follow-up|0|||
148695924|NCT02480764|536359425|FG001|Overall Study|Lost to Follow-up|1|||
148695925|NCT02480764|536359426|FG002|Overall Study|Lost to Follow-up|2|||
148695926|NCT02480764|536359424|FG000|Overall Study|Voluntary Withdrawal|6|||
148695927|NCT02480764|536359425|FG001|Overall Study|Voluntary Withdrawal|5|||
148695928|NCT02480764|536359426|FG002|Overall Study|Voluntary Withdrawal|10|||
148695929|NCT02480764|536359424|FG000|Overall Study|Lack of Efficacy|0|||
148695930|NCT02480764|536359425|FG001|Overall Study|Lack of Efficacy|3|||
148695931|NCT02480764|536359426|FG002|Overall Study|Lack of Efficacy|3|||
148695932|NCT02480764|536359424|FG000|Overall Study|Reason not Specified|0|||
148695933|NCT02480764|536359425|FG001|Overall Study|Reason not Specified|1|||
148695934|NCT02480764|536359426|FG002|Overall Study|Reason not Specified|0|||
148695935|NCT02457832|536359427|FG000|Training|Lost to Follow-up|10|||
148695936|NCT02457832|536359428|FG001|Training|Lost to Follow-up|6|||
148695937|NCT02457832|536359429|FG002|Training|Lost to Follow-up|3|||
148695938|NCT02457832|536359427|FG000|One Month Washout|Lost to Follow-up|0|||
148695939|NCT02457832|536359428|FG001|One Month Washout|Lost to Follow-up|1|||
148695940|NCT02457832|536359429|FG002|One Month Washout|Lost to Follow-up|1|||
148695941|NCT01868009|536359432|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
148695942|NCT01868009|536359433|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
148695943|NCT01868009|536359432|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
148695944|NCT01868009|536359433|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
148695945|NCT01868009|536359432|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
148695946|NCT01868009|536359433|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
148695947|NCT00860028|536359437|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
148695948|NCT00860028|536359438|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
148695949|NCT02514174|536359442|FG000|Overall Study|Patient refused to continue medication|1|||
148695950|NCT02514174|536359442|FG000|Overall Study|Adverse Event|2|||
148695951|NCT02514174|536359442|FG000|Overall Study|Study closed by sponsor|9|||
148695952|NCT02514174|536359442|FG000|Overall Study|Progressive disease|11|||
148695953|NCT02514174|536359442|FG000|Overall Study|Treatment change|1|||
148695954|NCT02514174|536359442|FG000|Overall Study|Treated off study with Afatinib.|1|||
148695955|NCT00416520|536360820|FG000|Open-label Period|Adverse Event|28|||
148695956|NCT00416520|536360821|FG001|Open-label Period|Adverse Event|10|||
148695957|NCT00416520|536360822|FG002|Open-label Period|Adverse Event|0|||
148695958|NCT00416520|536360823|FG003|Open-label Period|Adverse Event|0|||
148695959|NCT00416520|536360820|FG000|Open-label Period|Death|2|||
148695960|NCT00416520|536360821|FG001|Open-label Period|Death|1|||
148695961|NCT00416520|536360822|FG002|Open-label Period|Death|0|||
148695962|NCT00416520|536360823|FG003|Open-label Period|Death|0|||
148695963|NCT00416520|536360820|FG000|Open-label Period|Lack of Efficacy|8|||
148695964|NCT00416520|536360821|FG001|Open-label Period|Lack of Efficacy|1|||
148695965|NCT00416520|536360822|FG002|Open-label Period|Lack of Efficacy|0|||
148695966|NCT00416520|536360823|FG003|Open-label Period|Lack of Efficacy|0|||
148695967|NCT00416520|536360820|FG000|Open-label Period|Protocol Violation|3|||
148695968|NCT00416520|536360821|FG001|Open-label Period|Protocol Violation|3|||
148695969|NCT00416520|536360822|FG002|Open-label Period|Protocol Violation|0|||
148695970|NCT00416520|536360823|FG003|Open-label Period|Protocol Violation|0|||
148695971|NCT00416520|536360820|FG000|Open-label Period|Withdrawal by Subject|16|||
148813195|NCT04835441|536790616|FG001|Overall Study|Lost to Follow-up|1|||
148813196|NCT04611126|536790617|FG000|Overall Study|TIL expansion unsuccessful|1|||
148813197|NCT04611126|536790618|FG001|Overall Study|TIL expansion unsuccessful|0|||
148813198|NCT06717399|536790619|FG000|Overall Study|Death|1|||
148813199|NCT02293499|536791640|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
148813200|NCT02293499|536791641|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
148813201|NCT02293499|536791642|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
148813202|NCT02293499|536791640|FG000|Intervention - Camp|Withdrawal by Subject|3|||
148813203|NCT02293499|536791641|FG001|Intervention - Camp|Withdrawal by Subject|6|||
148813204|NCT02293499|536791642|FG002|Intervention - Camp|Withdrawal by Subject|2|||
148813205|NCT02293499|536791640|FG000|Intervention - Camp|these are those not showing up at camp|24|||
148813206|NCT02293499|536791641|FG001|Intervention - Camp|these are those not showing up at camp|28|||
148813207|NCT02293499|536791642|FG002|Intervention - Camp|these are those not showing up at camp|4|||
148813208|NCT02293499|536791640|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
148813209|NCT02293499|536791641|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
148695972|NCT00416520|536360821|FG001|Open-label Period|Withdrawal by Subject|5|||
148695973|NCT00416520|536360822|FG002|Open-label Period|Withdrawal by Subject|0|||
148695974|NCT00416520|536360823|FG003|Open-label Period|Withdrawal by Subject|0|||
148695975|NCT00416520|536360820|FG000|Open-label Period|Other Reasons|3|||
148695976|NCT00416520|536360821|FG001|Open-label Period|Other Reasons|12|||
148695977|NCT00416520|536360822|FG002|Open-label Period|Other Reasons|0|||
148695978|NCT00416520|536360823|FG003|Open-label Period|Other Reasons|0|||
148695979|NCT00416520|536360820|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
148695980|NCT00416520|536360821|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
148695981|NCT00416520|536360822|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
148695982|NCT00416520|536360823|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
148695983|NCT00416520|536360820|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
148695984|NCT00416520|536360821|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
148695985|NCT00416520|536360822|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
148695986|NCT00416520|536360823|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
148695987|NCT00416520|536360820|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
148695988|NCT00416520|536360821|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
148695989|NCT00416520|536360822|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
148695990|NCT00416520|536360823|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
148695991|NCT03601637|536360825|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
148695992|NCT03601637|536360826|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
148695993|NCT03601637|536360825|FG000|Overall Study|Adverse Event|1|||
148695994|NCT03601637|536360826|FG001|Overall Study|Adverse Event|1|||
148695995|NCT03601637|536360825|FG000|Overall Study|Other|0|||
148695996|NCT03601637|536360826|FG001|Overall Study|Other|1|||
148695997|NCT01108094|536360827|FG000|Overall Study|Adverse Event|2|||
148695998|NCT01108094|536360828|FG001|Overall Study|Adverse Event|0|||
148813210|NCT02293499|536791642|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
148964318|NCT03506373|537354592|FG000|Overall Study|Withdrawal by Subject|2|||
148964319|NCT03506373|537354592|FG000|Overall Study|Disease progression|5|||
148964320|NCT03506373|537354592|FG000|Overall Study|Other|3|||
148964321|NCT00885755|537354593|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
148964322|NCT00885755|537354594|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
148964323|NCT00885755|537354595|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
148964324|NCT00885755|537354593|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
148964325|NCT00885755|537354594|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
148964326|NCT00885755|537354595|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
148964327|NCT00885755|537354593|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
148964328|NCT00885755|537354594|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
148964329|NCT00885755|537354595|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
148964330|NCT00885755|537354593|FG000|Part I: Trastuzumab+Taxane|Death|0|||
148964331|NCT00885755|537354594|FG001|Part I: Trastuzumab+Taxane|Death|0|||
148964332|NCT00885755|537354595|FG002|Part I: Trastuzumab+Taxane|Death|1|||
148964333|NCT00885755|537354593|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
148964334|NCT00885755|537354594|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
148964335|NCT00885755|537354595|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
148964336|NCT00107198|537354597|FG000|Overall Study|Lack of Efficacy|28|||
148964337|NCT00107198|537354597|FG000|Overall Study|Lost to Follow-up|12|||
148964338|NCT00107198|537354597|FG000|Overall Study|Protocol Violation|1|||
148964339|NCT00107198|537354597|FG000|Overall Study|Withdrawal by Subject|6|||
148964340|NCT00107198|537354597|FG000|Overall Study|Ineligible|5|||
148964341|NCT03340025|537354603|FG000|Overall Study|Lost to Follow-up|2|||
148964342|NCT03340025|537354604|FG001|Overall Study|Lost to Follow-up|2|||
148964343|NCT00751348|537354607|FG000|Overall Study|Withdrawal by Subject|5|||
148964344|NCT00751348|537354608|FG001|Overall Study|Withdrawal by Subject|2|||
148964345|NCT00751348|537354607|FG000|Overall Study|Migration from study area|1|||
148964346|NCT00751348|537354608|FG001|Overall Study|Migration from study area|0|||
148964347|NCT03965962|537354609|FG000|Overall Study|Adverse Event|1|||
148964348|NCT03965962|537354610|FG001|Overall Study|Adverse Event|0|||
148964349|NCT03965962|537354611|FG002|Overall Study|Adverse Event|0|||
148964350|NCT03965962|537354612|FG003|Overall Study|Adverse Event|0|||
148964351|NCT03965962|537354609|FG000|Overall Study|Protocol Violation|21|||
148964352|NCT03965962|537354610|FG001|Overall Study|Protocol Violation|4|||
148964353|NCT03965962|537354611|FG002|Overall Study|Protocol Violation|10|||
148964354|NCT03965962|537354612|FG003|Overall Study|Protocol Violation|5|||
148964355|NCT03965962|537354609|FG000|Overall Study|Lost to Follow-up|0|||
148964356|NCT03965962|537354610|FG001|Overall Study|Lost to Follow-up|1|||
148964357|NCT03965962|537354611|FG002|Overall Study|Lost to Follow-up|0|||
148964358|NCT03965962|537354612|FG003|Overall Study|Lost to Follow-up|0|||
148964359|NCT03965962|537354609|FG000|Overall Study|Withdrawal by Subject|3|||
148964360|NCT03965962|537354610|FG001|Overall Study|Withdrawal by Subject|0|||
148964361|NCT03965962|537354611|FG002|Overall Study|Withdrawal by Subject|0|||
148964362|NCT03965962|537354612|FG003|Overall Study|Withdrawal by Subject|1|||
148964363|NCT00741039|537354613|FG000|Overall Study|Patient non-compliance|2|||
148964364|NCT00741039|537354614|FG001|Overall Study|Patient non-compliance|0|||
149024147|NCT03303105|537564197|FG001|Overall Study|Protocol Violation|0|||
148964365|NCT01712854|537354615|FG000|Overall Study|Physician Decision|1|||
148964366|NCT00322842|537354616|FG000|Overall Study|Withdrawal by Subject|0|||
148964367|NCT00322842|537354617|FG001|Overall Study|Withdrawal by Subject|1|||
148964368|NCT00322842|537354616|FG000|Overall Study|Lost to Follow-up|0|||
148964369|NCT00322842|537354617|FG001|Overall Study|Lost to Follow-up|1|||
148964370|NCT00322842|537354616|FG000|Overall Study|Refused transplant|1|||
148964371|NCT00322842|537354617|FG001|Overall Study|Refused transplant|0|||
148964372|NCT00322842|537354616|FG000|Overall Study|Death|1|||
148964373|NCT00322842|537354617|FG001|Overall Study|Death|0|||
148964374|NCT02946047|537354628|FG000|Overall Study|Adverse Event|1|||
148964375|NCT02946047|537354629|FG001|Overall Study|Adverse Event|0|||
148964376|NCT02946047|537354630|FG002|Overall Study|Adverse Event|0|||
148964377|NCT02946047|537354631|FG003|Overall Study|Adverse Event|0|||
148964378|NCT04364620|537354632|FG000|Overall Study|Disease Progression|20|||
148964379|NCT04364620|537354632|FG000|Overall Study|Adverse Event|5|||
148964380|NCT04364620|537354632|FG000|Overall Study|Physician Decision|4|||
148964381|NCT04364620|537354632|FG000|Overall Study|Death|3|||
148964382|NCT04364620|537354632|FG000|Overall Study|Other|2|||
148964383|NCT04364620|537354632|FG000|Overall Study|Withdrawal by Subject|1|||
148964384|NCT00156533|537356023|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
148964385|NCT00156533|537356024|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
148964386|NCT00156533|537356025|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
148964387|NCT00156533|537356026|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
148964388|NCT00156533|537356023|FG000|Overall Study|Withdrawal by Subject|1|||
148964389|NCT00156533|537356024|FG001|Overall Study|Withdrawal by Subject|0|||
148964390|NCT00156533|537356025|FG002|Overall Study|Withdrawal by Subject|0|||
148964391|NCT00156533|537356026|FG003|Overall Study|Withdrawal by Subject|1|||
148964392|NCT00156533|537356023|FG000|Overall Study|Failed Screening|1|||
148964393|NCT00156533|537356024|FG001|Overall Study|Failed Screening|0|||
148964394|NCT00156533|537356025|FG002|Overall Study|Failed Screening|1|||
148964395|NCT00156533|537356026|FG003|Overall Study|Failed Screening|1|||
148964396|NCT01541969|537356027|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
148964397|NCT01541969|537356028|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
148964398|NCT01541969|537356027|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
148964399|NCT01541969|537356028|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
148964400|NCT01541969|537356027|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
148964401|NCT01541969|537356028|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
148964402|NCT01541969|537356027|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
148964403|NCT01541969|537356028|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
148964404|NCT01541969|537356027|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
148964405|NCT01541969|537356028|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
148964406|NCT01541969|537356027|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
148964407|NCT01541969|537356028|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
148964408|NCT01541969|537356027|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
148964409|NCT01541969|537356028|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
148964410|NCT01541969|537356027|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
148964411|NCT01541969|537356028|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
148964412|NCT01541969|537356027|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
148964413|NCT01541969|537356028|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
148964414|NCT01541969|537356027|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
148964415|NCT01541969|537356028|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
148964416|NCT01365507|537356029|FG000|Overall Study|Withdrawal Criteria|8|||
148964417|NCT01365507|537356030|FG001|Overall Study|Withdrawal Criteria|5|||
148964418|NCT01365507|537356029|FG000|Overall Study|Unclassified|1|||
148964419|NCT01365507|537356030|FG001|Overall Study|Unclassified|4|||
148964420|NCT03265249|537356033|FG000|Overall Study|Withdrawal by Subject|0|||
148964421|NCT03265249|537356034|FG001|Overall Study|Withdrawal by Subject|1|||
148964422|NCT01614990|537356035|FG000|Overall Study|Protocol Violation|1|||
148964423|NCT01614990|537356036|FG001|Overall Study|Protocol Violation|1|||
148964424|NCT02255500|537356041|FG000|Overall Study|Withdrawal by Subject|1|||
148964425|NCT02255500|537356042|FG001|Overall Study|Withdrawal by Subject|0|||
148964426|NCT04254978|537356045|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
148964427|NCT04254978|537356045|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
148964428|NCT04254978|537356045|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
148964429|NCT04254978|537356045|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
148964430|NCT04254978|537356045|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
148964431|NCT04254978|537356045|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
148964432|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
148964433|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
148964434|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
148964435|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
148964436|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
148964437|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
148964438|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
148964439|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
148964440|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
148695999|NCT01108094|536360829|FG002|Overall Study|Adverse Event|0|||
148964441|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
149024148|NCT03303105|537564196|FG000|Overall Study|Withdrawal by Subject|0|||
148964442|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
148964443|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
148964444|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
148964445|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
148964446|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
148964447|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
148964448|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
148964449|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
148813211|NCT02293499|536791640|FG000|3 Month Follow Up|Lost to Follow-up|14|||
148813212|NCT02293499|536791641|FG001|3 Month Follow Up|Lost to Follow-up|15|||
148813213|NCT02293499|536791642|FG002|3 Month Follow Up|Lost to Follow-up|6|||
148813214|NCT02293499|536791640|FG000|6 Month Follow Up|Lost to Follow-up|17|||
148813215|NCT02293499|536791641|FG001|6 Month Follow Up|Lost to Follow-up|27|||
148696000|NCT01108094|536360830|FG003|Overall Study|Adverse Event|0|||
148964450|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
148964451|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
148964452|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
148964453|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
148964454|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
148964455|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
148964456|NCT00277212|537356047|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
148964457|NCT00277212|537356048|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
148964458|NCT00277212|537356049|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
148964459|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
148964460|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
148964461|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
148964462|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
148813216|NCT02293499|536791642|FG002|6 Month Follow Up|Lost to Follow-up|6|||
148813217|NCT02293499|536791640|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
148813218|NCT02293499|536791641|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
148813219|NCT02293499|536791642|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
148813220|NCT02293499|536791640|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
148696001|NCT01108094|536360827|FG000|Overall Study|Withdrawal by Subject|1|||
148696002|NCT01108094|536360828|FG001|Overall Study|Withdrawal by Subject|0|||
148696003|NCT01108094|536360829|FG002|Overall Study|Withdrawal by Subject|0|||
148696004|NCT01108094|536360830|FG003|Overall Study|Withdrawal by Subject|0|||
148696005|NCT02918877|536360836|FG000|Overall Study|Withdrawal by Subject|2|||
148696006|NCT02918877|536360837|FG001|Overall Study|Withdrawal by Subject|2|||
148696007|NCT02918877|536360836|FG000|Overall Study|Surgery cancelled|1|||
148696008|NCT02918877|536360837|FG001|Overall Study|Surgery cancelled|0|||
148696009|NCT02918877|536360836|FG000|Overall Study|Physician Decision|1|||
148696010|NCT02918877|536360837|FG001|Overall Study|Physician Decision|0|||
148696011|NCT02918877|536360836|FG000|Overall Study|Received intraoperative steroids|1|||
148696012|NCT02918877|536360837|FG001|Overall Study|Received intraoperative steroids|0|||
148696013|NCT02918877|536360836|FG000|Overall Study|Unable to obtain lab samples|1|||
148696014|NCT02918877|536360837|FG001|Overall Study|Unable to obtain lab samples|0|||
148696015|NCT02918877|536360836|FG000|Overall Study|Unsafe to perform BAL|0|||
148696016|NCT02918877|536360837|FG001|Overall Study|Unsafe to perform BAL|1|||
148696017|NCT05818137|536360838|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
148696018|NCT05818137|536360838|FG000|Extension Treatment Period|Ongoing participants|44|||
148696019|NCT05346055|536360841|FG000|Overall Study|Withdrawal by Subject|1|||
148696020|NCT05346055|536360841|FG000|Overall Study|Protocol Violation|1|||
148696021|NCT05346055|536360841|FG000|Overall Study|Therapist decision|1|||
148696022|NCT00728949|536360842|FG000|Overall Study|Adverse Event|8|||
148696023|NCT00728949|536360843|FG001|Overall Study|Adverse Event|0|||
148696024|NCT00728949|536360842|FG000|Overall Study|Withdrawal by Subject|2|||
148696025|NCT00728949|536360843|FG001|Overall Study|Withdrawal by Subject|2|||
148696026|NCT00728949|536360842|FG000|Overall Study|Abnormal Lab Results|0|||
148696027|NCT00728949|536360843|FG001|Overall Study|Abnormal Lab Results|2|||
148696028|NCT00728949|536360842|FG000|Overall Study|On treatment at cutoff date|1|||
148696029|NCT00728949|536360843|FG001|Overall Study|On treatment at cutoff date|0|||
148696030|NCT01996033|536360844|FG000|Overall Study|Death|1|||
148696031|NCT01996033|536360844|FG000|Overall Study|Physician Decision|1|||
148696032|NCT01996033|536360844|FG000|Overall Study|Withdrawal by Subject|4|||
148696033|NCT01996033|536360844|FG000|Overall Study|Lost to Follow-up|3|||
148696034|NCT01087970|536360849|FG000|Overall Study|Protocol Violation|2|||
148696035|NCT02143102|536360852|FG000|Overall Study|Lost to Follow-up|11|||
148964463|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
148696036|NCT02143102|536360853|FG001|Overall Study|Lost to Follow-up|0|||
148696037|NCT02636907|536360856|FG000|Autoinjector Assessment Period|Adverse Event|2|||
148696038|NCT02636907|536360856|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
148696039|NCT02636907|536360856|FG000|Extension Phase|Adverse Event|2|||
148696040|NCT02636907|536360856|FG000|Extension Phase|Withdrawal by Subject|4|||
148696041|NCT02636907|536360856|FG000|Extension Phase|Physician Decision|1|||
148696042|NCT02636907|536360856|FG000|Extension Phase|Lost to Follow-up|2|||
148696043|NCT02636907|536360856|FG000|Extension Phase|Lack of Efficacy|1|||
148696044|NCT04099888|536360861|FG000|Overall Study|Study terminated by sponsor|9|||
148696045|NCT04099888|536360862|FG001|Overall Study|Study terminated by sponsor|11|||
148696046|NCT04099888|536360861|FG000|Overall Study|Lost to Follow-up|1|||
148696047|NCT04099888|536360862|FG001|Overall Study|Lost to Follow-up|1|||
148696048|NCT04099888|536360861|FG000|Overall Study|Withdrawal by Subject|5|||
148696049|NCT04099888|536360862|FG001|Overall Study|Withdrawal by Subject|6|||
148696050|NCT04099888|536360861|FG000|Overall Study|Death|5|||
148696051|NCT04099888|536360862|FG001|Overall Study|Death|2|||
148696052|NCT04099888|536360861|FG000|Overall Study|Other|1|||
148696053|NCT04099888|536360862|FG001|Overall Study|Other|0|||
148696054|NCT04538170|536360865|FG000|Overall Study|Withdrawal by Subject|104|||
148696055|NCT04538170|536360866|FG001|Overall Study|Withdrawal by Subject|210|||
148696056|NCT06354270|536360869|FG000|Overall Study|Withdrawal by Subject|1|||
148696057|NCT06354270|536360870|FG001|Overall Study|Withdrawal by Subject|0|||
148696058|NCT02545998|536360877|FG000|Overall Study|Lost to Follow-up|12|||
148696059|NCT02545998|536360878|FG001|Overall Study|Lost to Follow-up|3|||
148696060|NCT02545998|536360877|FG000|Overall Study|Withdrawal by Subject|3|||
148696061|NCT02545998|536360878|FG001|Overall Study|Withdrawal by Subject|2|||
148696062|NCT02603952|536360887|FG000|Overall Study|Withdrawal by Subject|1|||
148696063|NCT02603952|536360888|FG001|Overall Study|Withdrawal by Subject|0|||
148696064|NCT02603952|536360889|FG002|Overall Study|Withdrawal by Subject|0|||
148696065|NCT02603952|536360890|FG003|Overall Study|Withdrawal by Subject|0|||
148696066|NCT02603952|536360887|FG000|Overall Study|Received oseltamivir by error|0|||
148696067|NCT02603952|536360888|FG001|Overall Study|Received oseltamivir by error|0|||
148696068|NCT02603952|536360889|FG002|Overall Study|Received oseltamivir by error|0|||
148696069|NCT02603952|536360890|FG003|Overall Study|Received oseltamivir by error|1|||
148696070|NCT00958243|536360902|FG000|Overall Study|Withdrawal by Subject|0|||
148696071|NCT00958243|536360903|FG001|Overall Study|Withdrawal by Subject|1|||
148696072|NCT00958243|536360904|FG002|Overall Study|Withdrawal by Subject|3|||
148696073|NCT00958243|536360905|FG003|Overall Study|Withdrawal by Subject|1|||
148696074|NCT00958243|536360906|FG004|Overall Study|Withdrawal by Subject|1|||
148696075|NCT00958243|536360907|FG005|Overall Study|Withdrawal by Subject|5|||
148696076|NCT00958243|536360902|FG000|Overall Study|Lost to Follow-up|2|||
148696077|NCT00958243|536360903|FG001|Overall Study|Lost to Follow-up|5|||
148696078|NCT00958243|536360904|FG002|Overall Study|Lost to Follow-up|11|||
148696079|NCT00958243|536360905|FG003|Overall Study|Lost to Follow-up|2|||
148696080|NCT00958243|536360906|FG004|Overall Study|Lost to Follow-up|8|||
148696081|NCT00958243|536360907|FG005|Overall Study|Lost to Follow-up|5|||
148696082|NCT04646109|536360908|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
148696083|NCT04646109|536360909|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
148696084|NCT06176768|536360910|FG000|Overall Study|Adverse Event|1|||
148696085|NCT06176768|536360911|FG001|Overall Study|Adverse Event|0|||
148696086|NCT06176768|536360910|FG000|Overall Study|Assigned treatment by mistake|1|||
148696087|NCT06176768|536360911|FG001|Overall Study|Assigned treatment by mistake|0|||
148696088|NCT06176768|536360910|FG000|Overall Study|Lost to Follow-up|0|||
148696089|NCT06176768|536360911|FG001|Overall Study|Lost to Follow-up|3|||
148696090|NCT06176768|536360910|FG000|Overall Study|Physician Decision|1|||
148696091|NCT06176768|536360911|FG001|Overall Study|Physician Decision|0|||
148696092|NCT06176768|536360910|FG000|Overall Study|Protocol deviation|3|||
148696093|NCT06176768|536360911|FG001|Overall Study|Protocol deviation|1|||
148696094|NCT06176768|536360910|FG000|Overall Study|Other|1|||
148696095|NCT06176768|536360911|FG001|Overall Study|Other|0|||
148696096|NCT06176768|536360910|FG000|Overall Study|Withdrawal by Subject|6|||
148696097|NCT06176768|536360911|FG001|Overall Study|Withdrawal by Subject|9|||
148696098|NCT01226797|536360914|FG000|Overall Study|Adverse Event|1|||
148696099|NCT01226797|536360915|FG001|Overall Study|Adverse Event|0|||
148696100|NCT01226797|536360914|FG000|Overall Study|No longer willing to participate|1|||
148964464|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
148964465|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
148696101|NCT01226797|536360915|FG001|Overall Study|No longer willing to participate|0|||
148696102|NCT01226797|536360914|FG000|Overall Study|Protocol Violation|0|||
148696103|NCT01226797|536360915|FG001|Overall Study|Protocol Violation|1|||
148964466|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
148964467|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
148696104|NCT00577460|536360916|FG000|Overall Study|Adverse Event|11|||
148696105|NCT00577460|536360917|FG001|Overall Study|Adverse Event|7|||
148696106|NCT00577460|536360918|FG002|Overall Study|Adverse Event|14|||
148696107|NCT00577460|536360916|FG000|Overall Study|Protocol Violation|0|||
148696108|NCT00577460|536360917|FG001|Overall Study|Protocol Violation|1|||
148696109|NCT00577460|536360918|FG002|Overall Study|Protocol Violation|1|||
148696110|NCT00577460|536360916|FG000|Overall Study|Lost to Follow-up|0|||
148696111|NCT00577460|536360917|FG001|Overall Study|Lost to Follow-up|3|||
148696112|NCT00577460|536360918|FG002|Overall Study|Lost to Follow-up|4|||
148696113|NCT00577460|536360916|FG000|Overall Study|Withdrawal by Subject|5|||
148964468|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
148964469|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
148964470|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
148964471|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
148964472|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
148964473|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
148964474|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
148964475|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
148964476|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
148964477|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
148964478|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
149024149|NCT03303105|537564197|FG001|Overall Study|Withdrawal by Subject|2|||
149024150|NCT04822298|537564200|FG000|Overall Study|Death|3|||
148696114|NCT00577460|536360917|FG001|Overall Study|Withdrawal by Subject|5|||
148696115|NCT00577460|536360918|FG002|Overall Study|Withdrawal by Subject|6|||
148964479|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
149024151|NCT01333943|537564204|FG000|Overall Study|Known neuropathy|1|||
149024152|NCT01333943|537564205|FG001|Overall Study|Known neuropathy|0|||
148813221|NCT02293499|536791641|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
148813222|NCT02293499|536791642|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
148813223|NCT02293499|536791640|FG000|9 Month Follow Up|Lost to Follow-up|24|||
148813224|NCT02293499|536791641|FG001|9 Month Follow Up|Lost to Follow-up|28|||
148813225|NCT02293499|536791642|FG002|9 Month Follow Up|Lost to Follow-up|4|||
148813226|NCT02293499|536791640|FG000|12 Month Follow Up|Lost to Follow-up|26|||
148813227|NCT02293499|536791641|FG001|12 Month Follow Up|Lost to Follow-up|25|||
148813228|NCT02293499|536791642|FG002|12 Month Follow Up|Lost to Follow-up|6|||
148813229|NCT02293499|536791640|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
148813230|NCT02293499|536791641|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
148813231|NCT02293499|536791642|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
148813232|NCT02293499|536791640|FG000|15 Month Follow Up|Lost to Follow-up|22|||
148813233|NCT02293499|536791641|FG001|15 Month Follow Up|Lost to Follow-up|22|||
148813234|NCT02293499|536791642|FG002|15 Month Follow Up|Lost to Follow-up|7|||
148813235|NCT00690898|536791643|FG000|SCREENING|Screen failure|18|||
148813236|NCT00690898|536791643|FG000|TREATMENT|Adverse Event|3|||
148813237|NCT00690898|536791643|FG000|TREATMENT|Lack of Efficacy|18|||
148813238|NCT00690898|536791643|FG000|TREATMENT|Withdrawal by Subject|4|||
148813239|NCT00690898|536791643|FG000|TREATMENT|Other (not otherwise specified)|1|||
148813240|NCT05977868|536791644|FG000|Overall Study|Withdrawal by Subject|1|||
148813241|NCT05977868|536791645|FG001|Overall Study|Withdrawal by Subject|2|||
148813242|NCT05977868|536791644|FG000|Overall Study|Transitioned to comfort care|1|||
148813243|NCT05977868|536791645|FG001|Overall Study|Transitioned to comfort care|0|||
148813244|NCT01970371|536791658|FG000|Overall Study|Death|8|||
148813245|NCT01970371|536791659|FG001|Overall Study|Death|13|||
148813246|NCT01970371|536791660|FG002|Overall Study|Death|12|||
148813247|NCT01970371|536791658|FG000|Overall Study|Lost to Follow-up|0|||
148813248|NCT01970371|536791659|FG001|Overall Study|Lost to Follow-up|0|||
148813249|NCT01970371|536791660|FG002|Overall Study|Lost to Follow-up|1|||
148813250|NCT01481779|536791661|FG000|Overall Study|Adverse Event|23|||
148813251|NCT01481779|536791662|FG001|Overall Study|Adverse Event|5|||
148813252|NCT01481779|536791661|FG000|Overall Study|Lost to Follow-up|3|||
148813253|NCT01481779|536791662|FG001|Overall Study|Lost to Follow-up|2|||
148813254|NCT01481779|536791661|FG000|Overall Study|Protocol Violation|2|||
148813255|NCT01481779|536791662|FG001|Overall Study|Protocol Violation|3|||
148813256|NCT01481779|536791661|FG000|Overall Study|Withdrawal by Subject|26|||
148813257|NCT01481779|536791662|FG001|Overall Study|Withdrawal by Subject|13|||
148813258|NCT01481779|536791661|FG000|Overall Study|Physician Decision|13|||
148813259|NCT01481779|536791662|FG001|Overall Study|Physician Decision|4|||
148813260|NCT01481779|536791661|FG000|Overall Study|Sponsor Decision|3|||
148813261|NCT01481779|536791662|FG001|Overall Study|Sponsor Decision|1|||
148813262|NCT00487188|536791668|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
148813263|NCT00487188|536791669|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
148813264|NCT00487188|536791670|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
148813265|NCT00487188|536791668|FG000|Induction Phase|Adverse Event|5|||
148964480|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
148964481|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
148813266|NCT00487188|536791669|FG001|Induction Phase|Adverse Event|0|||
148813267|NCT00487188|536791670|FG002|Induction Phase|Adverse Event|0|||
148964482|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
148964483|NCT00277212|537356047|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
148964484|NCT00277212|537356048|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
148964485|NCT00277212|537356049|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
148964486|NCT00902564|537356050|FG000|Overall Study|Withdrawal by Subject|2|||
148964487|NCT03336216|537356056|FG000|Randomization|Not reported|2|||
148964488|NCT03336216|537356057|FG001|Randomization|Not reported|0|||
148964489|NCT03336216|537356058|FG002|Randomization|Not reported|1|||
148964490|NCT03336216|537356059|FG003|Randomization|Not reported|0|||
148964491|NCT03336216|537356056|FG000|Randomization|Other reasons|1|||
148964492|NCT03336216|537356057|FG001|Randomization|Other reasons|1|||
148964493|NCT03336216|537356058|FG002|Randomization|Other reasons|1|||
148964494|NCT03336216|537356059|FG003|Randomization|Other reasons|0|||
148964495|NCT03336216|537356056|FG000|Randomization|Participant no longer meets study criteria|0|||
148964496|NCT03336216|537356057|FG001|Randomization|Participant no longer meets study criteria|2|||
148964497|NCT03336216|537356058|FG002|Randomization|Participant no longer meets study criteria|4|||
148964498|NCT03336216|537356059|FG003|Randomization|Participant no longer meets study criteria|1|||
148964499|NCT03336216|537356056|FG000|Randomization|Lost to Follow-up|1|||
148964500|NCT03336216|537356057|FG001|Randomization|Lost to Follow-up|0|||
148964501|NCT03336216|537356058|FG002|Randomization|Lost to Follow-up|0|||
148964502|NCT03336216|537356059|FG003|Randomization|Lost to Follow-up|0|||
148964503|NCT03336216|537356056|FG000|Randomization|Participant withdrew consent|9|||
148964504|NCT03336216|537356057|FG001|Randomization|Participant withdrew consent|1|||
148964505|NCT03336216|537356058|FG002|Randomization|Participant withdrew consent|0|||
148964506|NCT03336216|537356059|FG003|Randomization|Participant withdrew consent|0|||
148964507|NCT03336216|537356056|FG000|Randomization|Adverse Event|1|||
148964508|NCT03336216|537356057|FG001|Randomization|Adverse Event|1|||
148964509|NCT03336216|537356058|FG002|Randomization|Adverse Event|0|||
148964510|NCT03336216|537356059|FG003|Randomization|Adverse Event|0|||
148964511|NCT03336216|537356056|FG000|Treatment|Adverse Event|2|||
148964512|NCT03336216|537356057|FG001|Treatment|Adverse Event|3|||
148964513|NCT03336216|537356058|FG002|Treatment|Adverse Event|4|||
148964514|NCT03336216|537356059|FG003|Treatment|Adverse Event|4|||
148964515|NCT03336216|537356056|FG000|Treatment|Participant request to discontinue treatment|2|||
148964516|NCT03336216|537356057|FG001|Treatment|Participant request to discontinue treatment|1|||
148964517|NCT03336216|537356058|FG002|Treatment|Participant request to discontinue treatment|2|||
148964518|NCT03336216|537356059|FG003|Treatment|Participant request to discontinue treatment|2|||
148964519|NCT03336216|537356056|FG000|Treatment|Participant withdrew consent|7|||
148964520|NCT03336216|537356057|FG001|Treatment|Participant withdrew consent|2|||
148964521|NCT03336216|537356058|FG002|Treatment|Participant withdrew consent|3|||
148964522|NCT03336216|537356059|FG003|Treatment|Participant withdrew consent|2|||
148964523|NCT03336216|537356056|FG000|Treatment|Death|2|||
148964524|NCT03336216|537356057|FG001|Treatment|Death|3|||
148964525|NCT03336216|537356058|FG002|Treatment|Death|3|||
148964526|NCT03336216|537356059|FG003|Treatment|Death|4|||
148964527|NCT03336216|537356056|FG000|Treatment|Participant no longer meets study criteria|0|||
148964528|NCT03336216|537356057|FG001|Treatment|Participant no longer meets study criteria|1|||
148964529|NCT03336216|537356058|FG002|Treatment|Participant no longer meets study criteria|0|||
148964530|NCT03336216|537356059|FG003|Treatment|Participant no longer meets study criteria|0|||
148964531|NCT03336216|537356056|FG000|Treatment|Other reasons|2|||
148964532|NCT03336216|537356057|FG001|Treatment|Other reasons|0|||
148964533|NCT03336216|537356058|FG002|Treatment|Other reasons|0|||
148964534|NCT03336216|537356059|FG003|Treatment|Other reasons|3|||
148964535|NCT03336216|537356056|FG000|Treatment|Disease progression|23|||
148964536|NCT03336216|537356057|FG001|Treatment|Disease progression|34|||
148964537|NCT03336216|537356058|FG002|Treatment|Disease progression|33|||
148964538|NCT03336216|537356059|FG003|Treatment|Disease progression|26|||
148964539|NCT03336216|537356056|FG000|Treatment|Study drug toxicity|0|||
148964540|NCT03336216|537356057|FG001|Treatment|Study drug toxicity|3|||
148964541|NCT03336216|537356058|FG002|Treatment|Study drug toxicity|2|||
148964542|NCT03336216|537356059|FG003|Treatment|Study drug toxicity|0|||
148964543|NCT03336216|537356056|FG000|Treatment|Adverse Event unrelated to study drug|1|||
148964544|NCT03336216|537356057|FG001|Treatment|Adverse Event unrelated to study drug|1|||
149024153|NCT02028884|537564208|FG000|Double-blind Period|Adverse Event|5|||
149024154|NCT02028884|537564209|FG001|Double-blind Period|Adverse Event|3|||
149024155|NCT02028884|537564210|FG002|Double-blind Period|Adverse Event|0|||
148964545|NCT03336216|537356058|FG002|Treatment|Adverse Event unrelated to study drug|1|||
148964546|NCT03336216|537356059|FG003|Treatment|Adverse Event unrelated to study drug|0|||
148964547|NCT03336216|537356056|FG000|Treatment|Disease Recurrence|1|||
148964548|NCT03336216|537356057|FG001|Treatment|Disease Recurrence|0|||
148964549|NCT03336216|537356058|FG002|Treatment|Disease Recurrence|0|||
148964550|NCT03336216|537356059|FG003|Treatment|Disease Recurrence|0|||
148964551|NCT05954052|537356065|FG000|Overall Study|Adverse Event|1|||
148964552|NCT01957462|537356066|FG000|Test Period 1|Withdrawal by Subject|1|||
148964553|NCT01957462|537356067|FG001|Test Period 1|Withdrawal by Subject|0|||
148964554|NCT01957462|537356066|FG000|Test Period 1|Adverse Event|1|||
148964555|NCT01957462|537356067|FG001|Test Period 1|Adverse Event|0|||
148964556|NCT01856790|537356070|FG000|Closed Loop Control|Withdrawal by Subject|2|||
148964557|NCT01856790|537356070|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
148964558|NCT01124604|537356071|FG000|Overall Study|Adverse Event|10|||
148964559|NCT01124604|537356072|FG001|Overall Study|Adverse Event|1|||
148964560|NCT01124604|537356071|FG000|Overall Study|Lack of Efficacy|1|||
148964561|NCT01124604|537356072|FG001|Overall Study|Lack of Efficacy|0|||
148964562|NCT01124604|537356071|FG000|Overall Study|Withdrawal by Subject|4|||
148964563|NCT01124604|537356072|FG001|Overall Study|Withdrawal by Subject|0|||
148964564|NCT01124604|537356071|FG000|Overall Study|Disease Progression|0|||
148964565|NCT01124604|537356072|FG001|Overall Study|Disease Progression|1|||
148964566|NCT03102918|537356073|FG000|Overall Study|Protocol Violation|1|||
148964567|NCT03102918|537356074|FG001|Overall Study|Protocol Violation|0|||
148964568|NCT04765358|537356075|FG000|Overall Study|Withdrawal by Subject|1|||
148964569|NCT01344447|537356076|FG000|Overall Study|Adverse Event|1|||
148964570|NCT01344447|537356076|FG000|Overall Study|Protocol Violation|1|||
148964571|NCT01344447|537356076|FG000|Overall Study|Withdrawal by Subject|1|||
148964572|NCT01344447|537356076|FG000|Overall Study|The contrast was not seen|1|||
148964573|NCT01344447|537356076|FG000|Overall Study|Physician Decision|1|||
148964574|NCT01344447|537356076|FG000|Overall Study|MRA unsuccessful|1|||
148964575|NCT01344447|537356076|FG000|Overall Study|Bolus tracking failed|1|||
148964576|NCT01344447|537356076|FG000|Overall Study|Error of power injector|1|||
148964577|NCT01660711|537356077|FG000|Overall Study|Adverse Event|7|||
148964578|NCT01660711|537356077|FG000|Overall Study|Withdrawal by Subject|1|||
148964579|NCT00952341|537356079|FG000|Cycle 1|Adverse Event|4|||
148964580|NCT00952341|537356080|FG001|Cycle 1|Adverse Event|1|||
148964581|NCT00952341|537356079|FG000|Cycle 1|Withdrawal by Subject|3|||
148964582|NCT00952341|537356080|FG001|Cycle 1|Withdrawal by Subject|8|||
148964583|NCT00952341|537356079|FG000|Cycle 1|Protocol Violation|2|||
148964584|NCT00952341|537356080|FG001|Cycle 1|Protocol Violation|1|||
148964585|NCT00952341|537356079|FG000|Cycle 1|Lost to Follow-up|11|||
148964586|NCT00952341|537356080|FG001|Cycle 1|Lost to Follow-up|2|||
148964587|NCT00952341|537356079|FG000|Cycle 1|Physician Decision|0|||
148964588|NCT00952341|537356080|FG001|Cycle 1|Physician Decision|1|||
148964589|NCT00952341|537356079|FG000|Cycle 2|Withdrawal by Subject|1|||
148964590|NCT00952341|537356080|FG001|Cycle 2|Withdrawal by Subject|1|||
148964591|NCT00952341|537356079|FG000|Cycle 2|Protocol Violation|1|||
148964592|NCT00952341|537356080|FG001|Cycle 2|Protocol Violation|0|||
148964593|NCT00952341|537356079|FG000|Cycle 2|Lost to Follow-up|6|||
148964594|NCT00952341|537356080|FG001|Cycle 2|Lost to Follow-up|9|||
148964595|NCT00952341|537356079|FG000|Cycle 2|Physician Decision|1|||
148964596|NCT00952341|537356080|FG001|Cycle 2|Physician Decision|1|||
149024156|NCT02028884|537564208|FG000|Double-blind Period|Eligibility Violation|1|||
148964597|NCT00952341|537356079|FG000|Cycle 2|Progressive Disease|0|||
148964598|NCT00952341|537356080|FG001|Cycle 2|Progressive Disease|1|||
149024157|NCT02028884|537564209|FG001|Double-blind Period|Eligibility Violation|0|||
149024158|NCT02028884|537564210|FG002|Double-blind Period|Eligibility Violation|0|||
149024159|NCT02028884|537564208|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
149024160|NCT02028884|537564209|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
149024161|NCT02028884|537564210|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
149024162|NCT02028884|537564208|FG000|Double-blind Period|Withdrawal by Subject|2|||
149024163|NCT02028884|537564209|FG001|Double-blind Period|Withdrawal by Subject|0|||
149024164|NCT02028884|537564210|FG002|Double-blind Period|Withdrawal by Subject|0|||
149024165|NCT02028884|537564208|FG000|Open-label Extension Period|Adverse Event|3|||
149024166|NCT02028884|537564209|FG001|Open-label Extension Period|Adverse Event|1|||
149024167|NCT02028884|537564210|FG002|Open-label Extension Period|Adverse Event|0|||
149024168|NCT02028884|537564208|FG000|Open-label Extension Period|Lack of Efficacy|3|||
148964615|NCT06027866|537356085|FG000|Overall Study|Withdrawal by Subject|2|||
148964616|NCT05071183|537356086|FG000|Overall Study|Death|1|||
148964617|NCT05071183|537356087|FG001|Overall Study|Death|2|||
148964618|NCT05071183|537356088|FG002|Overall Study|Death|0|||
148964619|NCT05071183|537356086|FG000|Overall Study|Other Reasons|1|||
148964620|NCT05071183|537356087|FG001|Overall Study|Other Reasons|3|||
148964621|NCT05071183|537356088|FG002|Overall Study|Other Reasons|2|||
148964622|NCT02046148|537356089|FG000|Overall Study|Lost to Follow-up|1|||
148964623|NCT02046148|537356090|FG001|Overall Study|Lost to Follow-up|1|||
148964624|NCT02046148|537356089|FG000|Overall Study|Withdrawal by Subject|0|||
148964625|NCT02046148|537356090|FG001|Overall Study|Withdrawal by Subject|2|||
148964626|NCT02420691|537356093|FG000|Overall Study|Adverse Event|3|||
148964627|NCT02420691|537356093|FG000|Overall Study|Withdrawal by Subject|3|||
148964628|NCT02120950|537356096|FG000|Overall Study|Adverse Event|5|||
148964629|NCT02120950|537356097|FG001|Overall Study|Adverse Event|4|||
148964630|NCT02120950|537356098|FG002|Overall Study|Adverse Event|3|||
148964631|NCT02120950|537356096|FG000|Overall Study|Death|3|||
148964632|NCT02120950|537356097|FG001|Overall Study|Death|0|||
148964633|NCT02120950|537356098|FG002|Overall Study|Death|1|||
148964634|NCT02120950|537356096|FG000|Overall Study|Withdrawal by Subject|6|||
148964635|NCT02120950|537356097|FG001|Overall Study|Withdrawal by Subject|3|||
148964636|NCT02120950|537356098|FG002|Overall Study|Withdrawal by Subject|2|||
148964637|NCT02120950|537356096|FG000|Overall Study|Protocol Violation|1|||
148964638|NCT02120950|537356097|FG001|Overall Study|Protocol Violation|1|||
148964639|NCT02120950|537356098|FG002|Overall Study|Protocol Violation|7|||
148964640|NCT02120950|537356096|FG000|Overall Study|Other reasons|5|||
148964641|NCT02120950|537356097|FG001|Overall Study|Other reasons|4|||
148964642|NCT02120950|537356098|FG002|Overall Study|Other reasons|1|||
148964643|NCT02120950|537356096|FG000|Overall Study|Lost to Follow-up|0|||
148696116|NCT00577460|536360916|FG000|Overall Study|Other|0|||
148696117|NCT00577460|536360917|FG001|Overall Study|Other|3|||
148696118|NCT00577460|536360918|FG002|Overall Study|Other|2|||
148696119|NCT01936948|536360922|FG000|Overall Study|no 30-day follow-up data|0|||
148696120|NCT01936948|536360923|FG001|Overall Study|no 30-day follow-up data|3|||
148696121|NCT01936948|536360924|FG002|Overall Study|no 30-day follow-up data|3|||
148964644|NCT02120950|537356097|FG001|Overall Study|Lost to Follow-up|2|||
148964645|NCT02120950|537356098|FG002|Overall Study|Lost to Follow-up|1|||
148964646|NCT01852812|537356099|FG000|Overall Study|Adverse Event|0|||
148964647|NCT01852812|537356100|FG001|Overall Study|Adverse Event|0|||
148964648|NCT01852812|537356101|FG002|Overall Study|Adverse Event|1|||
148964649|NCT01852812|537356099|FG000|Overall Study|Non-compliance With Study Drug|0|||
148964650|NCT01852812|537356100|FG001|Overall Study|Non-compliance With Study Drug|1|||
148964651|NCT01852812|537356101|FG002|Overall Study|Non-compliance With Study Drug|0|||
148964652|NCT02625090|537356105|FG000|Overall Study|Participant wants to be pregnant|2|||
148964653|NCT02625090|537356105|FG000|Overall Study|For the Promoter|1|||
148964654|NCT02625090|537356105|FG000|Overall Study|Sponsor's Decision|9|||
148964655|NCT02625090|537356105|FG000|Overall Study|Somnolence|1|||
148964656|NCT02625090|537356105|FG000|Overall Study|Study terminated by Sponsor|7|||
148964657|NCT02625090|537356105|FG000|Overall Study|Negative Benefit/Risk|1|||
148964658|NCT02625090|537356105|FG000|Overall Study|Protocol Deviation|2|||
148964659|NCT02625090|537356105|FG000|Overall Study|Lack of Efficacy|16|||
148964660|NCT02625090|537356105|FG000|Overall Study|Adverse Event|3|||
148964661|NCT02250443|537356106|FG000|Overall Study|Administrative problems|7|||
148964662|NCT02250443|537356106|FG000|Overall Study|Adverse Event|3|||
148964663|NCT01549964|537356107|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
148964664|NCT01549964|537356108|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
148964665|NCT01549964|537356109|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
148964666|NCT01549964|537356110|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
148964667|NCT01549964|537356107|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
148964668|NCT01549964|537356108|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
148964669|NCT01549964|537356109|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
148964670|NCT01549964|537356110|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
148964671|NCT01549964|537356107|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
148964672|NCT01549964|537356108|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
148964673|NCT01549964|537356109|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
148964674|NCT01549964|537356110|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
148964675|NCT01549964|537356107|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
148964676|NCT01549964|537356108|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
148964677|NCT01549964|537356109|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
148964678|NCT01549964|537356110|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
148964679|NCT01549964|537356107|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
148964680|NCT01549964|537356108|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
148964681|NCT01549964|537356109|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
148964682|NCT01549964|537356110|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
148964683|NCT01549964|537356107|FG000|24-Week Treatment Period|Other|1|||
148964684|NCT01549964|537356108|FG001|24-Week Treatment Period|Other|0|||
148964685|NCT01549964|537356109|FG002|24-Week Treatment Period|Other|1|||
148964686|NCT01549964|537356110|FG003|24-Week Treatment Period|Other|0|||
148964687|NCT01549964|537356107|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
148964688|NCT01549964|537356108|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
148964689|NCT01549964|537356109|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
148964690|NCT01549964|537356110|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
148964691|NCT01549964|537356107|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
148964692|NCT01549964|537356108|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
148964693|NCT01549964|537356109|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
148964694|NCT01549964|537356110|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
148964695|NCT01549964|537356107|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
148964696|NCT01549964|537356108|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
148964697|NCT01549964|537356109|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
148964698|NCT01549964|537356110|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
148964699|NCT01549964|537356107|FG000|80-Week Extension Period|Pregnancy|0|||
148964700|NCT01549964|537356108|FG001|80-Week Extension Period|Pregnancy|0|||
148964701|NCT01549964|537356109|FG002|80-Week Extension Period|Pregnancy|1|||
148964702|NCT01549964|537356110|FG003|80-Week Extension Period|Pregnancy|0|||
148964703|NCT01549964|537356107|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
149024169|NCT02028884|537564209|FG001|Open-label Extension Period|Lack of Efficacy|0|||
148696122|NCT01936948|536360925|FG003|Overall Study|no 30-day follow-up data|3|||
148696123|NCT02365207|536360926|FG000|Overall Study|Withdrawal by Subject|1|||
148964704|NCT01549964|537356108|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
148964705|NCT01549964|537356109|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
148964706|NCT01549964|537356110|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
148696124|NCT02365207|536360926|FG000|Overall Study|Physician Decision|1|||
148696125|NCT01318499|536360929|FG000|Overall Study|Adverse Event|16|||
148696126|NCT01318499|536360930|FG001|Overall Study|Adverse Event|11|||
148696127|NCT01318499|536360931|FG002|Overall Study|Adverse Event|6|||
148696128|NCT01318499|536360929|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
148696129|NCT01318499|536360930|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
148696130|NCT01318499|536360931|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
148696131|NCT01318499|536360929|FG000|Overall Study|Noncompliance|2|||
148696132|NCT01318499|536360930|FG001|Overall Study|Noncompliance|3|||
148696133|NCT01318499|536360931|FG002|Overall Study|Noncompliance|0|||
148696134|NCT01318499|536360929|FG000|Overall Study|Treatment Failure|19|||
148696135|NCT01318499|536360930|FG001|Overall Study|Treatment Failure|19|||
148696136|NCT01318499|536360931|FG002|Overall Study|Treatment Failure|101|||
148696137|NCT01318499|536360929|FG000|Overall Study|Protocol Violation|2|||
148696138|NCT01318499|536360930|FG001|Overall Study|Protocol Violation|4|||
148696139|NCT01318499|536360931|FG002|Overall Study|Protocol Violation|2|||
148696140|NCT01318499|536360929|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
148696141|NCT01318499|536360930|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
148696142|NCT01318499|536360931|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
148696143|NCT01318499|536360929|FG000|Overall Study|Other|7|||
148696144|NCT01318499|536360930|FG001|Overall Study|Other|10|||
148696145|NCT01318499|536360931|FG002|Overall Study|Other|22|||
148696146|NCT01395030|536360932|FG000|Overall Study|Did not complete FCH PET/CT|7|||
148696147|NCT01974141|536360936|FG000|Overall Study|Other Reasons|28|||
148696148|NCT01974141|536360937|FG001|Overall Study|Other Reasons|18|||
148696149|NCT01974141|536360936|FG000|Overall Study|Protocol Violation|2|||
148696150|NCT01974141|536360937|FG001|Overall Study|Protocol Violation|6|||
148696151|NCT01974141|536360936|FG000|Overall Study|Personal Reasons|21|||
148696152|NCT01974141|536360937|FG001|Overall Study|Personal Reasons|20|||
148696153|NCT01974141|536360936|FG000|Overall Study|Lost to Follow-up|38|||
148696154|NCT01974141|536360937|FG001|Overall Study|Lost to Follow-up|29|||
148696155|NCT01974141|536360936|FG000|Overall Study|Pregnancy|3|||
148696156|NCT01974141|536360937|FG001|Overall Study|Pregnancy|3|||
148696157|NCT01974141|536360936|FG000|Overall Study|Lack of Efficacy|0|||
148696158|NCT01974141|536360937|FG001|Overall Study|Lack of Efficacy|1|||
148696159|NCT01974141|536360936|FG000|Overall Study|Adverse Event|4|||
148696160|NCT01974141|536360937|FG001|Overall Study|Adverse Event|5|||
148696161|NCT04977336|536360940|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
148696162|NCT04977336|536360941|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
148696163|NCT04977336|536360942|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
148696164|NCT04977336|536360943|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
148964707|NCT01549964|537356107|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
148696165|NCT04977336|536360944|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
148696166|NCT04977336|536360940|FG000|Overall Study|Lost to Follow-up|0|||
148696167|NCT04977336|536360941|FG001|Overall Study|Lost to Follow-up|0|||
148696168|NCT04977336|536360942|FG002|Overall Study|Lost to Follow-up|1|||
148696169|NCT04977336|536360943|FG003|Overall Study|Lost to Follow-up|0|||
148696170|NCT04977336|536360944|FG004|Overall Study|Lost to Follow-up|0|||
148696171|NCT01606306|536360947|FG000|Overall Study|Lack of Efficacy|2|||
149024170|NCT02028884|537564210|FG002|Open-label Extension Period|Lack of Efficacy|0|||
148696172|NCT01606306|536360948|FG001|Overall Study|Lack of Efficacy|1|||
148696173|NCT01606306|536360949|FG002|Overall Study|Lack of Efficacy|4|||
148696174|NCT01606306|536360950|FG003|Overall Study|Lack of Efficacy|4|||
148696175|NCT01606306|536360951|FG004|Overall Study|Lack of Efficacy|1|||
148696176|NCT01606306|536360952|FG005|Overall Study|Lack of Efficacy|2|||
148696177|NCT01606306|536360947|FG000|Overall Study|Adverse Event|1|||
148696178|NCT01606306|536360948|FG001|Overall Study|Adverse Event|0|||
148696179|NCT01606306|536360949|FG002|Overall Study|Adverse Event|1|||
148696180|NCT01606306|536360950|FG003|Overall Study|Adverse Event|1|||
148696181|NCT01606306|536360951|FG004|Overall Study|Adverse Event|2|||
148696182|NCT01606306|536360952|FG005|Overall Study|Adverse Event|0|||
148696183|NCT01606306|536360947|FG000|Overall Study|Lost to Follow-up|7|||
148696184|NCT01606306|536360948|FG001|Overall Study|Lost to Follow-up|4|||
148696185|NCT01606306|536360949|FG002|Overall Study|Lost to Follow-up|5|||
148696186|NCT01606306|536360950|FG003|Overall Study|Lost to Follow-up|4|||
148696187|NCT01606306|536360951|FG004|Overall Study|Lost to Follow-up|3|||
148696188|NCT01606306|536360952|FG005|Overall Study|Lost to Follow-up|5|||
148696189|NCT01606306|536360947|FG000|Overall Study|Withdrawal by Subject|4|||
148696190|NCT01606306|536360948|FG001|Overall Study|Withdrawal by Subject|3|||
148696191|NCT01606306|536360949|FG002|Overall Study|Withdrawal by Subject|4|||
148696192|NCT01606306|536360950|FG003|Overall Study|Withdrawal by Subject|4|||
148696193|NCT01606306|536360951|FG004|Overall Study|Withdrawal by Subject|5|||
148696194|NCT01606306|536360952|FG005|Overall Study|Withdrawal by Subject|4|||
148696195|NCT01606306|536360947|FG000|Overall Study|Physician Decision|1|||
148696196|NCT01606306|536360948|FG001|Overall Study|Physician Decision|2|||
148696197|NCT01606306|536360949|FG002|Overall Study|Physician Decision|0|||
148696198|NCT01606306|536360950|FG003|Overall Study|Physician Decision|0|||
148696199|NCT01606306|536360951|FG004|Overall Study|Physician Decision|0|||
148696200|NCT01606306|536360952|FG005|Overall Study|Physician Decision|0|||
148696201|NCT00950872|536360953|FG000|Overall Study|Withdrawal by Subject|1|||
148696202|NCT00950872|536360953|FG000|Overall Study|Did not have surgery|2|||
148696203|NCT01759290|536360956|FG000|Overall Study|Subjects withdrawn consent|5|||
148696204|NCT01759290|536360956|FG000|Overall Study|Physician Decision|2|||
148696205|NCT01759290|536360956|FG000|Overall Study|Death|17|||
148696206|NCT01759290|536360956|FG000|Overall Study|Lost to Follow-up|53|||
148696207|NCT01759290|536360956|FG000|Overall Study|Unknown reason|4|||
148696208|NCT00352690|536360957|FG000|Overall Study|Determined to be ineligible|2|||
148696209|NCT00352690|536360958|FG001|Overall Study|Determined to be ineligible|0|||
148696210|NCT01475474|536360959|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
148696211|NCT01475474|536360959|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
148696212|NCT06096168|536360960|FG000|Overall Study|Death|30|||
148696213|NCT06096168|536360960|FG000|Overall Study|Revision|2|||
148696214|NCT01471522|536360967|FG000|Overall Study|Withdrawal by Subject|28|||
148696215|NCT01471522|536360968|FG001|Overall Study|Withdrawal by Subject|22|||
148696216|NCT01471522|536360967|FG000|Overall Study|Lost to Follow-up|36|||
148696217|NCT01471522|536360968|FG001|Overall Study|Lost to Follow-up|26|||
148696218|NCT01691248|536360969|FG000|Overall Study|Protocol Violation|43|||
148964708|NCT01549964|537356108|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
148964709|NCT01549964|537356109|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
148964710|NCT01549964|537356110|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
148964711|NCT01549964|537356107|FG000|80-Week Extension Period|Lost to Follow-up|1|||
148964712|NCT01549964|537356108|FG001|80-Week Extension Period|Lost to Follow-up|0|||
148964713|NCT01549964|537356109|FG002|80-Week Extension Period|Lost to Follow-up|2|||
148964714|NCT01549964|537356110|FG003|80-Week Extension Period|Lost to Follow-up|1|||
148964715|NCT01549964|537356107|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
148964716|NCT01549964|537356108|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
148964717|NCT01549964|537356109|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
148964718|NCT01549964|537356110|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
148964719|NCT02290821|537356111|FG000|Overall Study|Withdrawal by Subject|1|||
148813268|NCT00487188|536791668|FG000|Induction Phase|Lack of Efficacy|0|||
148813269|NCT00487188|536791669|FG001|Induction Phase|Lack of Efficacy|1|||
148813270|NCT00487188|536791670|FG002|Induction Phase|Lack of Efficacy|0|||
148813271|NCT00487188|536791668|FG000|Induction Phase|Protocol Violation|1|||
148813272|NCT00487188|536791669|FG001|Induction Phase|Protocol Violation|0|||
148813273|NCT00487188|536791670|FG002|Induction Phase|Protocol Violation|0|||
148813274|NCT00487188|536791668|FG000|Induction Phase|Refused Treatment|1|||
148813275|NCT00487188|536791669|FG001|Induction Phase|Refused Treatment|2|||
148813276|NCT00487188|536791670|FG002|Induction Phase|Refused Treatment|0|||
148813277|NCT00487188|536791668|FG000|Induction Phase|Lost to Follow-up|2|||
148813278|NCT00487188|536791669|FG001|Induction Phase|Lost to Follow-up|2|||
148813279|NCT00487188|536791670|FG002|Induction Phase|Lost to Follow-up|0|||
148813280|NCT00487188|536791668|FG000|Induction Phase|Administrative|0|||
148813281|NCT00487188|536791669|FG001|Induction Phase|Administrative|1|||
148813282|NCT00487188|536791670|FG002|Induction Phase|Administrative|0|||
148813283|NCT00487188|536791668|FG000|Maintenance Phase|Adverse Event|1|||
148813284|NCT00487188|536791669|FG001|Maintenance Phase|Adverse Event|0|||
148813285|NCT00487188|536791670|FG002|Maintenance Phase|Adverse Event|0|||
148813286|NCT00487188|536791668|FG000|Maintenance Phase|Death|1|||
148813287|NCT00487188|536791669|FG001|Maintenance Phase|Death|0|||
148813288|NCT00487188|536791670|FG002|Maintenance Phase|Death|0|||
148813289|NCT00487188|536791668|FG000|Maintenance Phase|Lost to Follow-up|1|||
148813290|NCT00487188|536791669|FG001|Maintenance Phase|Lost to Follow-up|0|||
148813291|NCT00487188|536791670|FG002|Maintenance Phase|Lost to Follow-up|0|||
148813292|NCT00487188|536791668|FG000|Maintenance Phase|Administrative|0|||
148813293|NCT00487188|536791669|FG001|Maintenance Phase|Administrative|0|||
148813294|NCT00487188|536791670|FG002|Maintenance Phase|Administrative|1|||
148813295|NCT05696847|536791672|FG000|Overall Study|Withdrawal by Subject|1|||
148813296|NCT05696847|536791673|FG001|Overall Study|Withdrawal by Subject|0|||
148813297|NCT05696847|536791674|FG002|Overall Study|Withdrawal by Subject|0|||
148813298|NCT05696847|536791675|FG003|Overall Study|Withdrawal by Subject|0|||
148813299|NCT05696847|536791676|FG004|Overall Study|Withdrawal by Subject|0|||
148813300|NCT05696847|536791677|FG005|Overall Study|Withdrawal by Subject|0|||
148813301|NCT05696847|536791672|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148813302|NCT05696847|536791673|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
148813303|NCT05696847|536791674|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
148813304|NCT05696847|536791675|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
148813305|NCT05696847|536791676|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
148813306|NCT05696847|536791677|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
148813307|NCT05696847|536791672|FG000|Overall Study|Adverse Event|0|||
148813308|NCT05696847|536791673|FG001|Overall Study|Adverse Event|0|||
148813309|NCT05696847|536791674|FG002|Overall Study|Adverse Event|0|||
148813310|NCT05696847|536791675|FG003|Overall Study|Adverse Event|0|||
148813311|NCT05696847|536791676|FG004|Overall Study|Adverse Event|0|||
148813312|NCT05696847|536791677|FG005|Overall Study|Adverse Event|1|||
148813313|NCT05696847|536791672|FG000|Overall Study|Sponsor Decision|0|||
148813314|NCT05696847|536791673|FG001|Overall Study|Sponsor Decision|0|||
148813315|NCT05696847|536791674|FG002|Overall Study|Sponsor Decision|0|||
148813316|NCT05696847|536791675|FG003|Overall Study|Sponsor Decision|1|||
148813317|NCT05696847|536791676|FG004|Overall Study|Sponsor Decision|0|||
148813318|NCT05696847|536791677|FG005|Overall Study|Sponsor Decision|0|||
148813319|NCT01697579|536791678|FG000|Base Study-Cycle 1|Adverse Event|1|||
148813320|NCT01697579|536791679|FG001|Base Study-Cycle 1|Adverse Event|0|||
148813321|NCT01697579|536791680|FG002|Base Study-Cycle 1|Adverse Event|0|||
148813322|NCT01697579|536791681|FG003|Base Study-Cycle 1|Adverse Event|0|||
148813323|NCT01697579|536791682|FG004|Base Study-Cycle 1|Adverse Event|0|||
148813324|NCT01697579|536791683|FG005|Base Study-Cycle 1|Adverse Event|0|||
148813325|NCT01697579|536791684|FG006|Base Study-Cycle 1|Adverse Event|0|||
148813326|NCT01697579|536791678|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
148813327|NCT01697579|536791679|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
148813328|NCT01697579|536791680|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
148813329|NCT01697579|536791681|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
148813330|NCT01697579|536791682|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
148813331|NCT01697579|536791683|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
148964720|NCT02290821|537356112|FG001|Overall Study|Withdrawal by Subject|1|||
148964721|NCT02290821|537356111|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
148964722|NCT02290821|537356112|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
148964723|NCT02290821|537356111|FG000|Overall Study|Lost to Follow-up|3|||
148813332|NCT01697579|536791684|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
148813333|NCT01697579|536791678|FG000|Base Study-Cycle 1|Protocol Violation|0|||
148813334|NCT01697579|536791679|FG001|Base Study-Cycle 1|Protocol Violation|0|||
148813335|NCT01697579|536791680|FG002|Base Study-Cycle 1|Protocol Violation|0|||
148813336|NCT01697579|536791681|FG003|Base Study-Cycle 1|Protocol Violation|0|||
148964724|NCT02290821|537356112|FG001|Overall Study|Lost to Follow-up|2|||
148813337|NCT01697579|536791682|FG004|Base Study-Cycle 1|Protocol Violation|3|||
148813338|NCT01697579|536791683|FG005|Base Study-Cycle 1|Protocol Violation|0|||
148813339|NCT01697579|536791684|FG006|Base Study-Cycle 1|Protocol Violation|0|||
148696219|NCT01691248|536360970|FG001|Overall Study|Protocol Violation|27|||
148696220|NCT01691248|536360969|FG000|Overall Study|Adverse Event|24|||
148696221|NCT01691248|536360970|FG001|Overall Study|Adverse Event|22|||
148696222|NCT01691248|536360969|FG000|Overall Study|Withdrawal by Subject|20|||
148696223|NCT01691248|536360970|FG001|Overall Study|Withdrawal by Subject|18|||
148696224|NCT01691248|536360969|FG000|Overall Study|Confirmed CDAD|14|||
148696225|NCT01691248|536360970|FG001|Overall Study|Confirmed CDAD|31|||
148696226|NCT01691248|536360969|FG000|Overall Study|Lost to Follow-up|2|||
148696227|NCT01691248|536360970|FG001|Overall Study|Lost to Follow-up|5|||
148696228|NCT01691248|536360969|FG000|Overall Study|Reason not provided|4|||
148696229|NCT01691248|536360970|FG001|Overall Study|Reason not provided|4|||
148696230|NCT01691248|536360969|FG000|Overall Study|Not Treated|4|||
148696231|NCT01691248|536360970|FG001|Overall Study|Not Treated|7|||
148696232|NCT02863575|536360971|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
148696233|NCT02863575|536360972|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
148696234|NCT02863575|536360973|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
148696235|NCT02863575|536360971|FG000|Overall Study|Withdrawal by Subject|0|||
148696236|NCT02863575|536360972|FG001|Overall Study|Withdrawal by Subject|1|||
148696237|NCT02863575|536360973|FG002|Overall Study|Withdrawal by Subject|1|||
148696238|NCT02863575|536360971|FG000|Overall Study|Adverse Event|0|||
148696239|NCT02863575|536360972|FG001|Overall Study|Adverse Event|1|||
148696240|NCT02863575|536360973|FG002|Overall Study|Adverse Event|0|||
148696241|NCT05628675|536362708|FG000|Overall Study|Lost to Follow-up|2|||
148696242|NCT05628675|536362708|FG000|Overall Study|Withdrawal by Subject|1|||
148696243|NCT00088829|536362711|FG000|Overall Study|PI left institution and study was close|22|||
148696244|NCT01367275|536362712|FG000|Overall Study|Ineligible|1|||
148696245|NCT01367275|536362712|FG000|Overall Study|Disease Progression|2|||
148696246|NCT01648166|536362713|FG000|Overall Study|inadequate toenail samples|53|||
148696247|NCT01648166|536362714|FG001|Overall Study|inadequate toenail samples|100|||
148696248|NCT00883090|536362715|FG000|Overall Study|Sponsor's decision|1|||
148696249|NCT00883090|536362715|FG000|Overall Study|Withdrawal by Subject|1|||
148696250|NCT02532764|536362716|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696251|NCT02532764|536362717|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696252|NCT02532764|536362718|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696253|NCT02532764|536362719|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696254|NCT02532764|536362720|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696255|NCT02532764|536362721|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696256|NCT02532764|536362722|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
148696257|NCT02532764|536362723|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
148696258|NCT02532764|536362724|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
148696259|NCT02532764|536362725|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
148696260|NCT01475838|536362726|FG000|Randomized Phase|Randomized but Not Treated|0|||
148696261|NCT01475838|536362727|FG001|Randomized Phase|Randomized but Not Treated|5|||
148696262|NCT01475838|536362726|FG000|Randomized Phase|Adverse Event|6|||
148696263|NCT01475838|536362727|FG001|Randomized Phase|Adverse Event|1|||
149024171|NCT02028884|537564208|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
148696264|NCT01475838|536362726|FG000|Randomized Phase|Pregnancy|0|||
148696265|NCT01475838|536362727|FG001|Randomized Phase|Pregnancy|1|||
148696266|NCT01475838|536362726|FG000|Randomized Phase|Investigators Discretion|1|||
148696267|NCT01475838|536362727|FG001|Randomized Phase|Investigators Discretion|2|||
148696268|NCT01475838|536362726|FG000|Randomized Phase|Withdrew Consent|10|||
148696269|NCT01475838|536362727|FG001|Randomized Phase|Withdrew Consent|14|||
148696270|NCT01475838|536362726|FG000|Randomized Phase|Lost to Follow-up|3|||
148696271|NCT01475838|536362727|FG001|Randomized Phase|Lost to Follow-up|4|||
148696272|NCT01475838|536362726|FG000|Randomized Phase|Participant Noncompliance|1|||
148696273|NCT01475838|536362727|FG001|Randomized Phase|Participant Noncompliance|5|||
148696274|NCT01475838|536362726|FG000|Randomized Phase|Protocol Violation|9|||
148696275|NCT01475838|536362727|FG001|Randomized Phase|Protocol Violation|4|||
148696276|NCT01475838|536362726|FG000|Extension Phase|Participant Noncompliance|1|||
148696277|NCT01475838|536362727|FG001|Extension Phase|Participant Noncompliance|0|||
148696278|NCT01717976|536362728|FG000|Overall Study|Protocol Violation|0|||
148696279|NCT01717976|536362729|FG001|Overall Study|Protocol Violation|1|||
148696280|NCT02932878|536362749|FG000|Overall Study|Due to Lab Results|2|||
148696281|NCT02932878|536362750|FG001|Overall Study|Due to Lab Results|1|||
148696282|NCT00262223|536362751|FG000|Treatment Phase|Withdrawal by Subject|3|||
148696283|NCT00262223|536362752|FG001|Treatment Phase|Withdrawal by Subject|6|||
148696284|NCT00262223|536362751|FG000|Treatment Phase|Adverse Event|1|||
148696285|NCT00262223|536362752|FG001|Treatment Phase|Adverse Event|2|||
148696286|NCT00262223|536362751|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
148696287|NCT00262223|536362752|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
148696288|NCT00262223|536362751|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
148696289|NCT00262223|536362752|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
148696290|NCT00262223|536362751|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
148696291|NCT00262223|536362752|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
148696292|NCT00437658|536362753|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
148696293|NCT00437658|536362754|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
148696294|NCT00437658|536362755|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
148696295|NCT00437658|536362753|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
148696296|NCT00437658|536362754|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
148696297|NCT00437658|536362755|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
148696298|NCT00437658|536362753|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
148696299|NCT00437658|536362754|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
148696300|NCT00437658|536362755|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
148696301|NCT00437658|536362753|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
148696302|NCT00437658|536362754|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
148696303|NCT00437658|536362755|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
148696304|NCT00437658|536362753|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
148696305|NCT00437658|536362754|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
148696306|NCT00437658|536362755|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
148696307|NCT00437658|536362753|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
148696308|NCT00437658|536362754|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
148696309|NCT00437658|536362755|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
148696310|NCT00437658|536362753|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
148696311|NCT00437658|536362754|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
148696312|NCT00437658|536362755|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
148696313|NCT00437658|536362753|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
148696314|NCT00437658|536362754|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
148696315|NCT00437658|536362755|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
148696316|NCT00437658|536362753|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
148696317|NCT00437658|536362754|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
148813340|NCT01697579|536791678|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
148964725|NCT02438722|537356113|FG000|Overall Study|Adverse Event|12|||
148964726|NCT02438722|537356114|FG001|Overall Study|Adverse Event|9|||
148964727|NCT02438722|537356113|FG000|Overall Study|Refusal unrelated to AE|2|||
148964728|NCT02438722|537356114|FG001|Overall Study|Refusal unrelated to AE|5|||
148696318|NCT00437658|536362755|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
148696319|NCT00437658|536362753|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
148696320|NCT00437658|536362754|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
148964729|NCT02438722|537356113|FG000|Overall Study|Disease progression/relapse|46|||
148964730|NCT02438722|537356114|FG001|Overall Study|Disease progression/relapse|51|||
148964731|NCT02438722|537356113|FG000|Overall Study|Death|0|||
148964732|NCT02438722|537356114|FG001|Overall Study|Death|3|||
148696321|NCT00437658|536362755|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
148696322|NCT00437658|536362753|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
148696323|NCT00437658|536362754|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
148696324|NCT00437658|536362755|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
148696325|NCT00437658|536362753|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
148696326|NCT00437658|536362754|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
148696327|NCT00437658|536362755|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
148964733|NCT02438722|537356113|FG000|Overall Study|Physician Decision|2|||
148964734|NCT02438722|537356114|FG001|Overall Study|Physician Decision|2|||
149005472|NCT03217747|537497905|FG013|Overall Study|Withdrawal by Subject|1|||
148696328|NCT03952143|536362756|FG000|Lead-In Period|Adverse Event|2|||
148696329|NCT03952143|536362757|FG001|Lead-In Period|Adverse Event|0|||
148696330|NCT03952143|536362758|FG002|Lead-In Period|Adverse Event|0|||
148696331|NCT03952143|536362756|FG000|Lead-In Period|Lack of Efficacy|2|||
148696332|NCT03952143|536362757|FG001|Lead-In Period|Lack of Efficacy|0|||
148696333|NCT03952143|536362758|FG002|Lead-In Period|Lack of Efficacy|0|||
148696334|NCT03952143|536362756|FG000|Lead-In Period|Physician Decision|5|||
148696335|NCT03952143|536362757|FG001|Lead-In Period|Physician Decision|0|||
148696336|NCT03952143|536362758|FG002|Lead-In Period|Physician Decision|0|||
148696337|NCT03952143|536362756|FG000|Lead-In Period|Protocol Violation|5|||
148696338|NCT03952143|536362757|FG001|Lead-In Period|Protocol Violation|0|||
148696339|NCT03952143|536362758|FG002|Lead-In Period|Protocol Violation|0|||
148696340|NCT03952143|536362756|FG000|Lead-In Period|Withdrawal by Subject|19|||
148696341|NCT03952143|536362757|FG001|Lead-In Period|Withdrawal by Subject|0|||
148696342|NCT03952143|536362758|FG002|Lead-In Period|Withdrawal by Subject|0|||
148696343|NCT03952143|536362756|FG000|Treatment Period|Adverse Event|0|||
148696344|NCT03952143|536362757|FG001|Treatment Period|Adverse Event|0|||
148696345|NCT03952143|536362758|FG002|Treatment Period|Adverse Event|1|||
148696346|NCT03952143|536362756|FG000|Treatment Period|Lost to Follow-up|0|||
148696347|NCT03952143|536362757|FG001|Treatment Period|Lost to Follow-up|2|||
148696348|NCT03952143|536362758|FG002|Treatment Period|Lost to Follow-up|0|||
148696349|NCT03952143|536362756|FG000|Treatment Period|Physician Decision|0|||
148696350|NCT03952143|536362757|FG001|Treatment Period|Physician Decision|0|||
148696351|NCT03952143|536362758|FG002|Treatment Period|Physician Decision|2|||
148696352|NCT03952143|536362756|FG000|Treatment Period|Protocol Violation|0|||
148696353|NCT03952143|536362757|FG001|Treatment Period|Protocol Violation|0|||
148696354|NCT03952143|536362758|FG002|Treatment Period|Protocol Violation|1|||
148696355|NCT03952143|536362756|FG000|Treatment Period|Withdrawal by Subject|0|||
148696356|NCT03952143|536362757|FG001|Treatment Period|Withdrawal by Subject|5|||
148696357|NCT03952143|536362758|FG002|Treatment Period|Withdrawal by Subject|26|||
148696358|NCT03952143|536362756|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
148696359|NCT03952143|536362757|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
148696360|NCT03952143|536362758|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
148696361|NCT03952143|536362756|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
148696362|NCT03952143|536362757|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
148696363|NCT03952143|536362758|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
148696364|NCT01866319|536362759|FG000|Overall Study|Adverse Event|12|||
148696365|NCT01866319|536362760|FG001|Overall Study|Adverse Event|5|||
148696366|NCT01866319|536362761|FG002|Overall Study|Adverse Event|9|||
148696367|NCT01866319|536362759|FG000|Overall Study|Clinical progression|3|||
148696368|NCT01866319|536362760|FG001|Overall Study|Clinical progression|2|||
148696369|NCT01866319|536362761|FG002|Overall Study|Clinical progression|2|||
148696370|NCT01866319|536362759|FG000|Overall Study|Death|153|||
148696371|NCT01866319|536362760|FG001|Overall Study|Death|154|||
148696372|NCT01866319|536362761|FG002|Overall Study|Death|147|||
148696373|NCT01866319|536362759|FG000|Overall Study|Lost to Follow-up|6|||
148696374|NCT01866319|536362760|FG001|Overall Study|Lost to Follow-up|3|||
148696375|NCT01866319|536362761|FG002|Overall Study|Lost to Follow-up|8|||
148696376|NCT01866319|536362759|FG000|Overall Study|Physician Decision|1|||
148696377|NCT01866319|536362760|FG001|Overall Study|Physician Decision|0|||
148696378|NCT01866319|536362761|FG002|Overall Study|Physician Decision|1|||
148696379|NCT01866319|536362759|FG000|Overall Study|Protocol Violation|0|||
148696380|NCT01866319|536362760|FG001|Overall Study|Protocol Violation|0|||
148696381|NCT01866319|536362761|FG002|Overall Study|Protocol Violation|1|||
148696382|NCT01866319|536362759|FG000|Overall Study|Withdrawal by Subject|32|||
148696383|NCT01866319|536362760|FG001|Overall Study|Withdrawal by Subject|14|||
148696384|NCT01866319|536362761|FG002|Overall Study|Withdrawal by Subject|12|||
148696385|NCT02731157|536362762|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
148696386|NCT00623779|536362764|FG000|Overall Study|Adverse Event|1|||
148696387|NCT00623779|536362765|FG001|Overall Study|Adverse Event|3|||
148696388|NCT00623779|536362766|FG002|Overall Study|Adverse Event|0|||
148696389|NCT00623779|536362764|FG000|Overall Study|Criteria from CSR|2|||
148696390|NCT00623779|536362765|FG001|Overall Study|Criteria from CSR|0|||
148696391|NCT00623779|536362766|FG002|Overall Study|Criteria from CSR|1|||
148696392|NCT01856309|536362767|FG000|Overall Study|Death|4|||
148696393|NCT01856309|536362768|FG001|Overall Study|Death|6|||
148696394|NCT01856309|536362769|FG002|Overall Study|Death|11|||
148696395|NCT01856309|536362770|FG003|Overall Study|Death|6|||
148696396|NCT01856309|536362767|FG000|Overall Study|Lost to Follow-up|6|||
148696397|NCT01856309|536362768|FG001|Overall Study|Lost to Follow-up|2|||
148696398|NCT01856309|536362769|FG002|Overall Study|Lost to Follow-up|4|||
148696399|NCT01856309|536362770|FG003|Overall Study|Lost to Follow-up|8|||
148696400|NCT01856309|536362767|FG000|Overall Study|Withdrawal by Subject|11|||
148696401|NCT01856309|536362768|FG001|Overall Study|Withdrawal by Subject|13|||
148696402|NCT01856309|536362769|FG002|Overall Study|Withdrawal by Subject|28|||
148696403|NCT01856309|536362770|FG003|Overall Study|Withdrawal by Subject|26|||
148696404|NCT01856309|536362767|FG000|Overall Study|Other|227|||
148696405|NCT01856309|536362768|FG001|Overall Study|Other|225|||
148696406|NCT01856309|536362769|FG002|Overall Study|Other|447|||
148696407|NCT01856309|536362770|FG003|Overall Study|Other|469|||
148696408|NCT01856309|536362767|FG000|Overall Study|Lack of Efficacy|14|||
148696409|NCT01856309|536362768|FG001|Overall Study|Lack of Efficacy|9|||
148696410|NCT01856309|536362769|FG002|Overall Study|Lack of Efficacy|40|||
148696411|NCT01856309|536362770|FG003|Overall Study|Lack of Efficacy|25|||
148696412|NCT01856309|536362767|FG000|Overall Study|Adverse Event|31|||
148696413|NCT01856309|536362768|FG001|Overall Study|Adverse Event|31|||
148696414|NCT01856309|536362769|FG002|Overall Study|Adverse Event|55|||
148696415|NCT01856309|536362770|FG003|Overall Study|Adverse Event|65|||
148696416|NCT01856309|536362767|FG000|Overall Study|Pregnancy|0|||
148696417|NCT01856309|536362768|FG001|Overall Study|Pregnancy|0|||
148696418|NCT01856309|536362769|FG002|Overall Study|Pregnancy|0|||
148696419|NCT01856309|536362770|FG003|Overall Study|Pregnancy|1|||
148696420|NCT01856309|536362767|FG000|Overall Study|Physician Decision|6|||
148696421|NCT01856309|536362768|FG001|Overall Study|Physician Decision|1|||
148696422|NCT01856309|536362769|FG002|Overall Study|Physician Decision|6|||
148696423|NCT01856309|536362770|FG003|Overall Study|Physician Decision|8|||
148696424|NCT01856309|536362767|FG000|Overall Study|Noncompliance With Study Drug|0|||
148696425|NCT01856309|536362768|FG001|Overall Study|Noncompliance With Study Drug|1|||
148696426|NCT01856309|536362769|FG002|Overall Study|Noncompliance With Study Drug|4|||
148696427|NCT01856309|536362770|FG003|Overall Study|Noncompliance With Study Drug|1|||
148696428|NCT00220337|536362771|FG000|Overall Study|Adverse Event|70|||
148696429|NCT00220337|536362771|FG000|Overall Study|Lack of Efficacy|17|||
148696430|NCT00220337|536362771|FG000|Overall Study|Withdrawal by Subject|68|||
148696431|NCT00220337|536362771|FG000|Overall Study|Protocol Violation|2|||
148696432|NCT00220337|536362771|FG000|Overall Study|Lost to Follow-up|5|||
148696433|NCT00220337|536362771|FG000|Overall Study|Other|12|||
148696434|NCT00220337|536362771|FG000|Overall Study|Unsatisfactory compliance|5|||
148696435|NCT00832377|536362772|FG000|Overall Study|Protocol Violation|1|||
148696436|NCT00944697|536362773|FG000|Overall Study|Withdrawal by Subject|1|||
148696437|NCT00944697|536362774|FG001|Overall Study|Withdrawal by Subject|1|||
148696438|NCT00944697|536362773|FG000|Overall Study|Adverse Event|0|||
148696439|NCT00944697|536362774|FG001|Overall Study|Adverse Event|3|||
148696440|NCT00944697|536362773|FG000|Overall Study|Administrative|1|||
148696441|NCT00944697|536362774|FG001|Overall Study|Administrative|1|||
148696442|NCT01273181|536362775|FG000|Phase I, Dose 1|Study termination|1|||
148696443|NCT01273181|536362776|FG001|Phase I, Dose 1|Study termination|0|||
148696444|NCT01273181|536362777|FG002|Phase I, Dose 1|Study termination|0|||
148696445|NCT01273181|536362778|FG003|Phase I, Dose 1|Study termination|0|||
148696446|NCT01273181|536362775|FG000|Phase I, Dose 2|Death during treatment|0|||
148813341|NCT01697579|536791679|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
148696447|NCT01273181|536362776|FG001|Phase I, Dose 2|Death during treatment|1|||
148696448|NCT01273181|536362777|FG002|Phase I, Dose 2|Death during treatment|0|||
148696449|NCT01273181|536362778|FG003|Phase I, Dose 2|Death during treatment|0|||
148696450|NCT01273181|536362775|FG000|Phase 2, Dose 1|Study termination|0|||
148696451|NCT01273181|536362776|FG001|Phase 2, Dose 1|Study termination|0|||
148696452|NCT01273181|536362777|FG002|Phase 2, Dose 1|Study termination|1|||
148696453|NCT01273181|536362778|FG003|Phase 2, Dose 1|Study termination|0|||
148696454|NCT01273181|536362775|FG000|Phase 2, Dose 2|Death during treatment|0|||
148696455|NCT01273181|536362776|FG001|Phase 2, Dose 2|Death during treatment|0|||
148696456|NCT01273181|536362777|FG002|Phase 2, Dose 2|Death during treatment|0|||
148696457|NCT01273181|536362778|FG003|Phase 2, Dose 2|Death during treatment|1|||
148696458|NCT01876706|536362781|FG000|Overall Study|BPH Intervention|9|||
148696459|NCT01876706|536362781|FG000|Overall Study|Lost to Follow-up|7|||
148696460|NCT01876706|536362781|FG000|Overall Study|Withdrawals|6|||
148696461|NCT01876706|536362781|FG000|Overall Study|Death|3|||
148696462|NCT00604500|536362782|FG000|Overall Study|Adverse Event|2|||
148696463|NCT00604500|536362782|FG000|Overall Study|Protocol Violation|2|||
148696464|NCT00604500|536362782|FG000|Overall Study|Treatment Failure|1|||
148696465|NCT00604500|536362782|FG000|Overall Study|Withdrawal by Subject|4|||
148696466|NCT00604500|536362782|FG000|Overall Study|Administrative|1|||
148696467|NCT00604500|536362782|FG000|Overall Study|Did not meet protocol eligibility|1|||
148696468|NCT02191891|536362784|FG000|Overall Study|Withdrawal by Subject|0|||
148696469|NCT02191891|536362785|FG001|Overall Study|Withdrawal by Subject|1|||
148696470|NCT02191891|536362786|FG002|Overall Study|Withdrawal by Subject|0|||
148696471|NCT02191891|536362787|FG003|Overall Study|Withdrawal by Subject|0|||
148696472|NCT02191891|536362788|FG004|Overall Study|Withdrawal by Subject|1|||
148696473|NCT02191891|536362784|FG000|Overall Study|Adverse Event|0|||
148696474|NCT02191891|536362785|FG001|Overall Study|Adverse Event|1|||
148696475|NCT02191891|536362786|FG002|Overall Study|Adverse Event|0|||
148696476|NCT02191891|536362787|FG003|Overall Study|Adverse Event|0|||
148696477|NCT02191891|536362788|FG004|Overall Study|Adverse Event|2|||
148696478|NCT02191891|536362784|FG000|Overall Study|Disease Progression|4|||
148696479|NCT02191891|536362785|FG001|Overall Study|Disease Progression|10|||
148696480|NCT02191891|536362786|FG002|Overall Study|Disease Progression|4|||
148696481|NCT02191891|536362787|FG003|Overall Study|Disease Progression|2|||
148696482|NCT02191891|536362788|FG004|Overall Study|Disease Progression|7|||
148696483|NCT01062256|536362792|FG000|Overall Study|Adverse Event|1|||
148696484|NCT01062256|536362793|FG001|Overall Study|Adverse Event|0|||
148696485|NCT01062256|536362794|FG002|Overall Study|Adverse Event|0|||
148696486|NCT01062256|536362792|FG000|Overall Study|Withdrawal by Subject|1|||
148696487|NCT01062256|536362793|FG001|Overall Study|Withdrawal by Subject|1|||
148696488|NCT01062256|536362794|FG002|Overall Study|Withdrawal by Subject|1|||
148696489|NCT01062256|536362792|FG000|Overall Study|Ineligible|1|||
148696490|NCT01062256|536362793|FG001|Overall Study|Ineligible|4|||
148696491|NCT01062256|536362794|FG002|Overall Study|Ineligible|3|||
148696492|NCT01062256|536362792|FG000|Overall Study|Administrative|0|||
148696493|NCT01062256|536362793|FG001|Overall Study|Administrative|2|||
148696494|NCT01062256|536362794|FG002|Overall Study|Administrative|0|||
148696495|NCT03049488|536362795|FG000|Overall Study|Lost to Follow-up|1|||
148696496|NCT03049488|536362796|FG001|Overall Study|Lost to Follow-up|1|||
148696497|NCT03049488|536362797|FG002|Overall Study|Lost to Follow-up|0|||
148696498|NCT03049488|536362798|FG003|Overall Study|Lost to Follow-up|0|||
148696499|NCT03049488|536362799|FG004|Overall Study|Lost to Follow-up|0|||
148696500|NCT03049488|536362800|FG005|Overall Study|Lost to Follow-up|0|||
148696501|NCT03049488|536362795|FG000|Overall Study|Moved from Area|1|||
148696502|NCT03049488|536362796|FG001|Overall Study|Moved from Area|0|||
148696503|NCT03049488|536362797|FG002|Overall Study|Moved from Area|0|||
148696504|NCT03049488|536362798|FG003|Overall Study|Moved from Area|1|||
148696505|NCT03049488|536362799|FG004|Overall Study|Moved from Area|1|||
148696506|NCT03049488|536362800|FG005|Overall Study|Moved from Area|0|||
148696507|NCT03049488|536362795|FG000|Overall Study|Physician Decision|0|||
148696508|NCT03049488|536362796|FG001|Overall Study|Physician Decision|1|||
148696509|NCT03049488|536362797|FG002|Overall Study|Physician Decision|0|||
148696510|NCT03049488|536362798|FG003|Overall Study|Physician Decision|0|||
148696511|NCT03049488|536362799|FG004|Overall Study|Physician Decision|0|||
148696512|NCT03049488|536362800|FG005|Overall Study|Physician Decision|0|||
148696513|NCT03049488|536362795|FG000|Overall Study|Withdrawal by Subject|0|||
148696514|NCT03049488|536362796|FG001|Overall Study|Withdrawal by Subject|0|||
148696515|NCT03049488|536362797|FG002|Overall Study|Withdrawal by Subject|0|||
148696516|NCT03049488|536362798|FG003|Overall Study|Withdrawal by Subject|1|||
148696517|NCT03049488|536362799|FG004|Overall Study|Withdrawal by Subject|1|||
148696518|NCT03049488|536362800|FG005|Overall Study|Withdrawal by Subject|0|||
148696519|NCT00891293|536362802|FG000|Overall Study|Adverse Event|2|||
148696520|NCT00891293|536362802|FG000|Overall Study|Protocol Violation|2|||
148696521|NCT00891293|536362802|FG000|Overall Study|Laboratory abnormality|4|||
148696522|NCT00891293|536362802|FG000|Overall Study|Lost to Follow-up|7|||
148696523|NCT00891293|536362802|FG000|Overall Study|Subject withdrew consent|7|||
148696524|NCT00891293|536362802|FG000|Overall Study|Sponsor termination|62|||
148696525|NCT01448057|536362803|FG000|Overall Study|Protocol Violation|3|||
148696526|NCT01448057|536362804|FG001|Overall Study|Protocol Violation|2|||
148696527|NCT01448057|536362803|FG000|Overall Study|Lost to Follow-up|3|||
148696528|NCT01448057|536362804|FG001|Overall Study|Lost to Follow-up|0|||
148696529|NCT01448057|536362803|FG000|Overall Study|Adverse Event|0|||
148696530|NCT01448057|536362804|FG001|Overall Study|Adverse Event|2|||
148696531|NCT01448057|536362803|FG000|Overall Study|Withdrawal by Subject|2|||
148696532|NCT01448057|536362804|FG001|Overall Study|Withdrawal by Subject|0|||
148696533|NCT03883906|536362809|FG000|Overall Study|Withdrawal by Subject|2|||
148696534|NCT03883906|536362809|FG000|Overall Study|Physician Decision|5|||
148696535|NCT00874237|536362810|FG000|Overall Study|Physician Decision|0|||
148696536|NCT00874237|536362811|FG001|Overall Study|Physician Decision|1|||
148696537|NCT00874237|536362812|FG002|Overall Study|Physician Decision|0|||
148696538|NCT00874237|536362813|FG003|Overall Study|Physician Decision|0|||
148696539|NCT00874237|536362814|FG004|Overall Study|Physician Decision|0|||
148696540|NCT00874237|536362815|FG005|Overall Study|Physician Decision|0|||
148696541|NCT00874237|536362810|FG000|Overall Study|Withdrawal by Subject|0|||
148696542|NCT00874237|536362811|FG001|Overall Study|Withdrawal by Subject|0|||
148696543|NCT00874237|536362812|FG002|Overall Study|Withdrawal by Subject|1|||
148696544|NCT00874237|536362813|FG003|Overall Study|Withdrawal by Subject|0|||
148696545|NCT00874237|536362814|FG004|Overall Study|Withdrawal by Subject|0|||
148696546|NCT00874237|536362815|FG005|Overall Study|Withdrawal by Subject|0|||
148696547|NCT03912337|536362832|FG000|Overall Study|Withdrawal of Consent From Study|1|||
148696548|NCT03912337|536362833|FG001|Overall Study|Withdrawal of Consent From Study|0|||
148696549|NCT03912337|536362832|FG000|Overall Study|Lost to Follow-up|1|||
148696550|NCT03912337|536362833|FG001|Overall Study|Lost to Follow-up|1|||
148696551|NCT00537030|536362834|FG000|Overall Study|Physician Decision|2|||
148696552|NCT00537030|536362834|FG000|Overall Study|Withdrawal by Subject|2|||
148696553|NCT00537030|536362834|FG000|Overall Study|≥ Grade 2 allergy|7|||
148696554|NCT00537030|536362834|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
148696555|NCT00537030|536362834|FG000|Overall Study|Ineligible|2|||
148696556|NCT00537030|536362834|FG000|Overall Study|Inevaluable|2|||
148696557|NCT02458469|536362835|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148696558|NCT02458469|536362836|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148696559|NCT02458469|536362837|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
148696560|NCT02458469|536362838|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148696561|NCT02458469|536362839|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148696562|NCT02458469|536362840|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148696563|NCT02458469|536362835|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
148696564|NCT02458469|536362836|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
148696565|NCT02458469|536362837|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
148696566|NCT02458469|536362838|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
148696567|NCT02458469|536362839|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
148696568|NCT02458469|536362840|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
148696569|NCT02458469|536362835|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
148696570|NCT02458469|536362836|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
148696571|NCT02458469|536362837|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
148696572|NCT02458469|536362838|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
148696573|NCT02458469|536362839|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
148813342|NCT01697579|536791680|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
148813343|NCT01697579|536791681|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
148813344|NCT01697579|536791682|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
148696574|NCT02458469|536362840|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
148696575|NCT01496183|536362842|FG000|Overall Study|Physician Decision|3|||
148696576|NCT01496183|536362843|FG001|Overall Study|Physician Decision|1|||
148696577|NCT01496183|536362842|FG000|Overall Study|Withdrawal by Subject|0|||
148696578|NCT01496183|536362843|FG001|Overall Study|Withdrawal by Subject|1|||
148696579|NCT03130699|536362844|FG000|Overall Study|Lost to Follow-up|34|||
148813345|NCT01697579|536791683|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
148813346|NCT01697579|536791684|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
148813347|NCT01697579|536791678|FG000|Base Study-Cycle 1|Technical Problems|0|||
148813348|NCT01697579|536791679|FG001|Base Study-Cycle 1|Technical Problems|0|||
148813349|NCT01697579|536791680|FG002|Base Study-Cycle 1|Technical Problems|1|||
148813350|NCT01697579|536791681|FG003|Base Study-Cycle 1|Technical Problems|1|||
148813351|NCT01697579|536791682|FG004|Base Study-Cycle 1|Technical Problems|0|||
148813352|NCT01697579|536791683|FG005|Base Study-Cycle 1|Technical Problems|0|||
148813353|NCT01697579|536791684|FG006|Base Study-Cycle 1|Technical Problems|0|||
148813354|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Death|0|||
148813355|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Death|0|||
148813356|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Death|0|||
148813357|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Death|0|||
148813358|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Death|0|||
148813359|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Death|0|||
148813360|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Death|2|||
148813361|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148813362|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148813363|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148813364|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148813365|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148813366|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
148813367|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
148813368|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
148813369|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
148813370|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
148813371|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
148813372|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
148813373|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
148813374|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
148813375|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
148813376|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
148813377|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
148813378|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
148813379|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
148813380|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
148813381|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
148813382|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
148813383|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
148813384|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
148813385|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
148813386|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
148813387|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
148813388|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
148813389|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
148813390|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
148813391|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
148813392|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
148813393|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
148813394|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
148813395|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
148813396|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
148813397|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
148813398|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
148813399|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
148813400|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
148813401|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
148813402|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
148813403|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
148813404|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
148813405|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
148813406|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
148813407|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
148813408|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
149024172|NCT02028884|537564209|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
149024173|NCT02028884|537564210|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
148696580|NCT03130699|536362845|FG001|Overall Study|Lost to Follow-up|37|||
148964735|NCT02438722|537356113|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
148696581|NCT03130699|536362846|FG002|Overall Study|Lost to Follow-up|26|||
148813409|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
148813410|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
148813411|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
148813412|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
148813413|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
148813414|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
148813415|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
148813416|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
148813417|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
148813418|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
148813419|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
148813420|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
148813421|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
148813422|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
148813423|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
148813424|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
148813425|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
148813426|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
148813427|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
148813428|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
148813429|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
148813430|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
148813431|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
148813432|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
148813433|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
148813434|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
148813435|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
148813436|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
148813437|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
148813438|NCT01697579|536791678|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
148813439|NCT01697579|536791679|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
148813440|NCT01697579|536791680|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
148813441|NCT01697579|536791681|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
148813442|NCT01697579|536791682|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
148813443|NCT01697579|536791683|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
148813444|NCT01697579|536791684|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
148813445|NCT04092777|536791687|FG000|Overall Study|Lost to Follow-up|28|||
148813446|NCT04092777|536791688|FG001|Overall Study|Lost to Follow-up|46|||
148813447|NCT04092777|536791687|FG000|Overall Study|Withdrawal by Subject|8|||
148813448|NCT04092777|536791688|FG001|Overall Study|Withdrawal by Subject|5|||
148813449|NCT03330197|536791691|FG000|Overall Study|Adverse Event|0|||
148813450|NCT03330197|536791692|FG001|Overall Study|Adverse Event|1|||
148813451|NCT03330197|536791691|FG000|Overall Study|Withdrawal by Subject|0|||
148813452|NCT03330197|536791692|FG001|Overall Study|Withdrawal by Subject|1|||
148813453|NCT00876343|536791694|FG000|Overall Study|Adverse Event|7|||
148813454|NCT00876343|536791695|FG001|Overall Study|Adverse Event|8|||
148813455|NCT00876343|536791696|FG002|Overall Study|Adverse Event|2|||
148813456|NCT00876343|536791694|FG000|Overall Study|Withdrawal by Subject|4|||
148813457|NCT00876343|536791695|FG001|Overall Study|Withdrawal by Subject|4|||
148813458|NCT00876343|536791696|FG002|Overall Study|Withdrawal by Subject|3|||
148813459|NCT00876343|536791694|FG000|Overall Study|Lack of Efficacy|0|||
148813460|NCT00876343|536791695|FG001|Overall Study|Lack of Efficacy|0|||
148813461|NCT00876343|536791696|FG002|Overall Study|Lack of Efficacy|1|||
148813462|NCT00876343|536791694|FG000|Overall Study|Protocol Violation|4|||
148813463|NCT00876343|536791695|FG001|Overall Study|Protocol Violation|1|||
148813464|NCT00876343|536791696|FG002|Overall Study|Protocol Violation|1|||
148813465|NCT00876343|536791694|FG000|Overall Study|Physician Decision|0|||
148813466|NCT00876343|536791695|FG001|Overall Study|Physician Decision|1|||
148813467|NCT00876343|536791696|FG002|Overall Study|Physician Decision|1|||
148813468|NCT00876343|536791694|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
148813469|NCT00876343|536791695|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
148813470|NCT00876343|536791696|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
148813471|NCT00876343|536791694|FG000|Overall Study|Change of residence or other commitments|2|||
148813472|NCT00876343|536791695|FG001|Overall Study|Change of residence or other commitments|2|||
148964736|NCT02438722|537356114|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
148964737|NCT02438722|537356113|FG000|Overall Study|Withdrawal by Subject|0|||
148964738|NCT02438722|537356114|FG001|Overall Study|Withdrawal by Subject|1|||
148696582|NCT03130699|536362844|FG000|Overall Study|Withdrawal by Subject|5|||
148696583|NCT03130699|536362845|FG001|Overall Study|Withdrawal by Subject|1|||
148696584|NCT03130699|536362846|FG002|Overall Study|Withdrawal by Subject|0|||
148696585|NCT03130699|536362844|FG000|Overall Study|Withdrawal by PI|1|||
148696586|NCT03130699|536362845|FG001|Overall Study|Withdrawal by PI|2|||
148696587|NCT03130699|536362846|FG002|Overall Study|Withdrawal by PI|5|||
149024174|NCT02028884|537564208|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
148696588|NCT03130699|536362844|FG000|Overall Study|Death|0|||
148964739|NCT02438722|537356113|FG000|Overall Study|On protocol treatment|15|||
148964740|NCT02438722|537356114|FG001|Overall Study|On protocol treatment|14|||
148964741|NCT02438722|537356113|FG000|Overall Study|Did not receive protocol treatment|5|||
148964742|NCT02438722|537356114|FG001|Overall Study|Did not receive protocol treatment|0|||
148964743|NCT01520363|537356120|FG000|Overall Study|Withdrawal by Subject|2|||
148964744|NCT01520363|537356121|FG001|Overall Study|Withdrawal by Subject|0|||
148964745|NCT04191382|537356126|FG000|Overall Study|Withdrawal by Subject|1|||
148964746|NCT04191382|537356127|FG001|Overall Study|Withdrawal by Subject|0|||
148964747|NCT04191382|537356128|FG002|Overall Study|Withdrawal by Subject|0|||
148964748|NCT05237206|537356129|FG000|Overall Study|screen failure-did not receive treatment|8|||
148964749|NCT05237206|537356129|FG000|Overall Study|did not receive treatment|3|||
148964750|NCT01476696|537356130|FG000|Overall Study|Sponsor decision|2|||
148964751|NCT01476696|537356131|FG001|Overall Study|Sponsor decision|1|||
148964752|NCT01476696|537356132|FG002|Overall Study|Sponsor decision|0|||
148964753|NCT01476696|537356130|FG000|Overall Study|Withdrawal by Subject|1|||
149024175|NCT02028884|537564209|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
149024176|NCT02028884|537564210|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
149024177|NCT02028884|537564208|FG000|Open-label Extension Period|Switched to another treatment option|3|||
149024178|NCT02028884|537564209|FG001|Open-label Extension Period|Switched to another treatment option|0|||
148696589|NCT03130699|536362845|FG001|Overall Study|Death|0|||
148696590|NCT03130699|536362846|FG002|Overall Study|Death|1|||
148696591|NCT00669864|536362849|FG000|Overall Study|Lost to Follow-up|2|||
148696592|NCT00669864|536362849|FG000|Overall Study|Protocol Violation|2|||
148696593|NCT00669864|536362849|FG000|Overall Study|Withdrawal by Subject|3|||
148696594|NCT00669864|536362849|FG000|Overall Study|Other|2|||
148696595|NCT00680121|536362852|FG000|Overall Study|Lost to Follow-up|27|||
148696596|NCT00680121|536362853|FG001|Overall Study|Lost to Follow-up|23|||
148696597|NCT00408902|536362854|FG000|Overall Study|Lack of Efficacy|7|||
148696598|NCT00408902|536362854|FG000|Overall Study|Adverse Event|3|||
148696599|NCT00970281|536362857|FG000|Overall Study|Lack of Efficacy|1|||
148696600|NCT00970281|536362858|FG001|Overall Study|Lack of Efficacy|14|||
148696601|NCT00970281|536362857|FG000|Overall Study|Withdrawal by Subject|0|||
148696602|NCT00970281|536362858|FG001|Overall Study|Withdrawal by Subject|1|||
148696603|NCT00970281|536362857|FG000|Overall Study|Physician Decision|1|||
148696604|NCT00970281|536362858|FG001|Overall Study|Physician Decision|1|||
148696605|NCT00841100|536362859|FG000|Phase 1 (28 Days)|Adverse Event|1|||
148696606|NCT00841100|536362859|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
148696607|NCT03338972|536362860|FG000|Overall Study|Death|1|||
148696608|NCT03338972|536362861|FG001|Overall Study|Death|1|||
148696609|NCT03338972|536362862|FG002|Overall Study|Death|0|||
148696610|NCT03338972|536362863|FG003|Overall Study|Death|0|||
148696611|NCT03338972|536362860|FG000|Overall Study|Withdrawal by Subject|1|||
148696612|NCT03338972|536362861|FG001|Overall Study|Withdrawal by Subject|0|||
148964754|NCT01476696|537356131|FG001|Overall Study|Withdrawal by Subject|0|||
148964755|NCT01476696|537356132|FG002|Overall Study|Withdrawal by Subject|0|||
148696613|NCT03338972|536362862|FG002|Overall Study|Withdrawal by Subject|0|||
148696614|NCT03338972|536362863|FG003|Overall Study|Withdrawal by Subject|0|||
148696615|NCT03629249|536362864|FG000|Overall Study|Study terminated by sponsor|197|||
148696616|NCT03629249|536362865|FG001|Overall Study|Study terminated by sponsor|197|||
148696617|NCT03629249|536362866|FG002|Overall Study|Study terminated by sponsor|194|||
148696618|NCT03629249|536362864|FG000|Overall Study|Protocol deviation|0|||
148696619|NCT03629249|536362865|FG001|Overall Study|Protocol deviation|2|||
148696620|NCT03629249|536362866|FG002|Overall Study|Protocol deviation|5|||
148696621|NCT03629249|536362864|FG000|Overall Study|Subject decision|1|||
148696622|NCT03629249|536362865|FG001|Overall Study|Subject decision|1|||
148696623|NCT03629249|536362866|FG002|Overall Study|Subject decision|3|||
148696624|NCT03629249|536362864|FG000|Overall Study|Adverse Event|1|||
148696625|NCT03629249|536362865|FG001|Overall Study|Adverse Event|1|||
148696626|NCT03629249|536362866|FG002|Overall Study|Adverse Event|0|||
148696627|NCT03629249|536362864|FG000|Overall Study|Death|1|||
148696628|NCT03629249|536362865|FG001|Overall Study|Death|0|||
148696629|NCT03629249|536362866|FG002|Overall Study|Death|0|||
148696630|NCT03629249|536362864|FG000|Overall Study|Physician Decision|1|||
148696631|NCT03629249|536362865|FG001|Overall Study|Physician Decision|0|||
148696632|NCT03629249|536362866|FG002|Overall Study|Physician Decision|0|||
148696633|NCT03633721|536362871|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
148696634|NCT03633721|536362872|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
148813473|NCT00876343|536791696|FG002|Overall Study|Change of residence or other commitments|3|||
148813474|NCT00005047|536791700|FG000|Overall Study|Withdrawal by Subject|12|||
148813475|NCT00005047|536791701|FG001|Overall Study|Withdrawal by Subject|0|||
148813476|NCT00005047|536791702|FG002|Overall Study|Withdrawal by Subject|0|||
148813477|NCT00005047|536791703|FG003|Overall Study|Withdrawal by Subject|0|||
148813478|NCT00005047|536791700|FG000|Overall Study|Adverse Event|5|||
148813479|NCT00005047|536791701|FG001|Overall Study|Adverse Event|0|||
148813480|NCT00005047|536791702|FG002|Overall Study|Adverse Event|0|||
148813481|NCT00005047|536791703|FG003|Overall Study|Adverse Event|0|||
148813482|NCT00005047|536791700|FG000|Overall Study|Lost to Follow-up|1|||
148813483|NCT00005047|536791701|FG001|Overall Study|Lost to Follow-up|0|||
148813484|NCT00005047|536791702|FG002|Overall Study|Lost to Follow-up|0|||
148813485|NCT00005047|536791703|FG003|Overall Study|Lost to Follow-up|0|||
148813486|NCT00005047|536791700|FG000|Overall Study|Lack of Efficacy|1|||
148813487|NCT00005047|536791701|FG001|Overall Study|Lack of Efficacy|0|||
148813488|NCT00005047|536791702|FG002|Overall Study|Lack of Efficacy|0|||
148813489|NCT00005047|536791703|FG003|Overall Study|Lack of Efficacy|0|||
148813490|NCT05252702|536791709|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
148813491|NCT05252702|536791709|FG000|Overall Study|Death|16|||
148813492|NCT05252702|536791709|FG000|Overall Study|System explant|5|||
148813493|NCT05252702|536791709|FG000|Overall Study|Lost to Follow-up|1|||
148813494|NCT05252702|536791709|FG000|Overall Study|Withdrawn by investigator|1|||
148813495|NCT05252702|536791709|FG000|Overall Study|Visit not due|306|||
148813496|NCT05252702|536791709|FG000|Overall Study|Visit within window but not completed|92|||
148813497|NCT05252702|536791709|FG000|Overall Study|Unsuccessful implant|1|||
148813498|NCT04717557|536791718|FG000|Overall Study|Withdrawal by Subject|2|||
148813499|NCT04717557|536791719|FG001|Overall Study|Withdrawal by Subject|0|||
148813500|NCT04717557|536791718|FG000|Overall Study|Death|1|||
148813501|NCT04717557|536791719|FG001|Overall Study|Death|0|||
148813502|NCT03168672|536791724|FG000|Overall Study|Withdrawal by Subject|13|||
148813503|NCT03168672|536791724|FG000|Overall Study|Death|3|||
148813504|NCT03168672|536791724|FG000|Overall Study|Investigator's Decision|137|||
148813505|NCT03168672|536791724|FG000|Overall Study|Adverse Event|1|||
148813506|NCT03168672|536791724|FG000|Overall Study|Other|2|||
148813507|NCT03168672|536791724|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
148813508|NCT00927472|536791725|FG000|Overall Study|Withdrawal by Subject|10|||
148813509|NCT00927472|536791726|FG001|Overall Study|Withdrawal by Subject|11|||
148813510|NCT00927472|536791725|FG000|Overall Study|Lost to Follow-up|1|||
148813511|NCT00927472|536791726|FG001|Overall Study|Lost to Follow-up|6|||
148813512|NCT00927472|536791725|FG000|Overall Study|Protocol Violation|0|||
148813513|NCT00927472|536791726|FG001|Overall Study|Protocol Violation|1|||
148813514|NCT00927472|536791725|FG000|Overall Study|Post treatment Assessment out of window|0|||
148813515|NCT00927472|536791726|FG001|Overall Study|Post treatment Assessment out of window|4|||
148813516|NCT00433537|536791727|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
148813517|NCT00433537|536791728|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
148813518|NCT00433537|536791729|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
148813519|NCT00433537|536791727|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
148813520|NCT00433537|536791728|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
148813521|NCT00433537|536791729|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
148696635|NCT03633721|536362873|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
148696636|NCT03633721|536362874|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
148813522|NCT00433537|536791727|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
148813523|NCT00433537|536791728|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
148813524|NCT00433537|536791729|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
148696637|NCT05277389|536362878|FG000|Overall Study|Lost to Follow-up|1|||
148696638|NCT05277389|536362879|FG001|Overall Study|Lost to Follow-up|4|||
148696639|NCT03069937|536362880|FG000|Overall Study|Second primary malignancy noted|1|||
148696640|NCT01046253|536362881|FG000|Second Intervention|Adverse Event|0|||
148696641|NCT01046253|536362882|FG001|Second Intervention|Adverse Event|1|||
148696642|NCT01046253|536362881|FG000|Second Intervention|Protocol Violation|0|||
148696643|NCT01046253|536362882|FG001|Second Intervention|Protocol Violation|1|||
148696644|NCT02339909|536362883|FG000|Overall Study|Became ineligible after randomisation|89|||
148696645|NCT02339909|536362884|FG001|Overall Study|Became ineligible after randomisation|63|||
148696646|NCT02339909|536362885|FG002|Overall Study|Became ineligible after randomisation|71|||
148696647|NCT01766778|536362886|FG000|Overall Study|Adverse Event|4|||
148696648|NCT01766778|536362887|FG001|Overall Study|Adverse Event|4|||
148696649|NCT01766778|536362886|FG000|Overall Study|Withdrawal by Subject|1|||
148696650|NCT01766778|536362887|FG001|Overall Study|Withdrawal by Subject|0|||
148696651|NCT04349917|536364650|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
148696652|NCT04349917|536364651|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
148696653|NCT04349917|536364650|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
148696654|NCT04349917|536364651|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
148696655|NCT04188106|536364652|FG000|Overall Study|Lost to Follow-up|5|||
148696656|NCT04188106|536364652|FG000|Overall Study|Non-Compliance|1|||
148696657|NCT01507051|536364653|FG000|Overall Study|Withdrawal by Subject|1|||
148696658|NCT01507051|536364654|FG001|Overall Study|Withdrawal by Subject|3|||
148696659|NCT01507051|536364655|FG002|Overall Study|Withdrawal by Subject|1|||
148696660|NCT01507051|536364656|FG003|Overall Study|Withdrawal by Subject|6|||
148696661|NCT01507051|536364653|FG000|Overall Study|Physician Decision|0|||
148696662|NCT01507051|536364654|FG001|Overall Study|Physician Decision|0|||
148696663|NCT01507051|536364655|FG002|Overall Study|Physician Decision|0|||
148813525|NCT00433537|536791727|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
148813526|NCT00433537|536791728|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
148696664|NCT01507051|536364656|FG003|Overall Study|Physician Decision|1|||
148696665|NCT01507051|536364653|FG000|Overall Study|Adverse Event|1|||
148696666|NCT01507051|536364654|FG001|Overall Study|Adverse Event|0|||
148696667|NCT01507051|536364655|FG002|Overall Study|Adverse Event|0|||
148813527|NCT00433537|536791729|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
148964756|NCT01466387|537356140|FG000|Overall Study|Adverse Event|0|||
148696668|NCT01507051|536364656|FG003|Overall Study|Adverse Event|0|||
148696669|NCT01519661|536364657|FG000|Overall Study|Protocol deviation|6|||
148813528|NCT00433537|536791727|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
148813529|NCT00433537|536791728|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
148813530|NCT00433537|536791729|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
148813531|NCT00433537|536791727|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
148813532|NCT00433537|536791728|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
148813533|NCT00433537|536791729|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
148813534|NCT00433537|536791727|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
148813535|NCT00433537|536791728|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
148813536|NCT00433537|536791729|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
148813537|NCT00433537|536791727|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
148813538|NCT00433537|536791728|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
148813539|NCT00433537|536791729|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
148813540|NCT00433537|536791727|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
148813541|NCT00433537|536791728|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
148813542|NCT00433537|536791729|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
148813543|NCT05436613|536791730|FG000|Overall Study|Lost to Follow-up|9|||
148813544|NCT05436613|536791730|FG000|Overall Study|Withdrawal by Subject|3|||
148813545|NCT05317546|536791733|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
148813546|NCT05317546|536791734|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
148813547|NCT05350202|536791735|FG000|Visit 1 - Baseline|Not-treated|18|||
148813548|NCT05350202|536791736|FG001|Visit 1 - Baseline|Not-treated|0|||
148813549|NCT05350202|536791735|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
148813550|NCT05350202|536791736|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
148813551|NCT05350202|536791735|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
148813552|NCT05350202|536791736|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
148813553|NCT05350202|536791735|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
148813554|NCT05350202|536791736|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
148813555|NCT05350202|536791735|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
148813556|NCT05350202|536791736|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
148813557|NCT05350202|536791735|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
148813558|NCT05350202|536791736|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
148813559|NCT05350202|536791735|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
148813560|NCT05350202|536791736|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
148813561|NCT05556057|536791737|FG000|Overall Study|Lost to Follow-up|5|||
148813562|NCT05556057|536791738|FG001|Overall Study|Lost to Follow-up|4|||
148813563|NCT05556057|536791737|FG000|Overall Study|Withdrawal by Subject|0|||
148813564|NCT05556057|536791738|FG001|Overall Study|Withdrawal by Subject|2|||
148813565|NCT05253807|536791741|FG000|Overall Study|Death|1|||
148813566|NCT05253807|536791742|FG001|Overall Study|Death|4|||
148813567|NCT05253807|536791741|FG000|Overall Study|Withdrawal by Subject|1|||
148813568|NCT05253807|536791742|FG001|Overall Study|Withdrawal by Subject|0|||
148813569|NCT05253807|536791741|FG000|Overall Study|Study Terminated by Sponsor|1|||
148813570|NCT05253807|536791742|FG001|Overall Study|Study Terminated by Sponsor|1|||
148813571|NCT00177671|536792747|FG000|Overall Study|Withdrawal by Subject|5|||
148813572|NCT00177671|536792748|FG001|Overall Study|Withdrawal by Subject|6|||
148813573|NCT00177671|536792747|FG000|Overall Study|medical complications|2|||
148813574|NCT00177671|536792748|FG001|Overall Study|medical complications|0|||
148813575|NCT00177671|536792747|FG000|Overall Study|Adverse Event|6|||
148813576|NCT00177671|536792748|FG001|Overall Study|Adverse Event|0|||
148813577|NCT00177671|536792747|FG000|Overall Study|Physician Decision|12|||
148813578|NCT00177671|536792748|FG001|Overall Study|Physician Decision|8|||
148813579|NCT01991314|536792751|FG000|Overall Study|Adverse Event|5|||
148813580|NCT01991314|536792752|FG001|Overall Study|Adverse Event|1|||
148813581|NCT01991314|536792751|FG000|Overall Study|Lost to Follow-up|6|||
148813582|NCT01991314|536792752|FG001|Overall Study|Lost to Follow-up|10|||
148813583|NCT01136954|536792753|FG000|Overall Study|Adverse Event|3|||
148813584|NCT01136954|536792754|FG001|Overall Study|Adverse Event|2|||
148813585|NCT01136954|536792753|FG000|Overall Study|Withdrawal by Subject|6|||
148813586|NCT01136954|536792754|FG001|Overall Study|Withdrawal by Subject|2|||
148813587|NCT01136954|536792753|FG000|Overall Study|Lack of Efficacy|14|||
148964757|NCT01466387|537356141|FG001|Overall Study|Adverse Event|0|||
148813588|NCT01136954|536792754|FG001|Overall Study|Lack of Efficacy|13|||
148813589|NCT01136954|536792753|FG000|Overall Study|Physician Decision|0|||
148813590|NCT01136954|536792754|FG001|Overall Study|Physician Decision|1|||
148813591|NCT01136954|536792753|FG000|Overall Study|Other|1|||
148964758|NCT01466387|537356142|FG002|Overall Study|Adverse Event|1|||
148964759|NCT01466387|537356143|FG003|Overall Study|Adverse Event|1|||
148813592|NCT01136954|536792754|FG001|Overall Study|Other|3|||
148813593|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
148813594|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
148813595|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
148813596|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
148813597|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
148813598|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
148813599|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
148813600|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
148813601|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
148813602|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
148813603|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Death|0|||
148813604|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Death|0|||
148813605|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Death|1|||
148813606|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Death|0|||
148813607|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Death|0|||
148813608|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
148813609|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
148813610|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
148813611|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
148813612|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
148813613|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Other|2|||
148813614|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Other|1|||
148813615|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Other|0|||
148813616|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Other|0|||
148813617|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Other|0|||
148813618|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
148813619|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
148813620|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
148813621|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
148813622|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
148813623|NCT03317496|536792755|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
148813624|NCT03317496|536792756|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
148813625|NCT03317496|536792757|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
148813626|NCT03317496|536792758|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
148813627|NCT03317496|536792759|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
148813628|NCT03317496|536792755|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
148813629|NCT03317496|536792756|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
148813630|NCT03317496|536792757|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
148813631|NCT03317496|536792758|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
148813632|NCT03317496|536792759|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
148813633|NCT03317496|536792755|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
148813634|NCT03317496|536792756|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
148813635|NCT03317496|536792757|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
148813636|NCT03317496|536792758|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
148813637|NCT03317496|536792759|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
148813638|NCT03317496|536792755|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
148813639|NCT03317496|536792756|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
148813640|NCT03317496|536792757|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
148813641|NCT03317496|536792758|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
148813642|NCT03317496|536792759|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
148813643|NCT03317496|536792755|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
148813644|NCT03317496|536792756|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
148813645|NCT03317496|536792757|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
148813646|NCT03317496|536792758|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
148813647|NCT03317496|536792759|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
148813648|NCT03317496|536792755|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
148813649|NCT03317496|536792756|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
148813650|NCT03317496|536792757|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
148813651|NCT03317496|536792758|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
148813652|NCT03317496|536792759|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
148813653|NCT03317496|536792755|FG000|Phase 2: Treatment|Adverse Event|0|||
148813654|NCT03317496|536792756|FG001|Phase 2: Treatment|Adverse Event|0|||
148813655|NCT03317496|536792757|FG002|Phase 2: Treatment|Adverse Event|0|||
148813656|NCT03317496|536792758|FG003|Phase 2: Treatment|Adverse Event|0|||
148813657|NCT03317496|536792759|FG004|Phase 2: Treatment|Adverse Event|6|||
148813658|NCT03317496|536792755|FG000|Phase 2: Treatment|Progressive disease|0|||
148813659|NCT03317496|536792756|FG001|Phase 2: Treatment|Progressive disease|0|||
148813660|NCT03317496|536792757|FG002|Phase 2: Treatment|Progressive disease|0|||
148813661|NCT03317496|536792758|FG003|Phase 2: Treatment|Progressive disease|0|||
148813662|NCT03317496|536792759|FG004|Phase 2: Treatment|Progressive disease|22|||
148813663|NCT03317496|536792755|FG000|Phase 2: Treatment|Other|0|||
148813664|NCT03317496|536792756|FG001|Phase 2: Treatment|Other|0|||
148813665|NCT03317496|536792757|FG002|Phase 2: Treatment|Other|0|||
148813666|NCT03317496|536792758|FG003|Phase 2: Treatment|Other|0|||
148813667|NCT03317496|536792759|FG004|Phase 2: Treatment|Other|4|||
148813668|NCT03317496|536792755|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
148813669|NCT03317496|536792756|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
148813670|NCT03317496|536792757|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
148813671|NCT03317496|536792758|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
148696670|NCT01519661|536364657|FG000|Overall Study|Lost to Follow-up|3|||
148696671|NCT01519661|536364657|FG000|Overall Study|Withdrawal by Subject|17|||
148696672|NCT01519661|536364657|FG000|Overall Study|Lack of Efficacy|6|||
148696673|NCT01519661|536364657|FG000|Overall Study|Adverse Event|29|||
148696674|NCT00420303|536364658|FG000|Overall Study|Serious Adverse Event|1|||
148696675|NCT00420303|536364659|FG001|Overall Study|Serious Adverse Event|0|||
148696676|NCT00420303|536364658|FG000|Overall Study|Lack of Efficacy|0|||
148696677|NCT00420303|536364659|FG001|Overall Study|Lack of Efficacy|3|||
148696678|NCT00420303|536364658|FG000|Overall Study|Physician Decision|0|||
148696679|NCT00420303|536364659|FG001|Overall Study|Physician Decision|1|||
148696680|NCT02311361|536364660|FG000|Overall Study|Did not receive treatment|0|||
148696681|NCT02311361|536364661|FG001|Overall Study|Did not receive treatment|1|||
148696682|NCT02311361|536364662|FG002|Overall Study|Did not receive treatment|0|||
148696683|NCT02311361|536364663|FG003|Overall Study|Did not receive treatment|1|||
148696684|NCT00745420|536364665|FG000|Overall Study|Ineligible|1|||
148696685|NCT01941095|536364666|FG000|Overall Study|Insufficient therapeutic response|13|||
148696686|NCT01941095|536364666|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
148696687|NCT01941095|536364666|FG000|Overall Study|Adverse Event|11|||
148696688|NCT01941095|536364666|FG000|Overall Study|Physician Decision|3|||
148696689|NCT01941095|536364666|FG000|Overall Study|Withdrawal by Subject|17|||
148696690|NCT01941095|536364666|FG000|Overall Study|Lost to Follow-up|10|||
148696691|NCT04455633|536364674|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
148696692|NCT04455633|536364675|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
148696693|NCT04455633|536364676|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
148696694|NCT04455633|536364674|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
148696695|NCT04455633|536364675|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
148696696|NCT04455633|536364676|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
148696697|NCT04455633|536364674|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
148696698|NCT04455633|536364675|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
148696699|NCT04455633|536364676|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
148696700|NCT04455633|536364674|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
148696701|NCT04455633|536364675|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
148696702|NCT04455633|536364676|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
148696703|NCT03527745|536364677|FG000|Overall Study|Lost to Follow-up|3|||
148696704|NCT03527745|536364678|FG001|Overall Study|Lost to Follow-up|6|||
148696705|NCT03527745|536364679|FG002|Overall Study|Lost to Follow-up|7|||
148696706|NCT03527745|536364680|FG003|Overall Study|Lost to Follow-up|9|||
148696707|NCT03527745|536364681|FG004|Overall Study|Lost to Follow-up|0|||
148696708|NCT03527745|536364682|FG005|Overall Study|Lost to Follow-up|2|||
148696709|NCT03527745|536364683|FG006|Overall Study|Lost to Follow-up|3|||
148696710|NCT03527745|536364684|FG007|Overall Study|Lost to Follow-up|2|||
148696711|NCT03527745|536364685|FG008|Overall Study|Lost to Follow-up|3|||
148696712|NCT03527745|536364686|FG009|Overall Study|Lost to Follow-up|2|||
148696713|NCT03527745|536364687|FG010|Overall Study|Lost to Follow-up|1|||
148696714|NCT03527745|536364688|FG011|Overall Study|Lost to Follow-up|1|||
148696715|NCT03527745|536364689|FG012|Overall Study|Lost to Follow-up|0|||
148696716|NCT03527745|536364690|FG013|Overall Study|Lost to Follow-up|0|||
148696717|NCT03527745|536364691|FG014|Overall Study|Lost to Follow-up|0|||
148696718|NCT03527745|536364692|FG015|Overall Study|Lost to Follow-up|0|||
148696719|NCT03527745|536364693|FG016|Overall Study|Lost to Follow-up|1|||
148696720|NCT03527745|536364694|FG017|Overall Study|Lost to Follow-up|0|||
148696721|NCT03527745|536364695|FG018|Overall Study|Lost to Follow-up|0|||
148696722|NCT03527745|536364696|FG019|Overall Study|Lost to Follow-up|1|||
148813672|NCT03317496|536792759|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
149024179|NCT02028884|537564210|FG002|Open-label Extension Period|Switched to another treatment option|0|||
149024180|NCT02403674|537564211|FG000|Base Study|Death|1|||
148696723|NCT03527745|536364697|FG020|Overall Study|Lost to Follow-up|1|||
148696724|NCT03527745|536364698|FG021|Overall Study|Lost to Follow-up|5|||
148696725|NCT03527745|536364699|FG022|Overall Study|Lost to Follow-up|6|||
148696726|NCT03527745|536364700|FG023|Overall Study|Lost to Follow-up|8|||
148696727|NCT03527745|536364701|FG024|Overall Study|Lost to Follow-up|1|||
148696728|NCT03527745|536364702|FG025|Overall Study|Lost to Follow-up|3|||
148696729|NCT00048568|536364711|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
148696730|NCT00048568|536364712|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
148696731|NCT00048568|536364713|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
148696732|NCT00048568|536364711|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
148696733|NCT00048568|536364712|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
148696734|NCT00048568|536364713|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
148696735|NCT00048568|536364711|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
148696736|NCT00048568|536364712|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
148696737|NCT00048568|536364713|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
148696738|NCT00048568|536364711|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
148696739|NCT00048568|536364712|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
148696740|NCT00048568|536364713|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
148696741|NCT00048568|536364711|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
148696742|NCT00048568|536364712|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
148696743|NCT00048568|536364713|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
148696744|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|Death|1|||
148696745|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|Death|1|||
148696746|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|Death|0|||
148696747|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
148696748|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
148696749|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
148696750|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
148696751|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
148696752|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
148696753|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
148696754|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
148696755|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
148696756|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
148696757|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
148696758|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
148696759|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
148696760|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
148696761|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
148696762|NCT00048568|536364711|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
148696763|NCT00048568|536364712|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
148696764|NCT00048568|536364713|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
148696765|NCT00048568|536364711|FG000|Open-Label Period|Death|0|||
148696766|NCT00048568|536364712|FG001|Open-Label Period|Death|0|||
148696767|NCT00048568|536364713|FG002|Open-Label Period|Death|13|||
148696768|NCT00048568|536364711|FG000|Open-Label Period|Adverse Event|0|||
148696769|NCT00048568|536364712|FG001|Open-Label Period|Adverse Event|0|||
148696770|NCT00048568|536364713|FG002|Open-Label Period|Adverse Event|49|||
148696771|NCT00048568|536364711|FG000|Open-Label Period|Lack of Efficacy|0|||
148696772|NCT00048568|536364712|FG001|Open-Label Period|Lack of Efficacy|0|||
148696773|NCT00048568|536364713|FG002|Open-Label Period|Lack of Efficacy|32|||
148696774|NCT00048568|536364711|FG000|Open-Label Period|Withdrawal by Subject|0|||
148696775|NCT00048568|536364712|FG001|Open-Label Period|Withdrawal by Subject|0|||
148696776|NCT00048568|536364713|FG002|Open-Label Period|Withdrawal by Subject|26|||
148813673|NCT03317496|536792755|FG000|Phase 2: Treatment|Physician Decision|0|||
149024181|NCT02403674|537564212|FG001|Base Study|Death|4|||
148964760|NCT01466387|537356144|FG004|Overall Study|Adverse Event|0|||
148964761|NCT01466387|537356145|FG005|Overall Study|Adverse Event|0|||
148696777|NCT00048568|536364711|FG000|Open-Label Period|Pregnancy|0|||
148696778|NCT00048568|536364712|FG001|Open-Label Period|Pregnancy|0|||
148696779|NCT00048568|536364713|FG002|Open-Label Period|Pregnancy|5|||
148696780|NCT00048568|536364711|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
148696781|NCT00048568|536364712|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
148696782|NCT00048568|536364713|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
148696783|NCT00048568|536364711|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
148696784|NCT00048568|536364712|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
148696785|NCT00048568|536364713|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
148696786|NCT00048568|536364711|FG000|Open-Label Period|Unknown Reasons|0|||
148696787|NCT00048568|536364712|FG001|Open-Label Period|Unknown Reasons|0|||
148696788|NCT00048568|536364713|FG002|Open-Label Period|Unknown Reasons|25|||
148696789|NCT00048568|536364711|FG000|Open-Label Period|Lost to Follow-up|0|||
148696790|NCT00048568|536364712|FG001|Open-Label Period|Lost to Follow-up|0|||
148696791|NCT00048568|536364713|FG002|Open-Label Period|Lost to Follow-up|7|||
148696792|NCT03831048|536364714|FG000|Overall Study|Protocol Violation|9|||
148696793|NCT03831048|536364715|FG001|Overall Study|Protocol Violation|3|||
148696794|NCT03831048|536364714|FG000|Overall Study|Death|4|||
148696795|NCT03831048|536364715|FG001|Overall Study|Death|9|||
148696796|NCT03831048|536364714|FG000|Overall Study|Re-transplant|0|||
148696797|NCT03831048|536364715|FG001|Overall Study|Re-transplant|2|||
148696798|NCT03831048|536364714|FG000|Overall Study|Protocol violation and death|1|||
148696799|NCT03831048|536364715|FG001|Overall Study|Protocol violation and death|1|||
148696800|NCT01315249|536364718|FG000|Overall Study|Adverse Event|22|||
148696801|NCT01315249|536364719|FG001|Overall Study|Adverse Event|26|||
148696802|NCT01315249|536364718|FG000|Overall Study|Withdrawal by Subject|11|||
148696803|NCT01315249|536364719|FG001|Overall Study|Withdrawal by Subject|10|||
148813674|NCT03317496|536792756|FG001|Phase 2: Treatment|Physician Decision|0|||
148964762|NCT01466387|537356140|FG000|Overall Study|Lost to Follow-up|0|||
148964763|NCT01466387|537356141|FG001|Overall Study|Lost to Follow-up|0|||
148964764|NCT01466387|537356142|FG002|Overall Study|Lost to Follow-up|0|||
148964765|NCT01466387|537356143|FG003|Overall Study|Lost to Follow-up|0|||
148964766|NCT01466387|537356144|FG004|Overall Study|Lost to Follow-up|0|||
148964767|NCT01466387|537356145|FG005|Overall Study|Lost to Follow-up|1|||
148964768|NCT01466387|537356140|FG000|Overall Study|Protocol Violation|1|||
148964769|NCT01466387|537356141|FG001|Overall Study|Protocol Violation|0|||
148964770|NCT01466387|537356142|FG002|Overall Study|Protocol Violation|0|||
148964771|NCT01466387|537356143|FG003|Overall Study|Protocol Violation|1|||
148964772|NCT01466387|537356144|FG004|Overall Study|Protocol Violation|0|||
148964773|NCT01466387|537356145|FG005|Overall Study|Protocol Violation|0|||
148964774|NCT01319877|537356148|FG000|Overall Study|Lost to Follow-up|100|||
149024182|NCT02403674|537564211|FG000|Base Study|Adverse Event|11|||
149024183|NCT02403674|537564212|FG001|Base Study|Adverse Event|26|||
148696804|NCT01315249|536364718|FG000|Overall Study|Protocol Violation|8|||
148696805|NCT01315249|536364719|FG001|Overall Study|Protocol Violation|5|||
148696806|NCT01315249|536364718|FG000|Overall Study|Abnormal test results|1|||
148696807|NCT01315249|536364719|FG001|Overall Study|Abnormal test results|2|||
148696808|NCT01315249|536364718|FG000|Overall Study|Administrative problems|1|||
148696809|NCT01315249|536364719|FG001|Overall Study|Administrative problems|0|||
148696810|NCT01315249|536364718|FG000|Overall Study|inability to use device|1|||
148696811|NCT01315249|536364719|FG001|Overall Study|inability to use device|0|||
148696812|NCT01315249|536364718|FG000|Overall Study|Lack of Efficacy|0|||
148696813|NCT01315249|536364719|FG001|Overall Study|Lack of Efficacy|1|||
148696814|NCT01315249|536364718|FG000|Overall Study|Lost to Follow-up|0|||
148696815|NCT01315249|536364719|FG001|Overall Study|Lost to Follow-up|2|||
148696816|NCT01315249|536364718|FG000|Overall Study|Death|0|||
148696817|NCT01315249|536364719|FG001|Overall Study|Death|1|||
148696818|NCT03227445|536364720|FG000|Period 1 (28 Days)|Adverse Event|1|||
148696819|NCT03227445|536364721|FG001|Period 1 (28 Days)|Adverse Event|2|||
148696820|NCT03227445|536364722|FG002|Period 1 (28 Days)|Adverse Event|0|||
148696821|NCT03227445|536364723|FG003|Period 1 (28 Days)|Adverse Event|1|||
148696822|NCT03227445|536364720|FG000|Period 1 (28 Days)|Protocol Violation|1|||
148696823|NCT03227445|536364721|FG001|Period 1 (28 Days)|Protocol Violation|0|||
148696824|NCT03227445|536364722|FG002|Period 1 (28 Days)|Protocol Violation|0|||
148813675|NCT03317496|536792757|FG002|Phase 2: Treatment|Physician Decision|0|||
148964775|NCT01319877|537356149|FG001|Overall Study|Lost to Follow-up|37|||
148964776|NCT01319877|537356148|FG000|Overall Study|Physician Decision|2|||
148964777|NCT01319877|537356149|FG001|Overall Study|Physician Decision|0|||
148696825|NCT03227445|536364723|FG003|Period 1 (28 Days)|Protocol Violation|0|||
148696826|NCT03227445|536364720|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
148696827|NCT03227445|536364721|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
148696828|NCT03227445|536364722|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
148696829|NCT03227445|536364723|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
148696830|NCT03227445|536364720|FG000|Period 2 (28 Days)|Adverse Event|1|||
148813676|NCT03317496|536792758|FG003|Phase 2: Treatment|Physician Decision|0|||
148813677|NCT03317496|536792759|FG004|Phase 2: Treatment|Physician Decision|1|||
148813678|NCT03317496|536792755|FG000|Phase 2: Treatment|Death|0|||
148813679|NCT03317496|536792756|FG001|Phase 2: Treatment|Death|0|||
148813680|NCT03317496|536792757|FG002|Phase 2: Treatment|Death|0|||
148813681|NCT03317496|536792758|FG003|Phase 2: Treatment|Death|0|||
148813682|NCT03317496|536792759|FG004|Phase 2: Treatment|Death|1|||
148813683|NCT03317496|536792755|FG000|Phase 2: Follow-up|Death|0|||
148813684|NCT03317496|536792756|FG001|Phase 2: Follow-up|Death|0|||
148813685|NCT03317496|536792757|FG002|Phase 2: Follow-up|Death|0|||
148813686|NCT03317496|536792758|FG003|Phase 2: Follow-up|Death|0|||
148813687|NCT03317496|536792759|FG004|Phase 2: Follow-up|Death|24|||
148813688|NCT03317496|536792755|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
148964778|NCT01319877|537356148|FG000|Overall Study|Disease Progression|2|||
148964779|NCT01319877|537356149|FG001|Overall Study|Disease Progression|2|||
148813689|NCT03317496|536792756|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
148964780|NCT01319877|537356148|FG000|Overall Study|Withdrawal by Subject|0|||
148964781|NCT01319877|537356149|FG001|Overall Study|Withdrawal by Subject|1|||
148813690|NCT03317496|536792757|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
148813691|NCT03317496|536792758|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
148813692|NCT03317496|536792759|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
148813693|NCT03317496|536792755|FG000|Phase 2: Follow-up|Other|0|||
148813694|NCT03317496|536792756|FG001|Phase 2: Follow-up|Other|0|||
148813695|NCT03317496|536792757|FG002|Phase 2: Follow-up|Other|0|||
148696831|NCT03227445|536364721|FG001|Period 2 (28 Days)|Adverse Event|0|||
148696832|NCT03227445|536364722|FG002|Period 2 (28 Days)|Adverse Event|2|||
148696833|NCT03227445|536364723|FG003|Period 2 (28 Days)|Adverse Event|1|||
148696834|NCT03227445|536364720|FG000|Period 2 (28 Days)|Protocol Violation|0|||
148696835|NCT03227445|536364721|FG001|Period 2 (28 Days)|Protocol Violation|0|||
148696836|NCT03227445|536364722|FG002|Period 2 (28 Days)|Protocol Violation|0|||
148696837|NCT03227445|536364723|FG003|Period 2 (28 Days)|Protocol Violation|1|||
148696838|NCT03227445|536364720|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
148696839|NCT03227445|536364721|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
148696840|NCT03227445|536364722|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
148696841|NCT03227445|536364723|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
148696842|NCT03164772|536364724|FG000|Overall Study|Death|4|||
148696843|NCT03164772|536364725|FG001|Overall Study|Death|2|||
148696844|NCT03164772|536364724|FG000|Overall Study|Adverse Event|1|||
148696845|NCT03164772|536364725|FG001|Overall Study|Adverse Event|4|||
148696846|NCT03164772|536364724|FG000|Overall Study|Progressive Disease|11|||
148696847|NCT03164772|536364725|FG001|Overall Study|Progressive Disease|21|||
148696848|NCT03164772|536364724|FG000|Overall Study|Physician Decision|2|||
148696849|NCT03164772|536364725|FG001|Overall Study|Physician Decision|0|||
148696850|NCT03164772|536364724|FG000|Overall Study|Withdrawal by Subject|0|||
148696851|NCT03164772|536364725|FG001|Overall Study|Withdrawal by Subject|4|||
148696852|NCT01029353|536364727|FG000|Overall Study|Lost to Follow-up|4|||
148696853|NCT01029353|536364728|FG001|Overall Study|Lost to Follow-up|5|||
148696854|NCT01029353|536364729|FG002|Overall Study|Lost to Follow-up|5|||
148696855|NCT01029353|536364730|FG003|Overall Study|Lost to Follow-up|4|||
148696856|NCT01029353|536364727|FG000|Overall Study|Consent Withdrawn|2|||
148696857|NCT01029353|536364728|FG001|Overall Study|Consent Withdrawn|0|||
148696858|NCT01029353|536364729|FG002|Overall Study|Consent Withdrawn|0|||
148696859|NCT01029353|536364730|FG003|Overall Study|Consent Withdrawn|0|||
148696860|NCT01029353|536364727|FG000|Overall Study|Primary Outcome Indeterminate|1|||
148696861|NCT01029353|536364728|FG001|Overall Study|Primary Outcome Indeterminate|3|||
148696862|NCT01029353|536364729|FG002|Overall Study|Primary Outcome Indeterminate|2|||
148696863|NCT01029353|536364730|FG003|Overall Study|Primary Outcome Indeterminate|0|||
148696864|NCT00849901|536364733|FG000|Acute Treatment Phase|Adverse Event|9|||
148696865|NCT00849901|536364734|FG001|Acute Treatment Phase|Adverse Event|1|||
148813696|NCT03317496|536792758|FG003|Phase 2: Follow-up|Other|0|||
148813697|NCT03317496|536792759|FG004|Phase 2: Follow-up|Other|1|||
148696866|NCT00849901|536364735|FG002|Acute Treatment Phase|Adverse Event|3|||
148696867|NCT00849901|536364733|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
148696868|NCT00849901|536364734|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
148696869|NCT00849901|536364735|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
148696870|NCT00849901|536364733|FG000|Acute Treatment Phase|Protocol Violation|0|||
148696871|NCT00849901|536364734|FG001|Acute Treatment Phase|Protocol Violation|2|||
148696872|NCT00849901|536364735|FG002|Acute Treatment Phase|Protocol Violation|1|||
148696873|NCT00849901|536364733|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
148696874|NCT00849901|536364734|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
148696875|NCT00849901|536364735|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
149024184|NCT02403674|537564211|FG000|Base Study|Lack of Efficacy|31|||
148696876|NCT00849901|536364733|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
148696877|NCT00849901|536364734|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
148696878|NCT00849901|536364735|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
148696879|NCT00849901|536364733|FG000|Acute Treatment Phase|Physician Decision|1|||
148696880|NCT00849901|536364734|FG001|Acute Treatment Phase|Physician Decision|1|||
148696881|NCT00849901|536364735|FG002|Acute Treatment Phase|Physician Decision|1|||
148696882|NCT00849901|536364733|FG000|Acute Treatment Phase|Sponsor Decision|1|||
148696883|NCT00849901|536364734|FG001|Acute Treatment Phase|Sponsor Decision|0|||
148696884|NCT00849901|536364735|FG002|Acute Treatment Phase|Sponsor Decision|0|||
148696885|NCT00849901|536364733|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
148696886|NCT00849901|536364734|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
148696887|NCT00849901|536364735|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
148696888|NCT00849901|536364733|FG000|Extension Phase|Adverse Event|2|||
148696889|NCT00849901|536364734|FG001|Extension Phase|Adverse Event|8|||
148696890|NCT00849901|536364735|FG002|Extension Phase|Adverse Event|4|||
148696891|NCT00849901|536364733|FG000|Extension Phase|Lost to Follow-up|3|||
148696892|NCT00849901|536364734|FG001|Extension Phase|Lost to Follow-up|0|||
148696893|NCT00849901|536364735|FG002|Extension Phase|Lost to Follow-up|1|||
148696894|NCT00849901|536364733|FG000|Extension Phase|Protocol Violation|2|||
148696895|NCT00849901|536364734|FG001|Extension Phase|Protocol Violation|2|||
148696896|NCT00849901|536364735|FG002|Extension Phase|Protocol Violation|4|||
148696897|NCT00849901|536364733|FG000|Extension Phase|Withdrawal by Subject|7|||
148696898|NCT00849901|536364734|FG001|Extension Phase|Withdrawal by Subject|6|||
148696899|NCT00849901|536364735|FG002|Extension Phase|Withdrawal by Subject|3|||
148696900|NCT00849901|536364733|FG000|Extension Phase|Parent or Caregiver Decision|10|||
148696901|NCT00849901|536364734|FG001|Extension Phase|Parent or Caregiver Decision|4|||
148696902|NCT00849901|536364735|FG002|Extension Phase|Parent or Caregiver Decision|4|||
148696903|NCT00849901|536364733|FG000|Extension Phase|Physician Decision|1|||
148696904|NCT00849901|536364734|FG001|Extension Phase|Physician Decision|2|||
148696905|NCT00849901|536364735|FG002|Extension Phase|Physician Decision|0|||
148696906|NCT00849901|536364733|FG000|Extension Phase|Lack of Efficacy|2|||
148696907|NCT00849901|536364734|FG001|Extension Phase|Lack of Efficacy|4|||
148696908|NCT00849901|536364735|FG002|Extension Phase|Lack of Efficacy|1|||
148696909|NCT02152566|536364738|FG000|Overall Study|Lost to Follow-up|1|||
148696910|NCT02152566|536364738|FG000|Overall Study|Withdrawal by Subject|2|||
148696911|NCT00162123|536364740|FG000|Overall Study|Disease progression|27|||
148696912|NCT00162123|536364741|FG001|Overall Study|Disease progression|19|||
148696913|NCT00162123|536364742|FG002|Overall Study|Disease progression|10|||
148696914|NCT00162123|536364743|FG003|Overall Study|Disease progression|4|||
148696915|NCT00162123|536364744|FG004|Overall Study|Disease progression|8|||
148696916|NCT00162123|536364745|FG005|Overall Study|Disease progression|3|||
148696917|NCT00162123|536364746|FG006|Overall Study|Disease progression|1|||
148696918|NCT00162123|536364747|FG007|Overall Study|Disease progression|0|||
148696919|NCT00162123|536364740|FG000|Overall Study|Study drug toxicity|6|||
148696920|NCT00162123|536364741|FG001|Overall Study|Study drug toxicity|1|||
148696921|NCT00162123|536364742|FG002|Overall Study|Study drug toxicity|5|||
148696922|NCT00162123|536364743|FG003|Overall Study|Study drug toxicity|0|||
148696923|NCT00162123|536364744|FG004|Overall Study|Study drug toxicity|4|||
148696924|NCT00162123|536364745|FG005|Overall Study|Study drug toxicity|1|||
148696925|NCT00162123|536364746|FG006|Overall Study|Study drug toxicity|1|||
148696926|NCT00162123|536364747|FG007|Overall Study|Study drug toxicity|0|||
148696927|NCT00162123|536364740|FG000|Overall Study|Death|3|||
148696928|NCT00162123|536364741|FG001|Overall Study|Death|3|||
148696929|NCT00162123|536364742|FG002|Overall Study|Death|1|||
148696930|NCT00162123|536364743|FG003|Overall Study|Death|1|||
148696931|NCT00162123|536364744|FG004|Overall Study|Death|1|||
148696932|NCT00162123|536364745|FG005|Overall Study|Death|1|||
148696933|NCT00162123|536364746|FG006|Overall Study|Death|0|||
148696934|NCT00162123|536364747|FG007|Overall Study|Death|0|||
148696935|NCT00162123|536364740|FG000|Overall Study|Withdrawal by Subject|2|||
148696936|NCT00162123|536364741|FG001|Overall Study|Withdrawal by Subject|0|||
148696937|NCT00162123|536364742|FG002|Overall Study|Withdrawal by Subject|2|||
148696938|NCT00162123|536364743|FG003|Overall Study|Withdrawal by Subject|1|||
148696939|NCT00162123|536364744|FG004|Overall Study|Withdrawal by Subject|1|||
148696940|NCT00162123|536364745|FG005|Overall Study|Withdrawal by Subject|2|||
148696941|NCT00162123|536364746|FG006|Overall Study|Withdrawal by Subject|1|||
148696942|NCT00162123|536364747|FG007|Overall Study|Withdrawal by Subject|0|||
148696943|NCT00162123|536364740|FG000|Overall Study|Deterioration without progression|2|||
148696944|NCT00162123|536364741|FG001|Overall Study|Deterioration without progression|2|||
148696945|NCT00162123|536364742|FG002|Overall Study|Deterioration without progression|3|||
148696946|NCT00162123|536364743|FG003|Overall Study|Deterioration without progression|0|||
148696947|NCT00162123|536364744|FG004|Overall Study|Deterioration without progression|1|||
148696948|NCT00162123|536364745|FG005|Overall Study|Deterioration without progression|0|||
148696949|NCT00162123|536364746|FG006|Overall Study|Deterioration without progression|0|||
148696950|NCT00162123|536364747|FG007|Overall Study|Deterioration without progression|0|||
148696951|NCT00162123|536364740|FG000|Overall Study|Adverse Event|1|||
148696952|NCT00162123|536364741|FG001|Overall Study|Adverse Event|2|||
148964782|NCT01319877|537356148|FG000|Overall Study|Reason Not Specified|4|||
148964783|NCT01319877|537356149|FG001|Overall Study|Reason Not Specified|5|||
148964784|NCT00832585|537356150|FG000|Overall Study|Withdrawal by Subject|1|||
148696953|NCT00162123|536364742|FG002|Overall Study|Adverse Event|0|||
148696954|NCT00162123|536364743|FG003|Overall Study|Adverse Event|2|||
148813698|NCT03317496|536792755|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
148813699|NCT03317496|536792756|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
148813700|NCT03317496|536792757|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
148813701|NCT03317496|536792758|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
148813702|NCT03317496|536792759|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
148813703|NCT02034591|536792768|FG000|Overall Study|Withdrawal by Subject|0|||
148813704|NCT02034591|536792769|FG001|Overall Study|Withdrawal by Subject|0|||
148813705|NCT02034591|536792770|FG002|Overall Study|Withdrawal by Subject|0|||
148813706|NCT02034591|536792771|FG003|Overall Study|Withdrawal by Subject|0|||
148813707|NCT02034591|536792772|FG004|Overall Study|Withdrawal by Subject|1|||
148813708|NCT02034591|536792773|FG005|Overall Study|Withdrawal by Subject|0|||
148813709|NCT00817063|536792774|FG000|Overall Study|Adverse Event|32|||
148813710|NCT00817063|536792775|FG001|Overall Study|Adverse Event|13|||
148813711|NCT00817063|536792774|FG000|Overall Study|Death|1|||
148813712|NCT00817063|536792775|FG001|Overall Study|Death|1|||
148696955|NCT00162123|536364744|FG004|Overall Study|Adverse Event|1|||
148696956|NCT00162123|536364745|FG005|Overall Study|Adverse Event|0|||
148696957|NCT00162123|536364746|FG006|Overall Study|Adverse Event|0|||
148696958|NCT00162123|536364747|FG007|Overall Study|Adverse Event|0|||
148696959|NCT00162123|536364740|FG000|Overall Study|Not specified (before treatment)|2|||
148696960|NCT00162123|536364741|FG001|Overall Study|Not specified (before treatment)|0|||
148964785|NCT00832585|537356150|FG000|Overall Study|Lost to Follow-up|1|||
148696961|NCT00162123|536364742|FG002|Overall Study|Not specified (before treatment)|0|||
148696962|NCT00162123|536364743|FG003|Overall Study|Not specified (before treatment)|0|||
148696963|NCT00162123|536364744|FG004|Overall Study|Not specified (before treatment)|12|||
148696964|NCT00162123|536364745|FG005|Overall Study|Not specified (before treatment)|1|||
148696965|NCT00162123|536364746|FG006|Overall Study|Not specified (before treatment)|0|||
148696966|NCT00162123|536364747|FG007|Overall Study|Not specified (before treatment)|0|||
148696967|NCT00162123|536364740|FG000|Overall Study|Not specified (after start of treatment)|0|||
148696968|NCT00162123|536364741|FG001|Overall Study|Not specified (after start of treatment)|0|||
148696969|NCT00162123|536364742|FG002|Overall Study|Not specified (after start of treatment)|0|||
148696970|NCT00162123|536364743|FG003|Overall Study|Not specified (after start of treatment)|0|||
148696971|NCT00162123|536364744|FG004|Overall Study|Not specified (after start of treatment)|3|||
148696972|NCT00162123|536364745|FG005|Overall Study|Not specified (after start of treatment)|0|||
148696973|NCT00162123|536364746|FG006|Overall Study|Not specified (after start of treatment)|0|||
148696974|NCT00162123|536364747|FG007|Overall Study|Not specified (after start of treatment)|0|||
148696975|NCT00162123|536364740|FG000|Overall Study|Physician Decision|1|||
148696976|NCT00162123|536364741|FG001|Overall Study|Physician Decision|2|||
148696977|NCT00162123|536364742|FG002|Overall Study|Physician Decision|0|||
148696978|NCT00162123|536364743|FG003|Overall Study|Physician Decision|0|||
148696979|NCT00162123|536364744|FG004|Overall Study|Physician Decision|0|||
148813713|NCT00817063|536792774|FG000|Overall Study|Lack of Efficacy|33|||
148813714|NCT00817063|536792775|FG001|Overall Study|Lack of Efficacy|86|||
148813715|NCT00817063|536792774|FG000|Overall Study|Failure to Return|13|||
148813716|NCT00817063|536792775|FG001|Overall Study|Failure to Return|12|||
148813717|NCT00817063|536792774|FG000|Overall Study|Violation of Selection at Entry|7|||
148813718|NCT00817063|536792775|FG001|Overall Study|Violation of Selection at Entry|4|||
148964786|NCT02347189|537356152|FG000|Overall Study|No implant attempted of study device|9|||
148964787|NCT02347189|537356152|FG000|Overall Study|No primary outcome data available|2|||
148964788|NCT02677987|537356154|FG000|Overall Study|Withdrawal by Subject|3|||
148813719|NCT00817063|536792774|FG000|Overall Study|Protocol Violation|3|||
148696980|NCT00162123|536364745|FG005|Overall Study|Physician Decision|1|||
148813720|NCT00817063|536792775|FG001|Overall Study|Protocol Violation|8|||
148813721|NCT00817063|536792774|FG000|Overall Study|Withdrawal by Subject|17|||
148813722|NCT00817063|536792775|FG001|Overall Study|Withdrawal by Subject|37|||
148964789|NCT02677987|537356155|FG001|Overall Study|Withdrawal by Subject|0|||
148696981|NCT00162123|536364746|FG006|Overall Study|Physician Decision|1|||
148696982|NCT00162123|536364747|FG007|Overall Study|Physician Decision|0|||
148696983|NCT00162123|536364740|FG000|Overall Study|Tumor assessment only (not treated)|0|||
148696984|NCT00162123|536364741|FG001|Overall Study|Tumor assessment only (not treated)|0|||
148696985|NCT00162123|536364742|FG002|Overall Study|Tumor assessment only (not treated)|0|||
148696986|NCT00162123|536364743|FG003|Overall Study|Tumor assessment only (not treated)|0|||
148696987|NCT00162123|536364744|FG004|Overall Study|Tumor assessment only (not treated)|0|||
148696988|NCT00162123|536364745|FG005|Overall Study|Tumor assessment only (not treated)|0|||
148696989|NCT00162123|536364746|FG006|Overall Study|Tumor assessment only (not treated)|0|||
148696990|NCT00162123|536364747|FG007|Overall Study|Tumor assessment only (not treated)|1|||
148696991|NCT00162123|536364740|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
148696992|NCT00162123|536364741|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
148696993|NCT00162123|536364742|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
148696994|NCT00162123|536364743|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
148696995|NCT00162123|536364744|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
148696996|NCT00162123|536364745|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
148696997|NCT00162123|536364746|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
148696998|NCT00162123|536364747|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
148696999|NCT02016170|536364748|FG000|Overall Study|Adverse Event|1|||
148697000|NCT02016170|536364749|FG001|Overall Study|Adverse Event|1|||
148697001|NCT02016170|536364750|FG002|Overall Study|Adverse Event|0|||
148697002|NCT02016170|536364748|FG000|Overall Study|Protocol Violation|1|||
148697003|NCT02016170|536364749|FG001|Overall Study|Protocol Violation|0|||
148697004|NCT02016170|536364750|FG002|Overall Study|Protocol Violation|0|||
148697005|NCT02327130|536364751|FG000|Overall Study|Discharged in less than 5 days|5|||
148697006|NCT02327130|536364751|FG000|Overall Study|Physician Decision|2|||
148697007|NCT02327130|536364751|FG000|Overall Study|Unable to provide breath sample|1|||
148697008|NCT02327130|536364751|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
148697009|NCT02327130|536364751|FG000|Overall Study|Met exclusion criteria|3|||
148697010|NCT05214560|536364753|FG000|Overall Study|Screening Failure|1|||
148697011|NCT05214560|536364753|FG000|Overall Study|Physician Decision|4|||
148697012|NCT05214560|536364753|FG000|Overall Study|Withdrawal by Subject|1|||
148697013|NCT05214560|536364753|FG000|Overall Study|Lost to Follow-up|2|||
148697014|NCT05214560|536364753|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
148697015|NCT05214560|536364753|FG000|Overall Study|Study physician not available for the anesthesia|3|||
148697016|NCT05214560|536364753|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
148697017|NCT05214560|536364753|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
148697018|NCT05214560|536364753|FG000|Overall Study|Surgery not performed|3|||
148697019|NCT02672553|536364754|FG000|Overall Study|Death|3|||
148697020|NCT02672553|536364755|FG001|Overall Study|Death|5|||
148697021|NCT02672553|536364754|FG000|Overall Study|Valve Explant|1|||
148697022|NCT02672553|536364755|FG001|Overall Study|Valve Explant|0|||
148697023|NCT02672553|536364754|FG000|Overall Study|Conversion to Commercial Valve|3|||
148697024|NCT02672553|536364755|FG001|Overall Study|Conversion to Commercial Valve|0|||
148697025|NCT02672553|536364754|FG000|Overall Study|Withdrawal by Subject|3|||
148697026|NCT02672553|536364755|FG001|Overall Study|Withdrawal by Subject|3|||
148697027|NCT02672553|536364754|FG000|Overall Study|Intraoperative screen failure|2|||
148697028|NCT02672553|536364755|FG001|Overall Study|Intraoperative screen failure|0|||
148697029|NCT02003183|536364756|FG000|Overall Study|Lost to Follow-up|0|||
148697030|NCT02003183|536364757|FG001|Overall Study|Lost to Follow-up|2|||
148697031|NCT02343120|536364760|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
148697032|NCT02343120|536364761|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
148697033|NCT02343120|536364762|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
148697034|NCT02343120|536364763|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
148697035|NCT02343120|536364764|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
148697036|NCT02343120|536364760|FG000|Part 1: Dose Escalation|Death|1|||
148813723|NCT00817063|536792774|FG000|Overall Study|Early Improvement|19|||
148813724|NCT00817063|536792775|FG001|Overall Study|Early Improvement|4|||
148964790|NCT02677987|537356154|FG000|Overall Study|Lost to Follow-up|1|||
148964791|NCT02677987|537356155|FG001|Overall Study|Lost to Follow-up|0|||
148697037|NCT02343120|536364761|FG001|Part 1: Dose Escalation|Death|2|||
148697038|NCT02343120|536364762|FG002|Part 1: Dose Escalation|Death|2|||
148697039|NCT02343120|536364763|FG003|Part 1: Dose Escalation|Death|2|||
148697040|NCT02343120|536364764|FG004|Part 1: Dose Escalation|Death|1|||
148697041|NCT02343120|536364760|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
148697042|NCT02343120|536364761|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
148697043|NCT02343120|536364762|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
148697044|NCT02343120|536364763|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
148697045|NCT02343120|536364764|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
148697046|NCT02343120|536364760|FG000|Part 2: Expansion|Sponsor decision|0|||
148697047|NCT02343120|536364761|FG001|Part 2: Expansion|Sponsor decision|0|||
148697048|NCT02343120|536364762|FG002|Part 2: Expansion|Sponsor decision|0|||
148697049|NCT02343120|536364763|FG003|Part 2: Expansion|Sponsor decision|165|||
148697050|NCT02343120|536364764|FG004|Part 2: Expansion|Sponsor decision|67|||
148697051|NCT02343120|536364760|FG000|Part 2: Expansion|Death|0|||
148697052|NCT02343120|536364761|FG001|Part 2: Expansion|Death|0|||
148697053|NCT02343120|536364762|FG002|Part 2: Expansion|Death|0|||
148697054|NCT02343120|536364763|FG003|Part 2: Expansion|Death|74|||
148813725|NCT00817063|536792774|FG000|Overall Study|Administrative|10|||
148813726|NCT00817063|536792775|FG001|Overall Study|Administrative|4|||
148697055|NCT02343120|536364764|FG004|Part 2: Expansion|Death|17|||
148697056|NCT02343120|536364760|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
148697057|NCT02343120|536364761|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
148964792|NCT00735878|537356156|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
148964793|NCT00735878|537356157|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
148813727|NCT00817063|536792774|FG000|Overall Study|Abnormality of Laboratory Test|2|||
148813728|NCT00817063|536792775|FG001|Overall Study|Abnormality of Laboratory Test|1|||
148813729|NCT01496456|536792776|FG000|Overall Study|Protocol Violation|1|||
148813730|NCT01496456|536792776|FG000|Overall Study|Lost to Follow-up|7|||
148813731|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
148813732|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
148813733|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
148813734|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
148813735|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
148813736|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
148813737|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
148813738|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
148813739|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
148813740|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
148813741|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
148813742|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
148813743|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
148813744|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
148813745|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
148813746|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
148813747|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
148813748|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
148813749|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
148813750|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
148697058|NCT02343120|536364762|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
148697059|NCT02343120|536364763|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
148697060|NCT02343120|536364764|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
148697061|NCT02343120|536364760|FG000|Part 2: Expansion|Lost to Follow-up|0|||
148697062|NCT02343120|536364761|FG001|Part 2: Expansion|Lost to Follow-up|0|||
148697063|NCT02343120|536364762|FG002|Part 2: Expansion|Lost to Follow-up|0|||
148813751|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
148964794|NCT00735878|537356158|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
148697064|NCT02343120|536364763|FG003|Part 2: Expansion|Lost to Follow-up|5|||
148697065|NCT02343120|536364764|FG004|Part 2: Expansion|Lost to Follow-up|2|||
148697066|NCT02343120|536364760|FG000|Part 2: Expansion|Other|0|||
148697067|NCT02343120|536364761|FG001|Part 2: Expansion|Other|0|||
148697068|NCT02343120|536364762|FG002|Part 2: Expansion|Other|0|||
148697069|NCT02343120|536364763|FG003|Part 2: Expansion|Other|1|||
148697070|NCT02343120|536364764|FG004|Part 2: Expansion|Other|5|||
148697071|NCT02343120|536364760|FG000|Part 2: Expansion|Adverse Event|0|||
148697072|NCT02343120|536364761|FG001|Part 2: Expansion|Adverse Event|0|||
148697073|NCT02343120|536364762|FG002|Part 2: Expansion|Adverse Event|0|||
148697074|NCT02343120|536364763|FG003|Part 2: Expansion|Adverse Event|1|||
148697075|NCT02343120|536364764|FG004|Part 2: Expansion|Adverse Event|1|||
148697076|NCT02534493|536364765|FG000|Overall Study|Lost to Follow-up|1|||
148697077|NCT02534493|536364765|FG000|Overall Study|Withdrawal by Subject|1|||
148697078|NCT01054599|536364773|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
148697079|NCT01054599|536364774|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
148697080|NCT01054599|536364773|FG000|Overall Study|Protocol Violation|1|||
148697081|NCT01054599|536364774|FG001|Overall Study|Protocol Violation|0|||
148697082|NCT01054599|536364773|FG000|Overall Study|Spells/seizure-like episodes|1|||
148697083|NCT01054599|536364774|FG001|Overall Study|Spells/seizure-like episodes|1|||
148697084|NCT01054599|536364773|FG000|Overall Study|Timing/scheduling difficulties|1|||
148697085|NCT01054599|536364774|FG001|Overall Study|Timing/scheduling difficulties|1|||
148697086|NCT01054599|536364773|FG000|Overall Study|Visual impairment, WTAR <80|0|||
148697087|NCT01054599|536364774|FG001|Overall Study|Visual impairment, WTAR <80|1|||
148697088|NCT01054599|536364773|FG000|Overall Study|Lost to Follow-up|0|||
148697089|NCT01054599|536364774|FG001|Overall Study|Lost to Follow-up|2|||
148697090|NCT01054599|536364773|FG000|Overall Study|Adverse Event|0|||
148697091|NCT01054599|536364774|FG001|Overall Study|Adverse Event|1|||
148697092|NCT01054599|536364773|FG000|Overall Study|Withdrawal by Subject|0|||
148697093|NCT01054599|536364774|FG001|Overall Study|Withdrawal by Subject|1|||
148697094|NCT01104662|536364775|FG000|Overall Study|Adverse Event|2|||
148697095|NCT01104662|536364776|FG001|Overall Study|Adverse Event|2|||
148697096|NCT01104662|536364777|FG002|Overall Study|Adverse Event|0|||
148697097|NCT01104662|536364778|FG003|Overall Study|Adverse Event|1|||
148697098|NCT01104662|536364779|FG004|Overall Study|Adverse Event|1|||
148697099|NCT01104662|536364780|FG005|Overall Study|Adverse Event|1|||
148697100|NCT01104662|536364781|FG006|Overall Study|Adverse Event|0|||
148697101|NCT01104662|536364782|FG007|Overall Study|Adverse Event|0|||
148697102|NCT01104662|536364775|FG000|Overall Study|Clinical Failure|1|||
148697103|NCT01104662|536364776|FG001|Overall Study|Clinical Failure|0|||
148697104|NCT01104662|536364777|FG002|Overall Study|Clinical Failure|0|||
148964795|NCT04404855|537356159|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
148964796|NCT04404855|537356160|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
148964797|NCT03200899|537356161|FG000|Overall Study|Lost to Follow-up|10|||
148964798|NCT03200899|537356162|FG001|Overall Study|Lost to Follow-up|23|||
148697105|NCT01104662|536364778|FG003|Overall Study|Clinical Failure|0|||
148697106|NCT01104662|536364779|FG004|Overall Study|Clinical Failure|0|||
148697107|NCT01104662|536364780|FG005|Overall Study|Clinical Failure|1|||
148697108|NCT01104662|536364781|FG006|Overall Study|Clinical Failure|0|||
148697109|NCT01104662|536364782|FG007|Overall Study|Clinical Failure|0|||
148697110|NCT01104662|536364775|FG000|Overall Study|Participant left investigator's care|1|||
148813752|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
148813753|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
148813754|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
148813755|NCT00620542|536792779|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
148813756|NCT00620542|536792780|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
148813757|NCT00620542|536792781|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
148813758|NCT00620542|536792782|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
148813759|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
148813760|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
148813761|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
148813762|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
148813763|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
148813764|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
148813765|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
148813766|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
148813767|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
148813768|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
148813769|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
148813770|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
148813771|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
148813772|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
148813773|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
148813774|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
148813775|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
148813776|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
148813777|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
148813778|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
148813779|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
148813780|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
148813781|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
148813782|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
148813783|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
148813784|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
148813785|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
148813786|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
148813787|NCT00620542|536792779|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
148813788|NCT00620542|536792780|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
148813789|NCT00620542|536792781|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
148813790|NCT00620542|536792782|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
148813791|NCT02696616|536792783|FG000|Overall Study|Adverse Event|0|||
148813792|NCT02696616|536792784|FG001|Overall Study|Adverse Event|1|||
148813793|NCT02696616|536792785|FG002|Overall Study|Adverse Event|0|||
148813794|NCT02696616|536792786|FG003|Overall Study|Adverse Event|0|||
148813795|NCT02696616|536792787|FG004|Overall Study|Adverse Event|0|||
148813796|NCT02696616|536792788|FG005|Overall Study|Adverse Event|0|||
148813797|NCT02696616|536792789|FG006|Overall Study|Adverse Event|0|||
148813798|NCT01732783|536792792|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
148813799|NCT01732783|536792793|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
148813800|NCT01732783|536792794|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
148813801|NCT01732783|536792792|FG000|Overall Study|Death|13|||
148813802|NCT01732783|536792793|FG001|Overall Study|Death|4|||
148813803|NCT01732783|536792794|FG002|Overall Study|Death|1|||
148813804|NCT01732783|536792792|FG000|Overall Study|Lost to Follow-up|7|||
148813805|NCT01732783|536792793|FG001|Overall Study|Lost to Follow-up|1|||
148813806|NCT01732783|536792794|FG002|Overall Study|Lost to Follow-up|1|||
148813807|NCT01732783|536792792|FG000|Overall Study|Administrative Decision|8|||
148813808|NCT01732783|536792793|FG001|Overall Study|Administrative Decision|2|||
148813809|NCT01732783|536792794|FG002|Overall Study|Administrative Decision|1|||
148813810|NCT01732783|536792792|FG000|Overall Study|Withdrawal by Subject|1|||
148813811|NCT01732783|536792793|FG001|Overall Study|Withdrawal by Subject|0|||
148813812|NCT01732783|536792794|FG002|Overall Study|Withdrawal by Subject|0|||
148813813|NCT01500083|536792795|FG000|Overall Study|Adverse Event|4|||
148813814|NCT01500083|536792796|FG001|Overall Study|Adverse Event|17|||
148813815|NCT01500083|536792795|FG000|Overall Study|Death|0|||
148813816|NCT01500083|536792796|FG001|Overall Study|Death|2|||
148813817|NCT01500083|536792795|FG000|Overall Study|Lost to Follow-up|1|||
148813818|NCT01500083|536792796|FG001|Overall Study|Lost to Follow-up|0|||
148813819|NCT01500083|536792795|FG000|Overall Study|Withdrawal of Consent|0|||
148813820|NCT01500083|536792796|FG001|Overall Study|Withdrawal of Consent|1|||
148813821|NCT01500083|536792795|FG000|Overall Study|Disease Progression|2|||
148813822|NCT01500083|536792796|FG001|Overall Study|Disease Progression|10|||
148813823|NCT01500083|536792795|FG000|Overall Study|Investigator Discretion|3|||
148813824|NCT01500083|536792796|FG001|Overall Study|Investigator Discretion|8|||
148813825|NCT01500083|536792795|FG000|Overall Study|Other Reasons|2|||
148697111|NCT01104662|536364776|FG001|Overall Study|Participant left investigator's care|1|||
148697112|NCT01104662|536364777|FG002|Overall Study|Participant left investigator's care|0|||
148813826|NCT01500083|536792796|FG001|Overall Study|Other Reasons|5|||
148964799|NCT00549562|537356176|FG000|Overall Study|Adverse Event|1|||
148813827|NCT04225039|536792801|FG000|Overall Study|Withdrawal by Subject|1|||
148813828|NCT04225039|536792802|FG001|Overall Study|Withdrawal by Subject|0|||
148813829|NCT04225039|536792803|FG002|Overall Study|Withdrawal by Subject|0|||
148813830|NCT04225039|536792804|FG003|Overall Study|Withdrawal by Subject|1|||
148813831|NCT04225039|536792801|FG000|Overall Study|Currently active on study treatment|0|||
148813832|NCT04225039|536792802|FG001|Overall Study|Currently active on study treatment|1|||
148813833|NCT04225039|536792803|FG002|Overall Study|Currently active on study treatment|0|||
148813834|NCT04225039|536792804|FG003|Overall Study|Currently active on study treatment|0|||
148813835|NCT04225039|536792801|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
148813836|NCT04225039|536792802|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
148813837|NCT04225039|536792803|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
148813838|NCT04225039|536792804|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
148813839|NCT04225039|536792801|FG000|Overall Study|Ineligible for treatment|0|||
148813840|NCT04225039|536792802|FG001|Overall Study|Ineligible for treatment|0|||
148813841|NCT04225039|536792803|FG002|Overall Study|Ineligible for treatment|0|||
148813842|NCT04225039|536792804|FG003|Overall Study|Ineligible for treatment|4|||
148813843|NCT00975923|536792805|FG000|Overall Study|Withdrawal by Subject|0|||
148813844|NCT00975923|536792806|FG001|Overall Study|Withdrawal by Subject|1|||
148813845|NCT00088153|536792807|FG000|Overall Study|Physician Decision|3|||
148813846|NCT00088153|536792808|FG001|Overall Study|Physician Decision|3|||
148813847|NCT00088153|536792807|FG000|Overall Study|Withdrawal by Subject|10|||
148813848|NCT00088153|536792808|FG001|Overall Study|Withdrawal by Subject|10|||
148813849|NCT00088153|536792807|FG000|Overall Study|Lost to Follow-up|11|||
148813850|NCT00088153|536792808|FG001|Overall Study|Lost to Follow-up|12|||
148813851|NCT02246777|536792811|FG000|Overall Study|Adverse Event|2|||
148813852|NCT02246777|536792811|FG000|Overall Study|Change of residence|1|||
148813853|NCT03331250|536792817|FG000|Overall Study|Withdrawal by Subject|1|||
148813868|NCT06455111|536792838|FG000|Overall Study|Withdrawal by Subject|11|||
148813869|NCT06455111|536792839|FG001|Overall Study|Withdrawal by Subject|4|||
148813870|NCT03069989|536792847|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
148813871|NCT03069989|536792848|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
148813872|NCT02145390|536792849|FG000|Overall Study|Withdrawal by Subject|1|||
148813873|NCT00143507|536794333|FG000|Overall Study|Death|572|||
148813874|NCT00143507|536794334|FG001|Overall Study|Death|547|||
148813875|NCT00143507|536794333|FG000|Overall Study|Withdrawal by Subject|114|||
148813876|NCT00143507|536794334|FG001|Overall Study|Withdrawal by Subject|102|||
148813877|NCT00143507|536794333|FG000|Overall Study|Lost to Follow-up|1|||
148813878|NCT00143507|536794334|FG001|Overall Study|Lost to Follow-up|0|||
148813879|NCT00143507|536794333|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
148813880|NCT00143507|536794334|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
148813881|NCT00876395|536794335|FG000|Overall Study|Untreated|8|||
148813882|NCT00876395|536794336|FG001|Overall Study|Untreated|1|||
148813883|NCT00876395|536794335|FG000|Overall Study|Adverse Event|63|||
148813884|NCT00876395|536794336|FG001|Overall Study|Adverse Event|11|||
148964800|NCT00549562|537356176|FG000|Overall Study|Lack of Efficacy|1|||
148964801|NCT00323115|537356182|FG000|Vaccine Administration|Adverse Event|1|||
148964802|NCT00323115|537356182|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
148964803|NCT04439318|537356183|FG000|Overall Study|Ineligible|1|||
148964804|NCT04439318|537356183|FG000|Overall Study|Never Started Treatment|3|||
148964805|NCT04439318|537356183|FG000|Overall Study|Adverse Event|10|||
148964806|NCT04439318|537356183|FG000|Overall Study|Death|2|||
148964807|NCT04439318|537356183|FG000|Overall Study|Disease Progression|25|||
148813885|NCT00876395|536794335|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148813886|NCT00876395|536794336|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148813887|NCT00876395|536794335|FG000|Overall Study|Disease progression|259|||
148813888|NCT00876395|536794336|FG001|Overall Study|Disease progression|162|||
148813889|NCT00876395|536794335|FG000|Overall Study|New cancer therapy|25|||
148813890|NCT00876395|536794336|FG001|Overall Study|New cancer therapy|7|||
148813891|NCT00876395|536794335|FG000|Overall Study|Protocol Violation|5|||
148813892|NCT00876395|536794336|FG001|Overall Study|Protocol Violation|2|||
148964808|NCT04439318|537356183|FG000|Overall Study|Other Complicating Disease|2|||
148964809|NCT04439318|537356183|FG000|Overall Study|Withdrawal by Subject|4|||
148813893|NCT00876395|536794335|FG000|Overall Study|Withdrawal by Subject|66|||
148813894|NCT00876395|536794336|FG001|Overall Study|Withdrawal by Subject|33|||
148813895|NCT00876395|536794335|FG000|Overall Study|Lost to Follow-up|2|||
148813896|NCT00876395|536794336|FG001|Overall Study|Lost to Follow-up|0|||
148813897|NCT00876395|536794335|FG000|Overall Study|Administrative problems|39|||
148813898|NCT00876395|536794336|FG001|Overall Study|Administrative problems|23|||
148813899|NCT00876395|536794335|FG000|Overall Study|Death|12|||
148813900|NCT00876395|536794336|FG001|Overall Study|Death|0|||
148813901|NCT00970944|536794356|FG000|Overall Study|Death|1|||
148813902|NCT00970944|536794357|FG001|Overall Study|Death|0|||
148813903|NCT00970944|536794356|FG000|Overall Study|Physician Decision|0|||
148813904|NCT00970944|536794357|FG001|Overall Study|Physician Decision|2|||
148813905|NCT02008370|536794358|FG000|Overall Study|Lost to Follow-up|7|||
148813906|NCT00662259|536794359|FG000|Overall Study|Adverse Event|2|||
148813907|NCT00662259|536794360|FG001|Overall Study|Adverse Event|0|||
148813908|NCT00972738|536794361|FG000|Overall Study|Adverse Event|7|||
148813909|NCT00972738|536794362|FG001|Overall Study|Adverse Event|1|||
148813910|NCT00972738|536794363|FG002|Overall Study|Adverse Event|8|||
148813911|NCT00972738|536794361|FG000|Overall Study|Protocol Violation|2|||
148813912|NCT00972738|536794362|FG001|Overall Study|Protocol Violation|1|||
148813913|NCT00972738|536794363|FG002|Overall Study|Protocol Violation|3|||
148813914|NCT00972738|536794361|FG000|Overall Study|Lost to Follow-up|1|||
148813915|NCT00972738|536794362|FG001|Overall Study|Lost to Follow-up|0|||
148813916|NCT00972738|536794363|FG002|Overall Study|Lost to Follow-up|1|||
148964810|NCT04439318|537356183|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
148964811|NCT04439318|537356183|FG000|Overall Study|Non-Compliance|1|||
148964812|NCT04439318|537356183|FG000|Overall Study|Still on Treatment|1|||
148964813|NCT00699972|537358401|FG000|Overall Study|Adverse Event|7|||
148964814|NCT00699972|537358402|FG001|Overall Study|Adverse Event|9|||
148964815|NCT00699972|537358403|FG002|Overall Study|Adverse Event|24|||
148964816|NCT00699972|537358401|FG000|Overall Study|Lost to Follow-up|0|||
148964817|NCT00699972|537358402|FG001|Overall Study|Lost to Follow-up|2|||
148813917|NCT00972738|536794361|FG000|Overall Study|Lack of Efficacy|5|||
148813918|NCT00972738|536794362|FG001|Overall Study|Lack of Efficacy|1|||
148813919|NCT00972738|536794363|FG002|Overall Study|Lack of Efficacy|11|||
148813920|NCT00972738|536794361|FG000|Overall Study|Withdrawal by Subject|5|||
148813921|NCT00972738|536794362|FG001|Overall Study|Withdrawal by Subject|1|||
148813922|NCT00972738|536794363|FG002|Overall Study|Withdrawal by Subject|4|||
148813923|NCT00972738|536794361|FG000|Overall Study|Moved|0|||
148813924|NCT00972738|536794362|FG001|Overall Study|Moved|0|||
148813925|NCT00972738|536794363|FG002|Overall Study|Moved|1|||
148813926|NCT00972738|536794361|FG000|Overall Study|Other|1|||
148813927|NCT00972738|536794362|FG001|Overall Study|Other|2|||
148813928|NCT00972738|536794363|FG002|Overall Study|Other|1|||
148813929|NCT03915067|536794365|FG000|Overall Study|Adverse Event|0|||
148813930|NCT03915067|536794366|FG001|Overall Study|Adverse Event|0|||
148813931|NCT03915067|536794367|FG002|Overall Study|Adverse Event|1|||
148813932|NCT03915067|536794365|FG000|Overall Study|Withdrawal by Subject|4|||
148813933|NCT03915067|536794366|FG001|Overall Study|Withdrawal by Subject|3|||
148813934|NCT03915067|536794367|FG002|Overall Study|Withdrawal by Subject|0|||
148813935|NCT03915067|536794365|FG000|Overall Study|Lost to Follow-up|3|||
148813936|NCT03915067|536794366|FG001|Overall Study|Lost to Follow-up|2|||
148813937|NCT03915067|536794367|FG002|Overall Study|Lost to Follow-up|0|||
148813938|NCT03915067|536794365|FG000|Overall Study|Protocol Deviation|0|||
148813939|NCT03915067|536794366|FG001|Overall Study|Protocol Deviation|0|||
148813940|NCT03915067|536794367|FG002|Overall Study|Protocol Deviation|1|||
148813941|NCT03915067|536794365|FG000|Overall Study|Covid-19 Related Issues|2|||
148813942|NCT03915067|536794366|FG001|Overall Study|Covid-19 Related Issues|4|||
148813943|NCT03915067|536794367|FG002|Overall Study|Covid-19 Related Issues|4|||
148813944|NCT03915067|536794365|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
148964818|NCT00699972|537358403|FG002|Overall Study|Lost to Follow-up|0|||
148964819|NCT00699972|537358401|FG000|Overall Study|Withdrawal by Subject|3|||
148964820|NCT00699972|537358402|FG001|Overall Study|Withdrawal by Subject|7|||
149024185|NCT02403674|537564212|FG001|Base Study|Lack of Efficacy|23|||
149024186|NCT02403674|537564211|FG000|Base Study|Lost to Follow-up|6|||
148813945|NCT03915067|536794366|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
148813946|NCT03915067|536794367|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
148813947|NCT02693418|536794368|FG000|Overall Study|Lost to Follow-up|1|||
148813948|NCT02693418|536794369|FG001|Overall Study|Lost to Follow-up|2|||
148964821|NCT00699972|537358403|FG002|Overall Study|Withdrawal by Subject|4|||
148964822|NCT00699972|537358401|FG000|Overall Study|Lack of Efficacy|2|||
148813949|NCT02693418|536794370|FG002|Overall Study|Lost to Follow-up|0|||
148813950|NCT02693418|536794371|FG003|Overall Study|Lost to Follow-up|0|||
149024187|NCT02403674|537564212|FG001|Base Study|Lost to Follow-up|8|||
148813951|NCT02693418|536794372|FG004|Overall Study|Lost to Follow-up|0|||
148813952|NCT02693418|536794368|FG000|Overall Study|Menses during study period|0|||
148813953|NCT02693418|536794369|FG001|Overall Study|Menses during study period|0|||
148813954|NCT02693418|536794370|FG002|Overall Study|Menses during study period|2|||
148813955|NCT02693418|536794371|FG003|Overall Study|Menses during study period|0|||
149024188|NCT02403674|537564211|FG000|Base Study|Withdrawal by Subject|10|||
148813956|NCT02693418|536794372|FG004|Overall Study|Menses during study period|0|||
148813957|NCT01750346|536794374|FG000|Overall Study|Adverse Event|1|||
148813958|NCT01750346|536794375|FG001|Overall Study|Adverse Event|0|||
148813959|NCT01750346|536794376|FG002|Overall Study|Adverse Event|0|||
148813960|NCT01001104|536794377|FG000|Overall Study|Adverse Event|2|||
148813961|NCT01001104|536794378|FG001|Overall Study|Adverse Event|1|||
148813962|NCT01001104|536794379|FG002|Overall Study|Adverse Event|0|||
148813963|NCT01001104|536794380|FG003|Overall Study|Adverse Event|0|||
148813964|NCT01001104|536794377|FG000|Overall Study|Lost to Follow-up|0|||
148813965|NCT01001104|536794378|FG001|Overall Study|Lost to Follow-up|0|||
148813966|NCT01001104|536794379|FG002|Overall Study|Lost to Follow-up|1|||
148813967|NCT01001104|536794380|FG003|Overall Study|Lost to Follow-up|0|||
148813968|NCT01001104|536794377|FG000|Overall Study|Entry Criteria Not Met|0|||
148813969|NCT01001104|536794378|FG001|Overall Study|Entry Criteria Not Met|0|||
148813970|NCT01001104|536794379|FG002|Overall Study|Entry Criteria Not Met|0|||
148813971|NCT01001104|536794380|FG003|Overall Study|Entry Criteria Not Met|1|||
148813972|NCT01001104|536794377|FG000|Overall Study|Withdrawal by Subject|0|||
148813973|NCT01001104|536794378|FG001|Overall Study|Withdrawal by Subject|0|||
148813974|NCT01001104|536794379|FG002|Overall Study|Withdrawal by Subject|0|||
148813975|NCT01001104|536794380|FG003|Overall Study|Withdrawal by Subject|2|||
148813976|NCT00599313|536794381|FG000|Overall Study|Adverse Event|19|||
148813977|NCT00599313|536794381|FG000|Overall Study|Disease Progression|12|||
148813978|NCT00599313|536794381|FG000|Overall Study|Patient Request|4|||
148813979|NCT00599313|536794381|FG000|Overall Study|Ineligible|1|||
148813980|NCT01793935|536794384|FG000|Overall Study|Pregnancy|1|||
148813981|NCT01793935|536794385|FG001|Overall Study|Pregnancy|0|||
148813982|NCT01793935|536794384|FG000|Overall Study|Protocol Violation|2|||
148813983|NCT01793935|536794385|FG001|Overall Study|Protocol Violation|1|||
148813984|NCT01793935|536794384|FG000|Overall Study|Adverse Event|2|||
148813985|NCT01793935|536794385|FG001|Overall Study|Adverse Event|0|||
148813986|NCT01793935|536794384|FG000|Overall Study|Patient did not take study medication|1|||
148813987|NCT01793935|536794385|FG001|Overall Study|Patient did not take study medication|1|||
148813988|NCT01793935|536794384|FG000|Overall Study|Lost to Follow-up|0|||
148813989|NCT01793935|536794385|FG001|Overall Study|Lost to Follow-up|1|||
148813990|NCT01121926|536794386|FG000|First Intervention Period|Adverse Event|1|||
148813991|NCT01121926|536794387|FG001|First Intervention Period|Adverse Event|0|||
148813992|NCT01121926|536794386|FG000|Washout Period|Adverse Event|0|||
148813993|NCT01121926|536794387|FG001|Washout Period|Adverse Event|1|||
148813994|NCT01121926|536794386|FG000|Washout Period|Positive pregnancy test|0|||
148813995|NCT01121926|536794387|FG001|Washout Period|Positive pregnancy test|1|||
148813996|NCT02782468|536794388|FG000|Overall Study|Progressive Disease|2|||
148813997|NCT02782468|536794389|FG001|Overall Study|Progressive Disease|5|||
148813998|NCT02782468|536794390|FG002|Overall Study|Progressive Disease|0|||
148813999|NCT02782468|536794391|FG003|Overall Study|Progressive Disease|4|||
148814000|NCT02782468|536794388|FG000|Overall Study|Adverse Event|0|||
148814001|NCT02782468|536794389|FG001|Overall Study|Adverse Event|2|||
148814002|NCT02782468|536794390|FG002|Overall Study|Adverse Event|2|||
148964823|NCT00699972|537358402|FG001|Overall Study|Lack of Efficacy|0|||
148964824|NCT00699972|537358403|FG002|Overall Study|Lack of Efficacy|2|||
148964825|NCT00699972|537358401|FG000|Overall Study|Administrative/Other|3|||
148964826|NCT00699972|537358402|FG001|Overall Study|Administrative/Other|1|||
148964827|NCT00699972|537358403|FG002|Overall Study|Administrative/Other|4|||
148964828|NCT00699972|537358401|FG000|Overall Study|Randomized, Not Treated|1|||
148964829|NCT00699972|537358402|FG001|Overall Study|Randomized, Not Treated|0|||
148964830|NCT00699972|537358403|FG002|Overall Study|Randomized, Not Treated|1|||
148964831|NCT00922766|537358409|FG000|Overall Study|Death|3|||
148964832|NCT00922766|537358409|FG000|Overall Study|Withdrawal by Subject|2|||
148964833|NCT00922766|537358409|FG000|Overall Study|Other|1|||
148964834|NCT00922766|537358409|FG000|Overall Study|Adverse Event|1|||
148964835|NCT02622828|537358410|FG000|Overall Study|participant withdrew|3|||
148964836|NCT01231581|537358411|FG000|Overall Study|Lost to Follow-up|2|||
148964837|NCT01231581|537358412|FG001|Overall Study|Lost to Follow-up|2|||
148814003|NCT02782468|536794391|FG003|Overall Study|Adverse Event|3|||
148814004|NCT02782468|536794388|FG000|Overall Study|Other|0|||
148814005|NCT02782468|536794389|FG001|Overall Study|Other|0|||
148814006|NCT02782468|536794390|FG002|Overall Study|Other|1|||
148814007|NCT02782468|536794391|FG003|Overall Study|Other|1|||
148814008|NCT02782468|536794388|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
148814009|NCT02782468|536794389|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
148814010|NCT02782468|536794390|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
148814011|NCT02782468|536794391|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
148814012|NCT02782468|536794388|FG000|Overall Study|Symptomatic Deterioration|0|||
148814013|NCT02782468|536794389|FG001|Overall Study|Symptomatic Deterioration|0|||
148814014|NCT02782468|536794390|FG002|Overall Study|Symptomatic Deterioration|0|||
148814015|NCT02782468|536794391|FG003|Overall Study|Symptomatic Deterioration|1|||
148964838|NCT01231581|537358411|FG000|Overall Study|Withdrawal by Subject|6|||
148964839|NCT01231581|537358412|FG001|Overall Study|Withdrawal by Subject|9|||
148697113|NCT01104662|536364778|FG003|Overall Study|Participant left investigator's care|0|||
148697114|NCT01104662|536364779|FG004|Overall Study|Participant left investigator's care|0|||
148697115|NCT01104662|536364780|FG005|Overall Study|Participant left investigator's care|0|||
148697116|NCT01104662|536364781|FG006|Overall Study|Participant left investigator's care|0|||
148697117|NCT01104662|536364782|FG007|Overall Study|Participant left investigator's care|0|||
148697118|NCT01104662|536364775|FG000|Overall Study|Reason not specified|3|||
148697119|NCT01104662|536364776|FG001|Overall Study|Reason not specified|3|||
148697120|NCT01104662|536364777|FG002|Overall Study|Reason not specified|0|||
148697121|NCT01104662|536364778|FG003|Overall Study|Reason not specified|0|||
148697122|NCT01104662|536364779|FG004|Overall Study|Reason not specified|0|||
148697123|NCT01104662|536364780|FG005|Overall Study|Reason not specified|1|||
148697124|NCT01104662|536364781|FG006|Overall Study|Reason not specified|0|||
148697125|NCT01104662|536364782|FG007|Overall Study|Reason not specified|0|||
148697126|NCT01104662|536364775|FG000|Overall Study|Randomized but not treated|3|||
148697127|NCT01104662|536364776|FG001|Overall Study|Randomized but not treated|4|||
148697128|NCT01104662|536364777|FG002|Overall Study|Randomized but not treated|1|||
148697129|NCT01104662|536364778|FG003|Overall Study|Randomized but not treated|0|||
148697130|NCT01104662|536364779|FG004|Overall Study|Randomized but not treated|0|||
148697131|NCT01104662|536364780|FG005|Overall Study|Randomized but not treated|1|||
148697132|NCT01104662|536364781|FG006|Overall Study|Randomized but not treated|0|||
148697133|NCT01104662|536364782|FG007|Overall Study|Randomized but not treated|0|||
148697134|NCT00743197|536364783|FG000|Overall Study|Study terminated due to departure of PI.|1|||
148697135|NCT00743197|536364784|FG001|Overall Study|Study terminated due to departure of PI.|2|||
148697136|NCT01478620|536364785|FG000|Overall Study|Lost to Follow-up|6|||
148697137|NCT01411332|536364790|FG000|Enrollment|Protocol Violation|0|||
148697138|NCT01411332|536364791|FG001|Enrollment|Protocol Violation|1|||
148697139|NCT01411332|536364790|FG000|Enrollment|Withdrawal by Subject|0|||
148697140|NCT01411332|536364791|FG001|Enrollment|Withdrawal by Subject|1|||
148697141|NCT01411332|536364790|FG000|Treatment|Lost to Follow-up|1|||
148697142|NCT01411332|536364791|FG001|Treatment|Lost to Follow-up|0|||
148697143|NCT02170688|536364792|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
148697144|NCT02170688|536364793|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
148697145|NCT02170688|536364794|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
148697146|NCT02170688|536364795|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
148697147|NCT02170688|536364796|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
148697148|NCT02170688|536364792|FG000|Overall Study|Full dose not received|0|||
148697149|NCT02170688|536364793|FG001|Overall Study|Full dose not received|1|||
148697150|NCT02170688|536364794|FG002|Overall Study|Full dose not received|0|||
148697151|NCT02170688|536364795|FG003|Overall Study|Full dose not received|0|||
148697152|NCT02170688|536364796|FG004|Overall Study|Full dose not received|0|||
148697153|NCT02170688|536364792|FG000|Overall Study|Physician Decision|0|||
148697154|NCT02170688|536364793|FG001|Overall Study|Physician Decision|0|||
148697155|NCT02170688|536364794|FG002|Overall Study|Physician Decision|1|||
148697156|NCT02170688|536364795|FG003|Overall Study|Physician Decision|0|||
148697157|NCT02170688|536364796|FG004|Overall Study|Physician Decision|0|||
148697158|NCT02079532|536364797|FG000|Overall Study|Adverse Event|7|||
148697159|NCT02079532|536364797|FG000|Overall Study|Additional or changed therapy|2|||
148697160|NCT02079532|536364797|FG000|Overall Study|Lack of Efficacy|9|||
148697161|NCT02079532|536364797|FG000|Overall Study|Protocol Violation|3|||
148697162|NCT02079532|536364797|FG000|Overall Study|Withdrawal by Subject|1|||
148697163|NCT02079532|536364797|FG000|Overall Study|Administrative problems|1|||
148697164|NCT02079532|536364797|FG000|Overall Study|Inclusion into ReFIRST|3|||
148697165|NCT02079532|536364797|FG000|Overall Study|Other|3|||
148697166|NCT01432171|536364798|FG000|Overall Study|Death|1|||
148697167|NCT01432171|536364799|FG001|Overall Study|Death|2|||
148697168|NCT01432171|536364798|FG000|Overall Study|Lost to Follow-up|6|||
148697169|NCT01432171|536364799|FG001|Overall Study|Lost to Follow-up|5|||
148697170|NCT01432171|536364798|FG000|Overall Study|Withdrawal by Subject|3|||
148697171|NCT01432171|536364799|FG001|Overall Study|Withdrawal by Subject|1|||
148697172|NCT01432171|536364798|FG000|Overall Study|Noncompliance|2|||
148697173|NCT01432171|536364799|FG001|Overall Study|Noncompliance|3|||
148697174|NCT01432171|536364798|FG000|Overall Study|Insurance denial trial coverage|1|||
148697175|NCT01432171|536364799|FG001|Overall Study|Insurance denial trial coverage|0|||
148697176|NCT01432171|536364798|FG000|Overall Study|Patient moved to palliative care|1|||
148697177|NCT01432171|536364799|FG001|Overall Study|Patient moved to palliative care|0|||
148697178|NCT01706926|536364800|FG000|Overall Study|Lost to Follow-up|0|||
148697179|NCT01706926|536364801|FG001|Overall Study|Lost to Follow-up|0|||
148697180|NCT01706926|536364802|FG002|Overall Study|Lost to Follow-up|1|||
148697181|NCT01706926|536364803|FG003|Overall Study|Lost to Follow-up|0|||
148697182|NCT01706926|536364800|FG000|Overall Study|Withdrawal by Subject|2|||
148697183|NCT01706926|536364801|FG001|Overall Study|Withdrawal by Subject|0|||
148697184|NCT01706926|536364802|FG002|Overall Study|Withdrawal by Subject|1|||
148697185|NCT01706926|536364803|FG003|Overall Study|Withdrawal by Subject|2|||
148697186|NCT01706926|536364800|FG000|Overall Study|Other|4|||
148697187|NCT01706926|536364801|FG001|Overall Study|Other|4|||
148697188|NCT01706926|536364802|FG002|Overall Study|Other|4|||
148964840|NCT01231581|537358411|FG000|Overall Study|Study Closed/Terminated|6|||
148964841|NCT01231581|537358412|FG001|Overall Study|Study Closed/Terminated|5|||
148697189|NCT01706926|536364803|FG003|Overall Study|Other|3|||
148697190|NCT00441467|536366448|FG000|Overall Study|Adverse Event|6|||
148697191|NCT00441467|536366448|FG000|Overall Study|Withdrawal by Subject|3|||
148697192|NCT00441467|536366448|FG000|Overall Study|Progressive disease|9|||
148697193|NCT02289963|536366449|FG000|Overall Study|Adverse Event|1|||
148697194|NCT02289963|536366450|FG001|Overall Study|Adverse Event|2|||
148697195|NCT02289963|536366449|FG000|Overall Study|Poor compliance to protocol|1|||
148697196|NCT02289963|536366450|FG001|Overall Study|Poor compliance to protocol|0|||
148697197|NCT02289963|536366449|FG000|Overall Study|Withdrawal by Subject|1|||
148697198|NCT02289963|536366450|FG001|Overall Study|Withdrawal by Subject|0|||
148697199|NCT02289963|536366449|FG000|Overall Study|Last injection missed|2|||
148697200|NCT02289963|536366450|FG001|Overall Study|Last injection missed|2|||
148697201|NCT02289963|536366449|FG000|Overall Study|End treatment visit outside visit window|0|||
148697202|NCT02289963|536366450|FG001|Overall Study|End treatment visit outside visit window|4|||
148697203|NCT02289963|536366449|FG000|Overall Study|Other than specified above|0|||
148697204|NCT02289963|536366450|FG001|Overall Study|Other than specified above|2|||
148697205|NCT01042522|536366452|FG000|Overall Study|Adverse Event|1|||
148697206|NCT01042522|536366453|FG001|Overall Study|Adverse Event|2|||
148697207|NCT01042522|536366452|FG000|Overall Study|Disease Progression|5|||
148697208|NCT01042522|536366453|FG001|Overall Study|Disease Progression|0|||
148697209|NCT01042522|536366452|FG000|Overall Study|Death|1|||
148697210|NCT01042522|536366453|FG001|Overall Study|Death|0|||
148697211|NCT01042522|536366452|FG000|Overall Study|Patient Refused|0|||
148697212|NCT01042522|536366453|FG001|Overall Study|Patient Refused|3|||
148697213|NCT01042522|536366452|FG000|Overall Study|Withdrawal by Subject|1|||
148697214|NCT01042522|536366453|FG001|Overall Study|Withdrawal by Subject|1|||
148697215|NCT01746017|536366456|FG000|Period 1|Withdrawal by Subject|0|||
148697216|NCT01746017|536366457|FG001|Period 1|Withdrawal by Subject|0|||
148697217|NCT01746017|536366458|FG002|Period 1|Withdrawal by Subject|0|||
148697218|NCT01746017|536366459|FG003|Period 1|Withdrawal by Subject|0|||
148697219|NCT01746017|536366460|FG004|Period 1|Withdrawal by Subject|0|||
148697220|NCT01746017|536366461|FG005|Period 1|Withdrawal by Subject|0|||
148697221|NCT01746017|536366462|FG006|Period 1|Withdrawal by Subject|1|||
148697222|NCT01746017|536366463|FG007|Period 1|Withdrawal by Subject|0|||
148697223|NCT01746017|536366464|FG008|Period 1|Withdrawal by Subject|0|||
148697224|NCT01746017|536366465|FG009|Period 1|Withdrawal by Subject|0|||
148697225|NCT01746017|536366466|FG010|Period 1|Withdrawal by Subject|0|||
148697226|NCT01746017|536366456|FG000|Period 3|Withdrawal by Subject|0|||
148697227|NCT01746017|536366457|FG001|Period 3|Withdrawal by Subject|0|||
148697228|NCT01746017|536366458|FG002|Period 3|Withdrawal by Subject|0|||
148697229|NCT01746017|536366459|FG003|Period 3|Withdrawal by Subject|0|||
148697230|NCT01746017|536366460|FG004|Period 3|Withdrawal by Subject|0|||
148697231|NCT01746017|536366461|FG005|Period 3|Withdrawal by Subject|1|||
148697232|NCT01746017|536366462|FG006|Period 3|Withdrawal by Subject|0|||
148697233|NCT01746017|536366463|FG007|Period 3|Withdrawal by Subject|0|||
148697234|NCT01746017|536366464|FG008|Period 3|Withdrawal by Subject|0|||
148697235|NCT01746017|536366465|FG009|Period 3|Withdrawal by Subject|0|||
148697236|NCT01746017|536366466|FG010|Period 3|Withdrawal by Subject|0|||
148697237|NCT01675622|536366470|FG000|Overall Study|Withdrawal by Subject|2|||
148697238|NCT01675622|536366471|FG001|Overall Study|Withdrawal by Subject|2|||
148697239|NCT01675622|536366470|FG000|Overall Study|Adverse Event|12|||
148697240|NCT01675622|536366471|FG001|Overall Study|Adverse Event|10|||
148697241|NCT01675622|536366470|FG000|Overall Study|Protocol Violation|4|||
148697242|NCT01675622|536366471|FG001|Overall Study|Protocol Violation|1|||
148697243|NCT01675622|536366470|FG000|Overall Study|Lack of Efficacy|2|||
148697244|NCT01675622|536366471|FG001|Overall Study|Lack of Efficacy|4|||
148697245|NCT01675622|536366470|FG000|Overall Study|Lost to Follow-up|1|||
148697246|NCT01675622|536366471|FG001|Overall Study|Lost to Follow-up|3|||
148697247|NCT01675622|536366470|FG000|Overall Study|Other|5|||
148697248|NCT01675622|536366471|FG001|Overall Study|Other|4|||
148697249|NCT01101022|536366472|FG000|Overall Study|Adverse Event|6|||
148697250|NCT01101022|536366473|FG001|Overall Study|Adverse Event|2|||
148697251|NCT01101022|536366472|FG000|Overall Study|Protocol Violation|4|||
148697252|NCT01101022|536366473|FG001|Overall Study|Protocol Violation|3|||
148697253|NCT01101022|536366472|FG000|Overall Study|Withdrawal by Subject|3|||
148697254|NCT01101022|536366473|FG001|Overall Study|Withdrawal by Subject|8|||
148697255|NCT01101022|536366472|FG000|Overall Study|Lost to Follow-up|1|||
148697256|NCT01101022|536366473|FG001|Overall Study|Lost to Follow-up|4|||
148697257|NCT01101022|536366472|FG000|Overall Study|Lack of Efficacy|0|||
148697258|NCT01101022|536366473|FG001|Overall Study|Lack of Efficacy|7|||
148697259|NCT01101022|536366472|FG000|Overall Study|Sponsor decision|1|||
148697260|NCT01101022|536366473|FG001|Overall Study|Sponsor decision|1|||
148697261|NCT01101022|536366472|FG000|Overall Study|Non-compliance|1|||
148697262|NCT01101022|536366473|FG001|Overall Study|Non-compliance|0|||
148697263|NCT01101022|536366472|FG000|Overall Study|Work schedule|1|||
148697264|NCT01101022|536366473|FG001|Overall Study|Work schedule|1|||
148697265|NCT01101022|536366472|FG000|Overall Study|Vacation|0|||
148697266|NCT01101022|536366473|FG001|Overall Study|Vacation|1|||
148697267|NCT01139047|536366474|FG000|Overall Study|Withdrawal by Subject|1|||
148697268|NCT00365300|536366481|FG000|Open-label Phase|Adverse Event|4|||
148697269|NCT00365300|536366482|FG001|Open-label Phase|Adverse Event|0|||
148697270|NCT00365300|536366481|FG000|Open-label Phase|Failed to Return|1|||
148697271|NCT00365300|536366482|FG001|Open-label Phase|Failed to Return|0|||
148697272|NCT00365300|536366481|FG000|Open-label Phase|Physician Decision|1|||
148697273|NCT00365300|536366482|FG001|Open-label Phase|Physician Decision|0|||
148697274|NCT00365300|536366481|FG000|Open-label Phase|Noncompliance|9|||
148697275|NCT00365300|536366482|FG001|Open-label Phase|Noncompliance|0|||
148814016|NCT02782468|536794388|FG000|Overall Study|Withdrawal by Subject|1|||
148814017|NCT02782468|536794389|FG001|Overall Study|Withdrawal by Subject|0|||
148814018|NCT02782468|536794390|FG002|Overall Study|Withdrawal by Subject|0|||
148814019|NCT02782468|536794391|FG003|Overall Study|Withdrawal by Subject|0|||
148814020|NCT00356590|536794398|FG000|Overall Study|Adverse Event|54|||
148814021|NCT00356590|536794398|FG000|Overall Study|Death|10|||
148814022|NCT00356590|536794398|FG000|Overall Study|Lost to Follow-up|35|||
148814023|NCT00356590|536794398|FG000|Overall Study|Physician Decision|46|||
148814024|NCT00356590|536794398|FG000|Overall Study|Withdrawal by Subject|41|||
148814025|NCT00356590|536794398|FG000|Overall Study|Completed month 12 only|2|||
148814026|NCT00356590|536794398|FG000|Overall Study|Protocol issues|6|||
148814027|NCT00356590|536794398|FG000|Overall Study|Response status|28|||
148814028|NCT00356590|536794398|FG000|Overall Study|Other|52|||
148814029|NCT04919161|536794405|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
148814030|NCT04919161|536794406|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
148814031|NCT04919161|536794405|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
148814032|NCT04919161|536794406|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
148814033|NCT04919161|536794405|FG000|Overall Study|Acute ankle sprain after session 1|0|||
148814034|NCT04919161|536794406|FG001|Overall Study|Acute ankle sprain after session 1|1|||
148814035|NCT02489773|536794407|FG000|Overall Study|Lost to Follow-up|4|||
148814036|NCT02489773|536794408|FG001|Overall Study|Lost to Follow-up|1|||
148814037|NCT02489773|536794407|FG000|Overall Study|Physician Decision|1|||
148814038|NCT02489773|536794408|FG001|Overall Study|Physician Decision|0|||
148814039|NCT02489773|536794407|FG000|Overall Study|Withdrawal by Subject|1|||
148814040|NCT02489773|536794408|FG001|Overall Study|Withdrawal by Subject|0|||
148814041|NCT02489773|536794407|FG000|Overall Study|Leave the country or the state|1|||
148814042|NCT02489773|536794408|FG001|Overall Study|Leave the country or the state|1|||
148814043|NCT00712920|536794409|FG000|Overall Study|Adverse Event|3|||
148814044|NCT00712920|536794410|FG001|Overall Study|Adverse Event|4|||
148814045|NCT00712920|536794411|FG002|Overall Study|Adverse Event|7|||
148814046|NCT00712920|536794409|FG000|Overall Study|Withdrawal by Subject|4|||
148814047|NCT00712920|536794410|FG001|Overall Study|Withdrawal by Subject|2|||
148814048|NCT00712920|536794411|FG002|Overall Study|Withdrawal by Subject|1|||
148814049|NCT00712920|536794409|FG000|Overall Study|Lost to Follow-up|1|||
148814050|NCT00712920|536794410|FG001|Overall Study|Lost to Follow-up|4|||
148814051|NCT00712920|536794411|FG002|Overall Study|Lost to Follow-up|0|||
148814052|NCT00712920|536794409|FG000|Overall Study|Lack of Efficacy|1|||
148814053|NCT00712920|536794410|FG001|Overall Study|Lack of Efficacy|0|||
148814054|NCT00712920|536794411|FG002|Overall Study|Lack of Efficacy|1|||
148814055|NCT00712920|536794409|FG000|Overall Study|Other|5|||
148814056|NCT00712920|536794410|FG001|Overall Study|Other|7|||
148814057|NCT00712920|536794411|FG002|Overall Study|Other|3|||
148814058|NCT00712920|536794409|FG000|Overall Study|Non-compliance|3|||
148814059|NCT00712920|536794410|FG001|Overall Study|Non-compliance|0|||
148814060|NCT00712920|536794411|FG002|Overall Study|Non-compliance|0|||
148814061|NCT02362451|536794413|FG000|Overall Study|Withdrawal by Subject|0|||
148814062|NCT02362451|536794414|FG001|Overall Study|Withdrawal by Subject|1|||
148814063|NCT02362451|536794413|FG000|Overall Study|Lack of Efficacy|2|||
148814064|NCT02362451|536794414|FG001|Overall Study|Lack of Efficacy|0|||
148814065|NCT02362451|536794413|FG000|Overall Study|Progression|1|||
148814066|NCT02362451|536794414|FG001|Overall Study|Progression|0|||
148814067|NCT02362451|536794413|FG000|Overall Study|Participant chose other therapy.|1|||
148814068|NCT02362451|536794414|FG001|Overall Study|Participant chose other therapy.|0|||
148814069|NCT01555931|536794415|FG000|Overall Study|Lost to Follow-up|2|||
148814070|NCT01555931|536794416|FG001|Overall Study|Lost to Follow-up|5|||
148964842|NCT01231581|537358411|FG000|Overall Study|Death|65|||
148964843|NCT01231581|537358412|FG001|Overall Study|Death|64|||
148964844|NCT01231581|537358411|FG000|Overall Study|Ongoing|1|||
148814071|NCT04398134|536794417|FG000|Overall Study|Adverse Event|0|||
148814072|NCT04398134|536794418|FG001|Overall Study|Adverse Event|0|||
148814073|NCT04398134|536794419|FG002|Overall Study|Adverse Event|1|||
148814074|NCT04398134|536794420|FG003|Overall Study|Adverse Event|0|||
148814075|NCT04398134|536794417|FG000|Overall Study|Withdrawal by Subject|2|||
148814076|NCT04398134|536794418|FG001|Overall Study|Withdrawal by Subject|0|||
148814077|NCT04398134|536794419|FG002|Overall Study|Withdrawal by Subject|0|||
148814078|NCT04398134|536794420|FG003|Overall Study|Withdrawal by Subject|1|||
148814079|NCT04398134|536794417|FG000|Overall Study|Study Terminated by Sponsor|30|||
148814080|NCT04398134|536794418|FG001|Overall Study|Study Terminated by Sponsor|11|||
148964845|NCT01231581|537358412|FG001|Overall Study|Ongoing|0|||
148964846|NCT03616912|537358413|FG000|Overall Study|Adverse Event|17|||
148964847|NCT03616912|537358414|FG001|Overall Study|Adverse Event|21|||
148964848|NCT03616912|537358415|FG002|Overall Study|Adverse Event|9|||
148697276|NCT00365300|536366481|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
148697277|NCT00365300|536366482|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
148697278|NCT00365300|536366481|FG000|Open-label Phase|Protocol Violation|1|||
148964849|NCT03616912|537358416|FG003|Overall Study|Adverse Event|0|||
148964850|NCT03616912|537358417|FG004|Overall Study|Adverse Event|0|||
148814081|NCT04398134|536794419|FG002|Overall Study|Study Terminated by Sponsor|32|||
148814082|NCT04398134|536794420|FG003|Overall Study|Study Terminated by Sponsor|11|||
148814083|NCT01044498|536794422|FG000|Overall Study|Withdrew consent|1|||
148814084|NCT01044498|536794423|FG001|Overall Study|Withdrew consent|1|||
148814085|NCT01044498|536794422|FG000|Overall Study|Adverse Event|1|||
148814086|NCT01044498|536794423|FG001|Overall Study|Adverse Event|1|||
148814087|NCT01044498|536794422|FG000|Overall Study|Other|1|||
148964851|NCT03616912|537358418|FG005|Overall Study|Adverse Event|0|||
148964852|NCT03616912|537358413|FG000|Overall Study|Death|1|||
148814088|NCT01044498|536794423|FG001|Overall Study|Other|0|||
148814089|NCT05513950|536794424|FG000|Overall Study|Not treated due to technical reasons|0|||
148814090|NCT05513950|536794425|FG001|Overall Study|Not treated due to technical reasons|0|||
148814091|NCT05513950|536794426|FG002|Overall Study|Not treated due to technical reasons|1|||
148814092|NCT05513950|536794427|FG003|Overall Study|Not treated due to technical reasons|0|||
148814093|NCT02903914|536794428|FG000|Overall Study|Adverse Event|0|||
148814094|NCT02903914|536794429|FG001|Overall Study|Adverse Event|0|||
148814095|NCT02903914|536794430|FG002|Overall Study|Adverse Event|1|||
148814096|NCT02903914|536794431|FG003|Overall Study|Adverse Event|0|||
148814097|NCT02903914|536794432|FG004|Overall Study|Adverse Event|0|||
148814098|NCT02903914|536794433|FG005|Overall Study|Adverse Event|0|||
148814099|NCT02903914|536794434|FG006|Overall Study|Adverse Event|2|||
148814100|NCT02903914|536794435|FG007|Overall Study|Adverse Event|0|||
148814101|NCT02903914|536794428|FG000|Overall Study|Withdrawal by Subject|3|||
148814102|NCT02903914|536794429|FG001|Overall Study|Withdrawal by Subject|1|||
148814103|NCT02903914|536794430|FG002|Overall Study|Withdrawal by Subject|28|||
148814104|NCT02903914|536794431|FG003|Overall Study|Withdrawal by Subject|0|||
148814105|NCT02903914|536794432|FG004|Overall Study|Withdrawal by Subject|1|||
148814106|NCT02903914|536794433|FG005|Overall Study|Withdrawal by Subject|2|||
148814107|NCT02903914|536794434|FG006|Overall Study|Withdrawal by Subject|12|||
148814108|NCT02903914|536794435|FG007|Overall Study|Withdrawal by Subject|0|||
148814109|NCT02903914|536794428|FG000|Overall Study|Progressive Disease|1|||
148814110|NCT02903914|536794429|FG001|Overall Study|Progressive Disease|0|||
148814111|NCT02903914|536794430|FG002|Overall Study|Progressive Disease|4|||
148814112|NCT02903914|536794431|FG003|Overall Study|Progressive Disease|0|||
148814113|NCT02903914|536794432|FG004|Overall Study|Progressive Disease|0|||
148814114|NCT02903914|536794433|FG005|Overall Study|Progressive Disease|0|||
148814115|NCT02903914|536794434|FG006|Overall Study|Progressive Disease|2|||
148814116|NCT02903914|536794435|FG007|Overall Study|Progressive Disease|0|||
148814117|NCT02903914|536794428|FG000|Overall Study|Death|0|||
148814118|NCT02903914|536794429|FG001|Overall Study|Death|0|||
148814119|NCT02903914|536794430|FG002|Overall Study|Death|9|||
148814120|NCT02903914|536794431|FG003|Overall Study|Death|0|||
148814121|NCT02903914|536794432|FG004|Overall Study|Death|1|||
148814122|NCT02903914|536794433|FG005|Overall Study|Death|3|||
148814123|NCT02903914|536794434|FG006|Overall Study|Death|24|||
148814124|NCT02903914|536794435|FG007|Overall Study|Death|2|||
148814125|NCT02903914|536794428|FG000|Overall Study|Lost to Follow-up|0|||
148814126|NCT02903914|536794429|FG001|Overall Study|Lost to Follow-up|1|||
148814127|NCT02903914|536794430|FG002|Overall Study|Lost to Follow-up|0|||
148814128|NCT02903914|536794431|FG003|Overall Study|Lost to Follow-up|0|||
148814129|NCT02903914|536794432|FG004|Overall Study|Lost to Follow-up|2|||
148814130|NCT02903914|536794433|FG005|Overall Study|Lost to Follow-up|0|||
148814131|NCT02903914|536794434|FG006|Overall Study|Lost to Follow-up|1|||
148814132|NCT02903914|536794435|FG007|Overall Study|Lost to Follow-up|0|||
148814133|NCT02903914|536794428|FG000|Overall Study|Physician Decision|0|||
148814134|NCT02903914|536794429|FG001|Overall Study|Physician Decision|0|||
148814135|NCT02903914|536794430|FG002|Overall Study|Physician Decision|1|||
148814136|NCT02903914|536794431|FG003|Overall Study|Physician Decision|0|||
148814137|NCT02903914|536794432|FG004|Overall Study|Physician Decision|0|||
148814138|NCT02903914|536794433|FG005|Overall Study|Physician Decision|0|||
148814139|NCT02903914|536794434|FG006|Overall Study|Physician Decision|1|||
148814140|NCT02903914|536794435|FG007|Overall Study|Physician Decision|0|||
148814141|NCT02903914|536794428|FG000|Overall Study|Symptomatic Deterioration|0|||
148814142|NCT02903914|536794429|FG001|Overall Study|Symptomatic Deterioration|0|||
148964853|NCT03616912|537358414|FG001|Overall Study|Death|1|||
148697279|NCT00365300|536366482|FG001|Open-label Phase|Protocol Violation|0|||
148697280|NCT00365300|536366481|FG000|Open-label Phase|Lack of Efficacy|1|||
148697281|NCT00365300|536366482|FG001|Open-label Phase|Lack of Efficacy|0|||
148814143|NCT02903914|536794430|FG002|Overall Study|Symptomatic Deterioration|1|||
148814144|NCT02903914|536794431|FG003|Overall Study|Symptomatic Deterioration|0|||
148814145|NCT02903914|536794432|FG004|Overall Study|Symptomatic Deterioration|0|||
148814146|NCT02903914|536794433|FG005|Overall Study|Symptomatic Deterioration|0|||
148814147|NCT02903914|536794434|FG006|Overall Study|Symptomatic Deterioration|0|||
148814148|NCT02903914|536794435|FG007|Overall Study|Symptomatic Deterioration|0|||
148814149|NCT02903914|536794428|FG000|Overall Study|New Cancer Therapy|2|||
148814150|NCT02903914|536794429|FG001|Overall Study|New Cancer Therapy|2|||
148814151|NCT02903914|536794430|FG002|Overall Study|New Cancer Therapy|21|||
148814152|NCT02903914|536794431|FG003|Overall Study|New Cancer Therapy|4|||
148814153|NCT02903914|536794432|FG004|Overall Study|New Cancer Therapy|3|||
148814154|NCT02903914|536794433|FG005|Overall Study|New Cancer Therapy|6|||
148814155|NCT02903914|536794434|FG006|Overall Study|New Cancer Therapy|56|||
148814156|NCT02903914|536794435|FG007|Overall Study|New Cancer Therapy|3|||
148814157|NCT02903914|536794428|FG000|Overall Study|Didn't Return to Site|1|||
148814158|NCT02903914|536794429|FG001|Overall Study|Didn't Return to Site|0|||
148814159|NCT02903914|536794430|FG002|Overall Study|Didn't Return to Site|1|||
148814160|NCT02903914|536794431|FG003|Overall Study|Didn't Return to Site|1|||
148814161|NCT02903914|536794432|FG004|Overall Study|Didn't Return to Site|0|||
148814162|NCT02903914|536794433|FG005|Overall Study|Didn't Return to Site|0|||
148814163|NCT02903914|536794434|FG006|Overall Study|Didn't Return to Site|2|||
148814164|NCT02903914|536794435|FG007|Overall Study|Didn't Return to Site|0|||
148814165|NCT02903914|536794428|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
148814166|NCT02903914|536794429|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
148814167|NCT02903914|536794430|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
148814168|NCT02903914|536794431|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
148814169|NCT02903914|536794432|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
148814170|NCT02903914|536794433|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
148814171|NCT02903914|536794434|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
148814172|NCT02903914|536794435|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
148814173|NCT02903914|536794428|FG000|Overall Study|Follow-up Did Not Occur|0|||
148814174|NCT02903914|536794429|FG001|Overall Study|Follow-up Did Not Occur|1|||
148814175|NCT02903914|536794430|FG002|Overall Study|Follow-up Did Not Occur|1|||
148814176|NCT02903914|536794431|FG003|Overall Study|Follow-up Did Not Occur|0|||
148814177|NCT02903914|536794432|FG004|Overall Study|Follow-up Did Not Occur|2|||
148814178|NCT02903914|536794433|FG005|Overall Study|Follow-up Did Not Occur|0|||
148814179|NCT02903914|536794434|FG006|Overall Study|Follow-up Did Not Occur|8|||
148814180|NCT02903914|536794435|FG007|Overall Study|Follow-up Did Not Occur|0|||
148814181|NCT02903914|536794428|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
148814182|NCT02903914|536794429|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
148814183|NCT02903914|536794430|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
148814184|NCT02903914|536794431|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
148814185|NCT02903914|536794432|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
148814186|NCT02903914|536794433|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
148814187|NCT02903914|536794434|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
148814188|NCT02903914|536794435|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
148814189|NCT02903914|536794428|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
148814190|NCT02903914|536794429|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
148814191|NCT02903914|536794430|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
148814192|NCT02903914|536794431|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
148814193|NCT02903914|536794432|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
148814194|NCT02903914|536794433|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
148814195|NCT02903914|536794434|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
148814196|NCT02903914|536794435|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
148814197|NCT02903914|536794428|FG000|Overall Study|Clinical Disease Progression|0|||
148814198|NCT02903914|536794429|FG001|Overall Study|Clinical Disease Progression|0|||
148814199|NCT02903914|536794430|FG002|Overall Study|Clinical Disease Progression|2|||
148814200|NCT02903914|536794431|FG003|Overall Study|Clinical Disease Progression|0|||
148814201|NCT02903914|536794432|FG004|Overall Study|Clinical Disease Progression|0|||
148814202|NCT02903914|536794433|FG005|Overall Study|Clinical Disease Progression|0|||
148814203|NCT02903914|536794434|FG006|Overall Study|Clinical Disease Progression|0|||
148814204|NCT02903914|536794435|FG007|Overall Study|Clinical Disease Progression|0|||
148814205|NCT02903914|536794428|FG000|Overall Study|Completed Follow-up Period|0|||
148697282|NCT00365300|536366481|FG000|Open-label Phase|Patient skipped open label phase|1|||
148697283|NCT00365300|536366482|FG001|Open-label Phase|Patient skipped open label phase|0|||
148697284|NCT00365300|536366481|FG000|Double-blind Phase|Failed to return|1|||
148697285|NCT00365300|536366482|FG001|Double-blind Phase|Failed to return|0|||
148697286|NCT00365300|536366481|FG000|Double-blind Phase|Noncompliance|1|||
148697287|NCT00365300|536366482|FG001|Double-blind Phase|Noncompliance|1|||
148697288|NCT00365300|536366481|FG000|Double-blind Phase|Withdrawal by Subject|0|||
148697289|NCT00365300|536366482|FG001|Double-blind Phase|Withdrawal by Subject|1|||
148697290|NCT00365300|536366481|FG000|Double-blind Phase|Protocol Violation|3|||
148697291|NCT00365300|536366482|FG001|Double-blind Phase|Protocol Violation|1|||
148697292|NCT00365300|536366481|FG000|Double-blind Phase|Lack of Efficacy|6|||
148697293|NCT00365300|536366482|FG001|Double-blind Phase|Lack of Efficacy|6|||
148697294|NCT01991470|536366483|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
148697295|NCT01991470|536366483|FG000|Enlite 1 Period|Adverse Event|1|||
148697296|NCT01991470|536366483|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
148697297|NCT01991470|536366483|FG000|Enlite 3 Period|Lost to Follow-up|1|||
148697298|NCT01991470|536366483|FG000|Enlite 3 Period|Physician Decision|2|||
148697299|NCT01991470|536366483|FG000|Enlite 3 Period|Physician Decision|8|||
148697300|NCT01991470|536366483|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
148697301|NCT02896361|536366484|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
148697302|NCT02896361|536366485|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
148697303|NCT02896361|536366486|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
148697304|NCT02896361|536366484|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
148697305|NCT02896361|536366485|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
148697306|NCT02896361|536366486|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
148697307|NCT02942264|536366489|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697308|NCT02942264|536366490|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
148814206|NCT02903914|536794429|FG001|Overall Study|Completed Follow-up Period|0|||
148814207|NCT02903914|536794430|FG002|Overall Study|Completed Follow-up Period|6|||
148814208|NCT02903914|536794431|FG003|Overall Study|Completed Follow-up Period|2|||
148697309|NCT02942264|536366491|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697310|NCT02942264|536366492|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697311|NCT02942264|536366493|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697312|NCT02942264|536366494|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697313|NCT02942264|536366495|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
148697314|NCT02942264|536366496|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697315|NCT02942264|536366497|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
148697316|NCT02942264|536366489|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697317|NCT02942264|536366490|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697318|NCT02942264|536366491|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697319|NCT02942264|536366492|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148814209|NCT02903914|536794432|FG004|Overall Study|Completed Follow-up Period|1|||
148814210|NCT02903914|536794433|FG005|Overall Study|Completed Follow-up Period|0|||
148814211|NCT02903914|536794434|FG006|Overall Study|Completed Follow-up Period|9|||
148814212|NCT02903914|536794435|FG007|Overall Study|Completed Follow-up Period|1|||
148814213|NCT02903914|536794428|FG000|Overall Study|Taken off Treatment per Protocol|0|||
148814214|NCT02903914|536794429|FG001|Overall Study|Taken off Treatment per Protocol|0|||
148814215|NCT02903914|536794430|FG002|Overall Study|Taken off Treatment per Protocol|0|||
148814216|NCT02903914|536794431|FG003|Overall Study|Taken off Treatment per Protocol|0|||
148814217|NCT02903914|536794432|FG004|Overall Study|Taken off Treatment per Protocol|0|||
148814218|NCT02903914|536794433|FG005|Overall Study|Taken off Treatment per Protocol|1|||
148814219|NCT02903914|536794434|FG006|Overall Study|Taken off Treatment per Protocol|0|||
148814220|NCT02903914|536794435|FG007|Overall Study|Taken off Treatment per Protocol|0|||
148814221|NCT02903914|536794428|FG000|Overall Study|Refused Further Treatment/Contact|0|||
148814222|NCT02903914|536794429|FG001|Overall Study|Refused Further Treatment/Contact|0|||
148697320|NCT02942264|536366493|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697321|NCT02942264|536366494|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697322|NCT02942264|536366495|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697323|NCT02942264|536366496|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
148697324|NCT02942264|536366497|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
148697325|NCT01328093|536366498|FG000|Double-Blind Phase|Adverse Event|78|||
148697326|NCT01328093|536366499|FG001|Double-Blind Phase|Adverse Event|15|||
148697327|NCT01328093|536366498|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
148697328|NCT01328093|536366499|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
148697329|NCT01328093|536366498|FG000|Double-Blind Phase|Lost to Follow-up|39|||
148697330|NCT01328093|536366499|FG001|Double-Blind Phase|Lost to Follow-up|14|||
148814223|NCT02903914|536794430|FG002|Overall Study|Refused Further Treatment/Contact|0|||
148814224|NCT02903914|536794431|FG003|Overall Study|Refused Further Treatment/Contact|0|||
148814225|NCT02903914|536794432|FG004|Overall Study|Refused Further Treatment/Contact|0|||
148814226|NCT02903914|536794433|FG005|Overall Study|Refused Further Treatment/Contact|0|||
148697331|NCT01328093|536366498|FG000|Double-Blind Phase|Protocol Violation|30|||
148964854|NCT03616912|537358415|FG002|Overall Study|Death|0|||
148964855|NCT03616912|537358416|FG003|Overall Study|Death|0|||
148964856|NCT03616912|537358417|FG004|Overall Study|Death|0|||
148964857|NCT03616912|537358418|FG005|Overall Study|Death|0|||
148964858|NCT03616912|537358413|FG000|Overall Study|Lack of Efficacy|13|||
148964859|NCT03616912|537358414|FG001|Overall Study|Lack of Efficacy|6|||
148964860|NCT03616912|537358415|FG002|Overall Study|Lack of Efficacy|8|||
148964861|NCT03616912|537358416|FG003|Overall Study|Lack of Efficacy|4|||
148964862|NCT03616912|537358417|FG004|Overall Study|Lack of Efficacy|5|||
148964863|NCT03616912|537358418|FG005|Overall Study|Lack of Efficacy|1|||
148964864|NCT03616912|537358413|FG000|Overall Study|Lost to Follow-up|1|||
148697332|NCT01328093|536366499|FG001|Double-Blind Phase|Protocol Violation|10|||
148697333|NCT01328093|536366498|FG000|Double-Blind Phase|Lack of Efficacy|55|||
148697334|NCT01328093|536366499|FG001|Double-Blind Phase|Lack of Efficacy|13|||
148697335|NCT01328093|536366498|FG000|Double-Blind Phase|Sponsor Decision|17|||
148697336|NCT01328093|536366499|FG001|Double-Blind Phase|Sponsor Decision|3|||
148697337|NCT01328093|536366498|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
148697338|NCT01328093|536366499|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
148697339|NCT01328093|536366498|FG000|Double-Blind Phase|Scheduling conflict|8|||
148697340|NCT01328093|536366499|FG001|Double-Blind Phase|Scheduling conflict|3|||
148697341|NCT01328093|536366498|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
148697342|NCT01328093|536366499|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
148697343|NCT01328093|536366498|FG000|Double-Blind Phase|Death|1|||
148697344|NCT01328093|536366499|FG001|Double-Blind Phase|Death|0|||
148697345|NCT01328093|536366498|FG000|Open-Label Phase|Sponsor Decision|98|||
148697346|NCT01328093|536366499|FG001|Open-Label Phase|Sponsor Decision|34|||
148697347|NCT01328093|536366498|FG000|Open-Label Phase|Protocol Violation|8|||
148697348|NCT01328093|536366499|FG001|Open-Label Phase|Protocol Violation|3|||
148697349|NCT01328093|536366498|FG000|Open-Label Phase|Lost to Follow-up|10|||
148697350|NCT01328093|536366499|FG001|Open-Label Phase|Lost to Follow-up|1|||
148697351|NCT01328093|536366498|FG000|Open-Label Phase|Adverse Event|10|||
148697352|NCT01328093|536366499|FG001|Open-Label Phase|Adverse Event|4|||
148697353|NCT01328093|536366498|FG000|Open-Label Phase|Lack of Efficacy|5|||
148697354|NCT01328093|536366499|FG001|Open-Label Phase|Lack of Efficacy|6|||
148697355|NCT01328093|536366498|FG000|Open-Label Phase|Withdrawal by Subject|4|||
148697356|NCT01328093|536366499|FG001|Open-Label Phase|Withdrawal by Subject|1|||
148697357|NCT01328093|536366498|FG000|Open-Label Phase|Scheduling conflict|2|||
148697358|NCT01328093|536366499|FG001|Open-Label Phase|Scheduling conflict|1|||
148697359|NCT01328093|536366498|FG000|Open-Label Phase|Subject is moving or has moved|2|||
148697360|NCT01328093|536366499|FG001|Open-Label Phase|Subject is moving or has moved|0|||
148697361|NCT01328093|536366498|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
148697362|NCT01328093|536366499|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
148697363|NCT03980483|536366502|FG000|Overall Study|Adverse Event|13|||
148697364|NCT03980483|536366503|FG001|Overall Study|Adverse Event|29|||
148697365|NCT03980483|536366504|FG002|Overall Study|Adverse Event|11|||
148697366|NCT03980483|536366505|FG003|Overall Study|Adverse Event|2|||
148697367|NCT03980483|536366506|FG004|Overall Study|Adverse Event|2|||
148697368|NCT03980483|536366507|FG005|Overall Study|Adverse Event|2|||
148697369|NCT03980483|536366502|FG000|Overall Study|Lack of Efficacy|7|||
148697370|NCT03980483|536366503|FG001|Overall Study|Lack of Efficacy|6|||
148697371|NCT03980483|536366504|FG002|Overall Study|Lack of Efficacy|0|||
148697372|NCT03980483|536366505|FG003|Overall Study|Lack of Efficacy|3|||
148697373|NCT03980483|536366506|FG004|Overall Study|Lack of Efficacy|1|||
148697374|NCT03980483|536366507|FG005|Overall Study|Lack of Efficacy|1|||
148697375|NCT03980483|536366502|FG000|Overall Study|Lost to Follow-up|2|||
148697376|NCT03980483|536366503|FG001|Overall Study|Lost to Follow-up|4|||
148697377|NCT03980483|536366504|FG002|Overall Study|Lost to Follow-up|2|||
149024189|NCT02403674|537564212|FG001|Base Study|Withdrawal by Subject|17|||
149024190|NCT02403674|537564211|FG000|Base Study|Physician Decision|2|||
148697378|NCT03980483|536366505|FG003|Overall Study|Lost to Follow-up|1|||
148697379|NCT03980483|536366506|FG004|Overall Study|Lost to Follow-up|2|||
148697380|NCT03980483|536366507|FG005|Overall Study|Lost to Follow-up|0|||
148697381|NCT03980483|536366502|FG000|Overall Study|Protocol Violation|4|||
148964865|NCT03616912|537358414|FG001|Overall Study|Lost to Follow-up|2|||
148964866|NCT03616912|537358415|FG002|Overall Study|Lost to Follow-up|3|||
148964867|NCT03616912|537358416|FG003|Overall Study|Lost to Follow-up|0|||
148697382|NCT03980483|536366503|FG001|Overall Study|Protocol Violation|2|||
148964868|NCT03616912|537358417|FG004|Overall Study|Lost to Follow-up|0|||
148964869|NCT03616912|537358418|FG005|Overall Study|Lost to Follow-up|0|||
148697383|NCT03980483|536366504|FG002|Overall Study|Protocol Violation|1|||
148697384|NCT03980483|536366505|FG003|Overall Study|Protocol Violation|1|||
148697385|NCT03980483|536366506|FG004|Overall Study|Protocol Violation|0|||
148697386|NCT03980483|536366507|FG005|Overall Study|Protocol Violation|0|||
148697387|NCT03980483|536366502|FG000|Overall Study|Physician Decision|14|||
148697388|NCT03980483|536366503|FG001|Overall Study|Physician Decision|10|||
148697389|NCT03980483|536366504|FG002|Overall Study|Physician Decision|7|||
148697390|NCT03980483|536366505|FG003|Overall Study|Physician Decision|4|||
148697391|NCT03980483|536366506|FG004|Overall Study|Physician Decision|4|||
148697392|NCT03980483|536366507|FG005|Overall Study|Physician Decision|2|||
148697393|NCT03980483|536366502|FG000|Overall Study|Withdrawal by Subject|38|||
148697394|NCT03980483|536366503|FG001|Overall Study|Withdrawal by Subject|21|||
148697395|NCT03980483|536366504|FG002|Overall Study|Withdrawal by Subject|15|||
148697396|NCT03980483|536366505|FG003|Overall Study|Withdrawal by Subject|5|||
148814227|NCT02903914|536794434|FG006|Overall Study|Refused Further Treatment/Contact|1|||
148697397|NCT03980483|536366506|FG004|Overall Study|Withdrawal by Subject|3|||
148697398|NCT03980483|536366507|FG005|Overall Study|Withdrawal by Subject|4|||
148697399|NCT03980483|536366502|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
148697400|NCT03980483|536366503|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
148814228|NCT02903914|536794435|FG007|Overall Study|Refused Further Treatment/Contact|0|||
148814229|NCT02903914|536794428|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814230|NCT02903914|536794429|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814231|NCT02903914|536794430|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814232|NCT02903914|536794431|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814233|NCT02903914|536794432|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814234|NCT02903914|536794433|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814235|NCT02903914|536794434|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
148814236|NCT02903914|536794435|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
148814237|NCT01757847|536794449|FG000|Overall Study|Withdrawal by Subject|3|||
148814238|NCT01757847|536794450|FG001|Overall Study|Withdrawal by Subject|4|||
148814239|NCT04556097|536794451|FG000|Overall Study|Death|0|||
148964870|NCT03616912|537358413|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
148964871|NCT03616912|537358414|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
148964872|NCT03616912|537358415|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
148964873|NCT03616912|537358416|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
148964874|NCT03616912|537358417|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
148697401|NCT03980483|536366504|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148697402|NCT03980483|536366505|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
148697403|NCT03980483|536366506|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148814240|NCT04556097|536794452|FG001|Overall Study|Death|5|||
148697404|NCT03980483|536366507|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148697405|NCT03980483|536366502|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
148697406|NCT03980483|536366503|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
148697407|NCT03980483|536366504|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
148697408|NCT03980483|536366505|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
148697409|NCT03980483|536366506|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
148697410|NCT03980483|536366507|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
148697411|NCT03980483|536366502|FG000|Overall Study|Other|0|||
148697412|NCT03980483|536366503|FG001|Overall Study|Other|1|||
148697413|NCT03980483|536366504|FG002|Overall Study|Other|0|||
148697414|NCT03980483|536366505|FG003|Overall Study|Other|0|||
148697415|NCT03980483|536366506|FG004|Overall Study|Other|0|||
148697416|NCT03980483|536366507|FG005|Overall Study|Other|0|||
148697417|NCT00760266|536366510|FG000|Overall Study|Adverse Event|13|||
148697418|NCT00760266|536366511|FG001|Overall Study|Adverse Event|7|||
148697419|NCT00760266|536366510|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148697420|NCT00760266|536366511|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148697421|NCT00760266|536366510|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148697422|NCT00760266|536366511|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148814241|NCT04556097|536794453|FG002|Overall Study|Death|0|||
148814242|NCT04556097|536794454|FG003|Overall Study|Death|0|||
148814243|NCT04556097|536794451|FG000|Overall Study|No caregiver|43|||
148814244|NCT04556097|536794452|FG001|Overall Study|No caregiver|53|||
148814245|NCT04556097|536794453|FG002|Overall Study|No caregiver|0|||
148814246|NCT04556097|536794454|FG003|Overall Study|No caregiver|0|||
148814247|NCT04556097|536794451|FG000|Overall Study|Ineligible, SNF|2|||
148814248|NCT04556097|536794452|FG001|Overall Study|Ineligible, SNF|2|||
148814249|NCT04556097|536794453|FG002|Overall Study|Ineligible, SNF|0|||
148814250|NCT04556097|536794454|FG003|Overall Study|Ineligible, SNF|0|||
148814251|NCT04556097|536794451|FG000|Overall Study|Ineligible, health|3|||
148814252|NCT04556097|536794452|FG001|Overall Study|Ineligible, health|4|||
149024191|NCT02403674|537564212|FG001|Base Study|Physician Decision|2|||
148697423|NCT00760266|536366510|FG000|Overall Study|Lack of Efficacy|2|||
148697424|NCT00760266|536366511|FG001|Overall Study|Lack of Efficacy|2|||
148697425|NCT00760266|536366510|FG000|Overall Study|Protocol deviation|2|||
148697426|NCT00760266|536366511|FG001|Overall Study|Protocol deviation|4|||
148697427|NCT00760266|536366510|FG000|Overall Study|Patient withdrew consent|3|||
148814253|NCT04556097|536794453|FG002|Overall Study|Ineligible, health|0|||
148964875|NCT03616912|537358418|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
148697428|NCT00760266|536366511|FG001|Overall Study|Patient withdrew consent|3|||
148697429|NCT00760266|536366510|FG000|Overall Study|Lost to Follow-up|2|||
148697430|NCT00760266|536366511|FG001|Overall Study|Lost to Follow-up|1|||
148697431|NCT00760266|536366510|FG000|Overall Study|Administrative Problems|0|||
148697432|NCT00760266|536366511|FG001|Overall Study|Administrative Problems|1|||
148697433|NCT05150964|536366512|FG000|Overall Study|Lost to Follow-up|2|||
148697434|NCT03657160|536366513|FG000|Overall Study|Adverse Event|5|||
148697435|NCT03657160|536366514|FG001|Overall Study|Adverse Event|6|||
148697436|NCT03657160|536366513|FG000|Overall Study|Protocol Deviation|3|||
148697437|NCT03657160|536366514|FG001|Overall Study|Protocol Deviation|0|||
148697438|NCT03657160|536366513|FG000|Overall Study|Withdrawal by Subject|18|||
148697439|NCT03657160|536366514|FG001|Overall Study|Withdrawal by Subject|16|||
148697440|NCT03657160|536366513|FG000|Overall Study|Site Termination|1|||
148697441|NCT03657160|536366514|FG001|Overall Study|Site Termination|0|||
148697442|NCT03657160|536366513|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
148697443|NCT03657160|536366514|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
148697444|NCT03657160|536366513|FG000|Overall Study|Death|33|||
148697445|NCT03657160|536366514|FG001|Overall Study|Death|26|||
148697446|NCT03657160|536366513|FG000|Overall Study|Death (COVID-19-Related)|1|||
148697447|NCT03657160|536366514|FG001|Overall Study|Death (COVID-19-Related)|0|||
148697448|NCT03657160|536366513|FG000|Overall Study|Reason Not Specified|5|||
148697449|NCT03657160|536366514|FG001|Overall Study|Reason Not Specified|5|||
148697450|NCT03657160|536366513|FG000|Overall Study|Other (COVID-19-Related)|0|||
148697451|NCT03657160|536366514|FG001|Overall Study|Other (COVID-19-Related)|1|||
148697452|NCT00686959|536366516|FG000|Overall Study|Participants censored (no death events)|124|||
148697453|NCT00686959|536366517|FG001|Overall Study|Participants censored (no death events)|117|||
148697454|NCT02178722|536366518|FG000|Overall Study|Withdrawal by Subject|0|||
148697455|NCT02178722|536366519|FG001|Overall Study|Withdrawal by Subject|0|||
148697456|NCT02178722|536366520|FG002|Overall Study|Withdrawal by Subject|0|||
148697457|NCT02178722|536366521|FG003|Overall Study|Withdrawal by Subject|2|||
148697458|NCT02178722|536366522|FG004|Overall Study|Withdrawal by Subject|33|||
148697459|NCT02178722|536366518|FG000|Overall Study|Death|2|||
148964876|NCT03616912|537358413|FG000|Overall Study|Withdrawal by Subject|12|||
148697460|NCT02178722|536366519|FG001|Overall Study|Death|13|||
148697461|NCT02178722|536366520|FG002|Overall Study|Death|12|||
148697462|NCT02178722|536366521|FG003|Overall Study|Death|12|||
148697463|NCT02178722|536366522|FG004|Overall Study|Death|205|||
148964877|NCT03616912|537358414|FG001|Overall Study|Withdrawal by Subject|12|||
148697464|NCT02178722|536366518|FG000|Overall Study|Lost to Follow-up|0|||
148697465|NCT02178722|536366519|FG001|Overall Study|Lost to Follow-up|0|||
148697466|NCT02178722|536366520|FG002|Overall Study|Lost to Follow-up|0|||
148697467|NCT02178722|536366521|FG003|Overall Study|Lost to Follow-up|2|||
148697468|NCT02178722|536366522|FG004|Overall Study|Lost to Follow-up|11|||
148697469|NCT02178722|536366518|FG000|Overall Study|Study terminated by Sponsor|2|||
148697470|NCT02178722|536366519|FG001|Overall Study|Study terminated by Sponsor|7|||
148697471|NCT02178722|536366520|FG002|Overall Study|Study terminated by Sponsor|6|||
148697472|NCT02178722|536366521|FG003|Overall Study|Study terminated by Sponsor|4|||
148697473|NCT02178722|536366522|FG004|Overall Study|Study terminated by Sponsor|128|||
148697474|NCT02178722|536366518|FG000|Overall Study|Physician Decision|0|||
148697475|NCT02178722|536366519|FG001|Overall Study|Physician Decision|0|||
148697476|NCT02178722|536366520|FG002|Overall Study|Physician Decision|0|||
148697477|NCT02178722|536366521|FG003|Overall Study|Physician Decision|0|||
148697478|NCT02178722|536366522|FG004|Overall Study|Physician Decision|3|||
148697479|NCT02178722|536366518|FG000|Overall Study|Other|0|||
148697480|NCT02178722|536366519|FG001|Overall Study|Other|0|||
148697481|NCT02178722|536366520|FG002|Overall Study|Other|0|||
148697482|NCT02178722|536366521|FG003|Overall Study|Other|0|||
148697483|NCT02178722|536366522|FG004|Overall Study|Other|2|||
148697484|NCT00440557|536366523|FG000|Overall Study|Withdrawal by Subject|10|||
148697485|NCT00440557|536366524|FG001|Overall Study|Withdrawal by Subject|5|||
148697486|NCT00440557|536366525|FG002|Overall Study|Withdrawal by Subject|11|||
148697487|NCT00440557|536366523|FG000|Overall Study|Lost to Follow-up|1|||
148814254|NCT04556097|536794454|FG003|Overall Study|Ineligible, health|0|||
148697488|NCT00440557|536366524|FG001|Overall Study|Lost to Follow-up|2|||
148697489|NCT00440557|536366525|FG002|Overall Study|Lost to Follow-up|6|||
148697490|NCT00440557|536366523|FG000|Overall Study|Adverse Event|3|||
148697491|NCT00440557|536366524|FG001|Overall Study|Adverse Event|3|||
148964878|NCT03616912|537358415|FG002|Overall Study|Withdrawal by Subject|15|||
148964879|NCT03616912|537358416|FG003|Overall Study|Withdrawal by Subject|2|||
148964880|NCT03616912|537358417|FG004|Overall Study|Withdrawal by Subject|0|||
148964881|NCT03616912|537358418|FG005|Overall Study|Withdrawal by Subject|2|||
148697492|NCT00440557|536366525|FG002|Overall Study|Adverse Event|5|||
148697493|NCT00440557|536366523|FG000|Overall Study|Death|2|||
148697494|NCT00440557|536366524|FG001|Overall Study|Death|6|||
148697495|NCT00440557|536366525|FG002|Overall Study|Death|3|||
148697496|NCT00440557|536366523|FG000|Overall Study|Began Dialysis|4|||
148697497|NCT00440557|536366524|FG001|Overall Study|Began Dialysis|1|||
148697498|NCT00440557|536366525|FG002|Overall Study|Began Dialysis|4|||
148697499|NCT00440557|536366523|FG000|Overall Study|Principal Investigator decision|0|||
148697500|NCT00440557|536366524|FG001|Overall Study|Principal Investigator decision|3|||
148814255|NCT04556097|536794451|FG000|Overall Study|Ineligible, language|0|||
148697501|NCT00440557|536366525|FG002|Overall Study|Principal Investigator decision|1|||
148697502|NCT00440557|536366523|FG000|Overall Study|Patient moved|1|||
148814256|NCT04556097|536794452|FG001|Overall Study|Ineligible, language|1|||
148814257|NCT04556097|536794453|FG002|Overall Study|Ineligible, language|0|||
148814258|NCT04556097|536794454|FG003|Overall Study|Ineligible, language|0|||
148697503|NCT00440557|536366524|FG001|Overall Study|Patient moved|2|||
148697504|NCT00440557|536366525|FG002|Overall Study|Patient moved|1|||
148697505|NCT00440557|536366523|FG000|Overall Study|Principal Investigator's office closed|3|||
148697506|NCT00440557|536366524|FG001|Overall Study|Principal Investigator's office closed|6|||
148697507|NCT00440557|536366525|FG002|Overall Study|Principal Investigator's office closed|4|||
148697508|NCT00440557|536366523|FG000|Overall Study|Patient transferred to nursing home|0|||
148697509|NCT00440557|536366524|FG001|Overall Study|Patient transferred to nursing home|1|||
148697510|NCT00440557|536366525|FG002|Overall Study|Patient transferred to nursing home|0|||
148697511|NCT00440557|536366523|FG000|Overall Study|Patient had surgery|1|||
148697512|NCT00440557|536366524|FG001|Overall Study|Patient had surgery|0|||
148697513|NCT00440557|536366525|FG002|Overall Study|Patient had surgery|0|||
148697514|NCT01572948|536366526|FG000|Overall Study|Lost to Follow-up|1|||
148697515|NCT01572948|536366527|FG001|Overall Study|Lost to Follow-up|0|||
148697516|NCT01572948|536366526|FG000|Overall Study|unable to contact|0|||
148697517|NCT01572948|536366527|FG001|Overall Study|unable to contact|1|||
148697518|NCT01126736|536366533|FG000|Overall Study|Death|2|||
148814259|NCT04556097|536794451|FG000|Overall Study|Ineligible, no longer in care management|0|||
148814260|NCT04556097|536794452|FG001|Overall Study|Ineligible, no longer in care management|2|||
148814261|NCT04556097|536794453|FG002|Overall Study|Ineligible, no longer in care management|1|||
148814262|NCT04556097|536794454|FG003|Overall Study|Ineligible, no longer in care management|0|||
148814263|NCT04556097|536794451|FG000|Overall Study|No dementia|13|||
148964882|NCT03616912|537358413|FG000|Overall Study|Study Terminated by Sponsor|0|||
148964883|NCT03616912|537358414|FG001|Overall Study|Study Terminated by Sponsor|0|||
148964884|NCT03616912|537358415|FG002|Overall Study|Study Terminated by Sponsor|0|||
148964885|NCT03616912|537358416|FG003|Overall Study|Study Terminated by Sponsor|10|||
148697519|NCT01126736|536366534|FG001|Overall Study|Death|2|||
148697520|NCT01126736|536366535|FG002|Overall Study|Death|1|||
148697521|NCT01126736|536366536|FG003|Overall Study|Death|19|||
148697522|NCT01126736|536366537|FG004|Overall Study|Death|19|||
148697523|NCT01126736|536366533|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
148697524|NCT01126736|536366534|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
148697525|NCT01126736|536366535|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
148697526|NCT01126736|536366536|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
148697527|NCT01126736|536366537|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
148964886|NCT03616912|537358417|FG004|Overall Study|Study Terminated by Sponsor|9|||
148964887|NCT03616912|537358418|FG005|Overall Study|Study Terminated by Sponsor|11|||
148964888|NCT03616912|537358413|FG000|Overall Study|Protocol Deviation|1|||
148964889|NCT03616912|537358414|FG001|Overall Study|Protocol Deviation|1|||
148964890|NCT03616912|537358415|FG002|Overall Study|Protocol Deviation|0|||
148964891|NCT03616912|537358416|FG003|Overall Study|Protocol Deviation|0|||
148964892|NCT03616912|537358417|FG004|Overall Study|Protocol Deviation|0|||
148964893|NCT03616912|537358418|FG005|Overall Study|Protocol Deviation|0|||
148964894|NCT03616912|537358413|FG000|Overall Study|Pregnancy|1|||
148964895|NCT03616912|537358414|FG001|Overall Study|Pregnancy|0|||
148964896|NCT03616912|537358415|FG002|Overall Study|Pregnancy|4|||
148697528|NCT01126736|536366533|FG000|Overall Study|Lost to Follow-up|0|||
148697529|NCT01126736|536366534|FG001|Overall Study|Lost to Follow-up|0|||
148697530|NCT01126736|536366535|FG002|Overall Study|Lost to Follow-up|0|||
148697531|NCT01126736|536366536|FG003|Overall Study|Lost to Follow-up|1|||
148964897|NCT03616912|537358416|FG003|Overall Study|Pregnancy|0|||
148964898|NCT03616912|537358417|FG004|Overall Study|Pregnancy|0|||
148964899|NCT03616912|537358418|FG005|Overall Study|Pregnancy|0|||
148964900|NCT03616912|537358413|FG000|Overall Study|Protocol Violation|1|||
148964901|NCT03616912|537358414|FG001|Overall Study|Protocol Violation|0|||
148964902|NCT03616912|537358415|FG002|Overall Study|Protocol Violation|2|||
148964903|NCT03616912|537358416|FG003|Overall Study|Protocol Violation|0|||
148964904|NCT03616912|537358417|FG004|Overall Study|Protocol Violation|0|||
148964905|NCT03616912|537358418|FG005|Overall Study|Protocol Violation|0|||
148964906|NCT03616912|537358413|FG000|Overall Study|Physician Decision|2|||
148964907|NCT03616912|537358414|FG001|Overall Study|Physician Decision|0|||
148964908|NCT03616912|537358415|FG002|Overall Study|Physician Decision|0|||
148964909|NCT03616912|537358416|FG003|Overall Study|Physician Decision|0|||
148964910|NCT03616912|537358417|FG004|Overall Study|Physician Decision|1|||
148964911|NCT03616912|537358418|FG005|Overall Study|Physician Decision|0|||
148964912|NCT03616912|537358413|FG000|Overall Study|Randomized But Never Treated|0|||
148697532|NCT01126736|536366537|FG004|Overall Study|Lost to Follow-up|1|||
148697533|NCT01126736|536366533|FG000|Overall Study|Administrative reasons|0|||
148697534|NCT01126736|536366534|FG001|Overall Study|Administrative reasons|0|||
148697535|NCT01126736|536366535|FG002|Overall Study|Administrative reasons|0|||
148697536|NCT01126736|536366536|FG003|Overall Study|Administrative reasons|0|||
148697537|NCT01126736|536366537|FG004|Overall Study|Administrative reasons|1|||
148697538|NCT01126736|536366533|FG000|Overall Study|Progressive disease|0|||
148697539|NCT01126736|536366534|FG001|Overall Study|Progressive disease|0|||
148697540|NCT01126736|536366535|FG002|Overall Study|Progressive disease|0|||
148697541|NCT01126736|536366536|FG003|Overall Study|Progressive disease|2|||
148697542|NCT01126736|536366537|FG004|Overall Study|Progressive disease|1|||
148697543|NCT01126736|536366533|FG000|Overall Study|Withdrawal by Subject|0|||
148697544|NCT01126736|536366534|FG001|Overall Study|Withdrawal by Subject|0|||
148697545|NCT01126736|536366535|FG002|Overall Study|Withdrawal by Subject|0|||
148697546|NCT01126736|536366536|FG003|Overall Study|Withdrawal by Subject|1|||
148697547|NCT01126736|536366537|FG004|Overall Study|Withdrawal by Subject|1|||
148697548|NCT01126736|536366533|FG000|Overall Study|Other|2|||
148697549|NCT01126736|536366534|FG001|Overall Study|Other|4|||
148697550|NCT01126736|536366535|FG002|Overall Study|Other|4|||
148697551|NCT01126736|536366536|FG003|Overall Study|Other|16|||
148697552|NCT01126736|536366537|FG004|Overall Study|Other|15|||
148697553|NCT01720264|536366542|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
148697554|NCT01720264|536366542|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
148697555|NCT01720264|536366542|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
148697556|NCT03018249|536366549|FG000|Overall Study|Withdrawal by Subject|2|||
148697557|NCT03018249|536366550|FG001|Overall Study|Withdrawal by Subject|2|||
148697558|NCT01030965|536366554|FG000|Overall Study|Lack of Efficacy|3|||
148697559|NCT01030965|536366555|FG001|Overall Study|Lack of Efficacy|2|||
148697560|NCT01030965|536366556|FG002|Overall Study|Lack of Efficacy|0|||
148697561|NCT01030965|536366557|FG003|Overall Study|Lack of Efficacy|3|||
148697562|NCT01030965|536366554|FG000|Overall Study|Protocol Violation|1|||
148697563|NCT01030965|536366555|FG001|Overall Study|Protocol Violation|1|||
148697564|NCT01030965|536366556|FG002|Overall Study|Protocol Violation|1|||
148697565|NCT01030965|536366557|FG003|Overall Study|Protocol Violation|1|||
148697566|NCT01030965|536366554|FG000|Overall Study|Adverse Event|0|||
148697567|NCT01030965|536366555|FG001|Overall Study|Adverse Event|1|||
148697568|NCT01030965|536366556|FG002|Overall Study|Adverse Event|2|||
148697569|NCT01030965|536366557|FG003|Overall Study|Adverse Event|1|||
148697570|NCT01030965|536366554|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
148697571|NCT01030965|536366555|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
148697572|NCT01030965|536366556|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
148697573|NCT01030965|536366557|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
148697574|NCT01030965|536366554|FG000|Overall Study|Withdrawal by Subject|0|||
148697575|NCT01030965|536366555|FG001|Overall Study|Withdrawal by Subject|1|||
148697576|NCT01030965|536366556|FG002|Overall Study|Withdrawal by Subject|0|||
148697577|NCT01030965|536366557|FG003|Overall Study|Withdrawal by Subject|2|||
148697578|NCT02097290|536366558|FG000|Overall Study|Death|6|||
148697579|NCT02097290|536366558|FG000|Overall Study|Total Withdrawals|3|||
148697580|NCT02097290|536366558|FG000|Overall Study|Attempt|8|||
148697581|NCT03144687|536366561|FG000|Overall Study|Death|0|||
148697582|NCT03144687|536366562|FG001|Overall Study|Death|2|||
148697583|NCT03144687|536366561|FG000|Overall Study|Lost to Follow-up|0|||
148697584|NCT03144687|536366562|FG001|Overall Study|Lost to Follow-up|1|||
148697585|NCT03144687|536366561|FG000|Overall Study|Physician Decision|0|||
148697586|NCT03144687|536366562|FG001|Overall Study|Physician Decision|1|||
148697587|NCT03144687|536366561|FG000|Overall Study|Withdrawal by Subject|1|||
148697588|NCT03144687|536366562|FG001|Overall Study|Withdrawal by Subject|3|||
148697589|NCT03144687|536366561|FG000|Overall Study|Not Reported|2|||
148697590|NCT03144687|536366562|FG001|Overall Study|Not Reported|0|||
148697591|NCT00824265|536366565|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
148697592|NCT00824265|536366566|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
148697593|NCT00824265|536366565|FG000|Treatment Phase|Protocol Violation|1|||
148697594|NCT00824265|536366566|FG001|Treatment Phase|Protocol Violation|0|||
148697595|NCT00824265|536366565|FG000|Treatment Phase|Lost to Follow-up|1|||
148697596|NCT00824265|536366566|FG001|Treatment Phase|Lost to Follow-up|1|||
148697597|NCT00824265|536366565|FG000|Treatment Phase|Physician Decision|6|||
148697598|NCT00824265|536366566|FG001|Treatment Phase|Physician Decision|12|||
148697599|NCT00824265|536366565|FG000|Treatment Phase|Withdrawal by Subject|6|||
148697600|NCT00824265|536366566|FG001|Treatment Phase|Withdrawal by Subject|15|||
148697601|NCT00824265|536366565|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
148697602|NCT00824265|536366566|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
148697603|NCT00824265|536366565|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
148697604|NCT00824265|536366566|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
148697605|NCT02888171|536366567|FG000|Overall Study|Lost to Follow-up|2|||
148697606|NCT02888171|536366568|FG001|Overall Study|Lost to Follow-up|1|||
148697607|NCT02888171|536366567|FG000|Overall Study|Withdrawal by Subject|3|||
148697608|NCT02888171|536366568|FG001|Overall Study|Withdrawal by Subject|2|||
148697609|NCT02888171|536366567|FG000|Overall Study|Adverse Event|0|||
148697610|NCT02888171|536366568|FG001|Overall Study|Adverse Event|1|||
148697611|NCT01402947|536366571|FG000|First Intervention|Adverse Event|0|||
148697612|NCT01402947|536366572|FG001|First Intervention|Adverse Event|1|||
148697613|NCT00591630|536366573|FG000|Overall Study|Death|0|||
148697614|NCT00591630|536366574|FG001|Overall Study|Death|0|||
148964913|NCT03616912|537358414|FG001|Overall Study|Randomized But Never Treated|2|||
148964914|NCT03616912|537358415|FG002|Overall Study|Randomized But Never Treated|0|||
148964915|NCT03616912|537358416|FG003|Overall Study|Randomized But Never Treated|0|||
148964916|NCT03616912|537358417|FG004|Overall Study|Randomized But Never Treated|0|||
148814264|NCT04556097|536794452|FG001|Overall Study|No dementia|3|||
148814265|NCT04556097|536794453|FG002|Overall Study|No dementia|0|||
148814266|NCT04556097|536794454|FG003|Overall Study|No dementia|0|||
148814267|NCT04556097|536794451|FG000|Overall Study|Missing identifier|2|||
148814268|NCT04556097|536794452|FG001|Overall Study|Missing identifier|4|||
148814269|NCT04556097|536794453|FG002|Overall Study|Missing identifier|0|||
148814270|NCT04556097|536794454|FG003|Overall Study|Missing identifier|0|||
148814271|NCT04556097|536794451|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
148814272|NCT04556097|536794452|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
148814273|NCT04556097|536794453|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
148814274|NCT04556097|536794454|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
148814275|NCT02337686|536794456|FG000|Overall Study|Adverse Event|1|||
148814276|NCT03439514|536795579|FG000|Double-Blind Treatment Period|Other|4|||
148697615|NCT00591630|536366575|FG002|Overall Study|Death|1|||
148697616|NCT00591630|536366576|FG003|Overall Study|Death|0|||
148697617|NCT01387737|536367816|FG000|Overall Study|Adverse Event|20|||
148697618|NCT01387737|536367817|FG001|Overall Study|Adverse Event|30|||
149024192|NCT02403674|537564211|FG000|Base Study|Pregnancy|2|||
149024193|NCT02403674|537564212|FG001|Base Study|Pregnancy|2|||
149024194|NCT02403674|537564211|FG000|Base Study|Protocol Violation|8|||
148697619|NCT01387737|536367816|FG000|Overall Study|Lack of Efficacy|1|||
148697620|NCT01387737|536367817|FG001|Overall Study|Lack of Efficacy|0|||
148697621|NCT01387737|536367816|FG000|Overall Study|Physician Decision|3|||
148697622|NCT01387737|536367817|FG001|Overall Study|Physician Decision|10|||
148697623|NCT01387737|536367816|FG000|Overall Study|Withdrawal by Subject|27|||
148697624|NCT01387737|536367817|FG001|Overall Study|Withdrawal by Subject|31|||
148697625|NCT01387737|536367816|FG000|Overall Study|Clearly not eligible for the study|1|||
148697626|NCT01387737|536367817|FG001|Overall Study|Clearly not eligible for the study|3|||
148697627|NCT03075761|536367818|FG000|Overall Study|Lost to Follow-up|1|||
148697628|NCT03075761|536367819|FG001|Overall Study|Lost to Follow-up|6|||
148697629|NCT00485472|536367820|FG000|Overall Study|Adverse Event|8|||
148814277|NCT03439514|536795580|FG001|Double-Blind Treatment Period|Other|1|||
148814278|NCT03439514|536795579|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
148697630|NCT00485472|536367821|FG001|Overall Study|Adverse Event|5|||
148964917|NCT03616912|537358418|FG005|Overall Study|Randomized But Never Treated|0|||
148964918|NCT04091646|537358419|FG000|Overall Study|Adverse Event|2|||
148964919|NCT04091646|537358420|FG001|Overall Study|Adverse Event|1|||
148964920|NCT04091646|537358419|FG000|Overall Study|Lost to Follow-up|6|||
148697631|NCT00485472|536367820|FG000|Overall Study|Lack of Efficacy|5|||
148697632|NCT00485472|536367821|FG001|Overall Study|Lack of Efficacy|4|||
148697633|NCT00485472|536367820|FG000|Overall Study|Withdrawal by Subject|1|||
148697634|NCT00485472|536367821|FG001|Overall Study|Withdrawal by Subject|0|||
148697635|NCT00485472|536367820|FG000|Overall Study|Protocol Violation|0|||
148697636|NCT00485472|536367821|FG001|Overall Study|Protocol Violation|1|||
148814279|NCT03439514|536795580|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
148814280|NCT03439514|536795579|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
148697637|NCT00485472|536367820|FG000|Overall Study|Other|2|||
148697638|NCT00485472|536367821|FG001|Overall Study|Other|1|||
148697639|NCT00485472|536367820|FG000|Overall Study|Lost to Follow-up|0|||
148697640|NCT00485472|536367821|FG001|Overall Study|Lost to Follow-up|1|||
148697641|NCT01492361|536367822|FG000|Overall Study|Withdrawal by Subject|281|||
148697642|NCT01492361|536367823|FG001|Overall Study|Withdrawal by Subject|297|||
148697643|NCT01492361|536367822|FG000|Overall Study|Physician Decision|12|||
148697644|NCT01492361|536367823|FG001|Overall Study|Physician Decision|12|||
148697645|NCT01492361|536367822|FG000|Overall Study|Lost to Follow-up|6|||
148697646|NCT01492361|536367823|FG001|Overall Study|Lost to Follow-up|13|||
149024195|NCT02403674|537564212|FG001|Base Study|Protocol Violation|4|||
148697647|NCT01492361|536367822|FG000|Overall Study|Other than specified above|106|||
148697648|NCT01492361|536367823|FG001|Overall Study|Other than specified above|138|||
148964921|NCT04091646|537358420|FG001|Overall Study|Lost to Follow-up|2|||
148964922|NCT04091646|537358419|FG000|Overall Study|Protocol Violation|0|||
149024196|NCT02403674|537564211|FG000|Base Study|Non-Compliance with study drug|1|||
149024197|NCT02403674|537564212|FG001|Base Study|Non-Compliance with study drug|4|||
149024198|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
148697649|NCT00560235|536367824|FG000|Phase 1|Discontinued|8|||
148697650|NCT00560235|536367825|FG001|Phase 1|Discontinued|0|||
148697651|NCT00560235|536367826|FG002|Phase 1|Discontinued|0|||
148697652|NCT00560235|536367824|FG000|Phase 1B|Discontinued|0|||
148697653|NCT00560235|536367825|FG001|Phase 1B|Discontinued|19|||
148697654|NCT00560235|536367826|FG002|Phase 1B|Discontinued|0|||
148697655|NCT00560235|536367824|FG000|Phase 2|Discontinued|0|||
148697656|NCT00560235|536367825|FG001|Phase 2|Discontinued|0|||
148697657|NCT00560235|536367826|FG002|Phase 2|Discontinued|96|||
148697658|NCT00560235|536367824|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
148814281|NCT03439514|536795580|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
148814282|NCT03439514|536795579|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
148814283|NCT03439514|536795580|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
148814284|NCT03439514|536795579|FG000|Double-Blind Treatment Period|Death|1|||
148814285|NCT03439514|536795580|FG001|Double-Blind Treatment Period|Death|2|||
148697659|NCT00560235|536367825|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
148697660|NCT00560235|536367826|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
148697661|NCT04015232|536367827|FG000|Overall Study|Withdrawal by Subject|7|||
148697662|NCT04015232|536367828|FG001|Overall Study|Withdrawal by Subject|4|||
148814286|NCT02175758|536795581|FG000|Treatment Phase|Lost to Follow-up|0|||
148814287|NCT02175758|536795582|FG001|Treatment Phase|Lost to Follow-up|1|||
148697663|NCT04015232|536367827|FG000|Overall Study|Protocol Violation|1|||
148697664|NCT04015232|536367828|FG001|Overall Study|Protocol Violation|0|||
148697665|NCT04015232|536367827|FG000|Overall Study|Medical Grounds|3|||
148697666|NCT04015232|536367828|FG001|Overall Study|Medical Grounds|3|||
148814288|NCT02175758|536795583|FG002|Treatment Phase|Lost to Follow-up|0|||
148814289|NCT02175758|536795584|FG003|Treatment Phase|Lost to Follow-up|0|||
148814290|NCT02175758|536795585|FG004|Treatment Phase|Lost to Follow-up|0|||
148814291|NCT02175758|536795586|FG005|Treatment Phase|Lost to Follow-up|0|||
148814292|NCT02175758|536795581|FG000|Treatment Phase|Adverse Event|0|||
148814293|NCT02175758|536795582|FG001|Treatment Phase|Adverse Event|0|||
148814294|NCT02175758|536795583|FG002|Treatment Phase|Adverse Event|0|||
148814295|NCT02175758|536795584|FG003|Treatment Phase|Adverse Event|0|||
148814296|NCT02175758|536795585|FG004|Treatment Phase|Adverse Event|1|||
148964923|NCT04091646|537358420|FG001|Overall Study|Protocol Violation|1|||
148964924|NCT04091646|537358419|FG000|Overall Study|Withdrawal by Subject|4|||
148964925|NCT04091646|537358420|FG001|Overall Study|Withdrawal by Subject|1|||
148964926|NCT04091646|537358419|FG000|Overall Study|Participant Incarcerated|1|||
148964927|NCT04091646|537358420|FG001|Overall Study|Participant Incarcerated|0|||
148964928|NCT01921829|537358421|FG000|Overall Study|Withdrawal by Subject|0|||
148964929|NCT01921829|537358422|FG001|Overall Study|Withdrawal by Subject|1|||
148964930|NCT01762943|537358423|FG000|Overall Study|Physician Decision|1|||
148964931|NCT01762943|537358424|FG001|Overall Study|Physician Decision|1|||
148964932|NCT01762943|537358423|FG000|Overall Study|Protocol Violation|1|||
148697667|NCT00496964|536367835|FG000|Overall Study|Withdrawal by Subject|0|||
148964933|NCT01762943|537358424|FG001|Overall Study|Protocol Violation|0|||
148964934|NCT01762943|537358423|FG000|Overall Study|Withdrawal by Subject|2|||
148697668|NCT00496964|536367836|FG001|Overall Study|Withdrawal by Subject|1|||
148964935|NCT01762943|537358424|FG001|Overall Study|Withdrawal by Subject|1|||
148964936|NCT00539838|537358425|FG000|Overall Study|Fail to return|2|||
148964937|NCT00539838|537358426|FG001|Overall Study|Fail to return|0|||
148964938|NCT00539838|537358427|FG002|Overall Study|Fail to return|0|||
148964939|NCT00539838|537358425|FG000|Overall Study|Withdrawal by Subject|0|||
148964940|NCT00539838|537358426|FG001|Overall Study|Withdrawal by Subject|4|||
148964941|NCT00539838|537358427|FG002|Overall Study|Withdrawal by Subject|0|||
148964942|NCT00539838|537358425|FG000|Overall Study|Death|0|||
148964943|NCT00539838|537358426|FG001|Overall Study|Death|2|||
148964944|NCT00539838|537358427|FG002|Overall Study|Death|0|||
148964945|NCT00539838|537358425|FG000|Overall Study|Did not cooperate|1|||
148964946|NCT00539838|537358426|FG001|Overall Study|Did not cooperate|0|||
148964947|NCT00539838|537358427|FG002|Overall Study|Did not cooperate|1|||
148964948|NCT00539838|537358425|FG000|Overall Study|Administrative|4|||
148964949|NCT00539838|537358426|FG001|Overall Study|Administrative|0|||
148964950|NCT00539838|537358427|FG002|Overall Study|Administrative|8|||
148964951|NCT02658890|537358430|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964952|NCT02658890|537358431|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148697669|NCT01239121|536367839|FG000|Overall Study|Withdrawal by Subject|2|||
148697670|NCT01239121|536367840|FG001|Overall Study|Withdrawal by Subject|4|||
148697671|NCT01239121|536367841|FG002|Overall Study|Withdrawal by Subject|0|||
148697672|NCT02017964|536367844|FG000|Overall Study|Patient deemed ineligible|1|||
148697673|NCT01434693|536367845|FG000|Overall Study|Adverse Event|1|||
148697674|NCT01434693|536367846|FG001|Overall Study|Adverse Event|0|||
148964953|NCT02658890|537358432|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964954|NCT02658890|537358433|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964955|NCT02658890|537358434|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148697675|NCT01434693|536367847|FG002|Overall Study|Adverse Event|0|||
148697676|NCT01434693|536367848|FG003|Overall Study|Adverse Event|0|||
148697677|NCT01434693|536367845|FG000|Overall Study|Withdrawal by Subject|1|||
148697678|NCT01434693|536367846|FG001|Overall Study|Withdrawal by Subject|0|||
148697679|NCT01434693|536367847|FG002|Overall Study|Withdrawal by Subject|1|||
148697680|NCT01434693|536367848|FG003|Overall Study|Withdrawal by Subject|1|||
148697681|NCT01434693|536367845|FG000|Overall Study|Lost to Follow-up|1|||
148697682|NCT01434693|536367846|FG001|Overall Study|Lost to Follow-up|0|||
148697683|NCT01434693|536367847|FG002|Overall Study|Lost to Follow-up|0|||
148697684|NCT01434693|536367848|FG003|Overall Study|Lost to Follow-up|0|||
148697685|NCT04006171|536367849|FG000|Overall Study|Withdrawal by Subject|8|||
148697686|NCT04006171|536367850|FG001|Overall Study|Withdrawal by Subject|7|||
148697687|NCT04006171|536367849|FG000|Overall Study|missing serum samples|2|||
148964956|NCT02658890|537358435|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964957|NCT02658890|537358436|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964958|NCT02658890|537358437|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964959|NCT02658890|537358438|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
148964960|NCT02658890|537358439|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964961|NCT02658890|537358440|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964962|NCT02658890|537358441|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964963|NCT02658890|537358442|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964964|NCT02658890|537358443|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964965|NCT02658890|537358444|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964966|NCT02658890|537358445|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964967|NCT02658890|537358446|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964968|NCT02658890|537358447|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964969|NCT02658890|537358448|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964970|NCT02658890|537358449|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964971|NCT02658890|537358450|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964972|NCT02658890|537358451|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964973|NCT02658890|537358452|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148814297|NCT02175758|536795586|FG005|Treatment Phase|Adverse Event|0|||
148814298|NCT02299167|536795589|FG000|Overall Study|patients were excluded from the study|11|||
148814299|NCT03600428|536795590|FG000|Overall Study|Not eligible|0|||
148814300|NCT03600428|536795591|FG001|Overall Study|Not eligible|1|||
148814301|NCT03600428|536795590|FG000|Overall Study|Lost to Follow-up|5|||
148814302|NCT03600428|536795591|FG001|Overall Study|Lost to Follow-up|4|||
148814303|NCT03506477|536795598|FG000|Overall Study|Withdrawal by Subject|1|||
148814304|NCT03506477|536795599|FG001|Overall Study|Withdrawal by Subject|0|||
148814305|NCT03462680|536795600|FG000|Overall Study|Withdrawal by Subject|3|||
148814306|NCT03462680|536795601|FG001|Overall Study|Withdrawal by Subject|5|||
148814307|NCT02516241|536795602|FG000|Overall Study|Death|255|||
148814308|NCT02516241|536795603|FG001|Overall Study|Death|262|||
148814309|NCT02516241|536795604|FG002|Overall Study|Death|270|||
148814310|NCT02516241|536795602|FG000|Overall Study|Lost to Follow-up|1|||
148814311|NCT02516241|536795603|FG001|Overall Study|Lost to Follow-up|1|||
148814312|NCT02516241|536795604|FG002|Overall Study|Lost to Follow-up|3|||
148814313|NCT02516241|536795602|FG000|Overall Study|Withdrawal by Subject|2|||
148964974|NCT02658890|537358453|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148814314|NCT02516241|536795603|FG001|Overall Study|Withdrawal by Subject|7|||
148814315|NCT02516241|536795604|FG002|Overall Study|Withdrawal by Subject|12|||
148814316|NCT02516241|536795602|FG000|Overall Study|participants ongoing at data cut-off|84|||
148814317|NCT02516241|536795603|FG001|Overall Study|participants ongoing at data cut-off|76|||
148814318|NCT02516241|536795604|FG002|Overall Study|participants ongoing at data cut-off|59|||
148814319|NCT04057365|536795605|FG000|Overall Study|Withdrawal by Subject|2|||
148814320|NCT04057365|536795606|FG001|Overall Study|Withdrawal by Subject|0|||
148814321|NCT04738487|536795607|FG000|Overall Study|Participant Ongoing in Study|298|||
148964975|NCT02658890|537358454|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148814322|NCT04738487|536795608|FG001|Overall Study|Participant Ongoing in Study|297|||
148964976|NCT02658890|537358455|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964977|NCT02658890|537358456|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148964978|NCT02658890|537358430|FG000|Treatment Phase|Adverse Event|0|||
148964979|NCT02658890|537358431|FG001|Treatment Phase|Adverse Event|1|||
148964980|NCT02658890|537358432|FG002|Treatment Phase|Adverse Event|2|||
148964981|NCT02658890|537358433|FG003|Treatment Phase|Adverse Event|2|||
148964982|NCT02658890|537358434|FG004|Treatment Phase|Adverse Event|1|||
148964983|NCT02658890|537358435|FG005|Treatment Phase|Adverse Event|0|||
148964984|NCT02658890|537358436|FG006|Treatment Phase|Adverse Event|0|||
148697688|NCT04006171|536367850|FG001|Overall Study|missing serum samples|2|||
148697689|NCT04006171|536367849|FG000|Overall Study|insufficient sample volume|2|||
148697690|NCT04006171|536367850|FG001|Overall Study|insufficient sample volume|3|||
148697691|NCT00912288|536367851|FG000|Overall Study|Death|0|||
148697692|NCT00912288|536367852|FG001|Overall Study|Death|1|||
148697693|NCT00912288|536367851|FG000|Overall Study|Adverse Event|1|||
148697694|NCT00912288|536367852|FG001|Overall Study|Adverse Event|1|||
148697695|NCT00912288|536367851|FG000|Overall Study|Lost to Follow-up|1|||
148697696|NCT00912288|536367852|FG001|Overall Study|Lost to Follow-up|0|||
148697697|NCT00912288|536367851|FG000|Overall Study|Protocol Violation|1|||
148814323|NCT04738487|536795607|FG000|Overall Study|Withdrawal by Subject|7|||
148814324|NCT04738487|536795608|FG001|Overall Study|Withdrawal by Subject|9|||
148814325|NCT04738487|536795607|FG000|Overall Study|Lost to Follow-up|2|||
148814326|NCT04738487|536795608|FG001|Overall Study|Lost to Follow-up|0|||
148814327|NCT04738487|536795607|FG000|Overall Study|Death|287|||
148814328|NCT04738487|536795608|FG001|Overall Study|Death|306|||
148814329|NCT01260948|536795609|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
148814330|NCT01260948|536795610|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
148814331|NCT01260948|536795609|FG000|Second Intervention|Emesis|0|||
148814332|NCT01260948|536795610|FG001|Second Intervention|Emesis|1|||
148814333|NCT00462462|536795611|FG000|Overall Study|Physician Decision|0|||
148814334|NCT00462462|536795612|FG001|Overall Study|Physician Decision|1|||
148814335|NCT02555878|536795613|FG000|Overall Study|Lost to Follow-up|2|||
148814336|NCT02555878|536795614|FG001|Overall Study|Lost to Follow-up|3|||
148814337|NCT02555878|536795613|FG000|Overall Study|Withdrawal by Subject|48|||
148814338|NCT02555878|536795614|FG001|Overall Study|Withdrawal by Subject|48|||
148814339|NCT02555878|536795613|FG000|Overall Study|Adverse Event|12|||
148814340|NCT02555878|536795614|FG001|Overall Study|Adverse Event|8|||
148814341|NCT02555878|536795613|FG000|Overall Study|Death|74|||
148814342|NCT02555878|536795614|FG001|Overall Study|Death|59|||
148814343|NCT02555878|536795613|FG000|Overall Study|Protocol Violation|1|||
148814344|NCT02555878|536795614|FG001|Overall Study|Protocol Violation|2|||
148814345|NCT02555878|536795613|FG000|Overall Study|Physician Decision|12|||
148814346|NCT02555878|536795614|FG001|Overall Study|Physician Decision|13|||
148814347|NCT02555878|536795613|FG000|Overall Study|Other|17|||
148814348|NCT02555878|536795614|FG001|Overall Study|Other|17|||
148814349|NCT00765076|536795615|FG000|Overall Study|Adverse Event|1|||
148814350|NCT00765076|536795616|FG001|Overall Study|Adverse Event|0|||
148814351|NCT00765076|536795617|FG002|Overall Study|Adverse Event|0|||
148814352|NCT00765076|536795615|FG000|Overall Study|Withdrawal by Subject|0|||
148814353|NCT00765076|536795616|FG001|Overall Study|Withdrawal by Subject|0|||
148814354|NCT00765076|536795617|FG002|Overall Study|Withdrawal by Subject|1|||
148964985|NCT02658890|537358437|FG007|Treatment Phase|Adverse Event|2|||
148964986|NCT02658890|537358438|FG008|Treatment Phase|Adverse Event|1|||
148697698|NCT00912288|536367852|FG001|Overall Study|Protocol Violation|0|||
148697699|NCT00912288|536367851|FG000|Overall Study|Withdrawal by Subject|3|||
148697700|NCT00912288|536367852|FG001|Overall Study|Withdrawal by Subject|3|||
148697701|NCT00912288|536367851|FG000|Overall Study|Study terminated by sponsor|34|||
148814355|NCT01163617|536795618|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148814356|NCT01163617|536795619|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
148814357|NCT01163617|536795620|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148814358|NCT01163617|536795621|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148964987|NCT02658890|537358439|FG009|Treatment Phase|Adverse Event|2|||
148964988|NCT02658890|537358440|FG010|Treatment Phase|Adverse Event|3|||
148964989|NCT02658890|537358441|FG011|Treatment Phase|Adverse Event|0|||
148814359|NCT01163617|536795622|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148814360|NCT01163617|536795623|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148964990|NCT02658890|537358442|FG012|Treatment Phase|Adverse Event|1|||
148697702|NCT00912288|536367852|FG001|Overall Study|Study terminated by sponsor|35|||
148697703|NCT00912288|536367851|FG000|Overall Study|Other|1|||
148697704|NCT00912288|536367852|FG001|Overall Study|Other|0|||
148814361|NCT01163617|536795624|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148814362|NCT01163617|536795625|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
148814363|NCT01163617|536795618|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148814364|NCT01163617|536795619|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
148814365|NCT01163617|536795620|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148814366|NCT01163617|536795621|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148814367|NCT01163617|536795622|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148814368|NCT01163617|536795623|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148814369|NCT01163617|536795624|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148814370|NCT01163617|536795625|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
148964991|NCT02658890|537358443|FG013|Treatment Phase|Adverse Event|4|||
148964992|NCT02658890|537358444|FG014|Treatment Phase|Adverse Event|0|||
148964993|NCT02658890|537358445|FG015|Treatment Phase|Adverse Event|0|||
148964994|NCT02658890|537358446|FG016|Treatment Phase|Adverse Event|0|||
148964995|NCT02658890|537358447|FG017|Treatment Phase|Adverse Event|0|||
148964996|NCT02658890|537358448|FG018|Treatment Phase|Adverse Event|5|||
148964997|NCT02658890|537358449|FG019|Treatment Phase|Adverse Event|1|||
148964998|NCT02658890|537358450|FG020|Treatment Phase|Adverse Event|3|||
148964999|NCT02658890|537358451|FG021|Treatment Phase|Adverse Event|0|||
148965000|NCT02658890|537358452|FG022|Treatment Phase|Adverse Event|5|||
148965001|NCT02658890|537358453|FG023|Treatment Phase|Adverse Event|0|||
148965002|NCT02658890|537358454|FG024|Treatment Phase|Adverse Event|0|||
148965003|NCT02658890|537358455|FG025|Treatment Phase|Adverse Event|2|||
148965004|NCT02658890|537358456|FG026|Treatment Phase|Adverse Event|1|||
148965005|NCT02658890|537358430|FG000|Treatment Phase|Death|0|||
148965006|NCT02658890|537358431|FG001|Treatment Phase|Death|0|||
148965007|NCT02658890|537358432|FG002|Treatment Phase|Death|0|||
148965008|NCT02658890|537358433|FG003|Treatment Phase|Death|0|||
148965009|NCT02658890|537358434|FG004|Treatment Phase|Death|0|||
148965010|NCT02658890|537358435|FG005|Treatment Phase|Death|0|||
148965011|NCT02658890|537358436|FG006|Treatment Phase|Death|0|||
148965012|NCT02658890|537358437|FG007|Treatment Phase|Death|0|||
148965013|NCT02658890|537358438|FG008|Treatment Phase|Death|0|||
148965014|NCT02658890|537358439|FG009|Treatment Phase|Death|0|||
148965015|NCT02658890|537358440|FG010|Treatment Phase|Death|0|||
148965016|NCT02658890|537358441|FG011|Treatment Phase|Death|0|||
148965017|NCT02658890|537358442|FG012|Treatment Phase|Death|0|||
148965018|NCT02658890|537358443|FG013|Treatment Phase|Death|0|||
148965019|NCT02658890|537358444|FG014|Treatment Phase|Death|0|||
148965020|NCT02658890|537358445|FG015|Treatment Phase|Death|0|||
148965021|NCT02658890|537358446|FG016|Treatment Phase|Death|0|||
148965022|NCT02658890|537358447|FG017|Treatment Phase|Death|0|||
148965023|NCT02658890|537358448|FG018|Treatment Phase|Death|1|||
148965024|NCT02658890|537358449|FG019|Treatment Phase|Death|0|||
148965025|NCT02658890|537358450|FG020|Treatment Phase|Death|0|||
148965026|NCT02658890|537358451|FG021|Treatment Phase|Death|0|||
148965027|NCT02658890|537358452|FG022|Treatment Phase|Death|0|||
148965028|NCT02658890|537358453|FG023|Treatment Phase|Death|0|||
148965029|NCT02658890|537358454|FG024|Treatment Phase|Death|0|||
148965030|NCT02658890|537358455|FG025|Treatment Phase|Death|0|||
148965031|NCT02658890|537358456|FG026|Treatment Phase|Death|0|||
148965032|NCT02658890|537358430|FG000|Treatment Phase|Lost to Follow-up|0|||
148965033|NCT02658890|537358431|FG001|Treatment Phase|Lost to Follow-up|0|||
148965034|NCT02658890|537358432|FG002|Treatment Phase|Lost to Follow-up|0|||
148697705|NCT01440283|536367853|FG000|Overall Study|Death|3|||
148697706|NCT01440283|536367853|FG000|Overall Study|Withdrawal by Subject|4|||
148697707|NCT01440283|536367853|FG000|Overall Study|Physician Decision|3|||
148697708|NCT01449630|536367857|FG000|Period 1|Physician Decision|1|||
148697709|NCT01449630|536367858|FG001|Period 1|Physician Decision|0|||
148697710|NCT01449630|536367859|FG002|Period 1|Physician Decision|0|||
148697711|NCT01449630|536367860|FG003|Period 1|Physician Decision|1|||
148697712|NCT01449630|536367861|FG004|Period 1|Physician Decision|0|||
148697713|NCT01449630|536367862|FG005|Period 1|Physician Decision|0|||
148697714|NCT01449630|536367863|FG006|Period 1|Physician Decision|0|||
148697715|NCT01449630|536367864|FG007|Period 1|Physician Decision|0|||
148697716|NCT01449630|536367865|FG008|Period 1|Physician Decision|0|||
148697717|NCT01449630|536367857|FG000|Period 1|Sponsor Decision|0|||
148697718|NCT01449630|536367858|FG001|Period 1|Sponsor Decision|0|||
148697719|NCT01449630|536367859|FG002|Period 1|Sponsor Decision|0|||
148697720|NCT01449630|536367860|FG003|Period 1|Sponsor Decision|0|||
148697721|NCT01449630|536367861|FG004|Period 1|Sponsor Decision|0|||
148697722|NCT01449630|536367862|FG005|Period 1|Sponsor Decision|1|||
148697723|NCT01449630|536367863|FG006|Period 1|Sponsor Decision|0|||
148697724|NCT01449630|536367864|FG007|Period 1|Sponsor Decision|0|||
148697725|NCT01449630|536367865|FG008|Period 1|Sponsor Decision|0|||
148697726|NCT01449630|536367857|FG000|Period 2|Sponsor Decision|0|||
148697727|NCT01449630|536367858|FG001|Period 2|Sponsor Decision|0|||
148697728|NCT01449630|536367859|FG002|Period 2|Sponsor Decision|0|||
148697729|NCT01449630|536367860|FG003|Period 2|Sponsor Decision|0|||
148697730|NCT01449630|536367861|FG004|Period 2|Sponsor Decision|0|||
148697731|NCT01449630|536367862|FG005|Period 2|Sponsor Decision|0|||
148697732|NCT01449630|536367863|FG006|Period 2|Sponsor Decision|1|||
148697733|NCT01449630|536367864|FG007|Period 2|Sponsor Decision|0|||
148697734|NCT01449630|536367865|FG008|Period 2|Sponsor Decision|0|||
148965035|NCT02658890|537358433|FG003|Treatment Phase|Lost to Follow-up|0|||
148697735|NCT02087904|536367870|FG000|Overall Study|Did Not Receive Study Drug|0|||
148697736|NCT02087904|536367871|FG001|Overall Study|Did Not Receive Study Drug|0|||
148697737|NCT02087904|536367872|FG002|Overall Study|Did Not Receive Study Drug|2|||
148697738|NCT02087904|536367873|FG003|Overall Study|Did Not Receive Study Drug|1|||
148697739|NCT02087904|536367870|FG000|Overall Study|Adverse Event|8|||
148697740|NCT02087904|536367871|FG001|Overall Study|Adverse Event|4|||
148965036|NCT02658890|537358434|FG004|Treatment Phase|Lost to Follow-up|0|||
148965037|NCT02658890|537358435|FG005|Treatment Phase|Lost to Follow-up|0|||
148697741|NCT02087904|536367872|FG002|Overall Study|Adverse Event|4|||
148697742|NCT02087904|536367873|FG003|Overall Study|Adverse Event|12|||
148697743|NCT02087904|536367870|FG000|Overall Study|Lack of Efficacy|3|||
148697744|NCT02087904|536367871|FG001|Overall Study|Lack of Efficacy|6|||
148888858|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888859|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888860|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888861|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148814371|NCT01163617|536795618|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148814372|NCT01163617|536795619|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148814373|NCT01163617|536795620|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
148814374|NCT01163617|536795621|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148814375|NCT01163617|536795622|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148814376|NCT01163617|536795623|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148965038|NCT02658890|537358436|FG006|Treatment Phase|Lost to Follow-up|1|||
148965039|NCT02658890|537358437|FG007|Treatment Phase|Lost to Follow-up|0|||
148697745|NCT02087904|536367872|FG002|Overall Study|Lack of Efficacy|3|||
148697746|NCT02087904|536367873|FG003|Overall Study|Lack of Efficacy|2|||
148697747|NCT02087904|536367870|FG000|Overall Study|Other|6|||
148697748|NCT02087904|536367871|FG001|Overall Study|Other|2|||
148697749|NCT02087904|536367872|FG002|Overall Study|Other|4|||
148697750|NCT02087904|536367873|FG003|Overall Study|Other|4|||
148697751|NCT02087904|536367870|FG000|Overall Study|Withdrawal by Subject|8|||
148697752|NCT02087904|536367871|FG001|Overall Study|Withdrawal by Subject|3|||
148697753|NCT02087904|536367872|FG002|Overall Study|Withdrawal by Subject|7|||
148697754|NCT02087904|536367873|FG003|Overall Study|Withdrawal by Subject|4|||
148697755|NCT02087904|536367870|FG000|Overall Study|Lost to Follow-up|0|||
148697756|NCT02087904|536367871|FG001|Overall Study|Lost to Follow-up|4|||
148697757|NCT02087904|536367872|FG002|Overall Study|Lost to Follow-up|2|||
148697758|NCT02087904|536367873|FG003|Overall Study|Lost to Follow-up|2|||
148697759|NCT01735630|536367874|FG000|Overall Study|Adverse Event|8|||
148697760|NCT01735630|536367875|FG001|Overall Study|Adverse Event|7|||
148697761|NCT01735630|536367874|FG000|Overall Study|Lost to Follow-up|1|||
148697762|NCT01735630|536367875|FG001|Overall Study|Lost to Follow-up|0|||
148697763|NCT01735630|536367874|FG000|Overall Study|Physician Decision|0|||
148697764|NCT01735630|536367875|FG001|Overall Study|Physician Decision|1|||
148697765|NCT01735630|536367874|FG000|Overall Study|Sponsor Decision|2|||
148697766|NCT01735630|536367875|FG001|Overall Study|Sponsor Decision|1|||
148697767|NCT01735630|536367874|FG000|Overall Study|Withdrawal by Subject|7|||
148697768|NCT01735630|536367875|FG001|Overall Study|Withdrawal by Subject|9|||
148697769|NCT03099538|536367877|FG000|Overall Study|Lack of Efficacy|3|||
148965040|NCT02658890|537358438|FG008|Treatment Phase|Lost to Follow-up|0|||
148965041|NCT02658890|537358439|FG009|Treatment Phase|Lost to Follow-up|0|||
148965042|NCT02658890|537358440|FG010|Treatment Phase|Lost to Follow-up|0|||
148965043|NCT02658890|537358441|FG011|Treatment Phase|Lost to Follow-up|0|||
148965044|NCT02658890|537358442|FG012|Treatment Phase|Lost to Follow-up|0|||
148965045|NCT02658890|537358443|FG013|Treatment Phase|Lost to Follow-up|0|||
148697770|NCT01196052|536367878|FG000|Overall Study|Adverse Event|9|||
148697771|NCT01196052|536367878|FG000|Overall Study|Lost to Follow-up|1|||
148697772|NCT01196052|536367878|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
148697773|NCT01196052|536367878|FG000|Overall Study|Reason not Specified|5|||
148697774|NCT01196052|536367878|FG000|Overall Study|Withdrawal by Subject|6|||
148697775|NCT04625114|536367879|FG000|Overall Study|Adverse Event|3|||
148697776|NCT04625114|536367880|FG001|Overall Study|Adverse Event|1|||
148697777|NCT04625114|536367879|FG000|Overall Study|Withdrawal by Subject|2|||
148697778|NCT04625114|536367880|FG001|Overall Study|Withdrawal by Subject|0|||
148965046|NCT02658890|537358444|FG014|Treatment Phase|Lost to Follow-up|0|||
148697779|NCT01629381|536367881|FG000|Overall Study|Withdrawal by Subject|2|||
148965047|NCT02658890|537358445|FG015|Treatment Phase|Lost to Follow-up|0|||
148965048|NCT02658890|537358446|FG016|Treatment Phase|Lost to Follow-up|0|||
148697780|NCT01629381|536367882|FG001|Overall Study|Withdrawal by Subject|5|||
148697781|NCT00906347|536367885|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
148697782|NCT00906347|536367886|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
148697783|NCT00906347|536367885|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
148697784|NCT00906347|536367886|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
149024199|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
148697785|NCT00906347|536367885|FG000|Received Study Drug|Refused study drug|1|||
148697786|NCT00906347|536367886|FG001|Received Study Drug|Refused study drug|0|||
148697787|NCT00906347|536367885|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
148697788|NCT00906347|536367886|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
148697789|NCT02849652|536367894|FG000|Overall Study|Lost to Follow-up|104|||
148697790|NCT02849652|536367895|FG001|Overall Study|Lost to Follow-up|35|||
148697791|NCT02849652|536367896|FG002|Overall Study|Lost to Follow-up|116|||
148697792|NCT02849652|536367897|FG003|Overall Study|Lost to Follow-up|22|||
148697793|NCT02849652|536367894|FG000|Overall Study|Withdrawal by Subject|10|||
148697794|NCT02849652|536367895|FG001|Overall Study|Withdrawal by Subject|2|||
148697795|NCT02849652|536367896|FG002|Overall Study|Withdrawal by Subject|8|||
148697796|NCT02849652|536367897|FG003|Overall Study|Withdrawal by Subject|4|||
148697797|NCT00472290|536367898|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
148697798|NCT00472290|536367898|FG000|Overall Study|Protocol Specified Criteria|7|||
148697799|NCT00472290|536367898|FG000|Overall Study|Administrative Decision|37|||
148697800|NCT00472290|536367898|FG000|Overall Study|Death|3|||
148697801|NCT00472290|536367898|FG000|Overall Study|Lost to Follow-up|1|||
148697802|NCT00472290|536367898|FG000|Overall Study|Lack of Efficacy|1|||
148697803|NCT00472290|536367898|FG000|Overall Study|Disease Progression|4|||
148697804|NCT00472290|536367898|FG000|Overall Study|Withdrawal by Subject|5|||
148697805|NCT00472290|536367898|FG000|Overall Study|Adverse Event|6|||
148697806|NCT00472290|536367898|FG000|Overall Study|Requirement for alternative therapy|7|||
148697807|NCT00777829|536367899|FG000|Overall Study|Withdrawal by Subject|0|||
148697808|NCT00777829|536367900|FG001|Overall Study|Withdrawal by Subject|2|||
148697809|NCT00854308|536367909|FG000|Overall Study|Disease progression|42|||
148697810|NCT00854308|536367910|FG001|Overall Study|Disease progression|50|||
148697811|NCT00854308|536367909|FG000|Overall Study|Adverse Event|8|||
148697812|NCT00854308|536367910|FG001|Overall Study|Adverse Event|3|||
148965049|NCT02658890|537358447|FG017|Treatment Phase|Lost to Follow-up|0|||
148965050|NCT02658890|537358448|FG018|Treatment Phase|Lost to Follow-up|0|||
148965051|NCT02658890|537358449|FG019|Treatment Phase|Lost to Follow-up|0|||
148697813|NCT00854308|536367909|FG000|Overall Study|Death|2|||
148697814|NCT00854308|536367910|FG001|Overall Study|Death|5|||
148697815|NCT00854308|536367909|FG000|Overall Study|Physician Decision|6|||
148697816|NCT00854308|536367910|FG001|Overall Study|Physician Decision|6|||
148697817|NCT00854308|536367909|FG000|Overall Study|Withdrawal by Subject|4|||
148697818|NCT00854308|536367910|FG001|Overall Study|Withdrawal by Subject|2|||
148697819|NCT00854308|536367909|FG000|Overall Study|Sponsor's decision to terminate study|0|||
148965052|NCT02658890|537358450|FG020|Treatment Phase|Lost to Follow-up|0|||
148965053|NCT02658890|537358451|FG021|Treatment Phase|Lost to Follow-up|0|||
148965054|NCT02658890|537358452|FG022|Treatment Phase|Lost to Follow-up|0|||
148965055|NCT02658890|537358453|FG023|Treatment Phase|Lost to Follow-up|0|||
148965056|NCT02658890|537358454|FG024|Treatment Phase|Lost to Follow-up|0|||
148697820|NCT00854308|536367910|FG001|Overall Study|Sponsor's decision to terminate study|1|||
148697821|NCT01390844|536367911|FG000|Treatment Phase|Adverse Event|12|||
148697822|NCT01390844|536367912|FG001|Treatment Phase|Adverse Event|2|||
148697823|NCT01390844|536367913|FG002|Treatment Phase|Adverse Event|3|||
148697824|NCT01390844|536367914|FG003|Treatment Phase|Adverse Event|2|||
149024200|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
148697825|NCT01390844|536367911|FG000|Treatment Phase|Treatment Failure|23|||
148697826|NCT01390844|536367912|FG001|Treatment Phase|Treatment Failure|25|||
148697827|NCT01390844|536367913|FG002|Treatment Phase|Treatment Failure|10|||
148697828|NCT01390844|536367914|FG003|Treatment Phase|Treatment Failure|13|||
148697829|NCT01390844|536367911|FG000|Treatment Phase|Non-Medical Reasons|5|||
148965057|NCT02658890|537358455|FG025|Treatment Phase|Lost to Follow-up|0|||
148965058|NCT02658890|537358456|FG026|Treatment Phase|Lost to Follow-up|0|||
148965059|NCT02658890|537358430|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
148965060|NCT02658890|537358431|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
148965061|NCT02658890|537358432|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
148697830|NCT01390844|536367912|FG001|Treatment Phase|Non-Medical Reasons|1|||
148697831|NCT01390844|536367913|FG002|Treatment Phase|Non-Medical Reasons|8|||
148697832|NCT01390844|536367914|FG003|Treatment Phase|Non-Medical Reasons|1|||
148697833|NCT01390844|536367911|FG000|Treatment Phase|Non-GCP Compliant|0|||
148697834|NCT01390844|536367912|FG001|Treatment Phase|Non-GCP Compliant|0|||
148697835|NCT01390844|536367913|FG002|Treatment Phase|Non-GCP Compliant|10|||
148697836|NCT01390844|536367914|FG003|Treatment Phase|Non-GCP Compliant|3|||
148697837|NCT01390844|536367911|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
148814377|NCT01163617|536795624|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148814378|NCT01163617|536795625|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
148814379|NCT02875080|536795626|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
148814380|NCT02875080|536795627|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
148814381|NCT02875080|536795628|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
148814382|NCT02394756|536795629|FG000|Period 1|Lens Discomfort|0|||
148814383|NCT02394756|536795630|FG001|Period 1|Lens Discomfort|0|||
148814384|NCT02394756|536795631|FG002|Period 1|Lens Discomfort|0|||
148814385|NCT02394756|536795632|FG003|Period 1|Lens Discomfort|0|||
148814386|NCT02394756|536795633|FG004|Period 1|Lens Discomfort|0|||
148814387|NCT02394756|536795634|FG005|Period 1|Lens Discomfort|1|||
148814388|NCT02394756|536795629|FG000|Period 1|Withdrawal by Subject|0|||
148814389|NCT02394756|536795630|FG001|Period 1|Withdrawal by Subject|1|||
148814390|NCT02394756|536795631|FG002|Period 1|Withdrawal by Subject|1|||
148814391|NCT02394756|536795632|FG003|Period 1|Withdrawal by Subject|1|||
148814392|NCT02394756|536795633|FG004|Period 1|Withdrawal by Subject|0|||
148814393|NCT02394756|536795634|FG005|Period 1|Withdrawal by Subject|0|||
148814394|NCT02394756|536795629|FG000|Period 2|Unsatisfactory Visual Response|0|||
148814395|NCT02394756|536795630|FG001|Period 2|Unsatisfactory Visual Response|0|||
148814396|NCT02394756|536795631|FG002|Period 2|Unsatisfactory Visual Response|0|||
148814397|NCT02394756|536795632|FG003|Period 2|Unsatisfactory Visual Response|0|||
148814398|NCT02394756|536795633|FG004|Period 2|Unsatisfactory Visual Response|1|||
148814399|NCT02394756|536795634|FG005|Period 2|Unsatisfactory Visual Response|0|||
148814400|NCT00768053|536795635|FG000|Overall Study|Adverse Event|10|||
148814401|NCT00768053|536795635|FG000|Overall Study|Lost to Follow-up|1|||
148814402|NCT01164475|536795636|FG000|Overall Study|Lack of Efficacy|1|||
148814403|NCT01164475|536795637|FG001|Overall Study|Lack of Efficacy|0|||
148814404|NCT01164475|536795636|FG000|Overall Study|Other|0|||
148814405|NCT01164475|536795637|FG001|Overall Study|Other|1|||
148814406|NCT01164475|536795636|FG000|Overall Study|Progressive disease|0|||
148814407|NCT01164475|536795637|FG001|Overall Study|Progressive disease|1|||
148814408|NCT01164475|536795636|FG000|Overall Study|Protocol Violation|1|||
148814409|NCT01164475|536795637|FG001|Overall Study|Protocol Violation|0|||
148814410|NCT02335944|536795638|FG000|Treatment Phase|Progressive Disease|2|||
148814411|NCT02335944|536795639|FG001|Treatment Phase|Progressive Disease|5|||
148814412|NCT02335944|536795640|FG002|Treatment Phase|Progressive Disease|2|||
148814413|NCT02335944|536795641|FG003|Treatment Phase|Progressive Disease|11|||
148814414|NCT02335944|536795642|FG004|Treatment Phase|Progressive Disease|4|||
148697838|NCT01390844|536367912|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
148697839|NCT01390844|536367913|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
148697840|NCT01390844|536367914|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
148697841|NCT00745095|536367915|FG000|Overall Study|Declined to participate|1|||
148697842|NCT00745095|536367916|FG001|Overall Study|Declined to participate|0|||
148697843|NCT00745095|536367917|FG002|Overall Study|Declined to participate|0|||
148697844|NCT00745095|536367918|FG003|Overall Study|Declined to participate|0|||
148814415|NCT02335944|536795643|FG005|Treatment Phase|Progressive Disease|25|||
148814416|NCT02335944|536795644|FG006|Treatment Phase|Progressive Disease|2|||
148814417|NCT02335944|536795645|FG007|Treatment Phase|Progressive Disease|30|||
148814418|NCT02335944|536795646|FG008|Treatment Phase|Progressive Disease|27|||
148965062|NCT02658890|537358433|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
148965063|NCT02658890|537358434|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
148814419|NCT02335944|536795647|FG009|Treatment Phase|Progressive Disease|0|||
148814420|NCT02335944|536795638|FG000|Treatment Phase|Adverse Event|2|||
148697845|NCT00745095|536367919|FG004|Overall Study|Declined to participate|92|||
148697846|NCT00745095|536367920|FG005|Overall Study|Declined to participate|95|||
148814421|NCT02335944|536795639|FG001|Treatment Phase|Adverse Event|0|||
148814422|NCT02335944|536795640|FG002|Treatment Phase|Adverse Event|0|||
148814423|NCT02335944|536795641|FG003|Treatment Phase|Adverse Event|2|||
148814424|NCT02335944|536795642|FG004|Treatment Phase|Adverse Event|1|||
148814425|NCT02335944|536795643|FG005|Treatment Phase|Adverse Event|15|||
148814426|NCT02335944|536795644|FG006|Treatment Phase|Adverse Event|0|||
148814427|NCT02335944|536795645|FG007|Treatment Phase|Adverse Event|5|||
148814428|NCT02335944|536795646|FG008|Treatment Phase|Adverse Event|7|||
148814429|NCT02335944|536795647|FG009|Treatment Phase|Adverse Event|0|||
148814430|NCT02335944|536795638|FG000|Treatment Phase|Physician Decision|0|||
148697847|NCT00745095|536367915|FG000|Overall Study|Ineligible due to GFR criteria|0|||
148697848|NCT00745095|536367916|FG001|Overall Study|Ineligible due to GFR criteria|2|||
148697849|NCT00745095|536367917|FG002|Overall Study|Ineligible due to GFR criteria|3|||
148697850|NCT00745095|536367918|FG003|Overall Study|Ineligible due to GFR criteria|3|||
148697851|NCT00745095|536367919|FG004|Overall Study|Ineligible due to GFR criteria|30|||
148697852|NCT00745095|536367920|FG005|Overall Study|Ineligible due to GFR criteria|28|||
148697853|NCT01479439|536367925|FG000|Overall Study|Adverse Event|1|||
148697854|NCT01479439|536367926|FG001|Overall Study|Adverse Event|0|||
148697855|NCT01479439|536367927|FG002|Overall Study|Adverse Event|0|||
148697856|NCT01479439|536367925|FG000|Overall Study|Lost to Follow-up|0|||
148697857|NCT01479439|536367926|FG001|Overall Study|Lost to Follow-up|1|||
148697858|NCT01479439|536367927|FG002|Overall Study|Lost to Follow-up|0|||
148697859|NCT01479439|536367925|FG000|Overall Study|Protocol Violation|0|||
148697860|NCT01479439|536367926|FG001|Overall Study|Protocol Violation|0|||
148697861|NCT01479439|536367927|FG002|Overall Study|Protocol Violation|2|||
148697862|NCT02079766|536367928|FG000|Overall Study|Physician Decision|1|||
148697863|NCT02079766|536367929|FG001|Overall Study|Physician Decision|0|||
148697864|NCT02079766|536367928|FG000|Overall Study|Withdrawal by Subject|1|||
148697865|NCT02079766|536367929|FG001|Overall Study|Withdrawal by Subject|0|||
148814431|NCT02335944|536795639|FG001|Treatment Phase|Physician Decision|0|||
148697866|NCT00304083|536367935|FG000|Overall Study|Withdrawal by Subject|4|||
148814432|NCT02335944|536795640|FG002|Treatment Phase|Physician Decision|0|||
148814433|NCT02335944|536795641|FG003|Treatment Phase|Physician Decision|1|||
148814434|NCT02335944|536795642|FG004|Treatment Phase|Physician Decision|0|||
148814435|NCT02335944|536795643|FG005|Treatment Phase|Physician Decision|6|||
148814436|NCT02335944|536795644|FG006|Treatment Phase|Physician Decision|1|||
148814437|NCT02335944|536795645|FG007|Treatment Phase|Physician Decision|2|||
148814438|NCT02335944|536795646|FG008|Treatment Phase|Physician Decision|1|||
148814439|NCT02335944|536795647|FG009|Treatment Phase|Physician Decision|0|||
148814440|NCT02335944|536795638|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
148814441|NCT02335944|536795639|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
148814442|NCT02335944|536795640|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
148814443|NCT02335944|536795641|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
148814444|NCT02335944|536795642|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
148814445|NCT02335944|536795643|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
148697867|NCT00304083|536367936|FG001|Overall Study|Withdrawal by Subject|2|||
148697868|NCT00304083|536367935|FG000|Overall Study|Physician Decision|8|||
148697869|NCT00304083|536367936|FG001|Overall Study|Physician Decision|3|||
148697870|NCT00304083|536367935|FG000|Overall Study|Disease Progression|5|||
148965064|NCT02658890|537358435|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
148965065|NCT02658890|537358436|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
148965066|NCT02658890|537358437|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
148965067|NCT02658890|537358438|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
148965068|NCT02658890|537358439|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
148965069|NCT02658890|537358440|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
148965070|NCT02658890|537358441|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
148965071|NCT02658890|537358442|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
148965072|NCT02658890|537358443|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
148697871|NCT00304083|536367936|FG001|Overall Study|Disease Progression|1|||
148697872|NCT00304083|536367935|FG000|Overall Study|Other|5|||
148697873|NCT00304083|536367936|FG001|Overall Study|Other|2|||
148697874|NCT01044732|536367937|FG000|Overall Study|Lost to Follow-up|2|||
148697875|NCT01044732|536367938|FG001|Overall Study|Lost to Follow-up|1|||
148697876|NCT01044732|536367937|FG000|Overall Study|Physician Decision|5|||
148697877|NCT01044732|536367938|FG001|Overall Study|Physician Decision|3|||
148697878|NCT01044732|536367937|FG000|Overall Study|Protocol Violation|11|||
148697879|NCT01044732|536367938|FG001|Overall Study|Protocol Violation|12|||
148697880|NCT01044732|536367937|FG000|Overall Study|Withdrawal by Subject|0|||
148697881|NCT01044732|536367938|FG001|Overall Study|Withdrawal by Subject|1|||
148697882|NCT01044732|536367937|FG000|Overall Study|Inadequate bowel preparation|11|||
148697883|NCT01044732|536367938|FG001|Overall Study|Inadequate bowel preparation|17|||
148697884|NCT01044732|536367937|FG000|Overall Study|Inability to reach cecum|5|||
148697885|NCT01044732|536367938|FG001|Overall Study|Inability to reach cecum|2|||
148697886|NCT01044732|536367937|FG000|Overall Study|Technical error or malfunction|15|||
148697887|NCT01044732|536367938|FG001|Overall Study|Technical error or malfunction|14|||
148697888|NCT03991494|536367943|FG000|Overall Study|Progressive Disease|4|||
148697889|NCT00683293|536367949|FG000|Overall Study|Withdrawal by Subject|2|||
148697890|NCT00683293|536367950|FG001|Overall Study|Withdrawal by Subject|3|||
148697891|NCT02920996|536367953|FG000|Overall Study|Adverse Event|8|||
148697892|NCT02920996|536367954|FG001|Overall Study|Adverse Event|0|||
148697893|NCT02920996|536367953|FG000|Overall Study|Physician Decision|1|||
148697894|NCT02920996|536367954|FG001|Overall Study|Physician Decision|0|||
148697895|NCT02920996|536367953|FG000|Overall Study|Death|1|||
148697896|NCT02920996|536367954|FG001|Overall Study|Death|0|||
148697897|NCT02920996|536367953|FG000|Overall Study|Missing|1|||
148697898|NCT02920996|536367954|FG001|Overall Study|Missing|0|||
148697899|NCT02920996|536367953|FG000|Overall Study|Subject Non-Compliance|1|||
148697900|NCT02920996|536367954|FG001|Overall Study|Subject Non-Compliance|0|||
148697901|NCT02507375|536367955|FG000|Overall Study|Progressive Disease|4|||
148697902|NCT02507375|536367956|FG001|Overall Study|Progressive Disease|5|||
148697903|NCT02507375|536367955|FG000|Overall Study|Death|0|||
148965073|NCT02658890|537358444|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
148965074|NCT02658890|537358445|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
148965075|NCT02658890|537358446|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
148965076|NCT02658890|537358447|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
148965077|NCT02658890|537358448|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
148697904|NCT02507375|536367956|FG001|Overall Study|Death|1|||
148697905|NCT02507375|536367955|FG000|Overall Study|Refused treatment|0|||
148697906|NCT02507375|536367956|FG001|Overall Study|Refused treatment|1|||
148697907|NCT02507375|536367955|FG000|Overall Study|Adverse Event|0|||
148697908|NCT02507375|536367956|FG001|Overall Study|Adverse Event|1|||
148697909|NCT02158936|536367957|FG000|Overall Study|Study closed/ terminated|57|||
148697910|NCT02158936|536367958|FG001|Overall Study|Study closed/ terminated|77|||
148697911|NCT02158936|536367957|FG000|Overall Study|Azacitidine tx discontinued|53|||
148697912|NCT02158936|536367958|FG001|Overall Study|Azacitidine tx discontinued|46|||
148697913|NCT02158936|536367957|FG000|Overall Study|Adverse Event|39|||
148697914|NCT02158936|536367958|FG001|Overall Study|Adverse Event|24|||
148697915|NCT02158936|536367957|FG000|Overall Study|Withdrawal by Subject|15|||
148697916|NCT02158936|536367958|FG001|Overall Study|Withdrawal by Subject|16|||
148697917|NCT02158936|536367957|FG000|Overall Study|Physician Decision|15|||
148697918|NCT02158936|536367958|FG001|Overall Study|Physician Decision|13|||
148697919|NCT02158936|536367957|FG000|Overall Study|Lost to Follow-up|0|||
148697920|NCT02158936|536367958|FG001|Overall Study|Lost to Follow-up|1|||
148697921|NCT00522457|536367959|FG000|Overall Study|Due to disease progression|16|||
148697922|NCT00522457|536367959|FG000|Overall Study|Adverse Event|2|||
148697923|NCT01248247|536369480|FG000|Overall Study|Adverse Event|2|||
148697924|NCT01248247|536369481|FG001|Overall Study|Adverse Event|4|||
148697925|NCT01248247|536369482|FG002|Overall Study|Adverse Event|4|||
148697926|NCT01248247|536369483|FG003|Overall Study|Adverse Event|2|||
148697927|NCT01248247|536369480|FG000|Overall Study|Death|0|||
148697928|NCT01248247|536369481|FG001|Overall Study|Death|1|||
148697929|NCT01248247|536369482|FG002|Overall Study|Death|4|||
148697930|NCT01248247|536369483|FG003|Overall Study|Death|7|||
148697931|NCT01248247|536369480|FG000|Overall Study|Lost to Follow-up|0|||
148965078|NCT02658890|537358449|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
148697932|NCT01248247|536369481|FG001|Overall Study|Lost to Follow-up|1|||
148697933|NCT01248247|536369482|FG002|Overall Study|Lost to Follow-up|1|||
148697934|NCT01248247|536369483|FG003|Overall Study|Lost to Follow-up|0|||
148697935|NCT01248247|536369480|FG000|Overall Study|Alternative treatment|0|||
148697936|NCT01248247|536369481|FG001|Overall Study|Alternative treatment|1|||
148697937|NCT01248247|536369482|FG002|Overall Study|Alternative treatment|0|||
148697938|NCT01248247|536369483|FG003|Overall Study|Alternative treatment|0|||
148697939|NCT01248247|536369480|FG000|Overall Study|Other|2|||
148697940|NCT01248247|536369481|FG001|Overall Study|Other|8|||
148697941|NCT01248247|536369482|FG002|Overall Study|Other|8|||
148697942|NCT01248247|536369483|FG003|Overall Study|Other|5|||
148697943|NCT01248247|536369480|FG000|Overall Study|Progression|18|||
148697944|NCT01248247|536369481|FG001|Overall Study|Progression|27|||
148697945|NCT01248247|536369482|FG002|Overall Study|Progression|56|||
148814446|NCT02335944|536795644|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
148814447|NCT02335944|536795645|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
148697946|NCT01248247|536369483|FG003|Overall Study|Progression|44|||
148697947|NCT01248247|536369480|FG000|Overall Study|Refuse further treatment|0|||
148697948|NCT01248247|536369481|FG001|Overall Study|Refuse further treatment|0|||
148697949|NCT01248247|536369482|FG002|Overall Study|Refuse further treatment|1|||
148814448|NCT02335944|536795646|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
148814449|NCT02335944|536795647|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
148814450|NCT02335944|536795638|FG000|Treatment Phase|Subject/Guardian Decision|0|||
148814451|NCT02335944|536795639|FG001|Treatment Phase|Subject/Guardian Decision|0|||
148814452|NCT02335944|536795640|FG002|Treatment Phase|Subject/Guardian Decision|1|||
148814453|NCT02335944|536795641|FG003|Treatment Phase|Subject/Guardian Decision|0|||
148814454|NCT02335944|536795642|FG004|Treatment Phase|Subject/Guardian Decision|0|||
148814455|NCT02335944|536795643|FG005|Treatment Phase|Subject/Guardian Decision|1|||
148697950|NCT01248247|536369483|FG003|Overall Study|Refuse further treatment|2|||
148697951|NCT01248247|536369480|FG000|Overall Study|Complicating disease|0|||
148697952|NCT01248247|536369481|FG001|Overall Study|Complicating disease|0|||
148697953|NCT01248247|536369482|FG002|Overall Study|Complicating disease|1|||
148697954|NCT01248247|536369483|FG003|Overall Study|Complicating disease|1|||
148697955|NCT02817841|536369484|FG000|Overall Study|Lost to Follow-up|287|||
148697956|NCT02817841|536369484|FG000|Overall Study|Withdrawal by Subject|183|||
148697957|NCT02817841|536369484|FG000|Overall Study|Adverse event not related to bleeding|131|||
148697958|NCT02817841|536369484|FG000|Overall Study|Adverse event related to bleeding|51|||
148814456|NCT02335944|536795644|FG006|Treatment Phase|Subject/Guardian Decision|0|||
148814457|NCT02335944|536795645|FG007|Treatment Phase|Subject/Guardian Decision|4|||
148814458|NCT02335944|536795646|FG008|Treatment Phase|Subject/Guardian Decision|0|||
148965079|NCT02658890|537358450|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
148697959|NCT02817841|536369484|FG000|Overall Study|Pregnancy|32|||
148697960|NCT02817841|536369484|FG000|Overall Study|Pregnancy wish|17|||
148697961|NCT02817841|536369484|FG000|Overall Study|Other reasons|53|||
148814459|NCT02335944|536795647|FG009|Treatment Phase|Subject/Guardian Decision|0|||
148814460|NCT02335944|536795638|FG000|Post-treatment Follow-up|Progressive Disease|0|||
148697962|NCT02817841|536369484|FG000|Overall Study|Protocol Violation|94|||
148814461|NCT02335944|536795639|FG001|Post-treatment Follow-up|Progressive Disease|0|||
148814462|NCT02335944|536795640|FG002|Post-treatment Follow-up|Progressive Disease|0|||
148814463|NCT02335944|536795641|FG003|Post-treatment Follow-up|Progressive Disease|1|||
148814464|NCT02335944|536795642|FG004|Post-treatment Follow-up|Progressive Disease|0|||
148814465|NCT02335944|536795643|FG005|Post-treatment Follow-up|Progressive Disease|9|||
148814466|NCT02335944|536795644|FG006|Post-treatment Follow-up|Progressive Disease|0|||
148814467|NCT02335944|536795645|FG007|Post-treatment Follow-up|Progressive Disease|2|||
148814468|NCT02335944|536795646|FG008|Post-treatment Follow-up|Progressive Disease|3|||
148814469|NCT02335944|536795647|FG009|Post-treatment Follow-up|Progressive Disease|0|||
148814470|NCT02335944|536795638|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814471|NCT02335944|536795639|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814472|NCT02335944|536795640|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814473|NCT02335944|536795641|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814474|NCT02335944|536795642|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814475|NCT02335944|536795643|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
148814476|NCT02335944|536795644|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814477|NCT02335944|536795645|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814478|NCT02335944|536795646|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814479|NCT02335944|536795647|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
148814480|NCT02335944|536795638|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814481|NCT02335944|536795639|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
148697963|NCT00705536|536369485|FG000|Start Period 1|Withdrawal by Subject|0|||
148697964|NCT00705536|536369486|FG001|Start Period 1|Withdrawal by Subject|0|||
148697965|NCT00705536|536369487|FG002|Start Period 1|Withdrawal by Subject|0|||
148697966|NCT00705536|536369488|FG003|Start Period 1|Withdrawal by Subject|1|||
148697967|NCT00549718|536369489|FG000|Overall Study|Insufficient clinical response|20|||
148697968|NCT00549718|536369490|FG001|Overall Study|Insufficient clinical response|7|||
148697969|NCT00549718|536369491|FG002|Overall Study|Insufficient clinical response|18|||
148697970|NCT00549718|536369492|FG003|Overall Study|Insufficient clinical response|32|||
148697971|NCT00549718|536369489|FG000|Overall Study|Adverse Event|6|||
148697972|NCT00549718|536369490|FG001|Overall Study|Adverse Event|8|||
148697973|NCT00549718|536369491|FG002|Overall Study|Adverse Event|7|||
148697974|NCT00549718|536369492|FG003|Overall Study|Adverse Event|3|||
148697975|NCT00549718|536369489|FG000|Overall Study|Lost to Follow-up|4|||
148697976|NCT00549718|536369490|FG001|Overall Study|Lost to Follow-up|2|||
148697977|NCT00549718|536369491|FG002|Overall Study|Lost to Follow-up|0|||
148697978|NCT00549718|536369492|FG003|Overall Study|Lost to Follow-up|6|||
148697979|NCT00549718|536369489|FG000|Overall Study|Withdrawal by Subject|9|||
148697980|NCT00549718|536369490|FG001|Overall Study|Withdrawal by Subject|18|||
148697981|NCT00549718|536369491|FG002|Overall Study|Withdrawal by Subject|12|||
148697982|NCT00549718|536369492|FG003|Overall Study|Withdrawal by Subject|13|||
148697983|NCT00549718|536369489|FG000|Overall Study|Administrative|2|||
148697984|NCT00549718|536369490|FG001|Overall Study|Administrative|2|||
148697985|NCT00549718|536369491|FG002|Overall Study|Administrative|2|||
148697986|NCT00549718|536369492|FG003|Overall Study|Administrative|1|||
148697987|NCT00397488|536369493|FG000|Overall Study|Withdrawal by Subject|3|||
148697988|NCT00397488|536369493|FG000|Overall Study|Adverse Event|3|||
148697989|NCT00397488|536369493|FG000|Overall Study|Death|1|||
148697990|NCT04032977|536369498|FG000|Overall Study|Withdrawal by Subject|6|||
148697991|NCT04032977|536369499|FG001|Overall Study|Withdrawal by Subject|1|||
148697992|NCT04032977|536369498|FG000|Overall Study|Lost to Follow-up|2|||
148697993|NCT04032977|536369499|FG001|Overall Study|Lost to Follow-up|7|||
148697994|NCT04032977|536369498|FG000|Overall Study|Pregnancy|1|||
148697995|NCT04032977|536369499|FG001|Overall Study|Pregnancy|0|||
148697996|NCT02880761|536369501|FG000|Overall Study|Death|6|||
148697997|NCT02880761|536369502|FG001|Overall Study|Death|8|||
148697998|NCT02880761|536369501|FG000|Overall Study|Withdrawal by Subject|3|||
148697999|NCT02880761|536369502|FG001|Overall Study|Withdrawal by Subject|6|||
148698000|NCT02880761|536369501|FG000|Overall Study|Protocol Violation|4|||
148698001|NCT02880761|536369502|FG001|Overall Study|Protocol Violation|3|||
148698002|NCT02880761|536369501|FG000|Overall Study|Lost to Follow-up|3|||
148698003|NCT02880761|536369502|FG001|Overall Study|Lost to Follow-up|4|||
148698004|NCT03597256|536369503|FG000|Overall Study|Lost to Follow-up|3|||
148698005|NCT03597256|536369504|FG001|Overall Study|Lost to Follow-up|1|||
148698006|NCT03597256|536369503|FG000|Overall Study|Withdrawal by Subject|0|||
148698007|NCT03597256|536369504|FG001|Overall Study|Withdrawal by Subject|1|||
148698008|NCT03597256|536369503|FG000|Overall Study|Could not return for treatment|0|||
148698009|NCT03597256|536369504|FG001|Overall Study|Could not return for treatment|1|||
148698010|NCT03597256|536369503|FG000|Overall Study|Moved from location|0|||
148965080|NCT02658890|537358451|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
148698011|NCT03597256|536369504|FG001|Overall Study|Moved from location|1|||
148698012|NCT03597256|536369503|FG000|Overall Study|Not accepted the treatment|0|||
148965081|NCT02658890|537358452|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
148698013|NCT03597256|536369504|FG001|Overall Study|Not accepted the treatment|1|||
148698014|NCT02106156|536369505|FG000|Overall Study|Patient Died|19|||
148698015|NCT02106156|536369506|FG001|Overall Study|Patient Died|0|||
148698016|NCT02106156|536369507|FG002|Overall Study|Patient Died|0|||
148698017|NCT02106156|536369505|FG000|Overall Study|Lack of Tolerability|305|||
148698018|NCT02106156|536369506|FG001|Overall Study|Lack of Tolerability|3|||
148698019|NCT02106156|536369507|FG002|Overall Study|Lack of Tolerability|0|||
148698020|NCT02106156|536369505|FG000|Overall Study|Lack of Virological Response|1044|||
148698021|NCT02106156|536369506|FG001|Overall Study|Lack of Virological Response|8|||
148698022|NCT02106156|536369507|FG002|Overall Study|Lack of Virological Response|0|||
148698023|NCT02106156|536369505|FG000|Overall Study|Concomitant Disease|74|||
148698024|NCT02106156|536369506|FG001|Overall Study|Concomitant Disease|2|||
148698025|NCT02106156|536369507|FG002|Overall Study|Concomitant Disease|0|||
148698026|NCT02106156|536369505|FG000|Overall Study|Lack of Compliance|211|||
148698027|NCT02106156|536369506|FG001|Overall Study|Lack of Compliance|7|||
148698028|NCT02106156|536369507|FG002|Overall Study|Lack of Compliance|0|||
148698029|NCT02106156|536369505|FG000|Overall Study|Patients Request|307|||
148698030|NCT02106156|536369506|FG001|Overall Study|Patients Request|9|||
148698031|NCT02106156|536369507|FG002|Overall Study|Patients Request|0|||
148698032|NCT02106156|536369505|FG000|Overall Study|Lost to Follow-up|451|||
148698033|NCT02106156|536369506|FG001|Overall Study|Lost to Follow-up|8|||
148698034|NCT02106156|536369507|FG002|Overall Study|Lost to Follow-up|0|||
148698035|NCT02106156|536369505|FG000|Overall Study|Unplanned Event|82|||
148698036|NCT02106156|536369506|FG001|Overall Study|Unplanned Event|2|||
148698037|NCT02106156|536369507|FG002|Overall Study|Unplanned Event|0|||
148698038|NCT02106156|536369505|FG000|Overall Study|Change of Laboratory Parameter|10|||
148698039|NCT02106156|536369506|FG001|Overall Study|Change of Laboratory Parameter|0|||
148698040|NCT02106156|536369507|FG002|Overall Study|Change of Laboratory Parameter|0|||
148698041|NCT02106156|536369505|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
148698042|NCT02106156|536369506|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
148814482|NCT02335944|536795640|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814483|NCT02335944|536795641|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814484|NCT02335944|536795642|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814485|NCT02335944|536795643|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814486|NCT02335944|536795644|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814487|NCT02335944|536795645|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
148814488|NCT02335944|536795646|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814489|NCT02335944|536795647|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
148814490|NCT02335944|536795638|FG000|Post-treatment Follow-up|Adverse Event|0|||
148698043|NCT02106156|536369507|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
148698044|NCT02106156|536369505|FG000|Overall Study|Relocation/Change of Physician|40|||
148698045|NCT02106156|536369506|FG001|Overall Study|Relocation/Change of Physician|1|||
148965082|NCT02658890|537358453|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
148965083|NCT02658890|537358454|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
148965084|NCT02658890|537358455|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
149024201|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
149024202|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
149024203|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
149024204|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
149024205|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
149024206|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
149024207|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
149024208|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
149024209|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
149024210|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Death|1|||
149024211|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Death|0|||
149024212|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
149024213|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
149024214|NCT02403674|537564211|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
149024215|NCT02403674|537564212|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
149024216|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
149024217|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
149024218|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
149024219|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
149024220|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
149024221|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
149024222|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
149024223|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
149024224|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
149024225|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
149024226|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Death|2|||
149024227|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Death|2|||
149024228|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
149024229|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
149024230|NCT02403674|537564211|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
149024231|NCT02403674|537564212|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
149024232|NCT02403674|537564211|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
149024233|NCT02403674|537564212|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
148698046|NCT02106156|536369507|FG002|Overall Study|Relocation/Change of Physician|0|||
149024234|NCT02403674|537564211|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
149024235|NCT02403674|537564212|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
149024236|NCT02403674|537564211|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
149024237|NCT02403674|537564212|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
149024238|NCT02403674|537564211|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
149024239|NCT02403674|537564212|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
149024240|NCT02403674|537564211|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
149024241|NCT02403674|537564212|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
149024242|NCT00826280|537564213|FG000|Overall Study|Randomized but drug not received|1|||
149024243|NCT00826280|537564214|FG001|Overall Study|Randomized but drug not received|0|||
149024244|NCT00826280|537564215|FG002|Overall Study|Randomized but drug not received|1|||
149024245|NCT00826280|537564213|FG000|Overall Study|Adverse Event|1|||
149024246|NCT00826280|537564214|FG001|Overall Study|Adverse Event|3|||
149024247|NCT00826280|537564215|FG002|Overall Study|Adverse Event|0|||
149024248|NCT00826280|537564213|FG000|Overall Study|Lost to Follow-up|0|||
149024249|NCT00826280|537564214|FG001|Overall Study|Lost to Follow-up|1|||
149024250|NCT00826280|537564215|FG002|Overall Study|Lost to Follow-up|0|||
149024251|NCT00826280|537564213|FG000|Overall Study|Sponsor discontinued subject or study|1|||
149024252|NCT00826280|537564214|FG001|Overall Study|Sponsor discontinued subject or study|0|||
149024253|NCT00826280|537564215|FG002|Overall Study|Sponsor discontinued subject or study|0|||
149024254|NCT00826280|537564213|FG000|Overall Study|Reversible ischemic defect not present|43|||
149024255|NCT00826280|537564214|FG001|Overall Study|Reversible ischemic defect not present|40|||
149024256|NCT00826280|537564215|FG002|Overall Study|Reversible ischemic defect not present|44|||
149024257|NCT00826280|537564213|FG000|Overall Study|Interpretation Failure|1|||
149024258|NCT00826280|537564214|FG001|Overall Study|Interpretation Failure|0|||
149024259|NCT00826280|537564215|FG002|Overall Study|Interpretation Failure|0|||
149024260|NCT00826280|537564213|FG000|Overall Study|Machine Failure|1|||
149024261|NCT00826280|537564214|FG001|Overall Study|Machine Failure|1|||
149024262|NCT00826280|537564215|FG002|Overall Study|Machine Failure|0|||
149024263|NCT00826280|537564213|FG000|Overall Study|One or more non-interpretable scan|0|||
149024264|NCT00826280|537564214|FG001|Overall Study|One or more non-interpretable scan|1|||
149024265|NCT00826280|537564215|FG002|Overall Study|One or more non-interpretable scan|1|||
149024266|NCT03487666|537564216|FG000|Overall Study|Disease progression|4|||
149024267|NCT03487666|537564217|FG001|Overall Study|Disease progression|2|||
149024268|NCT03487666|537564218|FG002|Overall Study|Disease progression|0|||
149024269|NCT03487666|537564216|FG000|Overall Study|Adverse Event|0|||
149024270|NCT03487666|537564217|FG001|Overall Study|Adverse Event|0|||
149024271|NCT03487666|537564218|FG002|Overall Study|Adverse Event|1|||
149024272|NCT03201757|537564219|FG000|Overall Study|Withdrawal by Subject|133|||
149024273|NCT03201757|537564219|FG000|Overall Study|Adverse Event|44|||
149024274|NCT03201757|537564219|FG000|Overall Study|Lost to Follow-up|37|||
149024275|NCT03201757|537564219|FG000|Overall Study|Pregnancy|2|||
149024276|NCT03201757|537564219|FG000|Overall Study|Lack of Efficacy|1|||
149024277|NCT03201757|537564219|FG000|Overall Study|Protocol Violation|20|||
149024278|NCT03201757|537564219|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
149024279|NCT03201757|537564219|FG000|Overall Study|Not Yet Determined|5|||
149024280|NCT03201757|537564219|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
149024281|NCT03201757|537564219|FG000|Overall Study|Other|20|||
149024282|NCT02800928|537564224|FG000|Overall Study|Withdrawal by Subject|1|||
149024283|NCT02800928|537564225|FG001|Overall Study|Withdrawal by Subject|1|||
149024284|NCT02800928|537564224|FG000|Overall Study|Protocol Violation|1|||
149024285|NCT02800928|537564225|FG001|Overall Study|Protocol Violation|1|||
149024286|NCT02886728|537564230|FG000|Overall Study|Withdrew Consent|31|||
149024287|NCT02886728|537564231|FG001|Overall Study|Withdrew Consent|13|||
149024288|NCT02886728|537564232|FG002|Overall Study|Withdrew Consent|11|||
149024289|NCT02886728|537564233|FG003|Overall Study|Withdrew Consent|47|||
149024290|NCT02886728|537564230|FG000|Overall Study|Lost to Follow-up|12|||
149024291|NCT02886728|537564231|FG001|Overall Study|Lost to Follow-up|6|||
149024292|NCT02886728|537564232|FG002|Overall Study|Lost to Follow-up|13|||
149024293|NCT02886728|537564233|FG003|Overall Study|Lost to Follow-up|12|||
149024294|NCT02886728|537564230|FG000|Overall Study|Adverse Event|13|||
149024295|NCT02886728|537564231|FG001|Overall Study|Adverse Event|5|||
149024296|NCT02886728|537564232|FG002|Overall Study|Adverse Event|5|||
149024297|NCT02886728|537564233|FG003|Overall Study|Adverse Event|11|||
149024298|NCT02886728|537564230|FG000|Overall Study|Investigator's Discretion|11|||
149024299|NCT02886728|537564231|FG001|Overall Study|Investigator's Discretion|7|||
149024300|NCT02886728|537564232|FG002|Overall Study|Investigator's Discretion|5|||
149024301|NCT02886728|537564233|FG003|Overall Study|Investigator's Discretion|11|||
149024302|NCT02886728|537564230|FG000|Overall Study|Death|3|||
149024303|NCT02886728|537564231|FG001|Overall Study|Death|1|||
149024304|NCT02886728|537564232|FG002|Overall Study|Death|0|||
149024305|NCT02886728|537564233|FG003|Overall Study|Death|0|||
149024306|NCT02886728|537564230|FG000|Overall Study|Protocol Violation|0|||
149024307|NCT02886728|537564231|FG001|Overall Study|Protocol Violation|0|||
149024308|NCT02886728|537564232|FG002|Overall Study|Protocol Violation|0|||
149024309|NCT02886728|537564233|FG003|Overall Study|Protocol Violation|4|||
149024310|NCT02886728|537564230|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149024311|NCT02886728|537564231|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149024312|NCT02886728|537564232|FG002|Overall Study|Non-Compliance with Study Drug|1|||
149024313|NCT02886728|537564233|FG003|Overall Study|Non-Compliance with Study Drug|0|||
149024314|NCT02886728|537564230|FG000|Overall Study|Pregnancy|0|||
149024315|NCT02886728|537564231|FG001|Overall Study|Pregnancy|0|||
149024316|NCT02886728|537564232|FG002|Overall Study|Pregnancy|1|||
149024317|NCT02886728|537564233|FG003|Overall Study|Pregnancy|0|||
149024318|NCT02886728|537564230|FG000|Overall Study|Randomized but Not Dosed|1|||
149024319|NCT02886728|537564231|FG001|Overall Study|Randomized but Not Dosed|0|||
149024320|NCT02886728|537564232|FG002|Overall Study|Randomized but Not Dosed|0|||
149024321|NCT02886728|537564233|FG003|Overall Study|Randomized but Not Dosed|2|||
149024322|NCT04990440|537564242|FG000|Overall Study|Sponsor's Decision|0|||
149024323|NCT04990440|537564243|FG001|Overall Study|Sponsor's Decision|0|||
149024324|NCT04990440|537564244|FG002|Overall Study|Sponsor's Decision|1|||
149024325|NCT03712098|537564245|FG000|Overall Study|Lost to Follow-up|3|||
149024326|NCT03712098|537564246|FG001|Overall Study|Lost to Follow-up|7|||
149024327|NCT03712098|537564245|FG000|Overall Study|Withdrawal by Subject|9|||
149024328|NCT03712098|537564246|FG001|Overall Study|Withdrawal by Subject|4|||
149024329|NCT03712098|537564245|FG000|Overall Study|Protocol Violation|2|||
149024330|NCT03712098|537564246|FG001|Overall Study|Protocol Violation|1|||
149024331|NCT01066156|537564253|FG000|Overall Study|ineligible|2|||
149024332|NCT01066156|537564253|FG000|Overall Study|Lost to Follow-up|7|||
149024333|NCT01066156|537564253|FG000|Overall Study|Withdrawal by Subject|1|||
149024334|NCT01052662|537564257|FG000|Overall Study|Lost to Follow-up|15|||
149024335|NCT01052662|537564258|FG001|Overall Study|Lost to Follow-up|13|||
149024336|NCT01052662|537564259|FG002|Overall Study|Lost to Follow-up|18|||
149024337|NCT01052662|537564257|FG000|Overall Study|Withdrawal by Subject|3|||
149024338|NCT01052662|537564258|FG001|Overall Study|Withdrawal by Subject|2|||
149024339|NCT01052662|537564259|FG002|Overall Study|Withdrawal by Subject|1|||
149024340|NCT01052662|537564257|FG000|Overall Study|Pharmacy issue|1|||
149024341|NCT01052662|537564258|FG001|Overall Study|Pharmacy issue|3|||
149024342|NCT01052662|537564259|FG002|Overall Study|Pharmacy issue|3|||
149024343|NCT01052662|537564257|FG000|Overall Study|Adverse Event|1|||
149024344|NCT01052662|537564258|FG001|Overall Study|Adverse Event|1|||
149024345|NCT01052662|537564259|FG002|Overall Study|Adverse Event|0|||
149024346|NCT01052662|537564257|FG000|Overall Study|Legal Problem|2|||
149024347|NCT01052662|537564258|FG001|Overall Study|Legal Problem|0|||
149024348|NCT01052662|537564259|FG002|Overall Study|Legal Problem|0|||
149024349|NCT01052662|537564257|FG000|Overall Study|Administrative|0|||
149024350|NCT01052662|537564258|FG001|Overall Study|Administrative|3|||
149024351|NCT01052662|537564259|FG002|Overall Study|Administrative|0|||
149024352|NCT01627340|537564263|FG000|Overall Study|Adverse Event|1|||
149024353|NCT01627340|537564264|FG001|Overall Study|Adverse Event|0|||
149024354|NCT01627340|537564263|FG000|Overall Study|Lost to Follow-up|8|||
149024355|NCT01627340|537564264|FG001|Overall Study|Lost to Follow-up|4|||
149024356|NCT01627340|537564263|FG000|Overall Study|Pregnancy|1|||
149024357|NCT01627340|537564264|FG001|Overall Study|Pregnancy|0|||
149024358|NCT01627340|537564263|FG000|Overall Study|Withdrawal by Subject|2|||
149024359|NCT01627340|537564264|FG001|Overall Study|Withdrawal by Subject|0|||
149024360|NCT01272011|537564265|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
149024361|NCT01272011|537564266|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
149024362|NCT01272011|537564267|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
149024363|NCT02240680|537564268|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
149024364|NCT02240680|537564269|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
149024365|NCT02240680|537564270|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
149024366|NCT02240680|537564271|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
149024367|NCT02240680|537564268|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
149024368|NCT02240680|537564269|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
148965085|NCT02658890|537358456|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
148965086|NCT02658890|537358430|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
148965087|NCT02658890|537358431|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
148965088|NCT02658890|537358432|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
148965089|NCT02658890|537358433|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
148965090|NCT02658890|537358434|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
148965091|NCT02658890|537358435|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
148965092|NCT02658890|537358436|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
148965093|NCT02658890|537358437|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
148965094|NCT02658890|537358438|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
148965095|NCT02658890|537358439|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
148965096|NCT02658890|537358440|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
148965097|NCT02658890|537358441|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
148965098|NCT02658890|537358442|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
148965099|NCT02658890|537358443|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
148965100|NCT02658890|537358444|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
149024369|NCT02240680|537564270|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
149024370|NCT02240680|537564271|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
149024371|NCT02240680|537564268|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
149024372|NCT02240680|537564269|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
149024373|NCT02240680|537564270|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
149024374|NCT02240680|537564271|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
149024375|NCT02240680|537564268|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
149024376|NCT02240680|537564269|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
149024377|NCT02240680|537564270|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
149024378|NCT02240680|537564271|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
149024379|NCT02240680|537564268|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
149024380|NCT02240680|537564269|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
149024381|NCT02240680|537564270|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
149024382|NCT02240680|537564271|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
148698047|NCT00840632|536369518|FG000|First Intervention|Withdrawal by Subject|0|||
149024383|NCT02240680|537564268|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
149024384|NCT02240680|537564269|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
149024385|NCT02240680|537564270|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
149024386|NCT02240680|537564271|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
149024387|NCT02240680|537564268|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
149024388|NCT02240680|537564269|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
149024389|NCT02240680|537564270|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
149024390|NCT02240680|537564271|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
149024391|NCT02240680|537564268|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
149024392|NCT02240680|537564269|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
149024393|NCT02240680|537564270|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
149024394|NCT02240680|537564271|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
149024395|NCT01657032|537564272|FG000|Overall Study|Lost to Follow-up|0|||
149024396|NCT01657032|537564273|FG001|Overall Study|Lost to Follow-up|7|||
149024397|NCT02839681|537564287|FG000|Overall Study|Death|2|||
149024398|NCT01653847|537564288|FG000|Overall Study|Withdrawal by Subject|1|||
149024399|NCT01653847|537564289|FG001|Overall Study|Withdrawal by Subject|0|||
149024400|NCT02015195|537564295|FG000|Overall Study|Adverse Event|0|||
149024401|NCT02015195|537564296|FG001|Overall Study|Adverse Event|0|||
149024402|NCT02015195|537564297|FG002|Overall Study|Adverse Event|0|||
149024403|NCT02015195|537564298|FG003|Overall Study|Adverse Event|1|||
149024404|NCT02015195|537564299|FG004|Overall Study|Adverse Event|0|||
149024405|NCT02015195|537564300|FG005|Overall Study|Adverse Event|0|||
149024406|NCT02015195|537564301|FG006|Overall Study|Adverse Event|0|||
149024407|NCT01318811|537564302|FG000|Overall Study|Physician Decision|1|||
149024408|NCT01318811|537564303|FG001|Overall Study|Physician Decision|1|||
149024409|NCT01318811|537564302|FG000|Overall Study|CRRT stopped for head CT|0|||
149024410|NCT01318811|537564303|FG001|Overall Study|CRRT stopped for head CT|1|||
149024411|NCT01318811|537564302|FG000|Overall Study|Death|0|||
148698048|NCT00840632|536369519|FG001|First Intervention|Withdrawal by Subject|1|||
148698049|NCT00840632|536369518|FG000|Washout|Withdrawal by Subject|1|||
148698050|NCT00840632|536369519|FG001|Washout|Withdrawal by Subject|1|||
148698051|NCT01725529|536369520|FG000|Overall Study|Adverse Event|1|||
148698052|NCT01725529|536369521|FG001|Overall Study|Adverse Event|0|||
148698053|NCT01725529|536369522|FG002|Overall Study|Adverse Event|0|||
148698054|NCT01725529|536369520|FG000|Overall Study|Lost to Follow-up|2|||
148698055|NCT01725529|536369521|FG001|Overall Study|Lost to Follow-up|1|||
148698056|NCT01725529|536369522|FG002|Overall Study|Lost to Follow-up|1|||
148698057|NCT01725529|536369520|FG000|Overall Study|Protocol Violation|0|||
148698058|NCT01725529|536369521|FG001|Overall Study|Protocol Violation|1|||
148698059|NCT01725529|536369522|FG002|Overall Study|Protocol Violation|1|||
149024412|NCT01318811|537564303|FG001|Overall Study|Death|1|||
149024413|NCT01318811|537564302|FG000|Overall Study|CRRT stopped for head MRI|0|||
149024414|NCT01318811|537564303|FG001|Overall Study|CRRT stopped for head MRI|1|||
149024415|NCT00131911|537564304|FG000|Overall Study|Withdrawal by Subject|1|||
149024416|NCT00131911|537564305|FG001|Overall Study|Withdrawal by Subject|0|||
149024417|NCT03658811|537564307|FG000|Overall Study|Lost to Follow-up|3|||
149024418|NCT04951479|537564308|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
149024419|NCT01789203|537566142|FG000|Overall Study|Adverse Event|2|||
148698060|NCT01725529|536369520|FG000|Overall Study|Withdrawal by Subject|12|||
148698061|NCT01725529|536369521|FG001|Overall Study|Withdrawal by Subject|14|||
149024420|NCT01789203|537566143|FG001|Overall Study|Adverse Event|2|||
149024421|NCT01789203|537566142|FG000|Overall Study|Withdrawal by Subject|1|||
149024422|NCT01789203|537566143|FG001|Overall Study|Withdrawal by Subject|0|||
149024423|NCT01789203|537566142|FG000|Overall Study|Death|1|||
149024424|NCT01789203|537566143|FG001|Overall Study|Death|0|||
149024425|NCT01789203|537566142|FG000|Overall Study|Protocol Violation|2|||
149024426|NCT01789203|537566143|FG001|Overall Study|Protocol Violation|1|||
149024427|NCT01789203|537566142|FG000|Overall Study|Other|1|||
149024428|NCT01789203|537566143|FG001|Overall Study|Other|1|||
149024429|NCT01789203|537566142|FG000|Overall Study|patient non-adherent|2|||
149024430|NCT01789203|537566143|FG001|Overall Study|patient non-adherent|0|||
149024431|NCT01254305|537566150|FG000|Overall Study|Adverse Event|6|||
149024432|NCT01254305|537566151|FG001|Overall Study|Adverse Event|3|||
149024433|NCT01254305|537566152|FG002|Overall Study|Adverse Event|2|||
149024434|NCT01254305|537566150|FG000|Overall Study|Lack of Efficacy|1|||
149024435|NCT01254305|537566151|FG001|Overall Study|Lack of Efficacy|0|||
149024436|NCT01254305|537566152|FG002|Overall Study|Lack of Efficacy|1|||
149024437|NCT01254305|537566150|FG000|Overall Study|Protocol Violation|1|||
149024438|NCT01254305|537566151|FG001|Overall Study|Protocol Violation|7|||
149024439|NCT01254305|537566152|FG002|Overall Study|Protocol Violation|3|||
149024440|NCT01254305|537566150|FG000|Overall Study|Withdrawal by Subject|4|||
149024441|NCT01254305|537566151|FG001|Overall Study|Withdrawal by Subject|2|||
149024442|NCT01254305|537566152|FG002|Overall Study|Withdrawal by Subject|4|||
149024443|NCT01254305|537566150|FG000|Overall Study|Lost to Follow-up|10|||
149024444|NCT01254305|537566151|FG001|Overall Study|Lost to Follow-up|6|||
149024445|NCT01254305|537566152|FG002|Overall Study|Lost to Follow-up|5|||
149024446|NCT01254305|537566150|FG000|Overall Study|Other Reasons|0|||
149024447|NCT01254305|537566151|FG001|Overall Study|Other Reasons|0|||
149024448|NCT01254305|537566152|FG002|Overall Study|Other Reasons|2|||
149024449|NCT00765362|537566153|FG000|Overall Study|Death|9|||
149024450|NCT00765362|537566153|FG000|Overall Study|Adverse Event|2|||
149024451|NCT00765362|537566153|FG000|Overall Study|Protocol Violation|18|||
149024452|NCT00765362|537566153|FG000|Overall Study|Withdrawal by Subject|13|||
149024453|NCT00765362|537566153|FG000|Overall Study|Lost to Follow-up|95|||
149024454|NCT03019458|537566157|FG000|Overall Study|Death|0|||
149024455|NCT03019458|537566158|FG001|Overall Study|Death|1|||
149024456|NCT00557505|537566159|FG000|Overall Study|Death|0|||
149024457|NCT00557505|537566160|FG001|Overall Study|Death|0|||
149024458|NCT00557505|537566161|FG002|Overall Study|Death|0|||
149024459|NCT00557505|537566162|FG003|Overall Study|Death|0|||
149024460|NCT00557505|537566163|FG004|Overall Study|Death|0|||
149024461|NCT00557505|537566164|FG005|Overall Study|Death|0|||
149024462|NCT00557505|537566165|FG006|Overall Study|Death|0|||
149024463|NCT00557505|537566166|FG007|Overall Study|Death|0|||
149024464|NCT00557505|537566167|FG008|Overall Study|Death|1|||
149024465|NCT00557505|537566159|FG000|Overall Study|Adverse Event|0|||
148698062|NCT01725529|536369522|FG002|Overall Study|Withdrawal by Subject|8|||
148698063|NCT01900730|536369529|FG000|Overall Study|Withdrawal by Subject|1|||
148698064|NCT01900730|536369530|FG001|Overall Study|Withdrawal by Subject|0|||
148698065|NCT01900730|536369529|FG000|Overall Study|Screen Failure|1|||
148698066|NCT01900730|536369530|FG001|Overall Study|Screen Failure|0|||
148698067|NCT00051025|536369531|FG000|Overall Study|Progressive Disease|1|||
148698068|NCT00051025|536369532|FG001|Overall Study|Progressive Disease|1|||
148698069|NCT00051025|536369531|FG000|Overall Study|Adverse Event|1|||
148698070|NCT00051025|536369532|FG001|Overall Study|Adverse Event|1|||
148698071|NCT00051025|536369531|FG000|Overall Study|Withdrawal by Subject|0|||
148698072|NCT00051025|536369532|FG001|Overall Study|Withdrawal by Subject|1|||
148698073|NCT00051025|536369531|FG000|Overall Study|Death|0|||
148698074|NCT00051025|536369532|FG001|Overall Study|Death|1|||
148698075|NCT01179048|536369533|FG000|Overall Study|Withdrawn - does not allow contact|4|||
148698076|NCT01179048|536369534|FG001|Overall Study|Withdrawn - does not allow contact|8|||
148698077|NCT01179048|536369533|FG000|Overall Study|Lost to Follow-up|8|||
148698078|NCT01179048|536369534|FG001|Overall Study|Lost to Follow-up|9|||
148698079|NCT01179048|536369533|FG000|Overall Study|Alive|127|||
148698080|NCT01179048|536369534|FG001|Overall Study|Alive|142|||
148698081|NCT02109042|536369535|FG000|Overall Study|Sponsor Decision|15|||
148698082|NCT03203447|536369540|FG000|Overall Study|Withdrawal by Subject|2|||
148698083|NCT03203447|536369541|FG001|Overall Study|Withdrawal by Subject|1|||
148698084|NCT03203447|536369540|FG000|Overall Study|Lost to Follow-up|1|||
148698085|NCT03203447|536369541|FG001|Overall Study|Lost to Follow-up|10|||
148698086|NCT03203447|536369540|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
148965101|NCT02658890|537358445|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
148965102|NCT02658890|537358446|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
148965103|NCT02658890|537358447|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
148965104|NCT02658890|537358448|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
148965105|NCT02658890|537358449|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
148965106|NCT02658890|537358450|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
148965107|NCT02658890|537358451|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
148965108|NCT02658890|537358452|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
148965109|NCT02658890|537358453|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
148965110|NCT02658890|537358454|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
148965111|NCT02658890|537358455|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
148965112|NCT02658890|537358456|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
148965113|NCT02658890|537358430|FG000|Treatment Phase|Other Reasons|0|||
148965114|NCT02658890|537358431|FG001|Treatment Phase|Other Reasons|0|||
148965115|NCT02658890|537358432|FG002|Treatment Phase|Other Reasons|0|||
148965116|NCT02658890|537358433|FG003|Treatment Phase|Other Reasons|0|||
148965117|NCT02658890|537358434|FG004|Treatment Phase|Other Reasons|0|||
148965118|NCT02658890|537358435|FG005|Treatment Phase|Other Reasons|0|||
148965119|NCT02658890|537358436|FG006|Treatment Phase|Other Reasons|1|||
148965120|NCT02658890|537358437|FG007|Treatment Phase|Other Reasons|0|||
148965121|NCT02658890|537358438|FG008|Treatment Phase|Other Reasons|1|||
149024466|NCT00557505|537566160|FG001|Overall Study|Adverse Event|0|||
149024467|NCT00557505|537566161|FG002|Overall Study|Adverse Event|1|||
149024468|NCT00557505|537566162|FG003|Overall Study|Adverse Event|0|||
149024469|NCT00557505|537566163|FG004|Overall Study|Adverse Event|0|||
149024470|NCT00557505|537566164|FG005|Overall Study|Adverse Event|0|||
149024471|NCT00557505|537566165|FG006|Overall Study|Adverse Event|1|||
149024472|NCT00557505|537566166|FG007|Overall Study|Adverse Event|0|||
149024473|NCT00557505|537566167|FG008|Overall Study|Adverse Event|0|||
149024474|NCT00557505|537566159|FG000|Overall Study|Global deterioration of health|1|||
149024475|NCT00557505|537566160|FG001|Overall Study|Global deterioration of health|0|||
148698087|NCT03203447|536369541|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
148698088|NCT00324168|536369542|FG000|Overall Study|Lost to Follow-up|19|||
148698089|NCT00324168|536369543|FG001|Overall Study|Lost to Follow-up|18|||
148698090|NCT00324168|536369542|FG000|Overall Study|Death|3|||
148698091|NCT00324168|536369543|FG001|Overall Study|Death|3|||
148698092|NCT00324168|536369542|FG000|Overall Study|Patient did not visit in f/u window|6|||
148698093|NCT00324168|536369543|FG001|Overall Study|Patient did not visit in f/u window|9|||
148698094|NCT01203878|536369544|FG000|Overall Study|Withdrawal by Subject|0|||
148698095|NCT01203878|536369545|FG001|Overall Study|Withdrawal by Subject|0|||
148698096|NCT01203878|536369546|FG002|Overall Study|Withdrawal by Subject|1|||
148698097|NCT01203878|536369544|FG000|Overall Study|Adverse Event|0|||
148698098|NCT01203878|536369545|FG001|Overall Study|Adverse Event|0|||
148698099|NCT01203878|536369546|FG002|Overall Study|Adverse Event|2|||
148698100|NCT00274937|536369547|FG000|Overall Study|Physician Decision|10|||
148698101|NCT00274937|536369547|FG000|Overall Study|Withdrawal by Subject|6|||
148698102|NCT00274937|536369547|FG000|Overall Study|Progressive Disease|4|||
148698103|NCT02189941|536369548|FG000|Overall Study|Non-compliance|0|||
148698104|NCT02189941|536369549|FG001|Overall Study|Non-compliance|0|||
148698105|NCT02189941|536369550|FG002|Overall Study|Non-compliance|1|||
148698106|NCT00445003|536369551|FG000|Overall Study|Death|1|||
148698107|NCT00445003|536369552|FG001|Overall Study|Death|2|||
148698108|NCT00445003|536369553|FG002|Overall Study|Death|1|||
148698109|NCT00445003|536369551|FG000|Overall Study|Missed Visit|3|||
148698110|NCT00445003|536369552|FG001|Overall Study|Missed Visit|5|||
148698111|NCT00445003|536369553|FG002|Overall Study|Missed Visit|1|||
148698112|NCT00445003|536369551|FG000|Overall Study|Dropped|1|||
148698113|NCT00445003|536369552|FG001|Overall Study|Dropped|3|||
148698114|NCT00445003|536369553|FG002|Overall Study|Dropped|2|||
148698115|NCT00528606|536369554|FG000|Overall Study|Withdrew consent|4|||
148698116|NCT00528606|536369555|FG001|Overall Study|Withdrew consent|3|||
148698117|NCT00528606|536369554|FG000|Overall Study|Lost to Follow-up|4|||
148698118|NCT00528606|536369555|FG001|Overall Study|Lost to Follow-up|1|||
148698119|NCT00528606|536369554|FG000|Overall Study|Adverse Event|3|||
148698120|NCT00528606|536369555|FG001|Overall Study|Adverse Event|0|||
148698121|NCT00528606|536369554|FG000|Overall Study|Other|2|||
148698122|NCT00528606|536369555|FG001|Overall Study|Other|0|||
148698123|NCT02475954|536369556|FG000|Overall Study|Withdrawal by Subject|2|||
148698124|NCT02475954|536369557|FG001|Overall Study|Withdrawal by Subject|2|||
148698125|NCT02475954|536369556|FG000|Overall Study|Lost to Follow-up|11|||
148698126|NCT02475954|536369557|FG001|Overall Study|Lost to Follow-up|9|||
148698127|NCT02475954|536369556|FG000|Overall Study|Death|1|||
148698128|NCT02475954|536369557|FG001|Overall Study|Death|1|||
148698129|NCT01918397|536369562|FG000|Overall Study|Never started treatment|2|||
148698130|NCT01918397|536369563|FG001|Overall Study|Never started treatment|1|||
148698131|NCT01918397|536369564|FG002|Overall Study|Never started treatment|0|||
148698132|NCT01918397|536369565|FG003|Overall Study|Never started treatment|0|||
148698133|NCT01918397|536369562|FG000|Overall Study|Adverse Event|1|||
148814491|NCT02335944|536795639|FG001|Post-treatment Follow-up|Adverse Event|0|||
148698134|NCT01918397|536369563|FG001|Overall Study|Adverse Event|1|||
148698135|NCT01918397|536369564|FG002|Overall Study|Adverse Event|1|||
148698136|NCT01918397|536369565|FG003|Overall Study|Adverse Event|0|||
148698137|NCT01918397|536369562|FG000|Overall Study|Lack of compliance|2|||
148698138|NCT01918397|536369563|FG001|Overall Study|Lack of compliance|2|||
148814492|NCT02335944|536795640|FG002|Post-treatment Follow-up|Adverse Event|0|||
148814493|NCT02335944|536795641|FG003|Post-treatment Follow-up|Adverse Event|0|||
148814494|NCT02335944|536795642|FG004|Post-treatment Follow-up|Adverse Event|0|||
148814495|NCT02335944|536795643|FG005|Post-treatment Follow-up|Adverse Event|1|||
148814496|NCT02335944|536795644|FG006|Post-treatment Follow-up|Adverse Event|0|||
148814497|NCT02335944|536795645|FG007|Post-treatment Follow-up|Adverse Event|0|||
148814498|NCT02335944|536795646|FG008|Post-treatment Follow-up|Adverse Event|0|||
148814499|NCT02335944|536795647|FG009|Post-treatment Follow-up|Adverse Event|0|||
148814500|NCT02335944|536795638|FG000|Post-treatment Follow-up|Death|0|||
148814501|NCT02335944|536795639|FG001|Post-treatment Follow-up|Death|0|||
148814502|NCT02335944|536795640|FG002|Post-treatment Follow-up|Death|0|||
148814503|NCT02335944|536795641|FG003|Post-treatment Follow-up|Death|1|||
148814504|NCT02335944|536795642|FG004|Post-treatment Follow-up|Death|0|||
148814505|NCT02335944|536795643|FG005|Post-treatment Follow-up|Death|1|||
148814506|NCT02335944|536795644|FG006|Post-treatment Follow-up|Death|0|||
148814507|NCT02335944|536795645|FG007|Post-treatment Follow-up|Death|0|||
148814508|NCT02335944|536795646|FG008|Post-treatment Follow-up|Death|0|||
148814509|NCT02335944|536795647|FG009|Post-treatment Follow-up|Death|0|||
149024476|NCT00557505|537566161|FG002|Overall Study|Global deterioration of health|0|||
149024477|NCT00557505|537566162|FG003|Overall Study|Global deterioration of health|0|||
149024478|NCT00557505|537566163|FG004|Overall Study|Global deterioration of health|0|||
149024479|NCT00557505|537566164|FG005|Overall Study|Global deterioration of health|0|||
149024480|NCT00557505|537566165|FG006|Overall Study|Global deterioration of health|0|||
149024481|NCT00557505|537566166|FG007|Overall Study|Global deterioration of health|0|||
149024482|NCT00557505|537566167|FG008|Overall Study|Global deterioration of health|0|||
149024483|NCT00557505|537566159|FG000|Overall Study|Objective progression or relapse|2|||
149024484|NCT00557505|537566160|FG001|Overall Study|Objective progression or relapse|3|||
149024485|NCT00557505|537566161|FG002|Overall Study|Objective progression or relapse|3|||
149024486|NCT00557505|537566162|FG003|Overall Study|Objective progression or relapse|2|||
149024487|NCT00557505|537566163|FG004|Overall Study|Objective progression or relapse|2|||
149024488|NCT00557505|537566164|FG005|Overall Study|Objective progression or relapse|3|||
149024489|NCT00557505|537566165|FG006|Overall Study|Objective progression or relapse|2|||
149024490|NCT00557505|537566166|FG007|Overall Study|Objective progression or relapse|5|||
149024491|NCT00557505|537566167|FG008|Overall Study|Objective progression or relapse|15|||
149024492|NCT00557505|537566159|FG000|Overall Study|Withdrawal by Subject|0|||
149024493|NCT00557505|537566160|FG001|Overall Study|Withdrawal by Subject|0|||
148814510|NCT02335944|536795638|FG000|Post-treatment Follow-up|Physician Decision|1|||
148814511|NCT02335944|536795639|FG001|Post-treatment Follow-up|Physician Decision|0|||
148814512|NCT02335944|536795640|FG002|Post-treatment Follow-up|Physician Decision|0|||
148814513|NCT02335944|536795641|FG003|Post-treatment Follow-up|Physician Decision|0|||
148814514|NCT02335944|536795642|FG004|Post-treatment Follow-up|Physician Decision|0|||
149024494|NCT00557505|537566161|FG002|Overall Study|Withdrawal by Subject|0|||
149024495|NCT00557505|537566162|FG003|Overall Study|Withdrawal by Subject|1|||
149024496|NCT00557505|537566163|FG004|Overall Study|Withdrawal by Subject|0|||
149024497|NCT00557505|537566164|FG005|Overall Study|Withdrawal by Subject|0|||
149024498|NCT00557505|537566165|FG006|Overall Study|Withdrawal by Subject|0|||
149024499|NCT00557505|537566166|FG007|Overall Study|Withdrawal by Subject|0|||
149024500|NCT00557505|537566167|FG008|Overall Study|Withdrawal by Subject|1|||
149024501|NCT00031447|537566168|FG000|Overall Study|Lost to Follow-up|0|||
149024502|NCT00031447|537566169|FG001|Overall Study|Lost to Follow-up|1|||
149024503|NCT00031447|537566168|FG000|Overall Study|Non-compliant|1|||
149024504|NCT00031447|537566169|FG001|Overall Study|Non-compliant|1|||
149024505|NCT00031447|537566168|FG000|Overall Study|Re-activation of Disease|2|||
149024506|NCT00031447|537566169|FG001|Overall Study|Re-activation of Disease|1|||
149024507|NCT00031447|537566168|FG000|Overall Study|Disruption of blinded study drug supply|7|||
149024508|NCT00031447|537566169|FG001|Overall Study|Disruption of blinded study drug supply|4|||
149024509|NCT01636362|537566170|FG000|Overall Study|Physician Decision|6|||
149024510|NCT01636362|537566170|FG000|Overall Study|Subject healed, not returning|1|||
149024511|NCT01636362|537566170|FG000|Overall Study|Withdrawal by Subject|1|||
149024512|NCT00519779|537566171|FG000|Overall Study|Withdrawal by Subject|0|||
149024513|NCT00519779|537566172|FG001|Overall Study|Withdrawal by Subject|1|||
149024514|NCT03330119|537566173|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
149024515|NCT03330119|537566174|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
149024516|NCT01561079|537566175|FG000|Overall Study|Physician Decision|17|||
149024517|NCT01561079|537566175|FG000|Overall Study|Withdrawal by Subject|59|||
149024518|NCT01561079|537566175|FG000|Overall Study|Protocol Violation|2|||
149024519|NCT00664521|537566178|FG000|Overall Study|Adverse Event|4|||
149024520|NCT00664521|537566179|FG001|Overall Study|Adverse Event|1|||
149024521|NCT00664521|537566178|FG000|Overall Study|Lost to Follow-up|1|||
149024522|NCT00664521|537566179|FG001|Overall Study|Lost to Follow-up|0|||
149024523|NCT00664521|537566178|FG000|Overall Study|Other|1|||
149024524|NCT00664521|537566179|FG001|Overall Study|Other|0|||
149024525|NCT01323660|537566180|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
149024526|NCT01323660|537566181|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
149024527|NCT01323660|537566182|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
149024528|NCT01323660|537566183|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
149024529|NCT01323660|537566184|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
149024530|NCT01323660|537566185|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
149024531|NCT01323660|537566180|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
149024532|NCT01323660|537566181|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
149024533|NCT01323660|537566182|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
149024534|NCT01323660|537566183|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
149024535|NCT01323660|537566184|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
149024536|NCT01323660|537566185|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
149024537|NCT01323660|537566180|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
149024538|NCT01323660|537566181|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
149024539|NCT01323660|537566182|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
149024540|NCT01323660|537566183|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
149024541|NCT01323660|537566184|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
149024542|NCT01323660|537566185|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
149024543|NCT01323660|537566180|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149024544|NCT01323660|537566181|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149024545|NCT01323660|537566182|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149024546|NCT01323660|537566183|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149024547|NCT01323660|537566184|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
149024548|NCT01323660|537566185|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
149024549|NCT01323660|537566180|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149024550|NCT01323660|537566181|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149024551|NCT01323660|537566182|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149024552|NCT01323660|537566183|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149024553|NCT01323660|537566184|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
149024554|NCT01323660|537566185|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
149024555|NCT01323660|537566180|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
149024556|NCT01323660|537566181|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149024557|NCT01323660|537566182|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
149024558|NCT01323660|537566183|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
149024559|NCT01323660|537566184|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
149024560|NCT01323660|537566185|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
149024561|NCT01323660|537566180|FG000|Washout Period (14 Days)|Adverse Event|0|||
149024562|NCT01323660|537566181|FG001|Washout Period (14 Days)|Adverse Event|0|||
149024563|NCT01323660|537566182|FG002|Washout Period (14 Days)|Adverse Event|0|||
149024564|NCT01323660|537566183|FG003|Washout Period (14 Days)|Adverse Event|0|||
149024565|NCT01323660|537566184|FG004|Washout Period (14 Days)|Adverse Event|1|||
149024566|NCT01323660|537566185|FG005|Washout Period (14 Days)|Adverse Event|0|||
149024567|NCT01323660|537566180|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
149024568|NCT01323660|537566181|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
149024569|NCT01323660|537566182|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
149024570|NCT01323660|537566183|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
149024571|NCT01323660|537566184|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
149024572|NCT01323660|537566185|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
149024573|NCT01323660|537566180|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
149024574|NCT01323660|537566181|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149024575|NCT01323660|537566182|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
149024576|NCT01323660|537566183|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
149024577|NCT01323660|537566184|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
149024578|NCT01323660|537566185|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
149024579|NCT01323660|537566180|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
149024580|NCT01323660|537566181|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
149024581|NCT01323660|537566182|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
149024582|NCT01323660|537566183|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
149024583|NCT01323660|537566184|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
149024584|NCT01323660|537566185|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
149024585|NCT01323660|537566180|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
149024586|NCT01323660|537566181|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
149024587|NCT01323660|537566182|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
149024588|NCT01323660|537566183|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
149024589|NCT01323660|537566184|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
149024590|NCT01323660|537566185|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
149024591|NCT01323660|537566180|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
149024592|NCT01323660|537566181|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
149024593|NCT01323660|537566182|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
149024594|NCT01323660|537566183|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
149024595|NCT01323660|537566184|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
149024596|NCT01323660|537566185|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
149024597|NCT01323660|537566180|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149024598|NCT01323660|537566181|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149024599|NCT01323660|537566182|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149024600|NCT01323660|537566183|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149024601|NCT01323660|537566184|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
149024602|NCT01323660|537566185|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149024603|NCT03566680|537566194|FG000|Overall Study|Pregnancy|1|||
149024604|NCT03566680|537566194|FG000|Overall Study|Lost to Follow-up|13|||
149024605|NCT03566680|537566194|FG000|Overall Study|Withdrawal by Subject|3|||
149024606|NCT03836664|537566195|FG000|Overall Study|Didn't complete forms and lost drug|3|||
149024607|NCT03836664|537566196|FG001|Overall Study|Didn't complete forms and lost drug|3|||
149024608|NCT02724020|537566197|FG000|Overall Study|Death|16|||
149024609|NCT02724020|537566198|FG001|Overall Study|Death|18|||
149024610|NCT02724020|537566199|FG002|Overall Study|Death|19|||
149024611|NCT02724020|537566197|FG000|Overall Study|Lost to Follow-up|0|||
149024612|NCT02724020|537566198|FG001|Overall Study|Lost to Follow-up|3|||
149024613|NCT02724020|537566199|FG002|Overall Study|Lost to Follow-up|0|||
149024614|NCT02724020|537566197|FG000|Overall Study|Site Terminated by Sponsor|15|||
149024615|NCT02724020|537566198|FG001|Overall Study|Site Terminated by Sponsor|8|||
149024616|NCT02724020|537566199|FG002|Overall Study|Site Terminated by Sponsor|8|||
149024617|NCT02724020|537566197|FG000|Overall Study|Withdrawal by Subject|1|||
148698139|NCT01918397|536369564|FG002|Overall Study|Lack of compliance|3|||
148698140|NCT01918397|536369565|FG003|Overall Study|Lack of compliance|0|||
148698141|NCT01918397|536369562|FG000|Overall Study|Pregnancy|0|||
148698142|NCT01918397|536369563|FG001|Overall Study|Pregnancy|1|||
149024618|NCT02724020|537566198|FG001|Overall Study|Withdrawal by Subject|3|||
149024619|NCT02724020|537566199|FG002|Overall Study|Withdrawal by Subject|5|||
149024620|NCT00425503|537566200|FG000|Overall Study|Adverse Event|2|||
149024621|NCT00425503|537566200|FG000|Overall Study|Protocol Violation|1|||
149024622|NCT02179918|537566201|FG000|Overall Study|Death|0|||
148814515|NCT02335944|536795643|FG005|Post-treatment Follow-up|Physician Decision|0|||
148698143|NCT01918397|536369564|FG002|Overall Study|Pregnancy|0|||
148698144|NCT01918397|536369565|FG003|Overall Study|Pregnancy|0|||
148698145|NCT01918397|536369562|FG000|Overall Study|Rifampin susceptible|0|||
148698146|NCT01918397|536369563|FG001|Overall Study|Rifampin susceptible|0|||
148698147|NCT01918397|536369564|FG002|Overall Study|Rifampin susceptible|0|||
148698148|NCT01918397|536369565|FG003|Overall Study|Rifampin susceptible|2|||
148698149|NCT01918397|536369562|FG000|Overall Study|Treatment failure|0|||
148698150|NCT01918397|536369563|FG001|Overall Study|Treatment failure|0|||
148698151|NCT01918397|536369564|FG002|Overall Study|Treatment failure|0|||
148698152|NCT01918397|536369565|FG003|Overall Study|Treatment failure|1|||
148698153|NCT01918397|536369562|FG000|Overall Study|Withdrawal by Subject|3|||
148698154|NCT01918397|536369563|FG001|Overall Study|Withdrawal by Subject|2|||
148698155|NCT01918397|536369564|FG002|Overall Study|Withdrawal by Subject|1|||
148698156|NCT01918397|536369565|FG003|Overall Study|Withdrawal by Subject|1|||
148698157|NCT01918397|536369562|FG000|Overall Study|XDR at baseline|0|||
148698158|NCT01918397|536369563|FG001|Overall Study|XDR at baseline|0|||
148698159|NCT01918397|536369564|FG002|Overall Study|XDR at baseline|1|||
148698160|NCT01918397|536369565|FG003|Overall Study|XDR at baseline|0|||
148698161|NCT01918397|536369562|FG000|Overall Study|Lost to Follow-up|2|||
148814516|NCT02335944|536795644|FG006|Post-treatment Follow-up|Physician Decision|0|||
148965122|NCT02658890|537358439|FG009|Treatment Phase|Other Reasons|0|||
148965123|NCT02658890|537358440|FG010|Treatment Phase|Other Reasons|0|||
148965124|NCT02658890|537358441|FG011|Treatment Phase|Other Reasons|0|||
148965125|NCT02658890|537358442|FG012|Treatment Phase|Other Reasons|0|||
148965126|NCT02658890|537358443|FG013|Treatment Phase|Other Reasons|2|||
148965127|NCT02658890|537358444|FG014|Treatment Phase|Other Reasons|0|||
148965128|NCT02658890|537358445|FG015|Treatment Phase|Other Reasons|0|||
148965129|NCT02658890|537358446|FG016|Treatment Phase|Other Reasons|0|||
148965130|NCT02658890|537358447|FG017|Treatment Phase|Other Reasons|0|||
148965131|NCT02658890|537358448|FG018|Treatment Phase|Other Reasons|1|||
148965132|NCT02658890|537358449|FG019|Treatment Phase|Other Reasons|0|||
148965133|NCT02658890|537358450|FG020|Treatment Phase|Other Reasons|0|||
148965134|NCT02658890|537358451|FG021|Treatment Phase|Other Reasons|0|||
148965135|NCT02658890|537358452|FG022|Treatment Phase|Other Reasons|0|||
148965136|NCT02658890|537358453|FG023|Treatment Phase|Other Reasons|0|||
148965137|NCT02658890|537358454|FG024|Treatment Phase|Other Reasons|1|||
148965138|NCT02658890|537358455|FG025|Treatment Phase|Other Reasons|0|||
148965139|NCT02658890|537358456|FG026|Treatment Phase|Other Reasons|1|||
148965140|NCT02658890|537358430|FG000|Treatment Phase|Progressive Disease|6|||
148965141|NCT02658890|537358431|FG001|Treatment Phase|Progressive Disease|7|||
148965142|NCT02658890|537358432|FG002|Treatment Phase|Progressive Disease|6|||
148965143|NCT02658890|537358433|FG003|Treatment Phase|Progressive Disease|12|||
148965144|NCT02658890|537358434|FG004|Treatment Phase|Progressive Disease|6|||
148965145|NCT02658890|537358435|FG005|Treatment Phase|Progressive Disease|18|||
148965146|NCT02658890|537358436|FG006|Treatment Phase|Progressive Disease|12|||
148965147|NCT02658890|537358437|FG007|Treatment Phase|Progressive Disease|19|||
148965148|NCT02658890|537358438|FG008|Treatment Phase|Progressive Disease|26|||
148965149|NCT02658890|537358439|FG009|Treatment Phase|Progressive Disease|8|||
148965150|NCT02658890|537358440|FG010|Treatment Phase|Progressive Disease|7|||
148965151|NCT02658890|537358441|FG011|Treatment Phase|Progressive Disease|9|||
148965152|NCT02658890|537358442|FG012|Treatment Phase|Progressive Disease|8|||
148965153|NCT02658890|537358443|FG013|Treatment Phase|Progressive Disease|29|||
148965154|NCT02658890|537358444|FG014|Treatment Phase|Progressive Disease|6|||
148965155|NCT02658890|537358445|FG015|Treatment Phase|Progressive Disease|2|||
148965156|NCT02658890|537358446|FG016|Treatment Phase|Progressive Disease|32|||
148965157|NCT02658890|537358447|FG017|Treatment Phase|Progressive Disease|14|||
148965158|NCT02658890|537358448|FG018|Treatment Phase|Progressive Disease|40|||
148965159|NCT02658890|537358449|FG019|Treatment Phase|Progressive Disease|32|||
148965160|NCT02658890|537358450|FG020|Treatment Phase|Progressive Disease|19|||
148965161|NCT02658890|537358451|FG021|Treatment Phase|Progressive Disease|30|||
148965162|NCT02658890|537358452|FG022|Treatment Phase|Progressive Disease|15|||
148965163|NCT02658890|537358453|FG023|Treatment Phase|Progressive Disease|0|||
148965164|NCT02658890|537358454|FG024|Treatment Phase|Progressive Disease|0|||
148965165|NCT02658890|537358455|FG025|Treatment Phase|Progressive Disease|14|||
148965166|NCT02658890|537358456|FG026|Treatment Phase|Progressive Disease|11|||
148698162|NCT01918397|536369563|FG001|Overall Study|Lost to Follow-up|1|||
148698163|NCT01918397|536369564|FG002|Overall Study|Lost to Follow-up|1|||
148698164|NCT01918397|536369565|FG003|Overall Study|Lost to Follow-up|1|||
148698165|NCT01918397|536369562|FG000|Overall Study|Increased QTc|1|||
148698166|NCT01918397|536369563|FG001|Overall Study|Increased QTc|0|||
148698167|NCT01918397|536369564|FG002|Overall Study|Increased QTc|0|||
148698168|NCT01918397|536369565|FG003|Overall Study|Increased QTc|1|||
148698169|NCT01918397|536369562|FG000|Overall Study|Death|0|||
148698170|NCT01918397|536369563|FG001|Overall Study|Death|0|||
148698171|NCT01918397|536369564|FG002|Overall Study|Death|1|||
148698172|NCT01918397|536369565|FG003|Overall Study|Death|0|||
148698173|NCT01918397|536369562|FG000|Overall Study|Involved in another investigative trial|0|||
148698174|NCT01918397|536369563|FG001|Overall Study|Involved in another investigative trial|0|||
148698175|NCT01918397|536369564|FG002|Overall Study|Involved in another investigative trial|0|||
148698176|NCT01918397|536369565|FG003|Overall Study|Involved in another investigative trial|1|||
148698177|NCT00880568|536369566|FG000|Overall Study|Disease progression|3|||
148698178|NCT00880568|536369567|FG001|Overall Study|Disease progression|3|||
148698179|NCT00880568|536369568|FG002|Overall Study|Disease progression|3|||
148814517|NCT02335944|536795645|FG007|Post-treatment Follow-up|Physician Decision|1|||
148698180|NCT00880568|536369569|FG003|Overall Study|Disease progression|1|||
148814518|NCT02335944|536795646|FG008|Post-treatment Follow-up|Physician Decision|0|||
148814519|NCT02335944|536795647|FG009|Post-treatment Follow-up|Physician Decision|0|||
148698181|NCT00880568|536369570|FG004|Overall Study|Disease progression|3|||
148698182|NCT00880568|536369571|FG005|Overall Study|Disease progression|3|||
148698183|NCT00880568|536369572|FG006|Overall Study|Disease progression|5|||
148965167|NCT02658890|537358430|FG000|Treatment Phase|Study Drug Toxicity|0|||
148965168|NCT02658890|537358431|FG001|Treatment Phase|Study Drug Toxicity|0|||
148965169|NCT02658890|537358432|FG002|Treatment Phase|Study Drug Toxicity|2|||
148698184|NCT00880568|536369573|FG007|Overall Study|Disease progression|0|||
148698185|NCT00880568|536369574|FG008|Overall Study|Disease progression|3|||
148698186|NCT00880568|536369566|FG000|Overall Study|Adverse Event|0|||
148698187|NCT00880568|536369567|FG001|Overall Study|Adverse Event|0|||
148814520|NCT01202591|536795648|FG000|Overall Study|Adverse Event|2|||
148965170|NCT02658890|537358433|FG003|Treatment Phase|Study Drug Toxicity|0|||
148965171|NCT02658890|537358434|FG004|Treatment Phase|Study Drug Toxicity|0|||
148965172|NCT02658890|537358435|FG005|Treatment Phase|Study Drug Toxicity|0|||
148965173|NCT02658890|537358436|FG006|Treatment Phase|Study Drug Toxicity|0|||
148965174|NCT02658890|537358437|FG007|Treatment Phase|Study Drug Toxicity|0|||
148965175|NCT02658890|537358438|FG008|Treatment Phase|Study Drug Toxicity|3|||
148965176|NCT02658890|537358439|FG009|Treatment Phase|Study Drug Toxicity|0|||
148965177|NCT02658890|537358440|FG010|Treatment Phase|Study Drug Toxicity|1|||
148965178|NCT02658890|537358441|FG011|Treatment Phase|Study Drug Toxicity|1|||
148965179|NCT02658890|537358442|FG012|Treatment Phase|Study Drug Toxicity|2|||
148965180|NCT02658890|537358443|FG013|Treatment Phase|Study Drug Toxicity|9|||
148965181|NCT02658890|537358444|FG014|Treatment Phase|Study Drug Toxicity|0|||
148965182|NCT02658890|537358445|FG015|Treatment Phase|Study Drug Toxicity|1|||
148965183|NCT02658890|537358446|FG016|Treatment Phase|Study Drug Toxicity|1|||
148965184|NCT02658890|537358447|FG017|Treatment Phase|Study Drug Toxicity|0|||
148965185|NCT02658890|537358448|FG018|Treatment Phase|Study Drug Toxicity|8|||
148965186|NCT02658890|537358449|FG019|Treatment Phase|Study Drug Toxicity|3|||
148965187|NCT02658890|537358450|FG020|Treatment Phase|Study Drug Toxicity|2|||
148965188|NCT02658890|537358451|FG021|Treatment Phase|Study Drug Toxicity|0|||
148965189|NCT02658890|537358452|FG022|Treatment Phase|Study Drug Toxicity|8|||
148965190|NCT02658890|537358453|FG023|Treatment Phase|Study Drug Toxicity|0|||
148965191|NCT02658890|537358454|FG024|Treatment Phase|Study Drug Toxicity|0|||
148965192|NCT02658890|537358455|FG025|Treatment Phase|Study Drug Toxicity|2|||
148965193|NCT02658890|537358456|FG026|Treatment Phase|Study Drug Toxicity|0|||
148965194|NCT02658890|537358430|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965195|NCT02658890|537358431|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965196|NCT02658890|537358432|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965197|NCT02658890|537358433|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
148965198|NCT02658890|537358434|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965199|NCT02658890|537358435|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965200|NCT02658890|537358436|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965201|NCT02658890|537358437|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965202|NCT02658890|537358438|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965203|NCT02658890|537358439|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
148965204|NCT02658890|537358440|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965205|NCT02658890|537358441|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965206|NCT02658890|537358442|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965207|NCT02658890|537358443|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965208|NCT02658890|537358444|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965209|NCT02658890|537358445|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965210|NCT02658890|537358446|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965211|NCT02658890|537358447|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965212|NCT02658890|537358448|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
148965213|NCT02658890|537358449|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965214|NCT02658890|537358450|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148698188|NCT00880568|536369568|FG002|Overall Study|Adverse Event|0|||
149024623|NCT02179918|537566202|FG001|Overall Study|Death|0|||
149024624|NCT02179918|537566203|FG002|Overall Study|Death|0|||
149024625|NCT02179918|537566204|FG003|Overall Study|Death|1|||
149024626|NCT02179918|537566205|FG004|Overall Study|Death|0|||
149024627|NCT02179918|537566201|FG000|Overall Study|Lost to Follow-up|0|||
149024628|NCT02179918|537566202|FG001|Overall Study|Lost to Follow-up|0|||
149024629|NCT02179918|537566203|FG002|Overall Study|Lost to Follow-up|1|||
149024630|NCT02179918|537566204|FG003|Overall Study|Lost to Follow-up|0|||
149024631|NCT02179918|537566205|FG004|Overall Study|Lost to Follow-up|0|||
149024632|NCT02179918|537566201|FG000|Overall Study|Progressive Disease|4|||
149024633|NCT02179918|537566202|FG001|Overall Study|Progressive Disease|1|||
149024634|NCT02179918|537566203|FG002|Overall Study|Progressive Disease|1|||
149024635|NCT02179918|537566204|FG003|Overall Study|Progressive Disease|2|||
149024636|NCT02179918|537566205|FG004|Overall Study|Progressive Disease|6|||
149024637|NCT02179918|537566201|FG000|Overall Study|Other|0|||
149024638|NCT02179918|537566202|FG001|Overall Study|Other|1|||
149024639|NCT02179918|537566203|FG002|Overall Study|Other|0|||
149024640|NCT02179918|537566204|FG003|Overall Study|Other|0|||
149024641|NCT02179918|537566205|FG004|Overall Study|Other|1|||
149024642|NCT02179918|537566201|FG000|Overall Study|Subject refused further follow-up|0|||
149024643|NCT02179918|537566202|FG001|Overall Study|Subject refused further follow-up|1|||
148698189|NCT00880568|536369569|FG003|Overall Study|Adverse Event|0|||
148698190|NCT00880568|536369570|FG004|Overall Study|Adverse Event|0|||
148698191|NCT00880568|536369571|FG005|Overall Study|Adverse Event|0|||
148698192|NCT00880568|536369572|FG006|Overall Study|Adverse Event|1|||
148698193|NCT00880568|536369573|FG007|Overall Study|Adverse Event|1|||
148698194|NCT00880568|536369574|FG008|Overall Study|Adverse Event|0|||
148698195|NCT00880568|536369566|FG000|Overall Study|Withdrawal by Subject|0|||
148698196|NCT00880568|536369567|FG001|Overall Study|Withdrawal by Subject|0|||
148698197|NCT00880568|536369568|FG002|Overall Study|Withdrawal by Subject|0|||
148698198|NCT00880568|536369569|FG003|Overall Study|Withdrawal by Subject|0|||
148698199|NCT00880568|536369570|FG004|Overall Study|Withdrawal by Subject|0|||
148698200|NCT00880568|536369571|FG005|Overall Study|Withdrawal by Subject|0|||
148698201|NCT00880568|536369572|FG006|Overall Study|Withdrawal by Subject|0|||
148698202|NCT00880568|536369573|FG007|Overall Study|Withdrawal by Subject|1|||
148698203|NCT00880568|536369574|FG008|Overall Study|Withdrawal by Subject|0|||
148698204|NCT00620022|536369575|FG000|Treatment Period 1|Adverse Event|4|||
148698205|NCT00620022|536369576|FG001|Treatment Period 1|Adverse Event|6|||
148698206|NCT00620022|536369575|FG000|Treatment Period 1|Subject withdrew consent|1|||
148698207|NCT00620022|536369576|FG001|Treatment Period 1|Subject withdrew consent|0|||
148698208|NCT00620022|536369575|FG000|Treatment Period 2|Adverse Event|2|||
148698209|NCT00620022|536369576|FG001|Treatment Period 2|Adverse Event|2|||
148698210|NCT03340727|536369583|FG000|Overall Study|Death|1|||
148698211|NCT03340727|536369584|FG001|Overall Study|Death|0|||
148698212|NCT03340727|536369583|FG000|Overall Study|Lost to Follow-up|31|||
148698213|NCT03340727|536369584|FG001|Overall Study|Lost to Follow-up|35|||
148698214|NCT03340727|536369583|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
148698215|NCT03340727|536369584|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
148698216|NCT03340727|536369583|FG000|Overall Study|Transferred to another facility|10|||
148698217|NCT03340727|536369584|FG001|Overall Study|Transferred to another facility|7|||
148698218|NCT03340727|536369583|FG000|Overall Study|Withdrawal by Subject|28|||
148698219|NCT03340727|536369584|FG001|Overall Study|Withdrawal by Subject|17|||
148965215|NCT02658890|537358451|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965216|NCT02658890|537358452|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
148965217|NCT02658890|537358453|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965218|NCT02658890|537358454|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965219|NCT02658890|537358455|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965220|NCT02658890|537358456|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
148965221|NCT02658890|537358430|FG000|Treatment Phase|Withdrawal by Subject|0|||
148965222|NCT02658890|537358431|FG001|Treatment Phase|Withdrawal by Subject|1|||
148965223|NCT02658890|537358432|FG002|Treatment Phase|Withdrawal by Subject|0|||
148965224|NCT02658890|537358433|FG003|Treatment Phase|Withdrawal by Subject|0|||
148965225|NCT02658890|537358434|FG004|Treatment Phase|Withdrawal by Subject|0|||
148965226|NCT02658890|537358435|FG005|Treatment Phase|Withdrawal by Subject|0|||
148965227|NCT02658890|537358436|FG006|Treatment Phase|Withdrawal by Subject|1|||
148965228|NCT02658890|537358437|FG007|Treatment Phase|Withdrawal by Subject|0|||
148965229|NCT02658890|537358438|FG008|Treatment Phase|Withdrawal by Subject|0|||
148965230|NCT02658890|537358439|FG009|Treatment Phase|Withdrawal by Subject|1|||
148965231|NCT02658890|537358440|FG010|Treatment Phase|Withdrawal by Subject|0|||
148965232|NCT02658890|537358441|FG011|Treatment Phase|Withdrawal by Subject|0|||
148965233|NCT02658890|537358442|FG012|Treatment Phase|Withdrawal by Subject|1|||
148965234|NCT02658890|537358443|FG013|Treatment Phase|Withdrawal by Subject|3|||
148965235|NCT02658890|537358444|FG014|Treatment Phase|Withdrawal by Subject|0|||
148965236|NCT02658890|537358445|FG015|Treatment Phase|Withdrawal by Subject|0|||
148965237|NCT02658890|537358446|FG016|Treatment Phase|Withdrawal by Subject|1|||
148965238|NCT02658890|537358447|FG017|Treatment Phase|Withdrawal by Subject|0|||
148965239|NCT02658890|537358448|FG018|Treatment Phase|Withdrawal by Subject|4|||
148965240|NCT02658890|537358449|FG019|Treatment Phase|Withdrawal by Subject|3|||
148965241|NCT02658890|537358450|FG020|Treatment Phase|Withdrawal by Subject|0|||
148965242|NCT02658890|537358451|FG021|Treatment Phase|Withdrawal by Subject|4|||
148965243|NCT02658890|537358452|FG022|Treatment Phase|Withdrawal by Subject|1|||
148965244|NCT02658890|537358453|FG023|Treatment Phase|Withdrawal by Subject|1|||
148965245|NCT02658890|537358454|FG024|Treatment Phase|Withdrawal by Subject|0|||
148965246|NCT02658890|537358455|FG025|Treatment Phase|Withdrawal by Subject|0|||
148965247|NCT02658890|537358456|FG026|Treatment Phase|Withdrawal by Subject|0|||
148965248|NCT02474199|537358460|FG000|Overall Study|Lost to Follow-up|1|||
148965249|NCT02474199|537358461|FG001|Overall Study|Lost to Follow-up|0|||
148965250|NCT02474199|537358462|FG002|Overall Study|Lost to Follow-up|0|||
148965251|NCT02474199|537358463|FG003|Overall Study|Lost to Follow-up|0|||
148965252|NCT02474199|537358460|FG000|Overall Study|Withdrawal by Subject|1|||
148965253|NCT02474199|537358461|FG001|Overall Study|Withdrawal by Subject|2|||
148965254|NCT02474199|537358462|FG002|Overall Study|Withdrawal by Subject|0|||
148965255|NCT02474199|537358463|FG003|Overall Study|Withdrawal by Subject|1|||
148965256|NCT02474199|537358460|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
148965257|NCT02474199|537358461|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
148965258|NCT02474199|537358462|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
148965259|NCT02474199|537358463|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
148965260|NCT02474199|537358460|FG000|Overall Study|Did not meet eligibility criteria|0|||
148965261|NCT02474199|537358461|FG001|Overall Study|Did not meet eligibility criteria|0|||
148965262|NCT02474199|537358462|FG002|Overall Study|Did not meet eligibility criteria|2|||
148965263|NCT02474199|537358463|FG003|Overall Study|Did not meet eligibility criteria|2|||
148965264|NCT03090100|537358464|FG000|Overall Study|Adverse Event|9|||
148965265|NCT03090100|537358465|FG001|Overall Study|Adverse Event|11|||
148965266|NCT03090100|537358464|FG000|Overall Study|Pregnancy|1|||
148965267|NCT03090100|537358465|FG001|Overall Study|Pregnancy|1|||
148965268|NCT03090100|537358464|FG000|Overall Study|Lack of Efficacy|2|||
148965269|NCT03090100|537358465|FG001|Overall Study|Lack of Efficacy|7|||
148965270|NCT03090100|537358464|FG000|Overall Study|Lost to Follow-up|2|||
148965271|NCT03090100|537358465|FG001|Overall Study|Lost to Follow-up|2|||
148965272|NCT03090100|537358464|FG000|Overall Study|Withdrawal by Subject|7|||
148965273|NCT03090100|537358465|FG001|Overall Study|Withdrawal by Subject|19|||
148965274|NCT03090100|537358464|FG000|Overall Study|Protocol Violation|2|||
148965275|NCT03090100|537358465|FG001|Overall Study|Protocol Violation|6|||
148965276|NCT03090100|537358464|FG000|Overall Study|Non-compliance|2|||
148965277|NCT03090100|537358465|FG001|Overall Study|Non-compliance|0|||
148965278|NCT03090100|537358464|FG000|Overall Study|Other|2|||
148965279|NCT03090100|537358465|FG001|Overall Study|Other|2|||
148965280|NCT02731729|537358470|FG000|Overall Study|Death|2|||
148965281|NCT02731729|537358471|FG001|Overall Study|Death|2|||
148965282|NCT02731729|537358470|FG000|Overall Study|Study terminated by Sponsor|6|||
148965283|NCT02731729|537358471|FG001|Overall Study|Study terminated by Sponsor|6|||
148965284|NCT02731729|537358470|FG000|Overall Study|Withdrawal by Subject|1|||
148965285|NCT02731729|537358471|FG001|Overall Study|Withdrawal by Subject|0|||
148965286|NCT00159588|537358472|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
148965287|NCT00159588|537358473|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
148965288|NCT00159588|537358474|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
148965289|NCT03446040|537358475|FG000|Overall Study|Disease progression|3|||
148965290|NCT03446040|537358476|FG001|Overall Study|Disease progression|3|||
148965291|NCT03446040|537358477|FG002|Overall Study|Disease progression|3|||
148965292|NCT03446040|537358478|FG003|Overall Study|Disease progression|4|||
148965293|NCT03446040|537358479|FG004|Overall Study|Disease progression|4|||
148965294|NCT03446040|537358480|FG005|Overall Study|Disease progression|6|||
148965295|NCT03446040|537358481|FG006|Overall Study|Disease progression|3|||
148965296|NCT03446040|537358482|FG007|Overall Study|Disease progression|4|||
148965297|NCT03446040|537358483|FG008|Overall Study|Disease progression|2|||
148965298|NCT03446040|537358484|FG009|Overall Study|Disease progression|4|||
148965299|NCT03446040|537358485|FG010|Overall Study|Disease progression|9|||
148965300|NCT03446040|537358486|FG011|Overall Study|Disease progression|3|||
148965301|NCT03446040|537358487|FG012|Overall Study|Disease progression|7|||
148965302|NCT03446040|537358488|FG013|Overall Study|Disease progression|7|||
148965303|NCT03446040|537358475|FG000|Overall Study|Study drug toxicity|0|||
148965304|NCT03446040|537358476|FG001|Overall Study|Study drug toxicity|0|||
148965305|NCT03446040|537358477|FG002|Overall Study|Study drug toxicity|0|||
148965306|NCT03446040|537358478|FG003|Overall Study|Study drug toxicity|0|||
148965307|NCT03446040|537358479|FG004|Overall Study|Study drug toxicity|0|||
148965308|NCT03446040|537358480|FG005|Overall Study|Study drug toxicity|0|||
148965309|NCT03446040|537358481|FG006|Overall Study|Study drug toxicity|0|||
149024644|NCT02179918|537566203|FG002|Overall Study|Subject refused further follow-up|0|||
149024645|NCT02179918|537566204|FG003|Overall Study|Subject refused further follow-up|0|||
149024646|NCT02179918|537566205|FG004|Overall Study|Subject refused further follow-up|1|||
149024647|NCT02118714|537566210|FG000|Overall Study|Lost to Follow-up|2|||
149024648|NCT02118714|537566210|FG000|Overall Study|Protocol Violation|1|||
149024649|NCT02954575|537566211|FG000|Overall Study|Withdrawal by Subject|2|||
149024650|NCT02954575|537566211|FG000|Overall Study|Adverse Event|1|||
149024651|NCT00570661|537566213|FG000|Overall Study|Disease worsening|5|||
149024652|NCT00570661|537566213|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
149024653|NCT00570661|537566213|FG000|Overall Study|Adverse Event|1|||
149024654|NCT01734382|537566214|FG000|Part 1|Adverse Event|2|||
149024655|NCT01734382|537566215|FG001|Part 1|Adverse Event|0|||
149024656|NCT01734382|537566216|FG002|Part 1|Adverse Event|0|||
149024657|NCT01734382|537566214|FG000|Part 2|Adverse Event|0|||
149024658|NCT01734382|537566215|FG001|Part 2|Adverse Event|0|||
149024659|NCT01734382|537566216|FG002|Part 2|Adverse Event|1|||
149024660|NCT01734382|537566214|FG000|Part 2|Lack of Efficacy|0|||
149024661|NCT01734382|537566215|FG001|Part 2|Lack of Efficacy|1|||
149024662|NCT01734382|537566216|FG002|Part 2|Lack of Efficacy|1|||
149024663|NCT01734382|537566214|FG000|Part 2|Other|0|||
149024664|NCT01734382|537566215|FG001|Part 2|Other|0|||
149024665|NCT01734382|537566216|FG002|Part 2|Other|1|||
149024666|NCT01734382|537566214|FG000|Part 2|Physician Decision|0|||
149024667|NCT01734382|537566215|FG001|Part 2|Physician Decision|0|||
149024668|NCT01734382|537566216|FG002|Part 2|Physician Decision|3|||
149024669|NCT01734382|537566214|FG000|Part 2|Protocol Violation|0|||
149024670|NCT01734382|537566215|FG001|Part 2|Protocol Violation|1|||
149024671|NCT01734382|537566216|FG002|Part 2|Protocol Violation|0|||
149024672|NCT01734382|537566214|FG000|Part 2|Withdrawal by Subject|0|||
149024673|NCT01734382|537566215|FG001|Part 2|Withdrawal by Subject|0|||
149024674|NCT01734382|537566216|FG002|Part 2|Withdrawal by Subject|1|||
149024675|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
149024676|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
149024677|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
149024678|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
149024679|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
149024680|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
149024681|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
149024682|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
149024683|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
149024684|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
149024685|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
149024686|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
149024687|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
149024688|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
149024689|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
149024690|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
149024691|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
149024692|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
149024693|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
149024694|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
148698220|NCT00877032|536369585|FG000|Overall Study|Did not meet entrance criteria|0|||
148698221|NCT00877032|536369586|FG001|Overall Study|Did not meet entrance criteria|0|||
149024695|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
148698222|NCT00877032|536369587|FG002|Overall Study|Did not meet entrance criteria|0|||
148698223|NCT00877032|536369588|FG003|Overall Study|Did not meet entrance criteria|1|||
148698224|NCT00877032|536369589|FG004|Overall Study|Did not meet entrance criteria|0|||
149024696|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
149024697|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
148698225|NCT00877032|536369590|FG005|Overall Study|Did not meet entrance criteria|0|||
149024698|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
149024699|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
149024700|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
149024701|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
149024702|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
149024703|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
149024704|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
149024705|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
149024706|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
149024707|NCT03890120|537566217|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
149024708|NCT03890120|537566218|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
149024709|NCT03890120|537566219|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
149024710|NCT03890120|537566220|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
149024711|NCT03890120|537566217|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
149024712|NCT03890120|537566218|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
149024713|NCT03890120|537566219|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
149024714|NCT03890120|537566220|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
149024715|NCT03890120|537566217|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
149024716|NCT03890120|537566218|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
149024717|NCT03890120|537566219|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
149024718|NCT03890120|537566220|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
149024719|NCT03890120|537566217|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
149024720|NCT03890120|537566218|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
149024721|NCT03890120|537566219|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
149024722|NCT03890120|537566220|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
149024723|NCT03890120|537566217|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
149024724|NCT03890120|537566218|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
149024725|NCT03890120|537566219|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
149024726|NCT03890120|537566220|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
149024727|NCT04537949|537566221|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
149024728|NCT04537949|537566222|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
149024729|NCT04537949|537566223|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
149024730|NCT04537949|537566224|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
149024731|NCT04537949|537566225|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
149024732|NCT04537949|537566226|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
149024733|NCT04537949|537566227|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
149024734|NCT04537949|537566228|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
149024735|NCT04537949|537566221|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
149024736|NCT04537949|537566222|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
149024737|NCT04537949|537566223|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
149024738|NCT04537949|537566224|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
149024739|NCT04537949|537566225|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
149024740|NCT04537949|537566226|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
149024741|NCT04537949|537566227|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
149024742|NCT04537949|537566228|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
149024743|NCT04537949|537566221|FG000|Follow-up Phase|Lost to Follow-up|0|||
149024744|NCT04537949|537566222|FG001|Follow-up Phase|Lost to Follow-up|3|||
149024745|NCT04537949|537566223|FG002|Follow-up Phase|Lost to Follow-up|0|||
149024746|NCT04537949|537566224|FG003|Follow-up Phase|Lost to Follow-up|0|||
149024747|NCT04537949|537566225|FG004|Follow-up Phase|Lost to Follow-up|0|||
149024748|NCT04537949|537566226|FG005|Follow-up Phase|Lost to Follow-up|0|||
149024749|NCT04537949|537566227|FG006|Follow-up Phase|Lost to Follow-up|0|||
149024750|NCT04537949|537566228|FG007|Follow-up Phase|Lost to Follow-up|0|||
149024751|NCT04537949|537566221|FG000|Follow-up Phase|personal reasons|0|||
148698226|NCT00877032|536369591|FG006|Overall Study|Did not meet entrance criteria|2|||
148698227|NCT00669942|536369592|FG000|Parts 2 and 3|Adverse Event|0|||
148698228|NCT00669942|536369593|FG001|Parts 2 and 3|Adverse Event|0|||
148698229|NCT00669942|536369594|FG002|Parts 2 and 3|Adverse Event|0|||
148698230|NCT00669942|536369595|FG003|Parts 2 and 3|Adverse Event|0|||
148698231|NCT00669942|536369596|FG004|Parts 2 and 3|Adverse Event|0|||
148698232|NCT00669942|536369597|FG005|Parts 2 and 3|Adverse Event|0|||
148698233|NCT00669942|536369598|FG006|Parts 2 and 3|Adverse Event|0|||
148698234|NCT00669942|536369599|FG007|Parts 2 and 3|Adverse Event|2|||
148698235|NCT00669942|536369600|FG008|Parts 2 and 3|Adverse Event|1|||
149024752|NCT04537949|537566222|FG001|Follow-up Phase|personal reasons|0|||
149024753|NCT04537949|537566223|FG002|Follow-up Phase|personal reasons|0|||
149024754|NCT04537949|537566224|FG003|Follow-up Phase|personal reasons|1|||
148698236|NCT00669942|536369601|FG009|Parts 2 and 3|Adverse Event|0|||
148698237|NCT00669942|536369602|FG010|Parts 2 and 3|Adverse Event|0|||
148698238|NCT00669942|536369603|FG011|Parts 2 and 3|Adverse Event|0|||
149024755|NCT04537949|537566225|FG004|Follow-up Phase|personal reasons|1|||
149024756|NCT04537949|537566226|FG005|Follow-up Phase|personal reasons|0|||
149024757|NCT04537949|537566227|FG006|Follow-up Phase|personal reasons|0|||
149024758|NCT04537949|537566228|FG007|Follow-up Phase|personal reasons|0|||
149024759|NCT04537949|537566221|FG000|Follow-up Phase|Withdrawal by Subject|0|||
149024760|NCT04537949|537566222|FG001|Follow-up Phase|Withdrawal by Subject|0|||
149024761|NCT04537949|537566223|FG002|Follow-up Phase|Withdrawal by Subject|0|||
149024762|NCT04537949|537566224|FG003|Follow-up Phase|Withdrawal by Subject|0|||
149024763|NCT04537949|537566225|FG004|Follow-up Phase|Withdrawal by Subject|1|||
149024764|NCT04537949|537566226|FG005|Follow-up Phase|Withdrawal by Subject|0|||
149024765|NCT04537949|537566227|FG006|Follow-up Phase|Withdrawal by Subject|0|||
149024766|NCT04537949|537566228|FG007|Follow-up Phase|Withdrawal by Subject|0|||
149024767|NCT04003974|537566229|FG000|Overall Study|Missing|1|||
149024768|NCT04003974|537566230|FG001|Overall Study|Missing|0|||
149024769|NCT04003974|537566229|FG000|Overall Study|Withdrawal by Subject|0|||
149024770|NCT04003974|537566230|FG001|Overall Study|Withdrawal by Subject|2|||
149024771|NCT02400307|537566231|FG000|Overall Study|Enrolled and Never Dosed|1|||
149024772|NCT02400307|537566232|FG001|Overall Study|Enrolled and Never Dosed|0|||
149024773|NCT02015663|537566235|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
149024774|NCT02015663|537566236|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
149024775|NCT02015663|537566235|FG000|Overall Study|Withdrawal by Subject|1|||
149024776|NCT02015663|537566236|FG001|Overall Study|Withdrawal by Subject|0|||
149024777|NCT02015663|537566235|FG000|Overall Study|Protocol Violation|0|||
149024778|NCT02015663|537566236|FG001|Overall Study|Protocol Violation|1|||
149024779|NCT02015663|537566235|FG000|Overall Study|Adverse Event|3|||
149024780|NCT02015663|537566236|FG001|Overall Study|Adverse Event|0|||
149024781|NCT02015663|537566235|FG000|Overall Study|Administrative problems|10|||
149024782|NCT02015663|537566236|FG001|Overall Study|Administrative problems|11|||
149024783|NCT00479674|537566238|FG000|Overall Study|Adverse Event|18|||
149024784|NCT00479674|537566238|FG000|Overall Study|Withdrawal by Subject|6|||
149024785|NCT00479674|537566238|FG000|Overall Study|Physician Decision|14|||
149024786|NCT00479674|537566238|FG000|Overall Study|none provided|3|||
149024787|NCT03293485|537566241|FG000|Overall Study|Death|1|||
149024788|NCT03293485|537566241|FG000|Overall Study|Screen Failure|2|||
149024789|NCT03293485|537566241|FG000|Overall Study|Withdrawal by Subject|2|||
149024790|NCT03023332|537566242|FG000|Overall Study|Withdrawal by Subject|10|||
149024791|NCT03023332|537566243|FG001|Overall Study|Withdrawal by Subject|5|||
149024792|NCT03023332|537566244|FG002|Overall Study|Withdrawal by Subject|4|||
149024793|NCT03023332|537566245|FG003|Overall Study|Withdrawal by Subject|7|||
149024794|NCT03023332|537566242|FG000|Overall Study|Lost to Follow-up|13|||
149024795|NCT03023332|537566243|FG001|Overall Study|Lost to Follow-up|16|||
149024796|NCT03023332|537566244|FG002|Overall Study|Lost to Follow-up|8|||
149024797|NCT03023332|537566245|FG003|Overall Study|Lost to Follow-up|13|||
149024798|NCT03023332|537566242|FG000|Overall Study|Death|1|||
149024799|NCT03023332|537566243|FG001|Overall Study|Death|0|||
149024800|NCT03023332|537566244|FG002|Overall Study|Death|0|||
149024801|NCT03023332|537566245|FG003|Overall Study|Death|0|||
149024802|NCT03633903|537566250|FG000|Overall Study|Withdrawal by Subject|1|||
149024803|NCT03633903|537566251|FG001|Overall Study|Withdrawal by Subject|2|||
149024804|NCT03633903|537566250|FG000|Overall Study|Lost to Follow-up|5|||
149024805|NCT03633903|537566251|FG001|Overall Study|Lost to Follow-up|5|||
149024806|NCT01657682|537566252|FG000|Overall Study|Lost to Follow-up|1|||
149024807|NCT01657682|537566253|FG001|Overall Study|Lost to Follow-up|0|||
149024808|NCT01657682|537566254|FG002|Overall Study|Lost to Follow-up|0|||
149024809|NCT01657682|537566252|FG000|Overall Study|Withdrawal by Subject|0|||
148698239|NCT00669942|536369592|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
148698240|NCT00669942|536369593|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
148698241|NCT00669942|536369594|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
148698242|NCT00669942|536369595|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
149024810|NCT01657682|537566253|FG001|Overall Study|Withdrawal by Subject|1|||
149024811|NCT01657682|537566254|FG002|Overall Study|Withdrawal by Subject|1|||
149024812|NCT01657682|537566252|FG000|Overall Study|Adverse Event|0|||
149024813|NCT01657682|537566253|FG001|Overall Study|Adverse Event|1|||
149024814|NCT01657682|537566254|FG002|Overall Study|Adverse Event|0|||
149024815|NCT01719861|537566256|FG000|Cycle 1|Death|4|||
149024816|NCT01719861|537566256|FG000|Cycle 2|Death|1|||
149024817|NCT00087490|537566257|FG000|Overall Study|Death|6|||
148698243|NCT00669942|536369596|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
148698244|NCT00669942|536369597|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
149024818|NCT00087490|537566258|FG001|Overall Study|Death|4|||
149024819|NCT00087490|537566257|FG000|Overall Study|Adverse Event|3|||
149024820|NCT00087490|537566258|FG001|Overall Study|Adverse Event|8|||
149024821|NCT00087490|537566257|FG000|Overall Study|Lack of Efficacy|0|||
149024822|NCT00087490|537566258|FG001|Overall Study|Lack of Efficacy|2|||
149024823|NCT00087490|537566257|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
149024824|NCT00087490|537566258|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
149024825|NCT00087490|537566257|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
149024826|NCT00087490|537566258|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
149024827|NCT00087490|537566257|FG000|Overall Study|Randomized but not treated|7|||
149024828|NCT00087490|537566258|FG001|Overall Study|Randomized but not treated|18|||
149024829|NCT00761774|537566259|FG000|Overall Study|Adverse Event|17|||
149024830|NCT00761774|537566259|FG000|Overall Study|Lack of Efficacy|37|||
149024831|NCT00761774|537566259|FG000|Overall Study|Lost to Follow-up|2|||
149024832|NCT00761774|537566259|FG000|Overall Study|Withdrawal by Subject|9|||
149024833|NCT00761774|537566259|FG000|Overall Study|Non-compliance|4|||
149024834|NCT00761774|537566259|FG000|Overall Study|End of study|2|||
149024835|NCT00761774|537566259|FG000|Overall Study|Reclassification of seizures|1|||
149024836|NCT00761774|537566259|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
149024837|NCT00761774|537566259|FG000|Overall Study|Sponsor decision|1|||
149024838|NCT00761774|537566259|FG000|Overall Study|Investigator clinical judgement|1|||
149024839|NCT00761774|537566259|FG000|Overall Study|Patient moved out of study area|1|||
149024840|NCT00761774|537566259|FG000|Overall Study|Coordinator leaving site|1|||
149024841|NCT00761774|537566259|FG000|Overall Study|Subject IP non-compliance|1|||
149024842|NCT00761774|537566259|FG000|Overall Study|IP stopped by hospital physician|1|||
149024843|NCT01077024|537566260|FG000|Overall Study|Lost to Follow-up|20|||
149024844|NCT01077024|537566261|FG001|Overall Study|Lost to Follow-up|14|||
149024845|NCT01077024|537566260|FG000|Overall Study|Withdrawal by Subject|0|||
149024846|NCT01077024|537566261|FG001|Overall Study|Withdrawal by Subject|2|||
149024847|NCT01077024|537566260|FG000|Overall Study|Incarcerated|7|||
149024848|NCT01077024|537566261|FG001|Overall Study|Incarcerated|8|||
149024849|NCT01077024|537566260|FG000|Overall Study|Other|4|||
149024850|NCT01077024|537566261|FG001|Overall Study|Other|4|||
149024851|NCT02300311|537566265|FG000|Overall Study|Other than the reason specified|1|||
149024852|NCT02300311|537566266|FG001|Overall Study|Other than the reason specified|0|||
149024853|NCT02300311|537566265|FG000|Overall Study|Refused to continue taking medication|18|||
149024854|NCT02300311|537566266|FG001|Overall Study|Refused to continue taking medication|0|||
149024855|NCT00419003|537566267|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
149024856|NCT00419003|537566268|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
149024857|NCT00419003|537566267|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
149024858|NCT00419003|537566268|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
149024859|NCT02687919|537566269|FG000|Overall Study|Withdrawal by Subject|6|||
149024860|NCT02687919|537566270|FG001|Overall Study|Withdrawal by Subject|6|||
149024861|NCT02687919|537566269|FG000|Overall Study|Protocol Violation|2|||
149024862|NCT02687919|537566270|FG001|Overall Study|Protocol Violation|0|||
149024863|NCT00772928|537566271|FG000|Overall Study|Lost to Follow-up|9|||
149024864|NCT00772928|537566272|FG001|Overall Study|Lost to Follow-up|6|||
149024865|NCT00772928|537566271|FG000|Overall Study|Protocol Violation|10|||
149024866|NCT00772928|537566272|FG001|Overall Study|Protocol Violation|12|||
149024867|NCT00772928|537566271|FG000|Overall Study|Withdrawal by Subject|25|||
149024868|NCT00772928|537566272|FG001|Overall Study|Withdrawal by Subject|22|||
149024869|NCT00772928|537566271|FG000|Overall Study|Did not receive vaccine|0|||
149024870|NCT00772928|537566272|FG001|Overall Study|Did not receive vaccine|1|||
149024871|NCT01653743|537566273|FG000|Overall Study|Withdrawal by Subject|1|||
149024872|NCT01653743|537566274|FG001|Overall Study|Withdrawal by Subject|0|||
149024873|NCT01653743|537566273|FG000|Overall Study|Investigator discretion|3|||
148698245|NCT00669942|536369598|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
148698246|NCT00669942|536369599|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
148698247|NCT00669942|536369600|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
148698248|NCT00669942|536369601|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
148698249|NCT00669942|536369602|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
148698250|NCT00669942|536369603|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
148698251|NCT00669942|536369592|FG000|Parts 2 and 3|Protocol Violation|0|||
148698252|NCT00669942|536369593|FG001|Parts 2 and 3|Protocol Violation|0|||
148698253|NCT00669942|536369594|FG002|Parts 2 and 3|Protocol Violation|0|||
148698254|NCT00669942|536369595|FG003|Parts 2 and 3|Protocol Violation|0|||
148698255|NCT00669942|536369596|FG004|Parts 2 and 3|Protocol Violation|0|||
148698256|NCT00669942|536369597|FG005|Parts 2 and 3|Protocol Violation|1|||
148698257|NCT00669942|536369598|FG006|Parts 2 and 3|Protocol Violation|0|||
148698258|NCT00669942|536369599|FG007|Parts 2 and 3|Protocol Violation|0|||
149024874|NCT01653743|537566274|FG001|Overall Study|Investigator discretion|0|||
149024875|NCT02303574|537566282|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024876|NCT02303574|537566283|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024877|NCT02303574|537566284|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
149024878|NCT02303574|537566285|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
148698259|NCT00669942|536369600|FG008|Parts 2 and 3|Protocol Violation|0|||
148698260|NCT00669942|536369601|FG009|Parts 2 and 3|Protocol Violation|0|||
148698261|NCT00669942|536369602|FG010|Parts 2 and 3|Protocol Violation|0|||
149024879|NCT02303574|537566286|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024880|NCT02303574|537566287|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
148698262|NCT00669942|536369603|FG011|Parts 2 and 3|Protocol Violation|0|||
148698263|NCT03752528|536369604|FG000|Part A|Lost to Follow-up|1|||
148698264|NCT03752528|536369604|FG000|Part A|Protocol Violation|1|||
148698265|NCT03752528|536369604|FG000|Part B|Protocol Violation|1|||
149024881|NCT02303574|537566288|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024882|NCT02303574|537566289|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024883|NCT02303574|537566290|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024884|NCT02303574|537566291|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
149024885|NCT02303574|537566282|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024886|NCT02303574|537566283|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024887|NCT02303574|537566284|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024888|NCT02303574|537566285|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024889|NCT02303574|537566286|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024890|NCT02303574|537566287|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024891|NCT02303574|537566288|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024892|NCT02303574|537566289|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
149024893|NCT02303574|537566290|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024894|NCT02303574|537566291|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
149024895|NCT00994279|537566296|FG000|Overall Study|Withdrawal by Subject|2|||
149024896|NCT00994279|537566297|FG001|Overall Study|Withdrawal by Subject|2|||
149024897|NCT00994279|537566296|FG000|Overall Study|Toxicity|1|||
149024898|NCT00994279|537566297|FG001|Overall Study|Toxicity|0|||
149024899|NCT00994279|537566296|FG000|Overall Study|Multiple reasons|1|||
149024900|NCT00994279|537566297|FG001|Overall Study|Multiple reasons|3|||
149024901|NCT01606189|537566298|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
149024902|NCT01606189|537566299|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
149024903|NCT01606189|537566300|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
149024904|NCT01606189|537566301|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
149024905|NCT01606189|537566302|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
149024906|NCT01606189|537566303|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
149024907|NCT01606189|537566298|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
149024908|NCT01606189|537566299|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
149024909|NCT01606189|537566300|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
149024910|NCT01606189|537566301|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
149024911|NCT01606189|537566302|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
149024912|NCT01606189|537566303|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
149024913|NCT01354938|537566304|FG000|Overall Study|Lost to Follow-up|1|||
149024914|NCT00410384|537566305|FG000|Overall Study|Withdrawal by Subject|28|||
149024915|NCT00410384|537566306|FG001|Overall Study|Withdrawal by Subject|17|||
149024916|NCT00410384|537566307|FG002|Overall Study|Withdrawal by Subject|20|||
149024917|NCT00410384|537566305|FG000|Overall Study|Adverse Event|23|||
149024918|NCT00410384|537566306|FG001|Overall Study|Adverse Event|18|||
149024919|NCT00410384|537566307|FG002|Overall Study|Adverse Event|23|||
149024920|NCT00410384|537566305|FG000|Overall Study|Lack of Efficacy|20|||
149024921|NCT00410384|537566306|FG001|Overall Study|Lack of Efficacy|12|||
149024922|NCT00410384|537566307|FG002|Overall Study|Lack of Efficacy|17|||
149024923|NCT00410384|537566305|FG000|Overall Study|Lack of Compliance|2|||
149024924|NCT00410384|537566306|FG001|Overall Study|Lack of Compliance|2|||
149024925|NCT00410384|537566307|FG002|Overall Study|Lack of Compliance|2|||
149024926|NCT00410384|537566305|FG000|Overall Study|Lost to Follow-up|4|||
149024927|NCT00410384|537566306|FG001|Overall Study|Lost to Follow-up|6|||
149024928|NCT00410384|537566307|FG002|Overall Study|Lost to Follow-up|6|||
149024929|NCT00410384|537566305|FG000|Overall Study|Protocol Violation|6|||
149024930|NCT00410384|537566306|FG001|Overall Study|Protocol Violation|6|||
149024931|NCT00410384|537566307|FG002|Overall Study|Protocol Violation|6|||
149024932|NCT00410384|537566305|FG000|Overall Study|Physician Decision|3|||
149024933|NCT00410384|537566306|FG001|Overall Study|Physician Decision|3|||
149024934|NCT00410384|537566307|FG002|Overall Study|Physician Decision|4|||
149024935|NCT00410384|537566305|FG000|Overall Study|Other|3|||
149024936|NCT00410384|537566306|FG001|Overall Study|Other|8|||
149024937|NCT00410384|537566307|FG002|Overall Study|Other|4|||
149024938|NCT01167023|537566308|FG000|Overall Study|Lost to Follow-up|0|||
149024939|NCT01167023|537566309|FG001|Overall Study|Lost to Follow-up|1|||
149024940|NCT01167023|537566310|FG002|Overall Study|Lost to Follow-up|1|||
149024941|NCT01167023|537566308|FG000|Overall Study|Screen Failure|0|||
149024942|NCT01167023|537566309|FG001|Overall Study|Screen Failure|1|||
149024943|NCT01167023|537566310|FG002|Overall Study|Screen Failure|0|||
149024944|NCT01167023|537566308|FG000|Overall Study|Sponsor Decision|0|||
149024945|NCT01167023|537566309|FG001|Overall Study|Sponsor Decision|1|||
149024946|NCT01167023|537566310|FG002|Overall Study|Sponsor Decision|0|||
149024947|NCT01167023|537566308|FG000|Overall Study|Withdrawal by Subject|0|||
149024948|NCT01167023|537566309|FG001|Overall Study|Withdrawal by Subject|0|||
149024949|NCT01167023|537566310|FG002|Overall Study|Withdrawal by Subject|1|||
149024950|NCT03706690|537566311|FG000|Overall Study|Withdrawal by Subject|8|||
149024951|NCT03706690|537566312|FG001|Overall Study|Withdrawal by Subject|8|||
149024952|NCT03706690|537566311|FG000|Overall Study|Death|143|||
149024953|NCT03706690|537566312|FG001|Overall Study|Death|75|||
149024954|NCT03706690|537566311|FG000|Overall Study|Ongoing at DCO|121|||
148814521|NCT01202591|536795649|FG001|Overall Study|Adverse Event|1|||
148814522|NCT01202591|536795650|FG002|Overall Study|Adverse Event|4|||
148814523|NCT01202591|536795651|FG003|Overall Study|Adverse Event|4|||
148814524|NCT01202591|536795652|FG004|Overall Study|Adverse Event|0|||
148814525|NCT01202591|536795653|FG005|Overall Study|Adverse Event|0|||
148814526|NCT01202591|536795648|FG000|Overall Study|Other reason as per investigator|3|||
148814527|NCT01202591|536795649|FG001|Overall Study|Other reason as per investigator|4|||
148814528|NCT01202591|536795650|FG002|Overall Study|Other reason as per investigator|7|||
148814529|NCT01202591|536795651|FG003|Overall Study|Other reason as per investigator|3|||
148814530|NCT01202591|536795652|FG004|Overall Study|Other reason as per investigator|1|||
148814531|NCT01202591|536795653|FG005|Overall Study|Other reason as per investigator|3|||
148814532|NCT01202591|536795648|FG000|Overall Study|Withdrawal by Subject|0|||
148814533|NCT01202591|536795649|FG001|Overall Study|Withdrawal by Subject|0|||
148814534|NCT01202591|536795650|FG002|Overall Study|Withdrawal by Subject|0|||
148814535|NCT01202591|536795651|FG003|Overall Study|Withdrawal by Subject|0|||
148814536|NCT01202591|536795652|FG004|Overall Study|Withdrawal by Subject|2|||
148814537|NCT01202591|536795653|FG005|Overall Study|Withdrawal by Subject|1|||
148814538|NCT01202591|536795648|FG000|Overall Study|Objective Disease Progression|0|||
148814539|NCT01202591|536795649|FG001|Overall Study|Objective Disease Progression|0|||
148814540|NCT01202591|536795650|FG002|Overall Study|Objective Disease Progression|0|||
148814541|NCT01202591|536795651|FG003|Overall Study|Objective Disease Progression|0|||
148814542|NCT01202591|536795652|FG004|Overall Study|Objective Disease Progression|2|||
148814543|NCT01202591|536795653|FG005|Overall Study|Objective Disease Progression|0|||
148814544|NCT03018938|536795654|FG000|Overall Study|Death|0|||
148814545|NCT03018938|536795655|FG001|Overall Study|Death|1|||
148814546|NCT03018938|536795654|FG000|Overall Study|Lost to Follow-up|21|||
148814547|NCT03018938|536795655|FG001|Overall Study|Lost to Follow-up|32|||
148814548|NCT03018938|536795654|FG000|Overall Study|Withdrawal by Subject|38|||
148814549|NCT03018938|536795655|FG001|Overall Study|Withdrawal by Subject|45|||
148814550|NCT03018938|536795654|FG000|Overall Study|Physician Decision|3|||
148814551|NCT03018938|536795655|FG001|Overall Study|Physician Decision|2|||
149024955|NCT03706690|537566312|FG001|Overall Study|Ongoing at DCO|52|||
149024956|NCT00465361|537567952|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
149024957|NCT00515086|537567953|FG000|Overall Study|Adverse Event|1|||
149024958|NCT00515086|537567954|FG001|Overall Study|Adverse Event|1|||
149024959|NCT00515086|537567955|FG002|Overall Study|Adverse Event|2|||
149024960|NCT00515086|537567956|FG003|Overall Study|Adverse Event|3|||
148814552|NCT03018938|536795654|FG000|Overall Study|Sponsor Decision|0|||
148814553|NCT03018938|536795655|FG001|Overall Study|Sponsor Decision|1|||
148814554|NCT03018938|536795654|FG000|Overall Study|Screen failure-After randomization|4|||
148814555|NCT03018938|536795655|FG001|Overall Study|Screen failure-After randomization|2|||
148814556|NCT03018938|536795654|FG000|Overall Study|Not recorded|0|||
148814557|NCT03018938|536795655|FG001|Overall Study|Not recorded|2|||
148814558|NCT00191100|536795658|FG000|Overall Study|Adverse Event|18|||
149024961|NCT00515086|537567953|FG000|Overall Study|Administrative|1|||
149024962|NCT00515086|537567954|FG001|Overall Study|Administrative|1|||
149024963|NCT00515086|537567955|FG002|Overall Study|Administrative|0|||
149024964|NCT00515086|537567956|FG003|Overall Study|Administrative|0|||
149024965|NCT00515086|537567953|FG000|Overall Study|Withdrawal by Subject|1|||
149024966|NCT00515086|537567954|FG001|Overall Study|Withdrawal by Subject|0|||
149024967|NCT00515086|537567955|FG002|Overall Study|Withdrawal by Subject|0|||
149024968|NCT00515086|537567956|FG003|Overall Study|Withdrawal by Subject|1|||
149024969|NCT00515086|537567953|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
149024970|NCT00515086|537567954|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149024971|NCT00515086|537567955|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
149024972|NCT00515086|537567956|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
149024973|NCT00515086|537567953|FG000|Overall Study|Lost to Follow-up|1|||
149024974|NCT00515086|537567954|FG001|Overall Study|Lost to Follow-up|0|||
149024975|NCT00515086|537567955|FG002|Overall Study|Lost to Follow-up|0|||
149024976|NCT00515086|537567956|FG003|Overall Study|Lost to Follow-up|0|||
149024977|NCT00515086|537567953|FG000|Overall Study|Study drug no longer required|0|||
149024978|NCT00515086|537567954|FG001|Overall Study|Study drug no longer required|1|||
149024979|NCT00515086|537567955|FG002|Overall Study|Study drug no longer required|0|||
149024980|NCT00515086|537567956|FG003|Overall Study|Study drug no longer required|0|||
149024981|NCT00515086|537567953|FG000|Overall Study|Death|2|||
149024982|NCT00515086|537567954|FG001|Overall Study|Death|0|||
149024983|NCT00515086|537567955|FG002|Overall Study|Death|0|||
149024984|NCT00515086|537567956|FG003|Overall Study|Death|0|||
149024985|NCT01511536|537567963|FG000|Phase 1|Other|0|||
149024986|NCT01511536|537567964|FG001|Phase 1|Other|1|||
149024987|NCT01511536|537567965|FG002|Phase 1|Other|0|||
149024988|NCT01511536|537567963|FG000|Phase 2|Other|0|||
149024989|NCT01511536|537567964|FG001|Phase 2|Other|0|||
149024990|NCT01511536|537567965|FG002|Phase 2|Other|9|||
149024991|NCT02297503|537567969|FG000|Overall Study|Withdrawal by Subject|1|||
149024992|NCT02297503|537567970|FG001|Overall Study|Withdrawal by Subject|1|||
149024993|NCT02297503|537567969|FG000|Overall Study|Protocol Violation|1|||
149024994|NCT02297503|537567970|FG001|Overall Study|Protocol Violation|0|||
149024995|NCT02297503|537567969|FG000|Overall Study|Pregnancy|0|||
149024996|NCT02297503|537567970|FG001|Overall Study|Pregnancy|1|||
149024997|NCT02297503|537567969|FG000|Overall Study|Lost to Follow-up|0|||
149024998|NCT02297503|537567970|FG001|Overall Study|Lost to Follow-up|1|||
149024999|NCT02297503|537567969|FG000|Overall Study|Medical reason|0|||
149025000|NCT02297503|537567970|FG001|Overall Study|Medical reason|1|||
149025001|NCT02703532|537567972|FG000|Overall Study|Withdrawal by Subject|0|||
149025002|NCT02703532|537567973|FG001|Overall Study|Withdrawal by Subject|1|||
149025003|NCT02703532|537567974|FG002|Overall Study|Withdrawal by Subject|0|||
149025004|NCT02703532|537567975|FG003|Overall Study|Withdrawal by Subject|1|||
149025005|NCT02703532|537567972|FG000|Overall Study|Lost to Follow-up|2|||
149025006|NCT02703532|537567973|FG001|Overall Study|Lost to Follow-up|0|||
149025007|NCT02703532|537567974|FG002|Overall Study|Lost to Follow-up|2|||
149025008|NCT02703532|537567975|FG003|Overall Study|Lost to Follow-up|0|||
149025009|NCT03738241|537567979|FG000|Overall Study|Withdrawal by Subject|0|||
148814559|NCT00191100|536795659|FG001|Overall Study|Adverse Event|1|||
148814560|NCT00191100|536795658|FG000|Overall Study|Lost to Follow-up|2|||
148814561|NCT00191100|536795659|FG001|Overall Study|Lost to Follow-up|0|||
148814562|NCT00191100|536795658|FG000|Overall Study|Patient Moved|0|||
148814563|NCT00191100|536795659|FG001|Overall Study|Patient Moved|1|||
148814564|NCT00191100|536795658|FG000|Overall Study|Withdrawal by Subject|9|||
148814565|NCT00191100|536795659|FG001|Overall Study|Withdrawal by Subject|3|||
148814566|NCT00191100|536795658|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
148965310|NCT03446040|537358482|FG007|Overall Study|Study drug toxicity|0|||
148965311|NCT03446040|537358483|FG008|Overall Study|Study drug toxicity|1|||
148965312|NCT03446040|537358484|FG009|Overall Study|Study drug toxicity|0|||
148965313|NCT03446040|537358485|FG010|Overall Study|Study drug toxicity|0|||
148965314|NCT03446040|537358486|FG011|Overall Study|Study drug toxicity|0|||
148965315|NCT03446040|537358487|FG012|Overall Study|Study drug toxicity|0|||
148965316|NCT03446040|537358488|FG013|Overall Study|Study drug toxicity|0|||
148965317|NCT03446040|537358475|FG000|Overall Study|Adverse Event|0|||
148965318|NCT03446040|537358476|FG001|Overall Study|Adverse Event|0|||
148814567|NCT00191100|536795659|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
148814568|NCT00191100|536795658|FG000|Overall Study|Clinical Relapse|2|||
148965319|NCT03446040|537358477|FG002|Overall Study|Adverse Event|0|||
148965320|NCT03446040|537358478|FG003|Overall Study|Adverse Event|0|||
148814569|NCT00191100|536795659|FG001|Overall Study|Clinical Relapse|1|||
148965321|NCT03446040|537358479|FG004|Overall Study|Adverse Event|0|||
148965322|NCT03446040|537358480|FG005|Overall Study|Adverse Event|2|||
148965323|NCT03446040|537358481|FG006|Overall Study|Adverse Event|0|||
148965324|NCT03446040|537358482|FG007|Overall Study|Adverse Event|0|||
148965325|NCT03446040|537358483|FG008|Overall Study|Adverse Event|1|||
148965326|NCT03446040|537358484|FG009|Overall Study|Adverse Event|0|||
148965327|NCT03446040|537358485|FG010|Overall Study|Adverse Event|0|||
148965328|NCT03446040|537358486|FG011|Overall Study|Adverse Event|0|||
148965329|NCT03446040|537358487|FG012|Overall Study|Adverse Event|0|||
148698266|NCT03752528|536369604|FG000|Part B|Study terminated by sponsor|3|||
148698267|NCT02107092|536369606|FG000|Overall Study|Miscellaneous|3|||
148698268|NCT02107092|536369606|FG000|Overall Study|Subject compliance|3|||
148698269|NCT02107092|536369606|FG000|Overall Study|Hypo-or hyperkalemia|2|||
148698270|NCT02107092|536369606|FG000|Overall Study|Met ECG withdrawal criteria|3|||
148698271|NCT02107092|536369606|FG000|Overall Study|Physician Decision|3|||
148698272|NCT02107092|536369606|FG000|Overall Study|Lost to Follow-up|2|||
148698273|NCT02107092|536369606|FG000|Overall Study|Withdrawal by Subject|9|||
148698274|NCT02107092|536369606|FG000|Overall Study|Adverse Event|7|||
148698275|NCT02107092|536369606|FG000|Overall Study|Expected progression of CKD|12|||
148698276|NCT00259012|536369607|FG000|Overall Study|Adverse Event|0|||
148698277|NCT00259012|536369608|FG001|Overall Study|Adverse Event|1|||
148698278|NCT00259012|536369607|FG000|Overall Study|Withdrawal by Subject|1|||
148698279|NCT00259012|536369608|FG001|Overall Study|Withdrawal by Subject|0|||
148698280|NCT00259012|536369607|FG000|Overall Study|Physician Decision|0|||
148698281|NCT00259012|536369608|FG001|Overall Study|Physician Decision|1|||
148698282|NCT00259012|536369607|FG000|Overall Study|Lost to Follow-up|0|||
148698283|NCT00259012|536369608|FG001|Overall Study|Lost to Follow-up|1|||
148698284|NCT00259012|536369607|FG000|Overall Study|Protocol Violation|1|||
148698285|NCT00259012|536369608|FG001|Overall Study|Protocol Violation|1|||
148698286|NCT04213326|536369613|FG000|Overall Study|Consent withdrawn|51|||
148698287|NCT04213326|536369614|FG001|Overall Study|Consent withdrawn|241|||
148698288|NCT04213326|536369613|FG000|Overall Study|Lost to Follow-up|50|||
148698289|NCT04213326|536369614|FG001|Overall Study|Lost to Follow-up|902|||
148698290|NCT04213326|536369613|FG000|Overall Study|Protocol Violation|3|||
148698291|NCT04213326|536369614|FG001|Overall Study|Protocol Violation|25|||
148698292|NCT04213326|536369613|FG000|Overall Study|Participant eligibility changed|106|||
148698293|NCT04213326|536369614|FG001|Overall Study|Participant eligibility changed|19|||
148698294|NCT04213326|536369613|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
148698295|NCT04213326|536369614|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
148698296|NCT04213326|536369613|FG000|Overall Study|Incomplete study visit|0|||
148698297|NCT04213326|536369614|FG001|Overall Study|Incomplete study visit|367|||
148698298|NCT02549092|536369615|FG000|Treatment Period|Adverse Event|2|||
148698299|NCT02549092|536369616|FG001|Treatment Period|Adverse Event|2|||
148698300|NCT02549092|536369615|FG000|Treatment Period|Withdrawal by Subject|1|||
148698301|NCT02549092|536369616|FG001|Treatment Period|Withdrawal by Subject|3|||
148698302|NCT02549092|536369615|FG000|Treatment Period|Lack of Efficacy|0|||
148698303|NCT02549092|536369616|FG001|Treatment Period|Lack of Efficacy|2|||
148698304|NCT02549092|536369615|FG000|Extension/Transition Period|Adverse Event|1|||
148698305|NCT02549092|536369616|FG001|Extension/Transition Period|Adverse Event|1|||
148698306|NCT02549092|536369615|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
148698307|NCT02549092|536369616|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
148698308|NCT02549092|536369615|FG000|Extension/Transition Period|Other, Not Specified|4|||
148698309|NCT02549092|536369616|FG001|Extension/Transition Period|Other, Not Specified|2|||
148698310|NCT03002077|536369623|FG000|Overall Study|Non-compliance with Study Drug|4|||
148698311|NCT03002077|536369623|FG000|Overall Study|Non-compliance w/Background ADT|1|||
148814570|NCT00191100|536795658|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
148814571|NCT00191100|536795659|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
148814572|NCT00191100|536795658|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
148814573|NCT00191100|536795659|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
148814574|NCT00191100|536795658|FG000|Overall Study|Physician Decision|3|||
148814575|NCT00191100|536795659|FG001|Overall Study|Physician Decision|1|||
148698312|NCT03002077|536369623|FG000|Overall Study|Study Terminated by Sponsor|257|||
148698313|NCT03002077|536369623|FG000|Overall Study|Site Terminated by Sponsor|5|||
148698314|NCT03002077|536369623|FG000|Overall Study|Miscellaneous Reasons|10|||
148698315|NCT03002077|536369623|FG000|Overall Study|Adverse Event|23|||
148698316|NCT03002077|536369623|FG000|Overall Study|Lack of Efficacy|20|||
148698317|NCT03002077|536369623|FG000|Overall Study|Withdrawal by Subject|72|||
148698318|NCT03002077|536369623|FG000|Overall Study|Lost to Follow-up|21|||
148698319|NCT03002077|536369623|FG000|Overall Study|Pregnancy|4|||
148698320|NCT03002077|536369623|FG000|Overall Study|Protocol Violation|21|||
148965330|NCT03446040|537358488|FG013|Overall Study|Adverse Event|0|||
148698321|NCT02781727|536369634|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
148698322|NCT02781727|536369635|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
148698323|NCT02781727|536369634|FG000|Treatment Period|Withdrawal by Subject|1|||
148698324|NCT02781727|536369635|FG001|Treatment Period|Withdrawal by Subject|0|||
148698325|NCT02781727|536369634|FG000|Treatment Period|Lost to Follow-up|0|||
148814576|NCT00191100|536795658|FG000|Overall Study|Death from Study Drug Toxicity|2|||
148814577|NCT00191100|536795659|FG001|Overall Study|Death from Study Drug Toxicity|0|||
148814578|NCT00191100|536795658|FG000|Overall Study|Protocol Violation|1|||
148814579|NCT00191100|536795659|FG001|Overall Study|Protocol Violation|1|||
148698326|NCT02781727|536369635|FG001|Treatment Period|Lost to Follow-up|1|||
148698327|NCT01378975|536369636|FG000|Overall Study|Death|77|||
148698328|NCT01378975|536369637|FG001|Overall Study|Death|46|||
148698329|NCT01378975|536369636|FG000|Overall Study|Investigator Request|1|||
148698330|NCT01378975|536369637|FG001|Overall Study|Investigator Request|0|||
148698331|NCT01378975|536369636|FG000|Overall Study|Lost to Follow-up|4|||
148698332|NCT01378975|536369637|FG001|Overall Study|Lost to Follow-up|1|||
148698333|NCT01378975|536369636|FG000|Overall Study|Withdrew Consent|4|||
148698334|NCT01378975|536369637|FG001|Overall Study|Withdrew Consent|3|||
148698335|NCT00694551|536369641|FG000|Overall Study|Disease Progression|1|||
148698336|NCT00694551|536369642|FG001|Overall Study|Disease Progression|0|||
148698337|NCT00694551|536369643|FG002|Overall Study|Disease Progression|1|||
148698338|NCT02424097|536371548|FG000|Overall Study|Lost to Follow-up|1|||
148698339|NCT02424097|536371549|FG001|Overall Study|Lost to Follow-up|2|||
148698340|NCT01215981|536371550|FG000|Overall Study|Physician Decision|0|||
148698341|NCT01215981|536371551|FG001|Overall Study|Physician Decision|1|||
148698342|NCT01215981|536371550|FG000|Overall Study|Protocol Violation|1|||
148698343|NCT01215981|536371551|FG001|Overall Study|Protocol Violation|0|||
148698344|NCT01215981|536371550|FG000|Overall Study|Withdrawal by Subject|1|||
148698345|NCT01215981|536371551|FG001|Overall Study|Withdrawal by Subject|0|||
148698346|NCT02943447|536371552|FG000|Blinded Study Phase|Withdrew Consent|1|||
148698347|NCT02943447|536371553|FG001|Blinded Study Phase|Withdrew Consent|2|||
148698348|NCT02943447|536371554|FG002|Blinded Study Phase|Withdrew Consent|1|||
148698349|NCT02943447|536371552|FG000|Blinded Study Phase|Adverse Event|3|||
148698350|NCT02943447|536371553|FG001|Blinded Study Phase|Adverse Event|0|||
148698351|NCT02943447|536371554|FG002|Blinded Study Phase|Adverse Event|0|||
148698352|NCT02943447|536371552|FG000|Blinded Study Phase|Investigator's discretion|1|||
148698353|NCT02943447|536371553|FG001|Blinded Study Phase|Investigator's discretion|0|||
148698354|NCT02943447|536371554|FG002|Blinded Study Phase|Investigator's discretion|0|||
148698355|NCT02943447|536371552|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
148698356|NCT02943447|536371553|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
148698357|NCT02943447|536371554|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
148698358|NCT02943447|536371552|FG000|Open-Label Extension Phase|Adverse Event|4|||
148698359|NCT02943447|536371553|FG001|Open-Label Extension Phase|Adverse Event|7|||
148698360|NCT02943447|536371554|FG002|Open-Label Extension Phase|Adverse Event|3|||
148698361|NCT02943447|536371552|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
148814580|NCT00191100|536795658|FG000|Overall Study|Death from Other Cause|1|||
148814581|NCT00191100|536795659|FG001|Overall Study|Death from Other Cause|0|||
148814582|NCT00191100|536795658|FG000|Overall Study|Reason Not Specified|0|||
148814583|NCT00191100|536795659|FG001|Overall Study|Reason Not Specified|1|||
148814584|NCT02406612|536795660|FG000|Overall Study|Screening Failure|3|||
148814585|NCT02406612|536795661|FG001|Overall Study|Screening Failure|0|||
148814586|NCT02406612|536795660|FG000|Overall Study|Intra-procedural Exclusion|1|||
148814587|NCT02406612|536795661|FG001|Overall Study|Intra-procedural Exclusion|3|||
148814588|NCT02406612|536795660|FG000|Overall Study|Guidewire Failure|0|||
148814589|NCT02406612|536795661|FG001|Overall Study|Guidewire Failure|1|||
148814590|NCT02830087|536795666|FG000|Overall Study|No study staff to follow-up patients|4|||
148698362|NCT02943447|536371553|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
148698363|NCT02943447|536371554|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
148698364|NCT02943447|536371552|FG000|Open-Label Extension Phase|Withdrew consent|1|||
148698365|NCT02943447|536371553|FG001|Open-Label Extension Phase|Withdrew consent|1|||
148698366|NCT02943447|536371554|FG002|Open-Label Extension Phase|Withdrew consent|1|||
148814591|NCT02830087|536795667|FG001|Overall Study|No study staff to follow-up patients|4|||
148965331|NCT03446040|537358475|FG000|Overall Study|Death|0|||
148698367|NCT02943447|536371552|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
148965332|NCT03446040|537358476|FG001|Overall Study|Death|0|||
148698368|NCT02943447|536371553|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
148698369|NCT02943447|536371554|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
148814592|NCT02830087|536795668|FG002|Overall Study|No study staff to follow-up patients|4|||
148965333|NCT03446040|537358477|FG002|Overall Study|Death|0|||
148814593|NCT02830087|536795669|FG003|Overall Study|No study staff to follow-up patients|3|||
148698370|NCT05017480|536371555|FG000|Stage 1 Study|Withdrawal by Subject|8|||
148965334|NCT03446040|537358478|FG003|Overall Study|Death|0|||
148965335|NCT03446040|537358479|FG004|Overall Study|Death|0|||
148698371|NCT05017480|536371556|FG001|Stage 1 Study|Withdrawal by Subject|6|||
148698372|NCT05017480|536371557|FG002|Stage 1 Study|Withdrawal by Subject|0|||
148965336|NCT03446040|537358480|FG005|Overall Study|Death|0|||
148698373|NCT05017480|536371558|FG003|Stage 1 Study|Withdrawal by Subject|0|||
148698374|NCT05017480|536371559|FG004|Stage 1 Study|Withdrawal by Subject|0|||
148965337|NCT03446040|537358481|FG006|Overall Study|Death|0|||
148698375|NCT05017480|536371555|FG000|Stage 1 Study|Adverse Event|1|||
148698376|NCT05017480|536371556|FG001|Stage 1 Study|Adverse Event|1|||
148698377|NCT05017480|536371557|FG002|Stage 1 Study|Adverse Event|0|||
148698378|NCT05017480|536371558|FG003|Stage 1 Study|Adverse Event|0|||
148698379|NCT05017480|536371559|FG004|Stage 1 Study|Adverse Event|0|||
148698380|NCT05017480|536371555|FG000|Stage 1 Study|Poor Compliance|1|||
148698381|NCT05017480|536371556|FG001|Stage 1 Study|Poor Compliance|1|||
148814594|NCT02830087|536795670|FG004|Overall Study|No study staff to follow-up patients|3|||
148965338|NCT03446040|537358482|FG007|Overall Study|Death|0|||
148698382|NCT05017480|536371557|FG002|Stage 1 Study|Poor Compliance|0|||
148965339|NCT03446040|537358483|FG008|Overall Study|Death|0|||
148965340|NCT03446040|537358484|FG009|Overall Study|Death|0|||
148698383|NCT05017480|536371558|FG003|Stage 1 Study|Poor Compliance|0|||
148698384|NCT05017480|536371559|FG004|Stage 1 Study|Poor Compliance|0|||
148698385|NCT05017480|536371555|FG000|Stage 1 Study|Physician Decision|0|||
148698386|NCT05017480|536371556|FG001|Stage 1 Study|Physician Decision|1|||
148698387|NCT05017480|536371557|FG002|Stage 1 Study|Physician Decision|0|||
148698388|NCT05017480|536371558|FG003|Stage 1 Study|Physician Decision|0|||
148698389|NCT05017480|536371559|FG004|Stage 1 Study|Physician Decision|0|||
148698390|NCT05017480|536371555|FG000|Stage 2 Study|Withdrawal by Subject|0|||
148814595|NCT02830087|536795671|FG005|Overall Study|No study staff to follow-up patients|3|||
148814596|NCT02916771|536795672|FG000|Overall Study|Withdrawal by Subject|9|||
148814597|NCT02916771|536795672|FG000|Overall Study|Physician Decision|1|||
148814598|NCT02916771|536795672|FG000|Overall Study|Began treatment for another active malignancy|1|||
148814599|NCT00479232|536796477|FG000|Overall Study|Adverse Event|0|||
148814600|NCT00479232|536796478|FG001|Overall Study|Adverse Event|0|||
148814601|NCT00479232|536796479|FG002|Overall Study|Adverse Event|5|||
148814602|NCT00479232|536796480|FG003|Overall Study|Adverse Event|0|||
148814603|NCT00479232|536796481|FG004|Overall Study|Adverse Event|0|||
148814604|NCT00479232|536796482|FG005|Overall Study|Adverse Event|10|||
148814605|NCT00479232|536796477|FG000|Overall Study|Deviation from Protocol|0|||
148814606|NCT00479232|536796478|FG001|Overall Study|Deviation from Protocol|0|||
148814607|NCT00479232|536796479|FG002|Overall Study|Deviation from Protocol|1|||
148814608|NCT00479232|536796480|FG003|Overall Study|Deviation from Protocol|0|||
148814609|NCT00479232|536796481|FG004|Overall Study|Deviation from Protocol|0|||
148814610|NCT00479232|536796482|FG005|Overall Study|Deviation from Protocol|0|||
148814611|NCT00479232|536796477|FG000|Overall Study|Lack of Efficacy|0|||
148814612|NCT00479232|536796478|FG001|Overall Study|Lack of Efficacy|0|||
148814613|NCT00479232|536796479|FG002|Overall Study|Lack of Efficacy|2|||
148814614|NCT00479232|536796480|FG003|Overall Study|Lack of Efficacy|0|||
148814615|NCT00479232|536796481|FG004|Overall Study|Lack of Efficacy|0|||
148814616|NCT00479232|536796482|FG005|Overall Study|Lack of Efficacy|4|||
148814617|NCT00479232|536796477|FG000|Overall Study|Physician Decision|0|||
148814618|NCT00479232|536796478|FG001|Overall Study|Physician Decision|0|||
148814619|NCT00479232|536796479|FG002|Overall Study|Physician Decision|2|||
148814620|NCT00479232|536796480|FG003|Overall Study|Physician Decision|0|||
148814621|NCT00479232|536796481|FG004|Overall Study|Physician Decision|0|||
148814622|NCT00479232|536796482|FG005|Overall Study|Physician Decision|1|||
148814623|NCT00479232|536796477|FG000|Overall Study|Progressive Disease|3|||
148814624|NCT00479232|536796478|FG001|Overall Study|Progressive Disease|1|||
148814625|NCT00479232|536796479|FG002|Overall Study|Progressive Disease|12|||
148814626|NCT00479232|536796480|FG003|Overall Study|Progressive Disease|3|||
148814627|NCT00479232|536796481|FG004|Overall Study|Progressive Disease|3|||
148814628|NCT00479232|536796482|FG005|Overall Study|Progressive Disease|12|||
148814629|NCT00479232|536796477|FG000|Overall Study|Withdrew Consent|0|||
148814630|NCT00479232|536796478|FG001|Overall Study|Withdrew Consent|2|||
148814631|NCT00479232|536796479|FG002|Overall Study|Withdrew Consent|6|||
148814632|NCT00479232|536796480|FG003|Overall Study|Withdrew Consent|0|||
148814633|NCT00479232|536796481|FG004|Overall Study|Withdrew Consent|1|||
148814634|NCT00479232|536796482|FG005|Overall Study|Withdrew Consent|3|||
148814635|NCT02493855|536796483|FG000|Overall Study|Non-compliance|1|||
148814636|NCT02493855|536796484|FG001|Overall Study|Non-compliance|0|||
148814637|NCT02493855|536796485|FG002|Overall Study|Non-compliance|0|||
148814638|NCT02493855|536796483|FG000|Overall Study|Adverse Event|0|||
148814639|NCT02493855|536796484|FG001|Overall Study|Adverse Event|1|||
148814640|NCT02493855|536796485|FG002|Overall Study|Adverse Event|0|||
148814641|NCT02493855|536796483|FG000|Overall Study|Withdrawal by Subject|1|||
148814642|NCT02493855|536796484|FG001|Overall Study|Withdrawal by Subject|0|||
148965341|NCT03446040|537358485|FG010|Overall Study|Death|1|||
148814643|NCT02493855|536796485|FG002|Overall Study|Withdrawal by Subject|0|||
148814644|NCT00741611|536796486|FG000|Overall Study|Death|0|||
148814645|NCT00741611|536796487|FG001|Overall Study|Death|0|||
148814646|NCT00741611|536796488|FG002|Overall Study|Death|1|||
148814647|NCT00741611|536796486|FG000|Overall Study|Withdrawal by Subject|0|||
148814648|NCT00741611|536796487|FG001|Overall Study|Withdrawal by Subject|2|||
148814649|NCT00741611|536796488|FG002|Overall Study|Withdrawal by Subject|2|||
148814650|NCT00325416|536796498|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
148814651|NCT00325416|536796499|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
148814652|NCT00325416|536796498|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
148814653|NCT00325416|536796499|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
148814654|NCT00325416|536796498|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
148814655|NCT00325416|536796499|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
148814656|NCT00325416|536796498|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
148814657|NCT00325416|536796499|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
148965342|NCT03446040|537358486|FG011|Overall Study|Death|0|||
148814658|NCT00325416|536796498|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
148698391|NCT05017480|536371556|FG001|Stage 2 Study|Withdrawal by Subject|0|||
148698392|NCT05017480|536371557|FG002|Stage 2 Study|Withdrawal by Subject|6|||
148814659|NCT00325416|536796499|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
148814660|NCT00325416|536796498|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
148814661|NCT00325416|536796499|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
148814662|NCT06239610|536796500|FG000|Overall Study|no usable migration data for minimum of one day|11|||
148814663|NCT02324153|536796503|FG000|Overall Study|Withdrawal by Subject|4|||
148814664|NCT02324153|536796504|FG001|Overall Study|Withdrawal by Subject|1|||
148814665|NCT02324153|536796503|FG000|Overall Study|Surgery postponed after randomization|3|||
148814666|NCT02324153|536796504|FG001|Overall Study|Surgery postponed after randomization|0|||
148814667|NCT02324153|536796503|FG000|Overall Study|Developed delirium preoperatively|1|||
148814668|NCT02324153|536796504|FG001|Overall Study|Developed delirium preoperatively|0|||
148814669|NCT01937299|536796507|FG000|Overall Study|Adverse Event|13|||
148965343|NCT03446040|537358487|FG012|Overall Study|Death|0|||
148965344|NCT03446040|537358488|FG013|Overall Study|Death|2|||
148698393|NCT05017480|536371558|FG003|Stage 2 Study|Withdrawal by Subject|9|||
148698394|NCT05017480|536371559|FG004|Stage 2 Study|Withdrawal by Subject|11|||
148698395|NCT05017480|536371555|FG000|Stage 2 Study|Lost to Follow-up|0|||
148698396|NCT05017480|536371556|FG001|Stage 2 Study|Lost to Follow-up|0|||
148698397|NCT05017480|536371557|FG002|Stage 2 Study|Lost to Follow-up|0|||
148698398|NCT05017480|536371558|FG003|Stage 2 Study|Lost to Follow-up|2|||
148698399|NCT05017480|536371559|FG004|Stage 2 Study|Lost to Follow-up|1|||
148698400|NCT05017480|536371555|FG000|Stage 2 Study|Adverse Event|0|||
148698401|NCT05017480|536371556|FG001|Stage 2 Study|Adverse Event|0|||
148698402|NCT05017480|536371557|FG002|Stage 2 Study|Adverse Event|0|||
148698403|NCT05017480|536371558|FG003|Stage 2 Study|Adverse Event|1|||
148698404|NCT05017480|536371559|FG004|Stage 2 Study|Adverse Event|0|||
148698405|NCT05017480|536371555|FG000|Stage 2 Study|COVID-19|0|||
148698406|NCT05017480|536371556|FG001|Stage 2 Study|COVID-19|0|||
148698407|NCT05017480|536371557|FG002|Stage 2 Study|COVID-19|0|||
148698408|NCT05017480|536371558|FG003|Stage 2 Study|COVID-19|1|||
148698409|NCT05017480|536371559|FG004|Stage 2 Study|COVID-19|0|||
148698410|NCT05017480|536371555|FG000|Stage 2 Study|Pregnancy|0|||
148698411|NCT05017480|536371556|FG001|Stage 2 Study|Pregnancy|0|||
148698412|NCT05017480|536371557|FG002|Stage 2 Study|Pregnancy|0|||
148698413|NCT05017480|536371558|FG003|Stage 2 Study|Pregnancy|0|||
148698414|NCT05017480|536371559|FG004|Stage 2 Study|Pregnancy|1|||
148698415|NCT01136382|536371562|FG000|Overall Study|Other|8|||
148698416|NCT01136382|536371563|FG001|Overall Study|Other|3|||
148698417|NCT01136382|536371562|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
148698418|NCT01136382|536371563|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
148698419|NCT01136382|536371562|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
148698420|NCT01136382|536371563|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
148698421|NCT01136382|536371562|FG000|Overall Study|Withdrawal by Subject|4|||
148698422|NCT01136382|536371563|FG001|Overall Study|Withdrawal by Subject|1|||
148698423|NCT02653664|536371571|FG000|Post-Treatment|Withdrawal by Subject|6|||
148698424|NCT02653664|536371572|FG001|Post-Treatment|Withdrawal by Subject|5|||
148698425|NCT02653664|536371573|FG002|Post-Treatment|Withdrawal by Subject|7|||
148698426|NCT02653664|536371571|FG000|Post-Treatment|Lost to Follow-up|8|||
148698427|NCT02653664|536371572|FG001|Post-Treatment|Lost to Follow-up|1|||
148698428|NCT02653664|536371573|FG002|Post-Treatment|Lost to Follow-up|7|||
148698429|NCT02653664|536371571|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
148698430|NCT02653664|536371572|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
148698431|NCT02653664|536371573|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
148965345|NCT03446040|537358475|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
148965346|NCT03446040|537358476|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
148698432|NCT02653664|536371571|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
148965347|NCT03446040|537358477|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
148698433|NCT02653664|536371572|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
148698434|NCT02653664|536371573|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
148698435|NCT02653664|536371571|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
148965348|NCT03446040|537358478|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
148814670|NCT01937299|536796508|FG001|Overall Study|Adverse Event|0|||
148814671|NCT01937299|536796507|FG000|Overall Study|Lack of Efficacy|0|||
148965349|NCT03446040|537358479|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
148965350|NCT03446040|537358480|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
148698436|NCT02653664|536371572|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
148814672|NCT01937299|536796508|FG001|Overall Study|Lack of Efficacy|4|||
148814673|NCT01937299|536796507|FG000|Overall Study|Withdrawal by Subject|1|||
148814674|NCT01937299|536796508|FG001|Overall Study|Withdrawal by Subject|0|||
148814675|NCT03611946|536796512|FG000|Overall Study|Withdrawal by Subject|0|||
148814676|NCT03611946|536796513|FG001|Overall Study|Withdrawal by Subject|0|||
148814677|NCT03611946|536796514|FG002|Overall Study|Withdrawal by Subject|1|||
148814678|NCT03611946|536796515|FG003|Overall Study|Withdrawal by Subject|0|||
148698437|NCT02653664|536371573|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
148698438|NCT02653664|536371571|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
148698439|NCT02653664|536371572|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
148698440|NCT02653664|536371573|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
148698441|NCT02653664|536371571|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
148698442|NCT02653664|536371572|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
148698443|NCT02653664|536371573|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
148698444|NCT02653664|536371571|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
148698445|NCT02653664|536371572|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
148698446|NCT02653664|536371573|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
148698447|NCT02653664|536371571|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
148698448|NCT02653664|536371572|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
148698449|NCT02653664|536371573|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
148698450|NCT02653664|536371571|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
148814679|NCT00632359|536796522|FG000|Overall Study|Withdrawal by Subject|2|||
148814680|NCT03043573|536796527|FG000|Overall Study|Lost to Follow-up|3|||
148814681|NCT03043573|536796528|FG001|Overall Study|Lost to Follow-up|3|||
148814682|NCT03043573|536796527|FG000|Overall Study|Physician Decision|0|||
148814683|NCT03043573|536796528|FG001|Overall Study|Physician Decision|5|||
148814684|NCT03043573|536796527|FG000|Overall Study|Withdrawal by Subject|0|||
148814685|NCT03043573|536796528|FG001|Overall Study|Withdrawal by Subject|4|||
148814686|NCT05578872|536796531|FG000|Overall Study|Withdrawal by Subject|2|||
148814687|NCT05578872|536796532|FG001|Overall Study|Withdrawal by Subject|1|||
148814688|NCT05578872|536796531|FG000|Overall Study|Adverse Event|1|||
148814689|NCT05578872|536796532|FG001|Overall Study|Adverse Event|1|||
148814690|NCT05578872|536796531|FG000|Overall Study|Physician Decision|1|||
148814691|NCT05578872|536796532|FG001|Overall Study|Physician Decision|2|||
148814692|NCT05578872|536796531|FG000|Overall Study|Progressive disease|10|||
148814693|NCT05578872|536796532|FG001|Overall Study|Progressive disease|9|||
148814694|NCT05578872|536796531|FG000|Overall Study|Sponsor decision|0|||
148698451|NCT02653664|536371572|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
148698452|NCT02653664|536371573|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
148698453|NCT00727571|536371576|FG000|Overall Study|Ineligibility determined|1|||
148698454|NCT00727571|536371577|FG001|Overall Study|Ineligibility determined|1|||
148698455|NCT00727571|536371578|FG002|Overall Study|Ineligibility determined|1|||
148698456|NCT00727571|536371579|FG003|Overall Study|Ineligibility determined|0|||
148698457|NCT00727571|536371576|FG000|Overall Study|Death|0|||
148698458|NCT00727571|536371577|FG001|Overall Study|Death|19|||
148698459|NCT00727571|536371578|FG002|Overall Study|Death|5|||
148698460|NCT00727571|536371579|FG003|Overall Study|Death|1|||
148965351|NCT03446040|537358481|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
148965352|NCT03446040|537358482|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
148965353|NCT03446040|537358483|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
148698461|NCT00727571|536371576|FG000|Overall Study|Physician Decision|0|||
148698462|NCT00727571|536371577|FG001|Overall Study|Physician Decision|5|||
148698463|NCT00727571|536371578|FG002|Overall Study|Physician Decision|0|||
148814695|NCT05578872|536796532|FG001|Overall Study|Sponsor decision|1|||
148814696|NCT05578872|536796531|FG000|Overall Study|Toxicity and Patient's decision|0|||
148814697|NCT05578872|536796532|FG001|Overall Study|Toxicity and Patient's decision|1|||
148814698|NCT03641924|536797961|FG000|Overall Study|Withdrawal by Subject|26|||
148814699|NCT03641924|536797961|FG000|Overall Study|Lost to Follow-up|16|||
148814700|NCT03641924|536797961|FG000|Overall Study|Protocol Violation|10|||
148814701|NCT04333498|536797962|FG000|Overall Study|Lost to Follow-up|1|||
148814702|NCT04333498|536797963|FG001|Overall Study|Lost to Follow-up|0|||
148814703|NCT04333498|536797962|FG000|Overall Study|Lost to Follow-up|0|||
148814704|NCT04333498|536797963|FG001|Overall Study|Lost to Follow-up|1|||
148814705|NCT05399771|536797964|FG000|Overall Study|Physician Decision|3|||
148814706|NCT05399771|536797964|FG000|Overall Study|Adverse Event|1|||
148814707|NCT00484159|536797968|FG000|Overall Study|Lost to Follow-up|1|||
148814708|NCT00484159|536797969|FG001|Overall Study|Lost to Follow-up|1|||
148965354|NCT03446040|537358484|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
148965355|NCT03446040|537358485|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
148965356|NCT03446040|537358486|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
148965357|NCT03446040|537358487|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
148814709|NCT00484159|536797970|FG002|Overall Study|Lost to Follow-up|0|||
148814710|NCT04766333|536797971|FG000|Overall Study|Lost to Follow-up|40|||
148814711|NCT04766333|536797972|FG001|Overall Study|Lost to Follow-up|826|||
148814712|NCT01239680|536797975|FG000|Overall Study|Withdrawal by Subject|2|||
148965358|NCT03446040|537358488|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
148965359|NCT03446040|537358475|FG000|Overall Study|Participant withdrew consent|0|||
148965360|NCT03446040|537358476|FG001|Overall Study|Participant withdrew consent|0|||
148965361|NCT03446040|537358477|FG002|Overall Study|Participant withdrew consent|0|||
148965362|NCT03446040|537358478|FG003|Overall Study|Participant withdrew consent|0|||
148965363|NCT03446040|537358479|FG004|Overall Study|Participant withdrew consent|0|||
148965364|NCT03446040|537358480|FG005|Overall Study|Participant withdrew consent|1|||
148965365|NCT03446040|537358481|FG006|Overall Study|Participant withdrew consent|0|||
148965366|NCT03446040|537358482|FG007|Overall Study|Participant withdrew consent|1|||
148965367|NCT03446040|537358483|FG008|Overall Study|Participant withdrew consent|0|||
148965368|NCT03446040|537358484|FG009|Overall Study|Participant withdrew consent|0|||
148965369|NCT03446040|537358485|FG010|Overall Study|Participant withdrew consent|0|||
148965370|NCT03446040|537358486|FG011|Overall Study|Participant withdrew consent|0|||
148965371|NCT03446040|537358487|FG012|Overall Study|Participant withdrew consent|0|||
148965372|NCT03446040|537358488|FG013|Overall Study|Participant withdrew consent|0|||
148965373|NCT03446040|537358475|FG000|Overall Study|Not reported|0|||
148965374|NCT03446040|537358476|FG001|Overall Study|Not reported|0|||
148965375|NCT03446040|537358477|FG002|Overall Study|Not reported|1|||
148965376|NCT03446040|537358478|FG003|Overall Study|Not reported|0|||
148965377|NCT03446040|537358479|FG004|Overall Study|Not reported|0|||
148965378|NCT03446040|537358480|FG005|Overall Study|Not reported|0|||
148965379|NCT03446040|537358481|FG006|Overall Study|Not reported|0|||
148965380|NCT03446040|537358482|FG007|Overall Study|Not reported|0|||
148965381|NCT03446040|537358483|FG008|Overall Study|Not reported|0|||
148965382|NCT03446040|537358484|FG009|Overall Study|Not reported|0|||
148965383|NCT03446040|537358485|FG010|Overall Study|Not reported|0|||
148965384|NCT03446040|537358486|FG011|Overall Study|Not reported|0|||
148965385|NCT03446040|537358487|FG012|Overall Study|Not reported|0|||
148965386|NCT03446040|537358488|FG013|Overall Study|Not reported|0|||
148965387|NCT00605475|537358489|FG000|Overall Study|Abnormal Laboratory Values|0|||
148965388|NCT00605475|537358490|FG001|Overall Study|Abnormal Laboratory Values|0|||
148965389|NCT00605475|537358491|FG002|Overall Study|Abnormal Laboratory Values|0|||
148965390|NCT00605475|537358492|FG003|Overall Study|Abnormal Laboratory Values|0|||
148965391|NCT00605475|537358493|FG004|Overall Study|Abnormal Laboratory Values|0|||
148965392|NCT00605475|537358494|FG005|Overall Study|Abnormal Laboratory Values|0|||
148965393|NCT00605475|537358495|FG006|Overall Study|Abnormal Laboratory Values|0|||
148965394|NCT00605475|537358496|FG007|Overall Study|Abnormal Laboratory Values|0|||
148965395|NCT00605475|537358497|FG008|Overall Study|Abnormal Laboratory Values|1|||
148965396|NCT00605475|537358498|FG009|Overall Study|Abnormal Laboratory Values|0|||
148965397|NCT00605475|537358489|FG000|Overall Study|Administrative problems|0|||
148965398|NCT00605475|537358490|FG001|Overall Study|Administrative problems|0|||
148965399|NCT00605475|537358491|FG002|Overall Study|Administrative problems|0|||
148965400|NCT00605475|537358492|FG003|Overall Study|Administrative problems|0|||
148965401|NCT00605475|537358493|FG004|Overall Study|Administrative problems|0|||
148965402|NCT00605475|537358494|FG005|Overall Study|Administrative problems|0|||
148965403|NCT00605475|537358495|FG006|Overall Study|Administrative problems|1|||
148965404|NCT00605475|537358496|FG007|Overall Study|Administrative problems|0|||
148965405|NCT00605475|537358497|FG008|Overall Study|Administrative problems|0|||
148698464|NCT00727571|536371579|FG003|Overall Study|Physician Decision|0|||
148965406|NCT00605475|537358498|FG009|Overall Study|Administrative problems|0|||
148965407|NCT00605475|537358489|FG000|Overall Study|Lost to Follow-up|0|||
148965408|NCT00605475|537358490|FG001|Overall Study|Lost to Follow-up|0|||
148965409|NCT00605475|537358491|FG002|Overall Study|Lost to Follow-up|0|||
148965410|NCT00605475|537358492|FG003|Overall Study|Lost to Follow-up|0|||
148965411|NCT00605475|537358493|FG004|Overall Study|Lost to Follow-up|0|||
148965412|NCT00605475|537358494|FG005|Overall Study|Lost to Follow-up|0|||
148965413|NCT00605475|537358495|FG006|Overall Study|Lost to Follow-up|0|||
148965414|NCT00605475|537358496|FG007|Overall Study|Lost to Follow-up|0|||
148965415|NCT00605475|537358497|FG008|Overall Study|Lost to Follow-up|1|||
148965416|NCT00605475|537358498|FG009|Overall Study|Lost to Follow-up|1|||
148965417|NCT00605475|537358489|FG000|Overall Study|Protocol Violation|0|||
148965418|NCT00605475|537358490|FG001|Overall Study|Protocol Violation|0|||
148965419|NCT00605475|537358491|FG002|Overall Study|Protocol Violation|0|||
148965420|NCT00605475|537358492|FG003|Overall Study|Protocol Violation|0|||
148965421|NCT00605475|537358493|FG004|Overall Study|Protocol Violation|1|||
148965422|NCT00605475|537358494|FG005|Overall Study|Protocol Violation|0|||
148965423|NCT00605475|537358495|FG006|Overall Study|Protocol Violation|0|||
148965424|NCT00605475|537358496|FG007|Overall Study|Protocol Violation|0|||
148965425|NCT00605475|537358497|FG008|Overall Study|Protocol Violation|0|||
148965426|NCT00605475|537358498|FG009|Overall Study|Protocol Violation|0|||
148965427|NCT00605475|537358489|FG000|Overall Study|Withdrawal by Subject|0|||
148965428|NCT00605475|537358490|FG001|Overall Study|Withdrawal by Subject|0|||
148965429|NCT00605475|537358491|FG002|Overall Study|Withdrawal by Subject|0|||
148965430|NCT00605475|537358492|FG003|Overall Study|Withdrawal by Subject|0|||
148965431|NCT00605475|537358493|FG004|Overall Study|Withdrawal by Subject|0|||
148965432|NCT00605475|537358494|FG005|Overall Study|Withdrawal by Subject|2|||
148965433|NCT00605475|537358495|FG006|Overall Study|Withdrawal by Subject|0|||
148965434|NCT00605475|537358496|FG007|Overall Study|Withdrawal by Subject|0|||
148965435|NCT00605475|537358497|FG008|Overall Study|Withdrawal by Subject|0|||
148965436|NCT00605475|537358498|FG009|Overall Study|Withdrawal by Subject|1|||
148965437|NCT02596854|537358499|FG000|Overall Study|Withdrawn|8|||
148965438|NCT03314584|537358500|FG000|Overall Study|Withdrawal by Subject|3|||
148965439|NCT03314584|537358501|FG001|Overall Study|Withdrawal by Subject|3|||
148965440|NCT03314584|537358500|FG000|Overall Study|Lost to Follow-up|4|||
148965441|NCT03314584|537358501|FG001|Overall Study|Lost to Follow-up|0|||
148965442|NCT04343521|537358511|FG000|Overall Study|Adverse Event|0|||
148965443|NCT04343521|537358512|FG001|Overall Study|Adverse Event|2|||
148965444|NCT04343521|537358511|FG000|Overall Study|Death|1|||
148965445|NCT04343521|537358512|FG001|Overall Study|Death|2|||
148965446|NCT04343521|537358511|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
148965447|NCT04343521|537358512|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
148965448|NCT04343521|537358511|FG000|Overall Study|Withdrawal by Subject|70|||
148965449|NCT04343521|537358512|FG001|Overall Study|Withdrawal by Subject|95|||
148965450|NCT04343521|537358511|FG000|Overall Study|Withdrawal by study team|6|||
148965451|NCT04343521|537358512|FG001|Overall Study|Withdrawal by study team|12|||
148965452|NCT02532647|537358513|FG000|Overall Study|Did not receive trial medication|1|||
148965453|NCT02532647|537358514|FG001|Overall Study|Did not receive trial medication|0|||
148965454|NCT02532647|537358515|FG002|Overall Study|Did not receive trial medication|1|||
148965455|NCT02939560|537358516|FG000|Overall Study|Withdrawal by Subject|2|||
148965456|NCT02939560|537358516|FG000|Overall Study|Protocol Violation|1|||
148965457|NCT03897179|537358517|FG000|Overall Study|Withdrawal by Subject|1|||
148965458|NCT00704535|537358518|FG000|Overall Study|Adverse Event|2|||
148965459|NCT00704535|537358518|FG000|Overall Study|Death|2|||
148965460|NCT00704535|537358518|FG000|Overall Study|Lost to Follow-up|8|||
148965461|NCT00704535|537358518|FG000|Overall Study|Protocol Violation|10|||
148698465|NCT00727571|536371576|FG000|Overall Study|Withdrawal by Subject|0|||
148698466|NCT00727571|536371577|FG001|Overall Study|Withdrawal by Subject|10|||
148698467|NCT00727571|536371578|FG002|Overall Study|Withdrawal by Subject|11|||
148965462|NCT00704535|537358518|FG000|Overall Study|Completed status not on Case Report Form|124|||
148965463|NCT01480076|537358519|FG000|Overall Study|Run-in Failure|52|||
148965464|NCT01480076|537358519|FG000|Overall Study|Adverse Event|39|||
148965465|NCT01480076|537358519|FG000|Overall Study|Death|2|||
148965466|NCT01480076|537358519|FG000|Overall Study|Disease Progression|5|||
148965467|NCT01480076|537358519|FG000|Overall Study|Non-compliance With Study Protocol|15|||
148965468|NCT01480076|537358519|FG000|Overall Study|Withdrawal by Subject|105|||
148965469|NCT01480076|537358519|FG000|Overall Study|Lost to Follow-up|7|||
148965470|NCT01480076|537358519|FG000|Overall Study|Investigator Decision|13|||
148965471|NCT01480076|537358519|FG000|Overall Study|Other|52|||
148965472|NCT02503332|537358520|FG000|Overall Study|Adverse Event|17|||
148965473|NCT02503332|537358521|FG001|Overall Study|Adverse Event|5|||
148965474|NCT02503332|537358522|FG002|Overall Study|Adverse Event|3|||
148965475|NCT02503332|537358523|FG003|Overall Study|Adverse Event|1|||
148965476|NCT02503332|537358520|FG000|Overall Study|Investigator's Decision|5|||
148965477|NCT02503332|537358521|FG001|Overall Study|Investigator's Decision|1|||
148965478|NCT02503332|537358522|FG002|Overall Study|Investigator's Decision|0|||
148965479|NCT02503332|537358523|FG003|Overall Study|Investigator's Decision|0|||
148965480|NCT02503332|537358520|FG000|Overall Study|Sponsor's Decision|1|||
148965481|NCT02503332|537358521|FG001|Overall Study|Sponsor's Decision|0|||
148965482|NCT02503332|537358522|FG002|Overall Study|Sponsor's Decision|0|||
148965483|NCT02503332|537358523|FG003|Overall Study|Sponsor's Decision|1|||
148965484|NCT02503332|537358520|FG000|Overall Study|Subject Request|6|||
148965485|NCT02503332|537358521|FG001|Overall Study|Subject Request|5|||
148965486|NCT02503332|537358522|FG002|Overall Study|Subject Request|2|||
148965487|NCT02503332|537358523|FG003|Overall Study|Subject Request|1|||
148965488|NCT02503332|537358520|FG000|Overall Study|Death|0|||
148965489|NCT02503332|537358521|FG001|Overall Study|Death|2|||
148965490|NCT02503332|537358522|FG002|Overall Study|Death|2|||
148965491|NCT02503332|537358523|FG003|Overall Study|Death|0|||
148965492|NCT02503332|537358520|FG000|Overall Study|Other|5|||
148965493|NCT02503332|537358521|FG001|Overall Study|Other|6|||
148965494|NCT02503332|537358522|FG002|Overall Study|Other|1|||
148965495|NCT02503332|537358523|FG003|Overall Study|Other|1|||
148965496|NCT05694546|537358527|FG000|Overall Study|Lost to Follow-up|11|||
148965497|NCT02424383|537358528|FG000|Overall Study|Withdrawal by Subject|32|||
148965498|NCT02424383|537358528|FG000|Overall Study|Death|170|||
148965499|NCT02424383|537358528|FG000|Overall Study|Sponsor's decision|3|||
148965500|NCT02424383|537358528|FG000|Overall Study|Investigator's decision|44|||
148965501|NCT02424383|537358528|FG000|Overall Study|Lost to Follow-up|81|||
148965502|NCT02424383|537358528|FG000|Overall Study|Other|7|||
148965503|NCT02424383|537358528|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
148965504|NCT00325754|537358532|FG000|Overall Study|Adverse Event|4|||
148965505|NCT00325754|537358533|FG001|Overall Study|Adverse Event|1|||
148965506|NCT01752855|537358540|FG000|Overall Study|Adverse Event|1|||
148965507|NCT01752855|537358541|FG001|Overall Study|Adverse Event|0|||
148965508|NCT01752855|537358540|FG000|Overall Study|Withdrew Consent|0|||
148965509|NCT01752855|537358541|FG001|Overall Study|Withdrew Consent|2|||
148965510|NCT01752855|537358540|FG000|Overall Study|Lack of Efficacy|0|||
148965511|NCT01752855|537358541|FG001|Overall Study|Lack of Efficacy|2|||
148965512|NCT03168464|537358542|FG000|Overall Study|Death|9|||
148965513|NCT03168464|537358542|FG000|Overall Study|Progression of disease|6|||
148965514|NCT04649164|537358543|FG000|Overall Study|Withdrawal by Subject|1|||
148965515|NCT04649164|537358544|FG001|Overall Study|Withdrawal by Subject|1|||
148965516|NCT04649164|537358545|FG002|Overall Study|Withdrawal by Subject|2|||
148965517|NCT04649164|537358543|FG000|Overall Study|Participant's care recipient expired|0|||
148965518|NCT04649164|537358544|FG001|Overall Study|Participant's care recipient expired|0|||
148965519|NCT04649164|537358545|FG002|Overall Study|Participant's care recipient expired|2|||
148965520|NCT00634088|537358548|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
148965521|NCT00634088|537358549|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
148965522|NCT00634088|537358550|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
148965523|NCT00634088|537358551|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
148965524|NCT00634088|537358548|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
148965525|NCT00634088|537358549|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
148965526|NCT00634088|537358550|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
148965527|NCT00634088|537358551|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
148965528|NCT00634088|537358548|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
148965529|NCT00634088|537358549|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
148965530|NCT00634088|537358550|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
148965531|NCT00634088|537358551|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
148965532|NCT00634088|537358548|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
148965533|NCT00634088|537358549|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
148965534|NCT00634088|537358550|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
148965535|NCT00634088|537358551|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
148965536|NCT00634088|537358548|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
148965537|NCT00634088|537358549|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
148965538|NCT00634088|537358550|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
148965539|NCT00634088|537358551|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
148965540|NCT00634088|537358548|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
148965541|NCT00634088|537358549|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
148965542|NCT00634088|537358550|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
148965543|NCT00634088|537358551|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
148965544|NCT02439320|537358558|FG000|Overall Study|Adverse Event|0|||
148965545|NCT02439320|537358559|FG001|Overall Study|Adverse Event|2|||
148965546|NCT02439320|537358560|FG002|Overall Study|Adverse Event|0|||
148965547|NCT02439320|537358558|FG000|Overall Study|Lost to Follow-up|37|||
148965548|NCT02439320|537358559|FG001|Overall Study|Lost to Follow-up|34|||
148965549|NCT02439320|537358560|FG002|Overall Study|Lost to Follow-up|42|||
148965550|NCT02439320|537358558|FG000|Overall Study|Death|0|||
148965551|NCT02439320|537358559|FG001|Overall Study|Death|1|||
148965552|NCT02439320|537358560|FG002|Overall Study|Death|0|||
148965553|NCT02439320|537358558|FG000|Overall Study|Noncompliance with Protocol|10|||
148965554|NCT02439320|537358559|FG001|Overall Study|Noncompliance with Protocol|11|||
148965555|NCT02439320|537358560|FG002|Overall Study|Noncompliance with Protocol|7|||
148965556|NCT02439320|537358558|FG000|Overall Study|Pregnancy|0|||
148965557|NCT02439320|537358559|FG001|Overall Study|Pregnancy|1|||
148965558|NCT02439320|537358560|FG002|Overall Study|Pregnancy|1|||
148965559|NCT02439320|537358558|FG000|Overall Study|Withdrawal by Subject|12|||
148965560|NCT02439320|537358559|FG001|Overall Study|Withdrawal by Subject|16|||
148965561|NCT02439320|537358560|FG002|Overall Study|Withdrawal by Subject|14|||
148965562|NCT02439320|537358558|FG000|Overall Study|Physician Decision|2|||
148965563|NCT02439320|537358559|FG001|Overall Study|Physician Decision|1|||
148965564|NCT02439320|537358560|FG002|Overall Study|Physician Decision|0|||
148965565|NCT02439320|537358558|FG000|Overall Study|Sponsor Request|0|||
148965566|NCT02439320|537358559|FG001|Overall Study|Sponsor Request|2|||
148965567|NCT02439320|537358560|FG002|Overall Study|Sponsor Request|1|||
148965568|NCT02439320|537358558|FG000|Overall Study|Randomization Failure|35|||
148965569|NCT02439320|537358559|FG001|Overall Study|Randomization Failure|46|||
148965570|NCT02439320|537358560|FG002|Overall Study|Randomization Failure|34|||
148698468|NCT00727571|536371579|FG003|Overall Study|Withdrawal by Subject|0|||
148698469|NCT00727571|536371576|FG000|Overall Study|Subject Non Compliance|0|||
148698470|NCT00727571|536371577|FG001|Overall Study|Subject Non Compliance|6|||
148698471|NCT00727571|536371578|FG002|Overall Study|Subject Non Compliance|0|||
148965571|NCT01251380|537358563|FG000|Overall Study|Other (Not otherwise specified)|12|||
148965572|NCT01251380|537358563|FG000|Overall Study|Withdrawal by Subject|6|||
148965573|NCT01251380|537358563|FG000|Overall Study|Lack of Efficacy|1|||
148965574|NCT01251380|537358563|FG000|Overall Study|Adverse Event|1|||
148965575|NCT01251380|537358563|FG000|Overall Study|Lost to Follow-up|2|||
148965576|NCT00600756|537358564|FG000|Analysis After 6 Months|Adverse Event|43|||
148965577|NCT00600756|537358565|FG001|Analysis After 6 Months|Adverse Event|33|||
148965578|NCT00600756|537358564|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
148965579|NCT00600756|537358565|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
148965580|NCT00600756|537358564|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
148965581|NCT00600756|537358565|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
148965582|NCT00600756|537358564|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
148965583|NCT00600756|537358565|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
148965584|NCT00600756|537358564|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
148965585|NCT00600756|537358565|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
148965586|NCT00600756|537358564|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
148965587|NCT00600756|537358565|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
148965588|NCT00600756|537358564|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
148965589|NCT00600756|537358565|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
148965590|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
148965591|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
148965592|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
148965593|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
148965594|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
148965595|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
148965596|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
148965597|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
148965598|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
148965599|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
148965600|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
148965601|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
148965602|NCT00600756|537358564|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
148965603|NCT00600756|537358565|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
148965604|NCT00768144|537358570|FG000|Overall Study|Adverse Event|13|||
148965605|NCT00768144|537358570|FG000|Overall Study|Progressive Disease|21|||
148965606|NCT00768144|537358570|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
148965607|NCT00768144|537358570|FG000|Overall Study|Pt Withdrew Consent|1|||
148965608|NCT01150123|537358571|FG000|Overall Study|Withdrawal by Subject|1|||
148965609|NCT01150123|537358572|FG001|Overall Study|Withdrawal by Subject|1|||
148965610|NCT01150123|537358573|FG002|Overall Study|Withdrawal by Subject|2|||
148965611|NCT01150123|537358574|FG003|Overall Study|Withdrawal by Subject|1|||
148965612|NCT01150123|537358575|FG004|Overall Study|Withdrawal by Subject|1|||
148965613|NCT01150123|537358576|FG005|Overall Study|Withdrawal by Subject|1|||
148965614|NCT01150123|537358577|FG006|Overall Study|Withdrawal by Subject|0|||
148965615|NCT01150123|537358578|FG007|Overall Study|Withdrawal by Subject|3|||
148965616|NCT01150123|537358579|FG008|Overall Study|Withdrawal by Subject|2|||
148965617|NCT01150123|537358580|FG009|Overall Study|Withdrawal by Subject|0|||
148965618|NCT01150123|537358581|FG010|Overall Study|Withdrawal by Subject|1|||
148965619|NCT01150123|537358582|FG011|Overall Study|Withdrawal by Subject|0|||
148965620|NCT01150123|537358583|FG012|Overall Study|Withdrawal by Subject|1|||
148965621|NCT01150123|537358584|FG013|Overall Study|Withdrawal by Subject|0|||
148965622|NCT01150123|537358585|FG014|Overall Study|Withdrawal by Subject|0|||
148965623|NCT01150123|537358586|FG015|Overall Study|Withdrawal by Subject|1|||
148965624|NCT01150123|537358587|FG016|Overall Study|Withdrawal by Subject|0|||
148965625|NCT01150123|537358588|FG017|Overall Study|Withdrawal by Subject|1|||
148965626|NCT01150123|537358571|FG000|Overall Study|Lost to Follow-up|2|||
148965627|NCT01150123|537358572|FG001|Overall Study|Lost to Follow-up|1|||
148965628|NCT01150123|537358573|FG002|Overall Study|Lost to Follow-up|2|||
148965629|NCT01150123|537358574|FG003|Overall Study|Lost to Follow-up|2|||
148965630|NCT01150123|537358575|FG004|Overall Study|Lost to Follow-up|2|||
148965631|NCT01150123|537358576|FG005|Overall Study|Lost to Follow-up|5|||
148965632|NCT01150123|537358577|FG006|Overall Study|Lost to Follow-up|0|||
148965633|NCT01150123|537358578|FG007|Overall Study|Lost to Follow-up|0|||
148965634|NCT01150123|537358579|FG008|Overall Study|Lost to Follow-up|3|||
148965635|NCT01150123|537358580|FG009|Overall Study|Lost to Follow-up|1|||
148965636|NCT01150123|537358581|FG010|Overall Study|Lost to Follow-up|1|||
148965637|NCT01150123|537358582|FG011|Overall Study|Lost to Follow-up|1|||
148965638|NCT01150123|537358583|FG012|Overall Study|Lost to Follow-up|2|||
148965639|NCT01150123|537358584|FG013|Overall Study|Lost to Follow-up|0|||
148965640|NCT01150123|537358585|FG014|Overall Study|Lost to Follow-up|0|||
148965641|NCT01150123|537358586|FG015|Overall Study|Lost to Follow-up|0|||
148965642|NCT01150123|537358587|FG016|Overall Study|Lost to Follow-up|0|||
148965643|NCT01150123|537358588|FG017|Overall Study|Lost to Follow-up|0|||
148965644|NCT00673179|537358591|FG000|Overall Study|Toxicity/Complications|3|||
148965645|NCT00673179|537358592|FG001|Overall Study|Toxicity/Complications|0|||
148965646|NCT01531387|537358595|FG000|Overall Study|Early termination of study|11|||
148965647|NCT01531387|537358596|FG001|Overall Study|Early termination of study|11|||
148965648|NCT04248933|537358597|FG000|Overall Study|Lost to Follow-up|9|||
148965649|NCT04248933|537358597|FG000|Overall Study|Withdrawal by Subject|2|||
148965650|NCT00578942|537358598|FG000|Overall Study|Lost to Follow-up|1|||
148965651|NCT03509675|537359944|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
148965652|NCT03509675|537359945|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
148965653|NCT03509675|537359944|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
148965654|NCT03509675|537359945|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
148965655|NCT03509675|537359944|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
148965656|NCT03509675|537359945|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
148965657|NCT03509675|537359944|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
148965658|NCT03509675|537359945|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
148965659|NCT05620576|537359948|FG000|Overall Study|Adverse Event|1|||
148965660|NCT05620576|537359949|FG001|Overall Study|Adverse Event|1|||
148965661|NCT05620576|537359948|FG000|Overall Study|Lost to Follow-up|3|||
148965662|NCT05620576|537359949|FG001|Overall Study|Lost to Follow-up|1|||
148965663|NCT05620576|537359948|FG000|Overall Study|Physician Decision|0|||
148965664|NCT05620576|537359949|FG001|Overall Study|Physician Decision|1|||
148965665|NCT05620576|537359948|FG000|Overall Study|Protocol Deviation|1|||
149025010|NCT03738241|537567980|FG001|Overall Study|Withdrawal by Subject|0|||
149025011|NCT03738241|537567981|FG002|Overall Study|Withdrawal by Subject|0|||
148698472|NCT00727571|536371579|FG003|Overall Study|Subject Non Compliance|4|||
148698473|NCT00727571|536371576|FG000|Overall Study|Dismissed from nursing home|0|||
148698474|NCT00727571|536371577|FG001|Overall Study|Dismissed from nursing home|9|||
148698475|NCT00727571|536371578|FG002|Overall Study|Dismissed from nursing home|5|||
148965666|NCT05620576|537359949|FG001|Overall Study|Protocol Deviation|1|||
149025012|NCT03738241|537567982|FG003|Overall Study|Withdrawal by Subject|0|||
149025013|NCT03738241|537567983|FG004|Overall Study|Withdrawal by Subject|0|||
149025014|NCT03738241|537567984|FG005|Overall Study|Withdrawal by Subject|0|||
149025015|NCT03738241|537567985|FG006|Overall Study|Withdrawal by Subject|0|||
148965667|NCT05620576|537359948|FG000|Overall Study|Withdrawal by Subject|2|||
148965668|NCT05620576|537359949|FG001|Overall Study|Withdrawal by Subject|3|||
148965669|NCT03239470|537359950|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
148965670|NCT03239470|537359951|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
148814713|NCT01239680|536797976|FG001|Overall Study|Withdrawal by Subject|0|||
148814714|NCT03033901|536797977|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
148814715|NCT03033901|536797977|FG000|Overall Study|Refused PSG|23|||
148814716|NCT03033901|536797977|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
148965671|NCT06134817|537359960|FG000|Overall Study|Physician Departure - termination of study|1|||
148965672|NCT03261947|537359961|FG000|Overall Study|Death|10|||
148965673|NCT03261947|537359962|FG001|Overall Study|Death|13|||
148965674|NCT03261947|537359963|FG002|Overall Study|Death|17|||
148965675|NCT03261947|537359964|FG003|Overall Study|Death|12|||
148965676|NCT03261947|537359965|FG004|Overall Study|Death|8|||
148965677|NCT03261947|537359961|FG000|Overall Study|Lost to Follow-up|0|||
148965678|NCT03261947|537359962|FG001|Overall Study|Lost to Follow-up|0|||
148965679|NCT03261947|537359963|FG002|Overall Study|Lost to Follow-up|2|||
148965680|NCT03261947|537359964|FG003|Overall Study|Lost to Follow-up|1|||
148965681|NCT03261947|537359965|FG004|Overall Study|Lost to Follow-up|0|||
148965682|NCT03261947|537359961|FG000|Overall Study|Withdrawal by Subject|0|||
148965683|NCT03261947|537359962|FG001|Overall Study|Withdrawal by Subject|0|||
148965684|NCT03261947|537359963|FG002|Overall Study|Withdrawal by Subject|3|||
148965685|NCT03261947|537359964|FG003|Overall Study|Withdrawal by Subject|0|||
148965686|NCT03261947|537359965|FG004|Overall Study|Withdrawal by Subject|1|||
148965687|NCT03261947|537359961|FG000|Overall Study|Site Terminated by Sponsor|0|||
148965688|NCT03261947|537359962|FG001|Overall Study|Site Terminated by Sponsor|0|||
148965689|NCT03261947|537359963|FG002|Overall Study|Site Terminated by Sponsor|4|||
148965690|NCT03261947|537359964|FG003|Overall Study|Site Terminated by Sponsor|7|||
148965691|NCT03261947|537359965|FG004|Overall Study|Site Terminated by Sponsor|5|||
148965692|NCT03261947|537359961|FG000|Overall Study|Reason not Specified|2|||
148965693|NCT03261947|537359962|FG001|Overall Study|Reason not Specified|0|||
148965694|NCT03261947|537359963|FG002|Overall Study|Reason not Specified|4|||
148814717|NCT03033901|536797977|FG000|Overall Study|Missing Oximetry Data|3|||
148814718|NCT01797185|536797978|FG000|Overall Study|Adverse Event|5|||
148814719|NCT01797185|536797979|FG001|Overall Study|Adverse Event|15|||
148814720|NCT01797185|536797980|FG002|Overall Study|Adverse Event|6|||
148814721|NCT01797185|536797978|FG000|Overall Study|Withdrawal by Subject|6|||
148814722|NCT01797185|536797979|FG001|Overall Study|Withdrawal by Subject|9|||
148814723|NCT01797185|536797980|FG002|Overall Study|Withdrawal by Subject|5|||
148814724|NCT01797185|536797978|FG000|Overall Study|Site terminated|8|||
148814725|NCT01797185|536797979|FG001|Overall Study|Site terminated|4|||
148814726|NCT01797185|536797980|FG002|Overall Study|Site terminated|0|||
148814727|NCT01797185|536797978|FG000|Overall Study|Lost to Follow-up|2|||
148814728|NCT01797185|536797979|FG001|Overall Study|Lost to Follow-up|6|||
148814729|NCT01797185|536797980|FG002|Overall Study|Lost to Follow-up|1|||
148814730|NCT01797185|536797978|FG000|Overall Study|Withdrawn per sponsor|5|||
148965695|NCT03261947|537359964|FG003|Overall Study|Reason not Specified|1|||
148965696|NCT03261947|537359965|FG004|Overall Study|Reason not Specified|3|||
148965697|NCT03969992|537359966|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
148814731|NCT01797185|536797979|FG001|Overall Study|Withdrawn per sponsor|0|||
148814732|NCT01797185|536797980|FG002|Overall Study|Withdrawn per sponsor|0|||
148814733|NCT01797185|536797978|FG000|Overall Study|Physician Decision|1|||
148814734|NCT01797185|536797979|FG001|Overall Study|Physician Decision|3|||
148814735|NCT01797185|536797980|FG002|Overall Study|Physician Decision|0|||
148814736|NCT01797185|536797978|FG000|Overall Study|Protocol Violation|1|||
148814737|NCT01797185|536797979|FG001|Overall Study|Protocol Violation|1|||
148814738|NCT01797185|536797980|FG002|Overall Study|Protocol Violation|0|||
148814739|NCT00729586|536797981|FG000|Overall Study|Ineligible|0|||
148814740|NCT00729586|536797982|FG001|Overall Study|Ineligible|1|||
148814741|NCT00729586|536797981|FG000|Overall Study|never treated|1|||
148814742|NCT00729586|536797982|FG001|Overall Study|never treated|0|||
148814743|NCT05177094|536797985|FG000|Overall Study|Adverse Event|5|||
148814744|NCT05177094|536797986|FG001|Overall Study|Adverse Event|5|||
148814745|NCT05177094|536797985|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
148814746|NCT05177094|536797986|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
148965698|NCT03969992|537359967|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
148965699|NCT03969992|537359968|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
148965700|NCT03969992|537359966|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
148965701|NCT03969992|537359967|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
148965702|NCT03969992|537359968|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
148965703|NCT03969992|537359966|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
148965704|NCT03969992|537359967|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
148965705|NCT03969992|537359968|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
148814747|NCT05177094|536797985|FG000|Overall Study|Protocol Deviation|3|||
148814748|NCT05177094|536797986|FG001|Overall Study|Protocol Deviation|0|||
148814749|NCT05177094|536797985|FG000|Overall Study|Withdrawal by Subject|6|||
148814750|NCT05177094|536797986|FG001|Overall Study|Withdrawal by Subject|3|||
148814751|NCT05177094|536797985|FG000|Overall Study|Participant could not tolerate long study visits|1|||
148814752|NCT05177094|536797986|FG001|Overall Study|Participant could not tolerate long study visits|0|||
148814753|NCT01033942|536797989|FG000|Overall Study|Withdrawal by Subject|1|||
148965706|NCT03969992|537359966|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
148965707|NCT03969992|537359967|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
148698476|NCT00727571|536371579|FG003|Overall Study|Dismissed from nursing home|0|||
148698477|NCT00727571|536371576|FG000|Overall Study|Hospitalization|0|||
148698478|NCT00727571|536371577|FG001|Overall Study|Hospitalization|1|||
148698479|NCT00727571|536371578|FG002|Overall Study|Hospitalization|0|||
148698480|NCT00727571|536371579|FG003|Overall Study|Hospitalization|1|||
148698481|NCT00727571|536371576|FG000|Overall Study|AE not leading to hospitalization|0|||
148698482|NCT00727571|536371577|FG001|Overall Study|AE not leading to hospitalization|0|||
148698483|NCT00727571|536371578|FG002|Overall Study|AE not leading to hospitalization|2|||
148698484|NCT00727571|536371579|FG003|Overall Study|AE not leading to hospitalization|0|||
148698485|NCT00727571|536371576|FG000|Overall Study|Other|0|||
148698486|NCT00727571|536371577|FG001|Overall Study|Other|4|||
148698487|NCT00727571|536371578|FG002|Overall Study|Other|6|||
148698488|NCT00727571|536371579|FG003|Overall Study|Other|0|||
148698489|NCT03247556|536371580|FG000|Overall Study|Adverse Event|1|||
148698490|NCT03247556|536371581|FG001|Overall Study|Adverse Event|4|||
148698491|NCT03247556|536371582|FG002|Overall Study|Adverse Event|5|||
148698492|NCT03247556|536371580|FG000|Overall Study|Lost to Follow-up|5|||
148698493|NCT03247556|536371581|FG001|Overall Study|Lost to Follow-up|5|||
148698494|NCT03247556|536371582|FG002|Overall Study|Lost to Follow-up|4|||
148698495|NCT03247556|536371580|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
148698496|NCT03247556|536371581|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
148698497|NCT03247556|536371582|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
148698498|NCT03247556|536371580|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
148698499|NCT03247556|536371581|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
148698500|NCT03247556|536371582|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
148698501|NCT03247556|536371580|FG000|Overall Study|Protocol Violation|2|||
148698502|NCT03247556|536371581|FG001|Overall Study|Protocol Violation|0|||
148698503|NCT03247556|536371582|FG002|Overall Study|Protocol Violation|1|||
148698504|NCT03247556|536371580|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
148698505|NCT03247556|536371581|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
148698506|NCT03247556|536371582|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
148698507|NCT03478397|536371583|FG000|Overall Study|Refused to participate|31|||
148698508|NCT03478397|536371584|FG001|Overall Study|Refused to participate|7|||
148698509|NCT04206332|536371586|FG000|Part A|Lost to Follow-up|0|||
148698510|NCT04206332|536371587|FG001|Part A|Lost to Follow-up|1|||
148698511|NCT04206332|536371588|FG002|Part A|Lost to Follow-up|0|||
148698512|NCT04206332|536371589|FG003|Part A|Lost to Follow-up|0|||
148698513|NCT04206332|536371590|FG004|Part A|Lost to Follow-up|0|||
148698514|NCT04206332|536371591|FG005|Part A|Lost to Follow-up|0|||
148698515|NCT04206332|536371592|FG006|Part A|Lost to Follow-up|0|||
148698516|NCT04206332|536371593|FG007|Part A|Lost to Follow-up|0|||
148698517|NCT04206332|536371594|FG008|Part A|Lost to Follow-up|0|||
148698518|NCT04206332|536371595|FG009|Part A|Lost to Follow-up|0|||
148698519|NCT04206332|536371596|FG010|Part A|Lost to Follow-up|0|||
148698520|NCT04206332|536371597|FG011|Part A|Lost to Follow-up|0|||
148698521|NCT04206332|536371598|FG012|Part A|Lost to Follow-up|0|||
148698522|NCT04206332|536371599|FG013|Part A|Lost to Follow-up|0|||
148698523|NCT04206332|536371600|FG014|Part A|Lost to Follow-up|0|||
148698524|NCT04206332|536371601|FG015|Part A|Lost to Follow-up|0|||
148698525|NCT04206332|536371602|FG016|Part A|Lost to Follow-up|0|||
148698526|NCT04206332|536371586|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698527|NCT04206332|536371587|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698528|NCT04206332|536371588|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698529|NCT04206332|536371589|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698530|NCT04206332|536371590|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698531|NCT04206332|536371591|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
148698532|NCT04206332|536371592|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698533|NCT04206332|536371593|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698534|NCT04206332|536371594|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698535|NCT04206332|536371595|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698536|NCT04206332|536371596|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698537|NCT04206332|536371597|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698538|NCT04206332|536371598|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698539|NCT04206332|536371599|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698540|NCT04206332|536371600|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698541|NCT04206332|536371601|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698542|NCT04206332|536371602|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
148698543|NCT04206332|536371586|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148965708|NCT03969992|537359968|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
148965709|NCT03969992|537359966|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
148965710|NCT03969992|537359967|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
148965711|NCT03969992|537359968|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
148965712|NCT02063737|537359969|FG000|Overall Study|Lost to Follow-up|11|||
148965713|NCT02063737|537359970|FG001|Overall Study|Lost to Follow-up|4|||
148965714|NCT00439556|537359971|FG000|Overall Study|Patient was taken off study for non-comp|0|||
148965715|NCT00439556|537359972|FG001|Overall Study|Patient was taken off study for non-comp|1|||
148965716|NCT00439556|537359973|FG002|Overall Study|Patient was taken off study for non-comp|0|||
148965717|NCT01324388|537359976|FG000|Part 1 of Study|Adverse Event|2|||
148965718|NCT01324388|537359977|FG001|Part 1 of Study|Adverse Event|0|||
148965719|NCT01324388|537359978|FG002|Part 1 of Study|Adverse Event|0|||
148965720|NCT01324388|537359979|FG003|Part 1 of Study|Adverse Event|0|||
148965721|NCT01324388|537359976|FG000|Part 1 of Study|Protocol Violation|1|||
148965722|NCT01324388|537359977|FG001|Part 1 of Study|Protocol Violation|2|||
148965723|NCT01324388|537359978|FG002|Part 1 of Study|Protocol Violation|0|||
148965724|NCT01324388|537359979|FG003|Part 1 of Study|Protocol Violation|0|||
148965725|NCT01324388|537359976|FG000|Part 1 of Study|Physician Decision|1|||
148965726|NCT01324388|537359977|FG001|Part 1 of Study|Physician Decision|0|||
148965727|NCT01324388|537359978|FG002|Part 1 of Study|Physician Decision|0|||
148965728|NCT01324388|537359979|FG003|Part 1 of Study|Physician Decision|0|||
148965729|NCT01324388|537359976|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
148965730|NCT01324388|537359977|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
148965731|NCT01324388|537359978|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
148965732|NCT01324388|537359979|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
148965733|NCT01324388|537359976|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
148965734|NCT01324388|537359977|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
148965735|NCT01324388|537359978|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
148965736|NCT01324388|537359979|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
148965737|NCT01405963|537359980|FG000|Overall Study|Moved Away|2|||
148965738|NCT01405963|537359981|FG001|Overall Study|Moved Away|0|||
148965739|NCT01405963|537359980|FG000|Overall Study|Adverse Event|0|||
148965740|NCT01405963|537359981|FG001|Overall Study|Adverse Event|1|||
148965741|NCT01405963|537359980|FG000|Overall Study|Lost to Follow-up|0|||
148965742|NCT01405963|537359981|FG001|Overall Study|Lost to Follow-up|1|||
148965743|NCT01498640|537359982|FG000|Overall Study|Lost to Follow-up|1|||
148965744|NCT01498640|537359982|FG000|Overall Study|Death|1|||
148965745|NCT01498640|537359982|FG000|Overall Study|Other|3|||
148965746|NCT01737047|537359983|FG000|Overall Study|Death|10|||
148965747|NCT01737047|537359984|FG001|Overall Study|Death|0|||
148965748|NCT01737047|537359985|FG002|Overall Study|Death|1|||
148965749|NCT01737047|537359983|FG000|Overall Study|Withdrawal by Subject|17|||
148965750|NCT01737047|537359984|FG001|Overall Study|Withdrawal by Subject|11|||
148965751|NCT01737047|537359985|FG002|Overall Study|Withdrawal by Subject|4|||
148965752|NCT00129129|537359986|FG000|Primary Phase|Adverse Event|2|||
148965753|NCT00129129|537359987|FG001|Primary Phase|Adverse Event|1|||
148965754|NCT00129129|537359988|FG002|Primary Phase|Adverse Event|0|||
148965755|NCT00129129|537359989|FG003|Primary Phase|Adverse Event|0|||
148965756|NCT00129129|537359990|FG004|Primary Phase|Adverse Event|0|||
148965757|NCT00129129|537359986|FG000|Primary Phase|Withdrawal by Subject|12|||
148965758|NCT00129129|537359987|FG001|Primary Phase|Withdrawal by Subject|10|||
148965759|NCT00129129|537359988|FG002|Primary Phase|Withdrawal by Subject|0|||
148965760|NCT00129129|537359989|FG003|Primary Phase|Withdrawal by Subject|0|||
148965761|NCT00129129|537359990|FG004|Primary Phase|Withdrawal by Subject|0|||
148965762|NCT00129129|537359986|FG000|Primary Phase|Migration from study area|1|||
148965763|NCT00129129|537359987|FG001|Primary Phase|Migration from study area|3|||
148965764|NCT00129129|537359988|FG002|Primary Phase|Migration from study area|0|||
148965765|NCT00129129|537359989|FG003|Primary Phase|Migration from study area|0|||
148965766|NCT00129129|537359990|FG004|Primary Phase|Migration from study area|0|||
148965767|NCT00129129|537359986|FG000|Primary Phase|Lost to Follow-up|8|||
148965768|NCT00129129|537359987|FG001|Primary Phase|Lost to Follow-up|6|||
148698544|NCT04206332|536371587|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698545|NCT04206332|536371588|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698546|NCT04206332|536371589|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698547|NCT04206332|536371590|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698548|NCT04206332|536371591|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698549|NCT04206332|536371592|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698550|NCT04206332|536371593|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
148698551|NCT04206332|536371594|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698552|NCT04206332|536371595|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698553|NCT04206332|536371596|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
148698554|NCT04206332|536371597|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698555|NCT04206332|536371598|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698556|NCT04206332|536371599|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698557|NCT04206332|536371600|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698558|NCT04206332|536371601|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698559|NCT04206332|536371602|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698560|NCT04206332|536371586|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698561|NCT04206332|536371587|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698562|NCT04206332|536371588|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698563|NCT04206332|536371589|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698564|NCT04206332|536371590|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698565|NCT04206332|536371591|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698566|NCT04206332|536371592|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698567|NCT04206332|536371593|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698568|NCT04206332|536371594|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698569|NCT04206332|536371595|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698570|NCT04206332|536371596|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698571|NCT04206332|536371597|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698572|NCT04206332|536371598|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698573|NCT04206332|536371599|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698574|NCT04206332|536371600|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698575|NCT04206332|536371601|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
148698576|NCT04206332|536371602|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
148698577|NCT04206332|536371586|FG000|Part C|Withdrawal by Subject|0|||
148698578|NCT04206332|536371587|FG001|Part C|Withdrawal by Subject|0|||
148698579|NCT04206332|536371588|FG002|Part C|Withdrawal by Subject|0|||
148698580|NCT04206332|536371589|FG003|Part C|Withdrawal by Subject|0|||
148698581|NCT04206332|536371590|FG004|Part C|Withdrawal by Subject|0|||
148698582|NCT04206332|536371591|FG005|Part C|Withdrawal by Subject|0|||
148698583|NCT04206332|536371592|FG006|Part C|Withdrawal by Subject|0|||
148698584|NCT04206332|536371593|FG007|Part C|Withdrawal by Subject|0|||
148965769|NCT00129129|537359988|FG002|Primary Phase|Lost to Follow-up|0|||
148965770|NCT00129129|537359989|FG003|Primary Phase|Lost to Follow-up|0|||
148965771|NCT00129129|537359990|FG004|Primary Phase|Lost to Follow-up|0|||
148965772|NCT00129129|537359986|FG000|Primary Phase|Other|2|||
148965773|NCT00129129|537359987|FG001|Primary Phase|Other|5|||
148965774|NCT00129129|537359988|FG002|Primary Phase|Other|0|||
148965775|NCT00129129|537359989|FG003|Primary Phase|Other|0|||
148965776|NCT00129129|537359990|FG004|Primary Phase|Other|0|||
148965777|NCT00129129|537359986|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
148965778|NCT00129129|537359987|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
148965779|NCT00129129|537359988|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
148965780|NCT00129129|537359989|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
148965781|NCT00129129|537359990|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
148965782|NCT00129129|537359986|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
148698585|NCT04206332|536371594|FG008|Part C|Withdrawal by Subject|0|||
148698586|NCT04206332|536371595|FG009|Part C|Withdrawal by Subject|0|||
148698587|NCT04206332|536371596|FG010|Part C|Withdrawal by Subject|0|||
148698588|NCT04206332|536371597|FG011|Part C|Withdrawal by Subject|0|||
148698589|NCT04206332|536371598|FG012|Part C|Withdrawal by Subject|0|||
148698590|NCT04206332|536371599|FG013|Part C|Withdrawal by Subject|0|||
148698591|NCT04206332|536371600|FG014|Part C|Withdrawal by Subject|2|||
148698592|NCT04206332|536371601|FG015|Part C|Withdrawal by Subject|0|||
148698593|NCT04206332|536371602|FG016|Part C|Withdrawal by Subject|0|||
148698594|NCT05612724|536371603|FG000|Overall Study|Lost to Follow-up|4|||
148698595|NCT04000815|536371604|FG000|Overall Study|Lost to Follow-up|9|||
148698596|NCT04000815|536371605|FG001|Overall Study|Lost to Follow-up|2|||
148698597|NCT04000815|536371606|FG002|Overall Study|Lost to Follow-up|3|||
148698598|NCT04000815|536371604|FG000|Overall Study|Withdrawal by Subject|4|||
148698599|NCT04000815|536371605|FG001|Overall Study|Withdrawal by Subject|3|||
148698600|NCT04000815|536371606|FG002|Overall Study|Withdrawal by Subject|2|||
148698601|NCT04000815|536371604|FG000|Overall Study|Right ovarian cyst occured|1|||
148698602|NCT04000815|536371605|FG001|Overall Study|Right ovarian cyst occured|0|||
148698603|NCT04000815|536371606|FG002|Overall Study|Right ovarian cyst occured|0|||
148698604|NCT04000815|536371604|FG000|Overall Study|Hypertension occured on follow up|0|||
148698605|NCT04000815|536371605|FG001|Overall Study|Hypertension occured on follow up|0|||
148698606|NCT04000815|536371606|FG002|Overall Study|Hypertension occured on follow up|2|||
148698607|NCT00239577|536371607|FG000|Primary Phase|Adverse Event|0|||
148698608|NCT00239577|536371608|FG001|Primary Phase|Adverse Event|0|||
148698609|NCT00239577|536371609|FG002|Primary Phase|Adverse Event|1|||
148698610|NCT00239577|536371610|FG003|Primary Phase|Adverse Event|0|||
148698611|NCT00239577|536371607|FG000|Primary Phase|Other|5|||
148698612|NCT00239577|536371608|FG001|Primary Phase|Other|3|||
148698613|NCT00239577|536371609|FG002|Primary Phase|Other|2|||
148698614|NCT00239577|536371610|FG003|Primary Phase|Other|0|||
148698615|NCT02422264|536371611|FG000|Overall Study|Serious Adverse Event|1|||
148698616|NCT02422264|536371612|FG001|Overall Study|Serious Adverse Event|0|||
148698617|NCT02422264|536371611|FG000|Overall Study|Withdrawal by Subject|1|||
148698618|NCT02422264|536371612|FG001|Overall Study|Withdrawal by Subject|2|||
148698619|NCT02422264|536371611|FG000|Overall Study|Migrated/moved from study area|3|||
148698620|NCT02422264|536371612|FG001|Overall Study|Migrated/moved from study area|1|||
148698621|NCT02422264|536371611|FG000|Overall Study|Subject vaccinated outside of the study|0|||
148698622|NCT02422264|536371612|FG001|Overall Study|Subject vaccinated outside of the study|1|||
148698623|NCT03021018|536371615|FG000|Overall Study|Adverse Event|1|||
148698624|NCT03021018|536371616|FG001|Overall Study|Adverse Event|0|||
148698625|NCT03021018|536371617|FG002|Overall Study|Adverse Event|0|||
148698626|NCT03021018|536371615|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
148698627|NCT03021018|536371616|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
148698628|NCT03021018|536371617|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
148698629|NCT00856388|536371618|FG000|Overall Study|Other|1|||
148698630|NCT01617668|536371619|FG000|Overall Study|Adverse Event|7|||
148698631|NCT01617668|536371620|FG001|Overall Study|Adverse Event|0|||
148698632|NCT01617668|536371621|FG002|Overall Study|Adverse Event|12|||
148698633|NCT01617668|536371622|FG003|Overall Study|Adverse Event|5|||
148698634|NCT01617668|536371619|FG000|Overall Study|Physician Decision|1|||
148698635|NCT01617668|536371620|FG001|Overall Study|Physician Decision|2|||
148698636|NCT01617668|536371621|FG002|Overall Study|Physician Decision|3|||
148698637|NCT01617668|536371622|FG003|Overall Study|Physician Decision|0|||
148698638|NCT01617668|536371619|FG000|Overall Study|Progressive Disease|4|||
148698639|NCT01617668|536371620|FG001|Overall Study|Progressive Disease|4|||
148698640|NCT01617668|536371621|FG002|Overall Study|Progressive Disease|6|||
148698641|NCT01617668|536371622|FG003|Overall Study|Progressive Disease|9|||
148698642|NCT01617668|536371619|FG000|Overall Study|Subject/guardian decision|1|||
148698643|NCT01617668|536371620|FG001|Overall Study|Subject/guardian decision|3|||
148698644|NCT01617668|536371621|FG002|Overall Study|Subject/guardian decision|2|||
148698645|NCT01617668|536371622|FG003|Overall Study|Subject/guardian decision|1|||
148698646|NCT00925769|536371623|FG000|Overall Study|Major toxicity|1|||
148698647|NCT00925769|536371624|FG001|Overall Study|Major toxicity|0|||
148965783|NCT00129129|537359987|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
148698648|NCT00925769|536371625|FG002|Overall Study|Major toxicity|1|||
148698649|NCT00925769|536371626|FG003|Overall Study|Major toxicity|1|||
148698650|NCT00925769|536371627|FG004|Overall Study|Major toxicity|0|||
148698651|NCT00925769|536371628|FG005|Overall Study|Major toxicity|0|||
148698652|NCT00925769|536371623|FG000|Overall Study|Disease progression|4|||
148965784|NCT00129129|537359988|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
148965785|NCT00129129|537359989|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
148965786|NCT00129129|537359990|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
148965787|NCT00129129|537359986|FG000|Fourth Dose Phase|Migration from study area|0|||
148965788|NCT00129129|537359987|FG001|Fourth Dose Phase|Migration from study area|0|||
148965789|NCT00129129|537359988|FG002|Fourth Dose Phase|Migration from study area|0|||
148965790|NCT00129129|537359989|FG003|Fourth Dose Phase|Migration from study area|0|||
148965791|NCT00129129|537359990|FG004|Fourth Dose Phase|Migration from study area|2|||
148965792|NCT00129129|537359986|FG000|Fourth Dose Phase|Other|0|||
148965793|NCT00129129|537359987|FG001|Fourth Dose Phase|Other|0|||
148965794|NCT00129129|537359988|FG002|Fourth Dose Phase|Other|0|||
148965795|NCT00129129|537359989|FG003|Fourth Dose Phase|Other|1|||
148965796|NCT00129129|537359990|FG004|Fourth Dose Phase|Other|1|||
148965797|NCT00129129|537359986|FG000|Fourth Dose Phase|Protocol Violation|0|||
148965798|NCT00129129|537359987|FG001|Fourth Dose Phase|Protocol Violation|0|||
148965799|NCT00129129|537359988|FG002|Fourth Dose Phase|Protocol Violation|0|||
148965800|NCT00129129|537359989|FG003|Fourth Dose Phase|Protocol Violation|1|||
148965801|NCT00129129|537359990|FG004|Fourth Dose Phase|Protocol Violation|0|||
148965802|NCT03089606|537359991|FG000|Overall Study|Progression after Cycle 1|1|||
148965803|NCT00335972|537359992|FG000|Overall Study|not given treatments|0|||
148965804|NCT00335972|537359993|FG001|Overall Study|not given treatments|3|||
148965805|NCT02140567|537359996|FG000|Overall Study|Problems with recording equipment|6|||
148965806|NCT02802592|537359998|FG000|Overall Study|Study terminated due to loss of funding|4|||
148965807|NCT02882854|537360001|FG000|Overall Study|Lost to Follow-up|1|||
148965808|NCT02882854|537360002|FG001|Overall Study|Lost to Follow-up|2|||
148965809|NCT02882854|537360001|FG000|Overall Study|Physician Decision|0|||
148965810|NCT02882854|537360002|FG001|Overall Study|Physician Decision|1|||
148965811|NCT01826487|537360005|FG000|Overall Study|Adverse Event|1|||
148965812|NCT01826487|537360006|FG001|Overall Study|Adverse Event|1|||
148965813|NCT01826487|537360005|FG000|Overall Study|Lost to Follow-up|1|||
148965814|NCT01826487|537360006|FG001|Overall Study|Lost to Follow-up|0|||
148965815|NCT01826487|537360005|FG000|Overall Study|Withdrawal by Subject|1|||
148965816|NCT01826487|537360006|FG001|Overall Study|Withdrawal by Subject|3|||
148965817|NCT01826487|537360005|FG000|Overall Study|Protocol Violation|1|||
148965818|NCT01826487|537360006|FG001|Overall Study|Protocol Violation|1|||
148965819|NCT01358357|537360007|FG000|Open Label Phase|Adverse Event|0|||
148965820|NCT01358357|537360008|FG001|Open Label Phase|Adverse Event|0|||
148965821|NCT01358357|537360009|FG002|Open Label Phase|Adverse Event|59|||
148965822|NCT01358357|537360007|FG000|Open Label Phase|Lack of Efficacy|0|||
148965823|NCT01358357|537360008|FG001|Open Label Phase|Lack of Efficacy|0|||
148965824|NCT01358357|537360009|FG002|Open Label Phase|Lack of Efficacy|107|||
148965825|NCT01358357|537360007|FG000|Open Label Phase|Lost to Follow-up|0|||
148965826|NCT01358357|537360008|FG001|Open Label Phase|Lost to Follow-up|0|||
148965827|NCT01358357|537360009|FG002|Open Label Phase|Lost to Follow-up|76|||
148965828|NCT01358357|537360007|FG000|Open Label Phase|Protocol Violation|0|||
148965829|NCT01358357|537360008|FG001|Open Label Phase|Protocol Violation|0|||
148965830|NCT01358357|537360009|FG002|Open Label Phase|Protocol Violation|45|||
148965831|NCT01358357|537360007|FG000|Open Label Phase|Withdrawal by Subject|0|||
148965832|NCT01358357|537360008|FG001|Open Label Phase|Withdrawal by Subject|0|||
148965833|NCT01358357|537360009|FG002|Open Label Phase|Withdrawal by Subject|112|||
148698653|NCT00925769|536371624|FG001|Overall Study|Disease progression|5|||
148698654|NCT00925769|536371625|FG002|Overall Study|Disease progression|3|||
148698655|NCT00925769|536371626|FG003|Overall Study|Disease progression|4|||
148965834|NCT01358357|537360007|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
148965835|NCT01358357|537360008|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
148965836|NCT01358357|537360009|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
148965837|NCT01358357|537360007|FG000|Open Label Phase|Terminated at study completion|0|||
148965838|NCT01358357|537360008|FG001|Open Label Phase|Terminated at study completion|0|||
148965839|NCT01358357|537360009|FG002|Open Label Phase|Terminated at study completion|5|||
148965840|NCT01358357|537360007|FG000|Open Label Phase|Mood episode|0|||
148965841|NCT01358357|537360008|FG001|Open Label Phase|Mood episode|0|||
148965842|NCT01358357|537360009|FG002|Open Label Phase|Mood episode|42|||
148965843|NCT01358357|537360007|FG000|Double-Blind Phase|Adverse Event|8|||
148965844|NCT01358357|537360008|FG001|Double-Blind Phase|Adverse Event|5|||
148965845|NCT01358357|537360009|FG002|Double-Blind Phase|Adverse Event|0|||
148698656|NCT00925769|536371627|FG004|Overall Study|Disease progression|2|||
148698657|NCT00925769|536371628|FG005|Overall Study|Disease progression|3|||
148698658|NCT00925769|536371623|FG000|Overall Study|Death|0|||
148698659|NCT00925769|536371624|FG001|Overall Study|Death|0|||
148698660|NCT00925769|536371625|FG002|Overall Study|Death|1|||
148698661|NCT00925769|536371626|FG003|Overall Study|Death|0|||
148698662|NCT00925769|536371627|FG004|Overall Study|Death|0|||
148698663|NCT00925769|536371628|FG005|Overall Study|Death|0|||
148698664|NCT00925769|536371623|FG000|Overall Study|Physician Decision|1|||
148698665|NCT00925769|536371624|FG001|Overall Study|Physician Decision|0|||
148698666|NCT00925769|536371625|FG002|Overall Study|Physician Decision|0|||
148698667|NCT00925769|536371626|FG003|Overall Study|Physician Decision|0|||
148698668|NCT00925769|536371627|FG004|Overall Study|Physician Decision|0|||
148698669|NCT00925769|536371628|FG005|Overall Study|Physician Decision|0|||
148698670|NCT00925769|536371623|FG000|Overall Study|Missing documentation|0|||
148698671|NCT00925769|536371624|FG001|Overall Study|Missing documentation|1|||
148698672|NCT00925769|536371625|FG002|Overall Study|Missing documentation|0|||
148698673|NCT00925769|536371626|FG003|Overall Study|Missing documentation|0|||
148698674|NCT00925769|536371627|FG004|Overall Study|Missing documentation|0|||
148698675|NCT00925769|536371628|FG005|Overall Study|Missing documentation|0|||
148698676|NCT00925769|536371623|FG000|Overall Study|End of study visit not done|0|||
148698677|NCT00925769|536371624|FG001|Overall Study|End of study visit not done|0|||
148698678|NCT00925769|536371625|FG002|Overall Study|End of study visit not done|1|||
148698679|NCT00925769|536371626|FG003|Overall Study|End of study visit not done|0|||
148698680|NCT00925769|536371627|FG004|Overall Study|End of study visit not done|0|||
148698681|NCT00925769|536371628|FG005|Overall Study|End of study visit not done|0|||
148698682|NCT00925769|536371623|FG000|Overall Study|Participant is unable to swallow drug|0|||
148698683|NCT00925769|536371624|FG001|Overall Study|Participant is unable to swallow drug|0|||
148698684|NCT00925769|536371625|FG002|Overall Study|Participant is unable to swallow drug|0|||
148698685|NCT00925769|536371626|FG003|Overall Study|Participant is unable to swallow drug|1|||
148698686|NCT00925769|536371627|FG004|Overall Study|Participant is unable to swallow drug|0|||
148698687|NCT00925769|536371628|FG005|Overall Study|Participant is unable to swallow drug|0|||
148698688|NCT00925769|536371623|FG000|Overall Study|Adverse Event|0|||
148698689|NCT00925769|536371624|FG001|Overall Study|Adverse Event|0|||
148698690|NCT00925769|536371625|FG002|Overall Study|Adverse Event|0|||
148698691|NCT00925769|536371626|FG003|Overall Study|Adverse Event|0|||
148698692|NCT00925769|536371627|FG004|Overall Study|Adverse Event|1|||
148698693|NCT00925769|536371628|FG005|Overall Study|Adverse Event|0|||
148698694|NCT01038856|536371631|FG000|Overall Study|Adverse Event|2|||
148698695|NCT02300103|536371634|FG000|Overall Study|Lack of Efficacy|3|||
148698696|NCT02300103|536371634|FG000|Overall Study|Protocol Violation|1|||
148698697|NCT02300103|536371634|FG000|Overall Study|Withdrew Consent|2|||
148698698|NCT04091971|536371635|FG000|Overall Study|Withdrawal by Subject|1|||
148698699|NCT04091971|536371635|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
148698700|NCT04091971|536371635|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
148698701|NCT00150462|536371636|FG000|Overall Study|Disease Progression or Relapse|3|||
148698702|NCT00150462|536371637|FG001|Overall Study|Disease Progression or Relapse|1|||
148698703|NCT00150462|536371638|FG002|Overall Study|Disease Progression or Relapse|2|||
148698704|NCT00150462|536371639|FG003|Overall Study|Disease Progression or Relapse|1|||
148698705|NCT00150462|536371640|FG004|Overall Study|Disease Progression or Relapse|2|||
148698706|NCT00150462|536371641|FG005|Overall Study|Disease Progression or Relapse|2|||
148698707|NCT00150462|536371642|FG006|Overall Study|Disease Progression or Relapse|3|||
148698708|NCT00150462|536371643|FG007|Overall Study|Disease Progression or Relapse|5|||
148698709|NCT00150462|536371644|FG008|Overall Study|Disease Progression or Relapse|5|||
148698710|NCT00150462|536371645|FG009|Overall Study|Disease Progression or Relapse|3|||
148965846|NCT01358357|537360007|FG000|Double-Blind Phase|Lost to Follow-up|5|||
148965847|NCT01358357|537360008|FG001|Double-Blind Phase|Lost to Follow-up|7|||
148698711|NCT00150462|536371646|FG010|Overall Study|Disease Progression or Relapse|2|||
148698712|NCT00150462|536371636|FG000|Overall Study|Withdrawal by Subject|0|||
148698713|NCT00150462|536371637|FG001|Overall Study|Withdrawal by Subject|1|||
148698714|NCT00150462|536371638|FG002|Overall Study|Withdrawal by Subject|1|||
148698715|NCT00150462|536371639|FG003|Overall Study|Withdrawal by Subject|0|||
148698716|NCT00150462|536371640|FG004|Overall Study|Withdrawal by Subject|1|||
148698717|NCT00150462|536371641|FG005|Overall Study|Withdrawal by Subject|2|||
148698718|NCT00150462|536371642|FG006|Overall Study|Withdrawal by Subject|0|||
148698719|NCT00150462|536371643|FG007|Overall Study|Withdrawal by Subject|1|||
148698720|NCT00150462|536371644|FG008|Overall Study|Withdrawal by Subject|0|||
148698721|NCT00150462|536371645|FG009|Overall Study|Withdrawal by Subject|1|||
148965848|NCT01358357|537360009|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148965849|NCT01358357|537360007|FG000|Double-Blind Phase|Protocol Violation|1|||
148965850|NCT01358357|537360008|FG001|Double-Blind Phase|Protocol Violation|11|||
148965851|NCT01358357|537360009|FG002|Double-Blind Phase|Protocol Violation|0|||
148965852|NCT01358357|537360007|FG000|Double-Blind Phase|Protocol Violation|16|||
148965853|NCT01358357|537360008|FG001|Double-Blind Phase|Protocol Violation|12|||
148965854|NCT01358357|537360009|FG002|Double-Blind Phase|Protocol Violation|0|||
148965855|NCT01358357|537360007|FG000|Double-Blind Phase|Terminated at study completion|2|||
148965856|NCT01358357|537360008|FG001|Double-Blind Phase|Terminated at study completion|0|||
148965857|NCT01358357|537360009|FG002|Double-Blind Phase|Terminated at study completion|0|||
148965858|NCT01358357|537360007|FG000|Double-Blind Phase|Recurrence of mood event|48|||
148965859|NCT01358357|537360008|FG001|Double-Blind Phase|Recurrence of mood event|64|||
148965860|NCT01358357|537360009|FG002|Double-Blind Phase|Recurrence of mood event|0|||
148965861|NCT01358357|537360007|FG000|Double-Blind Phase|Administrative|0|||
148965862|NCT01358357|537360008|FG001|Double-Blind Phase|Administrative|1|||
148965863|NCT01358357|537360009|FG002|Double-Blind Phase|Administrative|0|||
148965864|NCT02590939|537360010|FG000|Overall Study|Withdrawal by Subject|3|||
148965865|NCT02590939|537360011|FG001|Overall Study|Withdrawal by Subject|1|||
148965866|NCT02590939|537360010|FG000|Overall Study|Failed the nociceptive test|2|||
148965867|NCT02590939|537360011|FG001|Overall Study|Failed the nociceptive test|1|||
148965868|NCT02171260|537360022|FG000|Overall Study|Death|0|||
148965869|NCT02171260|537360023|FG001|Overall Study|Death|0|||
148965870|NCT02171260|537360024|FG002|Overall Study|Death|0|||
148965871|NCT02171260|537360025|FG003|Overall Study|Death|1|||
148965872|NCT02171260|537360022|FG000|Overall Study|Physician Decision|1|||
148965873|NCT02171260|537360023|FG001|Overall Study|Physician Decision|0|||
148965874|NCT02171260|537360024|FG002|Overall Study|Physician Decision|1|||
148965875|NCT02171260|537360025|FG003|Overall Study|Physician Decision|0|||
148965876|NCT02171260|537360022|FG000|Overall Study|Withdrawal by Subject|1|||
148965877|NCT02171260|537360023|FG001|Overall Study|Withdrawal by Subject|0|||
148965878|NCT02171260|537360024|FG002|Overall Study|Withdrawal by Subject|0|||
148965879|NCT02171260|537360025|FG003|Overall Study|Withdrawal by Subject|0|||
148965880|NCT02171260|537360022|FG000|Overall Study|Evidence of progressive disease|4|||
148965881|NCT02171260|537360023|FG001|Overall Study|Evidence of progressive disease|6|||
148965882|NCT02171260|537360024|FG002|Overall Study|Evidence of progressive disease|4|||
148965883|NCT02171260|537360025|FG003|Overall Study|Evidence of progressive disease|4|||
148965884|NCT00323492|537360030|FG000|Study Phase 1|Adverse Event|2|||
148965885|NCT00323492|537360031|FG001|Study Phase 1|Adverse Event|0|||
148965886|NCT00323492|537360032|FG002|Study Phase 1|Adverse Event|0|||
148965887|NCT00323492|537360030|FG000|Study Phase 2|Adverse Event|1|||
148965888|NCT00323492|537360031|FG001|Study Phase 2|Adverse Event|0|||
148965889|NCT00323492|537360032|FG002|Study Phase 2|Adverse Event|0|||
148965890|NCT00323492|537360030|FG000|Study Phase 2|Physician Decision|1|||
148965891|NCT00323492|537360031|FG001|Study Phase 2|Physician Decision|0|||
148965892|NCT00323492|537360032|FG002|Study Phase 2|Physician Decision|0|||
148965893|NCT00323492|537360030|FG000|Study Phase 2|Lost to Follow-up|1|||
148965894|NCT00323492|537360031|FG001|Study Phase 2|Lost to Follow-up|0|||
148965895|NCT00323492|537360032|FG002|Study Phase 2|Lost to Follow-up|0|||
148965896|NCT00323492|537360030|FG000|Study Phase 2|Withdrawal by Subject|0|||
148965897|NCT00323492|537360031|FG001|Study Phase 2|Withdrawal by Subject|1|||
148965898|NCT00323492|537360032|FG002|Study Phase 2|Withdrawal by Subject|0|||
148965899|NCT00323492|537360030|FG000|Study Phase 2|Noncompliance with study schedule|0|||
148965900|NCT00323492|537360031|FG001|Study Phase 2|Noncompliance with study schedule|0|||
148965901|NCT00323492|537360032|FG002|Study Phase 2|Noncompliance with study schedule|1|||
148965902|NCT00323492|537360030|FG000|Study Phase 2|Protocol Violation|1|||
148965903|NCT00323492|537360031|FG001|Study Phase 2|Protocol Violation|0|||
148965904|NCT00323492|537360032|FG002|Study Phase 2|Protocol Violation|0|||
148965905|NCT02486042|537360033|FG000|Overall Study|Physician Decision|1|||
148965906|NCT02486042|537360034|FG001|Overall Study|Physician Decision|7|||
148965907|NCT02486042|537360033|FG000|Overall Study|Hospital transfer|2|||
148965908|NCT02486042|537360034|FG001|Overall Study|Hospital transfer|2|||
148965909|NCT02486042|537360033|FG000|Overall Study|Withdrawal by Subject|0|||
148965910|NCT02486042|537360034|FG001|Overall Study|Withdrawal by Subject|2|||
148965911|NCT03320564|537360037|FG000|Overall Study|Protocol Violation|1|||
148965912|NCT00352846|537360038|FG000|Overall Study|Disease progression|0|||
148965913|NCT00352846|537360039|FG001|Overall Study|Disease progression|2|||
148965914|NCT00352846|537360038|FG000|Overall Study|Withdrawal by Subject|3|||
148965915|NCT00352846|537360039|FG001|Overall Study|Withdrawal by Subject|8|||
148965916|NCT00352846|537360038|FG000|Overall Study|Ineligible|3|||
148965917|NCT00352846|537360039|FG001|Overall Study|Ineligible|2|||
148965918|NCT00352846|537360038|FG000|Overall Study|Non-compliance|2|||
148965919|NCT00352846|537360039|FG001|Overall Study|Non-compliance|0|||
148965920|NCT00352846|537360038|FG000|Overall Study|Death|0|||
148965921|NCT00352846|537360039|FG001|Overall Study|Death|1|||
148965922|NCT00788827|537360040|FG000|Overall Study|Lack of Efficacy|2|||
148814754|NCT01033942|536797990|FG001|Overall Study|Withdrawal by Subject|1|||
148965923|NCT01527682|537360041|FG000|Overall Study|Protocol Violation|8|||
148965924|NCT04668950|537360048|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
148965925|NCT04668950|537360049|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
148965926|NCT04668950|537360048|FG000|Overall Study|Could not confirm started study medication|15|||
148965927|NCT04668950|537360049|FG001|Overall Study|Could not confirm started study medication|15|||
148965928|NCT04668950|537360048|FG000|Overall Study|Could not confirm baseline status|6|||
148965929|NCT04668950|537360049|FG001|Overall Study|Could not confirm baseline status|2|||
148965930|NCT04668950|537360048|FG000|Overall Study|Drop out and did not start medication|15|||
148965931|NCT04668950|537360049|FG001|Overall Study|Drop out and did not start medication|17|||
148965932|NCT04668950|537360048|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
148965933|NCT04668950|537360049|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
148965934|NCT04668950|537360048|FG000|Overall Study|Other|2|||
148965935|NCT04668950|537360049|FG001|Overall Study|Other|4|||
148965936|NCT03979638|537360050|FG000|Period 1|Physician Decision|1|||
148965937|NCT03979638|537360051|FG001|Period 1|Physician Decision|1|||
148965938|NCT03979638|537360050|FG000|Period 1|Withdrawal by Subject|4|||
148965939|NCT03979638|537360051|FG001|Period 1|Withdrawal by Subject|3|||
148965940|NCT03979638|537360050|FG000|Period 1|Study terminated by Sponsor|1|||
148965941|NCT03979638|537360051|FG001|Period 1|Study terminated by Sponsor|3|||
148965942|NCT03979638|537360050|FG000|Period 1|Protocol Violation|1|||
148965943|NCT03979638|537360051|FG001|Period 1|Protocol Violation|0|||
148965944|NCT03979638|537360050|FG000|Period 2|Study terminated by Sponsor|1|||
148965945|NCT03979638|537360051|FG001|Period 2|Study terminated by Sponsor|1|||
148965946|NCT00600938|537360056|FG000|Core Study|Abnormal test procedure result(s)|3|||
148965947|NCT00600938|537360057|FG001|Core Study|Abnormal test procedure result(s)|2|||
148965948|NCT00600938|537360058|FG002|Core Study|Abnormal test procedure result(s)|0|||
148814755|NCT01033942|536797991|FG002|Overall Study|Withdrawal by Subject|1|||
148814756|NCT01033942|536797989|FG000|Overall Study|Lost to Follow-up|1|||
148814757|NCT01033942|536797990|FG001|Overall Study|Lost to Follow-up|0|||
148814758|NCT01033942|536797991|FG002|Overall Study|Lost to Follow-up|0|||
148965949|NCT00600938|537360059|FG003|Core Study|Abnormal test procedure result(s)|0|||
148965950|NCT00600938|537360056|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
148965951|NCT00600938|537360057|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
148965952|NCT00600938|537360058|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
148965953|NCT00600938|537360059|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
148965954|NCT00600938|537360056|FG000|Core Study|Patient withdrew consent|7|||
148965955|NCT00600938|537360057|FG001|Core Study|Patient withdrew consent|12|||
148965956|NCT00600938|537360058|FG002|Core Study|Patient withdrew consent|0|||
148965957|NCT00600938|537360059|FG003|Core Study|Patient withdrew consent|0|||
148965958|NCT00600938|537360056|FG000|Core Study|Lost to Follow-up|3|||
148965959|NCT00600938|537360057|FG001|Core Study|Lost to Follow-up|2|||
148965960|NCT00600938|537360058|FG002|Core Study|Lost to Follow-up|0|||
148965961|NCT00600938|537360059|FG003|Core Study|Lost to Follow-up|0|||
148965962|NCT00600938|537360056|FG000|Core Study|Death|1|||
148965963|NCT00600938|537360057|FG001|Core Study|Death|1|||
148965964|NCT00600938|537360058|FG002|Core Study|Death|0|||
148965965|NCT00600938|537360059|FG003|Core Study|Death|0|||
148965966|NCT00600938|537360056|FG000|Core Study|Protocol Violation|1|||
148965967|NCT00600938|537360057|FG001|Core Study|Protocol Violation|2|||
148965968|NCT00600938|537360058|FG002|Core Study|Protocol Violation|0|||
148965969|NCT00600938|537360059|FG003|Core Study|Protocol Violation|0|||
148965970|NCT00600938|537360056|FG000|Extension Study|Adverse Event|1|||
148965971|NCT00600938|537360057|FG001|Extension Study|Adverse Event|0|||
148965972|NCT00600938|537360058|FG002|Extension Study|Adverse Event|2|||
148965973|NCT00600938|537360059|FG003|Extension Study|Adverse Event|0|||
148965974|NCT00600938|537360056|FG000|Extension Study|Abnormal test procedure results|0|||
148965975|NCT00600938|537360057|FG001|Extension Study|Abnormal test procedure results|1|||
148965976|NCT00600938|537360058|FG002|Extension Study|Abnormal test procedure results|1|||
148965977|NCT00600938|537360059|FG003|Extension Study|Abnormal test procedure results|1|||
148965978|NCT00600938|537360056|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
148814759|NCT01033942|536797989|FG000|Overall Study|Enrolled in Extension Study|0|||
148814760|NCT01033942|536797990|FG001|Overall Study|Enrolled in Extension Study|3|||
148965979|NCT00600938|537360057|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
148965980|NCT00600938|537360058|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
148965981|NCT00600938|537360059|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
148965982|NCT00600938|537360056|FG000|Extension Study|Withdrawal by Subject|2|||
148965983|NCT00600938|537360057|FG001|Extension Study|Withdrawal by Subject|2|||
148965984|NCT00600938|537360058|FG002|Extension Study|Withdrawal by Subject|3|||
148965985|NCT00600938|537360059|FG003|Extension Study|Withdrawal by Subject|0|||
148965986|NCT00600938|537360056|FG000|Extension Study|Lost to Follow-up|1|||
148965987|NCT00600938|537360057|FG001|Extension Study|Lost to Follow-up|1|||
148965988|NCT00600938|537360058|FG002|Extension Study|Lost to Follow-up|2|||
148965989|NCT00600938|537360059|FG003|Extension Study|Lost to Follow-up|0|||
148965990|NCT00600938|537360056|FG000|Extension Study|Death|1|||
148965991|NCT00600938|537360057|FG001|Extension Study|Death|0|||
148965992|NCT00600938|537360058|FG002|Extension Study|Death|0|||
148965993|NCT00600938|537360059|FG003|Extension Study|Death|0|||
148965994|NCT04220411|537360060|FG000|Overall Study|Adverse Event|0|||
148965995|NCT04220411|537360061|FG001|Overall Study|Adverse Event|0|||
148965996|NCT04220411|537360062|FG002|Overall Study|Adverse Event|0|||
149025016|NCT03738241|537567986|FG007|Overall Study|Withdrawal by Subject|0|||
149025017|NCT03738241|537567987|FG008|Overall Study|Withdrawal by Subject|0|||
149025018|NCT03738241|537567988|FG009|Overall Study|Withdrawal by Subject|1|||
149025019|NCT03738241|537567979|FG000|Overall Study|Physician Decision|0|||
148965997|NCT04220411|537360063|FG003|Overall Study|Adverse Event|1|||
148965998|NCT02680639|537360064|FG000|Screening Period|Screen Failure|7|||
148965999|NCT02680639|537360065|FG001|Screening Period|Screen Failure|0|||
148966000|NCT02680639|537360066|FG002|Screening Period|Screen Failure|0|||
148966001|NCT04837131|537360068|FG000|Overall Study|Death|1|||
148966002|NCT04837131|537360068|FG000|Overall Study|Withdrawal by Subject|1|||
148966003|NCT04837131|537360068|FG000|Overall Study|Adverse Event|1|||
148966004|NCT04837131|537360068|FG000|Overall Study|Protocol Violation|1|||
148966005|NCT02496533|537360069|FG000|Overall Study|Lack of data on outcome|3|||
148966006|NCT02496533|537360070|FG001|Overall Study|Lack of data on outcome|0|||
148966007|NCT02496533|537360069|FG000|Overall Study|Patient did not complete all measures|0|||
148966008|NCT02496533|537360070|FG001|Overall Study|Patient did not complete all measures|4|||
148966009|NCT02496533|537360069|FG000|Overall Study|Late for radiologic testing|0|||
148966010|NCT02496533|537360070|FG001|Overall Study|Late for radiologic testing|2|||
148966011|NCT00502697|537361557|FG000|Overall Study|Withdrawal by Subject|3|||
148966012|NCT00502697|537361558|FG001|Overall Study|Withdrawal by Subject|1|||
148966013|NCT00502697|537361557|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
148966014|NCT00502697|537361558|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
148966015|NCT00502697|537361557|FG000|Overall Study|found not to meet eligibility criteria|3|||
148966016|NCT00502697|537361558|FG001|Overall Study|found not to meet eligibility criteria|4|||
148966017|NCT00502697|537361557|FG000|Overall Study|did not meet assignment criteria|4|||
148966018|NCT00502697|537361558|FG001|Overall Study|did not meet assignment criteria|2|||
148966019|NCT00589108|537361560|FG000|Overall Study|Lost to Follow-up|1|||
148966020|NCT00589108|537361561|FG001|Overall Study|Lost to Follow-up|1|||
148966021|NCT00589108|537361562|FG002|Overall Study|Lost to Follow-up|1|||
148966022|NCT00589108|537361560|FG000|Overall Study|Death|3|||
148966023|NCT00589108|537361561|FG001|Overall Study|Death|3|||
148966024|NCT00589108|537361562|FG002|Overall Study|Death|4|||
148966025|NCT03256552|537361563|FG000|Overall Study|Protocol Violation|1|||
148966026|NCT03256552|537361563|FG000|Overall Study|Physician Decision|1|||
148966027|NCT03256552|537361563|FG000|Overall Study|Adverse Event|1|||
148966028|NCT03256552|537361563|FG000|Overall Study|Withdrawal by Subject|2|||
148966029|NCT02268409|537361570|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
148966030|NCT02268409|537361570|FG000|Overall Study|Death|1|||
148966031|NCT02268409|537361570|FG000|Overall Study|Lost to Follow-up|1|||
148966032|NCT02268409|537361570|FG000|Overall Study|Protocol Violation|3|||
148966033|NCT02268409|537361570|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
148966034|NCT02268409|537361570|FG000|Overall Study|Withdrawal by Subject|5|||
148966035|NCT00489853|537361573|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
148966036|NCT00489853|537361574|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
148966037|NCT00489853|537361575|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
148966038|NCT00489853|537361573|FG000|Wash-out Period 1|Adverse Event|0|||
148966039|NCT00489853|537361574|FG001|Wash-out Period 1|Adverse Event|1|||
148966040|NCT00489853|537361575|FG002|Wash-out Period 1|Adverse Event|1|||
148966041|NCT00489853|537361573|FG000|Wash-out Period 1|Protocol Violation|0|||
148966042|NCT00489853|537361574|FG001|Wash-out Period 1|Protocol Violation|1|||
148966043|NCT00489853|537361575|FG002|Wash-out Period 1|Protocol Violation|1|||
148966044|NCT00489853|537361573|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
148966045|NCT00489853|537361574|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
148966046|NCT00489853|537361575|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
148966047|NCT00489853|537361573|FG000|Wash-out Period 2|Adverse Event|1|||
148966048|NCT00489853|537361574|FG001|Wash-out Period 2|Adverse Event|1|||
148966049|NCT00489853|537361575|FG002|Wash-out Period 2|Adverse Event|0|||
148966050|NCT00489853|537361573|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
148966051|NCT00489853|537361574|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
148698722|NCT00150462|536371646|FG010|Overall Study|Withdrawal by Subject|0|||
148814761|NCT01033942|536797991|FG002|Overall Study|Enrolled in Extension Study|0|||
148814762|NCT02513199|536797992|FG000|Treatment|Death|1|||
148814763|NCT02513199|536797992|FG000|Treatment|Lost to Follow-up|1|||
148966052|NCT00489853|537361575|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
148966053|NCT00489853|537361573|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
148966054|NCT00489853|537361574|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
148966055|NCT00489853|537361575|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
148966056|NCT05083442|537361576|FG000|Overall Study|Lost to Follow-up|1|||
148966057|NCT05083442|537361577|FG001|Overall Study|Lost to Follow-up|0|||
148966058|NCT05083442|537361576|FG000|Overall Study|Lack of Efficacy|0|||
148814764|NCT02513199|536797992|FG000|Follow-Up|Death|11|||
148814765|NCT00313170|536797997|FG000|Overall Study|Death|2|||
148814766|NCT00313170|536797998|FG001|Overall Study|Death|4|||
148814767|NCT00313170|536797999|FG002|Overall Study|Death|2|||
148814768|NCT00313170|536797997|FG000|Overall Study|Adverse Event|1|||
148814769|NCT00313170|536797998|FG001|Overall Study|Adverse Event|2|||
148814770|NCT00313170|536797999|FG002|Overall Study|Adverse Event|0|||
148814771|NCT00313170|536797997|FG000|Overall Study|Disease progression|31|||
148814772|NCT00313170|536797998|FG001|Overall Study|Disease progression|26|||
148814773|NCT00313170|536797999|FG002|Overall Study|Disease progression|27|||
148966059|NCT05083442|537361577|FG001|Overall Study|Lack of Efficacy|1|||
148814774|NCT00313170|536797997|FG000|Overall Study|Withdrawal by Subject|1|||
148814775|NCT00313170|536797998|FG001|Overall Study|Withdrawal by Subject|0|||
148814776|NCT00313170|536797999|FG002|Overall Study|Withdrawal by Subject|1|||
148814777|NCT00313170|536797997|FG000|Overall Study|Incorrect enrollment|0|||
148814778|NCT00313170|536797998|FG001|Overall Study|Incorrect enrollment|2|||
148814779|NCT00313170|536797999|FG002|Overall Study|Incorrect enrollment|1|||
148814780|NCT00313170|536797997|FG000|Overall Study|Lost to Follow-up|0|||
148814781|NCT00313170|536797998|FG001|Overall Study|Lost to Follow-up|0|||
148814782|NCT00313170|536797999|FG002|Overall Study|Lost to Follow-up|1|||
148814783|NCT00313170|536797997|FG000|Overall Study|Progression (investigators opinion)|1|||
148814784|NCT00313170|536797998|FG001|Overall Study|Progression (investigators opinion)|0|||
148814785|NCT00313170|536797999|FG002|Overall Study|Progression (investigators opinion)|0|||
148814786|NCT00529035|536798000|FG000|Overall Study|Withdrawal by Subject|1|||
148814787|NCT01879852|536798001|FG000|Overall Study|Withdrawal by Subject|2|||
148814788|NCT01879852|536798002|FG001|Overall Study|Withdrawal by Subject|0|||
148814789|NCT02115386|536798003|FG000|Overall Study|Protocol Violation|1|||
148814790|NCT02115386|536798003|FG000|Overall Study|Administrative - trial was terminated|6|||
148698723|NCT00150462|536371636|FG000|Overall Study|Death|0|||
148966060|NCT05083442|537361576|FG000|Overall Study|Withdrawal by Subject|1|||
148966061|NCT05083442|537361577|FG001|Overall Study|Withdrawal by Subject|3|||
148966062|NCT05083442|537361576|FG000|Overall Study|scheduling difficulties|1|||
148966063|NCT05083442|537361577|FG001|Overall Study|scheduling difficulties|2|||
148966064|NCT04865354|537361583|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
148966065|NCT04865354|537361584|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
148966066|NCT04865354|537361583|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
148966067|NCT04865354|537361584|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
148966068|NCT04865354|537361583|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
148966069|NCT04865354|537361584|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
148966070|NCT03873987|537361590|FG000|Overall Study|Adverse Event|1|||
148966071|NCT03873987|537361591|FG001|Overall Study|Adverse Event|0|||
148966072|NCT03873987|537361590|FG000|Overall Study|staff was unable to start a new IV line|1|||
148966073|NCT03873987|537361591|FG001|Overall Study|staff was unable to start a new IV line|0|||
148966074|NCT03873987|537361590|FG000|Overall Study|Lost to Follow-up|0|||
148966075|NCT03873987|537361591|FG001|Overall Study|Lost to Follow-up|1|||
148966076|NCT01465022|537361592|FG000|Overall Study|Lost to Follow-up|15|||
148966077|NCT01465022|537361593|FG001|Overall Study|Lost to Follow-up|14|||
148966078|NCT01465022|537361594|FG002|Overall Study|Lost to Follow-up|0|||
148966079|NCT01465022|537361592|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
148966080|NCT01465022|537361593|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
148966081|NCT01465022|537361594|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
148966082|NCT01465022|537361592|FG000|Overall Study|Not Randomized|0|||
148966083|NCT01465022|537361593|FG001|Overall Study|Not Randomized|0|||
148966084|NCT01465022|537361594|FG002|Overall Study|Not Randomized|70|||
148966085|NCT00004888|537361595|FG000|Overall Study|Adverse Event|5|||
148966086|NCT00004888|537361596|FG001|Overall Study|Adverse Event|10|||
148966087|NCT00004888|537361595|FG000|Overall Study|Withdrawal by Subject|0|||
148966088|NCT00004888|537361596|FG001|Overall Study|Withdrawal by Subject|3|||
148966089|NCT00004888|537361595|FG000|Overall Study|Physician Decision|1|||
148966090|NCT00004888|537361596|FG001|Overall Study|Physician Decision|1|||
148966091|NCT00004888|537361595|FG000|Overall Study|Progressive Disease|4|||
148966092|NCT00004888|537361596|FG001|Overall Study|Progressive Disease|9|||
148966093|NCT00004888|537361595|FG000|Overall Study|Death without progressive disease|0|||
148966094|NCT00004888|537361596|FG001|Overall Study|Death without progressive disease|1|||
148966095|NCT00004888|537361595|FG000|Overall Study|Toxic death|1|||
148966096|NCT00004888|537361596|FG001|Overall Study|Toxic death|0|||
148966097|NCT00136084|537361597|FG000|Overall Study|Death|12|||
148966098|NCT00136084|537361598|FG001|Overall Study|Death|5|||
148966099|NCT00136084|537361597|FG000|Overall Study|Unacceptable toxicity|8|||
148966100|NCT00136084|537361598|FG001|Overall Study|Unacceptable toxicity|11|||
148966101|NCT00136084|537361597|FG000|Overall Study|Relapse|20|||
148966102|NCT00136084|537361598|FG001|Overall Study|Relapse|23|||
148966103|NCT00136084|537361597|FG000|Overall Study|Lost to Follow-up|2|||
148966104|NCT00136084|537361598|FG001|Overall Study|Lost to Follow-up|0|||
148966105|NCT00136084|537361597|FG000|Overall Study|No Response|1|||
148966106|NCT00136084|537361598|FG001|Overall Study|No Response|2|||
148966107|NCT00136084|537361597|FG000|Overall Study|Withdrawal by Subject|5|||
148966108|NCT00136084|537361598|FG001|Overall Study|Withdrawal by Subject|1|||
148698724|NCT00150462|536371637|FG001|Overall Study|Death|1|||
148698725|NCT00150462|536371638|FG002|Overall Study|Death|0|||
148698726|NCT00150462|536371639|FG003|Overall Study|Death|0|||
148698727|NCT00150462|536371640|FG004|Overall Study|Death|0|||
148698728|NCT00150462|536371641|FG005|Overall Study|Death|0|||
148698729|NCT00150462|536371642|FG006|Overall Study|Death|0|||
148698730|NCT00150462|536371643|FG007|Overall Study|Death|0|||
148698731|NCT00150462|536371644|FG008|Overall Study|Death|1|||
148966109|NCT02579265|537361599|FG000|Overall Study|Weaned off earlier than 28 days|44|||
148966110|NCT02579265|537361600|FG001|Overall Study|Weaned off earlier than 28 days|43|||
148966111|NCT02579265|537361599|FG000|Overall Study|Adverse Event|2|||
148966112|NCT02579265|537361600|FG001|Overall Study|Adverse Event|0|||
148966113|NCT02579265|537361599|FG000|Overall Study|Any other reason not specified|0|||
148966114|NCT02579265|537361600|FG001|Overall Study|Any other reason not specified|2|||
148966115|NCT02579265|537361599|FG000|Overall Study|Withdrawal by Subject|2|||
148966116|NCT02579265|537361600|FG001|Overall Study|Withdrawal by Subject|0|||
148966117|NCT02579265|537361599|FG000|Overall Study|Physician Decision|1|||
148698732|NCT00150462|536371645|FG009|Overall Study|Death|0|||
148814791|NCT02453048|536798004|FG000|Overall Study|Only part of initial 6 mo. study|0|||
148814792|NCT02453048|536798005|FG001|Overall Study|Only part of initial 6 mo. study|0|||
148814793|NCT02453048|536798006|FG002|Overall Study|Only part of initial 6 mo. study|0|||
148814794|NCT02453048|536798007|FG003|Overall Study|Only part of initial 6 mo. study|0|||
148814795|NCT02453048|536798008|FG004|Overall Study|Only part of initial 6 mo. study|6|||
148814796|NCT02453048|536798004|FG000|Overall Study|Lost to Follow-up|0|||
148814797|NCT02453048|536798005|FG001|Overall Study|Lost to Follow-up|1|||
148966118|NCT02579265|537361600|FG001|Overall Study|Physician Decision|0|||
148966119|NCT02579265|537361599|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
148966120|NCT02579265|537361600|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
148966121|NCT02174848|537361601|FG000|Overall Study|Adverse Event|2|||
148966122|NCT02174848|537361602|FG001|Overall Study|Adverse Event|1|||
148966123|NCT02174848|537361601|FG000|Overall Study|Withdrawal by Subject|3|||
148966124|NCT02174848|537361602|FG001|Overall Study|Withdrawal by Subject|3|||
148966125|NCT02174848|537361601|FG000|Overall Study|Lost to Follow-up|0|||
148966126|NCT02174848|537361602|FG001|Overall Study|Lost to Follow-up|1|||
148966127|NCT02174848|537361601|FG000|Overall Study|Worsening of disease|1|||
148966128|NCT02174848|537361602|FG001|Overall Study|Worsening of disease|1|||
148966129|NCT02174848|537361601|FG000|Overall Study|Unable to comply with study requirements|1|||
148966130|NCT02174848|537361602|FG001|Overall Study|Unable to comply with study requirements|0|||
148966131|NCT02520011|537361606|FG000|Overall Study|Adverse Event|0|||
148966132|NCT02520011|537361607|FG001|Overall Study|Adverse Event|1|||
148966133|NCT02520011|537361608|FG002|Overall Study|Adverse Event|2|||
148966134|NCT02520011|537361606|FG000|Overall Study|Death|0|||
148966135|NCT02520011|537361607|FG001|Overall Study|Death|8|||
148966136|NCT02520011|537361608|FG002|Overall Study|Death|1|||
148814798|NCT02453048|536798006|FG002|Overall Study|Lost to Follow-up|2|||
148814799|NCT02453048|536798007|FG003|Overall Study|Lost to Follow-up|0|||
148814800|NCT02453048|536798008|FG004|Overall Study|Lost to Follow-up|0|||
148814801|NCT00549328|536798010|FG000|Overall Study|Adverse Event|2|||
148814802|NCT00549328|536798010|FG000|Overall Study|Disease Progression|10|||
148814803|NCT00549328|536798010|FG000|Overall Study|Death|1|||
149025020|NCT03738241|537567980|FG001|Overall Study|Physician Decision|0|||
149025021|NCT03738241|537567981|FG002|Overall Study|Physician Decision|0|||
149025022|NCT03738241|537567982|FG003|Overall Study|Physician Decision|0|||
149025023|NCT03738241|537567983|FG004|Overall Study|Physician Decision|0|||
149025024|NCT03738241|537567984|FG005|Overall Study|Physician Decision|0|||
148966137|NCT02520011|537361606|FG000|Overall Study|Lack of Efficacy|4|||
148966138|NCT02520011|537361607|FG001|Overall Study|Lack of Efficacy|26|||
148966139|NCT02520011|537361608|FG002|Overall Study|Lack of Efficacy|4|||
148966140|NCT02520011|537361606|FG000|Overall Study|Physician Decision|0|||
148966141|NCT02520011|537361607|FG001|Overall Study|Physician Decision|2|||
148966142|NCT02520011|537361608|FG002|Overall Study|Physician Decision|0|||
148966143|NCT02520011|537361606|FG000|Overall Study|Withdrawal by Subject|1|||
148966144|NCT02520011|537361607|FG001|Overall Study|Withdrawal by Subject|3|||
148966145|NCT02520011|537361608|FG002|Overall Study|Withdrawal by Subject|0|||
148966146|NCT02520011|537361606|FG000|Overall Study|Protocol Deviation|0|||
148814804|NCT00549328|536798010|FG000|Overall Study|Use of Prohibited Medication|1|||
148966147|NCT02520011|537361607|FG001|Overall Study|Protocol Deviation|1|||
148966148|NCT02520011|537361608|FG002|Overall Study|Protocol Deviation|0|||
148698733|NCT00150462|536371646|FG010|Overall Study|Death|0|||
148698734|NCT00150462|536371636|FG000|Overall Study|Adverse Event|0|||
148966149|NCT02520011|537361606|FG000|Overall Study|Patient went to hospice|0|||
148966150|NCT02520011|537361607|FG001|Overall Study|Patient went to hospice|1|||
148966151|NCT02520011|537361608|FG002|Overall Study|Patient went to hospice|0|||
148966152|NCT02520011|537361606|FG000|Overall Study|Progressive disease following response|0|||
148966153|NCT02520011|537361607|FG001|Overall Study|Progressive disease following response|4|||
148966154|NCT02520011|537361608|FG002|Overall Study|Progressive disease following response|2|||
148966155|NCT00644969|537361609|FG000|Treatment Phase|Randomized, not treated|1|||
148966156|NCT00644969|537361610|FG001|Treatment Phase|Randomized, not treated|0|||
148966157|NCT00644969|537361609|FG000|Treatment Phase|Adverse Event|3|||
148966158|NCT00644969|537361610|FG001|Treatment Phase|Adverse Event|0|||
148966159|NCT00644969|537361609|FG000|Treatment Phase|Withdrawal by Subject|4|||
148966160|NCT00644969|537361610|FG001|Treatment Phase|Withdrawal by Subject|0|||
148966161|NCT00644969|537361609|FG000|Treatment Phase|Lost to Follow-up|2|||
148966162|NCT00644969|537361610|FG001|Treatment Phase|Lost to Follow-up|2|||
148966163|NCT00644969|537361609|FG000|Treatment Phase|Other|4|||
148966164|NCT00644969|537361610|FG001|Treatment Phase|Other|1|||
148966165|NCT00644969|537361609|FG000|Post Treatment Phase|Death|1|||
148966166|NCT00644969|537361610|FG001|Post Treatment Phase|Death|0|||
148966167|NCT00644969|537361609|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
148966168|NCT00644969|537361610|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
148966169|NCT00644969|537361609|FG000|Post Treatment Phase|Lost to Follow-up|4|||
148966170|NCT00644969|537361610|FG001|Post Treatment Phase|Lost to Follow-up|1|||
148966171|NCT00644969|537361609|FG000|Post Treatment Phase|Other|1|||
148966172|NCT00644969|537361610|FG001|Post Treatment Phase|Other|0|||
148966173|NCT02449239|537361611|FG000|Induction Phase|Lack of Efficacy|64|||
148966174|NCT02449239|537361611|FG000|Induction Phase|Adverse Event|1|||
148966175|NCT02449239|537361611|FG000|Induction Phase|Lost to Follow-up|1|||
148966176|NCT02449239|537361611|FG000|Induction Phase|Protocol Violation|1|||
148966177|NCT02449239|537361611|FG000|Induction Phase|Physician Decision|1|||
148966178|NCT02449239|537361611|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
148966179|NCT02449239|537361611|FG000|Induction Phase|Withdrawal by Subject|1|||
148966180|NCT02449239|537361611|FG000|Maintenance Month 3|Lack of Efficacy|14|||
148966181|NCT02449239|537361611|FG000|Maintenance Month 6|Lack of Efficacy|10|||
148966182|NCT02449239|537361611|FG000|Maintenance Month 6|Adverse Event|2|||
148966183|NCT02449239|537361611|FG000|Maintenance Month 6|Physician Decision|1|||
148966184|NCT02449239|537361611|FG000|Maintenance Month 9|Lack of Efficacy|2|||
148966185|NCT02449239|537361611|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
148966186|NCT02449239|537361611|FG000|Maintenance Month 12|Lack of Efficacy|5|||
148966187|NCT02449239|537361611|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
148966188|NCT02449239|537361611|FG000|Maintenance Month 12|Subject moved from area|1|||
148966189|NCT02449239|537361611|FG000|Maintenance Month 15|Lack of Efficacy|1|||
148966190|NCT02449239|537361611|FG000|Maintenance Month 21|Lack of Efficacy|1|||
148966191|NCT02449239|537361611|FG000|Maintenance Month 21|Sponsor decision|1|||
148966192|NCT02586493|537361616|FG000|Overall Study|Adverse Event|4|||
148966193|NCT02586493|537361616|FG000|Overall Study|Protocol Violation|6|||
148966194|NCT02586493|537361616|FG000|Overall Study|Lost to Follow-up|1|||
148966195|NCT02586493|537361616|FG000|Overall Study|Withdrawal by Subject|1|||
148966196|NCT01589445|537361624|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
148966197|NCT01589445|537361624|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
148966198|NCT01589445|537361624|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
148966199|NCT01589445|537361624|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
148966200|NCT01589445|537361624|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
148966201|NCT01589445|537361624|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
148966202|NCT01589445|537361624|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
148966203|NCT01589445|537361624|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
148966204|NCT01589445|537361624|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
148966205|NCT01589445|537361624|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
148966206|NCT01478321|537361627|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
148966207|NCT01478321|537361627|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
148966208|NCT01478321|537361627|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
148814805|NCT00770484|536798011|FG000|Overall Study|Withdrawal by Subject|1|||
148966209|NCT01478321|537361627|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
148814806|NCT00770484|536798012|FG001|Overall Study|Withdrawal by Subject|0|||
148966210|NCT01478321|537361627|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
148698735|NCT00150462|536371637|FG001|Overall Study|Adverse Event|0|||
148966211|NCT01478321|537361627|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
148966212|NCT01478321|537361627|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
148966213|NCT01478321|537361627|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
148966214|NCT03343483|537361639|FG000|Overall Study|Death|0|||
148966215|NCT03343483|537361640|FG001|Overall Study|Death|3|||
148966216|NCT03343483|537361639|FG000|Overall Study|Lost to Follow-up|9|||
148966217|NCT03343483|537361640|FG001|Overall Study|Lost to Follow-up|13|||
148966218|NCT03343483|537361639|FG000|Overall Study|Withdrawal by Subject|8|||
148966219|NCT03343483|537361640|FG001|Overall Study|Withdrawal by Subject|17|||
148966220|NCT01505608|537361641|FG000|Phase I|Lack of Efficacy|0|||
148888862|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888863|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
148888864|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
148888865|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
148888866|NCT02159066|537072253|FG000|Part I|Adverse Event|7|||
148888867|NCT02159066|537072254|FG001|Part I|Adverse Event|5|||
148888868|NCT02159066|537072255|FG002|Part I|Adverse Event|0|||
148888869|NCT02159066|537072256|FG003|Part I|Adverse Event|0|||
148888870|NCT02159066|537072257|FG004|Part I|Adverse Event|0|||
148888871|NCT02159066|537072258|FG005|Part I|Adverse Event|0|||
148888872|NCT02159066|537072253|FG000|Part I|Death|11|||
148888873|NCT02159066|537072254|FG001|Part I|Death|9|||
148888874|NCT02159066|537072255|FG002|Part I|Death|0|||
148888875|NCT02159066|537072256|FG003|Part I|Death|0|||
148888876|NCT02159066|537072257|FG004|Part I|Death|0|||
148698736|NCT00150462|536371638|FG002|Overall Study|Adverse Event|0|||
148698737|NCT00150462|536371639|FG003|Overall Study|Adverse Event|1|||
148698738|NCT00150462|536371640|FG004|Overall Study|Adverse Event|0|||
148698739|NCT00150462|536371641|FG005|Overall Study|Adverse Event|0|||
148698740|NCT00150462|536371642|FG006|Overall Study|Adverse Event|0|||
148698741|NCT00150462|536371643|FG007|Overall Study|Adverse Event|2|||
148698742|NCT00150462|536371644|FG008|Overall Study|Adverse Event|0|||
148698743|NCT00150462|536371645|FG009|Overall Study|Adverse Event|1|||
148698744|NCT00150462|536371646|FG010|Overall Study|Adverse Event|0|||
148698745|NCT00150462|536371636|FG000|Overall Study|Physician Decision|0|||
148698746|NCT00150462|536371637|FG001|Overall Study|Physician Decision|0|||
148698747|NCT00150462|536371638|FG002|Overall Study|Physician Decision|1|||
148698748|NCT00150462|536371639|FG003|Overall Study|Physician Decision|1|||
148698749|NCT00150462|536371640|FG004|Overall Study|Physician Decision|0|||
148698750|NCT00150462|536371641|FG005|Overall Study|Physician Decision|0|||
148698751|NCT00150462|536371642|FG006|Overall Study|Physician Decision|0|||
148698752|NCT00150462|536371643|FG007|Overall Study|Physician Decision|0|||
148698753|NCT00150462|536371644|FG008|Overall Study|Physician Decision|0|||
148698754|NCT00150462|536371645|FG009|Overall Study|Physician Decision|0|||
148698755|NCT00150462|536371646|FG010|Overall Study|Physician Decision|0|||
148698756|NCT00150462|536371636|FG000|Overall Study|Other|0|||
148698757|NCT00150462|536371637|FG001|Overall Study|Other|0|||
148698758|NCT00150462|536371638|FG002|Overall Study|Other|0|||
148698759|NCT00150462|536371639|FG003|Overall Study|Other|0|||
148698760|NCT00150462|536371640|FG004|Overall Study|Other|0|||
148698761|NCT00150462|536371641|FG005|Overall Study|Other|0|||
148698762|NCT00150462|536371642|FG006|Overall Study|Other|0|||
148698763|NCT00150462|536371643|FG007|Overall Study|Other|0|||
148698764|NCT00150462|536371644|FG008|Overall Study|Other|0|||
148698765|NCT00150462|536371645|FG009|Overall Study|Other|1|||
148698766|NCT00150462|536371646|FG010|Overall Study|Other|1|||
148698767|NCT00569374|536371647|FG000|Overall Study|Withdrawal by Subject|4|||
148698768|NCT01666730|536371650|FG000|Overall Study|Adverse Event|16|||
148698769|NCT01666730|536371650|FG000|Overall Study|Death|2|||
148698770|NCT01666730|536371650|FG000|Overall Study|Physician Decision|5|||
148698771|NCT01666730|536371650|FG000|Overall Study|Withdrawal by Subject|9|||
148698772|NCT01666730|536371650|FG000|Overall Study|Disease progression/relapse|18|||
148698773|NCT04638153|536371651|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148698774|NCT04638153|536371652|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148698775|NCT04638153|536371653|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148698776|NCT04638153|536371651|FG000|Overall Study|Study terminated by sponsor|4|||
148698777|NCT04638153|536371652|FG001|Overall Study|Study terminated by sponsor|2|||
148814807|NCT03384966|536798016|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
148698778|NCT04638153|536371653|FG002|Overall Study|Study terminated by sponsor|14|||
148698779|NCT03553823|536371658|FG000|Overall Study|Physician Decision|0|||
148966221|NCT01505608|537361642|FG001|Phase I|Lack of Efficacy|4|||
148966222|NCT01505608|537361641|FG000|Phase I|Adverse Event|0|||
148966223|NCT01505608|537361642|FG001|Phase I|Adverse Event|1|||
148966224|NCT01505608|537361641|FG000|Phase I|Withdrawal by Subject|0|||
148698780|NCT03553823|536371659|FG001|Overall Study|Physician Decision|1|||
148698781|NCT03603314|536371660|FG000|Overall Study|Lost to Follow-up|0|||
148698782|NCT03603314|536371661|FG001|Overall Study|Lost to Follow-up|3|||
148966225|NCT01505608|537361642|FG001|Phase I|Withdrawal by Subject|1|||
148698783|NCT03603314|536371662|FG002|Overall Study|Lost to Follow-up|0|||
148698784|NCT03603314|536371660|FG000|Overall Study|Protocol Violation|0|||
148698785|NCT03603314|536371661|FG001|Overall Study|Protocol Violation|1|||
148966226|NCT01505608|537361641|FG000|Phase II|Lack of Efficacy|2|||
148966227|NCT01505608|537361642|FG001|Phase II|Lack of Efficacy|1|||
148698786|NCT03603314|536371662|FG002|Overall Study|Protocol Violation|0|||
148698787|NCT03603314|536371660|FG000|Overall Study|Adverse Event|2|||
148698788|NCT03603314|536371661|FG001|Overall Study|Adverse Event|0|||
148698789|NCT03603314|536371662|FG002|Overall Study|Adverse Event|0|||
148698790|NCT03603314|536371660|FG000|Overall Study|Physician Decision|1|||
148698791|NCT03603314|536371661|FG001|Overall Study|Physician Decision|1|||
148698792|NCT03603314|536371662|FG002|Overall Study|Physician Decision|0|||
148698793|NCT03603314|536371660|FG000|Overall Study|Withdrawal by Subject|4|||
148698794|NCT03603314|536371661|FG001|Overall Study|Withdrawal by Subject|5|||
148698795|NCT03603314|536371662|FG002|Overall Study|Withdrawal by Subject|3|||
148698796|NCT03603314|536371660|FG000|Overall Study|Other|0|||
148698797|NCT03603314|536371661|FG001|Overall Study|Other|1|||
148698798|NCT03603314|536371662|FG002|Overall Study|Other|0|||
148698799|NCT01389102|536371663|FG000|Overall Study|Adverse Event|1|||
148698800|NCT01389102|536371664|FG001|Overall Study|Adverse Event|3|||
148698801|NCT01389102|536371665|FG002|Overall Study|Adverse Event|2|||
148698802|NCT01389102|536371666|FG003|Overall Study|Adverse Event|2|||
148698803|NCT01389102|536371667|FG004|Overall Study|Adverse Event|2|||
148698804|NCT01389102|536371668|FG005|Overall Study|Adverse Event|2|||
148698805|NCT01389102|536371663|FG000|Overall Study|Hurricane Katrina|4|||
148966228|NCT01505608|537361641|FG000|Phase II|Protocol Violation|0|||
148966229|NCT01505608|537361642|FG001|Phase II|Protocol Violation|1|||
148966230|NCT01488097|537361643|FG000|Overall Study|Lost to Follow-up|1|||
148698806|NCT01389102|536371664|FG001|Overall Study|Hurricane Katrina|2|||
148698807|NCT01389102|536371665|FG002|Overall Study|Hurricane Katrina|3|||
148698808|NCT01389102|536371666|FG003|Overall Study|Hurricane Katrina|0|||
148698809|NCT01389102|536371667|FG004|Overall Study|Hurricane Katrina|3|||
148698810|NCT01389102|536371668|FG005|Overall Study|Hurricane Katrina|1|||
148698811|NCT01389102|536371663|FG000|Overall Study|Lost to Follow-up|4|||
148698812|NCT01389102|536371664|FG001|Overall Study|Lost to Follow-up|1|||
148698813|NCT01389102|536371665|FG002|Overall Study|Lost to Follow-up|1|||
148698814|NCT01389102|536371666|FG003|Overall Study|Lost to Follow-up|2|||
148698815|NCT01389102|536371667|FG004|Overall Study|Lost to Follow-up|4|||
148698816|NCT01389102|536371668|FG005|Overall Study|Lost to Follow-up|1|||
148698817|NCT01389102|536371663|FG000|Overall Study|Protocol Violation|0|||
148698818|NCT01389102|536371664|FG001|Overall Study|Protocol Violation|0|||
148698819|NCT01389102|536371665|FG002|Overall Study|Protocol Violation|3|||
148966231|NCT01577758|537361644|FG000|Dose Escalation Phase|Adverse Event|0|||
148966232|NCT01577758|537361645|FG001|Dose Escalation Phase|Adverse Event|0|||
148966233|NCT01577758|537361646|FG002|Dose Escalation Phase|Adverse Event|0|||
148966234|NCT01577758|537361647|FG003|Dose Escalation Phase|Adverse Event|0|||
148698820|NCT01389102|536371666|FG003|Overall Study|Protocol Violation|0|||
148698821|NCT01389102|536371667|FG004|Overall Study|Protocol Violation|1|||
148698822|NCT01389102|536371668|FG005|Overall Study|Protocol Violation|1|||
148698823|NCT01389102|536371663|FG000|Overall Study|Withdrawal by Subject|7|||
148966235|NCT01577758|537361648|FG004|Dose Escalation Phase|Adverse Event|0|||
148966236|NCT01577758|537361649|FG005|Dose Escalation Phase|Adverse Event|2|||
148698824|NCT01389102|536371664|FG001|Overall Study|Withdrawal by Subject|4|||
148966237|NCT01577758|537361650|FG006|Dose Escalation Phase|Adverse Event|1|||
148698825|NCT01389102|536371665|FG002|Overall Study|Withdrawal by Subject|9|||
148698826|NCT01389102|536371666|FG003|Overall Study|Withdrawal by Subject|2|||
148698827|NCT01389102|536371667|FG004|Overall Study|Withdrawal by Subject|3|||
148698828|NCT01389102|536371668|FG005|Overall Study|Withdrawal by Subject|3|||
148698829|NCT01389102|536371663|FG000|Overall Study|Subject Traveling Out of Country|0|||
148698830|NCT01389102|536371664|FG001|Overall Study|Subject Traveling Out of Country|0|||
148698831|NCT01389102|536371665|FG002|Overall Study|Subject Traveling Out of Country|0|||
148698832|NCT01389102|536371666|FG003|Overall Study|Subject Traveling Out of Country|1|||
148698833|NCT01389102|536371667|FG004|Overall Study|Subject Traveling Out of Country|0|||
148698834|NCT01389102|536371668|FG005|Overall Study|Subject Traveling Out of Country|0|||
148698835|NCT01389102|536371663|FG000|Overall Study|Subject Moved|2|||
148698836|NCT01389102|536371664|FG001|Overall Study|Subject Moved|0|||
148698837|NCT01389102|536371665|FG002|Overall Study|Subject Moved|1|||
148698838|NCT01389102|536371666|FG003|Overall Study|Subject Moved|0|||
148698839|NCT01389102|536371667|FG004|Overall Study|Subject Moved|0|||
148698840|NCT01389102|536371668|FG005|Overall Study|Subject Moved|0|||
148698841|NCT01389102|536371663|FG000|Overall Study|Unavailable due to husband's illness|0|||
148888877|NCT02159066|537072258|FG005|Part I|Death|0|||
148966238|NCT01577758|537361651|FG007|Dose Escalation Phase|Adverse Event|0|||
148966239|NCT01577758|537361644|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
148966240|NCT01577758|537361645|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
148966241|NCT01577758|537361646|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
148966242|NCT01577758|537361647|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
148966243|NCT01577758|537361648|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
148966244|NCT01577758|537361649|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
148966245|NCT01577758|537361650|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
148966246|NCT01577758|537361651|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
148966247|NCT01577758|537361644|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
148966248|NCT01577758|537361645|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
148966249|NCT01577758|537361646|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
148966250|NCT01577758|537361647|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
148966251|NCT01577758|537361648|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
148966252|NCT01577758|537361649|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
148966253|NCT01577758|537361650|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
148698842|NCT01389102|536371664|FG001|Overall Study|Unavailable due to husband's illness|1|||
148698843|NCT01389102|536371665|FG002|Overall Study|Unavailable due to husband's illness|0|||
148698844|NCT01389102|536371666|FG003|Overall Study|Unavailable due to husband's illness|0|||
148698845|NCT01389102|536371667|FG004|Overall Study|Unavailable due to husband's illness|0|||
148698846|NCT01389102|536371668|FG005|Overall Study|Unavailable due to husband's illness|0|||
148698847|NCT01389102|536371663|FG000|Overall Study|Investigator Judgement|0|||
148698848|NCT01389102|536371664|FG001|Overall Study|Investigator Judgement|1|||
148966254|NCT01577758|537361651|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
148966255|NCT01577758|537361644|FG000|Dose Escalation Phase|Progression Disease|2|||
148698849|NCT01389102|536371665|FG002|Overall Study|Investigator Judgement|0|||
148966256|NCT01577758|537361645|FG001|Dose Escalation Phase|Progression Disease|2|||
148966257|NCT01577758|537361646|FG002|Dose Escalation Phase|Progression Disease|1|||
148966258|NCT01577758|537361647|FG003|Dose Escalation Phase|Progression Disease|2|||
148966259|NCT01577758|537361648|FG004|Dose Escalation Phase|Progression Disease|5|||
148966260|NCT01577758|537361649|FG005|Dose Escalation Phase|Progression Disease|0|||
148966261|NCT01577758|537361650|FG006|Dose Escalation Phase|Progression Disease|0|||
148966262|NCT01577758|537361651|FG007|Dose Escalation Phase|Progression Disease|0|||
148966263|NCT01577758|537361644|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966264|NCT01577758|537361645|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966265|NCT01577758|537361646|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966266|NCT01577758|537361647|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966267|NCT01577758|537361648|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966268|NCT01577758|537361649|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966269|NCT01577758|537361650|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
148966270|NCT01577758|537361651|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
148966271|NCT01577758|537361644|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966272|NCT01577758|537361645|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966273|NCT01577758|537361646|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966274|NCT01577758|537361647|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966275|NCT01577758|537361648|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966276|NCT01577758|537361649|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966277|NCT01577758|537361650|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
148966278|NCT01577758|537361651|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
148966279|NCT01577758|537361644|FG000|mCRC Expansion Phase|Progression Disease|0|||
148966280|NCT01577758|537361645|FG001|mCRC Expansion Phase|Progression Disease|0|||
148966281|NCT01577758|537361646|FG002|mCRC Expansion Phase|Progression Disease|0|||
148966282|NCT01577758|537361647|FG003|mCRC Expansion Phase|Progression Disease|0|||
148966283|NCT01577758|537361648|FG004|mCRC Expansion Phase|Progression Disease|0|||
148966284|NCT01577758|537361649|FG005|mCRC Expansion Phase|Progression Disease|0|||
148966285|NCT01577758|537361650|FG006|mCRC Expansion Phase|Progression Disease|0|||
148966286|NCT01577758|537361651|FG007|mCRC Expansion Phase|Progression Disease|19|||
148966287|NCT01293240|537361652|FG000|Overall Study|Noncompliance|2|||
148966288|NCT02404350|537361662|FG000|Overall Study|Adverse Event|2|||
148966289|NCT02404350|537361663|FG001|Overall Study|Adverse Event|2|||
148966290|NCT02404350|537361664|FG002|Overall Study|Adverse Event|3|||
148966291|NCT02404350|537361665|FG003|Overall Study|Adverse Event|9|||
148966292|NCT02404350|537361662|FG000|Overall Study|Lack of Efficacy|3|||
148966293|NCT02404350|537361663|FG001|Overall Study|Lack of Efficacy|1|||
148966294|NCT02404350|537361664|FG002|Overall Study|Lack of Efficacy|0|||
148966295|NCT02404350|537361665|FG003|Overall Study|Lack of Efficacy|3|||
148966296|NCT02404350|537361662|FG000|Overall Study|Lost to Follow-up|2|||
148966297|NCT02404350|537361663|FG001|Overall Study|Lost to Follow-up|0|||
148966298|NCT02404350|537361664|FG002|Overall Study|Lost to Follow-up|0|||
148966299|NCT02404350|537361665|FG003|Overall Study|Lost to Follow-up|1|||
148966300|NCT02404350|537361662|FG000|Overall Study|Physician Decision|1|||
148966301|NCT02404350|537361663|FG001|Overall Study|Physician Decision|0|||
148966302|NCT02404350|537361664|FG002|Overall Study|Physician Decision|0|||
148966303|NCT02404350|537361665|FG003|Overall Study|Physician Decision|2|||
148966304|NCT02404350|537361662|FG000|Overall Study|Pregnancy|0|||
148966305|NCT02404350|537361663|FG001|Overall Study|Pregnancy|0|||
148966306|NCT02404350|537361664|FG002|Overall Study|Pregnancy|0|||
148966307|NCT02404350|537361665|FG003|Overall Study|Pregnancy|1|||
148966308|NCT02404350|537361662|FG000|Overall Study|Withdrawal by Subject|7|||
148966309|NCT02404350|537361663|FG001|Overall Study|Withdrawal by Subject|3|||
148966310|NCT02404350|537361664|FG002|Overall Study|Withdrawal by Subject|3|||
148698850|NCT01389102|536371666|FG003|Overall Study|Investigator Judgement|0|||
148698851|NCT01389102|536371667|FG004|Overall Study|Investigator Judgement|0|||
148966311|NCT02404350|537361665|FG003|Overall Study|Withdrawal by Subject|19|||
148966312|NCT02404350|537361662|FG000|Overall Study|Due to Non-compliance with treatment|0|||
148966313|NCT02404350|537361663|FG001|Overall Study|Due to Non-compliance with treatment|0|||
148966314|NCT02404350|537361664|FG002|Overall Study|Due to Non-compliance with treatment|0|||
148966315|NCT02404350|537361665|FG003|Overall Study|Due to Non-compliance with treatment|1|||
148966316|NCT02404350|537361662|FG000|Overall Study|Due to Technical problems|0|||
148966317|NCT02404350|537361663|FG001|Overall Study|Due to Technical problems|0|||
148966318|NCT02404350|537361664|FG002|Overall Study|Due to Technical problems|0|||
148966319|NCT02404350|537361665|FG003|Overall Study|Due to Technical problems|1|||
148966320|NCT05389657|537361666|FG000|Overall Study|Lost to Follow-up|7|||
148966321|NCT05389657|537361667|FG001|Overall Study|Lost to Follow-up|8|||
148966322|NCT02039674|537361672|FG000|Overall Study|Adverse Event|0|||
148966323|NCT02039674|537361673|FG001|Overall Study|Adverse Event|0|||
148966324|NCT02039674|537361674|FG002|Overall Study|Adverse Event|0|||
148966325|NCT02039674|537361675|FG003|Overall Study|Adverse Event|1|||
148966326|NCT02039674|537361676|FG004|Overall Study|Adverse Event|0|||
148966327|NCT02039674|537361677|FG005|Overall Study|Adverse Event|0|||
148698852|NCT01389102|536371668|FG005|Overall Study|Investigator Judgement|0|||
148698853|NCT03450070|536371669|FG000|Overall Study|Withdrawal by Subject|8|||
148698854|NCT00050778|536371670|FG000|Overall Study|Adverse Event|13|||
148966328|NCT02039674|537361678|FG006|Overall Study|Adverse Event|0|||
148966329|NCT02039674|537361679|FG007|Overall Study|Adverse Event|0|||
148966330|NCT02039674|537361680|FG008|Overall Study|Adverse Event|2|||
148966331|NCT02039674|537361681|FG009|Overall Study|Adverse Event|1|||
148966332|NCT02039674|537361682|FG010|Overall Study|Adverse Event|0|||
148966333|NCT02039674|537361683|FG011|Overall Study|Adverse Event|2|||
148966334|NCT02039674|537361684|FG012|Overall Study|Adverse Event|3|||
148966335|NCT02039674|537361685|FG013|Overall Study|Adverse Event|1|||
148966336|NCT02039674|537361672|FG000|Overall Study|Death|2|||
148966337|NCT02039674|537361673|FG001|Overall Study|Death|0|||
148966338|NCT02039674|537361674|FG002|Overall Study|Death|2|||
148966339|NCT02039674|537361675|FG003|Overall Study|Death|3|||
148966340|NCT02039674|537361676|FG004|Overall Study|Death|0|||
148966341|NCT02039674|537361677|FG005|Overall Study|Death|0|||
148966342|NCT02039674|537361678|FG006|Overall Study|Death|1|||
148966343|NCT02039674|537361679|FG007|Overall Study|Death|0|||
148966344|NCT02039674|537361680|FG008|Overall Study|Death|2|||
148966345|NCT02039674|537361681|FG009|Overall Study|Death|0|||
148966346|NCT02039674|537361682|FG010|Overall Study|Death|1|||
148966347|NCT02039674|537361683|FG011|Overall Study|Death|3|||
148966348|NCT02039674|537361684|FG012|Overall Study|Death|2|||
148966349|NCT02039674|537361685|FG013|Overall Study|Death|8|||
148966350|NCT02039674|537361672|FG000|Overall Study|Excluded Medication|1|||
148966351|NCT02039674|537361673|FG001|Overall Study|Excluded Medication|1|||
148966352|NCT02039674|537361674|FG002|Overall Study|Excluded Medication|0|||
148966353|NCT02039674|537361675|FG003|Overall Study|Excluded Medication|1|||
148966354|NCT02039674|537361676|FG004|Overall Study|Excluded Medication|0|||
148966355|NCT02039674|537361677|FG005|Overall Study|Excluded Medication|1|||
148966356|NCT02039674|537361678|FG006|Overall Study|Excluded Medication|0|||
148966357|NCT02039674|537361679|FG007|Overall Study|Excluded Medication|0|||
148966358|NCT02039674|537361680|FG008|Overall Study|Excluded Medication|2|||
148966359|NCT02039674|537361681|FG009|Overall Study|Excluded Medication|3|||
148966360|NCT02039674|537361682|FG010|Overall Study|Excluded Medication|5|||
148966361|NCT02039674|537361683|FG011|Overall Study|Excluded Medication|6|||
148966362|NCT02039674|537361684|FG012|Overall Study|Excluded Medication|8|||
148966363|NCT02039674|537361685|FG013|Overall Study|Excluded Medication|3|||
148966364|NCT02039674|537361672|FG000|Overall Study|Lost to Follow-up|0|||
148966365|NCT02039674|537361673|FG001|Overall Study|Lost to Follow-up|0|||
148966366|NCT02039674|537361674|FG002|Overall Study|Lost to Follow-up|0|||
148966367|NCT02039674|537361675|FG003|Overall Study|Lost to Follow-up|0|||
148966368|NCT02039674|537361676|FG004|Overall Study|Lost to Follow-up|1|||
148966369|NCT02039674|537361677|FG005|Overall Study|Lost to Follow-up|1|||
148966370|NCT02039674|537361678|FG006|Overall Study|Lost to Follow-up|0|||
148966371|NCT02039674|537361679|FG007|Overall Study|Lost to Follow-up|0|||
148966372|NCT02039674|537361680|FG008|Overall Study|Lost to Follow-up|0|||
148966373|NCT02039674|537361681|FG009|Overall Study|Lost to Follow-up|0|||
148966374|NCT02039674|537361682|FG010|Overall Study|Lost to Follow-up|0|||
148966375|NCT02039674|537361683|FG011|Overall Study|Lost to Follow-up|2|||
148966376|NCT02039674|537361684|FG012|Overall Study|Lost to Follow-up|2|||
148966377|NCT02039674|537361685|FG013|Overall Study|Lost to Follow-up|1|||
148966378|NCT02039674|537361672|FG000|Overall Study|Physician Decision|0|||
148966379|NCT02039674|537361673|FG001|Overall Study|Physician Decision|0|||
148966380|NCT02039674|537361674|FG002|Overall Study|Physician Decision|0|||
148966381|NCT02039674|537361675|FG003|Overall Study|Physician Decision|0|||
148966382|NCT02039674|537361676|FG004|Overall Study|Physician Decision|0|||
148966383|NCT02039674|537361677|FG005|Overall Study|Physician Decision|0|||
148966384|NCT02039674|537361678|FG006|Overall Study|Physician Decision|0|||
148966385|NCT02039674|537361679|FG007|Overall Study|Physician Decision|0|||
148966386|NCT02039674|537361680|FG008|Overall Study|Physician Decision|0|||
148966387|NCT02039674|537361681|FG009|Overall Study|Physician Decision|0|||
148966388|NCT02039674|537361682|FG010|Overall Study|Physician Decision|0|||
148966389|NCT02039674|537361683|FG011|Overall Study|Physician Decision|1|||
148966390|NCT02039674|537361684|FG012|Overall Study|Physician Decision|1|||
148966391|NCT02039674|537361685|FG013|Overall Study|Physician Decision|0|||
148966392|NCT02039674|537361672|FG000|Overall Study|Progressive Disease|8|||
148966393|NCT02039674|537361673|FG001|Overall Study|Progressive Disease|8|||
148966394|NCT02039674|537361674|FG002|Overall Study|Progressive Disease|6|||
148966395|NCT02039674|537361675|FG003|Overall Study|Progressive Disease|7|||
148966396|NCT02039674|537361676|FG004|Overall Study|Progressive Disease|9|||
148966397|NCT02039674|537361677|FG005|Overall Study|Progressive Disease|10|||
148966398|NCT02039674|537361678|FG006|Overall Study|Progressive Disease|1|||
148966399|NCT02039674|537361679|FG007|Overall Study|Progressive Disease|3|||
148966400|NCT02039674|537361680|FG008|Overall Study|Progressive Disease|6|||
148966401|NCT02039674|537361681|FG009|Overall Study|Progressive Disease|4|||
148966402|NCT02039674|537361682|FG010|Overall Study|Progressive Disease|0|||
148698855|NCT00050778|536371671|FG001|Overall Study|Adverse Event|3|||
148698856|NCT00050778|536371672|FG002|Overall Study|Adverse Event|2|||
148698857|NCT00050778|536371670|FG000|Overall Study|Death|0|||
148698858|NCT00050778|536371671|FG001|Overall Study|Death|1|||
148966403|NCT02039674|537361683|FG011|Overall Study|Progressive Disease|34|||
148966404|NCT02039674|537361684|FG012|Overall Study|Progressive Disease|34|||
148966405|NCT02039674|537361685|FG013|Overall Study|Progressive Disease|18|||
148966406|NCT02039674|537361672|FG000|Overall Study|Withdrawal by Subject|1|||
148966407|NCT02039674|537361673|FG001|Overall Study|Withdrawal by Subject|2|||
148966408|NCT02039674|537361674|FG002|Overall Study|Withdrawal by Subject|3|||
148966409|NCT02039674|537361675|FG003|Overall Study|Withdrawal by Subject|0|||
148966410|NCT02039674|537361676|FG004|Overall Study|Withdrawal by Subject|1|||
148966411|NCT02039674|537361677|FG005|Overall Study|Withdrawal by Subject|0|||
148966412|NCT02039674|537361678|FG006|Overall Study|Withdrawal by Subject|0|||
148966413|NCT02039674|537361679|FG007|Overall Study|Withdrawal by Subject|0|||
148966414|NCT02039674|537361680|FG008|Overall Study|Withdrawal by Subject|0|||
148966415|NCT02039674|537361681|FG009|Overall Study|Withdrawal by Subject|1|||
148966416|NCT02039674|537361682|FG010|Overall Study|Withdrawal by Subject|1|||
148966417|NCT02039674|537361683|FG011|Overall Study|Withdrawal by Subject|4|||
148966418|NCT02039674|537361684|FG012|Overall Study|Withdrawal by Subject|6|||
148966419|NCT02039674|537361685|FG013|Overall Study|Withdrawal by Subject|2|||
148966420|NCT02039674|537361672|FG000|Overall Study|Clinical Progression|0|||
148966421|NCT02039674|537361673|FG001|Overall Study|Clinical Progression|0|||
148966422|NCT02039674|537361674|FG002|Overall Study|Clinical Progression|0|||
148966423|NCT02039674|537361675|FG003|Overall Study|Clinical Progression|0|||
148966424|NCT02039674|537361676|FG004|Overall Study|Clinical Progression|0|||
148966425|NCT02039674|537361677|FG005|Overall Study|Clinical Progression|0|||
148966426|NCT02039674|537361678|FG006|Overall Study|Clinical Progression|1|||
148966427|NCT02039674|537361679|FG007|Overall Study|Clinical Progression|0|||
148966428|NCT02039674|537361680|FG008|Overall Study|Clinical Progression|0|||
148966429|NCT02039674|537361681|FG009|Overall Study|Clinical Progression|0|||
148966430|NCT02039674|537361682|FG010|Overall Study|Clinical Progression|0|||
148966431|NCT02039674|537361683|FG011|Overall Study|Clinical Progression|0|||
148966432|NCT02039674|537361684|FG012|Overall Study|Clinical Progression|1|||
148966433|NCT02039674|537361685|FG013|Overall Study|Clinical Progression|0|||
148966434|NCT02039674|537361672|FG000|Overall Study|Sponsor Decision|1|||
148966435|NCT02039674|537361673|FG001|Overall Study|Sponsor Decision|1|||
148966436|NCT02039674|537361674|FG002|Overall Study|Sponsor Decision|1|||
148966437|NCT02039674|537361675|FG003|Overall Study|Sponsor Decision|1|||
148966438|NCT02039674|537361676|FG004|Overall Study|Sponsor Decision|1|||
148966439|NCT02039674|537361677|FG005|Overall Study|Sponsor Decision|0|||
148966440|NCT02039674|537361678|FG006|Overall Study|Sponsor Decision|0|||
148966441|NCT02039674|537361679|FG007|Overall Study|Sponsor Decision|0|||
148966442|NCT02039674|537361680|FG008|Overall Study|Sponsor Decision|0|||
148966443|NCT02039674|537361681|FG009|Overall Study|Sponsor Decision|3|||
148966444|NCT02039674|537361682|FG010|Overall Study|Sponsor Decision|0|||
148966445|NCT02039674|537361683|FG011|Overall Study|Sponsor Decision|8|||
148966446|NCT02039674|537361684|FG012|Overall Study|Sponsor Decision|5|||
148966447|NCT02039674|537361685|FG013|Overall Study|Sponsor Decision|0|||
148966448|NCT02039674|537361672|FG000|Overall Study|Other|0|||
148966449|NCT02039674|537361673|FG001|Overall Study|Other|0|||
148966450|NCT02039674|537361674|FG002|Overall Study|Other|0|||
148966451|NCT02039674|537361675|FG003|Overall Study|Other|0|||
148966452|NCT02039674|537361676|FG004|Overall Study|Other|0|||
148966453|NCT02039674|537361677|FG005|Overall Study|Other|0|||
148966454|NCT02039674|537361678|FG006|Overall Study|Other|0|||
148966455|NCT02039674|537361679|FG007|Overall Study|Other|0|||
148966456|NCT02039674|537361680|FG008|Overall Study|Other|0|||
148966457|NCT02039674|537361681|FG009|Overall Study|Other|0|||
148966458|NCT02039674|537361682|FG010|Overall Study|Other|0|||
148966459|NCT02039674|537361683|FG011|Overall Study|Other|0|||
148966460|NCT02039674|537361684|FG012|Overall Study|Other|1|||
148966461|NCT02039674|537361685|FG013|Overall Study|Other|0|||
148966462|NCT01408030|537361686|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
148966463|NCT01408030|537361687|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
148966464|NCT01408030|537361688|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
148966465|NCT01408030|537361689|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
148966466|NCT01408030|537361686|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
148966467|NCT01408030|537361687|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
148966468|NCT01408030|537361688|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
148966469|NCT01408030|537361689|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
148966470|NCT01408030|537361686|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
148966471|NCT01408030|537361687|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
148698859|NCT00050778|536371672|FG002|Overall Study|Death|1|||
148698860|NCT00050778|536371670|FG000|Overall Study|Lack of Efficacy|16|||
148698861|NCT00050778|536371671|FG001|Overall Study|Lack of Efficacy|2|||
148698862|NCT00050778|536371672|FG002|Overall Study|Lack of Efficacy|2|||
148698863|NCT00050778|536371670|FG000|Overall Study|Lost to Follow-up|0|||
148698864|NCT00050778|536371671|FG001|Overall Study|Lost to Follow-up|2|||
148698865|NCT00050778|536371672|FG002|Overall Study|Lost to Follow-up|4|||
148698866|NCT00050778|536371670|FG000|Overall Study|Physician Decision|3|||
148698867|NCT00050778|536371671|FG001|Overall Study|Physician Decision|0|||
148966472|NCT01408030|537361688|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
148966473|NCT01408030|537361689|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
148966474|NCT01408030|537361686|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
148966475|NCT01408030|537361687|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
148966476|NCT01408030|537361688|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
148966477|NCT01408030|537361689|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
148966478|NCT01408030|537361686|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
148966479|NCT01408030|537361687|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
148966480|NCT01408030|537361688|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
148966481|NCT01408030|537361689|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
148966482|NCT01408030|537361686|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
148966483|NCT01408030|537361687|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
148966484|NCT01408030|537361688|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
148966485|NCT01408030|537361689|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
148966486|NCT01408030|537361686|FG000|Observation Phase (Off Drug)|Other|1|||
148966487|NCT01408030|537361687|FG001|Observation Phase (Off Drug)|Other|1|||
148966488|NCT01408030|537361688|FG002|Observation Phase (Off Drug)|Other|1|||
148966489|NCT01408030|537361689|FG003|Observation Phase (Off Drug)|Other|1|||
148966490|NCT00108160|537361690|FG000|Overall Study|Lost to Follow-up|25|||
148966491|NCT00108160|537361691|FG001|Overall Study|Lost to Follow-up|12|||
148966492|NCT00108160|537361690|FG000|Overall Study|Death|1|||
148966493|NCT00108160|537361691|FG001|Overall Study|Death|2|||
148966494|NCT00108160|537361690|FG000|Overall Study|Withdrawal by Subject|4|||
148966495|NCT00108160|537361691|FG001|Overall Study|Withdrawal by Subject|2|||
148966496|NCT00108160|537361690|FG000|Overall Study|Protocol Violation|9|||
148966497|NCT00108160|537361691|FG001|Overall Study|Protocol Violation|5|||
148966498|NCT02385084|537361692|FG000|Period 2|Protocol Violation|0|||
148966499|NCT02385084|537361693|FG001|Period 2|Protocol Violation|0|||
148966500|NCT02385084|537361694|FG002|Period 2|Protocol Violation|1|||
148966501|NCT02385084|537361695|FG003|Period 2|Protocol Violation|0|||
148966502|NCT02385084|537361696|FG004|Period 2|Protocol Violation|0|||
148966503|NCT02385084|537361697|FG005|Period 2|Protocol Violation|0|||
148966504|NCT05045144|537361698|FG000|Overall Study|Lost to Follow-up|3|||
148966505|NCT05045144|537361699|FG001|Overall Study|Lost to Follow-up|2|||
148966506|NCT05045144|537361700|FG002|Overall Study|Lost to Follow-up|3|||
148966507|NCT05045144|537361701|FG003|Overall Study|Lost to Follow-up|5|||
148966508|NCT05045144|537361702|FG004|Overall Study|Lost to Follow-up|13|||
148966509|NCT05045144|537361698|FG000|Overall Study|Withdrawal by Subject|0|||
148966510|NCT05045144|537361699|FG001|Overall Study|Withdrawal by Subject|1|||
148966511|NCT05045144|537361700|FG002|Overall Study|Withdrawal by Subject|0|||
148698868|NCT00050778|536371672|FG002|Overall Study|Physician Decision|2|||
148698869|NCT00050778|536371670|FG000|Overall Study|Protocol Violation|2|||
148698870|NCT00050778|536371671|FG001|Overall Study|Protocol Violation|0|||
148698871|NCT00050778|536371672|FG002|Overall Study|Protocol Violation|1|||
148966512|NCT05045144|537361701|FG003|Overall Study|Withdrawal by Subject|0|||
148698872|NCT00050778|536371670|FG000|Overall Study|Withdrawal by Subject|6|||
148698873|NCT00050778|536371671|FG001|Overall Study|Withdrawal by Subject|8|||
148698874|NCT00050778|536371672|FG002|Overall Study|Withdrawal by Subject|4|||
148698875|NCT00050778|536371670|FG000|Overall Study|Randomized but not treated|4|||
148698876|NCT00050778|536371671|FG001|Overall Study|Randomized but not treated|5|||
148698877|NCT00050778|536371672|FG002|Overall Study|Randomized but not treated|2|||
148698878|NCT00050778|536371670|FG000|Overall Study|Familial and personal reasons|1|||
148698879|NCT00050778|536371671|FG001|Overall Study|Familial and personal reasons|0|||
148698880|NCT00050778|536371672|FG002|Overall Study|Familial and personal reasons|0|||
148698881|NCT02015390|536371673|FG000|Overall Study|Lost to Follow-up|1|||
148814808|NCT03384966|536798017|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
148814809|NCT03384966|536798018|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
148966513|NCT05045144|537361702|FG004|Overall Study|Withdrawal by Subject|0|||
148966514|NCT05045144|537361698|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148966515|NCT05045144|537361699|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148966516|NCT05045144|537361700|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148966517|NCT05045144|537361701|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148966518|NCT05045144|537361702|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148966519|NCT02081079|537361703|FG000|Overall Study|Lack of Efficacy|3|||
148966520|NCT02081079|537361704|FG001|Overall Study|Lack of Efficacy|2|||
148966521|NCT02081079|537361703|FG000|Overall Study|Lost to Follow-up|1|||
148966522|NCT02081079|537361704|FG001|Overall Study|Lost to Follow-up|0|||
148966523|NCT02968979|537361705|FG000|Overall Study|Protocol Violation|7|||
148966524|NCT02968979|537361705|FG000|Overall Study|Withdrawal by Subject|1|||
148966525|NCT00729183|537361706|FG000|Overall Study|Adverse Event|11|||
148966526|NCT00729183|537361707|FG001|Overall Study|Adverse Event|5|||
148966527|NCT00729183|537361706|FG000|Overall Study|Lack of Efficacy|0|||
148966528|NCT00729183|537361707|FG001|Overall Study|Lack of Efficacy|1|||
148966529|NCT00729183|537361706|FG000|Overall Study|Lost to Follow-up|3|||
148966530|NCT00729183|537361707|FG001|Overall Study|Lost to Follow-up|1|||
148966531|NCT00729183|537361706|FG000|Overall Study|Physician Decision|1|||
148966532|NCT00729183|537361707|FG001|Overall Study|Physician Decision|1|||
148966533|NCT00729183|537361706|FG000|Overall Study|Protocol Violation|1|||
148966534|NCT00729183|537361707|FG001|Overall Study|Protocol Violation|0|||
148966535|NCT00729183|537361706|FG000|Overall Study|Withdrawal by Subject|9|||
148966536|NCT00729183|537361707|FG001|Overall Study|Withdrawal by Subject|7|||
148966537|NCT01342510|537361714|FG000|Overall Study|Protocol Violation|12|||
148966538|NCT01342510|537361715|FG001|Overall Study|Protocol Violation|6|||
148966539|NCT01342510|537361716|FG002|Overall Study|Protocol Violation|13|||
148966540|NCT01342510|537361717|FG003|Overall Study|Protocol Violation|11|||
148966541|NCT04365556|537361718|FG000|Overall Study|No longer eligible due to treatment plan|1|||
148966542|NCT04365556|537361719|FG001|Overall Study|No longer eligible due to treatment plan|0|||
148966543|NCT04365556|537361718|FG000|Overall Study|Lost to Follow-up|3|||
148966544|NCT04365556|537361719|FG001|Overall Study|Lost to Follow-up|2|||
148966545|NCT05756790|537361720|FG000|Overall Study|Withdrawal by Subject|1|||
148966546|NCT05756790|537361721|FG001|Overall Study|Withdrawal by Subject|1|||
148966547|NCT05756790|537361722|FG002|Overall Study|Withdrawal by Subject|1|||
148966548|NCT05756790|537361723|FG003|Overall Study|Withdrawal by Subject|1|||
148966549|NCT05756790|537361724|FG004|Overall Study|Withdrawal by Subject|0|||
148966550|NCT05756790|537361725|FG005|Overall Study|Withdrawal by Subject|0|||
148966551|NCT05756790|537361720|FG000|Overall Study|Protocol Violation|0|||
148966552|NCT05756790|537361721|FG001|Overall Study|Protocol Violation|0|||
148966553|NCT05756790|537361722|FG002|Overall Study|Protocol Violation|1|||
148966554|NCT05756790|537361723|FG003|Overall Study|Protocol Violation|1|||
148966555|NCT05756790|537361724|FG004|Overall Study|Protocol Violation|0|||
148966556|NCT05756790|537361725|FG005|Overall Study|Protocol Violation|0|||
148966557|NCT05756790|537361720|FG000|Overall Study|Ineligible|0|||
148966558|NCT05756790|537361721|FG001|Overall Study|Ineligible|0|||
148966559|NCT05756790|537361722|FG002|Overall Study|Ineligible|0|||
148966560|NCT05756790|537361723|FG003|Overall Study|Ineligible|0|||
148966561|NCT05756790|537361724|FG004|Overall Study|Ineligible|2|||
148966562|NCT05756790|537361725|FG005|Overall Study|Ineligible|2|||
148966563|NCT01023581|537363333|FG000|Overall Study|Adverse Event|4|||
148966564|NCT01023581|537363334|FG001|Overall Study|Adverse Event|4|||
148966565|NCT01023581|537363335|FG002|Overall Study|Adverse Event|7|||
148966566|NCT01023581|537363336|FG003|Overall Study|Adverse Event|3|||
148966567|NCT01023581|537363337|FG004|Overall Study|Adverse Event|2|||
148966568|NCT01023581|537363338|FG005|Overall Study|Adverse Event|5|||
148966569|NCT01023581|537363339|FG006|Overall Study|Adverse Event|11|||
148966570|NCT01023581|537363333|FG000|Overall Study|Major protocol deviation|2|||
148966571|NCT01023581|537363334|FG001|Overall Study|Major protocol deviation|0|||
148966572|NCT01023581|537363335|FG002|Overall Study|Major protocol deviation|3|||
148966573|NCT01023581|537363336|FG003|Overall Study|Major protocol deviation|0|||
148966574|NCT01023581|537363337|FG004|Overall Study|Major protocol deviation|0|||
148966575|NCT01023581|537363338|FG005|Overall Study|Major protocol deviation|0|||
148966576|NCT01023581|537363339|FG006|Overall Study|Major protocol deviation|0|||
148966577|NCT01023581|537363333|FG000|Overall Study|Lost to Follow-up|4|||
148966578|NCT01023581|537363334|FG001|Overall Study|Lost to Follow-up|8|||
148966579|NCT01023581|537363335|FG002|Overall Study|Lost to Follow-up|7|||
148966580|NCT01023581|537363336|FG003|Overall Study|Lost to Follow-up|2|||
148966581|NCT01023581|537363337|FG004|Overall Study|Lost to Follow-up|5|||
148966582|NCT01023581|537363338|FG005|Overall Study|Lost to Follow-up|2|||
148966583|NCT01023581|537363339|FG006|Overall Study|Lost to Follow-up|2|||
148966584|NCT01023581|537363333|FG000|Overall Study|Withdrawal by Subject|13|||
148966585|NCT01023581|537363334|FG001|Overall Study|Withdrawal by Subject|8|||
148966586|NCT01023581|537363335|FG002|Overall Study|Withdrawal by Subject|16|||
148966587|NCT01023581|537363336|FG003|Overall Study|Withdrawal by Subject|10|||
148966588|NCT01023581|537363337|FG004|Overall Study|Withdrawal by Subject|6|||
148966589|NCT01023581|537363338|FG005|Overall Study|Withdrawal by Subject|8|||
148966590|NCT01023581|537363339|FG006|Overall Study|Withdrawal by Subject|5|||
148966591|NCT01023581|537363333|FG000|Overall Study|Pregnancy|0|||
148966592|NCT01023581|537363334|FG001|Overall Study|Pregnancy|0|||
148966593|NCT01023581|537363335|FG002|Overall Study|Pregnancy|0|||
148966594|NCT01023581|537363336|FG003|Overall Study|Pregnancy|2|||
148966595|NCT01023581|537363337|FG004|Overall Study|Pregnancy|0|||
148966596|NCT01023581|537363338|FG005|Overall Study|Pregnancy|1|||
148966597|NCT01023581|537363339|FG006|Overall Study|Pregnancy|0|||
148966598|NCT01023581|537363333|FG000|Overall Study|Lack of Efficacy|9|||
148966599|NCT01023581|537363334|FG001|Overall Study|Lack of Efficacy|3|||
148966600|NCT01023581|537363335|FG002|Overall Study|Lack of Efficacy|6|||
148966601|NCT01023581|537363336|FG003|Overall Study|Lack of Efficacy|2|||
148966602|NCT01023581|537363337|FG004|Overall Study|Lack of Efficacy|1|||
148966603|NCT01023581|537363338|FG005|Overall Study|Lack of Efficacy|2|||
148966604|NCT01023581|537363339|FG006|Overall Study|Lack of Efficacy|1|||
148966605|NCT01023581|537363333|FG000|Overall Study|Physician Decision|2|||
148966606|NCT01023581|537363334|FG001|Overall Study|Physician Decision|0|||
148698882|NCT02015390|536371674|FG001|Overall Study|Lost to Follow-up|0|||
148698883|NCT02015390|536371673|FG000|Overall Study|Adverse Event|0|||
148698884|NCT02015390|536371674|FG001|Overall Study|Adverse Event|3|||
148966607|NCT01023581|537363335|FG002|Overall Study|Physician Decision|2|||
148966608|NCT01023581|537363336|FG003|Overall Study|Physician Decision|1|||
148966609|NCT01023581|537363337|FG004|Overall Study|Physician Decision|1|||
148698885|NCT02015390|536371673|FG000|Overall Study|Physician Decision|0|||
148966610|NCT01023581|537363338|FG005|Overall Study|Physician Decision|1|||
148966611|NCT01023581|537363339|FG006|Overall Study|Physician Decision|1|||
148966612|NCT01023581|537363333|FG000|Overall Study|Other|1|||
148966613|NCT01023581|537363334|FG001|Overall Study|Other|0|||
148966614|NCT01023581|537363335|FG002|Overall Study|Other|1|||
148966615|NCT01023581|537363336|FG003|Overall Study|Other|0|||
148966616|NCT01023581|537363337|FG004|Overall Study|Other|1|||
148966617|NCT01023581|537363338|FG005|Overall Study|Other|0|||
148966618|NCT01023581|537363339|FG006|Overall Study|Other|0|||
148966619|NCT01176292|537363343|FG000|Overall Study|Lost to Follow-up|2|||
148966620|NCT01176292|537363344|FG001|Overall Study|Lost to Follow-up|4|||
148966621|NCT01176292|537363343|FG000|Overall Study|Adverse Event|1|||
148966622|NCT01176292|537363344|FG001|Overall Study|Adverse Event|1|||
148966623|NCT01176292|537363343|FG000|Overall Study|Physician Decision|0|||
148966624|NCT01176292|537363344|FG001|Overall Study|Physician Decision|2|||
148966625|NCT01176292|537363343|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
148966626|NCT01176292|537363344|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
148966627|NCT01933048|537363345|FG000|Overall Study|Lost to Follow-up|15|||
148966628|NCT01933048|537363346|FG001|Overall Study|Lost to Follow-up|18|||
148966629|NCT01933048|537363345|FG000|Overall Study|personal reasons|1|||
148966630|NCT01933048|537363346|FG001|Overall Study|personal reasons|1|||
148966631|NCT01933048|537363345|FG000|Overall Study|Protocol Violation|7|||
148966632|NCT01933048|537363346|FG001|Overall Study|Protocol Violation|8|||
148966633|NCT01933048|537363345|FG000|Overall Study|Physician Decision|1|||
148966634|NCT01933048|537363346|FG001|Overall Study|Physician Decision|0|||
148966635|NCT01933048|537363345|FG000|Overall Study|unknown reasons|1|||
148966636|NCT01933048|537363346|FG001|Overall Study|unknown reasons|1|||
148966637|NCT02780804|537363347|FG000|Overall Study|Death|1|||
148966638|NCT02780804|537363348|FG001|Overall Study|Death|0|||
148966639|NCT02780804|537363349|FG002|Overall Study|Death|0|||
148966640|NCT02780804|537363347|FG000|Overall Study|Lack of Efficacy|5|||
148966641|NCT02780804|537363348|FG001|Overall Study|Lack of Efficacy|8|||
148966642|NCT02780804|537363349|FG002|Overall Study|Lack of Efficacy|4|||
148966643|NCT02780804|537363347|FG000|Overall Study|Physician Decision|0|||
148966644|NCT02780804|537363348|FG001|Overall Study|Physician Decision|0|||
148966645|NCT02780804|537363349|FG002|Overall Study|Physician Decision|2|||
148966646|NCT02780804|537363347|FG000|Overall Study|Withdrawal by Subject|0|||
148966647|NCT02780804|537363348|FG001|Overall Study|Withdrawal by Subject|1|||
148966648|NCT02780804|537363349|FG002|Overall Study|Withdrawal by Subject|0|||
148966649|NCT02476968|537363350|FG000|Overall Study|Other|0|||
148966650|NCT02476968|537363351|FG001|Overall Study|Other|2|||
148966651|NCT02476968|537363352|FG002|Overall Study|Other|0|||
148966652|NCT02476968|537363350|FG000|Overall Study|Lost to Follow-up|10|||
148966653|NCT02476968|537363351|FG001|Overall Study|Lost to Follow-up|0|||
148966654|NCT02476968|537363352|FG002|Overall Study|Lost to Follow-up|1|||
148966655|NCT02476968|537363350|FG000|Overall Study|Death|48|||
148966656|NCT02476968|537363351|FG001|Overall Study|Death|8|||
148966657|NCT02476968|537363352|FG002|Overall Study|Death|1|||
148966658|NCT02476968|537363350|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148966659|NCT02476968|537363351|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148966660|NCT02476968|537363352|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
148966661|NCT02476968|537363350|FG000|Overall Study|Patient decision|37|||
148966662|NCT02476968|537363351|FG001|Overall Study|Patient decision|8|||
148966663|NCT02476968|537363352|FG002|Overall Study|Patient decision|0|||
148966664|NCT01859507|537363353|FG000|Overall Study|left the country|4|||
148966665|NCT04476030|537363354|FG000|Overall Study|Withdrawal by Subject|20|||
148966666|NCT04476030|537363355|FG001|Overall Study|Withdrawal by Subject|16|||
148966667|NCT04476030|537363354|FG000|Overall Study|Adverse Event|10|||
148966668|NCT04476030|537363355|FG001|Overall Study|Adverse Event|11|||
148966669|NCT04476030|537363354|FG000|Overall Study|Lost to Follow-up|7|||
148966670|NCT04476030|537363355|FG001|Overall Study|Lost to Follow-up|4|||
148966671|NCT04476030|537363354|FG000|Overall Study|Physician Decision|1|||
148966672|NCT04476030|537363355|FG001|Overall Study|Physician Decision|1|||
148966673|NCT04476030|537363354|FG000|Overall Study|Protocol Deviation|2|||
148966674|NCT04476030|537363355|FG001|Overall Study|Protocol Deviation|0|||
148966675|NCT04476030|537363354|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
148966676|NCT04476030|537363355|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
148966677|NCT04476030|537363354|FG000|Overall Study|Randomized but not Dosed|2|||
148966678|NCT04476030|537363355|FG001|Overall Study|Randomized but not Dosed|8|||
148966679|NCT02404311|537363356|FG000|Part A: Month 0-18|Death|2|||
148966680|NCT02404311|537363357|FG001|Part A: Month 0-18|Death|0|||
148814810|NCT03384966|536798016|FG000|Follow-up Period|Adverse Event|1|||
148966681|NCT02404311|537363358|FG002|Part A: Month 0-18|Death|0|||
148966682|NCT02404311|537363359|FG003|Part A: Month 0-18|Death|0|||
148966683|NCT02404311|537363360|FG004|Part A: Month 0-18|Death|0|||
148966684|NCT02404311|537363356|FG000|Part A: Month 0-18|Physician Decision|1|||
148966685|NCT02404311|537363357|FG001|Part A: Month 0-18|Physician Decision|0|||
148966686|NCT02404311|537363358|FG002|Part A: Month 0-18|Physician Decision|0|||
148966687|NCT02404311|537363359|FG003|Part A: Month 0-18|Physician Decision|0|||
148966688|NCT02404311|537363360|FG004|Part A: Month 0-18|Physician Decision|0|||
148966689|NCT02404311|537363356|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
148966690|NCT02404311|537363357|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
148966691|NCT02404311|537363358|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
148966692|NCT02404311|537363359|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
148966693|NCT02404311|537363360|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
148966694|NCT02404311|537363356|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
148966695|NCT02404311|537363357|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
148966696|NCT02404311|537363358|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
148966697|NCT02404311|537363359|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
148966698|NCT02404311|537363360|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
148966699|NCT02404311|537363356|FG000|Part A: Month 0-18|HIV Infection|6|||
148966700|NCT02404311|537363357|FG001|Part A: Month 0-18|HIV Infection|2|||
148966701|NCT02404311|537363358|FG002|Part A: Month 0-18|HIV Infection|0|||
148966702|NCT02404311|537363359|FG003|Part A: Month 0-18|HIV Infection|0|||
148966703|NCT02404311|537363360|FG004|Part A: Month 0-18|HIV Infection|0|||
148966704|NCT02404311|537363356|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
148966705|NCT02404311|537363357|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
148966706|NCT02404311|537363358|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
148966707|NCT02404311|537363359|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
148966708|NCT02404311|537363360|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
148966709|NCT02256891|537363365|FG000|Overall Study|Death|0|||
148966710|NCT02256891|537363366|FG001|Overall Study|Death|2|||
148966711|NCT02256891|537363365|FG000|Overall Study|Lost to Follow-up|0|||
148966712|NCT02256891|537363366|FG001|Overall Study|Lost to Follow-up|3|||
148966713|NCT02256891|537363365|FG000|Overall Study|Physician Decision|7|||
148966714|NCT02256891|537363366|FG001|Overall Study|Physician Decision|3|||
148698886|NCT02015390|536371674|FG001|Overall Study|Physician Decision|1|||
148698887|NCT01661686|536371680|FG000|Overall Study|Lost to Follow-up|2|||
148698888|NCT01661686|536371681|FG001|Overall Study|Lost to Follow-up|1|||
148698889|NCT01661686|536371680|FG000|Overall Study|did not receive allocated intervention|0|||
148698890|NCT01661686|536371681|FG001|Overall Study|did not receive allocated intervention|1|||
148698891|NCT04869787|536371684|FG000|Screening|Physician Decision|1|||
148698892|NCT04869787|536371684|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
148698893|NCT00813293|536371685|FG000|Overall Study|Intercurrent illness|1|||
148698894|NCT00813293|536371686|FG001|Overall Study|Intercurrent illness|0|||
148698895|NCT00813293|536371685|FG000|Overall Study|Adverse Event|0|||
148814811|NCT03384966|536798017|FG001|Follow-up Period|Adverse Event|0|||
148814812|NCT03384966|536798018|FG002|Follow-up Period|Adverse Event|0|||
148814813|NCT02202616|536798019|FG000|Overall Study|Screen failed|24|||
148814814|NCT02202616|536798019|FG000|Overall Study|Adverse Event|32|||
148814815|NCT02202616|536798019|FG000|Overall Study|Protocol deviation|18|||
148966715|NCT02256891|537363365|FG000|Overall Study|Screen Fail|5|||
148966716|NCT02256891|537363366|FG001|Overall Study|Screen Fail|4|||
148966717|NCT02256891|537363365|FG000|Overall Study|Equipment Malfunction|0|||
148966718|NCT02256891|537363366|FG001|Overall Study|Equipment Malfunction|1|||
148966719|NCT04171414|537363375|FG000|Overall Study|Death|1|||
148966720|NCT04171414|537363375|FG000|Overall Study|Withdrawal by Subject|1|||
148966721|NCT00278954|537363376|FG000|Overall Study|Adverse Event|3|||
148966722|NCT00278954|537363376|FG000|Overall Study|Lost to Follow-up|1|||
148966723|NCT00278954|537363376|FG000|Overall Study|Withdrawal by Subject|1|||
148966724|NCT02211131|537363388|FG000|Overall Study|Death|26|||
148966725|NCT02211131|537363389|FG001|Overall Study|Death|16|||
148966726|NCT02211131|537363388|FG000|Overall Study|Lost to Follow-up|4|||
148966727|NCT02211131|537363389|FG001|Overall Study|Lost to Follow-up|3|||
148966728|NCT02211131|537363388|FG000|Overall Study|Decision by Sponsor|1|||
148966729|NCT02211131|537363389|FG001|Overall Study|Decision by Sponsor|1|||
148966730|NCT02211131|537363388|FG000|Overall Study|Withdrawal by Subject|3|||
148814816|NCT02202616|536798019|FG000|Overall Study|Patient withdrew consent|12|||
148814817|NCT02202616|536798019|FG000|Overall Study|Lost to Follow-up|6|||
148966731|NCT02211131|537363389|FG001|Overall Study|Withdrawal by Subject|8|||
148966732|NCT05664490|537363391|FG000|Overall Study|Withdrawal by Subject|0|||
148966733|NCT05664490|537363392|FG001|Overall Study|Withdrawal by Subject|1|||
148966734|NCT05664490|537363391|FG000|Overall Study|Lost to Follow-up|14|||
148966735|NCT05664490|537363392|FG001|Overall Study|Lost to Follow-up|22|||
148814818|NCT02202616|536798019|FG000|Overall Study|Administrative problems|6|||
148966736|NCT05442554|537363393|FG000|Overall Study|Adverse Event|1|||
148966737|NCT01990495|537363398|FG000|Overall Study|Physician Decision|5|||
149025025|NCT03738241|537567985|FG006|Overall Study|Physician Decision|0|||
148698896|NCT00813293|536371686|FG001|Overall Study|Adverse Event|1|||
148698897|NCT02794974|536371687|FG000|Overall Study|Physician Decision|0|||
148698898|NCT02794974|536371688|FG001|Overall Study|Physician Decision|1|||
148966738|NCT01990495|537363399|FG001|Overall Study|Physician Decision|4|||
148966739|NCT03412084|537363400|FG000|Overall Study|Withdrawal by Subject|2|||
148966740|NCT03412084|537363401|FG001|Overall Study|Withdrawal by Subject|0|||
148966741|NCT03412084|537363400|FG000|Overall Study|Participant moved|1|||
148966742|NCT03412084|537363401|FG001|Overall Study|Participant moved|0|||
148966743|NCT03412084|537363400|FG000|Overall Study|Lost to Follow-up|1|||
148966744|NCT03412084|537363401|FG001|Overall Study|Lost to Follow-up|1|||
148966745|NCT01928862|537363402|FG000|Overall Study|Lost to Follow-up|1|||
148966746|NCT01928862|537363403|FG001|Overall Study|Lost to Follow-up|0|||
148966747|NCT01928862|537363404|FG002|Overall Study|Lost to Follow-up|0|||
148966748|NCT01928862|537363405|FG003|Overall Study|Lost to Follow-up|0|||
148966749|NCT01928862|537363406|FG004|Overall Study|Lost to Follow-up|1|||
148966750|NCT02053753|537363410|FG000|Overall Study|Withdrawal by Subject|2|||
148966751|NCT02053753|537363411|FG001|Overall Study|Withdrawal by Subject|4|||
148966752|NCT02053753|537363410|FG000|Overall Study|Decision by Sponsor|1|||
148966753|NCT02053753|537363411|FG001|Overall Study|Decision by Sponsor|1|||
148966754|NCT02053753|537363410|FG000|Overall Study|Lost to Follow-up|4|||
148966755|NCT02053753|537363411|FG001|Overall Study|Lost to Follow-up|3|||
148966756|NCT02972632|537363416|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
148698899|NCT00533273|536371689|FG000|Double-blind|Withdrew consent|0|||
148698900|NCT00533273|536371690|FG001|Double-blind|Withdrew consent|2|||
148698901|NCT00533273|536371689|FG000|Open-label|Withdrawal by Subject|6|||
148698902|NCT00533273|536371690|FG001|Open-label|Withdrawal by Subject|0|||
148698903|NCT01873586|536371692|FG000|Overall Study|Lost to Follow-up|3|||
148698904|NCT00454909|536371693|FG000|Overall Study|Withdrawal by Subject|1|||
148698905|NCT00454909|536371694|FG001|Overall Study|Withdrawal by Subject|0|||
148698906|NCT00454909|536371695|FG002|Overall Study|Withdrawal by Subject|0|||
148698907|NCT00454909|536371693|FG000|Overall Study|Migrated/moved from study area|0|||
148698908|NCT00454909|536371694|FG001|Overall Study|Migrated/moved from study area|0|||
148698909|NCT00454909|536371695|FG002|Overall Study|Migrated/moved from study area|1|||
148698910|NCT00454909|536371693|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
148698911|NCT00454909|536371694|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
148698912|NCT00454909|536371695|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
148698913|NCT00454909|536371693|FG000|Overall Study|Others|1|||
148698914|NCT00454909|536371694|FG001|Overall Study|Others|0|||
148698915|NCT00454909|536371695|FG002|Overall Study|Others|0|||
148698916|NCT00282048|536371696|FG000|Overall Study|Lack of Efficacy|30|||
148698917|NCT00282048|536371696|FG000|Overall Study|Adverse Event|22|||
148698918|NCT00282048|536371696|FG000|Overall Study|Withdrawal by Subject|1|||
148698919|NCT00282048|536371696|FG000|Overall Study|Other|8|||
148698920|NCT00282048|536371696|FG000|Overall Study|Ongoing|1|||
148698921|NCT03048500|536371698|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
148698922|NCT03048500|536371698|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
148698923|NCT03048500|536371698|FG000|Reached 1st Response/Continued Treatment|Death|1|||
148698924|NCT03048500|536371698|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
148698925|NCT03048500|536371698|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
148698926|NCT03048500|536371698|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
148698927|NCT03048500|536371698|FG000|Follow up for 3 Years|Death|12|||
148698928|NCT01941030|536371701|FG000|Overall Study|Death|3|||
148698929|NCT01941030|536371702|FG001|Overall Study|Death|2|||
148698930|NCT01941030|536371701|FG000|Overall Study|Lost to Follow-up|6|||
148698931|NCT01941030|536371702|FG001|Overall Study|Lost to Follow-up|5|||
148698932|NCT01941030|536371701|FG000|Overall Study|Withdrawal by Subject|4|||
148698933|NCT01941030|536371702|FG001|Overall Study|Withdrawal by Subject|6|||
148698934|NCT00870870|536371705|FG000|Overall Study|Withdrawal by Subject|0|||
148698935|NCT00870870|536371706|FG001|Overall Study|Withdrawal by Subject|1|||
148698936|NCT00870870|536371707|FG002|Overall Study|Withdrawal by Subject|1|||
148698937|NCT00870870|536371708|FG003|Overall Study|Withdrawal by Subject|3|||
148698938|NCT00870870|536371705|FG000|Overall Study|Adverse Event|0|||
148698939|NCT00870870|536371706|FG001|Overall Study|Adverse Event|0|||
148698940|NCT00870870|536371707|FG002|Overall Study|Adverse Event|2|||
148814819|NCT02202616|536798019|FG000|Overall Study|Abnormal test procedure result|1|||
148814820|NCT02202616|536798019|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148966757|NCT02972632|537363416|FG000|Overall Study|Lost to Follow-up|4|||
148966758|NCT02972632|537363416|FG000|Overall Study|Voluntary Withdrawal|10|||
148966759|NCT00337103|537363420|FG000|Overall Study|Progressive Disease|414|||
148966760|NCT00337103|537363421|FG001|Overall Study|Progressive Disease|410|||
148698941|NCT00870870|536371708|FG003|Overall Study|Adverse Event|2|||
148698942|NCT03639311|536371714|FG000|Maintenance Phase|Lost to Follow-up|1|||
148698943|NCT03639311|536371715|FG001|Maintenance Phase|Lost to Follow-up|0|||
148698944|NCT03639311|536371716|FG002|Maintenance Phase|Lost to Follow-up|0|||
148698945|NCT03639311|536371714|FG000|Maintenance Phase|Adverse Event|1|||
148698946|NCT03639311|536371715|FG001|Maintenance Phase|Adverse Event|0|||
148698947|NCT03639311|536371716|FG002|Maintenance Phase|Adverse Event|0|||
148698948|NCT03639311|536371714|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
148698949|NCT03639311|536371715|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
148698950|NCT03639311|536371716|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
148698951|NCT03639311|536371714|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
148698952|NCT03639311|536371715|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
148966761|NCT00337103|537363420|FG000|Overall Study|Adverse Event|45|||
148966762|NCT00337103|537363421|FG001|Overall Study|Adverse Event|59|||
148966763|NCT00337103|537363420|FG000|Overall Study|Subject Choice|34|||
148966764|NCT00337103|537363421|FG001|Overall Study|Subject Choice|27|||
148966765|NCT00337103|537363420|FG000|Overall Study|Clinical Progression|27|||
148966766|NCT00337103|537363421|FG001|Overall Study|Clinical Progression|24|||
148966767|NCT00337103|537363420|FG000|Overall Study|Physician Decision|15|||
148966768|NCT00337103|537363421|FG001|Overall Study|Physician Decision|14|||
148966769|NCT00337103|537363420|FG000|Overall Study|Withdrawal by Subject|8|||
148966770|NCT00337103|537363421|FG001|Overall Study|Withdrawal by Subject|5|||
148966771|NCT00337103|537363420|FG000|Overall Study|Other|5|||
148966772|NCT00337103|537363421|FG001|Overall Study|Other|6|||
148966773|NCT00337103|537363420|FG000|Overall Study|Entry Criteria Not Met|4|||
148966774|NCT00337103|537363421|FG001|Overall Study|Entry Criteria Not Met|1|||
148966775|NCT00337103|537363420|FG000|Overall Study|Lost to Follow-up|1|||
148966776|NCT00337103|537363421|FG001|Overall Study|Lost to Follow-up|2|||
148966777|NCT00337103|537363420|FG000|Overall Study|Death|1|||
148966778|NCT00337103|537363421|FG001|Overall Study|Death|0|||
148966779|NCT02016482|537363422|FG000|Period A|Adverse Event|3|||
148966780|NCT02016482|537363423|FG001|Period A|Adverse Event|5|||
148966781|NCT02016482|537363422|FG000|Period A|Withdrawal by Subject|3|||
148966782|NCT02016482|537363423|FG001|Period A|Withdrawal by Subject|4|||
148966783|NCT02016482|537363422|FG000|Period A|Lost to Follow-up|3|||
148966784|NCT02016482|537363423|FG001|Period A|Lost to Follow-up|3|||
148966785|NCT02016482|537363422|FG000|Period A|Lack of Efficacy|2|||
148966786|NCT02016482|537363423|FG001|Period A|Lack of Efficacy|1|||
148966787|NCT02016482|537363422|FG000|Period A|Other|3|||
148966788|NCT02016482|537363423|FG001|Period A|Other|0|||
148966789|NCT02016482|537363422|FG000|Period A|Protocol Violation|0|||
148966790|NCT02016482|537363423|FG001|Period A|Protocol Violation|1|||
148966791|NCT02016482|537363422|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
148966792|NCT02016482|537363423|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
148966793|NCT02016482|537363422|FG000|Period B|Withdrawal by Subject|1|||
148966794|NCT02016482|537363423|FG001|Period B|Withdrawal by Subject|1|||
148966795|NCT02016482|537363422|FG000|Period B|Lost to Follow-up|2|||
148966796|NCT02016482|537363423|FG001|Period B|Lost to Follow-up|0|||
148966797|NCT02016482|537363422|FG000|Period B|Lack of Efficacy|6|||
148966798|NCT02016482|537363423|FG001|Period B|Lack of Efficacy|4|||
148966799|NCT02016482|537363422|FG000|Period B|Other|4|||
148966800|NCT02016482|537363423|FG001|Period B|Other|0|||
148966801|NCT02016482|537363422|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
148966802|NCT02016482|537363423|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
148966803|NCT01289847|537363424|FG000|Overall Study|Patient could not comply with visits|1|||
148966804|NCT03774433|537363445|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
148966805|NCT02741700|537363446|FG000|Overall Study|Lost to Follow-up|17|||
148966806|NCT02741700|537363447|FG001|Overall Study|Lost to Follow-up|8|||
148966807|NCT02741700|537363446|FG000|Overall Study|Withdrawal by Subject|2|||
148966808|NCT02741700|537363447|FG001|Overall Study|Withdrawal by Subject|5|||
148966809|NCT02741700|537363446|FG000|Overall Study|Physician Decision|3|||
148966810|NCT02741700|537363447|FG001|Overall Study|Physician Decision|0|||
148966811|NCT02741700|537363446|FG000|Overall Study|Moved out of State|0|||
148966812|NCT02741700|537363447|FG001|Overall Study|Moved out of State|1|||
148966813|NCT02741700|537363446|FG000|Overall Study|Death|4|||
148966814|NCT02741700|537363447|FG001|Overall Study|Death|5|||
148966815|NCT01774786|537363449|FG000|Overall Study|Death|300|||
148966816|NCT01774786|537363450|FG001|Overall Study|Death|319|||
148966817|NCT01774786|537363449|FG000|Overall Study|Lost to Follow-up|6|||
148966818|NCT01774786|537363450|FG001|Overall Study|Lost to Follow-up|7|||
148966819|NCT01774786|537363449|FG000|Overall Study|Withdrawal by Subject|18|||
148966820|NCT01774786|537363450|FG001|Overall Study|Withdrawal by Subject|14|||
148966821|NCT01774786|537363449|FG000|Overall Study|Physician Decision|2|||
148966822|NCT01774786|537363450|FG001|Overall Study|Physician Decision|0|||
148966823|NCT01774786|537363449|FG000|Overall Study|Non-compliance|0|||
148966824|NCT01774786|537363450|FG001|Overall Study|Non-compliance|1|||
148966825|NCT01774786|537363449|FG000|Overall Study|Reason Not Specified|2|||
148966826|NCT01774786|537363450|FG001|Overall Study|Reason Not Specified|5|||
148966827|NCT02268812|537363451|FG000|Overall Study|Adverse Event|8|||
148966828|NCT02268812|537363452|FG001|Overall Study|Adverse Event|26|||
148966829|NCT02268812|537363453|FG002|Overall Study|Adverse Event|7|||
148966830|NCT02268812|537363454|FG003|Overall Study|Adverse Event|10|||
148966831|NCT02268812|537363451|FG000|Overall Study|Protocol deviation|0|||
148966832|NCT02268812|537363452|FG001|Overall Study|Protocol deviation|0|||
148966833|NCT02268812|537363453|FG002|Overall Study|Protocol deviation|1|||
148966834|NCT02268812|537363454|FG003|Overall Study|Protocol deviation|0|||
148966835|NCT02268812|537363451|FG000|Overall Study|Withdrawal by Subject|0|||
148966836|NCT02268812|537363452|FG001|Overall Study|Withdrawal by Subject|1|||
148966837|NCT02268812|537363453|FG002|Overall Study|Withdrawal by Subject|0|||
148966838|NCT02268812|537363454|FG003|Overall Study|Withdrawal by Subject|0|||
148966839|NCT02268812|537363451|FG000|Overall Study|Physician Decision|3|||
148966840|NCT02268812|537363452|FG001|Overall Study|Physician Decision|1|||
148966841|NCT02268812|537363453|FG002|Overall Study|Physician Decision|0|||
148966842|NCT02268812|537363454|FG003|Overall Study|Physician Decision|1|||
148966843|NCT02268812|537363451|FG000|Overall Study|Other|5|||
148966844|NCT02268812|537363452|FG001|Overall Study|Other|4|||
148966845|NCT02268812|537363453|FG002|Overall Study|Other|1|||
148966846|NCT02268812|537363454|FG003|Overall Study|Other|3|||
148966847|NCT04544293|537363455|FG000|Double-blind|Adverse Event|2|||
148966848|NCT04544293|537363456|FG001|Double-blind|Adverse Event|1|||
148966849|NCT04544293|537363455|FG000|Double-blind|Pregnancy|0|||
148966850|NCT04544293|537363456|FG001|Double-blind|Pregnancy|1|||
148966851|NCT04544293|537363455|FG000|Double-blind|Lost to Follow-up|0|||
148966852|NCT04544293|537363456|FG001|Double-blind|Lost to Follow-up|1|||
148966853|NCT04544293|537363455|FG000|Open-Label Extension|Study ongoing|79|||
148966854|NCT04544293|537363456|FG001|Open-Label Extension|Study ongoing|81|||
148966855|NCT02965703|537363462|FG000|Overall Study|Withdrawal by Subject|6|||
148966856|NCT02965703|537363463|FG001|Overall Study|Withdrawal by Subject|3|||
148966857|NCT02965703|537363464|FG002|Overall Study|Withdrawal by Subject|1|||
148966858|NCT02965703|537363462|FG000|Overall Study|Protocol Violation|1|||
148966859|NCT02965703|537363463|FG001|Overall Study|Protocol Violation|0|||
148966860|NCT02965703|537363464|FG002|Overall Study|Protocol Violation|0|||
148966861|NCT02965703|537363462|FG000|Overall Study|Adverse Event|1|||
148966862|NCT02965703|537363463|FG001|Overall Study|Adverse Event|1|||
148966863|NCT02965703|537363464|FG002|Overall Study|Adverse Event|0|||
148966864|NCT02965703|537363462|FG000|Overall Study|Lost to Follow-up|2|||
148966865|NCT02965703|537363463|FG001|Overall Study|Lost to Follow-up|1|||
148966866|NCT02965703|537363464|FG002|Overall Study|Lost to Follow-up|1|||
148966867|NCT01951157|537363465|FG000|Overall Study|Progressive Disease|12|||
148966868|NCT01951157|537363466|FG001|Overall Study|Progressive Disease|13|||
148966869|NCT01951157|537363467|FG002|Overall Study|Progressive Disease|10|||
148966870|NCT01951157|537363465|FG000|Overall Study|Treatment-unrelated AE|1|||
148966871|NCT01951157|537363466|FG001|Overall Study|Treatment-unrelated AE|0|||
148966872|NCT01951157|537363467|FG002|Overall Study|Treatment-unrelated AE|3|||
148966873|NCT01951157|537363465|FG000|Overall Study|Study Termination|0|||
148966874|NCT01951157|537363466|FG001|Overall Study|Study Termination|0|||
148966875|NCT01951157|537363467|FG002|Overall Study|Study Termination|1|||
148966876|NCT01951157|537363465|FG000|Overall Study|Physician Decision|5|||
148966877|NCT01951157|537363466|FG001|Overall Study|Physician Decision|3|||
148966878|NCT01951157|537363467|FG002|Overall Study|Physician Decision|2|||
148966879|NCT01951157|537363465|FG000|Overall Study|Non-treatmentrelated death|2|||
148966880|NCT01951157|537363466|FG001|Overall Study|Non-treatmentrelated death|2|||
148966881|NCT01951157|537363467|FG002|Overall Study|Non-treatmentrelated death|2|||
148966882|NCT01951157|537363465|FG000|Overall Study|No treated|0|||
148966883|NCT01951157|537363466|FG001|Overall Study|No treated|1|||
148966884|NCT01951157|537363467|FG002|Overall Study|No treated|0|||
148966885|NCT01951157|537363465|FG000|Overall Study|Treatment-related AE|2|||
148966886|NCT01951157|537363466|FG001|Overall Study|Treatment-related AE|0|||
148966887|NCT01951157|537363467|FG002|Overall Study|Treatment-related AE|4|||
148966888|NCT01951157|537363465|FG000|Overall Study|Consent withdrawn by subject|0|||
148966889|NCT01951157|537363466|FG001|Overall Study|Consent withdrawn by subject|1|||
148966890|NCT01951157|537363467|FG002|Overall Study|Consent withdrawn by subject|3|||
148966891|NCT01951157|537363465|FG000|Overall Study|Treatment-related death|0|||
148966892|NCT01951157|537363466|FG001|Overall Study|Treatment-related death|2|||
148966893|NCT01951157|537363467|FG002|Overall Study|Treatment-related death|0|||
148966894|NCT02268786|537363469|FG000|Overall Study|No Euploid Embryos available|42|||
148966895|NCT02268786|537363470|FG001|Overall Study|No Euploid Embryos available|0|||
148966896|NCT02268786|537363469|FG000|Overall Study|Withdrawal by Subject|7|||
148966897|NCT02268786|537363470|FG001|Overall Study|Withdrawal by Subject|14|||
148966898|NCT02268786|537363469|FG000|Overall Study|Thaw Failure|6|||
148966899|NCT02268786|537363470|FG001|Overall Study|Thaw Failure|4|||
148966900|NCT02268786|537363469|FG000|Overall Study|Protocol Violation|1|||
148966901|NCT02268786|537363470|FG001|Overall Study|Protocol Violation|0|||
148966902|NCT01062555|537363472|FG000|Phase 1|Death|10|||
148966903|NCT01062555|537363473|FG001|Phase 1|Death|17|||
148966904|NCT01062555|537363474|FG002|Phase 1|Death|0|||
148966905|NCT01062555|537363475|FG003|Phase 1|Death|0|||
148966906|NCT01062555|537363472|FG000|Phase 1|Graft Failure|12|||
148966907|NCT01062555|537363473|FG001|Phase 1|Graft Failure|8|||
148966908|NCT01062555|537363474|FG002|Phase 1|Graft Failure|0|||
148966909|NCT01062555|537363475|FG003|Phase 1|Graft Failure|0|||
148966910|NCT01062555|537363472|FG000|Phase 1|Withdrawal by Subject|1|||
148966911|NCT01062555|537363473|FG001|Phase 1|Withdrawal by Subject|1|||
148966912|NCT01062555|537363474|FG002|Phase 1|Withdrawal by Subject|0|||
148966913|NCT01062555|537363475|FG003|Phase 1|Withdrawal by Subject|0|||
148966914|NCT01062555|537363472|FG000|Phase 2|Death|0|||
148966915|NCT01062555|537363473|FG001|Phase 2|Death|0|||
148966916|NCT01062555|537363474|FG002|Phase 2|Death|8|||
148966917|NCT01062555|537363475|FG003|Phase 2|Death|3|||
148966918|NCT01062555|537363472|FG000|Phase 2|Graft failure|0|||
148966919|NCT01062555|537363473|FG001|Phase 2|Graft failure|0|||
148966920|NCT01062555|537363474|FG002|Phase 2|Graft failure|7|||
148966921|NCT01062555|537363475|FG003|Phase 2|Graft failure|4|||
148966922|NCT01062555|537363472|FG000|Phase 2|Withdrawal by Subject|0|||
148966923|NCT01062555|537363473|FG001|Phase 2|Withdrawal by Subject|0|||
148966924|NCT01062555|537363474|FG002|Phase 2|Withdrawal by Subject|0|||
148966925|NCT01062555|537363475|FG003|Phase 2|Withdrawal by Subject|7|||
148966926|NCT01062555|537363472|FG000|Phase 2|Protocol Violation|0|||
148966927|NCT01062555|537363473|FG001|Phase 2|Protocol Violation|0|||
148966928|NCT01062555|537363474|FG002|Phase 2|Protocol Violation|0|||
148966929|NCT01062555|537363475|FG003|Phase 2|Protocol Violation|3|||
148966930|NCT01062555|537363472|FG000|Phase 2|Physician Decision|0|||
148698953|NCT03639311|536371716|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
148966931|NCT01062555|537363473|FG001|Phase 2|Physician Decision|0|||
148966932|NCT01062555|537363474|FG002|Phase 2|Physician Decision|0|||
148966933|NCT01062555|537363475|FG003|Phase 2|Physician Decision|17|||
148966934|NCT01359254|537363476|FG000|Overall Study|Death|1|||
148966935|NCT01359254|537363477|FG001|Overall Study|Death|0|||
148966936|NCT01124643|537363478|FG000|Overall Study|Death|1|||
148966937|NCT02028988|537363479|FG000|Overall Study|Withdrawal by Subject|2|||
148966938|NCT02678676|537363482|FG000|Overall Study|Death|619|||
148966939|NCT02678676|537363483|FG001|Overall Study|Death|649|||
148966940|NCT02678676|537363482|FG000|Overall Study|Withdrawal by Subject|13|||
148966941|NCT02678676|537363483|FG001|Overall Study|Withdrawal by Subject|5|||
148966942|NCT02678676|537363482|FG000|Overall Study|Lost to Follow-up|171|||
148966943|NCT02678676|537363483|FG001|Overall Study|Lost to Follow-up|151|||
148966944|NCT02678676|537363482|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
148966945|NCT02678676|537363483|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
148966946|NCT00851799|537363484|FG000|Overall Study|Death|1|||
148966947|NCT00851799|537363485|FG001|Overall Study|Death|0|||
148966948|NCT00851799|537363486|FG002|Overall Study|Death|1|||
148966949|NCT00851799|537363484|FG000|Overall Study|Lost to Follow-up|5|||
148966950|NCT00851799|537363485|FG001|Overall Study|Lost to Follow-up|3|||
148966951|NCT00851799|537363486|FG002|Overall Study|Lost to Follow-up|10|||
148966952|NCT00851799|537363484|FG000|Overall Study|Not able to get to clinic|8|||
148966953|NCT00851799|537363485|FG001|Overall Study|Not able to get to clinic|5|||
148966954|NCT00851799|537363486|FG002|Overall Study|Not able to get to clinic|9|||
148966955|NCT00851799|537363484|FG000|Overall Study|Not willing to adhere to requirements|1|||
148966956|NCT00851799|537363485|FG001|Overall Study|Not willing to adhere to requirements|2|||
148966957|NCT00851799|537363486|FG002|Overall Study|Not willing to adhere to requirements|2|||
148966958|NCT00851799|537363484|FG000|Overall Study|Withdrew consent prior study completion|1|||
148966959|NCT00851799|537363485|FG001|Overall Study|Withdrew consent prior study completion|2|||
148966960|NCT00851799|537363486|FG002|Overall Study|Withdrew consent prior study completion|1|||
148966961|NCT00851799|537363484|FG000|Overall Study|Severe Debilitation|0|||
148966962|NCT00851799|537363485|FG001|Overall Study|Severe Debilitation|1|||
148966963|NCT00851799|537363486|FG002|Overall Study|Severe Debilitation|0|||
148966964|NCT00851799|537363484|FG000|Overall Study|Completed protocol due to pregnancy|0|||
148966965|NCT00851799|537363485|FG001|Overall Study|Completed protocol due to pregnancy|0|||
148966966|NCT00851799|537363486|FG002|Overall Study|Completed protocol due to pregnancy|1|||
148966967|NCT01449526|537363487|FG000|Overall Study|Lost to Follow-up|1|||
148966968|NCT01449526|537363488|FG001|Overall Study|Lost to Follow-up|2|||
148966969|NCT01449526|537363487|FG000|Overall Study|Withdrawal by Subject|1|||
148966970|NCT01449526|537363488|FG001|Overall Study|Withdrawal by Subject|1|||
148966971|NCT01449526|537363487|FG000|Overall Study|Symptoms/complaints|0|||
148966972|NCT01449526|537363488|FG001|Overall Study|Symptoms/complaints|1|||
148966973|NCT01449526|537363487|FG000|Overall Study|Lack of Motivation|0|||
148966974|NCT01449526|537363488|FG001|Overall Study|Lack of Motivation|1|||
148966975|NCT01449526|537363487|FG000|Overall Study|Cannot maintain visits|0|||
148966976|NCT01449526|537363488|FG001|Overall Study|Cannot maintain visits|1|||
148966977|NCT02181556|537364920|FG000|Overall Study|Withdrawal by Subject|1|||
148966978|NCT00997503|537364921|FG000|Overall Study|Death|53|||
148966979|NCT00997503|537364921|FG000|Overall Study|Withdrawal by Subject|76|||
148966980|NCT00997503|537364921|FG000|Overall Study|Lost to Follow-up|33|||
148966981|NCT00997503|537364921|FG000|Overall Study|Adverse Event|3|||
148966982|NCT00997503|537364921|FG000|Overall Study|Physician Decision|10|||
148966983|NCT00997503|537364921|FG000|Overall Study|Missed 12-month follow-up|85|||
148966984|NCT00997503|537364921|FG000|Overall Study|Other reason|13|||
148966985|NCT00380393|537364922|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
148698954|NCT03639311|536371714|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
148698955|NCT03639311|536371715|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
148698956|NCT03639311|536371716|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
148698957|NCT03639311|536371714|FG000|Maintenance Phase|Lack of Efficacy|1|||
148698958|NCT03639311|536371715|FG001|Maintenance Phase|Lack of Efficacy|0|||
148698959|NCT03639311|536371716|FG002|Maintenance Phase|Lack of Efficacy|0|||
148698960|NCT00822926|536371717|FG000|Second Injection Visit|Lost to Follow-up|1|||
148698961|NCT00822926|536371718|FG001|Second Injection Visit|Lost to Follow-up|0|||
148698962|NCT00822926|536371717|FG000|Second Injection Visit|Withdrawal by Subject|0|||
148698963|NCT00822926|536371718|FG001|Second Injection Visit|Withdrawal by Subject|1|||
148698964|NCT03125200|536371720|FG000|Overall Study|Study Termination|0|||
148966986|NCT00380393|537364923|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
148966987|NCT00380393|537364922|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
148966988|NCT00380393|537364923|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
148966989|NCT00380393|537364922|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
148966990|NCT00380393|537364923|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
148966991|NCT00380393|537364922|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
148966992|NCT00380393|537364923|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
148966993|NCT00380393|537364922|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
148966994|NCT00380393|537364923|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
148966995|NCT00380393|537364922|FG000|Month 14|Withdrawal by Subject|9|||
148966996|NCT00380393|537364923|FG001|Month 14|Withdrawal by Subject|7|||
148966997|NCT00380393|537364922|FG000|Month 14|Death|1|||
148966998|NCT00380393|537364923|FG001|Month 14|Death|0|||
148966999|NCT00380393|537364922|FG000|Month 14|Lost to Follow-up|0|||
148967000|NCT00380393|537364923|FG001|Month 14|Lost to Follow-up|1|||
148967001|NCT00380393|537364922|FG000|Month 14|Migrated/moved from study area|39|||
148967002|NCT00380393|537364923|FG001|Month 14|Migrated/moved from study area|42|||
148967003|NCT00380393|537364922|FG000|Month 14|Protocol Violation|2|||
148967004|NCT00380393|537364923|FG001|Month 14|Protocol Violation|0|||
148967005|NCT00380393|537364922|FG000|Month 14|Others|6|||
148967006|NCT00380393|537364923|FG001|Month 14|Others|6|||
148698965|NCT03125200|536371721|FG001|Overall Study|Study Termination|0|||
148698966|NCT03125200|536371722|FG002|Overall Study|Study Termination|0|||
148698967|NCT03125200|536371723|FG003|Overall Study|Study Termination|1|||
148967007|NCT04920123|537364924|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
148967008|NCT04920123|537364925|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
148967009|NCT04920123|537364926|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
148967010|NCT00218296|537364932|FG000|Overall Study|Lost to Follow-up|9|||
148967011|NCT00218296|537364933|FG001|Overall Study|Lost to Follow-up|7|||
148967012|NCT00218296|537364932|FG000|Overall Study|Withdrawal by Subject|36|||
148967013|NCT00218296|537364933|FG001|Overall Study|Withdrawal by Subject|47|||
148967014|NCT00218296|537364932|FG000|Overall Study|Randomized but did not enter treatment|66|||
148967015|NCT00218296|537364933|FG001|Overall Study|Randomized but did not enter treatment|67|||
148814821|NCT04327271|536798024|FG000|Overall Study|Death|1|||
148967016|NCT00314574|537364951|FG000|Overall Study|Death|3|||
149025026|NCT03738241|537567986|FG007|Overall Study|Physician Decision|0|||
148814822|NCT04327271|536798025|FG001|Overall Study|Death|0|||
148814823|NCT04327271|536798024|FG000|Overall Study|Withdrawal by Subject|1|||
148814824|NCT04327271|536798025|FG001|Overall Study|Withdrawal by Subject|0|||
148967017|NCT00314574|537364952|FG001|Overall Study|Death|0|||
148967018|NCT00314574|537364951|FG000|Overall Study|Adverse Event|11|||
148967019|NCT00314574|537364952|FG001|Overall Study|Adverse Event|16|||
148967020|NCT00314574|537364951|FG000|Overall Study|Lost to Follow-up|19|||
148967021|NCT00314574|537364952|FG001|Overall Study|Lost to Follow-up|25|||
148967022|NCT00314574|537364951|FG000|Overall Study|Withdrawal by Subject|33|||
148967023|NCT00314574|537364952|FG001|Overall Study|Withdrawal by Subject|22|||
148698968|NCT03125200|536371724|FG004|Overall Study|Study Termination|1|||
148698969|NCT03125200|536371725|FG005|Overall Study|Study Termination|2|||
148967024|NCT00314574|537364951|FG000|Overall Study|Physician Decision|22|||
148967025|NCT00314574|537364952|FG001|Overall Study|Physician Decision|15|||
148967026|NCT00314574|537364951|FG000|Overall Study|Pregnancy|6|||
148967027|NCT00314574|537364952|FG001|Overall Study|Pregnancy|4|||
148967028|NCT00314574|537364951|FG000|Overall Study|Data unknown at database lock|0|||
148967029|NCT00314574|537364952|FG001|Overall Study|Data unknown at database lock|1|||
148967030|NCT00449956|537364953|FG000|Overall Study|Adverse Event|7|||
148698970|NCT03125200|536371726|FG006|Overall Study|Study Termination|1|||
148698971|NCT03125200|536371720|FG000|Overall Study|Clinical Progression|0|||
148698972|NCT03125200|536371721|FG001|Overall Study|Clinical Progression|0|||
148698973|NCT03125200|536371722|FG002|Overall Study|Clinical Progression|0|||
148698974|NCT03125200|536371723|FG003|Overall Study|Clinical Progression|1|||
148698975|NCT03125200|536371724|FG004|Overall Study|Clinical Progression|0|||
148698976|NCT03125200|536371725|FG005|Overall Study|Clinical Progression|1|||
148698977|NCT03125200|536371726|FG006|Overall Study|Clinical Progression|0|||
148698978|NCT03125200|536371720|FG000|Overall Study|Progressive Disease|2|||
148814825|NCT04327271|536798024|FG000|Overall Study|randomization error (data capture)|4|||
148698979|NCT03125200|536371721|FG001|Overall Study|Progressive Disease|1|||
148698980|NCT03125200|536371722|FG002|Overall Study|Progressive Disease|2|||
148967031|NCT00449956|537364954|FG001|Overall Study|Adverse Event|1|||
148967032|NCT00449956|537364955|FG002|Overall Study|Adverse Event|6|||
148698981|NCT03125200|536371723|FG003|Overall Study|Progressive Disease|1|||
148967033|NCT00449956|537364953|FG000|Overall Study|Lack of Efficacy|0|||
148698982|NCT03125200|536371724|FG004|Overall Study|Progressive Disease|2|||
148967034|NCT00449956|537364954|FG001|Overall Study|Lack of Efficacy|0|||
148967035|NCT00449956|537364955|FG002|Overall Study|Lack of Efficacy|1|||
148967036|NCT00449956|537364953|FG000|Overall Study|Protocol Violation|1|||
148967037|NCT00449956|537364954|FG001|Overall Study|Protocol Violation|1|||
148967038|NCT00449956|537364955|FG002|Overall Study|Protocol Violation|1|||
148814826|NCT04327271|536798025|FG001|Overall Study|randomization error (data capture)|3|||
148967039|NCT00449956|537364953|FG000|Overall Study|Withdrawal by Subject|0|||
148967040|NCT00449956|537364954|FG001|Overall Study|Withdrawal by Subject|1|||
148967041|NCT00449956|537364955|FG002|Overall Study|Withdrawal by Subject|0|||
148967042|NCT00449956|537364953|FG000|Overall Study|Physician Decision|2|||
148967043|NCT00449956|537364954|FG001|Overall Study|Physician Decision|1|||
148967044|NCT00449956|537364955|FG002|Overall Study|Physician Decision|1|||
148967045|NCT01446965|537364960|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
148967046|NCT01446965|537364961|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
148967047|NCT01446965|537364960|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
148967048|NCT01446965|537364961|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
148967049|NCT02023151|537364962|FG000|Overall Study|Lost to Follow-up|4|||
148967050|NCT04064294|537364963|FG000|Overall Study|Adverse Event|1|||
148967051|NCT04064294|537364964|FG001|Overall Study|Adverse Event|0|||
148967052|NCT04064294|537364965|FG002|Overall Study|Adverse Event|0|||
148967053|NCT03450707|537364966|FG000|Overall Study|Outside enrollment window|4|||
148967054|NCT03450707|537364967|FG001|Overall Study|Outside enrollment window|1|||
148967055|NCT03450707|537364966|FG000|Overall Study|Death|1|||
148967056|NCT03450707|537364967|FG001|Overall Study|Death|0|||
148967057|NCT03450707|537364966|FG000|Overall Study|Indication for thiamine|1|||
148967058|NCT03450707|537364967|FG001|Overall Study|Indication for thiamine|1|||
148967059|NCT03450707|537364966|FG000|Overall Study|Evidence of traumatic brain injury|1|||
148967060|NCT03450707|537364967|FG001|Overall Study|Evidence of traumatic brain injury|0|||
148967061|NCT03450707|537364966|FG000|Overall Study|Following commands|0|||
148967062|NCT03450707|537364967|FG001|Overall Study|Following commands|3|||
148967063|NCT03450707|537364966|FG000|Overall Study|Lactate < 3.5|0|||
148967064|NCT03450707|537364967|FG001|Overall Study|Lactate < 3.5|2|||
148967065|NCT03450707|537364966|FG000|Overall Study|Rearrest with ECMO|0|||
148967066|NCT03450707|537364967|FG001|Overall Study|Rearrest with ECMO|1|||
148967067|NCT03450707|537364966|FG000|Overall Study|Indication for thiamine + head CT results|0|||
148967068|NCT03450707|537364967|FG001|Overall Study|Indication for thiamine + head CT results|1|||
148967069|NCT03450707|537364966|FG000|Overall Study|Family/patient goals of care|0|||
148967070|NCT03450707|537364967|FG001|Overall Study|Family/patient goals of care|1|||
148967071|NCT00004412|537364968|FG000|Randomized Period|Moved to Crossover Period|3|||
148967072|NCT00004412|537364969|FG001|Randomized Period|Moved to Crossover Period|0|||
148967073|NCT00004412|537364970|FG002|Randomized Period|Moved to Crossover Period|0|||
148967074|NCT00481195|537364971|FG000|Overall Study|Adverse Event|16|||
148967075|NCT00481195|537364972|FG001|Overall Study|Adverse Event|11|||
148967076|NCT00481195|537364971|FG000|Overall Study|Lack of Efficacy|1|||
148967077|NCT00481195|537364972|FG001|Overall Study|Lack of Efficacy|3|||
148967078|NCT00481195|537364971|FG000|Overall Study|Lost to Follow-up|4|||
148967079|NCT00481195|537364972|FG001|Overall Study|Lost to Follow-up|6|||
148967080|NCT00481195|537364971|FG000|Overall Study|Physician Decision|3|||
148967081|NCT00481195|537364972|FG001|Overall Study|Physician Decision|1|||
148967082|NCT00481195|537364971|FG000|Overall Study|Protocol Violation|10|||
148967083|NCT00481195|537364972|FG001|Overall Study|Protocol Violation|7|||
148967084|NCT00481195|537364971|FG000|Overall Study|Withdrawal by Subject|3|||
148967085|NCT00481195|537364972|FG001|Overall Study|Withdrawal by Subject|9|||
148967086|NCT00481195|537364971|FG000|Overall Study|Miscellaneous|2|||
148967087|NCT00481195|537364972|FG001|Overall Study|Miscellaneous|2|||
148967088|NCT02932904|537364979|FG000|Overall Study|Reason not Specified|1|||
148967089|NCT02932904|537364980|FG001|Overall Study|Reason not Specified|0|||
148967090|NCT02932904|537364981|FG002|Overall Study|Reason not Specified|2|||
148967091|NCT02932904|537364982|FG003|Overall Study|Reason not Specified|2|||
148967092|NCT02932904|537364979|FG000|Overall Study|Noncompliance with Study Drug|2|||
148967093|NCT02932904|537364980|FG001|Overall Study|Noncompliance with Study Drug|3|||
148967094|NCT02932904|537364981|FG002|Overall Study|Noncompliance with Study Drug|3|||
148967095|NCT02932904|537364982|FG003|Overall Study|Noncompliance with Study Drug|4|||
148967096|NCT02932904|537364979|FG000|Overall Study|Pregnancy|0|||
148967097|NCT02932904|537364980|FG001|Overall Study|Pregnancy|1|||
148967098|NCT02932904|537364981|FG002|Overall Study|Pregnancy|1|||
148967099|NCT02932904|537364982|FG003|Overall Study|Pregnancy|0|||
148967100|NCT02932904|537364979|FG000|Overall Study|Study Termination|0|||
148967101|NCT02932904|537364980|FG001|Overall Study|Study Termination|1|||
148967102|NCT02932904|537364981|FG002|Overall Study|Study Termination|0|||
148967103|NCT02932904|537364982|FG003|Overall Study|Study Termination|0|||
148967104|NCT02932904|537364979|FG000|Overall Study|Voluntary Withdrawal|2|||
148814827|NCT04339972|536798026|FG000|Overall Study|Scheduling Issues|3|||
148814828|NCT04339972|536798027|FG001|Overall Study|Scheduling Issues|3|||
148967105|NCT02932904|537364980|FG001|Overall Study|Voluntary Withdrawal|1|||
148967106|NCT02932904|537364981|FG002|Overall Study|Voluntary Withdrawal|4|||
148967107|NCT02932904|537364982|FG003|Overall Study|Voluntary Withdrawal|2|||
148967108|NCT02932904|537364979|FG000|Overall Study|Lost to Follow-up|5|||
148967109|NCT02932904|537364980|FG001|Overall Study|Lost to Follow-up|3|||
148967110|NCT02932904|537364981|FG002|Overall Study|Lost to Follow-up|6|||
148967111|NCT02932904|537364982|FG003|Overall Study|Lost to Follow-up|0|||
148967112|NCT02932904|537364979|FG000|Overall Study|Significant Protocol Deviation|2|||
148967113|NCT02932904|537364980|FG001|Overall Study|Significant Protocol Deviation|3|||
148967114|NCT02932904|537364981|FG002|Overall Study|Significant Protocol Deviation|6|||
148967115|NCT02932904|537364982|FG003|Overall Study|Significant Protocol Deviation|1|||
148967116|NCT02932904|537364979|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
148967117|NCT02932904|537364980|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
148967118|NCT02932904|537364981|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
148967119|NCT02932904|537364982|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
148967120|NCT02932904|537364979|FG000|Overall Study|Randomized But Not Treated|1|||
148967121|NCT02932904|537364980|FG001|Overall Study|Randomized But Not Treated|1|||
148967122|NCT02932904|537364981|FG002|Overall Study|Randomized But Not Treated|0|||
148967123|NCT02932904|537364982|FG003|Overall Study|Randomized But Not Treated|2|||
148967124|NCT02871739|537364983|FG000|Overall Study|Lost to Follow-up|3|||
148967125|NCT02871739|537364984|FG001|Overall Study|Lost to Follow-up|2|||
148967126|NCT02871739|537364985|FG002|Overall Study|Lost to Follow-up|0|||
148967127|NCT02871739|537364986|FG003|Overall Study|Lost to Follow-up|2|||
148967128|NCT03818516|537364987|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
148967129|NCT04372602|537364988|FG000|Overall Study|Withdrawal by Subject|1|||
148967130|NCT04372602|537364989|FG001|Overall Study|Withdrawal by Subject|1|||
148967131|NCT04372602|537364988|FG000|Overall Study|Adverse Event|0|||
148967132|NCT04372602|537364989|FG001|Overall Study|Adverse Event|1|||
148967133|NCT04372602|537364988|FG000|Overall Study|Transitioned to comfort care|0|||
148967134|NCT04372602|537364989|FG001|Overall Study|Transitioned to comfort care|1|||
148967135|NCT00594464|537364990|FG000|Overall Study|Withdrawal by Subject|1|||
148967136|NCT00594464|537364990|FG000|Overall Study|Delay in operation|2|||
148967137|NCT02907359|537364991|FG000|Overall Study|Death|234|||
148967138|NCT02907359|537364992|FG001|Overall Study|Death|117|||
148967139|NCT02907359|537364991|FG000|Overall Study|Withdrawal by Subject|6|||
148967140|NCT02907359|537364992|FG001|Overall Study|Withdrawal by Subject|11|||
148967141|NCT02907359|537364991|FG000|Overall Study|Lost to Follow-up|1|||
148967142|NCT02907359|537364992|FG001|Overall Study|Lost to Follow-up|0|||
148967143|NCT01085097|537364997|FG000|Overall Study|Adverse Event|0|||
148967144|NCT01085097|537364998|FG001|Overall Study|Adverse Event|0|||
148967145|NCT01085097|537364999|FG002|Overall Study|Adverse Event|2|||
148967146|NCT01085097|537364997|FG000|Overall Study|Treatment failure|2|||
148967147|NCT01085097|537364998|FG001|Overall Study|Treatment failure|0|||
148967148|NCT01085097|537364999|FG002|Overall Study|Treatment failure|0|||
148967149|NCT03742141|537365004|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
148967150|NCT00850395|537365009|FG000|Overall Study|Death|1|||
148967151|NCT00850395|537365009|FG000|Overall Study|Adverse Event|1|||
148967152|NCT00850395|537365009|FG000|Overall Study|Insufficient clinical response|3|||
148967153|NCT00850395|537365009|FG000|Overall Study|Other|5|||
148967154|NCT06049043|537365010|FG000|Overall Study|Lost to Follow-up|11|||
148967155|NCT06049043|537365011|FG001|Overall Study|Lost to Follow-up|9|||
148967156|NCT01354496|537365016|FG000|Period 1|Adverse Event|0|||
148967157|NCT01354496|537365017|FG001|Period 1|Adverse Event|0|||
148967158|NCT01354496|537365018|FG002|Period 1|Adverse Event|1|||
148967159|NCT01354496|537365019|FG003|Period 1|Adverse Event|0|||
148967160|NCT01354496|537365020|FG004|Period 1|Adverse Event|0|||
148967161|NCT01354496|537365021|FG005|Period 1|Adverse Event|0|||
148967162|NCT01354496|537365016|FG000|Period 1|Physician Decision|0|||
148967163|NCT01354496|537365017|FG001|Period 1|Physician Decision|0|||
148967164|NCT01354496|537365018|FG002|Period 1|Physician Decision|1|||
148967165|NCT01354496|537365019|FG003|Period 1|Physician Decision|0|||
148967166|NCT01354496|537365020|FG004|Period 1|Physician Decision|0|||
148967167|NCT01354496|537365021|FG005|Period 1|Physician Decision|0|||
148967168|NCT01354496|537365016|FG000|Period 2|Adverse Event|0|||
148967169|NCT01354496|537365017|FG001|Period 2|Adverse Event|0|||
148967170|NCT01354496|537365018|FG002|Period 2|Adverse Event|0|||
148967171|NCT01354496|537365019|FG003|Period 2|Adverse Event|1|||
148967172|NCT01354496|537365020|FG004|Period 2|Adverse Event|0|||
148967173|NCT01354496|537365021|FG005|Period 2|Adverse Event|0|||
148967174|NCT01354496|537365016|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
148967175|NCT01354496|537365017|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
148967176|NCT01354496|537365018|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
148967177|NCT01354496|537365019|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
148967178|NCT01354496|537365020|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
148967179|NCT01354496|537365021|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
148967180|NCT01894152|537365022|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
148967181|NCT01708174|537365023|FG000|Treatment Period|Withdrawal by Subject|1|||
148967182|NCT01708174|537365024|FG001|Treatment Period|Withdrawal by Subject|0|||
148967183|NCT01708174|537365025|FG002|Treatment Period|Withdrawal by Subject|0|||
148967184|NCT01708174|537365023|FG000|Treatment Period|Progressive disease|0|||
148967185|NCT01708174|537365024|FG001|Treatment Period|Progressive disease|1|||
148967186|NCT01708174|537365025|FG002|Treatment Period|Progressive disease|0|||
148967187|NCT01708174|537365023|FG000|Treatment Period|Death|0|||
148967188|NCT01708174|537365024|FG001|Treatment Period|Death|0|||
148967189|NCT01708174|537365025|FG002|Treatment Period|Death|1|||
148967190|NCT01708174|537365023|FG000|Treatment Period|Adverse Event|0|||
148967191|NCT01708174|537365024|FG001|Treatment Period|Adverse Event|1|||
148967192|NCT01708174|537365025|FG002|Treatment Period|Adverse Event|0|||
148967193|NCT00923559|537365026|FG000|Overall Study|Lost to Follow-up|2|||
148967194|NCT00923559|537365027|FG001|Overall Study|Lost to Follow-up|3|||
148967195|NCT00744627|537365028|FG000|Overall Study|Adverse Event|6|||
148967196|NCT00744627|537365029|FG001|Overall Study|Adverse Event|9|||
148967197|NCT00744627|537365028|FG000|Overall Study|Lack of Efficacy|7|||
148967198|NCT00744627|537365029|FG001|Overall Study|Lack of Efficacy|3|||
148967199|NCT00744627|537365028|FG000|Overall Study|Noncompliance|0|||
148967200|NCT00744627|537365029|FG001|Overall Study|Noncompliance|1|||
148967201|NCT00744627|537365028|FG000|Overall Study|Protocol Deviations|0|||
148967202|NCT00744627|537365029|FG001|Overall Study|Protocol Deviations|2|||
148967203|NCT00744627|537365028|FG000|Overall Study|Voluntary Withdrawal|9|||
148967204|NCT00744627|537365029|FG001|Overall Study|Voluntary Withdrawal|6|||
148814829|NCT04339972|536798026|FG000|Overall Study|dropout|1|||
148814830|NCT04339972|536798027|FG001|Overall Study|dropout|1|||
148967205|NCT00744627|537365028|FG000|Overall Study|Lost to Follow-up|2|||
148967206|NCT00744627|537365029|FG001|Overall Study|Lost to Follow-up|1|||
148967207|NCT00744627|537365028|FG000|Overall Study|Other|1|||
148967208|NCT00744627|537365029|FG001|Overall Study|Other|0|||
148967209|NCT03560531|537365030|FG000|Overall Study|Death|4|||
148967210|NCT03560531|537365031|FG001|Overall Study|Death|1|||
148967211|NCT03560531|537365032|FG002|Overall Study|Death|1|||
148814831|NCT04339972|536798026|FG000|Overall Study|Technical issues|1|||
148698983|NCT03125200|536371725|FG005|Overall Study|Progressive Disease|0|||
148698984|NCT03125200|536371726|FG006|Overall Study|Progressive Disease|1|||
148698985|NCT03125200|536371720|FG000|Overall Study|Lack of Efficacy|0|||
148698986|NCT03125200|536371721|FG001|Overall Study|Lack of Efficacy|0|||
148698987|NCT03125200|536371722|FG002|Overall Study|Lack of Efficacy|0|||
148698988|NCT03125200|536371723|FG003|Overall Study|Lack of Efficacy|1|||
148698989|NCT03125200|536371724|FG004|Overall Study|Lack of Efficacy|0|||
148698990|NCT03125200|536371725|FG005|Overall Study|Lack of Efficacy|0|||
148698991|NCT03125200|536371726|FG006|Overall Study|Lack of Efficacy|0|||
148698992|NCT03125200|536371720|FG000|Overall Study|Toxicity|0|||
148698993|NCT03125200|536371721|FG001|Overall Study|Toxicity|0|||
148698994|NCT03125200|536371722|FG002|Overall Study|Toxicity|0|||
148698995|NCT03125200|536371723|FG003|Overall Study|Toxicity|1|||
148698996|NCT03125200|536371724|FG004|Overall Study|Toxicity|0|||
148698997|NCT03125200|536371725|FG005|Overall Study|Toxicity|0|||
148698998|NCT03125200|536371726|FG006|Overall Study|Toxicity|0|||
148698999|NCT03125200|536371720|FG000|Overall Study|Consent Withdrawn by Subject|0|||
148699000|NCT03125200|536371721|FG001|Overall Study|Consent Withdrawn by Subject|1|||
148699001|NCT03125200|536371722|FG002|Overall Study|Consent Withdrawn by Subject|0|||
148699002|NCT03125200|536371723|FG003|Overall Study|Consent Withdrawn by Subject|0|||
148699003|NCT03125200|536371724|FG004|Overall Study|Consent Withdrawn by Subject|1|||
148699004|NCT03125200|536371725|FG005|Overall Study|Consent Withdrawn by Subject|0|||
148699005|NCT03125200|536371726|FG006|Overall Study|Consent Withdrawn by Subject|1|||
148814832|NCT04339972|536798027|FG001|Overall Study|Technical issues|0|||
148699006|NCT01937390|536371730|FG000|Overall Study|Death|2|||
148699007|NCT01937390|536371730|FG000|Overall Study|Lost to Follow-up|7|||
148814833|NCT04339972|536798026|FG000|Overall Study|Claustraphobia|0|||
148699008|NCT01937390|536371730|FG000|Overall Study|Withdrawal by Subject|5|||
148699009|NCT01937390|536371730|FG000|Overall Study|Fail to return|21|||
148699010|NCT03544138|536371735|FG000|Overall Study|Lost to Follow-up|29|||
148699011|NCT04657770|536373028|FG000|Overall Study|Withdrawal by Subject|3|||
148699012|NCT04657770|536373028|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
148699013|NCT00746798|536373029|FG000|Overall Study|Protocol Violation|0|||
148699014|NCT00746798|536373030|FG001|Overall Study|Protocol Violation|1|||
148967212|NCT03560531|537365033|FG003|Overall Study|Death|2|||
148699015|NCT00746798|536373031|FG002|Overall Study|Protocol Violation|0|||
148967213|NCT03560531|537365034|FG004|Overall Study|Death|6|||
148967214|NCT03560531|537365035|FG005|Overall Study|Death|1|||
148967215|NCT03560531|537365036|FG006|Overall Study|Death|4|||
148967216|NCT03560531|537365037|FG007|Overall Study|Death|8|||
148967217|NCT03560531|537365038|FG008|Overall Study|Death|1|||
148967218|NCT03560531|537365039|FG009|Overall Study|Death|3|||
148967219|NCT03560531|537365040|FG010|Overall Study|Death|2|||
148967220|NCT03560531|537365041|FG011|Overall Study|Death|0|||
148967221|NCT03560531|537365042|FG012|Overall Study|Death|4|||
148967222|NCT03560531|537365043|FG013|Overall Study|Death|1|||
148967223|NCT03560531|537365030|FG000|Overall Study|Lost to Follow-up|1|||
148967224|NCT03560531|537365031|FG001|Overall Study|Lost to Follow-up|1|||
148699016|NCT00746798|536373032|FG003|Overall Study|Protocol Violation|0|||
148699017|NCT00746798|536373029|FG000|Overall Study|Withdrawal by Subject|0|||
148699018|NCT00746798|536373030|FG001|Overall Study|Withdrawal by Subject|1|||
148967225|NCT03560531|537365032|FG002|Overall Study|Lost to Follow-up|0|||
148967226|NCT03560531|537365033|FG003|Overall Study|Lost to Follow-up|0|||
148967227|NCT03560531|537365034|FG004|Overall Study|Lost to Follow-up|0|||
148967228|NCT03560531|537365035|FG005|Overall Study|Lost to Follow-up|0|||
148967229|NCT03560531|537365036|FG006|Overall Study|Lost to Follow-up|1|||
148699019|NCT00746798|536373031|FG002|Overall Study|Withdrawal by Subject|1|||
148699020|NCT00746798|536373032|FG003|Overall Study|Withdrawal by Subject|0|||
148699021|NCT00746798|536373029|FG000|Overall Study|Death|0|||
148814834|NCT04339972|536798027|FG001|Overall Study|Claustraphobia|1|||
148967230|NCT03560531|537365037|FG007|Overall Study|Lost to Follow-up|0|||
148967231|NCT03560531|537365038|FG008|Overall Study|Lost to Follow-up|0|||
148699022|NCT00746798|536373030|FG001|Overall Study|Death|0|||
148699023|NCT00746798|536373031|FG002|Overall Study|Death|2|||
148699024|NCT00746798|536373032|FG003|Overall Study|Death|0|||
148699025|NCT00746798|536373029|FG000|Overall Study|Participant unable to return for visit|1|||
148699026|NCT00746798|536373030|FG001|Overall Study|Participant unable to return for visit|0|||
148699027|NCT00746798|536373031|FG002|Overall Study|Participant unable to return for visit|0|||
148699028|NCT00746798|536373032|FG003|Overall Study|Participant unable to return for visit|0|||
148699029|NCT00633594|536373035|FG000|Overall Study|Adverse Event|0|||
148699030|NCT00633594|536373036|FG001|Overall Study|Adverse Event|4|||
148699031|NCT00633594|536373037|FG002|Overall Study|Adverse Event|7|||
148699032|NCT00633594|536373035|FG000|Overall Study|Death|0|||
148699033|NCT00633594|536373036|FG001|Overall Study|Death|1|||
148814835|NCT00776997|536798028|FG000|Overall Study|Adverse Event|2|||
148814836|NCT02403271|536798029|FG000|Period 1|Other varied reasons|1|||
148814837|NCT02403271|536798030|FG001|Period 1|Other varied reasons|0|||
148814838|NCT02403271|536798029|FG000|Period 2|Withdrawal by Subject|0|||
148814839|NCT02403271|536798030|FG001|Period 2|Withdrawal by Subject|14|||
148967232|NCT03560531|537365039|FG009|Overall Study|Lost to Follow-up|0|||
148814840|NCT02403271|536798029|FG000|Period 2|Death|0|||
148814841|NCT02403271|536798030|FG001|Period 2|Death|84|||
148967233|NCT03560531|537365040|FG010|Overall Study|Lost to Follow-up|0|||
148967234|NCT03560531|537365041|FG011|Overall Study|Lost to Follow-up|0|||
148699034|NCT00633594|536373037|FG002|Overall Study|Death|2|||
148699035|NCT00633594|536373035|FG000|Overall Study|Disease Progression|0|||
148814842|NCT02403271|536798029|FG000|Period 2|Lost to Follow-up|0|||
148814843|NCT02403271|536798030|FG001|Period 2|Lost to Follow-up|2|||
148814844|NCT02403271|536798029|FG000|Period 2|Study Terminated by Sponsor|0|||
148814845|NCT02403271|536798030|FG001|Period 2|Study Terminated by Sponsor|14|||
148814846|NCT02403271|536798029|FG000|Period 2|Other varied reasons|0|||
148814847|NCT02403271|536798030|FG001|Period 2|Other varied reasons|10|||
148967235|NCT03560531|537365042|FG012|Overall Study|Lost to Follow-up|0|||
148967236|NCT03560531|537365043|FG013|Overall Study|Lost to Follow-up|0|||
148967237|NCT03560531|537365030|FG000|Overall Study|Withdrawal by Subject|1|||
148967238|NCT03560531|537365031|FG001|Overall Study|Withdrawal by Subject|0|||
148967239|NCT03560531|537365032|FG002|Overall Study|Withdrawal by Subject|0|||
148967240|NCT03560531|537365033|FG003|Overall Study|Withdrawal by Subject|0|||
148967241|NCT03560531|537365034|FG004|Overall Study|Withdrawal by Subject|0|||
148967242|NCT03560531|537365035|FG005|Overall Study|Withdrawal by Subject|0|||
148967243|NCT03560531|537365036|FG006|Overall Study|Withdrawal by Subject|0|||
148967244|NCT03560531|537365037|FG007|Overall Study|Withdrawal by Subject|3|||
148967245|NCT03560531|537365038|FG008|Overall Study|Withdrawal by Subject|2|||
148967246|NCT03560531|537365039|FG009|Overall Study|Withdrawal by Subject|0|||
148967247|NCT03560531|537365040|FG010|Overall Study|Withdrawal by Subject|0|||
148967248|NCT03560531|537365041|FG011|Overall Study|Withdrawal by Subject|0|||
148967249|NCT03560531|537365042|FG012|Overall Study|Withdrawal by Subject|2|||
148814848|NCT05221866|536798033|FG000|Overall Study|Withdrawal by Subject|5|||
148814849|NCT05221866|536798034|FG001|Overall Study|Withdrawal by Subject|7|||
148814850|NCT05221866|536798035|FG002|Overall Study|Withdrawal by Subject|6|||
148967250|NCT03560531|537365043|FG013|Overall Study|Withdrawal by Subject|0|||
148967251|NCT03560531|537365030|FG000|Overall Study|Study end per-protocol|1|||
148967252|NCT03560531|537365031|FG001|Overall Study|Study end per-protocol|1|||
148967253|NCT03560531|537365032|FG002|Overall Study|Study end per-protocol|2|||
148967254|NCT03560531|537365033|FG003|Overall Study|Study end per-protocol|0|||
148967255|NCT03560531|537365034|FG004|Overall Study|Study end per-protocol|1|||
148967256|NCT03560531|537365035|FG005|Overall Study|Study end per-protocol|0|||
148967257|NCT03560531|537365036|FG006|Overall Study|Study end per-protocol|0|||
148967258|NCT03560531|537365037|FG007|Overall Study|Study end per-protocol|0|||
148967259|NCT03560531|537365038|FG008|Overall Study|Study end per-protocol|0|||
148967260|NCT03560531|537365039|FG009|Overall Study|Study end per-protocol|0|||
148967261|NCT03560531|537365040|FG010|Overall Study|Study end per-protocol|0|||
148967262|NCT03560531|537365041|FG011|Overall Study|Study end per-protocol|0|||
148967263|NCT03560531|537365042|FG012|Overall Study|Study end per-protocol|0|||
148967264|NCT03560531|537365043|FG013|Overall Study|Study end per-protocol|0|||
148967265|NCT03560531|537365030|FG000|Overall Study|Early study termination by sponsor|9|||
148967266|NCT03560531|537365031|FG001|Overall Study|Early study termination by sponsor|0|||
148967267|NCT03560531|537365032|FG002|Overall Study|Early study termination by sponsor|0|||
148967268|NCT03560531|537365033|FG003|Overall Study|Early study termination by sponsor|4|||
148699036|NCT00633594|536373036|FG001|Overall Study|Disease Progression|0|||
148699037|NCT00633594|536373037|FG002|Overall Study|Disease Progression|1|||
148699038|NCT02028715|536373038|FG000|Overall Study|Adverse Event|2|||
148699039|NCT02028715|536373039|FG001|Overall Study|Adverse Event|2|||
148967269|NCT03560531|537365034|FG004|Overall Study|Early study termination by sponsor|8|||
148699040|NCT02028715|536373038|FG000|Overall Study|Physician Decision|1|||
148699041|NCT02028715|536373039|FG001|Overall Study|Physician Decision|0|||
148699042|NCT02028715|536373038|FG000|Overall Study|Did not complete satisfaction surveys|2|||
148888878|NCT02159066|537072253|FG000|Part I|Progressive Disease|37|||
148699043|NCT02028715|536373039|FG001|Overall Study|Did not complete satisfaction surveys|2|||
148888879|NCT02159066|537072254|FG001|Part I|Progressive Disease|46|||
148888880|NCT02159066|537072255|FG002|Part I|Progressive Disease|0|||
148888881|NCT02159066|537072256|FG003|Part I|Progressive Disease|0|||
148888882|NCT02159066|537072257|FG004|Part I|Progressive Disease|0|||
148888883|NCT02159066|537072258|FG005|Part I|Progressive Disease|0|||
148888884|NCT02159066|537072253|FG000|Part I|New Therapy for Study Indication|5|||
148888885|NCT02159066|537072254|FG001|Part I|New Therapy for Study Indication|4|||
148888886|NCT02159066|537072255|FG002|Part I|New Therapy for Study Indication|0|||
148888887|NCT02159066|537072256|FG003|Part I|New Therapy for Study Indication|0|||
148888888|NCT02159066|537072257|FG004|Part I|New Therapy for Study Indication|0|||
148699044|NCT01287013|536373040|FG000|Overall Study|Non-evaluable|3|||
148699045|NCT01287013|536373041|FG001|Overall Study|Non-evaluable|5|||
148699046|NCT01287013|536373042|FG002|Overall Study|Non-evaluable|21|||
148699047|NCT01471093|536373043|FG000|Overall Study|Adverse Event|1|||
148699048|NCT01471093|536373044|FG001|Overall Study|Adverse Event|0|||
148699049|NCT01471093|536373045|FG002|Overall Study|Adverse Event|0|||
148699050|NCT01471093|536373046|FG003|Overall Study|Adverse Event|0|||
148699051|NCT01710657|536373047|FG000|Overall Study|Lost to Follow-up|2|||
148699052|NCT01710657|536373048|FG001|Overall Study|Lost to Follow-up|0|||
148699053|NCT01710657|536373049|FG002|Overall Study|Lost to Follow-up|1|||
148699054|NCT01710657|536373047|FG000|Overall Study|Protocol Violation|2|||
148699055|NCT01710657|536373048|FG001|Overall Study|Protocol Violation|2|||
148699056|NCT01710657|536373049|FG002|Overall Study|Protocol Violation|0|||
148699057|NCT01710657|536373047|FG000|Overall Study|Adverse Event|14|||
148699058|NCT01710657|536373048|FG001|Overall Study|Adverse Event|8|||
148699059|NCT01710657|536373049|FG002|Overall Study|Adverse Event|28|||
148699060|NCT01710657|536373047|FG000|Overall Study|Withdrawal by Subject|0|||
148699061|NCT01710657|536373048|FG001|Overall Study|Withdrawal by Subject|1|||
148699062|NCT01710657|536373049|FG002|Overall Study|Withdrawal by Subject|2|||
148699063|NCT01710657|536373047|FG000|Overall Study|Lack of Efficacy|0|||
148699064|NCT01710657|536373048|FG001|Overall Study|Lack of Efficacy|1|||
148699065|NCT01710657|536373049|FG002|Overall Study|Lack of Efficacy|1|||
148699066|NCT00358449|536373052|FG000|Overall Study|Adverse Event|1|||
148699067|NCT00358449|536373053|FG001|Overall Study|Adverse Event|0|||
148699068|NCT00358449|536373054|FG002|Overall Study|Adverse Event|1|||
148699069|NCT00358449|536373052|FG000|Overall Study|Lost to Follow-up|1|||
148699070|NCT00358449|536373053|FG001|Overall Study|Lost to Follow-up|0|||
148699071|NCT00358449|536373054|FG002|Overall Study|Lost to Follow-up|0|||
148699072|NCT00358449|536373052|FG000|Overall Study|Withdrawal by Subject|2|||
148699073|NCT00358449|536373053|FG001|Overall Study|Withdrawal by Subject|0|||
148699074|NCT00358449|536373054|FG002|Overall Study|Withdrawal by Subject|0|||
148699075|NCT00358449|536373052|FG000|Overall Study|Lack of Efficacy|0|||
148699076|NCT00358449|536373053|FG001|Overall Study|Lack of Efficacy|1|||
148699077|NCT00358449|536373054|FG002|Overall Study|Lack of Efficacy|0|||
148699078|NCT00358449|536373052|FG000|Overall Study|Steriod Inhaler was Increased|0|||
148699079|NCT00358449|536373053|FG001|Overall Study|Steriod Inhaler was Increased|0|||
148699080|NCT00358449|536373054|FG002|Overall Study|Steriod Inhaler was Increased|1|||
148699081|NCT01804270|536373055|FG000|Overall Study|Withdrawal by Subject|1|||
148699082|NCT01804270|536373056|FG001|Overall Study|Withdrawal by Subject|1|||
148699083|NCT04407806|536373061|FG000|Overall Study|Withdrawal by Subject|1|||
148699084|NCT04407806|536373062|FG001|Overall Study|Withdrawal by Subject|2|||
148699085|NCT05327491|536373065|FG000|Periods 1 & 2|Miscellaneous|0|||
148699086|NCT05327491|536373066|FG001|Periods 1 & 2|Miscellaneous|1|||
148699087|NCT05327491|536373067|FG002|Periods 1 & 2|Miscellaneous|0|||
148699088|NCT05327491|536373068|FG003|Periods 1 & 2|Miscellaneous|0|||
148699089|NCT05327491|536373065|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
148699090|NCT05327491|536373066|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
148699091|NCT05327491|536373067|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
148699092|NCT05327491|536373068|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
148699093|NCT02188303|536373069|FG000|Overall Study|Adverse Event|0|||
148699094|NCT02188303|536373070|FG001|Overall Study|Adverse Event|0|||
148699095|NCT02188303|536373071|FG002|Overall Study|Adverse Event|0|||
148699096|NCT02188303|536373072|FG003|Overall Study|Adverse Event|0|||
148699097|NCT02188303|536373073|FG004|Overall Study|Adverse Event|0|||
148699098|NCT02188303|536373074|FG005|Overall Study|Adverse Event|2|||
148699099|NCT02188303|536373075|FG006|Overall Study|Adverse Event|0|||
148699100|NCT02188303|536373076|FG007|Overall Study|Adverse Event|2|||
148699101|NCT02188303|536373069|FG000|Overall Study|Dose Termination Criteria Met|0|||
148699102|NCT02188303|536373070|FG001|Overall Study|Dose Termination Criteria Met|0|||
148699103|NCT02188303|536373071|FG002|Overall Study|Dose Termination Criteria Met|0|||
148699104|NCT02188303|536373072|FG003|Overall Study|Dose Termination Criteria Met|0|||
148699105|NCT02188303|536373073|FG004|Overall Study|Dose Termination Criteria Met|0|||
148699106|NCT02188303|536373074|FG005|Overall Study|Dose Termination Criteria Met|0|||
148699107|NCT02188303|536373075|FG006|Overall Study|Dose Termination Criteria Met|2|||
148699108|NCT02188303|536373076|FG007|Overall Study|Dose Termination Criteria Met|4|||
148699109|NCT02334722|536373077|FG000|Overall Study|Lost to Follow-up|4|||
148699110|NCT02334722|536373078|FG001|Overall Study|Lost to Follow-up|0|||
148699111|NCT02334722|536373077|FG000|Overall Study|6 week questionnaire not completed|2|||
148699112|NCT02334722|536373078|FG001|Overall Study|6 week questionnaire not completed|0|||
148699113|NCT02334722|536373077|FG000|Overall Study|Unable to obtain medication|1|||
148699114|NCT02334722|536373078|FG001|Overall Study|Unable to obtain medication|1|||
148699115|NCT02334722|536373077|FG000|Overall Study|Withdrawal by Subject|0|||
148699116|NCT02334722|536373078|FG001|Overall Study|Withdrawal by Subject|3|||
148699117|NCT02334722|536373077|FG000|Overall Study|Adverse Event|0|||
148699118|NCT02334722|536373078|FG001|Overall Study|Adverse Event|2|||
148699119|NCT02334722|536373077|FG000|Overall Study|Physician Decision|0|||
148699120|NCT02334722|536373078|FG001|Overall Study|Physician Decision|1|||
148699121|NCT01035060|536373088|FG000|Overall Study|Lost to Follow-up|0|||
148699122|NCT01035060|536373089|FG001|Overall Study|Lost to Follow-up|7|||
148699123|NCT01035060|536373088|FG000|Overall Study|Did not quality after 2nd screening|14|||
148699124|NCT01035060|536373089|FG001|Overall Study|Did not quality after 2nd screening|1|||
148699125|NCT01035060|536373088|FG000|Overall Study|Withdrawal by Subject|8|||
148699126|NCT01035060|536373089|FG001|Overall Study|Withdrawal by Subject|6|||
148699127|NCT01035060|536373088|FG000|Overall Study|Physician Decision|2|||
148699128|NCT01035060|536373089|FG001|Overall Study|Physician Decision|0|||
148699129|NCT00064753|536373095|FG000|Overall Study|Death|251|||
148699130|NCT00064753|536373096|FG001|Overall Study|Death|242|||
148699131|NCT00064753|536373095|FG000|Overall Study|Withdrawal by Subject|198|||
148699132|NCT00064753|536373096|FG001|Overall Study|Withdrawal by Subject|171|||
148699133|NCT00064753|536373095|FG000|Overall Study|Lost to Follow-up|225|||
148699134|NCT00064753|536373096|FG001|Overall Study|Lost to Follow-up|235|||
148699135|NCT02193880|536373099|FG000|Overall Study|patients did not collect enough HPC|3|||
148699136|NCT02202850|536373100|FG000|Overall Study|Other|2|||
148699137|NCT02202850|536373101|FG001|Overall Study|Other|2|||
148699138|NCT02202850|536373100|FG000|Overall Study|Enbrel treatment discontinued|15|||
148699139|NCT02202850|536373101|FG001|Overall Study|Enbrel treatment discontinued|3|||
148699140|NCT02202850|536373100|FG000|Overall Study|Lost to Follow-up|7|||
148699141|NCT02202850|536373101|FG001|Overall Study|Lost to Follow-up|1|||
148699142|NCT00615069|536373102|FG000|Overall Study|Death|10|||
148699143|NCT00615069|536373102|FG000|Overall Study|Physician Decision|2|||
148699144|NCT00615069|536373102|FG000|Overall Study|Withdrawal by Subject|4|||
148699145|NCT02996682|536373103|FG000|Overall Study|Death|0|||
148699146|NCT02996682|536373104|FG001|Overall Study|Death|3|||
148699147|NCT01981720|536373105|FG000|Overall Study|Adverse Event|1|||
148699148|NCT01981720|536373105|FG000|Overall Study|Withdrawal by Subject|3|||
148699149|NCT01981720|536373105|FG000|Overall Study|Pregnancy|1|||
148699150|NCT03522675|536373106|FG000|Overall Study|Screen fail|1|||
148699151|NCT03522675|536373106|FG000|Overall Study|Non-reactive to histamine|1|||
148699152|NCT00707161|536373107|FG000|Overall Study|Physician Decision|6|||
148699153|NCT02674477|536373108|FG000|Overall Study|Protocol Violation|8|||
148699154|NCT02674477|536373109|FG001|Overall Study|Protocol Violation|2|||
148699155|NCT02511782|536373110|FG000|Overall Study|Withdrawal by Subject|1|||
148699156|NCT02511782|536373111|FG001|Overall Study|Withdrawal by Subject|0|||
148699157|NCT02511782|536373112|FG002|Overall Study|Withdrawal by Subject|0|||
148699158|NCT05093205|536373114|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
148699159|NCT05093205|536373115|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
148699160|NCT05093205|536373116|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
148699161|NCT05093205|536373117|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
148699162|NCT05093205|536373118|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
148699163|NCT05093205|536373119|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
148699164|NCT05093205|536373120|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
148699165|NCT05093205|536373121|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
148699166|NCT05093205|536373122|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
148699167|NCT05093205|536373123|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
148699168|NCT05093205|536373124|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
148699169|NCT05093205|536373125|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
148699170|NCT05093205|536373126|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
148699171|NCT05093205|536373114|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699172|NCT05093205|536373115|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699173|NCT05093205|536373116|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
148699174|NCT05093205|536373117|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699175|NCT05093205|536373118|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699176|NCT05093205|536373119|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699177|NCT05093205|536373120|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699178|NCT05093205|536373121|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699179|NCT05093205|536373122|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699180|NCT05093205|536373123|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699181|NCT05093205|536373124|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699182|NCT05093205|536373125|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699183|NCT05093205|536373126|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
148699184|NCT05093205|536373114|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
148699185|NCT05093205|536373115|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
148699186|NCT05093205|536373116|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
148699187|NCT05093205|536373117|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
148699188|NCT05093205|536373118|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
148699189|NCT05093205|536373119|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
148699190|NCT05093205|536373120|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
148699191|NCT05093205|536373121|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
148699192|NCT05093205|536373122|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
148699193|NCT05093205|536373123|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
148699194|NCT05093205|536373124|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
148699195|NCT05093205|536373125|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
148699196|NCT05093205|536373126|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
148699197|NCT05093205|536373114|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
148699198|NCT05093205|536373115|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
148699199|NCT05093205|536373116|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
148699200|NCT05093205|536373117|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
148699201|NCT05093205|536373118|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
148699202|NCT05093205|536373119|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
148699203|NCT05093205|536373120|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
148699204|NCT05093205|536373121|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
148699205|NCT05093205|536373122|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
148699206|NCT05093205|536373123|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
148699207|NCT05093205|536373124|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
148699208|NCT05093205|536373125|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
148699209|NCT05093205|536373126|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
148699210|NCT05093205|536373114|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
148699211|NCT05093205|536373115|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
148699212|NCT05093205|536373116|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
148699213|NCT05093205|536373117|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
148699214|NCT05093205|536373118|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
148699215|NCT05093205|536373119|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
148699216|NCT05093205|536373120|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
148699217|NCT05093205|536373121|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
148699218|NCT05093205|536373122|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
148699219|NCT05093205|536373123|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
148699220|NCT05093205|536373124|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
149025027|NCT03738241|537567987|FG008|Overall Study|Physician Decision|1|||
148699221|NCT05093205|536373125|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
148699222|NCT05093205|536373126|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
148699223|NCT05093205|536373114|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
148699224|NCT05093205|536373115|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
148699225|NCT05093205|536373116|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
148699226|NCT05093205|536373117|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
148967270|NCT03560531|537365035|FG005|Overall Study|Early study termination by sponsor|2|||
148967271|NCT03560531|537365036|FG006|Overall Study|Early study termination by sponsor|5|||
148967272|NCT03560531|537365037|FG007|Overall Study|Early study termination by sponsor|64|||
148967273|NCT03560531|537365038|FG008|Overall Study|Early study termination by sponsor|7|||
148699227|NCT05093205|536373118|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
148699228|NCT05093205|536373119|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
148699229|NCT05093205|536373120|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
148699230|NCT05093205|536373121|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
148699231|NCT05093205|536373122|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
148699232|NCT05093205|536373123|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
148699233|NCT05093205|536373124|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
148699234|NCT05093205|536373125|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
148699235|NCT05093205|536373126|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
148699236|NCT05093205|536373114|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
148699237|NCT05093205|536373115|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
148699238|NCT05093205|536373116|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
148699239|NCT05093205|536373117|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
148699240|NCT05093205|536373118|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
148699241|NCT05093205|536373119|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
148699242|NCT05093205|536373120|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
148699243|NCT05093205|536373121|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
148699244|NCT05093205|536373122|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
148699245|NCT05093205|536373123|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
148699246|NCT05093205|536373124|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
148699247|NCT05093205|536373125|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
148699248|NCT05093205|536373126|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
148699249|NCT05093205|536373114|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
148699250|NCT05093205|536373115|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
148814851|NCT05221866|536798036|FG003|Overall Study|Withdrawal by Subject|4|||
148699251|NCT05093205|536373116|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
148699252|NCT05093205|536373117|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
148699253|NCT05093205|536373118|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
148699254|NCT05093205|536373119|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
148699255|NCT05093205|536373120|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
148699256|NCT05093205|536373121|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
148699257|NCT05093205|536373122|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
148699258|NCT05093205|536373123|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
148699259|NCT05093205|536373124|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
148699260|NCT05093205|536373125|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
148699261|NCT05093205|536373126|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
148699262|NCT05093205|536373114|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699263|NCT05093205|536373115|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699264|NCT05093205|536373116|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148967274|NCT03560531|537365039|FG009|Overall Study|Early study termination by sponsor|2|||
148967275|NCT03560531|537365040|FG010|Overall Study|Early study termination by sponsor|16|||
148967276|NCT03560531|537365041|FG011|Overall Study|Early study termination by sponsor|2|||
148967277|NCT03560531|537365042|FG012|Overall Study|Early study termination by sponsor|6|||
148967278|NCT03560531|537365043|FG013|Overall Study|Early study termination by sponsor|2|||
148967279|NCT01471379|537365044|FG000|Overall Study|Adverse Event|1|||
148967280|NCT01471379|537365045|FG001|Overall Study|Adverse Event|0|||
148967281|NCT01471379|537365046|FG002|Overall Study|Adverse Event|0|||
148967282|NCT01471379|537365044|FG000|Overall Study|Study terminated|0|||
148967283|NCT01471379|537365045|FG001|Overall Study|Study terminated|1|||
148967284|NCT01471379|537365046|FG002|Overall Study|Study terminated|0|||
148967285|NCT01200797|537365047|FG000|Overall Study|symptomatic deterioration|2|||
148967286|NCT01200797|537365047|FG000|Overall Study|Adverse Event|4|||
148967287|NCT01200797|537365047|FG000|Overall Study|Disease Progression|13|||
148967288|NCT03745144|537365048|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
148967289|NCT03745144|537365049|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
148967290|NCT03745144|537365050|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
149025028|NCT03738241|537567988|FG009|Overall Study|Physician Decision|0|||
148967291|NCT03745144|537365048|FG000|Period 1|Other|0|||
148967292|NCT03745144|537365049|FG001|Period 1|Other|0|||
148699265|NCT05093205|536373117|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699266|NCT05093205|536373118|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699267|NCT05093205|536373119|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699268|NCT05093205|536373120|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699269|NCT05093205|536373121|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699270|NCT05093205|536373122|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699271|NCT05093205|536373123|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
148967293|NCT03745144|537365050|FG002|Period 1|Other|1|||
148967294|NCT03608774|537365051|FG000|Overall Study|Lost to Follow-up|5|||
148699272|NCT05093205|536373124|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148967295|NCT03608774|537365052|FG001|Overall Study|Lost to Follow-up|5|||
148699273|NCT05093205|536373125|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148967296|NCT03608774|537365051|FG000|Overall Study|Withdrawal by Subject|1|||
148699274|NCT05093205|536373126|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
148699275|NCT05093205|536373114|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
148699276|NCT05093205|536373115|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
148814852|NCT05221866|536798033|FG000|Overall Study|Physician Decision|3|||
148814853|NCT05221866|536798034|FG001|Overall Study|Physician Decision|2|||
148814854|NCT05221866|536798035|FG002|Overall Study|Physician Decision|1|||
148699277|NCT05093205|536373116|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
148699278|NCT05093205|536373117|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
148699279|NCT05093205|536373118|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
148699280|NCT05093205|536373119|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
148699281|NCT05093205|536373120|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
148699282|NCT05093205|536373121|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
148699283|NCT05093205|536373122|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
148699284|NCT05093205|536373123|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
148699285|NCT05093205|536373124|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
148699286|NCT05093205|536373125|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
148699287|NCT05093205|536373126|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
148699288|NCT05093205|536373114|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148814855|NCT05221866|536798036|FG003|Overall Study|Physician Decision|4|||
148814856|NCT05221866|536798033|FG000|Overall Study|Lost to Follow-up|12|||
148814857|NCT05221866|536798034|FG001|Overall Study|Lost to Follow-up|17|||
148814858|NCT05221866|536798035|FG002|Overall Study|Lost to Follow-up|14|||
148967297|NCT03608774|537365052|FG001|Overall Study|Withdrawal by Subject|0|||
148967298|NCT03608774|537365051|FG000|Overall Study|Protocol Violation|1|||
148699289|NCT05093205|536373115|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699290|NCT05093205|536373116|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699291|NCT05093205|536373117|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699292|NCT05093205|536373118|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148967299|NCT03608774|537365052|FG001|Overall Study|Protocol Violation|0|||
148814859|NCT05221866|536798036|FG003|Overall Study|Lost to Follow-up|14|||
148814860|NCT05221866|536798033|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
148814861|NCT05221866|536798034|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
148814862|NCT05221866|536798035|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
148699293|NCT05093205|536373119|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699294|NCT05093205|536373120|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699295|NCT05093205|536373121|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699296|NCT05093205|536373122|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699297|NCT05093205|536373123|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699298|NCT05093205|536373124|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
148699299|NCT05093205|536373125|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699300|NCT05093205|536373126|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
148699301|NCT05093205|536373114|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699302|NCT05093205|536373115|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699303|NCT05093205|536373116|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699304|NCT05093205|536373117|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699305|NCT05093205|536373118|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699306|NCT05093205|536373119|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699307|NCT05093205|536373120|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699308|NCT05093205|536373121|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699309|NCT05093205|536373122|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699310|NCT05093205|536373123|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699311|NCT05093205|536373124|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699312|NCT05093205|536373125|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
148699313|NCT05093205|536373126|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
148699314|NCT05093205|536373114|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
148699315|NCT05093205|536373115|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
148699316|NCT05093205|536373116|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
148699317|NCT05093205|536373117|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
148699318|NCT05093205|536373118|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
148699319|NCT05093205|536373119|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
148699320|NCT05093205|536373120|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
148699321|NCT05093205|536373121|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
148699322|NCT05093205|536373122|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
148699323|NCT05093205|536373123|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
148699324|NCT05093205|536373124|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
148699325|NCT05093205|536373125|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
148699326|NCT05093205|536373126|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
148699327|NCT05093205|536373114|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699328|NCT05093205|536373115|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699329|NCT05093205|536373116|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699330|NCT05093205|536373117|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699331|NCT05093205|536373118|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699332|NCT05093205|536373119|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699333|NCT05093205|536373120|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699334|NCT05093205|536373121|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699335|NCT05093205|536373122|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699336|NCT05093205|536373123|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699337|NCT05093205|536373124|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699338|NCT05093205|536373125|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
148699339|NCT05093205|536373126|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
148699340|NCT00585689|536373127|FG000|Overall Study|Received different ABI-007 schedule|3|||
148699341|NCT00585689|536373127|FG000|Overall Study|Adverse Event|1|||
148699342|NCT00585689|536373127|FG000|Overall Study|Patient Declined Surgery|1|||
148699343|NCT00585689|536373127|FG000|Overall Study|Patient had unresectable disease|1|||
148699344|NCT00585689|536373127|FG000|Overall Study|Death|1|||
148699345|NCT02930005|536373129|FG000|Overall Study|Lost to Follow-up|1|||
148699346|NCT02930005|536373130|FG001|Overall Study|Lost to Follow-up|5|||
148699347|NCT02373098|536373131|FG000|Overall Study|Lost to Follow-up|1|||
148699348|NCT02373098|536373132|FG001|Overall Study|Lost to Follow-up|0|||
148699349|NCT02373098|536373131|FG000|Overall Study|Protocol Violation|3|||
148699350|NCT02373098|536373132|FG001|Overall Study|Protocol Violation|0|||
148699351|NCT02373098|536373131|FG000|Overall Study|Withdrawal by Subject|5|||
148699352|NCT02373098|536373132|FG001|Overall Study|Withdrawal by Subject|0|||
148699353|NCT02373098|536373131|FG000|Overall Study|Adverse Event|3|||
148699354|NCT02373098|536373132|FG001|Overall Study|Adverse Event|0|||
148699355|NCT05067647|536373136|FG000|Overall Study|Lost to Follow-up|1|||
148699356|NCT00855738|536373145|FG000|Overall Study|Lost to Follow-up|2|||
148699357|NCT00855738|536373145|FG000|Overall Study|Adverse Event|1|||
148699358|NCT00855738|536373145|FG000|Overall Study|Subject Defaulted|1|||
148699359|NCT00855738|536373145|FG000|Overall Study|Death|1|||
148699360|NCT03929393|536373150|FG000|Overall Study|Death|1|||
148699361|NCT03929393|536373151|FG001|Overall Study|Death|0|||
148814863|NCT05221866|536798036|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
149025029|NCT03738241|537567979|FG000|Overall Study|Adverse Event|1|||
148699362|NCT03929393|536373150|FG000|Overall Study|Time Commitment|2|||
148699363|NCT03929393|536373151|FG001|Overall Study|Time Commitment|5|||
148699364|NCT03929393|536373150|FG000|Overall Study|Motor Vehicle Accident|0|||
148699365|NCT03929393|536373151|FG001|Overall Study|Motor Vehicle Accident|1|||
148814864|NCT03487445|536798037|FG000|Randomization|Not treated for administrative reasons|1|||
149025030|NCT03738241|537567980|FG001|Overall Study|Adverse Event|0|||
149025031|NCT03738241|537567981|FG002|Overall Study|Adverse Event|0|||
149025032|NCT03738241|537567982|FG003|Overall Study|Adverse Event|0|||
148967300|NCT03608774|537365051|FG000|Overall Study|Not eligible at enrollment|0|||
148967301|NCT03608774|537365052|FG001|Overall Study|Not eligible at enrollment|1|||
148967302|NCT03608774|537365051|FG000|Overall Study|Health related event|0|||
148967303|NCT03608774|537365052|FG001|Overall Study|Health related event|1|||
148967304|NCT00642668|537365053|FG000|Overall Study|Lost to Follow-up|1|||
148699366|NCT03929393|536373150|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
148699367|NCT03929393|536373151|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
148699368|NCT03929393|536373150|FG000|Overall Study|Other|1|||
148699369|NCT03929393|536373151|FG001|Overall Study|Other|3|||
148699370|NCT00119379|536373157|FG000|Overall Study|Adverse Event|4|||
148699371|NCT00119379|536373158|FG001|Overall Study|Adverse Event|1|||
148699372|NCT00154102|536373159|FG000|Overall Study|investigational study phase ongoing|7|||
148699373|NCT00154102|536373160|FG001|Overall Study|investigational study phase ongoing|2|||
148699374|NCT03988803|536375066|FG000|Period 2|Prematurely discontinued from medication|2|||
148699375|NCT03988803|536375066|FG000|Period 2|Adverse Event|1|||
148699376|NCT05038293|536375074|FG000|Overall Study|device was not operating properly for one subject.|1|||
148699377|NCT05038293|536375075|FG001|Overall Study|device was not operating properly for one subject.|0|||
148699378|NCT05038293|536375074|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
148699379|NCT05038293|536375075|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
148699380|NCT01838941|536375077|FG000|Overall Study|Adverse Event|1|||
148699381|NCT01838941|536375077|FG000|Overall Study|Withdrawal by Subject|1|||
148699382|NCT02822235|536375078|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
148699383|NCT02822235|536375079|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
148699384|NCT02822235|536375078|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
148699385|NCT02822235|536375079|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
148699386|NCT02822235|536375078|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
148699387|NCT02822235|536375079|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
148699388|NCT02822235|536375078|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
148699389|NCT02822235|536375079|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
148699390|NCT02822235|536375078|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
148699391|NCT02822235|536375079|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
148699392|NCT02822235|536375078|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
148699393|NCT02822235|536375079|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
148699394|NCT02910037|536375082|FG000|Overall Study|Withdrawal by Subject|4|||
148699395|NCT02910037|536375082|FG000|Overall Study|Lost to Follow-up|6|||
148699396|NCT00436553|536375083|FG000|Overall Study|Adverse Event|4|||
148699397|NCT00436553|536375084|FG001|Overall Study|Adverse Event|3|||
148699398|NCT00436553|536375085|FG002|Overall Study|Adverse Event|4|||
148699399|NCT00436553|536375083|FG000|Overall Study|Death|3|||
148699400|NCT00436553|536375084|FG001|Overall Study|Death|1|||
148699401|NCT00436553|536375085|FG002|Overall Study|Death|3|||
148699402|NCT00436553|536375083|FG000|Overall Study|Lost to Follow-up|0|||
148699403|NCT00436553|536375084|FG001|Overall Study|Lost to Follow-up|2|||
148699404|NCT00436553|536375085|FG002|Overall Study|Lost to Follow-up|0|||
148699405|NCT00436553|536375083|FG000|Overall Study|Protocol Violation|1|||
148699406|NCT00436553|536375084|FG001|Overall Study|Protocol Violation|0|||
148699407|NCT00436553|536375085|FG002|Overall Study|Protocol Violation|0|||
148699408|NCT00436553|536375083|FG000|Overall Study|Withdrawal by Subject|5|||
148967305|NCT00642668|537365053|FG000|Overall Study|Adverse Event|2|||
148967306|NCT00642668|537365053|FG000|Overall Study|Death|2|||
148967307|NCT00642668|537365053|FG000|Overall Study|Insufficient Therapeutic Response|1|||
148967308|NCT00642668|537365053|FG000|Overall Study|Failure to Return|1|||
148967309|NCT00642668|537365053|FG000|Overall Study|Dialysis Initiation|5|||
148967310|NCT00642668|537365053|FG000|Overall Study|Blood Transfusion|2|||
148967311|NCT01586819|537365054|FG000|Overall Study|Withdrawal by Subject|1|||
148967312|NCT01586819|537365055|FG001|Overall Study|Withdrawal by Subject|0|||
148967313|NCT04059146|537365066|FG000|Overall Study|Withdrawal by Subject|0|||
149025033|NCT03738241|537567983|FG004|Overall Study|Adverse Event|0|||
148814865|NCT03487445|536798038|FG001|Randomization|Not treated for administrative reasons|0|||
148814866|NCT00221104|536798039|FG000|Overall Study|Adverse Event|1|||
148967314|NCT04059146|537365067|FG001|Overall Study|Withdrawal by Subject|1|||
148699409|NCT00436553|536375084|FG001|Overall Study|Withdrawal by Subject|6|||
148699410|NCT00436553|536375085|FG002|Overall Study|Withdrawal by Subject|3|||
148699411|NCT02457520|536375086|FG000|Active Treatment Phase|Adverse Event|10|||
148699412|NCT02457520|536375086|FG000|Active Treatment Phase|Lost to Follow-up|8|||
148699413|NCT02457520|536375086|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
148699414|NCT02457520|536375086|FG000|Active Treatment Phase|other|4|||
148699415|NCT02457520|536375086|FG000|Active Treatment Phase|Physician Decision|1|||
148967315|NCT01623596|537365068|FG000|Overall Study|Abnormal laboratory values|2|||
148699416|NCT02457520|536375086|FG000|Active Treatment Phase|Protocol Violation|1|||
148699417|NCT02457520|536375086|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
148699418|NCT02457520|536375086|FG000|Post-treatment Period|Other: Retreatment Required|7|||
148699419|NCT02457520|536375086|FG000|Post-treatment Period|Lost to Follow-up|23|||
148699420|NCT02457520|536375086|FG000|Post-treatment Period|Other|3|||
148699421|NCT02457520|536375086|FG000|Post-treatment Period|Physician Decision|1|||
148699422|NCT02457520|536375086|FG000|Post-treatment Period|Withdrawal by Subject|14|||
148967316|NCT01623596|537365069|FG001|Overall Study|Abnormal laboratory values|0|||
149025034|NCT03738241|537567984|FG005|Overall Study|Adverse Event|0|||
149025035|NCT03738241|537567985|FG006|Overall Study|Adverse Event|0|||
148699423|NCT00450190|536375087|FG000|Overall Study|Withdrawal by Subject|2|||
148699424|NCT01536574|536375088|FG000|Overall Study|Adverse Event|4|||
148699425|NCT01536574|536375089|FG001|Overall Study|Adverse Event|5|||
148699426|NCT01536574|536375088|FG000|Overall Study|Withdrawal by Subject|1|||
148699427|NCT01536574|536375089|FG001|Overall Study|Withdrawal by Subject|2|||
148699428|NCT01536574|536375088|FG000|Overall Study|Lack of Efficacy|1|||
148699429|NCT01536574|536375089|FG001|Overall Study|Lack of Efficacy|0|||
148699430|NCT01376167|536375090|FG000|Overall Study|Lost to Follow-up|2|||
148699431|NCT01376167|536375091|FG001|Overall Study|Lost to Follow-up|4|||
148699432|NCT01376167|536375092|FG002|Overall Study|Lost to Follow-up|2|||
148699433|NCT01376167|536375090|FG000|Overall Study|Physician Decision|1|||
148699434|NCT01376167|536375091|FG001|Overall Study|Physician Decision|1|||
148699435|NCT01376167|536375092|FG002|Overall Study|Physician Decision|0|||
148699436|NCT01376167|536375090|FG000|Overall Study|Withdrawal by Subject|1|||
148699437|NCT01376167|536375091|FG001|Overall Study|Withdrawal by Subject|5|||
148699438|NCT01376167|536375092|FG002|Overall Study|Withdrawal by Subject|4|||
148699439|NCT00834756|536375093|FG000|First Intervention|Adverse Event|1|||
148699440|NCT00834756|536375094|FG001|First Intervention|Adverse Event|0|||
148699441|NCT00834756|536375093|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
148699442|NCT00834756|536375094|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
148699443|NCT02193165|536375097|FG000|4 Week Product Use|Lost to Follow-up|1|||
148699444|NCT02193165|536375098|FG001|4 Week Product Use|Lost to Follow-up|1|||
148699445|NCT02193165|536375099|FG002|4 Week Product Use|Lost to Follow-up|1|||
148699446|NCT02193165|536375097|FG000|6 Week Product Use|Lost to Follow-up|0|||
148699447|NCT02193165|536375098|FG001|6 Week Product Use|Lost to Follow-up|1|||
148699448|NCT02193165|536375099|FG002|6 Week Product Use|Lost to Follow-up|0|||
148699449|NCT04239872|536375100|FG000|Overall Study|Lost to Follow-up|0|||
148699450|NCT04239872|536375101|FG001|Overall Study|Lost to Follow-up|1|||
148699451|NCT01173692|536375105|FG000|Overall Study|Adverse Event|1|||
148699452|NCT01173692|536375106|FG001|Overall Study|Adverse Event|2|||
148699453|NCT01173692|536375105|FG000|Overall Study|Withdrawal by Subject|1|||
148699454|NCT01173692|536375106|FG001|Overall Study|Withdrawal by Subject|3|||
148699455|NCT01472341|536375107|FG000|Overall Study|Started insulin therapy|55|||
148699456|NCT01472341|536375107|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
148699457|NCT01472341|536375107|FG000|Overall Study|Withdrawal by Subject|39|||
148699458|NCT01472341|536375107|FG000|Overall Study|Lost to Follow-up|52|||
148699459|NCT01472341|536375107|FG000|Overall Study|Laboratory parameters unavailable|25|||
148699460|NCT01472341|536375107|FG000|Overall Study|Death|9|||
148699461|NCT00579670|536375108|FG000|Overall Study|Death|1|||
148699462|NCT00579670|536375109|FG001|Overall Study|Death|0|||
148699463|NCT00579670|536375110|FG002|Overall Study|Death|0|||
148699464|NCT00579670|536375111|FG003|Overall Study|Death|0|||
148699465|NCT00579670|536375112|FG004|Overall Study|Death|0|||
148699466|NCT00579670|536375108|FG000|Overall Study|Adverse Event|1|||
148699467|NCT00579670|536375109|FG001|Overall Study|Adverse Event|0|||
148699468|NCT00579670|536375110|FG002|Overall Study|Adverse Event|1|||
148699469|NCT00579670|536375111|FG003|Overall Study|Adverse Event|2|||
149025036|NCT03738241|537567986|FG007|Overall Study|Adverse Event|0|||
148814867|NCT00221104|536798040|FG001|Overall Study|Adverse Event|0|||
148814868|NCT00221104|536798039|FG000|Overall Study|Physician Decision|1|||
148814869|NCT00221104|536798040|FG001|Overall Study|Physician Decision|0|||
148814870|NCT00221104|536798039|FG000|Overall Study|Protocol Violation|2|||
148814871|NCT00221104|536798040|FG001|Overall Study|Protocol Violation|0|||
148814872|NCT00221104|536798039|FG000|Overall Study|Withdrawal by Subject|42|||
148814873|NCT00221104|536798040|FG001|Overall Study|Withdrawal by Subject|29|||
148814874|NCT00221104|536798039|FG000|Overall Study|Others|37|||
148814875|NCT00221104|536798040|FG001|Overall Study|Others|47|||
148967317|NCT01623596|537365068|FG000|Overall Study|Administrative problems|9|||
148967318|NCT01623596|537365069|FG001|Overall Study|Administrative problems|13|||
148967319|NCT01623596|537365068|FG000|Overall Study|Adverse Event|20|||
148967320|NCT01623596|537365069|FG001|Overall Study|Adverse Event|29|||
148967321|NCT01623596|537365068|FG000|Overall Study|Death|0|||
148967322|NCT01623596|537365069|FG001|Overall Study|Death|2|||
148967323|NCT01623596|537365068|FG000|Overall Study|Lost to Follow-up|12|||
148967324|NCT01623596|537365069|FG001|Overall Study|Lost to Follow-up|16|||
148967325|NCT01623596|537365068|FG000|Overall Study|Withdrawal by Subject|13|||
148967326|NCT01623596|537365069|FG001|Overall Study|Withdrawal by Subject|31|||
148967327|NCT01623596|537365068|FG000|Overall Study|Patient no longer requires study drug|1|||
148967328|NCT01623596|537365069|FG001|Overall Study|Patient no longer requires study drug|0|||
148967329|NCT01623596|537365068|FG000|Overall Study|Protocol Violation|0|||
148699470|NCT00579670|536375112|FG004|Overall Study|Adverse Event|0|||
148967330|NCT01623596|537365069|FG001|Overall Study|Protocol Violation|6|||
148967331|NCT01623596|537365068|FG000|Overall Study|Lack of Efficacy|5|||
148699471|NCT00579670|536375108|FG000|Overall Study|Lack of Efficacy|0|||
148967332|NCT01623596|537365069|FG001|Overall Study|Lack of Efficacy|3|||
148967333|NCT00747435|537365070|FG000|Overall Study|Lost to Follow-up|2|||
148967334|NCT00747435|537365070|FG000|Overall Study|Withdrawal by Subject|3|||
148967335|NCT00747435|537365070|FG000|Overall Study|Still undergoing follow up|1|||
148967336|NCT01324349|537365071|FG000|Overall Study|Death|1|||
148699472|NCT00579670|536375109|FG001|Overall Study|Lack of Efficacy|0|||
148699473|NCT00579670|536375110|FG002|Overall Study|Lack of Efficacy|1|||
148699474|NCT00579670|536375111|FG003|Overall Study|Lack of Efficacy|14|||
148699475|NCT00579670|536375112|FG004|Overall Study|Lack of Efficacy|0|||
148699476|NCT00579670|536375108|FG000|Overall Study|Lost to Follow-up|0|||
148699477|NCT00579670|536375109|FG001|Overall Study|Lost to Follow-up|1|||
148699478|NCT00579670|536375110|FG002|Overall Study|Lost to Follow-up|0|||
148699479|NCT00579670|536375111|FG003|Overall Study|Lost to Follow-up|4|||
148699480|NCT00579670|536375112|FG004|Overall Study|Lost to Follow-up|0|||
148699481|NCT00579670|536375108|FG000|Overall Study|Other|0|||
148814876|NCT02989389|536798041|FG000|Period 1|Lost to Follow-up|0|||
148814877|NCT02989389|536798042|FG001|Period 1|Lost to Follow-up|1|||
148814878|NCT02989389|536798043|FG002|Period 1|Lost to Follow-up|0|||
148699482|NCT00579670|536375109|FG001|Overall Study|Other|0|||
148699483|NCT00579670|536375110|FG002|Overall Study|Other|1|||
148699484|NCT00579670|536375111|FG003|Overall Study|Other|2|||
148699485|NCT00579670|536375112|FG004|Overall Study|Other|0|||
148699486|NCT00579670|536375108|FG000|Overall Study|Withdrawal by Subject|0|||
148699487|NCT00579670|536375109|FG001|Overall Study|Withdrawal by Subject|0|||
148699488|NCT00579670|536375110|FG002|Overall Study|Withdrawal by Subject|1|||
148699489|NCT00579670|536375111|FG003|Overall Study|Withdrawal by Subject|0|||
148699490|NCT00579670|536375112|FG004|Overall Study|Withdrawal by Subject|0|||
148699491|NCT00112463|536375116|FG000|Overall Study|Physician Decision|1|||
148699492|NCT00112463|536375116|FG000|Overall Study|Progression|30|||
148699493|NCT00112463|536375116|FG000|Overall Study|Second Primary|1|||
148699494|NCT00112463|536375116|FG000|Overall Study|Toxicity|3|||
148699495|NCT00112463|536375116|FG000|Overall Study|Withdrawal by Subject|2|||
148699496|NCT00112463|536375116|FG000|Overall Study|Never started treatment|2|||
148699497|NCT00296647|536375117|FG000|Overall Study|Death|4|||
148699498|NCT00296647|536375118|FG001|Overall Study|Death|1|||
148699499|NCT00296647|536375119|FG002|Overall Study|Death|2|||
148699500|NCT00296647|536375120|FG003|Overall Study|Death|1|||
148699501|NCT00296647|536375121|FG004|Overall Study|Death|1|||
148699502|NCT00296647|536375117|FG000|Overall Study|Withdrawal by Subject|28|||
148699503|NCT00296647|536375118|FG001|Overall Study|Withdrawal by Subject|27|||
148699504|NCT00296647|536375119|FG002|Overall Study|Withdrawal by Subject|32|||
148814879|NCT02989389|536798044|FG003|Period 1|Lost to Follow-up|0|||
148814880|NCT02989389|536798045|FG004|Period 1|Lost to Follow-up|0|||
148967337|NCT01324349|537365072|FG001|Overall Study|Death|1|||
148967338|NCT01324349|537365071|FG000|Overall Study|Withdrawal by Subject|0|||
148699505|NCT00296647|536375120|FG003|Overall Study|Withdrawal by Subject|16|||
148699506|NCT00296647|536375121|FG004|Overall Study|Withdrawal by Subject|19|||
148699507|NCT00986245|536375122|FG000|First Intervention|Poor compliance|8|||
148699508|NCT00986245|536375123|FG001|First Intervention|Poor compliance|4|||
148699509|NCT00986245|536375122|FG000|First Intervention|Lack of Efficacy|1|||
148699510|NCT00986245|536375123|FG001|First Intervention|Lack of Efficacy|2|||
148699511|NCT00986245|536375122|FG000|First Intervention|Withdrawal by Subject|0|||
148699512|NCT00986245|536375123|FG001|First Intervention|Withdrawal by Subject|1|||
148967339|NCT01324349|537365072|FG001|Overall Study|Withdrawal by Subject|1|||
148967340|NCT00748215|537365073|FG000|Overall Study|Withdrawal by Subject|7|||
148967341|NCT00748215|537365074|FG001|Overall Study|Withdrawal by Subject|7|||
148967342|NCT00748215|537365073|FG000|Overall Study|Treatment change|2|||
148967343|NCT00748215|537365074|FG001|Overall Study|Treatment change|1|||
148967344|NCT00748215|537365073|FG000|Overall Study|Change in patient condition|0|||
148967345|NCT00748215|537365074|FG001|Overall Study|Change in patient condition|3|||
148814881|NCT02989389|536798046|FG005|Period 1|Lost to Follow-up|0|||
148699513|NCT00986245|536375122|FG000|First Intervention|Protocol Violation|0|||
148699514|NCT00986245|536375123|FG001|First Intervention|Protocol Violation|1|||
148699515|NCT00986245|536375122|FG000|First Intervention|Out of indication|1|||
148699516|NCT00986245|536375123|FG001|First Intervention|Out of indication|0|||
148699517|NCT00986245|536375122|FG000|Second Intervention|Poor compliance|1|||
148699518|NCT00986245|536375123|FG001|Second Intervention|Poor compliance|0|||
148699519|NCT00986245|536375122|FG000|Second Intervention|Lost to Follow-up|1|||
148699520|NCT00986245|536375123|FG001|Second Intervention|Lost to Follow-up|0|||
148814882|NCT02989389|536798047|FG006|Period 1|Lost to Follow-up|0|||
148814883|NCT02989389|536798048|FG007|Period 1|Lost to Follow-up|0|||
148814884|NCT02989389|536798049|FG008|Period 1|Lost to Follow-up|0|||
148814885|NCT02989389|536798050|FG009|Period 1|Lost to Follow-up|0|||
148814886|NCT02989389|536798041|FG000|Period 1|Physician Decision|0|||
148814887|NCT02989389|536798042|FG001|Period 1|Physician Decision|0|||
148814888|NCT02989389|536798043|FG002|Period 1|Physician Decision|0|||
148814889|NCT02989389|536798044|FG003|Period 1|Physician Decision|0|||
148814890|NCT02989389|536798045|FG004|Period 1|Physician Decision|0|||
148814891|NCT02989389|536798046|FG005|Period 1|Physician Decision|0|||
148814892|NCT02989389|536798047|FG006|Period 1|Physician Decision|0|||
148814893|NCT02989389|536798048|FG007|Period 1|Physician Decision|0|||
148814894|NCT02989389|536798049|FG008|Period 1|Physician Decision|1|||
148814895|NCT02989389|536798050|FG009|Period 1|Physician Decision|0|||
148814896|NCT01666652|536798051|FG000|Overall Study|Serious Adverse Event|0|||
148814897|NCT01666652|536798052|FG001|Overall Study|Serious Adverse Event|0|||
148814898|NCT01666652|536798053|FG002|Overall Study|Serious Adverse Event|0|||
148814899|NCT01666652|536798054|FG003|Overall Study|Serious Adverse Event|1|||
148814900|NCT01666652|536798055|FG004|Overall Study|Serious Adverse Event|0|||
148814901|NCT01666652|536798051|FG000|Overall Study|Withdrawal by Subject|0|||
148814902|NCT01666652|536798052|FG001|Overall Study|Withdrawal by Subject|0|||
148814903|NCT01666652|536798053|FG002|Overall Study|Withdrawal by Subject|0|||
148814904|NCT01666652|536798054|FG003|Overall Study|Withdrawal by Subject|0|||
148814905|NCT01666652|536798055|FG004|Overall Study|Withdrawal by Subject|1|||
148814906|NCT01666652|536798051|FG000|Overall Study|Moved from study area|1|||
148814907|NCT01666652|536798052|FG001|Overall Study|Moved from study area|0|||
148814908|NCT01666652|536798053|FG002|Overall Study|Moved from study area|0|||
148814909|NCT01666652|536798054|FG003|Overall Study|Moved from study area|2|||
148699521|NCT00986245|536375122|FG000|Second Intervention|Protocol Violation|0|||
148814910|NCT01666652|536798055|FG004|Overall Study|Moved from study area|0|||
148814911|NCT01666652|536798051|FG000|Overall Study|Lost to Follow-up|1|||
148814912|NCT01666652|536798052|FG001|Overall Study|Lost to Follow-up|1|||
148699522|NCT00986245|536375123|FG001|Second Intervention|Protocol Violation|1|||
148814913|NCT01666652|536798053|FG002|Overall Study|Lost to Follow-up|1|||
148814914|NCT01666652|536798054|FG003|Overall Study|Lost to Follow-up|1|||
148814915|NCT01666652|536798055|FG004|Overall Study|Lost to Follow-up|0|||
148699523|NCT01214850|536375124|FG000|Overall Study|Withdrawal by Subject|38|||
148814916|NCT04470427|536798056|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
148814917|NCT04470427|536798057|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
148814918|NCT04470427|536798058|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
148814919|NCT04470427|536798059|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
148967346|NCT00748215|537365073|FG000|Overall Study|Non-compliant|0|||
148967347|NCT00748215|537365074|FG001|Overall Study|Non-compliant|2|||
148967348|NCT00748215|537365073|FG000|Overall Study|Adverse Event|0|||
148967349|NCT00748215|537365074|FG001|Overall Study|Adverse Event|5|||
148967350|NCT00427635|537366646|FG000|Treatment Phase|Withdrawal by Subject|1|||
148814920|NCT04470427|536798060|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
148814921|NCT04470427|536798061|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
148814922|NCT04470427|536798056|FG000|Part B :Open-label|Other than specified|0|||
148967351|NCT00427635|537366647|FG001|Treatment Phase|Withdrawal by Subject|0|||
148699524|NCT01214850|536375125|FG001|Overall Study|Withdrawal by Subject|31|||
148699525|NCT01214850|536375126|FG002|Overall Study|Withdrawal by Subject|28|||
148699526|NCT01214850|536375124|FG000|Overall Study|Lost to Follow-up|124|||
148699527|NCT01214850|536375125|FG001|Overall Study|Lost to Follow-up|98|||
148699528|NCT01214850|536375126|FG002|Overall Study|Lost to Follow-up|123|||
148699529|NCT01214850|536375124|FG000|Overall Study|Protocol Violation|5|||
148699530|NCT01214850|536375125|FG001|Overall Study|Protocol Violation|5|||
148699531|NCT01214850|536375126|FG002|Overall Study|Protocol Violation|6|||
148699532|NCT01214850|536375124|FG000|Overall Study|Adverse event or death|11|||
148699533|NCT01214850|536375125|FG001|Overall Study|Adverse event or death|8|||
148699534|NCT01214850|536375126|FG002|Overall Study|Adverse event or death|3|||
148699535|NCT01214850|536375124|FG000|Overall Study|Inappropriate enrollment|2|||
148699536|NCT01214850|536375125|FG001|Overall Study|Inappropriate enrollment|1|||
148699537|NCT01214850|536375126|FG002|Overall Study|Inappropriate enrollment|0|||
148699538|NCT01214850|536375124|FG000|Overall Study|Administrative reason|1|||
148699539|NCT01214850|536375125|FG001|Overall Study|Administrative reason|0|||
148814923|NCT04470427|536798057|FG001|Part B :Open-label|Other than specified|0|||
148814924|NCT04470427|536798058|FG002|Part B :Open-label|Other than specified|788|||
148967352|NCT00427635|537366646|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
148699540|NCT01214850|536375126|FG002|Overall Study|Administrative reason|0|||
148699541|NCT01214850|536375124|FG000|Overall Study|Unable to classify|2|||
148699542|NCT01214850|536375125|FG001|Overall Study|Unable to classify|1|||
148699543|NCT01214850|536375126|FG002|Overall Study|Unable to classify|1|||
148699544|NCT00565448|536375127|FG000|Overall Study|Adverse Event|1|||
148699545|NCT00565448|536375128|FG001|Overall Study|Adverse Event|2|||
148699546|NCT00565448|536375127|FG000|Overall Study|Disease progression|1|||
148699547|NCT00565448|536375128|FG001|Overall Study|Disease progression|0|||
148967353|NCT00427635|537366647|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
148699548|NCT00565448|536375127|FG000|Overall Study|Withdrawal by Subject|1|||
148967354|NCT02558790|537366648|FG000|Overall Study|Lost to Follow-up|2|||
148967355|NCT02558790|537366648|FG000|Overall Study|Physician Decision|1|||
148967356|NCT02558790|537366648|FG000|Overall Study|Withdrawal by Subject|1|||
148699549|NCT00565448|536375128|FG001|Overall Study|Withdrawal by Subject|0|||
148699550|NCT01863745|536375129|FG000|Overall Study|Disease Progression|9|||
148699551|NCT01863745|536375129|FG000|Overall Study|Adverse Event|2|||
148699552|NCT01863745|536375129|FG000|Overall Study|Death|1|||
148699553|NCT01863745|536375129|FG000|Overall Study|Withdrawal by Subject|1|||
148699554|NCT00193609|536375130|FG000|Overall Study|Lack of Efficacy|2|||
148699555|NCT00193609|536375130|FG000|Overall Study|Adverse Event|2|||
148967357|NCT02558790|537366648|FG000|Overall Study|Screen Fail|3|||
148967358|NCT00838201|537366649|FG000|Overall Study|Investigator decision, or other reasons|2|||
148699556|NCT00735904|536375131|FG000|Overall Study|Adverse Event|3|||
148699557|NCT00735904|536375131|FG000|Overall Study|Death|20|||
148699558|NCT00735904|536375131|FG000|Overall Study|Protocol Violation|1|||
148967359|NCT00838201|537366650|FG001|Overall Study|Investigator decision, or other reasons|3|||
148967360|NCT00838201|537366649|FG000|Overall Study|Noncompliance|0|||
148967361|NCT00838201|537366650|FG001|Overall Study|Noncompliance|1|||
148967362|NCT00838201|537366649|FG000|Overall Study|Administrative decision|1|||
148967363|NCT00838201|537366650|FG001|Overall Study|Administrative decision|2|||
148967364|NCT00838201|537366649|FG000|Overall Study|Disease progression|3|||
148967365|NCT00838201|537366650|FG001|Overall Study|Disease progression|3|||
148967366|NCT00838201|537366649|FG000|Overall Study|Consent withdrawn|16|||
148967367|NCT00838201|537366650|FG001|Overall Study|Consent withdrawn|19|||
148967368|NCT00838201|537366649|FG000|Overall Study|Lost to Follow-up|4|||
148967369|NCT00838201|537366650|FG001|Overall Study|Lost to Follow-up|3|||
148967370|NCT00838201|537366649|FG000|Overall Study|Adverse Event|5|||
148967371|NCT00838201|537366650|FG001|Overall Study|Adverse Event|9|||
148699559|NCT00735904|536375131|FG000|Overall Study|Withdrawal by Subject|1|||
148699560|NCT00735904|536375131|FG000|Overall Study|Study Terminated by Sponsor|5|||
148699561|NCT00735904|536375131|FG000|Overall Study|Other|8|||
148699562|NCT00610363|536375135|FG000|Overall Study|Non-compliance with protocol|0|||
148699563|NCT00610363|536375136|FG001|Overall Study|Non-compliance with protocol|1|||
148699564|NCT00610363|536375135|FG000|Overall Study|Adverse Event|3|||
148699565|NCT00610363|536375136|FG001|Overall Study|Adverse Event|1|||
148967372|NCT00838201|537366649|FG000|Overall Study|Death|11|||
148967373|NCT00838201|537366650|FG001|Overall Study|Death|13|||
148967374|NCT02711800|537366658|FG000|Overall Study|Lost to Follow-up|1|||
148967375|NCT02711800|537366658|FG000|Overall Study|Withdrawal by Subject|1|||
148967376|NCT00006478|537366668|FG000|Overall Study|Vaccine could not be produced|1|||
148967377|NCT00006478|537366668|FG000|Overall Study|Physician Decision|6|||
148699566|NCT00610363|536375135|FG000|Overall Study|Lack of Efficacy|2|||
148699567|NCT00610363|536375136|FG001|Overall Study|Lack of Efficacy|0|||
148967378|NCT03161483|537366671|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
148967379|NCT03161483|537366672|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
148967380|NCT03161483|537366673|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
148967381|NCT03161483|537366674|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
148699568|NCT00610363|536375135|FG000|Overall Study|Lost to Follow-up|4|||
148967382|NCT03161483|537366671|FG000|Treatment Period|Death|1|||
148967383|NCT03161483|537366672|FG001|Treatment Period|Death|0|||
148699569|NCT00610363|536375136|FG001|Overall Study|Lost to Follow-up|0|||
148699570|NCT00610363|536375135|FG000|Overall Study|Withdrawal by Subject|1|||
148699571|NCT00610363|536375136|FG001|Overall Study|Withdrawal by Subject|0|||
148699572|NCT00610363|536375135|FG000|Overall Study|Other than specified above|1|||
148699573|NCT00610363|536375136|FG001|Overall Study|Other than specified above|1|||
148699574|NCT03204539|536375137|FG000|Overall Study|Loss of funding|0|||
148699575|NCT03204539|536375138|FG001|Overall Study|Loss of funding|1|||
148699576|NCT01171963|536375139|FG000|Overall Study|Adverse Event|10|||
148699577|NCT01171963|536375140|FG001|Overall Study|Adverse Event|15|||
148699578|NCT01171963|536375139|FG000|Overall Study|Lost to Follow-up|23|||
148699579|NCT01171963|536375140|FG001|Overall Study|Lost to Follow-up|24|||
148699580|NCT01171963|536375139|FG000|Overall Study|Other - diarrhoea|1|||
148699581|NCT01171963|536375140|FG001|Overall Study|Other - diarrhoea|0|||
148699582|NCT01171963|536375139|FG000|Overall Study|Withdrawal by Subject|114|||
148699583|NCT01171963|536375140|FG001|Overall Study|Withdrawal by Subject|129|||
148699584|NCT03361228|536375154|FG000|Overall Study|Other|1|||
148699585|NCT03361228|536375155|FG001|Overall Study|Other|1|||
148699586|NCT03361228|536375154|FG000|Overall Study|Death|3|||
148699587|NCT03361228|536375155|FG001|Overall Study|Death|0|||
148699588|NCT00302952|536375156|FG000|Overall Study|Physician Decision|1|||
148699589|NCT00302952|536375157|FG001|Overall Study|Physician Decision|1|||
148699590|NCT00302952|536375156|FG000|Overall Study|Withdrawal by Subject|2|||
148699591|NCT00302952|536375157|FG001|Overall Study|Withdrawal by Subject|3|||
148699592|NCT00302952|536375156|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
148699593|NCT00302952|536375157|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
148699594|NCT02979353|536375166|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
148699595|NCT02979353|536375167|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
148699596|NCT02979353|536375166|FG000|Overall Study|Withdrawal by Subject|16|||
148699597|NCT02979353|536375167|FG001|Overall Study|Withdrawal by Subject|12|||
148699598|NCT02979353|536375166|FG000|Overall Study|Death|10|||
148699599|NCT02979353|536375167|FG001|Overall Study|Death|11|||
148699600|NCT02979353|536375166|FG000|Overall Study|Transfer to Hospice Care|19|||
148814925|NCT04470427|536798059|FG003|Part B :Open-label|Other than specified|0|||
148814926|NCT04470427|536798060|FG004|Part B :Open-label|Other than specified|523|||
148814927|NCT04470427|536798061|FG005|Part B :Open-label|Other than specified|0|||
148814928|NCT04470427|536798056|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
148814929|NCT04470427|536798057|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
148814930|NCT04470427|536798058|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
148814931|NCT04470427|536798059|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
148814932|NCT04470427|536798060|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
148814933|NCT04470427|536798061|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
148814934|NCT04470427|536798056|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
148814935|NCT04470427|536798057|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
148699601|NCT02979353|536375167|FG001|Overall Study|Transfer to Hospice Care|14|||
148699602|NCT02979353|536375166|FG000|Overall Study|Lost to Follow-up|1|||
148699603|NCT02979353|536375167|FG001|Overall Study|Lost to Follow-up|5|||
148699604|NCT01722877|536375171|FG000|Overall Study|Death|1|||
148699605|NCT01722877|536375171|FG000|Overall Study|Lost to Follow-up|1|||
148699606|NCT03693430|536375174|FG000|Overall Study|Lost to Follow-up|3|||
148699607|NCT03693430|536375175|FG001|Overall Study|Lost to Follow-up|14|||
148699608|NCT03693430|536375174|FG000|Overall Study|Death|1|||
148699609|NCT03693430|536375175|FG001|Overall Study|Death|0|||
148699610|NCT03693430|536375174|FG000|Overall Study|Withdrawal by Subject|0|||
148699611|NCT03693430|536375175|FG001|Overall Study|Withdrawal by Subject|4|||
148699612|NCT03897088|536375176|FG000|Overall Study|Withdrawal by Subject|12|||
148699613|NCT03897088|536375177|FG001|Overall Study|Withdrawal by Subject|12|||
148699614|NCT03897088|536375176|FG000|Overall Study|Lost to Follow-up|7|||
148699615|NCT03897088|536375177|FG001|Overall Study|Lost to Follow-up|15|||
148699616|NCT03897088|536375176|FG000|Overall Study|Sponsor Decision|1|||
148699617|NCT03897088|536375177|FG001|Overall Study|Sponsor Decision|2|||
148699618|NCT03897088|536375176|FG000|Overall Study|COVID-19|2|||
148699619|NCT03897088|536375177|FG001|Overall Study|COVID-19|0|||
148699620|NCT03897088|536375176|FG000|Overall Study|Other|3|||
148699621|NCT03897088|536375177|FG001|Overall Study|Other|0|||
148699622|NCT03897088|536375176|FG000|Overall Study|Non-compliance with Study Drug|1|||
148699623|NCT03897088|536375177|FG001|Overall Study|Non-compliance with Study Drug|1|||
148699624|NCT03897088|536375176|FG000|Overall Study|Pregnancy|0|||
148699625|NCT03897088|536375177|FG001|Overall Study|Pregnancy|1|||
148699626|NCT04320849|536375180|FG000|Overall Study|Withdrawal by Subject|4|||
148699627|NCT04320849|536375180|FG000|Overall Study|Imaging data unavailable|2|||
148699628|NCT04320849|536375180|FG000|Overall Study|Incomplete imaging|2|||
148699629|NCT00319735|536375189|FG000|Overall Study|Death|2|||
148699630|NCT01569152|536375196|FG000|Phase IIa, Period 1|Early Escape|5|||
148699631|NCT01569152|536375197|FG001|Phase IIa, Period 1|Early Escape|22|||
148699632|NCT01569152|536375198|FG002|Phase IIa, Period 1|Early Escape|0|||
148699633|NCT01569152|536375196|FG000|Phase IIa, Period 1|Adverse Event|4|||
148699634|NCT01569152|536375197|FG001|Phase IIa, Period 1|Adverse Event|0|||
148699635|NCT01569152|536375198|FG002|Phase IIa, Period 1|Adverse Event|0|||
148699636|NCT01569152|536375196|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
148699637|NCT01569152|536375197|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
148699638|NCT01569152|536375198|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
148699639|NCT01569152|536375196|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
148699640|NCT01569152|536375197|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
148699641|NCT01569152|536375198|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
148699642|NCT01569152|536375196|FG000|Phase IIa, Period 1|Protocol Violation|0|||
148699643|NCT01569152|536375197|FG001|Phase IIa, Period 1|Protocol Violation|1|||
148699644|NCT01569152|536375198|FG002|Phase IIa, Period 1|Protocol Violation|0|||
148699645|NCT01569152|536375196|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
148699646|NCT01569152|536375197|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
148699647|NCT01569152|536375198|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
148699648|NCT01569152|536375196|FG000|Safety Extension, Period 3|Adverse Event|0|||
148699649|NCT01569152|536375197|FG001|Safety Extension, Period 3|Adverse Event|0|||
148699650|NCT01569152|536375198|FG002|Safety Extension, Period 3|Adverse Event|4|||
148699651|NCT01569152|536375196|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
148699652|NCT01569152|536375197|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
148699653|NCT01569152|536375198|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
148699654|NCT01569152|536375196|FG000|Safety Extension, Period 3|Physician Decision|0|||
148699655|NCT01569152|536375197|FG001|Safety Extension, Period 3|Physician Decision|0|||
148699656|NCT01569152|536375198|FG002|Safety Extension, Period 3|Physician Decision|2|||
148814936|NCT04470427|536798058|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
148814937|NCT04470427|536798059|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
148814938|NCT04470427|536798060|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
148814939|NCT04470427|536798061|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
148814940|NCT01018979|536798062|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
148814941|NCT01018979|536798063|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
148967384|NCT03161483|537366673|FG002|Treatment Period|Death|0|||
148967385|NCT03161483|537366674|FG003|Treatment Period|Death|0|||
148967386|NCT03161483|537366671|FG000|Treatment Period|Adverse Event|5|||
148967387|NCT03161483|537366672|FG001|Treatment Period|Adverse Event|2|||
148967388|NCT03161483|537366673|FG002|Treatment Period|Adverse Event|1|||
148814942|NCT01018979|536798062|FG000|Overall Study|Not received at least one dose|0|||
148967389|NCT03161483|537366674|FG003|Treatment Period|Adverse Event|11|||
148967390|NCT03161483|537366671|FG000|Treatment Period|Pregnancy|1|||
148967391|NCT03161483|537366672|FG001|Treatment Period|Pregnancy|0|||
148699657|NCT01569152|536375196|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
148699658|NCT01569152|536375197|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
148699659|NCT01569152|536375198|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
148699660|NCT01706536|536375199|FG000|Overall Study|Withdrawal by Subject|1|||
148699661|NCT01706536|536375200|FG001|Overall Study|Withdrawal by Subject|0|||
148699662|NCT01706536|536375201|FG002|Overall Study|Withdrawal by Subject|1|||
148699663|NCT01706536|536375202|FG003|Overall Study|Withdrawal by Subject|0|||
148699664|NCT01706536|536375203|FG004|Overall Study|Withdrawal by Subject|0|||
148699665|NCT01706536|536375199|FG000|Overall Study|Adverse Event|2|||
148699666|NCT01706536|536375200|FG001|Overall Study|Adverse Event|3|||
148699667|NCT01706536|536375201|FG002|Overall Study|Adverse Event|4|||
148967392|NCT03161483|537366673|FG002|Treatment Period|Pregnancy|0|||
148967393|NCT03161483|537366674|FG003|Treatment Period|Pregnancy|0|||
148967394|NCT03161483|537366671|FG000|Treatment Period|Lack of Efficacy|0|||
148699668|NCT01706536|536375202|FG003|Overall Study|Adverse Event|3|||
148699669|NCT01706536|536375203|FG004|Overall Study|Adverse Event|2|||
148699670|NCT01706536|536375199|FG000|Overall Study|Lack of Efficacy|1|||
148699671|NCT01706536|536375200|FG001|Overall Study|Lack of Efficacy|0|||
148699672|NCT01706536|536375201|FG002|Overall Study|Lack of Efficacy|0|||
148699673|NCT01706536|536375202|FG003|Overall Study|Lack of Efficacy|1|||
148699674|NCT01706536|536375203|FG004|Overall Study|Lack of Efficacy|0|||
148699675|NCT01706536|536375199|FG000|Overall Study|non compliance|0|||
148699676|NCT01706536|536375200|FG001|Overall Study|non compliance|1|||
148699677|NCT01706536|536375201|FG002|Overall Study|non compliance|0|||
148699678|NCT01706536|536375202|FG003|Overall Study|non compliance|0|||
148699679|NCT01706536|536375203|FG004|Overall Study|non compliance|0|||
148699680|NCT03262012|536375204|FG000|Overall Study|Withdrawal by Subject|15|||
148699681|NCT03262012|536375205|FG001|Overall Study|Withdrawal by Subject|13|||
148699682|NCT03262012|536375206|FG002|Overall Study|Withdrawal by Subject|8|||
148699683|NCT03262012|536375207|FG003|Overall Study|Withdrawal by Subject|7|||
148699684|NCT03262012|536375204|FG000|Overall Study|Adverse Event|10|||
148699685|NCT03262012|536375205|FG001|Overall Study|Adverse Event|12|||
148699686|NCT03262012|536375206|FG002|Overall Study|Adverse Event|4|||
148699687|NCT03262012|536375207|FG003|Overall Study|Adverse Event|6|||
148699688|NCT03262012|536375204|FG000|Overall Study|Physician Decision|2|||
148699689|NCT03262012|536375205|FG001|Overall Study|Physician Decision|5|||
148699690|NCT03262012|536375206|FG002|Overall Study|Physician Decision|1|||
148699691|NCT03262012|536375207|FG003|Overall Study|Physician Decision|0|||
148699692|NCT03262012|536375204|FG000|Overall Study|Lack of Efficacy|0|||
148699693|NCT03262012|536375205|FG001|Overall Study|Lack of Efficacy|5|||
148699694|NCT03262012|536375206|FG002|Overall Study|Lack of Efficacy|1|||
148699695|NCT03262012|536375207|FG003|Overall Study|Lack of Efficacy|2|||
148699696|NCT03262012|536375204|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
148699697|NCT03262012|536375205|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
148699698|NCT03262012|536375206|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
148699699|NCT03262012|536375207|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
148699700|NCT01469546|536375210|FG000|Received 5 mg Dose|Adverse Event|13|||
148699701|NCT01469546|536375210|FG000|Received 5 mg Dose|Death|2|||
148699702|NCT01469546|536375210|FG000|Received 5 mg Dose|Protocol Violation|2|||
148699703|NCT01469546|536375210|FG000|Received 5 mg Dose|Progressive Disease|3|||
148699704|NCT01469546|536375210|FG000|Received 5 mg Dose|Physician Decision|3|||
148699705|NCT00385684|536375213|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
148699706|NCT00385684|536375214|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
148699707|NCT00385684|536375213|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
148699708|NCT00385684|536375214|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
148699709|NCT00385684|536375213|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
148699710|NCT00385684|536375214|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
148699711|NCT02801877|536375215|FG000|Overall Study|Lost to Follow-up|1|||
148699712|NCT02801877|536375216|FG001|Overall Study|Lost to Follow-up|1|||
148699713|NCT02801877|536375217|FG002|Overall Study|Lost to Follow-up|2|||
148699714|NCT02801877|536375218|FG003|Overall Study|Lost to Follow-up|0|||
148699715|NCT02801877|536375215|FG000|Overall Study|Never Started Treatment|2|||
148699716|NCT02801877|536375216|FG001|Overall Study|Never Started Treatment|0|||
148699717|NCT02801877|536375217|FG002|Overall Study|Never Started Treatment|4|||
148699718|NCT02801877|536375218|FG003|Overall Study|Never Started Treatment|0|||
148699719|NCT00463606|536375219|FG000|Overall Study|Adverse Event|21|||
148699720|NCT00463606|536375220|FG001|Overall Study|Adverse Event|18|||
148699721|NCT00463606|536375221|FG002|Overall Study|Adverse Event|11|||
148699722|NCT00463606|536375219|FG000|Overall Study|Withdrawal by Subject|11|||
148699723|NCT00463606|536375220|FG001|Overall Study|Withdrawal by Subject|11|||
148699724|NCT00463606|536375221|FG002|Overall Study|Withdrawal by Subject|5|||
148699725|NCT00463606|536375219|FG000|Overall Study|Lost to Follow-up|2|||
148699726|NCT00463606|536375220|FG001|Overall Study|Lost to Follow-up|2|||
148699727|NCT00463606|536375221|FG002|Overall Study|Lost to Follow-up|3|||
148699728|NCT00463606|536375219|FG000|Overall Study|Subject noncompliance|1|||
148699729|NCT00463606|536375220|FG001|Overall Study|Subject noncompliance|1|||
148699730|NCT00463606|536375221|FG002|Overall Study|Subject noncompliance|0|||
148699731|NCT00463606|536375219|FG000|Overall Study|Subject moved out of town|1|||
148699732|NCT00463606|536375220|FG001|Overall Study|Subject moved out of town|0|||
148699733|NCT00463606|536375221|FG002|Overall Study|Subject moved out of town|0|||
148699734|NCT00463606|536375219|FG000|Overall Study|Physician Decision|0|||
148699735|NCT00463606|536375220|FG001|Overall Study|Physician Decision|1|||
148699736|NCT00463606|536375221|FG002|Overall Study|Physician Decision|0|||
148699737|NCT00463606|536375219|FG000|Overall Study|Sponsor request|0|||
148699738|NCT00463606|536375220|FG001|Overall Study|Sponsor request|1|||
148699739|NCT00463606|536375221|FG002|Overall Study|Sponsor request|0|||
148699740|NCT00463606|536375219|FG000|Overall Study|Exclusion criteria violation|2|||
148699741|NCT00463606|536375220|FG001|Overall Study|Exclusion criteria violation|0|||
148699742|NCT00463606|536375221|FG002|Overall Study|Exclusion criteria violation|0|||
148699743|NCT00463606|536375219|FG000|Overall Study|Coordinator error|1|||
148699744|NCT00463606|536375220|FG001|Overall Study|Coordinator error|0|||
148699745|NCT00463606|536375221|FG002|Overall Study|Coordinator error|0|||
148699746|NCT00463606|536375219|FG000|Overall Study|Patient randomized in error|1|||
148699747|NCT00463606|536375220|FG001|Overall Study|Patient randomized in error|0|||
148699748|NCT00463606|536375221|FG002|Overall Study|Patient randomized in error|0|||
148699749|NCT00463606|536375219|FG000|Overall Study|Participation in another ABT-335 trial|1|||
148699750|NCT00463606|536375220|FG001|Overall Study|Participation in another ABT-335 trial|0|||
148699751|NCT00463606|536375221|FG002|Overall Study|Participation in another ABT-335 trial|0|||
148699752|NCT00463606|536375219|FG000|Overall Study|Protocol Violation|0|||
148699753|NCT00463606|536375220|FG001|Overall Study|Protocol Violation|0|||
148699754|NCT00463606|536375221|FG002|Overall Study|Protocol Violation|1|||
148699755|NCT01223365|536375222|FG000|Open-label Titration Period|Enrolled but not treated|1|||
148699756|NCT01223365|536375222|FG000|Open-label Titration Period|Adverse Event|23|||
148699757|NCT01223365|536375222|FG000|Open-label Titration Period|Lack of Efficacy|3|||
148699758|NCT01223365|536375222|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
148699759|NCT01223365|536375222|FG000|Open-label Titration Period|Protocol Violation|1|||
148699760|NCT01223365|536375222|FG000|Open-label Titration Period|Lost to Follow-up|2|||
148699761|NCT01223365|536375222|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
148699762|NCT01223365|536375222|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
148699763|NCT01223365|536375222|FG000|Open-label Titration Period|Starting physical therapy|1|||
148699764|NCT01223365|536375222|FG000|Open-label Treatment Period|Adverse Event|39|||
148699765|NCT01223365|536375222|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
148699766|NCT01223365|536375222|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
148699767|NCT01223365|536375222|FG000|Open-label Treatment Period|Protocol Violation|15|||
148699768|NCT01223365|536375222|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
148699769|NCT01223365|536375222|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
148699770|NCT01223365|536375222|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
148699771|NCT01223365|536375222|FG000|Open-label Treatment Period|Moved out of area|2|||
148699772|NCT01223365|536375222|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
148699773|NCT01223365|536375222|FG000|Open-label Treatment Period|"Out of window"|1|||
148699774|NCT01223365|536375222|FG000|Open-label Treatment Period|Starting physical therapy|1|||
148699775|NCT01223365|536375222|FG000|Open-label Treatment Period|Physician Decision|2|||
148699776|NCT02682602|536375223|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
148699777|NCT02682602|536375224|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
148699778|NCT02682602|536375223|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
148699779|NCT02682602|536375224|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
148699780|NCT02140060|536375225|FG000|Overall Study|Adverse Event|0|||
148699781|NCT02140060|536375226|FG001|Overall Study|Adverse Event|0|||
148699782|NCT02140060|536375227|FG002|Overall Study|Adverse Event|0|||
148699783|NCT02140060|536375228|FG003|Overall Study|Adverse Event|1|||
148699784|NCT02140060|536375229|FG004|Overall Study|Adverse Event|1|||
148699785|NCT02140060|536375230|FG005|Overall Study|Adverse Event|1|||
148699786|NCT02140060|536375225|FG000|Overall Study|Lack of Efficacy|0|||
148699787|NCT02140060|536375226|FG001|Overall Study|Lack of Efficacy|0|||
148699788|NCT02140060|536375227|FG002|Overall Study|Lack of Efficacy|0|||
148699789|NCT02140060|536375228|FG003|Overall Study|Lack of Efficacy|1|||
148699790|NCT02140060|536375229|FG004|Overall Study|Lack of Efficacy|0|||
148699791|NCT02140060|536375230|FG005|Overall Study|Lack of Efficacy|0|||
148699792|NCT06358820|536376851|FG000|Overall Study|Adverse Event|11|||
148699793|NCT06358820|536376851|FG000|Overall Study|kidney transplantation|3|||
148699794|NCT06358820|536376851|FG000|Overall Study|patient voluntary withdrawal|6|||
148699795|NCT06358820|536376851|FG000|Overall Study|Physician Decision|1|||
148699796|NCT01811953|536376852|FG000|Overall Study|Adverse Event|0|||
148699797|NCT01811953|536376853|FG001|Overall Study|Adverse Event|0|||
148699798|NCT01811953|536376854|FG002|Overall Study|Adverse Event|0|||
148699799|NCT01811953|536376855|FG003|Overall Study|Adverse Event|1|||
148699800|NCT01811953|536376856|FG004|Overall Study|Adverse Event|0|||
149025037|NCT03738241|537567987|FG008|Overall Study|Adverse Event|0|||
149025038|NCT03738241|537567988|FG009|Overall Study|Adverse Event|0|||
149025039|NCT01244763|537567989|FG000|Overall Study|Adverse Event|1|||
149025040|NCT01244763|537567990|FG001|Overall Study|Adverse Event|0|||
149025041|NCT01244763|537567991|FG002|Overall Study|Adverse Event|0|||
149025042|NCT01244763|537567992|FG003|Overall Study|Adverse Event|0|||
148699801|NCT01811953|536376857|FG005|Overall Study|Adverse Event|1|||
148699802|NCT01811953|536376852|FG000|Overall Study|Protocol Violation|0|||
148699803|NCT01811953|536376853|FG001|Overall Study|Protocol Violation|0|||
148699804|NCT01811953|536376854|FG002|Overall Study|Protocol Violation|0|||
148699805|NCT01811953|536376855|FG003|Overall Study|Protocol Violation|0|||
148699806|NCT01811953|536376856|FG004|Overall Study|Protocol Violation|1|||
148699807|NCT01811953|536376857|FG005|Overall Study|Protocol Violation|0|||
148699808|NCT00520130|536376862|FG000|Overall Study|Disease progression on study|4|||
148699809|NCT00520130|536376863|FG001|Overall Study|Disease progression on study|0|||
148699810|NCT00520130|536376862|FG000|Overall Study|Physician Decision|1|||
148699811|NCT00520130|536376863|FG001|Overall Study|Physician Decision|1|||
148699812|NCT04915755|536376864|FG000|Overall Study|Physician Decision|3|||
148699813|NCT04915755|536376865|FG001|Overall Study|Physician Decision|2|||
148699814|NCT04915755|536376864|FG000|Overall Study|Withdrawal by Subject|1|||
148699815|NCT04915755|536376865|FG001|Overall Study|Withdrawal by Subject|1|||
148699816|NCT04915755|536376864|FG000|Overall Study|Ongoing for PACT|3|||
148699817|NCT04915755|536376865|FG001|Overall Study|Ongoing for PACT|2|||
148699818|NCT04915755|536376864|FG000|Overall Study|Other|7|||
148699819|NCT04915755|536376865|FG001|Overall Study|Other|11|||
148699820|NCT02533258|536376866|FG000|Overall Study|Adverse Event|1|||
148699821|NCT02533258|536376866|FG000|Overall Study|Death|2|||
148699822|NCT02533258|536376866|FG000|Overall Study|Other|1|||
148699823|NCT02533258|536376866|FG000|Overall Study|Economic factor|1|||
148699824|NCT02533258|536376866|FG000|Overall Study|Progression of pleural effusion|1|||
148699825|NCT02533258|536376866|FG000|Overall Study|Lack of Efficacy|2|||
148699826|NCT03655106|536376867|FG000|Overall Study|Withdrawal by Subject|3|||
148699827|NCT03655106|536376868|FG001|Overall Study|Withdrawal by Subject|2|||
148699828|NCT03655106|536376867|FG000|Overall Study|Lost to Follow-up|2|||
148699829|NCT03655106|536376868|FG001|Overall Study|Lost to Follow-up|1|||
148699830|NCT03655106|536376867|FG000|Overall Study|Duplicate Enrollment|1|||
148699831|NCT03655106|536376868|FG001|Overall Study|Duplicate Enrollment|1|||
148699832|NCT03655106|536376867|FG000|Overall Study|Protocol Violation|3|||
148699833|NCT03655106|536376868|FG001|Overall Study|Protocol Violation|0|||
148699834|NCT00723528|536376872|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
148699835|NCT00723528|536376873|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
148699836|NCT00723528|536376874|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
148699837|NCT00723528|536376875|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
148699838|NCT00723528|536376876|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
148699839|NCT00723528|536376877|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
148699840|NCT00723528|536376878|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
148699841|NCT00723528|536376872|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
148699842|NCT00723528|536376873|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
148699843|NCT00723528|536376874|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
148699844|NCT00723528|536376875|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
148699845|NCT00723528|536376876|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
148699846|NCT00723528|536376877|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
148699847|NCT00723528|536376878|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
148699848|NCT00723528|536376872|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
148967395|NCT03161483|537366672|FG001|Treatment Period|Lack of Efficacy|0|||
148967396|NCT03161483|537366673|FG002|Treatment Period|Lack of Efficacy|0|||
148967397|NCT03161483|537366674|FG003|Treatment Period|Lack of Efficacy|1|||
148699849|NCT00723528|536376873|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
148699850|NCT00723528|536376874|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
148699851|NCT00723528|536376875|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
148699852|NCT00723528|536376876|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
148699853|NCT00723528|536376877|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
148699854|NCT00723528|536376878|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
148699855|NCT00723528|536376872|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
148699856|NCT00723528|536376873|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
148699857|NCT00723528|536376874|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
148699858|NCT00723528|536376875|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
148699859|NCT00723528|536376876|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
148699860|NCT00723528|536376877|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
148699861|NCT00723528|536376878|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
148699862|NCT00723528|536376872|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
148967398|NCT03161483|537366671|FG000|Treatment Period|Withdrawal by Subject|2|||
148967399|NCT03161483|537366672|FG001|Treatment Period|Withdrawal by Subject|5|||
148967400|NCT03161483|537366673|FG002|Treatment Period|Withdrawal by Subject|2|||
148967401|NCT03161483|537366674|FG003|Treatment Period|Withdrawal by Subject|6|||
148699863|NCT00723528|536376873|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
148967402|NCT03161483|537366671|FG000|Treatment Period|Lost to Follow-up|0|||
148967403|NCT03161483|537366672|FG001|Treatment Period|Lost to Follow-up|0|||
149025043|NCT01244763|537567993|FG004|Overall Study|Adverse Event|0|||
148814943|NCT01018979|536798063|FG001|Overall Study|Not received at least one dose|1|||
148814944|NCT01695746|536798064|FG000|Overall Study|Adverse Event|1|||
148699864|NCT00723528|536376874|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
148699865|NCT00723528|536376875|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
148699866|NCT00723528|536376876|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
148699867|NCT00723528|536376877|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
148699868|NCT00723528|536376878|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
148699869|NCT00723528|536376872|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
148699870|NCT00723528|536376873|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
148699871|NCT00723528|536376874|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
148699872|NCT00723528|536376875|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
148699873|NCT00723528|536376876|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
148699874|NCT00723528|536376877|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
148699875|NCT00723528|536376878|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
148699876|NCT00723528|536376872|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
148814945|NCT01695746|536798064|FG000|Overall Study|Non-compliance by the participant|3|||
148967404|NCT03161483|537366673|FG002|Treatment Period|Lost to Follow-up|0|||
148967405|NCT03161483|537366674|FG003|Treatment Period|Lost to Follow-up|1|||
148967406|NCT03161483|537366671|FG000|Treatment Period|Protocol Violation|0|||
148967407|NCT03161483|537366672|FG001|Treatment Period|Protocol Violation|0|||
148967408|NCT03161483|537366673|FG002|Treatment Period|Protocol Violation|0|||
148967409|NCT03161483|537366674|FG003|Treatment Period|Protocol Violation|1|||
148967410|NCT03161483|537366671|FG000|Treatment Period|Other reasons|1|||
148967411|NCT03161483|537366672|FG001|Treatment Period|Other reasons|1|||
148967412|NCT03161483|537366673|FG002|Treatment Period|Other reasons|0|||
148967413|NCT03161483|537366674|FG003|Treatment Period|Other reasons|0|||
148967414|NCT00228917|537366685|FG000|Overall Study|Migrated/moved from study area|0|||
148967415|NCT00228917|537366686|FG001|Overall Study|Migrated/moved from study area|0|||
149025044|NCT01244763|537567994|FG005|Overall Study|Adverse Event|1|||
149025045|NCT01244763|537567989|FG000|Overall Study|Death|1|||
149025046|NCT01244763|537567990|FG001|Overall Study|Death|0|||
149025047|NCT01244763|537567991|FG002|Overall Study|Death|1|||
149025048|NCT01244763|537567992|FG003|Overall Study|Death|0|||
149025049|NCT01244763|537567993|FG004|Overall Study|Death|2|||
149025050|NCT01244763|537567994|FG005|Overall Study|Death|0|||
149025051|NCT01244763|537567989|FG000|Overall Study|Physician Decision|0|||
149025052|NCT01244763|537567990|FG001|Overall Study|Physician Decision|0|||
149025053|NCT01244763|537567991|FG002|Overall Study|Physician Decision|1|||
149025054|NCT01244763|537567992|FG003|Overall Study|Physician Decision|0|||
149025055|NCT01244763|537567993|FG004|Overall Study|Physician Decision|0|||
149025056|NCT01244763|537567994|FG005|Overall Study|Physician Decision|0|||
149025057|NCT01244763|537567989|FG000|Overall Study|Withdrawal by Subject|1|||
149025058|NCT01244763|537567990|FG001|Overall Study|Withdrawal by Subject|2|||
149025059|NCT01244763|537567991|FG002|Overall Study|Withdrawal by Subject|0|||
149025060|NCT01244763|537567992|FG003|Overall Study|Withdrawal by Subject|1|||
149025061|NCT01244763|537567993|FG004|Overall Study|Withdrawal by Subject|1|||
149025062|NCT01244763|537567994|FG005|Overall Study|Withdrawal by Subject|2|||
149025063|NCT01244763|537567989|FG000|Overall Study|Lost to Follow-up|0|||
149025064|NCT01244763|537567990|FG001|Overall Study|Lost to Follow-up|1|||
148967416|NCT00228917|537366687|FG002|Overall Study|Migrated/moved from study area|0|||
149025065|NCT01244763|537567991|FG002|Overall Study|Lost to Follow-up|0|||
149025066|NCT01244763|537567992|FG003|Overall Study|Lost to Follow-up|0|||
149025067|NCT01244763|537567993|FG004|Overall Study|Lost to Follow-up|0|||
149025068|NCT01244763|537567994|FG005|Overall Study|Lost to Follow-up|0|||
149025069|NCT01244763|537567989|FG000|Overall Study|Enrolled into the Extension Study|0|||
148967417|NCT00228917|537366688|FG003|Overall Study|Migrated/moved from study area|0|||
148699877|NCT00723528|536376873|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
148699878|NCT00723528|536376874|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
148699879|NCT00723528|536376875|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
148699880|NCT00723528|536376876|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
148699881|NCT00723528|536376877|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
148699882|NCT00723528|536376878|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
148699883|NCT00723528|536376872|FG000|Period 2: After Controlled Period|Other|0|||
148699884|NCT00723528|536376873|FG001|Period 2: After Controlled Period|Other|0|||
148699885|NCT00723528|536376874|FG002|Period 2: After Controlled Period|Other|0|||
148699886|NCT00723528|536376875|FG003|Period 2: After Controlled Period|Other|0|||
148699887|NCT00723528|536376876|FG004|Period 2: After Controlled Period|Other|1|||
148699888|NCT00723528|536376877|FG005|Period 2: After Controlled Period|Other|4|||
148699889|NCT00723528|536376878|FG006|Period 2: After Controlled Period|Other|0|||
148699890|NCT00723528|536376872|FG000|Period 2: After Controlled Period|Adverse Event|0|||
148699891|NCT00723528|536376873|FG001|Period 2: After Controlled Period|Adverse Event|0|||
148699892|NCT00723528|536376874|FG002|Period 2: After Controlled Period|Adverse Event|0|||
148699893|NCT00723528|536376875|FG003|Period 2: After Controlled Period|Adverse Event|0|||
148699894|NCT00723528|536376876|FG004|Period 2: After Controlled Period|Adverse Event|1|||
148699895|NCT00723528|536376877|FG005|Period 2: After Controlled Period|Adverse Event|0|||
148699896|NCT00723528|536376878|FG006|Period 2: After Controlled Period|Adverse Event|1|||
148699897|NCT00723528|536376872|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
148699898|NCT00723528|536376873|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
148699899|NCT00723528|536376874|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
148699900|NCT00723528|536376875|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
148699901|NCT00723528|536376876|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
148699902|NCT00723528|536376877|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
148699903|NCT00723528|536376878|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
148699904|NCT00723528|536376872|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
148699905|NCT00723528|536376873|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
148699906|NCT00723528|536376874|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
148699907|NCT00723528|536376875|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
148699908|NCT00723528|536376876|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
148699909|NCT00723528|536376877|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
148699910|NCT00723528|536376878|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
148699911|NCT01993030|536376882|FG000|Overall Study|Adverse Event|0|||
148699912|NCT01993030|536376883|FG001|Overall Study|Adverse Event|4|||
148699913|NCT01591785|536376886|FG000|Overall Study|worsening condition|1|||
148699914|NCT01591785|536376887|FG001|Overall Study|worsening condition|2|||
148699915|NCT01591785|536376886|FG000|Overall Study|Protocol Violation|2|||
148699916|NCT01591785|536376887|FG001|Overall Study|Protocol Violation|0|||
148699917|NCT01591785|536376886|FG000|Overall Study|Lost to Follow-up|1|||
148699918|NCT01591785|536376887|FG001|Overall Study|Lost to Follow-up|0|||
148699919|NCT00667862|536376888|FG000|Overall Study|Adverse Event|9|||
148699920|NCT00667862|536376888|FG000|Overall Study|Death|1|||
148699921|NCT00667862|536376888|FG000|Overall Study|Disease Progression|22|||
148699922|NCT00667862|536376888|FG000|Overall Study|Withdrawal by Subject|3|||
148699923|NCT01049334|536376890|FG000|Overall Study|Withdrawal by Subject|5|||
148699924|NCT01049334|536376891|FG001|Overall Study|Withdrawal by Subject|3|||
148699925|NCT01049334|536376890|FG000|Overall Study|Adverse Event|2|||
148699926|NCT01049334|536376891|FG001|Overall Study|Adverse Event|3|||
148699927|NCT01049334|536376890|FG000|Overall Study|Physician Decision|2|||
148699928|NCT01049334|536376891|FG001|Overall Study|Physician Decision|0|||
148699929|NCT01049334|536376890|FG000|Overall Study|Protocol Violation|0|||
148699930|NCT01049334|536376891|FG001|Overall Study|Protocol Violation|1|||
148699931|NCT01367457|536376899|FG000|Overall Study|Death|2|||
148699932|NCT01367457|536376900|FG001|Overall Study|Death|0|||
148699933|NCT01367457|536376901|FG002|Overall Study|Death|0|||
148699934|NCT01367457|536376899|FG000|Overall Study|Investigator's decision|2|||
148699935|NCT01367457|536376900|FG001|Overall Study|Investigator's decision|0|||
148699936|NCT01367457|536376901|FG002|Overall Study|Investigator's decision|0|||
148699937|NCT01367457|536376899|FG000|Overall Study|Clinical decline (CD)|2|||
148699938|NCT01367457|536376900|FG001|Overall Study|Clinical decline (CD)|0|||
148699939|NCT01367457|536376901|FG002|Overall Study|Clinical decline (CD)|0|||
148699940|NCT01367457|536376899|FG000|Overall Study|Progression and death|8|||
148699941|NCT01367457|536376900|FG001|Overall Study|Progression and death|0|||
148699942|NCT01367457|536376901|FG002|Overall Study|Progression and death|0|||
148699943|NCT01367457|536376899|FG000|Overall Study|Toxicity|16|||
148699944|NCT01367457|536376900|FG001|Overall Study|Toxicity|0|||
148699945|NCT01367457|536376901|FG002|Overall Study|Toxicity|0|||
148699946|NCT01367457|536376899|FG000|Overall Study|Progression|137|||
148699947|NCT01367457|536376900|FG001|Overall Study|Progression|0|||
148967418|NCT00228917|537366689|FG004|Overall Study|Migrated/moved from study area|0|||
148967419|NCT00228917|537366690|FG005|Overall Study|Migrated/moved from study area|2|||
148699948|NCT01367457|536376901|FG002|Overall Study|Progression|0|||
148699949|NCT01367457|536376899|FG000|Overall Study|Patient asks for rest + slow progression|1|||
148699950|NCT01367457|536376900|FG001|Overall Study|Patient asks for rest + slow progression|0|||
148699951|NCT01367457|536376901|FG002|Overall Study|Patient asks for rest + slow progression|0|||
148699952|NCT01367457|536376899|FG000|Overall Study|Investigator's opinion, stable disease|1|||
148699953|NCT01367457|536376900|FG001|Overall Study|Investigator's opinion, stable disease|0|||
148699954|NCT01367457|536376901|FG002|Overall Study|Investigator's opinion, stable disease|0|||
148699955|NCT01367457|536376899|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
148699956|NCT01367457|536376900|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
148699957|NCT01367457|536376901|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
148699958|NCT01367457|536376899|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
148699959|NCT01367457|536376900|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
148699960|NCT01367457|536376901|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
148699961|NCT01367457|536376899|FG000|Overall Study|low grade toxicities + stable disease|1|||
148699962|NCT01367457|536376900|FG001|Overall Study|low grade toxicities + stable disease|0|||
148699963|NCT01367457|536376901|FG002|Overall Study|low grade toxicities + stable disease|0|||
148699964|NCT01367457|536376899|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
148699965|NCT01367457|536376900|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
148699966|NCT01367457|536376901|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
148699967|NCT01367457|536376899|FG000|Overall Study|Withdrawal by Subject|1|||
148699968|NCT01367457|536376900|FG001|Overall Study|Withdrawal by Subject|0|||
148699969|NCT01367457|536376901|FG002|Overall Study|Withdrawal by Subject|0|||
148699970|NCT01367457|536376899|FG000|Overall Study|CD, associated leukaemia|1|||
148699971|NCT01367457|536376900|FG001|Overall Study|CD, associated leukaemia|0|||
148699972|NCT01367457|536376901|FG002|Overall Study|CD, associated leukaemia|0|||
148699973|NCT01367457|536376899|FG000|Overall Study|Uncontrolled pain|1|||
148699974|NCT01367457|536376900|FG001|Overall Study|Uncontrolled pain|0|||
148699975|NCT01367457|536376901|FG002|Overall Study|Uncontrolled pain|0|||
148699976|NCT01367457|536376899|FG000|Overall Study|Overall status worsens to grade 4|1|||
148699977|NCT01367457|536376900|FG001|Overall Study|Overall status worsens to grade 4|0|||
148699978|NCT01367457|536376901|FG002|Overall Study|Overall status worsens to grade 4|0|||
148699979|NCT01367457|536376899|FG000|Overall Study|Stabilisation + frequent infections|1|||
148699980|NCT01367457|536376900|FG001|Overall Study|Stabilisation + frequent infections|0|||
148699981|NCT01367457|536376901|FG002|Overall Study|Stabilisation + frequent infections|0|||
148699982|NCT01367457|536376899|FG000|Overall Study|No clinical benefit|1|||
148699983|NCT01367457|536376900|FG001|Overall Study|No clinical benefit|0|||
148699984|NCT01367457|536376901|FG002|Overall Study|No clinical benefit|0|||
148699985|NCT01367457|536376899|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
148699986|NCT01367457|536376900|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
148699987|NCT01367457|536376901|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
148699988|NCT01367457|536376899|FG000|Overall Study|Overall decline|1|||
148699989|NCT01367457|536376900|FG001|Overall Study|Overall decline|0|||
148699990|NCT01367457|536376901|FG002|Overall Study|Overall decline|0|||
148699991|NCT01367457|536376899|FG000|Overall Study|Rejection of treatment|1|||
148699992|NCT01367457|536376900|FG001|Overall Study|Rejection of treatment|0|||
148699993|NCT01367457|536376901|FG002|Overall Study|Rejection of treatment|0|||
148699994|NCT01367457|536376899|FG000|Overall Study|Lost to Follow-up|1|||
148699995|NCT01367457|536376900|FG001|Overall Study|Lost to Follow-up|0|||
148699996|NCT01367457|536376901|FG002|Overall Study|Lost to Follow-up|0|||
148699997|NCT01367457|536376899|FG000|Overall Study|Death from septic shock|1|||
148699998|NCT01367457|536376900|FG001|Overall Study|Death from septic shock|0|||
148699999|NCT01367457|536376901|FG002|Overall Study|Death from septic shock|0|||
148700000|NCT01367457|536376899|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
148700001|NCT01367457|536376900|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
148700002|NCT01367457|536376901|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
148700003|NCT01367457|536376899|FG000|Overall Study|Patient's Wish|1|||
148700004|NCT01367457|536376900|FG001|Overall Study|Patient's Wish|0|||
148700005|NCT01367457|536376901|FG002|Overall Study|Patient's Wish|0|||
148700006|NCT01367457|536376899|FG000|Overall Study|Palliative. Overall decline|1|||
148700007|NCT01367457|536376900|FG001|Overall Study|Palliative. Overall decline|0|||
148700008|NCT01367457|536376901|FG002|Overall Study|Palliative. Overall decline|0|||
148700009|NCT01367457|536376899|FG000|Overall Study|Suspected DP/suspected active infection|1|||
148700010|NCT01367457|536376900|FG001|Overall Study|Suspected DP/suspected active infection|0|||
148700011|NCT01367457|536376901|FG002|Overall Study|Suspected DP/suspected active infection|0|||
148700012|NCT02495857|536376902|FG000|Overall Study|Adverse Event|5|||
148700013|NCT02495857|536376903|FG001|Overall Study|Adverse Event|0|||
148700014|NCT02495857|536376904|FG002|Overall Study|Adverse Event|1|||
148700015|NCT02495857|536376902|FG000|Overall Study|Withdrawal by Subject|9|||
148700016|NCT02495857|536376903|FG001|Overall Study|Withdrawal by Subject|6|||
148700017|NCT02495857|536376904|FG002|Overall Study|Withdrawal by Subject|10|||
148700018|NCT02495857|536376902|FG000|Overall Study|Physician Decision|0|||
148700019|NCT02495857|536376903|FG001|Overall Study|Physician Decision|1|||
148700020|NCT02495857|536376904|FG002|Overall Study|Physician Decision|0|||
148700021|NCT02495857|536376902|FG000|Overall Study|Protocol Violation|1|||
148700022|NCT02495857|536376903|FG001|Overall Study|Protocol Violation|1|||
148967420|NCT00228917|537366691|FG006|Overall Study|Migrated/moved from study area|0|||
148967421|NCT00228917|537366692|FG007|Overall Study|Migrated/moved from study area|0|||
148967422|NCT00409617|537366693|FG000|Overall Study|Adverse Event|57|||
148967423|NCT00409617|537366693|FG000|Overall Study|Lack of Efficacy|54|||
148967424|NCT00409617|537366693|FG000|Overall Study|Lost to Follow-up|2|||
148967425|NCT00409617|537366693|FG000|Overall Study|Protocol Violation|24|||
148700023|NCT02495857|536376904|FG002|Overall Study|Protocol Violation|2|||
148700024|NCT02495857|536376902|FG000|Overall Study|Lost to Follow-up|4|||
148700025|NCT02495857|536376903|FG001|Overall Study|Lost to Follow-up|5|||
148700026|NCT02495857|536376904|FG002|Overall Study|Lost to Follow-up|3|||
148700027|NCT02495857|536376902|FG000|Overall Study|Other|3|||
148700028|NCT02495857|536376903|FG001|Overall Study|Other|3|||
148700029|NCT02495857|536376904|FG002|Overall Study|Other|2|||
148700030|NCT03447262|536376905|FG000|Overall Study|Adverse Event|7|||
148700031|NCT03447262|536376905|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
148700032|NCT03447262|536376905|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
148700033|NCT03447262|536376905|FG000|Overall Study|Death|2|||
148700034|NCT03447262|536376905|FG000|Overall Study|Study Termination by Sponsor|455|||
148700035|NCT03447262|536376905|FG000|Overall Study|Other|4|||
148700036|NCT02058498|536376906|FG000|Overall Study|Withdrawal by Subject|4|||
148700037|NCT01171989|536376909|FG000|Overall Study|Lost to Follow-up|0|||
148700038|NCT01171989|536376910|FG001|Overall Study|Lost to Follow-up|0|||
148700039|NCT01171989|536376911|FG002|Overall Study|Lost to Follow-up|1|||
148700040|NCT00627016|536376912|FG000|Overall Study|Adverse Event|1|||
148700041|NCT00627016|536376913|FG001|Overall Study|Adverse Event|1|||
148700042|NCT00627016|536376912|FG000|Overall Study|Protocol Violation|0|||
148700043|NCT00627016|536376913|FG001|Overall Study|Protocol Violation|2|||
148700044|NCT00627016|536376912|FG000|Overall Study|Lost to Follow-up|0|||
148700045|NCT00627016|536376913|FG001|Overall Study|Lost to Follow-up|1|||
148700046|NCT00627016|536376912|FG000|Overall Study|Withdrawal by Subject|2|||
148700047|NCT00627016|536376913|FG001|Overall Study|Withdrawal by Subject|1|||
148700048|NCT00627016|536376912|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
148700049|NCT00627016|536376913|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
148700050|NCT00627016|536376912|FG000|Overall Study|Lack of Efficacy|1|||
148700051|NCT00627016|536376913|FG001|Overall Study|Lack of Efficacy|0|||
148700052|NCT00627016|536376912|FG000|Overall Study|Placed on Excluded Drugs|1|||
148700053|NCT00627016|536376913|FG001|Overall Study|Placed on Excluded Drugs|0|||
148700054|NCT00627016|536376912|FG000|Overall Study|Pregnancy|1|||
148700055|NCT00627016|536376913|FG001|Overall Study|Pregnancy|0|||
148700056|NCT04088760|536376916|FG000|Overall Study|Physician Decision|1|||
148700057|NCT00377260|536376917|FG000|Overall Study|Lost to Follow-up|0|||
148700058|NCT00377260|536376918|FG001|Overall Study|Lost to Follow-up|1|||
148700059|NCT00377260|536376917|FG000|Overall Study|Withdrawal by Subject|2|||
148700060|NCT00377260|536376918|FG001|Overall Study|Withdrawal by Subject|4|||
148700061|NCT00829530|536376919|FG000|First Intervention|Adverse Event|0|||
148700062|NCT00829530|536376920|FG001|First Intervention|Adverse Event|1|||
148700063|NCT00829530|536376919|FG000|First Intervention|Intolerance to Venopuncture|0|||
148700064|NCT00829530|536376920|FG001|First Intervention|Intolerance to Venopuncture|1|||
148700065|NCT00829530|536376919|FG000|Second Intervention|Intolerance to Venopuncture|1|||
148700066|NCT00829530|536376920|FG001|Second Intervention|Intolerance to Venopuncture|0|||
148700067|NCT01391793|536376921|FG000|Overall Study|Ineligible|3|||
148700068|NCT01391793|536376922|FG001|Overall Study|Ineligible|0|||
148700069|NCT01391793|536376921|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
148700070|NCT01391793|536376922|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
148700071|NCT01391793|536376921|FG000|Overall Study|No DMSA|73|||
148967426|NCT00409617|537366693|FG000|Overall Study|Withdrawal by Subject|8|||
148967427|NCT00409617|537366693|FG000|Overall Study|Administrative reasons|1|||
148967428|NCT00409617|537366693|FG000|Overall Study|Not described|14|||
148967429|NCT00149747|537366701|FG000|Overall Study|Death|1|||
148967430|NCT00149747|537366702|FG001|Overall Study|Death|0|||
148967431|NCT00149747|537366701|FG000|Overall Study|Withdrawal by Subject|3|||
148967432|NCT00149747|537366702|FG001|Overall Study|Withdrawal by Subject|3|||
148967433|NCT00694369|537366705|FG000|Overall Study|Adverse Event|0|||
148700072|NCT01391793|536376922|FG001|Overall Study|No DMSA|57|||
148700073|NCT01015625|536376923|FG000|Overall Study|Lost to Follow-up|3|||
148700074|NCT01015625|536376924|FG001|Overall Study|Lost to Follow-up|1|||
148700075|NCT01015625|536376923|FG000|Overall Study|Withdrawal by Subject|2|||
148700076|NCT01015625|536376924|FG001|Overall Study|Withdrawal by Subject|3|||
148700077|NCT01015625|536376923|FG000|Overall Study|Physician Decision|2|||
148700078|NCT01015625|536376924|FG001|Overall Study|Physician Decision|0|||
148700079|NCT01015625|536376923|FG000|Overall Study|Death|30|||
148967434|NCT00694369|537366706|FG001|Overall Study|Adverse Event|1|||
148967435|NCT00694369|537366707|FG002|Overall Study|Adverse Event|0|||
148700080|NCT01015625|536376924|FG001|Overall Study|Death|22|||
148700081|NCT04466111|536376927|FG000|Prior to Trial Phase|Physician Decision|1|||
148700082|NCT00286754|536376928|FG000|Overall Study|Adverse Event|2|||
148700083|NCT00286754|536376929|FG001|Overall Study|Adverse Event|2|||
148700084|NCT00286754|536376930|FG002|Overall Study|Adverse Event|3|||
148700085|NCT00286754|536376928|FG000|Overall Study|Withdrawal by Subject|6|||
148700086|NCT00286754|536376929|FG001|Overall Study|Withdrawal by Subject|2|||
148967436|NCT00694369|537366708|FG003|Overall Study|Adverse Event|1|||
148967437|NCT00694369|537366709|FG004|Overall Study|Adverse Event|3|||
148967438|NCT00694369|537366705|FG000|Overall Study|Lost to Follow-up|0|||
148967439|NCT00694369|537366706|FG001|Overall Study|Lost to Follow-up|0|||
148700087|NCT00286754|536376930|FG002|Overall Study|Withdrawal by Subject|0|||
148700088|NCT00286754|536376928|FG000|Overall Study|Lost to Follow-up|12|||
148700089|NCT00286754|536376929|FG001|Overall Study|Lost to Follow-up|14|||
148700090|NCT00286754|536376930|FG002|Overall Study|Lost to Follow-up|6|||
148700091|NCT00286754|536376928|FG000|Overall Study|Moved out of state|0|||
148700092|NCT00286754|536376929|FG001|Overall Study|Moved out of state|0|||
148700093|NCT00286754|536376930|FG002|Overall Study|Moved out of state|1|||
148700094|NCT00910663|536376931|FG000|Period 1|Withdrawal by Subject|0|||
148700095|NCT00910663|536376932|FG001|Period 1|Withdrawal by Subject|1|||
148700096|NCT01844375|536376936|FG000|Overall Study|Protocol Violation|1|||
148700097|NCT01844375|536376937|FG001|Overall Study|Protocol Violation|1|||
148700098|NCT01772537|536376938|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
148700099|NCT01772537|536376939|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
148700100|NCT01772537|536376940|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
148700101|NCT03627091|536376941|FG000|Overall Study|Adverse Event|0|||
148700102|NCT03627091|536376942|FG001|Overall Study|Adverse Event|0|||
148700103|NCT03627091|536376943|FG002|Overall Study|Adverse Event|2|||
148700104|NCT03627091|536376941|FG000|Overall Study|Withdrawal by Subject|2|||
148700105|NCT03627091|536376942|FG001|Overall Study|Withdrawal by Subject|0|||
148700106|NCT03627091|536376943|FG002|Overall Study|Withdrawal by Subject|2|||
148700107|NCT03627091|536376941|FG000|Overall Study|Physician Decision|2|||
148700108|NCT03627091|536376942|FG001|Overall Study|Physician Decision|0|||
148700109|NCT03627091|536376943|FG002|Overall Study|Physician Decision|0|||
148700110|NCT03627091|536376941|FG000|Overall Study|Site terminated by sponsor|0|||
148700111|NCT03627091|536376942|FG001|Overall Study|Site terminated by sponsor|1|||
148700112|NCT03627091|536376943|FG002|Overall Study|Site terminated by sponsor|0|||
148700113|NCT03627091|536376941|FG000|Overall Study|Disease relapse|7|||
148700114|NCT03627091|536376942|FG001|Overall Study|Disease relapse|5|||
148700115|NCT03627091|536376943|FG002|Overall Study|Disease relapse|1|||
148700116|NCT03627091|536376941|FG000|Overall Study|Other|1|||
148700117|NCT03627091|536376942|FG001|Overall Study|Other|0|||
148700118|NCT03627091|536376943|FG002|Overall Study|Other|0|||
148700119|NCT01498120|536376944|FG000|Overall Study|Lost to Follow-up|1|||
148700120|NCT01498120|536376944|FG000|Overall Study|Withdrawal by Subject|5|||
148700121|NCT01498120|536376944|FG000|Overall Study|AE, non-serious non-fatal|3|||
148700122|NCT01498120|536376944|FG000|Overall Study|Other|4|||
148700123|NCT00678639|536376947|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
148700124|NCT00678639|536376948|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
148700125|NCT01546545|536376951|FG000|Overall Study|Withdrawal by Subject|1|||
148700126|NCT04060147|536376952|FG000|Overall Study|Withdrew consent|1|||
148700127|NCT00336479|536376953|FG000|Overall Study|Adverse Event|8|||
148700128|NCT00336479|536376954|FG001|Overall Study|Adverse Event|11|||
148700129|NCT00336479|536376955|FG002|Overall Study|Adverse Event|18|||
148700130|NCT00336479|536376956|FG003|Overall Study|Adverse Event|4|||
148700131|NCT00336479|536376953|FG000|Overall Study|Noncompliant|1|||
148700132|NCT00336479|536376954|FG001|Overall Study|Noncompliant|7|||
148700133|NCT00336479|536376955|FG002|Overall Study|Noncompliant|3|||
148700134|NCT00336479|536376956|FG003|Overall Study|Noncompliant|0|||
148700135|NCT00336479|536376953|FG000|Overall Study|Physician Decision|2|||
148967440|NCT00694369|537366707|FG002|Overall Study|Lost to Follow-up|1|||
148700136|NCT00336479|536376954|FG001|Overall Study|Physician Decision|3|||
148700137|NCT00336479|536376955|FG002|Overall Study|Physician Decision|1|||
148700138|NCT00336479|536376956|FG003|Overall Study|Physician Decision|0|||
148700139|NCT00336479|536376953|FG000|Overall Study|Lost to Follow-up|3|||
148700140|NCT00336479|536376954|FG001|Overall Study|Lost to Follow-up|2|||
148967441|NCT00694369|537366708|FG003|Overall Study|Lost to Follow-up|1|||
148700141|NCT00336479|536376955|FG002|Overall Study|Lost to Follow-up|0|||
148700142|NCT00336479|536376956|FG003|Overall Study|Lost to Follow-up|0|||
148700143|NCT00336479|536376953|FG000|Overall Study|Withdrawal by Subject|3|||
148700144|NCT00336479|536376954|FG001|Overall Study|Withdrawal by Subject|2|||
148700145|NCT00336479|536376955|FG002|Overall Study|Withdrawal by Subject|3|||
148700146|NCT00336479|536376956|FG003|Overall Study|Withdrawal by Subject|0|||
148700147|NCT00336479|536376953|FG000|Overall Study|Other|0|||
148700148|NCT00336479|536376954|FG001|Overall Study|Other|0|||
148700149|NCT00336479|536376955|FG002|Overall Study|Other|1|||
148700150|NCT00336479|536376956|FG003|Overall Study|Other|0|||
148700151|NCT00336479|536376953|FG000|Overall Study|Virologic Stopping Rule|20|||
148967442|NCT00694369|537366709|FG004|Overall Study|Lost to Follow-up|0|||
148700152|NCT00336479|536376954|FG001|Overall Study|Virologic Stopping Rule|0|||
148700153|NCT00336479|536376955|FG002|Overall Study|Virologic Stopping Rule|0|||
148700154|NCT00336479|536376956|FG003|Overall Study|Virologic Stopping Rule|0|||
148700155|NCT00550537|536376957|FG000|Overall Study|Death|18|||
148967443|NCT00694369|537366705|FG000|Overall Study|Physician Decision|0|||
148814946|NCT01695746|536798064|FG000|Overall Study|Protocol Violation|5|||
148814947|NCT01695746|536798064|FG000|Overall Study|Participant not willing to participate|3|||
148967444|NCT00694369|537366706|FG001|Overall Study|Physician Decision|0|||
148967445|NCT00694369|537366707|FG002|Overall Study|Physician Decision|0|||
148967446|NCT00694369|537366708|FG003|Overall Study|Physician Decision|0|||
148967447|NCT00694369|537366709|FG004|Overall Study|Physician Decision|1|||
148967448|NCT00694369|537366705|FG000|Overall Study|Protocol Violation|0|||
148967449|NCT00694369|537366706|FG001|Overall Study|Protocol Violation|1|||
148967450|NCT00694369|537366707|FG002|Overall Study|Protocol Violation|0|||
148967451|NCT00694369|537366708|FG003|Overall Study|Protocol Violation|0|||
148967452|NCT00694369|537366709|FG004|Overall Study|Protocol Violation|0|||
148967453|NCT00694369|537366705|FG000|Overall Study|Withdrawal by Subject|1|||
148967454|NCT00694369|537366706|FG001|Overall Study|Withdrawal by Subject|1|||
148967455|NCT00694369|537366707|FG002|Overall Study|Withdrawal by Subject|1|||
148967456|NCT00694369|537366708|FG003|Overall Study|Withdrawal by Subject|1|||
148967457|NCT00694369|537366709|FG004|Overall Study|Withdrawal by Subject|2|||
148700156|NCT00550537|536376957|FG000|Overall Study|Adverse Event|20|||
148700157|NCT00550537|536376957|FG000|Overall Study|Disease progression before|46|||
148700158|NCT00550537|536376957|FG000|Overall Study|Withdrawal by Subject|7|||
148700159|NCT00550537|536376957|FG000|Overall Study|Change in treatment plan|4|||
148700160|NCT00550537|536376957|FG000|Overall Study|Other complicating ilness|3|||
148700161|NCT00550537|536376957|FG000|Overall Study|Declining performance status|2|||
148700162|NCT00550537|536376957|FG000|Overall Study|Treated closer to home|4|||
148700163|NCT02008565|536376958|FG000|Overall Study|Protocol Violation|1|||
148700164|NCT02008565|536376959|FG001|Overall Study|Protocol Violation|1|||
148700165|NCT02008565|536376960|FG002|Overall Study|Protocol Violation|2|||
148700166|NCT02008565|536376961|FG003|Overall Study|Protocol Violation|0|||
148700167|NCT00268905|536376962|FG000|Overall Study|Adverse Event|3|||
148700168|NCT00268905|536376963|FG001|Overall Study|Adverse Event|0|||
148700169|NCT00268905|536376964|FG002|Overall Study|Adverse Event|4|||
148700170|NCT00268905|536376962|FG000|Overall Study|Lost to Follow-up|0|||
148700171|NCT00268905|536376963|FG001|Overall Study|Lost to Follow-up|1|||
148700172|NCT00268905|536376964|FG002|Overall Study|Lost to Follow-up|0|||
148700173|NCT00268905|536376962|FG000|Overall Study|Withdrawal by Subject|0|||
148700174|NCT00268905|536376963|FG001|Overall Study|Withdrawal by Subject|0|||
148700175|NCT00268905|536376964|FG002|Overall Study|Withdrawal by Subject|3|||
148700176|NCT00268905|536376962|FG000|Overall Study|Progressive Disease|28|||
148700177|NCT00268905|536376963|FG001|Overall Study|Progressive Disease|4|||
148700178|NCT00268905|536376964|FG002|Overall Study|Progressive Disease|3|||
148700179|NCT00268905|536376962|FG000|Overall Study|Physician Decision|3|||
148700180|NCT00268905|536376963|FG001|Overall Study|Physician Decision|0|||
148700181|NCT00268905|536376964|FG002|Overall Study|Physician Decision|1|||
148700182|NCT00268905|536376962|FG000|Overall Study|Clinical Progression|9|||
148700183|NCT00268905|536376963|FG001|Overall Study|Clinical Progression|4|||
148700184|NCT00268905|536376964|FG002|Overall Study|Clinical Progression|1|||
148700185|NCT00617305|536376965|FG000|Overall Study|Adverse Event|4|||
148700186|NCT00617305|536376966|FG001|Overall Study|Adverse Event|0|||
148700187|NCT00617305|536376967|FG002|Overall Study|Adverse Event|0|||
148700188|NCT00617305|536376965|FG000|Overall Study|Death|1|||
148700189|NCT00617305|536376966|FG001|Overall Study|Death|0|||
148700190|NCT00617305|536376967|FG002|Overall Study|Death|0|||
148700191|NCT00617305|536376965|FG000|Overall Study|Physician Decision|1|||
148700192|NCT00617305|536376966|FG001|Overall Study|Physician Decision|0|||
148700193|NCT00617305|536376967|FG002|Overall Study|Physician Decision|0|||
148700194|NCT00617305|536376965|FG000|Overall Study|Protocol Violation|1|||
148700195|NCT00617305|536376966|FG001|Overall Study|Protocol Violation|0|||
148700196|NCT00617305|536376967|FG002|Overall Study|Protocol Violation|1|||
148700197|NCT00617305|536376965|FG000|Overall Study|Withdrawal by Subject|1|||
148700198|NCT00617305|536376966|FG001|Overall Study|Withdrawal by Subject|0|||
148700199|NCT00617305|536376967|FG002|Overall Study|Withdrawal by Subject|0|||
148700200|NCT02193178|536376968|FG000|Overall Study|Lost to Follow-up|1|||
148700201|NCT02193178|536376968|FG000|Overall Study|Dry eyes|1|||
148700202|NCT03435081|536376969|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
148700203|NCT03435081|536376970|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
148700204|NCT03435081|536376971|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
148700205|NCT03435081|536376969|FG000|Week 0 to Week 16|Adverse Event|2|||
148700206|NCT03435081|536376970|FG001|Week 0 to Week 16|Adverse Event|2|||
148700207|NCT03435081|536376971|FG002|Week 0 to Week 16|Adverse Event|2|||
148700208|NCT03435081|536376969|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
148700209|NCT03435081|536376970|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
148700210|NCT03435081|536376971|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
148700211|NCT03435081|536376969|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
148700212|NCT03435081|536376970|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
148700213|NCT03435081|536376971|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
148700214|NCT03435081|536376969|FG000|Week 0 to Week 16|Pregnancy|1|||
148700215|NCT03435081|536376970|FG001|Week 0 to Week 16|Pregnancy|0|||
148814948|NCT02717611|536798065|FG000|Overall Study|Death|13|||
148814949|NCT02717611|536798065|FG000|Overall Study|Withdrawal by Subject|6|||
148814950|NCT02717611|536798065|FG000|Overall Study|Active, not recruiting|40|||
148700216|NCT03435081|536376971|FG002|Week 0 to Week 16|Pregnancy|0|||
148700217|NCT03435081|536376969|FG000|Week 0 to Week 16|Non-compliance|1|||
148700218|NCT03435081|536376970|FG001|Week 0 to Week 16|Non-compliance|0|||
148700219|NCT03435081|536376971|FG002|Week 0 to Week 16|Non-compliance|2|||
148700220|NCT03435081|536376969|FG000|Week 0 to Week 16|Inadequate Response|0|||
148700221|NCT03435081|536376970|FG001|Week 0 to Week 16|Inadequate Response|1|||
148700222|NCT03435081|536376971|FG002|Week 0 to Week 16|Inadequate Response|0|||
148700223|NCT03435081|536376969|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
148700224|NCT03435081|536376970|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
148700225|NCT03435081|536376971|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
148700226|NCT03435081|536376969|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
148700227|NCT03435081|536376970|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
148700228|NCT03435081|536376971|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
148700229|NCT03435081|536376969|FG000|Week 16 to Week 104|Adverse Event|1|||
148814951|NCT02717611|536798065|FG000|Overall Study|Complicating disease|1|||
148700230|NCT03435081|536376970|FG001|Week 16 to Week 104|Adverse Event|0|||
148700231|NCT03435081|536376971|FG002|Week 16 to Week 104|Adverse Event|2|||
148700232|NCT03435081|536376969|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
148700233|NCT03435081|536376970|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
148700234|NCT03435081|536376971|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
148700235|NCT03435081|536376969|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
148700236|NCT03435081|536376970|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
148700237|NCT03435081|536376971|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
148700238|NCT03435081|536376969|FG000|Week 16 to Week 104|Non--Compliance|0|||
148700239|NCT03435081|536376970|FG001|Week 16 to Week 104|Non--Compliance|0|||
148700240|NCT03435081|536376971|FG002|Week 16 to Week 104|Non--Compliance|1|||
148700241|NCT00420238|536376972|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
148700242|NCT00420238|536376973|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
148700243|NCT00420238|536376972|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
148700244|NCT00420238|536376973|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
148700245|NCT00420238|536376972|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
148700246|NCT00420238|536376973|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
148700247|NCT00420238|536376972|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
148700248|NCT00420238|536376973|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
148700249|NCT00420238|536376972|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
148700250|NCT00420238|536376973|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
148700251|NCT00420238|536376972|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
148700252|NCT00420238|536376973|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
148700253|NCT00048581|536376974|FG000|Double-Blind Period|Adverse Event|9|||
148700254|NCT00048581|536376975|FG001|Double-Blind Period|Adverse Event|5|||
148700255|NCT00048581|536376976|FG002|Double-Blind Period|Adverse Event|0|||
148700256|NCT00048581|536376974|FG000|Double-Blind Period|Lack of Efficacy|14|||
148700257|NCT00048581|536376975|FG001|Double-Blind Period|Lack of Efficacy|27|||
148700258|NCT00048581|536376976|FG002|Double-Blind Period|Lack of Efficacy|0|||
148700259|NCT00048581|536376974|FG000|Double-Blind Period|Lost to Follow-up|5|||
148700260|NCT00048581|536376975|FG001|Double-Blind Period|Lost to Follow-up|0|||
148700261|NCT00048581|536376976|FG002|Double-Blind Period|Lost to Follow-up|0|||
148700262|NCT00048581|536376974|FG000|Double-Blind Period|Withdrawal by Subject|5|||
148700263|NCT00048581|536376975|FG001|Double-Blind Period|Withdrawal by Subject|2|||
148700264|NCT00048581|536376976|FG002|Double-Blind Period|Withdrawal by Subject|0|||
148700265|NCT00048581|536376974|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
148700266|NCT00048581|536376975|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
148700267|NCT00048581|536376976|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
148700268|NCT00048581|536376974|FG000|Double-Blind Period|Investigator Decision|1|||
148700269|NCT00048581|536376975|FG001|Double-Blind Period|Investigator Decision|0|||
148700270|NCT00048581|536376976|FG002|Double-Blind Period|Investigator Decision|0|||
148700271|NCT00048581|536376974|FG000|Open-Label Period|Death|0|||
148700272|NCT00048581|536376975|FG001|Open-Label Period|Death|0|||
148700273|NCT00048581|536376976|FG002|Open-Label Period|Death|4|||
149025070|NCT01244763|537567990|FG001|Overall Study|Enrolled into the Extension Study|0|||
148700274|NCT00048581|536376974|FG000|Open-Label Period|Adverse Event|0|||
148700275|NCT00048581|536376975|FG001|Open-Label Period|Adverse Event|0|||
148700276|NCT00048581|536376976|FG002|Open-Label Period|Adverse Event|37|||
148700277|NCT00048581|536376974|FG000|Open-Label Period|Lack of Efficacy|0|||
148700278|NCT00048581|536376975|FG001|Open-Label Period|Lack of Efficacy|0|||
148700279|NCT00048581|536376976|FG002|Open-Label Period|Lack of Efficacy|69|||
148700280|NCT00048581|536376974|FG000|Open-Label Period|Lost to Follow-up|0|||
148700281|NCT00048581|536376975|FG001|Open-Label Period|Lost to Follow-up|0|||
148700282|NCT00048581|536376976|FG002|Open-Label Period|Lost to Follow-up|14|||
149025071|NCT01244763|537567991|FG002|Overall Study|Enrolled into the Extension Study|0|||
149025072|NCT01244763|537567992|FG003|Overall Study|Enrolled into the Extension Study|0|||
148700283|NCT00048581|536376974|FG000|Open-Label Period|Withdrawal by Subject|0|||
148700284|NCT00048581|536376975|FG001|Open-Label Period|Withdrawal by Subject|0|||
148700285|NCT00048581|536376976|FG002|Open-Label Period|Withdrawal by Subject|20|||
148700286|NCT00048581|536376974|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
148700287|NCT00048581|536376975|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
148700288|NCT00048581|536376976|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
148700289|NCT00048581|536376974|FG000|Open-Label Period|Poor/Non-compliance|0|||
148700290|NCT00048581|536376975|FG001|Open-Label Period|Poor/Non-compliance|0|||
148700291|NCT00048581|536376976|FG002|Open-Label Period|Poor/Non-compliance|5|||
148700292|NCT00048581|536376974|FG000|Open-Label Period|Pregnancy|0|||
148700293|NCT00048581|536376975|FG001|Open-Label Period|Pregnancy|0|||
148700294|NCT00048581|536376976|FG002|Open-Label Period|Pregnancy|7|||
148700295|NCT00048581|536376974|FG000|Open-Label Period|Study Site Closure|0|||
148700296|NCT00048581|536376975|FG001|Open-Label Period|Study Site Closure|0|||
148700297|NCT00048581|536376976|FG002|Open-Label Period|Study Site Closure|2|||
148700298|NCT00048581|536376974|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
148700299|NCT00048581|536376975|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
148700300|NCT00048581|536376976|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
148700301|NCT00048581|536376974|FG000|Open-Label Period|Problem With Transportation To Site|0|||
148700302|NCT00048581|536376975|FG001|Open-Label Period|Problem With Transportation To Site|0|||
148700303|NCT00048581|536376976|FG002|Open-Label Period|Problem With Transportation To Site|1|||
148700304|NCT00048581|536376974|FG000|Open-Label Period|Primary Investigator Retired|0|||
148700305|NCT00048581|536376975|FG001|Open-Label Period|Primary Investigator Retired|0|||
148700306|NCT00048581|536376976|FG002|Open-Label Period|Primary Investigator Retired|2|||
148700307|NCT00048581|536376974|FG000|Open-Label Period|Study Ended By Sponsor|0|||
148700308|NCT00048581|536376975|FG001|Open-Label Period|Study Ended By Sponsor|0|||
148700309|NCT00048581|536376976|FG002|Open-Label Period|Study Ended By Sponsor|1|||
148700310|NCT01406795|536376977|FG000|Overall Study|Withdrawal by Subject|1|||
148700311|NCT03966365|536376978|FG000|Overall Study|Protocol Violation|1|||
148700312|NCT03966365|536376979|FG001|Overall Study|Protocol Violation|0|||
148700313|NCT03567174|536376981|FG000|Overall Study|Death|24|||
148700314|NCT03567174|536376982|FG001|Overall Study|Death|31|||
148700315|NCT03567174|536376981|FG000|Overall Study|Lost to Follow-up|165|||
148700316|NCT03567174|536376982|FG001|Overall Study|Lost to Follow-up|174|||
148700317|NCT05376319|536379037|FG000|Overall Study|Funding termination|2|||
148700318|NCT05376319|536379038|FG001|Overall Study|Funding termination|4|||
148700319|NCT01124175|536379039|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
148700320|NCT01124175|536379040|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
148700321|NCT00942968|536379041|FG000|Overall Study|Adverse Event|60|||
148700322|NCT00942968|536379041|FG000|Overall Study|Death|76|||
148700323|NCT00942968|536379041|FG000|Overall Study|Protocol Violation|9|||
148700324|NCT00942968|536379041|FG000|Overall Study|Lost to Follow-up|4|||
148700325|NCT00942968|536379041|FG000|Overall Study|Withdrawal by Subject|44|||
148700326|NCT00942968|536379041|FG000|Overall Study|Sponsor request|5|||
148700327|NCT00942968|536379041|FG000|Overall Study|Physician Decision|11|||
148700328|NCT00942968|536379041|FG000|Overall Study|Progression of disease|12|||
148700329|NCT00942968|536379041|FG000|Overall Study|Inferior vena cava filter placement|4|||
148700330|NCT00942968|536379041|FG000|Overall Study|Pulmonary embolism (PE)|1|||
148700331|NCT00942968|536379041|FG000|Overall Study|Participant required pancreatic biopsy|1|||
148700332|NCT00942968|536379041|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
148700333|NCT01340495|536379046|FG000|Overall Study|Withdrawal by Subject|1|||
148700334|NCT00070291|536379047|FG000|Step 1|Withdrawal by Subject|1|||
148700335|NCT00070291|536379047|FG000|Step 1|Adverse Event|1|||
148700336|NCT00070291|536379047|FG000|Step 2|Adverse Event|1|||
148700337|NCT02262377|536379048|FG000|Overall Study|Lost to Follow-up|5|||
148700338|NCT02262377|536379049|FG001|Overall Study|Lost to Follow-up|6|||
148700339|NCT02262377|536379048|FG000|Overall Study|Found ineligible after enrollment|3|||
148700340|NCT02262377|536379049|FG001|Overall Study|Found ineligible after enrollment|0|||
148700341|NCT02262377|536379048|FG000|Overall Study|Withdrawal by Subject|4|||
148700342|NCT02262377|536379049|FG001|Overall Study|Withdrawal by Subject|0|||
148700343|NCT01045096|536379050|FG000|Overall Study|Withdrawal by Subject|2|||
148700344|NCT01045096|536379051|FG001|Overall Study|Withdrawal by Subject|0|||
148967458|NCT03131440|537366711|FG000|Overall Study|Withdrawal by Subject|1|||
148967459|NCT03131440|537366712|FG001|Overall Study|Withdrawal by Subject|3|||
148967460|NCT03131440|537366713|FG002|Overall Study|Withdrawal by Subject|0|||
148700345|NCT01045096|536379052|FG002|Overall Study|Withdrawal by Subject|0|||
148700346|NCT01045096|536379050|FG000|Overall Study|Other|1|||
148700347|NCT01045096|536379051|FG001|Overall Study|Other|0|||
148700348|NCT01045096|536379052|FG002|Overall Study|Other|0|||
148967461|NCT03131440|537366714|FG003|Overall Study|Withdrawal by Subject|0|||
148700349|NCT01511939|536379054|FG000|Overall Study|Withdrawal by Subject|2|||
148700350|NCT01511939|536379055|FG001|Overall Study|Withdrawal by Subject|1|||
148700351|NCT01511939|536379056|FG002|Overall Study|Withdrawal by Subject|0|||
148700352|NCT03497897|536379060|FG000|Overall Study|Adverse Event|1|||
148700353|NCT03497897|536379061|FG001|Overall Study|Adverse Event|1|||
148700354|NCT03497897|536379062|FG002|Overall Study|Adverse Event|1|||
148967462|NCT03131440|537366715|FG004|Overall Study|Withdrawal by Subject|1|||
148967463|NCT03131440|537366716|FG005|Overall Study|Withdrawal by Subject|0|||
148967464|NCT03131440|537366717|FG006|Overall Study|Withdrawal by Subject|0|||
148967465|NCT03131440|537366718|FG007|Overall Study|Withdrawal by Subject|1|||
148967466|NCT03131440|537366719|FG008|Overall Study|Withdrawal by Subject|1|||
148967467|NCT03131440|537366720|FG009|Overall Study|Withdrawal by Subject|1|||
148967468|NCT03131440|537366721|FG010|Overall Study|Withdrawal by Subject|0|||
148700355|NCT03497897|536379060|FG000|Overall Study|Lost to Follow-up|2|||
148700356|NCT03497897|536379061|FG001|Overall Study|Lost to Follow-up|0|||
148700357|NCT03497897|536379062|FG002|Overall Study|Lost to Follow-up|2|||
148700358|NCT03497897|536379060|FG000|Overall Study|Physician Decision|1|||
148700359|NCT03497897|536379061|FG001|Overall Study|Physician Decision|0|||
148700360|NCT03497897|536379062|FG002|Overall Study|Physician Decision|0|||
148700361|NCT03497897|536379060|FG000|Overall Study|Subject/Guardian Decision|2|||
148700362|NCT03497897|536379061|FG001|Overall Study|Subject/Guardian Decision|1|||
148700363|NCT03497897|536379062|FG002|Overall Study|Subject/Guardian Decision|3|||
148700364|NCT02883452|536379066|FG000|Overall Study|Withdrawal by Subject|1|||
148700365|NCT02883452|536379067|FG001|Overall Study|Withdrawal by Subject|1|||
148700366|NCT02883452|536379068|FG002|Overall Study|Withdrawal by Subject|3|||
148700367|NCT02883452|536379069|FG003|Overall Study|Withdrawal by Subject|0|||
148700368|NCT02883452|536379070|FG004|Overall Study|Withdrawal by Subject|2|||
148700369|NCT02883452|536379071|FG005|Overall Study|Withdrawal by Subject|5|||
148700370|NCT02883452|536379066|FG000|Overall Study|Disease progression|1|||
148700371|NCT02883452|536379067|FG001|Overall Study|Disease progression|0|||
148700372|NCT02883452|536379068|FG002|Overall Study|Disease progression|0|||
148700373|NCT02883452|536379069|FG003|Overall Study|Disease progression|1|||
148700374|NCT02883452|536379070|FG004|Overall Study|Disease progression|4|||
148700375|NCT02883452|536379071|FG005|Overall Study|Disease progression|5|||
148700376|NCT02883452|536379066|FG000|Overall Study|Adverse Event|2|||
148700377|NCT02883452|536379067|FG001|Overall Study|Adverse Event|1|||
148700378|NCT02883452|536379068|FG002|Overall Study|Adverse Event|1|||
148700379|NCT02883452|536379069|FG003|Overall Study|Adverse Event|1|||
148700380|NCT02883452|536379070|FG004|Overall Study|Adverse Event|1|||
148700381|NCT02883452|536379071|FG005|Overall Study|Adverse Event|3|||
148700382|NCT02883452|536379066|FG000|Overall Study|Physician Decision|0|||
148700383|NCT02883452|536379067|FG001|Overall Study|Physician Decision|0|||
148700384|NCT02883452|536379068|FG002|Overall Study|Physician Decision|0|||
148700385|NCT02883452|536379069|FG003|Overall Study|Physician Decision|0|||
148700386|NCT02883452|536379070|FG004|Overall Study|Physician Decision|4|||
148700387|NCT02883452|536379071|FG005|Overall Study|Physician Decision|1|||
148700388|NCT02883452|536379066|FG000|Overall Study|Death|1|||
148700389|NCT02883452|536379067|FG001|Overall Study|Death|0|||
148700390|NCT02883452|536379068|FG002|Overall Study|Death|1|||
148700391|NCT02883452|536379069|FG003|Overall Study|Death|0|||
148700392|NCT02883452|536379070|FG004|Overall Study|Death|0|||
148700393|NCT02883452|536379071|FG005|Overall Study|Death|0|||
148700394|NCT02883452|536379066|FG000|Overall Study|Other|0|||
148700395|NCT02883452|536379067|FG001|Overall Study|Other|0|||
148700396|NCT02883452|536379068|FG002|Overall Study|Other|0|||
148700397|NCT02883452|536379069|FG003|Overall Study|Other|0|||
148700398|NCT02883452|536379070|FG004|Overall Study|Other|0|||
148700399|NCT02883452|536379071|FG005|Overall Study|Other|1|||
148700400|NCT00667095|536379081|FG000|Overall Study|Withdrawal by Subject|0|||
148700401|NCT00667095|536379082|FG001|Overall Study|Withdrawal by Subject|1|||
148700402|NCT01520909|536379083|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
148700403|NCT01520909|536379084|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
148700404|NCT01520909|536379085|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
148814952|NCT04598828|536798066|FG000|Overall Study|Physician Decision|1|||
148814953|NCT04598828|536798067|FG001|Overall Study|Physician Decision|0|||
148814954|NCT04598828|536798066|FG000|Overall Study|Withdrawal by Subject|0|||
148814955|NCT04598828|536798067|FG001|Overall Study|Withdrawal by Subject|1|||
148967469|NCT03131440|537366722|FG011|Overall Study|Withdrawal by Subject|1|||
148967470|NCT03131440|537366723|FG012|Overall Study|Withdrawal by Subject|1|||
148967471|NCT03131440|537366724|FG013|Overall Study|Withdrawal by Subject|0|||
148967472|NCT03131440|537366725|FG014|Overall Study|Withdrawal by Subject|1|||
148967473|NCT03131440|537366726|FG015|Overall Study|Withdrawal by Subject|0|||
148967474|NCT03131440|537366727|FG016|Overall Study|Withdrawal by Subject|0|||
148700405|NCT01520909|536379083|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
148700406|NCT01520909|536379084|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
148700407|NCT01520909|536379085|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
148700408|NCT01520909|536379083|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
148700409|NCT01520909|536379084|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
148700410|NCT01520909|536379085|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
148700411|NCT01520909|536379083|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
148700412|NCT01520909|536379084|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
148700413|NCT01520909|536379085|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
148700414|NCT01882257|536379086|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
148967475|NCT03131440|537366728|FG017|Overall Study|Withdrawal by Subject|0|||
148967476|NCT03131440|537366729|FG018|Overall Study|Withdrawal by Subject|1|||
148967477|NCT03131440|537366730|FG019|Overall Study|Withdrawal by Subject|0|||
148967478|NCT03131440|537366731|FG020|Overall Study|Withdrawal by Subject|1|||
148967479|NCT03131440|537366732|FG021|Overall Study|Withdrawal by Subject|1|||
148967480|NCT03131440|537366733|FG022|Overall Study|Withdrawal by Subject|1|||
148967481|NCT03131440|537366734|FG023|Overall Study|Withdrawal by Subject|0|||
148814956|NCT04598828|536798066|FG000|Overall Study|Withdrawal by Subject|0|||
148814957|NCT04598828|536798067|FG001|Overall Study|Withdrawal by Subject|1|||
148814958|NCT04818112|536798068|FG000|Overall Study|Withdrawal by Subject|54|||
148814959|NCT04818112|536798069|FG001|Overall Study|Withdrawal by Subject|12|||
148700415|NCT01882257|536379087|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
148700416|NCT01882257|536379088|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
148700417|NCT01882257|536379086|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
148700418|NCT01882257|536379087|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
148700419|NCT01882257|536379088|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
148700420|NCT00830206|536379090|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
148700421|NCT00830206|536379091|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
148700422|NCT02736721|536379092|FG000|Overall Study|Adverse Event|8|||
148700423|NCT02736721|536379092|FG000|Overall Study|Lost to Follow-up|3|||
148700424|NCT02736721|536379092|FG000|Overall Study|Other|5|||
148700425|NCT04123548|536379093|FG000|Overall Study|Withdrawal by Subject|1|||
148700426|NCT04123548|536379093|FG000|Overall Study|Lost to Follow-up|8|||
148700427|NCT04123548|536379093|FG000|Overall Study|Death|4|||
148700428|NCT04123548|536379093|FG000|Overall Study|Reason Not Specified|1|||
148700429|NCT01247701|536379096|FG000|Overall Study|Death|2|||
148700430|NCT01247701|536379096|FG000|Overall Study|Relapsed|8|||
148700431|NCT04166630|536379097|FG000|Overall Study|Withdrawal by Subject|0|||
148700432|NCT04166630|536379098|FG001|Overall Study|Withdrawal by Subject|1|||
148700433|NCT01034358|536379099|FG000|Overall Study|Withdrawal by Subject|1|||
148700434|NCT01034358|536379099|FG000|Overall Study|Protocol Violation|1|||
148700435|NCT01534663|536379102|FG000|Overall Study|Lost to Follow-up|0|||
148700436|NCT01534663|536379103|FG001|Overall Study|Lost to Follow-up|2|||
148700437|NCT01534663|536379102|FG000|Overall Study|Adverse Event|2|||
148700438|NCT01534663|536379103|FG001|Overall Study|Adverse Event|1|||
148700439|NCT00105196|536379104|FG000|Overall Study|Lack of Efficacy|2|||
148700440|NCT00105196|536379105|FG001|Overall Study|Lack of Efficacy|3|||
148700441|NCT00105196|536379104|FG000|Overall Study|Adverse Event|11|||
148700442|NCT00105196|536379105|FG001|Overall Study|Adverse Event|3|||
148700443|NCT00105196|536379104|FG000|Overall Study|Withdrawal by Subject|6|||
148700444|NCT00105196|536379105|FG001|Overall Study|Withdrawal by Subject|6|||
148700445|NCT00105196|536379104|FG000|Overall Study|Lost to Follow-up|3|||
148700446|NCT00105196|536379105|FG001|Overall Study|Lost to Follow-up|2|||
148700447|NCT00105196|536379104|FG000|Overall Study|Poor/noncompliance|3|||
148700448|NCT00105196|536379105|FG001|Overall Study|Poor/noncompliance|4|||
148700449|NCT00105196|536379104|FG000|Overall Study|Protocol Violation|5|||
148700450|NCT00105196|536379105|FG001|Overall Study|Protocol Violation|2|||
148700451|NCT00105196|536379104|FG000|Overall Study|pending surgery|0|||
148700452|NCT00105196|536379105|FG001|Overall Study|pending surgery|1|||
148700453|NCT00105196|536379104|FG000|Overall Study|marijuana use|0|||
148700454|NCT00105196|536379105|FG001|Overall Study|marijuana use|1|||
148700455|NCT00105196|536379104|FG000|Overall Study|Subject became unblinded|0|||
148700456|NCT00105196|536379105|FG001|Overall Study|Subject became unblinded|1|||
148700457|NCT00893464|536379106|FG000|Overall Study|Did not complete therapy/experience PD|0|||
148700458|NCT00893464|536379107|FG001|Overall Study|Did not complete therapy/experience PD|0|||
148700459|NCT00893464|536379108|FG002|Overall Study|Did not complete therapy/experience PD|0|||
148700460|NCT00893464|536379109|FG003|Overall Study|Did not complete therapy/experience PD|0|||
148700461|NCT00893464|536379110|FG004|Overall Study|Did not complete therapy/experience PD|0|||
148700462|NCT00893464|536379111|FG005|Overall Study|Did not complete therapy/experience PD|0|||
148700463|NCT00893464|536379112|FG006|Overall Study|Did not complete therapy/experience PD|2|||
148814960|NCT04818112|536798068|FG000|Overall Study|Lost to Follow-up|38|||
148967482|NCT03131440|537366735|FG024|Overall Study|Withdrawal by Subject|0|||
148700464|NCT00893464|536379113|FG007|Overall Study|Did not complete therapy/experience PD|2|||
148700465|NCT03136380|536379114|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
148700466|NCT03136380|536379115|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
148700467|NCT03136380|536379116|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
148700468|NCT03136380|536379117|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
148967483|NCT03131440|537366736|FG025|Overall Study|Withdrawal by Subject|0|||
148967484|NCT03131440|537366737|FG026|Overall Study|Withdrawal by Subject|0|||
148967485|NCT03131440|537366738|FG027|Overall Study|Withdrawal by Subject|0|||
148700469|NCT03136380|536379118|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
148700470|NCT02419937|536379122|FG000|Overall Study|Lost to Follow-up|1|||
148700471|NCT02419937|536379123|FG001|Overall Study|Lost to Follow-up|0|||
148700472|NCT01544127|536379124|FG000|Overall Study|Lost to Follow-up|4|||
148700473|NCT01544127|536379125|FG001|Overall Study|Lost to Follow-up|2|||
148700474|NCT01544127|536379126|FG002|Overall Study|Lost to Follow-up|9|||
148700475|NCT01544127|536379124|FG000|Overall Study|Withdrawal by Subject|2|||
148700476|NCT01544127|536379125|FG001|Overall Study|Withdrawal by Subject|2|||
148700477|NCT01544127|536379126|FG002|Overall Study|Withdrawal by Subject|1|||
148700478|NCT01544127|536379124|FG000|Overall Study|Discharged out of catchment area|1|||
148700479|NCT01544127|536379125|FG001|Overall Study|Discharged out of catchment area|1|||
148967486|NCT03131440|537366739|FG028|Overall Study|Withdrawal by Subject|0|||
148700480|NCT01544127|536379126|FG002|Overall Study|Discharged out of catchment area|1|||
148700481|NCT01544127|536379124|FG000|Overall Study|Death|1|||
148700482|NCT01544127|536379125|FG001|Overall Study|Death|0|||
148700483|NCT01544127|536379126|FG002|Overall Study|Death|0|||
148700484|NCT01544127|536379124|FG000|Overall Study|Jail or Prison|1|||
148700485|NCT01544127|536379125|FG001|Overall Study|Jail or Prison|1|||
148700486|NCT01544127|536379126|FG002|Overall Study|Jail or Prison|2|||
148700487|NCT01544127|536379124|FG000|Overall Study|Became Psychotic|1|||
148700488|NCT01544127|536379125|FG001|Overall Study|Became Psychotic|0|||
148700489|NCT01544127|536379126|FG002|Overall Study|Became Psychotic|0|||
148700490|NCT01544127|536379124|FG000|Overall Study|Researcher withdrew|1|||
148700491|NCT01544127|536379125|FG001|Overall Study|Researcher withdrew|0|||
148700492|NCT01544127|536379126|FG002|Overall Study|Researcher withdrew|0|||
148700493|NCT01544127|536379124|FG000|Overall Study|Went active duty|0|||
148700494|NCT01544127|536379125|FG001|Overall Study|Went active duty|0|||
148700495|NCT01544127|536379126|FG002|Overall Study|Went active duty|1|||
148700496|NCT01256684|536379127|FG000|Overall Study|Adverse Event|1|||
148700497|NCT01256684|536379128|FG001|Overall Study|Adverse Event|4|||
148700498|NCT01256684|536379129|FG002|Overall Study|Adverse Event|2|||
148700499|NCT01256684|536379127|FG000|Overall Study|Withdrawal by Subject|4|||
148700500|NCT01256684|536379128|FG001|Overall Study|Withdrawal by Subject|0|||
148700501|NCT01256684|536379129|FG002|Overall Study|Withdrawal by Subject|2|||
148700502|NCT01256684|536379127|FG000|Overall Study|Physician Decision|0|||
148700503|NCT01256684|536379128|FG001|Overall Study|Physician Decision|1|||
148700504|NCT01256684|536379129|FG002|Overall Study|Physician Decision|0|||
148700505|NCT01256684|536379127|FG000|Overall Study|Lack of Efficacy|0|||
148700506|NCT01256684|536379128|FG001|Overall Study|Lack of Efficacy|1|||
148700507|NCT01256684|536379129|FG002|Overall Study|Lack of Efficacy|1|||
148700508|NCT01256684|536379127|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
148700509|NCT01256684|536379128|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
148700510|NCT01256684|536379129|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
148700511|NCT02914600|536379130|FG000|Overall Study|Adverse Event|298|||
148700512|NCT02914600|536379131|FG001|Overall Study|Adverse Event|35|||
148700513|NCT02914600|536379132|FG002|Overall Study|Adverse Event|25|||
148700514|NCT02914600|536379130|FG000|Overall Study|Sponsors decision|287|||
148814961|NCT04818112|536798069|FG001|Overall Study|Lost to Follow-up|10|||
148814962|NCT02676973|536798070|FG000|Overall Study|Withdrawal by Subject|9|||
148814963|NCT02676973|536798071|FG001|Overall Study|Withdrawal by Subject|8|||
148700515|NCT02914600|536379131|FG001|Overall Study|Sponsors decision|41|||
148700516|NCT02914600|536379132|FG002|Overall Study|Sponsors decision|12|||
148700517|NCT02914600|536379130|FG000|Overall Study|Withdrawal by Subject|158|||
148700518|NCT02914600|536379131|FG001|Overall Study|Withdrawal by Subject|20|||
148700519|NCT02914600|536379132|FG002|Overall Study|Withdrawal by Subject|18|||
148700520|NCT02914600|536379130|FG000|Overall Study|Investigators discretion|169|||
148700521|NCT02914600|536379131|FG001|Overall Study|Investigators discretion|14|||
148700522|NCT02914600|536379132|FG002|Overall Study|Investigators discretion|13|||
148700523|NCT02914600|536379130|FG000|Overall Study|Lost to Follow-up|10|||
148700524|NCT02914600|536379131|FG001|Overall Study|Lost to Follow-up|4|||
148700525|NCT02914600|536379132|FG002|Overall Study|Lost to Follow-up|0|||
148700526|NCT02914600|536379130|FG000|Overall Study|Pregnancy|8|||
148700527|NCT02914600|536379131|FG001|Overall Study|Pregnancy|0|||
148700528|NCT02914600|536379132|FG002|Overall Study|Pregnancy|0|||
148700529|NCT02914600|536379130|FG000|Overall Study|Protocol Violation|5|||
148700530|NCT02914600|536379131|FG001|Overall Study|Protocol Violation|3|||
148700531|NCT02914600|536379132|FG002|Overall Study|Protocol Violation|0|||
148700532|NCT02914600|536379130|FG000|Overall Study|Non-compliance with study drug|6|||
148700533|NCT02914600|536379131|FG001|Overall Study|Non-compliance with study drug|1|||
148700534|NCT02914600|536379132|FG002|Overall Study|Non-compliance with study drug|0|||
148700535|NCT02914600|536379130|FG000|Overall Study|Death|3|||
148700536|NCT02914600|536379131|FG001|Overall Study|Death|1|||
148814964|NCT02676973|536798072|FG002|Overall Study|Withdrawal by Subject|11|||
148814965|NCT02676973|536798070|FG000|Overall Study|Lost to Follow-up|8|||
148814966|NCT02676973|536798071|FG001|Overall Study|Lost to Follow-up|12|||
148700537|NCT02914600|536379132|FG002|Overall Study|Death|1|||
148700538|NCT02914600|536379130|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
148700539|NCT02914600|536379131|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
148700540|NCT02914600|536379132|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
148700541|NCT02914600|536379130|FG000|Overall Study|Enrolled but not treated|1|||
148700542|NCT02914600|536379131|FG001|Overall Study|Enrolled but not treated|0|||
148700543|NCT02914600|536379132|FG002|Overall Study|Enrolled but not treated|0|||
148700544|NCT01185548|536379133|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
148700545|NCT01422538|536379136|FG000|Overall Study|Lost to Follow-up|0|||
148700546|NCT01422538|536379137|FG001|Overall Study|Lost to Follow-up|1|||
148814967|NCT02676973|536798072|FG002|Overall Study|Lost to Follow-up|8|||
148814968|NCT02676973|536798070|FG000|Overall Study|Death|2|||
148700547|NCT01422538|536379138|FG002|Overall Study|Lost to Follow-up|1|||
148700548|NCT01422538|536379136|FG000|Overall Study|Missed visit|0|||
148700549|NCT01422538|536379137|FG001|Overall Study|Missed visit|1|||
148700550|NCT01422538|536379138|FG002|Overall Study|Missed visit|1|||
148700551|NCT00184600|536379139|FG000|Overall Study|Adverse Event|9|||
148700552|NCT00184600|536379140|FG001|Overall Study|Adverse Event|0|||
148700553|NCT00184600|536379141|FG002|Overall Study|Adverse Event|5|||
148700554|NCT00184600|536379139|FG000|Overall Study|Death|3|||
148700555|NCT00184600|536379140|FG001|Overall Study|Death|9|||
148700556|NCT00184600|536379141|FG002|Overall Study|Death|7|||
148700557|NCT00184600|536379139|FG000|Overall Study|Lack of Efficacy|3|||
148700558|NCT00184600|536379140|FG001|Overall Study|Lack of Efficacy|1|||
148700559|NCT00184600|536379141|FG002|Overall Study|Lack of Efficacy|3|||
148700560|NCT00184600|536379139|FG000|Overall Study|Lost to Follow-up|4|||
148700561|NCT00184600|536379140|FG001|Overall Study|Lost to Follow-up|6|||
148700562|NCT00184600|536379141|FG002|Overall Study|Lost to Follow-up|1|||
148700563|NCT00184600|536379139|FG000|Overall Study|Protocol Violation|2|||
148700564|NCT00184600|536379140|FG001|Overall Study|Protocol Violation|2|||
148700565|NCT00184600|536379141|FG002|Overall Study|Protocol Violation|3|||
148700566|NCT00184600|536379139|FG000|Overall Study|Withdrawal by Subject|20|||
148700567|NCT00184600|536379140|FG001|Overall Study|Withdrawal by Subject|28|||
148700568|NCT00184600|536379141|FG002|Overall Study|Withdrawal by Subject|12|||
148700569|NCT00184600|536379139|FG000|Overall Study|Unclassified|4|||
148700570|NCT00184600|536379140|FG001|Overall Study|Unclassified|5|||
148700571|NCT00184600|536379141|FG002|Overall Study|Unclassified|3|||
148700572|NCT00624065|536379144|FG000|Overall Study|Adverse Event|5|||
148700573|NCT00624065|536379145|FG001|Overall Study|Adverse Event|6|||
148700574|NCT00624065|536379144|FG000|Overall Study|Lost to Follow-up|4|||
148700575|NCT00624065|536379145|FG001|Overall Study|Lost to Follow-up|1|||
148700576|NCT00624065|536379144|FG000|Overall Study|Consent withdrawn|6|||
148700577|NCT00624065|536379145|FG001|Overall Study|Consent withdrawn|5|||
148700578|NCT00624065|536379144|FG000|Overall Study|Lack of Efficacy|0|||
148700579|NCT00624065|536379145|FG001|Overall Study|Lack of Efficacy|3|||
148700580|NCT00624065|536379144|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
148700581|NCT00624065|536379145|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
148700582|NCT00696020|536379146|FG000|Overall Study|Adverse Event|3|||
148700583|NCT00696020|536379147|FG001|Overall Study|Adverse Event|1|||
148700584|NCT00696020|536379148|FG002|Overall Study|Adverse Event|2|||
148700585|NCT00696020|536379149|FG003|Overall Study|Adverse Event|1|||
148700586|NCT00696020|536379146|FG000|Overall Study|Lack of Efficacy|1|||
148700587|NCT00696020|536379147|FG001|Overall Study|Lack of Efficacy|0|||
148700588|NCT00696020|536379148|FG002|Overall Study|Lack of Efficacy|0|||
148700589|NCT00696020|536379149|FG003|Overall Study|Lack of Efficacy|0|||
148700590|NCT00696020|536379146|FG000|Overall Study|Protocol Violation|0|||
148700591|NCT00696020|536379147|FG001|Overall Study|Protocol Violation|0|||
148700592|NCT00696020|536379148|FG002|Overall Study|Protocol Violation|0|||
148700593|NCT00696020|536379149|FG003|Overall Study|Protocol Violation|1|||
148700594|NCT00696020|536379146|FG000|Overall Study|Withdrawal by Subject|0|||
148700595|NCT00696020|536379147|FG001|Overall Study|Withdrawal by Subject|1|||
148700596|NCT00696020|536379148|FG002|Overall Study|Withdrawal by Subject|0|||
148700597|NCT00696020|536379149|FG003|Overall Study|Withdrawal by Subject|1|||
148700598|NCT00696020|536379146|FG000|Overall Study|Other not stated above|0|||
148700599|NCT00696020|536379147|FG001|Overall Study|Other not stated above|0|||
148700600|NCT00696020|536379148|FG002|Overall Study|Other not stated above|1|||
148700601|NCT00696020|536379149|FG003|Overall Study|Other not stated above|1|||
148700602|NCT01387022|536379151|FG000|Overall Study|Death|1|||
148700603|NCT01387022|536379152|FG001|Overall Study|Death|1|||
148700604|NCT01387022|536379151|FG000|Overall Study|Lost to Follow-up|0|||
148700605|NCT01387022|536379152|FG001|Overall Study|Lost to Follow-up|3|||
148700606|NCT02076022|536379155|FG000|Overall Study|Withdrawal by Subject|2|||
148700607|NCT02076022|536379156|FG001|Overall Study|Withdrawal by Subject|0|||
148700608|NCT02661295|536379160|FG000|Overall Study|Death|1|||
148700609|NCT02661295|536379160|FG000|Overall Study|Transferred Out|1|||
148700610|NCT02661295|536379160|FG000|Overall Study|Kidney Transplant|1|||
148700611|NCT02661295|536379160|FG000|Overall Study|Withdrawn due to side effects|8|||
148700612|NCT02661295|536379160|FG000|Overall Study|Withdrawn due to access type|1|||
148700613|NCT02661295|536379160|FG000|Overall Study|Withdrawn due to allergies|1|||
148700614|NCT02661295|536379160|FG000|Overall Study|Withdrawn due to non-compliance|1|||
148700615|NCT02661295|536379160|FG000|Overall Study|Withdrawal by Subject|3|||
148700616|NCT02661295|536379160|FG000|Overall Study|Failed screening|2|||
148700617|NCT02336165|536379161|FG000|Overall Study|Death|3|||
149025073|NCT01244763|537567993|FG004|Overall Study|Enrolled into the Extension Study|0|||
149025074|NCT01244763|537567994|FG005|Overall Study|Enrolled into the Extension Study|1|||
148700618|NCT02336165|536379162|FG001|Overall Study|Death|0|||
148700619|NCT02336165|536379163|FG002|Overall Study|Death|0|||
148700620|NCT02336165|536379164|FG003|Overall Study|Death|0|||
148700621|NCT02336165|536379165|FG004|Overall Study|Death|1|||
148700622|NCT02336165|536379161|FG000|Overall Study|Physician Decision|2|||
148700623|NCT02336165|536379162|FG001|Overall Study|Physician Decision|2|||
148700624|NCT02336165|536379163|FG002|Overall Study|Physician Decision|1|||
148700625|NCT02336165|536379164|FG003|Overall Study|Physician Decision|1|||
148700626|NCT02336165|536379165|FG004|Overall Study|Physician Decision|0|||
149025075|NCT00751790|537567995|FG000|Overall Study|Lost to Follow-up|1|||
148700627|NCT02336165|536379161|FG000|Overall Study|Withdrawal by Subject|0|||
148700628|NCT02336165|536379162|FG001|Overall Study|Withdrawal by Subject|0|||
148700629|NCT02336165|536379163|FG002|Overall Study|Withdrawal by Subject|1|||
148700630|NCT02336165|536379164|FG003|Overall Study|Withdrawal by Subject|0|||
148700631|NCT02336165|536379165|FG004|Overall Study|Withdrawal by Subject|1|||
148700632|NCT02336165|536379161|FG000|Overall Study|Adverse Event|4|||
148700633|NCT02336165|536379162|FG001|Overall Study|Adverse Event|1|||
148700634|NCT02336165|536379163|FG002|Overall Study|Adverse Event|2|||
148700635|NCT02336165|536379164|FG003|Overall Study|Adverse Event|4|||
148700636|NCT02336165|536379165|FG004|Overall Study|Adverse Event|1|||
148700637|NCT02336165|536379161|FG000|Overall Study|Progressive disease|23|||
148700638|NCT02336165|536379162|FG001|Overall Study|Progressive disease|22|||
148700639|NCT02336165|536379163|FG002|Overall Study|Progressive disease|27|||
148700640|NCT02336165|536379164|FG003|Overall Study|Progressive disease|24|||
148700641|NCT02336165|536379165|FG004|Overall Study|Progressive disease|19|||
148700642|NCT02336165|536379161|FG000|Overall Study|Non-compliance|1|||
148700643|NCT02336165|536379162|FG001|Overall Study|Non-compliance|0|||
148700644|NCT02336165|536379163|FG002|Overall Study|Non-compliance|0|||
148700645|NCT02336165|536379164|FG003|Overall Study|Non-compliance|1|||
148700646|NCT02336165|536379165|FG004|Overall Study|Non-compliance|0|||
148700647|NCT02336165|536379161|FG000|Overall Study|Other|1|||
148700648|NCT02336165|536379162|FG001|Overall Study|Other|0|||
148700649|NCT02336165|536379163|FG002|Overall Study|Other|0|||
148700650|NCT02336165|536379164|FG003|Overall Study|Other|1|||
148700651|NCT02336165|536379165|FG004|Overall Study|Other|0|||
148700652|NCT02726581|536379168|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
148700653|NCT02726581|536379169|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
148700654|NCT02726581|536379170|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
148700655|NCT02726581|536379168|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
148700656|NCT02726581|536379169|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
148700657|NCT02726581|536379170|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
148700658|NCT02726581|536379168|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
148700659|NCT02726581|536379169|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148700660|NCT02726581|536379170|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148700661|NCT02726581|536379168|FG000|Treatment Period|Disease progression|47|||
148700662|NCT02726581|536379169|FG001|Treatment Period|Disease progression|50|||
148700663|NCT02726581|536379170|FG002|Treatment Period|Disease progression|16|||
148700664|NCT02726581|536379168|FG000|Treatment Period|Other reasons|9|||
148700665|NCT02726581|536379169|FG001|Treatment Period|Other reasons|8|||
148700666|NCT02726581|536379170|FG002|Treatment Period|Other reasons|2|||
148700667|NCT02726581|536379168|FG000|Treatment Period|Study drug toxicity|6|||
148700668|NCT02726581|536379169|FG001|Treatment Period|Study drug toxicity|3|||
148700669|NCT02726581|536379170|FG002|Treatment Period|Study drug toxicity|2|||
148700670|NCT02726581|536379168|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
148700671|NCT02726581|536379169|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
148700672|NCT02726581|536379170|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
148700673|NCT02726581|536379168|FG000|Treatment Period|Participant withdrew consent|3|||
148700674|NCT02726581|536379169|FG001|Treatment Period|Participant withdrew consent|1|||
148700675|NCT02726581|536379170|FG002|Treatment Period|Participant withdrew consent|1|||
148700676|NCT02726581|536379168|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
148700677|NCT02726581|536379169|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
148700678|NCT02726581|536379170|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
148700679|NCT02726581|536379168|FG000|Treatment Period|Maximum clinical benefit|0|||
148700680|NCT02726581|536379169|FG001|Treatment Period|Maximum clinical benefit|2|||
148700681|NCT02726581|536379170|FG002|Treatment Period|Maximum clinical benefit|0|||
148700682|NCT02726581|536379168|FG000|Treatment Period|Death|1|||
148700683|NCT02726581|536379169|FG001|Treatment Period|Death|0|||
148700684|NCT02726581|536379170|FG002|Treatment Period|Death|0|||
148700685|NCT02726581|536379168|FG000|Treatment Period|Poor/non-compliance|1|||
148700686|NCT02726581|536379169|FG001|Treatment Period|Poor/non-compliance|0|||
148700687|NCT02726581|536379170|FG002|Treatment Period|Poor/non-compliance|0|||
148700688|NCT02726581|536379168|FG000|Treatment Period|Participant no longer meets study criteria|0|||
148700689|NCT02726581|536379169|FG001|Treatment Period|Participant no longer meets study criteria|1|||
148814969|NCT02676973|536798071|FG001|Overall Study|Death|1|||
148967487|NCT03131440|537366740|FG029|Overall Study|Withdrawal by Subject|0|||
148967488|NCT03131440|537366741|FG030|Overall Study|Withdrawal by Subject|1|||
148967489|NCT03131440|537366742|FG031|Overall Study|Withdrawal by Subject|0|||
148700690|NCT02726581|536379170|FG002|Treatment Period|Participant no longer meets study criteria|0|||
148700691|NCT02865850|536379171|FG000|Overall Study|Death|15|||
148700692|NCT02865850|536379172|FG001|Overall Study|Death|19|||
148700693|NCT02865850|536379171|FG000|Overall Study|Withdrawal by Subject|3|||
148700694|NCT02865850|536379172|FG001|Overall Study|Withdrawal by Subject|2|||
148700695|NCT02865850|536379171|FG000|Overall Study|Lost to Follow-up|3|||
148967490|NCT03131440|537366711|FG000|Overall Study|Lost to Follow-up|0|||
148700696|NCT02865850|536379172|FG001|Overall Study|Lost to Follow-up|2|||
148700697|NCT01010542|536379174|FG000|Overall Study|Adverse Event|0|||
148700698|NCT01010542|536379175|FG001|Overall Study|Adverse Event|1|||
148700699|NCT01010542|536379176|FG002|Overall Study|Adverse Event|0|||
148700700|NCT01010542|536379174|FG000|Overall Study|Lost to Follow-up|0|||
148700701|NCT01010542|536379175|FG001|Overall Study|Lost to Follow-up|1|||
148700702|NCT01010542|536379176|FG002|Overall Study|Lost to Follow-up|0|||
148700703|NCT01010542|536379174|FG000|Overall Study|Withdrawal by Subject|0|||
148700704|NCT01010542|536379175|FG001|Overall Study|Withdrawal by Subject|3|||
148700705|NCT01010542|536379176|FG002|Overall Study|Withdrawal by Subject|2|||
148700706|NCT01118312|536379177|FG000|Overall Study|Lost to Follow-up|33|||
148700707|NCT01118312|536379178|FG001|Overall Study|Lost to Follow-up|32|||
148700708|NCT01118312|536379177|FG000|Overall Study|Withdrawal by Subject|1|||
148700709|NCT01118312|536379178|FG001|Overall Study|Withdrawal by Subject|3|||
148700710|NCT04510285|536379181|FG000|Overall Study|Death|1|||
148700711|NCT03555305|536379182|FG000|Period 1|Physician Decision|0|||
148700712|NCT03555305|536379183|FG001|Period 1|Physician Decision|1|||
148700713|NCT03555305|536379182|FG000|Period 1|Adverse Event|0|||
148700714|NCT03555305|536379183|FG001|Period 1|Adverse Event|1|||
148700715|NCT03135834|536379189|FG000|Stage 1|Adverse Event|1|||
148700716|NCT03135834|536379190|FG001|Stage 1|Adverse Event|2|||
148700717|NCT03135834|536379191|FG002|Stage 1|Adverse Event|2|||
148700718|NCT03135834|536379192|FG003|Stage 1|Adverse Event|1|||
148700719|NCT03135834|536379189|FG000|Stage 1|Death|1|||
148700720|NCT03135834|536379190|FG001|Stage 1|Death|0|||
148700721|NCT03135834|536379191|FG002|Stage 1|Death|0|||
148700722|NCT03135834|536379192|FG003|Stage 1|Death|0|||
148700723|NCT03135834|536379189|FG000|Stage 1|Lost to Follow-up|17|||
148700724|NCT03135834|536379190|FG001|Stage 1|Lost to Follow-up|24|||
148700725|NCT03135834|536379191|FG002|Stage 1|Lost to Follow-up|21|||
148700726|NCT03135834|536379192|FG003|Stage 1|Lost to Follow-up|38|||
148700727|NCT03135834|536379189|FG000|Stage 1|No longer met eligibility criteria|1|||
148700728|NCT03135834|536379190|FG001|Stage 1|No longer met eligibility criteria|6|||
148700729|NCT03135834|536379191|FG002|Stage 1|No longer met eligibility criteria|2|||
148700730|NCT03135834|536379192|FG003|Stage 1|No longer met eligibility criteria|5|||
148700731|NCT03135834|536379189|FG000|Stage 1|Other|0|||
148700732|NCT03135834|536379190|FG001|Stage 1|Other|2|||
148700733|NCT03135834|536379191|FG002|Stage 1|Other|1|||
148700734|NCT03135834|536379192|FG003|Stage 1|Other|0|||
148700735|NCT03135834|536379189|FG000|Stage 1|Physician Decision|0|||
148700736|NCT03135834|536379190|FG001|Stage 1|Physician Decision|1|||
148700737|NCT03135834|536379191|FG002|Stage 1|Physician Decision|0|||
148700738|NCT03135834|536379192|FG003|Stage 1|Physician Decision|0|||
148700739|NCT03135834|536379189|FG000|Stage 1|Pregnancy|0|||
148700740|NCT03135834|536379190|FG001|Stage 1|Pregnancy|4|||
148700741|NCT03135834|536379191|FG002|Stage 1|Pregnancy|2|||
148700742|NCT03135834|536379192|FG003|Stage 1|Pregnancy|4|||
148700743|NCT03135834|536379189|FG000|Stage 1|Protocol Violation|1|||
148700744|NCT03135834|536379190|FG001|Stage 1|Protocol Violation|1|||
148700745|NCT03135834|536379191|FG002|Stage 1|Protocol Violation|2|||
148700746|NCT03135834|536379192|FG003|Stage 1|Protocol Violation|1|||
148700747|NCT03135834|536379189|FG000|Stage 1|Withdrawal by parent/guardian|2|||
148700748|NCT03135834|536379190|FG001|Stage 1|Withdrawal by parent/guardian|10|||
148700749|NCT03135834|536379191|FG002|Stage 1|Withdrawal by parent/guardian|2|||
148700750|NCT03135834|536379192|FG003|Stage 1|Withdrawal by parent/guardian|1|||
148700751|NCT03135834|536379189|FG000|Stage 1|Withdrawal by Subject|16|||
148700752|NCT03135834|536379190|FG001|Stage 1|Withdrawal by Subject|22|||
148700753|NCT03135834|536379191|FG002|Stage 1|Withdrawal by Subject|7|||
148700754|NCT03135834|536379192|FG003|Stage 1|Withdrawal by Subject|10|||
148700755|NCT03135834|536379189|FG000|Stage 1|Randomized but not Vaccinated|0|||
148700756|NCT03135834|536379190|FG001|Stage 1|Randomized but not Vaccinated|3|||
148700757|NCT03135834|536379191|FG002|Stage 1|Randomized but not Vaccinated|1|||
148700758|NCT03135834|536379192|FG003|Stage 1|Randomized but not Vaccinated|6|||
148700759|NCT03135834|536379189|FG000|Stage 2|Lost to Follow-up|0|||
148700760|NCT03135834|536379190|FG001|Stage 2|Lost to Follow-up|1|||
148700761|NCT03135834|536379191|FG002|Stage 2|Lost to Follow-up|0|||
148700762|NCT03135834|536379192|FG003|Stage 2|Lost to Follow-up|0|||
148700763|NCT03135834|536379189|FG000|Stage 2|Withdrawal by Subject|0|||
148700764|NCT03135834|536379190|FG001|Stage 2|Withdrawal by Subject|1|||
148700765|NCT03135834|536379191|FG002|Stage 2|Withdrawal by Subject|0|||
148700766|NCT03135834|536379192|FG003|Stage 2|Withdrawal by Subject|0|||
148700767|NCT03135834|536379189|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
148700768|NCT03135834|536379190|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
148700769|NCT03135834|536379191|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
148700770|NCT03135834|536379192|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
148700771|NCT03135834|536379189|FG000|Stage 2|Did not receive Booster Vaccination|1|||
148700772|NCT03135834|536379190|FG001|Stage 2|Did not receive Booster Vaccination|1|||
148700773|NCT03135834|536379191|FG002|Stage 2|Did not receive Booster Vaccination|0|||
148700774|NCT03135834|536379192|FG003|Stage 2|Did not receive Booster Vaccination|0|||
148700775|NCT02100228|536379193|FG000|Overall Study|Other|19|||
148700776|NCT02100228|536379194|FG001|Overall Study|Other|19|||
148814970|NCT02676973|536798072|FG002|Overall Study|Death|5|||
148814971|NCT01078662|536798074|FG000|Overall Study|Death|41|||
148814972|NCT01078662|536798075|FG001|Overall Study|Death|103|||
148814973|NCT01078662|536798076|FG002|Overall Study|Death|18|||
148967491|NCT03131440|537366712|FG001|Overall Study|Lost to Follow-up|0|||
148814974|NCT01078662|536798077|FG003|Overall Study|Death|5|||
148814975|NCT01078662|536798078|FG004|Overall Study|Death|8|||
148814976|NCT01078662|536798074|FG000|Overall Study|Patients reached data cut-off|12|||
148814977|NCT01078662|536798075|FG001|Overall Study|Patients reached data cut-off|53|||
148700777|NCT02100228|536379193|FG000|Overall Study|Administrative reason|0|||
148700778|NCT02100228|536379194|FG001|Overall Study|Administrative reason|1|||
148700779|NCT02100228|536379193|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
148700780|NCT02100228|536379194|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
148700781|NCT02100228|536379193|FG000|Overall Study|Non-compliance|0|||
148700782|NCT02100228|536379194|FG001|Overall Study|Non-compliance|3|||
148700783|NCT02100228|536379193|FG000|Overall Study|Lost to Follow-up|0|||
148700784|NCT02100228|536379194|FG001|Overall Study|Lost to Follow-up|1|||
148700785|NCT02100228|536379193|FG000|Overall Study|Withdrawal by Subject|27|||
148700786|NCT02100228|536379194|FG001|Overall Study|Withdrawal by Subject|37|||
148700787|NCT02100228|536379193|FG000|Overall Study|Adverse Event|16|||
148700788|NCT02100228|536379194|FG001|Overall Study|Adverse Event|12|||
148700789|NCT02100228|536379193|FG000|Overall Study|Death|1|||
148700790|NCT02100228|536379194|FG001|Overall Study|Death|1|||
148700791|NCT00214422|536379195|FG000|Overall Study|Physician Decision|2|||
148700792|NCT00214422|536379196|FG001|Overall Study|Physician Decision|0|||
148700793|NCT00214422|536379197|FG002|Overall Study|Physician Decision|0|||
148700794|NCT00214422|536379195|FG000|Overall Study|Developed esophageal ca|1|||
148700795|NCT00214422|536379196|FG001|Overall Study|Developed esophageal ca|0|||
148700796|NCT00214422|536379197|FG002|Overall Study|Developed esophageal ca|0|||
148700797|NCT00214422|536379195|FG000|Overall Study|Pt taken off study|1|||
148700798|NCT00214422|536379196|FG001|Overall Study|Pt taken off study|1|||
148700799|NCT00214422|536379197|FG002|Overall Study|Pt taken off study|0|||
148700800|NCT00214422|536379195|FG000|Overall Study|Disease progression on study|1|||
148700801|NCT00214422|536379196|FG001|Overall Study|Disease progression on study|0|||
148700802|NCT00214422|536379197|FG002|Overall Study|Disease progression on study|0|||
148700803|NCT00214422|536379195|FG000|Overall Study|Unable to make a radiation treatment|0|||
148700804|NCT00214422|536379196|FG001|Overall Study|Unable to make a radiation treatment|0|||
148700805|NCT00214422|536379197|FG002|Overall Study|Unable to make a radiation treatment|1|||
148700806|NCT02421952|536379200|FG000|Overall Study|Diary Not Returned|93|||
148700807|NCT02421952|536379200|FG000|Overall Study|Failed seriation task|13|||
148700808|NCT02421952|536379200|FG000|Overall Study|Subject uncooperative for baseline test|2|||
148700809|NCT02421952|536379200|FG000|Overall Study|Surgery cancelled|1|||
148700810|NCT00854100|536379201|FG000|Overall Study|Inability to complete the study visits|0|||
148700811|NCT00854100|536379202|FG001|Overall Study|Inability to complete the study visits|0|||
148700812|NCT00854100|536379203|FG002|Overall Study|Inability to complete the study visits|1|||
148700813|NCT00854100|536379201|FG000|Overall Study|Lost to Follow-up|2|||
148700814|NCT00854100|536379202|FG001|Overall Study|Lost to Follow-up|0|||
148700815|NCT00854100|536379203|FG002|Overall Study|Lost to Follow-up|3|||
148700816|NCT00854100|536379201|FG000|Overall Study|Withdrawal by Subject|3|||
148700817|NCT00854100|536379202|FG001|Overall Study|Withdrawal by Subject|1|||
148700818|NCT00854100|536379203|FG002|Overall Study|Withdrawal by Subject|2|||
148700819|NCT00854100|536379201|FG000|Overall Study|Protocol Violation|2|||
148700820|NCT00854100|536379202|FG001|Overall Study|Protocol Violation|4|||
148700821|NCT00854100|536379203|FG002|Overall Study|Protocol Violation|3|||
148700822|NCT00854100|536379201|FG000|Overall Study|Adverse Event|2|||
148700823|NCT00854100|536379202|FG001|Overall Study|Adverse Event|1|||
148700824|NCT00854100|536379203|FG002|Overall Study|Adverse Event|2|||
148700825|NCT02216071|536379215|FG000|Overall Study|Withdrawal by Subject|7|||
148700826|NCT02216071|536379216|FG001|Overall Study|Withdrawal by Subject|2|||
148700827|NCT02216071|536379215|FG000|Overall Study|Lost to Follow-up|3|||
148700828|NCT02216071|536379216|FG001|Overall Study|Lost to Follow-up|3|||
148700829|NCT02216071|536379215|FG000|Overall Study|Protocol Violation|3|||
148700830|NCT02216071|536379216|FG001|Overall Study|Protocol Violation|5|||
148700831|NCT02216071|536379215|FG000|Overall Study|Other|2|||
148700832|NCT02216071|536379216|FG001|Overall Study|Other|2|||
148700833|NCT04753437|536379217|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
148700834|NCT04753437|536379218|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
148700835|NCT04753437|536379217|FG000|Overall Study|Liver Function Test Abnormalities|2|||
148700836|NCT04753437|536379218|FG001|Overall Study|Liver Function Test Abnormalities|4|||
148700837|NCT02865122|536379219|FG000|Overall Study|Adverse Event|1|||
148700838|NCT02865122|536379220|FG001|Overall Study|Adverse Event|0|||
148700839|NCT02865122|536379221|FG002|Overall Study|Adverse Event|0|||
148700840|NCT01066143|536380771|FG000|Overall Study|ineligible for the study|8|||
148700841|NCT01294787|536380772|FG000|Period 1|Adverse Event|0|||
148700842|NCT01294787|536380773|FG001|Period 1|Adverse Event|0|||
148700843|NCT01294787|536380774|FG002|Period 1|Adverse Event|0|||
148700844|NCT01294787|536380775|FG003|Period 1|Adverse Event|0|||
148700845|NCT01294787|536380776|FG004|Period 1|Adverse Event|1|||
148967492|NCT03131440|537366713|FG002|Overall Study|Lost to Follow-up|0|||
148700846|NCT01294787|536380777|FG005|Period 1|Adverse Event|0|||
148700847|NCT01294787|536380772|FG000|Period 1|Withdrawal by Subject|0|||
148700848|NCT01294787|536380773|FG001|Period 1|Withdrawal by Subject|0|||
148700849|NCT01294787|536380774|FG002|Period 1|Withdrawal by Subject|0|||
148700850|NCT01294787|536380775|FG003|Period 1|Withdrawal by Subject|1|||
148700851|NCT01294787|536380776|FG004|Period 1|Withdrawal by Subject|1|||
148700852|NCT01294787|536380777|FG005|Period 1|Withdrawal by Subject|1|||
148700853|NCT01294787|536380772|FG000|Period 1|Administrative problem|0|||
148700854|NCT01294787|536380773|FG001|Period 1|Administrative problem|0|||
148700855|NCT01294787|536380774|FG002|Period 1|Administrative problem|1|||
148700856|NCT01294787|536380775|FG003|Period 1|Administrative problem|0|||
148700857|NCT01294787|536380776|FG004|Period 1|Administrative problem|0|||
148700858|NCT01294787|536380777|FG005|Period 1|Administrative problem|1|||
148700859|NCT01294787|536380772|FG000|Period 2|Adverse Event|0|||
148700860|NCT01294787|536380773|FG001|Period 2|Adverse Event|3|||
148700861|NCT01294787|536380774|FG002|Period 2|Adverse Event|0|||
148700862|NCT01294787|536380775|FG003|Period 2|Adverse Event|1|||
148700863|NCT01294787|536380776|FG004|Period 2|Adverse Event|0|||
148700864|NCT01294787|536380777|FG005|Period 2|Adverse Event|0|||
148700865|NCT01294787|536380772|FG000|Period 2|No longer needs study drug|0|||
148700866|NCT01294787|536380773|FG001|Period 2|No longer needs study drug|0|||
148700867|NCT01294787|536380774|FG002|Period 2|No longer needs study drug|0|||
148700868|NCT01294787|536380775|FG003|Period 2|No longer needs study drug|1|||
148700869|NCT01294787|536380776|FG004|Period 2|No longer needs study drug|0|||
148700870|NCT01294787|536380777|FG005|Period 2|No longer needs study drug|0|||
148700871|NCT01294787|536380772|FG000|Period 3|Adverse Event|0|||
148700872|NCT01294787|536380773|FG001|Period 3|Adverse Event|0|||
148700873|NCT01294787|536380774|FG002|Period 3|Adverse Event|0|||
148700874|NCT01294787|536380775|FG003|Period 3|Adverse Event|0|||
148700875|NCT01294787|536380776|FG004|Period 3|Adverse Event|1|||
148700876|NCT01294787|536380777|FG005|Period 3|Adverse Event|0|||
148700877|NCT01948258|536380778|FG000|Overall Study|Pregnancy|41|||
148700878|NCT01948258|536380778|FG000|Overall Study|Did not complete by cut-off date|35|||
148700879|NCT01948258|536380778|FG000|Overall Study|Lost to Follow-up|27|||
148700880|NCT01948258|536380778|FG000|Overall Study|Withdrawal by SPD|8|||
148700881|NCT01948258|536380778|FG000|Overall Study|Withdrawal by Subject|6|||
148700882|NCT01948258|536380778|FG000|Overall Study|Health Care Professional|43|||
148700883|NCT01948258|536380778|FG000|Overall Study|Removed from statistical analysis|2|||
148700884|NCT03785548|536380784|FG000|Overall Study|age > 80|1|||
148700885|NCT03785548|536380785|FG001|Overall Study|age > 80|0|||
148700886|NCT03785548|536380784|FG000|Overall Study|no Postop queries|1|||
148700887|NCT03785548|536380785|FG001|Overall Study|no Postop queries|0|||
148700888|NCT00396279|536380786|FG000|Overall Study|Ongoing in study|26|||
148700889|NCT00396279|536380786|FG000|Overall Study|Disease progression|2|||
148700890|NCT00396279|536380786|FG000|Overall Study|Withdrawal by Subject|1|||
148700891|NCT00396279|536380786|FG000|Overall Study|Physician Decision|1|||
148700892|NCT00905346|536380794|FG000|Period 1|Withdrawal by Subject|1|||
148700893|NCT00905346|536380795|FG001|Period 1|Withdrawal by Subject|0|||
148700894|NCT01435265|536380796|FG000|Overall Study|Lost to Follow-up|0|||
148700895|NCT01435265|536380797|FG001|Overall Study|Lost to Follow-up|1|||
148700896|NCT03351335|536380798|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
148700897|NCT03351335|536380799|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
148700898|NCT03351335|536380800|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
148700899|NCT04605094|536380801|FG000|Overall Study|Adverse Event|2|||
148700900|NCT04605094|536380802|FG001|Overall Study|Adverse Event|2|||
148700901|NCT04605094|536380801|FG000|Overall Study|Lost to Follow-up|1|||
148700902|NCT04605094|536380802|FG001|Overall Study|Lost to Follow-up|4|||
148700903|NCT04605094|536380801|FG000|Overall Study|Physician Decision|2|||
148700904|NCT04605094|536380802|FG001|Overall Study|Physician Decision|2|||
148700905|NCT04605094|536380801|FG000|Overall Study|Study terminated by Sponsor|31|||
148700906|NCT04605094|536380802|FG001|Overall Study|Study terminated by Sponsor|33|||
148700907|NCT04605094|536380801|FG000|Overall Study|Withdrawal by Subject|22|||
148700908|NCT04605094|536380802|FG001|Overall Study|Withdrawal by Subject|19|||
148700909|NCT04605094|536380801|FG000|Overall Study|Other|1|||
148700910|NCT04605094|536380802|FG001|Overall Study|Other|1|||
148700911|NCT01900691|536380803|FG000|Overall Study|Death|7|||
148700912|NCT01900691|536380803|FG000|Overall Study|Lost to Follow-up|4|||
148700913|NCT01900691|536380803|FG000|Overall Study|Study Device Not Placed|3|||
148700914|NCT01900691|536380803|FG000|Overall Study|Non study stent placed|2|||
148700915|NCT01900691|536380803|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
148700916|NCT01900691|536380803|FG000|Overall Study|Complete stent migration through digestive tract|1|||
148814978|NCT01078662|536798076|FG002|Overall Study|Patients reached data cut-off|2|||
148700917|NCT02724462|536380804|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
148700918|NCT02724462|536380805|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
148700919|NCT02724462|536380804|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
148700920|NCT02724462|536380805|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
148700921|NCT02724462|536380804|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
148700922|NCT02724462|536380805|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
148700923|NCT02724462|536380804|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
148700924|NCT02724462|536380805|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
148700925|NCT02724462|536380804|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
148700926|NCT02724462|536380805|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
148700927|NCT02724462|536380804|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
148700928|NCT02724462|536380805|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
148967493|NCT03131440|537366714|FG003|Overall Study|Lost to Follow-up|0|||
148967494|NCT03131440|537366715|FG004|Overall Study|Lost to Follow-up|0|||
148967495|NCT03131440|537366716|FG005|Overall Study|Lost to Follow-up|1|||
148967496|NCT03131440|537366717|FG006|Overall Study|Lost to Follow-up|0|||
148967497|NCT03131440|537366718|FG007|Overall Study|Lost to Follow-up|0|||
148967498|NCT03131440|537366719|FG008|Overall Study|Lost to Follow-up|0|||
148967499|NCT03131440|537366720|FG009|Overall Study|Lost to Follow-up|0|||
148967500|NCT03131440|537366721|FG010|Overall Study|Lost to Follow-up|0|||
148967501|NCT03131440|537366722|FG011|Overall Study|Lost to Follow-up|0|||
148967502|NCT03131440|537366723|FG012|Overall Study|Lost to Follow-up|0|||
148967503|NCT03131440|537366724|FG013|Overall Study|Lost to Follow-up|0|||
148967504|NCT03131440|537366725|FG014|Overall Study|Lost to Follow-up|0|||
148967505|NCT03131440|537366726|FG015|Overall Study|Lost to Follow-up|0|||
148967506|NCT03131440|537366727|FG016|Overall Study|Lost to Follow-up|0|||
148967507|NCT03131440|537366728|FG017|Overall Study|Lost to Follow-up|0|||
148967508|NCT03131440|537366729|FG018|Overall Study|Lost to Follow-up|0|||
148967509|NCT03131440|537366730|FG019|Overall Study|Lost to Follow-up|2|||
148967510|NCT03131440|537366731|FG020|Overall Study|Lost to Follow-up|1|||
148967511|NCT03131440|537366732|FG021|Overall Study|Lost to Follow-up|0|||
148700929|NCT00469417|536380808|FG000|Overall Study|Treatment failure all lesions|18|||
148700930|NCT00469417|536380809|FG001|Overall Study|Treatment failure all lesions|11|||
148700931|NCT00469417|536380808|FG000|Overall Study|Consent withdrawn|1|||
148967512|NCT03131440|537366733|FG022|Overall Study|Lost to Follow-up|1|||
148967513|NCT03131440|537366734|FG023|Overall Study|Lost to Follow-up|0|||
148967514|NCT03131440|537366735|FG024|Overall Study|Lost to Follow-up|1|||
148700932|NCT00469417|536380809|FG001|Overall Study|Consent withdrawn|1|||
148700933|NCT00469417|536380808|FG000|Overall Study|Adverse Event|8|||
148700934|NCT00469417|536380809|FG001|Overall Study|Adverse Event|2|||
148700935|NCT00469417|536380808|FG000|Overall Study|Lost to Follow-up|1|||
148700936|NCT00469417|536380809|FG001|Overall Study|Lost to Follow-up|2|||
148700937|NCT00469417|536380808|FG000|Overall Study|Intercurrent disease|0|||
148700938|NCT00469417|536380809|FG001|Overall Study|Intercurrent disease|1|||
148700939|NCT00469417|536380808|FG000|Overall Study|Randomized but not treated|2|||
148700940|NCT00469417|536380809|FG001|Overall Study|Randomized but not treated|0|||
148700941|NCT01954394|536380812|FG000|Overall Study|Enrolled but not treated|1|||
148700942|NCT01954394|536380813|FG001|Overall Study|Enrolled but not treated|0|||
148700943|NCT01954394|536380812|FG000|Overall Study|Adverse Event|10|||
148700944|NCT01954394|536380813|FG001|Overall Study|Adverse Event|23|||
148700945|NCT01954394|536380812|FG000|Overall Study|Poor compliance to protocol|7|||
148700946|NCT01954394|536380813|FG001|Overall Study|Poor compliance to protocol|7|||
148700947|NCT01954394|536380812|FG000|Overall Study|Participant Moved|0|||
148700948|NCT01954394|536380813|FG001|Overall Study|Participant Moved|4|||
148700949|NCT01954394|536380812|FG000|Overall Study|Related to Study Drug administration|2|||
148700950|NCT01954394|536380813|FG001|Overall Study|Related to Study Drug administration|2|||
148700951|NCT01954394|536380812|FG000|Overall Study|Other than specified above|10|||
148700952|NCT01954394|536380813|FG001|Overall Study|Other than specified above|21|||
148700953|NCT00909610|536380814|FG000|Period: First Intervention|Adverse Event|0|||
148700954|NCT00909610|536380815|FG001|Period: First Intervention|Adverse Event|1|||
148967515|NCT03131440|537366736|FG025|Overall Study|Lost to Follow-up|0|||
148700955|NCT00909610|536380814|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
148700956|NCT00909610|536380815|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
148700957|NCT00909610|536380814|FG000|Period: Second Intervention|Adverse Event|1|||
148700958|NCT00909610|536380815|FG001|Period: Second Intervention|Adverse Event|0|||
148700959|NCT04089735|536380820|FG000|Overall Study|Adverse Event|1|||
148700960|NCT04089735|536380821|FG001|Overall Study|Adverse Event|0|||
148700961|NCT04089735|536380822|FG002|Overall Study|Adverse Event|1|||
148700962|NCT04089735|536380823|FG003|Overall Study|Adverse Event|1|||
148700963|NCT04089735|536380824|FG004|Overall Study|Adverse Event|0|||
148700964|NCT04089735|536380825|FG005|Overall Study|Adverse Event|0|||
148700965|NCT04089735|536380820|FG000|Overall Study|Physician Decision|0|||
148700966|NCT04089735|536380821|FG001|Overall Study|Physician Decision|3|||
148700967|NCT04089735|536380822|FG002|Overall Study|Physician Decision|0|||
148700968|NCT04089735|536380823|FG003|Overall Study|Physician Decision|0|||
148700969|NCT04089735|536380824|FG004|Overall Study|Physician Decision|0|||
148700970|NCT04089735|536380825|FG005|Overall Study|Physician Decision|0|||
148700971|NCT04089735|536380820|FG000|Overall Study|Withdrawal by Subject|0|||
148700972|NCT04089735|536380821|FG001|Overall Study|Withdrawal by Subject|0|||
148700973|NCT04089735|536380822|FG002|Overall Study|Withdrawal by Subject|1|||
148700974|NCT04089735|536380823|FG003|Overall Study|Withdrawal by Subject|0|||
148700975|NCT04089735|536380824|FG004|Overall Study|Withdrawal by Subject|0|||
148700976|NCT04089735|536380825|FG005|Overall Study|Withdrawal by Subject|0|||
148700977|NCT04089735|536380820|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
148700978|NCT04089735|536380821|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
148700979|NCT04089735|536380822|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
148700980|NCT04089735|536380823|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
148700981|NCT04089735|536380824|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
148700982|NCT04089735|536380825|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
148700983|NCT02128997|536380830|FG000|Overall Study|Lost to Follow-up|6|||
148700984|NCT02128997|536380831|FG001|Overall Study|Lost to Follow-up|11|||
148700985|NCT00418184|536380840|FG000|Double-blind Phase|Withdrawal by Subject|22|||
148700986|NCT00418184|536380841|FG001|Double-blind Phase|Withdrawal by Subject|9|||
148700987|NCT00418184|536380840|FG000|Double-blind Phase|Adverse Event|2|||
148700988|NCT00418184|536380841|FG001|Double-blind Phase|Adverse Event|1|||
148700989|NCT00418184|536380840|FG000|Double-blind Phase|Poor compliance|3|||
148700990|NCT00418184|536380841|FG001|Double-blind Phase|Poor compliance|1|||
148700991|NCT04112823|536380846|FG000|Overall Study|Lost to Follow-up|2|||
148700992|NCT04112823|536380847|FG001|Overall Study|Lost to Follow-up|3|||
148700993|NCT03107091|536380850|FG000|Overall Study|Physician Decision|1|||
148700994|NCT03025880|536380855|FG000|Overall Study|Adverse Event|1|||
148700995|NCT03025880|536380856|FG001|Overall Study|Adverse Event|0|||
148700996|NCT03025880|536380855|FG000|Overall Study|Death|1|||
148700997|NCT03025880|536380856|FG001|Overall Study|Death|1|||
148700998|NCT03025880|536380855|FG000|Overall Study|Withdrawal by Subject|0|||
148700999|NCT03025880|536380856|FG001|Overall Study|Withdrawal by Subject|1|||
148701000|NCT03025880|536380855|FG000|Overall Study|Physician Decision|0|||
148701001|NCT03025880|536380856|FG001|Overall Study|Physician Decision|1|||
148701002|NCT03025880|536380855|FG000|Overall Study|Progressive Disease|12|||
148701003|NCT03025880|536380856|FG001|Overall Study|Progressive Disease|19|||
148701004|NCT00625443|536380858|FG000|Overall Study|Adverse Event|1|||
148701005|NCT00625443|536380859|FG001|Overall Study|Adverse Event|4|||
148701006|NCT00625443|536380860|FG002|Overall Study|Adverse Event|0|||
148701007|NCT00625443|536380858|FG000|Overall Study|Non-compliance with protocol|0|||
148701008|NCT00625443|536380859|FG001|Overall Study|Non-compliance with protocol|1|||
148701009|NCT00625443|536380860|FG002|Overall Study|Non-compliance with protocol|0|||
148701010|NCT00625443|536380858|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
148701011|NCT00625443|536380859|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
148701012|NCT00625443|536380860|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
148701013|NCT00625443|536380858|FG000|Overall Study|Withdrawal by Subject|0|||
148701014|NCT00625443|536380859|FG001|Overall Study|Withdrawal by Subject|1|||
148701015|NCT00625443|536380860|FG002|Overall Study|Withdrawal by Subject|2|||
148701016|NCT00625443|536380858|FG000|Overall Study|Physician Decision|0|||
148701017|NCT00625443|536380859|FG001|Overall Study|Physician Decision|4|||
148967516|NCT03131440|537366737|FG026|Overall Study|Lost to Follow-up|0|||
148701018|NCT00625443|536380860|FG002|Overall Study|Physician Decision|2|||
148701019|NCT00625443|536380858|FG000|Overall Study|Other|0|||
148701020|NCT00625443|536380859|FG001|Overall Study|Other|1|||
148701021|NCT00625443|536380860|FG002|Overall Study|Other|1|||
148967517|NCT03131440|537366738|FG027|Overall Study|Lost to Follow-up|2|||
148967518|NCT03131440|537366739|FG028|Overall Study|Lost to Follow-up|0|||
148967519|NCT03131440|537366740|FG029|Overall Study|Lost to Follow-up|2|||
148701022|NCT02728102|536380861|FG000|Overall Study|Death|3|||
148967520|NCT03131440|537366741|FG030|Overall Study|Lost to Follow-up|0|||
148967521|NCT03131440|537366742|FG031|Overall Study|Lost to Follow-up|0|||
148701023|NCT02728102|536380862|FG001|Overall Study|Death|0|||
148701024|NCT02728102|536380863|FG002|Overall Study|Death|1|||
148701025|NCT02728102|536380861|FG000|Overall Study|Withdrawal by Subject|0|||
148701026|NCT02728102|536380862|FG001|Overall Study|Withdrawal by Subject|2|||
148967522|NCT03131440|537366711|FG000|Overall Study|Death|0|||
148967523|NCT03131440|537366712|FG001|Overall Study|Death|0|||
148967524|NCT03131440|537366713|FG002|Overall Study|Death|0|||
148967525|NCT03131440|537366714|FG003|Overall Study|Death|0|||
148967526|NCT03131440|537366715|FG004|Overall Study|Death|0|||
148967527|NCT03131440|537366716|FG005|Overall Study|Death|0|||
148967528|NCT03131440|537366717|FG006|Overall Study|Death|0|||
148967529|NCT03131440|537366718|FG007|Overall Study|Death|0|||
148967530|NCT03131440|537366719|FG008|Overall Study|Death|0|||
148967531|NCT03131440|537366720|FG009|Overall Study|Death|0|||
148967532|NCT03131440|537366721|FG010|Overall Study|Death|0|||
148967533|NCT03131440|537366722|FG011|Overall Study|Death|0|||
148967534|NCT03131440|537366723|FG012|Overall Study|Death|0|||
148967535|NCT03131440|537366724|FG013|Overall Study|Death|0|||
148967536|NCT03131440|537366725|FG014|Overall Study|Death|0|||
148967537|NCT03131440|537366726|FG015|Overall Study|Death|0|||
148967538|NCT03131440|537366727|FG016|Overall Study|Death|0|||
148967539|NCT03131440|537366728|FG017|Overall Study|Death|0|||
148967540|NCT03131440|537366729|FG018|Overall Study|Death|0|||
148967541|NCT03131440|537366730|FG019|Overall Study|Death|0|||
148967542|NCT03131440|537366731|FG020|Overall Study|Death|0|||
148967543|NCT03131440|537366732|FG021|Overall Study|Death|0|||
149025076|NCT00751790|537567995|FG000|Overall Study|Death|3|||
148967544|NCT03131440|537366733|FG022|Overall Study|Death|0|||
148967545|NCT03131440|537366734|FG023|Overall Study|Death|0|||
148967546|NCT03131440|537366735|FG024|Overall Study|Death|0|||
148967547|NCT03131440|537366736|FG025|Overall Study|Death|1|||
148701027|NCT02728102|536380863|FG002|Overall Study|Withdrawal by Subject|3|||
148701028|NCT02728102|536380861|FG000|Overall Study|Physician Decision|1|||
148701029|NCT02728102|536380862|FG001|Overall Study|Physician Decision|1|||
148701030|NCT02728102|536380863|FG002|Overall Study|Physician Decision|0|||
148701031|NCT02728102|536380861|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
148814979|NCT01078662|536798077|FG003|Overall Study|Patients reached data cut-off|2|||
148814980|NCT01078662|536798078|FG004|Overall Study|Patients reached data cut-off|3|||
148814981|NCT01078662|536798074|FG000|Overall Study|Withdrawal by Subject|4|||
148814982|NCT01078662|536798075|FG001|Overall Study|Withdrawal by Subject|11|||
148814983|NCT01078662|536798076|FG002|Overall Study|Withdrawal by Subject|1|||
148814984|NCT01078662|536798077|FG003|Overall Study|Withdrawal by Subject|0|||
148814985|NCT01078662|536798078|FG004|Overall Study|Withdrawal by Subject|0|||
148814986|NCT01078662|536798074|FG000|Overall Study|Protocol Violation|0|||
148814987|NCT01078662|536798075|FG001|Overall Study|Protocol Violation|1|||
148814988|NCT01078662|536798076|FG002|Overall Study|Protocol Violation|0|||
148814989|NCT01078662|536798077|FG003|Overall Study|Protocol Violation|0|||
148814990|NCT01078662|536798078|FG004|Overall Study|Protocol Violation|0|||
148814991|NCT01078662|536798074|FG000|Overall Study|Lost to Follow-up|1|||
148814992|NCT01078662|536798075|FG001|Overall Study|Lost to Follow-up|0|||
148814993|NCT01078662|536798076|FG002|Overall Study|Lost to Follow-up|0|||
148814994|NCT01078662|536798077|FG003|Overall Study|Lost to Follow-up|0|||
148814995|NCT01078662|536798078|FG004|Overall Study|Lost to Follow-up|0|||
148814996|NCT01913353|536798080|FG000|Overall Study|Adverse Event|2|||
148814997|NCT01913353|536798081|FG001|Overall Study|Adverse Event|0|||
148814998|NCT01913353|536798080|FG000|Overall Study|Physician Decision|0|||
148814999|NCT01913353|536798081|FG001|Overall Study|Physician Decision|2|||
148815000|NCT01913353|536798080|FG000|Overall Study|Withdrawal by Subject|20|||
148815001|NCT01913353|536798081|FG001|Overall Study|Withdrawal by Subject|6|||
148815002|NCT01913353|536798080|FG000|Overall Study|multiple reasons|10|||
148815003|NCT01913353|536798081|FG001|Overall Study|multiple reasons|7|||
148815004|NCT00385840|536798082|FG000|Overall Study|Adverse Event|1|||
148815005|NCT00385840|536798083|FG001|Overall Study|Adverse Event|1|||
148815006|NCT00385840|536798082|FG000|Overall Study|Lost to Follow-up|3|||
148815007|NCT00385840|536798083|FG001|Overall Study|Lost to Follow-up|13|||
148967548|NCT03131440|537366737|FG026|Overall Study|Death|0|||
148967549|NCT03131440|537366738|FG027|Overall Study|Death|0|||
148967550|NCT03131440|537366739|FG028|Overall Study|Death|0|||
148967551|NCT03131440|537366740|FG029|Overall Study|Death|0|||
148967552|NCT03131440|537366741|FG030|Overall Study|Death|0|||
148967553|NCT03131440|537366742|FG031|Overall Study|Death|0|||
148701032|NCT02728102|536380862|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
148701033|NCT02728102|536380863|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
148701034|NCT02728102|536380861|FG000|Overall Study|Covid|0|||
148701035|NCT02728102|536380862|FG001|Overall Study|Covid|0|||
148701036|NCT02728102|536380863|FG002|Overall Study|Covid|1|||
148701037|NCT02924883|536380865|FG000|Overall Study|Death|39|||
148701038|NCT02924883|536380866|FG001|Overall Study|Death|20|||
148701039|NCT02924883|536380865|FG000|Overall Study|Lost to Follow-up|1|||
148701040|NCT02924883|536380866|FG001|Overall Study|Lost to Follow-up|0|||
148701041|NCT02924883|536380865|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
148701042|NCT02924883|536380866|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
148701043|NCT02924883|536380865|FG000|Overall Study|Protocol Violation|1|||
148701044|NCT02924883|536380866|FG001|Overall Study|Protocol Violation|0|||
148701045|NCT02924883|536380865|FG000|Overall Study|Withdrawal by Subject|22|||
148967554|NCT00746941|537366743|FG000|Overall Study|Death|2|||
148967555|NCT00746941|537366744|FG001|Overall Study|Death|0|||
148701046|NCT02924883|536380866|FG001|Overall Study|Withdrawal by Subject|16|||
148701047|NCT02924883|536380865|FG000|Overall Study|Progressive Disease|1|||
148701048|NCT02924883|536380866|FG001|Overall Study|Progressive Disease|0|||
148701049|NCT02924883|536380865|FG000|Overall Study|Study Terminated by Sponsor|69|||
148701050|NCT02924883|536380866|FG001|Overall Study|Study Terminated by Sponsor|32|||
148701051|NCT00553280|536380867|FG000|Overall Study|Adverse Event|19|||
148701052|NCT00553280|536380867|FG000|Overall Study|Lack of Efficacy|3|||
148701053|NCT00553280|536380867|FG000|Overall Study|Withdrawal by Subject|3|||
148701054|NCT00553280|536380867|FG000|Overall Study|Physician Decision|1|||
148815008|NCT04017962|536798084|FG000|Overall Study|Death|2|||
148967556|NCT00746941|537366745|FG002|Overall Study|Death|0|||
148701055|NCT01182415|536380868|FG000|Overall Study|Lost to Follow-up|1|||
148815009|NCT04017962|536798085|FG001|Overall Study|Death|0|||
148815010|NCT04017962|536798084|FG000|Overall Study|Lost to Follow-up|2|||
148815011|NCT04017962|536798085|FG001|Overall Study|Lost to Follow-up|0|||
148815012|NCT04017962|536798084|FG000|Overall Study|Physician Decision|1|||
148815013|NCT04017962|536798085|FG001|Overall Study|Physician Decision|0|||
148815014|NCT04017962|536798084|FG000|Overall Study|Discontinued LTV|5|||
148967557|NCT00746941|537366746|FG003|Overall Study|Death|6|||
148701056|NCT02587962|536380874|FG000|Overall Study|Adverse Event|0|||
148701057|NCT02587962|536380875|FG001|Overall Study|Adverse Event|0|||
148701058|NCT02587962|536380876|FG002|Overall Study|Adverse Event|1|||
148815015|NCT04017962|536798085|FG001|Overall Study|Discontinued LTV|0|||
148967558|NCT00746941|537366743|FG000|Overall Study|Physician Decision|0|||
148701059|NCT02587962|536380877|FG003|Overall Study|Adverse Event|0|||
148701060|NCT02587962|536380878|FG004|Overall Study|Adverse Event|0|||
148701061|NCT02587962|536380874|FG000|Overall Study|Withdrawal by Subject|0|||
148701062|NCT02587962|536380875|FG001|Overall Study|Withdrawal by Subject|0|||
148701063|NCT02587962|536380876|FG002|Overall Study|Withdrawal by Subject|1|||
148701064|NCT02587962|536380877|FG003|Overall Study|Withdrawal by Subject|1|||
148701065|NCT02587962|536380878|FG004|Overall Study|Withdrawal by Subject|4|||
148701066|NCT02587962|536380874|FG000|Overall Study|Radiological progression|2|||
148701067|NCT02587962|536380875|FG001|Overall Study|Radiological progression|2|||
148701068|NCT02587962|536380876|FG002|Overall Study|Radiological progression|2|||
148701069|NCT02587962|536380877|FG003|Overall Study|Radiological progression|5|||
148701070|NCT02587962|536380878|FG004|Overall Study|Radiological progression|10|||
148701071|NCT02587962|536380874|FG000|Overall Study|Clinical progression|0|||
148701072|NCT02587962|536380875|FG001|Overall Study|Clinical progression|1|||
148701073|NCT02587962|536380876|FG002|Overall Study|Clinical progression|2|||
148701074|NCT02587962|536380877|FG003|Overall Study|Clinical progression|0|||
148701075|NCT02587962|536380878|FG004|Overall Study|Clinical progression|1|||
148701076|NCT00312663|536380881|FG000|Immunization Phase|Adverse Event|0|||
148701077|NCT00312663|536380882|FG001|Immunization Phase|Adverse Event|1|||
148701078|NCT00312663|536380883|FG002|Immunization Phase|Adverse Event|0|||
148701079|NCT01536405|536380884|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
148701080|NCT01536405|536380885|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
148701081|NCT01536405|536380884|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
148701082|NCT01536405|536380885|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
148701083|NCT01536405|536380884|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
148701084|NCT01536405|536380885|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
148701085|NCT01536405|536380884|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
148701086|NCT01536405|536380885|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
148701087|NCT01536405|536380884|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
148701088|NCT01536405|536380885|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
148701089|NCT01536405|536380884|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
148701090|NCT01536405|536380885|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
148701091|NCT01536405|536380884|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
148701092|NCT01536405|536380885|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
148701093|NCT01536405|536380884|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
148701094|NCT01536405|536380885|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
148701095|NCT01536405|536380884|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
148701096|NCT01536405|536380885|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
148701097|NCT01536405|536380884|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
148701098|NCT01536405|536380885|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
148701099|NCT01536405|536380884|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
148701100|NCT01536405|536380885|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
148701101|NCT01536405|536380884|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
148701102|NCT01536405|536380885|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
148701103|NCT01536405|536380884|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
148701104|NCT01536405|536380885|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
148701105|NCT01263704|536380890|FG000|Overall Study|Progressive disease|18|||
148701106|NCT01263704|536380890|FG000|Overall Study|Adverse Event|3|||
148701107|NCT01263704|536380890|FG000|Overall Study|Death|2|||
148701108|NCT01263704|536380890|FG000|Overall Study|Patient withdrew consent|2|||
148701109|NCT01263704|536380890|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
148701110|NCT01263704|536380890|FG000|Overall Study|Lost to Follow-up|1|||
148701111|NCT01263704|536380890|FG000|Overall Study|Colon metastases|1|||
148701112|NCT01263704|536380890|FG000|Overall Study|Principal Investigator (PI) decision|1|||
148701113|NCT01061866|536380891|FG000|Overall Study|Adverse Event|2|||
148815016|NCT00700635|536798086|FG000|Overall Study|Adverse Event|1|||
148815017|NCT00700635|536798087|FG001|Overall Study|Adverse Event|0|||
148815018|NCT00700635|536798088|FG002|Overall Study|Adverse Event|0|||
148815019|NCT00700635|536798086|FG000|Overall Study|Lost to Follow-up|1|||
148815020|NCT00700635|536798087|FG001|Overall Study|Lost to Follow-up|3|||
148701114|NCT00102440|536380892|FG000|Overall Study|Lost to Follow-up|25|||
148701115|NCT00102440|536380893|FG001|Overall Study|Lost to Follow-up|18|||
148815021|NCT00700635|536798088|FG002|Overall Study|Lost to Follow-up|0|||
148701116|NCT00102440|536380894|FG002|Overall Study|Lost to Follow-up|21|||
148701117|NCT00102440|536380892|FG000|Overall Study|Adverse Event|16|||
148815022|NCT00700635|536798086|FG000|Overall Study|Protocol Violation|2|||
148815023|NCT00700635|536798087|FG001|Overall Study|Protocol Violation|2|||
148967559|NCT00746941|537366744|FG001|Overall Study|Physician Decision|0|||
148701118|NCT00102440|536380893|FG001|Overall Study|Adverse Event|23|||
148701119|NCT00102440|536380894|FG002|Overall Study|Adverse Event|8|||
148701120|NCT00102440|536380892|FG000|Overall Study|Gout Flare|10|||
148815024|NCT00700635|536798088|FG002|Overall Study|Protocol Violation|0|||
148815025|NCT00700635|536798086|FG000|Overall Study|Withdrawal by Subject|7|||
148967560|NCT00746941|537366745|FG002|Overall Study|Physician Decision|2|||
148701121|NCT00102440|536380893|FG001|Overall Study|Gout Flare|28|||
148701122|NCT00102440|536380894|FG002|Overall Study|Gout Flare|9|||
148701123|NCT00102440|536380892|FG000|Overall Study|Personal Reason(s)|19|||
148701124|NCT00102440|536380893|FG001|Overall Study|Personal Reason(s)|13|||
148701125|NCT00102440|536380894|FG002|Overall Study|Personal Reason(s)|13|||
148701126|NCT00102440|536380892|FG000|Overall Study|Other|11|||
148701127|NCT00102440|536380893|FG001|Overall Study|Other|14|||
148701128|NCT00102440|536380894|FG002|Overall Study|Other|14|||
148701129|NCT00102440|536380892|FG000|Overall Study|Protocol Violation|7|||
148701130|NCT00102440|536380893|FG001|Overall Study|Protocol Violation|2|||
148701131|NCT00102440|536380894|FG002|Overall Study|Protocol Violation|1|||
148701132|NCT00772941|536380895|FG000|Overall Study|CRFs not available|195|||
148701133|NCT00772941|536380895|FG000|Overall Study|Study not completed|16|||
148701134|NCT00772941|536380895|FG000|Overall Study|Missed Visits|374|||
148701135|NCT00772941|536380895|FG000|Overall Study|Poor Compliance|7|||
148701136|NCT00772941|536380895|FG000|Overall Study|GPSP Violation|90|||
148701137|NCT04786184|536380897|FG000|Overall Study|Adverse Event|4|||
148701138|NCT04786184|536380898|FG001|Overall Study|Adverse Event|0|||
148701139|NCT04786184|536380897|FG000|Overall Study|Withdrawal by Subject|3|||
148701140|NCT04786184|536380898|FG001|Overall Study|Withdrawal by Subject|1|||
148701141|NCT04786184|536380897|FG000|Overall Study|Lost to Follow-up|4|||
148701142|NCT04786184|536380898|FG001|Overall Study|Lost to Follow-up|2|||
148701143|NCT02255097|536380899|FG000|Overall Study|Death|151|||
148701144|NCT02255097|536380899|FG000|Overall Study|Lost to Follow-up|5|||
148701145|NCT02255097|536380899|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
148701146|NCT02255097|536380899|FG000|Overall Study|Withdrawal by Subject|7|||
148701147|NCT02255097|536380899|FG000|Overall Study|Allocated but not treated|1|||
148701148|NCT02514122|536380900|FG000|Overall Study|Withdrawal by Subject|2|||
148701149|NCT02514122|536380901|FG001|Overall Study|Withdrawal by Subject|0|||
148701150|NCT01534520|536380903|FG000|Overall Study|Adverse Event|0|||
148701151|NCT01534520|536380904|FG001|Overall Study|Adverse Event|1|||
148701152|NCT00857623|536380907|FG000|Overall Study|Adverse Event|5|||
148701153|NCT00857623|536380908|FG001|Overall Study|Adverse Event|2|||
148701154|NCT00857623|536380907|FG000|Overall Study|Study-specific discontinuation criteria|5|||
148701155|NCT00857623|536380908|FG001|Overall Study|Study-specific discontinuation criteria|3|||
148701156|NCT00857623|536380907|FG000|Overall Study|Withdrawal by Subject|2|||
148701157|NCT00857623|536380908|FG001|Overall Study|Withdrawal by Subject|1|||
148701158|NCT00857623|536380907|FG000|Overall Study|Lack of Efficacy|1|||
148701159|NCT00857623|536380908|FG001|Overall Study|Lack of Efficacy|1|||
148701160|NCT00857623|536380907|FG000|Overall Study|Severe non-compliance to protocol|1|||
148701161|NCT00857623|536380908|FG001|Overall Study|Severe non-compliance to protocol|1|||
148701162|NCT00857623|536380907|FG000|Overall Study|Intake of prohibited medication|0|||
148701163|NCT00857623|536380908|FG001|Overall Study|Intake of prohibited medication|1|||
148701164|NCT00857623|536380907|FG000|Overall Study|Positive for HEP C|0|||
148701165|NCT00857623|536380908|FG001|Overall Study|Positive for HEP C|1|||
148701166|NCT04185909|536380909|FG000|Overall Study|Lost to Follow-up|1|||
148701167|NCT01417078|536380910|FG000|Overall Study|Withdrawal by Subject|1|||
148701168|NCT00626548|536380911|FG000|Overall Study|Adverse Event|164|||
148701169|NCT00626548|536380912|FG001|Overall Study|Adverse Event|44|||
148701170|NCT00626548|536380911|FG000|Overall Study|Withdrawal by Subject|42|||
148701171|NCT00626548|536380912|FG001|Overall Study|Withdrawal by Subject|46|||
148701172|NCT00626548|536380911|FG000|Overall Study|Protocol Violation|4|||
148701173|NCT00626548|536380912|FG001|Overall Study|Protocol Violation|11|||
148701174|NCT00626548|536380911|FG000|Overall Study|Lost to Follow-up|2|||
148701175|NCT00626548|536380912|FG001|Overall Study|Lost to Follow-up|2|||
148701176|NCT00626548|536380911|FG000|Overall Study|Other termination reason|493|||
148701177|NCT00626548|536380912|FG001|Overall Study|Other termination reason|613|||
148701178|NCT01059903|536380916|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
148701179|NCT01059903|536380917|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
148701180|NCT04384978|536380918|FG000|Overall Study|Withdrawal by Subject|4|||
148701181|NCT04384978|536380919|FG001|Overall Study|Withdrawal by Subject|0|||
148701182|NCT00385593|536380920|FG000|Overall Study|Adverse Event|3|||
148701183|NCT00385593|536380921|FG001|Overall Study|Adverse Event|2|||
148701184|NCT00385593|536380920|FG000|Overall Study|Withdrawal by Subject|17|||
148701185|NCT00385593|536380921|FG001|Overall Study|Withdrawal by Subject|7|||
148701186|NCT00385593|536380920|FG000|Overall Study|Lost to Follow-up|12|||
148815026|NCT00700635|536798087|FG001|Overall Study|Withdrawal by Subject|3|||
148815027|NCT00700635|536798088|FG002|Overall Study|Withdrawal by Subject|1|||
148701187|NCT00385593|536380921|FG001|Overall Study|Lost to Follow-up|8|||
148701188|NCT00385593|536380920|FG000|Overall Study|Protocol Violation|7|||
148701189|NCT00385593|536380921|FG001|Overall Study|Protocol Violation|4|||
148701190|NCT00385593|536380920|FG000|Overall Study|Several reasons|17|||
148701191|NCT00385593|536380921|FG001|Overall Study|Several reasons|15|||
148701192|NCT00385593|536380920|FG000|Overall Study|Incorrect inclusion|2|||
148701193|NCT00385593|536380921|FG001|Overall Study|Incorrect inclusion|0|||
148701194|NCT00385593|536380920|FG000|Overall Study|Incorrect randomization|0|||
148701195|NCT00385593|536380921|FG001|Overall Study|Incorrect randomization|1|||
148701196|NCT02612337|536380923|FG000|Overall Study|Lack of Efficacy|1|||
148701197|NCT02612337|536380924|FG001|Overall Study|Lack of Efficacy|0|||
148701198|NCT02612337|536380923|FG000|Overall Study|Withdrawal by Subject|2|||
148701199|NCT02612337|536380924|FG001|Overall Study|Withdrawal by Subject|2|||
148701200|NCT02612337|536380923|FG000|Overall Study|Did not receive study drug|0|||
148701201|NCT02612337|536380924|FG001|Overall Study|Did not receive study drug|1|||
148701202|NCT00371839|536382225|FG000|Overall Study|Death|4|||
148701203|NCT00371839|536382226|FG001|Overall Study|Death|0|||
148701204|NCT00371839|536382227|FG002|Overall Study|Death|0|||
148701205|NCT00371839|536382225|FG000|Overall Study|Withdrawal by Subject|7|||
148701206|NCT00371839|536382226|FG001|Overall Study|Withdrawal by Subject|4|||
148701207|NCT00371839|536382227|FG002|Overall Study|Withdrawal by Subject|0|||
148701208|NCT00371839|536382225|FG000|Overall Study|Lost to Follow-up|6|||
148701209|NCT00371839|536382226|FG001|Overall Study|Lost to Follow-up|3|||
148701210|NCT00371839|536382227|FG002|Overall Study|Lost to Follow-up|2|||
148701211|NCT01149473|536382228|FG000|First Intervention|Adverse Event|1|||
148701212|NCT01149473|536382229|FG001|First Intervention|Adverse Event|1|||
148701213|NCT01149473|536382228|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
148701214|NCT01149473|536382229|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
148701215|NCT00834249|536382233|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
148701216|NCT00834249|536382234|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
148701217|NCT00834249|536382233|FG000|Second Intervention|Adverse Event|1|||
148701218|NCT00834249|536382234|FG001|Second Intervention|Adverse Event|0|||
148701219|NCT00851877|536382235|FG000|Phase I-1|Death|1|||
148701220|NCT00851877|536382236|FG001|Phase I-1|Death|0|||
148701221|NCT00851877|536382237|FG002|Phase I-1|Death|0|||
148701222|NCT00851877|536382235|FG000|Phase II|Withdrawal by Subject|0|||
148701223|NCT00851877|536382236|FG001|Phase II|Withdrawal by Subject|0|||
148701224|NCT00851877|536382237|FG002|Phase II|Withdrawal by Subject|3|||
148701225|NCT00620074|536382238|FG000|Overall Study|Adverse Event|1|||
148701226|NCT00829673|536382239|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
148701227|NCT00829673|536382240|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
148701228|NCT00096447|536382241|FG000|Overall Study|Never treated|1|||
148701229|NCT00573066|536382242|FG000|Overall Study|Exclusion criteria|18|||
148701230|NCT00573066|536382242|FG000|Overall Study|IV malfunction|1|||
148701231|NCT00573066|536382242|FG000|Overall Study|Postoperative bleeding|1|||
148701232|NCT02246166|536382245|FG000|Overall Study|Protocol Violation|1|||
148701233|NCT02246166|536382246|FG001|Overall Study|Protocol Violation|0|||
148701234|NCT00834743|536382247|FG000|Second Intervention|Withdrawal by Subject|1|||
148701235|NCT00834743|536382248|FG001|Second Intervention|Withdrawal by Subject|0|||
148701236|NCT00086996|536382249|FG000|Overall Study|Adverse Event|29|||
148701237|NCT00086996|536382249|FG000|Overall Study|Death|4|||
148701238|NCT00086996|536382249|FG000|Overall Study|progression/relapse|7|||
148701239|NCT00086996|536382249|FG000|Overall Study|Withdrawal by Subject|13|||
148701240|NCT00086996|536382249|FG000|Overall Study|Other|6|||
148701241|NCT00086996|536382249|FG000|Overall Study|not eligible|5|||
148701242|NCT02770820|536382250|FG000|Overall Study|Death|1|||
148701243|NCT02770820|536382250|FG000|Overall Study|Physician Decision|2|||
148701244|NCT02331394|536382251|FG000|Overall Study|Disease progression|1|||
148701245|NCT00552669|536382254|FG000|Overall Study|Death|3|||
148701246|NCT00552669|536382255|FG001|Overall Study|Death|7|||
148701247|NCT02098876|536382258|FG000|Overall Study|Withdrawal by Subject|5|||
148701248|NCT02098876|536382259|FG001|Overall Study|Withdrawal by Subject|5|||
148701249|NCT03195491|536382260|FG000|Overall Study|Study drug toxicity|25|||
148701250|NCT03195491|536382261|FG001|Overall Study|Study drug toxicity|3|||
148701251|NCT03195491|536382260|FG000|Overall Study|Maximum clinical benefit|5|||
148701252|NCT03195491|536382261|FG001|Overall Study|Maximum clinical benefit|0|||
148701253|NCT03195491|536382260|FG000|Overall Study|Lost to Follow-up|1|||
148701254|NCT03195491|536382261|FG001|Overall Study|Lost to Follow-up|0|||
148701255|NCT03195491|536382260|FG000|Overall Study|Death|3|||
148701256|NCT03195491|536382261|FG001|Overall Study|Death|0|||
148701257|NCT03195491|536382260|FG000|Overall Study|Adverse event unrelated to study drug|19|||
148701258|NCT03195491|536382261|FG001|Overall Study|Adverse event unrelated to study drug|2|||
148701259|NCT03195491|536382260|FG000|Overall Study|Disease progression|266|||
148701260|NCT03195491|536382261|FG001|Overall Study|Disease progression|8|||
148701261|NCT03195491|536382260|FG000|Overall Study|Other reasons|10|||
148701262|NCT03195491|536382261|FG001|Overall Study|Other reasons|0|||
148701263|NCT03195491|536382260|FG000|Overall Study|Participant withdrew consent|8|||
148701264|NCT03195491|536382261|FG001|Overall Study|Participant withdrew consent|1|||
148701265|NCT03195491|536382260|FG000|Overall Study|Participant no longer meets study criteria|0|||
148701266|NCT03195491|536382261|FG001|Overall Study|Participant no longer meets study criteria|1|||
148701267|NCT03195491|536382260|FG000|Overall Study|Participant request to discontinue study treatment|10|||
148701268|NCT03195491|536382261|FG001|Overall Study|Participant request to discontinue study treatment|0|||
148701269|NCT01270503|536382262|FG000|Overall Study|Lost to Follow-up|1|||
148701270|NCT02459951|536382263|FG000|Overall Study|Unable to meet holding requirement|1|||
148701271|NCT00252720|536382265|FG000|Overall Study|Withdrawal by Subject|95|||
148701272|NCT00252720|536382266|FG001|Overall Study|Withdrawal by Subject|97|||
148701273|NCT00252720|536382265|FG000|Overall Study|Death|7|||
148701274|NCT00252720|536382266|FG001|Overall Study|Death|8|||
148701275|NCT00252720|536382265|FG000|Overall Study|Moving|23|||
148967561|NCT00746941|537366746|FG003|Overall Study|Physician Decision|0|||
148967562|NCT00746941|537366743|FG000|Overall Study|Withdrawal by Subject|3|||
148967563|NCT00746941|537366744|FG001|Overall Study|Withdrawal by Subject|0|||
148967564|NCT00746941|537366745|FG002|Overall Study|Withdrawal by Subject|0|||
148967565|NCT00746941|537366746|FG003|Overall Study|Withdrawal by Subject|2|||
148967566|NCT00746941|537366743|FG000|Overall Study|Other, reason not provided|2|||
148967567|NCT00746941|537366744|FG001|Overall Study|Other, reason not provided|4|||
148967568|NCT00746941|537366745|FG002|Overall Study|Other, reason not provided|0|||
148967569|NCT00746941|537366746|FG003|Overall Study|Other, reason not provided|4|||
148967570|NCT00746941|537366743|FG000|Overall Study|Adverse Event|0|||
148701276|NCT00252720|536382266|FG001|Overall Study|Moving|42|||
148701277|NCT00252720|536382265|FG000|Overall Study|Mainly patients lost to follow-up|7|||
148967571|NCT00746941|537366744|FG001|Overall Study|Adverse Event|0|||
148701278|NCT00252720|536382266|FG001|Overall Study|Mainly patients lost to follow-up|18|||
148701279|NCT01745120|536382267|FG000|Overall Study|Investigator decision|1|||
148701280|NCT01745120|536382268|FG001|Overall Study|Investigator decision|0|||
148701281|NCT01675765|536382269|FG000|Overall Study|Progressive disease|4|||
148701282|NCT01675765|536382270|FG001|Overall Study|Progressive disease|4|||
148701283|NCT01675765|536382269|FG000|Overall Study|Adverse Event|1|||
148701284|NCT01675765|536382270|FG001|Overall Study|Adverse Event|2|||
148701285|NCT01675765|536382269|FG000|Overall Study|Withdrawal by Subject|2|||
148701286|NCT01675765|536382270|FG001|Overall Study|Withdrawal by Subject|0|||
148701287|NCT01675765|536382269|FG000|Overall Study|Death|1|||
148701288|NCT01675765|536382270|FG001|Overall Study|Death|0|||
148701289|NCT01675765|536382269|FG000|Overall Study|Clinical progression|3|||
148701290|NCT01675765|536382270|FG001|Overall Study|Clinical progression|2|||
148701291|NCT03965091|536382272|FG000|Overall Study|Adverse Event|0|||
148701292|NCT03965091|536382273|FG001|Overall Study|Adverse Event|2|||
148701293|NCT03965091|536382274|FG002|Overall Study|Adverse Event|3|||
148701294|NCT03965091|536382272|FG000|Overall Study|Withdrawal by Subject|11|||
148701295|NCT03965091|536382273|FG001|Overall Study|Withdrawal by Subject|3|||
148701296|NCT03965091|536382274|FG002|Overall Study|Withdrawal by Subject|5|||
148701297|NCT03965091|536382272|FG000|Overall Study|Non-compliance with study drug|0|||
148701298|NCT03965091|536382273|FG001|Overall Study|Non-compliance with study drug|0|||
148701299|NCT03965091|536382274|FG002|Overall Study|Non-compliance with study drug|1|||
148701300|NCT03965091|536382272|FG000|Overall Study|Lost to Follow-up|1|||
148701301|NCT03965091|536382273|FG001|Overall Study|Lost to Follow-up|1|||
148701302|NCT03965091|536382274|FG002|Overall Study|Lost to Follow-up|1|||
148701303|NCT03965091|536382272|FG000|Overall Study|Lack of Efficacy|2|||
148701304|NCT03965091|536382273|FG001|Overall Study|Lack of Efficacy|0|||
148701305|NCT03965091|536382274|FG002|Overall Study|Lack of Efficacy|0|||
148701306|NCT03965091|536382272|FG000|Overall Study|Other than specified|9|||
148701307|NCT03965091|536382273|FG001|Overall Study|Other than specified|11|||
148701308|NCT03965091|536382274|FG002|Overall Study|Other than specified|8|||
148701309|NCT01185821|536382277|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148701310|NCT01185821|536382278|FG001|Overall Study|Abnormal laboratory value(s)|2|||
148701311|NCT01185821|536382279|FG002|Overall Study|Abnormal laboratory value(s)|1|||
148701312|NCT01185821|536382280|FG003|Overall Study|Abnormal laboratory value(s)|0|||
148701313|NCT01185821|536382281|FG004|Overall Study|Abnormal laboratory value(s)|0|||
148701314|NCT01185821|536382277|FG000|Overall Study|Protocol Violation|0|||
148701315|NCT01185821|536382278|FG001|Overall Study|Protocol Violation|0|||
148701316|NCT01185821|536382279|FG002|Overall Study|Protocol Violation|0|||
148701317|NCT01185821|536382280|FG003|Overall Study|Protocol Violation|1|||
148701318|NCT01185821|536382281|FG004|Overall Study|Protocol Violation|1|||
148701319|NCT01185821|536382277|FG000|Overall Study|Abnormal test procedure result|0|||
148701320|NCT01185821|536382278|FG001|Overall Study|Abnormal test procedure result|0|||
148701321|NCT01185821|536382279|FG002|Overall Study|Abnormal test procedure result|0|||
148701322|NCT01185821|536382280|FG003|Overall Study|Abnormal test procedure result|0|||
148701323|NCT01185821|536382281|FG004|Overall Study|Abnormal test procedure result|1|||
148701324|NCT01185821|536382277|FG000|Overall Study|Death|0|||
148701325|NCT01185821|536382278|FG001|Overall Study|Death|1|||
148701326|NCT01185821|536382279|FG002|Overall Study|Death|0|||
148701327|NCT01185821|536382280|FG003|Overall Study|Death|0|||
148701328|NCT01185821|536382281|FG004|Overall Study|Death|0|||
148701329|NCT01185821|536382277|FG000|Overall Study|Condition no longer required study drug|0|||
148701330|NCT01185821|536382278|FG001|Overall Study|Condition no longer required study drug|0|||
148701331|NCT01185821|536382279|FG002|Overall Study|Condition no longer required study drug|0|||
148701332|NCT01185821|536382280|FG003|Overall Study|Condition no longer required study drug|0|||
148701333|NCT01185821|536382281|FG004|Overall Study|Condition no longer required study drug|1|||
148701334|NCT01185821|536382277|FG000|Overall Study|Adverse Event|2|||
148701335|NCT01185821|536382278|FG001|Overall Study|Adverse Event|3|||
148701336|NCT01185821|536382279|FG002|Overall Study|Adverse Event|1|||
148701337|NCT01185821|536382280|FG003|Overall Study|Adverse Event|2|||
148701338|NCT01185821|536382281|FG004|Overall Study|Adverse Event|5|||
148701339|NCT01185821|536382277|FG000|Overall Study|Lack of Efficacy|0|||
148701340|NCT01185821|536382278|FG001|Overall Study|Lack of Efficacy|0|||
148701341|NCT01185821|536382279|FG002|Overall Study|Lack of Efficacy|3|||
148701342|NCT01185821|536382280|FG003|Overall Study|Lack of Efficacy|0|||
148701343|NCT01185821|536382281|FG004|Overall Study|Lack of Efficacy|9|||
149025077|NCT00751790|537567995|FG000|Overall Study|Withdrawal by Subject|1|||
148701344|NCT01185821|536382277|FG000|Overall Study|Withdrawal by Subject|3|||
148701345|NCT01185821|536382278|FG001|Overall Study|Withdrawal by Subject|2|||
149025078|NCT01106976|537567997|FG000|Overall Study|Lost to Follow-up|8|||
148701346|NCT01185821|536382279|FG002|Overall Study|Withdrawal by Subject|2|||
148701347|NCT01185821|536382280|FG003|Overall Study|Withdrawal by Subject|1|||
148701348|NCT01185821|536382281|FG004|Overall Study|Withdrawal by Subject|3|||
148701349|NCT01185821|536382277|FG000|Overall Study|Lost to Follow-up|1|||
148701350|NCT01185821|536382278|FG001|Overall Study|Lost to Follow-up|1|||
148701351|NCT01185821|536382279|FG002|Overall Study|Lost to Follow-up|2|||
148701352|NCT01185821|536382280|FG003|Overall Study|Lost to Follow-up|1|||
148701353|NCT01185821|536382281|FG004|Overall Study|Lost to Follow-up|2|||
148701354|NCT01185821|536382277|FG000|Overall Study|Administrative problems|0|||
148701355|NCT01185821|536382278|FG001|Overall Study|Administrative problems|0|||
148701356|NCT01185821|536382279|FG002|Overall Study|Administrative problems|1|||
148701357|NCT01185821|536382280|FG003|Overall Study|Administrative problems|1|||
148701358|NCT01185821|536382281|FG004|Overall Study|Administrative problems|2|||
148701359|NCT00846495|536382287|FG000|Overall Study|Lost to Follow-up|1|||
148701360|NCT00846495|536382288|FG001|Overall Study|Lost to Follow-up|0|||
148701361|NCT00846495|536382287|FG000|Overall Study|Adverse Event|5|||
148701362|NCT00846495|536382288|FG001|Overall Study|Adverse Event|1|||
148701363|NCT00846495|536382287|FG000|Overall Study|Lack of Efficacy|1|||
148701364|NCT00846495|536382288|FG001|Overall Study|Lack of Efficacy|2|||
148701365|NCT00846495|536382287|FG000|Overall Study|Physician Decision|1|||
148701366|NCT00846495|536382288|FG001|Overall Study|Physician Decision|0|||
148701367|NCT02601560|536382290|FG000|Overall Study|Other|0|||
148701368|NCT02601560|536382291|FG001|Overall Study|Other|0|||
148701369|NCT02601560|536382292|FG002|Overall Study|Other|0|||
148701370|NCT02601560|536382293|FG003|Overall Study|Other|0|||
148701371|NCT02601560|536382294|FG004|Overall Study|Other|0|||
148701372|NCT02601560|536382295|FG005|Overall Study|Other|0|||
148701373|NCT02601560|536382296|FG006|Overall Study|Other|1|||
148701374|NCT02601560|536382297|FG007|Overall Study|Other|0|||
148701375|NCT03459807|536382298|FG000|Overall Study|Withdrawal due to transplant|0|||
148701376|NCT03459807|536382299|FG001|Overall Study|Withdrawal due to transplant|1|||
148701377|NCT02392000|536382305|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
148701378|NCT02392000|536382305|FG000|Overall Study|Withdrawal by Subject|1|||
148701379|NCT02392000|536382305|FG000|Overall Study|Lost to Follow-up|8|||
148701380|NCT03586726|536382310|FG000|Overall Study|Withdrawal by Subject|1|||
148701381|NCT00965185|536382311|FG000|Overall Study|Lost to Follow-up|2|||
148701382|NCT00965185|536382312|FG001|Overall Study|Lost to Follow-up|0|||
148701383|NCT00965185|536382311|FG000|Overall Study|Withdrawal by Subject|0|||
148701384|NCT00965185|536382312|FG001|Overall Study|Withdrawal by Subject|1|||
148701385|NCT03197883|536382313|FG000|Overall Study|Adverse Event|1|||
148701386|NCT03197883|536382314|FG001|Overall Study|Adverse Event|1|||
148701387|NCT03197883|536382313|FG000|Overall Study|Lost to Follow-up|1|||
148701388|NCT03197883|536382314|FG001|Overall Study|Lost to Follow-up|0|||
148701389|NCT03197883|536382313|FG000|Overall Study|Protocol Violation|1|||
148701390|NCT03197883|536382314|FG001|Overall Study|Protocol Violation|0|||
148701391|NCT03197883|536382313|FG000|Overall Study|Other (Not Specified)|0|||
148701392|NCT03197883|536382314|FG001|Overall Study|Other (Not Specified)|5|||
148701393|NCT00389064|536382321|FG000|Overall Study|Adverse Event|11|||
148701394|NCT00389064|536382322|FG001|Overall Study|Adverse Event|3|||
148701395|NCT00389064|536382321|FG000|Overall Study|Lack of Efficacy|3|||
148701396|NCT00389064|536382322|FG001|Overall Study|Lack of Efficacy|14|||
148701397|NCT00389064|536382321|FG000|Overall Study|Withdrawal by Subject|17|||
148701398|NCT00389064|536382322|FG001|Overall Study|Withdrawal by Subject|27|||
148701399|NCT00389064|536382321|FG000|Overall Study|Physician Decision|2|||
148701400|NCT00389064|536382322|FG001|Overall Study|Physician Decision|2|||
148701401|NCT00389064|536382321|FG000|Overall Study|Lost to Follow-up|1|||
148701402|NCT00389064|536382322|FG001|Overall Study|Lost to Follow-up|2|||
148701403|NCT00389064|536382321|FG000|Overall Study|Protocol Violation|2|||
148701404|NCT00389064|536382322|FG001|Overall Study|Protocol Violation|0|||
148701405|NCT00389064|536382321|FG000|Overall Study|Multiple Reasons|9|||
148701406|NCT00389064|536382322|FG001|Overall Study|Multiple Reasons|11|||
148701407|NCT02963259|536382327|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
148701408|NCT02963259|536382327|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
148701409|NCT02963259|536382327|FG000|Overall Study|Death|1|||
148701410|NCT02963259|536382327|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
148701411|NCT03243630|536382329|FG000|Overall Study|Protocol Violation|1|||
148701412|NCT03243630|536382329|FG000|Overall Study|Physician Decision|1|||
148701413|NCT00939003|536382330|FG000|Double-blind Treatment Period|Adverse Event|1|||
148701414|NCT00939003|536382331|FG001|Double-blind Treatment Period|Adverse Event|1|||
148701415|NCT00939003|536382330|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
148701416|NCT00939003|536382331|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
148701417|NCT00939003|536382330|FG000|Double-blind Treatment Period|Pregnancy|0|||
148701418|NCT00939003|536382331|FG001|Double-blind Treatment Period|Pregnancy|1|||
148701419|NCT00939003|536382330|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
148701420|NCT00939003|536382331|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
148701421|NCT00939003|536382330|FG000|Open-label Treatment Period|Adverse Event|4|||
148701422|NCT00939003|536382331|FG001|Open-label Treatment Period|Adverse Event|8|||
148701423|NCT00939003|536382330|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
148701424|NCT00939003|536382331|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
148701425|NCT00939003|536382330|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
148701426|NCT00939003|536382331|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
148701427|NCT00939003|536382330|FG000|Open-label Treatment Period|Pregnancy|1|||
148701428|NCT00939003|536382331|FG001|Open-label Treatment Period|Pregnancy|1|||
148701429|NCT00939003|536382330|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
148701430|NCT00939003|536382331|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
148701431|NCT00939003|536382330|FG000|Open-label Treatment Period|Site Closure|3|||
148701432|NCT00939003|536382331|FG001|Open-label Treatment Period|Site Closure|4|||
148701433|NCT02131129|536382332|FG000|Overall Study|Withdrawal by Subject|1|||
148701434|NCT02131129|536382333|FG001|Overall Study|Withdrawal by Subject|0|||
148701435|NCT03707912|536382334|FG000|Overall Study|Violation of inclusion criteria|1|||
148701436|NCT03707912|536382335|FG001|Overall Study|Violation of inclusion criteria|0|||
148701437|NCT05369208|536383515|FG000|Core Phase|Prohibited Medication Required|2|||
148701438|NCT05369208|536383515|FG000|Core Phase|Adverse Event|1|||
148701439|NCT05369208|536383515|FG000|Core Phase|Lack of Efficacy|1|||
148701440|NCT04934722|536383516|FG000|Overall Study|Death|4|||
148701441|NCT04934722|536383517|FG001|Overall Study|Death|3|||
148701442|NCT04934722|536383516|FG000|Overall Study|Participants Ongoing|88|||
148701443|NCT04934722|536383517|FG001|Overall Study|Participants Ongoing|91|||
148701444|NCT01466166|536383523|FG000|Overall Study|Death|1|||
148701445|NCT01466166|536383523|FG000|Overall Study|Lost to Follow-up|7|||
148701446|NCT01466166|536383523|FG000|Overall Study|Infusion Reaction (IR)|27|||
148701447|NCT01466166|536383523|FG000|Overall Study|Adverse Event (Other than IR)|11|||
148701448|NCT01466166|536383523|FG000|Overall Study|Elevated Serum Uric Acid|78|||
148701449|NCT01466166|536383523|FG000|Overall Study|Withdrawal by Subject|13|||
148701450|NCT01466166|536383523|FG000|Overall Study|Sponsor Decision|4|||
148701451|NCT01466166|536383523|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
148701452|NCT01466166|536383523|FG000|Overall Study|Other|20|||
148701453|NCT03450057|536383526|FG000|Overall Study|Death|17|||
148701454|NCT03450057|536383526|FG000|Overall Study|ICF withdrawal|4|||
148701455|NCT03450057|536383526|FG000|Overall Study|Lost to Follow-up|2|||
148701456|NCT05755282|536383527|FG000|Overall Study|Protocol Violation|0|||
148701457|NCT05755282|536383528|FG001|Overall Study|Protocol Violation|1|||
148701458|NCT00829790|536383529|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
148701459|NCT00829790|536383530|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
148701460|NCT03214952|536383531|FG000|Overall Study|Protocol Deviation|45|||
148701461|NCT03214952|536383531|FG000|Overall Study|Case Report Forms Uncollected|13|||
148701462|NCT03769896|536383532|FG000|Open-label Phase|Lack of Efficacy|5|||
148701463|NCT03769896|536383533|FG001|Open-label Phase|Lack of Efficacy|0|||
148701464|NCT03769896|536383532|FG000|Open-label Phase|Adverse Event|3|||
148701465|NCT03769896|536383533|FG001|Open-label Phase|Adverse Event|0|||
148701466|NCT03769896|536383532|FG000|Open-label Phase|Withdrawal by Subject|1|||
148701467|NCT03769896|536383533|FG001|Open-label Phase|Withdrawal by Subject|0|||
148701468|NCT01015703|536383534|FG000|Overall Study|Withdrawal by Subject|0|||
148701469|NCT01015703|536383535|FG001|Overall Study|Withdrawal by Subject|1|||
148701470|NCT01015703|536383536|FG002|Overall Study|Withdrawal by Subject|0|||
148701471|NCT01015703|536383537|FG003|Overall Study|Withdrawal by Subject|0|||
148701472|NCT01015703|536383538|FG004|Overall Study|Withdrawal by Subject|0|||
148701473|NCT01015703|536383534|FG000|Overall Study|Adverse Event|1|||
148701474|NCT01015703|536383535|FG001|Overall Study|Adverse Event|0|||
148701475|NCT01015703|536383536|FG002|Overall Study|Adverse Event|0|||
148701476|NCT01015703|536383537|FG003|Overall Study|Adverse Event|0|||
148701477|NCT01015703|536383538|FG004|Overall Study|Adverse Event|0|||
148701478|NCT01015703|536383534|FG000|Overall Study|Protocol Violation|1|||
148701479|NCT01015703|536383535|FG001|Overall Study|Protocol Violation|0|||
148701480|NCT01015703|536383536|FG002|Overall Study|Protocol Violation|0|||
148701481|NCT01015703|536383537|FG003|Overall Study|Protocol Violation|0|||
148701482|NCT01015703|536383538|FG004|Overall Study|Protocol Violation|0|||
148701483|NCT01693523|536383539|FG000|Overall Study|Adverse Event|2|||
148701484|NCT01693523|536383540|FG001|Overall Study|Adverse Event|1|||
148701485|NCT01693523|536383541|FG002|Overall Study|Adverse Event|0|||
148701486|NCT01693523|536383539|FG000|Overall Study|Death|0|||
148701487|NCT01693523|536383540|FG001|Overall Study|Death|1|||
148701488|NCT01693523|536383541|FG002|Overall Study|Death|1|||
148701489|NCT01693523|536383539|FG000|Overall Study|Lost to Follow-up|0|||
148701490|NCT01693523|536383540|FG001|Overall Study|Lost to Follow-up|0|||
148701491|NCT01693523|536383541|FG002|Overall Study|Lost to Follow-up|4|||
148701492|NCT01693523|536383539|FG000|Overall Study|Physician Decision|0|||
148701493|NCT01693523|536383540|FG001|Overall Study|Physician Decision|0|||
148701494|NCT01693523|536383541|FG002|Overall Study|Physician Decision|1|||
148701495|NCT01693523|536383539|FG000|Overall Study|Withdrawal by Subject|1|||
148701496|NCT01693523|536383540|FG001|Overall Study|Withdrawal by Subject|2|||
148701497|NCT01693523|536383541|FG002|Overall Study|Withdrawal by Subject|2|||
148967572|NCT00746941|537366745|FG002|Overall Study|Adverse Event|0|||
148967573|NCT00746941|537366746|FG003|Overall Study|Adverse Event|1|||
148701498|NCT01693523|536383539|FG000|Overall Study|Lack of compliance study medication|1|||
148701499|NCT01693523|536383540|FG001|Overall Study|Lack of compliance study medication|2|||
148701500|NCT01693523|536383541|FG002|Overall Study|Lack of compliance study medication|0|||
148701501|NCT01693523|536383539|FG000|Overall Study|Chemotherapy was held|1|||
148701502|NCT01693523|536383540|FG001|Overall Study|Chemotherapy was held|2|||
148701503|NCT01693523|536383541|FG002|Overall Study|Chemotherapy was held|0|||
148701504|NCT00834418|536383542|FG000|Overall Study|Adverse Event|0|||
148701505|NCT00834418|536383543|FG001|Overall Study|Adverse Event|2|||
148701506|NCT00004562|536383545|FG000|Overall Study|Lost to Follow-up|102|||
148701507|NCT00004562|536383546|FG001|Overall Study|Lost to Follow-up|91|||
148701508|NCT04247282|536383547|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
148701509|NCT04247282|536383548|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
148701510|NCT04247282|536383549|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
148701511|NCT04247282|536383550|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
148701512|NCT04247282|536383547|FG000|Overall Study|Refused further treatment|0|||
148701513|NCT04247282|536383548|FG001|Overall Study|Refused further treatment|1|||
148701514|NCT04247282|536383549|FG002|Overall Study|Refused further treatment|0|||
148701515|NCT04247282|536383550|FG003|Overall Study|Refused further treatment|0|||
148701516|NCT00301366|536383551|FG000|Overall Study|Adverse Event|1|||
148701517|NCT01313273|536383552|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
148701518|NCT01313273|536383553|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
148701519|NCT01313273|536383552|FG000|Overall Study|Withdrawal by Subject|1|||
148701520|NCT01313273|536383553|FG001|Overall Study|Withdrawal by Subject|0|||
148701521|NCT01313273|536383552|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
148701522|NCT01313273|536383553|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
148701523|NCT03687736|536383554|FG000|Overall Study|Lost to Follow-up|7|||
148701524|NCT03687736|536383554|FG000|Overall Study|Withdrawal by Subject|3|||
148701525|NCT01602419|536383558|FG000|Overall Study|Not treated with Wilate|9|||
148701526|NCT01602419|536383558|FG000|Overall Study|Adverse Drug Reaction|4|||
148701527|NCT01602419|536383558|FG000|Overall Study|Insurance issues|3|||
148701528|NCT01602419|536383558|FG000|Overall Study|Changed treatment centre|1|||
148701529|NCT01602419|536383558|FG000|Overall Study|Treatment centre closed|1|||
148701530|NCT01602419|536383558|FG000|Overall Study|Withdrawal by Subject|5|||
148701531|NCT01602419|536383558|FG000|Overall Study|Lost to Follow-up|6|||
148701532|NCT01792635|536383559|FG000|Part B|Adverse Event|0|||
148701533|NCT01792635|536383560|FG001|Part B|Adverse Event|0|||
148701534|NCT01792635|536383561|FG002|Part B|Adverse Event|1|||
148701535|NCT01792635|536383559|FG000|Part B|Study terminated|0|||
148701536|NCT01792635|536383560|FG001|Part B|Study terminated|4|||
148701537|NCT01792635|536383561|FG002|Part B|Study terminated|3|||
148701538|NCT03956862|536383565|FG000|Overall Study|Lost to Follow-up|1|||
148701539|NCT03956862|536383566|FG001|Overall Study|Lost to Follow-up|1|||
148701540|NCT03956862|536383565|FG000|Overall Study|Withdrawal by Subject|1|||
148701541|NCT03956862|536383566|FG001|Overall Study|Withdrawal by Subject|1|||
148701542|NCT02714062|536383567|FG000|Overall Study|Adverse Event|0|||
148701543|NCT02714062|536383568|FG001|Overall Study|Adverse Event|0|||
148701544|NCT02714062|536383569|FG002|Overall Study|Adverse Event|2|||
148701545|NCT02714062|536383567|FG000|Overall Study|Withdrawal by Subject|1|||
148701546|NCT02714062|536383568|FG001|Overall Study|Withdrawal by Subject|0|||
148701547|NCT02714062|536383569|FG002|Overall Study|Withdrawal by Subject|1|||
148701548|NCT02714062|536383567|FG000|Overall Study|Protocol Violation|0|||
148701549|NCT02714062|536383568|FG001|Overall Study|Protocol Violation|1|||
148701550|NCT02714062|536383569|FG002|Overall Study|Protocol Violation|0|||
148701551|NCT02294604|536383570|FG000|Overall Study|Did not provide samples for culture|0|||
148701552|NCT02294604|536383571|FG001|Overall Study|Did not provide samples for culture|1|||
148701553|NCT02294604|536383572|FG002|Overall Study|Did not provide samples for culture|0|||
148701554|NCT02294604|536383570|FG000|Overall Study|Culture contamination|1|||
148701555|NCT02294604|536383571|FG001|Overall Study|Culture contamination|2|||
148701556|NCT02294604|536383572|FG002|Overall Study|Culture contamination|0|||
148701557|NCT01363765|536383575|FG000|Overall Study|non-diagnostic|2621|||
148701558|NCT01363765|536383576|FG001|Overall Study|non-diagnostic|1124|||
148701559|NCT01363765|536383575|FG000|Overall Study|duplicate records|736|||
148701560|NCT01363765|536383576|FG001|Overall Study|duplicate records|3177|||
148701561|NCT01363765|536383575|FG000|Overall Study|non-resident|156|||
148701562|NCT01363765|536383576|FG001|Overall Study|non-resident|76|||
148701563|NCT01363765|536383575|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
148701564|NCT01363765|536383576|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
148701565|NCT01363765|536383575|FG000|Overall Study|smear during intervention|2170|||
148701566|NCT01363765|536383576|FG001|Overall Study|smear during intervention|0|||
148701567|NCT01900626|536383577|FG000|Overall Study|study was closed due to low enrollment|1|||
148701568|NCT01900626|536383578|FG001|Overall Study|study was closed due to low enrollment|1|||
148701569|NCT02682784|536383586|FG000|Overall Study|Withdrawal by Subject|0|||
148701570|NCT02682784|536383587|FG001|Overall Study|Withdrawal by Subject|2|||
148815028|NCT06170827|536798089|FG000|Overall Study|Withdrawal by Subject|1|||
148815029|NCT06170827|536798090|FG001|Overall Study|Withdrawal by Subject|1|||
148815030|NCT02872714|536798092|FG000|Overall Study|Progressive Disease|1|||
148701571|NCT02682784|536383588|FG002|Overall Study|Withdrawal by Subject|1|||
148701572|NCT02682784|536383589|FG003|Overall Study|Withdrawal by Subject|2|||
148701573|NCT02682784|536383586|FG000|Overall Study|Physician Decision|1|||
148701574|NCT02682784|536383587|FG001|Overall Study|Physician Decision|0|||
148701575|NCT02682784|536383588|FG002|Overall Study|Physician Decision|1|||
148701576|NCT02682784|536383589|FG003|Overall Study|Physician Decision|1|||
148701577|NCT01702987|536383590|FG000|Overall Study|Withdrawal by Subject|1|||
148701578|NCT01702987|536383591|FG001|Overall Study|Withdrawal by Subject|0|||
148701579|NCT02017223|536383592|FG000|Overall Study|Algorithm problems|2|||
148701580|NCT01401647|536383593|FG000|Overall Study|Withdrawal by Subject|1|||
148701581|NCT01401647|536383594|FG001|Overall Study|Withdrawal by Subject|5|||
148701582|NCT01401647|536383595|FG002|Overall Study|Withdrawal by Subject|2|||
148701583|NCT01401647|536383593|FG000|Overall Study|Lost to Follow-up|3|||
148701584|NCT01401647|536383594|FG001|Overall Study|Lost to Follow-up|3|||
148701585|NCT01401647|536383595|FG002|Overall Study|Lost to Follow-up|1|||
148701586|NCT00365846|536383600|FG000|Overall Study|Lost to Follow-up|1|||
148701587|NCT04263649|536383602|FG000|Overall Study|Adverse Event|53|||
148701588|NCT04263649|536383602|FG000|Overall Study|Lost to Follow-up|3|||
148701589|NCT04263649|536383602|FG000|Overall Study|Death|29|||
148701590|NCT04263649|536383602|FG000|Overall Study|Device deficiency|19|||
148701591|NCT04263649|536383602|FG000|Overall Study|other reasons|11|||
148701592|NCT02057458|536383603|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
148701593|NCT02057458|536383604|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
148701594|NCT02057458|536383605|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
148701595|NCT02057458|536383603|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
148701596|NCT02057458|536383604|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
148701597|NCT02057458|536383605|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
148701598|NCT02057458|536383603|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
148701599|NCT02057458|536383604|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
148701600|NCT02057458|536383605|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
148701601|NCT01265056|536383613|FG000|Initial Study Period|Withdrawal by Subject|1|||
148701602|NCT01265056|536383614|FG001|Initial Study Period|Withdrawal by Subject|1|||
148701603|NCT01265056|536383613|FG000|Initial Study Period|Withdrawal by Subject|1|||
148701604|NCT01265056|536383614|FG001|Initial Study Period|Withdrawal by Subject|1|||
148701605|NCT01265056|536383613|FG000|Follow up|Lost to Follow-up|7|||
148701606|NCT01265056|536383614|FG001|Follow up|Lost to Follow-up|3|||
148701607|NCT00537979|536383619|FG000|Overall Study|Adverse Event|2|||
148701608|NCT00537979|536383620|FG001|Overall Study|Adverse Event|2|||
148701609|NCT00537979|536383619|FG000|Overall Study|Withdrawal by Subject|1|||
148701610|NCT00537979|536383620|FG001|Overall Study|Withdrawal by Subject|4|||
148701611|NCT00537979|536383619|FG000|Overall Study|Lost to Follow-up|1|||
148701612|NCT00537979|536383620|FG001|Overall Study|Lost to Follow-up|4|||
148701613|NCT00537979|536383619|FG000|Overall Study|Lack of Efficacy|0|||
148701614|NCT00537979|536383620|FG001|Overall Study|Lack of Efficacy|1|||
148701615|NCT00537979|536383619|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
148701616|NCT00537979|536383620|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
148701617|NCT00537979|536383619|FG000|Overall Study|Death|0|||
148701618|NCT00537979|536383620|FG001|Overall Study|Death|3|||
148701619|NCT00537979|536383619|FG000|Overall Study|Kidney transplant|0|||
148701620|NCT00537979|536383620|FG001|Overall Study|Kidney transplant|3|||
148701621|NCT00537979|536383619|FG000|Overall Study|Heart failure|0|||
148701622|NCT00537979|536383620|FG001|Overall Study|Heart failure|1|||
148701623|NCT00576056|536383621|FG000|Overall Study|Adverse Event|1|||
148701624|NCT00576056|536383621|FG000|Overall Study|Death|1|||
148701625|NCT00576056|536383621|FG000|Overall Study|Lack of Efficacy|1|||
148701626|NCT00576056|536383621|FG000|Overall Study|Withdrawal by Subject|2|||
148701627|NCT00576056|536383621|FG000|Overall Study|did not meet eligibility criteria|8|||
148701628|NCT00576056|536383621|FG000|Overall Study|Physician Decision|1|||
148701629|NCT00858845|536383622|FG000|Overall Study|Patient underwent heart transplant.|0|||
148701630|NCT00858845|536383623|FG001|Overall Study|Patient underwent heart transplant.|1|||
148701631|NCT03420300|536383629|FG000|Overall Study|Death|2|||
148701632|NCT05275205|536383637|FG000|Overall Study|Adverse Event|1|||
148701633|NCT05275205|536383638|FG001|Overall Study|Adverse Event|2|||
148701634|NCT05275205|536383637|FG000|Overall Study|Physician Decision|1|||
148701635|NCT05275205|536383638|FG001|Overall Study|Physician Decision|1|||
148701636|NCT05275205|536383637|FG000|Overall Study|Withdrawal by Subject|2|||
148701637|NCT05275205|536383638|FG001|Overall Study|Withdrawal by Subject|3|||
148701638|NCT05275205|536383637|FG000|Overall Study|Death|1|||
148701639|NCT05275205|536383638|FG001|Overall Study|Death|0|||
148701640|NCT05275205|536383637|FG000|Overall Study|Patient unable to attend visits|1|||
148701641|NCT05275205|536383638|FG001|Overall Study|Patient unable to attend visits|0|||
148701642|NCT03880266|536383642|FG000|Overall Study|Withdrawal by Subject|0|||
148701643|NCT03880266|536383643|FG001|Overall Study|Withdrawal by Subject|1|||
148701644|NCT03880266|536383644|FG002|Overall Study|Withdrawal by Subject|1|||
148701645|NCT03880266|536383645|FG003|Overall Study|Withdrawal by Subject|0|||
148701646|NCT03880266|536383646|FG004|Overall Study|Withdrawal by Subject|0|||
148701647|NCT03880266|536383647|FG005|Overall Study|Withdrawal by Subject|0|||
148701648|NCT03880266|536383648|FG006|Overall Study|Withdrawal by Subject|0|||
148701649|NCT03880266|536383649|FG007|Overall Study|Withdrawal by Subject|0|||
148701650|NCT01577381|536383653|FG000|Overall Study|Discontinued|2|||
148701651|NCT01577381|536383654|FG001|Overall Study|Discontinued|1|||
148701652|NCT01577381|536383655|FG002|Overall Study|Discontinued|2|||
148701653|NCT01577381|536383656|FG003|Overall Study|Discontinued|2|||
148701654|NCT01577381|536383653|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
148701655|NCT01577381|536383654|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
148701656|NCT01577381|536383655|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
148701657|NCT01577381|536383656|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
148701658|NCT01313780|536383657|FG000|Overall Study|Lack of Efficacy|4|||
148701659|NCT01313780|536383658|FG001|Overall Study|Lack of Efficacy|2|||
148701660|NCT01313780|536383657|FG000|Overall Study|Adverse Event|6|||
148701661|NCT01313780|536383658|FG001|Overall Study|Adverse Event|11|||
148701662|NCT01313780|536383657|FG000|Overall Study|Withdrawal by Subject|2|||
148701663|NCT01313780|536383658|FG001|Overall Study|Withdrawal by Subject|8|||
148701664|NCT01313780|536383657|FG000|Overall Study|Protocol Violation|10|||
148701665|NCT01313780|536383658|FG001|Overall Study|Protocol Violation|4|||
148701666|NCT01313780|536383657|FG000|Overall Study|missing data|3|||
148701667|NCT01313780|536383658|FG001|Overall Study|missing data|3|||
148701668|NCT00467896|536385463|FG000|Overall Study|Consent Withdrawal|18|||
148701669|NCT00467896|536385463|FG000|Overall Study|Adverse Event|7|||
148701670|NCT00467896|536385463|FG000|Overall Study|Serious Adverse Event|13|||
148701671|NCT00467896|536385463|FG000|Overall Study|Non-compliance|3|||
148701672|NCT00467896|536385463|FG000|Overall Study|Changed therapy|2|||
148701673|NCT00467896|536385463|FG000|Overall Study|Patient received transplant|2|||
148701674|NCT00467896|536385463|FG000|Overall Study|Patient had atrial septostomy|1|||
148701675|NCT00467896|536385463|FG000|Overall Study|Patient weaned off iloprost|1|||
148701676|NCT00467896|536385463|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
148701677|NCT00467896|536385463|FG000|Overall Study|Started intravenous prostacyclin|1|||
148701678|NCT00467896|536385463|FG000|Overall Study|Started inhaled Remodulin|1|||
148701679|NCT00467896|536385463|FG000|Overall Study|Patient had no improvement|1|||
148701680|NCT03772522|536385464|FG000|Pre-intervention|Withdrawal by Subject|3|||
148701681|NCT03772522|536385465|FG001|Pre-intervention|Withdrawal by Subject|4|||
148701682|NCT03772522|536385464|FG000|Intervention|Withdrawal by Subject|1|||
148701683|NCT03772522|536385465|FG001|Intervention|Withdrawal by Subject|0|||
148701684|NCT03772522|536385464|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
148701685|NCT03772522|536385465|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
148701686|NCT03818581|536385468|FG000|Overall Study|Adverse Event|1|||
148701687|NCT03818581|536385469|FG001|Overall Study|Adverse Event|0|||
148701688|NCT03818581|536385470|FG002|Overall Study|Adverse Event|0|||
148701689|NCT03818581|536385471|FG003|Overall Study|Adverse Event|0|||
148701690|NCT03818581|536385472|FG004|Overall Study|Adverse Event|0|||
148701691|NCT03818581|536385468|FG000|Overall Study|Covid-19|2|||
148701692|NCT03818581|536385469|FG001|Overall Study|Covid-19|0|||
148701693|NCT03818581|536385470|FG002|Overall Study|Covid-19|0|||
148701694|NCT03818581|536385471|FG003|Overall Study|Covid-19|0|||
148701695|NCT03818581|536385472|FG004|Overall Study|Covid-19|1|||
148701696|NCT03818581|536385468|FG000|Overall Study|Withdrawal by Subject|0|||
148701697|NCT03818581|536385469|FG001|Overall Study|Withdrawal by Subject|0|||
148701698|NCT03818581|536385470|FG002|Overall Study|Withdrawal by Subject|0|||
148701699|NCT03818581|536385471|FG003|Overall Study|Withdrawal by Subject|0|||
148701700|NCT03818581|536385472|FG004|Overall Study|Withdrawal by Subject|1|||
148701701|NCT03818581|536385468|FG000|Overall Study|No longer met study criteria|0|||
148701702|NCT03818581|536385469|FG001|Overall Study|No longer met study criteria|0|||
148701703|NCT03818581|536385470|FG002|Overall Study|No longer met study criteria|0|||
148701704|NCT03818581|536385471|FG003|Overall Study|No longer met study criteria|0|||
148701705|NCT03818581|536385472|FG004|Overall Study|No longer met study criteria|1|||
148701706|NCT02096211|536385475|FG000|Overall Study|Death|2|||
148701707|NCT02096211|536385475|FG000|Overall Study|Withdrawal by Subject|8|||
148701708|NCT02096211|536385475|FG000|Overall Study|Revision of implant|7|||
148701709|NCT02096211|536385475|FG000|Overall Study|Lost to Follow-up|43|||
148701710|NCT01439880|536385480|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
148701711|NCT01439880|536385481|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
148701712|NCT01439880|536385480|FG000|SOC-controlled Period (Year 1)|Death|2|||
148967574|NCT01524692|537366752|FG000|Overall Study|Withdrawal by Subject|3|||
148967575|NCT03190889|537366753|FG000|Overall Study|Lost to Follow-up|7|||
148967576|NCT03190889|537366754|FG001|Overall Study|Lost to Follow-up|7|||
148967577|NCT03190889|537366755|FG002|Overall Study|Lost to Follow-up|3|||
148701713|NCT01439880|536385481|FG001|SOC-controlled Period (Year 1)|Death|1|||
148967578|NCT03190889|537366753|FG000|Overall Study|Withdrawal by Subject|1|||
148967579|NCT03190889|537366754|FG001|Overall Study|Withdrawal by Subject|1|||
148701714|NCT01439880|536385480|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
148701715|NCT01439880|536385481|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
148701716|NCT01439880|536385480|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
148701717|NCT01439880|536385481|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
148701718|NCT01439880|536385480|FG000|SOC-controlled Period (Year 1)|Other|8|||
148701719|NCT01439880|536385481|FG001|SOC-controlled Period (Year 1)|Other|13|||
148701720|NCT01439880|536385480|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
148967580|NCT03190889|537366755|FG002|Overall Study|Withdrawal by Subject|2|||
148701721|NCT01439880|536385481|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
148701722|NCT01439880|536385480|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
148701723|NCT01439880|536385481|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
148701724|NCT01439880|536385480|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
148967581|NCT03190889|537366753|FG000|Overall Study|Did not complete protocol|4|||
148967582|NCT03190889|537366754|FG001|Overall Study|Did not complete protocol|9|||
148701725|NCT01439880|536385481|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
148701726|NCT01439880|536385480|FG000|All-IP Period (Years 2 to 5)|Death|3|||
148701727|NCT01439880|536385481|FG001|All-IP Period (Years 2 to 5)|Death|13|||
148701728|NCT01439880|536385480|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
148701729|NCT01439880|536385481|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
148701730|NCT01439880|536385480|FG000|All-IP Period (Years 2 to 5)|Other|14|||
148701731|NCT01439880|536385481|FG001|All-IP Period (Years 2 to 5)|Other|31|||
148701732|NCT01439880|536385480|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
148701733|NCT01439880|536385481|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
148701734|NCT00328926|536385482|FG000|Overall Study|Pregnancy|2|||
148701735|NCT00328926|536385483|FG001|Overall Study|Pregnancy|1|||
148701736|NCT00328926|536385484|FG002|Overall Study|Pregnancy|0|||
148701737|NCT00328926|536385482|FG000|Overall Study|Lost to Follow-up|0|||
148701738|NCT00328926|536385483|FG001|Overall Study|Lost to Follow-up|1|||
148701739|NCT00328926|536385484|FG002|Overall Study|Lost to Follow-up|0|||
148701740|NCT00328926|536385482|FG000|Overall Study|Death|0|||
148701741|NCT00328926|536385483|FG001|Overall Study|Death|0|||
148701742|NCT00328926|536385484|FG002|Overall Study|Death|1|||
148701743|NCT00328926|536385482|FG000|Overall Study|In vitro fertilization treatment|0|||
148701744|NCT00328926|536385483|FG001|Overall Study|In vitro fertilization treatment|0|||
148701745|NCT00328926|536385484|FG002|Overall Study|In vitro fertilization treatment|1|||
148701746|NCT00328926|536385482|FG000|Overall Study|Lack of ovarian response|0|||
148701747|NCT00328926|536385483|FG001|Overall Study|Lack of ovarian response|1|||
148701748|NCT00328926|536385484|FG002|Overall Study|Lack of ovarian response|0|||
148701749|NCT02269657|536385485|FG000|Overall Study|Protocol Violation|3|||
148701750|NCT02956460|536385486|FG000|Lens 1|Lost to Follow-up|1|||
148701751|NCT02956460|536385487|FG001|Lens 1|Lost to Follow-up|0|||
148701752|NCT02378935|536385488|FG000|Overall Study|Lack of Efficacy|10|||
148701753|NCT02378935|536385489|FG001|Overall Study|Lack of Efficacy|0|||
148701754|NCT02378935|536385490|FG002|Overall Study|Lack of Efficacy|2|||
148701755|NCT02378935|536385491|FG003|Overall Study|Lack of Efficacy|6|||
148701756|NCT02378935|536385492|FG004|Overall Study|Lack of Efficacy|0|||
148701757|NCT02378935|536385493|FG005|Overall Study|Lack of Efficacy|0|||
148701758|NCT02378935|536385494|FG006|Overall Study|Lack of Efficacy|0|||
148701759|NCT02378935|536385488|FG000|Overall Study|Death|0|||
148701760|NCT02378935|536385489|FG001|Overall Study|Death|0|||
148701761|NCT02378935|536385490|FG002|Overall Study|Death|1|||
148701762|NCT02378935|536385491|FG003|Overall Study|Death|0|||
148701763|NCT02378935|536385492|FG004|Overall Study|Death|0|||
148701764|NCT02378935|536385493|FG005|Overall Study|Death|0|||
148701765|NCT02378935|536385494|FG006|Overall Study|Death|0|||
148701766|NCT00272779|536385495|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
148701767|NCT00272779|536385496|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
148701768|NCT00272779|536385495|FG000|Baseline Through Week 48|Death before Week 48|4|||
148701769|NCT00272779|536385496|FG001|Baseline Through Week 48|Death before Week 48|4|||
148701770|NCT00272779|536385495|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
148701771|NCT00272779|536385496|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
148701772|NCT00272779|536385495|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
148701773|NCT00272779|536385496|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
148701774|NCT00272779|536385495|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
148701775|NCT00272779|536385496|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
148701776|NCT00272779|536385495|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
148701777|NCT00272779|536385496|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
148701778|NCT00272779|536385495|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
148967583|NCT03190889|537366755|FG002|Overall Study|Did not complete protocol|0|||
148967584|NCT03190889|537366753|FG000|Overall Study|COVID-19|1|||
148967585|NCT03190889|537366754|FG001|Overall Study|COVID-19|0|||
148967586|NCT03190889|537366755|FG002|Overall Study|COVID-19|2|||
148967587|NCT01709695|537366756|FG000|Overall Study|Withdrawal by Subject|1|||
148967588|NCT01709695|537366757|FG001|Overall Study|Withdrawal by Subject|1|||
148967589|NCT04007523|537366758|FG000|Overall Study|Withdrawal by Subject|0|||
148701779|NCT00272779|536385496|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
148701780|NCT00272779|536385495|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
148701781|NCT00272779|536385496|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
148701782|NCT00272779|536385495|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
148701783|NCT00272779|536385496|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
148701784|NCT00272779|536385495|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
148701785|NCT00272779|536385496|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
148701786|NCT00272779|536385495|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
148701787|NCT00272779|536385496|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
148701788|NCT00272779|536385495|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
148701789|NCT00272779|536385496|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
148701790|NCT00272779|536385495|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
148701791|NCT00272779|536385496|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
148701792|NCT00272779|536385495|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
148701793|NCT00272779|536385496|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
148701794|NCT00272779|536385495|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
148701795|NCT00272779|536385496|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
148701796|NCT00272779|536385495|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
148701797|NCT00272779|536385496|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
148701798|NCT00272779|536385495|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
148701799|NCT00272779|536385496|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
148701800|NCT00272779|536385495|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
148701801|NCT00272779|536385496|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
148701802|NCT00272779|536385495|FG000|Baseline Through Week 48|Continuing treatment|385|||
148701803|NCT00272779|536385496|FG001|Baseline Through Week 48|Continuing treatment|368|||
148701804|NCT00272779|536385495|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
148701805|NCT00272779|536385496|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
148701806|NCT00272779|536385495|FG000|Baseline Through Week 48|Never treated|2|||
148701807|NCT00272779|536385496|FG001|Baseline Through Week 48|Never treated|3|||
148701808|NCT00272779|536385495|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
148701809|NCT00272779|536385496|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
148701810|NCT00272779|536385495|FG000|Baseline Through Week 96|Death before Week 96|6|||
148701811|NCT00272779|536385496|FG001|Baseline Through Week 96|Death before Week 96|5|||
148701812|NCT00272779|536385495|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
148701813|NCT00272779|536385496|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
148701814|NCT00272779|536385495|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
148701815|NCT00272779|536385496|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
148701816|NCT00272779|536385495|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
148701817|NCT00272779|536385496|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
148701818|NCT00272779|536385495|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
148701819|NCT00272779|536385496|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
148701820|NCT00272779|536385495|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
148701821|NCT00272779|536385496|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
148701822|NCT00272779|536385495|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
148701823|NCT00272779|536385496|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
148701824|NCT00272779|536385495|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
148701825|NCT00272779|536385496|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
148701826|NCT00272779|536385495|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
148701827|NCT00272779|536385496|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
148701828|NCT00272779|536385495|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
148701829|NCT00272779|536385496|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
148701830|NCT00272779|536385495|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
148701831|NCT00272779|536385496|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
148701832|NCT00272779|536385495|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
148701833|NCT00272779|536385496|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
148701834|NCT00272779|536385495|FG000|Baseline Through Week 96|Never treated|2|||
148701835|NCT00272779|536385496|FG001|Baseline Through Week 96|Never treated|3|||
148701836|NCT00272779|536385495|FG000|Baseline Through Week 96|Continuing on treatment|61|||
148701837|NCT00272779|536385496|FG001|Baseline Through Week 96|Continuing on treatment|38|||
148701838|NCT02440711|536385497|FG000|Second Intervention|Lost to Follow-up|1|||
148701839|NCT02440711|536385498|FG001|Second Intervention|Lost to Follow-up|0|||
148701840|NCT04129346|536385504|FG000|Overall Study|Death|1|||
148701841|NCT04129346|536385505|FG001|Overall Study|Death|0|||
148701842|NCT03935880|536385507|FG000|Overall Study|Lost to Follow-up|0|||
148701843|NCT03935880|536385508|FG001|Overall Study|Lost to Follow-up|1|||
148701844|NCT02476994|536385509|FG000|Overall Study|Based on feedback from FDA|1|||
148701845|NCT02476994|536385510|FG001|Overall Study|Based on feedback from FDA|0|||
148701846|NCT02563561|536385511|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
148701847|NCT02563561|536385512|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
148701848|NCT02563561|536385513|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
148701849|NCT02563561|536385511|FG000|Overall Study|Withdrew of Consent|1|||
148701850|NCT02563561|536385512|FG001|Overall Study|Withdrew of Consent|1|||
148701851|NCT02563561|536385513|FG002|Overall Study|Withdrew of Consent|2|||
148701852|NCT02563561|536385511|FG000|Overall Study|Lost to Follow-up|1|||
148701853|NCT02563561|536385512|FG001|Overall Study|Lost to Follow-up|1|||
148701854|NCT02563561|536385513|FG002|Overall Study|Lost to Follow-up|0|||
148701855|NCT02563561|536385511|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
148815031|NCT02872714|536798093|FG001|Overall Study|Progressive Disease|2|||
148701856|NCT02563561|536385512|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
148701857|NCT02563561|536385513|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
148701858|NCT02563561|536385511|FG000|Overall Study|Investigator Decision|3|||
148701859|NCT02563561|536385512|FG001|Overall Study|Investigator Decision|4|||
148701860|NCT02563561|536385513|FG002|Overall Study|Investigator Decision|2|||
148701861|NCT02563561|536385511|FG000|Overall Study|Sponsor Decision|5|||
148701862|NCT02563561|536385512|FG001|Overall Study|Sponsor Decision|2|||
148701863|NCT02563561|536385513|FG002|Overall Study|Sponsor Decision|4|||
148701864|NCT02563561|536385511|FG000|Overall Study|Other|1|||
148701865|NCT02563561|536385512|FG001|Overall Study|Other|5|||
148701866|NCT02563561|536385513|FG002|Overall Study|Other|2|||
148701867|NCT03154047|536385514|FG000|Overall Study|Death|1|||
148701868|NCT03154047|536385514|FG000|Overall Study|Study terminated by sponsor|76|||
148701869|NCT03154047|536385514|FG000|Overall Study|Withdrawal by Subject|3|||
148701870|NCT00365365|536385515|FG000|Overall Study|Randomized but not treated|0|||
148701871|NCT00365365|536385516|FG001|Overall Study|Randomized but not treated|2|||
148701872|NCT00365365|536385517|FG002|Overall Study|Randomized but not treated|0|||
148701873|NCT00365365|536385515|FG000|Overall Study|Poor compliance to protocol|0|||
148701874|NCT00365365|536385516|FG001|Overall Study|Poor compliance to protocol|1|||
148701875|NCT00365365|536385517|FG002|Overall Study|Poor compliance to protocol|0|||
148701876|NCT00365365|536385515|FG000|Overall Study|Lost to Follow-up|3|||
148701877|NCT00365365|536385516|FG001|Overall Study|Lost to Follow-up|3|||
148701878|NCT00365365|536385517|FG002|Overall Study|Lost to Follow-up|3|||
148701879|NCT00365365|536385515|FG000|Overall Study|Death|1|||
148701880|NCT00365365|536385516|FG001|Overall Study|Death|3|||
148701881|NCT00365365|536385517|FG002|Overall Study|Death|0|||
148701882|NCT00365365|536385515|FG000|Overall Study|Subject's request|11|||
148701883|NCT00365365|536385516|FG001|Overall Study|Subject's request|13|||
148701884|NCT00365365|536385517|FG002|Overall Study|Subject's request|1|||
148701885|NCT00365365|536385515|FG000|Overall Study|Disease progression/relapse|9|||
148701886|NCT00365365|536385516|FG001|Overall Study|Disease progression/relapse|6|||
148701887|NCT00365365|536385517|FG002|Overall Study|Disease progression/relapse|7|||
148701888|NCT00365365|536385515|FG000|Overall Study|Adverse Event|6|||
148701889|NCT00365365|536385516|FG001|Overall Study|Adverse Event|6|||
148701890|NCT00365365|536385517|FG002|Overall Study|Adverse Event|3|||
148701891|NCT00365365|536385515|FG000|Overall Study|Moved|2|||
148701892|NCT00365365|536385516|FG001|Overall Study|Moved|0|||
148701893|NCT00365365|536385517|FG002|Overall Study|Moved|0|||
148701894|NCT00365365|536385515|FG000|Overall Study|New cancer|1|||
148701895|NCT00365365|536385516|FG001|Overall Study|New cancer|0|||
148701896|NCT00365365|536385517|FG002|Overall Study|New cancer|0|||
148701897|NCT00365365|536385515|FG000|Overall Study|Withdrew consent|1|||
148701898|NCT00365365|536385516|FG001|Overall Study|Withdrew consent|1|||
148701899|NCT00365365|536385517|FG002|Overall Study|Withdrew consent|0|||
148701900|NCT00365365|536385515|FG000|Overall Study|Second malignancy|0|||
148701901|NCT00365365|536385516|FG001|Overall Study|Second malignancy|1|||
148701902|NCT00365365|536385517|FG002|Overall Study|Second malignancy|0|||
148701903|NCT00365365|536385515|FG000|Overall Study|Patient/physician decision|0|||
148701904|NCT00365365|536385516|FG001|Overall Study|Patient/physician decision|0|||
148701905|NCT00365365|536385517|FG002|Overall Study|Patient/physician decision|1|||
148701906|NCT00418561|536385518|FG000|Overall Study|Participant's (guardian's) decision|0|||
148701907|NCT00418561|536385519|FG001|Overall Study|Participant's (guardian's) decision|1|||
148701908|NCT00418561|536385520|FG002|Overall Study|Participant's (guardian's) decision|0|||
148701909|NCT01796171|536385521|FG000|Enrolled|Death|0|||
148701910|NCT01796171|536385522|FG001|Enrolled|Death|0|||
148701911|NCT01796171|536385523|FG002|Enrolled|Death|0|||
148701912|NCT01796171|536385524|FG003|Enrolled|Death|0|||
148701913|NCT01796171|536385525|FG004|Enrolled|Death|0|||
148701914|NCT01796171|536385526|FG005|Enrolled|Death|0|||
148701915|NCT01796171|536385527|FG006|Enrolled|Death|0|||
148701916|NCT01796171|536385528|FG007|Enrolled|Death|0|||
148815032|NCT02872714|536798094|FG002|Overall Study|Progressive Disease|0|||
148967590|NCT04007523|537366759|FG001|Overall Study|Withdrawal by Subject|1|||
148701917|NCT01796171|536385529|FG008|Enrolled|Death|0|||
148701918|NCT01796171|536385530|FG009|Enrolled|Death|0|||
148701919|NCT01796171|536385531|FG010|Enrolled|Death|0|||
148701920|NCT01796171|536385532|FG011|Enrolled|Death|0|||
148701921|NCT01796171|536385533|FG012|Enrolled|Death|0|||
148701922|NCT01796171|536385534|FG013|Enrolled|Death|0|||
148701923|NCT01796171|536385535|FG014|Enrolled|Death|1|||
148701924|NCT01796171|536385521|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
148701925|NCT01796171|536385522|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
148701926|NCT01796171|536385523|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
148701927|NCT01796171|536385524|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
148701928|NCT01796171|536385525|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
148701929|NCT01796171|536385526|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
148701930|NCT01796171|536385527|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
148701931|NCT01796171|536385528|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
148701932|NCT01796171|536385529|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
148701933|NCT01796171|536385530|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
148701934|NCT01796171|536385531|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
148701935|NCT01796171|536385532|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
148701936|NCT01796171|536385533|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
148701937|NCT01796171|536385534|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
148701938|NCT01796171|536385535|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
148701939|NCT01796171|536385521|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701940|NCT01796171|536385522|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701941|NCT01796171|536385523|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701942|NCT01796171|536385524|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701943|NCT01796171|536385525|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701944|NCT01796171|536385526|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701945|NCT01796171|536385527|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701946|NCT01796171|536385528|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701947|NCT01796171|536385529|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701948|NCT01796171|536385530|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701949|NCT01796171|536385531|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701950|NCT01796171|536385532|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701951|NCT01796171|536385533|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701952|NCT01796171|536385534|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
148701953|NCT01796171|536385535|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
148701954|NCT01796171|536385521|FG000|Treatment Period With Betalutin|Progressive disease|0|||
148701955|NCT01796171|536385522|FG001|Treatment Period With Betalutin|Progressive disease|1|||
148701956|NCT01796171|536385523|FG002|Treatment Period With Betalutin|Progressive disease|0|||
148701957|NCT01796171|536385524|FG003|Treatment Period With Betalutin|Progressive disease|0|||
148701958|NCT01796171|536385525|FG004|Treatment Period With Betalutin|Progressive disease|0|||
148701959|NCT01796171|536385526|FG005|Treatment Period With Betalutin|Progressive disease|0|||
148701960|NCT01796171|536385527|FG006|Treatment Period With Betalutin|Progressive disease|0|||
148701961|NCT01796171|536385528|FG007|Treatment Period With Betalutin|Progressive disease|0|||
148701962|NCT01796171|536385529|FG008|Treatment Period With Betalutin|Progressive disease|0|||
148701963|NCT01796171|536385530|FG009|Treatment Period With Betalutin|Progressive disease|0|||
148701964|NCT01796171|536385531|FG010|Treatment Period With Betalutin|Progressive disease|0|||
148701965|NCT01796171|536385532|FG011|Treatment Period With Betalutin|Progressive disease|0|||
148701966|NCT01796171|536385533|FG012|Treatment Period With Betalutin|Progressive disease|0|||
148815033|NCT02872714|536798095|FG003|Overall Study|Progressive Disease|0|||
148701967|NCT01796171|536385534|FG013|Treatment Period With Betalutin|Progressive disease|0|||
148701968|NCT01796171|536385535|FG014|Treatment Period With Betalutin|Progressive disease|0|||
148701969|NCT01796171|536385521|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701970|NCT01796171|536385522|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701971|NCT01796171|536385523|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701972|NCT01796171|536385524|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701973|NCT01796171|536385525|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701974|NCT01796171|536385526|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701975|NCT01796171|536385527|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701976|NCT01796171|536385528|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701977|NCT01796171|536385529|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
148701978|NCT01796171|536385530|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701979|NCT01796171|536385531|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
148701980|NCT01796171|536385532|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
148701981|NCT01796171|536385533|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701982|NCT01796171|536385534|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701983|NCT01796171|536385535|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
148701984|NCT01796171|536385521|FG000|Treatment Period With Betalutin|Physician Decision|0|||
148701985|NCT01796171|536385522|FG001|Treatment Period With Betalutin|Physician Decision|0|||
148701986|NCT01796171|536385523|FG002|Treatment Period With Betalutin|Physician Decision|0|||
148701987|NCT01796171|536385524|FG003|Treatment Period With Betalutin|Physician Decision|0|||
148701988|NCT01796171|536385525|FG004|Treatment Period With Betalutin|Physician Decision|0|||
148701989|NCT01796171|536385526|FG005|Treatment Period With Betalutin|Physician Decision|0|||
148701990|NCT01796171|536385527|FG006|Treatment Period With Betalutin|Physician Decision|0|||
148701991|NCT01796171|536385528|FG007|Treatment Period With Betalutin|Physician Decision|0|||
148701992|NCT01796171|536385529|FG008|Treatment Period With Betalutin|Physician Decision|0|||
148701993|NCT01796171|536385530|FG009|Treatment Period With Betalutin|Physician Decision|0|||
148701994|NCT01796171|536385531|FG010|Treatment Period With Betalutin|Physician Decision|5|||
148701995|NCT01796171|536385532|FG011|Treatment Period With Betalutin|Physician Decision|1|||
148701996|NCT01796171|536385533|FG012|Treatment Period With Betalutin|Physician Decision|1|||
148701997|NCT01796171|536385534|FG013|Treatment Period With Betalutin|Physician Decision|0|||
148701998|NCT01796171|536385535|FG014|Treatment Period With Betalutin|Physician Decision|0|||
148967591|NCT04007523|537366760|FG002|Overall Study|Withdrawal by Subject|1|||
148967592|NCT04007523|537366761|FG003|Overall Study|Withdrawal by Subject|0|||
148967593|NCT04007523|537366758|FG000|Overall Study|ICU Transfer|0|||
148967594|NCT04007523|537366759|FG001|Overall Study|ICU Transfer|1|||
148967595|NCT04007523|537366760|FG002|Overall Study|ICU Transfer|0|||
148967596|NCT04007523|537366761|FG003|Overall Study|ICU Transfer|0|||
148967597|NCT04007523|537366758|FG000|Overall Study|COVID hospital closure|0|||
148967598|NCT04007523|537366759|FG001|Overall Study|COVID hospital closure|0|||
148701999|NCT01796171|536385521|FG000|Treatment Period With Betalutin|Death|0|||
148702000|NCT01796171|536385522|FG001|Treatment Period With Betalutin|Death|0|||
148702001|NCT01796171|536385523|FG002|Treatment Period With Betalutin|Death|0|||
148702002|NCT01796171|536385524|FG003|Treatment Period With Betalutin|Death|0|||
148702003|NCT01796171|536385525|FG004|Treatment Period With Betalutin|Death|0|||
148702004|NCT01796171|536385526|FG005|Treatment Period With Betalutin|Death|0|||
148702005|NCT01796171|536385527|FG006|Treatment Period With Betalutin|Death|0|||
148702006|NCT01796171|536385528|FG007|Treatment Period With Betalutin|Death|0|||
148702007|NCT01796171|536385529|FG008|Treatment Period With Betalutin|Death|0|||
148702008|NCT01796171|536385530|FG009|Treatment Period With Betalutin|Death|0|||
148702009|NCT01796171|536385531|FG010|Treatment Period With Betalutin|Death|2|||
148702010|NCT01796171|536385532|FG011|Treatment Period With Betalutin|Death|0|||
148702011|NCT01796171|536385533|FG012|Treatment Period With Betalutin|Death|0|||
148702012|NCT01796171|536385534|FG013|Treatment Period With Betalutin|Death|0|||
148702013|NCT01796171|536385535|FG014|Treatment Period With Betalutin|Death|0|||
148702014|NCT01796171|536385521|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
148702015|NCT01796171|536385522|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
148702016|NCT01796171|536385523|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
148702017|NCT01796171|536385524|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
148702018|NCT01796171|536385525|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
148702019|NCT01796171|536385526|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
148702020|NCT01796171|536385527|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
148702021|NCT01796171|536385528|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
148702022|NCT01796171|536385529|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
148702023|NCT01796171|536385530|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
148702024|NCT01796171|536385531|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
148702025|NCT01796171|536385532|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
148702026|NCT01796171|536385533|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
148702027|NCT01796171|536385534|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
148702028|NCT01796171|536385535|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
148702029|NCT01796171|536385521|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702030|NCT01796171|536385522|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702031|NCT01796171|536385523|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702032|NCT01796171|536385524|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702033|NCT01796171|536385525|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702034|NCT01796171|536385526|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702035|NCT01796171|536385527|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702036|NCT01796171|536385528|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702037|NCT01796171|536385529|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702038|NCT01796171|536385530|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702039|NCT01796171|536385531|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
148702040|NCT01796171|536385532|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
148702041|NCT01796171|536385533|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702042|NCT01796171|536385534|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702043|NCT01796171|536385535|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
148702044|NCT01796171|536385521|FG000|Follow-up Period|Start of further anticancer therapy|4|||
148702045|NCT01796171|536385522|FG001|Follow-up Period|Start of further anticancer therapy|25|||
148702046|NCT01796171|536385523|FG002|Follow-up Period|Start of further anticancer therapy|2|||
148702047|NCT01796171|536385524|FG003|Follow-up Period|Start of further anticancer therapy|1|||
148702048|NCT01796171|536385525|FG004|Follow-up Period|Start of further anticancer therapy|2|||
148702049|NCT01796171|536385526|FG005|Follow-up Period|Start of further anticancer therapy|2|||
148702050|NCT01796171|536385527|FG006|Follow-up Period|Start of further anticancer therapy|1|||
148702051|NCT01796171|536385528|FG007|Follow-up Period|Start of further anticancer therapy|15|||
148702052|NCT01796171|536385529|FG008|Follow-up Period|Start of further anticancer therapy|2|||
148702053|NCT01796171|536385530|FG009|Follow-up Period|Start of further anticancer therapy|0|||
148702054|NCT01796171|536385531|FG010|Follow-up Period|Start of further anticancer therapy|0|||
148702055|NCT01796171|536385532|FG011|Follow-up Period|Start of further anticancer therapy|0|||
148702056|NCT01796171|536385533|FG012|Follow-up Period|Start of further anticancer therapy|0|||
148702057|NCT01796171|536385534|FG013|Follow-up Period|Start of further anticancer therapy|0|||
148815034|NCT02872714|536798096|FG004|Overall Study|Progressive Disease|0|||
148967599|NCT04007523|537366760|FG002|Overall Study|COVID hospital closure|1|||
148967600|NCT04007523|537366761|FG003|Overall Study|COVID hospital closure|2|||
148702058|NCT01796171|536385535|FG014|Follow-up Period|Start of further anticancer therapy|0|||
148702059|NCT01796171|536385521|FG000|Follow-up Period|Progressive disease|0|||
148702060|NCT01796171|536385522|FG001|Follow-up Period|Progressive disease|1|||
148702061|NCT01796171|536385523|FG002|Follow-up Period|Progressive disease|0|||
148702062|NCT01796171|536385524|FG003|Follow-up Period|Progressive disease|0|||
148702063|NCT01796171|536385525|FG004|Follow-up Period|Progressive disease|0|||
148702064|NCT01796171|536385526|FG005|Follow-up Period|Progressive disease|0|||
148702065|NCT01796171|536385527|FG006|Follow-up Period|Progressive disease|0|||
148702066|NCT01796171|536385528|FG007|Follow-up Period|Progressive disease|3|||
148702067|NCT01796171|536385529|FG008|Follow-up Period|Progressive disease|0|||
148702068|NCT01796171|536385530|FG009|Follow-up Period|Progressive disease|0|||
148702069|NCT01796171|536385531|FG010|Follow-up Period|Progressive disease|0|||
148702070|NCT01796171|536385532|FG011|Follow-up Period|Progressive disease|0|||
148702071|NCT01796171|536385533|FG012|Follow-up Period|Progressive disease|0|||
148702072|NCT01796171|536385534|FG013|Follow-up Period|Progressive disease|0|||
148702073|NCT01796171|536385535|FG014|Follow-up Period|Progressive disease|0|||
148702074|NCT01796171|536385521|FG000|Follow-up Period|Physician Decision|0|||
148702075|NCT01796171|536385522|FG001|Follow-up Period|Physician Decision|2|||
148702076|NCT01796171|536385523|FG002|Follow-up Period|Physician Decision|0|||
148702077|NCT01796171|536385524|FG003|Follow-up Period|Physician Decision|0|||
148702078|NCT01796171|536385525|FG004|Follow-up Period|Physician Decision|0|||
148702079|NCT01796171|536385526|FG005|Follow-up Period|Physician Decision|0|||
148702080|NCT01796171|536385527|FG006|Follow-up Period|Physician Decision|0|||
148702081|NCT01796171|536385528|FG007|Follow-up Period|Physician Decision|0|||
148967601|NCT04007523|537366758|FG000|Overall Study|Surgery cancelled|0|||
148967602|NCT04007523|537366759|FG001|Overall Study|Surgery cancelled|0|||
148967603|NCT04007523|537366760|FG002|Overall Study|Surgery cancelled|1|||
148702082|NCT01796171|536385529|FG008|Follow-up Period|Physician Decision|0|||
148702083|NCT01796171|536385530|FG009|Follow-up Period|Physician Decision|0|||
148702084|NCT01796171|536385531|FG010|Follow-up Period|Physician Decision|5|||
148702085|NCT01796171|536385532|FG011|Follow-up Period|Physician Decision|0|||
148702086|NCT01796171|536385533|FG012|Follow-up Period|Physician Decision|0|||
148702087|NCT01796171|536385534|FG013|Follow-up Period|Physician Decision|0|||
148702088|NCT01796171|536385535|FG014|Follow-up Period|Physician Decision|0|||
148702089|NCT01796171|536385521|FG000|Follow-up Period|Withdrawal by Subject|0|||
148702090|NCT01796171|536385522|FG001|Follow-up Period|Withdrawal by Subject|1|||
148702091|NCT01796171|536385523|FG002|Follow-up Period|Withdrawal by Subject|0|||
148702092|NCT01796171|536385524|FG003|Follow-up Period|Withdrawal by Subject|0|||
148702093|NCT01796171|536385525|FG004|Follow-up Period|Withdrawal by Subject|0|||
148702094|NCT01796171|536385526|FG005|Follow-up Period|Withdrawal by Subject|1|||
148702095|NCT01796171|536385527|FG006|Follow-up Period|Withdrawal by Subject|0|||
148702096|NCT01796171|536385528|FG007|Follow-up Period|Withdrawal by Subject|0|||
148702097|NCT01796171|536385529|FG008|Follow-up Period|Withdrawal by Subject|0|||
148702098|NCT01796171|536385530|FG009|Follow-up Period|Withdrawal by Subject|0|||
148702099|NCT01796171|536385531|FG010|Follow-up Period|Withdrawal by Subject|3|||
148702100|NCT01796171|536385532|FG011|Follow-up Period|Withdrawal by Subject|1|||
148702101|NCT01796171|536385533|FG012|Follow-up Period|Withdrawal by Subject|0|||
148702102|NCT01796171|536385534|FG013|Follow-up Period|Withdrawal by Subject|0|||
148702103|NCT01796171|536385535|FG014|Follow-up Period|Withdrawal by Subject|0|||
148702104|NCT01796171|536385521|FG000|Follow-up Period|Death|0|||
148702105|NCT01796171|536385522|FG001|Follow-up Period|Death|0|||
148702106|NCT01796171|536385523|FG002|Follow-up Period|Death|0|||
148702107|NCT01796171|536385524|FG003|Follow-up Period|Death|0|||
148702108|NCT01796171|536385525|FG004|Follow-up Period|Death|0|||
148702109|NCT01796171|536385526|FG005|Follow-up Period|Death|0|||
148702110|NCT01796171|536385527|FG006|Follow-up Period|Death|1|||
148702111|NCT01796171|536385528|FG007|Follow-up Period|Death|0|||
148702112|NCT01796171|536385529|FG008|Follow-up Period|Death|0|||
148967604|NCT04007523|537366761|FG003|Overall Study|Surgery cancelled|1|||
148702113|NCT01796171|536385530|FG009|Follow-up Period|Death|0|||
148702114|NCT01796171|536385531|FG010|Follow-up Period|Death|17|||
148702115|NCT01796171|536385532|FG011|Follow-up Period|Death|9|||
148702116|NCT01796171|536385533|FG012|Follow-up Period|Death|1|||
148702117|NCT01796171|536385534|FG013|Follow-up Period|Death|0|||
148702118|NCT01796171|536385535|FG014|Follow-up Period|Death|0|||
148702119|NCT01796171|536385521|FG000|Follow-up Period|Patient transferred to other hospital|0|||
148702120|NCT01796171|536385522|FG001|Follow-up Period|Patient transferred to other hospital|1|||
148702121|NCT01796171|536385523|FG002|Follow-up Period|Patient transferred to other hospital|0|||
148702122|NCT01796171|536385524|FG003|Follow-up Period|Patient transferred to other hospital|0|||
148702123|NCT01796171|536385525|FG004|Follow-up Period|Patient transferred to other hospital|0|||
148702124|NCT01796171|536385526|FG005|Follow-up Period|Patient transferred to other hospital|0|||
148702125|NCT01796171|536385527|FG006|Follow-up Period|Patient transferred to other hospital|0|||
148702126|NCT01796171|536385528|FG007|Follow-up Period|Patient transferred to other hospital|0|||
148967605|NCT02136576|537366763|FG000|Overall Study|Lost to Follow-up|2|||
148702127|NCT01796171|536385529|FG008|Follow-up Period|Patient transferred to other hospital|0|||
148967606|NCT02136576|537366764|FG001|Overall Study|Lost to Follow-up|0|||
148702128|NCT01796171|536385530|FG009|Follow-up Period|Patient transferred to other hospital|0|||
148702129|NCT01796171|536385531|FG010|Follow-up Period|Patient transferred to other hospital|0|||
148702130|NCT01796171|536385532|FG011|Follow-up Period|Patient transferred to other hospital|0|||
148702131|NCT01796171|536385533|FG012|Follow-up Period|Patient transferred to other hospital|0|||
148702132|NCT01796171|536385534|FG013|Follow-up Period|Patient transferred to other hospital|0|||
148702133|NCT01796171|536385535|FG014|Follow-up Period|Patient transferred to other hospital|0|||
148702134|NCT01796171|536385521|FG000|Follow-up Period|Sponsor Decision|0|||
148702135|NCT01796171|536385522|FG001|Follow-up Period|Sponsor Decision|0|||
148702136|NCT01796171|536385523|FG002|Follow-up Period|Sponsor Decision|0|||
148702137|NCT01796171|536385524|FG003|Follow-up Period|Sponsor Decision|0|||
148702138|NCT01796171|536385525|FG004|Follow-up Period|Sponsor Decision|0|||
148702139|NCT01796171|536385526|FG005|Follow-up Period|Sponsor Decision|0|||
148702140|NCT01796171|536385527|FG006|Follow-up Period|Sponsor Decision|0|||
148702141|NCT01796171|536385528|FG007|Follow-up Period|Sponsor Decision|0|||
148702142|NCT01796171|536385529|FG008|Follow-up Period|Sponsor Decision|0|||
148702143|NCT01796171|536385530|FG009|Follow-up Period|Sponsor Decision|0|||
148702144|NCT01796171|536385531|FG010|Follow-up Period|Sponsor Decision|40|||
148702145|NCT01796171|536385532|FG011|Follow-up Period|Sponsor Decision|15|||
148702146|NCT01796171|536385533|FG012|Follow-up Period|Sponsor Decision|7|||
148702147|NCT01796171|536385534|FG013|Follow-up Period|Sponsor Decision|0|||
148702148|NCT01796171|536385535|FG014|Follow-up Period|Sponsor Decision|0|||
148702149|NCT01083693|536385538|FG000|Overall Study|Adverse Event|1|||
148702150|NCT01083693|536385539|FG001|Overall Study|Adverse Event|1|||
148702151|NCT01083693|536385540|FG002|Overall Study|Adverse Event|0|||
148702152|NCT01083693|536385538|FG000|Overall Study|Lost to Follow-up|2|||
148702153|NCT01083693|536385539|FG001|Overall Study|Lost to Follow-up|0|||
148702154|NCT01083693|536385540|FG002|Overall Study|Lost to Follow-up|2|||
148702155|NCT01083693|536385538|FG000|Overall Study|Lack of effectiveness|13|||
148702156|NCT01083693|536385539|FG001|Overall Study|Lack of effectiveness|2|||
148702157|NCT01083693|536385540|FG002|Overall Study|Lack of effectiveness|2|||
148702158|NCT01083693|536385538|FG000|Overall Study|Patient Moved|0|||
148702159|NCT01083693|536385539|FG001|Overall Study|Patient Moved|1|||
148702160|NCT01083693|536385540|FG002|Overall Study|Patient Moved|0|||
148702161|NCT01083693|536385538|FG000|Overall Study|Complete remission|0|||
148702162|NCT01083693|536385539|FG001|Overall Study|Complete remission|1|||
148702163|NCT01083693|536385540|FG002|Overall Study|Complete remission|0|||
148702164|NCT01083693|536385538|FG000|Overall Study|Other medical condition/surgery|1|||
148702165|NCT01083693|536385539|FG001|Overall Study|Other medical condition/surgery|1|||
148702166|NCT01083693|536385540|FG002|Overall Study|Other medical condition/surgery|0|||
148967607|NCT02136576|537366765|FG002|Overall Study|Lost to Follow-up|0|||
148967608|NCT02197806|537366767|FG000|Overall Study|Adverse Event|0|||
148967609|NCT02197806|537366768|FG001|Overall Study|Adverse Event|1|||
148967610|NCT02197806|537366769|FG002|Overall Study|Adverse Event|0|||
148967611|NCT02197806|537366770|FG003|Overall Study|Adverse Event|1|||
148967612|NCT00537381|537366771|FG000|Overall Study|Adverse Event|13|||
148967613|NCT00537381|537366772|FG001|Overall Study|Adverse Event|9|||
148967614|NCT00537381|537366771|FG000|Overall Study|Death|3|||
149025079|NCT04170023|537568004|FG000|LTE Period|Withdrawal by Subject|1|||
148702167|NCT01083693|536385538|FG000|Overall Study|Withdrawal by Subject|3|||
148702168|NCT01083693|536385539|FG001|Overall Study|Withdrawal by Subject|0|||
148702169|NCT01083693|536385540|FG002|Overall Study|Withdrawal by Subject|2|||
148702170|NCT01083693|536385538|FG000|Overall Study|Reason unknown|0|||
148702171|NCT01083693|536385539|FG001|Overall Study|Reason unknown|0|||
148702172|NCT01083693|536385540|FG002|Overall Study|Reason unknown|1|||
148702173|NCT04567186|536385543|FG000|Period 1|COVID-19 related|1|||
148967615|NCT00537381|537366772|FG001|Overall Study|Death|3|||
148702174|NCT04567186|536385544|FG001|Period 1|COVID-19 related|0|||
148702175|NCT04567186|536385543|FG000|Period 1|Protocol Violation|0|||
148702176|NCT04567186|536385544|FG001|Period 1|Protocol Violation|1|||
148702177|NCT04567186|536385543|FG000|Period 1|Adverse Event|0|||
148702178|NCT04567186|536385544|FG001|Period 1|Adverse Event|2|||
148702179|NCT04567186|536385543|FG000|Period 2|COVID-19 Related|0|||
148702180|NCT04567186|536385544|FG001|Period 2|COVID-19 Related|1|||
148702181|NCT04567186|536385543|FG000|Period 2|Protocol Violation|0|||
148702182|NCT04567186|536385544|FG001|Period 2|Protocol Violation|1|||
148702183|NCT04567186|536385543|FG000|Period 2|Lost to Follow-up|0|||
148702184|NCT04567186|536385544|FG001|Period 2|Lost to Follow-up|1|||
148702185|NCT04567186|536385543|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
148702186|NCT04567186|536385544|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
148702187|NCT04274686|536385547|FG000|Overall Study|Physician Decision|1|||
148702188|NCT04274686|536385548|FG001|Overall Study|Physician Decision|0|||
148702189|NCT00376623|536385549|FG000|Overall Study|Progressive disease|35|||
148702190|NCT00376623|536385550|FG001|Overall Study|Progressive disease|22|||
148702191|NCT00376623|536385551|FG002|Overall Study|Progressive disease|17|||
148702192|NCT00376623|536385549|FG000|Overall Study|Lost to Follow-up|0|||
148702193|NCT00376623|536385550|FG001|Overall Study|Lost to Follow-up|1|||
148967616|NCT00537381|537366771|FG000|Overall Study|Withdrawal by Subject|5|||
148967617|NCT00537381|537366772|FG001|Overall Study|Withdrawal by Subject|14|||
148967618|NCT00537381|537366771|FG000|Overall Study|Physician Decision|7|||
148702194|NCT00376623|536385551|FG002|Overall Study|Lost to Follow-up|0|||
148702195|NCT00376623|536385549|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
148702196|NCT00376623|536385550|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
148702197|NCT00376623|536385551|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
148702198|NCT00376623|536385549|FG000|Overall Study|Not treated with BI 2536|1|||
148702199|NCT00376623|536385550|FG001|Overall Study|Not treated with BI 2536|0|||
148702200|NCT00376623|536385551|FG002|Overall Study|Not treated with BI 2536|0|||
148702201|NCT00376623|536385549|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
148702202|NCT00376623|536385550|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
148702203|NCT00376623|536385551|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
148702204|NCT00376623|536385549|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
148702205|NCT00376623|536385550|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
148702206|NCT00376623|536385551|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
148702207|NCT00376623|536385549|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
148702208|NCT00376623|536385550|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
148702209|NCT00376623|536385551|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
148702210|NCT00376623|536385549|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
148702211|NCT00376623|536385550|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
148702212|NCT00376623|536385551|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
148702213|NCT00376623|536385549|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
148702214|NCT00376623|536385550|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
148702215|NCT00376623|536385551|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
148702216|NCT00376623|536385549|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
148702217|NCT00376623|536385550|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
148702218|NCT00376623|536385551|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
148702219|NCT00376623|536385549|FG000|Overall Study|Increase of tumour markers|0|||
148702220|NCT00376623|536385550|FG001|Overall Study|Increase of tumour markers|1|||
148702221|NCT00376623|536385551|FG002|Overall Study|Increase of tumour markers|0|||
148702222|NCT00376623|536385549|FG000|Overall Study|Bone metastasis|1|||
148702223|NCT00376623|536385550|FG001|Overall Study|Bone metastasis|0|||
148702224|NCT00376623|536385551|FG002|Overall Study|Bone metastasis|0|||
148702225|NCT03496623|536385554|FG000|Run-In Period (2 Weeks)|Death|1|||
148702226|NCT03496623|536385555|FG001|Run-In Period (2 Weeks)|Death|0|||
148702227|NCT03496623|536385556|FG002|Run-In Period (2 Weeks)|Death|0|||
148702228|NCT03496623|536385557|FG003|Run-In Period (2 Weeks)|Death|0|||
148702229|NCT03496623|536385558|FG004|Run-In Period (2 Weeks)|Death|0|||
148702230|NCT03496623|536385554|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
148702231|NCT03496623|536385555|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
148702232|NCT03496623|536385556|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
148702233|NCT03496623|536385557|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
148702234|NCT03496623|536385558|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
148702235|NCT03496623|536385554|FG000|Period 1 (12 Weeks)|Death|0|||
148702236|NCT03496623|536385555|FG001|Period 1 (12 Weeks)|Death|3|||
148702237|NCT03496623|536385556|FG002|Period 1 (12 Weeks)|Death|0|||
148702238|NCT03496623|536385557|FG003|Period 1 (12 Weeks)|Death|0|||
148702239|NCT03496623|536385558|FG004|Period 1 (12 Weeks)|Death|0|||
148702240|NCT03496623|536385554|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
148702241|NCT03496623|536385555|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
148702242|NCT03496623|536385556|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
148702243|NCT03496623|536385557|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
148702244|NCT03496623|536385558|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
148702245|NCT03496623|536385554|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
148702246|NCT03496623|536385555|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
148702247|NCT03496623|536385556|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
148702248|NCT03496623|536385557|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
148702249|NCT03496623|536385558|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
148702250|NCT03496623|536385554|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
148702251|NCT03496623|536385555|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
148702252|NCT03496623|536385556|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
148702253|NCT03496623|536385557|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
148702254|NCT03496623|536385558|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
148702255|NCT03496623|536385554|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
148702256|NCT03496623|536385555|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
148702257|NCT03496623|536385556|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
148702258|NCT03496623|536385557|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
148702259|NCT03496623|536385558|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
148815035|NCT02872714|536798092|FG000|Overall Study|Death|87|||
148702260|NCT03496623|536385554|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
148702261|NCT03496623|536385555|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
148702262|NCT03496623|536385556|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
148702263|NCT03496623|536385557|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
148702264|NCT03496623|536385558|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
148702265|NCT03496623|536385554|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148702266|NCT03496623|536385555|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
148702267|NCT03496623|536385556|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
148702268|NCT03496623|536385557|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148702269|NCT03496623|536385558|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148702270|NCT02543203|536385559|FG000|Overall Study|Unpalatable Fragrance|2|||
148702271|NCT02543203|536385560|FG001|Overall Study|Unpalatable Fragrance|2|||
148702272|NCT02543203|536385559|FG000|Overall Study|Lost to Follow-up|1|||
148702273|NCT02543203|536385560|FG001|Overall Study|Lost to Follow-up|0|||
148702274|NCT02543203|536385559|FG000|Overall Study|Increased Irritability|1|||
148702275|NCT02543203|536385560|FG001|Overall Study|Increased Irritability|0|||
148702276|NCT02543203|536385559|FG000|Overall Study|Family|1|||
148702277|NCT02543203|536385560|FG001|Overall Study|Family|2|||
148702278|NCT02543203|536385559|FG000|Overall Study|Negative Behavior|1|||
148702279|NCT02543203|536385560|FG001|Overall Study|Negative Behavior|0|||
148702280|NCT02543203|536385559|FG000|Overall Study|Withdrawal by Subject|0|||
148702281|NCT02543203|536385560|FG001|Overall Study|Withdrawal by Subject|1|||
148702282|NCT03020615|536385561|FG000|Overall Study|Physician Decision|3|||
148702283|NCT03020615|536385562|FG001|Overall Study|Physician Decision|1|||
148702284|NCT03020615|536385563|FG002|Overall Study|Physician Decision|2|||
148702285|NCT03020615|536385561|FG000|Overall Study|Parent/guardian/patient choice|3|||
148702286|NCT03020615|536385562|FG001|Overall Study|Parent/guardian/patient choice|0|||
148702287|NCT03020615|536385563|FG002|Overall Study|Parent/guardian/patient choice|4|||
148702288|NCT03020615|536385561|FG000|Overall Study|Screen failure|0|||
148702289|NCT03020615|536385562|FG001|Overall Study|Screen failure|0|||
148702290|NCT03020615|536385563|FG002|Overall Study|Screen failure|1|||
148702291|NCT03020615|536385561|FG000|Overall Study|Death|1|||
148702292|NCT03020615|536385562|FG001|Overall Study|Death|0|||
148702293|NCT03020615|536385563|FG002|Overall Study|Death|0|||
148702294|NCT03020615|536385561|FG000|Overall Study|Lost to Follow-up|0|||
148702295|NCT03020615|536385562|FG001|Overall Study|Lost to Follow-up|1|||
148702296|NCT03020615|536385563|FG002|Overall Study|Lost to Follow-up|0|||
148702297|NCT00089661|536385564|FG000|Overall Study|Adverse Event|0|||
148702298|NCT00089661|536385565|FG001|Overall Study|Adverse Event|2|||
148702299|NCT00089661|536385564|FG000|Overall Study|Death|1|||
148702300|NCT00089661|536385565|FG001|Overall Study|Death|0|||
148702301|NCT00089661|536385564|FG000|Overall Study|Lost to Follow-up|0|||
148702302|NCT00089661|536385565|FG001|Overall Study|Lost to Follow-up|3|||
148702303|NCT00089661|536385564|FG000|Overall Study|Withdrawal by Subject|11|||
148702304|NCT00089661|536385565|FG001|Overall Study|Withdrawal by Subject|9|||
148702305|NCT00089661|536385564|FG000|Overall Study|Disease progression|1|||
148702306|NCT00089661|536385565|FG001|Overall Study|Disease progression|3|||
148702307|NCT00089661|536385564|FG000|Overall Study|Ineligibility determined|4|||
148702308|NCT00089661|536385565|FG001|Overall Study|Ineligibility determined|4|||
148702309|NCT00089661|536385564|FG000|Overall Study|Noncompliance|2|||
148702310|NCT00089661|536385565|FG001|Overall Study|Noncompliance|4|||
148702311|NCT00089661|536385564|FG000|Overall Study|Other|2|||
148702312|NCT00089661|536385565|FG001|Overall Study|Other|1|||
148702313|NCT00794963|536385566|FG000|Overall Study|Withdrawal by Subject|1|||
148702314|NCT00794963|536385567|FG001|Overall Study|Withdrawal by Subject|4|||
148702315|NCT01827163|536385568|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
148702316|NCT01827163|536385568|FG000|Overall Study|Adverse Event|9|||
148702317|NCT03375463|536385569|FG000|Period 1|Lost to Follow-up|0|||
148702318|NCT03375463|536385570|FG001|Period 1|Lost to Follow-up|0|||
148702319|NCT03375463|536385571|FG002|Period 1|Lost to Follow-up|1|||
148702320|NCT03375463|536385572|FG003|Period 1|Lost to Follow-up|0|||
148702321|NCT03375463|536385573|FG004|Period 1|Lost to Follow-up|0|||
148702322|NCT03375463|536385574|FG005|Period 1|Lost to Follow-up|0|||
148702323|NCT03375463|536385569|FG000|Period 1|Adverse Event|0|||
148702324|NCT03375463|536385570|FG001|Period 1|Adverse Event|0|||
148702325|NCT03375463|536385571|FG002|Period 1|Adverse Event|0|||
148702326|NCT03375463|536385572|FG003|Period 1|Adverse Event|0|||
148702327|NCT03375463|536385573|FG004|Period 1|Adverse Event|1|||
148702328|NCT03375463|536385574|FG005|Period 1|Adverse Event|0|||
148702329|NCT03375463|536385569|FG000|Period 2|Lost to Follow-up|1|||
148702330|NCT03375463|536385570|FG001|Period 2|Lost to Follow-up|1|||
148702331|NCT03375463|536385571|FG002|Period 2|Lost to Follow-up|0|||
148702332|NCT03375463|536385572|FG003|Period 2|Lost to Follow-up|0|||
148702333|NCT03375463|536385573|FG004|Period 2|Lost to Follow-up|0|||
148702334|NCT03375463|536385574|FG005|Period 2|Lost to Follow-up|0|||
148702335|NCT01037114|536385575|FG000|Year 20|Others|1|||
148702336|NCT03620747|536385577|FG000|Overall Study|Participant decision|7|||
148702337|NCT03620747|536385577|FG000|Overall Study|Adverse Event|6|||
148702338|NCT03620747|536385577|FG000|Overall Study|Lack of Efficacy|1|||
148702339|NCT03620747|536385577|FG000|Overall Study|Poor compliance to protocol|2|||
148702340|NCT03620747|536385577|FG000|Overall Study|Other-unspecified|3|||
148702341|NCT01513174|536385592|FG000|Overall Study|Inclusion Error|1|||
148702342|NCT01513174|536385593|FG001|Overall Study|Inclusion Error|7|||
148702343|NCT01513174|536385592|FG000|Overall Study|Not receive study treatment|3|||
148702344|NCT01513174|536385593|FG001|Overall Study|Not receive study treatment|1|||
148702345|NCT00850174|536385594|FG000|Washout: One Week|Withdrawal by Subject|0|||
148702346|NCT00850174|536385595|FG001|Washout: One Week|Withdrawal by Subject|2|||
148702347|NCT00850174|536385594|FG000|Second Intervention|Withdrawal by Subject|1|||
148702348|NCT00850174|536385595|FG001|Second Intervention|Withdrawal by Subject|0|||
148702349|NCT00635492|536385598|FG000|Overall Study|Death|12|||
148702350|NCT00635492|536385599|FG001|Overall Study|Death|40|||
148702351|NCT00635492|536385598|FG000|Overall Study|Lost to Follow-up|151|||
148702352|NCT00635492|536385599|FG001|Overall Study|Lost to Follow-up|172|||
148702353|NCT00635492|536385598|FG000|Overall Study|Physician Decision|32|||
148702354|NCT00635492|536385599|FG001|Overall Study|Physician Decision|22|||
148702355|NCT00635492|536385598|FG000|Overall Study|Sponsor decision|2|||
148702356|NCT00635492|536385599|FG001|Overall Study|Sponsor decision|3|||
148702357|NCT00635492|536385598|FG000|Overall Study|Withdrawal by Subject|82|||
148702358|NCT00635492|536385599|FG001|Overall Study|Withdrawal by Subject|45|||
148702359|NCT00467363|536385605|FG000|Overall Study|Lost to Follow-up|80|||
148702360|NCT00467363|536385606|FG001|Overall Study|Lost to Follow-up|70|||
148702361|NCT04400890|536385610|FG000|Overall Study|Withdrawal by Subject|3|||
148702362|NCT04400890|536385611|FG001|Overall Study|Withdrawal by Subject|2|||
148702363|NCT05615935|536385612|FG000|Overall Study|Lost to Follow-up|1|||
148702364|NCT05615935|536385613|FG001|Overall Study|Lost to Follow-up|1|||
148702365|NCT00836056|536385615|FG000|First Intervention|Adverse Event|1|||
148702366|NCT00836056|536385616|FG001|First Intervention|Adverse Event|0|||
148702367|NCT02158663|536385617|FG000|Overall Study|Withdrawal by Subject|5|||
148702368|NCT02158663|536385618|FG001|Overall Study|Withdrawal by Subject|4|||
148702369|NCT02711852|536385619|FG000|Overall Study|Death|5|||
148702370|NCT02711852|536385619|FG000|Overall Study|Lost to Follow-up|1|||
148702371|NCT02711852|536385619|FG000|Overall Study|Completed follow-up|3|||
148702372|NCT02711852|536385619|FG000|Overall Study|Withdrawal by Subject|1|||
148702373|NCT03500692|536385621|FG000|Overall Study|Death|163|||
148702374|NCT03500692|536385621|FG000|Overall Study|Lost to Follow-up|75|||
148702375|NCT03500692|536385621|FG000|Overall Study|Termination Reasons|3|||
148702376|NCT04149964|536385622|FG000|Overall Study|Lost to Follow-up|19|||
148702377|NCT04149964|536385623|FG001|Overall Study|Lost to Follow-up|18|||
148702378|NCT03616106|536385626|FG000|Overall Study|Removed by PI|6|||
148702379|NCT03616106|536385627|FG001|Overall Study|Removed by PI|0|||
148702380|NCT03616106|536385626|FG000|Overall Study|Withdrawal by Subject|1|||
148702381|NCT03616106|536385627|FG001|Overall Study|Withdrawal by Subject|1|||
148702382|NCT03616106|536385626|FG000|Overall Study|Lost to Follow-up|7|||
148702383|NCT03616106|536385627|FG001|Overall Study|Lost to Follow-up|0|||
148702384|NCT01880593|536385628|FG000|Overall Study|Adverse Event|1|||
148702385|NCT01880593|536385629|FG001|Overall Study|Adverse Event|0|||
148702386|NCT01880593|536385628|FG000|Overall Study|Lack of Efficacy|1|||
148702387|NCT01880593|536385629|FG001|Overall Study|Lack of Efficacy|5|||
148702388|NCT01880593|536385628|FG000|Overall Study|Withdrawal by Subject|6|||
148702389|NCT01880593|536385629|FG001|Overall Study|Withdrawal by Subject|1|||
148702390|NCT02272777|536385630|FG000|Overall Study|Adverse Event|0|||
148702391|NCT02272777|536385631|FG001|Overall Study|Adverse Event|1|||
148702392|NCT02272777|536385630|FG000|Overall Study|Withdrawal by Subject|0|||
148702393|NCT02272777|536385631|FG001|Overall Study|Withdrawal by Subject|3|||
148702394|NCT02272777|536385630|FG000|Overall Study|Lost to Follow-up|2|||
148702395|NCT02272777|536385631|FG001|Overall Study|Lost to Follow-up|0|||
148702396|NCT02272777|536385630|FG000|Overall Study|Other|2|||
148702397|NCT02272777|536385631|FG001|Overall Study|Other|0|||
148702398|NCT00440297|536385635|FG000|Overall Study|Adverse Event|8|||
148702399|NCT00440297|536385636|FG001|Overall Study|Adverse Event|5|||
148702400|NCT00440297|536385635|FG000|Overall Study|Lost to Follow-up|1|||
148702401|NCT00440297|536385636|FG001|Overall Study|Lost to Follow-up|0|||
148702402|NCT00440297|536385635|FG000|Overall Study|Physician Decision|1|||
148702403|NCT00440297|536385636|FG001|Overall Study|Physician Decision|0|||
148702404|NCT00440297|536385635|FG000|Overall Study|Protocol Violation|11|||
148702405|NCT00440297|536385636|FG001|Overall Study|Protocol Violation|7|||
148702406|NCT00440297|536385635|FG000|Overall Study|Withdrawal by Subject|1|||
148702407|NCT00440297|536385636|FG001|Overall Study|Withdrawal by Subject|6|||
148702408|NCT00440297|536385635|FG000|Overall Study|Randomized by mistake|1|||
148815036|NCT02872714|536798093|FG001|Overall Study|Death|36|||
148702409|NCT00440297|536385636|FG001|Overall Study|Randomized by mistake|0|||
148702410|NCT03206177|536385637|FG000|Overall Study|Withdrawal by Subject|1|||
148702411|NCT02445339|536385638|FG000|Overall Study|Physician Decision|1|||
148702412|NCT02445339|536385639|FG001|Overall Study|Physician Decision|0|||
148702413|NCT02445339|536385638|FG000|Overall Study|Lost to Follow-up|11|||
148702414|NCT02445339|536385639|FG001|Overall Study|Lost to Follow-up|15|||
148702415|NCT02024932|536385640|FG000|Overall Study|Adverse Event|2|||
148702416|NCT02024932|536385641|FG001|Overall Study|Adverse Event|3|||
148702417|NCT02024932|536385642|FG002|Overall Study|Adverse Event|0|||
148702418|NCT02024932|536385643|FG003|Overall Study|Adverse Event|0|||
148967619|NCT00537381|537366772|FG001|Overall Study|Physician Decision|6|||
148702419|NCT02024932|536385644|FG004|Overall Study|Adverse Event|2|||
148702420|NCT02024932|536385645|FG005|Overall Study|Adverse Event|0|||
148702421|NCT02024932|536385640|FG000|Overall Study|Abnormal laboratory value|0|||
148702422|NCT02024932|536385641|FG001|Overall Study|Abnormal laboratory value|0|||
148702423|NCT02024932|536385642|FG002|Overall Study|Abnormal laboratory value|0|||
148702424|NCT02024932|536385643|FG003|Overall Study|Abnormal laboratory value|2|||
148702425|NCT02024932|536385644|FG004|Overall Study|Abnormal laboratory value|0|||
148702426|NCT02024932|536385645|FG005|Overall Study|Abnormal laboratory value|0|||
148702427|NCT03041025|536385646|FG000|Overall Study|Adverse Event|0|||
148702428|NCT03041025|536385647|FG001|Overall Study|Adverse Event|0|||
148702429|NCT03041025|536385648|FG002|Overall Study|Adverse Event|1|||
148702430|NCT03041025|536385646|FG000|Overall Study|Lost to Follow-up|1|||
148702431|NCT03041025|536385647|FG001|Overall Study|Lost to Follow-up|0|||
148702432|NCT03041025|536385648|FG002|Overall Study|Lost to Follow-up|0|||
148702433|NCT03041025|536385646|FG000|Overall Study|Withdrawal by Subject|0|||
148702434|NCT03041025|536385647|FG001|Overall Study|Withdrawal by Subject|0|||
148702435|NCT03041025|536385648|FG002|Overall Study|Withdrawal by Subject|1|||
148702436|NCT02186821|536385649|FG000|Overall Study|Adverse Event|9|||
148702437|NCT02186821|536385649|FG000|Overall Study|Death|2|||
148702438|NCT02186821|536385649|FG000|Overall Study|Disease progression|32|||
148702439|NCT02186821|536385649|FG000|Overall Study|Protocol Violation|1|||
148702440|NCT02186821|536385649|FG000|Overall Study|Physician Decision|1|||
148702441|NCT02186821|536385649|FG000|Overall Study|Study terminated by sponsor|2|||
148702442|NCT05472038|536387375|FG000|Overall Study|Adverse Event|0|||
148702443|NCT05472038|536387376|FG001|Overall Study|Adverse Event|0|||
148702444|NCT05472038|536387377|FG002|Overall Study|Adverse Event|1|||
148702445|NCT05472038|536387378|FG003|Overall Study|Adverse Event|0|||
148702446|NCT05472038|536387379|FG004|Overall Study|Adverse Event|0|||
148702447|NCT05472038|536387380|FG005|Overall Study|Adverse Event|0|||
148702448|NCT05472038|536387381|FG006|Overall Study|Adverse Event|0|||
148702449|NCT05472038|536387382|FG007|Overall Study|Adverse Event|0|||
148702450|NCT05472038|536387383|FG008|Overall Study|Adverse Event|0|||
148702451|NCT05472038|536387384|FG009|Overall Study|Adverse Event|0|||
148702452|NCT05472038|536387385|FG010|Overall Study|Adverse Event|0|||
148702453|NCT05472038|536387386|FG011|Overall Study|Adverse Event|0|||
148702454|NCT05472038|536387375|FG000|Overall Study|Death|0|||
148702455|NCT05472038|536387376|FG001|Overall Study|Death|0|||
148702456|NCT05472038|536387377|FG002|Overall Study|Death|0|||
148702457|NCT05472038|536387378|FG003|Overall Study|Death|0|||
148702458|NCT05472038|536387379|FG004|Overall Study|Death|0|||
148702459|NCT05472038|536387380|FG005|Overall Study|Death|1|||
148702460|NCT05472038|536387381|FG006|Overall Study|Death|0|||
148702461|NCT05472038|536387382|FG007|Overall Study|Death|0|||
148702462|NCT05472038|536387383|FG008|Overall Study|Death|0|||
148702463|NCT05472038|536387384|FG009|Overall Study|Death|0|||
148702464|NCT05472038|536387385|FG010|Overall Study|Death|0|||
148702465|NCT05472038|536387386|FG011|Overall Study|Death|0|||
148702466|NCT05472038|536387375|FG000|Overall Study|Lost to Follow-up|1|||
148702467|NCT05472038|536387376|FG001|Overall Study|Lost to Follow-up|3|||
148702468|NCT05472038|536387377|FG002|Overall Study|Lost to Follow-up|3|||
148702469|NCT05472038|536387378|FG003|Overall Study|Lost to Follow-up|9|||
148702470|NCT05472038|536387379|FG004|Overall Study|Lost to Follow-up|2|||
148702471|NCT05472038|536387380|FG005|Overall Study|Lost to Follow-up|2|||
148702472|NCT05472038|536387381|FG006|Overall Study|Lost to Follow-up|1|||
148702473|NCT05472038|536387382|FG007|Overall Study|Lost to Follow-up|0|||
148702474|NCT05472038|536387383|FG008|Overall Study|Lost to Follow-up|1|||
148702475|NCT05472038|536387384|FG009|Overall Study|Lost to Follow-up|0|||
148702476|NCT05472038|536387385|FG010|Overall Study|Lost to Follow-up|2|||
148702477|NCT05472038|536387386|FG011|Overall Study|Lost to Follow-up|1|||
148702478|NCT05472038|536387375|FG000|Overall Study|Physician Decision|0|||
148967620|NCT00537381|537366771|FG000|Overall Study|Disease Progression|9|||
148967621|NCT00537381|537366772|FG001|Overall Study|Disease Progression|18|||
148702479|NCT05472038|536387376|FG001|Overall Study|Physician Decision|0|||
148702480|NCT05472038|536387377|FG002|Overall Study|Physician Decision|0|||
148702481|NCT05472038|536387378|FG003|Overall Study|Physician Decision|0|||
148702482|NCT05472038|536387379|FG004|Overall Study|Physician Decision|1|||
148702483|NCT05472038|536387380|FG005|Overall Study|Physician Decision|0|||
148702484|NCT05472038|536387381|FG006|Overall Study|Physician Decision|0|||
148702485|NCT05472038|536387382|FG007|Overall Study|Physician Decision|0|||
148702486|NCT05472038|536387383|FG008|Overall Study|Physician Decision|0|||
148702487|NCT05472038|536387384|FG009|Overall Study|Physician Decision|0|||
148702488|NCT05472038|536387385|FG010|Overall Study|Physician Decision|0|||
148702489|NCT05472038|536387386|FG011|Overall Study|Physician Decision|0|||
148702490|NCT05472038|536387375|FG000|Overall Study|Withdrawal by Subject|1|||
148702491|NCT05472038|536387376|FG001|Overall Study|Withdrawal by Subject|3|||
148702492|NCT05472038|536387377|FG002|Overall Study|Withdrawal by Subject|1|||
148702493|NCT05472038|536387378|FG003|Overall Study|Withdrawal by Subject|6|||
148702494|NCT05472038|536387379|FG004|Overall Study|Withdrawal by Subject|1|||
148702495|NCT05472038|536387380|FG005|Overall Study|Withdrawal by Subject|3|||
148967622|NCT00537381|537366771|FG000|Overall Study|Sponsor decision|14|||
148967623|NCT00537381|537366772|FG001|Overall Study|Sponsor decision|9|||
148967624|NCT00537381|537366771|FG000|Overall Study|Other|5|||
148702496|NCT05472038|536387381|FG006|Overall Study|Withdrawal by Subject|0|||
148702497|NCT05472038|536387382|FG007|Overall Study|Withdrawal by Subject|2|||
148702498|NCT05472038|536387383|FG008|Overall Study|Withdrawal by Subject|3|||
148702499|NCT05472038|536387384|FG009|Overall Study|Withdrawal by Subject|1|||
148702500|NCT05472038|536387385|FG010|Overall Study|Withdrawal by Subject|2|||
148702501|NCT05472038|536387386|FG011|Overall Study|Withdrawal by Subject|2|||
148702502|NCT05472038|536387375|FG000|Overall Study|Protocol Violation|0|||
148702503|NCT05472038|536387376|FG001|Overall Study|Protocol Violation|0|||
148702504|NCT05472038|536387377|FG002|Overall Study|Protocol Violation|0|||
148702505|NCT05472038|536387378|FG003|Overall Study|Protocol Violation|0|||
148702506|NCT05472038|536387379|FG004|Overall Study|Protocol Violation|0|||
148702507|NCT05472038|536387380|FG005|Overall Study|Protocol Violation|0|||
148702508|NCT05472038|536387381|FG006|Overall Study|Protocol Violation|0|||
148702509|NCT05472038|536387382|FG007|Overall Study|Protocol Violation|1|||
148702510|NCT05472038|536387383|FG008|Overall Study|Protocol Violation|1|||
148702511|NCT05472038|536387384|FG009|Overall Study|Protocol Violation|1|||
148702512|NCT05472038|536387385|FG010|Overall Study|Protocol Violation|1|||
148702513|NCT05472038|536387386|FG011|Overall Study|Protocol Violation|1|||
148702514|NCT05472038|536387375|FG000|Overall Study|Not vaccinated|0|||
148702515|NCT05472038|536387376|FG001|Overall Study|Not vaccinated|0|||
148702516|NCT05472038|536387377|FG002|Overall Study|Not vaccinated|0|||
148702517|NCT05472038|536387378|FG003|Overall Study|Not vaccinated|1|||
148702518|NCT05472038|536387379|FG004|Overall Study|Not vaccinated|0|||
148702519|NCT05472038|536387380|FG005|Overall Study|Not vaccinated|0|||
148702520|NCT05472038|536387381|FG006|Overall Study|Not vaccinated|0|||
148702521|NCT05472038|536387382|FG007|Overall Study|Not vaccinated|0|||
148702522|NCT05472038|536387383|FG008|Overall Study|Not vaccinated|0|||
148702523|NCT05472038|536387384|FG009|Overall Study|Not vaccinated|0|||
148702524|NCT05472038|536387385|FG010|Overall Study|Not vaccinated|0|||
148702525|NCT05472038|536387386|FG011|Overall Study|Not vaccinated|0|||
148702526|NCT03235739|536387389|FG000|Overall Study|Withdrawal by Subject|2|||
148702527|NCT03235739|536387390|FG001|Overall Study|Withdrawal by Subject|2|||
148702528|NCT03235739|536387389|FG000|Overall Study|Physician Decision|0|||
148702529|NCT03235739|536387390|FG001|Overall Study|Physician Decision|1|||
148702530|NCT02847650|536387391|FG000|Overall Study|Adverse Event|2|||
148702531|NCT02847650|536387392|FG001|Overall Study|Adverse Event|4|||
148702532|NCT02847650|536387391|FG000|Overall Study|Lost to Follow-up|1|||
148702533|NCT02847650|536387392|FG001|Overall Study|Lost to Follow-up|0|||
148702534|NCT02847650|536387391|FG000|Overall Study|Protocol Violation|0|||
148702535|NCT02847650|536387392|FG001|Overall Study|Protocol Violation|1|||
148702536|NCT02847650|536387391|FG000|Overall Study|Withdrawal by Subject|1|||
148702537|NCT02847650|536387392|FG001|Overall Study|Withdrawal by Subject|1|||
148702538|NCT00218257|536387393|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
148702539|NCT00218257|536387394|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
148702540|NCT02175095|536387397|FG000|Overall Study|Withdrawal by Subject|3|||
148702541|NCT00462345|536387398|FG000|Overall Study|Withdrawal by Subject|2|||
148702542|NCT00462345|536387398|FG000|Overall Study|Did not complete second course|1|||
148702543|NCT03255733|536387399|FG000|Overall Study|Lost to Follow-up|4|||
148702544|NCT02146105|536387402|FG000|Overall Study|Adverse Event|1|||
148702545|NCT02146105|536387402|FG000|Overall Study|Withdrawal by Subject|5|||
148702546|NCT02718326|536387405|FG000|Overall Study|Adverse Event|4|||
148702547|NCT02718326|536387406|FG001|Overall Study|Adverse Event|9|||
148702548|NCT02718326|536387407|FG002|Overall Study|Adverse Event|0|||
148702549|NCT02718326|536387405|FG000|Overall Study|Death|8|||
148702550|NCT02718326|536387406|FG001|Overall Study|Death|1|||
148702551|NCT02718326|536387407|FG002|Overall Study|Death|2|||
148702552|NCT02718326|536387405|FG000|Overall Study|Withdrawal by Subject|4|||
148702553|NCT02718326|536387406|FG001|Overall Study|Withdrawal by Subject|9|||
148702554|NCT02718326|536387407|FG002|Overall Study|Withdrawal by Subject|6|||
148702555|NCT02718326|536387405|FG000|Overall Study|Lost to Follow-up|18|||
148702556|NCT02718326|536387406|FG001|Overall Study|Lost to Follow-up|5|||
148702557|NCT02718326|536387407|FG002|Overall Study|Lost to Follow-up|14|||
148702558|NCT02718326|536387405|FG000|Overall Study|Protocol Deviation|1|||
148702559|NCT02718326|536387406|FG001|Overall Study|Protocol Deviation|0|||
148702560|NCT02718326|536387407|FG002|Overall Study|Protocol Deviation|0|||
148702561|NCT02718326|536387405|FG000|Overall Study|Pregnancy|1|||
148702562|NCT02718326|536387406|FG001|Overall Study|Pregnancy|0|||
148702563|NCT02718326|536387407|FG002|Overall Study|Pregnancy|0|||
148702564|NCT03122535|536387408|FG000|Overall Study|Lost to Follow-up|68|||
148702565|NCT03122535|536387409|FG001|Overall Study|Lost to Follow-up|68|||
148702566|NCT03122535|536387408|FG000|Overall Study|Physician Decision|3|||
148702567|NCT03122535|536387409|FG001|Overall Study|Physician Decision|3|||
148702568|NCT03122535|536387408|FG000|Overall Study|Withdrawal by Subject|2|||
148702569|NCT03122535|536387409|FG001|Overall Study|Withdrawal by Subject|2|||
148702570|NCT02646124|536387410|FG000|Overall Study|Lost to Follow-up|0|||
148702571|NCT02646124|536387411|FG001|Overall Study|Lost to Follow-up|2|||
148702572|NCT00857454|536387415|FG000|Overall Study|Withdrawal by Subject|2|||
148967625|NCT00537381|537366772|FG001|Overall Study|Other|3|||
148967626|NCT00500292|537366779|FG000|Overall Study|Adverse Event|3|||
148967627|NCT00500292|537366780|FG001|Overall Study|Adverse Event|6|||
148967628|NCT00500292|537366781|FG002|Overall Study|Adverse Event|4|||
149025080|NCT04170023|537568005|FG001|LTE Period|Withdrawal by Subject|0|||
148702573|NCT00857454|536387415|FG000|Overall Study|Lost to Follow-up|1|||
148702574|NCT00857454|536387415|FG000|Overall Study|Adverse Event|2|||
148702575|NCT00857454|536387415|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
148702576|NCT00857454|536387415|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
148702577|NCT00857454|536387415|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
148702578|NCT00984022|536387416|FG000|Overall Study|Lost to Follow-up|10|||
148702579|NCT00984022|536387417|FG001|Overall Study|Lost to Follow-up|14|||
148702580|NCT00573443|536387421|FG000|Double-Blind Phase|Lost to Follow-up|1|||
148702581|NCT00573443|536387422|FG001|Double-Blind Phase|Lost to Follow-up|3|||
148702582|NCT00573443|536387423|FG002|Double-Blind Phase|Lost to Follow-up|2|||
148702583|NCT00573443|536387421|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
148702584|NCT00573443|536387422|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
148702585|NCT00573443|536387423|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
148702586|NCT00573443|536387421|FG000|Double-Blind Phase|Adverse Event|1|||
148702587|NCT00573443|536387422|FG001|Double-Blind Phase|Adverse Event|5|||
148702588|NCT00573443|536387423|FG002|Double-Blind Phase|Adverse Event|0|||
148702589|NCT00573443|536387421|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
148702590|NCT00573443|536387422|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
148702591|NCT00573443|536387423|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
148702592|NCT00573443|536387421|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
148702593|NCT00573443|536387422|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
148702594|NCT00573443|536387423|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
148702595|NCT00573443|536387421|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
148702596|NCT00573443|536387422|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
148702597|NCT00573443|536387423|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
148702598|NCT00573443|536387421|FG000|Double-Blind Phase|Protocol Violation|0|||
148702599|NCT00573443|536387422|FG001|Double-Blind Phase|Protocol Violation|2|||
148702600|NCT00573443|536387423|FG002|Double-Blind Phase|Protocol Violation|1|||
148702601|NCT00573443|536387421|FG000|Double-Blind Phase|Other|0|||
148702602|NCT00573443|536387422|FG001|Double-Blind Phase|Other|2|||
148702603|NCT00573443|536387423|FG002|Double-Blind Phase|Other|3|||
148702604|NCT00573443|536387421|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
148702605|NCT00573443|536387422|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
148702606|NCT00573443|536387423|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
148702607|NCT00573443|536387421|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
148702608|NCT00573443|536387422|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
148702609|NCT00573443|536387423|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
148702610|NCT00573443|536387421|FG000|Open-Label Extension Phase|Adverse Event|3|||
148702611|NCT00573443|536387422|FG001|Open-Label Extension Phase|Adverse Event|0|||
148702612|NCT00573443|536387423|FG002|Open-Label Extension Phase|Adverse Event|0|||
148702613|NCT00573443|536387421|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
148702614|NCT00573443|536387422|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
148702615|NCT00573443|536387423|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
148702616|NCT00573443|536387421|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
148702617|NCT00573443|536387422|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
148702618|NCT00573443|536387423|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
148702619|NCT00573443|536387421|FG000|Open-Label Extension Phase|Protocol Violation|2|||
148702620|NCT00573443|536387422|FG001|Open-Label Extension Phase|Protocol Violation|0|||
148702621|NCT00573443|536387423|FG002|Open-Label Extension Phase|Protocol Violation|0|||
148702622|NCT00573443|536387421|FG000|Open-Label Extension Phase|Other|2|||
148702623|NCT00573443|536387422|FG001|Open-Label Extension Phase|Other|0|||
148702624|NCT00573443|536387423|FG002|Open-Label Extension Phase|Other|0|||
148702625|NCT02472366|536387426|FG000|Overall Study|Lost to Follow-up|1|||
148702626|NCT02472366|536387427|FG001|Overall Study|Lost to Follow-up|0|||
148702627|NCT03699020|536387430|FG000|Overall Study|Withdrawal by Subject|3|||
148702628|NCT03699020|536387431|FG001|Overall Study|Withdrawal by Subject|2|||
148702629|NCT02077465|536387436|FG000|Overall Study|Withdrew Consent|0|||
148702630|NCT02077465|536387437|FG001|Overall Study|Withdrew Consent|1|||
148702631|NCT02077465|536387436|FG000|Overall Study|Lost to Follow-up|1|||
148702632|NCT02077465|536387437|FG001|Overall Study|Lost to Follow-up|0|||
148702633|NCT02481830|536387438|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
148702634|NCT02481830|536387439|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
148702635|NCT02481830|536387438|FG000|Pre-treatment|Withdrawal by Subject|0|||
148967629|NCT00500292|537366779|FG000|Overall Study|Condition under investigation worsened|21|||
148967630|NCT00500292|537366780|FG001|Overall Study|Condition under investigation worsened|23|||
148702636|NCT02481830|536387439|FG001|Pre-treatment|Withdrawal by Subject|10|||
148702637|NCT02481830|536387438|FG000|Pre-treatment|Disease Progression|1|||
148702638|NCT02481830|536387439|FG001|Pre-treatment|Disease Progression|1|||
148702639|NCT02481830|536387438|FG000|Pre-treatment|Other reasons|0|||
148702640|NCT02481830|536387439|FG001|Pre-treatment|Other reasons|1|||
148702641|NCT02481830|536387438|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
148702642|NCT02481830|536387439|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
148702643|NCT02481830|536387438|FG000|Treatment|Disease Progression|233|||
148702644|NCT02481830|536387439|FG001|Treatment|Disease Progression|171|||
148702645|NCT02481830|536387438|FG000|Treatment|Study drug toxicity|18|||
148702646|NCT02481830|536387439|FG001|Treatment|Study drug toxicity|38|||
148702647|NCT02481830|536387438|FG000|Treatment|Death|1|||
148702648|NCT02481830|536387439|FG001|Treatment|Death|1|||
148702649|NCT02481830|536387438|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
148702650|NCT02481830|536387439|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
148702651|NCT02481830|536387438|FG000|Treatment|Participants request to discontinue Study treatment|6|||
148702652|NCT02481830|536387439|FG001|Treatment|Participants request to discontinue Study treatment|34|||
148702653|NCT02481830|536387438|FG000|Treatment|Withdrawal by Subject|2|||
148702654|NCT02481830|536387439|FG001|Treatment|Withdrawal by Subject|3|||
148702655|NCT02481830|536387438|FG000|Treatment|Lost to Follow-up|1|||
148702656|NCT02481830|536387439|FG001|Treatment|Lost to Follow-up|0|||
148702657|NCT02481830|536387438|FG000|Treatment|Maximum Clinical Benefit|0|||
148702658|NCT02481830|536387439|FG001|Treatment|Maximum Clinical Benefit|5|||
148702659|NCT02481830|536387438|FG000|Treatment|Administrative reason by sponsor|1|||
148702660|NCT02481830|536387439|FG001|Treatment|Administrative reason by sponsor|1|||
148702661|NCT02481830|536387438|FG000|Treatment|Other reasons|6|||
148702662|NCT02481830|536387439|FG001|Treatment|Other reasons|1|||
148702663|NCT04627038|536387440|FG000|Overall Study|Adverse Event|36|||
148702664|NCT04627038|536387441|FG001|Overall Study|Adverse Event|8|||
148702665|NCT04627038|536387440|FG000|Overall Study|Lost to Follow-up|1|||
148702666|NCT04627038|536387441|FG001|Overall Study|Lost to Follow-up|0|||
148702667|NCT04627038|536387440|FG000|Overall Study|Physician Decision|0|||
148702668|NCT04627038|536387441|FG001|Overall Study|Physician Decision|1|||
148702669|NCT04627038|536387440|FG000|Overall Study|Protocol Violation|3|||
148702670|NCT04627038|536387441|FG001|Overall Study|Protocol Violation|1|||
148702671|NCT04627038|536387440|FG000|Overall Study|Withdrawal by Subject|13|||
148702672|NCT04627038|536387441|FG001|Overall Study|Withdrawal by Subject|3|||
148702673|NCT04627038|536387440|FG000|Overall Study|Non-compliance with study drug|0|||
148702674|NCT04627038|536387441|FG001|Overall Study|Non-compliance with study drug|1|||
148702675|NCT04627038|536387440|FG000|Overall Study|Prohibited Concomitant Medication|1|||
148702676|NCT04627038|536387441|FG001|Overall Study|Prohibited Concomitant Medication|0|||
148702677|NCT04533594|536387446|FG000|Overall Study|Death|26|||
148702678|NCT00473330|536387450|FG000|Core Study|Adverse Event|4|||
148702679|NCT00473330|536387451|FG001|Core Study|Adverse Event|4|||
148702680|NCT00473330|536387452|FG002|Core Study|Adverse Event|1|||
148702681|NCT00473330|536387450|FG000|Core Study|Death|6|||
148702682|NCT00473330|536387451|FG001|Core Study|Death|4|||
148702683|NCT00473330|536387452|FG002|Core Study|Death|4|||
148702684|NCT00473330|536387450|FG000|Core Study|Lost to Follow-up|5|||
148702685|NCT00473330|536387451|FG001|Core Study|Lost to Follow-up|5|||
148702686|NCT00473330|536387452|FG002|Core Study|Lost to Follow-up|10|||
148702687|NCT00473330|536387450|FG000|Core Study|Physician Decision|2|||
148702688|NCT00473330|536387451|FG001|Core Study|Physician Decision|1|||
148702689|NCT00473330|536387452|FG002|Core Study|Physician Decision|3|||
148702690|NCT00473330|536387450|FG000|Core Study|Subject Non-compliance|1|||
148702691|NCT00473330|536387451|FG001|Core Study|Subject Non-compliance|2|||
148702692|NCT00473330|536387452|FG002|Core Study|Subject Non-compliance|1|||
148702693|NCT00473330|536387450|FG000|Core Study|Subject Required Other Therapy|0|||
148702694|NCT00473330|536387451|FG001|Core Study|Subject Required Other Therapy|1|||
148702695|NCT00473330|536387452|FG002|Core Study|Subject Required Other Therapy|3|||
148702696|NCT00473330|536387450|FG000|Core Study|Subject's Decision|9|||
148702697|NCT00473330|536387451|FG001|Core Study|Subject's Decision|8|||
148702698|NCT00473330|536387452|FG002|Core Study|Subject's Decision|19|||
148702699|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
148702700|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
148702701|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
148702702|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Death|2|||
148702703|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Death|0|||
148702704|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Death|0|||
148702705|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
148702706|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
148702707|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
148702708|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
148702709|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
148702710|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
148702711|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
148702712|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
148702713|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
148702714|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
148702715|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
148702716|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
148967631|NCT00500292|537366781|FG002|Overall Study|Condition under investigation worsened|19|||
148967632|NCT00500292|537366779|FG000|Overall Study|Withdrawal by Subject|0|||
148967633|NCT00500292|537366780|FG001|Overall Study|Withdrawal by Subject|1|||
148702717|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
148702718|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
148702719|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
148702720|NCT00473330|536387450|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
148702721|NCT00473330|536387451|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
148702722|NCT00473330|536387452|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
148702723|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
148702724|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
148702725|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
148702726|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Death|2|||
148702727|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Death|2|||
148702728|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Death|1|||
148702729|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
148702730|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
148702731|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
148702732|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
148702733|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
148702734|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
148702735|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
148702736|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
148702737|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
148702738|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
148702739|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
148702740|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
148702741|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
148702742|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
148702743|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
148702744|NCT00473330|536387450|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
148702745|NCT00473330|536387451|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
148702746|NCT00473330|536387452|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
148702747|NCT01975948|536387453|FG000|Overall Study|Withdrawal by Subject|17|||
148702748|NCT01975948|536387454|FG001|Overall Study|Withdrawal by Subject|21|||
148702749|NCT01975948|536387455|FG002|Overall Study|Withdrawal by Subject|7|||
148702750|NCT01975948|536387456|FG003|Overall Study|Withdrawal by Subject|6|||
148702751|NCT05169710|536387459|FG000|Overall Study|Adverse Event|1|||
148702752|NCT05169710|536387460|FG001|Overall Study|Adverse Event|2|||
148702753|NCT05169710|536387461|FG002|Overall Study|Adverse Event|2|||
148702754|NCT05169710|536387459|FG000|Overall Study|Lost to Follow-up|0|||
148702755|NCT05169710|536387460|FG001|Overall Study|Lost to Follow-up|0|||
148702756|NCT05169710|536387461|FG002|Overall Study|Lost to Follow-up|1|||
148702757|NCT05169710|536387459|FG000|Overall Study|Withdrawal by Subject|2|||
148702758|NCT05169710|536387460|FG001|Overall Study|Withdrawal by Subject|1|||
148702759|NCT05169710|536387461|FG002|Overall Study|Withdrawal by Subject|0|||
148702760|NCT05169710|536387459|FG000|Overall Study|Other Study Discontinuation Reason|0|||
148702761|NCT05169710|536387460|FG001|Overall Study|Other Study Discontinuation Reason|2|||
148702762|NCT05169710|536387461|FG002|Overall Study|Other Study Discontinuation Reason|0|||
148702763|NCT01079988|536387462|FG000|Overall Study|Lost to Follow-up|0|||
148702764|NCT01079988|536387463|FG001|Overall Study|Lost to Follow-up|0|||
148702765|NCT01079988|536387464|FG002|Overall Study|Lost to Follow-up|0|||
148702766|NCT01079988|536387465|FG003|Overall Study|Lost to Follow-up|1|||
148702767|NCT01079988|536387466|FG004|Overall Study|Lost to Follow-up|0|||
148702768|NCT01079988|536387462|FG000|Overall Study|Lack of Efficacy|1|||
148702769|NCT01079988|536387463|FG001|Overall Study|Lack of Efficacy|0|||
148702770|NCT01079988|536387464|FG002|Overall Study|Lack of Efficacy|0|||
148702771|NCT01079988|536387465|FG003|Overall Study|Lack of Efficacy|0|||
148702772|NCT01079988|536387466|FG004|Overall Study|Lack of Efficacy|0|||
148702773|NCT01079988|536387462|FG000|Overall Study|Other|0|||
148702774|NCT01079988|536387463|FG001|Overall Study|Other|0|||
148702775|NCT01079988|536387464|FG002|Overall Study|Other|0|||
148702776|NCT01079988|536387465|FG003|Overall Study|Other|2|||
148702777|NCT01079988|536387466|FG004|Overall Study|Other|1|||
148702778|NCT01001208|536387467|FG000|Overall Study|Adverse Event|10|||
148702779|NCT01001208|536387468|FG001|Overall Study|Adverse Event|5|||
148702780|NCT01001208|536387467|FG000|Overall Study|Lost to Follow-up|5|||
148702781|NCT01001208|536387468|FG001|Overall Study|Lost to Follow-up|9|||
148702782|NCT01001208|536387467|FG000|Overall Study|Physician Decision|1|||
148702783|NCT01001208|536387468|FG001|Overall Study|Physician Decision|0|||
148702784|NCT01001208|536387467|FG000|Overall Study|Withdrawal by Subject|4|||
148702785|NCT01001208|536387468|FG001|Overall Study|Withdrawal by Subject|5|||
148702786|NCT01001208|536387467|FG000|Overall Study|Ineligibility Determined|4|||
148702787|NCT01001208|536387468|FG001|Overall Study|Ineligibility Determined|2|||
148967634|NCT00500292|537366781|FG002|Overall Study|Withdrawal by Subject|0|||
148967635|NCT00500292|537366779|FG000|Overall Study|Other|1|||
148967636|NCT00500292|537366780|FG001|Overall Study|Other|1|||
148967637|NCT00500292|537366781|FG002|Overall Study|Other|4|||
148702788|NCT01001208|536387467|FG000|Overall Study|Noncompliance|4|||
148702789|NCT01001208|536387468|FG001|Overall Study|Noncompliance|7|||
148702790|NCT01001208|536387467|FG000|Overall Study|Disease Progression|0|||
148702791|NCT01001208|536387468|FG001|Overall Study|Disease Progression|3|||
148702792|NCT01001208|536387467|FG000|Overall Study|Other|0|||
148702793|NCT01001208|536387468|FG001|Overall Study|Other|2|||
148702794|NCT03546842|536387469|FG000|Overall Study|Protocol Violation|1|||
148702795|NCT03546842|536387469|FG000|Overall Study|Withdrawal by Subject|2|||
148702796|NCT01723397|536387470|FG000|Study Period 1|Protocol Violation|0|||
148702797|NCT01723397|536387471|FG001|Study Period 1|Protocol Violation|1|||
148702798|NCT01723397|536387470|FG000|Study Period 2|Protocol Violation|0|||
148702799|NCT01723397|536387471|FG001|Study Period 2|Protocol Violation|1|||
148702800|NCT00833937|536387477|FG000|Washout|Withdrawal by Subject|1|||
148702801|NCT00833937|536387478|FG001|Washout|Withdrawal by Subject|0|||
148702802|NCT03031847|536387486|FG000|Overall Study|Death|1|||
148702803|NCT03031847|536387487|FG001|Overall Study|Death|1|||
148702804|NCT03031847|536387488|FG002|Overall Study|Death|2|||
148702805|NCT03031847|536387489|FG003|Overall Study|Death|3|||
148702806|NCT03031847|536387486|FG000|Overall Study|Lost to Follow-up|1|||
148702807|NCT03031847|536387487|FG001|Overall Study|Lost to Follow-up|1|||
148702808|NCT03031847|536387488|FG002|Overall Study|Lost to Follow-up|2|||
148702809|NCT03031847|536387489|FG003|Overall Study|Lost to Follow-up|3|||
148702810|NCT01353664|536387490|FG000|Overall Study|Other|3|||
148702811|NCT01353664|536387490|FG000|Overall Study|Disease Progression|16|||
148702812|NCT03273153|536387491|FG000|Overall Study|Adverse Event|1|||
148702813|NCT03273153|536387492|FG001|Overall Study|Adverse Event|2|||
148702814|NCT03273153|536387491|FG000|Overall Study|Missing|0|||
148702815|NCT03273153|536387492|FG001|Overall Study|Missing|2|||
148702816|NCT03273153|536387491|FG000|Overall Study|Other|3|||
148702817|NCT03273153|536387492|FG001|Overall Study|Other|2|||
148702818|NCT03273153|536387491|FG000|Overall Study|Symptomatic Deterioration|0|||
148702819|NCT03273153|536387492|FG001|Overall Study|Symptomatic Deterioration|1|||
148702820|NCT03273153|536387491|FG000|Overall Study|Progressive Disease|6|||
148702821|NCT03273153|536387492|FG001|Overall Study|Progressive Disease|5|||
148702822|NCT03273153|536387491|FG000|Overall Study|Physician Decision|1|||
148702823|NCT03273153|536387492|FG001|Overall Study|Physician Decision|3|||
148702824|NCT03273153|536387491|FG000|Overall Study|Study Terminated by Sponsor|112|||
148702825|NCT03273153|536387492|FG001|Overall Study|Study Terminated by Sponsor|102|||
148702826|NCT03273153|536387491|FG000|Overall Study|Withdrawal by Subject|26|||
148702827|NCT03273153|536387492|FG001|Overall Study|Withdrawal by Subject|25|||
148702828|NCT03273153|536387491|FG000|Overall Study|Protocol Deviation|3|||
148702829|NCT03273153|536387492|FG001|Overall Study|Protocol Deviation|0|||
148702830|NCT03273153|536387491|FG000|Overall Study|Lost to Follow-up|6|||
148702831|NCT03273153|536387492|FG001|Overall Study|Lost to Follow-up|11|||
148702832|NCT03273153|536387491|FG000|Overall Study|Death|66|||
148702833|NCT03273153|536387492|FG001|Overall Study|Death|69|||
148702834|NCT01237054|536387495|FG000|Overall Study|imaging 10C0096|1|||
148702835|NCT00838539|536387496|FG000|Overall Study|Disease Progression|2|||
148702836|NCT00838539|536387497|FG001|Overall Study|Disease Progression|4|||
148702837|NCT00838539|536387498|FG002|Overall Study|Disease Progression|3|||
148702838|NCT00838539|536387499|FG003|Overall Study|Disease Progression|2|||
148702839|NCT00838539|536387500|FG004|Overall Study|Disease Progression|4|||
148702840|NCT00838539|536387501|FG005|Overall Study|Disease Progression|2|||
148702841|NCT00838539|536387502|FG006|Overall Study|Disease Progression|3|||
148702842|NCT00838539|536387503|FG007|Overall Study|Disease Progression|4|||
148702843|NCT00838539|536387504|FG008|Overall Study|Disease Progression|4|||
148702844|NCT00838539|536387505|FG009|Overall Study|Disease Progression|5|||
148702845|NCT00838539|536387506|FG010|Overall Study|Disease Progression|1|||
148702846|NCT00838539|536387507|FG011|Overall Study|Disease Progression|4|||
148702847|NCT00838539|536387496|FG000|Overall Study|Adverse Event|1|||
148702848|NCT00838539|536387497|FG001|Overall Study|Adverse Event|1|||
148702849|NCT00838539|536387498|FG002|Overall Study|Adverse Event|1|||
148702850|NCT00838539|536387499|FG003|Overall Study|Adverse Event|1|||
148702851|NCT00838539|536387500|FG004|Overall Study|Adverse Event|2|||
148702852|NCT00838539|536387501|FG005|Overall Study|Adverse Event|1|||
148702853|NCT00838539|536387502|FG006|Overall Study|Adverse Event|0|||
148702854|NCT00838539|536387503|FG007|Overall Study|Adverse Event|2|||
148967638|NCT03065244|537366782|FG000|Overall Study|Lost to Follow-up|1|||
148702855|NCT00838539|536387504|FG008|Overall Study|Adverse Event|0|||
148702856|NCT00838539|536387505|FG009|Overall Study|Adverse Event|1|||
148702857|NCT00838539|536387506|FG010|Overall Study|Adverse Event|2|||
148702858|NCT00838539|536387507|FG011|Overall Study|Adverse Event|0|||
148702859|NCT00838539|536387496|FG000|Overall Study|Withdrawal by Subject|0|||
148702860|NCT00838539|536387497|FG001|Overall Study|Withdrawal by Subject|1|||
148702861|NCT00838539|536387498|FG002|Overall Study|Withdrawal by Subject|0|||
148702862|NCT00838539|536387499|FG003|Overall Study|Withdrawal by Subject|0|||
148702863|NCT00838539|536387500|FG004|Overall Study|Withdrawal by Subject|0|||
148702864|NCT00838539|536387501|FG005|Overall Study|Withdrawal by Subject|0|||
148702865|NCT00838539|536387502|FG006|Overall Study|Withdrawal by Subject|0|||
148702866|NCT00838539|536387503|FG007|Overall Study|Withdrawal by Subject|0|||
148702867|NCT00838539|536387504|FG008|Overall Study|Withdrawal by Subject|0|||
148702868|NCT00838539|536387505|FG009|Overall Study|Withdrawal by Subject|1|||
148702869|NCT00838539|536387506|FG010|Overall Study|Withdrawal by Subject|2|||
148702870|NCT00838539|536387507|FG011|Overall Study|Withdrawal by Subject|0|||
148702871|NCT00838539|536387496|FG000|Overall Study|Death|0|||
148702872|NCT00838539|536387497|FG001|Overall Study|Death|0|||
148702873|NCT00838539|536387498|FG002|Overall Study|Death|0|||
148702874|NCT00838539|536387499|FG003|Overall Study|Death|0|||
148702875|NCT00838539|536387500|FG004|Overall Study|Death|0|||
148702876|NCT00838539|536387501|FG005|Overall Study|Death|0|||
148702877|NCT00838539|536387502|FG006|Overall Study|Death|1|||
148702878|NCT00838539|536387503|FG007|Overall Study|Death|0|||
148702879|NCT00838539|536387504|FG008|Overall Study|Death|0|||
148702880|NCT00838539|536387505|FG009|Overall Study|Death|0|||
148702881|NCT00838539|536387506|FG010|Overall Study|Death|0|||
148702882|NCT00838539|536387507|FG011|Overall Study|Death|0|||
148702883|NCT00838539|536387496|FG000|Overall Study|Physician Decision|0|||
148702884|NCT00838539|536387497|FG001|Overall Study|Physician Decision|0|||
148702885|NCT00838539|536387498|FG002|Overall Study|Physician Decision|0|||
148702886|NCT00838539|536387499|FG003|Overall Study|Physician Decision|0|||
148702887|NCT00838539|536387500|FG004|Overall Study|Physician Decision|0|||
148702888|NCT00838539|536387501|FG005|Overall Study|Physician Decision|0|||
148702889|NCT00838539|536387502|FG006|Overall Study|Physician Decision|0|||
148702890|NCT00838539|536387503|FG007|Overall Study|Physician Decision|0|||
148702891|NCT00838539|536387504|FG008|Overall Study|Physician Decision|1|||
148967639|NCT03065244|537366783|FG001|Overall Study|Lost to Follow-up|1|||
148967640|NCT03065244|537366782|FG000|Overall Study|Diagnosed with a different disease|1|||
148702892|NCT00838539|536387505|FG009|Overall Study|Physician Decision|0|||
148702893|NCT00838539|536387506|FG010|Overall Study|Physician Decision|0|||
148702894|NCT00838539|536387507|FG011|Overall Study|Physician Decision|0|||
148702895|NCT00838539|536387496|FG000|Overall Study|Clinical Progression|0|||
148702896|NCT00838539|536387497|FG001|Overall Study|Clinical Progression|0|||
148702897|NCT00838539|536387498|FG002|Overall Study|Clinical Progression|0|||
148702898|NCT00838539|536387499|FG003|Overall Study|Clinical Progression|0|||
148702899|NCT00838539|536387500|FG004|Overall Study|Clinical Progression|0|||
148702900|NCT00838539|536387501|FG005|Overall Study|Clinical Progression|0|||
148702901|NCT00838539|536387502|FG006|Overall Study|Clinical Progression|1|||
148702902|NCT00838539|536387503|FG007|Overall Study|Clinical Progression|0|||
148702903|NCT00838539|536387504|FG008|Overall Study|Clinical Progression|0|||
148702904|NCT00838539|536387505|FG009|Overall Study|Clinical Progression|0|||
148702905|NCT00838539|536387506|FG010|Overall Study|Clinical Progression|0|||
148702906|NCT00838539|536387507|FG011|Overall Study|Clinical Progression|0|||
148702907|NCT00838539|536387496|FG000|Overall Study|Symptomatic Deterioration|0|||
148702908|NCT00838539|536387497|FG001|Overall Study|Symptomatic Deterioration|0|||
148702909|NCT00838539|536387498|FG002|Overall Study|Symptomatic Deterioration|1|||
148702910|NCT00838539|536387499|FG003|Overall Study|Symptomatic Deterioration|1|||
148702911|NCT00838539|536387500|FG004|Overall Study|Symptomatic Deterioration|0|||
148702912|NCT00838539|536387501|FG005|Overall Study|Symptomatic Deterioration|1|||
148702913|NCT00838539|536387502|FG006|Overall Study|Symptomatic Deterioration|0|||
148702914|NCT00838539|536387503|FG007|Overall Study|Symptomatic Deterioration|0|||
148702915|NCT00838539|536387504|FG008|Overall Study|Symptomatic Deterioration|0|||
148702916|NCT00838539|536387505|FG009|Overall Study|Symptomatic Deterioration|1|||
148702917|NCT00838539|536387506|FG010|Overall Study|Symptomatic Deterioration|0|||
148702918|NCT00838539|536387507|FG011|Overall Study|Symptomatic Deterioration|0|||
148702919|NCT01908205|536387508|FG000|Overall Study|Lost to Follow-up|2|||
148702920|NCT01908205|536387509|FG001|Overall Study|Lost to Follow-up|0|||
148702921|NCT01908205|536387508|FG000|Overall Study|Withdrawal by Subject|3|||
148702922|NCT01908205|536387509|FG001|Overall Study|Withdrawal by Subject|1|||
148702923|NCT05323396|536387510|FG000|Overall Study|Lost to Follow-up|1|||
148702924|NCT05323396|536387511|FG001|Overall Study|Lost to Follow-up|35|||
148702925|NCT05323396|536387510|FG000|Overall Study|Pregnancy|1|||
148702926|NCT05323396|536387511|FG001|Overall Study|Pregnancy|0|||
148702927|NCT00095212|536387520|FG000|Overall Study|Withdrawal by Subject|1|||
148702928|NCT00095212|536387521|FG001|Overall Study|Withdrawal by Subject|3|||
148702929|NCT02242201|536387524|FG000|Overall Study|preoperative identified neuropathy|2|||
148702930|NCT02242201|536387525|FG001|Overall Study|preoperative identified neuropathy|0|||
148702931|NCT02242201|536387526|FG002|Overall Study|preoperative identified neuropathy|0|||
148702932|NCT02242201|536387524|FG000|Overall Study|planned post-op anticoagulation|1|||
148702933|NCT02242201|536387525|FG001|Overall Study|planned post-op anticoagulation|0|||
148702934|NCT02242201|536387526|FG002|Overall Study|planned post-op anticoagulation|0|||
148702935|NCT02242201|536387524|FG000|Overall Study|changed surgical procedure|1|||
148702936|NCT02242201|536387525|FG001|Overall Study|changed surgical procedure|0|||
148702937|NCT02242201|536387526|FG002|Overall Study|changed surgical procedure|0|||
148702938|NCT02242201|536387524|FG000|Overall Study|postponed surgery|0|||
148702939|NCT02242201|536387525|FG001|Overall Study|postponed surgery|0|||
148702940|NCT02242201|536387526|FG002|Overall Study|postponed surgery|1|||
148702941|NCT02242201|536387524|FG000|Overall Study|preoperative opioid consumption|0|||
148702942|NCT02242201|536387525|FG001|Overall Study|preoperative opioid consumption|1|||
148702943|NCT02242201|536387526|FG002|Overall Study|preoperative opioid consumption|0|||
148702944|NCT01697696|536387527|FG000|Overall Study|Study terminated by sponsor|0|||
148702945|NCT01697696|536387528|FG001|Overall Study|Study terminated by sponsor|3|||
148702946|NCT01697696|536387527|FG000|Overall Study|Protocol deviation|1|||
148702947|NCT01697696|536387528|FG001|Overall Study|Protocol deviation|0|||
148702948|NCT01697696|536387527|FG000|Overall Study|Physician Decision|1|||
148702949|NCT01697696|536387528|FG001|Overall Study|Physician Decision|0|||
148702950|NCT01697696|536387527|FG000|Overall Study|Death|4|||
148702951|NCT01697696|536387528|FG001|Overall Study|Death|2|||
148702952|NCT01697696|536387527|FG000|Overall Study|Lost to Follow-up|10|||
148702953|NCT01697696|536387528|FG001|Overall Study|Lost to Follow-up|7|||
148702954|NCT01697696|536387527|FG000|Overall Study|Subject/guardian decision|31|||
148702955|NCT01697696|536387528|FG001|Overall Study|Subject/guardian decision|35|||
148702956|NCT01424644|536387529|FG000|Overall Study|Adverse Event|2|||
148702957|NCT01424644|536387530|FG001|Overall Study|Adverse Event|0|||
148702958|NCT01424644|536387529|FG000|Overall Study|Withdrawal by Subject|9|||
148702959|NCT01424644|536387530|FG001|Overall Study|Withdrawal by Subject|12|||
148702960|NCT01424644|536387529|FG000|Overall Study|Lost to Follow-up|16|||
148702961|NCT01424644|536387530|FG001|Overall Study|Lost to Follow-up|12|||
148702962|NCT01424644|536387529|FG000|Overall Study|Protocol Violation|4|||
148702963|NCT01424644|536387530|FG001|Overall Study|Protocol Violation|3|||
148702964|NCT01424644|536387529|FG000|Overall Study|Administrative Reason|1|||
148702965|NCT01424644|536387530|FG001|Overall Study|Administrative Reason|0|||
148702966|NCT01424644|536387529|FG000|Overall Study|Unable to Classify|1|||
148702967|NCT01424644|536387530|FG001|Overall Study|Unable to Classify|0|||
148702968|NCT05593965|536387531|FG000|1st Intervention (1 Day)|Technical error|1|||
148702969|NCT05593965|536387532|FG001|1st Intervention (1 Day)|Technical error|0|||
148702970|NCT02066922|536387533|FG000|Overall Study|Adverse Event|1|||
148702971|NCT03020641|536387534|FG000|Overall Study|Lost to Follow-up|0|||
148702972|NCT03020641|536387535|FG001|Overall Study|Lost to Follow-up|1|||
148702973|NCT03020641|536387534|FG000|Overall Study|Converted to open surgery|2|||
148702974|NCT03020641|536387535|FG001|Overall Study|Converted to open surgery|1|||
148702975|NCT03020641|536387534|FG000|Overall Study|for surgery not performed|0|||
148702976|NCT03020641|536387535|FG001|Overall Study|for surgery not performed|1|||
148702977|NCT04611789|536387536|FG000|Overall Study|Lost to Follow-up|1|||
148702978|NCT04611789|536387537|FG001|Overall Study|Lost to Follow-up|0|||
148702979|NCT04611789|536387538|FG002|Overall Study|Lost to Follow-up|0|||
148702980|NCT00727961|536387540|FG000|Overall Study|Lost to Follow-up|1|||
148702981|NCT00727961|536387540|FG000|Overall Study|Adverse Event|4|||
148702982|NCT00727961|536387540|FG000|Overall Study|Patient's refusal|2|||
148702983|NCT00727961|536387540|FG000|Overall Study|Progression|30|||
148702984|NCT03238781|536387541|FG000|Overall Study|Adverse Event|1|||
148702985|NCT03238781|536387542|FG001|Overall Study|Adverse Event|1|||
148702986|NCT03238781|536387543|FG002|Overall Study|Adverse Event|2|||
148702987|NCT03238781|536387541|FG000|Overall Study|Lost to Follow-up|2|||
148702988|NCT03238781|536387542|FG001|Overall Study|Lost to Follow-up|1|||
148702989|NCT03238781|536387543|FG002|Overall Study|Lost to Follow-up|2|||
148702990|NCT03238781|536387541|FG000|Overall Study|Withdrawal by Subject|23|||
148702991|NCT03238781|536387542|FG001|Overall Study|Withdrawal by Subject|14|||
148702992|NCT03238781|536387543|FG002|Overall Study|Withdrawal by Subject|16|||
148702993|NCT03238781|536387541|FG000|Overall Study|Decision by sponsor|0|||
148702994|NCT03238781|536387542|FG001|Overall Study|Decision by sponsor|1|||
148702995|NCT03238781|536387543|FG002|Overall Study|Decision by sponsor|0|||
148702996|NCT03161405|536387544|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
148702997|NCT00837486|536387545|FG000|Blinded-treatment Phase|Physician Decision|1|||
148702998|NCT00837486|536387546|FG001|Blinded-treatment Phase|Physician Decision|0|||
148702999|NCT00837486|536387545|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
148703000|NCT00837486|536387546|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
148703001|NCT00837486|536387545|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
148703002|NCT00837486|536387546|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
148703003|NCT00837486|536387545|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
148703004|NCT00837486|536387546|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
148703005|NCT01597245|536387547|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
148703006|NCT01597245|536387548|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
148703007|NCT01597245|536387549|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
148703008|NCT01597245|536387550|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
148703009|NCT01597245|536387551|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703010|NCT01597245|536387552|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703011|NCT01597245|536387553|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703012|NCT01597245|536387554|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703013|NCT01597245|536387555|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703014|NCT01597245|536387556|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703015|NCT01597245|536387557|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703016|NCT01597245|536387558|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703017|NCT01597245|536387559|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703018|NCT01597245|536387560|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703019|NCT01597245|536387561|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703020|NCT01597245|536387562|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703021|NCT01597245|536387563|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703022|NCT01597245|536387564|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703023|NCT01597245|536387565|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703024|NCT01597245|536387566|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703025|NCT01597245|536387567|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
148703026|NCT01597245|536387547|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
148703027|NCT01597245|536387548|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
148703028|NCT01597245|536387549|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
148703029|NCT01597245|536387550|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
148703030|NCT01597245|536387551|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703031|NCT01597245|536387552|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703032|NCT01597245|536387553|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703033|NCT01597245|536387554|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703034|NCT01597245|536387555|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703035|NCT01597245|536387556|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703036|NCT01597245|536387557|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703037|NCT01597245|536387558|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703038|NCT01597245|536387559|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703039|NCT01597245|536387560|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703040|NCT01597245|536387561|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703041|NCT01597245|536387562|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703042|NCT01597245|536387563|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703043|NCT01597245|536387564|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703044|NCT01597245|536387565|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703045|NCT01597245|536387566|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148703046|NCT01597245|536387567|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
148815037|NCT02872714|536798094|FG002|Overall Study|Death|8|||
148703047|NCT01597245|536387547|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
148703048|NCT01597245|536387548|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
148703049|NCT01597245|536387549|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
148703050|NCT01597245|536387550|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
148703051|NCT01597245|536387551|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703052|NCT01597245|536387552|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703053|NCT01597245|536387553|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703054|NCT01597245|536387554|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703055|NCT01597245|536387555|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703056|NCT01597245|536387556|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703057|NCT01597245|536387557|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703058|NCT01597245|536387558|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703059|NCT01597245|536387559|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703060|NCT01597245|536387560|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703061|NCT01597245|536387561|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703062|NCT01597245|536387562|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703063|NCT01597245|536387563|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703064|NCT01597245|536387564|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703065|NCT01597245|536387565|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703066|NCT01597245|536387566|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703067|NCT01597245|536387567|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
148703068|NCT01597245|536387547|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
148703069|NCT01597245|536387548|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
148703070|NCT01597245|536387549|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
148703071|NCT01597245|536387550|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703072|NCT01597245|536387551|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703073|NCT01597245|536387552|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703074|NCT01597245|536387553|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703075|NCT01597245|536387554|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703076|NCT01597245|536387555|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703077|NCT01597245|536387556|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703078|NCT01597245|536387557|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703079|NCT01597245|536387558|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703080|NCT01597245|536387559|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703081|NCT01597245|536387560|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703082|NCT01597245|536387561|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703083|NCT01597245|536387562|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703084|NCT01597245|536387563|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703085|NCT01597245|536387564|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703086|NCT01597245|536387565|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703087|NCT01597245|536387566|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703088|NCT01597245|536387567|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
148703089|NCT01597245|536387547|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
148703090|NCT01597245|536387548|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703091|NCT01597245|536387549|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703092|NCT01597245|536387550|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
148703093|NCT01597245|536387551|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703094|NCT01597245|536387552|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703095|NCT01597245|536387553|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703096|NCT01597245|536387554|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703097|NCT01597245|536387555|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703098|NCT01597245|536387556|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703099|NCT01597245|536387557|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703100|NCT01597245|536387558|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703101|NCT01597245|536387559|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703102|NCT01597245|536387560|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703103|NCT01597245|536387561|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703104|NCT01597245|536387562|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703105|NCT01597245|536387563|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703106|NCT01597245|536387564|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703107|NCT01597245|536387565|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703108|NCT01597245|536387566|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148703109|NCT01597245|536387567|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
148815038|NCT02872714|536798095|FG003|Overall Study|Death|81|||
148815039|NCT02872714|536798096|FG004|Overall Study|Death|2|||
148815040|NCT02872714|536798092|FG000|Overall Study|Lost to Follow-up|2|||
148703110|NCT01597245|536387547|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
148703111|NCT01597245|536387548|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
148703112|NCT01597245|536387549|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
148703113|NCT01597245|536387550|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703114|NCT01597245|536387551|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703115|NCT01597245|536387552|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703116|NCT01597245|536387553|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703117|NCT01597245|536387554|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703118|NCT01597245|536387555|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703119|NCT01597245|536387556|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703120|NCT01597245|536387557|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703121|NCT01597245|536387558|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703122|NCT01597245|536387559|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703123|NCT01597245|536387560|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703124|NCT01597245|536387561|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703125|NCT01597245|536387562|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703126|NCT01597245|536387563|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703127|NCT01597245|536387564|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703128|NCT01597245|536387565|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703129|NCT01597245|536387566|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703130|NCT01597245|536387567|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
148703131|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703132|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703133|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703134|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703135|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703136|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
148703137|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
148703138|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703139|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703140|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703141|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703142|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703143|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703144|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703145|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703146|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703147|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703148|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703149|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703150|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703151|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
148703152|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703153|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703154|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703155|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703156|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
148703157|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
148703158|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
148703159|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
148703160|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703161|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
148703162|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703163|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703164|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703165|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703166|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703167|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703168|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703169|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703170|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703171|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703172|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
148703173|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703174|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148815041|NCT02872714|536798093|FG001|Overall Study|Lost to Follow-up|1|||
148703175|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703176|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703177|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703178|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
148703179|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703180|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703181|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
148703182|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703183|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
148703184|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
148703185|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
148703186|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703187|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703188|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703189|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703190|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703191|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703192|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703193|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
148703194|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703195|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703196|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703197|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703198|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
148703199|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
148703200|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
148703201|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
148703202|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
148703203|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
148703204|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
148703205|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
148703206|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
148703207|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703208|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703209|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703210|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703211|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703212|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703213|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703214|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
148703215|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703216|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703217|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703218|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703219|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
148703220|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
148703221|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
148703222|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703223|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
148703224|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
148703225|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
148703226|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
148703227|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
148703228|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703229|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703230|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703231|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703232|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703233|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703234|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703235|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
148703236|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703237|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148815042|NCT02872714|536798094|FG002|Overall Study|Lost to Follow-up|0|||
148967641|NCT03065244|537366783|FG001|Overall Study|Diagnosed with a different disease|1|||
148967642|NCT03065244|537366782|FG000|Overall Study|Protocol Violation|0|||
148967643|NCT03065244|537366783|FG001|Overall Study|Protocol Violation|1|||
148703238|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703239|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703240|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
148703241|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703242|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703243|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703244|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
148703245|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
148703246|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
148703247|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703248|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
148703249|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703250|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703251|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703252|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703253|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703254|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703255|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703256|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
148703257|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703258|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703259|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703260|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703261|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
148703262|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
148703263|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
148703264|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703265|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
148703266|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
148703267|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
148703268|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
148703269|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
148703270|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703271|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703272|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703273|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703274|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703275|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703276|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703277|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
148703278|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703279|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703280|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703281|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703282|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703283|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
148703284|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703285|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703286|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
148703287|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
148703288|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
148703289|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
148703290|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703291|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703292|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703293|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703294|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703295|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703296|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703297|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
149025081|NCT04170023|537568006|FG002|LTE Period|Withdrawal by Subject|0|||
148967644|NCT03065244|537366782|FG000|Overall Study|Withdrawal by Subject|1|||
148967645|NCT03065244|537366783|FG001|Overall Study|Withdrawal by Subject|1|||
148967646|NCT03717480|537366784|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
148967647|NCT04809220|537366787|FG000|Overall Study|Adverse Event|4|||
148967648|NCT04809220|537366788|FG001|Overall Study|Adverse Event|0|||
148967649|NCT04809220|537366787|FG000|Overall Study|Death|1|||
148967650|NCT04809220|537366788|FG001|Overall Study|Death|0|||
148967651|NCT04809220|537366787|FG000|Overall Study|Lost to Follow-up|3|||
148815043|NCT02872714|536798095|FG003|Overall Study|Lost to Follow-up|3|||
148703298|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
148703299|NCT01597245|536387547|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703300|NCT01597245|536387548|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703301|NCT01597245|536387549|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703302|NCT01597245|536387550|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703303|NCT01597245|536387551|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703304|NCT01597245|536387552|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703305|NCT01597245|536387553|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703306|NCT01597245|536387554|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703307|NCT01597245|536387555|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703308|NCT01597245|536387556|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703309|NCT01597245|536387557|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
148703310|NCT01597245|536387558|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703311|NCT01597245|536387559|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703312|NCT01597245|536387560|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703313|NCT01597245|536387561|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703314|NCT01597245|536387562|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703315|NCT01597245|536387563|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703316|NCT01597245|536387564|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703317|NCT01597245|536387565|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703318|NCT01597245|536387566|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703319|NCT01597245|536387567|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
148703320|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703321|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703322|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703323|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703324|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703325|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703326|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703327|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703328|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703329|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703330|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703331|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703332|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703333|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
148703334|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
148703335|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
148703336|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703337|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703338|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703339|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703340|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
148703341|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703342|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703343|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703344|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703345|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703346|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703347|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703348|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703349|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703350|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703351|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703352|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703353|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703354|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
148703355|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
148703356|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
148815044|NCT02872714|536798096|FG004|Overall Study|Lost to Follow-up|0|||
148703357|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703358|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148815045|NCT02872714|536798092|FG000|Overall Study|Physician Decision|0|||
148703359|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148815046|NCT02872714|536798093|FG001|Overall Study|Physician Decision|0|||
148703360|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703361|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
148703362|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703363|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703364|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703365|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703366|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703367|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703368|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703369|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703370|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703371|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703372|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703373|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703374|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703375|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703376|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
148703377|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
148703378|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703379|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703380|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703381|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703382|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
148703383|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703384|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703385|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703386|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703387|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703388|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703389|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703390|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703391|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703392|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703393|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703394|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703395|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703396|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703397|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
148703398|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
148703399|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703400|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703401|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703402|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703403|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
148703404|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703405|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703406|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703407|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703408|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703409|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703410|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703411|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703412|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703413|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703414|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703415|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703416|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703417|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
148703418|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
148703419|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
148703420|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703421|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703422|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703423|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703424|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
148703425|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703426|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703427|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703428|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703429|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703430|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703431|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703432|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703433|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703434|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703435|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703436|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703437|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703438|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703439|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
148703440|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
148703441|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703442|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703443|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703444|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703445|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
148703446|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703447|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703448|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703449|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703450|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703451|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703452|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703453|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703454|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703455|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703456|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703457|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703458|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703459|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703460|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
148703461|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
148703462|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703463|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703464|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703465|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703466|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
148703467|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703468|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703469|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703470|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703471|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703472|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703473|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703474|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703475|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703476|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703477|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703478|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703479|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703480|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703481|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
148703482|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
148703483|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703484|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703485|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703486|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148967652|NCT04809220|537366788|FG001|Overall Study|Lost to Follow-up|0|||
148967653|NCT04809220|537366787|FG000|Overall Study|Physician Decision|0|||
148703487|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
148703488|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703489|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148967654|NCT04809220|537366788|FG001|Overall Study|Physician Decision|1|||
148967655|NCT04809220|537366787|FG000|Overall Study|Withdrawal by Subject|9|||
148703490|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703491|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703492|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703493|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703494|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703495|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703496|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703497|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703498|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703499|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703500|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703501|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703502|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
148703503|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
148703504|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703505|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703506|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703507|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703508|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
148703509|NCT01597245|536387547|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703510|NCT01597245|536387548|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703511|NCT01597245|536387549|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703512|NCT01597245|536387550|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703513|NCT01597245|536387551|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703514|NCT01597245|536387552|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703515|NCT01597245|536387553|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703516|NCT01597245|536387554|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703517|NCT01597245|536387555|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703518|NCT01597245|536387556|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703519|NCT01597245|536387557|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703520|NCT01597245|536387558|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703521|NCT01597245|536387559|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703522|NCT01597245|536387560|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
148703523|NCT01597245|536387561|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703524|NCT01597245|536387562|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703525|NCT01597245|536387563|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703526|NCT01597245|536387564|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703527|NCT01597245|536387565|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703528|NCT01597245|536387566|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703529|NCT01597245|536387567|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
148703530|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703531|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703532|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703533|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703534|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703535|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703536|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703537|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703538|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703539|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703540|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148967656|NCT04809220|537366788|FG001|Overall Study|Withdrawal by Subject|5|||
148967657|NCT04809220|537366787|FG000|Overall Study|Due to long-term overseas business trips|1|||
148967658|NCT04809220|537366788|FG001|Overall Study|Due to long-term overseas business trips|0|||
148967659|NCT02120794|537366792|FG000|Overall Study|Withdrawal by Subject|43|||
148967660|NCT02120794|537366792|FG000|Overall Study|Adverse Event|10|||
148703541|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148967661|NCT02120794|537366792|FG000|Overall Study|Physician Decision|4|||
148967662|NCT02120794|537366792|FG000|Overall Study|Due to insurance coverage|1|||
148967663|NCT00994240|537366794|FG000|Overall Study|Lost to Follow-up|3|||
148967664|NCT00994240|537366795|FG001|Overall Study|Lost to Follow-up|2|||
148703542|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703543|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703544|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703545|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
148703546|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
148703547|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
148703548|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
148703549|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
148703550|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
148703551|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703552|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703553|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703554|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703555|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703556|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703557|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703558|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703559|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703560|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703561|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703562|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703563|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703564|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703565|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703566|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703567|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
148703568|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
148703569|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
148703570|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
148703571|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
148967665|NCT00994240|537366794|FG000|Overall Study|Withdrawal by Subject|1|||
148967666|NCT00994240|537366795|FG001|Overall Study|Withdrawal by Subject|0|||
148967667|NCT00994240|537366794|FG000|Overall Study|study termination|2|||
148703572|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703573|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703574|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703575|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703576|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703577|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703578|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703579|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703580|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703581|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703582|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703583|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703584|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703585|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703586|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148967668|NCT00994240|537366795|FG001|Overall Study|study termination|3|||
148967669|NCT00896337|537366800|FG000|Overall Study|Death|7|||
148703587|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703588|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
148967670|NCT00896337|537366800|FG000|Overall Study|Withdrawal by Subject|7|||
148967671|NCT00896337|537366800|FG000|Overall Study|Lost to Follow-up|11|||
148967672|NCT01063595|537366808|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
148967673|NCT01063595|537366809|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
148967674|NCT01063595|537366808|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
148967675|NCT01063595|537366809|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
148967676|NCT01063595|537366808|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
148967677|NCT01063595|537366809|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
148967678|NCT01063595|537366808|FG000|First Intervention|Adverse Event|1|||
148967679|NCT01063595|537366809|FG001|First Intervention|Adverse Event|4|||
148967680|NCT01063595|537366808|FG000|First Intervention|Withdrawal by Subject|1|||
148967681|NCT01063595|537366809|FG001|First Intervention|Withdrawal by Subject|0|||
148967682|NCT01063595|537366808|FG000|First Intervention|Reason not Specified|0|||
148967683|NCT01063595|537366809|FG001|First Intervention|Reason not Specified|1|||
148967684|NCT00082433|537366816|FG000|Overall Study|Adverse Event|12|||
148967685|NCT00082433|537366817|FG001|Overall Study|Adverse Event|17|||
148967686|NCT00082433|537366816|FG000|Overall Study|Death|8|||
148967687|NCT00082433|537366817|FG001|Overall Study|Death|18|||
148967688|NCT00082433|537366816|FG000|Overall Study|Disease Progression/Relapse|270|||
148967689|NCT00082433|537366817|FG001|Overall Study|Disease Progression/Relapse|388|||
148967690|NCT00082433|537366816|FG000|Overall Study|Physician Decision|50|||
148967691|NCT00082433|537366817|FG001|Overall Study|Physician Decision|61|||
148967692|NCT00082433|537366816|FG000|Overall Study|Lost to Follow-up|1|||
148967693|NCT00082433|537366817|FG001|Overall Study|Lost to Follow-up|2|||
148703589|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703590|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
148703591|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
148703592|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
148703593|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703594|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703595|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703596|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703597|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703598|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703599|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703600|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703601|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703602|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703603|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703604|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703605|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703606|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703607|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703608|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703609|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703610|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
148703611|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
148703612|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
148703613|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
148703614|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703615|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703616|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148815047|NCT02872714|536798094|FG002|Overall Study|Physician Decision|0|||
148815048|NCT02872714|536798095|FG003|Overall Study|Physician Decision|1|||
148815049|NCT02872714|536798096|FG004|Overall Study|Physician Decision|0|||
148815050|NCT02872714|536798092|FG000|Overall Study|Withdrawal by Subject|1|||
148815051|NCT02872714|536798093|FG001|Overall Study|Withdrawal by Subject|3|||
148815052|NCT02872714|536798094|FG002|Overall Study|Withdrawal by Subject|0|||
148815053|NCT02872714|536798095|FG003|Overall Study|Withdrawal by Subject|2|||
148815054|NCT02872714|536798096|FG004|Overall Study|Withdrawal by Subject|0|||
148815055|NCT02872714|536798092|FG000|Overall Study|Captured as Other|2|||
148815056|NCT02872714|536798093|FG001|Overall Study|Captured as Other|0|||
148815057|NCT02872714|536798094|FG002|Overall Study|Captured as Other|0|||
148815058|NCT02872714|536798095|FG003|Overall Study|Captured as Other|1|||
148815059|NCT02872714|536798096|FG004|Overall Study|Captured as Other|0|||
148815060|NCT03599713|536798099|FG000|Overall Study|Death|38|||
148815061|NCT03599713|536798100|FG001|Overall Study|Death|3|||
148815062|NCT03599713|536798099|FG000|Overall Study|Withdrawal by Subject|17|||
148815063|NCT03599713|536798100|FG001|Overall Study|Withdrawal by Subject|0|||
148815064|NCT03599713|536798099|FG000|Overall Study|Lost to Follow-up|4|||
148815065|NCT03599713|536798100|FG001|Overall Study|Lost to Follow-up|0|||
148815066|NCT03599713|536798099|FG000|Overall Study|Discontinued Due to End of Study|42|||
148815067|NCT03599713|536798100|FG001|Overall Study|Discontinued Due to End of Study|3|||
148815068|NCT02737618|536799388|FG000|Overall Study|Withdrawal by Subject|9|||
148815069|NCT02260986|536799396|FG000|Overall Study|Adverse Event|24|||
148815070|NCT02260986|536799397|FG001|Overall Study|Adverse Event|0|||
148815071|NCT02260986|536799398|FG002|Overall Study|Adverse Event|11|||
148815072|NCT02260986|536799396|FG000|Overall Study|Lack of Efficacy|27|||
148815073|NCT02260986|536799397|FG001|Overall Study|Lack of Efficacy|3|||
148815074|NCT02260986|536799398|FG002|Overall Study|Lack of Efficacy|0|||
148815075|NCT02260986|536799396|FG000|Overall Study|Protocol Violation|14|||
148815076|NCT02260986|536799397|FG001|Overall Study|Protocol Violation|5|||
148815077|NCT02260986|536799398|FG002|Overall Study|Protocol Violation|16|||
148815078|NCT02260986|536799396|FG000|Overall Study|Car accident|0|||
148815079|NCT02260986|536799397|FG001|Overall Study|Car accident|0|||
148815080|NCT02260986|536799398|FG002|Overall Study|Car accident|1|||
148815081|NCT02260986|536799396|FG000|Overall Study|Withdrawal by Subject|17|||
148815082|NCT02260986|536799397|FG001|Overall Study|Withdrawal by Subject|4|||
148815083|NCT02260986|536799398|FG002|Overall Study|Withdrawal by Subject|9|||
148815084|NCT02260986|536799396|FG000|Overall Study|Incorrect randomization|0|||
148815085|NCT02260986|536799397|FG001|Overall Study|Incorrect randomization|1|||
148815086|NCT02260986|536799398|FG002|Overall Study|Incorrect randomization|0|||
148815087|NCT02260986|536799396|FG000|Overall Study|Lack of investigation product supply|2|||
148815088|NCT02260986|536799397|FG001|Overall Study|Lack of investigation product supply|0|||
148815089|NCT02260986|536799398|FG002|Overall Study|Lack of investigation product supply|1|||
148815090|NCT02260986|536799396|FG000|Overall Study|Lost to Follow-up|4|||
148815091|NCT02260986|536799397|FG001|Overall Study|Lost to Follow-up|0|||
148815092|NCT02260986|536799398|FG002|Overall Study|Lost to Follow-up|3|||
148815093|NCT02260986|536799396|FG000|Overall Study|Pregnancy|2|||
148815094|NCT02260986|536799397|FG001|Overall Study|Pregnancy|0|||
148703617|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703618|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703619|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703620|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703621|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703622|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703623|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703624|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703625|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703626|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703627|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703628|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703629|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703630|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
148703631|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703632|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
148703633|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
148703634|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
148703635|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703636|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703637|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703638|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703639|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703640|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703641|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703642|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703643|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703644|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703645|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703646|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703647|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703648|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703649|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703650|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703651|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
148703652|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703653|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
148703654|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
148703655|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
148703656|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703657|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703658|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703659|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703660|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703661|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703662|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148815095|NCT02260986|536799398|FG002|Overall Study|Pregnancy|0|||
148967694|NCT00082433|537366816|FG000|Overall Study|Study Drug Toxicity|179|||
148967695|NCT00082433|537366817|FG001|Overall Study|Study Drug Toxicity|66|||
148967696|NCT00082433|537366816|FG000|Overall Study|Withdrawal by Subject|55|||
148967697|NCT00082433|537366817|FG001|Overall Study|Withdrawal by Subject|30|||
148967698|NCT00082433|537366816|FG000|Overall Study|Still On Treatment|2|||
148967699|NCT00082433|537366817|FG001|Overall Study|Still On Treatment|1|||
148967700|NCT00082433|537366816|FG000|Overall Study|Not Treated|12|||
148703663|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703664|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703665|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703666|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703667|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703668|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703669|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703670|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703671|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703672|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
148703673|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703674|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703675|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
148703676|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
148703677|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703678|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703679|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703680|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703681|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703682|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703683|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703684|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703685|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703686|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703687|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703688|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703689|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703690|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703691|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703692|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703693|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
148703694|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703695|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703696|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
148703697|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
148703698|NCT01597245|536387547|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703699|NCT01597245|536387548|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703700|NCT01597245|536387549|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703701|NCT01597245|536387550|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703702|NCT01597245|536387551|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703703|NCT01597245|536387552|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703704|NCT01597245|536387553|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703705|NCT01597245|536387554|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703706|NCT01597245|536387555|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703707|NCT01597245|536387556|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703708|NCT01597245|536387557|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703709|NCT01597245|536387558|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703710|NCT01597245|536387559|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703711|NCT01597245|536387560|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703712|NCT01597245|536387561|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703713|NCT01597245|536387562|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703714|NCT01597245|536387563|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703715|NCT01597245|536387564|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703716|NCT01597245|536387565|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148703717|NCT01597245|536387566|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
148703718|NCT01597245|536387567|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
148967701|NCT00082433|537366817|FG001|Overall Study|Not Treated|11|||
148967702|NCT00082433|537366816|FG000|Overall Study|Ineligible|2|||
148967703|NCT00082433|537366817|FG001|Overall Study|Ineligible|1|||
148967704|NCT00082433|537366816|FG000|Overall Study|Noncompliance|2|||
148967705|NCT00082433|537366817|FG001|Overall Study|Noncompliance|1|||
148967706|NCT00082433|537366816|FG000|Overall Study|New primary cancer|1|||
148967707|NCT00082433|537366817|FG001|Overall Study|New primary cancer|0|||
148967708|NCT00082433|537366816|FG000|Overall Study|Impending surgery|0|||
148967709|NCT00082433|537366817|FG001|Overall Study|Impending surgery|1|||
148967710|NCT01796197|537366818|FG000|Overall Study|Lost to Follow-up|1|||
148967711|NCT01796197|537366818|FG000|Overall Study|Lack of Efficacy|1|||
148967712|NCT04097821|537366819|FG000|Overall Study|Subject Decision|0|||
148967713|NCT04097821|537366820|FG001|Overall Study|Subject Decision|0|||
148967714|NCT04097821|537366821|FG002|Overall Study|Subject Decision|0|||
148967715|NCT04097821|537366822|FG003|Overall Study|Subject Decision|1|||
148967716|NCT04097821|537366823|FG004|Overall Study|Subject Decision|2|||
148703719|NCT00731783|536387568|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
148703720|NCT00731783|536387569|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
148703721|NCT00731783|536387568|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
148703722|NCT00731783|536387569|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
148703723|NCT00731783|536387568|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
148703724|NCT00731783|536387569|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
148703725|NCT00731783|536387568|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
148703726|NCT00731783|536387569|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
148703727|NCT02267187|536388996|FG000|Overall Study|Physician Decision|2|||
148703728|NCT02267187|536388996|FG000|Overall Study|Screen fail|3|||
148703729|NCT02222818|536388997|FG000|Period 1|Eligibility criteria not met|0|||
148703730|NCT02222818|536388998|FG001|Period 1|Eligibility criteria not met|3|||
148703731|NCT03874715|536389003|FG000|Overall Study|Adverse Event|2|||
148703732|NCT03874715|536389004|FG001|Overall Study|Adverse Event|0|||
148703733|NCT03874715|536389003|FG000|Overall Study|Poor compliance to protocol|5|||
148703734|NCT03874715|536389004|FG001|Overall Study|Poor compliance to protocol|1|||
148703735|NCT03874715|536389003|FG000|Overall Study|Withdrawal by Subject|1|||
148703736|NCT03874715|536389004|FG001|Overall Study|Withdrawal by Subject|0|||
148703737|NCT03874715|536389003|FG000|Overall Study|Other-unspecified|1|||
148703738|NCT03874715|536389004|FG001|Overall Study|Other-unspecified|0|||
148703739|NCT00461786|536389005|FG000|Overall Study|Entry Criteria Not Met|2|||
148703740|NCT00461786|536389005|FG000|Overall Study|Inevaluable (Never Treated)|1|||
148703741|NCT00835991|536389008|FG000|First Intervention|Adverse Event|0|||
148703742|NCT00835991|536389009|FG001|First Intervention|Adverse Event|1|||
148703743|NCT00835991|536389008|FG000|Washout|Protocol Violation|0|||
148703744|NCT00835991|536389009|FG001|Washout|Protocol Violation|2|||
148703745|NCT00835991|536389008|FG000|Washout|Withdrawal by Subject|3|||
148703746|NCT00835991|536389009|FG001|Washout|Withdrawal by Subject|1|||
148703747|NCT00829309|536389010|FG000|Washout: 7 Days|Protocol Violation|1|||
148703748|NCT00829309|536389011|FG001|Washout: 7 Days|Protocol Violation|0|||
148703749|NCT01705574|536389012|FG000|Double-Blind Phase|Lost to Follow-up|12|||
148703750|NCT01705574|536389013|FG001|Double-Blind Phase|Lost to Follow-up|16|||
148703751|NCT01705574|536389014|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148703752|NCT01705574|536389015|FG003|Double-Blind Phase|Lost to Follow-up|0|||
148703753|NCT01705574|536389012|FG000|Double-Blind Phase|Adverse Event|3|||
148703754|NCT01705574|536389013|FG001|Double-Blind Phase|Adverse Event|10|||
148967717|NCT04097821|537366824|FG005|Overall Study|Subject Decision|2|||
148703755|NCT01705574|536389014|FG002|Double-Blind Phase|Adverse Event|0|||
148703756|NCT01705574|536389015|FG003|Double-Blind Phase|Adverse Event|0|||
148703757|NCT01705574|536389012|FG000|Double-Blind Phase|Withdrew Consent|8|||
148703758|NCT01705574|536389013|FG001|Double-Blind Phase|Withdrew Consent|5|||
148703759|NCT01705574|536389014|FG002|Double-Blind Phase|Withdrew Consent|0|||
148703760|NCT01705574|536389015|FG003|Double-Blind Phase|Withdrew Consent|0|||
148703761|NCT01705574|536389012|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
148703762|NCT01705574|536389013|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
148703763|NCT01705574|536389014|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
148703764|NCT01705574|536389015|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
148703765|NCT01705574|536389012|FG000|Double-Blind Phase|Pregnancy|1|||
148703766|NCT01705574|536389013|FG001|Double-Blind Phase|Pregnancy|1|||
148703767|NCT01705574|536389014|FG002|Double-Blind Phase|Pregnancy|0|||
148703768|NCT01705574|536389015|FG003|Double-Blind Phase|Pregnancy|0|||
148703769|NCT01705574|536389012|FG000|Double-Blind Phase|Protocol Violation|1|||
148703770|NCT01705574|536389013|FG001|Double-Blind Phase|Protocol Violation|0|||
148703771|NCT01705574|536389014|FG002|Double-Blind Phase|Protocol Violation|0|||
148703772|NCT01705574|536389015|FG003|Double-Blind Phase|Protocol Violation|0|||
148703773|NCT01705574|536389012|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
148703774|NCT01705574|536389013|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
148703775|NCT01705574|536389014|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
148703776|NCT01705574|536389015|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
148703777|NCT01705574|536389012|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
148703778|NCT01705574|536389013|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
148703779|NCT01705574|536389014|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
148703780|NCT01705574|536389015|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
148967718|NCT04097821|537366825|FG006|Overall Study|Subject Decision|0|||
148703781|NCT01705574|536389012|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
148703782|NCT01705574|536389013|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
148703783|NCT01705574|536389014|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
148703784|NCT01705574|536389015|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
148703785|NCT01705574|536389012|FG000|Open-Label Extension Phase|Adverse Event|3|||
148703786|NCT01705574|536389013|FG001|Open-Label Extension Phase|Adverse Event|0|||
148703787|NCT01705574|536389014|FG002|Open-Label Extension Phase|Adverse Event|0|||
148703788|NCT01705574|536389015|FG003|Open-Label Extension Phase|Adverse Event|1|||
148703789|NCT01705574|536389012|FG000|Open-Label Extension Phase|Death|2|||
148703790|NCT01705574|536389013|FG001|Open-Label Extension Phase|Death|0|||
148703791|NCT01705574|536389014|FG002|Open-Label Extension Phase|Death|1|||
148703792|NCT01705574|536389015|FG003|Open-Label Extension Phase|Death|0|||
148703793|NCT01705574|536389012|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
148703794|NCT01705574|536389013|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
148703795|NCT01705574|536389014|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
148703796|NCT01705574|536389015|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
148703797|NCT01705574|536389012|FG000|Open-Label Extension Phase|Physician Decision|0|||
148703798|NCT01705574|536389013|FG001|Open-Label Extension Phase|Physician Decision|0|||
148703799|NCT01705574|536389014|FG002|Open-Label Extension Phase|Physician Decision|2|||
148703800|NCT01705574|536389015|FG003|Open-Label Extension Phase|Physician Decision|0|||
148703801|NCT01705574|536389012|FG000|Open-Label Extension Phase|Pregnancy|0|||
148703802|NCT01705574|536389013|FG001|Open-Label Extension Phase|Pregnancy|0|||
148703803|NCT01705574|536389014|FG002|Open-Label Extension Phase|Pregnancy|1|||
148703804|NCT01705574|536389015|FG003|Open-Label Extension Phase|Pregnancy|1|||
148703805|NCT00777023|536389016|FG000|Overall Study|Adverse Event|15|||
148703806|NCT00777023|536389017|FG001|Overall Study|Adverse Event|21|||
148703807|NCT00777023|536389018|FG002|Overall Study|Adverse Event|8|||
148703808|NCT00777023|536389016|FG000|Overall Study|Lack of Efficacy|1|||
148703809|NCT00777023|536389017|FG001|Overall Study|Lack of Efficacy|0|||
148703810|NCT00777023|536389018|FG002|Overall Study|Lack of Efficacy|14|||
148703811|NCT00777023|536389016|FG000|Overall Study|Protocol Violation|2|||
148703812|NCT00777023|536389017|FG001|Overall Study|Protocol Violation|1|||
148703813|NCT00777023|536389018|FG002|Overall Study|Protocol Violation|1|||
148703814|NCT00777023|536389016|FG000|Overall Study|Lost to Follow-up|2|||
148703815|NCT00777023|536389017|FG001|Overall Study|Lost to Follow-up|3|||
148703816|NCT00777023|536389018|FG002|Overall Study|Lost to Follow-up|3|||
148703817|NCT00777023|536389016|FG000|Overall Study|Death|0|||
148703818|NCT00777023|536389017|FG001|Overall Study|Death|1|||
148703819|NCT00777023|536389018|FG002|Overall Study|Death|0|||
148703820|NCT00777023|536389016|FG000|Overall Study|Withdrawal by Subject|7|||
148703821|NCT00777023|536389017|FG001|Overall Study|Withdrawal by Subject|7|||
148703822|NCT00777023|536389018|FG002|Overall Study|Withdrawal by Subject|8|||
148703823|NCT00777023|536389016|FG000|Overall Study|Missing data|1|||
148703824|NCT00777023|536389017|FG001|Overall Study|Missing data|1|||
148703825|NCT00777023|536389018|FG002|Overall Study|Missing data|0|||
148703826|NCT00777023|536389016|FG000|Overall Study|Reasons not specified|4|||
148703827|NCT00777023|536389017|FG001|Overall Study|Reasons not specified|4|||
148703828|NCT00777023|536389018|FG002|Overall Study|Reasons not specified|2|||
148703829|NCT00777023|536389016|FG000|Overall Study|Last dose date unknown|3|||
148703830|NCT00777023|536389017|FG001|Overall Study|Last dose date unknown|3|||
148703831|NCT00777023|536389018|FG002|Overall Study|Last dose date unknown|1|||
148703832|NCT02659150|536389019|FG000|Subject Enrollment|Physician Decision|3|||
148703833|NCT02659150|536389019|FG000|Subject Enrollment|Withdrawal by Subject|2|||
148703834|NCT02659150|536389019|FG000|Baseline Imaging|Withdrawal by Subject|1|||
148703835|NCT02659150|536389019|FG000|Baseline Imaging|Physician Decision|1|||
148703836|NCT02659150|536389019|FG000|Study Drug Dosing|Adverse Event|1|||
148703837|NCT00448019|536389023|FG000|Overall Study|Withdrawal by Subject|3|||
148703838|NCT00448019|536389023|FG000|Overall Study|Disease progression|1|||
148703839|NCT00448019|536389023|FG000|Overall Study|Death|2|||
148703840|NCT00448019|536389023|FG000|Overall Study|Insurance Issues|1|||
148703841|NCT01273805|536389024|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
148703842|NCT01273805|536389025|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
148703843|NCT02647944|536389026|FG000|Overall Study|Withdrawal by Subject|0|||
148703844|NCT02647944|536389027|FG001|Overall Study|Withdrawal by Subject|3|||
148703845|NCT02647944|536389026|FG000|Overall Study|Adverse Event|2|||
148703846|NCT02647944|536389027|FG001|Overall Study|Adverse Event|0|||
148703847|NCT02760368|536389028|FG000|Overall Study|Withdrawal by Subject|8|||
148703848|NCT02760368|536389029|FG001|Overall Study|Withdrawal by Subject|12|||
148703849|NCT02760368|536389030|FG002|Overall Study|Withdrawal by Subject|9|||
148703850|NCT02760368|536389028|FG000|Overall Study|Screen Failure|0|||
148703851|NCT02760368|536389029|FG001|Overall Study|Screen Failure|0|||
148703852|NCT02760368|536389030|FG002|Overall Study|Screen Failure|1|||
148703853|NCT02760368|536389028|FG000|Overall Study|Death|0|||
148703854|NCT02760368|536389029|FG001|Overall Study|Death|1|||
148703855|NCT02760368|536389030|FG002|Overall Study|Death|0|||
148703856|NCT02760368|536389028|FG000|Overall Study|Withdrawal by Sponsor|0|||
148703857|NCT02760368|536389029|FG001|Overall Study|Withdrawal by Sponsor|0|||
148967719|NCT04097821|537366826|FG007|Overall Study|Subject Decision|1|||
148703858|NCT02760368|536389030|FG002|Overall Study|Withdrawal by Sponsor|1|||
148967720|NCT04097821|537366819|FG000|Overall Study|Death|0|||
148967721|NCT04097821|537366820|FG001|Overall Study|Death|0|||
148967722|NCT04097821|537366821|FG002|Overall Study|Death|3|||
148703859|NCT01200810|536389038|FG000|Overall Study|Physician Decision|1|||
148703860|NCT01200810|536389039|FG001|Overall Study|Physician Decision|0|||
148703861|NCT01200810|536389038|FG000|Overall Study|Withdrawal by Subject|1|||
148703862|NCT01200810|536389039|FG001|Overall Study|Withdrawal by Subject|2|||
148703863|NCT01200810|536389038|FG000|Overall Study|Sponsor stopped making study drug|3|||
148703864|NCT01200810|536389039|FG001|Overall Study|Sponsor stopped making study drug|3|||
148703865|NCT00904215|536389041|FG000|Overall Study|Adverse Event|25|||
148703866|NCT00904215|536389041|FG000|Overall Study|Protocol Violation|10|||
148703867|NCT00904215|536389041|FG000|Overall Study|Lost to Follow-up|63|||
148703868|NCT00904215|536389041|FG000|Overall Study|Withdrawal by Subject|9|||
148703869|NCT00904215|536389041|FG000|Overall Study|Other|28|||
148703870|NCT00640562|536389042|FG000|Overall Study|Adverse Event|8|||
148703871|NCT00640562|536389043|FG001|Overall Study|Adverse Event|5|||
148703872|NCT00640562|536389042|FG000|Overall Study|Lack of Efficacy|1|||
148703873|NCT00640562|536389043|FG001|Overall Study|Lack of Efficacy|4|||
148703874|NCT00640562|536389042|FG000|Overall Study|Protocol Violation|2|||
148703875|NCT00640562|536389043|FG001|Overall Study|Protocol Violation|4|||
148703876|NCT00640562|536389042|FG000|Overall Study|Withdrawal by Subject|6|||
148703877|NCT00640562|536389043|FG001|Overall Study|Withdrawal by Subject|10|||
148703878|NCT00640562|536389042|FG000|Overall Study|Known risperidone intolerance|0|||
148703879|NCT00640562|536389043|FG001|Overall Study|Known risperidone intolerance|1|||
148703880|NCT00640562|536389042|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
148703881|NCT00640562|536389043|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
148703882|NCT00640562|536389042|FG000|Overall Study|Low study drug dose|0|||
148703883|NCT00640562|536389043|FG001|Overall Study|Low study drug dose|1|||
148703884|NCT00640562|536389042|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
148703885|NCT00640562|536389043|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
148703886|NCT00448591|536389044|FG000|Overall Study|Withdrawal by Subject|178|||
148703887|NCT00448591|536389044|FG000|Overall Study|Progressive Disease|1382|||
148703888|NCT00448591|536389044|FG000|Overall Study|Adverse Event|382|||
148703889|NCT00448591|536389044|FG000|Overall Study|Protocol Violation|41|||
148703890|NCT00448591|536389044|FG000|Overall Study|Lost to Follow-up|19|||
148703891|NCT00448591|536389044|FG000|Overall Study|Treatment Regimen Completed|70|||
148703892|NCT00448591|536389044|FG000|Overall Study|Other|154|||
148703893|NCT00448591|536389044|FG000|Overall Study|Termination of Study|70|||
148703894|NCT02937870|536389045|FG000|Overall Study|Adverse Event|1|||
148703895|NCT02937870|536389045|FG000|Overall Study|Protocol Deviation|2|||
148703896|NCT03098394|536389049|FG000|Overall Study|Pregnancy|0|||
148703897|NCT03098394|536389050|FG001|Overall Study|Pregnancy|1|||
148703898|NCT00609674|536389051|FG000|Overall Study|Adverse Event|1|||
148703899|NCT00609674|536389052|FG001|Overall Study|Adverse Event|1|||
148703900|NCT00609674|536389051|FG000|Overall Study|Protocol Violation|3|||
148703901|NCT00609674|536389052|FG001|Overall Study|Protocol Violation|5|||
148703902|NCT00609674|536389051|FG000|Overall Study|Lost to Follow-up|1|||
148703903|NCT00609674|536389052|FG001|Overall Study|Lost to Follow-up|0|||
148703904|NCT00609674|536389051|FG000|Overall Study|Withdrew consent|2|||
148703905|NCT00609674|536389052|FG001|Overall Study|Withdrew consent|1|||
148703906|NCT00244764|536389056|FG000|Overall Study|Adverse Event|37|||
148703907|NCT00244764|536389056|FG000|Overall Study|Lost to Follow-up|23|||
148703908|NCT00244764|536389056|FG000|Overall Study|Withdrawal by Subject|12|||
148703909|NCT00244764|536389056|FG000|Overall Study|Disease Progression|13|||
148703910|NCT00244764|536389056|FG000|Overall Study|Protocol Violation|2|||
148703911|NCT00244764|536389056|FG000|Overall Study|Death|1|||
148703912|NCT00244764|536389056|FG000|Overall Study|Off Study Medication for >21 Days|1|||
148703913|NCT00244764|536389056|FG000|Overall Study|Declining Performance Status|1|||
148703914|NCT00244764|536389056|FG000|Overall Study|Participant was Hospitalized until Death|1|||
148703915|NCT00244764|536389056|FG000|Overall Study|Primary Investigator Discretion|2|||
148703916|NCT00244764|536389056|FG000|Overall Study|Sponsor Terminated Study|2|||
148703917|NCT00244764|536389056|FG000|Overall Study|Developed Secondary Malignancy|1|||
148703918|NCT00003659|536389059|FG000|Overall Study|Withdrawal by Subject|3|||
148703919|NCT03925532|536389060|FG000|Overall Study|Lost to Follow-up|1|||
148703920|NCT04405570|536389062|FG000|Overall Study|Adverse Event|0|||
148703921|NCT04405570|536389063|FG001|Overall Study|Adverse Event|1|||
148703922|NCT04405570|536389064|FG002|Overall Study|Adverse Event|1|||
148703923|NCT04405570|536389065|FG003|Overall Study|Adverse Event|1|||
148703924|NCT04405570|536389062|FG000|Overall Study|Lost to Follow-up|0|||
148703925|NCT04405570|536389063|FG001|Overall Study|Lost to Follow-up|1|||
148703926|NCT04405570|536389064|FG002|Overall Study|Lost to Follow-up|0|||
148703927|NCT04405570|536389065|FG003|Overall Study|Lost to Follow-up|0|||
148703928|NCT04405570|536389062|FG000|Overall Study|Physician Decision|0|||
148703929|NCT04405570|536389063|FG001|Overall Study|Physician Decision|0|||
148703930|NCT04405570|536389064|FG002|Overall Study|Physician Decision|1|||
148967723|NCT04097821|537366822|FG003|Overall Study|Death|1|||
148967724|NCT04097821|537366823|FG004|Overall Study|Death|0|||
148703931|NCT04405570|536389065|FG003|Overall Study|Physician Decision|0|||
148703932|NCT04405570|536389062|FG000|Overall Study|Withdrawal by Subject|0|||
148703933|NCT04405570|536389063|FG001|Overall Study|Withdrawal by Subject|1|||
148703934|NCT04405570|536389064|FG002|Overall Study|Withdrawal by Subject|1|||
148703935|NCT04405570|536389065|FG003|Overall Study|Withdrawal by Subject|0|||
148703936|NCT04405570|536389062|FG000|Overall Study|Randomized not dosed|0|||
148703937|NCT04405570|536389063|FG001|Overall Study|Randomized not dosed|2|||
148703938|NCT04405570|536389064|FG002|Overall Study|Randomized not dosed|0|||
148703939|NCT04405570|536389065|FG003|Overall Study|Randomized not dosed|0|||
148703940|NCT04499963|536389066|FG000|Overall Study|Adverse Event|3|||
148703941|NCT04499963|536389067|FG001|Overall Study|Adverse Event|0|||
148703942|NCT04499963|536389066|FG000|Overall Study|Death|3|||
148703943|NCT04499963|536389067|FG001|Overall Study|Death|0|||
148703944|NCT04499963|536389066|FG000|Overall Study|Lack of Efficacy|7|||
148703945|NCT04499963|536389067|FG001|Overall Study|Lack of Efficacy|0|||
148703946|NCT04499963|536389066|FG000|Overall Study|Lost to Follow-up|2|||
148703947|NCT04499963|536389067|FG001|Overall Study|Lost to Follow-up|0|||
148703948|NCT01005745|536389068|FG000|Overall Study|No TIL growth|1|||
148703949|NCT01005745|536389068|FG000|Overall Study|Disease progressed during TIL growth|3|||
148703950|NCT01005745|536389068|FG000|Overall Study|Death prior to treatment|1|||
148703951|NCT01005745|536389068|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
148703952|NCT01208337|536389076|FG000|Overall Study|Death|3|||
148703953|NCT00984126|536389080|FG000|Overall Study|Protocol Violation|0|||
148703954|NCT00984126|536389081|FG001|Overall Study|Protocol Violation|0|||
148703955|NCT00984126|536389082|FG002|Overall Study|Protocol Violation|1|||
148703956|NCT00984126|536389083|FG003|Overall Study|Protocol Violation|2|||
148703957|NCT00984126|536389080|FG000|Overall Study|Adverse Event|0|||
148703958|NCT00984126|536389081|FG001|Overall Study|Adverse Event|0|||
148703959|NCT00984126|536389082|FG002|Overall Study|Adverse Event|0|||
148703960|NCT00984126|536389083|FG003|Overall Study|Adverse Event|2|||
148703961|NCT00984126|536389080|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
148703962|NCT00984126|536389081|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
148703963|NCT00984126|536389082|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
148703964|NCT00984126|536389083|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
148703965|NCT00984126|536389080|FG000|Overall Study|Withdrawal criteria|0|||
148703966|NCT00984126|536389081|FG001|Overall Study|Withdrawal criteria|1|||
148703967|NCT00984126|536389082|FG002|Overall Study|Withdrawal criteria|3|||
148703968|NCT00984126|536389083|FG003|Overall Study|Withdrawal criteria|9|||
148703969|NCT02739997|536389090|FG000|Overall Study|Death|1|||
148703970|NCT02739997|536389090|FG000|Overall Study|Withdrawal by Subject|1|||
148703971|NCT02196675|536389091|FG000|Overall Study|Withdrawal by Subject|1|||
148703972|NCT02196675|536389092|FG001|Overall Study|Withdrawal by Subject|0|||
148703973|NCT02196675|536389093|FG002|Overall Study|Withdrawal by Subject|0|||
148703974|NCT02196675|536389091|FG000|Overall Study|Intra-operative surgical exclusion|1|||
148703975|NCT02196675|536389092|FG001|Overall Study|Intra-operative surgical exclusion|1|||
148703976|NCT02196675|536389093|FG002|Overall Study|Intra-operative surgical exclusion|0|||
148703977|NCT02196675|536389091|FG000|Overall Study|Protocol Violation|0|||
148703978|NCT02196675|536389092|FG001|Overall Study|Protocol Violation|1|||
148703979|NCT02196675|536389093|FG002|Overall Study|Protocol Violation|0|||
148703980|NCT02196675|536389091|FG000|Overall Study|Death|0|||
148703981|NCT02196675|536389092|FG001|Overall Study|Death|0|||
148703982|NCT02196675|536389093|FG002|Overall Study|Death|1|||
148703983|NCT00359281|536389094|FG000|Overall Study|Adverse Event|1|||
148703984|NCT00359281|536389095|FG001|Overall Study|Adverse Event|0|||
148703985|NCT00359281|536389096|FG002|Overall Study|Adverse Event|0|||
148703986|NCT00359281|536389097|FG003|Overall Study|Adverse Event|0|||
148703987|NCT00359281|536389098|FG004|Overall Study|Adverse Event|0|||
148703988|NCT00359281|536389099|FG005|Overall Study|Adverse Event|0|||
148703989|NCT00359281|536389100|FG006|Overall Study|Adverse Event|1|||
148703990|NCT00359281|536389101|FG007|Overall Study|Adverse Event|0|||
148703991|NCT00359281|536389102|FG008|Overall Study|Adverse Event|0|||
148703992|NCT00359281|536389094|FG000|Overall Study|Withdrawal by Subject|0|||
148703993|NCT00359281|536389095|FG001|Overall Study|Withdrawal by Subject|0|||
148703994|NCT00359281|536389096|FG002|Overall Study|Withdrawal by Subject|0|||
148703995|NCT00359281|536389097|FG003|Overall Study|Withdrawal by Subject|0|||
148703996|NCT00359281|536389098|FG004|Overall Study|Withdrawal by Subject|0|||
148703997|NCT00359281|536389099|FG005|Overall Study|Withdrawal by Subject|0|||
148703998|NCT00359281|536389100|FG006|Overall Study|Withdrawal by Subject|1|||
148703999|NCT00359281|536389101|FG007|Overall Study|Withdrawal by Subject|0|||
148704000|NCT00359281|536389102|FG008|Overall Study|Withdrawal by Subject|0|||
148704001|NCT01474551|536389103|FG000|Overall Study|Death|1|||
148704002|NCT03686033|536389115|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
148704003|NCT03686033|536389116|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
148704004|NCT03686033|536389117|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
148704005|NCT03686033|536389118|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
148704006|NCT03686033|536389119|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
148704007|NCT03686033|536389120|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
148704008|NCT01854047|536389121|FG000|Overall Study|Lack of Efficacy|1|||
148967725|NCT04097821|537366824|FG005|Overall Study|Death|0|||
148704009|NCT01854047|536389122|FG001|Overall Study|Lack of Efficacy|0|||
148704010|NCT01854047|536389123|FG002|Overall Study|Lack of Efficacy|0|||
148704011|NCT01854047|536389124|FG003|Overall Study|Lack of Efficacy|0|||
148704012|NCT01854047|536389125|FG004|Overall Study|Lack of Efficacy|0|||
148704013|NCT01854047|536389121|FG000|Overall Study|Poor compliance to protocol|3|||
148704014|NCT01854047|536389122|FG001|Overall Study|Poor compliance to protocol|0|||
148704015|NCT01854047|536389123|FG002|Overall Study|Poor compliance to protocol|2|||
148704016|NCT01854047|536389124|FG003|Overall Study|Poor compliance to protocol|0|||
148704017|NCT01854047|536389125|FG004|Overall Study|Poor compliance to protocol|0|||
148704018|NCT01854047|536389121|FG000|Overall Study|Adverse Event|5|||
148704019|NCT01854047|536389122|FG001|Overall Study|Adverse Event|4|||
148704020|NCT01854047|536389123|FG002|Overall Study|Adverse Event|6|||
148704021|NCT01854047|536389124|FG003|Overall Study|Adverse Event|10|||
148704022|NCT01854047|536389125|FG004|Overall Study|Adverse Event|7|||
148704023|NCT01854047|536389121|FG000|Overall Study|Randomized but not treated|0|||
148704024|NCT01854047|536389122|FG001|Overall Study|Randomized but not treated|1|||
148704025|NCT01854047|536389123|FG002|Overall Study|Randomized but not treated|2|||
148704026|NCT01854047|536389124|FG003|Overall Study|Randomized but not treated|0|||
148704027|NCT01854047|536389125|FG004|Overall Study|Randomized but not treated|4|||
148704028|NCT01854047|536389121|FG000|Overall Study|Other than specified above|3|||
148704029|NCT01854047|536389122|FG001|Overall Study|Other than specified above|3|||
148704030|NCT01854047|536389123|FG002|Overall Study|Other than specified above|3|||
148704031|NCT01854047|536389124|FG003|Overall Study|Other than specified above|5|||
148704032|NCT01854047|536389125|FG004|Overall Study|Other than specified above|8|||
148704033|NCT03134222|536389126|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
148704034|NCT03134222|536389127|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
148704035|NCT03134222|536389128|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
148704036|NCT03134222|536389129|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
148704037|NCT03134222|536389130|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
148704038|NCT03134222|536389126|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
148704039|NCT03134222|536389127|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
148704040|NCT03134222|536389128|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
148704041|NCT03134222|536389129|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
148704042|NCT03134222|536389130|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
148704043|NCT03134222|536389126|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
148704044|NCT03134222|536389127|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
148704045|NCT03134222|536389128|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
148704046|NCT03134222|536389129|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
148704047|NCT03134222|536389130|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
148704048|NCT03134222|536389126|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
148704049|NCT03134222|536389127|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
148704050|NCT03134222|536389128|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
148704051|NCT03134222|536389129|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
148704052|NCT03134222|536389130|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
148704053|NCT03134222|536389126|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
148704054|NCT03134222|536389127|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
148704055|NCT03134222|536389128|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
148704056|NCT03134222|536389129|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
148704057|NCT03134222|536389130|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
148704058|NCT03134222|536389126|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
148704059|NCT03134222|536389127|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
148704060|NCT03134222|536389128|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
148704061|NCT03134222|536389129|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
148704062|NCT03134222|536389130|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
148704063|NCT03134222|536389126|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
148704064|NCT03134222|536389127|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
148704065|NCT03134222|536389128|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
148704066|NCT03134222|536389129|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
148704067|NCT03134222|536389130|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
148704068|NCT03134222|536389126|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
148704069|NCT03134222|536389127|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
148704070|NCT03134222|536389128|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
148704071|NCT03134222|536389129|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
148704072|NCT03134222|536389130|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
148704073|NCT02089997|536389140|FG000|Overall Study|Case report forms uncollected|99|||
148704074|NCT02089997|536389140|FG000|Overall Study|Protocol Violation|147|||
148704075|NCT02374853|536389142|FG000|Overall Study|Surgery Cancelled|5|||
148704076|NCT02374853|536389143|FG001|Overall Study|Surgery Cancelled|11|||
148704077|NCT02281084|536389144|FG000|Overall Study|Death|21|||
148704078|NCT02281084|536389145|FG001|Overall Study|Death|18|||
148967726|NCT04097821|537366825|FG006|Overall Study|Death|0|||
148967727|NCT04097821|537366826|FG007|Overall Study|Death|0|||
148967728|NCT04097821|537366819|FG000|Overall Study|Physician Decision|1|||
148967729|NCT04097821|537366820|FG001|Overall Study|Physician Decision|2|||
148967730|NCT04097821|537366821|FG002|Overall Study|Physician Decision|0|||
148967731|NCT04097821|537366822|FG003|Overall Study|Physician Decision|0|||
148967732|NCT04097821|537366823|FG004|Overall Study|Physician Decision|0|||
148967733|NCT04097821|537366824|FG005|Overall Study|Physician Decision|0|||
148704079|NCT02281084|536389146|FG002|Overall Study|Death|3|||
148704080|NCT02281084|536389147|FG003|Overall Study|Death|5|||
148704081|NCT02281084|536389144|FG000|Overall Study|Adverse Event|1|||
148704082|NCT02281084|536389145|FG001|Overall Study|Adverse Event|0|||
148704083|NCT02281084|536389146|FG002|Overall Study|Adverse Event|0|||
148704084|NCT02281084|536389147|FG003|Overall Study|Adverse Event|0|||
148704085|NCT02281084|536389144|FG000|Overall Study|Withdrawal by Subject|2|||
148704086|NCT02281084|536389145|FG001|Overall Study|Withdrawal by Subject|2|||
148704087|NCT02281084|536389146|FG002|Overall Study|Withdrawal by Subject|0|||
148704088|NCT02281084|536389147|FG003|Overall Study|Withdrawal by Subject|0|||
148704089|NCT02281084|536389144|FG000|Overall Study|Site Closure by Sponsor|5|||
148704090|NCT02281084|536389145|FG001|Overall Study|Site Closure by Sponsor|1|||
148704091|NCT02281084|536389146|FG002|Overall Study|Site Closure by Sponsor|2|||
148704092|NCT02281084|536389147|FG003|Overall Study|Site Closure by Sponsor|0|||
148704093|NCT03681470|536389148|FG000|Overall Study|Lack of Efficacy|3|||
148704094|NCT03681470|536389148|FG000|Overall Study|Lost to Follow-up|1|||
148704095|NCT03681470|536389148|FG000|Overall Study|Protocol Violation|3|||
148704096|NCT03681470|536389148|FG000|Overall Study|Withdrawal by Subject|1|||
148704097|NCT02335658|536389149|FG000|Overall Study|Adverse Event|18|||
148704098|NCT02335658|536389150|FG001|Overall Study|Adverse Event|12|||
148704099|NCT02335658|536389149|FG000|Overall Study|Lack of Efficacy|4|||
148704100|NCT02335658|536389150|FG001|Overall Study|Lack of Efficacy|5|||
148704101|NCT02335658|536389149|FG000|Overall Study|Pregnancy|1|||
148704102|NCT02335658|536389150|FG001|Overall Study|Pregnancy|0|||
148704103|NCT02335658|536389149|FG000|Overall Study|Withdrawal by Subject|13|||
148704104|NCT02335658|536389150|FG001|Overall Study|Withdrawal by Subject|21|||
148704105|NCT02335658|536389149|FG000|Overall Study|non-compliance|2|||
148704106|NCT02335658|536389150|FG001|Overall Study|non-compliance|3|||
148704107|NCT02335658|536389149|FG000|Overall Study|other reason|2|||
148704108|NCT02335658|536389150|FG001|Overall Study|other reason|3|||
148704109|NCT02032888|536389151|FG000|Treatment Period|Poor compliance/noncompliance|1|||
148704110|NCT02032888|536389152|FG001|Treatment Period|Poor compliance/noncompliance|1|||
148704111|NCT02032888|536389153|FG002|Treatment Period|Poor compliance/noncompliance|0|||
148704112|NCT02032888|536389151|FG000|Treatment Period|Other|1|||
148704113|NCT02032888|536389152|FG001|Treatment Period|Other|1|||
148704114|NCT02032888|536389153|FG002|Treatment Period|Other|0|||
148704115|NCT02032888|536389151|FG000|Follow-up Period|Lost to Follow-up|1|||
148704116|NCT02032888|536389152|FG001|Follow-up Period|Lost to Follow-up|1|||
148704117|NCT02032888|536389153|FG002|Follow-up Period|Lost to Follow-up|0|||
148704118|NCT02032888|536389151|FG000|Follow-up Period|Death|1|||
148704119|NCT02032888|536389152|FG001|Follow-up Period|Death|1|||
148704120|NCT02032888|536389153|FG002|Follow-up Period|Death|0|||
148704121|NCT02032888|536389151|FG000|Follow-up Period|Other|1|||
148704122|NCT02032888|536389152|FG001|Follow-up Period|Other|0|||
148704123|NCT02032888|536389153|FG002|Follow-up Period|Other|0|||
148704124|NCT02655679|536389156|FG000|Overall Study|Adverse Event|0|||
148704125|NCT02655679|536389157|FG001|Overall Study|Adverse Event|1|||
148704126|NCT02655679|536389158|FG002|Overall Study|Adverse Event|0|||
148704127|NCT02655679|536389159|FG003|Overall Study|Adverse Event|0|||
148704128|NCT02655679|536389160|FG004|Overall Study|Adverse Event|0|||
148967734|NCT04097821|537366825|FG006|Overall Study|Physician Decision|0|||
148967735|NCT04097821|537366826|FG007|Overall Study|Physician Decision|0|||
148967736|NCT04097821|537366819|FG000|Overall Study|Adverse Event|0|||
148967737|NCT04097821|537366820|FG001|Overall Study|Adverse Event|0|||
148704129|NCT02655679|536389156|FG000|Overall Study|Withdrawal by Subject|1|||
148704130|NCT02655679|536389157|FG001|Overall Study|Withdrawal by Subject|1|||
148704131|NCT02655679|536389158|FG002|Overall Study|Withdrawal by Subject|0|||
148704132|NCT02655679|536389159|FG003|Overall Study|Withdrawal by Subject|3|||
148704133|NCT02655679|536389160|FG004|Overall Study|Withdrawal by Subject|1|||
148967738|NCT04097821|537366821|FG002|Overall Study|Adverse Event|1|||
148967739|NCT04097821|537366822|FG003|Overall Study|Adverse Event|1|||
148704134|NCT02655679|536389156|FG000|Overall Study|Inability to Comply with the Protocol|1|||
148704135|NCT02655679|536389157|FG001|Overall Study|Inability to Comply with the Protocol|0|||
148704136|NCT02655679|536389158|FG002|Overall Study|Inability to Comply with the Protocol|0|||
148704137|NCT02655679|536389159|FG003|Overall Study|Inability to Comply with the Protocol|0|||
148704138|NCT02655679|536389160|FG004|Overall Study|Inability to Comply with the Protocol|0|||
148704139|NCT02655679|536389156|FG000|Overall Study|Lost to Follow-up|0|||
148704140|NCT02655679|536389157|FG001|Overall Study|Lost to Follow-up|1|||
148967740|NCT04097821|537366823|FG004|Overall Study|Adverse Event|0|||
148967741|NCT04097821|537366824|FG005|Overall Study|Adverse Event|0|||
148967742|NCT04097821|537366825|FG006|Overall Study|Adverse Event|0|||
148704141|NCT02655679|536389158|FG002|Overall Study|Lost to Follow-up|1|||
148704142|NCT02655679|536389159|FG003|Overall Study|Lost to Follow-up|1|||
148704143|NCT02655679|536389160|FG004|Overall Study|Lost to Follow-up|0|||
148704144|NCT02655679|536389156|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148704145|NCT02655679|536389157|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148704146|NCT02655679|536389158|FG002|Overall Study|Other Miscellaneous Reasons|0|||
148704147|NCT02655679|536389159|FG003|Overall Study|Other Miscellaneous Reasons|0|||
148704148|NCT02655679|536389160|FG004|Overall Study|Other Miscellaneous Reasons|0|||
148704149|NCT01421277|536389161|FG000|Overall Study|Lack of qualifying event|0|||
148704150|NCT01421277|536389162|FG001|Overall Study|Lack of qualifying event|61|||
148704151|NCT01421277|536389161|FG000|Overall Study|Incomplete baseline data|0|||
148704152|NCT01421277|536389162|FG001|Overall Study|Incomplete baseline data|31|||
148704153|NCT02039908|536389163|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
148704154|NCT02039908|536389164|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
148704155|NCT02039908|536389165|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
148704156|NCT02039908|536389166|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
148704157|NCT02039908|536389163|FG000|Phase 1-Summer|Protocol Violation|6|||
148704158|NCT02039908|536389164|FG001|Phase 1-Summer|Protocol Violation|0|||
148704159|NCT02039908|536389165|FG002|Phase 1-Summer|Protocol Violation|0|||
148704160|NCT02039908|536389166|FG003|Phase 1-Summer|Protocol Violation|0|||
148704161|NCT02039908|536389163|FG000|Phase 2-School Year|Lost to Follow-up|0|||
148704162|NCT02039908|536389164|FG001|Phase 2-School Year|Lost to Follow-up|0|||
148704163|NCT02039908|536389165|FG002|Phase 2-School Year|Lost to Follow-up|1|||
148704164|NCT02039908|536389166|FG003|Phase 2-School Year|Lost to Follow-up|3|||
148704165|NCT02039908|536389163|FG000|Phase 2-School Year|Protocol Violation|0|||
148704166|NCT02039908|536389164|FG001|Phase 2-School Year|Protocol Violation|0|||
148704167|NCT02039908|536389165|FG002|Phase 2-School Year|Protocol Violation|3|||
148704168|NCT02039908|536389166|FG003|Phase 2-School Year|Protocol Violation|0|||
148704169|NCT02039908|536389163|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
148704170|NCT02039908|536389164|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
148704171|NCT02039908|536389165|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
148704172|NCT02039908|536389166|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
148704173|NCT02674152|536390435|FG000|Overall Study|Personal Reasons|1|||
148704174|NCT02674152|536390436|FG001|Overall Study|Personal Reasons|0|||
148704175|NCT02674152|536390437|FG002|Overall Study|Personal Reasons|0|||
148704176|NCT02674152|536390438|FG003|Overall Study|Personal Reasons|1|||
148704177|NCT02674152|536390439|FG004|Overall Study|Personal Reasons|1|||
148704178|NCT02674152|536390435|FG000|Overall Study|Other adverse event or clinical progression|0|||
148704179|NCT02674152|536390436|FG001|Overall Study|Other adverse event or clinical progression|1|||
148704180|NCT02674152|536390437|FG002|Overall Study|Other adverse event or clinical progression|0|||
148704181|NCT02674152|536390438|FG003|Overall Study|Other adverse event or clinical progression|3|||
148704182|NCT02674152|536390439|FG004|Overall Study|Other adverse event or clinical progression|0|||
148704183|NCT02674152|536390435|FG000|Overall Study|Dose-limiting toxicity|0|||
148704184|NCT02674152|536390436|FG001|Overall Study|Dose-limiting toxicity|0|||
148704185|NCT02674152|536390437|FG002|Overall Study|Dose-limiting toxicity|0|||
148704186|NCT02674152|536390438|FG003|Overall Study|Dose-limiting toxicity|0|||
148704187|NCT02674152|536390439|FG004|Overall Study|Dose-limiting toxicity|1|||
148704188|NCT02674152|536390435|FG000|Overall Study|Progressive Disease|2|||
148704189|NCT02674152|536390436|FG001|Overall Study|Progressive Disease|1|||
148704190|NCT02674152|536390437|FG002|Overall Study|Progressive Disease|1|||
148704191|NCT02674152|536390438|FG003|Overall Study|Progressive Disease|13|||
148704192|NCT02674152|536390439|FG004|Overall Study|Progressive Disease|2|||
148704193|NCT02674152|536390435|FG000|Overall Study|Adverse Event|0|||
148704194|NCT02674152|536390436|FG001|Overall Study|Adverse Event|0|||
148704195|NCT02674152|536390437|FG002|Overall Study|Adverse Event|1|||
148704196|NCT02674152|536390438|FG003|Overall Study|Adverse Event|0|||
148704197|NCT02674152|536390439|FG004|Overall Study|Adverse Event|1|||
148704198|NCT00579345|536390440|FG000|Overall Study|Withdrawal by Subject|2|||
148704199|NCT00579345|536390441|FG001|Overall Study|Withdrawal by Subject|0|||
148704200|NCT00579345|536390442|FG002|Overall Study|Withdrawal by Subject|0|||
148967743|NCT04097821|537366826|FG007|Overall Study|Adverse Event|0|||
148967744|NCT04097821|537366819|FG000|Overall Study|New Therapy For Study Indication|0|||
148967745|NCT04097821|537366820|FG001|Overall Study|New Therapy For Study Indication|0|||
148704201|NCT00579345|536390443|FG003|Overall Study|Withdrawal by Subject|0|||
148704202|NCT00579345|536390444|FG004|Overall Study|Withdrawal by Subject|0|||
148704203|NCT00579345|536390445|FG005|Overall Study|Withdrawal by Subject|0|||
148704204|NCT00579345|536390446|FG006|Overall Study|Withdrawal by Subject|0|||
148704205|NCT00579345|536390447|FG007|Overall Study|Withdrawal by Subject|1|||
148704206|NCT00579345|536390440|FG000|Overall Study|Lost to Follow-up|1|||
148704207|NCT00579345|536390441|FG001|Overall Study|Lost to Follow-up|0|||
148704208|NCT00579345|536390442|FG002|Overall Study|Lost to Follow-up|0|||
148704209|NCT00579345|536390443|FG003|Overall Study|Lost to Follow-up|0|||
148704210|NCT00579345|536390444|FG004|Overall Study|Lost to Follow-up|0|||
148704211|NCT00579345|536390445|FG005|Overall Study|Lost to Follow-up|0|||
148704212|NCT00579345|536390446|FG006|Overall Study|Lost to Follow-up|0|||
148704213|NCT00579345|536390447|FG007|Overall Study|Lost to Follow-up|0|||
149025082|NCT04170023|537568004|FG000|LTE Period|Study Termination|11|||
148704214|NCT00579345|536390440|FG000|Overall Study|Adverse Event|0|||
148704215|NCT00579345|536390441|FG001|Overall Study|Adverse Event|0|||
148704216|NCT00579345|536390442|FG002|Overall Study|Adverse Event|1|||
148704217|NCT00579345|536390443|FG003|Overall Study|Adverse Event|0|||
148704218|NCT00579345|536390444|FG004|Overall Study|Adverse Event|0|||
148704219|NCT00579345|536390445|FG005|Overall Study|Adverse Event|0|||
148704220|NCT00579345|536390446|FG006|Overall Study|Adverse Event|0|||
148704221|NCT00579345|536390447|FG007|Overall Study|Adverse Event|0|||
148704222|NCT00579345|536390440|FG000|Overall Study|Protocol Violation|1|||
148704223|NCT00579345|536390441|FG001|Overall Study|Protocol Violation|0|||
148704224|NCT00579345|536390442|FG002|Overall Study|Protocol Violation|0|||
148967746|NCT04097821|537366821|FG002|Overall Study|New Therapy For Study Indication|0|||
148967747|NCT04097821|537366822|FG003|Overall Study|New Therapy For Study Indication|0|||
148967748|NCT04097821|537366823|FG004|Overall Study|New Therapy For Study Indication|0|||
148967749|NCT04097821|537366824|FG005|Overall Study|New Therapy For Study Indication|0|||
148967750|NCT04097821|537366825|FG006|Overall Study|New Therapy For Study Indication|1|||
148967751|NCT04097821|537366826|FG007|Overall Study|New Therapy For Study Indication|0|||
148967752|NCT00244712|537366827|FG000|Overall Study|Adverse Event|20|||
148967753|NCT00244712|537366828|FG001|Overall Study|Adverse Event|21|||
148967754|NCT00244712|537366827|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
148967755|NCT00244712|537366828|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
148967756|NCT00244712|537366827|FG000|Overall Study|Lack of Compliance|10|||
148967757|NCT00244712|537366828|FG001|Overall Study|Lack of Compliance|11|||
148967758|NCT00244712|537366827|FG000|Overall Study|Lost to Follow-up|45|||
148967759|NCT00244712|537366828|FG001|Overall Study|Lost to Follow-up|52|||
148967760|NCT00244712|537366827|FG000|Overall Study|Withdrawal by Subject|13|||
148967761|NCT00244712|537366828|FG001|Overall Study|Withdrawal by Subject|23|||
148967762|NCT00244712|537366827|FG000|Overall Study|Protocol Violation, disease progression|13|||
148967763|NCT00244712|537366828|FG001|Overall Study|Protocol Violation, disease progression|11|||
148967764|NCT02776917|537366831|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
148967765|NCT00574405|537368507|FG000|Overall Study|Withdrawal by Subject|3|||
148704225|NCT00579345|536390443|FG003|Overall Study|Protocol Violation|0|||
148704226|NCT00579345|536390444|FG004|Overall Study|Protocol Violation|0|||
148704227|NCT00579345|536390445|FG005|Overall Study|Protocol Violation|0|||
148704228|NCT00579345|536390446|FG006|Overall Study|Protocol Violation|0|||
148704229|NCT00579345|536390447|FG007|Overall Study|Protocol Violation|1|||
148704230|NCT00579345|536390440|FG000|Overall Study|Death|1|||
148704231|NCT00579345|536390441|FG001|Overall Study|Death|1|||
148704232|NCT00579345|536390442|FG002|Overall Study|Death|1|||
148704233|NCT00579345|536390443|FG003|Overall Study|Death|1|||
148704234|NCT00579345|536390444|FG004|Overall Study|Death|0|||
148704235|NCT00579345|536390445|FG005|Overall Study|Death|0|||
148704236|NCT00579345|536390446|FG006|Overall Study|Death|0|||
148704237|NCT00579345|536390447|FG007|Overall Study|Death|0|||
148704238|NCT00508651|536390451|FG000|Overall Study|Lost to Follow-up|3|||
148704239|NCT00508651|536390452|FG001|Overall Study|Lost to Follow-up|1|||
148704240|NCT00508651|536390451|FG000|Overall Study|Withdrawal by Subject|1|||
148704241|NCT00508651|536390452|FG001|Overall Study|Withdrawal by Subject|1|||
148704242|NCT00934050|536390454|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
148704243|NCT00934050|536390455|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
148704244|NCT00934050|536390456|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
148704245|NCT00934050|536390457|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
148704246|NCT00934050|536390458|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
148704247|NCT00934050|536390459|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
148704248|NCT00934050|536390454|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
148704249|NCT00934050|536390455|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
148704250|NCT00934050|536390456|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
148704251|NCT00934050|536390457|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
148704252|NCT00934050|536390458|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
148704253|NCT00934050|536390459|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
148704254|NCT00934050|536390454|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
148704255|NCT00934050|536390455|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
148704256|NCT00934050|536390456|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
148704257|NCT00934050|536390457|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
148704258|NCT00934050|536390458|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
148704259|NCT00934050|536390459|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
148704260|NCT00934050|536390454|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
148704261|NCT00934050|536390455|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
148704262|NCT00934050|536390456|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
148704263|NCT00934050|536390457|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
148704264|NCT00934050|536390458|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
148704265|NCT00934050|536390459|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
148704266|NCT00934050|536390454|FG000|Enrolled After 15 Dec 2009|Death|0|||
148704267|NCT00934050|536390455|FG001|Enrolled After 15 Dec 2009|Death|0|||
148704268|NCT00934050|536390456|FG002|Enrolled After 15 Dec 2009|Death|0|||
148704269|NCT00934050|536390457|FG003|Enrolled After 15 Dec 2009|Death|0|||
148704270|NCT00934050|536390458|FG004|Enrolled After 15 Dec 2009|Death|0|||
148704271|NCT00934050|536390459|FG005|Enrolled After 15 Dec 2009|Death|1|||
148704272|NCT00934050|536390454|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
148704273|NCT00934050|536390455|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
148704274|NCT00934050|536390456|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
148704275|NCT00934050|536390457|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
148704276|NCT00934050|536390458|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
148704277|NCT00934050|536390459|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
148704278|NCT00934050|536390454|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
148704279|NCT00934050|536390455|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
148704280|NCT00934050|536390456|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
148704281|NCT00934050|536390457|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
148704282|NCT00934050|536390458|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
148704283|NCT00934050|536390459|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
148704284|NCT02149420|536390462|FG000|Core Study|Administrative problems|0|||
148704285|NCT02149420|536390463|FG001|Core Study|Administrative problems|1|||
148704286|NCT02149420|536390464|FG002|Core Study|Administrative problems|2|||
148704287|NCT02149420|536390462|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
148704288|NCT02149420|536390463|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
148704289|NCT02149420|536390464|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
148967766|NCT00574405|537368508|FG001|Overall Study|Withdrawal by Subject|2|||
148704290|NCT00834067|536390467|FG000|Washout of 21 Days|Protocol Violation|0|||
148704291|NCT00834067|536390468|FG001|Washout of 21 Days|Protocol Violation|1|||
148704292|NCT00440518|536390469|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
148704293|NCT00440518|536390470|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
148704294|NCT00440518|536390471|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
148704295|NCT00440518|536390469|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
148704296|NCT00440518|536390470|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
148967767|NCT03026257|537368509|FG000|Overall Study|Adverse Event|3|||
148704297|NCT00440518|536390471|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
148704298|NCT00440518|536390469|FG000|Randomized /Titration Period|Protocol Deviation|1|||
148704299|NCT00440518|536390470|FG001|Randomized /Titration Period|Protocol Deviation|0|||
148704300|NCT00440518|536390471|FG002|Randomized /Titration Period|Protocol Deviation|0|||
148704301|NCT00440518|536390469|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
148704302|NCT00440518|536390470|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
148704303|NCT00440518|536390471|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
148704304|NCT00440518|536390469|FG000|Randomized /Titration Period|Other|1|||
148704305|NCT00440518|536390470|FG001|Randomized /Titration Period|Other|0|||
148704306|NCT00440518|536390471|FG002|Randomized /Titration Period|Other|0|||
148704307|NCT00440518|536390469|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
148704308|NCT00440518|536390470|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
148704309|NCT00440518|536390471|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
148704310|NCT00440518|536390469|FG000|Randomized /Titration Period|Adverse Event|2|||
148704311|NCT00440518|536390470|FG001|Randomized /Titration Period|Adverse Event|3|||
148704312|NCT00440518|536390471|FG002|Randomized /Titration Period|Adverse Event|0|||
148704313|NCT00440518|536390469|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
148704314|NCT00440518|536390470|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
148704315|NCT00440518|536390471|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
148704316|NCT00440518|536390469|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
148704317|NCT00440518|536390470|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
148704318|NCT00440518|536390471|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
148704319|NCT00440518|536390469|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
148704320|NCT00440518|536390470|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
148704321|NCT00440518|536390471|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
148704322|NCT00440518|536390469|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
148704323|NCT00440518|536390470|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
148704324|NCT00440518|536390471|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
148704325|NCT00440518|536390469|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
148704326|NCT00440518|536390470|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
148704327|NCT00440518|536390471|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
148704328|NCT00440518|536390469|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
148704329|NCT00440518|536390470|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
148704330|NCT00440518|536390471|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
148704331|NCT02246920|536390472|FG000|Overall Study|Adverse Event|3|||
148704332|NCT02246920|536390473|FG001|Overall Study|Adverse Event|1|||
148704333|NCT02246920|536390474|FG002|Overall Study|Adverse Event|1|||
148704334|NCT02246920|536390472|FG000|Overall Study|Lost to Follow-up|2|||
148704335|NCT02246920|536390473|FG001|Overall Study|Lost to Follow-up|1|||
148704336|NCT02246920|536390474|FG002|Overall Study|Lost to Follow-up|0|||
148704337|NCT02246920|536390472|FG000|Overall Study|Protocol Violation|2|||
148704338|NCT02246920|536390473|FG001|Overall Study|Protocol Violation|5|||
148704339|NCT02246920|536390474|FG002|Overall Study|Protocol Violation|1|||
148704340|NCT02246920|536390472|FG000|Overall Study|Withdrawal by Subject|0|||
148704341|NCT02246920|536390473|FG001|Overall Study|Withdrawal by Subject|0|||
148704342|NCT02246920|536390474|FG002|Overall Study|Withdrawal by Subject|1|||
148704343|NCT02678286|536390475|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
148704344|NCT02678286|536390476|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
148704345|NCT02678286|536390475|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
148704346|NCT02678286|536390476|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
148704347|NCT02678286|536390475|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
148704348|NCT02678286|536390476|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
148704349|NCT02678286|536390475|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
148704350|NCT02678286|536390476|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
148704351|NCT02678286|536390475|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
148704352|NCT02678286|536390476|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
148704353|NCT02902211|536390482|FG000|First Three Months|Withdrawal by Subject|7|||
148704354|NCT02902211|536390483|FG001|First Three Months|Withdrawal by Subject|3|||
148704355|NCT03247972|536390487|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
148704356|NCT03247972|536390487|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
148704357|NCT00968812|536390490|FG000|Overall Study|Adverse Event|30|||
148704358|NCT00968812|536390491|FG001|Overall Study|Adverse Event|46|||
148704359|NCT00968812|536390492|FG002|Overall Study|Adverse Event|33|||
148704360|NCT00968812|536390490|FG000|Overall Study|Death|2|||
148704361|NCT00968812|536390491|FG001|Overall Study|Death|2|||
148704362|NCT00968812|536390492|FG002|Overall Study|Death|1|||
148704363|NCT00968812|536390490|FG000|Overall Study|Lack of Efficacy|9|||
148704364|NCT00968812|536390491|FG001|Overall Study|Lack of Efficacy|7|||
148704365|NCT00968812|536390492|FG002|Overall Study|Lack of Efficacy|16|||
148704366|NCT00968812|536390490|FG000|Overall Study|Lost to Follow-up|17|||
148704367|NCT00968812|536390491|FG001|Overall Study|Lost to Follow-up|12|||
148704368|NCT00968812|536390492|FG002|Overall Study|Lost to Follow-up|11|||
148704369|NCT00968812|536390490|FG000|Overall Study|Physician Decision|8|||
148704370|NCT00968812|536390491|FG001|Overall Study|Physician Decision|5|||
148704371|NCT00968812|536390492|FG002|Overall Study|Physician Decision|9|||
148704372|NCT00968812|536390490|FG000|Overall Study|Protocol Violation|7|||
148704373|NCT00968812|536390491|FG001|Overall Study|Protocol Violation|4|||
148704374|NCT00968812|536390492|FG002|Overall Study|Protocol Violation|3|||
148704375|NCT00968812|536390490|FG000|Overall Study|Withdrawal by Subject|17|||
148704376|NCT00968812|536390491|FG001|Overall Study|Withdrawal by Subject|23|||
148704377|NCT00968812|536390492|FG002|Overall Study|Withdrawal by Subject|25|||
148704378|NCT00968812|536390490|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
148704379|NCT00968812|536390491|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
148704380|NCT00968812|536390492|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
148704381|NCT00968812|536390490|FG000|Overall Study|Noncompliance with study drug|4|||
148704382|NCT00968812|536390491|FG001|Overall Study|Noncompliance with study drug|1|||
148704383|NCT00968812|536390492|FG002|Overall Study|Noncompliance with study drug|6|||
148704384|NCT00968812|536390490|FG000|Overall Study|Unable to take rescue therapy|12|||
148704385|NCT00968812|536390491|FG001|Overall Study|Unable to take rescue therapy|12|||
148704386|NCT00968812|536390492|FG002|Overall Study|Unable to take rescue therapy|17|||
148704387|NCT00968812|536390490|FG000|Overall Study|Other|25|||
148704388|NCT00968812|536390491|FG001|Overall Study|Other|37|||
148704389|NCT00968812|536390492|FG002|Overall Study|Other|40|||
148704390|NCT03500341|536390493|FG000|Overall Study|Withdrawn prior to Completion|2|||
148704391|NCT02576938|536390494|FG000|Overall Study|Adverse Event|5|||
148704392|NCT02576938|536390495|FG001|Overall Study|Adverse Event|3|||
148704393|NCT02576938|536390496|FG002|Overall Study|Adverse Event|6|||
148704394|NCT02576938|536390494|FG000|Overall Study|Protocol Violation|1|||
148704395|NCT02576938|536390495|FG001|Overall Study|Protocol Violation|1|||
148704396|NCT02576938|536390496|FG002|Overall Study|Protocol Violation|1|||
148704397|NCT02576938|536390494|FG000|Overall Study|Withdrawal by Subject|3|||
148704398|NCT02576938|536390495|FG001|Overall Study|Withdrawal by Subject|2|||
148704399|NCT02576938|536390496|FG002|Overall Study|Withdrawal by Subject|4|||
148704400|NCT02576938|536390494|FG000|Overall Study|Lack of Efficacy|9|||
148704401|NCT02576938|536390495|FG001|Overall Study|Lack of Efficacy|4|||
148704402|NCT02576938|536390496|FG002|Overall Study|Lack of Efficacy|0|||
148704403|NCT02576938|536390494|FG000|Overall Study|Lost to Follow-up|2|||
148704404|NCT02576938|536390495|FG001|Overall Study|Lost to Follow-up|0|||
148704405|NCT02576938|536390496|FG002|Overall Study|Lost to Follow-up|1|||
148704406|NCT02576938|536390494|FG000|Overall Study|Physician Decision|0|||
148704407|NCT02576938|536390495|FG001|Overall Study|Physician Decision|1|||
148704408|NCT02576938|536390496|FG002|Overall Study|Physician Decision|0|||
148704409|NCT02576938|536390494|FG000|Overall Study|Met Exclusion Criteria|0|||
148704410|NCT02576938|536390495|FG001|Overall Study|Met Exclusion Criteria|1|||
148704411|NCT02576938|536390496|FG002|Overall Study|Met Exclusion Criteria|0|||
148704412|NCT00838630|536390499|FG000|First Intervention|Adverse Event|1|||
148704413|NCT00838630|536390500|FG001|First Intervention|Adverse Event|0|||
148704414|NCT00838630|536390499|FG000|Washout: 7 Days|Protocol Violation|1|||
148704415|NCT00838630|536390500|FG001|Washout: 7 Days|Protocol Violation|0|||
148704416|NCT00571064|536390501|FG000|Overall Study|Adverse Event|13|||
148704417|NCT00571064|536390501|FG000|Overall Study|Protocol Violation|4|||
148704418|NCT00571064|536390501|FG000|Overall Study|Withdrawal by Subject|2|||
148704419|NCT00571064|536390501|FG000|Overall Study|Other|2|||
148704420|NCT04022954|536390502|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
148704421|NCT04022954|536390502|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
148704422|NCT04022954|536390502|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
148704423|NCT03017885|536390503|FG000|Overall Study|Adverse Event|2|||
148704424|NCT03017885|536390504|FG001|Overall Study|Adverse Event|0|||
148704425|NCT03017885|536390505|FG002|Overall Study|Adverse Event|0|||
148704426|NCT03017885|536390506|FG003|Overall Study|Adverse Event|0|||
148704427|NCT03017885|536390507|FG004|Overall Study|Adverse Event|0|||
148704428|NCT03017885|536390508|FG005|Overall Study|Adverse Event|0|||
148704429|NCT03017885|536390503|FG000|Overall Study|Progression of disease|4|||
148704430|NCT03017885|536390504|FG001|Overall Study|Progression of disease|3|||
148704431|NCT03017885|536390505|FG002|Overall Study|Progression of disease|4|||
148704432|NCT03017885|536390506|FG003|Overall Study|Progression of disease|0|||
148704433|NCT03017885|536390507|FG004|Overall Study|Progression of disease|0|||
148704434|NCT03017885|536390508|FG005|Overall Study|Progression of disease|0|||
148704435|NCT03017885|536390503|FG000|Overall Study|Other than listed|1|||
148704436|NCT03017885|536390504|FG001|Overall Study|Other than listed|2|||
148704437|NCT03017885|536390505|FG002|Overall Study|Other than listed|1|||
148704438|NCT03017885|536390506|FG003|Overall Study|Other than listed|0|||
148704439|NCT03017885|536390507|FG004|Overall Study|Other than listed|0|||
148704440|NCT03017885|536390508|FG005|Overall Study|Other than listed|0|||
148704441|NCT03017885|536390503|FG000|Overall Study|Lost to Follow-up|2|||
148704442|NCT03017885|536390504|FG001|Overall Study|Lost to Follow-up|0|||
148704443|NCT03017885|536390505|FG002|Overall Study|Lost to Follow-up|3|||
148704444|NCT03017885|536390506|FG003|Overall Study|Lost to Follow-up|0|||
148704445|NCT03017885|536390507|FG004|Overall Study|Lost to Follow-up|0|||
148704446|NCT03017885|536390508|FG005|Overall Study|Lost to Follow-up|0|||
148704447|NCT03017885|536390503|FG000|Overall Study|Change to other anti-cancer therapy|0|||
148704448|NCT03017885|536390504|FG001|Overall Study|Change to other anti-cancer therapy|0|||
148704449|NCT03017885|536390505|FG002|Overall Study|Change to other anti-cancer therapy|1|||
148704450|NCT03017885|536390506|FG003|Overall Study|Change to other anti-cancer therapy|0|||
148704451|NCT03017885|536390507|FG004|Overall Study|Change to other anti-cancer therapy|0|||
148704452|NCT03017885|536390508|FG005|Overall Study|Change to other anti-cancer therapy|0|||
148704453|NCT02648438|536390513|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148704454|NCT02648438|536390514|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
148704455|NCT02648438|536390515|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
148704456|NCT02648438|536390513|FG000|Overall Study|Protocol Violation|2|||
148704457|NCT02648438|536390514|FG001|Overall Study|Protocol Violation|0|||
148704458|NCT02648438|536390515|FG002|Overall Study|Protocol Violation|0|||
148704459|NCT02648438|536390513|FG000|Overall Study|Withdrawal by Subject|1|||
148704460|NCT02648438|536390514|FG001|Overall Study|Withdrawal by Subject|1|||
148704461|NCT02648438|536390515|FG002|Overall Study|Withdrawal by Subject|0|||
148704462|NCT03138967|536390516|FG000|Overall Study|Death|0|||
148704463|NCT03138967|536390517|FG001|Overall Study|Death|1|||
148704464|NCT03138967|536390516|FG000|Overall Study|Physician Decision|1|||
148704465|NCT03138967|536390517|FG001|Overall Study|Physician Decision|3|||
148704466|NCT04604275|536390518|FG000|Washout-1 Week|Withdrawal by Subject|1|||
148704467|NCT04604275|536390519|FG001|Washout-1 Week|Withdrawal by Subject|0|||
148704468|NCT02258074|536390520|FG000|Overall Study|Withdrawal by Subject|1|||
148704469|NCT02258074|536390521|FG001|Overall Study|Withdrawal by Subject|0|||
148704470|NCT02258074|536390522|FG002|Overall Study|Withdrawal by Subject|0|||
148704471|NCT02258074|536390523|FG003|Overall Study|Withdrawal by Subject|0|||
148704472|NCT05446870|536390524|FG000|Overall Study|Death|6|||
148704473|NCT05446870|536390525|FG001|Overall Study|Death|5|||
148704474|NCT05446870|536390524|FG000|Overall Study|Lost to Follow-up|0|||
148704475|NCT05446870|536390525|FG001|Overall Study|Lost to Follow-up|1|||
148704476|NCT05446870|536390524|FG000|Overall Study|Physician Decision|52|||
148704477|NCT05446870|536390525|FG001|Overall Study|Physician Decision|53|||
148704478|NCT05446870|536390524|FG000|Overall Study|Withdrawal by Subject|3|||
148704479|NCT05446870|536390525|FG001|Overall Study|Withdrawal by Subject|3|||
148704480|NCT02689505|536390526|FG000|Overall Study|Progressive disease|2|||
148704481|NCT02689505|536390527|FG001|Overall Study|Progressive disease|2|||
148704482|NCT02689505|536390528|FG002|Overall Study|Progressive disease|3|||
148704483|NCT02689505|536390529|FG003|Overall Study|Progressive disease|9|||
148704484|NCT02689505|536390530|FG004|Overall Study|Progressive disease|1|||
148704485|NCT02689505|536390526|FG000|Overall Study|Dose Limiting Toxicity|0|||
148704486|NCT02689505|536390527|FG001|Overall Study|Dose Limiting Toxicity|1|||
148704487|NCT02689505|536390528|FG002|Overall Study|Dose Limiting Toxicity|0|||
148704488|NCT02689505|536390529|FG003|Overall Study|Dose Limiting Toxicity|0|||
148704489|NCT02689505|536390530|FG004|Overall Study|Dose Limiting Toxicity|2|||
148704490|NCT02689505|536390526|FG000|Overall Study|Other AE or clinical progression|0|||
148704491|NCT02689505|536390527|FG001|Overall Study|Other AE or clinical progression|2|||
148704492|NCT02689505|536390528|FG002|Overall Study|Other AE or clinical progression|0|||
148704493|NCT02689505|536390529|FG003|Overall Study|Other AE or clinical progression|2|||
148704494|NCT02689505|536390530|FG004|Overall Study|Other AE or clinical progression|0|||
148704495|NCT00723710|536390534|FG000|Overall Study|Disease progression|48|||
148704496|NCT00723710|536390534|FG000|Overall Study|Adverse Event|88|||
148704497|NCT00723710|536390534|FG000|Overall Study|Withdrawal by Subject|36|||
148704498|NCT00723710|536390534|FG000|Overall Study|Physician Decision|2|||
148704499|NCT01615198|536390535|FG000|Overall Study|Withdrawal by Subject|5|||
148704500|NCT01615198|536390536|FG001|Overall Study|Withdrawal by Subject|5|||
148967768|NCT03026257|537368510|FG001|Overall Study|Adverse Event|0|||
148967769|NCT03026257|537368511|FG002|Overall Study|Adverse Event|0|||
148967770|NCT03026257|537368512|FG003|Overall Study|Adverse Event|0|||
148967771|NCT03026257|537368513|FG004|Overall Study|Adverse Event|0|||
148967772|NCT03026257|537368514|FG005|Overall Study|Adverse Event|0|||
148704501|NCT01615198|536390535|FG000|Overall Study|Protocol deviation|1|||
148704502|NCT01615198|536390536|FG001|Overall Study|Protocol deviation|1|||
148704503|NCT01615198|536390535|FG000|Overall Study|Physician Decision|5|||
148704504|NCT01615198|536390536|FG001|Overall Study|Physician Decision|1|||
148967773|NCT03026257|537368509|FG000|Overall Study|Lost to Follow-up|1|||
148704505|NCT01615198|536390535|FG000|Overall Study|Lost to Follow-up|1|||
148704506|NCT01615198|536390536|FG001|Overall Study|Lost to Follow-up|1|||
148704507|NCT01615198|536390535|FG000|Overall Study|Lack of Efficacy|1|||
148704508|NCT01615198|536390536|FG001|Overall Study|Lack of Efficacy|6|||
148704509|NCT01615198|536390535|FG000|Overall Study|Adverse Event|11|||
148704510|NCT01615198|536390536|FG001|Overall Study|Adverse Event|5|||
148704511|NCT01686438|536390537|FG000|Overall Study|Lost to Follow-up|8|||
148704512|NCT01686438|536390538|FG001|Overall Study|Lost to Follow-up|9|||
148704513|NCT01686438|536390539|FG002|Overall Study|Lost to Follow-up|10|||
148704514|NCT01686438|536390537|FG000|Overall Study|Adverse Event|0|||
148967774|NCT03026257|537368510|FG001|Overall Study|Lost to Follow-up|0|||
148967775|NCT03026257|537368511|FG002|Overall Study|Lost to Follow-up|0|||
148704515|NCT01686438|536390538|FG001|Overall Study|Adverse Event|0|||
148704516|NCT01686438|536390539|FG002|Overall Study|Adverse Event|1|||
148704517|NCT01686438|536390537|FG000|Overall Study|Protocol Violation|0|||
148704518|NCT01686438|536390538|FG001|Overall Study|Protocol Violation|0|||
148704519|NCT01686438|536390539|FG002|Overall Study|Protocol Violation|1|||
148704520|NCT01686438|536390537|FG000|Overall Study|Withdrawal by Subject|0|||
148704521|NCT01686438|536390538|FG001|Overall Study|Withdrawal by Subject|0|||
148704522|NCT01686438|536390539|FG002|Overall Study|Withdrawal by Subject|1|||
148704523|NCT01029340|536390540|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
148704524|NCT01029340|536390541|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
148704525|NCT01029340|536390542|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
148704526|NCT01029340|536390543|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
148704527|NCT01029340|536390544|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
148704528|NCT01029340|536390545|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
148704529|NCT01029340|536390540|FG000|Part B Treatment Period|Protocol Violation|0|||
148704530|NCT01029340|536390541|FG001|Part B Treatment Period|Protocol Violation|0|||
148704531|NCT01029340|536390542|FG002|Part B Treatment Period|Protocol Violation|1|||
148704532|NCT01029340|536390543|FG003|Part B Treatment Period|Protocol Violation|0|||
148704533|NCT01029340|536390544|FG004|Part B Treatment Period|Protocol Violation|0|||
148704534|NCT01029340|536390545|FG005|Part B Treatment Period|Protocol Violation|0|||
148704535|NCT01029340|536390540|FG000|Extension Period|Adverse Event|0|||
148704536|NCT01029340|536390541|FG001|Extension Period|Adverse Event|0|||
148704537|NCT01029340|536390542|FG002|Extension Period|Adverse Event|0|||
148704538|NCT01029340|536390543|FG003|Extension Period|Adverse Event|0|||
148704539|NCT01029340|536390544|FG004|Extension Period|Adverse Event|0|||
148704540|NCT01029340|536390545|FG005|Extension Period|Adverse Event|1|||
148704541|NCT01029340|536390540|FG000|Extension Period|starting another study|0|||
148704542|NCT01029340|536390541|FG001|Extension Period|starting another study|0|||
148704543|NCT01029340|536390542|FG002|Extension Period|starting another study|0|||
148704544|NCT01029340|536390543|FG003|Extension Period|starting another study|0|||
148704545|NCT01029340|536390544|FG004|Extension Period|starting another study|0|||
148704546|NCT01029340|536390545|FG005|Extension Period|starting another study|8|||
148704547|NCT01029340|536390540|FG000|Extension Period|non-compliance|0|||
148704548|NCT01029340|536390541|FG001|Extension Period|non-compliance|0|||
148704549|NCT01029340|536390542|FG002|Extension Period|non-compliance|0|||
148704550|NCT01029340|536390543|FG003|Extension Period|non-compliance|0|||
148704551|NCT01029340|536390544|FG004|Extension Period|non-compliance|0|||
148704552|NCT01029340|536390545|FG005|Extension Period|non-compliance|1|||
148704553|NCT01029340|536390540|FG000|Extension Period|Withdrawal by Subject|0|||
148704554|NCT01029340|536390541|FG001|Extension Period|Withdrawal by Subject|0|||
148704555|NCT01029340|536390542|FG002|Extension Period|Withdrawal by Subject|0|||
148704556|NCT01029340|536390543|FG003|Extension Period|Withdrawal by Subject|0|||
148704557|NCT01029340|536390544|FG004|Extension Period|Withdrawal by Subject|0|||
148704558|NCT01029340|536390545|FG005|Extension Period|Withdrawal by Subject|1|||
148704559|NCT01029340|536390540|FG000|Extension Period|Physician Decision|0|||
148704560|NCT01029340|536390541|FG001|Extension Period|Physician Decision|0|||
148704561|NCT01029340|536390542|FG002|Extension Period|Physician Decision|0|||
148704562|NCT01029340|536390543|FG003|Extension Period|Physician Decision|0|||
148704563|NCT01029340|536390544|FG004|Extension Period|Physician Decision|0|||
148704564|NCT01029340|536390545|FG005|Extension Period|Physician Decision|1|||
148704565|NCT01864174|536390546|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
148704566|NCT01864174|536390547|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
148704567|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
148704568|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
148704569|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
148704570|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
148704571|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
148704572|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
148704573|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Death|1|||
148704574|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Death|0|||
148704575|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
148704576|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
148967776|NCT03026257|537368512|FG003|Overall Study|Lost to Follow-up|0|||
148704577|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
148704578|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
148704579|NCT01864174|536390546|FG000|Double Blind - Compliant Randomized|Other|6|||
148704580|NCT01864174|536390547|FG001|Double Blind - Compliant Randomized|Other|10|||
148704581|NCT01864174|536390546|FG000|Off Treatment Follow-Up|Other|2|||
148704582|NCT01864174|536390547|FG001|Off Treatment Follow-Up|Other|0|||
148704583|NCT01864174|536390546|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
148704584|NCT01864174|536390547|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
148704585|NCT02648347|536390548|FG000|Overall Study|Death|174|||
148704586|NCT02648347|536390549|FG001|Overall Study|Death|167|||
148704587|NCT02648347|536390548|FG000|Overall Study|Withdrawal by Subject|16|||
148704588|NCT02648347|536390549|FG001|Overall Study|Withdrawal by Subject|9|||
148704589|NCT02648347|536390548|FG000|Overall Study|Lost to Follow-up|18|||
148704590|NCT02648347|536390549|FG001|Overall Study|Lost to Follow-up|21|||
148704591|NCT02648347|536390548|FG000|Overall Study|Missing|1|||
148704592|NCT02648347|536390549|FG001|Overall Study|Missing|0|||
148704593|NCT00468286|536390554|FG000|Overall Study|Adverse Event|1|||
148704594|NCT00468286|536390555|FG001|Overall Study|Adverse Event|6|||
148704595|NCT00468286|536390554|FG000|Overall Study|Protocol Violation|2|||
148704596|NCT00468286|536390555|FG001|Overall Study|Protocol Violation|2|||
148704597|NCT00468286|536390554|FG000|Overall Study|Withdrawal by Subject|4|||
148704598|NCT00468286|536390555|FG001|Overall Study|Withdrawal by Subject|3|||
148704599|NCT00468286|536390554|FG000|Overall Study|Physician Decision|0|||
148704600|NCT00468286|536390555|FG001|Overall Study|Physician Decision|1|||
148704601|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
148704602|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
148704603|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
148704604|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
148704605|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
148704606|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
148704607|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
148704608|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
148704609|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
148704610|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
148704611|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
148704612|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
148704613|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
148704614|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
148704615|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
148704616|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
148704617|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
148704618|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
148704619|NCT02009163|536390558|FG000|Open-label Period (Non-randomized)|Other|13|||
148704620|NCT02009163|536390559|FG001|Open-label Period (Non-randomized)|Other|0|||
148704621|NCT02009163|536390560|FG002|Open-label Period (Non-randomized)|Other|0|||
148704622|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
148704623|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
148704624|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
148704625|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
148704626|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
148704627|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
148704628|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Adverse Event|0|||
148704629|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Adverse Event|0|||
148704630|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Adverse Event|6|||
148704631|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
148704632|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
148704633|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
148704634|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
148704635|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
148704636|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
148704637|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Pregnancy|0|||
148704638|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Pregnancy|0|||
148704639|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Pregnancy|2|||
148704640|NCT02009163|536390558|FG000|Randomized-withdrawal Period|Other|0|||
148704641|NCT02009163|536390559|FG001|Randomized-withdrawal Period|Other|9|||
148704642|NCT02009163|536390560|FG002|Randomized-withdrawal Period|Other|5|||
148704643|NCT04419311|536390562|FG000|Overall Study|Lost to Follow-up|1|||
148704644|NCT04419311|536390563|FG001|Overall Study|Lost to Follow-up|0|||
148704645|NCT03482882|536390565|FG000|Overall Study|Adverse Event|3|||
148704646|NCT03482882|536390565|FG000|Overall Study|Lost to Follow-up|1|||
148704647|NCT03482882|536390565|FG000|Overall Study|Protocol Violation|2|||
148704648|NCT03482882|536390565|FG000|Overall Study|Not further specified|1|||
148704649|NCT04659603|536390566|FG000|Overall Study|Study terminated by sponsor|0|||
148704650|NCT04659603|536390567|FG001|Overall Study|Study terminated by sponsor|0|||
148704651|NCT04659603|536390568|FG002|Overall Study|Study terminated by sponsor|2|||
148704652|NCT04659603|536390566|FG000|Overall Study|Withdrawal by Subject|0|||
148967777|NCT03026257|537368513|FG004|Overall Study|Lost to Follow-up|0|||
148967778|NCT03026257|537368514|FG005|Overall Study|Lost to Follow-up|0|||
148967779|NCT03026257|537368509|FG000|Overall Study|Protocol Violation|1|||
148967780|NCT03026257|537368510|FG001|Overall Study|Protocol Violation|0|||
148704653|NCT04659603|536390567|FG001|Overall Study|Withdrawal by Subject|5|||
148967781|NCT03026257|537368511|FG002|Overall Study|Protocol Violation|0|||
148967782|NCT03026257|537368512|FG003|Overall Study|Protocol Violation|1|||
148704654|NCT04659603|536390568|FG002|Overall Study|Withdrawal by Subject|0|||
148704655|NCT04659603|536390566|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
148704656|NCT04659603|536390567|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
148704657|NCT04659603|536390568|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
148704658|NCT02305758|536390573|FG000|Overall Study|Death|27|||
148704659|NCT02305758|536390574|FG001|Overall Study|Death|27|||
148704660|NCT02305758|536390573|FG000|Overall Study|Withdrew consent|9|||
148704661|NCT02305758|536390574|FG001|Overall Study|Withdrew consent|2|||
148704662|NCT02305758|536390573|FG000|Overall Study|Lost to Follow-up|6|||
148704663|NCT02305758|536390574|FG001|Overall Study|Lost to Follow-up|1|||
148704664|NCT02305758|536390573|FG000|Overall Study|Study Terminated by Sponsor|21|||
148704665|NCT02305758|536390574|FG001|Overall Study|Study Terminated by Sponsor|34|||
148704666|NCT02305758|536390573|FG000|Overall Study|Other, not specified|2|||
148704667|NCT02305758|536390574|FG001|Overall Study|Other, not specified|1|||
148704668|NCT00811655|536390575|FG000|Overall Study|Physician Decision|1|||
148704669|NCT02820350|536390576|FG000|Overall Study|Withdrawal by Subject|3|||
148704670|NCT02820350|536390576|FG000|Overall Study|Death|4|||
148704671|NCT01754597|536390577|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
148704672|NCT01754597|536390578|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
148704673|NCT01802320|536390579|FG000|Overall Study|Death|1|||
148704674|NCT01802320|536390579|FG000|Overall Study|Withdrawal by Subject|1|||
148704675|NCT05265624|536392354|FG000|Overall Study|Lost to Follow-up|3|||
148704676|NCT05265624|536392355|FG001|Overall Study|Lost to Follow-up|0|||
148704677|NCT05265624|536392354|FG000|Overall Study|Withdrawal by Subject|1|||
148704678|NCT05265624|536392355|FG001|Overall Study|Withdrawal by Subject|0|||
148704679|NCT00001703|536392356|FG000|Overall Study|progressed disease|2|||
148704680|NCT00001703|536392356|FG000|Overall Study|No evidence of disease|1|||
148704681|NCT00001703|536392356|FG000|Overall Study|recurrent disease|2|||
148704682|NCT03071575|536392357|FG000|Overall Study|Death|0|||
148704683|NCT03071575|536392358|FG001|Overall Study|Death|1|||
148704684|NCT03071575|536392357|FG000|Overall Study|Lost to Follow-up|5|||
148704685|NCT03071575|536392358|FG001|Overall Study|Lost to Follow-up|11|||
148704686|NCT03071575|536392357|FG000|Overall Study|Withdrawal by Subject|4|||
148704687|NCT03071575|536392358|FG001|Overall Study|Withdrawal by Subject|2|||
148704688|NCT00834795|536392363|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
148704689|NCT00834795|536392364|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
148704690|NCT00834795|536392363|FG000|Second Intervention|Adverse Event|1|||
148704691|NCT00834795|536392364|FG001|Second Intervention|Adverse Event|0|||
148704692|NCT03447353|536392365|FG000|Overall Study|Failure at Screening Visit|2|||
148704693|NCT03447353|536392365|FG000|Overall Study|Lost to Follow-up|4|||
148704694|NCT03447353|536392365|FG000|Overall Study|Scheduling Conflicts|3|||
148704695|NCT03447353|536392365|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
148704696|NCT01376037|536392366|FG000|Overall Study|Lost to Follow-up|0|||
148704697|NCT01376037|536392367|FG001|Overall Study|Lost to Follow-up|2|||
148704698|NCT03570749|536392368|FG000|Overall Study|Ongoing|26|||
148704699|NCT03570749|536392369|FG001|Overall Study|Ongoing|25|||
148704700|NCT03570749|536392370|FG002|Overall Study|Ongoing|25|||
148704701|NCT03570749|536392371|FG003|Overall Study|Ongoing|26|||
148704702|NCT03570749|536392372|FG004|Overall Study|Ongoing|140|||
148704703|NCT03570749|536392373|FG005|Overall Study|Ongoing|142|||
148704704|NCT03570749|536392374|FG006|Overall Study|Ongoing|220|||
148704705|NCT03570749|536392368|FG000|Overall Study|Adverse Event|0|||
148704706|NCT03570749|536392369|FG001|Overall Study|Adverse Event|0|||
148704707|NCT03570749|536392370|FG002|Overall Study|Adverse Event|0|||
148704708|NCT03570749|536392371|FG003|Overall Study|Adverse Event|0|||
148704709|NCT03570749|536392372|FG004|Overall Study|Adverse Event|2|||
148704710|NCT03570749|536392373|FG005|Overall Study|Adverse Event|3|||
148704711|NCT03570749|536392374|FG006|Overall Study|Adverse Event|6|||
148704712|NCT03570749|536392368|FG000|Overall Study|Lack of Efficacy|0|||
148704713|NCT03570749|536392369|FG001|Overall Study|Lack of Efficacy|0|||
148704714|NCT03570749|536392370|FG002|Overall Study|Lack of Efficacy|0|||
148967783|NCT03026257|537368513|FG004|Overall Study|Protocol Violation|1|||
148967784|NCT03026257|537368514|FG005|Overall Study|Protocol Violation|0|||
148967785|NCT03026257|537368509|FG000|Overall Study|Withdrawal by Subject|1|||
148704715|NCT03570749|536392371|FG003|Overall Study|Lack of Efficacy|0|||
148704716|NCT03570749|536392372|FG004|Overall Study|Lack of Efficacy|8|||
148704717|NCT03570749|536392373|FG005|Overall Study|Lack of Efficacy|2|||
148704718|NCT03570749|536392374|FG006|Overall Study|Lack of Efficacy|7|||
148704719|NCT03570749|536392368|FG000|Overall Study|Lost to Follow-up|0|||
148704720|NCT03570749|536392369|FG001|Overall Study|Lost to Follow-up|0|||
148704721|NCT03570749|536392370|FG002|Overall Study|Lost to Follow-up|0|||
148704722|NCT03570749|536392371|FG003|Overall Study|Lost to Follow-up|0|||
148704723|NCT03570749|536392372|FG004|Overall Study|Lost to Follow-up|5|||
148704724|NCT03570749|536392373|FG005|Overall Study|Lost to Follow-up|10|||
148704725|NCT03570749|536392374|FG006|Overall Study|Lost to Follow-up|10|||
148704726|NCT03570749|536392368|FG000|Overall Study|Pregnancy|0|||
148704727|NCT03570749|536392369|FG001|Overall Study|Pregnancy|0|||
148704728|NCT03570749|536392370|FG002|Overall Study|Pregnancy|0|||
148704729|NCT03570749|536392371|FG003|Overall Study|Pregnancy|0|||
148704730|NCT03570749|536392372|FG004|Overall Study|Pregnancy|0|||
148704731|NCT03570749|536392373|FG005|Overall Study|Pregnancy|1|||
148704732|NCT03570749|536392374|FG006|Overall Study|Pregnancy|1|||
148704733|NCT03570749|536392368|FG000|Overall Study|Screen Fail|0|||
148704734|NCT03570749|536392369|FG001|Overall Study|Screen Fail|0|||
148704735|NCT03570749|536392370|FG002|Overall Study|Screen Fail|0|||
148704736|NCT03570749|536392371|FG003|Overall Study|Screen Fail|0|||
148704737|NCT03570749|536392372|FG004|Overall Study|Screen Fail|0|||
148704738|NCT03570749|536392373|FG005|Overall Study|Screen Fail|0|||
148704739|NCT03570749|536392374|FG006|Overall Study|Screen Fail|1|||
148704740|NCT03570749|536392368|FG000|Overall Study|Withdrawal by Subject|2|||
148704741|NCT03570749|536392369|FG001|Overall Study|Withdrawal by Subject|3|||
149025083|NCT04170023|537568005|FG001|LTE Period|Study Termination|11|||
149025084|NCT04170023|537568006|FG002|LTE Period|Study Termination|5|||
149025085|NCT02531438|537568014|FG000|Overall Study|Adverse Event|7|||
149025086|NCT02531438|537568015|FG001|Overall Study|Adverse Event|9|||
148704742|NCT03570749|536392370|FG002|Overall Study|Withdrawal by Subject|2|||
148704743|NCT03570749|536392371|FG003|Overall Study|Withdrawal by Subject|1|||
148704744|NCT03570749|536392372|FG004|Overall Study|Withdrawal by Subject|17|||
148704745|NCT03570749|536392373|FG005|Overall Study|Withdrawal by Subject|12|||
148704746|NCT03570749|536392374|FG006|Overall Study|Withdrawal by Subject|15|||
148704747|NCT03570749|536392368|FG000|Overall Study|Other|0|||
148704748|NCT03570749|536392369|FG001|Overall Study|Other|0|||
148704749|NCT03570749|536392370|FG002|Overall Study|Other|0|||
148704750|NCT03570749|536392371|FG003|Overall Study|Other|0|||
148704751|NCT03570749|536392372|FG004|Overall Study|Other|17|||
148704752|NCT03570749|536392373|FG005|Overall Study|Other|14|||
149025087|NCT02531438|537568014|FG000|Overall Study|Lost to Follow-up|0|||
148704753|NCT03570749|536392374|FG006|Overall Study|Other|21|||
148704754|NCT00561015|536392375|FG000|Overall Study|Adverse Event|0|||
148704755|NCT00561015|536392376|FG001|Overall Study|Adverse Event|0|||
148704756|NCT00561015|536392377|FG002|Overall Study|Adverse Event|0|||
148704757|NCT00561015|536392378|FG003|Overall Study|Adverse Event|0|||
148704758|NCT00561015|536392379|FG004|Overall Study|Adverse Event|1|||
148704759|NCT00561015|536392380|FG005|Overall Study|Adverse Event|0|||
148704760|NCT00561015|536392375|FG000|Overall Study|Lost to Follow-up|2|||
148704761|NCT00561015|536392376|FG001|Overall Study|Lost to Follow-up|0|||
148704762|NCT00561015|536392377|FG002|Overall Study|Lost to Follow-up|0|||
148704763|NCT00561015|536392378|FG003|Overall Study|Lost to Follow-up|1|||
148704764|NCT00561015|536392379|FG004|Overall Study|Lost to Follow-up|0|||
148704765|NCT00561015|536392380|FG005|Overall Study|Lost to Follow-up|3|||
148704766|NCT00561015|536392375|FG000|Overall Study|Participant non-compliance|2|||
148704767|NCT00561015|536392376|FG001|Overall Study|Participant non-compliance|0|||
148704768|NCT00561015|536392377|FG002|Overall Study|Participant non-compliance|0|||
148704769|NCT00561015|536392378|FG003|Overall Study|Participant non-compliance|0|||
148704770|NCT00561015|536392379|FG004|Overall Study|Participant non-compliance|0|||
148704771|NCT00561015|536392380|FG005|Overall Study|Participant non-compliance|0|||
148704772|NCT03616535|536392381|FG000|Overall Study|Death|2|||
148704773|NCT03616535|536392382|FG001|Overall Study|Death|0|||
148704774|NCT03616535|536392383|FG002|Overall Study|Death|0|||
148704775|NCT03616535|536392384|FG003|Overall Study|Death|1|||
148704776|NCT03616535|536392381|FG000|Overall Study|Lost to Follow-up|2|||
148704777|NCT03616535|536392382|FG001|Overall Study|Lost to Follow-up|1|||
148704778|NCT03616535|536392383|FG002|Overall Study|Lost to Follow-up|0|||
148704779|NCT03616535|536392384|FG003|Overall Study|Lost to Follow-up|2|||
148704780|NCT03616535|536392381|FG000|Overall Study|Withdrawal by Subject|1|||
148704781|NCT03616535|536392382|FG001|Overall Study|Withdrawal by Subject|2|||
148704782|NCT03616535|536392383|FG002|Overall Study|Withdrawal by Subject|5|||
148704783|NCT03616535|536392384|FG003|Overall Study|Withdrawal by Subject|1|||
148704784|NCT03616535|536392381|FG000|Overall Study|Not specified or change in eligibility|2|||
148704785|NCT03616535|536392382|FG001|Overall Study|Not specified or change in eligibility|3|||
148704786|NCT03616535|536392383|FG002|Overall Study|Not specified or change in eligibility|3|||
148704787|NCT03616535|536392384|FG003|Overall Study|Not specified or change in eligibility|1|||
148704788|NCT00583453|536392387|FG000|Overall Study|discontinued intervention|0|||
148704789|NCT00583453|536392388|FG001|Overall Study|discontinued intervention|2|||
148704790|NCT02436005|536392389|FG000|Second Intervention|Adverse Event|0|||
148704791|NCT02436005|536392390|FG001|Second Intervention|Adverse Event|1|||
148704792|NCT00905606|536392391|FG000|Period 1|Adverse Event|0|||
148704793|NCT00905606|536392392|FG001|Period 1|Adverse Event|1|||
148704794|NCT00905606|536392391|FG000|Washout|Withdrawal by Subject|1|||
148704795|NCT00905606|536392392|FG001|Washout|Withdrawal by Subject|0|||
148704796|NCT03635320|536392393|FG000|Overall Study|not implanted the device|1|||
148704797|NCT03635320|536392394|FG001|Overall Study|not implanted the device|2|||
148704798|NCT03635320|536392393|FG000|Overall Study|Withdrawal by Subject|11|||
148704799|NCT03635320|536392394|FG001|Overall Study|Withdrawal by Subject|6|||
148704800|NCT00804856|536392397|FG000|Overall Study|Progressive Disease|3|||
148704801|NCT00804856|536392398|FG001|Overall Study|Progressive Disease|2|||
148704802|NCT00804856|536392399|FG002|Overall Study|Progressive Disease|4|||
148704803|NCT00804856|536392400|FG003|Overall Study|Progressive Disease|6|||
148704804|NCT00804856|536392401|FG004|Overall Study|Progressive Disease|4|||
148704805|NCT00804856|536392402|FG005|Overall Study|Progressive Disease|1|||
148704806|NCT00804856|536392403|FG006|Overall Study|Progressive Disease|8|||
148704807|NCT00804856|536392404|FG007|Overall Study|Progressive Disease|2|||
148704808|NCT00804856|536392405|FG008|Overall Study|Progressive Disease|4|||
148704809|NCT00804856|536392406|FG009|Overall Study|Progressive Disease|5|||
148704810|NCT00804856|536392407|FG010|Overall Study|Progressive Disease|12|||
148704811|NCT00804856|536392408|FG011|Overall Study|Progressive Disease|2|||
148704812|NCT00804856|536392409|FG012|Overall Study|Progressive Disease|2|||
148704813|NCT00804856|536392410|FG013|Overall Study|Progressive Disease|26|||
148704814|NCT00804856|536392411|FG014|Overall Study|Progressive Disease|20|||
148704815|NCT00804856|536392397|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704816|NCT00804856|536392398|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704817|NCT00804856|536392399|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704818|NCT00804856|536392400|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704819|NCT00804856|536392401|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
148704820|NCT00804856|536392402|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704821|NCT00804856|536392403|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704822|NCT00804856|536392404|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704823|NCT00804856|536392405|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704824|NCT00804856|536392406|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704825|NCT00804856|536392407|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704826|NCT00804856|536392408|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704827|NCT00804856|536392409|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704828|NCT00804856|536392410|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
148704829|NCT00804856|536392411|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
148704830|NCT00804856|536392397|FG000|Overall Study|Other Adverse Event|1|||
148704831|NCT00804856|536392398|FG001|Overall Study|Other Adverse Event|1|||
148704832|NCT00804856|536392399|FG002|Overall Study|Other Adverse Event|1|||
148704833|NCT00804856|536392400|FG003|Overall Study|Other Adverse Event|2|||
148704834|NCT00804856|536392401|FG004|Overall Study|Other Adverse Event|2|||
148704835|NCT00804856|536392402|FG005|Overall Study|Other Adverse Event|1|||
148704836|NCT00804856|536392403|FG006|Overall Study|Other Adverse Event|3|||
148704837|NCT00804856|536392404|FG007|Overall Study|Other Adverse Event|0|||
148704838|NCT00804856|536392405|FG008|Overall Study|Other Adverse Event|0|||
148704839|NCT00804856|536392406|FG009|Overall Study|Other Adverse Event|1|||
148704840|NCT00804856|536392407|FG010|Overall Study|Other Adverse Event|5|||
148704841|NCT00804856|536392408|FG011|Overall Study|Other Adverse Event|2|||
148704842|NCT00804856|536392409|FG012|Overall Study|Other Adverse Event|0|||
148704843|NCT00804856|536392410|FG013|Overall Study|Other Adverse Event|6|||
148704844|NCT00804856|536392411|FG014|Overall Study|Other Adverse Event|13|||
148704845|NCT00804856|536392397|FG000|Overall Study|Non compliance with protocol|0|||
148704846|NCT00804856|536392398|FG001|Overall Study|Non compliance with protocol|0|||
148704847|NCT00804856|536392399|FG002|Overall Study|Non compliance with protocol|0|||
148704848|NCT00804856|536392400|FG003|Overall Study|Non compliance with protocol|0|||
148704849|NCT00804856|536392401|FG004|Overall Study|Non compliance with protocol|0|||
148704850|NCT00804856|536392402|FG005|Overall Study|Non compliance with protocol|0|||
148704851|NCT00804856|536392403|FG006|Overall Study|Non compliance with protocol|0|||
148704852|NCT00804856|536392404|FG007|Overall Study|Non compliance with protocol|0|||
148704853|NCT00804856|536392405|FG008|Overall Study|Non compliance with protocol|0|||
148704854|NCT00804856|536392406|FG009|Overall Study|Non compliance with protocol|0|||
148704855|NCT00804856|536392407|FG010|Overall Study|Non compliance with protocol|0|||
148704856|NCT00804856|536392408|FG011|Overall Study|Non compliance with protocol|0|||
148704857|NCT00804856|536392409|FG012|Overall Study|Non compliance with protocol|0|||
148704858|NCT00804856|536392410|FG013|Overall Study|Non compliance with protocol|2|||
148704859|NCT00804856|536392411|FG014|Overall Study|Non compliance with protocol|0|||
148704860|NCT00804856|536392397|FG000|Overall Study|Refused to continue medication|0|||
148704861|NCT00804856|536392398|FG001|Overall Study|Refused to continue medication|0|||
148704862|NCT00804856|536392399|FG002|Overall Study|Refused to continue medication|0|||
148704863|NCT00804856|536392400|FG003|Overall Study|Refused to continue medication|1|||
148704864|NCT00804856|536392401|FG004|Overall Study|Refused to continue medication|1|||
148704865|NCT00804856|536392402|FG005|Overall Study|Refused to continue medication|0|||
148704866|NCT00804856|536392403|FG006|Overall Study|Refused to continue medication|0|||
148704867|NCT00804856|536392404|FG007|Overall Study|Refused to continue medication|0|||
148704868|NCT00804856|536392405|FG008|Overall Study|Refused to continue medication|0|||
148704869|NCT00804856|536392406|FG009|Overall Study|Refused to continue medication|0|||
148704870|NCT00804856|536392407|FG010|Overall Study|Refused to continue medication|3|||
148704871|NCT00804856|536392408|FG011|Overall Study|Refused to continue medication|0|||
148704872|NCT00804856|536392409|FG012|Overall Study|Refused to continue medication|1|||
148704873|NCT00804856|536392410|FG013|Overall Study|Refused to continue medication|1|||
148704874|NCT00804856|536392411|FG014|Overall Study|Refused to continue medication|5|||
148704875|NCT00804856|536392397|FG000|Overall Study|Other reason than listed above|0|||
148704876|NCT00804856|536392398|FG001|Overall Study|Other reason than listed above|0|||
148704877|NCT00804856|536392399|FG002|Overall Study|Other reason than listed above|0|||
148704878|NCT00804856|536392400|FG003|Overall Study|Other reason than listed above|0|||
148704879|NCT00804856|536392401|FG004|Overall Study|Other reason than listed above|0|||
148704880|NCT00804856|536392402|FG005|Overall Study|Other reason than listed above|1|||
148967786|NCT03026257|537368510|FG001|Overall Study|Withdrawal by Subject|1|||
148967787|NCT03026257|537368511|FG002|Overall Study|Withdrawal by Subject|0|||
148967788|NCT03026257|537368512|FG003|Overall Study|Withdrawal by Subject|0|||
148967789|NCT03026257|537368513|FG004|Overall Study|Withdrawal by Subject|0|||
148967790|NCT03026257|537368514|FG005|Overall Study|Withdrawal by Subject|0|||
148967791|NCT04380857|537368515|FG000|Overall Study|Lost to Follow-up|3|||
148967792|NCT04380857|537368516|FG001|Overall Study|Lost to Follow-up|3|||
148967793|NCT02042924|537368520|FG000|Overall Study|Early Death|1|||
148967794|NCT04033003|537368521|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
148704881|NCT00804856|536392403|FG006|Overall Study|Other reason than listed above|0|||
148704882|NCT00804856|536392404|FG007|Overall Study|Other reason than listed above|0|||
148704883|NCT00804856|536392405|FG008|Overall Study|Other reason than listed above|1|||
148704884|NCT00804856|536392406|FG009|Overall Study|Other reason than listed above|0|||
148704885|NCT00804856|536392407|FG010|Overall Study|Other reason than listed above|3|||
148704886|NCT00804856|536392408|FG011|Overall Study|Other reason than listed above|1|||
148704887|NCT00804856|536392409|FG012|Overall Study|Other reason than listed above|1|||
148704888|NCT00804856|536392410|FG013|Overall Study|Other reason than listed above|10|||
148704889|NCT00804856|536392411|FG014|Overall Study|Other reason than listed above|3|||
148704890|NCT01558635|536392412|FG000|Overall Study|Death|1|||
148704891|NCT01558635|536392412|FG000|Overall Study|Withdrawal by Subject|2|||
148704892|NCT01558635|536392412|FG000|Overall Study|Physician Decision|1|||
148704893|NCT01558635|536392412|FG000|Overall Study|Subject received other treatment|1|||
148704894|NCT01558635|536392412|FG000|Overall Study|Reveal XT was explanted|1|||
148704895|NCT00455312|536392413|FG000|Overall Study|Death|0|||
148704896|NCT00455312|536392414|FG001|Overall Study|Death|1|||
148704897|NCT03868891|536392415|FG000|Overall Study|Adverse Event|1|||
148704898|NCT03868891|536392416|FG001|Overall Study|Adverse Event|0|||
148704899|NCT03868891|536392415|FG000|Overall Study|Lost to Follow-up|2|||
148704900|NCT03868891|536392416|FG001|Overall Study|Lost to Follow-up|1|||
148704901|NCT03868891|536392415|FG000|Overall Study|COVID-19 Restrictions|1|||
148704902|NCT03868891|536392416|FG001|Overall Study|COVID-19 Restrictions|2|||
148704903|NCT03181594|536392417|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
148704904|NCT03181594|536392417|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
148704905|NCT03181594|536392417|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
148704906|NCT03181594|536392417|FG000|Initial Study Protocol (12-month FU)|Death|1|||
148704907|NCT03181594|536392417|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
148704908|NCT03181594|536392417|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
148704909|NCT00960297|536392420|FG000|Overall Study|Physician Decision|1|||
148704910|NCT00960297|536392420|FG000|Overall Study|Venous port infection|1|||
148704911|NCT00960297|536392420|FG000|Overall Study|Disease progression|1|||
148704912|NCT01518972|536392427|FG000|Overall Study|Lost to Follow-up|2|||
148704913|NCT01518972|536392428|FG001|Overall Study|Lost to Follow-up|1|||
148704914|NCT01518972|536392427|FG000|Overall Study|Withdrawal by Subject|1|||
148704915|NCT01518972|536392428|FG001|Overall Study|Withdrawal by Subject|0|||
148704916|NCT01518972|536392427|FG000|Overall Study|Moved from area|1|||
148704917|NCT01518972|536392428|FG001|Overall Study|Moved from area|0|||
148704918|NCT01518972|536392427|FG000|Overall Study|Transportation problems|1|||
148704919|NCT01518972|536392428|FG001|Overall Study|Transportation problems|0|||
148704920|NCT01518972|536392427|FG000|Overall Study|Exclusionary medical condition|1|||
148704921|NCT01518972|536392428|FG001|Overall Study|Exclusionary medical condition|0|||
148704922|NCT01518972|536392427|FG000|Overall Study|Missed safety visits|0|||
148704923|NCT01518972|536392428|FG001|Overall Study|Missed safety visits|1|||
148704924|NCT01518972|536392427|FG000|Overall Study|Exclusionary medication|0|||
148704925|NCT01518972|536392428|FG001|Overall Study|Exclusionary medication|1|||
148704926|NCT01518972|536392427|FG000|Overall Study|Declined medication starting on day 12|0|||
148704927|NCT01518972|536392428|FG001|Overall Study|Declined medication starting on day 12|1|||
148704928|NCT02159950|536392439|FG000|Overall Study|Adverse Event|0|||
148704929|NCT02159950|536392440|FG001|Overall Study|Adverse Event|1|||
148704930|NCT02159950|536392439|FG000|Overall Study|Progression|0|||
148704931|NCT02159950|536392440|FG001|Overall Study|Progression|1|||
148704932|NCT04108858|536392446|FG000|Overall Study|Adverse Event|1|||
148704933|NCT03663179|536392449|FG000|Overall Study|Withdrawal by Subject|2|||
148704934|NCT03663179|536392450|FG001|Overall Study|Withdrawal by Subject|0|||
148704935|NCT03663179|536392449|FG000|Overall Study|Lost to Follow-up|1|||
148704936|NCT03663179|536392450|FG001|Overall Study|Lost to Follow-up|1|||
148704937|NCT03663179|536392449|FG000|Overall Study|Revealed exclusionary condition|1|||
148704938|NCT03663179|536392450|FG001|Overall Study|Revealed exclusionary condition|0|||
148704939|NCT02453386|536392454|FG000|Overall Study|Adverse Event|22|||
148704940|NCT02453386|536392455|FG001|Overall Study|Adverse Event|30|||
148704941|NCT02453386|536392456|FG002|Overall Study|Adverse Event|15|||
148704942|NCT02453386|536392454|FG000|Overall Study|Protocol Violation|1|||
148704943|NCT02453386|536392455|FG001|Overall Study|Protocol Violation|0|||
148704944|NCT02453386|536392456|FG002|Overall Study|Protocol Violation|1|||
148704945|NCT02453386|536392454|FG000|Overall Study|Withdrawal by Subject|10|||
148704946|NCT02453386|536392455|FG001|Overall Study|Withdrawal by Subject|9|||
148704947|NCT02453386|536392456|FG002|Overall Study|Withdrawal by Subject|9|||
148704948|NCT02453386|536392454|FG000|Overall Study|Sponsor Terminated Study|14|||
148704949|NCT02453386|536392455|FG001|Overall Study|Sponsor Terminated Study|8|||
148704950|NCT02453386|536392456|FG002|Overall Study|Sponsor Terminated Study|11|||
148704951|NCT02453386|536392454|FG000|Overall Study|Subject Terminated by Sponsor|1|||
148704952|NCT02453386|536392455|FG001|Overall Study|Subject Terminated by Sponsor|1|||
148704953|NCT02453386|536392456|FG002|Overall Study|Subject Terminated by Sponsor|1|||
148704954|NCT02453386|536392454|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
148704955|NCT02453386|536392455|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
148704956|NCT02453386|536392456|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
148704957|NCT02453386|536392454|FG000|Overall Study|Lost to Follow-up|0|||
148704958|NCT02453386|536392455|FG001|Overall Study|Lost to Follow-up|0|||
148704959|NCT02453386|536392456|FG002|Overall Study|Lost to Follow-up|1|||
148704960|NCT02453386|536392454|FG000|Overall Study|Other|1|||
148704961|NCT02453386|536392455|FG001|Overall Study|Other|0|||
148704962|NCT02453386|536392456|FG002|Overall Study|Other|1|||
148704963|NCT02601625|536392457|FG000|Overall Study|Lost to Follow-up|0|||
148704964|NCT02601625|536392458|FG001|Overall Study|Lost to Follow-up|0|||
148704965|NCT02601625|536392459|FG002|Overall Study|Lost to Follow-up|1|||
148704966|NCT02601625|536392460|FG003|Overall Study|Lost to Follow-up|1|||
148704967|NCT00838279|536392465|FG000|Washout|Protocol Violation|1|||
148704968|NCT00838279|536392466|FG001|Washout|Protocol Violation|0|||
148704969|NCT00838279|536392465|FG000|Washout|Withdrawal by Subject|0|||
148704970|NCT00838279|536392466|FG001|Washout|Withdrawal by Subject|1|||
148704971|NCT01415986|536392467|FG000|Overall Study|Lost to Follow-up|1|||
148704972|NCT03792477|536392470|FG000|Overall Study|Adverse Event|0|||
148704973|NCT03792477|536392471|FG001|Overall Study|Adverse Event|0|||
148704974|NCT03792477|536392472|FG002|Overall Study|Adverse Event|0|||
148704975|NCT03792477|536392473|FG003|Overall Study|Adverse Event|1|||
148704976|NCT03792477|536392474|FG004|Overall Study|Adverse Event|0|||
148704977|NCT03792477|536392470|FG000|Overall Study|Lost to Follow-up|0|||
148704978|NCT03792477|536392471|FG001|Overall Study|Lost to Follow-up|0|||
148704979|NCT03792477|536392472|FG002|Overall Study|Lost to Follow-up|2|||
148704980|NCT03792477|536392473|FG003|Overall Study|Lost to Follow-up|0|||
148704981|NCT03792477|536392474|FG004|Overall Study|Lost to Follow-up|0|||
148704982|NCT03792477|536392470|FG000|Overall Study|Other|0|||
148704983|NCT03792477|536392471|FG001|Overall Study|Other|0|||
148704984|NCT03792477|536392472|FG002|Overall Study|Other|0|||
148704985|NCT03792477|536392473|FG003|Overall Study|Other|0|||
148704986|NCT03792477|536392474|FG004|Overall Study|Other|1|||
148704987|NCT00840411|536392475|FG000|First Intervention|Adverse Event|1|||
148704988|NCT00840411|536392476|FG001|First Intervention|Adverse Event|0|||
148704989|NCT00840411|536392475|FG000|Washout|Withdrawal by Subject|1|||
148704990|NCT00840411|536392476|FG001|Washout|Withdrawal by Subject|0|||
148704991|NCT03122457|536392477|FG000|Overall Study|Withdrawal by Subject|6|||
148704992|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
148704993|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
148704994|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
148704995|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
148704996|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
148704997|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
148704998|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
148704999|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
148705000|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
148705001|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
148705002|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
148705003|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
148705004|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
148705005|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
148705006|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
148705007|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
148705008|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
148705009|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
148705010|NCT01045161|536392478|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
148705011|NCT01045161|536392479|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
148705012|NCT01045161|536392480|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
148705013|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
148705014|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
148705015|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
148705016|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
148705017|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
148705018|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
148705019|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
148705020|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
148705021|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
148705022|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
148705023|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
148705024|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
148705025|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
148705026|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
148705027|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
148705028|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
148705029|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
148705030|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
148705031|NCT01045161|536392478|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
148705032|NCT01045161|536392479|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
148705033|NCT01045161|536392480|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
148705034|NCT00657553|536392483|FG000|Overall Study|low accrual, no analysis run|5|||
148705035|NCT00657553|536392484|FG001|Overall Study|low accrual, no analysis run|5|||
148705036|NCT03173547|536392485|FG000|Overall Study|Adverse Event|2|||
148705037|NCT03173547|536392486|FG001|Overall Study|Adverse Event|0|||
148705038|NCT03173547|536392485|FG000|Overall Study|Withdrawal by Subject|2|||
148705039|NCT03173547|536392486|FG001|Overall Study|Withdrawal by Subject|2|||
148705040|NCT00446563|536392487|FG000|Overall Study|Adverse Event|4|||
148705041|NCT00446563|536392488|FG001|Overall Study|Adverse Event|3|||
148705042|NCT00446563|536392487|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148705043|NCT00446563|536392488|FG001|Overall Study|Abnormal laboratory value(s)|1|||
148705044|NCT00446563|536392487|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148705045|NCT00446563|536392488|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148705046|NCT00446563|536392487|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148705047|NCT00446563|536392488|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
148705048|NCT00446563|536392487|FG000|Overall Study|Withdrawal by Subject|2|||
148705049|NCT00446563|536392488|FG001|Overall Study|Withdrawal by Subject|1|||
148705050|NCT00446563|536392487|FG000|Overall Study|Administrative problems|0|||
148705051|NCT00446563|536392488|FG001|Overall Study|Administrative problems|1|||
148705052|NCT01169558|536392489|FG000|Overall Study|Disease progression|98|||
148705053|NCT01169558|536392489|FG000|Overall Study|Adverse Event|25|||
148705054|NCT01169558|536392489|FG000|Overall Study|Withdrawal of Consent|8|||
148705055|NCT01169558|536392489|FG000|Overall Study|Medical Decision|7|||
148705056|NCT01169558|536392489|FG000|Overall Study|Stable Disease|4|||
148705057|NCT01169558|536392489|FG000|Overall Study|Lost to Follow-up|4|||
148705058|NCT01169558|536392489|FG000|Overall Study|Need for Surgery|4|||
148705059|NCT01169558|536392489|FG000|Overall Study|Non-compliance|2|||
148705060|NCT01169558|536392489|FG000|Overall Study|Protocol Violation|2|||
148705061|NCT01169558|536392489|FG000|Overall Study|Partial response|2|||
148705062|NCT02911701|536392490|FG000|Overall Study|Withdrawal by Subject|2|||
148705063|NCT02911701|536392491|FG001|Overall Study|Withdrawal by Subject|4|||
148705064|NCT02911701|536392490|FG000|Overall Study|Adverse Event|1|||
148705065|NCT02911701|536392491|FG001|Overall Study|Adverse Event|0|||
148705066|NCT01302548|536392492|FG000|Overall Study|Lost to Follow-up|2|||
148705067|NCT01302548|536392493|FG001|Overall Study|Lost to Follow-up|1|||
148705068|NCT02409355|536392496|FG000|Overall Study|Withdrawal by Subject|1|||
148705069|NCT02409355|536392497|FG001|Overall Study|Withdrawal by Subject|0|||
148705070|NCT02409355|536392496|FG000|Overall Study|Death|1|||
148705071|NCT02409355|536392497|FG001|Overall Study|Death|1|||
148705072|NCT02409355|536392496|FG000|Overall Study|Study terminated by Sponsor|2|||
148705073|NCT02409355|536392497|FG001|Overall Study|Study terminated by Sponsor|3|||
148705074|NCT02605928|536392502|FG000|Overall Study|Model tuning phase|28|||
148705075|NCT02605928|536392502|FG000|Overall Study|Lack of Efficacy|5|||
148705076|NCT02530905|536392505|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
148705077|NCT02530905|536392506|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
148705078|NCT02530905|536392507|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
148705079|NCT01231906|536392509|FG000|Overall Study|Lack of Efficacy|75|||
148705080|NCT01231906|536392510|FG001|Overall Study|Lack of Efficacy|68|||
148705081|NCT01231906|536392509|FG000|Overall Study|Lost to Follow-up|1|||
148705082|NCT01231906|536392510|FG001|Overall Study|Lost to Follow-up|0|||
148705083|NCT01231906|536392509|FG000|Overall Study|Physician Decision|34|||
148705084|NCT01231906|536392510|FG001|Overall Study|Physician Decision|24|||
148705085|NCT01231906|536392509|FG000|Overall Study|Withdrawal by Subject|0|||
148705086|NCT01231906|536392510|FG001|Overall Study|Withdrawal by Subject|4|||
148705087|NCT01231906|536392509|FG000|Overall Study|Ineligible|10|||
148705088|NCT01231906|536392510|FG001|Overall Study|Ineligible|3|||
148705089|NCT01231906|536392509|FG000|Overall Study|No treatment|1|||
148705090|NCT01231906|536392510|FG001|Overall Study|No treatment|2|||
148705091|NCT01110005|536392511|FG000|Overall Study|ineligible|1|||
148705092|NCT01110005|536392512|FG001|Overall Study|ineligible|2|||
148705093|NCT01110005|536392511|FG000|Overall Study|missing consent|3|||
148705094|NCT01110005|536392512|FG001|Overall Study|missing consent|2|||
148705095|NCT01110005|536392511|FG000|Overall Study|Withdrawal by Subject|0|||
148705096|NCT01110005|536392512|FG001|Overall Study|Withdrawal by Subject|1|||
148705097|NCT04646213|536392513|FG000|Overall Study|Physician Decision|3|||
148705098|NCT04646213|536392513|FG000|Overall Study|Withdrawal by Subject|2|||
148705099|NCT02441309|536392516|FG000|Overall Study|Disease progression|2|||
148705100|NCT02441309|536392517|FG001|Overall Study|Disease progression|1|||
148705101|NCT02441309|536392518|FG002|Overall Study|Disease progression|2|||
148705102|NCT02441309|536392516|FG000|Overall Study|Adverse Event|0|||
148705103|NCT02441309|536392517|FG001|Overall Study|Adverse Event|1|||
148705104|NCT02441309|536392518|FG002|Overall Study|Adverse Event|0|||
148705105|NCT02441309|536392516|FG000|Overall Study|Withdrawal by Subject|1|||
148705106|NCT02441309|536392517|FG001|Overall Study|Withdrawal by Subject|0|||
148705107|NCT02441309|536392518|FG002|Overall Study|Withdrawal by Subject|1|||
148705108|NCT00415363|536392519|FG000|Overall Study|Withdrawal by Subject|4|||
148705109|NCT00415363|536392520|FG001|Overall Study|Withdrawal by Subject|4|||
148705110|NCT00415363|536392519|FG000|Overall Study|Adverse Event|4|||
148705111|NCT00415363|536392520|FG001|Overall Study|Adverse Event|4|||
148705112|NCT00415363|536392519|FG000|Overall Study|Lost to Follow-up|2|||
148705113|NCT00415363|536392520|FG001|Overall Study|Lost to Follow-up|1|||
148815096|NCT02397837|536799399|FG000|Overall Study|Withdrawal by Subject|6|||
148705114|NCT00415363|536392519|FG000|Overall Study|Physician Decision|3|||
148705115|NCT00415363|536392520|FG001|Overall Study|Physician Decision|1|||
148705116|NCT00415363|536392519|FG000|Overall Study|Death|16|||
148705117|NCT00415363|536392520|FG001|Overall Study|Death|12|||
148705118|NCT00415363|536392519|FG000|Overall Study|Progressive disease|26|||
148705119|NCT00415363|536392520|FG001|Overall Study|Progressive disease|32|||
148705120|NCT01136174|536392535|FG000|Overall Study|Adverse Event|0|||
148705121|NCT01136174|536392536|FG001|Overall Study|Adverse Event|0|||
148705122|NCT01136174|536392537|FG002|Overall Study|Adverse Event|0|||
148705123|NCT01136174|536392538|FG003|Overall Study|Adverse Event|4|||
148705124|NCT00819741|536392541|FG000|Overall Study|Adverse Event|5|||
148705125|NCT00819741|536392542|FG001|Overall Study|Adverse Event|2|||
148705126|NCT00819741|536392541|FG000|Overall Study|Lack of Efficacy|0|||
148705127|NCT00819741|536392542|FG001|Overall Study|Lack of Efficacy|2|||
148705128|NCT00819741|536392541|FG000|Overall Study|Lost to Follow-up|3|||
148705129|NCT00819741|536392542|FG001|Overall Study|Lost to Follow-up|1|||
148705130|NCT00819741|536392541|FG000|Overall Study|Protocol Violation|3|||
148705131|NCT00819741|536392542|FG001|Overall Study|Protocol Violation|4|||
148705132|NCT00819741|536392541|FG000|Overall Study|Withdrawal by Subject|2|||
148705133|NCT00819741|536392542|FG001|Overall Study|Withdrawal by Subject|2|||
148705134|NCT00819741|536392541|FG000|Overall Study|Unclassified|6|||
148705135|NCT00819741|536392542|FG001|Overall Study|Unclassified|0|||
148705136|NCT00819741|536392541|FG000|Overall Study|Reasons unknown|3|||
148705137|NCT00819741|536392542|FG001|Overall Study|Reasons unknown|3|||
148705138|NCT00119015|536392543|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
148705139|NCT00119015|536392544|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
148705140|NCT00119015|536392545|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
148705141|NCT04115293|536393840|FG000|Overall Study|Adverse Event|0|||
148705142|NCT04115293|536393841|FG001|Overall Study|Adverse Event|2|||
148705143|NCT04115293|536393840|FG000|Overall Study|Withdrawal by Subject|2|||
148705144|NCT04115293|536393841|FG001|Overall Study|Withdrawal by Subject|1|||
148705145|NCT04115293|536393840|FG000|Overall Study|Physician Decision|1|||
148705146|NCT04115293|536393841|FG001|Overall Study|Physician Decision|0|||
148705147|NCT04115293|536393840|FG000|Overall Study|Death|1|||
148705148|NCT04115293|536393841|FG001|Overall Study|Death|1|||
148705149|NCT02571907|536393842|FG000|Overall Study|Death|4|||
148705150|NCT02571907|536393842|FG000|Overall Study|Lost to Follow-up|3|||
148705151|NCT02571907|536393842|FG000|Overall Study|Withdrawal by Subject|3|||
148705152|NCT02286739|536393843|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
148705153|NCT02286739|536393844|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
148705154|NCT02286739|536393843|FG000|Overall Study|No Verasense type documented|0|||
148705155|NCT02286739|536393844|FG001|Overall Study|No Verasense type documented|23|||
148705156|NCT02286739|536393843|FG000|Overall Study|Adverse Event|1|||
148705157|NCT02286739|536393844|FG001|Overall Study|Adverse Event|2|||
148705158|NCT02286739|536393843|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
148705159|NCT02286739|536393844|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
148705160|NCT02057835|536393845|FG000|Overall Study|Withdrawal by Subject|0|||
148705161|NCT02057835|536393846|FG001|Overall Study|Withdrawal by Subject|2|||
148705162|NCT02057835|536393847|FG002|Overall Study|Withdrawal by Subject|0|||
148705163|NCT02057835|536393848|FG003|Overall Study|Withdrawal by Subject|0|||
148705164|NCT02057835|536393849|FG004|Overall Study|Withdrawal by Subject|0|||
148705165|NCT02057835|536393850|FG005|Overall Study|Withdrawal by Subject|0|||
148705166|NCT02057835|536393851|FG006|Overall Study|Withdrawal by Subject|0|||
148705167|NCT02057835|536393852|FG007|Overall Study|Withdrawal by Subject|0|||
148705168|NCT02057835|536393853|FG008|Overall Study|Withdrawal by Subject|0|||
148705169|NCT02057835|536393854|FG009|Overall Study|Withdrawal by Subject|0|||
148705170|NCT04299087|536393855|FG000|Overall Study|Lost to Follow-up|2|||
148705171|NCT04299087|536393856|FG001|Overall Study|Lost to Follow-up|1|||
148705172|NCT03025087|536393857|FG000|Overall Study|Physician Decision|3|||
148705173|NCT03025087|536393858|FG001|Overall Study|Physician Decision|3|||
148705174|NCT03025087|536393859|FG002|Overall Study|Physician Decision|0|||
148705175|NCT03025087|536393860|FG003|Overall Study|Physician Decision|0|||
148705176|NCT03025087|536393861|FG004|Overall Study|Physician Decision|0|||
148815097|NCT02397837|536799400|FG001|Overall Study|Withdrawal by Subject|5|||
148815098|NCT02397837|536799399|FG000|Overall Study|Physician Decision|1|||
148967795|NCT04033003|537368522|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
148967796|NCT04033003|537368521|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
148705177|NCT03025087|536393857|FG000|Overall Study|Withdrawal by Subject|1|||
148705178|NCT03025087|536393858|FG001|Overall Study|Withdrawal by Subject|1|||
148705179|NCT03025087|536393859|FG002|Overall Study|Withdrawal by Subject|0|||
148705180|NCT03025087|536393860|FG003|Overall Study|Withdrawal by Subject|0|||
148705181|NCT03025087|536393861|FG004|Overall Study|Withdrawal by Subject|0|||
148705182|NCT03025087|536393857|FG000|Overall Study|Unable to complete MRI|2|||
148705183|NCT03025087|536393858|FG001|Overall Study|Unable to complete MRI|2|||
148705184|NCT03025087|536393859|FG002|Overall Study|Unable to complete MRI|0|||
148705185|NCT03025087|536393860|FG003|Overall Study|Unable to complete MRI|0|||
148705186|NCT03025087|536393861|FG004|Overall Study|Unable to complete MRI|0|||
148705187|NCT05604170|536393862|FG000|Overall Study|Lack of Efficacy|5|||
149025088|NCT02531438|537568015|FG001|Overall Study|Lost to Follow-up|3|||
148705188|NCT05604170|536393862|FG000|Overall Study|Adverse Event|6|||
148705189|NCT05604170|536393862|FG000|Overall Study|Physician Decision|6|||
148705190|NCT05604170|536393862|FG000|Overall Study|Lost to Follow-up|6|||
148705191|NCT05604170|536393862|FG000|Overall Study|Withdrawal by Subject|11|||
148705192|NCT05604170|536393862|FG000|Overall Study|Early study termination by sponsor|77|||
148705193|NCT05604170|536393862|FG000|Overall Study|Other|6|||
148705194|NCT03697109|536393863|FG000|Open-label (OL) Phase|Adverse Event|24|||
148705195|NCT03697109|536393864|FG001|Open-label (OL) Phase|Adverse Event|0|||
148705196|NCT03697109|536393865|FG002|Open-label (OL) Phase|Adverse Event|0|||
148705197|NCT03697109|536393863|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
148705198|NCT03697109|536393864|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
148705199|NCT03697109|536393865|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
148705200|NCT03697109|536393863|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
148705201|NCT03697109|536393864|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
148705202|NCT03697109|536393865|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
148705203|NCT03697109|536393863|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
148705204|NCT03697109|536393864|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
148705205|NCT03697109|536393865|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
148705206|NCT03697109|536393863|FG000|Open-label (OL) Phase|Physician Decision|2|||
148705207|NCT03697109|536393864|FG001|Open-label (OL) Phase|Physician Decision|0|||
148705208|NCT03697109|536393865|FG002|Open-label (OL) Phase|Physician Decision|0|||
148705209|NCT03697109|536393863|FG000|Open-label (OL) Phase|Death|2|||
148705210|NCT03697109|536393864|FG001|Open-label (OL) Phase|Death|0|||
148705211|NCT03697109|536393865|FG002|Open-label (OL) Phase|Death|0|||
148705212|NCT03697109|536393863|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
148705213|NCT03697109|536393864|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
148705214|NCT03697109|536393865|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
148705215|NCT03697109|536393863|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
148705216|NCT03697109|536393864|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
148705217|NCT03697109|536393865|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
148705218|NCT03697109|536393863|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
148705219|NCT03697109|536393864|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
148705220|NCT03697109|536393865|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
148705221|NCT03032172|536393866|FG000|Treatment Period|Adverse Event|0|||
148705222|NCT03032172|536393867|FG001|Treatment Period|Adverse Event|1|||
148705223|NCT03032172|536393868|FG002|Treatment Period|Adverse Event|0|||
148705224|NCT03032172|536393869|FG003|Treatment Period|Adverse Event|0|||
148705225|NCT03032172|536393870|FG004|Treatment Period|Adverse Event|0|||
148705226|NCT03032172|536393871|FG005|Treatment Period|Adverse Event|0|||
148705227|NCT03032172|536393872|FG006|Treatment Period|Adverse Event|0|||
148705228|NCT03032172|536393873|FG007|Treatment Period|Adverse Event|0|||
148705229|NCT03032172|536393866|FG000|Treatment Period|Lack of Efficacy|0|||
148705230|NCT03032172|536393867|FG001|Treatment Period|Lack of Efficacy|1|||
148705231|NCT03032172|536393868|FG002|Treatment Period|Lack of Efficacy|0|||
148705232|NCT03032172|536393869|FG003|Treatment Period|Lack of Efficacy|0|||
148705233|NCT03032172|536393870|FG004|Treatment Period|Lack of Efficacy|0|||
148705234|NCT03032172|536393871|FG005|Treatment Period|Lack of Efficacy|0|||
148705235|NCT03032172|536393872|FG006|Treatment Period|Lack of Efficacy|0|||
148705236|NCT03032172|536393873|FG007|Treatment Period|Lack of Efficacy|0|||
148705237|NCT03032172|536393866|FG000|Treatment Period|Non-compliance With Study Drug|0|||
148705238|NCT03032172|536393867|FG001|Treatment Period|Non-compliance With Study Drug|1|||
148705239|NCT03032172|536393868|FG002|Treatment Period|Non-compliance With Study Drug|0|||
148705240|NCT03032172|536393869|FG003|Treatment Period|Non-compliance With Study Drug|0|||
148705241|NCT03032172|536393870|FG004|Treatment Period|Non-compliance With Study Drug|0|||
148705242|NCT03032172|536393871|FG005|Treatment Period|Non-compliance With Study Drug|0|||
148705243|NCT03032172|536393872|FG006|Treatment Period|Non-compliance With Study Drug|0|||
148705244|NCT03032172|536393873|FG007|Treatment Period|Non-compliance With Study Drug|0|||
148705245|NCT03032172|536393866|FG000|Treatment Period|Reason Not Specified|0|||
148705246|NCT03032172|536393867|FG001|Treatment Period|Reason Not Specified|4|||
148705247|NCT03032172|536393868|FG002|Treatment Period|Reason Not Specified|1|||
148705248|NCT03032172|536393869|FG003|Treatment Period|Reason Not Specified|0|||
148705249|NCT03032172|536393870|FG004|Treatment Period|Reason Not Specified|0|||
148705250|NCT03032172|536393871|FG005|Treatment Period|Reason Not Specified|0|||
148705251|NCT03032172|536393872|FG006|Treatment Period|Reason Not Specified|0|||
148705252|NCT03032172|536393873|FG007|Treatment Period|Reason Not Specified|0|||
148705253|NCT03032172|536393866|FG000|Treatment Period|Physician Decision|0|||
148705254|NCT03032172|536393867|FG001|Treatment Period|Physician Decision|2|||
148705255|NCT03032172|536393868|FG002|Treatment Period|Physician Decision|1|||
148705256|NCT03032172|536393869|FG003|Treatment Period|Physician Decision|0|||
148705257|NCT03032172|536393870|FG004|Treatment Period|Physician Decision|0|||
148705258|NCT03032172|536393871|FG005|Treatment Period|Physician Decision|0|||
148705259|NCT03032172|536393872|FG006|Treatment Period|Physician Decision|0|||
148705260|NCT03032172|536393873|FG007|Treatment Period|Physician Decision|0|||
148705261|NCT03032172|536393866|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
148705262|NCT03032172|536393867|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
148705263|NCT03032172|536393868|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
148705264|NCT03032172|536393869|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
148705265|NCT03032172|536393870|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
148705266|NCT03032172|536393871|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
148705267|NCT03032172|536393872|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
148705268|NCT03032172|536393873|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
148705269|NCT03032172|536393866|FG000|Treatment Period|Withdrawal by Subject|2|||
148705270|NCT03032172|536393867|FG001|Treatment Period|Withdrawal by Subject|0|||
148705271|NCT03032172|536393868|FG002|Treatment Period|Withdrawal by Subject|3|||
148705272|NCT03032172|536393869|FG003|Treatment Period|Withdrawal by Subject|0|||
148705273|NCT03032172|536393870|FG004|Treatment Period|Withdrawal by Subject|0|||
148705274|NCT03032172|536393871|FG005|Treatment Period|Withdrawal by Subject|0|||
148705275|NCT03032172|536393872|FG006|Treatment Period|Withdrawal by Subject|0|||
148705276|NCT03032172|536393873|FG007|Treatment Period|Withdrawal by Subject|0|||
148705277|NCT03032172|536393866|FG000|Open-label Extension Period|Death|0|||
148705278|NCT03032172|536393867|FG001|Open-label Extension Period|Death|0|||
148705279|NCT03032172|536393868|FG002|Open-label Extension Period|Death|0|||
148705280|NCT03032172|536393869|FG003|Open-label Extension Period|Death|0|||
148705281|NCT03032172|536393870|FG004|Open-label Extension Period|Death|0|||
148705282|NCT03032172|536393871|FG005|Open-label Extension Period|Death|0|||
148705283|NCT03032172|536393872|FG006|Open-label Extension Period|Death|0|||
148705284|NCT03032172|536393873|FG007|Open-label Extension Period|Death|2|||
148705285|NCT03032172|536393866|FG000|Open-label Extension Period|Reason Not Specified|0|||
148705286|NCT03032172|536393867|FG001|Open-label Extension Period|Reason Not Specified|0|||
148705287|NCT03032172|536393868|FG002|Open-label Extension Period|Reason Not Specified|0|||
148705288|NCT03032172|536393869|FG003|Open-label Extension Period|Reason Not Specified|0|||
148705289|NCT03032172|536393870|FG004|Open-label Extension Period|Reason Not Specified|0|||
148705290|NCT03032172|536393871|FG005|Open-label Extension Period|Reason Not Specified|5|||
148705291|NCT03032172|536393872|FG006|Open-label Extension Period|Reason Not Specified|3|||
148705292|NCT03032172|536393873|FG007|Open-label Extension Period|Reason Not Specified|0|||
148705293|NCT03032172|536393866|FG000|Open-label Extension Period|Pregnancy|0|||
148705294|NCT03032172|536393867|FG001|Open-label Extension Period|Pregnancy|0|||
148705295|NCT03032172|536393868|FG002|Open-label Extension Period|Pregnancy|0|||
148705296|NCT03032172|536393869|FG003|Open-label Extension Period|Pregnancy|0|||
148705297|NCT03032172|536393870|FG004|Open-label Extension Period|Pregnancy|0|||
148705298|NCT03032172|536393871|FG005|Open-label Extension Period|Pregnancy|0|||
148705299|NCT03032172|536393872|FG006|Open-label Extension Period|Pregnancy|1|||
148705300|NCT03032172|536393873|FG007|Open-label Extension Period|Pregnancy|0|||
148705301|NCT03032172|536393866|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
148705302|NCT03032172|536393867|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
148705303|NCT03032172|536393868|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
148705304|NCT03032172|536393869|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
148705305|NCT03032172|536393870|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
148705306|NCT03032172|536393871|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
148705307|NCT03032172|536393872|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
148705308|NCT03032172|536393873|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
148705309|NCT06284525|536393874|FG000|Overall Study|Withdrawal by Subject|1|||
148967797|NCT04033003|537368522|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
148967798|NCT04033003|537368521|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
148967799|NCT04033003|537368522|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
148967800|NCT04033003|537368521|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
148967801|NCT04033003|537368522|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
148967802|NCT04033003|537368521|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
148967803|NCT04033003|537368522|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
148967804|NCT04033003|537368521|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
148967805|NCT04033003|537368522|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
148967806|NCT04033003|537368521|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
148967807|NCT04033003|537368522|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
148967808|NCT04033003|537368521|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
148967809|NCT04033003|537368522|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
148967810|NCT04033003|537368521|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
148967811|NCT04033003|537368522|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
148705310|NCT01111461|536393875|FG000|Overall Study|Adverse Event|32|||
148705311|NCT01111461|536393875|FG000|Overall Study|Participant choice|11|||
148967812|NCT04033003|537368521|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
148967813|NCT04033003|537368522|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
148967814|NCT04033003|537368521|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
148705312|NCT01111461|536393875|FG000|Overall Study|Lost to Follow-up|1|||
148705313|NCT01111461|536393875|FG000|Overall Study|Withdrawal by Subject|1|||
148705314|NCT01111461|536393875|FG000|Overall Study|Other|6|||
148705315|NCT02545283|536393877|FG000|Overall Study|Lost to Follow-up|2|||
148705316|NCT02545283|536393878|FG001|Overall Study|Lost to Follow-up|4|||
148705317|NCT02545283|536393877|FG000|Overall Study|Withdrawal by Subject|5|||
148705318|NCT02545283|536393878|FG001|Overall Study|Withdrawal by Subject|9|||
148705319|NCT02545283|536393877|FG000|Overall Study|Death|109|||
148705320|NCT02545283|536393878|FG001|Overall Study|Death|211|||
148705321|NCT02545283|536393877|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
148705322|NCT02545283|536393878|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
148705323|NCT02545283|536393877|FG000|Overall Study|Study Terminated By Sponsor|33|||
148705324|NCT02545283|536393878|FG001|Overall Study|Study Terminated By Sponsor|71|||
148705325|NCT03343535|536393880|FG000|Overall Study|Lost to Follow-up|1|||
148705326|NCT03343535|536393880|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
148705327|NCT03343535|536393880|FG000|Overall Study|Death|12|||
148705328|NCT04994535|536393881|FG000|Overall Study|Lost to Follow-up|7|||
148705329|NCT04994535|536393882|FG001|Overall Study|Lost to Follow-up|7|||
148705330|NCT04994535|536393881|FG000|Overall Study|Withdrawal by Subject|10|||
148705331|NCT04994535|536393882|FG001|Overall Study|Withdrawal by Subject|7|||
148705332|NCT04994535|536393881|FG000|Overall Study|Other|1|||
148705333|NCT04994535|536393882|FG001|Overall Study|Other|1|||
148705334|NCT01158118|536393883|FG000|Overall Study|Screen failure|1|||
148705335|NCT01158118|536393884|FG001|Overall Study|Screen failure|0|||
148705336|NCT01158118|536393883|FG000|Overall Study|Donor match was a screen failure|0|||
148705337|NCT01158118|536393884|FG001|Overall Study|Donor match was a screen failure|1|||
148705338|NCT01158118|536393883|FG000|Overall Study|Suffered stroke prior to transplant|0|||
148705339|NCT01158118|536393884|FG001|Overall Study|Suffered stroke prior to transplant|1|||
148705340|NCT01158118|536393883|FG000|Overall Study|Death|0|||
148705341|NCT01158118|536393884|FG001|Overall Study|Death|1|||
148705342|NCT00905840|536393887|FG000|Overall Study|Lost to Follow-up|11|||
148705343|NCT00905840|536393887|FG000|Overall Study|Death|3|||
148705344|NCT00905840|536393887|FG000|Overall Study|Withdrawal by Subject|1|||
148705345|NCT00905840|536393887|FG000|Overall Study|Adverse Event|1|||
148705346|NCT03872128|536393896|FG000|Overall Study|Dropped out before treatment|1|||
148705347|NCT03872128|536393897|FG001|Overall Study|Dropped out before treatment|0|||
148705348|NCT03872128|536393898|FG002|Overall Study|Dropped out before treatment|4|||
148705349|NCT03872128|536393896|FG000|Overall Study|Lost to Follow-up|2|||
148705350|NCT03872128|536393897|FG001|Overall Study|Lost to Follow-up|5|||
148705351|NCT03872128|536393898|FG002|Overall Study|Lost to Follow-up|8|||
148705352|NCT01289262|536393903|FG000|Overall Study|Lost to Follow-up|29|||
148705353|NCT01289262|536393904|FG001|Overall Study|Lost to Follow-up|16|||
148705354|NCT01289262|536393903|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
148705355|NCT01289262|536393904|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
148705356|NCT04608188|536393905|FG000|Overall Study|Withdrawal by Subject|4|||
148705357|NCT04608188|536393906|FG001|Overall Study|Withdrawal by Subject|8|||
148705358|NCT05646251|536393910|FG000|Overall Study|Physician Decision|1|||
148705359|NCT05646251|536393911|FG001|Overall Study|Physician Decision|0|||
148705360|NCT05646251|536393912|FG002|Overall Study|Physician Decision|2|||
148705361|NCT01218867|536393913|FG000|Overall Study|Death during treatment|0|||
149025089|NCT02531438|537568014|FG000|Overall Study|Withdrawal by Subject|7|||
149025090|NCT02531438|537568015|FG001|Overall Study|Withdrawal by Subject|8|||
149025091|NCT02531438|537568014|FG000|Overall Study|Physician Decision|0|||
148705362|NCT01218867|536393914|FG001|Overall Study|Death during treatment|0|||
148705363|NCT01218867|536393915|FG002|Overall Study|Death during treatment|0|||
148705364|NCT01218867|536393916|FG003|Overall Study|Death during treatment|0|||
148705365|NCT01218867|536393917|FG004|Overall Study|Death during treatment|0|||
148705366|NCT01218867|536393918|FG005|Overall Study|Death during treatment|0|||
148705367|NCT01218867|536393919|FG006|Overall Study|Death during treatment|1|||
148705368|NCT01218867|536393920|FG007|Overall Study|Death during treatment|0|||
148705369|NCT01218867|536393921|FG008|Overall Study|Death during treatment|0|||
148705370|NCT01218867|536393922|FG009|Overall Study|Death during treatment|0|||
148705371|NCT01218867|536393923|FG010|Overall Study|Death during treatment|0|||
148705372|NCT01576042|536393928|FG000|Overall Study|Physician Decision|2|||
148705373|NCT01576042|536393929|FG001|Overall Study|Physician Decision|0|||
148705374|NCT00465270|536393930|FG000|Overall Study|Death|7|||
148705375|NCT00465270|536393931|FG001|Overall Study|Death|11|||
148705376|NCT00465270|536393930|FG000|Overall Study|Withdrawal by Subject|34|||
148705377|NCT00465270|536393931|FG001|Overall Study|Withdrawal by Subject|78|||
148705378|NCT00465270|536393930|FG000|Overall Study|Lost to Follow-up|60|||
148705379|NCT00465270|536393931|FG001|Overall Study|Lost to Follow-up|67|||
148705380|NCT00465270|536393930|FG000|Overall Study|Investigator request|3|||
148705381|NCT00465270|536393931|FG001|Overall Study|Investigator request|4|||
148705382|NCT03233724|536393932|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
148705383|NCT03233724|536393933|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
148705384|NCT03233724|536393934|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
148815099|NCT02397837|536799400|FG001|Overall Study|Physician Decision|1|||
148705385|NCT03233724|536393935|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
148705386|NCT03233724|536393936|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
148705387|NCT03233724|536393932|FG000|Phase I Dose Escalation|Best interest of participant|1|||
148705388|NCT03233724|536393933|FG001|Phase I Dose Escalation|Best interest of participant|1|||
148705389|NCT03233724|536393934|FG002|Phase I Dose Escalation|Best interest of participant|1|||
148705390|NCT03233724|536393935|FG003|Phase I Dose Escalation|Best interest of participant|0|||
148705391|NCT03233724|536393936|FG004|Phase I Dose Escalation|Best interest of participant|0|||
148705392|NCT03233724|536393932|FG000|Phase I Dose Escalation|Physician Decision|0|||
148705393|NCT03233724|536393933|FG001|Phase I Dose Escalation|Physician Decision|0|||
148705394|NCT03233724|536393934|FG002|Phase I Dose Escalation|Physician Decision|1|||
148705395|NCT03233724|536393935|FG003|Phase I Dose Escalation|Physician Decision|0|||
148705396|NCT03233724|536393936|FG004|Phase I Dose Escalation|Physician Decision|0|||
148705397|NCT03233724|536393932|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
148705398|NCT03233724|536393933|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
148705399|NCT03233724|536393934|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
148705400|NCT03233724|536393935|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
148705401|NCT03233724|536393936|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
148705402|NCT00651820|536393939|FG000|Overall Study|Lost to Follow-up|2|||
148705403|NCT02388191|536393940|FG000|Overall Study|Patient did not receive IUD|1|||
148705404|NCT02388191|536393941|FG001|Overall Study|Patient did not receive IUD|0|||
148705405|NCT01921062|536393942|FG000|Overall Study|Withdrawal by Subject|0|||
148705406|NCT01921062|536393943|FG001|Overall Study|Withdrawal by Subject|7|||
148705407|NCT01921062|536393942|FG000|Overall Study|Adverse Event|5|||
148705408|NCT01921062|536393943|FG001|Overall Study|Adverse Event|6|||
148705409|NCT01921062|536393942|FG000|Overall Study|Protocol Violation|0|||
148705410|NCT01921062|536393943|FG001|Overall Study|Protocol Violation|1|||
148705411|NCT01921062|536393942|FG000|Overall Study|VMIQ score > 72|4|||
148705412|NCT01921062|536393943|FG001|Overall Study|VMIQ score > 72|1|||
148705413|NCT01921062|536393942|FG000|Overall Study|Logistic error|0|||
148705414|NCT01921062|536393943|FG001|Overall Study|Logistic error|1|||
148705415|NCT01911676|536393944|FG000|Period 1 of Study|Withdrawal by Subject|4|||
148705416|NCT01911676|536393945|FG001|Period 1 of Study|Withdrawal by Subject|2|||
148705417|NCT01911676|536393946|FG002|Period 1 of Study|Withdrawal by Subject|1|||
148705418|NCT01911676|536393947|FG003|Period 1 of Study|Withdrawal by Subject|2|||
148705419|NCT01911676|536393944|FG000|Period 1 of Study|Physician Decision|2|||
148705420|NCT01911676|536393945|FG001|Period 1 of Study|Physician Decision|0|||
148705421|NCT01911676|536393946|FG002|Period 1 of Study|Physician Decision|0|||
148705422|NCT01911676|536393947|FG003|Period 1 of Study|Physician Decision|1|||
148705423|NCT01911676|536393944|FG000|Period 2 of Study|Physician Decision|2|||
148705424|NCT01911676|536393945|FG001|Period 2 of Study|Physician Decision|0|||
148705425|NCT01911676|536393946|FG002|Period 2 of Study|Physician Decision|0|||
148705426|NCT01911676|536393947|FG003|Period 2 of Study|Physician Decision|1|||
148705427|NCT01911676|536393944|FG000|Period 2 of Study|Lost to Follow-up|0|||
148705428|NCT01911676|536393945|FG001|Period 2 of Study|Lost to Follow-up|0|||
148705429|NCT01911676|536393946|FG002|Period 2 of Study|Lost to Follow-up|0|||
148705430|NCT01911676|536393947|FG003|Period 2 of Study|Lost to Follow-up|1|||
148705431|NCT00773253|536393948|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
148705432|NCT00773253|536393949|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
148705433|NCT01566721|536393955|FG000|Treatment Period|Withdrawal by Subject|35|||
148705434|NCT01566721|536393956|FG001|Treatment Period|Withdrawal by Subject|9|||
148705435|NCT01566721|536393955|FG000|Treatment Period|Disease Progression/Recurrence|37|||
148705436|NCT01566721|536393956|FG001|Treatment Period|Disease Progression/Recurrence|13|||
148705437|NCT01566721|536393955|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
148705438|NCT01566721|536393956|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
148705439|NCT01566721|536393955|FG000|Treatment Period|Other|13|||
148705440|NCT01566721|536393956|FG001|Treatment Period|Other|2|||
148705441|NCT01566721|536393955|FG000|Treatment Period|Lack of Compliance|5|||
148705442|NCT01566721|536393956|FG001|Treatment Period|Lack of Compliance|1|||
148705443|NCT01566721|536393955|FG000|Treatment Period|Adverse Event|100|||
148705444|NCT01566721|536393956|FG001|Treatment Period|Adverse Event|30|||
148705445|NCT01566721|536393955|FG000|Treatment Period|Pregnancy|1|||
148705446|NCT01566721|536393956|FG001|Treatment Period|Pregnancy|0|||
148967815|NCT04033003|537368522|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
148705447|NCT01566721|536393955|FG000|Safety Follow-up|Physician Decision|6|||
148705448|NCT01566721|536393956|FG001|Safety Follow-up|Physician Decision|4|||
148967816|NCT04033003|537368521|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
148967817|NCT04033003|537368522|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
148967818|NCT04033003|537368521|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
148967819|NCT04033003|537368522|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
148967820|NCT01714310|537368523|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
148705449|NCT01566721|536393955|FG000|Safety Follow-up|Lost to Follow-up|101|||
148705450|NCT01566721|536393956|FG001|Safety Follow-up|Lost to Follow-up|48|||
148705451|NCT01566721|536393955|FG000|Safety Follow-up|Withdrawal by Subject|155|||
148705452|NCT01566721|536393956|FG001|Safety Follow-up|Withdrawal by Subject|49|||
148705453|NCT01566721|536393955|FG000|Safety Follow-up|Death|28|||
148705454|NCT01566721|536393956|FG001|Safety Follow-up|Death|4|||
148705455|NCT01566721|536393955|FG000|Safety Follow-up|Non-compliance|7|||
148705456|NCT01566721|536393956|FG001|Safety Follow-up|Non-compliance|3|||
148705457|NCT01566721|536393955|FG000|Safety Follow-up|Protocol Violation|7|||
148705458|NCT01566721|536393956|FG001|Safety Follow-up|Protocol Violation|0|||
148705459|NCT01566721|536393955|FG000|Safety Follow-up|Site closure|2|||
148705460|NCT01566721|536393956|FG001|Safety Follow-up|Site closure|3|||
148705461|NCT01566721|536393955|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
148705462|NCT01566721|536393956|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
148705463|NCT01566721|536393955|FG000|Safety Follow-up|Missing|7|||
148705464|NCT01566721|536393956|FG001|Safety Follow-up|Missing|2|||
148705465|NCT01566721|536393955|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
148705466|NCT01566721|536393956|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
148705467|NCT01566721|536393955|FG000|Safety Follow-up|Sponsor decision|1|||
148705468|NCT01566721|536393956|FG001|Safety Follow-up|Sponsor decision|0|||
148705469|NCT01566721|536393955|FG000|Safety Follow-up|Adverse Event|8|||
148815100|NCT05276804|536799402|FG000|Overall Study|screen failure|23|||
148815101|NCT05276804|536799403|FG001|Overall Study|screen failure|0|||
148815102|NCT02827708|536799404|FG000|Overall Study|Lost to Follow-up|3|||
148815103|NCT02827708|536799405|FG001|Overall Study|Lost to Follow-up|1|||
148705470|NCT01566721|536393956|FG001|Safety Follow-up|Adverse Event|4|||
148705471|NCT03769025|536393957|FG000|Overall Study|Withdrawal by Subject|1|||
148705472|NCT03769025|536393958|FG001|Overall Study|Withdrawal by Subject|1|||
148705473|NCT03769025|536393957|FG000|Overall Study|Lost to Follow-up|4|||
148705474|NCT03769025|536393958|FG001|Overall Study|Lost to Follow-up|3|||
148705475|NCT02658084|536393967|FG000|Overall Study|Withdrawal by Subject|1|||
148705476|NCT02658084|536393968|FG001|Overall Study|Withdrawal by Subject|0|||
148705477|NCT02658084|536393967|FG000|Overall Study|Study Termination|1|||
148705478|NCT02658084|536393968|FG001|Overall Study|Study Termination|0|||
148705479|NCT03290781|536393970|FG000|Overall Study|Adverse Event|5|||
148705480|NCT03290781|536393971|FG001|Overall Study|Adverse Event|7|||
148705481|NCT03290781|536393972|FG002|Overall Study|Adverse Event|4|||
148705482|NCT03290781|536393973|FG003|Overall Study|Adverse Event|1|||
148705483|NCT03290781|536393974|FG004|Overall Study|Adverse Event|0|||
148705484|NCT03290781|536393975|FG005|Overall Study|Adverse Event|0|||
148705485|NCT03290781|536393976|FG006|Overall Study|Adverse Event|0|||
148705486|NCT03290781|536393970|FG000|Overall Study|Death|0|||
148705487|NCT03290781|536393971|FG001|Overall Study|Death|0|||
148705488|NCT03290781|536393972|FG002|Overall Study|Death|1|||
148705489|NCT03290781|536393973|FG003|Overall Study|Death|0|||
148705490|NCT03290781|536393974|FG004|Overall Study|Death|1|||
148705491|NCT03290781|536393975|FG005|Overall Study|Death|0|||
148705492|NCT03290781|536393976|FG006|Overall Study|Death|0|||
148705493|NCT03290781|536393970|FG000|Overall Study|Withdrawal by Subject|6|||
148705494|NCT03290781|536393971|FG001|Overall Study|Withdrawal by Subject|5|||
148705495|NCT03290781|536393972|FG002|Overall Study|Withdrawal by Subject|9|||
148705496|NCT03290781|536393973|FG003|Overall Study|Withdrawal by Subject|10|||
148705497|NCT03290781|536393974|FG004|Overall Study|Withdrawal by Subject|1|||
148705498|NCT03290781|536393975|FG005|Overall Study|Withdrawal by Subject|2|||
148705499|NCT03290781|536393976|FG006|Overall Study|Withdrawal by Subject|0|||
148705500|NCT03290781|536393970|FG000|Overall Study|Physician Decision|0|||
148705501|NCT03290781|536393971|FG001|Overall Study|Physician Decision|1|||
148705502|NCT03290781|536393972|FG002|Overall Study|Physician Decision|0|||
148815104|NCT02827708|536799404|FG000|Overall Study|Withdrawal by Subject|1|||
148815105|NCT02827708|536799405|FG001|Overall Study|Withdrawal by Subject|2|||
148815106|NCT02827708|536799404|FG000|Overall Study|Death|1|||
148815107|NCT02827708|536799405|FG001|Overall Study|Death|2|||
148815108|NCT00898807|536799411|FG000|Overall Study|Withdrawal by Subject|5|||
148815109|NCT00898807|536799412|FG001|Overall Study|Withdrawal by Subject|3|||
148815110|NCT00898807|536799411|FG000|Overall Study|Family pressure to discontinue|2|||
148705503|NCT03290781|536393973|FG003|Overall Study|Physician Decision|0|||
148815111|NCT00898807|536799412|FG001|Overall Study|Family pressure to discontinue|2|||
148815112|NCT00898807|536799411|FG000|Overall Study|Lost to Follow-up|1|||
148815113|NCT00898807|536799412|FG001|Overall Study|Lost to Follow-up|3|||
148815114|NCT00898807|536799411|FG000|Overall Study|Death|0|||
148705504|NCT03290781|536393974|FG004|Overall Study|Physician Decision|0|||
148705505|NCT03290781|536393975|FG005|Overall Study|Physician Decision|0|||
148705506|NCT03290781|536393976|FG006|Overall Study|Physician Decision|0|||
148705507|NCT03290781|536393970|FG000|Overall Study|Site Terminated by Sponsor|1|||
148705508|NCT03290781|536393971|FG001|Overall Study|Site Terminated by Sponsor|0|||
148705509|NCT03290781|536393972|FG002|Overall Study|Site Terminated by Sponsor|2|||
148705510|NCT03290781|536393973|FG003|Overall Study|Site Terminated by Sponsor|1|||
148705511|NCT03290781|536393974|FG004|Overall Study|Site Terminated by Sponsor|0|||
148705512|NCT03290781|536393975|FG005|Overall Study|Site Terminated by Sponsor|0|||
148815115|NCT00898807|536799412|FG001|Overall Study|Death|1|||
148815116|NCT00407511|536799415|FG000|Overall Study|Adverse Event|9|||
148705513|NCT03290781|536393976|FG006|Overall Study|Site Terminated by Sponsor|0|||
148705514|NCT03290781|536393970|FG000|Overall Study|Lost to Follow-up|0|||
148705515|NCT03290781|536393971|FG001|Overall Study|Lost to Follow-up|0|||
148705516|NCT03290781|536393972|FG002|Overall Study|Lost to Follow-up|0|||
148705517|NCT03290781|536393973|FG003|Overall Study|Lost to Follow-up|1|||
148705518|NCT03290781|536393974|FG004|Overall Study|Lost to Follow-up|0|||
148705519|NCT03290781|536393975|FG005|Overall Study|Lost to Follow-up|0|||
148705520|NCT03290781|536393976|FG006|Overall Study|Lost to Follow-up|0|||
148705521|NCT03290781|536393970|FG000|Overall Study|Protocol Deviation|2|||
148705522|NCT03290781|536393971|FG001|Overall Study|Protocol Deviation|0|||
148705523|NCT03290781|536393972|FG002|Overall Study|Protocol Deviation|0|||
148705524|NCT03290781|536393973|FG003|Overall Study|Protocol Deviation|1|||
148705525|NCT03290781|536393974|FG004|Overall Study|Protocol Deviation|0|||
148705526|NCT03290781|536393975|FG005|Overall Study|Protocol Deviation|0|||
148705527|NCT03290781|536393976|FG006|Overall Study|Protocol Deviation|0|||
148705528|NCT03290781|536393970|FG000|Overall Study|Disease Relapse|32|||
148705529|NCT03290781|536393971|FG001|Overall Study|Disease Relapse|5|||
148705530|NCT03290781|536393972|FG002|Overall Study|Disease Relapse|38|||
148705531|NCT03290781|536393973|FG003|Overall Study|Disease Relapse|7|||
148705532|NCT03290781|536393974|FG004|Overall Study|Disease Relapse|3|||
148705533|NCT03290781|536393975|FG005|Overall Study|Disease Relapse|1|||
148705534|NCT03290781|536393976|FG006|Overall Study|Disease Relapse|4|||
148705535|NCT03290781|536393970|FG000|Overall Study|Other|3|||
148705536|NCT03290781|536393971|FG001|Overall Study|Other|0|||
148705537|NCT03290781|536393972|FG002|Overall Study|Other|2|||
148705538|NCT03290781|536393973|FG003|Overall Study|Other|2|||
148705539|NCT03290781|536393974|FG004|Overall Study|Other|0|||
148705540|NCT03290781|536393975|FG005|Overall Study|Other|0|||
148705541|NCT03290781|536393976|FG006|Overall Study|Other|0|||
148705542|NCT02957942|536393977|FG000|Overall Study|Withdrawal by Subject|0|||
148705543|NCT02957942|536393978|FG001|Overall Study|Withdrawal by Subject|1|||
148705544|NCT02957942|536393977|FG000|Overall Study|Practicing experiment protocol|0|||
148705545|NCT02957942|536393978|FG001|Overall Study|Practicing experiment protocol|6|||
148705546|NCT01588236|536393987|FG000|Overall Study|Adverse Event|5|||
148705547|NCT01588236|536393988|FG001|Overall Study|Adverse Event|4|||
148705548|NCT01588236|536393989|FG002|Overall Study|Adverse Event|1|||
148705549|NCT01588236|536393987|FG000|Overall Study|Lost to Follow-up|8|||
148705550|NCT01588236|536393988|FG001|Overall Study|Lost to Follow-up|13|||
148705551|NCT01588236|536393989|FG002|Overall Study|Lost to Follow-up|6|||
148705552|NCT01588236|536393987|FG000|Overall Study|Physician Decision|1|||
148705553|NCT01588236|536393988|FG001|Overall Study|Physician Decision|2|||
148705554|NCT01588236|536393989|FG002|Overall Study|Physician Decision|0|||
148705555|NCT01588236|536393987|FG000|Overall Study|Protocol Violation|0|||
148705556|NCT01588236|536393988|FG001|Overall Study|Protocol Violation|1|||
148705557|NCT01588236|536393989|FG002|Overall Study|Protocol Violation|1|||
148705558|NCT01588236|536393987|FG000|Overall Study|Withdrawal by Subject|14|||
148705559|NCT01588236|536393988|FG001|Overall Study|Withdrawal by Subject|16|||
148705560|NCT01588236|536393989|FG002|Overall Study|Withdrawal by Subject|18|||
148705561|NCT01588236|536393987|FG000|Overall Study|Exclusion Criteria met during study|2|||
148705562|NCT01588236|536393988|FG001|Overall Study|Exclusion Criteria met during study|1|||
148705563|NCT01588236|536393989|FG002|Overall Study|Exclusion Criteria met during study|0|||
148705564|NCT01588236|536393987|FG000|Overall Study|sponsor decision|1|||
148705565|NCT01588236|536393988|FG001|Overall Study|sponsor decision|6|||
148705566|NCT01588236|536393989|FG002|Overall Study|sponsor decision|2|||
148705567|NCT04516967|536395648|FG000|Core Phase|Adverse Event|2|||
148705568|NCT04516967|536395649|FG001|Core Phase|Adverse Event|1|||
148705569|NCT04516967|536395650|FG002|Core Phase|Adverse Event|0|||
148705570|NCT04516967|536395648|FG000|Core Phase|Physician Decision|1|||
148705571|NCT04516967|536395649|FG001|Core Phase|Physician Decision|1|||
148705572|NCT04516967|536395650|FG002|Core Phase|Physician Decision|0|||
148705573|NCT04516967|536395648|FG000|Core Phase|Lack of Efficacy|7|||
148705574|NCT04516967|536395649|FG001|Core Phase|Lack of Efficacy|18|||
148705575|NCT04516967|536395650|FG002|Core Phase|Lack of Efficacy|0|||
148705576|NCT03123094|536395651|FG000|Overall Study|Withdrawal by Subject|0|||
148705577|NCT03123094|536395652|FG001|Overall Study|Withdrawal by Subject|2|||
148705578|NCT03123094|536395653|FG002|Overall Study|Withdrawal by Subject|1|||
148705579|NCT03123094|536395654|FG003|Overall Study|Withdrawal by Subject|0|||
148705580|NCT03123094|536395655|FG004|Overall Study|Withdrawal by Subject|1|||
148705581|NCT01735994|536395656|FG000|Overall Study|Withdrawal by Subject|6|||
148705582|NCT01735994|536395657|FG001|Overall Study|Withdrawal by Subject|4|||
148705583|NCT01735994|536395656|FG000|Overall Study|Injury|2|||
148705584|NCT01735994|536395657|FG001|Overall Study|Injury|0|||
148705585|NCT01735994|536395656|FG000|Overall Study|Kicked off team|5|||
148705586|NCT01735994|536395657|FG001|Overall Study|Kicked off team|0|||
148705587|NCT01735994|536395656|FG000|Overall Study|Lost to Follow-up|50|||
148705588|NCT01735994|536395657|FG001|Overall Study|Lost to Follow-up|62|||
148705589|NCT00604162|536395658|FG000|Overall Study|Physician Decision|3|||
148705590|NCT00604162|536395658|FG000|Overall Study|Withdrawal by Subject|1|||
148705591|NCT00736190|536395660|FG000|Overall Study|Pregnancy|1|||
148705592|NCT00736190|536395660|FG000|Overall Study|Withdrawal by Subject|1|||
148705593|NCT00736190|536395660|FG000|Overall Study|Adverse Event|1|||
148705594|NCT03128723|536395664|FG000|Overall Study|Withdrawal by Subject|2|||
148705595|NCT02909907|536395666|FG000|Overall Study|Withdrawal by Subject|0|||
148705596|NCT02909907|536395667|FG001|Overall Study|Withdrawal by Subject|1|||
148705597|NCT02699866|536395672|FG000|Overall Study|Withdrawal by Subject|3|||
148705598|NCT02699866|536395672|FG000|Overall Study|Physician Decision|2|||
148705599|NCT02699866|536395672|FG000|Overall Study|Adverse Event|3|||
148705600|NCT02849457|536395673|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
148705601|NCT02849457|536395674|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
148705602|NCT02849457|536395675|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
148705603|NCT02849457|536395676|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
148705604|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
148705605|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
148705606|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
148705607|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
148705608|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
148705609|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
148705610|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
148705611|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
148705612|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
148705613|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
148705614|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
148705615|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
148705616|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
148705617|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
148705618|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
148705619|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
148705620|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
148705621|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
148705622|NCT01667679|536395677|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
148705623|NCT01667679|536395678|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
148705624|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
148705625|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
148705626|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
148705627|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
148705628|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
148705629|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
148705630|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
148705631|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
148705632|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
148705633|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
148705634|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
148705635|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
148705636|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
148705637|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
148705638|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
148705639|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
148705640|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
148705641|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
148705642|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
148705643|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
148705644|NCT01667679|536395677|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
148705645|NCT01667679|536395678|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
148705646|NCT01294917|536395681|FG000|Overall Study|Relocation|5|||
148705647|NCT01294917|536395681|FG000|Overall Study|Inconvenience|1|||
148705648|NCT01175018|536395682|FG000|Overall Study|Adverse Event|3|||
148705649|NCT01175018|536395683|FG001|Overall Study|Adverse Event|1|||
148705650|NCT03285594|536395684|FG000|Overall Study|At the Participant's Own Request|10|||
148705651|NCT03285594|536395685|FG001|Overall Study|At the Participant's Own Request|5|||
148705652|NCT03285594|536395686|FG002|Overall Study|At the Participant's Own Request|21|||
148705653|NCT03285594|536395684|FG000|Overall Study|Adverse Event|2|||
148705654|NCT03285594|536395685|FG001|Overall Study|Adverse Event|2|||
148705655|NCT03285594|536395686|FG002|Overall Study|Adverse Event|6|||
148705656|NCT03285594|536395684|FG000|Overall Study|Poor Compliance to Protocol|0|||
148705657|NCT03285594|536395685|FG001|Overall Study|Poor Compliance to Protocol|0|||
148705658|NCT03285594|536395686|FG002|Overall Study|Poor Compliance to Protocol|1|||
148815117|NCT00407511|536799415|FG000|Overall Study|Lost to Follow-up|4|||
148967821|NCT01714310|537368524|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
148705659|NCT03285594|536395684|FG000|Overall Study|Lost to Follow-up|0|||
148705660|NCT03285594|536395685|FG001|Overall Study|Lost to Follow-up|0|||
148705661|NCT03285594|536395686|FG002|Overall Study|Lost to Follow-up|1|||
148705662|NCT03285594|536395684|FG000|Overall Study|Reason Not Specified|3|||
148705663|NCT03285594|536395685|FG001|Overall Study|Reason Not Specified|4|||
148705664|NCT03285594|536395686|FG002|Overall Study|Reason Not Specified|8|||
148705665|NCT02558491|536395687|FG000|First Invention|Withdrawal by Subject|3|||
148705666|NCT02558491|536395688|FG001|First Invention|Withdrawal by Subject|1|||
148705667|NCT02558491|536395687|FG000|First Invention|Data collection issues|1|||
148705668|NCT02558491|536395688|FG001|First Invention|Data collection issues|0|||
148705669|NCT02558491|536395687|FG000|First Invention|Stopping criteria|0|||
148705670|NCT02558491|536395688|FG001|First Invention|Stopping criteria|1|||
148705671|NCT02558491|536395687|FG000|First Invention|Changed parameters during trial|1|||
148705672|NCT02558491|536395688|FG001|First Invention|Changed parameters during trial|0|||
148705673|NCT02558491|536395687|FG000|Second Intervention|Withdrawal by Subject|1|||
148705674|NCT02558491|536395688|FG001|Second Intervention|Withdrawal by Subject|0|||
148705675|NCT02558491|536395687|FG000|Second Intervention|Stopping Criteria|1|||
148705676|NCT02558491|536395688|FG001|Second Intervention|Stopping Criteria|0|||
148705677|NCT00834431|536395691|FG000|First Intervention|Adverse Event|0|||
148705678|NCT00834431|536395692|FG001|First Intervention|Adverse Event|1|||
148705679|NCT00834431|536395691|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
148705680|NCT00834431|536395692|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
148705681|NCT03733444|536395693|FG000|Overall Study|Adverse Event|8|||
148705682|NCT03733444|536395694|FG001|Overall Study|Adverse Event|10|||
148705683|NCT03733444|536395695|FG002|Overall Study|Adverse Event|5|||
148705684|NCT03733444|536395693|FG000|Overall Study|Death|20|||
148967822|NCT01714310|537368525|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
148967823|NCT01714310|537368523|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
148967824|NCT01714310|537368524|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
148967825|NCT01714310|537368525|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
148967826|NCT01714310|537368523|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
148967827|NCT01714310|537368524|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
148967828|NCT01714310|537368525|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
148967829|NCT01714310|537368523|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
148967830|NCT01714310|537368524|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
148705685|NCT03733444|536395694|FG001|Overall Study|Death|19|||
148705686|NCT03733444|536395695|FG002|Overall Study|Death|11|||
148705687|NCT03733444|536395693|FG000|Overall Study|Lost to Follow-up|3|||
148705688|NCT03733444|536395694|FG001|Overall Study|Lost to Follow-up|0|||
148967831|NCT01714310|537368525|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
148967832|NCT02487394|537368526|FG000|Phase 1|Withdrawal by Subject|0|||
148967833|NCT02487394|537368527|FG001|Phase 1|Withdrawal by Subject|1|||
148967834|NCT00826267|537368532|FG000|Overall Study|Other Adverse Event|1|||
148967835|NCT00826267|537368533|FG001|Overall Study|Other Adverse Event|0|||
148967836|NCT00826267|537368534|FG002|Overall Study|Other Adverse Event|0|||
148967837|NCT01675882|537368535|FG000|Overall Study|Adverse Event|0|||
148705689|NCT03733444|536395695|FG002|Overall Study|Lost to Follow-up|1|||
148705690|NCT03733444|536395693|FG000|Overall Study|Lack of Efficacy|0|||
148705691|NCT03733444|536395694|FG001|Overall Study|Lack of Efficacy|1|||
148705692|NCT03733444|536395695|FG002|Overall Study|Lack of Efficacy|1|||
148705693|NCT03733444|536395693|FG000|Overall Study|Physician Decision|2|||
148705694|NCT03733444|536395694|FG001|Overall Study|Physician Decision|1|||
148705695|NCT03733444|536395695|FG002|Overall Study|Physician Decision|0|||
148705696|NCT03733444|536395693|FG000|Overall Study|Protocol Violation|2|||
148705697|NCT03733444|536395694|FG001|Overall Study|Protocol Violation|1|||
148705698|NCT03733444|536395695|FG002|Overall Study|Protocol Violation|0|||
148705699|NCT03733444|536395693|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
148705700|NCT03733444|536395694|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
148967838|NCT01675882|537368536|FG001|Overall Study|Adverse Event|2|||
148967839|NCT01675882|537368537|FG002|Overall Study|Adverse Event|1|||
148705701|NCT03733444|536395695|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
148705702|NCT03733444|536395693|FG000|Overall Study|Study Terminated by Sponsor|203|||
148705703|NCT03733444|536395694|FG001|Overall Study|Study Terminated by Sponsor|209|||
148705704|NCT03733444|536395695|FG002|Overall Study|Study Terminated by Sponsor|221|||
148705705|NCT03733444|536395693|FG000|Overall Study|Withdrawal by Subject|19|||
148705706|NCT03733444|536395694|FG001|Overall Study|Withdrawal by Subject|18|||
148967840|NCT01675882|537368538|FG003|Overall Study|Adverse Event|0|||
148705707|NCT03733444|536395695|FG002|Overall Study|Withdrawal by Subject|16|||
148705708|NCT03733444|536395693|FG000|Overall Study|Miscellaneous|1|||
148705709|NCT03733444|536395694|FG001|Overall Study|Miscellaneous|0|||
148705710|NCT03733444|536395695|FG002|Overall Study|Miscellaneous|1|||
148705711|NCT03733444|536395693|FG000|Overall Study|Not Treated|1|||
148967841|NCT01675882|537368535|FG000|Overall Study|Participant unwilling to continue|2|||
148967842|NCT01675882|537368536|FG001|Overall Study|Participant unwilling to continue|4|||
148705712|NCT03733444|536395694|FG001|Overall Study|Not Treated|2|||
148815118|NCT00407511|536799415|FG000|Overall Study|Other|5|||
148815119|NCT00407511|536799415|FG000|Overall Study|Withdrawal by Subject|4|||
148815120|NCT01521364|536799416|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
148815121|NCT01521364|536799416|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
148815122|NCT02636283|536799417|FG000|Overall Study|Adverse Event|2|||
148815123|NCT02636283|536799418|FG001|Overall Study|Adverse Event|0|||
148815124|NCT02636283|536799417|FG000|Overall Study|Trial Terminated Prematurely|0|||
148815125|NCT02636283|536799418|FG001|Overall Study|Trial Terminated Prematurely|3|||
148815126|NCT03418675|536799419|FG000|Overall Study|Lost to Follow-up|13|||
148815127|NCT03418675|536799420|FG001|Overall Study|Lost to Follow-up|10|||
148815128|NCT03418675|536799419|FG000|Overall Study|Adverse Event|2|||
148815129|NCT03418675|536799420|FG001|Overall Study|Adverse Event|0|||
148815130|NCT01482221|536799423|FG000|Overall Study|Lack of Efficacy|1|||
148815131|NCT01482221|536799424|FG001|Overall Study|Lack of Efficacy|0|||
148815132|NCT01482221|536799425|FG002|Overall Study|Lack of Efficacy|1|||
148815133|NCT01482221|536799423|FG000|Overall Study|Lost to Follow-up|3|||
148815134|NCT01482221|536799424|FG001|Overall Study|Lost to Follow-up|2|||
148815135|NCT01482221|536799425|FG002|Overall Study|Lost to Follow-up|1|||
148815136|NCT01482221|536799423|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
148815137|NCT01482221|536799424|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
148815138|NCT01482221|536799425|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
148815139|NCT01482221|536799423|FG000|Overall Study|Condition under Investigation Worsened|3|||
148815140|NCT01482221|536799424|FG001|Overall Study|Condition under Investigation Worsened|2|||
148815141|NCT01482221|536799425|FG002|Overall Study|Condition under Investigation Worsened|4|||
148815142|NCT01482221|536799423|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
148815143|NCT01482221|536799424|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
148815144|NCT01482221|536799425|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
148815145|NCT01482221|536799423|FG000|Overall Study|Adverse Event|1|||
148815146|NCT01482221|536799424|FG001|Overall Study|Adverse Event|7|||
148815147|NCT01482221|536799425|FG002|Overall Study|Adverse Event|3|||
148815148|NCT01482221|536799423|FG000|Overall Study|Withdrawal by Subject|10|||
148815149|NCT01482221|536799424|FG001|Overall Study|Withdrawal by Subject|7|||
148815150|NCT01482221|536799425|FG002|Overall Study|Withdrawal by Subject|12|||
148815151|NCT01482221|536799423|FG000|Overall Study|Incorrect randomization|0|||
148815152|NCT01482221|536799424|FG001|Overall Study|Incorrect randomization|1|||
148815153|NCT01482221|536799425|FG002|Overall Study|Incorrect randomization|0|||
148815154|NCT01482221|536799423|FG000|Overall Study|Physician Decision|0|||
148815155|NCT01482221|536799424|FG001|Overall Study|Physician Decision|1|||
148815156|NCT01482221|536799425|FG002|Overall Study|Physician Decision|0|||
148815157|NCT03086343|536799426|FG000|Period 1|Adverse Event|7|||
148815158|NCT03086343|536799427|FG001|Period 1|Adverse Event|7|||
148815159|NCT03086343|536799428|FG002|Period 1|Adverse Event|0|||
148815160|NCT03086343|536799429|FG003|Period 1|Adverse Event|1|||
148705713|NCT03733444|536395695|FG002|Overall Study|Not Treated|1|||
148705714|NCT03637764|536395696|FG000|Overall Study|Adverse Event|2|||
148705715|NCT03637764|536395697|FG001|Overall Study|Adverse Event|0|||
148705716|NCT03637764|536395698|FG002|Overall Study|Adverse Event|0|||
148705717|NCT03637764|536395699|FG003|Overall Study|Adverse Event|1|||
148705718|NCT03637764|536395696|FG000|Overall Study|Progressive Disease|23|||
148705719|NCT03637764|536395697|FG001|Overall Study|Progressive Disease|23|||
148705720|NCT03637764|536395698|FG002|Overall Study|Progressive Disease|18|||
148705721|NCT03637764|536395699|FG003|Overall Study|Progressive Disease|31|||
148705722|NCT03637764|536395696|FG000|Overall Study|Withdrawal by Subject|1|||
148705723|NCT03637764|536395697|FG001|Overall Study|Withdrawal by Subject|3|||
148705724|NCT03637764|536395698|FG002|Overall Study|Withdrawal by Subject|0|||
148705725|NCT03637764|536395699|FG003|Overall Study|Withdrawal by Subject|1|||
148705726|NCT00835263|536395700|FG000|Second Intervention|Adverse Event|1|||
148705727|NCT00835263|536395701|FG001|Second Intervention|Adverse Event|0|||
148705728|NCT01020474|536395702|FG000|Overall Study|Adverse Event|4|||
148705729|NCT01020474|536395703|FG001|Overall Study|Adverse Event|4|||
148705730|NCT01020474|536395702|FG000|Overall Study|Protocol Violation|0|||
148705731|NCT01020474|536395703|FG001|Overall Study|Protocol Violation|2|||
148815161|NCT03086343|536799426|FG000|Period 1|Withdrawal by Subject|6|||
148815162|NCT03086343|536799427|FG001|Period 1|Withdrawal by Subject|10|||
148815163|NCT03086343|536799428|FG002|Period 1|Withdrawal by Subject|0|||
148815164|NCT03086343|536799429|FG003|Period 1|Withdrawal by Subject|0|||
148815165|NCT03086343|536799426|FG000|Period 1|Lost to Follow-up|1|||
148815166|NCT03086343|536799427|FG001|Period 1|Lost to Follow-up|3|||
148815167|NCT03086343|536799428|FG002|Period 1|Lost to Follow-up|1|||
148815168|NCT03086343|536799429|FG003|Period 1|Lost to Follow-up|0|||
148705732|NCT01020474|536395702|FG000|Overall Study|Withdrawal by Subject|5|||
148705733|NCT01020474|536395703|FG001|Overall Study|Withdrawal by Subject|7|||
148705734|NCT01020474|536395702|FG000|Overall Study|Other Reasons|1|||
148705735|NCT01020474|536395703|FG001|Overall Study|Other Reasons|1|||
148815169|NCT03086343|536799426|FG000|Period 1|Other, Not Specified|10|||
148815170|NCT03086343|536799427|FG001|Period 1|Other, Not Specified|12|||
148815171|NCT03086343|536799428|FG002|Period 1|Other, Not Specified|2|||
148815172|NCT03086343|536799429|FG003|Period 1|Other, Not Specified|1|||
148705736|NCT01020474|536395702|FG000|Overall Study|Insufficient Clinical Response|0|||
148705737|NCT01020474|536395703|FG001|Overall Study|Insufficient Clinical Response|3|||
148705738|NCT03987191|536395704|FG000|Overall Study|COVID-19 related research disruption|0|||
148705739|NCT03987191|536395705|FG001|Overall Study|COVID-19 related research disruption|2|||
148705740|NCT03406156|536395706|FG000|Overall Study|Death|9|||
148705741|NCT03406156|536395707|FG001|Overall Study|Death|3|||
148705742|NCT03406156|536395706|FG000|Overall Study|Withdrawal by Subject|1|||
148705743|NCT03406156|536395707|FG001|Overall Study|Withdrawal by Subject|2|||
148705744|NCT03406156|536395706|FG000|Overall Study|COVID-19 infection|1|||
148705745|NCT03406156|536395707|FG001|Overall Study|COVID-19 infection|0|||
148705746|NCT03406156|536395706|FG000|Overall Study|Non-compliance with study procedures|1|||
148705747|NCT03406156|536395707|FG001|Overall Study|Non-compliance with study procedures|1|||
148705748|NCT03406156|536395706|FG000|Overall Study|Lost to Follow-up|0|||
148815173|NCT03086343|536799426|FG000|Period 1|Missing|1|||
148815174|NCT03086343|536799427|FG001|Period 1|Missing|0|||
148815175|NCT03086343|536799428|FG002|Period 1|Missing|0|||
148815176|NCT03086343|536799429|FG003|Period 1|Missing|0|||
148815177|NCT03086343|536799426|FG000|Period 2|Adverse Event|20|||
148705749|NCT03406156|536395707|FG001|Overall Study|Lost to Follow-up|2|||
148705750|NCT03406156|536395706|FG000|Overall Study|Other, not specified|72|||
148705751|NCT03406156|536395707|FG001|Overall Study|Other, not specified|28|||
148705752|NCT02838420|536395709|FG000|Overall Study|Ongoing in Study|113|||
148815178|NCT03086343|536799427|FG001|Period 2|Adverse Event|11|||
148815179|NCT03086343|536799428|FG002|Period 2|Adverse Event|1|||
148815180|NCT03086343|536799429|FG003|Period 2|Adverse Event|2|||
148815181|NCT03086343|536799426|FG000|Period 2|Withdrawal by Subject|15|||
148815182|NCT03086343|536799427|FG001|Period 2|Withdrawal by Subject|25|||
148815183|NCT03086343|536799428|FG002|Period 2|Withdrawal by Subject|2|||
148815184|NCT03086343|536799429|FG003|Period 2|Withdrawal by Subject|2|||
148815185|NCT03086343|536799426|FG000|Period 2|Lost to Follow-up|6|||
148815186|NCT03086343|536799427|FG001|Period 2|Lost to Follow-up|11|||
148815187|NCT03086343|536799428|FG002|Period 2|Lost to Follow-up|1|||
148815188|NCT03086343|536799429|FG003|Period 2|Lost to Follow-up|0|||
148815189|NCT03086343|536799426|FG000|Period 2|COVID-19 Infection|5|||
148815190|NCT03086343|536799427|FG001|Period 2|COVID-19 Infection|0|||
148815191|NCT03086343|536799428|FG002|Period 2|COVID-19 Infection|0|||
148815192|NCT03086343|536799429|FG003|Period 2|COVID-19 Infection|0|||
148815193|NCT03086343|536799426|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
148815194|NCT03086343|536799427|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
148815195|NCT03086343|536799428|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
148815196|NCT03086343|536799429|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
148815197|NCT03086343|536799426|FG000|Period 2|Other, Not Specified|23|||
148815198|NCT03086343|536799427|FG001|Period 2|Other, Not Specified|22|||
148815199|NCT03086343|536799428|FG002|Period 2|Other, Not Specified|2|||
148815200|NCT03086343|536799429|FG003|Period 2|Other, Not Specified|4|||
148815201|NCT01047501|536799431|FG000|Overall Study|Adverse Event|7|||
148815202|NCT01047501|536799432|FG001|Overall Study|Adverse Event|8|||
148815203|NCT01047501|536799433|FG002|Overall Study|Adverse Event|5|||
148815204|NCT01047501|536799431|FG000|Overall Study|Withdrew Consent|6|||
148705753|NCT02838420|536395710|FG001|Overall Study|Ongoing in Study|45|||
148705754|NCT02838420|536395709|FG000|Overall Study|Lost to Follow-up|1|||
148705755|NCT02838420|536395710|FG001|Overall Study|Lost to Follow-up|0|||
148705756|NCT02838420|536395709|FG000|Overall Study|Withdrawal by Subject|3|||
148705757|NCT02838420|536395710|FG001|Overall Study|Withdrawal by Subject|4|||
148705758|NCT02838420|536395709|FG000|Overall Study|Death|8|||
148705759|NCT02838420|536395710|FG001|Overall Study|Death|13|||
148705760|NCT03419403|536395711|FG000|Overall Study|Withdrawal by Subject|5|||
148705761|NCT03419403|536395712|FG001|Overall Study|Withdrawal by Subject|2|||
148705762|NCT03419403|536395713|FG002|Overall Study|Withdrawal by Subject|5|||
148705763|NCT03419403|536395714|FG003|Overall Study|Withdrawal by Subject|1|||
148815205|NCT01047501|536799432|FG001|Overall Study|Withdrew Consent|2|||
148815206|NCT01047501|536799433|FG002|Overall Study|Withdrew Consent|4|||
148815207|NCT01047501|536799431|FG000|Overall Study|Lost to Follow-up|0|||
148815208|NCT01047501|536799432|FG001|Overall Study|Lost to Follow-up|1|||
148815209|NCT01047501|536799433|FG002|Overall Study|Lost to Follow-up|1|||
148815210|NCT01047501|536799431|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
148815211|NCT01047501|536799432|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
148815212|NCT01047501|536799433|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
148815213|NCT01047501|536799431|FG000|Overall Study|Death|1|||
148815214|NCT01047501|536799432|FG001|Overall Study|Death|0|||
148815215|NCT01047501|536799433|FG002|Overall Study|Death|0|||
148815216|NCT01047501|536799431|FG000|Overall Study|Other discontinuation|1|||
148815217|NCT01047501|536799432|FG001|Overall Study|Other discontinuation|0|||
148815218|NCT01047501|536799433|FG002|Overall Study|Other discontinuation|1|||
148705764|NCT03419403|536395711|FG000|Overall Study|Progressive disease (per protocol)|0|||
148705765|NCT03419403|536395712|FG001|Overall Study|Progressive disease (per protocol)|2|||
148705766|NCT03419403|536395713|FG002|Overall Study|Progressive disease (per protocol)|2|||
148705767|NCT03419403|536395714|FG003|Overall Study|Progressive disease (per protocol)|0|||
148815219|NCT01047501|536799431|FG000|Overall Study|Investigator judgement|0|||
148705768|NCT03419403|536395711|FG000|Overall Study|Other, not specified|6|||
148705769|NCT03419403|536395712|FG001|Overall Study|Other, not specified|4|||
148705770|NCT03419403|536395713|FG002|Overall Study|Other, not specified|5|||
148705771|NCT03419403|536395714|FG003|Overall Study|Other, not specified|1|||
148705772|NCT03419403|536395711|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
148705773|NCT03419403|536395712|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
148705774|NCT03419403|536395713|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
148705775|NCT03419403|536395714|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
148705776|NCT00796653|536395715|FG000|Overall Study|Adverse Event|19|||
148705777|NCT00796653|536395716|FG001|Overall Study|Adverse Event|16|||
148705778|NCT00796653|536395717|FG002|Overall Study|Adverse Event|16|||
148705779|NCT00796653|536395718|FG003|Overall Study|Adverse Event|16|||
148705780|NCT00796653|536395715|FG000|Overall Study|Lost to Follow-up|2|||
148705781|NCT00796653|536395716|FG001|Overall Study|Lost to Follow-up|1|||
148705782|NCT00796653|536395717|FG002|Overall Study|Lost to Follow-up|2|||
148705783|NCT00796653|536395718|FG003|Overall Study|Lost to Follow-up|3|||
148705784|NCT00796653|536395715|FG000|Overall Study|Withdrawal by Subject|16|||
148705785|NCT00796653|536395716|FG001|Overall Study|Withdrawal by Subject|8|||
148705786|NCT00796653|536395717|FG002|Overall Study|Withdrawal by Subject|8|||
148705787|NCT00796653|536395718|FG003|Overall Study|Withdrawal by Subject|13|||
148705788|NCT00796653|536395715|FG000|Overall Study|Lack of Efficacy|8|||
148705789|NCT00796653|536395716|FG001|Overall Study|Lack of Efficacy|1|||
148705790|NCT00796653|536395717|FG002|Overall Study|Lack of Efficacy|3|||
148705791|NCT00796653|536395718|FG003|Overall Study|Lack of Efficacy|2|||
148705792|NCT00796653|536395715|FG000|Overall Study|Non compliance with protocol|2|||
148705793|NCT00796653|536395716|FG001|Overall Study|Non compliance with protocol|2|||
148705794|NCT00796653|536395717|FG002|Overall Study|Non compliance with protocol|0|||
148705795|NCT00796653|536395718|FG003|Overall Study|Non compliance with protocol|2|||
148705796|NCT00796653|536395715|FG000|Overall Study|Other reason not described above|4|||
148705797|NCT00796653|536395716|FG001|Overall Study|Other reason not described above|9|||
148705798|NCT00796653|536395717|FG002|Overall Study|Other reason not described above|7|||
148705799|NCT00796653|536395718|FG003|Overall Study|Other reason not described above|4|||
148705800|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
148705801|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
148705802|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
148705803|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
148705804|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
148705805|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
148705806|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
148705807|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
148705808|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
148705809|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
148705810|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
148705811|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
148705812|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
148705813|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
148705814|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
148705815|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
148705816|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
148705817|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
148705818|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
148705819|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
148705820|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Death|0|||
148705821|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Death|1|||
148705822|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Death|0|||
148705823|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Death|0|||
148705824|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
148705825|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
148705826|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
148705827|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
148705828|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
148705829|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
148705830|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
148705831|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
148705832|NCT01940341|536395723|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
148705833|NCT01940341|536395724|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
148705834|NCT01940341|536395725|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
149025092|NCT02531438|537568015|FG001|Overall Study|Physician Decision|1|||
149025093|NCT02531438|537568014|FG000|Overall Study|Death|6|||
148705835|NCT01940341|536395726|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
148705836|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
148705837|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
148705838|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
148705839|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
148705840|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
148705841|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
148705842|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
148705843|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
148705844|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
148705845|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
148705846|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
148705847|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
148705848|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
148705849|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
148705850|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
148705851|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
148705852|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
148705853|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
148705854|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
148705855|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
148705856|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
148705857|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
148705858|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
148705859|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
148705860|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
148705861|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
148705862|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
148705863|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
148705864|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
148705865|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
148705866|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
148705867|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
148705868|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
148705869|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
148705870|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
148705871|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
148705872|NCT01940341|536395723|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
148705873|NCT01940341|536395724|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
148705874|NCT01940341|536395725|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
148705875|NCT01940341|536395726|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
148705876|NCT03552393|536395727|FG000|Core Period|Kidney Transplant|1|||
148705877|NCT03552393|536395727|FG000|Core Period|Prohibited Medication|1|||
148705878|NCT03552393|536395727|FG000|Safety Extension Period|Kidney Transplant|4|||
148705879|NCT02414152|536395728|FG000|Overall Study|Withdrawal by Subject|1|||
148705880|NCT02414152|536395728|FG000|Overall Study|Lack of Efficacy|1|||
148705881|NCT04887415|536395732|FG000|Overall Study|Lost to Follow-up|2|||
148705882|NCT01250912|536395735|FG000|Overall Study|Lost to Follow-up|1|||
148705883|NCT03123471|536395740|FG000|Placebo-controlled Phase|Adverse Event|3|||
148705884|NCT03123471|536395741|FG001|Placebo-controlled Phase|Adverse Event|8|||
148705885|NCT03123471|536395740|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
148705886|NCT03123471|536395741|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
148705887|NCT03123471|536395740|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
148705888|NCT03123471|536395741|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
148705889|NCT03123471|536395740|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
148705890|NCT03123471|536395741|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
148967843|NCT01675882|537368537|FG002|Overall Study|Participant unwilling to continue|2|||
148967844|NCT01675882|537368538|FG003|Overall Study|Participant unwilling to continue|1|||
148967845|NCT01675882|537368535|FG000|Overall Study|Lost to Follow-up|0|||
148705891|NCT03123471|536395740|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
148705892|NCT03123471|536395741|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
148705893|NCT03123471|536395740|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
148705894|NCT03123471|536395741|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
148705895|NCT03123471|536395740|FG000|Placebo-controlled Phase|Miscellaneous|0|||
148705896|NCT03123471|536395741|FG001|Placebo-controlled Phase|Miscellaneous|1|||
148967846|NCT01675882|537368536|FG001|Overall Study|Lost to Follow-up|1|||
148705897|NCT03123471|536395740|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
148967847|NCT01675882|537368537|FG002|Overall Study|Lost to Follow-up|0|||
148705898|NCT03123471|536395741|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
148705899|NCT03123471|536395740|FG000|Apremilast Extension Phase|Adverse Event|1|||
148705900|NCT03123471|536395741|FG001|Apremilast Extension Phase|Adverse Event|5|||
148705901|NCT03123471|536395740|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
148705902|NCT03123471|536395741|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
148705903|NCT03123471|536395740|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
148705904|NCT03123471|536395741|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
148705905|NCT05341622|536395745|FG000|Overall Study|Death|0|||
148705906|NCT05341622|536395746|FG001|Overall Study|Death|0|||
148705907|NCT05341622|536395747|FG002|Overall Study|Death|0|||
148705908|NCT05341622|536395748|FG003|Overall Study|Death|0|||
148705909|NCT05341622|536395749|FG004|Overall Study|Death|1|||
148705910|NCT05341622|536395750|FG005|Overall Study|Death|0|||
148705911|NCT05341622|536395751|FG006|Overall Study|Death|0|||
148967848|NCT01675882|537368538|FG003|Overall Study|Lost to Follow-up|0|||
148967849|NCT01675882|537368535|FG000|Overall Study|Non-compliance|0|||
148967850|NCT01675882|537368536|FG001|Overall Study|Non-compliance|0|||
148967851|NCT01675882|537368537|FG002|Overall Study|Non-compliance|0|||
148967852|NCT01675882|537368538|FG003|Overall Study|Non-compliance|1|||
148967853|NCT01828034|537368539|FG000|Overall Study|Withdrawal by Subject|0|||
148967854|NCT01828034|537368540|FG001|Overall Study|Withdrawal by Subject|0|||
148967855|NCT01828034|537368541|FG002|Overall Study|Withdrawal by Subject|0|||
148967856|NCT01828034|537368542|FG003|Overall Study|Withdrawal by Subject|1|||
148967857|NCT01988571|537368543|FG000|Overall Study|Death|3|||
148967858|NCT01988571|537368544|FG001|Overall Study|Death|1|||
148967859|NCT01988571|537368543|FG000|Overall Study|Physician Decision|2|||
148967860|NCT01988571|537368544|FG001|Overall Study|Physician Decision|1|||
148967861|NCT01988571|537368543|FG000|Overall Study|Lost to Follow-up|3|||
148967862|NCT01988571|537368544|FG001|Overall Study|Lost to Follow-up|0|||
148967863|NCT01988571|537368543|FG000|Overall Study|Withdrawal by Subject|31|||
148705912|NCT05341622|536395752|FG007|Overall Study|Death|1|||
148705913|NCT05341622|536395745|FG000|Overall Study|Invalid Address|0|||
148705914|NCT05341622|536395746|FG001|Overall Study|Invalid Address|1|||
148705915|NCT05341622|536395747|FG002|Overall Study|Invalid Address|0|||
148705916|NCT05341622|536395748|FG003|Overall Study|Invalid Address|0|||
148705917|NCT05341622|536395749|FG004|Overall Study|Invalid Address|0|||
148705918|NCT05341622|536395750|FG005|Overall Study|Invalid Address|0|||
148705919|NCT05341622|536395751|FG006|Overall Study|Invalid Address|0|||
148705920|NCT05341622|536395752|FG007|Overall Study|Invalid Address|0|||
148705921|NCT05341622|536395745|FG000|Overall Study|Ineligible|26|||
148705922|NCT05341622|536395746|FG001|Overall Study|Ineligible|21|||
148705923|NCT05341622|536395747|FG002|Overall Study|Ineligible|28|||
148705924|NCT05341622|536395748|FG003|Overall Study|Ineligible|24|||
148705925|NCT05341622|536395749|FG004|Overall Study|Ineligible|29|||
148705926|NCT05341622|536395750|FG005|Overall Study|Ineligible|31|||
148705927|NCT05341622|536395751|FG006|Overall Study|Ineligible|28|||
148705928|NCT05341622|536395752|FG007|Overall Study|Ineligible|26|||
148705929|NCT01249651|536395755|FG000|Overall Study|Withdrawal by Subject|4|||
148705930|NCT01249651|536395755|FG000|Overall Study|Adverse Event|1|||
148705931|NCT01249651|536395755|FG000|Overall Study|Protocol Violation|1|||
148705932|NCT01249651|536395755|FG000|Overall Study|Sponsor Decision|1|||
148705933|NCT03801707|536395766|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
148705934|NCT00787254|536395769|FG000|Overall Study|Adverse Event|24|||
148705935|NCT00787254|536395770|FG001|Overall Study|Adverse Event|23|||
148815220|NCT01047501|536799432|FG001|Overall Study|Investigator judgement|0|||
148967864|NCT01988571|537368544|FG001|Overall Study|Withdrawal by Subject|33|||
148967865|NCT03144180|537368550|FG000|Overall Study|STAT Delivery|1|||
148967866|NCT03144180|537368551|FG001|Overall Study|STAT Delivery|1|||
148967867|NCT03144180|537368550|FG000|Overall Study|Provider forgot to fill out forms|1|||
148967868|NCT03144180|537368551|FG001|Overall Study|Provider forgot to fill out forms|3|||
148967869|NCT03144180|537368550|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
148967870|NCT03144180|537368551|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
148967871|NCT03144180|537368550|FG000|Overall Study|Scrub tech removed tube cap|0|||
148967872|NCT03144180|537368551|FG001|Overall Study|Scrub tech removed tube cap|1|||
149025094|NCT02531438|537568015|FG001|Overall Study|Death|3|||
148705936|NCT00787254|536395769|FG000|Overall Study|Protocol Violation|26|||
148705937|NCT00787254|536395770|FG001|Overall Study|Protocol Violation|23|||
148705938|NCT00787254|536395769|FG000|Overall Study|Withdrawal by Subject|16|||
148967873|NCT03387813|537368554|FG000|Overall Study|Death|40|||
148967874|NCT03387813|537368555|FG001|Overall Study|Death|37|||
148705939|NCT00787254|536395770|FG001|Overall Study|Withdrawal by Subject|11|||
148705940|NCT00787254|536395769|FG000|Overall Study|Lack of Efficacy|4|||
148705941|NCT00787254|536395770|FG001|Overall Study|Lack of Efficacy|15|||
148705942|NCT00787254|536395769|FG000|Overall Study|NSAIDs discontinuation|1|||
148705943|NCT00787254|536395770|FG001|Overall Study|NSAIDs discontinuation|2|||
148705944|NCT00787254|536395769|FG000|Overall Study|Institution closed|1|||
148705945|NCT00787254|536395770|FG001|Overall Study|Institution closed|0|||
148705946|NCT00787254|536395769|FG000|Overall Study|Physician Decision|4|||
148967875|NCT03387813|537368556|FG002|Overall Study|Death|190|||
148705947|NCT00787254|536395770|FG001|Overall Study|Physician Decision|8|||
148705948|NCT03761173|536395771|FG000|Overall Study|Lost to Follow-up|93|||
148705949|NCT03761173|536395771|FG000|Overall Study|Withdrawal by Subject|74|||
148705950|NCT03761173|536395771|FG000|Overall Study|Death|45|||
148705951|NCT03761173|536395771|FG000|Overall Study|Withdrawal for Other Reasons|29|||
148705952|NCT03761173|536395771|FG000|Overall Study|Protocol Violation|1|||
148705953|NCT00316186|536395772|FG000|Overall Study|Adverse Event|6|||
148705954|NCT00316186|536395772|FG000|Overall Study|Disease Progression|4|||
148705955|NCT00316186|536395772|FG000|Overall Study|Lost to Follow-up|1|||
148705956|NCT00316186|536395772|FG000|Overall Study|Other|1|||
148705957|NCT02635750|536397884|FG000|Part 1, Period 2|Adverse Event|1|||
148705958|NCT02635750|536397885|FG001|Part 1, Period 2|Adverse Event|0|||
148705959|NCT02635750|536397886|FG002|Part 1, Period 2|Adverse Event|0|||
148705960|NCT02642653|536397891|FG000|Overall Study|Adverse Event|2|||
148705961|NCT02642653|536397892|FG001|Overall Study|Adverse Event|0|||
148705962|NCT02875392|536397893|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
148705963|NCT02875392|536397894|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
148705964|NCT00834717|536397900|FG000|First Intervention|Adverse Event|1|||
148705965|NCT00834717|536397901|FG001|First Intervention|Adverse Event|0|||
148705966|NCT00834717|536397900|FG000|First Intervention|Withdrawal by Subject|0|||
148705967|NCT00834717|536397901|FG001|First Intervention|Withdrawal by Subject|1|||
148705968|NCT00594035|536397902|FG000|Overall Study|Lost to Follow-up|1|||
148705969|NCT00594035|536397903|FG001|Overall Study|Lost to Follow-up|1|||
148705970|NCT00594035|536397902|FG000|Overall Study|Withdrawal by Subject|1|||
148705971|NCT00594035|536397903|FG001|Overall Study|Withdrawal by Subject|0|||
148705972|NCT00594035|536397902|FG000|Overall Study|Subject transferred to nursing home|0|||
148705973|NCT00594035|536397903|FG001|Overall Study|Subject transferred to nursing home|1|||
148705974|NCT00594035|536397902|FG000|Overall Study|Subject couldn't return due to job|0|||
148705975|NCT00594035|536397903|FG001|Overall Study|Subject couldn't return due to job|1|||
148705976|NCT00795821|536397906|FG000|Acute Treatment Phase|Adverse Event|23|||
148705977|NCT00795821|536397907|FG001|Acute Treatment Phase|Adverse Event|4|||
148705978|NCT00795821|536397906|FG000|Acute Treatment Phase|Death|1|||
148705979|NCT00795821|536397907|FG001|Acute Treatment Phase|Death|0|||
148705980|NCT00795821|536397906|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
148705981|NCT00795821|536397907|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
148705982|NCT00795821|536397906|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
148705983|NCT00795821|536397907|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
148705984|NCT00795821|536397906|FG000|Acute Treatment Phase|Physician Decision|1|||
148705985|NCT00795821|536397907|FG001|Acute Treatment Phase|Physician Decision|1|||
148705986|NCT00795821|536397906|FG000|Acute Treatment Phase|Protocol Violation|1|||
148705987|NCT00795821|536397907|FG001|Acute Treatment Phase|Protocol Violation|2|||
148705988|NCT00795821|536397906|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
148705989|NCT00795821|536397907|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
148705990|NCT00795821|536397906|FG000|Long-term Extension Phase|Adverse Event|25|||
148705991|NCT00795821|536397907|FG001|Long-term Extension Phase|Adverse Event|32|||
148705992|NCT00795821|536397906|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
148705993|NCT00795821|536397907|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
148705994|NCT00795821|536397906|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
148705995|NCT00795821|536397907|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
148705996|NCT00795821|536397906|FG000|Long-term Extension Phase|Physician Decision|1|||
148705997|NCT00795821|536397907|FG001|Long-term Extension Phase|Physician Decision|2|||
148705998|NCT00795821|536397906|FG000|Long-term Extension Phase|Protocol Violation|3|||
148705999|NCT00795821|536397907|FG001|Long-term Extension Phase|Protocol Violation|5|||
148706000|NCT00795821|536397906|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
148706001|NCT00795821|536397907|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
148706002|NCT00795821|536397906|FG000|Taper Phase|Adverse Event|2|||
148706003|NCT00795821|536397907|FG001|Taper Phase|Adverse Event|0|||
148706004|NCT00795821|536397906|FG000|Taper Phase|Lost to Follow-up|1|||
148706005|NCT00795821|536397907|FG001|Taper Phase|Lost to Follow-up|0|||
148706006|NCT00795821|536397906|FG000|Taper Phase|Physician Decision|2|||
148706007|NCT00795821|536397907|FG001|Taper Phase|Physician Decision|0|||
148706008|NCT00795821|536397906|FG000|Taper Phase|Withdrawal by Subject|4|||
148706009|NCT00795821|536397907|FG001|Taper Phase|Withdrawal by Subject|0|||
148706010|NCT02255149|536397914|FG000|Overall Study|Lost to Follow-up|2|||
148706011|NCT02255149|536397914|FG000|Overall Study|Withdrawal by Subject|1|||
148706012|NCT02255149|536397914|FG000|Overall Study|Withdrawal by PI|1|||
148706013|NCT02255149|536397914|FG000|Overall Study|Implant Failure|1|||
148706014|NCT01701674|536397916|FG000|Overall Study|Unable to safely complete treatment|1|||
148706015|NCT00834522|536397925|FG000|Washout|Adverse Event|1|||
148706016|NCT00834522|536397926|FG001|Washout|Adverse Event|0|||
148706017|NCT00834522|536397925|FG000|Washout|Withdrawal by Subject|2|||
148706018|NCT00834522|536397926|FG001|Washout|Withdrawal by Subject|1|||
148706019|NCT00519194|536397927|FG000|Overall Study|Withdrawal by Subject|9|||
148706020|NCT00519194|536397927|FG000|Overall Study|Death|9|||
148706021|NCT00519194|536397927|FG000|Overall Study|Lost to Follow-up|3|||
148706022|NCT03165994|536397928|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
148706023|NCT03165994|536397928|FG000|Overall Study|Death|2|||
148706024|NCT03165994|536397928|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
148706025|NCT03165994|536397928|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
148706026|NCT03165994|536397928|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
148706027|NCT03165994|536397928|FG000|Overall Study|Miscellaneous|1|||
148967876|NCT03387813|537368554|FG000|Overall Study|Withdrawal by Subject|9|||
148967877|NCT03387813|537368555|FG001|Overall Study|Withdrawal by Subject|19|||
148967878|NCT03387813|537368556|FG002|Overall Study|Withdrawal by Subject|32|||
148967879|NCT03387813|537368554|FG000|Overall Study|Lost to Follow-up|3|||
148967880|NCT03387813|537368555|FG001|Overall Study|Lost to Follow-up|9|||
148967881|NCT03387813|537368556|FG002|Overall Study|Lost to Follow-up|15|||
148967882|NCT03387813|537368554|FG000|Overall Study|Non-Compliance|6|||
148706028|NCT02301975|536397931|FG000|Overall Study|Adverse Event|8|||
148706029|NCT02301975|536397932|FG001|Overall Study|Adverse Event|3|||
148706030|NCT02301975|536397933|FG002|Overall Study|Adverse Event|2|||
148967883|NCT03387813|537368555|FG001|Overall Study|Non-Compliance|6|||
148706031|NCT02301975|536397931|FG000|Overall Study|Lack of Efficacy|1|||
148706032|NCT02301975|536397932|FG001|Overall Study|Lack of Efficacy|1|||
148706033|NCT02301975|536397933|FG002|Overall Study|Lack of Efficacy|1|||
148706034|NCT02301975|536397931|FG000|Overall Study|Protocol Violation|3|||
148706035|NCT02301975|536397932|FG001|Overall Study|Protocol Violation|5|||
148706036|NCT02301975|536397933|FG002|Overall Study|Protocol Violation|3|||
148706037|NCT02301975|536397931|FG000|Overall Study|Lost to Follow-up|0|||
148706038|NCT02301975|536397932|FG001|Overall Study|Lost to Follow-up|2|||
148706039|NCT02301975|536397933|FG002|Overall Study|Lost to Follow-up|2|||
148706040|NCT02301975|536397931|FG000|Overall Study|Physician Decision|4|||
148706041|NCT02301975|536397932|FG001|Overall Study|Physician Decision|2|||
148706042|NCT02301975|536397933|FG002|Overall Study|Physician Decision|3|||
148706043|NCT02301975|536397931|FG000|Overall Study|Withdrawal by Subject|15|||
148706044|NCT02301975|536397932|FG001|Overall Study|Withdrawal by Subject|12|||
148706045|NCT02301975|536397933|FG002|Overall Study|Withdrawal by Subject|11|||
148706046|NCT04278560|536397935|FG000|Overall Study|Adverse Event|1|||
148706047|NCT04278560|536397936|FG001|Overall Study|Adverse Event|2|||
148706048|NCT04278560|536397935|FG000|Overall Study|Withdrawal by Subject|0|||
148706049|NCT04278560|536397936|FG001|Overall Study|Withdrawal by Subject|1|||
148967884|NCT03387813|537368556|FG002|Overall Study|Non-Compliance|31|||
148967885|NCT03387813|537368554|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
148967886|NCT03387813|537368555|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
148967887|NCT03387813|537368556|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
148967888|NCT02308735|537368557|FG000|Overall Study|Physician Decision|2|||
149025095|NCT02531438|537568014|FG000|Overall Study|Randomized, but Not Treated|4|||
149025096|NCT02531438|537568015|FG001|Overall Study|Randomized, but Not Treated|0|||
149025097|NCT02531438|537568014|FG000|Overall Study|Missed EOT/PTE Visit|5|||
149025098|NCT02531438|537568015|FG001|Overall Study|Missed EOT/PTE Visit|2|||
149025099|NCT02531438|537568014|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
149025100|NCT02531438|537568015|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
148967889|NCT02308735|537368558|FG001|Overall Study|Physician Decision|0|||
149025101|NCT01813422|537568017|FG000|Overall Study|Withdrawal by Subject|14|||
148706050|NCT00163657|536397937|FG000|Overall Study|Death|12|||
148706051|NCT00163657|536397938|FG001|Overall Study|Death|14|||
148706052|NCT00163657|536397939|FG002|Overall Study|Death|19|||
148706053|NCT00163657|536397937|FG000|Overall Study|graft loss|4|||
148706054|NCT00163657|536397938|FG001|Overall Study|graft loss|1|||
148706055|NCT00163657|536397939|FG002|Overall Study|graft loss|2|||
148706056|NCT00163657|536397937|FG000|Overall Study|Withdrawal by Subject|2|||
148706057|NCT00163657|536397938|FG001|Overall Study|Withdrawal by Subject|3|||
148706058|NCT00163657|536397939|FG002|Overall Study|Withdrawal by Subject|2|||
148706059|NCT00163657|536397937|FG000|Overall Study|Physician Decision|0|||
148706060|NCT00163657|536397938|FG001|Overall Study|Physician Decision|1|||
148706061|NCT00163657|536397939|FG002|Overall Study|Physician Decision|1|||
148706062|NCT00163657|536397937|FG000|Overall Study|Non Compliance|1|||
148706063|NCT00163657|536397938|FG001|Overall Study|Non Compliance|0|||
148706064|NCT00163657|536397939|FG002|Overall Study|Non Compliance|0|||
148706065|NCT00163657|536397937|FG000|Overall Study|Lost to Follow-up|1|||
148706066|NCT00163657|536397938|FG001|Overall Study|Lost to Follow-up|3|||
148706067|NCT00163657|536397939|FG002|Overall Study|Lost to Follow-up|10|||
148706068|NCT00163657|536397937|FG000|Overall Study|Other reason|0|||
148706069|NCT00163657|536397938|FG001|Overall Study|Other reason|1|||
148706070|NCT00163657|536397939|FG002|Overall Study|Other reason|3|||
148706071|NCT01319383|536397940|FG000|Overall Study|No ex vivo or in vivo response|4|||
148706072|NCT01319383|536397941|FG001|Overall Study|No ex vivo or in vivo response|0|||
148706073|NCT01319383|536397940|FG000|Overall Study|Physician Decision|3|||
148706074|NCT01319383|536397941|FG001|Overall Study|Physician Decision|0|||
148706075|NCT01319383|536397940|FG000|Overall Study|Lack of Efficacy|5|||
148706076|NCT01319383|536397941|FG001|Overall Study|Lack of Efficacy|9|||
148706077|NCT01319383|536397940|FG000|Overall Study|No in vivo response to interval doses|0|||
148706078|NCT01319383|536397941|FG001|Overall Study|No in vivo response to interval doses|1|||
148706079|NCT01531894|536397946|FG000|Overall Study|Physician Decision|8|||
148706080|NCT01531894|536397946|FG000|Overall Study|Death|1|||
148706081|NCT03086460|536397947|FG000|Study Participants|Lost to Follow-up|2|||
148706082|NCT03086460|536397947|FG000|Study Participants|Protocol Violation|1|||
148706083|NCT03086460|536397947|FG000|Study Participants|Withdrawal by Subject|6|||
148706084|NCT03086460|536397947|FG000|Treatment A|Lost to Follow-up|1|||
148706085|NCT03086460|536397947|FG000|Treatment A|Protocol Violation|1|||
148706086|NCT03086460|536397947|FG000|Treatment A|Withdrawal by Subject|2|||
148706087|NCT03086460|536397947|FG000|Treatment C|Withdrawal by Subject|2|||
148706088|NCT03086460|536397947|FG000|Treatment E|Lost to Follow-up|1|||
148706089|NCT03086460|536397947|FG000|Treatment E|Withdrawal by Subject|3|||
148706090|NCT03600805|536397956|FG000|Overall Study|Adverse Event|2|||
148706091|NCT03600805|536397957|FG001|Overall Study|Adverse Event|1|||
148706092|NCT03600805|536397958|FG002|Overall Study|Adverse Event|1|||
148706093|NCT03600805|536397959|FG003|Overall Study|Adverse Event|7|||
148706094|NCT03600805|536397956|FG000|Overall Study|Lack of Efficacy|2|||
148706095|NCT03600805|536397957|FG001|Overall Study|Lack of Efficacy|1|||
148706096|NCT03600805|536397958|FG002|Overall Study|Lack of Efficacy|0|||
148706097|NCT03600805|536397959|FG003|Overall Study|Lack of Efficacy|0|||
148706098|NCT03600805|536397956|FG000|Overall Study|Withdrawal by Subject|1|||
148706099|NCT03600805|536397957|FG001|Overall Study|Withdrawal by Subject|0|||
148706100|NCT03600805|536397958|FG002|Overall Study|Withdrawal by Subject|0|||
148706101|NCT03600805|536397959|FG003|Overall Study|Withdrawal by Subject|1|||
148706102|NCT03600805|536397956|FG000|Overall Study|Other unspecified|14|||
148706103|NCT03600805|536397957|FG001|Overall Study|Other unspecified|6|||
148706104|NCT03600805|536397958|FG002|Overall Study|Other unspecified|7|||
148706105|NCT03600805|536397959|FG003|Overall Study|Other unspecified|11|||
148706106|NCT06195579|536397960|FG000|Overall Study|Withdrawal by Subject|1|||
148706107|NCT00834340|536397965|FG000|Washout|Adverse Event|1|||
148706108|NCT00834340|536397966|FG001|Washout|Adverse Event|0|||
148706109|NCT00834340|536397965|FG000|Washout|Withdrawal by Subject|1|||
148706110|NCT00834340|536397966|FG001|Washout|Withdrawal by Subject|0|||
148706111|NCT00395694|536397967|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
148967890|NCT02308735|537368559|FG002|Overall Study|Physician Decision|0|||
148967891|NCT02308735|537368560|FG003|Overall Study|Physician Decision|2|||
148967892|NCT03792672|537368561|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
148967893|NCT03792672|537368562|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
148706112|NCT00395694|536397968|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
148706113|NCT00395694|536397967|FG000|Continuation Phase|Adverse Event|1|||
148706114|NCT00395694|536397968|FG001|Continuation Phase|Adverse Event|0|||
148967894|NCT03792672|537368563|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
148706115|NCT00395694|536397967|FG000|Continuation Phase|Lack of Efficacy|12|||
148706116|NCT00395694|536397968|FG001|Continuation Phase|Lack of Efficacy|11|||
148706117|NCT00395694|536397967|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
148706118|NCT00395694|536397968|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
148706119|NCT00395694|536397967|FG000|Continuation Phase|Poor Compliance|1|||
148706120|NCT00395694|536397968|FG001|Continuation Phase|Poor Compliance|0|||
148706121|NCT00395694|536397967|FG000|Continuation Phase|Withdrawal by Subject|0|||
148706122|NCT00395694|536397968|FG001|Continuation Phase|Withdrawal by Subject|2|||
148706123|NCT00392665|536397971|FG000|Overall Study|Death|16|||
148967895|NCT03792672|537368564|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
148967896|NCT03792672|537368565|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
148967897|NCT03792672|537368566|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
148706124|NCT00392665|536397972|FG001|Overall Study|Death|14|||
148706125|NCT00392665|536397971|FG000|Overall Study|Lost to Follow-up|1|||
148706126|NCT00392665|536397972|FG001|Overall Study|Lost to Follow-up|1|||
148706127|NCT03673670|536397976|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
148706128|NCT03673670|536397977|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
148706129|NCT03673670|536397978|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
148706130|NCT03673670|536397979|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
148706131|NCT03673670|536397980|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
148706132|NCT03673670|536397981|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
148706133|NCT03673670|536397976|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
148706134|NCT03673670|536397977|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
148706135|NCT03673670|536397978|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
148706136|NCT03673670|536397979|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
148706137|NCT03673670|536397980|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
148706138|NCT03673670|536397981|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
148706139|NCT03673670|536397976|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
148706140|NCT03673670|536397977|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
148706141|NCT03673670|536397978|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
148706142|NCT03673670|536397979|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
148706143|NCT03673670|536397980|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
148706144|NCT03673670|536397981|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
148706145|NCT03673670|536397976|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
148706146|NCT03673670|536397977|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
148706147|NCT03673670|536397978|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
148706148|NCT03673670|536397979|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
148706149|NCT03673670|536397980|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
148706150|NCT03673670|536397981|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
148706151|NCT03673670|536397976|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
148706152|NCT03673670|536397977|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
148706153|NCT03673670|536397978|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
148706154|NCT03673670|536397979|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
148706155|NCT03673670|536397980|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
148706156|NCT03673670|536397981|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
148706157|NCT03673670|536397976|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
148706158|NCT03673670|536397977|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
148706159|NCT03673670|536397978|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
148706160|NCT03673670|536397979|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
148706161|NCT03673670|536397980|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
148706162|NCT03673670|536397981|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
148706163|NCT03673670|536397976|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
148706164|NCT03673670|536397977|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
148706165|NCT03673670|536397978|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
148706166|NCT03673670|536397979|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
148706167|NCT03673670|536397980|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
148706168|NCT03673670|536397981|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
148706169|NCT03437265|536397984|FG000|Overall Study|Protocol Violation|6|||
148706170|NCT02294786|536397987|FG000|Overall Study|Withdrawal by Subject|0|||
148706171|NCT02294786|536397988|FG001|Overall Study|Withdrawal by Subject|1|||
148706172|NCT02294786|536397987|FG000|Overall Study|Physician Decision|6|||
148706173|NCT02294786|536397988|FG001|Overall Study|Physician Decision|7|||
148706174|NCT02294786|536397987|FG000|Overall Study|Lost to Follow-up|1|||
148706175|NCT02294786|536397988|FG001|Overall Study|Lost to Follow-up|2|||
148706176|NCT02294786|536397987|FG000|Overall Study|Protocol Violation|1|||
148706177|NCT02294786|536397988|FG001|Overall Study|Protocol Violation|0|||
148706178|NCT02294786|536397987|FG000|Overall Study|Adverse Event|1|||
148706179|NCT02294786|536397988|FG001|Overall Study|Adverse Event|1|||
148706180|NCT02294786|536397987|FG000|Overall Study|Death|2|||
148706181|NCT02294786|536397988|FG001|Overall Study|Death|3|||
148967898|NCT03792672|537368561|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
148967899|NCT03792672|537368562|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
148706182|NCT01778010|536397989|FG000|Overall Study|Withdrawal by Subject|2|||
148706183|NCT01778010|536397989|FG000|Overall Study|abnormal ECG before meds|1|||
148706184|NCT01778010|536397989|FG000|Overall Study|Arrested|1|||
148706185|NCT01778010|536397989|FG000|Overall Study|rash while on placebo|1|||
148967900|NCT03792672|537368563|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
148706186|NCT04238754|536397997|FG000|Washout - 1 Week|Lost to Follow-up|1|||
148706187|NCT04238754|536397998|FG001|Washout - 1 Week|Lost to Follow-up|0|||
148967901|NCT03792672|537368564|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
148967902|NCT03792672|537368565|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
148706188|NCT02321098|536398002|FG000|12 Weeks Treament|Lost to Follow-up|1|||
148706189|NCT02321098|536398003|FG001|12 Weeks Treament|Lost to Follow-up|1|||
148706190|NCT02321098|536398004|FG002|12 Weeks Treament|Lost to Follow-up|0|||
148706191|NCT02321098|536398002|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
148706192|NCT02321098|536398003|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
148706193|NCT02321098|536398004|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
148706194|NCT02321098|536398002|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
148706195|NCT02321098|536398003|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
148706196|NCT02321098|536398004|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
148706197|NCT02321098|536398002|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
148706198|NCT02321098|536398003|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
148706199|NCT02321098|536398004|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
148706200|NCT01788423|536398005|FG000|Overall Study|See Comments in Completed (above)|0|||
148706201|NCT01788423|536398006|FG001|Overall Study|See Comments in Completed (above)|4|||
148706202|NCT01788423|536398007|FG002|Overall Study|See Comments in Completed (above)|5|||
148706203|NCT00705666|536398012|FG000|Overall Study|No post-treatment questionnaire|279|||
148706204|NCT00705666|536398012|FG000|Overall Study|Withdrawal by Subject|21|||
148706205|NCT00705666|536398012|FG000|Overall Study|Physician Decision|7|||
148706206|NCT00705666|536398012|FG000|Overall Study|Lost to Follow-up|5|||
148706207|NCT00705666|536398012|FG000|Overall Study|Death|1|||
148706208|NCT00705666|536398012|FG000|Overall Study|Adverse Event|4|||
148706209|NCT00705666|536398012|FG000|Overall Study|Other|12|||
148706210|NCT00705666|536398012|FG000|Overall Study|Other|2|||
148706211|NCT00705666|536398012|FG000|Overall Study|Lack of data|3|||
148706212|NCT00705666|536398012|FG000|Overall Study|Untreated|5|||
148706213|NCT02105272|536398013|FG000|Overall Study|Adverse Event|1|||
148706214|NCT02105272|536398014|FG001|Overall Study|Adverse Event|2|||
148706215|NCT02105272|536398013|FG000|Overall Study|Physician Decision|0|||
148706216|NCT02105272|536398014|FG001|Overall Study|Physician Decision|1|||
148706217|NCT02105272|536398013|FG000|Overall Study|Protocol Violation|2|||
148706218|NCT02105272|536398014|FG001|Overall Study|Protocol Violation|0|||
148706219|NCT02105272|536398013|FG000|Overall Study|Withdrawal by Subject|2|||
148706220|NCT02105272|536398014|FG001|Overall Study|Withdrawal by Subject|0|||
148967903|NCT03792672|537368566|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
148706221|NCT02964039|536398022|FG000|Overall Study|Medical reason unrelated to study participation|1|||
148706222|NCT02964039|536398023|FG001|Overall Study|Medical reason unrelated to study participation|0|||
148706223|NCT02964039|536398024|FG002|Overall Study|Medical reason unrelated to study participation|3|||
148706224|NCT02964039|536398022|FG000|Overall Study|Research shutdown due to pandemic|2|||
148706225|NCT02964039|536398023|FG001|Overall Study|Research shutdown due to pandemic|0|||
148706226|NCT02964039|536398024|FG002|Overall Study|Research shutdown due to pandemic|1|||
148706227|NCT02964039|536398022|FG000|Overall Study|Withdrawal by Subject|0|||
148706228|NCT02964039|536398023|FG001|Overall Study|Withdrawal by Subject|1|||
148706229|NCT02964039|536398024|FG002|Overall Study|Withdrawal by Subject|0|||
148706230|NCT02964039|536398022|FG000|Overall Study|Lost to Follow-up|1|||
148706231|NCT02964039|536398023|FG001|Overall Study|Lost to Follow-up|0|||
148706232|NCT02964039|536398024|FG002|Overall Study|Lost to Follow-up|1|||
148706233|NCT05479058|536398025|FG000|Overall Study|Withdrawal by Subject|1|||
148706234|NCT05479058|536398026|FG001|Overall Study|Withdrawal by Subject|1|||
148706235|NCT05479058|536398025|FG000|Overall Study|Study terminated by sponsor|10|||
148706236|NCT05479058|536398026|FG001|Overall Study|Study terminated by sponsor|10|||
148706237|NCT05630885|536398027|FG000|Study Completion|Took prohibited medications|2|||
148706238|NCT05630885|536398028|FG001|Study Completion|Took prohibited medications|0|||
148706239|NCT05630885|536398027|FG000|Study Completion|Non-compliance with study drug|1|||
148706240|NCT05630885|536398028|FG001|Study Completion|Non-compliance with study drug|0|||
148706241|NCT05630885|536398027|FG000|Study Completion|Adverse Event|1|||
148706242|NCT05630885|536398028|FG001|Study Completion|Adverse Event|0|||
148706243|NCT05630885|536398027|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
148706244|NCT05630885|536398028|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
148706245|NCT05630885|536398027|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
148706246|NCT05630885|536398028|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
148706247|NCT01878292|536398029|FG000|Randomized|Protocol Violation|1|||
148706248|NCT01878292|536398030|FG001|Randomized|Protocol Violation|0|||
148706249|NCT01878292|536398031|FG002|Randomized|Protocol Violation|0|||
148706250|NCT01878292|536398029|FG000|Randomized|Lost to Follow-up|1|||
148706251|NCT01878292|536398030|FG001|Randomized|Lost to Follow-up|0|||
148706252|NCT01878292|536398031|FG002|Randomized|Lost to Follow-up|0|||
148706253|NCT01878292|536398029|FG000|Randomized|Adverse Event|1|||
148706254|NCT01878292|536398030|FG001|Randomized|Adverse Event|0|||
148706255|NCT01878292|536398031|FG002|Randomized|Adverse Event|0|||
148706256|NCT01878292|536398029|FG000|Double-blind Treatment Period|Other Reasons|2|||
148706257|NCT01878292|536398030|FG001|Double-blind Treatment Period|Other Reasons|0|||
148706258|NCT01878292|536398031|FG002|Double-blind Treatment Period|Other Reasons|0|||
148967904|NCT03792672|537368561|FG000|Treatment Period 4 (2 Days)|Other|1|||
148967905|NCT03792672|537368562|FG001|Treatment Period 4 (2 Days)|Other|0|||
148706259|NCT01878292|536398029|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
148706260|NCT01878292|536398030|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
148706261|NCT01878292|536398031|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
148706262|NCT01878292|536398029|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
148706263|NCT01878292|536398030|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
148706264|NCT01878292|536398031|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
148706265|NCT01878292|536398029|FG000|Double-blind Treatment Period|Protocol Violation|3|||
148706266|NCT01878292|536398030|FG001|Double-blind Treatment Period|Protocol Violation|4|||
148706267|NCT01878292|536398031|FG002|Double-blind Treatment Period|Protocol Violation|2|||
148706268|NCT01878292|536398029|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
148706269|NCT01878292|536398030|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
148706270|NCT01878292|536398031|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
148706271|NCT01878292|536398029|FG000|Double-blind Treatment Period|Adverse Event|4|||
148706272|NCT01878292|536398030|FG001|Double-blind Treatment Period|Adverse Event|9|||
148706273|NCT01878292|536398031|FG002|Double-blind Treatment Period|Adverse Event|8|||
148706274|NCT01878292|536398029|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
148706275|NCT01878292|536398030|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
148706276|NCT01878292|536398031|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
148706277|NCT00950989|536398032|FG000|Overall Study|Death|0|||
148706278|NCT00950989|536398033|FG001|Overall Study|Death|0|||
148706279|NCT00950989|536398034|FG002|Overall Study|Death|1|||
148706280|NCT00950989|536398035|FG003|Overall Study|Death|0|||
148706281|NCT00950989|536398032|FG000|Overall Study|Administrative Decision|0|||
148706282|NCT00950989|536398033|FG001|Overall Study|Administrative Decision|1|||
148706283|NCT00950989|536398034|FG002|Overall Study|Administrative Decision|0|||
148706284|NCT00950989|536398035|FG003|Overall Study|Administrative Decision|0|||
148706285|NCT00950989|536398032|FG000|Overall Study|Disease Progression|0|||
148706286|NCT00950989|536398033|FG001|Overall Study|Disease Progression|0|||
148706287|NCT00950989|536398034|FG002|Overall Study|Disease Progression|1|||
148706288|NCT00950989|536398035|FG003|Overall Study|Disease Progression|0|||
148706289|NCT00950989|536398032|FG000|Overall Study|Withdrawal by Subject|2|||
148706290|NCT00950989|536398033|FG001|Overall Study|Withdrawal by Subject|1|||
148706291|NCT00950989|536398034|FG002|Overall Study|Withdrawal by Subject|0|||
148706292|NCT00950989|536398035|FG003|Overall Study|Withdrawal by Subject|0|||
148706293|NCT00950989|536398032|FG000|Overall Study|Adverse Event|2|||
148706294|NCT00950989|536398033|FG001|Overall Study|Adverse Event|1|||
148706295|NCT00950989|536398034|FG002|Overall Study|Adverse Event|1|||
148706296|NCT00950989|536398035|FG003|Overall Study|Adverse Event|0|||
148706297|NCT01686477|536398036|FG000|Feeding Intervention|Death|1|||
148706298|NCT01686477|536398037|FG001|Feeding Intervention|Death|0|||
148706299|NCT01686477|536398038|FG002|Feeding Intervention|Death|1|||
148706300|NCT01686477|536398036|FG000|Feeding Intervention|Withdrawal by Subject|0|||
148706301|NCT01686477|536398037|FG001|Feeding Intervention|Withdrawal by Subject|6|||
148706302|NCT01686477|536398038|FG002|Feeding Intervention|Withdrawal by Subject|0|||
148706303|NCT01686477|536398036|FG000|Feeding Intervention|Physician Decision|1|||
148706304|NCT01686477|536398037|FG001|Feeding Intervention|Physician Decision|2|||
148706305|NCT01686477|536398038|FG002|Feeding Intervention|Physician Decision|0|||
148706306|NCT01686477|536398036|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
148706307|NCT01686477|536398037|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
148706308|NCT01686477|536398038|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
148706309|NCT01686477|536398036|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
148706310|NCT01686477|536398037|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
148706311|NCT01686477|536398038|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
148706312|NCT01686477|536398036|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
148706313|NCT01686477|536398037|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
148706314|NCT01686477|536398038|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
148706315|NCT01686477|536398036|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
148706316|NCT01686477|536398037|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
148706317|NCT01686477|536398038|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
148815221|NCT01047501|536799433|FG002|Overall Study|Investigator judgement|1|||
148815222|NCT04602000|536799434|FG000|Overall Study|Withdrawal by Subject|3|||
148706318|NCT01686477|536398036|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
148706319|NCT01686477|536398037|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
148706320|NCT01686477|536398038|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
148706321|NCT01686477|536398036|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
148706322|NCT01686477|536398037|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
148706323|NCT01686477|536398038|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
148706324|NCT01686477|536398036|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
148706325|NCT01686477|536398037|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
148706326|NCT01686477|536398038|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
148706327|NCT00813592|536398040|FG000|Overall Study|Disease assessment was not completed per|2|||
148706328|NCT03873272|536398043|FG000|Overall Study|Withdrawal by Subject|2|||
148706329|NCT03873272|536398044|FG001|Overall Study|Withdrawal by Subject|0|||
148706330|NCT03873272|536398045|FG002|Overall Study|Withdrawal by Subject|1|||
148706331|NCT03873272|536398043|FG000|Overall Study|Death|0|||
148706332|NCT03873272|536398044|FG001|Overall Study|Death|2|||
148706333|NCT03873272|536398045|FG002|Overall Study|Death|1|||
148706334|NCT04493684|536398046|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
148706335|NCT04493684|536398047|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706336|NCT04493684|536398048|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
148706337|NCT04493684|536398049|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706338|NCT04493684|536398050|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706339|NCT04493684|536398051|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
148706340|NCT04493684|536398052|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706341|NCT04493684|536398053|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706342|NCT04493684|536398054|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706343|NCT04493684|536398055|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706344|NCT04493684|536398056|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706345|NCT04493684|536398057|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706346|NCT04493684|536398058|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706347|NCT04493684|536398059|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706348|NCT04493684|536398060|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706349|NCT04493684|536398061|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706350|NCT04493684|536398062|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
148706351|NCT04493684|536398046|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
148706352|NCT04493684|536398047|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706353|NCT04493684|536398048|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706354|NCT04493684|536398049|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706355|NCT04493684|536398050|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706356|NCT04493684|536398051|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706357|NCT04493684|536398052|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706358|NCT04493684|536398053|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706359|NCT04493684|536398054|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706360|NCT04493684|536398055|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706361|NCT04493684|536398056|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706362|NCT04493684|536398057|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706363|NCT04493684|536398058|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706364|NCT04493684|536398059|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706365|NCT04493684|536398060|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706366|NCT04493684|536398061|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706367|NCT04493684|536398062|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
148706368|NCT04493684|536398046|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706369|NCT04493684|536398047|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706370|NCT04493684|536398048|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706371|NCT04493684|536398049|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706372|NCT04493684|536398050|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706373|NCT04493684|536398051|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706374|NCT04493684|536398052|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
148706375|NCT04493684|536398053|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706376|NCT04493684|536398054|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706377|NCT04493684|536398055|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706378|NCT04493684|536398056|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706379|NCT04493684|536398057|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706380|NCT04493684|536398058|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706381|NCT04493684|536398059|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706382|NCT04493684|536398060|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706383|NCT04493684|536398061|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706384|NCT04493684|536398062|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
148706385|NCT04493684|536398046|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
148706386|NCT04493684|536398047|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706387|NCT04493684|536398048|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148967906|NCT03792672|537368563|FG002|Treatment Period 4 (2 Days)|Other|0|||
148706388|NCT04493684|536398049|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706389|NCT04493684|536398050|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148967907|NCT03792672|537368564|FG003|Treatment Period 4 (2 Days)|Other|0|||
148706390|NCT04493684|536398051|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706391|NCT04493684|536398052|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706392|NCT04493684|536398053|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706393|NCT04493684|536398054|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706394|NCT04493684|536398055|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706395|NCT04493684|536398056|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706396|NCT04493684|536398057|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706397|NCT04493684|536398058|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706398|NCT04493684|536398059|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706399|NCT04493684|536398060|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706400|NCT04493684|536398061|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706401|NCT04493684|536398062|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
148706402|NCT04493684|536398046|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706403|NCT04493684|536398047|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706404|NCT04493684|536398048|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706405|NCT04493684|536398049|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706406|NCT04493684|536398050|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706407|NCT04493684|536398051|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
148706408|NCT04493684|536398052|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706409|NCT04493684|536398053|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706410|NCT04493684|536398054|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706411|NCT04493684|536398055|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706412|NCT04493684|536398056|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706413|NCT04493684|536398057|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706414|NCT04493684|536398058|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706415|NCT04493684|536398059|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706416|NCT04493684|536398060|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706417|NCT04493684|536398061|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706418|NCT04493684|536398062|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
148706419|NCT04493684|536398046|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706420|NCT04493684|536398047|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706421|NCT04493684|536398048|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706422|NCT04493684|536398049|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706423|NCT04493684|536398050|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706424|NCT04493684|536398051|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706425|NCT04493684|536398052|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706426|NCT04493684|536398053|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706427|NCT04493684|536398054|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706428|NCT04493684|536398055|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706429|NCT04493684|536398056|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706430|NCT04493684|536398057|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
148706431|NCT04493684|536398058|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706432|NCT04493684|536398059|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706433|NCT04493684|536398060|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706434|NCT04493684|536398061|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706435|NCT04493684|536398062|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
148706436|NCT04493684|536398046|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706437|NCT04493684|536398047|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706438|NCT04493684|536398048|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706439|NCT04493684|536398049|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706440|NCT04493684|536398050|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706441|NCT04493684|536398051|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706442|NCT04493684|536398052|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706443|NCT04493684|536398053|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706444|NCT04493684|536398054|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706445|NCT04493684|536398055|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706446|NCT04493684|536398056|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706447|NCT04493684|536398057|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706448|NCT04493684|536398058|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706449|NCT04493684|536398059|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706450|NCT04493684|536398060|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148815223|NCT04602000|536799435|FG001|Overall Study|Withdrawal by Subject|6|||
148967908|NCT03792672|537368565|FG004|Treatment Period 4 (2 Days)|Other|0|||
148706451|NCT04493684|536398061|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
148706452|NCT04493684|536398062|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
148706453|NCT04493684|536398046|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706454|NCT04493684|536398047|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706455|NCT04493684|536398048|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706456|NCT04493684|536398049|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706457|NCT04493684|536398050|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706458|NCT04493684|536398051|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706459|NCT04493684|536398052|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706460|NCT04493684|536398053|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706461|NCT04493684|536398054|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706462|NCT04493684|536398055|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706463|NCT04493684|536398056|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706464|NCT04493684|536398057|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706465|NCT04493684|536398058|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706466|NCT04493684|536398059|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706467|NCT04493684|536398060|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706468|NCT04493684|536398061|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
148706469|NCT04493684|536398062|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
148706470|NCT00859430|536398063|FG000|First Intervention|Withdrawal by Subject|0|||
148706471|NCT00859430|536398064|FG001|First Intervention|Withdrawal by Subject|1|||
148706472|NCT01660243|536399507|FG000|Overall Study|Adverse Event|1|||
148706473|NCT01660243|536399508|FG001|Overall Study|Adverse Event|0|||
148706474|NCT01660243|536399509|FG002|Overall Study|Adverse Event|1|||
148706475|NCT01660243|536399510|FG003|Overall Study|Adverse Event|0|||
148706476|NCT01660243|536399507|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
148706477|NCT01660243|536399508|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
148706478|NCT01660243|536399509|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
148706479|NCT01660243|536399510|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
148706480|NCT01660243|536399507|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
148706481|NCT01660243|536399508|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
148706482|NCT01660243|536399509|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
148706483|NCT01660243|536399510|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
148706484|NCT01660243|536399507|FG000|Overall Study|Randomization error|0|||
148706485|NCT01660243|536399508|FG001|Overall Study|Randomization error|0|||
148706486|NCT01660243|536399509|FG002|Overall Study|Randomization error|0|||
148706487|NCT01660243|536399510|FG003|Overall Study|Randomization error|1|||
148706488|NCT00712959|536399511|FG000|Overall Study|Protocol Violation|3|||
148706489|NCT00712959|536399512|FG001|Overall Study|Protocol Violation|1|||
148706490|NCT00712959|536399511|FG000|Overall Study|Lost to Follow-up|13|||
148706491|NCT00712959|536399512|FG001|Overall Study|Lost to Follow-up|2|||
148706492|NCT00712959|536399511|FG000|Overall Study|Withdrawal by Subject|3|||
148706493|NCT00712959|536399512|FG001|Overall Study|Withdrawal by Subject|0|||
148706494|NCT03049748|536399513|FG000|Overall Study|Lost to Follow-up|1|||
148706495|NCT03049748|536399514|FG001|Overall Study|Lost to Follow-up|0|||
148706496|NCT03049748|536399513|FG000|Overall Study|Death|3|||
148706497|NCT03049748|536399514|FG001|Overall Study|Death|0|||
148706498|NCT03049748|536399513|FG000|Overall Study|Withdrawal by Subject|0|||
148706499|NCT03049748|536399514|FG001|Overall Study|Withdrawal by Subject|3|||
148706500|NCT03049748|536399513|FG000|Overall Study|Protocol Violation|0|||
148706501|NCT03049748|536399514|FG001|Overall Study|Protocol Violation|2|||
148706502|NCT03049748|536399513|FG000|Overall Study|Moved out of state (relocation)|0|||
148706503|NCT03049748|536399514|FG001|Overall Study|Moved out of state (relocation)|1|||
148706504|NCT05014828|536399523|FG000|Overall Study|Study Completed by Sponsor|16|||
148706505|NCT05014828|536399524|FG001|Overall Study|Study Completed by Sponsor|16|||
148706506|NCT05014828|536399525|FG002|Overall Study|Study Completed by Sponsor|3|||
148706507|NCT05014828|536399526|FG003|Overall Study|Study Completed by Sponsor|3|||
148706508|NCT05014828|536399523|FG000|Overall Study|Death|11|||
148706509|NCT05014828|536399524|FG001|Overall Study|Death|6|||
148706510|NCT05014828|536399525|FG002|Overall Study|Death|0|||
148706511|NCT05014828|536399526|FG003|Overall Study|Death|0|||
148706512|NCT05014828|536399523|FG000|Overall Study|Lost to Follow-up|0|||
148706513|NCT05014828|536399524|FG001|Overall Study|Lost to Follow-up|0|||
148706514|NCT05014828|536399525|FG002|Overall Study|Lost to Follow-up|2|||
148706515|NCT05014828|536399526|FG003|Overall Study|Lost to Follow-up|0|||
148706516|NCT05014828|536399523|FG000|Overall Study|Miscellaneous.|0|||
148706517|NCT05014828|536399524|FG001|Overall Study|Miscellaneous.|1|||
148706518|NCT05014828|536399525|FG002|Overall Study|Miscellaneous.|0|||
148706519|NCT05014828|536399526|FG003|Overall Study|Miscellaneous.|0|||
148706520|NCT02682238|536399527|FG000|Overall Study|Lost to Follow-up|0|||
148706521|NCT02682238|536399528|FG001|Overall Study|Lost to Follow-up|2|||
148706522|NCT02682238|536399527|FG000|Overall Study|Withdrawal by Subject|1|||
148706523|NCT02682238|536399528|FG001|Overall Study|Withdrawal by Subject|0|||
148706524|NCT02682238|536399527|FG000|Overall Study|Adverse Event|1|||
148706525|NCT02682238|536399528|FG001|Overall Study|Adverse Event|0|||
148706526|NCT02682238|536399527|FG000|Overall Study|Non-compliance with Study Drug|1|||
148706527|NCT02682238|536399528|FG001|Overall Study|Non-compliance with Study Drug|0|||
148706528|NCT02682238|536399527|FG000|Overall Study|Non-compliance with Protocol|0|||
148706529|NCT02682238|536399528|FG001|Overall Study|Non-compliance with Protocol|2|||
148706530|NCT01370317|536399529|FG000|Overall Study|Participant withdrew consent|1|||
148706531|NCT01370317|536399530|FG001|Overall Study|Participant withdrew consent|0|||
148706532|NCT01370317|536399529|FG000|Overall Study|Protocol deviation|0|||
148706533|NCT01370317|536399530|FG001|Overall Study|Protocol deviation|1|||
148706534|NCT00075478|536399531|FG000|Overall Study|not eligible|1|||
148706535|NCT00075478|536399532|FG001|Overall Study|not eligible|0|||
148706536|NCT00075478|536399531|FG000|Overall Study|Physician Decision|0|||
148706537|NCT00075478|536399532|FG001|Overall Study|Physician Decision|1|||
148706538|NCT02075463|536399535|FG000|Overall Study|Adverse Event|3|||
148706539|NCT02075463|536399535|FG000|Overall Study|Par. reached stopping criteria|4|||
148706540|NCT02075463|536399535|FG000|Overall Study|Withdrawal by Subject|1|||
148706541|NCT00673660|536399536|FG000|Overall Study|Lost to Follow-up|107|||
148706542|NCT01527006|536399537|FG000|Core Study|Adverse Event|0|||
148706543|NCT01527006|536399538|FG001|Core Study|Adverse Event|2|||
148706544|NCT01527006|536399537|FG000|Core Study|Lost to Follow-up|0|||
148706545|NCT01527006|536399538|FG001|Core Study|Lost to Follow-up|1|||
148706546|NCT01527006|536399537|FG000|Core Study|Subject Choice|1|||
148706547|NCT01527006|536399538|FG001|Core Study|Subject Choice|0|||
148706548|NCT01527006|536399537|FG000|Core Study|Inadequate Therapeutic Effect|1|||
148706549|NCT01527006|536399538|FG001|Core Study|Inadequate Therapeutic Effect|0|||
148706550|NCT01527006|536399537|FG000|Core Study|Withdrawal by Subject|0|||
148706551|NCT01527006|536399538|FG001|Core Study|Withdrawal by Subject|1|||
148706552|NCT01527006|536399537|FG000|Core Study|Other|0|||
148706553|NCT01527006|536399538|FG001|Core Study|Other|2|||
148706554|NCT01527006|536399537|FG000|Extension Phase|Adverse Event|4|||
148706555|NCT01527006|536399538|FG001|Extension Phase|Adverse Event|2|||
148706556|NCT01527006|536399537|FG000|Extension Phase|Lost to Follow-up|0|||
148706557|NCT01527006|536399538|FG001|Extension Phase|Lost to Follow-up|1|||
148706558|NCT01527006|536399537|FG000|Extension Phase|Subject Choice|1|||
148706559|NCT01527006|536399538|FG001|Extension Phase|Subject Choice|1|||
148706560|NCT01527006|536399537|FG000|Extension Phase|Inadequate therapeutic effect|1|||
148706561|NCT01527006|536399538|FG001|Extension Phase|Inadequate therapeutic effect|1|||
148706562|NCT01527006|536399537|FG000|Extension Phase|Other|0|||
148706563|NCT01527006|536399538|FG001|Extension Phase|Other|3|||
148706564|NCT00824291|536399539|FG000|Overall Study|Adverse Event|15|||
148706565|NCT00824291|536399540|FG001|Overall Study|Adverse Event|6|||
148706566|NCT00824291|536399539|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
148706567|NCT00824291|536399540|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
148706568|NCT00824291|536399539|FG000|Overall Study|Lost to Follow-up|11|||
148706569|NCT00824291|536399540|FG001|Overall Study|Lost to Follow-up|9|||
148706570|NCT00824291|536399539|FG000|Overall Study|Non-compliance|1|||
148706571|NCT00824291|536399540|FG001|Overall Study|Non-compliance|1|||
148706572|NCT00824291|536399539|FG000|Overall Study|Protocol Violation|4|||
148706573|NCT00824291|536399540|FG001|Overall Study|Protocol Violation|1|||
148706574|NCT00824291|536399539|FG000|Overall Study|Withdrawal by Subject|14|||
148706575|NCT00824291|536399540|FG001|Overall Study|Withdrawal by Subject|8|||
148706576|NCT00824291|536399539|FG000|Overall Study|Lack of Efficacy|7|||
148706577|NCT00824291|536399540|FG001|Overall Study|Lack of Efficacy|8|||
148706578|NCT00824291|536399539|FG000|Overall Study|Participant on prohibited medication|1|||
148706579|NCT00824291|536399540|FG001|Overall Study|Participant on prohibited medication|0|||
148706580|NCT00933686|536399541|FG000|Overall Study|Protocol Violation|0|||
148706581|NCT00933686|536399542|FG001|Overall Study|Protocol Violation|1|||
148706582|NCT00933686|536399541|FG000|Overall Study|Lost to Follow-up|2|||
148706583|NCT00933686|536399542|FG001|Overall Study|Lost to Follow-up|2|||
148706584|NCT00933686|536399541|FG000|Overall Study|Withdrawal by Subject|6|||
148706585|NCT00933686|536399542|FG001|Overall Study|Withdrawal by Subject|5|||
148815224|NCT04602000|536799436|FG002|Overall Study|Withdrawal by Subject|3|||
148815225|NCT04602000|536799437|FG003|Overall Study|Withdrawal by Subject|27|||
148706586|NCT00933686|536399541|FG000|Overall Study|Adverse Event|1|||
148706587|NCT00933686|536399542|FG001|Overall Study|Adverse Event|1|||
148706588|NCT00933686|536399541|FG000|Overall Study|Physician Decision|1|||
148706589|NCT00933686|536399542|FG001|Overall Study|Physician Decision|0|||
148706590|NCT00933686|536399541|FG000|Overall Study|Failure to show up at endpoint visits|0|||
148706591|NCT00933686|536399542|FG001|Overall Study|Failure to show up at endpoint visits|2|||
148706592|NCT00123734|536399544|FG000|Overall Study|Death|3|||
148706593|NCT00123734|536399544|FG000|Overall Study|Lost to Follow-up|3|||
148706594|NCT00123734|536399544|FG000|Overall Study|Dropout|1|||
148706595|NCT00123734|536399544|FG000|Overall Study|Withdrawal by Subject|1|||
148706596|NCT00113386|536399545|FG000|Overall Study|Withdrawal by Subject|1|||
148706597|NCT00113386|536399546|FG001|Overall Study|Withdrawal by Subject|0|||
148706598|NCT00113386|536399545|FG000|Overall Study|Physician Decision|0|||
148706599|NCT00113386|536399546|FG001|Overall Study|Physician Decision|1|||
148706600|NCT00113386|536399545|FG000|Overall Study|Toxicity|3|||
148706601|NCT00113386|536399546|FG001|Overall Study|Toxicity|0|||
148706602|NCT00113386|536399545|FG000|Overall Study|Ineligible|1|||
148706603|NCT00113386|536399546|FG001|Overall Study|Ineligible|2|||
148706604|NCT00113386|536399545|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
148706605|NCT00113386|536399546|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
148706606|NCT01648582|536399547|FG000|Overall Study|Adverse Event|6|||
148706607|NCT01648582|536399548|FG001|Overall Study|Adverse Event|11|||
148706608|NCT01648582|536399549|FG002|Overall Study|Adverse Event|2|||
148706609|NCT01648582|536399547|FG000|Overall Study|Lost to Follow-up|9|||
148706610|NCT01648582|536399548|FG001|Overall Study|Lost to Follow-up|6|||
148706611|NCT01648582|536399549|FG002|Overall Study|Lost to Follow-up|8|||
148706612|NCT01648582|536399547|FG000|Overall Study|Protocol Violation|1|||
148706613|NCT01648582|536399548|FG001|Overall Study|Protocol Violation|2|||
148706614|NCT01648582|536399549|FG002|Overall Study|Protocol Violation|1|||
148706615|NCT01648582|536399547|FG000|Overall Study|Withdrawal by Subject|15|||
148706616|NCT01648582|536399548|FG001|Overall Study|Withdrawal by Subject|17|||
148706617|NCT01648582|536399549|FG002|Overall Study|Withdrawal by Subject|17|||
148706618|NCT01648582|536399547|FG000|Overall Study|Physician Decision|0|||
148706619|NCT01648582|536399548|FG001|Overall Study|Physician Decision|1|||
148706620|NCT01648582|536399549|FG002|Overall Study|Physician Decision|3|||
148706621|NCT01648582|536399547|FG000|Overall Study|Death|1|||
148706622|NCT01648582|536399548|FG001|Overall Study|Death|0|||
148706623|NCT01648582|536399549|FG002|Overall Study|Death|0|||
148706624|NCT01648582|536399547|FG000|Overall Study|Sponsor Decision|0|||
148706625|NCT01648582|536399548|FG001|Overall Study|Sponsor Decision|1|||
148706626|NCT01648582|536399549|FG002|Overall Study|Sponsor Decision|1|||
148706627|NCT04408794|536399550|FG000|Overall Study|Adverse Event|43|||
148706628|NCT04408794|536399550|FG000|Overall Study|Infrequent study drug usage|43|||
148706629|NCT04408794|536399550|FG000|Overall Study|Lack of Efficacy|61|||
148706630|NCT04408794|536399550|FG000|Overall Study|Lost to Follow-up|33|||
148706631|NCT04408794|536399550|FG000|Overall Study|Non-compliance|6|||
148706632|NCT04408794|536399550|FG000|Overall Study|Physician Decision|1|||
148706633|NCT04408794|536399550|FG000|Overall Study|Pregnancy|6|||
148706634|NCT04408794|536399550|FG000|Overall Study|Protocol Deviation|9|||
148706635|NCT04408794|536399550|FG000|Overall Study|Sheehan-STS Result|1|||
148706636|NCT04408794|536399550|FG000|Overall Study|Withdrawal by Subject|57|||
148706637|NCT04408794|536399550|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
148706638|NCT04408794|536399550|FG000|Overall Study|Never Treated Migraine|5|||
148706639|NCT02159183|536399551|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
148706640|NCT02159183|536399552|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
148706641|NCT02159183|536399551|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
148706642|NCT02159183|536399552|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
148706643|NCT02159183|536399551|FG000|Analysis After the 36 Months Follow-up|Death|0|||
148706644|NCT02159183|536399552|FG001|Analysis After the 36 Months Follow-up|Death|1|||
148706645|NCT02159183|536399551|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
148706646|NCT02159183|536399552|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
148706647|NCT02159183|536399551|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
148706648|NCT02159183|536399552|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
148706649|NCT01444378|536399558|FG000|Overall Study|Lost to Follow-up|1|||
148706650|NCT01444378|536399558|FG000|Overall Study|Withdrawal by Subject|1|||
148706651|NCT01444378|536399558|FG000|Overall Study|Death|3|||
148706652|NCT01444378|536399558|FG000|Overall Study|Administrative Closure Of The Study|2|||
148706653|NCT01444378|536399558|FG000|Overall Study|Missed Visits|10|||
148706654|NCT01244620|536399559|FG000|Overall Study|Study terminated|4|||
148706655|NCT01244620|536399560|FG001|Overall Study|Study terminated|4|||
148706656|NCT01244620|536399561|FG002|Overall Study|Study terminated|4|||
148815226|NCT04602000|536799438|FG004|Overall Study|Withdrawal by Subject|39|||
148967909|NCT03792672|537368566|FG005|Treatment Period 4 (2 Days)|Other|0|||
148967910|NCT00453999|537368567|FG000|Overall Study|Adverse Event|1|||
148967911|NCT00453999|537368568|FG001|Overall Study|Adverse Event|2|||
148967912|NCT00453999|537368569|FG002|Overall Study|Adverse Event|1|||
148706657|NCT01244620|536399562|FG003|Overall Study|Study terminated|4|||
148706658|NCT00840073|536399563|FG000|Second Intervention|Missed 72 hour blood draw|1|||
148706659|NCT00840073|536399564|FG001|Second Intervention|Missed 72 hour blood draw|1|||
148706660|NCT01663233|536399565|FG000|Overall Study|Withdrawal by Subject|3|||
148706661|NCT01663233|536399566|FG001|Overall Study|Withdrawal by Subject|2|||
148706662|NCT01663233|536399565|FG000|Overall Study|Protocol Deviation|1|||
148706663|NCT01663233|536399566|FG001|Overall Study|Protocol Deviation|4|||
148706664|NCT01663233|536399565|FG000|Overall Study|Lost to Follow-up|0|||
148706665|NCT01663233|536399566|FG001|Overall Study|Lost to Follow-up|1|||
148706666|NCT00556322|536399569|FG000|Overall Study|Insufficient therapeutic response|158|||
148815227|NCT04602000|536799434|FG000|Overall Study|Physician Decision|1|||
148706667|NCT00556322|536399570|FG001|Overall Study|Insufficient therapeutic response|168|||
148706668|NCT00556322|536399569|FG000|Overall Study|Adverse Event|7|||
148706669|NCT00556322|536399570|FG001|Overall Study|Adverse Event|4|||
148706670|NCT00556322|536399569|FG000|Overall Study|Other|4|||
148706671|NCT00556322|536399570|FG001|Overall Study|Other|1|||
148706672|NCT00556322|536399569|FG000|Overall Study|Lost to Follow-up|5|||
148706673|NCT00556322|536399570|FG001|Overall Study|Lost to Follow-up|3|||
148706674|NCT00556322|536399569|FG000|Overall Study|Withdrawal by Subject|19|||
148706675|NCT00556322|536399570|FG001|Overall Study|Withdrawal by Subject|7|||
148706676|NCT00556322|536399569|FG000|Overall Study|Protocol Violation|5|||
148706677|NCT00556322|536399570|FG001|Overall Study|Protocol Violation|1|||
148706678|NCT00556322|536399569|FG000|Overall Study|Ongoing at data cutoff|3|||
148706679|NCT00556322|536399570|FG001|Overall Study|Ongoing at data cutoff|5|||
148706680|NCT00556322|536399569|FG000|Overall Study|Death|20|||
148706681|NCT00556322|536399570|FG001|Overall Study|Death|14|||
148706682|NCT03249454|536399571|FG000|Overall Study|Withdrawal by Subject|0|||
148706683|NCT03249454|536399572|FG001|Overall Study|Withdrawal by Subject|0|||
148706684|NCT03249454|536399573|FG002|Overall Study|Withdrawal by Subject|0|||
148706685|NCT03249454|536399574|FG003|Overall Study|Withdrawal by Subject|0|||
148706686|NCT03249454|536399575|FG004|Overall Study|Withdrawal by Subject|0|||
148706687|NCT03249454|536399576|FG005|Overall Study|Withdrawal by Subject|0|||
148706688|NCT03249454|536399577|FG006|Overall Study|Withdrawal by Subject|0|||
148706689|NCT03249454|536399578|FG007|Overall Study|Withdrawal by Subject|0|||
148706690|NCT03249454|536399579|FG008|Overall Study|Withdrawal by Subject|0|||
148706691|NCT03249454|536399580|FG009|Overall Study|Withdrawal by Subject|1|||
148706692|NCT03249454|536399581|FG010|Overall Study|Withdrawal by Subject|1|||
148706693|NCT01913405|536399582|FG000|Overall Study|Withdrawal by Subject|1|||
148706694|NCT01913405|536399582|FG000|Overall Study|Adverse Event|1|||
148706695|NCT03261167|536399585|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
148706696|NCT03261167|536399586|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
148706697|NCT03261167|536399585|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
148706698|NCT03261167|536399586|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
148706699|NCT03261167|536399585|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
148706700|NCT03261167|536399586|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
148706701|NCT03261167|536399585|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
148706702|NCT03261167|536399586|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
148706703|NCT03261167|536399585|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
148706704|NCT03261167|536399586|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
148706705|NCT01103713|536399593|FG000|Overall Study|Lost to Follow-up|2|||
148706706|NCT01103713|536399593|FG000|Overall Study|Withdrawal by Subject|8|||
148706707|NCT01103713|536399593|FG000|Overall Study|Study terminated by sponsor|2|||
148706708|NCT01103713|536399593|FG000|Overall Study|Other|1|||
148706709|NCT01929863|536399598|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
148706710|NCT01929863|536399599|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
148706711|NCT01929863|536399598|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
148706712|NCT01929863|536399599|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
148706713|NCT01929863|536399598|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
148706714|NCT01929863|536399599|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
148706715|NCT00251979|536399600|FG000|Overall Study|Protocol Violation|3|||
148706716|NCT00251979|536399601|FG001|Overall Study|Protocol Violation|5|||
148706717|NCT00251979|536399600|FG000|Overall Study|Adverse Event|11|||
148706718|NCT00251979|536399601|FG001|Overall Study|Adverse Event|17|||
148706719|NCT00251979|536399600|FG000|Overall Study|Withdrawal by Subject|13|||
148706720|NCT00251979|536399601|FG001|Overall Study|Withdrawal by Subject|7|||
148706721|NCT00251979|536399600|FG000|Overall Study|Lost to Follow-up|8|||
148706722|NCT00251979|536399601|FG001|Overall Study|Lost to Follow-up|6|||
148706723|NCT00251979|536399600|FG000|Overall Study|Death|3|||
148706724|NCT00251979|536399601|FG001|Overall Study|Death|5|||
148706725|NCT00323882|536399607|FG000|Overall Study|Adverse Event|2|||
148706726|NCT00323882|536399608|FG001|Overall Study|Adverse Event|1|||
148706727|NCT00323882|536399609|FG002|Overall Study|Adverse Event|1|||
148706728|NCT00323882|536399610|FG003|Overall Study|Adverse Event|1|||
148706729|NCT00323882|536399611|FG004|Overall Study|Adverse Event|3|||
148706730|NCT00323882|536399607|FG000|Overall Study|Disease Progression|6|||
148706731|NCT00323882|536399608|FG001|Overall Study|Disease Progression|4|||
148706732|NCT00323882|536399609|FG002|Overall Study|Disease Progression|10|||
148706733|NCT00323882|536399610|FG003|Overall Study|Disease Progression|5|||
148706734|NCT00323882|536399611|FG004|Overall Study|Disease Progression|22|||
148706735|NCT00323882|536399607|FG000|Overall Study|Death|0|||
148706736|NCT00323882|536399608|FG001|Overall Study|Death|1|||
148706737|NCT00323882|536399609|FG002|Overall Study|Death|1|||
148706738|NCT00323882|536399610|FG003|Overall Study|Death|0|||
148706739|NCT00323882|536399611|FG004|Overall Study|Death|5|||
148706740|NCT00323882|536399607|FG000|Overall Study|Lost to Follow-up|0|||
148706741|NCT00323882|536399608|FG001|Overall Study|Lost to Follow-up|0|||
148706742|NCT00323882|536399609|FG002|Overall Study|Lost to Follow-up|1|||
148706743|NCT00323882|536399610|FG003|Overall Study|Lost to Follow-up|0|||
148706744|NCT00323882|536399611|FG004|Overall Study|Lost to Follow-up|1|||
148706745|NCT00323882|536399607|FG000|Overall Study|Other|0|||
148706746|NCT00323882|536399608|FG001|Overall Study|Other|0|||
148706747|NCT00323882|536399609|FG002|Overall Study|Other|0|||
148706748|NCT00323882|536399610|FG003|Overall Study|Other|1|||
148706749|NCT00323882|536399611|FG004|Overall Study|Other|1|||
148706750|NCT00835536|536399612|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
148706751|NCT00835536|536399613|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
148706752|NCT00429416|536399616|FG000|Overall Study|Death|1|||
148706753|NCT04544410|536399618|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
148706754|NCT04544410|536399619|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
148706755|NCT04544410|536399618|FG000|Double-blind Treatment Period|Adverse Event|1|||
148706756|NCT04544410|536399619|FG001|Double-blind Treatment Period|Adverse Event|0|||
148706757|NCT04544410|536399618|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
148706758|NCT04544410|536399619|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
148706759|NCT04544410|536399618|FG000|Double-blind Treatment Period|Protocol Violation|1|||
148706760|NCT04544410|536399619|FG001|Double-blind Treatment Period|Protocol Violation|0|||
148706761|NCT04544410|536399618|FG000|Open-Label Treatment Period|Study Terminated|15|||
148706762|NCT04544410|536399619|FG001|Open-Label Treatment Period|Study Terminated|19|||
148706763|NCT04544410|536399618|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
148706764|NCT04544410|536399619|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
148706765|NCT04544410|536399618|FG000|Open-Label Treatment Period|Adverse Event|0|||
148706766|NCT04544410|536399619|FG001|Open-Label Treatment Period|Adverse Event|1|||
148706767|NCT04544410|536399618|FG000|Open-Label Treatment Period|Physician Decision|1|||
148706768|NCT04544410|536399619|FG001|Open-Label Treatment Period|Physician Decision|0|||
148706769|NCT04544410|536399618|FG000|Open-Label Treatment Period|Other|0|||
148706770|NCT04544410|536399619|FG001|Open-Label Treatment Period|Other|1|||
148706771|NCT02430480|536399620|FG000|Overall Study|Death|1|||
148706772|NCT02430480|536399620|FG000|Overall Study|Anesthesia concerns|1|||
148706773|NCT02430480|536399620|FG000|Overall Study|Progressed on treatment|1|||
148706774|NCT01963728|536399625|FG000|Overall Study|Study terminated early|0|||
148706775|NCT01963728|536399626|FG001|Overall Study|Study terminated early|1|||
148706776|NCT05152576|536399629|FG000|Overall Study|Lost to Follow-up|3|||
148706777|NCT05152576|536399630|FG001|Overall Study|Lost to Follow-up|0|||
148706778|NCT05152576|536399631|FG002|Overall Study|Lost to Follow-up|0|||
148706779|NCT05152576|536399632|FG003|Overall Study|Lost to Follow-up|1|||
148706780|NCT05152576|536399629|FG000|Overall Study|Withdrawal by Subject|0|||
148706781|NCT05152576|536399630|FG001|Overall Study|Withdrawal by Subject|1|||
148706782|NCT05152576|536399631|FG002|Overall Study|Withdrawal by Subject|0|||
148706783|NCT05152576|536399632|FG003|Overall Study|Withdrawal by Subject|1|||
148706784|NCT05152576|536399629|FG000|Overall Study|Other|2|||
148706785|NCT05152576|536399630|FG001|Overall Study|Other|0|||
148706786|NCT05152576|536399631|FG002|Overall Study|Other|0|||
148706787|NCT05152576|536399632|FG003|Overall Study|Other|0|||
148706788|NCT02328040|536400854|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
148706789|NCT02328040|536400855|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
148706790|NCT03246503|536400858|FG000|Overall Study|Lost to Follow-up|23|||
148706791|NCT03246503|536400858|FG000|Overall Study|Withdrawal by Subject|20|||
148706792|NCT03246503|536400858|FG000|Overall Study|Physician Decision|5|||
148815228|NCT04602000|536799435|FG001|Overall Study|Physician Decision|0|||
148815229|NCT04602000|536799436|FG002|Overall Study|Physician Decision|0|||
148815230|NCT04602000|536799437|FG003|Overall Study|Physician Decision|2|||
148815231|NCT04602000|536799438|FG004|Overall Study|Physician Decision|2|||
148706793|NCT03246503|536400858|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
148706794|NCT00796328|536400861|FG000|Overall Study|experienced hypotension requiring tx|6|||
148706795|NCT03669861|536400864|FG000|Overall Study|Disease Flare|5|||
148706796|NCT03669861|536400864|FG000|Overall Study|Lack of Efficacy|2|||
148706797|NCT02760927|536400865|FG000|Overall Study|Tube Slippage from Device|1|||
148706798|NCT03256695|536400866|FG000|Overall Study|Adverse Event|8|||
148706799|NCT03256695|536400866|FG000|Overall Study|Death|2|||
148706800|NCT03256695|536400866|FG000|Overall Study|Withdrawal by Subject|14|||
148706801|NCT03256695|536400866|FG000|Overall Study|Non-compliance with study drug|1|||
148706802|NCT03256695|536400866|FG000|Overall Study|Lost to Follow-up|3|||
148706803|NCT03256695|536400866|FG000|Overall Study|Lack of Efficacy|3|||
148706804|NCT03256695|536400866|FG000|Overall Study|Protocol Violation|5|||
148706805|NCT03256695|536400866|FG000|Overall Study|Other than specified|3|||
148706806|NCT02645409|536400867|FG000|Overall Study|Withdrawal by Subject|3|||
148706807|NCT02645409|536400868|FG001|Overall Study|Withdrawal by Subject|0|||
148706808|NCT02645409|536400867|FG000|Overall Study|Physician Decision|1|||
148706809|NCT02645409|536400868|FG001|Overall Study|Physician Decision|0|||
148706810|NCT02089685|536400871|FG000|Overall Study|Adverse Event|1|||
148815232|NCT04602000|536799434|FG000|Overall Study|Death|0|||
148815233|NCT04602000|536799435|FG001|Overall Study|Death|1|||
148815234|NCT04602000|536799436|FG002|Overall Study|Death|0|||
148815235|NCT04602000|536799437|FG003|Overall Study|Death|1|||
148706811|NCT02089685|536400872|FG001|Overall Study|Adverse Event|0|||
148706812|NCT02089685|536400873|FG002|Overall Study|Adverse Event|0|||
148706813|NCT02089685|536400874|FG003|Overall Study|Adverse Event|0|||
148706814|NCT02089685|536400875|FG004|Overall Study|Adverse Event|1|||
148706815|NCT02089685|536400876|FG005|Overall Study|Adverse Event|0|||
148706816|NCT02089685|536400871|FG000|Overall Study|Clinical Progression|4|||
148706817|NCT02089685|536400872|FG001|Overall Study|Clinical Progression|0|||
148706818|NCT02089685|536400873|FG002|Overall Study|Clinical Progression|0|||
148706819|NCT02089685|536400874|FG003|Overall Study|Clinical Progression|5|||
148706820|NCT02089685|536400875|FG004|Overall Study|Clinical Progression|1|||
148706821|NCT02089685|536400876|FG005|Overall Study|Clinical Progression|2|||
148706822|NCT02089685|536400871|FG000|Overall Study|Excluded Medication|1|||
148706823|NCT02089685|536400872|FG001|Overall Study|Excluded Medication|0|||
148706824|NCT02089685|536400873|FG002|Overall Study|Excluded Medication|0|||
148706825|NCT02089685|536400874|FG003|Overall Study|Excluded Medication|11|||
148706826|NCT02089685|536400875|FG004|Overall Study|Excluded Medication|2|||
148706827|NCT02089685|536400876|FG005|Overall Study|Excluded Medication|1|||
148706828|NCT02089685|536400871|FG000|Overall Study|Progressive disease|13|||
148706829|NCT02089685|536400872|FG001|Overall Study|Progressive disease|10|||
148706830|NCT02089685|536400873|FG002|Overall Study|Progressive disease|3|||
148706831|NCT02089685|536400874|FG003|Overall Study|Progressive disease|51|||
148706832|NCT02089685|536400875|FG004|Overall Study|Progressive disease|17|||
148706833|NCT02089685|536400876|FG005|Overall Study|Progressive disease|12|||
148706834|NCT02089685|536400871|FG000|Overall Study|Follow up ended by sponsor|2|||
148706835|NCT02089685|536400872|FG001|Overall Study|Follow up ended by sponsor|2|||
148706836|NCT02089685|536400873|FG002|Overall Study|Follow up ended by sponsor|0|||
148706837|NCT02089685|536400874|FG003|Overall Study|Follow up ended by sponsor|70|||
148706838|NCT02089685|536400875|FG004|Overall Study|Follow up ended by sponsor|26|||
148706839|NCT02089685|536400876|FG005|Overall Study|Follow up ended by sponsor|26|||
148706840|NCT02089685|536400871|FG000|Overall Study|Withdrawal by Subject|0|||
148706841|NCT02089685|536400872|FG001|Overall Study|Withdrawal by Subject|2|||
148706842|NCT02089685|536400873|FG002|Overall Study|Withdrawal by Subject|0|||
148706843|NCT02089685|536400874|FG003|Overall Study|Withdrawal by Subject|8|||
148706844|NCT02089685|536400875|FG004|Overall Study|Withdrawal by Subject|1|||
148706845|NCT02089685|536400876|FG005|Overall Study|Withdrawal by Subject|1|||
148706846|NCT02089685|536400871|FG000|Overall Study|Status not recorded|1|||
148706847|NCT02089685|536400872|FG001|Overall Study|Status not recorded|0|||
148706848|NCT02089685|536400873|FG002|Overall Study|Status not recorded|0|||
148706849|NCT02089685|536400874|FG003|Overall Study|Status not recorded|0|||
148706850|NCT02089685|536400875|FG004|Overall Study|Status not recorded|1|||
148706851|NCT02089685|536400876|FG005|Overall Study|Status not recorded|0|||
148706852|NCT02089685|536400871|FG000|Overall Study|Death|0|||
148706853|NCT02089685|536400872|FG001|Overall Study|Death|0|||
148706854|NCT02089685|536400873|FG002|Overall Study|Death|0|||
148706855|NCT02089685|536400874|FG003|Overall Study|Death|7|||
148706856|NCT02089685|536400875|FG004|Overall Study|Death|2|||
148706857|NCT02089685|536400876|FG005|Overall Study|Death|5|||
148706858|NCT02089685|536400871|FG000|Overall Study|Lost to Follow-up|0|||
148706859|NCT02089685|536400872|FG001|Overall Study|Lost to Follow-up|0|||
148706860|NCT02089685|536400873|FG002|Overall Study|Lost to Follow-up|0|||
148706861|NCT02089685|536400874|FG003|Overall Study|Lost to Follow-up|1|||
148706862|NCT02089685|536400875|FG004|Overall Study|Lost to Follow-up|0|||
148706863|NCT02089685|536400876|FG005|Overall Study|Lost to Follow-up|0|||
148706864|NCT02089685|536400871|FG000|Overall Study|Physician Decision|0|||
148706865|NCT02089685|536400872|FG001|Overall Study|Physician Decision|0|||
148706866|NCT02089685|536400873|FG002|Overall Study|Physician Decision|0|||
148706867|NCT02089685|536400874|FG003|Overall Study|Physician Decision|0|||
148706868|NCT02089685|536400875|FG004|Overall Study|Physician Decision|0|||
148706869|NCT02089685|536400876|FG005|Overall Study|Physician Decision|4|||
148706870|NCT02089685|536400871|FG000|Overall Study|Screen failure|1|||
148706871|NCT02089685|536400872|FG001|Overall Study|Screen failure|0|||
148706872|NCT02089685|536400873|FG002|Overall Study|Screen failure|0|||
148706873|NCT02089685|536400874|FG003|Overall Study|Screen failure|0|||
148706874|NCT02089685|536400875|FG004|Overall Study|Screen failure|0|||
148706875|NCT02089685|536400876|FG005|Overall Study|Screen failure|0|||
148706876|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Adverse Event|11|||
148706877|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Adverse Event|23|||
148706878|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Adverse Event|29|||
148706879|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Adverse Event|2|||
148706880|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Adverse Event|8|||
148706881|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
148706882|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
148706883|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
148706884|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
148706885|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
148706886|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
148706887|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
148706888|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
148706889|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
148706890|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
148706891|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
148706892|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
148706893|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
148706894|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
148706895|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
148706896|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
148706897|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
148706898|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
148706899|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
148706900|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
148706901|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
148706902|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
148706903|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
148706904|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
148706905|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
148706906|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
148706907|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
148706908|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
148706909|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
148706910|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
148706911|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Move|0|||
148706912|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Move|1|||
148706913|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Move|0|||
148706914|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Move|0|||
148706915|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Move|0|||
148706916|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
148706917|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
148706918|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
148706919|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
148706920|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
148706921|NCT00318461|536400879|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
148706922|NCT00318461|536400880|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
148706923|NCT00318461|536400881|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
148706924|NCT00318461|536400882|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
148706925|NCT00318461|536400883|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
148706926|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Work commitment|0|||
148706927|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Work commitment|0|||
148706928|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Work commitment|0|||
148706929|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Work commitment|0|||
148706930|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Work commitment|1|||
148706931|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Investigator decision|0|||
148967913|NCT00453999|537368567|FG000|Overall Study|Lost to Follow-up|0|||
148706932|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Investigator decision|0|||
148706933|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Investigator decision|0|||
148706934|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Investigator decision|0|||
148706935|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Investigator decision|1|||
148706936|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Lack of time|1|||
148706937|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Lack of time|0|||
148706938|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Lack of time|0|||
148706939|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Lack of time|0|||
148706940|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Lack of time|0|||
148706941|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
148706942|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
148706943|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
148706944|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
148706945|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
148706946|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
148706947|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
148706948|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
148706949|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
148967914|NCT00453999|537368568|FG001|Overall Study|Lost to Follow-up|1|||
148967915|NCT00453999|537368569|FG002|Overall Study|Lost to Follow-up|1|||
148967916|NCT00453999|537368567|FG000|Overall Study|Withdrawal by Subject|2|||
148706950|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
148706951|NCT00318461|536400879|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
148967917|NCT00453999|537368568|FG001|Overall Study|Withdrawal by Subject|1|||
148706952|NCT00318461|536400880|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
148706953|NCT00318461|536400881|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
148815236|NCT04602000|536799438|FG004|Overall Study|Death|2|||
148967918|NCT00453999|537368569|FG002|Overall Study|Withdrawal by Subject|1|||
148706954|NCT00318461|536400882|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
148706955|NCT00318461|536400883|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
148706956|NCT00318461|536400879|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
148706957|NCT00318461|536400880|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
148706958|NCT00318461|536400881|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
148706959|NCT00318461|536400882|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
148706960|NCT00318461|536400883|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
148706961|NCT00318461|536400879|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
148706962|NCT00318461|536400880|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
148706963|NCT00318461|536400881|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
148706964|NCT00318461|536400882|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
148706965|NCT00318461|536400883|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
148706966|NCT00318461|536400879|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
148706967|NCT00318461|536400880|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
148706968|NCT00318461|536400881|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
148706969|NCT00318461|536400882|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
148706970|NCT00318461|536400883|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
148706971|NCT00318461|536400879|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
148706972|NCT00318461|536400880|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
148706973|NCT00318461|536400881|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
148706974|NCT00318461|536400882|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
148706975|NCT00318461|536400883|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
148706976|NCT00318461|536400879|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
148706977|NCT00318461|536400880|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
148706978|NCT00318461|536400881|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
148706979|NCT00318461|536400882|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
148706980|NCT00318461|536400883|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
148706981|NCT03084471|536400889|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
148706982|NCT03084471|536400889|FG000|Overall Study|Condition under investigation worsened|84|||
148706983|NCT03084471|536400889|FG000|Overall Study|Lack of therapeutic response|2|||
148706984|NCT03084471|536400889|FG000|Overall Study|Protocol Violation|1|||
148706985|NCT03084471|536400889|FG000|Overall Study|Adverse Event|73|||
148706986|NCT03084471|536400889|FG000|Overall Study|Withdrawal by Subject|12|||
148706987|NCT03084471|536400889|FG000|Overall Study|Disease relapse|181|||
148706988|NCT03084471|536400889|FG000|Overall Study|Subjective disease progression|359|||
148706989|NCT03084471|536400889|FG000|Overall Study|Other (as recorded)|33|||
148706990|NCT03084471|536400889|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
148706991|NCT00505622|536400890|FG000|Overall Study|Adverse Event|5|||
148706992|NCT00505622|536400891|FG001|Overall Study|Adverse Event|6|||
148706993|NCT00505622|536400892|FG002|Overall Study|Adverse Event|4|||
148706994|NCT00505622|536400890|FG000|Overall Study|Protocol Violation|1|||
148706995|NCT00505622|536400891|FG001|Overall Study|Protocol Violation|1|||
148706996|NCT00505622|536400892|FG002|Overall Study|Protocol Violation|0|||
148706997|NCT00505622|536400890|FG000|Overall Study|Withdrawal by Subject|0|||
148706998|NCT00505622|536400891|FG001|Overall Study|Withdrawal by Subject|3|||
148706999|NCT00505622|536400892|FG002|Overall Study|Withdrawal by Subject|2|||
148707000|NCT00505622|536400890|FG000|Overall Study|Study termination by sponsor|115|||
148707001|NCT00505622|536400891|FG001|Overall Study|Study termination by sponsor|98|||
148707002|NCT00505622|536400892|FG002|Overall Study|Study termination by sponsor|90|||
148707003|NCT01848938|536400903|FG000|Overall Study|Lost to Follow-up|1|||
148707004|NCT01848938|536400904|FG001|Overall Study|Lost to Follow-up|1|||
148707005|NCT01757392|536400905|FG000|Overall Study|Withdrawal by Subject|1|||
148707006|NCT01757392|536400905|FG000|Overall Study|Screen Fail|3|||
148707007|NCT00207090|536400910|FG000|Overall Study|Study drug toxicity|3|||
148707008|NCT00207090|536400910|FG000|Overall Study|Chest wall mass larger|1|||
148707009|NCT00207090|536400910|FG000|Overall Study|Disease progression/relapse|2|||
148707010|NCT00207090|536400910|FG000|Overall Study|Physician Decision|1|||
148707011|NCT00841698|536400913|FG000|First Intervention|Withdrawal by Subject|1|||
148707012|NCT00841698|536400914|FG001|First Intervention|Withdrawal by Subject|0|||
148707013|NCT00835692|536400915|FG000|First Intervention|Withdrawal by Subject|1|||
148707014|NCT00835692|536400916|FG001|First Intervention|Withdrawal by Subject|0|||
148707015|NCT04078022|536400921|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
148707016|NCT04078022|536400922|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
148707017|NCT00191815|536400923|FG000|Overall Study|Adverse Event|2|||
148707018|NCT00191815|536400923|FG000|Overall Study|Disease progression or relapse|24|||
148707019|NCT00191815|536400923|FG000|Overall Study|Death|2|||
148707020|NCT00191815|536400923|FG000|Overall Study|Protocol Violation|3|||
148707021|NCT00191815|536400923|FG000|Overall Study|Physician Decision|2|||
148707022|NCT00191815|536400923|FG000|Overall Study|Withdrawal by Subject|7|||
148707023|NCT03644550|536400924|FG000|Overall Study|Withdrawal by Subject|3|||
148815237|NCT04602000|536799434|FG000|Overall Study|Lost to Follow-up|0|||
148967919|NCT00453999|537368567|FG000|Overall Study|Subject Request|2|||
148967920|NCT00453999|537368568|FG001|Overall Study|Subject Request|1|||
148967921|NCT00453999|537368569|FG002|Overall Study|Subject Request|0|||
148967922|NCT04238728|537368579|FG000|Overall Study|Withdrawal by Subject|1|||
148967923|NCT04238728|537368579|FG000|Overall Study|Lost to Follow-up|2|||
148707024|NCT03644550|536400924|FG000|Overall Study|Progressive disease|15|||
148707025|NCT01348789|536400927|FG000|Overall Study|Protocol Violation|2|||
148707026|NCT01348789|536400927|FG000|Overall Study|Withdrawal by Subject|2|||
148707027|NCT00830024|536400932|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
148707028|NCT00830024|536400933|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
148707029|NCT01983969|536400934|FG000|Overall Study|Disease Progression|0|||
148707030|NCT01983969|536400935|FG001|Overall Study|Disease Progression|1|||
148707031|NCT01983969|536400936|FG002|Overall Study|Disease Progression|0|||
148707032|NCT02619682|536400937|FG000|Overall Study|Withdrawal by Subject|3|||
148707033|NCT02619682|536400937|FG000|Overall Study|Lack of Efficacy|8|||
148707034|NCT02619682|536400937|FG000|Overall Study|new secondary cancer|1|||
148707035|NCT02619682|536400937|FG000|Overall Study|post surgery complications|2|||
148707036|NCT00268203|536400938|FG000|Overall Study|Lost to Follow-up|92|||
148707037|NCT00268203|536400938|FG000|Overall Study|Withdrawal by Subject|9|||
148707038|NCT00268203|536400938|FG000|Overall Study|Received Other NHL Therapy|7|||
148707039|NCT00268203|536400938|FG000|Overall Study|Progressive Disease|359|||
148707040|NCT00268203|536400938|FG000|Overall Study|Death|84|||
148707041|NCT00268203|536400938|FG000|Overall Study|Reason Not Specified|34|||
148707042|NCT00268203|536400938|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
148707043|NCT03600376|536400939|FG000|Overall Study|Adverse Event|1|||
148707044|NCT03600376|536400940|FG001|Overall Study|Adverse Event|1|||
148707045|NCT03600376|536400939|FG000|Overall Study|Transferred to other facility|1|||
148707046|NCT03600376|536400940|FG001|Overall Study|Transferred to other facility|0|||
148707047|NCT03600376|536400939|FG000|Overall Study|Investigator Decision|0|||
148707048|NCT03600376|536400940|FG001|Overall Study|Investigator Decision|4|||
148707049|NCT03600376|536400939|FG000|Overall Study|Determined to be ineligible for study|0|||
148707050|NCT03600376|536400940|FG001|Overall Study|Determined to be ineligible for study|1|||
148707051|NCT03804983|536400941|FG000|Overall Study|Adverse Event|0|||
148707052|NCT03804983|536400942|FG001|Overall Study|Adverse Event|1|||
148707053|NCT03804983|536400941|FG000|Overall Study|Family Obligation|1|||
148707054|NCT03804983|536400942|FG001|Overall Study|Family Obligation|0|||
148707055|NCT02358538|536400943|FG000|Through Week 26|Adverse Event|0|||
148707056|NCT02358538|536400944|FG001|Through Week 26|Adverse Event|1|||
148707057|NCT02358538|536400945|FG002|Through Week 26|Adverse Event|1|||
148707058|NCT02358538|536400946|FG003|Through Week 26|Adverse Event|2|||
148707059|NCT02358538|536400943|FG000|Through Week 26|Lack of Efficacy|1|||
148707060|NCT02358538|536400944|FG001|Through Week 26|Lack of Efficacy|1|||
148707061|NCT02358538|536400945|FG002|Through Week 26|Lack of Efficacy|3|||
148707062|NCT02358538|536400946|FG003|Through Week 26|Lack of Efficacy|3|||
148707063|NCT02358538|536400943|FG000|Through Week 26|Withdrawal by Subject|1|||
148707064|NCT02358538|536400944|FG001|Through Week 26|Withdrawal by Subject|0|||
148707065|NCT02358538|536400945|FG002|Through Week 26|Withdrawal by Subject|0|||
148707066|NCT02358538|536400946|FG003|Through Week 26|Withdrawal by Subject|0|||
148707067|NCT02358538|536400943|FG000|Through Week 26|Non-Compliance|0|||
148707068|NCT02358538|536400944|FG001|Through Week 26|Non-Compliance|0|||
148707069|NCT02358538|536400945|FG002|Through Week 26|Non-Compliance|1|||
148707070|NCT02358538|536400946|FG003|Through Week 26|Non-Compliance|0|||
148707071|NCT02358538|536400943|FG000|Through Week 26|Family did not see benefit from IP|1|||
148707072|NCT02358538|536400944|FG001|Through Week 26|Family did not see benefit from IP|0|||
148967924|NCT00743652|537368581|FG000|Overall Study|Parent/Legal Guardian Request|3|||
148967925|NCT00743652|537368582|FG001|Overall Study|Parent/Legal Guardian Request|2|||
148967926|NCT00743652|537368583|FG002|Overall Study|Parent/Legal Guardian Request|2|||
148967927|NCT00743652|537368584|FG003|Overall Study|Parent/Legal Guardian Request|2|||
148967928|NCT00743652|537368585|FG004|Overall Study|Parent/Legal Guardian Request|0|||
148967929|NCT00743652|537368581|FG000|Overall Study|Adverse Event|3|||
148967930|NCT00743652|537368582|FG001|Overall Study|Adverse Event|0|||
148967931|NCT00743652|537368583|FG002|Overall Study|Adverse Event|0|||
148967932|NCT00743652|537368584|FG003|Overall Study|Adverse Event|0|||
148967933|NCT00743652|537368585|FG004|Overall Study|Adverse Event|0|||
148707073|NCT02358538|536400945|FG002|Through Week 26|Family did not see benefit from IP|0|||
148707074|NCT02358538|536400946|FG003|Through Week 26|Family did not see benefit from IP|0|||
148707075|NCT02358538|536400943|FG000|52 Week Extension Period|Lack of Efficacy|0|||
148707076|NCT02358538|536400944|FG001|52 Week Extension Period|Lack of Efficacy|0|||
148707077|NCT02358538|536400945|FG002|52 Week Extension Period|Lack of Efficacy|2|||
148967934|NCT00743652|537368581|FG000|Overall Study|Death|2|||
148967935|NCT00743652|537368582|FG001|Overall Study|Death|0|||
148707078|NCT02358538|536400946|FG003|52 Week Extension Period|Lack of Efficacy|4|||
148707079|NCT06999265|536400947|FG000|Overall Study|Lost to Follow-up|1|||
148707080|NCT06999265|536400948|FG001|Overall Study|Lost to Follow-up|1|||
148707081|NCT00730691|536400949|FG000|Overall Study|Adverse Event|4|||
148707082|NCT00730691|536400950|FG001|Overall Study|Adverse Event|8|||
148707083|NCT00730691|536400951|FG002|Overall Study|Adverse Event|11|||
148707084|NCT00730691|536400952|FG003|Overall Study|Adverse Event|11|||
148707085|NCT00730691|536400953|FG004|Overall Study|Adverse Event|23|||
148707086|NCT00730691|536400949|FG000|Overall Study|Lack of Efficacy|4|||
148707087|NCT00730691|536400950|FG001|Overall Study|Lack of Efficacy|4|||
148707088|NCT00730691|536400951|FG002|Overall Study|Lack of Efficacy|2|||
148707089|NCT00730691|536400952|FG003|Overall Study|Lack of Efficacy|1|||
148707090|NCT00730691|536400953|FG004|Overall Study|Lack of Efficacy|1|||
148707091|NCT00730691|536400949|FG000|Overall Study|Non-compliance with Study Drug|6|||
148707092|NCT00730691|536400950|FG001|Overall Study|Non-compliance with Study Drug|1|||
148707093|NCT00730691|536400951|FG002|Overall Study|Non-compliance with Study Drug|6|||
148707094|NCT00730691|536400952|FG003|Overall Study|Non-compliance with Study Drug|3|||
148707095|NCT00730691|536400953|FG004|Overall Study|Non-compliance with Study Drug|3|||
148707096|NCT00730691|536400949|FG000|Overall Study|Protocol Deviations|3|||
148707097|NCT00730691|536400950|FG001|Overall Study|Protocol Deviations|5|||
148707098|NCT00730691|536400951|FG002|Overall Study|Protocol Deviations|3|||
148707099|NCT00730691|536400952|FG003|Overall Study|Protocol Deviations|7|||
148707100|NCT00730691|536400953|FG004|Overall Study|Protocol Deviations|5|||
148707101|NCT00730691|536400949|FG000|Overall Study|Withdrawal of Consent|7|||
148707102|NCT00730691|536400950|FG001|Overall Study|Withdrawal of Consent|9|||
148707103|NCT00730691|536400951|FG002|Overall Study|Withdrawal of Consent|3|||
148707104|NCT00730691|536400952|FG003|Overall Study|Withdrawal of Consent|6|||
148707105|NCT00730691|536400953|FG004|Overall Study|Withdrawal of Consent|3|||
148707106|NCT00730691|536400949|FG000|Overall Study|Lost to Follow-up|11|||
148707107|NCT00730691|536400950|FG001|Overall Study|Lost to Follow-up|8|||
148707108|NCT00730691|536400951|FG002|Overall Study|Lost to Follow-up|13|||
148707109|NCT00730691|536400952|FG003|Overall Study|Lost to Follow-up|15|||
148707110|NCT00730691|536400953|FG004|Overall Study|Lost to Follow-up|13|||
148707111|NCT00730691|536400949|FG000|Overall Study|Other|1|||
148707112|NCT00730691|536400950|FG001|Overall Study|Other|1|||
148707113|NCT00730691|536400951|FG002|Overall Study|Other|1|||
148707114|NCT00730691|536400952|FG003|Overall Study|Other|2|||
148707115|NCT00730691|536400953|FG004|Overall Study|Other|2|||
148707116|NCT02178787|536400954|FG000|Overall Study|Lost to Follow-up|1|||
148707117|NCT02178787|536400955|FG001|Overall Study|Lost to Follow-up|0|||
148707118|NCT02178787|536400954|FG000|Overall Study|Withdrawal by Subject|0|||
148707119|NCT02178787|536400955|FG001|Overall Study|Withdrawal by Subject|2|||
148707120|NCT02178787|536400954|FG000|Overall Study|No TCD window|3|||
148707121|NCT02178787|536400955|FG001|Overall Study|No TCD window|7|||
148707122|NCT02178787|536400954|FG000|Overall Study|Physician Decision|1|||
148707123|NCT02178787|536400955|FG001|Overall Study|Physician Decision|0|||
148707124|NCT02554890|536400956|FG000|Double-blind|Adverse Event|45|||
148707125|NCT02554890|536400957|FG001|Double-blind|Adverse Event|51|||
148707126|NCT02554890|536400956|FG000|Double-blind|Death|6|||
148707127|NCT02554890|536400957|FG001|Double-blind|Death|4|||
148707128|NCT02554890|536400956|FG000|Double-blind|Protocol Violation|1|||
148707129|NCT02554890|536400957|FG001|Double-blind|Protocol Violation|1|||
148707130|NCT02554890|536400956|FG000|Double-blind|Physician Decision|4|||
148707131|NCT02554890|536400957|FG001|Double-blind|Physician Decision|3|||
148707132|NCT02554890|536400956|FG000|Double-blind|Subject/Guardian decision|21|||
148707133|NCT02554890|536400957|FG001|Double-blind|Subject/Guardian decision|16|||
148707134|NCT02554890|536400956|FG000|Double-blind|Lost to Follow-up|7|||
148707135|NCT02554890|536400957|FG001|Double-blind|Lost to Follow-up|5|||
148707136|NCT02554890|536400956|FG000|Double-blind|Technical problems|1|||
148707137|NCT02554890|536400957|FG001|Double-blind|Technical problems|0|||
148707138|NCT02554890|536400956|FG000|Double-blind|Withdrawal by Subject|5|||
148707139|NCT02554890|536400957|FG001|Double-blind|Withdrawal by Subject|6|||
148707140|NCT02554890|536400956|FG000|Double-blind|Noncompliance with study treatment|6|||
148707141|NCT02554890|536400957|FG001|Double-blind|Noncompliance with study treatment|5|||
148707142|NCT02554890|536400956|FG000|Open-label|Adverse Event|0|||
148707143|NCT02554890|536400957|FG001|Open-label|Adverse Event|30|||
148707144|NCT02554890|536400956|FG000|Open-label|Death|0|||
148707145|NCT02554890|536400957|FG001|Open-label|Death|1|||
148707146|NCT02554890|536400956|FG000|Open-label|Physician Decision|0|||
148707147|NCT02554890|536400957|FG001|Open-label|Physician Decision|1|||
148707148|NCT02554890|536400956|FG000|Open-label|Subject/Guardian decision|0|||
148707149|NCT02554890|536400957|FG001|Open-label|Subject/Guardian decision|11|||
148707150|NCT02554890|536400956|FG000|Open-label|Lost to Follow-up|0|||
148707151|NCT02554890|536400957|FG001|Open-label|Lost to Follow-up|7|||
148707152|NCT02554890|536400956|FG000|Open-label|Technical problems|0|||
148707153|NCT02554890|536400957|FG001|Open-label|Technical problems|1|||
148707154|NCT02554890|536400956|FG000|Open-label|Withdrawal by Subject|0|||
148707155|NCT02554890|536400957|FG001|Open-label|Withdrawal by Subject|1|||
148707156|NCT03649477|536400963|FG000|Overall Study|Adverse Event|2|||
148707157|NCT03649477|536400964|FG001|Overall Study|Adverse Event|0|||
148707158|NCT03649477|536400965|FG002|Overall Study|Adverse Event|0|||
148707159|NCT01030133|536400966|FG000|Overall Study|failed to experience pain at level 7/10|2|||
148707160|NCT01030133|536400967|FG001|Overall Study|failed to experience pain at level 7/10|2|||
148707161|NCT05776901|536402679|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
148707162|NCT00682461|536402680|FG000|Overall Study|Adverse Event|5|||
148707163|NCT00682461|536402681|FG001|Overall Study|Adverse Event|7|||
148707164|NCT00682461|536402680|FG000|Overall Study|Lost to Follow-up|8|||
148707165|NCT00682461|536402681|FG001|Overall Study|Lost to Follow-up|5|||
148707166|NCT00682461|536402680|FG000|Overall Study|Withdrawal by Subject|12|||
148707167|NCT00682461|536402681|FG001|Overall Study|Withdrawal by Subject|19|||
148707168|NCT00835705|536402682|FG000|First Intervention|Difficulty with vein|1|||
148707169|NCT00835705|536402683|FG001|First Intervention|Difficulty with vein|0|||
148707170|NCT00835705|536402682|FG000|Second Intervention|Difficulty with vein|1|||
148707171|NCT00835705|536402683|FG001|Second Intervention|Difficulty with vein|0|||
148707172|NCT01750294|536402684|FG000|Overall Study|Withdrawal by Subject|1|||
148707173|NCT01750294|536402684|FG000|Overall Study|Safety Endpoint|1|||
148707174|NCT00665925|536402685|FG000|Overall Study|Lack of Efficacy|10|||
148707175|NCT00665925|536402686|FG001|Overall Study|Lack of Efficacy|8|||
148707176|NCT00665925|536402687|FG002|Overall Study|Lack of Efficacy|9|||
148707177|NCT00665925|536402688|FG003|Overall Study|Lack of Efficacy|8|||
148707178|NCT00665925|536402685|FG000|Overall Study|Lost to Follow-up|1|||
148707179|NCT00665925|536402686|FG001|Overall Study|Lost to Follow-up|2|||
148707180|NCT00665925|536402687|FG002|Overall Study|Lost to Follow-up|2|||
148707181|NCT00665925|536402688|FG003|Overall Study|Lost to Follow-up|2|||
148707182|NCT00665925|536402685|FG000|Overall Study|Withdrawal by Subject|2|||
148707183|NCT00665925|536402686|FG001|Overall Study|Withdrawal by Subject|2|||
148707184|NCT00665925|536402687|FG002|Overall Study|Withdrawal by Subject|3|||
148707185|NCT00665925|536402688|FG003|Overall Study|Withdrawal by Subject|2|||
148707186|NCT00665925|536402685|FG000|Overall Study|Physician Decision|0|||
148707187|NCT00665925|536402686|FG001|Overall Study|Physician Decision|0|||
148707188|NCT00665925|536402687|FG002|Overall Study|Physician Decision|1|||
148707189|NCT00665925|536402688|FG003|Overall Study|Physician Decision|2|||
148707190|NCT00665925|536402685|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
148707191|NCT00665925|536402686|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
148707192|NCT00665925|536402687|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
148707193|NCT00665925|536402688|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
148707194|NCT00665925|536402685|FG000|Overall Study|Adverse Event|1|||
148707195|NCT00665925|536402686|FG001|Overall Study|Adverse Event|5|||
148707196|NCT00665925|536402687|FG002|Overall Study|Adverse Event|10|||
148707197|NCT00665925|536402688|FG003|Overall Study|Adverse Event|5|||
148707198|NCT00665925|536402685|FG000|Overall Study|Enrolled by mistake|0|||
148707199|NCT00665925|536402686|FG001|Overall Study|Enrolled by mistake|0|||
148707200|NCT00665925|536402687|FG002|Overall Study|Enrolled by mistake|0|||
148707201|NCT00665925|536402688|FG003|Overall Study|Enrolled by mistake|1|||
148707202|NCT00665925|536402685|FG000|Overall Study|Due to exclusion criteria|1|||
148707203|NCT00665925|536402686|FG001|Overall Study|Due to exclusion criteria|0|||
148707204|NCT00665925|536402687|FG002|Overall Study|Due to exclusion criteria|0|||
148707205|NCT00665925|536402688|FG003|Overall Study|Due to exclusion criteria|0|||
148707206|NCT04035187|536402689|FG000|Overall Study|Withdrawal by Subject|2|||
148707207|NCT04035187|536402690|FG001|Overall Study|Withdrawal by Subject|1|||
148707208|NCT04035187|536402691|FG002|Overall Study|Withdrawal by Subject|0|||
148707209|NCT04035187|536402692|FG003|Overall Study|Withdrawal by Subject|0|||
148707210|NCT04035187|536402689|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
148707211|NCT04035187|536402690|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
148707212|NCT04035187|536402691|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
148707213|NCT04035187|536402692|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
148707214|NCT01987765|536402697|FG000|Overall Study|Protocol Violation|65|||
148707215|NCT01987765|536402697|FG000|Overall Study|Lost to Follow-up|37|||
148707216|NCT01471353|536402701|FG000|Overall Study|remain on study|3|||
148707217|NCT00836472|536402702|FG000|Washout|Adverse Event|1|||
148707218|NCT00836472|536402703|FG001|Washout|Adverse Event|2|||
148707219|NCT00836472|536402702|FG000|Washout|Withdrawal by Subject|1|||
148707220|NCT00836472|536402703|FG001|Washout|Withdrawal by Subject|1|||
148707221|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
148707222|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
148707223|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
148707224|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
148707225|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707226|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707227|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707228|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707229|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707230|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707231|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707232|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707233|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707234|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
148707235|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
148707236|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
148707237|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
148707238|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
148707239|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707240|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707241|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707242|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707243|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707244|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707245|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707246|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707247|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707248|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
148707249|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
148707250|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707251|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
148707252|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707253|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707254|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707255|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707256|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707257|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707258|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707259|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707260|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707261|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707262|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
148707263|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
148707264|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
148707265|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
148707266|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707267|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707268|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707269|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707270|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707271|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707272|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707273|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707274|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707275|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707276|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
148707277|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
148707278|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707279|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
148707280|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707281|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707282|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707283|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707284|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707285|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707286|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707287|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707288|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707289|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707290|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
148707291|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
148707292|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707293|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
148707294|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707295|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707296|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707297|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707298|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707299|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707300|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707301|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707302|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707303|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707304|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
148707305|NCT01695239|536402704|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
148707306|NCT01695239|536402705|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707307|NCT01695239|536402706|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707308|NCT01695239|536402707|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707309|NCT01695239|536402708|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707310|NCT01695239|536402709|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707311|NCT01695239|536402710|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707312|NCT01695239|536402711|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707313|NCT01695239|536402712|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707314|NCT01695239|536402713|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707315|NCT01695239|536402714|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707316|NCT01695239|536402715|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707317|NCT01695239|536402716|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707318|NCT01695239|536402717|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
148707319|NCT01695239|536402704|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707320|NCT01695239|536402705|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707321|NCT01695239|536402706|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707322|NCT01695239|536402707|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707323|NCT01695239|536402708|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707324|NCT01695239|536402709|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707325|NCT01695239|536402710|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707326|NCT01695239|536402711|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
148707327|NCT01695239|536402712|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707328|NCT01695239|536402713|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707329|NCT01695239|536402714|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707330|NCT01695239|536402715|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707331|NCT01695239|536402716|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707332|NCT01695239|536402717|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
148707333|NCT01695239|536402704|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707334|NCT01695239|536402705|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707335|NCT01695239|536402706|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707336|NCT01695239|536402707|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707337|NCT01695239|536402708|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707338|NCT01695239|536402709|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707339|NCT01695239|536402710|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707340|NCT01695239|536402711|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
148707341|NCT01695239|536402712|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707342|NCT01695239|536402713|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707343|NCT01695239|536402714|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707344|NCT01695239|536402715|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707345|NCT01695239|536402716|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707346|NCT01695239|536402717|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
148707347|NCT01695239|536402704|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707348|NCT01695239|536402705|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707349|NCT01695239|536402706|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707350|NCT01695239|536402707|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707351|NCT01695239|536402708|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707352|NCT01695239|536402709|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707353|NCT01695239|536402710|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707354|NCT01695239|536402711|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
148707355|NCT01695239|536402712|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707356|NCT01695239|536402713|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707357|NCT01695239|536402714|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707358|NCT01695239|536402715|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707359|NCT01695239|536402716|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707360|NCT01695239|536402717|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
148707361|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707362|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707363|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707364|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707365|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148815238|NCT04602000|536799435|FG001|Overall Study|Lost to Follow-up|0|||
148707366|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707367|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707368|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707369|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
148707370|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
148707371|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707372|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707373|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707374|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
148707375|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
148707376|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
148707377|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
148707378|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
148707379|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
148707380|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
148707381|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
148707382|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
148707383|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
148707384|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
148707385|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
148707386|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
148707387|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
148707388|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
148707389|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707390|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707391|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707392|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707393|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707394|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707395|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707396|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707397|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
148707398|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
148707399|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707400|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707401|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707402|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
148707403|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
148707404|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
148707405|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
148707406|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
148707407|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
148707408|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
148707409|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
148707410|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
148707411|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
148707412|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
148707413|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
148707414|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
148707415|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
148815239|NCT04602000|536799436|FG002|Overall Study|Lost to Follow-up|0|||
148707416|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
148707417|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707418|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707419|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707420|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707421|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707422|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707423|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707424|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707425|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
148707426|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
148707427|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707428|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148815240|NCT04602000|536799437|FG003|Overall Study|Lost to Follow-up|3|||
148707429|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707430|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
148707431|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707432|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707433|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707434|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707435|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707436|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707437|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707438|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707439|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
148707440|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
148707441|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707442|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707443|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707444|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
148707445|NCT01695239|536402704|FG000|Extension Long-Term Extension Periods|Death|0|||
148707446|NCT01695239|536402705|FG001|Extension Long-Term Extension Periods|Death|0|||
148707447|NCT01695239|536402706|FG002|Extension Long-Term Extension Periods|Death|0|||
148707448|NCT01695239|536402707|FG003|Extension Long-Term Extension Periods|Death|0|||
148707449|NCT01695239|536402708|FG004|Extension Long-Term Extension Periods|Death|0|||
148707450|NCT01695239|536402709|FG005|Extension Long-Term Extension Periods|Death|0|||
148707451|NCT01695239|536402710|FG006|Extension Long-Term Extension Periods|Death|0|||
148707452|NCT01695239|536402711|FG007|Extension Long-Term Extension Periods|Death|0|||
148707453|NCT01695239|536402712|FG008|Extension Long-Term Extension Periods|Death|1|||
148707454|NCT01695239|536402713|FG009|Extension Long-Term Extension Periods|Death|0|||
148707455|NCT01695239|536402714|FG010|Extension Long-Term Extension Periods|Death|0|||
148707456|NCT01695239|536402715|FG011|Extension Long-Term Extension Periods|Death|0|||
148707457|NCT01695239|536402716|FG012|Extension Long-Term Extension Periods|Death|0|||
148707458|NCT01695239|536402717|FG013|Extension Long-Term Extension Periods|Death|0|||
148707459|NCT01695239|536402704|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707460|NCT01695239|536402705|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707461|NCT01695239|536402706|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707462|NCT01695239|536402707|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707463|NCT01695239|536402708|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707464|NCT01695239|536402709|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707465|NCT01695239|536402710|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707466|NCT01695239|536402711|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707467|NCT01695239|536402712|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707468|NCT01695239|536402713|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707469|NCT01695239|536402714|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
148707470|NCT01695239|536402715|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
148707471|NCT01695239|536402716|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
148707472|NCT01695239|536402717|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
148707473|NCT01695239|536402704|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707474|NCT01695239|536402705|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707475|NCT01695239|536402706|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707476|NCT01695239|536402707|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707477|NCT01695239|536402708|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707478|NCT01695239|536402709|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707479|NCT01695239|536402710|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707480|NCT01695239|536402711|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707481|NCT01695239|536402712|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707482|NCT01695239|536402713|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707483|NCT01695239|536402714|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707484|NCT01695239|536402715|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148707485|NCT01695239|536402716|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
148707486|NCT01695239|536402717|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
148707487|NCT01695239|536402704|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707488|NCT01695239|536402705|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707489|NCT01695239|536402706|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707490|NCT01695239|536402707|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707491|NCT01695239|536402708|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707492|NCT01695239|536402709|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707493|NCT01695239|536402710|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707494|NCT01695239|536402711|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707495|NCT01695239|536402712|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707496|NCT01695239|536402713|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707497|NCT01695239|536402714|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707498|NCT01695239|536402715|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707499|NCT01695239|536402716|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
148707500|NCT01695239|536402717|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
148707501|NCT01695239|536402704|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707502|NCT01695239|536402705|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707503|NCT01695239|536402706|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707504|NCT01695239|536402707|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707505|NCT01695239|536402708|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707506|NCT01695239|536402709|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707507|NCT01695239|536402710|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707508|NCT01695239|536402711|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707509|NCT01695239|536402712|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707510|NCT01695239|536402713|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707511|NCT01695239|536402714|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707512|NCT01695239|536402715|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707513|NCT01695239|536402716|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
148707514|NCT01695239|536402717|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
148707515|NCT03502811|536402720|FG000|Overall Study|Death|157|||
148707516|NCT03502811|536402720|FG000|Overall Study|Withdrawal by Subject|105|||
148707517|NCT03502811|536402720|FG000|Overall Study|Lost to Follow-up|26|||
148707518|NCT03502811|536402720|FG000|Overall Study|No Visits (Missed)|31|||
148707519|NCT03913377|536402721|FG000|Period 1|Test Article no longer available|0|||
148707520|NCT03913377|536402722|FG001|Period 1|Test Article no longer available|1|||
148707521|NCT03913377|536402723|FG002|Period 1|Test Article no longer available|0|||
148707522|NCT03913377|536402721|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
148707523|NCT03913377|536402722|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
148707524|NCT03913377|536402723|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
148707525|NCT02241551|536402724|FG000|Overall Study|Adverse Event|1|||
148707526|NCT02241551|536402725|FG001|Overall Study|Adverse Event|0|||
148707527|NCT01205035|536402728|FG000|Overall Study|Withdrawal by Subject|1|||
148707528|NCT01205035|536402729|FG001|Overall Study|Withdrawal by Subject|0|||
148707529|NCT01205035|536402728|FG000|Overall Study|Physician Decision|1|||
148707530|NCT01205035|536402729|FG001|Overall Study|Physician Decision|0|||
148707531|NCT02751424|536402737|FG000|Part 2|Adverse Event|0|||
148707532|NCT02751424|536402738|FG001|Part 2|Adverse Event|0|||
148707533|NCT02751424|536402739|FG002|Part 2|Adverse Event|0|||
148707534|NCT02751424|536402740|FG003|Part 2|Adverse Event|0|||
148707535|NCT02751424|536402741|FG004|Part 2|Adverse Event|0|||
148707536|NCT02751424|536402742|FG005|Part 2|Adverse Event|0|||
148707537|NCT02751424|536402743|FG006|Part 2|Adverse Event|0|||
148707538|NCT02751424|536402744|FG007|Part 2|Adverse Event|5|||
148707539|NCT02751424|536402745|FG008|Part 2|Adverse Event|0|||
148707540|NCT01896934|536402746|FG000|Overall Study|Adverse Event|1|||
148707541|NCT01896934|536402746|FG000|Overall Study|Withdrawal by Subject|1|||
148967936|NCT00743652|537368583|FG002|Overall Study|Death|0|||
148967937|NCT00743652|537368584|FG003|Overall Study|Death|0|||
148967938|NCT00743652|537368585|FG004|Overall Study|Death|0|||
148707545|NCT02197416|536402748|FG000|Overall Study|Other reasons|0|||
148707546|NCT02197416|536402749|FG001|Overall Study|Other reasons|2|||
148707547|NCT02197416|536402750|FG002|Overall Study|Other reasons|5|||
148707548|NCT02197416|536402748|FG000|Overall Study|Withdrawal by Subject|0|||
148707549|NCT02197416|536402749|FG001|Overall Study|Withdrawal by Subject|2|||
148707550|NCT02197416|536402750|FG002|Overall Study|Withdrawal by Subject|1|||
148707551|NCT02197416|536402748|FG000|Overall Study|Protocol Violation|1|||
148707552|NCT02197416|536402749|FG001|Overall Study|Protocol Violation|0|||
148707553|NCT02197416|536402750|FG002|Overall Study|Protocol Violation|1|||
148707554|NCT02197416|536402748|FG000|Overall Study|Adverse Event|0|||
148707555|NCT02197416|536402749|FG001|Overall Study|Adverse Event|0|||
148707556|NCT02197416|536402750|FG002|Overall Study|Adverse Event|1|||
148707557|NCT00716625|536402751|FG000|Overall Study|Safety was not Assessable|1|||
148707558|NCT01492439|536402752|FG000|Overall Study|Withdrew from RTE|4|||
148707559|NCT01492439|536402753|FG001|Overall Study|Withdrew from RTE|9|||
148707560|NCT01204294|536402754|FG000|Overall Study|Adverse Event|2|||
148707561|NCT01204294|536402755|FG001|Overall Study|Adverse Event|6|||
148707562|NCT01204294|536402756|FG002|Overall Study|Adverse Event|0|||
148707563|NCT01204294|536402757|FG003|Overall Study|Adverse Event|7|||
148707564|NCT01204294|536402758|FG004|Overall Study|Adverse Event|1|||
148707565|NCT01204294|536402759|FG005|Overall Study|Adverse Event|4|||
148707566|NCT01204294|536402760|FG006|Overall Study|Adverse Event|0|||
148707567|NCT01204294|536402754|FG000|Overall Study|Protocol Violation|1|||
148707568|NCT01204294|536402755|FG001|Overall Study|Protocol Violation|0|||
148707569|NCT01204294|536402756|FG002|Overall Study|Protocol Violation|2|||
148707570|NCT01204294|536402757|FG003|Overall Study|Protocol Violation|1|||
148707571|NCT01204294|536402758|FG004|Overall Study|Protocol Violation|0|||
148967939|NCT00743652|537368581|FG000|Overall Study|Investigator Request|0|||
148967940|NCT00743652|537368582|FG001|Overall Study|Investigator Request|0|||
148967941|NCT00743652|537368583|FG002|Overall Study|Investigator Request|0|||
148967942|NCT00743652|537368584|FG003|Overall Study|Investigator Request|2|||
148967943|NCT00743652|537368585|FG004|Overall Study|Investigator Request|0|||
148967944|NCT00743652|537368581|FG000|Overall Study|Other|1|||
148967945|NCT00743652|537368582|FG001|Overall Study|Other|1|||
148967946|NCT00743652|537368583|FG002|Overall Study|Other|0|||
148967947|NCT00743652|537368584|FG003|Overall Study|Other|0|||
148967948|NCT00743652|537368585|FG004|Overall Study|Other|0|||
148967949|NCT00743652|537368581|FG000|Overall Study|Lost to Follow-up|1|||
148967950|NCT00743652|537368582|FG001|Overall Study|Lost to Follow-up|0|||
148707572|NCT01204294|536402759|FG005|Overall Study|Protocol Violation|0|||
148707573|NCT01204294|536402760|FG006|Overall Study|Protocol Violation|0|||
148707574|NCT01204294|536402754|FG000|Overall Study|Withdrawal by Subject|0|||
148707575|NCT01204294|536402755|FG001|Overall Study|Withdrawal by Subject|2|||
148707576|NCT01204294|536402756|FG002|Overall Study|Withdrawal by Subject|2|||
148707577|NCT01204294|536402757|FG003|Overall Study|Withdrawal by Subject|1|||
148707578|NCT01204294|536402758|FG004|Overall Study|Withdrawal by Subject|1|||
148707579|NCT01204294|536402759|FG005|Overall Study|Withdrawal by Subject|1|||
148707580|NCT01204294|536402760|FG006|Overall Study|Withdrawal by Subject|2|||
148707581|NCT01204294|536402754|FG000|Overall Study|Lack of Efficacy|0|||
148707582|NCT01204294|536402755|FG001|Overall Study|Lack of Efficacy|0|||
148707583|NCT01204294|536402756|FG002|Overall Study|Lack of Efficacy|0|||
148707584|NCT01204294|536402757|FG003|Overall Study|Lack of Efficacy|2|||
148707585|NCT01204294|536402758|FG004|Overall Study|Lack of Efficacy|0|||
148707586|NCT01204294|536402759|FG005|Overall Study|Lack of Efficacy|0|||
148707587|NCT01204294|536402760|FG006|Overall Study|Lack of Efficacy|0|||
148707588|NCT01204294|536402754|FG000|Overall Study|Other (house moving)|0|||
148707589|NCT01204294|536402755|FG001|Overall Study|Other (house moving)|0|||
148707590|NCT01204294|536402756|FG002|Overall Study|Other (house moving)|1|||
148707591|NCT01204294|536402757|FG003|Overall Study|Other (house moving)|0|||
148707592|NCT01204294|536402758|FG004|Overall Study|Other (house moving)|0|||
148707593|NCT01204294|536402759|FG005|Overall Study|Other (house moving)|0|||
148707594|NCT01204294|536402760|FG006|Overall Study|Other (house moving)|0|||
148707595|NCT04590027|536402761|FG000|Overall Study|Lost to Follow-up|17|||
148707596|NCT04590027|536402762|FG001|Overall Study|Lost to Follow-up|14|||
148707597|NCT04590027|536402761|FG000|Overall Study|Protocol Violation|0|||
148707598|NCT04590027|536402762|FG001|Overall Study|Protocol Violation|3|||
148707599|NCT01383486|536402763|FG000|Overall Study|Lost to Follow-up|10|||
148707600|NCT01383486|536402763|FG000|Overall Study|Incomplete information for analysis|2|||
148707601|NCT01383486|536402763|FG000|Overall Study|Did not take any product|6|||
148707602|NCT00245063|536402764|FG000|Overall Study|Adverse Event|6|||
148707603|NCT00245063|536402765|FG001|Overall Study|Adverse Event|5|||
148707604|NCT00245063|536402764|FG000|Overall Study|Death|1|||
148707605|NCT00245063|536402765|FG001|Overall Study|Death|0|||
148707606|NCT01839279|536402767|FG000|Overall Study|Adverse Event|4|||
148707607|NCT01839279|536402768|FG001|Overall Study|Adverse Event|1|||
148707608|NCT01839279|536402769|FG002|Overall Study|Adverse Event|1|||
148707609|NCT01839279|536402767|FG000|Overall Study|Withdrawal by Subject|4|||
148707610|NCT01839279|536402768|FG001|Overall Study|Withdrawal by Subject|1|||
148707611|NCT01839279|536402769|FG002|Overall Study|Withdrawal by Subject|1|||
148707612|NCT01839279|536402767|FG000|Overall Study|Classified as 'Other'|5|||
148707613|NCT01839279|536402768|FG001|Overall Study|Classified as 'Other'|0|||
148707614|NCT01839279|536402769|FG002|Overall Study|Classified as 'Other'|0|||
148707615|NCT00840216|536402773|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
148707616|NCT00840216|536402774|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
148707617|NCT03276754|536402775|FG000|Overall Study|Withdrawal of informed consent|4|||
148707618|NCT03276754|536402775|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
148707619|NCT03276754|536402775|FG000|Overall Study|Lost to Follow-up|27|||
148707620|NCT03276754|536402775|FG000|Overall Study|No data reported at Month 24|31|||
148707621|NCT03276754|536402775|FG000|Overall Study|Death|39|||
148707622|NCT01058668|536402776|FG000|Double-blind Treatment Phase|Adverse Event|8|||
148707623|NCT01058668|536402777|FG001|Double-blind Treatment Phase|Adverse Event|15|||
148707624|NCT01058668|536402778|FG002|Double-blind Treatment Phase|Adverse Event|25|||
148707625|NCT01058668|536402776|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
148707626|NCT01058668|536402777|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
148707627|NCT01058668|536402778|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
148707628|NCT01058668|536402776|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
148707629|NCT01058668|536402777|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
148707630|NCT01058668|536402778|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
148707631|NCT01058668|536402776|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
148967951|NCT00743652|537368583|FG002|Overall Study|Lost to Follow-up|0|||
148707632|NCT01058668|536402777|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
148707633|NCT01058668|536402778|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
148967952|NCT00743652|537368584|FG003|Overall Study|Lost to Follow-up|0|||
148707634|NCT01058668|536402776|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
148707635|NCT01058668|536402777|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
148707636|NCT01058668|536402778|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
148707637|NCT01058668|536402776|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
148707638|NCT01058668|536402777|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
148707639|NCT01058668|536402778|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
148707640|NCT00316277|536402779|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
148707641|NCT00316277|536402780|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
148707642|NCT00316277|536402779|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
148707643|NCT00316277|536402780|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
148707644|NCT00316277|536402779|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
148707645|NCT00316277|536402780|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
148707646|NCT00316277|536402779|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
148707647|NCT00316277|536402780|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
148707648|NCT00316277|536402779|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
148707649|NCT00316277|536402780|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
148707650|NCT00927069|536402785|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
148707651|NCT00927069|536402786|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
148707652|NCT00927069|536402787|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
148707653|NCT00927069|536402788|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
148707654|NCT00927069|536402785|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
148707655|NCT00927069|536402786|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
148707656|NCT00927069|536402787|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
148707657|NCT00927069|536402788|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
148707658|NCT00927069|536402785|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
148707659|NCT00927069|536402786|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
148707660|NCT00927069|536402787|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
148707661|NCT00927069|536402788|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
148707662|NCT00927069|536402785|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
148707663|NCT00927069|536402786|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
148707664|NCT00927069|536402787|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
148707665|NCT00927069|536402788|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
148707666|NCT00927069|536402785|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
148707667|NCT00927069|536402786|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
148707668|NCT00927069|536402787|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
148707669|NCT00927069|536402788|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
148707670|NCT02911792|536402789|FG000|Overall Study|Lost to Follow-up|3|||
148707671|NCT02911792|536402790|FG001|Overall Study|Lost to Follow-up|3|||
148707672|NCT02911792|536402791|FG002|Overall Study|Lost to Follow-up|3|||
148707673|NCT02911792|536402792|FG003|Overall Study|Lost to Follow-up|3|||
148707674|NCT00848536|536402793|FG000|Overall Study|Adverse Event|2|||
148707675|NCT00848536|536402794|FG001|Overall Study|Adverse Event|2|||
148707676|NCT00848536|536402793|FG000|Overall Study|Withdrawal by Subject|0|||
148707677|NCT00848536|536402794|FG001|Overall Study|Withdrawal by Subject|1|||
148707678|NCT00848536|536402793|FG000|Overall Study|Protocol Violation|0|||
148707679|NCT00848536|536402794|FG001|Overall Study|Protocol Violation|1|||
148707680|NCT00848536|536402793|FG000|Overall Study|Noncompliance|1|||
148707681|NCT00848536|536402794|FG001|Overall Study|Noncompliance|0|||
148707682|NCT00848536|536402793|FG000|Overall Study|Inadequate Control of IOP|1|||
148707683|NCT00848536|536402794|FG001|Overall Study|Inadequate Control of IOP|1|||
148707684|NCT00848536|536402793|FG000|Overall Study|Patient Moved|0|||
148707685|NCT00848536|536402794|FG001|Overall Study|Patient Moved|2|||
148707686|NCT00466167|536402800|FG000|Overall Study|Adverse Event|8|||
148707687|NCT00466167|536402801|FG001|Overall Study|Adverse Event|8|||
148707688|NCT00466167|536402802|FG002|Overall Study|Adverse Event|7|||
148707689|NCT00466167|536402800|FG000|Overall Study|Lack of Efficacy|2|||
148707690|NCT00466167|536402801|FG001|Overall Study|Lack of Efficacy|0|||
148707691|NCT00466167|536402802|FG002|Overall Study|Lack of Efficacy|3|||
148707692|NCT00466167|536402800|FG000|Overall Study|Protocol Violation|1|||
148707693|NCT00466167|536402801|FG001|Overall Study|Protocol Violation|1|||
148707694|NCT00466167|536402802|FG002|Overall Study|Protocol Violation|2|||
148707695|NCT00466167|536402800|FG000|Overall Study|Lost to Follow-up|3|||
148707696|NCT00466167|536402801|FG001|Overall Study|Lost to Follow-up|2|||
148707697|NCT00466167|536402802|FG002|Overall Study|Lost to Follow-up|2|||
148707698|NCT00466167|536402800|FG000|Overall Study|Withdrawal by Subject|4|||
148707699|NCT00466167|536402801|FG001|Overall Study|Withdrawal by Subject|1|||
148707700|NCT00466167|536402802|FG002|Overall Study|Withdrawal by Subject|6|||
148707701|NCT00466167|536402800|FG000|Overall Study|patient did not meet inclusion criteria|1|||
148707702|NCT00466167|536402801|FG001|Overall Study|patient did not meet inclusion criteria|0|||
148707703|NCT00466167|536402802|FG002|Overall Study|patient did not meet inclusion criteria|1|||
148707704|NCT00466167|536402800|FG000|Overall Study|Not treated|1|||
148707705|NCT00466167|536402801|FG001|Overall Study|Not treated|0|||
148707706|NCT00466167|536402802|FG002|Overall Study|Not treated|0|||
148707707|NCT03199963|536402803|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
148707708|NCT03199963|536402804|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
148707709|NCT03199963|536402803|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
148707710|NCT03199963|536402804|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
148707711|NCT03199963|536402803|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
148707712|NCT03199963|536402804|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
148707713|NCT03199963|536402803|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
148707714|NCT03199963|536402804|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
148707715|NCT03199963|536402803|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
148707716|NCT03199963|536402804|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
148707717|NCT03199963|536402803|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
148707718|NCT03199963|536402804|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
148707719|NCT00107991|536402805|FG000|Eligibility Assessment|Disease not severe enough|7|||
148707720|NCT00107991|536402805|FG000|Eligibility Assessment|Unwilling to participate|7|||
148707721|NCT00107991|536402805|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
148707722|NCT00107991|536402805|FG000|Eligibility Assessment|Abnormal labs|2|||
148707723|NCT00107991|536402805|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
148707724|NCT00107991|536402805|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
148707725|NCT00107991|536402805|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
148707726|NCT00107991|536402805|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
148707727|NCT00107991|536402805|FG000|12 Week Treatment Period|Adverse Event|1|||
148707728|NCT00107991|536402805|FG000|12 Week Treatment Period|Protocol Violation|1|||
148707729|NCT00107991|536402805|FG000|12 Week Treatment Period|Incarcerated|1|||
148707730|NCT00107991|536402805|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
148707731|NCT01535222|536402806|FG000|Overall Study|Inclusion/exclusion|0|||
148707732|NCT01535222|536402807|FG001|Overall Study|Inclusion/exclusion|0|||
148707733|NCT01535222|536402808|FG002|Overall Study|Inclusion/exclusion|1|||
148707734|NCT01535222|536402809|FG003|Overall Study|Inclusion/exclusion|0|||
148707735|NCT01535222|536402810|FG004|Overall Study|Inclusion/exclusion|0|||
148707736|NCT01535222|536402811|FG005|Overall Study|Inclusion/exclusion|0|||
148707737|NCT03930732|536402812|FG000|Overall Study|Adverse Event|9|||
148707738|NCT03930732|536402813|FG001|Overall Study|Adverse Event|7|||
148707739|NCT03930732|536402812|FG000|Overall Study|Poor compliance to protocol|0|||
148707740|NCT03930732|536402813|FG001|Overall Study|Poor compliance to protocol|1|||
148707741|NCT03930732|536402812|FG000|Overall Study|Withdrawal by Subject|23|||
148707742|NCT03930732|536402813|FG001|Overall Study|Withdrawal by Subject|11|||
148707743|NCT03930732|536402812|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
148707744|NCT03930732|536402813|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
148707745|NCT03930732|536402812|FG000|Overall Study|Other reason not related to COVID-19|5|||
148707746|NCT03930732|536402813|FG001|Overall Study|Other reason not related to COVID-19|8|||
148707747|NCT03808376|536402820|FG000|Overall Study|Withdrawal by Subject|10|||
148707748|NCT02152163|536402821|FG000|Overall Study|Physician Decision|12|||
148707749|NCT02152163|536402822|FG001|Overall Study|Physician Decision|13|||
148707750|NCT01154231|536402826|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
148707751|NCT01154231|536402826|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
148707752|NCT01097577|536402834|FG000|Overall Study|Adverse Event|0|||
148707753|NCT01097577|536402835|FG001|Overall Study|Adverse Event|1|||
148707754|NCT03114891|536402838|FG000|First Treatment Round|Lost to Follow-up|0|||
148707755|NCT03114891|536402839|FG001|First Treatment Round|Lost to Follow-up|1|||
148707756|NCT03114891|536402840|FG002|First Treatment Round|Lost to Follow-up|1|||
148707757|NCT03114891|536402841|FG003|First Treatment Round|Lost to Follow-up|0|||
148707758|NCT03114891|536402838|FG000|First Treatment Round|Withdrawal by Subject|0|||
148707759|NCT03114891|536402839|FG001|First Treatment Round|Withdrawal by Subject|2|||
148707760|NCT03114891|536402840|FG002|First Treatment Round|Withdrawal by Subject|0|||
148707761|NCT03114891|536402841|FG003|First Treatment Round|Withdrawal by Subject|1|||
148707762|NCT03114891|536402838|FG000|3 Week Break|Lost to Follow-up|1|||
148707763|NCT03114891|536402839|FG001|3 Week Break|Lost to Follow-up|0|||
148707764|NCT03114891|536402840|FG002|3 Week Break|Lost to Follow-up|0|||
148707765|NCT03114891|536402841|FG003|3 Week Break|Lost to Follow-up|1|||
148707766|NCT03114891|536402838|FG000|3 Week Break|Withdrawal by Subject|0|||
148707767|NCT03114891|536402839|FG001|3 Week Break|Withdrawal by Subject|1|||
148707768|NCT03114891|536402840|FG002|3 Week Break|Withdrawal by Subject|0|||
148707769|NCT03114891|536402841|FG003|3 Week Break|Withdrawal by Subject|0|||
148707770|NCT03114891|536402838|FG000|Second Treatment Round|Lost to Follow-up|1|||
148707771|NCT03114891|536402839|FG001|Second Treatment Round|Lost to Follow-up|0|||
148707772|NCT03114891|536402840|FG002|Second Treatment Round|Lost to Follow-up|0|||
148707773|NCT03114891|536402841|FG003|Second Treatment Round|Lost to Follow-up|0|||
148707774|NCT03114891|536402838|FG000|Second Treatment Round|Physician Decision|1|||
148707775|NCT03114891|536402839|FG001|Second Treatment Round|Physician Decision|0|||
148707776|NCT03114891|536402840|FG002|Second Treatment Round|Physician Decision|0|||
148707777|NCT03114891|536402841|FG003|Second Treatment Round|Physician Decision|0|||
148707778|NCT01116739|536404515|FG000|Overall Study|Child had 2 years of HS|110|||
148815241|NCT04602000|536799438|FG004|Overall Study|Lost to Follow-up|4|||
148707779|NCT01116739|536404516|FG001|Overall Study|Child had 2 years of HS|128|||
148707780|NCT01116739|536404515|FG000|Overall Study|Withdrawal by Subject|6|||
148707781|NCT01116739|536404516|FG001|Overall Study|Withdrawal by Subject|0|||
148707782|NCT01116739|536404515|FG000|Overall Study|child too young|2|||
148707783|NCT01116739|536404516|FG001|Overall Study|child too young|6|||
148707784|NCT01116739|536404515|FG000|Overall Study|child not enrolled in head start|10|||
148707785|NCT01116739|536404516|FG001|Overall Study|child not enrolled in head start|2|||
148707786|NCT01116739|536404515|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
148707787|NCT01116739|536404516|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
148707788|NCT05511935|536404517|FG000|Overall Study|Lost to Follow-up|9|||
148707789|NCT05511935|536404518|FG001|Overall Study|Lost to Follow-up|27|||
148707790|NCT01624233|536404519|FG000|Period 2 - Induction|Adverse Event|1|||
148707791|NCT01624233|536404519|FG000|Period 3 - Maintenance|Adverse Event|2|||
148707792|NCT01624233|536404519|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
148707793|NCT01624233|536404519|FG000|Period 3 - Maintenance|Physician Decision|2|||
148707794|NCT01624233|536404519|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
148707795|NCT01624233|536404519|FG000|Period 4 - Drug Free Period|Relapsed|61|||
148707796|NCT01624233|536404519|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
148707797|NCT01624233|536404519|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
148707798|NCT01624233|536404519|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
148707799|NCT01624233|536404519|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
148707800|NCT01624233|536404519|FG000|Period 6: Follow-up|Adverse Event|3|||
148707801|NCT01624233|536404519|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
148707802|NCT01624233|536404519|FG000|Period 6: Follow-up|Physician Decision|1|||
148707803|NCT01624233|536404519|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
148707804|NCT05090839|536404520|FG000|Overall Study|Lost to Follow-up|2|||
148707805|NCT05090839|536404521|FG001|Overall Study|Lost to Follow-up|3|||
148707806|NCT05090839|536404522|FG002|Overall Study|Lost to Follow-up|1|||
148707807|NCT05090839|536404523|FG003|Overall Study|Lost to Follow-up|1|||
148707808|NCT00373256|536404524|FG000|Overall Study|Adverse Event (AE)|1|||
148707809|NCT00373256|536404525|FG001|Overall Study|Adverse Event (AE)|5|||
148707810|NCT00373256|536404524|FG000|Overall Study|Lost to Follow-up|2|||
148707811|NCT00373256|536404525|FG001|Overall Study|Lost to Follow-up|1|||
148707812|NCT00373256|536404524|FG000|Overall Study|Death|9|||
148707813|NCT00373256|536404525|FG001|Overall Study|Death|8|||
148707814|NCT00373256|536404524|FG000|Overall Study|Objective Progression or Relapse|111|||
148707815|NCT00373256|536404525|FG001|Overall Study|Objective Progression or Relapse|104|||
148707816|NCT00373256|536404524|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
148707817|NCT00373256|536404525|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
148707818|NCT00373256|536404524|FG000|Overall Study|Other|73|||
148707819|NCT00373256|536404525|FG001|Overall Study|Other|107|||
148707820|NCT00373256|536404524|FG000|Overall Study|Protocol Violation|0|||
148707821|NCT00373256|536404525|FG001|Overall Study|Protocol Violation|2|||
148707822|NCT00373256|536404524|FG000|Overall Study|Study Terminated by Sponsor|41|||
148707823|NCT00373256|536404525|FG001|Overall Study|Study Terminated by Sponsor|13|||
148707824|NCT05710718|536404526|FG000|Overall Study|Withdrawal by Subject|5|||
148707825|NCT05710718|536404527|FG001|Overall Study|Withdrawal by Subject|1|||
148707826|NCT05710718|536404526|FG000|Overall Study|Lost to Follow-up|0|||
148707827|NCT05710718|536404527|FG001|Overall Study|Lost to Follow-up|1|||
148707828|NCT05710718|536404526|FG000|Overall Study|Death|0|||
148707829|NCT05710718|536404527|FG001|Overall Study|Death|1|||
148707830|NCT04372238|536404528|FG000|Overall Study|Duplicate|3|||
148707831|NCT04372238|536404529|FG001|Overall Study|Duplicate|3|||
148707832|NCT04372238|536404528|FG000|Overall Study|Did not consent for data linkage|6|||
148707833|NCT04372238|536404529|FG001|Overall Study|Did not consent for data linkage|10|||
148707834|NCT04241458|536404530|FG000|Overall Study|Withdrawal by Subject|0|||
148707835|NCT04241458|536404531|FG001|Overall Study|Withdrawal by Subject|0|||
148707836|NCT04241458|536404532|FG002|Overall Study|Withdrawal by Subject|0|||
148707837|NCT04241458|536404533|FG003|Overall Study|Withdrawal by Subject|0|||
148707838|NCT04241458|536404534|FG004|Overall Study|Withdrawal by Subject|1|||
148707839|NCT00334815|536404535|FG000|Overall Study|Adverse Event|3|||
148707840|NCT00334815|536404536|FG001|Overall Study|Adverse Event|2|||
148707841|NCT00334815|536404535|FG000|Overall Study|Death|0|||
148707842|NCT00334815|536404536|FG001|Overall Study|Death|2|||
148707843|NCT00334815|536404535|FG000|Overall Study|Progression|1|||
148707844|NCT00334815|536404536|FG001|Overall Study|Progression|0|||
148707845|NCT00334815|536404535|FG000|Overall Study|ineligible|1|||
148707846|NCT00334815|536404536|FG001|Overall Study|ineligible|1|||
148707847|NCT00334815|536404535|FG000|Overall Study|patient refused treatment|0|||
148707848|NCT00334815|536404536|FG001|Overall Study|patient refused treatment|1|||
148707849|NCT00334815|536404535|FG000|Overall Study|Physician Decision|2|||
148707850|NCT00334815|536404536|FG001|Overall Study|Physician Decision|4|||
148707851|NCT06144424|536404537|FG000|Overall Study|Withdrawal by Subject|2|||
148707852|NCT06144424|536404538|FG001|Overall Study|Withdrawal by Subject|0|||
148707853|NCT06144424|536404537|FG000|Overall Study|Incarceration|1|||
148707854|NCT06144424|536404538|FG001|Overall Study|Incarceration|0|||
148707855|NCT03121586|536404539|FG000|Overall Study|Study terminated by sponsor|0|||
148815242|NCT04602000|536799434|FG000|Overall Study|Other|4|||
148707856|NCT03121586|536404540|FG001|Overall Study|Study terminated by sponsor|0|||
148707857|NCT03121586|536404541|FG002|Overall Study|Study terminated by sponsor|99|||
148707858|NCT03121586|536404539|FG000|Overall Study|Withdrawal by Subject|37|||
148707859|NCT03121586|536404540|FG001|Overall Study|Withdrawal by Subject|14|||
148815243|NCT04602000|536799435|FG001|Overall Study|Other|1|||
148815244|NCT04602000|536799436|FG002|Overall Study|Other|2|||
148815245|NCT04602000|536799437|FG003|Overall Study|Other|5|||
148815246|NCT04602000|536799438|FG004|Overall Study|Other|4|||
148815247|NCT04602000|536799434|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
148707860|NCT03121586|536404541|FG002|Overall Study|Withdrawal by Subject|9|||
148707861|NCT03121586|536404539|FG000|Overall Study|Not further specified|6|||
148707862|NCT03121586|536404540|FG001|Overall Study|Not further specified|11|||
148707863|NCT03121586|536404541|FG002|Overall Study|Not further specified|10|||
148707864|NCT03121586|536404539|FG000|Overall Study|Adverse Event|16|||
148707865|NCT03121586|536404540|FG001|Overall Study|Adverse Event|5|||
148707866|NCT03121586|536404541|FG002|Overall Study|Adverse Event|6|||
148707867|NCT03121586|536404539|FG000|Overall Study|Protocol Violation|0|||
148707868|NCT03121586|536404540|FG001|Overall Study|Protocol Violation|5|||
148707869|NCT03121586|536404541|FG002|Overall Study|Protocol Violation|0|||
148707870|NCT03121586|536404539|FG000|Overall Study|Lack of Efficacy|3|||
148707871|NCT03121586|536404540|FG001|Overall Study|Lack of Efficacy|3|||
148707872|NCT03121586|536404541|FG002|Overall Study|Lack of Efficacy|1|||
148707873|NCT03121586|536404539|FG000|Overall Study|Physician Decision|2|||
148707874|NCT03121586|536404540|FG001|Overall Study|Physician Decision|2|||
148707875|NCT03121586|536404541|FG002|Overall Study|Physician Decision|0|||
148707876|NCT03121586|536404539|FG000|Overall Study|Noncompliance with study drug|5|||
148707877|NCT03121586|536404540|FG001|Overall Study|Noncompliance with study drug|3|||
148707878|NCT03121586|536404541|FG002|Overall Study|Noncompliance with study drug|5|||
148707879|NCT03121586|536404539|FG000|Overall Study|Lost to Follow-up|4|||
148707880|NCT03121586|536404540|FG001|Overall Study|Lost to Follow-up|2|||
148707881|NCT03121586|536404541|FG002|Overall Study|Lost to Follow-up|0|||
148707882|NCT03121586|536404539|FG000|Overall Study|Death|2|||
148707883|NCT03121586|536404540|FG001|Overall Study|Death|0|||
148707884|NCT03121586|536404541|FG002|Overall Study|Death|0|||
148707885|NCT06381102|536404542|FG000|Washout 5 Days|Withdrawal by Subject|0|||
148707886|NCT06381102|536404543|FG001|Washout 5 Days|Withdrawal by Subject|2|||
148707887|NCT02832063|536404545|FG000|Overall Study|Adverse Event|2|||
148707888|NCT02832063|536404546|FG001|Overall Study|Adverse Event|1|||
148707889|NCT02832063|536404545|FG000|Overall Study|Physician Decision|5|||
148707890|NCT02832063|536404546|FG001|Overall Study|Physician Decision|7|||
148707891|NCT02832063|536404545|FG000|Overall Study|Lost to Follow-up|15|||
148707892|NCT02832063|536404546|FG001|Overall Study|Lost to Follow-up|8|||
148707893|NCT02832063|536404545|FG000|Overall Study|Withdrawal by Subject|10|||
148707894|NCT02832063|536404546|FG001|Overall Study|Withdrawal by Subject|21|||
148707895|NCT02832063|536404545|FG000|Overall Study|Other|2|||
148707896|NCT02832063|536404546|FG001|Overall Study|Other|1|||
148707897|NCT03733730|536404547|FG000|Overall Study|Lost to Follow-up|1|||
148707898|NCT03733730|536404548|FG001|Overall Study|Lost to Follow-up|32|||
148707899|NCT03733730|536404547|FG000|Overall Study|Other|1|||
148707900|NCT03733730|536404548|FG001|Overall Study|Other|0|||
148707901|NCT03733730|536404547|FG000|Overall Study|Adverse Event|0|||
148707902|NCT03733730|536404548|FG001|Overall Study|Adverse Event|4|||
148707903|NCT03733730|536404547|FG000|Overall Study|Death|0|||
148707904|NCT03733730|536404548|FG001|Overall Study|Death|5|||
148707905|NCT03733730|536404547|FG000|Overall Study|Withdrawal by Subject|0|||
148707906|NCT03733730|536404548|FG001|Overall Study|Withdrawal by Subject|8|||
148707907|NCT00772603|536404549|FG000|Overall Study|Withdrawal by Subject|11|||
148707908|NCT00772603|536404550|FG001|Overall Study|Withdrawal by Subject|10|||
148707909|NCT00772603|536404551|FG002|Overall Study|Withdrawal by Subject|6|||
148707910|NCT00772603|536404549|FG000|Overall Study|Adverse Event|37|||
148707911|NCT00772603|536404550|FG001|Overall Study|Adverse Event|18|||
148707912|NCT00772603|536404551|FG002|Overall Study|Adverse Event|10|||
148707913|NCT00772603|536404549|FG000|Overall Study|Subject Non-compliance|1|||
148707914|NCT00772603|536404550|FG001|Overall Study|Subject Non-compliance|6|||
148707915|NCT00772603|536404551|FG002|Overall Study|Subject Non-compliance|4|||
148707916|NCT00772603|536404549|FG000|Overall Study|Protocol Violation|0|||
148707917|NCT00772603|536404550|FG001|Overall Study|Protocol Violation|1|||
148707918|NCT00772603|536404551|FG002|Overall Study|Protocol Violation|1|||
148707919|NCT00772603|536404549|FG000|Overall Study|Lost to Follow-up|1|||
148707920|NCT00772603|536404550|FG001|Overall Study|Lost to Follow-up|5|||
148707921|NCT00772603|536404551|FG002|Overall Study|Lost to Follow-up|2|||
148707922|NCT00772603|536404549|FG000|Overall Study|Physician Decision|0|||
148707923|NCT00772603|536404550|FG001|Overall Study|Physician Decision|0|||
148707924|NCT00772603|536404551|FG002|Overall Study|Physician Decision|1|||
148707925|NCT00772603|536404549|FG000|Overall Study|Other|2|||
148707926|NCT00772603|536404550|FG001|Overall Study|Other|0|||
148707927|NCT00772603|536404551|FG002|Overall Study|Other|2|||
148707928|NCT01528696|536404554|FG000|Overall Study|See detailed description|18|||
148815248|NCT04602000|536799435|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
148707929|NCT01528696|536404555|FG001|Overall Study|See detailed description|19|||
148967953|NCT00743652|537368585|FG004|Overall Study|Lost to Follow-up|0|||
148967954|NCT02547129|537368586|FG000|Overall Study|Difficulty with ongoing infection|1|||
148967955|NCT02547129|537368587|FG001|Overall Study|Difficulty with ongoing infection|0|||
148967956|NCT00805766|537368588|FG000|Screening Period|Adverse Event|1|||
148707930|NCT01056484|536404556|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
148707931|NCT01056484|536404557|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
148707932|NCT01056484|536404556|FG000|Randomized Controlled Trial|Physician Decision|1|||
148707933|NCT01056484|536404557|FG001|Randomized Controlled Trial|Physician Decision|0|||
148707934|NCT01056484|536404556|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
148707935|NCT01056484|536404557|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
148707936|NCT00446966|536404561|FG000|Overall Study|Lost to Follow-up|10|||
148707937|NCT00446966|536404562|FG001|Overall Study|Lost to Follow-up|7|||
148707938|NCT00835575|536404563|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
148707939|NCT00835575|536404564|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
148707940|NCT01440803|536404565|FG000|Overall Study|Met study stopping rule|2|||
148707941|NCT01440803|536404566|FG001|Overall Study|Met study stopping rule|1|||
148707942|NCT01440803|536404565|FG000|Overall Study|Lost to Follow-up|0|||
148707943|NCT01440803|536404566|FG001|Overall Study|Lost to Follow-up|2|||
148707944|NCT01440803|536404565|FG000|Overall Study|Withdrawal by Subject|0|||
148707945|NCT01440803|536404566|FG001|Overall Study|Withdrawal by Subject|1|||
148707946|NCT00443651|536404569|FG000|Overall Study|Death|1|||
148707947|NCT00443651|536404570|FG001|Overall Study|Death|5|||
148707948|NCT00443651|536404569|FG000|Overall Study|Adverse Event|5|||
148707949|NCT00443651|536404570|FG001|Overall Study|Adverse Event|6|||
148707950|NCT00443651|536404569|FG000|Overall Study|Lost to Follow-up|18|||
148707951|NCT00443651|536404570|FG001|Overall Study|Lost to Follow-up|12|||
148707952|NCT00443651|536404569|FG000|Overall Study|Patient's/Guardian's Decision|58|||
148707953|NCT00443651|536404570|FG001|Overall Study|Patient's/Guardian's Decision|30|||
148707954|NCT00443651|536404569|FG000|Overall Study|Physician Decision|13|||
148707955|NCT00443651|536404570|FG001|Overall Study|Physician Decision|4|||
148707956|NCT00443651|536404569|FG000|Overall Study|Pregnancy|0|||
148707957|NCT00443651|536404570|FG001|Overall Study|Pregnancy|1|||
148707958|NCT01564394|536404573|FG000|Overall Study|Withdrawal by Subject|6|||
148707959|NCT01564394|536404574|FG001|Overall Study|Withdrawal by Subject|10|||
148707960|NCT03606174|536404575|FG000|Overall Study|Death|37|||
148707961|NCT03606174|536404576|FG001|Overall Study|Death|15|||
148707962|NCT03606174|536404577|FG002|Overall Study|Death|15|||
148707963|NCT03606174|536404578|FG003|Overall Study|Death|7|||
148707964|NCT03606174|536404579|FG004|Overall Study|Death|35|||
148707965|NCT03606174|536404580|FG005|Overall Study|Death|12|||
148707966|NCT03606174|536404581|FG006|Overall Study|Death|35|||
148707967|NCT03606174|536404582|FG007|Overall Study|Death|8|||
148707968|NCT03606174|536404583|FG008|Overall Study|Death|5|||
148707969|NCT03606174|536404584|FG009|Overall Study|Death|3|||
148707970|NCT03606174|536404585|FG010|Overall Study|Death|0|||
148707971|NCT03606174|536404575|FG000|Overall Study|Lost to Follow-up|0|||
148707972|NCT03606174|536404576|FG001|Overall Study|Lost to Follow-up|0|||
148707973|NCT03606174|536404577|FG002|Overall Study|Lost to Follow-up|0|||
148707974|NCT03606174|536404578|FG003|Overall Study|Lost to Follow-up|0|||
148707975|NCT03606174|536404579|FG004|Overall Study|Lost to Follow-up|1|||
148707976|NCT03606174|536404580|FG005|Overall Study|Lost to Follow-up|1|||
148707977|NCT03606174|536404581|FG006|Overall Study|Lost to Follow-up|0|||
148707978|NCT03606174|536404582|FG007|Overall Study|Lost to Follow-up|0|||
148707979|NCT03606174|536404583|FG008|Overall Study|Lost to Follow-up|0|||
148707980|NCT03606174|536404584|FG009|Overall Study|Lost to Follow-up|0|||
148707981|NCT03606174|536404585|FG010|Overall Study|Lost to Follow-up|0|||
148707982|NCT03606174|536404575|FG000|Overall Study|Withdrawal by Subject|6|||
148707983|NCT03606174|536404576|FG001|Overall Study|Withdrawal by Subject|0|||
148707984|NCT03606174|536404577|FG002|Overall Study|Withdrawal by Subject|0|||
148967957|NCT00805766|537368588|FG000|Screening Period|Lack of Efficacy|2|||
148707985|NCT03606174|536404578|FG003|Overall Study|Withdrawal by Subject|1|||
148707986|NCT03606174|536404579|FG004|Overall Study|Withdrawal by Subject|2|||
148707987|NCT03606174|536404580|FG005|Overall Study|Withdrawal by Subject|1|||
148707988|NCT03606174|536404581|FG006|Overall Study|Withdrawal by Subject|4|||
148707989|NCT03606174|536404582|FG007|Overall Study|Withdrawal by Subject|0|||
148707990|NCT03606174|536404583|FG008|Overall Study|Withdrawal by Subject|0|||
148707991|NCT03606174|536404584|FG009|Overall Study|Withdrawal by Subject|0|||
148707992|NCT03606174|536404585|FG010|Overall Study|Withdrawal by Subject|1|||
148707993|NCT03606174|536404575|FG000|Overall Study|Study Terminated by Sponsor|5|||
148707994|NCT03606174|536404576|FG001|Overall Study|Study Terminated by Sponsor|7|||
148707995|NCT03606174|536404577|FG002|Overall Study|Study Terminated by Sponsor|3|||
148707996|NCT03606174|536404578|FG003|Overall Study|Study Terminated by Sponsor|0|||
148707997|NCT03606174|536404579|FG004|Overall Study|Study Terminated by Sponsor|11|||
148707998|NCT03606174|536404580|FG005|Overall Study|Study Terminated by Sponsor|6|||
148707999|NCT03606174|536404581|FG006|Overall Study|Study Terminated by Sponsor|12|||
148708000|NCT03606174|536404582|FG007|Overall Study|Study Terminated by Sponsor|1|||
148708001|NCT03606174|536404583|FG008|Overall Study|Study Terminated by Sponsor|3|||
148708002|NCT03606174|536404584|FG009|Overall Study|Study Terminated by Sponsor|1|||
148708003|NCT03606174|536404585|FG010|Overall Study|Study Terminated by Sponsor|2|||
148708004|NCT03606174|536404575|FG000|Overall Study|Miscellaneous|1|||
148708005|NCT03606174|536404576|FG001|Overall Study|Miscellaneous|1|||
148708006|NCT03606174|536404577|FG002|Overall Study|Miscellaneous|0|||
148708007|NCT03606174|536404578|FG003|Overall Study|Miscellaneous|1|||
148708008|NCT03606174|536404579|FG004|Overall Study|Miscellaneous|4|||
148708009|NCT03606174|536404580|FG005|Overall Study|Miscellaneous|7|||
148708010|NCT03606174|536404581|FG006|Overall Study|Miscellaneous|5|||
148708011|NCT03606174|536404582|FG007|Overall Study|Miscellaneous|0|||
148708012|NCT03606174|536404583|FG008|Overall Study|Miscellaneous|0|||
148708013|NCT03606174|536404584|FG009|Overall Study|Miscellaneous|0|||
148708014|NCT03606174|536404585|FG010|Overall Study|Miscellaneous|1|||
148708015|NCT00859521|536404586|FG000|Washout|Withdrawal by Subject|0|||
148708016|NCT00859521|536404587|FG001|Washout|Withdrawal by Subject|1|||
148708017|NCT01609257|536404588|FG000|Overall Study|Lost to Follow-up|2|||
148708018|NCT01609257|536404589|FG001|Overall Study|Lost to Follow-up|1|||
148708019|NCT01609257|536404588|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
148708020|NCT01609257|536404589|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
148708021|NCT01609257|536404588|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
148708022|NCT01609257|536404589|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
148708023|NCT02125461|536404590|FG000|Overall Study|Withdrawal by Subject|30|||
148708024|NCT02125461|536404591|FG001|Overall Study|Withdrawal by Subject|16|||
148708025|NCT02125461|536404590|FG000|Overall Study|Lost to Follow-up|8|||
148708026|NCT02125461|536404591|FG001|Overall Study|Lost to Follow-up|3|||
148708027|NCT02125461|536404590|FG000|Overall Study|Death|260|||
148708028|NCT02125461|536404591|FG001|Overall Study|Death|149|||
148708029|NCT02125461|536404590|FG000|Overall Study|Missing Termination Reason|0|||
148708030|NCT02125461|536404591|FG001|Overall Study|Missing Termination Reason|1|||
148708031|NCT02888756|536404595|FG000|Analytical Treatment Interruption|Physician Decision|10|||
148708032|NCT02888756|536404596|FG001|Analytical Treatment Interruption|Physician Decision|6|||
148708033|NCT02888756|536404597|FG002|Analytical Treatment Interruption|Physician Decision|5|||
148708034|NCT01547286|536404603|FG000|Overall Study|Did not meet all eligibility criteria|1|||
148708035|NCT01547286|536404603|FG000|Overall Study|Physician Decision|1|||
148708036|NCT03415308|536404607|FG000|Overall Study|Lost to Follow-up|0|||
148708037|NCT03415308|536404608|FG001|Overall Study|Lost to Follow-up|0|||
148708038|NCT03415308|536404609|FG002|Overall Study|Lost to Follow-up|1|||
148708039|NCT03415308|536404607|FG000|Overall Study|Scheduling Conflicts|0|||
148708040|NCT03415308|536404608|FG001|Overall Study|Scheduling Conflicts|0|||
148708041|NCT03415308|536404609|FG002|Overall Study|Scheduling Conflicts|7|||
148708042|NCT05239195|536404611|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
148708043|NCT05239195|536404612|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
148708044|NCT03552484|536404615|FG000|Overall Study|Death|6|||
148708045|NCT03552484|536404616|FG001|Overall Study|Death|4|||
148708046|NCT03552484|536404615|FG000|Overall Study|Lost to Follow-up|0|||
148708047|NCT03552484|536404616|FG001|Overall Study|Lost to Follow-up|16|||
148708048|NCT03499353|536404617|FG000|Treatment|Adverse Event|3|||
148708049|NCT03499353|536404617|FG000|Treatment|Progressive Disease|10|||
148708050|NCT03499353|536404617|FG000|Treatment|Other|1|||
148708051|NCT03499353|536404617|FG000|Treatment|Withdrawal by Subject|2|||
148708052|NCT03499353|536404617|FG000|Long-Term Follow-up|Death|2|||
148708053|NCT03499353|536404617|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
148708054|NCT03499353|536404617|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
148708055|NCT00081653|536404618|FG000|Overall Study|Adverse Event|23|||
148708056|NCT00081653|536404619|FG001|Overall Study|Adverse Event|17|||
148708057|NCT00081653|536404618|FG000|Overall Study|Lost to Follow-up|2|||
148708058|NCT00081653|536404619|FG001|Overall Study|Lost to Follow-up|4|||
148815249|NCT04602000|536799436|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
148815250|NCT04602000|536799437|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
148815251|NCT04602000|536799438|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
148815252|NCT05607043|536799439|FG000|Overall Study|Lost to Follow-up|2|||
148708059|NCT00081653|536404618|FG000|Overall Study|Refused Treatment|18|||
148708060|NCT00081653|536404619|FG001|Overall Study|Refused Treatment|14|||
148708061|NCT00081653|536404618|FG000|Overall Study|Low bone mineral density|1|||
148708062|NCT00081653|536404619|FG001|Overall Study|Low bone mineral density|0|||
148708063|NCT00081653|536404618|FG000|Overall Study|Bone loss|2|||
148708064|NCT00081653|536404619|FG001|Overall Study|Bone loss|0|||
148708065|NCT00081653|536404618|FG000|Overall Study|Participant leaving country|1|||
148708066|NCT00081653|536404619|FG001|Overall Study|Participant leaving country|0|||
148708067|NCT00081653|536404618|FG000|Overall Study|Loss of bone mass|0|||
148708068|NCT00081653|536404619|FG001|Overall Study|Loss of bone mass|2|||
148708069|NCT01015287|536404622|FG000|Overall Study|Death|21|||
148708070|NCT01015287|536404623|FG001|Overall Study|Death|16|||
148708071|NCT01015287|536404622|FG000|Overall Study|Adverse Event|1|||
148708072|NCT01015287|536404623|FG001|Overall Study|Adverse Event|0|||
148708073|NCT01015287|536404622|FG000|Overall Study|Sponsor Decision|3|||
148815253|NCT00429299|536799446|FG000|Overall Study|Disease Progression|1|||
148708074|NCT01015287|536404623|FG001|Overall Study|Sponsor Decision|7|||
148708075|NCT01015287|536404622|FG000|Overall Study|Physician Decision|19|||
148708076|NCT01015287|536404623|FG001|Overall Study|Physician Decision|21|||
148708077|NCT01015287|536404622|FG000|Overall Study|Withdrawal by Subject|14|||
148708078|NCT01015287|536404623|FG001|Overall Study|Withdrawal by Subject|19|||
148708079|NCT01015287|536404622|FG000|Overall Study|Entry Criteria not Met|11|||
148708080|NCT01015287|536404623|FG001|Overall Study|Entry Criteria not Met|14|||
148708081|NCT01015287|536404622|FG000|Overall Study|Lost to Follow-up|2|||
148708082|NCT01015287|536404623|FG001|Overall Study|Lost to Follow-up|1|||
148708083|NCT01015287|536404622|FG000|Overall Study|Protocol Violation|1|||
148708084|NCT01015287|536404623|FG001|Overall Study|Protocol Violation|1|||
148708085|NCT01592240|536404624|FG000|Overall Study|Adverse Event|1|||
148708086|NCT01592240|536404625|FG001|Overall Study|Adverse Event|0|||
148708087|NCT01592240|536404626|FG002|Overall Study|Adverse Event|0|||
148708088|NCT01592240|536404627|FG003|Overall Study|Adverse Event|1|||
148708089|NCT01592240|536404628|FG004|Overall Study|Adverse Event|1|||
148708090|NCT01592240|536404629|FG005|Overall Study|Adverse Event|0|||
148708091|NCT01592240|536404630|FG006|Overall Study|Adverse Event|0|||
148708092|NCT01592240|536404624|FG000|Overall Study|Death|0|||
148708093|NCT01592240|536404625|FG001|Overall Study|Death|1|||
148708094|NCT01592240|536404626|FG002|Overall Study|Death|0|||
148708095|NCT01592240|536404627|FG003|Overall Study|Death|0|||
148708096|NCT01592240|536404628|FG004|Overall Study|Death|0|||
148708097|NCT01592240|536404629|FG005|Overall Study|Death|0|||
148708098|NCT01592240|536404630|FG006|Overall Study|Death|0|||
148708099|NCT01592240|536404624|FG000|Overall Study|Lost to Follow-up|1|||
148708100|NCT01592240|536404625|FG001|Overall Study|Lost to Follow-up|3|||
148708101|NCT01592240|536404626|FG002|Overall Study|Lost to Follow-up|1|||
148708102|NCT01592240|536404627|FG003|Overall Study|Lost to Follow-up|0|||
148708103|NCT01592240|536404628|FG004|Overall Study|Lost to Follow-up|3|||
148708104|NCT01592240|536404629|FG005|Overall Study|Lost to Follow-up|2|||
148708105|NCT01592240|536404630|FG006|Overall Study|Lost to Follow-up|0|||
148708106|NCT01592240|536404624|FG000|Overall Study|Protocol Violation|0|||
148708107|NCT01592240|536404625|FG001|Overall Study|Protocol Violation|0|||
148708108|NCT01592240|536404626|FG002|Overall Study|Protocol Violation|0|||
148708109|NCT01592240|536404627|FG003|Overall Study|Protocol Violation|0|||
148708110|NCT01592240|536404628|FG004|Overall Study|Protocol Violation|0|||
148708111|NCT01592240|536404629|FG005|Overall Study|Protocol Violation|1|||
148708112|NCT01592240|536404630|FG006|Overall Study|Protocol Violation|0|||
148708113|NCT01592240|536404624|FG000|Overall Study|Withdrawal by Subject|0|||
148708114|NCT01592240|536404625|FG001|Overall Study|Withdrawal by Subject|4|||
148708115|NCT01592240|536404626|FG002|Overall Study|Withdrawal by Subject|4|||
148708116|NCT01592240|536404627|FG003|Overall Study|Withdrawal by Subject|1|||
148708117|NCT01592240|536404628|FG004|Overall Study|Withdrawal by Subject|3|||
148708118|NCT01592240|536404629|FG005|Overall Study|Withdrawal by Subject|0|||
148708119|NCT01592240|536404630|FG006|Overall Study|Withdrawal by Subject|2|||
148708120|NCT01592240|536404624|FG000|Overall Study|Other|0|||
148708121|NCT01592240|536404625|FG001|Overall Study|Other|3|||
148708122|NCT01592240|536404626|FG002|Overall Study|Other|1|||
148708123|NCT01592240|536404627|FG003|Overall Study|Other|1|||
148708124|NCT01592240|536404628|FG004|Overall Study|Other|0|||
148708125|NCT01592240|536404629|FG005|Overall Study|Other|0|||
148708126|NCT01592240|536404630|FG006|Overall Study|Other|1|||
148708127|NCT01592240|536404624|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
148708128|NCT01592240|536404625|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
148708129|NCT01592240|536404626|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
148708130|NCT01592240|536404627|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
148708131|NCT01592240|536404628|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
148708132|NCT01592240|536404629|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
148708133|NCT01592240|536404630|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
148708134|NCT01117623|536404631|FG000|Overall Study|Adverse Event|0|||
148708135|NCT01117623|536404632|FG001|Overall Study|Adverse Event|2|||
148708136|NCT01117623|536404633|FG002|Overall Study|Adverse Event|4|||
148708137|NCT01117623|536404634|FG003|Overall Study|Adverse Event|0|||
148708138|NCT01117623|536404635|FG004|Overall Study|Adverse Event|2|||
148708139|NCT01117623|536404636|FG005|Overall Study|Adverse Event|0|||
148708140|NCT01117623|536404637|FG006|Overall Study|Adverse Event|0|||
148708141|NCT01117623|536404638|FG007|Overall Study|Adverse Event|2|||
148708142|NCT01117623|536404631|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
148708143|NCT01117623|536404632|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
148708144|NCT01117623|536404633|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
148708145|NCT01117623|536404634|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
148708146|NCT01117623|536404635|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
148708147|NCT01117623|536404636|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
148708148|NCT01117623|536404637|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
148708149|NCT01117623|536404638|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
148708150|NCT01117623|536404631|FG000|Overall Study|Withdrawal by Subject|0|||
148708151|NCT01117623|536404632|FG001|Overall Study|Withdrawal by Subject|0|||
148708152|NCT01117623|536404633|FG002|Overall Study|Withdrawal by Subject|2|||
148708153|NCT01117623|536404634|FG003|Overall Study|Withdrawal by Subject|0|||
148708154|NCT01117623|536404635|FG004|Overall Study|Withdrawal by Subject|0|||
148708155|NCT01117623|536404636|FG005|Overall Study|Withdrawal by Subject|1|||
148708156|NCT01117623|536404637|FG006|Overall Study|Withdrawal by Subject|1|||
148708157|NCT01117623|536404638|FG007|Overall Study|Withdrawal by Subject|1|||
148708158|NCT01117623|536404631|FG000|Overall Study|Non-compliance with study medication|0|||
148708159|NCT01117623|536404632|FG001|Overall Study|Non-compliance with study medication|0|||
148708160|NCT01117623|536404633|FG002|Overall Study|Non-compliance with study medication|0|||
148708161|NCT01117623|536404634|FG003|Overall Study|Non-compliance with study medication|0|||
148708162|NCT01117623|536404635|FG004|Overall Study|Non-compliance with study medication|0|||
148708163|NCT01117623|536404636|FG005|Overall Study|Non-compliance with study medication|0|||
148708164|NCT01117623|536404637|FG006|Overall Study|Non-compliance with study medication|0|||
148708165|NCT01117623|536404638|FG007|Overall Study|Non-compliance with study medication|1|||
148708166|NCT01117623|536404631|FG000|Overall Study|Invest. text: completed all planned txs|0|||
148708167|NCT01117623|536404632|FG001|Overall Study|Invest. text: completed all planned txs|0|||
148708168|NCT01117623|536404633|FG002|Overall Study|Invest. text: completed all planned txs|0|||
148708169|NCT01117623|536404634|FG003|Overall Study|Invest. text: completed all planned txs|0|||
148708170|NCT01117623|536404635|FG004|Overall Study|Invest. text: completed all planned txs|0|||
148708171|NCT01117623|536404636|FG005|Overall Study|Invest. text: completed all planned txs|1|||
148708172|NCT01117623|536404637|FG006|Overall Study|Invest. text: completed all planned txs|0|||
148708173|NCT01117623|536404638|FG007|Overall Study|Invest. text: completed all planned txs|0|||
148708174|NCT00469898|536404646|FG000|Overall Study|Adverse Event|7|||
148708175|NCT00469898|536404646|FG000|Overall Study|Withdrawal by Subject|4|||
148708176|NCT00469898|536404646|FG000|Overall Study|Death|4|||
148708177|NCT00469898|536404646|FG000|Overall Study|Disease progression|9|||
148708178|NCT00469898|536404646|FG000|Overall Study|Decreased performance status|1|||
148708179|NCT02663349|536404649|FG000|Overall Study|Withdrawal by Subject|6|||
148708180|NCT01572662|536404650|FG000|Overall Study|Withdrawal by Subject|1|||
148708181|NCT01572662|536404651|FG001|Overall Study|Withdrawal by Subject|0|||
148708182|NCT01572662|536404650|FG000|Overall Study|Physician Decision|0|||
148708183|NCT01572662|536404651|FG001|Overall Study|Physician Decision|1|||
148708184|NCT04547192|536404654|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
148708185|NCT04547192|536404655|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
148708186|NCT04547192|536404656|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
148708187|NCT04547192|536404657|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
148708188|NCT04547192|536404654|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
148708189|NCT04547192|536404655|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
148708190|NCT04547192|536404656|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
148708191|NCT04547192|536404657|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
148708192|NCT04547192|536404654|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
148708193|NCT04547192|536404655|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
148708194|NCT04547192|536404656|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
148708195|NCT04547192|536404657|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
148708196|NCT04547192|536404654|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
148708197|NCT04547192|536404655|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
148708198|NCT04547192|536404656|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
148708199|NCT04547192|536404657|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
148708200|NCT04547192|536404654|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
148708201|NCT04547192|536404655|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
148708202|NCT04547192|536404656|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
148708203|NCT04547192|536404657|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
148708204|NCT00935012|536404660|FG000|Overall Study|Death|19|||
148708205|NCT00935012|536404660|FG000|Overall Study|Withdrawal by Subject|3|||
148708206|NCT00935012|536404660|FG000|Overall Study|Other|5|||
148708207|NCT00935012|536404660|FG000|Overall Study|Adverse Event|2|||
148708208|NCT01442155|536404661|FG000|Overall Study|Complete remission|35|||
148708209|NCT01442155|536404661|FG000|Overall Study|Recurrence|26|||
148708210|NCT01442155|536404661|FG000|Overall Study|Adverse Event|2|||
148708211|NCT01442155|536404661|FG000|Overall Study|Lost to Follow-up|2|||
148708212|NCT01590563|536404670|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
148708213|NCT01952691|536406137|FG000|Overall Study|Lost to Follow-up|2|||
148815254|NCT00429299|536799447|FG001|Overall Study|Disease Progression|1|||
148708214|NCT00199901|536406138|FG000|Overall Study|Protocol Violation|2|||
148708215|NCT00199901|536406139|FG001|Overall Study|Protocol Violation|0|||
148708216|NCT00199901|536406138|FG000|Overall Study|Withdrawal by Subject|1|||
148815255|NCT00429299|536799448|FG002|Overall Study|Disease Progression|0|||
148708217|NCT00199901|536406139|FG001|Overall Study|Withdrawal by Subject|0|||
148708218|NCT00199901|536406138|FG000|Overall Study|Progressive Disease|24|||
148708219|NCT00199901|536406139|FG001|Overall Study|Progressive Disease|24|||
148708220|NCT01958294|536406149|FG000|Overall Study|Clinical Circumstances|2|||
148708221|NCT02566850|536406150|FG000|Overall Study|Protocol Violation|1|||
148708222|NCT03599193|536406151|FG000|Overall Study|Adverse Event|0|||
148708223|NCT03599193|536406152|FG001|Overall Study|Adverse Event|2|||
148815256|NCT00429299|536799446|FG000|Overall Study|Adverse Event|2|||
148708224|NCT03599193|536406151|FG000|Overall Study|Withdrawal by Subject|1|||
148708225|NCT03599193|536406152|FG001|Overall Study|Withdrawal by Subject|0|||
148708226|NCT03599193|536406151|FG000|Overall Study|Protocol Violation|1|||
148708227|NCT03599193|536406152|FG001|Overall Study|Protocol Violation|0|||
148708228|NCT03599193|536406151|FG000|Overall Study|Lost to Follow-up|0|||
148708229|NCT03599193|536406152|FG001|Overall Study|Lost to Follow-up|1|||
148708230|NCT00798603|536406153|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
148708231|NCT00798603|536406153|FG000|Overall Study|Withdrawal by Subject|10|||
148708232|NCT00798603|536406153|FG000|Overall Study|Adverse Event|22|||
148708233|NCT00798603|536406153|FG000|Overall Study|Physician Decision|1|||
148708234|NCT00798603|536406153|FG000|Overall Study|Lack of insurance coverage|1|||
148708235|NCT00928057|536406157|FG000|Overall Study|Adverse Event|1|||
148708236|NCT00928057|536406158|FG001|Overall Study|Adverse Event|2|||
148708237|NCT00928057|536406157|FG000|Overall Study|Withdrawal by Subject|1|||
148708238|NCT00928057|536406158|FG001|Overall Study|Withdrawal by Subject|0|||
148708239|NCT00928057|536406157|FG000|Overall Study|Lost to Follow-up|0|||
148708240|NCT00928057|536406158|FG001|Overall Study|Lost to Follow-up|1|||
148708241|NCT00928057|536406157|FG000|Overall Study|Protocol Violation|0|||
148708242|NCT00928057|536406158|FG001|Overall Study|Protocol Violation|1|||
148708243|NCT02451696|536406159|FG000|Overall Study|Surgery postponed|1|||
148708244|NCT02451696|536406160|FG001|Overall Study|Surgery postponed|0|||
148708245|NCT01557751|536406161|FG000|Overall Study|Physician Decision|3|||
148708246|NCT03674892|536406163|FG000|Overall Study|Lack of Efficacy|5|||
148708247|NCT03674892|536406163|FG000|Overall Study|Lost to Follow-up|3|||
148708248|NCT03674892|536406163|FG000|Overall Study|Migraine|2|||
148708249|NCT03674892|536406163|FG000|Overall Study|Excessive Tearing|1|||
148708250|NCT03674892|536406163|FG000|Overall Study|Increased Eye Pain|1|||
148708251|NCT03674892|536406163|FG000|Overall Study|Increased Facial Pain|1|||
148708252|NCT03674892|536406163|FG000|Overall Study|Sinus Irritation|1|||
148708253|NCT03674892|536406163|FG000|Overall Study|Sinus Infection|1|||
148708254|NCT05099380|536406164|FG000|Overall Study|Subject enrolled in error|1|||
148708255|NCT05099380|536406165|FG001|Overall Study|Subject enrolled in error|0|||
148708256|NCT05099380|536406164|FG000|Overall Study|Study Procedure|1|||
148708257|NCT05099380|536406165|FG001|Overall Study|Study Procedure|0|||
148708258|NCT05099380|536406164|FG000|Overall Study|Protocol Violation|1|||
148708259|NCT05099380|536406165|FG001|Overall Study|Protocol Violation|0|||
148708260|NCT05099380|536406164|FG000|Overall Study|Adverse Event|1|||
148708261|NCT05099380|536406165|FG001|Overall Study|Adverse Event|1|||
148708262|NCT05099380|536406164|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
148708263|NCT05099380|536406165|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
148708264|NCT02842853|536406166|FG000|Overall Study|Non-compliance with the protocol|3|||
148708265|NCT02842853|536406167|FG001|Overall Study|Non-compliance with the protocol|7|||
148708266|NCT02842853|536406168|FG002|Overall Study|Non-compliance with the protocol|2|||
148708267|NCT02842853|536406169|FG003|Overall Study|Non-compliance with the protocol|5|||
148708268|NCT02842853|536406166|FG000|Overall Study|Subject met exclusion criteria|0|||
148708269|NCT02842853|536406167|FG001|Overall Study|Subject met exclusion criteria|1|||
148708270|NCT02842853|536406168|FG002|Overall Study|Subject met exclusion criteria|0|||
148708271|NCT02842853|536406169|FG003|Overall Study|Subject met exclusion criteria|0|||
148708272|NCT02842853|536406166|FG000|Overall Study|Withdrawal by Subject|11|||
148708273|NCT02842853|536406167|FG001|Overall Study|Withdrawal by Subject|13|||
148708274|NCT02842853|536406168|FG002|Overall Study|Withdrawal by Subject|9|||
148708275|NCT02842853|536406169|FG003|Overall Study|Withdrawal by Subject|8|||
148708276|NCT02842853|536406166|FG000|Overall Study|Lost to Follow-up|9|||
148708277|NCT02842853|536406167|FG001|Overall Study|Lost to Follow-up|13|||
148708278|NCT02842853|536406168|FG002|Overall Study|Lost to Follow-up|10|||
148708279|NCT02842853|536406169|FG003|Overall Study|Lost to Follow-up|11|||
148708280|NCT04089553|536406170|FG000|Overall Study|Death|1|||
148708281|NCT04089553|536406171|FG001|Overall Study|Death|1|||
148708282|NCT04089553|536406170|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
148708283|NCT04089553|536406171|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
148708284|NCT04089553|536406170|FG000|Overall Study|Withdrawal by Subject|3|||
148708285|NCT04089553|536406171|FG001|Overall Study|Withdrawal by Subject|3|||
148708286|NCT04089553|536406170|FG000|Overall Study|Physician Decision|1|||
148967958|NCT00805766|537368588|FG000|Screening Period|Pregnancy|1|||
148967959|NCT00805766|537368588|FG000|Screening Period|Responder|2|||
148708287|NCT04089553|536406171|FG001|Overall Study|Physician Decision|0|||
148708288|NCT04089553|536406170|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
148708289|NCT04089553|536406171|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
148708290|NCT04089553|536406170|FG000|Overall Study|Other|1|||
148708291|NCT04089553|536406171|FG001|Overall Study|Other|0|||
148708292|NCT04089553|536406170|FG000|Overall Study|Adverse Event|1|||
148708293|NCT04089553|536406171|FG001|Overall Study|Adverse Event|1|||
148708294|NCT01175135|536406179|FG000|Overall Study|Adverse Event|2|||
148708295|NCT01175135|536406180|FG001|Overall Study|Adverse Event|5|||
148708296|NCT01175135|536406181|FG002|Overall Study|Adverse Event|3|||
148708297|NCT01175135|536406182|FG003|Overall Study|Adverse Event|4|||
148708298|NCT01175135|536406179|FG000|Overall Study|Death|1|||
148967960|NCT00805766|537368588|FG000|Increased Dose Period|Adverse Event|4|||
148967961|NCT00805766|537368588|FG000|Increased Dose Period|Lack of Efficacy|7|||
148967962|NCT00805766|537368588|FG000|Increased Dose Period|Pregnancy|1|||
148967963|NCT00805766|537368588|FG000|Increased Dose Period|Withdrawal by Subject|1|||
148967964|NCT03925324|537368589|FG000|Overall Study|Death|1|||
148967965|NCT03925324|537368590|FG001|Overall Study|Death|1|||
148967966|NCT00794196|537368591|FG000|Overall Study|Lost to Follow-up|5|||
148967967|NCT00794196|537368592|FG001|Overall Study|Lost to Follow-up|23|||
148967968|NCT02129803|537368598|FG000|Overall Study|Protocol Violation|4|||
148967969|NCT02129803|537368599|FG001|Overall Study|Protocol Violation|0|||
148967970|NCT02129803|537368598|FG000|Overall Study|Physician Decision|0|||
148967971|NCT02129803|537368599|FG001|Overall Study|Physician Decision|1|||
148967972|NCT02129803|537368598|FG000|Overall Study|Difficulty sleeping|1|||
148967973|NCT02129803|537368599|FG001|Overall Study|Difficulty sleeping|0|||
148967974|NCT02129803|537368598|FG000|Overall Study|Morning headache|0|||
148967975|NCT02129803|537368599|FG001|Overall Study|Morning headache|1|||
148708299|NCT01175135|536406180|FG001|Overall Study|Death|0|||
148708300|NCT01175135|536406181|FG002|Overall Study|Death|0|||
148708301|NCT01175135|536406182|FG003|Overall Study|Death|0|||
148708302|NCT01175135|536406179|FG000|Overall Study|Lack of Efficacy|4|||
148708303|NCT01175135|536406180|FG001|Overall Study|Lack of Efficacy|5|||
148708304|NCT01175135|536406181|FG002|Overall Study|Lack of Efficacy|0|||
148708305|NCT01175135|536406182|FG003|Overall Study|Lack of Efficacy|5|||
148708306|NCT01175135|536406179|FG000|Overall Study|Lost to Follow-up|1|||
148708307|NCT01175135|536406180|FG001|Overall Study|Lost to Follow-up|2|||
148708308|NCT01175135|536406181|FG002|Overall Study|Lost to Follow-up|0|||
148708309|NCT01175135|536406182|FG003|Overall Study|Lost to Follow-up|0|||
148708310|NCT01175135|536406179|FG000|Overall Study|Protocol Violation|1|||
148708311|NCT01175135|536406180|FG001|Overall Study|Protocol Violation|1|||
148708312|NCT01175135|536406181|FG002|Overall Study|Protocol Violation|0|||
148708313|NCT01175135|536406182|FG003|Overall Study|Protocol Violation|0|||
148708314|NCT01175135|536406179|FG000|Overall Study|Withdrawal by Subject|4|||
148708315|NCT01175135|536406180|FG001|Overall Study|Withdrawal by Subject|8|||
148708316|NCT01175135|536406181|FG002|Overall Study|Withdrawal by Subject|5|||
148708317|NCT01175135|536406182|FG003|Overall Study|Withdrawal by Subject|5|||
148708318|NCT01175135|536406179|FG000|Overall Study|Other|3|||
148708319|NCT01175135|536406180|FG001|Overall Study|Other|1|||
148708320|NCT01175135|536406181|FG002|Overall Study|Other|3|||
148708321|NCT01175135|536406182|FG003|Overall Study|Other|0|||
148708322|NCT01175135|536406179|FG000|Overall Study|Randomized But Not Treated|0|||
148708323|NCT01175135|536406180|FG001|Overall Study|Randomized But Not Treated|0|||
148708324|NCT01175135|536406181|FG002|Overall Study|Randomized But Not Treated|1|||
148708325|NCT01175135|536406182|FG003|Overall Study|Randomized But Not Treated|0|||
148708326|NCT03364192|536406183|FG000|Overall Study|Ineligible|10|||
148708327|NCT03364192|536406183|FG000|Overall Study|Withdrawal by Subject|5|||
148708328|NCT03364192|536406183|FG000|Overall Study|Lost to Follow-up|1|||
148708329|NCT04692155|536406184|FG000|Overall Study|Death|1|||
148708330|NCT02699463|536406185|FG000|Overall Study|Lost to Follow-up|11|||
148708331|NCT02699463|536406186|FG001|Overall Study|Lost to Follow-up|8|||
148708332|NCT02699463|536406185|FG000|Overall Study|Withdrawal by Subject|4|||
148708333|NCT02699463|536406186|FG001|Overall Study|Withdrawal by Subject|1|||
148708334|NCT01370733|536406187|FG000|Overall Study|Withdrawal by Subject|8|||
148708335|NCT01370733|536406188|FG001|Overall Study|Withdrawal by Subject|8|||
148708336|NCT01370733|536406187|FG000|Overall Study|Lost to Follow-up|3|||
148708337|NCT01370733|536406188|FG001|Overall Study|Lost to Follow-up|0|||
148708338|NCT01370733|536406187|FG000|Overall Study|Adverse Event|2|||
148708339|NCT01370733|536406188|FG001|Overall Study|Adverse Event|4|||
148708340|NCT01370733|536406187|FG000|Overall Study|Lack of Efficacy|3|||
148708341|NCT01370733|536406188|FG001|Overall Study|Lack of Efficacy|5|||
148708342|NCT01370733|536406187|FG000|Overall Study|Physician Decision|0|||
148708343|NCT01370733|536406188|FG001|Overall Study|Physician Decision|2|||
148708344|NCT01370733|536406187|FG000|Overall Study|Protocol Violation|1|||
148967976|NCT02129803|537368598|FG000|Overall Study|Withdrawal by Subject|1|||
148967977|NCT02129803|537368599|FG001|Overall Study|Withdrawal by Subject|1|||
148967978|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
148967979|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
148967980|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
148708345|NCT01370733|536406188|FG001|Overall Study|Protocol Violation|3|||
148708346|NCT02294981|536406189|FG000|Overall Study|Lost to Follow-up|1|||
148708347|NCT06539676|536406190|FG000|Overall Study|Early study termination|1|||
148708348|NCT06539676|536406191|FG001|Overall Study|Early study termination|0|||
148708349|NCT06539676|536406192|FG002|Overall Study|Early study termination|6|||
148708350|NCT00909038|536406195|FG000|Overall Study|Protocol Violation|187|||
148708351|NCT00909038|536406195|FG000|Overall Study|Non-evaluable Subjects|230|||
148708352|NCT00909753|536406198|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
148708353|NCT00909753|536406199|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
148708354|NCT00909753|536406198|FG000|Period: Second Intervention|Protocol Violation|1|||
148708355|NCT00909753|536406199|FG001|Period: Second Intervention|Protocol Violation|0|||
148708356|NCT03214588|536406200|FG000|Overall Study|Adverse Event|1|||
148708357|NCT03214588|536406201|FG001|Overall Study|Adverse Event|0|||
148708358|NCT03214588|536406202|FG002|Overall Study|Adverse Event|2|||
148708359|NCT03214588|536406200|FG000|Overall Study|Reason Not Specified|0|||
148708360|NCT03214588|536406201|FG001|Overall Study|Reason Not Specified|1|||
148708361|NCT03214588|536406202|FG002|Overall Study|Reason Not Specified|0|||
148708362|NCT01895335|536406203|FG000|Overall Study|Adverse Event|106|||
148708363|NCT01895335|536406203|FG000|Overall Study|Lack of Efficacy|53|||
148708364|NCT01895335|536406203|FG000|Overall Study|Poor Compliance to Protocol|11|||
148708365|NCT01895335|536406203|FG000|Overall Study|Included But Not treated|1|||
148708366|NCT01895335|536406203|FG000|Overall Study|Other than Specified Above|44|||
148708367|NCT01647828|536406204|FG000|Overall Study|Death|3|||
148708368|NCT01647828|536406205|FG001|Overall Study|Death|4|||
148708369|NCT01647828|536406206|FG002|Overall Study|Death|4|||
148708370|NCT01647828|536406207|FG003|Overall Study|Death|5|||
148708371|NCT01647828|536406208|FG004|Overall Study|Death|6|||
148708372|NCT01647828|536406209|FG005|Overall Study|Death|3|||
148708373|NCT01647828|536406210|FG006|Overall Study|Death|10|||
148708374|NCT01647828|536406211|FG007|Overall Study|Death|60|||
148708375|NCT01647828|536406212|FG008|Overall Study|Death|71|||
148708376|NCT01647828|536406204|FG000|Overall Study|Withdrawal by Subject|2|||
148708377|NCT01647828|536406205|FG001|Overall Study|Withdrawal by Subject|0|||
148708378|NCT01647828|536406206|FG002|Overall Study|Withdrawal by Subject|0|||
148708379|NCT01647828|536406207|FG003|Overall Study|Withdrawal by Subject|1|||
148708380|NCT01647828|536406208|FG004|Overall Study|Withdrawal by Subject|0|||
148708381|NCT01647828|536406209|FG005|Overall Study|Withdrawal by Subject|0|||
148708382|NCT01647828|536406210|FG006|Overall Study|Withdrawal by Subject|1|||
148708383|NCT01647828|536406211|FG007|Overall Study|Withdrawal by Subject|0|||
148708384|NCT01647828|536406212|FG008|Overall Study|Withdrawal by Subject|2|||
148708385|NCT01647828|536406204|FG000|Overall Study|Study terminated by Sponsor|0|||
148708386|NCT01647828|536406205|FG001|Overall Study|Study terminated by Sponsor|0|||
148708387|NCT01647828|536406206|FG002|Overall Study|Study terminated by Sponsor|0|||
148708388|NCT01647828|536406207|FG003|Overall Study|Study terminated by Sponsor|0|||
148708389|NCT01647828|536406208|FG004|Overall Study|Study terminated by Sponsor|0|||
148708390|NCT01647828|536406209|FG005|Overall Study|Study terminated by Sponsor|0|||
148708391|NCT01647828|536406210|FG006|Overall Study|Study terminated by Sponsor|1|||
148708392|NCT01647828|536406211|FG007|Overall Study|Study terminated by Sponsor|26|||
148708393|NCT01647828|536406212|FG008|Overall Study|Study terminated by Sponsor|16|||
148708394|NCT01647828|536406204|FG000|Overall Study|Lost to Follow-up|0|||
148708395|NCT01647828|536406205|FG001|Overall Study|Lost to Follow-up|0|||
148708396|NCT01647828|536406206|FG002|Overall Study|Lost to Follow-up|0|||
148708397|NCT01647828|536406207|FG003|Overall Study|Lost to Follow-up|0|||
148708398|NCT01647828|536406208|FG004|Overall Study|Lost to Follow-up|0|||
148708399|NCT01647828|536406209|FG005|Overall Study|Lost to Follow-up|0|||
148708400|NCT01647828|536406210|FG006|Overall Study|Lost to Follow-up|0|||
148708401|NCT01647828|536406211|FG007|Overall Study|Lost to Follow-up|2|||
148708402|NCT01647828|536406212|FG008|Overall Study|Lost to Follow-up|0|||
148708403|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
148708404|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
148708405|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
148708406|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
148708407|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
148708408|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
148708409|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Death|9|||
148708410|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Death|7|||
148708411|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Death|14|||
148708412|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Death|7|||
148708413|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Death|0|||
148708414|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Death|0|||
148708415|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
148708416|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
148708417|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
148708418|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
148708419|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
148708420|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
148708421|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Other Event|49|||
148708422|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Other Event|52|||
148708423|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Other Event|41|||
148708424|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Other Event|58|||
148708425|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Other Event|0|||
148708426|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Other Event|0|||
148708427|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
148708428|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
148708429|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
148708430|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
148708431|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
148708432|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
148708433|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
148708434|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
148708435|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
148708436|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
148708437|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
148708438|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
148708439|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
148708440|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
148708441|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
148708442|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
148708443|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
148708444|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
148708445|NCT00205777|536406215|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
148708446|NCT00205777|536406216|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
148708447|NCT00205777|536406217|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
148708448|NCT00205777|536406218|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
148708449|NCT00205777|536406219|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
148708450|NCT00205777|536406220|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
148708451|NCT00205777|536406215|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
148708452|NCT00205777|536406216|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
148708453|NCT00205777|536406217|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
148708454|NCT00205777|536406218|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
148708455|NCT00205777|536406219|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
148708456|NCT00205777|536406220|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
148708457|NCT00205777|536406215|FG000|Completed Core Study, Entered SE I|Other Event|52|||
148708458|NCT00205777|536406216|FG001|Completed Core Study, Entered SE I|Other Event|46|||
148708459|NCT00205777|536406217|FG002|Completed Core Study, Entered SE I|Other Event|47|||
148708460|NCT00205777|536406218|FG003|Completed Core Study, Entered SE I|Other Event|50|||
148708461|NCT00205777|536406219|FG004|Completed Core Study, Entered SE I|Other Event|0|||
148708462|NCT00205777|536406220|FG005|Completed Core Study, Entered SE I|Other Event|0|||
148708463|NCT00205777|536406215|FG000|Study Extension I|Adverse Event|57|||
148708464|NCT00205777|536406216|FG001|Study Extension I|Adverse Event|0|||
148708465|NCT00205777|536406217|FG002|Study Extension I|Adverse Event|0|||
148708466|NCT00205777|536406218|FG003|Study Extension I|Adverse Event|61|||
148708467|NCT00205777|536406219|FG004|Study Extension I|Adverse Event|58|||
148708468|NCT00205777|536406220|FG005|Study Extension I|Adverse Event|0|||
148708469|NCT00205777|536406215|FG000|Study Extension I|Death|5|||
148708470|NCT00205777|536406216|FG001|Study Extension I|Death|0|||
148708471|NCT00205777|536406217|FG002|Study Extension I|Death|0|||
148708472|NCT00205777|536406218|FG003|Study Extension I|Death|1|||
148708473|NCT00205777|536406219|FG004|Study Extension I|Death|2|||
148708474|NCT00205777|536406220|FG005|Study Extension I|Death|0|||
148708475|NCT00205777|536406215|FG000|Study Extension I|Withdrawal by Subject|99|||
148708476|NCT00205777|536406216|FG001|Study Extension I|Withdrawal by Subject|0|||
148708477|NCT00205777|536406217|FG002|Study Extension I|Withdrawal by Subject|0|||
148708478|NCT00205777|536406218|FG003|Study Extension I|Withdrawal by Subject|106|||
148708479|NCT00205777|536406219|FG004|Study Extension I|Withdrawal by Subject|89|||
148708480|NCT00205777|536406220|FG005|Study Extension I|Withdrawal by Subject|0|||
148708481|NCT00205777|536406215|FG000|Study Extension I|Protocol Violation|4|||
148708482|NCT00205777|536406216|FG001|Study Extension I|Protocol Violation|0|||
148708483|NCT00205777|536406217|FG002|Study Extension I|Protocol Violation|0|||
148708484|NCT00205777|536406218|FG003|Study Extension I|Protocol Violation|8|||
148708485|NCT00205777|536406219|FG004|Study Extension I|Protocol Violation|8|||
148708486|NCT00205777|536406220|FG005|Study Extension I|Protocol Violation|0|||
148708487|NCT00205777|536406215|FG000|Study Extension I|Lack of Efficacy|0|||
148708488|NCT00205777|536406216|FG001|Study Extension I|Lack of Efficacy|0|||
148708489|NCT00205777|536406217|FG002|Study Extension I|Lack of Efficacy|0|||
148708490|NCT00205777|536406218|FG003|Study Extension I|Lack of Efficacy|1|||
148708491|NCT00205777|536406219|FG004|Study Extension I|Lack of Efficacy|2|||
148708492|NCT00205777|536406220|FG005|Study Extension I|Lack of Efficacy|0|||
148708493|NCT00205777|536406215|FG000|Study Extension I|Failed to return|15|||
148708494|NCT00205777|536406216|FG001|Study Extension I|Failed to return|0|||
148708495|NCT00205777|536406217|FG002|Study Extension I|Failed to return|0|||
148708496|NCT00205777|536406218|FG003|Study Extension I|Failed to return|17|||
148708497|NCT00205777|536406219|FG004|Study Extension I|Failed to return|13|||
148708498|NCT00205777|536406220|FG005|Study Extension I|Failed to return|0|||
148708499|NCT00205777|536406215|FG000|Study Extension I|Other Event|34|||
148708500|NCT00205777|536406216|FG001|Study Extension I|Other Event|0|||
148708501|NCT00205777|536406217|FG002|Study Extension I|Other Event|0|||
148708502|NCT00205777|536406218|FG003|Study Extension I|Other Event|34|||
148708503|NCT00205777|536406219|FG004|Study Extension I|Other Event|29|||
148708504|NCT00205777|536406220|FG005|Study Extension I|Other Event|0|||
148708505|NCT00205777|536406215|FG000|Study Extension I|Withdrawn as per protocol|0|||
148708506|NCT00205777|536406216|FG001|Study Extension I|Withdrawn as per protocol|0|||
148708507|NCT00205777|536406217|FG002|Study Extension I|Withdrawn as per protocol|1070|||
148708508|NCT00205777|536406218|FG003|Study Extension I|Withdrawn as per protocol|0|||
148708509|NCT00205777|536406219|FG004|Study Extension I|Withdrawn as per protocol|0|||
148708510|NCT00205777|536406220|FG005|Study Extension I|Withdrawn as per protocol|0|||
148708511|NCT00205777|536406215|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
148708512|NCT00205777|536406216|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
148708513|NCT00205777|536406217|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
148708514|NCT00205777|536406218|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
148708515|NCT00205777|536406219|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
148708516|NCT00205777|536406220|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
148708517|NCT00205777|536406215|FG000|Study Extension II|Adverse Event|0|||
148708518|NCT00205777|536406216|FG001|Study Extension II|Adverse Event|0|||
148708519|NCT00205777|536406217|FG002|Study Extension II|Adverse Event|0|||
148708520|NCT00205777|536406218|FG003|Study Extension II|Adverse Event|14|||
148708521|NCT00205777|536406219|FG004|Study Extension II|Adverse Event|0|||
148708522|NCT00205777|536406220|FG005|Study Extension II|Adverse Event|30|||
148708523|NCT00205777|536406215|FG000|Study Extension II|Death|0|||
148708524|NCT00205777|536406216|FG001|Study Extension II|Death|0|||
148708525|NCT00205777|536406217|FG002|Study Extension II|Death|0|||
148708526|NCT00205777|536406218|FG003|Study Extension II|Death|2|||
148708527|NCT00205777|536406219|FG004|Study Extension II|Death|0|||
148708528|NCT00205777|536406220|FG005|Study Extension II|Death|5|||
148708529|NCT00205777|536406215|FG000|Study Extension II|Withdrawal by Subject|0|||
148708530|NCT00205777|536406216|FG001|Study Extension II|Withdrawal by Subject|0|||
148708531|NCT00205777|536406217|FG002|Study Extension II|Withdrawal by Subject|0|||
148708532|NCT00205777|536406218|FG003|Study Extension II|Withdrawal by Subject|35|||
148708533|NCT00205777|536406219|FG004|Study Extension II|Withdrawal by Subject|0|||
148708534|NCT00205777|536406220|FG005|Study Extension II|Withdrawal by Subject|59|||
148708535|NCT00205777|536406215|FG000|Study Extension II|Protocol Violation|0|||
148708536|NCT00205777|536406216|FG001|Study Extension II|Protocol Violation|0|||
148708537|NCT00205777|536406217|FG002|Study Extension II|Protocol Violation|0|||
148708538|NCT00205777|536406218|FG003|Study Extension II|Protocol Violation|1|||
148708539|NCT00205777|536406219|FG004|Study Extension II|Protocol Violation|0|||
148708540|NCT00205777|536406220|FG005|Study Extension II|Protocol Violation|10|||
148708541|NCT00205777|536406215|FG000|Study Extension II|Lack of Efficacy|0|||
148708542|NCT00205777|536406216|FG001|Study Extension II|Lack of Efficacy|0|||
148708543|NCT00205777|536406217|FG002|Study Extension II|Lack of Efficacy|0|||
148708544|NCT00205777|536406218|FG003|Study Extension II|Lack of Efficacy|0|||
148708545|NCT00205777|536406219|FG004|Study Extension II|Lack of Efficacy|0|||
148708546|NCT00205777|536406220|FG005|Study Extension II|Lack of Efficacy|1|||
148708547|NCT00205777|536406215|FG000|Study Extension II|Failed to return|0|||
148708548|NCT00205777|536406216|FG001|Study Extension II|Failed to return|0|||
148708549|NCT00205777|536406217|FG002|Study Extension II|Failed to return|0|||
148708550|NCT00205777|536406218|FG003|Study Extension II|Failed to return|14|||
148708551|NCT00205777|536406219|FG004|Study Extension II|Failed to return|0|||
148708552|NCT00205777|536406220|FG005|Study Extension II|Failed to return|26|||
148708553|NCT00205777|536406215|FG000|Study Extension II|Other Event|0|||
148708554|NCT00205777|536406216|FG001|Study Extension II|Other Event|0|||
148708555|NCT00205777|536406217|FG002|Study Extension II|Other Event|0|||
148708556|NCT00205777|536406218|FG003|Study Extension II|Other Event|12|||
148708557|NCT00205777|536406219|FG004|Study Extension II|Other Event|0|||
148708558|NCT00205777|536406220|FG005|Study Extension II|Other Event|20|||
148708559|NCT00205777|536406215|FG000|Study Extension II|Enrolled but not treated|0|||
148708560|NCT00205777|536406216|FG001|Study Extension II|Enrolled but not treated|0|||
148708561|NCT00205777|536406217|FG002|Study Extension II|Enrolled but not treated|0|||
148708562|NCT00205777|536406218|FG003|Study Extension II|Enrolled but not treated|71|||
148708563|NCT00205777|536406219|FG004|Study Extension II|Enrolled but not treated|0|||
148708564|NCT00205777|536406220|FG005|Study Extension II|Enrolled but not treated|131|||
148708565|NCT00700739|536406223|FG000|Overall Study|Lost to Follow-up|4|||
148708566|NCT00700739|536406224|FG001|Overall Study|Lost to Follow-up|4|||
148708567|NCT00185458|536406228|FG000|Contraception Phase|Adverse Event|37|||
148708568|NCT00185458|536406228|FG000|Contraception Phase|Lost to Follow-up|10|||
148708569|NCT00185458|536406228|FG000|Contraception Phase|Protocol Violation|2|||
148708570|NCT00185458|536406228|FG000|Contraception Phase|Physician Decision|2|||
148708571|NCT00185458|536406228|FG000|Contraception Phase|Withdrawal by Subject|7|||
148708572|NCT00185458|536406228|FG000|HRT Phase|Adverse Event|18|||
148708573|NCT00185458|536406228|FG000|HRT Phase|Lost to Follow-up|4|||
148708574|NCT00185458|536406228|FG000|HRT Phase|Protocol Violation|2|||
148708575|NCT00185458|536406228|FG000|HRT Phase|Withdrawal by Subject|3|||
148708576|NCT03503318|536406230|FG000|Overall Study|Death|1|||
148708577|NCT03503318|536406231|FG001|Overall Study|Death|0|||
148708578|NCT03503318|536406232|FG002|Overall Study|Death|4|||
148708579|NCT03503318|536406230|FG000|Overall Study|Adverse Event|3|||
148708580|NCT03503318|536406231|FG001|Overall Study|Adverse Event|4|||
148708581|NCT03503318|536406232|FG002|Overall Study|Adverse Event|2|||
148708582|NCT03503318|536406230|FG000|Overall Study|Withdrawal by Subject|12|||
148708583|NCT03503318|536406231|FG001|Overall Study|Withdrawal by Subject|17|||
148708584|NCT03503318|536406232|FG002|Overall Study|Withdrawal by Subject|16|||
148708585|NCT03503318|536406230|FG000|Overall Study|Protocol Violation|5|||
148708586|NCT03503318|536406231|FG001|Overall Study|Protocol Violation|0|||
148708587|NCT03503318|536406232|FG002|Overall Study|Protocol Violation|3|||
148708588|NCT03503318|536406230|FG000|Overall Study|Lost to Follow-up|17|||
148708589|NCT03503318|536406231|FG001|Overall Study|Lost to Follow-up|15|||
148708590|NCT03503318|536406232|FG002|Overall Study|Lost to Follow-up|12|||
148708591|NCT03503318|536406230|FG000|Overall Study|Other than specified|1|||
148708592|NCT03503318|536406231|FG001|Overall Study|Other than specified|3|||
148708593|NCT03503318|536406232|FG002|Overall Study|Other than specified|3|||
148708594|NCT01794845|536406233|FG000|Overall Study|Withdrawal by Subject|1|||
148708595|NCT02139826|536406234|FG000|Overall Study|Adverse Event|1|||
148708596|NCT00436163|536406237|FG000|Overall Study|Lost to Follow-up|2|||
148708597|NCT00436163|536406237|FG000|Overall Study|Adverse Event|1|||
148708598|NCT03719040|536406238|FG000|Overall Study|Withdrawal by Subject|177|||
148708599|NCT03719040|536406238|FG000|Overall Study|Lost to Follow-up|26|||
148708600|NCT06647173|536406242|FG000|Overall Study|Lost to Follow-up|24|||
148708601|NCT02923349|536406243|FG000|Overall Study|Other|1|||
148708602|NCT02923349|536406244|FG001|Overall Study|Other|2|||
148708603|NCT02923349|536406245|FG002|Overall Study|Other|4|||
148708604|NCT02923349|536406246|FG003|Overall Study|Other|1|||
148708605|NCT02923349|536406247|FG004|Overall Study|Other|3|||
148708606|NCT02923349|536406248|FG005|Overall Study|Other|0|||
148708607|NCT02923349|536406249|FG006|Overall Study|Other|1|||
148708608|NCT02923349|536406243|FG000|Overall Study|Withdrawal by Subject|2|||
148708609|NCT02923349|536406244|FG001|Overall Study|Withdrawal by Subject|2|||
148708610|NCT02923349|536406245|FG002|Overall Study|Withdrawal by Subject|8|||
148708611|NCT02923349|536406246|FG003|Overall Study|Withdrawal by Subject|10|||
148708612|NCT02923349|536406247|FG004|Overall Study|Withdrawal by Subject|12|||
148708613|NCT02923349|536406248|FG005|Overall Study|Withdrawal by Subject|3|||
148708614|NCT02923349|536406249|FG006|Overall Study|Withdrawal by Subject|0|||
148708615|NCT02923349|536406243|FG000|Overall Study|Physician Decision|0|||
148708616|NCT02923349|536406244|FG001|Overall Study|Physician Decision|0|||
148708617|NCT02923349|536406245|FG002|Overall Study|Physician Decision|0|||
148708618|NCT02923349|536406246|FG003|Overall Study|Physician Decision|1|||
148708619|NCT02923349|536406247|FG004|Overall Study|Physician Decision|1|||
148708620|NCT02923349|536406248|FG005|Overall Study|Physician Decision|0|||
148708621|NCT02923349|536406249|FG006|Overall Study|Physician Decision|2|||
148708622|NCT02923349|536406243|FG000|Overall Study|Lost to Follow-up|0|||
148708623|NCT02923349|536406244|FG001|Overall Study|Lost to Follow-up|0|||
148708624|NCT02923349|536406245|FG002|Overall Study|Lost to Follow-up|3|||
148708625|NCT02923349|536406246|FG003|Overall Study|Lost to Follow-up|0|||
148708626|NCT02923349|536406247|FG004|Overall Study|Lost to Follow-up|1|||
148708627|NCT02923349|536406248|FG005|Overall Study|Lost to Follow-up|1|||
148708628|NCT02923349|536406249|FG006|Overall Study|Lost to Follow-up|0|||
148708629|NCT02923349|536406243|FG000|Overall Study|Death|1|||
148708630|NCT02923349|536406244|FG001|Overall Study|Death|0|||
148708631|NCT02923349|536406245|FG002|Overall Study|Death|2|||
148708632|NCT02923349|536406246|FG003|Overall Study|Death|4|||
148708633|NCT02923349|536406247|FG004|Overall Study|Death|2|||
148708634|NCT02923349|536406248|FG005|Overall Study|Death|3|||
148708635|NCT02923349|536406249|FG006|Overall Study|Death|0|||
148708636|NCT01120028|536406252|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
148708637|NCT01120028|536406253|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
148708638|NCT01120028|536406254|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
148708639|NCT01120028|536406255|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
148708640|NCT01120028|536406252|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
148708641|NCT01120028|536406253|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
148708642|NCT01120028|536406254|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
148708643|NCT01120028|536406255|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
149025102|NCT01813422|537568018|FG001|Overall Study|Withdrawal by Subject|8|||
149025103|NCT01813422|537568017|FG000|Overall Study|Death|2|||
149025104|NCT01813422|537568018|FG001|Overall Study|Death|3|||
149025105|NCT01813422|537568017|FG000|Overall Study|Sponsor Decision|2|||
148708644|NCT03250117|536406256|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
148708645|NCT03250117|536406257|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
148708646|NCT03250117|536406258|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
148708647|NCT03250117|536406259|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
148708648|NCT04063878|536406260|FG000|Overall Study|Withdrawal by Subject|2|||
148708649|NCT04063878|536406260|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
148708650|NCT02751827|536406261|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
148708651|NCT02751827|536406262|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
149025106|NCT01813422|537568018|FG001|Overall Study|Sponsor Decision|1|||
149025107|NCT01813422|537568017|FG000|Overall Study|Lost to Follow-up|2|||
148708652|NCT02751827|536406263|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
148708653|NCT01248728|536406264|FG000|Overall Study|Adverse Event|1|||
148708654|NCT01248728|536406265|FG001|Overall Study|Adverse Event|1|||
148708655|NCT01248728|536406264|FG000|Overall Study|Withdrawal by Subject|2|||
148708656|NCT01248728|536406265|FG001|Overall Study|Withdrawal by Subject|1|||
148708657|NCT01248728|536406264|FG000|Overall Study|Lack of Efficacy|1|||
148708658|NCT01248728|536406265|FG001|Overall Study|Lack of Efficacy|0|||
148708659|NCT01841554|536406266|FG000|Overall Study|Death|7|||
148708660|NCT01841554|536406266|FG000|Overall Study|No Implantation|1|||
148708661|NCT01841554|536406266|FG000|Overall Study|Discontinued Follow Up|5|||
148708662|NCT01841554|536406266|FG000|Overall Study|Study exit due to secondary intervention|6|||
148708663|NCT01838681|536406270|FG000|Period A|Adverse Event|39|||
148708664|NCT01838681|536406271|FG001|Period A|Adverse Event|0|||
148708665|NCT01838681|536406272|FG002|Period A|Adverse Event|0|||
148708666|NCT01838681|536406273|FG003|Period A|Adverse Event|0|||
148708667|NCT01838681|536406270|FG000|Period A|Lack of Efficacy|21|||
148708668|NCT01838681|536406271|FG001|Period A|Lack of Efficacy|0|||
148708669|NCT01838681|536406272|FG002|Period A|Lack of Efficacy|0|||
148708670|NCT01838681|536406273|FG003|Period A|Lack of Efficacy|0|||
148708671|NCT01838681|536406270|FG000|Period A|Early response|148|||
148708672|NCT01838681|536406271|FG001|Period A|Early response|0|||
148708673|NCT01838681|536406272|FG002|Period A|Early response|0|||
148708674|NCT01838681|536406273|FG003|Period A|Early response|0|||
148708675|NCT01838681|536406270|FG000|Period A|Withdrawal by Subject|70|||
148708676|NCT01838681|536406271|FG001|Period A|Withdrawal by Subject|0|||
148708677|NCT01838681|536406272|FG002|Period A|Withdrawal by Subject|0|||
148708678|NCT01838681|536406273|FG003|Period A|Withdrawal by Subject|0|||
148708679|NCT01838681|536406270|FG000|Period A|Protocol Violation|16|||
148708680|NCT01838681|536406271|FG001|Period A|Protocol Violation|0|||
148708681|NCT01838681|536406272|FG002|Period A|Protocol Violation|0|||
148708682|NCT01838681|536406273|FG003|Period A|Protocol Violation|0|||
148708683|NCT01838681|536406270|FG000|Period A|Non-compliance with IMP|6|||
148708684|NCT01838681|536406271|FG001|Period A|Non-compliance with IMP|0|||
148708685|NCT01838681|536406272|FG002|Period A|Non-compliance with IMP|0|||
148708686|NCT01838681|536406273|FG003|Period A|Non-compliance with IMP|0|||
148708687|NCT01838681|536406270|FG000|Period A|Lost to Follow-up|4|||
148708688|NCT01838681|536406271|FG001|Period A|Lost to Follow-up|0|||
148708689|NCT01838681|536406272|FG002|Period A|Lost to Follow-up|0|||
148708690|NCT01838681|536406273|FG003|Period A|Lost to Follow-up|0|||
148708691|NCT01838681|536406270|FG000|Period A|Withdrawal before treatment|4|||
148708692|NCT01838681|536406271|FG001|Period A|Withdrawal before treatment|0|||
148708693|NCT01838681|536406272|FG002|Period A|Withdrawal before treatment|0|||
148708694|NCT01838681|536406273|FG003|Period A|Withdrawal before treatment|0|||
148708695|NCT01838681|536406270|FG000|Period A|Administrative or other reasons|17|||
148708696|NCT01838681|536406271|FG001|Period A|Administrative or other reasons|0|||
148708697|NCT01838681|536406272|FG002|Period A|Administrative or other reasons|0|||
148708698|NCT01838681|536406273|FG003|Period A|Administrative or other reasons|0|||
148708699|NCT01838681|536406270|FG000|Period B/A+|Adverse Event|0|||
148708700|NCT01838681|536406271|FG001|Period B/A+|Adverse Event|13|||
148708701|NCT01838681|536406272|FG002|Period B/A+|Adverse Event|27|||
148708702|NCT01838681|536406273|FG003|Period B/A+|Adverse Event|16|||
148708703|NCT01838681|536406270|FG000|Period B/A+|Lack of Efficacy|0|||
148708704|NCT01838681|536406271|FG001|Period B/A+|Lack of Efficacy|9|||
148967981|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
148967982|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
148967983|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
148967984|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
148967985|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
148967986|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
148967987|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
148967988|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
148967989|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
148967990|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
148967991|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
148708705|NCT01838681|536406272|FG002|Period B/A+|Lack of Efficacy|11|||
148708706|NCT01838681|536406273|FG003|Period B/A+|Lack of Efficacy|6|||
148708707|NCT01838681|536406270|FG000|Period B/A+|Withdrawal by Subject|0|||
148708708|NCT01838681|536406271|FG001|Period B/A+|Withdrawal by Subject|28|||
148967992|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
148967993|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
148967994|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
148708709|NCT01838681|536406272|FG002|Period B/A+|Withdrawal by Subject|35|||
148708710|NCT01838681|536406273|FG003|Period B/A+|Withdrawal by Subject|47|||
148708711|NCT01838681|536406270|FG000|Period B/A+|Protocol Violation|0|||
148708712|NCT01838681|536406271|FG001|Period B/A+|Protocol Violation|1|||
148708713|NCT01838681|536406272|FG002|Period B/A+|Protocol Violation|4|||
148708714|NCT01838681|536406273|FG003|Period B/A+|Protocol Violation|6|||
148708715|NCT01838681|536406270|FG000|Period B/A+|Non-compliance with IMP|0|||
148708716|NCT01838681|536406271|FG001|Period B/A+|Non-compliance with IMP|2|||
148708717|NCT01838681|536406272|FG002|Period B/A+|Non-compliance with IMP|3|||
148708718|NCT01838681|536406273|FG003|Period B/A+|Non-compliance with IMP|3|||
148708719|NCT01838681|536406270|FG000|Period B/A+|Lost to Follow-up|0|||
148708720|NCT01838681|536406271|FG001|Period B/A+|Lost to Follow-up|2|||
148708721|NCT01838681|536406272|FG002|Period B/A+|Lost to Follow-up|5|||
148708722|NCT01838681|536406273|FG003|Period B/A+|Lost to Follow-up|11|||
148708723|NCT01838681|536406270|FG000|Period B/A+|Withdrawal before treatment|0|||
148708724|NCT01838681|536406271|FG001|Period B/A+|Withdrawal before treatment|1|||
148708725|NCT01838681|536406272|FG002|Period B/A+|Withdrawal before treatment|0|||
148708726|NCT01838681|536406273|FG003|Period B/A+|Withdrawal before treatment|0|||
148708727|NCT01838681|536406270|FG000|Period B/A+|Administrative or other reasons|0|||
148708728|NCT01838681|536406271|FG001|Period B/A+|Administrative or other reasons|6|||
148708729|NCT01838681|536406272|FG002|Period B/A+|Administrative or other reasons|10|||
148708730|NCT01838681|536406273|FG003|Period B/A+|Administrative or other reasons|28|||
148708731|NCT00796562|536406274|FG000|Overall Study|Death|49|||
148708732|NCT00424047|536406275|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
148708733|NCT00424047|536406276|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
148708734|NCT00424047|536406275|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
148708735|NCT00424047|536406276|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
148708736|NCT00424047|536406275|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
148708737|NCT00424047|536406276|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
148708738|NCT00424047|536406275|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
148708739|NCT00424047|536406276|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
148708740|NCT00424047|536406275|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
148708741|NCT00424047|536406276|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
148708742|NCT00424047|536406275|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
148708743|NCT00424047|536406276|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
148708744|NCT00424047|536406275|FG000|On Study at Time of Unblinding|Adverse Event|22|||
148708745|NCT00424047|536406276|FG001|On Study at Time of Unblinding|Adverse Event|12|||
148708746|NCT00424047|536406275|FG000|On Study at Time of Unblinding|Progression of disease|92|||
148708747|NCT00424047|536406276|FG001|On Study at Time of Unblinding|Progression of disease|128|||
148708748|NCT00424047|536406275|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
148708749|NCT00424047|536406276|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
148708750|NCT00424047|536406275|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
148708751|NCT00424047|536406276|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
148708752|NCT00424047|536406275|FG000|On Study at Time of Unblinding|Death|11|||
148708753|NCT00424047|536406276|FG001|On Study at Time of Unblinding|Death|11|||
148708754|NCT00424047|536406275|FG000|On Study at Time of Unblinding|Other|5|||
148708755|NCT00424047|536406276|FG001|On Study at Time of Unblinding|Other|4|||
148708756|NCT00424047|536406275|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
148708757|NCT00424047|536406276|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
148708758|NCT00424047|536406275|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
148708759|NCT00424047|536406276|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
148708760|NCT00424047|536406275|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
148708761|NCT00424047|536406276|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
148708762|NCT00424047|536406275|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
148708763|NCT00424047|536406276|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
148708764|NCT00424047|536406275|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
148708765|NCT00424047|536406276|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
148708766|NCT01010503|536406278|FG000|Overall Study|Adverse Event|1|||
148708767|NCT01010503|536406278|FG000|Overall Study|Death|1|||
148708768|NCT00640341|536407723|FG000|Overall Study|Adverse Event|0|||
148708769|NCT00640341|536407724|FG001|Overall Study|Adverse Event|0|||
148708770|NCT00640341|536407725|FG002|Overall Study|Adverse Event|1|||
148708771|NCT00640341|536407723|FG000|Overall Study|Positive Slit Lamp Findings|0|||
148708772|NCT00640341|536407724|FG001|Overall Study|Positive Slit Lamp Findings|0|||
148708773|NCT00640341|536407725|FG002|Overall Study|Positive Slit Lamp Findings|1|||
148708774|NCT00640341|536407723|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
148708775|NCT00640341|536407724|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
148708776|NCT00640341|536407725|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
148708777|NCT00640341|536407723|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
148708778|NCT00640341|536407724|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
148708779|NCT00640341|536407725|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
148708780|NCT00640341|536407723|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
148708781|NCT00640341|536407724|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
148708782|NCT00640341|536407725|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
148708783|NCT00640341|536407723|FG000|Overall Study|Lost to Follow-up|2|||
148708784|NCT00640341|536407724|FG001|Overall Study|Lost to Follow-up|0|||
148708785|NCT00640341|536407725|FG002|Overall Study|Lost to Follow-up|0|||
148708786|NCT00640341|536407723|FG000|Overall Study|Withdrawal by Subject|4|||
148708787|NCT00640341|536407724|FG001|Overall Study|Withdrawal by Subject|0|||
148708788|NCT00640341|536407725|FG002|Overall Study|Withdrawal by Subject|1|||
148708789|NCT00640341|536407723|FG000|Overall Study|Unacceptable Lens Movement|1|||
148708790|NCT00640341|536407724|FG001|Overall Study|Unacceptable Lens Movement|0|||
148708791|NCT00640341|536407725|FG002|Overall Study|Unacceptable Lens Movement|0|||
148708792|NCT00640341|536407723|FG000|Overall Study|Poor fit/Uncomfortable|4|||
148708793|NCT00640341|536407724|FG001|Overall Study|Poor fit/Uncomfortable|0|||
148708794|NCT00640341|536407725|FG002|Overall Study|Poor fit/Uncomfortable|0|||
148708795|NCT00640341|536407723|FG000|Overall Study|Ineligable at Baseline|5|||
148708796|NCT00640341|536407724|FG001|Overall Study|Ineligable at Baseline|3|||
148708797|NCT00640341|536407725|FG002|Overall Study|Ineligable at Baseline|2|||
148708798|NCT00640341|536407723|FG000|Overall Study|Adverse event and positive slit lamp|1|||
148708799|NCT00640341|536407724|FG001|Overall Study|Adverse event and positive slit lamp|0|||
148708800|NCT00640341|536407725|FG002|Overall Study|Adverse event and positive slit lamp|0|||
148708801|NCT03578809|536407726|FG000|Overall Study|Death|0|||
148708802|NCT03578809|536407727|FG001|Overall Study|Death|2|||
148708803|NCT03578809|536407728|FG002|Overall Study|Death|0|||
148708804|NCT03578809|536407729|FG003|Overall Study|Death|1|||
148708805|NCT03578809|536407726|FG000|Overall Study|Lost to Follow-up|0|||
148708806|NCT03578809|536407727|FG001|Overall Study|Lost to Follow-up|1|||
148708807|NCT03578809|536407728|FG002|Overall Study|Lost to Follow-up|0|||
148708808|NCT03578809|536407729|FG003|Overall Study|Lost to Follow-up|0|||
148708809|NCT03578809|536407726|FG000|Overall Study|Withdrawal by Subject|3|||
148708810|NCT03578809|536407727|FG001|Overall Study|Withdrawal by Subject|5|||
148708811|NCT03578809|536407728|FG002|Overall Study|Withdrawal by Subject|2|||
148708812|NCT03578809|536407729|FG003|Overall Study|Withdrawal by Subject|0|||
148708813|NCT03578809|536407726|FG000|Overall Study|Other|3|||
148708814|NCT03578809|536407727|FG001|Overall Study|Other|6|||
148708815|NCT03578809|536407728|FG002|Overall Study|Other|2|||
148708816|NCT03578809|536407729|FG003|Overall Study|Other|8|||
148708817|NCT00830258|536407730|FG000|First Intervention|Adverse Event|1|||
148708818|NCT00830258|536407731|FG001|First Intervention|Adverse Event|0|||
148708819|NCT00830258|536407730|FG000|Washout: 7 Days|Protocol Violation|1|||
148708820|NCT00830258|536407731|FG001|Washout: 7 Days|Protocol Violation|0|||
148708821|NCT03206749|536407734|FG000|Overall Study|Withdrawal of consent|5|||
148708822|NCT03206749|536407735|FG001|Overall Study|Withdrawal of consent|3|||
148708823|NCT03206749|536407736|FG002|Overall Study|Withdrawal of consent|6|||
148708824|NCT03206749|536407734|FG000|Overall Study|Lost to Follow-up|0|||
148708825|NCT03206749|536407735|FG001|Overall Study|Lost to Follow-up|0|||
148708826|NCT03206749|536407736|FG002|Overall Study|Lost to Follow-up|1|||
148708827|NCT02752074|536407737|FG000|Overall Study|Lost to Follow-up|1|||
148708828|NCT02752074|536407738|FG001|Overall Study|Lost to Follow-up|4|||
148708829|NCT02752074|536407737|FG000|Overall Study|Death|146|||
148708830|NCT02752074|536407738|FG001|Overall Study|Death|129|||
148708831|NCT02752074|536407737|FG000|Overall Study|Withdrawal by Subject|9|||
148708832|NCT02752074|536407738|FG001|Overall Study|Withdrawal by Subject|10|||
148708833|NCT00488774|536407739|FG000|Overall Study|Withdrawal of consent|2|||
148708834|NCT00488774|536407740|FG001|Overall Study|Withdrawal of consent|2|||
148708835|NCT00488774|536407741|FG002|Overall Study|Withdrawal of consent|2|||
148708836|NCT00488774|536407742|FG003|Overall Study|Withdrawal of consent|0|||
148708837|NCT00488774|536407739|FG000|Overall Study|Other|6|||
148708838|NCT00488774|536407740|FG001|Overall Study|Other|3|||
148708839|NCT00488774|536407741|FG002|Overall Study|Other|2|||
148708840|NCT00488774|536407742|FG003|Overall Study|Other|2|||
148708841|NCT00488774|536407739|FG000|Overall Study|Lost to Follow-up|0|||
148708842|NCT00488774|536407740|FG001|Overall Study|Lost to Follow-up|0|||
148708843|NCT00488774|536407741|FG002|Overall Study|Lost to Follow-up|1|||
148708844|NCT00488774|536407742|FG003|Overall Study|Lost to Follow-up|1|||
148708845|NCT05523895|536407743|FG000|Overall Study|Adverse Event|2|||
148708846|NCT05523895|536407744|FG001|Overall Study|Adverse Event|1|||
148708847|NCT05523895|536407745|FG002|Overall Study|Adverse Event|1|||
148708848|NCT05523895|536407743|FG000|Overall Study|Lost to Follow-up|0|||
148708849|NCT05523895|536407744|FG001|Overall Study|Lost to Follow-up|1|||
148708850|NCT05523895|536407745|FG002|Overall Study|Lost to Follow-up|2|||
148708851|NCT05523895|536407743|FG000|Overall Study|Noncompliance with study drug|1|||
148708852|NCT05523895|536407744|FG001|Overall Study|Noncompliance with study drug|1|||
148708853|NCT05523895|536407745|FG002|Overall Study|Noncompliance with study drug|1|||
148708854|NCT05523895|536407743|FG000|Overall Study|Protocol Violation|0|||
148708855|NCT05523895|536407744|FG001|Overall Study|Protocol Violation|2|||
148708856|NCT05523895|536407745|FG002|Overall Study|Protocol Violation|0|||
148708857|NCT05523895|536407743|FG000|Overall Study|Withdrawal by Subject|1|||
148708858|NCT05523895|536407744|FG001|Overall Study|Withdrawal by Subject|3|||
148708859|NCT05523895|536407745|FG002|Overall Study|Withdrawal by Subject|1|||
148708860|NCT05523895|536407743|FG000|Overall Study|Not further specified|0|||
148708861|NCT05523895|536407744|FG001|Overall Study|Not further specified|3|||
148815257|NCT00429299|536799447|FG001|Overall Study|Adverse Event|5|||
148708862|NCT05523895|536407745|FG002|Overall Study|Not further specified|1|||
148708863|NCT01959672|536407751|FG000|Overall Study|Death|1|||
148708864|NCT02392195|536407752|FG000|Overall Study|Lost to Follow-up|4|||
148708865|NCT02392195|536407752|FG000|Overall Study|Withdrawal by Subject|4|||
148708866|NCT00545792|536407755|FG000|Overall Study|Withdrawal by Subject|1|||
148708867|NCT05041361|536407756|FG000|Overall Study|Lost to Follow-up|1|||
148708868|NCT05041361|536407757|FG001|Overall Study|Lost to Follow-up|3|||
148708869|NCT01642277|536407758|FG000|Overall Study|Adverse Event|10|||
148708870|NCT01642277|536407759|FG001|Overall Study|Adverse Event|0|||
148708871|NCT01642277|536407758|FG000|Overall Study|Physician Decision|2|||
148708872|NCT01642277|536407759|FG001|Overall Study|Physician Decision|0|||
148708873|NCT01642277|536407758|FG000|Overall Study|Protocol Violation|1|||
148708874|NCT01642277|536407759|FG001|Overall Study|Protocol Violation|0|||
148708875|NCT01642277|536407758|FG000|Overall Study|Withdrawal by Subject|11|||
148708876|NCT01642277|536407759|FG001|Overall Study|Withdrawal by Subject|0|||
148708877|NCT03679598|536407760|FG000|Overall Study|Adverse Event|2|||
148708878|NCT03679598|536407761|FG001|Overall Study|Adverse Event|0|||
148708879|NCT03605342|536407762|FG000|Overall Study|Withdrawal by Subject|9|||
148708880|NCT03605342|536407763|FG001|Overall Study|Withdrawal by Subject|7|||
148708881|NCT03605342|536407762|FG000|Overall Study|Lost to Follow-up|1|||
148708882|NCT03605342|536407763|FG001|Overall Study|Lost to Follow-up|1|||
148708883|NCT01403194|536407766|FG000|Overall Study|Screen Failure|2|||
148708884|NCT01403194|536407766|FG000|Overall Study|Lost to Follow-up|8|||
148708885|NCT03428750|536407769|FG000|Overall Study|Withdrawal by Subject|11|||
148708886|NCT03428750|536407770|FG001|Overall Study|Withdrawal by Subject|10|||
148708887|NCT03428750|536407769|FG000|Overall Study|Lost to Follow-up|3|||
148708888|NCT03428750|536407770|FG001|Overall Study|Lost to Follow-up|9|||
148708889|NCT03428750|536407769|FG000|Overall Study|Adverse Event|9|||
148708890|NCT03428750|536407770|FG001|Overall Study|Adverse Event|1|||
148708891|NCT03428750|536407769|FG000|Overall Study|Protocol Violation|1|||
148708892|NCT03428750|536407770|FG001|Overall Study|Protocol Violation|0|||
148708893|NCT03428750|536407769|FG000|Overall Study|Administrative|0|||
148708894|NCT03428750|536407770|FG001|Overall Study|Administrative|1|||
148708895|NCT01919112|536407771|FG000|Secondary Analysis-day 30|Death|1|||
148708896|NCT01919112|536407772|FG001|Secondary Analysis-day 30|Death|1|||
148708897|NCT01919112|536407773|FG002|Secondary Analysis-day 30|Death|1|||
148708898|NCT01919112|536407771|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
148708899|NCT01919112|536407772|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
148708900|NCT01919112|536407773|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
148708901|NCT02554877|536407776|FG000|Overall Study|Adverse Event|2|||
148708902|NCT02554877|536407777|FG001|Overall Study|Adverse Event|0|||
148708903|NCT02554877|536407778|FG002|Overall Study|Adverse Event|0|||
148708904|NCT02554877|536407779|FG003|Overall Study|Adverse Event|1|||
148708905|NCT02554877|536407776|FG000|Overall Study|Lost to Follow-up|1|||
148708906|NCT02554877|536407777|FG001|Overall Study|Lost to Follow-up|1|||
148708907|NCT02554877|536407778|FG002|Overall Study|Lost to Follow-up|1|||
148708908|NCT02554877|536407779|FG003|Overall Study|Lost to Follow-up|2|||
148708909|NCT02554877|536407776|FG000|Overall Study|Did not meet entrance criteria|0|||
148708910|NCT02554877|536407777|FG001|Overall Study|Did not meet entrance criteria|0|||
148708911|NCT02554877|536407778|FG002|Overall Study|Did not meet entrance criteria|1|||
148708912|NCT02554877|536407779|FG003|Overall Study|Did not meet entrance criteria|0|||
148708913|NCT02554877|536407776|FG000|Overall Study|No longer met eligibility criteria|1|||
148708914|NCT02554877|536407777|FG001|Overall Study|No longer met eligibility criteria|0|||
148708915|NCT02554877|536407778|FG002|Overall Study|No longer met eligibility criteria|1|||
148708916|NCT02554877|536407779|FG003|Overall Study|No longer met eligibility criteria|1|||
148708917|NCT02554877|536407776|FG000|Overall Study|Protocol Violation|3|||
148708918|NCT02554877|536407777|FG001|Overall Study|Protocol Violation|1|||
148708919|NCT02554877|536407778|FG002|Overall Study|Protocol Violation|1|||
148708920|NCT02554877|536407779|FG003|Overall Study|Protocol Violation|0|||
148708921|NCT02554877|536407776|FG000|Overall Study|Other|1|||
148708922|NCT02554877|536407777|FG001|Overall Study|Other|3|||
148708923|NCT02554877|536407778|FG002|Overall Study|Other|0|||
148708924|NCT02554877|536407779|FG003|Overall Study|Other|3|||
148708925|NCT02554877|536407776|FG000|Overall Study|Insufficient clinical response|4|||
148708926|NCT02554877|536407777|FG001|Overall Study|Insufficient clinical response|0|||
148708927|NCT02554877|536407778|FG002|Overall Study|Insufficient clinical response|0|||
148708928|NCT02554877|536407779|FG003|Overall Study|Insufficient clinical response|0|||
148708929|NCT02554877|536407776|FG000|Overall Study|No longer willing to participate|0|||
148708930|NCT02554877|536407777|FG001|Overall Study|No longer willing to participate|2|||
148708931|NCT02554877|536407778|FG002|Overall Study|No longer willing to participate|2|||
148708932|NCT02554877|536407779|FG003|Overall Study|No longer willing to participate|0|||
148708933|NCT00274651|536407780|FG000|Overall Study|Adverse Event|6|||
148708934|NCT00274651|536407781|FG001|Overall Study|Adverse Event|3|||
148708935|NCT00274651|536407780|FG000|Overall Study|Lack of Efficacy|13|||
148967995|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
148708936|NCT00274651|536407781|FG001|Overall Study|Lack of Efficacy|6|||
148708937|NCT00274651|536407780|FG000|Overall Study|Death|1|||
148708938|NCT00274651|536407781|FG001|Overall Study|Death|3|||
148708939|NCT00274651|536407780|FG000|Overall Study|Withdrawal by Subject|0|||
148708940|NCT00274651|536407781|FG001|Overall Study|Withdrawal by Subject|1|||
148708941|NCT00274651|536407780|FG000|Overall Study|Physician Decision|8|||
148708942|NCT00274651|536407781|FG001|Overall Study|Physician Decision|7|||
148708943|NCT04474405|536407782|FG000|Overall Study|Withdrawal by Subject|0|||
148708944|NCT04474405|536407783|FG001|Overall Study|Withdrawal by Subject|0|||
148708945|NCT04474405|536407784|FG002|Overall Study|Withdrawal by Subject|1|||
148708946|NCT04474405|536407785|FG003|Overall Study|Withdrawal by Subject|0|||
148708947|NCT04474405|536407786|FG004|Overall Study|Withdrawal by Subject|1|||
148708948|NCT04474405|536407787|FG005|Overall Study|Withdrawal by Subject|0|||
148708949|NCT04474405|536407782|FG000|Overall Study|Other|0|||
148708950|NCT04474405|536407783|FG001|Overall Study|Other|0|||
148708951|NCT04474405|536407784|FG002|Overall Study|Other|0|||
148708952|NCT04474405|536407785|FG003|Overall Study|Other|0|||
148708953|NCT04474405|536407786|FG004|Overall Study|Other|3|||
148708954|NCT04474405|536407787|FG005|Overall Study|Other|0|||
148708955|NCT00918645|536407788|FG000|Overall Study|Withdrawal by Subject|1|||
148708956|NCT05133180|536407789|FG000|Overall Study|Withdrawal of consent|1|||
148708957|NCT05133180|536407790|FG001|Overall Study|Withdrawal of consent|1|||
148708958|NCT05133180|536407789|FG000|Overall Study|Lost to Follow-up|1|||
148708959|NCT05133180|536407790|FG001|Overall Study|Lost to Follow-up|1|||
148708960|NCT05133180|536407789|FG000|Overall Study|Documented disease progression|0|||
148708961|NCT05133180|536407790|FG001|Overall Study|Documented disease progression|1|||
148708962|NCT03446768|536407791|FG000|Overall Study|Withdrawal by Subject|0|||
148708963|NCT03446768|536407792|FG001|Overall Study|Withdrawal by Subject|1|||
148708964|NCT01604941|536407793|FG000|Overall Study|Adverse Event|1|||
148708965|NCT01604941|536407794|FG001|Overall Study|Adverse Event|2|||
148708966|NCT01604941|536407795|FG002|Overall Study|Adverse Event|0|||
148708967|NCT01604941|536407796|FG003|Overall Study|Adverse Event|0|||
148708968|NCT01604941|536407797|FG004|Overall Study|Adverse Event|1|||
148708969|NCT01604941|536407798|FG005|Overall Study|Adverse Event|5|||
148708970|NCT01604941|536407793|FG000|Overall Study|Non-compliance|1|||
148708971|NCT01604941|536407794|FG001|Overall Study|Non-compliance|0|||
148708972|NCT01604941|536407795|FG002|Overall Study|Non-compliance|0|||
148708973|NCT01604941|536407796|FG003|Overall Study|Non-compliance|0|||
148708974|NCT01604941|536407797|FG004|Overall Study|Non-compliance|0|||
148708975|NCT01604941|536407798|FG005|Overall Study|Non-compliance|0|||
148708976|NCT01604941|536407793|FG000|Overall Study|Participant Decision|0|||
148708977|NCT01604941|536407794|FG001|Overall Study|Participant Decision|0|||
148708978|NCT01604941|536407795|FG002|Overall Study|Participant Decision|0|||
148708979|NCT01604941|536407796|FG003|Overall Study|Participant Decision|0|||
148708980|NCT01604941|536407797|FG004|Overall Study|Participant Decision|0|||
148708981|NCT01604941|536407798|FG005|Overall Study|Participant Decision|2|||
148708982|NCT01604941|536407793|FG000|Overall Study|Early Study Termination|9|||
148708983|NCT01604941|536407794|FG001|Overall Study|Early Study Termination|2|||
148708984|NCT01604941|536407795|FG002|Overall Study|Early Study Termination|3|||
148708985|NCT01604941|536407796|FG003|Overall Study|Early Study Termination|3|||
148708986|NCT01604941|536407797|FG004|Overall Study|Early Study Termination|0|||
148708987|NCT01604941|536407798|FG005|Overall Study|Early Study Termination|0|||
148708988|NCT03366792|536407799|FG000|Overall Study|Withdrawal by Subject|7|||
148708989|NCT03366792|536407799|FG000|Overall Study|Lost to Follow-up|2|||
148708990|NCT03366792|536407799|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
148708991|NCT03366792|536407799|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
148708992|NCT02488239|536407802|FG000|Overall Study|Death|3|||
148708993|NCT02488239|536407802|FG000|Overall Study|Withdrawal by Subject|3|||
148708994|NCT02488239|536407802|FG000|Overall Study|Physician Decision|2|||
148708995|NCT02488239|536407802|FG000|Overall Study|Consent ineligible|1|||
148708996|NCT02488239|536407802|FG000|Overall Study|Did not undergo implant procedure|1|||
148708997|NCT03325881|536407808|FG000|Overall Study|Protocol Violation|0|||
148708998|NCT03325881|536407809|FG001|Overall Study|Protocol Violation|1|||
148708999|NCT03325881|536407808|FG000|Overall Study|Withdrawal by Subject|0|||
148709000|NCT03325881|536407809|FG001|Overall Study|Withdrawal by Subject|2|||
148709001|NCT03325881|536407808|FG000|Overall Study|Lack of Efficacy|2|||
148709002|NCT03325881|536407809|FG001|Overall Study|Lack of Efficacy|0|||
148709003|NCT03325881|536407808|FG000|Overall Study|Not treated|1|||
148709004|NCT03325881|536407809|FG001|Overall Study|Not treated|0|||
148709005|NCT03676634|536407811|FG000|Overall Study|Red blood cell loss|1|||
148709006|NCT03676634|536407811|FG000|Overall Study|Out-of-limit pulse|2|||
148709007|NCT02213263|536407814|FG000|Overall Study|Insufficient clinical response|4|||
148709008|NCT02213263|536407815|FG001|Overall Study|Insufficient clinical response|3|||
148815258|NCT00429299|536799448|FG002|Overall Study|Adverse Event|1|||
148815259|NCT00429299|536799446|FG000|Overall Study|Protocol Violation|1|||
148815260|NCT00429299|536799447|FG001|Overall Study|Protocol Violation|0|||
148815261|NCT00429299|536799448|FG002|Overall Study|Protocol Violation|0|||
148815262|NCT00429299|536799446|FG000|Overall Study|Withdrawal by Subject|0|||
148815263|NCT00429299|536799447|FG001|Overall Study|Withdrawal by Subject|1|||
148815264|NCT00429299|536799448|FG002|Overall Study|Withdrawal by Subject|3|||
148815265|NCT01510756|536799449|FG000|Overall Study|Death|1|||
148815266|NCT01510756|536799449|FG000|Overall Study|Lack of Efficacy|2|||
148815267|NCT01510756|536799449|FG000|Overall Study|Physician Decision|1|||
148815268|NCT01922011|536799450|FG000|Overall Study|Protocol Violation|0|||
148815269|NCT01922011|536799451|FG001|Overall Study|Protocol Violation|1|||
148709009|NCT02213263|536407814|FG000|Overall Study|Lost to Follow-up|0|||
148709010|NCT02213263|536407815|FG001|Overall Study|Lost to Follow-up|1|||
148709011|NCT02213263|536407814|FG000|Overall Study|No longer willing to participate|3|||
148709012|NCT02213263|536407815|FG001|Overall Study|No longer willing to participate|4|||
148709013|NCT02213263|536407814|FG000|Overall Study|Progressive disease|20|||
148709014|NCT02213263|536407815|FG001|Overall Study|Progressive disease|14|||
148709015|NCT02213263|536407814|FG000|Overall Study|Protocol Violation|0|||
148709016|NCT02213263|536407815|FG001|Overall Study|Protocol Violation|1|||
148709017|NCT02213263|536407814|FG000|Overall Study|Adverse Event|1|||
148709018|NCT02213263|536407815|FG001|Overall Study|Adverse Event|3|||
148709019|NCT01188681|536407816|FG000|Overall Study|bladder cancer|0|||
148709020|NCT01188681|536407817|FG001|Overall Study|bladder cancer|0|||
148709021|NCT01188681|536407818|FG002|Overall Study|bladder cancer|1|||
148709022|NCT01188681|536407819|FG003|Overall Study|bladder cancer|0|||
148709023|NCT01188681|536407816|FG000|Overall Study|Withdrawal by Subject|0|||
148709024|NCT01188681|536407817|FG001|Overall Study|Withdrawal by Subject|0|||
148709025|NCT01188681|536407818|FG002|Overall Study|Withdrawal by Subject|0|||
148709026|NCT01188681|536407819|FG003|Overall Study|Withdrawal by Subject|1|||
148709027|NCT04345653|536407822|FG000|Overall Study|Withdrawal by Subject|2|||
148709028|NCT03480763|536407827|FG000|Overall Study|Withdrawal by Subject|18|||
148709029|NCT03480763|536407828|FG001|Overall Study|Withdrawal by Subject|10|||
148709030|NCT03480763|536407827|FG000|Overall Study|Lost to Follow-up|4|||
148709031|NCT03480763|536407828|FG001|Overall Study|Lost to Follow-up|7|||
148709032|NCT03480763|536407827|FG000|Overall Study|non-study pneumococcal vaccine|1|||
148709033|NCT03480763|536407828|FG001|Overall Study|non-study pneumococcal vaccine|0|||
148709034|NCT03480763|536407827|FG000|Overall Study|oncological treatment|0|||
148709035|NCT03480763|536407828|FG001|Overall Study|oncological treatment|2|||
148709036|NCT03480763|536407827|FG000|Overall Study|pain with vaccination|1|||
148709037|NCT03480763|536407828|FG001|Overall Study|pain with vaccination|0|||
148709038|NCT00418938|536407829|FG000|Overall Study|Reimbursement|1|||
148709039|NCT00418938|536407830|FG001|Overall Study|Reimbursement|0|||
148709040|NCT00418938|536407829|FG000|Overall Study|Administrative decision|3|||
148709041|NCT00418938|536407830|FG001|Overall Study|Administrative decision|3|||
148709042|NCT00418938|536407829|FG000|Overall Study|Withdrawal by Subject|16|||
148709043|NCT00418938|536407830|FG001|Overall Study|Withdrawal by Subject|15|||
148709044|NCT00418938|536407829|FG000|Overall Study|Lost to Follow-up|1|||
148709045|NCT00418938|536407830|FG001|Overall Study|Lost to Follow-up|3|||
148709046|NCT00418938|536407829|FG000|Overall Study|Adverse Event|1|||
148709047|NCT00418938|536407830|FG001|Overall Study|Adverse Event|1|||
148709048|NCT00418938|536407829|FG000|Overall Study|On-going|1|||
148709049|NCT00418938|536407830|FG001|Overall Study|On-going|1|||
148709050|NCT00418938|536407829|FG000|Overall Study|Ineligibility Determined|1|||
148709051|NCT00418938|536407830|FG001|Overall Study|Ineligibility Determined|0|||
148709052|NCT00115063|536407833|FG000|Overall Study|Lost to Follow-up|98|||
148709053|NCT00115063|536407834|FG001|Overall Study|Lost to Follow-up|104|||
148709054|NCT00115063|536407833|FG000|Overall Study|Death|1|||
148709055|NCT00115063|536407834|FG001|Overall Study|Death|0|||
148709056|NCT01473953|536407837|FG000|Overall Study|Other|1|||
148709057|NCT01473953|536407838|FG001|Overall Study|Other|0|||
148709058|NCT01473953|536407839|FG002|Overall Study|Other|0|||
148709059|NCT01473953|536407840|FG003|Overall Study|Other|0|||
148709060|NCT01473953|536407841|FG004|Overall Study|Other|0|||
148709061|NCT00312897|536407844|FG000|Overall Study|Adverse Event|1|||
148709062|NCT00312897|536407845|FG001|Overall Study|Adverse Event|0|||
148709063|NCT00312897|536407844|FG000|Overall Study|Lost to Follow-up|2|||
148709064|NCT00312897|536407845|FG001|Overall Study|Lost to Follow-up|0|||
148709065|NCT00312897|536407844|FG000|Overall Study|Physician Decision|1|||
148709066|NCT00312897|536407845|FG001|Overall Study|Physician Decision|0|||
148709067|NCT00312897|536407844|FG000|Overall Study|Withdrawal by Subject|1|||
148709068|NCT00312897|536407845|FG001|Overall Study|Withdrawal by Subject|3|||
148709069|NCT00312897|536407844|FG000|Overall Study|Pregnancy|1|||
148709070|NCT00312897|536407845|FG001|Overall Study|Pregnancy|0|||
148709071|NCT00312897|536407844|FG000|Overall Study|discontinued prior to getting treatment|0|||
148709072|NCT00312897|536407845|FG001|Overall Study|discontinued prior to getting treatment|3|||
148709073|NCT03100344|536407846|FG000|Overall Study|Adverse Event|0|||
148709074|NCT03100344|536407847|FG001|Overall Study|Adverse Event|3|||
148709075|NCT03100344|536407848|FG002|Overall Study|Adverse Event|2|||
148709076|NCT03100344|536407849|FG003|Overall Study|Adverse Event|3|||
148709077|NCT03100344|536407846|FG000|Overall Study|Lack of Efficacy|2|||
148709078|NCT03100344|536407847|FG001|Overall Study|Lack of Efficacy|0|||
148709079|NCT03100344|536407848|FG002|Overall Study|Lack of Efficacy|0|||
148709080|NCT03100344|536407849|FG003|Overall Study|Lack of Efficacy|0|||
148709081|NCT03100344|536407846|FG000|Overall Study|Protocol Violation|1|||
148709082|NCT03100344|536407847|FG001|Overall Study|Protocol Violation|0|||
148709083|NCT03100344|536407848|FG002|Overall Study|Protocol Violation|0|||
148709084|NCT03100344|536407849|FG003|Overall Study|Protocol Violation|0|||
148815270|NCT01922011|536799450|FG000|Overall Study|Physician Decision|0|||
148709085|NCT03100344|536407846|FG000|Overall Study|Withdrawal by Subject|10|||
148709086|NCT03100344|536407847|FG001|Overall Study|Withdrawal by Subject|7|||
148709087|NCT03100344|536407848|FG002|Overall Study|Withdrawal by Subject|4|||
148709088|NCT03100344|536407849|FG003|Overall Study|Withdrawal by Subject|8|||
148709089|NCT03100344|536407846|FG000|Overall Study|Lost to Follow-up|1|||
148709090|NCT03100344|536407847|FG001|Overall Study|Lost to Follow-up|1|||
148709091|NCT03100344|536407848|FG002|Overall Study|Lost to Follow-up|1|||
148709092|NCT03100344|536407849|FG003|Overall Study|Lost to Follow-up|1|||
148709093|NCT04633564|536407850|FG000|Period 1|Adverse Event|28|||
148709094|NCT04633564|536407851|FG001|Period 1|Adverse Event|19|||
148709095|NCT04633564|536407850|FG000|Period 1|Death|8|||
148709096|NCT04633564|536407851|FG001|Period 1|Death|7|||
148709097|NCT04633564|536407850|FG000|Period 1|Lost to Follow-up|3|||
148709098|NCT04633564|536407851|FG001|Period 1|Lost to Follow-up|5|||
148709099|NCT04633564|536407850|FG000|Period 1|Physician Decision|4|||
148709100|NCT04633564|536407851|FG001|Period 1|Physician Decision|12|||
148709101|NCT04633564|536407850|FG000|Period 1|Protocol Violation|0|||
148709102|NCT04633564|536407851|FG001|Period 1|Protocol Violation|1|||
148709103|NCT04633564|536407850|FG000|Period 1|Withdrawal by Subject|10|||
148709104|NCT04633564|536407851|FG001|Period 1|Withdrawal by Subject|8|||
148709105|NCT04633564|536407850|FG000|Period 1|Progressive disease|47|||
148709106|NCT04633564|536407851|FG001|Period 1|Progressive disease|51|||
148709107|NCT04633564|536407850|FG000|Period 1|Terminated by Sponsor|8|||
148709108|NCT04633564|536407851|FG001|Period 1|Terminated by Sponsor|6|||
148709109|NCT04633564|536407850|FG000|Period 2|Adverse Event|3|||
148709110|NCT04633564|536407851|FG001|Period 2|Adverse Event|4|||
148709111|NCT04633564|536407850|FG000|Period 2|Death|0|||
148709112|NCT04633564|536407851|FG001|Period 2|Death|2|||
148709113|NCT04633564|536407850|FG000|Period 2|Lost to Follow-up|0|||
148709114|NCT04633564|536407851|FG001|Period 2|Lost to Follow-up|1|||
148709115|NCT04633564|536407850|FG000|Period 2|Physician Decision|2|||
148709116|NCT04633564|536407851|FG001|Period 2|Physician Decision|4|||
148709117|NCT04633564|536407850|FG000|Period 2|Withdrawal by Subject|5|||
148709118|NCT04633564|536407851|FG001|Period 2|Withdrawal by Subject|1|||
148709119|NCT04633564|536407850|FG000|Period 2|Progressive Disease|74|||
148709120|NCT04633564|536407851|FG001|Period 2|Progressive Disease|82|||
148709121|NCT04633564|536407850|FG000|Period 2|Terminated by Sponsor|9|||
148709122|NCT04633564|536407851|FG001|Period 2|Terminated by Sponsor|3|||
148709123|NCT02011945|536407852|FG000|Overall Study|Participant requested to Discontinue|0|||
148709124|NCT02011945|536407853|FG001|Overall Study|Participant requested to Discontinue|1|||
148709125|NCT02011945|536407854|FG002|Overall Study|Participant requested to Discontinue|1|||
148709126|NCT02011945|536407852|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
148709127|NCT02011945|536407853|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
148709128|NCT02011945|536407854|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
148709129|NCT02011945|536407852|FG000|Overall Study|Study Drug Toxicity|0|||
148709130|NCT02011945|536407853|FG001|Overall Study|Study Drug Toxicity|0|||
148709131|NCT02011945|536407854|FG002|Overall Study|Study Drug Toxicity|1|||
148709132|NCT02011945|536407852|FG000|Overall Study|Treatment Failure|0|||
148709133|NCT02011945|536407853|FG001|Overall Study|Treatment Failure|7|||
148709134|NCT02011945|536407854|FG002|Overall Study|Treatment Failure|6|||
148709135|NCT02011945|536407852|FG000|Overall Study|No Longer Meets Study Criteria|1|||
148709136|NCT02011945|536407853|FG001|Overall Study|No Longer Meets Study Criteria|0|||
148709137|NCT02011945|536407854|FG002|Overall Study|No Longer Meets Study Criteria|0|||
148709138|NCT02011945|536407852|FG000|Overall Study|Proceeded to stem cell transplant|0|||
148709139|NCT02011945|536407853|FG001|Overall Study|Proceeded to stem cell transplant|0|||
148709140|NCT02011945|536407854|FG002|Overall Study|Proceeded to stem cell transplant|1|||
148709141|NCT02011945|536407852|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
148709142|NCT02011945|536407853|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
148709143|NCT02011945|536407854|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
148709144|NCT00902538|536407855|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
148709145|NCT00902538|536407856|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
148709146|NCT00902538|536407857|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
148709147|NCT00902538|536407858|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
148709148|NCT00902538|536407859|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
148709149|NCT00902538|536407860|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
148709150|NCT00902538|536407855|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
148709151|NCT00902538|536407856|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
148709152|NCT00902538|536407857|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
148709153|NCT00902538|536407858|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
148709154|NCT00902538|536407859|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
148709155|NCT00902538|536407860|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
148709156|NCT00902538|536407855|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
148709157|NCT00902538|536407856|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
148709158|NCT00902538|536407857|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
148709159|NCT00902538|536407858|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
148709160|NCT00902538|536407859|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
148709161|NCT00902538|536407860|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
148709162|NCT00902538|536407855|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
148709163|NCT00902538|536407856|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
148709164|NCT00902538|536407857|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
148709165|NCT00902538|536407858|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
148709166|NCT00902538|536407859|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
148709167|NCT00902538|536407860|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
148709168|NCT00902538|536407855|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
148709169|NCT00902538|536407856|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
148709170|NCT00902538|536407857|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
148709171|NCT00902538|536407858|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
148709172|NCT00902538|536407859|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
148709173|NCT00902538|536407860|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
148709174|NCT00902538|536407855|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
148709175|NCT00902538|536407856|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
148709176|NCT00902538|536407857|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
148709177|NCT00902538|536407858|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
148709178|NCT00902538|536407859|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
148709179|NCT00902538|536407860|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
148709180|NCT00902538|536407855|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
148709181|NCT00902538|536407856|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
148709182|NCT00902538|536407857|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
148709183|NCT00902538|536407858|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
148709184|NCT00902538|536407859|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
148709185|NCT00902538|536407860|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
148709186|NCT00902538|536407855|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
148709187|NCT00902538|536407856|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
148709188|NCT00902538|536407857|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
148709189|NCT00902538|536407858|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
148709190|NCT00902538|536407859|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
148709191|NCT00902538|536407860|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
148709192|NCT00902538|536407855|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
148709193|NCT00902538|536407856|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
148709194|NCT00902538|536407857|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
148709195|NCT00902538|536407858|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
148709196|NCT00902538|536407859|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
148709197|NCT00902538|536407860|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
148709198|NCT00902538|536407855|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
148709199|NCT00902538|536407856|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
148709200|NCT00902538|536407857|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
148709201|NCT00902538|536407858|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
148709202|NCT00902538|536407859|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
148709203|NCT00902538|536407860|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
148709204|NCT00902538|536407855|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
148709205|NCT00902538|536407856|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
148709206|NCT00902538|536407857|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
148709207|NCT00902538|536407858|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
148709208|NCT00902538|536407859|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
148709209|NCT00902538|536407860|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
148709210|NCT00902538|536407855|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
148709211|NCT00902538|536407856|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
148709212|NCT00902538|536407857|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
148709213|NCT00902538|536407858|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
148709214|NCT00902538|536407859|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
148709215|NCT00902538|536407860|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
148709216|NCT00902538|536407855|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
148709217|NCT00902538|536407856|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
148709218|NCT00902538|536407857|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
148709219|NCT00902538|536407858|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
148709220|NCT00902538|536407859|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
149025108|NCT01813422|537568018|FG001|Overall Study|Lost to Follow-up|4|||
148709221|NCT00902538|536407860|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
148709222|NCT00902538|536407855|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
148709223|NCT00902538|536407856|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
148709224|NCT00902538|536407857|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
148709225|NCT00902538|536407858|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
148709226|NCT00902538|536407859|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
148709227|NCT00902538|536407860|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
148709228|NCT00902538|536407855|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
148709229|NCT00902538|536407856|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
148709230|NCT00902538|536407857|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
148709231|NCT00902538|536407858|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
148709232|NCT00902538|536407859|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
148709233|NCT00902538|536407860|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
148709234|NCT00902538|536407855|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
148709235|NCT00902538|536407856|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
148709236|NCT00902538|536407857|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
148709237|NCT00902538|536407858|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
148709238|NCT00902538|536407859|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
148709239|NCT00902538|536407860|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
148709240|NCT00902538|536407855|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
148709241|NCT00902538|536407856|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
148709242|NCT00902538|536407857|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
148709243|NCT00902538|536407858|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
148709244|NCT00902538|536407859|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
148709245|NCT00902538|536407860|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
148709246|NCT04198363|536407867|FG000|Overall Study|Adverse Event|1|||
148709247|NCT04198363|536407868|FG001|Overall Study|Adverse Event|1|||
148709248|NCT04198363|536407867|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
148709249|NCT04198363|536407868|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
148709250|NCT04198363|536407867|FG000|Overall Study|Reason not Specified|1|||
148709251|NCT04198363|536407868|FG001|Overall Study|Reason not Specified|0|||
148709252|NCT03067987|536407871|FG000|Overall Study|Lost to Follow-up|7|||
148709253|NCT03067987|536407872|FG001|Overall Study|Lost to Follow-up|10|||
148709254|NCT03067987|536407871|FG000|Overall Study|Protocol Violation|1|||
148709255|NCT03067987|536407872|FG001|Overall Study|Protocol Violation|2|||
148709256|NCT03067987|536407871|FG000|Overall Study|Withdrawal by Subject|2|||
148709257|NCT03067987|536407872|FG001|Overall Study|Withdrawal by Subject|1|||
148709258|NCT04827394|536407873|FG000|Overall Study|Physician Decision|0|||
148709259|NCT04827394|536407874|FG001|Overall Study|Physician Decision|2|||
148709260|NCT02488109|536409892|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
148709261|NCT02488109|536409893|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
148709262|NCT02488109|536409892|FG000|12-month Follow-Up|Lost to Follow-up|4|||
148709263|NCT02488109|536409893|FG001|12-month Follow-Up|Lost to Follow-up|7|||
148709264|NCT02302716|536409894|FG000|Overall Study|Adverse Event|1|||
148709265|NCT02302716|536409895|FG001|Overall Study|Adverse Event|1|||
148709266|NCT02302716|536409894|FG000|Overall Study|Death|0|||
148709267|NCT02302716|536409895|FG001|Overall Study|Death|1|||
148709268|NCT02302716|536409894|FG000|Overall Study|Lack of Efficacy|0|||
148709269|NCT02302716|536409895|FG001|Overall Study|Lack of Efficacy|1|||
148709270|NCT02302716|536409894|FG000|Overall Study|Lost to Follow-up|2|||
148709271|NCT02302716|536409895|FG001|Overall Study|Lost to Follow-up|4|||
148709272|NCT02302716|536409894|FG000|Overall Study|Physician Decision|3|||
148709273|NCT02302716|536409895|FG001|Overall Study|Physician Decision|4|||
148709274|NCT02302716|536409894|FG000|Overall Study|Withdrawal by Subject|13|||
148709275|NCT02302716|536409895|FG001|Overall Study|Withdrawal by Subject|7|||
148709276|NCT02302716|536409894|FG000|Overall Study|Protocol Violation|0|||
148709277|NCT02302716|536409895|FG001|Overall Study|Protocol Violation|1|||
148709278|NCT00557245|536409899|FG000|Overall Study|Lost to Follow-up|7|||
148709279|NCT00557245|536409900|FG001|Overall Study|Lost to Follow-up|8|||
148709280|NCT00557245|536409901|FG002|Overall Study|Lost to Follow-up|10|||
148709281|NCT00557245|536409899|FG000|Overall Study|Ineligible|5|||
148967996|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
148967997|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
148967998|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
148967999|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
148968000|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
148968001|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
148968002|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
148968003|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
148709282|NCT00557245|536409900|FG001|Overall Study|Ineligible|4|||
148709283|NCT00557245|536409901|FG002|Overall Study|Ineligible|2|||
148709284|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Subject request|8|||
148709285|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Subject request|11|||
148709286|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
148709287|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
148709288|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
148815271|NCT01922011|536799451|FG001|Overall Study|Physician Decision|1|||
148709289|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
148709290|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
148709291|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
148709292|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
148709293|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
148709294|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
148709295|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
148709296|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Death|1|||
148709297|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Death|0|||
148709298|NCT00521586|536409902|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
148709299|NCT00521586|536409903|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
148709300|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
148709301|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
148709302|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
148709303|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
148709304|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
148709305|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
148709306|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
148709307|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
148709308|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
148709309|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
148709310|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
148709311|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
148709312|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
148709313|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
148709314|NCT00521586|536409902|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
148709315|NCT00521586|536409903|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
148709316|NCT00521586|536409902|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
148709317|NCT00521586|536409903|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
148709318|NCT00521586|536409902|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
148709319|NCT00521586|536409903|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
148709320|NCT00521586|536409902|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
148709321|NCT00521586|536409903|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
148709322|NCT02727192|536409910|FG000|Overall Study|Lost to Follow-up|1|||
148709323|NCT02727192|536409911|FG001|Overall Study|Lost to Follow-up|0|||
148709324|NCT02727192|536409912|FG002|Overall Study|Lost to Follow-up|0|||
148709325|NCT03497130|536409914|FG000|Overall Study|Lost to Follow-up|1|||
148709326|NCT03497130|536409915|FG001|Overall Study|Lost to Follow-up|1|||
148709327|NCT00216736|536409917|FG000|Overall Study|Lost to Follow-up|1|||
148709328|NCT00216736|536409918|FG001|Overall Study|Lost to Follow-up|1|||
148709329|NCT00918684|536409919|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
148709330|NCT00918684|536409919|FG000|Treatment Phase|Lack of Efficacy|6|||
148709331|NCT00918684|536409919|FG000|Treatment Phase|Lost to Follow-up|2|||
148709332|NCT00918684|536409919|FG000|Treatment Phase|Physician Decision|8|||
148709333|NCT00918684|536409919|FG000|Treatment Phase|Protocol Violation|1|||
148709334|NCT00918684|536409919|FG000|Treatment Phase|Withdrawal by Subject|8|||
148709335|NCT01051349|536409920|FG000|Overall Study|Adverse Event|88|||
148709336|NCT01051349|536409920|FG000|Overall Study|Consent Withdrawn|54|||
148709337|NCT01051349|536409920|FG000|Overall Study|Investigator Decision|6|||
148709338|NCT01051349|536409920|FG000|Overall Study|Lost to Follow-up|6|||
148709339|NCT01051349|536409920|FG000|Overall Study|Subject non-compliance|7|||
148709340|NCT01051349|536409920|FG000|Overall Study|Reason not Specified|12|||
148709341|NCT00402103|536409921|FG000|Overall Study|Adverse Event|60|||
148709342|NCT00402103|536409922|FG001|Overall Study|Adverse Event|7|||
148709343|NCT00402103|536409921|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148709344|NCT00402103|536409922|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148709345|NCT00402103|536409921|FG000|Overall Study|Condition no longer requires study drug|2|||
148709346|NCT00402103|536409922|FG001|Overall Study|Condition no longer requires study drug|0|||
148709347|NCT00402103|536409921|FG000|Overall Study|Protocol Deviation|8|||
148709348|NCT00402103|536409922|FG001|Overall Study|Protocol Deviation|0|||
148709349|NCT00402103|536409921|FG000|Overall Study|Patient withdrew consent|12|||
148709350|NCT00402103|536409922|FG001|Overall Study|Patient withdrew consent|1|||
148709351|NCT00402103|536409921|FG000|Overall Study|Lost to Follow-up|6|||
148709352|NCT00402103|536409922|FG001|Overall Study|Lost to Follow-up|3|||
148709353|NCT00402103|536409921|FG000|Overall Study|Administrative problems|2|||
148709354|NCT00402103|536409922|FG001|Overall Study|Administrative problems|0|||
148709355|NCT00418145|536409923|FG000|Overall Study|study terminated|6|||
148709356|NCT01316055|536409927|FG000|Overall Study|Lost to Follow-up|1|||
148709357|NCT01316055|536409928|FG001|Overall Study|Lost to Follow-up|0|||
148968004|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
148709358|NCT01316055|536409929|FG002|Overall Study|Lost to Follow-up|0|||
148968005|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
148968006|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
148968007|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
148968008|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
148968009|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
148968010|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
148968011|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
148968012|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
148968013|NCT03373383|537368600|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
148709359|NCT00003470|536409930|FG000|Overall Study|Not evaluable|6|||
148709360|NCT02679729|536409932|FG000|Overall Study|Lost to Follow-up|0|||
148709361|NCT02679729|536409933|FG001|Overall Study|Lost to Follow-up|1|||
148709362|NCT02679729|536409934|FG002|Overall Study|Lost to Follow-up|0|||
148709363|NCT02679729|536409935|FG003|Overall Study|Lost to Follow-up|0|||
148709364|NCT02679729|536409936|FG004|Overall Study|Lost to Follow-up|1|||
148709365|NCT02679729|536409937|FG005|Overall Study|Lost to Follow-up|0|||
148709366|NCT02679729|536409938|FG006|Overall Study|Lost to Follow-up|0|||
148709367|NCT02679729|536409939|FG007|Overall Study|Lost to Follow-up|0|||
148709368|NCT02679729|536409940|FG008|Overall Study|Lost to Follow-up|0|||
148709369|NCT02679729|536409932|FG000|Overall Study|Participant decision|0|||
148709370|NCT02679729|536409933|FG001|Overall Study|Participant decision|1|||
148709371|NCT02679729|536409934|FG002|Overall Study|Participant decision|0|||
148709372|NCT02679729|536409935|FG003|Overall Study|Participant decision|0|||
148709373|NCT02679729|536409936|FG004|Overall Study|Participant decision|0|||
148709374|NCT02679729|536409937|FG005|Overall Study|Participant decision|0|||
148709375|NCT02679729|536409938|FG006|Overall Study|Participant decision|1|||
148709376|NCT02679729|536409939|FG007|Overall Study|Participant decision|0|||
148709377|NCT02679729|536409940|FG008|Overall Study|Participant decision|0|||
148709378|NCT00748566|536409943|FG000|Overall Study|Adverse Event|49|||
148709379|NCT00748566|536409943|FG000|Overall Study|Death|1|||
148709380|NCT00748566|536409943|FG000|Overall Study|Lack of Efficacy|12|||
148709381|NCT00748566|536409943|FG000|Overall Study|Lost to Follow-up|1|||
148709382|NCT00748566|536409943|FG000|Overall Study|Protocol Violation|13|||
148709383|NCT00748566|536409943|FG000|Overall Study|Withdrawal by Subject|22|||
148709384|NCT00748566|536409943|FG000|Overall Study|Study terminated by sponsor|5|||
148709385|NCT00748566|536409943|FG000|Overall Study|Other|9|||
148709386|NCT00624286|536409946|FG000|Overall Study|Protocol Deviation|7|||
148709387|NCT00624286|536409947|FG001|Overall Study|Protocol Deviation|9|||
148709388|NCT00624286|536409946|FG000|Overall Study|Adverse Event|6|||
148709389|NCT00624286|536409947|FG001|Overall Study|Adverse Event|3|||
148709390|NCT00624286|536409946|FG000|Overall Study|Withdrawal by Subject|5|||
148709391|NCT00624286|536409947|FG001|Overall Study|Withdrawal by Subject|4|||
148709392|NCT00624286|536409946|FG000|Overall Study|Lost to Follow-up|3|||
148709393|NCT00624286|536409947|FG001|Overall Study|Lost to Follow-up|2|||
148709394|NCT00624286|536409946|FG000|Overall Study|Administrative problems|3|||
148709395|NCT00624286|536409947|FG001|Overall Study|Administrative problems|0|||
148709396|NCT00624286|536409946|FG000|Overall Study|Lack of Efficacy|1|||
148709397|NCT00624286|536409947|FG001|Overall Study|Lack of Efficacy|6|||
148709398|NCT00624286|536409946|FG000|Overall Study|Not stated|0|||
148709399|NCT00624286|536409947|FG001|Overall Study|Not stated|1|||
148709400|NCT00624286|536409946|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148709401|NCT00624286|536409947|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148709402|NCT00624286|536409946|FG000|Overall Study|Death|0|||
148709403|NCT00624286|536409947|FG001|Overall Study|Death|1|||
148968014|NCT03373383|537368601|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
148709404|NCT01442376|536409952|FG000|Overall Study|Adverse Event|0|||
148709405|NCT01442376|536409953|FG001|Overall Study|Adverse Event|3|||
148709406|NCT01442376|536409954|FG002|Overall Study|Adverse Event|2|||
148709407|NCT01442376|536409952|FG000|Overall Study|Death|0|||
148709408|NCT01442376|536409953|FG001|Overall Study|Death|1|||
148709409|NCT01442376|536409954|FG002|Overall Study|Death|1|||
148709410|NCT01442376|536409952|FG000|Overall Study|Withdrawal of consent|0|||
148709411|NCT01442376|536409953|FG001|Overall Study|Withdrawal of consent|0|||
148709412|NCT01442376|536409954|FG002|Overall Study|Withdrawal of consent|1|||
148709413|NCT01442376|536409952|FG000|Overall Study|Patients not treated|2|||
148709414|NCT01442376|536409953|FG001|Overall Study|Patients not treated|3|||
148709415|NCT01442376|536409954|FG002|Overall Study|Patients not treated|1|||
148709416|NCT01442376|536409952|FG000|Overall Study|Not eligible for subsequent cycles|1|||
148709417|NCT01442376|536409953|FG001|Overall Study|Not eligible for subsequent cycles|2|||
148709418|NCT01442376|536409954|FG002|Overall Study|Not eligible for subsequent cycles|0|||
148709419|NCT00863330|536409955|FG000|Overall Study|study terminated early due to administra|6|||
148709420|NCT04404725|536409956|FG000|First Intervention|Withdrawal by Subject|0|||
148709421|NCT04404725|536409957|FG001|First Intervention|Withdrawal by Subject|2|||
148968015|NCT03373383|537368602|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
148709422|NCT04404725|536409956|FG000|Second Intervention|Adverse Event|1|||
148709423|NCT04404725|536409957|FG001|Second Intervention|Adverse Event|1|||
148709424|NCT04404725|536409956|FG000|Second Intervention|Withdrawal by Subject|0|||
148709425|NCT04404725|536409957|FG001|Second Intervention|Withdrawal by Subject|1|||
148709426|NCT01075516|536409958|FG000|Overall Study|Death|5|||
148709427|NCT01075516|536409959|FG001|Overall Study|Death|9|||
148709428|NCT01075516|536409958|FG000|Overall Study|Lost to Follow-up|10|||
148709429|NCT01075516|536409959|FG001|Overall Study|Lost to Follow-up|2|||
148709430|NCT01075516|536409958|FG000|Overall Study|Withdrawal by Subject|3|||
148709431|NCT01075516|536409959|FG001|Overall Study|Withdrawal by Subject|5|||
148709432|NCT02252016|536409960|FG000|Overall Study|Lost to Follow-up|2|||
148709433|NCT02252016|536409961|FG001|Overall Study|Lost to Follow-up|1|||
148709434|NCT02252016|536409960|FG000|Overall Study|Physician Decision|1|||
148709435|NCT02252016|536409961|FG001|Overall Study|Physician Decision|0|||
148709436|NCT02252016|536409960|FG000|Overall Study|Withdrawal by Subject|0|||
148709437|NCT02252016|536409961|FG001|Overall Study|Withdrawal by Subject|2|||
148709438|NCT00674128|536409962|FG000|Overall Study|Withdrawal by Subject|25|||
148709439|NCT00674128|536409963|FG001|Overall Study|Withdrawal by Subject|23|||
148709440|NCT04631562|536409964|FG000|Overall Study|Withdrawal by Subject|0|||
148709441|NCT04631562|536409965|FG001|Overall Study|Withdrawal by Subject|0|||
148709442|NCT04631562|536409966|FG002|Overall Study|Withdrawal by Subject|0|||
148709443|NCT04631562|536409967|FG003|Overall Study|Withdrawal by Subject|0|||
148709444|NCT04631562|536409968|FG004|Overall Study|Withdrawal by Subject|0|||
148709445|NCT04631562|536409969|FG005|Overall Study|Withdrawal by Subject|0|||
148709446|NCT04631562|536409970|FG006|Overall Study|Withdrawal by Subject|0|||
148709447|NCT04631562|536409971|FG007|Overall Study|Withdrawal by Subject|1|||
148709448|NCT04631562|536409972|FG008|Overall Study|Withdrawal by Subject|0|||
148709449|NCT04631562|536409964|FG000|Overall Study|Other|0|||
148709450|NCT04631562|536409965|FG001|Overall Study|Other|0|||
148709451|NCT04631562|536409966|FG002|Overall Study|Other|0|||
148709452|NCT04631562|536409967|FG003|Overall Study|Other|0|||
148709453|NCT04631562|536409968|FG004|Overall Study|Other|0|||
148709454|NCT04631562|536409969|FG005|Overall Study|Other|0|||
148709455|NCT04631562|536409970|FG006|Overall Study|Other|0|||
148709456|NCT04631562|536409971|FG007|Overall Study|Other|0|||
148709457|NCT04631562|536409972|FG008|Overall Study|Other|1|||
148709458|NCT04631562|536409964|FG000|Overall Study|Lost to Follow-up|0|||
148709459|NCT04631562|536409965|FG001|Overall Study|Lost to Follow-up|0|||
148709460|NCT04631562|536409966|FG002|Overall Study|Lost to Follow-up|0|||
148709461|NCT04631562|536409967|FG003|Overall Study|Lost to Follow-up|1|||
148709462|NCT04631562|536409968|FG004|Overall Study|Lost to Follow-up|0|||
148709463|NCT04631562|536409969|FG005|Overall Study|Lost to Follow-up|0|||
148709464|NCT04631562|536409970|FG006|Overall Study|Lost to Follow-up|0|||
148709465|NCT04631562|536409971|FG007|Overall Study|Lost to Follow-up|0|||
148709466|NCT04631562|536409972|FG008|Overall Study|Lost to Follow-up|0|||
148709467|NCT04631562|536409964|FG000|Overall Study|Adverse Event|0|||
148709468|NCT04631562|536409965|FG001|Overall Study|Adverse Event|0|||
148709469|NCT04631562|536409966|FG002|Overall Study|Adverse Event|0|||
148709470|NCT04631562|536409967|FG003|Overall Study|Adverse Event|0|||
148709471|NCT04631562|536409968|FG004|Overall Study|Adverse Event|0|||
148709472|NCT04631562|536409969|FG005|Overall Study|Adverse Event|0|||
148709473|NCT04631562|536409970|FG006|Overall Study|Adverse Event|1|||
148709474|NCT04631562|536409971|FG007|Overall Study|Adverse Event|0|||
148709475|NCT04631562|536409972|FG008|Overall Study|Adverse Event|0|||
148709476|NCT01825798|536409974|FG000|Overall Study|Adverse Event|1|||
148709477|NCT01825798|536409975|FG001|Overall Study|Adverse Event|5|||
148709478|NCT01825798|536409974|FG000|Overall Study|Lost to Follow-up|1|||
148709479|NCT01825798|536409975|FG001|Overall Study|Lost to Follow-up|0|||
148709480|NCT00834873|536409982|FG000|First Intervention|Adverse Event|0|||
148709481|NCT00834873|536409983|FG001|First Intervention|Adverse Event|1|||
148709482|NCT02055547|536409984|FG000|Overall Study|Protocol Violation|0|||
148709483|NCT02055547|536409985|FG001|Overall Study|Protocol Violation|0|||
148709484|NCT02055547|536409986|FG002|Overall Study|Protocol Violation|1|||
148709485|NCT02055547|536409987|FG003|Overall Study|Protocol Violation|0|||
148709486|NCT02055547|536409988|FG004|Overall Study|Protocol Violation|0|||
148709487|NCT02055547|536409989|FG005|Overall Study|Protocol Violation|0|||
148709488|NCT02055547|536409990|FG006|Overall Study|Protocol Violation|1|||
148709489|NCT02055547|536409991|FG007|Overall Study|Protocol Violation|0|||
148709490|NCT02055547|536409992|FG008|Overall Study|Protocol Violation|0|||
148709491|NCT02055547|536409993|FG009|Overall Study|Protocol Violation|0|||
148709492|NCT02055547|536409994|FG010|Overall Study|Protocol Violation|0|||
148709493|NCT02055547|536409995|FG011|Overall Study|Protocol Violation|0|||
148709494|NCT02055547|536409996|FG012|Overall Study|Protocol Violation|0|||
148709495|NCT02055547|536409997|FG013|Overall Study|Protocol Violation|0|||
148815272|NCT01922011|536799450|FG000|Overall Study|Parent/Guardian Decision|3|||
148815273|NCT01922011|536799451|FG001|Overall Study|Parent/Guardian Decision|0|||
148815274|NCT01922011|536799450|FG000|Overall Study|Lost to Follow-up|0|||
148815275|NCT01922011|536799451|FG001|Overall Study|Lost to Follow-up|1|||
148815276|NCT01922011|536799450|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
148815277|NCT01922011|536799451|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
148815278|NCT01922011|536799450|FG000|Overall Study|Not Treated|1|||
148815279|NCT01922011|536799451|FG001|Overall Study|Not Treated|0|||
148815280|NCT01922011|536799450|FG000|Overall Study|Lack of willing home health agency|1|||
148815281|NCT01922011|536799451|FG001|Overall Study|Lack of willing home health agency|0|||
148968016|NCT03373383|537368603|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
148968017|NCT03373383|537368604|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
148968018|NCT03373383|537368600|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
148968019|NCT03373383|537368601|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
148968020|NCT03373383|537368602|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
148968021|NCT03373383|537368603|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
148968022|NCT03373383|537368604|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
148968023|NCT02159521|537368605|FG000|Overall Study|Enrolled but not treated|3|||
148709496|NCT02055547|536409998|FG014|Overall Study|Protocol Violation|0|||
148709497|NCT02055547|536409999|FG015|Overall Study|Protocol Violation|0|||
148709498|NCT02055547|536410000|FG016|Overall Study|Protocol Violation|0|||
148709499|NCT02055547|536410001|FG017|Overall Study|Protocol Violation|0|||
148709500|NCT02055547|536410002|FG018|Overall Study|Protocol Violation|0|||
148709501|NCT02055547|536409984|FG000|Overall Study|Physician Decision|0|||
148709502|NCT02055547|536409985|FG001|Overall Study|Physician Decision|1|||
148709503|NCT02055547|536409986|FG002|Overall Study|Physician Decision|1|||
148709504|NCT02055547|536409987|FG003|Overall Study|Physician Decision|0|||
148709505|NCT02055547|536409988|FG004|Overall Study|Physician Decision|1|||
148709506|NCT02055547|536409989|FG005|Overall Study|Physician Decision|0|||
148709507|NCT02055547|536409990|FG006|Overall Study|Physician Decision|0|||
148709508|NCT02055547|536409991|FG007|Overall Study|Physician Decision|0|||
148709509|NCT02055547|536409992|FG008|Overall Study|Physician Decision|0|||
148709510|NCT02055547|536409993|FG009|Overall Study|Physician Decision|1|||
148709511|NCT02055547|536409994|FG010|Overall Study|Physician Decision|1|||
148709512|NCT02055547|536409995|FG011|Overall Study|Physician Decision|0|||
148709513|NCT02055547|536409996|FG012|Overall Study|Physician Decision|0|||
148709514|NCT02055547|536409997|FG013|Overall Study|Physician Decision|0|||
148709515|NCT02055547|536409998|FG014|Overall Study|Physician Decision|0|||
148709516|NCT02055547|536409999|FG015|Overall Study|Physician Decision|0|||
148709517|NCT02055547|536410000|FG016|Overall Study|Physician Decision|0|||
148709518|NCT02055547|536410001|FG017|Overall Study|Physician Decision|0|||
148709519|NCT02055547|536410002|FG018|Overall Study|Physician Decision|0|||
148709520|NCT02055547|536409984|FG000|Overall Study|Adverse Event|0|||
148709521|NCT02055547|536409985|FG001|Overall Study|Adverse Event|0|||
148709522|NCT02055547|536409986|FG002|Overall Study|Adverse Event|0|||
148709523|NCT02055547|536409987|FG003|Overall Study|Adverse Event|0|||
148709524|NCT02055547|536409988|FG004|Overall Study|Adverse Event|0|||
148709525|NCT02055547|536409989|FG005|Overall Study|Adverse Event|0|||
148709526|NCT02055547|536409990|FG006|Overall Study|Adverse Event|1|||
148709527|NCT02055547|536409991|FG007|Overall Study|Adverse Event|0|||
148709528|NCT02055547|536409992|FG008|Overall Study|Adverse Event|1|||
148709529|NCT02055547|536409993|FG009|Overall Study|Adverse Event|0|||
148709530|NCT02055547|536409994|FG010|Overall Study|Adverse Event|0|||
148709531|NCT02055547|536409995|FG011|Overall Study|Adverse Event|0|||
148709532|NCT02055547|536409996|FG012|Overall Study|Adverse Event|0|||
148709533|NCT02055547|536409997|FG013|Overall Study|Adverse Event|0|||
148709534|NCT02055547|536409998|FG014|Overall Study|Adverse Event|0|||
148709535|NCT02055547|536409999|FG015|Overall Study|Adverse Event|0|||
148709536|NCT02055547|536410000|FG016|Overall Study|Adverse Event|0|||
148709537|NCT02055547|536410001|FG017|Overall Study|Adverse Event|0|||
148709538|NCT02055547|536410002|FG018|Overall Study|Adverse Event|0|||
148709539|NCT02055547|536409984|FG000|Overall Study|Withdrawal by Subject|0|||
148709540|NCT02055547|536409985|FG001|Overall Study|Withdrawal by Subject|0|||
148709541|NCT02055547|536409986|FG002|Overall Study|Withdrawal by Subject|0|||
148709542|NCT02055547|536409987|FG003|Overall Study|Withdrawal by Subject|0|||
148709543|NCT02055547|536409988|FG004|Overall Study|Withdrawal by Subject|0|||
148709544|NCT02055547|536409989|FG005|Overall Study|Withdrawal by Subject|1|||
148709545|NCT02055547|536409990|FG006|Overall Study|Withdrawal by Subject|0|||
148709546|NCT02055547|536409991|FG007|Overall Study|Withdrawal by Subject|0|||
148709547|NCT02055547|536409992|FG008|Overall Study|Withdrawal by Subject|1|||
148709548|NCT02055547|536409993|FG009|Overall Study|Withdrawal by Subject|0|||
148709549|NCT02055547|536409994|FG010|Overall Study|Withdrawal by Subject|0|||
148709550|NCT02055547|536409995|FG011|Overall Study|Withdrawal by Subject|0|||
148815282|NCT01922011|536799450|FG000|Overall Study|Randomized in error|1|||
148709551|NCT02055547|536409996|FG012|Overall Study|Withdrawal by Subject|0|||
148709552|NCT02055547|536409997|FG013|Overall Study|Withdrawal by Subject|1|||
148709553|NCT02055547|536409998|FG014|Overall Study|Withdrawal by Subject|0|||
148709554|NCT02055547|536409999|FG015|Overall Study|Withdrawal by Subject|1|||
148709555|NCT02055547|536410000|FG016|Overall Study|Withdrawal by Subject|0|||
148709556|NCT02055547|536410001|FG017|Overall Study|Withdrawal by Subject|0|||
148709557|NCT02055547|536410002|FG018|Overall Study|Withdrawal by Subject|0|||
148709558|NCT02055547|536409984|FG000|Overall Study|Lost to Follow-up|0|||
148709559|NCT02055547|536409985|FG001|Overall Study|Lost to Follow-up|0|||
148709560|NCT02055547|536409986|FG002|Overall Study|Lost to Follow-up|1|||
148709561|NCT02055547|536409987|FG003|Overall Study|Lost to Follow-up|0|||
148709562|NCT02055547|536409988|FG004|Overall Study|Lost to Follow-up|0|||
148709563|NCT02055547|536409989|FG005|Overall Study|Lost to Follow-up|0|||
148709564|NCT02055547|536409990|FG006|Overall Study|Lost to Follow-up|0|||
148709565|NCT02055547|536409991|FG007|Overall Study|Lost to Follow-up|0|||
148709566|NCT02055547|536409992|FG008|Overall Study|Lost to Follow-up|0|||
148709567|NCT02055547|536409993|FG009|Overall Study|Lost to Follow-up|0|||
148709568|NCT02055547|536409994|FG010|Overall Study|Lost to Follow-up|0|||
148709569|NCT02055547|536409995|FG011|Overall Study|Lost to Follow-up|0|||
148709570|NCT02055547|536409996|FG012|Overall Study|Lost to Follow-up|0|||
148815283|NCT01922011|536799451|FG001|Overall Study|Randomized in error|0|||
148815284|NCT04871113|536799452|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815285|NCT04871113|536799453|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148709571|NCT02055547|536409997|FG013|Overall Study|Lost to Follow-up|0|||
148709572|NCT02055547|536409998|FG014|Overall Study|Lost to Follow-up|0|||
148709573|NCT02055547|536409999|FG015|Overall Study|Lost to Follow-up|0|||
148709574|NCT02055547|536410000|FG016|Overall Study|Lost to Follow-up|0|||
148709575|NCT02055547|536410001|FG017|Overall Study|Lost to Follow-up|0|||
148709576|NCT02055547|536410002|FG018|Overall Study|Lost to Follow-up|0|||
148709577|NCT01456221|536410003|FG000|Overall Study|Withdrawal by Subject|56|||
148709578|NCT01456221|536410004|FG001|Overall Study|Withdrawal by Subject|49|||
148709579|NCT01456221|536410003|FG000|Overall Study|Lost to Follow-up|1|||
148709580|NCT01456221|536410004|FG001|Overall Study|Lost to Follow-up|4|||
148709581|NCT01456221|536410003|FG000|Overall Study|Received medication|3|||
148709582|NCT01456221|536410004|FG001|Overall Study|Received medication|2|||
148709583|NCT01456221|536410003|FG000|Overall Study|Incomplete data|4|||
148709584|NCT01456221|536410004|FG001|Overall Study|Incomplete data|2|||
148709585|NCT04025021|536410005|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
148709586|NCT04025021|536410006|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
148709587|NCT01004510|536410008|FG000|Overall Study|Adverse Event|1|||
148709588|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
148709589|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
148709590|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
148709591|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
148709592|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
148709593|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709594|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709595|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709596|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709597|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709598|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709599|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709600|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709601|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709602|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709603|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709604|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709605|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709606|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709607|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709608|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709609|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709610|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709611|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709612|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709613|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
148709614|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709615|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
148709616|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709617|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709618|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709619|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709620|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709621|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709622|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709623|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709624|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709625|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709626|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709627|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709628|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709629|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709630|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709631|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709632|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709633|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709634|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709635|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709636|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709637|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709638|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709639|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
148709640|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709641|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
148709642|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709643|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709644|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709645|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709646|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709647|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709648|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709649|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709650|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709651|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709652|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709653|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709654|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709655|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709656|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709657|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709658|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709659|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709660|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709661|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709662|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709663|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709664|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709665|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
148709666|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
148709667|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709668|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
148709669|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
148709670|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
148709671|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709672|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709673|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709674|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709675|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709676|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709677|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709678|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709679|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709680|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709681|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709682|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709683|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709684|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709685|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709686|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709687|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709688|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709689|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709690|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709691|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
148709692|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
148709693|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
148709694|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
148709695|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
148709696|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
148709697|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709698|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709699|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709700|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709701|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709702|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709703|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709704|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709705|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709706|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709707|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709708|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709709|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709710|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709711|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148815286|NCT04871113|536799454|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815287|NCT04871113|536799455|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815288|NCT04871113|536799456|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148968024|NCT02159521|537368605|FG000|Overall Study|Withdrawal by Subject|7|||
148968025|NCT02159521|537368605|FG000|Overall Study|Lost to Follow-up|6|||
148968026|NCT02159521|537368605|FG000|Overall Study|Death|1|||
148968027|NCT02159521|537368605|FG000|Overall Study|Other than specified|1|||
148968028|NCT00907374|537368606|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
148968029|NCT00907374|537368607|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
148968030|NCT00680901|537368613|FG000|Overall Study|Ongoing: On Study Treatment|1|||
148968031|NCT00680901|537368614|FG001|Overall Study|Ongoing: On Study Treatment|0|||
148709712|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709713|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148968032|NCT00680901|537368613|FG000|Overall Study|Ongoing: In Follow Up|1|||
148968033|NCT00680901|537368614|FG001|Overall Study|Ongoing: In Follow Up|0|||
148968034|NCT00680901|537368613|FG000|Overall Study|Adverse Event|1|||
148709714|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709715|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709716|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709717|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
148709718|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|moved|0|||
148709719|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|moved|1|||
148709720|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|moved|1|||
148709721|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|moved|0|||
148709722|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|moved|0|||
148709723|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|moved|0|||
148709724|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|moved|0|||
148709725|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|moved|0|||
148709726|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|moved|0|||
148709727|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|moved|0|||
148709728|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|moved|0|||
148709729|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|moved|0|||
148709730|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|moved|0|||
148709731|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|moved|0|||
148709732|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|moved|0|||
148709733|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|moved|0|||
148709734|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|moved|0|||
148709735|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|moved|0|||
148709736|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|moved|0|||
148709737|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|moved|0|||
148709738|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|moved|0|||
148709739|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|moved|0|||
148709740|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|moved|0|||
148709741|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|moved|0|||
148709742|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|moved|0|||
148709743|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|moved|0|||
148709744|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709745|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709746|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709747|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
148709748|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709749|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709750|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709751|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709752|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709753|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709754|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709755|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709756|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709757|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709758|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709759|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709760|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709761|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709762|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709763|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709764|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709765|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148968035|NCT00680901|537368614|FG001|Overall Study|Adverse Event|1|||
148968036|NCT00680901|537368613|FG000|Overall Study|Lost to Follow-up|3|||
148709766|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709767|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148968037|NCT00680901|537368614|FG001|Overall Study|Lost to Follow-up|5|||
148968038|NCT00680901|537368613|FG000|Overall Study|Subject decided to withdraw from the study|4|||
148968039|NCT00680901|537368614|FG001|Overall Study|Subject decided to withdraw from the study|15|||
148968040|NCT00680901|537368613|FG000|Overall Study|Sponsor decision|1|||
148968041|NCT00680901|537368614|FG001|Overall Study|Sponsor decision|0|||
148968042|NCT00680901|537368613|FG000|Overall Study|Physician Decision|0|||
148968043|NCT00680901|537368614|FG001|Overall Study|Physician Decision|2|||
148968044|NCT00680901|537368613|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
148968045|NCT00680901|537368614|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
148968046|NCT00680901|537368613|FG000|Overall Study|Other protocol defined stopping criteria|17|||
148968047|NCT00680901|537368614|FG001|Overall Study|Other protocol defined stopping criteria|17|||
148968048|NCT00075582|537368615|FG000|Overall Study|Adverse Event|3|||
148968049|NCT00075582|537368616|FG001|Overall Study|Adverse Event|1|||
148968050|NCT00075582|537368615|FG000|Overall Study|Lack of Efficacy|4|||
148968051|NCT00075582|537368616|FG001|Overall Study|Lack of Efficacy|8|||
148968052|NCT00075582|537368615|FG000|Overall Study|Physician Decision|5|||
148968053|NCT00075582|537368616|FG001|Overall Study|Physician Decision|8|||
148709768|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709769|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
148709770|NCT00112437|536410011|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709771|NCT00112437|536410012|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709772|NCT00112437|536410013|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709773|NCT00112437|536410014|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709774|NCT00112437|536410015|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
148709775|NCT00112437|536410016|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709776|NCT00112437|536410017|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709777|NCT00112437|536410018|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709778|NCT00112437|536410019|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709779|NCT00112437|536410020|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709780|NCT00112437|536410021|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709781|NCT00112437|536410022|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709782|NCT00112437|536410023|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709783|NCT00112437|536410024|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709784|NCT00112437|536410025|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709785|NCT00112437|536410026|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709786|NCT00112437|536410027|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709787|NCT00112437|536410028|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709788|NCT00112437|536410029|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709789|NCT00112437|536410030|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709790|NCT00112437|536410031|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709791|NCT00112437|536410032|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709792|NCT00112437|536410033|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709793|NCT00112437|536410034|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709794|NCT00112437|536410035|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709795|NCT00112437|536410036|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
148709796|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
148709797|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
148709798|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
148709799|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
148709800|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
148709801|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
148709802|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
148709803|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
148709804|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
148709805|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
148709806|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
148709807|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
148709808|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
148709809|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
148709810|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
148709811|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
148709812|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
148709813|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
148968054|NCT00075582|537368615|FG000|Overall Study|Withdrawal by Subject|2|||
148968055|NCT00075582|537368616|FG001|Overall Study|Withdrawal by Subject|2|||
148968056|NCT00075582|537368615|FG000|Overall Study|Ineligible for study|36|||
148968057|NCT00075582|537368616|FG001|Overall Study|Ineligible for study|16|||
148709814|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
148709815|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
148709816|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
148709817|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
148709818|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
148709819|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
148709820|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
148709821|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
148709822|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709823|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709824|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709825|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709826|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709827|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
148709828|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
148709829|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709830|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709831|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
148709832|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709833|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709834|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709835|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709836|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709837|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709838|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709839|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709840|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709841|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709842|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709843|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709844|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709845|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709846|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709847|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
148709848|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709849|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709850|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709851|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709852|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709853|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709854|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709855|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709856|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
148709857|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709858|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709859|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709860|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709861|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709862|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709863|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709864|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709865|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709866|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709867|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709868|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709869|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709870|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709871|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709872|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709873|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
148709874|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709875|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709876|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709877|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709878|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
148815289|NCT04871113|536799457|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
148815290|NCT04871113|536799458|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815291|NCT04871113|536799459|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815292|NCT04871113|536799460|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815293|NCT04871113|536799461|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
148815294|NCT04871113|536799452|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148815295|NCT04871113|536799453|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148709879|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709880|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709881|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709882|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
148709883|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709884|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709885|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709886|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709887|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709888|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709889|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709890|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709891|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709892|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709893|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709894|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709895|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709896|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709897|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709898|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709899|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
148709900|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709901|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709902|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709903|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709904|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709905|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
148709906|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
148709907|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
148709908|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
148709909|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
148709910|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709911|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709912|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709913|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709914|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709915|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709916|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709917|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709918|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709919|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709920|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709921|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709922|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709923|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709924|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709925|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
148709926|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709927|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709928|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709929|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709930|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709931|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709932|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148968058|NCT04258605|537368618|FG000|Overall Study|Death|1|||
148968059|NCT04258605|537368619|FG001|Overall Study|Death|0|||
148709933|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709934|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709935|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
148709936|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709937|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709938|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709939|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709940|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709941|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709942|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148968060|NCT04258605|537368618|FG000|Overall Study|Early study termination|21|||
148968061|NCT04258605|537368619|FG001|Overall Study|Early study termination|2|||
148968062|NCT01177540|537368620|FG000|Overall Study|Adverse Event|1|||
148968063|NCT01177540|537368621|FG001|Overall Study|Adverse Event|0|||
148968064|NCT02818777|537368629|FG000|Overall Study|Adverse Event|3|||
148968065|NCT02910167|537368631|FG000|Overall Study|Adverse Event|1|||
148968066|NCT02910167|537368631|FG000|Overall Study|Lost to Follow-up|18|||
148968067|NCT01418937|537368632|FG000|Overall Study|Lost to Follow-up|5|||
148968068|NCT01418937|537368632|FG000|Overall Study|Protocol Violation|1|||
148968069|NCT01418937|537368632|FG000|Overall Study|Pregnancy|1|||
148968070|NCT01418937|537368632|FG000|Overall Study|Withdrawal by Subject|1|||
148968071|NCT00856908|537368648|FG000|Overall Study|Lost to Follow-up|1|||
148968072|NCT00856908|537368649|FG001|Overall Study|Lost to Follow-up|0|||
148968073|NCT01070316|537368654|FG000|Extension Phase|Lack of Efficacy|3|||
148968074|NCT01070316|537368654|FG000|Extension Phase|Withdrawal by Subject|1|||
148968075|NCT02013167|537368655|FG000|Overall Study|Withdrawal by Subject|15|||
148968076|NCT02013167|537368656|FG001|Overall Study|Withdrawal by Subject|14|||
148968077|NCT02013167|537368655|FG000|Overall Study|Sponsor Decision|1|||
148968078|NCT02013167|537368656|FG001|Overall Study|Sponsor Decision|3|||
148968079|NCT02013167|537368655|FG000|Overall Study|Lost to Follow-up|0|||
148968080|NCT02013167|537368656|FG001|Overall Study|Lost to Follow-up|1|||
148968081|NCT02013167|537368655|FG000|Overall Study|Death|85|||
148968082|NCT02013167|537368656|FG001|Overall Study|Death|160|||
148968083|NCT00026793|537368659|FG000|Overall Study|Death on study due to underlying disease|4|||
148968084|NCT00026793|537368659|FG000|Overall Study|Physician Decision|2|||
148968085|NCT00026793|537368659|FG000|Overall Study|Off study|2|||
148968086|NCT04151290|537368660|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
148968087|NCT02276612|537368663|FG000|Overall Study|Death|1|||
148968088|NCT02276612|537368664|FG001|Overall Study|Death|0|||
148968089|NCT02276612|537368663|FG000|Overall Study|Pregnancy|1|||
148968090|NCT02276612|537368664|FG001|Overall Study|Pregnancy|0|||
148968091|NCT02276612|537368663|FG000|Overall Study|Withdrew Consent|1|||
148968092|NCT02276612|537368664|FG001|Overall Study|Withdrew Consent|0|||
148968093|NCT02276612|537368663|FG000|Overall Study|Lost to Follow-up|1|||
148968094|NCT02276612|537368664|FG001|Overall Study|Lost to Follow-up|0|||
148968095|NCT01077804|537368665|FG000|Overall Study|Unreachable|102|||
148968096|NCT01077804|537368665|FG000|Overall Study|Refused to continue|79|||
148968097|NCT01077804|537368665|FG000|Overall Study|Other|18|||
148968098|NCT02620046|537368666|FG000|Overall Study|Adverse Event|22|||
148709943|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709944|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709945|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709946|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709947|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709948|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709949|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709950|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709951|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
148709952|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709953|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709954|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709955|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709956|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709957|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709958|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709959|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709960|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709961|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
148709962|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709963|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709964|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709965|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709966|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709967|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709968|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709969|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709970|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709971|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709972|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
148968099|NCT02620046|537368667|FG001|Overall Study|Adverse Event|42|||
148968100|NCT02620046|537368666|FG000|Overall Study|Lost to Follow-up|4|||
148968101|NCT02620046|537368667|FG001|Overall Study|Lost to Follow-up|10|||
148968102|NCT02620046|537368666|FG000|Overall Study|Withdrawal by Subject|36|||
148968103|NCT02620046|537368667|FG001|Overall Study|Withdrawal by Subject|66|||
148968104|NCT02620046|537368666|FG000|Overall Study|Site Termination|3|||
148709973|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
148968105|NCT02620046|537368667|FG001|Overall Study|Site Termination|3|||
148968106|NCT02620046|537368666|FG000|Overall Study|Pregnancy|3|||
148968107|NCT02620046|537368667|FG001|Overall Study|Pregnancy|7|||
148968108|NCT02620046|537368666|FG000|Overall Study|Lack of Efficacy|81|||
148968109|NCT02620046|537368667|FG001|Overall Study|Lack of Efficacy|146|||
148709974|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709975|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709976|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709977|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
148709978|NCT00112437|536410011|FG000|Year 2 (12-Month Extension)|Moved|0|||
148709979|NCT00112437|536410012|FG001|Year 2 (12-Month Extension)|Moved|0|||
148709980|NCT00112437|536410013|FG002|Year 2 (12-Month Extension)|Moved|0|||
148709981|NCT00112437|536410014|FG003|Year 2 (12-Month Extension)|Moved|0|||
148709982|NCT00112437|536410015|FG004|Year 2 (12-Month Extension)|Moved|0|||
148709983|NCT00112437|536410016|FG005|Year 2 (12-Month Extension)|Moved|0|||
148709984|NCT00112437|536410017|FG006|Year 2 (12-Month Extension)|Moved|0|||
148709985|NCT00112437|536410018|FG007|Year 2 (12-Month Extension)|Moved|0|||
148709986|NCT00112437|536410019|FG008|Year 2 (12-Month Extension)|Moved|0|||
148709987|NCT00112437|536410020|FG009|Year 2 (12-Month Extension)|Moved|1|||
148709988|NCT00112437|536410021|FG010|Year 2 (12-Month Extension)|Moved|0|||
148709989|NCT00112437|536410022|FG011|Year 2 (12-Month Extension)|Moved|0|||
148709990|NCT00112437|536410023|FG012|Year 2 (12-Month Extension)|Moved|0|||
148709991|NCT00112437|536410024|FG013|Year 2 (12-Month Extension)|Moved|0|||
148709992|NCT00112437|536410025|FG014|Year 2 (12-Month Extension)|Moved|0|||
148709993|NCT00112437|536410026|FG015|Year 2 (12-Month Extension)|Moved|0|||
148709994|NCT00112437|536410027|FG016|Year 2 (12-Month Extension)|Moved|0|||
148709995|NCT00112437|536410028|FG017|Year 2 (12-Month Extension)|Moved|0|||
148709996|NCT00112437|536410029|FG018|Year 2 (12-Month Extension)|Moved|0|||
148709997|NCT00112437|536410030|FG019|Year 2 (12-Month Extension)|Moved|0|||
148709998|NCT00112437|536410031|FG020|Year 2 (12-Month Extension)|Moved|0|||
148709999|NCT00112437|536410032|FG021|Year 2 (12-Month Extension)|Moved|0|||
148710000|NCT00112437|536410033|FG022|Year 2 (12-Month Extension)|Moved|0|||
148710001|NCT00112437|536410034|FG023|Year 2 (12-Month Extension)|Moved|0|||
148710002|NCT00112437|536410035|FG024|Year 2 (12-Month Extension)|Moved|0|||
148710003|NCT00112437|536410036|FG025|Year 2 (12-Month Extension)|Moved|0|||
148710004|NCT00112437|536410011|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
148710005|NCT00112437|536410012|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
148710006|NCT00112437|536410013|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
148710007|NCT00112437|536410014|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
148710008|NCT00112437|536410015|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
148710009|NCT00112437|536410016|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
148710010|NCT00112437|536410017|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
148710011|NCT00112437|536410018|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
148710012|NCT00112437|536410019|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
148710013|NCT00112437|536410020|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
148710014|NCT00112437|536410021|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
148710015|NCT00112437|536410022|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
148710016|NCT00112437|536410023|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
148710017|NCT00112437|536410024|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
148968110|NCT02620046|537368666|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
148968111|NCT02620046|537368667|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
148968112|NCT02620046|537368666|FG000|Overall Study|Reason Not Specified|13|||
148968113|NCT02620046|537368667|FG001|Overall Study|Reason Not Specified|21|||
148710018|NCT00112437|536410025|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
148710019|NCT00112437|536410026|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
148710020|NCT00112437|536410027|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
148710021|NCT00112437|536410028|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
148710022|NCT00112437|536410029|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
148710023|NCT00112437|536410030|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
148710024|NCT00112437|536410031|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
148710025|NCT00112437|536410032|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
148710026|NCT00112437|536410033|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
148710027|NCT00112437|536410034|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
148710028|NCT00112437|536410035|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
148710029|NCT00112437|536410036|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
148710030|NCT00112437|536410011|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148815296|NCT04871113|536799454|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148815297|NCT04871113|536799455|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148710031|NCT00112437|536410012|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710032|NCT00112437|536410013|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710033|NCT00112437|536410014|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710034|NCT00112437|536410015|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710035|NCT00112437|536410016|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148968114|NCT02620046|537368666|FG000|Overall Study|Significant Protocol Deviation|0|||
148968115|NCT02620046|537368667|FG001|Overall Study|Significant Protocol Deviation|1|||
148710036|NCT00112437|536410017|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710037|NCT00112437|536410018|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710038|NCT00112437|536410019|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710039|NCT00112437|536410020|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710040|NCT00112437|536410021|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710041|NCT00112437|536410022|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
148710042|NCT00112437|536410023|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710043|NCT00112437|536410024|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
148710044|NCT00112437|536410025|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710045|NCT00112437|536410026|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
148710046|NCT00112437|536410027|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710047|NCT00112437|536410028|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710048|NCT00112437|536410029|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
148710049|NCT00112437|536410030|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710050|NCT00112437|536410031|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710051|NCT00112437|536410032|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710052|NCT00112437|536410033|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710053|NCT00112437|536410034|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710054|NCT00112437|536410035|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710055|NCT00112437|536410036|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
148710056|NCT00112437|536410011|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710057|NCT00112437|536410012|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710058|NCT00112437|536410013|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710059|NCT00112437|536410014|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710060|NCT00112437|536410015|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710061|NCT00112437|536410016|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710062|NCT00112437|536410017|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710063|NCT00112437|536410018|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710064|NCT00112437|536410019|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710065|NCT00112437|536410020|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710066|NCT00112437|536410021|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710067|NCT00112437|536410022|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710068|NCT00112437|536410023|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710069|NCT00112437|536410024|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710070|NCT00112437|536410025|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710071|NCT00112437|536410026|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
148710072|NCT00112437|536410027|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710073|NCT00112437|536410028|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710074|NCT00112437|536410029|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710075|NCT00112437|536410030|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710076|NCT00112437|536410031|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710077|NCT00112437|536410032|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710078|NCT00112437|536410033|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710079|NCT00112437|536410034|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710080|NCT00112437|536410035|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710081|NCT00112437|536410036|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
148710082|NCT00112437|536410011|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710083|NCT00112437|536410012|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710084|NCT00112437|536410013|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710085|NCT00112437|536410014|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710086|NCT00112437|536410015|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710087|NCT00112437|536410016|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710088|NCT00112437|536410017|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710089|NCT00112437|536410018|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710090|NCT00112437|536410019|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710091|NCT00112437|536410020|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710092|NCT00112437|536410021|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710093|NCT00112437|536410022|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710094|NCT00112437|536410023|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710095|NCT00112437|536410024|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710096|NCT00112437|536410025|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710097|NCT00112437|536410026|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
148710098|NCT00112437|536410027|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710099|NCT00112437|536410028|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710100|NCT00112437|536410029|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710101|NCT00112437|536410030|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710102|NCT00112437|536410031|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710103|NCT00112437|536410032|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710104|NCT00112437|536410033|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710105|NCT00112437|536410034|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
148968116|NCT01572038|537370243|FG000|Overall Study|Death|648|||
148968117|NCT01572038|537370243|FG000|Overall Study|Withdrawal by Subject|204|||
148968118|NCT01572038|537370243|FG000|Overall Study|Lost to Follow-up|81|||
148710106|NCT00112437|536410035|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710107|NCT00112437|536410036|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
148710108|NCT00112437|536410011|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710109|NCT00112437|536410012|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710110|NCT00112437|536410013|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710111|NCT00112437|536410014|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710112|NCT00112437|536410015|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710113|NCT00112437|536410016|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710114|NCT00112437|536410017|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710115|NCT00112437|536410018|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710116|NCT00112437|536410019|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710117|NCT00112437|536410020|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710118|NCT00112437|536410021|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710119|NCT00112437|536410022|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
148710120|NCT00112437|536410023|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710121|NCT00112437|536410024|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710122|NCT00112437|536410025|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
148710123|NCT00112437|536410026|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710124|NCT00112437|536410027|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710125|NCT00112437|536410028|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710126|NCT00112437|536410029|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710127|NCT00112437|536410030|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710128|NCT00112437|536410031|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710129|NCT00112437|536410032|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710130|NCT00112437|536410033|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710131|NCT00112437|536410034|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710132|NCT00112437|536410035|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710133|NCT00112437|536410036|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
148710134|NCT00112437|536410011|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710135|NCT00112437|536410012|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710136|NCT00112437|536410013|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710137|NCT00112437|536410014|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710138|NCT00112437|536410015|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710139|NCT00112437|536410016|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710140|NCT00112437|536410017|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710141|NCT00112437|536410018|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710142|NCT00112437|536410019|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710143|NCT00112437|536410020|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710144|NCT00112437|536410021|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
148710145|NCT00112437|536410022|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
148710146|NCT00112437|536410023|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710147|NCT00112437|536410024|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710148|NCT00112437|536410025|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710149|NCT00112437|536410026|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710150|NCT00112437|536410027|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710151|NCT00112437|536410028|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710152|NCT00112437|536410029|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710153|NCT00112437|536410030|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710154|NCT00112437|536410031|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710155|NCT00112437|536410032|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710156|NCT00112437|536410033|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710157|NCT00112437|536410034|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710158|NCT00112437|536410035|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710159|NCT00112437|536410036|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
148710160|NCT00112437|536410011|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710161|NCT00112437|536410012|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710162|NCT00112437|536410013|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710163|NCT00112437|536410014|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710164|NCT00112437|536410015|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710165|NCT00112437|536410016|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148968119|NCT01572038|537370243|FG000|Overall Study|Physician Decision|20|||
148710166|NCT00112437|536410017|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710167|NCT00112437|536410018|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148968120|NCT01572038|537370243|FG000|Overall Study|Patient Decision|14|||
148710168|NCT00112437|536410019|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710169|NCT00112437|536410020|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710170|NCT00112437|536410021|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710171|NCT00112437|536410022|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710172|NCT00112437|536410023|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710173|NCT00112437|536410024|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710174|NCT00112437|536410025|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710175|NCT00112437|536410026|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710176|NCT00112437|536410027|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710177|NCT00112437|536410028|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710178|NCT00112437|536410029|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710179|NCT00112437|536410030|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710180|NCT00112437|536410031|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
148710181|NCT00112437|536410032|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
148710182|NCT00112437|536410033|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710183|NCT00112437|536410034|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710184|NCT00112437|536410035|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710185|NCT00112437|536410036|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
148710186|NCT00112437|536410011|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710187|NCT00112437|536410012|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710188|NCT00112437|536410013|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710189|NCT00112437|536410014|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710190|NCT00112437|536410015|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710191|NCT00112437|536410016|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710192|NCT00112437|536410017|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710193|NCT00112437|536410018|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710194|NCT00112437|536410019|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710195|NCT00112437|536410020|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710196|NCT00112437|536410021|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710197|NCT00112437|536410022|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710198|NCT00112437|536410023|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710199|NCT00112437|536410024|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710200|NCT00112437|536410025|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710201|NCT00112437|536410026|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710202|NCT00112437|536410027|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710203|NCT00112437|536410028|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710204|NCT00112437|536410029|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710205|NCT00112437|536410030|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710206|NCT00112437|536410031|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
148710207|NCT00112437|536410032|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710208|NCT00112437|536410033|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710209|NCT00112437|536410034|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710210|NCT00112437|536410035|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710211|NCT00112437|536410036|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
148710212|NCT00112437|536410011|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710213|NCT00112437|536410012|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710214|NCT00112437|536410013|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710215|NCT00112437|536410014|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710216|NCT00112437|536410015|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148815298|NCT04871113|536799456|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148815299|NCT04871113|536799457|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148815300|NCT04871113|536799458|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
148968121|NCT01572038|537370243|FG000|Overall Study|Progressive Disease|8|||
148968122|NCT01572038|537370243|FG000|Overall Study|Site Closed Before Completing Form|6|||
148968123|NCT01572038|537370243|FG000|Overall Study|Enrolled into Another Trial|3|||
148968124|NCT01572038|537370243|FG000|Overall Study|Participated in Another Trial|3|||
148968125|NCT01572038|537370243|FG000|Overall Study|Termination by Sponsor|2|||
148968126|NCT01572038|537370243|FG000|Overall Study|Patient Deterioration|1|||
148968127|NCT01572038|537370243|FG000|Overall Study|Sponsor Decision|1|||
148968128|NCT04013191|537370244|FG000|Overall Study|Adverse Event|1|||
148968129|NCT04013191|537370245|FG001|Overall Study|Adverse Event|0|||
148968130|NCT01275066|537370250|FG000|Overall Study|Withdrawal by Subject|0|||
148710217|NCT00112437|536410016|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710218|NCT00112437|536410017|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710219|NCT00112437|536410018|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148968131|NCT01275066|537370251|FG001|Overall Study|Withdrawal by Subject|0|||
148968132|NCT01275066|537370252|FG002|Overall Study|Withdrawal by Subject|1|||
148710220|NCT00112437|536410019|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710221|NCT00112437|536410020|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710222|NCT00112437|536410021|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710223|NCT00112437|536410022|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710224|NCT00112437|536410023|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710225|NCT00112437|536410024|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710226|NCT00112437|536410025|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710227|NCT00112437|536410026|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710228|NCT00112437|536410027|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710229|NCT00112437|536410028|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710230|NCT00112437|536410029|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710231|NCT00112437|536410030|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710232|NCT00112437|536410031|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710233|NCT00112437|536410032|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
148710234|NCT00112437|536410033|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710235|NCT00112437|536410034|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710236|NCT00112437|536410035|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710237|NCT00112437|536410036|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
148710238|NCT00112437|536410011|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710239|NCT00112437|536410012|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710240|NCT00112437|536410013|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
148815301|NCT04871113|536799459|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
148815302|NCT04871113|536799460|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148815303|NCT04871113|536799461|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
148815304|NCT02447029|536799462|FG000|Overall Study|Withdrawal by Subject|3|||
148815305|NCT02447029|536799463|FG001|Overall Study|Withdrawal by Subject|2|||
148815306|NCT01239745|536799464|FG000|Overall Study|Study terminated by sponsor|45|||
148815307|NCT01239745|536799464|FG000|Overall Study|Adverse Event|1|||
148815308|NCT01257542|536799469|FG000|Overall Study|Protocol Violation|3|||
148815309|NCT01257542|536799470|FG001|Overall Study|Protocol Violation|5|||
148815310|NCT01257542|536799469|FG000|Overall Study|Withdrawal by Subject|0|||
148815311|NCT01257542|536799470|FG001|Overall Study|Withdrawal by Subject|2|||
148815312|NCT00081458|536799471|FG000|Overall Study|Adverse Event|1|||
148815313|NCT00081458|536799472|FG001|Overall Study|Adverse Event|5|||
148815314|NCT00081458|536799473|FG002|Overall Study|Adverse Event|2|||
148815315|NCT00081458|536799471|FG000|Overall Study|Withdrawal by Subject|0|||
148815316|NCT00081458|536799472|FG001|Overall Study|Withdrawal by Subject|3|||
148815317|NCT00081458|536799473|FG002|Overall Study|Withdrawal by Subject|1|||
148815318|NCT00081458|536799471|FG000|Overall Study|Randomized but not dosed|0|||
148815319|NCT00081458|536799472|FG001|Overall Study|Randomized but not dosed|0|||
148815320|NCT00081458|536799473|FG002|Overall Study|Randomized but not dosed|1|||
148815321|NCT01946802|536799481|FG000|Overall Study|Death|1|||
148815322|NCT01946802|536799481|FG000|Overall Study|Withdrawal by Subject|2|||
148815323|NCT01946802|536799481|FG000|Overall Study|Combined septic shock|1|||
148815324|NCT01946802|536799481|FG000|Overall Study|Protocol Violation|1|||
148815325|NCT03097315|536799482|FG000|Overall Study|Withdrawal by Subject|1|||
148815326|NCT00153920|536799483|FG000|Overall Study|Adverse Event|9|||
148815327|NCT00153920|536799483|FG000|Overall Study|Progressive Disease|9|||
148815328|NCT00153920|536799483|FG000|Overall Study|Physician Decision|3|||
148815329|NCT00153920|536799483|FG000|Overall Study|Lack of Response|3|||
148815330|NCT00153920|536799483|FG000|Overall Study|Death|2|||
148815331|NCT00153920|536799483|FG000|Overall Study|Withdrawal by Subject|1|||
148815332|NCT00153920|536799483|FG000|Overall Study|Non-Protocol Therapy|1|||
148815333|NCT00153920|536799483|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
148815334|NCT00153920|536799483|FG000|Overall Study|Progressive Disease before Trt|1|||
148815335|NCT00195429|536799484|FG000|Overall Study|Adverse Event|2|||
148815336|NCT00195429|536799485|FG001|Overall Study|Adverse Event|4|||
148815337|NCT00195429|536799484|FG000|Overall Study|Lack of Efficacy|2|||
148815338|NCT00195429|536799485|FG001|Overall Study|Lack of Efficacy|1|||
148815339|NCT00195429|536799484|FG000|Overall Study|Lost to Follow-up|1|||
148815340|NCT00195429|536799485|FG001|Overall Study|Lost to Follow-up|0|||
148815341|NCT02143778|536799486|FG000|Overall Study|Withdrawal by Subject|2|||
148815342|NCT02143778|536799486|FG000|Overall Study|Device malfunction|1|||
148710241|NCT00112437|536410014|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710242|NCT00112437|536410015|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710243|NCT00112437|536410016|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710244|NCT00112437|536410017|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
148815343|NCT00367458|536799487|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
148815344|NCT00367458|536799488|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
148815345|NCT01334515|536799489|FG000|Overall Study|Adverse Event|1|||
148815346|NCT01334515|536799490|FG001|Overall Study|Adverse Event|6|||
148815347|NCT01334515|536799489|FG000|Overall Study|Death|1|||
148815348|NCT01334515|536799490|FG001|Overall Study|Death|0|||
148815349|NCT01334515|536799489|FG000|Overall Study|Lack of Efficacy|8|||
148815350|NCT01334515|536799490|FG001|Overall Study|Lack of Efficacy|21|||
148710245|NCT00112437|536410018|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710246|NCT00112437|536410019|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710247|NCT00112437|536410020|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710248|NCT00112437|536410021|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710249|NCT00112437|536410022|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710250|NCT00112437|536410023|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710251|NCT00112437|536410024|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710252|NCT00112437|536410025|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710253|NCT00112437|536410026|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710254|NCT00112437|536410027|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710255|NCT00112437|536410028|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710256|NCT00112437|536410029|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710257|NCT00112437|536410030|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710258|NCT00112437|536410031|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710259|NCT00112437|536410032|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
148710260|NCT00112437|536410033|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710261|NCT00112437|536410034|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710262|NCT00112437|536410035|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710263|NCT00112437|536410036|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
148710264|NCT00112437|536410011|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710265|NCT00112437|536410012|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710266|NCT00112437|536410013|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710267|NCT00112437|536410014|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710268|NCT00112437|536410015|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710269|NCT00112437|536410016|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710270|NCT00112437|536410017|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710271|NCT00112437|536410018|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710272|NCT00112437|536410019|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710273|NCT00112437|536410020|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710274|NCT00112437|536410021|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710275|NCT00112437|536410022|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710276|NCT00112437|536410023|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710277|NCT00112437|536410024|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710278|NCT00112437|536410025|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710279|NCT00112437|536410026|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710280|NCT00112437|536410027|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710281|NCT00112437|536410028|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710282|NCT00112437|536410029|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710283|NCT00112437|536410030|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710284|NCT00112437|536410031|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
148710285|NCT00112437|536410032|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
148710286|NCT00112437|536410033|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710287|NCT00112437|536410034|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710288|NCT00112437|536410035|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710289|NCT00112437|536410036|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
148710290|NCT00112437|536410011|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710291|NCT00112437|536410012|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710292|NCT00112437|536410013|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710293|NCT00112437|536410014|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710294|NCT00112437|536410015|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710295|NCT00112437|536410016|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710296|NCT00112437|536410017|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710297|NCT00112437|536410018|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710298|NCT00112437|536410019|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710299|NCT00112437|536410020|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710300|NCT00112437|536410021|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710301|NCT00112437|536410022|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710302|NCT00112437|536410023|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710303|NCT00112437|536410024|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710304|NCT00112437|536410025|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710305|NCT00112437|536410026|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149025109|NCT00811187|537568019|FG000|Overall Study|Unable to place device / procedure abort|3|||
148710306|NCT00112437|536410027|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710307|NCT00112437|536410028|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710308|NCT00112437|536410029|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
149025110|NCT00811187|537568020|FG001|Overall Study|Unable to place device / procedure abort|3|||
148710309|NCT00112437|536410030|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710310|NCT00112437|536410031|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710311|NCT00112437|536410032|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710312|NCT00112437|536410033|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
148968133|NCT01275066|537370250|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
148968134|NCT01275066|537370251|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
148968135|NCT01275066|537370252|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
148968136|NCT00394212|537370255|FG000|Overall Study|Lost to Follow-up|3|||
148968137|NCT00394212|537370256|FG001|Overall Study|Lost to Follow-up|0|||
148968138|NCT00394212|537370255|FG000|Overall Study|Withdrawal by Subject|4|||
148710313|NCT00112437|536410034|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
148710314|NCT00112437|536410035|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
148710315|NCT00112437|536410036|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
148710316|NCT00112437|536410011|FG000|Years 6-10 (60-Month Extension)|Death|0|||
148710317|NCT00112437|536410012|FG001|Years 6-10 (60-Month Extension)|Death|0|||
148710318|NCT00112437|536410013|FG002|Years 6-10 (60-Month Extension)|Death|0|||
148710319|NCT00112437|536410014|FG003|Years 6-10 (60-Month Extension)|Death|0|||
148710320|NCT00112437|536410015|FG004|Years 6-10 (60-Month Extension)|Death|0|||
148710321|NCT00112437|536410016|FG005|Years 6-10 (60-Month Extension)|Death|0|||
148710322|NCT00112437|536410017|FG006|Years 6-10 (60-Month Extension)|Death|0|||
148710323|NCT00112437|536410018|FG007|Years 6-10 (60-Month Extension)|Death|0|||
148710324|NCT00112437|536410019|FG008|Years 6-10 (60-Month Extension)|Death|0|||
148710325|NCT00112437|536410020|FG009|Years 6-10 (60-Month Extension)|Death|0|||
148710326|NCT00112437|536410021|FG010|Years 6-10 (60-Month Extension)|Death|0|||
148710327|NCT00112437|536410022|FG011|Years 6-10 (60-Month Extension)|Death|0|||
148710328|NCT00112437|536410023|FG012|Years 6-10 (60-Month Extension)|Death|0|||
148710329|NCT00112437|536410024|FG013|Years 6-10 (60-Month Extension)|Death|0|||
148710330|NCT00112437|536410025|FG014|Years 6-10 (60-Month Extension)|Death|0|||
148710331|NCT00112437|536410026|FG015|Years 6-10 (60-Month Extension)|Death|0|||
148710332|NCT00112437|536410027|FG016|Years 6-10 (60-Month Extension)|Death|0|||
148710333|NCT00112437|536410028|FG017|Years 6-10 (60-Month Extension)|Death|0|||
148710334|NCT00112437|536410029|FG018|Years 6-10 (60-Month Extension)|Death|0|||
148710335|NCT00112437|536410030|FG019|Years 6-10 (60-Month Extension)|Death|0|||
148710336|NCT00112437|536410031|FG020|Years 6-10 (60-Month Extension)|Death|0|||
148710337|NCT00112437|536410032|FG021|Years 6-10 (60-Month Extension)|Death|0|||
148710338|NCT00112437|536410033|FG022|Years 6-10 (60-Month Extension)|Death|0|||
148815351|NCT01334515|536799489|FG000|Overall Study|Physician Decision|1|||
148815352|NCT01334515|536799490|FG001|Overall Study|Physician Decision|1|||
148815353|NCT01334515|536799489|FG000|Overall Study|Withdrawal by Subject|1|||
148815354|NCT01334515|536799490|FG001|Overall Study|Withdrawal by Subject|1|||
148815355|NCT02948400|536799491|FG000|Overall Study|Withdrawal by Subject|17|||
148815356|NCT02948400|536799492|FG001|Overall Study|Withdrawal by Subject|10|||
148815357|NCT02948400|536799491|FG000|Overall Study|failed to attend appointments|47|||
148815358|NCT02948400|536799492|FG001|Overall Study|failed to attend appointments|34|||
148815359|NCT02948400|536799491|FG000|Overall Study|COVID-related closure|6|||
148815360|NCT02948400|536799492|FG001|Overall Study|COVID-related closure|2|||
148815361|NCT02948400|536799491|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
148815362|NCT02948400|536799492|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
148815363|NCT02948400|536799491|FG000|Overall Study|motion sickness in virtual reality|2|||
148815364|NCT02948400|536799492|FG001|Overall Study|motion sickness in virtual reality|0|||
148815365|NCT00825175|536799495|FG000|Overall Study|Withdrawal by Subject|0|||
148815366|NCT00825175|536799496|FG001|Overall Study|Withdrawal by Subject|5|||
148815367|NCT04822194|536799497|FG000|Overall Study|Withdrawal by Subject|5|||
148815368|NCT04822194|536799498|FG001|Overall Study|Withdrawal by Subject|4|||
148815369|NCT04822194|536799497|FG000|Overall Study|Technical issues with MR scanner|1|||
148815370|NCT04822194|536799498|FG001|Overall Study|Technical issues with MR scanner|0|||
148815371|NCT04822194|536799497|FG000|Overall Study|Lost to Follow-up|5|||
148815372|NCT04822194|536799498|FG001|Overall Study|Lost to Follow-up|7|||
148815373|NCT03976375|536799499|FG000|Overall Study|Death|158|||
148815374|NCT03976375|536799500|FG001|Overall Study|Death|160|||
148815375|NCT03976375|536799501|FG002|Overall Study|Death|42|||
148815376|NCT03976375|536799499|FG000|Overall Study|Lost to Follow-up|2|||
148815377|NCT03976375|536799500|FG001|Overall Study|Lost to Follow-up|1|||
148815378|NCT03976375|536799501|FG002|Overall Study|Lost to Follow-up|1|||
148815379|NCT03976375|536799499|FG000|Overall Study|Withdrawal by Subject|5|||
148815380|NCT03976375|536799500|FG001|Overall Study|Withdrawal by Subject|9|||
148968139|NCT00394212|537370256|FG001|Overall Study|Withdrawal by Subject|1|||
148815381|NCT03976375|536799501|FG002|Overall Study|Withdrawal by Subject|4|||
148968140|NCT00588445|537370257|FG000|Overall Study|Protocol Violation|1|||
148710339|NCT00112437|536410034|FG023|Years 6-10 (60-Month Extension)|Death|2|||
148710340|NCT00112437|536410035|FG024|Years 6-10 (60-Month Extension)|Death|0|||
148710341|NCT00112437|536410036|FG025|Years 6-10 (60-Month Extension)|Death|0|||
148815382|NCT03976375|536799499|FG000|Overall Study|Sponsor decision|20|||
148815383|NCT03976375|536799500|FG001|Overall Study|Sponsor decision|19|||
148815384|NCT03976375|536799501|FG002|Overall Study|Sponsor decision|1|||
148815385|NCT03122106|536799502|FG000|Overall Study|Not enough tissue|1|||
148968141|NCT00588445|537370257|FG000|Overall Study|Withdrawal by Subject|3|||
148710342|NCT00112437|536410011|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710343|NCT00112437|536410012|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710344|NCT00112437|536410013|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710345|NCT00112437|536410014|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710346|NCT00112437|536410015|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710347|NCT00112437|536410016|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710348|NCT00112437|536410017|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710349|NCT00112437|536410018|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710350|NCT00112437|536410019|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710351|NCT00112437|536410020|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710352|NCT00112437|536410021|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710353|NCT00112437|536410022|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710354|NCT00112437|536410023|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710355|NCT00112437|536410024|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710356|NCT00112437|536410025|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710357|NCT00112437|536410026|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710358|NCT00112437|536410027|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710359|NCT00112437|536410028|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710360|NCT00112437|536410029|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710361|NCT00112437|536410030|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710362|NCT00112437|536410031|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710363|NCT00112437|536410032|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710364|NCT00112437|536410033|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710365|NCT00112437|536410034|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710366|NCT00112437|536410035|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
148710367|NCT00112437|536410036|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
148710368|NCT00112437|536410011|FG000|Years 6-10 (60-Month Extension)|Other|0|||
148710369|NCT00112437|536410012|FG001|Years 6-10 (60-Month Extension)|Other|0|||
148710370|NCT00112437|536410013|FG002|Years 6-10 (60-Month Extension)|Other|0|||
148710371|NCT00112437|536410014|FG003|Years 6-10 (60-Month Extension)|Other|0|||
148710372|NCT00112437|536410015|FG004|Years 6-10 (60-Month Extension)|Other|0|||
148710373|NCT00112437|536410016|FG005|Years 6-10 (60-Month Extension)|Other|0|||
148710374|NCT00112437|536410017|FG006|Years 6-10 (60-Month Extension)|Other|0|||
148710375|NCT00112437|536410018|FG007|Years 6-10 (60-Month Extension)|Other|0|||
148710376|NCT00112437|536410019|FG008|Years 6-10 (60-Month Extension)|Other|0|||
148710377|NCT00112437|536410020|FG009|Years 6-10 (60-Month Extension)|Other|0|||
148710378|NCT00112437|536410021|FG010|Years 6-10 (60-Month Extension)|Other|0|||
148710379|NCT00112437|536410022|FG011|Years 6-10 (60-Month Extension)|Other|0|||
148710380|NCT00112437|536410023|FG012|Years 6-10 (60-Month Extension)|Other|0|||
148710381|NCT00112437|536410024|FG013|Years 6-10 (60-Month Extension)|Other|0|||
148710382|NCT00112437|536410025|FG014|Years 6-10 (60-Month Extension)|Other|0|||
148710383|NCT00112437|536410026|FG015|Years 6-10 (60-Month Extension)|Other|0|||
148710384|NCT00112437|536410027|FG016|Years 6-10 (60-Month Extension)|Other|0|||
148710385|NCT00112437|536410028|FG017|Years 6-10 (60-Month Extension)|Other|0|||
148710386|NCT00112437|536410029|FG018|Years 6-10 (60-Month Extension)|Other|0|||
148710387|NCT00112437|536410030|FG019|Years 6-10 (60-Month Extension)|Other|0|||
148710388|NCT00112437|536410031|FG020|Years 6-10 (60-Month Extension)|Other|0|||
148710389|NCT00112437|536410032|FG021|Years 6-10 (60-Month Extension)|Other|0|||
148710390|NCT00112437|536410033|FG022|Years 6-10 (60-Month Extension)|Other|0|||
148710391|NCT00112437|536410034|FG023|Years 6-10 (60-Month Extension)|Other|0|||
148710392|NCT00112437|536410035|FG024|Years 6-10 (60-Month Extension)|Other|1|||
148710393|NCT00112437|536410036|FG025|Years 6-10 (60-Month Extension)|Other|0|||
148710394|NCT00112437|536410011|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710395|NCT00112437|536410012|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710396|NCT00112437|536410013|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710397|NCT00112437|536410014|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710398|NCT00112437|536410015|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710399|NCT00112437|536410016|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710400|NCT00112437|536410017|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710401|NCT00112437|536410018|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710402|NCT00112437|536410019|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710403|NCT00112437|536410020|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710404|NCT00112437|536410021|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710405|NCT00112437|536410022|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710406|NCT00112437|536410023|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710407|NCT00112437|536410024|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710408|NCT00112437|536410025|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710409|NCT00112437|536410026|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710410|NCT00112437|536410027|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710411|NCT00112437|536410028|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148968142|NCT00588445|537370257|FG000|Overall Study|Disease Progression|1|||
148710412|NCT00112437|536410029|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710413|NCT00112437|536410030|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710414|NCT00112437|536410031|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710415|NCT00112437|536410032|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710416|NCT00112437|536410033|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710417|NCT00112437|536410034|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
148710418|NCT00112437|536410035|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710419|NCT00112437|536410036|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
148710420|NCT00112437|536410011|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710421|NCT00112437|536410012|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710422|NCT00112437|536410013|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710423|NCT00112437|536410014|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710424|NCT00112437|536410015|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710425|NCT00112437|536410016|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710426|NCT00112437|536410017|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710427|NCT00112437|536410018|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710428|NCT00112437|536410019|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710429|NCT00112437|536410020|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710430|NCT00112437|536410021|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710431|NCT00112437|536410022|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710432|NCT00112437|536410023|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710433|NCT00112437|536410024|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710434|NCT00112437|536410025|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710435|NCT00112437|536410026|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710436|NCT00112437|536410027|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710437|NCT00112437|536410028|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710438|NCT00112437|536410029|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710439|NCT00112437|536410030|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710440|NCT00112437|536410031|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710441|NCT00112437|536410032|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710442|NCT00112437|536410033|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
148710443|NCT00112437|536410034|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
148710444|NCT00112437|536410035|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
148710445|NCT00112437|536410036|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
148968143|NCT00588445|537370257|FG000|Overall Study|Not Treated|10|||
148710446|NCT01824576|536410037|FG000|Overall Study|Device deficiency|2|||
148710447|NCT02911025|536410041|FG000|Overall Study|Lost to Follow-up|3|||
148710448|NCT03218787|536410042|FG000|Overall Study|Lost to Follow-up|12|||
148710449|NCT03218787|536410042|FG000|Overall Study|Withdrawal by Subject|72|||
148710450|NCT03218787|536410042|FG000|Overall Study|Physician Decision|11|||
148710451|NCT03218787|536410042|FG000|Overall Study|Death|111|||
148710452|NCT00147498|536410043|FG000|Overall Study|Adverse Event|1|||
148710453|NCT00147498|536410044|FG001|Overall Study|Adverse Event|6|||
148710454|NCT00147498|536410045|FG002|Overall Study|Adverse Event|7|||
148710455|NCT00147498|536410046|FG003|Overall Study|Adverse Event|3|||
148710456|NCT00147498|536410043|FG000|Overall Study|Lack of Efficacy|1|||
148710457|NCT00147498|536410044|FG001|Overall Study|Lack of Efficacy|1|||
148710458|NCT00147498|536410045|FG002|Overall Study|Lack of Efficacy|1|||
148710459|NCT00147498|536410046|FG003|Overall Study|Lack of Efficacy|8|||
148710460|NCT00147498|536410043|FG000|Overall Study|Laboratory abnormality|0|||
148710461|NCT00147498|536410044|FG001|Overall Study|Laboratory abnormality|0|||
148710462|NCT00147498|536410045|FG002|Overall Study|Laboratory abnormality|2|||
148710463|NCT00147498|536410046|FG003|Overall Study|Laboratory abnormality|0|||
148710464|NCT00147498|536410043|FG000|Overall Study|Participant defaulted|0|||
148710465|NCT00147498|536410044|FG001|Overall Study|Participant defaulted|1|||
148710466|NCT00147498|536410045|FG002|Overall Study|Participant defaulted|4|||
148710467|NCT00147498|536410046|FG003|Overall Study|Participant defaulted|3|||
148710468|NCT00147498|536410043|FG000|Overall Study|Other|1|||
148710469|NCT00147498|536410044|FG001|Overall Study|Other|1|||
148710470|NCT00147498|536410045|FG002|Overall Study|Other|3|||
148710471|NCT00147498|536410046|FG003|Overall Study|Other|3|||
148710472|NCT01494532|536410049|FG000|Overall Study|Adverse Event|4|||
148710473|NCT01494532|536410050|FG001|Overall Study|Adverse Event|1|||
148710474|NCT01494532|536410051|FG002|Overall Study|Adverse Event|8|||
148710475|NCT01494532|536410052|FG003|Overall Study|Adverse Event|6|||
148710476|NCT01494532|536410053|FG004|Overall Study|Adverse Event|5|||
148710477|NCT01494532|536410054|FG005|Overall Study|Adverse Event|0|||
148710478|NCT01494532|536410049|FG000|Overall Study|Lack of Efficacy|0|||
148710479|NCT01494532|536410050|FG001|Overall Study|Lack of Efficacy|0|||
148710480|NCT01494532|536410051|FG002|Overall Study|Lack of Efficacy|0|||
148710481|NCT01494532|536410052|FG003|Overall Study|Lack of Efficacy|0|||
148710482|NCT01494532|536410053|FG004|Overall Study|Lack of Efficacy|2|||
148710483|NCT01494532|536410054|FG005|Overall Study|Lack of Efficacy|0|||
148710484|NCT01494532|536410049|FG000|Overall Study|Protocol deviation|2|||
148710485|NCT01494532|536410050|FG001|Overall Study|Protocol deviation|1|||
148710486|NCT01494532|536410051|FG002|Overall Study|Protocol deviation|3|||
148710487|NCT01494532|536410052|FG003|Overall Study|Protocol deviation|2|||
148710488|NCT01494532|536410053|FG004|Overall Study|Protocol deviation|3|||
148710489|NCT01494532|536410054|FG005|Overall Study|Protocol deviation|0|||
148968144|NCT03240133|537370258|FG000|Overall Study|Withdrawal by Subject|0|||
148968145|NCT03240133|537370259|FG001|Overall Study|Withdrawal by Subject|1|||
148968146|NCT03240133|537370260|FG002|Overall Study|Withdrawal by Subject|0|||
148968147|NCT03240133|537370258|FG000|Overall Study|Adverse Event|1|||
148968148|NCT03240133|537370259|FG001|Overall Study|Adverse Event|1|||
148968149|NCT03240133|537370260|FG002|Overall Study|Adverse Event|0|||
148710490|NCT01494532|536410049|FG000|Overall Study|Protocol-defined stopping criteria|0|||
148710491|NCT01494532|536410050|FG001|Overall Study|Protocol-defined stopping criteria|0|||
148710492|NCT01494532|536410051|FG002|Overall Study|Protocol-defined stopping criteria|1|||
148710493|NCT01494532|536410052|FG003|Overall Study|Protocol-defined stopping criteria|0|||
148710494|NCT01494532|536410053|FG004|Overall Study|Protocol-defined stopping criteria|0|||
148710495|NCT01494532|536410054|FG005|Overall Study|Protocol-defined stopping criteria|0|||
148710496|NCT01494532|536410049|FG000|Overall Study|Lost to Follow-up|1|||
148710497|NCT01494532|536410050|FG001|Overall Study|Lost to Follow-up|0|||
148710498|NCT01494532|536410051|FG002|Overall Study|Lost to Follow-up|0|||
148710499|NCT01494532|536410052|FG003|Overall Study|Lost to Follow-up|2|||
148710500|NCT01494532|536410053|FG004|Overall Study|Lost to Follow-up|0|||
148710501|NCT01494532|536410054|FG005|Overall Study|Lost to Follow-up|0|||
148710502|NCT01494532|536410049|FG000|Overall Study|Physician Decision|0|||
148710503|NCT01494532|536410050|FG001|Overall Study|Physician Decision|1|||
148710504|NCT01494532|536410051|FG002|Overall Study|Physician Decision|1|||
148710505|NCT01494532|536410052|FG003|Overall Study|Physician Decision|2|||
148710506|NCT01494532|536410053|FG004|Overall Study|Physician Decision|0|||
148710507|NCT01494532|536410054|FG005|Overall Study|Physician Decision|0|||
148710508|NCT01494532|536410049|FG000|Overall Study|Withdrawal by Subject|3|||
148710509|NCT01494532|536410050|FG001|Overall Study|Withdrawal by Subject|1|||
148710510|NCT01494532|536410051|FG002|Overall Study|Withdrawal by Subject|4|||
148710511|NCT01494532|536410052|FG003|Overall Study|Withdrawal by Subject|3|||
148710512|NCT01494532|536410053|FG004|Overall Study|Withdrawal by Subject|2|||
148710513|NCT01494532|536410054|FG005|Overall Study|Withdrawal by Subject|0|||
148710514|NCT00679081|536410055|FG000|Overall Study|Lost to Follow-up|1|||
148710515|NCT00725322|536410056|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
148710516|NCT00725322|536410057|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
148710517|NCT00725322|536410056|FG000|Washout (28 Days)|Protocol Violation|0|||
148710518|NCT00725322|536410057|FG001|Washout (28 Days)|Protocol Violation|1|||
148710519|NCT01279486|536410058|FG000|Overall Study|Lost to Follow-up|1|||
148710520|NCT03500094|536410062|FG000|Overall Study|Withdrawal by Subject|1|||
148710521|NCT03500094|536410062|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
148710522|NCT03500094|536410062|FG000|Overall Study|Lost to Follow-up|1|||
148815386|NCT03122106|536799502|FG000|Overall Study|Disease progression during screening|2|||
148815387|NCT03122106|536799502|FG000|Overall Study|Poor RNA quality for vaccine|1|||
148815388|NCT03550209|536799503|FG000|Overall Study|Lost to Follow-up|1|||
148815389|NCT03550209|536799504|FG001|Overall Study|Lost to Follow-up|0|||
148815390|NCT03550209|536799505|FG002|Overall Study|Lost to Follow-up|1|||
148815391|NCT03550209|536799506|FG003|Overall Study|Lost to Follow-up|0|||
148815392|NCT03550209|536799503|FG000|Overall Study|Withdrawal by Subject|0|||
148815393|NCT03550209|536799504|FG001|Overall Study|Withdrawal by Subject|3|||
148815394|NCT03550209|536799505|FG002|Overall Study|Withdrawal by Subject|1|||
148815395|NCT03550209|536799506|FG003|Overall Study|Withdrawal by Subject|2|||
148815396|NCT03550209|536799503|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
148815397|NCT03550209|536799504|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
148815398|NCT03550209|536799505|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
148815399|NCT03550209|536799506|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
148815400|NCT03244189|536799507|FG000|Overall Study|Death|0|||
148815401|NCT03244189|536799508|FG001|Overall Study|Death|2|||
148815402|NCT03244189|536799507|FG000|Overall Study|Lost to Follow-up|92|||
148968150|NCT03240133|537370258|FG000|Overall Study|Rash|1|||
148968151|NCT03240133|537370259|FG001|Overall Study|Rash|0|||
148968152|NCT03240133|537370260|FG002|Overall Study|Rash|0|||
148968153|NCT03240133|537370258|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
148815403|NCT03244189|536799508|FG001|Overall Study|Lost to Follow-up|107|||
148815404|NCT03244189|536799507|FG000|Overall Study|Physician Decision|4|||
148815405|NCT03244189|536799508|FG001|Overall Study|Physician Decision|2|||
148968154|NCT03240133|537370259|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
149025111|NCT00329303|537568021|FG000|Overall Study|Lack of Efficacy|1|||
148710523|NCT01404988|536410063|FG000|Overall Study|Death|2|||
148710524|NCT01404988|536410064|FG001|Overall Study|Death|0|||
148710525|NCT01404988|536410065|FG002|Overall Study|Death|2|||
148710526|NCT01404988|536410063|FG000|Overall Study|Adverse Event|1|||
148710527|NCT01404988|536410064|FG001|Overall Study|Adverse Event|0|||
148710528|NCT01404988|536410065|FG002|Overall Study|Adverse Event|0|||
148710529|NCT01404988|536410063|FG000|Overall Study|Withdrawal by Subject|2|||
148710530|NCT01404988|536410064|FG001|Overall Study|Withdrawal by Subject|2|||
148710531|NCT01404988|536410065|FG002|Overall Study|Withdrawal by Subject|0|||
148710532|NCT01404988|536410063|FG000|Overall Study|Lost to Follow-up|1|||
148710533|NCT01404988|536410064|FG001|Overall Study|Lost to Follow-up|2|||
148710534|NCT01404988|536410065|FG002|Overall Study|Lost to Follow-up|1|||
148710535|NCT00829764|536410066|FG000|First Intervention|Adverse Event|1|||
148710536|NCT00829764|536410067|FG001|First Intervention|Adverse Event|0|||
148710537|NCT00829764|536410066|FG000|First Intervention|Withdrawal by Subject|1|||
148710538|NCT00829764|536410067|FG001|First Intervention|Withdrawal by Subject|1|||
148710539|NCT04594252|536410068|FG000|Overall Study|Adverse Event|0|||
148710540|NCT04594252|536410069|FG001|Overall Study|Adverse Event|2|||
148710541|NCT00477594|536410070|FG000|Year 1 and Year 2|Adverse Event|4|||
148710542|NCT00477594|536410071|FG001|Year 1 and Year 2|Adverse Event|2|||
148710543|NCT00477594|536410070|FG000|Year 1 and Year 2|Physician Decision|2|||
148710544|NCT00477594|536410071|FG001|Year 1 and Year 2|Physician Decision|1|||
148710545|NCT00477594|536410070|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
148710546|NCT00477594|536410071|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
148710547|NCT00477594|536410070|FG000|Year 1 and Year 2|Other|1|||
148710548|NCT00477594|536410071|FG001|Year 1 and Year 2|Other|0|||
148710549|NCT00477594|536410070|FG000|Year 3|Adverse Event|1|||
148710550|NCT00477594|536410071|FG001|Year 3|Adverse Event|0|||
148710551|NCT00477594|536410070|FG000|Year 3|Withdrawal by Subject|1|||
148710552|NCT00477594|536410071|FG001|Year 3|Withdrawal by Subject|0|||
148710553|NCT00477594|536410070|FG000|Follow-up Period|Withdrawal by Subject|2|||
148710554|NCT00477594|536410071|FG001|Follow-up Period|Withdrawal by Subject|1|||
148710555|NCT00477594|536410070|FG000|Follow-up Period|Other|1|||
148710556|NCT00477594|536410071|FG001|Follow-up Period|Other|0|||
148710557|NCT03506633|536412437|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
148710558|NCT03506633|536412438|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
148710559|NCT00258856|536412442|FG000|Overall Study|Lost to Follow-up|1|||
148710560|NCT00258856|536412443|FG001|Overall Study|Lost to Follow-up|0|||
148710561|NCT00258856|536412444|FG002|Overall Study|Lost to Follow-up|2|||
148710562|NCT00258856|536412445|FG003|Overall Study|Lost to Follow-up|0|||
148710563|NCT00258856|536412442|FG000|Overall Study|Non-compliance|2|||
148710564|NCT00258856|536412443|FG001|Overall Study|Non-compliance|0|||
148710565|NCT00258856|536412444|FG002|Overall Study|Non-compliance|0|||
148710566|NCT00258856|536412445|FG003|Overall Study|Non-compliance|1|||
148710567|NCT03247686|536412446|FG000|Overall Study|Withdrawal by Subject|1|||
148710568|NCT03247686|536412447|FG001|Overall Study|Withdrawal by Subject|2|||
148710569|NCT01109849|536412450|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
148710570|NCT01109849|536412451|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
148710571|NCT01109849|536412452|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
148710572|NCT01109849|536412453|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
148710573|NCT01109849|536412454|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
148710574|NCT01109849|536412450|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
148710575|NCT01109849|536412451|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
148710576|NCT01109849|536412452|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
148710577|NCT01109849|536412453|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
148710578|NCT01109849|536412454|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
148710579|NCT01109849|536412450|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
148710580|NCT01109849|536412451|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
148710581|NCT01109849|536412452|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
148710582|NCT01109849|536412453|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
148710583|NCT01109849|536412454|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
148710584|NCT01109849|536412450|FG000|Initial Randomization: ADHD Treatment|move away|2|||
148710585|NCT01109849|536412451|FG001|Initial Randomization: ADHD Treatment|move away|7|||
148710586|NCT01109849|536412452|FG002|Initial Randomization: ADHD Treatment|move away|0|||
148710587|NCT01109849|536412453|FG003|Initial Randomization: ADHD Treatment|move away|0|||
148710588|NCT01109849|536412454|FG004|Initial Randomization: ADHD Treatment|move away|0|||
148710589|NCT01109849|536412450|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
148710590|NCT01109849|536412451|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
148710591|NCT01109849|536412452|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
148710592|NCT01109849|536412453|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
148710593|NCT01109849|536412454|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
148710594|NCT01109849|536412450|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
148710595|NCT01109849|536412451|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
148710596|NCT01109849|536412452|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
148710597|NCT01109849|536412453|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
148710598|NCT01109849|536412454|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
148710599|NCT01541215|536412462|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
148710600|NCT01541215|536412463|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
148710601|NCT01541215|536412462|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
148710602|NCT01541215|536412463|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
148710603|NCT01541215|536412462|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
148710604|NCT01541215|536412463|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
148710605|NCT01541215|536412462|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
148710606|NCT01541215|536412463|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
148710607|NCT01541215|536412462|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
148710608|NCT01541215|536412463|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
148710609|NCT01541215|536412462|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
148710610|NCT01541215|536412463|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
148710611|NCT02316223|536412474|FG000|Overall Study|Lack of Efficacy|0|||
148710612|NCT02316223|536412475|FG001|Overall Study|Lack of Efficacy|1|||
148710613|NCT02316223|536412476|FG002|Overall Study|Lack of Efficacy|1|||
148710614|NCT02316223|536412474|FG000|Overall Study|Lost to Follow-up|27|||
148710615|NCT02316223|536412475|FG001|Overall Study|Lost to Follow-up|34|||
148710616|NCT02316223|536412476|FG002|Overall Study|Lost to Follow-up|36|||
148710617|NCT02316223|536412474|FG000|Overall Study|COPD Diagnosis|3|||
148710618|NCT02316223|536412475|FG001|Overall Study|COPD Diagnosis|2|||
148710619|NCT02316223|536412476|FG002|Overall Study|COPD Diagnosis|3|||
148710620|NCT02316223|536412474|FG000|Overall Study|Reside outside study area|1|||
148710621|NCT02316223|536412475|FG001|Overall Study|Reside outside study area|1|||
148710622|NCT02316223|536412476|FG002|Overall Study|Reside outside study area|1|||
148710623|NCT02316223|536412474|FG000|Overall Study|No asthma|2|||
148710624|NCT02316223|536412475|FG001|Overall Study|No asthma|0|||
148710625|NCT02316223|536412476|FG002|Overall Study|No asthma|0|||
148710626|NCT02316223|536412474|FG000|Overall Study|Discontinued by PI|11|||
148710627|NCT02316223|536412475|FG001|Overall Study|Discontinued by PI|19|||
148710628|NCT02316223|536412476|FG002|Overall Study|Discontinued by PI|3|||
148710629|NCT00529763|536412478|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
148710630|NCT00529763|536412479|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
148710631|NCT00529763|536412480|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
148710632|NCT00529763|536412478|FG000|Overall Study|Death|1|||
148815406|NCT03244189|536799507|FG000|Overall Study|Pregnancy|7|||
148815407|NCT03244189|536799508|FG001|Overall Study|Pregnancy|5|||
148815408|NCT03244189|536799507|FG000|Overall Study|Protocol Violation|0|||
148815409|NCT03244189|536799508|FG001|Overall Study|Protocol Violation|2|||
148815410|NCT03244189|536799507|FG000|Overall Study|Withdrawal by Subject|45|||
148815411|NCT03244189|536799508|FG001|Overall Study|Withdrawal by Subject|23|||
148815412|NCT03244189|536799507|FG000|Overall Study|Technical Problems|2|||
148815413|NCT03244189|536799508|FG001|Overall Study|Technical Problems|0|||
149025112|NCT00329303|537568022|FG001|Overall Study|Lack of Efficacy|0|||
148815414|NCT03580928|536799511|FG000|Overall Study|Death|0|||
148815415|NCT03580928|536799512|FG001|Overall Study|Death|3|||
148815416|NCT03580928|536799511|FG000|Overall Study|Withdrawal by Subject|2|||
148815417|NCT03580928|536799512|FG001|Overall Study|Withdrawal by Subject|1|||
148815418|NCT03580928|536799511|FG000|Overall Study|Lost to Follow-up|2|||
148815419|NCT03580928|536799512|FG001|Overall Study|Lost to Follow-up|0|||
148815420|NCT03580928|536799511|FG000|Overall Study|Progressive Disease|0|||
148815421|NCT03580928|536799512|FG001|Overall Study|Progressive Disease|1|||
148815422|NCT01565694|536800531|FG000|Dose-Titration Period|Adverse Event|4|||
148815423|NCT01565694|536800531|FG000|Dose-Titration Period|Protocol Violation|10|||
148815424|NCT01565694|536800531|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
148815425|NCT01373229|536800532|FG000|Overall Study|Death|3|||
148815426|NCT01373229|536800532|FG000|Overall Study|Physician Decision|3|||
148815427|NCT00587457|536800534|FG000|Overall Study|Adverse Event|1|||
148815428|NCT00587457|536800535|FG001|Overall Study|Adverse Event|2|||
148815429|NCT00587457|536800536|FG002|Overall Study|Adverse Event|1|||
148815430|NCT00587457|536800534|FG000|Overall Study|Disease progression|2|||
148815431|NCT00587457|536800535|FG001|Overall Study|Disease progression|0|||
148815432|NCT00587457|536800536|FG002|Overall Study|Disease progression|2|||
148815433|NCT00587457|536800534|FG000|Overall Study|Initiation of alternative therapy|0|||
148815434|NCT00587457|536800535|FG001|Overall Study|Initiation of alternative therapy|1|||
148815435|NCT00587457|536800536|FG002|Overall Study|Initiation of alternative therapy|0|||
148815436|NCT00587457|536800534|FG000|Overall Study|Undefined|0|||
148815437|NCT00587457|536800535|FG001|Overall Study|Undefined|0|||
148710633|NCT00529763|536412479|FG001|Overall Study|Death|1|||
148710634|NCT00529763|536412480|FG002|Overall Study|Death|1|||
148710635|NCT00529763|536412478|FG000|Overall Study|Disease Progression|10|||
148710636|NCT00529763|536412479|FG001|Overall Study|Disease Progression|16|||
148710637|NCT00529763|536412480|FG002|Overall Study|Disease Progression|11|||
148710638|NCT00529763|536412478|FG000|Overall Study|Lost to Follow-up|1|||
148815438|NCT00587457|536800536|FG002|Overall Study|Undefined|1|||
148815439|NCT00587457|536800534|FG000|Overall Study|Development of neutralizing Abs|0|||
148815440|NCT00587457|536800535|FG001|Overall Study|Development of neutralizing Abs|0|||
148815441|NCT00587457|536800536|FG002|Overall Study|Development of neutralizing Abs|1|||
148815442|NCT03234881|536800537|FG000|Overall Study|Lost to Follow-up|9|||
148815443|NCT03234881|536800538|FG001|Overall Study|Lost to Follow-up|3|||
148815444|NCT00541229|536800539|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
148710639|NCT00529763|536412479|FG001|Overall Study|Lost to Follow-up|2|||
148710640|NCT00529763|536412480|FG002|Overall Study|Lost to Follow-up|3|||
148710641|NCT00529763|536412478|FG000|Overall Study|Stem Cell Transplant|0|||
148710642|NCT00529763|536412479|FG001|Overall Study|Stem Cell Transplant|3|||
148710643|NCT00529763|536412480|FG002|Overall Study|Stem Cell Transplant|1|||
148710644|NCT00529763|536412478|FG000|Overall Study|Study Drug Toxicity|3|||
148710645|NCT00529763|536412479|FG001|Overall Study|Study Drug Toxicity|6|||
148710646|NCT00529763|536412480|FG002|Overall Study|Study Drug Toxicity|4|||
148710647|NCT00529763|536412478|FG000|Overall Study|Participant Withdrew Consent|2|||
148710648|NCT00529763|536412479|FG001|Overall Study|Participant Withdrew Consent|3|||
148710649|NCT00529763|536412480|FG002|Overall Study|Participant Withdrew Consent|4|||
148710650|NCT00529763|536412478|FG000|Overall Study|Other reasons|2|||
148710651|NCT00529763|536412479|FG001|Overall Study|Other reasons|0|||
148710652|NCT00529763|536412480|FG002|Overall Study|Other reasons|2|||
148710653|NCT00529763|536412478|FG000|Overall Study|Participant request to discontinue treatment|1|||
148710654|NCT00529763|536412479|FG001|Overall Study|Participant request to discontinue treatment|1|||
148710655|NCT00529763|536412480|FG002|Overall Study|Participant request to discontinue treatment|3|||
148710656|NCT03669250|536412481|FG000|Overall Study|Adverse Event|0|||
148710657|NCT03669250|536412482|FG001|Overall Study|Adverse Event|0|||
148710658|NCT03669250|536412483|FG002|Overall Study|Adverse Event|0|||
148710659|NCT03669250|536412484|FG003|Overall Study|Adverse Event|0|||
148710660|NCT03669250|536412485|FG004|Overall Study|Adverse Event|1|||
148710661|NCT03669250|536412486|FG005|Overall Study|Adverse Event|0|||
148710662|NCT03669250|536412481|FG000|Overall Study|Withdrawal by Subject|0|||
148710663|NCT03669250|536412482|FG001|Overall Study|Withdrawal by Subject|1|||
148710664|NCT03669250|536412483|FG002|Overall Study|Withdrawal by Subject|0|||
148710665|NCT03669250|536412484|FG003|Overall Study|Withdrawal by Subject|1|||
148710666|NCT03669250|536412485|FG004|Overall Study|Withdrawal by Subject|0|||
148710667|NCT03669250|536412486|FG005|Overall Study|Withdrawal by Subject|0|||
148710668|NCT00828321|536412487|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
148710669|NCT00828321|536412488|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
148710670|NCT00828321|536412487|FG000|Second Intervention|Protocol Violation|0|||
148710671|NCT00828321|536412488|FG001|Second Intervention|Protocol Violation|1|||
148710672|NCT02997176|536412489|FG000|Overall Study|Adverse Event|0|||
148710673|NCT02997176|536412490|FG001|Overall Study|Adverse Event|0|||
148710674|NCT02997176|536412491|FG002|Overall Study|Adverse Event|0|||
148710675|NCT02997176|536412492|FG003|Overall Study|Adverse Event|8|||
148710676|NCT02997176|536412489|FG000|Overall Study|Progressive Disease|1|||
148710677|NCT02997176|536412490|FG001|Overall Study|Progressive Disease|0|||
148710678|NCT02997176|536412491|FG002|Overall Study|Progressive Disease|1|||
148710679|NCT02997176|536412492|FG003|Overall Study|Progressive Disease|1|||
148710680|NCT02997176|536412489|FG000|Overall Study|Death|0|||
148710681|NCT02997176|536412490|FG001|Overall Study|Death|0|||
148710682|NCT02997176|536412491|FG002|Overall Study|Death|1|||
148710683|NCT02997176|536412492|FG003|Overall Study|Death|1|||
148710684|NCT02997176|536412489|FG000|Overall Study|Withdrawal by Subject|0|||
148710685|NCT02997176|536412490|FG001|Overall Study|Withdrawal by Subject|2|||
148710686|NCT02997176|536412491|FG002|Overall Study|Withdrawal by Subject|0|||
148710687|NCT02997176|536412492|FG003|Overall Study|Withdrawal by Subject|1|||
148710688|NCT01630616|536412497|FG000|Overall Study|Adverse Event|0|||
148710689|NCT01630616|536412498|FG001|Overall Study|Adverse Event|0|||
148710690|NCT01630616|536412499|FG002|Overall Study|Adverse Event|0|||
148710691|NCT01630616|536412500|FG003|Overall Study|Adverse Event|1|||
148710692|NCT01630616|536412501|FG004|Overall Study|Adverse Event|0|||
148710693|NCT01630616|536412502|FG005|Overall Study|Adverse Event|0|||
148710694|NCT01630616|536412497|FG000|Overall Study|Withdrawal by Subject|0|||
148710695|NCT01630616|536412498|FG001|Overall Study|Withdrawal by Subject|0|||
148710696|NCT01630616|536412499|FG002|Overall Study|Withdrawal by Subject|0|||
148710697|NCT01630616|536412500|FG003|Overall Study|Withdrawal by Subject|2|||
148710698|NCT01630616|536412501|FG004|Overall Study|Withdrawal by Subject|0|||
148710699|NCT01630616|536412502|FG005|Overall Study|Withdrawal by Subject|0|||
148710700|NCT00691704|536412504|FG000|Induction Therapy|Disease Progression|1|||
148710701|NCT00691704|536412504|FG000|Induction Therapy|Active Hepatitis|1|||
148710702|NCT00691704|536412504|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
148710703|NCT00691704|536412504|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
148710704|NCT00691704|536412504|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
148710705|NCT04406194|536412505|FG000|Period 1|Withdrawal by Subject|0|||
148710706|NCT04406194|536412506|FG001|Period 1|Withdrawal by Subject|1|||
148710707|NCT04102345|536412508|FG000|Overall Study|Withdrawal by Subject|1|||
148710708|NCT04102345|536412509|FG001|Overall Study|Withdrawal by Subject|0|||
148710709|NCT00385736|536412514|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
148710710|NCT00385736|536412515|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
148710711|NCT00385736|536412516|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
148710712|NCT00385736|536412514|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
148710713|NCT00385736|536412515|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
148710714|NCT00385736|536412516|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
148710715|NCT00385736|536412514|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
148968155|NCT03240133|537370260|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
148968156|NCT03240133|537370258|FG000|Overall Study|Intercurrent illness.|0|||
148968157|NCT03240133|537370259|FG001|Overall Study|Intercurrent illness.|1|||
148968158|NCT03240133|537370260|FG002|Overall Study|Intercurrent illness.|0|||
148968159|NCT03240133|537370258|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
148710716|NCT00385736|536412515|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
148710717|NCT00385736|536412516|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
148710718|NCT00385736|536412514|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
148710719|NCT00385736|536412515|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
148710720|NCT00385736|536412516|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
148710721|NCT00385736|536412514|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
148710722|NCT00385736|536412515|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
148710723|NCT00385736|536412516|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
148710724|NCT00385736|536412514|FG000|Efficacy Analysis Set - Induction|Other|0|||
148710725|NCT00385736|536412515|FG001|Efficacy Analysis Set - Induction|Other|0|||
148710726|NCT00385736|536412516|FG002|Efficacy Analysis Set - Induction|Other|1|||
148710727|NCT00385736|536412514|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
148710728|NCT00385736|536412515|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
148710729|NCT00385736|536412516|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
148710730|NCT00385736|536412514|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
148710731|NCT00385736|536412515|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
148710732|NCT00385736|536412516|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
148710733|NCT00385736|536412514|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
148710734|NCT00385736|536412515|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
148710735|NCT00385736|536412516|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
148710736|NCT00385736|536412514|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
148710737|NCT00385736|536412515|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
148710738|NCT00385736|536412516|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
148710739|NCT00385736|536412514|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
148710740|NCT00385736|536412515|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
148710741|NCT00385736|536412516|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
148710742|NCT00385736|536412514|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
148710743|NCT00385736|536412515|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
148710744|NCT00385736|536412516|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
148710745|NCT00385736|536412514|FG000|Safety Analysis Set|Adverse Event|23|||
148710746|NCT00385736|536412515|FG001|Safety Analysis Set|Adverse Event|15|||
148710747|NCT00385736|536412516|FG002|Safety Analysis Set|Adverse Event|23|||
148710748|NCT00385736|536412514|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
148710749|NCT00385736|536412515|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
148710750|NCT00385736|536412516|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
148710751|NCT00385736|536412514|FG000|Safety Analysis Set|Lost to Follow-up|0|||
148710752|NCT00385736|536412515|FG001|Safety Analysis Set|Lost to Follow-up|2|||
148710753|NCT00385736|536412516|FG002|Safety Analysis Set|Lost to Follow-up|2|||
148710754|NCT00385736|536412514|FG000|Safety Analysis Set|Lack of Efficacy|38|||
148710755|NCT00385736|536412515|FG001|Safety Analysis Set|Lack of Efficacy|16|||
148710756|NCT00385736|536412516|FG002|Safety Analysis Set|Lack of Efficacy|31|||
148710757|NCT00385736|536412514|FG000|Safety Analysis Set|Protocol Violation|2|||
148710758|NCT00385736|536412515|FG001|Safety Analysis Set|Protocol Violation|1|||
148710759|NCT00385736|536412516|FG002|Safety Analysis Set|Protocol Violation|6|||
148710760|NCT00385736|536412514|FG000|Safety Analysis Set|Other|1|||
148710761|NCT00385736|536412515|FG001|Safety Analysis Set|Other|4|||
148710762|NCT00385736|536412516|FG002|Safety Analysis Set|Other|4|||
148710763|NCT01380782|536412522|FG000|Overall Study|Adverse Event|0|||
148710764|NCT01380782|536412523|FG001|Overall Study|Adverse Event|1|||
148710765|NCT01380782|536412524|FG002|Overall Study|Adverse Event|0|||
148710766|NCT01380782|536412525|FG003|Overall Study|Adverse Event|0|||
148710767|NCT01380782|536412522|FG000|Overall Study|Death|1|||
148710768|NCT01380782|536412523|FG001|Overall Study|Death|0|||
148710769|NCT01380782|536412524|FG002|Overall Study|Death|0|||
148710770|NCT01380782|536412525|FG003|Overall Study|Death|0|||
148710771|NCT01380782|536412522|FG000|Overall Study|Lack of Efficacy|10|||
148710772|NCT01380782|536412523|FG001|Overall Study|Lack of Efficacy|9|||
148710773|NCT01380782|536412524|FG002|Overall Study|Lack of Efficacy|10|||
148710774|NCT01380782|536412525|FG003|Overall Study|Lack of Efficacy|3|||
148710775|NCT01380782|536412522|FG000|Overall Study|Physician Decision|1|||
148710776|NCT01380782|536412523|FG001|Overall Study|Physician Decision|0|||
148710777|NCT01380782|536412524|FG002|Overall Study|Physician Decision|0|||
148710778|NCT01380782|536412525|FG003|Overall Study|Physician Decision|0|||
148710779|NCT01380782|536412522|FG000|Overall Study|Withdrawal by Subject|0|||
148710780|NCT01380782|536412523|FG001|Overall Study|Withdrawal by Subject|0|||
148710781|NCT01380782|536412524|FG002|Overall Study|Withdrawal by Subject|1|||
148710782|NCT01380782|536412525|FG003|Overall Study|Withdrawal by Subject|1|||
148710783|NCT01701063|536412526|FG000|Overall Study|Lost to Follow-up|0|||
148710784|NCT01701063|536412527|FG001|Overall Study|Lost to Follow-up|1|||
148710785|NCT01701063|536412528|FG002|Overall Study|Lost to Follow-up|0|||
148710786|NCT01701063|536412526|FG000|Overall Study|Withdrawal by Subject|0|||
148710787|NCT01701063|536412527|FG001|Overall Study|Withdrawal by Subject|0|||
148710788|NCT01701063|536412528|FG002|Overall Study|Withdrawal by Subject|1|||
148710789|NCT01701063|536412526|FG000|Overall Study|Other|0|||
148710790|NCT01701063|536412527|FG001|Overall Study|Other|0|||
148710791|NCT01701063|536412528|FG002|Overall Study|Other|1|||
148710792|NCT02043132|536412529|FG000|Overall Study|Lost to Follow-up|1|||
148710793|NCT02043132|536412530|FG001|Overall Study|Lost to Follow-up|1|||
148710794|NCT02043132|536412529|FG000|Overall Study|screen failures|4|||
148710795|NCT02043132|536412530|FG001|Overall Study|screen failures|8|||
148710796|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
148710797|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
148710798|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
148710799|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
148710800|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
148710801|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
148710802|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
148710803|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
148710804|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
148710805|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
148710806|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
148710807|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
148710808|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
148710809|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
148710810|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
148710811|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
148710812|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
148710813|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
148710814|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
148710815|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
148710816|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
148710817|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
148710818|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
148710819|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
148710820|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
148710821|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
148710822|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
148710823|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
148710824|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
148710825|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
148710826|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
148710827|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
148710828|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
148710829|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
148710830|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
148710831|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
148710832|NCT04194801|536412531|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
148710833|NCT04194801|536412532|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
148710834|NCT04194801|536412533|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
148710835|NCT04194801|536412531|FG000|Part Ib/II End of Study|Death|2|||
148710836|NCT04194801|536412532|FG001|Part Ib/II End of Study|Death|3|||
148710837|NCT04194801|536412533|FG002|Part Ib/II End of Study|Death|3|||
148710838|NCT04194801|536412531|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
148710839|NCT04194801|536412532|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
148710840|NCT04194801|536412533|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
148710841|NCT04194801|536412531|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
148710842|NCT04194801|536412532|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
148710843|NCT04194801|536412533|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
148710844|NCT04194801|536412531|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
148710845|NCT04194801|536412532|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
148710846|NCT04194801|536412533|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
148710847|NCT04194801|536412531|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
148710848|NCT04194801|536412532|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
148710849|NCT04194801|536412533|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
148710850|NCT00506831|536412534|FG000|Overall Study|Death|1|||
148710851|NCT00506831|536412534|FG000|Overall Study|Withdrawal by Subject|1|||
148710852|NCT01410227|536412538|FG000|Overall Study|Adverse Event|1|||
148710853|NCT01410227|536412539|FG001|Overall Study|Adverse Event|0|||
148710854|NCT01410227|536412540|FG002|Overall Study|Adverse Event|0|||
148710855|NCT01410227|536412541|FG003|Overall Study|Adverse Event|0|||
148710856|NCT01410227|536412538|FG000|Overall Study|Withdrawal by Subject|3|||
148710857|NCT01410227|536412539|FG001|Overall Study|Withdrawal by Subject|0|||
148710858|NCT01410227|536412540|FG002|Overall Study|Withdrawal by Subject|1|||
148710859|NCT01410227|536412541|FG003|Overall Study|Withdrawal by Subject|0|||
148710860|NCT01410227|536412538|FG000|Overall Study|Pregnancy|0|||
148710861|NCT01410227|536412539|FG001|Overall Study|Pregnancy|0|||
148710862|NCT01410227|536412540|FG002|Overall Study|Pregnancy|0|||
148710863|NCT01410227|536412541|FG003|Overall Study|Pregnancy|1|||
148710864|NCT01410227|536412538|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
148710865|NCT01410227|536412539|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
148710866|NCT01410227|536412540|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
148710867|NCT01410227|536412541|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
148710868|NCT01808651|536412542|FG000|Study Period 1|Lost to Follow-up|1|||
148710869|NCT01808651|536412543|FG001|Study Period 1|Lost to Follow-up|3|||
148710870|NCT01808651|536412544|FG002|Study Period 1|Lost to Follow-up|0|||
148710871|NCT01808651|536412542|FG000|Study Period 1|Protocol Violation|1|||
148710872|NCT01808651|536412543|FG001|Study Period 1|Protocol Violation|0|||
148710873|NCT01808651|536412544|FG002|Study Period 1|Protocol Violation|1|||
148710874|NCT01808651|536412542|FG000|Study Period 1|Physician Decision|3|||
148710875|NCT01808651|536412543|FG001|Study Period 1|Physician Decision|2|||
148710876|NCT01808651|536412544|FG002|Study Period 1|Physician Decision|0|||
148710877|NCT01808651|536412542|FG000|Study Period 1|Lack of Efficacy|2|||
148710878|NCT01808651|536412543|FG001|Study Period 1|Lack of Efficacy|1|||
148710879|NCT01808651|536412544|FG002|Study Period 1|Lack of Efficacy|0|||
148710880|NCT01808651|536412542|FG000|Study Period 1|Adverse Event|10|||
148710881|NCT01808651|536412543|FG001|Study Period 1|Adverse Event|4|||
148710882|NCT01808651|536412544|FG002|Study Period 1|Adverse Event|1|||
148710883|NCT01808651|536412542|FG000|Study Period 1|Participant Decision|9|||
148710884|NCT01808651|536412543|FG001|Study Period 1|Participant Decision|7|||
148710885|NCT01808651|536412544|FG002|Study Period 1|Participant Decision|3|||
148710886|NCT00585286|536412547|FG000|Overall Study|Lost to Follow-up|1|||
148710887|NCT00608322|536412549|FG000|Overall Study|Death|2|||
148710888|NCT00608322|536412550|FG001|Overall Study|Death|1|||
148710889|NCT04002648|536412551|FG000|Overall Study|Lost to Follow-up|2|||
148710890|NCT04002648|536412552|FG001|Overall Study|Lost to Follow-up|0|||
148710891|NCT00829712|536412557|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
148710892|NCT00829712|536412558|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
148710893|NCT00606281|536412559|FG000|Overall Study|Adverse Event|11|||
148710894|NCT00606281|536412560|FG001|Overall Study|Adverse Event|12|||
148710895|NCT00606281|536412559|FG000|Overall Study|Death|1|||
148710896|NCT00606281|536412560|FG001|Overall Study|Death|0|||
148710897|NCT00606281|536412559|FG000|Overall Study|Lack of Efficacy|28|||
148710898|NCT00606281|536412560|FG001|Overall Study|Lack of Efficacy|35|||
148710899|NCT00606281|536412559|FG000|Overall Study|Physician Decision|0|||
148710900|NCT00606281|536412560|FG001|Overall Study|Physician Decision|1|||
148710901|NCT00606281|536412559|FG000|Overall Study|Protocol Violation|3|||
148710902|NCT00606281|536412560|FG001|Overall Study|Protocol Violation|3|||
148710903|NCT00606281|536412559|FG000|Overall Study|Withdrawal by Subject|11|||
148710904|NCT00606281|536412560|FG001|Overall Study|Withdrawal by Subject|13|||
148710905|NCT00606281|536412559|FG000|Overall Study|Progression to depressive phase|1|||
148710906|NCT00606281|536412560|FG001|Overall Study|Progression to depressive phase|1|||
148710907|NCT00606281|536412559|FG000|Overall Study|Change of residence or other commitments|1|||
148710908|NCT00606281|536412560|FG001|Overall Study|Change of residence or other commitments|1|||
148710909|NCT03131895|536412562|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
148710910|NCT03131895|536412563|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
148710911|NCT03131895|536412564|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
148710912|NCT03131895|536412565|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
148710913|NCT03131895|536412562|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
148710914|NCT03131895|536412563|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
148968160|NCT03240133|537370259|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
148968161|NCT03240133|537370260|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
148968162|NCT00116831|537370263|FG000|Overall Study|Adverse Event|14|||
148968163|NCT00116831|537370264|FG001|Overall Study|Adverse Event|16|||
148968164|NCT00116831|537370263|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
148968165|NCT00116831|537370264|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
148710915|NCT03131895|536412564|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
148710916|NCT03131895|536412565|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
148710917|NCT03131895|536412562|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148710918|NCT03131895|536412563|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
148710919|NCT03131895|536412564|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148710920|NCT03131895|536412565|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
148710921|NCT03131895|536412562|FG000|Washout Period (at Least 5 Days)|Other|0|||
148710922|NCT03131895|536412563|FG001|Washout Period (at Least 5 Days)|Other|0|||
148710923|NCT03131895|536412564|FG002|Washout Period (at Least 5 Days)|Other|2|||
148710924|NCT03131895|536412565|FG003|Washout Period (at Least 5 Days)|Other|0|||
148710925|NCT03131895|536412562|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
148710926|NCT03131895|536412563|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
148710927|NCT03131895|536412564|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
148710928|NCT03131895|536412565|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
148710929|NCT03131895|536412562|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
148710930|NCT03131895|536412563|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
148710931|NCT03131895|536412564|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
148710932|NCT03131895|536412565|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
148710933|NCT05752721|536412568|FG000|Overall Study|Lost to Follow-up|22|||
148710934|NCT05752721|536412569|FG001|Overall Study|Lost to Follow-up|20|||
148710935|NCT05752721|536412568|FG000|Overall Study|Withdrawal by Subject|15|||
148710936|NCT05752721|536412569|FG001|Overall Study|Withdrawal by Subject|12|||
148710937|NCT02280863|536412570|FG000|Integrated Platform|Met stopping criteria|0|||
148710938|NCT02280863|536412571|FG001|Integrated Platform|Met stopping criteria|1|||
148710939|NCT02622386|536412582|FG000|First Assignment|Withdrawal by Subject|3|||
148710940|NCT02622386|536412583|FG001|First Assignment|Withdrawal by Subject|2|||
148710941|NCT02622386|536412582|FG000|Washout|Withdrawal by Subject|4|||
148710942|NCT02622386|536412583|FG001|Washout|Withdrawal by Subject|4|||
148710943|NCT02622386|536412582|FG000|Second Assignment|Withdrawal by Subject|0|||
148710944|NCT02622386|536412583|FG001|Second Assignment|Withdrawal by Subject|2|||
148710945|NCT02890992|536412584|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710946|NCT02890992|536412585|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
148710947|NCT02890992|536412586|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710948|NCT02890992|536412587|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710949|NCT02890992|536412588|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710950|NCT02890992|536412589|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710951|NCT02890992|536412590|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710952|NCT02890992|536412591|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
148710953|NCT02890992|536412584|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
148710954|NCT02890992|536412585|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
148710955|NCT02890992|536412586|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
148815445|NCT00541229|536800540|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
148815446|NCT00541229|536800541|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
148815447|NCT00541229|536800542|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
148815448|NCT00541229|536800543|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
148968166|NCT00116831|537370263|FG000|Overall Study|Lost to Follow-up|8|||
148968167|NCT00116831|537370264|FG001|Overall Study|Lost to Follow-up|6|||
148968168|NCT00116831|537370263|FG000|Overall Study|Protocol Violation|3|||
148968169|NCT00116831|537370264|FG001|Overall Study|Protocol Violation|6|||
148968170|NCT00116831|537370263|FG000|Overall Study|Hypoglycaemic events|1|||
148968171|NCT00116831|537370264|FG001|Overall Study|Hypoglycaemic events|0|||
148968172|NCT00116831|537370263|FG000|Overall Study|Low haemoglobin on screening|1|||
148968173|NCT00116831|537370264|FG001|Overall Study|Low haemoglobin on screening|0|||
148968174|NCT00116831|537370263|FG000|Overall Study|Withdrawn investigational product|1|||
148968175|NCT00116831|537370264|FG001|Overall Study|Withdrawn investigational product|0|||
148968176|NCT00116831|537370263|FG000|Overall Study|Withdrawal by Subject|32|||
148968177|NCT00116831|537370264|FG001|Overall Study|Withdrawal by Subject|32|||
148968178|NCT00116831|537370263|FG000|Overall Study|Insufficient therapeutic effect|0|||
148968179|NCT00116831|537370264|FG001|Overall Study|Insufficient therapeutic effect|1|||
148968180|NCT00116831|537370263|FG000|Overall Study|Missing data for participant|1|||
148968181|NCT00116831|537370264|FG001|Overall Study|Missing data for participant|0|||
148968182|NCT02945410|537370265|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
148968183|NCT02945410|537370266|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
148968184|NCT02945410|537370267|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
148968185|NCT02945410|537370268|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
148968186|NCT02945410|537370269|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
148968187|NCT02945410|537370270|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
148968188|NCT02945410|537370265|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
148968189|NCT02945410|537370266|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
148968190|NCT02945410|537370267|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
148968191|NCT02945410|537370268|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
148968192|NCT02945410|537370269|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
148968193|NCT02945410|537370270|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
148710956|NCT02890992|536412587|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
148815449|NCT00541229|536800544|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
148968194|NCT02945410|537370265|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
148968195|NCT02945410|537370266|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
148968196|NCT02945410|537370267|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
148968197|NCT02945410|537370268|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
148710957|NCT02890992|536412588|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
148710958|NCT02890992|536412589|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
148710959|NCT02890992|536412590|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
148710960|NCT02890992|536412591|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
148710961|NCT02890992|536412584|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710962|NCT02890992|536412585|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
148710963|NCT02890992|536412586|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710964|NCT02890992|536412587|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710965|NCT02890992|536412588|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710966|NCT02890992|536412589|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710967|NCT02890992|536412590|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710968|NCT02890992|536412591|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
148710969|NCT03158727|536412592|FG000|Overall Study|Withdrawal by Subject|2|||
148710970|NCT03158727|536412593|FG001|Overall Study|Withdrawal by Subject|6|||
148710971|NCT03158727|536412592|FG000|Overall Study|Death|11|||
148710972|NCT03158727|536412593|FG001|Overall Study|Death|12|||
148710973|NCT03158727|536412592|FG000|Overall Study|Lost to Follow-up|1|||
148710974|NCT03158727|536412593|FG001|Overall Study|Lost to Follow-up|0|||
148710975|NCT03158727|536412592|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
148710976|NCT03158727|536412593|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
148710977|NCT03158727|536412592|FG000|Overall Study|Visit 11 not done by mistake|0|||
148710978|NCT03158727|536412593|FG001|Overall Study|Visit 11 not done by mistake|1|||
148710979|NCT03158727|536412592|FG000|Overall Study|Enrolled, not treated|1|||
148710980|NCT03158727|536412593|FG001|Overall Study|Enrolled, not treated|0|||
148968198|NCT02945410|537370269|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
148968199|NCT02945410|537370270|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
148968200|NCT04904185|537370271|FG000|Overall Study|Expansion failure|1|||
148968201|NCT04904185|537370272|FG001|Overall Study|Expansion failure|0|||
148968202|NCT04904185|537370271|FG000|Overall Study|Late response on prior treatment|1|||
148968203|NCT04904185|537370272|FG001|Overall Study|Late response on prior treatment|0|||
148710981|NCT03236311|536412594|FG000|Overall Study|Study terminated by sponsor|0|||
148710982|NCT03236311|536412595|FG001|Overall Study|Study terminated by sponsor|2|||
148710983|NCT03236311|536412594|FG000|Overall Study|Adverse Event|0|||
148710984|NCT03236311|536412595|FG001|Overall Study|Adverse Event|1|||
148710985|NCT00669162|536412596|FG000|Overall Study|Withdrawal by Subject|1|||
148710986|NCT00807495|536412598|FG000|Overall Study|Adverse Event|6|||
148710987|NCT00807495|536412599|FG001|Overall Study|Adverse Event|3|||
148710988|NCT00807495|536412600|FG002|Overall Study|Adverse Event|1|||
148710989|NCT00807495|536412601|FG003|Overall Study|Adverse Event|1|||
148710990|NCT00807495|536412602|FG004|Overall Study|Adverse Event|2|||
148710991|NCT00807495|536412598|FG000|Overall Study|Withdrawal by Patient|2|||
148710992|NCT00807495|536412599|FG001|Overall Study|Withdrawal by Patient|0|||
148710993|NCT00807495|536412600|FG002|Overall Study|Withdrawal by Patient|1|||
148710994|NCT00807495|536412601|FG003|Overall Study|Withdrawal by Patient|0|||
148710995|NCT00807495|536412602|FG004|Overall Study|Withdrawal by Patient|0|||
148710996|NCT00807495|536412598|FG000|Overall Study|Reason Not Specified|0|||
148710997|NCT00807495|536412599|FG001|Overall Study|Reason Not Specified|3|||
148710998|NCT00807495|536412600|FG002|Overall Study|Reason Not Specified|2|||
148710999|NCT00807495|536412601|FG003|Overall Study|Reason Not Specified|0|||
148711000|NCT00807495|536412602|FG004|Overall Study|Reason Not Specified|3|||
148711001|NCT00484679|536412603|FG000|Overall Study|Withdrawal by Subject|3|||
148711002|NCT00841542|536412604|FG000|Period 1|Adverse Event|1|||
148711003|NCT00841542|536412605|FG001|Period 1|Adverse Event|0|||
148711004|NCT02462837|536412606|FG000|Overall Study|pt developed hives|1|||
148711005|NCT02462837|536412607|FG001|Overall Study|pt developed hives|0|||
148711006|NCT02462837|536412606|FG000|Overall Study|Withdrawal by Subject|1|||
148711007|NCT02462837|536412607|FG001|Overall Study|Withdrawal by Subject|0|||
148711008|NCT01075282|536412608|FG000|Overall Study|Withdrawal by Subject|11|||
148711009|NCT01075282|536412609|FG001|Overall Study|Withdrawal by Subject|7|||
148711010|NCT01075282|536412610|FG002|Overall Study|Withdrawal by Subject|11|||
148711011|NCT01075282|536412608|FG000|Overall Study|Adverse Event|9|||
148711012|NCT01075282|536412609|FG001|Overall Study|Adverse Event|8|||
148711013|NCT01075282|536412610|FG002|Overall Study|Adverse Event|5|||
148711014|NCT01075282|536412608|FG000|Overall Study|Entry Criteria Not Met|3|||
148711015|NCT01075282|536412609|FG001|Overall Study|Entry Criteria Not Met|2|||
148815450|NCT00541229|536800539|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
148968204|NCT00110812|537370275|FG000|Main Study|Death|0|||
148711016|NCT01075282|536412610|FG002|Overall Study|Entry Criteria Not Met|0|||
148711017|NCT01075282|536412608|FG000|Overall Study|Lost to Follow-up|3|||
148711018|NCT01075282|536412609|FG001|Overall Study|Lost to Follow-up|3|||
148815451|NCT00541229|536800540|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
148968205|NCT00110812|537370276|FG001|Main Study|Death|0|||
148968206|NCT00110812|537370277|FG002|Main Study|Death|2|||
149025113|NCT00329303|537568021|FG000|Overall Study|Decision of the sponsor|0|||
148711019|NCT01075282|536412610|FG002|Overall Study|Lost to Follow-up|3|||
148711020|NCT01075282|536412608|FG000|Overall Study|Physician Decision|3|||
148711021|NCT01075282|536412609|FG001|Overall Study|Physician Decision|3|||
148711022|NCT01075282|536412610|FG002|Overall Study|Physician Decision|3|||
148711023|NCT01075282|536412608|FG000|Overall Study|Lack of Efficacy|1|||
148711024|NCT01075282|536412609|FG001|Overall Study|Lack of Efficacy|1|||
148711025|NCT01075282|536412610|FG002|Overall Study|Lack of Efficacy|0|||
148711026|NCT01075282|536412608|FG000|Overall Study|Treatment Non-compliance|1|||
148711027|NCT01075282|536412609|FG001|Overall Study|Treatment Non-compliance|2|||
148711028|NCT01075282|536412610|FG002|Overall Study|Treatment Non-compliance|2|||
148968207|NCT00110812|537370275|FG000|Main Study|Withdrawal by Subject|0|||
148711029|NCT01075282|536412608|FG000|Overall Study|Protocol Violation|0|||
148711030|NCT01075282|536412609|FG001|Overall Study|Protocol Violation|2|||
148711031|NCT01075282|536412610|FG002|Overall Study|Protocol Violation|1|||
148711032|NCT01075282|536412608|FG000|Overall Study|Death|0|||
148711033|NCT01075282|536412609|FG001|Overall Study|Death|1|||
148711034|NCT01075282|536412610|FG002|Overall Study|Death|2|||
148711035|NCT00906399|536412628|FG000|Year 1|Randomized But Not Treated|0|||
148711036|NCT00906399|536412629|FG001|Year 1|Randomized But Not Treated|1|||
148711037|NCT00906399|536412630|FG002|Year 1|Randomized But Not Treated|3|||
148711038|NCT00906399|536412631|FG003|Year 1|Randomized But Not Treated|0|||
148711039|NCT00906399|536412632|FG004|Year 1|Randomized But Not Treated|0|||
148711040|NCT00906399|536412633|FG005|Year 1|Randomized But Not Treated|0|||
148711041|NCT00906399|536412634|FG006|Year 1|Randomized But Not Treated|0|||
148711042|NCT00906399|536412628|FG000|Year 1|Adverse Event|4|||
148711043|NCT00906399|536412629|FG001|Year 1|Adverse Event|22|||
148711044|NCT00906399|536412630|FG002|Year 1|Adverse Event|24|||
148711045|NCT00906399|536412631|FG003|Year 1|Adverse Event|0|||
148711046|NCT00906399|536412632|FG004|Year 1|Adverse Event|0|||
148711047|NCT00906399|536412633|FG005|Year 1|Adverse Event|0|||
148711048|NCT00906399|536412634|FG006|Year 1|Adverse Event|0|||
148711049|NCT00906399|536412628|FG000|Year 1|Lost to Follow-up|4|||
148711050|NCT00906399|536412629|FG001|Year 1|Lost to Follow-up|4|||
148711051|NCT00906399|536412630|FG002|Year 1|Lost to Follow-up|2|||
148711052|NCT00906399|536412631|FG003|Year 1|Lost to Follow-up|0|||
148711053|NCT00906399|536412632|FG004|Year 1|Lost to Follow-up|0|||
148711054|NCT00906399|536412633|FG005|Year 1|Lost to Follow-up|0|||
148711055|NCT00906399|536412634|FG006|Year 1|Lost to Follow-up|0|||
148711056|NCT00906399|536412628|FG000|Year 1|Withdrawal by Subject|30|||
148711057|NCT00906399|536412629|FG001|Year 1|Withdrawal by Subject|32|||
148711058|NCT00906399|536412630|FG002|Year 1|Withdrawal by Subject|36|||
148711059|NCT00906399|536412631|FG003|Year 1|Withdrawal by Subject|0|||
148711060|NCT00906399|536412632|FG004|Year 1|Withdrawal by Subject|0|||
148711061|NCT00906399|536412633|FG005|Year 1|Withdrawal by Subject|0|||
148711062|NCT00906399|536412634|FG006|Year 1|Withdrawal by Subject|0|||
148711063|NCT00906399|536412628|FG000|Year 1|Physician Decision|0|||
148711064|NCT00906399|536412629|FG001|Year 1|Physician Decision|1|||
148711065|NCT00906399|536412630|FG002|Year 1|Physician Decision|3|||
148711066|NCT00906399|536412631|FG003|Year 1|Physician Decision|0|||
148711067|NCT00906399|536412632|FG004|Year 1|Physician Decision|0|||
148711068|NCT00906399|536412633|FG005|Year 1|Physician Decision|0|||
148711069|NCT00906399|536412634|FG006|Year 1|Physician Decision|0|||
148968208|NCT00110812|537370276|FG001|Main Study|Withdrawal by Subject|0|||
148968209|NCT00110812|537370277|FG002|Main Study|Withdrawal by Subject|1|||
148968210|NCT00110812|537370275|FG000|Main Study|Lost to Follow-up|8|||
148968211|NCT00110812|537370276|FG001|Main Study|Lost to Follow-up|11|||
148968212|NCT00110812|537370277|FG002|Main Study|Lost to Follow-up|10|||
148968213|NCT00110812|537370275|FG000|Extended Follow-up|Death|1|||
148968214|NCT00110812|537370276|FG001|Extended Follow-up|Death|0|||
148968215|NCT00110812|537370277|FG002|Extended Follow-up|Death|3|||
148711070|NCT00906399|536412628|FG000|Year 1|Death|2|||
148711071|NCT00906399|536412629|FG001|Year 1|Death|1|||
148711072|NCT00906399|536412630|FG002|Year 1|Death|1|||
148711073|NCT00906399|536412631|FG003|Year 1|Death|0|||
148711074|NCT00906399|536412632|FG004|Year 1|Death|0|||
148711075|NCT00906399|536412633|FG005|Year 1|Death|0|||
148711076|NCT00906399|536412634|FG006|Year 1|Death|0|||
148711077|NCT00906399|536412628|FG000|Year 1|Other|4|||
148968216|NCT00110812|537370275|FG000|Extended Follow-up|Withdrawal by Subject|0|||
148968217|NCT00110812|537370276|FG001|Extended Follow-up|Withdrawal by Subject|1|||
148968218|NCT00110812|537370277|FG002|Extended Follow-up|Withdrawal by Subject|0|||
148711078|NCT00906399|536412629|FG001|Year 1|Other|2|||
148711079|NCT00906399|536412630|FG002|Year 1|Other|7|||
148711080|NCT00906399|536412631|FG003|Year 1|Other|0|||
148711081|NCT00906399|536412632|FG004|Year 1|Other|0|||
148711082|NCT00906399|536412633|FG005|Year 1|Other|0|||
148711083|NCT00906399|536412634|FG006|Year 1|Other|0|||
148711084|NCT00906399|536412628|FG000|Year 2|Adverse Event|0|||
148711085|NCT00906399|536412629|FG001|Year 2|Adverse Event|0|||
148711086|NCT00906399|536412630|FG002|Year 2|Adverse Event|0|||
148711087|NCT00906399|536412631|FG003|Year 2|Adverse Event|9|||
148711088|NCT00906399|536412632|FG004|Year 2|Adverse Event|8|||
148711089|NCT00906399|536412633|FG005|Year 2|Adverse Event|11|||
148711090|NCT00906399|536412634|FG006|Year 2|Adverse Event|6|||
148711091|NCT00906399|536412628|FG000|Year 2|Lost to Follow-up|0|||
148711092|NCT00906399|536412629|FG001|Year 2|Lost to Follow-up|0|||
148968219|NCT00110812|537370275|FG000|Extended Follow-up|Lost to Follow-up|1|||
148968220|NCT00110812|537370276|FG001|Extended Follow-up|Lost to Follow-up|3|||
148968221|NCT00110812|537370277|FG002|Extended Follow-up|Lost to Follow-up|1|||
148968222|NCT04200248|537370280|FG000|Overall Study|Personal reasons|0|||
148968223|NCT04200248|537370281|FG001|Overall Study|Personal reasons|0|||
148968224|NCT04200248|537370282|FG002|Overall Study|Personal reasons|1|||
148968225|NCT04200248|537370280|FG000|Overall Study|Discontinued prior to treatment|3|||
148968226|NCT04200248|537370281|FG001|Overall Study|Discontinued prior to treatment|3|||
148968227|NCT04200248|537370282|FG002|Overall Study|Discontinued prior to treatment|2|||
148968228|NCT01454726|537370283|FG000|Overall Study|Withdrawal by Subject|0|||
148968229|NCT01454726|537370284|FG001|Overall Study|Withdrawal by Subject|1|||
148968230|NCT02919670|537370285|FG000|Overall Study|Only 17 participants met compliance|43|||
148968231|NCT02919670|537370286|FG001|Overall Study|Only 17 participants met compliance|39|||
148968232|NCT00735371|537370291|FG000|Overall Study|Adverse Event|3|||
148968233|NCT00735371|537370292|FG001|Overall Study|Adverse Event|3|||
148968234|NCT00735371|537370293|FG002|Overall Study|Adverse Event|4|||
148968235|NCT00735371|537370294|FG003|Overall Study|Adverse Event|1|||
148968236|NCT00735371|537370291|FG000|Overall Study|Protocol Violation|2|||
148711093|NCT00906399|536412630|FG002|Year 2|Lost to Follow-up|0|||
148711094|NCT00906399|536412631|FG003|Year 2|Lost to Follow-up|1|||
148711095|NCT00906399|536412632|FG004|Year 2|Lost to Follow-up|4|||
148711096|NCT00906399|536412633|FG005|Year 2|Lost to Follow-up|2|||
148711097|NCT00906399|536412634|FG006|Year 2|Lost to Follow-up|4|||
148711098|NCT00906399|536412628|FG000|Year 2|Withdrawal by Subject|0|||
148711099|NCT00906399|536412629|FG001|Year 2|Withdrawal by Subject|0|||
148711100|NCT00906399|536412630|FG002|Year 2|Withdrawal by Subject|0|||
148711101|NCT00906399|536412631|FG003|Year 2|Withdrawal by Subject|17|||
148711102|NCT00906399|536412632|FG004|Year 2|Withdrawal by Subject|18|||
148711103|NCT00906399|536412633|FG005|Year 2|Withdrawal by Subject|27|||
148711104|NCT00906399|536412634|FG006|Year 2|Withdrawal by Subject|13|||
148711105|NCT00906399|536412628|FG000|Year 2|Physician Decision|0|||
148711106|NCT00906399|536412629|FG001|Year 2|Physician Decision|0|||
148711107|NCT00906399|536412630|FG002|Year 2|Physician Decision|0|||
148711108|NCT00906399|536412631|FG003|Year 2|Physician Decision|0|||
148711109|NCT00906399|536412632|FG004|Year 2|Physician Decision|2|||
148711110|NCT00906399|536412633|FG005|Year 2|Physician Decision|6|||
148711111|NCT00906399|536412634|FG006|Year 2|Physician Decision|3|||
148711112|NCT00906399|536412628|FG000|Year 2|Death|0|||
148711113|NCT00906399|536412629|FG001|Year 2|Death|0|||
148711114|NCT00906399|536412630|FG002|Year 2|Death|0|||
148711115|NCT00906399|536412631|FG003|Year 2|Death|1|||
148711116|NCT00906399|536412632|FG004|Year 2|Death|0|||
148711117|NCT00906399|536412633|FG005|Year 2|Death|0|||
148711118|NCT00906399|536412634|FG006|Year 2|Death|3|||
148711119|NCT00906399|536412628|FG000|Year 2|Other|0|||
148711120|NCT00906399|536412629|FG001|Year 2|Other|0|||
148711121|NCT00906399|536412630|FG002|Year 2|Other|0|||
148711122|NCT00906399|536412631|FG003|Year 2|Other|2|||
148968237|NCT00735371|537370292|FG001|Overall Study|Protocol Violation|2|||
148968238|NCT00735371|537370293|FG002|Overall Study|Protocol Violation|0|||
148968239|NCT00735371|537370294|FG003|Overall Study|Protocol Violation|3|||
148968240|NCT00735371|537370291|FG000|Overall Study|Withdrawal by Subject|0|||
148968241|NCT00735371|537370292|FG001|Overall Study|Withdrawal by Subject|2|||
148968242|NCT00735371|537370293|FG002|Overall Study|Withdrawal by Subject|2|||
148968243|NCT00735371|537370294|FG003|Overall Study|Withdrawal by Subject|0|||
148968244|NCT00735371|537370291|FG000|Overall Study|Lost to Follow-up|1|||
148968245|NCT00735371|537370292|FG001|Overall Study|Lost to Follow-up|1|||
148968246|NCT00735371|537370293|FG002|Overall Study|Lost to Follow-up|3|||
148968247|NCT00735371|537370294|FG003|Overall Study|Lost to Follow-up|1|||
148968248|NCT00735371|537370291|FG000|Overall Study|Lack of Efficacy|4|||
148711123|NCT00906399|536412632|FG004|Year 2|Other|3|||
148711124|NCT00906399|536412633|FG005|Year 2|Other|1|||
148711125|NCT00906399|536412634|FG006|Year 2|Other|0|||
148711126|NCT03488108|536412638|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
148711127|NCT03488108|536412639|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
148711128|NCT03488108|536412638|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
148711129|NCT03488108|536412639|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
148711130|NCT02615249|536412648|FG000|Overall Study|Withdrawal by Subject|1|||
148968249|NCT00735371|537370292|FG001|Overall Study|Lack of Efficacy|2|||
148968250|NCT00735371|537370293|FG002|Overall Study|Lack of Efficacy|0|||
148968251|NCT00735371|537370294|FG003|Overall Study|Lack of Efficacy|4|||
148968252|NCT00735371|537370291|FG000|Overall Study|Sponsor Decision|3|||
148711131|NCT03498560|536412650|FG000|Overall Study|Found Ineligible|2|||
148711132|NCT03498560|536412650|FG000|Overall Study|Withdrawal by Subject|14|||
148711133|NCT03498560|536412650|FG000|Overall Study|Lost to Follow-up|4|||
148711134|NCT03498560|536412650|FG000|Overall Study|Death|1|||
148711135|NCT00867360|536412655|FG000|Overall Study|Withdrawal by Subject|1|||
148711136|NCT00867360|536412656|FG001|Overall Study|Withdrawal by Subject|0|||
148711137|NCT00867360|536412655|FG000|Overall Study|Physician Decision|0|||
148711138|NCT00867360|536412656|FG001|Overall Study|Physician Decision|1|||
148968253|NCT00735371|537370292|FG001|Overall Study|Sponsor Decision|1|||
148968254|NCT00735371|537370293|FG002|Overall Study|Sponsor Decision|0|||
148968255|NCT00735371|537370294|FG003|Overall Study|Sponsor Decision|1|||
148968256|NCT00735371|537370291|FG000|Overall Study|Protocol Violation|0|||
148968257|NCT00735371|537370292|FG001|Overall Study|Protocol Violation|1|||
148968258|NCT00735371|537370293|FG002|Overall Study|Protocol Violation|2|||
148968259|NCT00735371|537370294|FG003|Overall Study|Protocol Violation|0|||
148968260|NCT00735371|537370291|FG000|Overall Study|Prior Vyvanse Exposure|1|||
148968261|NCT00735371|537370292|FG001|Overall Study|Prior Vyvanse Exposure|1|||
148968262|NCT00735371|537370293|FG002|Overall Study|Prior Vyvanse Exposure|0|||
148968263|NCT00735371|537370294|FG003|Overall Study|Prior Vyvanse Exposure|0|||
148968264|NCT00735371|537370291|FG000|Overall Study|Exclusion criteria|1|||
148968265|NCT00735371|537370292|FG001|Overall Study|Exclusion criteria|0|||
148968266|NCT00735371|537370293|FG002|Overall Study|Exclusion criteria|0|||
148968267|NCT00735371|537370294|FG003|Overall Study|Exclusion criteria|0|||
148968268|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
148968269|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
148711139|NCT01229150|536412658|FG000|Overall Study|Toxicity|2|||
148711140|NCT01229150|536412659|FG001|Overall Study|Toxicity|2|||
148711141|NCT01229150|536412660|FG002|Overall Study|Toxicity|0|||
148711142|NCT01229150|536412661|FG003|Overall Study|Toxicity|0|||
148711143|NCT03531827|536412662|FG000|Overall Study|Adverse Event|2|||
148711144|NCT03531827|536412663|FG001|Overall Study|Adverse Event|0|||
148711145|NCT03531827|536412662|FG000|Overall Study|Progressive disease|1|||
148711146|NCT03531827|536412663|FG001|Overall Study|Progressive disease|0|||
148711147|NCT00849797|536412664|FG000|First Intervention|bad veins|1|||
148711148|NCT00849797|536412665|FG001|First Intervention|bad veins|0|||
148711149|NCT00849797|536412664|FG000|First Intervention|Adverse Event|0|||
148711150|NCT00849797|536412665|FG001|First Intervention|Adverse Event|1|||
148711151|NCT00849797|536412664|FG000|Washout: One Week|Withdrawal by Subject|0|||
148711152|NCT00849797|536412665|FG001|Washout: One Week|Withdrawal by Subject|2|||
148711153|NCT02658019|536414353|FG000|Overall Study|Adverse Event|1|||
148711154|NCT00414726|536414354|FG000|Overall Study|Withdrawal by Subject|0|||
148711155|NCT00414726|536414355|FG001|Overall Study|Withdrawal by Subject|1|||
148711156|NCT02107196|536414356|FG000|12-week Treatment Period|Adverse Event|6|||
148711157|NCT02107196|536414357|FG001|12-week Treatment Period|Adverse Event|3|||
148711158|NCT02107196|536414356|FG000|12-week Treatment Period|Lack of Efficacy|2|||
148711159|NCT02107196|536414357|FG001|12-week Treatment Period|Lack of Efficacy|1|||
148711160|NCT02107196|536414356|FG000|12-week Treatment Period|Lost to Follow-up|3|||
148711161|NCT02107196|536414357|FG001|12-week Treatment Period|Lost to Follow-up|6|||
148711162|NCT02107196|536414356|FG000|12-week Treatment Period|Physician Decision|0|||
148711163|NCT02107196|536414357|FG001|12-week Treatment Period|Physician Decision|1|||
148711164|NCT02107196|536414356|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
148711165|NCT02107196|536414357|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
148711166|NCT02107196|536414356|FG000|12-week Treatment Period|Protocol Violation|7|||
148711167|NCT02107196|536414357|FG001|12-week Treatment Period|Protocol Violation|8|||
148711168|NCT02107196|536414356|FG000|12-week Treatment Period|Reason Missing|11|||
148711169|NCT02107196|536414357|FG001|12-week Treatment Period|Reason Missing|8|||
148711170|NCT02107196|536414356|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
148711171|NCT02107196|536414357|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
148711172|NCT02107196|536414356|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
148711173|NCT02107196|536414357|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
148711174|NCT02107196|536414356|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
148711175|NCT02107196|536414357|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
148711176|NCT02107196|536414356|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
148711177|NCT02107196|536414357|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
148711178|NCT01993186|536414358|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
148711179|NCT01993186|536414359|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
148711180|NCT01993186|536414358|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
148711181|NCT01993186|536414359|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
148711182|NCT01993186|536414358|FG000|Open-Label Extension Period|Other, Not Specified|0|||
148711183|NCT01993186|536414359|FG001|Open-Label Extension Period|Other, Not Specified|1|||
148711184|NCT01993186|536414358|FG000|Open-Label Extension Period|Adverse Event|1|||
148711185|NCT01993186|536414359|FG001|Open-Label Extension Period|Adverse Event|0|||
148711186|NCT01993186|536414358|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
148968270|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
148968271|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
148711187|NCT01993186|536414359|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
148711188|NCT01993186|536414358|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
148711189|NCT01993186|536414359|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
148711190|NCT01993186|536414358|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
148711191|NCT01993186|536414359|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
148711192|NCT04158687|536414360|FG000|Overall Study|Adverse Event|2|||
148711193|NCT04158687|536414361|FG001|Overall Study|Adverse Event|3|||
148711194|NCT04158687|536414362|FG002|Overall Study|Adverse Event|0|||
148711195|NCT04158687|536414363|FG003|Overall Study|Adverse Event|3|||
148711196|NCT04158687|536414360|FG000|Overall Study|Lost to Follow-up|5|||
148711197|NCT04158687|536414361|FG001|Overall Study|Lost to Follow-up|12|||
148711198|NCT04158687|536414362|FG002|Overall Study|Lost to Follow-up|4|||
148711199|NCT04158687|536414363|FG003|Overall Study|Lost to Follow-up|5|||
148711200|NCT04158687|536414360|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
148711201|NCT04158687|536414361|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
148711202|NCT04158687|536414362|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
148711203|NCT04158687|536414363|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
148711204|NCT04158687|536414360|FG000|Overall Study|Non-Compliance with Study Medication|2|||
148711205|NCT04158687|536414361|FG001|Overall Study|Non-Compliance with Study Medication|2|||
148711206|NCT04158687|536414362|FG002|Overall Study|Non-Compliance with Study Medication|3|||
148711207|NCT04158687|536414363|FG003|Overall Study|Non-Compliance with Study Medication|0|||
148711208|NCT04158687|536414360|FG000|Overall Study|Investigator Decision|0|||
148711209|NCT04158687|536414361|FG001|Overall Study|Investigator Decision|0|||
148711210|NCT04158687|536414362|FG002|Overall Study|Investigator Decision|2|||
148711211|NCT04158687|536414363|FG003|Overall Study|Investigator Decision|0|||
148711212|NCT04158687|536414360|FG000|Overall Study|Protocol Violation|0|||
148711213|NCT04158687|536414361|FG001|Overall Study|Protocol Violation|2|||
148711214|NCT04158687|536414362|FG002|Overall Study|Protocol Violation|1|||
148711215|NCT04158687|536414363|FG003|Overall Study|Protocol Violation|0|||
148711216|NCT04158687|536414360|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
148711217|NCT04158687|536414361|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
148711218|NCT04158687|536414362|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
148711219|NCT04158687|536414363|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
148711220|NCT04158687|536414360|FG000|Overall Study|Reason not Specified|3|||
148711221|NCT04158687|536414361|FG001|Overall Study|Reason not Specified|2|||
148711222|NCT04158687|536414362|FG002|Overall Study|Reason not Specified|4|||
148711223|NCT04158687|536414363|FG003|Overall Study|Reason not Specified|4|||
148711224|NCT04523480|536414364|FG000|Overall Study|Lost to Follow-up|30|||
148711225|NCT04523480|536414365|FG001|Overall Study|Lost to Follow-up|35|||
148711226|NCT04523480|536414366|FG002|Overall Study|Lost to Follow-up|0|||
148711227|NCT00640393|536414367|FG000|Part 1|Lost to Follow-up|2|||
148711228|NCT00640393|536414368|FG001|Part 1|Lost to Follow-up|0|||
148711229|NCT00640393|536414369|FG002|Part 1|Lost to Follow-up|0|||
148711230|NCT00640393|536414367|FG000|Part 1|Withdrawal by Subject|3|||
148711231|NCT00640393|536414368|FG001|Part 1|Withdrawal by Subject|0|||
148711232|NCT00640393|536414369|FG002|Part 1|Withdrawal by Subject|0|||
148711233|NCT00640393|536414367|FG000|Randomization|Withdrawn per protocol|17|||
148711234|NCT00640393|536414368|FG001|Randomization|Withdrawn per protocol|0|||
148711235|NCT00640393|536414369|FG002|Randomization|Withdrawn per protocol|0|||
148711236|NCT00640393|536414367|FG000|Randomization|Never randomized by site|2|||
148711237|NCT00640393|536414368|FG001|Randomization|Never randomized by site|0|||
148711238|NCT00640393|536414369|FG002|Randomization|Never randomized by site|0|||
148711239|NCT00640393|536414367|FG000|Part 2|Lost to Follow-up|0|||
148711240|NCT00640393|536414368|FG001|Part 2|Lost to Follow-up|2|||
148711241|NCT00640393|536414369|FG002|Part 2|Lost to Follow-up|2|||
148711242|NCT00640393|536414367|FG000|Part 2|Withdrawal by Subject|0|||
148711243|NCT00640393|536414368|FG001|Part 2|Withdrawal by Subject|6|||
148711244|NCT00640393|536414369|FG002|Part 2|Withdrawal by Subject|1|||
148711245|NCT00640393|536414367|FG000|Part 2|Non-adherence|0|||
148711246|NCT00640393|536414368|FG001|Part 2|Non-adherence|1|||
148711247|NCT00640393|536414369|FG002|Part 2|Non-adherence|0|||
148711248|NCT00640393|536414367|FG000|Part 2|Adverse Event|0|||
148711249|NCT00640393|536414368|FG001|Part 2|Adverse Event|1|||
148815452|NCT00541229|536800541|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
148815453|NCT00541229|536800542|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
148968272|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
148711250|NCT00640393|536414369|FG002|Part 2|Adverse Event|0|||
148711251|NCT05497557|536414370|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
148815454|NCT00541229|536800543|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
148815455|NCT00541229|536800544|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
148968273|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
148711252|NCT05497557|536414371|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
148711253|NCT05497557|536414372|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
148815456|NCT00541229|536800539|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
148711254|NCT03540160|536414376|FG000|Overall Study|Protocol Violation|1|||
148711255|NCT03540160|536414376|FG000|Overall Study|Physician Decision|8|||
148711256|NCT03540160|536414376|FG000|Overall Study|Lack of Efficacy|60|||
148711257|NCT03540160|536414376|FG000|Overall Study|Pregnancy|1|||
148711258|NCT03540160|536414376|FG000|Overall Study|Adverse Event|20|||
148711259|NCT03540160|536414376|FG000|Overall Study|Withdrawal by Subject|68|||
148711260|NCT03540160|536414376|FG000|Overall Study|COVID-19|2|||
148711261|NCT03540160|536414376|FG000|Overall Study|Study Closure|10|||
148711262|NCT03540160|536414376|FG000|Overall Study|Lost to Follow-up|18|||
148968274|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
148968275|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
148968276|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
148968277|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
148968278|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
148968279|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
148968280|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
148968281|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
148968282|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
148968283|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Death|5|||
148968284|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Death|0|||
148968285|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Death|2|||
148968286|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Death|0|||
148968287|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Death|4|||
148968288|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
148968289|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
148968290|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
148968291|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
148815457|NCT00541229|536800540|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
148815458|NCT00541229|536800541|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
148968292|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
148968293|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
148968294|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
148711263|NCT03540160|536414376|FG000|Overall Study|Sponsor decision|191|||
148711264|NCT03827395|536414377|FG000|Overall Study|Lost to Follow-up|1|||
148711265|NCT03827395|536414378|FG001|Overall Study|Lost to Follow-up|0|||
148711266|NCT03827395|536414377|FG000|Overall Study|Protocol Violation|1|||
148711267|NCT03827395|536414378|FG001|Overall Study|Protocol Violation|0|||
148711268|NCT03827395|536414377|FG000|Overall Study|Became ineligible after enrollment|1|||
148711269|NCT03827395|536414378|FG001|Overall Study|Became ineligible after enrollment|2|||
148711270|NCT01923740|536414379|FG000|Overall Study|Lost to Follow-up|4|||
148711271|NCT01923740|536414380|FG001|Overall Study|Lost to Follow-up|9|||
148711272|NCT01923740|536414379|FG000|Overall Study|Withdrawal by Subject|2|||
148711273|NCT01923740|536414380|FG001|Overall Study|Withdrawal by Subject|0|||
148711274|NCT01537887|536414381|FG000|Period 1|Physician Decision|0|||
148711275|NCT01537887|536414382|FG001|Period 1|Physician Decision|0|||
148711276|NCT01537887|536414383|FG002|Period 1|Physician Decision|0|||
148711277|NCT01537887|536414384|FG003|Period 1|Physician Decision|0|||
148711278|NCT01537887|536414385|FG004|Period 1|Physician Decision|1|||
148711279|NCT01537887|536414386|FG005|Period 1|Physician Decision|1|||
148711280|NCT01537887|536414381|FG000|Period 1|Did not receive treatment|0|||
148711281|NCT01537887|536414382|FG001|Period 1|Did not receive treatment|0|||
148711282|NCT01537887|536414383|FG002|Period 1|Did not receive treatment|1|||
148711283|NCT01537887|536414384|FG003|Period 1|Did not receive treatment|0|||
148711284|NCT01537887|536414385|FG004|Period 1|Did not receive treatment|0|||
148711285|NCT01537887|536414386|FG005|Period 1|Did not receive treatment|0|||
148711286|NCT01537887|536414381|FG000|Period 2|Withdrawal by Subject|0|||
148711287|NCT01537887|536414382|FG001|Period 2|Withdrawal by Subject|1|||
148711288|NCT01537887|536414383|FG002|Period 2|Withdrawal by Subject|0|||
148711289|NCT01537887|536414384|FG003|Period 2|Withdrawal by Subject|0|||
148711290|NCT01537887|536414385|FG004|Period 2|Withdrawal by Subject|0|||
148711291|NCT01537887|536414386|FG005|Period 2|Withdrawal by Subject|0|||
148711292|NCT01537887|536414381|FG000|Period 3|Adverse Event|0|||
148711293|NCT01537887|536414382|FG001|Period 3|Adverse Event|0|||
148711294|NCT01537887|536414383|FG002|Period 3|Adverse Event|1|||
148711295|NCT01537887|536414384|FG003|Period 3|Adverse Event|0|||
148711296|NCT01537887|536414385|FG004|Period 3|Adverse Event|0|||
148711297|NCT01537887|536414386|FG005|Period 3|Adverse Event|0|||
148711298|NCT01537887|536414381|FG000|Period 3|Withdrawal by Subject|0|||
148711299|NCT01537887|536414382|FG001|Period 3|Withdrawal by Subject|1|||
148711300|NCT01537887|536414383|FG002|Period 3|Withdrawal by Subject|0|||
148711301|NCT01537887|536414384|FG003|Period 3|Withdrawal by Subject|0|||
148711302|NCT01537887|536414385|FG004|Period 3|Withdrawal by Subject|0|||
148711303|NCT01537887|536414386|FG005|Period 3|Withdrawal by Subject|0|||
148711304|NCT04723693|536414387|FG000|Overall Study|Withdrawal by Subject|2|||
148968295|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
148711305|NCT00294047|536414388|FG000|Month 48|Adverse Event|28|||
148711306|NCT00294047|536414389|FG001|Month 48|Adverse Event|13|||
148711307|NCT00294047|536414388|FG000|Month 48|Protocol Violation|4|||
148711308|NCT00294047|536414389|FG001|Month 48|Protocol Violation|4|||
148711309|NCT00294047|536414388|FG000|Month 48|Withdrawal by Subject|111|||
148711310|NCT00294047|536414389|FG001|Month 48|Withdrawal by Subject|115|||
148711311|NCT00294047|536414388|FG000|Month 48|Lost to Follow-up|272|||
148711312|NCT00294047|536414389|FG001|Month 48|Lost to Follow-up|287|||
148711313|NCT00294047|536414388|FG000|Month 48|Other|10|||
148968296|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
148968297|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
148968298|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
148968299|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
148968300|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
148968301|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
148968302|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
148968303|NCT01604343|537370295|FG000|Prior to W52 Administration(Through W52)|Other|15|||
148968304|NCT01604343|537370296|FG001|Prior to W52 Administration(Through W52)|Other|0|||
148968305|NCT01604343|537370297|FG002|Prior to W52 Administration(Through W52)|Other|10|||
148968306|NCT01604343|537370298|FG003|Prior to W52 Administration(Through W52)|Other|0|||
148968307|NCT01604343|537370299|FG004|Prior to W52 Administration(Through W52)|Other|6|||
148968308|NCT01604343|537370295|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
148968309|NCT01604343|537370296|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
148968310|NCT01604343|537370297|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
148968311|NCT01604343|537370298|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
148968312|NCT01604343|537370299|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
148968313|NCT01604343|537370295|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
148968314|NCT01604343|537370296|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
148968315|NCT01604343|537370297|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
148968316|NCT01604343|537370298|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
148968317|NCT01604343|537370299|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
148968318|NCT01604343|537370295|FG000|Week 52 to Week 104|Adverse Event|0|||
148968319|NCT01604343|537370296|FG001|Week 52 to Week 104|Adverse Event|12|||
148968320|NCT01604343|537370297|FG002|Week 52 to Week 104|Adverse Event|26|||
148968321|NCT01604343|537370298|FG003|Week 52 to Week 104|Adverse Event|21|||
148968322|NCT01604343|537370299|FG004|Week 52 to Week 104|Adverse Event|27|||
148968323|NCT01604343|537370295|FG000|Week 52 to Week 104|Death|0|||
148968324|NCT01604343|537370296|FG001|Week 52 to Week 104|Death|4|||
148711314|NCT00294047|536414389|FG001|Month 48|Other|14|||
148711315|NCT00294047|536414388|FG000|Month 84|Adverse Event|4|||
148711316|NCT00294047|536414389|FG001|Month 84|Adverse Event|2|||
148711317|NCT00294047|536414388|FG000|Month 84|Protocol Violation|1|||
148711318|NCT00294047|536414389|FG001|Month 84|Protocol Violation|1|||
148711319|NCT00294047|536414388|FG000|Month 84|Withdrawal by Subject|33|||
148711320|NCT00294047|536414389|FG001|Month 84|Withdrawal by Subject|31|||
148711321|NCT00294047|536414388|FG000|Month 84|Lost to Follow-up|187|||
148711322|NCT00294047|536414389|FG001|Month 84|Lost to Follow-up|190|||
148711323|NCT00294047|536414388|FG000|Month 84|Absent Cervix|2|||
148711324|NCT00294047|536414389|FG001|Month 84|Absent Cervix|0|||
148711325|NCT00294047|536414388|FG000|Month 84|Work related reasons|4|||
148711326|NCT00294047|536414389|FG001|Month 84|Work related reasons|2|||
148711327|NCT00294047|536414388|FG000|Month 84|Center closed, subject did not transfer|1|||
148711328|NCT00294047|536414389|FG001|Month 84|Center closed, subject did not transfer|0|||
148711329|NCT00294047|536414388|FG000|Month 84|Family problems|2|||
148711330|NCT00294047|536414389|FG001|Month 84|Family problems|2|||
148711331|NCT00294047|536414388|FG000|Month 84|Lack of time|3|||
148711332|NCT00294047|536414389|FG001|Month 84|Lack of time|1|||
148711333|NCT00294047|536414388|FG000|Month 84|Personal reason|2|||
148711334|NCT00294047|536414389|FG001|Month 84|Personal reason|4|||
148711335|NCT00294047|536414388|FG000|Month 84|Subject does not want male physician|1|||
148711336|NCT00294047|536414389|FG001|Month 84|Subject does not want male physician|0|||
148711337|NCT00294047|536414388|FG000|Month 84|Transport reimbursement delayed|0|||
148711338|NCT00294047|536414389|FG001|Month 84|Transport reimbursement delayed|1|||
148711339|NCT00294047|536414388|FG000|Month 84|Unable to reach study site|1|||
148711340|NCT00294047|536414389|FG001|Month 84|Unable to reach study site|0|||
148711341|NCT00294047|536414388|FG000|Month 84|Under investigation locally|1|||
148711342|NCT00294047|536414389|FG001|Month 84|Under investigation locally|0|||
148711343|NCT00294047|536414388|FG000|Month 84|Visit missed|0|||
148711344|NCT00294047|536414389|FG001|Month 84|Visit missed|1|||
148711345|NCT00294047|536414388|FG000|Month 84|No consent for Month 84 Follow-up|731|||
148711346|NCT00294047|536414389|FG001|Month 84|No consent for Month 84 Follow-up|754|||
148711347|NCT02157974|536414390|FG000|Overall Study|Withdrawal by Subject|0|||
148711348|NCT02157974|536414391|FG001|Overall Study|Withdrawal by Subject|1|||
148711349|NCT02157974|536414392|FG002|Overall Study|Withdrawal by Subject|0|||
148711350|NCT02157974|536414393|FG003|Overall Study|Withdrawal by Subject|0|||
148968325|NCT01604343|537370297|FG002|Week 52 to Week 104|Death|2|||
148968326|NCT01604343|537370298|FG003|Week 52 to Week 104|Death|5|||
148711351|NCT02157974|536414394|FG004|Overall Study|Withdrawal by Subject|0|||
148711352|NCT02157974|536414390|FG000|Overall Study|Screen Failure|0|||
148968327|NCT01604343|537370299|FG004|Week 52 to Week 104|Death|0|||
148968328|NCT01604343|537370295|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
148968329|NCT01604343|537370296|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
148711353|NCT02157974|536414391|FG001|Overall Study|Screen Failure|1|||
148711354|NCT02157974|536414392|FG002|Overall Study|Screen Failure|0|||
148711355|NCT02157974|536414393|FG003|Overall Study|Screen Failure|0|||
148711356|NCT02157974|536414394|FG004|Overall Study|Screen Failure|0|||
148968330|NCT01604343|537370297|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
148968331|NCT01604343|537370298|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
148968332|NCT01604343|537370299|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
148968333|NCT01604343|537370295|FG000|Week 52 to Week 104|Physician Decision|0|||
148968334|NCT01604343|537370296|FG001|Week 52 to Week 104|Physician Decision|1|||
148968335|NCT01604343|537370297|FG002|Week 52 to Week 104|Physician Decision|0|||
148711357|NCT02157974|536414390|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
148711358|NCT02157974|536414391|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
148711359|NCT02157974|536414392|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
148711360|NCT02157974|536414393|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
148711361|NCT02157974|536414394|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
148711362|NCT00540423|536414397|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148711363|NCT00540423|536414398|FG001|Double-Blind Treatment Period|Adverse Event|1|||
148711364|NCT00540423|536414399|FG002|Double-Blind Treatment Period|Adverse Event|0|||
148711365|NCT00540423|536414397|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
148711366|NCT00540423|536414398|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
148711367|NCT00540423|536414399|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
148711368|NCT00263588|536414403|FG000|Overall Study|Death|54|||
148711369|NCT00263588|536414404|FG001|Overall Study|Death|90|||
148711370|NCT00263588|536414403|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
148711371|NCT00263588|536414404|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
148711372|NCT00263588|536414403|FG000|Overall Study|Lost to Follow-up|7|||
148711373|NCT00263588|536414404|FG001|Overall Study|Lost to Follow-up|10|||
148711374|NCT00263588|536414403|FG000|Overall Study|Withdrawal by Subject|3|||
148711375|NCT00263588|536414404|FG001|Overall Study|Withdrawal by Subject|4|||
148711376|NCT00263588|536414403|FG000|Overall Study|Protocol Violation|0|||
148711377|NCT00263588|536414404|FG001|Overall Study|Protocol Violation|1|||
148711378|NCT00263588|536414403|FG000|Overall Study|Investigator decision|7|||
148711379|NCT00263588|536414404|FG001|Overall Study|Investigator decision|15|||
148711380|NCT00263588|536414403|FG000|Overall Study|Sponsor terminated study|0|||
148711381|NCT00263588|536414404|FG001|Overall Study|Sponsor terminated study|1|||
148711382|NCT02412852|536414405|FG000|Overall Study|Withdrawal by Subject|0|||
148711383|NCT02412852|536414406|FG001|Overall Study|Withdrawal by Subject|1|||
148711384|NCT02412852|536414407|FG002|Overall Study|Withdrawal by Subject|0|||
148711385|NCT02412852|536414408|FG003|Overall Study|Withdrawal by Subject|0|||
148711386|NCT02412852|536414405|FG000|Overall Study|Physician Decision|0|||
148711387|NCT02412852|536414406|FG001|Overall Study|Physician Decision|0|||
148711388|NCT02412852|536414407|FG002|Overall Study|Physician Decision|0|||
148711389|NCT02412852|536414408|FG003|Overall Study|Physician Decision|1|||
148711390|NCT00985439|536414409|FG000|Overall Study|Adverse Event|0|||
148711391|NCT00985439|536414410|FG001|Overall Study|Adverse Event|0|||
148711392|NCT00985439|536414411|FG002|Overall Study|Adverse Event|1|||
148711393|NCT00985439|536414412|FG003|Overall Study|Adverse Event|0|||
148711394|NCT01174186|536414413|FG000|Overall Study|Lost to Follow-up|0|||
148711395|NCT01174186|536414414|FG001|Overall Study|Lost to Follow-up|1|||
148711396|NCT01174186|536414413|FG000|Overall Study|Withdrawal by Subject|0|||
148711397|NCT01174186|536414414|FG001|Overall Study|Withdrawal by Subject|2|||
148711398|NCT05274763|536414415|FG000|Overall Study|Lost to Follow-up|1|||
148711399|NCT00463684|536414422|FG000|Overall Study|Withdrawal by Subject|1|||
148711400|NCT00463684|536414422|FG000|Overall Study|Lost to Follow-up|3|||
148711401|NCT01906372|536414423|FG000|Overall Study|Withdrawal by Subject|2|||
148711402|NCT03629054|536414425|FG000|Period 2 (4 Days)|Not treated|0|||
148711403|NCT03629054|536414426|FG001|Period 2 (4 Days)|Not treated|1|||
148711404|NCT00924638|536414430|FG000|Overall Study|Death|3|||
148711405|NCT00924638|536414431|FG001|Overall Study|Death|2|||
148711406|NCT00924638|536414430|FG000|Overall Study|Lost to Follow-up|1|||
148711407|NCT00924638|536414431|FG001|Overall Study|Lost to Follow-up|1|||
148711408|NCT00924638|536414430|FG000|Overall Study|Withdrawal by Subject|5|||
148711409|NCT00924638|536414431|FG001|Overall Study|Withdrawal by Subject|7|||
148711410|NCT00924638|536414430|FG000|Overall Study|Physician Decision|3|||
148711411|NCT00924638|536414431|FG001|Overall Study|Physician Decision|3|||
148711412|NCT00367133|536414432|FG000|2 Years|Death|20|||
148711413|NCT00367133|536414433|FG001|2 Years|Death|12|||
148711414|NCT00367133|536414434|FG002|2 Years|Death|12|||
148968336|NCT01604343|537370298|FG003|Week 52 to Week 104|Physician Decision|0|||
148968337|NCT01604343|537370299|FG004|Week 52 to Week 104|Physician Decision|2|||
148968338|NCT01604343|537370295|FG000|Week 52 to Week 104|Pregnancy|0|||
148968339|NCT01604343|537370296|FG001|Week 52 to Week 104|Pregnancy|0|||
148968340|NCT01604343|537370297|FG002|Week 52 to Week 104|Pregnancy|1|||
148968341|NCT01604343|537370298|FG003|Week 52 to Week 104|Pregnancy|2|||
148968342|NCT01604343|537370299|FG004|Week 52 to Week 104|Pregnancy|1|||
148968343|NCT01604343|537370295|FG000|Week 52 to Week 104|Other|0|||
148968344|NCT01604343|537370296|FG001|Week 52 to Week 104|Other|11|||
148968345|NCT01604343|537370297|FG002|Week 52 to Week 104|Other|11|||
148968346|NCT01604343|537370298|FG003|Week 52 to Week 104|Other|6|||
148968347|NCT01604343|537370299|FG004|Week 52 to Week 104|Other|3|||
148968348|NCT01604343|537370295|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
148711415|NCT00367133|536414432|FG000|2 Years|Dropped|34|||
148711416|NCT00367133|536414433|FG001|2 Years|Dropped|19|||
148711417|NCT00367133|536414434|FG002|2 Years|Dropped|33|||
148711418|NCT00367133|536414432|FG000|2 Years|Missed visit|4|||
148711419|NCT00367133|536414433|FG001|2 Years|Missed visit|5|||
148711420|NCT00367133|536414434|FG002|2 Years|Missed visit|4|||
148711421|NCT00847535|536414440|FG000|Overall Study|Withdrawal by Subject|2|||
148711422|NCT00847535|536414441|FG001|Overall Study|Withdrawal by Subject|1|||
148711423|NCT00847535|536414442|FG002|Overall Study|Withdrawal by Subject|1|||
148711424|NCT00847535|536414440|FG000|Overall Study|Lost to Follow-up|0|||
148711425|NCT00847535|536414441|FG001|Overall Study|Lost to Follow-up|1|||
148711426|NCT00847535|536414442|FG002|Overall Study|Lost to Follow-up|0|||
148711427|NCT01252953|536414443|FG000|Overall Study|Withdrawal by Subject|16|||
148711428|NCT01252953|536414444|FG001|Overall Study|Withdrawal by Subject|17|||
148711429|NCT01252953|536414443|FG000|Overall Study|Lost to Follow-up|22|||
148711430|NCT01252953|536414444|FG001|Overall Study|Lost to Follow-up|21|||
148711431|NCT02336074|536414445|FG000|Overall Study|Adverse Event|0|||
148711432|NCT02336074|536414446|FG001|Overall Study|Adverse Event|2|||
148711433|NCT00958724|536414447|FG000|Overall Study|Disease Progression|6|||
148711434|NCT02121184|536414449|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
148711435|NCT02121184|536414450|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
148711436|NCT02121184|536414449|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
148711437|NCT02121184|536414450|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
148711438|NCT02121184|536414449|FG000|Overall Study|Emergency cesarean section required|0|||
148711439|NCT02121184|536414450|FG001|Overall Study|Emergency cesarean section required|2|||
148711440|NCT02121184|536414449|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
148711441|NCT02121184|536414450|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
148711442|NCT00840203|536414451|FG000|First Intervention|Protocol Violation|1|||
148711443|NCT00840203|536414452|FG001|First Intervention|Protocol Violation|1|||
148711444|NCT00840203|536414451|FG000|Washout|Protocol Violation|1|||
148711445|NCT00840203|536414452|FG001|Washout|Protocol Violation|0|||
148711446|NCT00989950|536414459|FG000|Randomized Phase|Protocol Violation|1|||
148711447|NCT00989950|536414460|FG001|Randomized Phase|Protocol Violation|0|||
148711448|NCT00989950|536414461|FG002|Randomized Phase|Protocol Violation|0|||
148711449|NCT00989950|536414462|FG003|Randomized Phase|Protocol Violation|0|||
148711450|NCT00989950|536414459|FG000|Randomized Phase|Adverse Event|0|||
148711451|NCT00989950|536414460|FG001|Randomized Phase|Adverse Event|1|||
148711452|NCT00989950|536414461|FG002|Randomized Phase|Adverse Event|0|||
148711453|NCT00989950|536414462|FG003|Randomized Phase|Adverse Event|0|||
148711454|NCT00101439|536414463|FG000|Period 2|Withdrawal by Subject|0|||
148711455|NCT00101439|536414464|FG001|Period 2|Withdrawal by Subject|2|||
148711456|NCT02845336|536414468|FG000|Overall Study|Lost to Follow-up|3|||
148711457|NCT02845336|536414469|FG001|Overall Study|Lost to Follow-up|1|||
148711458|NCT02845336|536414468|FG000|Overall Study|Inability to get medication|2|||
148711459|NCT02845336|536414469|FG001|Overall Study|Inability to get medication|0|||
148711460|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Refused|1|||
148711461|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Refused|3|||
148711462|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Medical|0|||
148711463|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Medical|1|||
148711464|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
148711465|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
148711466|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
148711467|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
148711468|NCT02054715|536414471|FG000|Baseline/Follow-up 1|No Reason|0|||
148711469|NCT02054715|536414472|FG001|Baseline/Follow-up 1|No Reason|1|||
148711470|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
148711471|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
148711472|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Ineligible|3|||
148711473|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Ineligible|0|||
148711474|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Hospitalization|1|||
148711475|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Hospitalization|0|||
148711476|NCT02054715|536414471|FG000|Baseline/Follow-up 1|Changed Mind|1|||
148711477|NCT02054715|536414472|FG001|Baseline/Follow-up 1|Changed Mind|0|||
148711478|NCT02054715|536414471|FG000|Follow-up 2|Lost to Followup|3|||
148711479|NCT02054715|536414472|FG001|Follow-up 2|Lost to Followup|1|||
148711480|NCT02054715|536414471|FG000|Follow-up 2|Refused|3|||
148711481|NCT02054715|536414472|FG001|Follow-up 2|Refused|2|||
148711482|NCT02054715|536414471|FG000|Follow-up 2|Followup Not Completed|3|||
148711483|NCT02054715|536414472|FG001|Follow-up 2|Followup Not Completed|4|||
148711484|NCT02054715|536414471|FG000|Follow-up 2|Ineligible|4|||
148711485|NCT02054715|536414472|FG001|Follow-up 2|Ineligible|5|||
148711486|NCT02054715|536414471|FG000|Follow-up 2|Death|3|||
148711487|NCT02054715|536414472|FG001|Follow-up 2|Death|3|||
148815459|NCT00541229|536800542|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
148711488|NCT02054715|536414471|FG000|Follow-up 2|Hospitalization|0|||
148711489|NCT02054715|536414472|FG001|Follow-up 2|Hospitalization|2|||
148711490|NCT02054715|536414471|FG000|Follow-up 2|Changed MD/Facility|0|||
148711491|NCT02054715|536414472|FG001|Follow-up 2|Changed MD/Facility|1|||
148711492|NCT02054715|536414471|FG000|Follow-up 2|Changed Mind|0|||
148711493|NCT02054715|536414472|FG001|Follow-up 2|Changed Mind|1|||
148711494|NCT02054715|536414471|FG000|Follow-up 2|No Reason|2|||
148711495|NCT02054715|536414472|FG001|Follow-up 2|No Reason|0|||
148711496|NCT02054715|536414471|FG000|Follow-up 2|Treatment Change or Delay|1|||
148711497|NCT02054715|536414472|FG001|Follow-up 2|Treatment Change or Delay|0|||
148711498|NCT00858780|536414473|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
148711499|NCT00858780|536414474|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
148711500|NCT00858780|536414475|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
148711501|NCT00858780|536414476|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
148711502|NCT00858780|536414477|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
148711503|NCT00858780|536414473|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
148711504|NCT00858780|536414474|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
148711505|NCT00858780|536414475|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
148711506|NCT00858780|536414476|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
148711507|NCT00858780|536414477|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
148711508|NCT00858780|536414473|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
148711509|NCT00858780|536414474|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
148711510|NCT00858780|536414475|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
148711511|NCT00858780|536414476|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
148711512|NCT00858780|536414477|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
148711513|NCT00858780|536414473|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
148711514|NCT00858780|536414474|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
148711515|NCT00858780|536414475|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
148711516|NCT00858780|536414476|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
148711517|NCT00858780|536414477|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
148968349|NCT01604343|537370296|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
148968350|NCT01604343|537370297|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
148968351|NCT01604343|537370298|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
148711518|NCT00858780|536414473|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
148711519|NCT00858780|536414474|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
148711520|NCT00858780|536414475|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
148711521|NCT00858780|536414476|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
148711522|NCT00858780|536414477|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
148711523|NCT00858780|536414473|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
148711524|NCT00858780|536414474|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
148711525|NCT00858780|536414475|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
148711526|NCT00858780|536414476|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
148711527|NCT00858780|536414477|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
148711528|NCT05098743|536414481|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
148711529|NCT05098743|536414482|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
148711530|NCT05098743|536414481|FG000|Overall Study|Lost to Follow-up|1|||
148711531|NCT05098743|536414482|FG001|Overall Study|Lost to Follow-up|2|||
148711532|NCT02896296|536414486|FG000|Overall Study|Adverse Event|1|||
148711533|NCT02896296|536414486|FG000|Overall Study|Lost to Follow-up|19|||
148711534|NCT02896296|536414486|FG000|Overall Study|Pregnancy|1|||
148711535|NCT02896296|536414486|FG000|Overall Study|Physician Decision|2|||
148711536|NCT02896296|536414486|FG000|Overall Study|Withdrawal by Subject|10|||
148711537|NCT02896296|536414486|FG000|Overall Study|Site closing|7|||
148711538|NCT02896296|536414486|FG000|Overall Study|Incarceration|1|||
148711539|NCT02896296|536414486|FG000|Overall Study|Relocation|1|||
148711540|NCT03969641|536415796|FG000|Overall Study|Lost to Follow-up|5|||
148711541|NCT03969641|536415797|FG001|Overall Study|Lost to Follow-up|3|||
148711542|NCT03969641|536415796|FG000|Overall Study|Withdrawal by Subject|1|||
148711543|NCT03969641|536415797|FG001|Overall Study|Withdrawal by Subject|2|||
148711544|NCT03969641|536415796|FG000|Overall Study|Found to be ineligible|1|||
148711545|NCT03969641|536415797|FG001|Overall Study|Found to be ineligible|1|||
148711546|NCT03969641|536415796|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
148968352|NCT01604343|537370299|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
148968353|NCT01604343|537370295|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
148968354|NCT01604343|537370296|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
148711547|NCT03969641|536415797|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
148711548|NCT03969641|536415796|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
148711549|NCT03969641|536415797|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
148711550|NCT03969641|536415796|FG000|Overall Study|Elective termination|0|||
148711551|NCT03969641|536415797|FG001|Overall Study|Elective termination|1|||
148711552|NCT00754052|536415801|FG000|Overall Study|Study terminated by Sponsor|5|||
148711553|NCT00754052|536415802|FG001|Overall Study|Study terminated by Sponsor|3|||
148711554|NCT02485158|536415806|FG000|Overall Study|Withdrawal by Subject|3|||
148711555|NCT02485158|536415806|FG000|Overall Study|expected drug side effect|1|||
148711556|NCT01098851|536415807|FG000|Overall Study|Equipment failure|1|||
148711557|NCT01098851|536415808|FG001|Overall Study|Equipment failure|0|||
148711558|NCT03087786|536415809|FG000|Overall Study|Withdrawal by Subject|2|||
148711559|NCT03087786|536415810|FG001|Overall Study|Withdrawal by Subject|0|||
148711560|NCT03234907|536415811|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
148711561|NCT03234907|536415812|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
148711562|NCT03234907|536415813|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
148711563|NCT03234907|536415814|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
148711564|NCT03234907|536415815|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
148711565|NCT03234907|536415816|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
148711566|NCT03234907|536415811|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
148711567|NCT03234907|536415812|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
148711568|NCT03234907|536415813|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
148711569|NCT03234907|536415814|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
148711570|NCT03234907|536415815|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
148711571|NCT03234907|536415816|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
148711572|NCT03234907|536415811|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
148711573|NCT03234907|536415812|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
148711574|NCT03234907|536415813|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
148711575|NCT03234907|536415814|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
148711576|NCT03234907|536415815|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
148711577|NCT03234907|536415816|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
148711578|NCT03234907|536415811|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
148711579|NCT03234907|536415812|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
148711580|NCT03234907|536415813|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
148711581|NCT03234907|536415814|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
148711582|NCT03234907|536415815|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
148711583|NCT03234907|536415816|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
148711584|NCT03234907|536415811|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
148711585|NCT03234907|536415812|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
148711586|NCT03234907|536415813|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
148711587|NCT03234907|536415814|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
148711588|NCT03234907|536415815|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
148711589|NCT03234907|536415816|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
148711590|NCT03234907|536415811|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
148711591|NCT03234907|536415812|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
148711592|NCT03234907|536415813|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
148711593|NCT03234907|536415814|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
148711594|NCT03234907|536415815|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
148711595|NCT03234907|536415816|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
148711596|NCT03234907|536415811|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
148711597|NCT03234907|536415812|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
148711598|NCT03234907|536415813|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
148711599|NCT03234907|536415814|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
148711600|NCT03234907|536415815|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
148711601|NCT03234907|536415816|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
148711602|NCT02986139|536415819|FG000|Overall Study|Sponsor Decision|1|||
148711603|NCT02986139|536415820|FG001|Overall Study|Sponsor Decision|2|||
148711604|NCT02986139|536415819|FG000|Overall Study|Withdrawal by Subject|0|||
148711605|NCT02986139|536415820|FG001|Overall Study|Withdrawal by Subject|1|||
148711606|NCT02986139|536415819|FG000|Overall Study|Lost to Follow-up|0|||
148711607|NCT02986139|536415820|FG001|Overall Study|Lost to Follow-up|1|||
148711608|NCT00198133|536415822|FG000|Overall Study|Disease progression|2|||
148711609|NCT00198133|536415823|FG001|Overall Study|Disease progression|5|||
148711610|NCT00198133|536415822|FG000|Overall Study|Adverse Event|1|||
148711611|NCT00198133|536415823|FG001|Overall Study|Adverse Event|3|||
148711612|NCT00198133|536415822|FG000|Overall Study|Withdrawal by Subject|1|||
148711613|NCT00198133|536415823|FG001|Overall Study|Withdrawal by Subject|0|||
148711614|NCT00198133|536415822|FG000|Overall Study|Physician Decision|1|||
148711615|NCT00198133|536415823|FG001|Overall Study|Physician Decision|0|||
148711616|NCT00835666|536415826|FG000|Washout|Protocol Violation|1|||
148711617|NCT00835666|536415827|FG001|Washout|Protocol Violation|0|||
148711618|NCT00835666|536415826|FG000|Washout|Withdrawal by Subject|1|||
148711619|NCT00835666|536415827|FG001|Washout|Withdrawal by Subject|0|||
148711620|NCT00635648|536415828|FG000|Overall Study|Adverse Event|12|||
148711621|NCT00635648|536415828|FG000|Overall Study|Withdrawal by Subject|9|||
148711622|NCT00635648|536415828|FG000|Overall Study|Physician Decision|4|||
148711623|NCT00635648|536415828|FG000|Overall Study|Rapid progression of baseline disease|4|||
148711624|NCT00635648|536415828|FG000|Overall Study|Use of other antifungal agent needed|1|||
148711625|NCT00635648|536415828|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
148711626|NCT00635648|536415828|FG000|Overall Study|Noncompliance with protocol|1|||
148711627|NCT00635648|536415828|FG000|Overall Study|Other reason|2|||
148711628|NCT01484912|536415832|FG000|Overall Study|Withdrawal by Subject|1|||
148711629|NCT01484912|536415833|FG001|Overall Study|Withdrawal by Subject|0|||
148711630|NCT01484912|536415832|FG000|Overall Study|Physician Decision|0|||
148711631|NCT01484912|536415833|FG001|Overall Study|Physician Decision|1|||
148711632|NCT00731939|536415834|FG000|Overall Study|Adverse Event|6|||
148711633|NCT00731939|536415834|FG000|Overall Study|Lost to Follow-up|15|||
148711634|NCT00731939|536415834|FG000|Overall Study|Not implanted with study device|9|||
148711635|NCT00731939|536415834|FG000|Overall Study|Withdrawal by Subject|2|||
148711636|NCT00731939|536415834|FG000|Overall Study|Did not meet enrollment criteria|2|||
148711637|NCT05604014|536415838|FG000|Overall Study|Lost to Follow-up|13|||
148711638|NCT01867658|536415839|FG000|Overall Study|Withdrawal by Subject|6|||
148711639|NCT01867658|536415839|FG000|Overall Study|Death|2|||
148711640|NCT01867658|536415839|FG000|Overall Study|Subject could not be contacted|1|||
148711641|NCT02426918|536415840|FG000|Overall Study|Adverse Event|2|||
148711642|NCT02426918|536415841|FG001|Overall Study|Adverse Event|2|||
148711643|NCT02426918|536415842|FG002|Overall Study|Adverse Event|0|||
148711644|NCT02426918|536415840|FG000|Overall Study|Physician Decision|1|||
148711645|NCT02426918|536415841|FG001|Overall Study|Physician Decision|1|||
148711646|NCT02426918|536415842|FG002|Overall Study|Physician Decision|1|||
148711647|NCT02426918|536415840|FG000|Overall Study|Withdrawal by Subject|5|||
148711648|NCT02426918|536415841|FG001|Overall Study|Withdrawal by Subject|5|||
148711649|NCT02426918|536415842|FG002|Overall Study|Withdrawal by Subject|4|||
148711650|NCT02426918|536415840|FG000|Overall Study|Other|9|||
148711651|NCT02426918|536415841|FG001|Overall Study|Other|11|||
148711652|NCT02426918|536415842|FG002|Overall Study|Other|9|||
148711653|NCT01496118|536415843|FG000|Overall Study|Disease progression|3|||
148711654|NCT01496118|536415844|FG001|Overall Study|Disease progression|2|||
148711655|NCT01496118|536415845|FG002|Overall Study|Disease progression|3|||
148711656|NCT01496118|536415846|FG003|Overall Study|Disease progression|1|||
148711657|NCT01496118|536415847|FG004|Overall Study|Disease progression|2|||
148711658|NCT01496118|536415848|FG005|Overall Study|Disease progression|2|||
148711659|NCT01496118|536415849|FG006|Overall Study|Disease progression|14|||
148711660|NCT01496118|536415850|FG007|Overall Study|Disease progression|10|||
148711661|NCT01496118|536415843|FG000|Overall Study|Physician Decision|0|||
148711662|NCT01496118|536415844|FG001|Overall Study|Physician Decision|0|||
148711663|NCT01496118|536415845|FG002|Overall Study|Physician Decision|0|||
148711664|NCT01496118|536415846|FG003|Overall Study|Physician Decision|0|||
148711665|NCT01496118|536415847|FG004|Overall Study|Physician Decision|1|||
148711666|NCT01496118|536415848|FG005|Overall Study|Physician Decision|0|||
148711667|NCT01496118|536415849|FG006|Overall Study|Physician Decision|3|||
148711668|NCT01496118|536415850|FG007|Overall Study|Physician Decision|6|||
148711669|NCT01496118|536415843|FG000|Overall Study|Adverse Event|1|||
148711670|NCT01496118|536415844|FG001|Overall Study|Adverse Event|1|||
148711671|NCT01496118|536415845|FG002|Overall Study|Adverse Event|0|||
148711672|NCT01496118|536415846|FG003|Overall Study|Adverse Event|0|||
148711673|NCT01496118|536415847|FG004|Overall Study|Adverse Event|0|||
148711674|NCT01496118|536415848|FG005|Overall Study|Adverse Event|0|||
148711675|NCT01496118|536415849|FG006|Overall Study|Adverse Event|6|||
148711676|NCT01496118|536415850|FG007|Overall Study|Adverse Event|10|||
148711677|NCT01496118|536415843|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148711678|NCT01496118|536415844|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148711679|NCT01496118|536415845|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148711680|NCT01496118|536415846|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148711681|NCT01496118|536415847|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148815460|NCT00541229|536800543|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
148815461|NCT00541229|536800544|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
148815462|NCT00541229|536800539|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
148815463|NCT00541229|536800540|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
148815464|NCT00541229|536800541|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
148815465|NCT00541229|536800542|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
148815466|NCT00541229|536800543|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
148815467|NCT00541229|536800544|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
148815468|NCT00541229|536800539|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
148815469|NCT00541229|536800540|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
148815470|NCT00541229|536800541|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
148815471|NCT00541229|536800542|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
148815472|NCT00541229|536800543|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
148815473|NCT00541229|536800544|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
148815474|NCT00541229|536800539|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
148711682|NCT01496118|536415848|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148711683|NCT01496118|536415849|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
148711684|NCT01496118|536415850|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
148711685|NCT01496118|536415843|FG000|Overall Study|Death|0|||
148711686|NCT01496118|536415844|FG001|Overall Study|Death|0|||
148711687|NCT01496118|536415845|FG002|Overall Study|Death|0|||
148711688|NCT01496118|536415846|FG003|Overall Study|Death|0|||
148815475|NCT00541229|536800540|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
148711689|NCT01496118|536415847|FG004|Overall Study|Death|0|||
148711690|NCT01496118|536415848|FG005|Overall Study|Death|0|||
148711691|NCT01496118|536415849|FG006|Overall Study|Death|1|||
148711692|NCT01496118|536415850|FG007|Overall Study|Death|1|||
148711693|NCT01496118|536415843|FG000|Overall Study|Withdrawal by Subject|0|||
148711694|NCT01496118|536415844|FG001|Overall Study|Withdrawal by Subject|0|||
148711695|NCT01496118|536415845|FG002|Overall Study|Withdrawal by Subject|0|||
148711696|NCT01496118|536415846|FG003|Overall Study|Withdrawal by Subject|2|||
148711697|NCT01496118|536415847|FG004|Overall Study|Withdrawal by Subject|0|||
148711698|NCT01496118|536415848|FG005|Overall Study|Withdrawal by Subject|1|||
148711699|NCT01496118|536415849|FG006|Overall Study|Withdrawal by Subject|6|||
148711700|NCT01496118|536415850|FG007|Overall Study|Withdrawal by Subject|3|||
148711701|NCT01190865|536415855|FG000|Overall Study|Withdrawal by Subject|1|||
148711702|NCT01190865|536415855|FG000|Overall Study|Non-compliance|2|||
148711703|NCT00574847|536415856|FG000|Overall Study|Adverse Event|2|||
148711704|NCT00574847|536415857|FG001|Overall Study|Adverse Event|0|||
148711705|NCT00574847|536415856|FG000|Overall Study|Death|1|||
148711706|NCT00574847|536415857|FG001|Overall Study|Death|0|||
148711707|NCT00574847|536415856|FG000|Overall Study|Withdrawal by Subject|2|||
148711708|NCT00574847|536415857|FG001|Overall Study|Withdrawal by Subject|2|||
148711709|NCT00574847|536415856|FG000|Overall Study|Physician Decision|1|||
148711710|NCT00574847|536415857|FG001|Overall Study|Physician Decision|0|||
148711711|NCT00574847|536415856|FG000|Overall Study|Did not receive medication (declined)|2|||
148711712|NCT00574847|536415857|FG001|Overall Study|Did not receive medication (declined)|5|||
148711713|NCT02471807|536415862|FG000|Overall Study|Death|14|||
148711714|NCT02471807|536415862|FG000|Overall Study|Withdrawal by Subject|2|||
148711715|NCT02471807|536415862|FG000|Overall Study|Explant|5|||
148711716|NCT02471807|536415862|FG000|Overall Study|Lost to Follow-up|1|||
148711717|NCT00562718|536415880|FG000|Overall Study|Death|1|||
148711718|NCT00562718|536415880|FG000|Overall Study|Withdrawal by Subject|3|||
148711719|NCT00562718|536415880|FG000|Overall Study|Adverse Event|4|||
148711720|NCT00562718|536415880|FG000|Overall Study|Lack of Efficacy|2|||
148711721|NCT00562718|536415880|FG000|Overall Study|not stated|1|||
148711722|NCT01151618|536415881|FG000|Overall Study|Adverse Event|2|||
148711723|NCT01151618|536415881|FG000|Overall Study|Withdrawal by Subject|7|||
148711724|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
148711725|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
148711726|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
148711727|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
148711728|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
148711729|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
148711730|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
148711731|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
148711732|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
148711733|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
148711734|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
148711735|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
148711736|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
148711737|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
148711738|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
148711739|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
148711740|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
148711741|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
148711742|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
148711743|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
148815476|NCT00541229|536800541|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
148815477|NCT00541229|536800542|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
148711744|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
148711745|NCT02227238|536415882|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
148711746|NCT02227238|536415883|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
148711747|NCT02227238|536415884|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
148711748|NCT02227238|536415882|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
148711749|NCT02227238|536415883|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
148711750|NCT02227238|536415884|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
148711751|NCT02227238|536415882|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
148711752|NCT02227238|536415883|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
148711753|NCT02227238|536415884|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
148711754|NCT02227238|536415882|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
148711755|NCT02227238|536415883|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
148711756|NCT02227238|536415884|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
148711757|NCT02227238|536415882|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
148711758|NCT02227238|536415883|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
148711759|NCT02227238|536415884|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
148711760|NCT02227238|536415882|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
148711761|NCT02227238|536415883|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
148711762|NCT02227238|536415884|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
148711763|NCT02227238|536415882|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
148711764|NCT02227238|536415883|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
148711765|NCT02227238|536415884|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
148711766|NCT01986647|536415885|FG000|Overall Study|Lost to Follow-up|4|||
148711767|NCT01986647|536415886|FG001|Overall Study|Lost to Follow-up|1|||
148711768|NCT01986647|536415887|FG002|Overall Study|Lost to Follow-up|4|||
148711769|NCT01986647|536415888|FG003|Overall Study|Lost to Follow-up|4|||
148711770|NCT01986647|536415885|FG000|Overall Study|Withdrawal by Subject|1|||
148711771|NCT01986647|536415886|FG001|Overall Study|Withdrawal by Subject|3|||
148711772|NCT01986647|536415887|FG002|Overall Study|Withdrawal by Subject|2|||
148711773|NCT01986647|536415888|FG003|Overall Study|Withdrawal by Subject|3|||
148711774|NCT01986647|536415885|FG000|Overall Study|Health|5|||
148711775|NCT01986647|536415886|FG001|Overall Study|Health|3|||
148711776|NCT01986647|536415887|FG002|Overall Study|Health|6|||
148711777|NCT01986647|536415888|FG003|Overall Study|Health|4|||
148711778|NCT00868998|536415889|FG000|Overall Study|Screen Failure|1|||
148711779|NCT00868998|536415889|FG000|Overall Study|Withdrawal by Subject|1|||
148711780|NCT00868998|536415889|FG000|Overall Study|Progression of disease|2|||
148711781|NCT00868998|536415889|FG000|Overall Study|Death|1|||
148711782|NCT01483820|536415890|FG000|Overall Study|Lack of Efficacy|6|||
148711783|NCT01483820|536415890|FG000|Overall Study|Adverse Event|1|||
148711784|NCT01483820|536415890|FG000|Overall Study|Death|1|||
148711785|NCT01507662|536415891|FG000|Overall Study|Death|26|||
148711786|NCT01507662|536415892|FG001|Overall Study|Death|18|||
148711787|NCT01507662|536415891|FG000|Overall Study|Withdrawal by Subject|290|||
148711788|NCT01507662|536415892|FG001|Overall Study|Withdrawal by Subject|287|||
148711789|NCT01507662|536415891|FG000|Overall Study|Lost to Follow-up|498|||
148711790|NCT01507662|536415892|FG001|Overall Study|Lost to Follow-up|523|||
148711791|NCT01507662|536415891|FG000|Overall Study|Proxy interview done|2|||
148711792|NCT01507662|536415892|FG001|Overall Study|Proxy interview done|3|||
148711793|NCT03541252|536415897|FG000|Overall Study|Withdrawal by Subject|1|||
148711794|NCT01960296|536415904|FG000|Overall Study|Postponed surgery|1|||
148711795|NCT01960296|536415905|FG001|Overall Study|Postponed surgery|0|||
148711796|NCT01960296|536415904|FG000|Overall Study|Received different procedure|1|||
148711797|NCT01960296|536415905|FG001|Overall Study|Received different procedure|3|||
148711798|NCT02003391|536415906|FG000|Overall Study|Withdrawal by Subject|2|||
148711799|NCT02003391|536415907|FG001|Overall Study|Withdrawal by Subject|1|||
148711800|NCT02003391|536415906|FG000|Overall Study|Protocol Violation|0|||
148711801|NCT02003391|536415907|FG001|Overall Study|Protocol Violation|1|||
148711802|NCT02003391|536415906|FG000|Overall Study|Adverse Event|1|||
148711803|NCT02003391|536415907|FG001|Overall Study|Adverse Event|0|||
148711804|NCT02272803|536415908|FG000|Overall Study|Disease progression|16|||
148711805|NCT02272803|536415909|FG001|Overall Study|Disease progression|8|||
148711806|NCT02272803|536415908|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
148711807|NCT02272803|536415909|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
148711808|NCT02272803|536415908|FG000|Overall Study|Study drug toxicity|4|||
148711809|NCT02272803|536415909|FG001|Overall Study|Study drug toxicity|9|||
148711810|NCT02272803|536415908|FG000|Overall Study|Participant request to discontinue study treatment|3|||
148711811|NCT02272803|536415909|FG001|Overall Study|Participant request to discontinue study treatment|7|||
148711812|NCT02272803|536415908|FG000|Overall Study|Maximum clinical benefit|4|||
148711813|NCT02272803|536415909|FG001|Overall Study|Maximum clinical benefit|2|||
148711814|NCT02272803|536415908|FG000|Overall Study|Poor/non-compliance|2|||
148711815|NCT02272803|536415909|FG001|Overall Study|Poor/non-compliance|2|||
148711816|NCT02272803|536415908|FG000|Overall Study|Withdrawal by Subject|2|||
148711817|NCT02272803|536415909|FG001|Overall Study|Withdrawal by Subject|1|||
148711818|NCT02272803|536415908|FG000|Overall Study|Death|0|||
148711819|NCT02272803|536415909|FG001|Overall Study|Death|1|||
148711820|NCT02272803|536415908|FG000|Overall Study|Other reasons|1|||
148711821|NCT02272803|536415909|FG001|Overall Study|Other reasons|3|||
148711822|NCT02272803|536415908|FG000|Overall Study|Administrative reason by sponsor|5|||
148711823|NCT02272803|536415909|FG001|Overall Study|Administrative reason by sponsor|4|||
148711824|NCT02611323|536415910|FG000|Overall Study|Death|3|||
148711825|NCT02611323|536415911|FG001|Overall Study|Death|1|||
148711826|NCT02611323|536415912|FG002|Overall Study|Death|0|||
148711827|NCT02611323|536415913|FG003|Overall Study|Death|0|||
148711828|NCT02611323|536415914|FG004|Overall Study|Death|1|||
148711829|NCT02611323|536415915|FG005|Overall Study|Death|1|||
148711830|NCT02611323|536415916|FG006|Overall Study|Death|8|||
148711831|NCT02611323|536415917|FG007|Overall Study|Death|0|||
148968355|NCT01604343|537370297|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
148968356|NCT01604343|537370298|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
148968357|NCT01604343|537370299|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
148711832|NCT02611323|536415918|FG008|Overall Study|Death|4|||
148711833|NCT02611323|536415919|FG009|Overall Study|Death|6|||
148711834|NCT02611323|536415920|FG010|Overall Study|Death|26|||
148711835|NCT02611323|536415910|FG000|Overall Study|Lost to Follow-up|1|||
148711836|NCT02611323|536415911|FG001|Overall Study|Lost to Follow-up|0|||
148711837|NCT02611323|536415912|FG002|Overall Study|Lost to Follow-up|0|||
148711838|NCT02611323|536415913|FG003|Overall Study|Lost to Follow-up|0|||
148711839|NCT02611323|536415914|FG004|Overall Study|Lost to Follow-up|0|||
148711840|NCT02611323|536415915|FG005|Overall Study|Lost to Follow-up|0|||
148711841|NCT02611323|536415916|FG006|Overall Study|Lost to Follow-up|3|||
148711842|NCT02611323|536415917|FG007|Overall Study|Lost to Follow-up|0|||
148711843|NCT02611323|536415918|FG008|Overall Study|Lost to Follow-up|0|||
148711844|NCT02611323|536415919|FG009|Overall Study|Lost to Follow-up|0|||
148711845|NCT02611323|536415920|FG010|Overall Study|Lost to Follow-up|2|||
148711846|NCT02611323|536415910|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711847|NCT02611323|536415911|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711848|NCT02611323|536415912|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711849|NCT02611323|536415913|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711850|NCT02611323|536415914|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711851|NCT02611323|536415915|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711852|NCT02611323|536415916|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711853|NCT02611323|536415917|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711854|NCT02611323|536415918|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711855|NCT02611323|536415919|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
148711856|NCT02611323|536415920|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
148711857|NCT02611323|536415910|FG000|Overall Study|Progressive Disease|0|||
148711858|NCT02611323|536415911|FG001|Overall Study|Progressive Disease|0|||
148711859|NCT02611323|536415912|FG002|Overall Study|Progressive Disease|0|||
148711860|NCT02611323|536415913|FG003|Overall Study|Progressive Disease|0|||
148711861|NCT02611323|536415914|FG004|Overall Study|Progressive Disease|0|||
148711862|NCT02611323|536415915|FG005|Overall Study|Progressive Disease|0|||
148711863|NCT02611323|536415916|FG006|Overall Study|Progressive Disease|0|||
148711864|NCT02611323|536415917|FG007|Overall Study|Progressive Disease|0|||
148711865|NCT02611323|536415918|FG008|Overall Study|Progressive Disease|0|||
148711866|NCT02611323|536415919|FG009|Overall Study|Progressive Disease|0|||
148711867|NCT02611323|536415920|FG010|Overall Study|Progressive Disease|1|||
148711868|NCT02611323|536415910|FG000|Overall Study|Withdrawal by Subject|1|||
148711869|NCT02611323|536415911|FG001|Overall Study|Withdrawal by Subject|0|||
148711870|NCT02611323|536415912|FG002|Overall Study|Withdrawal by Subject|0|||
148711871|NCT02611323|536415913|FG003|Overall Study|Withdrawal by Subject|0|||
148711872|NCT02611323|536415914|FG004|Overall Study|Withdrawal by Subject|0|||
148711873|NCT02611323|536415915|FG005|Overall Study|Withdrawal by Subject|0|||
148711874|NCT02611323|536415916|FG006|Overall Study|Withdrawal by Subject|0|||
148711875|NCT02611323|536415917|FG007|Overall Study|Withdrawal by Subject|1|||
148711876|NCT02611323|536415918|FG008|Overall Study|Withdrawal by Subject|0|||
148711877|NCT02611323|536415919|FG009|Overall Study|Withdrawal by Subject|1|||
148711878|NCT02611323|536415920|FG010|Overall Study|Withdrawal by Subject|0|||
148711879|NCT00858403|536415921|FG000|Overall Study|Withdrawal by Subject|1|||
148711880|NCT00858403|536415921|FG000|Overall Study|Death|3|||
148711881|NCT00858403|536415921|FG000|Overall Study|Disease Progression|1|||
148711882|NCT02597049|536415922|FG000|Overall Study|Lost to Follow-up|0|||
148711883|NCT02597049|536415923|FG001|Overall Study|Lost to Follow-up|3|||
148711884|NCT02597049|536415924|FG002|Overall Study|Lost to Follow-up|2|||
148711885|NCT02597049|536415922|FG000|Overall Study|Withdrawal by Subject|2|||
148968358|NCT01604343|537370295|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
148711886|NCT02597049|536415923|FG001|Overall Study|Withdrawal by Subject|2|||
148711887|NCT02597049|536415924|FG002|Overall Study|Withdrawal by Subject|1|||
148711888|NCT02597049|536415922|FG000|Overall Study|Adverse Event|2|||
148711889|NCT02597049|536415923|FG001|Overall Study|Adverse Event|0|||
148711890|NCT02597049|536415924|FG002|Overall Study|Adverse Event|0|||
148711891|NCT02597049|536415922|FG000|Overall Study|Death|2|||
148711892|NCT02597049|536415923|FG001|Overall Study|Death|0|||
148711893|NCT02597049|536415924|FG002|Overall Study|Death|0|||
148711894|NCT02597049|536415922|FG000|Overall Study|Noncompliant with Study Visits|1|||
148711895|NCT02597049|536415923|FG001|Overall Study|Noncompliant with Study Visits|0|||
148711896|NCT02597049|536415924|FG002|Overall Study|Noncompliant with Study Visits|0|||
148711897|NCT00243347|536415927|FG000|Overall Study|Lack of Efficacy|4|||
148711898|NCT00243347|536415927|FG000|Overall Study|Adverse Event|2|||
148711899|NCT00243347|536415927|FG000|Overall Study|Death|1|||
148711900|NCT00243347|536415927|FG000|Overall Study|Withdrawal by Subject|5|||
148711901|NCT00243347|536415927|FG000|Overall Study|Condition worsened|7|||
148711902|NCT02264977|536415928|FG000|Overall Study|Death|3|||
148711903|NCT02264977|536415928|FG000|Overall Study|Physician Decision|1|||
148711904|NCT02264977|536415928|FG000|Overall Study|Refuse to return|1|||
148711905|NCT00227370|536415932|FG000|Overall Study|Withdrawal by Subject|1|||
148711906|NCT00227370|536415933|FG001|Overall Study|Withdrawal by Subject|2|||
148711907|NCT00227370|536415932|FG000|Overall Study|Death|3|||
148711908|NCT00227370|536415933|FG001|Overall Study|Death|4|||
148711909|NCT00227370|536415932|FG000|Overall Study|Adverse Event|6|||
148711910|NCT00227370|536415933|FG001|Overall Study|Adverse Event|11|||
148711911|NCT00227370|536415932|FG000|Overall Study|Physician Decision|9|||
148711912|NCT00227370|536415933|FG001|Overall Study|Physician Decision|6|||
148711913|NCT00227370|536415932|FG000|Overall Study|Other reasons|2|||
148711914|NCT00227370|536415933|FG001|Overall Study|Other reasons|1|||
148711915|NCT03961204|536415934|FG000|Overall Study|Withdrawal by Subject|2|||
148711916|NCT03961204|536415934|FG000|Overall Study|Lost to Follow-up|3|||
148711917|NCT03961204|536415934|FG000|Overall Study|Other|1|||
148711918|NCT03961204|536415934|FG000|Overall Study|Missing|1|||
148711919|NCT02452463|536415937|FG000|Overall Study|Death|1|||
148711920|NCT02452463|536415938|FG001|Overall Study|Death|0|||
148711921|NCT02452463|536415939|FG002|Overall Study|Death|0|||
148711922|NCT02452463|536415937|FG000|Overall Study|Study Suspended|1|||
148711923|NCT02452463|536415938|FG001|Overall Study|Study Suspended|0|||
148711924|NCT02452463|536415939|FG002|Overall Study|Study Suspended|0|||
148711925|NCT02452463|536415937|FG000|Overall Study|Recommended by DSMB|0|||
148711926|NCT02452463|536415938|FG001|Overall Study|Recommended by DSMB|1|||
148711927|NCT02452463|536415939|FG002|Overall Study|Recommended by DSMB|0|||
148711928|NCT02452463|536415937|FG000|Overall Study|Withdrawal by Subject|0|||
148711929|NCT02452463|536415938|FG001|Overall Study|Withdrawal by Subject|1|||
148711930|NCT02452463|536415939|FG002|Overall Study|Withdrawal by Subject|0|||
148711931|NCT01018862|536415944|FG000|Overall Study|Adverse Event|2|||
148711932|NCT01018862|536415945|FG001|Overall Study|Adverse Event|0|||
148711933|NCT01018862|536415946|FG002|Overall Study|Adverse Event|6|||
148711934|NCT01018862|536415944|FG000|Overall Study|Lack of Efficacy|1|||
148711935|NCT01018862|536415945|FG001|Overall Study|Lack of Efficacy|0|||
148711936|NCT01018862|536415946|FG002|Overall Study|Lack of Efficacy|2|||
148711937|NCT01018862|536415944|FG000|Overall Study|Lost to Follow-up|3|||
148711938|NCT01018862|536415945|FG001|Overall Study|Lost to Follow-up|1|||
148711939|NCT01018862|536415946|FG002|Overall Study|Lost to Follow-up|0|||
148711940|NCT01018862|536415944|FG000|Overall Study|Protocol Violation|1|||
148711941|NCT01018862|536415945|FG001|Overall Study|Protocol Violation|3|||
148711942|NCT01018862|536415946|FG002|Overall Study|Protocol Violation|3|||
148711943|NCT01018862|536415944|FG000|Overall Study|Withdrawal by Subject|1|||
148711944|NCT01018862|536415945|FG001|Overall Study|Withdrawal by Subject|2|||
148711945|NCT01018862|536415946|FG002|Overall Study|Withdrawal by Subject|1|||
148711946|NCT01018862|536415944|FG000|Overall Study|administrative problems|5|||
148711947|NCT01018862|536415945|FG001|Overall Study|administrative problems|4|||
148711948|NCT01018862|536415946|FG002|Overall Study|administrative problems|4|||
148711949|NCT01968031|536415950|FG000|Overall Study|Adverse Event|13|||
148711950|NCT01968031|536415951|FG001|Overall Study|Adverse Event|10|||
148711951|NCT01968031|536415952|FG002|Overall Study|Adverse Event|22|||
148711952|NCT01968031|536415950|FG000|Overall Study|Withdrawal by Subject|3|||
148711953|NCT01968031|536415951|FG001|Overall Study|Withdrawal by Subject|7|||
148711954|NCT01968031|536415952|FG002|Overall Study|Withdrawal by Subject|3|||
148711955|NCT01968031|536415950|FG000|Overall Study|Did not meet entry criteria|1|||
148711956|NCT01968031|536415951|FG001|Overall Study|Did not meet entry criteria|1|||
148711957|NCT01968031|536415952|FG002|Overall Study|Did not meet entry criteria|1|||
148711958|NCT01968031|536415950|FG000|Overall Study|Noncompliance|0|||
148711959|NCT01968031|536415951|FG001|Overall Study|Noncompliance|0|||
148711960|NCT01968031|536415952|FG002|Overall Study|Noncompliance|2|||
148711961|NCT01968031|536415950|FG000|Overall Study|Failed inclusion criteria|0|||
148711962|NCT01968031|536415951|FG001|Overall Study|Failed inclusion criteria|2|||
148711963|NCT01968031|536415952|FG002|Overall Study|Failed inclusion criteria|0|||
148711964|NCT01968031|536415950|FG000|Overall Study|Death|0|||
148711965|NCT01968031|536415951|FG001|Overall Study|Death|0|||
148711966|NCT01968031|536415952|FG002|Overall Study|Death|1|||
148711967|NCT01968031|536415950|FG000|Overall Study|Prohibited concomitant medication|1|||
148711968|NCT01968031|536415951|FG001|Overall Study|Prohibited concomitant medication|0|||
148711969|NCT01968031|536415952|FG002|Overall Study|Prohibited concomitant medication|0|||
148711970|NCT01891357|536415953|FG000|Overall Study|Protocol Violation|3|||
148711971|NCT00840879|536415954|FG000|Second Intervention|Withdrawal by Subject|1|||
148711972|NCT00840879|536415955|FG001|Second Intervention|Withdrawal by Subject|0|||
148711973|NCT03707587|536417574|FG000|Overall Study|Death|0|||
148711974|NCT03707587|536417575|FG001|Overall Study|Death|1|||
148711975|NCT02450539|536417576|FG000|Overall Study|Withdrawal by Subject|12|||
148711976|NCT02450539|536417577|FG001|Overall Study|Withdrawal by Subject|6|||
148711977|NCT02450539|536417576|FG000|Overall Study|Lost to Follow-up|4|||
148711978|NCT02450539|536417577|FG001|Overall Study|Lost to Follow-up|1|||
148711979|NCT00834444|536417578|FG000|First Intervention|Adverse Event|1|||
148711980|NCT00834444|536417579|FG001|First Intervention|Adverse Event|0|||
148711981|NCT00834444|536417578|FG000|First Intervention|Intolerance to Venopuncture|0|||
148711982|NCT00834444|536417579|FG001|First Intervention|Intolerance to Venopuncture|1|||
148711983|NCT00834444|536417578|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
148711984|NCT00834444|536417579|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
148711985|NCT00834444|536417578|FG000|Second Intervention|Adverse Event|1|||
148711986|NCT00834444|536417579|FG001|Second Intervention|Adverse Event|0|||
148711987|NCT02704091|536417585|FG000|Overall Study|Adverse Event|4|||
148711988|NCT02704091|536417586|FG001|Overall Study|Adverse Event|3|||
148711989|NCT02704091|536417585|FG000|Overall Study|Protocol Violation|5|||
148711990|NCT02704091|536417586|FG001|Overall Study|Protocol Violation|3|||
148711991|NCT02704091|536417585|FG000|Overall Study|Consent withdrawn|4|||
148711992|NCT02704091|536417586|FG001|Overall Study|Consent withdrawn|4|||
148711993|NCT02704091|536417585|FG000|Overall Study|Lost to Follow-up|13|||
148711994|NCT02704091|536417586|FG001|Overall Study|Lost to Follow-up|5|||
148711995|NCT02704091|536417585|FG000|Overall Study|Other|2|||
148711996|NCT02704091|536417586|FG001|Overall Study|Other|8|||
148711997|NCT00425308|536417587|FG000|Overall Study|Adverse Event|2|||
148711998|NCT00425308|536417588|FG001|Overall Study|Adverse Event|1|||
148711999|NCT00425308|536417587|FG000|Overall Study|Withdrawal by Subject|1|||
148712000|NCT00425308|536417588|FG001|Overall Study|Withdrawal by Subject|0|||
148712001|NCT00425308|536417587|FG000|Overall Study|Death|1|||
148712002|NCT00425308|536417588|FG001|Overall Study|Death|0|||
148712003|NCT00472212|536417589|FG000|Overall Study|Lost to Follow-up|6|||
148712004|NCT00472212|536417590|FG001|Overall Study|Lost to Follow-up|4|||
148712005|NCT01266902|536417593|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
148712006|NCT01266902|536417594|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
148712007|NCT01266902|536417595|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
148712008|NCT01266902|536417593|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
148712009|NCT01266902|536417594|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
148712010|NCT01266902|536417595|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
148712011|NCT01266902|536417593|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
148712012|NCT01266902|536417594|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
148712013|NCT01266902|536417595|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
148712014|NCT01266902|536417593|FG000|Period 1 (Main Study)|Adverse Event|3|||
148712015|NCT01266902|536417594|FG001|Period 1 (Main Study)|Adverse Event|11|||
148712016|NCT01266902|536417595|FG002|Period 1 (Main Study)|Adverse Event|0|||
148712017|NCT01266902|536417593|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
148712018|NCT01266902|536417594|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
148712019|NCT01266902|536417595|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
148712020|NCT01266902|536417593|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
148712021|NCT01266902|536417594|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
148712022|NCT01266902|536417595|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
148712023|NCT01266902|536417593|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
148712024|NCT01266902|536417594|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
148712025|NCT01266902|536417595|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
148712026|NCT01266902|536417593|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
148712027|NCT01266902|536417594|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
148712028|NCT01266902|536417595|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
148712029|NCT01266902|536417593|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
148712030|NCT01266902|536417594|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
148712031|NCT01266902|536417595|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
148712032|NCT01266902|536417593|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
148712033|NCT01266902|536417594|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
148712034|NCT01266902|536417595|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
148815478|NCT00541229|536800543|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
148815479|NCT00541229|536800544|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
148815480|NCT00541229|536800539|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
148815481|NCT00541229|536800540|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
148815482|NCT00541229|536800541|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
148815483|NCT00541229|536800542|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
148815484|NCT00541229|536800543|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
148815485|NCT00541229|536800544|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
148815486|NCT00541229|536800539|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
148712035|NCT05562011|536417605|FG000|Overall Study|Withdrawal by Subject|3|||
148712036|NCT05562011|536417605|FG000|Overall Study|Lost to Follow-up|1|||
148712037|NCT05562011|536417605|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
148712038|NCT05562011|536417605|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
148712039|NCT05562011|536417605|FG000|Overall Study|Device malfunction|13|||
148968359|NCT01604343|537370296|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
148968360|NCT01604343|537370297|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
148968361|NCT01604343|537370298|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
148968362|NCT01604343|537370299|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
148968363|NCT00850200|537370300|FG000|Overall Study|Physician Decision|2|||
148968364|NCT00850200|537370300|FG000|Overall Study|Did not recieve treatment|2|||
148968365|NCT00850200|537370300|FG000|Overall Study|Withdrawal by Subject|1|||
148968366|NCT00097721|537370301|FG000|Overall Study|Adverse Event|8|||
148968367|NCT00097721|537370302|FG001|Overall Study|Adverse Event|1|||
148968368|NCT00097721|537370301|FG000|Overall Study|Withdrawal by Subject|6|||
148968369|NCT00097721|537370302|FG001|Overall Study|Withdrawal by Subject|1|||
148968370|NCT00097721|537370301|FG000|Overall Study|Progressive Disease|55|||
148968371|NCT00097721|537370302|FG001|Overall Study|Progressive Disease|27|||
148968372|NCT00097721|537370301|FG000|Overall Study|Physician Decision|1|||
148968373|NCT00097721|537370302|FG001|Overall Study|Physician Decision|3|||
148968374|NCT00097721|537370301|FG000|Overall Study|Reason not given|1|||
148968375|NCT00097721|537370302|FG001|Overall Study|Reason not given|1|||
148968376|NCT02871375|537370306|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
148968377|NCT02871375|537370307|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
148968378|NCT04327999|537370314|FG000|Overall Study|Protocol Violation|1|||
148968379|NCT02872116|537370319|FG000|Pre-Treatment|Disease Progression|0|||
148968380|NCT02872116|537370320|FG001|Pre-Treatment|Disease Progression|1|||
148968381|NCT02872116|537370321|FG002|Pre-Treatment|Disease Progression|0|||
148968382|NCT02872116|537370319|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
148968383|NCT02872116|537370320|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
148968384|NCT02872116|537370321|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
148968385|NCT02872116|537370319|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
148968386|NCT02872116|537370320|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
148968387|NCT02872116|537370321|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
148968388|NCT02872116|537370319|FG000|Pre-Treatment|Participant withdrew consent|2|||
148968389|NCT02872116|537370320|FG001|Pre-Treatment|Participant withdrew consent|20|||
148968390|NCT02872116|537370321|FG002|Pre-Treatment|Participant withdrew consent|3|||
148968391|NCT02872116|537370319|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
148968392|NCT02872116|537370320|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
148968393|NCT02872116|537370321|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
148968394|NCT02872116|537370319|FG000|Pre-Treatment|Other reasons|1|||
148712040|NCT04411680|536417606|FG000|Treatment Period|Adverse Event|3|||
148712041|NCT04411680|536417607|FG001|Treatment Period|Adverse Event|0|||
148712042|NCT04411680|536417606|FG000|Treatment Period|Discharged from hospital|18|||
148712043|NCT04411680|536417607|FG001|Treatment Period|Discharged from hospital|7|||
148712044|NCT04411680|536417606|FG000|Treatment Period|Missed 1 or more doses|8|||
148712045|NCT04411680|536417607|FG001|Treatment Period|Missed 1 or more doses|0|||
148712046|NCT04411680|536417606|FG000|Treatment Period|Transferred to another hospital|0|||
148712047|NCT04411680|536417607|FG001|Treatment Period|Transferred to another hospital|1|||
148712048|NCT04411680|536417606|FG000|Follow up Period|Withdrawal by Subject|2|||
148712049|NCT04411680|536417607|FG001|Follow up Period|Withdrawal by Subject|0|||
148712050|NCT04411680|536417606|FG000|Follow up Period|Lost to Follow-up|5|||
148712051|NCT04411680|536417607|FG001|Follow up Period|Lost to Follow-up|6|||
148712052|NCT04411680|536417606|FG000|Follow up Period|Death|11|||
148712053|NCT04411680|536417607|FG001|Follow up Period|Death|8|||
148712054|NCT03101358|536417608|FG000|Overall Study|Non-compliance with study schedule|1|||
148712055|NCT03101358|536417609|FG001|Overall Study|Non-compliance with study schedule|0|||
148712056|NCT03101358|536417610|FG002|Overall Study|Non-compliance with study schedule|0|||
148712057|NCT03101358|536417611|FG003|Overall Study|Non-compliance with study schedule|1|||
148712058|NCT03101358|536417608|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
148712059|NCT03101358|536417609|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
148712060|NCT03101358|536417610|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
148712061|NCT03101358|536417611|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
148712062|NCT03101358|536417608|FG000|Overall Study|Physician Decision|1|||
148712063|NCT03101358|536417609|FG001|Overall Study|Physician Decision|0|||
148712064|NCT03101358|536417610|FG002|Overall Study|Physician Decision|0|||
148712065|NCT03101358|536417611|FG003|Overall Study|Physician Decision|3|||
148712066|NCT03101358|536417608|FG000|Overall Study|Adverse Event|0|||
148712067|NCT03101358|536417609|FG001|Overall Study|Adverse Event|0|||
148968395|NCT02872116|537370320|FG001|Pre-Treatment|Other reasons|2|||
148968396|NCT02872116|537370321|FG002|Pre-Treatment|Other reasons|2|||
148968397|NCT02872116|537370319|FG000|Treatment|Death|121|||
148968398|NCT02872116|537370320|FG001|Treatment|Death|94|||
148968399|NCT02872116|537370321|FG002|Treatment|Death|68|||
148968400|NCT02872116|537370319|FG000|Treatment|Lost to Follow-up|5|||
148712068|NCT03101358|536417610|FG002|Overall Study|Adverse Event|1|||
148712069|NCT03101358|536417611|FG003|Overall Study|Adverse Event|0|||
148712070|NCT03101358|536417608|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
148712071|NCT03101358|536417609|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
148712072|NCT03101358|536417610|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
148712073|NCT03101358|536417611|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
148712074|NCT03101358|536417608|FG000|Overall Study|Lost to Follow-up|1|||
148712075|NCT03101358|536417609|FG001|Overall Study|Lost to Follow-up|0|||
148712076|NCT03101358|536417610|FG002|Overall Study|Lost to Follow-up|0|||
148712077|NCT03101358|536417611|FG003|Overall Study|Lost to Follow-up|1|||
148712078|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
148712079|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
148712080|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
148712081|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
148712082|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
148712083|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
148712084|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
148712085|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
148712086|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
148712087|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
148712088|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
148712089|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
148712090|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
148712091|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
148712092|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
148712093|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
148712094|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
148712095|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
148712096|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
148712097|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
148712098|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
148712099|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
148712100|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
148712101|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
148712102|NCT00073307|536417618|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
148712103|NCT00073307|536417619|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
148712104|NCT00073307|536417620|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
148712105|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
148712106|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
148712107|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
148712108|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
148712109|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
148712110|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
148712111|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
148712112|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
148712113|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
148712114|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
148712115|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
148712116|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
148712117|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
148712118|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
148712119|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
148712120|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
148712121|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
148712122|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
148712123|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
148712124|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
148712125|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
148712126|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
148712127|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
148712128|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
148712129|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
148712130|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
148712131|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
148968401|NCT02872116|537370320|FG001|Treatment|Lost to Follow-up|7|||
148712132|NCT00073307|536417618|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
148712133|NCT00073307|536417619|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
148712134|NCT00073307|536417620|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
148712135|NCT01438060|536417621|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
148712136|NCT01438060|536417622|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
148712137|NCT01438060|536417621|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
148712138|NCT01438060|536417622|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
148712139|NCT01438060|536417621|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
148712140|NCT01438060|536417622|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
148712141|NCT01438060|536417621|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
148712142|NCT01438060|536417622|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
148712143|NCT01438060|536417621|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
148712144|NCT01438060|536417622|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
148712145|NCT01438060|536417621|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
148712146|NCT01438060|536417622|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
148712147|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
148712148|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
148712149|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
148712150|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
148712151|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
148712152|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
148712153|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
148712154|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
148712155|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
148712156|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
148712157|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
148712158|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
148712159|NCT01438060|536417621|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
148712160|NCT01438060|536417622|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
148712161|NCT01438060|536417621|FG000|On Study Beyond Week 140|Adverse Event|0|||
148712162|NCT01438060|536417622|FG001|On Study Beyond Week 140|Adverse Event|2|||
148712163|NCT01438060|536417621|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
148712164|NCT01438060|536417622|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
148712165|NCT01438060|536417621|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
148712166|NCT01438060|536417622|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
148712167|NCT01438060|536417621|FG000|On Study Beyond Week 140|Death|0|||
148712168|NCT01438060|536417622|FG001|On Study Beyond Week 140|Death|1|||
148712169|NCT01438060|536417621|FG000|On Study Beyond Week 140|Other Reason|0|||
148712170|NCT01438060|536417622|FG001|On Study Beyond Week 140|Other Reason|3|||
148712171|NCT04608448|536417623|FG000|Overall Study|Withdrawal by Subject|1|||
148712172|NCT04608448|536417623|FG000|Overall Study|Adverse Event|1|||
148712173|NCT01149057|536417624|FG000|Overall Study|Lack of Efficacy|16|||
148712174|NCT01149057|536417624|FG000|Overall Study|Adverse Event|13|||
148712175|NCT01149057|536417624|FG000|Overall Study|Withdrawal by Subject|9|||
148712176|NCT01149057|536417624|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
148712177|NCT01149057|536417624|FG000|Overall Study|B Cell Depletion|4|||
148712178|NCT01149057|536417624|FG000|Overall Study|Participant Non-Compliance|2|||
148712179|NCT01149057|536417624|FG000|Overall Study|Lost to Follow-up|1|||
148712180|NCT01149057|536417624|FG000|Overall Study|High Parathyroid Hormone Value|1|||
148712181|NCT01149057|536417624|FG000|Overall Study|Other|6|||
148712182|NCT03499873|536417625|FG000|Overall Study|Withdrawal by Subject|4|||
148712183|NCT03499873|536417626|FG001|Overall Study|Withdrawal by Subject|6|||
148712184|NCT03499873|536417627|FG002|Overall Study|Withdrawal by Subject|1|||
148712185|NCT03499873|536417625|FG000|Overall Study|Subjects condition worsened|0|||
148712186|NCT03499873|536417626|FG001|Overall Study|Subjects condition worsened|3|||
148712187|NCT03499873|536417627|FG002|Overall Study|Subjects condition worsened|11|||
148712188|NCT03499873|536417625|FG000|Overall Study|Adverse Event|8|||
148712189|NCT03499873|536417626|FG001|Overall Study|Adverse Event|3|||
148712190|NCT03499873|536417627|FG002|Overall Study|Adverse Event|6|||
148712191|NCT03499873|536417625|FG000|Overall Study|Physician Decision|1|||
148712192|NCT03499873|536417626|FG001|Overall Study|Physician Decision|0|||
148712193|NCT03499873|536417627|FG002|Overall Study|Physician Decision|0|||
148712194|NCT03499873|536417625|FG000|Overall Study|Administrative reasons|0|||
148712195|NCT03499873|536417626|FG001|Overall Study|Administrative reasons|1|||
148712196|NCT03499873|536417627|FG002|Overall Study|Administrative reasons|0|||
148712197|NCT03499873|536417625|FG000|Overall Study|Concomitant therapy|5|||
148712198|NCT03499873|536417626|FG001|Overall Study|Concomitant therapy|4|||
148712199|NCT03499873|536417627|FG002|Overall Study|Concomitant therapy|7|||
148712200|NCT03499873|536417625|FG000|Overall Study|Miscellaneous|1|||
148712201|NCT03499873|536417626|FG001|Overall Study|Miscellaneous|2|||
148712202|NCT03499873|536417627|FG002|Overall Study|Miscellaneous|2|||
148712203|NCT03499873|536417625|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
148968402|NCT02872116|537370321|FG002|Treatment|Lost to Follow-up|3|||
148968403|NCT02872116|537370319|FG000|Treatment|Participant withdrew consent|20|||
148968404|NCT02872116|537370320|FG001|Treatment|Participant withdrew consent|40|||
148968405|NCT02872116|537370321|FG002|Treatment|Participant withdrew consent|8|||
148968406|NCT02872116|537370319|FG000|Treatment|Other reasons|13|||
148968407|NCT02872116|537370320|FG001|Treatment|Other reasons|12|||
148968408|NCT02872116|537370321|FG002|Treatment|Other reasons|5|||
148968409|NCT02346136|537370322|FG000|Overall Study|Withdrawal by Subject|7|||
148968410|NCT02346136|537370323|FG001|Overall Study|Withdrawal by Subject|5|||
148968411|NCT02346136|537370322|FG000|Overall Study|Death|1|||
148968412|NCT02346136|537370323|FG001|Overall Study|Death|0|||
148968413|NCT02346136|537370322|FG000|Overall Study|Study termination|14|||
148968414|NCT02346136|537370323|FG001|Overall Study|Study termination|18|||
148968415|NCT01417481|537370339|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
148712204|NCT03499873|536417626|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
148712205|NCT03499873|536417627|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
148712206|NCT01964950|536417628|FG000|Overall Study|Protocol Violation|25|||
148712207|NCT01297504|536417629|FG000|Overall Study|Invalid Consent|1|||
148712208|NCT01297504|536417629|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
148712209|NCT01297504|536417629|FG000|Overall Study|No Study Visits|4|||
148712210|NCT01297504|536417629|FG000|Overall Study|Death|3|||
148712211|NCT01297504|536417629|FG000|Overall Study|Lost to Follow-up|43|||
148712212|NCT01297504|536417629|FG000|Overall Study|Withdrawal by Subject|9|||
148712213|NCT01297504|536417629|FG000|Overall Study|Site Closure|3|||
148712214|NCT01297504|536417629|FG000|Overall Study|Protocol Violation|3|||
148712215|NCT03602339|536417630|FG000|Overall Study|Withdrawal by Subject|9|||
148712216|NCT03602339|536417630|FG000|Overall Study|Physician Decision|2|||
148712217|NCT03602339|536417630|FG000|Overall Study|Other reason|4|||
148712218|NCT03306277|536417638|FG000|Overall Study|Death|1|||
148712219|NCT03306277|536417638|FG000|Overall Study|Adverse Event|1|||
148712220|NCT03306277|536417638|FG000|Overall Study|Withdrawal by Subject|1|||
148712221|NCT00829452|536417639|FG000|First Intervention|Withdrawal by Subject|0|||
148712222|NCT00829452|536417640|FG001|First Intervention|Withdrawal by Subject|1|||
148712223|NCT00829452|536417639|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
148712224|NCT00829452|536417640|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
148712225|NCT00829452|536417639|FG000|Second Intervention|Physician Decision|0|||
148712226|NCT00829452|536417640|FG001|Second Intervention|Physician Decision|1|||
148712227|NCT00881751|536417645|FG000|Overall Study|Physician Decision|0|||
148712228|NCT00881751|536417646|FG001|Overall Study|Physician Decision|1|||
148712229|NCT00881751|536417645|FG000|Overall Study|Adverse Event|0|||
148712230|NCT00881751|536417646|FG001|Overall Study|Adverse Event|2|||
148712231|NCT00881751|536417645|FG000|Overall Study|Withdrawal by Subject|0|||
148712232|NCT00881751|536417646|FG001|Overall Study|Withdrawal by Subject|2|||
148712233|NCT02436200|536417647|FG000|Overall Study|Significant outlier|1|||
148712234|NCT01559363|536417650|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
148712235|NCT01559363|536417651|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
148712236|NCT01559363|536417652|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
148712237|NCT01559363|536417653|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
148712238|NCT01559363|536417654|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
148712239|NCT01559363|536417655|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
148712240|NCT01559363|536417650|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
148712241|NCT01559363|536417651|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
148712242|NCT01559363|536417652|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
148712243|NCT01559363|536417653|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
148712244|NCT01559363|536417654|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
148712245|NCT01559363|536417655|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
148712246|NCT01559363|536417650|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
148712247|NCT01559363|536417651|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
148712248|NCT01559363|536417652|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
148712249|NCT01559363|536417653|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
148712250|NCT01559363|536417654|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
148712251|NCT01559363|536417655|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
148968416|NCT01417481|537370340|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
149025114|NCT00329303|537568022|FG001|Overall Study|Decision of the sponsor|1|||
148712252|NCT01559363|536417650|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
148712253|NCT01559363|536417651|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
148712254|NCT01559363|536417652|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
148712255|NCT01559363|536417653|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
148712256|NCT01559363|536417654|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
148712257|NCT01559363|536417655|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
148712258|NCT01559363|536417650|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
148712259|NCT01559363|536417651|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
148968417|NCT00829296|537370346|FG000|Overall Study|Adverse Event|5|||
148968418|NCT00829296|537370347|FG001|Overall Study|Adverse Event|4|||
148968419|NCT01907828|537370348|FG000|Overall Study|Exclusion criteria not met|0|||
148968420|NCT01907828|537370349|FG001|Overall Study|Exclusion criteria not met|1|||
148968421|NCT01907828|537370348|FG000|Overall Study|Withdrawal by Subject|3|||
148968422|NCT01907828|537370349|FG001|Overall Study|Withdrawal by Subject|4|||
148712260|NCT01559363|536417652|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
148712261|NCT01559363|536417653|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
148712262|NCT01559363|536417654|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
148712263|NCT01559363|536417655|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
148712264|NCT01559363|536417650|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
148712265|NCT01559363|536417651|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
148712266|NCT01559363|536417652|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
148712267|NCT01559363|536417653|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
148712268|NCT01559363|536417654|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
148712269|NCT01559363|536417655|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
148712270|NCT01559363|536417650|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
148712271|NCT01559363|536417651|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
148712272|NCT01559363|536417652|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
148712273|NCT01559363|536417653|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
148712274|NCT01559363|536417654|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
148712275|NCT01559363|536417655|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
148712276|NCT00957021|536417658|FG000|Overall Study|Death|5|||
148712277|NCT00957021|536417658|FG000|Overall Study|Lost to Follow-up|8|||
148712278|NCT00957021|536417658|FG000|Overall Study|Withdrawal by Subject|34|||
148712279|NCT00957021|536417658|FG000|Overall Study|No 2 yr ROM data|35|||
148712280|NCT00957021|536417658|FG000|Overall Study|Revised study component by 2 yr visit|8|||
148712281|NCT00957021|536417658|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
148712282|NCT00957021|536417658|FG000|Overall Study|Surgery Cancelled|9|||
148712283|NCT00957021|536417658|FG000|Overall Study|Termination due to language issue|2|||
148712284|NCT04060251|536417660|FG000|Overall Study|Study terminated due to low enrollment.|7|||
148712285|NCT04060251|536417661|FG001|Overall Study|Study terminated due to low enrollment.|5|||
148712286|NCT04060251|536417662|FG002|Overall Study|Study terminated due to low enrollment.|7|||
148712287|NCT04060251|536417660|FG000|Overall Study|Adverse Event|1|||
148712288|NCT04060251|536417661|FG001|Overall Study|Adverse Event|1|||
148712289|NCT04060251|536417662|FG002|Overall Study|Adverse Event|0|||
148712290|NCT00487435|536417663|FG000|Overall Study|Adverse Event|146|||
148712291|NCT00487435|536417663|FG000|Overall Study|Death|2|||
148712292|NCT00487435|536417663|FG000|Overall Study|Lack of Efficacy|33|||
148712293|NCT00487435|536417663|FG000|Overall Study|Lost to Follow-up|54|||
148712294|NCT00487435|536417663|FG000|Overall Study|Pregnancy|2|||
148712295|NCT00487435|536417663|FG000|Overall Study|Withdrawal by Subject|132|||
148712296|NCT00487435|536417663|FG000|Overall Study|Resolution Of Pain|1|||
148712297|NCT00487435|536417663|FG000|Overall Study|Study Medication Non-Compliant|32|||
148712298|NCT00487435|536417663|FG000|Overall Study|Other|83|||
148712299|NCT01155531|536417664|FG000|Overall Study|Adverse Event|0|||
148712300|NCT01155531|536417665|FG001|Overall Study|Adverse Event|0|||
148712301|NCT01155531|536417666|FG002|Overall Study|Adverse Event|1|||
148712302|NCT01155531|536417667|FG003|Overall Study|Adverse Event|0|||
148712303|NCT01155531|536417664|FG000|Overall Study|Lost to Follow-up|0|||
148712304|NCT01155531|536417665|FG001|Overall Study|Lost to Follow-up|0|||
148712305|NCT01155531|536417666|FG002|Overall Study|Lost to Follow-up|0|||
148712306|NCT01155531|536417667|FG003|Overall Study|Lost to Follow-up|1|||
148712307|NCT01155531|536417664|FG000|Overall Study|Withdrawal by Subject|1|||
148712308|NCT01155531|536417665|FG001|Overall Study|Withdrawal by Subject|0|||
148712309|NCT01155531|536417666|FG002|Overall Study|Withdrawal by Subject|1|||
148712310|NCT01155531|536417667|FG003|Overall Study|Withdrawal by Subject|0|||
148712311|NCT01087502|536417668|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
148712312|NCT01087502|536417669|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
148712313|NCT01087502|536417668|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
148712314|NCT01087502|536417669|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
148712315|NCT01087502|536417668|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
148815487|NCT00541229|536800540|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
148968423|NCT01907828|537370348|FG000|Overall Study|Lost to Follow-up|3|||
148968424|NCT01907828|537370349|FG001|Overall Study|Lost to Follow-up|0|||
148968425|NCT01907828|537370348|FG000|Overall Study|Participant refused 24-month follow-up|1|||
148968426|NCT01907828|537370349|FG001|Overall Study|Participant refused 24-month follow-up|0|||
148968427|NCT01907828|537370348|FG000|Overall Study|Participant met exclusion criteria|0|||
148712316|NCT01087502|536417669|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
148712317|NCT01087502|536417668|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
148712318|NCT01087502|536417669|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
148712319|NCT01087502|536417668|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
148968428|NCT01907828|537370349|FG001|Overall Study|Participant met exclusion criteria|1|||
148968429|NCT04960228|537370354|FG000|Overall Study|Withdrawal by Subject|216|||
148968430|NCT04960228|537370355|FG001|Overall Study|Withdrawal by Subject|35|||
148815488|NCT00541229|536800541|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
148712320|NCT01087502|536417669|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
148712321|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
148712322|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
148712323|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
148712324|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
148712325|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
148712326|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
148712327|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
148712328|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
148712329|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
148712330|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
148712331|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
148712332|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
148712333|NCT01087502|536417668|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
148712334|NCT01087502|536417669|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
148712335|NCT01653704|536417670|FG000|Overall Study|Technical failure during recording|1|||
148712336|NCT01653704|536417671|FG001|Overall Study|Technical failure during recording|1|||
148712337|NCT01653704|536417670|FG000|Overall Study|Performance not reflective of training|1|||
148712338|NCT01653704|536417671|FG001|Overall Study|Performance not reflective of training|0|||
148712339|NCT02705716|536417672|FG000|Overall Study|Adverse Event|0|||
148712340|NCT02705716|536417673|FG001|Overall Study|Adverse Event|1|||
148712341|NCT02705716|536417672|FG000|Overall Study|Protocol Violation|3|||
148712342|NCT02705716|536417673|FG001|Overall Study|Protocol Violation|0|||
148712343|NCT02705716|536417672|FG000|Overall Study|Withdrawal of Consent|1|||
148712344|NCT02705716|536417673|FG001|Overall Study|Withdrawal of Consent|1|||
148712345|NCT03966911|536417674|FG000|Overall Study|Adverse Event|1|||
148712346|NCT03966911|536417675|FG001|Overall Study|Adverse Event|1|||
148712347|NCT03966911|536417674|FG000|Overall Study|Withdrawal by Subject|8|||
148712348|NCT03966911|536417675|FG001|Overall Study|Withdrawal by Subject|2|||
148712349|NCT03966911|536417674|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
148712350|NCT03966911|536417675|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
148712351|NCT00985751|536417677|FG000|Overall Study|Adverse Event|0|||
148712352|NCT00985751|536417678|FG001|Overall Study|Adverse Event|0|||
148712353|NCT00985751|536417679|FG002|Overall Study|Adverse Event|0|||
148712354|NCT00985751|536417680|FG003|Overall Study|Adverse Event|0|||
148712355|NCT00985751|536417681|FG004|Overall Study|Adverse Event|1|||
148712356|NCT01663896|536417685|FG000|Overall Study|Various reasons|43|||
148712357|NCT01395017|536417686|FG000|Overall Study|Lost to Follow-up|1|||
148712358|NCT01395017|536417687|FG001|Overall Study|Lost to Follow-up|0|||
148712359|NCT01395017|536417686|FG000|Overall Study|Adverse Event|26|||
148712360|NCT01395017|536417687|FG001|Overall Study|Adverse Event|12|||
148712361|NCT01395017|536417686|FG000|Overall Study|Physician Decision|11|||
148712362|NCT01395017|536417687|FG001|Overall Study|Physician Decision|15|||
148712363|NCT01395017|536417686|FG000|Overall Study|Withdrawal by Subject|14|||
148712364|NCT01395017|536417687|FG001|Overall Study|Withdrawal by Subject|8|||
148712365|NCT01395017|536417686|FG000|Overall Study|Protocol deviation|1|||
148712366|NCT01395017|536417687|FG001|Overall Study|Protocol deviation|2|||
148712367|NCT01395017|536417686|FG000|Overall Study|Death|4|||
148712368|NCT01395017|536417687|FG001|Overall Study|Death|3|||
148712369|NCT01395017|536417686|FG000|Overall Study|Disease progression|42|||
148712370|NCT01395017|536417687|FG001|Overall Study|Disease progression|58|||
148712371|NCT01395017|536417686|FG000|Overall Study|Sponsor discontinued study|1|||
148712372|NCT01395017|536417687|FG001|Overall Study|Sponsor discontinued study|4|||
148712373|NCT00999687|536417689|FG000|First Intervention|Withdrawal by Subject|1|||
148712374|NCT00999687|536417689|FG000|Second Intervention|Withdrawal by Subject|2|||
148712375|NCT00999687|536417689|FG000|Second Intervention|Lack of Efficacy|1|||
148712376|NCT03727139|536417692|FG000|Overall Study|Protocol Violation|60|||
148712377|NCT03573544|536417693|FG000|Overall Study|Adverse Event|0|||
148815489|NCT00541229|536800542|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
148815490|NCT00541229|536800543|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
148712378|NCT03573544|536417694|FG001|Overall Study|Adverse Event|0|||
148712379|NCT03573544|536417695|FG002|Overall Study|Adverse Event|0|||
148712380|NCT03573544|536417696|FG003|Overall Study|Adverse Event|3|||
148712381|NCT03573544|536417697|FG004|Overall Study|Adverse Event|1|||
148712382|NCT03573544|536417698|FG005|Overall Study|Adverse Event|0|||
148712383|NCT03573544|536417699|FG006|Overall Study|Adverse Event|2|||
148712384|NCT03573544|536417700|FG007|Overall Study|Adverse Event|0|||
148712385|NCT03573544|536417693|FG000|Overall Study|Physician Decision|0|||
148712386|NCT03573544|536417694|FG001|Overall Study|Physician Decision|0|||
148712387|NCT03573544|536417695|FG002|Overall Study|Physician Decision|0|||
148712388|NCT03573544|536417696|FG003|Overall Study|Physician Decision|0|||
148712389|NCT03573544|536417697|FG004|Overall Study|Physician Decision|0|||
148712390|NCT03573544|536417698|FG005|Overall Study|Physician Decision|0|||
148712391|NCT03573544|536417699|FG006|Overall Study|Physician Decision|1|||
148712392|NCT03573544|536417700|FG007|Overall Study|Physician Decision|0|||
148712393|NCT03573544|536417693|FG000|Overall Study|Withdrawal by Subject|2|||
148712394|NCT03573544|536417694|FG001|Overall Study|Withdrawal by Subject|0|||
148712395|NCT03573544|536417695|FG002|Overall Study|Withdrawal by Subject|0|||
148712396|NCT03573544|536417696|FG003|Overall Study|Withdrawal by Subject|1|||
148712397|NCT03573544|536417697|FG004|Overall Study|Withdrawal by Subject|1|||
148712398|NCT03573544|536417698|FG005|Overall Study|Withdrawal by Subject|1|||
148712399|NCT03573544|536417699|FG006|Overall Study|Withdrawal by Subject|0|||
148712400|NCT03573544|536417700|FG007|Overall Study|Withdrawal by Subject|1|||
148712401|NCT03573544|536417693|FG000|Overall Study|Disease progression|3|||
148712402|NCT03573544|536417694|FG001|Overall Study|Disease progression|3|||
148712403|NCT03573544|536417695|FG002|Overall Study|Disease progression|6|||
148712404|NCT03573544|536417696|FG003|Overall Study|Disease progression|4|||
148712405|NCT03573544|536417697|FG004|Overall Study|Disease progression|5|||
148712406|NCT03573544|536417698|FG005|Overall Study|Disease progression|7|||
148712407|NCT03573544|536417699|FG006|Overall Study|Disease progression|6|||
148712408|NCT03573544|536417700|FG007|Overall Study|Disease progression|7|||
148712409|NCT01899053|536417701|FG000|Overall Study|Progressive Disease|4|||
148712410|NCT01899053|536417702|FG001|Overall Study|Progressive Disease|0|||
148712411|NCT01899053|536417703|FG002|Overall Study|Progressive Disease|3|||
148712412|NCT01899053|536417704|FG003|Overall Study|Progressive Disease|0|||
148712413|NCT01899053|536417705|FG004|Overall Study|Progressive Disease|3|||
148712414|NCT01899053|536417706|FG005|Overall Study|Progressive Disease|1|||
148712415|NCT01899053|536417707|FG006|Overall Study|Progressive Disease|1|||
148712416|NCT01899053|536417708|FG007|Overall Study|Progressive Disease|1|||
148712417|NCT01899053|536417709|FG008|Overall Study|Progressive Disease|4|||
148712418|NCT01899053|536417710|FG009|Overall Study|Progressive Disease|3|||
148712419|NCT01899053|536417711|FG010|Overall Study|Progressive Disease|12|||
148712420|NCT01899053|536417712|FG011|Overall Study|Progressive Disease|5|||
148712421|NCT01899053|536417713|FG012|Overall Study|Progressive Disease|8|||
148712422|NCT01899053|536417714|FG013|Overall Study|Progressive Disease|17|||
148712423|NCT01899053|536417701|FG000|Overall Study|Adverse Event|1|||
148712424|NCT01899053|536417702|FG001|Overall Study|Adverse Event|1|||
148712425|NCT01899053|536417703|FG002|Overall Study|Adverse Event|1|||
148712426|NCT01899053|536417704|FG003|Overall Study|Adverse Event|3|||
148712427|NCT01899053|536417705|FG004|Overall Study|Adverse Event|1|||
148712428|NCT01899053|536417706|FG005|Overall Study|Adverse Event|1|||
148712429|NCT01899053|536417707|FG006|Overall Study|Adverse Event|1|||
148712430|NCT01899053|536417708|FG007|Overall Study|Adverse Event|0|||
148712431|NCT01899053|536417709|FG008|Overall Study|Adverse Event|2|||
148712432|NCT01899053|536417710|FG009|Overall Study|Adverse Event|0|||
148712433|NCT01899053|536417711|FG010|Overall Study|Adverse Event|3|||
148712434|NCT01899053|536417712|FG011|Overall Study|Adverse Event|1|||
148712435|NCT01899053|536417713|FG012|Overall Study|Adverse Event|2|||
148712436|NCT01899053|536417714|FG013|Overall Study|Adverse Event|2|||
148712437|NCT01899053|536417701|FG000|Overall Study|Reason Not Specified|0|||
148712438|NCT01899053|536417702|FG001|Overall Study|Reason Not Specified|0|||
148712439|NCT01899053|536417703|FG002|Overall Study|Reason Not Specified|0|||
148712440|NCT01899053|536417704|FG003|Overall Study|Reason Not Specified|0|||
148712441|NCT01899053|536417705|FG004|Overall Study|Reason Not Specified|0|||
148712442|NCT01899053|536417706|FG005|Overall Study|Reason Not Specified|0|||
148712443|NCT01899053|536417707|FG006|Overall Study|Reason Not Specified|1|||
148712444|NCT01899053|536417708|FG007|Overall Study|Reason Not Specified|0|||
148712445|NCT01899053|536417709|FG008|Overall Study|Reason Not Specified|0|||
148712446|NCT01899053|536417710|FG009|Overall Study|Reason Not Specified|0|||
148712447|NCT01899053|536417711|FG010|Overall Study|Reason Not Specified|0|||
148712448|NCT01899053|536417712|FG011|Overall Study|Reason Not Specified|0|||
148712449|NCT01899053|536417713|FG012|Overall Study|Reason Not Specified|1|||
148712450|NCT01899053|536417714|FG013|Overall Study|Reason Not Specified|0|||
148712451|NCT01899053|536417701|FG000|Overall Study|Withdrawal by Subject|1|||
148712452|NCT01899053|536417702|FG001|Overall Study|Withdrawal by Subject|1|||
148712453|NCT01899053|536417703|FG002|Overall Study|Withdrawal by Subject|2|||
148712454|NCT01899053|536417704|FG003|Overall Study|Withdrawal by Subject|0|||
148712455|NCT01899053|536417705|FG004|Overall Study|Withdrawal by Subject|2|||
148712456|NCT01899053|536417706|FG005|Overall Study|Withdrawal by Subject|0|||
148712457|NCT01899053|536417707|FG006|Overall Study|Withdrawal by Subject|0|||
148712458|NCT01899053|536417708|FG007|Overall Study|Withdrawal by Subject|1|||
148712459|NCT01899053|536417709|FG008|Overall Study|Withdrawal by Subject|0|||
148712460|NCT01899053|536417710|FG009|Overall Study|Withdrawal by Subject|0|||
148712461|NCT01899053|536417711|FG010|Overall Study|Withdrawal by Subject|0|||
148712462|NCT01899053|536417712|FG011|Overall Study|Withdrawal by Subject|0|||
148712463|NCT01899053|536417713|FG012|Overall Study|Withdrawal by Subject|1|||
148712464|NCT01899053|536417714|FG013|Overall Study|Withdrawal by Subject|1|||
148712465|NCT01899053|536417701|FG000|Overall Study|Protocol Violation|0|||
148712466|NCT01899053|536417702|FG001|Overall Study|Protocol Violation|0|||
148712467|NCT01899053|536417703|FG002|Overall Study|Protocol Violation|1|||
148712468|NCT01899053|536417704|FG003|Overall Study|Protocol Violation|0|||
148815491|NCT00541229|536800544|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
148712469|NCT01899053|536417705|FG004|Overall Study|Protocol Violation|0|||
148712470|NCT01899053|536417706|FG005|Overall Study|Protocol Violation|0|||
148712471|NCT01899053|536417707|FG006|Overall Study|Protocol Violation|0|||
148712472|NCT01899053|536417708|FG007|Overall Study|Protocol Violation|0|||
148712473|NCT01899053|536417709|FG008|Overall Study|Protocol Violation|0|||
148712474|NCT01899053|536417710|FG009|Overall Study|Protocol Violation|0|||
148712475|NCT01899053|536417711|FG010|Overall Study|Protocol Violation|0|||
148712476|NCT01899053|536417712|FG011|Overall Study|Protocol Violation|0|||
148712477|NCT01899053|536417713|FG012|Overall Study|Protocol Violation|0|||
148712478|NCT01899053|536417714|FG013|Overall Study|Protocol Violation|0|||
148712479|NCT01899053|536417701|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
148712480|NCT01899053|536417702|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
148712481|NCT01899053|536417703|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712482|NCT01899053|536417704|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712483|NCT01899053|536417705|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712484|NCT01899053|536417706|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712485|NCT01899053|536417707|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712486|NCT01899053|536417708|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712487|NCT01899053|536417709|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712488|NCT01899053|536417710|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712489|NCT01899053|536417711|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
148712490|NCT01899053|536417712|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712491|NCT01899053|536417713|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712492|NCT01899053|536417714|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
148712493|NCT01899053|536417701|FG000|Overall Study|Symptomatic Deterioration|0|||
148712494|NCT01899053|536417702|FG001|Overall Study|Symptomatic Deterioration|0|||
148712495|NCT01899053|536417703|FG002|Overall Study|Symptomatic Deterioration|0|||
148712496|NCT01899053|536417704|FG003|Overall Study|Symptomatic Deterioration|0|||
148712497|NCT01899053|536417705|FG004|Overall Study|Symptomatic Deterioration|0|||
148712498|NCT01899053|536417706|FG005|Overall Study|Symptomatic Deterioration|1|||
148712499|NCT01899053|536417707|FG006|Overall Study|Symptomatic Deterioration|0|||
148712500|NCT01899053|536417708|FG007|Overall Study|Symptomatic Deterioration|1|||
148712501|NCT01899053|536417709|FG008|Overall Study|Symptomatic Deterioration|0|||
148712502|NCT01899053|536417710|FG009|Overall Study|Symptomatic Deterioration|0|||
148712503|NCT01899053|536417711|FG010|Overall Study|Symptomatic Deterioration|0|||
148712504|NCT01899053|536417712|FG011|Overall Study|Symptomatic Deterioration|1|||
148712505|NCT01899053|536417713|FG012|Overall Study|Symptomatic Deterioration|2|||
148712506|NCT01899053|536417714|FG013|Overall Study|Symptomatic Deterioration|0|||
148712507|NCT03105297|536417715|FG000|Baseline Phase (Day 1)|Other|21|||
148712508|NCT03105297|536417715|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
148712509|NCT03105297|536417715|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
148712510|NCT03846193|536417717|FG000|Overall Study|Physician Decision|0|||
148712511|NCT03846193|536417718|FG001|Overall Study|Physician Decision|0|||
148712512|NCT03846193|536417719|FG002|Overall Study|Physician Decision|1|||
148712513|NCT03846193|536417720|FG003|Overall Study|Physician Decision|0|||
148712514|NCT03846193|536417721|FG004|Overall Study|Physician Decision|0|||
148712515|NCT03846193|536417717|FG000|Overall Study|Lost to Follow-up|0|||
148712516|NCT03846193|536417718|FG001|Overall Study|Lost to Follow-up|0|||
148712517|NCT03846193|536417719|FG002|Overall Study|Lost to Follow-up|0|||
148712518|NCT03846193|536417720|FG003|Overall Study|Lost to Follow-up|0|||
148712519|NCT03846193|536417721|FG004|Overall Study|Lost to Follow-up|1|||
148712520|NCT03846193|536417717|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
148712521|NCT03846193|536417718|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
148712522|NCT03846193|536417719|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
148712523|NCT03846193|536417720|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
148712524|NCT03846193|536417721|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
148712525|NCT03867760|536417725|FG000|Overall Study|Lost to Follow-up|2|||
148712526|NCT03867760|536417726|FG001|Overall Study|Lost to Follow-up|3|||
148815492|NCT00541229|536800539|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
148815493|NCT00541229|536800540|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
148815494|NCT00541229|536800541|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
148815495|NCT00541229|536800542|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
148815496|NCT00541229|536800543|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
148815497|NCT00541229|536800544|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
148815498|NCT00541229|536800539|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
148815499|NCT00541229|536800540|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
148815500|NCT00541229|536800541|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
148815501|NCT00541229|536800542|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
148815502|NCT00541229|536800543|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
148815503|NCT00541229|536800544|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
148712527|NCT03867760|536417725|FG000|Overall Study|Withdrawal by Subject|1|||
148712528|NCT03867760|536417726|FG001|Overall Study|Withdrawal by Subject|2|||
148815504|NCT00541229|536800539|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
148712529|NCT03867760|536417725|FG000|Overall Study|subject could not meet study logistics|3|||
148712530|NCT03867760|536417726|FG001|Overall Study|subject could not meet study logistics|3|||
148712531|NCT01073631|536417727|FG000|Overall Study|Death|82|||
148712532|NCT01073631|536417727|FG000|Overall Study|Adverse Event|24|||
148712533|NCT01073631|536417727|FG000|Overall Study|Other|63|||
148712534|NCT01401062|536417732|FG000|Overall Study|Death|9|||
148712535|NCT01401062|536417733|FG001|Overall Study|Death|7|||
148712536|NCT01401062|536417732|FG000|Overall Study|Physician Decision|1|||
148712537|NCT01401062|536417733|FG001|Overall Study|Physician Decision|0|||
148712538|NCT01401062|536417732|FG000|Overall Study|Withdrawal by Subject|1|||
148712539|NCT01401062|536417733|FG001|Overall Study|Withdrawal by Subject|1|||
148712540|NCT01131260|536417734|FG000|Overall Study|Randomization error|5|||
148712541|NCT01131260|536417735|FG001|Overall Study|Randomization error|1|||
148712542|NCT01131260|536417734|FG000|Overall Study|Declined to continue participation|8|||
148712543|NCT01131260|536417735|FG001|Overall Study|Declined to continue participation|13|||
148712544|NCT01131260|536417734|FG000|Overall Study|Physician Decision|22|||
148712545|NCT01131260|536417735|FG001|Overall Study|Physician Decision|24|||
148712546|NCT01131260|536417734|FG000|Overall Study|Technical problems|7|||
148712547|NCT01131260|536417735|FG001|Overall Study|Technical problems|6|||
148712548|NCT01131260|536417734|FG000|Overall Study|Staff error|2|||
148712549|NCT01131260|536417735|FG001|Overall Study|Staff error|1|||
148712550|NCT01131260|536417734|FG000|Overall Study|Ineligible|0|||
148712551|NCT01131260|536417735|FG001|Overall Study|Ineligible|2|||
148712552|NCT03684928|536417741|FG000|First Intervention|Lost to Follow-up|0|||
148712553|NCT03684928|536417742|FG001|First Intervention|Lost to Follow-up|1|||
148712554|NCT03684928|536417741|FG000|First Intervention|Withdrawal by Subject|0|||
148712555|NCT03684928|536417742|FG001|First Intervention|Withdrawal by Subject|2|||
148712556|NCT03684928|536417741|FG000|Second Intervention|Soft Tissue Injury|1|||
148712557|NCT03684928|536417742|FG001|Second Intervention|Soft Tissue Injury|0|||
148712558|NCT00874276|536417743|FG000|Overall Study|Withdrawal by Subject|1|||
148712559|NCT00874276|536417744|FG001|Overall Study|Withdrawal by Subject|1|||
148712560|NCT03733145|536417745|FG000|Overall Study|screenfail|3|||
148712561|NCT03733145|536417746|FG001|Overall Study|screenfail|3|||
148712562|NCT03733145|536417747|FG002|Overall Study|screenfail|2|||
148712563|NCT00660387|536419320|FG000|Overall Study|Adverse Event|1|||
148712564|NCT00660387|536419321|FG001|Overall Study|Adverse Event|2|||
148712565|NCT00660387|536419320|FG000|Overall Study|Lack of Efficacy|0|||
148712566|NCT00660387|536419321|FG001|Overall Study|Lack of Efficacy|1|||
148712567|NCT00660387|536419320|FG000|Overall Study|Protocol Violation|1|||
148712568|NCT00660387|536419321|FG001|Overall Study|Protocol Violation|0|||
148712569|NCT01622660|536419322|FG000|Overall Study|Adverse Event|1|||
148712570|NCT02259348|536419323|FG000|Overall Study|Donors|6|||
148712571|NCT02259348|536419323|FG000|Overall Study|Death|4|||
148712572|NCT02583048|536419324|FG000|Overall Study|Withdrawal by Subject|0|||
148712573|NCT02583048|536419325|FG001|Overall Study|Withdrawal by Subject|1|||
148712574|NCT02583048|536419326|FG002|Overall Study|Withdrawal by Subject|0|||
148712575|NCT02583048|536419324|FG000|Overall Study|Failed to meet eligibility criterion|0|||
148712576|NCT02583048|536419325|FG001|Overall Study|Failed to meet eligibility criterion|0|||
148712577|NCT02583048|536419326|FG002|Overall Study|Failed to meet eligibility criterion|1|||
148712578|NCT00516295|536419330|FG000|Overall Study|Lack of Efficacy|2|||
148712579|NCT00516295|536419331|FG001|Overall Study|Lack of Efficacy|0|||
148712580|NCT00516295|536419332|FG002|Overall Study|Lack of Efficacy|0|||
148712581|NCT00516295|536419330|FG000|Overall Study|Ineligible|1|||
148712582|NCT00516295|536419331|FG001|Overall Study|Ineligible|0|||
148712583|NCT00516295|536419332|FG002|Overall Study|Ineligible|0|||
148712584|NCT02034513|536419333|FG000|Overall Study|Adverse Event|11|||
148712585|NCT02034513|536419334|FG001|Overall Study|Adverse Event|10|||
148712586|NCT02034513|536419333|FG000|Overall Study|Lack of Efficacy|0|||
148712587|NCT02034513|536419334|FG001|Overall Study|Lack of Efficacy|1|||
148712588|NCT02034513|536419333|FG000|Overall Study|Lost to Follow-up|6|||
148712589|NCT02034513|536419334|FG001|Overall Study|Lost to Follow-up|7|||
148712590|NCT02034513|536419333|FG000|Overall Study|Pregnancy|0|||
148712591|NCT02034513|536419334|FG001|Overall Study|Pregnancy|3|||
148712592|NCT02034513|536419333|FG000|Overall Study|Protocol Violation|7|||
148712593|NCT02034513|536419334|FG001|Overall Study|Protocol Violation|10|||
148712594|NCT02034513|536419333|FG000|Overall Study|Withdrawal by Subject|25|||
148712595|NCT02034513|536419334|FG001|Overall Study|Withdrawal by Subject|25|||
148712596|NCT02034513|536419333|FG000|Overall Study|Unclassified|0|||
148712597|NCT02034513|536419334|FG001|Overall Study|Unclassified|1|||
148712598|NCT00960154|536419335|FG000|Overall Study|Study termination|25|||
148815505|NCT00541229|536800540|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
148815506|NCT00541229|536800541|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
148815507|NCT00541229|536800542|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
148815508|NCT00541229|536800543|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
148815509|NCT00541229|536800544|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
148815510|NCT00541229|536800539|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
148815511|NCT00541229|536800540|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
148815512|NCT00541229|536800541|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
148712599|NCT00960154|536419336|FG001|Overall Study|Study termination|25|||
148712600|NCT04661202|536419340|FG000|Overall Study|Withdrawal by Subject|1|||
148712601|NCT04661202|536419341|FG001|Overall Study|Withdrawal by Subject|1|||
148712602|NCT04661202|536419340|FG000|Overall Study|Lack of Efficacy|2|||
148712603|NCT04661202|536419341|FG001|Overall Study|Lack of Efficacy|0|||
148712604|NCT02578641|536419342|FG000|Overall Study|Adverse Event|5|||
148712605|NCT02578641|536419343|FG001|Overall Study|Adverse Event|15|||
148712606|NCT02578641|536419342|FG000|Overall Study|Death|16|||
148712607|NCT02578641|536419343|FG001|Overall Study|Death|8|||
148712608|NCT02578641|536419342|FG000|Overall Study|Lost to Follow-up|0|||
148712609|NCT02578641|536419343|FG001|Overall Study|Lost to Follow-up|1|||
148712610|NCT02578641|536419342|FG000|Overall Study|Withdrawal by Subject|14|||
148712611|NCT02578641|536419343|FG001|Overall Study|Withdrawal by Subject|7|||
148712612|NCT02578641|536419342|FG000|Overall Study|Progressive Disease|69|||
148712613|NCT02578641|536419343|FG001|Overall Study|Progressive Disease|21|||
148712614|NCT02578641|536419342|FG000|Overall Study|No Study Drug|2|||
148712615|NCT02578641|536419343|FG001|Overall Study|No Study Drug|0|||
148712616|NCT02578641|536419342|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
148712617|NCT02578641|536419343|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
148712618|NCT02578641|536419342|FG000|Overall Study|Non-compliance with Study Schedule|1|||
148712619|NCT02578641|536419343|FG001|Overall Study|Non-compliance with Study Schedule|0|||
148712620|NCT02578641|536419342|FG000|Overall Study|Other|1|||
148712621|NCT02578641|536419343|FG001|Overall Study|Other|10|||
148712622|NCT02578641|536419342|FG000|Overall Study|Not treated|1|||
148712623|NCT02578641|536419343|FG001|Overall Study|Not treated|4|||
148712624|NCT02313558|536419344|FG000|Overall Study|Withdrawal by Subject|2|||
148712625|NCT02313558|536419345|FG001|Overall Study|Withdrawal by Subject|0|||
148712626|NCT02313558|536419344|FG000|Overall Study|Lost to Follow-up|4|||
148712627|NCT02313558|536419345|FG001|Overall Study|Lost to Follow-up|4|||
148712628|NCT01513239|536419350|FG000|Period 1: Main Phase|Adverse Event|1|||
148712629|NCT01513239|536419351|FG001|Period 1: Main Phase|Adverse Event|1|||
148712630|NCT01513239|536419352|FG002|Period 1: Main Phase|Adverse Event|2|||
148712631|NCT01513239|536419353|FG003|Period 1: Main Phase|Adverse Event|0|||
148712632|NCT01513239|536419354|FG004|Period 1: Main Phase|Adverse Event|0|||
148712633|NCT01513239|536419355|FG005|Period 1: Main Phase|Adverse Event|0|||
148712634|NCT01513239|536419350|FG000|Period 1: Main Phase|Death|29|||
148712635|NCT01513239|536419351|FG001|Period 1: Main Phase|Death|22|||
148712636|NCT01513239|536419352|FG002|Period 1: Main Phase|Death|32|||
148712637|NCT01513239|536419353|FG003|Period 1: Main Phase|Death|0|||
148712638|NCT01513239|536419354|FG004|Period 1: Main Phase|Death|0|||
148712639|NCT01513239|536419355|FG005|Period 1: Main Phase|Death|0|||
148712640|NCT01513239|536419350|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
148712641|NCT01513239|536419351|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
148712642|NCT01513239|536419352|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
148712643|NCT01513239|536419353|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
148712644|NCT01513239|536419354|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
148712645|NCT01513239|536419355|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
148712646|NCT01513239|536419350|FG000|Period 1: Main Phase|Physician Decision|4|||
148712647|NCT01513239|536419351|FG001|Period 1: Main Phase|Physician Decision|4|||
148712648|NCT01513239|536419352|FG002|Period 1: Main Phase|Physician Decision|4|||
148712649|NCT01513239|536419353|FG003|Period 1: Main Phase|Physician Decision|0|||
148712650|NCT01513239|536419354|FG004|Period 1: Main Phase|Physician Decision|0|||
148712651|NCT01513239|536419355|FG005|Period 1: Main Phase|Physician Decision|0|||
148712652|NCT01513239|536419350|FG000|Period 1: Main Phase|Protocol Violation|2|||
148712653|NCT01513239|536419351|FG001|Period 1: Main Phase|Protocol Violation|2|||
148712654|NCT01513239|536419352|FG002|Period 1: Main Phase|Protocol Violation|2|||
148712655|NCT01513239|536419353|FG003|Period 1: Main Phase|Protocol Violation|0|||
148712656|NCT01513239|536419354|FG004|Period 1: Main Phase|Protocol Violation|0|||
148712657|NCT01513239|536419355|FG005|Period 1: Main Phase|Protocol Violation|0|||
148712658|NCT01513239|536419350|FG000|Period 1: Main Phase|Technical Problems|1|||
148712659|NCT01513239|536419351|FG001|Period 1: Main Phase|Technical Problems|2|||
148712660|NCT01513239|536419352|FG002|Period 1: Main Phase|Technical Problems|0|||
148712661|NCT01513239|536419353|FG003|Period 1: Main Phase|Technical Problems|0|||
148712662|NCT01513239|536419354|FG004|Period 1: Main Phase|Technical Problems|0|||
148712663|NCT01513239|536419355|FG005|Period 1: Main Phase|Technical Problems|0|||
148712664|NCT01513239|536419350|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
148712665|NCT01513239|536419351|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
148712666|NCT01513239|536419352|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
148712667|NCT01513239|536419353|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
148712668|NCT01513239|536419354|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
148815513|NCT00541229|536800542|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
148712669|NCT01513239|536419355|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
148712670|NCT01513239|536419350|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
148712671|NCT01513239|536419351|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
148712672|NCT01513239|536419352|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
148712673|NCT01513239|536419353|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
148712674|NCT01513239|536419354|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
148712675|NCT01513239|536419355|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
148712676|NCT01513239|536419350|FG000|Period 2: 9 Month Extension Phase|Death|0|||
148712677|NCT01513239|536419351|FG001|Period 2: 9 Month Extension Phase|Death|0|||
148712678|NCT01513239|536419352|FG002|Period 2: 9 Month Extension Phase|Death|0|||
148712679|NCT01513239|536419353|FG003|Period 2: 9 Month Extension Phase|Death|2|||
148712680|NCT01513239|536419354|FG004|Period 2: 9 Month Extension Phase|Death|5|||
148712681|NCT01513239|536419355|FG005|Period 2: 9 Month Extension Phase|Death|2|||
148712682|NCT01513239|536419350|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
148712683|NCT01513239|536419351|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
148712684|NCT01513239|536419352|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
148815514|NCT00541229|536800543|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
148815515|NCT00541229|536800544|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
148815516|NCT00541229|536800539|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
148815517|NCT00541229|536800540|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
148815518|NCT00541229|536800541|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
148815519|NCT00541229|536800542|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
148815520|NCT00541229|536800543|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
148815521|NCT00541229|536800544|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
148815522|NCT00541229|536800539|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
148815523|NCT00541229|536800540|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
148815524|NCT00541229|536800541|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
148815525|NCT00541229|536800542|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
148815526|NCT00541229|536800543|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
148815527|NCT00541229|536800544|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
148815528|NCT00541229|536800539|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
148815529|NCT00541229|536800540|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
148815530|NCT00541229|536800541|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
148815531|NCT00541229|536800542|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
148815532|NCT00541229|536800543|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
148815533|NCT00541229|536800544|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
148815534|NCT00541229|536800539|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
148815535|NCT00541229|536800540|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
148815536|NCT00541229|536800541|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
148815537|NCT00541229|536800542|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
148815538|NCT00541229|536800543|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
148815539|NCT00541229|536800544|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
148815540|NCT03807843|536800545|FG000|Overall Study|Lost to Follow-up|1|||
148815541|NCT03807843|536800546|FG001|Overall Study|Lost to Follow-up|0|||
148815542|NCT01312129|536800547|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
148815543|NCT01312129|536800548|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
148815544|NCT03720847|536800549|FG000|Washout|Physician Decision|1|||
148815545|NCT03720847|536800550|FG001|Washout|Physician Decision|2|||
148815546|NCT00924651|536800553|FG000|Overall Study|Chemo started too soon|2|||
148815547|NCT00924651|536800554|FG001|Overall Study|Chemo started too soon|3|||
148815548|NCT00924651|536800553|FG000|Overall Study|No Reason|3|||
148815549|NCT00924651|536800554|FG001|Overall Study|No Reason|7|||
148815550|NCT00924651|536800553|FG000|Overall Study|Overwhelmed|6|||
148815551|NCT00924651|536800554|FG001|Overall Study|Overwhelmed|6|||
148815552|NCT00924651|536800553|FG000|Overall Study|Noncompliant|1|||
148815553|NCT00924651|536800554|FG001|Overall Study|Noncompliant|4|||
148815554|NCT00924651|536800553|FG000|Overall Study|Medical|1|||
148815555|NCT00924651|536800554|FG001|Overall Study|Medical|3|||
148815556|NCT00924651|536800553|FG000|Overall Study|Changed Mind|10|||
148815557|NCT00924651|536800554|FG001|Overall Study|Changed Mind|1|||
148815558|NCT00924651|536800553|FG000|Overall Study|Incomplete Form|2|||
148815559|NCT00924651|536800554|FG001|Overall Study|Incomplete Form|1|||
148815560|NCT02506036|536800555|FG000|First Intervention (4-6 Weeks)|Death|1|||
148815561|NCT02506036|536800556|FG001|First Intervention (4-6 Weeks)|Death|0|||
148815562|NCT02506036|536800555|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
148815563|NCT02506036|536800556|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
148815564|NCT02506036|536800555|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
148815565|NCT02506036|536800556|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
148815566|NCT01178411|536800557|FG000|Overall Study|Adverse Event|5|||
148712685|NCT01513239|536419353|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
148712686|NCT01513239|536419354|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
148712687|NCT01513239|536419355|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
148712688|NCT01513239|536419350|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
148815567|NCT01178411|536800557|FG000|Overall Study|Withdrawal by Subject|4|||
148815568|NCT01178411|536800557|FG000|Overall Study|Protocol Violation|1|||
148815569|NCT01178411|536800557|FG000|Overall Study|Progressive disease per RECIST|32|||
148712689|NCT01513239|536419351|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
148712690|NCT01513239|536419352|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
148712691|NCT01513239|536419353|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
148712692|NCT01513239|536419354|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
148712693|NCT01513239|536419355|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
148712694|NCT01513239|536419350|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
148712695|NCT01513239|536419351|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
148712696|NCT01513239|536419352|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
148712697|NCT01513239|536419353|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
148712698|NCT01513239|536419354|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
148712699|NCT01513239|536419355|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
148712700|NCT00396162|536419356|FG000|Overall Study|Withdrawal by Subject|2|||
148712701|NCT00396162|536419357|FG001|Overall Study|Withdrawal by Subject|3|||
148712702|NCT02694536|536419361|FG000|Overall Study|Progressive Disease|40|||
148712703|NCT02694536|536419361|FG000|Overall Study|Lost to Follow-up|1|||
148712704|NCT02694536|536419361|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
148712705|NCT02694536|536419361|FG000|Overall Study|Withdrawal by Subject|8|||
148712706|NCT02694536|536419361|FG000|Overall Study|Death|8|||
148712707|NCT02694536|536419361|FG000|Overall Study|Other|22|||
148712708|NCT01911429|536419362|FG000|Overall Study|Adverse Event|5|||
148712709|NCT01911429|536419363|FG001|Overall Study|Adverse Event|3|||
148712710|NCT01911429|536419364|FG002|Overall Study|Adverse Event|9|||
148712711|NCT01911429|536419362|FG000|Overall Study|Lack of Efficacy|1|||
148712712|NCT01911429|536419363|FG001|Overall Study|Lack of Efficacy|2|||
148712713|NCT01911429|536419364|FG002|Overall Study|Lack of Efficacy|4|||
148712714|NCT01911429|536419362|FG000|Overall Study|Lost to Follow-up|0|||
148712715|NCT01911429|536419363|FG001|Overall Study|Lost to Follow-up|0|||
148712716|NCT01911429|536419364|FG002|Overall Study|Lost to Follow-up|1|||
148712717|NCT01911429|536419362|FG000|Overall Study|Protocol Violation|0|||
148712718|NCT01911429|536419363|FG001|Overall Study|Protocol Violation|0|||
148712719|NCT01911429|536419364|FG002|Overall Study|Protocol Violation|1|||
148712720|NCT01911429|536419362|FG000|Overall Study|Withdrawal by Subject|5|||
148712721|NCT01911429|536419363|FG001|Overall Study|Withdrawal by Subject|5|||
148712722|NCT01911429|536419364|FG002|Overall Study|Withdrawal by Subject|4|||
148712723|NCT01911429|536419362|FG000|Overall Study|Accidental randomization|0|||
148712724|NCT01911429|536419363|FG001|Overall Study|Accidental randomization|0|||
148712725|NCT01911429|536419364|FG002|Overall Study|Accidental randomization|1|||
148712726|NCT01911429|536419362|FG000|Overall Study|subject left study|1|||
148712727|NCT01911429|536419363|FG001|Overall Study|subject left study|0|||
148712728|NCT01911429|536419364|FG002|Overall Study|subject left study|0|||
148712729|NCT01634139|536419367|FG000|Overall Study|Non compliant with protocol|1|||
148712730|NCT01634139|536419368|FG001|Overall Study|Non compliant with protocol|0|||
148712731|NCT01634139|536419369|FG002|Overall Study|Non compliant with protocol|0|||
148712732|NCT01634139|536419367|FG000|Overall Study|Consent withdrawn not due to AE|4|||
148712733|NCT01634139|536419368|FG001|Overall Study|Consent withdrawn not due to AE|3|||
148712734|NCT01634139|536419369|FG002|Overall Study|Consent withdrawn not due to AE|2|||
148815570|NCT01178411|536800557|FG000|Overall Study|Progressive disease per clinician|9|||
148815571|NCT01178411|536800557|FG000|Overall Study|Physician Decision|6|||
148815572|NCT01178411|536800557|FG000|Overall Study|Death|1|||
148815573|NCT01178411|536800557|FG000|Overall Study|No reason provided|1|||
148815574|NCT01178411|536800557|FG000|Overall Study|Drug manufacturing ended|1|||
148815575|NCT02383173|536800561|FG000|Overall Study|Palliative Care Team withdrew|0|||
148712735|NCT01634139|536419367|FG000|Overall Study|Other|4|||
148712736|NCT01634139|536419368|FG001|Overall Study|Other|0|||
148712737|NCT01634139|536419369|FG002|Overall Study|Other|3|||
148712738|NCT01634139|536419367|FG000|Overall Study|Lost to Follow-up|0|||
148712739|NCT01634139|536419368|FG001|Overall Study|Lost to Follow-up|2|||
148712740|NCT01634139|536419369|FG002|Overall Study|Lost to Follow-up|0|||
148712741|NCT01634139|536419367|FG000|Overall Study|Not treated|1|||
148712742|NCT01634139|536419368|FG001|Overall Study|Not treated|1|||
148712743|NCT01634139|536419369|FG002|Overall Study|Not treated|0|||
148712744|NCT04567329|536419374|FG000|Overall Study|Withdrawal by Subject|5|||
148712745|NCT04567329|536419375|FG001|Overall Study|Withdrawal by Subject|6|||
148712746|NCT04567329|536419374|FG000|Overall Study|Protocol Violation|2|||
148712747|NCT04567329|536419375|FG001|Overall Study|Protocol Violation|3|||
148712748|NCT04567329|536419374|FG000|Overall Study|Discontinued|2|||
148712749|NCT04567329|536419375|FG001|Overall Study|Discontinued|2|||
148712750|NCT04567329|536419374|FG000|Overall Study|Lost to Follow-up|0|||
148712751|NCT04567329|536419375|FG001|Overall Study|Lost to Follow-up|1|||
148712752|NCT04567329|536419374|FG000|Overall Study|Lack of Efficacy|0|||
148712753|NCT04567329|536419375|FG001|Overall Study|Lack of Efficacy|1|||
148712754|NCT02933060|536419376|FG000|Overall Study|Withdrawal by Subject|0|||
148712755|NCT02933060|536419377|FG001|Overall Study|Withdrawal by Subject|1|||
148712756|NCT05034874|536419380|FG000|Overall Study|Withdrawal by Subject|6|||
148712757|NCT05034874|536419381|FG001|Overall Study|Withdrawal by Subject|6|||
148712758|NCT05034874|536419380|FG000|Overall Study|Lost to Follow-up|18|||
148712759|NCT05034874|536419381|FG001|Overall Study|Lost to Follow-up|8|||
148968431|NCT04960228|537370354|FG000|Overall Study|Failed attention check|69|||
148968432|NCT04960228|537370355|FG001|Overall Study|Failed attention check|148|||
148712760|NCT05034874|536419380|FG000|Overall Study|Physician Decision|0|||
148712761|NCT05034874|536419381|FG001|Overall Study|Physician Decision|1|||
148712762|NCT05034874|536419380|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
148712763|NCT05034874|536419381|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
148712764|NCT02640235|536419382|FG000|Overall Study|Withdrawal by Subject|7|||
148712765|NCT02640235|536419383|FG001|Overall Study|Withdrawal by Subject|6|||
148712766|NCT02640235|536419382|FG000|Overall Study|Lost to Follow-up|4|||
148712767|NCT02640235|536419383|FG001|Overall Study|Lost to Follow-up|3|||
148712768|NCT02640235|536419382|FG000|Overall Study|Death|2|||
148712769|NCT02640235|536419383|FG001|Overall Study|Death|3|||
148712770|NCT02640235|536419382|FG000|Overall Study|Other|1|||
148712771|NCT02640235|536419383|FG001|Overall Study|Other|2|||
148712772|NCT00841659|536419384|FG000|Washout: 2 Weeks|Protocol Violation|1|||
148712773|NCT00841659|536419385|FG001|Washout: 2 Weeks|Protocol Violation|0|||
148712774|NCT02420353|536419392|FG000|Overall Study|Withdrawal by Subject|0|||
148712775|NCT02420353|536419393|FG001|Overall Study|Withdrawal by Subject|1|||
148712776|NCT00654186|536419394|FG000|Overall Study|Withdrawal by Subject|5|||
148712777|NCT01024855|536419395|FG000|Overall Study|Inclusion/exclusion criteria|1|||
148712778|NCT01968551|536419409|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
148712779|NCT01968551|536419410|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
148712780|NCT01968551|536419411|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
148712781|NCT01968551|536419409|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
148712782|NCT01968551|536419410|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
148712783|NCT01968551|536419411|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
148712784|NCT01968551|536419409|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
148712785|NCT01968551|536419410|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
148712786|NCT01968551|536419411|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
148712787|NCT01968551|536419409|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
148712788|NCT01968551|536419410|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
148712789|NCT01968551|536419411|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
148712790|NCT01968551|536419409|FG000|Extension Phase|Adverse Event|0|||
148712791|NCT01968551|536419410|FG001|Extension Phase|Adverse Event|0|||
148712792|NCT01968551|536419411|FG002|Extension Phase|Adverse Event|2|||
148712793|NCT01968551|536419409|FG000|Extension Phase|Death|0|||
148712794|NCT01968551|536419410|FG001|Extension Phase|Death|1|||
148712795|NCT01968551|536419411|FG002|Extension Phase|Death|0|||
148712796|NCT01968551|536419409|FG000|Extension Phase|Withdrew Consent|0|||
148712797|NCT01968551|536419410|FG001|Extension Phase|Withdrew Consent|0|||
148712798|NCT01968551|536419411|FG002|Extension Phase|Withdrew Consent|1|||
148712799|NCT01968551|536419409|FG000|Extension Phase|Lost to Follow-up|1|||
148712800|NCT01968551|536419410|FG001|Extension Phase|Lost to Follow-up|0|||
148712801|NCT01968551|536419411|FG002|Extension Phase|Lost to Follow-up|1|||
148712802|NCT00819169|536419412|FG000|Overall Study|Withdrawal by Subject|2|||
148712803|NCT00819169|536419413|FG001|Overall Study|Withdrawal by Subject|0|||
148712804|NCT00819169|536419414|FG002|Overall Study|Withdrawal by Subject|0|||
148712805|NCT00819169|536419415|FG003|Overall Study|Withdrawal by Subject|1|||
148712806|NCT00819169|536419416|FG004|Overall Study|Withdrawal by Subject|1|||
148712807|NCT00819169|536419417|FG005|Overall Study|Withdrawal by Subject|1|||
148712808|NCT00819169|536419418|FG006|Overall Study|Withdrawal by Subject|5|||
148712809|NCT00819169|536419419|FG007|Overall Study|Withdrawal by Subject|1|||
148712810|NCT00819169|536419420|FG008|Overall Study|Withdrawal by Subject|4|||
148712811|NCT00819169|536419412|FG000|Overall Study|Lost to Follow-up|0|||
148712812|NCT00819169|536419413|FG001|Overall Study|Lost to Follow-up|2|||
148712813|NCT00819169|536419414|FG002|Overall Study|Lost to Follow-up|0|||
148712814|NCT00819169|536419415|FG003|Overall Study|Lost to Follow-up|1|||
148712815|NCT00819169|536419416|FG004|Overall Study|Lost to Follow-up|0|||
148712816|NCT00819169|536419417|FG005|Overall Study|Lost to Follow-up|6|||
148712817|NCT00819169|536419418|FG006|Overall Study|Lost to Follow-up|2|||
148712818|NCT00819169|536419419|FG007|Overall Study|Lost to Follow-up|2|||
148712819|NCT00819169|536419420|FG008|Overall Study|Lost to Follow-up|1|||
148712820|NCT00819169|536419412|FG000|Overall Study|Death|1|||
148712821|NCT00819169|536419413|FG001|Overall Study|Death|1|||
148712822|NCT00819169|536419414|FG002|Overall Study|Death|3|||
148712823|NCT00819169|536419415|FG003|Overall Study|Death|8|||
148712824|NCT00819169|536419416|FG004|Overall Study|Death|5|||
148712825|NCT00819169|536419417|FG005|Overall Study|Death|7|||
148815576|NCT02383173|536800562|FG001|Overall Study|Palliative Care Team withdrew|2|||
148712826|NCT00819169|536419418|FG006|Overall Study|Death|9|||
148712827|NCT00819169|536419419|FG007|Overall Study|Death|4|||
148712828|NCT00819169|536419420|FG008|Overall Study|Death|7|||
148712829|NCT00819169|536419412|FG000|Overall Study|Ineligibility determined|0|||
148712830|NCT00819169|536419413|FG001|Overall Study|Ineligibility determined|0|||
148712831|NCT00819169|536419414|FG002|Overall Study|Ineligibility determined|0|||
148712832|NCT00819169|536419415|FG003|Overall Study|Ineligibility determined|2|||
148712833|NCT00819169|536419416|FG004|Overall Study|Ineligibility determined|0|||
148815577|NCT04900272|536800563|FG000|Overall Study|Lost to Follow-up|2|||
148815578|NCT04900272|536800563|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
148815579|NCT04900272|536800563|FG000|Overall Study|Withdrawal by Subject|1|||
148815580|NCT01625182|536800564|FG000|Overall Study|Administrative problems|1|||
148968433|NCT04960228|537370354|FG000|Overall Study|Flagged for response quality by Dynata|3|||
148712834|NCT00819169|536419417|FG005|Overall Study|Ineligibility determined|0|||
148712835|NCT00819169|536419418|FG006|Overall Study|Ineligibility determined|0|||
148712836|NCT00819169|536419419|FG007|Overall Study|Ineligibility determined|0|||
148712837|NCT00819169|536419420|FG008|Overall Study|Ineligibility determined|1|||
148712838|NCT00819169|536419412|FG000|Overall Study|Adverse Event|0|||
148712839|NCT00819169|536419413|FG001|Overall Study|Adverse Event|0|||
148712840|NCT00819169|536419414|FG002|Overall Study|Adverse Event|0|||
148712841|NCT00819169|536419415|FG003|Overall Study|Adverse Event|0|||
148712842|NCT00819169|536419416|FG004|Overall Study|Adverse Event|1|||
148712843|NCT00819169|536419417|FG005|Overall Study|Adverse Event|0|||
148712844|NCT00819169|536419418|FG006|Overall Study|Adverse Event|0|||
148712845|NCT00819169|536419419|FG007|Overall Study|Adverse Event|0|||
148712846|NCT00819169|536419420|FG008|Overall Study|Adverse Event|0|||
148712847|NCT00819169|536419412|FG000|Overall Study|Administrative Decision|0|||
148712848|NCT00819169|536419413|FG001|Overall Study|Administrative Decision|0|||
148712849|NCT00819169|536419414|FG002|Overall Study|Administrative Decision|0|||
148712850|NCT00819169|536419415|FG003|Overall Study|Administrative Decision|0|||
148712851|NCT00819169|536419416|FG004|Overall Study|Administrative Decision|1|||
148712852|NCT00819169|536419417|FG005|Overall Study|Administrative Decision|2|||
148712853|NCT00819169|536419418|FG006|Overall Study|Administrative Decision|0|||
148712854|NCT00819169|536419419|FG007|Overall Study|Administrative Decision|2|||
148712855|NCT00819169|536419420|FG008|Overall Study|Administrative Decision|0|||
148712856|NCT02096705|536419421|FG000|Treatment|Adverse Event|6|||
148712857|NCT02096705|536419422|FG001|Treatment|Adverse Event|3|||
148712858|NCT02096705|536419421|FG000|Treatment|Subject request to discontinue treatment|1|||
148712859|NCT02096705|536419422|FG001|Treatment|Subject request to discontinue treatment|1|||
148712860|NCT02096705|536419421|FG000|Treatment|Withdrawal by Subject|1|||
148712861|NCT02096705|536419422|FG001|Treatment|Withdrawal by Subject|0|||
148712862|NCT02096705|536419421|FG000|Treatment|Other|1|||
148712863|NCT02096705|536419422|FG001|Treatment|Other|1|||
148712864|NCT02096705|536419421|FG000|Follow-up|Withdrawal by Subject|1|||
148712865|NCT02096705|536419422|FG001|Follow-up|Withdrawal by Subject|0|||
148712866|NCT02096705|536419421|FG000|Follow-up|Adverse Event|2|||
148712867|NCT02096705|536419422|FG001|Follow-up|Adverse Event|2|||
148712868|NCT02096705|536419421|FG000|Follow-up|Subjects not reporting status|1|||
148712869|NCT02096705|536419422|FG001|Follow-up|Subjects not reporting status|2|||
148712870|NCT01046084|536419432|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
148712871|NCT01046084|536419433|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
148712872|NCT00474188|536419434|FG000|Overall Study|Withdrawal by Subject|1|||
148712873|NCT00474188|536419434|FG000|Overall Study|Study discontinued by sponsor|5|||
148712874|NCT03614728|536419435|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
148712875|NCT03614728|536419436|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
148712876|NCT03614728|536419437|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
148712877|NCT03614728|536419438|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
148712878|NCT03614728|536419435|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
148712879|NCT03614728|536419436|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
148712880|NCT03614728|536419437|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
148712881|NCT03614728|536419438|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
148712882|NCT05412121|536419439|FG000|Overall Study|Withdrawal by Subject|4|||
148712883|NCT05412121|536419439|FG000|Overall Study|Physician Decision|1|||
148712884|NCT05412121|536419439|FG000|Overall Study|Lost to Follow-up|5|||
148712885|NCT00842309|536419442|FG000|Overall Study|Withdrawal by Subject|3|||
148712886|NCT00842309|536419443|FG001|Overall Study|Withdrawal by Subject|1|||
148712887|NCT01962298|536419444|FG000|Overall Study|Protocol Violation|1|||
148712888|NCT01962298|536419445|FG001|Overall Study|Protocol Violation|0|||
148712889|NCT01962298|536419446|FG002|Overall Study|Protocol Violation|1|||
148712890|NCT01962298|536419447|FG003|Overall Study|Protocol Violation|1|||
148712891|NCT01962298|536419448|FG004|Overall Study|Protocol Violation|0|||
148712892|NCT01962298|536419444|FG000|Overall Study|Data quality insufficient|2|||
148712893|NCT01962298|536419445|FG001|Overall Study|Data quality insufficient|0|||
148712894|NCT01962298|536419446|FG002|Overall Study|Data quality insufficient|3|||
148712895|NCT01962298|536419447|FG003|Overall Study|Data quality insufficient|1|||
148712896|NCT01962298|536419448|FG004|Overall Study|Data quality insufficient|4|||
148815581|NCT01625182|536800565|FG001|Overall Study|Administrative problems|0|||
148815582|NCT01625182|536800564|FG000|Overall Study|Protocol deviation|0|||
148968434|NCT04960228|537370355|FG001|Overall Study|Flagged for response quality by Dynata|3|||
148712897|NCT01962298|536419444|FG000|Overall Study|Insufficient data|0|||
148712898|NCT01962298|536419445|FG001|Overall Study|Insufficient data|2|||
148712899|NCT01962298|536419446|FG002|Overall Study|Insufficient data|1|||
148712900|NCT01962298|536419447|FG003|Overall Study|Insufficient data|0|||
148712901|NCT01962298|536419448|FG004|Overall Study|Insufficient data|1|||
148712902|NCT01962298|536419444|FG000|Overall Study|Incorrect data recorded|0|||
148712903|NCT01962298|536419445|FG001|Overall Study|Incorrect data recorded|1|||
148712904|NCT01962298|536419446|FG002|Overall Study|Incorrect data recorded|0|||
148712905|NCT01962298|536419447|FG003|Overall Study|Incorrect data recorded|0|||
148712906|NCT01962298|536419448|FG004|Overall Study|Incorrect data recorded|0|||
148712907|NCT01962298|536419444|FG000|Overall Study|Physician Decision|0|||
148712908|NCT01962298|536419445|FG001|Overall Study|Physician Decision|1|||
148712909|NCT01962298|536419446|FG002|Overall Study|Physician Decision|0|||
148712910|NCT01962298|536419447|FG003|Overall Study|Physician Decision|0|||
148712911|NCT01962298|536419448|FG004|Overall Study|Physician Decision|1|||
148712912|NCT04476277|536419449|FG000|Overall Study|Withdrawal by Subject|0|||
148712913|NCT04476277|536419450|FG001|Overall Study|Withdrawal by Subject|0|||
148712914|NCT04476277|536419451|FG002|Overall Study|Withdrawal by Subject|1|||
148712915|NCT04476277|536419452|FG003|Overall Study|Withdrawal by Subject|0|||
148712916|NCT01576705|536419453|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
148712917|NCT01576705|536419454|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
148712918|NCT01576705|536419455|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
148712919|NCT01576705|536419456|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
148712920|NCT01576705|536419453|FG000|Overall Study|invalid ICF|0|||
148712921|NCT01576705|536419454|FG001|Overall Study|invalid ICF|1|||
148712922|NCT01576705|536419455|FG002|Overall Study|invalid ICF|0|||
148712923|NCT01576705|536419456|FG003|Overall Study|invalid ICF|0|||
148712924|NCT00566722|536419457|FG000|Overall Study|Adverse Event|0|||
148712925|NCT00566722|536419458|FG001|Overall Study|Adverse Event|1|||
148712926|NCT00566722|536419459|FG002|Overall Study|Adverse Event|0|||
148712927|NCT00566722|536419457|FG000|Overall Study|Withdrawal by Subject|0|||
148712928|NCT00566722|536419458|FG001|Overall Study|Withdrawal by Subject|0|||
148712929|NCT00566722|536419459|FG002|Overall Study|Withdrawal by Subject|1|||
148712930|NCT00566722|536419457|FG000|Overall Study|Lost to Follow-up|1|||
148712931|NCT00566722|536419458|FG001|Overall Study|Lost to Follow-up|1|||
148712932|NCT00566722|536419459|FG002|Overall Study|Lost to Follow-up|1|||
148712933|NCT00566722|536419457|FG000|Overall Study|Lack of Efficacy|1|||
148712934|NCT00566722|536419458|FG001|Overall Study|Lack of Efficacy|2|||
148712935|NCT00566722|536419459|FG002|Overall Study|Lack of Efficacy|4|||
148712936|NCT00566722|536419457|FG000|Overall Study|Did not meet exclusion criteria|0|||
148712937|NCT00566722|536419458|FG001|Overall Study|Did not meet exclusion criteria|0|||
148712938|NCT00566722|536419459|FG002|Overall Study|Did not meet exclusion criteria|2|||
148712939|NCT00566722|536419457|FG000|Overall Study|Serious adverse event|0|||
148712940|NCT00566722|536419458|FG001|Overall Study|Serious adverse event|1|||
148712941|NCT00566722|536419459|FG002|Overall Study|Serious adverse event|0|||
148712942|NCT00566722|536419457|FG000|Overall Study|Noncompliant with drug administration|0|||
148712943|NCT00566722|536419458|FG001|Overall Study|Noncompliant with drug administration|0|||
148712944|NCT00566722|536419459|FG002|Overall Study|Noncompliant with drug administration|1|||
148712945|NCT01390948|536419460|FG000|Overall Study|End of Study|1|||
148712946|NCT01390948|536419461|FG001|Overall Study|End of Study|0|||
148712947|NCT01390948|536419462|FG002|Overall Study|End of Study|0|||
148712948|NCT01390948|536419460|FG000|Overall Study|Withdrew consent|2|||
148712949|NCT01390948|536419461|FG001|Overall Study|Withdrew consent|2|||
148712950|NCT01390948|536419462|FG002|Overall Study|Withdrew consent|0|||
148712951|NCT01390948|536419460|FG000|Overall Study|Progressive Disease|2|||
148712952|NCT01390948|536419461|FG001|Overall Study|Progressive Disease|5|||
148712953|NCT01390948|536419462|FG002|Overall Study|Progressive Disease|0|||
148712954|NCT01390948|536419460|FG000|Overall Study|Death during follow-up|10|||
148712955|NCT01390948|536419461|FG001|Overall Study|Death during follow-up|11|||
148712956|NCT01390948|536419462|FG002|Overall Study|Death during follow-up|1|||
148712957|NCT02218216|536419465|FG000|Overall Study|Study terminated before completed|6|||
148712958|NCT02218216|536419466|FG001|Overall Study|Study terminated before completed|0|||
148712959|NCT02218216|536419467|FG002|Overall Study|Study terminated before completed|0|||
148712960|NCT05740098|536419470|FG000|Overall Study|Lost to Follow-up|26|||
148712961|NCT05740098|536419471|FG001|Overall Study|Lost to Follow-up|17|||
148712962|NCT05740098|536419472|FG002|Overall Study|Lost to Follow-up|21|||
148712963|NCT02588339|536419476|FG000|Overall Study|Withdrawal by Subject|1|||
148712964|NCT02588339|536419476|FG000|Overall Study|GVHD Progression prior to treatment|2|||
148712965|NCT04573309|536421080|FG000|Overall Study|Protocol Violation|1|||
148712966|NCT04573309|536421081|FG001|Overall Study|Protocol Violation|0|||
148712967|NCT01691430|536421084|FG000|Overall Study|Death|17|||
148712968|NCT01691430|536421085|FG001|Overall Study|Death|16|||
148712969|NCT01691430|536421084|FG000|Overall Study|Withdrawal by Subject|5|||
148968435|NCT03029624|537370356|FG000|Overall Study|Adverse Event|1|||
148712970|NCT01691430|536421085|FG001|Overall Study|Withdrawal by Subject|1|||
148712971|NCT01691430|536421084|FG000|Overall Study|Lost to Follow-up|0|||
148712972|NCT01691430|536421085|FG001|Overall Study|Lost to Follow-up|3|||
148712973|NCT01894230|536421086|FG000|Overall Study|Lost to Follow-up|2|||
148712974|NCT01894230|536421087|FG001|Overall Study|Lost to Follow-up|2|||
148712975|NCT01894230|536421086|FG000|Overall Study|Withdrawal by Subject|4|||
148712976|NCT01894230|536421087|FG001|Overall Study|Withdrawal by Subject|4|||
148712977|NCT01894230|536421086|FG000|Overall Study|Non-adherent|0|||
148712978|NCT01894230|536421087|FG001|Overall Study|Non-adherent|1|||
148712979|NCT01894230|536421086|FG000|Overall Study|Death|1|||
148712980|NCT01894230|536421087|FG001|Overall Study|Death|0|||
148712981|NCT02219009|536421090|FG000|Overall Study|Withdrawal by Subject|5|||
148712982|NCT02219009|536421091|FG001|Overall Study|Withdrawal by Subject|1|||
148712983|NCT02219009|536421090|FG000|Overall Study|Adverse Event|2|||
148712984|NCT02219009|536421091|FG001|Overall Study|Adverse Event|4|||
148712985|NCT02219009|536421090|FG000|Overall Study|Lost to Follow-up|2|||
148712986|NCT02219009|536421091|FG001|Overall Study|Lost to Follow-up|2|||
148712987|NCT02219009|536421090|FG000|Overall Study|Protocol deviation|1|||
148712988|NCT02219009|536421091|FG001|Overall Study|Protocol deviation|0|||
148712989|NCT02219009|536421090|FG000|Overall Study|Physician Decision|0|||
148712990|NCT02219009|536421091|FG001|Overall Study|Physician Decision|1|||
148712991|NCT02966340|536421092|FG000|Overall Study|Adverse Event|0|||
148712992|NCT02966340|536421093|FG001|Overall Study|Adverse Event|1|||
148712993|NCT02966340|536421092|FG000|Overall Study|Lost to Follow-up|0|||
148712994|NCT02966340|536421093|FG001|Overall Study|Lost to Follow-up|1|||
148712995|NCT02966340|536421092|FG000|Overall Study|Withdrawal by Subject|1|||
148712996|NCT02966340|536421093|FG001|Overall Study|Withdrawal by Subject|0|||
148712997|NCT02966340|536421092|FG000|Overall Study|data acquisition error|1|||
148712998|NCT02966340|536421093|FG001|Overall Study|data acquisition error|0|||
148712999|NCT02966340|536421092|FG000|Overall Study|startle non-responder|1|||
148713000|NCT02966340|536421093|FG001|Overall Study|startle non-responder|1|||
148713001|NCT04211766|536421094|FG000|Overall Study|Withdrawal by Subject|5|||
148713002|NCT04211766|536421095|FG001|Overall Study|Withdrawal by Subject|1|||
148713003|NCT00202839|536421096|FG000|Overall Study|Adverse Event|1|||
148713004|NCT00202839|536421097|FG001|Overall Study|Adverse Event|5|||
148713005|NCT00202839|536421096|FG000|Overall Study|Physician Decision|12|||
148713006|NCT00202839|536421097|FG001|Overall Study|Physician Decision|0|||
148713007|NCT00202839|536421096|FG000|Overall Study|Withdrawal by Subject|6|||
148713008|NCT00202839|536421097|FG001|Overall Study|Withdrawal by Subject|2|||
148713009|NCT00202839|536421096|FG000|Overall Study|Protocol Violation|2|||
148713010|NCT00202839|536421097|FG001|Overall Study|Protocol Violation|1|||
148713011|NCT00202839|536421096|FG000|Overall Study|Lost to Follow-up|3|||
148713012|NCT00202839|536421097|FG001|Overall Study|Lost to Follow-up|2|||
148713013|NCT00642993|536421098|FG000|Overall Study|Adverse Event|85|||
148713014|NCT00642993|536421099|FG001|Overall Study|Adverse Event|4|||
148713015|NCT00642993|536421098|FG000|Overall Study|Lost to Follow-up|8|||
148713016|NCT00642993|536421099|FG001|Overall Study|Lost to Follow-up|4|||
148713017|NCT00642993|536421098|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
148713018|NCT00642993|536421099|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
148713019|NCT00642993|536421098|FG000|Overall Study|Protocol Violation|1|||
148713020|NCT00642993|536421099|FG001|Overall Study|Protocol Violation|4|||
148713021|NCT00642993|536421098|FG000|Overall Study|Did not meet protocol eligibility|0|||
148713022|NCT00642993|536421099|FG001|Overall Study|Did not meet protocol eligibility|1|||
148713023|NCT00642993|536421098|FG000|Overall Study|Administrative|1|||
148713024|NCT00642993|536421099|FG001|Overall Study|Administrative|0|||
148713025|NCT03119662|536421100|FG000|Overall Study|Withdrawal by Subject|0|||
148713026|NCT03119662|536421101|FG001|Overall Study|Withdrawal by Subject|1|||
148713027|NCT02817828|536421102|FG000|Overall Study|Lost to Follow-up|41|||
148713028|NCT02817828|536421102|FG000|Overall Study|Adverse event not related to bleeding|104|||
148713029|NCT02817828|536421102|FG000|Overall Study|Adverse event related to bleeding|53|||
148713030|NCT02817828|536421102|FG000|Overall Study|Protocol Violation|11|||
148713031|NCT02817828|536421102|FG000|Overall Study|Pregnancy|7|||
148713032|NCT02817828|536421102|FG000|Overall Study|Pregnancy wish|15|||
148713033|NCT02817828|536421102|FG000|Overall Study|Withdrawal by Subject|78|||
148713034|NCT02817828|536421102|FG000|Overall Study|Other|26|||
148713035|NCT00757705|536421103|FG000|Overall Study|Adverse Event|19|||
148713036|NCT00757705|536421103|FG000|Overall Study|Lost to Follow-up|16|||
148713037|NCT00757705|536421103|FG000|Overall Study|Withdrawal by Subject|25|||
148713038|NCT00757705|536421103|FG000|Overall Study|Insufficient Response|26|||
148713039|NCT00757705|536421103|FG000|Overall Study|Ineligible to continue|8|||
148713040|NCT00757705|536421103|FG000|Overall Study|Non-compliant|9|||
148713041|NCT00757705|536421103|FG000|Overall Study|Other|18|||
148713042|NCT00660660|536421107|FG000|Overall Study|Adverse Event|1|||
148713043|NCT00660660|536421108|FG001|Overall Study|Adverse Event|0|||
148713044|NCT00660660|536421107|FG000|Overall Study|Lost to Follow-up|0|||
148713045|NCT00660660|536421108|FG001|Overall Study|Lost to Follow-up|6|||
148713046|NCT00660660|536421107|FG000|Overall Study|Lack of Efficacy|0|||
148713047|NCT00660660|536421108|FG001|Overall Study|Lack of Efficacy|2|||
148713048|NCT00660660|536421107|FG000|Overall Study|Withdrawal by Subject|3|||
148713049|NCT00660660|536421108|FG001|Overall Study|Withdrawal by Subject|0|||
148713050|NCT00660660|536421107|FG000|Overall Study|Incorrect enrollment and other|0|||
148713051|NCT00660660|536421108|FG001|Overall Study|Incorrect enrollment and other|1|||
148713052|NCT00660660|536421107|FG000|Overall Study|New medication after randomization|1|||
148713053|NCT00660660|536421108|FG001|Overall Study|New medication after randomization|0|||
148713054|NCT02308241|536421109|FG000|Overall Study|Withdrawal by Subject|3|||
148713055|NCT00659815|536421110|FG000|Overall Study|Study related symptoms and complaints|2|||
148713056|NCT00659815|536421111|FG001|Overall Study|Study related symptoms and complaints|1|||
148713057|NCT00659815|536421110|FG000|Overall Study|Inability to maintain wearing schedule|1|||
148713058|NCT00659815|536421111|FG001|Overall Study|Inability to maintain wearing schedule|2|||
148713059|NCT00659815|536421110|FG000|Overall Study|Withdrawal by Subject|1|||
148713060|NCT00659815|536421111|FG001|Overall Study|Withdrawal by Subject|1|||
148968436|NCT03029624|537370356|FG000|Overall Study|Withdrawal by Subject|1|||
148968437|NCT03029624|537370356|FG000|Overall Study|Lack of Efficacy|1|||
148968438|NCT03029624|537370356|FG000|Overall Study|MRI need|2|||
148968439|NCT01364428|537370357|FG000|Overall Study|Adverse Event|1|||
148968440|NCT01364428|537370358|FG001|Overall Study|Adverse Event|2|||
148968441|NCT01364428|537370357|FG000|Overall Study|Protocol Violation|2|||
148968442|NCT01364428|537370358|FG001|Overall Study|Protocol Violation|0|||
148968443|NCT01364428|537370357|FG000|Overall Study|Withdrawal Criteria|14|||
148968444|NCT01364428|537370358|FG001|Overall Study|Withdrawal Criteria|10|||
148968445|NCT01364428|537370357|FG000|Overall Study|Other|3|||
148968446|NCT01364428|537370358|FG001|Overall Study|Other|3|||
148968447|NCT01987427|537370359|FG000|Overall Study|Adverse Event|4|||
148968448|NCT01987427|537370360|FG001|Overall Study|Adverse Event|2|||
148968449|NCT01987427|537370361|FG002|Overall Study|Adverse Event|8|||
148968450|NCT01987427|537370359|FG000|Overall Study|Lost to Follow-up|6|||
148968451|NCT01987427|537370360|FG001|Overall Study|Lost to Follow-up|6|||
148968452|NCT01987427|537370361|FG002|Overall Study|Lost to Follow-up|9|||
148968453|NCT01987427|537370359|FG000|Overall Study|Withdrawal by Subject|2|||
148968454|NCT01987427|537370360|FG001|Overall Study|Withdrawal by Subject|1|||
148968455|NCT01987427|537370361|FG002|Overall Study|Withdrawal by Subject|3|||
148968456|NCT01987427|537370359|FG000|Overall Study|Lack of Efficacy|1|||
148968457|NCT01987427|537370360|FG001|Overall Study|Lack of Efficacy|0|||
148968458|NCT01987427|537370361|FG002|Overall Study|Lack of Efficacy|0|||
148968459|NCT01987427|537370359|FG000|Overall Study|Other|1|||
148968460|NCT01987427|537370360|FG001|Overall Study|Other|1|||
148968461|NCT01987427|537370361|FG002|Overall Study|Other|0|||
148968462|NCT01073865|537370362|FG000|Overall Study|Reasons other than below|19|||
148713061|NCT02651987|536421112|FG000|Overall Study|Adverse Event|2|||
148713062|NCT02651987|536421113|FG001|Overall Study|Adverse Event|2|||
148713063|NCT02651987|536421112|FG000|Overall Study|Consent Withdrawn|2|||
148713064|NCT02651987|536421113|FG001|Overall Study|Consent Withdrawn|0|||
148713065|NCT02651987|536421112|FG000|Overall Study|Local PD|0|||
148713066|NCT02651987|536421113|FG001|Overall Study|Local PD|2|||
148713067|NCT02651987|536421112|FG000|Overall Study|Investigator Decision|1|||
148713068|NCT02651987|536421113|FG001|Overall Study|Investigator Decision|1|||
148713069|NCT04408924|536421114|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
148713070|NCT04408924|536421114|FG000|Overall Study|Lost to Follow-up|3|||
148713071|NCT04408924|536421114|FG000|Overall Study|Withdrawal by Subject|5|||
148713072|NCT04408924|536421114|FG000|Overall Study|Sponsor Decision|2|||
148713073|NCT00486434|536421115|FG000|Overall Study|Withdrawal by Subject|34|||
148713074|NCT00486434|536421116|FG001|Overall Study|Withdrawal by Subject|39|||
148713075|NCT00486434|536421115|FG000|Overall Study|Adverse Event|118|||
148713076|NCT00486434|536421116|FG001|Overall Study|Adverse Event|44|||
148713077|NCT00486434|536421115|FG000|Overall Study|Protocol Violation|22|||
148713078|NCT00486434|536421116|FG001|Overall Study|Protocol Violation|21|||
148713079|NCT00486434|536421115|FG000|Overall Study|Lack of Efficacy|12|||
148713080|NCT00486434|536421116|FG001|Overall Study|Lack of Efficacy|19|||
148713081|NCT00486434|536421115|FG000|Overall Study|Lost to Follow-up|2|||
148713082|NCT00486434|536421116|FG001|Overall Study|Lost to Follow-up|3|||
148713083|NCT00486434|536421115|FG000|Overall Study|Death|1|||
148713084|NCT00486434|536421116|FG001|Overall Study|Death|2|||
148713085|NCT00486434|536421115|FG000|Overall Study|Personal reasons|5|||
148713086|NCT00486434|536421116|FG001|Overall Study|Personal reasons|6|||
148713087|NCT02218541|536421117|FG000|Overall Study|Lost to Follow-up|2|||
148713088|NCT02218541|536421118|FG001|Overall Study|Lost to Follow-up|1|||
148968463|NCT01073865|537370363|FG001|Overall Study|Reasons other than below|31|||
148968464|NCT01073865|537370362|FG000|Overall Study|Lost to Follow-up|1|||
148968465|NCT01073865|537370363|FG001|Overall Study|Lost to Follow-up|1|||
148968466|NCT01073865|537370362|FG000|Overall Study|Death|3|||
148968467|NCT01073865|537370363|FG001|Overall Study|Death|2|||
148968468|NCT01073865|537370362|FG000|Overall Study|Withdrawal by Subject|5|||
148968469|NCT01073865|537370363|FG001|Overall Study|Withdrawal by Subject|5|||
148713089|NCT02218541|536421117|FG000|Overall Study|Implant Failure|4|||
148713090|NCT02218541|536421118|FG001|Overall Study|Implant Failure|1|||
148713091|NCT00856349|536421119|FG000|Overall Study|Death|418|||
148713092|NCT00856349|536421119|FG000|Overall Study|Withdrawal by Subject|116|||
148713093|NCT00856349|536421119|FG000|Overall Study|Lost to Follow-up|91|||
148713094|NCT00856349|536421119|FG000|Overall Study|Protocol Violation|38|||
148968470|NCT04414553|537370367|FG000|Overall Study|Lost to Follow-up|20|||
148968471|NCT02689258|537370368|FG000|Overall Study|Subject Non-Compliance|0|||
148968472|NCT02689258|537370369|FG001|Overall Study|Subject Non-Compliance|1|||
148713095|NCT00856349|536421119|FG000|Overall Study|Physician Decision|13|||
148968473|NCT02689258|537370370|FG002|Overall Study|Subject Non-Compliance|0|||
148968474|NCT02689258|537370371|FG003|Overall Study|Subject Non-Compliance|0|||
148968475|NCT02689258|537370372|FG004|Overall Study|Subject Non-Compliance|0|||
148968476|NCT02689258|537370373|FG005|Overall Study|Subject Non-Compliance|0|||
148713096|NCT00856349|536421119|FG000|Overall Study|Subject relocation|104|||
148713097|NCT00856349|536421119|FG000|Overall Study|Device explant|33|||
148713098|NCT00856349|536421119|FG000|Overall Study|Site closure|78|||
148713099|NCT00856349|536421119|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
148713100|NCT02725515|536421120|FG000|Overall Study|Refused infusion (no study treatment)|1|||
148713101|NCT02725515|536421121|FG001|Overall Study|Refused infusion (no study treatment)|0|||
148713102|NCT02725515|536421120|FG000|Overall Study|Loss of Improvement per Protocol|14|||
148713103|NCT02725515|536421121|FG001|Overall Study|Loss of Improvement per Protocol|25|||
148713104|NCT02725515|536421120|FG000|Overall Study|Withdrawal by Subject|2|||
148713105|NCT02725515|536421121|FG001|Overall Study|Withdrawal by Subject|1|||
148713106|NCT02725515|536421120|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148713107|NCT02725515|536421121|FG001|Overall Study|Non-Compliance With Study Drug|3|||
148713108|NCT02725515|536421120|FG000|Overall Study|Lost to Follow-up|1|||
148713109|NCT02725515|536421121|FG001|Overall Study|Lost to Follow-up|1|||
148713110|NCT02725515|536421120|FG000|Overall Study|Adverse Event|7|||
148713111|NCT02725515|536421121|FG001|Overall Study|Adverse Event|2|||
148713112|NCT02725515|536421120|FG000|Overall Study|No Documented Disease Improvement|0|||
148713113|NCT02725515|536421121|FG001|Overall Study|No Documented Disease Improvement|1|||
148713114|NCT02725515|536421120|FG000|Overall Study|Completed Study Under Original Protocol|0|||
148713115|NCT02725515|536421121|FG001|Overall Study|Completed Study Under Original Protocol|1|||
148713116|NCT02725515|536421120|FG000|Overall Study|Lack of Response|0|||
148713117|NCT02725515|536421121|FG001|Overall Study|Lack of Response|1|||
148713118|NCT02998541|536421132|FG000|Overall Study|Adverse Event|4|||
148713119|NCT02998541|536421133|FG001|Overall Study|Adverse Event|5|||
148713120|NCT02998541|536421134|FG002|Overall Study|Adverse Event|1|||
148713121|NCT02998541|536421132|FG000|Overall Study|Protocol Violation|1|||
148713122|NCT02998541|536421133|FG001|Overall Study|Protocol Violation|0|||
148713123|NCT02998541|536421134|FG002|Overall Study|Protocol Violation|0|||
148713124|NCT02998541|536421132|FG000|Overall Study|Withdrawal by Subject|3|||
148713125|NCT02998541|536421133|FG001|Overall Study|Withdrawal by Subject|1|||
148713126|NCT02998541|536421134|FG002|Overall Study|Withdrawal by Subject|0|||
148713127|NCT02998541|536421132|FG000|Overall Study|Lost to Follow-up|0|||
148713128|NCT02998541|536421133|FG001|Overall Study|Lost to Follow-up|3|||
148713129|NCT02998541|536421134|FG002|Overall Study|Lost to Follow-up|1|||
148713130|NCT02998541|536421132|FG000|Overall Study|Physician Decision|0|||
148713131|NCT02998541|536421133|FG001|Overall Study|Physician Decision|0|||
148713132|NCT02998541|536421134|FG002|Overall Study|Physician Decision|3|||
148713133|NCT02998541|536421132|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148713134|NCT02998541|536421133|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148713135|NCT02998541|536421134|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
148713136|NCT01741545|536421140|FG000|Treatment Period|Lack of Efficacy|0|||
148713137|NCT01741545|536421141|FG001|Treatment Period|Lack of Efficacy|1|||
148713138|NCT01741545|536421140|FG000|Treatment Period|Adverse event, non-fatal|1|||
148713139|NCT01741545|536421141|FG001|Treatment Period|Adverse event, non-fatal|3|||
148713140|NCT01741545|536421140|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
148713141|NCT01741545|536421141|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
148713142|NCT01741545|536421140|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
148713143|NCT01741545|536421141|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
148713144|NCT01456962|536421142|FG000|Overall Study|Lost to Follow-up|2|||
148713145|NCT01456962|536421143|FG001|Overall Study|Lost to Follow-up|1|||
148713146|NCT02906917|536421147|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
148713147|NCT02906917|536421148|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
148713148|NCT02906917|536421147|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
148713149|NCT02906917|536421148|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
149025115|NCT00329303|537568021|FG000|Overall Study|Patient no longer available|1|||
149025116|NCT00329303|537568022|FG001|Overall Study|Patient no longer available|0|||
149025117|NCT00329303|537568021|FG000|Overall Study|Patient relocated|0|||
148713150|NCT02906917|536421147|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
148713151|NCT02906917|536421148|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
148713152|NCT02906917|536421147|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
148713153|NCT02906917|536421148|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
148713154|NCT02906917|536421147|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
148815583|NCT01625182|536800565|FG001|Overall Study|Protocol deviation|2|||
148713155|NCT02906917|536421148|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
148713156|NCT02906917|536421147|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
148713157|NCT02906917|536421148|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
148713158|NCT02906917|536421147|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
148713159|NCT02906917|536421148|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
148815584|NCT01625182|536800564|FG000|Overall Study|Adverse Event|2|||
148815585|NCT01625182|536800565|FG001|Overall Study|Adverse Event|0|||
148713160|NCT02906917|536421147|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
148713161|NCT02906917|536421148|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
148713162|NCT00687739|536421149|FG000|Overall Study|Lost to Follow-up|2|||
148713163|NCT00687739|536421150|FG001|Overall Study|Lost to Follow-up|2|||
148713164|NCT00687739|536421151|FG002|Overall Study|Lost to Follow-up|1|||
148713165|NCT00687739|536421152|FG003|Overall Study|Lost to Follow-up|2|||
148713166|NCT00687739|536421149|FG000|Overall Study|Adverse Event|0|||
148713167|NCT00687739|536421150|FG001|Overall Study|Adverse Event|1|||
148713168|NCT00687739|536421151|FG002|Overall Study|Adverse Event|1|||
148713169|NCT00687739|536421152|FG003|Overall Study|Adverse Event|0|||
148713170|NCT03599362|536421157|FG000|Overall Study|Screen Failure|3|||
148713171|NCT01370083|536421159|FG000|Overall Study|Lost to Follow-up|2|||
148713172|NCT01370083|536421160|FG001|Overall Study|Lost to Follow-up|0|||
148713173|NCT01370083|536421159|FG000|Overall Study|Adverse Event|0|||
148713174|NCT01370083|536421160|FG001|Overall Study|Adverse Event|1|||
148713175|NCT03358147|536421162|FG000|Overall Study|Withdrawal by Subject|13|||
148713176|NCT03358147|536421163|FG001|Overall Study|Withdrawal by Subject|19|||
148713177|NCT03358147|536421164|FG002|Overall Study|Withdrawal by Subject|16|||
148713178|NCT03358147|536421165|FG003|Overall Study|Withdrawal by Subject|10|||
148713179|NCT03358147|536421166|FG004|Overall Study|Withdrawal by Subject|5|||
148713180|NCT03358147|536421162|FG000|Overall Study|Adverse Event|3|||
148713181|NCT03358147|536421163|FG001|Overall Study|Adverse Event|9|||
148713182|NCT03358147|536421164|FG002|Overall Study|Adverse Event|7|||
148713183|NCT03358147|536421165|FG003|Overall Study|Adverse Event|5|||
148713184|NCT03358147|536421166|FG004|Overall Study|Adverse Event|2|||
148713185|NCT03358147|536421162|FG000|Overall Study|Lost to Follow-up|4|||
148713186|NCT03358147|536421163|FG001|Overall Study|Lost to Follow-up|3|||
148713187|NCT03358147|536421164|FG002|Overall Study|Lost to Follow-up|7|||
148713188|NCT03358147|536421165|FG003|Overall Study|Lost to Follow-up|6|||
148713189|NCT03358147|536421166|FG004|Overall Study|Lost to Follow-up|4|||
148713190|NCT03358147|536421162|FG000|Overall Study|Major Protocol Deviation|11|||
148713191|NCT03358147|536421163|FG001|Overall Study|Major Protocol Deviation|3|||
148713192|NCT03358147|536421164|FG002|Overall Study|Major Protocol Deviation|2|||
148713193|NCT03358147|536421165|FG003|Overall Study|Major Protocol Deviation|3|||
148713194|NCT03358147|536421166|FG004|Overall Study|Major Protocol Deviation|1|||
148713195|NCT03358147|536421162|FG000|Overall Study|Protocol specified criteria|2|||
148713196|NCT03358147|536421163|FG001|Overall Study|Protocol specified criteria|3|||
148713197|NCT03358147|536421164|FG002|Overall Study|Protocol specified criteria|0|||
148713198|NCT03358147|536421165|FG003|Overall Study|Protocol specified criteria|3|||
148713199|NCT03358147|536421166|FG004|Overall Study|Protocol specified criteria|1|||
148713200|NCT03358147|536421162|FG000|Overall Study|Physician Decision|1|||
148713201|NCT03358147|536421163|FG001|Overall Study|Physician Decision|0|||
148713202|NCT03358147|536421164|FG002|Overall Study|Physician Decision|1|||
148713203|NCT03358147|536421165|FG003|Overall Study|Physician Decision|6|||
148713204|NCT03358147|536421166|FG004|Overall Study|Physician Decision|1|||
148713205|NCT03358147|536421162|FG000|Overall Study|Administrative reasons|0|||
148713206|NCT03358147|536421163|FG001|Overall Study|Administrative reasons|1|||
148713207|NCT03358147|536421164|FG002|Overall Study|Administrative reasons|0|||
148713208|NCT03358147|536421165|FG003|Overall Study|Administrative reasons|3|||
148713209|NCT03358147|536421166|FG004|Overall Study|Administrative reasons|0|||
148713210|NCT03358147|536421162|FG000|Overall Study|Lack of Efficacy|0|||
148713211|NCT03358147|536421163|FG001|Overall Study|Lack of Efficacy|1|||
148713212|NCT03358147|536421164|FG002|Overall Study|Lack of Efficacy|1|||
148713213|NCT03358147|536421165|FG003|Overall Study|Lack of Efficacy|0|||
148713214|NCT03358147|536421166|FG004|Overall Study|Lack of Efficacy|0|||
148713215|NCT02072096|536421167|FG000|Overall Study|Lack of Efficacy|18|||
148713216|NCT02072096|536421168|FG001|Overall Study|Lack of Efficacy|29|||
148713217|NCT02072096|536421167|FG000|Overall Study|Protocol Violation|7|||
148713218|NCT02072096|536421168|FG001|Overall Study|Protocol Violation|7|||
148713219|NCT02072096|536421167|FG000|Overall Study|Withdrawal by Subject|5|||
148713220|NCT02072096|536421168|FG001|Overall Study|Withdrawal by Subject|7|||
148713221|NCT02072096|536421167|FG000|Overall Study|Adverse Event|5|||
148713222|NCT02072096|536421168|FG001|Overall Study|Adverse Event|2|||
148713223|NCT02072096|536421167|FG000|Overall Study|No Reason Provided|4|||
148713224|NCT02072096|536421168|FG001|Overall Study|No Reason Provided|2|||
148713225|NCT02072096|536421167|FG000|Overall Study|Death|2|||
148713226|NCT02072096|536421168|FG001|Overall Study|Death|0|||
148713227|NCT02072096|536421167|FG000|Overall Study|Physician Decision|0|||
148713228|NCT02072096|536421168|FG001|Overall Study|Physician Decision|1|||
148713229|NCT02072096|536421167|FG000|Overall Study|Study Terminated by Sponsor|43|||
148815586|NCT01625182|536800564|FG000|Overall Study|Withdrawal by Subject|5|||
148713230|NCT02072096|536421168|FG001|Overall Study|Study Terminated by Sponsor|30|||
148713231|NCT02072096|536421167|FG000|Overall Study|Lost to Follow-up|1|||
148713232|NCT02072096|536421168|FG001|Overall Study|Lost to Follow-up|0|||
148713233|NCT01168856|536421179|FG000|Overall Study|Lost to Follow-up|4|||
148815587|NCT01625182|536800565|FG001|Overall Study|Withdrawal by Subject|1|||
148713234|NCT01168856|536421180|FG001|Overall Study|Lost to Follow-up|34|||
148713235|NCT01168856|536421179|FG000|Overall Study|Withdrawal by Subject|6|||
148713236|NCT01168856|536421180|FG001|Overall Study|Withdrawal by Subject|8|||
148713237|NCT01168856|536421179|FG000|Overall Study|Physician Decision|2|||
148713238|NCT01168856|536421180|FG001|Overall Study|Physician Decision|1|||
148713239|NCT01168856|536421179|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
148713240|NCT01168856|536421180|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
148713241|NCT01168856|536421179|FG000|Overall Study|Participant received anti-HCV treatment|1|||
148713242|NCT01168856|536421180|FG001|Overall Study|Participant received anti-HCV treatment|0|||
148713243|NCT01168856|536421179|FG000|Overall Study|Death|0|||
148713244|NCT01168856|536421180|FG001|Overall Study|Death|2|||
148713245|NCT01168856|536421179|FG000|Overall Study|Other|1|||
148713246|NCT01168856|536421180|FG001|Overall Study|Other|291|||
148713247|NCT01168856|536421179|FG000|Overall Study|Protocol Violation|4|||
148713248|NCT01168856|536421180|FG001|Overall Study|Protocol Violation|6|||
148713249|NCT04442503|536421181|FG000|Overall Study|Adverse Event|1|||
148713250|NCT04442503|536421182|FG001|Overall Study|Adverse Event|1|||
148713251|NCT04442503|536421181|FG000|Overall Study|Lost to Follow-up|8|||
148713252|NCT04442503|536421182|FG001|Overall Study|Lost to Follow-up|6|||
148713253|NCT04442503|536421181|FG000|Overall Study|Physician Decision|0|||
148713254|NCT04442503|536421182|FG001|Overall Study|Physician Decision|2|||
148713255|NCT04442503|536421181|FG000|Overall Study|Withdrawal by Subject|3|||
148713256|NCT04442503|536421182|FG001|Overall Study|Withdrawal by Subject|4|||
148713257|NCT04442503|536421181|FG000|Overall Study|Reason not Specified|0|||
148713258|NCT04442503|536421182|FG001|Overall Study|Reason not Specified|1|||
148713259|NCT04442503|536421181|FG000|Overall Study|Randomized but not Treated|3|||
148713260|NCT04442503|536421182|FG001|Overall Study|Randomized but not Treated|1|||
148713261|NCT00387153|536421183|FG000|Overall Study|Adverse Event|1|||
148713262|NCT00387153|536421183|FG000|Overall Study|Disease Progression|3|||
148713263|NCT00387153|536421183|FG000|Overall Study|Lack of Response|4|||
148713264|NCT01945580|536421186|FG000|Overall Study|Withdrawal by Subject|13|||
148713265|NCT01945580|536421187|FG001|Overall Study|Withdrawal by Subject|35|||
148713266|NCT01945580|536421186|FG000|Overall Study|Physician Decision|3|||
148713267|NCT01945580|536421187|FG001|Overall Study|Physician Decision|2|||
148713268|NCT01945580|536421186|FG000|Overall Study|Lost to Follow-up|26|||
148713269|NCT01945580|536421187|FG001|Overall Study|Lost to Follow-up|39|||
148713270|NCT01945580|536421186|FG000|Overall Study|Death|7|||
148713271|NCT01945580|536421187|FG001|Overall Study|Death|2|||
148713272|NCT01945580|536421186|FG000|Overall Study|Patient moved out of state|0|||
148713273|NCT01945580|536421187|FG001|Overall Study|Patient moved out of state|1|||
148713274|NCT01945580|536421186|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
148713275|NCT01945580|536421187|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
148713276|NCT01945580|536421186|FG000|Overall Study|Family illness - unable to return|0|||
148713277|NCT01945580|536421187|FG001|Overall Study|Family illness - unable to return|1|||
148713278|NCT01945580|536421186|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
148713279|NCT01945580|536421187|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
148713280|NCT01945580|536421186|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
148713281|NCT01945580|536421187|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
148713282|NCT01945580|536421186|FG000|Overall Study|Noncompliance with 36 month visit|1|||
148713283|NCT01945580|536421187|FG001|Overall Study|Noncompliance with 36 month visit|0|||
148713284|NCT01945580|536421186|FG000|Overall Study|The patient moved.|1|||
148713285|NCT01945580|536421187|FG001|Overall Study|The patient moved.|0|||
148713286|NCT01945580|536421186|FG000|Overall Study|No data available|0|||
148713287|NCT01945580|536421187|FG001|Overall Study|No data available|2|||
148713288|NCT00474058|536421188|FG000|Overall Study|Adverse Event|11|||
148713289|NCT00474058|536421189|FG001|Overall Study|Adverse Event|6|||
148713290|NCT00474058|536421188|FG000|Overall Study|Lack of Efficacy|0|||
148713291|NCT00474058|536421189|FG001|Overall Study|Lack of Efficacy|4|||
148713292|NCT00474058|536421188|FG000|Overall Study|Withdrawal by Subject|11|||
148713293|NCT00474058|536421189|FG001|Overall Study|Withdrawal by Subject|7|||
148713294|NCT00474058|536421188|FG000|Overall Study|Other|2|||
148713295|NCT00474058|536421189|FG001|Overall Study|Other|0|||
148713296|NCT00503867|536421198|FG000|Overall Study|Lost to Follow-up|1|||
148713297|NCT00503867|536421198|FG000|Overall Study|Adverse Event|1|||
148713298|NCT05616728|536421199|FG000|Overall Study|Lost to Follow-up|0|||
148713299|NCT05616728|536421200|FG001|Overall Study|Lost to Follow-up|0|||
148713300|NCT05616728|536421201|FG002|Overall Study|Lost to Follow-up|1|||
148713301|NCT05616728|536421199|FG000|Overall Study|Withdrawal by Subject|1|||
148713302|NCT05616728|536421200|FG001|Overall Study|Withdrawal by Subject|1|||
148713303|NCT05616728|536421201|FG002|Overall Study|Withdrawal by Subject|0|||
148713304|NCT05616728|536421199|FG000|Overall Study|Physician Decision|1|||
148713305|NCT05616728|536421200|FG001|Overall Study|Physician Decision|1|||
148713306|NCT05616728|536421201|FG002|Overall Study|Physician Decision|1|||
148713307|NCT05616728|536421199|FG000|Overall Study|Other|0|||
148713308|NCT05616728|536421200|FG001|Overall Study|Other|2|||
148713309|NCT05616728|536421201|FG002|Overall Study|Other|0|||
148713310|NCT00577655|536421202|FG000|Overall Study|Patient Request|0|||
148713311|NCT00577655|536421203|FG001|Overall Study|Patient Request|2|||
148713312|NCT00577655|536421202|FG000|Overall Study|Protocol Violation|0|||
148713313|NCT00577655|536421203|FG001|Overall Study|Protocol Violation|1|||
148713314|NCT00577655|536421202|FG000|Overall Study|Lost to Follow-up|1|||
148968477|NCT02689258|537370374|FG006|Overall Study|Subject Non-Compliance|0|||
148713315|NCT00577655|536421203|FG001|Overall Study|Lost to Follow-up|1|||
148713316|NCT00672984|536421207|FG000|First Intervention|Adverse Event|5|||
148713317|NCT00672984|536421208|FG001|First Intervention|Adverse Event|0|||
148713318|NCT00672984|536421209|FG002|First Intervention|Adverse Event|0|||
148713319|NCT00672984|536421207|FG000|First Intervention|Withdrawal by Subject|1|||
148713320|NCT00672984|536421208|FG001|First Intervention|Withdrawal by Subject|2|||
148713321|NCT00672984|536421209|FG002|First Intervention|Withdrawal by Subject|2|||
148713322|NCT00672984|536421207|FG000|First Intervention|Sponsor decision|3|||
148713323|NCT00672984|536421208|FG001|First Intervention|Sponsor decision|0|||
148713324|NCT00672984|536421209|FG002|First Intervention|Sponsor decision|0|||
148713325|NCT00672984|536421207|FG000|Second Intervention|Non-compliance with facility policies|0|||
148713326|NCT00672984|536421208|FG001|Second Intervention|Non-compliance with facility policies|2|||
148713327|NCT00672984|536421209|FG002|Second Intervention|Non-compliance with facility policies|0|||
148713328|NCT00672984|536421207|FG000|Second Intervention|Withdrawal by Subject|0|||
148713329|NCT00672984|536421208|FG001|Second Intervention|Withdrawal by Subject|3|||
148713330|NCT00672984|536421209|FG002|Second Intervention|Withdrawal by Subject|0|||
148713331|NCT00672984|536421207|FG000|Second Intervention|Protocol Violation|0|||
148713332|NCT00672984|536421208|FG001|Second Intervention|Protocol Violation|1|||
148968478|NCT02689258|537370375|FG007|Overall Study|Subject Non-Compliance|0|||
148968479|NCT02689258|537370376|FG008|Overall Study|Subject Non-Compliance|0|||
148968480|NCT02689258|537370377|FG009|Overall Study|Subject Non-Compliance|0|||
148968481|NCT02689258|537370378|FG010|Overall Study|Subject Non-Compliance|0|||
148968482|NCT02689258|537370379|FG011|Overall Study|Subject Non-Compliance|0|||
148968483|NCT02689258|537370368|FG000|Overall Study|Subject Refusal to Continue|0|||
148968484|NCT02689258|537370369|FG001|Overall Study|Subject Refusal to Continue|1|||
148968485|NCT02689258|537370370|FG002|Overall Study|Subject Refusal to Continue|0|||
148968486|NCT02689258|537370371|FG003|Overall Study|Subject Refusal to Continue|0|||
148968487|NCT02689258|537370372|FG004|Overall Study|Subject Refusal to Continue|0|||
148968488|NCT02689258|537370373|FG005|Overall Study|Subject Refusal to Continue|0|||
148968489|NCT02689258|537370374|FG006|Overall Study|Subject Refusal to Continue|0|||
148968490|NCT02689258|537370375|FG007|Overall Study|Subject Refusal to Continue|0|||
148968491|NCT02689258|537370376|FG008|Overall Study|Subject Refusal to Continue|1|||
148968492|NCT02689258|537370377|FG009|Overall Study|Subject Refusal to Continue|0|||
148968493|NCT02689258|537370378|FG010|Overall Study|Subject Refusal to Continue|0|||
148968494|NCT02689258|537370379|FG011|Overall Study|Subject Refusal to Continue|1|||
148968495|NCT02689258|537370368|FG000|Overall Study|Other|0|||
148968496|NCT02689258|537370369|FG001|Overall Study|Other|2|||
148968497|NCT02689258|537370370|FG002|Overall Study|Other|0|||
148968498|NCT02689258|537370371|FG003|Overall Study|Other|0|||
148968499|NCT02689258|537370372|FG004|Overall Study|Other|1|||
148968500|NCT02689258|537370373|FG005|Overall Study|Other|0|||
148968501|NCT02689258|537370374|FG006|Overall Study|Other|0|||
148968502|NCT02689258|537370375|FG007|Overall Study|Other|0|||
148968503|NCT02689258|537370376|FG008|Overall Study|Other|1|||
148968504|NCT02689258|537370377|FG009|Overall Study|Other|0|||
148968505|NCT02689258|537370378|FG010|Overall Study|Other|0|||
148968506|NCT02689258|537370379|FG011|Overall Study|Other|0|||
148968507|NCT04753164|537370381|FG000|Overall Study|Adverse Event|0|||
148968508|NCT04753164|537370382|FG001|Overall Study|Adverse Event|2|||
148968509|NCT04753164|537370381|FG000|Overall Study|Withdrawal by Subject|9|||
148968510|NCT04753164|537370382|FG001|Overall Study|Withdrawal by Subject|7|||
148968511|NCT04753164|537370381|FG000|Overall Study|Lost to Follow-up|6|||
148968512|NCT04753164|537370382|FG001|Overall Study|Lost to Follow-up|6|||
148968513|NCT04753164|537370381|FG000|Overall Study|Other|12|||
148968514|NCT04753164|537370382|FG001|Overall Study|Other|5|||
148968515|NCT01465464|537370384|FG000|Overall Study|Adverse Event|96|||
148968516|NCT01465464|537370385|FG001|Overall Study|Adverse Event|49|||
148968517|NCT01465464|537370384|FG000|Overall Study|Lack of Efficacy|139|||
148968518|NCT01465464|537370385|FG001|Overall Study|Lack of Efficacy|190|||
148968519|NCT01465464|537370384|FG000|Overall Study|Physician Decision|13|||
148968520|NCT01465464|537370385|FG001|Overall Study|Physician Decision|5|||
148968521|NCT01465464|537370384|FG000|Overall Study|Protocol Violation|1|||
148968522|NCT01465464|537370385|FG001|Overall Study|Protocol Violation|1|||
148968523|NCT01465464|537370384|FG000|Overall Study|Withdrawal by Subject|46|||
148968524|NCT01465464|537370385|FG001|Overall Study|Withdrawal by Subject|30|||
148968525|NCT01465464|537370384|FG000|Overall Study|Other|9|||
148968526|NCT01465464|537370385|FG001|Overall Study|Other|3|||
148968527|NCT01465464|537370384|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
148968528|NCT01465464|537370385|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
148968529|NCT00785486|537370391|FG000|Midazolam Alone|Withdrawal by Subject|1|||
148968530|NCT00775437|537370392|FG000|Overall Study|Loss of efficacy|2|||
148968531|NCT00775437|537370392|FG000|Overall Study|Withdrawal by Subject|3|||
148968532|NCT00775437|537370392|FG000|Overall Study|Lost to Follow-up|1|||
148968533|NCT01183975|537370393|FG000|Overall Study|Lost to Follow-up|73|||
148713333|NCT00672984|536421209|FG002|Second Intervention|Protocol Violation|1|||
148968534|NCT04371380|537370394|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
148968535|NCT04371380|537370395|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
148968536|NCT04371380|537370396|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
148713334|NCT00672984|536421207|FG000|Third Intervention|Adverse Event|1|||
148713335|NCT00672984|536421208|FG001|Third Intervention|Adverse Event|0|||
148713336|NCT00672984|536421209|FG002|Third Intervention|Adverse Event|1|||
148713337|NCT00009945|536421210|FG000|Overall Study|no follow up data|7|||
148713338|NCT00009945|536421211|FG001|Overall Study|no follow up data|5|||
148713339|NCT00406393|536421212|FG000|Overall Study|Did not undergo transplantation|2|||
148713340|NCT00406393|536421213|FG001|Overall Study|Did not undergo transplantation|1|||
148713341|NCT01632306|536421214|FG000|Overall Study|Protocol Violation|1|||
148713342|NCT01632306|536421215|FG001|Overall Study|Protocol Violation|0|||
148713343|NCT01632306|536421216|FG002|Overall Study|Protocol Violation|0|||
148713344|NCT00380588|536421219|FG000|Overall Study|Unequivocal Disease Progression|25|||
148713345|NCT00380588|536421220|FG001|Overall Study|Unequivocal Disease Progression|34|||
148713346|NCT00380588|536421219|FG000|Overall Study|Next Cycle Not Started|4|||
148713347|NCT00380588|536421220|FG001|Overall Study|Next Cycle Not Started|0|||
148713348|NCT00380588|536421219|FG000|Overall Study|Adverse Event|7|||
148713349|NCT00380588|536421220|FG001|Overall Study|Adverse Event|3|||
148713350|NCT00380588|536421219|FG000|Overall Study|Withdrawal by Subject|1|||
148713351|NCT00380588|536421220|FG001|Overall Study|Withdrawal by Subject|3|||
148713352|NCT00380588|536421219|FG000|Overall Study|Physician Decision|2|||
148713353|NCT00380588|536421220|FG001|Overall Study|Physician Decision|0|||
148713354|NCT02905435|536421221|FG000|Overall Study|Death|2|||
148713355|NCT02905435|536421221|FG000|Overall Study|Physician Decision|1|||
148713356|NCT02905435|536421221|FG000|Overall Study|Lost to Follow-up|4|||
148713357|NCT02377349|536421222|FG000|Overall Study|Serious Adverse Event|1|||
148713358|NCT02377349|536421223|FG001|Overall Study|Serious Adverse Event|0|||
148713359|NCT02377349|536421222|FG000|Overall Study|Protocol Violation|3|||
148713360|NCT02377349|536421223|FG001|Overall Study|Protocol Violation|2|||
148713361|NCT02377349|536421222|FG000|Overall Study|Withdrawal by Subject|5|||
148713362|NCT02377349|536421223|FG001|Overall Study|Withdrawal by Subject|3|||
148713363|NCT02377349|536421222|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
148713364|NCT02377349|536421223|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
148713365|NCT02377349|536421222|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
148713366|NCT02377349|536421223|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
148713367|NCT02377349|536421222|FG000|Overall Study|Other|0|||
148713368|NCT02377349|536421223|FG001|Overall Study|Other|1|||
148713369|NCT03086135|536422268|FG000|Overall Study|Adverse Event|1|||
148713370|NCT03086135|536422268|FG000|Overall Study|Lost to Follow-up|2|||
148713371|NCT01023061|536422269|FG000|Overall Study|Withdrawal prior to treatment|2|||
148713372|NCT01120899|536422270|FG000|Overall Study|Withdrawal by Subject|3|||
148713373|NCT02664415|536422271|FG000|Overall Study|Adverse Event|1|||
148713374|NCT02664415|536422272|FG001|Overall Study|Adverse Event|0|||
148713375|NCT01151280|536422273|FG000|Overall Study|Adverse Event|1|||
148713376|NCT01151280|536422273|FG000|Overall Study|Lack of Efficacy|3|||
148713377|NCT00183196|536422274|FG000|Overall Study|Withdrawal by Subject|18|||
148713378|NCT00183196|536422275|FG001|Overall Study|Withdrawal by Subject|11|||
148713379|NCT00183196|536422276|FG002|Overall Study|Withdrawal by Subject|13|||
148713380|NCT00183196|536422274|FG000|Overall Study|Adverse Event|1|||
148713381|NCT00183196|536422275|FG001|Overall Study|Adverse Event|2|||
148713382|NCT00183196|536422276|FG002|Overall Study|Adverse Event|2|||
148713383|NCT00183196|536422274|FG000|Overall Study|Legal event|1|||
148713384|NCT00183196|536422275|FG001|Overall Study|Legal event|1|||
148713385|NCT00183196|536422276|FG002|Overall Study|Legal event|1|||
148713386|NCT00183196|536422274|FG000|Overall Study|Required more intensive care|0|||
148713387|NCT00183196|536422275|FG001|Overall Study|Required more intensive care|1|||
148713388|NCT00183196|536422276|FG002|Overall Study|Required more intensive care|2|||
148713389|NCT03387462|536422277|FG000|Overall Study|Lost to Follow-up|1|||
148713390|NCT01460628|536422278|FG000|Overall Study|Adverse Event|3|||
148713391|NCT01460628|536422278|FG000|Overall Study|Withdrawal by Subject|2|||
148713392|NCT01664039|536422282|FG000|Overall Study|Adverse Event|3|||
148713393|NCT01664039|536422283|FG001|Overall Study|Adverse Event|4|||
148713394|NCT01664039|536422282|FG000|Overall Study|Lost to Follow-up|1|||
148713395|NCT01664039|536422283|FG001|Overall Study|Lost to Follow-up|1|||
148713396|NCT01664039|536422282|FG000|Overall Study|Withdrawal by Subject|1|||
148713397|NCT01664039|536422283|FG001|Overall Study|Withdrawal by Subject|3|||
148713398|NCT01664039|536422282|FG000|Overall Study|Noncompliance|1|||
148713399|NCT01664039|536422283|FG001|Overall Study|Noncompliance|1|||
148713400|NCT01944722|536422286|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
148713401|NCT01944722|536422286|FG000|Overall Study|Specimen Shipping Issues|34|||
148713402|NCT01944722|536422286|FG000|Overall Study|Improper Storage/Transport|5|||
148713403|NCT01944722|536422286|FG000|Overall Study|Insufficient Volume for Test|1|||
148713404|NCT01944722|536422286|FG000|Overall Study|Missing Specimens|3|||
148713405|NCT01944722|536422286|FG000|Overall Study|Specimens Mislabeled|2|||
148713406|NCT01944722|536422286|FG000|Overall Study|Withdrawal by Subject|8|||
148713407|NCT01944722|536422286|FG000|Overall Study|NILM Subjects <30 years old|8106|||
148713408|NCT01944722|536422286|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
148713409|NCT01944722|536422286|FG000|Overall Study|>ASCUS Cytology|1122|||
148713410|NCT01853176|536422287|FG000|Overall Study|Study terminated|4|||
148713411|NCT01853176|536422288|FG001|Overall Study|Study terminated|0|||
148713412|NCT00874822|536422291|FG000|Overall Study|excluded by criteria|8|||
148713413|NCT02854800|536422292|FG000|Overall Study|Protocol Violation|16|||
148713414|NCT02854800|536422293|FG001|Overall Study|Protocol Violation|11|||
148713415|NCT02854800|536422294|FG002|Overall Study|Protocol Violation|3|||
148713416|NCT02854800|536422292|FG000|Overall Study|Withdrawal by Subject|4|||
148713417|NCT02854800|536422293|FG001|Overall Study|Withdrawal by Subject|2|||
148713418|NCT02854800|536422294|FG002|Overall Study|Withdrawal by Subject|3|||
148713419|NCT00875524|536422297|FG000|Overall Study|Serious adverse event|0|||
148713420|NCT00875524|536422298|FG001|Overall Study|Serious adverse event|1|||
148713421|NCT00875524|536422297|FG000|Overall Study|Protocol Violation|4|||
148713422|NCT00875524|536422298|FG001|Overall Study|Protocol Violation|0|||
148713423|NCT00875524|536422297|FG000|Overall Study|Lost to Follow-up|1|||
148713424|NCT00875524|536422298|FG001|Overall Study|Lost to Follow-up|0|||
148713425|NCT00875524|536422297|FG000|Overall Study|Withdrawal by Subject|3|||
148713426|NCT00875524|536422298|FG001|Overall Study|Withdrawal by Subject|5|||
148713427|NCT01370863|536422299|FG000|Overall Study|Adverse Event|1|||
148713428|NCT01370863|536422300|FG001|Overall Study|Adverse Event|1|||
148713429|NCT01370863|536422299|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
148713430|NCT01370863|536422300|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
148713431|NCT01370863|536422299|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
148713432|NCT01370863|536422300|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
148713433|NCT03504085|536422305|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
148713434|NCT03504085|536422306|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
148713435|NCT03504085|536422305|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
148713436|NCT03504085|536422306|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
148713437|NCT01926119|536422317|FG000|Overall Study|Withdrawal by Subject|1|||
148713438|NCT02654145|536422321|FG000|Overall Study|Lack of Efficacy|1|||
148713439|NCT02654145|536422321|FG000|Overall Study|Protocol Violation|1|||
148713440|NCT02654145|536422321|FG000|Overall Study|Withdrawal by Subject|5|||
148713441|NCT00354835|536422322|FG000|Overall Study|Death|1|||
148713442|NCT00354835|536422323|FG001|Overall Study|Death|1|||
148713443|NCT00354835|536422322|FG000|Overall Study|Physician Decision|8|||
148713444|NCT00354835|536422323|FG001|Overall Study|Physician Decision|13|||
148713445|NCT00354835|536422322|FG000|Overall Study|Withdrawal by Subject|2|||
148713446|NCT00354835|536422323|FG001|Overall Study|Withdrawal by Subject|1|||
148713447|NCT00354835|536422322|FG000|Overall Study|Ineligible|17|||
148713448|NCT00354835|536422323|FG001|Overall Study|Ineligible|16|||
148713449|NCT00354835|536422322|FG000|Overall Study|Disease progression or relapse|15|||
148713450|NCT00354835|536422323|FG001|Overall Study|Disease progression or relapse|22|||
148713451|NCT00354835|536422322|FG000|Overall Study|Adverse Event|6|||
148713452|NCT00354835|536422323|FG001|Overall Study|Adverse Event|0|||
148713453|NCT00354835|536422322|FG000|Overall Study|Refusal of further therapy|3|||
148713454|NCT00354835|536422323|FG001|Overall Study|Refusal of further therapy|8|||
148713455|NCT00645853|536422324|FG000|Overall Study|Adverse Event|18|||
148713456|NCT00645853|536422325|FG001|Overall Study|Adverse Event|7|||
148713457|NCT00645853|536422324|FG000|Overall Study|AZ study closure in Hungary|60|||
148713458|NCT00645853|536422325|FG001|Overall Study|AZ study closure in Hungary|40|||
148713459|NCT00645853|536422324|FG000|Overall Study|Withdrawal by Subject|5|||
148713460|NCT00645853|536422325|FG001|Overall Study|Withdrawal by Subject|2|||
148713461|NCT00645853|536422324|FG000|Overall Study|Protocol Violation|0|||
148713462|NCT00645853|536422325|FG001|Overall Study|Protocol Violation|2|||
148713463|NCT00645853|536422324|FG000|Overall Study|Discontinuation criteria|2|||
148713464|NCT00645853|536422325|FG001|Overall Study|Discontinuation criteria|2|||
148713465|NCT00645853|536422324|FG000|Overall Study|recall of ICF, planned operation, death|7|||
148713466|NCT00645853|536422325|FG001|Overall Study|recall of ICF, planned operation, death|4|||
148713467|NCT02637141|536422328|FG000|Overall Study|Adverse Event|1|||
148713468|NCT02637141|536422329|FG001|Overall Study|Adverse Event|1|||
148713469|NCT02637141|536422330|FG002|Overall Study|Adverse Event|0|||
148713470|NCT02637141|536422328|FG000|Overall Study|Withdrawal by Subject|1|||
148713471|NCT02637141|536422329|FG001|Overall Study|Withdrawal by Subject|1|||
148713472|NCT02637141|536422330|FG002|Overall Study|Withdrawal by Subject|1|||
148713473|NCT03255980|536422331|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
149025118|NCT00329303|537568022|FG001|Overall Study|Patient relocated|1|||
149025119|NCT03704298|537568023|FG000|Overall Study|Death|3|||
148713474|NCT03255980|536422332|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
148713475|NCT03255980|536422333|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
148713476|NCT03255980|536422334|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
148713477|NCT03255980|536422331|FG000|Overall Study|Adverse Event|1|||
148713478|NCT03255980|536422332|FG001|Overall Study|Adverse Event|1|||
148713479|NCT03255980|536422333|FG002|Overall Study|Adverse Event|0|||
148815588|NCT01625182|536800564|FG000|Overall Study|Lack of Efficacy|12|||
149025120|NCT03704298|537568024|FG001|Overall Study|Death|1|||
148713480|NCT03255980|536422334|FG003|Overall Study|Adverse Event|1|||
148713481|NCT03255980|536422331|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
148713482|NCT03255980|536422332|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
149025121|NCT03704298|537568025|FG002|Overall Study|Death|1|||
148713483|NCT03255980|536422333|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
148713484|NCT03255980|536422334|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
148713485|NCT03255980|536422331|FG000|Overall Study|Lost to Follow-up|1|||
148713486|NCT03255980|536422332|FG001|Overall Study|Lost to Follow-up|1|||
148713487|NCT03255980|536422333|FG002|Overall Study|Lost to Follow-up|0|||
148713488|NCT03255980|536422334|FG003|Overall Study|Lost to Follow-up|3|||
148713489|NCT03255980|536422331|FG000|Overall Study|Withdrawal by Subject|0|||
148713490|NCT03255980|536422332|FG001|Overall Study|Withdrawal by Subject|1|||
148713491|NCT03255980|536422333|FG002|Overall Study|Withdrawal by Subject|0|||
148713492|NCT03255980|536422334|FG003|Overall Study|Withdrawal by Subject|3|||
148713493|NCT01597791|536422335|FG000|Overall Study|Physician Decision|2|||
148713494|NCT01597791|536422336|FG001|Overall Study|Physician Decision|1|||
148713495|NCT01597791|536422335|FG000|Overall Study|Cesarean Section|6|||
148713496|NCT01597791|536422336|FG001|Overall Study|Cesarean Section|7|||
148713497|NCT01597791|536422335|FG000|Overall Study|Subject withdrawal|0|||
148713498|NCT01597791|536422336|FG001|Overall Study|Subject withdrawal|1|||
148713499|NCT01597791|536422335|FG000|Overall Study|Protocol Violation|0|||
148713500|NCT01597791|536422336|FG001|Overall Study|Protocol Violation|1|||
148713501|NCT01728116|536422339|FG000|Overall Study|Sponsor Terminated Study|106|||
148713502|NCT01728116|536422340|FG001|Overall Study|Sponsor Terminated Study|35|||
148713503|NCT01728116|536422339|FG000|Overall Study|Withdrawal by Subject|16|||
148713504|NCT01728116|536422340|FG001|Overall Study|Withdrawal by Subject|9|||
148713505|NCT01728116|536422339|FG000|Overall Study|Adverse Event|13|||
148713506|NCT01728116|536422340|FG001|Overall Study|Adverse Event|0|||
148713507|NCT01728116|536422339|FG000|Overall Study|Procedure/device failure|7|||
148713508|NCT01728116|536422340|FG001|Overall Study|Procedure/device failure|0|||
148713509|NCT01728116|536422339|FG000|Overall Study|Lost to Follow-up|9|||
148713510|NCT01728116|536422340|FG001|Overall Study|Lost to Follow-up|2|||
148713511|NCT01728116|536422339|FG000|Overall Study|Physician Decision|2|||
148713512|NCT01728116|536422340|FG001|Overall Study|Physician Decision|0|||
148713513|NCT01728116|536422339|FG000|Overall Study|Subject Non-Compliance|2|||
148713514|NCT01728116|536422340|FG001|Overall Study|Subject Non-Compliance|0|||
148713515|NCT01728116|536422339|FG000|Overall Study|Inter-current finding at procedure|1|||
148713516|NCT01728116|536422340|FG001|Overall Study|Inter-current finding at procedure|0|||
148713517|NCT01728116|536422339|FG000|Overall Study|Incorrectly enrolled in Study|0|||
148713518|NCT01728116|536422340|FG001|Overall Study|Incorrectly enrolled in Study|1|||
148713519|NCT01728116|536422339|FG000|Overall Study|various not noted previously|5|||
148713520|NCT01728116|536422340|FG001|Overall Study|various not noted previously|0|||
148713521|NCT03277248|536422343|FG000|Overall Study|Adverse Event|3|||
148713522|NCT03277248|536422344|FG001|Overall Study|Adverse Event|1|||
148713523|NCT03277248|536422343|FG000|Overall Study|Subject Withdrawal of Consent|6|||
148713524|NCT03277248|536422344|FG001|Overall Study|Subject Withdrawal of Consent|23|||
148713525|NCT03277248|536422343|FG000|Overall Study|Investigator/Sponsor Decision|2|||
148713526|NCT03277248|536422344|FG001|Overall Study|Investigator/Sponsor Decision|2|||
148713527|NCT03277248|536422343|FG000|Overall Study|Pregnancy|4|||
148713528|NCT03277248|536422344|FG001|Overall Study|Pregnancy|1|||
148713529|NCT03277248|536422343|FG000|Overall Study|Lost to Follow-up|0|||
148713530|NCT03277248|536422344|FG001|Overall Study|Lost to Follow-up|2|||
148713531|NCT03277248|536422343|FG000|Overall Study|Lack of Efficacy|0|||
148713532|NCT03277248|536422344|FG001|Overall Study|Lack of Efficacy|2|||
148713533|NCT03277248|536422343|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
148713534|NCT03277248|536422344|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
148713535|NCT01451541|536422351|FG000|Overall Study|Adverse Event|4|||
148713536|NCT01451541|536422352|FG001|Overall Study|Adverse Event|3|||
148713537|NCT01451541|536422353|FG002|Overall Study|Adverse Event|6|||
148713538|NCT01451541|536422351|FG000|Overall Study|Lack of Efficacy|2|||
148713539|NCT01451541|536422352|FG001|Overall Study|Lack of Efficacy|0|||
148713540|NCT01451541|536422353|FG002|Overall Study|Lack of Efficacy|0|||
148713541|NCT01451541|536422351|FG000|Overall Study|Lost to Follow-up|4|||
148713542|NCT01451541|536422352|FG001|Overall Study|Lost to Follow-up|4|||
148713543|NCT01451541|536422353|FG002|Overall Study|Lost to Follow-up|7|||
148713544|NCT01451541|536422351|FG000|Overall Study|Withdrawal by Subject|15|||
148713545|NCT01451541|536422352|FG001|Overall Study|Withdrawal by Subject|8|||
148713546|NCT01451541|536422353|FG002|Overall Study|Withdrawal by Subject|6|||
148713547|NCT01451541|536422351|FG000|Overall Study|randomization error, noncompliance|11|||
148713548|NCT01451541|536422352|FG001|Overall Study|randomization error, noncompliance|10|||
148713549|NCT01451541|536422353|FG002|Overall Study|randomization error, noncompliance|8|||
148713550|NCT04164758|536422356|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
148713551|NCT04164758|536422357|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
148713552|NCT04164758|536422358|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
148713553|NCT04164758|536422356|FG000|Overall Study|Adverse Event|0|||
148713554|NCT04164758|536422357|FG001|Overall Study|Adverse Event|1|||
148713555|NCT04164758|536422358|FG002|Overall Study|Adverse Event|0|||
148713556|NCT03366428|536422359|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
148713557|NCT03366428|536422359|FG000|Overall Study|Adverse Event|12|||
148713558|NCT03366428|536422359|FG000|Overall Study|Clinical progression|2|||
148713559|NCT03366428|536422359|FG000|Overall Study|Withdrawal by Subject|4|||
148713560|NCT02166606|536422360|FG000|Overall Study|Adverse Event|3|||
148713561|NCT02166606|536422360|FG000|Overall Study|Death|31|||
148713562|NCT02166606|536422360|FG000|Overall Study|Protocol Violation|7|||
148713563|NCT02166606|536422360|FG000|Overall Study|Lost to Follow-up|30|||
148713564|NCT02166606|536422360|FG000|Overall Study|Withdrawal by Subject|1|||
148713565|NCT02166606|536422360|FG000|Overall Study|Physician Decision|1|||
148713566|NCT02166606|536422360|FG000|Overall Study|Device upgrade|1|||
148713567|NCT02166606|536422360|FG000|Overall Study|Enrolled after End of Enrollment|4|||
148713568|NCT01958476|536422363|FG000|Overall Study|Parent requested exclusion from analysis|1|||
148713569|NCT01958476|536422364|FG001|Overall Study|Parent requested exclusion from analysis|0|||
148713570|NCT02670551|536422367|FG000|Overall Study|Adverse Event|4|||
148713571|NCT02670551|536422368|FG001|Overall Study|Adverse Event|7|||
148713572|NCT02670551|536422369|FG002|Overall Study|Adverse Event|9|||
148713573|NCT02670551|536422367|FG000|Overall Study|Lack of Efficacy|2|||
148713574|NCT02670551|536422368|FG001|Overall Study|Lack of Efficacy|0|||
148713575|NCT02670551|536422369|FG002|Overall Study|Lack of Efficacy|3|||
148713576|NCT02670551|536422367|FG000|Overall Study|Withdrawal of Consent|6|||
148713577|NCT02670551|536422368|FG001|Overall Study|Withdrawal of Consent|3|||
148713578|NCT02670551|536422369|FG002|Overall Study|Withdrawal of Consent|8|||
148713579|NCT02670551|536422367|FG000|Overall Study|Lost to Follow-up|5|||
148713580|NCT02670551|536422368|FG001|Overall Study|Lost to Follow-up|7|||
148713581|NCT02670551|536422369|FG002|Overall Study|Lost to Follow-up|6|||
148713582|NCT02670551|536422367|FG000|Overall Study|Protocol Violation|1|||
148713583|NCT02670551|536422368|FG001|Overall Study|Protocol Violation|0|||
148713584|NCT02670551|536422369|FG002|Overall Study|Protocol Violation|0|||
148713585|NCT02670551|536422367|FG000|Overall Study|Noncompliance with study drug|3|||
148713586|NCT02670551|536422368|FG001|Overall Study|Noncompliance with study drug|3|||
148713587|NCT02670551|536422369|FG002|Overall Study|Noncompliance with study drug|2|||
148713588|NCT02670551|536422367|FG000|Overall Study|Other Miscellaneous Reasons|2|||
148713589|NCT02670551|536422368|FG001|Overall Study|Other Miscellaneous Reasons|3|||
148713590|NCT02670551|536422369|FG002|Overall Study|Other Miscellaneous Reasons|3|||
148713591|NCT02670551|536422367|FG000|Overall Study|Did Not Receive Treatment|5|||
148713592|NCT02670551|536422368|FG001|Overall Study|Did Not Receive Treatment|3|||
148713593|NCT02670551|536422369|FG002|Overall Study|Did Not Receive Treatment|0|||
148713594|NCT01971645|536422370|FG000|Overall Study|Adverse Event|1|||
148713595|NCT01971645|536422371|FG001|Overall Study|Adverse Event|0|||
148713596|NCT01971645|536422372|FG002|Overall Study|Adverse Event|0|||
148713597|NCT01971645|536422370|FG000|Overall Study|Lost to Follow-up|1|||
148713598|NCT01971645|536422371|FG001|Overall Study|Lost to Follow-up|0|||
148713599|NCT01971645|536422372|FG002|Overall Study|Lost to Follow-up|1|||
148713600|NCT01971645|536422370|FG000|Overall Study|Protocol Violation|0|||
148713601|NCT01971645|536422371|FG001|Overall Study|Protocol Violation|0|||
148713602|NCT01971645|536422372|FG002|Overall Study|Protocol Violation|1|||
148713603|NCT00714051|536422373|FG000|Overall Study|Withdrawal by Subject|1|||
148713604|NCT00714051|536422374|FG001|Overall Study|Withdrawal by Subject|0|||
148713605|NCT00714051|536422373|FG000|Overall Study|Death|0|||
148713606|NCT00714051|536422374|FG001|Overall Study|Death|1|||
148713607|NCT02119936|536422375|FG000|Overall Study|Lost to Follow-up|10|||
148713608|NCT00570128|536422376|FG000|Overall Study|Adverse Event|1|||
148713609|NCT00570128|536422377|FG001|Overall Study|Adverse Event|0|||
148713610|NCT00570128|536422376|FG000|Overall Study|Lost to Follow-up|1|||
148713611|NCT00570128|536422377|FG001|Overall Study|Lost to Follow-up|0|||
148713612|NCT00570128|536422376|FG000|Overall Study|Withdrawal by Subject|2|||
148713613|NCT00570128|536422377|FG001|Overall Study|Withdrawal by Subject|0|||
148713614|NCT03868631|536422378|FG000|Baseline to Week 6|Adverse Event|0|||
148713615|NCT03868631|536422379|FG001|Baseline to Week 6|Adverse Event|3|||
148713616|NCT03868631|536422378|FG000|Baseline to Week 6|Protocol Violation|1|||
148713617|NCT03868631|536422379|FG001|Baseline to Week 6|Protocol Violation|1|||
148713618|NCT03868631|536422378|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
148713619|NCT03868631|536422379|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
148815589|NCT01625182|536800565|FG001|Overall Study|Lack of Efficacy|8|||
148713620|NCT03868631|536422378|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
148713621|NCT03868631|536422379|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
148713622|NCT03868631|536422378|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
148815590|NCT05059080|536800566|FG000|Overall Study|Withdrawal by Subject|3|||
148713623|NCT03868631|536422379|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
148713624|NCT03868631|536422378|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
148713625|NCT03868631|536422379|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
148713626|NCT05315713|536422380|FG000|Overall Study|Death|5|||
148713627|NCT05315713|536422380|FG000|Overall Study|Progressive disease|1|||
148713628|NCT05315713|536422380|FG000|Overall Study|Withdrawal by Subject|1|||
148713629|NCT05315713|536422380|FG000|Overall Study|Study terminated by sponsor|1|||
149025122|NCT03704298|537568026|FG003|Overall Study|Death|0|||
148713630|NCT01566435|536422383|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
148713631|NCT02535923|536422384|FG000|Overall Study|Lost to Follow-up|5|||
148713632|NCT02535923|536422385|FG001|Overall Study|Lost to Follow-up|5|||
148713633|NCT02535923|536422384|FG000|Overall Study|Withdrawal by Subject|4|||
148713634|NCT02535923|536422385|FG001|Overall Study|Withdrawal by Subject|3|||
148713635|NCT04236596|536422386|FG000|Overall Study|Withdrawal by Subject|1|||
148713636|NCT04236596|536422386|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
148713637|NCT04236596|536422386|FG000|Overall Study|Participants did not receive implant at all|4|||
148713638|NCT02957331|536422387|FG000|Overall Study|Protocol Violation|1|||
148713639|NCT02957331|536422388|FG001|Overall Study|Protocol Violation|0|||
148713640|NCT02300987|536423659|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
148713641|NCT02300987|536423660|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
148713642|NCT02300987|536423659|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
148713643|NCT02300987|536423660|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
148713644|NCT02300987|536423659|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
148713645|NCT02300987|536423660|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
148713646|NCT02300987|536423659|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
148713647|NCT02300987|536423660|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
148713648|NCT02300987|536423659|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
148713649|NCT02300987|536423660|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
148713650|NCT04590781|536423662|FG000|Overall Study|Death|0|||
148713651|NCT04590781|536423663|FG001|Overall Study|Death|2|||
148713652|NCT04590781|536423662|FG000|Overall Study|Withdrawal by Subject|2|||
148713653|NCT04590781|536423663|FG001|Overall Study|Withdrawal by Subject|0|||
148713654|NCT00820599|536423666|FG000|Overall Study|Death|129|||
148713655|NCT00820599|536423666|FG000|Overall Study|Withdrawal by Subject|2|||
148713656|NCT03686215|536423667|FG000|Overall Study|Adverse Event|0|||
148713657|NCT03686215|536423668|FG001|Overall Study|Adverse Event|0|||
148713658|NCT03686215|536423669|FG002|Overall Study|Adverse Event|7|||
148713659|NCT03686215|536423667|FG000|Overall Study|Physician Decision|0|||
148713660|NCT03686215|536423668|FG001|Overall Study|Physician Decision|0|||
148713661|NCT03686215|536423669|FG002|Overall Study|Physician Decision|1|||
148713662|NCT03686215|536423667|FG000|Overall Study|Protocol Violation|0|||
148713663|NCT03686215|536423668|FG001|Overall Study|Protocol Violation|0|||
148713664|NCT03686215|536423669|FG002|Overall Study|Protocol Violation|4|||
148713665|NCT03686215|536423667|FG000|Overall Study|Device issue|1|||
148713666|NCT03686215|536423668|FG001|Overall Study|Device issue|0|||
148713667|NCT03686215|536423669|FG002|Overall Study|Device issue|2|||
148713668|NCT00522041|536423670|FG000|Overall Study|Adverse Event|9|||
148713669|NCT00522041|536423671|FG001|Overall Study|Adverse Event|3|||
148713670|NCT00522041|536423670|FG000|Overall Study|Protocol Violation|2|||
148713671|NCT00522041|536423671|FG001|Overall Study|Protocol Violation|0|||
148713672|NCT00522041|536423670|FG000|Overall Study|Lost to Follow-up|1|||
148713673|NCT00522041|536423671|FG001|Overall Study|Lost to Follow-up|4|||
148713674|NCT00522041|536423670|FG000|Overall Study|Voluntary withdrawal|5|||
148713675|NCT00522041|536423671|FG001|Overall Study|Voluntary withdrawal|4|||
148713676|NCT00522041|536423670|FG000|Overall Study|Did not receive treatment|0|||
148713677|NCT00522041|536423671|FG001|Overall Study|Did not receive treatment|1|||
148713678|NCT00874549|536423672|FG000|Overall Study|Adverse Event|0|||
148713679|NCT00874549|536423673|FG001|Overall Study|Adverse Event|0|||
148713680|NCT00874549|536423674|FG002|Overall Study|Adverse Event|1|||
148713681|NCT00874549|536423675|FG003|Overall Study|Adverse Event|0|||
148713682|NCT00874549|536423672|FG000|Overall Study|Protocol Violation|1|||
148713683|NCT00874549|536423673|FG001|Overall Study|Protocol Violation|0|||
148713684|NCT00874549|536423674|FG002|Overall Study|Protocol Violation|2|||
148713685|NCT00874549|536423675|FG003|Overall Study|Protocol Violation|1|||
148713686|NCT00874549|536423672|FG000|Overall Study|Lost to Follow-up|0|||
148713687|NCT00874549|536423673|FG001|Overall Study|Lost to Follow-up|0|||
148713688|NCT00874549|536423674|FG002|Overall Study|Lost to Follow-up|1|||
148713689|NCT00874549|536423675|FG003|Overall Study|Lost to Follow-up|0|||
148713690|NCT00874549|536423672|FG000|Overall Study|Withdrawal by Subject|0|||
148713691|NCT00874549|536423673|FG001|Overall Study|Withdrawal by Subject|1|||
148713692|NCT00874549|536423674|FG002|Overall Study|Withdrawal by Subject|0|||
148713693|NCT00874549|536423675|FG003|Overall Study|Withdrawal by Subject|1|||
148713694|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
148713695|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
148713696|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
148713697|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
148713698|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
148713699|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
148713700|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
148713701|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
148713702|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
148713703|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
148713704|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
148713705|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
148713706|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
149025123|NCT03704298|537568023|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
149025124|NCT03704298|537568024|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
149025125|NCT03704298|537568025|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
149025126|NCT03704298|537568026|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
149025127|NCT03704298|537568023|FG000|Overall Study|Withdrawal by Subject|1|||
149025128|NCT03704298|537568024|FG001|Overall Study|Withdrawal by Subject|0|||
149025129|NCT03704298|537568025|FG002|Overall Study|Withdrawal by Subject|0|||
149025130|NCT03704298|537568026|FG003|Overall Study|Withdrawal by Subject|0|||
149025131|NCT03704298|537568023|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
149025132|NCT03704298|537568024|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
149025133|NCT03704298|537568025|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
149025134|NCT03704298|537568026|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
149025135|NCT00558753|537568027|FG000|Overall Study|Lost to Follow-up|5|||
149025136|NCT00558753|537568028|FG001|Overall Study|Lost to Follow-up|7|||
149025137|NCT00577629|537568040|FG000|Treatment Period|Death|1|||
149025138|NCT00577629|537568040|FG000|Long Term Follow-Up|Death|15|||
149025139|NCT00577629|537568040|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
149025140|NCT00577629|537568040|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
149025141|NCT00577629|537568040|FG000|Long Term Follow-Up|Physician Decision|1|||
149025142|NCT04159896|537568042|FG000|Overall Study|Lack of Efficacy|7|||
149025143|NCT04159896|537568042|FG000|Overall Study|Withdrawal by Subject|1|||
149025144|NCT04159896|537568042|FG000|Overall Study|Adverse Event|1|||
149025145|NCT04159896|537568042|FG000|Overall Study|A transient ischaemic attack|1|||
149025146|NCT04529538|537568043|FG000|Overall Study|Lost to Follow-up|3|||
149025147|NCT04529538|537568044|FG001|Overall Study|Lost to Follow-up|2|||
149025148|NCT04529538|537568045|FG002|Overall Study|Lost to Follow-up|1|||
149025149|NCT04529538|537568046|FG003|Overall Study|Lost to Follow-up|0|||
149025150|NCT04529538|537568047|FG004|Overall Study|Lost to Follow-up|1|||
149025151|NCT04529538|537568048|FG005|Overall Study|Lost to Follow-up|1|||
149025152|NCT04529538|537568049|FG006|Overall Study|Lost to Follow-up|2|||
149025153|NCT04529538|537568050|FG007|Overall Study|Lost to Follow-up|0|||
149025154|NCT04529538|537568043|FG000|Overall Study|Not eligible at enrollment|0|||
149025155|NCT04529538|537568044|FG001|Overall Study|Not eligible at enrollment|1|||
149025156|NCT04529538|537568045|FG002|Overall Study|Not eligible at enrollment|2|||
149025157|NCT04529538|537568046|FG003|Overall Study|Not eligible at enrollment|1|||
149025158|NCT04529538|537568047|FG004|Overall Study|Not eligible at enrollment|0|||
149025159|NCT04529538|537568048|FG005|Overall Study|Not eligible at enrollment|0|||
149025160|NCT04529538|537568049|FG006|Overall Study|Not eligible at enrollment|0|||
149025161|NCT04529538|537568050|FG007|Overall Study|Not eligible at enrollment|1|||
149025162|NCT04529538|537568043|FG000|Overall Study|Withdrawal by Subject|0|||
149025163|NCT04529538|537568044|FG001|Overall Study|Withdrawal by Subject|1|||
149025164|NCT04529538|537568045|FG002|Overall Study|Withdrawal by Subject|1|||
148713707|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
148713708|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
148713709|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
148713710|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
148713711|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
148713712|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
148713713|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
148713714|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
148713715|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
148713716|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
148713717|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
148713718|NCT01710358|536423676|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
148713719|NCT01710358|536423677|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
148713720|NCT01710358|536423678|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
148713721|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
148713722|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
148713723|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
148713724|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
148713725|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
148713726|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
148713727|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
148713728|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
148713729|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
148713730|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
148713731|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
148713732|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
148713733|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
148713734|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
148713735|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
148713736|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
148713737|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
148713738|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
148713739|NCT01710358|536423676|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
148713740|NCT01710358|536423677|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
148713741|NCT01710358|536423678|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
148713742|NCT01710358|536423676|FG000|Rescue Period|Adverse Event|0|||
148713743|NCT01710358|536423677|FG001|Rescue Period|Adverse Event|15|||
148713744|NCT01710358|536423678|FG002|Rescue Period|Adverse Event|0|||
148713745|NCT01710358|536423676|FG000|Rescue Period|Death|0|||
148713746|NCT01710358|536423677|FG001|Rescue Period|Death|1|||
148713747|NCT01710358|536423678|FG002|Rescue Period|Death|0|||
148713748|NCT01710358|536423676|FG000|Rescue Period|Lack of Efficacy|0|||
148713749|NCT01710358|536423677|FG001|Rescue Period|Lack of Efficacy|7|||
148713750|NCT01710358|536423678|FG002|Rescue Period|Lack of Efficacy|0|||
148713751|NCT01710358|536423676|FG000|Rescue Period|Withdrawal by Subject|0|||
148713752|NCT01710358|536423677|FG001|Rescue Period|Withdrawal by Subject|8|||
148713753|NCT01710358|536423678|FG002|Rescue Period|Withdrawal by Subject|0|||
148713754|NCT00084864|536423679|FG000|Overall Study|Adverse Event|1|||
148713755|NCT00084864|536423680|FG001|Overall Study|Adverse Event|0|||
148815591|NCT05059080|536800566|FG000|Overall Study|Study Terminated by Sponsor|64|||
148815592|NCT00263562|536800567|FG000|Overall Study|Protocol Violation|3|||
148815593|NCT00263562|536800568|FG001|Overall Study|Protocol Violation|0|||
148713756|NCT00084864|536423681|FG002|Overall Study|Adverse Event|0|||
148713757|NCT00084864|536423682|FG003|Overall Study|Adverse Event|0|||
148713758|NCT01721772|536423687|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
148713759|NCT01721772|536423688|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
148713760|NCT01721772|536423687|FG000|Pre-Treatment|Poor/non-compliance|0|||
148713761|NCT01721772|536423688|FG001|Pre-Treatment|Poor/non-compliance|1|||
148713762|NCT01721772|536423687|FG000|Pre-Treatment|Participant withdrew consent|0|||
148713763|NCT01721772|536423688|FG001|Pre-Treatment|Participant withdrew consent|1|||
148815594|NCT03637374|536800571|FG000|Overall Study|Death|2|||
148815595|NCT03637374|536800572|FG001|Overall Study|Death|0|||
148815596|NCT00376506|536800574|FG000|Overall Study|Death|0|||
148815597|NCT00376506|536800575|FG001|Overall Study|Death|2|||
148815598|NCT01716156|536800582|FG000|Overall Study|Protocol Violation|1|||
148815599|NCT01716156|536800583|FG001|Overall Study|Protocol Violation|0|||
148815600|NCT01716156|536800584|FG002|Overall Study|Protocol Violation|0|||
148815601|NCT01716156|536800582|FG000|Overall Study|Withdrawal by Subject|0|||
148815602|NCT01716156|536800583|FG001|Overall Study|Withdrawal by Subject|1|||
148815603|NCT01716156|536800584|FG002|Overall Study|Withdrawal by Subject|2|||
148815604|NCT01716156|536800582|FG000|Overall Study|Lost to Follow-up|1|||
148815605|NCT01716156|536800583|FG001|Overall Study|Lost to Follow-up|0|||
148815606|NCT01716156|536800584|FG002|Overall Study|Lost to Follow-up|0|||
148815607|NCT05561140|536800585|FG000|Randomized Treatment Period|Adverse Event|1|||
148815608|NCT05561140|536800586|FG001|Randomized Treatment Period|Adverse Event|0|||
148815609|NCT05561140|536800585|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
148815610|NCT05561140|536800586|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
148815611|NCT05561140|536800585|FG000|Open Label Treatment Period|Adverse Event|6|||
148815612|NCT05561140|536800586|FG001|Open Label Treatment Period|Adverse Event|4|||
148815613|NCT05561140|536800585|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
148815614|NCT05561140|536800586|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
148815615|NCT05561140|536800585|FG000|Open Label Treatment Period|Physician Decision|0|||
148815616|NCT05561140|536800586|FG001|Open Label Treatment Period|Physician Decision|1|||
148815617|NCT05561140|536800585|FG000|Open Label Treatment Period|Pregnancy|1|||
148815618|NCT05561140|536800586|FG001|Open Label Treatment Period|Pregnancy|0|||
148815619|NCT05561140|536800585|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
148815620|NCT05561140|536800586|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
148815621|NCT05561140|536800585|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
148815622|NCT05561140|536800586|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
148815623|NCT05561140|536800585|FG000|Open Label Treatment Period|Other|1|||
148815624|NCT05561140|536800586|FG001|Open Label Treatment Period|Other|0|||
148815625|NCT02949934|536800591|FG000|Natural Drinking Period|Adverse Event|1|||
148815626|NCT02949934|536800592|FG001|Natural Drinking Period|Adverse Event|0|||
148815627|NCT02949934|536800593|FG002|Natural Drinking Period|Adverse Event|0|||
148815628|NCT02949934|536800594|FG003|Natural Drinking Period|Adverse Event|1|||
148815629|NCT02949934|536800595|FG004|Natural Drinking Period|Adverse Event|0|||
148815630|NCT02949934|536800596|FG005|Natural Drinking Period|Adverse Event|0|||
148815631|NCT02949934|536800591|FG000|Natural Drinking Period|Lost to Follow-up|0|||
148815632|NCT02949934|536800592|FG001|Natural Drinking Period|Lost to Follow-up|0|||
148815633|NCT02949934|536800593|FG002|Natural Drinking Period|Lost to Follow-up|0|||
148815634|NCT02949934|536800594|FG003|Natural Drinking Period|Lost to Follow-up|0|||
148713764|NCT01721772|536423687|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
148968537|NCT01640366|537370400|FG000|Overall Study|Withdrawal by Subject|1|||
148968538|NCT01640366|537370400|FG000|Overall Study|Protocol Violation|16|||
148968539|NCT01640366|537370400|FG000|Overall Study|Lost to Follow-up|5|||
148968540|NCT02739269|537370401|FG000|Overall Study|Protocol Violation|5|||
148968541|NCT02739269|537370402|FG001|Overall Study|Protocol Violation|0|||
148968542|NCT02739269|537370401|FG000|Overall Study|Cycle cancellation|2|||
148968543|NCT02739269|537370402|FG001|Overall Study|Cycle cancellation|2|||
148968544|NCT02739269|537370401|FG000|Overall Study|Withdrawal by Subject|0|||
148968545|NCT02739269|537370402|FG001|Overall Study|Withdrawal by Subject|2|||
148968546|NCT00405548|537370405|FG000|Overall Study|Cognitive Memory problems on study day|1|||
148968547|NCT00405548|537370406|FG001|Overall Study|Cognitive Memory problems on study day|0|||
148968548|NCT00405548|537370405|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
148968549|NCT00405548|537370406|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
148968550|NCT00405548|537370405|FG000|Overall Study|Unable to self-administer shots|1|||
148968551|NCT00405548|537370406|FG001|Overall Study|Unable to self-administer shots|0|||
148968552|NCT00405548|537370405|FG000|Overall Study|Venous access failed during study day|1|||
148968553|NCT00405548|537370406|FG001|Overall Study|Venous access failed during study day|0|||
148968554|NCT00405548|537370405|FG000|Overall Study|Withdrawal by Subject|1|||
148968555|NCT00405548|537370406|FG001|Overall Study|Withdrawal by Subject|0|||
148968556|NCT01148511|537370410|FG000|Exposed to Study Drug|Protocol Violation|2|||
148968557|NCT01148511|537370411|FG001|Exposed to Study Drug|Protocol Violation|0|||
148815635|NCT02949934|536800595|FG004|Natural Drinking Period|Lost to Follow-up|1|||
148815636|NCT02949934|536800596|FG005|Natural Drinking Period|Lost to Follow-up|0|||
148815637|NCT02949934|536800591|FG000|Neuroimaging|Protocol Violation|2|||
148815638|NCT02949934|536800592|FG001|Neuroimaging|Protocol Violation|0|||
148815639|NCT02949934|536800593|FG002|Neuroimaging|Protocol Violation|0|||
148815640|NCT02949934|536800594|FG003|Neuroimaging|Protocol Violation|0|||
148815641|NCT02949934|536800595|FG004|Neuroimaging|Protocol Violation|1|||
148815642|NCT02949934|536800596|FG005|Neuroimaging|Protocol Violation|0|||
148815643|NCT02949934|536800591|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
148815644|NCT02949934|536800592|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
148815645|NCT02949934|536800593|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
148815646|NCT02949934|536800594|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
148815647|NCT02949934|536800595|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
148815648|NCT02949934|536800596|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
148815649|NCT02949934|536800591|FG000|Neuroimaging|Not scanned|0|||
148815650|NCT02949934|536800592|FG001|Neuroimaging|Not scanned|0|||
148815651|NCT02949934|536800593|FG002|Neuroimaging|Not scanned|1|||
148815652|NCT02949934|536800594|FG003|Neuroimaging|Not scanned|0|||
148815653|NCT02949934|536800595|FG004|Neuroimaging|Not scanned|0|||
148815654|NCT02949934|536800596|FG005|Neuroimaging|Not scanned|2|||
148815655|NCT02949934|536800591|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
148815656|NCT02949934|536800592|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
148815657|NCT02949934|536800593|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
148815658|NCT02949934|536800594|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
148815659|NCT02949934|536800595|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
148815660|NCT02949934|536800596|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
148815661|NCT02949934|536800591|FG000|Bar Laboratory|Adverse Event|1|||
148815662|NCT02949934|536800592|FG001|Bar Laboratory|Adverse Event|0|||
148815663|NCT02949934|536800593|FG002|Bar Laboratory|Adverse Event|2|||
148815664|NCT02949934|536800594|FG003|Bar Laboratory|Adverse Event|0|||
148815665|NCT02949934|536800595|FG004|Bar Laboratory|Adverse Event|1|||
148815666|NCT02949934|536800596|FG005|Bar Laboratory|Adverse Event|0|||
148815667|NCT02949934|536800591|FG000|Bar Laboratory|Protocol Violation|0|||
148815668|NCT02949934|536800592|FG001|Bar Laboratory|Protocol Violation|0|||
148815669|NCT02949934|536800593|FG002|Bar Laboratory|Protocol Violation|0|||
148815670|NCT02949934|536800594|FG003|Bar Laboratory|Protocol Violation|1|||
148815671|NCT02949934|536800595|FG004|Bar Laboratory|Protocol Violation|0|||
148815672|NCT02949934|536800596|FG005|Bar Laboratory|Protocol Violation|0|||
148815673|NCT04069520|536800600|FG000|Overall Study|Lost to Follow-up|0|||
148815674|NCT04069520|536800601|FG001|Overall Study|Lost to Follow-up|2|||
148815675|NCT04069520|536800600|FG000|Overall Study|Withdrawal by Subject|0|||
148815676|NCT04069520|536800601|FG001|Overall Study|Withdrawal by Subject|1|||
148815677|NCT04069520|536800600|FG000|Overall Study|Prior Injury|1|||
148815678|NCT04069520|536800601|FG001|Overall Study|Prior Injury|0|||
148815679|NCT04069520|536800600|FG000|Overall Study|Orthodontia|1|||
148968558|NCT01148511|537370412|FG002|Exposed to Study Drug|Protocol Violation|0|||
148815680|NCT04069520|536800601|FG001|Overall Study|Orthodontia|0|||
148815681|NCT04069520|536800600|FG000|Overall Study|Cut from team|0|||
148815682|NCT04069520|536800601|FG001|Overall Study|Cut from team|2|||
148815683|NCT00849472|536800602|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
148815684|NCT00849472|536800602|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
148815685|NCT00849472|536800602|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
148815686|NCT00849472|536800602|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
148815687|NCT00849472|536800602|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
148713765|NCT01721772|536423688|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
148713766|NCT01721772|536423687|FG000|Treatment|Disease progression|119|||
148713767|NCT01721772|536423688|FG001|Treatment|Disease progression|168|||
148713768|NCT01721772|536423687|FG000|Treatment|Study drug toxicity|19|||
148713769|NCT01721772|536423688|FG001|Treatment|Study drug toxicity|10|||
148713770|NCT01721772|536423687|FG000|Treatment|Adverse event unrelated to study drug|7|||
148713771|NCT01721772|536423688|FG001|Treatment|Adverse event unrelated to study drug|7|||
148713772|NCT01721772|536423687|FG000|Treatment|Maximum clinical benefit|16|||
148713773|NCT01721772|536423688|FG001|Treatment|Maximum clinical benefit|4|||
148713774|NCT01721772|536423687|FG000|Treatment|Other|19|||
148713775|NCT01721772|536423688|FG001|Treatment|Other|2|||
148713776|NCT01721772|536423687|FG000|Treatment|Participant withdrew consent|2|||
148713777|NCT01721772|536423688|FG001|Treatment|Participant withdrew consent|5|||
148713778|NCT01721772|536423687|FG000|Treatment|Participant request to discontinue study treatment|21|||
148713779|NCT01721772|536423688|FG001|Treatment|Participant request to discontinue study treatment|8|||
148713780|NCT01721772|536423687|FG000|Treatment|Death|1|||
148713781|NCT01721772|536423688|FG001|Treatment|Death|0|||
148713782|NCT01721772|536423687|FG000|Treatment|Not reported|1|||
148713783|NCT01721772|536423688|FG001|Treatment|Not reported|0|||
148713784|NCT01721772|536423687|FG000|Treatment|Poor/non-compliance|1|||
148713785|NCT01721772|536423688|FG001|Treatment|Poor/non-compliance|0|||
148713786|NCT01721772|536423687|FG000|Treatment|Lost to Follow-up|0|||
148713787|NCT01721772|536423688|FG001|Treatment|Lost to Follow-up|1|||
148713788|NCT04542694|536423690|FG000|Overall Study|The need for prohibited therapy|2|||
148713789|NCT04542694|536423691|FG001|Overall Study|The need for prohibited therapy|0|||
148713790|NCT04542694|536423690|FG000|Overall Study|Adverse Event|1|||
148713791|NCT04542694|536423691|FG001|Overall Study|Adverse Event|0|||
148713792|NCT04542694|536423690|FG000|Overall Study|Protocol Violation|1|||
148713793|NCT04542694|536423691|FG001|Overall Study|Protocol Violation|0|||
148713794|NCT00969124|536423692|FG000|Overall Study|Protocol Violation|2|||
148713795|NCT00969124|536423692|FG000|Overall Study|Inadequate bowel preparation|15|||
148713796|NCT00969124|536423692|FG000|Overall Study|Inability to reach cecum|9|||
148713797|NCT00969124|536423692|FG000|Overall Study|Previously unrecognized disease|3|||
148713798|NCT00969124|536423692|FG000|Overall Study|Technical error|1|||
148713799|NCT05387408|536423693|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
148713800|NCT02786953|536423702|FG000|Overall Study|Withdrawal by Subject|3|||
148713801|NCT02786953|536423703|FG001|Overall Study|Withdrawal by Subject|0|||
148713802|NCT02786953|536423702|FG000|Overall Study|Physician Decision|0|||
148713803|NCT02786953|536423703|FG001|Overall Study|Physician Decision|1|||
148713804|NCT05278858|536423706|FG000|Overall Study|Withdrawal by Subject|1|||
148713805|NCT00840658|536423707|FG000|Overall Study|Death|2|||
148713806|NCT00840658|536423708|FG001|Overall Study|Death|2|||
148713807|NCT00840658|536423709|FG002|Overall Study|Death|3|||
148713808|NCT00840658|536423710|FG003|Overall Study|Death|3|||
148713809|NCT00840658|536423707|FG000|Overall Study|Lost to Follow-up|3|||
148713810|NCT00840658|536423708|FG001|Overall Study|Lost to Follow-up|1|||
148713811|NCT00840658|536423709|FG002|Overall Study|Lost to Follow-up|2|||
148713812|NCT00840658|536423710|FG003|Overall Study|Lost to Follow-up|1|||
148713813|NCT00301964|536423712|FG000|Overall Study|Second primary|2|||
148713814|NCT00301964|536423712|FG000|Overall Study|Wrong primary|1|||
148713815|NCT00301964|536423712|FG000|Overall Study|Inadequate pathology|1|||
148713816|NCT02385708|536423713|FG000|Overall Study|Withdrawal by Subject|0|||
148713817|NCT02385708|536423714|FG001|Overall Study|Withdrawal by Subject|2|||
148713818|NCT02385708|536423713|FG000|Overall Study|Withdrawn - surgery canceled|2|||
148713819|NCT02385708|536423714|FG001|Overall Study|Withdrawn - surgery canceled|5|||
148713820|NCT02385708|536423713|FG000|Overall Study|Investigator decision|5|||
148713821|NCT02385708|536423714|FG001|Overall Study|Investigator decision|7|||
148713822|NCT02385708|536423713|FG000|Overall Study|Protocol Violation|1|||
148713823|NCT02385708|536423714|FG001|Overall Study|Protocol Violation|1|||
148713824|NCT01143337|536423715|FG000|Overall Study|Adverse Event|3|||
148713825|NCT01143337|536423716|FG001|Overall Study|Adverse Event|9|||
148713826|NCT01143337|536423717|FG002|Overall Study|Adverse Event|5|||
148713827|NCT01143337|536423715|FG000|Overall Study|Lack of Efficacy|6|||
148713828|NCT01143337|536423716|FG001|Overall Study|Lack of Efficacy|2|||
148713829|NCT01143337|536423717|FG002|Overall Study|Lack of Efficacy|1|||
148713830|NCT01143337|536423715|FG000|Overall Study|Protocol Violation|1|||
148713831|NCT01143337|536423716|FG001|Overall Study|Protocol Violation|0|||
148713832|NCT01143337|536423717|FG002|Overall Study|Protocol Violation|0|||
148713833|NCT01143337|536423715|FG000|Overall Study|Withdrawal by Subject|0|||
148713834|NCT01143337|536423716|FG001|Overall Study|Withdrawal by Subject|0|||
148713835|NCT01143337|536423717|FG002|Overall Study|Withdrawal by Subject|1|||
148713836|NCT01143337|536423715|FG000|Overall Study|Other reason|0|||
148713837|NCT01143337|536423716|FG001|Overall Study|Other reason|0|||
148713838|NCT01143337|536423717|FG002|Overall Study|Other reason|5|||
148713839|NCT02761915|536423718|FG000|Overall Study|Death|3|||
148713840|NCT02761915|536423719|FG001|Overall Study|Death|1|||
148713841|NCT02761915|536423720|FG002|Overall Study|Death|1|||
148713842|NCT02761915|536423721|FG003|Overall Study|Death|1|||
148713843|NCT02761915|536423722|FG004|Overall Study|Death|0|||
148713844|NCT02761915|536423723|FG005|Overall Study|Death|1|||
148713845|NCT02761915|536423718|FG000|Overall Study|Withdrawal by Subject|1|||
148713846|NCT02761915|536423719|FG001|Overall Study|Withdrawal by Subject|0|||
148713847|NCT02761915|536423720|FG002|Overall Study|Withdrawal by Subject|0|||
148713848|NCT02761915|536423721|FG003|Overall Study|Withdrawal by Subject|0|||
148713849|NCT02761915|536423722|FG004|Overall Study|Withdrawal by Subject|1|||
148713850|NCT02761915|536423723|FG005|Overall Study|Withdrawal by Subject|2|||
148713851|NCT02761915|536423718|FG000|Overall Study|Disease Progression|0|||
148713852|NCT02761915|536423719|FG001|Overall Study|Disease Progression|0|||
148713853|NCT02761915|536423720|FG002|Overall Study|Disease Progression|0|||
148713854|NCT02761915|536423721|FG003|Overall Study|Disease Progression|2|||
148713855|NCT02761915|536423722|FG004|Overall Study|Disease Progression|2|||
148713856|NCT02761915|536423723|FG005|Overall Study|Disease Progression|2|||
148713857|NCT01868243|536423724|FG000|Overall Study|Death|0|||
148713858|NCT01868243|536423725|FG001|Overall Study|Death|1|||
148713859|NCT00467597|536423726|FG000|Overall Study|Withdrawal by Subject|2|||
148713860|NCT00467597|536423727|FG001|Overall Study|Withdrawal by Subject|0|||
148713861|NCT00379353|536423730|FG000|Overall Study|Hospitalization|3|||
148713862|NCT00379353|536423731|FG001|Overall Study|Hospitalization|3|||
148713863|NCT00379353|536423730|FG000|Overall Study|Withdrawal by Subject|5|||
148713864|NCT00379353|536423731|FG001|Overall Study|Withdrawal by Subject|2|||
148713865|NCT00379353|536423730|FG000|Overall Study|Death|1|||
148713866|NCT00379353|536423731|FG001|Overall Study|Death|0|||
148713867|NCT00379353|536423730|FG000|Overall Study|Cardiac Tamponade|1|||
148713868|NCT00379353|536423731|FG001|Overall Study|Cardiac Tamponade|0|||
148713869|NCT00379353|536423730|FG000|Overall Study|Non-compliance|1|||
148713870|NCT00379353|536423731|FG001|Overall Study|Non-compliance|0|||
148713871|NCT00379353|536423730|FG000|Overall Study|Conflicting drug treatment|0|||
148713872|NCT00379353|536423731|FG001|Overall Study|Conflicting drug treatment|1|||
148713873|NCT01050764|536423732|FG000|Overall Study|Death, before HSCT|1|||
148713874|NCT01050764|536423732|FG000|Overall Study|Donor mobilization failure, death|1|||
148713875|NCT01050764|536423732|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
148713876|NCT01929681|536423745|FG000|Overall Study|Withdrawal by Subject|1|||
148713877|NCT01929681|536423746|FG001|Overall Study|Withdrawal by Subject|0|||
148713878|NCT01929681|536423745|FG000|Overall Study|Physician Decision|1|||
148713879|NCT01929681|536423746|FG001|Overall Study|Physician Decision|1|||
148713880|NCT01971554|536423750|FG000|Overall Study|Lost to Follow-up|1|||
148713881|NCT01971554|536423751|FG001|Overall Study|Lost to Follow-up|0|||
148713882|NCT01971554|536423752|FG002|Overall Study|Lost to Follow-up|0|||
148713883|NCT01971554|536423753|FG003|Overall Study|Lost to Follow-up|0|||
148713884|NCT00757172|536423754|FG000|Overall Study|Withdrawal by Subject|4|||
148713885|NCT00757172|536423754|FG000|Overall Study|Physician Decision|3|||
148713886|NCT00757172|536423754|FG000|Overall Study|Progression|4|||
148713887|NCT01426854|536423755|FG000|Overall Study|Adverse Event|1|||
148713888|NCT01426854|536423756|FG001|Overall Study|Adverse Event|5|||
148713889|NCT01426854|536423755|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
148713890|NCT01426854|536423756|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
148713891|NCT01426854|536423755|FG000|Overall Study|Lost to Follow-up|3|||
148713892|NCT01426854|536423756|FG001|Overall Study|Lost to Follow-up|0|||
148713893|NCT01426854|536423755|FG000|Overall Study|Noncompliance|0|||
148713894|NCT01426854|536423756|FG001|Overall Study|Noncompliance|1|||
148713895|NCT01426854|536423755|FG000|Overall Study|Treatment Failure|0|||
148713896|NCT01426854|536423756|FG001|Overall Study|Treatment Failure|16|||
148713897|NCT01426854|536423755|FG000|Overall Study|Protocol Deviation|0|||
148713898|NCT01426854|536423756|FG001|Overall Study|Protocol Deviation|1|||
148713899|NCT01426854|536423755|FG000|Overall Study|Other|3|||
148713900|NCT01426854|536423756|FG001|Overall Study|Other|2|||
148713901|NCT03555695|536423757|FG000|Overall Study|Withdrawal by Subject|1|||
148713902|NCT03555695|536423757|FG000|Overall Study|Lost to Follow-up|1|||
148713903|NCT03555695|536423757|FG000|Overall Study|appendicitis (unrelated)|1|||
148713904|NCT03555695|536423757|FG000|Overall Study|pre-existing sciatica|1|||
148815688|NCT00849472|536800602|FG000|Weekly Paclitaxel|Disease Progression|1|||
148713905|NCT01942135|536423759|FG000|Overall Study|Adverse Event|21|||
148713906|NCT01942135|536423760|FG001|Overall Study|Adverse Event|7|||
148713907|NCT01942135|536423759|FG000|Overall Study|Global Deterioration of Health Status|9|||
148713908|NCT01942135|536423760|FG001|Overall Study|Global Deterioration of Health Status|6|||
148713909|NCT01942135|536423759|FG000|Overall Study|Randomized Not Treated|2|||
148713910|NCT01942135|536423760|FG001|Overall Study|Randomized Not Treated|2|||
148713911|NCT01942135|536423759|FG000|Overall Study|Death|2|||
148713912|NCT01942135|536423760|FG001|Overall Study|Death|1|||
148713913|NCT01942135|536423759|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
148713914|NCT01942135|536423760|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
148713915|NCT01942135|536423759|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
148713916|NCT01942135|536423760|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
148713917|NCT01942135|536423759|FG000|Overall Study|Withdrawal by Subject|4|||
148713918|NCT01942135|536423760|FG001|Overall Study|Withdrawal by Subject|3|||
148713919|NCT01942135|536423759|FG000|Overall Study|Protocol Violation|1|||
148713920|NCT01942135|536423760|FG001|Overall Study|Protocol Violation|0|||
148713921|NCT01942135|536423759|FG000|Overall Study|Other|19|||
148713922|NCT01942135|536423760|FG001|Overall Study|Other|4|||
148713923|NCT01717040|536423761|FG000|Overall Study|Lost to Follow-up|2|||
148713924|NCT01717040|536423762|FG001|Overall Study|Lost to Follow-up|3|||
148713925|NCT01717040|536423761|FG000|Overall Study|Lack of Efficacy|1|||
148713926|NCT01717040|536423762|FG001|Overall Study|Lack of Efficacy|1|||
148713927|NCT01717040|536423761|FG000|Overall Study|Adverse Event|1|||
148713928|NCT01717040|536423762|FG001|Overall Study|Adverse Event|0|||
148713929|NCT01717040|536423761|FG000|Overall Study|Required Medication Change|0|||
148713930|NCT01717040|536423762|FG001|Overall Study|Required Medication Change|1|||
148713931|NCT01717040|536423761|FG000|Overall Study|New Substance Use Disorder|1|||
148713932|NCT01717040|536423762|FG001|Overall Study|New Substance Use Disorder|0|||
148713933|NCT04194151|536423763|FG000|Overall Study|Physician Decision|1|||
148713934|NCT04194151|536423764|FG001|Overall Study|Physician Decision|1|||
148713935|NCT04194151|536423765|FG002|Overall Study|Physician Decision|1|||
148713936|NCT04194151|536423766|FG003|Overall Study|Physician Decision|1|||
148713937|NCT04194151|536423767|FG004|Overall Study|Physician Decision|0|||
148713938|NCT04194151|536423768|FG005|Overall Study|Physician Decision|1|||
148713939|NCT04194151|536423763|FG000|Overall Study|Monitorization problem|0|||
148713940|NCT04194151|536423764|FG001|Overall Study|Monitorization problem|1|||
148713941|NCT04194151|536423765|FG002|Overall Study|Monitorization problem|0|||
148713942|NCT04194151|536423766|FG003|Overall Study|Monitorization problem|0|||
148713943|NCT04194151|536423767|FG004|Overall Study|Monitorization problem|0|||
148713944|NCT04194151|536423768|FG005|Overall Study|Monitorization problem|0|||
148713945|NCT04203823|536423769|FG000|Overall Study|Withdrawal by Subject|2|||
148713946|NCT04203823|536423770|FG001|Overall Study|Withdrawal by Subject|2|||
148713947|NCT04203823|536423769|FG000|Overall Study|Adverse Event|1|||
148713948|NCT04203823|536423770|FG001|Overall Study|Adverse Event|1|||
148713949|NCT04203823|536423769|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148713950|NCT04203823|536423770|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
148713951|NCT01499043|536423771|FG000|Overall Study|Progressive disease (radiographic)|2|||
148713952|NCT01499043|536423771|FG000|Overall Study|Progressive disease (clinical)|1|||
148713953|NCT01499043|536423771|FG000|Overall Study|Withdrawal by Subject|2|||
148713954|NCT01499043|536423771|FG000|Overall Study|Adverse Event|1|||
148713955|NCT03193021|536423772|FG000|Overall Study|Lost to Follow-up|1|||
148713956|NCT03193021|536423773|FG001|Overall Study|Lost to Follow-up|1|||
148713957|NCT02286466|536423774|FG000|Overall Study|Death|1|||
148713958|NCT02286466|536423775|FG001|Overall Study|Death|3|||
148713959|NCT02286466|536423774|FG000|Overall Study|Withdrawal by Subject|5|||
148713960|NCT02286466|536423775|FG001|Overall Study|Withdrawal by Subject|2|||
148713961|NCT02286466|536423774|FG000|Overall Study|Lost to Follow-up|1|||
148713962|NCT02286466|536423775|FG001|Overall Study|Lost to Follow-up|4|||
148713963|NCT02286466|536423774|FG000|Overall Study|Declined Clinician Assessment|0|||
148713964|NCT02286466|536423775|FG001|Overall Study|Declined Clinician Assessment|1|||
148713965|NCT00835081|536423776|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
148713966|NCT00835081|536423777|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
148713967|NCT03196284|536423778|FG000|Main Part|Withdrawal by Subject|0|||
148713968|NCT03196284|536423779|FG001|Main Part|Withdrawal by Subject|1|||
148713969|NCT03196284|536423780|FG002|Main Part|Withdrawal by Subject|0|||
148713970|NCT03196284|536423778|FG000|Extension Part|Lack of Efficacy|0|||
148713971|NCT03196284|536423779|FG001|Extension Part|Lack of Efficacy|0|||
148713972|NCT03196284|536423780|FG002|Extension Part|Lack of Efficacy|1|||
148713973|NCT03196284|536423778|FG000|Extension Part|Withdrawal by Subject|0|||
148713974|NCT03196284|536423779|FG001|Extension Part|Withdrawal by Subject|0|||
148968559|NCT01148511|537370410|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
148968560|NCT01148511|537370411|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
148968561|NCT01148511|537370412|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
148968562|NCT01148511|537370410|FG000|Randomized|Adverse Event|0|||
148713975|NCT03196284|536423780|FG002|Extension Part|Withdrawal by Subject|1|||
148713976|NCT03196284|536423778|FG000|Extension Part|Physician Decision|0|||
148713977|NCT03196284|536423779|FG001|Extension Part|Physician Decision|0|||
148713978|NCT03196284|536423780|FG002|Extension Part|Physician Decision|1|||
148713979|NCT01139762|536423781|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
148713980|NCT01139762|536423782|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
148713981|NCT01139762|536423783|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
148713982|NCT01139762|536423781|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
148713983|NCT01139762|536423782|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
148713984|NCT01139762|536423783|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
148713985|NCT01139762|536423781|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
148713986|NCT01139762|536423782|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
148713987|NCT01139762|536423783|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
148713988|NCT01139762|536423781|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
148713989|NCT01139762|536423782|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
148713990|NCT01139762|536423783|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
148713991|NCT01139762|536423781|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
148713992|NCT01139762|536423782|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
148713993|NCT01139762|536423783|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
148713994|NCT01139762|536423781|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
148713995|NCT01139762|536423782|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
148713996|NCT01139762|536423783|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
148713997|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
148713998|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
148713999|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
148714000|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Death|0|||
148714001|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Death|1|||
148714002|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Death|1|||
148714003|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
148714004|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
148714005|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
148714006|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
148714007|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
148714008|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
148714009|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
148714010|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
148714011|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
148714012|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
148714013|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
148714014|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
148714015|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
148714016|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
148714017|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
148714018|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
148714019|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
148714020|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
148714021|NCT01139762|536423781|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
148714022|NCT01139762|536423782|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
148714023|NCT01139762|536423783|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
148714024|NCT01675596|536423784|FG000|Overall Study|Death|6|||
148714025|NCT01675596|536423784|FG000|Overall Study|Exit with other reason|1|||
148714026|NCT01675596|536423784|FG000|Overall Study|Missed Visit|1|||
148714027|NCT00087529|536423786|FG000|Overall Study|Death|1|||
148714028|NCT00087529|536423787|FG001|Overall Study|Death|0|||
148714029|NCT00087529|536423786|FG000|Overall Study|Adverse Event|0|||
148714030|NCT00087529|536423787|FG001|Overall Study|Adverse Event|8|||
148714031|NCT00087529|536423786|FG000|Overall Study|Pregnancy|0|||
148714032|NCT00087529|536423787|FG001|Overall Study|Pregnancy|1|||
148714033|NCT00087529|536423786|FG000|Overall Study|Lost to Follow-up|2|||
148714034|NCT00087529|536423787|FG001|Overall Study|Lost to Follow-up|3|||
148714035|NCT00087529|536423786|FG000|Overall Study|Participant Decision|14|||
148714036|NCT00087529|536423787|FG001|Overall Study|Participant Decision|37|||
148714037|NCT00087529|536423786|FG000|Overall Study|Physician Decision|4|||
148714038|NCT00087529|536423787|FG001|Overall Study|Physician Decision|8|||
148714039|NCT00087529|536423786|FG000|Overall Study|Initiation of Excluded Therapy|0|||
148714040|NCT00087529|536423787|FG001|Overall Study|Initiation of Excluded Therapy|1|||
148714041|NCT00087529|536423786|FG000|Overall Study|Participant Noncompliance|0|||
148714042|NCT00087529|536423787|FG001|Overall Study|Participant Noncompliance|1|||
148714043|NCT00087529|536423786|FG000|Overall Study|Disease Progression|5|||
148714044|NCT00087529|536423787|FG001|Overall Study|Disease Progression|4|||
148714045|NCT00087529|536423786|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
148714046|NCT00087529|536423787|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
148714047|NCT00685334|536423795|FG000|Overall Study|Withdrawal by Subject|5|||
148714048|NCT00685334|536423796|FG001|Overall Study|Withdrawal by Subject|6|||
148968563|NCT01148511|537370411|FG001|Randomized|Adverse Event|1|||
148968564|NCT01148511|537370412|FG002|Randomized|Adverse Event|0|||
148714049|NCT00685334|536423795|FG000|Overall Study|Lost to Follow-up|4|||
148714050|NCT00685334|536423796|FG001|Overall Study|Lost to Follow-up|0|||
148714051|NCT00685334|536423795|FG000|Overall Study|Chose to enter hospital|1|||
148714052|NCT00685334|536423796|FG001|Overall Study|Chose to enter hospital|1|||
148714053|NCT03694197|536423797|FG000|Overall Study|Adverse Event|9|||
148714054|NCT03694197|536423797|FG000|Overall Study|Protocol became inconvenient to participate|1|||
148714055|NCT03694197|536423797|FG000|Overall Study|Physician Decision|4|||
148714056|NCT03694197|536423797|FG000|Overall Study|Study terminated by sponsor|1350|||
148714057|NCT03694197|536423797|FG000|Overall Study|Participant moved|5|||
148714058|NCT03694197|536423797|FG000|Overall Study|Participant withdrew consent|10|||
148714059|NCT03694197|536423797|FG000|Overall Study|Related to IMP administration|1|||
148714060|NCT03694197|536423797|FG000|Overall Study|Not disclosed|5|||
148714061|NCT01520987|536425399|FG000|Overall Study|Withdrawal by Subject|1|||
148714062|NCT01520987|536425400|FG001|Overall Study|Withdrawal by Subject|0|||
148968565|NCT01148511|537370410|FG000|Randomized|Protocol Violation|0|||
148968566|NCT01148511|537370411|FG001|Randomized|Protocol Violation|2|||
148968567|NCT01148511|537370412|FG002|Randomized|Protocol Violation|1|||
148968568|NCT01148511|537370410|FG000|Randomized|Lost to Follow-up|0|||
148968569|NCT01148511|537370411|FG001|Randomized|Lost to Follow-up|1|||
148968570|NCT01148511|537370412|FG002|Randomized|Lost to Follow-up|1|||
148968571|NCT01148511|537370410|FG000|Randomized|Consent withdrawal|0|||
148968572|NCT01148511|537370411|FG001|Randomized|Consent withdrawal|5|||
148968573|NCT01148511|537370412|FG002|Randomized|Consent withdrawal|3|||
148968574|NCT01148511|537370410|FG000|Randomized|Other|0|||
148968575|NCT01148511|537370411|FG001|Randomized|Other|1|||
148968576|NCT01148511|537370412|FG002|Randomized|Other|1|||
148968577|NCT00842348|537370416|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
148968578|NCT00842348|537370417|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
148968579|NCT00842348|537370416|FG000|Study 729|Disease progression/death|19|||
148968580|NCT00842348|537370417|FG001|Study 729|Disease progression/death|30|||
148968581|NCT00842348|537370416|FG000|Study 729|Adverse Event|1|||
148968582|NCT00842348|537370417|FG001|Study 729|Adverse Event|1|||
148968583|NCT00842348|537370416|FG000|Study 729|Protocol Violation|1|||
148968584|NCT00842348|537370417|FG001|Study 729|Protocol Violation|1|||
148968585|NCT00842348|537370416|FG000|Study 729|Withdrawal by Subject|2|||
148968586|NCT00842348|537370417|FG001|Study 729|Withdrawal by Subject|4|||
148968587|NCT00842348|537370416|FG000|Study 729|Due to Sponsor stopping the study|1|||
148968588|NCT00842348|537370417|FG001|Study 729|Due to Sponsor stopping the study|1|||
148968589|NCT00842348|537370416|FG000|Study 729|Due to non-availability of IP|0|||
148968590|NCT00842348|537370417|FG001|Study 729|Due to non-availability of IP|1|||
148968591|NCT00842348|537370416|FG000|Study 729|Sponsor's decision|1|||
148968592|NCT00842348|537370417|FG001|Study 729|Sponsor's decision|0|||
148968593|NCT00842348|537370416|FG000|Study 729|Surgical resection|1|||
148968594|NCT00842348|537370417|FG001|Study 729|Surgical resection|0|||
148968595|NCT01113879|537370420|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
148968596|NCT01113879|537370421|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
148968597|NCT01132495|537370422|FG000|Overall Study|Various reasons|40|||
148968598|NCT01132495|537370423|FG001|Overall Study|Various reasons|38|||
148968599|NCT01132495|537370424|FG002|Overall Study|Various reasons|20|||
148968600|NCT01132495|537370425|FG003|Overall Study|Various reasons|12|||
148968601|NCT00403273|537372733|FG000|Overall Study|Lost to Follow-up|3|||
148968602|NCT00403273|537372734|FG001|Overall Study|Lost to Follow-up|2|||
148968603|NCT00403273|537372733|FG000|Overall Study|Physician Decision|0|||
148968604|NCT00403273|537372734|FG001|Overall Study|Physician Decision|1|||
148968605|NCT00403273|537372733|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
148968606|NCT00403273|537372734|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
148968607|NCT01336738|537372736|FG000|Overall Study|Adverse Event|0|||
148968608|NCT01336738|537372737|FG001|Overall Study|Adverse Event|3|||
148968609|NCT01336738|537372738|FG002|Overall Study|Adverse Event|2|||
148968610|NCT01336738|537372739|FG003|Overall Study|Adverse Event|1|||
148968611|NCT01336738|537372740|FG004|Overall Study|Adverse Event|3|||
148968612|NCT01336738|537372736|FG000|Overall Study|Lost to Follow-up|2|||
148968613|NCT01336738|537372737|FG001|Overall Study|Lost to Follow-up|1|||
148968614|NCT01336738|537372738|FG002|Overall Study|Lost to Follow-up|2|||
148968615|NCT01336738|537372739|FG003|Overall Study|Lost to Follow-up|2|||
148968616|NCT01336738|537372740|FG004|Overall Study|Lost to Follow-up|2|||
148968617|NCT01336738|537372736|FG000|Overall Study|Did not meet entrance criteria|0|||
148968618|NCT01336738|537372737|FG001|Overall Study|Did not meet entrance criteria|1|||
148968619|NCT01336738|537372738|FG002|Overall Study|Did not meet entrance criteria|0|||
148968620|NCT01336738|537372739|FG003|Overall Study|Did not meet entrance criteria|0|||
148968621|NCT01336738|537372740|FG004|Overall Study|Did not meet entrance criteria|0|||
148968622|NCT01336738|537372736|FG000|Overall Study|Protocol Violation|0|||
148968623|NCT01336738|537372737|FG001|Overall Study|Protocol Violation|1|||
148968624|NCT01336738|537372738|FG002|Overall Study|Protocol Violation|0|||
148968625|NCT01336738|537372739|FG003|Overall Study|Protocol Violation|0|||
148968626|NCT01336738|537372740|FG004|Overall Study|Protocol Violation|0|||
148968627|NCT01336738|537372736|FG000|Overall Study|Withdrawal by Subject|2|||
148968628|NCT01336738|537372737|FG001|Overall Study|Withdrawal by Subject|0|||
148968629|NCT01336738|537372738|FG002|Overall Study|Withdrawal by Subject|2|||
148968630|NCT01336738|537372739|FG003|Overall Study|Withdrawal by Subject|1|||
148968631|NCT01336738|537372740|FG004|Overall Study|Withdrawal by Subject|1|||
148968632|NCT01336738|537372736|FG000|Overall Study|Other|3|||
148968633|NCT01336738|537372737|FG001|Overall Study|Other|3|||
148968634|NCT01336738|537372738|FG002|Overall Study|Other|2|||
148968635|NCT01336738|537372739|FG003|Overall Study|Other|3|||
148968636|NCT01336738|537372740|FG004|Overall Study|Other|4|||
148968637|NCT01083433|537372741|FG000|Overall Study|Lost to Follow-up|2|||
148968638|NCT01083433|537372742|FG001|Overall Study|Lost to Follow-up|1|||
148968639|NCT01083433|537372743|FG002|Overall Study|Lost to Follow-up|1|||
148968640|NCT01083433|537372741|FG000|Overall Study|Withdrawal by Subject|0|||
148714063|NCT01520987|536425401|FG002|Overall Study|Withdrawal by Subject|0|||
148714064|NCT01520987|536425402|FG003|Overall Study|Withdrawal by Subject|0|||
148714065|NCT01520987|536425403|FG004|Overall Study|Withdrawal by Subject|0|||
148714066|NCT01520987|536425404|FG005|Overall Study|Withdrawal by Subject|1|||
148714067|NCT01520987|536425405|FG006|Overall Study|Withdrawal by Subject|0|||
148714068|NCT01520987|536425406|FG007|Overall Study|Withdrawal by Subject|0|||
148714069|NCT02005562|536425407|FG000|Overall Study|Death|2|||
148714070|NCT02005562|536425408|FG001|Overall Study|Death|2|||
148714071|NCT02005562|536425407|FG000|Overall Study|Graft loss|7|||
148714072|NCT02005562|536425408|FG001|Overall Study|Graft loss|6|||
148714073|NCT02005562|536425407|FG000|Overall Study|Withdrawal by Subject|2|||
148714074|NCT02005562|536425408|FG001|Overall Study|Withdrawal by Subject|2|||
148714075|NCT02005562|536425407|FG000|Overall Study|No transplant|1|||
148714076|NCT02005562|536425408|FG001|Overall Study|No transplant|4|||
148714077|NCT02005562|536425407|FG000|Overall Study|Physician Decision|0|||
148714078|NCT02005562|536425408|FG001|Overall Study|Physician Decision|1|||
148714079|NCT00274625|536425409|FG000|Overall Study|Lost to Follow-up|46|||
148714080|NCT00274625|536425410|FG001|Overall Study|Lost to Follow-up|54|||
148714081|NCT00274625|536425409|FG000|Overall Study|Excluded from analysis|14|||
148714082|NCT00274625|536425410|FG001|Overall Study|Excluded from analysis|8|||
148714083|NCT01662024|536425417|FG000|Overall Study|Pregnancy|2|||
148714084|NCT01662024|536425417|FG000|Overall Study|Withdrawal by Subject|3|||
148714085|NCT04768296|536425418|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
148714086|NCT04768296|536425419|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
148714087|NCT01119625|536425422|FG000|Overall Study|Lost to Follow-up|1|||
148714088|NCT01119625|536425423|FG001|Overall Study|Lost to Follow-up|2|||
148714089|NCT01119625|536425422|FG000|Overall Study|Withdrawal by Subject|2|||
148714090|NCT01119625|536425423|FG001|Overall Study|Withdrawal by Subject|1|||
148714091|NCT01119625|536425422|FG000|Overall Study|Other|0|||
148714092|NCT01119625|536425423|FG001|Overall Study|Other|1|||
148714093|NCT00210639|536425430|FG000|Overall Study|Lost to Follow-up|37|||
148714094|NCT00210639|536425431|FG001|Overall Study|Lost to Follow-up|29|||
148714095|NCT00210639|536425430|FG000|Overall Study|Withdrawal by Subject|8|||
148714096|NCT00210639|536425431|FG001|Overall Study|Withdrawal by Subject|1|||
148714097|NCT00210639|536425430|FG000|Overall Study|Other|18|||
148714098|NCT00210639|536425431|FG001|Overall Study|Other|12|||
148714099|NCT00397254|536425432|FG000|Overall Study|Lost to Follow-up|2|||
148714100|NCT00397254|536425433|FG001|Overall Study|Lost to Follow-up|2|||
148714101|NCT02627963|536425439|FG000|Overall Study|Randomized but not treated|2|||
148714102|NCT02627963|536425440|FG001|Overall Study|Randomized but not treated|6|||
148714103|NCT03073798|536425441|FG000|Overall Study|Adverse Event|1|||
148714104|NCT03073798|536425441|FG000|Overall Study|Withdrawal by Subject|1|||
148714105|NCT04697173|536425444|FG000|Overall Study|Withdrawal by Subject|34|||
148714106|NCT04697173|536425445|FG001|Overall Study|Withdrawal by Subject|38|||
148714107|NCT05004649|536425449|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
148714108|NCT05004649|536425449|FG000|Overall Study|Lost to Follow-up|1|||
148714109|NCT05004649|536425449|FG000|Overall Study|Withdrawal by Subject|2|||
148714110|NCT05004649|536425449|FG000|Overall Study|COVID-19|1|||
148714111|NCT04133311|536425451|FG000|Period 1 Double Masked Treatment Period|Death|1|||
148714112|NCT04133311|536425452|FG001|Period 1 Double Masked Treatment Period|Death|0|||
148714113|NCT04133311|536425453|FG002|Period 1 Double Masked Treatment Period|Death|0|||
148714114|NCT04133311|536425454|FG003|Period 1 Double Masked Treatment Period|Death|0|||
148714115|NCT04133311|536425451|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
148714116|NCT04133311|536425452|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
148714117|NCT04133311|536425453|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
148714118|NCT04133311|536425454|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
148714119|NCT04133311|536425451|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
148714120|NCT04133311|536425452|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
148714121|NCT04133311|536425453|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
148714122|NCT04133311|536425454|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
148714123|NCT04133311|536425451|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
148714124|NCT04133311|536425452|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
148714125|NCT04133311|536425453|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
148714126|NCT04133311|536425454|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
148714127|NCT04133311|536425451|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
148714128|NCT04133311|536425452|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
148815689|NCT00849472|536800602|FG000|Weekly Paclitaxel|Adverse Event|11|||
148714129|NCT04133311|536425453|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
148714130|NCT04133311|536425454|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
148714131|NCT04133311|536425451|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
148714132|NCT04133311|536425452|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
148714133|NCT04133311|536425453|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
148815690|NCT00849472|536800602|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
148714134|NCT04133311|536425454|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
148714135|NCT04133311|536425451|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
148714136|NCT04133311|536425452|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
148714137|NCT04133311|536425453|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
148714138|NCT04133311|536425454|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
148714139|NCT04133311|536425451|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
148714140|NCT04133311|536425452|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
148714141|NCT04133311|536425453|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
148714142|NCT04133311|536425454|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
148714143|NCT00728754|536425457|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
148714144|NCT00728754|536425458|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
148714145|NCT00728754|536425457|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
148714146|NCT00728754|536425458|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
148714147|NCT00728754|536425457|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
148714148|NCT00728754|536425458|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
148714149|NCT01859598|536425459|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
148714150|NCT00573313|536425464|FG000|Overall Study|Protocol Violation|5|||
148714151|NCT00573313|536425465|FG001|Overall Study|Protocol Violation|0|||
148714152|NCT00573313|536425466|FG002|Overall Study|Protocol Violation|6|||
148714153|NCT00573313|536425467|FG003|Overall Study|Protocol Violation|0|||
148714154|NCT00295490|536425470|FG000|Overall Study|Protocol Violation|0|||
148714155|NCT00295490|536425471|FG001|Overall Study|Protocol Violation|0|||
148714156|NCT00295490|536425472|FG002|Overall Study|Protocol Violation|3|||
148714157|NCT00295490|536425473|FG003|Overall Study|Protocol Violation|3|||
148714158|NCT00295490|536425470|FG000|Overall Study|Withdrawal by Subject|0|||
148714159|NCT00295490|536425471|FG001|Overall Study|Withdrawal by Subject|2|||
148714160|NCT00295490|536425472|FG002|Overall Study|Withdrawal by Subject|0|||
148714161|NCT00295490|536425473|FG003|Overall Study|Withdrawal by Subject|1|||
148714162|NCT00295490|536425470|FG000|Overall Study|Lost to Follow-up|0|||
148714163|NCT00295490|536425471|FG001|Overall Study|Lost to Follow-up|0|||
148714164|NCT00295490|536425472|FG002|Overall Study|Lost to Follow-up|1|||
148714165|NCT00295490|536425473|FG003|Overall Study|Lost to Follow-up|0|||
148714166|NCT00295490|536425470|FG000|Overall Study|Adverse Event|1|||
148714167|NCT00295490|536425471|FG001|Overall Study|Adverse Event|0|||
148714168|NCT00295490|536425472|FG002|Overall Study|Adverse Event|0|||
148714169|NCT00295490|536425473|FG003|Overall Study|Adverse Event|0|||
148714170|NCT00295490|536425470|FG000|Overall Study|Other|0|||
148714171|NCT00295490|536425471|FG001|Overall Study|Other|2|||
148714172|NCT00295490|536425472|FG002|Overall Study|Other|0|||
148714173|NCT00295490|536425473|FG003|Overall Study|Other|1|||
148714174|NCT03885934|536425474|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
148714175|NCT03885934|536425475|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
148714176|NCT03885934|536425476|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
148714177|NCT03885934|536425477|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
148714178|NCT03885934|536425478|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
148714179|NCT03885934|536425479|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
148714180|NCT04473326|536425480|FG000|Overall Study|Death|0|||
148714181|NCT04473326|536425481|FG001|Overall Study|Death|1|||
148714182|NCT04473326|536425480|FG000|Overall Study|Withdrawal by Subject|1|||
148714183|NCT04473326|536425481|FG001|Overall Study|Withdrawal by Subject|2|||
148714184|NCT00354159|536425482|FG000|Randomized Study Period|Withdrawal by Subject|5|||
148714185|NCT00354159|536425483|FG001|Randomized Study Period|Withdrawal by Subject|3|||
148714186|NCT00354159|536425482|FG000|Randomized Study Period|Physician Decision|6|||
148714187|NCT00354159|536425483|FG001|Randomized Study Period|Physician Decision|10|||
148714188|NCT00354159|536425482|FG000|Randomized Study Period|Lost to Follow-up|4|||
148714189|NCT00354159|536425483|FG001|Randomized Study Period|Lost to Follow-up|0|||
148968641|NCT01083433|537372742|FG001|Overall Study|Withdrawal by Subject|5|||
148968642|NCT01083433|537372743|FG002|Overall Study|Withdrawal by Subject|3|||
148968643|NCT01083433|537372741|FG000|Overall Study|Pregnancy|0|||
148714190|NCT00354159|536425482|FG000|Randomized Study Period|Death|7|||
148714191|NCT00354159|536425483|FG001|Randomized Study Period|Death|9|||
148714192|NCT00354159|536425482|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
148714193|NCT00354159|536425483|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
148968644|NCT01083433|537372742|FG001|Overall Study|Pregnancy|0|||
148968645|NCT01083433|537372743|FG002|Overall Study|Pregnancy|1|||
148714194|NCT00354159|536425482|FG000|Long-term Follow-up|Physician Decision|127|||
148714195|NCT00354159|536425483|FG001|Long-term Follow-up|Physician Decision|122|||
148714196|NCT00354159|536425482|FG000|Long-term Follow-up|Lost to Follow-up|1|||
148714197|NCT00354159|536425483|FG001|Long-term Follow-up|Lost to Follow-up|0|||
148714198|NCT00354159|536425482|FG000|Long-term Follow-up|Death|14|||
148815691|NCT00849472|536800602|FG000|Weekly Paclitaxel|Physician Decision|3|||
148714199|NCT00354159|536425483|FG001|Long-term Follow-up|Death|11|||
148714200|NCT00354159|536425482|FG000|Long-term Follow-up|Study Closed|29|||
148714201|NCT00354159|536425483|FG001|Long-term Follow-up|Study Closed|34|||
148968646|NCT03003520|537372745|FG000|Overall Study|Adverse Event|9|||
148968647|NCT03003520|537372746|FG001|Overall Study|Adverse Event|0|||
148714202|NCT01532908|536425491|FG000|Overall Study|Not Transplanted|1|||
148714203|NCT01532908|536425492|FG001|Overall Study|Not Transplanted|0|||
148714204|NCT04610580|536425493|FG000|Two-way Crossover Period|Adverse Event|1|||
148714205|NCT04610580|536425494|FG001|Two-way Crossover Period|Adverse Event|0|||
148714206|NCT04610580|536425495|FG002|Two-way Crossover Period|Adverse Event|0|||
148714207|NCT04610580|536425496|FG003|Two-way Crossover Period|Adverse Event|0|||
148714208|NCT04610580|536425497|FG004|Two-way Crossover Period|Adverse Event|0|||
148714209|NCT04610580|536425498|FG005|Two-way Crossover Period|Adverse Event|0|||
148714210|NCT04610580|536425493|FG000|Two-way Crossover Period|Physician Decision|1|||
148714211|NCT04610580|536425494|FG001|Two-way Crossover Period|Physician Decision|0|||
148714212|NCT04610580|536425495|FG002|Two-way Crossover Period|Physician Decision|0|||
148714213|NCT04610580|536425496|FG003|Two-way Crossover Period|Physician Decision|0|||
148714214|NCT04610580|536425497|FG004|Two-way Crossover Period|Physician Decision|0|||
148714215|NCT04610580|536425498|FG005|Two-way Crossover Period|Physician Decision|0|||
148714216|NCT04610580|536425493|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
148714217|NCT04610580|536425494|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
148714218|NCT04610580|536425495|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
148714219|NCT04610580|536425496|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
148714220|NCT04610580|536425497|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
148714221|NCT04610580|536425498|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
148714222|NCT04610580|536425493|FG000|Two-way Crossover Period|Other than specified|0|||
148714223|NCT04610580|536425494|FG001|Two-way Crossover Period|Other than specified|1|||
148714224|NCT04610580|536425495|FG002|Two-way Crossover Period|Other than specified|0|||
148714225|NCT04610580|536425496|FG003|Two-way Crossover Period|Other than specified|0|||
148714226|NCT04610580|536425497|FG004|Two-way Crossover Period|Other than specified|0|||
148714227|NCT04610580|536425498|FG005|Two-way Crossover Period|Other than specified|0|||
148714228|NCT04610580|536425493|FG000|Washout Before Extension Period|Other than specified|0|||
148714229|NCT04610580|536425494|FG001|Washout Before Extension Period|Other than specified|1|||
148714230|NCT04610580|536425495|FG002|Washout Before Extension Period|Other than specified|0|||
148714231|NCT04610580|536425496|FG003|Washout Before Extension Period|Other than specified|0|||
148714232|NCT04610580|536425497|FG004|Washout Before Extension Period|Other than specified|0|||
148714233|NCT04610580|536425498|FG005|Washout Before Extension Period|Other than specified|0|||
148714234|NCT04610580|536425493|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
148714235|NCT04610580|536425494|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
148714236|NCT04610580|536425495|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
148714237|NCT04610580|536425496|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
148714238|NCT04610580|536425497|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
148714239|NCT04610580|536425498|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
148714240|NCT04610580|536425493|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
148714241|NCT04610580|536425494|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
148714242|NCT04610580|536425495|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
148714243|NCT04610580|536425496|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
148714244|NCT04610580|536425497|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
148714245|NCT04610580|536425498|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
148714246|NCT01993940|536425499|FG000|Overall Study|Adverse Event|16|||
148714247|NCT01993940|536425500|FG001|Overall Study|Adverse Event|11|||
148714248|NCT01993940|536425499|FG000|Overall Study|Withdrawal by Subject|15|||
148714249|NCT01993940|536425500|FG001|Overall Study|Withdrawal by Subject|19|||
148714250|NCT01993940|536425499|FG000|Overall Study|Lost to Follow-up|2|||
148714251|NCT01993940|536425500|FG001|Overall Study|Lost to Follow-up|5|||
148714252|NCT01993940|536425499|FG000|Overall Study|Protocol Violation|5|||
148714253|NCT01993940|536425500|FG001|Overall Study|Protocol Violation|8|||
148714254|NCT01993940|536425499|FG000|Overall Study|Death|1|||
148714255|NCT01993940|536425500|FG001|Overall Study|Death|0|||
148714256|NCT01993940|536425499|FG000|Overall Study|Other - Miscellaneous|1|||
148714257|NCT01993940|536425500|FG001|Overall Study|Other - Miscellaneous|1|||
148714258|NCT01670097|536425505|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
148714259|NCT01670097|536425506|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
148714260|NCT01670097|536425505|FG000|Overall Study|Study burden|1|||
148714261|NCT01670097|536425506|FG001|Overall Study|Study burden|0|||
148714262|NCT01670097|536425505|FG000|Overall Study|COPD exacerbation|0|||
148714263|NCT01670097|536425506|FG001|Overall Study|COPD exacerbation|1|||
148714264|NCT01670097|536425505|FG000|Overall Study|Neutropenia|0|||
148714265|NCT01670097|536425506|FG001|Overall Study|Neutropenia|1|||
148714266|NCT01670097|536425505|FG000|Overall Study|Clinical deterioration|0|||
148714267|NCT01670097|536425506|FG001|Overall Study|Clinical deterioration|1|||
148714268|NCT01670097|536425505|FG000|Overall Study|Disease progression|0|||
148714269|NCT01670097|536425506|FG001|Overall Study|Disease progression|1|||
148714270|NCT01824498|536425507|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
148714271|NCT01824498|536425508|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
148714272|NCT01824498|536425509|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
148968648|NCT03003520|537372745|FG000|Overall Study|Death|1|||
148968649|NCT03003520|537372746|FG001|Overall Study|Death|0|||
148714273|NCT01824498|536425510|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
148714274|NCT01824498|536425511|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
148714275|NCT01824498|536425512|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
148714276|NCT01567527|536425513|FG000|Conversion Phase.|Protocol deviation|3|||
148714277|NCT01567527|536425514|FG001|Conversion Phase.|Protocol deviation|0|||
148714278|NCT01567527|536425515|FG002|Conversion Phase.|Protocol deviation|0|||
148714279|NCT01567527|536425516|FG003|Conversion Phase.|Protocol deviation|0|||
148714280|NCT01567527|536425517|FG004|Conversion Phase.|Protocol deviation|0|||
148714281|NCT01567527|536425513|FG000|Conversion Phase.|Met withdrawal criteria|10|||
148714282|NCT01567527|536425514|FG001|Conversion Phase.|Met withdrawal criteria|0|||
148714283|NCT01567527|536425515|FG002|Conversion Phase.|Met withdrawal criteria|0|||
148714284|NCT01567527|536425516|FG003|Conversion Phase.|Met withdrawal criteria|0|||
148714285|NCT01567527|536425517|FG004|Conversion Phase.|Met withdrawal criteria|0|||
148714286|NCT01567527|536425513|FG000|Conversion Phase.|Withdrawal by Subject|32|||
148714287|NCT01567527|536425514|FG001|Conversion Phase.|Withdrawal by Subject|0|||
148714288|NCT01567527|536425515|FG002|Conversion Phase.|Withdrawal by Subject|0|||
148714289|NCT01567527|536425516|FG003|Conversion Phase.|Withdrawal by Subject|0|||
148714290|NCT01567527|536425517|FG004|Conversion Phase.|Withdrawal by Subject|0|||
148714291|NCT01567527|536425513|FG000|Conversion Phase.|Lost to Follow-up|16|||
148714292|NCT01567527|536425514|FG001|Conversion Phase.|Lost to Follow-up|0|||
148714293|NCT01567527|536425515|FG002|Conversion Phase.|Lost to Follow-up|0|||
148714294|NCT01567527|536425516|FG003|Conversion Phase.|Lost to Follow-up|0|||
148714295|NCT01567527|536425517|FG004|Conversion Phase.|Lost to Follow-up|0|||
148714296|NCT01567527|536425513|FG000|Conversion Phase.|Lack of Efficacy|2|||
148714297|NCT01567527|536425514|FG001|Conversion Phase.|Lack of Efficacy|0|||
148714298|NCT01567527|536425515|FG002|Conversion Phase.|Lack of Efficacy|0|||
148714299|NCT01567527|536425516|FG003|Conversion Phase.|Lack of Efficacy|0|||
148714300|NCT01567527|536425517|FG004|Conversion Phase.|Lack of Efficacy|0|||
148714301|NCT01567527|536425513|FG000|Conversion Phase.|Adverse Event|33|||
148714302|NCT01567527|536425514|FG001|Conversion Phase.|Adverse Event|0|||
148714303|NCT01567527|536425515|FG002|Conversion Phase.|Adverse Event|0|||
148714304|NCT01567527|536425516|FG003|Conversion Phase.|Adverse Event|0|||
148968650|NCT03003520|537372745|FG000|Overall Study|Other reasons|4|||
148968651|NCT03003520|537372746|FG001|Overall Study|Other reasons|0|||
148968652|NCT03003520|537372745|FG000|Overall Study|Withdrawal by Subject|6|||
148968653|NCT03003520|537372746|FG001|Overall Study|Withdrawal by Subject|0|||
148968654|NCT03003520|537372745|FG000|Overall Study|Progressive disease|9|||
148968655|NCT03003520|537372746|FG001|Overall Study|Progressive disease|1|||
148968656|NCT01332149|537372747|FG000|Overall Study|Adverse Event|11|||
148968657|NCT01332149|537372748|FG001|Overall Study|Adverse Event|9|||
148968658|NCT01332149|537372747|FG000|Overall Study|Other unspecified|5|||
148968659|NCT01332149|537372748|FG001|Overall Study|Other unspecified|7|||
148968660|NCT01332149|537372747|FG000|Overall Study|Protocol Violation|1|||
148968661|NCT01332149|537372748|FG001|Overall Study|Protocol Violation|3|||
148968662|NCT01332149|537372747|FG000|Overall Study|Withdrawal by Subject|4|||
148968663|NCT01332149|537372748|FG001|Overall Study|Withdrawal by Subject|5|||
148968664|NCT01332149|537372747|FG000|Overall Study|Lost to Follow-up|1|||
148968665|NCT01332149|537372748|FG001|Overall Study|Lost to Follow-up|1|||
148968666|NCT01332149|537372747|FG000|Overall Study|Insufficient clinical response|4|||
148968667|NCT01332149|537372748|FG001|Overall Study|Insufficient clinical response|7|||
148968668|NCT01332149|537372747|FG000|Overall Study|Did not meet entrance criteria|3|||
148968669|NCT01332149|537372748|FG001|Overall Study|Did not meet entrance criteria|4|||
148968670|NCT01332149|537372747|FG000|Overall Study|Randomized but not treated|1|||
148968671|NCT01332149|537372748|FG001|Overall Study|Randomized but not treated|2|||
148968672|NCT04982029|537372749|FG000|Overall Study|Lost to Follow-up|2|||
148968673|NCT04982029|537372750|FG001|Overall Study|Lost to Follow-up|3|||
148968674|NCT03264404|537372751|FG000|Overall Study|Death|2|||
148968675|NCT03264404|537372751|FG000|Overall Study|Physician Decision|1|||
148968676|NCT03264404|537372751|FG000|Overall Study|Disease Progression|28|||
148968677|NCT03264404|537372751|FG000|Overall Study|Adverse Event|1|||
148968678|NCT03264404|537372751|FG000|Overall Study|Off study prior to treatment|2|||
148968679|NCT04615949|537372752|FG000|Overall Study|Withdrawal by Subject|2|||
148968680|NCT04615949|537372753|FG001|Overall Study|Withdrawal by Subject|4|||
148968681|NCT04615949|537372752|FG000|Overall Study|Lost to Follow-up|2|||
148968682|NCT04615949|537372753|FG001|Overall Study|Lost to Follow-up|2|||
148968683|NCT04615949|537372752|FG000|Overall Study|Death|0|||
148968684|NCT04615949|537372753|FG001|Overall Study|Death|2|||
148968685|NCT03036566|537372754|FG000|Overall Study|Lost to Follow-up|3|||
148968686|NCT05458856|537372755|FG000|Overall Study|Withdrawal by Subject|5|||
148968687|NCT05458856|537372755|FG000|Overall Study|Death|4|||
148968688|NCT05458856|537372755|FG000|Overall Study|Protocol Deviation|3|||
148968689|NCT05458856|537372755|FG000|Overall Study|Physician Decision|1|||
148968690|NCT01852292|537372756|FG000|Overall Study|Untreated - did not receive study drug|3|||
148968691|NCT01852292|537372757|FG001|Overall Study|Untreated - did not receive study drug|1|||
148968692|NCT01852292|537372756|FG000|Overall Study|Death|9|||
148968693|NCT01852292|537372757|FG001|Overall Study|Death|8|||
148714305|NCT01567527|536425517|FG004|Conversion Phase.|Adverse Event|0|||
148714306|NCT01567527|536425513|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
148714307|NCT01567527|536425514|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
148714308|NCT01567527|536425515|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
148714309|NCT01567527|536425516|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
148714310|NCT01567527|536425517|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
148714311|NCT01567527|536425513|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
148714312|NCT01567527|536425514|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
148714313|NCT01567527|536425515|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
148714314|NCT01567527|536425516|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
148714315|NCT01567527|536425517|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
148714316|NCT01567527|536425513|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
148714317|NCT01567527|536425514|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
148714318|NCT01567527|536425515|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
148714319|NCT01567527|536425516|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
148714320|NCT01567527|536425517|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
148714321|NCT01567527|536425513|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
148714322|NCT01567527|536425514|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
148714323|NCT01567527|536425515|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
148714324|NCT01567527|536425516|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
148714325|NCT01567527|536425517|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
148714326|NCT01567527|536425513|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
148714327|NCT01567527|536425514|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
148714328|NCT01567527|536425515|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
148714329|NCT01567527|536425516|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
148714330|NCT01567527|536425517|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
148714331|NCT01567527|536425513|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
148714332|NCT01567527|536425514|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
148714333|NCT01567527|536425515|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
148714334|NCT01567527|536425516|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
148714335|NCT01567527|536425517|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
148714336|NCT01567527|536425513|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
148714337|NCT01567527|536425514|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
148714338|NCT01567527|536425515|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
148714339|NCT01567527|536425516|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
148714340|NCT01567527|536425517|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
148714341|NCT01567527|536425513|FG000|IM Depot Stabilization.|Protocol deviation|0|||
148714342|NCT01567527|536425514|FG001|IM Depot Stabilization.|Protocol deviation|0|||
148714343|NCT01567527|536425515|FG002|IM Depot Stabilization.|Protocol deviation|5|||
148714344|NCT01567527|536425516|FG003|IM Depot Stabilization.|Protocol deviation|0|||
148714345|NCT01567527|536425517|FG004|IM Depot Stabilization.|Protocol deviation|0|||
148714346|NCT01567527|536425513|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
148714347|NCT01567527|536425514|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
148714348|NCT01567527|536425515|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
148714349|NCT01567527|536425516|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
148714350|NCT01567527|536425517|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
148714351|NCT01567527|536425513|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
148714352|NCT01567527|536425514|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
148714353|NCT01567527|536425515|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
148714354|NCT01567527|536425516|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
148714355|NCT01567527|536425517|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
148714356|NCT01567527|536425513|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
148714357|NCT01567527|536425514|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
148714358|NCT01567527|536425515|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
148714359|NCT01567527|536425516|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
148714360|NCT01567527|536425517|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
148714361|NCT01567527|536425513|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
148714362|NCT01567527|536425514|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
148714363|NCT01567527|536425515|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
148714364|NCT01567527|536425516|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
148714365|NCT01567527|536425517|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
148714366|NCT01567527|536425513|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
148968694|NCT01852292|537372756|FG000|Overall Study|Patient/guardian decision|8|||
148968695|NCT01852292|537372757|FG001|Overall Study|Patient/guardian decision|4|||
148968696|NCT01852292|537372756|FG000|Overall Study|Adverse Event|8|||
148714367|NCT01567527|536425514|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
148714368|NCT01567527|536425515|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
148968697|NCT01852292|537372757|FG001|Overall Study|Adverse Event|11|||
148714369|NCT01567527|536425516|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
148714370|NCT01567527|536425517|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
148714371|NCT01567527|536425513|FG000|IM Depot Stabilization.|Adverse Event|0|||
148714372|NCT01567527|536425514|FG001|IM Depot Stabilization.|Adverse Event|0|||
148714373|NCT01567527|536425515|FG002|IM Depot Stabilization.|Adverse Event|37|||
148714374|NCT01567527|536425516|FG003|IM Depot Stabilization.|Adverse Event|0|||
148714375|NCT01567527|536425517|FG004|IM Depot Stabilization.|Adverse Event|0|||
148714376|NCT01567527|536425513|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
148714377|NCT01567527|536425514|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
148714378|NCT01567527|536425515|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
148714379|NCT01567527|536425516|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
148714380|NCT01567527|536425517|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
148714381|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
148714382|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
148714383|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
148714384|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
148714385|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
148714386|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
148714387|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
148714388|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
148714389|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
148714390|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
148714391|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
148714392|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
148714393|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
148714394|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
148714395|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
148714396|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
148714397|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
148714398|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
148714399|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
148714400|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
148714401|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
148714402|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
148714403|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
148714404|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
148714405|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
148714406|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
148714407|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
148714408|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
148714409|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
148714410|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
148714411|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
148714412|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
148714413|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
148714414|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
148714415|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
148714416|NCT01567527|536425513|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
148714417|NCT01567527|536425514|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
148714418|NCT01567527|536425515|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
148714419|NCT01567527|536425516|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
148968698|NCT01852292|537372756|FG000|Overall Study|Physician Decision|6|||
148968699|NCT01852292|537372757|FG001|Overall Study|Physician Decision|2|||
148968700|NCT01852292|537372756|FG000|Overall Study|Protocol Violation|2|||
148968701|NCT01852292|537372757|FG001|Overall Study|Protocol Violation|0|||
148968702|NCT01852292|537372756|FG000|Overall Study|Non-compliance with study treatment|1|||
148968703|NCT01852292|537372757|FG001|Overall Study|Non-compliance with study treatment|0|||
148968704|NCT01852292|537372756|FG000|Overall Study|Study terminated by Sponsor|0|||
148968705|NCT01852292|537372757|FG001|Overall Study|Study terminated by Sponsor|1|||
148968706|NCT01852292|537372756|FG000|Overall Study|Progressive disease|42|||
148968707|NCT01852292|537372757|FG001|Overall Study|Progressive disease|52|||
148968708|NCT02388737|537372759|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
148968709|NCT02388737|537372760|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
148968710|NCT02388737|537372761|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
148714420|NCT01567527|536425517|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
148714421|NCT02311894|536425519|FG000|Overall Study|Discontinued in error|1|||
148714422|NCT02311894|536425519|FG000|Overall Study|Lost to Follow-up|1|||
148714423|NCT02311894|536425519|FG000|Overall Study|Adverse Event|1|||
148714424|NCT02311894|536425519|FG000|Overall Study|Withdrawal by Subject|1|||
148714425|NCT00537095|536425521|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
148714426|NCT00537095|536425522|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
148714427|NCT00537095|536425521|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
148714428|NCT00537095|536425522|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
148714429|NCT00537095|536425521|FG000|Randomized Treatment Period (433 Days)|Death|3|||
148714430|NCT00537095|536425522|FG001|Randomized Treatment Period (433 Days)|Death|1|||
148714431|NCT00537095|536425521|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
148714432|NCT00537095|536425522|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
148714433|NCT00537095|536425521|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
148714434|NCT00537095|536425522|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
148714435|NCT00537095|536425521|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
148714436|NCT00537095|536425522|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
148714437|NCT00537095|536425521|FG000|Open-label Period (590 Days)|Adverse Event|2|||
148714438|NCT00537095|536425522|FG001|Open-label Period (590 Days)|Adverse Event|11|||
148714439|NCT00537095|536425521|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
148714440|NCT00537095|536425522|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
148714441|NCT00537095|536425521|FG000|Open-label Period (590 Days)|Death|2|||
148714442|NCT00537095|536425522|FG001|Open-label Period (590 Days)|Death|2|||
148714443|NCT00537095|536425521|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
148714444|NCT00537095|536425522|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
148714445|NCT00537095|536425521|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
148714446|NCT00537095|536425522|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
148714447|NCT00533507|536425523|FG000|Overall Study|Withdrawal by Subject|1|||
148714448|NCT02943096|536425526|FG000|Overall Study|Lack of Efficacy|0|||
148714449|NCT02943096|536425527|FG001|Overall Study|Lack of Efficacy|1|||
148714450|NCT05065619|536425528|FG000|Up to Day 42|Lost to Follow-up|1|||
148714451|NCT05065619|536425529|FG001|Up to Day 42|Lost to Follow-up|0|||
148714452|NCT05065619|536425528|FG000|Up to Day 42|Withdrawal by Subject|1|||
148714453|NCT05065619|536425529|FG001|Up to Day 42|Withdrawal by Subject|0|||
148714454|NCT05065619|536425528|FG000|After Day 43|Lost to Follow-up|1|||
148714455|NCT05065619|536425529|FG001|After Day 43|Lost to Follow-up|0|||
148714456|NCT05065619|536425528|FG000|After Day 43|Physician Decision|3|||
148714457|NCT05065619|536425529|FG001|After Day 43|Physician Decision|0|||
148714458|NCT05065619|536425528|FG000|After Day 43|Withdrawal by Subject|1|||
148714459|NCT05065619|536425529|FG001|After Day 43|Withdrawal by Subject|2|||
148714460|NCT05065619|536425528|FG000|After Day 43|Public vaccination|6|||
148714461|NCT05065619|536425529|FG001|After Day 43|Public vaccination|8|||
148714462|NCT05065619|536425528|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
148714463|NCT05065619|536425529|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
148714464|NCT05065619|536425528|FG000|After Day 43|Study Terminated by Sponsor|88|||
148714465|NCT05065619|536425529|FG001|After Day 43|Study Terminated by Sponsor|16|||
148714466|NCT00939523|536425530|FG000|Overall Study|Lack of Efficacy|1|||
148714467|NCT00939523|536425530|FG000|Overall Study|Physician Decision|2|||
148714468|NCT01528735|536425536|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
148714469|NCT01528735|536425537|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
148714470|NCT01528735|536425536|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
148714471|NCT01528735|536425537|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
148714472|NCT00556673|536425538|FG000|Overall Study|Protocol deviation|3|||
148714473|NCT00556673|536425539|FG001|Overall Study|Protocol deviation|2|||
148714474|NCT00494013|536425540|FG000|Overall Study|Adverse Event|0|||
148714475|NCT00494013|536425541|FG001|Overall Study|Adverse Event|1|||
148714476|NCT00494013|536425540|FG000|Overall Study|Entry Criteria Not Met|1|||
148714477|NCT00494013|536425541|FG001|Overall Study|Entry Criteria Not Met|4|||
148714478|NCT00494013|536425540|FG000|Overall Study|Lost to Follow-up|5|||
148714479|NCT00494013|536425541|FG001|Overall Study|Lost to Follow-up|6|||
148714480|NCT00494013|536425540|FG000|Overall Study|Physician Decision|3|||
148714481|NCT00494013|536425541|FG001|Overall Study|Physician Decision|5|||
148714482|NCT00494013|536425540|FG000|Overall Study|Protocol Violation|8|||
148714483|NCT00494013|536425541|FG001|Overall Study|Protocol Violation|5|||
148714484|NCT00494013|536425540|FG000|Overall Study|Withdrawal by Subject|13|||
148714485|NCT00494013|536425541|FG001|Overall Study|Withdrawal by Subject|14|||
148714486|NCT00494013|536425540|FG000|Overall Study|Sponsor Decision|0|||
148714487|NCT00494013|536425541|FG001|Overall Study|Sponsor Decision|1|||
148714488|NCT00421304|536425542|FG000|Overall Study|Lost to Follow-up|5|||
148714489|NCT00421304|536425543|FG001|Overall Study|Lost to Follow-up|2|||
148714490|NCT00421304|536425544|FG002|Overall Study|Lost to Follow-up|5|||
148968711|NCT02388737|537372759|FG000|Overall Study|Major Protocol Deviation|18|||
148968712|NCT02388737|537372760|FG001|Overall Study|Major Protocol Deviation|25|||
148968713|NCT02388737|537372761|FG002|Overall Study|Major Protocol Deviation|22|||
148968714|NCT02388737|537372759|FG000|Overall Study|Lost to Follow-up|5|||
148968715|NCT02388737|537372760|FG001|Overall Study|Lost to Follow-up|1|||
148968716|NCT02388737|537372761|FG002|Overall Study|Lost to Follow-up|4|||
148968717|NCT02388737|537372759|FG000|Overall Study|Voluntary Withdrawal|10|||
148968718|NCT02388737|537372760|FG001|Overall Study|Voluntary Withdrawal|18|||
148968719|NCT02388737|537372761|FG002|Overall Study|Voluntary Withdrawal|17|||
148968720|NCT02388737|537372759|FG000|Overall Study|Lack of Efficacy|3|||
148714491|NCT00421304|536425542|FG000|Overall Study|Withdrawal by Subject|2|||
148714492|NCT00421304|536425543|FG001|Overall Study|Withdrawal by Subject|2|||
148714493|NCT00421304|536425544|FG002|Overall Study|Withdrawal by Subject|2|||
148714494|NCT00421304|536425542|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
148714495|NCT00421304|536425543|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
148714496|NCT00421304|536425544|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
148714497|NCT00421304|536425542|FG000|Overall Study|Did not attend Day 360 visit|0|||
148714498|NCT00421304|536425543|FG001|Overall Study|Did not attend Day 360 visit|0|||
148714499|NCT00421304|536425544|FG002|Overall Study|Did not attend Day 360 visit|1|||
148714500|NCT04750239|536425545|FG000|Overall Study|Withdrawal by Subject|2|||
148714501|NCT04750239|536425545|FG000|Overall Study|Trial terminated by sponsor|1|||
148714502|NCT01912807|536425546|FG000|Overall Study|Did not meet elegibility criteria|6|||
148714503|NCT01912807|536425547|FG001|Overall Study|Did not meet elegibility criteria|4|||
148714504|NCT01912807|536425546|FG000|Overall Study|Lost to Follow-up|36|||
148714505|NCT01912807|536425547|FG001|Overall Study|Lost to Follow-up|37|||
148714506|NCT00919711|536425548|FG000|Overall Study|Withdrawal by Subject|15|||
148714507|NCT00919711|536425549|FG001|Overall Study|Withdrawal by Subject|7|||
148714508|NCT00919711|536425548|FG000|Overall Study|Adverse Event|13|||
148714509|NCT00919711|536425549|FG001|Overall Study|Adverse Event|3|||
148714510|NCT00919711|536425548|FG000|Overall Study|Other|1|||
148714511|NCT00919711|536425549|FG001|Overall Study|Other|2|||
148714512|NCT00919711|536425548|FG000|Overall Study|Administrative Decision|0|||
148714513|NCT00919711|536425549|FG001|Overall Study|Administrative Decision|1|||
148714514|NCT00919711|536425548|FG000|Overall Study|Lost to Follow-up|2|||
148714515|NCT00919711|536425549|FG001|Overall Study|Lost to Follow-up|0|||
148714516|NCT00919711|536425548|FG000|Overall Study|Death|1|||
148714517|NCT00919711|536425549|FG001|Overall Study|Death|0|||
148714518|NCT00919711|536425548|FG000|Overall Study|Noncompliance|1|||
148714519|NCT00919711|536425549|FG001|Overall Study|Noncompliance|0|||
148714520|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Adverse Event|8|||
148714521|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Adverse Event|5|||
148714522|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Adverse Event|9|||
148714523|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Adverse Event|0|||
148714524|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Adverse Event|0|||
148714525|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Adverse Event|0|||
148714526|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
148714527|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
148714528|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
148714529|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
148714530|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
148714531|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
148714532|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
148815692|NCT00849472|536800602|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
148968721|NCT02388737|537372760|FG001|Overall Study|Lack of Efficacy|0|||
148968722|NCT02388737|537372761|FG002|Overall Study|Lack of Efficacy|3|||
148968723|NCT02388737|537372759|FG000|Overall Study|Reason Not Specified|5|||
148968724|NCT02388737|537372760|FG001|Overall Study|Reason Not Specified|5|||
148968725|NCT02388737|537372761|FG002|Overall Study|Reason Not Specified|4|||
148714533|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
148714534|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
148714535|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
148714536|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
148714537|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
148714538|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Physician Decision|4|||
148714539|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Physician Decision|0|||
148714540|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Physician Decision|2|||
148714541|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Physician Decision|0|||
148714542|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Physician Decision|0|||
148714543|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Physician Decision|0|||
148714544|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Pregnancy|1|||
148714545|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Pregnancy|2|||
148714546|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Pregnancy|0|||
148714547|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Pregnancy|0|||
148714548|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Pregnancy|0|||
148714549|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Pregnancy|0|||
148714550|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
148714551|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
148714552|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
148714553|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
148714554|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
148714555|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
148714556|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
148714557|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
148714558|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
148714559|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
148714560|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
148714561|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
148714562|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
148714563|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
148714564|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
148714565|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
148714566|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
148714567|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
148714568|NCT02614196|536425550|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
148714569|NCT02614196|536425551|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
148714570|NCT02614196|536425552|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
148714571|NCT02614196|536425553|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
148714572|NCT02614196|536425554|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
148714573|NCT02614196|536425555|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
148714574|NCT02614196|536425550|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
148714575|NCT02614196|536425551|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
148714576|NCT02614196|536425552|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
148714577|NCT02614196|536425553|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
148714578|NCT02614196|536425554|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
148714579|NCT02614196|536425555|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
148714580|NCT02614196|536425550|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
148714581|NCT02614196|536425551|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
148714582|NCT02614196|536425552|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
148714583|NCT02614196|536425553|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
148714584|NCT02614196|536425554|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
148714585|NCT02614196|536425555|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
148714586|NCT02614196|536425550|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
148714587|NCT02614196|536425551|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
148815693|NCT00849472|536800602|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
148815694|NCT00849472|536800602|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
148815695|NCT00849472|536800602|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
148815696|NCT00849472|536800602|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
148815697|NCT00849472|536800602|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
148815698|NCT00849472|536800602|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
148815699|NCT00849472|536800602|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
148968726|NCT01888497|537372762|FG000|Washout Period 1|Withdrawal by Subject|0|||
148714588|NCT02614196|536425552|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
148714589|NCT02614196|536425553|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
148714590|NCT02614196|536425554|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
148714591|NCT02614196|536425555|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
148714592|NCT02614196|536425550|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
148714593|NCT02614196|536425551|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
148714594|NCT02614196|536425552|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
148714595|NCT02614196|536425553|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
148714596|NCT02614196|536425554|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
148714597|NCT02614196|536425555|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
148714598|NCT00903877|536425556|FG000|Overall Study|Did not meet study criteria|33|||
148714599|NCT00903877|536425556|FG000|Overall Study|Withdrawal by Subject|3|||
148968727|NCT01888497|537372763|FG001|Washout Period 1|Withdrawal by Subject|0|||
148714600|NCT00903877|536425556|FG000|Overall Study|Adverse Event|2|||
148714601|NCT00903877|536425556|FG000|Overall Study|Lost to Follow-up|1|||
148714602|NCT00903877|536425556|FG000|Overall Study|Participation put on hold|4|||
148714603|NCT01562613|536425557|FG000|Overall Study|Lost to Follow-up|2|||
148714604|NCT01562613|536425557|FG000|Overall Study|Withdrawal by Subject|2|||
148714605|NCT04388787|536425558|FG000|Blinded Period|Patient could not follow instructions|1|||
148714606|NCT04388787|536425558|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
148714607|NCT00663234|536425559|FG000|Overall Study|Not willing to adhere to requirements|1|||
148714608|NCT01253564|536425562|FG000|Overall Study|Disease Progression|22|||
148714609|NCT01253564|536425562|FG000|Overall Study|Withdrawal by Subject|1|||
148714610|NCT01253564|536425562|FG000|Overall Study|Serious Adverse Event|1|||
148714611|NCT04729101|536427739|FG000|Overall Study|Adverse Event|1|||
148714612|NCT04729101|536427740|FG001|Overall Study|Adverse Event|0|||
148714613|NCT04729101|536427739|FG000|Overall Study|Physician Decision|1|||
148714614|NCT04729101|536427740|FG001|Overall Study|Physician Decision|0|||
148714615|NCT04729101|536427739|FG000|Overall Study|Withdrawal by Subject|1|||
148714616|NCT04729101|536427740|FG001|Overall Study|Withdrawal by Subject|0|||
148714617|NCT02940522|536427741|FG000|Overall Study|Lost to Follow-up|1|||
148714618|NCT02940522|536427742|FG001|Overall Study|Lost to Follow-up|2|||
148714619|NCT02940522|536427741|FG000|Overall Study|Withdrawal by Subject|1|||
148714620|NCT02940522|536427742|FG001|Overall Study|Withdrawal by Subject|0|||
148714621|NCT00762411|536427745|FG000|Initial Treatment|Death|7|||
148714622|NCT00762411|536427746|FG001|Initial Treatment|Death|6|||
148714623|NCT00762411|536427745|FG000|Initial Treatment|Adverse Event|132|||
148714624|NCT00762411|536427746|FG001|Initial Treatment|Adverse Event|40|||
148714625|NCT00762411|536427745|FG000|Initial Treatment|Protocol Violation|4|||
148714626|NCT00762411|536427746|FG001|Initial Treatment|Protocol Violation|1|||
148714627|NCT00762411|536427745|FG000|Initial Treatment|Withdrawal by Subject|65|||
148714628|NCT00762411|536427746|FG001|Initial Treatment|Withdrawal by Subject|52|||
148714629|NCT00762411|536427745|FG000|Initial Treatment|Physician Decision|1|||
148714630|NCT00762411|536427746|FG001|Initial Treatment|Physician Decision|0|||
148714631|NCT00762411|536427745|FG000|Initial Treatment|Sponsor Decision|293|||
148714632|NCT00762411|536427746|FG001|Initial Treatment|Sponsor Decision|401|||
148714633|NCT00762411|536427745|FG000|Initial Treatment|Lost to Follow-up|5|||
148714634|NCT00762411|536427746|FG001|Initial Treatment|Lost to Follow-up|0|||
148714635|NCT00762411|536427745|FG000|Initial Treatment|Caregiver Decision|21|||
148714636|NCT00762411|536427746|FG001|Initial Treatment|Caregiver Decision|16|||
148714637|NCT00762411|536427745|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
148714638|NCT00762411|536427746|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
148714639|NCT00762411|536427745|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
148714640|NCT00762411|536427746|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
148714641|NCT00762411|536427745|FG000|Delayed Start|Adverse Event|0|||
148714642|NCT00762411|536427746|FG001|Delayed Start|Adverse Event|4|||
148714643|NCT00762411|536427745|FG000|Delayed Start|Protocol Violation|0|||
148714644|NCT00762411|536427746|FG001|Delayed Start|Protocol Violation|1|||
148714645|NCT00762411|536427745|FG000|Delayed Start|Sponsor Decision|16|||
148714646|NCT00762411|536427746|FG001|Delayed Start|Sponsor Decision|20|||
148714647|NCT00762411|536427745|FG000|Delayed Start|Caregiver Decision|1|||
148714648|NCT00762411|536427746|FG001|Delayed Start|Caregiver Decision|1|||
148714649|NCT00762411|536427745|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
148714650|NCT00762411|536427746|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
148714651|NCT00762411|536427745|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
148714652|NCT00762411|536427746|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
148714653|NCT00762411|536427745|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
148714654|NCT00762411|536427746|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
148714655|NCT00762411|536427745|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
148714656|NCT00762411|536427746|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
148714657|NCT00762411|536427745|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
148714658|NCT00762411|536427746|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
148714659|NCT00762411|536427745|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
148714660|NCT00762411|536427746|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
148714661|NCT02710214|536427750|FG000|Overall Study|Lost to Follow-up|1|||
148714662|NCT02710214|536427751|FG001|Overall Study|Lost to Follow-up|0|||
148714663|NCT02710214|536427750|FG000|Overall Study|Lack of Efficacy|0|||
148714664|NCT02710214|536427751|FG001|Overall Study|Lack of Efficacy|1|||
148714665|NCT02710214|536427750|FG000|Overall Study|Death|0|||
148714666|NCT02710214|536427751|FG001|Overall Study|Death|1|||
148714667|NCT02832167|536427752|FG000|Treatment Period 1|Disease progression|90|||
148714668|NCT02832167|536427752|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
148714669|NCT02832167|536427752|FG000|Treatment Period 1|Death|2|||
148714670|NCT02832167|536427752|FG000|Treatment Period 1|Study Drug Toxicity|6|||
148714671|NCT02832167|536427752|FG000|Treatment Period 1|Participant request to discontinue|9|||
148714672|NCT02832167|536427752|FG000|Treatment Period 1|No longer meet study criteria|1|||
148714673|NCT02832167|536427752|FG000|Treatment Period 1|Participant withdrew consent|3|||
148714674|NCT02832167|536427752|FG000|Treatment Period 1|Other reasons|6|||
148714675|NCT02832167|536427752|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
148714676|NCT02832167|536427752|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
148714677|NCT02832167|536427752|FG000|Transition From Period 1 to Period 2|Death|2|||
148714678|NCT02832167|536427752|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
148714679|NCT02832167|536427752|FG000|Treatment Period 2|Disease progression|69|||
148714680|NCT02832167|536427752|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
148714681|NCT02832167|536427752|FG000|Treatment Period 2|Maximum clinical benefit|1|||
148714682|NCT02832167|536427752|FG000|Treatment Period 2|Study Drug Toxicity|5|||
148714683|NCT02832167|536427752|FG000|Treatment Period 2|Participant request to discontinue|2|||
148714684|NCT02832167|536427752|FG000|Treatment Period 2|Participant withdrew consent|3|||
148714685|NCT02832167|536427752|FG000|Treatment Period 2|Other reasons|3|||
148714686|NCT01754376|536427753|FG000|Overall Study|Adverse Event|1|||
148714687|NCT01754376|536427753|FG000|Overall Study|Lack of Efficacy|2|||
148714688|NCT04556734|536427754|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
148714689|NCT04556734|536427755|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
148714690|NCT04556734|536427756|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
148968728|NCT01888497|537372764|FG002|Washout Period 1|Withdrawal by Subject|1|||
148968729|NCT01888497|537372765|FG003|Washout Period 1|Withdrawal by Subject|1|||
148968730|NCT01888497|537372762|FG000|Washout Period 2|Adverse Event|0|||
148968731|NCT01888497|537372763|FG001|Washout Period 2|Adverse Event|0|||
148968732|NCT01888497|537372764|FG002|Washout Period 2|Adverse Event|0|||
148968733|NCT01888497|537372765|FG003|Washout Period 2|Adverse Event|1|||
148968734|NCT01888497|537372762|FG000|Washout Period 2|Withdrawal by Subject|0|||
148968735|NCT01888497|537372763|FG001|Washout Period 2|Withdrawal by Subject|0|||
148968736|NCT01888497|537372764|FG002|Washout Period 2|Withdrawal by Subject|0|||
148968737|NCT01888497|537372765|FG003|Washout Period 2|Withdrawal by Subject|1|||
148968738|NCT04152447|537372766|FG000|Overall Study|Lost to Follow-up|1|||
148968739|NCT04152447|537372767|FG001|Overall Study|Lost to Follow-up|0|||
148968740|NCT04152447|537372766|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
148968741|NCT04152447|537372767|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
148968742|NCT04152447|537372766|FG000|Overall Study|Withdrawal by Subject|0|||
148968743|NCT04152447|537372767|FG001|Overall Study|Withdrawal by Subject|1|||
148968744|NCT04152447|537372766|FG000|Overall Study|Found ineligible after enrolling|1|||
148968745|NCT04152447|537372767|FG001|Overall Study|Found ineligible after enrolling|1|||
148968746|NCT04152447|537372766|FG000|Overall Study|Did not receive VR headset in time.|0|||
148968747|NCT04152447|537372767|FG001|Overall Study|Did not receive VR headset in time.|2|||
148968748|NCT03711162|537372776|FG000|Overall Study|Adverse Event|5|||
148968749|NCT03711162|537372777|FG001|Overall Study|Adverse Event|2|||
148968750|NCT03711162|537372778|FG002|Overall Study|Adverse Event|4|||
148714691|NCT04556734|536427757|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148714692|NCT04556734|536427758|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148714693|NCT04556734|536427759|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148714694|NCT04556734|536427760|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148714695|NCT04556734|536427761|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148714696|NCT04556734|536427754|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
148714697|NCT04556734|536427755|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714698|NCT04556734|536427756|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714699|NCT04556734|536427757|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714700|NCT04556734|536427758|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714701|NCT04556734|536427759|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714702|NCT04556734|536427760|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714703|NCT04556734|536427761|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
148714704|NCT04556734|536427754|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
148714705|NCT04556734|536427755|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148714706|NCT04556734|536427756|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
148714707|NCT04556734|536427757|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148714708|NCT04556734|536427758|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148714709|NCT04556734|536427759|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148714710|NCT04556734|536427760|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148968751|NCT03711162|537372776|FG000|Overall Study|Death|11|||
148968752|NCT03711162|537372777|FG001|Overall Study|Death|7|||
148968753|NCT03711162|537372778|FG002|Overall Study|Death|8|||
148714711|NCT04556734|536427761|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
148714712|NCT04556734|536427754|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
148968754|NCT03711162|537372776|FG000|Overall Study|Lost to Follow-up|1|||
148968755|NCT03711162|537372777|FG001|Overall Study|Lost to Follow-up|0|||
148714713|NCT04556734|536427755|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148968756|NCT03711162|537372778|FG002|Overall Study|Lost to Follow-up|1|||
148968757|NCT03711162|537372776|FG000|Overall Study|Study Terminated by Sponsor|139|||
148714714|NCT04556734|536427756|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148714715|NCT04556734|536427757|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148968758|NCT03711162|537372777|FG001|Overall Study|Study Terminated by Sponsor|152|||
148714716|NCT04556734|536427758|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148714717|NCT04556734|536427759|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148714718|NCT04556734|536427760|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148714719|NCT04556734|536427761|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
148714720|NCT04556734|536427754|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714721|NCT04556734|536427755|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714722|NCT04556734|536427756|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
148714723|NCT04556734|536427757|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714724|NCT04556734|536427758|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714725|NCT04556734|536427759|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714726|NCT04556734|536427760|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714727|NCT04556734|536427761|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
148714728|NCT04556734|536427754|FG000|OLE Period (28 Weeks)|Not reported|0|||
148714729|NCT04556734|536427755|FG001|OLE Period (28 Weeks)|Not reported|0|||
148714730|NCT04556734|536427756|FG002|OLE Period (28 Weeks)|Not reported|0|||
148714731|NCT04556734|536427757|FG003|OLE Period (28 Weeks)|Not reported|0|||
148714732|NCT04556734|536427758|FG004|OLE Period (28 Weeks)|Not reported|0|||
148714733|NCT04556734|536427759|FG005|OLE Period (28 Weeks)|Not reported|1|||
148714734|NCT04556734|536427760|FG006|OLE Period (28 Weeks)|Not reported|0|||
148714735|NCT04556734|536427761|FG007|OLE Period (28 Weeks)|Not reported|0|||
148714736|NCT04556734|536427754|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714737|NCT04556734|536427755|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714738|NCT04556734|536427756|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714739|NCT04556734|536427757|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714740|NCT04556734|536427758|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714741|NCT04556734|536427759|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714742|NCT04556734|536427760|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
148714743|NCT04556734|536427761|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
148714744|NCT04556734|536427754|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
148714745|NCT04556734|536427755|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
148714746|NCT04556734|536427756|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
148714747|NCT04556734|536427757|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
148714748|NCT04556734|536427758|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
148714749|NCT04556734|536427759|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
148714750|NCT04556734|536427760|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
148714751|NCT04556734|536427761|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
148714752|NCT04556734|536427754|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148714753|NCT04556734|536427755|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148714754|NCT04556734|536427756|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148714755|NCT04556734|536427757|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
148714756|NCT04556734|536427758|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
148714757|NCT04556734|536427759|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
148714758|NCT04556734|536427760|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
148714759|NCT04556734|536427761|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
148714760|NCT04264819|536427767|FG000|Overall Study|Physician Decision|19|||
148714761|NCT04264819|536427767|FG000|Overall Study|Adverse Event|12|||
148714762|NCT04264819|536427767|FG000|Overall Study|Withdrawal by Subject|11|||
148714763|NCT04264819|536427767|FG000|Overall Study|Lost to Follow-up|2|||
148714764|NCT04264819|536427767|FG000|Overall Study|Death|2|||
148714765|NCT01680016|536427768|FG000|Overall Study|Adverse Event|0|||
148714766|NCT01680016|536427769|FG001|Overall Study|Adverse Event|0|||
148714767|NCT01680016|536427770|FG002|Overall Study|Adverse Event|1|||
148714768|NCT01680016|536427771|FG003|Overall Study|Adverse Event|4|||
148714769|NCT01680016|536427768|FG000|Overall Study|The Subject went out of The Trial|1|||
148714770|NCT01680016|536427769|FG001|Overall Study|The Subject went out of The Trial|0|||
148714771|NCT01680016|536427770|FG002|Overall Study|The Subject went out of The Trial|3|||
148714772|NCT01680016|536427771|FG003|Overall Study|The Subject went out of The Trial|0|||
148714773|NCT01680016|536427768|FG000|Overall Study|Protocol Violation|0|||
148714774|NCT01680016|536427769|FG001|Overall Study|Protocol Violation|1|||
148714775|NCT01680016|536427770|FG002|Overall Study|Protocol Violation|0|||
148714776|NCT01680016|536427771|FG003|Overall Study|Protocol Violation|0|||
148714777|NCT01680016|536427768|FG000|Overall Study|Withdrawal by Subject|5|||
148968759|NCT03711162|537372778|FG002|Overall Study|Study Terminated by Sponsor|146|||
148714778|NCT01680016|536427769|FG001|Overall Study|Withdrawal by Subject|7|||
148714779|NCT01680016|536427770|FG002|Overall Study|Withdrawal by Subject|1|||
148714780|NCT01680016|536427771|FG003|Overall Study|Withdrawal by Subject|1|||
148714781|NCT02846883|536427779|FG000|Overall Study|Death|0|||
148714782|NCT02846883|536427780|FG001|Overall Study|Death|1|||
148968760|NCT03711162|537372776|FG000|Overall Study|Withdrawal by Subject|17|||
148714783|NCT02846883|536427781|FG002|Overall Study|Death|1|||
148714784|NCT02846883|536427779|FG000|Overall Study|Lost to Follow-up|0|||
148714785|NCT02846883|536427780|FG001|Overall Study|Lost to Follow-up|0|||
148714786|NCT02846883|536427781|FG002|Overall Study|Lost to Follow-up|1|||
148714787|NCT02846883|536427779|FG000|Overall Study|Withdrawal by Subject|1|||
148968761|NCT03711162|537372777|FG001|Overall Study|Withdrawal by Subject|10|||
148968762|NCT03711162|537372778|FG002|Overall Study|Withdrawal by Subject|10|||
148968763|NCT03711162|537372776|FG000|Overall Study|Miscellaneous|1|||
148968764|NCT03711162|537372777|FG001|Overall Study|Miscellaneous|2|||
148968765|NCT03711162|537372778|FG002|Overall Study|Miscellaneous|2|||
148968766|NCT03711162|537372776|FG000|Overall Study|Not Treated|1|||
148968767|NCT03711162|537372777|FG001|Overall Study|Not Treated|0|||
148968768|NCT03711162|537372778|FG002|Overall Study|Not Treated|1|||
148968769|NCT03711162|537372776|FG000|Overall Study|Physician Decision|0|||
148968770|NCT03711162|537372777|FG001|Overall Study|Physician Decision|2|||
148968771|NCT03711162|537372778|FG002|Overall Study|Physician Decision|0|||
148968772|NCT03711162|537372776|FG000|Overall Study|Lack of Efficacy|0|||
148968773|NCT03711162|537372777|FG001|Overall Study|Lack of Efficacy|0|||
148968774|NCT03711162|537372778|FG002|Overall Study|Lack of Efficacy|2|||
148968775|NCT03711162|537372776|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
148968776|NCT03711162|537372777|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
148968777|NCT03711162|537372778|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
148968778|NCT03034954|537372779|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
148968779|NCT03034954|537372780|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
148968780|NCT01344369|537372783|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
148968781|NCT01344369|537372784|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
148968782|NCT01344369|537372783|FG000|Washout of 28 Days|Physician Decision|0|||
148968783|NCT01344369|537372784|FG001|Washout of 28 Days|Physician Decision|1|||
148968784|NCT01344369|537372783|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
148714788|NCT02846883|536427780|FG001|Overall Study|Withdrawal by Subject|0|||
148714789|NCT02846883|536427781|FG002|Overall Study|Withdrawal by Subject|0|||
148714790|NCT02846883|536427779|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
148714791|NCT02846883|536427780|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
148714792|NCT02846883|536427781|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
148714793|NCT02846883|536427779|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
148714794|NCT02846883|536427780|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
148714795|NCT02846883|536427781|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
148714796|NCT00927251|536427782|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
148714797|NCT00442351|536427786|FG000|Overall Study|Administrative|6|||
148714798|NCT00442351|536427787|FG001|Overall Study|Administrative|5|||
148714799|NCT00442351|536427786|FG000|Overall Study|Did not meet protocol eligibility|1|||
148714800|NCT00442351|536427787|FG001|Overall Study|Did not meet protocol eligibility|0|||
148714801|NCT00442351|536427786|FG000|Overall Study|Other|0|||
148714802|NCT00442351|536427787|FG001|Overall Study|Other|1|||
148714803|NCT00108628|536427797|FG000|Overall Study|Withdrawal by Subject|17|||
148714804|NCT00108628|536427798|FG001|Overall Study|Withdrawal by Subject|9|||
148714805|NCT00108628|536427797|FG000|Overall Study|Lack of Efficacy|2|||
148714806|NCT00108628|536427798|FG001|Overall Study|Lack of Efficacy|1|||
148714807|NCT00108628|536427797|FG000|Overall Study|Death|1|||
148714808|NCT00108628|536427798|FG001|Overall Study|Death|0|||
148714809|NCT01453153|536427799|FG000|Overall Study|Physician Decision|0|||
148968785|NCT01344369|537372784|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
148968786|NCT01886833|537372785|FG000|Overall Study|IgA not available from both periods|204|||
148968787|NCT02342704|537372788|FG000|Overall Study|Physician Decision|0|||
148968788|NCT02342704|537372789|FG001|Overall Study|Physician Decision|3|||
148968789|NCT02342704|537372788|FG000|Overall Study|Sponsor Termination|49|||
148714810|NCT01453153|536427800|FG001|Overall Study|Physician Decision|0|||
148714811|NCT01453153|536427801|FG002|Overall Study|Physician Decision|1|||
148714812|NCT01453153|536427799|FG000|Overall Study|Progressive Disease|3|||
148714813|NCT01453153|536427800|FG001|Overall Study|Progressive Disease|2|||
148714814|NCT01453153|536427801|FG002|Overall Study|Progressive Disease|16|||
148714815|NCT01453153|536427799|FG000|Overall Study|Withdrawal by Subject|0|||
148714816|NCT01453153|536427800|FG001|Overall Study|Withdrawal by Subject|1|||
148714817|NCT01453153|536427801|FG002|Overall Study|Withdrawal by Subject|2|||
148714818|NCT01453153|536427799|FG000|Overall Study|Adverse Event|1|||
148714819|NCT01453153|536427800|FG001|Overall Study|Adverse Event|1|||
148714820|NCT01453153|536427801|FG002|Overall Study|Adverse Event|1|||
148714821|NCT01813435|536427802|FG000|Overall Study|did not finish experimental regimen|1902|||
148714822|NCT01813435|536427803|FG001|Overall Study|did not finish experimental regimen|770|||
148968790|NCT02342704|537372789|FG001|Overall Study|Sponsor Termination|43|||
148968791|NCT02342704|537372788|FG000|Overall Study|Other|0|||
148968792|NCT02342704|537372789|FG001|Overall Study|Other|1|||
148968793|NCT02342704|537372788|FG000|Overall Study|Withdrawal by Subject|1|||
148968794|NCT02342704|537372789|FG001|Overall Study|Withdrawal by Subject|0|||
148968795|NCT02342704|537372788|FG000|Overall Study|Lost to Follow-up|2|||
148714823|NCT01813435|536427802|FG000|Overall Study|Lost to Follow-up|268|||
148714824|NCT01813435|536427803|FG001|Overall Study|Lost to Follow-up|237|||
148968796|NCT02342704|537372789|FG001|Overall Study|Lost to Follow-up|1|||
148968797|NCT02342704|537372788|FG000|Overall Study|Adverse Event|1|||
148968798|NCT02342704|537372789|FG001|Overall Study|Adverse Event|3|||
148968799|NCT02118428|537372791|FG000|Overall Study|Physician Decision|0|||
148968800|NCT02118428|537372792|FG001|Overall Study|Physician Decision|1|||
148968801|NCT02118428|537372793|FG002|Overall Study|Physician Decision|0|||
148714825|NCT02415387|536427804|FG000|Overall Study|Withdrawal by Subject|6|||
148714826|NCT02415387|536427805|FG001|Overall Study|Withdrawal by Subject|1|||
148714827|NCT02415387|536427804|FG000|Overall Study|blood draw problem|0|||
148714828|NCT02415387|536427805|FG001|Overall Study|blood draw problem|1|||
148714829|NCT02415387|536427804|FG000|Overall Study|Protocol Violation|1|||
148714830|NCT02415387|536427805|FG001|Overall Study|Protocol Violation|0|||
148714831|NCT03035890|536427806|FG000|Overall Study|Death|1|||
148714832|NCT03243396|536427807|FG000|Overall Study|Lost to Follow-up|2|||
148714833|NCT03243396|536427808|FG001|Overall Study|Lost to Follow-up|3|||
148714834|NCT03243396|536427809|FG002|Overall Study|Lost to Follow-up|15|||
148714835|NCT03243396|536427810|FG003|Overall Study|Lost to Follow-up|8|||
148714836|NCT03243396|536427811|FG004|Overall Study|Lost to Follow-up|1|||
148714837|NCT03243396|536427812|FG005|Overall Study|Lost to Follow-up|4|||
148714838|NCT03243396|536427813|FG006|Overall Study|Lost to Follow-up|9|||
148714839|NCT00452348|536427815|FG000|Overall Study|Adverse Event|6|||
148714840|NCT00452348|536427816|FG001|Overall Study|Adverse Event|9|||
148714841|NCT00452348|536427815|FG000|Overall Study|Lack of Efficacy|10|||
148714842|NCT00452348|536427816|FG001|Overall Study|Lack of Efficacy|9|||
148714843|NCT00452348|536427815|FG000|Overall Study|Lost to Follow-up|14|||
148714844|NCT00452348|536427816|FG001|Overall Study|Lost to Follow-up|8|||
148714845|NCT00452348|536427815|FG000|Overall Study|Protocol Violation|22|||
148714846|NCT00452348|536427816|FG001|Overall Study|Protocol Violation|28|||
148714847|NCT00452348|536427815|FG000|Overall Study|Withdrawal by Subject|18|||
148714848|NCT00452348|536427816|FG001|Overall Study|Withdrawal by Subject|21|||
148714849|NCT00452348|536427815|FG000|Overall Study|Other|9|||
148714850|NCT00452348|536427816|FG001|Overall Study|Other|9|||
148714851|NCT01490190|536427817|FG000|Overall Study|Withdrawal by Subject|9|||
148714852|NCT01490190|536427817|FG000|Overall Study|Adverse Event|17|||
148714853|NCT01490190|536427817|FG000|Overall Study|Protocol Violation|5|||
148714854|NCT01490190|536427817|FG000|Overall Study|Lost to Follow-up|13|||
148714855|NCT01490190|536427817|FG000|Overall Study|Relocation|1|||
148714856|NCT01490190|536427817|FG000|Overall Study|Inconvenience|1|||
148714857|NCT01490190|536427817|FG000|Overall Study|Ring expulsion|2|||
148714858|NCT02435433|536427823|FG000|Overall Study|Withdrawal by Subject|2|||
148714859|NCT02435433|536427824|FG001|Overall Study|Withdrawal by Subject|3|||
148714860|NCT02435433|536427825|FG002|Overall Study|Withdrawal by Subject|1|||
148714861|NCT02435433|536427826|FG003|Overall Study|Withdrawal by Subject|0|||
148714862|NCT02435433|536427827|FG004|Overall Study|Withdrawal by Subject|0|||
148714863|NCT02435433|536427823|FG000|Overall Study|Lost to Follow-up|2|||
148714864|NCT02435433|536427824|FG001|Overall Study|Lost to Follow-up|2|||
148714865|NCT02435433|536427825|FG002|Overall Study|Lost to Follow-up|4|||
148714866|NCT02435433|536427826|FG003|Overall Study|Lost to Follow-up|1|||
148714867|NCT02435433|536427827|FG004|Overall Study|Lost to Follow-up|0|||
148714868|NCT01243151|536427828|FG000|Overall Study|Adverse Event|0|||
148714869|NCT01243151|536427829|FG001|Overall Study|Adverse Event|1|||
148714870|NCT01243151|536427830|FG002|Overall Study|Adverse Event|0|||
148714871|NCT01243151|536427831|FG003|Overall Study|Adverse Event|0|||
148714872|NCT01243151|536427832|FG004|Overall Study|Adverse Event|0|||
148714873|NCT01243151|536427828|FG000|Overall Study|Protocol Violation|0|||
148714874|NCT01243151|536427829|FG001|Overall Study|Protocol Violation|0|||
148714875|NCT01243151|536427830|FG002|Overall Study|Protocol Violation|1|||
148714876|NCT01243151|536427831|FG003|Overall Study|Protocol Violation|0|||
148714877|NCT01243151|536427832|FG004|Overall Study|Protocol Violation|0|||
148714878|NCT01243151|536427828|FG000|Overall Study|Other|0|||
148714879|NCT01243151|536427829|FG001|Overall Study|Other|0|||
148714880|NCT01243151|536427830|FG002|Overall Study|Other|0|||
148714881|NCT01243151|536427831|FG003|Overall Study|Other|1|||
148714882|NCT01243151|536427832|FG004|Overall Study|Other|0|||
148714883|NCT01243151|536427828|FG000|Overall Study|Randomized but not treated|0|||
148714884|NCT01243151|536427829|FG001|Overall Study|Randomized but not treated|0|||
148714885|NCT01243151|536427830|FG002|Overall Study|Randomized but not treated|0|||
148714886|NCT01243151|536427831|FG003|Overall Study|Randomized but not treated|1|||
148714887|NCT01243151|536427832|FG004|Overall Study|Randomized but not treated|0|||
148714888|NCT00544167|536427833|FG000|Overall Study|Adverse Event|21|||
148714889|NCT00544167|536427833|FG000|Overall Study|Physician Decision|8|||
148714890|NCT03343639|536427838|FG000|Overall Study|Withdrawal by Subject|10|||
148714891|NCT03343639|536427839|FG001|Overall Study|Withdrawal by Subject|6|||
148714892|NCT03343639|536427838|FG000|Overall Study|Lost to Follow-up|4|||
148714893|NCT03343639|536427839|FG001|Overall Study|Lost to Follow-up|5|||
148714894|NCT03343639|536427838|FG000|Overall Study|Protocol Violation|0|||
148714895|NCT03343639|536427839|FG001|Overall Study|Protocol Violation|1|||
148714896|NCT00735696|536427844|FG000|Overall Study|Withdrawal by Subject|1|||
148714897|NCT00735696|536427844|FG000|Overall Study|Enrolled but never Treated|1|||
148968802|NCT02118428|537372791|FG000|Overall Study|Withdrawal by Subject|2|||
148968803|NCT02118428|537372792|FG001|Overall Study|Withdrawal by Subject|2|||
148968804|NCT02118428|537372793|FG002|Overall Study|Withdrawal by Subject|0|||
148968805|NCT02118428|537372791|FG000|Overall Study|Death|7|||
148968806|NCT02118428|537372792|FG001|Overall Study|Death|5|||
148968807|NCT02118428|537372793|FG002|Overall Study|Death|0|||
148968808|NCT02118428|537372791|FG000|Overall Study|Lost to Follow-up|3|||
148968809|NCT02118428|537372792|FG001|Overall Study|Lost to Follow-up|1|||
148968810|NCT02118428|537372793|FG002|Overall Study|Lost to Follow-up|0|||
148968811|NCT02118428|537372791|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
148968812|NCT02118428|537372792|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
148968813|NCT02118428|537372793|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
148968814|NCT01641367|537372794|FG000|Cohorts|Death|18|||
148968815|NCT01641367|537372795|FG001|Cohorts|Death|1|||
148968816|NCT01641367|537372796|FG002|Cohorts|Death|2|||
148968817|NCT01641367|537372797|FG003|Cohorts|Death|0|||
148968818|NCT01641367|537372798|FG004|Cohorts|Death|1|||
148968819|NCT01641367|537372799|FG005|Cohorts|Death|1|||
148968820|NCT01641367|537372800|FG006|Cohorts|Death|0|||
148968821|NCT01641367|537372801|FG007|Cohorts|Death|0|||
148968822|NCT01641367|537372794|FG000|Cohorts|Lost to Follow-up|16|||
148968823|NCT01641367|537372795|FG001|Cohorts|Lost to Follow-up|0|||
148968824|NCT01641367|537372796|FG002|Cohorts|Lost to Follow-up|2|||
148968825|NCT01641367|537372797|FG003|Cohorts|Lost to Follow-up|0|||
148968826|NCT01641367|537372798|FG004|Cohorts|Lost to Follow-up|2|||
148968827|NCT01641367|537372799|FG005|Cohorts|Lost to Follow-up|0|||
148968828|NCT01641367|537372800|FG006|Cohorts|Lost to Follow-up|0|||
148968829|NCT01641367|537372801|FG007|Cohorts|Lost to Follow-up|0|||
148968830|NCT01641367|537372794|FG000|Randomized Adherence Intervention|Death|0|||
148968831|NCT01641367|537372795|FG001|Randomized Adherence Intervention|Death|0|||
148968832|NCT01641367|537372796|FG002|Randomized Adherence Intervention|Death|0|||
148968833|NCT01641367|537372797|FG003|Randomized Adherence Intervention|Death|0|||
148968834|NCT01641367|537372798|FG004|Randomized Adherence Intervention|Death|0|||
148968835|NCT01641367|537372799|FG005|Randomized Adherence Intervention|Death|0|||
148714932|NCT02655224|536427862|FG000|Overall Study|Adverse Event|1|||
148714933|NCT02655224|536427863|FG001|Overall Study|Adverse Event|1|||
148714934|NCT02754492|536427864|FG000|Overall Study|Protocol Violation|2|||
148714935|NCT02754492|536427865|FG001|Overall Study|Protocol Violation|2|||
148714936|NCT02754492|536427866|FG002|Overall Study|Protocol Violation|0|||
148714937|NCT02754492|536427867|FG003|Overall Study|Protocol Violation|1|||
148714938|NCT02754492|536427864|FG000|Overall Study|Withdrawal by Subject|2|||
148714939|NCT02754492|536427865|FG001|Overall Study|Withdrawal by Subject|0|||
148714940|NCT02754492|536427866|FG002|Overall Study|Withdrawal by Subject|0|||
148714941|NCT02754492|536427867|FG003|Overall Study|Withdrawal by Subject|0|||
148714942|NCT02754492|536427864|FG000|Overall Study|Equipment malfuntion|0|||
148714943|NCT02754492|536427865|FG001|Overall Study|Equipment malfuntion|0|||
148714944|NCT02754492|536427866|FG002|Overall Study|Equipment malfuntion|2|||
148714945|NCT02754492|536427867|FG003|Overall Study|Equipment malfuntion|5|||
148714946|NCT02754492|536427864|FG000|Overall Study|Adverse Event|0|||
148714947|NCT02754492|536427865|FG001|Overall Study|Adverse Event|0|||
148714948|NCT02754492|536427866|FG002|Overall Study|Adverse Event|0|||
148714949|NCT02754492|536427867|FG003|Overall Study|Adverse Event|13|||
148714950|NCT02754492|536427864|FG000|Overall Study|Venous access issues not resulting in AE|0|||
148714951|NCT02754492|536427865|FG001|Overall Study|Venous access issues not resulting in AE|0|||
148714952|NCT02754492|536427866|FG002|Overall Study|Venous access issues not resulting in AE|0|||
148714953|NCT02754492|536427867|FG003|Overall Study|Venous access issues not resulting in AE|4|||
148714954|NCT01186458|536427871|FG000|Overall Study|Adverse Event|1|||
148714955|NCT04281472|536427872|FG000|Stage A|Lack of Efficacy|8|||
148714956|NCT04281472|536427873|FG001|Stage A|Lack of Efficacy|0|||
148714957|NCT04281472|536427874|FG002|Stage A|Lack of Efficacy|0|||
148714958|NCT04281472|536427872|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
148714959|NCT04281472|536427873|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
148714960|NCT04281472|536427874|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
148714961|NCT04281472|536427872|FG000|Stage A|Adverse Event|20|||
148714962|NCT04281472|536427873|FG001|Stage A|Adverse Event|0|||
148714963|NCT04281472|536427874|FG002|Stage A|Adverse Event|0|||
148714964|NCT04281472|536427872|FG000|Stage A|Death|1|||
148714965|NCT04281472|536427873|FG001|Stage A|Death|0|||
148714966|NCT04281472|536427874|FG002|Stage A|Death|0|||
148714967|NCT04281472|536427872|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
148714968|NCT04281472|536427873|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
148714969|NCT04281472|536427874|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
148714970|NCT04281472|536427872|FG000|Stage A|Lost to Follow-up|2|||
148714971|NCT04281472|536427873|FG001|Stage A|Lost to Follow-up|0|||
148714972|NCT04281472|536427874|FG002|Stage A|Lost to Follow-up|0|||
148714973|NCT04281472|536427872|FG000|Stage A|Non-compliance with study drug|1|||
148714974|NCT04281472|536427873|FG001|Stage A|Non-compliance with study drug|0|||
148714975|NCT04281472|536427874|FG002|Stage A|Non-compliance with study drug|0|||
148714976|NCT04281472|536427872|FG000|Stage A|Physician Decision|1|||
148714977|NCT04281472|536427873|FG001|Stage A|Physician Decision|0|||
148714978|NCT04281472|536427874|FG002|Stage A|Physician Decision|0|||
148968836|NCT01641367|537372800|FG006|Randomized Adherence Intervention|Death|11|||
148968837|NCT01641367|537372801|FG007|Randomized Adherence Intervention|Death|12|||
148968838|NCT01641367|537372794|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
148815700|NCT04615507|536800603|FG000|Period 1|Covid-19 exposure|2|||
148815701|NCT04615507|536800604|FG001|Period 1|Covid-19 exposure|1|||
148968839|NCT01641367|537372795|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
148968840|NCT01641367|537372796|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
148968841|NCT01641367|537372797|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
148968842|NCT01641367|537372798|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
148968843|NCT01641367|537372799|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
148714979|NCT04281472|536427872|FG000|Stage A|Prohibited medications|2|||
148714980|NCT04281472|536427873|FG001|Stage A|Prohibited medications|0|||
148714981|NCT04281472|536427874|FG002|Stage A|Prohibited medications|0|||
148714982|NCT04281472|536427872|FG000|Stage A|Withdrawal by Subject|11|||
148714983|NCT04281472|536427873|FG001|Stage A|Withdrawal by Subject|0|||
148714984|NCT04281472|536427874|FG002|Stage A|Withdrawal by Subject|0|||
148714985|NCT04281472|536427872|FG000|Stage A|Other|5|||
148714986|NCT04281472|536427873|FG001|Stage A|Other|0|||
148714987|NCT04281472|536427874|FG002|Stage A|Other|0|||
148714988|NCT04281472|536427872|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
148714989|NCT04281472|536427873|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
148714990|NCT04281472|536427874|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
148714991|NCT04281472|536427872|FG000|Stage B|Adverse Event|0|||
148714992|NCT04281472|536427873|FG001|Stage B|Adverse Event|3|||
148714993|NCT04281472|536427874|FG002|Stage B|Adverse Event|0|||
148714994|NCT04281472|536427872|FG000|Stage B|Death|0|||
148714995|NCT04281472|536427873|FG001|Stage B|Death|0|||
148714996|NCT04281472|536427874|FG002|Stage B|Death|1|||
148714997|NCT04281472|536427872|FG000|Stage B|Lack of Efficacy|0|||
148714998|NCT04281472|536427873|FG001|Stage B|Lack of Efficacy|0|||
148714999|NCT04281472|536427874|FG002|Stage B|Lack of Efficacy|1|||
148715000|NCT04281472|536427872|FG000|Stage B|Lost to Follow-up|0|||
148715001|NCT04281472|536427873|FG001|Stage B|Lost to Follow-up|0|||
148715002|NCT04281472|536427874|FG002|Stage B|Lost to Follow-up|2|||
148715003|NCT04281472|536427872|FG000|Stage B|Prohibited medications|0|||
148715004|NCT04281472|536427873|FG001|Stage B|Prohibited medications|2|||
148715005|NCT04281472|536427874|FG002|Stage B|Prohibited medications|1|||
148715006|NCT04281472|536427872|FG000|Stage B|Protocol Violation|0|||
148715007|NCT04281472|536427873|FG001|Stage B|Protocol Violation|1|||
148715008|NCT04281472|536427874|FG002|Stage B|Protocol Violation|1|||
148715009|NCT04281472|536427872|FG000|Stage B|Sponsor decision|0|||
148715010|NCT04281472|536427873|FG001|Stage B|Sponsor decision|0|||
148715011|NCT04281472|536427874|FG002|Stage B|Sponsor decision|1|||
148715012|NCT04281472|536427872|FG000|Stage B|Withdrawal by Subject|0|||
148715013|NCT04281472|536427873|FG001|Stage B|Withdrawal by Subject|3|||
148715014|NCT04281472|536427874|FG002|Stage B|Withdrawal by Subject|3|||
148715015|NCT04281472|536427872|FG000|Stage B|Other|0|||
148715016|NCT04281472|536427873|FG001|Stage B|Other|3|||
148715017|NCT04281472|536427874|FG002|Stage B|Other|0|||
148715018|NCT02372006|536427878|FG000|Overall Study|Progressive disease|8|||
148715019|NCT02372006|536427879|FG001|Overall Study|Progressive disease|7|||
148715020|NCT02372006|536427880|FG002|Overall Study|Progressive disease|34|||
148715021|NCT02372006|536427878|FG000|Overall Study|Dose limiting toxicity|0|||
148715022|NCT02372006|536427879|FG001|Overall Study|Dose limiting toxicity|1|||
148715023|NCT02372006|536427880|FG002|Overall Study|Dose limiting toxicity|0|||
148715024|NCT02372006|536427878|FG000|Overall Study|Adverse Event|0|||
148715025|NCT02372006|536427879|FG001|Overall Study|Adverse Event|0|||
148715026|NCT02372006|536427880|FG002|Overall Study|Adverse Event|3|||
148715027|NCT02372006|536427878|FG000|Overall Study|Withdrawal by Subject|0|||
148715028|NCT02372006|536427879|FG001|Overall Study|Withdrawal by Subject|1|||
148715029|NCT02372006|536427880|FG002|Overall Study|Withdrawal by Subject|1|||
148715030|NCT02372006|536427878|FG000|Overall Study|Other reason for not completing|0|||
148968844|NCT01641367|537372800|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
148715031|NCT02372006|536427879|FG001|Overall Study|Other reason for not completing|0|||
148715032|NCT02372006|536427880|FG002|Overall Study|Other reason for not completing|1|||
148715033|NCT02611362|536427882|FG000|Overall Study|Withdrawal by Subject|7|||
148715034|NCT02611362|536427883|FG001|Overall Study|Withdrawal by Subject|2|||
148715035|NCT02611362|536427882|FG000|Overall Study|Lost to Follow-up|2|||
148715036|NCT02611362|536427883|FG001|Overall Study|Lost to Follow-up|4|||
148715037|NCT02229084|536427885|FG000|Overall Study|Adverse Event|1|||
148715038|NCT02229084|536427886|FG001|Overall Study|Adverse Event|0|||
148715039|NCT02229084|536427887|FG002|Overall Study|Adverse Event|0|||
148715040|NCT02229084|536427888|FG003|Overall Study|Adverse Event|0|||
148715041|NCT02229084|536427889|FG004|Overall Study|Adverse Event|0|||
148715042|NCT02229084|536427890|FG005|Overall Study|Adverse Event|0|||
148715043|NCT02229084|536427891|FG006|Overall Study|Adverse Event|0|||
148715044|NCT02229084|536427885|FG000|Overall Study|Lost to Follow-up|0|||
148715045|NCT02229084|536427886|FG001|Overall Study|Lost to Follow-up|0|||
148715046|NCT02229084|536427887|FG002|Overall Study|Lost to Follow-up|1|||
148715047|NCT02229084|536427888|FG003|Overall Study|Lost to Follow-up|1|||
148968845|NCT01641367|537372801|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
148715048|NCT02229084|536427889|FG004|Overall Study|Lost to Follow-up|0|||
148715049|NCT02229084|536427890|FG005|Overall Study|Lost to Follow-up|0|||
148715050|NCT02229084|536427891|FG006|Overall Study|Lost to Follow-up|1|||
148715051|NCT02229084|536427885|FG000|Overall Study|Physician Decision|0|||
148715052|NCT02229084|536427886|FG001|Overall Study|Physician Decision|0|||
148715053|NCT02229084|536427887|FG002|Overall Study|Physician Decision|0|||
148715054|NCT02229084|536427888|FG003|Overall Study|Physician Decision|1|||
148715055|NCT02229084|536427889|FG004|Overall Study|Physician Decision|3|||
148715056|NCT02229084|536427890|FG005|Overall Study|Physician Decision|0|||
148715057|NCT02229084|536427891|FG006|Overall Study|Physician Decision|1|||
148715058|NCT02229084|536427885|FG000|Overall Study|Withdrawal by Subject|0|||
148715059|NCT02229084|536427886|FG001|Overall Study|Withdrawal by Subject|0|||
148715060|NCT02229084|536427887|FG002|Overall Study|Withdrawal by Subject|1|||
148715061|NCT02229084|536427888|FG003|Overall Study|Withdrawal by Subject|0|||
148715062|NCT02229084|536427889|FG004|Overall Study|Withdrawal by Subject|1|||
148715063|NCT02229084|536427890|FG005|Overall Study|Withdrawal by Subject|1|||
148715064|NCT02229084|536427891|FG006|Overall Study|Withdrawal by Subject|1|||
148715065|NCT02229084|536427885|FG000|Overall Study|Death|0|||
148715066|NCT02229084|536427886|FG001|Overall Study|Death|0|||
148715067|NCT02229084|536427887|FG002|Overall Study|Death|0|||
148715068|NCT02229084|536427888|FG003|Overall Study|Death|0|||
148715069|NCT02229084|536427889|FG004|Overall Study|Death|0|||
148715070|NCT02229084|536427890|FG005|Overall Study|Death|0|||
148715071|NCT02229084|536427891|FG006|Overall Study|Death|1|||
148715072|NCT01559116|536427899|FG000|Overall Study|Adverse Event|10|||
148715073|NCT01559116|536427899|FG000|Overall Study|Lack of Efficacy|1|||
148715074|NCT01559116|536427899|FG000|Overall Study|Lost to Follow-up|1|||
148715075|NCT01559116|536427899|FG000|Overall Study|Protocol Violation|1|||
148715076|NCT01559116|536427899|FG000|Overall Study|Withdrawal by Subject|4|||
148715077|NCT01559116|536427899|FG000|Overall Study|other than stated above|9|||
148715078|NCT01745094|536427900|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
148715079|NCT01745094|536427901|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
148715080|NCT01745094|536427902|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
148715081|NCT01745094|536427903|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
148715082|NCT01745094|536427900|FG000|Overall Study|Adverse Event|0|||
148715083|NCT01745094|536427901|FG001|Overall Study|Adverse Event|0|||
148715084|NCT01745094|536427902|FG002|Overall Study|Adverse Event|3|||
148715085|NCT01745094|536427903|FG003|Overall Study|Adverse Event|0|||
148715086|NCT01745094|536427900|FG000|Overall Study|Withdrawal by Subject|2|||
148715087|NCT01745094|536427901|FG001|Overall Study|Withdrawal by Subject|0|||
148715088|NCT01745094|536427902|FG002|Overall Study|Withdrawal by Subject|1|||
148715089|NCT01745094|536427903|FG003|Overall Study|Withdrawal by Subject|2|||
148715090|NCT01745094|536427900|FG000|Overall Study|Protocol Violation|1|||
148715091|NCT01745094|536427901|FG001|Overall Study|Protocol Violation|0|||
148715092|NCT01745094|536427902|FG002|Overall Study|Protocol Violation|3|||
148715093|NCT01745094|536427903|FG003|Overall Study|Protocol Violation|1|||
148715094|NCT01745094|536427900|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
148715095|NCT01745094|536427901|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
148715096|NCT01745094|536427902|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
148715097|NCT01745094|536427903|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
148715098|NCT01745094|536427900|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
148715099|NCT01745094|536427901|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
148715100|NCT01745094|536427902|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
148715101|NCT01745094|536427903|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
148715102|NCT01745094|536427900|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
148715103|NCT01745094|536427901|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
148715104|NCT01745094|536427902|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
148715105|NCT01745094|536427903|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
148715106|NCT01097694|536427904|FG000|Overall Study|Adverse Event|5|||
148715107|NCT01097694|536427905|FG001|Overall Study|Adverse Event|0|||
148715108|NCT01097694|536427904|FG000|Overall Study|Lost to Follow-up|0|||
148715109|NCT01097694|536427905|FG001|Overall Study|Lost to Follow-up|3|||
148715110|NCT01097694|536427904|FG000|Overall Study|Withdrawal by Subject|3|||
148715111|NCT01097694|536427905|FG001|Overall Study|Withdrawal by Subject|1|||
148715112|NCT02179190|536427906|FG000|Enrollment|Exit Prior to Device Attempt|11|||
148968846|NCT02319031|537372803|FG000|Treatment Period|Death|1|||
148815702|NCT04615507|536800603|FG000|Period 2|Covid-19 exposure|0|||
148968847|NCT02319031|537372804|FG001|Treatment Period|Death|0|||
148715113|NCT02179190|536427906|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
148715114|NCT02179190|536427906|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
148968848|NCT00696137|537372814|FG000|Overall Study|Withdrawal by Subject|2|||
148715115|NCT02179190|536427906|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
148715116|NCT02179190|536427906|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
148715117|NCT02179190|536427906|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
148715118|NCT00881569|536427909|FG000|Overall Study|Disease progression|1|||
148715119|NCT00881569|536427910|FG001|Overall Study|Disease progression|1|||
148715120|NCT03480022|536427911|FG000|Overall Study|Pregnancy|2|||
148968849|NCT03316885|537372824|FG000|Overall Study|Adverse Event|1|||
148968850|NCT03316885|537372824|FG000|Overall Study|Death|10|||
148715121|NCT03480022|536427912|FG001|Overall Study|Pregnancy|0|||
148715122|NCT03480022|536427911|FG000|Overall Study|Adverse Event|6|||
148715123|NCT03480022|536427912|FG001|Overall Study|Adverse Event|0|||
148715124|NCT03480022|536427911|FG000|Overall Study|Lack of Efficacy|0|||
148715125|NCT03480022|536427912|FG001|Overall Study|Lack of Efficacy|2|||
148715126|NCT03480022|536427911|FG000|Overall Study|Physician Decision|0|||
148715127|NCT03480022|536427912|FG001|Overall Study|Physician Decision|1|||
148715128|NCT03480022|536427911|FG000|Overall Study|Withdrawal by Subject|2|||
148715129|NCT03480022|536427912|FG001|Overall Study|Withdrawal by Subject|0|||
148715130|NCT03480022|536427911|FG000|Overall Study|Medication concerns|1|||
148715131|NCT03480022|536427912|FG001|Overall Study|Medication concerns|0|||
148715132|NCT03480022|536427911|FG000|Overall Study|Family member COVID exposure|0|||
148715133|NCT03480022|536427912|FG001|Overall Study|Family member COVID exposure|1|||
148715134|NCT03922750|536427917|FG000|Overall Study|Unclassified|0|||
148715135|NCT03922750|536427918|FG001|Overall Study|Unclassified|0|||
148715136|NCT03922750|536427919|FG002|Overall Study|Unclassified|1|||
148715137|NCT03922750|536427917|FG000|Overall Study|Adverse Event|0|||
148715138|NCT03922750|536427918|FG001|Overall Study|Adverse Event|1|||
148715139|NCT03922750|536427919|FG002|Overall Study|Adverse Event|0|||
148715140|NCT00668395|536427920|FG000|Overall Study|Withdrawal by Subject|4|||
148715141|NCT00668395|536427921|FG001|Overall Study|Withdrawal by Subject|4|||
148715142|NCT00668395|536427922|FG002|Overall Study|Withdrawal by Subject|1|||
148715143|NCT00668395|536427920|FG000|Overall Study|Adverse Event|1|||
148715144|NCT00668395|536427921|FG001|Overall Study|Adverse Event|1|||
148715145|NCT00668395|536427922|FG002|Overall Study|Adverse Event|0|||
148715146|NCT00668395|536427920|FG000|Overall Study|Physician Decision|1|||
148715147|NCT00668395|536427921|FG001|Overall Study|Physician Decision|1|||
148715148|NCT00668395|536427922|FG002|Overall Study|Physician Decision|0|||
148715149|NCT01751087|536427923|FG000|Overall Study|Withdrawal by Subject|1|||
148715150|NCT01751087|536427924|FG001|Overall Study|Withdrawal by Subject|0|||
148715151|NCT01751087|536427925|FG002|Overall Study|Withdrawal by Subject|0|||
148715152|NCT01751087|536427923|FG000|Overall Study|Physician Decision|0|||
148715153|NCT01751087|536427924|FG001|Overall Study|Physician Decision|0|||
148715154|NCT01751087|536427925|FG002|Overall Study|Physician Decision|1|||
148715155|NCT01350934|536429378|FG000|Base Study|Adverse Event|6|||
148715156|NCT01350934|536429379|FG001|Base Study|Adverse Event|0|||
148715157|NCT01350934|536429378|FG000|Base Study|Lost to Follow-up|1|||
148715158|NCT01350934|536429379|FG001|Base Study|Lost to Follow-up|0|||
148715159|NCT01350934|536429378|FG000|Base Study|Protocol Violation|1|||
148715160|NCT01350934|536429379|FG001|Base Study|Protocol Violation|1|||
148715161|NCT01350934|536429378|FG000|Base Study|Withdrawal by Subject|1|||
148715162|NCT01350934|536429379|FG001|Base Study|Withdrawal by Subject|2|||
148715163|NCT01350934|536429378|FG000|Base Study|Non-Compliance With Study Drug|2|||
148715164|NCT01350934|536429379|FG001|Base Study|Non-Compliance With Study Drug|0|||
148715165|NCT01350934|536429378|FG000|Extension Study|Adverse Event|2|||
148715166|NCT01350934|536429379|FG001|Extension Study|Adverse Event|1|||
148715167|NCT01350934|536429378|FG000|Extension Study|Lost to Follow-up|2|||
148715168|NCT01350934|536429379|FG001|Extension Study|Lost to Follow-up|0|||
148715169|NCT01350934|536429378|FG000|Extension Study|Protocol Violation|1|||
148715170|NCT01350934|536429379|FG001|Extension Study|Protocol Violation|1|||
148715171|NCT01350934|536429378|FG000|Extension Study|Lack of Efficacy|0|||
148715172|NCT01350934|536429379|FG001|Extension Study|Lack of Efficacy|1|||
148715173|NCT01350934|536429378|FG000|Extension Study|Withdrawal by Subject|0|||
148715174|NCT01350934|536429379|FG001|Extension Study|Withdrawal by Subject|1|||
148715175|NCT01011335|536429380|FG000|Overall Study|Lost to Follow-up|0|||
148715176|NCT01011335|536429381|FG001|Overall Study|Lost to Follow-up|0|||
148715177|NCT01011335|536429382|FG002|Overall Study|Lost to Follow-up|1|||
148715178|NCT01011335|536429383|FG003|Overall Study|Lost to Follow-up|1|||
148715179|NCT01011335|536429384|FG004|Overall Study|Lost to Follow-up|1|||
148715180|NCT01011335|536429385|FG005|Overall Study|Lost to Follow-up|1|||
148715181|NCT01011335|536429386|FG006|Overall Study|Lost to Follow-up|2|||
148715182|NCT01011335|536429387|FG007|Overall Study|Lost to Follow-up|2|||
148968851|NCT03316885|537372824|FG000|Overall Study|Lost to Follow-up|4|||
148715183|NCT01011335|536429388|FG008|Overall Study|Lost to Follow-up|1|||
148715184|NCT01011335|536429389|FG009|Overall Study|Lost to Follow-up|0|||
148715185|NCT01011335|536429390|FG010|Overall Study|Lost to Follow-up|0|||
148715186|NCT01011335|536429391|FG011|Overall Study|Lost to Follow-up|1|||
148715187|NCT01011335|536429392|FG012|Overall Study|Lost to Follow-up|2|||
148715188|NCT01011335|536429380|FG000|Overall Study|Protocol Violation|0|||
148715189|NCT01011335|536429381|FG001|Overall Study|Protocol Violation|1|||
148715190|NCT01011335|536429382|FG002|Overall Study|Protocol Violation|0|||
148715191|NCT01011335|536429383|FG003|Overall Study|Protocol Violation|0|||
148715192|NCT01011335|536429384|FG004|Overall Study|Protocol Violation|0|||
148715193|NCT01011335|536429385|FG005|Overall Study|Protocol Violation|0|||
148715194|NCT01011335|536429386|FG006|Overall Study|Protocol Violation|0|||
148715195|NCT01011335|536429387|FG007|Overall Study|Protocol Violation|0|||
148715196|NCT01011335|536429388|FG008|Overall Study|Protocol Violation|0|||
148715197|NCT01011335|536429389|FG009|Overall Study|Protocol Violation|0|||
148968852|NCT03316885|537372824|FG000|Overall Study|Withdrawal by Subject|9|||
148968853|NCT03316885|537372824|FG000|Overall Study|COVID related|8|||
148968854|NCT04180020|537372827|FG000|Overall Study|missed visit|18|||
148968855|NCT04180020|537372828|FG001|Overall Study|missed visit|16|||
148968856|NCT04180020|537372827|FG000|Overall Study|Death|2|||
148715198|NCT01011335|536429390|FG010|Overall Study|Protocol Violation|0|||
148715199|NCT01011335|536429391|FG011|Overall Study|Protocol Violation|0|||
148715200|NCT01011335|536429392|FG012|Overall Study|Protocol Violation|0|||
148715201|NCT01011335|536429380|FG000|Overall Study|Moved/deployed or no booster|1|||
148715202|NCT01011335|536429381|FG001|Overall Study|Moved/deployed or no booster|0|||
148715203|NCT01011335|536429382|FG002|Overall Study|Moved/deployed or no booster|0|||
148715204|NCT01011335|536429383|FG003|Overall Study|Moved/deployed or no booster|1|||
148715205|NCT01011335|536429384|FG004|Overall Study|Moved/deployed or no booster|0|||
148715206|NCT01011335|536429385|FG005|Overall Study|Moved/deployed or no booster|0|||
148715207|NCT01011335|536429386|FG006|Overall Study|Moved/deployed or no booster|1|||
148715208|NCT01011335|536429387|FG007|Overall Study|Moved/deployed or no booster|0|||
148715209|NCT01011335|536429388|FG008|Overall Study|Moved/deployed or no booster|1|||
148715210|NCT01011335|536429389|FG009|Overall Study|Moved/deployed or no booster|0|||
148715211|NCT01011335|536429390|FG010|Overall Study|Moved/deployed or no booster|2|||
148715212|NCT01011335|536429391|FG011|Overall Study|Moved/deployed or no booster|0|||
148715213|NCT01011335|536429392|FG012|Overall Study|Moved/deployed or no booster|0|||
148715214|NCT01011335|536429380|FG000|Overall Study|Adverse Event|0|||
148715215|NCT01011335|536429381|FG001|Overall Study|Adverse Event|0|||
148715216|NCT01011335|536429382|FG002|Overall Study|Adverse Event|0|||
148715217|NCT01011335|536429383|FG003|Overall Study|Adverse Event|0|||
148715218|NCT01011335|536429384|FG004|Overall Study|Adverse Event|0|||
148715219|NCT01011335|536429385|FG005|Overall Study|Adverse Event|0|||
148715220|NCT01011335|536429386|FG006|Overall Study|Adverse Event|0|||
148715221|NCT01011335|536429387|FG007|Overall Study|Adverse Event|0|||
148715222|NCT01011335|536429388|FG008|Overall Study|Adverse Event|0|||
148715223|NCT01011335|536429389|FG009|Overall Study|Adverse Event|0|||
148715224|NCT01011335|536429390|FG010|Overall Study|Adverse Event|4|||
148715225|NCT01011335|536429391|FG011|Overall Study|Adverse Event|0|||
148715226|NCT01011335|536429392|FG012|Overall Study|Adverse Event|1|||
148715227|NCT02460835|536429401|FG000|Overall Study|Disease progression prior to treatment|3|||
148715228|NCT02460835|536429401|FG000|Overall Study|Unable to complete planning scans|2|||
148715229|NCT02460835|536429401|FG000|Overall Study|Decrease in performance status|1|||
148715230|NCT02460835|536429401|FG000|Overall Study|Withdrawal by Subject|3|||
148715231|NCT02460835|536429401|FG000|Overall Study|Underwent fractionated RT|10|||
148715232|NCT02460835|536429401|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
148715233|NCT00059332|536429403|FG000|Overall Study|Withdrawal by Subject|2|||
148715234|NCT00059332|536429404|FG001|Overall Study|Withdrawal by Subject|1|||
148715235|NCT00059332|536429403|FG000|Overall Study|Lost to Follow-up|1|||
148715236|NCT00059332|536429404|FG001|Overall Study|Lost to Follow-up|1|||
148715237|NCT02483416|536429405|FG000|Overall Study|Other reason|0|||
148715238|NCT02483416|536429406|FG001|Overall Study|Other reason|1|||
148715239|NCT02483416|536429405|FG000|Overall Study|Treatment stop|3|||
148715240|NCT02483416|536429406|FG001|Overall Study|Treatment stop|0|||
148715241|NCT02587143|536429407|FG000|Overall Study|Adverse Event|1|||
148715242|NCT02587143|536429408|FG001|Overall Study|Adverse Event|0|||
148715243|NCT00152451|536429409|FG000|Overall Study|Adverse Event|4|||
148715244|NCT01717313|536429410|FG000|Phase A (Weeks 0 to 24)|Death|0|||
148715245|NCT01717313|536429411|FG001|Phase A (Weeks 0 to 24)|Death|1|||
148715246|NCT01717313|536429410|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
148715247|NCT01717313|536429411|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
148715248|NCT01717313|536429410|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
148715249|NCT01717313|536429411|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
148715250|NCT01717313|536429410|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
148715251|NCT01717313|536429411|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
148715252|NCT01717313|536429410|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
148715253|NCT01717313|536429411|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
148968857|NCT04180020|537372828|FG001|Overall Study|Death|3|||
148715254|NCT01717313|536429410|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
148715255|NCT01717313|536429411|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
148968858|NCT04180020|537372827|FG000|Overall Study|Withdrawal by Subject|1|||
148715256|NCT01717313|536429410|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
148715257|NCT01717313|536429411|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
148715258|NCT01717313|536429410|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
148715259|NCT01717313|536429411|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
148715260|NCT01717313|536429410|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
148715261|NCT01717313|536429411|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
148715262|NCT00743145|536429413|FG000|Overall Study|Withdrawal by Subject|1|||
148715263|NCT00743145|536429413|FG000|Overall Study|Adverse Event|2|||
148968859|NCT04180020|537372828|FG001|Overall Study|Withdrawal by Subject|5|||
148968860|NCT04180020|537372827|FG000|Overall Study|incarcerated|1|||
148715264|NCT00743145|536429413|FG000|Overall Study|Pregnancy|1|||
148715265|NCT03259165|536429414|FG000|Overall Study|COVID 19 pandemic|1|||
148715266|NCT03259165|536429415|FG001|Overall Study|COVID 19 pandemic|1|||
148715267|NCT01949532|536429416|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
148715268|NCT01949532|536429417|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
148715269|NCT05665387|536429418|FG000|Overall Study|Withdrawal by Subject|1|||
148715270|NCT05665387|536429419|FG001|Overall Study|Withdrawal by Subject|0|||
148715271|NCT05665387|536429420|FG002|Overall Study|Withdrawal by Subject|1|||
148715272|NCT02004691|536429421|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
148715273|NCT02004691|536429422|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
148715274|NCT02004691|536429421|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
148715275|NCT02004691|536429422|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
148715276|NCT02004691|536429421|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
148715277|NCT02004691|536429422|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
148715278|NCT02004691|536429421|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
148715279|NCT02004691|536429422|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
148715280|NCT02004691|536429421|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
148715281|NCT02004691|536429422|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
148715282|NCT02004691|536429421|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
148968861|NCT04180020|537372828|FG001|Overall Study|incarcerated|1|||
148968862|NCT04180020|537372827|FG000|Overall Study|Physician Decision|0|||
148968863|NCT04180020|537372828|FG001|Overall Study|Physician Decision|2|||
148968864|NCT02244580|537372829|FG000|Overall Study|No cancer tissues available|241|||
148968865|NCT01228747|537372830|FG000|Overall Study|Adverse Event|8|||
148968866|NCT01228747|537372831|FG001|Overall Study|Adverse Event|4|||
148968867|NCT01228747|537372830|FG000|Overall Study|Lack of Efficacy|40|||
148968868|NCT01228747|537372831|FG001|Overall Study|Lack of Efficacy|27|||
148968869|NCT01228747|537372830|FG000|Overall Study|Protocol Violation|6|||
148968870|NCT01228747|537372831|FG001|Overall Study|Protocol Violation|5|||
148968871|NCT01228747|537372830|FG000|Overall Study|Lost to Follow-up|4|||
148715283|NCT02004691|536429422|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
148715284|NCT00884390|536429423|FG000|Overall Study|Adverse Event|0|||
148715285|NCT00884390|536429424|FG001|Overall Study|Adverse Event|1|||
148715286|NCT00884390|536429423|FG000|Overall Study|Lost to Follow-up|0|||
148715287|NCT00884390|536429424|FG001|Overall Study|Lost to Follow-up|1|||
148715288|NCT00884390|536429423|FG000|Overall Study|Physician Decision|2|||
148715289|NCT00884390|536429424|FG001|Overall Study|Physician Decision|1|||
148715290|NCT00884390|536429423|FG000|Overall Study|Protocol Violation|4|||
148715291|NCT00884390|536429424|FG001|Overall Study|Protocol Violation|1|||
148715292|NCT00884390|536429423|FG000|Overall Study|Withdrawal by Subject|4|||
148715293|NCT00884390|536429424|FG001|Overall Study|Withdrawal by Subject|1|||
148715294|NCT00884390|536429423|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
148715295|NCT00884390|536429424|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
148715296|NCT00884390|536429423|FG000|Overall Study|Other|11|||
148715297|NCT00884390|536429424|FG001|Overall Study|Other|1|||
148715298|NCT01691612|536429427|FG000|Overall Study|deemed ineligible after 1st visit|6|||
148715299|NCT01691612|536429427|FG000|Overall Study|Adverse Event|1|||
148715300|NCT02623218|536429429|FG000|Overall Study|Lost to Follow-up|0|||
148715301|NCT02623218|536429430|FG001|Overall Study|Lost to Follow-up|1|||
148715302|NCT02623218|536429431|FG002|Overall Study|Lost to Follow-up|0|||
148715303|NCT02623218|536429432|FG003|Overall Study|Lost to Follow-up|0|||
148715304|NCT02623218|536429433|FG004|Overall Study|Lost to Follow-up|0|||
148715305|NCT01726803|536429434|FG000|Overall Study|Lost to Follow-up|6|||
148715306|NCT01726803|536429435|FG001|Overall Study|Lost to Follow-up|1|||
148715307|NCT01726803|536429434|FG000|Overall Study|Withdrawal by Subject|1|||
148715308|NCT01726803|536429435|FG001|Overall Study|Withdrawal by Subject|0|||
148715309|NCT01211262|536429440|FG000|Overall Study|Progressive Disease|18|||
148715310|NCT01211262|536429441|FG001|Overall Study|Progressive Disease|9|||
148715311|NCT01211262|536429440|FG000|Overall Study|Adverse Event|4|||
148715312|NCT01211262|536429441|FG001|Overall Study|Adverse Event|0|||
148715313|NCT01211262|536429440|FG000|Overall Study|Withdrawal of Consent|1|||
148715314|NCT01211262|536429441|FG001|Overall Study|Withdrawal of Consent|0|||
148715315|NCT01211262|536429440|FG000|Overall Study|Other|0|||
148715316|NCT01211262|536429441|FG001|Overall Study|Other|1|||
148715317|NCT01277510|536429442|FG000|Double-blind Phase|Non-compliance|0|||
148715318|NCT01277510|536429443|FG001|Double-blind Phase|Non-compliance|1|||
148715319|NCT01277510|536429442|FG000|Double-blind Phase|Adverse Event|1|||
148715320|NCT01277510|536429443|FG001|Double-blind Phase|Adverse Event|0|||
148715321|NCT01277510|536429442|FG000|Double-blind Phase|Withdrawal by Subject|2|||
148715322|NCT01277510|536429443|FG001|Double-blind Phase|Withdrawal by Subject|0|||
148715323|NCT01277510|536429442|FG000|Double-blind Phase|Administrative decision|7|||
148715324|NCT01277510|536429443|FG001|Double-blind Phase|Administrative decision|9|||
148715325|NCT01277510|536429442|FG000|Double-blind Phase|Death|0|||
148715326|NCT01277510|536429443|FG001|Double-blind Phase|Death|1|||
148968872|NCT01228747|537372831|FG001|Overall Study|Lost to Follow-up|3|||
148968873|NCT01228747|537372830|FG000|Overall Study|Withdrawal by Subject|5|||
148968874|NCT01228747|537372831|FG001|Overall Study|Withdrawal by Subject|1|||
148715327|NCT01277510|536429442|FG000|Double-blind Phase|Protocol-specified criteria|2|||
148715328|NCT01277510|536429443|FG001|Double-blind Phase|Protocol-specified criteria|6|||
148715329|NCT01277510|536429442|FG000|Double-blind Phase|Other|1|||
148715330|NCT01277510|536429443|FG001|Double-blind Phase|Other|1|||
148715331|NCT01277510|536429442|FG000|Open-label Phase|Administrative decision|4|||
148715332|NCT01277510|536429443|FG001|Open-label Phase|Administrative decision|3|||
148715333|NCT01277510|536429442|FG000|Open-label Phase|Protocol-specified criteria|1|||
148715334|NCT01277510|536429443|FG001|Open-label Phase|Protocol-specified criteria|0|||
148715335|NCT01277510|536429442|FG000|Open-label Phase|Never received investigational product|2|||
148715336|NCT01277510|536429443|FG001|Open-label Phase|Never received investigational product|0|||
148715337|NCT04049097|536429444|FG000|Overall Study|Adverse Event|18|||
148715338|NCT04049097|536429444|FG000|Overall Study|Death|2|||
148715339|NCT04049097|536429444|FG000|Overall Study|Lost to Follow-up|1|||
148715340|NCT04049097|536429444|FG000|Overall Study|Physician Decision|2|||
148715341|NCT04049097|536429444|FG000|Overall Study|Withdrawal by Subject|9|||
148715342|NCT04049097|536429444|FG000|Overall Study|Protocol Violation|2|||
148715343|NCT04049097|536429444|FG000|Overall Study|Other|1|||
148715344|NCT04049097|536429444|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
148715345|NCT02005276|536429445|FG000|Overall Study|No longer interested|5|||
148715346|NCT02005276|536429446|FG001|Overall Study|No longer interested|2|||
148715347|NCT02005276|536429447|FG002|Overall Study|No longer interested|3|||
148715348|NCT02005276|536429448|FG003|Overall Study|No longer interested|3|||
148715349|NCT01970592|536429449|FG000|Overall Study|Withdrawal by Subject|4|||
148715350|NCT01970592|536429449|FG000|Overall Study|Physician Decision|1|||
148715351|NCT01970592|536429449|FG000|Overall Study|Adverse Event|1|||
148715352|NCT03980522|536429452|FG000|Treatment Period|Adverse Event|1|||
148715353|NCT03980522|536429453|FG001|Treatment Period|Adverse Event|0|||
148715354|NCT03980522|536429454|FG002|Treatment Period|Adverse Event|0|||
148715355|NCT03980522|536429455|FG003|Treatment Period|Adverse Event|0|||
148715356|NCT03980522|536429456|FG004|Treatment Period|Adverse Event|0|||
148715357|NCT01320722|536429457|FG000|Overall Study|Did not Receive Intervention|3|||
148715358|NCT01320722|536429458|FG001|Overall Study|Did not Receive Intervention|2|||
148715359|NCT01320722|536429459|FG002|Overall Study|Did not Receive Intervention|1|||
148715360|NCT01320722|536429460|FG003|Overall Study|Did not Receive Intervention|1|||
148715361|NCT01320722|536429461|FG004|Overall Study|Did not Receive Intervention|2|||
148715362|NCT01320722|536429457|FG000|Overall Study|Lost to Follow-up|0|||
148715363|NCT01320722|536429458|FG001|Overall Study|Lost to Follow-up|1|||
148715364|NCT01320722|536429459|FG002|Overall Study|Lost to Follow-up|0|||
148715365|NCT01320722|536429460|FG003|Overall Study|Lost to Follow-up|1|||
148715366|NCT01320722|536429461|FG004|Overall Study|Lost to Follow-up|3|||
148715367|NCT01320722|536429457|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
148715368|NCT01320722|536429458|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
148715369|NCT01320722|536429459|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
148715370|NCT01320722|536429460|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
148715371|NCT01320722|536429461|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
148715372|NCT01320722|536429457|FG000|Overall Study|Participant Developed a Rash|0|||
148715373|NCT01320722|536429458|FG001|Overall Study|Participant Developed a Rash|0|||
148715374|NCT01320722|536429459|FG002|Overall Study|Participant Developed a Rash|2|||
148715375|NCT01320722|536429460|FG003|Overall Study|Participant Developed a Rash|1|||
148715376|NCT01320722|536429461|FG004|Overall Study|Participant Developed a Rash|1|||
148715377|NCT01320722|536429457|FG000|Overall Study|Non-compliant with Medication|0|||
148715378|NCT01320722|536429458|FG001|Overall Study|Non-compliant with Medication|0|||
148715379|NCT01320722|536429459|FG002|Overall Study|Non-compliant with Medication|1|||
148715380|NCT01320722|536429460|FG003|Overall Study|Non-compliant with Medication|0|||
148715381|NCT01320722|536429461|FG004|Overall Study|Non-compliant with Medication|0|||
148715382|NCT01320722|536429457|FG000|Overall Study|Adverse Event|0|||
148715383|NCT01320722|536429458|FG001|Overall Study|Adverse Event|0|||
148715384|NCT01320722|536429459|FG002|Overall Study|Adverse Event|3|||
148715385|NCT01320722|536429460|FG003|Overall Study|Adverse Event|6|||
148715386|NCT01320722|536429461|FG004|Overall Study|Adverse Event|0|||
148715387|NCT01320722|536429457|FG000|Overall Study|Not Compliant with Study Procedures|0|||
148715388|NCT01320722|536429458|FG001|Overall Study|Not Compliant with Study Procedures|0|||
148715389|NCT01320722|536429459|FG002|Overall Study|Not Compliant with Study Procedures|0|||
148715390|NCT01320722|536429460|FG003|Overall Study|Not Compliant with Study Procedures|4|||
148715391|NCT01320722|536429461|FG004|Overall Study|Not Compliant with Study Procedures|0|||
148715392|NCT01320722|536429457|FG000|Overall Study|Pregnancy|0|||
148715393|NCT01320722|536429458|FG001|Overall Study|Pregnancy|0|||
148715394|NCT01320722|536429459|FG002|Overall Study|Pregnancy|0|||
148715395|NCT01320722|536429460|FG003|Overall Study|Pregnancy|1|||
148715396|NCT01320722|536429461|FG004|Overall Study|Pregnancy|0|||
148715397|NCT01320722|536429457|FG000|Overall Study|Started an Exclusionary Medication|0|||
148715398|NCT01320722|536429458|FG001|Overall Study|Started an Exclusionary Medication|0|||
148715399|NCT01320722|536429459|FG002|Overall Study|Started an Exclusionary Medication|0|||
148715400|NCT01320722|536429460|FG003|Overall Study|Started an Exclusionary Medication|0|||
149025165|NCT04529538|537568046|FG003|Overall Study|Withdrawal by Subject|2|||
148968875|NCT01228747|537372830|FG000|Overall Study|Other Reason|2|||
148968876|NCT01228747|537372831|FG001|Overall Study|Other Reason|5|||
148968877|NCT02036502|537372832|FG000|Part 1:Dose Determination/Escalation|Death|3|||
148968878|NCT02036502|537372833|FG001|Part 1:Dose Determination/Escalation|Death|2|||
148968879|NCT02036502|537372834|FG002|Part 1:Dose Determination/Escalation|Death|0|||
148968880|NCT02036502|537372835|FG003|Part 1:Dose Determination/Escalation|Death|0|||
148968881|NCT02036502|537372836|FG004|Part 1:Dose Determination/Escalation|Death|0|||
148968882|NCT02036502|537372837|FG005|Part 1:Dose Determination/Escalation|Death|0|||
148968883|NCT02036502|537372838|FG006|Part 1:Dose Determination/Escalation|Death|0|||
148968884|NCT02036502|537372839|FG007|Part 1:Dose Determination/Escalation|Death|0|||
148968885|NCT02036502|537372832|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
148968886|NCT02036502|537372833|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148968887|NCT02036502|537372834|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148968888|NCT02036502|537372835|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148968889|NCT02036502|537372836|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148968890|NCT02036502|537372837|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148715401|NCT01320722|536429461|FG004|Overall Study|Started an Exclusionary Medication|1|||
148715402|NCT01320722|536429457|FG000|Overall Study|Withdrew due to Health Condition|0|||
148715403|NCT01320722|536429458|FG001|Overall Study|Withdrew due to Health Condition|0|||
148715404|NCT01320722|536429459|FG002|Overall Study|Withdrew due to Health Condition|0|||
148715405|NCT01320722|536429460|FG003|Overall Study|Withdrew due to Health Condition|0|||
148715406|NCT01320722|536429461|FG004|Overall Study|Withdrew due to Health Condition|1|||
148715407|NCT01091363|536429462|FG000|Overall Study|Withdrawal by Subject|11|||
148715408|NCT01091363|536429463|FG001|Overall Study|Withdrawal by Subject|15|||
148715409|NCT01091363|536429462|FG000|Overall Study|Lost to Follow-up|2|||
148715410|NCT01091363|536429463|FG001|Overall Study|Lost to Follow-up|2|||
148715411|NCT00021541|536429464|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
148715412|NCT00021541|536429465|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
148715413|NCT00021541|536429464|FG000|Period 1-First Treatment|Adverse Event|2|||
148715414|NCT00021541|536429465|FG001|Period 1-First Treatment|Adverse Event|1|||
148715415|NCT00021541|536429464|FG000|Period 1-First Treatment|non-adherence|3|||
148715416|NCT00021541|536429465|FG001|Period 1-First Treatment|non-adherence|0|||
148715417|NCT00021541|536429464|FG000|Period 1-First Treatment|Death|1|||
148715418|NCT00021541|536429465|FG001|Period 1-First Treatment|Death|0|||
148715419|NCT00021541|536429464|FG000|Period 1-First Treatment|Pts that did not progress|2|||
148715420|NCT00021541|536429465|FG001|Period 1-First Treatment|Pts that did not progress|2|||
148715421|NCT00021541|536429464|FG000|Period 1-First Treatment|Ineligible|0|||
148715422|NCT00021541|536429465|FG001|Period 1-First Treatment|Ineligible|2|||
148715423|NCT00021541|536429464|FG000|Period 2-crossover|refused phase B|2|||
148715424|NCT00021541|536429465|FG001|Period 2-crossover|refused phase B|2|||
148715425|NCT00021541|536429464|FG000|Period 2-crossover|Withdrawal by Subject|3|||
148715426|NCT00021541|536429465|FG001|Period 2-crossover|Withdrawal by Subject|4|||
148715427|NCT00021541|536429464|FG000|Period 2-crossover|Adverse Event|2|||
148715428|NCT00021541|536429465|FG001|Period 2-crossover|Adverse Event|2|||
148715429|NCT00021541|536429464|FG000|Period 2-crossover|non-adherence|1|||
148715430|NCT00021541|536429465|FG001|Period 2-crossover|non-adherence|0|||
148715431|NCT00021541|536429464|FG000|Period 2-crossover|Pts that did not progress|2|||
148715432|NCT00021541|536429465|FG001|Period 2-crossover|Pts that did not progress|3|||
148715433|NCT01874535|536429469|FG000|Overall Study|Lost to Follow-up|10|||
148715434|NCT01874535|536429470|FG001|Overall Study|Lost to Follow-up|9|||
148715435|NCT01874535|536429469|FG000|Overall Study|incomplete symptom resolution|45|||
148715436|NCT01874535|536429470|FG001|Overall Study|incomplete symptom resolution|35|||
148715437|NCT01215721|536429472|FG000|Overall Study|Adverse Event|2|||
148715438|NCT00045162|536429473|FG000|Overall Study|Ineligible|12|||
148715439|NCT00045162|536429474|FG001|Overall Study|Ineligible|8|||
148715440|NCT00045162|536429473|FG000|Overall Study|Not treated|7|||
148715441|NCT00045162|536429474|FG001|Overall Study|Not treated|2|||
148715442|NCT00045162|536429473|FG000|Overall Study|Adverse Event|55|||
148715443|NCT00045162|536429474|FG001|Overall Study|Adverse Event|50|||
148715444|NCT00045162|536429473|FG000|Overall Study|Lack of Efficacy|32|||
148715445|NCT00045162|536429474|FG001|Overall Study|Lack of Efficacy|29|||
148715446|NCT00045162|536429473|FG000|Overall Study|Death|10|||
148715447|NCT00045162|536429474|FG001|Overall Study|Death|10|||
148715448|NCT00045162|536429473|FG000|Overall Study|Withdrawal by Subject|5|||
148715449|NCT00045162|536429474|FG001|Overall Study|Withdrawal by Subject|3|||
148715450|NCT00045162|536429473|FG000|Overall Study|Other|21|||
148715451|NCT00045162|536429474|FG001|Overall Study|Other|16|||
148715452|NCT01044433|536429476|FG000|Overall Study|Lost to Follow-up|3|||
148715453|NCT01044433|536429476|FG000|Overall Study|Withdrawal by Subject|3|||
148715454|NCT03828539|536429479|FG000|Overall Study|Adverse Event|3|||
148715455|NCT03828539|536429480|FG001|Overall Study|Adverse Event|12|||
148715456|NCT03828539|536429479|FG000|Overall Study|Patient's/guardian's decision|3|||
148715457|NCT03828539|536429480|FG001|Overall Study|Patient's/guardian's decision|5|||
148715458|NCT03828539|536429479|FG000|Overall Study|Lost to Follow-up|4|||
148715459|NCT03828539|536429480|FG001|Overall Study|Lost to Follow-up|2|||
148715460|NCT03828539|536429479|FG000|Overall Study|Protocol Violation|3|||
148715461|NCT03828539|536429480|FG001|Overall Study|Protocol Violation|2|||
148715462|NCT03828539|536429479|FG000|Overall Study|Withdrawal of informed consent|2|||
148715463|NCT03828539|536429480|FG001|Overall Study|Withdrawal of informed consent|1|||
148715464|NCT03828539|536429479|FG000|Overall Study|New therapy for study indication|1|||
148715465|NCT03828539|536429480|FG001|Overall Study|New therapy for study indication|0|||
148715466|NCT01341405|536429481|FG000|Overall Study|Adverse Event|0|||
148715467|NCT01341405|536429482|FG001|Overall Study|Adverse Event|1|||
148715468|NCT01341405|536429483|FG002|Overall Study|Adverse Event|1|||
148715469|NCT01341405|536429481|FG000|Overall Study|Withdrawal by Subject|3|||
148715470|NCT01341405|536429482|FG001|Overall Study|Withdrawal by Subject|2|||
148715471|NCT01341405|536429483|FG002|Overall Study|Withdrawal by Subject|1|||
148715472|NCT05263505|536429484|FG000|Overall Study|Adverse Event|0|||
148715473|NCT05263505|536429485|FG001|Overall Study|Adverse Event|1|||
148715474|NCT02616380|536429486|FG000|Overall Study|Lost to Follow-up|1|||
148715475|NCT02616380|536429486|FG000|Overall Study|Other|2|||
148715476|NCT00826241|536429487|FG000|Overall Study|Withdrawal from Follow-up|1|||
148715477|NCT00826241|536429487|FG000|Overall Study|Withdrew consent|2|||
148715478|NCT00826241|536429487|FG000|Overall Study|Death|4|||
148715479|NCT00826241|536429487|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
148715480|NCT00826241|536429487|FG000|Overall Study|Non-compliance|1|||
148715481|NCT00826241|536429487|FG000|Overall Study|Progression of disease|1|||
148715482|NCT00826241|536429487|FG000|Overall Study|Patient refused follow-up|3|||
148715483|NCT00826241|536429487|FG000|Overall Study|Lost to Follow-up|9|||
148715484|NCT00826241|536429487|FG000|Overall Study|Could not obtain records|1|||
148715485|NCT00826241|536429487|FG000|Overall Study|Screen failure|2|||
148715486|NCT00826241|536429487|FG000|Overall Study|Pt unable to proceed to registration|1|||
148715487|NCT00826241|536429487|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
148715488|NCT03407729|536429488|FG000|Overall Study|Lost to Follow-up|2|||
148715489|NCT03407729|536429489|FG001|Overall Study|Lost to Follow-up|0|||
148715490|NCT03407729|536429488|FG000|Overall Study|Unable to schedule|0|||
148715491|NCT03407729|536429489|FG001|Overall Study|Unable to schedule|3|||
148715492|NCT01849458|536429490|FG000|Overall Study|Lost to Follow-up|4|||
148715493|NCT00024258|536429495|FG000|Overall Study|Withdrawal by Subject|1|||
148715494|NCT00024258|536429495|FG000|Overall Study|Disease Progression|8|||
148715495|NCT03950674|536429496|FG000|Overall Study|Death|16|||
148715496|NCT03950674|536429497|FG001|Overall Study|Death|15|||
148715497|NCT03950674|536429496|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
148715498|NCT03950674|536429497|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
148715499|NCT01898598|536429498|FG000|Overall Study|Adverse Event|1|||
148715500|NCT01898598|536429499|FG001|Overall Study|Adverse Event|0|||
148715501|NCT01898598|536429498|FG000|Overall Study|Withdrawal by Subject|3|||
148715502|NCT01898598|536429499|FG001|Overall Study|Withdrawal by Subject|0|||
148715503|NCT01898598|536429498|FG000|Overall Study|Lost to Follow-up|0|||
148715504|NCT01898598|536429499|FG001|Overall Study|Lost to Follow-up|1|||
148715505|NCT01898598|536429498|FG000|Overall Study|Other|0|||
148715506|NCT01898598|536429499|FG001|Overall Study|Other|1|||
148715507|NCT03833427|536429500|FG000|Overall Study|Death|4|||
148715508|NCT03833427|536429501|FG001|Overall Study|Death|2|||
148715509|NCT03833427|536429502|FG002|Overall Study|Death|9|||
148715510|NCT03833427|536429503|FG003|Overall Study|Death|11|||
148715511|NCT03833427|536429504|FG004|Overall Study|Death|0|||
148715512|NCT03833427|536429505|FG005|Overall Study|Death|0|||
148715513|NCT03833427|536429506|FG006|Overall Study|Death|0|||
148715514|NCT03833427|536429500|FG000|Overall Study|Withdrawal by Subject|0|||
148715515|NCT03833427|536429501|FG001|Overall Study|Withdrawal by Subject|1|||
148715516|NCT03833427|536429502|FG002|Overall Study|Withdrawal by Subject|1|||
148715517|NCT03833427|536429503|FG003|Overall Study|Withdrawal by Subject|0|||
148715518|NCT03833427|536429504|FG004|Overall Study|Withdrawal by Subject|0|||
148715519|NCT03833427|536429505|FG005|Overall Study|Withdrawal by Subject|0|||
148715520|NCT03833427|536429506|FG006|Overall Study|Withdrawal by Subject|0|||
148715521|NCT03833427|536429500|FG000|Overall Study|Sponsor Decision|0|||
148715522|NCT03833427|536429501|FG001|Overall Study|Sponsor Decision|0|||
148968891|NCT02036502|537372838|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148968892|NCT02036502|537372839|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
148715523|NCT03833427|536429502|FG002|Overall Study|Sponsor Decision|1|||
148715524|NCT03833427|536429503|FG003|Overall Study|Sponsor Decision|3|||
148715525|NCT03833427|536429504|FG004|Overall Study|Sponsor Decision|0|||
148715526|NCT03833427|536429505|FG005|Overall Study|Sponsor Decision|0|||
148715527|NCT03833427|536429506|FG006|Overall Study|Sponsor Decision|0|||
148715528|NCT03428945|536429514|FG000|Overall Study|Lost to Follow-up|5|||
148715529|NCT03428945|536429515|FG001|Overall Study|Lost to Follow-up|3|||
148715530|NCT03428945|536429514|FG000|Overall Study|Withdrawal by Subject|10|||
148715531|NCT03428945|536429515|FG001|Overall Study|Withdrawal by Subject|10|||
148715532|NCT00982228|536429516|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
148715533|NCT00982228|536429517|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
148715534|NCT00982228|536429516|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
148715535|NCT00982228|536429517|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
148715536|NCT00982228|536429516|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
148715537|NCT00982228|536429517|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
148715538|NCT00982228|536429516|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
148715539|NCT00982228|536429517|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
148715540|NCT00982228|536429516|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
148715541|NCT00982228|536429517|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
148715542|NCT00982228|536429516|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
148715543|NCT00982228|536429517|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
148715544|NCT00982228|536429516|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
148715545|NCT00982228|536429517|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
148715546|NCT00982228|536429516|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
148715547|NCT00982228|536429517|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
148715548|NCT00982228|536429516|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
148715549|NCT00982228|536429517|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
148715550|NCT00982228|536429516|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
148715551|NCT00982228|536429517|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
148715552|NCT00360490|536429521|FG000|Overall Study|Adverse Event|4|||
148715553|NCT00360490|536429522|FG001|Overall Study|Adverse Event|2|||
148715554|NCT00360490|536429521|FG000|Overall Study|Lost to Follow-up|2|||
148715555|NCT00360490|536429522|FG001|Overall Study|Lost to Follow-up|1|||
148715556|NCT00360490|536429521|FG000|Overall Study|Physician Decision|2|||
148715557|NCT00360490|536429522|FG001|Overall Study|Physician Decision|1|||
148715558|NCT00360490|536429521|FG000|Overall Study|Protocol Violation|0|||
148715559|NCT00360490|536429522|FG001|Overall Study|Protocol Violation|4|||
148715560|NCT00360490|536429521|FG000|Overall Study|Withdrawal by Subject|1|||
148715561|NCT00360490|536429522|FG001|Overall Study|Withdrawal by Subject|3|||
148715562|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
148715563|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
148715564|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
148715565|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
148715566|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
148715567|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
148715568|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
148715569|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
148715570|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
148715571|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
148715572|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
148715573|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
148715574|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
148715575|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
148715576|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
148715577|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
148715578|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
148715579|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
148715580|NCT00950300|536429523|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
148715581|NCT00950300|536429524|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
148715582|NCT00950300|536429523|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
148715583|NCT00950300|536429524|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
148715584|NCT00950300|536429523|FG000|TFFU Period|Death|4|||
148715585|NCT00950300|536429524|FG001|TFFU Period|Death|1|||
148715586|NCT00950300|536429523|FG000|TFFU Period|Refused Treatment|10|||
148715587|NCT00950300|536429524|FG001|TFFU Period|Refused Treatment|11|||
148815703|NCT04615507|536800604|FG001|Period 2|Covid-19 exposure|1|||
148815704|NCT04615507|536800603|FG000|Period 2|Protocol Violation|1|||
148815705|NCT04615507|536800604|FG001|Period 2|Protocol Violation|0|||
148815706|NCT04615507|536800603|FG000|Period 2|Withdrawal by Subject|1|||
148815707|NCT04615507|536800604|FG001|Period 2|Withdrawal by Subject|0|||
148815708|NCT04615507|536800603|FG000|Period 2|Adverse Event|0|||
148815709|NCT04615507|536800604|FG001|Period 2|Adverse Event|1|||
148815710|NCT04615507|536800603|FG000|Period 3|Covid-19 exposure|0|||
148815711|NCT04615507|536800604|FG001|Period 3|Covid-19 exposure|1|||
148815712|NCT00118287|536800607|FG000|Overall Study|Intracranial haemorrhage|1|||
148815713|NCT00118287|536800607|FG000|Overall Study|Muscle pain|1|||
148715588|NCT00950300|536429523|FG000|TFFU Period|Failure to Return|16|||
148815714|NCT03091439|536800612|FG000|Overall Study|Study Terminated by the Sponsor|1|||
148815715|NCT03091439|536800613|FG001|Overall Study|Study Terminated by the Sponsor|0|||
148715589|NCT00950300|536429524|FG001|TFFU Period|Failure to Return|16|||
148715590|NCT00950300|536429523|FG000|TFFU Period|Recurrence of Disease|63|||
148715591|NCT00950300|536429524|FG001|TFFU Period|Recurrence of Disease|72|||
148715592|NCT00950300|536429523|FG000|TFFU Period|Other|4|||
148715593|NCT00950300|536429524|FG001|TFFU Period|Other|3|||
148715594|NCT00950300|536429523|FG000|SFU Period|Death|44|||
148715595|NCT00950300|536429524|FG001|SFU Period|Death|42|||
148715596|NCT00950300|536429523|FG000|SFU Period|Lost to Follow-up|30|||
148715597|NCT00950300|536429524|FG001|SFU Period|Lost to Follow-up|28|||
148715598|NCT00950300|536429523|FG000|SFU Period|Withdrawal by Subject|4|||
148715599|NCT00950300|536429524|FG001|SFU Period|Withdrawal by Subject|8|||
148715600|NCT01596127|536429526|FG000|Overall Study|Patient Ineligible|1|||
148715601|NCT00438633|536429527|FG000|Overall Study|Withdrawal by Subject|1|||
148715602|NCT00438633|536429528|FG001|Overall Study|Withdrawal by Subject|0|||
148715603|NCT00438633|536429527|FG000|Overall Study|Lost to Follow-up|15|||
148715604|NCT00438633|536429528|FG001|Overall Study|Lost to Follow-up|17|||
148715605|NCT01539239|536429529|FG000|Overall Study|Death|5|||
148715606|NCT01539239|536429530|FG001|Overall Study|Death|5|||
148715607|NCT01539239|536429529|FG000|Overall Study|Lost to Follow-up|7|||
148715608|NCT01539239|536429530|FG001|Overall Study|Lost to Follow-up|12|||
148715609|NCT00633022|536429533|FG000|Overall Study|Adverse Event|1|||
148715610|NCT00633022|536429534|FG001|Overall Study|Adverse Event|0|||
148715611|NCT00633022|536429535|FG002|Overall Study|Adverse Event|5|||
148715612|NCT00633022|536429533|FG000|Overall Study|Physician Decision|0|||
148715613|NCT00633022|536429534|FG001|Overall Study|Physician Decision|1|||
148715614|NCT00633022|536429535|FG002|Overall Study|Physician Decision|0|||
148715615|NCT05135273|536430887|FG000|Overall Study|Recruited into the army|0|||
148715616|NCT05135273|536430888|FG001|Overall Study|Recruited into the army|0|||
148715617|NCT05135273|536430889|FG002|Overall Study|Recruited into the army|0|||
148715618|NCT05135273|536430890|FG003|Overall Study|Recruited into the army|0|||
148715619|NCT05135273|536430891|FG004|Overall Study|Recruited into the army|1|||
148715620|NCT05135273|536430892|FG005|Overall Study|Recruited into the army|0|||
148715621|NCT05135273|536430893|FG006|Overall Study|Recruited into the army|0|||
148715622|NCT05135273|536430894|FG007|Overall Study|Recruited into the army|0|||
148715623|NCT05135273|536430887|FG000|Overall Study|Moved away from study site|0|||
148715624|NCT05135273|536430888|FG001|Overall Study|Moved away from study site|0|||
148715625|NCT05135273|536430889|FG002|Overall Study|Moved away from study site|0|||
148715626|NCT05135273|536430890|FG003|Overall Study|Moved away from study site|0|||
148715627|NCT05135273|536430891|FG004|Overall Study|Moved away from study site|0|||
148715628|NCT05135273|536430892|FG005|Overall Study|Moved away from study site|1|||
148715629|NCT05135273|536430893|FG006|Overall Study|Moved away from study site|1|||
148715630|NCT05135273|536430894|FG007|Overall Study|Moved away from study site|0|||
148715631|NCT05135273|536430887|FG000|Overall Study|Travel|0|||
148715632|NCT05135273|536430888|FG001|Overall Study|Travel|0|||
148715633|NCT05135273|536430889|FG002|Overall Study|Travel|0|||
148715634|NCT05135273|536430890|FG003|Overall Study|Travel|0|||
148715635|NCT05135273|536430891|FG004|Overall Study|Travel|0|||
148715636|NCT05135273|536430892|FG005|Overall Study|Travel|0|||
148715637|NCT05135273|536430893|FG006|Overall Study|Travel|0|||
148715638|NCT05135273|536430894|FG007|Overall Study|Travel|1|||
148715639|NCT01958060|536430897|FG000|Overall Study|Not treated|2|||
148715640|NCT01958060|536430898|FG001|Overall Study|Not treated|0|||
148715641|NCT01958060|536430899|FG002|Overall Study|Not treated|0|||
148715642|NCT01958060|536430900|FG003|Overall Study|Not treated|0|||
148715643|NCT01958060|536430901|FG004|Overall Study|Not treated|1|||
148715644|NCT01958060|536430902|FG005|Overall Study|Not treated|0|||
148715645|NCT01705717|536430903|FG000|Overall Study|Adverse Event|2|||
148715646|NCT01705717|536430904|FG001|Overall Study|Adverse Event|2|||
148715647|NCT01705717|536430903|FG000|Overall Study|Lack of Efficacy|0|||
148715648|NCT01705717|536430904|FG001|Overall Study|Lack of Efficacy|1|||
148715649|NCT01705717|536430903|FG000|Overall Study|Other|0|||
148715650|NCT01705717|536430904|FG001|Overall Study|Other|2|||
148715651|NCT02293460|536430905|FG000|Overall Study|Protocol Violation|1|||
148715652|NCT02293460|536430905|FG000|Overall Study|Lack of Efficacy|2|||
148715653|NCT02293460|536430905|FG000|Overall Study|Adverse Event|2|||
148715654|NCT02293460|536430905|FG000|Overall Study|Withdrawal by Subject|1|||
148715655|NCT00500318|536430907|FG000|Overall Study|Adverse Event|3|||
148715656|NCT00500318|536430908|FG001|Overall Study|Adverse Event|8|||
148715657|NCT00500318|536430907|FG000|Overall Study|Protocol Violation|1|||
148715658|NCT00500318|536430908|FG001|Overall Study|Protocol Violation|3|||
148715659|NCT00500318|536430907|FG000|Overall Study|Withdrawal by Subject|1|||
148715660|NCT00500318|536430908|FG001|Overall Study|Withdrawal by Subject|2|||
148715661|NCT00500318|536430907|FG000|Overall Study|Lack of Efficacy|0|||
148715662|NCT00500318|536430908|FG001|Overall Study|Lack of Efficacy|3|||
148715663|NCT00500318|536430907|FG000|Overall Study|Other Reason|0|||
148715664|NCT00500318|536430908|FG001|Overall Study|Other Reason|1|||
148715665|NCT03547635|536430929|FG000|Overall Study|Adverse Event|5|||
148715666|NCT03547635|536430930|FG001|Overall Study|Adverse Event|2|||
148715667|NCT03547635|536430931|FG002|Overall Study|Adverse Event|3|||
148715668|NCT03547635|536430929|FG000|Overall Study|Lost to Follow-up|1|||
148715669|NCT03547635|536430930|FG001|Overall Study|Lost to Follow-up|3|||
148715670|NCT03547635|536430931|FG002|Overall Study|Lost to Follow-up|4|||
148715671|NCT03547635|536430929|FG000|Overall Study|Withdrawal by Subject|1|||
148715672|NCT03547635|536430930|FG001|Overall Study|Withdrawal by Subject|0|||
148715673|NCT03547635|536430931|FG002|Overall Study|Withdrawal by Subject|0|||
148715674|NCT03547635|536430929|FG000|Overall Study|Withdrawal By PI|0|||
148715675|NCT03547635|536430930|FG001|Overall Study|Withdrawal By PI|1|||
148715676|NCT03547635|536430931|FG002|Overall Study|Withdrawal By PI|0|||
148715677|NCT03547635|536430929|FG000|Overall Study|Withdrawal by Sponsor|0|||
148715678|NCT03547635|536430930|FG001|Overall Study|Withdrawal by Sponsor|0|||
148715679|NCT03547635|536430931|FG002|Overall Study|Withdrawal by Sponsor|1|||
148715680|NCT03547635|536430929|FG000|Overall Study|Errant Randomization before Treatment|0|||
148715681|NCT03547635|536430930|FG001|Overall Study|Errant Randomization before Treatment|1|||
148715682|NCT03547635|536430931|FG002|Overall Study|Errant Randomization before Treatment|0|||
148715683|NCT03547635|536430929|FG000|Overall Study|Withdrawal by Subject|1|||
148715684|NCT03547635|536430930|FG001|Overall Study|Withdrawal by Subject|0|||
148715685|NCT03547635|536430931|FG002|Overall Study|Withdrawal by Subject|0|||
148715686|NCT01765751|536430938|FG000|Overall Study|Lost to Follow-up|0|||
148715687|NCT01765751|536430939|FG001|Overall Study|Lost to Follow-up|2|||
148715688|NCT01765751|536430940|FG002|Overall Study|Lost to Follow-up|1|||
148715689|NCT02274558|536430945|FG000|Overall Study|Adverse Event|2|||
148715690|NCT02274558|536430946|FG001|Overall Study|Adverse Event|4|||
148715691|NCT02274558|536430947|FG002|Overall Study|Adverse Event|2|||
148715692|NCT02274558|536430945|FG000|Overall Study|Non-compliance|2|||
148715693|NCT02274558|536430946|FG001|Overall Study|Non-compliance|1|||
148715694|NCT02274558|536430947|FG002|Overall Study|Non-compliance|0|||
148715695|NCT02274558|536430945|FG000|Overall Study|Withdrawal by Subject|1|||
148715696|NCT02274558|536430946|FG001|Overall Study|Withdrawal by Subject|5|||
148715697|NCT02274558|536430947|FG002|Overall Study|Withdrawal by Subject|4|||
148715698|NCT02274558|536430945|FG000|Overall Study|Death|0|||
148715699|NCT02274558|536430946|FG001|Overall Study|Death|0|||
148715700|NCT02274558|536430947|FG002|Overall Study|Death|1|||
148715701|NCT02274558|536430945|FG000|Overall Study|Lost to Follow-up|2|||
148715702|NCT02274558|536430946|FG001|Overall Study|Lost to Follow-up|1|||
148715703|NCT02274558|536430947|FG002|Overall Study|Lost to Follow-up|1|||
148715704|NCT02274558|536430945|FG000|Overall Study|Physician Decision|0|||
148715705|NCT02274558|536430946|FG001|Overall Study|Physician Decision|2|||
148715706|NCT02274558|536430947|FG002|Overall Study|Physician Decision|1|||
148715707|NCT01257581|536430948|FG000|Overall Study|Early Termination|3|||
148715708|NCT01257581|536430949|FG001|Overall Study|Early Termination|1|||
148715709|NCT01257581|536430950|FG002|Overall Study|Early Termination|2|||
148715710|NCT01257581|536430948|FG000|Overall Study|Death|2|||
148715711|NCT01257581|536430949|FG001|Overall Study|Death|2|||
148715712|NCT01257581|536430950|FG002|Overall Study|Death|4|||
148715713|NCT00517192|536430957|FG000|Overall Study|Adverse Event|1|||
148715714|NCT00517192|536430958|FG001|Overall Study|Adverse Event|1|||
148715715|NCT00517192|536430957|FG000|Overall Study|Lost to Follow-up|1|||
148715716|NCT00517192|536430958|FG001|Overall Study|Lost to Follow-up|1|||
148715717|NCT00517192|536430957|FG000|Overall Study|Withdrawal by Subject|1|||
148715718|NCT00517192|536430958|FG001|Overall Study|Withdrawal by Subject|0|||
148715719|NCT00517192|536430957|FG000|Overall Study|Early termination of the trial|16|||
148715720|NCT00517192|536430958|FG001|Overall Study|Early termination of the trial|18|||
148715721|NCT00063258|536430974|FG000|Overall Study|Physician Decision|2|||
148715722|NCT00063258|536430975|FG001|Overall Study|Physician Decision|0|||
148715723|NCT00063258|536430974|FG000|Overall Study|Lack of Efficacy|2|||
148715724|NCT00063258|536430975|FG001|Overall Study|Lack of Efficacy|0|||
148715725|NCT02733627|536430976|FG000|Overall Study|Adverse Event|0|||
148715726|NCT02733627|536430977|FG001|Overall Study|Adverse Event|1|||
148715727|NCT02733627|536430978|FG002|Overall Study|Adverse Event|1|||
148715728|NCT02733627|536430979|FG003|Overall Study|Adverse Event|0|||
148715729|NCT02733627|536430976|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
148715730|NCT02733627|536430977|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
148715731|NCT02733627|536430978|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
148715732|NCT02733627|536430979|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
148715733|NCT02246764|536430980|FG000|Overall Study|Adverse Event|15|||
148968893|NCT02036502|537372832|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148715734|NCT02246764|536430981|FG001|Overall Study|Adverse Event|29|||
148715735|NCT02246764|536430982|FG002|Overall Study|Adverse Event|1|||
148715736|NCT02246764|536430980|FG000|Overall Study|Withdrawal by Subject|0|||
148715737|NCT02246764|536430981|FG001|Overall Study|Withdrawal by Subject|0|||
148715738|NCT02246764|536430982|FG002|Overall Study|Withdrawal by Subject|1|||
148715739|NCT02246764|536430980|FG000|Overall Study|Disallowed Concomitant Medication|1|||
148715740|NCT02246764|536430981|FG001|Overall Study|Disallowed Concomitant Medication|0|||
148715741|NCT02246764|536430982|FG002|Overall Study|Disallowed Concomitant Medication|0|||
148715742|NCT02246764|536430980|FG000|Overall Study|Physician Decision|0|||
148715743|NCT02246764|536430981|FG001|Overall Study|Physician Decision|2|||
148715744|NCT02246764|536430982|FG002|Overall Study|Physician Decision|1|||
148715745|NCT02246764|536430980|FG000|Overall Study|Protocol Violation|2|||
148715746|NCT02246764|536430981|FG001|Overall Study|Protocol Violation|1|||
148715747|NCT02246764|536430982|FG002|Overall Study|Protocol Violation|1|||
148715748|NCT03167606|536430983|FG000|Overall Study|Lost to Follow-up|73|||
148715749|NCT03167606|536430984|FG001|Overall Study|Lost to Follow-up|64|||
148715750|NCT03167606|536430983|FG000|Overall Study|Withdrawal by Subject|6|||
148715751|NCT03167606|536430984|FG001|Overall Study|Withdrawal by Subject|5|||
148715752|NCT03167606|536430983|FG000|Overall Study|Withdrawal by Investigator|0|||
148715753|NCT03167606|536430984|FG001|Overall Study|Withdrawal by Investigator|2|||
148715754|NCT03314857|536430986|FG000|Overall Study|Death|4|||
148715755|NCT03314857|536430986|FG000|Overall Study|Physician Decision|1|||
148715756|NCT01408888|536430991|FG000|First Intervention|Adverse Event|0|||
148715757|NCT01408888|536430992|FG001|First Intervention|Adverse Event|1|||
148715758|NCT01408888|536430991|FG000|First Intervention|Withdrawal by Subject|0|||
148715759|NCT01408888|536430992|FG001|First Intervention|Withdrawal by Subject|2|||
148715760|NCT01408888|536430991|FG000|Second Intervention|Withdrawal by Subject|1|||
148715761|NCT01408888|536430992|FG001|Second Intervention|Withdrawal by Subject|0|||
148715762|NCT01408888|536430991|FG000|Second Intervention|Adverse Event|1|||
148715763|NCT01408888|536430992|FG001|Second Intervention|Adverse Event|0|||
148715764|NCT00487695|536430993|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
148715765|NCT00487695|536430994|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
148715766|NCT00487695|536430993|FG000|First Procedure|active wheezing (did not have procedure)|1|||
148715767|NCT00487695|536430994|FG001|First Procedure|active wheezing (did not have procedure)|0|||
148715768|NCT00487695|536430993|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
148715769|NCT00487695|536430994|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
148715770|NCT00487695|536430993|FG000|Second Procedure|active wheezing|0|||
148715771|NCT00487695|536430994|FG001|Second Procedure|active wheezing|1|||
148715772|NCT00487695|536430993|FG000|Second Procedure|Withdrawal by Subject|1|||
148968894|NCT02036502|537372833|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
148968895|NCT02036502|537372834|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148968896|NCT02036502|537372835|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148968897|NCT02036502|537372836|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148968898|NCT02036502|537372837|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148968899|NCT02036502|537372838|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148968900|NCT02036502|537372839|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
148968901|NCT02036502|537372832|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
148968902|NCT02036502|537372833|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
148968903|NCT02036502|537372834|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
148968904|NCT02036502|537372835|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
148968905|NCT02036502|537372836|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
148968906|NCT02036502|537372837|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
148968907|NCT02036502|537372838|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
148968908|NCT02036502|537372839|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
148968909|NCT02036502|537372832|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
148968910|NCT02036502|537372833|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
148968911|NCT02036502|537372834|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
148968912|NCT02036502|537372835|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
148968913|NCT02036502|537372836|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
148968914|NCT02036502|537372837|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
148968915|NCT02036502|537372838|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
148715773|NCT00487695|536430994|FG001|Second Procedure|Withdrawal by Subject|2|||
148715774|NCT02104817|536430995|FG000|Overall Study|Death|363|||
148715775|NCT02104817|536430996|FG001|Overall Study|Death|330|||
148715776|NCT02104817|536430995|FG000|Overall Study|Lost to Follow-up|3|||
148715777|NCT02104817|536430996|FG001|Overall Study|Lost to Follow-up|2|||
148715778|NCT02104817|536430995|FG000|Overall Study|Protocol Violation|0|||
148715779|NCT02104817|536430996|FG001|Overall Study|Protocol Violation|1|||
148715780|NCT02104817|536430995|FG000|Overall Study|Study terminated by sponsor|5854|||
148715781|NCT02104817|536430996|FG001|Overall Study|Study terminated by sponsor|5901|||
148715782|NCT02104817|536430995|FG000|Overall Study|Withdrawal by Subject|111|||
148715783|NCT02104817|536430996|FG001|Overall Study|Withdrawal by Subject|78|||
148815716|NCT05172570|536800614|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
148815717|NCT05172570|536800615|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
148968916|NCT02036502|537372839|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
148968917|NCT02036502|537372832|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148715784|NCT02104817|536430995|FG000|Overall Study|Other reasons|128|||
148715785|NCT02104817|536430996|FG001|Overall Study|Other reasons|135|||
148715786|NCT04633642|536430999|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
148715787|NCT04633642|536431000|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
148715788|NCT00611884|536431001|FG000|Overall Study|Adverse Event|1|||
148715789|NCT00611884|536431002|FG001|Overall Study|Adverse Event|0|||
148715790|NCT00611884|536431003|FG002|Overall Study|Adverse Event|0|||
148715791|NCT00611884|536431004|FG003|Overall Study|Adverse Event|1|||
148715792|NCT00611884|536431001|FG000|Overall Study|Non-Compliance|1|||
148715793|NCT00611884|536431002|FG001|Overall Study|Non-Compliance|4|||
148715794|NCT00611884|536431003|FG002|Overall Study|Non-Compliance|2|||
148715795|NCT00611884|536431004|FG003|Overall Study|Non-Compliance|2|||
148715796|NCT00611884|536431001|FG000|Overall Study|Lack of Efficacy|0|||
148715797|NCT00611884|536431002|FG001|Overall Study|Lack of Efficacy|1|||
148715798|NCT00611884|536431003|FG002|Overall Study|Lack of Efficacy|0|||
148715799|NCT00611884|536431004|FG003|Overall Study|Lack of Efficacy|0|||
148715800|NCT00611884|536431001|FG000|Overall Study|Unclassified|7|||
148715801|NCT00611884|536431002|FG001|Overall Study|Unclassified|4|||
148715802|NCT00611884|536431003|FG002|Overall Study|Unclassified|2|||
148715803|NCT00611884|536431004|FG003|Overall Study|Unclassified|3|||
148715804|NCT00981799|536431005|FG000|Overall Study|Adverse Event|1|||
148715805|NCT00981799|536431006|FG001|Overall Study|Adverse Event|1|||
148715806|NCT00981799|536431007|FG002|Overall Study|Adverse Event|0|||
148715807|NCT00981799|536431008|FG003|Overall Study|Adverse Event|0|||
148715808|NCT02167594|536431009|FG000|Overall Study|Withdrawal by Subject|2|||
148715809|NCT02167594|536431010|FG001|Overall Study|Withdrawal by Subject|0|||
148715810|NCT02167594|536431011|FG002|Overall Study|Withdrawal by Subject|0|||
148715811|NCT02167594|536431009|FG000|Overall Study|Death|0|||
148715812|NCT02167594|536431010|FG001|Overall Study|Death|1|||
148715813|NCT02167594|536431011|FG002|Overall Study|Death|0|||
148715814|NCT03433703|536431012|FG000|Overall Study|Study terminated by Sponsor|2|||
148715815|NCT00323258|536431016|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
148715816|NCT00323258|536431017|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
148715817|NCT00323258|536431016|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
148715818|NCT00323258|536431017|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
148715819|NCT00323258|536431016|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
148715820|NCT00323258|536431017|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
148715821|NCT00323258|536431016|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
148715822|NCT00323258|536431017|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
148715823|NCT00323258|536431016|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
148715824|NCT00323258|536431017|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
148715825|NCT00323258|536431016|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
148715826|NCT00323258|536431017|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
148715827|NCT00323258|536431016|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
148715828|NCT00323258|536431017|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
148715829|NCT01055834|536431027|FG000|Treatment Period I|Adverse Event|1|||
148715830|NCT01055834|536431028|FG001|Treatment Period I|Adverse Event|0|||
148715831|NCT01943435|536431031|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
148715832|NCT01943435|536431032|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
148715833|NCT01943435|536431033|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
148715834|NCT01943435|536431031|FG000|Intervention Period|Withdrawal by Subject|3|||
148715835|NCT01943435|536431032|FG001|Intervention Period|Withdrawal by Subject|3|||
148715836|NCT01943435|536431033|FG002|Intervention Period|Withdrawal by Subject|4|||
148715837|NCT01943435|536431031|FG000|2 Month Follow up|Lost to Follow-up|2|||
148715838|NCT01943435|536431032|FG001|2 Month Follow up|Lost to Follow-up|3|||
148715839|NCT01943435|536431033|FG002|2 Month Follow up|Lost to Follow-up|0|||
148715840|NCT01943435|536431031|FG000|6 Month Follow up|Lost to Follow-up|12|||
148715841|NCT01943435|536431032|FG001|6 Month Follow up|Lost to Follow-up|7|||
148715842|NCT01943435|536431033|FG002|6 Month Follow up|Lost to Follow-up|15|||
148715843|NCT01617096|536431040|FG000|Overall Study|Withdrawal by Subject|96|||
148715844|NCT01617096|536431041|FG001|Overall Study|Withdrawal by Subject|81|||
148715845|NCT01617096|536431040|FG000|Overall Study|Lost to Follow-up|37|||
148715846|NCT01617096|536431041|FG001|Overall Study|Lost to Follow-up|32|||
148715847|NCT01617096|536431040|FG000|Overall Study|Physician Decision|10|||
148715848|NCT01617096|536431041|FG001|Overall Study|Physician Decision|18|||
148715849|NCT01617096|536431040|FG000|Overall Study|Death|4|||
148715850|NCT01617096|536431041|FG001|Overall Study|Death|3|||
148715851|NCT01617096|536431040|FG000|Overall Study|Other|1|||
148715852|NCT01617096|536431041|FG001|Overall Study|Other|3|||
148715853|NCT02046122|536431046|FG000|Overall Study|Physician Decision|8|||
148715854|NCT02046122|536431046|FG000|Overall Study|Withdrawal by Subject|1|||
148715855|NCT04535986|536431049|FG000|Overall Study|Death|4|||
148715856|NCT04535986|536431050|FG001|Overall Study|Death|5|||
148715857|NCT04535986|536431049|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
148715858|NCT04535986|536431050|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
148715859|NCT04535986|536431049|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
148815718|NCT05172570|536800616|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
148715860|NCT04535986|536431050|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
148715861|NCT04535986|536431049|FG000|Overall Study|Adverse Event|10|||
148715862|NCT04535986|536431050|FG001|Overall Study|Adverse Event|1|||
148715863|NCT04535986|536431049|FG000|Overall Study|Lack of Efficacy|3|||
148715864|NCT04535986|536431050|FG001|Overall Study|Lack of Efficacy|2|||
148715865|NCT04535986|536431049|FG000|Overall Study|Investigator discretion|3|||
148715866|NCT04535986|536431050|FG001|Overall Study|Investigator discretion|0|||
148715867|NCT04535986|536431049|FG000|Overall Study|Withdrawal by Subject|32|||
148715868|NCT04535986|536431050|FG001|Overall Study|Withdrawal by Subject|14|||
148715869|NCT04535986|536431049|FG000|Overall Study|Lost to Follow-up|5|||
148715870|NCT04535986|536431050|FG001|Overall Study|Lost to Follow-up|3|||
148715871|NCT04535986|536431049|FG000|Overall Study|Other|7|||
148715872|NCT04535986|536431050|FG001|Overall Study|Other|3|||
148715873|NCT01196390|536431051|FG000|Overall Study|Protocol Violation|4|||
148715874|NCT01196390|536431052|FG001|Overall Study|Protocol Violation|5|||
148715875|NCT00697827|536431061|FG000|Overall Study|enrolled but not treated|2|||
148715876|NCT00697827|536431062|FG001|Overall Study|enrolled but not treated|1|||
148715877|NCT03732833|536431067|FG000|Overall Study|Adverse Event|0|||
148715878|NCT03732833|536431068|FG001|Overall Study|Adverse Event|3|||
148715879|NCT03732833|536431069|FG002|Overall Study|Adverse Event|1|||
148715880|NCT03732833|536431067|FG000|Overall Study|Withdrawal by Subject|11|||
148715881|NCT03732833|536431068|FG001|Overall Study|Withdrawal by Subject|13|||
148715882|NCT03732833|536431069|FG002|Overall Study|Withdrawal by Subject|8|||
148715883|NCT03732833|536431067|FG000|Overall Study|Lost to Follow-up|3|||
148715884|NCT03732833|536431068|FG001|Overall Study|Lost to Follow-up|5|||
148715885|NCT03732833|536431069|FG002|Overall Study|Lost to Follow-up|4|||
148715886|NCT03732833|536431067|FG000|Overall Study|Pregnancy|0|||
148715887|NCT03732833|536431068|FG001|Overall Study|Pregnancy|2|||
148715888|NCT03732833|536431069|FG002|Overall Study|Pregnancy|0|||
148715889|NCT03732833|536431067|FG000|Overall Study|Physician Decision|2|||
148715890|NCT03732833|536431068|FG001|Overall Study|Physician Decision|3|||
148715891|NCT03732833|536431069|FG002|Overall Study|Physician Decision|1|||
148715892|NCT03732833|536431067|FG000|Overall Study|Covid-19 related and other reasons|2|||
148715893|NCT03732833|536431068|FG001|Overall Study|Covid-19 related and other reasons|7|||
148715894|NCT03732833|536431069|FG002|Overall Study|Covid-19 related and other reasons|3|||
148715895|NCT01188226|536432786|FG000|Overall Study|Withdrawal by Subject|4|||
148715896|NCT04980456|536432787|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
148715897|NCT04980456|536432788|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
148715898|NCT04980456|536432787|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
148715899|NCT04980456|536432788|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
148715900|NCT04980456|536432787|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
148715901|NCT04980456|536432788|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
148715902|NCT04980456|536432787|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
148715903|NCT04980456|536432788|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
148715904|NCT01074008|536432792|FG000|Overall Study|Adverse Event|0|||
148715905|NCT01074008|536432793|FG001|Overall Study|Adverse Event|1|||
148715906|NCT01074008|536432794|FG002|Overall Study|Adverse Event|0|||
148715907|NCT01074008|536432795|FG003|Overall Study|Adverse Event|0|||
148715908|NCT01074008|536432796|FG004|Overall Study|Adverse Event|0|||
148715909|NCT01074008|536432797|FG005|Overall Study|Adverse Event|0|||
148715910|NCT01074008|536432798|FG006|Overall Study|Adverse Event|0|||
148715911|NCT01074008|536432799|FG007|Overall Study|Adverse Event|0|||
148715912|NCT01074008|536432800|FG008|Overall Study|Adverse Event|0|||
148715913|NCT01074008|536432792|FG000|Overall Study|Withdrawal by Subject|1|||
148715914|NCT01074008|536432793|FG001|Overall Study|Withdrawal by Subject|1|||
148715915|NCT01074008|536432794|FG002|Overall Study|Withdrawal by Subject|1|||
148715916|NCT01074008|536432795|FG003|Overall Study|Withdrawal by Subject|0|||
148715917|NCT01074008|536432796|FG004|Overall Study|Withdrawal by Subject|1|||
148715918|NCT01074008|536432797|FG005|Overall Study|Withdrawal by Subject|0|||
148715919|NCT01074008|536432798|FG006|Overall Study|Withdrawal by Subject|0|||
148715920|NCT01074008|536432799|FG007|Overall Study|Withdrawal by Subject|0|||
148715921|NCT01074008|536432800|FG008|Overall Study|Withdrawal by Subject|0|||
148715922|NCT01074008|536432792|FG000|Overall Study|Lost to Follow-up|0|||
148715923|NCT01074008|536432793|FG001|Overall Study|Lost to Follow-up|1|||
148715924|NCT01074008|536432794|FG002|Overall Study|Lost to Follow-up|1|||
148715925|NCT01074008|536432795|FG003|Overall Study|Lost to Follow-up|1|||
148968918|NCT02036502|537372833|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148715926|NCT01074008|536432796|FG004|Overall Study|Lost to Follow-up|1|||
148715927|NCT01074008|536432797|FG005|Overall Study|Lost to Follow-up|0|||
148715928|NCT01074008|536432798|FG006|Overall Study|Lost to Follow-up|1|||
148715929|NCT01074008|536432799|FG007|Overall Study|Lost to Follow-up|0|||
148715930|NCT01074008|536432800|FG008|Overall Study|Lost to Follow-up|4|||
148715931|NCT00224484|536432801|FG000|Overall Study|Serious Adverse Event|1|||
148715932|NCT00224484|536432802|FG001|Overall Study|Serious Adverse Event|1|||
148715933|NCT00224484|536432803|FG002|Overall Study|Serious Adverse Event|0|||
148715934|NCT00224484|536432801|FG000|Overall Study|Non-Serious Adverse Event|5|||
148715935|NCT00224484|536432802|FG001|Overall Study|Non-Serious Adverse Event|7|||
148715936|NCT00224484|536432803|FG002|Overall Study|Non-Serious Adverse Event|3|||
148715937|NCT00224484|536432801|FG000|Overall Study|Protocol Violation|2|||
148715938|NCT00224484|536432802|FG001|Overall Study|Protocol Violation|2|||
148715939|NCT00224484|536432803|FG002|Overall Study|Protocol Violation|0|||
148715940|NCT00224484|536432801|FG000|Overall Study|Withdrawal by Subject|49|||
148715941|NCT00224484|536432802|FG001|Overall Study|Withdrawal by Subject|18|||
148715942|NCT00224484|536432803|FG002|Overall Study|Withdrawal by Subject|16|||
148715943|NCT00224484|536432801|FG000|Overall Study|Migrated/moved from study area|18|||
148715944|NCT00224484|536432802|FG001|Overall Study|Migrated/moved from study area|5|||
148715945|NCT00224484|536432803|FG002|Overall Study|Migrated/moved from study area|5|||
148715946|NCT00224484|536432801|FG000|Overall Study|Lost to Follow-up|66|||
148715947|NCT00224484|536432802|FG001|Overall Study|Lost to Follow-up|28|||
148715948|NCT00224484|536432803|FG002|Overall Study|Lost to Follow-up|36|||
148715949|NCT00224484|536432801|FG000|Overall Study|Reason not specified|5|||
148715950|NCT00224484|536432802|FG001|Overall Study|Reason not specified|4|||
148715951|NCT00224484|536432803|FG002|Overall Study|Reason not specified|2|||
148715952|NCT02805309|536432804|FG000|Overall Study|Lost to Follow-up|2|||
148715953|NCT02805309|536432805|FG001|Overall Study|Lost to Follow-up|2|||
148715954|NCT02805309|536432806|FG002|Overall Study|Lost to Follow-up|2|||
148715955|NCT02805309|536432804|FG000|Overall Study|Post-Randomization Exclusion|0|||
148715956|NCT02805309|536432805|FG001|Overall Study|Post-Randomization Exclusion|2|||
148715957|NCT02805309|536432806|FG002|Overall Study|Post-Randomization Exclusion|1|||
148715958|NCT01636934|536432807|FG000|Overall Study|Withdrawal by Subject|3|||
148715959|NCT01636934|536432808|FG001|Overall Study|Withdrawal by Subject|2|||
148715960|NCT01636934|536432807|FG000|Overall Study|Chemo cancel|1|||
148715961|NCT01636934|536432808|FG001|Overall Study|Chemo cancel|0|||
148715962|NCT01636934|536432807|FG000|Overall Study|Too ill to continue|1|||
148715963|NCT01636934|536432808|FG001|Overall Study|Too ill to continue|0|||
148715964|NCT01636934|536432807|FG000|Overall Study|Never started study medication|1|||
148715965|NCT01636934|536432808|FG001|Overall Study|Never started study medication|1|||
148715966|NCT03687242|536432811|FG000|Overall Study|Adverse Event|1|||
148715967|NCT00799708|536432812|FG000|Overall Study|non-compliance|1|||
148715968|NCT00799708|536432813|FG001|Overall Study|non-compliance|0|||
148715969|NCT00799708|536432814|FG002|Overall Study|non-compliance|0|||
148715970|NCT00880334|536432815|FG000|Randomized Phase|Physician Decision|1|||
148715971|NCT00880334|536432816|FG001|Randomized Phase|Physician Decision|0|||
148715972|NCT00880334|536432815|FG000|Randomized Phase|Withdrawal by Subject|2|||
148715973|NCT00880334|536432816|FG001|Randomized Phase|Withdrawal by Subject|1|||
148715974|NCT00880334|536432815|FG000|Randomized Phase|Inadequate Labs|1|||
148715975|NCT00880334|536432816|FG001|Randomized Phase|Inadequate Labs|1|||
148715976|NCT00880334|536432815|FG000|Randomized Phase|Brain Metastasis|0|||
148715977|NCT00880334|536432816|FG001|Randomized Phase|Brain Metastasis|1|||
148715978|NCT00880334|536432815|FG000|Randomized Phase|Crossover Participants|0|||
148715979|NCT00880334|536432816|FG001|Randomized Phase|Crossover Participants|37|||
148715980|NCT02473393|536432817|FG000|Overall Study|Adverse Event|0|||
148715981|NCT02473393|536432818|FG001|Overall Study|Adverse Event|0|||
148715982|NCT02473393|536432819|FG002|Overall Study|Adverse Event|1|||
148715983|NCT02473393|536432820|FG003|Overall Study|Adverse Event|0|||
148715984|NCT02473393|536432817|FG000|Overall Study|Withdrawal by Subject|0|||
148715985|NCT02473393|536432818|FG001|Overall Study|Withdrawal by Subject|0|||
148715986|NCT02473393|536432819|FG002|Overall Study|Withdrawal by Subject|1|||
148715987|NCT02473393|536432820|FG003|Overall Study|Withdrawal by Subject|1|||
148715988|NCT05393271|536432822|FG000|Overall Study|Physician Decision|0|||
148715989|NCT05393271|536432823|FG001|Overall Study|Physician Decision|0|||
148715990|NCT05393271|536432824|FG002|Overall Study|Physician Decision|0|||
148715991|NCT05393271|536432825|FG003|Overall Study|Physician Decision|0|||
148715992|NCT05393271|536432826|FG004|Overall Study|Physician Decision|0|||
148715993|NCT05393271|536432827|FG005|Overall Study|Physician Decision|0|||
148715994|NCT05393271|536432828|FG006|Overall Study|Physician Decision|1|||
148715995|NCT05393271|536432829|FG007|Overall Study|Physician Decision|0|||
148715996|NCT05393271|536432830|FG008|Overall Study|Physician Decision|0|||
148715997|NCT05393271|536432831|FG009|Overall Study|Physician Decision|0|||
148715998|NCT05393271|536432832|FG010|Overall Study|Physician Decision|0|||
148715999|NCT00695110|536432843|FG000|Treatment Period 1|Adverse Event|1|||
148716000|NCT00695110|536432843|FG000|Treatment Period 1|Withdrawal by Subject|2|||
148716001|NCT00695110|536432843|FG000|Treatment Period 3|Withdrawal by Subject|1|||
148716002|NCT00695110|536432843|FG000|Treatment Period 4|Adverse Event|1|||
148716003|NCT02575339|536432847|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
148716004|NCT02575339|536432848|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
148716005|NCT02575339|536432849|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
148716006|NCT02575339|536432847|FG000|Study Treatment|Disease Progression|5|||
148716007|NCT02575339|536432848|FG001|Study Treatment|Disease Progression|2|||
148716008|NCT02575339|536432849|FG002|Study Treatment|Disease Progression|0|||
148716009|NCT02575339|536432847|FG000|Study Treatment|Adverse Event|1|||
148716010|NCT02575339|536432848|FG001|Study Treatment|Adverse Event|2|||
148716011|NCT02575339|536432849|FG002|Study Treatment|Adverse Event|0|||
148716012|NCT02575339|536432847|FG000|Follow up|Death|6|||
148716013|NCT02575339|536432848|FG001|Follow up|Death|2|||
148716014|NCT02575339|536432849|FG002|Follow up|Death|0|||
148716015|NCT02575339|536432847|FG000|Follow up|Study Terminated|0|||
148716016|NCT02575339|536432848|FG001|Follow up|Study Terminated|2|||
148716017|NCT02575339|536432849|FG002|Follow up|Study Terminated|0|||
148716018|NCT02575339|536432847|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
148716019|NCT02575339|536432848|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
148716020|NCT02575339|536432849|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
148716021|NCT02340780|536432851|FG000|Overall Study|Ineligible|1|||
148716022|NCT01957150|536432852|FG000|Overall Study|Adverse Event|23|||
148716023|NCT01957150|536432853|FG001|Overall Study|Adverse Event|20|||
148716024|NCT01957150|536432852|FG000|Overall Study|Withdrawal by Subject|13|||
148716025|NCT01957150|536432853|FG001|Overall Study|Withdrawal by Subject|17|||
148716026|NCT01957150|536432852|FG000|Overall Study|Physician Decision|3|||
148716027|NCT01957150|536432853|FG001|Overall Study|Physician Decision|6|||
148716028|NCT01957150|536432852|FG000|Overall Study|Lost to Follow-up|4|||
148716029|NCT01957150|536432853|FG001|Overall Study|Lost to Follow-up|4|||
148716030|NCT01957150|536432852|FG000|Overall Study|Protocol Violation|1|||
148716031|NCT01957150|536432853|FG001|Overall Study|Protocol Violation|0|||
148716032|NCT01957150|536432852|FG000|Overall Study|Lack of Efficacy|11|||
148716033|NCT01957150|536432853|FG001|Overall Study|Lack of Efficacy|11|||
148716034|NCT01698554|536432854|FG000|Overall Study|Adverse Event|2|||
148716035|NCT01698554|536432855|FG001|Overall Study|Adverse Event|5|||
148716036|NCT01698554|536432856|FG002|Overall Study|Adverse Event|0|||
148716037|NCT01698554|536432857|FG003|Overall Study|Adverse Event|1|||
148716038|NCT01698554|536432854|FG000|Overall Study|Lost to Follow-up|1|||
148716039|NCT01698554|536432855|FG001|Overall Study|Lost to Follow-up|0|||
148716040|NCT01698554|536432856|FG002|Overall Study|Lost to Follow-up|0|||
148716041|NCT01698554|536432857|FG003|Overall Study|Lost to Follow-up|0|||
148716042|NCT01698554|536432854|FG000|Overall Study|Personal Reasons|0|||
148716043|NCT01698554|536432855|FG001|Overall Study|Personal Reasons|5|||
148716044|NCT01698554|536432856|FG002|Overall Study|Personal Reasons|1|||
148716045|NCT01698554|536432857|FG003|Overall Study|Personal Reasons|1|||
148716046|NCT01698554|536432854|FG000|Overall Study|Protocol Violation|2|||
148716047|NCT01698554|536432855|FG001|Overall Study|Protocol Violation|0|||
148716048|NCT01698554|536432856|FG002|Overall Study|Protocol Violation|1|||
148716049|NCT01698554|536432857|FG003|Overall Study|Protocol Violation|0|||
148716050|NCT01698554|536432854|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148716051|NCT01698554|536432855|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148716052|NCT01698554|536432856|FG002|Overall Study|Other Miscellaneous Reasons|0|||
148716053|NCT01698554|536432857|FG003|Overall Study|Other Miscellaneous Reasons|0|||
148716054|NCT00252564|536432858|FG000|Overall Study|Adverse Event|17|||
148716055|NCT00252564|536432859|FG001|Overall Study|Adverse Event|13|||
148716056|NCT00252564|536432858|FG000|Overall Study|Unrelated Complication|2|||
148716057|NCT00252564|536432859|FG001|Overall Study|Unrelated Complication|1|||
148716058|NCT00252564|536432858|FG000|Overall Study|Disease Progression|14|||
148716059|NCT00252564|536432859|FG001|Overall Study|Disease Progression|20|||
148716060|NCT00252564|536432858|FG000|Overall Study|Death|0|||
148716061|NCT00252564|536432859|FG001|Overall Study|Death|3|||
148716062|NCT00252564|536432858|FG000|Overall Study|Physician Decision|1|||
148716063|NCT00252564|536432859|FG001|Overall Study|Physician Decision|0|||
148716064|NCT00252564|536432858|FG000|Overall Study|Lost to Follow-up|1|||
148716065|NCT00252564|536432859|FG001|Overall Study|Lost to Follow-up|0|||
148716066|NCT00252564|536432858|FG000|Overall Study|Patient Request|4|||
148716067|NCT00252564|536432859|FG001|Overall Study|Patient Request|5|||
148716068|NCT00252564|536432858|FG000|Overall Study|Withdrawal by Subject|0|||
148716069|NCT00252564|536432859|FG001|Overall Study|Withdrawal by Subject|2|||
148716070|NCT03141151|536432860|FG000|Overall Study|Lost to Follow-up|3|||
148716071|NCT03141151|536432861|FG001|Overall Study|Lost to Follow-up|2|||
148716072|NCT03141151|536432860|FG000|Overall Study|Withdrawal by Subject|3|||
148716073|NCT03141151|536432861|FG001|Overall Study|Withdrawal by Subject|2|||
148716074|NCT04561115|536432862|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
148716075|NCT04561115|536432863|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
148716076|NCT04561115|536432862|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
148716077|NCT04561115|536432863|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
148716078|NCT04561115|536432862|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
148716079|NCT04561115|536432863|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
148716080|NCT02985398|536432864|FG000|Overall Study|Adverse Event|1|||
148716081|NCT02985398|536432864|FG000|Overall Study|Lost to Follow-up|4|||
148716082|NCT02985398|536432864|FG000|Overall Study|Withdrawal by Subject|8|||
148716083|NCT02985398|536432864|FG000|Overall Study|Study Burden|9|||
148716084|NCT00283842|536432867|FG000|Overall Study|Adverse Event|8|||
148716085|NCT00283842|536432868|FG001|Overall Study|Adverse Event|7|||
148716086|NCT00283842|536432869|FG002|Overall Study|Adverse Event|21|||
148716087|NCT00283842|536432870|FG003|Overall Study|Adverse Event|21|||
148716088|NCT00283842|536432871|FG004|Overall Study|Adverse Event|5|||
148716089|NCT00283842|536432867|FG000|Overall Study|Protocol Violation|1|||
148716090|NCT00283842|536432868|FG001|Overall Study|Protocol Violation|5|||
148716091|NCT00283842|536432869|FG002|Overall Study|Protocol Violation|4|||
148716092|NCT00283842|536432870|FG003|Overall Study|Protocol Violation|0|||
148716093|NCT00283842|536432871|FG004|Overall Study|Protocol Violation|0|||
148716094|NCT00283842|536432867|FG000|Overall Study|Protocol deviation|0|||
148716095|NCT00283842|536432868|FG001|Overall Study|Protocol deviation|0|||
148716096|NCT00283842|536432869|FG002|Overall Study|Protocol deviation|0|||
148716097|NCT00283842|536432870|FG003|Overall Study|Protocol deviation|0|||
148716098|NCT00283842|536432871|FG004|Overall Study|Protocol deviation|2|||
148716099|NCT00283842|536432867|FG000|Overall Study|Withdrawal by Subject|2|||
148716100|NCT00283842|536432868|FG001|Overall Study|Withdrawal by Subject|1|||
148716101|NCT00283842|536432869|FG002|Overall Study|Withdrawal by Subject|1|||
148716102|NCT00283842|536432870|FG003|Overall Study|Withdrawal by Subject|5|||
148716103|NCT00283842|536432871|FG004|Overall Study|Withdrawal by Subject|4|||
148716104|NCT00283842|536432867|FG000|Overall Study|Lack of Efficacy|1|||
148716105|NCT00283842|536432868|FG001|Overall Study|Lack of Efficacy|3|||
148716106|NCT00283842|536432869|FG002|Overall Study|Lack of Efficacy|1|||
148716107|NCT00283842|536432870|FG003|Overall Study|Lack of Efficacy|0|||
148716108|NCT00283842|536432871|FG004|Overall Study|Lack of Efficacy|3|||
148716109|NCT00283842|536432867|FG000|Overall Study|Lost to Follow-up|0|||
148716110|NCT00283842|536432868|FG001|Overall Study|Lost to Follow-up|2|||
148716111|NCT00283842|536432869|FG002|Overall Study|Lost to Follow-up|4|||
148716112|NCT00283842|536432870|FG003|Overall Study|Lost to Follow-up|1|||
148716113|NCT00283842|536432871|FG004|Overall Study|Lost to Follow-up|1|||
148716114|NCT00550147|536432872|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
148716115|NCT00550147|536432872|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
148716116|NCT00550147|536432872|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
148716117|NCT00550147|536432872|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
148716118|NCT00550147|536432872|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
148716119|NCT04320745|536432873|FG000|Overall Study|Adverse Event|26|||
148716120|NCT04320745|536432873|FG000|Overall Study|Withdrawal by Subject|4|||
148716121|NCT04320745|536432873|FG000|Overall Study|Lost to Follow-up|12|||
148716122|NCT04320745|536432873|FG000|Overall Study|Protocol Deviation|2|||
148716123|NCT04320745|536432873|FG000|Overall Study|Non-compliance With Study Drug|2|||
148716124|NCT04320745|536432873|FG000|Overall Study|Reason Not Specified|1|||
148716125|NCT00046839|536432874|FG000|Overall Study|Ineligible / No protocol treatment|0|||
148716126|NCT00046839|536432875|FG001|Overall Study|Ineligible / No protocol treatment|2|||
148716127|NCT00046839|536432874|FG000|Overall Study|Withdrawal of consent|1|||
148716128|NCT00046839|536432875|FG001|Overall Study|Withdrawal of consent|0|||
148716129|NCT02472639|536432876|FG000|Overall Study|Physician Decision|4|||
148716130|NCT02472639|536432877|FG001|Overall Study|Physician Decision|3|||
148716131|NCT00751023|536432878|FG000|Overall Study|Lost to Follow-up|11|||
148716132|NCT00751023|536432879|FG001|Overall Study|Lost to Follow-up|7|||
148716133|NCT04768114|536432882|FG000|Overall Study|Lost to Follow-up|5|||
148716134|NCT04768114|536432883|FG001|Overall Study|Lost to Follow-up|10|||
148716135|NCT04768114|536432882|FG000|Overall Study|Withdrawal by Subject|0|||
148716136|NCT04768114|536432883|FG001|Overall Study|Withdrawal by Subject|1|||
148716137|NCT01685008|536432884|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
148716138|NCT01685008|536432885|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
148716139|NCT01685008|536432886|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
148716140|NCT01685008|536432887|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
148716141|NCT01685008|536432884|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
148716142|NCT01685008|536432885|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
148716143|NCT01685008|536432886|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
148716144|NCT01685008|536432887|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
148716145|NCT01685008|536432884|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
148716146|NCT01685008|536432885|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
148716147|NCT01685008|536432886|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
148716148|NCT01685008|536432887|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
148716149|NCT01685008|536432884|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
148716150|NCT01685008|536432885|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
148716151|NCT01685008|536432886|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
148716152|NCT01685008|536432887|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
148716153|NCT01685008|536432884|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
148716154|NCT01685008|536432885|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
148716155|NCT01685008|536432886|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
148716156|NCT01685008|536432887|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
148716157|NCT00715676|536432896|FG000|Overall Study|Adverse Event|3|||
148716158|NCT00715676|536432897|FG001|Overall Study|Adverse Event|5|||
148716159|NCT00715676|536432898|FG002|Overall Study|Adverse Event|21|||
148716160|NCT00715676|536432896|FG000|Overall Study|Withdrawal by Subject|1|||
148716161|NCT00715676|536432897|FG001|Overall Study|Withdrawal by Subject|3|||
148716162|NCT00715676|536432898|FG002|Overall Study|Withdrawal by Subject|8|||
148716163|NCT00715676|536432896|FG000|Overall Study|Lost to Follow-up|1|||
148716164|NCT00715676|536432897|FG001|Overall Study|Lost to Follow-up|2|||
148716165|NCT00715676|536432898|FG002|Overall Study|Lost to Follow-up|1|||
148716166|NCT00715676|536432896|FG000|Overall Study|Terminated by Sponsor|1|||
148716167|NCT00715676|536432897|FG001|Overall Study|Terminated by Sponsor|0|||
148716168|NCT00715676|536432898|FG002|Overall Study|Terminated by Sponsor|0|||
148716169|NCT00715676|536432896|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
148716170|NCT00715676|536432897|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
148716171|NCT00715676|536432898|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
148716172|NCT00715676|536432896|FG000|Overall Study|Use of Exclusionary Medication|0|||
148716173|NCT00715676|536432897|FG001|Overall Study|Use of Exclusionary Medication|0|||
148716174|NCT00715676|536432898|FG002|Overall Study|Use of Exclusionary Medication|1|||
148716175|NCT00715676|536432896|FG000|Overall Study|Elevated Blood Glucose|0|||
148716176|NCT00715676|536432897|FG001|Overall Study|Elevated Blood Glucose|1|||
148716177|NCT00715676|536432898|FG002|Overall Study|Elevated Blood Glucose|0|||
148716178|NCT01963260|536432899|FG000|Overall Study|Withdrawal by Subject|2|||
148716179|NCT01963260|536432900|FG001|Overall Study|Withdrawal by Subject|0|||
148716180|NCT01963260|536432901|FG002|Overall Study|Withdrawal by Subject|0|||
148716181|NCT01963260|536432902|FG003|Overall Study|Withdrawal by Subject|1|||
148716182|NCT01963260|536432903|FG004|Overall Study|Withdrawal by Subject|2|||
148716183|NCT01963260|536432904|FG005|Overall Study|Withdrawal by Subject|0|||
148716184|NCT01963260|536432905|FG006|Overall Study|Withdrawal by Subject|0|||
148716185|NCT01963260|536432906|FG007|Overall Study|Withdrawal by Subject|0|||
148716186|NCT01963260|536432907|FG008|Overall Study|Withdrawal by Subject|0|||
148716187|NCT01963260|536432908|FG009|Overall Study|Withdrawal by Subject|0|||
148716188|NCT04994431|536432909|FG000|Overall Study|Adverse Event|1|||
148716189|NCT04994431|536432910|FG001|Overall Study|Adverse Event|0|||
148716190|NCT04892147|536432911|FG000|Overall Study|Withdrawal by Subject|2|||
148716191|NCT04892147|536432912|FG001|Overall Study|Withdrawal by Subject|0|||
148716192|NCT01547728|536432913|FG000|Overall Study|Change in procedure and equipment|1|||
148716193|NCT01547728|536432913|FG000|Overall Study|Drug not ready for subject|1|||
148716194|NCT01547728|536432913|FG000|Overall Study|Screen failure|39|||
148716195|NCT00057941|536432914|FG000|Overall Study|Death|1|||
148716196|NCT00057941|536432915|FG001|Overall Study|Death|2|||
148716197|NCT00057941|536432914|FG000|Overall Study|Adverse Event|7|||
148716198|NCT00057941|536432915|FG001|Overall Study|Adverse Event|9|||
148716199|NCT00057941|536432914|FG000|Overall Study|Lack of Efficacy|54|||
148716200|NCT00057941|536432915|FG001|Overall Study|Lack of Efficacy|53|||
148716201|NCT00057941|536432914|FG000|Overall Study|Withdrawal by Subject|6|||
148716202|NCT00057941|536432915|FG001|Overall Study|Withdrawal by Subject|1|||
148716203|NCT00057941|536432914|FG000|Overall Study|still on treatment|3|||
148716204|NCT00057941|536432915|FG001|Overall Study|still on treatment|1|||
148716205|NCT00057941|536432914|FG000|Overall Study|insurance, symptomatic deterioration|1|||
148716206|NCT00057941|536432915|FG001|Overall Study|insurance, symptomatic deterioration|3|||
148716207|NCT00057941|536432914|FG000|Overall Study|Ineligible|2|||
148716208|NCT00057941|536432915|FG001|Overall Study|Ineligible|5|||
148716209|NCT02760433|536432916|FG000|Overall Study|Lost to Follow-up|1|||
148716210|NCT02760433|536432917|FG001|Overall Study|Lost to Follow-up|0|||
148716211|NCT02760433|536432918|FG002|Overall Study|Lost to Follow-up|1|||
148716212|NCT02760433|536432919|FG003|Overall Study|Lost to Follow-up|0|||
148716213|NCT02760433|536432920|FG004|Overall Study|Lost to Follow-up|0|||
148716214|NCT02760433|536432916|FG000|Overall Study|Withdrawal by Subject|23|||
148716215|NCT02760433|536432917|FG001|Overall Study|Withdrawal by Subject|9|||
148716216|NCT02760433|536432918|FG002|Overall Study|Withdrawal by Subject|0|||
148716217|NCT02760433|536432919|FG003|Overall Study|Withdrawal by Subject|2|||
148716218|NCT02760433|536432920|FG004|Overall Study|Withdrawal by Subject|9|||
148716219|NCT02760433|536432916|FG000|Overall Study|Lack of Response At Week 14|0|||
148716220|NCT02760433|536432917|FG001|Overall Study|Lack of Response At Week 14|0|||
148716221|NCT02760433|536432918|FG002|Overall Study|Lack of Response At Week 14|0|||
148716222|NCT02760433|536432919|FG003|Overall Study|Lack of Response At Week 14|0|||
148716223|NCT02760433|536432920|FG004|Overall Study|Lack of Response At Week 14|1|||
148716224|NCT02760433|536432916|FG000|Overall Study|Subject refused to continue the study|1|||
148716225|NCT02760433|536432917|FG001|Overall Study|Subject refused to continue the study|0|||
148716226|NCT02760433|536432918|FG002|Overall Study|Subject refused to continue the study|0|||
148716227|NCT02760433|536432919|FG003|Overall Study|Subject refused to continue the study|0|||
148716228|NCT02760433|536432920|FG004|Overall Study|Subject refused to continue the study|0|||
148716229|NCT02760433|536432916|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
148716230|NCT02760433|536432917|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
148716231|NCT02760433|536432918|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
148716232|NCT02760433|536432919|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
148716233|NCT02760433|536432920|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
148716234|NCT02760433|536432916|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
148716235|NCT02760433|536432917|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
148716236|NCT02760433|536432918|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
148716237|NCT02760433|536432919|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
148716238|NCT02760433|536432920|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
148716239|NCT00766493|536432921|FG000|30 Days Post-Procedure|Discontinued|7|||
148716240|NCT00766493|536432921|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
148716241|NCT00766493|536432921|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
148716242|NCT03439085|536432923|FG000|Overall Study|Death|2|||
148716243|NCT03439085|536432923|FG000|Overall Study|Screen Failure|20|||
148716244|NCT01863433|536432924|FG000|Overall Study|Protocol Violation|1|||
148716245|NCT02224053|536432925|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
148716246|NCT02224053|536432925|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
148716247|NCT02224053|536432925|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
148716248|NCT02224053|536432925|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
148716249|NCT02224053|536432925|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
148716250|NCT03448692|536432926|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
148716251|NCT03448692|536432927|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
148716252|NCT03448692|536432926|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
148716253|NCT03448692|536432927|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
148716254|NCT03448692|536432926|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
148716255|NCT03448692|536432927|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
148716256|NCT03448692|536432926|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
148716257|NCT03448692|536432927|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
148716258|NCT03448692|536432926|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
148716259|NCT03448692|536432927|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
148716260|NCT02289820|536432928|FG000|Overall Study|Withdrawal by Subject|2|||
148716261|NCT02289820|536432929|FG001|Overall Study|Withdrawal by Subject|1|||
148716262|NCT02289820|536432930|FG002|Overall Study|Withdrawal by Subject|2|||
148716263|NCT02289820|536432931|FG003|Overall Study|Withdrawal by Subject|1|||
148716264|NCT02289820|536432932|FG004|Overall Study|Withdrawal by Subject|0|||
148716265|NCT02289820|536432933|FG005|Overall Study|Withdrawal by Subject|0|||
148716266|NCT02289820|536432934|FG006|Overall Study|Withdrawal by Subject|1|||
148716267|NCT02289820|536432928|FG000|Overall Study|Death|0|||
148716268|NCT02289820|536432929|FG001|Overall Study|Death|0|||
148716269|NCT02289820|536432930|FG002|Overall Study|Death|1|||
148716270|NCT02289820|536432931|FG003|Overall Study|Death|0|||
148716271|NCT02289820|536432932|FG004|Overall Study|Death|0|||
148716272|NCT02289820|536432933|FG005|Overall Study|Death|0|||
148716273|NCT02289820|536432934|FG006|Overall Study|Death|0|||
148716274|NCT02289820|536432928|FG000|Overall Study|Lost to Follow-up|0|||
148716275|NCT02289820|536432929|FG001|Overall Study|Lost to Follow-up|0|||
148716276|NCT02289820|536432930|FG002|Overall Study|Lost to Follow-up|3|||
148716277|NCT02289820|536432931|FG003|Overall Study|Lost to Follow-up|1|||
148716278|NCT02289820|536432932|FG004|Overall Study|Lost to Follow-up|0|||
148716279|NCT02289820|536432933|FG005|Overall Study|Lost to Follow-up|1|||
148716280|NCT02289820|536432934|FG006|Overall Study|Lost to Follow-up|1|||
148716281|NCT02289820|536432928|FG000|Overall Study|withdrawal of consent|0|||
148716282|NCT02289820|536432929|FG001|Overall Study|withdrawal of consent|1|||
148716283|NCT02289820|536432930|FG002|Overall Study|withdrawal of consent|0|||
148716284|NCT02289820|536432931|FG003|Overall Study|withdrawal of consent|0|||
148716285|NCT02289820|536432932|FG004|Overall Study|withdrawal of consent|0|||
148716286|NCT02289820|536432933|FG005|Overall Study|withdrawal of consent|0|||
148716287|NCT02289820|536432934|FG006|Overall Study|withdrawal of consent|0|||
148716288|NCT02786927|536432941|FG000|Overall Study|Adverse Event|1|||
148716289|NCT02786927|536432941|FG000|Overall Study|Protocol Violation|4|||
148716290|NCT03919695|536432942|FG000|3-month Follow-up|Death|1|||
148716291|NCT03919695|536432943|FG001|3-month Follow-up|Death|1|||
148716292|NCT03919695|536432942|FG000|3-month Follow-up|unable to contact|0|||
148716293|NCT03919695|536432943|FG001|3-month Follow-up|unable to contact|3|||
148716294|NCT03919695|536432942|FG000|3-month Follow-up|in prison|0|||
148716295|NCT03919695|536432943|FG001|3-month Follow-up|in prison|1|||
148716296|NCT03919695|536432942|FG000|6-month Follow-up|Death|0|||
148716297|NCT03919695|536432943|FG001|6-month Follow-up|Death|1|||
148716298|NCT03919695|536432942|FG000|6-month Follow-up|Lost to Follow-up|1|||
148716299|NCT03919695|536432943|FG001|6-month Follow-up|Lost to Follow-up|2|||
148716300|NCT03919695|536432942|FG000|6-month Follow-up|in prison|0|||
148716301|NCT03919695|536432943|FG001|6-month Follow-up|in prison|2|||
148716302|NCT03919695|536432942|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
148716303|NCT03919695|536432943|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
148716304|NCT03919695|536432942|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
148716305|NCT03919695|536432943|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
148716306|NCT01688882|536432944|FG000|Overall Study|Adverse Event|1|||
148716307|NCT01688882|536432945|FG001|Overall Study|Adverse Event|0|||
148716308|NCT01688882|536432944|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148716309|NCT01688882|536432945|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148716310|NCT01688882|536432944|FG000|Overall Study|Administrative problems|1|||
148716311|NCT01688882|536432945|FG001|Overall Study|Administrative problems|0|||
148716312|NCT02416934|536432947|FG000|Overall Study|given steroids|1|||
148716313|NCT02416934|536432948|FG001|Overall Study|given steroids|2|||
148716314|NCT02416934|536432947|FG000|Overall Study|Lost to Follow-up|0|||
148716315|NCT02416934|536432948|FG001|Overall Study|Lost to Follow-up|2|||
148716316|NCT02416934|536432947|FG000|Overall Study|Withdrawal by Subject|1|||
148716317|NCT02416934|536432948|FG001|Overall Study|Withdrawal by Subject|0|||
148716318|NCT02416934|536432947|FG000|Overall Study|recruited during continuing renewal proc|0|||
148716319|NCT02416934|536432948|FG001|Overall Study|recruited during continuing renewal proc|1|||
148716320|NCT02416934|536432947|FG000|Overall Study|Protocol Violation|0|||
148716321|NCT02416934|536432948|FG001|Overall Study|Protocol Violation|1|||
148716322|NCT02416934|536432947|FG000|Overall Study|surgery started late|0|||
148716323|NCT02416934|536432948|FG001|Overall Study|surgery started late|1|||
148716324|NCT02416934|536432947|FG000|Overall Study|re-operation|1|||
148716325|NCT02416934|536432948|FG001|Overall Study|re-operation|0|||
148716326|NCT00697619|536432955|FG000|Overall Study|Lack of Efficacy|2|||
148716327|NCT00697619|536432956|FG001|Overall Study|Lack of Efficacy|2|||
148716328|NCT00697619|536432955|FG000|Overall Study|Adverse Event|4|||
148716329|NCT00697619|536432956|FG001|Overall Study|Adverse Event|6|||
148716330|NCT04662710|536434373|FG000|Overall Study|Death|14|||
148716331|NCT04662710|536434374|FG001|Overall Study|Death|331|||
148716332|NCT04662710|536434375|FG002|Overall Study|Death|367|||
148716333|NCT04662710|536434373|FG000|Overall Study|Ongoing|1|||
148716334|NCT04662710|536434374|FG001|Overall Study|Ongoing|109|||
148716335|NCT04662710|536434375|FG002|Overall Study|Ongoing|56|||
148716336|NCT04662710|536434373|FG000|Overall Study|Withdrawal by Subject|0|||
148716337|NCT04662710|536434374|FG001|Overall Study|Withdrawal by Subject|3|||
148716338|NCT04662710|536434375|FG002|Overall Study|Withdrawal by Subject|14|||
148716339|NCT05480800|536434380|FG000|Overall Study|Withdrawal by Subject|0|||
148716340|NCT05480800|536434381|FG001|Overall Study|Withdrawal by Subject|0|||
148716341|NCT05480800|536434382|FG002|Overall Study|Withdrawal by Subject|2|||
148716342|NCT05480800|536434383|FG003|Overall Study|Withdrawal by Subject|1|||
148716343|NCT05480800|536434384|FG004|Overall Study|Withdrawal by Subject|0|||
148716344|NCT05480800|536434385|FG005|Overall Study|Withdrawal by Subject|0|||
148716345|NCT05480800|536434386|FG006|Overall Study|Withdrawal by Subject|1|||
148716346|NCT05480800|536434387|FG007|Overall Study|Withdrawal by Subject|0|||
148716347|NCT05480800|536434380|FG000|Overall Study|Other|0|||
148716348|NCT05480800|536434381|FG001|Overall Study|Other|0|||
148716349|NCT05480800|536434382|FG002|Overall Study|Other|0|||
148716350|NCT05480800|536434383|FG003|Overall Study|Other|0|||
148716351|NCT05480800|536434384|FG004|Overall Study|Other|0|||
148716352|NCT05480800|536434385|FG005|Overall Study|Other|0|||
148716353|NCT05480800|536434386|FG006|Overall Study|Other|1|||
148716354|NCT05480800|536434387|FG007|Overall Study|Other|0|||
148716355|NCT00377156|536434390|FG000|Overall Study|Death|23|||
148716356|NCT00377156|536434391|FG001|Overall Study|Death|19|||
148716357|NCT00377156|536434390|FG000|Overall Study|Withdrawal by Subject|16|||
148716358|NCT00377156|536434391|FG001|Overall Study|Withdrawal by Subject|24|||
148716359|NCT00377156|536434390|FG000|Overall Study|Had follow-up <90 d|3|||
148716360|NCT00377156|536434391|FG001|Overall Study|Had follow-up <90 d|6|||
148716361|NCT00377156|536434390|FG000|Overall Study|Cancellation|1|||
148716362|NCT00377156|536434391|FG001|Overall Study|Cancellation|0|||
148716363|NCT00377156|536434390|FG000|Overall Study|Refused testing|0|||
148716364|NCT00377156|536434391|FG001|Overall Study|Refused testing|1|||
148716365|NCT00377156|536434390|FG000|Overall Study|Ineligible|0|||
148716366|NCT00377156|536434391|FG001|Overall Study|Ineligible|1|||
148716367|NCT00377156|536434390|FG000|Overall Study|Disability or language problem|0|||
148716368|NCT00377156|536434391|FG001|Overall Study|Disability or language problem|1|||
148716369|NCT00377156|536434390|FG000|Overall Study|Other|5|||
148716370|NCT00377156|536434391|FG001|Overall Study|Other|2|||
148716371|NCT00288704|536434392|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
148716372|NCT00288704|536434393|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
148716373|NCT00288704|536434394|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
148716374|NCT00288704|536434392|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
148716375|NCT00288704|536434393|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
148716376|NCT00288704|536434394|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
148968919|NCT02036502|537372834|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
148968920|NCT02036502|537372835|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148968921|NCT02036502|537372836|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148968922|NCT02036502|537372837|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148968923|NCT02036502|537372838|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148968924|NCT02036502|537372839|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
148716377|NCT00288704|536434392|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
148716378|NCT00288704|536434393|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
148716379|NCT00288704|536434394|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
148716380|NCT00288704|536434392|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
148716381|NCT00288704|536434393|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
148716382|NCT00288704|536434394|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
148716383|NCT00288704|536434392|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
148716384|NCT00288704|536434393|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
148716385|NCT00288704|536434394|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
148716386|NCT00288704|536434392|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
148716387|NCT00288704|536434393|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
148716388|NCT00288704|536434394|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
148716389|NCT00288704|536434392|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
148716390|NCT00288704|536434393|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
148716391|NCT00288704|536434394|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
148716392|NCT01579006|536434395|FG000|Overall Study|Lack of Efficacy|10|||
148716393|NCT01579006|536434395|FG000|Overall Study|Adverse Event|13|||
148716394|NCT01579006|536434395|FG000|Overall Study|Withdrawal by Subject|5|||
148716395|NCT01579006|536434395|FG000|Overall Study|Non-compliance|3|||
148716396|NCT01579006|536434395|FG000|Overall Study|Due to participant's health fund|1|||
148716397|NCT01579006|536434395|FG000|Overall Study|Scheduled surgery|1|||
148716398|NCT01802216|536434398|FG000|4 Month Visit|Participant did not show to visit|3|||
148716399|NCT01802216|536434399|FG001|4 Month Visit|Participant did not show to visit|4|||
148716400|NCT01802216|536434398|FG000|8 Month Visit|Participant did not show to visit|3|||
148716401|NCT01802216|536434399|FG001|8 Month Visit|Participant did not show to visit|5|||
148716402|NCT01802216|536434398|FG000|12 Month Visit|Participant did not show to visit|3|||
148716403|NCT01802216|536434399|FG001|12 Month Visit|Participant did not show to visit|4|||
148716404|NCT01157234|536434404|FG000|Overall Study|Withdrawal by Subject|1|||
148716405|NCT01157234|536434405|FG001|Overall Study|Withdrawal by Subject|0|||
148716406|NCT05347693|536434408|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
148716407|NCT05347693|536434409|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
148716408|NCT05347693|536434410|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
148716409|NCT05347693|536434408|FG000|Inpatient Period|Withdrawal of consent|10|||
148716410|NCT05347693|536434409|FG001|Inpatient Period|Withdrawal of consent|0|||
148716411|NCT05347693|536434410|FG002|Inpatient Period|Withdrawal of consent|0|||
148716412|NCT05347693|536434408|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
148716413|NCT05347693|536434409|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
148716414|NCT05347693|536434410|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
148716415|NCT05347693|536434408|FG000|Inpatient Period|Screening Failure|8|||
148716416|NCT05347693|536434409|FG001|Inpatient Period|Screening Failure|0|||
148716417|NCT05347693|536434410|FG002|Inpatient Period|Screening Failure|0|||
148716418|NCT05347693|536434408|FG000|Inpatient Period|Death|2|||
148716419|NCT05347693|536434409|FG001|Inpatient Period|Death|0|||
148716420|NCT05347693|536434410|FG002|Inpatient Period|Death|0|||
148716421|NCT05347693|536434408|FG000|Inpatient Period|Physician Decision|5|||
148716422|NCT05347693|536434409|FG001|Inpatient Period|Physician Decision|0|||
148716423|NCT05347693|536434410|FG002|Inpatient Period|Physician Decision|0|||
148716424|NCT05347693|536434408|FG000|Inpatient Period|Adverse Event|3|||
148716425|NCT05347693|536434409|FG001|Inpatient Period|Adverse Event|0|||
148716426|NCT05347693|536434410|FG002|Inpatient Period|Adverse Event|0|||
148716427|NCT05347693|536434408|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
148716428|NCT05347693|536434409|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
148716429|NCT05347693|536434410|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
148716430|NCT05347693|536434408|FG000|Outpatient Period|Adverse Event|0|||
148716431|NCT05347693|536434409|FG001|Outpatient Period|Adverse Event|9|||
148716432|NCT05347693|536434410|FG002|Outpatient Period|Adverse Event|0|||
148716433|NCT05347693|536434408|FG000|Outpatient Period|Death|0|||
148716434|NCT05347693|536434409|FG001|Outpatient Period|Death|6|||
148716435|NCT05347693|536434410|FG002|Outpatient Period|Death|2|||
148716436|NCT05347693|536434408|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
148716437|NCT05347693|536434409|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
148716438|NCT05347693|536434410|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
148716439|NCT05347693|536434408|FG000|Outpatient Period|Lost to Follow-up|0|||
148716440|NCT05347693|536434409|FG001|Outpatient Period|Lost to Follow-up|0|||
148716441|NCT05347693|536434410|FG002|Outpatient Period|Lost to Follow-up|1|||
148716442|NCT05347693|536434408|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
148716443|NCT05347693|536434409|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
148716444|NCT05347693|536434410|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
148716445|NCT05347693|536434408|FG000|Outpatient Period|Scheduled hemodialysis|0|||
148716446|NCT05347693|536434409|FG001|Outpatient Period|Scheduled hemodialysis|1|||
148716447|NCT05347693|536434410|FG002|Outpatient Period|Scheduled hemodialysis|0|||
148716448|NCT05347693|536434408|FG000|Outpatient Period|Severe HK|0|||
148716449|NCT05347693|536434409|FG001|Outpatient Period|Severe HK|0|||
148716450|NCT05347693|536434410|FG002|Outpatient Period|Severe HK|1|||
148716451|NCT05347693|536434408|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
148716452|NCT05347693|536434409|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
148716453|NCT05347693|536434410|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
148716454|NCT05347693|536434408|FG000|Outpatient Period|Start of dialysis|0|||
148716455|NCT05347693|536434409|FG001|Outpatient Period|Start of dialysis|0|||
148716456|NCT05347693|536434410|FG002|Outpatient Period|Start of dialysis|1|||
148716457|NCT05347693|536434408|FG000|Outpatient Period|The participant entered hemodialysis|0|||
148716458|NCT05347693|536434409|FG001|Outpatient Period|The participant entered hemodialysis|0|||
148716459|NCT05347693|536434410|FG002|Outpatient Period|The participant entered hemodialysis|1|||
148716460|NCT05347693|536434408|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
148716461|NCT05347693|536434409|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
148716462|NCT05347693|536434410|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
148716463|NCT05347693|536434408|FG000|Outpatient Period|Withdrawal by Subject|0|||
148716464|NCT05347693|536434409|FG001|Outpatient Period|Withdrawal by Subject|8|||
148716465|NCT05347693|536434410|FG002|Outpatient Period|Withdrawal by Subject|5|||
148716466|NCT02048813|536434411|FG000|Overall Study|Still on treatment|279|||
148716467|NCT02048813|536434412|FG001|Overall Study|Still on treatment|0|||
148716468|NCT02048813|536434411|FG000|Overall Study|Adverse Event|40|||
148716469|NCT02048813|536434412|FG001|Overall Study|Adverse Event|38|||
148716470|NCT02048813|536434411|FG000|Overall Study|Disease progression|13|||
148716471|NCT02048813|536434412|FG001|Overall Study|Disease progression|3|||
148716472|NCT02048813|536434411|FG000|Overall Study|Withdrawal by Subject|7|||
148716473|NCT02048813|536434412|FG001|Overall Study|Withdrawal by Subject|8|||
148716474|NCT02048813|536434411|FG000|Overall Study|Death|2|||
148716475|NCT02048813|536434412|FG001|Overall Study|Death|1|||
148716476|NCT02048813|536434411|FG000|Overall Study|Complication|2|||
148716477|NCT02048813|536434412|FG001|Overall Study|Complication|2|||
148815719|NCT05172570|536800614|FG000|Overall Study|PI Decision due to equipment shortages|0|||
148815720|NCT05172570|536800615|FG001|Overall Study|PI Decision due to equipment shortages|0|||
148815721|NCT05172570|536800616|FG002|Overall Study|PI Decision due to equipment shortages|1|||
148815722|NCT02347787|536800619|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
148815723|NCT02347787|536800620|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
148815724|NCT02347787|536800619|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
148815725|NCT02347787|536800620|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
148815726|NCT02347787|536800619|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
148815727|NCT02347787|536800620|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
148815728|NCT02347787|536800619|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
148815729|NCT02347787|536800620|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
148815730|NCT02207608|536800624|FG000|Overall Study|Adverse Event|1|||
148815731|NCT02207608|536800625|FG001|Overall Study|Adverse Event|0|||
148815732|NCT05800145|536800626|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
148815733|NCT05800145|536800627|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148815734|NCT05800145|536800628|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148815735|NCT05800145|536800629|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
148815736|NCT05800145|536800630|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148716478|NCT02048813|536434411|FG000|Overall Study|Non-protocol therapy|0|||
148716479|NCT02048813|536434412|FG001|Overall Study|Non-protocol therapy|1|||
148716480|NCT02048813|536434411|FG000|Overall Study|Second primary cancer|2|||
148716481|NCT02048813|536434412|FG001|Overall Study|Second primary cancer|0|||
148716482|NCT02048813|536434411|FG000|Overall Study|Insurance|2|||
148716483|NCT02048813|536434412|FG001|Overall Study|Insurance|0|||
148716484|NCT02048813|536434411|FG000|Overall Study|Wound infection/healing|2|||
148716485|NCT02048813|536434412|FG001|Overall Study|Wound infection/healing|0|||
148716486|NCT02048813|536434411|FG000|Overall Study|Missed appointment|3|||
148716487|NCT02048813|536434412|FG001|Overall Study|Missed appointment|0|||
148716488|NCT02048813|536434411|FG000|Overall Study|Never started treatment|2|||
148716489|NCT02048813|536434412|FG001|Overall Study|Never started treatment|17|||
148716490|NCT01708954|536434413|FG000|Step 1|Disease progression|26|||
148716491|NCT01708954|536434414|FG001|Step 1|Disease progression|17|||
148716492|NCT01708954|536434415|FG002|Step 1|Disease progression|14|||
148716493|NCT01708954|536434413|FG000|Step 1|Adverse Event|3|||
148716494|NCT01708954|536434414|FG001|Step 1|Adverse Event|11|||
148716495|NCT01708954|536434415|FG002|Step 1|Adverse Event|13|||
148716496|NCT01708954|536434413|FG000|Step 1|Death|3|||
148716497|NCT01708954|536434414|FG001|Step 1|Death|2|||
148716498|NCT01708954|536434415|FG002|Step 1|Death|3|||
148815737|NCT05800145|536800631|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148815738|NCT05800145|536800626|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
148815739|NCT05800145|536800627|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
148815740|NCT05800145|536800628|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
148716499|NCT01708954|536434413|FG000|Step 1|Withdrawal by Subject|2|||
148716500|NCT01708954|536434414|FG001|Step 1|Withdrawal by Subject|5|||
148716501|NCT01708954|536434415|FG002|Step 1|Withdrawal by Subject|3|||
148716502|NCT01708954|536434413|FG000|Step 1|Other complicating disease|0|||
148716503|NCT01708954|536434414|FG001|Step 1|Other complicating disease|2|||
148716504|NCT01708954|536434415|FG002|Step 1|Other complicating disease|0|||
148716505|NCT01708954|536434413|FG000|Step 1|Crossed over to Step 2|2|||
148716506|NCT01708954|536434414|FG001|Step 1|Crossed over to Step 2|0|||
148716507|NCT01708954|536434415|FG002|Step 1|Crossed over to Step 2|0|||
148716508|NCT01708954|536434413|FG000|Step 1|Symptomatic deterioration|1|||
148716509|NCT01708954|536434414|FG001|Step 1|Symptomatic deterioration|0|||
148716510|NCT01708954|536434415|FG002|Step 1|Symptomatic deterioration|1|||
148716511|NCT01708954|536434413|FG000|Step 1|Off-treatment reason not submitted|1|||
148716512|NCT01708954|536434414|FG001|Step 1|Off-treatment reason not submitted|1|||
148716513|NCT01708954|536434415|FG002|Step 1|Off-treatment reason not submitted|1|||
148716514|NCT01708954|536434413|FG000|Step 1|Ineligible or never received treatment|4|||
148716515|NCT01708954|536434414|FG001|Step 1|Ineligible or never received treatment|2|||
148716516|NCT01708954|536434415|FG002|Step 1|Ineligible or never received treatment|8|||
148716517|NCT01708954|536434413|FG000|Step 2|Disease progression|9|||
148716518|NCT01708954|536434414|FG001|Step 2|Disease progression|4|||
148716519|NCT01708954|536434415|FG002|Step 2|Disease progression|0|||
148716520|NCT01708954|536434413|FG000|Step 2|Adverse Event|3|||
148716521|NCT01708954|536434414|FG001|Step 2|Adverse Event|2|||
148716522|NCT01708954|536434415|FG002|Step 2|Adverse Event|0|||
148716523|NCT01708954|536434413|FG000|Step 2|Withdrawal by Subject|1|||
148716524|NCT01708954|536434414|FG001|Step 2|Withdrawal by Subject|1|||
148716525|NCT01708954|536434415|FG002|Step 2|Withdrawal by Subject|0|||
148716526|NCT05996198|536434416|FG000|Overall Study|Withdrawal by Subject|1|||
148716527|NCT05996198|536434417|FG001|Overall Study|Withdrawal by Subject|0|||
148716528|NCT00413049|536434418|FG000|Overall Study|Adverse Event|10|||
148716529|NCT00413049|536434419|FG001|Overall Study|Adverse Event|8|||
148716530|NCT00413049|536434418|FG000|Overall Study|Withdrawal by Subject|7|||
148716531|NCT00413049|536434419|FG001|Overall Study|Withdrawal by Subject|5|||
148716532|NCT00413049|536434418|FG000|Overall Study|Lost to Follow-up|2|||
148716533|NCT00413049|536434419|FG001|Overall Study|Lost to Follow-up|3|||
148716534|NCT00413049|536434418|FG000|Overall Study|Protocol Violation|3|||
148716535|NCT00413049|536434419|FG001|Overall Study|Protocol Violation|1|||
148716536|NCT00413049|536434418|FG000|Overall Study|Subject no longer requires study drug|0|||
148716537|NCT00413049|536434419|FG001|Overall Study|Subject no longer requires study drug|1|||
148716538|NCT00413049|536434418|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148716539|NCT00413049|536434419|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148716540|NCT00413049|536434418|FG000|Overall Study|Lack of Efficacy|1|||
148716541|NCT00413049|536434419|FG001|Overall Study|Lack of Efficacy|0|||
148716542|NCT04675775|536434420|FG000|Overall Study|Withdrawal by Subject|7|||
148716543|NCT03223909|536434421|FG000|Overall Study|Protocol Violation|48|||
148716544|NCT03223909|536434422|FG001|Overall Study|Protocol Violation|45|||
148716545|NCT03223909|536434423|FG002|Overall Study|Protocol Violation|16|||
148815741|NCT05800145|536800629|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
148815742|NCT05800145|536800630|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
148815743|NCT05800145|536800631|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
148815744|NCT05800145|536800626|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
148815745|NCT05800145|536800627|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
148815746|NCT05800145|536800628|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
148815747|NCT05800145|536800629|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
148815748|NCT05800145|536800630|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
148815749|NCT05800145|536800631|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
148815750|NCT02850406|536800632|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815751|NCT02850406|536800633|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815752|NCT02850406|536800634|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815753|NCT02850406|536800635|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
148815754|NCT02850406|536800636|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815755|NCT02850406|536800637|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815756|NCT02850406|536800638|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815757|NCT02850406|536800639|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
148815758|NCT02850406|536800632|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
148716546|NCT01856192|536434426|FG000|Overall Study|Adverse Event|12|||
148716547|NCT01856192|536434427|FG001|Overall Study|Adverse Event|4|||
148716548|NCT01856192|536434426|FG000|Overall Study|Alternative therapy|0|||
148716549|NCT01856192|536434427|FG001|Overall Study|Alternative therapy|3|||
148716550|NCT01856192|536434426|FG000|Overall Study|Death|3|||
148716551|NCT01856192|536434427|FG001|Overall Study|Death|5|||
148716552|NCT01856192|536434426|FG000|Overall Study|Lack of Efficacy|0|||
148716553|NCT01856192|536434427|FG001|Overall Study|Lack of Efficacy|5|||
148716554|NCT01856192|536434426|FG000|Overall Study|Withdrawal by Subject|1|||
148716555|NCT01856192|536434427|FG001|Overall Study|Withdrawal by Subject|1|||
148716556|NCT01856192|536434426|FG000|Overall Study|Other diseases|1|||
148716557|NCT01856192|536434427|FG001|Overall Study|Other diseases|0|||
148716558|NCT01856192|536434426|FG000|Overall Study|Never started treatment|7|||
148716559|NCT01856192|536434427|FG001|Overall Study|Never started treatment|5|||
148716560|NCT01856192|536434426|FG000|Overall Study|Path ineligible|20|||
148716561|NCT01856192|536434427|FG001|Overall Study|Path ineligible|34|||
148716562|NCT01856192|536434426|FG000|Overall Study|Non-path ineligible|2|||
148716563|NCT01856192|536434427|FG001|Overall Study|Non-path ineligible|2|||
148716564|NCT01856192|536434426|FG000|Overall Study|Physician Decision|1|||
148716565|NCT01856192|536434427|FG001|Overall Study|Physician Decision|1|||
148716566|NCT01856192|536434426|FG000|Overall Study|Suspicion of progressive disease|1|||
148716567|NCT01856192|536434427|FG001|Overall Study|Suspicion of progressive disease|0|||
148716568|NCT01856192|536434426|FG000|Overall Study|Non-compliance|1|||
148716569|NCT01856192|536434427|FG001|Overall Study|Non-compliance|0|||
148716570|NCT00098475|536434428|FG000|Step 1|Progressive disease|33|||
148716571|NCT00098475|536434429|FG001|Step 1|Progressive disease|35|||
148716572|NCT00098475|536434430|FG002|Step 1|Progressive disease|2|||
148716573|NCT00098475|536434431|FG003|Step 1|Progressive disease|1|||
148716574|NCT00098475|536434428|FG000|Step 1|Adverse Event|56|||
148716575|NCT00098475|536434429|FG001|Step 1|Adverse Event|37|||
148716576|NCT00098475|536434430|FG002|Step 1|Adverse Event|0|||
148716577|NCT00098475|536434431|FG003|Step 1|Adverse Event|1|||
148716578|NCT00098475|536434428|FG000|Step 1|Death|8|||
148716579|NCT00098475|536434429|FG001|Step 1|Death|5|||
148716580|NCT00098475|536434430|FG002|Step 1|Death|0|||
148716581|NCT00098475|536434431|FG003|Step 1|Death|1|||
148716582|NCT00098475|536434428|FG000|Step 1|Withdrawal by Subject|14|||
148716583|NCT00098475|536434429|FG001|Step 1|Withdrawal by Subject|11|||
148716584|NCT00098475|536434430|FG002|Step 1|Withdrawal by Subject|0|||
148716585|NCT00098475|536434431|FG003|Step 1|Withdrawal by Subject|0|||
148716586|NCT00098475|536434428|FG000|Step 1|Physician Decision|5|||
148716587|NCT00098475|536434429|FG001|Step 1|Physician Decision|2|||
148716588|NCT00098475|536434430|FG002|Step 1|Physician Decision|0|||
148716589|NCT00098475|536434431|FG003|Step 1|Physician Decision|0|||
148716590|NCT00098475|536434428|FG000|Step 1|Alternative therapy|31|||
148716591|NCT00098475|536434429|FG001|Step 1|Alternative therapy|43|||
148716592|NCT00098475|536434430|FG002|Step 1|Alternative therapy|1|||
148716593|NCT00098475|536434431|FG003|Step 1|Alternative therapy|0|||
148716594|NCT00098475|536434428|FG000|Step 1|Other disease|2|||
148716595|NCT00098475|536434429|FG001|Step 1|Other disease|1|||
148716596|NCT00098475|536434430|FG002|Step 1|Other disease|1|||
148716597|NCT00098475|536434431|FG003|Step 1|Other disease|0|||
148716598|NCT00098475|536434428|FG000|Step 1|Never started treatment|0|||
148716599|NCT00098475|536434429|FG001|Step 1|Never started treatment|2|||
148716600|NCT00098475|536434430|FG002|Step 1|Never started treatment|0|||
148716601|NCT00098475|536434431|FG003|Step 1|Never started treatment|0|||
148716602|NCT00098475|536434428|FG000|Step 1|Still on treatment as of this analysis|14|||
148716603|NCT00098475|536434429|FG001|Step 1|Still on treatment as of this analysis|27|||
148716604|NCT00098475|536434430|FG002|Step 1|Still on treatment as of this analysis|0|||
148716605|NCT00098475|536434431|FG003|Step 1|Still on treatment as of this analysis|0|||
148716606|NCT00098475|536434428|FG000|Step 1|Knee surgery|1|||
148716607|NCT00098475|536434429|FG001|Step 1|Knee surgery|0|||
148716608|NCT00098475|536434430|FG002|Step 1|Knee surgery|0|||
148716609|NCT00098475|536434431|FG003|Step 1|Knee surgery|0|||
148716610|NCT00098475|536434428|FG000|Step 1|Complications|1|||
148716611|NCT00098475|536434429|FG001|Step 1|Complications|0|||
148716612|NCT00098475|536434430|FG002|Step 1|Complications|0|||
148716613|NCT00098475|536434431|FG003|Step 1|Complications|0|||
148716614|NCT00098475|536434428|FG000|Step 1|Cannot comply due to other tx|0|||
148716615|NCT00098475|536434429|FG001|Step 1|Cannot comply due to other tx|1|||
148716616|NCT00098475|536434430|FG002|Step 1|Cannot comply due to other tx|0|||
148716617|NCT00098475|536434431|FG003|Step 1|Cannot comply due to other tx|0|||
148716618|NCT00098475|536434428|FG000|Step 1|Both patient and physician's decision|2|||
148716619|NCT00098475|536434429|FG001|Step 1|Both patient and physician's decision|1|||
148716620|NCT00098475|536434430|FG002|Step 1|Both patient and physician's decision|0|||
148716621|NCT00098475|536434431|FG003|Step 1|Both patient and physician's decision|0|||
148716622|NCT00098475|536434428|FG000|Step 1|Incorrect disease assessment|2|||
148716623|NCT00098475|536434429|FG001|Step 1|Incorrect disease assessment|0|||
148716624|NCT00098475|536434430|FG002|Step 1|Incorrect disease assessment|0|||
148716625|NCT00098475|536434431|FG003|Step 1|Incorrect disease assessment|0|||
148716626|NCT00098475|536434428|FG000|Step 1|Off treatment for > specified timeframe|1|||
148716627|NCT00098475|536434429|FG001|Step 1|Off treatment for > specified timeframe|1|||
148716628|NCT00098475|536434430|FG002|Step 1|Off treatment for > specified timeframe|0|||
148716629|NCT00098475|536434431|FG003|Step 1|Off treatment for > specified timeframe|0|||
148716630|NCT00098475|536434428|FG000|Step 1|Declining performance status|0|||
148716631|NCT00098475|536434429|FG001|Step 1|Declining performance status|1|||
148716632|NCT00098475|536434430|FG002|Step 1|Declining performance status|0|||
148716633|NCT00098475|536434431|FG003|Step 1|Declining performance status|0|||
148716634|NCT00098475|536434428|FG000|Step 1|Insurance issue|0|||
148716635|NCT00098475|536434429|FG001|Step 1|Insurance issue|1|||
148716636|NCT00098475|536434430|FG002|Step 1|Insurance issue|0|||
148716637|NCT00098475|536434431|FG003|Step 1|Insurance issue|0|||
148716638|NCT00098475|536434428|FG000|Step 1|Rising paraprotein|0|||
148716639|NCT00098475|536434429|FG001|Step 1|Rising paraprotein|1|||
148716640|NCT00098475|536434430|FG002|Step 1|Rising paraprotein|0|||
148716641|NCT00098475|536434431|FG003|Step 1|Rising paraprotein|0|||
148716642|NCT00098475|536434428|FG000|Step 1|Referred to other physicians|0|||
148716643|NCT00098475|536434429|FG001|Step 1|Referred to other physicians|1|||
148716644|NCT00098475|536434430|FG002|Step 1|Referred to other physicians|0|||
148716645|NCT00098475|536434431|FG003|Step 1|Referred to other physicians|0|||
148716646|NCT00098475|536434428|FG000|Step 1|Criteria to continue treatment not met|0|||
148716647|NCT00098475|536434429|FG001|Step 1|Criteria to continue treatment not met|1|||
148716648|NCT00098475|536434430|FG002|Step 1|Criteria to continue treatment not met|0|||
148716649|NCT00098475|536434431|FG003|Step 1|Criteria to continue treatment not met|0|||
148716650|NCT00098475|536434428|FG000|Step 1|Misinterpretation of lab data|0|||
148716651|NCT00098475|536434429|FG001|Step 1|Misinterpretation of lab data|1|||
148716652|NCT00098475|536434430|FG002|Step 1|Misinterpretation of lab data|0|||
148716653|NCT00098475|536434431|FG003|Step 1|Misinterpretation of lab data|0|||
148716654|NCT00098475|536434428|FG000|Step 1|Patient fell with fracture|1|||
148716655|NCT00098475|536434429|FG001|Step 1|Patient fell with fracture|0|||
148716656|NCT00098475|536434430|FG002|Step 1|Patient fell with fracture|0|||
148716657|NCT00098475|536434431|FG003|Step 1|Patient fell with fracture|0|||
148716658|NCT00098475|536434428|FG000|Step 1|Not documented|0|||
148716659|NCT00098475|536434429|FG001|Step 1|Not documented|1|||
148716660|NCT00098475|536434430|FG002|Step 1|Not documented|0|||
148716661|NCT00098475|536434431|FG003|Step 1|Not documented|0|||
148716662|NCT00098475|536434428|FG000|Step 2|Disease progression|1|||
148716663|NCT00098475|536434429|FG001|Step 2|Disease progression|4|||
148716664|NCT00098475|536434430|FG002|Step 2|Disease progression|0|||
148716665|NCT00098475|536434431|FG003|Step 2|Disease progression|0|||
148716666|NCT00098475|536434428|FG000|Step 2|Adverse Event|2|||
148716667|NCT00098475|536434429|FG001|Step 2|Adverse Event|0|||
148716668|NCT00098475|536434430|FG002|Step 2|Adverse Event|0|||
148716669|NCT00098475|536434431|FG003|Step 2|Adverse Event|0|||
148716670|NCT00098475|536434428|FG000|Step 2|Withdrawal by Subject|0|||
148716671|NCT00098475|536434429|FG001|Step 2|Withdrawal by Subject|2|||
148716672|NCT00098475|536434430|FG002|Step 2|Withdrawal by Subject|0|||
148716673|NCT00098475|536434431|FG003|Step 2|Withdrawal by Subject|0|||
148716674|NCT00098475|536434428|FG000|Step 2|Physician Decision|0|||
148716675|NCT00098475|536434429|FG001|Step 2|Physician Decision|1|||
148716676|NCT00098475|536434430|FG002|Step 2|Physician Decision|0|||
148716677|NCT00098475|536434431|FG003|Step 2|Physician Decision|0|||
148716678|NCT00098475|536434428|FG000|Step 2|Alternative therapy|1|||
148716679|NCT00098475|536434429|FG001|Step 2|Alternative therapy|2|||
148716680|NCT00098475|536434430|FG002|Step 2|Alternative therapy|0|||
148716681|NCT00098475|536434431|FG003|Step 2|Alternative therapy|0|||
148716682|NCT00098475|536434428|FG000|Step 2|Never started treatment|1|||
148716683|NCT00098475|536434429|FG001|Step 2|Never started treatment|1|||
148716684|NCT00098475|536434430|FG002|Step 2|Never started treatment|0|||
148716685|NCT00098475|536434431|FG003|Step 2|Never started treatment|0|||
148716686|NCT01841073|536434432|FG000|Overall Study|Adverse Event|1|||
148716687|NCT01841073|536434433|FG001|Overall Study|Adverse Event|1|||
148716688|NCT01841073|536434432|FG000|Overall Study|Physician Decision|1|||
148716689|NCT01841073|536434433|FG001|Overall Study|Physician Decision|0|||
148716690|NCT01841073|536434432|FG000|Overall Study|Lost to Follow-up|0|||
148716691|NCT01841073|536434433|FG001|Overall Study|Lost to Follow-up|2|||
148716692|NCT02858037|536434438|FG000|Overall Study|Death|1|||
148716693|NCT02858037|536434438|FG000|Overall Study|Withdrawal by Subject|18|||
148716694|NCT02858037|536434438|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
148716695|NCT02858037|536434438|FG000|Overall Study|Lost to Follow-up|3|||
148815759|NCT02850406|536800633|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
148815760|NCT02850406|536800634|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
148815761|NCT02850406|536800635|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
148815762|NCT02850406|536800636|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
148815763|NCT02850406|536800637|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
148716696|NCT02858037|536434438|FG000|Overall Study|Other|4|||
148716697|NCT02050321|536434440|FG000|Overall Study|Withdrawal by Subject|1|||
148716698|NCT02050321|536434440|FG000|Overall Study|Adverse Event|1|||
148815764|NCT02850406|536800638|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
148716699|NCT00160524|536434441|FG000|Overall Study|Adverse Event|119|||
148716700|NCT00160524|536434441|FG000|Overall Study|Adverse Event and Other|94|||
148716701|NCT00160524|536434441|FG000|Overall Study|Protocol Violation|16|||
148716702|NCT00160524|536434441|FG000|Overall Study|Protocol Violation and Other|2|||
148716703|NCT00160524|536434441|FG000|Overall Study|Withdrawal by Subject|141|||
148716704|NCT00160524|536434441|FG000|Overall Study|Withdrawal by Subject and Other|17|||
148716705|NCT00160524|536434441|FG000|Overall Study|Physician Decision|27|||
148716706|NCT00160524|536434441|FG000|Overall Study|Physician Decision and Other|6|||
148716707|NCT00160524|536434441|FG000|Overall Study|Lost to Follow-up|13|||
148716708|NCT00160524|536434441|FG000|Overall Study|Lost to Follow-up and Other|1|||
148716709|NCT00160524|536434441|FG000|Overall Study|Lack of Efficacy|21|||
148716710|NCT00160524|536434441|FG000|Overall Study|Lack of Efficacy and Other|1|||
148716711|NCT00160524|536434441|FG000|Overall Study|Other|20|||
148716712|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
148716713|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
148716714|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
148716715|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
148716716|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
148716717|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
148716718|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
148716719|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
148716720|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
148716721|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
148716722|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
148716723|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
148716724|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
148716725|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
148716726|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
148716727|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
148716728|NCT01067521|536434443|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
148716729|NCT01067521|536434444|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
148716730|NCT01067521|536434443|FG000|Open-Label Period|Death|3|||
148716731|NCT01067521|536434444|FG001|Open-Label Period|Death|1|||
148716732|NCT01067521|536434443|FG000|Open-Label Period|Adverse Event|30|||
148716733|NCT01067521|536434444|FG001|Open-Label Period|Adverse Event|28|||
148716734|NCT01067521|536434443|FG000|Open-Label Period|Withdrawal by Subject|160|||
148716735|NCT01067521|536434444|FG001|Open-Label Period|Withdrawal by Subject|88|||
148716736|NCT01067521|536434443|FG000|Open-Label Period|Physician Decision|13|||
148716737|NCT01067521|536434444|FG001|Open-Label Period|Physician Decision|11|||
148716738|NCT01067521|536434443|FG000|Open-Label Period|Non-compliance with study drug|5|||
148716739|NCT01067521|536434444|FG001|Open-Label Period|Non-compliance with study drug|0|||
148716740|NCT01067521|536434443|FG000|Open-Label Period|Protocol Violation|3|||
148716741|NCT01067521|536434444|FG001|Open-Label Period|Protocol Violation|0|||
148716742|NCT01067521|536434443|FG000|Open-Label Period|Pregnancy|14|||
148716743|NCT01067521|536434444|FG001|Open-Label Period|Pregnancy|8|||
148716744|NCT01067521|536434443|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
148716745|NCT01067521|536434444|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
148716746|NCT01067521|536434443|FG000|Open-Label Period|Lost to Follow-up|21|||
148716747|NCT01067521|536434444|FG001|Open-Label Period|Lost to Follow-up|20|||
148716748|NCT02151149|536434448|FG000|Treatment Period|Death|2|||
148716749|NCT02151149|536434449|FG001|Treatment Period|Death|3|||
148716750|NCT02151149|536434448|FG000|Treatment Period|Adverse Event|17|||
148716751|NCT02151149|536434449|FG001|Treatment Period|Adverse Event|14|||
148716752|NCT02151149|536434448|FG000|Treatment Period|Progressive Disease|25|||
148716753|NCT02151149|536434449|FG001|Treatment Period|Progressive Disease|24|||
148716754|NCT02151149|536434448|FG000|Treatment Period|Symptomatic Deterioration|2|||
148716755|NCT02151149|536434449|FG001|Treatment Period|Symptomatic Deterioration|10|||
148716756|NCT02151149|536434448|FG000|Treatment Period|Withdrawal by Subject|13|||
148716757|NCT02151149|536434449|FG001|Treatment Period|Withdrawal by Subject|11|||
148716758|NCT02151149|536434448|FG000|Treatment Period|Miscellaneous|8|||
148716759|NCT02151149|536434449|FG001|Treatment Period|Miscellaneous|7|||
148716760|NCT02151149|536434448|FG000|Treatment Period|Participants randomized but not treated|3|||
148716761|NCT02151149|536434449|FG001|Treatment Period|Participants randomized but not treated|2|||
148716762|NCT02151149|536434448|FG000|Follow-Up Period|Lost to Follow-up|2|||
148716763|NCT02151149|536434449|FG001|Follow-Up Period|Lost to Follow-up|3|||
148716764|NCT02151149|536434448|FG000|Follow-Up Period|Death|37|||
148716765|NCT02151149|536434449|FG001|Follow-Up Period|Death|34|||
148716766|NCT03419962|536434452|FG000|Overall Study|Change to other medication|1|||
148716767|NCT03419962|536434452|FG000|Overall Study|Refusal of continuing with trial drug|1|||
148716768|NCT03419962|536434452|FG000|Overall Study|Lost to Follow-up|3|||
148716769|NCT03419962|536434452|FG000|Overall Study|Difficulty in inhaling the doses|1|||
148716770|NCT03419962|536434452|FG000|Overall Study|Missing completion data|31|||
148716771|NCT04142658|536434453|FG000|Overall Study|Death|2|||
148716772|NCT04142658|536434454|FG001|Overall Study|Death|1|||
148716773|NCT04142658|536434453|FG000|Overall Study|Lost to Follow-up|4|||
148716774|NCT04142658|536434454|FG001|Overall Study|Lost to Follow-up|13|||
148716775|NCT04142658|536434453|FG000|Overall Study|Withdrawal by Subject|9|||
148968925|NCT02036502|537372832|FG000|Part 2:Dose Confirmation|Death|0|||
148968926|NCT02036502|537372833|FG001|Part 2:Dose Confirmation|Death|0|||
148716776|NCT04142658|536434454|FG001|Overall Study|Withdrawal by Subject|16|||
148815765|NCT02850406|536800639|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
148716777|NCT01781234|536434455|FG000|Overall Study|Adverse Event|2|||
148716778|NCT01781234|536434456|FG001|Overall Study|Adverse Event|0|||
148716779|NCT01781234|536434455|FG000|Overall Study|Protocol Violation|3|||
148716780|NCT01781234|536434456|FG001|Overall Study|Protocol Violation|0|||
148716781|NCT01781234|536434455|FG000|Overall Study|Withdrawal by Subject|4|||
148716782|NCT01781234|536434456|FG001|Overall Study|Withdrawal by Subject|3|||
148716783|NCT00830167|536434459|FG000|Overall Study|Lack of Efficacy|26|||
148716784|NCT00830167|536434460|FG001|Overall Study|Lack of Efficacy|10|||
148716785|NCT00830167|536434459|FG000|Overall Study|Adverse Event|8|||
148716786|NCT00830167|536434460|FG001|Overall Study|Adverse Event|24|||
148716787|NCT00830167|536434459|FG000|Overall Study|Not meeting entrance criteria|2|||
148716788|NCT00830167|536434460|FG001|Overall Study|Not meeting entrance criteria|5|||
148716789|NCT00830167|536434459|FG000|Overall Study|Withdrawal by Subject|2|||
148716790|NCT00830167|536434460|FG001|Overall Study|Withdrawal by Subject|0|||
148716791|NCT00830167|536434459|FG000|Overall Study|Lost to Follow-up|0|||
148716792|NCT00830167|536434460|FG001|Overall Study|Lost to Follow-up|1|||
148716793|NCT00830167|536434459|FG000|Overall Study|Protocol Violation|0|||
148716794|NCT00830167|536434460|FG001|Overall Study|Protocol Violation|1|||
148716795|NCT00830167|536434459|FG000|Overall Study|Other|2|||
148716796|NCT00830167|536434460|FG001|Overall Study|Other|2|||
148716797|NCT01801917|536434461|FG000|Period 1 - Randomized|Adverse Event|1|||
148716798|NCT01801917|536434462|FG001|Period 1 - Randomized|Adverse Event|0|||
148716799|NCT01801917|536434463|FG002|Period 1 - Randomized|Adverse Event|1|||
148716800|NCT01801917|536434464|FG003|Period 1 - Randomized|Adverse Event|0|||
148716801|NCT01924364|536434465|FG000|Overall Study|Physician Decision|3|||
148716802|NCT00265785|536434466|FG000|Overall Study|Adverse Event|4|||
148716803|NCT00265785|536434466|FG000|Overall Study|Withdrawal by Subject|3|||
148716804|NCT00265785|536434466|FG000|Overall Study|Progression/Relapse|15|||
148716805|NCT00265785|536434466|FG000|Overall Study|Not protocol specified|2|||
148716806|NCT00265785|536434466|FG000|Overall Study|Ineligible|1|||
148716807|NCT00265785|536434466|FG000|Overall Study|Did not receive protocol treatment|2|||
148716808|NCT00603512|536434467|FG000|Overall Study|Adverse Event|0|||
148716809|NCT00603512|536434468|FG001|Overall Study|Adverse Event|2|||
148716810|NCT00603512|536434469|FG002|Overall Study|Adverse Event|4|||
148716811|NCT00603512|536434470|FG003|Overall Study|Adverse Event|4|||
148716812|NCT00603512|536434471|FG004|Overall Study|Adverse Event|2|||
148716813|NCT00603512|536434467|FG000|Overall Study|Lack of Efficacy|0|||
148716814|NCT00603512|536434468|FG001|Overall Study|Lack of Efficacy|1|||
148716815|NCT00603512|536434469|FG002|Overall Study|Lack of Efficacy|0|||
148716816|NCT00603512|536434470|FG003|Overall Study|Lack of Efficacy|0|||
148716817|NCT00603512|536434471|FG004|Overall Study|Lack of Efficacy|1|||
148716818|NCT00603512|536434467|FG000|Overall Study|Other|2|||
148716819|NCT00603512|536434468|FG001|Overall Study|Other|1|||
148716820|NCT00603512|536434469|FG002|Overall Study|Other|0|||
148716821|NCT00603512|536434470|FG003|Overall Study|Other|1|||
148716822|NCT00603512|536434471|FG004|Overall Study|Other|1|||
148716823|NCT00603512|536434467|FG000|Overall Study|Withdrawal by Subject|0|||
148716824|NCT00603512|536434468|FG001|Overall Study|Withdrawal by Subject|0|||
148716825|NCT00603512|536434469|FG002|Overall Study|Withdrawal by Subject|0|||
148716826|NCT00603512|536434470|FG003|Overall Study|Withdrawal by Subject|0|||
148716827|NCT00603512|536434471|FG004|Overall Study|Withdrawal by Subject|1|||
148716828|NCT00603512|536434467|FG000|Overall Study|Randomized but not treated|0|||
148716829|NCT00603512|536434468|FG001|Overall Study|Randomized but not treated|1|||
148716830|NCT00603512|536434469|FG002|Overall Study|Randomized but not treated|1|||
148716831|NCT00603512|536434470|FG003|Overall Study|Randomized but not treated|2|||
148716832|NCT00603512|536434471|FG004|Overall Study|Randomized but not treated|0|||
148716833|NCT04979858|536434472|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
148716834|NCT04979858|536434473|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
148716835|NCT04253236|536434474|FG000|Overall Study|Adverse Event|1|||
148716836|NCT04253236|536434475|FG001|Overall Study|Adverse Event|0|||
148716837|NCT04253236|536434474|FG000|Overall Study|Safety Concerns|1|||
148716838|NCT04253236|536434475|FG001|Overall Study|Safety Concerns|0|||
148716839|NCT04253236|536434474|FG000|Overall Study|Study Terminated by Sponsor|1|||
148716840|NCT04253236|536434475|FG001|Overall Study|Study Terminated by Sponsor|0|||
148716841|NCT01337596|536434484|FG000|Overall Study|Withdrawal by Subject|0|||
148716842|NCT01337596|536434485|FG001|Overall Study|Withdrawal by Subject|0|||
148716843|NCT01337596|536434486|FG002|Overall Study|Withdrawal by Subject|0|||
148716844|NCT01337596|536434487|FG003|Overall Study|Withdrawal by Subject|0|||
148716845|NCT01337596|536434488|FG004|Overall Study|Withdrawal by Subject|2|||
148716846|NCT01337596|536434489|FG005|Overall Study|Withdrawal by Subject|0|||
148716847|NCT01337596|536434490|FG006|Overall Study|Withdrawal by Subject|0|||
148716848|NCT01337596|536434491|FG007|Overall Study|Withdrawal by Subject|0|||
148815766|NCT02850406|536800632|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148815767|NCT02850406|536800633|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148716849|NCT01337596|536434492|FG008|Overall Study|Withdrawal by Subject|0|||
148716850|NCT03201003|536434496|FG000|Overall Study|Adverse Event|14|||
148716851|NCT03201003|536434497|FG001|Overall Study|Adverse Event|1|||
148716852|NCT03201003|536434496|FG000|Overall Study|Other reasons|5|||
148716853|NCT03201003|536434497|FG001|Overall Study|Other reasons|1|||
148716854|NCT03201003|536434496|FG000|Overall Study|Withdrawal by Subject|4|||
148716855|NCT03201003|536434497|FG001|Overall Study|Withdrawal by Subject|1|||
148716856|NCT03201003|536434496|FG000|Overall Study|Lost to Follow-up|2|||
148716857|NCT03201003|536434497|FG001|Overall Study|Lost to Follow-up|0|||
148968927|NCT02036502|537372834|FG002|Part 2:Dose Confirmation|Death|1|||
148968928|NCT02036502|537372835|FG003|Part 2:Dose Confirmation|Death|0|||
148968929|NCT02036502|537372836|FG004|Part 2:Dose Confirmation|Death|0|||
148968930|NCT02036502|537372837|FG005|Part 2:Dose Confirmation|Death|0|||
148968931|NCT02036502|537372838|FG006|Part 2:Dose Confirmation|Death|0|||
148968932|NCT02036502|537372839|FG007|Part 2:Dose Confirmation|Death|0|||
148716858|NCT03201003|536434496|FG000|Overall Study|Protocol Violation|1|||
148968933|NCT02036502|537372832|FG000|Part 2:Dose Confirmation|Not treated|0|||
148968934|NCT02036502|537372833|FG001|Part 2:Dose Confirmation|Not treated|0|||
148968935|NCT02036502|537372834|FG002|Part 2:Dose Confirmation|Not treated|0|||
148968936|NCT02036502|537372835|FG003|Part 2:Dose Confirmation|Not treated|1|||
148968937|NCT02036502|537372836|FG004|Part 2:Dose Confirmation|Not treated|0|||
148968938|NCT02036502|537372837|FG005|Part 2:Dose Confirmation|Not treated|0|||
148968939|NCT02036502|537372838|FG006|Part 2:Dose Confirmation|Not treated|0|||
148968940|NCT02036502|537372839|FG007|Part 2:Dose Confirmation|Not treated|0|||
148968941|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Adverse Event|0|||
148968942|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Adverse Event|0|||
148968943|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Adverse Event|0|||
148968944|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Adverse Event|0|||
148968945|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Adverse Event|0|||
148968946|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Adverse Event|4|||
148968947|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Adverse Event|0|||
148968948|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Adverse Event|2|||
148968949|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Death|0|||
148968950|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Death|0|||
148968951|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Death|0|||
148968952|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Death|0|||
148968953|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Death|0|||
148716859|NCT03201003|536434497|FG001|Overall Study|Protocol Violation|0|||
148716860|NCT00834613|536434498|FG000|First Intervention|Protocol Violation|1|||
148716861|NCT00834613|536434499|FG001|First Intervention|Protocol Violation|0|||
148716862|NCT01709903|536434503|FG000|Overall Study|administrative problems|2|||
148716863|NCT01709903|536434504|FG001|Overall Study|administrative problems|6|||
148716864|NCT01709903|536434503|FG000|Overall Study|Abnormal test procedure results|1|||
148716865|NCT01709903|536434504|FG001|Overall Study|Abnormal test procedure results|0|||
148716866|NCT01709903|536434503|FG000|Overall Study|In ability to use device|1|||
148716867|NCT01709903|536434504|FG001|Overall Study|In ability to use device|1|||
148716868|NCT01709903|536434503|FG000|Overall Study|no longer needed study drug|0|||
148716869|NCT01709903|536434504|FG001|Overall Study|no longer needed study drug|1|||
148716870|NCT01709903|536434503|FG000|Overall Study|Lost to Follow-up|0|||
148716871|NCT01709903|536434504|FG001|Overall Study|Lost to Follow-up|2|||
148716872|NCT01709903|536434503|FG000|Overall Study|Death|2|||
148716873|NCT01709903|536434504|FG001|Overall Study|Death|0|||
148716874|NCT01709903|536434503|FG000|Overall Study|Protocol Violation|3|||
148716875|NCT01709903|536434504|FG001|Overall Study|Protocol Violation|2|||
148716876|NCT01709903|536434503|FG000|Overall Study|Lack of Efficacy|3|||
148716877|NCT01709903|536434504|FG001|Overall Study|Lack of Efficacy|3|||
148716878|NCT01709903|536434503|FG000|Overall Study|Withdrawal by Subject|6|||
148716879|NCT01709903|536434504|FG001|Overall Study|Withdrawal by Subject|6|||
148716880|NCT01709903|536434503|FG000|Overall Study|Adverse Event|11|||
148716881|NCT01709903|536434504|FG001|Overall Study|Adverse Event|18|||
148716882|NCT02061280|536434505|FG000|Overall Study|Protocol Violation|12|||
148716883|NCT02061280|536434506|FG001|Overall Study|Protocol Violation|8|||
148716884|NCT02061280|536434505|FG000|Overall Study|moved out of state|0|||
148716885|NCT02061280|536434506|FG001|Overall Study|moved out of state|1|||
148716886|NCT02061280|536434505|FG000|Overall Study|Withdrawal by Subject|1|||
148716887|NCT02061280|536434506|FG001|Overall Study|Withdrawal by Subject|2|||
148716888|NCT02061280|536434505|FG000|Overall Study|Lost to Follow-up|5|||
148716889|NCT02061280|536434506|FG001|Overall Study|Lost to Follow-up|1|||
148716890|NCT02722616|536435496|FG000|Overall Study|Sponsor closed study after one month|2|||
148716891|NCT02722616|536435497|FG001|Overall Study|Sponsor closed study after one month|0|||
148716892|NCT02722616|536435498|FG002|Overall Study|Sponsor closed study after one month|0|||
148716893|NCT02031237|536435499|FG000|Overall Study|Death|1|||
148716894|NCT02031237|536435500|FG001|Overall Study|Death|5|||
148815768|NCT02850406|536800634|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
148968954|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Death|24|||
148968955|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Death|0|||
148968956|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Death|3|||
148968957|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
148968958|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
148716895|NCT02031237|536435501|FG002|Overall Study|Death|0|||
148716896|NCT02031237|536435499|FG000|Overall Study|Physician Decision|0|||
148716897|NCT02031237|536435500|FG001|Overall Study|Physician Decision|1|||
148968959|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
148815769|NCT02850406|536800635|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148716898|NCT02031237|536435501|FG002|Overall Study|Physician Decision|0|||
148716899|NCT02031237|536435499|FG000|Overall Study|Withdrawal by Subject|2|||
148968960|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
148716900|NCT02031237|536435500|FG001|Overall Study|Withdrawal by Subject|2|||
148716901|NCT02031237|536435501|FG002|Overall Study|Withdrawal by Subject|0|||
148716902|NCT02031237|536435499|FG000|Overall Study|Protocol Violation|2|||
148716903|NCT02031237|536435500|FG001|Overall Study|Protocol Violation|6|||
148716904|NCT02031237|536435501|FG002|Overall Study|Protocol Violation|0|||
148716905|NCT02031237|536435499|FG000|Overall Study|Alternate Treatment Given|0|||
148716906|NCT02031237|536435500|FG001|Overall Study|Alternate Treatment Given|0|||
148716907|NCT02031237|536435501|FG002|Overall Study|Alternate Treatment Given|3|||
148716908|NCT00676650|536435506|FG000|Overall Study|Death|45|||
148716909|NCT00676650|536435507|FG001|Overall Study|Death|14|||
148716910|NCT00676650|536435506|FG000|Overall Study|Adverse Event|159|||
148716911|NCT00676650|536435507|FG001|Overall Study|Adverse Event|21|||
148716912|NCT00676650|536435506|FG000|Overall Study|Global deterioration of health status|66|||
148716913|NCT00676650|536435507|FG001|Overall Study|Global deterioration of health status|31|||
148716914|NCT00676650|536435506|FG000|Overall Study|Lost to Follow-up|0|||
148716915|NCT00676650|536435507|FG001|Overall Study|Lost to Follow-up|1|||
148716916|NCT00676650|536435506|FG000|Overall Study|Objective progression or relapse|189|||
148716917|NCT00676650|536435507|FG001|Overall Study|Objective progression or relapse|140|||
148716918|NCT00676650|536435506|FG000|Overall Study|Other|14|||
148716919|NCT00676650|536435507|FG001|Overall Study|Other|10|||
148716920|NCT00676650|536435506|FG000|Overall Study|Protocol Violation|3|||
148716921|NCT00676650|536435507|FG001|Overall Study|Protocol Violation|1|||
148716922|NCT00676650|536435506|FG000|Overall Study|Study terminated by sponsor|57|||
148716923|NCT00676650|536435507|FG001|Overall Study|Study terminated by sponsor|43|||
148716924|NCT00676650|536435506|FG000|Overall Study|Withdrawal by Subject|48|||
148716925|NCT00676650|536435507|FG001|Overall Study|Withdrawal by Subject|24|||
148716926|NCT00676650|536435506|FG000|Overall Study|Randomized but not treated|3|||
148716927|NCT00676650|536435507|FG001|Overall Study|Randomized but not treated|4|||
148716928|NCT02297841|536435511|FG000|Overall Study|Withdrawal by Subject|1|||
148716929|NCT02297841|536435511|FG000|Overall Study|Protocol Violation|7|||
148716930|NCT05061992|536435512|FG000|Overall Study|Excess bowel movements|1|||
148716931|NCT05061992|536435513|FG001|Overall Study|Excess bowel movements|0|||
148716932|NCT05061992|536435512|FG000|Overall Study|Complications of Medical Care|1|||
148716933|NCT05061992|536435513|FG001|Overall Study|Complications of Medical Care|0|||
148716934|NCT05061992|536435512|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
148716935|NCT05061992|536435513|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
148716936|NCT05061992|536435512|FG000|Overall Study|Withdrawal by Subject|0|||
148716937|NCT05061992|536435513|FG001|Overall Study|Withdrawal by Subject|1|||
148716938|NCT05693805|536435517|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
148716939|NCT05693805|536435518|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
148716940|NCT02152982|536435523|FG000|Overall Study|Withdrawal by Subject|17|||
148716941|NCT02152982|536435524|FG001|Overall Study|Withdrawal by Subject|16|||
148716942|NCT02152982|536435523|FG000|Overall Study|Did not start treatment|11|||
148716943|NCT02152982|536435524|FG001|Overall Study|Did not start treatment|5|||
148716944|NCT02152982|536435523|FG000|Overall Study|Disease progression|41|||
148716945|NCT02152982|536435524|FG001|Overall Study|Disease progression|52|||
148716946|NCT02152982|536435523|FG000|Overall Study|Adverse Event|7|||
148716947|NCT02152982|536435524|FG001|Overall Study|Adverse Event|12|||
148716948|NCT02152982|536435523|FG000|Overall Study|Complicating disease|1|||
148716949|NCT02152982|536435524|FG001|Overall Study|Complicating disease|1|||
148716950|NCT02152982|536435523|FG000|Overall Study|Death|0|||
148716951|NCT02152982|536435524|FG001|Overall Study|Death|3|||
148716952|NCT02152982|536435523|FG000|Overall Study|Physician Decision|3|||
148716953|NCT02152982|536435524|FG001|Overall Study|Physician Decision|0|||
148716954|NCT03230487|536435530|FG000|Overall Study|Adverse Event|0|||
148716955|NCT03230487|536435531|FG001|Overall Study|Adverse Event|0|||
148716956|NCT03230487|536435532|FG002|Overall Study|Adverse Event|0|||
148716957|NCT03230487|536435533|FG003|Overall Study|Adverse Event|1|||
148716958|NCT03230487|536435534|FG004|Overall Study|Adverse Event|0|||
148716959|NCT03230487|536435535|FG005|Overall Study|Adverse Event|0|||
148716960|NCT05212948|536435536|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
148716961|NCT05212948|536435537|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
148716962|NCT05212948|536435536|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
148716963|NCT05212948|536435537|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
148716964|NCT05212948|536435536|FG000|Initial Vaccination Period|Pregnancy|20|||
148716965|NCT05212948|536435537|FG001|Initial Vaccination Period|Pregnancy|14|||
148716966|NCT05212948|536435536|FG000|Initial Vaccination Period|Physician Decision|686|||
148716967|NCT05212948|536435537|FG001|Initial Vaccination Period|Physician Decision|401|||
148716968|NCT05212948|536435536|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
148716969|NCT05212948|536435537|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
148716970|NCT05212948|536435536|FG000|Initial Vaccination Period|Death|23|||
148716971|NCT05212948|536435537|FG001|Initial Vaccination Period|Death|18|||
148716972|NCT05212948|536435536|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
148968961|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
148968962|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
148968963|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
148968964|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
148968965|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Physician Decision|0|||
148968966|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Physician Decision|0|||
148968967|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Physician Decision|0|||
148968968|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Physician Decision|0|||
148716973|NCT05212948|536435537|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
148716974|NCT05212948|536435536|FG000|Initial Vaccination Period|Adverse Event|36|||
148716975|NCT05212948|536435537|FG001|Initial Vaccination Period|Adverse Event|23|||
148716976|NCT05212948|536435536|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
148716977|NCT05212948|536435537|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
148716978|NCT05212948|536435536|FG000|Crossover Vaccination Period|Pregnancy|6|||
148716979|NCT05212948|536435537|FG001|Crossover Vaccination Period|Pregnancy|1|||
148716980|NCT05212948|536435536|FG000|Crossover Vaccination Period|Physician Decision|49|||
148716981|NCT05212948|536435537|FG001|Crossover Vaccination Period|Physician Decision|24|||
148716982|NCT05212948|536435536|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
148716983|NCT05212948|536435537|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
148716984|NCT05212948|536435536|FG000|Crossover Vaccination Period|Death|10|||
148716985|NCT05212948|536435537|FG001|Crossover Vaccination Period|Death|5|||
148716986|NCT05212948|536435536|FG000|Crossover Vaccination Period|Adverse Event|9|||
148716987|NCT05212948|536435537|FG001|Crossover Vaccination Period|Adverse Event|4|||
148716988|NCT01192776|536435538|FG000|Overall Study|Death|8|||
148716989|NCT01192776|536435539|FG001|Overall Study|Death|15|||
148716990|NCT01192776|536435540|FG002|Overall Study|Death|18|||
148716991|NCT01192776|536435541|FG003|Overall Study|Death|15|||
148716992|NCT01192776|536435538|FG000|Overall Study|Lost to Follow-up|3|||
148716993|NCT01192776|536435539|FG001|Overall Study|Lost to Follow-up|6|||
148716994|NCT01192776|536435540|FG002|Overall Study|Lost to Follow-up|3|||
148716995|NCT01192776|536435541|FG003|Overall Study|Lost to Follow-up|5|||
148716996|NCT03422068|536435545|FG000|Overall Study|Adverse Event|0|||
148716997|NCT03422068|536435546|FG001|Overall Study|Adverse Event|1|||
148716998|NCT03422068|536435545|FG000|Overall Study|Inconvenience to frequent study visits|0|||
148716999|NCT03422068|536435546|FG001|Overall Study|Inconvenience to frequent study visits|1|||
148717000|NCT01583530|536435547|FG000|Overall Study|Adverse Event|0|||
148717001|NCT01583530|536435548|FG001|Overall Study|Adverse Event|0|||
148717002|NCT01583530|536435549|FG002|Overall Study|Adverse Event|0|||
148717003|NCT01583530|536435550|FG003|Overall Study|Adverse Event|0|||
148717004|NCT01583530|536435551|FG004|Overall Study|Adverse Event|0|||
148717005|NCT01583530|536435552|FG005|Overall Study|Adverse Event|1|||
148717006|NCT01583530|536435547|FG000|Overall Study|Withdrawal by Subject|0|||
148717007|NCT01583530|536435548|FG001|Overall Study|Withdrawal by Subject|3|||
148717008|NCT01583530|536435549|FG002|Overall Study|Withdrawal by Subject|0|||
148717009|NCT01583530|536435550|FG003|Overall Study|Withdrawal by Subject|1|||
148717010|NCT01583530|536435551|FG004|Overall Study|Withdrawal by Subject|1|||
148717011|NCT01583530|536435552|FG005|Overall Study|Withdrawal by Subject|2|||
148717012|NCT01583530|536435547|FG000|Overall Study|Lost to Follow-up|0|||
148717013|NCT01583530|536435548|FG001|Overall Study|Lost to Follow-up|0|||
148717014|NCT01583530|536435549|FG002|Overall Study|Lost to Follow-up|0|||
148717015|NCT01583530|536435550|FG003|Overall Study|Lost to Follow-up|0|||
148717016|NCT01583530|536435551|FG004|Overall Study|Lost to Follow-up|3|||
148717017|NCT01583530|536435552|FG005|Overall Study|Lost to Follow-up|0|||
148717018|NCT01583530|536435547|FG000|Overall Study|Lack of compliance|0|||
148717019|NCT01583530|536435548|FG001|Overall Study|Lack of compliance|0|||
148717020|NCT01583530|536435549|FG002|Overall Study|Lack of compliance|0|||
148717021|NCT01583530|536435550|FG003|Overall Study|Lack of compliance|0|||
148717022|NCT01583530|536435551|FG004|Overall Study|Lack of compliance|1|||
148717023|NCT01583530|536435552|FG005|Overall Study|Lack of compliance|0|||
148717024|NCT02416180|536435553|FG000|Overall Study|Withdrawal by Subject|1|||
148717025|NCT00640926|536435554|FG000|Overall Study|Adverse Event|2|||
148717026|NCT00640926|536435555|FG001|Overall Study|Adverse Event|3|||
148717027|NCT00640926|536435556|FG002|Overall Study|Adverse Event|2|||
148717028|NCT00640926|536435554|FG000|Overall Study|Lack of Efficacy|0|||
148717029|NCT00640926|536435555|FG001|Overall Study|Lack of Efficacy|2|||
148717030|NCT00640926|536435556|FG002|Overall Study|Lack of Efficacy|1|||
148717031|NCT00640926|536435554|FG000|Overall Study|Protocol Violation|2|||
148717032|NCT00640926|536435555|FG001|Overall Study|Protocol Violation|0|||
148717033|NCT00640926|536435556|FG002|Overall Study|Protocol Violation|2|||
148717034|NCT00640926|536435554|FG000|Overall Study|Lost to Follow-up|3|||
148717035|NCT00640926|536435555|FG001|Overall Study|Lost to Follow-up|1|||
148717036|NCT00640926|536435556|FG002|Overall Study|Lost to Follow-up|2|||
148717037|NCT00640926|536435554|FG000|Overall Study|Withdrawal by Subject|1|||
148717038|NCT00640926|536435555|FG001|Overall Study|Withdrawal by Subject|0|||
148717039|NCT00640926|536435556|FG002|Overall Study|Withdrawal by Subject|1|||
148717040|NCT01499160|536435562|FG000|Overall Study|Adverse Event|1|||
148717041|NCT01499160|536435562|FG000|Overall Study|Withdrawal by Subject|1|||
148717042|NCT01438476|536435563|FG000|Overall Study|Protocol Violation|1|||
148717043|NCT01438476|536435564|FG001|Overall Study|Protocol Violation|0|||
148717044|NCT01438476|536435563|FG000|Overall Study|Withdrawal by Subject|1|||
148717045|NCT01438476|536435564|FG001|Overall Study|Withdrawal by Subject|0|||
148717046|NCT01438476|536435563|FG000|Overall Study|No Surgery- Disease|8|||
148717047|NCT01438476|536435564|FG001|Overall Study|No Surgery- Disease|10|||
148717048|NCT01438476|536435563|FG000|Overall Study|Communication barrier|0|||
148717049|NCT01438476|536435564|FG001|Overall Study|Communication barrier|1|||
148717050|NCT03294317|536435566|FG000|Overall Study|Physician Decision|1|||
148717051|NCT03294317|536435566|FG000|Overall Study|Withdrawal by Subject|6|||
148717052|NCT03294317|536435566|FG000|Overall Study|Lost to Follow-up|1|||
148717053|NCT03294317|536435566|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
148717054|NCT03294317|536435566|FG000|Overall Study|Failed HB lead implant|8|||
148717055|NCT03294317|536435566|FG000|Overall Study|Received CRT instead|1|||
148717056|NCT03294317|536435566|FG000|Overall Study|Exited after lead revision|2|||
148717057|NCT03566238|536435567|FG000|Overall Study|Adverse Event|0|||
148717058|NCT03566238|536435568|FG001|Overall Study|Adverse Event|0|||
148717059|NCT03566238|536435569|FG002|Overall Study|Adverse Event|1|||
148717060|NCT03566238|536435567|FG000|Overall Study|Lack of Efficacy|5|||
148717061|NCT03566238|536435568|FG001|Overall Study|Lack of Efficacy|4|||
148717062|NCT03566238|536435569|FG002|Overall Study|Lack of Efficacy|2|||
148717063|NCT03566238|536435567|FG000|Overall Study|Other|0|||
148717064|NCT03566238|536435568|FG001|Overall Study|Other|1|||
148717065|NCT03566238|536435569|FG002|Overall Study|Other|0|||
148717066|NCT00860262|536435573|FG000|Overall Study|Adverse Event|9|||
148717067|NCT00860262|536435574|FG001|Overall Study|Adverse Event|6|||
148717068|NCT00860262|536435575|FG002|Overall Study|Adverse Event|7|||
148717069|NCT00860262|536435573|FG000|Overall Study|Protocol Violation|0|||
148717070|NCT00860262|536435574|FG001|Overall Study|Protocol Violation|1|||
148717071|NCT00860262|536435575|FG002|Overall Study|Protocol Violation|0|||
148717072|NCT00860262|536435573|FG000|Overall Study|Lost to Follow-up|2|||
148717073|NCT00860262|536435574|FG001|Overall Study|Lost to Follow-up|0|||
148717074|NCT00860262|536435575|FG002|Overall Study|Lost to Follow-up|1|||
148717075|NCT00860262|536435573|FG000|Overall Study|Withdrawal by Subject|4|||
148717076|NCT00860262|536435574|FG001|Overall Study|Withdrawal by Subject|8|||
148717077|NCT00860262|536435575|FG002|Overall Study|Withdrawal by Subject|6|||
148717078|NCT00860262|536435573|FG000|Overall Study|Lack of Efficacy|0|||
148717079|NCT00860262|536435574|FG001|Overall Study|Lack of Efficacy|4|||
148717080|NCT00860262|536435575|FG002|Overall Study|Lack of Efficacy|3|||
148717081|NCT00860262|536435573|FG000|Overall Study|Other|5|||
148717082|NCT00860262|536435574|FG001|Overall Study|Other|3|||
148717083|NCT00860262|536435575|FG002|Overall Study|Other|1|||
148717084|NCT00124618|536435576|FG000|Overall Study|Ineligible|1|||
148717085|NCT04640194|536435594|FG000|Overall Study|Adverse Event|3|||
148717086|NCT04640194|536435595|FG001|Overall Study|Adverse Event|7|||
148717087|NCT04640194|536435596|FG002|Overall Study|Adverse Event|0|||
148717088|NCT04640194|536435597|FG003|Overall Study|Adverse Event|5|||
148717089|NCT04640194|536435598|FG004|Overall Study|Adverse Event|0|||
148717090|NCT04640194|536435599|FG005|Overall Study|Adverse Event|4|||
148717091|NCT04640194|536435600|FG006|Overall Study|Adverse Event|0|||
148717092|NCT04640194|536435594|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
148717093|NCT04640194|536435595|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
148717094|NCT04640194|536435596|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
148717095|NCT04640194|536435597|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
148717096|NCT04640194|536435598|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
148717097|NCT04640194|536435599|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
148717098|NCT04640194|536435600|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
148717099|NCT04640194|536435594|FG000|Overall Study|fibrinogen level too low|0|||
148717100|NCT04640194|536435595|FG001|Overall Study|fibrinogen level too low|0|||
148717101|NCT04640194|536435596|FG002|Overall Study|fibrinogen level too low|0|||
148815770|NCT02850406|536800636|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148815771|NCT02850406|536800637|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148717102|NCT04640194|536435597|FG003|Overall Study|fibrinogen level too low|1|||
148717103|NCT04640194|536435598|FG004|Overall Study|fibrinogen level too low|0|||
148717104|NCT04640194|536435599|FG005|Overall Study|fibrinogen level too low|0|||
148717105|NCT04640194|536435600|FG006|Overall Study|fibrinogen level too low|0|||
148717106|NCT04640194|536435594|FG000|Overall Study|mild bleeding|0|||
148717107|NCT04640194|536435595|FG001|Overall Study|mild bleeding|0|||
148717108|NCT04640194|536435596|FG002|Overall Study|mild bleeding|0|||
148717109|NCT04640194|536435597|FG003|Overall Study|mild bleeding|1|||
148717110|NCT04640194|536435598|FG004|Overall Study|mild bleeding|0|||
148717111|NCT04640194|536435599|FG005|Overall Study|mild bleeding|0|||
148815772|NCT02850406|536800638|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148815773|NCT02850406|536800639|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
148717112|NCT04640194|536435600|FG006|Overall Study|mild bleeding|0|||
148717113|NCT04640194|536435594|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
148717114|NCT04640194|536435595|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
148717115|NCT04640194|536435596|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
148717116|NCT04640194|536435597|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
148717117|NCT04640194|536435598|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
148717118|NCT04640194|536435599|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
148717119|NCT04640194|536435600|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
148717120|NCT04490057|536435601|FG000|Stage 1|Death|1|||
148717121|NCT04490057|536435602|FG001|Stage 1|Death|2|||
148717122|NCT04490057|536435603|FG002|Stage 1|Death|0|||
148717123|NCT04490057|536435604|FG003|Stage 1|Death|0|||
148717124|NCT04490057|536435605|FG004|Stage 1|Death|0|||
148717125|NCT04490057|536435606|FG005|Stage 1|Death|0|||
148717126|NCT04490057|536435607|FG006|Stage 1|Death|0|||
148717127|NCT04490057|536435608|FG007|Stage 1|Death|0|||
148717128|NCT04490057|536435601|FG000|Stage 1|Withdrawal by Subject|2|||
148717129|NCT04490057|536435602|FG001|Stage 1|Withdrawal by Subject|0|||
148717130|NCT04490057|536435603|FG002|Stage 1|Withdrawal by Subject|0|||
148717131|NCT04490057|536435604|FG003|Stage 1|Withdrawal by Subject|0|||
148717132|NCT04490057|536435605|FG004|Stage 1|Withdrawal by Subject|0|||
148717133|NCT04490057|536435606|FG005|Stage 1|Withdrawal by Subject|0|||
148717134|NCT04490057|536435607|FG006|Stage 1|Withdrawal by Subject|0|||
148717135|NCT04490057|536435608|FG007|Stage 1|Withdrawal by Subject|0|||
148717136|NCT04490057|536435601|FG000|Stage 2|Death|0|||
148717137|NCT04490057|536435602|FG001|Stage 2|Death|0|||
148717138|NCT04490057|536435603|FG002|Stage 2|Death|0|||
148717139|NCT04490057|536435604|FG003|Stage 2|Death|0|||
148717140|NCT04490057|536435605|FG004|Stage 2|Death|1|||
148717141|NCT04490057|536435606|FG005|Stage 2|Death|0|||
148717142|NCT04490057|536435607|FG006|Stage 2|Death|0|||
148717143|NCT04490057|536435608|FG007|Stage 2|Death|0|||
148717144|NCT04490057|536435601|FG000|Stage 2|Lost to Follow-up|0|||
148717145|NCT04490057|536435602|FG001|Stage 2|Lost to Follow-up|0|||
148717146|NCT04490057|536435603|FG002|Stage 2|Lost to Follow-up|0|||
148717147|NCT04490057|536435604|FG003|Stage 2|Lost to Follow-up|11|||
148717148|NCT04490057|536435605|FG004|Stage 2|Lost to Follow-up|17|||
148717149|NCT04490057|536435606|FG005|Stage 2|Lost to Follow-up|4|||
148717150|NCT04490057|536435607|FG006|Stage 2|Lost to Follow-up|21|||
148717151|NCT04490057|536435608|FG007|Stage 2|Lost to Follow-up|14|||
148717152|NCT04584983|536435611|FG000|Overall Study|Parental request for withdraw|2|||
148717153|NCT04584983|536435612|FG001|Overall Study|Parental request for withdraw|0|||
148717154|NCT05377489|536435613|FG000|Overall Study|Withdrawal by Subject|122|||
148717155|NCT05377489|536435613|FG000|Overall Study|Lost to Follow-up|21|||
148717156|NCT05377489|536435613|FG000|Overall Study|Lack of Efficacy|10|||
148717157|NCT05377489|536435613|FG000|Overall Study|Adverse Event|5|||
148717158|NCT05377489|536435613|FG000|Overall Study|Death|4|||
148717159|NCT05377489|536435613|FG000|Overall Study|Physician Decision|3|||
148717160|NCT05377489|536435613|FG000|Overall Study|Protocol Violation|1|||
148717161|NCT05377489|536435613|FG000|Overall Study|Other|9|||
148717162|NCT02459418|536437156|FG000|Overall Study|Exclusion Criteria|4|||
148717163|NCT02459418|536437157|FG001|Overall Study|Exclusion Criteria|0|||
148717164|NCT02459418|536437156|FG000|Overall Study|Protocol Violation|0|||
148717165|NCT02459418|536437157|FG001|Overall Study|Protocol Violation|2|||
148717166|NCT02459418|536437156|FG000|Overall Study|Physician Decision|0|||
148717167|NCT02459418|536437157|FG001|Overall Study|Physician Decision|2|||
148717168|NCT02459418|536437156|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
148717169|NCT02459418|536437157|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
148717170|NCT02459418|536437156|FG000|Overall Study|Adverse Event|0|||
148717171|NCT02459418|536437157|FG001|Overall Study|Adverse Event|1|||
148717172|NCT02459418|536437156|FG000|Overall Study|Withdrawal by Subject|1|||
148717173|NCT02459418|536437157|FG001|Overall Study|Withdrawal by Subject|1|||
148717174|NCT02459418|536437156|FG000|Overall Study|Elevated Creatine Kinase|1|||
148717175|NCT02459418|536437157|FG001|Overall Study|Elevated Creatine Kinase|0|||
148717176|NCT02459418|536437156|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
148717177|NCT02459418|536437157|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
148717178|NCT00653159|536437158|FG000|Overall Study|Adverse Event|4|||
148717179|NCT00653159|536437159|FG001|Overall Study|Adverse Event|1|||
148717180|NCT00653159|536437158|FG000|Overall Study|Lost to Follow-up|1|||
148717181|NCT00653159|536437159|FG001|Overall Study|Lost to Follow-up|2|||
148815774|NCT02850406|536800632|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
148815775|NCT02850406|536800633|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
148815776|NCT02850406|536800634|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
148717182|NCT01872715|536437160|FG000|Overall Study|Adverse Event|1|||
148717183|NCT01872715|536437160|FG000|Overall Study|Protocol Violation|1|||
148717184|NCT01872715|536437160|FG000|Overall Study|Withdrawal by Subject|2|||
148717185|NCT02419573|536437161|FG000|Overall Study|Lost to Follow-up|3|||
148717186|NCT02419573|536437162|FG001|Overall Study|Lost to Follow-up|0|||
148717187|NCT02419573|536437161|FG000|Overall Study|Withdrawal by Subject|1|||
148717188|NCT02419573|536437162|FG001|Overall Study|Withdrawal by Subject|0|||
148717189|NCT00329160|536437163|FG000|Overall Study|Adverse Event|27|||
148717190|NCT00329160|536437163|FG000|Overall Study|Withdrawal by Subject|13|||
148717191|NCT00329160|536437163|FG000|Overall Study|Protocol Violation|2|||
148717192|NCT00329160|536437163|FG000|Overall Study|Did not Receive Study Drug|1|||
148717193|NCT00329160|536437163|FG000|Overall Study|Incomplete IVUS|45|||
148717194|NCT04167618|536437167|FG000|Overall Study|Trial terminated by sponsor|1|||
148717195|NCT04167618|536437168|FG001|Overall Study|Trial terminated by sponsor|1|||
148717196|NCT00852917|536437173|FG000|Overall Study|Adverse Event|13|||
148968969|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Physician Decision|0|||
148968970|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Physician Decision|1|||
148968971|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Physician Decision|0|||
148717197|NCT00852917|536437174|FG001|Overall Study|Adverse Event|20|||
148717198|NCT00852917|536437175|FG002|Overall Study|Adverse Event|35|||
148717199|NCT00852917|536437176|FG003|Overall Study|Adverse Event|17|||
148717200|NCT00852917|536437173|FG000|Overall Study|Lack of Efficacy|21|||
148717201|NCT00852917|536437174|FG001|Overall Study|Lack of Efficacy|11|||
148717202|NCT00852917|536437175|FG002|Overall Study|Lack of Efficacy|11|||
148717203|NCT00852917|536437176|FG003|Overall Study|Lack of Efficacy|47|||
148717204|NCT00852917|536437173|FG000|Overall Study|Withdrawal by Subject|4|||
148717205|NCT00852917|536437174|FG001|Overall Study|Withdrawal by Subject|8|||
148717206|NCT00852917|536437175|FG002|Overall Study|Withdrawal by Subject|10|||
148717207|NCT00852917|536437176|FG003|Overall Study|Withdrawal by Subject|9|||
148717208|NCT00852917|536437173|FG000|Overall Study|Physician Decision|6|||
148717209|NCT00852917|536437174|FG001|Overall Study|Physician Decision|7|||
148717210|NCT00852917|536437175|FG002|Overall Study|Physician Decision|2|||
148717211|NCT00852917|536437176|FG003|Overall Study|Physician Decision|19|||
148717212|NCT00852917|536437173|FG000|Overall Study|Death|0|||
148717213|NCT00852917|536437174|FG001|Overall Study|Death|0|||
148717214|NCT00852917|536437175|FG002|Overall Study|Death|0|||
148717215|NCT00852917|536437176|FG003|Overall Study|Death|1|||
148717216|NCT01358877|536437177|FG000|Overall Study|Withdrawal by Subject|475|||
148717217|NCT01358877|536437178|FG001|Overall Study|Withdrawal by Subject|466|||
148717218|NCT01358877|536437177|FG000|Overall Study|Recurrence of disease|181|||
148717219|NCT01358877|536437178|FG001|Overall Study|Recurrence of disease|269|||
148717220|NCT01358877|536437177|FG000|Overall Study|Lost to Follow-up|181|||
148717221|NCT01358877|536437178|FG001|Overall Study|Lost to Follow-up|176|||
148717222|NCT01358877|536437177|FG000|Overall Study|Death|41|||
148717223|NCT01358877|536437178|FG001|Overall Study|Death|46|||
148717224|NCT01358877|536437177|FG000|Overall Study|Adverse Event|39|||
148717225|NCT01358877|536437178|FG001|Overall Study|Adverse Event|42|||
148717226|NCT01358877|536437177|FG000|Overall Study|Physician Decision|43|||
148717227|NCT01358877|536437178|FG001|Overall Study|Physician Decision|32|||
148717228|NCT01358877|536437177|FG000|Overall Study|Contralateral breast cancer|42|||
148717229|NCT01358877|536437178|FG001|Overall Study|Contralateral breast cancer|28|||
148717230|NCT01358877|536437177|FG000|Overall Study|Reason not specified|37|||
148717231|NCT01358877|536437178|FG001|Overall Study|Reason not specified|29|||
148717232|NCT05552261|536437182|FG000|Overall Study|Withdrawal by Subject|1|||
148717233|NCT05552261|536437182|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
148717234|NCT02003222|536437183|FG000|Induction|Never started treatment|0|||
148717235|NCT02003222|536437184|FG001|Induction|Never started treatment|0|||
148717236|NCT02003222|536437185|FG002|Induction|Never started treatment|0|||
148717237|NCT02003222|536437186|FG003|Induction|Never started treatment|0|||
148717238|NCT02003222|536437187|FG004|Induction|Never started treatment|8|||
148717239|NCT02003222|536437183|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
148717240|NCT02003222|536437184|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
148717241|NCT02003222|536437185|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
148717242|NCT02003222|536437186|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
148717243|NCT02003222|536437187|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
148717244|NCT02003222|536437183|FG000|Induction|Adverse Event|0|||
148717245|NCT02003222|536437184|FG001|Induction|Adverse Event|0|||
148717246|NCT02003222|536437185|FG002|Induction|Adverse Event|0|||
148717247|NCT02003222|536437186|FG003|Induction|Adverse Event|0|||
148717248|NCT02003222|536437187|FG004|Induction|Adverse Event|13|||
148717249|NCT02003222|536437183|FG000|Induction|Alternative therapy|0|||
148717250|NCT02003222|536437184|FG001|Induction|Alternative therapy|0|||
148717251|NCT02003222|536437185|FG002|Induction|Alternative therapy|0|||
148717252|NCT02003222|536437186|FG003|Induction|Alternative therapy|0|||
148968972|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Physician Decision|0|||
148968973|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
148968974|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
148717253|NCT02003222|536437187|FG004|Induction|Alternative therapy|12|||
148717254|NCT02003222|536437183|FG000|Induction|Disease progression|0|||
148717255|NCT02003222|536437184|FG001|Induction|Disease progression|0|||
148717256|NCT02003222|536437185|FG002|Induction|Disease progression|0|||
148717257|NCT02003222|536437186|FG003|Induction|Disease progression|0|||
148717258|NCT02003222|536437187|FG004|Induction|Disease progression|22|||
148717259|NCT02003222|536437183|FG000|Induction|Death|0|||
148717260|NCT02003222|536437184|FG001|Induction|Death|0|||
148717261|NCT02003222|536437185|FG002|Induction|Death|0|||
148717262|NCT02003222|536437186|FG003|Induction|Death|0|||
148815777|NCT02850406|536800635|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
148968975|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
148717263|NCT02003222|536437187|FG004|Induction|Death|3|||
148717264|NCT02003222|536437183|FG000|Induction|Withdrawal by Subject|0|||
148717265|NCT02003222|536437184|FG001|Induction|Withdrawal by Subject|0|||
148717266|NCT02003222|536437185|FG002|Induction|Withdrawal by Subject|0|||
148815778|NCT02850406|536800636|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
148815779|NCT02850406|536800637|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
148815780|NCT02850406|536800638|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
148815781|NCT02850406|536800639|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
148815782|NCT02850406|536800632|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
148815783|NCT02850406|536800633|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
148815784|NCT02850406|536800634|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
148815785|NCT02850406|536800635|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
148815786|NCT02850406|536800636|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
148815787|NCT02850406|536800637|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
148815788|NCT02850406|536800638|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
148815789|NCT02850406|536800639|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
148968976|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
148968977|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
148968978|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
148968979|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
148968980|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
148968981|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
148968982|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
148717267|NCT02003222|536437186|FG003|Induction|Withdrawal by Subject|0|||
148717268|NCT02003222|536437187|FG004|Induction|Withdrawal by Subject|8|||
148717269|NCT02003222|536437183|FG000|Induction|Other reasons|0|||
148717270|NCT02003222|536437184|FG001|Induction|Other reasons|0|||
148717271|NCT02003222|536437185|FG002|Induction|Other reasons|0|||
148717272|NCT02003222|536437186|FG003|Induction|Other reasons|0|||
148717273|NCT02003222|536437187|FG004|Induction|Other reasons|22|||
148717274|NCT02003222|536437183|FG000|Intensification|Never started treatment|0|||
148717275|NCT02003222|536437184|FG001|Intensification|Never started treatment|0|||
148717276|NCT02003222|536437185|FG002|Intensification|Never started treatment|0|||
148717277|NCT02003222|536437186|FG003|Intensification|Never started treatment|0|||
148717278|NCT02003222|536437187|FG004|Intensification|Never started treatment|2|||
148717279|NCT02003222|536437183|FG000|Intensification|Adverse Event|0|||
148717280|NCT02003222|536437184|FG001|Intensification|Adverse Event|0|||
148717281|NCT02003222|536437185|FG002|Intensification|Adverse Event|0|||
148717282|NCT02003222|536437186|FG003|Intensification|Adverse Event|0|||
148717283|NCT02003222|536437187|FG004|Intensification|Adverse Event|6|||
148717284|NCT02003222|536437183|FG000|Intensification|Alternative therapy|0|||
148717285|NCT02003222|536437184|FG001|Intensification|Alternative therapy|0|||
148717286|NCT02003222|536437185|FG002|Intensification|Alternative therapy|0|||
148717287|NCT02003222|536437186|FG003|Intensification|Alternative therapy|0|||
148717288|NCT02003222|536437187|FG004|Intensification|Alternative therapy|8|||
148717289|NCT02003222|536437183|FG000|Intensification|Disease progression|0|||
148717290|NCT02003222|536437184|FG001|Intensification|Disease progression|0|||
148717291|NCT02003222|536437185|FG002|Intensification|Disease progression|0|||
148717292|NCT02003222|536437186|FG003|Intensification|Disease progression|0|||
148717293|NCT02003222|536437187|FG004|Intensification|Disease progression|18|||
148717294|NCT02003222|536437183|FG000|Intensification|Withdrawal by Subject|0|||
148717295|NCT02003222|536437184|FG001|Intensification|Withdrawal by Subject|0|||
148717296|NCT02003222|536437185|FG002|Intensification|Withdrawal by Subject|0|||
148717297|NCT02003222|536437186|FG003|Intensification|Withdrawal by Subject|0|||
148717298|NCT02003222|536437187|FG004|Intensification|Withdrawal by Subject|5|||
148717299|NCT02003222|536437183|FG000|Intensification|Other reasons|0|||
148717300|NCT02003222|536437184|FG001|Intensification|Other reasons|0|||
148717301|NCT02003222|536437185|FG002|Intensification|Other reasons|0|||
148717302|NCT02003222|536437186|FG003|Intensification|Other reasons|0|||
148717303|NCT02003222|536437187|FG004|Intensification|Other reasons|8|||
148717304|NCT04941768|536437192|FG000|Overall Study|Lost to Follow-up|10|||
148717305|NCT04941768|536437192|FG000|Overall Study|Death|24|||
148717306|NCT04941768|536437192|FG000|Overall Study|Progressive Disease|4|||
148717307|NCT04941768|536437192|FG000|Overall Study|Withdrawal by Subject|4|||
148717308|NCT04941768|536437192|FG000|Overall Study|Other|3|||
148717309|NCT04941768|536437192|FG000|Overall Study|Treatment ongoing|21|||
148717310|NCT04941768|536437192|FG000|Overall Study|Off treatment and in follow-up|21|||
148717311|NCT03302078|536437194|FG000|Washout Period|Adverse Event|0|||
148815790|NCT02850406|536800632|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
148717312|NCT03302078|536437195|FG001|Washout Period|Adverse Event|1|||
148717313|NCT01886872|536437196|FG000|Overall Study|Ineligible|7|||
148717314|NCT01886872|536437197|FG001|Overall Study|Ineligible|4|||
148968983|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
148717315|NCT01886872|536437198|FG002|Overall Study|Ineligible|12|||
148717316|NCT05148299|536437199|FG000|Treatment Period|Adverse Event|1|||
148717317|NCT05148299|536437199|FG000|Treatment Period|Physician Decision|1|||
148717318|NCT05148299|536437199|FG000|Treatment Period|Death|1|||
148717319|NCT05148299|536437199|FG000|Follow-up Period|Death|3|||
148717320|NCT02161549|536437203|FG000|Overall Study|Physician Decision|6|||
148717321|NCT02161549|536437204|FG001|Overall Study|Physician Decision|2|||
148815791|NCT02850406|536800633|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
148717322|NCT00979212|536437205|FG000|Overall Study|Protocol Violation|1|||
148717323|NCT00979212|536437206|FG001|Overall Study|Protocol Violation|8|||
148717324|NCT00979212|536437205|FG000|Overall Study|No protocol therapy received|1|||
148717325|NCT00979212|536437206|FG001|Overall Study|No protocol therapy received|0|||
148717326|NCT00965757|536437217|FG000|Double-blind Phase|Progression of concomitant disease|1|||
148717327|NCT00965757|536437218|FG001|Double-blind Phase|Progression of concomitant disease|2|||
148717328|NCT00965757|536437219|FG002|Double-blind Phase|Progression of concomitant disease|0|||
148717329|NCT00965757|536437220|FG003|Double-blind Phase|Progression of concomitant disease|0|||
148717330|NCT00965757|536437217|FG000|Double-blind Phase|Adverse drug reaction|2|||
148717331|NCT00965757|536437218|FG001|Double-blind Phase|Adverse drug reaction|1|||
148717332|NCT00965757|536437219|FG002|Double-blind Phase|Adverse drug reaction|0|||
148717333|NCT00965757|536437220|FG003|Double-blind Phase|Adverse drug reaction|0|||
148717334|NCT00965757|536437217|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
148717335|NCT00965757|536437218|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
148968984|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
148968985|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
148968986|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
148968987|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
148968988|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
148968989|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
148717336|NCT00965757|536437219|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
148717337|NCT00965757|536437220|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
148717338|NCT00965757|536437217|FG000|Double-blind Phase|Lack of Efficacy|7|||
148717339|NCT00965757|536437218|FG001|Double-blind Phase|Lack of Efficacy|11|||
148717340|NCT00965757|536437219|FG002|Double-blind Phase|Lack of Efficacy|0|||
148717341|NCT00965757|536437220|FG003|Double-blind Phase|Lack of Efficacy|0|||
148717342|NCT00965757|536437217|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
148717343|NCT00965757|536437218|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
148717344|NCT00965757|536437219|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
148717345|NCT00965757|536437220|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
148717346|NCT00965757|536437217|FG000|Double-blind Phase|Lost to Follow-up|0|||
148717347|NCT00965757|536437218|FG001|Double-blind Phase|Lost to Follow-up|1|||
148717348|NCT00965757|536437219|FG002|Double-blind Phase|Lost to Follow-up|0|||
148717349|NCT00965757|536437220|FG003|Double-blind Phase|Lost to Follow-up|0|||
148717350|NCT00965757|536437217|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
148717351|NCT00965757|536437218|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
148717352|NCT00965757|536437219|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
148717353|NCT00965757|536437220|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
148717354|NCT00965757|536437217|FG000|Double-blind Phase|Other|1|||
148717355|NCT00965757|536437218|FG001|Double-blind Phase|Other|0|||
148717356|NCT00965757|536437219|FG002|Double-blind Phase|Other|0|||
148717357|NCT00965757|536437220|FG003|Double-blind Phase|Other|0|||
148717358|NCT00965757|536437217|FG000|Extension Phase|Progression of concomitant disease|0|||
148717359|NCT00965757|536437218|FG001|Extension Phase|Progression of concomitant disease|0|||
148717360|NCT00965757|536437219|FG002|Extension Phase|Progression of concomitant disease|4|||
148717361|NCT00965757|536437220|FG003|Extension Phase|Progression of concomitant disease|2|||
148717362|NCT00965757|536437217|FG000|Extension Phase|Adverse drug reaction|0|||
148717363|NCT00965757|536437218|FG001|Extension Phase|Adverse drug reaction|0|||
148717364|NCT00965757|536437219|FG002|Extension Phase|Adverse drug reaction|6|||
148717365|NCT00965757|536437220|FG003|Extension Phase|Adverse drug reaction|3|||
148717366|NCT00965757|536437217|FG000|Extension Phase|Abnormal Laboratory Value|0|||
148717367|NCT00965757|536437218|FG001|Extension Phase|Abnormal Laboratory Value|0|||
148717368|NCT00965757|536437219|FG002|Extension Phase|Abnormal Laboratory Value|6|||
148717369|NCT00965757|536437220|FG003|Extension Phase|Abnormal Laboratory Value|1|||
148717370|NCT00965757|536437217|FG000|Extension Phase|Lack of Efficacy|0|||
148717371|NCT00965757|536437218|FG001|Extension Phase|Lack of Efficacy|0|||
148717372|NCT00965757|536437219|FG002|Extension Phase|Lack of Efficacy|8|||
148717373|NCT00965757|536437220|FG003|Extension Phase|Lack of Efficacy|12|||
148717374|NCT00965757|536437217|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
148717375|NCT00965757|536437218|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
148717376|NCT00965757|536437219|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
148717377|NCT00965757|536437220|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
148717378|NCT00965757|536437217|FG000|Extension Phase|Lost to Follow-up|0|||
148717379|NCT00965757|536437218|FG001|Extension Phase|Lost to Follow-up|0|||
148717380|NCT00965757|536437219|FG002|Extension Phase|Lost to Follow-up|0|||
148717381|NCT00965757|536437220|FG003|Extension Phase|Lost to Follow-up|1|||
148717382|NCT00965757|536437217|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
148717383|NCT00965757|536437218|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
148717384|NCT00965757|536437219|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
148717385|NCT00965757|536437220|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
148717386|NCT00965757|536437217|FG000|Extension Phase|Protocol Violation|0|||
148717387|NCT00965757|536437218|FG001|Extension Phase|Protocol Violation|0|||
148717388|NCT00965757|536437219|FG002|Extension Phase|Protocol Violation|0|||
148717389|NCT00965757|536437220|FG003|Extension Phase|Protocol Violation|1|||
148717390|NCT00965757|536437217|FG000|Extension Phase|Other|0|||
148717391|NCT00965757|536437218|FG001|Extension Phase|Other|0|||
148717392|NCT00965757|536437219|FG002|Extension Phase|Other|2|||
148717393|NCT00965757|536437220|FG003|Extension Phase|Other|1|||
148717394|NCT03807440|536437221|FG000|Overall Study|No documentation of index date 2|320|||
148717395|NCT03807440|536437221|FG000|Overall Study|No informed consent for index date 2|117|||
148717396|NCT02451358|536437222|FG000|Overall Study|Withdrawal by Subject|1|||
148717397|NCT02451358|536437223|FG001|Overall Study|Withdrawal by Subject|1|||
148717398|NCT02451358|536437224|FG002|Overall Study|Withdrawal by Subject|0|||
148717399|NCT02451358|536437225|FG003|Overall Study|Withdrawal by Subject|0|||
148717400|NCT02451358|536437222|FG000|Overall Study|Protocol Violation|0|||
148717401|NCT02451358|536437223|FG001|Overall Study|Protocol Violation|1|||
148717402|NCT02451358|536437224|FG002|Overall Study|Protocol Violation|1|||
148717403|NCT02451358|536437225|FG003|Overall Study|Protocol Violation|0|||
148717404|NCT06128525|536437226|FG000|Overall Study|Patient withdrew consent|1|||
148717405|NCT01398787|536437229|FG000|Overall Study|Adverse Event|1|||
148717406|NCT03414034|536437230|FG000|Overall Study|Adverse Event|6|||
148717407|NCT03414034|536437231|FG001|Overall Study|Adverse Event|1|||
148717408|NCT03414034|536437232|FG002|Overall Study|Adverse Event|1|||
148717409|NCT03414034|536437230|FG000|Overall Study|Death|0|||
148717410|NCT03414034|536437231|FG001|Overall Study|Death|0|||
148717411|NCT03414034|536437232|FG002|Overall Study|Death|1|||
148717412|NCT03414034|536437230|FG000|Overall Study|Non-compliance With Study Drug|0|||
148717413|NCT03414034|536437231|FG001|Overall Study|Non-compliance With Study Drug|0|||
148717414|NCT03414034|536437232|FG002|Overall Study|Non-compliance With Study Drug|1|||
148717415|NCT03414034|536437230|FG000|Overall Study|Physician Decision|1|||
148717416|NCT03414034|536437231|FG001|Overall Study|Physician Decision|3|||
148717417|NCT03414034|536437232|FG002|Overall Study|Physician Decision|2|||
148717418|NCT03414034|536437230|FG000|Overall Study|Withdrawal of Informed Consent|2|||
148717419|NCT03414034|536437231|FG001|Overall Study|Withdrawal of Informed Consent|1|||
148717420|NCT03414034|536437232|FG002|Overall Study|Withdrawal of Informed Consent|4|||
148717421|NCT03414034|536437230|FG000|Overall Study|Progressive Disease|15|||
148717422|NCT03414034|536437231|FG001|Overall Study|Progressive Disease|15|||
148717423|NCT03414034|536437232|FG002|Overall Study|Progressive Disease|17|||
148717424|NCT03414034|536437230|FG000|Overall Study|Miscellaneous|0|||
148717425|NCT03414034|536437231|FG001|Overall Study|Miscellaneous|0|||
148717426|NCT03414034|536437232|FG002|Overall Study|Miscellaneous|2|||
148717427|NCT04010227|536437233|FG000|Overall Study|Death|1|||
148717428|NCT04010227|536437234|FG001|Overall Study|Death|2|||
148717429|NCT04010227|536437233|FG000|Overall Study|Medical Reasons|4|||
148717430|NCT04010227|536437234|FG001|Overall Study|Medical Reasons|3|||
148717431|NCT04010227|536437233|FG000|Overall Study|Withdrawal by Subject|2|||
148717432|NCT04010227|536437234|FG001|Overall Study|Withdrawal by Subject|0|||
148717433|NCT04010227|536437233|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
148717434|NCT04010227|536437234|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
148717435|NCT02351167|536437235|FG000|Overall Study|Withdrawal by Subject|19|||
148717436|NCT02351167|536437236|FG001|Overall Study|Withdrawal by Subject|18|||
148717437|NCT02351167|536437237|FG002|Overall Study|Withdrawal by Subject|21|||
148717438|NCT00702507|536437238|FG000|Initial Treatment Phase|Adverse Event|2|||
148717439|NCT00702507|536437238|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
148717440|NCT00702507|536437238|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
148717441|NCT00702507|536437238|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
148717442|NCT00702507|536437238|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
148717443|NCT00702507|536437238|FG000|Follow-up Phase|Protocol Violation|2|||
148717444|NCT00702507|536437238|FG000|Follow-up Phase|Lost to Follow-up|23|||
148717445|NCT00702507|536437238|FG000|Follow-up Phase|Late Enrollment|1|||
148717446|NCT02308696|536437239|FG000|Overall Study|Lost to Follow-up|28|||
148717447|NCT02308696|536437240|FG001|Overall Study|Lost to Follow-up|21|||
148717448|NCT02308696|536437239|FG000|Overall Study|Death|8|||
148717449|NCT02308696|536437240|FG001|Overall Study|Death|4|||
148717450|NCT02308696|536437239|FG000|Overall Study|Moved to a Higher Level of Care|17|||
148717451|NCT02308696|536437240|FG001|Overall Study|Moved to a Higher Level of Care|6|||
148717452|NCT02260635|536437244|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
148717453|NCT02260635|536437245|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
148968990|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
148717454|NCT02260635|536437244|FG000|Open-Label Extension|Study Termination|25|||
148717455|NCT02260635|536437245|FG001|Open-Label Extension|Study Termination|25|||
148717456|NCT02260635|536437244|FG000|Open-Label Extension|Withdrawal by Subject|1|||
148717457|NCT02260635|536437245|FG001|Open-Label Extension|Withdrawal by Subject|0|||
148717458|NCT02911935|536437250|FG000|Overall Study|Lost to Follow-up|5|||
148717459|NCT02911935|536437251|FG001|Overall Study|Lost to Follow-up|7|||
148717460|NCT02466386|536437252|FG000|Overall Study|Adverse Event|5|||
148717461|NCT02466386|536437252|FG000|Overall Study|Protocol Violation|2|||
148717462|NCT02466386|536437252|FG000|Overall Study|Withdrawal by Subject|14|||
148717463|NCT02466386|536437252|FG000|Overall Study|Lost to Follow-up|5|||
148717464|NCT02466386|536437252|FG000|Overall Study|Lack of Efficacy|8|||
148717465|NCT02466386|536437252|FG000|Overall Study|Other|10|||
148717466|NCT05317195|536437253|FG000|Randomization|Withdrawal by Subject|1|||
148717467|NCT05317195|536437253|FG000|Randomization|Discontinued|6|||
148717468|NCT05317195|536437253|FG000|Admission|Withdrawal by Subject|2|||
148717469|NCT05467540|536437254|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
148717470|NCT05467540|536437254|FG000|3-Month Follow-up|Lost to Follow-up|4|||
148717471|NCT05467540|536437254|FG000|3-Month Follow-up|Death|5|||
148717472|NCT05467540|536437254|FG000|12-Month Follow-up|Lost to Follow-up|6|||
148717473|NCT05467540|536437254|FG000|12-Month Follow-up|Death|8|||
148717474|NCT05467540|536437254|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
148717475|NCT03370510|536437257|FG000|Overall Study|COVID-19|2|||
148717476|NCT03370510|536437258|FG001|Overall Study|COVID-19|0|||
148717477|NCT03382041|536437259|FG000|Overall Study|Consent Form Lost|2|||
148717478|NCT03382041|536437260|FG001|Overall Study|Consent Form Lost|1|||
148717479|NCT03382041|536437259|FG000|Overall Study|Withdrawal by Subject|1|||
148717480|NCT03382041|536437260|FG001|Overall Study|Withdrawal by Subject|4|||
148717481|NCT03382041|536437259|FG000|Overall Study|Lost to Follow-up|1|||
148717482|NCT03382041|536437260|FG001|Overall Study|Lost to Follow-up|4|||
148717483|NCT00688844|536437261|FG000|Overall Study|Lost to Follow-up|10|||
148717484|NCT01374451|536437262|FG000|Overall Study|Administrative problems|1|||
148717485|NCT01374451|536437263|FG001|Overall Study|Administrative problems|0|||
148717486|NCT03493919|536437264|FG000|Overall Study|Other|2|||
148717487|NCT03493919|536437265|FG001|Overall Study|Other|0|||
148717488|NCT03493919|536437266|FG002|Overall Study|Other|1|||
148717489|NCT03493919|536437267|FG003|Overall Study|Other|0|||
148717490|NCT03493919|536437264|FG000|Overall Study|Withdrawal by Subject|9|||
148717491|NCT03493919|536437265|FG001|Overall Study|Withdrawal by Subject|3|||
148717492|NCT03493919|536437266|FG002|Overall Study|Withdrawal by Subject|1|||
148717493|NCT03493919|536437267|FG003|Overall Study|Withdrawal by Subject|1|||
148717494|NCT03493919|536437264|FG000|Overall Study|Lost to Follow-up|5|||
148717495|NCT03493919|536437265|FG001|Overall Study|Lost to Follow-up|0|||
148717496|NCT03493919|536437266|FG002|Overall Study|Lost to Follow-up|0|||
148717497|NCT03493919|536437267|FG003|Overall Study|Lost to Follow-up|3|||
148717498|NCT03493919|536437264|FG000|Overall Study|Adverse Event|0|||
148717499|NCT03493919|536437265|FG001|Overall Study|Adverse Event|1|||
148717500|NCT03493919|536437266|FG002|Overall Study|Adverse Event|0|||
148717501|NCT03493919|536437267|FG003|Overall Study|Adverse Event|0|||
148717502|NCT00724958|536437269|FG000|Overall Study|Adverse Event|28|||
148717503|NCT00724958|536437269|FG000|Overall Study|Loss of Response|40|||
148717504|NCT00724958|536437269|FG000|Overall Study|No Response|18|||
148717505|NCT00724958|536437269|FG000|Overall Study|Remission|7|||
148717506|NCT00724958|536437269|FG000|Overall Study|Other Reason|76|||
148717507|NCT00724958|536437269|FG000|Overall Study|No documentation for end of therapy|13|||
148717508|NCT00965731|536437270|FG000|Overall Study|Death|0|||
148717509|NCT00965731|536437271|FG001|Overall Study|Death|4|||
148717510|NCT00965731|536437270|FG000|Overall Study|Withdrawal by Subject|0|||
148717511|NCT00965731|536437271|FG001|Overall Study|Withdrawal by Subject|1|||
148717512|NCT00965731|536437270|FG000|Overall Study|Other|7|||
148717513|NCT00965731|536437271|FG001|Overall Study|Other|15|||
148717514|NCT00683592|536438555|FG000|Overall Study|Adverse Event|12|||
148717515|NCT00683592|536438556|FG001|Overall Study|Adverse Event|4|||
148717516|NCT00683592|536438555|FG000|Overall Study|Withdrawal by Subject|11|||
148717517|NCT00683592|536438556|FG001|Overall Study|Withdrawal by Subject|11|||
148717518|NCT00683592|536438555|FG000|Overall Study|Lost to Follow-up|17|||
148717519|NCT00683592|536438556|FG001|Overall Study|Lost to Follow-up|17|||
148717520|NCT00683592|536438555|FG000|Overall Study|Lack of Efficacy|3|||
148717521|NCT00683592|536438556|FG001|Overall Study|Lack of Efficacy|7|||
148717522|NCT00683592|536438555|FG000|Overall Study|Physician Decision|0|||
148815792|NCT02850406|536800634|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
148968991|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
148968992|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
148968993|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
148968994|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
148968995|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
148717523|NCT00683592|536438556|FG001|Overall Study|Physician Decision|1|||
148717524|NCT00683592|536438555|FG000|Overall Study|Non-compliance|3|||
148717525|NCT00683592|536438556|FG001|Overall Study|Non-compliance|5|||
148717526|NCT00683592|536438555|FG000|Overall Study|Other|1|||
148717527|NCT00683592|536438556|FG001|Overall Study|Other|1|||
148717528|NCT03303417|536438564|FG000|Overall Study|Withdrawal by Subject|1|||
148717529|NCT03303417|536438565|FG001|Overall Study|Withdrawal by Subject|1|||
148717530|NCT02697617|536438566|FG000|Overall Study|Withdrawal by Subject|0|||
148717531|NCT02697617|536438567|FG001|Overall Study|Withdrawal by Subject|2|||
148717532|NCT02697617|536438566|FG000|Overall Study|Pregnancy|1|||
148717533|NCT02697617|536438567|FG001|Overall Study|Pregnancy|0|||
148717534|NCT00381849|536438570|FG000|Wash Out|Withdrawal by Subject|0|||
148717535|NCT00381849|536438571|FG001|Wash Out|Withdrawal by Subject|1|||
148717536|NCT01765270|536438575|FG000|Overall Study|Physician Decision|1|||
148717537|NCT01765270|536438576|FG001|Overall Study|Physician Decision|0|||
148717538|NCT01765270|536438575|FG000|Overall Study|Withdrawal by Subject|0|||
148717539|NCT01765270|536438576|FG001|Overall Study|Withdrawal by Subject|1|||
148717540|NCT00493792|536438577|FG000|Overall Study|Death|55|||
148717541|NCT00493792|536438578|FG001|Overall Study|Death|50|||
148717542|NCT00493792|536438577|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
148717543|NCT00493792|536438578|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
148717544|NCT02426541|536438579|FG000|Overall Study|Protocol Violation|1|||
148717545|NCT02426541|536438580|FG001|Overall Study|Protocol Violation|0|||
148717546|NCT02943993|536438583|FG000|Overall Study|Withdrawal by Subject|52|||
148717547|NCT02943993|536438583|FG000|Overall Study|Transfer to another institution|6|||
148717548|NCT02943993|536438583|FG000|Overall Study|Lost to Follow-up|135|||
148717549|NCT02943993|536438583|FG000|Overall Study|Death|98|||
148717550|NCT02943993|536438583|FG000|Overall Study|Other reason for premature termination|32|||
148717551|NCT02943993|536438583|FG000|Overall Study|Missing reason for termination|7|||
148717552|NCT00876265|536438587|FG000|Overall Study|Miscellaneous reasons|4|||
148717553|NCT00876265|536438587|FG000|Overall Study|Lost to Follow-up|6|||
148717554|NCT00876265|536438587|FG000|Overall Study|Withdrawal by Subject|2|||
148717555|NCT00996437|536438590|FG000|Overall Study|Death|1|||
148717556|NCT00996437|536438591|FG001|Overall Study|Death|0|||
148717557|NCT00996437|536438590|FG000|Overall Study|Dropped|2|||
148717558|NCT00996437|536438591|FG001|Overall Study|Dropped|2|||
148717559|NCT00996437|536438590|FG000|Overall Study|Missed|2|||
148717560|NCT00996437|536438591|FG001|Overall Study|Missed|5|||
148717561|NCT01755975|536438594|FG000|Overall Study|Adverse Event|0|||
148717562|NCT01755975|536438595|FG001|Overall Study|Adverse Event|0|||
148717563|NCT01755975|536438596|FG002|Overall Study|Adverse Event|1|||
148717564|NCT01755975|536438597|FG003|Overall Study|Adverse Event|0|||
148717565|NCT01755975|536438598|FG004|Overall Study|Adverse Event|2|||
148717566|NCT03653026|536438599|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
148717567|NCT03653026|536438600|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
148717568|NCT03653026|536438601|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
148717569|NCT03653026|536438602|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
148717570|NCT03653026|536438599|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
148717571|NCT03653026|536438600|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
148717572|NCT03653026|536438601|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148717573|NCT03653026|536438602|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148815793|NCT02850406|536800635|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815794|NCT02850406|536800636|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
148815795|NCT02850406|536800637|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
148815796|NCT02850406|536800638|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815797|NCT02850406|536800639|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815798|NCT02850406|536800632|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815799|NCT02850406|536800633|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815800|NCT02850406|536800634|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815801|NCT02850406|536800635|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815802|NCT02850406|536800636|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
148815803|NCT02850406|536800637|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815804|NCT02850406|536800638|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815805|NCT02850406|536800639|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
148815806|NCT02850406|536800632|FG000|Part C (Up to 52 Weeks)|Other|0|||
148815807|NCT02850406|536800633|FG001|Part C (Up to 52 Weeks)|Other|0|||
148815808|NCT02850406|536800634|FG002|Part C (Up to 52 Weeks)|Other|0|||
148815809|NCT02850406|536800635|FG003|Part C (Up to 52 Weeks)|Other|0|||
148815810|NCT02850406|536800636|FG004|Part C (Up to 52 Weeks)|Other|1|||
148815811|NCT02850406|536800637|FG005|Part C (Up to 52 Weeks)|Other|3|||
148815812|NCT02850406|536800638|FG006|Part C (Up to 52 Weeks)|Other|0|||
148815813|NCT02850406|536800639|FG007|Part C (Up to 52 Weeks)|Other|0|||
148815814|NCT02850406|536800632|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
148815815|NCT02850406|536800633|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
148815816|NCT02850406|536800634|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
148815817|NCT02850406|536800635|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
148815818|NCT02850406|536800636|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
148815819|NCT02850406|536800637|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
148717574|NCT03653026|536438599|FG000|Part 1: Placebo-controlled Period|Other|0|||
148717575|NCT03653026|536438600|FG001|Part 1: Placebo-controlled Period|Other|3|||
148717576|NCT03653026|536438601|FG002|Part 1: Placebo-controlled Period|Other|0|||
148717577|NCT03653026|536438602|FG003|Part 1: Placebo-controlled Period|Other|0|||
148717578|NCT03653026|536438599|FG000|Part 2: Open-label Extension|Adverse Event|0|||
148717579|NCT03653026|536438600|FG001|Part 2: Open-label Extension|Adverse Event|0|||
148717580|NCT03653026|536438601|FG002|Part 2: Open-label Extension|Adverse Event|1|||
148815820|NCT02850406|536800638|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
148815821|NCT02850406|536800639|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
148815822|NCT02850406|536800632|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148717581|NCT03653026|536438602|FG003|Part 2: Open-label Extension|Adverse Event|1|||
148717582|NCT03653026|536438599|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
148717583|NCT03653026|536438600|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
148717584|NCT03653026|536438601|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
148717585|NCT03653026|536438602|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
148717586|NCT03653026|536438599|FG000|Part 2: Open-label Extension|Other|0|||
148717587|NCT03653026|536438600|FG001|Part 2: Open-label Extension|Other|0|||
148717588|NCT03653026|536438601|FG002|Part 2: Open-label Extension|Other|1|||
148717589|NCT03653026|536438602|FG003|Part 2: Open-label Extension|Other|2|||
148717590|NCT01933919|536438605|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
148717591|NCT01933919|536438606|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
148717592|NCT01933919|536438605|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
148717593|NCT01933919|536438606|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
148717594|NCT01933919|536438605|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
148717595|NCT01933919|536438606|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
148717596|NCT01933919|536438605|FG000|Open-label Long-term Phase|Adverse Event|2|||
148717597|NCT01933919|536438606|FG001|Open-label Long-term Phase|Adverse Event|0|||
148717598|NCT01933919|536438605|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
148717599|NCT01933919|536438606|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
148717600|NCT01933919|536438605|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
148717601|NCT01933919|536438606|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
148717602|NCT01933919|536438605|FG000|Open-label Long-term Phase|Other|1|||
148717603|NCT01933919|536438606|FG001|Open-label Long-term Phase|Other|2|||
148717604|NCT00177164|536438613|FG000|Overall Study|Protocol Violation|0|||
148717605|NCT00177164|536438614|FG001|Overall Study|Protocol Violation|7|||
148717606|NCT00177164|536438613|FG000|Overall Study|Lost to Follow-up|4|||
148717607|NCT00177164|536438614|FG001|Overall Study|Lost to Follow-up|5|||
148717608|NCT00177164|536438613|FG000|Overall Study|increase in alcohol and drug use|1|||
148717609|NCT00177164|536438614|FG001|Overall Study|increase in alcohol and drug use|2|||
148717610|NCT00177164|536438613|FG000|Overall Study|Adverse Event|1|||
148717611|NCT00177164|536438614|FG001|Overall Study|Adverse Event|0|||
148968996|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
148968997|NCT02036502|537372832|FG000|Part 3:Dose Expansion|Not Treated|0|||
148968998|NCT02036502|537372833|FG001|Part 3:Dose Expansion|Not Treated|0|||
148968999|NCT02036502|537372834|FG002|Part 3:Dose Expansion|Not Treated|0|||
148969000|NCT02036502|537372835|FG003|Part 3:Dose Expansion|Not Treated|0|||
148969001|NCT02036502|537372836|FG004|Part 3:Dose Expansion|Not Treated|0|||
148969002|NCT02036502|537372837|FG005|Part 3:Dose Expansion|Not Treated|2|||
148969003|NCT02036502|537372838|FG006|Part 3:Dose Expansion|Not Treated|0|||
148969004|NCT02036502|537372839|FG007|Part 3:Dose Expansion|Not Treated|0|||
148969005|NCT00811577|537372840|FG000|Overall Study|Lost to Follow-up|7|||
148969006|NCT00811577|537372841|FG001|Overall Study|Lost to Follow-up|1|||
148969007|NCT00811577|537372840|FG000|Overall Study|Withdrawal by Subject|3|||
148969008|NCT00811577|537372841|FG001|Overall Study|Withdrawal by Subject|0|||
148969009|NCT04251221|537372842|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
148969010|NCT04251221|537372843|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
148969011|NCT02357940|537372844|FG000|Overall Study|Adverse Event|0|||
148969012|NCT02357940|537372845|FG001|Overall Study|Adverse Event|1|||
148969013|NCT02357940|537372844|FG000|Overall Study|Investigator's judgement|0|||
148969014|NCT02357940|537372845|FG001|Overall Study|Investigator's judgement|1|||
148969015|NCT02442778|537372846|FG000|Overall Study|Adverse Event|2|||
148969016|NCT02442778|537372847|FG001|Overall Study|Adverse Event|6|||
148969017|NCT02442778|537372848|FG002|Overall Study|Adverse Event|6|||
148717612|NCT00177164|536438613|FG000|Overall Study|discharge from hospital|1|||
148969018|NCT02442778|537372846|FG000|Overall Study|Death|0|||
148717613|NCT00177164|536438614|FG001|Overall Study|discharge from hospital|0|||
148717614|NCT00177164|536438613|FG000|Overall Study|Lack of Efficacy|2|||
148717615|NCT00177164|536438614|FG001|Overall Study|Lack of Efficacy|1|||
148717616|NCT00177164|536438613|FG000|Overall Study|Pregnancy|0|||
148717617|NCT00177164|536438614|FG001|Overall Study|Pregnancy|1|||
148717618|NCT02522780|536438615|FG000|Overall Study|Consent withdrawn by subject|5|||
148969019|NCT02442778|537372847|FG001|Overall Study|Death|2|||
148717619|NCT02522780|536438616|FG001|Overall Study|Consent withdrawn by subject|7|||
148717620|NCT02522780|536438615|FG000|Overall Study|Protocol deviation|1|||
148969020|NCT02442778|537372848|FG002|Overall Study|Death|0|||
148717621|NCT02522780|536438616|FG001|Overall Study|Protocol deviation|3|||
148717622|NCT02522780|536438615|FG000|Overall Study|Subject refused endoscopic procedure|0|||
148717623|NCT02522780|536438616|FG001|Overall Study|Subject refused endoscopic procedure|1|||
148969021|NCT02442778|537372846|FG000|Overall Study|Lack of Efficacy|1|||
148969022|NCT02442778|537372847|FG001|Overall Study|Lack of Efficacy|0|||
148717624|NCT02522780|536438615|FG000|Overall Study|Adverse event, non-fatal|11|||
148717625|NCT02522780|536438616|FG001|Overall Study|Adverse event, non-fatal|16|||
148969023|NCT02442778|537372848|FG002|Overall Study|Lack of Efficacy|0|||
148969024|NCT02442778|537372846|FG000|Overall Study|Lost to Follow-up|1|||
148969025|NCT02442778|537372847|FG001|Overall Study|Lost to Follow-up|1|||
148969026|NCT02442778|537372848|FG002|Overall Study|Lost to Follow-up|1|||
148969027|NCT02442778|537372846|FG000|Overall Study|Non-compliance with study drug|2|||
148969028|NCT02442778|537372847|FG001|Overall Study|Non-compliance with study drug|0|||
148969029|NCT02442778|537372848|FG002|Overall Study|Non-compliance with study drug|1|||
148969030|NCT02442778|537372846|FG000|Overall Study|Physician Decision|1|||
148969031|NCT02442778|537372847|FG001|Overall Study|Physician Decision|1|||
148969032|NCT02442778|537372848|FG002|Overall Study|Physician Decision|1|||
148969033|NCT02442778|537372846|FG000|Overall Study|Protocol Deviation|3|||
148969034|NCT02442778|537372847|FG001|Overall Study|Protocol Deviation|0|||
148969035|NCT02442778|537372848|FG002|Overall Study|Protocol Deviation|1|||
148969036|NCT02442778|537372846|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
148969037|NCT02442778|537372847|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
148969038|NCT02442778|537372848|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
148969039|NCT02442778|537372846|FG000|Overall Study|Withdrawal by Subject|4|||
148969040|NCT02442778|537372847|FG001|Overall Study|Withdrawal by Subject|4|||
148969041|NCT02442778|537372848|FG002|Overall Study|Withdrawal by Subject|3|||
148969042|NCT02442778|537372846|FG000|Overall Study|Reason not specified|1|||
148969043|NCT02442778|537372847|FG001|Overall Study|Reason not specified|4|||
148969044|NCT02442778|537372848|FG002|Overall Study|Reason not specified|0|||
148717626|NCT00926367|536438617|FG000|Overall Study|Withdrawal by Subject|0|||
148717627|NCT00926367|536438618|FG001|Overall Study|Withdrawal by Subject|1|||
148717628|NCT00926367|536438617|FG000|Overall Study|Lost to Follow-up|1|||
148717629|NCT00926367|536438618|FG001|Overall Study|Lost to Follow-up|0|||
148717630|NCT00926367|536438617|FG000|Overall Study|Skin Irritation|1|||
148717631|NCT00926367|536438618|FG001|Overall Study|Skin Irritation|2|||
148717632|NCT04307849|536438619|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
148969045|NCT01165138|537372851|FG000|Overall Study|Adverse Event|0|||
148969046|NCT01165138|537372852|FG001|Overall Study|Adverse Event|1|||
148969047|NCT01165138|537372853|FG002|Overall Study|Adverse Event|0|||
148969048|NCT01165138|537372854|FG003|Overall Study|Adverse Event|2|||
148969049|NCT01165138|537372851|FG000|Overall Study|Lack of Efficacy|0|||
148969050|NCT01165138|537372852|FG001|Overall Study|Lack of Efficacy|32|||
148969051|NCT01165138|537372853|FG002|Overall Study|Lack of Efficacy|6|||
148969052|NCT01165138|537372854|FG003|Overall Study|Lack of Efficacy|7|||
148969053|NCT01165138|537372851|FG000|Overall Study|Protocol Violation|0|||
148969054|NCT01165138|537372852|FG001|Overall Study|Protocol Violation|7|||
148969055|NCT01165138|537372853|FG002|Overall Study|Protocol Violation|0|||
148717633|NCT04307849|536438620|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
148717634|NCT04307849|536438621|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
148717635|NCT04307849|536438622|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
148717636|NCT04307849|536438623|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
148969056|NCT01165138|537372854|FG003|Overall Study|Protocol Violation|2|||
148969057|NCT01165138|537372851|FG000|Overall Study|Lost to Follow-up|0|||
148969058|NCT01165138|537372852|FG001|Overall Study|Lost to Follow-up|0|||
148969059|NCT01165138|537372853|FG002|Overall Study|Lost to Follow-up|1|||
148969060|NCT01165138|537372854|FG003|Overall Study|Lost to Follow-up|2|||
148969061|NCT01165138|537372851|FG000|Overall Study|Physician Decision|0|||
148969062|NCT01165138|537372852|FG001|Overall Study|Physician Decision|6|||
148969063|NCT01165138|537372853|FG002|Overall Study|Physician Decision|7|||
148969064|NCT01165138|537372854|FG003|Overall Study|Physician Decision|6|||
148969065|NCT01165138|537372851|FG000|Overall Study|Withdrawal by Subject|0|||
148969066|NCT01165138|537372852|FG001|Overall Study|Withdrawal by Subject|6|||
148717637|NCT04307849|536438624|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
148717638|NCT04307849|536438619|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
148717639|NCT04307849|536438620|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
148969067|NCT01165138|537372853|FG002|Overall Study|Withdrawal by Subject|6|||
148969068|NCT01165138|537372854|FG003|Overall Study|Withdrawal by Subject|3|||
148969069|NCT02641379|537372855|FG000|Overall Study|Exclusion criterion during screening|1|||
148969070|NCT02641379|537372856|FG001|Overall Study|Exclusion criterion during screening|0|||
148969071|NCT02641379|537372857|FG002|Overall Study|Exclusion criterion during screening|0|||
148969072|NCT02641379|537372858|FG003|Overall Study|Exclusion criterion during screening|1|||
148969073|NCT02641379|537372859|FG004|Overall Study|Exclusion criterion during screening|2|||
148969074|NCT02641379|537372860|FG005|Overall Study|Exclusion criterion during screening|0|||
148969075|NCT02641379|537372861|FG006|Overall Study|Exclusion criterion during screening|0|||
148969076|NCT02641379|537372862|FG007|Overall Study|Exclusion criterion during screening|0|||
148969077|NCT02641379|537372863|FG008|Overall Study|Exclusion criterion during screening|0|||
148969078|NCT02641379|537372864|FG009|Overall Study|Exclusion criterion during screening|0|||
148717640|NCT04307849|536438621|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
148969079|NCT02641379|537372865|FG010|Overall Study|Exclusion criterion during screening|0|||
148969080|NCT02641379|537372855|FG000|Overall Study|Withdrawal of informed consent|0|||
148969081|NCT02641379|537372856|FG001|Overall Study|Withdrawal of informed consent|1|||
148969082|NCT02641379|537372857|FG002|Overall Study|Withdrawal of informed consent|0|||
148969083|NCT02641379|537372858|FG003|Overall Study|Withdrawal of informed consent|0|||
148969084|NCT02641379|537372859|FG004|Overall Study|Withdrawal of informed consent|0|||
148717641|NCT04307849|536438622|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
148717642|NCT04307849|536438623|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
148717643|NCT04307849|536438624|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
148717644|NCT04307849|536438619|FG000|Overall Study|Family member did not want them to continue|0|||
148717645|NCT04307849|536438620|FG001|Overall Study|Family member did not want them to continue|0|||
148717646|NCT04307849|536438621|FG002|Overall Study|Family member did not want them to continue|1|||
148717647|NCT04307849|536438622|FG003|Overall Study|Family member did not want them to continue|0|||
148717648|NCT04307849|536438623|FG004|Overall Study|Family member did not want them to continue|0|||
148717649|NCT04307849|536438624|FG005|Overall Study|Family member did not want them to continue|0|||
148717650|NCT04307849|536438619|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
148717651|NCT04307849|536438620|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
148717652|NCT04307849|536438621|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
148717653|NCT04307849|536438622|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
148717654|NCT04307849|536438623|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
148717655|NCT04307849|536438624|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
148717656|NCT01294449|536438625|FG000|Overall Study|Death|11|||
148717657|NCT01294449|536438626|FG001|Overall Study|Death|12|||
148717658|NCT01294449|536438625|FG000|Overall Study|Withdrawal by Subject|1|||
148717659|NCT01294449|536438626|FG001|Overall Study|Withdrawal by Subject|3|||
148717660|NCT03259789|536438631|FG000|Overall Study|Adverse Event|3|||
148717661|NCT03259789|536438632|FG001|Overall Study|Adverse Event|2|||
148717662|NCT03259789|536438633|FG002|Overall Study|Adverse Event|1|||
148717663|NCT03259789|536438631|FG000|Overall Study|Withdrawal by Subject|9|||
148717664|NCT03259789|536438632|FG001|Overall Study|Withdrawal by Subject|5|||
148717665|NCT03259789|536438633|FG002|Overall Study|Withdrawal by Subject|1|||
148717666|NCT03259789|536438631|FG000|Overall Study|Lost to Follow-up|5|||
148717667|NCT03259789|536438632|FG001|Overall Study|Lost to Follow-up|9|||
148717668|NCT03259789|536438633|FG002|Overall Study|Lost to Follow-up|4|||
148717669|NCT03259789|536438631|FG000|Overall Study|Physician Decision|0|||
148717670|NCT03259789|536438632|FG001|Overall Study|Physician Decision|1|||
148717671|NCT03259789|536438633|FG002|Overall Study|Physician Decision|0|||
148717672|NCT02063217|536438634|FG000|Overall Study|Withdrawal by Subject|1|||
148717673|NCT02063217|536438635|FG001|Overall Study|Withdrawal by Subject|0|||
148717674|NCT02063217|536438636|FG002|Overall Study|Withdrawal by Subject|0|||
148717675|NCT00889252|536438637|FG000|Overall Study|Adverse Event|2|||
148717676|NCT00889252|536438638|FG001|Overall Study|Adverse Event|4|||
148717677|NCT00889252|536438637|FG000|Overall Study|Withdrawal by Subject|3|||
148717678|NCT00889252|536438638|FG001|Overall Study|Withdrawal by Subject|0|||
148717679|NCT00889252|536438637|FG000|Overall Study|Protocol Violation|2|||
148717680|NCT00889252|536438638|FG001|Overall Study|Protocol Violation|0|||
148717681|NCT02387762|536438645|FG000|Overall Study|Withdrawal by Subject|1|||
148717682|NCT02387762|536438646|FG001|Overall Study|Withdrawal by Subject|0|||
148717683|NCT04203667|536438647|FG000|Overall Study|Withdrawal by Subject|1|||
148717684|NCT04203667|536438647|FG000|Overall Study|Lost to Follow-up|1|||
148717685|NCT04203667|536438647|FG000|Overall Study|Death|1|||
148717686|NCT04203667|536438647|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
148717687|NCT00593827|536438648|FG000|Overall Study|On Active Treatment/Pending|0|||
148717688|NCT00593827|536438649|FG001|Overall Study|On Active Treatment/Pending|2|||
148717689|NCT01833169|536438650|FG000|Overall Study|Disease Progression|99|||
148717690|NCT01833169|536438650|FG000|Overall Study|Adverse Event|33|||
148717691|NCT01833169|536438650|FG000|Overall Study|Withdrawal by Subject|9|||
148717692|NCT01833169|536438650|FG000|Overall Study|Death|3|||
148717693|NCT01833169|536438650|FG000|Overall Study|Physician Decision|2|||
148717694|NCT01183884|536438654|FG000|Overall Study|Progressive Disease|26|||
148717695|NCT01183884|536438654|FG000|Overall Study|Adverse Event|3|||
148717696|NCT01183884|536438654|FG000|Overall Study|Withdrawal by Subject|1|||
148717697|NCT01183884|536438654|FG000|Overall Study|Other Complicating Disease|3|||
148717698|NCT01183884|536438654|FG000|Overall Study|Not Treated|1|||
148969085|NCT02641379|537372860|FG005|Overall Study|Withdrawal of informed consent|0|||
148969086|NCT02641379|537372861|FG006|Overall Study|Withdrawal of informed consent|0|||
148969087|NCT02641379|537372862|FG007|Overall Study|Withdrawal of informed consent|1|||
148969088|NCT02641379|537372863|FG008|Overall Study|Withdrawal of informed consent|0|||
148969089|NCT02641379|537372864|FG009|Overall Study|Withdrawal of informed consent|0|||
148969090|NCT02641379|537372865|FG010|Overall Study|Withdrawal of informed consent|0|||
148969091|NCT02641379|537372855|FG000|Overall Study|Adverse Event|7|||
148717699|NCT01183884|536438654|FG000|Overall Study|Other|4|||
148717700|NCT01160640|536438655|FG000|Overall Study|Physician Decision|3|||
148717701|NCT01160640|536438656|FG001|Overall Study|Physician Decision|3|||
148717702|NCT01160640|536438655|FG000|Overall Study|Incarceration|1|||
148717703|NCT01160640|536438656|FG001|Overall Study|Incarceration|0|||
148717704|NCT01160640|536438655|FG000|Overall Study|Withdrawal by Subject|0|||
148717705|NCT01160640|536438656|FG001|Overall Study|Withdrawal by Subject|3|||
148717706|NCT02169336|536438661|FG000|Overall Study|Lack of Efficacy|1|||
148717707|NCT02169336|536438662|FG001|Overall Study|Lack of Efficacy|1|||
148717708|NCT02169336|536438663|FG002|Overall Study|Lack of Efficacy|0|||
148717709|NCT02169336|536438661|FG000|Overall Study|Adverse Event|2|||
148717710|NCT02169336|536438662|FG001|Overall Study|Adverse Event|3|||
148717711|NCT02169336|536438663|FG002|Overall Study|Adverse Event|1|||
148717712|NCT02169336|536438661|FG000|Overall Study|Withdrawal by Subject|1|||
148717713|NCT02169336|536438662|FG001|Overall Study|Withdrawal by Subject|0|||
148717714|NCT02169336|536438663|FG002|Overall Study|Withdrawal by Subject|0|||
148717715|NCT02169336|536438661|FG000|Overall Study|Physician Decision|0|||
148717716|NCT02169336|536438662|FG001|Overall Study|Physician Decision|0|||
148717717|NCT02169336|536438663|FG002|Overall Study|Physician Decision|1|||
148717718|NCT02169336|536438661|FG000|Overall Study|Subject declined to continue dosing|0|||
148717719|NCT02169336|536438662|FG001|Overall Study|Subject declined to continue dosing|0|||
148717720|NCT02169336|536438663|FG002|Overall Study|Subject declined to continue dosing|1|||
148717721|NCT04718129|536438664|FG000|Overall Study|Lost to Follow-up|6|||
148717722|NCT04718129|536438665|FG001|Overall Study|Lost to Follow-up|7|||
148717723|NCT02212457|536438666|FG000|Overall Study|Adverse Event|1|||
148717724|NCT02212457|536438667|FG001|Overall Study|Adverse Event|2|||
148717725|NCT02212457|536438668|FG002|Overall Study|Adverse Event|2|||
148717726|NCT02212457|536438669|FG003|Overall Study|Adverse Event|2|||
148717727|NCT02212457|536438670|FG004|Overall Study|Adverse Event|0|||
148717728|NCT02212457|536438671|FG005|Overall Study|Adverse Event|1|||
148717729|NCT02212457|536438666|FG000|Overall Study|Withdrawal by Subject|8|||
148717730|NCT02212457|536438667|FG001|Overall Study|Withdrawal by Subject|10|||
148717731|NCT02212457|536438668|FG002|Overall Study|Withdrawal by Subject|8|||
148717732|NCT02212457|536438669|FG003|Overall Study|Withdrawal by Subject|6|||
148717733|NCT02212457|536438670|FG004|Overall Study|Withdrawal by Subject|5|||
148717734|NCT02212457|536438671|FG005|Overall Study|Withdrawal by Subject|4|||
148717735|NCT02212457|536438666|FG000|Overall Study|Lost to Follow-up|6|||
148717736|NCT02212457|536438667|FG001|Overall Study|Lost to Follow-up|7|||
148717737|NCT02212457|536438668|FG002|Overall Study|Lost to Follow-up|4|||
148717738|NCT02212457|536438669|FG003|Overall Study|Lost to Follow-up|1|||
148717739|NCT02212457|536438670|FG004|Overall Study|Lost to Follow-up|8|||
148717740|NCT02212457|536438671|FG005|Overall Study|Lost to Follow-up|4|||
148717741|NCT02212457|536438666|FG000|Overall Study|Protocol Violation|2|||
148717742|NCT02212457|536438667|FG001|Overall Study|Protocol Violation|1|||
148717743|NCT02212457|536438668|FG002|Overall Study|Protocol Violation|0|||
148717744|NCT02212457|536438669|FG003|Overall Study|Protocol Violation|1|||
148717745|NCT02212457|536438670|FG004|Overall Study|Protocol Violation|2|||
148717746|NCT02212457|536438671|FG005|Overall Study|Protocol Violation|3|||
148717747|NCT02212457|536438666|FG000|Overall Study|Other|2|||
148717748|NCT02212457|536438667|FG001|Overall Study|Other|1|||
148717749|NCT02212457|536438668|FG002|Overall Study|Other|2|||
148717750|NCT02212457|536438669|FG003|Overall Study|Other|1|||
148717751|NCT02212457|536438670|FG004|Overall Study|Other|0|||
148717752|NCT02212457|536438671|FG005|Overall Study|Other|1|||
148717753|NCT01598896|536438672|FG000|Overall Study|Withdrawal by Subject|0|||
148717754|NCT01598896|536438673|FG001|Overall Study|Withdrawal by Subject|1|||
148717755|NCT01598896|536438672|FG000|Overall Study|Lack of Efficacy|0|||
148717756|NCT01598896|536438673|FG001|Overall Study|Lack of Efficacy|1|||
148717757|NCT00420095|536438675|FG000|Overall Study|Adverse Event|1|||
148717758|NCT00420095|536438676|FG001|Overall Study|Adverse Event|0|||
148717759|NCT00420095|536438675|FG000|Overall Study|Protocol Violation|1|||
148717760|NCT00420095|536438676|FG001|Overall Study|Protocol Violation|1|||
148717761|NCT00420095|536438675|FG000|Overall Study|Lost to Follow-up|1|||
148717762|NCT00420095|536438676|FG001|Overall Study|Lost to Follow-up|0|||
148717763|NCT00393705|536438677|FG000|Overall Study|Adverse Event|0|||
148717764|NCT00393705|536438678|FG001|Overall Study|Adverse Event|2|||
148717765|NCT00393705|536438677|FG000|Overall Study|Death|0|||
148717766|NCT00393705|536438678|FG001|Overall Study|Death|1|||
148717767|NCT00393705|536438677|FG000|Overall Study|Lost to Follow-up|2|||
148717768|NCT00393705|536438678|FG001|Overall Study|Lost to Follow-up|2|||
148717769|NCT00393705|536438677|FG000|Overall Study|Entry Criteria Not Met|10|||
148815823|NCT02850406|536800633|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148717770|NCT00393705|536438678|FG001|Overall Study|Entry Criteria Not Met|10|||
148717771|NCT00393705|536438677|FG000|Overall Study|Protocol Violation|4|||
148717772|NCT00393705|536438678|FG001|Overall Study|Protocol Violation|3|||
148717773|NCT00393705|536438677|FG000|Overall Study|Withdrawal by Subject|5|||
148717774|NCT00393705|536438678|FG001|Overall Study|Withdrawal by Subject|3|||
148717775|NCT00393705|536438677|FG000|Overall Study|Physician Decision|2|||
148717776|NCT00393705|536438678|FG001|Overall Study|Physician Decision|2|||
148717777|NCT01120691|536438681|FG000|Overall Study|Adverse Event|59|||
148717778|NCT01120691|536438682|FG001|Overall Study|Adverse Event|67|||
148717779|NCT01120691|536438683|FG002|Overall Study|Adverse Event|47|||
148717780|NCT01120691|536438681|FG000|Overall Study|Subject withdrew consent|33|||
148717781|NCT01120691|536438682|FG001|Overall Study|Subject withdrew consent|50|||
148717782|NCT01120691|536438683|FG002|Overall Study|Subject withdrew consent|44|||
148717783|NCT01120691|536438681|FG000|Overall Study|Death|21|||
148717784|NCT01120691|536438682|FG001|Overall Study|Death|22|||
148717785|NCT01120691|536438683|FG002|Overall Study|Death|24|||
148717786|NCT01120691|536438681|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
148717787|NCT01120691|536438682|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
148717788|NCT01120691|536438683|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
148717789|NCT01120691|536438681|FG000|Overall Study|Administrative problems|15|||
148717790|NCT01120691|536438682|FG001|Overall Study|Administrative problems|8|||
148717791|NCT01120691|536438683|FG002|Overall Study|Administrative problems|9|||
148717792|NCT01120691|536438681|FG000|Overall Study|Protocol deviation|13|||
148717793|NCT01120691|536438682|FG001|Overall Study|Protocol deviation|12|||
148717794|NCT01120691|536438683|FG002|Overall Study|Protocol deviation|12|||
148717795|NCT01120691|536438681|FG000|Overall Study|Lost to Follow-up|5|||
148717796|NCT01120691|536438682|FG001|Overall Study|Lost to Follow-up|6|||
148717797|NCT01120691|536438683|FG002|Overall Study|Lost to Follow-up|4|||
148717798|NCT01120691|536438681|FG000|Overall Study|Abnormal test procedure result(s)|3|||
148717799|NCT01120691|536438682|FG001|Overall Study|Abnormal test procedure result(s)|2|||
148717800|NCT01120691|536438683|FG002|Overall Study|Abnormal test procedure result(s)|1|||
148717801|NCT01120691|536438681|FG000|Overall Study|Patient's inability to use the device|3|||
148717802|NCT01120691|536438682|FG001|Overall Study|Patient's inability to use the device|1|||
148717803|NCT01120691|536438683|FG002|Overall Study|Patient's inability to use the device|0|||
148717804|NCT01120691|536438681|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148717805|NCT01120691|536438682|FG001|Overall Study|Abnormal laboratory value(s)|3|||
148717806|NCT01120691|536438683|FG002|Overall Study|Abnormal laboratory value(s)|4|||
148717807|NCT00642811|536438684|FG000|Overall Study|Adverse Event|2|||
148717808|NCT00642811|536438685|FG001|Overall Study|Adverse Event|3|||
148717809|NCT00642811|536438686|FG002|Overall Study|Adverse Event|0|||
148717810|NCT00642811|536438687|FG003|Overall Study|Adverse Event|0|||
148717811|NCT00642811|536438688|FG004|Overall Study|Adverse Event|0|||
148717812|NCT00642811|536438689|FG005|Overall Study|Adverse Event|1|||
148717813|NCT00642811|536438684|FG000|Overall Study|Developement of discontinuation criteria|0|||
148717814|NCT00642811|536438685|FG001|Overall Study|Developement of discontinuation criteria|0|||
148717815|NCT00642811|536438686|FG002|Overall Study|Developement of discontinuation criteria|0|||
148717816|NCT00642811|536438687|FG003|Overall Study|Developement of discontinuation criteria|0|||
148717817|NCT00642811|536438688|FG004|Overall Study|Developement of discontinuation criteria|1|||
148717818|NCT00642811|536438689|FG005|Overall Study|Developement of discontinuation criteria|0|||
148717819|NCT00642811|536438684|FG000|Overall Study|Severe Non-compliance to protocol|1|||
148717820|NCT00642811|536438685|FG001|Overall Study|Severe Non-compliance to protocol|0|||
148717821|NCT00642811|536438686|FG002|Overall Study|Severe Non-compliance to protocol|0|||
148717822|NCT00642811|536438687|FG003|Overall Study|Severe Non-compliance to protocol|0|||
148717823|NCT00642811|536438688|FG004|Overall Study|Severe Non-compliance to protocol|0|||
148717824|NCT00642811|536438689|FG005|Overall Study|Severe Non-compliance to protocol|0|||
148717825|NCT00642811|536438684|FG000|Overall Study|Other|0|||
148717826|NCT00642811|536438685|FG001|Overall Study|Other|1|||
148717827|NCT00642811|536438686|FG002|Overall Study|Other|0|||
148717828|NCT00642811|536438687|FG003|Overall Study|Other|1|||
148717829|NCT00642811|536438688|FG004|Overall Study|Other|0|||
148717830|NCT00642811|536438689|FG005|Overall Study|Other|0|||
148717831|NCT04553406|536438693|FG000|Overall Study|Study Discontinuation|0|||
148717832|NCT04553406|536438694|FG001|Overall Study|Study Discontinuation|1|||
148717833|NCT00239005|536438695|FG000|Overall Study|Adverse Event|6|||
148717834|NCT00239005|536438696|FG001|Overall Study|Adverse Event|6|||
148717835|NCT00239005|536438695|FG000|Overall Study|Withdrawal by Subject|3|||
148717836|NCT00239005|536438696|FG001|Overall Study|Withdrawal by Subject|4|||
148717837|NCT00239005|536438695|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
148717838|NCT00239005|536438696|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
148717839|NCT00239005|536438695|FG000|Overall Study|Protocol Violation|1|||
148717840|NCT00239005|536438696|FG001|Overall Study|Protocol Violation|0|||
148717841|NCT00239005|536438695|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
148717842|NCT00239005|536438696|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
148717843|NCT00239005|536438695|FG000|Overall Study|Lost to Follow-up|0|||
148717844|NCT00239005|536438696|FG001|Overall Study|Lost to Follow-up|1|||
148717845|NCT02614898|536438697|FG000|Overall Study|Participated until study termination|10|||
148717846|NCT02614898|536438698|FG001|Overall Study|Participated until study termination|26|||
148717847|NCT02614898|536438697|FG000|Overall Study|Lost to Follow-up|0|||
148717848|NCT02614898|536438698|FG001|Overall Study|Lost to Follow-up|2|||
148717849|NCT02614898|536438697|FG000|Overall Study|Physician Decision|1|||
148717850|NCT02614898|536438698|FG001|Overall Study|Physician Decision|8|||
148717851|NCT02614898|536438697|FG000|Overall Study|Study Terminated by Sponsor|3|||
148717852|NCT02614898|536438698|FG001|Overall Study|Study Terminated by Sponsor|0|||
148717853|NCT02614898|536438697|FG000|Overall Study|Withdrawal by Subject|0|||
148717854|NCT02614898|536438698|FG001|Overall Study|Withdrawal by Subject|2|||
148717855|NCT02614898|536438697|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148717856|NCT02614898|536438698|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
148717857|NCT02614898|536438697|FG000|Overall Study|Other-Additional Information Unavailable|0|||
148717858|NCT02614898|536438698|FG001|Overall Study|Other-Additional Information Unavailable|11|||
148717859|NCT02614898|536438697|FG000|Overall Study|Missing|0|||
148717860|NCT02614898|536438698|FG001|Overall Study|Missing|1|||
148717861|NCT00089973|536438705|FG000|Overall Study|Adverse Event|3|||
148717862|NCT00089973|536438705|FG000|Overall Study|Withdrawal by Subject|1|||
148717863|NCT00089973|536438705|FG000|Overall Study|Disease progression|45|||
148717864|NCT00089973|536438705|FG000|Overall Study|Death|1|||
148717865|NCT01223027|536438706|FG000|Overall Study|Adverse Event|20|||
148717866|NCT01223027|536438707|FG001|Overall Study|Adverse Event|10|||
148717867|NCT01223027|536438706|FG000|Overall Study|Death|42|||
148717868|NCT01223027|536438707|FG001|Overall Study|Death|42|||
148717869|NCT01223027|536438706|FG000|Overall Study|Lost to Follow-up|2|||
148717870|NCT01223027|536438707|FG001|Overall Study|Lost to Follow-up|1|||
148969092|NCT02641379|537372856|FG001|Overall Study|Adverse Event|8|||
148969093|NCT02641379|537372857|FG002|Overall Study|Adverse Event|2|||
148969094|NCT02641379|537372858|FG003|Overall Study|Adverse Event|2|||
148969095|NCT02641379|537372859|FG004|Overall Study|Adverse Event|5|||
148969096|NCT02641379|537372860|FG005|Overall Study|Adverse Event|1|||
148969097|NCT02641379|537372861|FG006|Overall Study|Adverse Event|5|||
148969098|NCT02641379|537372862|FG007|Overall Study|Adverse Event|0|||
148969099|NCT02641379|537372863|FG008|Overall Study|Adverse Event|1|||
148969100|NCT02641379|537372864|FG009|Overall Study|Adverse Event|1|||
148969101|NCT02641379|537372865|FG010|Overall Study|Adverse Event|5|||
148969102|NCT02641379|537372855|FG000|Overall Study|Lack of Efficacy|0|||
148969103|NCT02641379|537372856|FG001|Overall Study|Lack of Efficacy|0|||
148969104|NCT02641379|537372857|FG002|Overall Study|Lack of Efficacy|2|||
148969105|NCT02641379|537372858|FG003|Overall Study|Lack of Efficacy|0|||
148969106|NCT02641379|537372859|FG004|Overall Study|Lack of Efficacy|0|||
148969107|NCT02641379|537372860|FG005|Overall Study|Lack of Efficacy|2|||
148969108|NCT02641379|537372861|FG006|Overall Study|Lack of Efficacy|0|||
148969109|NCT02641379|537372862|FG007|Overall Study|Lack of Efficacy|5|||
148969110|NCT02641379|537372863|FG008|Overall Study|Lack of Efficacy|0|||
148969111|NCT02641379|537372864|FG009|Overall Study|Lack of Efficacy|0|||
148969112|NCT02641379|537372865|FG010|Overall Study|Lack of Efficacy|0|||
148969113|NCT02641379|537372855|FG000|Overall Study|Participant unable to attend study visit|4|||
148969114|NCT02641379|537372856|FG001|Overall Study|Participant unable to attend study visit|10|||
148969115|NCT02641379|537372857|FG002|Overall Study|Participant unable to attend study visit|1|||
148969116|NCT02641379|537372858|FG003|Overall Study|Participant unable to attend study visit|2|||
148969117|NCT02641379|537372859|FG004|Overall Study|Participant unable to attend study visit|5|||
148969118|NCT02641379|537372860|FG005|Overall Study|Participant unable to attend study visit|1|||
148969119|NCT02641379|537372861|FG006|Overall Study|Participant unable to attend study visit|1|||
148969120|NCT02641379|537372862|FG007|Overall Study|Participant unable to attend study visit|1|||
148717871|NCT01223027|536438706|FG000|Overall Study|Physician Decision|4|||
148717872|NCT01223027|536438707|FG001|Overall Study|Physician Decision|8|||
148717873|NCT01223027|536438706|FG000|Overall Study|Progressive Disease|167|||
148717874|NCT01223027|536438707|FG001|Overall Study|Progressive Disease|183|||
148717875|NCT01223027|536438706|FG000|Overall Study|Protocol Violation|2|||
148717876|NCT01223027|536438707|FG001|Overall Study|Protocol Violation|1|||
148717877|NCT01223027|536438706|FG000|Overall Study|Subject/guardian decicion|18|||
148717878|NCT01223027|536438707|FG001|Overall Study|Subject/guardian decicion|16|||
148717879|NCT01223027|536438706|FG000|Overall Study|New therapy for study indication|17|||
148717880|NCT01223027|536438707|FG001|Overall Study|New therapy for study indication|8|||
148717881|NCT01223027|536438706|FG000|Overall Study|Study terminated by sponsor|2|||
148717882|NCT01223027|536438707|FG001|Overall Study|Study terminated by sponsor|8|||
148717883|NCT01977456|536438708|FG000|Overall Study|Death|5|||
148717884|NCT04773600|536438711|FG000|Overall Study|Withdrawal by Subject|15|||
148717885|NCT04773600|536438712|FG001|Overall Study|Withdrawal by Subject|9|||
148717886|NCT04773600|536438711|FG000|Overall Study|Lost to Follow-up|10|||
148717887|NCT04773600|536438712|FG001|Overall Study|Lost to Follow-up|6|||
148717888|NCT04773600|536438711|FG000|Overall Study|Adverse Event|8|||
148717889|NCT04773600|536438712|FG001|Overall Study|Adverse Event|2|||
148717890|NCT04773600|536438711|FG000|Overall Study|Lack of Efficacy|2|||
148717891|NCT04773600|536438712|FG001|Overall Study|Lack of Efficacy|3|||
148969121|NCT02641379|537372863|FG008|Overall Study|Participant unable to attend study visit|0|||
148969122|NCT02641379|537372864|FG009|Overall Study|Participant unable to attend study visit|2|||
148969123|NCT02641379|537372865|FG010|Overall Study|Participant unable to attend study visit|0|||
148717892|NCT04773600|536438711|FG000|Overall Study|Noncompliance|2|||
148717893|NCT04773600|536438712|FG001|Overall Study|Noncompliance|0|||
148717894|NCT04773600|536438711|FG000|Overall Study|Protocol Violation|2|||
148717895|NCT04773600|536438712|FG001|Overall Study|Protocol Violation|0|||
148717896|NCT04773600|536438711|FG000|Overall Study|Physician Decision|0|||
148717897|NCT04773600|536438712|FG001|Overall Study|Physician Decision|1|||
148717898|NCT04773600|536438711|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
148717899|NCT04773600|536438712|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
148717900|NCT04773600|536438711|FG000|Overall Study|Emergency Travel Out of Country|1|||
148717901|NCT04773600|536438712|FG001|Overall Study|Emergency Travel Out of Country|0|||
148717902|NCT02129062|536441216|FG000|Overall Study|Death|1|||
148717903|NCT02129062|536441216|FG000|Overall Study|Disease Progression|2|||
148717904|NCT01841060|536441219|FG000|Overall Study|Protocol Violation|10|||
148717905|NCT00784979|536441224|FG000|Overall Study|incomplete data|6|||
148969124|NCT02641379|537372855|FG000|Overall Study|Participant's compliance|0|||
148969125|NCT02641379|537372856|FG001|Overall Study|Participant's compliance|1|||
148969126|NCT02641379|537372857|FG002|Overall Study|Participant's compliance|0|||
148717906|NCT00631007|536441226|FG000|Overall Study|Adverse Event|0|||
148717907|NCT00631007|536441227|FG001|Overall Study|Adverse Event|2|||
148717908|NCT00631007|536441228|FG002|Overall Study|Adverse Event|0|||
148717909|NCT00631007|536441229|FG003|Overall Study|Adverse Event|2|||
148717910|NCT00631007|536441230|FG004|Overall Study|Adverse Event|3|||
148717911|NCT00631007|536441231|FG005|Overall Study|Adverse Event|2|||
148717912|NCT00631007|536441226|FG000|Overall Study|Lost to Follow-up|2|||
148717913|NCT00631007|536441227|FG001|Overall Study|Lost to Follow-up|1|||
148717914|NCT00631007|536441228|FG002|Overall Study|Lost to Follow-up|2|||
148717915|NCT00631007|536441229|FG003|Overall Study|Lost to Follow-up|4|||
148717916|NCT00631007|536441230|FG004|Overall Study|Lost to Follow-up|5|||
148717917|NCT00631007|536441231|FG005|Overall Study|Lost to Follow-up|3|||
148717918|NCT00631007|536441226|FG000|Overall Study|Physician Decision|1|||
148717919|NCT00631007|536441227|FG001|Overall Study|Physician Decision|0|||
148717920|NCT00631007|536441228|FG002|Overall Study|Physician Decision|1|||
148717921|NCT00631007|536441229|FG003|Overall Study|Physician Decision|0|||
148717922|NCT00631007|536441230|FG004|Overall Study|Physician Decision|0|||
148717923|NCT00631007|536441231|FG005|Overall Study|Physician Decision|2|||
148717924|NCT00631007|536441226|FG000|Overall Study|Persistent Hyperglycemia|2|||
148717925|NCT00631007|536441227|FG001|Overall Study|Persistent Hyperglycemia|2|||
148717926|NCT00631007|536441228|FG002|Overall Study|Persistent Hyperglycemia|5|||
148717927|NCT00631007|536441229|FG003|Overall Study|Persistent Hyperglycemia|1|||
148717928|NCT00631007|536441230|FG004|Overall Study|Persistent Hyperglycemia|2|||
148717929|NCT00631007|536441231|FG005|Overall Study|Persistent Hyperglycemia|5|||
148717930|NCT00631007|536441226|FG000|Overall Study|Withdrawal by Subject|4|||
148717931|NCT00631007|536441227|FG001|Overall Study|Withdrawal by Subject|5|||
148717932|NCT00631007|536441228|FG002|Overall Study|Withdrawal by Subject|2|||
148717933|NCT00631007|536441229|FG003|Overall Study|Withdrawal by Subject|2|||
148717934|NCT00631007|536441230|FG004|Overall Study|Withdrawal by Subject|1|||
148717935|NCT00631007|536441231|FG005|Overall Study|Withdrawal by Subject|3|||
148717936|NCT00631007|536441226|FG000|Overall Study|Other|2|||
148717937|NCT00631007|536441227|FG001|Overall Study|Other|1|||
148717938|NCT00631007|536441228|FG002|Overall Study|Other|0|||
148717939|NCT00631007|536441229|FG003|Overall Study|Other|0|||
148717940|NCT00631007|536441230|FG004|Overall Study|Other|1|||
148717941|NCT00631007|536441231|FG005|Overall Study|Other|0|||
148717942|NCT02674633|536441232|FG000|Overall Study|Lost to Follow-up|3|||
148717943|NCT02674633|536441233|FG001|Overall Study|Lost to Follow-up|2|||
148717944|NCT02674633|536441232|FG000|Overall Study|Physician Decision|1|||
148717945|NCT02674633|536441233|FG001|Overall Study|Physician Decision|0|||
148717946|NCT02674633|536441232|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148717947|NCT02674633|536441233|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
148717948|NCT00683787|536441234|FG000|Overall Study|Progression|3|||
148717949|NCT00683787|536441235|FG001|Overall Study|Progression|3|||
148717950|NCT00683787|536441236|FG002|Overall Study|Progression|0|||
148717951|NCT00683787|536441234|FG000|Overall Study|Adverse Event|0|||
148717952|NCT00683787|536441235|FG001|Overall Study|Adverse Event|0|||
148717953|NCT00683787|536441236|FG002|Overall Study|Adverse Event|2|||
148717954|NCT02344745|536441237|FG000|Overall Study|Data collection sheets were lost|2|||
148717955|NCT02344745|536441238|FG001|Overall Study|Data collection sheets were lost|0|||
148717956|NCT02788513|536441239|FG000|Overall Study|Withdrawal by Subject|3|||
148717957|NCT02788513|536441240|FG001|Overall Study|Withdrawal by Subject|0|||
148717958|NCT02788513|536441241|FG002|Overall Study|Withdrawal by Subject|2|||
148717959|NCT02788513|536441242|FG003|Overall Study|Withdrawal by Subject|3|||
148969127|NCT02641379|537372858|FG003|Overall Study|Participant's compliance|1|||
148969128|NCT02641379|537372859|FG004|Overall Study|Participant's compliance|0|||
148969129|NCT02641379|537372860|FG005|Overall Study|Participant's compliance|2|||
148969130|NCT02641379|537372861|FG006|Overall Study|Participant's compliance|0|||
148969131|NCT02641379|537372862|FG007|Overall Study|Participant's compliance|0|||
148969132|NCT02641379|537372863|FG008|Overall Study|Participant's compliance|1|||
148969133|NCT02641379|537372864|FG009|Overall Study|Participant's compliance|1|||
148717960|NCT02788513|536441243|FG004|Overall Study|Withdrawal by Subject|1|||
148717961|NCT02788513|536441239|FG000|Overall Study|Lost to Follow-up|1|||
148717962|NCT02788513|536441240|FG001|Overall Study|Lost to Follow-up|0|||
148717963|NCT02788513|536441241|FG002|Overall Study|Lost to Follow-up|0|||
148717964|NCT02788513|536441242|FG003|Overall Study|Lost to Follow-up|0|||
148717965|NCT02788513|536441243|FG004|Overall Study|Lost to Follow-up|1|||
148717966|NCT02788513|536441239|FG000|Overall Study|Adverse Event|5|||
148717967|NCT02788513|536441240|FG001|Overall Study|Adverse Event|8|||
148717968|NCT02788513|536441241|FG002|Overall Study|Adverse Event|4|||
148717969|NCT02788513|536441242|FG003|Overall Study|Adverse Event|2|||
148717970|NCT02788513|536441243|FG004|Overall Study|Adverse Event|2|||
148717971|NCT02788513|536441239|FG000|Overall Study|Protocol Violation|0|||
148717972|NCT02788513|536441240|FG001|Overall Study|Protocol Violation|0|||
148717973|NCT02788513|536441241|FG002|Overall Study|Protocol Violation|1|||
148717974|NCT02788513|536441242|FG003|Overall Study|Protocol Violation|1|||
148717975|NCT02788513|536441243|FG004|Overall Study|Protocol Violation|0|||
148717976|NCT02788513|536441239|FG000|Overall Study|Subject decided to stop taking treatment|0|||
148717977|NCT02788513|536441240|FG001|Overall Study|Subject decided to stop taking treatment|0|||
148717978|NCT02788513|536441241|FG002|Overall Study|Subject decided to stop taking treatment|1|||
148717979|NCT02788513|536441242|FG003|Overall Study|Subject decided to stop taking treatment|0|||
148717980|NCT02788513|536441243|FG004|Overall Study|Subject decided to stop taking treatment|0|||
148717981|NCT02788513|536441239|FG000|Overall Study|Decision by the study team|0|||
148717982|NCT02788513|536441240|FG001|Overall Study|Decision by the study team|0|||
148717983|NCT02788513|536441241|FG002|Overall Study|Decision by the study team|0|||
148717984|NCT02788513|536441242|FG003|Overall Study|Decision by the study team|0|||
148717985|NCT02788513|536441243|FG004|Overall Study|Decision by the study team|1|||
148717986|NCT04982445|536441244|FG000|Overall Study|Protocol Violation|1|||
148717987|NCT04982445|536441244|FG000|Overall Study|Withdrawal by Subject|4|||
148717988|NCT04982445|536441244|FG000|Overall Study|Lost to Follow-up|1|||
148717989|NCT04968925|536441247|FG000|Phase I- Period 1|COVID-19 related|0|||
148717990|NCT04968925|536441248|FG001|Phase I- Period 1|COVID-19 related|1|||
148717991|NCT04968925|536441249|FG002|Phase I- Period 1|COVID-19 related|0|||
148717992|NCT04968925|536441250|FG003|Phase I- Period 1|COVID-19 related|0|||
148717993|NCT04968925|536441247|FG000|Phase I- Period 1|Subject enrolled in error|1|||
148717994|NCT04968925|536441248|FG001|Phase I- Period 1|Subject enrolled in error|1|||
148717995|NCT04968925|536441249|FG002|Phase I- Period 1|Subject enrolled in error|0|||
148717996|NCT04968925|536441250|FG003|Phase I- Period 1|Subject enrolled in error|0|||
148717997|NCT04968925|536441247|FG000|Phase II- Period 1|COVID-19 Related|0|||
148717998|NCT04968925|536441248|FG001|Phase II- Period 1|COVID-19 Related|0|||
148717999|NCT04968925|536441249|FG002|Phase II- Period 1|COVID-19 Related|6|||
148718000|NCT04968925|536441250|FG003|Phase II- Period 1|COVID-19 Related|6|||
148718001|NCT04968925|536441247|FG000|Phase II- Period 1|Subject enrolled in error|0|||
148718002|NCT04968925|536441248|FG001|Phase II- Period 1|Subject enrolled in error|0|||
148718003|NCT04968925|536441249|FG002|Phase II- Period 1|Subject enrolled in error|1|||
148718004|NCT04968925|536441250|FG003|Phase II- Period 1|Subject enrolled in error|0|||
148718005|NCT04968925|536441247|FG000|Phase II -Period 2|COVID-19 related|0|||
148718006|NCT04968925|536441248|FG001|Phase II -Period 2|COVID-19 related|0|||
148718007|NCT04968925|536441249|FG002|Phase II -Period 2|COVID-19 related|4|||
148718008|NCT04968925|536441250|FG003|Phase II -Period 2|COVID-19 related|3|||
148718009|NCT04968925|536441247|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
148718010|NCT04968925|536441248|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
148718011|NCT04968925|536441249|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
148718012|NCT04968925|536441250|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
148718013|NCT00396630|536441252|FG000|Overall Study|Lost to Follow-up|1|||
148718014|NCT00396630|536441253|FG001|Overall Study|Lost to Follow-up|1|||
148718015|NCT00396630|536441252|FG000|Overall Study|Withdrawal by Subject|1|||
148718016|NCT00396630|536441253|FG001|Overall Study|Withdrawal by Subject|1|||
148718017|NCT00396630|536441252|FG000|Overall Study|Not vaccinated at Visit 3|3|||
148718018|NCT00396630|536441253|FG001|Overall Study|Not vaccinated at Visit 3|3|||
148718019|NCT02327325|536441254|FG000|Overall Study|Withdrawal by Subject|1|||
148718020|NCT02327325|536441255|FG001|Overall Study|Withdrawal by Subject|4|||
148718021|NCT02327325|536441256|FG002|Overall Study|Withdrawal by Subject|4|||
148718022|NCT02327325|536441254|FG000|Overall Study|Excluded by Study Team|0|||
148718023|NCT02327325|536441255|FG001|Overall Study|Excluded by Study Team|0|||
148718024|NCT02327325|536441256|FG002|Overall Study|Excluded by Study Team|1|||
148718025|NCT02457819|536441259|FG000|Overall Study|reason not given|8|||
148718026|NCT02457819|536441259|FG000|Overall Study|Withdrawal by Subject|24|||
148718027|NCT02457819|536441259|FG000|Overall Study|Protocol Violation|1|||
148718028|NCT02457819|536441259|FG000|Overall Study|non compliance with study drug|4|||
148718029|NCT02457819|536441259|FG000|Overall Study|Lost to Follow-up|10|||
148718030|NCT02457819|536441259|FG000|Overall Study|Lack of Efficacy|19|||
148718031|NCT02457819|536441259|FG000|Overall Study|Adverse Event|33|||
148718032|NCT00763555|536441260|FG000|Overall Study|Adverse Event|2|||
148718033|NCT00763555|536441261|FG001|Overall Study|Adverse Event|1|||
148718034|NCT00763555|536441260|FG000|Overall Study|Withdrawal by Subject|2|||
148718035|NCT00763555|536441261|FG001|Overall Study|Withdrawal by Subject|6|||
148718036|NCT00763555|536441260|FG000|Overall Study|Lost to Follow-up|0|||
148718037|NCT00763555|536441261|FG001|Overall Study|Lost to Follow-up|3|||
148969134|NCT02641379|537372865|FG010|Overall Study|Participant's compliance|1|||
148969135|NCT02641379|537372855|FG000|Overall Study|Participant cannot be reached|4|||
148969136|NCT02641379|537372856|FG001|Overall Study|Participant cannot be reached|4|||
148969137|NCT02641379|537372857|FG002|Overall Study|Participant cannot be reached|0|||
148718038|NCT02510261|536441262|FG000|Overall Study|Adverse Event|5|||
148718039|NCT02510261|536441263|FG001|Overall Study|Adverse Event|8|||
148718040|NCT02510261|536441264|FG002|Overall Study|Adverse Event|0|||
148718041|NCT02510261|536441262|FG000|Overall Study|Physician Decision|1|||
148718042|NCT02510261|536441263|FG001|Overall Study|Physician Decision|5|||
148815824|NCT02850406|536800634|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815825|NCT02850406|536800635|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148969138|NCT02641379|537372858|FG003|Overall Study|Participant cannot be reached|8|||
148718043|NCT02510261|536441264|FG002|Overall Study|Physician Decision|0|||
148718044|NCT02510261|536441262|FG000|Overall Study|Death|19|||
148718045|NCT02510261|536441263|FG001|Overall Study|Death|19|||
148718046|NCT02510261|536441264|FG002|Overall Study|Death|0|||
148718047|NCT02510261|536441262|FG000|Overall Study|Withdrawal by Subject|3|||
148718048|NCT02510261|536441263|FG001|Overall Study|Withdrawal by Subject|10|||
148718049|NCT02510261|536441264|FG002|Overall Study|Withdrawal by Subject|3|||
148718050|NCT04886063|536441267|FG000|Overall Study|Adverse Event|50|||
148718051|NCT04886063|536441267|FG000|Overall Study|Lack of Efficacy|31|||
148718052|NCT04886063|536441267|FG000|Overall Study|Withdrawal by Subject|45|||
148718053|NCT04886063|536441267|FG000|Overall Study|Physician Decision|3|||
148718054|NCT04886063|536441267|FG000|Overall Study|Protocol Violation|3|||
148718055|NCT04886063|536441267|FG000|Overall Study|Site closure|4|||
148718056|NCT04886063|536441267|FG000|Overall Study|Nursing home replacement|3|||
148718057|NCT04886063|536441267|FG000|Overall Study|Lost to Follow-up|5|||
148718058|NCT04886063|536441267|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
148718059|NCT04886063|536441267|FG000|Overall Study|>1 reason|20|||
148718060|NCT01344018|536441273|FG000|Overall Study|Death|22|||
148718061|NCT01344018|536441274|FG001|Overall Study|Death|25|||
148718062|NCT01344018|536441273|FG000|Overall Study|Lost to Follow-up|4|||
148718063|NCT01344018|536441274|FG001|Overall Study|Lost to Follow-up|7|||
148718064|NCT05070754|536441275|FG000|Overall Study|Withdrawal by Subject|0|||
148718065|NCT05070754|536441276|FG001|Overall Study|Withdrawal by Subject|0|||
148718066|NCT05070754|536441277|FG002|Overall Study|Withdrawal by Subject|0|||
148718067|NCT05070754|536441278|FG003|Overall Study|Withdrawal by Subject|1|||
148718068|NCT05070754|536441275|FG000|Overall Study|Protocol Violation|0|||
148718069|NCT05070754|536441276|FG001|Overall Study|Protocol Violation|0|||
148718070|NCT05070754|536441277|FG002|Overall Study|Protocol Violation|0|||
148718071|NCT05070754|536441278|FG003|Overall Study|Protocol Violation|1|||
148718072|NCT01332968|536441280|FG000|Induction Period|Adverse Event|23|||
148718073|NCT01332968|536441281|FG001|Induction Period|Adverse Event|26|||
148718074|NCT01332968|536441282|FG002|Induction Period|Adverse Event|0|||
148718075|NCT01332968|536441283|FG003|Induction Period|Adverse Event|0|||
148718076|NCT01332968|536441284|FG004|Induction Period|Adverse Event|0|||
148718077|NCT01332968|536441285|FG005|Induction Period|Adverse Event|0|||
148718078|NCT01332968|536441286|FG006|Induction Period|Adverse Event|0|||
148718079|NCT01332968|536441287|FG007|Induction Period|Adverse Event|0|||
148718080|NCT01332968|536441280|FG000|Induction Period|Death|1|||
148718081|NCT01332968|536441281|FG001|Induction Period|Death|4|||
148718082|NCT01332968|536441282|FG002|Induction Period|Death|0|||
148718083|NCT01332968|536441283|FG003|Induction Period|Death|0|||
148718084|NCT01332968|536441284|FG004|Induction Period|Death|0|||
148718085|NCT01332968|536441285|FG005|Induction Period|Death|0|||
148718086|NCT01332968|536441286|FG006|Induction Period|Death|0|||
148718087|NCT01332968|536441287|FG007|Induction Period|Death|0|||
148718088|NCT01332968|536441280|FG000|Induction Period|Non-compliance|1|||
148718089|NCT01332968|536441281|FG001|Induction Period|Non-compliance|0|||
148718090|NCT01332968|536441282|FG002|Induction Period|Non-compliance|0|||
148718091|NCT01332968|536441283|FG003|Induction Period|Non-compliance|0|||
148718092|NCT01332968|536441284|FG004|Induction Period|Non-compliance|0|||
148718093|NCT01332968|536441285|FG005|Induction Period|Non-compliance|0|||
148718094|NCT01332968|536441286|FG006|Induction Period|Non-compliance|0|||
148718095|NCT01332968|536441287|FG007|Induction Period|Non-compliance|0|||
148718096|NCT01332968|536441280|FG000|Induction Period|Other|2|||
148718097|NCT01332968|536441281|FG001|Induction Period|Other|2|||
148718098|NCT01332968|536441282|FG002|Induction Period|Other|0|||
148718099|NCT01332968|536441283|FG003|Induction Period|Other|0|||
148718100|NCT01332968|536441284|FG004|Induction Period|Other|0|||
148718101|NCT01332968|536441285|FG005|Induction Period|Other|0|||
148718102|NCT01332968|536441286|FG006|Induction Period|Other|0|||
148718103|NCT01332968|536441287|FG007|Induction Period|Other|0|||
148718104|NCT01332968|536441280|FG000|Induction Period|Physician Decision|6|||
148718105|NCT01332968|536441281|FG001|Induction Period|Physician Decision|1|||
148969139|NCT02641379|537372859|FG004|Overall Study|Participant cannot be reached|2|||
148969140|NCT02641379|537372860|FG005|Overall Study|Participant cannot be reached|1|||
148969141|NCT02641379|537372861|FG006|Overall Study|Participant cannot be reached|0|||
148969142|NCT02641379|537372862|FG007|Overall Study|Participant cannot be reached|1|||
148969143|NCT02641379|537372863|FG008|Overall Study|Participant cannot be reached|0|||
148969144|NCT02641379|537372864|FG009|Overall Study|Participant cannot be reached|2|||
148969145|NCT02641379|537372865|FG010|Overall Study|Participant cannot be reached|1|||
148969146|NCT02641379|537372855|FG000|Overall Study|PCR positive at Week 24|15|||
148969147|NCT02641379|537372856|FG001|Overall Study|PCR positive at Week 24|21|||
148718106|NCT01332968|536441282|FG002|Induction Period|Physician Decision|0|||
148718107|NCT01332968|536441283|FG003|Induction Period|Physician Decision|0|||
148718108|NCT01332968|536441284|FG004|Induction Period|Physician Decision|0|||
148718109|NCT01332968|536441285|FG005|Induction Period|Physician Decision|0|||
148718110|NCT01332968|536441286|FG006|Induction Period|Physician Decision|0|||
148718111|NCT01332968|536441287|FG007|Induction Period|Physician Decision|0|||
148718112|NCT01332968|536441280|FG000|Induction Period|Progressive Disease|15|||
148718113|NCT01332968|536441281|FG001|Induction Period|Progressive Disease|7|||
148969148|NCT02641379|537372857|FG002|Overall Study|PCR positive at Week 24|62|||
148969149|NCT02641379|537372858|FG003|Overall Study|PCR positive at Week 24|0|||
148969150|NCT02641379|537372859|FG004|Overall Study|PCR positive at Week 24|0|||
148969151|NCT02641379|537372860|FG005|Overall Study|PCR positive at Week 24|6|||
148969152|NCT02641379|537372861|FG006|Overall Study|PCR positive at Week 24|3|||
148718114|NCT01332968|536441282|FG002|Induction Period|Progressive Disease|0|||
148718115|NCT01332968|536441283|FG003|Induction Period|Progressive Disease|0|||
148718116|NCT01332968|536441284|FG004|Induction Period|Progressive Disease|0|||
148718117|NCT01332968|536441285|FG005|Induction Period|Progressive Disease|0|||
148718118|NCT01332968|536441286|FG006|Induction Period|Progressive Disease|0|||
148718119|NCT01332968|536441287|FG007|Induction Period|Progressive Disease|0|||
148718120|NCT01332968|536441280|FG000|Induction Period|Protocol Violation|3|||
148718121|NCT01332968|536441281|FG001|Induction Period|Protocol Violation|4|||
148718122|NCT01332968|536441282|FG002|Induction Period|Protocol Violation|0|||
148718123|NCT01332968|536441283|FG003|Induction Period|Protocol Violation|0|||
148718124|NCT01332968|536441284|FG004|Induction Period|Protocol Violation|0|||
148718125|NCT01332968|536441285|FG005|Induction Period|Protocol Violation|0|||
148718126|NCT01332968|536441286|FG006|Induction Period|Protocol Violation|0|||
148718127|NCT01332968|536441287|FG007|Induction Period|Protocol Violation|0|||
148718128|NCT01332968|536441280|FG000|Induction Period|Withdrawal by Subject|3|||
148718129|NCT01332968|536441281|FG001|Induction Period|Withdrawal by Subject|5|||
148718130|NCT01332968|536441282|FG002|Induction Period|Withdrawal by Subject|0|||
148718131|NCT01332968|536441283|FG003|Induction Period|Withdrawal by Subject|0|||
148718132|NCT01332968|536441284|FG004|Induction Period|Withdrawal by Subject|0|||
148718133|NCT01332968|536441285|FG005|Induction Period|Withdrawal by Subject|0|||
148718134|NCT01332968|536441286|FG006|Induction Period|Withdrawal by Subject|0|||
148718135|NCT01332968|536441287|FG007|Induction Period|Withdrawal by Subject|0|||
148718136|NCT01332968|536441280|FG000|Induction Period|Randomised but not treated|4|||
148718137|NCT01332968|536441281|FG001|Induction Period|Randomised but not treated|7|||
148718138|NCT01332968|536441282|FG002|Induction Period|Randomised but not treated|0|||
148718139|NCT01332968|536441283|FG003|Induction Period|Randomised but not treated|0|||
148718140|NCT01332968|536441284|FG004|Induction Period|Randomised but not treated|0|||
148718141|NCT01332968|536441285|FG005|Induction Period|Randomised but not treated|0|||
148718142|NCT01332968|536441286|FG006|Induction Period|Randomised but not treated|0|||
148718143|NCT01332968|536441287|FG007|Induction Period|Randomised but not treated|0|||
148718144|NCT01332968|536441280|FG000|Maintenance/Observation Period|Adverse Event|0|||
148718145|NCT01332968|536441281|FG001|Maintenance/Observation Period|Adverse Event|0|||
148718146|NCT01332968|536441282|FG002|Maintenance/Observation Period|Adverse Event|53|||
148718147|NCT01332968|536441283|FG003|Maintenance/Observation Period|Adverse Event|66|||
148718148|NCT01332968|536441284|FG004|Maintenance/Observation Period|Adverse Event|0|||
148718149|NCT01332968|536441285|FG005|Maintenance/Observation Period|Adverse Event|0|||
148718150|NCT01332968|536441286|FG006|Maintenance/Observation Period|Adverse Event|0|||
148718151|NCT01332968|536441287|FG007|Maintenance/Observation Period|Adverse Event|0|||
148718152|NCT01332968|536441280|FG000|Maintenance/Observation Period|Death|0|||
148718153|NCT01332968|536441281|FG001|Maintenance/Observation Period|Death|0|||
148718154|NCT01332968|536441282|FG002|Maintenance/Observation Period|Death|5|||
148718155|NCT01332968|536441283|FG003|Maintenance/Observation Period|Death|6|||
148815826|NCT02850406|536800636|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815827|NCT02850406|536800637|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815828|NCT02850406|536800638|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
148815829|NCT02850406|536800639|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
148815830|NCT02850406|536800632|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
148815831|NCT02850406|536800633|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
148815832|NCT02850406|536800634|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
148815833|NCT02850406|536800635|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
148815834|NCT02850406|536800636|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
148815835|NCT02850406|536800637|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
148815836|NCT02850406|536800638|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
148815837|NCT02850406|536800639|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
148815838|NCT02850406|536800632|FG000|Part D (Up to 52 Weeks)|Other|0|||
148815839|NCT02850406|536800633|FG001|Part D (Up to 52 Weeks)|Other|0|||
148815840|NCT02850406|536800634|FG002|Part D (Up to 52 Weeks)|Other|0|||
148969153|NCT02641379|537372862|FG007|Overall Study|PCR positive at Week 24|8|||
148969154|NCT02641379|537372863|FG008|Overall Study|PCR positive at Week 24|0|||
148718156|NCT01332968|536441284|FG004|Maintenance/Observation Period|Death|0|||
148718157|NCT01332968|536441285|FG005|Maintenance/Observation Period|Death|0|||
148718158|NCT01332968|536441286|FG006|Maintenance/Observation Period|Death|0|||
148718159|NCT01332968|536441287|FG007|Maintenance/Observation Period|Death|0|||
148718160|NCT01332968|536441280|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
148815841|NCT02850406|536800635|FG003|Part D (Up to 52 Weeks)|Other|0|||
148969155|NCT02641379|537372864|FG009|Overall Study|PCR positive at Week 24|1|||
148815842|NCT02850406|536800636|FG004|Part D (Up to 52 Weeks)|Other|0|||
148815843|NCT02850406|536800637|FG005|Part D (Up to 52 Weeks)|Other|0|||
148718161|NCT01332968|536441281|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
148718162|NCT01332968|536441282|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
148718163|NCT01332968|536441283|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
148718164|NCT01332968|536441284|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
148718165|NCT01332968|536441285|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
148718166|NCT01332968|536441286|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
148718167|NCT01332968|536441287|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
148718168|NCT01332968|536441280|FG000|Maintenance/Observation Period|Non-compliance|0|||
148718169|NCT01332968|536441281|FG001|Maintenance/Observation Period|Non-compliance|0|||
148718170|NCT01332968|536441282|FG002|Maintenance/Observation Period|Non-compliance|4|||
148969156|NCT02641379|537372865|FG010|Overall Study|PCR positive at Week 24|0|||
148718171|NCT01332968|536441283|FG003|Maintenance/Observation Period|Non-compliance|3|||
148718172|NCT01332968|536441284|FG004|Maintenance/Observation Period|Non-compliance|0|||
148718173|NCT01332968|536441285|FG005|Maintenance/Observation Period|Non-compliance|0|||
148718174|NCT01332968|536441286|FG006|Maintenance/Observation Period|Non-compliance|0|||
148718175|NCT01332968|536441287|FG007|Maintenance/Observation Period|Non-compliance|0|||
148718176|NCT01332968|536441280|FG000|Maintenance/Observation Period|Other|0|||
148718177|NCT01332968|536441281|FG001|Maintenance/Observation Period|Other|0|||
148718178|NCT01332968|536441282|FG002|Maintenance/Observation Period|Other|4|||
148718179|NCT01332968|536441283|FG003|Maintenance/Observation Period|Other|7|||
148718180|NCT01332968|536441284|FG004|Maintenance/Observation Period|Other|0|||
148718181|NCT01332968|536441285|FG005|Maintenance/Observation Period|Other|0|||
148718182|NCT01332968|536441286|FG006|Maintenance/Observation Period|Other|0|||
148718183|NCT01332968|536441287|FG007|Maintenance/Observation Period|Other|0|||
148718184|NCT01332968|536441280|FG000|Maintenance/Observation Period|Physician Decision|0|||
148718185|NCT01332968|536441281|FG001|Maintenance/Observation Period|Physician Decision|0|||
148718186|NCT01332968|536441282|FG002|Maintenance/Observation Period|Physician Decision|14|||
148718187|NCT01332968|536441283|FG003|Maintenance/Observation Period|Physician Decision|19|||
148718188|NCT01332968|536441284|FG004|Maintenance/Observation Period|Physician Decision|0|||
148718189|NCT01332968|536441285|FG005|Maintenance/Observation Period|Physician Decision|1|||
148718190|NCT01332968|536441286|FG006|Maintenance/Observation Period|Physician Decision|0|||
148718191|NCT01332968|536441287|FG007|Maintenance/Observation Period|Physician Decision|0|||
148718192|NCT01332968|536441280|FG000|Maintenance/Observation Period|Progressive Disease|0|||
148718193|NCT01332968|536441281|FG001|Maintenance/Observation Period|Progressive Disease|0|||
148718194|NCT01332968|536441282|FG002|Maintenance/Observation Period|Progressive Disease|72|||
148718195|NCT01332968|536441283|FG003|Maintenance/Observation Period|Progressive Disease|40|||
148718196|NCT01332968|536441284|FG004|Maintenance/Observation Period|Progressive Disease|0|||
148718197|NCT01332968|536441285|FG005|Maintenance/Observation Period|Progressive Disease|0|||
148718198|NCT01332968|536441286|FG006|Maintenance/Observation Period|Progressive Disease|0|||
148718199|NCT01332968|536441287|FG007|Maintenance/Observation Period|Progressive Disease|0|||
148718200|NCT01332968|536441280|FG000|Maintenance/Observation Period|Protocol Violation|0|||
148718201|NCT01332968|536441281|FG001|Maintenance/Observation Period|Protocol Violation|0|||
148718202|NCT01332968|536441282|FG002|Maintenance/Observation Period|Protocol Violation|1|||
148718203|NCT01332968|536441283|FG003|Maintenance/Observation Period|Protocol Violation|1|||
148718204|NCT01332968|536441284|FG004|Maintenance/Observation Period|Protocol Violation|0|||
148718205|NCT01332968|536441285|FG005|Maintenance/Observation Period|Protocol Violation|0|||
148718206|NCT01332968|536441286|FG006|Maintenance/Observation Period|Protocol Violation|0|||
148718207|NCT01332968|536441287|FG007|Maintenance/Observation Period|Protocol Violation|0|||
148718208|NCT01332968|536441280|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
148718209|NCT01332968|536441281|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
148718210|NCT01332968|536441282|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
148718211|NCT01332968|536441283|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
148718212|NCT01332968|536441284|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
148969157|NCT02641379|537372855|FG000|Overall Study|PCR positive at follow up 2|1|||
148969158|NCT02641379|537372856|FG001|Overall Study|PCR positive at follow up 2|0|||
148718213|NCT01332968|536441285|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
148718214|NCT01332968|536441286|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
148718215|NCT01332968|536441287|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
148718216|NCT01332968|536441280|FG000|Follow-Up Period|Adverse Event|0|||
148718217|NCT01332968|536441281|FG001|Follow-Up Period|Adverse Event|0|||
148969159|NCT02641379|537372857|FG002|Overall Study|PCR positive at follow up 2|0|||
148969160|NCT02641379|537372858|FG003|Overall Study|PCR positive at follow up 2|0|||
148969161|NCT02641379|537372859|FG004|Overall Study|PCR positive at follow up 2|0|||
148718218|NCT01332968|536441282|FG002|Follow-Up Period|Adverse Event|0|||
148718219|NCT01332968|536441283|FG003|Follow-Up Period|Adverse Event|0|||
148718220|NCT01332968|536441284|FG004|Follow-Up Period|Adverse Event|0|||
148718221|NCT01332968|536441285|FG005|Follow-Up Period|Adverse Event|0|||
148969162|NCT02641379|537372860|FG005|Overall Study|PCR positive at follow up 2|0|||
148969163|NCT02641379|537372861|FG006|Overall Study|PCR positive at follow up 2|0|||
148718222|NCT01332968|536441286|FG006|Follow-Up Period|Adverse Event|0|||
148969164|NCT02641379|537372862|FG007|Overall Study|PCR positive at follow up 2|0|||
148969165|NCT02641379|537372863|FG008|Overall Study|PCR positive at follow up 2|0|||
148969166|NCT02641379|537372864|FG009|Overall Study|PCR positive at follow up 2|0|||
148969167|NCT02641379|537372865|FG010|Overall Study|PCR positive at follow up 2|0|||
148969168|NCT02641379|537372855|FG000|Overall Study|Participant showed relapse|1|||
148969169|NCT02641379|537372856|FG001|Overall Study|Participant showed relapse|0|||
148969170|NCT02641379|537372857|FG002|Overall Study|Participant showed relapse|0|||
148969171|NCT02641379|537372858|FG003|Overall Study|Participant showed relapse|0|||
148969172|NCT02641379|537372859|FG004|Overall Study|Participant showed relapse|0|||
148969173|NCT02641379|537372860|FG005|Overall Study|Participant showed relapse|0|||
148969174|NCT02641379|537372861|FG006|Overall Study|Participant showed relapse|1|||
148969175|NCT02641379|537372862|FG007|Overall Study|Participant showed relapse|0|||
148969176|NCT02641379|537372863|FG008|Overall Study|Participant showed relapse|0|||
148969177|NCT02641379|537372864|FG009|Overall Study|Participant showed relapse|0|||
148969178|NCT02641379|537372865|FG010|Overall Study|Participant showed relapse|0|||
148969179|NCT02641379|537372855|FG000|Overall Study|Participant stopped study/treatment|1|||
148969180|NCT02641379|537372856|FG001|Overall Study|Participant stopped study/treatment|3|||
148969181|NCT02641379|537372857|FG002|Overall Study|Participant stopped study/treatment|1|||
148969182|NCT02641379|537372858|FG003|Overall Study|Participant stopped study/treatment|0|||
148969183|NCT02641379|537372859|FG004|Overall Study|Participant stopped study/treatment|0|||
148969184|NCT02641379|537372860|FG005|Overall Study|Participant stopped study/treatment|1|||
148969185|NCT02641379|537372861|FG006|Overall Study|Participant stopped study/treatment|2|||
148969186|NCT02641379|537372862|FG007|Overall Study|Participant stopped study/treatment|0|||
148969187|NCT02641379|537372863|FG008|Overall Study|Participant stopped study/treatment|1|||
148969188|NCT02641379|537372864|FG009|Overall Study|Participant stopped study/treatment|0|||
148969189|NCT02641379|537372865|FG010|Overall Study|Participant stopped study/treatment|0|||
148969190|NCT02641379|537372855|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
148718223|NCT01332968|536441287|FG007|Follow-Up Period|Adverse Event|4|||
148718224|NCT01332968|536441280|FG000|Follow-Up Period|Death|0|||
148718225|NCT01332968|536441281|FG001|Follow-Up Period|Death|0|||
148718226|NCT01332968|536441282|FG002|Follow-Up Period|Death|0|||
148718227|NCT01332968|536441283|FG003|Follow-Up Period|Death|0|||
148718228|NCT01332968|536441284|FG004|Follow-Up Period|Death|0|||
148718229|NCT01332968|536441285|FG005|Follow-Up Period|Death|0|||
148718230|NCT01332968|536441286|FG006|Follow-Up Period|Death|27|||
148718231|NCT01332968|536441287|FG007|Follow-Up Period|Death|30|||
148718232|NCT01332968|536441280|FG000|Follow-Up Period|Lost to Follow-up|0|||
148718233|NCT01332968|536441281|FG001|Follow-Up Period|Lost to Follow-up|0|||
148718234|NCT01332968|536441282|FG002|Follow-Up Period|Lost to Follow-up|0|||
148718235|NCT01332968|536441283|FG003|Follow-Up Period|Lost to Follow-up|0|||
148718236|NCT01332968|536441284|FG004|Follow-Up Period|Lost to Follow-up|0|||
148718237|NCT01332968|536441285|FG005|Follow-Up Period|Lost to Follow-up|0|||
148718238|NCT01332968|536441286|FG006|Follow-Up Period|Lost to Follow-up|11|||
148718239|NCT01332968|536441287|FG007|Follow-Up Period|Lost to Follow-up|15|||
148718240|NCT01332968|536441280|FG000|Follow-Up Period|Non-compliance|0|||
148718241|NCT01332968|536441281|FG001|Follow-Up Period|Non-compliance|0|||
148718242|NCT01332968|536441282|FG002|Follow-Up Period|Non-compliance|0|||
148718243|NCT01332968|536441283|FG003|Follow-Up Period|Non-compliance|0|||
148718244|NCT01332968|536441284|FG004|Follow-Up Period|Non-compliance|0|||
148718245|NCT01332968|536441285|FG005|Follow-Up Period|Non-compliance|0|||
148718246|NCT01332968|536441286|FG006|Follow-Up Period|Non-compliance|4|||
148718247|NCT01332968|536441287|FG007|Follow-Up Period|Non-compliance|9|||
148718248|NCT01332968|536441280|FG000|Follow-Up Period|Other|0|||
148718249|NCT01332968|536441281|FG001|Follow-Up Period|Other|0|||
148718250|NCT01332968|536441282|FG002|Follow-Up Period|Other|0|||
148718251|NCT01332968|536441283|FG003|Follow-Up Period|Other|0|||
148718252|NCT01332968|536441284|FG004|Follow-Up Period|Other|0|||
148718253|NCT01332968|536441285|FG005|Follow-Up Period|Other|0|||
148815844|NCT02850406|536800638|FG006|Part D (Up to 52 Weeks)|Other|0|||
148969191|NCT02641379|537372856|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
148718254|NCT01332968|536441286|FG006|Follow-Up Period|Other|18|||
148718255|NCT01332968|536441287|FG007|Follow-Up Period|Other|21|||
148718256|NCT01332968|536441280|FG000|Follow-Up Period|Physician Decision|0|||
148718257|NCT01332968|536441281|FG001|Follow-Up Period|Physician Decision|0|||
148969192|NCT02641379|537372857|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
148969193|NCT02641379|537372858|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
148718258|NCT01332968|536441282|FG002|Follow-Up Period|Physician Decision|0|||
148969194|NCT02641379|537372859|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
148969195|NCT02641379|537372860|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
148969196|NCT02641379|537372861|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
148718259|NCT01332968|536441283|FG003|Follow-Up Period|Physician Decision|0|||
148718260|NCT01332968|536441284|FG004|Follow-Up Period|Physician Decision|0|||
148718261|NCT01332968|536441285|FG005|Follow-Up Period|Physician Decision|0|||
148718262|NCT01332968|536441286|FG006|Follow-Up Period|Physician Decision|12|||
148718263|NCT01332968|536441287|FG007|Follow-Up Period|Physician Decision|15|||
148718264|NCT01332968|536441280|FG000|Follow-Up Period|Progressive Disease|0|||
148718265|NCT01332968|536441281|FG001|Follow-Up Period|Progressive Disease|0|||
148718266|NCT01332968|536441282|FG002|Follow-Up Period|Progressive Disease|0|||
148718267|NCT01332968|536441283|FG003|Follow-Up Period|Progressive Disease|0|||
148718268|NCT01332968|536441284|FG004|Follow-Up Period|Progressive Disease|0|||
148718269|NCT01332968|536441285|FG005|Follow-Up Period|Progressive Disease|0|||
148718270|NCT01332968|536441286|FG006|Follow-Up Period|Progressive Disease|126|||
148718271|NCT01332968|536441287|FG007|Follow-Up Period|Progressive Disease|106|||
148718272|NCT01332968|536441280|FG000|Follow-Up Period|Protocol Violation|0|||
148718273|NCT01332968|536441281|FG001|Follow-Up Period|Protocol Violation|0|||
148718274|NCT01332968|536441282|FG002|Follow-Up Period|Protocol Violation|0|||
148718275|NCT01332968|536441283|FG003|Follow-Up Period|Protocol Violation|0|||
148718276|NCT01332968|536441284|FG004|Follow-Up Period|Protocol Violation|0|||
148718277|NCT01332968|536441285|FG005|Follow-Up Period|Protocol Violation|0|||
148718278|NCT01332968|536441286|FG006|Follow-Up Period|Protocol Violation|1|||
148718279|NCT01332968|536441287|FG007|Follow-Up Period|Protocol Violation|0|||
148718280|NCT01332968|536441280|FG000|Follow-Up Period|Withdrawal by Subject|0|||
148718281|NCT01332968|536441281|FG001|Follow-Up Period|Withdrawal by Subject|0|||
148718282|NCT01332968|536441282|FG002|Follow-Up Period|Withdrawal by Subject|0|||
148718283|NCT01332968|536441283|FG003|Follow-Up Period|Withdrawal by Subject|0|||
148718284|NCT01332968|536441284|FG004|Follow-Up Period|Withdrawal by Subject|0|||
148718285|NCT01332968|536441285|FG005|Follow-Up Period|Withdrawal by Subject|0|||
148718286|NCT01332968|536441286|FG006|Follow-Up Period|Withdrawal by Subject|29|||
148718287|NCT01332968|536441287|FG007|Follow-Up Period|Withdrawal by Subject|32|||
148718288|NCT01332968|536441280|FG000|Follow-Up Period|No reason provided|0|||
148718289|NCT01332968|536441281|FG001|Follow-Up Period|No reason provided|0|||
148718290|NCT01332968|536441282|FG002|Follow-Up Period|No reason provided|0|||
148718291|NCT01332968|536441283|FG003|Follow-Up Period|No reason provided|0|||
148718292|NCT01332968|536441284|FG004|Follow-Up Period|No reason provided|0|||
148718293|NCT01332968|536441285|FG005|Follow-Up Period|No reason provided|0|||
148718294|NCT01332968|536441286|FG006|Follow-Up Period|No reason provided|2|||
148718295|NCT01332968|536441287|FG007|Follow-Up Period|No reason provided|3|||
148718296|NCT00194792|536441288|FG000|Overall Study|Withdrawal by Subject|1|||
148718297|NCT02340962|536441294|FG000|Overall Study|Lost to Follow-up|1|||
148718298|NCT02340962|536441295|FG001|Overall Study|Lost to Follow-up|0|||
148718299|NCT01292837|536441296|FG000|Overall Study|Adverse Event|1|||
148718300|NCT01292837|536441296|FG000|Overall Study|Further treatment determined|1|||
148718301|NCT02174276|536441297|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
148718302|NCT02174276|536441298|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
148718303|NCT02174276|536441299|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
148718304|NCT02174276|536441300|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
148718305|NCT02174276|536441297|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
148718306|NCT02174276|536441298|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
148718307|NCT02174276|536441299|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
148718308|NCT02174276|536441300|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
148718309|NCT02174276|536441297|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
148718310|NCT02174276|536441298|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
148718311|NCT02174276|536441299|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
148718312|NCT02174276|536441300|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
148718313|NCT02174276|536441297|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
148718314|NCT02174276|536441298|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
148718315|NCT02174276|536441299|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
148718316|NCT02174276|536441300|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
148718317|NCT02174276|536441297|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
148718318|NCT02174276|536441298|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
148718319|NCT02174276|536441299|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
148718320|NCT02174276|536441300|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
148718321|NCT02174276|536441297|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
148718322|NCT02174276|536441298|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
148718323|NCT02174276|536441299|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
148718324|NCT02174276|536441300|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
148718325|NCT01206439|536441303|FG000|Overall Study|subject did not meet inclusion criteria|1|||
148718326|NCT02661022|536441304|FG000|Overall Study|Withdrawal by Subject|3|||
148718327|NCT02661022|536441305|FG001|Overall Study|Withdrawal by Subject|0|||
148718328|NCT02661022|536441304|FG000|Overall Study|Adverse Event|1|||
148969197|NCT02641379|537372862|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
148969198|NCT02641379|537372863|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
148718329|NCT02661022|536441305|FG001|Overall Study|Adverse Event|1|||
148969199|NCT02641379|537372864|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
148718330|NCT02661022|536441304|FG000|Overall Study|Physician Decision|1|||
148969200|NCT02641379|537372865|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
148969201|NCT02641379|537372855|FG000|Overall Study|Financial problems|0|||
148969202|NCT02641379|537372856|FG001|Overall Study|Financial problems|1|||
148969203|NCT02641379|537372857|FG002|Overall Study|Financial problems|0|||
148718331|NCT02661022|536441305|FG001|Overall Study|Physician Decision|0|||
148718332|NCT02661022|536441304|FG000|Overall Study|Progressive Disease|2|||
148718333|NCT02661022|536441305|FG001|Overall Study|Progressive Disease|1|||
148718334|NCT05889039|536441306|FG000|Overall Study|error in completing survey|0|||
148718335|NCT05889039|536441307|FG001|Overall Study|error in completing survey|2|||
148718336|NCT05889039|536441308|FG002|Overall Study|error in completing survey|0|||
148718337|NCT05889039|536441309|FG003|Overall Study|error in completing survey|0|||
148718338|NCT05889039|536441306|FG000|Overall Study|Lost to Follow-up|4|||
148718339|NCT05889039|536441307|FG001|Overall Study|Lost to Follow-up|0|||
148718340|NCT05889039|536441308|FG002|Overall Study|Lost to Follow-up|0|||
148718341|NCT05889039|536441309|FG003|Overall Study|Lost to Follow-up|0|||
148718342|NCT01055886|536441310|FG000|Overall Study|Withdrawal by Subject|4|||
148718343|NCT01055886|536441311|FG001|Overall Study|Withdrawal by Subject|9|||
148718344|NCT01055886|536441310|FG000|Overall Study|Lost to Follow-up|1|||
148718345|NCT01055886|536441311|FG001|Overall Study|Lost to Follow-up|1|||
148718346|NCT01055886|536441310|FG000|Overall Study|Withdrawal by PI|0|||
148718347|NCT01055886|536441311|FG001|Overall Study|Withdrawal by PI|1|||
148718348|NCT00434837|536441315|FG000|Overall Study|Lost to Follow-up|20|||
148718349|NCT00434837|536441316|FG001|Overall Study|Lost to Follow-up|23|||
148718350|NCT00434837|536441317|FG002|Overall Study|Lost to Follow-up|30|||
148718351|NCT00726895|536441318|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
148718352|NCT00726895|536441319|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
148718353|NCT04194008|536441324|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
148718354|NCT04194008|536441324|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
148718355|NCT04194008|536441324|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
148718356|NCT04194008|536441324|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
148718357|NCT04194008|536441324|FG000|Treatment Phase With Nerivio|Missing data|4|||
148718358|NCT04194008|536441324|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
148718359|NCT01785615|536441326|FG000|Dietary Phase|Lost to Follow-up|0|||
148718360|NCT01785615|536441327|FG001|Dietary Phase|Lost to Follow-up|0|||
148718361|NCT01785615|536441328|FG002|Dietary Phase|Lost to Follow-up|0|||
148718362|NCT01785615|536441329|FG003|Dietary Phase|Lost to Follow-up|24|||
148718363|NCT01881737|536441330|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
148718364|NCT01881737|536441330|FG000|Overall Study|Withdrawal by Subject|1|||
148718365|NCT01881737|536441330|FG000|Overall Study|Worsening of baseline behavior|1|||
148718366|NCT02608476|536441333|FG000|Overall Study|Withdrawal by Subject|30|||
148718367|NCT02608476|536441334|FG001|Overall Study|Withdrawal by Subject|37|||
148718368|NCT02608476|536441333|FG000|Overall Study|Lost to Follow-up|24|||
148718369|NCT02608476|536441334|FG001|Overall Study|Lost to Follow-up|24|||
148718370|NCT02608476|536441333|FG000|Overall Study|Adverse Event|2|||
148718371|NCT02608476|536441334|FG001|Overall Study|Adverse Event|8|||
148718372|NCT02608476|536441333|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
148718373|NCT02608476|536441334|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
148718374|NCT02608476|536441333|FG000|Overall Study|Noncompliance with treatment|1|||
148718375|NCT02608476|536441334|FG001|Overall Study|Noncompliance with treatment|5|||
148718376|NCT02608476|536441333|FG000|Overall Study|Lack of Efficacy|3|||
148718377|NCT02608476|536441334|FG001|Overall Study|Lack of Efficacy|1|||
148718378|NCT02608476|536441333|FG000|Overall Study|Other|0|||
148718379|NCT02608476|536441334|FG001|Overall Study|Other|1|||
148718380|NCT02608476|536441333|FG000|Overall Study|Physician Decision|1|||
148718381|NCT02608476|536441334|FG001|Overall Study|Physician Decision|0|||
148718382|NCT02608476|536441333|FG000|Overall Study|Pregnancy|0|||
148718383|NCT02608476|536441334|FG001|Overall Study|Pregnancy|1|||
148718384|NCT02608476|536441333|FG000|Overall Study|Progressive disease|1|||
148718385|NCT02608476|536441334|FG001|Overall Study|Progressive disease|0|||
148718386|NCT04106817|536441335|FG000|Overall Study|Lost to Follow-up|1|||
148718387|NCT04106817|536441336|FG001|Overall Study|Lost to Follow-up|0|||
148718388|NCT04106817|536441337|FG002|Overall Study|Lost to Follow-up|0|||
148718389|NCT03310619|536441338|FG000|Pre-Treatment Period|Death|1|||
148718390|NCT03310619|536441339|FG001|Pre-Treatment Period|Death|0|||
148718391|NCT03310619|536441340|FG002|Pre-Treatment Period|Death|0|||
148718392|NCT03310619|536441341|FG003|Pre-Treatment Period|Death|0|||
148718393|NCT03310619|536441342|FG004|Pre-Treatment Period|Death|1|||
148718394|NCT03310619|536441343|FG005|Pre-Treatment Period|Death|0|||
148718395|NCT03310619|536441344|FG006|Pre-Treatment Period|Death|0|||
148718396|NCT03310619|536441345|FG007|Pre-Treatment Period|Death|0|||
148718397|NCT03310619|536441338|FG000|Pre-Treatment Period|Other reasons|2|||
148718398|NCT03310619|536441339|FG001|Pre-Treatment Period|Other reasons|1|||
148718399|NCT03310619|536441340|FG002|Pre-Treatment Period|Other reasons|2|||
148718400|NCT03310619|536441341|FG003|Pre-Treatment Period|Other reasons|0|||
148718401|NCT03310619|536441342|FG004|Pre-Treatment Period|Other reasons|0|||
148718402|NCT03310619|536441343|FG005|Pre-Treatment Period|Other reasons|0|||
148718403|NCT03310619|536441344|FG006|Pre-Treatment Period|Other reasons|2|||
148718404|NCT03310619|536441345|FG007|Pre-Treatment Period|Other reasons|0|||
148718405|NCT03310619|536441338|FG000|Treatment Period|Death|1|||
148718406|NCT03310619|536441339|FG001|Treatment Period|Death|2|||
148718407|NCT03310619|536441340|FG002|Treatment Period|Death|0|||
148718408|NCT03310619|536441341|FG003|Treatment Period|Death|0|||
148718409|NCT03310619|536441342|FG004|Treatment Period|Death|1|||
148718410|NCT03310619|536441343|FG005|Treatment Period|Death|0|||
148718411|NCT03310619|536441344|FG006|Treatment Period|Death|2|||
148718412|NCT03310619|536441345|FG007|Treatment Period|Death|0|||
148718413|NCT03310619|536441338|FG000|Treatment Period|Adverse Event|0|||
148718414|NCT03310619|536441339|FG001|Treatment Period|Adverse Event|1|||
148718415|NCT03310619|536441340|FG002|Treatment Period|Adverse Event|4|||
148718416|NCT03310619|536441341|FG003|Treatment Period|Adverse Event|1|||
148718417|NCT03310619|536441342|FG004|Treatment Period|Adverse Event|0|||
148718418|NCT03310619|536441343|FG005|Treatment Period|Adverse Event|0|||
148718419|NCT03310619|536441344|FG006|Treatment Period|Adverse Event|0|||
148718420|NCT03310619|536441345|FG007|Treatment Period|Adverse Event|0|||
148718421|NCT03310619|536441338|FG000|Treatment Period|Withdrawal by participant|0|||
148718422|NCT03310619|536441339|FG001|Treatment Period|Withdrawal by participant|0|||
148718423|NCT03310619|536441340|FG002|Treatment Period|Withdrawal by participant|1|||
148718424|NCT03310619|536441341|FG003|Treatment Period|Withdrawal by participant|0|||
148718425|NCT03310619|536441342|FG004|Treatment Period|Withdrawal by participant|0|||
148718426|NCT03310619|536441343|FG005|Treatment Period|Withdrawal by participant|0|||
148718427|NCT03310619|536441344|FG006|Treatment Period|Withdrawal by participant|0|||
148718428|NCT03310619|536441345|FG007|Treatment Period|Withdrawal by participant|0|||
148718429|NCT03310619|536441338|FG000|Treatment Period|Lost to Follow-up|0|||
148718430|NCT03310619|536441339|FG001|Treatment Period|Lost to Follow-up|0|||
148718431|NCT03310619|536441340|FG002|Treatment Period|Lost to Follow-up|0|||
148718432|NCT03310619|536441341|FG003|Treatment Period|Lost to Follow-up|0|||
148718433|NCT03310619|536441342|FG004|Treatment Period|Lost to Follow-up|0|||
148718434|NCT03310619|536441343|FG005|Treatment Period|Lost to Follow-up|0|||
148718435|NCT03310619|536441344|FG006|Treatment Period|Lost to Follow-up|0|||
148718436|NCT03310619|536441345|FG007|Treatment Period|Lost to Follow-up|1|||
148718437|NCT03310619|536441338|FG000|Treatment Period|Study terminated by sponsor|0|||
148718438|NCT03310619|536441339|FG001|Treatment Period|Study terminated by sponsor|0|||
148718439|NCT03310619|536441340|FG002|Treatment Period|Study terminated by sponsor|0|||
148718440|NCT03310619|536441341|FG003|Treatment Period|Study terminated by sponsor|0|||
148718441|NCT03310619|536441342|FG004|Treatment Period|Study terminated by sponsor|0|||
148718442|NCT03310619|536441343|FG005|Treatment Period|Study terminated by sponsor|0|||
148718443|NCT03310619|536441344|FG006|Treatment Period|Study terminated by sponsor|0|||
148718444|NCT03310619|536441345|FG007|Treatment Period|Study terminated by sponsor|1|||
148718445|NCT03310619|536441338|FG000|Treatment Period|Physician Decision|0|||
148718446|NCT03310619|536441339|FG001|Treatment Period|Physician Decision|0|||
148718447|NCT03310619|536441340|FG002|Treatment Period|Physician Decision|0|||
148718448|NCT03310619|536441341|FG003|Treatment Period|Physician Decision|0|||
148718449|NCT03310619|536441342|FG004|Treatment Period|Physician Decision|3|||
148718450|NCT03310619|536441343|FG005|Treatment Period|Physician Decision|0|||
148718451|NCT03310619|536441344|FG006|Treatment Period|Physician Decision|0|||
148718452|NCT03310619|536441345|FG007|Treatment Period|Physician Decision|0|||
148718453|NCT03310619|536441338|FG000|Treatment Period|Other reasons|1|||
148718454|NCT03310619|536441339|FG001|Treatment Period|Other reasons|0|||
148718455|NCT03310619|536441340|FG002|Treatment Period|Other reasons|2|||
148718456|NCT03310619|536441341|FG003|Treatment Period|Other reasons|0|||
148718457|NCT03310619|536441342|FG004|Treatment Period|Other reasons|0|||
148718458|NCT03310619|536441343|FG005|Treatment Period|Other reasons|0|||
148718459|NCT03310619|536441344|FG006|Treatment Period|Other reasons|0|||
148718460|NCT03310619|536441345|FG007|Treatment Period|Other reasons|0|||
148718461|NCT01517867|536441348|FG000|Overall Study|never started treatment|29|||
148718462|NCT01517867|536441349|FG001|Overall Study|never started treatment|32|||
148718463|NCT01517867|536441348|FG000|Overall Study|Withdrawal by Subject|34|||
148718464|NCT01517867|536441349|FG001|Overall Study|Withdrawal by Subject|30|||
148718465|NCT01517867|536441348|FG000|Overall Study|Still in treatment at study end|0|||
148718466|NCT01517867|536441349|FG001|Overall Study|Still in treatment at study end|3|||
148718467|NCT01266603|536441350|FG000|Overall Study|Adverse Event|1|||
148718468|NCT01266603|536441350|FG000|Overall Study|Lack of Efficacy|14|||
148718469|NCT01266603|536441350|FG000|Overall Study|Withdrawal by Subject|1|||
148969204|NCT02641379|537372858|FG003|Overall Study|Financial problems|0|||
148969205|NCT02641379|537372859|FG004|Overall Study|Financial problems|0|||
148969206|NCT02641379|537372860|FG005|Overall Study|Financial problems|0|||
148718470|NCT01266603|536441350|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
148718471|NCT02725411|536441351|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
148969207|NCT02641379|537372861|FG006|Overall Study|Financial problems|0|||
148969208|NCT02641379|537372862|FG007|Overall Study|Financial problems|0|||
148969209|NCT02641379|537372863|FG008|Overall Study|Financial problems|0|||
148718472|NCT02725411|536441352|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
148718473|NCT02725411|536441353|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
148718474|NCT02725411|536441351|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
148718475|NCT02725411|536441352|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
148718476|NCT02725411|536441353|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
148718477|NCT02725411|536441351|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
148718478|NCT02725411|536441352|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
148969210|NCT02641379|537372864|FG009|Overall Study|Financial problems|0|||
148969211|NCT02641379|537372865|FG010|Overall Study|Financial problems|0|||
148718479|NCT02725411|536441353|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
148718480|NCT02725411|536441351|FG000|Treatment Period (56 Weeks)|Other|1|||
148718481|NCT02725411|536441352|FG001|Treatment Period (56 Weeks)|Other|4|||
148718482|NCT02725411|536441353|FG002|Treatment Period (56 Weeks)|Other|5|||
148718483|NCT02725411|536441351|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
148718484|NCT02725411|536441352|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
148718485|NCT02725411|536441353|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
148718486|NCT02725411|536441351|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
148718487|NCT02725411|536441352|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
148718488|NCT02725411|536441353|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
148718489|NCT02725411|536441351|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
148718490|NCT02725411|536441352|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
148718491|NCT02725411|536441353|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
148718492|NCT02725411|536441351|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
148718493|NCT02725411|536441352|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
148718494|NCT02725411|536441353|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
148718495|NCT02725411|536441351|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
148718496|NCT02725411|536441352|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
148718497|NCT02725411|536441353|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
148718498|NCT02725411|536441351|FG000|Follow-up Period (24 Weeks)|Other|1|||
148718499|NCT02725411|536441352|FG001|Follow-up Period (24 Weeks)|Other|4|||
148718500|NCT02725411|536441353|FG002|Follow-up Period (24 Weeks)|Other|2|||
148718501|NCT02725411|536441351|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
148718502|NCT02725411|536441352|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
148718503|NCT02725411|536441353|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
148718504|NCT03847974|536441354|FG000|Overall Study|relocated out of region|3|||
148718505|NCT03847974|536441354|FG000|Overall Study|Withdrawal by Subject|2|||
148718506|NCT03847974|536441354|FG000|Overall Study|Adverse Event|1|||
148718507|NCT01685216|536441355|FG000|Overall Study|Did not receive study drug|1|||
148718508|NCT00756717|536441358|FG000|Overall Study|Withdrawal by Subject|2|||
148718509|NCT02654015|536441359|FG000|Overall Study|Death|12|||
148718510|NCT02654015|536441359|FG000|Overall Study|Lost to Follow-up|3|||
148718511|NCT02418754|536441360|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
148718512|NCT02418754|536441361|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
148718513|NCT02418754|536441362|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
148718514|NCT02418754|536441363|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
148718515|NCT02418754|536441364|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
148718516|NCT02418754|536441360|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
148718517|NCT02418754|536441361|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
148718518|NCT02418754|536441362|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
148718519|NCT02418754|536441363|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
148718520|NCT02418754|536441364|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
148718521|NCT02418754|536441360|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
148718522|NCT02418754|536441361|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
148718523|NCT02418754|536441362|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
148718524|NCT02418754|536441363|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
148718525|NCT02418754|536441364|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
148718526|NCT02418754|536441360|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
148718527|NCT02418754|536441361|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
148718528|NCT02418754|536441362|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
148718529|NCT02418754|536441363|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
148718530|NCT02418754|536441364|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
148718531|NCT02418754|536441360|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
148718532|NCT02418754|536441361|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
148718533|NCT02418754|536441362|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
148718534|NCT02418754|536441363|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
148718535|NCT02418754|536441364|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
148718536|NCT02418754|536441360|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
148718537|NCT02418754|536441361|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
148718538|NCT02418754|536441362|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
148718539|NCT02418754|536441363|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
148718540|NCT02418754|536441364|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
148718541|NCT02418754|536441360|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
148718542|NCT02418754|536441361|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
148718543|NCT02418754|536441362|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
148718544|NCT02418754|536441363|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
148718545|NCT02418754|536441364|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
148718546|NCT02418754|536441360|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
148718547|NCT02418754|536441361|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
148718548|NCT02418754|536441362|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
148718549|NCT02418754|536441363|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
148815845|NCT02850406|536800639|FG007|Part D (Up to 52 Weeks)|Other|1|||
148718550|NCT02418754|536441364|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
148718551|NCT02418754|536441360|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
148718552|NCT02418754|536441361|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
148718553|NCT02418754|536441362|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
148718554|NCT02418754|536441363|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
148718555|NCT02418754|536441364|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
148718556|NCT02418754|536441360|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
148718557|NCT02418754|536441361|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
148718558|NCT02418754|536441362|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
148718559|NCT02418754|536441363|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
148718560|NCT02418754|536441364|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
148718561|NCT02418754|536441360|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
148718562|NCT02418754|536441361|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
148718563|NCT02418754|536441362|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
148718564|NCT02418754|536441363|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
148718565|NCT02418754|536441364|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
148718566|NCT01896505|536441365|FG000|Overall Study|Adverse Event|1|||
148718567|NCT01896505|536441366|FG001|Overall Study|Adverse Event|0|||
148718568|NCT01896505|536441367|FG002|Overall Study|Adverse Event|2|||
148718569|NCT01896505|536441368|FG003|Overall Study|Adverse Event|1|||
148718570|NCT01896505|536441369|FG004|Overall Study|Adverse Event|1|||
148718571|NCT01896505|536441370|FG005|Overall Study|Adverse Event|0|||
148718572|NCT01896505|536441365|FG000|Overall Study|Physician Decision|1|||
148718573|NCT01896505|536441366|FG001|Overall Study|Physician Decision|3|||
148718574|NCT01896505|536441367|FG002|Overall Study|Physician Decision|2|||
148718575|NCT01896505|536441368|FG003|Overall Study|Physician Decision|0|||
148718576|NCT01896505|536441369|FG004|Overall Study|Physician Decision|0|||
148718577|NCT01896505|536441370|FG005|Overall Study|Physician Decision|1|||
148718578|NCT01896505|536441365|FG000|Overall Study|Withdrawal by Subject|1|||
148718579|NCT01896505|536441366|FG001|Overall Study|Withdrawal by Subject|0|||
148718580|NCT01896505|536441367|FG002|Overall Study|Withdrawal by Subject|3|||
148718581|NCT01896505|536441368|FG003|Overall Study|Withdrawal by Subject|1|||
148718582|NCT01896505|536441369|FG004|Overall Study|Withdrawal by Subject|0|||
148718583|NCT01896505|536441370|FG005|Overall Study|Withdrawal by Subject|0|||
148718584|NCT01896505|536441365|FG000|Overall Study|Disease Progression|7|||
148718585|NCT01896505|536441366|FG001|Overall Study|Disease Progression|5|||
148718586|NCT01896505|536441367|FG002|Overall Study|Disease Progression|8|||
148718587|NCT01896505|536441368|FG003|Overall Study|Disease Progression|4|||
148718588|NCT01896505|536441369|FG004|Overall Study|Disease Progression|4|||
148718589|NCT01896505|536441370|FG005|Overall Study|Disease Progression|4|||
148718590|NCT01896505|536441365|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
148718591|NCT01896505|536441366|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
148718592|NCT01896505|536441367|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
148718593|NCT01896505|536441368|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
148718594|NCT01896505|536441369|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
148718595|NCT01896505|536441370|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
148718596|NCT01896505|536441365|FG000|Overall Study|Intercurrent illness|0|||
148718597|NCT01896505|536441366|FG001|Overall Study|Intercurrent illness|1|||
148718598|NCT01896505|536441367|FG002|Overall Study|Intercurrent illness|0|||
148718599|NCT01896505|536441368|FG003|Overall Study|Intercurrent illness|0|||
148718600|NCT01896505|536441369|FG004|Overall Study|Intercurrent illness|0|||
148718601|NCT01896505|536441370|FG005|Overall Study|Intercurrent illness|0|||
148718602|NCT01896505|536441365|FG000|Overall Study|Death|0|||
148718603|NCT01896505|536441366|FG001|Overall Study|Death|0|||
148718604|NCT01896505|536441367|FG002|Overall Study|Death|1|||
148718605|NCT01896505|536441368|FG003|Overall Study|Death|1|||
148718606|NCT01896505|536441369|FG004|Overall Study|Death|0|||
148718607|NCT01896505|536441370|FG005|Overall Study|Death|1|||
148718608|NCT00772148|536441371|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
148718609|NCT00772148|536441372|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
148969212|NCT02641379|537372855|FG000|Overall Study|PCR positive at Week 68|0|||
148969213|NCT02641379|537372856|FG001|Overall Study|PCR positive at Week 68|1|||
148969214|NCT02641379|537372857|FG002|Overall Study|PCR positive at Week 68|0|||
148969215|NCT02641379|537372858|FG003|Overall Study|PCR positive at Week 68|0|||
148718610|NCT00772148|536441371|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
148718611|NCT00772148|536441372|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
148718612|NCT00772148|536441371|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
148718613|NCT00772148|536441372|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
148718614|NCT00772148|536441371|FG000|Maintenance Phase (Week 52)|Death|2|||
148718615|NCT00772148|536441372|FG001|Maintenance Phase (Week 52)|Death|2|||
148718616|NCT00772148|536441371|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
148718617|NCT00772148|536441372|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
148718618|NCT00772148|536441371|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
148718619|NCT00772148|536441372|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
148718620|NCT00772148|536441371|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
148718621|NCT00772148|536441372|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
148718622|NCT01525628|536441375|FG000|Overall Study|Adverse Event|1|||
148718623|NCT01525628|536441376|FG001|Overall Study|Adverse Event|1|||
148718624|NCT01525628|536441377|FG002|Overall Study|Adverse Event|2|||
148718625|NCT01525628|536441378|FG003|Overall Study|Adverse Event|0|||
148718626|NCT01525628|536441379|FG004|Overall Study|Adverse Event|1|||
148718627|NCT01525628|536441375|FG000|Overall Study|Lack of Efficacy|0|||
148718628|NCT01525628|536441376|FG001|Overall Study|Lack of Efficacy|2|||
148718629|NCT01525628|536441377|FG002|Overall Study|Lack of Efficacy|2|||
148718630|NCT01525628|536441378|FG003|Overall Study|Lack of Efficacy|1|||
148718631|NCT01525628|536441379|FG004|Overall Study|Lack of Efficacy|2|||
148718632|NCT01525628|536441375|FG000|Overall Study|Protocol Violation|0|||
148718633|NCT01525628|536441376|FG001|Overall Study|Protocol Violation|0|||
148718634|NCT01525628|536441377|FG002|Overall Study|Protocol Violation|1|||
148718635|NCT01525628|536441378|FG003|Overall Study|Protocol Violation|0|||
148718636|NCT01525628|536441379|FG004|Overall Study|Protocol Violation|0|||
148718637|NCT01525628|536441375|FG000|Overall Study|Lost to Follow-up|1|||
148718638|NCT01525628|536441376|FG001|Overall Study|Lost to Follow-up|1|||
148718639|NCT01525628|536441377|FG002|Overall Study|Lost to Follow-up|0|||
148718640|NCT01525628|536441378|FG003|Overall Study|Lost to Follow-up|0|||
148718641|NCT01525628|536441379|FG004|Overall Study|Lost to Follow-up|0|||
148718642|NCT01525628|536441375|FG000|Overall Study|Withdrawal by Subject|0|||
148718643|NCT01525628|536441376|FG001|Overall Study|Withdrawal by Subject|1|||
148718644|NCT01525628|536441377|FG002|Overall Study|Withdrawal by Subject|0|||
148718645|NCT01525628|536441378|FG003|Overall Study|Withdrawal by Subject|0|||
148718646|NCT01525628|536441379|FG004|Overall Study|Withdrawal by Subject|0|||
148718647|NCT01525628|536441375|FG000|Overall Study|Other reason not defined above|0|||
148718648|NCT01525628|536441376|FG001|Overall Study|Other reason not defined above|0|||
148718649|NCT01525628|536441377|FG002|Overall Study|Other reason not defined above|0|||
148718650|NCT01525628|536441378|FG003|Overall Study|Other reason not defined above|3|||
148718651|NCT01525628|536441379|FG004|Overall Study|Other reason not defined above|0|||
148718652|NCT03573336|536441380|FG000|Overall Study|Study terminated|2|||
148718653|NCT03573336|536441381|FG001|Overall Study|Study terminated|4|||
148718654|NCT03573336|536441382|FG002|Overall Study|Study terminated|2|||
148718655|NCT00787605|536441383|FG000|Overall Study|Administrative Problems|3|||
148718656|NCT00787605|536441384|FG001|Overall Study|Administrative Problems|0|||
148718657|NCT00787605|536441383|FG000|Overall Study|Adverse Event|14|||
148718658|NCT00787605|536441384|FG001|Overall Study|Adverse Event|25|||
148718659|NCT00787605|536441383|FG000|Overall Study|Lost to Follow-up|3|||
148718660|NCT00787605|536441384|FG001|Overall Study|Lost to Follow-up|6|||
148718661|NCT00787605|536441383|FG000|Overall Study|Protocol Violation|7|||
148718662|NCT00787605|536441384|FG001|Overall Study|Protocol Violation|3|||
148718663|NCT00787605|536441383|FG000|Overall Study|Withdrawal by Subject|6|||
148718664|NCT00787605|536441384|FG001|Overall Study|Withdrawal by Subject|13|||
148718665|NCT00787605|536441383|FG000|Overall Study|Lack of Efficacy|13|||
148718666|NCT00787605|536441384|FG001|Overall Study|Lack of Efficacy|9|||
148718667|NCT03108820|536441385|FG000|Overall Study|Lost to Follow-up|30|||
148718668|NCT03108820|536441386|FG001|Overall Study|Lost to Follow-up|28|||
148718669|NCT03108820|536441385|FG000|Overall Study|Withdrawal by Subject|32|||
148718670|NCT03108820|536441386|FG001|Overall Study|Withdrawal by Subject|24|||
148718671|NCT03108820|536441385|FG000|Overall Study|Death|6|||
148718672|NCT03108820|536441386|FG001|Overall Study|Death|11|||
148718673|NCT01475487|536441388|FG000|Overall Study|had to leave early for personal reasons|2|||
148718674|NCT01475487|536441389|FG001|Overall Study|had to leave early for personal reasons|1|||
148718675|NCT01992094|536441390|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
148718676|NCT01992094|536441391|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
148718677|NCT01992094|536441392|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
148718678|NCT01992094|536441390|FG000|Overall Study|Adverse Event|1|||
148718679|NCT01992094|536441391|FG001|Overall Study|Adverse Event|0|||
148718680|NCT01992094|536441392|FG002|Overall Study|Adverse Event|0|||
148718681|NCT01992094|536441390|FG000|Overall Study|Death|5|||
148718682|NCT01992094|536441391|FG001|Overall Study|Death|5|||
148718683|NCT01992094|536441392|FG002|Overall Study|Death|2|||
148718684|NCT01992094|536441390|FG000|Overall Study|Lost to Follow-up|26|||
148718685|NCT01992094|536441391|FG001|Overall Study|Lost to Follow-up|9|||
148718686|NCT01992094|536441392|FG002|Overall Study|Lost to Follow-up|13|||
148718687|NCT01992094|536441390|FG000|Overall Study|OTHER|4|||
148718688|NCT01992094|536441391|FG001|Overall Study|OTHER|0|||
148718689|NCT01992094|536441392|FG002|Overall Study|OTHER|0|||
148718690|NCT01992094|536441390|FG000|Overall Study|Protocol Violation|1|||
148718691|NCT01992094|536441391|FG001|Overall Study|Protocol Violation|0|||
148718692|NCT01992094|536441392|FG002|Overall Study|Protocol Violation|1|||
148718693|NCT01992094|536441390|FG000|Overall Study|Withdrawal by Subject|7|||
148718694|NCT01992094|536441391|FG001|Overall Study|Withdrawal by Subject|3|||
148718695|NCT01992094|536441392|FG002|Overall Study|Withdrawal by Subject|4|||
148969216|NCT02641379|537372859|FG004|Overall Study|PCR positive at Week 68|0|||
148969217|NCT02641379|537372860|FG005|Overall Study|PCR positive at Week 68|0|||
148969218|NCT02641379|537372861|FG006|Overall Study|PCR positive at Week 68|0|||
148969219|NCT02641379|537372862|FG007|Overall Study|PCR positive at Week 68|0|||
148718696|NCT04428645|536441395|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
148718697|NCT03168906|536441398|FG000|Overall Study|Lack of Efficacy|6|||
148718698|NCT03168906|536441399|FG001|Overall Study|Lack of Efficacy|6|||
148718699|NCT01214239|536441400|FG000|Overall Study|Adverse Event|3|||
148718700|NCT01214239|536441401|FG001|Overall Study|Adverse Event|4|||
148718701|NCT01214239|536441400|FG000|Overall Study|Protocol Violation|2|||
148718702|NCT01214239|536441401|FG001|Overall Study|Protocol Violation|1|||
148718703|NCT01214239|536441400|FG000|Overall Study|Lost to Follow-up|1|||
148718704|NCT01214239|536441401|FG001|Overall Study|Lost to Follow-up|1|||
148718705|NCT01214239|536441400|FG000|Overall Study|Withdrawal by Subject|4|||
148718706|NCT01214239|536441401|FG001|Overall Study|Withdrawal by Subject|9|||
148718707|NCT01214239|536441400|FG000|Overall Study|Lack of Efficacy|1|||
148718708|NCT01214239|536441401|FG001|Overall Study|Lack of Efficacy|2|||
148718709|NCT01214239|536441400|FG000|Overall Study|patient's private reason|1|||
148718710|NCT01214239|536441401|FG001|Overall Study|patient's private reason|1|||
148718711|NCT01321697|536441402|FG000|Overall Study|Study Terminated|7|||
148718712|NCT00857818|536441405|FG000|Overall Study|Lack of Efficacy|1|||
148718713|NCT00857818|536441406|FG001|Overall Study|Lack of Efficacy|0|||
148718714|NCT00857818|536441405|FG000|Overall Study|Adverse Event|3|||
148969220|NCT02641379|537372863|FG008|Overall Study|PCR positive at Week 68|0|||
148969221|NCT02641379|537372864|FG009|Overall Study|PCR positive at Week 68|0|||
148969222|NCT02641379|537372865|FG010|Overall Study|PCR positive at Week 68|0|||
148969223|NCT02641379|537372855|FG000|Overall Study|PCR positive at Week 48|0|||
148969224|NCT02641379|537372856|FG001|Overall Study|PCR positive at Week 48|1|||
148969225|NCT02641379|537372857|FG002|Overall Study|PCR positive at Week 48|0|||
148969226|NCT02641379|537372858|FG003|Overall Study|PCR positive at Week 48|0|||
148969227|NCT02641379|537372859|FG004|Overall Study|PCR positive at Week 48|0|||
148969228|NCT02641379|537372860|FG005|Overall Study|PCR positive at Week 48|0|||
148969229|NCT02641379|537372861|FG006|Overall Study|PCR positive at Week 48|0|||
148969230|NCT02641379|537372862|FG007|Overall Study|PCR positive at Week 48|0|||
148969231|NCT02641379|537372863|FG008|Overall Study|PCR positive at Week 48|0|||
148969232|NCT02641379|537372864|FG009|Overall Study|PCR positive at Week 48|0|||
148969233|NCT02641379|537372865|FG010|Overall Study|PCR positive at Week 48|0|||
148969234|NCT02641379|537372855|FG000|Overall Study|PCR not performed at Week 12|0|||
148969235|NCT02641379|537372856|FG001|Overall Study|PCR not performed at Week 12|0|||
148969236|NCT02641379|537372857|FG002|Overall Study|PCR not performed at Week 12|1|||
148969237|NCT02641379|537372858|FG003|Overall Study|PCR not performed at Week 12|0|||
148969238|NCT02641379|537372859|FG004|Overall Study|PCR not performed at Week 12|0|||
148969239|NCT02641379|537372860|FG005|Overall Study|PCR not performed at Week 12|0|||
148969240|NCT02641379|537372861|FG006|Overall Study|PCR not performed at Week 12|0|||
148969241|NCT02641379|537372862|FG007|Overall Study|PCR not performed at Week 12|0|||
148969242|NCT02641379|537372863|FG008|Overall Study|PCR not performed at Week 12|0|||
148969243|NCT02641379|537372864|FG009|Overall Study|PCR not performed at Week 12|0|||
148969244|NCT02641379|537372865|FG010|Overall Study|PCR not performed at Week 12|0|||
148969245|NCT02641379|537372855|FG000|Overall Study|No PCR at baseline|0|||
148969246|NCT02641379|537372856|FG001|Overall Study|No PCR at baseline|0|||
148969247|NCT02641379|537372857|FG002|Overall Study|No PCR at baseline|1|||
148969248|NCT02641379|537372858|FG003|Overall Study|No PCR at baseline|0|||
148969249|NCT02641379|537372859|FG004|Overall Study|No PCR at baseline|0|||
148969250|NCT02641379|537372860|FG005|Overall Study|No PCR at baseline|0|||
148969251|NCT02641379|537372861|FG006|Overall Study|No PCR at baseline|0|||
148969252|NCT02641379|537372862|FG007|Overall Study|No PCR at baseline|0|||
148969253|NCT02641379|537372863|FG008|Overall Study|No PCR at baseline|0|||
148969254|NCT02641379|537372864|FG009|Overall Study|No PCR at baseline|0|||
148969255|NCT02641379|537372865|FG010|Overall Study|No PCR at baseline|0|||
148969256|NCT02641379|537372855|FG000|Overall Study|PCR positive at Week 28|0|||
148969257|NCT02641379|537372856|FG001|Overall Study|PCR positive at Week 28|0|||
148969258|NCT02641379|537372857|FG002|Overall Study|PCR positive at Week 28|1|||
148969259|NCT02641379|537372858|FG003|Overall Study|PCR positive at Week 28|0|||
148969260|NCT02641379|537372859|FG004|Overall Study|PCR positive at Week 28|0|||
148969261|NCT02641379|537372860|FG005|Overall Study|PCR positive at Week 28|0|||
148969262|NCT02641379|537372861|FG006|Overall Study|PCR positive at Week 28|0|||
148969263|NCT02641379|537372862|FG007|Overall Study|PCR positive at Week 28|0|||
148969264|NCT02641379|537372863|FG008|Overall Study|PCR positive at Week 28|0|||
148969265|NCT02641379|537372864|FG009|Overall Study|PCR positive at Week 28|0|||
148969266|NCT02641379|537372865|FG010|Overall Study|PCR positive at Week 28|0|||
148718715|NCT00857818|536441406|FG001|Overall Study|Adverse Event|0|||
148718716|NCT00857818|536441405|FG000|Overall Study|Withdrawal by Subject|0|||
148718717|NCT00857818|536441406|FG001|Overall Study|Withdrawal by Subject|4|||
148718718|NCT00857818|536441405|FG000|Overall Study|Sponsor terminated study|6|||
148718719|NCT00857818|536441406|FG001|Overall Study|Sponsor terminated study|4|||
148718720|NCT00857818|536441405|FG000|Overall Study|Investigator decision|1|||
148969267|NCT02641379|537372855|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
148969268|NCT02641379|537372856|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
148969269|NCT02641379|537372857|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
148718721|NCT00857818|536441406|FG001|Overall Study|Investigator decision|0|||
148718722|NCT01049581|536441407|FG000|Overall Study|Lost to Follow-up|2|||
148718723|NCT01049581|536441408|FG001|Overall Study|Lost to Follow-up|1|||
148718724|NCT02625974|536441412|FG000|Part 1|Lost to Follow-up|9|||
148718725|NCT02625974|536441413|FG001|Part 1|Lost to Follow-up|3|||
148718726|NCT02625974|536441412|FG000|Part 2|Lost to Follow-up|4|||
148718727|NCT02625974|536441413|FG001|Part 2|Lost to Follow-up|6|||
148718728|NCT02625974|536441412|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
148718729|NCT02625974|536441413|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
148718730|NCT01142661|536441414|FG000|Overall Study|Adverse Event|2|||
148718731|NCT01142661|536441414|FG000|Overall Study|Withdrawal by Subject|1|||
148718732|NCT01142661|536441414|FG000|Overall Study|Physician Decision|1|||
148718733|NCT00559637|536442641|FG000|Overall Study|Adverse Event|22|||
148718734|NCT00559637|536442641|FG000|Overall Study|Withdrawal by Subject|4|||
148718735|NCT00559637|536442641|FG000|Overall Study|Protocol Violation|6|||
148718736|NCT00559637|536442641|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
148718737|NCT00559637|536442641|FG000|Overall Study|Failure to return|6|||
148718738|NCT00559637|536442641|FG000|Overall Study|Insufficient response|3|||
148718739|NCT00559637|536442641|FG000|Overall Study|Started requiring dialysis after month 7|2|||
148718740|NCT00559637|536442641|FG000|Overall Study|Suspected lung cancer|1|||
148718741|NCT00559637|536442641|FG000|Overall Study|Participation in another study|1|||
148718742|NCT00559637|536442641|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
148718743|NCT00559637|536442641|FG000|Overall Study|Change of center|1|||
148718744|NCT00559637|536442641|FG000|Overall Study|Change of home|1|||
148718745|NCT00559637|536442641|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
148718746|NCT01848210|536442646|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
148718747|NCT01848210|536442647|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
148718748|NCT01848210|536442646|FG000|Overall Study|Lost to Follow-up|24|||
148718749|NCT01848210|536442647|FG001|Overall Study|Lost to Follow-up|12|||
148718750|NCT01848210|536442646|FG000|Overall Study|Protocol Violation|3|||
148718751|NCT01848210|536442647|FG001|Overall Study|Protocol Violation|5|||
148718752|NCT01848210|536442646|FG000|Overall Study|Use of Forbidden Drugs|9|||
148718753|NCT01848210|536442647|FG001|Overall Study|Use of Forbidden Drugs|10|||
148718754|NCT01848210|536442646|FG000|Overall Study|Impedition Condition|5|||
148718755|NCT01848210|536442647|FG001|Overall Study|Impedition Condition|9|||
148718756|NCT01848210|536442646|FG000|Overall Study|Adverse Event|7|||
148718757|NCT01848210|536442647|FG001|Overall Study|Adverse Event|9|||
148718758|NCT01848210|536442646|FG000|Overall Study|Discontinuation Criterion|5|||
148718759|NCT01848210|536442647|FG001|Overall Study|Discontinuation Criterion|7|||
148718760|NCT01848210|536442646|FG000|Overall Study|Hypesensitivity|1|||
148718761|NCT01848210|536442647|FG001|Overall Study|Hypesensitivity|0|||
148718762|NCT01848210|536442646|FG000|Overall Study|Hepatic Function Alteration|4|||
148718763|NCT01848210|536442647|FG001|Overall Study|Hepatic Function Alteration|0|||
148718764|NCT01848210|536442646|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
148718765|NCT01848210|536442647|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
148718766|NCT01848210|536442646|FG000|Overall Study|Administrative|1|||
148718767|NCT01848210|536442647|FG001|Overall Study|Administrative|0|||
148718768|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
148718769|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
148718770|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
148969270|NCT02641379|537372858|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
148969271|NCT02641379|537372859|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
148718771|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
148718772|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
148718773|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
148718774|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
148969272|NCT02641379|537372860|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
148969273|NCT02641379|537372861|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
148969274|NCT02641379|537372862|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
148969275|NCT02641379|537372863|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
148718775|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
148718776|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
148718777|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
148718778|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
148718779|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
148718780|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
148718781|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
148718782|NCT04592419|536442648|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
148718783|NCT04592419|536442649|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
148718784|NCT04592419|536442648|FG000|Open-Label Extension Period|Adverse Event|1|||
148718785|NCT04592419|536442649|FG001|Open-Label Extension Period|Adverse Event|2|||
148718786|NCT04592419|536442648|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
148718787|NCT04592419|536442649|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
148718788|NCT04592419|536442648|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
148718789|NCT04592419|536442649|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
148718790|NCT04592419|536442648|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
148718791|NCT04592419|536442649|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
148718792|NCT04592419|536442648|FG000|Open-Label Extension Period|Sponsor Request|73|||
148718793|NCT04592419|536442649|FG001|Open-Label Extension Period|Sponsor Request|84|||
148718794|NCT04129944|536442650|FG000|Overall Study|Death|0|||
148718795|NCT04129944|536442651|FG001|Overall Study|Death|0|||
148718796|NCT04129944|536442652|FG002|Overall Study|Death|0|||
148718797|NCT04129944|536442653|FG003|Overall Study|Death|1|||
148718798|NCT04129944|536442650|FG000|Overall Study|Lost to Follow-up|1|||
148718799|NCT04129944|536442651|FG001|Overall Study|Lost to Follow-up|0|||
148718800|NCT04129944|536442652|FG002|Overall Study|Lost to Follow-up|0|||
148718801|NCT04129944|536442653|FG003|Overall Study|Lost to Follow-up|0|||
148718802|NCT04129944|536442650|FG000|Overall Study|Withdrawal by Subject|1|||
148718803|NCT04129944|536442651|FG001|Overall Study|Withdrawal by Subject|0|||
148718804|NCT04129944|536442652|FG002|Overall Study|Withdrawal by Subject|1|||
148718805|NCT04129944|536442653|FG003|Overall Study|Withdrawal by Subject|2|||
148718806|NCT04501094|536442656|FG000|Overall Study|Death (unrelated to research)|1|||
148718807|NCT04501094|536442657|FG001|Overall Study|Death (unrelated to research)|0|||
148718808|NCT00685035|536442658|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
148718809|NCT00685035|536442659|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
148718810|NCT00894933|536442663|FG000|Overall Study|Lost to Follow-up|2|||
148969276|NCT02641379|537372864|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
148969277|NCT02641379|537372865|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
148969278|NCT02641379|537372855|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
148969279|NCT02641379|537372856|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
148969280|NCT02641379|537372857|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
148718811|NCT00894933|536442663|FG000|Overall Study|Cancelled Procedure|1|||
148718812|NCT00894933|536442663|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
148718813|NCT04241133|536442664|FG000|Overall Study|COVID19 Precautions|14|||
148718814|NCT04241133|536442665|FG001|Overall Study|COVID19 Precautions|34|||
148718815|NCT00460109|536442669|FG000|Overall Study|Death|1|||
148718816|NCT01235715|536442670|FG000|Overall Study|Physician Decision|0|||
148718817|NCT01235715|536442671|FG001|Overall Study|Physician Decision|2|||
148718818|NCT03619876|536442672|FG000|Overall Study|Withdrawal by Subject|1|||
148718819|NCT03619876|536442673|FG001|Overall Study|Withdrawal by Subject|2|||
148718820|NCT03619876|536442672|FG000|Overall Study|Withdrawal due to incidental finding|0|||
148718821|NCT03619876|536442673|FG001|Overall Study|Withdrawal due to incidental finding|2|||
148718822|NCT02994394|536442674|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
148718823|NCT02994394|536442675|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
148718824|NCT02994394|536442676|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
148718825|NCT02994394|536442677|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
148718826|NCT02994394|536442678|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
148718827|NCT02994394|536442679|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
148718828|NCT02994394|536442674|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
148718829|NCT02994394|536442675|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
148718830|NCT02994394|536442676|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
148718831|NCT02994394|536442677|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
148718832|NCT02994394|536442678|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
148718833|NCT02994394|536442679|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
148718834|NCT00835796|536442680|FG000|First Intervention|Withdrawal by Subject|0|||
148718835|NCT00835796|536442681|FG001|First Intervention|Withdrawal by Subject|1|||
148718836|NCT00651183|536442682|FG000|Overall Study|Lack of Efficacy|1|||
148718837|NCT00651183|536442683|FG001|Overall Study|Lack of Efficacy|0|||
148718838|NCT00651183|536442682|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
148718839|NCT00651183|536442683|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
148718840|NCT00651183|536442682|FG000|Overall Study|Tolerability insufficient|5|||
148718841|NCT00651183|536442683|FG001|Overall Study|Tolerability insufficient|2|||
148718842|NCT00651183|536442682|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
148718843|NCT00651183|536442683|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
148718844|NCT00651183|536442682|FG000|Overall Study|Withdrawal by Subject|6|||
148718845|NCT00651183|536442683|FG001|Overall Study|Withdrawal by Subject|3|||
148718846|NCT00651183|536442682|FG000|Overall Study|Lost to Follow-up|3|||
148718847|NCT00651183|536442683|FG001|Overall Study|Lost to Follow-up|1|||
148718848|NCT00651183|536442682|FG000|Overall Study|Other reasons|4|||
148718849|NCT00651183|536442683|FG001|Overall Study|Other reasons|2|||
148718850|NCT00651183|536442682|FG000|Overall Study|missing|1|||
148718851|NCT00651183|536442683|FG001|Overall Study|missing|0|||
148718852|NCT02576717|536442686|FG000|Overall Study|Other Reasons|16|||
148969281|NCT02641379|537372858|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
148969282|NCT02641379|537372859|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
148969283|NCT02641379|537372860|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
148969284|NCT02641379|537372861|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
148969285|NCT02641379|537372862|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
148969286|NCT02641379|537372863|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
148969287|NCT02641379|537372864|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
148718853|NCT02576717|536442687|FG001|Overall Study|Other Reasons|18|||
148969288|NCT02641379|537372865|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
148969289|NCT02641379|537372855|FG000|Overall Study|Baseline viral load unavailable|0|||
148969290|NCT02641379|537372856|FG001|Overall Study|Baseline viral load unavailable|0|||
148969291|NCT02641379|537372857|FG002|Overall Study|Baseline viral load unavailable|0|||
148969292|NCT02641379|537372858|FG003|Overall Study|Baseline viral load unavailable|1|||
148969293|NCT02641379|537372859|FG004|Overall Study|Baseline viral load unavailable|0|||
148969294|NCT02641379|537372860|FG005|Overall Study|Baseline viral load unavailable|0|||
148969295|NCT02641379|537372861|FG006|Overall Study|Baseline viral load unavailable|0|||
148718854|NCT02576717|536442688|FG002|Overall Study|Other Reasons|15|||
148718855|NCT02576717|536442686|FG000|Overall Study|Covid-19 Pandemic|0|||
148718856|NCT02576717|536442687|FG001|Overall Study|Covid-19 Pandemic|1|||
148718857|NCT02576717|536442688|FG002|Overall Study|Covid-19 Pandemic|1|||
148718858|NCT02576717|536442686|FG000|Overall Study|Sponsor Decision|0|||
148718859|NCT02576717|536442687|FG001|Overall Study|Sponsor Decision|0|||
148718860|NCT02576717|536442688|FG002|Overall Study|Sponsor Decision|1|||
148718861|NCT02576717|536442686|FG000|Overall Study|Physician Decision|3|||
148718862|NCT02576717|536442687|FG001|Overall Study|Physician Decision|8|||
148718863|NCT02576717|536442688|FG002|Overall Study|Physician Decision|9|||
148718864|NCT02576717|536442686|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
148718865|NCT02576717|536442687|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
148718866|NCT02576717|536442688|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
148718867|NCT02576717|536442686|FG000|Overall Study|Death|3|||
148718868|NCT02576717|536442687|FG001|Overall Study|Death|5|||
148718869|NCT02576717|536442688|FG002|Overall Study|Death|3|||
148718870|NCT02576717|536442686|FG000|Overall Study|Lost to Follow-up|9|||
148718871|NCT02576717|536442687|FG001|Overall Study|Lost to Follow-up|10|||
148718872|NCT02576717|536442688|FG002|Overall Study|Lost to Follow-up|19|||
148718873|NCT02576717|536442686|FG000|Overall Study|Protocol Violation|4|||
148718874|NCT02576717|536442687|FG001|Overall Study|Protocol Violation|0|||
148718875|NCT02576717|536442688|FG002|Overall Study|Protocol Violation|5|||
148718876|NCT02576717|536442686|FG000|Overall Study|Lack of Efficacy|24|||
148718877|NCT02576717|536442687|FG001|Overall Study|Lack of Efficacy|28|||
148718878|NCT02576717|536442688|FG002|Overall Study|Lack of Efficacy|20|||
148718879|NCT02576717|536442686|FG000|Overall Study|Adverse Event|26|||
148718880|NCT02576717|536442687|FG001|Overall Study|Adverse Event|32|||
148718881|NCT02576717|536442688|FG002|Overall Study|Adverse Event|26|||
148718882|NCT00399893|536442689|FG000|Overall Study|Withdrawal by Subject|1|||
148718883|NCT00399893|536442690|FG001|Overall Study|Withdrawal by Subject|0|||
148718884|NCT01363011|536442691|FG000|Main Study|Adverse Event|2|||
148718885|NCT01363011|536442692|FG001|Main Study|Adverse Event|3|||
148718886|NCT01363011|536442691|FG000|Main Study|Investigator's Discretion|1|||
148718887|NCT01363011|536442692|FG001|Main Study|Investigator's Discretion|1|||
148718888|NCT01363011|536442691|FG000|Main Study|Withdrew Consent|1|||
148718889|NCT01363011|536442692|FG001|Main Study|Withdrew Consent|4|||
148718890|NCT01363011|536442691|FG000|Main Study|Protocol Violation|0|||
148718891|NCT01363011|536442692|FG001|Main Study|Protocol Violation|1|||
148718892|NCT01363011|536442691|FG000|Extension Phase|Adverse Event|1|||
148718893|NCT01363011|536442692|FG001|Extension Phase|Adverse Event|1|||
148718894|NCT01363011|536442691|FG000|Extension Phase|Lack of Efficacy|0|||
148718895|NCT01363011|536442692|FG001|Extension Phase|Lack of Efficacy|1|||
148718896|NCT01363011|536442691|FG000|Extension Phase|Investigator's Discretion|2|||
148718897|NCT01363011|536442692|FG001|Extension Phase|Investigator's Discretion|2|||
148718898|NCT01363011|536442691|FG000|Extension Phase|Withdrew Consent|0|||
148969296|NCT02641379|537372862|FG007|Overall Study|Baseline viral load unavailable|0|||
148969297|NCT02641379|537372863|FG008|Overall Study|Baseline viral load unavailable|0|||
148969298|NCT02641379|537372864|FG009|Overall Study|Baseline viral load unavailable|0|||
148969299|NCT02641379|537372865|FG010|Overall Study|Baseline viral load unavailable|0|||
148718899|NCT01363011|536442692|FG001|Extension Phase|Withdrew Consent|1|||
148718900|NCT01363011|536442691|FG000|Extension Phase|Lost to Follow-up|0|||
148718901|NCT01363011|536442692|FG001|Extension Phase|Lost to Follow-up|2|||
148718902|NCT01363011|536442691|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
148718903|NCT01363011|536442692|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
148718904|NCT03330236|536442695|FG000|Overall Study|Death|2|||
148718905|NCT03330236|536442696|FG001|Overall Study|Death|1|||
148718906|NCT03330236|536442695|FG000|Overall Study|Withdrawal by Subject|2|||
148718907|NCT03330236|536442696|FG001|Overall Study|Withdrawal by Subject|4|||
148718908|NCT03330236|536442695|FG000|Overall Study|Lost to Follow-up|0|||
148718909|NCT03330236|536442696|FG001|Overall Study|Lost to Follow-up|2|||
148718910|NCT03330236|536442695|FG000|Overall Study|Physician Decision|2|||
148969300|NCT02641379|537372855|FG000|Overall Study|Blood could not be drawn|0|||
148969301|NCT02641379|537372856|FG001|Overall Study|Blood could not be drawn|0|||
148969302|NCT02641379|537372857|FG002|Overall Study|Blood could not be drawn|0|||
148969303|NCT02641379|537372858|FG003|Overall Study|Blood could not be drawn|0|||
148969304|NCT02641379|537372859|FG004|Overall Study|Blood could not be drawn|1|||
148969305|NCT02641379|537372860|FG005|Overall Study|Blood could not be drawn|0|||
148969306|NCT02641379|537372861|FG006|Overall Study|Blood could not be drawn|0|||
148718911|NCT03330236|536442696|FG001|Overall Study|Physician Decision|0|||
148718912|NCT03330236|536442695|FG000|Overall Study|Protocol Violation|4|||
148718913|NCT03330236|536442696|FG001|Overall Study|Protocol Violation|3|||
148718914|NCT03330236|536442695|FG000|Overall Study|SedLine malfunction/blinding|19|||
148969307|NCT02641379|537372862|FG007|Overall Study|Blood could not be drawn|0|||
148718915|NCT03330236|536442696|FG001|Overall Study|SedLine malfunction/blinding|14|||
148718916|NCT03330236|536442695|FG000|Overall Study|Volatile anesthetics used|11|||
148718917|NCT03330236|536442696|FG001|Overall Study|Volatile anesthetics used|8|||
148718918|NCT03330236|536442695|FG000|Overall Study|Surgery aborted/converted to open|60|||
148718919|NCT03330236|536442696|FG001|Overall Study|Surgery aborted/converted to open|52|||
148718920|NCT00407745|536442701|FG000|Overall Study|Lack of Efficacy|1|||
148718921|NCT00407745|536442702|FG001|Overall Study|Lack of Efficacy|2|||
148718922|NCT00407745|536442701|FG000|Overall Study|Withdrawal by Subject|3|||
148718923|NCT00407745|536442702|FG001|Overall Study|Withdrawal by Subject|3|||
148718924|NCT00407745|536442701|FG000|Overall Study|Protocol Violation|5|||
148718925|NCT00407745|536442702|FG001|Overall Study|Protocol Violation|3|||
148718926|NCT00407745|536442701|FG000|Overall Study|Adverse Event|8|||
148718927|NCT00407745|536442702|FG001|Overall Study|Adverse Event|8|||
148718928|NCT00407745|536442701|FG000|Overall Study|Other|2|||
148718929|NCT00407745|536442702|FG001|Overall Study|Other|0|||
148718930|NCT00407745|536442701|FG000|Overall Study|Randomized, unknown if treated|0|||
148718931|NCT00407745|536442702|FG001|Overall Study|Randomized, unknown if treated|1|||
148718932|NCT00108082|536442703|FG000|Overall Study|Adverse Event|14|||
148718933|NCT00108082|536442704|FG001|Overall Study|Adverse Event|12|||
148718934|NCT00108082|536442705|FG002|Overall Study|Adverse Event|17|||
148718935|NCT00108082|536442703|FG000|Overall Study|Lost to Follow-up|6|||
148718936|NCT00108082|536442704|FG001|Overall Study|Lost to Follow-up|3|||
148718937|NCT00108082|536442705|FG002|Overall Study|Lost to Follow-up|7|||
148718938|NCT00108082|536442703|FG000|Overall Study|Consent Withdrawn|3|||
148718939|NCT00108082|536442704|FG001|Overall Study|Consent Withdrawn|3|||
148718940|NCT00108082|536442705|FG002|Overall Study|Consent Withdrawn|5|||
148718941|NCT00108082|536442703|FG000|Overall Study|Protocol Violation|1|||
148718942|NCT00108082|536442704|FG001|Overall Study|Protocol Violation|2|||
148718943|NCT00108082|536442705|FG002|Overall Study|Protocol Violation|0|||
148718944|NCT00108082|536442703|FG000|Overall Study|Lack of Efficacy|3|||
148718945|NCT00108082|536442704|FG001|Overall Study|Lack of Efficacy|1|||
148718946|NCT00108082|536442705|FG002|Overall Study|Lack of Efficacy|2|||
148718947|NCT00108082|536442703|FG000|Overall Study|Amendment 4: > Month 12|5|||
148718948|NCT00108082|536442704|FG001|Overall Study|Amendment 4: > Month 12|7|||
148718949|NCT00108082|536442705|FG002|Overall Study|Amendment 4: > Month 12|5|||
148718950|NCT00108082|536442703|FG000|Overall Study|Woman of Child-bearing Potential|2|||
148718951|NCT00108082|536442704|FG001|Overall Study|Woman of Child-bearing Potential|0|||
148718952|NCT00108082|536442705|FG002|Overall Study|Woman of Child-bearing Potential|2|||
148718953|NCT00108082|536442703|FG000|Overall Study|Incorrectly Randomized|0|||
148718954|NCT00108082|536442704|FG001|Overall Study|Incorrectly Randomized|0|||
148718955|NCT00108082|536442705|FG002|Overall Study|Incorrectly Randomized|2|||
148718956|NCT00108082|536442703|FG000|Overall Study|Non-compliance|1|||
148718957|NCT00108082|536442704|FG001|Overall Study|Non-compliance|0|||
148718958|NCT00108082|536442705|FG002|Overall Study|Non-compliance|2|||
148718959|NCT00108082|536442703|FG000|Overall Study|Stopped Study Medication|0|||
148718960|NCT00108082|536442704|FG001|Overall Study|Stopped Study Medication|0|||
148718961|NCT00108082|536442705|FG002|Overall Study|Stopped Study Medication|1|||
148718962|NCT00108082|536442703|FG000|Overall Study|Site Closed Study|0|||
148815846|NCT05643794|536801467|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
148969308|NCT02641379|537372863|FG008|Overall Study|Blood could not be drawn|0|||
148969309|NCT02641379|537372864|FG009|Overall Study|Blood could not be drawn|0|||
148969310|NCT02641379|537372865|FG010|Overall Study|Blood could not be drawn|0|||
148969311|NCT02641379|537372855|FG000|Overall Study|Protocol Violation|0|||
148969312|NCT02641379|537372856|FG001|Overall Study|Protocol Violation|0|||
148718963|NCT00108082|536442704|FG001|Overall Study|Site Closed Study|2|||
148718964|NCT00108082|536442705|FG002|Overall Study|Site Closed Study|0|||
148718965|NCT00108082|536442703|FG000|Overall Study|Protocol Amendment|0|||
148718966|NCT00108082|536442704|FG001|Overall Study|Protocol Amendment|1|||
148718967|NCT00108082|536442705|FG002|Overall Study|Protocol Amendment|0|||
148718968|NCT00108082|536442703|FG000|Overall Study|Study Medication Not Tapered|0|||
148718969|NCT00108082|536442704|FG001|Overall Study|Study Medication Not Tapered|1|||
148718970|NCT00108082|536442705|FG002|Overall Study|Study Medication Not Tapered|0|||
148718971|NCT00108082|536442703|FG000|Overall Study|Subject Left Site Location|1|||
148969313|NCT02641379|537372857|FG002|Overall Study|Protocol Violation|0|||
148969314|NCT02641379|537372858|FG003|Overall Study|Protocol Violation|0|||
148718972|NCT00108082|536442704|FG001|Overall Study|Subject Left Site Location|0|||
148718973|NCT00108082|536442705|FG002|Overall Study|Subject Left Site Location|0|||
148718974|NCT00108082|536442703|FG000|Overall Study|Investigator Not at Site|1|||
148718975|NCT00108082|536442704|FG001|Overall Study|Investigator Not at Site|0|||
148718976|NCT00108082|536442705|FG002|Overall Study|Investigator Not at Site|0|||
148718977|NCT00108082|536442703|FG000|Overall Study|Blood Pressure Not Controlled|1|||
148718978|NCT00108082|536442704|FG001|Overall Study|Blood Pressure Not Controlled|0|||
148718979|NCT00108082|536442705|FG002|Overall Study|Blood Pressure Not Controlled|0|||
148718980|NCT02940730|536442709|FG000|Intervention 2|Physician Decision|7|||
148718981|NCT02940730|536442710|FG001|Intervention 2|Physician Decision|0|||
148718982|NCT03449199|536442711|FG000|Overall Study|Lost to Follow-up|1|||
148718983|NCT03449199|536442712|FG001|Overall Study|Lost to Follow-up|1|||
148718984|NCT03449199|536442713|FG002|Overall Study|Lost to Follow-up|0|||
148718985|NCT03449199|536442711|FG000|Overall Study|Protocol Deviation|0|||
148718986|NCT03449199|536442712|FG001|Overall Study|Protocol Deviation|0|||
148718987|NCT03449199|536442713|FG002|Overall Study|Protocol Deviation|1|||
148718988|NCT03449199|536442711|FG000|Overall Study|Withdrawal by Subject|0|||
148718989|NCT03449199|536442712|FG001|Overall Study|Withdrawal by Subject|0|||
148718990|NCT03449199|536442713|FG002|Overall Study|Withdrawal by Subject|1|||
148718991|NCT00906373|536442715|FG000|Overall Study|Withdrawal by Subject|0|||
148718992|NCT00906373|536442716|FG001|Overall Study|Withdrawal by Subject|5|||
148718993|NCT00906373|536442715|FG000|Overall Study|Other|0|||
148718994|NCT00906373|536442716|FG001|Overall Study|Other|1|||
148718995|NCT00906373|536442715|FG000|Overall Study|Still on treatment at cutoff date|0|||
148718996|NCT00906373|536442716|FG001|Overall Study|Still on treatment at cutoff date|2|||
148718997|NCT01597479|536442717|FG000|Overall Study|Protocol Violation|1|||
148815847|NCT05643794|536801468|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
148815848|NCT05643794|536801469|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
148815849|NCT05643794|536801467|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
148815850|NCT05643794|536801468|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148815851|NCT05643794|536801469|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148815852|NCT05643794|536801467|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
148815853|NCT05643794|536801468|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
148815854|NCT05643794|536801469|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
148815855|NCT05643794|536801467|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
148815856|NCT05643794|536801468|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
148815857|NCT05643794|536801469|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
148815858|NCT05643794|536801467|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
148815859|NCT05643794|536801468|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
148815860|NCT05643794|536801469|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
148815861|NCT05643794|536801467|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
148815862|NCT05643794|536801468|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
148815863|NCT05643794|536801469|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
148815864|NCT04167670|536801472|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
148815865|NCT04167670|536801473|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
148815866|NCT04167670|536801474|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
148815867|NCT04167670|536801472|FG000|Overall Study|Significant protocol deviation|3|||
148815868|NCT04167670|536801473|FG001|Overall Study|Significant protocol deviation|1|||
148815869|NCT04167670|536801474|FG002|Overall Study|Significant protocol deviation|0|||
148815870|NCT04167670|536801472|FG000|Overall Study|Lost to Follow-up|0|||
148815871|NCT04167670|536801473|FG001|Overall Study|Lost to Follow-up|3|||
148815872|NCT04167670|536801474|FG002|Overall Study|Lost to Follow-up|3|||
148815873|NCT04167670|536801472|FG000|Overall Study|Voluntary Withdrawal|0|||
148815874|NCT04167670|536801473|FG001|Overall Study|Voluntary Withdrawal|1|||
148815875|NCT04167670|536801474|FG002|Overall Study|Voluntary Withdrawal|1|||
148815876|NCT04167670|536801472|FG000|Overall Study|Withdrawal of Consent|4|||
148815877|NCT04167670|536801473|FG001|Overall Study|Withdrawal of Consent|1|||
148815878|NCT04167670|536801474|FG002|Overall Study|Withdrawal of Consent|3|||
148815879|NCT04167670|536801472|FG000|Overall Study|Miscellaneous|7|||
148815880|NCT04167670|536801473|FG001|Overall Study|Miscellaneous|5|||
148718998|NCT01597479|536442718|FG001|Overall Study|Protocol Violation|0|||
148815881|NCT04167670|536801474|FG002|Overall Study|Miscellaneous|3|||
148815882|NCT01127061|536801477|FG000|Overall Study|Lost to Follow-up|7|||
148815883|NCT01127061|536801478|FG001|Overall Study|Lost to Follow-up|10|||
148718999|NCT01597479|536442717|FG000|Overall Study|Lost to Follow-up|1|||
148719000|NCT01597479|536442718|FG001|Overall Study|Lost to Follow-up|0|||
148719001|NCT00348816|536442719|FG000|Overall Study|Noncompliance with radiation treatment|1|||
148815884|NCT01127061|536801477|FG000|Overall Study|Physician Decision|3|||
148815885|NCT01127061|536801478|FG001|Overall Study|Physician Decision|3|||
148815886|NCT04827446|536801479|FG000|Overall Study|Lost to Follow-up|1|||
148815887|NCT04827446|536801480|FG001|Overall Study|Lost to Follow-up|1|||
148719002|NCT00848042|536442720|FG000|Overall Study|Death|1|||
148719003|NCT00848042|536442721|FG001|Overall Study|Death|2|||
148719004|NCT00848042|536442722|FG002|Overall Study|Death|0|||
148719005|NCT00848042|536442720|FG000|Overall Study|Other Therapy|3|||
148719006|NCT00848042|536442721|FG001|Overall Study|Other Therapy|0|||
148719007|NCT00848042|536442722|FG002|Overall Study|Other Therapy|0|||
148719008|NCT01190930|536442724|FG000|Induction|Adverse Event|17|||
148719009|NCT01190930|536442725|FG001|Induction|Adverse Event|0|||
148719010|NCT01190930|536442726|FG002|Induction|Adverse Event|0|||
148719011|NCT01190930|536442727|FG003|Induction|Adverse Event|0|||
148719012|NCT01190930|536442728|FG004|Induction|Adverse Event|0|||
148719013|NCT01190930|536442729|FG005|Induction|Adverse Event|0|||
148719014|NCT01190930|536442730|FG006|Induction|Adverse Event|0|||
148719015|NCT01190930|536442731|FG007|Induction|Adverse Event|0|||
148719016|NCT01190930|536442732|FG008|Induction|Adverse Event|0|||
148719017|NCT01190930|536442733|FG009|Induction|Adverse Event|0|||
148719018|NCT01190930|536442724|FG000|Induction|Death|34|||
148719019|NCT01190930|536442725|FG001|Induction|Death|0|||
148719020|NCT01190930|536442726|FG002|Induction|Death|0|||
148719021|NCT01190930|536442727|FG003|Induction|Death|0|||
148719022|NCT01190930|536442728|FG004|Induction|Death|0|||
148719023|NCT01190930|536442729|FG005|Induction|Death|0|||
148719024|NCT01190930|536442730|FG006|Induction|Death|0|||
148719025|NCT01190930|536442731|FG007|Induction|Death|0|||
148719026|NCT01190930|536442732|FG008|Induction|Death|0|||
148719027|NCT01190930|536442733|FG009|Induction|Death|0|||
148719028|NCT01190930|536442724|FG000|Induction|Lost to Follow-up|1|||
148719029|NCT01190930|536442725|FG001|Induction|Lost to Follow-up|0|||
148719030|NCT01190930|536442726|FG002|Induction|Lost to Follow-up|0|||
148719031|NCT01190930|536442727|FG003|Induction|Lost to Follow-up|0|||
148719032|NCT01190930|536442728|FG004|Induction|Lost to Follow-up|0|||
148719033|NCT01190930|536442729|FG005|Induction|Lost to Follow-up|0|||
148719034|NCT01190930|536442730|FG006|Induction|Lost to Follow-up|0|||
148719035|NCT01190930|536442731|FG007|Induction|Lost to Follow-up|0|||
148719036|NCT01190930|536442732|FG008|Induction|Lost to Follow-up|0|||
148719037|NCT01190930|536442733|FG009|Induction|Lost to Follow-up|0|||
148719038|NCT01190930|536442724|FG000|Induction|Physician Decision|125|||
148719039|NCT01190930|536442725|FG001|Induction|Physician Decision|3|||
148719040|NCT01190930|536442726|FG002|Induction|Physician Decision|0|||
148815888|NCT04827446|536801479|FG000|Overall Study|Death|2|||
148815889|NCT04827446|536801480|FG001|Overall Study|Death|0|||
148815890|NCT04827446|536801479|FG000|Overall Study|Withdrawal by Subject|2|||
148719041|NCT01190930|536442727|FG003|Induction|Physician Decision|0|||
148719042|NCT01190930|536442728|FG004|Induction|Physician Decision|0|||
148719043|NCT01190930|536442729|FG005|Induction|Physician Decision|0|||
148719044|NCT01190930|536442730|FG006|Induction|Physician Decision|0|||
148719045|NCT01190930|536442731|FG007|Induction|Physician Decision|0|||
148719046|NCT01190930|536442732|FG008|Induction|Physician Decision|0|||
148719047|NCT01190930|536442733|FG009|Induction|Physician Decision|0|||
148719048|NCT01190930|536442724|FG000|Induction|Withdrawal by Subject|9|||
148719049|NCT01190930|536442725|FG001|Induction|Withdrawal by Subject|0|||
148719050|NCT01190930|536442726|FG002|Induction|Withdrawal by Subject|0|||
148719051|NCT01190930|536442727|FG003|Induction|Withdrawal by Subject|0|||
148719052|NCT01190930|536442728|FG004|Induction|Withdrawal by Subject|0|||
148719053|NCT01190930|536442729|FG005|Induction|Withdrawal by Subject|0|||
148719054|NCT01190930|536442730|FG006|Induction|Withdrawal by Subject|0|||
148719055|NCT01190930|536442731|FG007|Induction|Withdrawal by Subject|0|||
148719056|NCT01190930|536442732|FG008|Induction|Withdrawal by Subject|0|||
148719057|NCT01190930|536442733|FG009|Induction|Withdrawal by Subject|0|||
148719058|NCT01190930|536442724|FG000|Induction|Refusal|235|||
148719059|NCT01190930|536442725|FG001|Induction|Refusal|0|||
148719060|NCT01190930|536442726|FG002|Induction|Refusal|0|||
148719061|NCT01190930|536442727|FG003|Induction|Refusal|0|||
148719062|NCT01190930|536442728|FG004|Induction|Refusal|0|||
148719063|NCT01190930|536442729|FG005|Induction|Refusal|0|||
148815891|NCT04827446|536801480|FG001|Overall Study|Withdrawal by Subject|2|||
148815892|NCT03921541|536801483|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
148815893|NCT03921541|536801484|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
148815894|NCT01410604|536801487|FG000|Overall Study|Adverse Event|2|||
148815895|NCT01410604|536801488|FG001|Overall Study|Adverse Event|1|||
148969315|NCT02641379|537372859|FG004|Overall Study|Protocol Violation|2|||
148719064|NCT01190930|536442730|FG006|Induction|Refusal|0|||
148719065|NCT01190930|536442731|FG007|Induction|Refusal|0|||
148719066|NCT01190930|536442732|FG008|Induction|Refusal|0|||
148719067|NCT01190930|536442733|FG009|Induction|Refusal|0|||
148719068|NCT01190930|536442724|FG000|Induction|Inevaluable|23|||
148719069|NCT01190930|536442725|FG001|Induction|Inevaluable|1|||
148719070|NCT01190930|536442726|FG002|Induction|Inevaluable|0|||
148719071|NCT01190930|536442727|FG003|Induction|Inevaluable|0|||
148719072|NCT01190930|536442728|FG004|Induction|Inevaluable|0|||
148719073|NCT01190930|536442729|FG005|Induction|Inevaluable|0|||
148719074|NCT01190930|536442730|FG006|Induction|Inevaluable|0|||
148719075|NCT01190930|536442731|FG007|Induction|Inevaluable|0|||
148719076|NCT01190930|536442732|FG008|Induction|Inevaluable|0|||
148815896|NCT01410604|536801487|FG000|Overall Study|Lost to Follow-up|1|||
148815897|NCT01410604|536801488|FG001|Overall Study|Lost to Follow-up|0|||
148719077|NCT01190930|536442733|FG009|Induction|Inevaluable|0|||
148719078|NCT01190930|536442724|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
148719079|NCT01190930|536442725|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719080|NCT01190930|536442726|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719081|NCT01190930|536442727|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719082|NCT01190930|536442728|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719083|NCT01190930|536442729|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719084|NCT01190930|536442730|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719085|NCT01190930|536442731|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719086|NCT01190930|536442732|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719087|NCT01190930|536442733|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
148719088|NCT01190930|536442724|FG000|Induction|High Risk Downs|80|||
148719089|NCT01190930|536442725|FG001|Induction|High Risk Downs|0|||
148719090|NCT01190930|536442726|FG002|Induction|High Risk Downs|0|||
148719091|NCT01190930|536442727|FG003|Induction|High Risk Downs|0|||
148719092|NCT01190930|536442728|FG004|Induction|High Risk Downs|0|||
148719093|NCT01190930|536442729|FG005|Induction|High Risk Downs|0|||
148719094|NCT01190930|536442730|FG006|Induction|High Risk Downs|0|||
148719095|NCT01190930|536442731|FG007|Induction|High Risk Downs|0|||
148719096|NCT01190930|536442732|FG008|Induction|High Risk Downs|0|||
148719097|NCT01190930|536442733|FG009|Induction|High Risk Downs|0|||
148719098|NCT01190930|536442724|FG000|Induction|Enrollment onto another COG Protocol|1|||
148719099|NCT01190930|536442725|FG001|Induction|Enrollment onto another COG Protocol|0|||
148719100|NCT01190930|536442726|FG002|Induction|Enrollment onto another COG Protocol|0|||
148719101|NCT01190930|536442727|FG003|Induction|Enrollment onto another COG Protocol|0|||
148719102|NCT01190930|536442728|FG004|Induction|Enrollment onto another COG Protocol|0|||
148719103|NCT01190930|536442729|FG005|Induction|Enrollment onto another COG Protocol|0|||
148719104|NCT01190930|536442730|FG006|Induction|Enrollment onto another COG Protocol|0|||
148815898|NCT01410604|536801487|FG000|Overall Study|Physician Decision|0|||
148815899|NCT01410604|536801488|FG001|Overall Study|Physician Decision|1|||
148815900|NCT05427916|536801489|FG000|Overall Study|Adverse Event|3|||
148815901|NCT05427916|536801490|FG001|Overall Study|Adverse Event|0|||
148815902|NCT05427916|536801489|FG000|Overall Study|Lack of Efficacy|6|||
148815903|NCT05427916|536801490|FG001|Overall Study|Lack of Efficacy|0|||
148815904|NCT05427916|536801489|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
148815905|NCT05427916|536801490|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
148815906|NCT03927157|536801491|FG000|Overall Study|Adverse Event|1|||
148815907|NCT03927157|536801492|FG001|Overall Study|Adverse Event|3|||
148815908|NCT03927157|536801491|FG000|Overall Study|Protocol Violation|1|||
148815909|NCT03927157|536801492|FG001|Overall Study|Protocol Violation|2|||
148815910|NCT03927157|536801491|FG000|Overall Study|Withdrawal by Subject|8|||
148815911|NCT03927157|536801492|FG001|Overall Study|Withdrawal by Subject|21|||
148815912|NCT03927157|536801491|FG000|Overall Study|Due to COVID-19 pandemic|5|||
148815913|NCT03927157|536801492|FG001|Overall Study|Due to COVID-19 pandemic|2|||
148815914|NCT03927157|536801491|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
148815915|NCT03927157|536801492|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
148815916|NCT03927157|536801491|FG000|Overall Study|Other than above|0|||
148815917|NCT03927157|536801492|FG001|Overall Study|Other than above|1|||
148815918|NCT00726557|536801493|FG000|Overall Study|Screening failure|4|||
148815919|NCT00726557|536801493|FG000|Overall Study|No end of treatment documentation|37|||
148815920|NCT00726557|536801493|FG000|Overall Study|No follow-up documentation available|55|||
148815921|NCT00726557|536801493|FG000|Overall Study|Treatment less than 3 months|17|||
148815922|NCT00726557|536801493|FG000|Overall Study|Inclusion criteria not met|15|||
148815923|NCT05630755|536801494|FG000|Overall Study|Lost to Follow-up|7|||
148815924|NCT05630755|536801495|FG001|Overall Study|Lost to Follow-up|0|||
148815925|NCT05630755|536801494|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
148815926|NCT05630755|536801495|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
148815927|NCT05630755|536801494|FG000|Overall Study|Withdrawal by Subject|9|||
148815928|NCT05630755|536801495|FG001|Overall Study|Withdrawal by Subject|3|||
148815929|NCT05630755|536801494|FG000|Overall Study|Participant moved away from trial site|0|||
148815930|NCT05630755|536801495|FG001|Overall Study|Participant moved away from trial site|1|||
148815931|NCT05630755|536801494|FG000|Overall Study|Status not Recorded|316|||
148815932|NCT05630755|536801495|FG001|Overall Study|Status not Recorded|161|||
148815933|NCT04868682|536801496|FG000|Post-treatment|Lost to Follow-up|1|||
148815934|NCT04868682|536801497|FG001|Post-treatment|Lost to Follow-up|1|||
148815935|NCT04868682|536801496|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
148815936|NCT04868682|536801497|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
148815937|NCT04868682|536801496|FG000|Six-month Assessment|Lost to Follow-up|1|||
148815938|NCT04868682|536801497|FG001|Six-month Assessment|Lost to Follow-up|0|||
148815939|NCT04868682|536801496|FG000|Six-month Assessment|Death|1|||
148719105|NCT01190930|536442731|FG007|Induction|Enrollment onto another COG Protocol|0|||
148719106|NCT01190930|536442732|FG008|Induction|Enrollment onto another COG Protocol|0|||
148815940|NCT04868682|536801497|FG001|Six-month Assessment|Death|0|||
148815941|NCT04868682|536801496|FG000|Six-month Assessment|Refused|0|||
148719107|NCT01190930|536442733|FG009|Induction|Enrollment onto another COG Protocol|0|||
148719108|NCT01190930|536442724|FG000|Induction|Average Risk|1847|||
148719109|NCT01190930|536442725|FG001|Induction|Average Risk|0|||
148719110|NCT01190930|536442726|FG002|Induction|Average Risk|0|||
148719111|NCT01190930|536442727|FG003|Induction|Average Risk|0|||
148719112|NCT01190930|536442728|FG004|Induction|Average Risk|0|||
148719113|NCT01190930|536442729|FG005|Induction|Average Risk|0|||
148719114|NCT01190930|536442730|FG006|Induction|Average Risk|0|||
148719115|NCT01190930|536442731|FG007|Induction|Average Risk|0|||
148719116|NCT01190930|536442732|FG008|Induction|Average Risk|0|||
148719117|NCT01190930|536442733|FG009|Induction|Average Risk|0|||
148719118|NCT01190930|536442724|FG000|Induction|High Risk|1227|||
148719119|NCT01190930|536442725|FG001|Induction|High Risk|0|||
148719120|NCT01190930|536442726|FG002|Induction|High Risk|0|||
148719121|NCT01190930|536442727|FG003|Induction|High Risk|0|||
148719122|NCT01190930|536442728|FG004|Induction|High Risk|0|||
148719123|NCT01190930|536442729|FG005|Induction|High Risk|0|||
148719124|NCT01190930|536442730|FG006|Induction|High Risk|0|||
148719125|NCT01190930|536442731|FG007|Induction|High Risk|0|||
148719126|NCT01190930|536442732|FG008|Induction|High Risk|0|||
148719127|NCT01190930|536442733|FG009|Induction|High Risk|0|||
148719128|NCT01190930|536442724|FG000|Induction|Low Risk|443|||
148719129|NCT01190930|536442725|FG001|Induction|Low Risk|0|||
148719130|NCT01190930|536442726|FG002|Induction|Low Risk|0|||
148719131|NCT01190930|536442727|FG003|Induction|Low Risk|0|||
148719132|NCT01190930|536442728|FG004|Induction|Low Risk|0|||
148719133|NCT01190930|536442729|FG005|Induction|Low Risk|0|||
148719134|NCT01190930|536442730|FG006|Induction|Low Risk|0|||
148719135|NCT01190930|536442731|FG007|Induction|Low Risk|0|||
148719136|NCT01190930|536442732|FG008|Induction|Low Risk|0|||
148719137|NCT01190930|536442733|FG009|Induction|Low Risk|0|||
148719138|NCT01190930|536442724|FG000|Induction|Very High Risk|1012|||
148719139|NCT01190930|536442725|FG001|Induction|Very High Risk|0|||
148719140|NCT01190930|536442726|FG002|Induction|Very High Risk|0|||
148719141|NCT01190930|536442727|FG003|Induction|Very High Risk|0|||
148719142|NCT01190930|536442728|FG004|Induction|Very High Risk|0|||
148719143|NCT01190930|536442729|FG005|Induction|Very High Risk|0|||
148719144|NCT01190930|536442730|FG006|Induction|Very High Risk|0|||
148719145|NCT01190930|536442731|FG007|Induction|Very High Risk|0|||
148719146|NCT01190930|536442732|FG008|Induction|Very High Risk|0|||
148719147|NCT01190930|536442733|FG009|Induction|Very High Risk|0|||
148719148|NCT01190930|536442724|FG000|Induction|Philadelphia chromosome-positive|99|||
148719149|NCT01190930|536442725|FG001|Induction|Philadelphia chromosome-positive|0|||
148719150|NCT01190930|536442726|FG002|Induction|Philadelphia chromosome-positive|0|||
148719151|NCT01190930|536442727|FG003|Induction|Philadelphia chromosome-positive|0|||
148719152|NCT01190930|536442728|FG004|Induction|Philadelphia chromosome-positive|0|||
148815942|NCT04868682|536801497|FG001|Six-month Assessment|Refused|1|||
148815943|NCT04868682|536801496|FG000|12-month Assessment|Lost to Follow-up|2|||
148719153|NCT01190930|536442729|FG005|Induction|Philadelphia chromosome-positive|0|||
148719154|NCT01190930|536442730|FG006|Induction|Philadelphia chromosome-positive|0|||
148719155|NCT01190930|536442731|FG007|Induction|Philadelphia chromosome-positive|0|||
148719156|NCT01190930|536442732|FG008|Induction|Philadelphia chromosome-positive|0|||
148719157|NCT01190930|536442733|FG009|Induction|Philadelphia chromosome-positive|0|||
148719158|NCT01190930|536442724|FG000|Induction|Incomplete Induction data|63|||
148719159|NCT01190930|536442725|FG001|Induction|Incomplete Induction data|0|||
148815944|NCT04868682|536801497|FG001|12-month Assessment|Lost to Follow-up|1|||
148815945|NCT04868682|536801496|FG000|12-month Assessment|Death|0|||
148815946|NCT04868682|536801497|FG001|12-month Assessment|Death|1|||
148815947|NCT03880565|536801498|FG000|Overall Study|Withdrawal by Subject|1|||
148815948|NCT03880565|536801499|FG001|Overall Study|Withdrawal by Subject|0|||
148815949|NCT04795323|536801502|FG000|Overall Study|Did not interact with TARA|1|||
148815950|NCT04795323|536801503|FG001|Overall Study|Did not interact with TARA|0|||
148815951|NCT01479530|536801504|FG000|Overall Study|Adverse Event|5|||
148815952|NCT01479530|536801505|FG001|Overall Study|Adverse Event|6|||
148815953|NCT01479530|536801504|FG000|Overall Study|Lack of Efficacy|0|||
148815954|NCT01479530|536801505|FG001|Overall Study|Lack of Efficacy|1|||
148815955|NCT01479530|536801504|FG000|Overall Study|Protocol Violation|2|||
148815956|NCT01479530|536801505|FG001|Overall Study|Protocol Violation|3|||
148815957|NCT01479530|536801504|FG000|Overall Study|Withdrawal of Consent|3|||
148815958|NCT01479530|536801505|FG001|Overall Study|Withdrawal of Consent|2|||
148815959|NCT02836769|536801506|FG000|Overall Study|Lost to Follow-up|10|||
148815960|NCT02836769|536801506|FG000|Overall Study|Medical withdrawal|2|||
148719160|NCT01190930|536442726|FG002|Induction|Incomplete Induction data|0|||
148719161|NCT01190930|536442727|FG003|Induction|Incomplete Induction data|0|||
148719162|NCT01190930|536442728|FG004|Induction|Incomplete Induction data|0|||
148719163|NCT01190930|536442729|FG005|Induction|Incomplete Induction data|0|||
148719164|NCT01190930|536442730|FG006|Induction|Incomplete Induction data|0|||
148815961|NCT02836769|536801506|FG000|Overall Study|Withdrawal by Subject|3|||
148815962|NCT00303628|536801511|FG000|Overall Study|Disease progression|0|||
148815963|NCT00303628|536801512|FG001|Overall Study|Disease progression|1|||
148815964|NCT00303628|536801511|FG000|Overall Study|Adverse Event|26|||
148815965|NCT00303628|536801512|FG001|Overall Study|Adverse Event|36|||
148719165|NCT01190930|536442731|FG007|Induction|Incomplete Induction data|0|||
148719166|NCT01190930|536442732|FG008|Induction|Incomplete Induction data|0|||
148719167|NCT01190930|536442733|FG009|Induction|Incomplete Induction data|0|||
148719168|NCT01190930|536442724|FG000|Induction|Progressive disease|0|||
148719169|NCT01190930|536442725|FG001|Induction|Progressive disease|1|||
148719170|NCT01190930|536442726|FG002|Induction|Progressive disease|0|||
148719171|NCT01190930|536442727|FG003|Induction|Progressive disease|0|||
148719172|NCT01190930|536442728|FG004|Induction|Progressive disease|0|||
148719173|NCT01190930|536442729|FG005|Induction|Progressive disease|0|||
148719174|NCT01190930|536442730|FG006|Induction|Progressive disease|0|||
148719175|NCT01190930|536442731|FG007|Induction|Progressive disease|0|||
148719176|NCT01190930|536442732|FG008|Induction|Progressive disease|0|||
148719177|NCT01190930|536442733|FG009|Induction|Progressive disease|0|||
148719178|NCT01190930|536442724|FG000|Induction|No treatment|3|||
148719179|NCT01190930|536442725|FG001|Induction|No treatment|0|||
148719180|NCT01190930|536442726|FG002|Induction|No treatment|0|||
148719181|NCT01190930|536442727|FG003|Induction|No treatment|0|||
148719182|NCT01190930|536442728|FG004|Induction|No treatment|0|||
148719183|NCT01190930|536442729|FG005|Induction|No treatment|0|||
148719184|NCT01190930|536442730|FG006|Induction|No treatment|0|||
148719185|NCT01190930|536442731|FG007|Induction|No treatment|0|||
148719186|NCT01190930|536442732|FG008|Induction|No treatment|0|||
148719187|NCT01190930|536442733|FG009|Induction|No treatment|0|||
148719188|NCT01190930|536442724|FG000|Induction|Ineligible|69|||
148719189|NCT01190930|536442725|FG001|Induction|Ineligible|4|||
148719190|NCT01190930|536442726|FG002|Induction|Ineligible|0|||
148719191|NCT01190930|536442727|FG003|Induction|Ineligible|0|||
148719192|NCT01190930|536442728|FG004|Induction|Ineligible|0|||
148719193|NCT01190930|536442729|FG005|Induction|Ineligible|0|||
148719194|NCT01190930|536442730|FG006|Induction|Ineligible|0|||
148719195|NCT01190930|536442731|FG007|Induction|Ineligible|0|||
148719196|NCT01190930|536442732|FG008|Induction|Ineligible|0|||
148719197|NCT01190930|536442733|FG009|Induction|Ineligible|0|||
148719198|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
148719199|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
148719200|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
148719201|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
148719202|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
148719203|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
148719204|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
148719205|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
148719206|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
148719207|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
148719208|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Death|0|||
148719209|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Death|0|||
148719210|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Death|8|||
148719211|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Death|4|||
148719212|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Death|0|||
148719213|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Death|0|||
148719214|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Death|0|||
148719215|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Death|0|||
148719216|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Death|0|||
148719217|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Death|0|||
148719218|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
148719219|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
148719220|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
148719221|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
148719222|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
148719223|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
148719224|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
148719225|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
148719226|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
148719227|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
148719228|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719229|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
148719230|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
148719231|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
148719232|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719233|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719234|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719235|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719236|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719237|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
148719238|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Refusal|0|||
148719239|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Refusal|2|||
148719240|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Refusal|694|||
148719241|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Refusal|4|||
148719242|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Refusal|0|||
148719243|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Refusal|3|||
148719244|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Refusal|0|||
148719245|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Refusal|0|||
148719246|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Refusal|0|||
148719247|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Refusal|0|||
148719248|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
148719249|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
148719250|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
148719251|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
148719252|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
148719253|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
148719254|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
148719255|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
148719256|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
148719257|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
148719258|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719259|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
148719260|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719261|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719262|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719263|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719264|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719265|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719266|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719267|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
148719268|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
148719269|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
148719270|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
148719271|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
148719272|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
148719273|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
148719274|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
148719275|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
148719276|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
148719277|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
148719278|NCT01190930|536442724|FG000|Post Induction Pre-Maintenance|Relapse|0|||
148719279|NCT01190930|536442725|FG001|Post Induction Pre-Maintenance|Relapse|0|||
148719280|NCT01190930|536442726|FG002|Post Induction Pre-Maintenance|Relapse|1|||
148719281|NCT01190930|536442727|FG003|Post Induction Pre-Maintenance|Relapse|0|||
148719282|NCT01190930|536442728|FG004|Post Induction Pre-Maintenance|Relapse|0|||
148719283|NCT01190930|536442729|FG005|Post Induction Pre-Maintenance|Relapse|0|||
148719284|NCT01190930|536442730|FG006|Post Induction Pre-Maintenance|Relapse|0|||
148719285|NCT01190930|536442731|FG007|Post Induction Pre-Maintenance|Relapse|0|||
148719286|NCT01190930|536442732|FG008|Post Induction Pre-Maintenance|Relapse|0|||
148719287|NCT01190930|536442733|FG009|Post Induction Pre-Maintenance|Relapse|0|||
148719288|NCT01190930|536442724|FG000|Maintenance|Adverse Event|0|||
148719289|NCT01190930|536442725|FG001|Maintenance|Adverse Event|0|||
148719290|NCT01190930|536442726|FG002|Maintenance|Adverse Event|0|||
148719291|NCT01190930|536442727|FG003|Maintenance|Adverse Event|0|||
148719292|NCT01190930|536442728|FG004|Maintenance|Adverse Event|0|||
148719293|NCT01190930|536442729|FG005|Maintenance|Adverse Event|1|||
148719294|NCT01190930|536442730|FG006|Maintenance|Adverse Event|1|||
148719295|NCT01190930|536442731|FG007|Maintenance|Adverse Event|3|||
148719296|NCT01190930|536442732|FG008|Maintenance|Adverse Event|3|||
148719297|NCT01190930|536442733|FG009|Maintenance|Adverse Event|0|||
148719298|NCT01190930|536442724|FG000|Maintenance|Death|0|||
148719299|NCT01190930|536442725|FG001|Maintenance|Death|0|||
148719300|NCT01190930|536442726|FG002|Maintenance|Death|0|||
148719301|NCT01190930|536442727|FG003|Maintenance|Death|1|||
148719302|NCT01190930|536442728|FG004|Maintenance|Death|0|||
148719303|NCT01190930|536442729|FG005|Maintenance|Death|0|||
148719304|NCT01190930|536442730|FG006|Maintenance|Death|2|||
148719305|NCT01190930|536442731|FG007|Maintenance|Death|2|||
148719306|NCT01190930|536442732|FG008|Maintenance|Death|2|||
148719307|NCT01190930|536442733|FG009|Maintenance|Death|2|||
148969316|NCT02641379|537372860|FG005|Overall Study|Protocol Violation|0|||
148719308|NCT01190930|536442724|FG000|Maintenance|Lost to Follow-up|0|||
148719309|NCT01190930|536442725|FG001|Maintenance|Lost to Follow-up|0|||
148719310|NCT01190930|536442726|FG002|Maintenance|Lost to Follow-up|0|||
148719311|NCT01190930|536442727|FG003|Maintenance|Lost to Follow-up|0|||
148719312|NCT01190930|536442728|FG004|Maintenance|Lost to Follow-up|0|||
148719313|NCT01190930|536442729|FG005|Maintenance|Lost to Follow-up|0|||
148719314|NCT01190930|536442730|FG006|Maintenance|Lost to Follow-up|1|||
148719315|NCT01190930|536442731|FG007|Maintenance|Lost to Follow-up|1|||
148719316|NCT01190930|536442732|FG008|Maintenance|Lost to Follow-up|1|||
148719317|NCT01190930|536442733|FG009|Maintenance|Lost to Follow-up|0|||
148719318|NCT01190930|536442724|FG000|Maintenance|Physician Decision|0|||
148719319|NCT01190930|536442725|FG001|Maintenance|Physician Decision|1|||
148719320|NCT01190930|536442726|FG002|Maintenance|Physician Decision|0|||
148719321|NCT01190930|536442727|FG003|Maintenance|Physician Decision|5|||
148719322|NCT01190930|536442728|FG004|Maintenance|Physician Decision|9|||
148719323|NCT01190930|536442729|FG005|Maintenance|Physician Decision|4|||
148719324|NCT01190930|536442730|FG006|Maintenance|Physician Decision|8|||
148719325|NCT01190930|536442731|FG007|Maintenance|Physician Decision|8|||
148719326|NCT01190930|536442732|FG008|Maintenance|Physician Decision|10|||
148719327|NCT01190930|536442733|FG009|Maintenance|Physician Decision|17|||
148719328|NCT01190930|536442724|FG000|Maintenance|Withdrawal by Subject|0|||
148719329|NCT01190930|536442725|FG001|Maintenance|Withdrawal by Subject|0|||
148719330|NCT01190930|536442726|FG002|Maintenance|Withdrawal by Subject|0|||
148719331|NCT01190930|536442727|FG003|Maintenance|Withdrawal by Subject|0|||
148719332|NCT01190930|536442728|FG004|Maintenance|Withdrawal by Subject|0|||
148719333|NCT01190930|536442729|FG005|Maintenance|Withdrawal by Subject|0|||
148719334|NCT01190930|536442730|FG006|Maintenance|Withdrawal by Subject|2|||
148719335|NCT01190930|536442731|FG007|Maintenance|Withdrawal by Subject|1|||
148719336|NCT01190930|536442732|FG008|Maintenance|Withdrawal by Subject|4|||
148719337|NCT01190930|536442733|FG009|Maintenance|Withdrawal by Subject|1|||
148719338|NCT01190930|536442724|FG000|Maintenance|Refusal|0|||
148815966|NCT00303628|536801511|FG000|Overall Study|Death|0|||
148815967|NCT00303628|536801512|FG001|Overall Study|Death|1|||
148815968|NCT00303628|536801511|FG000|Overall Study|Withdrawal by Subject|11|||
148815969|NCT00303628|536801512|FG001|Overall Study|Withdrawal by Subject|20|||
148815970|NCT00303628|536801511|FG000|Overall Study|Alternative therapy|2|||
148815971|NCT00303628|536801512|FG001|Overall Study|Alternative therapy|0|||
148815972|NCT00303628|536801511|FG000|Overall Study|Other complicating disease|0|||
148815973|NCT00303628|536801512|FG001|Overall Study|Other complicating disease|1|||
148815974|NCT00303628|536801511|FG000|Overall Study|Not start protocol therapy|3|||
148815975|NCT00303628|536801512|FG001|Overall Study|Not start protocol therapy|5|||
148815976|NCT00303628|536801511|FG000|Overall Study|Other|8|||
148815977|NCT00303628|536801512|FG001|Overall Study|Other|9|||
148815978|NCT04925934|536801513|FG000|Overall Study|Adverse Event|1|||
148815979|NCT04925934|536801514|FG001|Overall Study|Adverse Event|0|||
148815980|NCT04925934|536801515|FG002|Overall Study|Adverse Event|0|||
148815981|NCT04925934|536801513|FG000|Overall Study|Lost to Follow-up|2|||
148815982|NCT04925934|536801514|FG001|Overall Study|Lost to Follow-up|0|||
148815983|NCT04925934|536801515|FG002|Overall Study|Lost to Follow-up|1|||
148719339|NCT01190930|536442725|FG001|Maintenance|Refusal|1|||
148719340|NCT01190930|536442726|FG002|Maintenance|Refusal|0|||
148719341|NCT01190930|536442727|FG003|Maintenance|Refusal|2|||
148719342|NCT01190930|536442728|FG004|Maintenance|Refusal|0|||
148719343|NCT01190930|536442729|FG005|Maintenance|Refusal|4|||
148719344|NCT01190930|536442730|FG006|Maintenance|Refusal|5|||
148719345|NCT01190930|536442731|FG007|Maintenance|Refusal|17|||
148719346|NCT01190930|536442732|FG008|Maintenance|Refusal|13|||
148719347|NCT01190930|536442733|FG009|Maintenance|Refusal|6|||
148719348|NCT01190930|536442724|FG000|Maintenance|second malignant neoplasm|0|||
148719349|NCT01190930|536442725|FG001|Maintenance|second malignant neoplasm|0|||
148719350|NCT01190930|536442726|FG002|Maintenance|second malignant neoplasm|0|||
148719351|NCT01190930|536442727|FG003|Maintenance|second malignant neoplasm|1|||
148719352|NCT01190930|536442728|FG004|Maintenance|second malignant neoplasm|0|||
148719353|NCT01190930|536442729|FG005|Maintenance|second malignant neoplasm|1|||
148719354|NCT01190930|536442730|FG006|Maintenance|second malignant neoplasm|0|||
148719355|NCT01190930|536442731|FG007|Maintenance|second malignant neoplasm|0|||
148719356|NCT01190930|536442732|FG008|Maintenance|second malignant neoplasm|1|||
148719357|NCT01190930|536442733|FG009|Maintenance|second malignant neoplasm|0|||
148719358|NCT01190930|536442724|FG000|Maintenance|Inevaluable|0|||
148719359|NCT01190930|536442725|FG001|Maintenance|Inevaluable|0|||
148719360|NCT01190930|536442726|FG002|Maintenance|Inevaluable|0|||
148719361|NCT01190930|536442727|FG003|Maintenance|Inevaluable|0|||
148719362|NCT01190930|536442728|FG004|Maintenance|Inevaluable|0|||
148719363|NCT01190930|536442729|FG005|Maintenance|Inevaluable|1|||
148719364|NCT01190930|536442730|FG006|Maintenance|Inevaluable|1|||
148815984|NCT04925934|536801513|FG000|Overall Study|Death|0|||
148815985|NCT04925934|536801514|FG001|Overall Study|Death|1|||
148815986|NCT04925934|536801515|FG002|Overall Study|Death|0|||
148815987|NCT04925934|536801513|FG000|Overall Study|Withdrawal by Subject|8|||
148815988|NCT04925934|536801514|FG001|Overall Study|Withdrawal by Subject|5|||
148815989|NCT04925934|536801515|FG002|Overall Study|Withdrawal by Subject|9|||
148815990|NCT04925934|536801513|FG000|Overall Study|Other|2|||
148719365|NCT01190930|536442731|FG007|Maintenance|Inevaluable|1|||
148719366|NCT01190930|536442732|FG008|Maintenance|Inevaluable|0|||
148719367|NCT01190930|536442733|FG009|Maintenance|Inevaluable|0|||
148815991|NCT04925934|536801514|FG001|Overall Study|Other|2|||
148815992|NCT04925934|536801515|FG002|Overall Study|Other|2|||
148815993|NCT04925934|536801513|FG000|Overall Study|Eastern European Conflict|7|||
148719368|NCT01190930|536442724|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
148719369|NCT01190930|536442725|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
148719370|NCT01190930|536442726|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
148719371|NCT01190930|536442727|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
148719372|NCT01190930|536442728|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
148719373|NCT01190930|536442729|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
148719374|NCT01190930|536442730|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
148719375|NCT01190930|536442731|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
148719376|NCT01190930|536442732|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
148719377|NCT01190930|536442733|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
148719378|NCT01190930|536442724|FG000|Maintenance|Relapse|0|||
148719379|NCT01190930|536442725|FG001|Maintenance|Relapse|0|||
148719380|NCT01190930|536442726|FG002|Maintenance|Relapse|0|||
148719381|NCT01190930|536442727|FG003|Maintenance|Relapse|2|||
148719382|NCT01190930|536442728|FG004|Maintenance|Relapse|0|||
148719383|NCT01190930|536442729|FG005|Maintenance|Relapse|1|||
148719384|NCT01190930|536442730|FG006|Maintenance|Relapse|6|||
148815994|NCT04925934|536801514|FG001|Overall Study|Eastern European Conflict|3|||
148815995|NCT04925934|536801515|FG002|Overall Study|Eastern European Conflict|2|||
148815996|NCT03158688|536801516|FG000|Overall Study|Withdrawal by Subject|14|||
148815997|NCT03158688|536801517|FG001|Overall Study|Withdrawal by Subject|28|||
148815998|NCT03158688|536801516|FG000|Overall Study|Decision by sponsor|13|||
148815999|NCT03158688|536801517|FG001|Overall Study|Decision by sponsor|37|||
148816000|NCT03158688|536801516|FG000|Overall Study|Lost to Follow-up|4|||
148816001|NCT03158688|536801517|FG001|Overall Study|Lost to Follow-up|3|||
148816002|NCT03158688|536801516|FG000|Overall Study|Death|74|||
148816003|NCT03158688|536801517|FG001|Overall Study|Death|142|||
148816004|NCT03301714|536801519|FG000|Overall Study|Lost to Follow-up|10|||
148816005|NCT03301714|536801520|FG001|Overall Study|Lost to Follow-up|4|||
148816006|NCT03301714|536801521|FG002|Overall Study|Lost to Follow-up|4|||
148816007|NCT03301714|536801519|FG000|Overall Study|Did not receive allocated intervention|0|||
148816008|NCT03301714|536801520|FG001|Overall Study|Did not receive allocated intervention|2|||
148816009|NCT03301714|536801521|FG002|Overall Study|Did not receive allocated intervention|3|||
148816010|NCT02112552|536801524|FG000|Overall Study|Withdrawal by Subject|1|||
148816011|NCT02112552|536801524|FG000|Overall Study|Adverse Event|1|||
148816012|NCT03349515|536801526|FG000|Overall Study|Lack of Efficacy|2|||
148816013|NCT03349515|536801527|FG001|Overall Study|Lack of Efficacy|0|||
148816014|NCT03349515|536801526|FG000|Overall Study|Physician Decision|3|||
148816015|NCT03349515|536801527|FG001|Overall Study|Physician Decision|1|||
148816016|NCT01132755|536801532|FG000|Overall Study|Procedure not done due to medical reason|23|||
148816017|NCT01132755|536801532|FG000|Overall Study|Protocol Violation|15|||
148816018|NCT01132755|536801532|FG000|Overall Study|Withdrawal by Subject|4|||
148816019|NCT02393755|536801533|FG000|Overall Study|Withdrawal by Subject|0|||
148816020|NCT02393755|536801534|FG001|Overall Study|Withdrawal by Subject|3|||
148816021|NCT02393755|536801533|FG000|Overall Study|Adverse Event|0|||
148816022|NCT02393755|536801534|FG001|Overall Study|Adverse Event|2|||
148816023|NCT02393755|536801533|FG000|Overall Study|Physician Decision|0|||
148816024|NCT02393755|536801534|FG001|Overall Study|Physician Decision|2|||
148816025|NCT00640289|536801537|FG000|Overall Study|Death|3|||
148816026|NCT00640289|536801537|FG000|Overall Study|Withdrawal by Subject|1|||
148816027|NCT00640289|536801537|FG000|Overall Study|Lost to Follow-up|1|||
148816028|NCT00640289|536801537|FG000|Overall Study|Data collected under different amendment|2|||
148816029|NCT00640289|536801537|FG000|Overall Study|Transferred to another center|1|||
148816030|NCT00640289|536801537|FG000|Overall Study|Missing status|5|||
148816031|NCT00308685|536801551|FG000|Overall Study|Lost to Follow-up|1|||
148816032|NCT00308685|536801552|FG001|Overall Study|Lost to Follow-up|0|||
148816033|NCT00308685|536801551|FG000|Overall Study|Need to administer prohibited medication|1|||
148816034|NCT00308685|536801552|FG001|Overall Study|Need to administer prohibited medication|2|||
148816035|NCT00308685|536801551|FG000|Overall Study|Other than specified|1|||
148816036|NCT00308685|536801552|FG001|Overall Study|Other than specified|3|||
148719385|NCT01190930|536442731|FG007|Maintenance|Relapse|13|||
148719386|NCT01190930|536442732|FG008|Maintenance|Relapse|11|||
148719387|NCT01190930|536442733|FG009|Maintenance|Relapse|11|||
148719388|NCT01190930|536442724|FG000|Maintenance|Still on therapy|0|||
148816037|NCT05399485|536802756|FG000|DBT Phase|Other|6|||
148816038|NCT05399485|536802757|FG001|DBT Phase|Other|5|||
148816039|NCT05399485|536802756|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
148816040|NCT05399485|536802757|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
148719389|NCT01190930|536442725|FG001|Maintenance|Still on therapy|8|||
148816041|NCT05399485|536802756|FG000|DBT Phase|Withdrawal by Subject|3|||
148816042|NCT05399485|536802757|FG001|DBT Phase|Withdrawal by Subject|2|||
148816043|NCT05399485|536802756|FG000|DBT Phase|Protocol Violation|2|||
148816044|NCT05399485|536802757|FG001|DBT Phase|Protocol Violation|1|||
148816045|NCT05399485|536802756|FG000|DBT Phase|Physician Decision|0|||
148816046|NCT05399485|536802757|FG001|DBT Phase|Physician Decision|1|||
148719390|NCT01190930|536442726|FG002|Maintenance|Still on therapy|0|||
148719391|NCT01190930|536442727|FG003|Maintenance|Still on therapy|29|||
148816047|NCT05399485|536802756|FG000|DBT Phase|Adverse Event|2|||
148816048|NCT05399485|536802757|FG001|DBT Phase|Adverse Event|1|||
148816049|NCT05399485|536802756|FG000|OLE Phase|Protocol deviation|1|||
148816050|NCT05399485|536802757|FG001|OLE Phase|Protocol deviation|0|||
148816051|NCT05399485|536802756|FG000|OLE Phase|Other|5|||
148816052|NCT05399485|536802757|FG001|OLE Phase|Other|5|||
148816053|NCT05399485|536802756|FG000|OLE Phase|Withdrawal by Subject|12|||
148816054|NCT05399485|536802757|FG001|OLE Phase|Withdrawal by Subject|7|||
148816055|NCT05399485|536802756|FG000|OLE Phase|Pregnancy|0|||
148816056|NCT05399485|536802757|FG001|OLE Phase|Pregnancy|2|||
148816057|NCT05399485|536802756|FG000|OLE Phase|Physician Decision|3|||
148816058|NCT05399485|536802757|FG001|OLE Phase|Physician Decision|0|||
148816059|NCT05399485|536802756|FG000|OLE Phase|Adverse Event|2|||
148816060|NCT05399485|536802757|FG001|OLE Phase|Adverse Event|2|||
148816061|NCT01363076|536802760|FG000|Overall Study|Withdrawal by Subject|0|||
148816062|NCT01363076|536802761|FG001|Overall Study|Withdrawal by Subject|1|||
148816063|NCT04706403|536802762|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
148816064|NCT04706403|536802763|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
148816065|NCT04706403|536802764|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
148816066|NCT04706403|536802765|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
148816067|NCT04706403|536802766|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
148816068|NCT00182637|536802767|FG000|Overall Study|Adverse Event|2|||
148816069|NCT00182637|536802767|FG000|Overall Study|Disease Progression|1|||
148816070|NCT02642679|536802768|FG000|Overall Study|Withdrawal by Subject|1|||
148816071|NCT02642679|536802768|FG000|Overall Study|Physician Decision|1|||
148816072|NCT02642679|536802768|FG000|Overall Study|Physician Decision|1|||
148816073|NCT04941898|536802769|FG000|Overall Study|Protocol Violation|1|||
148816074|NCT01653262|536802770|FG000|Overall Study|Lack of Efficacy|1|||
148816075|NCT01653262|536802770|FG000|Overall Study|SAE, non-fatal|1|||
148816076|NCT01653262|536802770|FG000|Overall Study|AE, non-serious non-fatal|1|||
148816077|NCT01112267|536802772|FG000|Overall Study|Adverse Event|24|||
148816078|NCT01112267|536802773|FG001|Overall Study|Adverse Event|6|||
148816079|NCT01112267|536802772|FG000|Overall Study|Withdrawal by Subject|3|||
148816080|NCT01112267|536802773|FG001|Overall Study|Withdrawal by Subject|5|||
148816081|NCT01112267|536802772|FG000|Overall Study|Protocol Violation|5|||
148816082|NCT01112267|536802773|FG001|Overall Study|Protocol Violation|3|||
148816083|NCT01112267|536802772|FG000|Overall Study|Participants not compliant|1|||
148816084|NCT01112267|536802773|FG001|Overall Study|Participants not compliant|2|||
148816085|NCT01112267|536802772|FG000|Overall Study|Participants not receive any study drug|1|||
148816086|NCT01112267|536802773|FG001|Overall Study|Participants not receive any study drug|2|||
148816087|NCT00003456|536802774|FG000|Overall Study|Not evaluable|8|||
148719392|NCT01190930|536442728|FG004|Maintenance|Still on therapy|0|||
148719393|NCT01190930|536442729|FG005|Maintenance|Still on therapy|0|||
148719394|NCT01190930|536442730|FG006|Maintenance|Still on therapy|0|||
148719395|NCT01190930|536442731|FG007|Maintenance|Still on therapy|0|||
148719396|NCT01190930|536442732|FG008|Maintenance|Still on therapy|0|||
148719397|NCT01190930|536442733|FG009|Maintenance|Still on therapy|0|||
148719398|NCT01628549|536442736|FG000|Overall Study|Adverse Event|1|||
148719399|NCT01628549|536442737|FG001|Overall Study|Adverse Event|1|||
148719400|NCT01628549|536442738|FG002|Overall Study|Adverse Event|0|||
148719401|NCT01628549|536442739|FG003|Overall Study|Adverse Event|4|||
148719402|NCT01628549|536442736|FG000|Overall Study|Lost to Follow-up|3|||
148719403|NCT01628549|536442737|FG001|Overall Study|Lost to Follow-up|4|||
148719404|NCT01628549|536442738|FG002|Overall Study|Lost to Follow-up|3|||
148719405|NCT01628549|536442739|FG003|Overall Study|Lost to Follow-up|3|||
148719406|NCT01628549|536442736|FG000|Overall Study|Withdrawal by Subject|3|||
148719407|NCT01628549|536442737|FG001|Overall Study|Withdrawal by Subject|4|||
148719408|NCT01628549|536442738|FG002|Overall Study|Withdrawal by Subject|4|||
148719409|NCT01628549|536442739|FG003|Overall Study|Withdrawal by Subject|1|||
148719410|NCT01628549|536442736|FG000|Overall Study|Protocol Violation|2|||
148719411|NCT01628549|536442737|FG001|Overall Study|Protocol Violation|1|||
148719412|NCT01628549|536442738|FG002|Overall Study|Protocol Violation|1|||
148719413|NCT01628549|536442739|FG003|Overall Study|Protocol Violation|0|||
148719414|NCT01628549|536442736|FG000|Overall Study|withdrawn for noncompliance|0|||
148719415|NCT01628549|536442737|FG001|Overall Study|withdrawn for noncompliance|2|||
148719416|NCT01628549|536442738|FG002|Overall Study|withdrawn for noncompliance|1|||
148719417|NCT01628549|536442739|FG003|Overall Study|withdrawn for noncompliance|0|||
148719418|NCT01628549|536442736|FG000|Overall Study|abnormal laboratory test results|0|||
148719419|NCT01628549|536442737|FG001|Overall Study|abnormal laboratory test results|0|||
148719420|NCT01628549|536442738|FG002|Overall Study|abnormal laboratory test results|1|||
148719421|NCT01628549|536442739|FG003|Overall Study|abnormal laboratory test results|0|||
148816088|NCT00420407|536802775|FG000|Overall Study|Lost to Follow-up|0|||
148816089|NCT00420407|536802776|FG001|Overall Study|Lost to Follow-up|3|||
148816090|NCT00420407|536802775|FG000|Overall Study|Physician Decision|2|||
148816091|NCT00420407|536802776|FG001|Overall Study|Physician Decision|1|||
148719422|NCT01628549|536442736|FG000|Overall Study|positive pregnancy test|0|||
148719423|NCT01628549|536442737|FG001|Overall Study|positive pregnancy test|0|||
148719424|NCT01628549|536442738|FG002|Overall Study|positive pregnancy test|0|||
148719425|NCT01628549|536442739|FG003|Overall Study|positive pregnancy test|1|||
148719426|NCT01999894|536442742|FG000|Overall Study|Adverse Event|9|||
148719427|NCT01999894|536442742|FG000|Overall Study|Lack of Efficacy|5|||
148719428|NCT01999894|536442742|FG000|Overall Study|Protocol Violation|1|||
148719429|NCT01999894|536442742|FG000|Overall Study|Withdrawal by Subject|7|||
148719430|NCT01999894|536442742|FG000|Overall Study|Lost to Follow-up|10|||
148719431|NCT01999894|536442742|FG000|Overall Study|Other Reason|3|||
148719432|NCT01999894|536442742|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
148719433|NCT02448563|536442745|FG000|Overall Study|Lost to Follow-up|16|||
148719434|NCT02448563|536442746|FG001|Overall Study|Lost to Follow-up|10|||
148719435|NCT02448563|536442745|FG000|Overall Study|Withdrawal by Subject|0|||
148719436|NCT02448563|536442746|FG001|Overall Study|Withdrawal by Subject|1|||
148719437|NCT00113919|536442747|FG000|Overall Study|Physician Decision|8|||
148719438|NCT00113919|536442747|FG000|Overall Study|Death|6|||
148719439|NCT02914457|536442750|FG000|Overall Study|Withdrawal by Subject|1|||
148719440|NCT02914457|536442750|FG000|Overall Study|Physician Decision|1|||
148719441|NCT02914457|536442750|FG000|Overall Study|No veins available for lead placement|1|||
148719442|NCT02914457|536442750|FG000|Overall Study|Electrical instability of patient|1|||
148719443|NCT02914457|536442750|FG000|Overall Study|ECG acquisition error due to sweating|1|||
148719444|NCT02914457|536442750|FG000|Overall Study|Protocol Violation|1|||
148719445|NCT00609154|536442759|FG000|Overall Study|Protocol Violation|1|||
148719446|NCT00609154|536442760|FG001|Overall Study|Protocol Violation|2|||
148719447|NCT00609154|536442759|FG000|Overall Study|Unable to establish IV access|0|||
148719448|NCT00609154|536442760|FG001|Overall Study|Unable to establish IV access|4|||
148719449|NCT00609154|536442759|FG000|Overall Study|Adverse Event|0|||
148719450|NCT00609154|536442760|FG001|Overall Study|Adverse Event|2|||
148719451|NCT04531527|536442761|FG000|Overall Study|Found to be Ineligible|3|||
148719452|NCT00810602|536442764|FG000|Overall Study|Withdrawal by Subject|8|||
148719453|NCT00810602|536442765|FG001|Overall Study|Withdrawal by Subject|3|||
148719454|NCT03840382|536442766|FG000|Overall Study|Lost to Follow-up|11|||
148719455|NCT04412057|536444172|FG000|Overall Study|Death|3|||
148719456|NCT04412057|536444173|FG001|Overall Study|Death|7|||
148719457|NCT04412057|536444172|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
148719458|NCT04412057|536444173|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
148719459|NCT01961882|536444174|FG000|Overall Study|Adverse Event|3|||
148719460|NCT01961882|536444175|FG001|Overall Study|Adverse Event|2|||
148816092|NCT00420407|536802775|FG000|Overall Study|subject identified as detainee|1|||
148816093|NCT00420407|536802776|FG001|Overall Study|subject identified as detainee|0|||
148816094|NCT00420407|536802775|FG000|Overall Study|subject identified as Jehovah's witness|1|||
148816095|NCT00420407|536802776|FG001|Overall Study|subject identified as Jehovah's witness|0|||
148816096|NCT00420407|536802775|FG000|Overall Study|Withdrawal by Subject|0|||
148969317|NCT02641379|537372861|FG006|Overall Study|Protocol Violation|0|||
148969318|NCT02641379|537372862|FG007|Overall Study|Protocol Violation|0|||
148969319|NCT02641379|537372863|FG008|Overall Study|Protocol Violation|1|||
148969320|NCT02641379|537372864|FG009|Overall Study|Protocol Violation|0|||
148969321|NCT02641379|537372865|FG010|Overall Study|Protocol Violation|0|||
148969322|NCT02641379|537372855|FG000|Overall Study|Participation in sili rescue study|0|||
148969323|NCT02641379|537372856|FG001|Overall Study|Participation in sili rescue study|0|||
148719461|NCT01961882|536444174|FG000|Overall Study|Physician Decision|1|||
148816097|NCT00420407|536802776|FG001|Overall Study|Withdrawal by Subject|2|||
148816098|NCT04633447|536802779|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
148816099|NCT04633447|536802780|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
148816100|NCT04633447|536802779|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
148719462|NCT01961882|536444175|FG001|Overall Study|Physician Decision|0|||
148719463|NCT01961882|536444174|FG000|Overall Study|Withdrawal by Subject|4|||
148719464|NCT01961882|536444175|FG001|Overall Study|Withdrawal by Subject|1|||
148719465|NCT01961882|536444174|FG000|Overall Study|Relapse of AML|39|||
148719466|NCT01961882|536444175|FG001|Overall Study|Relapse of AML|37|||
148719467|NCT01961882|536444174|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
148816101|NCT04633447|536802780|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
148816102|NCT04633447|536802779|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
148816103|NCT04633447|536802780|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
148816104|NCT04633447|536802779|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
148816105|NCT04633447|536802780|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
148816106|NCT04633447|536802779|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
148816107|NCT04633447|536802780|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
148816108|NCT04633447|536802779|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
148719468|NCT01961882|536444175|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
148816109|NCT04633447|536802780|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
148969324|NCT02641379|537372857|FG002|Overall Study|Participation in sili rescue study|0|||
148969325|NCT02641379|537372858|FG003|Overall Study|Participation in sili rescue study|0|||
148719469|NCT01961882|536444174|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
148816110|NCT05417113|536802788|FG000|Overall Study|Lost to Follow-up|2|||
148816111|NCT05417113|536802789|FG001|Overall Study|Lost to Follow-up|2|||
148816112|NCT00134719|536802790|FG000|Primary Vaccination Phase|Adverse Event|4|||
148816113|NCT00134719|536802791|FG001|Primary Vaccination Phase|Adverse Event|0|||
148816114|NCT00134719|536802792|FG002|Primary Vaccination Phase|Adverse Event|0|||
148816115|NCT00134719|536802790|FG000|Primary Vaccination Phase|Protocol Violation|1|||
148816116|NCT00134719|536802791|FG001|Primary Vaccination Phase|Protocol Violation|0|||
148816117|NCT00134719|536802792|FG002|Primary Vaccination Phase|Protocol Violation|0|||
148816118|NCT00134719|536802790|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
148816119|NCT00134719|536802791|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
148816120|NCT00134719|536802792|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
148816121|NCT00134719|536802790|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
148816122|NCT00134719|536802791|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
148816123|NCT00134719|536802792|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
148816124|NCT00134719|536802790|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
148816125|NCT00134719|536802791|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
148816126|NCT00134719|536802792|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
148816127|NCT00134719|536802790|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
148816128|NCT00134719|536802791|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
148816129|NCT00134719|536802792|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
148816130|NCT01807520|536802793|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
148816131|NCT01807520|536802794|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
148816132|NCT01807520|536802795|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
148816133|NCT01807520|536802796|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
148816134|NCT01807520|536802797|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
148816135|NCT01807520|536802798|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
148816136|NCT01807520|536802799|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
148816137|NCT01807520|536802793|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
148816138|NCT01807520|536802794|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
148816139|NCT01807520|536802795|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
148816140|NCT01807520|536802796|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
148816141|NCT01807520|536802797|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
148816142|NCT01807520|536802798|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
148816143|NCT01807520|536802799|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
148816144|NCT01807520|536802793|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
148816145|NCT01807520|536802794|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
148816146|NCT01807520|536802795|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
148816147|NCT01807520|536802796|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
148719470|NCT01961882|536444175|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
148719471|NCT03710590|536444182|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
148719472|NCT03710590|536444183|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
148719473|NCT01522950|536444186|FG000|Overall Study|Withdrawal by Subject|3|||
148719474|NCT01522950|536444187|FG001|Overall Study|Withdrawal by Subject|2|||
148719475|NCT01522950|536444188|FG002|Overall Study|Withdrawal by Subject|1|||
148719476|NCT01522950|536444186|FG000|Overall Study|Adverse Event|3|||
148719477|NCT01522950|536444187|FG001|Overall Study|Adverse Event|1|||
148719478|NCT01522950|536444188|FG002|Overall Study|Adverse Event|1|||
148719479|NCT01522950|536444186|FG000|Overall Study|Protocol Violation|0|||
148719480|NCT01522950|536444187|FG001|Overall Study|Protocol Violation|0|||
148719481|NCT01522950|536444188|FG002|Overall Study|Protocol Violation|2|||
148719482|NCT01522950|536444186|FG000|Overall Study|Death|0|||
148719483|NCT01522950|536444187|FG001|Overall Study|Death|1|||
148719484|NCT01522950|536444188|FG002|Overall Study|Death|1|||
148719485|NCT01522950|536444186|FG000|Overall Study|Study Medication Sensitivity|0|||
148719486|NCT01522950|536444187|FG001|Overall Study|Study Medication Sensitivity|1|||
148719487|NCT01522950|536444188|FG002|Overall Study|Study Medication Sensitivity|0|||
148719488|NCT00412737|536444191|FG000|Overall Study|Death|1|||
148719489|NCT00412737|536444192|FG001|Overall Study|Death|0|||
148719490|NCT00412737|536444191|FG000|Overall Study|Adverse Event|3|||
148719491|NCT00412737|536444192|FG001|Overall Study|Adverse Event|2|||
148719492|NCT00412737|536444191|FG000|Overall Study|Refused Treatment|6|||
148816148|NCT01807520|536802797|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
148719493|NCT00412737|536444192|FG001|Overall Study|Refused Treatment|2|||
148719494|NCT00412737|536444191|FG000|Overall Study|Failure to Return|6|||
148816149|NCT01807520|536802798|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
148816150|NCT01807520|536802799|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
148816151|NCT01807520|536802793|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
148719495|NCT00412737|536444192|FG001|Overall Study|Failure to Return|2|||
148719496|NCT01064531|536444194|FG000|Overall Study|Lost to Follow-up|0|||
148719497|NCT01064531|536444195|FG001|Overall Study|Lost to Follow-up|2|||
148719498|NCT01064531|536444194|FG000|Overall Study|Physician Decision|0|||
148969326|NCT02641379|537372859|FG004|Overall Study|Participation in sili rescue study|0|||
148969327|NCT02641379|537372860|FG005|Overall Study|Participation in sili rescue study|1|||
148969328|NCT02641379|537372861|FG006|Overall Study|Participation in sili rescue study|0|||
148969329|NCT02641379|537372862|FG007|Overall Study|Participation in sili rescue study|0|||
148969330|NCT02641379|537372863|FG008|Overall Study|Participation in sili rescue study|0|||
148969331|NCT02641379|537372864|FG009|Overall Study|Participation in sili rescue study|0|||
148969332|NCT02641379|537372865|FG010|Overall Study|Participation in sili rescue study|0|||
148969333|NCT02641379|537372855|FG000|Overall Study|Lost to Follow-up|0|||
148969334|NCT02641379|537372856|FG001|Overall Study|Lost to Follow-up|0|||
148969335|NCT02641379|537372857|FG002|Overall Study|Lost to Follow-up|0|||
148719499|NCT01064531|536444195|FG001|Overall Study|Physician Decision|1|||
148969336|NCT02641379|537372858|FG003|Overall Study|Lost to Follow-up|0|||
148969337|NCT02641379|537372859|FG004|Overall Study|Lost to Follow-up|0|||
148969338|NCT02641379|537372860|FG005|Overall Study|Lost to Follow-up|0|||
148969339|NCT02641379|537372861|FG006|Overall Study|Lost to Follow-up|0|||
148969340|NCT02641379|537372862|FG007|Overall Study|Lost to Follow-up|0|||
148969341|NCT02641379|537372863|FG008|Overall Study|Lost to Follow-up|1|||
148969342|NCT02641379|537372864|FG009|Overall Study|Lost to Follow-up|0|||
148969343|NCT02641379|537372865|FG010|Overall Study|Lost to Follow-up|0|||
148969344|NCT02641379|537372855|FG000|Overall Study|Source data not found|0|||
148969345|NCT02641379|537372856|FG001|Overall Study|Source data not found|0|||
148969346|NCT02641379|537372857|FG002|Overall Study|Source data not found|0|||
148969347|NCT02641379|537372858|FG003|Overall Study|Source data not found|0|||
148969348|NCT02641379|537372859|FG004|Overall Study|Source data not found|0|||
148969349|NCT02641379|537372860|FG005|Overall Study|Source data not found|1|||
148969350|NCT02641379|537372861|FG006|Overall Study|Source data not found|0|||
148969351|NCT02641379|537372862|FG007|Overall Study|Source data not found|0|||
148969352|NCT02641379|537372863|FG008|Overall Study|Source data not found|0|||
148969353|NCT02641379|537372864|FG009|Overall Study|Source data not found|0|||
148969354|NCT02641379|537372865|FG010|Overall Study|Source data not found|0|||
148969355|NCT02641379|537372855|FG000|Overall Study|Participant showed weight reduction|0|||
148969356|NCT02641379|537372856|FG001|Overall Study|Participant showed weight reduction|0|||
148969357|NCT02641379|537372857|FG002|Overall Study|Participant showed weight reduction|0|||
148969358|NCT02641379|537372858|FG003|Overall Study|Participant showed weight reduction|0|||
148969359|NCT02641379|537372859|FG004|Overall Study|Participant showed weight reduction|0|||
148969360|NCT02641379|537372860|FG005|Overall Study|Participant showed weight reduction|0|||
148969361|NCT02641379|537372861|FG006|Overall Study|Participant showed weight reduction|0|||
148969362|NCT02641379|537372862|FG007|Overall Study|Participant showed weight reduction|1|||
148969363|NCT02641379|537372863|FG008|Overall Study|Participant showed weight reduction|0|||
148969364|NCT02641379|537372864|FG009|Overall Study|Participant showed weight reduction|0|||
148969365|NCT02641379|537372865|FG010|Overall Study|Participant showed weight reduction|0|||
148969366|NCT02641379|537372855|FG000|Overall Study|Non-response Week 12|0|||
148969367|NCT02641379|537372856|FG001|Overall Study|Non-response Week 12|0|||
148969368|NCT02641379|537372857|FG002|Overall Study|Non-response Week 12|0|||
148969369|NCT02641379|537372858|FG003|Overall Study|Non-response Week 12|0|||
148969370|NCT02641379|537372859|FG004|Overall Study|Non-response Week 12|0|||
148969371|NCT02641379|537372860|FG005|Overall Study|Non-response Week 12|0|||
148969372|NCT02641379|537372861|FG006|Overall Study|Non-response Week 12|0|||
148969373|NCT02641379|537372862|FG007|Overall Study|Non-response Week 12|1|||
148969374|NCT02641379|537372863|FG008|Overall Study|Non-response Week 12|0|||
148969375|NCT02641379|537372864|FG009|Overall Study|Non-response Week 12|0|||
148969376|NCT02641379|537372865|FG010|Overall Study|Non-response Week 12|0|||
148969377|NCT02641379|537372855|FG000|Overall Study|No 2 Log drop at Week 12|0|||
148969378|NCT02641379|537372856|FG001|Overall Study|No 2 Log drop at Week 12|0|||
148969379|NCT02641379|537372857|FG002|Overall Study|No 2 Log drop at Week 12|0|||
148969380|NCT02641379|537372858|FG003|Overall Study|No 2 Log drop at Week 12|0|||
148969381|NCT02641379|537372859|FG004|Overall Study|No 2 Log drop at Week 12|0|||
148969382|NCT02641379|537372860|FG005|Overall Study|No 2 Log drop at Week 12|0|||
148969383|NCT02641379|537372861|FG006|Overall Study|No 2 Log drop at Week 12|0|||
148719500|NCT01064531|536444194|FG000|Overall Study|Withdrawal by Subject|2|||
148719501|NCT01064531|536444195|FG001|Overall Study|Withdrawal by Subject|2|||
148969384|NCT02641379|537372862|FG007|Overall Study|No 2 Log drop at Week 12|0|||
148969385|NCT02641379|537372863|FG008|Overall Study|No 2 Log drop at Week 12|0|||
148719502|NCT01064531|536444194|FG000|Overall Study|Revision due to femoral stem loosening|1|||
148719503|NCT01064531|536444195|FG001|Overall Study|Revision due to femoral stem loosening|0|||
148719504|NCT01064531|536444194|FG000|Overall Study|Revision due to dislocation|0|||
148719505|NCT01064531|536444195|FG001|Overall Study|Revision due to dislocation|1|||
148969386|NCT02641379|537372864|FG009|Overall Study|No 2 Log drop at Week 12|0|||
148969387|NCT02641379|537372865|FG010|Overall Study|No 2 Log drop at Week 12|1|||
148969388|NCT02641379|537372855|FG000|Overall Study|Negative PCR result|0|||
148969389|NCT02641379|537372856|FG001|Overall Study|Negative PCR result|0|||
148969390|NCT02641379|537372857|FG002|Overall Study|Negative PCR result|0|||
148969391|NCT02641379|537372858|FG003|Overall Study|Negative PCR result|0|||
148969392|NCT02641379|537372859|FG004|Overall Study|Negative PCR result|0|||
148969393|NCT02641379|537372860|FG005|Overall Study|Negative PCR result|0|||
148719506|NCT01064531|536444194|FG000|Overall Study|Death|0|||
148719507|NCT01064531|536444195|FG001|Overall Study|Death|1|||
148719508|NCT00298740|536444196|FG000|Overall Study|Lack of Efficacy|6|||
148719509|NCT00298740|536444196|FG000|Overall Study|Withdrawal by Subject|3|||
148719510|NCT01091103|536444198|FG000|Overall Study|Adverse Event|1|||
148719511|NCT01091103|536444198|FG000|Overall Study|Progressive Disease|3|||
148719512|NCT01270620|536444199|FG000|Overall Study|Withdrawal by Subject|1|||
148719513|NCT01270620|536444200|FG001|Overall Study|Withdrawal by Subject|3|||
148719514|NCT00684567|536444201|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
148719515|NCT00684567|536444201|FG000|Monotherapy Period|Adverse Event|2|||
148719516|NCT00684567|536444201|FG000|Monotherapy Period|Death|1|||
148719517|NCT00684567|536444201|FG000|Monotherapy Period|Progression of primary disease|11|||
148719518|NCT03136406|536444202|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
148719519|NCT01201759|536444203|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
148719520|NCT01201759|536444204|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
148719521|NCT01201759|536444203|FG000|Visit 3 - Washout|Adverse Event|0|||
148719522|NCT01201759|536444204|FG001|Visit 3 - Washout|Adverse Event|3|||
148719523|NCT01201759|536444203|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
148719524|NCT01201759|536444204|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
148719525|NCT01201759|536444203|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
148719526|NCT01201759|536444204|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
148719527|NCT01045707|536444205|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
148719528|NCT01045707|536444206|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
148719529|NCT01045707|536444205|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
148719530|NCT01045707|536444206|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
148719531|NCT01045707|536444205|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
148719532|NCT01045707|536444206|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
148719533|NCT01045707|536444205|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
148719534|NCT01045707|536444206|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
148719535|NCT01045707|536444205|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
148719536|NCT01045707|536444206|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
148719537|NCT01045707|536444205|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
148719538|NCT01045707|536444206|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
148719539|NCT01045707|536444205|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
148719540|NCT01045707|536444206|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
148719541|NCT01045707|536444205|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
148719542|NCT01045707|536444206|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
148719543|NCT01045707|536444205|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
148719544|NCT01045707|536444206|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
148719545|NCT02744755|536444207|FG000|Study Period 1|Protocol Violation|2|||
148719546|NCT02744755|536444208|FG001|Study Period 1|Protocol Violation|1|||
148719547|NCT02744755|536444207|FG000|Study Period 1|not defined|0|||
148719548|NCT02744755|536444208|FG001|Study Period 1|not defined|1|||
148719549|NCT02744755|536444207|FG000|Study Period 1|Pregnancy|1|||
148719550|NCT02744755|536444208|FG001|Study Period 1|Pregnancy|0|||
148719551|NCT02744755|536444207|FG000|Study Period 1|Adverse Event|1|||
148719552|NCT02744755|536444208|FG001|Study Period 1|Adverse Event|1|||
148719553|NCT02744755|536444207|FG000|Study Period 1|Lost to Follow-up|1|||
148719554|NCT02744755|536444208|FG001|Study Period 1|Lost to Follow-up|1|||
148719555|NCT02744755|536444207|FG000|Study Period 1|Lack of Efficacy|1|||
148719556|NCT02744755|536444208|FG001|Study Period 1|Lack of Efficacy|0|||
148719557|NCT02744755|536444207|FG000|Study Period 1|Withdrawal by Subject|8|||
148719558|NCT02744755|536444208|FG001|Study Period 1|Withdrawal by Subject|4|||
148719559|NCT02744755|536444207|FG000|Study Period 2|Adverse Event|5|||
148719560|NCT02744755|536444208|FG001|Study Period 2|Adverse Event|0|||
148719561|NCT02744755|536444207|FG000|Study Period 2|Protocol Violation|1|||
148719562|NCT02744755|536444208|FG001|Study Period 2|Protocol Violation|0|||
148719563|NCT02744755|536444207|FG000|Study Period 2|not defined|3|||
148719564|NCT02744755|536444208|FG001|Study Period 2|not defined|2|||
148719565|NCT02744755|536444207|FG000|Study Period 2|Lost to Follow-up|0|||
148719566|NCT02744755|536444208|FG001|Study Period 2|Lost to Follow-up|2|||
148719567|NCT02744755|536444207|FG000|Study Period 2|Withdrawal by Subject|2|||
148719568|NCT02744755|536444208|FG001|Study Period 2|Withdrawal by Subject|2|||
148719569|NCT02744755|536444207|FG000|Study Period 2|Lack of Efficacy|3|||
148719570|NCT02744755|536444208|FG001|Study Period 2|Lack of Efficacy|2|||
148719571|NCT00809965|536444209|FG000|Overall Study|Death|194|||
148719572|NCT00809965|536444210|FG001|Overall Study|Death|147|||
148719573|NCT00809965|536444211|FG002|Overall Study|Death|196|||
148719574|NCT00809965|536444209|FG000|Overall Study|Lost to Follow-up|17|||
148719575|NCT00809965|536444210|FG001|Overall Study|Lost to Follow-up|10|||
148719576|NCT00809965|536444211|FG002|Overall Study|Lost to Follow-up|18|||
148719577|NCT00809965|536444209|FG000|Overall Study|Withdrawal by Subject|405|||
148719578|NCT00809965|536444210|FG001|Overall Study|Withdrawal by Subject|448|||
148719579|NCT00809965|536444211|FG002|Overall Study|Withdrawal by Subject|441|||
148719580|NCT00809965|536444209|FG000|Overall Study|Other Reason|167|||
148719581|NCT00809965|536444210|FG001|Overall Study|Other Reason|170|||
148719582|NCT00809965|536444211|FG002|Overall Study|Other Reason|189|||
148719583|NCT02916693|536444212|FG000|Overall Study|Lost to Follow-up|7|||
148719584|NCT04205162|536444213|FG000|Overall Study|Lost to Follow-up|1|||
148719585|NCT04205162|536444214|FG001|Overall Study|Lost to Follow-up|0|||
148719586|NCT04205162|536444213|FG000|Overall Study|Withdrawal by Subject|2|||
148719587|NCT04205162|536444214|FG001|Overall Study|Withdrawal by Subject|0|||
148719588|NCT04205162|536444213|FG000|Overall Study|University closure due to COVID-19|1|||
148719589|NCT04205162|536444214|FG001|Overall Study|University closure due to COVID-19|0|||
148719590|NCT00372996|536444215|FG000|Overall Study|Death|11|||
148719591|NCT00372996|536444216|FG001|Overall Study|Death|4|||
148719592|NCT00372996|536444217|FG002|Overall Study|Death|8|||
148719593|NCT00372996|536444218|FG003|Overall Study|Death|7|||
148719594|NCT00372996|536444215|FG000|Overall Study|Lost to Follow-up|0|||
148719595|NCT00372996|536444216|FG001|Overall Study|Lost to Follow-up|2|||
148719596|NCT00372996|536444217|FG002|Overall Study|Lost to Follow-up|0|||
148719597|NCT00372996|536444218|FG003|Overall Study|Lost to Follow-up|1|||
148719598|NCT00372996|536444215|FG000|Overall Study|Withdrawal by Subject|12|||
148719599|NCT00372996|536444216|FG001|Overall Study|Withdrawal by Subject|6|||
148719600|NCT00372996|536444217|FG002|Overall Study|Withdrawal by Subject|9|||
148719601|NCT00372996|536444218|FG003|Overall Study|Withdrawal by Subject|5|||
148719602|NCT00372996|536444215|FG000|Overall Study|Study Terminated by Sponsor|4|||
148719603|NCT00372996|536444216|FG001|Overall Study|Study Terminated by Sponsor|0|||
148719604|NCT00372996|536444217|FG002|Overall Study|Study Terminated by Sponsor|4|||
148719605|NCT00372996|536444218|FG003|Overall Study|Study Terminated by Sponsor|0|||
148719606|NCT00372996|536444215|FG000|Overall Study|Other|10|||
148719607|NCT00372996|536444216|FG001|Overall Study|Other|2|||
148719608|NCT00372996|536444217|FG002|Overall Study|Other|7|||
148719609|NCT00372996|536444218|FG003|Overall Study|Other|7|||
148719610|NCT00721955|536444219|FG000|Overall Study|Adverse Event|0|||
148719611|NCT00721955|536444220|FG001|Overall Study|Adverse Event|0|||
148719612|NCT00721955|536444221|FG002|Overall Study|Adverse Event|2|||
148719613|NCT01077258|536444224|FG000|Overall Study|Lost to Follow-up|1390|||
148719614|NCT01077258|536444224|FG000|Overall Study|Adverse drug reaction|218|||
148719615|NCT01077258|536444224|FG000|Overall Study|Lack of Efficacy|663|||
148719616|NCT01077258|536444224|FG000|Overall Study|Clinical remission|37|||
148719617|NCT01077258|536444224|FG000|Overall Study|Other reasons|260|||
148719618|NCT00515216|536444225|FG000|Overall Study|Withdrawal by Subject|1|||
148719619|NCT01450800|536444237|FG000|Overall Study|Protocol Violation|1|||
148719620|NCT01450800|536444238|FG001|Overall Study|Protocol Violation|3|||
148719621|NCT03496298|536444239|FG000|Overall Study|Adverse Event|49|||
148719622|NCT03496298|536444240|FG001|Overall Study|Adverse Event|68|||
148719623|NCT03496298|536444241|FG002|Overall Study|Adverse Event|79|||
148719624|NCT03496298|536444239|FG000|Overall Study|Study terminated by Sponsor|1050|||
148719625|NCT03496298|536444240|FG001|Overall Study|Study terminated by Sponsor|1063|||
148719626|NCT03496298|536444241|FG002|Overall Study|Study terminated by Sponsor|1071|||
148719627|NCT03496298|536444239|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
148719628|NCT03496298|536444240|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
148719629|NCT03496298|536444241|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
148719630|NCT03496298|536444239|FG000|Overall Study|Withdrawal by Subject|176|||
148719631|NCT03496298|536444240|FG001|Overall Study|Withdrawal by Subject|154|||
148719632|NCT03496298|536444241|FG002|Overall Study|Withdrawal by Subject|151|||
148719633|NCT03496298|536444239|FG000|Overall Study|Other|29|||
148719634|NCT03496298|536444240|FG001|Overall Study|Other|20|||
148719635|NCT03496298|536444241|FG002|Overall Study|Other|23|||
148719636|NCT03496298|536444239|FG000|Overall Study|Randomized and not treated|1|||
148719637|NCT03496298|536444240|FG001|Overall Study|Randomized and not treated|1|||
148719638|NCT03496298|536444241|FG002|Overall Study|Randomized and not treated|1|||
148719639|NCT02058160|536444248|FG000|Overall Study|Randomized but not treated|2|||
148719640|NCT02058160|536444249|FG001|Overall Study|Randomized but not treated|4|||
148719641|NCT02058160|536444248|FG000|Overall Study|Poor compliance to protocol|4|||
148719642|NCT02058160|536444249|FG001|Overall Study|Poor compliance to protocol|1|||
148719643|NCT02058160|536444248|FG000|Overall Study|Adverse Event|12|||
148719644|NCT02058160|536444249|FG001|Overall Study|Adverse Event|3|||
148719645|NCT02058160|536444248|FG000|Overall Study|Lost to Follow-up|1|||
148719646|NCT02058160|536444249|FG001|Overall Study|Lost to Follow-up|0|||
148719647|NCT02058160|536444248|FG000|Overall Study|Other than specified above|12|||
148719648|NCT02058160|536444249|FG001|Overall Study|Other than specified above|6|||
148719649|NCT01203917|536444251|FG000|Overall Study|Death|29|||
148719650|NCT01203917|536444251|FG000|Overall Study|Lost to Follow-up|2|||
148719651|NCT01203917|536444251|FG000|Overall Study|Withdrawal by Subject|3|||
148719652|NCT01203917|536444251|FG000|Overall Study|Due to objective disease progression|1|||
148719653|NCT01203917|536444251|FG000|Overall Study|Due to EGFR M+I patient|1|||
148719654|NCT00152516|536444256|FG000|Overall Study|Adverse Event|18|||
148719655|NCT00152516|536444256|FG000|Overall Study|Lack and Loss of Efficacy|30|||
148719656|NCT00152516|536444256|FG000|Overall Study|Lost to Follow-up|5|||
148719657|NCT00152516|536444256|FG000|Overall Study|Withdrawal by Subject|8|||
148719658|NCT00152516|536444256|FG000|Overall Study|Protocol Violation|3|||
148719659|NCT00152516|536444256|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
148969394|NCT02641379|537372861|FG006|Overall Study|Negative PCR result|0|||
148719660|NCT00152516|536444256|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
148719661|NCT00152516|536444256|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
148719662|NCT00152516|536444256|FG000|Overall Study|Other: Non-Compliance|2|||
148719663|NCT00152516|536444256|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
148719664|NCT00152516|536444256|FG000|Overall Study|Other: Moved Out Of State|1|||
148719665|NCT00152516|536444256|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
148719666|NCT00152516|536444256|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
148719667|NCT01115933|536444257|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
148719668|NCT01086969|536444266|FG000|Overall Study|Withdrawal by Subject|1|||
148719669|NCT01086969|536444267|FG001|Overall Study|Withdrawal by Subject|2|||
148719670|NCT01086969|536444268|FG002|Overall Study|Withdrawal by Subject|0|||
148719671|NCT01466036|536444273|FG000|Overall Study|Death|1|||
148719672|NCT01466036|536444274|FG001|Overall Study|Death|1|||
148719673|NCT01466036|536444273|FG000|Overall Study|Physician Decision|0|||
148719674|NCT01466036|536444274|FG001|Overall Study|Physician Decision|4|||
148719675|NCT01466036|536444273|FG000|Overall Study|Adverse Event|2|||
148719676|NCT01466036|536444274|FG001|Overall Study|Adverse Event|6|||
148719677|NCT01466036|536444273|FG000|Overall Study|Withdrawal by Subject|2|||
148719678|NCT01466036|536444274|FG001|Overall Study|Withdrawal by Subject|8|||
148719679|NCT01466036|536444273|FG000|Overall Study|progression/relapse|14|||
148719680|NCT01466036|536444274|FG001|Overall Study|progression/relapse|21|||
148719681|NCT01466036|536444273|FG000|Overall Study|prolonged treatment delay|1|||
148719682|NCT01466036|536444274|FG001|Overall Study|prolonged treatment delay|1|||
148719683|NCT00819767|536444277|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148719684|NCT00819767|536444278|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148719685|NCT00250705|536444281|FG000|Overall Study|Lack of Efficacy|2|||
148719686|NCT04291508|536444290|FG000|Overall Study|Withdrawal by Subject|1|||
148719687|NCT04291508|536444291|FG001|Overall Study|Withdrawal by Subject|0|||
148719688|NCT04291508|536444292|FG002|Overall Study|Withdrawal by Subject|1|||
148719689|NCT04291508|536444293|FG003|Overall Study|Withdrawal by Subject|0|||
148719690|NCT04291508|536444290|FG000|Overall Study|lost to follow up|4|||
148719691|NCT04291508|536444291|FG001|Overall Study|lost to follow up|0|||
148719692|NCT04291508|536444292|FG002|Overall Study|lost to follow up|1|||
148719693|NCT04291508|536444293|FG003|Overall Study|lost to follow up|0|||
148719694|NCT00398073|536444294|FG000|Overall Study|Withdrawal by Subject|1|||
148719695|NCT00398073|536444295|FG001|Overall Study|Withdrawal by Subject|0|||
148719696|NCT01263561|536444296|FG000|Overall Study|Death|1|||
148719697|NCT01263561|536444297|FG001|Overall Study|Death|2|||
148719698|NCT00879684|536444298|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
148719699|NCT00879684|536444299|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
148719700|NCT00879684|536444300|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
148719701|NCT00879684|536444301|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
148719702|NCT00879684|536444302|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
148719703|NCT00879684|536444303|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
148719704|NCT00879684|536444304|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
148719705|NCT00879684|536444298|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
148719706|NCT00879684|536444299|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
148719707|NCT00879684|536444300|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
148719708|NCT00879684|536444301|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
148719709|NCT00879684|536444302|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
148719710|NCT00879684|536444303|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
148719711|NCT00879684|536444304|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
148719712|NCT00879684|536444298|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
148719713|NCT00879684|536444299|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
148719714|NCT00879684|536444300|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
148719715|NCT00879684|536444301|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
148719716|NCT00879684|536444302|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
148969395|NCT02641379|537372862|FG007|Overall Study|Negative PCR result|0|||
148969396|NCT02641379|537372863|FG008|Overall Study|Negative PCR result|0|||
148969397|NCT02641379|537372864|FG009|Overall Study|Negative PCR result|1|||
148969398|NCT02641379|537372865|FG010|Overall Study|Negative PCR result|0|||
148969399|NCT02641379|537372855|FG000|Overall Study|Participant's PCR high|0|||
148969400|NCT02641379|537372856|FG001|Overall Study|Participant's PCR high|0|||
148969401|NCT02641379|537372857|FG002|Overall Study|Participant's PCR high|0|||
148969402|NCT02641379|537372858|FG003|Overall Study|Participant's PCR high|0|||
148969403|NCT02641379|537372859|FG004|Overall Study|Participant's PCR high|0|||
148969404|NCT02641379|537372860|FG005|Overall Study|Participant's PCR high|0|||
148719717|NCT00879684|536444303|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
148719718|NCT00879684|536444304|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
148719719|NCT00879684|536444298|FG000|Stage 1: Dose Escalation|Death|0|||
148719720|NCT00879684|536444299|FG001|Stage 1: Dose Escalation|Death|0|||
148719721|NCT00879684|536444300|FG002|Stage 1: Dose Escalation|Death|1|||
148719722|NCT00879684|536444301|FG003|Stage 1: Dose Escalation|Death|0|||
148719723|NCT00879684|536444302|FG004|Stage 1: Dose Escalation|Death|0|||
148719724|NCT00879684|536444303|FG005|Stage 1: Dose Escalation|Death|0|||
148719725|NCT00879684|536444304|FG006|Stage 1: Dose Escalation|Death|0|||
148719726|NCT00879684|536444298|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
148719727|NCT00879684|536444299|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
148719728|NCT00879684|536444300|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
148719729|NCT00879684|536444301|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
148719730|NCT00879684|536444302|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
148719731|NCT00879684|536444303|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
148719732|NCT00879684|536444304|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
148719733|NCT00879684|536444298|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
148719734|NCT00879684|536444299|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
148719735|NCT00879684|536444300|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
148719736|NCT00879684|536444301|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
148719737|NCT00879684|536444302|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
148719738|NCT00879684|536444303|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
148719739|NCT00879684|536444304|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
148719740|NCT00879684|536444298|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
148719741|NCT00879684|536444299|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
148719742|NCT00879684|536444300|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
148719743|NCT00879684|536444301|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
148719744|NCT00879684|536444302|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
148719745|NCT00879684|536444303|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
148719746|NCT00879684|536444304|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
148719747|NCT00708682|536444305|FG000|Infant Series|Adverse Event|1|||
148719748|NCT00708682|536444305|FG000|Infant Series|Lost to Follow-up|4|||
148719749|NCT00708682|536444305|FG000|Infant Series|Protocol Violation|1|||
148719750|NCT00708682|536444305|FG000|Infant Series|Parent/legal guardian request|6|||
148719751|NCT00708682|536444305|FG000|Infant Series|Failed to return|2|||
148719752|NCT00708682|536444305|FG000|Infant Series|Other|19|||
148719753|NCT00708682|536444305|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
148816152|NCT01807520|536802794|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
148816153|NCT01807520|536802795|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
148816154|NCT01807520|536802796|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
148816155|NCT01807520|536802797|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
148816156|NCT01807520|536802798|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
148816157|NCT01807520|536802799|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
148816158|NCT01807520|536802793|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
148816159|NCT01807520|536802794|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
148816160|NCT01807520|536802795|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
148816161|NCT01807520|536802796|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
148719754|NCT00708682|536444305|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
148719755|NCT00708682|536444305|FG000|Toddler Dose|Lost to Follow-up|3|||
148719756|NCT00708682|536444305|FG000|Toddler Dose|Failed to Return|4|||
148719757|NCT03185741|536444310|FG000|Baseline|Withdrawal by Subject|1|||
148719758|NCT03185741|536444311|FG001|Baseline|Withdrawal by Subject|3|||
148719759|NCT03185741|536444312|FG002|Baseline|Withdrawal by Subject|2|||
148719760|NCT03185741|536444310|FG000|Baseline|Lost to Follow-up|1|||
148719761|NCT03185741|536444311|FG001|Baseline|Lost to Follow-up|2|||
148719762|NCT03185741|536444312|FG002|Baseline|Lost to Follow-up|3|||
148719763|NCT03185741|536444310|FG000|3Month|Death|1|||
148719764|NCT03185741|536444311|FG001|3Month|Death|1|||
148719765|NCT03185741|536444312|FG002|3Month|Death|2|||
148719766|NCT03185741|536444310|FG000|3Month|Withdrawal by Subject|1|||
148719767|NCT03185741|536444311|FG001|3Month|Withdrawal by Subject|5|||
148719768|NCT03185741|536444312|FG002|3Month|Withdrawal by Subject|1|||
148719769|NCT03185741|536444310|FG000|3Month|Lost to Follow-up|7|||
148719770|NCT03185741|536444311|FG001|3Month|Lost to Follow-up|9|||
148719771|NCT03185741|536444312|FG002|3Month|Lost to Follow-up|8|||
148719772|NCT03185741|536444310|FG000|3Month|Unavailable for 3Month|11|||
148719773|NCT03185741|536444311|FG001|3Month|Unavailable for 3Month|10|||
148719774|NCT03185741|536444312|FG002|3Month|Unavailable for 3Month|11|||
148719775|NCT03185741|536444310|FG000|3Month|Protocol Violation|0|||
148719776|NCT03185741|536444311|FG001|3Month|Protocol Violation|0|||
148719777|NCT03185741|536444312|FG002|3Month|Protocol Violation|3|||
148719778|NCT03185741|536444310|FG000|6Month|Death|1|||
148719779|NCT03185741|536444311|FG001|6Month|Death|1|||
148719780|NCT03185741|536444312|FG002|6Month|Death|2|||
148719781|NCT03185741|536444310|FG000|6Month|Withdrawal by Subject|2|||
148719782|NCT03185741|536444311|FG001|6Month|Withdrawal by Subject|3|||
148816162|NCT01807520|536802797|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
148719783|NCT03185741|536444312|FG002|6Month|Withdrawal by Subject|1|||
148719784|NCT03185741|536444310|FG000|6Month|Lost to Follow-up|16|||
148719785|NCT03185741|536444311|FG001|6Month|Lost to Follow-up|15|||
148719786|NCT03185741|536444312|FG002|6Month|Lost to Follow-up|16|||
148719787|NCT01488448|536444314|FG000|Overall Study|Withdrawal by Subject|3|||
148719788|NCT01488448|536444315|FG001|Overall Study|Withdrawal by Subject|1|||
148719789|NCT01488448|536444314|FG000|Overall Study|Adverse Event|9|||
148719790|NCT01488448|536444315|FG001|Overall Study|Adverse Event|4|||
148719791|NCT01488448|536444314|FG000|Overall Study|Physician Decision|4|||
148719792|NCT01488448|536444315|FG001|Overall Study|Physician Decision|9|||
148719793|NCT01488448|536444314|FG000|Overall Study|Protocol Violation|4|||
148719794|NCT01488448|536444315|FG001|Overall Study|Protocol Violation|3|||
148719795|NCT00654641|536444316|FG000|Overall Study|Lost to Follow-up|2|||
148719796|NCT00654641|536444317|FG001|Overall Study|Lost to Follow-up|3|||
148719797|NCT00434590|536444318|FG000|Overall Study|Administrative problems|5|||
148719798|NCT00434590|536444319|FG001|Overall Study|Administrative problems|5|||
148719799|NCT01923311|536446677|FG000|Overall Study|Pregnancy|1|||
148719800|NCT01923311|536446678|FG001|Overall Study|Pregnancy|0|||
148719801|NCT01923311|536446677|FG000|Overall Study|Investigator's Discretion|1|||
148719802|NCT01923311|536446678|FG001|Overall Study|Investigator's Discretion|0|||
148719803|NCT01923311|536446677|FG000|Overall Study|Non-Compliance with Study Drug|2|||
148719804|NCT01923311|536446678|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148719805|NCT01923311|536446677|FG000|Overall Study|Withdrew Consent|1|||
148719806|NCT01923311|536446678|FG001|Overall Study|Withdrew Consent|0|||
148719807|NCT01923311|536446677|FG000|Overall Study|Study Terminated by Sponsor|12|||
148719808|NCT01923311|536446678|FG001|Overall Study|Study Terminated by Sponsor|0|||
148719809|NCT02839798|536446680|FG000|Overall Study|Withdrawal by Subject|2|||
148719810|NCT03429049|536446681|FG000|Overall Study|Adverse Event|2|||
148719811|NCT03429049|536446682|FG001|Overall Study|Adverse Event|3|||
148719812|NCT03429049|536446681|FG000|Overall Study|Death|0|||
148719813|NCT03429049|536446682|FG001|Overall Study|Death|1|||
148719814|NCT03429049|536446681|FG000|Overall Study|Lack of Efficacy|4|||
148719815|NCT03429049|536446682|FG001|Overall Study|Lack of Efficacy|2|||
148719816|NCT03429049|536446681|FG000|Overall Study|Lost to Follow-up|9|||
148719817|NCT03429049|536446682|FG001|Overall Study|Lost to Follow-up|8|||
148719818|NCT03429049|536446681|FG000|Overall Study|Physician Decision|1|||
148719819|NCT03429049|536446682|FG001|Overall Study|Physician Decision|0|||
148719820|NCT03429049|536446681|FG000|Overall Study|Protocol Violation|3|||
148719821|NCT03429049|536446682|FG001|Overall Study|Protocol Violation|0|||
148719822|NCT03429049|536446681|FG000|Overall Study|Sponsor Decision|2|||
148719823|NCT03429049|536446682|FG001|Overall Study|Sponsor Decision|0|||
148719824|NCT03429049|536446681|FG000|Overall Study|Withdrawal by Subject|4|||
148719825|NCT03429049|536446682|FG001|Overall Study|Withdrawal by Subject|20|||
148719826|NCT03429049|536446681|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
148719827|NCT03429049|536446682|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
148719828|NCT04703855|536446683|FG000|Overall Study|Heart Transplant|1|||
148719829|NCT05258630|536446685|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
148719830|NCT05258630|536446686|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
148719831|NCT05258630|536446685|FG000|Overall Study|Lost to Follow-up|0|||
148719832|NCT05258630|536446686|FG001|Overall Study|Lost to Follow-up|2|||
148719833|NCT03431337|536446687|FG000|Overall Study|Lost to Follow-up|21|||
148719834|NCT03431337|536446688|FG001|Overall Study|Lost to Follow-up|19|||
148719835|NCT03431337|536446687|FG000|Overall Study|Withdrawal by Subject|8|||
148719836|NCT03431337|536446688|FG001|Overall Study|Withdrawal by Subject|3|||
148719837|NCT00401245|536446689|FG000|Double Blind Titration Phase|Adverse Event|3|||
148719838|NCT00401245|536446690|FG001|Double Blind Titration Phase|Adverse Event|2|||
148719839|NCT00401245|536446691|FG002|Double Blind Titration Phase|Adverse Event|5|||
148719840|NCT00401245|536446692|FG003|Double Blind Titration Phase|Adverse Event|12|||
148719841|NCT00401245|536446693|FG004|Double Blind Titration Phase|Adverse Event|0|||
148719842|NCT00401245|536446694|FG005|Double Blind Titration Phase|Adverse Event|0|||
148719843|NCT00401245|536446695|FG006|Double Blind Titration Phase|Adverse Event|0|||
148719844|NCT00401245|536446696|FG007|Double Blind Titration Phase|Adverse Event|0|||
148719845|NCT00401245|536446689|FG000|Double Blind Titration Phase|Other|0|||
148719846|NCT00401245|536446690|FG001|Double Blind Titration Phase|Other|0|||
148719847|NCT00401245|536446691|FG002|Double Blind Titration Phase|Other|1|||
148719848|NCT00401245|536446692|FG003|Double Blind Titration Phase|Other|0|||
148719849|NCT00401245|536446693|FG004|Double Blind Titration Phase|Other|0|||
148719850|NCT00401245|536446694|FG005|Double Blind Titration Phase|Other|0|||
148719851|NCT00401245|536446695|FG006|Double Blind Titration Phase|Other|0|||
148719852|NCT00401245|536446696|FG007|Double Blind Titration Phase|Other|0|||
148719853|NCT00401245|536446689|FG000|Double Blind Titration Phase|Protocol Violation|0|||
148719854|NCT00401245|536446690|FG001|Double Blind Titration Phase|Protocol Violation|0|||
148719855|NCT00401245|536446691|FG002|Double Blind Titration Phase|Protocol Violation|0|||
148719856|NCT00401245|536446692|FG003|Double Blind Titration Phase|Protocol Violation|1|||
148719857|NCT00401245|536446693|FG004|Double Blind Titration Phase|Protocol Violation|0|||
148719858|NCT00401245|536446694|FG005|Double Blind Titration Phase|Protocol Violation|0|||
148719859|NCT00401245|536446695|FG006|Double Blind Titration Phase|Protocol Violation|0|||
148719860|NCT00401245|536446696|FG007|Double Blind Titration Phase|Protocol Violation|0|||
148719861|NCT00401245|536446689|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
148719862|NCT00401245|536446690|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
148719863|NCT00401245|536446691|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
148719864|NCT00401245|536446692|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
148719865|NCT00401245|536446693|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
148719866|NCT00401245|536446694|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
148719867|NCT00401245|536446695|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
148719868|NCT00401245|536446696|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
148719869|NCT00401245|536446689|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
148719870|NCT00401245|536446690|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
148719871|NCT00401245|536446691|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
148719872|NCT00401245|536446692|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
148719873|NCT00401245|536446693|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
148719874|NCT00401245|536446694|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
148719875|NCT00401245|536446695|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
148719876|NCT00401245|536446696|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
148719877|NCT00401245|536446689|FG000|Open Label Phase|Adverse Event|5|||
148719878|NCT00401245|536446690|FG001|Open Label Phase|Adverse Event|14|||
148719879|NCT00401245|536446691|FG002|Open Label Phase|Adverse Event|6|||
148719880|NCT00401245|536446692|FG003|Open Label Phase|Adverse Event|7|||
148719881|NCT00401245|536446693|FG004|Open Label Phase|Adverse Event|0|||
148719882|NCT00401245|536446694|FG005|Open Label Phase|Adverse Event|0|||
148719883|NCT00401245|536446695|FG006|Open Label Phase|Adverse Event|0|||
148719884|NCT00401245|536446696|FG007|Open Label Phase|Adverse Event|0|||
148719885|NCT00401245|536446689|FG000|Open Label Phase|Lost to Follow-up|5|||
148719886|NCT00401245|536446690|FG001|Open Label Phase|Lost to Follow-up|7|||
148719887|NCT00401245|536446691|FG002|Open Label Phase|Lost to Follow-up|5|||
148719888|NCT00401245|536446692|FG003|Open Label Phase|Lost to Follow-up|4|||
148719889|NCT00401245|536446693|FG004|Open Label Phase|Lost to Follow-up|0|||
148719890|NCT00401245|536446694|FG005|Open Label Phase|Lost to Follow-up|0|||
148719891|NCT00401245|536446695|FG006|Open Label Phase|Lost to Follow-up|0|||
148719892|NCT00401245|536446696|FG007|Open Label Phase|Lost to Follow-up|0|||
148719893|NCT00401245|536446689|FG000|Open Label Phase|Other|4|||
148719894|NCT00401245|536446690|FG001|Open Label Phase|Other|8|||
148719895|NCT00401245|536446691|FG002|Open Label Phase|Other|7|||
148719896|NCT00401245|536446692|FG003|Open Label Phase|Other|8|||
148719897|NCT00401245|536446693|FG004|Open Label Phase|Other|0|||
148719898|NCT00401245|536446694|FG005|Open Label Phase|Other|0|||
148719899|NCT00401245|536446695|FG006|Open Label Phase|Other|0|||
148719900|NCT00401245|536446696|FG007|Open Label Phase|Other|0|||
148719901|NCT00401245|536446689|FG000|Open Label Phase|Protocol Violation|0|||
148719902|NCT00401245|536446690|FG001|Open Label Phase|Protocol Violation|1|||
148719903|NCT00401245|536446691|FG002|Open Label Phase|Protocol Violation|0|||
148719904|NCT00401245|536446692|FG003|Open Label Phase|Protocol Violation|1|||
148719905|NCT00401245|536446693|FG004|Open Label Phase|Protocol Violation|0|||
148719906|NCT00401245|536446694|FG005|Open Label Phase|Protocol Violation|0|||
148719907|NCT00401245|536446695|FG006|Open Label Phase|Protocol Violation|0|||
148719908|NCT00401245|536446696|FG007|Open Label Phase|Protocol Violation|0|||
148719909|NCT00401245|536446689|FG000|Open Label Phase|Withdrawal by Subject|3|||
148719910|NCT00401245|536446690|FG001|Open Label Phase|Withdrawal by Subject|3|||
148719911|NCT00401245|536446691|FG002|Open Label Phase|Withdrawal by Subject|2|||
148719912|NCT00401245|536446692|FG003|Open Label Phase|Withdrawal by Subject|1|||
148719913|NCT00401245|536446693|FG004|Open Label Phase|Withdrawal by Subject|0|||
148719914|NCT00401245|536446694|FG005|Open Label Phase|Withdrawal by Subject|0|||
148719915|NCT00401245|536446695|FG006|Open Label Phase|Withdrawal by Subject|0|||
148719916|NCT00401245|536446696|FG007|Open Label Phase|Withdrawal by Subject|0|||
148719917|NCT00401245|536446689|FG000|Open Label Phase|Lack of Efficacy|4|||
148719918|NCT00401245|536446690|FG001|Open Label Phase|Lack of Efficacy|2|||
148719919|NCT00401245|536446691|FG002|Open Label Phase|Lack of Efficacy|3|||
148719920|NCT00401245|536446692|FG003|Open Label Phase|Lack of Efficacy|0|||
148719921|NCT00401245|536446693|FG004|Open Label Phase|Lack of Efficacy|0|||
148719922|NCT00401245|536446694|FG005|Open Label Phase|Lack of Efficacy|0|||
148719923|NCT00401245|536446695|FG006|Open Label Phase|Lack of Efficacy|0|||
148719924|NCT00401245|536446696|FG007|Open Label Phase|Lack of Efficacy|0|||
148719925|NCT00401245|536446689|FG000|Double Blind Tapering Phase|Adverse Event|0|||
148719926|NCT00401245|536446690|FG001|Double Blind Tapering Phase|Adverse Event|0|||
148719927|NCT00401245|536446691|FG002|Double Blind Tapering Phase|Adverse Event|0|||
148719928|NCT00401245|536446692|FG003|Double Blind Tapering Phase|Adverse Event|0|||
148719929|NCT00401245|536446693|FG004|Double Blind Tapering Phase|Adverse Event|1|||
148719930|NCT00401245|536446694|FG005|Double Blind Tapering Phase|Adverse Event|1|||
148719931|NCT00401245|536446695|FG006|Double Blind Tapering Phase|Adverse Event|2|||
148719932|NCT00401245|536446696|FG007|Double Blind Tapering Phase|Adverse Event|4|||
148719933|NCT00401245|536446689|FG000|Double Blind Tapering Phase|Investigator request|0|||
148719934|NCT00401245|536446690|FG001|Double Blind Tapering Phase|Investigator request|0|||
148719935|NCT00401245|536446691|FG002|Double Blind Tapering Phase|Investigator request|0|||
148719936|NCT00401245|536446692|FG003|Double Blind Tapering Phase|Investigator request|0|||
148719937|NCT00401245|536446693|FG004|Double Blind Tapering Phase|Investigator request|0|||
148719938|NCT00401245|536446694|FG005|Double Blind Tapering Phase|Investigator request|0|||
148719939|NCT00401245|536446695|FG006|Double Blind Tapering Phase|Investigator request|0|||
148719940|NCT00401245|536446696|FG007|Double Blind Tapering Phase|Investigator request|1|||
148969405|NCT02641379|537372861|FG006|Overall Study|Participant's PCR high|0|||
148969406|NCT02641379|537372862|FG007|Overall Study|Participant's PCR high|1|||
148719941|NCT00401245|536446689|FG000|Double Blind Tapering Phase|Other|0|||
148719942|NCT00401245|536446690|FG001|Double Blind Tapering Phase|Other|0|||
148719943|NCT00401245|536446691|FG002|Double Blind Tapering Phase|Other|0|||
148719944|NCT00401245|536446692|FG003|Double Blind Tapering Phase|Other|0|||
148719945|NCT00401245|536446693|FG004|Double Blind Tapering Phase|Other|1|||
148719946|NCT00401245|536446694|FG005|Double Blind Tapering Phase|Other|0|||
148719947|NCT00401245|536446695|FG006|Double Blind Tapering Phase|Other|2|||
148719948|NCT00401245|536446696|FG007|Double Blind Tapering Phase|Other|2|||
148719949|NCT00401245|536446689|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
148719950|NCT00401245|536446690|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
148719951|NCT00401245|536446691|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
148719952|NCT00401245|536446692|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
148719953|NCT00401245|536446693|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
148719954|NCT00401245|536446694|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
148719955|NCT00401245|536446695|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
148719956|NCT00401245|536446696|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
148719957|NCT00401245|536446689|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719958|NCT00401245|536446690|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719959|NCT00401245|536446691|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719960|NCT00401245|536446692|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719961|NCT00401245|536446693|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719962|NCT00401245|536446694|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
148719963|NCT00401245|536446695|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719964|NCT00401245|536446696|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
148719965|NCT01560819|536446697|FG000|Overall Study|Physician Decision|1|||
148719966|NCT01560819|536446698|FG001|Overall Study|Physician Decision|0|||
148719967|NCT02014441|536446699|FG000|Overall Study|Withdrawal by Subject|12|||
148719968|NCT00114231|536446700|FG000|Overall Study|No consent|2|||
148719969|NCT00114231|536446701|FG001|Overall Study|No consent|0|||
148719970|NCT00114231|536446700|FG000|Overall Study|QARC requirement not met|1|||
148719971|NCT00114231|536446701|FG001|Overall Study|QARC requirement not met|0|||
148719972|NCT00114231|536446700|FG000|Overall Study|Suspected metastatic disease|1|||
148719973|NCT00114231|536446701|FG001|Overall Study|Suspected metastatic disease|0|||
148719974|NCT00114231|536446700|FG000|Overall Study|No adenocarcinoma|1|||
148719975|NCT00114231|536446701|FG001|Overall Study|No adenocarcinoma|0|||
148719976|NCT00114231|536446700|FG000|Overall Study|Low creatinine clearance|0|||
148719977|NCT00114231|536446701|FG001|Overall Study|Low creatinine clearance|1|||
148719978|NCT00114231|536446700|FG000|Overall Study|Tumor size > 4cm|1|||
148719979|NCT00114231|536446701|FG001|Overall Study|Tumor size > 4cm|0|||
148719980|NCT00114231|536446700|FG000|Overall Study|Tumor fixed on digital exam|0|||
148719981|NCT00114231|536446701|FG001|Overall Study|Tumor fixed on digital exam|1|||
148719982|NCT00114231|536446700|FG000|Overall Study|No Absolute Neutrophil Count|2|||
148719983|NCT00114231|536446701|FG001|Overall Study|No Absolute Neutrophil Count|0|||
148719984|NCT00114231|536446700|FG000|Overall Study|Biopsy done after registration|1|||
148719985|NCT00114231|536446701|FG001|Overall Study|Biopsy done after registration|0|||
148719986|NCT01901848|536446706|FG000|Randomized and Treated|Lost to Follow-up|3|||
148816163|NCT01807520|536802798|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
148969407|NCT02641379|537372863|FG008|Overall Study|Participant's PCR high|0|||
148969408|NCT02641379|537372864|FG009|Overall Study|Participant's PCR high|0|||
148969409|NCT02641379|537372865|FG010|Overall Study|Participant's PCR high|0|||
148969410|NCT02641379|537372855|FG000|Overall Study|Participant treated after Week 24|0|||
148969411|NCT02641379|537372856|FG001|Overall Study|Participant treated after Week 24|0|||
148969412|NCT02641379|537372857|FG002|Overall Study|Participant treated after Week 24|0|||
148969413|NCT02641379|537372858|FG003|Overall Study|Participant treated after Week 24|0|||
148969414|NCT02641379|537372859|FG004|Overall Study|Participant treated after Week 24|0|||
148969415|NCT02641379|537372860|FG005|Overall Study|Participant treated after Week 24|0|||
148816164|NCT01807520|536802799|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
148816165|NCT01807520|536802793|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
148816166|NCT01807520|536802794|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
148816167|NCT01807520|536802795|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
148816168|NCT01807520|536802796|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
148816169|NCT01807520|536802797|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
148816170|NCT01807520|536802798|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
148969416|NCT02641379|537372861|FG006|Overall Study|Participant treated after Week 24|0|||
148719987|NCT01901848|536446707|FG001|Randomized and Treated|Lost to Follow-up|6|||
148719988|NCT01901848|536446706|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
148816171|NCT01807520|536802799|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
148719989|NCT01901848|536446707|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
148719990|NCT01729026|536446708|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
148719991|NCT01729026|536446709|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
148719992|NCT01729026|536446708|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
148719993|NCT01729026|536446709|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
148719994|NCT02488824|536446710|FG000|Overall Study|Adverse Event|1|||
148719995|NCT02488824|536446711|FG001|Overall Study|Adverse Event|1|||
148719996|NCT02668822|536446714|FG000|Overall Study|Protocol Violation|2|||
148719997|NCT02668822|536446715|FG001|Overall Study|Protocol Violation|0|||
148719998|NCT02668822|536446714|FG000|Overall Study|Study Terminated by Sponsor|7|||
148719999|NCT02668822|536446715|FG001|Overall Study|Study Terminated by Sponsor|9|||
148720000|NCT03036839|536446716|FG000|Overall Study|Adverse Event|0|||
148720001|NCT03036839|536446717|FG001|Overall Study|Adverse Event|0|||
148720002|NCT03036839|536446718|FG002|Overall Study|Adverse Event|1|||
148720003|NCT03036839|536446716|FG000|Overall Study|Death|3|||
148720004|NCT03036839|536446717|FG001|Overall Study|Death|0|||
148720005|NCT03036839|536446718|FG002|Overall Study|Death|3|||
148720006|NCT03036839|536446716|FG000|Overall Study|Withdrew Consent|0|||
148720007|NCT03036839|536446717|FG001|Overall Study|Withdrew Consent|0|||
148720008|NCT03036839|536446718|FG002|Overall Study|Withdrew Consent|1|||
148720009|NCT04317599|536446725|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
148720010|NCT04317599|536446725|FG000|Overall Study|treatment outside standard of care|4|||
148720011|NCT02780167|536446726|FG000|Overall Study|Adverse Event|9|||
148720012|NCT02780167|536446727|FG001|Overall Study|Adverse Event|8|||
148720013|NCT02780167|536446728|FG002|Overall Study|Adverse Event|8|||
148720014|NCT02780167|536446729|FG003|Overall Study|Adverse Event|12|||
148720015|NCT02780167|536446730|FG004|Overall Study|Adverse Event|8|||
148720016|NCT02780167|536446726|FG000|Overall Study|Lack of Efficacy|6|||
148720017|NCT02780167|536446727|FG001|Overall Study|Lack of Efficacy|5|||
148720018|NCT02780167|536446728|FG002|Overall Study|Lack of Efficacy|6|||
148720019|NCT02780167|536446729|FG003|Overall Study|Lack of Efficacy|1|||
148720020|NCT02780167|536446730|FG004|Overall Study|Lack of Efficacy|0|||
148720021|NCT02780167|536446726|FG000|Overall Study|Lost to Follow-up|2|||
148720022|NCT02780167|536446727|FG001|Overall Study|Lost to Follow-up|0|||
148720023|NCT02780167|536446728|FG002|Overall Study|Lost to Follow-up|1|||
148720024|NCT02780167|536446729|FG003|Overall Study|Lost to Follow-up|0|||
148720025|NCT02780167|536446730|FG004|Overall Study|Lost to Follow-up|0|||
148720026|NCT02780167|536446726|FG000|Overall Study|Does not meet entrance criteria|0|||
148720027|NCT02780167|536446727|FG001|Overall Study|Does not meet entrance criteria|0|||
148720028|NCT02780167|536446728|FG002|Overall Study|Does not meet entrance criteria|1|||
148720029|NCT02780167|536446729|FG003|Overall Study|Does not meet entrance criteria|0|||
148720030|NCT02780167|536446730|FG004|Overall Study|Does not meet entrance criteria|0|||
148720031|NCT02780167|536446726|FG000|Overall Study|No longer meets eligibility criteria|0|||
148720032|NCT02780167|536446727|FG001|Overall Study|No longer meets eligibility criteria|0|||
148720033|NCT02780167|536446728|FG002|Overall Study|No longer meets eligibility criteria|0|||
148720034|NCT02780167|536446729|FG003|Overall Study|No longer meets eligibility criteria|1|||
148720035|NCT02780167|536446730|FG004|Overall Study|No longer meets eligibility criteria|1|||
148720036|NCT02780167|536446726|FG000|Overall Study|Protocol Violation|5|||
148720037|NCT02780167|536446727|FG001|Overall Study|Protocol Violation|5|||
148720038|NCT02780167|536446728|FG002|Overall Study|Protocol Violation|1|||
148720039|NCT02780167|536446729|FG003|Overall Study|Protocol Violation|1|||
148720040|NCT02780167|536446730|FG004|Overall Study|Protocol Violation|2|||
148720041|NCT02780167|536446726|FG000|Overall Study|Withdrawal by Subject|6|||
148720042|NCT02780167|536446727|FG001|Overall Study|Withdrawal by Subject|4|||
148720043|NCT02780167|536446728|FG002|Overall Study|Withdrawal by Subject|4|||
148720044|NCT02780167|536446729|FG003|Overall Study|Withdrawal by Subject|3|||
148720045|NCT02780167|536446730|FG004|Overall Study|Withdrawal by Subject|4|||
148720046|NCT02780167|536446726|FG000|Overall Study|Other|0|||
148720047|NCT02780167|536446727|FG001|Overall Study|Other|0|||
148816172|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
148816173|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
148816174|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
148816175|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
148816176|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
148816177|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
148816178|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
148816179|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
148816180|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
148720048|NCT02780167|536446728|FG002|Overall Study|Other|3|||
148720049|NCT02780167|536446729|FG003|Overall Study|Other|1|||
148720050|NCT02780167|536446730|FG004|Overall Study|Other|2|||
148720051|NCT02315066|536446731|FG000|Overall Study|Lost to Follow-up|0|||
148720052|NCT02315066|536446732|FG001|Overall Study|Lost to Follow-up|1|||
148720053|NCT02315066|536446733|FG002|Overall Study|Lost to Follow-up|1|||
148816181|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
148969417|NCT02641379|537372862|FG007|Overall Study|Participant treated after Week 24|0|||
148969418|NCT02641379|537372863|FG008|Overall Study|Participant treated after Week 24|1|||
148720054|NCT02315066|536446734|FG003|Overall Study|Lost to Follow-up|0|||
148720055|NCT02315066|536446735|FG004|Overall Study|Lost to Follow-up|1|||
148720056|NCT02315066|536446736|FG005|Overall Study|Lost to Follow-up|0|||
148720057|NCT02315066|536446737|FG006|Overall Study|Lost to Follow-up|2|||
148720058|NCT02315066|536446738|FG007|Overall Study|Lost to Follow-up|1|||
148720059|NCT02315066|536446739|FG008|Overall Study|Lost to Follow-up|0|||
148720060|NCT02315066|536446740|FG009|Overall Study|Lost to Follow-up|0|||
148720061|NCT02315066|536446741|FG010|Overall Study|Lost to Follow-up|1|||
148720062|NCT02315066|536446742|FG011|Overall Study|Lost to Follow-up|2|||
148720063|NCT02315066|536446743|FG012|Overall Study|Lost to Follow-up|0|||
148720064|NCT02315066|536446744|FG013|Overall Study|Lost to Follow-up|4|||
148720065|NCT02315066|536446731|FG000|Overall Study|Death|2|||
148720066|NCT02315066|536446732|FG001|Overall Study|Death|7|||
148720067|NCT02315066|536446733|FG002|Overall Study|Death|6|||
148720068|NCT02315066|536446734|FG003|Overall Study|Death|11|||
148720069|NCT02315066|536446735|FG004|Overall Study|Death|10|||
148720070|NCT02315066|536446736|FG005|Overall Study|Death|3|||
148720071|NCT02315066|536446737|FG006|Overall Study|Death|9|||
148720072|NCT02315066|536446738|FG007|Overall Study|Death|9|||
148720073|NCT02315066|536446739|FG008|Overall Study|Death|10|||
148720074|NCT02315066|536446740|FG009|Overall Study|Death|8|||
148720075|NCT02315066|536446741|FG010|Overall Study|Death|10|||
148720076|NCT02315066|536446742|FG011|Overall Study|Death|7|||
148720077|NCT02315066|536446743|FG012|Overall Study|Death|8|||
148720078|NCT02315066|536446744|FG013|Overall Study|Death|21|||
148720079|NCT02315066|536446731|FG000|Overall Study|Other|0|||
148720080|NCT02315066|536446732|FG001|Overall Study|Other|0|||
148720081|NCT02315066|536446733|FG002|Overall Study|Other|0|||
148720082|NCT02315066|536446734|FG003|Overall Study|Other|0|||
148720083|NCT02315066|536446735|FG004|Overall Study|Other|0|||
148720084|NCT02315066|536446736|FG005|Overall Study|Other|0|||
148720085|NCT02315066|536446737|FG006|Overall Study|Other|0|||
148720086|NCT02315066|536446738|FG007|Overall Study|Other|1|||
148720087|NCT02315066|536446739|FG008|Overall Study|Other|1|||
148720088|NCT02315066|536446740|FG009|Overall Study|Other|2|||
148720089|NCT02315066|536446741|FG010|Overall Study|Other|0|||
148720090|NCT02315066|536446742|FG011|Overall Study|Other|0|||
148720091|NCT02315066|536446743|FG012|Overall Study|Other|0|||
148720092|NCT02315066|536446744|FG013|Overall Study|Other|0|||
148720093|NCT02315066|536446731|FG000|Overall Study|Subject refused further follow-up|0|||
148720094|NCT02315066|536446732|FG001|Overall Study|Subject refused further follow-up|2|||
148720095|NCT02315066|536446733|FG002|Overall Study|Subject refused further follow-up|2|||
148720096|NCT02315066|536446734|FG003|Overall Study|Subject refused further follow-up|0|||
148720097|NCT02315066|536446735|FG004|Overall Study|Subject refused further follow-up|0|||
148720098|NCT02315066|536446736|FG005|Overall Study|Subject refused further follow-up|0|||
148720099|NCT02315066|536446737|FG006|Overall Study|Subject refused further follow-up|2|||
148720100|NCT02315066|536446738|FG007|Overall Study|Subject refused further follow-up|3|||
148720101|NCT02315066|536446739|FG008|Overall Study|Subject refused further follow-up|0|||
148720102|NCT02315066|536446740|FG009|Overall Study|Subject refused further follow-up|1|||
148720103|NCT02315066|536446741|FG010|Overall Study|Subject refused further follow-up|1|||
148720104|NCT02315066|536446742|FG011|Overall Study|Subject refused further follow-up|2|||
148720105|NCT02315066|536446743|FG012|Overall Study|Subject refused further follow-up|2|||
148720106|NCT02315066|536446744|FG013|Overall Study|Subject refused further follow-up|4|||
148720107|NCT02315066|536446731|FG000|Overall Study|Study ongoing at date of cut-off|0|||
148720108|NCT02315066|536446732|FG001|Overall Study|Study ongoing at date of cut-off|0|||
148969419|NCT02641379|537372864|FG009|Overall Study|Participant treated after Week 24|0|||
148720109|NCT02315066|536446733|FG002|Overall Study|Study ongoing at date of cut-off|0|||
148720110|NCT02315066|536446734|FG003|Overall Study|Study ongoing at date of cut-off|0|||
148720111|NCT02315066|536446735|FG004|Overall Study|Study ongoing at date of cut-off|0|||
148720112|NCT02315066|536446736|FG005|Overall Study|Study ongoing at date of cut-off|0|||
148720113|NCT02315066|536446737|FG006|Overall Study|Study ongoing at date of cut-off|0|||
148720114|NCT02315066|536446738|FG007|Overall Study|Study ongoing at date of cut-off|0|||
148720115|NCT02315066|536446739|FG008|Overall Study|Study ongoing at date of cut-off|0|||
148720116|NCT02315066|536446740|FG009|Overall Study|Study ongoing at date of cut-off|0|||
148720117|NCT02315066|536446741|FG010|Overall Study|Study ongoing at date of cut-off|0|||
148720118|NCT02315066|536446742|FG011|Overall Study|Study ongoing at date of cut-off|0|||
148720119|NCT02315066|536446743|FG012|Overall Study|Study ongoing at date of cut-off|0|||
148720120|NCT02315066|536446744|FG013|Overall Study|Study ongoing at date of cut-off|1|||
148720121|NCT00035555|536446745|FG000|Overall Study|Adverse Event|5|||
148720122|NCT00035555|536446746|FG001|Overall Study|Adverse Event|8|||
148720123|NCT00035555|536446747|FG002|Overall Study|Adverse Event|9|||
148720124|NCT00035555|536446745|FG000|Overall Study|Allograft loss|1|||
148720125|NCT00035555|536446746|FG001|Overall Study|Allograft loss|1|||
148720126|NCT00035555|536446747|FG002|Overall Study|Allograft loss|2|||
148720127|NCT00035555|536446745|FG000|Overall Study|Death|0|||
148720128|NCT00035555|536446746|FG001|Overall Study|Death|0|||
148720129|NCT00035555|536446747|FG002|Overall Study|Death|2|||
148720130|NCT00035555|536446745|FG000|Overall Study|Lost to Follow-up|0|||
148720131|NCT00035555|536446746|FG001|Overall Study|Lost to Follow-up|0|||
148720132|NCT00035555|536446747|FG002|Overall Study|Lost to Follow-up|1|||
148720133|NCT00035555|536446745|FG000|Overall Study|Noncompliance|0|||
148720134|NCT00035555|536446746|FG001|Overall Study|Noncompliance|1|||
148720135|NCT00035555|536446747|FG002|Overall Study|Noncompliance|1|||
148720136|NCT00035555|536446745|FG000|Overall Study|Prohibited medication|1|||
148720137|NCT00035555|536446746|FG001|Overall Study|Prohibited medication|1|||
148720138|NCT00035555|536446747|FG002|Overall Study|Prohibited medication|0|||
148720139|NCT00035555|536446745|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
148720140|NCT00035555|536446746|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
148720141|NCT00035555|536446747|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
148720142|NCT00035555|536446745|FG000|Overall Study|Withdrawal by Subject|2|||
148720143|NCT00035555|536446746|FG001|Overall Study|Withdrawal by Subject|0|||
148720144|NCT00035555|536446747|FG002|Overall Study|Withdrawal by Subject|2|||
148720145|NCT00035555|536446745|FG000|Overall Study|Investigator deemed not a good candidate|0|||
148720146|NCT00035555|536446746|FG001|Overall Study|Investigator deemed not a good candidate|0|||
148720147|NCT00035555|536446747|FG002|Overall Study|Investigator deemed not a good candidate|1|||
148720148|NCT00035555|536446745|FG000|Overall Study|Received cyclosporin in error|0|||
148720149|NCT00035555|536446746|FG001|Overall Study|Received cyclosporin in error|0|||
148720150|NCT00035555|536446747|FG002|Overall Study|Received cyclosporin in error|1|||
148720151|NCT00337428|536446748|FG000|Overall Study|Withdrawal by Subject|1|||
148720152|NCT00337428|536446749|FG001|Overall Study|Withdrawal by Subject|2|||
148720153|NCT00337428|536446748|FG000|Overall Study|Lack of Time|1|||
148720154|NCT00337428|536446749|FG001|Overall Study|Lack of Time|1|||
148720155|NCT00337428|536446748|FG000|Overall Study|Unwilling to Continue|1|||
148720156|NCT00337428|536446749|FG001|Overall Study|Unwilling to Continue|0|||
148720157|NCT00337428|536446748|FG000|Overall Study|Anorexia|1|||
148720158|NCT00337428|536446749|FG001|Overall Study|Anorexia|0|||
148720159|NCT02618382|536446750|FG000|Overall Study|Physician Decision|1|||
148720160|NCT02618382|536446750|FG000|Overall Study|Withdrawal by Subject|1|||
148720161|NCT02618382|536446750|FG000|Overall Study|Protocol Violation|1|||
148720162|NCT01519947|536446752|FG000|Overall Study|Death|0|||
148720163|NCT01519947|536446753|FG001|Overall Study|Death|0|||
148720164|NCT01519947|536446754|FG002|Overall Study|Death|0|||
148720165|NCT01519947|536446755|FG003|Overall Study|Death|1|||
148720166|NCT01519947|536446752|FG000|Overall Study|Protocol Violation|0|||
148720167|NCT01519947|536446753|FG001|Overall Study|Protocol Violation|0|||
148720168|NCT01519947|536446754|FG002|Overall Study|Protocol Violation|2|||
148720169|NCT01519947|536446755|FG003|Overall Study|Protocol Violation|1|||
148720170|NCT01519947|536446752|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
148720171|NCT01519947|536446753|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
148720172|NCT01519947|536446754|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
148720173|NCT01519947|536446755|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
148720174|NCT01519947|536446752|FG000|Overall Study|Development of Anemia|0|||
148720175|NCT01519947|536446753|FG001|Overall Study|Development of Anemia|1|||
148720176|NCT01519947|536446754|FG002|Overall Study|Development of Anemia|0|||
148720177|NCT01519947|536446755|FG003|Overall Study|Development of Anemia|1|||
148720178|NCT01519947|536446752|FG000|Overall Study|Blood Transfusion|0|||
148720179|NCT01519947|536446753|FG001|Overall Study|Blood Transfusion|1|||
148720180|NCT01519947|536446754|FG002|Overall Study|Blood Transfusion|1|||
148720181|NCT01519947|536446755|FG003|Overall Study|Blood Transfusion|0|||
148720182|NCT01519947|536446752|FG000|Overall Study|Withdrawal by Subject|0|||
148720183|NCT01519947|536446753|FG001|Overall Study|Withdrawal by Subject|1|||
148720184|NCT01519947|536446754|FG002|Overall Study|Withdrawal by Subject|0|||
148816182|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
148816183|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
148816184|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
148816185|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
148816186|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
148816187|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
148816188|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
148816189|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
148816190|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
148816191|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
148816192|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
148816193|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
148816194|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
148816195|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
148816196|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
148816197|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
148816198|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
148888889|NCT02159066|537072258|FG005|Part I|New Therapy for Study Indication|0|||
148969420|NCT02641379|537372865|FG010|Overall Study|Participant treated after Week 24|0|||
148720185|NCT01519947|536446755|FG003|Overall Study|Withdrawal by Subject|1|||
148720186|NCT01519947|536446752|FG000|Overall Study|Lost to Follow-up|0|||
148720187|NCT01519947|536446753|FG001|Overall Study|Lost to Follow-up|0|||
148720188|NCT01519947|536446754|FG002|Overall Study|Lost to Follow-up|3|||
148720189|NCT01519947|536446755|FG003|Overall Study|Lost to Follow-up|2|||
148720190|NCT01519947|536446752|FG000|Overall Study|Poor Response|1|||
148720191|NCT01519947|536446753|FG001|Overall Study|Poor Response|0|||
148720192|NCT01519947|536446754|FG002|Overall Study|Poor Response|0|||
148720193|NCT01519947|536446755|FG003|Overall Study|Poor Response|1|||
148720194|NCT01519947|536446752|FG000|Overall Study|Adverse Event|1|||
148720195|NCT01519947|536446753|FG001|Overall Study|Adverse Event|0|||
148720196|NCT01519947|536446754|FG002|Overall Study|Adverse Event|1|||
148720197|NCT01519947|536446755|FG003|Overall Study|Adverse Event|1|||
148720198|NCT01186016|536446757|FG000|Overall Study|Withdrawal by Subject|46|||
148720199|NCT01186016|536446758|FG001|Overall Study|Withdrawal by Subject|29|||
148720200|NCT01386125|536446760|FG000|Overall Study|Lost to Follow-up|3|||
148720201|NCT01386125|536446761|FG001|Overall Study|Lost to Follow-up|9|||
148720202|NCT01386125|536446760|FG000|Overall Study|Physician Decision|0|||
148720203|NCT01386125|536446761|FG001|Overall Study|Physician Decision|1|||
148720204|NCT01386125|536446760|FG000|Overall Study|Protocol Violation|5|||
148720205|NCT01386125|536446761|FG001|Overall Study|Protocol Violation|7|||
148720206|NCT01386125|536446760|FG000|Overall Study|Disease Progress|1|||
148720207|NCT01386125|536446761|FG001|Overall Study|Disease Progress|2|||
148720208|NCT01386125|536446760|FG000|Overall Study|Withdrawal by Subject|13|||
148720209|NCT01386125|536446761|FG001|Overall Study|Withdrawal by Subject|12|||
148720210|NCT01386125|536446760|FG000|Overall Study|Adverse Event|2|||
148720211|NCT01386125|536446761|FG001|Overall Study|Adverse Event|5|||
148969421|NCT02641379|537372855|FG000|Overall Study|Missing PCR result at Week 8|0|||
148969422|NCT02641379|537372856|FG001|Overall Study|Missing PCR result at Week 8|0|||
148969423|NCT02641379|537372857|FG002|Overall Study|Missing PCR result at Week 8|0|||
148969424|NCT02641379|537372858|FG003|Overall Study|Missing PCR result at Week 8|0|||
148969425|NCT02641379|537372859|FG004|Overall Study|Missing PCR result at Week 8|0|||
148969426|NCT02641379|537372860|FG005|Overall Study|Missing PCR result at Week 8|0|||
148969427|NCT02641379|537372861|FG006|Overall Study|Missing PCR result at Week 8|0|||
148969428|NCT02641379|537372862|FG007|Overall Study|Missing PCR result at Week 8|0|||
148969429|NCT02641379|537372863|FG008|Overall Study|Missing PCR result at Week 8|0|||
148969430|NCT02641379|537372864|FG009|Overall Study|Missing PCR result at Week 8|1|||
148969431|NCT02641379|537372865|FG010|Overall Study|Missing PCR result at Week 8|0|||
148969432|NCT02641379|537372855|FG000|Overall Study|PCR positive|0|||
148969433|NCT02641379|537372856|FG001|Overall Study|PCR positive|0|||
148969434|NCT02641379|537372857|FG002|Overall Study|PCR positive|0|||
148969435|NCT02641379|537372858|FG003|Overall Study|PCR positive|0|||
148969436|NCT02641379|537372859|FG004|Overall Study|PCR positive|0|||
148969437|NCT02641379|537372860|FG005|Overall Study|PCR positive|0|||
148969438|NCT02641379|537372861|FG006|Overall Study|PCR positive|1|||
148969439|NCT02641379|537372862|FG007|Overall Study|PCR positive|0|||
148969440|NCT02641379|537372863|FG008|Overall Study|PCR positive|0|||
148969441|NCT02641379|537372864|FG009|Overall Study|PCR positive|0|||
148969442|NCT02641379|537372865|FG010|Overall Study|PCR positive|0|||
148969443|NCT04964128|537372866|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
148969444|NCT04964128|537372866|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
148969445|NCT01644175|537372869|FG000|Overall Study|Randomized But Not Treated|0|||
148969446|NCT01644175|537372870|FG001|Overall Study|Randomized But Not Treated|2|||
148969447|NCT01644175|537372869|FG000|Overall Study|Adverse Event|8|||
148720212|NCT01386125|536446760|FG000|Overall Study|Lack of Efficacy|0|||
148720213|NCT01386125|536446761|FG001|Overall Study|Lack of Efficacy|1|||
148720214|NCT01386125|536446760|FG000|Overall Study|Participant Leaving Country|1|||
148720215|NCT01386125|536446761|FG001|Overall Study|Participant Leaving Country|0|||
148720216|NCT03843125|536446762|FG000|Overall Study|Adverse Event|17|||
148969448|NCT01644175|537372870|FG001|Overall Study|Adverse Event|13|||
148969449|NCT01644175|537372869|FG000|Overall Study|Death|1|||
148969450|NCT01644175|537372870|FG001|Overall Study|Death|2|||
148720217|NCT03843125|536446763|FG001|Overall Study|Adverse Event|13|||
148720218|NCT03843125|536446764|FG002|Overall Study|Adverse Event|5|||
148720219|NCT03843125|536446765|FG003|Overall Study|Adverse Event|9|||
148720220|NCT03843125|536446762|FG000|Overall Study|Death|0|||
148720221|NCT03843125|536446763|FG001|Overall Study|Death|6|||
148720222|NCT03843125|536446764|FG002|Overall Study|Death|2|||
148720223|NCT03843125|536446765|FG003|Overall Study|Death|0|||
148720224|NCT03843125|536446762|FG000|Overall Study|Lack of Efficacy|14|||
148720225|NCT03843125|536446763|FG001|Overall Study|Lack of Efficacy|11|||
148969451|NCT01644175|537372869|FG000|Overall Study|Poor compliance to protocol|9|||
148969452|NCT01644175|537372870|FG001|Overall Study|Poor compliance to protocol|10|||
148969453|NCT01644175|537372869|FG000|Overall Study|Physician Decision|1|||
148720226|NCT03843125|536446764|FG002|Overall Study|Lack of Efficacy|9|||
148720227|NCT03843125|536446765|FG003|Overall Study|Lack of Efficacy|4|||
148720228|NCT03843125|536446762|FG000|Overall Study|Lost to Follow-up|3|||
148720229|NCT03843125|536446763|FG001|Overall Study|Lost to Follow-up|4|||
148720230|NCT03843125|536446764|FG002|Overall Study|Lost to Follow-up|0|||
148720231|NCT03843125|536446765|FG003|Overall Study|Lost to Follow-up|2|||
148720232|NCT03843125|536446762|FG000|Overall Study|Other|12|||
148720233|NCT03843125|536446763|FG001|Overall Study|Other|14|||
148720234|NCT03843125|536446764|FG002|Overall Study|Other|3|||
148720235|NCT03843125|536446765|FG003|Overall Study|Other|4|||
148720236|NCT03843125|536446762|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
148720237|NCT03843125|536446763|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
148969454|NCT01644175|537372870|FG001|Overall Study|Physician Decision|2|||
148969455|NCT01644175|537372869|FG000|Overall Study|Participant Moved|1|||
148969456|NCT01644175|537372870|FG001|Overall Study|Participant Moved|2|||
148969457|NCT01644175|537372869|FG000|Overall Study|Consent withdrawn by participant|3|||
148969458|NCT01644175|537372870|FG001|Overall Study|Consent withdrawn by participant|4|||
148969459|NCT01644175|537372869|FG000|Overall Study|Related to Autoinjector Administration|2|||
148969460|NCT01644175|537372870|FG001|Overall Study|Related to Autoinjector Administration|1|||
148969461|NCT01644175|537372869|FG000|Overall Study|Last visit outside protocol visit window|4|||
148969462|NCT01644175|537372870|FG001|Overall Study|Last visit outside protocol visit window|11|||
148969463|NCT01644175|537372869|FG000|Overall Study|Selection criteria finally not met|0|||
148969464|NCT01644175|537372870|FG001|Overall Study|Selection criteria finally not met|1|||
148969465|NCT01644175|537372869|FG000|Overall Study|Site closure|2|||
148969466|NCT01644175|537372870|FG001|Overall Study|Site closure|2|||
148969467|NCT01644175|537372869|FG000|Overall Study|Lost to Follow-up|1|||
148969468|NCT01644175|537372870|FG001|Overall Study|Lost to Follow-up|0|||
148720238|NCT03843125|536446764|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
148720239|NCT03843125|536446765|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
148720240|NCT03843125|536446762|FG000|Overall Study|Study Terminated by Sponsor|318|||
148720241|NCT03843125|536446763|FG001|Overall Study|Study Terminated by Sponsor|318|||
148720242|NCT03843125|536446764|FG002|Overall Study|Study Terminated by Sponsor|163|||
148720243|NCT03843125|536446765|FG003|Overall Study|Study Terminated by Sponsor|163|||
148720244|NCT03843125|536446762|FG000|Overall Study|Withdrawal by Subject|23|||
148720245|NCT03843125|536446763|FG001|Overall Study|Withdrawal by Subject|12|||
148720246|NCT03843125|536446764|FG002|Overall Study|Withdrawal by Subject|6|||
148720247|NCT03843125|536446765|FG003|Overall Study|Withdrawal by Subject|9|||
148720248|NCT03843125|536446762|FG000|Overall Study|Missing data|0|||
148720249|NCT03843125|536446763|FG001|Overall Study|Missing data|1|||
148720250|NCT03843125|536446764|FG002|Overall Study|Missing data|1|||
148720251|NCT03843125|536446765|FG003|Overall Study|Missing data|0|||
148720252|NCT03173560|536446766|FG000|Overall Study|Death|70|||
148720253|NCT03173560|536446767|FG001|Overall Study|Death|60|||
148720254|NCT03173560|536446766|FG000|Overall Study|Lost to Follow-up|1|||
148720255|NCT03173560|536446767|FG001|Overall Study|Lost to Follow-up|4|||
148720256|NCT03173560|536446766|FG000|Overall Study|Withdrawal by Subject|10|||
148720257|NCT03173560|536446767|FG001|Overall Study|Withdrawal by Subject|5|||
148720258|NCT03173560|536446766|FG000|Overall Study|Other|0|||
148720259|NCT03173560|536446767|FG001|Overall Study|Other|1|||
148720260|NCT02250651|536446771|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
148720261|NCT02250651|536446772|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
148720262|NCT02250651|536446773|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
148720263|NCT02250651|536446771|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
148720264|NCT02250651|536446772|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
148720265|NCT02250651|536446773|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
148720266|NCT02250651|536446771|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
148720267|NCT02250651|536446772|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
148720268|NCT02250651|536446773|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
148720269|NCT02250651|536446771|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
148720270|NCT02250651|536446772|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
148720271|NCT02250651|536446773|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
148720272|NCT02250651|536446771|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
148720273|NCT02250651|536446772|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
148720274|NCT02250651|536446773|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
148969469|NCT01644175|537372869|FG000|Overall Study|Other than specified above|0|||
148969470|NCT01644175|537372870|FG001|Overall Study|Other than specified above|3|||
148720275|NCT02250651|536446771|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
148720276|NCT02250651|536446772|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
148720277|NCT02250651|536446773|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
148720278|NCT02250651|536446771|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
148720279|NCT02250651|536446772|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
148720280|NCT02250651|536446773|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
148720281|NCT02250651|536446771|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
148969471|NCT01712256|537372885|FG000|Overall Study|Lost to Follow-up|1|||
148969472|NCT00962104|537372886|FG000|Overall Study|Adverse Event|10|||
148969473|NCT00962104|537372887|FG001|Overall Study|Adverse Event|3|||
148969474|NCT00962104|537372886|FG000|Overall Study|Entry Criteria Not Met|1|||
148969475|NCT00962104|537372887|FG001|Overall Study|Entry Criteria Not Met|2|||
148969476|NCT00962104|537372886|FG000|Overall Study|Lack of Efficacy|0|||
148720282|NCT02250651|536446772|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
148720283|NCT02250651|536446773|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
148720284|NCT02250651|536446771|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
148720285|NCT02250651|536446772|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
148720286|NCT02250651|536446773|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
148720287|NCT02250651|536446771|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
148720288|NCT02250651|536446772|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
148720289|NCT02250651|536446773|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
148969477|NCT00962104|537372887|FG001|Overall Study|Lack of Efficacy|1|||
148969478|NCT00962104|537372886|FG000|Overall Study|Lost to Follow-up|10|||
148969479|NCT00962104|537372887|FG001|Overall Study|Lost to Follow-up|4|||
148969480|NCT00962104|537372886|FG000|Overall Study|Physician Decision|1|||
148969481|NCT00962104|537372887|FG001|Overall Study|Physician Decision|0|||
148969482|NCT00962104|537372886|FG000|Overall Study|Protocol Violation|6|||
148969483|NCT00962104|537372887|FG001|Overall Study|Protocol Violation|8|||
148969484|NCT00962104|537372886|FG000|Overall Study|Sponsor Decision|0|||
148969485|NCT00962104|537372887|FG001|Overall Study|Sponsor Decision|1|||
148969486|NCT00962104|537372886|FG000|Overall Study|Withdrawal by Subject|10|||
148969487|NCT00962104|537372887|FG001|Overall Study|Withdrawal by Subject|6|||
148720290|NCT02250651|536446771|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
148720291|NCT02250651|536446772|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
148720292|NCT02250651|536446773|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
148720293|NCT02250651|536446771|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
148720294|NCT02250651|536446772|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
148720295|NCT02250651|536446773|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
148720296|NCT02250651|536446771|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
148720297|NCT02250651|536446772|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
148969488|NCT00962104|537372886|FG000|Overall Study|Other|2|||
148969489|NCT00962104|537372887|FG001|Overall Study|Other|0|||
148969490|NCT02196324|537372894|FG000|Overall Study|Withdrawal by Subject|8|||
148969491|NCT02196324|537372895|FG001|Overall Study|Withdrawal by Subject|4|||
148969492|NCT02196324|537372894|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
148969493|NCT02196324|537372895|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
148969494|NCT02196324|537372894|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
148969495|NCT02196324|537372895|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
148969496|NCT02196324|537372894|FG000|Overall Study|Other|1|||
148969497|NCT02196324|537372895|FG001|Overall Study|Other|0|||
148969498|NCT04243538|537372896|FG000|Overall Study|Withdrawal by Subject|0|||
148969499|NCT04243538|537372897|FG001|Overall Study|Withdrawal by Subject|2|||
148969500|NCT04243538|537372896|FG000|Overall Study|Lost to Follow-up|0|||
148969501|NCT04243538|537372897|FG001|Overall Study|Lost to Follow-up|3|||
148969502|NCT00655564|537372898|FG000|Overall Study|Adverse Event|1|||
148969503|NCT00655564|537372898|FG000|Overall Study|Lost to Follow-up|1|||
148969504|NCT00655564|537372898|FG000|Overall Study|Desired Alternate Therapy|1|||
148969505|NCT04536727|537372899|FG000|Overall Study|Lost to Follow-up|1|||
148969506|NCT04536727|537372900|FG001|Overall Study|Lost to Follow-up|1|||
148969507|NCT04536727|537372899|FG000|Overall Study|Death|0|||
148969508|NCT04536727|537372900|FG001|Overall Study|Death|1|||
148969509|NCT00344773|537372901|FG000|Overall Study|Adverse Event|2|||
148969510|NCT00344773|537372901|FG000|Overall Study|Objective Disease Progression|16|||
148969511|NCT00344773|537372901|FG000|Overall Study|Withdrawal by Subject|1|||
148969512|NCT00344773|537372901|FG000|Overall Study|Not Eligible for the study|2|||
148969513|NCT00500370|537372908|FG000|Overall Study|Adverse Event|9|||
148720298|NCT02250651|536446773|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
148720299|NCT02250651|536446771|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
148720300|NCT02250651|536446772|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
148969514|NCT00500370|537372909|FG001|Overall Study|Adverse Event|3|||
148969515|NCT00500370|537372908|FG000|Overall Study|Lost to Follow-up|10|||
148969516|NCT00500370|537372909|FG001|Overall Study|Lost to Follow-up|10|||
148969517|NCT00500370|537372908|FG000|Overall Study|Protocol Violation|2|||
148969518|NCT00500370|537372909|FG001|Overall Study|Protocol Violation|4|||
148969519|NCT00500370|537372908|FG000|Overall Study|Sponsor Decision|2|||
148969520|NCT00500370|537372909|FG001|Overall Study|Sponsor Decision|0|||
148969521|NCT00500370|537372908|FG000|Overall Study|Subject Decision|10|||
148969522|NCT00500370|537372909|FG001|Overall Study|Subject Decision|17|||
148969523|NCT05627518|537372910|FG000|Treatment Period 1|Adverse Event|0|||
148969524|NCT05627518|537372911|FG001|Treatment Period 1|Adverse Event|0|||
148969525|NCT05627518|537372912|FG002|Treatment Period 1|Adverse Event|1|||
148969526|NCT05627518|537372913|FG003|Treatment Period 1|Adverse Event|0|||
148969527|NCT05627518|537372914|FG004|Treatment Period 1|Adverse Event|0|||
148969528|NCT05627518|537372915|FG005|Treatment Period 1|Adverse Event|0|||
148969529|NCT05627518|537372916|FG006|Treatment Period 1|Adverse Event|0|||
148720301|NCT02250651|536446773|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
148720302|NCT02250651|536446771|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
148720303|NCT02250651|536446772|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
148720304|NCT02250651|536446773|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
148720305|NCT00676494|536446774|FG000|Overall Study|Missed Visit|8|||
148720306|NCT00676494|536446774|FG000|Overall Study|Withdrawal by Subject|6|||
148720307|NCT02427399|536446777|FG000|Overall Study|Protocol Violation|14|||
148720308|NCT02427399|536446778|FG001|Overall Study|Protocol Violation|16|||
148720309|NCT02427399|536446779|FG002|Overall Study|Protocol Violation|12|||
148720310|NCT02427399|536446780|FG003|Overall Study|Protocol Violation|18|||
148720311|NCT02427399|536446781|FG004|Overall Study|Protocol Violation|15|||
148720312|NCT00090753|536446782|FG000|First Treatment Period|Adverse Event|20|||
148720313|NCT00090753|536446783|FG001|First Treatment Period|Adverse Event|8|||
148720314|NCT00090753|536446782|FG000|First Treatment Period|Death|88|||
148720315|NCT00090753|536446783|FG001|First Treatment Period|Death|62|||
148720316|NCT00090753|536446782|FG000|First Treatment Period|Lack of Efficacy|2|||
148720317|NCT00090753|536446783|FG001|First Treatment Period|Lack of Efficacy|1|||
148720318|NCT00090753|536446782|FG000|First Treatment Period|Refused Treatment|32|||
148720319|NCT00090753|536446783|FG001|First Treatment Period|Refused Treatment|25|||
148720320|NCT00090753|536446782|FG000|First Treatment Period|Lost to Follow-up|4|||
148720321|NCT00090753|536446783|FG001|First Treatment Period|Lost to Follow-up|4|||
148720322|NCT00090753|536446782|FG000|First Treatment Period|Renal Transplant|70|||
148720323|NCT00090753|536446783|FG001|First Treatment Period|Renal Transplant|50|||
148720324|NCT00090753|536446782|FG000|First Treatment Period|Mircera Commercialization|1|||
148720325|NCT00090753|536446783|FG001|First Treatment Period|Mircera Commercialization|0|||
148720326|NCT00090753|536446782|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
148720327|NCT00090753|536446783|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
148720328|NCT00090753|536446782|FG000|Extended Treatment Period|Adverse Event|11|||
148720329|NCT00090753|536446783|FG001|Extended Treatment Period|Adverse Event|0|||
148720330|NCT00090753|536446782|FG000|Extended Treatment Period|Death|58|||
148720331|NCT00090753|536446783|FG001|Extended Treatment Period|Death|30|||
148720332|NCT00090753|536446782|FG000|Extended Treatment Period|Lack of Efficacy|1|||
148720333|NCT00090753|536446783|FG001|Extended Treatment Period|Lack of Efficacy|0|||
148720334|NCT00090753|536446782|FG000|Extended Treatment Period|Refused Treatment|18|||
148720335|NCT00090753|536446783|FG001|Extended Treatment Period|Refused Treatment|12|||
148720336|NCT00090753|536446782|FG000|Extended Treatment Period|Lost to Follow-up|3|||
148720337|NCT00090753|536446783|FG001|Extended Treatment Period|Lost to Follow-up|1|||
148720338|NCT00090753|536446782|FG000|Extended Treatment Period|Renal Transplant|15|||
148720339|NCT00090753|536446783|FG001|Extended Treatment Period|Renal Transplant|12|||
148720340|NCT00090753|536446782|FG000|Extended Treatment Period|Mircera Commercialization|188|||
148720341|NCT00090753|536446783|FG001|Extended Treatment Period|Mircera Commercialization|93|||
148720342|NCT00090753|536446782|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
148720343|NCT00090753|536446783|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
148720344|NCT01609582|536446784|FG000|Overall Study|Adverse Event|20|||
148720345|NCT01609582|536446785|FG001|Overall Study|Adverse Event|18|||
148720346|NCT01609582|536446784|FG000|Overall Study|Lost to Follow-up|10|||
148720347|NCT01609582|536446785|FG001|Overall Study|Lost to Follow-up|10|||
148720348|NCT01609582|536446784|FG000|Overall Study|Withdrawal by Subject|21|||
148720349|NCT01609582|536446785|FG001|Overall Study|Withdrawal by Subject|15|||
148720350|NCT01609582|536446784|FG000|Overall Study|Study Terminated by Sponsor|1543|||
148720351|NCT01609582|536446785|FG001|Overall Study|Study Terminated by Sponsor|1548|||
148720352|NCT01609582|536446784|FG000|Overall Study|Other|9|||
148720353|NCT01609582|536446785|FG001|Overall Study|Other|10|||
148720354|NCT01609582|536446784|FG000|Overall Study|Randomized, but not treated|0|||
148720355|NCT01609582|536446785|FG001|Overall Study|Randomized, but not treated|3|||
148720356|NCT00761176|536446788|FG000|Overall Study|Death|1|||
148720357|NCT00761176|536446789|FG001|Overall Study|Death|0|||
148720358|NCT00761176|536446788|FG000|Overall Study|Withdrawal by Subject|1|||
148720359|NCT00761176|536446789|FG001|Overall Study|Withdrawal by Subject|1|||
148720360|NCT02762994|536446790|FG000|Overall Study|Withdrawal by Subject|0|||
148720361|NCT02762994|536446791|FG001|Overall Study|Withdrawal by Subject|1|||
148720362|NCT02762994|536446792|FG002|Overall Study|Withdrawal by Subject|2|||
148720363|NCT02762994|536446793|FG003|Overall Study|Withdrawal by Subject|0|||
148720364|NCT02762994|536446790|FG000|Overall Study|Protocol Violation|1|||
148720365|NCT02762994|536446791|FG001|Overall Study|Protocol Violation|0|||
148720366|NCT02762994|536446792|FG002|Overall Study|Protocol Violation|0|||
148720367|NCT02762994|536446793|FG003|Overall Study|Protocol Violation|2|||
148720368|NCT05103657|536446796|FG000|Overall Study|Other reasons than listed|9|||
148720369|NCT05103657|536446797|FG001|Overall Study|Other reasons than listed|8|||
148720370|NCT05103657|536446796|FG000|Overall Study|Protocol deviation|2|||
148720371|NCT05103657|536446797|FG001|Overall Study|Protocol deviation|2|||
148720372|NCT05103657|536446796|FG000|Overall Study|No reason available|5|||
148720373|NCT05103657|536446797|FG001|Overall Study|No reason available|4|||
148720374|NCT05103657|536446796|FG000|Overall Study|Burden of study procedures|3|||
148720375|NCT05103657|536446797|FG001|Overall Study|Burden of study procedures|1|||
148720376|NCT05103657|536446796|FG000|Overall Study|Perceived lack of efficacy|1|||
148720377|NCT05103657|536446797|FG001|Overall Study|Perceived lack of efficacy|1|||
148720378|NCT05103657|536446796|FG000|Overall Study|Adverse Event|6|||
148720379|NCT05103657|536446797|FG001|Overall Study|Adverse Event|14|||
148720380|NCT05103657|536446796|FG000|Overall Study|Not Treated|1|||
148720381|NCT05103657|536446797|FG001|Overall Study|Not Treated|1|||
148720382|NCT02020967|536446798|FG000|Overall Study|Withdrawal by Subject|51|||
148720383|NCT03507686|536446799|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
148720384|NCT03507686|536446800|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
148720385|NCT03507686|536446799|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
148720386|NCT03507686|536446800|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
148720387|NCT03507686|536446799|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
148720388|NCT03507686|536446800|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
148720389|NCT03507686|536446799|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
148720390|NCT03507686|536446800|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
148720391|NCT03507686|536446799|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
148720392|NCT03507686|536446800|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
148720393|NCT03507686|536446799|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
148720394|NCT03507686|536446800|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
148720395|NCT00585312|536446801|FG000|Overall Study|Adverse Event|3|||
148720396|NCT00585312|536446802|FG001|Overall Study|Adverse Event|0|||
148720397|NCT00585312|536446801|FG000|Overall Study|Lack of Efficacy|6|||
148720398|NCT00585312|536446802|FG001|Overall Study|Lack of Efficacy|11|||
148720399|NCT00585312|536446801|FG000|Overall Study|Lost to Follow-up|1|||
148720400|NCT00585312|536446802|FG001|Overall Study|Lost to Follow-up|1|||
148720401|NCT00585312|536446801|FG000|Overall Study|Reason not specified|2|||
148720402|NCT00585312|536446802|FG001|Overall Study|Reason not specified|0|||
148720403|NCT00585312|536446801|FG000|Overall Study|Withdrawal by Subject|5|||
148720404|NCT00585312|536446802|FG001|Overall Study|Withdrawal by Subject|1|||
148720405|NCT00585312|536446801|FG000|Overall Study|Study terminated by the sponsor|34|||
148720406|NCT00585312|536446802|FG001|Overall Study|Study terminated by the sponsor|31|||
148720407|NCT00129116|536446803|FG000|Primary Phase|Lost to Follow-up|1|||
148720408|NCT00129116|536446804|FG001|Primary Phase|Lost to Follow-up|1|||
148720409|NCT00129116|536446805|FG002|Primary Phase|Lost to Follow-up|0|||
148720410|NCT00129116|536446806|FG003|Primary Phase|Lost to Follow-up|1|||
148720411|NCT00129116|536446807|FG004|Primary Phase|Lost to Follow-up|1|||
148720412|NCT00129116|536446803|FG000|Primary Phase|Protocol Violation|0|||
148720413|NCT00129116|536446804|FG001|Primary Phase|Protocol Violation|1|||
148720414|NCT00129116|536446805|FG002|Primary Phase|Protocol Violation|0|||
148720415|NCT00129116|536446806|FG003|Primary Phase|Protocol Violation|0|||
148720416|NCT00129116|536446807|FG004|Primary Phase|Protocol Violation|0|||
148720417|NCT00129116|536446803|FG000|Primary Phase|Adverse Event|1|||
148720418|NCT00129116|536446804|FG001|Primary Phase|Adverse Event|1|||
148720419|NCT00129116|536446805|FG002|Primary Phase|Adverse Event|0|||
148720420|NCT00129116|536446806|FG003|Primary Phase|Adverse Event|0|||
148720421|NCT00129116|536446807|FG004|Primary Phase|Adverse Event|0|||
148720422|NCT00129116|536446803|FG000|Primary Phase|Withdrawal by Subject|0|||
148720423|NCT00129116|536446804|FG001|Primary Phase|Withdrawal by Subject|1|||
148720424|NCT00129116|536446805|FG002|Primary Phase|Withdrawal by Subject|0|||
148720425|NCT00129116|536446806|FG003|Primary Phase|Withdrawal by Subject|0|||
148720426|NCT00129116|536446807|FG004|Primary Phase|Withdrawal by Subject|0|||
148720427|NCT00129116|536446803|FG000|Primary Phase|Other|0|||
148720428|NCT00129116|536446804|FG001|Primary Phase|Other|0|||
148720429|NCT00129116|536446805|FG002|Primary Phase|Other|1|||
148720430|NCT00129116|536446806|FG003|Primary Phase|Other|0|||
148720431|NCT00129116|536446807|FG004|Primary Phase|Other|0|||
148720432|NCT00129116|536446803|FG000|Booster Phase|Lost to Follow-up|2|||
148720433|NCT00129116|536446804|FG001|Booster Phase|Lost to Follow-up|0|||
148720434|NCT00129116|536446805|FG002|Booster Phase|Lost to Follow-up|0|||
148720435|NCT00129116|536446806|FG003|Booster Phase|Lost to Follow-up|0|||
148720436|NCT00129116|536446807|FG004|Booster Phase|Lost to Follow-up|1|||
148720437|NCT02539368|536446810|FG000|Overall Study|Death|4|||
148720438|NCT02539368|536446811|FG001|Overall Study|Death|2|||
148720439|NCT02539368|536446812|FG002|Overall Study|Death|1|||
148720440|NCT02539368|536446813|FG003|Overall Study|Death|0|||
148720441|NCT02539368|536446814|FG004|Overall Study|Death|0|||
148720442|NCT02539368|536446810|FG000|Overall Study|Withdrawal by Subject|44|||
148720443|NCT02539368|536446811|FG001|Overall Study|Withdrawal by Subject|35|||
148720444|NCT02539368|536446812|FG002|Overall Study|Withdrawal by Subject|9|||
148720445|NCT02539368|536446813|FG003|Overall Study|Withdrawal by Subject|1|||
148720446|NCT02539368|536446814|FG004|Overall Study|Withdrawal by Subject|3|||
148720447|NCT02539368|536446810|FG000|Overall Study|Physician Decision|49|||
148720448|NCT02539368|536446811|FG001|Overall Study|Physician Decision|15|||
148720449|NCT02539368|536446812|FG002|Overall Study|Physician Decision|7|||
148720450|NCT02539368|536446813|FG003|Overall Study|Physician Decision|0|||
148720451|NCT02539368|536446814|FG004|Overall Study|Physician Decision|2|||
148720452|NCT02539368|536446810|FG000|Overall Study|Lost to Follow-up|96|||
148720453|NCT02539368|536446811|FG001|Overall Study|Lost to Follow-up|21|||
148720454|NCT02539368|536446812|FG002|Overall Study|Lost to Follow-up|16|||
148720455|NCT02539368|536446813|FG003|Overall Study|Lost to Follow-up|4|||
148720456|NCT02539368|536446814|FG004|Overall Study|Lost to Follow-up|3|||
148720457|NCT02539368|536446810|FG000|Overall Study|Adverse Event|44|||
148720458|NCT02539368|536446811|FG001|Overall Study|Adverse Event|5|||
148720459|NCT02539368|536446812|FG002|Overall Study|Adverse Event|9|||
148720460|NCT02539368|536446813|FG003|Overall Study|Adverse Event|0|||
148720461|NCT02539368|536446814|FG004|Overall Study|Adverse Event|3|||
148720462|NCT02539368|536446810|FG000|Overall Study|Participant Non-compliant|13|||
148720463|NCT02539368|536446811|FG001|Overall Study|Participant Non-compliant|2|||
148720464|NCT02539368|536446812|FG002|Overall Study|Participant Non-compliant|1|||
148720465|NCT02539368|536446813|FG003|Overall Study|Participant Non-compliant|1|||
148720466|NCT02539368|536446814|FG004|Overall Study|Participant Non-compliant|0|||
148720467|NCT02539368|536446810|FG000|Overall Study|Other|145|||
148720468|NCT02539368|536446811|FG001|Overall Study|Other|18|||
148720469|NCT02539368|536446812|FG002|Overall Study|Other|24|||
148720470|NCT02539368|536446813|FG003|Overall Study|Other|1|||
148720471|NCT02539368|536446814|FG004|Overall Study|Other|3|||
148720472|NCT02539368|536446810|FG000|Overall Study|Missing|10|||
148720473|NCT02539368|536446811|FG001|Overall Study|Missing|3|||
148720474|NCT02539368|536446812|FG002|Overall Study|Missing|0|||
148720475|NCT02539368|536446813|FG003|Overall Study|Missing|0|||
148720476|NCT02539368|536446814|FG004|Overall Study|Missing|0|||
148720477|NCT01148225|536446816|FG000|Overall Study|Other|185|||
148720478|NCT03689894|536446817|FG000|Overall Study|Adverse Event|1|||
148720479|NCT00569777|536446818|FG000|Overall Study|Withdrawal by Subject|4|||
148720480|NCT00569777|536446819|FG001|Overall Study|Withdrawal by Subject|0|||
148720481|NCT00569777|536446818|FG000|Overall Study|Adverse Event|3|||
148720482|NCT00569777|536446819|FG001|Overall Study|Adverse Event|0|||
148720483|NCT00569777|536446818|FG000|Overall Study|Lost to Follow-up|1|||
148720484|NCT00569777|536446819|FG001|Overall Study|Lost to Follow-up|0|||
148720485|NCT00569777|536446818|FG000|Overall Study|scheduled eye surgery|0|||
148720486|NCT00569777|536446819|FG001|Overall Study|scheduled eye surgery|1|||
148720487|NCT00569777|536446818|FG000|Overall Study|did not meet exclusion criteria|1|||
148720488|NCT00569777|536446819|FG001|Overall Study|did not meet exclusion criteria|2|||
148720489|NCT00569777|536446818|FG000|Overall Study|pregnant|1|||
148720490|NCT00569777|536446819|FG001|Overall Study|pregnant|0|||
148720491|NCT02030535|536446824|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
148720492|NCT01169038|536446825|FG000|Overall Study|Death|1|||
148720493|NCT01169038|536446825|FG000|Overall Study|Adverse Event|5|||
148720494|NCT01169038|536446825|FG000|Overall Study|Required antibiotic administration|1|||
148720495|NCT03257254|536446826|FG000|Overall Study|Withdrawal by Subject|7|||
148720496|NCT03257254|536446826|FG000|Overall Study|Lost to Follow-up|9|||
148720497|NCT03257254|536446826|FG000|Overall Study|Study discontinued by sponsor|5|||
148720498|NCT02329431|536446827|FG000|Overall Study|Lost to Follow-up|20|||
148720499|NCT02329431|536446828|FG001|Overall Study|Lost to Follow-up|13|||
148720500|NCT01557582|536446829|FG000|Overall Study|Protocol Violation|4|||
148720501|NCT01557582|536446829|FG000|Overall Study|Operator error|2|||
148720502|NCT02843659|536446830|FG000|Overall Study|Subject Withdrew Consent|0|||
148720503|NCT02843659|536446831|FG001|Overall Study|Subject Withdrew Consent|0|||
148720504|NCT02843659|536446832|FG002|Overall Study|Subject Withdrew Consent|1|||
148720505|NCT02843659|536446830|FG000|Overall Study|Administrative Reason by Sponsor|4|||
148720506|NCT02843659|536446831|FG001|Overall Study|Administrative Reason by Sponsor|5|||
148720507|NCT02843659|536446832|FG002|Overall Study|Administrative Reason by Sponsor|4|||
148720508|NCT02843659|536446830|FG000|Overall Study|Adverse Event|0|||
148720509|NCT02843659|536446831|FG001|Overall Study|Adverse Event|1|||
148720510|NCT02843659|536446832|FG002|Overall Study|Adverse Event|0|||
148720511|NCT03203642|536446833|FG000|Overall Study|Adverse Event|3|||
148720512|NCT03203642|536446834|FG001|Overall Study|Adverse Event|1|||
148720513|NCT03203642|536446833|FG000|Overall Study|Withdrawal by Subject|6|||
148720514|NCT03203642|536446834|FG001|Overall Study|Withdrawal by Subject|6|||
148720515|NCT03203642|536446833|FG000|Overall Study|Lost to Follow-up|2|||
148720516|NCT03203642|536446834|FG001|Overall Study|Lost to Follow-up|1|||
148720517|NCT03203642|536446833|FG000|Overall Study|Termination of the study by sponsor|1|||
148720518|NCT03203642|536446834|FG001|Overall Study|Termination of the study by sponsor|1|||
148720519|NCT03203642|536446833|FG000|Overall Study|Participant moved|0|||
148720520|NCT03203642|536446834|FG001|Overall Study|Participant moved|1|||
148720521|NCT03203642|536446833|FG000|Overall Study|Investigator's decision|3|||
148720522|NCT03203642|536446834|FG001|Overall Study|Investigator's decision|0|||
148720523|NCT03203642|536446833|FG000|Overall Study|Other than above specified|0|||
148720524|NCT03203642|536446834|FG001|Overall Study|Other than above specified|1|||
148720525|NCT02413294|536446835|FG000|Overall Study|Withdrawal by Subject|1|||
148720526|NCT00112294|536448617|FG000|Overall Study|Still on study|5|||
148720527|NCT00112294|536448618|FG001|Overall Study|Still on study|0|||
148720528|NCT01142908|536448619|FG000|Overall Study|Lost to Follow-up|19|||
148720529|NCT01142908|536448620|FG001|Overall Study|Lost to Follow-up|13|||
148720530|NCT01142908|536448619|FG000|Overall Study|Death|1|||
148720531|NCT01142908|536448620|FG001|Overall Study|Death|4|||
148720532|NCT01142908|536448619|FG000|Overall Study|Excluded - did not meet criteria|9|||
148720533|NCT01142908|536448620|FG001|Overall Study|Excluded - did not meet criteria|5|||
148720534|NCT01142908|536448619|FG000|Overall Study|Withdrawal by Subject|3|||
148720535|NCT01142908|536448620|FG001|Overall Study|Withdrawal by Subject|0|||
148720536|NCT02418455|536448624|FG000|48-Week Treatment Period|Other- Not Specified|1|||
148720537|NCT02418455|536448624|FG000|Continuation Period|Sponsor Decision|7|||
148720538|NCT03235479|536448625|FG000|Overall Study|Lost to Follow-up|8|||
148720539|NCT03235479|536448626|FG001|Overall Study|Lost to Follow-up|11|||
148720540|NCT03235479|536448625|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
148720541|NCT03235479|536448626|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
148720542|NCT03235479|536448625|FG000|Overall Study|Pregnancy|1|||
148720543|NCT03235479|536448626|FG001|Overall Study|Pregnancy|0|||
148720544|NCT03235479|536448625|FG000|Overall Study|Protocol Deviation|1|||
148720545|NCT03235479|536448626|FG001|Overall Study|Protocol Deviation|3|||
148720546|NCT03235479|536448625|FG000|Overall Study|Technical Problems|3|||
148720547|NCT03235479|536448626|FG001|Overall Study|Technical Problems|2|||
148720548|NCT03235479|536448625|FG000|Overall Study|Withdrawal by Subject|2|||
148720549|NCT03235479|536448626|FG001|Overall Study|Withdrawal by Subject|2|||
148720550|NCT03235479|536448625|FG000|Overall Study|Other Reasons|3|||
148720551|NCT03235479|536448626|FG001|Overall Study|Other Reasons|5|||
148720552|NCT00529217|536448639|FG000|Overall Study|Lack of Efficacy|2|||
148720553|NCT00529217|536448639|FG000|Overall Study|Unable to adhere to study schedule|2|||
148720554|NCT00779402|536448640|FG000|Treatment Phase 1|Disease Progression|1|||
148720555|NCT00779402|536448641|FG001|Treatment Phase 1|Disease Progression|0|||
148720556|NCT00779402|536448640|FG000|Treatment Phase 1|Adverse Event|2|||
148720557|NCT00779402|536448641|FG001|Treatment Phase 1|Adverse Event|0|||
148720558|NCT00779402|536448640|FG000|Treatment Phase 1|Protocol Violation|1|||
148720559|NCT00779402|536448641|FG001|Treatment Phase 1|Protocol Violation|0|||
148720560|NCT00779402|536448640|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
148720561|NCT00779402|536448641|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
148720562|NCT00779402|536448640|FG000|Treatment Phase 1|Lost to Follow-up|0|||
148720563|NCT00779402|536448641|FG001|Treatment Phase 1|Lost to Follow-up|1|||
148720564|NCT00779402|536448640|FG000|Treatment Phase 1|Death|0|||
148720565|NCT00779402|536448641|FG001|Treatment Phase 1|Death|1|||
148720566|NCT00779402|536448640|FG000|Treatment Phase 1|Intercurrent Illness|1|||
148720567|NCT00779402|536448641|FG001|Treatment Phase 1|Intercurrent Illness|1|||
148720568|NCT00779402|536448640|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
148720569|NCT00779402|536448641|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
148720570|NCT00779402|536448640|FG000|Treatment Phase 1|Other|4|||
148720571|NCT00779402|536448641|FG001|Treatment Phase 1|Other|2|||
148720572|NCT00779402|536448640|FG000|Treatment Phase 1|Closure of Study|3|||
148720573|NCT00779402|536448641|FG001|Treatment Phase 1|Closure of Study|2|||
148720574|NCT00779402|536448640|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
148720575|NCT00779402|536448641|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
148720576|NCT00779402|536448640|FG000|Surveillance Phase|Protocol Violation|0|||
148720577|NCT00779402|536448641|FG001|Surveillance Phase|Protocol Violation|1|||
148720578|NCT00779402|536448640|FG000|Surveillance Phase|Patient refused to continue|22|||
148720579|NCT00779402|536448641|FG001|Surveillance Phase|Patient refused to continue|14|||
148720580|NCT00779402|536448640|FG000|Surveillance Phase|Lost to Follow-up|2|||
148720581|NCT00779402|536448641|FG001|Surveillance Phase|Lost to Follow-up|1|||
148720582|NCT00779402|536448640|FG000|Surveillance Phase|Death|0|||
148720583|NCT00779402|536448641|FG001|Surveillance Phase|Death|1|||
148720584|NCT00779402|536448640|FG000|Surveillance Phase|Intercurrent Illness|2|||
148720585|NCT00779402|536448641|FG001|Surveillance Phase|Intercurrent Illness|0|||
148720586|NCT00779402|536448640|FG000|Surveillance Phase|Other|5|||
148720587|NCT00779402|536448641|FG001|Surveillance Phase|Other|5|||
148720588|NCT00779402|536448640|FG000|Surveillance Phase|Withdrawal by Subject|4|||
148720589|NCT00779402|536448641|FG001|Surveillance Phase|Withdrawal by Subject|1|||
148720590|NCT00779402|536448640|FG000|Surveillance Phase|Closure of study|5|||
148720591|NCT00779402|536448641|FG001|Surveillance Phase|Closure of study|6|||
148720592|NCT00779402|536448640|FG000|Surveillance Phase|Completed Protocol Visits|3|||
148720593|NCT00779402|536448641|FG001|Surveillance Phase|Completed Protocol Visits|2|||
148720594|NCT00779402|536448640|FG000|Long-term Follow-up|Patient refused to continue|2|||
148720595|NCT00779402|536448641|FG001|Long-term Follow-up|Patient refused to continue|0|||
148720596|NCT00779402|536448640|FG000|Long-term Follow-up|Other|5|||
148720597|NCT00779402|536448641|FG001|Long-term Follow-up|Other|0|||
148720598|NCT00779402|536448640|FG000|Long-term Follow-up|Closure of Study|8|||
148720599|NCT00779402|536448641|FG001|Long-term Follow-up|Closure of Study|4|||
148720600|NCT00779402|536448640|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
148720601|NCT00779402|536448641|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
148720602|NCT00693225|536448646|FG000|Overall Study|Lost to Follow-up|1|||
148720603|NCT00693225|536448647|FG001|Overall Study|Lost to Follow-up|2|||
148720604|NCT00693225|536448646|FG000|Overall Study|Adverse Event|1|||
148720605|NCT00693225|536448647|FG001|Overall Study|Adverse Event|3|||
148720606|NCT01315028|536448648|FG000|Overall Study|Lost to Follow-up|1|||
148720607|NCT01315028|536448649|FG001|Overall Study|Lost to Follow-up|0|||
148720608|NCT01315028|536448648|FG000|Overall Study|Death|0|||
148720609|NCT01315028|536448649|FG001|Overall Study|Death|1|||
148720610|NCT02274948|536448650|FG000|Overall Study|Lost to Follow-up|28|||
148720611|NCT02274948|536448651|FG001|Overall Study|Lost to Follow-up|25|||
148720612|NCT02274948|536448650|FG000|Overall Study|Withdrawal by Subject|64|||
148720613|NCT02274948|536448651|FG001|Overall Study|Withdrawal by Subject|58|||
148720614|NCT02274948|536448650|FG000|Overall Study|Stopped on family Practitioner advice|2|||
148720615|NCT02274948|536448651|FG001|Overall Study|Stopped on family Practitioner advice|5|||
148720616|NCT02274948|536448650|FG000|Overall Study|Left the area|4|||
148720617|NCT02274948|536448651|FG001|Overall Study|Left the area|3|||
148720618|NCT01098539|536448654|FG000|Overall Study|Adverse Event|26|||
148720619|NCT01098539|536448655|FG001|Overall Study|Adverse Event|26|||
148720620|NCT01098539|536448654|FG000|Overall Study|Protocol Violation|1|||
148720621|NCT01098539|536448655|FG001|Overall Study|Protocol Violation|4|||
148720622|NCT01098539|536448654|FG000|Overall Study|Noncompliance|3|||
148720623|NCT01098539|536448655|FG001|Overall Study|Noncompliance|5|||
148720624|NCT01098539|536448654|FG000|Overall Study|Lost to Follow-up|4|||
148720625|NCT01098539|536448655|FG001|Overall Study|Lost to Follow-up|4|||
148720626|NCT01098539|536448654|FG000|Overall Study|Withdrawal by Subject|12|||
148720627|NCT01098539|536448655|FG001|Overall Study|Withdrawal by Subject|26|||
148720628|NCT01098539|536448654|FG000|Overall Study|Physician Decision|5|||
148720629|NCT01098539|536448655|FG001|Overall Study|Physician Decision|3|||
148720630|NCT04254809|536448657|FG000|Overall Study|Lost to Follow-up|5|||
148720631|NCT04254809|536448658|FG001|Overall Study|Lost to Follow-up|10|||
148720632|NCT01928615|536448659|FG000|Overall Study|Study Terminated by Sponsor|2|||
148720633|NCT02972515|536448660|FG000|Overall Study|Lost to Follow-up|78|||
148720634|NCT03023137|536448663|FG000|Overall Study|Multiple pregnancy|2|||
148720635|NCT03023137|536448664|FG001|Overall Study|Multiple pregnancy|4|||
148720636|NCT03023137|536448663|FG000|Overall Study|Lost to Follow-up|1|||
148720637|NCT03023137|536448664|FG001|Overall Study|Lost to Follow-up|1|||
148720638|NCT03023137|536448663|FG000|Overall Study|Protocol Violation|0|||
148720639|NCT03023137|536448664|FG001|Overall Study|Protocol Violation|4|||
148720640|NCT03023137|536448663|FG000|Overall Study|Lost the baby in a car accident|1|||
148720641|NCT03023137|536448664|FG001|Overall Study|Lost the baby in a car accident|0|||
148720642|NCT02795676|536448668|FG000|Overall Study|Adverse Event|2|||
148720643|NCT02795676|536448669|FG001|Overall Study|Adverse Event|0|||
148720644|NCT02795676|536448668|FG000|Overall Study|Withdrawal by Subject|3|||
148720645|NCT02795676|536448669|FG001|Overall Study|Withdrawal by Subject|1|||
148720646|NCT00732160|536448670|FG000|Overall Study|Adverse Event|1|||
148720647|NCT00732160|536448671|FG001|Overall Study|Adverse Event|0|||
148720648|NCT00732160|536448672|FG002|Overall Study|Adverse Event|1|||
148720649|NCT00732160|536448673|FG003|Overall Study|Adverse Event|1|||
148720650|NCT00732160|536448670|FG000|Overall Study|scheduling|4|||
148720651|NCT00732160|536448671|FG001|Overall Study|scheduling|4|||
148720652|NCT00732160|536448672|FG002|Overall Study|scheduling|2|||
148720653|NCT00732160|536448673|FG003|Overall Study|scheduling|1|||
148720654|NCT01264835|536448674|FG000|Overall Study|Lost to Follow-up|1|||
148720655|NCT04660032|536448677|FG000|Overall Study|Protocol Violation|1|||
148720656|NCT04660032|536448678|FG001|Overall Study|Protocol Violation|1|||
148720657|NCT01808248|536448679|FG000|Overall Study|Lack of Efficacy|3|||
148720658|NCT01808248|536448679|FG000|Overall Study|Withdrawal by Subject|1|||
148720659|NCT01808248|536448679|FG000|Overall Study|Lost to Follow-up|1|||
148720660|NCT00685750|536448682|FG000|Overall Study|Tumor sampling failure|0|||
148720661|NCT00685750|536448683|FG001|Overall Study|Tumor sampling failure|0|||
148720662|NCT00685750|536448684|FG002|Overall Study|Tumor sampling failure|1|||
148720663|NCT00685750|536448685|FG003|Overall Study|Tumor sampling failure|0|||
148720664|NCT00685750|536448686|FG004|Overall Study|Tumor sampling failure|0|||
148720665|NCT00685750|536448687|FG005|Overall Study|Tumor sampling failure|0|||
148720666|NCT00685750|536448688|FG006|Overall Study|Tumor sampling failure|0|||
148720667|NCT00685750|536448682|FG000|Overall Study|Patient didn't receive the treatment|0|||
148720668|NCT00685750|536448683|FG001|Overall Study|Patient didn't receive the treatment|0|||
148720669|NCT00685750|536448684|FG002|Overall Study|Patient didn't receive the treatment|0|||
148969530|NCT05627518|537372917|FG007|Treatment Period 1|Adverse Event|1|||
148720670|NCT00685750|536448685|FG003|Overall Study|Patient didn't receive the treatment|0|||
148969531|NCT05627518|537372910|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148969532|NCT05627518|537372911|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148720671|NCT00685750|536448686|FG004|Overall Study|Patient didn't receive the treatment|0|||
148969533|NCT05627518|537372912|FG002|Treatment Period 1|Withdrawal by Subject|1|||
148720672|NCT00685750|536448687|FG005|Overall Study|Patient didn't receive the treatment|0|||
148720673|NCT00685750|536448688|FG006|Overall Study|Patient didn't receive the treatment|1|||
148720674|NCT00685750|536448682|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148720675|NCT00685750|536448683|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148720676|NCT00685750|536448684|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
148720677|NCT00685750|536448685|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
148720678|NCT00685750|536448686|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
148720679|NCT00685750|536448687|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
148720680|NCT00685750|536448688|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
148720681|NCT04974580|536448689|FG000|Overall Study|Lost to Follow-up|33|||
148720682|NCT04974580|536448690|FG001|Overall Study|Lost to Follow-up|39|||
148720683|NCT04974580|536448691|FG002|Overall Study|Lost to Follow-up|30|||
148720684|NCT04974580|536448692|FG003|Overall Study|Lost to Follow-up|29|||
148720685|NCT00587431|536448693|FG000|Overall Study|Adverse Event|1|||
148720686|NCT00587431|536448694|FG001|Overall Study|Adverse Event|0|||
148720687|NCT00587431|536448693|FG000|Overall Study|Withdrawal by Subject|0|||
148720688|NCT00587431|536448694|FG001|Overall Study|Withdrawal by Subject|1|||
148720689|NCT05467982|536448695|FG000|Overall Study|Death|0|||
148720690|NCT05467982|536448696|FG001|Overall Study|Death|1|||
148720691|NCT05467982|536448695|FG000|Overall Study|Lost to Follow-up|3|||
148720692|NCT05467982|536448696|FG001|Overall Study|Lost to Follow-up|1|||
148720693|NCT00220727|536448721|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
148720694|NCT00220727|536448722|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
148720695|NCT02508116|536448725|FG000|Overall Study|Lost to Follow-up|2|||
148720696|NCT02508116|536448726|FG001|Overall Study|Lost to Follow-up|3|||
148720697|NCT02508116|536448725|FG000|Overall Study|Withdrawal by Subject|3|||
148720698|NCT02508116|536448726|FG001|Overall Study|Withdrawal by Subject|2|||
148720699|NCT02508116|536448725|FG000|Overall Study|Protocol Violation|1|||
148720700|NCT02508116|536448726|FG001|Overall Study|Protocol Violation|2|||
148720701|NCT02508116|536448725|FG000|Overall Study|Physician Decision|2|||
148720702|NCT02508116|536448726|FG001|Overall Study|Physician Decision|0|||
148720703|NCT00109850|536448727|FG000|Overall Study|Adverse Event|1|||
148720704|NCT00109850|536448727|FG000|Overall Study|Death|2|||
148720705|NCT00109850|536448727|FG000|Overall Study|Ineligible|1|||
148720706|NCT04234464|536448728|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
148720707|NCT04234464|536448729|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
148720708|NCT00476593|536448730|FG000|Overall Study|Lost to Follow-up|10|||
148720709|NCT00476593|536448731|FG001|Overall Study|Lost to Follow-up|2|||
148720710|NCT00476593|536448732|FG002|Overall Study|Lost to Follow-up|8|||
148720711|NCT00476593|536448733|FG003|Overall Study|Lost to Follow-up|22|||
148720712|NCT00983528|536448734|FG000|Overall Study|Death|4|||
148720713|NCT00983528|536448734|FG000|Overall Study|Lost to Follow-up|1|||
148720714|NCT00983528|536448734|FG000|Overall Study|Study Terminated|1|||
148720715|NCT03635983|536448735|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
148720716|NCT03635983|536448736|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
148720717|NCT03635983|536448735|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
148720718|NCT03635983|536448736|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148720719|NCT03635983|536448735|FG000|Pre-Treatment Period|Other reasons|0|||
148720720|NCT03635983|536448736|FG001|Pre-Treatment Period|Other reasons|1|||
148720721|NCT03635983|536448735|FG000|Pre-Treatment Period|Disease Progression|0|||
148720722|NCT03635983|536448736|FG001|Pre-Treatment Period|Disease Progression|1|||
148720723|NCT03635983|536448735|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
148720724|NCT03635983|536448736|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
148720725|NCT03635983|536448735|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
148720726|NCT03635983|536448736|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
148720727|NCT03635983|536448735|FG000|Treatment Period|Withdrawal by Subject|3|||
148720728|NCT03635983|536448736|FG001|Treatment Period|Withdrawal by Subject|5|||
148720729|NCT03635983|536448735|FG000|Treatment Period|Death|3|||
148720730|NCT03635983|536448736|FG001|Treatment Period|Death|5|||
148720731|NCT03635983|536448735|FG000|Treatment Period|Poor/Non-compliance|2|||
148720732|NCT03635983|536448736|FG001|Treatment Period|Poor/Non-compliance|1|||
148720733|NCT03635983|536448735|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
148720734|NCT03635983|536448736|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
148720735|NCT03635983|536448735|FG000|Treatment Period|Other reasons|7|||
148720736|NCT03635983|536448736|FG001|Treatment Period|Other reasons|4|||
148720737|NCT03635983|536448735|FG000|Treatment Period|Disease progression|230|||
148720738|NCT03635983|536448736|FG001|Treatment Period|Disease progression|201|||
148720739|NCT03635983|536448735|FG000|Treatment Period|Study drug toxicity|35|||
148720740|NCT03635983|536448736|FG001|Treatment Period|Study drug toxicity|36|||
148720741|NCT03635983|536448735|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
148720742|NCT03635983|536448736|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
148720743|NCT03635983|536448735|FG000|Treatment Period|Maximum clinical benefit|3|||
148720744|NCT03635983|536448736|FG001|Treatment Period|Maximum clinical benefit|5|||
148720745|NCT03635983|536448735|FG000|Treatment Period|Administrative reason by the sponsor|1|||
148720746|NCT03635983|536448736|FG001|Treatment Period|Administrative reason by the sponsor|2|||
148720747|NCT03635983|536448735|FG000|Treatment Period|Lost to Follow-up|0|||
148720748|NCT03635983|536448736|FG001|Treatment Period|Lost to Follow-up|1|||
148720749|NCT03430011|536448737|FG000|Pre-Treatment|Death|1|||
148720750|NCT03430011|536448738|FG001|Pre-Treatment|Death|0|||
148720751|NCT03430011|536448739|FG002|Pre-Treatment|Death|0|||
148720752|NCT03430011|536448740|FG003|Pre-Treatment|Death|0|||
148720753|NCT03430011|536448741|FG004|Pre-Treatment|Death|1|||
148720754|NCT03430011|536448742|FG005|Pre-Treatment|Death|0|||
148720755|NCT03430011|536448743|FG006|Pre-Treatment|Death|1|||
148720756|NCT03430011|536448744|FG007|Pre-Treatment|Death|0|||
148720757|NCT03430011|536448737|FG000|Pre-Treatment|Screen Fail|0|||
148720758|NCT03430011|536448738|FG001|Pre-Treatment|Screen Fail|0|||
148720759|NCT03430011|536448739|FG002|Pre-Treatment|Screen Fail|0|||
148720760|NCT03430011|536448740|FG003|Pre-Treatment|Screen Fail|0|||
148720761|NCT03430011|536448741|FG004|Pre-Treatment|Screen Fail|1|||
148720762|NCT03430011|536448742|FG005|Pre-Treatment|Screen Fail|0|||
148720763|NCT03430011|536448743|FG006|Pre-Treatment|Screen Fail|0|||
148720764|NCT03430011|536448744|FG007|Pre-Treatment|Screen Fail|0|||
148720765|NCT03430011|536448737|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720766|NCT03430011|536448738|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720767|NCT03430011|536448739|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
148720768|NCT03430011|536448740|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720769|NCT03430011|536448741|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720770|NCT03430011|536448742|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720771|NCT03430011|536448743|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720772|NCT03430011|536448744|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
148720773|NCT03430011|536448737|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
148720774|NCT03430011|536448738|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
148720775|NCT03430011|536448739|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
148720776|NCT03430011|536448740|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
148720777|NCT03430011|536448741|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
148720778|NCT03430011|536448742|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
148720779|NCT03430011|536448743|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
148720780|NCT03430011|536448744|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
148720781|NCT03430011|536448737|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
148720782|NCT03430011|536448738|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
148720783|NCT03430011|536448739|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
148720784|NCT03430011|536448740|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
148720785|NCT03430011|536448741|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
148720786|NCT03430011|536448742|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
148720787|NCT03430011|536448743|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
148720788|NCT03430011|536448744|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
148720789|NCT03430011|536448737|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
148720790|NCT03430011|536448738|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
148720791|NCT03430011|536448739|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
148720792|NCT03430011|536448740|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
148720793|NCT03430011|536448741|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
148720794|NCT03430011|536448742|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
148720795|NCT03430011|536448743|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
148720796|NCT03430011|536448744|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
148720797|NCT03430011|536448737|FG000|JCARH125 Treatment|Death|4|||
148720798|NCT03430011|536448738|FG001|JCARH125 Treatment|Death|19|||
148720799|NCT03430011|536448739|FG002|JCARH125 Treatment|Death|10|||
148720800|NCT03430011|536448740|FG003|JCARH125 Treatment|Death|8|||
148720801|NCT03430011|536448741|FG004|JCARH125 Treatment|Death|5|||
148720802|NCT03430011|536448742|FG005|JCARH125 Treatment|Death|3|||
148720803|NCT03430011|536448743|FG006|JCARH125 Treatment|Death|4|||
148720804|NCT03430011|536448744|FG007|JCARH125 Treatment|Death|2|||
148720805|NCT03430011|536448737|FG000|JCARH125 Treatment|Other reasons|1|||
148720806|NCT03430011|536448738|FG001|JCARH125 Treatment|Other reasons|0|||
148720807|NCT03430011|536448739|FG002|JCARH125 Treatment|Other reasons|4|||
148720808|NCT03430011|536448740|FG003|JCARH125 Treatment|Other reasons|2|||
148720809|NCT03430011|536448741|FG004|JCARH125 Treatment|Other reasons|2|||
148720810|NCT03430011|536448742|FG005|JCARH125 Treatment|Other reasons|1|||
148720811|NCT03430011|536448743|FG006|JCARH125 Treatment|Other reasons|3|||
148720812|NCT03430011|536448744|FG007|JCARH125 Treatment|Other reasons|2|||
148720813|NCT00330460|536448750|FG000|Overall Study|Physician Decision|1|||
148720814|NCT00330460|536448751|FG001|Overall Study|Physician Decision|0|||
148720815|NCT00330460|536448750|FG000|Overall Study|Adverse Event|10|||
148720816|NCT00330460|536448751|FG001|Overall Study|Adverse Event|8|||
148720817|NCT00330460|536448750|FG000|Overall Study|Withdrawal by Subject|18|||
148720818|NCT00330460|536448751|FG001|Overall Study|Withdrawal by Subject|17|||
148720819|NCT00330460|536448750|FG000|Overall Study|Death|1|||
148720820|NCT00330460|536448751|FG001|Overall Study|Death|1|||
148720821|NCT00330460|536448750|FG000|Overall Study|Ineligibility determined|1|||
148720822|NCT00330460|536448751|FG001|Overall Study|Ineligibility determined|3|||
148720823|NCT00330460|536448750|FG000|Overall Study|Lost to Follow-up|8|||
148969534|NCT05627518|537372913|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148720824|NCT00330460|536448751|FG001|Overall Study|Lost to Follow-up|3|||
148720825|NCT00330460|536448750|FG000|Overall Study|Noncompliance|2|||
148720826|NCT00330460|536448751|FG001|Overall Study|Noncompliance|1|||
148720827|NCT00330460|536448750|FG000|Overall Study|Other|1|||
148720828|NCT00330460|536448751|FG001|Overall Study|Other|0|||
148720829|NCT03712124|536448752|FG000|Overall Study|Protocol Violation|1|||
148720830|NCT03712124|536448753|FG001|Overall Study|Protocol Violation|0|||
148720831|NCT00602537|536448757|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
148720832|NCT00602537|536448758|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
148720833|NCT00602537|536448757|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
148720834|NCT00602537|536448758|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
148720835|NCT00602537|536448757|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
148720836|NCT00602537|536448758|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
148720837|NCT00602537|536448757|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
148720838|NCT00602537|536448758|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
148720839|NCT00602537|536448757|FG000|Follow Up Study Comparison|Adverse Event|1|||
148720840|NCT00602537|536448758|FG001|Follow Up Study Comparison|Adverse Event|0|||
148720841|NCT00602537|536448757|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
148720842|NCT00602537|536448758|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
148720843|NCT00602537|536448757|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
148720844|NCT00602537|536448758|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
148720845|NCT00388037|536448759|FG000|Overall Study|Protocol Violation|1|||
148720846|NCT02941523|536448760|FG000|Monotherapy|Withdrawal by Subject|0|||
148720847|NCT02941523|536448761|FG001|Monotherapy|Withdrawal by Subject|1|||
148720848|NCT02941523|536448760|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
148720849|NCT02941523|536448761|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
148720850|NCT02941523|536448760|FG000|Carboplatin Combination Therapy|Death|1|||
148720851|NCT02941523|536448761|FG001|Carboplatin Combination Therapy|Death|2|||
148720852|NCT02941523|536448760|FG000|Carboplatin Combination Therapy|Disease progression|2|||
148720853|NCT02941523|536448761|FG001|Carboplatin Combination Therapy|Disease progression|0|||
148720854|NCT02941523|536448760|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
148720855|NCT02941523|536448761|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
148720856|NCT04330157|536448762|FG000|Overall Study|Protocol Violation|4|||
148720857|NCT04330157|536448762|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
148720858|NCT04314843|536448764|FG000|Overall Study|Death|2|||
148720859|NCT04314843|536448765|FG001|Overall Study|Death|2|||
148720860|NCT04314843|536448764|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
148720861|NCT04314843|536448765|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
148720862|NCT01020526|536448766|FG000|Overall Study|Withdrawal by Subject|5|||
148720863|NCT01020526|536448766|FG000|Overall Study|Other reasons|3|||
148720864|NCT01020526|536448766|FG000|Overall Study|Insufficient clinical response|3|||
148720865|NCT01020526|536448766|FG000|Overall Study|Lost to Follow-up|1|||
148720866|NCT01020526|536448766|FG000|Overall Study|Adverse Event|2|||
148816199|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
148816200|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
148816201|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
148816202|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
148816203|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
148816204|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
148816205|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
148816206|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
148969535|NCT05627518|537372914|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148969536|NCT05627518|537372915|FG005|Treatment Period 1|Withdrawal by Subject|1|||
148969537|NCT05627518|537372916|FG006|Treatment Period 1|Withdrawal by Subject|0|||
148969538|NCT05627518|537372917|FG007|Treatment Period 1|Withdrawal by Subject|0|||
148969539|NCT05627518|537372910|FG000|Treatment Period 1|Protocol Violation|0|||
148969540|NCT05627518|537372911|FG001|Treatment Period 1|Protocol Violation|0|||
148816207|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
148969541|NCT05627518|537372912|FG002|Treatment Period 1|Protocol Violation|0|||
148969542|NCT05627518|537372913|FG003|Treatment Period 1|Protocol Violation|0|||
148969543|NCT05627518|537372914|FG004|Treatment Period 1|Protocol Violation|0|||
148969544|NCT05627518|537372915|FG005|Treatment Period 1|Protocol Violation|0|||
148969545|NCT05627518|537372916|FG006|Treatment Period 1|Protocol Violation|6|||
148969546|NCT05627518|537372917|FG007|Treatment Period 1|Protocol Violation|6|||
148969547|NCT05627518|537372910|FG000|Treatment Period 2|Adverse Event|1|||
148720867|NCT01899326|536448767|FG000|Overall Study|Withdrawal by Subject|1|||
148720868|NCT01899326|536448767|FG000|Overall Study|Adverse Event|2|||
148720869|NCT01899326|536448767|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
148720870|NCT03558139|536448768|FG000|Overall Study|Consent Withdrawn|1|||
148720871|NCT03558139|536448769|FG001|Overall Study|Consent Withdrawn|1|||
148720872|NCT03558139|536448770|FG002|Overall Study|Consent Withdrawn|4|||
148720873|NCT03558139|536448768|FG000|Overall Study|Death|5|||
148969548|NCT05627518|537372911|FG001|Treatment Period 2|Adverse Event|0|||
148720874|NCT03558139|536448769|FG001|Overall Study|Death|3|||
148720875|NCT03558139|536448770|FG002|Overall Study|Death|8|||
148720876|NCT03558139|536448768|FG000|Overall Study|Lost to Follow-up|0|||
148720877|NCT03558139|536448769|FG001|Overall Study|Lost to Follow-up|0|||
148720878|NCT03558139|536448770|FG002|Overall Study|Lost to Follow-up|3|||
148720879|NCT03558139|536448768|FG000|Overall Study|Study Ended Per Protocol|0|||
148720880|NCT03558139|536448769|FG001|Overall Study|Study Ended Per Protocol|3|||
148720881|NCT03558139|536448770|FG002|Overall Study|Study Ended Per Protocol|6|||
148720882|NCT00373425|536448771|FG000|Overall Study|Relapse of NSCLC|116|||
148720883|NCT00373425|536448772|FG001|Overall Study|Relapse of NSCLC|104|||
148720884|NCT00373425|536448773|FG002|Overall Study|Relapse of NSCLC|19|||
148720885|NCT00373425|536448774|FG003|Overall Study|Relapse of NSCLC|2|||
148720886|NCT00373425|536448775|FG004|Overall Study|Relapse of NSCLC|26|||
148720887|NCT00373425|536448771|FG000|Overall Study|Adverse Event|191|||
148720888|NCT00373425|536448772|FG001|Overall Study|Adverse Event|22|||
148720889|NCT00373425|536448773|FG002|Overall Study|Adverse Event|59|||
148720890|NCT00373425|536448774|FG003|Overall Study|Adverse Event|0|||
148720891|NCT00373425|536448775|FG004|Overall Study|Adverse Event|34|||
148720892|NCT00373425|536448771|FG000|Overall Study|Patient request|35|||
148720893|NCT00373425|536448772|FG001|Overall Study|Patient request|18|||
148720894|NCT00373425|536448773|FG002|Overall Study|Patient request|43|||
148720895|NCT00373425|536448774|FG003|Overall Study|Patient request|6|||
148720896|NCT00373425|536448775|FG004|Overall Study|Patient request|7|||
148720897|NCT00373425|536448771|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
148720898|NCT00373425|536448772|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
148720899|NCT00373425|536448773|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
148720900|NCT00373425|536448774|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
148720901|NCT00373425|536448775|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
148720902|NCT00373425|536448771|FG000|Overall Study|Death|7|||
148720903|NCT00373425|536448772|FG001|Overall Study|Death|0|||
148720904|NCT00373425|536448773|FG002|Overall Study|Death|3|||
148720905|NCT00373425|536448774|FG003|Overall Study|Death|1|||
148720906|NCT00373425|536448775|FG004|Overall Study|Death|0|||
148720907|NCT02752802|536448776|FG000|Overall Study|Contrast Volume Not Collected|1|||
148720908|NCT02752802|536448777|FG001|Overall Study|Contrast Volume Not Collected|0|||
148720909|NCT02808819|536448778|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
148720910|NCT02808819|536448779|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
148720911|NCT02808819|536448778|FG000|Overall Study|Withdrawal by Subject|10|||
148720912|NCT02808819|536448779|FG001|Overall Study|Withdrawal by Subject|13|||
148720913|NCT02808819|536448778|FG000|Overall Study|Site terminated by sponsor|2|||
148720914|NCT02808819|536448779|FG001|Overall Study|Site terminated by sponsor|0|||
148720915|NCT02808819|536448778|FG000|Overall Study|Pregnancy|1|||
148720916|NCT02808819|536448779|FG001|Overall Study|Pregnancy|0|||
148720917|NCT02808819|536448778|FG000|Overall Study|Lost to Follow-up|1|||
148720918|NCT02808819|536448779|FG001|Overall Study|Lost to Follow-up|6|||
148720919|NCT02808819|536448778|FG000|Overall Study|Protocol Violation|0|||
148720920|NCT02808819|536448779|FG001|Overall Study|Protocol Violation|1|||
148720921|NCT02808819|536448778|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
148720922|NCT02808819|536448779|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
148720923|NCT02808819|536448778|FG000|Overall Study|Death|1|||
148720924|NCT02808819|536448779|FG001|Overall Study|Death|0|||
148720925|NCT02808819|536448778|FG000|Overall Study|Adverse Event|3|||
148720926|NCT02808819|536448779|FG001|Overall Study|Adverse Event|4|||
148720927|NCT00251316|536448780|FG000|Overall Study|Physician Decision|2|||
148720928|NCT00251316|536448781|FG001|Overall Study|Physician Decision|3|||
148720929|NCT00105157|536448782|FG000|Double-Blind (DB)|Never Treated|1|||
148720930|NCT00105157|536448783|FG001|Double-Blind (DB)|Never Treated|0|||
148720931|NCT00105157|536448784|FG002|Double-Blind (DB)|Never Treated|0|||
148720932|NCT00105157|536448785|FG003|Double-Blind (DB)|Never Treated|0|||
148720933|NCT00105157|536448782|FG000|Double-Blind (DB)|Adverse Event|2|||
148720934|NCT00105157|536448783|FG001|Double-Blind (DB)|Adverse Event|0|||
148720935|NCT00105157|536448784|FG002|Double-Blind (DB)|Adverse Event|1|||
148720936|NCT00105157|536448785|FG003|Double-Blind (DB)|Adverse Event|1|||
148720937|NCT00105157|536448782|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
148720938|NCT00105157|536448783|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
148720939|NCT00105157|536448784|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
148720940|NCT00105157|536448785|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
148720941|NCT00105157|536448782|FG000|Open-Label Continuation of DB|Adverse Event|3|||
148720942|NCT00105157|536448783|FG001|Open-Label Continuation of DB|Adverse Event|1|||
148720943|NCT00105157|536448784|FG002|Open-Label Continuation of DB|Adverse Event|0|||
148720944|NCT00105157|536448785|FG003|Open-Label Continuation of DB|Adverse Event|0|||
148720945|NCT00105157|536448782|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
148720946|NCT00105157|536448783|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
148720947|NCT00105157|536448784|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
148720948|NCT00105157|536448785|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
148720949|NCT00105157|536448782|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
148720950|NCT00105157|536448783|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
148720951|NCT00105157|536448784|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
148720952|NCT00105157|536448785|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
148720953|NCT00105157|536448782|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
148969549|NCT05627518|537372912|FG002|Treatment Period 2|Adverse Event|0|||
148720954|NCT00105157|536448783|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
148720955|NCT00105157|536448784|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
148720956|NCT00105157|536448785|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
148720957|NCT00105157|536448782|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
148720958|NCT00105157|536448783|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
148720959|NCT00105157|536448784|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
148816208|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
148816209|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
148816210|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
148816211|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
148816212|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
148816213|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
148816214|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
148816215|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
148720960|NCT00105157|536448785|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
148720961|NCT00105157|536448782|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
148720962|NCT00105157|536448783|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
148720963|NCT00105157|536448784|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
148720964|NCT00105157|536448785|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
148720965|NCT00105157|536448782|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
148720966|NCT00105157|536448783|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
148720967|NCT00105157|536448784|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
148720968|NCT00105157|536448785|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
148720969|NCT00105157|536448782|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
148720970|NCT00105157|536448783|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
148720971|NCT00105157|536448784|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
148720972|NCT00105157|536448785|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
148720973|NCT00105157|536448782|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
148720974|NCT00105157|536448783|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
148720975|NCT00105157|536448784|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
148720976|NCT00105157|536448785|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
148720977|NCT00105157|536448782|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
148720978|NCT00105157|536448783|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
148720979|NCT00105157|536448784|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
148720980|NCT00105157|536448785|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
148720981|NCT00105157|536448782|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
148720982|NCT00105157|536448783|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
148720983|NCT00105157|536448784|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
148720984|NCT00105157|536448785|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
148720985|NCT00127166|536448786|FG000|Period I|Protocol Violation|0|||
148720986|NCT00127166|536448787|FG001|Period I|Protocol Violation|2|||
148720987|NCT00127166|536448786|FG000|Period I|Withdrawal by Subject|2|||
148720988|NCT00127166|536448787|FG001|Period I|Withdrawal by Subject|0|||
148720989|NCT00127166|536448786|FG000|Period I|Patient did not meet inclusion criteria|1|||
148720990|NCT00127166|536448787|FG001|Period I|Patient did not meet inclusion criteria|0|||
148720991|NCT00127166|536448786|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
148720992|NCT00127166|536448787|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
148720993|NCT00127166|536448786|FG000|Period II|Withdrawal by Subject|2|||
148720994|NCT00127166|536448787|FG001|Period II|Withdrawal by Subject|0|||
148720995|NCT00127166|536448786|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
148720996|NCT00127166|536448787|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
148720997|NCT01396421|536448790|FG000|Overall Study|Lost to Follow-up|0|||
148720998|NCT01396421|536448791|FG001|Overall Study|Lost to Follow-up|0|||
148720999|NCT01396421|536448792|FG002|Overall Study|Lost to Follow-up|0|||
148721000|NCT01396421|536448793|FG003|Overall Study|Lost to Follow-up|1|||
148721001|NCT01396421|536448790|FG000|Overall Study|Adverse Event|17|||
148721002|NCT01396421|536448791|FG001|Overall Study|Adverse Event|15|||
148721003|NCT01396421|536448792|FG002|Overall Study|Adverse Event|12|||
148721004|NCT01396421|536448793|FG003|Overall Study|Adverse Event|32|||
148721005|NCT01396421|536448790|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
148721006|NCT01396421|536448791|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
148721007|NCT01396421|536448792|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
148721008|NCT01396421|536448793|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
148721009|NCT01396421|536448790|FG000|Overall Study|Physician Decision|1|||
148721010|NCT01396421|536448791|FG001|Overall Study|Physician Decision|1|||
148721011|NCT01396421|536448792|FG002|Overall Study|Physician Decision|0|||
148721012|NCT01396421|536448793|FG003|Overall Study|Physician Decision|3|||
148721013|NCT01396421|536448790|FG000|Overall Study|Withdrawal by Subject|31|||
148721014|NCT01396421|536448791|FG001|Overall Study|Withdrawal by Subject|24|||
148721015|NCT01396421|536448792|FG002|Overall Study|Withdrawal by Subject|13|||
148721016|NCT01396421|536448793|FG003|Overall Study|Withdrawal by Subject|21|||
148721017|NCT01396421|536448790|FG000|Overall Study|Protocol Deviation|2|||
148721018|NCT01396421|536448791|FG001|Overall Study|Protocol Deviation|1|||
148721019|NCT01396421|536448792|FG002|Overall Study|Protocol Deviation|1|||
148721020|NCT01396421|536448793|FG003|Overall Study|Protocol Deviation|0|||
148721021|NCT01396421|536448790|FG000|Overall Study|Lack of Efficacy|7|||
148721022|NCT01396421|536448791|FG001|Overall Study|Lack of Efficacy|17|||
148721023|NCT01396421|536448792|FG002|Overall Study|Lack of Efficacy|7|||
148721024|NCT01396421|536448793|FG003|Overall Study|Lack of Efficacy|18|||
148721025|NCT01378962|536448795|FG000|Overall Study|Death|14|||
148721026|NCT01378962|536448795|FG000|Overall Study|Lost to Follow-up|1|||
148721027|NCT01378962|536448795|FG000|Overall Study|Other|2|||
148721028|NCT01835548|536448802|FG000|Dose Optimization Period|Adverse Event|0|||
148721029|NCT01835548|536448803|FG001|Dose Optimization Period|Adverse Event|0|||
148721030|NCT01835548|536448804|FG002|Dose Optimization Period|Adverse Event|1|||
148721031|NCT01835548|536448802|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
148721032|NCT01835548|536448803|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
148721033|NCT01835548|536448804|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
148721034|NCT01835548|536448802|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148721035|NCT01835548|536448803|FG001|Double-Blind Treatment Period|Adverse Event|1|||
148721036|NCT01835548|536448804|FG002|Double-Blind Treatment Period|Adverse Event|0|||
148721037|NCT01835548|536448802|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148721038|NCT01835548|536448803|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
148721039|NCT01835548|536448804|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148721040|NCT02490800|536448805|FG000|Overall Study|Adverse Event|0|||
148721041|NCT02490800|536448806|FG001|Overall Study|Adverse Event|0|||
148721042|NCT02490800|536448807|FG002|Overall Study|Adverse Event|0|||
148721043|NCT02490800|536448808|FG003|Overall Study|Adverse Event|2|||
148721044|NCT02490800|536448809|FG004|Overall Study|Adverse Event|3|||
148721045|NCT02490800|536448810|FG005|Overall Study|Adverse Event|2|||
148721046|NCT02490800|536448811|FG006|Overall Study|Adverse Event|0|||
148721047|NCT02490800|536448812|FG007|Overall Study|Adverse Event|0|||
148721048|NCT02490800|536448813|FG008|Overall Study|Adverse Event|0|||
148721049|NCT02490800|536448814|FG009|Overall Study|Adverse Event|0|||
148721050|NCT02490800|536448815|FG010|Overall Study|Adverse Event|0|||
148721051|NCT02490800|536448816|FG011|Overall Study|Adverse Event|2|||
148721052|NCT02490800|536448817|FG012|Overall Study|Adverse Event|2|||
148721053|NCT02490800|536448805|FG000|Overall Study|Withdrawal by Subject|0|||
148721054|NCT02490800|536448806|FG001|Overall Study|Withdrawal by Subject|0|||
148721055|NCT02490800|536448807|FG002|Overall Study|Withdrawal by Subject|0|||
148721056|NCT02490800|536448808|FG003|Overall Study|Withdrawal by Subject|1|||
148721057|NCT02490800|536448809|FG004|Overall Study|Withdrawal by Subject|0|||
148721058|NCT02490800|536448810|FG005|Overall Study|Withdrawal by Subject|0|||
148721059|NCT02490800|536448811|FG006|Overall Study|Withdrawal by Subject|0|||
148721060|NCT02490800|536448812|FG007|Overall Study|Withdrawal by Subject|0|||
148721061|NCT02490800|536448813|FG008|Overall Study|Withdrawal by Subject|1|||
148721062|NCT02490800|536448814|FG009|Overall Study|Withdrawal by Subject|0|||
148721063|NCT02490800|536448815|FG010|Overall Study|Withdrawal by Subject|0|||
148721064|NCT02490800|536448816|FG011|Overall Study|Withdrawal by Subject|0|||
148721065|NCT02490800|536448817|FG012|Overall Study|Withdrawal by Subject|0|||
148721066|NCT02490800|536448805|FG000|Overall Study|Progressive disease|3|||
148721067|NCT02490800|536448806|FG001|Overall Study|Progressive disease|3|||
148721068|NCT02490800|536448807|FG002|Overall Study|Progressive disease|3|||
148721069|NCT02490800|536448808|FG003|Overall Study|Progressive disease|4|||
148721070|NCT02490800|536448809|FG004|Overall Study|Progressive disease|4|||
148721071|NCT02490800|536448810|FG005|Overall Study|Progressive disease|1|||
148721072|NCT02490800|536448811|FG006|Overall Study|Progressive disease|4|||
148721073|NCT02490800|536448812|FG007|Overall Study|Progressive disease|3|||
148721074|NCT02490800|536448813|FG008|Overall Study|Progressive disease|6|||
148721075|NCT02490800|536448814|FG009|Overall Study|Progressive disease|2|||
148721076|NCT02490800|536448815|FG010|Overall Study|Progressive disease|7|||
148721077|NCT02490800|536448816|FG011|Overall Study|Progressive disease|1|||
148721078|NCT02490800|536448817|FG012|Overall Study|Progressive disease|10|||
148721079|NCT02490800|536448805|FG000|Overall Study|Patient enrolled in post-trial access|0|||
148721080|NCT02490800|536448806|FG001|Overall Study|Patient enrolled in post-trial access|0|||
148721081|NCT02490800|536448807|FG002|Overall Study|Patient enrolled in post-trial access|0|||
148721082|NCT02490800|536448808|FG003|Overall Study|Patient enrolled in post-trial access|0|||
148816216|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
148969550|NCT05627518|537372913|FG003|Treatment Period 2|Adverse Event|0|||
148721083|NCT02490800|536448809|FG004|Overall Study|Patient enrolled in post-trial access|0|||
148721084|NCT02490800|536448810|FG005|Overall Study|Patient enrolled in post-trial access|0|||
148721085|NCT02490800|536448811|FG006|Overall Study|Patient enrolled in post-trial access|0|||
148721086|NCT02490800|536448812|FG007|Overall Study|Patient enrolled in post-trial access|0|||
148721087|NCT02490800|536448813|FG008|Overall Study|Patient enrolled in post-trial access|0|||
148721088|NCT02490800|536448814|FG009|Overall Study|Patient enrolled in post-trial access|1|||
148721089|NCT02490800|536448815|FG010|Overall Study|Patient enrolled in post-trial access|1|||
148721090|NCT02490800|536448816|FG011|Overall Study|Patient enrolled in post-trial access|0|||
148721091|NCT02490800|536448817|FG012|Overall Study|Patient enrolled in post-trial access|6|||
148721092|NCT01634854|536448818|FG000|Overall Study|Cesarean delivery|2|||
148721093|NCT01634854|536448819|FG001|Overall Study|Cesarean delivery|7|||
148721094|NCT04149535|536448820|FG000|Overall Study|Death|11|||
148721095|NCT04149535|536448821|FG001|Overall Study|Death|7|||
148721096|NCT04149535|536448820|FG000|Overall Study|Physician Decision|10|||
148721097|NCT04149535|536448821|FG001|Overall Study|Physician Decision|4|||
148721098|NCT04149535|536448820|FG000|Overall Study|Withdrawal by Subject|6|||
148721099|NCT04149535|536448821|FG001|Overall Study|Withdrawal by Subject|7|||
148721100|NCT04149535|536448820|FG000|Overall Study|Not described|2|||
148721101|NCT04149535|536448821|FG001|Overall Study|Not described|0|||
148721102|NCT03180528|536450415|FG000|Overall Study|Adverse Event|1|||
148721103|NCT03180528|536450415|FG000|Overall Study|Withdrawal by Subject|1|||
148721104|NCT03180528|536450415|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
148721105|NCT02447887|536450416|FG000|Overall Study|Study was terminated|3|||
148721106|NCT00109837|536450417|FG000|Overall Study|Adverse Event|2|||
148721107|NCT00109837|536450417|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
148721108|NCT00109837|536450417|FG000|Overall Study|Death|1|||
148721109|NCT00109837|536450417|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
148721110|NCT00109837|536450417|FG000|Overall Study|Not treated|1|||
148721111|NCT00109837|536450417|FG000|Overall Study|Ineligible|1|||
148721112|NCT03941834|536450418|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
148721113|NCT03941834|536450419|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
148721114|NCT03941834|536450420|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
148721115|NCT03941834|536450418|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
148721116|NCT03941834|536450419|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
148721117|NCT03941834|536450420|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
148721118|NCT03941834|536450418|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
148721119|NCT03941834|536450419|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
148721120|NCT03941834|536450420|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
148721121|NCT03941834|536450418|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
148721122|NCT03941834|536450419|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
148721123|NCT03941834|536450420|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
148721124|NCT03941834|536450418|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
148721125|NCT03941834|536450419|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
148721126|NCT03941834|536450420|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
148721127|NCT03941834|536450418|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
148721128|NCT03941834|536450419|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
148721129|NCT03941834|536450420|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
148721130|NCT02688387|536450423|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721131|NCT02688387|536450424|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721132|NCT02688387|536450425|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
148721133|NCT02688387|536450426|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721134|NCT02688387|536450427|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721135|NCT02688387|536450428|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721136|NCT02688387|536450429|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721137|NCT02688387|536450430|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721138|NCT02688387|536450431|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721139|NCT02688387|536450432|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721140|NCT02688387|536450433|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721141|NCT02688387|536450434|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148816217|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
148816218|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
148816219|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
148816220|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
148816221|NCT01807520|536802793|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
148816222|NCT01807520|536802794|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
148816223|NCT01807520|536802795|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
148816224|NCT01807520|536802796|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
148816225|NCT01807520|536802797|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
148816226|NCT01807520|536802798|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
148816227|NCT01807520|536802799|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
148816228|NCT01807520|536802793|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
148816229|NCT01807520|536802794|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
148816230|NCT01807520|536802795|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
148721142|NCT02688387|536450435|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721143|NCT02688387|536450436|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721144|NCT02688387|536450437|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721145|NCT02688387|536450438|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721146|NCT02688387|536450439|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721147|NCT02688387|536450440|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721148|NCT02688387|536450441|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721149|NCT02688387|536450442|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721150|NCT02688387|536450443|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721151|NCT02688387|536450444|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
148721152|NCT02688387|536450423|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721153|NCT02688387|536450424|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721154|NCT02688387|536450425|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721155|NCT02688387|536450426|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
148721156|NCT02688387|536450427|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721157|NCT02688387|536450428|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721158|NCT02688387|536450429|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721159|NCT02688387|536450430|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721160|NCT02688387|536450431|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721161|NCT02688387|536450432|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721162|NCT02688387|536450433|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721163|NCT02688387|536450434|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721164|NCT02688387|536450435|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721165|NCT02688387|536450436|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721166|NCT02688387|536450437|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721167|NCT02688387|536450438|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721168|NCT02688387|536450439|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721169|NCT02688387|536450440|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721170|NCT02688387|536450441|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721171|NCT02688387|536450442|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721172|NCT02688387|536450443|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721173|NCT02688387|536450444|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721174|NCT02688387|536450423|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721175|NCT02688387|536450424|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
148721176|NCT02688387|536450425|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721177|NCT02688387|536450426|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721178|NCT02688387|536450427|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721179|NCT02688387|536450428|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721180|NCT02688387|536450429|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721181|NCT02688387|536450430|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721182|NCT02688387|536450431|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721183|NCT02688387|536450432|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721184|NCT02688387|536450433|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721185|NCT02688387|536450434|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721186|NCT02688387|536450435|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721187|NCT02688387|536450436|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721188|NCT02688387|536450437|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721189|NCT02688387|536450438|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721190|NCT02688387|536450439|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721191|NCT02688387|536450440|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721192|NCT02688387|536450441|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721193|NCT02688387|536450442|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721194|NCT02688387|536450443|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721195|NCT02688387|536450444|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
148721196|NCT02688387|536450423|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721197|NCT02688387|536450424|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721198|NCT02688387|536450425|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
148721199|NCT02688387|536450426|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721200|NCT02688387|536450427|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
148721201|NCT02688387|536450428|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721202|NCT02688387|536450429|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721203|NCT02688387|536450430|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721204|NCT02688387|536450431|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721205|NCT02688387|536450432|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721206|NCT02688387|536450433|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148969551|NCT05627518|537372914|FG004|Treatment Period 2|Adverse Event|0|||
148969552|NCT05627518|537372915|FG005|Treatment Period 2|Adverse Event|0|||
148969553|NCT05627518|537372916|FG006|Treatment Period 2|Adverse Event|0|||
148969554|NCT05627518|537372917|FG007|Treatment Period 2|Adverse Event|0|||
148969555|NCT05627518|537372910|FG000|Treatment Period 2|Withdrawal by Subject|1|||
148969556|NCT05627518|537372911|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148969557|NCT05627518|537372912|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148969558|NCT05627518|537372913|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148969559|NCT05627518|537372914|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148969560|NCT05627518|537372915|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148721207|NCT02688387|536450434|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721208|NCT02688387|536450435|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721209|NCT02688387|536450436|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721210|NCT02688387|536450437|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721211|NCT02688387|536450438|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721212|NCT02688387|536450439|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721213|NCT02688387|536450440|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721214|NCT02688387|536450441|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721215|NCT02688387|536450442|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721216|NCT02688387|536450443|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721217|NCT02688387|536450444|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
148721218|NCT02688387|536450423|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
148721219|NCT02688387|536450424|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721220|NCT02688387|536450425|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721221|NCT02688387|536450426|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721222|NCT02688387|536450427|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721223|NCT02688387|536450428|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721224|NCT02688387|536450429|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721225|NCT02688387|536450430|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721226|NCT02688387|536450431|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721227|NCT02688387|536450432|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721228|NCT02688387|536450433|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721229|NCT02688387|536450434|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721230|NCT02688387|536450435|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721231|NCT02688387|536450436|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721232|NCT02688387|536450437|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721233|NCT02688387|536450438|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721234|NCT02688387|536450439|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721235|NCT02688387|536450440|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721236|NCT02688387|536450441|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721237|NCT02688387|536450442|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721238|NCT02688387|536450443|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721239|NCT02688387|536450444|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
148721240|NCT02688387|536450423|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721241|NCT02688387|536450424|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721242|NCT02688387|536450425|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721243|NCT02688387|536450426|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721244|NCT02688387|536450427|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721245|NCT02688387|536450428|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721246|NCT02688387|536450429|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721247|NCT02688387|536450430|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721248|NCT02688387|536450431|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721249|NCT02688387|536450432|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721250|NCT02688387|536450433|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
148721251|NCT02688387|536450434|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721252|NCT02688387|536450435|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721253|NCT02688387|536450436|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721254|NCT02688387|536450437|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721255|NCT02688387|536450438|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721256|NCT02688387|536450439|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721257|NCT02688387|536450440|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148816231|NCT01807520|536802796|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
148816232|NCT01807520|536802797|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
148816233|NCT01807520|536802798|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
148816234|NCT01807520|536802799|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
148816235|NCT01807520|536802793|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
148969561|NCT05627518|537372916|FG006|Treatment Period 2|Withdrawal by Subject|0|||
148969562|NCT05627518|537372917|FG007|Treatment Period 2|Withdrawal by Subject|0|||
148721258|NCT02688387|536450441|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721259|NCT02688387|536450442|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721260|NCT02688387|536450443|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721261|NCT02688387|536450444|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
148721262|NCT02688387|536450423|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721263|NCT02688387|536450424|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721264|NCT02688387|536450425|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721265|NCT02688387|536450426|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721266|NCT02688387|536450427|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721267|NCT02688387|536450428|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721268|NCT02688387|536450429|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721269|NCT02688387|536450430|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721270|NCT02688387|536450431|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721271|NCT02688387|536450432|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721272|NCT02688387|536450433|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721273|NCT02688387|536450434|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721274|NCT02688387|536450435|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721275|NCT02688387|536450436|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721276|NCT02688387|536450437|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
148721277|NCT02688387|536450438|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721278|NCT02688387|536450439|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721279|NCT02688387|536450440|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721280|NCT02688387|536450441|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721281|NCT02688387|536450442|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721282|NCT02688387|536450443|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721283|NCT02688387|536450444|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
148721284|NCT02688387|536450423|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721285|NCT02688387|536450424|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721286|NCT02688387|536450425|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721287|NCT02688387|536450426|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721288|NCT02688387|536450427|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721289|NCT02688387|536450428|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721290|NCT02688387|536450429|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721291|NCT02688387|536450430|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721292|NCT02688387|536450431|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721293|NCT02688387|536450432|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721294|NCT02688387|536450433|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721295|NCT02688387|536450434|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721296|NCT02688387|536450435|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721297|NCT02688387|536450436|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721298|NCT02688387|536450437|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721299|NCT02688387|536450438|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721300|NCT02688387|536450439|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721301|NCT02688387|536450440|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721302|NCT02688387|536450441|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721303|NCT02688387|536450442|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721304|NCT02688387|536450443|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
148721305|NCT02688387|536450444|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
148721306|NCT02688387|536450423|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721307|NCT02688387|536450424|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721308|NCT02688387|536450425|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721309|NCT02688387|536450426|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721310|NCT02688387|536450427|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721311|NCT02688387|536450428|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721312|NCT02688387|536450429|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721313|NCT02688387|536450430|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721314|NCT02688387|536450431|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721315|NCT02688387|536450432|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721316|NCT02688387|536450433|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721317|NCT02688387|536450434|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721318|NCT02688387|536450435|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721319|NCT02688387|536450436|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721320|NCT02688387|536450437|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721321|NCT02688387|536450438|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721322|NCT02688387|536450439|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721323|NCT02688387|536450440|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721324|NCT02688387|536450441|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
148969563|NCT02917031|537372918|FG000|Overall Study|Reason not specified|7|||
148969564|NCT02917031|537372919|FG001|Overall Study|Reason not specified|5|||
148969565|NCT02917031|537372920|FG002|Overall Study|Reason not specified|6|||
148969566|NCT02917031|537372918|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
148721325|NCT02688387|536450442|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721326|NCT02688387|536450443|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
148721327|NCT02688387|536450444|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
148721328|NCT02688387|536450423|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721329|NCT02688387|536450424|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721330|NCT02688387|536450425|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721331|NCT02688387|536450426|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721332|NCT02688387|536450427|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721333|NCT02688387|536450428|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721334|NCT02688387|536450429|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721335|NCT02688387|536450430|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721336|NCT02688387|536450431|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721337|NCT02688387|536450432|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721338|NCT02688387|536450433|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721339|NCT02688387|536450434|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721340|NCT02688387|536450435|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721341|NCT02688387|536450436|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721342|NCT02688387|536450437|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721343|NCT02688387|536450438|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721344|NCT02688387|536450439|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721345|NCT02688387|536450440|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721346|NCT02688387|536450441|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721347|NCT02688387|536450442|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
148721348|NCT02688387|536450443|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721349|NCT02688387|536450444|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
148721350|NCT04100096|536450447|FG000|Overall Study|Adverse Event|19|||
148721351|NCT04100096|536450448|FG001|Overall Study|Adverse Event|7|||
148721352|NCT04100096|536450447|FG000|Overall Study|Lack of Efficacy|0|||
148721353|NCT04100096|536450448|FG001|Overall Study|Lack of Efficacy|1|||
148721354|NCT04100096|536450447|FG000|Overall Study|Lost to Follow-up|13|||
148721355|NCT04100096|536450448|FG001|Overall Study|Lost to Follow-up|11|||
148721356|NCT04100096|536450447|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148721357|NCT04100096|536450448|FG001|Overall Study|Non-Compliance With Study Drug|3|||
148721358|NCT04100096|536450447|FG000|Overall Study|Protocol Deviation|1|||
148721359|NCT04100096|536450448|FG001|Overall Study|Protocol Deviation|1|||
148721360|NCT04100096|536450447|FG000|Overall Study|Withdrawal by Participant|13|||
148721361|NCT04100096|536450448|FG001|Overall Study|Withdrawal by Participant|15|||
148721362|NCT00991510|536450451|FG000|Period I (Days 1-14)|Adverse Event|1|||
148721363|NCT00991510|536450452|FG001|Period I (Days 1-14)|Adverse Event|0|||
148721364|NCT00991510|536450451|FG000|Period III (Days 29-112)|Adverse Event|1|||
148721365|NCT00991510|536450452|FG001|Period III (Days 29-112)|Adverse Event|1|||
148721366|NCT02356211|536450453|FG000|Overall Study|Withdrawal by Subject|2|||
148721367|NCT02356211|536450454|FG001|Overall Study|Withdrawal by Subject|2|||
148721368|NCT02356211|536450453|FG000|Overall Study|ineligible|1|||
148721369|NCT02356211|536450454|FG001|Overall Study|ineligible|8|||
148721370|NCT01976728|536450455|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
148721371|NCT01976728|536450456|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
148721372|NCT01976728|536450457|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
148721373|NCT01976728|536450458|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
148721374|NCT01563237|536450460|FG000|Overall Study|Lost to Follow-up|6|||
148721375|NCT01563237|536450461|FG001|Overall Study|Lost to Follow-up|0|||
148721376|NCT01563237|536450460|FG000|Overall Study|Withdrawal by Subject|1|||
148721377|NCT01563237|536450461|FG001|Overall Study|Withdrawal by Subject|0|||
148721378|NCT01563237|536450460|FG000|Overall Study|Adverse Event|1|||
148721379|NCT01563237|536450461|FG001|Overall Study|Adverse Event|0|||
148721380|NCT01563237|536450460|FG000|Overall Study|Medical Reasons|1|||
148721381|NCT01563237|536450461|FG001|Overall Study|Medical Reasons|0|||
148721382|NCT01563237|536450460|FG000|Overall Study|Death|1|||
148721383|NCT01563237|536450461|FG001|Overall Study|Death|0|||
148721384|NCT00988208|536450462|FG000|Overall Study|Adverse Event|71|||
148721385|NCT00988208|536450463|FG001|Overall Study|Adverse Event|122|||
148721386|NCT00988208|536450462|FG000|Overall Study|Disease Progression|103|||
148969567|NCT02917031|537372919|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
148969568|NCT02917031|537372920|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
148721387|NCT00988208|536450463|FG001|Overall Study|Disease Progression|89|||
148721388|NCT00988208|536450462|FG000|Overall Study|Withdrawal by Subject|50|||
148721389|NCT00988208|536450463|FG001|Overall Study|Withdrawal by Subject|57|||
148721390|NCT00988208|536450462|FG000|Overall Study|Death|9|||
148721391|NCT00988208|536450463|FG001|Overall Study|Death|15|||
148721392|NCT00988208|536450462|FG000|Overall Study|Lost to Follow-up|2|||
148721393|NCT00988208|536450463|FG001|Overall Study|Lost to Follow-up|3|||
148721394|NCT00988208|536450462|FG000|Overall Study|Protocol Violation|9|||
148721395|NCT00988208|536450463|FG001|Overall Study|Protocol Violation|2|||
148721396|NCT00988208|536450462|FG000|Overall Study|Sponsor Decision|102|||
148721397|NCT00988208|536450463|FG001|Overall Study|Sponsor Decision|78|||
148721398|NCT00988208|536450462|FG000|Overall Study|Clinical Progression|17|||
148721399|NCT00988208|536450463|FG001|Overall Study|Clinical Progression|16|||
148721400|NCT00988208|536450462|FG000|Overall Study|Biochemical Progression|21|||
148721401|NCT00988208|536450463|FG001|Overall Study|Biochemical Progression|7|||
148721402|NCT00988208|536450462|FG000|Overall Study|Clinical Deterioration|7|||
148721403|NCT00988208|536450463|FG001|Overall Study|Clinical Deterioration|14|||
148721404|NCT00988208|536450462|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
148721405|NCT00988208|536450463|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
148721406|NCT00988208|536450462|FG000|Overall Study|Other|8|||
148721407|NCT00988208|536450463|FG001|Overall Study|Other|3|||
148721408|NCT01796964|536450466|FG000|Overall Study|Adverse Event|1|||
148721409|NCT01796964|536450467|FG001|Overall Study|Adverse Event|1|||
148721410|NCT01796964|536450466|FG000|Overall Study|Death|1|||
148721411|NCT01796964|536450467|FG001|Overall Study|Death|0|||
148721412|NCT01796964|536450466|FG000|Overall Study|Protocol Violation|0|||
148721413|NCT01796964|536450467|FG001|Overall Study|Protocol Violation|1|||
148721414|NCT01796964|536450466|FG000|Overall Study|Withdrawal by Subject|1|||
148721415|NCT01796964|536450467|FG001|Overall Study|Withdrawal by Subject|1|||
148721416|NCT02000531|536450473|FG000|Overall Study|Lost to Follow-up|1|||
148721417|NCT02000531|536450474|FG001|Overall Study|Lost to Follow-up|0|||
148721418|NCT02000531|536450473|FG000|Overall Study|Discontinued due to data cut-off|3|||
148721419|NCT02000531|536450474|FG001|Overall Study|Discontinued due to data cut-off|8|||
148721420|NCT00317642|536450479|FG000|Overall Study|Not Received Either Study Drug|1|||
148721421|NCT00317642|536450480|FG001|Overall Study|Not Received Either Study Drug|3|||
148721422|NCT00317642|536450479|FG000|Overall Study|Physician Decision|15|||
148721423|NCT00317642|536450480|FG001|Overall Study|Physician Decision|7|||
148721424|NCT00317642|536450479|FG000|Overall Study|Participant declined treatment|14|||
148721425|NCT00317642|536450480|FG001|Overall Study|Participant declined treatment|3|||
148721426|NCT00317642|536450479|FG000|Overall Study|Adverse Event|17|||
148721427|NCT00317642|536450480|FG001|Overall Study|Adverse Event|5|||
148721428|NCT00317642|536450479|FG000|Overall Study|Treatment Failure|56|||
148721429|NCT00317642|536450480|FG001|Overall Study|Treatment Failure|102|||
148721430|NCT00317642|536450479|FG000|Overall Study|Disease Recurrence|1|||
148721431|NCT00317642|536450480|FG001|Overall Study|Disease Recurrence|2|||
148721432|NCT00317642|536450479|FG000|Overall Study|Death|14|||
148969569|NCT02917031|537372918|FG000|Overall Study|Withdrawal by Subject|3|||
148721433|NCT00317642|536450480|FG001|Overall Study|Death|7|||
148721434|NCT00317642|536450479|FG000|Overall Study|Not Continue to Consolidation|2|||
148721435|NCT00317642|536450480|FG001|Overall Study|Not Continue to Consolidation|0|||
148721436|NCT00317642|536450479|FG000|Overall Study|Withdrawal by Subject|0|||
148721437|NCT00317642|536450480|FG001|Overall Study|Withdrawal by Subject|1|||
148721438|NCT00317642|536450479|FG000|Overall Study|Referred For Transplantation|1|||
148721439|NCT00317642|536450480|FG001|Overall Study|Referred For Transplantation|0|||
148721440|NCT00317642|536450479|FG000|Overall Study|AML Not Centrally Confirmed|1|||
148721441|NCT00317642|536450480|FG001|Overall Study|AML Not Centrally Confirmed|5|||
148721442|NCT03180801|536450484|FG000|Overall Study|Physician Decision|3|||
148721443|NCT03180801|536450485|FG001|Overall Study|Physician Decision|3|||
148721444|NCT03180801|536450486|FG002|Overall Study|Physician Decision|1|||
148721445|NCT03180801|536450484|FG000|Overall Study|Non-compliance|1|||
148721446|NCT03180801|536450485|FG001|Overall Study|Non-compliance|4|||
148721447|NCT03180801|536450486|FG002|Overall Study|Non-compliance|0|||
148969570|NCT02917031|537372919|FG001|Overall Study|Withdrawal by Subject|3|||
148721448|NCT03180801|536450484|FG000|Overall Study|Inoculation Target Reached|1|||
148721449|NCT03180801|536450485|FG001|Overall Study|Inoculation Target Reached|1|||
148721450|NCT03180801|536450486|FG002|Overall Study|Inoculation Target Reached|3|||
148721451|NCT03180801|536450484|FG000|Overall Study|Adverse Event|1|||
148969571|NCT02917031|537372920|FG002|Overall Study|Withdrawal by Subject|0|||
148721452|NCT03180801|536450485|FG001|Overall Study|Adverse Event|0|||
148721453|NCT03180801|536450486|FG002|Overall Study|Adverse Event|2|||
148721454|NCT03180801|536450484|FG000|Overall Study|Withdrawal by Subject|2|||
148721455|NCT03180801|536450485|FG001|Overall Study|Withdrawal by Subject|2|||
148969572|NCT02917031|537372918|FG000|Overall Study|Physician Decision|1|||
148721456|NCT03180801|536450486|FG002|Overall Study|Withdrawal by Subject|1|||
148721457|NCT03180801|536450484|FG000|Overall Study|Lost to Follow-up|0|||
148721458|NCT03180801|536450485|FG001|Overall Study|Lost to Follow-up|2|||
148721459|NCT03180801|536450486|FG002|Overall Study|Lost to Follow-up|3|||
148721460|NCT01049412|536450487|FG000|Period I|Withdrawal by Subject|4|||
148721461|NCT01049412|536450488|FG001|Period I|Withdrawal by Subject|6|||
148721462|NCT01049412|536450487|FG000|Period I|Lost to Follow-up|2|||
148721463|NCT01049412|536450488|FG001|Period I|Lost to Follow-up|2|||
148721464|NCT01049412|536450487|FG000|Period I|Physician Decision|0|||
148721465|NCT01049412|536450488|FG001|Period I|Physician Decision|3|||
148721466|NCT01049412|536450487|FG000|Period I|Protocol Violation|1|||
148721467|NCT01049412|536450488|FG001|Period I|Protocol Violation|2|||
148721468|NCT01049412|536450487|FG000|Period I|Adverse Event|1|||
148721469|NCT01049412|536450488|FG001|Period I|Adverse Event|0|||
148721470|NCT01049412|536450487|FG000|Period II|Withdrawal by Subject|2|||
148721471|NCT01049412|536450488|FG001|Period II|Withdrawal by Subject|3|||
148721472|NCT01049412|536450487|FG000|Period II|Adverse Event|1|||
148721473|NCT01049412|536450488|FG001|Period II|Adverse Event|0|||
148721474|NCT01049412|536450487|FG000|Period II|Lost to Follow-up|1|||
148721475|NCT01049412|536450488|FG001|Period II|Lost to Follow-up|0|||
148721476|NCT04364737|536450489|FG000|Overall Study|Withdrawal by Subject|4|||
148721477|NCT04364737|536450490|FG001|Overall Study|Withdrawal by Subject|9|||
148721478|NCT04364737|536450489|FG000|Overall Study|Lost to Follow-up|1|||
148721479|NCT04364737|536450490|FG001|Overall Study|Lost to Follow-up|1|||
148721480|NCT01220609|536450491|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
148721481|NCT01220609|536450491|FG000|Overall Study|Ineligible- Wrong cell type|1|||
148721482|NCT01220609|536450491|FG000|Overall Study|Ineligible-Never treated|1|||
148721483|NCT00868296|536450494|FG000|Overall Study|Adverse Event|0|||
148721484|NCT00868296|536450495|FG001|Overall Study|Adverse Event|2|||
148721485|NCT00868296|536450494|FG000|Overall Study|Withdrawal by Subject|0|||
148721486|NCT00868296|536450495|FG001|Overall Study|Withdrawal by Subject|1|||
148721487|NCT02001051|536450498|FG000|Overall Study|Deemed not eligible following enrollment|0|||
148721488|NCT02001051|536450499|FG001|Overall Study|Deemed not eligible following enrollment|1|||
148721489|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
148721490|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
148721491|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
148721492|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
148721493|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
148721494|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
148721495|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148721496|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148721497|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
148721498|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
148721499|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
148721500|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
148721501|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
148721502|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
148721503|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
148721504|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
148721505|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Death|2|||
148721506|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Death|1|||
148721507|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Death|0|||
148721508|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Death|0|||
148721509|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
148721510|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
148721511|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
148721512|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
148721513|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
148721514|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
148721515|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
148721516|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
148721517|NCT03110380|536450502|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
148721518|NCT03110380|536450503|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
148721519|NCT03110380|536450504|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
148721520|NCT03110380|536450505|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
148721521|NCT03110380|536450502|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
148721522|NCT03110380|536450503|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
148721523|NCT03110380|536450504|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
148721524|NCT03110380|536450505|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
148721525|NCT03110380|536450502|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
148721526|NCT03110380|536450503|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
148721527|NCT03110380|536450504|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
148721528|NCT03110380|536450505|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
148721529|NCT03110380|536450502|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
148721530|NCT03110380|536450503|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
148721531|NCT03110380|536450504|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
148721532|NCT03110380|536450505|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
148721533|NCT01546519|536450506|FG000|Overall Study|Adverse Event|0|||
148721534|NCT01546519|536450507|FG001|Overall Study|Adverse Event|0|||
148721535|NCT01546519|536450508|FG002|Overall Study|Adverse Event|1|||
148969573|NCT02917031|537372919|FG001|Overall Study|Physician Decision|0|||
148721536|NCT01546519|536450509|FG003|Overall Study|Adverse Event|1|||
148721537|NCT01546519|536450506|FG000|Overall Study|Death|0|||
148721538|NCT01546519|536450507|FG001|Overall Study|Death|1|||
148721539|NCT01546519|536450508|FG002|Overall Study|Death|3|||
148721540|NCT01546519|536450509|FG003|Overall Study|Death|1|||
148721541|NCT01546519|536450506|FG000|Overall Study|related to disease progression|2|||
148721542|NCT01546519|536450507|FG001|Overall Study|related to disease progression|2|||
148721543|NCT01546519|536450508|FG002|Overall Study|related to disease progression|2|||
148721544|NCT01546519|536450509|FG003|Overall Study|related to disease progression|1|||
148721545|NCT01546519|536450506|FG000|Overall Study|Physician Decision|6|||
148721546|NCT01546519|536450507|FG001|Overall Study|Physician Decision|5|||
148721547|NCT01546519|536450508|FG002|Overall Study|Physician Decision|2|||
148721548|NCT01546519|536450509|FG003|Overall Study|Physician Decision|3|||
148721549|NCT01546519|536450506|FG000|Overall Study|Withdrawal by Subject|1|||
148721550|NCT01546519|536450507|FG001|Overall Study|Withdrawal by Subject|0|||
148721551|NCT01546519|536450508|FG002|Overall Study|Withdrawal by Subject|0|||
148721552|NCT01546519|536450509|FG003|Overall Study|Withdrawal by Subject|0|||
148721553|NCT03750695|536450516|FG000|Overall Study|Lost to Follow-up|0|||
148721554|NCT03750695|536450517|FG001|Overall Study|Lost to Follow-up|1|||
148721555|NCT04480307|536450518|FG000|Overall Study|Withdrawal by Subject|0|||
148721556|NCT04480307|536450519|FG001|Overall Study|Withdrawal by Subject|1|||
148721557|NCT04480307|536450520|FG002|Overall Study|Withdrawal by Subject|0|||
148721558|NCT04480307|536450521|FG003|Overall Study|Withdrawal by Subject|0|||
148721559|NCT04480307|536450518|FG000|Overall Study|Adverse Event|0|||
148721560|NCT04480307|536450519|FG001|Overall Study|Adverse Event|0|||
148721561|NCT04480307|536450520|FG002|Overall Study|Adverse Event|0|||
148721562|NCT04480307|536450521|FG003|Overall Study|Adverse Event|1|||
148721563|NCT00605176|536450524|FG000|Overall Study|Adverse Event|2|||
148721564|NCT00605176|536450525|FG001|Overall Study|Adverse Event|1|||
148721565|NCT00605176|536450526|FG002|Overall Study|Adverse Event|3|||
148721566|NCT00605176|536450524|FG000|Overall Study|Withdrawal by Subject|4|||
148721567|NCT00605176|536450525|FG001|Overall Study|Withdrawal by Subject|2|||
148721568|NCT00605176|536450526|FG002|Overall Study|Withdrawal by Subject|4|||
148721569|NCT00605176|536450524|FG000|Overall Study|Lost to Follow-up|2|||
148721570|NCT00605176|536450525|FG001|Overall Study|Lost to Follow-up|2|||
148721571|NCT00605176|536450526|FG002|Overall Study|Lost to Follow-up|1|||
148721572|NCT00605176|536450524|FG000|Overall Study|Non-complicance with study procedures|1|||
148721573|NCT00605176|536450525|FG001|Overall Study|Non-complicance with study procedures|0|||
148721574|NCT00605176|536450526|FG002|Overall Study|Non-complicance with study procedures|0|||
148721575|NCT00605176|536450524|FG000|Overall Study|Use of concomitant therapy|1|||
148721576|NCT00605176|536450525|FG001|Overall Study|Use of concomitant therapy|0|||
148721577|NCT00605176|536450526|FG002|Overall Study|Use of concomitant therapy|1|||
148721578|NCT00605176|536450524|FG000|Overall Study|Other (not due to AE)|1|||
148721579|NCT00605176|536450525|FG001|Overall Study|Other (not due to AE)|1|||
148721580|NCT00605176|536450526|FG002|Overall Study|Other (not due to AE)|0|||
148721581|NCT01256060|536450527|FG000|Overall Study|Lost to Follow-up|0|||
148721582|NCT01256060|536450528|FG001|Overall Study|Lost to Follow-up|1|||
148721583|NCT01256060|536450529|FG002|Overall Study|Lost to Follow-up|0|||
148721584|NCT01256060|536450530|FG003|Overall Study|Lost to Follow-up|0|||
148721585|NCT00575380|536450535|FG000|Overall Study|Withdrawal by Subject|1|||
148721586|NCT00575380|536450536|FG001|Overall Study|Withdrawal by Subject|0|||
148721587|NCT00575380|536450535|FG000|Overall Study|Adverse Event|0|||
148721588|NCT00575380|536450536|FG001|Overall Study|Adverse Event|1|||
148721589|NCT00575380|536450535|FG000|Overall Study|Various|0|||
148721590|NCT00575380|536450536|FG001|Overall Study|Various|2|||
148721591|NCT01235442|536450537|FG000|Overall Study|Lost to Follow-up|12|||
148721592|NCT01235442|536450538|FG001|Overall Study|Lost to Follow-up|10|||
148721593|NCT01235442|536450537|FG000|Overall Study|Death|0|||
148721594|NCT01235442|536450538|FG001|Overall Study|Death|2|||
148721595|NCT01235442|536450537|FG000|Overall Study|Pregnancy|1|||
148721596|NCT01235442|536450538|FG001|Overall Study|Pregnancy|1|||
148721597|NCT01235442|536450537|FG000|Overall Study|Ineligibility determined|5|||
148721598|NCT01235442|536450538|FG001|Overall Study|Ineligibility determined|4|||
148721599|NCT01235442|536450537|FG000|Overall Study|Protocol Violation|3|||
148721600|NCT01235442|536450538|FG001|Overall Study|Protocol Violation|3|||
148721601|NCT01235442|536450537|FG000|Overall Study|Adverse Event|4|||
148721602|NCT01235442|536450538|FG001|Overall Study|Adverse Event|6|||
148721603|NCT01235442|536450537|FG000|Overall Study|Withdrawal by Subject|15|||
148721604|NCT01235442|536450538|FG001|Overall Study|Withdrawal by Subject|9|||
148969574|NCT02917031|537372920|FG002|Overall Study|Physician Decision|0|||
148721605|NCT01235442|536450537|FG000|Overall Study|Lack of Efficacy|1|||
148721606|NCT01235442|536450538|FG001|Overall Study|Lack of Efficacy|3|||
148721607|NCT01235442|536450537|FG000|Overall Study|Noncompliance|1|||
148721608|NCT01235442|536450538|FG001|Overall Study|Noncompliance|2|||
148721609|NCT01235442|536450537|FG000|Overall Study|Administrative decision|1|||
148721610|NCT01235442|536450538|FG001|Overall Study|Administrative decision|2|||
148721611|NCT01235442|536450537|FG000|Overall Study|Other unspecified|1|||
148969575|NCT02917031|537372918|FG000|Overall Study|Adverse Event|4|||
148721612|NCT01235442|536450538|FG001|Overall Study|Other unspecified|2|||
148721613|NCT02663882|536450539|FG000|Overall Study|Lost to Follow-up|4|||
148721614|NCT02663882|536450540|FG001|Overall Study|Lost to Follow-up|2|||
148721615|NCT04499482|536450545|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
148721616|NCT00869440|536450546|FG000|Overall Study|Withdrawal by Subject|1|||
148721617|NCT00869440|536450547|FG001|Overall Study|Withdrawal by Subject|0|||
148721618|NCT00869440|536450548|FG002|Overall Study|Withdrawal by Subject|0|||
148721619|NCT00869440|536450549|FG003|Overall Study|Withdrawal by Subject|0|||
148721620|NCT00869440|536450546|FG000|Overall Study|Physician Decision|1|||
148721621|NCT00869440|536450547|FG001|Overall Study|Physician Decision|1|||
148721622|NCT00869440|536450548|FG002|Overall Study|Physician Decision|0|||
148721623|NCT00869440|536450549|FG003|Overall Study|Physician Decision|0|||
148721624|NCT00551616|536450550|FG000|Overall Study|Lost to Follow-up|48|||
148721625|NCT00551616|536450551|FG001|Overall Study|Lost to Follow-up|40|||
148721626|NCT03546647|536450552|FG000|Overall Study|Adverse Event|1|||
148721627|NCT03546647|536450553|FG001|Overall Study|Adverse Event|0|||
148721628|NCT00124462|536450554|FG000|Overall Study|Lost to Follow-up|3|||
148721629|NCT00124462|536450555|FG001|Overall Study|Lost to Follow-up|3|||
148721630|NCT00124462|536450554|FG000|Overall Study|Physician Decision|3|||
148721631|NCT00124462|536450555|FG001|Overall Study|Physician Decision|4|||
148721632|NCT00124462|536450554|FG000|Overall Study|Withdrawal by Subject|4|||
148721633|NCT00124462|536450555|FG001|Overall Study|Withdrawal by Subject|5|||
148721634|NCT00124462|536450554|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
148721635|NCT00124462|536450555|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
148721636|NCT03139240|536450556|FG000|Overall Study|Lost to Follow-up|0|||
148721637|NCT03139240|536450557|FG001|Overall Study|Lost to Follow-up|1|||
148721638|NCT03139240|536450558|FG002|Overall Study|Lost to Follow-up|1|||
148721639|NCT03139240|536450559|FG003|Overall Study|Lost to Follow-up|0|||
148721640|NCT03314662|536450560|FG000|Overall Study|Withdrawal by Subject|1|||
148721641|NCT03314662|536450561|FG001|Overall Study|Withdrawal by Subject|1|||
148721642|NCT03314662|536450562|FG002|Overall Study|Withdrawal by Subject|1|||
148721643|NCT03314662|536450560|FG000|Overall Study|Lost to Follow-up|5|||
148721644|NCT03314662|536450561|FG001|Overall Study|Lost to Follow-up|4|||
148721645|NCT03314662|536450562|FG002|Overall Study|Lost to Follow-up|4|||
148721646|NCT03314662|536450560|FG000|Overall Study|Death|2|||
148721647|NCT03314662|536450561|FG001|Overall Study|Death|0|||
148721648|NCT03314662|536450562|FG002|Overall Study|Death|0|||
148721649|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
148721650|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721651|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721652|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721653|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721654|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721655|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721656|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721657|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
148721658|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
148721659|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721660|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721661|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721662|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721663|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721664|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721665|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721666|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
148721667|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
148721668|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721669|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721670|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721671|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721672|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721673|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721674|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721675|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
148721676|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
148721677|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721678|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721679|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721680|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721681|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148969576|NCT02917031|537372919|FG001|Overall Study|Adverse Event|1|||
148969577|NCT02917031|537372920|FG002|Overall Study|Adverse Event|5|||
148969578|NCT02917031|537372918|FG000|Overall Study|Death|2|||
148969579|NCT02917031|537372919|FG001|Overall Study|Death|3|||
148969580|NCT02917031|537372920|FG002|Overall Study|Death|4|||
148969581|NCT01581593|537374639|FG000|Overall Study|Withdrawal by Subject|1|||
148969582|NCT03299842|537374640|FG000|Overall Study|Caregiver withdrew consent|2|||
148969583|NCT03299842|537374640|FG000|Overall Study|Child would not keep the watch on|3|||
148969584|NCT02554656|537374643|FG000|Overall Study|Protocol Violation|3|||
148969585|NCT00358527|537374646|FG000|Overall Study|Adverse Event|4|||
148969586|NCT00358527|537374647|FG001|Overall Study|Adverse Event|0|||
148969587|NCT00358527|537374646|FG000|Overall Study|Withdrawal by Subject|1|||
148969588|NCT00358527|537374647|FG001|Overall Study|Withdrawal by Subject|1|||
148969589|NCT00358527|537374646|FG000|Overall Study|Non-compliance with protocol|6|||
148969590|NCT00358527|537374647|FG001|Overall Study|Non-compliance with protocol|1|||
148969591|NCT00358527|537374646|FG000|Overall Study|Administrative|2|||
148969592|NCT00358527|537374647|FG001|Overall Study|Administrative|1|||
148969593|NCT00749463|537374648|FG000|Overall Study|Adverse Event|0|||
148969594|NCT00749463|537374649|FG001|Overall Study|Adverse Event|4|||
148969595|NCT00749463|537374650|FG002|Overall Study|Adverse Event|1|||
148969596|NCT00749463|537374648|FG000|Overall Study|Withdrawal by Subject|1|||
148969597|NCT00749463|537374649|FG001|Overall Study|Withdrawal by Subject|0|||
148969598|NCT00749463|537374650|FG002|Overall Study|Withdrawal by Subject|0|||
148969599|NCT00913744|537374653|FG000|Overall Study|Adverse Event|2|||
148969600|NCT00913744|537374654|FG001|Overall Study|Adverse Event|0|||
148969601|NCT00913744|537374653|FG000|Overall Study|Withdrawal by Subject|2|||
148969602|NCT00913744|537374654|FG001|Overall Study|Withdrawal by Subject|1|||
148969603|NCT00913744|537374653|FG000|Overall Study|Death|1|||
148969604|NCT00913744|537374654|FG001|Overall Study|Death|0|||
148969605|NCT02433834|537374659|FG000|Overall Study|Protocol-specified criteria|7|||
148969606|NCT02433834|537374659|FG000|Overall Study|Protocol Violation|3|||
148969607|NCT02433834|537374659|FG000|Overall Study|Lost to Follow-up|6|||
148969608|NCT02433834|537374659|FG000|Overall Study|Withdrawal by Subject|14|||
148969609|NCT02433834|537374659|FG000|Overall Study|Adverse Event|6|||
148969610|NCT02433834|537374659|FG000|Overall Study|Physician Decision|1|||
148969611|NCT00302003|537374660|FG000|Overall Study|Lack of Efficacy|62|||
148969612|NCT00302003|537374660|FG000|Overall Study|Lost to Follow-up|1|||
148969613|NCT00302003|537374660|FG000|Overall Study|Physician Decision|2|||
148969614|NCT00302003|537374660|FG000|Overall Study|Withdrawal by Subject|5|||
148969615|NCT00302003|537374660|FG000|Overall Study|Ineligible|9|||
148969616|NCT00302003|537374660|FG000|Overall Study|Protocol Violation|1|||
148721682|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721683|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721684|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
148721685|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
148721686|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721687|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721688|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721689|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721690|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721691|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721692|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721693|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
148721694|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
148721695|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721696|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721697|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721698|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721699|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721700|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721701|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148721702|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
148969617|NCT01539226|537374661|FG000|Overall Study|Withdrawal by Subject|24|||
148969618|NCT01539226|537374662|FG001|Overall Study|Withdrawal by Subject|54|||
148969619|NCT01539226|537374661|FG000|Overall Study|Lost to Follow-up|20|||
148721703|NCT00739973|536450563|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
148969620|NCT01539226|537374662|FG001|Overall Study|Lost to Follow-up|54|||
148969621|NCT01539226|537374661|FG000|Overall Study|Death|1|||
148969622|NCT01539226|537374662|FG001|Overall Study|Death|2|||
148969623|NCT01539226|537374661|FG000|Overall Study|Adverse Event|2|||
148969624|NCT01539226|537374662|FG001|Overall Study|Adverse Event|0|||
148969625|NCT01539226|537374661|FG000|Overall Study|Pregnancy|13|||
148969626|NCT01539226|537374662|FG001|Overall Study|Pregnancy|29|||
148969627|NCT01539226|537374661|FG000|Overall Study|inappropriate enrollment|0|||
148969628|NCT01539226|537374662|FG001|Overall Study|inappropriate enrollment|1|||
148969629|NCT01539226|537374661|FG000|Overall Study|Multiple Reasons|3|||
148969630|NCT01539226|537374662|FG001|Overall Study|Multiple Reasons|1|||
148969631|NCT01539226|537374661|FG000|Overall Study|not HIV seroconversion-related|93|||
148969632|NCT01539226|537374662|FG001|Overall Study|not HIV seroconversion-related|176|||
148969633|NCT01539226|537374661|FG000|Overall Study|HIV seroconversion-related|55|||
148969634|NCT01539226|537374662|FG001|Overall Study|HIV seroconversion-related|80|||
148969635|NCT01539226|537374661|FG000|Overall Study|Non-compliance|6|||
148969636|NCT01539226|537374662|FG001|Overall Study|Non-compliance|8|||
148969637|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
148969638|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
148969639|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
148969640|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
148969641|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
148969642|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
148969643|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
148969644|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
148969645|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
148969646|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
148969647|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
148969648|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
148969649|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
148969650|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
148969651|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
148969652|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
148969653|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
148969654|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
148969655|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
148969656|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
148969657|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
148969658|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
148969659|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
148969660|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
148969661|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
148969662|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
148721704|NCT00739973|536450564|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721705|NCT00739973|536450565|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721706|NCT00739973|536450566|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721707|NCT00739973|536450567|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721708|NCT00739973|536450568|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721709|NCT00739973|536450569|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721710|NCT00739973|536450570|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721711|NCT00739973|536450571|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
148721712|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
148721713|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
148721714|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
148721715|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
148721716|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
148721717|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
148721718|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
148721719|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
148721720|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
148721721|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148721722|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148721723|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148721724|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148721725|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
148721726|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148721727|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148721728|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
148721729|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
148816236|NCT01807520|536802794|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
148816237|NCT01807520|536802795|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
148969663|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
148721730|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
148721731|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
148721732|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721733|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721734|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721735|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721736|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721737|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721738|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
148721739|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
148721740|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
148721741|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
148721742|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
148721743|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
148721744|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
148721745|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
148721746|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
148721747|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
148721748|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721749|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721750|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
148721751|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721752|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721753|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721754|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721755|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721756|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
148721757|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
148721758|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
148721759|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
148721760|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
148721761|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
148721762|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
148721763|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
148721764|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
148721765|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
148721766|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
148721767|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
148721768|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
148721769|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
148721770|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
148721771|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
148721772|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
148721773|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
148721774|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
148721775|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721776|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721777|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148969664|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
148721778|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721779|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721780|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721781|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
148721782|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721783|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
148721784|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
148721785|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
148969665|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
149005473|NCT03217747|537497892|FG000|Overall Study|Toxicity and progression|1|||
148969666|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
148969667|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
148969668|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
148969669|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
148969670|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
148969671|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
148969672|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
148969673|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
148969674|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
148969675|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
148969676|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
148969677|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
148969678|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
148969679|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
148721786|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
148721787|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
148721788|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
148721789|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
148721790|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
148721791|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
148721792|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
148721793|NCT00739973|536450563|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721794|NCT00739973|536450564|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
148721795|NCT00739973|536450565|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721796|NCT00739973|536450566|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721797|NCT00739973|536450567|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721798|NCT00739973|536450568|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721799|NCT00739973|536450569|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
148721800|NCT00739973|536450570|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721801|NCT00739973|536450571|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
148721802|NCT00987831|536450572|FG000|Overall Study|Never flared in 12 months|1|||
148721803|NCT00987831|536450573|FG001|Overall Study|Never flared in 12 months|0|||
148721804|NCT00987831|536450574|FG002|Overall Study|Never flared in 12 months|0|||
148721805|NCT00987831|536450572|FG000|Overall Study|Lost to Follow-up|0|||
148721806|NCT00987831|536450573|FG001|Overall Study|Lost to Follow-up|3|||
148721807|NCT00987831|536450574|FG002|Overall Study|Lost to Follow-up|0|||
148721808|NCT02219308|536450575|FG000|Overall Study|Withdrawal by Subject|1|||
148721809|NCT02219308|536450576|FG001|Overall Study|Withdrawal by Subject|2|||
148721810|NCT02175368|536450577|FG000|Overall Study|Lost to Follow-up|1|||
148721811|NCT02875028|536450578|FG000|Washout Period|Withdrawal by Subject|0|||
148721812|NCT02875028|536450579|FG001|Washout Period|Withdrawal by Subject|1|||
148721813|NCT05068284|536450580|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
148721814|NCT05068284|536450581|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
148721815|NCT05068284|536450582|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
148721816|NCT05068284|536450583|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
148721817|NCT05068284|536450584|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
148721818|NCT05068284|536450585|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
148721819|NCT05068284|536450586|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
148721820|NCT05068284|536450587|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
148721821|NCT05068284|536450580|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721822|NCT05068284|536450581|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721823|NCT05068284|536450582|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
148721824|NCT05068284|536450583|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721825|NCT05068284|536450584|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721826|NCT05068284|536450585|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721827|NCT05068284|536450586|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721828|NCT05068284|536450587|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
148721829|NCT05068284|536450580|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
148721830|NCT05068284|536450581|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
148721831|NCT05068284|536450582|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
148721832|NCT05068284|536450583|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
148721833|NCT05068284|536450584|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
148816238|NCT01807520|536802796|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
148721834|NCT05068284|536450585|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
148721835|NCT05068284|536450586|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
148721836|NCT05068284|536450587|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
148721837|NCT05068284|536450580|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
148721838|NCT05068284|536450581|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
148721839|NCT05068284|536450582|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
148721840|NCT05068284|536450583|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
148721841|NCT05068284|536450584|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
148721842|NCT05068284|536450585|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
148721843|NCT05068284|536450586|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
148721844|NCT05068284|536450587|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
148721845|NCT05068284|536450580|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721846|NCT05068284|536450581|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721847|NCT05068284|536450582|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721848|NCT05068284|536450583|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
148721849|NCT05068284|536450584|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721850|NCT05068284|536450585|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721851|NCT05068284|536450586|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721852|NCT05068284|536450587|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
148721853|NCT05068284|536450580|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
148721854|NCT05068284|536450581|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
148721855|NCT05068284|536450582|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
148721856|NCT05068284|536450583|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
148721857|NCT05068284|536450584|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
148721858|NCT05068284|536450585|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
148721859|NCT05068284|536450586|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
148721860|NCT05068284|536450587|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
148721861|NCT05068284|536450580|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721862|NCT05068284|536450581|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721863|NCT05068284|536450582|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
148721864|NCT05068284|536450583|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721865|NCT05068284|536450584|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721866|NCT05068284|536450585|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721867|NCT05068284|536450586|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721868|NCT05068284|536450587|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
148721869|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
148721870|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721871|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721872|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721873|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721874|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721875|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721876|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
148721877|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
148721878|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
148721879|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
148721880|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
148721881|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
148721882|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
148969680|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
148969681|NCT01218516|537374663|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
148969682|NCT01218516|537374664|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
148969683|NCT01218516|537374665|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
148969684|NCT01218516|537374666|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
148969685|NCT00283439|537374667|FG000|Overall Study|Adverse Event|0|||
148969686|NCT00283439|537374668|FG001|Overall Study|Adverse Event|0|||
148969687|NCT00283439|537374669|FG002|Overall Study|Adverse Event|0|||
148721883|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
148721884|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
148721885|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
148721886|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
148969688|NCT00283439|537374670|FG003|Overall Study|Adverse Event|1|||
148721887|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
148721888|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
148721889|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
148721890|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
148721891|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
148721892|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
148721893|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
148721894|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721895|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721896|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721897|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721898|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721899|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721900|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
148721901|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
148721902|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721903|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721904|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721905|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721906|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721907|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721908|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
148721909|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
148721910|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
148721911|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
148721912|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
148721913|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
148721914|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
148721915|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
148721916|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
148721917|NCT05068284|536450580|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721918|NCT05068284|536450581|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721919|NCT05068284|536450582|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721920|NCT05068284|536450583|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721921|NCT05068284|536450584|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721922|NCT05068284|536450585|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721923|NCT05068284|536450586|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
148721924|NCT05068284|536450587|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
148721925|NCT01989676|536452892|FG000|Overall Study|Death|52|||
148721926|NCT01989676|536452893|FG001|Overall Study|Death|60|||
148721927|NCT01989676|536452892|FG000|Overall Study|Protocol Violation|2|||
148721928|NCT01989676|536452893|FG001|Overall Study|Protocol Violation|1|||
148721929|NCT01989676|536452892|FG000|Overall Study|Lost to Follow-up|8|||
148721930|NCT01989676|536452893|FG001|Overall Study|Lost to Follow-up|18|||
148721931|NCT01989676|536452892|FG000|Overall Study|No longer willing to participate in study|26|||
148721932|NCT01989676|536452893|FG001|Overall Study|No longer willing to participate in study|26|||
148721933|NCT01989676|536452892|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
148721934|NCT01989676|536452893|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
148721935|NCT01989676|536452892|FG000|Overall Study|Other|4|||
148721936|NCT01989676|536452893|FG001|Overall Study|Other|3|||
148721937|NCT00802178|536452894|FG000|Overall Study|Lack of Efficacy|36|||
148721938|NCT00802178|536452894|FG000|Overall Study|Insufficient tolerability (IT)|17|||
148721939|NCT00802178|536452894|FG000|Overall Study|Withdrawal by Subject|18|||
148721940|NCT00802178|536452894|FG000|Overall Study|Other|32|||
148721941|NCT00802178|536452894|FG000|Overall Study|Lack of efficacy and patient wish|1|||
148721942|NCT00802178|536452894|FG000|Overall Study|IT and patient wish|8|||
148721943|NCT00802178|536452894|FG000|Overall Study|Patients wish and other reason|1|||
148721944|NCT01606228|536452895|FG000|Overall Study|Lost to Follow-up|20|||
148721945|NCT01606228|536452895|FG000|Overall Study|Withdrawal by Subject|3|||
148721946|NCT01606228|536452895|FG000|Overall Study|Non-compliant|3|||
148721947|NCT01606228|536452895|FG000|Overall Study|Lack of Efficacy|2|||
148721948|NCT01606228|536452895|FG000|Overall Study|Adverse Event|1|||
148721949|NCT00480324|536452896|FG000|Overall Study|Adverse Event|1|||
148721950|NCT00480324|536452897|FG001|Overall Study|Adverse Event|1|||
148721951|NCT00480324|536452896|FG000|Overall Study|Protocol Violation|0|||
148721952|NCT00480324|536452897|FG001|Overall Study|Protocol Violation|1|||
148721953|NCT00480324|536452896|FG000|Overall Study|Withdrawal by Subject|14|||
148721954|NCT00480324|536452897|FG001|Overall Study|Withdrawal by Subject|5|||
148721955|NCT00480324|536452896|FG000|Overall Study|Lost to Follow-up|17|||
148721956|NCT00480324|536452897|FG001|Overall Study|Lost to Follow-up|8|||
148721957|NCT00480324|536452896|FG000|Overall Study|Subject's mother pregnant|0|||
148721958|NCT00480324|536452897|FG001|Overall Study|Subject's mother pregnant|1|||
148721959|NCT00966381|536452898|FG000|Overall Study|Withdrawal by Subject|2|||
148721960|NCT00966381|536452899|FG001|Overall Study|Withdrawal by Subject|2|||
148721961|NCT02211014|536452900|FG000|Overall Study|Adverse Event|0|||
148721962|NCT02211014|536452901|FG001|Overall Study|Adverse Event|2|||
148721963|NCT02211014|536452900|FG000|Overall Study|Physician Decision|1|||
148721964|NCT02211014|536452901|FG001|Overall Study|Physician Decision|2|||
148721965|NCT02211014|536452900|FG000|Overall Study|Started another cancer therapy|1|||
148721966|NCT02211014|536452901|FG001|Overall Study|Started another cancer therapy|0|||
148721967|NCT02211014|536452900|FG000|Overall Study|Withdrawal by Subject|0|||
148721968|NCT02211014|536452901|FG001|Overall Study|Withdrawal by Subject|1|||
148721969|NCT02211014|536452900|FG000|Overall Study|In agreement with patient, no benefit|0|||
148721970|NCT02211014|536452901|FG001|Overall Study|In agreement with patient, no benefit|1|||
148721971|NCT01124695|536452905|FG000|Overall Study|Disease progression|77|||
148721972|NCT01124695|536452905|FG000|Overall Study|Adverse Event|11|||
148721973|NCT01124695|536452905|FG000|Overall Study|Death|1|||
148721974|NCT01124695|536452905|FG000|Overall Study|Withdrawal by Subject|7|||
148721975|NCT01124695|536452905|FG000|Overall Study|Physician Decision|3|||
148721976|NCT01124695|536452905|FG000|Overall Study|Alternative therapy|9|||
148721977|NCT01124695|536452905|FG000|Overall Study|No documentation that patient went off treatment|4|||
148721978|NCT01124695|536452905|FG000|Overall Study|Ineligible|9|||
148721979|NCT01124695|536452905|FG000|Overall Study|Ineligible and never start treatment|2|||
148721980|NCT02960438|536452906|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
148721981|NCT02960438|536452907|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
148721982|NCT02960438|536452908|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
148721983|NCT02960438|536452909|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
148721984|NCT02960438|536452906|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
148721985|NCT02960438|536452907|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
148721986|NCT02960438|536452908|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
148721987|NCT02960438|536452909|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
148721988|NCT02960438|536452906|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
148721989|NCT02960438|536452907|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
148721990|NCT02960438|536452908|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
148721991|NCT02960438|536452909|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
148721992|NCT02960438|536452906|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
148721993|NCT02960438|536452907|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
148721994|NCT02960438|536452908|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
148721995|NCT02960438|536452909|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
148721996|NCT02960438|536452906|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
148721997|NCT02960438|536452907|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
148721998|NCT02960438|536452908|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
148721999|NCT02960438|536452909|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
148722000|NCT02960438|536452906|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
148722001|NCT02960438|536452907|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
148722002|NCT02960438|536452908|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
148722003|NCT02960438|536452909|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
148722004|NCT02960438|536452906|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
148722005|NCT02960438|536452907|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
148722006|NCT02960438|536452908|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
148722007|NCT02960438|536452909|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
148722008|NCT02960438|536452906|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
148722009|NCT02960438|536452907|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
148722010|NCT02960438|536452908|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
148722011|NCT02960438|536452909|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
148722012|NCT02960438|536452906|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
148722013|NCT02960438|536452907|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
148722014|NCT02960438|536452908|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
148722015|NCT02960438|536452909|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
148722016|NCT02960438|536452906|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
148816239|NCT01807520|536802797|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
148816240|NCT01807520|536802798|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
148722017|NCT02960438|536452907|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
148722018|NCT02960438|536452908|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
148722019|NCT02960438|536452909|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
148722020|NCT02960438|536452906|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
148722021|NCT02960438|536452907|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
148722022|NCT02960438|536452908|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
148722023|NCT02960438|536452909|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
148722024|NCT02960438|536452906|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
148722025|NCT02960438|536452907|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
148722026|NCT02960438|536452908|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
148722027|NCT02960438|536452909|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
148722028|NCT03686150|536452910|FG000|Overall Study|Withdrawal by Subject|1|||
148722029|NCT03686150|536452911|FG001|Overall Study|Withdrawal by Subject|1|||
148722030|NCT03686150|536452912|FG002|Overall Study|Withdrawal by Subject|1|||
148722031|NCT03686150|536452913|FG003|Overall Study|Withdrawal by Subject|0|||
148722032|NCT03686150|536452914|FG004|Overall Study|Withdrawal by Subject|1|||
148722033|NCT03686150|536452915|FG005|Overall Study|Withdrawal by Subject|2|||
148722034|NCT03686150|536452910|FG000|Overall Study|Physician Decision|1|||
148722035|NCT03686150|536452911|FG001|Overall Study|Physician Decision|0|||
148722036|NCT03686150|536452912|FG002|Overall Study|Physician Decision|0|||
148722037|NCT03686150|536452913|FG003|Overall Study|Physician Decision|0|||
148722038|NCT03686150|536452914|FG004|Overall Study|Physician Decision|0|||
148722039|NCT03686150|536452915|FG005|Overall Study|Physician Decision|1|||
148722040|NCT03686150|536452910|FG000|Overall Study|Lost to Follow-up|0|||
148722041|NCT03686150|536452911|FG001|Overall Study|Lost to Follow-up|1|||
148722042|NCT03686150|536452912|FG002|Overall Study|Lost to Follow-up|0|||
148722043|NCT03686150|536452913|FG003|Overall Study|Lost to Follow-up|0|||
148722044|NCT03686150|536452914|FG004|Overall Study|Lost to Follow-up|0|||
148722045|NCT03686150|536452915|FG005|Overall Study|Lost to Follow-up|0|||
148816241|NCT01807520|536802799|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
148816242|NCT01807520|536802793|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
148969689|NCT00283439|537374667|FG000|Overall Study|Death|0|||
148969690|NCT00283439|537374668|FG001|Overall Study|Death|0|||
148969691|NCT00283439|537374669|FG002|Overall Study|Death|1|||
148969692|NCT00283439|537374670|FG003|Overall Study|Death|0|||
148969693|NCT00283439|537374667|FG000|Overall Study|Disease progression|0|||
148969694|NCT00283439|537374668|FG001|Overall Study|Disease progression|1|||
148969695|NCT00283439|537374669|FG002|Overall Study|Disease progression|0|||
148969696|NCT00283439|537374670|FG003|Overall Study|Disease progression|0|||
148969697|NCT00283439|537374667|FG000|Overall Study|Requirement for alternative therapy|1|||
148969698|NCT00283439|537374668|FG001|Overall Study|Requirement for alternative therapy|2|||
148969699|NCT00283439|537374669|FG002|Overall Study|Requirement for alternative therapy|5|||
148969700|NCT00283439|537374670|FG003|Overall Study|Requirement for alternative therapy|2|||
148969701|NCT00283439|537374667|FG000|Overall Study|Stem cell transplant|6|||
148969702|NCT00283439|537374668|FG001|Overall Study|Stem cell transplant|6|||
148969703|NCT00283439|537374669|FG002|Overall Study|Stem cell transplant|4|||
148969704|NCT00283439|537374670|FG003|Overall Study|Stem cell transplant|3|||
148969705|NCT00283439|537374667|FG000|Overall Study|Treatment discontinued|0|||
148969706|NCT00283439|537374668|FG001|Overall Study|Treatment discontinued|2|||
148969707|NCT00283439|537374669|FG002|Overall Study|Treatment discontinued|1|||
148969708|NCT00283439|537374670|FG003|Overall Study|Treatment discontinued|3|||
148969709|NCT00283439|537374667|FG000|Overall Study|Other|1|||
148969710|NCT00283439|537374668|FG001|Overall Study|Other|0|||
148969711|NCT00283439|537374669|FG002|Overall Study|Other|0|||
148969712|NCT00283439|537374670|FG003|Overall Study|Other|0|||
148969713|NCT01632891|537374671|FG000|Overall Study|Lost to Follow-up|0|||
148969714|NCT01632891|537374672|FG001|Overall Study|Lost to Follow-up|1|||
148969715|NCT01632891|537374671|FG000|Overall Study|Withdrawal by Subject|1|||
148969716|NCT01632891|537374672|FG001|Overall Study|Withdrawal by Subject|0|||
148969717|NCT00782210|537374686|FG000|Overall Study|Adverse Event|21|||
148722046|NCT01844531|536452918|FG000|Overall Study|Withdrawal by Subject|0|||
148722047|NCT01844531|536452919|FG001|Overall Study|Withdrawal by Subject|1|||
148722048|NCT01844531|536452920|FG002|Overall Study|Withdrawal by Subject|0|||
148722049|NCT01844531|536452921|FG003|Overall Study|Withdrawal by Subject|0|||
148722050|NCT01613378|536452927|FG000|Overall Study|Lack of Efficacy|13|||
148969718|NCT00782210|537374687|FG001|Overall Study|Adverse Event|17|||
148969719|NCT00782210|537374688|FG002|Overall Study|Adverse Event|16|||
148969720|NCT00782210|537374686|FG000|Overall Study|Lost to Follow-up|2|||
148969721|NCT00782210|537374687|FG001|Overall Study|Lost to Follow-up|1|||
148969722|NCT00782210|537374688|FG002|Overall Study|Lost to Follow-up|2|||
148969723|NCT00782210|537374686|FG000|Overall Study|Withdrawal by Subject|11|||
148969724|NCT00782210|537374687|FG001|Overall Study|Withdrawal by Subject|8|||
148969725|NCT00782210|537374688|FG002|Overall Study|Withdrawal by Subject|11|||
148722051|NCT01613378|536452927|FG000|Overall Study|Adverse Event|11|||
148722052|NCT01613378|536452927|FG000|Overall Study|Withdrawal by Subject|8|||
148722053|NCT01613378|536452927|FG000|Overall Study|Death|2|||
148969726|NCT00782210|537374686|FG000|Overall Study|Non compliance with protocol|0|||
148969727|NCT00782210|537374687|FG001|Overall Study|Non compliance with protocol|3|||
148722054|NCT01613378|536452927|FG000|Overall Study|Lost to Follow-up|1|||
148722055|NCT01613378|536452927|FG000|Overall Study|Other Reason|4|||
148722056|NCT00794417|536452928|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
148722057|NCT00794417|536452929|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
148722058|NCT00794417|536452930|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
148722059|NCT00794417|536452931|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
148722060|NCT00794417|536452928|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
148722061|NCT00794417|536452929|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
148722062|NCT00794417|536452930|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
148722063|NCT00794417|536452931|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
148722064|NCT00794417|536452928|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
148722065|NCT00794417|536452929|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
148722066|NCT00794417|536452930|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
148722067|NCT00794417|536452931|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
148722068|NCT00794417|536452928|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
148722069|NCT00794417|536452929|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
148722070|NCT00794417|536452930|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
148722071|NCT00794417|536452931|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
148722072|NCT00794417|536452928|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
148722073|NCT00794417|536452929|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
148722074|NCT00794417|536452930|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
148722075|NCT00794417|536452931|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
148722076|NCT00794417|536452928|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
148722077|NCT00794417|536452929|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
148722078|NCT00794417|536452930|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
148722079|NCT00794417|536452931|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
148722080|NCT01345318|536452937|FG000|Overall Study|Adverse Event|16|||
148722081|NCT01345318|536452937|FG000|Overall Study|Lack of Efficacy|17|||
148722082|NCT01345318|536452937|FG000|Overall Study|Lost to Follow-up|2|||
148722083|NCT01345318|536452937|FG000|Overall Study|Protocol Violation|1|||
148722084|NCT01345318|536452937|FG000|Overall Study|Withdrawal by Subject|41|||
148722085|NCT01345318|536452937|FG000|Overall Study|Other|3|||
148722086|NCT01239472|536452938|FG000|Overall Study|Withdrawal by Subject|5|||
148722087|NCT01239472|536452939|FG001|Overall Study|Withdrawal by Subject|1|||
148722088|NCT01239472|536452938|FG000|Overall Study|Adverse Event|0|||
148722089|NCT01239472|536452939|FG001|Overall Study|Adverse Event|1|||
148722090|NCT01239472|536452938|FG000|Overall Study|Lack of Efficacy|0|||
148722091|NCT01239472|536452939|FG001|Overall Study|Lack of Efficacy|1|||
148722092|NCT00418522|536452940|FG000|Overall Study|Adverse Event|7|||
148722093|NCT00418522|536452941|FG001|Overall Study|Adverse Event|1|||
148722094|NCT00418522|536452940|FG000|Overall Study|Lack of Efficacy|1|||
148722095|NCT00418522|536452941|FG001|Overall Study|Lack of Efficacy|3|||
148722096|NCT00418522|536452940|FG000|Overall Study|Lost to Follow-up|10|||
148722097|NCT00418522|536452941|FG001|Overall Study|Lost to Follow-up|4|||
148722098|NCT00418522|536452940|FG000|Overall Study|Withdrawal by Subject|31|||
148722099|NCT00418522|536452941|FG001|Overall Study|Withdrawal by Subject|7|||
148722100|NCT00418522|536452940|FG000|Overall Study|Other|27|||
148722101|NCT00418522|536452941|FG001|Overall Study|Other|23|||
148722102|NCT00418522|536452940|FG000|Overall Study|Randomized but did not receive treatment|7|||
148722103|NCT00418522|536452941|FG001|Overall Study|Randomized but did not receive treatment|4|||
148722104|NCT02695719|536452942|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
148722105|NCT02695719|536452943|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
148722106|NCT02695719|536452942|FG000|Overall Study|Significant Protocol Deviation|0|||
148722107|NCT02695719|536452943|FG001|Overall Study|Significant Protocol Deviation|1|||
148722108|NCT02695719|536452942|FG000|Overall Study|Voluntary Withdrawal|1|||
148722109|NCT02695719|536452943|FG001|Overall Study|Voluntary Withdrawal|0|||
148722110|NCT01652729|536452946|FG000|Overall Study|Withdrawal by Subject|14|||
148722111|NCT01652729|536452947|FG001|Overall Study|Withdrawal by Subject|7|||
148722112|NCT01652729|536452948|FG002|Overall Study|Withdrawal by Subject|7|||
148722113|NCT01652729|536452946|FG000|Overall Study|Adverse Event|4|||
148722114|NCT01652729|536452947|FG001|Overall Study|Adverse Event|0|||
148969728|NCT00782210|537374688|FG002|Overall Study|Non compliance with protocol|2|||
148722115|NCT01652729|536452948|FG002|Overall Study|Adverse Event|3|||
148722116|NCT01652729|536452946|FG000|Overall Study|Physician Decision|1|||
148722117|NCT01652729|536452947|FG001|Overall Study|Physician Decision|0|||
148722118|NCT01652729|536452948|FG002|Overall Study|Physician Decision|1|||
148969729|NCT00782210|537374686|FG000|Overall Study|Lack of Efficacy|13|||
148969730|NCT00782210|537374687|FG001|Overall Study|Lack of Efficacy|4|||
148969731|NCT00782210|537374688|FG002|Overall Study|Lack of Efficacy|1|||
148722119|NCT01652729|536452946|FG000|Overall Study|Protocol Violation|1|||
148969732|NCT00782210|537374686|FG000|Overall Study|Other reason not described above|3|||
148722120|NCT01652729|536452947|FG001|Overall Study|Protocol Violation|0|||
148722121|NCT01652729|536452948|FG002|Overall Study|Protocol Violation|0|||
148722122|NCT01652729|536452946|FG000|Overall Study|Lost to Follow-up|6|||
148722123|NCT01652729|536452947|FG001|Overall Study|Lost to Follow-up|6|||
148722124|NCT01652729|536452948|FG002|Overall Study|Lost to Follow-up|3|||
148722125|NCT01652729|536452946|FG000|Overall Study|Administrative|1|||
148722126|NCT01652729|536452947|FG001|Overall Study|Administrative|0|||
148722127|NCT01652729|536452948|FG002|Overall Study|Administrative|0|||
148722128|NCT00483548|536452949|FG000|Overall Study|Randomized; not treated with study drug|1|||
148722129|NCT00483548|536452950|FG001|Overall Study|Randomized; not treated with study drug|3|||
148722130|NCT00483548|536452949|FG000|Overall Study|Adverse Event|25|||
148722131|NCT00483548|536452950|FG001|Overall Study|Adverse Event|14|||
148722132|NCT00483548|536452949|FG000|Overall Study|Laboratory abnormality|1|||
148722133|NCT00483548|536452950|FG001|Overall Study|Laboratory abnormality|2|||
148722134|NCT00483548|536452949|FG000|Overall Study|Lack of Efficacy|4|||
148722135|NCT00483548|536452950|FG001|Overall Study|Lack of Efficacy|8|||
148722136|NCT00483548|536452949|FG000|Overall Study|Protocol Violation|11|||
148722137|NCT00483548|536452950|FG001|Overall Study|Protocol Violation|7|||
148722138|NCT00483548|536452949|FG000|Overall Study|Pregnancy|1|||
148722139|NCT00483548|536452950|FG001|Overall Study|Pregnancy|0|||
148722140|NCT00483548|536452949|FG000|Overall Study|Protocol required discontinuation|6|||
148722141|NCT00483548|536452950|FG001|Overall Study|Protocol required discontinuation|6|||
148722142|NCT00483548|536452949|FG000|Overall Study|Unable to comply with protocol schedule|1|||
148722143|NCT00483548|536452950|FG001|Overall Study|Unable to comply with protocol schedule|0|||
148722144|NCT00483548|536452949|FG000|Overall Study|Non-compliance with medication|2|||
148722145|NCT00483548|536452950|FG001|Overall Study|Non-compliance with medication|0|||
148722146|NCT00483548|536452949|FG000|Overall Study|Lost to Follow-up|3|||
148722147|NCT00483548|536452950|FG001|Overall Study|Lost to Follow-up|4|||
148722148|NCT00483548|536452949|FG000|Overall Study|Withdrawal by Subject|5|||
148722149|NCT00483548|536452950|FG001|Overall Study|Withdrawal by Subject|2|||
148722150|NCT05966090|536452956|FG000|Overall Study|Lost to Follow-up|6|||
148722151|NCT05966090|536452957|FG001|Overall Study|Lost to Follow-up|6|||
148722152|NCT05966090|536452956|FG000|Overall Study|Adverse Event|1|||
148722153|NCT05966090|536452957|FG001|Overall Study|Adverse Event|1|||
148722154|NCT05966090|536452956|FG000|Overall Study|Withdrawal by Subject|1|||
148722155|NCT05966090|536452957|FG001|Overall Study|Withdrawal by Subject|1|||
148722156|NCT05966090|536452956|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148722157|NCT05966090|536452957|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
148722158|NCT05966090|536452956|FG000|Overall Study|Other|1|||
148722159|NCT05966090|536452957|FG001|Overall Study|Other|1|||
148722160|NCT00804141|536452958|FG000|Overall Study|Adverse Event|157|||
148722161|NCT00804141|536452958|FG000|Overall Study|Death|4|||
148722162|NCT00804141|536452958|FG000|Overall Study|Failed to return|96|||
148722163|NCT00804141|536452958|FG000|Overall Study|Investigator request|8|||
148722164|NCT00804141|536452958|FG000|Overall Study|Protocol Violation|85|||
148722165|NCT00804141|536452958|FG000|Overall Study|Withdrawal by Subject|131|||
148722166|NCT00804141|536452958|FG000|Overall Study|Lack of Efficacy|46|||
148722167|NCT00804141|536452958|FG000|Overall Study|Other than specified|30|||
148722168|NCT00804141|536452958|FG000|Overall Study|Enrolled but not treated|6|||
148969733|NCT00782210|537374687|FG001|Overall Study|Other reason not described above|2|||
148969734|NCT00782210|537374688|FG002|Overall Study|Other reason not described above|3|||
148969735|NCT00436748|537374693|FG000|Overall Study|Ineligibility Determined|1|||
148722187|NCT01714739|536452971|FG000|Overall Study|Disease progression|3|||
148722188|NCT01714739|536452972|FG001|Overall Study|Disease progression|5|||
148722189|NCT01714739|536452973|FG002|Overall Study|Disease progression|5|||
148722190|NCT01714739|536452974|FG003|Overall Study|Disease progression|204|||
148722191|NCT01714739|536452975|FG004|Overall Study|Disease progression|1|||
148722192|NCT01714739|536452976|FG005|Overall Study|Disease progression|3|||
148722193|NCT01714739|536452977|FG006|Overall Study|Disease progression|5|||
148722194|NCT01714739|536452971|FG000|Overall Study|Study drug toxicity|1|||
148816243|NCT01807520|536802794|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
148722195|NCT01714739|536452972|FG001|Overall Study|Study drug toxicity|1|||
148722196|NCT01714739|536452973|FG002|Overall Study|Study drug toxicity|1|||
148722197|NCT01714739|536452974|FG003|Overall Study|Study drug toxicity|15|||
148722198|NCT01714739|536452975|FG004|Overall Study|Study drug toxicity|0|||
148722199|NCT01714739|536452976|FG005|Overall Study|Study drug toxicity|0|||
148722200|NCT01714739|536452977|FG006|Overall Study|Study drug toxicity|5|||
148722201|NCT01714739|536452971|FG000|Overall Study|Death|0|||
148722202|NCT01714739|536452972|FG001|Overall Study|Death|0|||
148722203|NCT01714739|536452973|FG002|Overall Study|Death|0|||
148722204|NCT01714739|536452974|FG003|Overall Study|Death|1|||
148722205|NCT01714739|536452975|FG004|Overall Study|Death|0|||
148722206|NCT01714739|536452976|FG005|Overall Study|Death|0|||
148722207|NCT01714739|536452977|FG006|Overall Study|Death|0|||
148722208|NCT01714739|536452971|FG000|Overall Study|Adverse Event unrelated to drug|0|||
148722209|NCT01714739|536452972|FG001|Overall Study|Adverse Event unrelated to drug|0|||
148722210|NCT01714739|536452973|FG002|Overall Study|Adverse Event unrelated to drug|3|||
148722211|NCT01714739|536452974|FG003|Overall Study|Adverse Event unrelated to drug|21|||
148722212|NCT01714739|536452975|FG004|Overall Study|Adverse Event unrelated to drug|0|||
148722213|NCT01714739|536452976|FG005|Overall Study|Adverse Event unrelated to drug|0|||
148722214|NCT01714739|536452977|FG006|Overall Study|Adverse Event unrelated to drug|0|||
148722215|NCT01714739|536452971|FG000|Overall Study|Participant request to stop therapy|0|||
148722216|NCT01714739|536452972|FG001|Overall Study|Participant request to stop therapy|1|||
148722217|NCT01714739|536452973|FG002|Overall Study|Participant request to stop therapy|0|||
148722218|NCT01714739|536452974|FG003|Overall Study|Participant request to stop therapy|6|||
148722219|NCT01714739|536452975|FG004|Overall Study|Participant request to stop therapy|0|||
148722220|NCT01714739|536452976|FG005|Overall Study|Participant request to stop therapy|0|||
148722221|NCT01714739|536452977|FG006|Overall Study|Participant request to stop therapy|0|||
148722222|NCT01714739|536452971|FG000|Overall Study|Participant withdrew consent|0|||
148722223|NCT01714739|536452972|FG001|Overall Study|Participant withdrew consent|1|||
148722224|NCT01714739|536452973|FG002|Overall Study|Participant withdrew consent|0|||
148722225|NCT01714739|536452974|FG003|Overall Study|Participant withdrew consent|8|||
148722226|NCT01714739|536452975|FG004|Overall Study|Participant withdrew consent|0|||
148722227|NCT01714739|536452976|FG005|Overall Study|Participant withdrew consent|0|||
148722228|NCT01714739|536452977|FG006|Overall Study|Participant withdrew consent|0|||
148722229|NCT01714739|536452971|FG000|Overall Study|Lost to Follow-up|0|||
148722230|NCT01714739|536452972|FG001|Overall Study|Lost to Follow-up|0|||
148722231|NCT01714739|536452973|FG002|Overall Study|Lost to Follow-up|0|||
148722232|NCT01714739|536452974|FG003|Overall Study|Lost to Follow-up|1|||
148722233|NCT01714739|536452975|FG004|Overall Study|Lost to Follow-up|0|||
148722234|NCT01714739|536452976|FG005|Overall Study|Lost to Follow-up|0|||
148722235|NCT01714739|536452977|FG006|Overall Study|Lost to Follow-up|0|||
148722236|NCT01714739|536452971|FG000|Overall Study|Maximum clinical benefit|0|||
148722237|NCT01714739|536452972|FG001|Overall Study|Maximum clinical benefit|1|||
148722238|NCT01714739|536452973|FG002|Overall Study|Maximum clinical benefit|1|||
148722239|NCT01714739|536452974|FG003|Overall Study|Maximum clinical benefit|3|||
148722240|NCT01714739|536452975|FG004|Overall Study|Maximum clinical benefit|0|||
148722241|NCT01714739|536452976|FG005|Overall Study|Maximum clinical benefit|0|||
148722242|NCT01714739|536452977|FG006|Overall Study|Maximum clinical benefit|0|||
148722243|NCT01714739|536452971|FG000|Overall Study|Poor/non-comliance|0|||
148722244|NCT01714739|536452972|FG001|Overall Study|Poor/non-comliance|1|||
148722245|NCT01714739|536452973|FG002|Overall Study|Poor/non-comliance|0|||
148722246|NCT01714739|536452974|FG003|Overall Study|Poor/non-comliance|1|||
148722247|NCT01714739|536452975|FG004|Overall Study|Poor/non-comliance|0|||
148722248|NCT01714739|536452976|FG005|Overall Study|Poor/non-comliance|0|||
148722249|NCT01714739|536452977|FG006|Overall Study|Poor/non-comliance|0|||
148722250|NCT01714739|536452971|FG000|Overall Study|No longer meets study criteria|0|||
148722251|NCT01714739|536452972|FG001|Overall Study|No longer meets study criteria|0|||
148722252|NCT01714739|536452973|FG002|Overall Study|No longer meets study criteria|0|||
148722253|NCT01714739|536452974|FG003|Overall Study|No longer meets study criteria|1|||
148722254|NCT01714739|536452975|FG004|Overall Study|No longer meets study criteria|0|||
148722255|NCT01714739|536452976|FG005|Overall Study|No longer meets study criteria|0|||
148722256|NCT01714739|536452977|FG006|Overall Study|No longer meets study criteria|0|||
148722257|NCT01714739|536452971|FG000|Overall Study|Other reason|0|||
148722258|NCT01714739|536452972|FG001|Overall Study|Other reason|0|||
148722259|NCT01714739|536452973|FG002|Overall Study|Other reason|0|||
148722260|NCT01714739|536452974|FG003|Overall Study|Other reason|3|||
148722261|NCT01714739|536452975|FG004|Overall Study|Other reason|1|||
148722262|NCT01714739|536452976|FG005|Overall Study|Other reason|0|||
148816244|NCT01807520|536802795|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
148816245|NCT01807520|536802796|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
148722263|NCT01714739|536452977|FG006|Overall Study|Other reason|0|||
148722264|NCT00707434|536452980|FG000|Overall Study|Adverse Event|1|||
148722265|NCT03585959|536452981|FG000|Overall Study|Physician Decision|1|||
148722266|NCT03585959|536452981|FG000|Overall Study|Unsuccessful Procedure|2|||
148722267|NCT02531594|536452982|FG000|Overall Study|Withdrawal by Subject|7|||
148969736|NCT00436748|537374694|FG001|Overall Study|Ineligibility Determined|1|||
148722268|NCT02531594|536452983|FG001|Overall Study|Withdrawal by Subject|8|||
148722269|NCT00614822|536452984|FG000|Overall Study|Adverse Event|3|||
148722270|NCT02359864|536452986|FG000|Overall Study|Withdrawal by Subject|1|||
148722271|NCT02359864|536452987|FG001|Overall Study|Withdrawal by Subject|0|||
148722272|NCT00725764|536452988|FG000|Overall Study|Withdrawal by Subject|2|||
148722273|NCT00725764|536452988|FG000|Overall Study|Physician Decision|1|||
148722274|NCT00725764|536452988|FG000|Overall Study|Progressive Disease|7|||
148722275|NCT00725764|536452988|FG000|Overall Study|Lost to Follow-up|1|||
148722276|NCT00725764|536452988|FG000|Overall Study|Death|1|||
148722277|NCT00725764|536452988|FG000|Overall Study|Participant non compliant with protocol|1|||
148722278|NCT00725764|536452988|FG000|Overall Study|Decline in performance status|1|||
148722279|NCT01857206|536453002|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
148722280|NCT01857206|536453003|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
148722281|NCT01857206|536453002|FG000|Overall Study|Lost to Follow-up|9|||
148722282|NCT01857206|536453003|FG001|Overall Study|Lost to Follow-up|6|||
148722283|NCT01857206|536453002|FG000|Overall Study|Unclassified|3|||
148722284|NCT01857206|536453003|FG001|Overall Study|Unclassified|3|||
148722285|NCT01857206|536453002|FG000|Overall Study|Withdrawal by Subject|1|||
148722286|NCT01857206|536453003|FG001|Overall Study|Withdrawal by Subject|0|||
148722287|NCT00559364|536453011|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
148722288|NCT00559364|536453012|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
148722289|NCT04126343|536453013|FG000|Overall Study|Adverse Event|0|||
148722290|NCT04126343|536453014|FG001|Overall Study|Adverse Event|0|||
148722291|NCT04126343|536453015|FG002|Overall Study|Adverse Event|0|||
148722292|NCT04126343|536453016|FG003|Overall Study|Adverse Event|0|||
148722293|NCT04126343|536453017|FG004|Overall Study|Adverse Event|0|||
148722294|NCT04126343|536453018|FG005|Overall Study|Adverse Event|1|||
148722295|NCT04126343|536453013|FG000|Overall Study|Withdrawal by Subject|0|||
148722296|NCT04126343|536453014|FG001|Overall Study|Withdrawal by Subject|0|||
148722297|NCT04126343|536453015|FG002|Overall Study|Withdrawal by Subject|0|||
148722298|NCT04126343|536453016|FG003|Overall Study|Withdrawal by Subject|1|||
148722299|NCT04126343|536453017|FG004|Overall Study|Withdrawal by Subject|0|||
148722300|NCT04126343|536453018|FG005|Overall Study|Withdrawal by Subject|0|||
148722301|NCT04126343|536453013|FG000|Overall Study|Related to COVID-19 pandemic|3|||
148722302|NCT04126343|536453014|FG001|Overall Study|Related to COVID-19 pandemic|4|||
148722303|NCT04126343|536453015|FG002|Overall Study|Related to COVID-19 pandemic|3|||
148722304|NCT04126343|536453016|FG003|Overall Study|Related to COVID-19 pandemic|3|||
148722305|NCT04126343|536453017|FG004|Overall Study|Related to COVID-19 pandemic|3|||
148722306|NCT04126343|536453018|FG005|Overall Study|Related to COVID-19 pandemic|3|||
148722307|NCT01857973|536453023|FG000|Overall Study|Subject did not meet required BG range|3|||
148722308|NCT01857973|536453023|FG000|Overall Study|drop out after 3 failed attempts|1|||
148722309|NCT01857973|536453023|FG000|Overall Study|Physician Decision|1|||
148722310|NCT01701973|536453024|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722311|NCT01701973|536453025|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
148722312|NCT01701973|536453026|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722313|NCT01701973|536453027|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722314|NCT01701973|536453028|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722315|NCT01701973|536453029|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722316|NCT01701973|536453030|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722317|NCT01701973|536453031|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
148722318|NCT02412722|536453036|FG000|Overall Study|Adverse Event|0|||
148722319|NCT02412722|536453037|FG001|Overall Study|Adverse Event|2|||
148722320|NCT02412722|536453038|FG002|Overall Study|Adverse Event|0|||
148722321|NCT02412722|536453039|FG003|Overall Study|Adverse Event|3|||
148722322|NCT02412722|536453040|FG004|Overall Study|Adverse Event|0|||
148722323|NCT02412722|536453041|FG005|Overall Study|Adverse Event|3|||
148722324|NCT02412722|536453036|FG000|Overall Study|Progressive Disease|6|||
148722325|NCT02412722|536453037|FG001|Overall Study|Progressive Disease|4|||
148722326|NCT02412722|536453038|FG002|Overall Study|Progressive Disease|4|||
148722327|NCT02412722|536453039|FG003|Overall Study|Progressive Disease|9|||
148722328|NCT02412722|536453040|FG004|Overall Study|Progressive Disease|3|||
148722329|NCT02412722|536453041|FG005|Overall Study|Progressive Disease|3|||
148722330|NCT02412722|536453036|FG000|Overall Study|Withdrawal by Subject|2|||
148969737|NCT00436748|537374693|FG000|Overall Study|Adverse Event|0|||
148969738|NCT00436748|537374694|FG001|Overall Study|Adverse Event|2|||
148722331|NCT02412722|536453037|FG001|Overall Study|Withdrawal by Subject|0|||
148722332|NCT02412722|536453038|FG002|Overall Study|Withdrawal by Subject|1|||
148722333|NCT02412722|536453039|FG003|Overall Study|Withdrawal by Subject|2|||
148722334|NCT02412722|536453040|FG004|Overall Study|Withdrawal by Subject|1|||
148722335|NCT02412722|536453041|FG005|Overall Study|Withdrawal by Subject|1|||
148722336|NCT02412722|536453036|FG000|Overall Study|Lost to Follow-up|0|||
148722337|NCT02412722|536453037|FG001|Overall Study|Lost to Follow-up|0|||
148722338|NCT02412722|536453038|FG002|Overall Study|Lost to Follow-up|0|||
148722339|NCT02412722|536453039|FG003|Overall Study|Lost to Follow-up|0|||
148722340|NCT02412722|536453040|FG004|Overall Study|Lost to Follow-up|1|||
148722341|NCT02412722|536453041|FG005|Overall Study|Lost to Follow-up|0|||
148722342|NCT02412722|536453036|FG000|Overall Study|Received drug in run-in and discontinued|0|||
148722343|NCT02412722|536453037|FG001|Overall Study|Received drug in run-in and discontinued|2|||
148722344|NCT02412722|536453038|FG002|Overall Study|Received drug in run-in and discontinued|0|||
148722345|NCT02412722|536453039|FG003|Overall Study|Received drug in run-in and discontinued|0|||
148722346|NCT02412722|536453040|FG004|Overall Study|Received drug in run-in and discontinued|0|||
148722347|NCT02412722|536453041|FG005|Overall Study|Received drug in run-in and discontinued|0|||
148722348|NCT02412722|536453036|FG000|Overall Study|Reason not Specified|3|||
148722349|NCT02412722|536453037|FG001|Overall Study|Reason not Specified|0|||
148722350|NCT02412722|536453038|FG002|Overall Study|Reason not Specified|2|||
148722351|NCT02412722|536453039|FG003|Overall Study|Reason not Specified|1|||
148722352|NCT02412722|536453040|FG004|Overall Study|Reason not Specified|2|||
148722353|NCT02412722|536453041|FG005|Overall Study|Reason not Specified|6|||
148722354|NCT04449341|536453042|FG000|Overall Study|Protocol Violation|1|||
148722355|NCT04449341|536453043|FG001|Overall Study|Protocol Violation|0|||
148722356|NCT02400476|536453047|FG000|Overall Study|Adverse Event|57|||
148722357|NCT02400476|536453048|FG001|Overall Study|Adverse Event|10|||
148722358|NCT02400476|536453049|FG002|Overall Study|Adverse Event|22|||
148722359|NCT02400476|536453050|FG003|Overall Study|Adverse Event|19|||
148722360|NCT02400476|536453051|FG004|Overall Study|Adverse Event|5|||
148722361|NCT02400476|536453052|FG005|Overall Study|Adverse Event|8|||
148722362|NCT02400476|536453047|FG000|Overall Study|Withdrawal by Subject|4|||
148722363|NCT02400476|536453048|FG001|Overall Study|Withdrawal by Subject|1|||
148722364|NCT02400476|536453049|FG002|Overall Study|Withdrawal by Subject|12|||
148722365|NCT02400476|536453050|FG003|Overall Study|Withdrawal by Subject|7|||
148722366|NCT02400476|536453051|FG004|Overall Study|Withdrawal by Subject|5|||
148722367|NCT02400476|536453052|FG005|Overall Study|Withdrawal by Subject|5|||
148722368|NCT02400476|536453047|FG000|Overall Study|Lost to Follow-up|0|||
148722369|NCT02400476|536453048|FG001|Overall Study|Lost to Follow-up|0|||
148722370|NCT02400476|536453049|FG002|Overall Study|Lost to Follow-up|0|||
148722371|NCT02400476|536453050|FG003|Overall Study|Lost to Follow-up|1|||
148722372|NCT02400476|536453051|FG004|Overall Study|Lost to Follow-up|3|||
148722373|NCT02400476|536453052|FG005|Overall Study|Lost to Follow-up|1|||
148722374|NCT02400476|536453047|FG000|Overall Study|Physician Decision|0|||
148722375|NCT02400476|536453048|FG001|Overall Study|Physician Decision|0|||
148722376|NCT02400476|536453049|FG002|Overall Study|Physician Decision|1|||
148722377|NCT02400476|536453050|FG003|Overall Study|Physician Decision|1|||
148722378|NCT02400476|536453051|FG004|Overall Study|Physician Decision|0|||
148722379|NCT02400476|536453052|FG005|Overall Study|Physician Decision|1|||
148722380|NCT02400476|536453047|FG000|Overall Study|Other, Disease Progression|0|||
148722381|NCT02400476|536453048|FG001|Overall Study|Other, Disease Progression|1|||
148722382|NCT02400476|536453049|FG002|Overall Study|Other, Disease Progression|2|||
148722383|NCT02400476|536453050|FG003|Overall Study|Other, Disease Progression|1|||
148722384|NCT02400476|536453051|FG004|Overall Study|Other, Disease Progression|2|||
148722385|NCT02400476|536453052|FG005|Overall Study|Other, Disease Progression|1|||
148722386|NCT02400476|536453047|FG000|Overall Study|Other, Decreased Quality of Life|0|||
148722387|NCT02400476|536453048|FG001|Overall Study|Other, Decreased Quality of Life|0|||
148722388|NCT02400476|536453049|FG002|Overall Study|Other, Decreased Quality of Life|2|||
148722389|NCT02400476|536453050|FG003|Overall Study|Other, Decreased Quality of Life|0|||
148722390|NCT02400476|536453051|FG004|Overall Study|Other, Decreased Quality of Life|0|||
148722391|NCT02400476|536453052|FG005|Overall Study|Other, Decreased Quality of Life|0|||
148722392|NCT02400476|536453047|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
148722393|NCT02400476|536453048|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
148722394|NCT02400476|536453049|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
148816246|NCT01807520|536802797|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
148816247|NCT01807520|536802798|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
148816248|NCT01807520|536802799|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
148816249|NCT01500096|536802800|FG000|Overall Study|Lost to Follow-up|1|||
148816250|NCT01500096|536802801|FG001|Overall Study|Lost to Follow-up|0|||
148816251|NCT01500096|536802802|FG002|Overall Study|Lost to Follow-up|0|||
148816252|NCT01500096|536802803|FG003|Overall Study|Lost to Follow-up|2|||
148816253|NCT00639379|536802804|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
148722395|NCT02400476|536453050|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
148722396|NCT02400476|536453051|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
148722397|NCT02400476|536453052|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
148722398|NCT02487082|536453053|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
148722399|NCT02487082|536453054|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
148722400|NCT02487082|536453053|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
148722401|NCT02487082|536453054|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
148816254|NCT00639379|536802805|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
148722402|NCT03297294|536453055|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
148816255|NCT00639379|536802804|FG000|Period 1 - 2 Weeks|lens issue|3|||
148816256|NCT00639379|536802805|FG001|Period 1 - 2 Weeks|lens issue|0|||
148816257|NCT03298061|536802808|FG000|Overall Study|Adverse Event|3|||
148722403|NCT03297294|536453056|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
148722404|NCT03297294|536453057|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
148722405|NCT03297294|536453058|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
148722406|NCT03297294|536453059|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
148722407|NCT03297294|536453055|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
148722408|NCT03297294|536453056|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
148722409|NCT03297294|536453057|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
148722410|NCT03297294|536453058|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
148722411|NCT03297294|536453059|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
148722412|NCT03297294|536453055|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
148722413|NCT03297294|536453056|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
148722414|NCT03297294|536453057|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
148722415|NCT03297294|536453058|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
148722416|NCT03297294|536453059|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
148722417|NCT03297294|536453055|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
148722418|NCT03297294|536453056|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
148722419|NCT03297294|536453057|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
148722420|NCT03297294|536453058|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
148722421|NCT03297294|536453059|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
148722422|NCT03297294|536453055|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
148722423|NCT03297294|536453056|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
148722424|NCT03297294|536453057|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
148722425|NCT03297294|536453058|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
148722426|NCT03297294|536453059|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
148722427|NCT02692482|536453066|FG000|Overall Study|Death|2|||
148722428|NCT02692482|536453067|FG001|Overall Study|Death|2|||
148722429|NCT02692482|536453066|FG000|Overall Study|Withdrawal by Subject|1|||
148722430|NCT02692482|536453067|FG001|Overall Study|Withdrawal by Subject|2|||
148722431|NCT01610063|536453070|FG000|Overall Study|Lost to Follow-up|42|||
148722432|NCT01610063|536453071|FG001|Overall Study|Lost to Follow-up|20|||
148722433|NCT03043560|536453078|FG000|Overall Study|Discontinued Intervention|1|||
148722434|NCT03043560|536453079|FG001|Overall Study|Discontinued Intervention|2|||
148722435|NCT03043560|536453078|FG000|Overall Study|Lost to Follow-up|0|||
148722436|NCT03043560|536453079|FG001|Overall Study|Lost to Follow-up|1|||
148722437|NCT00438659|536453080|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
148722438|NCT00438659|536453081|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
148722439|NCT00438659|536453080|FG000|Overall Study|Cancel|5|||
148722440|NCT00438659|536453081|FG001|Overall Study|Cancel|2|||
148816258|NCT03298061|536802808|FG000|Overall Study|Lack of Efficacy|6|||
148816259|NCT03298061|536802808|FG000|Overall Study|Protocol Violation|1|||
148816260|NCT03298061|536802808|FG000|Overall Study|Physician Decision|7|||
148816261|NCT03298061|536802808|FG000|Overall Study|Withdrawal by Subject|10|||
148816262|NCT00992836|536802814|FG000|Overall Study|Lost to Follow-up|1|||
148816263|NCT00992836|536802814|FG000|Overall Study|Withdrawal by Subject|2|||
148816264|NCT00992836|536802814|FG000|Overall Study|Protocol Violation|2|||
148816265|NCT01617967|536802816|FG000|Overall Study|Protocol Violation|0|||
148816266|NCT01617967|536802817|FG001|Overall Study|Protocol Violation|0|||
148816267|NCT01617967|536802818|FG002|Overall Study|Protocol Violation|0|||
148816268|NCT01617967|536802819|FG003|Overall Study|Protocol Violation|1|||
148816269|NCT01617967|536802820|FG004|Overall Study|Protocol Violation|0|||
148816270|NCT01617967|536802821|FG005|Overall Study|Protocol Violation|0|||
148816271|NCT01617967|536802816|FG000|Overall Study|Withdrawal by Subject|0|||
148816272|NCT01617967|536802817|FG001|Overall Study|Withdrawal by Subject|0|||
148816273|NCT01617967|536802818|FG002|Overall Study|Withdrawal by Subject|0|||
148816274|NCT01617967|536802819|FG003|Overall Study|Withdrawal by Subject|0|||
148816275|NCT01617967|536802820|FG004|Overall Study|Withdrawal by Subject|0|||
148816276|NCT01617967|536802821|FG005|Overall Study|Withdrawal by Subject|1|||
148816277|NCT01617967|536802816|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
148816278|NCT01617967|536802817|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
148816279|NCT01617967|536802818|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
148816280|NCT01617967|536802819|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
148816281|NCT01617967|536802820|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
148816282|NCT01617967|536802821|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
148816283|NCT02536794|536802822|FG000|Reached 1st Response Assessment|Adverse Event|2|||
148816284|NCT02536794|536802822|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
148816285|NCT02536794|536802822|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
148816286|NCT02536794|536802822|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
148816287|NCT02536794|536802822|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
148816288|NCT02536794|536802822|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
148816289|NCT00800540|536802827|FG000|Period One: 6 Weeks|Noncompliance|1|||
148816290|NCT00800540|536802828|FG001|Period One: 6 Weeks|Noncompliance|0|||
148816291|NCT00800540|536802827|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
148722441|NCT01867606|536453082|FG000|Overall Study|Withdrawal by Subject|10|||
148722442|NCT01867606|536453083|FG001|Overall Study|Withdrawal by Subject|14|||
148722443|NCT01867606|536453082|FG000|Overall Study|Protocol Violation|0|||
148722444|NCT01867606|536453083|FG001|Overall Study|Protocol Violation|1|||
148722445|NCT02056652|536453084|FG000|Overall Study|Withdrawal by Subject|1|||
148722446|NCT02056652|536453085|FG001|Overall Study|Withdrawal by Subject|0|||
148722447|NCT02056652|536453084|FG000|Overall Study|Lost to Follow-up|0|||
148722448|NCT02056652|536453085|FG001|Overall Study|Lost to Follow-up|3|||
148722449|NCT01588548|536453087|FG000|Overall Study|Withdrawal by Subject|0|||
148722450|NCT01588548|536453088|FG001|Overall Study|Withdrawal by Subject|1|||
148722451|NCT01588548|536453089|FG002|Overall Study|Withdrawal by Subject|1|||
148722452|NCT01588548|536453090|FG003|Overall Study|Withdrawal by Subject|1|||
148722453|NCT01588548|536453091|FG004|Overall Study|Withdrawal by Subject|2|||
148722454|NCT01588548|536453092|FG005|Overall Study|Withdrawal by Subject|3|||
148722455|NCT01588548|536453087|FG000|Overall Study|Adverse Event|0|||
148722456|NCT01588548|536453088|FG001|Overall Study|Adverse Event|0|||
148722457|NCT01588548|536453089|FG002|Overall Study|Adverse Event|1|||
148722458|NCT01588548|536453090|FG003|Overall Study|Adverse Event|2|||
148722459|NCT01588548|536453091|FG004|Overall Study|Adverse Event|1|||
148722460|NCT01588548|536453092|FG005|Overall Study|Adverse Event|0|||
148722461|NCT01588548|536453087|FG000|Overall Study|Condition Under Investigation Worsened|3|||
148722462|NCT01588548|536453088|FG001|Overall Study|Condition Under Investigation Worsened|6|||
148722463|NCT01588548|536453089|FG002|Overall Study|Condition Under Investigation Worsened|4|||
148722464|NCT01588548|536453090|FG003|Overall Study|Condition Under Investigation Worsened|4|||
148722465|NCT01588548|536453091|FG004|Overall Study|Condition Under Investigation Worsened|3|||
148722466|NCT01588548|536453092|FG005|Overall Study|Condition Under Investigation Worsened|3|||
148722467|NCT00292227|536453093|FG000|Patch Period|Adverse Event|1|||
148722468|NCT00292227|536453094|FG001|Patch Period|Adverse Event|0|||
148722469|NCT00292227|536453095|FG002|Patch Period|Adverse Event|2|||
148722470|NCT00292227|536453093|FG000|Patch Period|Withdrawal by Subject|0|||
148722471|NCT00292227|536453094|FG001|Patch Period|Withdrawal by Subject|0|||
148722472|NCT00292227|536453095|FG002|Patch Period|Withdrawal by Subject|1|||
148722473|NCT00537017|536453098|FG000|Treatment Phase|Adverse Event|19|||
148722474|NCT00537017|536453098|FG000|Treatment Phase|Withdrawal by Subject|13|||
148722475|NCT00537017|536453098|FG000|Treatment Phase|Protocol Violation|2|||
148722476|NCT00537017|536453098|FG000|Follow-up Phase|Withdrawal by Subject|9|||
148722477|NCT03365791|536453100|FG000|Overall Study|Adverse Event|5|||
148722478|NCT03365791|536453100|FG000|Overall Study|Death|1|||
148722479|NCT03365791|536453100|FG000|Overall Study|Lost to Follow-up|1|||
148722480|NCT03365791|536453100|FG000|Overall Study|Physician Decision|9|||
148722481|NCT03365791|536453100|FG000|Overall Study|Progressive disease|51|||
148722482|NCT03365791|536453100|FG000|Overall Study|Subject/guardian decision|5|||
148722483|NCT03253094|536453101|FG000|Overall Study|Adverse Event|2|||
148722484|NCT03253094|536453102|FG001|Overall Study|Adverse Event|0|||
148722485|NCT03253094|536453103|FG002|Overall Study|Adverse Event|0|||
148722486|NCT03253094|536453104|FG003|Overall Study|Adverse Event|0|||
148722487|NCT03253094|536453105|FG004|Overall Study|Adverse Event|0|||
148722488|NCT03253094|536453106|FG005|Overall Study|Adverse Event|0|||
148722489|NCT03253094|536453101|FG000|Overall Study|Lack of Efficacy|0|||
148722490|NCT03253094|536453102|FG001|Overall Study|Lack of Efficacy|0|||
148722491|NCT03253094|536453103|FG002|Overall Study|Lack of Efficacy|2|||
148722492|NCT03253094|536453104|FG003|Overall Study|Lack of Efficacy|1|||
148722493|NCT03253094|536453105|FG004|Overall Study|Lack of Efficacy|2|||
148722494|NCT03253094|536453106|FG005|Overall Study|Lack of Efficacy|1|||
148722495|NCT03253094|536453101|FG000|Overall Study|Lost to Follow-up|0|||
148722496|NCT03253094|536453102|FG001|Overall Study|Lost to Follow-up|0|||
148722497|NCT03253094|536453103|FG002|Overall Study|Lost to Follow-up|1|||
148722498|NCT03253094|536453104|FG003|Overall Study|Lost to Follow-up|1|||
148722499|NCT03253094|536453105|FG004|Overall Study|Lost to Follow-up|0|||
148722500|NCT03253094|536453106|FG005|Overall Study|Lost to Follow-up|1|||
148722501|NCT03253094|536453101|FG000|Overall Study|Physician Decision|1|||
148722502|NCT03253094|536453102|FG001|Overall Study|Physician Decision|0|||
148722503|NCT03253094|536453103|FG002|Overall Study|Physician Decision|0|||
148816292|NCT00800540|536802828|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
148816293|NCT00800540|536802827|FG000|Period 2: 6 Weeks|Adverse Event|0|||
148816294|NCT00800540|536802828|FG001|Period 2: 6 Weeks|Adverse Event|1|||
148816295|NCT02541903|536802831|FG000|Overall Study|Death|1|||
148816296|NCT02503865|536802838|FG000|Overall Study|Moved out of area|1|||
148816297|NCT02503865|536802839|FG001|Overall Study|Moved out of area|8|||
148816298|NCT02503865|536802840|FG002|Overall Study|Moved out of area|0|||
148816299|NCT02503865|536802838|FG000|Overall Study|Refused treatment|4|||
148722504|NCT03253094|536453104|FG003|Overall Study|Physician Decision|1|||
148722505|NCT03253094|536453105|FG004|Overall Study|Physician Decision|0|||
148722506|NCT03253094|536453106|FG005|Overall Study|Physician Decision|2|||
148722507|NCT03253094|536453101|FG000|Overall Study|Withdrawal by Subject|1|||
148722508|NCT03253094|536453102|FG001|Overall Study|Withdrawal by Subject|2|||
148722509|NCT03253094|536453103|FG002|Overall Study|Withdrawal by Subject|1|||
148722510|NCT03253094|536453104|FG003|Overall Study|Withdrawal by Subject|0|||
148722511|NCT03253094|536453105|FG004|Overall Study|Withdrawal by Subject|3|||
148722512|NCT03253094|536453106|FG005|Overall Study|Withdrawal by Subject|0|||
148722513|NCT03253094|536453101|FG000|Overall Study|Other|0|||
148722514|NCT03253094|536453102|FG001|Overall Study|Other|1|||
148722515|NCT03253094|536453103|FG002|Overall Study|Other|2|||
148722516|NCT03253094|536453104|FG003|Overall Study|Other|1|||
148722517|NCT03253094|536453105|FG004|Overall Study|Other|0|||
148722518|NCT03253094|536453106|FG005|Overall Study|Other|0|||
148969739|NCT00436748|537374693|FG000|Overall Study|Consent Withdrawn|1|||
148969740|NCT00436748|537374694|FG001|Overall Study|Consent Withdrawn|4|||
148969741|NCT00436748|537374693|FG000|Overall Study|Administrative Decision|1|||
148722519|NCT00576303|536453107|FG000|Dose Titration Period|Early withdrawal|17|||
148722520|NCT00576303|536453107|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
148722521|NCT00576303|536453107|FG000|Long Term Safety Period|Early withdrawal|16|||
148722522|NCT00824369|536453108|FG000|Overall Study|Nolonger willing to participate in study|1|||
148722523|NCT00824369|536453109|FG001|Overall Study|Nolonger willing to participate in study|0|||
148722524|NCT00824369|536453110|FG002|Overall Study|Nolonger willing to participate in study|1|||
148722525|NCT00824369|536453111|FG003|Overall Study|Nolonger willing to participate in study|2|||
148722526|NCT00824369|536453112|FG004|Overall Study|Nolonger willing to participate in study|0|||
148722527|NCT00824369|536453113|FG005|Overall Study|Nolonger willing to participate in study|1|||
148722528|NCT00824369|536453108|FG000|Overall Study|Lost to Follow-up|0|||
148722529|NCT00824369|536453109|FG001|Overall Study|Lost to Follow-up|0|||
148722530|NCT00824369|536453110|FG002|Overall Study|Lost to Follow-up|0|||
148722531|NCT00824369|536453111|FG003|Overall Study|Lost to Follow-up|0|||
148722532|NCT00824369|536453112|FG004|Overall Study|Lost to Follow-up|1|||
148722533|NCT00824369|536453113|FG005|Overall Study|Lost to Follow-up|0|||
148722534|NCT00442546|536453114|FG000|Overall Study|Adverse Event|11|||
148722535|NCT00442546|536453115|FG001|Overall Study|Adverse Event|17|||
148722536|NCT00442546|536453116|FG002|Overall Study|Adverse Event|13|||
148722537|NCT00442546|536453114|FG000|Overall Study|Lost to Follow-up|1|||
148722538|NCT00442546|536453115|FG001|Overall Study|Lost to Follow-up|2|||
148722539|NCT00442546|536453116|FG002|Overall Study|Lost to Follow-up|1|||
148722540|NCT00442546|536453114|FG000|Overall Study|Other|4|||
148722541|NCT00442546|536453115|FG001|Overall Study|Other|9|||
148722542|NCT00442546|536453116|FG002|Overall Study|Other|6|||
148722543|NCT00442546|536453114|FG000|Overall Study|Withdrawal by Subject|5|||
148722544|NCT00442546|536453115|FG001|Overall Study|Withdrawal by Subject|5|||
148722545|NCT00442546|536453116|FG002|Overall Study|Withdrawal by Subject|7|||
148722546|NCT00442546|536453114|FG000|Overall Study|Randomized But Not Treated|5|||
148722547|NCT00442546|536453115|FG001|Overall Study|Randomized But Not Treated|4|||
148722548|NCT00442546|536453116|FG002|Overall Study|Randomized But Not Treated|6|||
148722549|NCT02012452|536454673|FG000|Overall Study|Lost to Follow-up|2|||
148722550|NCT02012452|536454674|FG001|Overall Study|Lost to Follow-up|1|||
148722551|NCT02012452|536454673|FG000|Overall Study|Withdrawal by Subject|4|||
148722552|NCT02012452|536454674|FG001|Overall Study|Withdrawal by Subject|0|||
148722553|NCT02190279|536454675|FG000|Overall Study|Withdrawal consent|1|||
148722554|NCT02190279|536454676|FG001|Overall Study|Withdrawal consent|0|||
148722555|NCT02190279|536454677|FG002|Overall Study|Withdrawal consent|1|||
148722556|NCT02190279|536454675|FG000|Overall Study|Lost to Follow-up|2|||
148722557|NCT02190279|536454676|FG001|Overall Study|Lost to Follow-up|0|||
148722558|NCT02190279|536454677|FG002|Overall Study|Lost to Follow-up|0|||
148722559|NCT02190279|536454675|FG000|Overall Study|Refused further treatment|0|||
148722560|NCT02190279|536454676|FG001|Overall Study|Refused further treatment|0|||
148722561|NCT02190279|536454677|FG002|Overall Study|Refused further treatment|1|||
148722562|NCT02190279|536454675|FG000|Overall Study|Screening failure|0|||
148722563|NCT02190279|536454676|FG001|Overall Study|Screening failure|0|||
148722564|NCT02190279|536454677|FG002|Overall Study|Screening failure|1|||
148722565|NCT02938442|536454678|FG000|Overall Study|Death|0|||
148722566|NCT02938442|536454679|FG001|Overall Study|Death|1|||
148722567|NCT02938442|536454678|FG000|Overall Study|Lost to Follow-up|0|||
148722568|NCT02938442|536454679|FG001|Overall Study|Lost to Follow-up|1|||
148722569|NCT02938442|536454678|FG000|Overall Study|Physician Decision|0|||
148722570|NCT02938442|536454679|FG001|Overall Study|Physician Decision|1|||
148722571|NCT02938442|536454678|FG000|Overall Study|Withdrawal by Subject|2|||
148722572|NCT02938442|536454679|FG001|Overall Study|Withdrawal by Subject|0|||
148722573|NCT04403399|536454680|FG000|Period 2|Physician Decision|0|||
148816300|NCT02503865|536802839|FG001|Overall Study|Refused treatment|39|||
148722574|NCT04403399|536454681|FG001|Period 2|Physician Decision|1|||
148722575|NCT01115855|536454682|FG000|Overall Study|Adverse Event|16|||
148722576|NCT01115855|536454683|FG001|Overall Study|Adverse Event|18|||
148722577|NCT01115855|536454682|FG000|Overall Study|Death|6|||
148722578|NCT01115855|536454683|FG001|Overall Study|Death|5|||
148722579|NCT01115855|536454682|FG000|Overall Study|Lab Abnormality|1|||
148816301|NCT02503865|536802840|FG002|Overall Study|Refused treatment|2|||
148722580|NCT01115855|536454683|FG001|Overall Study|Lab Abnormality|1|||
148722581|NCT01115855|536454682|FG000|Overall Study|Protocol Violation|0|||
148722582|NCT01115855|536454683|FG001|Overall Study|Protocol Violation|1|||
148722583|NCT01115855|536454682|FG000|Overall Study|Withdrawal by Subject|5|||
148722584|NCT01115855|536454683|FG001|Overall Study|Withdrawal by Subject|5|||
148722585|NCT01115855|536454682|FG000|Overall Study|Other|8|||
148722586|NCT01115855|536454683|FG001|Overall Study|Other|6|||
148722587|NCT00831233|536454685|FG000|Overall Study|Adverse Event|0|||
148722588|NCT00831233|536454686|FG001|Overall Study|Adverse Event|1|||
148722589|NCT00831233|536454685|FG000|Overall Study|Protocol Violation|1|||
148722590|NCT00831233|536454686|FG001|Overall Study|Protocol Violation|0|||
148722591|NCT00831233|536454685|FG000|Overall Study|Selection Criteria Not Met|2|||
148722592|NCT00831233|536454686|FG001|Overall Study|Selection Criteria Not Met|0|||
148722593|NCT00784134|536454687|FG000|Overall Study|Lost to Follow-up|3|||
148722594|NCT00784134|536454688|FG001|Overall Study|Lost to Follow-up|6|||
148722595|NCT03785145|536454689|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
148722596|NCT03785145|536454690|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
148722597|NCT03785145|536454689|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
148722598|NCT03785145|536454690|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
148722599|NCT03785145|536454689|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
148722600|NCT03785145|536454690|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
148722601|NCT03785145|536454689|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
148722602|NCT03785145|536454690|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
148722603|NCT03785145|536454689|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
148722604|NCT03785145|536454690|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
148722605|NCT03785145|536454689|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
148722606|NCT03785145|536454690|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
148722607|NCT03785145|536454689|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
148722608|NCT03785145|536454690|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
148722609|NCT03785145|536454689|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
148722610|NCT03785145|536454690|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
148722611|NCT03785145|536454689|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
148722612|NCT03785145|536454690|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
148722613|NCT03785145|536454689|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
148722614|NCT03785145|536454690|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
148722615|NCT03785145|536454689|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
148722616|NCT03785145|536454690|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
148722617|NCT00097786|536454691|FG000|Overall Study|lost to follow-up for all-cause death|296|||
148722618|NCT00097786|536454692|FG001|Overall Study|lost to follow-up for all-cause death|292|||
148722619|NCT00097786|536454693|FG002|Overall Study|lost to follow-up for all-cause death|313|||
148722620|NCT00097786|536454694|FG003|Overall Study|lost to follow-up for all-cause death|310|||
148722621|NCT02443324|536454695|FG000|Overall Study|Death|4|||
148722622|NCT02443324|536454696|FG001|Overall Study|Death|1|||
148722623|NCT02443324|536454697|FG002|Overall Study|Death|0|||
148722624|NCT02443324|536454698|FG003|Overall Study|Death|3|||
148722625|NCT02443324|536454699|FG004|Overall Study|Death|1|||
148722626|NCT02443324|536454700|FG005|Overall Study|Death|3|||
148722627|NCT02443324|536454701|FG006|Overall Study|Death|2|||
148722628|NCT02443324|536454695|FG000|Overall Study|Lost to Follow-up|0|||
148722629|NCT02443324|536454696|FG001|Overall Study|Lost to Follow-up|0|||
148722630|NCT02443324|536454697|FG002|Overall Study|Lost to Follow-up|0|||
148722631|NCT02443324|536454698|FG003|Overall Study|Lost to Follow-up|1|||
148722632|NCT02443324|536454699|FG004|Overall Study|Lost to Follow-up|0|||
148722633|NCT02443324|536454700|FG005|Overall Study|Lost to Follow-up|1|||
148722634|NCT02443324|536454701|FG006|Overall Study|Lost to Follow-up|0|||
148722635|NCT02443324|536454695|FG000|Overall Study|Physician Decision|0|||
148722636|NCT02443324|536454696|FG001|Overall Study|Physician Decision|3|||
148722637|NCT02443324|536454697|FG002|Overall Study|Physician Decision|5|||
148722638|NCT02443324|536454698|FG003|Overall Study|Physician Decision|1|||
148722639|NCT02443324|536454699|FG004|Overall Study|Physician Decision|1|||
148722640|NCT02443324|536454700|FG005|Overall Study|Physician Decision|0|||
148969742|NCT00436748|537374694|FG001|Overall Study|Administrative Decision|0|||
148969743|NCT00436748|537374693|FG000|Overall Study|Lost to Follow-up|0|||
148969744|NCT00436748|537374694|FG001|Overall Study|Lost to Follow-up|1|||
148969745|NCT00436748|537374693|FG000|Overall Study|Protocol-specified Criteria|5|||
148722641|NCT02443324|536454701|FG006|Overall Study|Physician Decision|2|||
148722642|NCT02443324|536454695|FG000|Overall Study|Progressive Disease|20|||
148722643|NCT02443324|536454696|FG001|Overall Study|Progressive Disease|20|||
148969746|NCT00436748|537374694|FG001|Overall Study|Protocol-specified Criteria|4|||
148722644|NCT02443324|536454697|FG002|Overall Study|Progressive Disease|13|||
148722645|NCT02443324|536454698|FG003|Overall Study|Progressive Disease|10|||
148722646|NCT02443324|536454699|FG004|Overall Study|Progressive Disease|13|||
148722647|NCT02443324|536454700|FG005|Overall Study|Progressive Disease|17|||
148722648|NCT02443324|536454701|FG006|Overall Study|Progressive Disease|10|||
148722649|NCT02443324|536454695|FG000|Overall Study|Withdrawal by Subject|0|||
148722650|NCT02443324|536454696|FG001|Overall Study|Withdrawal by Subject|0|||
148722651|NCT02443324|536454697|FG002|Overall Study|Withdrawal by Subject|3|||
148722652|NCT02443324|536454698|FG003|Overall Study|Withdrawal by Subject|1|||
148722653|NCT02443324|536454699|FG004|Overall Study|Withdrawal by Subject|1|||
148722654|NCT02443324|536454700|FG005|Overall Study|Withdrawal by Subject|0|||
148722655|NCT02443324|536454701|FG006|Overall Study|Withdrawal by Subject|1|||
148722656|NCT02443324|536454695|FG000|Overall Study|Adverse Event|0|||
148722657|NCT02443324|536454696|FG001|Overall Study|Adverse Event|1|||
148722658|NCT02443324|536454697|FG002|Overall Study|Adverse Event|3|||
148722659|NCT02443324|536454698|FG003|Overall Study|Adverse Event|0|||
148722660|NCT02443324|536454699|FG004|Overall Study|Adverse Event|4|||
148722661|NCT02443324|536454700|FG005|Overall Study|Adverse Event|3|||
148722662|NCT02443324|536454701|FG006|Overall Study|Adverse Event|3|||
148722663|NCT02443324|536454695|FG000|Overall Study|Enrolled but Never Treated|0|||
148722664|NCT02443324|536454696|FG001|Overall Study|Enrolled but Never Treated|0|||
148722665|NCT02443324|536454697|FG002|Overall Study|Enrolled but Never Treated|1|||
148722666|NCT02443324|536454698|FG003|Overall Study|Enrolled but Never Treated|0|||
148722667|NCT02443324|536454699|FG004|Overall Study|Enrolled but Never Treated|1|||
148722668|NCT02443324|536454700|FG005|Overall Study|Enrolled but Never Treated|0|||
148722669|NCT02443324|536454701|FG006|Overall Study|Enrolled but Never Treated|1|||
148722670|NCT01647711|536454702|FG000|Overall Study|Progressive disease|6|||
148722671|NCT01647711|536454703|FG001|Overall Study|Progressive disease|2|||
148722672|NCT01647711|536454704|FG002|Overall Study|Progressive disease|6|||
148722673|NCT01647711|536454705|FG003|Overall Study|Progressive disease|8|||
148722674|NCT01647711|536454706|FG004|Overall Study|Progressive disease|2|||
148722675|NCT01647711|536454702|FG000|Overall Study|Other adverse event|0|||
148722676|NCT01647711|536454703|FG001|Overall Study|Other adverse event|0|||
148722677|NCT01647711|536454704|FG002|Overall Study|Other adverse event|2|||
148722678|NCT01647711|536454705|FG003|Overall Study|Other adverse event|0|||
148722679|NCT01647711|536454706|FG004|Overall Study|Other adverse event|2|||
148722680|NCT01647711|536454702|FG000|Overall Study|Protocol Violation|0|||
148722681|NCT01647711|536454703|FG001|Overall Study|Protocol Violation|0|||
148722682|NCT01647711|536454704|FG002|Overall Study|Protocol Violation|0|||
148722683|NCT01647711|536454705|FG003|Overall Study|Protocol Violation|0|||
148722684|NCT01647711|536454706|FG004|Overall Study|Protocol Violation|1|||
148722685|NCT01647711|536454702|FG000|Overall Study|Refused to continue taking medication|0|||
148722686|NCT01647711|536454703|FG001|Overall Study|Refused to continue taking medication|0|||
148722687|NCT01647711|536454704|FG002|Overall Study|Refused to continue taking medication|0|||
148722688|NCT01647711|536454705|FG003|Overall Study|Refused to continue taking medication|2|||
148722689|NCT01647711|536454706|FG004|Overall Study|Refused to continue taking medication|1|||
148722690|NCT01647711|536454702|FG000|Overall Study|Other reason not defined|0|||
148722691|NCT01647711|536454703|FG001|Overall Study|Other reason not defined|1|||
148722692|NCT01647711|536454704|FG002|Overall Study|Other reason not defined|1|||
148722693|NCT01647711|536454705|FG003|Overall Study|Other reason not defined|1|||
148722694|NCT01647711|536454706|FG004|Overall Study|Other reason not defined|0|||
148722695|NCT01316419|536454707|FG000|Overall Study|Not treated|103|||
148722696|NCT01316419|536454707|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
148722697|NCT01316419|536454707|FG000|Overall Study|Lost to Follow-up|19|||
148722698|NCT04025684|536454720|FG000|Overall Study|Withdrawal by Subject|1|||
148722699|NCT04025684|536454721|FG001|Overall Study|Withdrawal by Subject|1|||
148722700|NCT04025684|536454722|FG002|Overall Study|Withdrawal by Subject|0|||
148722701|NCT04025684|536454723|FG003|Overall Study|Withdrawal by Subject|0|||
148722702|NCT04025684|536454720|FG000|Overall Study|Multiple reasons|1|||
148722703|NCT04025684|536454721|FG001|Overall Study|Multiple reasons|3|||
148722704|NCT04025684|536454722|FG002|Overall Study|Multiple reasons|0|||
148722705|NCT04025684|536454723|FG003|Overall Study|Multiple reasons|1|||
148722706|NCT02070757|536454726|FG000|Overall Study|Adverse Event|107|||
148722707|NCT02070757|536454727|FG001|Overall Study|Adverse Event|99|||
148722708|NCT02070757|536454726|FG000|Overall Study|Lost to Follow-up|7|||
148722709|NCT02070757|536454727|FG001|Overall Study|Lost to Follow-up|4|||
148722710|NCT02070757|536454726|FG000|Overall Study|Protocol Violation|0|||
148722711|NCT02070757|536454727|FG001|Overall Study|Protocol Violation|4|||
148722712|NCT02070757|536454726|FG000|Overall Study|Withdrawal by Subject|1|||
148722713|NCT02070757|536454727|FG001|Overall Study|Withdrawal by Subject|3|||
148722714|NCT02070757|536454726|FG000|Overall Study|Investigator Decision|0|||
148722715|NCT02070757|536454727|FG001|Overall Study|Investigator Decision|2|||
148969747|NCT00436748|537374693|FG000|Overall Study|Other|3|||
148722716|NCT02070757|536454726|FG000|Overall Study|Discharged from Study Hospital|2|||
148722717|NCT02070757|536454727|FG001|Overall Study|Discharged from Study Hospital|2|||
148722718|NCT01546922|536454728|FG000|First Period of 10 Weeks|Protocol Violation|3|||
148969748|NCT00436748|537374694|FG001|Overall Study|Other|0|||
148722719|NCT01546922|536454729|FG001|First Period of 10 Weeks|Protocol Violation|1|||
148722720|NCT01546922|536454728|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
148969749|NCT01610791|537374695|FG000|Overall Study|Lost to Follow-up|7|||
148969750|NCT01610791|537374695|FG000|Overall Study|Adverse Event|6|||
148722721|NCT01546922|536454729|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
148722722|NCT01546922|536454728|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
148722723|NCT01546922|536454729|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
148722724|NCT01546922|536454728|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
148969751|NCT01610791|537374695|FG000|Overall Study|Physician Decision|1|||
148969752|NCT01610791|537374695|FG000|Overall Study|Adverse event and Investigator decision|1|||
148969753|NCT01610791|537374695|FG000|Overall Study|Death|1|||
148722725|NCT01546922|536454729|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
148722726|NCT01546922|536454728|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
148722727|NCT01546922|536454729|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
148722728|NCT00792623|536454731|FG000|Overall Study|Adverse Event|2|||
148722729|NCT00792623|536454731|FG000|Overall Study|Withdrawal by Subject|5|||
148722730|NCT00743509|536454732|FG000|Overall Study|Withdrawal by Subject|2|||
148722731|NCT01534078|536454733|FG000|Overall Study|Death|1|||
148722732|NCT01534078|536454733|FG000|Overall Study|Withdrawal by Subject|1|||
148722733|NCT01280617|536454734|FG000|Overall Study|Adverse Event|0|||
148722734|NCT01280617|536454735|FG001|Overall Study|Adverse Event|1|||
148722735|NCT00573170|536454736|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
148722736|NCT00573170|536454737|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
148722737|NCT00573170|536454738|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
148722738|NCT00573170|536454739|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
148722739|NCT00573170|536454740|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
148722740|NCT00573170|536454741|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
148722741|NCT00573170|536454736|FG000|First Washout Period|Adverse Event|1|||
148722742|NCT00573170|536454737|FG001|First Washout Period|Adverse Event|1|||
148722743|NCT00573170|536454738|FG002|First Washout Period|Adverse Event|0|||
148722744|NCT00573170|536454739|FG003|First Washout Period|Adverse Event|0|||
148722745|NCT00573170|536454740|FG004|First Washout Period|Adverse Event|0|||
148722746|NCT00573170|536454741|FG005|First Washout Period|Adverse Event|1|||
148722747|NCT00573170|536454736|FG000|First Washout Period|Lack of Efficacy|0|||
148722748|NCT00573170|536454737|FG001|First Washout Period|Lack of Efficacy|0|||
148722749|NCT00573170|536454738|FG002|First Washout Period|Lack of Efficacy|0|||
148722750|NCT00573170|536454739|FG003|First Washout Period|Lack of Efficacy|0|||
148722751|NCT00573170|536454740|FG004|First Washout Period|Lack of Efficacy|0|||
148722752|NCT00573170|536454741|FG005|First Washout Period|Lack of Efficacy|1|||
148722753|NCT00573170|536454736|FG000|First Washout Period|Lost to Follow-up|1|||
148722754|NCT00573170|536454737|FG001|First Washout Period|Lost to Follow-up|1|||
148722755|NCT00573170|536454738|FG002|First Washout Period|Lost to Follow-up|0|||
148722756|NCT00573170|536454739|FG003|First Washout Period|Lost to Follow-up|2|||
148722757|NCT00573170|536454740|FG004|First Washout Period|Lost to Follow-up|0|||
148722758|NCT00573170|536454741|FG005|First Washout Period|Lost to Follow-up|2|||
148722759|NCT00573170|536454736|FG000|First Washout Period|Withdrawal by Subject|2|||
148722760|NCT00573170|536454737|FG001|First Washout Period|Withdrawal by Subject|0|||
148722761|NCT00573170|536454738|FG002|First Washout Period|Withdrawal by Subject|0|||
148722762|NCT00573170|536454739|FG003|First Washout Period|Withdrawal by Subject|2|||
148722763|NCT00573170|536454740|FG004|First Washout Period|Withdrawal by Subject|3|||
148722764|NCT00573170|536454741|FG005|First Washout Period|Withdrawal by Subject|3|||
148722765|NCT00573170|536454736|FG000|First Washout Period|Other|4|||
148722766|NCT00573170|536454737|FG001|First Washout Period|Other|0|||
148722767|NCT00573170|536454738|FG002|First Washout Period|Other|1|||
148722768|NCT00573170|536454739|FG003|First Washout Period|Other|1|||
148722769|NCT00573170|536454740|FG004|First Washout Period|Other|0|||
148722770|NCT00573170|536454741|FG005|First Washout Period|Other|0|||
148722771|NCT00573170|536454736|FG000|Second Washout Period|Adverse Event|1|||
148722772|NCT00573170|536454737|FG001|Second Washout Period|Adverse Event|0|||
148722773|NCT00573170|536454738|FG002|Second Washout Period|Adverse Event|0|||
148722774|NCT00573170|536454739|FG003|Second Washout Period|Adverse Event|0|||
148722775|NCT00573170|536454740|FG004|Second Washout Period|Adverse Event|1|||
148722776|NCT00573170|536454741|FG005|Second Washout Period|Adverse Event|0|||
148722777|NCT00573170|536454736|FG000|Second Washout Period|Protocol Violation|2|||
148722778|NCT00573170|536454737|FG001|Second Washout Period|Protocol Violation|1|||
148722779|NCT00573170|536454738|FG002|Second Washout Period|Protocol Violation|1|||
148722780|NCT00573170|536454739|FG003|Second Washout Period|Protocol Violation|0|||
148722781|NCT00573170|536454740|FG004|Second Washout Period|Protocol Violation|0|||
148722782|NCT00573170|536454741|FG005|Second Washout Period|Protocol Violation|0|||
148969754|NCT01610791|537374695|FG000|Overall Study|Not determined|5|||
148969755|NCT02086110|537374709|FG000|Overall Study|Withdrawal by Subject|1|||
148969756|NCT02086110|537374710|FG001|Overall Study|Withdrawal by Subject|1|||
148722783|NCT00573170|536454736|FG000|Second Washout Period|Withdrawal by Subject|1|||
148722784|NCT00573170|536454737|FG001|Second Washout Period|Withdrawal by Subject|1|||
148722785|NCT00573170|536454738|FG002|Second Washout Period|Withdrawal by Subject|2|||
148722786|NCT00573170|536454739|FG003|Second Washout Period|Withdrawal by Subject|0|||
148722787|NCT00573170|536454740|FG004|Second Washout Period|Withdrawal by Subject|1|||
148722788|NCT00573170|536454741|FG005|Second Washout Period|Withdrawal by Subject|0|||
148722789|NCT00573170|536454736|FG000|Second Washout Period|Lost to Follow-up|0|||
148722790|NCT00573170|536454737|FG001|Second Washout Period|Lost to Follow-up|0|||
148722791|NCT00573170|536454738|FG002|Second Washout Period|Lost to Follow-up|0|||
148722792|NCT00573170|536454739|FG003|Second Washout Period|Lost to Follow-up|1|||
148722793|NCT00573170|536454740|FG004|Second Washout Period|Lost to Follow-up|0|||
148722794|NCT00573170|536454741|FG005|Second Washout Period|Lost to Follow-up|0|||
148722795|NCT00573170|536454736|FG000|Second Washout Period|Other|1|||
148722796|NCT00573170|536454737|FG001|Second Washout Period|Other|2|||
148722797|NCT00573170|536454738|FG002|Second Washout Period|Other|1|||
148722798|NCT00573170|536454739|FG003|Second Washout Period|Other|4|||
148722799|NCT00573170|536454740|FG004|Second Washout Period|Other|6|||
148722800|NCT00573170|536454741|FG005|Second Washout Period|Other|2|||
148722801|NCT00573170|536454736|FG000|Third Treatment Period|Withdrawal by Subject|1|||
148722802|NCT00573170|536454737|FG001|Third Treatment Period|Withdrawal by Subject|0|||
148722803|NCT00573170|536454738|FG002|Third Treatment Period|Withdrawal by Subject|0|||
148722804|NCT00573170|536454739|FG003|Third Treatment Period|Withdrawal by Subject|0|||
148722805|NCT00573170|536454740|FG004|Third Treatment Period|Withdrawal by Subject|0|||
148722806|NCT00573170|536454741|FG005|Third Treatment Period|Withdrawal by Subject|0|||
148722807|NCT00573170|536454736|FG000|Third Treatment Period|Lost to Follow-up|0|||
148722808|NCT00573170|536454737|FG001|Third Treatment Period|Lost to Follow-up|0|||
148722809|NCT00573170|536454738|FG002|Third Treatment Period|Lost to Follow-up|0|||
148722810|NCT00573170|536454739|FG003|Third Treatment Period|Lost to Follow-up|0|||
148722811|NCT00573170|536454740|FG004|Third Treatment Period|Lost to Follow-up|0|||
148722812|NCT00573170|536454741|FG005|Third Treatment Period|Lost to Follow-up|2|||
148722813|NCT00572039|536454742|FG000|Overall Study|Withdrawal by Subject|9|||
148722814|NCT00572039|536454743|FG001|Overall Study|Withdrawal by Subject|6|||
148722815|NCT00572039|536454742|FG000|Overall Study|Death|2|||
148722816|NCT00572039|536454743|FG001|Overall Study|Death|3|||
148722817|NCT00572039|536454742|FG000|Overall Study|Ill|5|||
148722818|NCT00572039|536454743|FG001|Overall Study|Ill|1|||
148722819|NCT02147587|536454745|FG000|Overall Study|Adverse Event|9|||
148722820|NCT02147587|536454746|FG001|Overall Study|Adverse Event|4|||
148722821|NCT02147587|536454745|FG000|Overall Study|Lack of Efficacy|2|||
148722822|NCT02147587|536454746|FG001|Overall Study|Lack of Efficacy|1|||
148722823|NCT01355302|536454747|FG000|Phase 1b|Death|4|||
148722824|NCT01355302|536454748|FG001|Phase 1b|Death|0|||
148722825|NCT01355302|536454749|FG002|Phase 1b|Death|0|||
148722826|NCT01355302|536454747|FG000|Phase 1b|Study terminated by sponsor|2|||
148722827|NCT01355302|536454748|FG001|Phase 1b|Study terminated by sponsor|0|||
148722828|NCT01355302|536454749|FG002|Phase 1b|Study terminated by sponsor|0|||
148722829|NCT00263887|536454750|FG000|Overall Study|Withdrawal by Subject|1|||
148722830|NCT00263887|536454751|FG001|Overall Study|Withdrawal by Subject|1|||
148722831|NCT00263887|536454750|FG000|Overall Study|Lung transplantation|1|||
148722832|NCT00263887|536454751|FG001|Overall Study|Lung transplantation|2|||
148722833|NCT00263887|536454750|FG000|Overall Study|Too ill to attend visit|1|||
148722834|NCT00263887|536454751|FG001|Overall Study|Too ill to attend visit|0|||
148722835|NCT00263887|536454750|FG000|Overall Study|Adverse Event|0|||
148722836|NCT00263887|536454751|FG001|Overall Study|Adverse Event|2|||
148722837|NCT00263887|536454750|FG000|Overall Study|Disease progression|0|||
148722838|NCT00263887|536454751|FG001|Overall Study|Disease progression|1|||
148722839|NCT00263887|536454750|FG000|Overall Study|Lack of Efficacy|0|||
148722840|NCT00263887|536454751|FG001|Overall Study|Lack of Efficacy|1|||
148722841|NCT03649412|536454752|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
148722842|NCT03649412|536454753|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
148722843|NCT03649412|536454752|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
148722844|NCT03649412|536454753|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
148722845|NCT03649412|536454752|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
148722846|NCT03649412|536454753|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
148722847|NCT03649412|536454752|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
148722848|NCT03649412|536454753|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
148722849|NCT03649412|536454752|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
148722850|NCT03649412|536454753|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
148722851|NCT03649412|536454752|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
148722852|NCT03649412|536454753|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
148722853|NCT00530348|536454754|FG000|Overall Study|Adverse Event|5|||
148722854|NCT00530348|536454755|FG001|Overall Study|Adverse Event|1|||
148722855|NCT00530348|536454754|FG000|Overall Study|Death|0|||
148722856|NCT00530348|536454755|FG001|Overall Study|Death|1|||
148722857|NCT00530348|536454754|FG000|Overall Study|Lack of Efficacy|2|||
148722858|NCT00530348|536454755|FG001|Overall Study|Lack of Efficacy|0|||
148722859|NCT00530348|536454754|FG000|Overall Study|Lost to Follow-up|0|||
148722860|NCT00530348|536454755|FG001|Overall Study|Lost to Follow-up|2|||
148722861|NCT00530348|536454754|FG000|Overall Study|Physician Decision|1|||
148722862|NCT00530348|536454755|FG001|Overall Study|Physician Decision|2|||
148722863|NCT00530348|536454754|FG000|Overall Study|Pregnancy|1|||
148722864|NCT00530348|536454755|FG001|Overall Study|Pregnancy|0|||
148722865|NCT00530348|536454754|FG000|Overall Study|Withdrawal by Subject|12|||
148722866|NCT00530348|536454755|FG001|Overall Study|Withdrawal by Subject|12|||
148722867|NCT00530348|536454754|FG000|Overall Study|Randomised in error|1|||
148722868|NCT00530348|536454755|FG001|Overall Study|Randomised in error|0|||
148722869|NCT00530348|536454754|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
148722870|NCT00530348|536454755|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
148722871|NCT04364763|536454756|FG000|Overall Study|Death|1|||
148722872|NCT04364763|536454757|FG001|Overall Study|Death|2|||
148722873|NCT04364763|536454756|FG000|Overall Study|Lost to Follow-up|1|||
148722874|NCT04364763|536454757|FG001|Overall Study|Lost to Follow-up|0|||
148722875|NCT01557920|536454766|FG000|Overall Study|Withdrawal by Subject|2|||
148722876|NCT01557920|536454767|FG001|Overall Study|Withdrawal by Subject|3|||
148722877|NCT01557920|536454766|FG000|Overall Study|Lack of Efficacy|1|||
148722878|NCT01557920|536454767|FG001|Overall Study|Lack of Efficacy|0|||
148722879|NCT00985231|536454768|FG000|Overall Study|ineligible|1|||
148722880|NCT00985231|536454769|FG001|Overall Study|ineligible|0|||
148722881|NCT00985231|536454768|FG000|Overall Study|Protocol Violation|1|||
148722882|NCT00985231|536454769|FG001|Overall Study|Protocol Violation|0|||
148722883|NCT00985231|536454768|FG000|Overall Study|Withdrawal by Subject|1|||
148722884|NCT00985231|536454769|FG001|Overall Study|Withdrawal by Subject|0|||
148722885|NCT00985231|536454768|FG000|Overall Study|Lost to Follow-up|0|||
148722886|NCT00985231|536454769|FG001|Overall Study|Lost to Follow-up|1|||
148722887|NCT00985231|536454768|FG000|Overall Study|Study related symptoms & complaints|0|||
148722888|NCT00985231|536454769|FG001|Overall Study|Study related symptoms & complaints|2|||
148722889|NCT00931463|536454774|FG000|Overall Study|Death|8|||
148722890|NCT00931463|536454775|FG001|Overall Study|Death|4|||
148722891|NCT00931463|536454774|FG000|Overall Study|Withdrawal by Subject|5|||
148722892|NCT00931463|536454775|FG001|Overall Study|Withdrawal by Subject|0|||
148722893|NCT00931463|536454774|FG000|Overall Study|Lost to Follow-up|4|||
148722894|NCT00931463|536454775|FG001|Overall Study|Lost to Follow-up|1|||
148722895|NCT01175473|536454778|FG000|Overall Study|Adverse Event|2|||
148722896|NCT01175473|536454779|FG001|Overall Study|Adverse Event|2|||
148722897|NCT00084799|536454782|FG000|Overall Study|Disease Progression|1|||
148722898|NCT00084799|536454783|FG001|Overall Study|Disease Progression|0|||
148722899|NCT01083680|536454784|FG000|Overall Study|Lost to Follow-up|2758|||
148722900|NCT01083680|536454784|FG000|Overall Study|Withdrawal by Subject|1086|||
148722901|NCT00003531|536454785|FG000|Overall Study|Not evaluable|10|||
148722902|NCT00346164|536454786|FG000|Overall Study|Adverse Event|0|||
148722903|NCT00346164|536454787|FG001|Overall Study|Adverse Event|0|||
148722904|NCT00346164|536454788|FG002|Overall Study|Adverse Event|0|||
148722905|NCT00346164|536454789|FG003|Overall Study|Adverse Event|1|||
148722906|NCT00346164|536454786|FG000|Overall Study|Lack of Efficacy|0|||
148722907|NCT00346164|536454787|FG001|Overall Study|Lack of Efficacy|1|||
148722908|NCT00346164|536454788|FG002|Overall Study|Lack of Efficacy|7|||
148722909|NCT00346164|536454789|FG003|Overall Study|Lack of Efficacy|25|||
148722910|NCT00346164|536454786|FG000|Overall Study|Physician Decision|0|||
148722911|NCT00346164|536454787|FG001|Overall Study|Physician Decision|1|||
148722912|NCT00346164|536454788|FG002|Overall Study|Physician Decision|2|||
148722913|NCT00346164|536454789|FG003|Overall Study|Physician Decision|27|||
148722914|NCT00346164|536454786|FG000|Overall Study|Protocol Violation|6|||
148722915|NCT00346164|536454787|FG001|Overall Study|Protocol Violation|2|||
148722916|NCT00346164|536454788|FG002|Overall Study|Protocol Violation|10|||
148722917|NCT00346164|536454789|FG003|Overall Study|Protocol Violation|4|||
148722918|NCT00346164|536454786|FG000|Overall Study|Withdrawal by Subject|0|||
148722919|NCT00346164|536454787|FG001|Overall Study|Withdrawal by Subject|0|||
148722920|NCT00346164|536454788|FG002|Overall Study|Withdrawal by Subject|2|||
148722921|NCT00346164|536454789|FG003|Overall Study|Withdrawal by Subject|0|||
148722922|NCT00346164|536454786|FG000|Overall Study|Ineligible|11|||
148722923|NCT00346164|536454787|FG001|Overall Study|Ineligible|2|||
148722924|NCT00346164|536454788|FG002|Overall Study|Ineligible|2|||
148722925|NCT00346164|536454789|FG003|Overall Study|Ineligible|23|||
148722926|NCT00346164|536454786|FG000|Overall Study|Refusal of further protocol therapy|0|||
148722927|NCT00346164|536454787|FG001|Overall Study|Refusal of further protocol therapy|1|||
148722928|NCT00346164|536454788|FG002|Overall Study|Refusal of further protocol therapy|3|||
148722929|NCT00346164|536454789|FG003|Overall Study|Refusal of further protocol therapy|15|||
148722930|NCT00346164|536454786|FG000|Overall Study|Inability to start week 16 tx on time|0|||
148722931|NCT00346164|536454787|FG001|Overall Study|Inability to start week 16 tx on time|0|||
148722932|NCT00346164|536454788|FG002|Overall Study|Inability to start week 16 tx on time|0|||
148722933|NCT00346164|536454789|FG003|Overall Study|Inability to start week 16 tx on time|11|||
148722934|NCT02260258|536454790|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
148722935|NCT02260258|536454791|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
148722936|NCT00605917|536454792|FG000|Overall Study|Protocol Violation|79|||
148722937|NCT00925301|536454793|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
148722938|NCT00925301|536454794|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
148722939|NCT00925301|536454795|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
148722940|NCT00925301|536454796|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
148722941|NCT00925301|536454793|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
148722942|NCT00925301|536454794|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
148722943|NCT00925301|536454795|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
148722944|NCT00925301|536454796|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
148722945|NCT00925301|536454793|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
148722946|NCT00925301|536454794|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
148816302|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
148816303|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
148722947|NCT00925301|536454795|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
148722948|NCT00925301|536454796|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
148722949|NCT00925301|536454793|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
148722950|NCT00925301|536454794|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
148722951|NCT00925301|536454795|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
148722952|NCT00925301|536454796|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
148722953|NCT00925301|536454793|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
148722954|NCT00925301|536454794|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
148722955|NCT00925301|536454795|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
148722956|NCT00925301|536454796|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
148722957|NCT00925301|536454793|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
148722958|NCT00925301|536454794|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
148722959|NCT00925301|536454795|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
148722960|NCT00925301|536454796|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
148722961|NCT00925301|536454793|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
148722962|NCT00925301|536454794|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
148722963|NCT00925301|536454795|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
148722964|NCT00925301|536454796|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
148722965|NCT05766787|536454797|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
148722966|NCT05766787|536454798|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
148722967|NCT05766787|536454797|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
148722968|NCT05766787|536454798|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
148722969|NCT05766787|536454797|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
148722970|NCT05766787|536454798|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
148722971|NCT03581188|536457228|FG000|Overall Study|Inclusion criteria not met|3|||
148722972|NCT03581188|536457229|FG001|Overall Study|Inclusion criteria not met|2|||
148722973|NCT03581188|536457228|FG000|Overall Study|Lost to Follow-up|5|||
148722974|NCT03581188|536457229|FG001|Overall Study|Lost to Follow-up|5|||
148722975|NCT03581188|536457228|FG000|Overall Study|Discontinued intervention|11|||
148722976|NCT03581188|536457229|FG001|Overall Study|Discontinued intervention|8|||
148722977|NCT01619579|536457230|FG000|Overall Study|Withdrawal by Subject|0|||
148722978|NCT01619579|536457231|FG001|Overall Study|Withdrawal by Subject|3|||
148722979|NCT00983918|536457237|FG000|Overall Study|conversion to open cholecystectomy|0|||
148722980|NCT00983918|536457238|FG001|Overall Study|conversion to open cholecystectomy|2|||
148722981|NCT00983918|536457239|FG002|Overall Study|conversion to open cholecystectomy|2|||
148722982|NCT00983918|536457240|FG003|Overall Study|conversion to open cholecystectomy|2|||
148722983|NCT03346070|536457248|FG000|Overall Study|Death|0|||
148722984|NCT03346070|536457249|FG001|Overall Study|Death|0|||
148722985|NCT03346070|536457250|FG002|Overall Study|Death|0|||
148722986|NCT03346070|536457251|FG003|Overall Study|Death|0|||
148722987|NCT03346070|536457252|FG004|Overall Study|Death|1|||
148722988|NCT03346070|536457248|FG000|Overall Study|Lost to Follow-up|0|||
148722989|NCT03346070|536457249|FG001|Overall Study|Lost to Follow-up|1|||
148722990|NCT03346070|536457250|FG002|Overall Study|Lost to Follow-up|2|||
148722991|NCT03346070|536457251|FG003|Overall Study|Lost to Follow-up|0|||
148722992|NCT03346070|536457252|FG004|Overall Study|Lost to Follow-up|0|||
148722993|NCT03346070|536457248|FG000|Overall Study|Physician Decision|0|||
148722994|NCT03346070|536457249|FG001|Overall Study|Physician Decision|0|||
148722995|NCT03346070|536457250|FG002|Overall Study|Physician Decision|0|||
148722996|NCT03346070|536457251|FG003|Overall Study|Physician Decision|1|||
148722997|NCT03346070|536457252|FG004|Overall Study|Physician Decision|1|||
148722998|NCT03346070|536457248|FG000|Overall Study|Withdrawal by Subject|1|||
148722999|NCT03346070|536457249|FG001|Overall Study|Withdrawal by Subject|0|||
148723000|NCT03346070|536457250|FG002|Overall Study|Withdrawal by Subject|0|||
148723001|NCT03346070|536457251|FG003|Overall Study|Withdrawal by Subject|1|||
148723002|NCT03346070|536457252|FG004|Overall Study|Withdrawal by Subject|0|||
148723003|NCT03346070|536457248|FG000|Overall Study|Study medication not received as planned|2|||
148723004|NCT03346070|536457249|FG001|Overall Study|Study medication not received as planned|3|||
148723005|NCT03346070|536457250|FG002|Overall Study|Study medication not received as planned|2|||
148723006|NCT03346070|536457251|FG003|Overall Study|Study medication not received as planned|3|||
148723007|NCT03346070|536457252|FG004|Overall Study|Study medication not received as planned|2|||
148723008|NCT03346070|536457248|FG000|Overall Study|Screen Failure|0|||
148723009|NCT03346070|536457249|FG001|Overall Study|Screen Failure|0|||
148816304|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
148723010|NCT03346070|536457250|FG002|Overall Study|Screen Failure|0|||
148723011|NCT03346070|536457251|FG003|Overall Study|Screen Failure|1|||
148816305|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Death|1|||
148816306|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Death|0|||
148723012|NCT03346070|536457252|FG004|Overall Study|Screen Failure|1|||
148723013|NCT04086641|536457255|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
148969757|NCT01869192|537374711|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
148969758|NCT01869192|537374712|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
148969759|NCT01869192|537374711|FG000|Postoperative Chemotherapy|Physician Decision|0|||
148969760|NCT01869192|537374712|FG001|Postoperative Chemotherapy|Physician Decision|2|||
148969761|NCT01203072|537374713|FG000|Overall Study|Adverse Event|5|||
148723014|NCT04086641|536457256|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
148723015|NCT00255151|536457257|FG000|Overall Study|Adverse Event|10|||
148723016|NCT00255151|536457258|FG001|Overall Study|Adverse Event|6|||
148723017|NCT00255151|536457259|FG002|Overall Study|Adverse Event|9|||
148723018|NCT00255151|536457257|FG000|Overall Study|Lost to Follow-up|4|||
148723019|NCT00255151|536457258|FG001|Overall Study|Lost to Follow-up|3|||
148723020|NCT00255151|536457259|FG002|Overall Study|Lost to Follow-up|4|||
148723021|NCT00255151|536457257|FG000|Overall Study|Withdrawal by Subject|18|||
148723022|NCT00255151|536457258|FG001|Overall Study|Withdrawal by Subject|17|||
148723023|NCT00255151|536457259|FG002|Overall Study|Withdrawal by Subject|8|||
148723024|NCT00255151|536457257|FG000|Overall Study|Noncompliance|0|||
148723025|NCT00255151|536457258|FG001|Overall Study|Noncompliance|1|||
148723026|NCT00255151|536457259|FG002|Overall Study|Noncompliance|2|||
148723027|NCT00255151|536457257|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
148723028|NCT00255151|536457258|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
148723029|NCT00255151|536457259|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
148723030|NCT00255151|536457257|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
148723031|NCT00255151|536457258|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
148723032|NCT00255151|536457259|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
148723033|NCT00255151|536457257|FG000|Overall Study|Possible Barrett's Esophagus|1|||
148723034|NCT00255151|536457258|FG001|Overall Study|Possible Barrett's Esophagus|3|||
148723035|NCT00255151|536457259|FG002|Overall Study|Possible Barrett's Esophagus|8|||
148723036|NCT00255151|536457257|FG000|Overall Study|Esophageal Stricture|0|||
148723037|NCT00255151|536457258|FG001|Overall Study|Esophageal Stricture|0|||
148723038|NCT00255151|536457259|FG002|Overall Study|Esophageal Stricture|1|||
148723039|NCT00255151|536457257|FG000|Overall Study|Therapeutic Failure|11|||
148723040|NCT00255151|536457258|FG001|Overall Study|Therapeutic Failure|2|||
148723041|NCT00255151|536457259|FG002|Overall Study|Therapeutic Failure|3|||
148723042|NCT01685073|536457260|FG000|Overall Study|Lost to Follow-up|6|||
148723043|NCT01685073|536457261|FG001|Overall Study|Lost to Follow-up|8|||
148723044|NCT01685073|536457260|FG000|Overall Study|Withdrawal by Subject|24|||
148723045|NCT01685073|536457261|FG001|Overall Study|Withdrawal by Subject|24|||
148723046|NCT00880087|536457264|FG000|Overall Study|Lost to Follow-up|0|||
148723047|NCT00880087|536457265|FG001|Overall Study|Lost to Follow-up|2|||
148723048|NCT00126126|536457266|FG000|Overall Study|Lost to Follow-up|0|||
148723049|NCT00126126|536457267|FG001|Overall Study|Lost to Follow-up|2|||
148723050|NCT00986570|536457271|FG000|Overall Study|Lost to Follow-up|6|||
148723051|NCT00986570|536457271|FG000|Overall Study|Potential bias for objective assessment|1|||
148723052|NCT02225665|536457272|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
148723053|NCT02225665|536457273|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
148723054|NCT02225665|536457272|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
148723055|NCT02225665|536457273|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
148723056|NCT00808509|536457277|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
148723057|NCT00808509|536457278|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
148723058|NCT00808509|536457277|FG000|Randomized Phase|Reduced methotrexate dose|1|||
148723059|NCT00808509|536457278|FG001|Randomized Phase|Reduced methotrexate dose|2|||
148723060|NCT00808509|536457277|FG000|Randomized Phase|Patient refused rescue therapy|0|||
148723061|NCT00808509|536457278|FG001|Randomized Phase|Patient refused rescue therapy|3|||
148723062|NCT00983476|536457284|FG000|Overall Study|Did not receive intervention|17|||
148723063|NCT00983476|536457285|FG001|Overall Study|Did not receive intervention|22|||
148723064|NCT00983476|536457286|FG002|Overall Study|Did not receive intervention|0|||
148969762|NCT01203072|537374714|FG001|Overall Study|Adverse Event|3|||
148969763|NCT01203072|537374715|FG002|Overall Study|Adverse Event|2|||
148723065|NCT01040793|536457292|FG000|Overall Study|Adverse Event|5|||
148723066|NCT01040793|536457293|FG001|Overall Study|Adverse Event|3|||
148723067|NCT01040793|536457294|FG002|Overall Study|Adverse Event|0|||
148723068|NCT01040793|536457295|FG003|Overall Study|Adverse Event|2|||
148723069|NCT01040793|536457296|FG004|Overall Study|Adverse Event|2|||
148723070|NCT01040793|536457297|FG005|Overall Study|Adverse Event|1|||
148723071|NCT01040793|536457292|FG000|Overall Study|Protocol Violation|1|||
148723072|NCT01040793|536457293|FG001|Overall Study|Protocol Violation|1|||
148723073|NCT01040793|536457294|FG002|Overall Study|Protocol Violation|1|||
148723074|NCT01040793|536457295|FG003|Overall Study|Protocol Violation|0|||
148723075|NCT01040793|536457296|FG004|Overall Study|Protocol Violation|1|||
148723076|NCT01040793|536457297|FG005|Overall Study|Protocol Violation|0|||
148723077|NCT01040793|536457292|FG000|Overall Study|Lost to Follow-up|0|||
148723078|NCT01040793|536457293|FG001|Overall Study|Lost to Follow-up|1|||
148723079|NCT01040793|536457294|FG002|Overall Study|Lost to Follow-up|1|||
148969764|NCT01203072|537374716|FG003|Overall Study|Adverse Event|4|||
148969765|NCT01203072|537374717|FG004|Overall Study|Adverse Event|2|||
148723080|NCT01040793|536457295|FG003|Overall Study|Lost to Follow-up|0|||
148723081|NCT01040793|536457296|FG004|Overall Study|Lost to Follow-up|0|||
148723082|NCT01040793|536457297|FG005|Overall Study|Lost to Follow-up|0|||
148723083|NCT01040793|536457292|FG000|Overall Study|Withdrawal by Subject|0|||
148723084|NCT01040793|536457293|FG001|Overall Study|Withdrawal by Subject|0|||
148723085|NCT01040793|536457294|FG002|Overall Study|Withdrawal by Subject|0|||
148723086|NCT01040793|536457295|FG003|Overall Study|Withdrawal by Subject|2|||
148723087|NCT01040793|536457296|FG004|Overall Study|Withdrawal by Subject|0|||
148723088|NCT01040793|536457297|FG005|Overall Study|Withdrawal by Subject|0|||
148723089|NCT01040793|536457292|FG000|Overall Study|Other reasons not listed above|0|||
148723090|NCT01040793|536457293|FG001|Overall Study|Other reasons not listed above|0|||
148723091|NCT01040793|536457294|FG002|Overall Study|Other reasons not listed above|1|||
148723092|NCT01040793|536457295|FG003|Overall Study|Other reasons not listed above|0|||
148723093|NCT01040793|536457296|FG004|Overall Study|Other reasons not listed above|1|||
148723094|NCT01040793|536457297|FG005|Overall Study|Other reasons not listed above|0|||
148723095|NCT00588731|536457301|FG000|Overall Study|Withdrawal by Subject|3|||
148723096|NCT00588731|536457302|FG001|Overall Study|Withdrawal by Subject|2|||
148723097|NCT01198873|536457303|FG000|Overall Study|Adverse Event|4|||
148723098|NCT01198873|536457304|FG001|Overall Study|Adverse Event|7|||
148723099|NCT01198873|536457303|FG000|Overall Study|Study closure|29|||
148723100|NCT01198873|536457304|FG001|Overall Study|Study closure|23|||
148723101|NCT01198873|536457303|FG000|Overall Study|Other than above|4|||
148723102|NCT01198873|536457304|FG001|Overall Study|Other than above|2|||
148723103|NCT04569786|536457305|FG000|Overall Study|Lost to Follow-up|1|||
148723104|NCT04569786|536457306|FG001|Overall Study|Lost to Follow-up|0|||
148723105|NCT04569786|536457307|FG002|Overall Study|Lost to Follow-up|4|||
148723106|NCT04569786|536457308|FG003|Overall Study|Lost to Follow-up|1|||
148723107|NCT04569786|536457309|FG004|Overall Study|Lost to Follow-up|0|||
148723108|NCT04569786|536457305|FG000|Overall Study|Withdrawal by Subject|0|||
148723109|NCT04569786|536457306|FG001|Overall Study|Withdrawal by Subject|0|||
148723110|NCT04569786|536457307|FG002|Overall Study|Withdrawal by Subject|0|||
148723111|NCT04569786|536457308|FG003|Overall Study|Withdrawal by Subject|5|||
148723112|NCT04569786|536457309|FG004|Overall Study|Withdrawal by Subject|1|||
148723113|NCT04569786|536457305|FG000|Overall Study|Physician Decision|0|||
148723114|NCT04569786|536457306|FG001|Overall Study|Physician Decision|0|||
148723115|NCT04569786|536457307|FG002|Overall Study|Physician Decision|0|||
148723116|NCT04569786|536457308|FG003|Overall Study|Physician Decision|1|||
148723117|NCT04569786|536457309|FG004|Overall Study|Physician Decision|0|||
148723118|NCT01684878|536457310|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
148723119|NCT01684878|536457311|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
148723120|NCT01684878|536457312|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
148723121|NCT01684878|536457313|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
148723122|NCT01684878|536457310|FG000|Part 1: Safety Run in Phase|Death|15|||
148723123|NCT01684878|536457311|FG001|Part 1: Safety Run in Phase|Death|20|||
148723124|NCT01684878|536457312|FG002|Part 1: Safety Run in Phase|Death|0|||
148723125|NCT01684878|536457313|FG003|Part 1: Safety Run in Phase|Death|0|||
148723126|NCT01684878|536457310|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
148723127|NCT01684878|536457311|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
148723128|NCT01684878|536457312|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
148723129|NCT01684878|536457313|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
148723130|NCT01684878|536457310|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
148723131|NCT01684878|536457311|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
148723132|NCT01684878|536457312|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
148723133|NCT01684878|536457313|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
148723134|NCT01684878|536457310|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
148723135|NCT01684878|536457311|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
148723136|NCT01684878|536457312|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
148723137|NCT01684878|536457313|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
148723138|NCT01684878|536457310|FG000|Part 2: Randomized Phase|Death|0|||
148723139|NCT01684878|536457311|FG001|Part 2: Randomized Phase|Death|0|||
148723140|NCT01684878|536457312|FG002|Part 2: Randomized Phase|Death|62|||
148723141|NCT01684878|536457313|FG003|Part 2: Randomized Phase|Death|68|||
148723142|NCT01684878|536457310|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
148723143|NCT01684878|536457311|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
148816307|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Death|0|||
148816308|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
148723144|NCT01684878|536457312|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
148723145|NCT01684878|536457313|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
148723146|NCT01684878|536457310|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
148723147|NCT01684878|536457311|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
148723148|NCT01684878|536457312|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
148723149|NCT01684878|536457313|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
148723150|NCT01435031|536457317|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
148723151|NCT01435031|536457317|FG000|ITT at 1 Month|Death|1|||
148723152|NCT01435031|536457317|FG000|ITT at 1 Month|Lost to Follow-up|4|||
148723153|NCT01435031|536457317|FG000|ITT at 6 Months|Death|2|||
148723154|NCT01435031|536457317|FG000|ITT at 6 Months|Lost to Follow-up|3|||
148723155|NCT01435031|536457317|FG000|ITT at 1 Year|Death|1|||
148723156|NCT01435031|536457317|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
148723157|NCT01435031|536457317|FG000|ITT at 1 Year|Lost to Follow-up|6|||
148723158|NCT01435031|536457317|FG000|ITT at 2 Years|Death|7|||
148723159|NCT01435031|536457317|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
148723160|NCT01435031|536457317|FG000|ITT at 2 Years|Lost to Follow-up|4|||
148723161|NCT01435031|536457317|FG000|ITT at 3 Years|Death|5|||
148723162|NCT01435031|536457317|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
148723163|NCT01435031|536457317|FG000|ITT at 3 Years|Lost to Follow-up|4|||
148723164|NCT01435031|536457317|FG000|ITT at 4 Years|Death|4|||
148723165|NCT01435031|536457317|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
148723166|NCT01435031|536457317|FG000|ITT at 4 Years|Lost to Follow-up|1|||
148723167|NCT03942211|536457318|FG000|Overall Study|Death|1|||
148723168|NCT03942211|536457319|FG001|Overall Study|Death|0|||
148723169|NCT03942211|536457318|FG000|Overall Study|Study terminated by sponsor|5|||
148723170|NCT03942211|536457319|FG001|Overall Study|Study terminated by sponsor|3|||
148723171|NCT03942211|536457318|FG000|Overall Study|Adverse Event|0|||
148723172|NCT03942211|536457319|FG001|Overall Study|Adverse Event|1|||
148723173|NCT01955044|536457322|FG000|Overall Study|Death|1|||
148723174|NCT01955044|536457323|FG001|Overall Study|Death|1|||
148723175|NCT01955044|536457324|FG002|Overall Study|Death|0|||
148723176|NCT00104247|536457328|FG000|Overall Study|Withdrawal by Subject|1|||
148723177|NCT00104247|536457329|FG001|Overall Study|Withdrawal by Subject|0|||
148723178|NCT00104247|536457328|FG000|Overall Study|Noncompliant with dosing|0|||
148723179|NCT00104247|536457329|FG001|Overall Study|Noncompliant with dosing|1|||
148723180|NCT00690482|536457331|FG000|Overall Study|Adverse Event|2|||
148723181|NCT00690482|536457332|FG001|Overall Study|Adverse Event|1|||
148723182|NCT00690482|536457331|FG000|Overall Study|Incorrect enrolment|0|||
148723183|NCT00690482|536457332|FG001|Overall Study|Incorrect enrolment|1|||
148723184|NCT00690482|536457331|FG000|Overall Study|Study-specific discontinuation criteria|1|||
148723185|NCT00690482|536457332|FG001|Overall Study|Study-specific discontinuation criteria|0|||
148723186|NCT00690482|536457331|FG000|Overall Study|Intake of prohibited medicine|1|||
148723187|NCT00690482|536457332|FG001|Overall Study|Intake of prohibited medicine|0|||
148723188|NCT00690482|536457331|FG000|Overall Study|withdrew consent at rand.day|0|||
148723189|NCT00690482|536457332|FG001|Overall Study|withdrew consent at rand.day|1|||
148723190|NCT04798482|536457335|FG000|Overall Study|Physician Decision|1|||
148723191|NCT04798482|536457335|FG000|Overall Study|Lost eligibility|1|||
148723192|NCT01930175|536457338|FG000|Core Study|Lost to Follow-up|0|||
148723193|NCT01930175|536457339|FG001|Core Study|Lost to Follow-up|1|||
148723194|NCT01930175|536457340|FG002|Core Study|Lost to Follow-up|0|||
148723195|NCT01930175|536457338|FG000|Core Study|Adverse Event|0|||
148723196|NCT01930175|536457339|FG001|Core Study|Adverse Event|0|||
148723197|NCT01930175|536457340|FG002|Core Study|Adverse Event|1|||
148723198|NCT00890552|536457341|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
148723199|NCT00890552|536457341|FG000|On-treatment|Early prog disease/ death|10|||
148723200|NCT00724373|536457343|FG000|Overall Study|Adverse Event|41|||
148723201|NCT00724373|536457343|FG000|Overall Study|Lack of Efficacy|82|||
148723202|NCT00724373|536457343|FG000|Overall Study|Lost to Follow-up|7|||
148723203|NCT00724373|536457343|FG000|Overall Study|Non-compliance|2|||
148723204|NCT00724373|536457343|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
148723205|NCT00724373|536457343|FG000|Overall Study|Participant moved away|1|||
148723206|NCT00724373|536457343|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
148723207|NCT00724373|536457343|FG000|Overall Study|Only to have 24 week regimen|1|||
148723208|NCT00724373|536457343|FG000|Overall Study|Viral Relapse|1|||
148723209|NCT00724373|536457343|FG000|Overall Study|Acute HCV infection|1|||
148723210|NCT00724373|536457343|FG000|Overall Study|Drug Relapse|1|||
148723211|NCT00724373|536457343|FG000|Overall Study|Tolerability|23|||
148723212|NCT01506908|536457344|FG000|Overall Study|Adverse Event|1|||
148723213|NCT01506908|536457345|FG001|Overall Study|Adverse Event|0|||
148723214|NCT01117766|536457352|FG000|First Intervention|Adverse Event|0|||
148723215|NCT01117766|536457353|FG001|First Intervention|Adverse Event|1|||
148723216|NCT01117766|536457352|FG000|First Intervention|Protocol Violation|1|||
148723217|NCT01117766|536457353|FG001|First Intervention|Protocol Violation|0|||
148723218|NCT01117766|536457352|FG000|Washout Period|Protocol Violation|0|||
148723219|NCT01117766|536457353|FG001|Washout Period|Protocol Violation|2|||
148723220|NCT01117766|536457352|FG000|Second Intervention|Lost to Follow-up|1|||
148723221|NCT01117766|536457353|FG001|Second Intervention|Lost to Follow-up|0|||
148723222|NCT01117766|536457352|FG000|Second Intervention|Other|1|||
148723223|NCT01117766|536457353|FG001|Second Intervention|Other|2|||
148723224|NCT01117766|536457352|FG000|Second Intervention|Adverse Event|0|||
148723225|NCT01117766|536457353|FG001|Second Intervention|Adverse Event|2|||
148723226|NCT01117766|536457352|FG000|Second Intervention|Withdrawal by Subject|0|||
148723227|NCT01117766|536457353|FG001|Second Intervention|Withdrawal by Subject|1|||
148723228|NCT04405739|536457354|FG000|Overall Study|Adverse Event|0|||
148723229|NCT04405739|536457355|FG001|Overall Study|Adverse Event|1|||
148723230|NCT04405739|536457356|FG002|Overall Study|Adverse Event|0|||
148723231|NCT04405739|536457357|FG003|Overall Study|Adverse Event|0|||
148723232|NCT04405739|536457354|FG000|Overall Study|Lost to Follow-up|0|||
148723233|NCT04405739|536457355|FG001|Overall Study|Lost to Follow-up|2|||
148723234|NCT04405739|536457356|FG002|Overall Study|Lost to Follow-up|1|||
148723235|NCT04405739|536457357|FG003|Overall Study|Lost to Follow-up|3|||
148723236|NCT04405739|536457354|FG000|Overall Study|Withdrawal by Subject|0|||
148723237|NCT04405739|536457355|FG001|Overall Study|Withdrawal by Subject|2|||
148723238|NCT04405739|536457356|FG002|Overall Study|Withdrawal by Subject|1|||
148723239|NCT04405739|536457357|FG003|Overall Study|Withdrawal by Subject|1|||
148723240|NCT04405739|536457354|FG000|Overall Study|Death|0|||
148723241|NCT04405739|536457355|FG001|Overall Study|Death|0|||
148723242|NCT04405739|536457356|FG002|Overall Study|Death|1|||
148723243|NCT04405739|536457357|FG003|Overall Study|Death|0|||
148723244|NCT04405739|536457354|FG000|Overall Study|Transferred to rehab|0|||
148723245|NCT04405739|536457355|FG001|Overall Study|Transferred to rehab|0|||
148723246|NCT04405739|536457356|FG002|Overall Study|Transferred to rehab|0|||
148723247|NCT04405739|536457357|FG003|Overall Study|Transferred to rehab|1|||
148723248|NCT04405739|536457354|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
148723249|NCT04405739|536457355|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
148723250|NCT04405739|536457356|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
148723251|NCT04405739|536457357|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
148723252|NCT03718117|536457358|FG000|Overall Study|Death|12|||
148723253|NCT03718117|536457359|FG001|Overall Study|Death|11|||
148723254|NCT03718117|536457360|FG002|Overall Study|Death|0|||
148723255|NCT03718117|536457358|FG000|Overall Study|Other|0|||
148723256|NCT03718117|536457359|FG001|Overall Study|Other|1|||
148723257|NCT03718117|536457360|FG002|Overall Study|Other|0|||
148723258|NCT03718117|536457358|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
148723259|NCT03718117|536457359|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
148723260|NCT03718117|536457360|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
148723261|NCT03718117|536457358|FG000|Overall Study|Participant not met eligibility criteria|0|||
148723262|NCT03718117|536457359|FG001|Overall Study|Participant not met eligibility criteria|0|||
148723263|NCT03718117|536457360|FG002|Overall Study|Participant not met eligibility criteria|2|||
148723264|NCT00206102|536457364|FG000|Overall Study|Adverse Event|119|||
148723265|NCT00206102|536457365|FG001|Overall Study|Adverse Event|82|||
148723266|NCT00206102|536457364|FG000|Overall Study|Protocol Violation|0|||
148723267|NCT00206102|536457365|FG001|Overall Study|Protocol Violation|2|||
148723268|NCT00206102|536457364|FG000|Overall Study|Lack of therapeutic response|16|||
148723269|NCT00206102|536457365|FG001|Overall Study|Lack of therapeutic response|11|||
148723270|NCT00206102|536457364|FG000|Overall Study|Lost to Follow-up|95|||
148723271|NCT00206102|536457365|FG001|Overall Study|Lost to Follow-up|66|||
148723272|NCT00206102|536457364|FG000|Overall Study|Withdrawal by Subject|118|||
148723273|NCT00206102|536457365|FG001|Overall Study|Withdrawal by Subject|101|||
148723274|NCT00206102|536457364|FG000|Overall Study|Study-specific discontinuation criteria|18|||
148723275|NCT00206102|536457365|FG001|Overall Study|Study-specific discontinuation criteria|17|||
148723276|NCT00206102|536457364|FG000|Overall Study|None of those categories|42|||
148723277|NCT00206102|536457365|FG001|Overall Study|None of those categories|36|||
148723278|NCT01917968|536457366|FG000|Overall Study|Death|3|||
148723279|NCT01917968|536457367|FG001|Overall Study|Death|2|||
148723280|NCT01917968|536457366|FG000|Overall Study|Lost to Follow-up|21|||
148723281|NCT01917968|536457367|FG001|Overall Study|Lost to Follow-up|39|||
148723282|NCT01917968|536457366|FG000|Overall Study|Physician Decision|1|||
148723283|NCT01917968|536457367|FG001|Overall Study|Physician Decision|2|||
148723284|NCT01917968|536457366|FG000|Overall Study|Withdrawal by Subject|20|||
148723285|NCT01917968|536457367|FG001|Overall Study|Withdrawal by Subject|35|||
148723286|NCT01917968|536457366|FG000|Overall Study|Subject Relocation|5|||
148723287|NCT01917968|536457367|FG001|Overall Study|Subject Relocation|1|||
148723288|NCT01917968|536457366|FG000|Overall Study|36M Missed Visit|3|||
148723289|NCT01917968|536457367|FG001|Overall Study|36M Missed Visit|2|||
148723290|NCT01917968|536457366|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
148723291|NCT01917968|536457367|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
148723292|NCT01917968|536457366|FG000|Overall Study|Change in Family Circumstances|0|||
148723293|NCT01917968|536457367|FG001|Overall Study|Change in Family Circumstances|1|||
148723294|NCT01917968|536457366|FG000|Overall Study|No Data Available|0|||
148723295|NCT01917968|536457367|FG001|Overall Study|No Data Available|2|||
148723296|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
148723297|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
148723298|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
148723299|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
148723300|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
148723301|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
148723302|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
148723303|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
148723304|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
148816309|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
148723305|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
148723306|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
148723307|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
148723308|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
148723309|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
148723310|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
148723311|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
148723312|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
148723313|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
148723314|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
148723315|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
148723316|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
148723317|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
148723318|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
148723319|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
148723320|NCT01435928|536457369|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
148723321|NCT01435928|536457370|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
148723322|NCT01435928|536457371|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
148723323|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
148723324|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
148723325|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
148723326|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
148723327|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
148723328|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
148723329|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
148723330|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
148723331|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
148723332|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
148723333|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
148723334|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
148723335|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
148723336|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
148723337|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
148723338|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
148723339|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
148723340|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
148723341|NCT01435928|536457369|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
148723342|NCT01435928|536457370|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
148723343|NCT01435928|536457371|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
148723344|NCT04232540|536457375|FG000|Overall Study|Lost to Follow-up|1|||
148723345|NCT04232540|536457376|FG001|Overall Study|Lost to Follow-up|0|||
148723346|NCT03234608|536457377|FG000|Overall Study|Lost to Follow-up|23|||
148723347|NCT03234608|536457378|FG001|Overall Study|Lost to Follow-up|21|||
148723348|NCT02105701|536457379|FG000|Overall Study|Lost to Follow-up|1|||
148723349|NCT02105701|536457380|FG001|Overall Study|Lost to Follow-up|0|||
148723350|NCT02105701|536457381|FG002|Overall Study|Lost to Follow-up|2|||
148723351|NCT02105701|536457382|FG003|Overall Study|Lost to Follow-up|1|||
148723352|NCT02105701|536457379|FG000|Overall Study|Protocol Violation|0|||
148723353|NCT02105701|536457380|FG001|Overall Study|Protocol Violation|0|||
148723354|NCT02105701|536457381|FG002|Overall Study|Protocol Violation|1|||
148723355|NCT02105701|536457382|FG003|Overall Study|Protocol Violation|0|||
148723356|NCT02105701|536457379|FG000|Overall Study|Withdrawal by Subject|2|||
148723357|NCT02105701|536457380|FG001|Overall Study|Withdrawal by Subject|1|||
148723358|NCT02105701|536457381|FG002|Overall Study|Withdrawal by Subject|0|||
148723359|NCT02105701|536457382|FG003|Overall Study|Withdrawal by Subject|1|||
148723360|NCT02105701|536457379|FG000|Overall Study|Death|1|||
148723361|NCT02105701|536457380|FG001|Overall Study|Death|0|||
148723362|NCT02105701|536457381|FG002|Overall Study|Death|0|||
148723363|NCT02105701|536457382|FG003|Overall Study|Death|0|||
148723364|NCT01362296|536457383|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
148723365|NCT01362296|536457384|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
148969766|NCT01203072|537374713|FG000|Overall Study|Lack of Efficacy|1|||
148723366|NCT01362296|536457385|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
148723367|NCT01362296|536457386|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
148723368|NCT01362296|536457383|FG000|Randomized Phase (RP)|Physician Decision|1|||
148723369|NCT01362296|536457384|FG001|Randomized Phase (RP)|Physician Decision|9|||
148969767|NCT01203072|537374714|FG001|Overall Study|Lack of Efficacy|0|||
148969768|NCT01203072|537374715|FG002|Overall Study|Lack of Efficacy|0|||
148723370|NCT01362296|536457385|FG002|Randomized Phase (RP)|Physician Decision|0|||
148723371|NCT01362296|536457386|FG003|Randomized Phase (RP)|Physician Decision|0|||
148723372|NCT01362296|536457383|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
148969769|NCT01203072|537374716|FG003|Overall Study|Lack of Efficacy|0|||
148723373|NCT01362296|536457384|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
148723374|NCT01362296|536457385|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
148723375|NCT01362296|536457386|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
148723376|NCT01362296|536457383|FG000|Randomized Phase (RP)|Adverse Event|20|||
148723377|NCT01362296|536457384|FG001|Randomized Phase (RP)|Adverse Event|4|||
148723378|NCT01362296|536457385|FG002|Randomized Phase (RP)|Adverse Event|0|||
148723379|NCT01362296|536457386|FG003|Randomized Phase (RP)|Adverse Event|0|||
148723380|NCT01362296|536457383|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
148723381|NCT01362296|536457384|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
148723382|NCT01362296|536457385|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
148723383|NCT01362296|536457386|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
148723384|NCT01362296|536457383|FG000|Crossover Phase|PD including Death due to PD|0|||
148723385|NCT01362296|536457384|FG001|Crossover Phase|PD including Death due to PD|0|||
148723386|NCT01362296|536457385|FG002|Crossover Phase|PD including Death due to PD|16|||
148723387|NCT01362296|536457386|FG003|Crossover Phase|PD including Death due to PD|1|||
148723388|NCT01362296|536457383|FG000|Crossover Phase|Withdrawal by Subject|0|||
148723389|NCT01362296|536457384|FG001|Crossover Phase|Withdrawal by Subject|0|||
148723390|NCT01362296|536457385|FG002|Crossover Phase|Withdrawal by Subject|2|||
148723391|NCT01362296|536457386|FG003|Crossover Phase|Withdrawal by Subject|1|||
148723392|NCT01362296|536457383|FG000|Crossover Phase|Adverse Event|0|||
148723393|NCT01362296|536457384|FG001|Crossover Phase|Adverse Event|0|||
148723394|NCT01362296|536457385|FG002|Crossover Phase|Adverse Event|4|||
148723395|NCT01362296|536457386|FG003|Crossover Phase|Adverse Event|0|||
148723396|NCT01362296|536457383|FG000|Crossover Phase|Study Closed/Terminated|0|||
148723397|NCT01362296|536457384|FG001|Crossover Phase|Study Closed/Terminated|0|||
148723398|NCT01362296|536457385|FG002|Crossover Phase|Study Closed/Terminated|1|||
148723399|NCT01362296|536457386|FG003|Crossover Phase|Study Closed/Terminated|0|||
148723400|NCT03693950|536457387|FG000|Overall Study|Withdrawal by Subject|1|||
148723401|NCT03693950|536457388|FG001|Overall Study|Withdrawal by Subject|0|||
148723402|NCT00248170|536457389|FG000|Overall Study|Withdrawal by Subject|71|||
148723403|NCT00248170|536457390|FG001|Overall Study|Withdrawal by Subject|79|||
148723404|NCT00248170|536457389|FG000|Overall Study|Protocol Violation|35|||
148723405|NCT00248170|536457390|FG001|Overall Study|Protocol Violation|30|||
148723406|NCT00248170|536457389|FG000|Overall Study|Lost to Follow-up|28|||
148723407|NCT00248170|536457390|FG001|Overall Study|Lost to Follow-up|35|||
148723408|NCT00248170|536457389|FG000|Overall Study|Disease progression|196|||
148723409|NCT00248170|536457390|FG001|Overall Study|Disease progression|216|||
148723410|NCT00248170|536457389|FG000|Overall Study|Death|28|||
148723411|NCT00248170|536457390|FG001|Overall Study|Death|47|||
148723412|NCT00248170|536457389|FG000|Overall Study|Adverse Event|311|||
148723413|NCT00248170|536457390|FG001|Overall Study|Adverse Event|296|||
148723414|NCT00248170|536457389|FG000|Overall Study|Administrative problems|22|||
148723415|NCT00248170|536457390|FG001|Overall Study|Administrative problems|25|||
148723416|NCT00248170|536457389|FG000|Overall Study|Abnormal test procedure(s) result|49|||
148723417|NCT00248170|536457390|FG001|Overall Study|Abnormal test procedure(s) result|61|||
148723418|NCT00248170|536457389|FG000|Overall Study|Abnormal laboratory values|4|||
148723419|NCT00248170|536457390|FG001|Overall Study|Abnormal laboratory values|0|||
148723420|NCT00248170|536457389|FG000|Overall Study|Protocol deviation|17|||
148723421|NCT00248170|536457390|FG001|Overall Study|Protocol deviation|19|||
148723422|NCT03123783|536457391|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
148723423|NCT03123783|536457392|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
148723424|NCT03123783|536457393|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
148723425|NCT03123783|536457394|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
148723426|NCT03123783|536457395|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
148723427|NCT03123783|536457396|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
148723428|NCT03123783|536457397|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
148723429|NCT03123783|536457391|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
148723430|NCT03123783|536457392|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
148723431|NCT03123783|536457393|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
148723432|NCT03123783|536457394|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
148723433|NCT03123783|536457395|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
148723434|NCT03123783|536457396|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
148723435|NCT03123783|536457397|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
148723436|NCT03123783|536457391|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
148723437|NCT03123783|536457392|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
148723438|NCT03123783|536457393|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
148723439|NCT03123783|536457394|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
148723440|NCT03123783|536457395|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
148723441|NCT03123783|536457396|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
148723442|NCT03123783|536457397|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
148723443|NCT03123783|536457391|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
148723444|NCT03123783|536457392|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
148723445|NCT03123783|536457393|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
148723446|NCT03123783|536457394|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
148723447|NCT03123783|536457395|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
148723448|NCT03123783|536457396|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
148723449|NCT03123783|536457397|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
148723450|NCT00749411|536457403|FG000|Overall Study|Adverse Event|0|||
148723451|NCT00749411|536457404|FG001|Overall Study|Adverse Event|2|||
148723452|NCT00749411|536457403|FG000|Overall Study|Lack of Efficacy|0|||
148723453|NCT00749411|536457404|FG001|Overall Study|Lack of Efficacy|1|||
148723454|NCT00749411|536457403|FG000|Overall Study|Protocol Violation|1|||
148723455|NCT00749411|536457404|FG001|Overall Study|Protocol Violation|1|||
148723456|NCT00749411|536457403|FG000|Overall Study|Protocol-defined stopping criteria|0|||
148723457|NCT00749411|536457404|FG001|Overall Study|Protocol-defined stopping criteria|1|||
148816310|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
148816311|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
148816312|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
148816313|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
148816314|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
148816315|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
148816316|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
148816317|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
148816318|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
148816319|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
148816320|NCT05073315|536802841|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
148816321|NCT05073315|536802842|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
148816322|NCT05073315|536802843|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
148816323|NCT05073315|536802841|FG000|Period 2|Adverse Event|0|||
148816324|NCT05073315|536802842|FG001|Period 2|Adverse Event|3|||
148816325|NCT05073315|536802843|FG002|Period 2|Adverse Event|6|||
148816326|NCT05073315|536802841|FG000|Period 2|Lost to Follow-up|0|||
148816327|NCT05073315|536802842|FG001|Period 2|Lost to Follow-up|5|||
148816328|NCT05073315|536802843|FG002|Period 2|Lost to Follow-up|5|||
148816329|NCT05073315|536802841|FG000|Period 2|Withdrawal by Subject|0|||
148816330|NCT05073315|536802842|FG001|Period 2|Withdrawal by Subject|4|||
148816331|NCT05073315|536802843|FG002|Period 2|Withdrawal by Subject|9|||
148816332|NCT05073315|536802841|FG000|Period 2|Protocol Violation|0|||
148816333|NCT05073315|536802842|FG001|Period 2|Protocol Violation|0|||
148816334|NCT05073315|536802843|FG002|Period 2|Protocol Violation|1|||
148816335|NCT01529268|536802844|FG000|Overall Study|Lost to Follow-up|9|||
148816336|NCT01529268|536802845|FG001|Overall Study|Lost to Follow-up|3|||
148816337|NCT01529268|536802844|FG000|Overall Study|Moved|3|||
148816338|NCT01529268|536802845|FG001|Overall Study|Moved|0|||
148816339|NCT00303953|536802846|FG000|Overall Study|Ineligible|1|||
148816340|NCT00303953|536802846|FG000|Overall Study|Death|1|||
148816341|NCT00303953|536802846|FG000|Overall Study|Adverse Event|4|||
148816342|NCT00303953|536802846|FG000|Overall Study|Lack of Efficacy|12|||
148816343|NCT00303953|536802846|FG000|Overall Study|Physician Decision|1|||
148816344|NCT00021255|536802847|FG000|Overall Study|Death|1|||
148816345|NCT00021255|536802848|FG001|Overall Study|Death|0|||
148816346|NCT00021255|536802849|FG002|Overall Study|Death|2|||
148816347|NCT00021255|536802847|FG000|Overall Study|Breast cancer relapse|5|||
148816348|NCT00021255|536802848|FG001|Overall Study|Breast cancer relapse|18|||
148816349|NCT00021255|536802849|FG002|Overall Study|Breast cancer relapse|11|||
148816350|NCT00021255|536802847|FG000|Overall Study|Second primary malignancy|0|||
148816351|NCT00021255|536802848|FG001|Overall Study|Second primary malignancy|4|||
148816352|NCT00021255|536802849|FG002|Overall Study|Second primary malignancy|1|||
148816353|NCT00021255|536802847|FG000|Overall Study|Withdrawal by Subject|41|||
148816354|NCT00021255|536802848|FG001|Overall Study|Withdrawal by Subject|64|||
148816355|NCT00021255|536802849|FG002|Overall Study|Withdrawal by Subject|26|||
148816356|NCT00021255|536802847|FG000|Overall Study|Lost to Follow-up|0|||
148816357|NCT00021255|536802848|FG001|Overall Study|Lost to Follow-up|2|||
148816358|NCT00021255|536802849|FG002|Overall Study|Lost to Follow-up|3|||
148816359|NCT00021255|536802847|FG000|Overall Study|Cardiac toxicity|0|||
148816360|NCT00021255|536802848|FG001|Overall Study|Cardiac toxicity|61|||
148816361|NCT00021255|536802849|FG002|Overall Study|Cardiac toxicity|32|||
148816362|NCT00021255|536802847|FG000|Overall Study|Herceptin toxicity|0|||
148816363|NCT00021255|536802848|FG001|Overall Study|Herceptin toxicity|22|||
148816364|NCT00021255|536802849|FG002|Overall Study|Herceptin toxicity|6|||
148816365|NCT00021255|536802847|FG000|Overall Study|Adverse Event|46|||
148816366|NCT00021255|536802848|FG001|Overall Study|Adverse Event|30|||
148816367|NCT00021255|536802849|FG002|Overall Study|Adverse Event|18|||
148816368|NCT00021255|536802847|FG000|Overall Study|Protocol Violation|0|||
148816369|NCT00021255|536802848|FG001|Overall Study|Protocol Violation|2|||
148723458|NCT01684215|536459024|FG000|Phase 1, Part 1|Adverse Event|1|||
148723459|NCT01684215|536459025|FG001|Phase 1, Part 1|Adverse Event|0|||
148723460|NCT01684215|536459026|FG002|Phase 1, Part 1|Adverse Event|0|||
148723461|NCT01684215|536459027|FG003|Phase 1, Part 1|Adverse Event|0|||
148723462|NCT01684215|536459024|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
148723463|NCT01684215|536459025|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
148723464|NCT01684215|536459026|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
148723465|NCT01684215|536459027|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
148723466|NCT01684215|536459024|FG000|Phase 1, Part 2|Adverse Event|0|||
148723467|NCT01684215|536459025|FG001|Phase 1, Part 2|Adverse Event|0|||
148723468|NCT01684215|536459026|FG002|Phase 1, Part 2|Adverse Event|1|||
148969770|NCT01203072|537374717|FG004|Overall Study|Lack of Efficacy|0|||
148723469|NCT01684215|536459027|FG003|Phase 1, Part 2|Adverse Event|0|||
148723470|NCT01684215|536459024|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
148723471|NCT01684215|536459025|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
148723472|NCT01684215|536459026|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
148723473|NCT01684215|536459027|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
148723474|NCT01684215|536459024|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
148723475|NCT01684215|536459025|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
148723476|NCT01684215|536459026|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
148723477|NCT01684215|536459027|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
148723478|NCT01684215|536459024|FG000|Phase 2|Death|0|||
148723479|NCT01684215|536459025|FG001|Phase 2|Death|0|||
148723480|NCT01684215|536459026|FG002|Phase 2|Death|0|||
148723481|NCT01684215|536459027|FG003|Phase 2|Death|8|||
148723482|NCT01684215|536459024|FG000|Phase 2|Study terminated by sponsor|0|||
148723483|NCT01684215|536459025|FG001|Phase 2|Study terminated by sponsor|0|||
148723484|NCT01684215|536459026|FG002|Phase 2|Study terminated by sponsor|0|||
148723485|NCT01684215|536459027|FG003|Phase 2|Study terminated by sponsor|30|||
148723486|NCT01684215|536459024|FG000|Phase 2|Enrolled but not treated|0|||
148723487|NCT01684215|536459025|FG001|Phase 2|Enrolled but not treated|0|||
148723488|NCT01684215|536459026|FG002|Phase 2|Enrolled but not treated|0|||
148723489|NCT01684215|536459027|FG003|Phase 2|Enrolled but not treated|1|||
148723490|NCT01684215|536459024|FG000|Phase 2|Lost to Follow-up|0|||
148723491|NCT01684215|536459025|FG001|Phase 2|Lost to Follow-up|0|||
148723492|NCT01684215|536459026|FG002|Phase 2|Lost to Follow-up|0|||
148723493|NCT01684215|536459027|FG003|Phase 2|Lost to Follow-up|4|||
148723494|NCT01301482|536459028|FG000|Overall Study|Withdrawal by Subject|1|||
148723495|NCT01915940|536459031|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
148723496|NCT01915940|536459032|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
148723497|NCT01915940|536459033|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
148723498|NCT01915940|536459031|FG000|Treatment Period|Decision of Participant|0|||
148969771|NCT01203072|537374713|FG000|Overall Study|Lost to Follow-up|0|||
148969772|NCT01203072|537374714|FG001|Overall Study|Lost to Follow-up|1|||
148969773|NCT01203072|537374715|FG002|Overall Study|Lost to Follow-up|0|||
148969774|NCT01203072|537374716|FG003|Overall Study|Lost to Follow-up|0|||
148969775|NCT01203072|537374717|FG004|Overall Study|Lost to Follow-up|0|||
148969776|NCT01203072|537374713|FG000|Overall Study|Protocol Violation|2|||
148969777|NCT01203072|537374714|FG001|Overall Study|Protocol Violation|0|||
148969778|NCT01203072|537374715|FG002|Overall Study|Protocol Violation|0|||
148969779|NCT01203072|537374716|FG003|Overall Study|Protocol Violation|0|||
148969780|NCT01203072|537374717|FG004|Overall Study|Protocol Violation|1|||
148969781|NCT01203072|537374713|FG000|Overall Study|Withdrawal by Subject|2|||
148969782|NCT01203072|537374714|FG001|Overall Study|Withdrawal by Subject|2|||
148969783|NCT01203072|537374715|FG002|Overall Study|Withdrawal by Subject|1|||
148969784|NCT01203072|537374716|FG003|Overall Study|Withdrawal by Subject|2|||
148969785|NCT01203072|537374717|FG004|Overall Study|Withdrawal by Subject|3|||
148969786|NCT02272413|537374719|FG000|Randomized Through Treatment Start|Not treated|3|||
148969787|NCT02272413|537374720|FG001|Randomized Through Treatment Start|Not treated|5|||
148969788|NCT02272413|537374719|FG000|Pre-switch Period|Adverse Event|38|||
148969789|NCT02272413|537374720|FG001|Pre-switch Period|Adverse Event|37|||
148969790|NCT02272413|537374719|FG000|Pre-switch Period|Death|26|||
148969791|NCT02272413|537374720|FG001|Pre-switch Period|Death|26|||
148969792|NCT02272413|537374719|FG000|Pre-switch Period|Withdrawal by Subject|27|||
148723499|NCT01915940|536459032|FG001|Treatment Period|Decision of Participant|1|||
148723500|NCT01915940|536459033|FG002|Treatment Period|Decision of Participant|3|||
148723501|NCT01915940|536459031|FG000|Treatment Period|Adverse Event|0|||
148723502|NCT01915940|536459032|FG001|Treatment Period|Adverse Event|9|||
148723503|NCT01915940|536459033|FG002|Treatment Period|Adverse Event|1|||
148723504|NCT01915940|536459031|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
148723505|NCT01915940|536459032|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
148723506|NCT01915940|536459033|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
148969793|NCT02272413|537374720|FG001|Pre-switch Period|Withdrawal by Subject|15|||
148969794|NCT02272413|537374719|FG000|Pre-switch Period|Physician Decision|6|||
148969795|NCT02272413|537374720|FG001|Pre-switch Period|Physician Decision|18|||
148969796|NCT02272413|537374719|FG000|Pre-switch Period|Progressive disease|185|||
148723507|NCT00614926|536459035|FG000|Overall Study|Burden of travel|1|||
148723508|NCT00614926|536459036|FG001|Overall Study|Burden of travel|0|||
148723509|NCT00614926|536459035|FG000|Overall Study|Adverse Event|3|||
148723510|NCT00614926|536459036|FG001|Overall Study|Adverse Event|0|||
148723511|NCT01005329|536459045|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
148723512|NCT03756883|536459050|FG000|Overall Study|Adverse Event|2|||
148723513|NCT03756883|536459051|FG001|Overall Study|Adverse Event|2|||
148723514|NCT03756883|536459052|FG002|Overall Study|Adverse Event|2|||
148723515|NCT03756883|536459050|FG000|Overall Study|Lack of Efficacy|0|||
148723516|NCT03756883|536459051|FG001|Overall Study|Lack of Efficacy|1|||
148723517|NCT03756883|536459052|FG002|Overall Study|Lack of Efficacy|2|||
148723518|NCT03756883|536459050|FG000|Overall Study|Lost to Follow-up|3|||
148723519|NCT03756883|536459051|FG001|Overall Study|Lost to Follow-up|3|||
148723520|NCT03756883|536459052|FG002|Overall Study|Lost to Follow-up|0|||
148723521|NCT03756883|536459050|FG000|Overall Study|Protocol Violation|2|||
148723522|NCT03756883|536459051|FG001|Overall Study|Protocol Violation|0|||
148723523|NCT03756883|536459052|FG002|Overall Study|Protocol Violation|1|||
148723524|NCT03756883|536459050|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
148723525|NCT03756883|536459051|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
148723526|NCT03756883|536459052|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
148723527|NCT03756883|536459050|FG000|Overall Study|Withdrawal by Subject|4|||
148723528|NCT03756883|536459051|FG001|Overall Study|Withdrawal by Subject|1|||
148723529|NCT03756883|536459052|FG002|Overall Study|Withdrawal by Subject|0|||
148723530|NCT03756883|536459050|FG000|Overall Study|Other Reasons|2|||
148723531|NCT03756883|536459051|FG001|Overall Study|Other Reasons|4|||
148723532|NCT03756883|536459052|FG002|Overall Study|Other Reasons|0|||
148723533|NCT01470417|536459053|FG000|Overall Study|Disease progression|0|||
148723534|NCT01470417|536459054|FG001|Overall Study|Disease progression|2|||
148723535|NCT02973321|536459055|FG000|Overall Study|Other than specified|0|||
148723536|NCT02973321|536459056|FG001|Overall Study|Other than specified|5|||
148723537|NCT02973321|536459057|FG002|Overall Study|Other than specified|3|||
148723538|NCT02973321|536459058|FG003|Overall Study|Other than specified|3|||
148723539|NCT02973321|536459059|FG004|Overall Study|Other than specified|1|||
148723540|NCT02973321|536459055|FG000|Overall Study|Lack of Efficacy|0|||
148723541|NCT02973321|536459056|FG001|Overall Study|Lack of Efficacy|0|||
148723542|NCT02973321|536459057|FG002|Overall Study|Lack of Efficacy|0|||
148723543|NCT02973321|536459058|FG003|Overall Study|Lack of Efficacy|0|||
148723544|NCT02973321|536459059|FG004|Overall Study|Lack of Efficacy|1|||
148723545|NCT02973321|536459055|FG000|Overall Study|Adverse Event|1|||
148723546|NCT02973321|536459056|FG001|Overall Study|Adverse Event|10|||
148723547|NCT02973321|536459057|FG002|Overall Study|Adverse Event|11|||
148723548|NCT02973321|536459058|FG003|Overall Study|Adverse Event|13|||
148723549|NCT02973321|536459059|FG004|Overall Study|Adverse Event|3|||
148723550|NCT01011556|536459062|FG000|Overall Study|Adverse Event|1|||
148723551|NCT01011556|536459063|FG001|Overall Study|Adverse Event|3|||
148723552|NCT01011556|536459064|FG002|Overall Study|Adverse Event|2|||
148723553|NCT01011556|536459065|FG003|Overall Study|Adverse Event|1|||
148723554|NCT01011556|536459062|FG000|Overall Study|Lost to Follow-up|1|||
148723555|NCT01011556|536459063|FG001|Overall Study|Lost to Follow-up|0|||
148723556|NCT01011556|536459064|FG002|Overall Study|Lost to Follow-up|0|||
148723557|NCT01011556|536459065|FG003|Overall Study|Lost to Follow-up|0|||
148723558|NCT01011556|536459062|FG000|Overall Study|Physician Decision|1|||
148723559|NCT01011556|536459063|FG001|Overall Study|Physician Decision|0|||
148723560|NCT01011556|536459064|FG002|Overall Study|Physician Decision|0|||
148723561|NCT01011556|536459065|FG003|Overall Study|Physician Decision|1|||
148723562|NCT01011556|536459062|FG000|Overall Study|Protocol Violation|0|||
148723563|NCT01011556|536459063|FG001|Overall Study|Protocol Violation|1|||
148723564|NCT01011556|536459064|FG002|Overall Study|Protocol Violation|0|||
148723565|NCT01011556|536459065|FG003|Overall Study|Protocol Violation|0|||
148723566|NCT01011556|536459062|FG000|Overall Study|Withdrawal by Subject|1|||
148969797|NCT02272413|537374720|FG001|Pre-switch Period|Progressive disease|173|||
148969798|NCT02272413|537374719|FG000|Pre-switch Period|Lost to Follow-up|0|||
148969799|NCT02272413|537374720|FG001|Pre-switch Period|Lost to Follow-up|2|||
148969800|NCT02272413|537374719|FG000|Pre-switch Period|Protocol Violation|1|||
148969801|NCT02272413|537374720|FG001|Pre-switch Period|Protocol Violation|0|||
148969802|NCT02272413|537374719|FG000|Pre-switch Period|Other than listed|10|||
148723567|NCT01011556|536459063|FG001|Overall Study|Withdrawal by Subject|2|||
148723568|NCT01011556|536459064|FG002|Overall Study|Withdrawal by Subject|4|||
148723569|NCT01011556|536459065|FG003|Overall Study|Withdrawal by Subject|4|||
148723570|NCT01011556|536459062|FG000|Overall Study|Sponsor decision|0|||
148723571|NCT01011556|536459063|FG001|Overall Study|Sponsor decision|1|||
148723572|NCT01011556|536459064|FG002|Overall Study|Sponsor decision|1|||
148723573|NCT01011556|536459065|FG003|Overall Study|Sponsor decision|2|||
148723574|NCT01011556|536459062|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
148723575|NCT01011556|536459063|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
148723576|NCT01011556|536459064|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
148723577|NCT01011556|536459065|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
148816370|NCT00021255|536802849|FG002|Overall Study|Protocol Violation|0|||
148723578|NCT01098110|536459069|FG000|Overall Study|Withdrawal by Subject|14|||
148723579|NCT01098110|536459070|FG001|Overall Study|Withdrawal by Subject|24|||
148723580|NCT01098110|536459071|FG002|Overall Study|Withdrawal by Subject|19|||
148723581|NCT01098110|536459069|FG000|Overall Study|Adverse Event|30|||
148723582|NCT01098110|536459070|FG001|Overall Study|Adverse Event|32|||
148723583|NCT01098110|536459071|FG002|Overall Study|Adverse Event|43|||
148723584|NCT01098110|536459069|FG000|Overall Study|Lack of Efficacy|13|||
148723585|NCT01098110|536459070|FG001|Overall Study|Lack of Efficacy|9|||
148723586|NCT01098110|536459071|FG002|Overall Study|Lack of Efficacy|27|||
148723587|NCT01098110|536459069|FG000|Overall Study|Other|4|||
148723588|NCT01098110|536459070|FG001|Overall Study|Other|7|||
148723589|NCT01098110|536459071|FG002|Overall Study|Other|5|||
148723590|NCT01098110|536459069|FG000|Overall Study|Untreated|1|||
148723591|NCT01098110|536459070|FG001|Overall Study|Untreated|1|||
148723592|NCT01098110|536459071|FG002|Overall Study|Untreated|0|||
148723593|NCT00865514|536459072|FG000|Overall Study|Infusion cost exceeded funding|2|||
148723594|NCT02865395|536459073|FG000|Overall Study|Physician Decision|6|||
148723595|NCT02865395|536459074|FG001|Overall Study|Physician Decision|10|||
148723596|NCT02865395|536459075|FG002|Overall Study|Physician Decision|7|||
148723597|NCT03920280|536459076|FG000|Overall Study|Adverse Event|2|||
148723598|NCT03920280|536459077|FG001|Overall Study|Adverse Event|3|||
148723599|NCT03920280|536459076|FG000|Overall Study|Lost to Follow-up|0|||
148723600|NCT03920280|536459077|FG001|Overall Study|Lost to Follow-up|1|||
148723601|NCT03920280|536459076|FG000|Overall Study|Withdrawal by Subject|1|||
148723602|NCT03920280|536459077|FG001|Overall Study|Withdrawal by Subject|1|||
148723603|NCT03920280|536459076|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
148723604|NCT03920280|536459077|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
148723605|NCT04220775|536459082|FG000|Overall Study|Adverse Event|1|||
148723606|NCT04220775|536459083|FG001|Overall Study|Adverse Event|0|||
148723607|NCT04220775|536459082|FG000|Overall Study|Disease Progression|1|||
148723608|NCT04220775|536459083|FG001|Overall Study|Disease Progression|0|||
148723609|NCT00089076|536459084|FG000|Overall Study|Alternate Therapy|1|||
148723610|NCT00089076|536459084|FG000|Overall Study|Withdrawal by Subject|2|||
148723611|NCT00089076|536459084|FG000|Overall Study|Progression|7|||
148723612|NCT00436917|536459085|FG000|Overall Study|Withdrawal by Subject|13|||
148723613|NCT00436917|536459085|FG000|Overall Study|Adverse Event|2|||
148723614|NCT00436917|536459085|FG000|Overall Study|Physician Decision|1|||
148723615|NCT00436917|536459085|FG000|Overall Study|Death|1|||
148723616|NCT00436917|536459085|FG000|Overall Study|Lost to Follow-up|1|||
148723617|NCT00436917|536459085|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
148723618|NCT00436917|536459085|FG000|Overall Study|Increased creatinine|1|||
148723619|NCT00436917|536459085|FG000|Overall Study|Personal conflicts of patient|1|||
148723620|NCT02169791|536459088|FG000|Overall Study|Death|6|||
148723621|NCT02169791|536459088|FG000|Overall Study|patient withdrew consent|1|||
148723622|NCT03170869|536459089|FG000|Overall Study|Protocol Violation|5|||
148723623|NCT03170869|536459089|FG000|Overall Study|Early study termination|3|||
148723624|NCT01501110|536459094|FG000|Overall Study|Death|0|||
148723625|NCT01501110|536459095|FG001|Overall Study|Death|1|||
148723626|NCT04019054|536459096|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
148723627|NCT04019054|536459097|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
148723628|NCT04019054|536459096|FG000|Overall Study|Withdrawal by Subject|3|||
148723629|NCT04019054|536459097|FG001|Overall Study|Withdrawal by Subject|1|||
148723630|NCT00271024|536459098|FG000|Overall Study|Lost Interest|3|||
148723631|NCT00271024|536459099|FG001|Overall Study|Lost Interest|4|||
148723632|NCT00271024|536459100|FG002|Overall Study|Lost Interest|2|||
148723633|NCT00271024|536459101|FG003|Overall Study|Lost Interest|3|||
148723634|NCT00271024|536459098|FG000|Overall Study|Unknown/Unspecified|11|||
148723635|NCT00271024|536459099|FG001|Overall Study|Unknown/Unspecified|11|||
148723636|NCT00271024|536459100|FG002|Overall Study|Unknown/Unspecified|8|||
148723637|NCT00271024|536459101|FG003|Overall Study|Unknown/Unspecified|4|||
148723638|NCT00271024|536459098|FG000|Overall Study|Protocol Violation|1|||
148723639|NCT00271024|536459099|FG001|Overall Study|Protocol Violation|6|||
148723640|NCT00271024|536459100|FG002|Overall Study|Protocol Violation|5|||
148723641|NCT00271024|536459101|FG003|Overall Study|Protocol Violation|11|||
148969803|NCT02272413|537374720|FG001|Pre-switch Period|Other than listed|11|||
148723642|NCT00271024|536459098|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
148723643|NCT00271024|536459099|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
148723644|NCT00271024|536459100|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
148723645|NCT00271024|536459101|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
148723646|NCT00271024|536459098|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
148723647|NCT00271024|536459099|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
148723648|NCT00271024|536459100|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
148723649|NCT00271024|536459101|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
148723650|NCT03877926|536459110|FG000|Overall Study|Adverse Event|1|||
148723651|NCT03877926|536459111|FG001|Overall Study|Adverse Event|0|||
148723652|NCT03877926|536459112|FG002|Overall Study|Adverse Event|0|||
148723653|NCT03877926|536459113|FG003|Overall Study|Adverse Event|0|||
148723654|NCT03877926|536459110|FG000|Overall Study|Death|2|||
148723655|NCT03877926|536459111|FG001|Overall Study|Death|2|||
148723656|NCT03877926|536459112|FG002|Overall Study|Death|2|||
148723657|NCT03877926|536459113|FG003|Overall Study|Death|0|||
148969804|NCT02272413|537374719|FG000|Post-switch Period|Adverse Event|4|||
148969805|NCT02272413|537374720|FG001|Post-switch Period|Adverse Event|4|||
148969806|NCT02272413|537374719|FG000|Post-switch Period|Death|3|||
148969807|NCT02272413|537374720|FG001|Post-switch Period|Death|2|||
148969808|NCT02272413|537374719|FG000|Post-switch Period|Withdrawal by Subject|1|||
148723658|NCT03877926|536459110|FG000|Overall Study|Lost to Follow-up|41|||
148723659|NCT03877926|536459111|FG001|Overall Study|Lost to Follow-up|52|||
148723660|NCT03877926|536459112|FG002|Overall Study|Lost to Follow-up|45|||
148723661|NCT03877926|536459113|FG003|Overall Study|Lost to Follow-up|17|||
148723662|NCT03877926|536459110|FG000|Overall Study|Physician Decision|2|||
148723663|NCT03877926|536459111|FG001|Overall Study|Physician Decision|0|||
148723664|NCT03877926|536459112|FG002|Overall Study|Physician Decision|2|||
148723665|NCT03877926|536459113|FG003|Overall Study|Physician Decision|0|||
148723666|NCT03877926|536459110|FG000|Overall Study|Withdrawal by Subject|18|||
148723667|NCT03877926|536459111|FG001|Overall Study|Withdrawal by Subject|21|||
148723668|NCT03877926|536459112|FG002|Overall Study|Withdrawal by Subject|12|||
148723669|NCT03877926|536459113|FG003|Overall Study|Withdrawal by Subject|4|||
148723670|NCT03877926|536459110|FG000|Overall Study|Other - Various|4|||
148723671|NCT03877926|536459111|FG001|Overall Study|Other - Various|1|||
148723672|NCT03877926|536459112|FG002|Overall Study|Other - Various|1|||
148723673|NCT03877926|536459113|FG003|Overall Study|Other - Various|0|||
148723674|NCT03877926|536459110|FG000|Overall Study|Not Treated|3|||
148723675|NCT03877926|536459111|FG001|Overall Study|Not Treated|1|||
148723676|NCT03877926|536459112|FG002|Overall Study|Not Treated|1|||
148723677|NCT03877926|536459113|FG003|Overall Study|Not Treated|0|||
148723678|NCT03554317|536459115|FG000|Overall Study|Withdrawal by Subject|1|||
148723679|NCT03554317|536459115|FG000|Overall Study|PSA Progression|3|||
148723680|NCT03554317|536459115|FG000|Overall Study|Radiographic Progression|4|||
148723681|NCT00537199|536459116|FG000|Overall Study|Study Terminated|1|||
148723682|NCT02039063|536459117|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
148723683|NCT02039063|536459118|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
148723684|NCT02039063|536459119|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
148723685|NCT02039063|536459120|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
148723686|NCT02039063|536459117|FG000|Treatment Phase|Progression of disease|0|||
148723687|NCT02039063|536459118|FG001|Treatment Phase|Progression of disease|0|||
148723688|NCT02039063|536459119|FG002|Treatment Phase|Progression of disease|1|||
148723689|NCT02039063|536459120|FG003|Treatment Phase|Progression of disease|1|||
148723690|NCT02039063|536459117|FG000|Extension Phase|Inadequate therapeutic effect|0|||
148723691|NCT02039063|536459118|FG001|Extension Phase|Inadequate therapeutic effect|1|||
148723692|NCT02039063|536459119|FG002|Extension Phase|Inadequate therapeutic effect|2|||
148723693|NCT02039063|536459120|FG003|Extension Phase|Inadequate therapeutic effect|0|||
148723694|NCT02039063|536459117|FG000|Extension Phase|Progression of disease|0|||
148723695|NCT02039063|536459118|FG001|Extension Phase|Progression of disease|0|||
148723696|NCT02039063|536459119|FG002|Extension Phase|Progression of disease|0|||
148723697|NCT02039063|536459120|FG003|Extension Phase|Progression of disease|1|||
148723698|NCT02039063|536459117|FG000|Extension Phase|Adverse Event|0|||
148723699|NCT02039063|536459118|FG001|Extension Phase|Adverse Event|0|||
148723700|NCT02039063|536459119|FG002|Extension Phase|Adverse Event|1|||
148723701|NCT02039063|536459120|FG003|Extension Phase|Adverse Event|0|||
148723702|NCT00467831|536459121|FG000|Overall Study|Death|2|||
148723703|NCT00467831|536459121|FG000|Overall Study|Withdrawal by Subject|1|||
148723704|NCT01832402|536459122|FG000|Overall Study|Lost to Follow-up|2|||
148723705|NCT01832402|536459123|FG001|Overall Study|Lost to Follow-up|0|||
148723706|NCT01832402|536459122|FG000|Overall Study|Withdrawal by Subject|3|||
148723707|NCT01832402|536459123|FG001|Overall Study|Withdrawal by Subject|3|||
148723708|NCT01832402|536459122|FG000|Overall Study|Declining Performance status|2|||
148723709|NCT01832402|536459123|FG001|Overall Study|Declining Performance status|1|||
148723710|NCT00612677|536459124|FG000|Overall Study|study closed before treatment started|1|||
148723711|NCT00860743|536459126|FG000|Overall Study|Withdrawal by Subject|3|||
148723712|NCT00860743|536459127|FG001|Overall Study|Withdrawal by Subject|0|||
148723713|NCT00823199|536459128|FG000|Overall Study|Withdrawal by Subject|2|||
148723714|NCT02776553|536459129|FG000|Overall Study|Lost to Follow-up|1|||
148723715|NCT02776553|536459130|FG001|Overall Study|Lost to Follow-up|0|||
148723716|NCT02776553|536459129|FG000|Overall Study|got liver transplant|1|||
148723717|NCT02776553|536459130|FG001|Overall Study|got liver transplant|2|||
148723718|NCT02776553|536459129|FG000|Overall Study|had other surgery|1|||
148723719|NCT02776553|536459130|FG001|Overall Study|had other surgery|0|||
148723720|NCT02776553|536459129|FG000|Overall Study|Protocol Violation|0|||
148723721|NCT02776553|536459130|FG001|Overall Study|Protocol Violation|1|||
148969809|NCT02272413|537374720|FG001|Post-switch Period|Withdrawal by Subject|2|||
148723722|NCT01640184|536459133|FG000|Overall Study|Death|1|||
148723723|NCT01640184|536459134|FG001|Overall Study|Death|0|||
148723724|NCT01640184|536459135|FG002|Overall Study|Death|0|||
148723725|NCT01640184|536459133|FG000|Overall Study|Lost to Follow-up|4|||
148723726|NCT01640184|536459134|FG001|Overall Study|Lost to Follow-up|1|||
148723727|NCT01640184|536459135|FG002|Overall Study|Lost to Follow-up|0|||
148723728|NCT01640184|536459133|FG000|Overall Study|Physician Decision|3|||
148723729|NCT01640184|536459134|FG001|Overall Study|Physician Decision|0|||
148723730|NCT01640184|536459135|FG002|Overall Study|Physician Decision|0|||
148723731|NCT01640184|536459133|FG000|Overall Study|Withdrawal by Subject|0|||
148723732|NCT01640184|536459134|FG001|Overall Study|Withdrawal by Subject|1|||
148723733|NCT01640184|536459135|FG002|Overall Study|Withdrawal by Subject|1|||
148723734|NCT01640184|536459133|FG000|Overall Study|Protocol Violation|0|||
148723735|NCT01640184|536459134|FG001|Overall Study|Protocol Violation|0|||
148723736|NCT01640184|536459135|FG002|Overall Study|Protocol Violation|1|||
148723737|NCT02927834|536459136|FG000|Overall Study|Lost to Follow-up|1|||
148723738|NCT02927834|536459137|FG001|Overall Study|Lost to Follow-up|2|||
148723739|NCT02927834|536459138|FG002|Overall Study|Lost to Follow-up|2|||
148723740|NCT02492841|536459139|FG000|Overall Study|Lost to Follow-up|34|||
148723741|NCT02492841|536459140|FG001|Overall Study|Lost to Follow-up|31|||
148723742|NCT02492841|536459141|FG002|Overall Study|Lost to Follow-up|35|||
148723743|NCT00613730|536459142|FG000|Overall Study|Disease progression|2|||
148723744|NCT00613730|536459142|FG000|Overall Study|Administrative decision|1|||
148723745|NCT00479388|536459143|FG000|Overall Study|Adverse Event|90|||
148723746|NCT00479388|536459144|FG001|Overall Study|Adverse Event|45|||
148723747|NCT00479388|536459143|FG000|Overall Study|Lost to Follow-up|0|||
148723748|NCT00479388|536459144|FG001|Overall Study|Lost to Follow-up|2|||
148723749|NCT00479388|536459143|FG000|Overall Study|Protocol Violation|10|||
148723750|NCT00479388|536459144|FG001|Overall Study|Protocol Violation|9|||
148723751|NCT00479388|536459143|FG000|Overall Study|Withdrawal by Subject|32|||
148723752|NCT00479388|536459144|FG001|Overall Study|Withdrawal by Subject|17|||
148723753|NCT01876368|536459147|FG000|Overall Study|Adverse Event|2|||
148723754|NCT01876368|536459148|FG001|Overall Study|Adverse Event|5|||
148723755|NCT01876368|536459147|FG000|Overall Study|Lack of Efficacy|1|||
148723756|NCT01876368|536459148|FG001|Overall Study|Lack of Efficacy|0|||
148723757|NCT01876368|536459147|FG000|Overall Study|Lost to Follow-up|0|||
148723758|NCT01876368|536459148|FG001|Overall Study|Lost to Follow-up|1|||
148723759|NCT01876368|536459147|FG000|Overall Study|Non-compliance with study treatment|0|||
148723760|NCT01876368|536459148|FG001|Overall Study|Non-compliance with study treatment|1|||
148723761|NCT01876368|536459147|FG000|Overall Study|Physician Decision|0|||
148723762|NCT01876368|536459148|FG001|Overall Study|Physician Decision|2|||
148723763|NCT01876368|536459147|FG000|Overall Study|Protocol deviation|3|||
148723764|NCT01876368|536459148|FG001|Overall Study|Protocol deviation|3|||
148723765|NCT01876368|536459147|FG000|Overall Study|Subject/guardian decision|3|||
148723766|NCT01876368|536459148|FG001|Overall Study|Subject/guardian decision|1|||
148723767|NCT02563769|536459149|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
148723768|NCT02563769|536459150|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
148723769|NCT02563769|536459151|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
148723770|NCT01644149|536459154|FG000|Overall Study|Withdrawal by Subject|1|||
148723771|NCT01644149|536459155|FG001|Overall Study|Withdrawal by Subject|0|||
148723772|NCT01644149|536459154|FG000|Overall Study|Lost to Follow-up|3|||
148723773|NCT01644149|536459155|FG001|Overall Study|Lost to Follow-up|1|||
148723774|NCT02820740|536459158|FG000|Overall Study|Did not have procedure|2|||
148723775|NCT04965389|536459159|FG000|Overall Study|Other reasons|1|||
148723776|NCT04965389|536459160|FG001|Overall Study|Other reasons|0|||
148723777|NCT04965389|536459161|FG002|Overall Study|Other reasons|0|||
148723778|NCT04965389|536459162|FG003|Overall Study|Other reasons|0|||
148723779|NCT04965389|536459159|FG000|Overall Study|Participant withdrew consent|0|||
148723780|NCT04965389|536459160|FG001|Overall Study|Participant withdrew consent|1|||
148723781|NCT04965389|536459161|FG002|Overall Study|Participant withdrew consent|0|||
148723782|NCT04965389|536459162|FG003|Overall Study|Participant withdrew consent|0|||
148723783|NCT04965389|536459159|FG000|Overall Study|Poor/Non-compliance|0|||
148723784|NCT04965389|536459160|FG001|Overall Study|Poor/Non-compliance|1|||
148723785|NCT04965389|536459161|FG002|Overall Study|Poor/Non-compliance|0|||
148723786|NCT04965389|536459162|FG003|Overall Study|Poor/Non-compliance|0|||
148723787|NCT03903159|536459163|FG000|Overall Study|Discharged with Staff Approval|2|||
148723788|NCT03903159|536459163|FG000|Overall Study|Discharged at Staff Request|2|||
148723789|NCT03903159|536459163|FG000|Overall Study|Discharged Against Staff Advice|1|||
148723790|NCT01436643|536459167|FG000|2-week Pre-treatment|Abnormal test result|0|||
148816371|NCT00021255|536802847|FG000|Overall Study|Other than specified above|0|||
148723791|NCT01436643|536459168|FG001|2-week Pre-treatment|Abnormal test result|0|||
148723792|NCT01436643|536459169|FG002|2-week Pre-treatment|Abnormal test result|0|||
148723793|NCT01436643|536459170|FG003|2-week Pre-treatment|Abnormal test result|1|||
148723794|NCT01436643|536459167|FG000|2-week Pre-treatment|Adverse Event|0|||
148723795|NCT01436643|536459168|FG001|2-week Pre-treatment|Adverse Event|0|||
148723796|NCT01436643|536459169|FG002|2-week Pre-treatment|Adverse Event|0|||
148723797|NCT01436643|536459170|FG003|2-week Pre-treatment|Adverse Event|5|||
148723798|NCT01436643|536459167|FG000|2-week Pre-treatment|Protocol Violation|0|||
148723799|NCT01436643|536459168|FG001|2-week Pre-treatment|Protocol Violation|0|||
148723800|NCT01436643|536459169|FG002|2-week Pre-treatment|Protocol Violation|0|||
148723801|NCT01436643|536459170|FG003|2-week Pre-treatment|Protocol Violation|4|||
148723802|NCT01436643|536459167|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
148723803|NCT01436643|536459168|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
148723804|NCT01436643|536459169|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
148723805|NCT01436643|536459170|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
148723806|NCT01436643|536459167|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
148723807|NCT01436643|536459168|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
148723808|NCT01436643|536459169|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
148723809|NCT01436643|536459170|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
148723810|NCT01436643|536459167|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
148723811|NCT01436643|536459168|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
148723812|NCT01436643|536459169|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
148723813|NCT01436643|536459170|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
148723814|NCT01382251|536459171|FG000|Overall Study|Surgeries cancelled or delayed|16|||
148723815|NCT01382251|536459172|FG001|Overall Study|Surgeries cancelled or delayed|16|||
148723816|NCT01382251|536459171|FG000|Overall Study|Lost to Follow-up|4|||
148723817|NCT01382251|536459172|FG001|Overall Study|Lost to Follow-up|4|||
148723818|NCT01382251|536459171|FG000|Overall Study|Contacted after study closed|1|||
148723819|NCT01382251|536459172|FG001|Overall Study|Contacted after study closed|1|||
148723820|NCT01117987|536459173|FG000|Overall Study|Protocol deviation|0|||
148723821|NCT01117987|536459174|FG001|Overall Study|Protocol deviation|1|||
148723822|NCT01117987|536459173|FG000|Overall Study|Subject no longer requires study drug|1|||
148723823|NCT01117987|536459174|FG001|Overall Study|Subject no longer requires study drug|0|||
148723824|NCT01117987|536459173|FG000|Overall Study|Lost to Follow-up|1|||
148723825|NCT01117987|536459174|FG001|Overall Study|Lost to Follow-up|1|||
148723826|NCT01117987|536459173|FG000|Overall Study|Abnormal test procedure result|2|||
148723827|NCT01117987|536459174|FG001|Overall Study|Abnormal test procedure result|0|||
148723828|NCT01117987|536459173|FG000|Overall Study|Lack of Efficacy|3|||
148723829|NCT01117987|536459174|FG001|Overall Study|Lack of Efficacy|4|||
148723830|NCT01117987|536459173|FG000|Overall Study|Death|5|||
148723831|NCT01117987|536459174|FG001|Overall Study|Death|10|||
148723832|NCT01117987|536459173|FG000|Overall Study|Withdrawal by Subject|5|||
148723833|NCT01117987|536459174|FG001|Overall Study|Withdrawal by Subject|10|||
148723834|NCT01117987|536459173|FG000|Overall Study|Adverse Event|19|||
148723835|NCT01117987|536459174|FG001|Overall Study|Adverse Event|26|||
148723836|NCT01117987|536459173|FG000|Overall Study|Administrative problems|25|||
148723837|NCT01117987|536459174|FG001|Overall Study|Administrative problems|22|||
148723838|NCT04117945|536459175|FG000|Overall Study|Death|1|||
148723839|NCT04117945|536459176|FG001|Overall Study|Death|0|||
148723840|NCT04117945|536459175|FG000|Overall Study|Withdrawal by Subject|3|||
148723841|NCT04117945|536459176|FG001|Overall Study|Withdrawal by Subject|1|||
148723842|NCT04117945|536459175|FG000|Overall Study|Disease Progression|0|||
148723843|NCT04117945|536459176|FG001|Overall Study|Disease Progression|2|||
148723844|NCT04117945|536459175|FG000|Overall Study|Ineligible|8|||
148723845|NCT04117945|536459176|FG001|Overall Study|Ineligible|7|||
148723846|NCT00562120|536459182|FG000|First Intervention Period|Adverse Event|1|||
148723847|NCT00562120|536459183|FG001|First Intervention Period|Adverse Event|0|||
148723848|NCT00562120|536459184|FG002|First Intervention Period|Adverse Event|0|||
148723849|NCT00562120|536459185|FG003|First Intervention Period|Adverse Event|0|||
148723850|NCT00562120|536459182|FG000|First Intervention Period|Randomized but not Treated|1|||
148723851|NCT00562120|536459183|FG001|First Intervention Period|Randomized but not Treated|0|||
148723852|NCT00562120|536459184|FG002|First Intervention Period|Randomized but not Treated|0|||
148723853|NCT00562120|536459185|FG003|First Intervention Period|Randomized but not Treated|0|||
148723854|NCT02148445|536459186|FG000|Overall Study|Death|1|||
148723855|NCT02148445|536459187|FG001|Overall Study|Death|3|||
148723856|NCT03450629|536459188|FG000|Overall Study|Adverse Event|15|||
148723857|NCT03450629|536459189|FG001|Overall Study|Adverse Event|14|||
148723858|NCT03450629|536459188|FG000|Overall Study|Physician Decision|2|||
148723859|NCT03450629|536459189|FG001|Overall Study|Physician Decision|2|||
148723860|NCT03450629|536459188|FG000|Overall Study|Lack of Efficacy|2|||
148723861|NCT03450629|536459189|FG001|Overall Study|Lack of Efficacy|0|||
148723862|NCT03450629|536459188|FG000|Overall Study|Lost to Follow-up|4|||
148723863|NCT03450629|536459189|FG001|Overall Study|Lost to Follow-up|2|||
148723864|NCT03450629|536459188|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
148723865|NCT03450629|536459189|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
148723866|NCT03450629|536459188|FG000|Overall Study|Non-Compliance With Study Drug|2|||
148723867|NCT03450629|536459189|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148723868|NCT03450629|536459188|FG000|Overall Study|Protocol Violation|11|||
148723869|NCT03450629|536459189|FG001|Overall Study|Protocol Violation|8|||
148723870|NCT03450629|536459188|FG000|Overall Study|Withdrawal by Subject|12|||
148723871|NCT03450629|536459189|FG001|Overall Study|Withdrawal by Subject|6|||
148723872|NCT04230876|536459191|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
148723873|NCT04230876|536459192|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
148723874|NCT02093923|536459193|FG000|Overall Study|Lost to Follow-up|0|||
148723875|NCT02093923|536459194|FG001|Overall Study|Lost to Follow-up|0|||
148723876|NCT02093923|536459195|FG002|Overall Study|Lost to Follow-up|0|||
148723877|NCT02093923|536459196|FG003|Overall Study|Lost to Follow-up|1|||
148723878|NCT02093923|536459197|FG004|Overall Study|Lost to Follow-up|0|||
148723879|NCT02093923|536459193|FG000|Overall Study|Screen failure after randomization|0|||
148723880|NCT02093923|536459194|FG001|Overall Study|Screen failure after randomization|0|||
148723881|NCT02093923|536459195|FG002|Overall Study|Screen failure after randomization|0|||
148723882|NCT02093923|536459196|FG003|Overall Study|Screen failure after randomization|1|||
148723883|NCT02093923|536459197|FG004|Overall Study|Screen failure after randomization|0|||
148723884|NCT03438006|536459198|FG000|Overall Study|Adverse Event|1|||
148723885|NCT03438006|536459198|FG000|Overall Study|Lost to Follow-up|67|||
148723886|NCT03438006|536459198|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
148723887|NCT03438006|536459198|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
148723888|NCT01662362|536459203|FG000|Overall Study|Lost to Follow-up|38|||
148723889|NCT02339090|536459209|FG000|Overall Study|Adverse Event|1|||
148723890|NCT02339090|536459210|FG001|Overall Study|Adverse Event|0|||
148723891|NCT02339090|536459209|FG000|Overall Study|Lost to Follow-up|0|||
148723892|NCT02339090|536459210|FG001|Overall Study|Lost to Follow-up|1|||
148723893|NCT02339090|536459209|FG000|Overall Study|Non-compliance With Study Drug|0|||
148723894|NCT02339090|536459210|FG001|Overall Study|Non-compliance With Study Drug|1|||
148723895|NCT02339090|536459209|FG000|Overall Study|Withdrawal by Subject|2|||
148723896|NCT02339090|536459210|FG001|Overall Study|Withdrawal by Subject|1|||
148723897|NCT02339090|536459209|FG000|Overall Study|Poor Growth|3|||
148723898|NCT02339090|536459210|FG001|Overall Study|Poor Growth|0|||
148723899|NCT02339090|536459209|FG000|Overall Study|Randomized but not treated|0|||
148723900|NCT02339090|536459210|FG001|Overall Study|Randomized but not treated|2|||
148723901|NCT02737592|536459212|FG000|Overall Study|Withdrawal by Subject|1|||
148723902|NCT01253317|536459218|FG000|Overall Study|Adverse Event|2|||
148723903|NCT04678817|536460962|FG000|Overall Study|Lost to Follow-up|28|||
148723904|NCT04678817|536460963|FG001|Overall Study|Lost to Follow-up|0|||
148723905|NCT04678817|536460964|FG002|Overall Study|Lost to Follow-up|0|||
148723906|NCT02284347|536460968|FG000|Overall Study|Lost to Follow-up|2|||
148723907|NCT02284347|536460968|FG000|Overall Study|Withdrawn prior to treatment|1|||
148723908|NCT02999984|536460981|FG000|Overall Study|Treatment Failure|1|||
148723909|NCT04039919|536460984|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148723910|NCT04039919|536460985|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148723911|NCT04039919|536460986|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148723912|NCT04039919|536460987|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148723913|NCT04039919|536460988|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148723914|NCT04039919|536460984|FG000|Treatment Period 1|Sponsor's decision|0|||
148723915|NCT04039919|536460985|FG001|Treatment Period 1|Sponsor's decision|0|||
148723916|NCT04039919|536460986|FG002|Treatment Period 1|Sponsor's decision|0|||
148723917|NCT04039919|536460987|FG003|Treatment Period 1|Sponsor's decision|0|||
148723918|NCT04039919|536460988|FG004|Treatment Period 1|Sponsor's decision|16|||
148723919|NCT04039919|536460984|FG000|Treatment Period 5|Withdrawal by Subject|1|||
148723920|NCT04039919|536460985|FG001|Treatment Period 5|Withdrawal by Subject|0|||
148723921|NCT04039919|536460986|FG002|Treatment Period 5|Withdrawal by Subject|0|||
148723922|NCT04039919|536460987|FG003|Treatment Period 5|Withdrawal by Subject|0|||
148723923|NCT04039919|536460988|FG004|Treatment Period 5|Withdrawal by Subject|0|||
148723924|NCT00754013|536460989|FG000|Overall Study|Lost to Follow-up|1|||
148723925|NCT00754013|536460990|FG001|Overall Study|Lost to Follow-up|1|||
148723926|NCT00754013|536460989|FG000|Overall Study|didn't return after study termed|3|||
148723927|NCT00754013|536460990|FG001|Overall Study|didn't return after study termed|4|||
148723928|NCT02310789|536460991|FG000|Overall Study|Adverse Event|1|||
148723929|NCT01197417|536460992|FG000|Overall Study|Physician Decision|3|||
148723930|NCT01197417|536460993|FG001|Overall Study|Physician Decision|2|||
148723931|NCT01197417|536460992|FG000|Overall Study|Withdrawal by Subject|2|||
148723932|NCT01197417|536460993|FG001|Overall Study|Withdrawal by Subject|4|||
148723933|NCT01197417|536460992|FG000|Overall Study|Site miscommunication|0|||
148723934|NCT01197417|536460993|FG001|Overall Study|Site miscommunication|1|||
148723935|NCT01197417|536460992|FG000|Overall Study|Subject transferred to intensive care|0|||
148723936|NCT01197417|536460993|FG001|Overall Study|Subject transferred to intensive care|1|||
148723937|NCT01197417|536460992|FG000|Overall Study|Not consented in time to receive drug|0|||
148723938|NCT01197417|536460993|FG001|Overall Study|Not consented in time to receive drug|1|||
148723939|NCT01197417|536460992|FG000|Overall Study|Hypotension|1|||
148723940|NCT01197417|536460993|FG001|Overall Study|Hypotension|2|||
148723941|NCT01197417|536460992|FG000|Overall Study|Found to be ineligible|2|||
148723942|NCT01197417|536460993|FG001|Overall Study|Found to be ineligible|5|||
148723943|NCT01197417|536460992|FG000|Overall Study|No 25-hour magnesium level|0|||
148723944|NCT01197417|536460993|FG001|Overall Study|No 25-hour magnesium level|2|||
148723945|NCT03250299|536460994|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
148723946|NCT03250299|536460995|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
148723947|NCT03250299|536460996|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
148723948|NCT03250299|536460997|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
148723949|NCT03250299|536460998|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
148723950|NCT03250299|536460994|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
148723951|NCT03250299|536460995|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
148723952|NCT03250299|536460996|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
148723953|NCT03250299|536460997|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
148723954|NCT03250299|536460998|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
148723955|NCT03250299|536460994|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
148723956|NCT03250299|536460995|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
148723957|NCT03250299|536460996|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
148723958|NCT03250299|536460997|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
148723959|NCT03250299|536460998|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
148723960|NCT03250299|536460994|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
148723961|NCT03250299|536460995|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
148723962|NCT03250299|536460996|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
148723963|NCT03250299|536460997|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
148723964|NCT03250299|536460998|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
148723965|NCT01546142|536461013|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
148723966|NCT01546142|536461014|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
148723967|NCT01546142|536461013|FG000|Overall Study|Subject Noncompliance|1|||
148723968|NCT01546142|536461014|FG001|Overall Study|Subject Noncompliance|1|||
148723969|NCT01546142|536461013|FG000|Overall Study|Adverse Event|6|||
148723970|NCT01546142|536461014|FG001|Overall Study|Adverse Event|3|||
148723971|NCT01546142|536461013|FG000|Overall Study|Lost to Follow-up|20|||
148723972|NCT01546142|536461014|FG001|Overall Study|Lost to Follow-up|15|||
148723973|NCT01546142|536461013|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
148723974|NCT01546142|536461014|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
148723975|NCT01546142|536461013|FG000|Overall Study|Subject Randomized but Not Treated|1|||
148723976|NCT01546142|536461014|FG001|Overall Study|Subject Randomized but Not Treated|0|||
148723977|NCT01213836|536461015|FG000|Period 1, First Intervention|Adverse Event|2|||
148723978|NCT01213836|536461016|FG001|Period 1, First Intervention|Adverse Event|1|||
148723979|NCT01213836|536461015|FG000|Period 1, First Intervention|Protocol Violation|0|||
148723980|NCT01213836|536461016|FG001|Period 1, First Intervention|Protocol Violation|1|||
148723981|NCT01213836|536461015|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
148723982|NCT01213836|536461016|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
148723983|NCT00706095|536461017|FG000|Overall Study|Progressive Disease|4|||
148723984|NCT00706095|536461018|FG001|Overall Study|Progressive Disease|5|||
148723985|NCT00706095|536461019|FG002|Overall Study|Progressive Disease|3|||
148723986|NCT00706095|536461017|FG000|Overall Study|Clinical Progression|1|||
148723987|NCT00706095|536461018|FG001|Overall Study|Clinical Progression|2|||
148723988|NCT00706095|536461019|FG002|Overall Study|Clinical Progression|2|||
148723989|NCT00706095|536461017|FG000|Overall Study|Withdrawal by Subject|1|||
148723990|NCT00706095|536461018|FG001|Overall Study|Withdrawal by Subject|0|||
148723991|NCT00706095|536461019|FG002|Overall Study|Withdrawal by Subject|0|||
148723992|NCT01311557|536461025|FG000|Overall Study|Serious adverse event|0|||
148723993|NCT01311557|536461026|FG001|Overall Study|Serious adverse event|1|||
148723994|NCT01311557|536461025|FG000|Overall Study|Protocol Violation|4|||
148723995|NCT01311557|536461026|FG001|Overall Study|Protocol Violation|2|||
148723996|NCT01311557|536461025|FG000|Overall Study|Lost to Follow-up|0|||
148723997|NCT01311557|536461026|FG001|Overall Study|Lost to Follow-up|1|||
148723998|NCT01311557|536461025|FG000|Overall Study|Withdrawal by Subject|1|||
148723999|NCT01311557|536461026|FG001|Overall Study|Withdrawal by Subject|2|||
148724000|NCT05212883|536461029|FG000|Overall Study|Invalid test result|125|||
148724001|NCT01009515|536461033|FG000|Overall Study|Withdrawal by Subject|3|||
148724002|NCT02075606|536461035|FG000|Overall Study|Adverse Event|5|||
148724003|NCT02075606|536461035|FG000|Overall Study|Withdrawal by Subject|1|||
148724004|NCT02075606|536461035|FG000|Overall Study|Death|1|||
148724005|NCT02075606|536461035|FG000|Overall Study|Investigator's decision|1|||
148724006|NCT02075606|536461035|FG000|Overall Study|Symptom management|1|||
148724007|NCT02075606|536461035|FG000|Overall Study|Increasing Symptoms|1|||
148724008|NCT01439724|536461036|FG000|Overall Study|missing consultation|9|||
148724009|NCT01439724|536461037|FG001|Overall Study|missing consultation|8|||
148724010|NCT01261624|536461043|FG000|Week 0 to Week 12|Disease Progression|1|||
148724011|NCT01261624|536461044|FG001|Week 0 to Week 12|Disease Progression|1|||
148724012|NCT01261624|536461043|FG000|Week 0 to Week 12|Insufficient Response|0|||
148724013|NCT01261624|536461044|FG001|Week 0 to Week 12|Insufficient Response|2|||
148724014|NCT01261624|536461043|FG000|Week 13 to Week 24|Insufficient Response|0|||
148724015|NCT01261624|536461044|FG001|Week 13 to Week 24|Insufficient Response|1|||
148724016|NCT03573817|536461049|FG000|Overall Study|Adverse Event|0|||
148724017|NCT03573817|536461050|FG001|Overall Study|Adverse Event|2|||
148724018|NCT03573817|536461049|FG000|Overall Study|Protocol Violation|0|||
148724019|NCT03573817|536461050|FG001|Overall Study|Protocol Violation|1|||
148724020|NCT03573817|536461049|FG000|Overall Study|Withdrawal by Subject|1|||
148724021|NCT03573817|536461050|FG001|Overall Study|Withdrawal by Subject|1|||
148724022|NCT01719562|536461051|FG000|Overall Study|Lost to Follow-up|1|||
148724023|NCT01719562|536461052|FG001|Overall Study|Lost to Follow-up|0|||
148724024|NCT01719562|536461051|FG000|Overall Study|Death|1|||
148724025|NCT01719562|536461052|FG001|Overall Study|Death|0|||
148724026|NCT01719562|536461051|FG000|Overall Study|New cancer diagnosis|1|||
148724027|NCT01719562|536461052|FG001|Overall Study|New cancer diagnosis|0|||
148724028|NCT00508027|536461053|FG000|Dose Level 1|Lost to Follow-up|4|||
148724029|NCT00508027|536461053|FG000|Dose Level 1|Withdrawal by Subject|2|||
148724030|NCT00508027|536461053|FG000|Dose Level 1|Physician Decision|2|||
148724031|NCT00508027|536461053|FG000|Dose Level 2|Lost to Follow-up|2|||
148969810|NCT02272413|537374719|FG000|Post-switch Period|Physician Decision|1|||
148969811|NCT02272413|537374720|FG001|Post-switch Period|Physician Decision|1|||
148969812|NCT02272413|537374719|FG000|Post-switch Period|Progressive disease|21|||
148969813|NCT02272413|537374720|FG001|Post-switch Period|Progressive disease|21|||
148969814|NCT02272413|537374719|FG000|Post-switch Period|Study terminated by sponsor|8|||
148969815|NCT02272413|537374720|FG001|Post-switch Period|Study terminated by sponsor|11|||
148969816|NCT02272413|537374719|FG000|Post-switch Period|Other than listed|4|||
148969817|NCT02272413|537374720|FG001|Post-switch Period|Other than listed|5|||
148969818|NCT02126969|537374723|FG000|Overall Study|Withdrawal by Subject|1|||
148969819|NCT02126969|537374724|FG001|Overall Study|Withdrawal by Subject|2|||
148969820|NCT01533246|537374732|FG000|Overall Study|Adverse Event|1|||
148969821|NCT01533246|537374732|FG000|Overall Study|Withdrawal by Subject|1|||
148969822|NCT02286193|537374733|FG000|Overall Study|Referred: CRS unable to make contact|62|||
148969823|NCT02286193|537374733|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
148969824|NCT02286193|537374733|FG000|Overall Study|Referred: Declined service|38|||
148969825|NCT00354172|537374734|FG000|Overall Study|Did not receive transplant|1|||
148969826|NCT00423891|537374735|FG000|Enrolled|Withdrawal by Subject|0|||
148969827|NCT00423891|537374736|FG001|Enrolled|Withdrawal by Subject|0|||
148969828|NCT00423891|537374737|FG002|Enrolled|Withdrawal by Subject|1|||
148969829|NCT00423891|537374735|FG000|Enrolled|Lost to Follow-up|0|||
148969830|NCT00423891|537374736|FG001|Enrolled|Lost to Follow-up|0|||
148969831|NCT00423891|537374737|FG002|Enrolled|Lost to Follow-up|1|||
148969832|NCT00423891|537374735|FG000|Enrolled|No longer met criteria|11|||
148969833|NCT00423891|537374736|FG001|Enrolled|No longer met criteria|2|||
148969834|NCT00423891|537374737|FG002|Enrolled|No longer met criteria|1|||
148969835|NCT00423891|537374735|FG000|Treatment|Withdrawal by Subject|1|||
148969836|NCT00423891|537374736|FG001|Treatment|Withdrawal by Subject|0|||
148969837|NCT00423891|537374737|FG002|Treatment|Withdrawal by Subject|0|||
148969838|NCT00423891|537374735|FG000|Treatment|Lost to Follow-up|1|||
148969839|NCT00423891|537374736|FG001|Treatment|Lost to Follow-up|0|||
148969840|NCT00423891|537374737|FG002|Treatment|Lost to Follow-up|0|||
148969841|NCT00423891|537374735|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
148724032|NCT00508027|536461053|FG000|Dose Level 2|Withdrawal by Subject|2|||
148724033|NCT02013531|536461054|FG000|Overall Study|Lost to Follow-up|3|||
148724034|NCT02013531|536461054|FG000|Overall Study|Met Withdrawal Criteria|1|||
148724035|NCT02013531|536461054|FG000|Overall Study|Withdrawal by Subject|1|||
148724036|NCT00939627|536461057|FG000|Overall Study|Disease Progression|16|||
148724037|NCT00939627|536461058|FG001|Overall Study|Disease Progression|12|||
148724038|NCT00939627|536461059|FG002|Overall Study|Disease Progression|0|||
148724039|NCT00939627|536461057|FG000|Overall Study|Adverse Event|6|||
148724040|NCT00939627|536461058|FG001|Overall Study|Adverse Event|7|||
148724041|NCT00939627|536461059|FG002|Overall Study|Adverse Event|0|||
148724042|NCT00939627|536461057|FG000|Overall Study|Death|0|||
148724043|NCT00939627|536461058|FG001|Overall Study|Death|2|||
148724044|NCT00939627|536461059|FG002|Overall Study|Death|0|||
148724045|NCT00939627|536461057|FG000|Overall Study|Withdrawal by Subject|2|||
148724046|NCT00939627|536461058|FG001|Overall Study|Withdrawal by Subject|4|||
148724047|NCT00939627|536461059|FG002|Overall Study|Withdrawal by Subject|0|||
148724048|NCT00939627|536461057|FG000|Overall Study|Other complicating disease|1|||
148724049|NCT00939627|536461058|FG001|Overall Study|Other complicating disease|1|||
148724050|NCT00939627|536461059|FG002|Overall Study|Other complicating disease|0|||
148724051|NCT00939627|536461057|FG000|Overall Study|Not compliant|2|||
148724052|NCT00939627|536461058|FG001|Overall Study|Not compliant|0|||
148724053|NCT00939627|536461059|FG002|Overall Study|Not compliant|0|||
148969842|NCT00423891|537374736|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
148969843|NCT00423891|537374737|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
148724054|NCT00939627|536461057|FG000|Overall Study|No off-tx reason given|0|||
148724055|NCT00939627|536461058|FG001|Overall Study|No off-tx reason given|2|||
148724056|NCT00939627|536461059|FG002|Overall Study|No off-tx reason given|0|||
148724057|NCT00941720|536461069|FG000|Overall Study|Withdrawal by Subject|1|||
148724058|NCT00941720|536461069|FG000|Overall Study|Insurance denied participation|11|||
148969844|NCT00423891|537374735|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
148969845|NCT00423891|537374736|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
148969846|NCT00423891|537374737|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
148969847|NCT04225923|537374742|FG000|Overall Study|Protocol Violation|1|||
148724059|NCT00941720|536461069|FG000|Overall Study|ineligible|2|||
148724060|NCT01998243|536461072|FG000|Overall Study|Pregnancy|0|||
148724061|NCT01998243|536461073|FG001|Overall Study|Pregnancy|1|||
148724062|NCT01998243|536461072|FG000|Overall Study|Protocol Violation|5|||
148724063|NCT01998243|536461073|FG001|Overall Study|Protocol Violation|2|||
148724064|NCT01998243|536461072|FG000|Overall Study|Withdrawal by Subject|3|||
148724065|NCT01998243|536461073|FG001|Overall Study|Withdrawal by Subject|4|||
148724066|NCT00268892|536461077|FG000|Overall Study|Adverse Event|14|||
148969848|NCT04225923|537374743|FG001|Overall Study|Protocol Violation|0|||
148969849|NCT04225923|537374744|FG002|Overall Study|Protocol Violation|1|||
148724067|NCT00268892|536461078|FG001|Overall Study|Adverse Event|17|||
148724068|NCT00268892|536461079|FG002|Overall Study|Adverse Event|20|||
148724069|NCT00268892|536461077|FG000|Overall Study|Lack of Efficacy|1|||
148724070|NCT00268892|536461078|FG001|Overall Study|Lack of Efficacy|3|||
148724071|NCT00268892|536461079|FG002|Overall Study|Lack of Efficacy|0|||
148724072|NCT00268892|536461077|FG000|Overall Study|Withdrawal by Subject|14|||
148724073|NCT00268892|536461078|FG001|Overall Study|Withdrawal by Subject|15|||
148724074|NCT00268892|536461079|FG002|Overall Study|Withdrawal by Subject|13|||
148724075|NCT00268892|536461077|FG000|Overall Study|Physician Decision|0|||
148724076|NCT00268892|536461078|FG001|Overall Study|Physician Decision|1|||
148724077|NCT00268892|536461079|FG002|Overall Study|Physician Decision|0|||
148724078|NCT00268892|536461077|FG000|Overall Study|Lost to Follow-up|5|||
148724079|NCT00268892|536461078|FG001|Overall Study|Lost to Follow-up|2|||
148724080|NCT00268892|536461079|FG002|Overall Study|Lost to Follow-up|4|||
148724081|NCT00268892|536461077|FG000|Overall Study|Protocol Violation|0|||
148724082|NCT00268892|536461078|FG001|Overall Study|Protocol Violation|1|||
148724083|NCT00268892|536461079|FG002|Overall Study|Protocol Violation|0|||
148724084|NCT00268892|536461077|FG000|Overall Study|Disease Progression|1|||
148724085|NCT00268892|536461078|FG001|Overall Study|Disease Progression|1|||
148724086|NCT00268892|536461079|FG002|Overall Study|Disease Progression|0|||
148724087|NCT00268892|536461077|FG000|Overall Study|Trial Site Closed|4|||
148724088|NCT00268892|536461078|FG001|Overall Study|Trial Site Closed|2|||
148724089|NCT00268892|536461079|FG002|Overall Study|Trial Site Closed|2|||
148724090|NCT01181531|536461093|FG000|Overall Study|Other|17|||
148724091|NCT01181531|536461094|FG001|Overall Study|Other|12|||
148724092|NCT01181531|536461093|FG000|Overall Study|Partial consent by subject withdrawn|0|||
148724093|NCT01181531|536461094|FG001|Overall Study|Partial consent by subject withdrawn|1|||
148724094|NCT01181531|536461093|FG000|Overall Study|Physician Decision|3|||
148724095|NCT01181531|536461094|FG001|Overall Study|Physician Decision|1|||
148724096|NCT01181531|536461093|FG000|Overall Study|Noncompliance|2|||
148724097|NCT01181531|536461094|FG001|Overall Study|Noncompliance|2|||
148724098|NCT01181531|536461093|FG000|Overall Study|Ineligibility determined|1|||
148724099|NCT01181531|536461094|FG001|Overall Study|Ineligibility determined|2|||
148724100|NCT01181531|536461093|FG000|Overall Study|Protocol Specified Criteria|15|||
148724101|NCT01181531|536461094|FG001|Overall Study|Protocol Specified Criteria|8|||
148724102|NCT01181531|536461093|FG000|Overall Study|Pregnancy|0|||
148724103|NCT01181531|536461094|FG001|Overall Study|Pregnancy|1|||
148724104|NCT01181531|536461093|FG000|Overall Study|Withdrawal by Subject|8|||
148724105|NCT01181531|536461094|FG001|Overall Study|Withdrawal by Subject|7|||
148724106|NCT01181531|536461093|FG000|Overall Study|Protocol Violation|6|||
148724107|NCT01181531|536461094|FG001|Overall Study|Protocol Violation|6|||
148724108|NCT01181531|536461093|FG000|Overall Study|Death|9|||
148724109|NCT01181531|536461094|FG001|Overall Study|Death|12|||
148724110|NCT01181531|536461093|FG000|Overall Study|Adverse Event|0|||
148724111|NCT01181531|536461094|FG001|Overall Study|Adverse Event|1|||
148724112|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
148724113|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
148724114|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
148724115|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
148724116|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
148724117|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
148724118|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
148724119|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
148724120|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
148724121|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
148724122|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
148724123|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
148724124|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Death|0|||
148724125|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Death|1|||
148724126|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Death|0|||
148724127|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Death|0|||
148724128|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
148724129|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
148724130|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
148724131|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
148724132|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
148724133|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
148724134|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
148724135|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
148724136|NCT00545688|536461095|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
148724137|NCT00545688|536461096|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
148724138|NCT00545688|536461097|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
148724139|NCT00545688|536461098|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
148724140|NCT00545688|536461095|FG000|Adjuvant Treatment Period|Disease Progression|3|||
148724141|NCT00545688|536461096|FG001|Adjuvant Treatment Period|Disease Progression|3|||
148724142|NCT00545688|536461097|FG002|Adjuvant Treatment Period|Disease Progression|0|||
148724143|NCT00545688|536461098|FG003|Adjuvant Treatment Period|Disease Progression|7|||
148724144|NCT00545688|536461095|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
148724145|NCT00545688|536461096|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
148724146|NCT00545688|536461097|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
148724147|NCT00545688|536461098|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
148724148|NCT00545688|536461095|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
148724149|NCT00545688|536461096|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
148724150|NCT00545688|536461097|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
148724151|NCT00545688|536461098|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
148724152|NCT00545688|536461095|FG000|Adjuvant Treatment Period|Adverse Event|0|||
148724153|NCT00545688|536461096|FG001|Adjuvant Treatment Period|Adverse Event|3|||
148724154|NCT00545688|536461097|FG002|Adjuvant Treatment Period|Adverse Event|2|||
148724155|NCT00545688|536461098|FG003|Adjuvant Treatment Period|Adverse Event|2|||
148724156|NCT00545688|536461095|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
148724157|NCT00545688|536461096|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
148724158|NCT00545688|536461097|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
148724159|NCT00545688|536461098|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
148724160|NCT00545688|536461095|FG000|Follow-Up Period|Death|4|||
148724161|NCT00545688|536461096|FG001|Follow-Up Period|Death|2|||
148724162|NCT00545688|536461097|FG002|Follow-Up Period|Death|2|||
148724163|NCT00545688|536461098|FG003|Follow-Up Period|Death|6|||
148724164|NCT00545688|536461095|FG000|Follow-Up Period|Disease Progression|6|||
148724165|NCT00545688|536461096|FG001|Follow-Up Period|Disease Progression|5|||
148724166|NCT00545688|536461097|FG002|Follow-Up Period|Disease Progression|9|||
148724167|NCT00545688|536461098|FG003|Follow-Up Period|Disease Progression|9|||
148724168|NCT00545688|536461095|FG000|Follow-Up Period|Refused Treatment|6|||
148724169|NCT00545688|536461096|FG001|Follow-Up Period|Refused Treatment|2|||
148724170|NCT00545688|536461097|FG002|Follow-Up Period|Refused Treatment|0|||
148724171|NCT00545688|536461098|FG003|Follow-Up Period|Refused Treatment|2|||
148724172|NCT00545688|536461095|FG000|Follow-Up Period|Lost to Follow-up|3|||
148724173|NCT00545688|536461096|FG001|Follow-Up Period|Lost to Follow-up|3|||
148724174|NCT00545688|536461097|FG002|Follow-Up Period|Lost to Follow-up|3|||
148724175|NCT00545688|536461098|FG003|Follow-Up Period|Lost to Follow-up|1|||
148724176|NCT00545688|536461095|FG000|Follow-Up Period|Unspecified Reason|2|||
148724177|NCT00545688|536461096|FG001|Follow-Up Period|Unspecified Reason|5|||
148724178|NCT00545688|536461097|FG002|Follow-Up Period|Unspecified Reason|6|||
148724179|NCT00545688|536461098|FG003|Follow-Up Period|Unspecified Reason|8|||
148724180|NCT00545688|536461095|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
148724181|NCT00545688|536461096|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
148724182|NCT00545688|536461097|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
148724183|NCT00545688|536461098|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
148724184|NCT02792218|536461101|FG000|Overall Study|Patient/guardian decision|15|||
148724185|NCT02792218|536461102|FG001|Overall Study|Patient/guardian decision|42|||
148724186|NCT02792218|536461101|FG000|Overall Study|Adverse Event|15|||
148724187|NCT02792218|536461102|FG001|Overall Study|Adverse Event|14|||
148724188|NCT02792218|536461101|FG000|Overall Study|Lost to Follow-up|10|||
148724189|NCT02792218|536461102|FG001|Overall Study|Lost to Follow-up|5|||
148724190|NCT02792218|536461101|FG000|Overall Study|Lack of Efficacy|1|||
148724191|NCT02792218|536461102|FG001|Overall Study|Lack of Efficacy|12|||
148724192|NCT02792218|536461101|FG000|Overall Study|Physician Decision|4|||
148724193|NCT02792218|536461102|FG001|Overall Study|Physician Decision|4|||
148724194|NCT02792218|536461101|FG000|Overall Study|Protocol deviation|3|||
148724195|NCT02792218|536461102|FG001|Overall Study|Protocol deviation|2|||
148724196|NCT02792218|536461101|FG000|Overall Study|New therapy for study indication|0|||
148724197|NCT02792218|536461102|FG001|Overall Study|New therapy for study indication|1|||
148724198|NCT02792218|536461101|FG000|Overall Study|Non-compliance with study treatment|0|||
148724199|NCT02792218|536461102|FG001|Overall Study|Non-compliance with study treatment|1|||
148816372|NCT00021255|536802848|FG001|Overall Study|Other than specified above|38|||
148816373|NCT00021255|536802849|FG002|Overall Study|Other than specified above|19|||
148816374|NCT00021255|536802847|FG000|Overall Study|Missing|0|||
148816375|NCT00021255|536802848|FG001|Overall Study|Missing|27|||
148724200|NCT02792218|536461101|FG000|Overall Study|Pregnancy|1|||
148724201|NCT02792218|536461102|FG001|Overall Study|Pregnancy|0|||
148724202|NCT00955721|536461103|FG000|Overall Study|Physician Decision|1|||
148724203|NCT00955721|536461104|FG001|Overall Study|Physician Decision|0|||
148724204|NCT00955721|536461103|FG000|Overall Study|Death|1|||
148724205|NCT00955721|536461104|FG001|Overall Study|Death|0|||
148724206|NCT00955721|536461103|FG000|Overall Study|Withdrawal by Subject|1|||
148724207|NCT00955721|536461104|FG001|Overall Study|Withdrawal by Subject|0|||
148724208|NCT03183141|536461114|FG000|Overall Study|Withdrawal by Subject|2|||
148724209|NCT03183141|536461115|FG001|Overall Study|Withdrawal by Subject|4|||
148724210|NCT03183141|536461114|FG000|Overall Study|Death|0|||
148816376|NCT00021255|536802849|FG002|Overall Study|Missing|13|||
148816377|NCT00021255|536802847|FG000|Overall Study|Randomized but not treated|28|||
148816378|NCT00021255|536802848|FG001|Overall Study|Randomized but not treated|2|||
148724211|NCT03183141|536461115|FG001|Overall Study|Death|8|||
148724212|NCT02756637|536461117|FG000|Overall Study|Not eligible for initial SWOG study|10|||
148724213|NCT02756637|536461118|FG001|Overall Study|Not eligible for initial SWOG study|10|||
148724214|NCT02756637|536461117|FG000|Overall Study|No available NLR value|44|||
148724215|NCT02756637|536461118|FG001|Overall Study|No available NLR value|44|||
148724216|NCT02756637|536461117|FG000|Overall Study|Did not complete curative therapy|33|||
148724217|NCT02756637|536461118|FG001|Overall Study|Did not complete curative therapy|0|||
148724218|NCT01507090|536461121|FG000|Overall Study|incomplete dataset|18|||
148724219|NCT04034355|536461122|FG000|Overall Study|Study terminated by Sponsor|10|||
148724220|NCT04034355|536461123|FG001|Overall Study|Study terminated by Sponsor|17|||
148724221|NCT04034355|536461122|FG000|Overall Study|Withdrawal by Subject|12|||
148724222|NCT04034355|536461123|FG001|Overall Study|Withdrawal by Subject|11|||
148724223|NCT04034355|536461122|FG000|Overall Study|Site terminated by Sponsor|4|||
148724224|NCT04034355|536461123|FG001|Overall Study|Site terminated by Sponsor|5|||
148969850|NCT04225923|537374742|FG000|Overall Study|Withdrawal by Subject|4|||
148969851|NCT04225923|537374743|FG001|Overall Study|Withdrawal by Subject|1|||
148969852|NCT04225923|537374744|FG002|Overall Study|Withdrawal by Subject|3|||
148969853|NCT04225923|537374742|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
148969854|NCT04225923|537374743|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
148969855|NCT04225923|537374744|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
148969856|NCT00855309|537374745|FG000|Overall Study|patient never recieved drug|1|||
148969857|NCT00855309|537374746|FG001|Overall Study|patient never recieved drug|0|||
148969858|NCT01585766|537374747|FG000|Overall Study|Withdrawal by Subject|0|||
148969859|NCT01585766|537374748|FG001|Overall Study|Withdrawal by Subject|1|||
148969860|NCT01585766|537374749|FG002|Overall Study|Withdrawal by Subject|1|||
148969861|NCT01585766|537374750|FG003|Overall Study|Withdrawal by Subject|0|||
148969862|NCT01585766|537374751|FG004|Overall Study|Withdrawal by Subject|0|||
148969863|NCT01585766|537374752|FG005|Overall Study|Withdrawal by Subject|0|||
148969864|NCT01585766|537374747|FG000|Overall Study|Death|0|||
148969865|NCT01585766|537374748|FG001|Overall Study|Death|1|||
148969866|NCT01585766|537374749|FG002|Overall Study|Death|0|||
148969867|NCT01585766|537374750|FG003|Overall Study|Death|0|||
148969868|NCT01585766|537374751|FG004|Overall Study|Death|0|||
148969869|NCT01585766|537374752|FG005|Overall Study|Death|0|||
148969870|NCT01585766|537374747|FG000|Overall Study|Physician Decision|0|||
148969871|NCT01585766|537374748|FG001|Overall Study|Physician Decision|0|||
148969872|NCT01585766|537374749|FG002|Overall Study|Physician Decision|1|||
148969873|NCT01585766|537374750|FG003|Overall Study|Physician Decision|0|||
148969874|NCT01585766|537374751|FG004|Overall Study|Physician Decision|0|||
148969875|NCT01585766|537374752|FG005|Overall Study|Physician Decision|0|||
148969876|NCT04116710|537374753|FG000|Overall Study|Death|4|||
148969877|NCT04116710|537374754|FG001|Overall Study|Death|6|||
148969878|NCT04116710|537374755|FG002|Overall Study|Death|3|||
148969879|NCT04116710|537374756|FG003|Overall Study|Death|1|||
148969880|NCT04116710|537374753|FG000|Overall Study|Withdrawal by Subject|0|||
148969881|NCT04116710|537374754|FG001|Overall Study|Withdrawal by Subject|0|||
148969882|NCT04116710|537374755|FG002|Overall Study|Withdrawal by Subject|0|||
148969883|NCT04116710|537374756|FG003|Overall Study|Withdrawal by Subject|1|||
148969884|NCT01256593|537374759|FG000|Overall Study|Protocol Violation|26|||
148969885|NCT01256593|537374759|FG000|Overall Study|No Drug Administration Information|2|||
148724225|NCT04034355|536461122|FG000|Overall Study|Adverse Event|2|||
148724226|NCT04034355|536461123|FG001|Overall Study|Adverse Event|0|||
148724227|NCT04034355|536461122|FG000|Overall Study|Death|1|||
148724228|NCT04034355|536461123|FG001|Overall Study|Death|1|||
148724229|NCT04034355|536461122|FG000|Overall Study|Not reported|2|||
148724230|NCT04034355|536461123|FG001|Overall Study|Not reported|0|||
148724231|NCT04034355|536461122|FG000|Overall Study|Lost to Follow-up|1|||
148724232|NCT04034355|536461123|FG001|Overall Study|Lost to Follow-up|0|||
148969886|NCT01256593|537374759|FG000|Overall Study|No Visit After Treatment|186|||
148969887|NCT00582933|537374760|FG000|Overall Study|Physician Decision|3|||
148969888|NCT01371656|537374761|FG000|Overall Study|Death|7|||
148969889|NCT01371656|537374762|FG001|Overall Study|Death|4|||
148969890|NCT01371656|537374761|FG000|Overall Study|Physician Decision|46|||
148969891|NCT01371656|537374762|FG001|Overall Study|Physician Decision|7|||
148969892|NCT01371656|537374761|FG000|Overall Study|Withdrawal by Subject|7|||
148969893|NCT01371656|537374762|FG001|Overall Study|Withdrawal by Subject|0|||
148724233|NCT04034355|536461122|FG000|Overall Study|Physician Decision|1|||
148724234|NCT04034355|536461123|FG001|Overall Study|Physician Decision|0|||
148724235|NCT04034355|536461122|FG000|Overall Study|Protocol Violation|0|||
148724236|NCT04034355|536461123|FG001|Overall Study|Protocol Violation|1|||
148724237|NCT04034355|536461122|FG000|Overall Study|Progressive disease|1|||
148969894|NCT01371656|537374761|FG000|Overall Study|Ineligible|4|||
148969895|NCT01371656|537374762|FG001|Overall Study|Ineligible|3|||
148969896|NCT04334460|537374769|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
148969897|NCT04334460|537374770|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
148969898|NCT04334460|537374769|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
148724238|NCT04034355|536461123|FG001|Overall Study|Progressive disease|0|||
148724239|NCT02124902|536462133|FG000|Overall Study|Adverse Event|7|||
148724240|NCT02124902|536462134|FG001|Overall Study|Adverse Event|2|||
148724241|NCT02124902|536462133|FG000|Overall Study|Went to alternative treatment|4|||
148724242|NCT02124902|536462134|FG001|Overall Study|Went to alternative treatment|0|||
148724243|NCT02124902|536462133|FG000|Overall Study|Withdrawal by Subject|2|||
148724244|NCT02124902|536462134|FG001|Overall Study|Withdrawal by Subject|1|||
148724245|NCT02124902|536462133|FG000|Overall Study|Physician Decision|2|||
148724246|NCT02124902|536462134|FG001|Overall Study|Physician Decision|0|||
148724247|NCT02124902|536462133|FG000|Overall Study|Not eligible|1|||
148724248|NCT02124902|536462134|FG001|Overall Study|Not eligible|0|||
148724249|NCT02124902|536462133|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
148724250|NCT02124902|536462134|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
148724251|NCT00546910|536462138|FG000|Overall Study|Adverse Event|2|||
148724252|NCT00546910|536462139|FG001|Overall Study|Adverse Event|3|||
148724253|NCT00546910|536462138|FG000|Overall Study|Lack of Efficacy|5|||
148724254|NCT00546910|536462139|FG001|Overall Study|Lack of Efficacy|7|||
148724255|NCT00546910|536462138|FG000|Overall Study|Physician Decision|0|||
148724256|NCT00546910|536462139|FG001|Overall Study|Physician Decision|1|||
148724257|NCT00546910|536462138|FG000|Overall Study|Withdrawal by Subject|2|||
148724258|NCT00546910|536462139|FG001|Overall Study|Withdrawal by Subject|0|||
148724259|NCT01467479|536462140|FG000|Overall Study|No Study Medication|1|||
148724260|NCT01467479|536462141|FG001|Overall Study|No Study Medication|0|||
148724261|NCT01467479|536462142|FG002|Overall Study|No Study Medication|2|||
148724262|NCT01467479|536462140|FG000|Overall Study|Adverse Event|1|||
148724263|NCT01467479|536462141|FG001|Overall Study|Adverse Event|2|||
148724264|NCT01467479|536462142|FG002|Overall Study|Adverse Event|0|||
148724265|NCT01467479|536462140|FG000|Overall Study|Death|0|||
148724266|NCT01467479|536462141|FG001|Overall Study|Death|0|||
148724267|NCT01467479|536462142|FG002|Overall Study|Death|1|||
148724268|NCT01467479|536462140|FG000|Overall Study|Lost to Follow-up|2|||
148724269|NCT01467479|536462141|FG001|Overall Study|Lost to Follow-up|5|||
148724270|NCT01467479|536462142|FG002|Overall Study|Lost to Follow-up|3|||
148724271|NCT01467479|536462140|FG000|Overall Study|Withdrawal of Consent|3|||
148724272|NCT01467479|536462141|FG001|Overall Study|Withdrawal of Consent|7|||
148724273|NCT01467479|536462142|FG002|Overall Study|Withdrawal of Consent|7|||
148724274|NCT01467479|536462140|FG000|Overall Study|Study Terminated by Sponsor|1|||
148724275|NCT01467479|536462141|FG001|Overall Study|Study Terminated by Sponsor|3|||
148724276|NCT01467479|536462142|FG002|Overall Study|Study Terminated by Sponsor|3|||
148724277|NCT01467479|536462140|FG000|Overall Study|Other|1|||
148724278|NCT01467479|536462141|FG001|Overall Study|Other|0|||
148724279|NCT01467479|536462142|FG002|Overall Study|Other|0|||
148724280|NCT01552369|536462152|FG000|Overall Study|Did not consent to extended follow up|8|||
148724281|NCT01552369|536462153|FG001|Overall Study|Did not consent to extended follow up|9|||
148724282|NCT00892281|536462161|FG000|Overall Study|Adverse Event|65|||
148724283|NCT00892281|536462162|FG001|Overall Study|Adverse Event|8|||
148724284|NCT00892281|536462161|FG000|Overall Study|Lost to Follow-up|81|||
148724285|NCT00892281|536462162|FG001|Overall Study|Lost to Follow-up|8|||
148724286|NCT00892281|536462161|FG000|Overall Study|Pregnancy|1|||
148724287|NCT00892281|536462162|FG001|Overall Study|Pregnancy|0|||
148724288|NCT00892281|536462161|FG000|Overall Study|Protocol Violation|7|||
148724289|NCT00892281|536462162|FG001|Overall Study|Protocol Violation|2|||
148724290|NCT00892281|536462161|FG000|Overall Study|Withdrawal by Subject|86|||
148724291|NCT00892281|536462162|FG001|Overall Study|Withdrawal by Subject|14|||
148724292|NCT00892281|536462161|FG000|Overall Study|Subject failed to return for final visit|2|||
148724293|NCT00892281|536462162|FG001|Overall Study|Subject failed to return for final visit|0|||
148724294|NCT00892281|536462161|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
148724295|NCT00892281|536462162|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
148724296|NCT00892281|536462161|FG000|Overall Study|Final visit completed 4 weeks late|0|||
148724297|NCT00892281|536462162|FG001|Overall Study|Final visit completed 4 weeks late|1|||
148724298|NCT00892281|536462161|FG000|Overall Study|Subject completed day after study closed|1|||
148724299|NCT00892281|536462162|FG001|Overall Study|Subject completed day after study closed|0|||
148724300|NCT00892281|536462161|FG000|Overall Study|Family emergency|1|||
148724301|NCT00892281|536462162|FG001|Overall Study|Family emergency|0|||
148724302|NCT00892281|536462161|FG000|Overall Study|Last visit not done - death in family|1|||
148724303|NCT00892281|536462162|FG001|Overall Study|Last visit not done - death in family|0|||
148724304|NCT00892281|536462161|FG000|Overall Study|Did not meet incl/excl criteria|1|||
148724305|NCT00892281|536462162|FG001|Overall Study|Did not meet incl/excl criteria|0|||
148724306|NCT00892281|536462161|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
148724307|NCT00892281|536462162|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
148724308|NCT00892281|536462161|FG000|Overall Study|Unable to redeem the drug voucher|1|||
148724309|NCT00892281|536462162|FG001|Overall Study|Unable to redeem the drug voucher|0|||
148724310|NCT00892281|536462161|FG000|Overall Study|Subject not good candidate for study|1|||
148724311|NCT00892281|536462162|FG001|Overall Study|Subject not good candidate for study|0|||
148724312|NCT00892281|536462161|FG000|Overall Study|Subject did not return for any visits|1|||
148724313|NCT00892281|536462162|FG001|Overall Study|Subject did not return for any visits|0|||
148724314|NCT00892281|536462161|FG000|Overall Study|Subject missed several visits/lost meds|1|||
148724315|NCT00892281|536462162|FG001|Overall Study|Subject missed several visits/lost meds|0|||
148724316|NCT00892281|536462161|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
148724317|NCT00892281|536462162|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
148724318|NCT00892281|536462161|FG000|Overall Study|Scheduled for knee replacement|0|||
148724319|NCT00892281|536462162|FG001|Overall Study|Scheduled for knee replacement|1|||
148724320|NCT00892281|536462161|FG000|Overall Study|PI complained of inadequate compensation|3|||
148724321|NCT00892281|536462162|FG001|Overall Study|PI complained of inadequate compensation|0|||
148724322|NCT00892281|536462161|FG000|Overall Study|Subject lost interest in program|0|||
148724323|NCT00892281|536462162|FG001|Overall Study|Subject lost interest in program|1|||
148724324|NCT00892281|536462161|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
148724325|NCT00892281|536462162|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
148724326|NCT00892281|536462161|FG000|Overall Study|Death in family|1|||
148724327|NCT00892281|536462162|FG001|Overall Study|Death in family|0|||
148724328|NCT00892281|536462161|FG000|Overall Study|Lack of efficacy of study product|2|||
148724329|NCT00892281|536462162|FG001|Overall Study|Lack of efficacy of study product|0|||
148724330|NCT00892281|536462161|FG000|Overall Study|Subject not seen by PI at final visit|1|||
148724331|NCT00892281|536462162|FG001|Overall Study|Subject not seen by PI at final visit|0|||
148724332|NCT00892281|536462161|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
148724333|NCT00892281|536462162|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
148724334|NCT00892281|536462161|FG000|Overall Study|Missed multiple visits|1|||
148724335|NCT00892281|536462162|FG001|Overall Study|Missed multiple visits|0|||
148724336|NCT00892281|536462161|FG000|Overall Study|Missed visits rescheduled out of window|1|||
148724337|NCT00892281|536462162|FG001|Overall Study|Missed visits rescheduled out of window|0|||
148724338|NCT00892281|536462161|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
148724339|NCT00892281|536462162|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
148724340|NCT00892281|536462161|FG000|Overall Study|Subject had history of drug abuse|1|||
148724341|NCT00892281|536462162|FG001|Overall Study|Subject had history of drug abuse|0|||
148724342|NCT00892281|536462161|FG000|Overall Study|Rash on hand|1|||
148724343|NCT00892281|536462162|FG001|Overall Study|Rash on hand|0|||
148724344|NCT00892281|536462161|FG000|Overall Study|Visit 4 date out of window|1|||
148724345|NCT00892281|536462162|FG001|Overall Study|Visit 4 date out of window|0|||
148724346|NCT02129647|536462163|FG000|Overall Study|Adverse Event|2|||
148724347|NCT02129647|536462163|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
148724348|NCT00608517|536462164|FG000|Overall Study|Death|1|||
148724349|NCT00608517|536462165|FG001|Overall Study|Death|0|||
148724350|NCT00608517|536462166|FG002|Overall Study|Death|0|||
148724351|NCT01833533|536462167|FG000|Overall Study|Adverse Event|0|||
148724352|NCT01833533|536462168|FG001|Overall Study|Adverse Event|1|||
148724353|NCT01833533|536462167|FG000|Overall Study|Lost to Follow-up|4|||
148724354|NCT01833533|536462168|FG001|Overall Study|Lost to Follow-up|9|||
148724355|NCT01833533|536462167|FG000|Overall Study|To Enter an Extension Study|0|||
148724356|NCT01833533|536462168|FG001|Overall Study|To Enter an Extension Study|4|||
148724357|NCT01833533|536462167|FG000|Overall Study|Other|2|||
148724358|NCT01833533|536462168|FG001|Overall Study|Other|7|||
148724359|NCT00685802|536462169|FG000|Washout Period of 7 Days|Protocol Violation|2|||
148724360|NCT00685802|536462170|FG001|Washout Period of 7 Days|Protocol Violation|0|||
148724361|NCT00685802|536462169|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
148724362|NCT00685802|536462170|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
148724363|NCT01333072|536462171|FG000|Overall Study|Lost to Follow-up|3|||
148724364|NCT01333072|536462172|FG001|Overall Study|Lost to Follow-up|0|||
148724365|NCT01333072|536462171|FG000|Overall Study|Adverse Event|2|||
148724366|NCT01333072|536462172|FG001|Overall Study|Adverse Event|4|||
148724367|NCT01333072|536462171|FG000|Overall Study|Physician Decision|1|||
148724368|NCT01333072|536462172|FG001|Overall Study|Physician Decision|0|||
148724369|NCT00619359|536462173|FG000|Overall Study|Adverse Event|32|||
148724370|NCT00619359|536462174|FG001|Overall Study|Adverse Event|36|||
148969899|NCT04334460|537374770|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
148969900|NCT02376166|537374777|FG000|Overall Study|Adverse Event|1|||
148724371|NCT00619359|536462173|FG000|Overall Study|Lost to Follow-up|12|||
148724372|NCT00619359|536462174|FG001|Overall Study|Lost to Follow-up|16|||
148724373|NCT00619359|536462173|FG000|Overall Study|Physician Decision|0|||
148724374|NCT00619359|536462174|FG001|Overall Study|Physician Decision|7|||
148816379|NCT00021255|536802849|FG002|Overall Study|Randomized but not treated|18|||
148816380|NCT02232698|536802850|FG000|Overall Study|Pregnancy|1|||
148816381|NCT02232698|536802851|FG001|Overall Study|Pregnancy|1|||
148724375|NCT00619359|536462173|FG000|Overall Study|Protocol Violation|1|||
148724376|NCT00619359|536462174|FG001|Overall Study|Protocol Violation|1|||
148724377|NCT00619359|536462173|FG000|Overall Study|Withdrawal by Subject|19|||
148724378|NCT00619359|536462174|FG001|Overall Study|Withdrawal by Subject|20|||
148816382|NCT02232698|536802850|FG000|Overall Study|Met exclusion criteria|1|||
148816383|NCT02232698|536802851|FG001|Overall Study|Met exclusion criteria|1|||
148724379|NCT00619359|536462173|FG000|Overall Study|Progressive Disease|3|||
148724380|NCT00619359|536462174|FG001|Overall Study|Progressive Disease|1|||
148724381|NCT00103038|536462176|FG000|Overall Study|Withdrawal by Subject|8|||
148724382|NCT00103038|536462176|FG000|Overall Study|Screen failure|3|||
148724383|NCT00103038|536462176|FG000|Overall Study|Death|1|||
148724384|NCT00103038|536462176|FG000|Overall Study|Physician Decision|1|||
148724385|NCT01740791|536462177|FG000|Overall Study|Randomized but never treated|5|||
148724386|NCT01740791|536462178|FG001|Overall Study|Randomized but never treated|3|||
148724387|NCT01740791|536462179|FG002|Overall Study|Randomized but never treated|2|||
148724388|NCT01740791|536462180|FG003|Overall Study|Randomized but never treated|2|||
148724389|NCT01740791|536462181|FG004|Overall Study|Randomized but never treated|1|||
148724390|NCT01740791|536462182|FG005|Overall Study|Randomized but never treated|3|||
148724391|NCT01740791|536462177|FG000|Overall Study|Lost to Follow-up|2|||
148724392|NCT01740791|536462178|FG001|Overall Study|Lost to Follow-up|0|||
148724393|NCT01740791|536462179|FG002|Overall Study|Lost to Follow-up|2|||
148724394|NCT01740791|536462180|FG003|Overall Study|Lost to Follow-up|3|||
148724395|NCT01740791|536462181|FG004|Overall Study|Lost to Follow-up|2|||
148724396|NCT01740791|536462182|FG005|Overall Study|Lost to Follow-up|3|||
148724397|NCT01740791|536462177|FG000|Overall Study|Withdrew Consent|4|||
148724398|NCT01740791|536462178|FG001|Overall Study|Withdrew Consent|0|||
148724399|NCT01740791|536462179|FG002|Overall Study|Withdrew Consent|1|||
148724400|NCT01740791|536462180|FG003|Overall Study|Withdrew Consent|2|||
148724401|NCT01740791|536462181|FG004|Overall Study|Withdrew Consent|0|||
148724402|NCT01740791|536462182|FG005|Overall Study|Withdrew Consent|3|||
148724403|NCT01740791|536462177|FG000|Overall Study|Investigator's discretion|1|||
148724404|NCT01740791|536462178|FG001|Overall Study|Investigator's discretion|0|||
148724405|NCT01740791|536462179|FG002|Overall Study|Investigator's discretion|1|||
148724406|NCT01740791|536462180|FG003|Overall Study|Investigator's discretion|0|||
148724407|NCT01740791|536462181|FG004|Overall Study|Investigator's discretion|0|||
148724408|NCT01740791|536462182|FG005|Overall Study|Investigator's discretion|1|||
148816384|NCT02232698|536802850|FG000|Overall Study|Had device-associated symptoms|7|||
148816385|NCT02232698|536802851|FG001|Overall Study|Had device-associated symptoms|0|||
148724409|NCT01740791|536462177|FG000|Overall Study|Adverse Event|0|||
148724410|NCT01740791|536462178|FG001|Overall Study|Adverse Event|0|||
148724411|NCT01740791|536462179|FG002|Overall Study|Adverse Event|0|||
148724412|NCT01740791|536462180|FG003|Overall Study|Adverse Event|0|||
148724413|NCT01740791|536462181|FG004|Overall Study|Adverse Event|0|||
148724414|NCT01740791|536462182|FG005|Overall Study|Adverse Event|1|||
148724415|NCT01463982|536462183|FG000|Overall Study|Withdrawal by Subject|0|||
148724416|NCT01463982|536462184|FG001|Overall Study|Withdrawal by Subject|1|||
148724417|NCT01463982|536462185|FG002|Overall Study|Withdrawal by Subject|1|||
148724418|NCT01463982|536462186|FG003|Overall Study|Withdrawal by Subject|0|||
148724419|NCT01463982|536462183|FG000|Overall Study|Treatment delay over 5 week|0|||
148724420|NCT01463982|536462184|FG001|Overall Study|Treatment delay over 5 week|0|||
148724421|NCT01463982|536462185|FG002|Overall Study|Treatment delay over 5 week|1|||
148724422|NCT01463982|536462186|FG003|Overall Study|Treatment delay over 5 week|0|||
148724423|NCT01483625|536462189|FG000|Overall Study|Adverse Event|1|||
148724424|NCT01483625|536462190|FG001|Overall Study|Adverse Event|1|||
148969901|NCT02376166|537374777|FG000|Overall Study|Discontinued metformin early|2|||
148969902|NCT01068509|537374784|FG000|Overall Study|Death|0|||
148969903|NCT01068509|537374785|FG001|Overall Study|Death|0|||
148969904|NCT01068509|537374786|FG002|Overall Study|Death|1|||
148969905|NCT01068509|537374784|FG000|Overall Study|Disease Progression|5|||
148969906|NCT01068509|537374785|FG001|Overall Study|Disease Progression|20|||
148724425|NCT01483625|536462189|FG000|Overall Study|Refused to continue medication|2|||
148816386|NCT02232698|536802850|FG000|Overall Study|Non-compliance with study device|1|||
148816387|NCT02232698|536802851|FG001|Overall Study|Non-compliance with study device|4|||
148816388|NCT02232698|536802850|FG000|Overall Study|Allocated to control group|0|||
148969907|NCT01068509|537374786|FG002|Overall Study|Disease Progression|18|||
148969908|NCT01068509|537374784|FG000|Overall Study|Lost to Follow-up|1|||
148969909|NCT01068509|537374785|FG001|Overall Study|Lost to Follow-up|0|||
148969910|NCT01068509|537374786|FG002|Overall Study|Lost to Follow-up|0|||
148724426|NCT01483625|536462190|FG001|Overall Study|Refused to continue medication|1|||
148816389|NCT02232698|536802851|FG001|Overall Study|Allocated to control group|3|||
148724427|NCT01483625|536462189|FG000|Overall Study|Due to other reason|1|||
148724428|NCT01483625|536462190|FG001|Overall Study|Due to other reason|0|||
148724429|NCT01731886|536462191|FG000|Overall Study|Death|1|||
148724430|NCT01731886|536462192|FG001|Overall Study|Death|0|||
148724431|NCT01731886|536462191|FG000|Overall Study|Never started treatment|0|||
148724432|NCT01731886|536462192|FG001|Overall Study|Never started treatment|1|||
148724433|NCT01731886|536462191|FG000|Overall Study|Non-compliant|1|||
148724434|NCT01731886|536462192|FG001|Overall Study|Non-compliant|0|||
148724435|NCT02280187|536462193|FG000|Overall Study|Lost to Follow-up|218|||
148724436|NCT02094261|536462194|FG000|Overall Study|Death|24|||
148816390|NCT02232698|536802850|FG000|Overall Study|Withdrawal by Subject|0|||
148969911|NCT01068509|537374784|FG000|Overall Study|Withdrew Consent|0|||
148724437|NCT02094261|536462194|FG000|Overall Study|Lost to Follow-up|1|||
148969912|NCT01068509|537374785|FG001|Overall Study|Withdrew Consent|1|||
148724438|NCT02094261|536462194|FG000|Overall Study|Withdrawal by Subject|4|||
148724439|NCT02094261|536462194|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
148724440|NCT03417830|536462198|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
148724441|NCT03417830|536462199|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
148724442|NCT02087176|536462204|FG000|Overall Study|Withdrawal by Subject|1|||
148724443|NCT02087176|536462204|FG000|Overall Study|Death|10|||
148724444|NCT02087176|536462204|FG000|Overall Study|Censored|19|||
148724445|NCT02087176|536462204|FG000|Overall Study|Study Terminated by Sponsor|2|||
148724446|NCT03812991|536462205|FG000|Overall Study|Lost to Follow-up|3|||
148724447|NCT03812991|536462206|FG001|Overall Study|Lost to Follow-up|1|||
148724448|NCT00895037|536462210|FG000|Overall Study|Death|0|||
148724449|NCT00895037|536462211|FG001|Overall Study|Death|2|||
148724450|NCT00895037|536462212|FG002|Overall Study|Death|1|||
148724451|NCT01192399|536462218|FG000|Overall Study|Lack of Efficacy|2|||
148724452|NCT01523587|536462220|FG000|Overall Study|Other than listed|5|||
148724453|NCT01523587|536462221|FG001|Overall Study|Other than listed|5|||
148724454|NCT01523587|536462220|FG000|Overall Study|Worsening of underlying cancer disease|19|||
148724455|NCT01523587|536462221|FG001|Overall Study|Worsening of underlying cancer disease|34|||
148724456|NCT01523587|536462220|FG000|Overall Study|Adverse Event|68|||
148724457|NCT01523587|536462221|FG001|Overall Study|Adverse Event|52|||
148724458|NCT01523587|536462220|FG000|Overall Study|Protocol Violation|5|||
148724459|NCT01523587|536462221|FG001|Overall Study|Protocol Violation|3|||
148724460|NCT01523587|536462220|FG000|Overall Study|Lost to Follow-up|2|||
148724461|NCT01523587|536462221|FG001|Overall Study|Lost to Follow-up|2|||
148724462|NCT01523587|536462220|FG000|Overall Study|Withdrawal by Subject|28|||
148724463|NCT01523587|536462221|FG001|Overall Study|Withdrawal by Subject|20|||
148724464|NCT01523587|536462220|FG000|Overall Study|Withdrew due to Progressive disease|265|||
148724465|NCT01523587|536462221|FG001|Overall Study|Withdrew due to Progressive disease|279|||
148724466|NCT01523587|536462220|FG000|Overall Study|Randomised but bot treated|6|||
148724467|NCT01523587|536462221|FG001|Overall Study|Randomised but bot treated|2|||
148724468|NCT01298778|536462222|FG000|Overall Study|Lost to Follow-up|2|||
148724469|NCT01298778|536462223|FG001|Overall Study|Lost to Follow-up|3|||
148724470|NCT01298778|536462222|FG000|Overall Study|Incorrect use of VAS|1|||
148724471|NCT01298778|536462223|FG001|Overall Study|Incorrect use of VAS|0|||
148724472|NCT01298778|536462222|FG000|Overall Study|Withdrawal by Subject|0|||
148724473|NCT01298778|536462223|FG001|Overall Study|Withdrawal by Subject|1|||
148724474|NCT01298778|536462222|FG000|Overall Study|Protocol Violation|0|||
148724475|NCT01298778|536462223|FG001|Overall Study|Protocol Violation|1|||
148724476|NCT01298778|536462222|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
148724477|NCT01298778|536462223|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
148724478|NCT00536484|536462224|FG000|Overall Study|Adverse Event|21|||
148724479|NCT00536484|536462225|FG001|Overall Study|Adverse Event|34|||
148724480|NCT00536484|536462224|FG000|Overall Study|Withdrawal by Subject|11|||
148724481|NCT00536484|536462225|FG001|Overall Study|Withdrawal by Subject|11|||
148724482|NCT00536484|536462224|FG000|Overall Study|Lost to Follow-up|8|||
148724483|NCT00536484|536462225|FG001|Overall Study|Lost to Follow-up|6|||
148724484|NCT00536484|536462224|FG000|Overall Study|Lack of Efficacy|16|||
148724485|NCT00536484|536462225|FG001|Overall Study|Lack of Efficacy|5|||
148724486|NCT00536484|536462224|FG000|Overall Study|Other|4|||
148724487|NCT00536484|536462225|FG001|Overall Study|Other|0|||
148724488|NCT02244424|536462227|FG000|Overall Study|Lost to Follow-up|20|||
148724489|NCT02244424|536462228|FG001|Overall Study|Lost to Follow-up|10|||
148724490|NCT03366194|536462229|FG000|Overall Study|Lost to Follow-up|2|||
148724491|NCT01961687|536463375|FG000|Overall Study|Lost to Follow-up|19|||
148724492|NCT01961687|536463375|FG000|Overall Study|Re-operation|17|||
148724493|NCT01961687|536463375|FG000|Overall Study|Death|7|||
148724494|NCT01961687|536463375|FG000|Overall Study|Withdrawal by Subject|6|||
148724495|NCT01961687|536463375|FG000|Overall Study|Adverse Event|6|||
148724496|NCT01961687|536463375|FG000|Overall Study|Moved to area without study site|2|||
148724497|NCT01961687|536463375|FG000|Overall Study|Sponsor decision|2|||
148724498|NCT01961687|536463375|FG000|Overall Study|Physician Decision|1|||
148724499|NCT01961687|536463375|FG000|Overall Study|Unable to meet follow-up requirements|1|||
148724500|NCT01730040|536463376|FG000|Overall Study|Randomized but not treated|0|||
148724501|NCT01730040|536463377|FG001|Overall Study|Randomized but not treated|0|||
148724502|NCT01730040|536463378|FG002|Overall Study|Randomized but not treated|0|||
148724503|NCT01730040|536463379|FG003|Overall Study|Randomized but not treated|0|||
148724504|NCT01730040|536463380|FG004|Overall Study|Randomized but not treated|0|||
148724505|NCT01730040|536463381|FG005|Overall Study|Randomized but not treated|1|||
148724506|NCT01730040|536463382|FG006|Overall Study|Randomized but not treated|0|||
148724507|NCT01730040|536463376|FG000|Overall Study|Subject moved|0|||
148724508|NCT01730040|536463377|FG001|Overall Study|Subject moved|0|||
148724509|NCT01730040|536463378|FG002|Overall Study|Subject moved|1|||
148816391|NCT02232698|536802851|FG001|Overall Study|Withdrawal by Subject|11|||
148724510|NCT01730040|536463379|FG003|Overall Study|Subject moved|0|||
148724511|NCT01730040|536463380|FG004|Overall Study|Subject moved|0|||
148724512|NCT01730040|536463381|FG005|Overall Study|Subject moved|0|||
148724513|NCT01730040|536463382|FG006|Overall Study|Subject moved|1|||
148724514|NCT01730040|536463376|FG000|Overall Study|Physician Decision|0|||
148724515|NCT01730040|536463377|FG001|Overall Study|Physician Decision|0|||
148724516|NCT01730040|536463378|FG002|Overall Study|Physician Decision|0|||
148724517|NCT01730040|536463379|FG003|Overall Study|Physician Decision|0|||
148724518|NCT01730040|536463380|FG004|Overall Study|Physician Decision|0|||
148724519|NCT01730040|536463381|FG005|Overall Study|Physician Decision|1|||
148724520|NCT01730040|536463382|FG006|Overall Study|Physician Decision|1|||
148724521|NCT01730040|536463376|FG000|Overall Study|Other than specified|7|||
148724522|NCT01730040|536463377|FG001|Overall Study|Other than specified|8|||
148724523|NCT01730040|536463378|FG002|Overall Study|Other than specified|5|||
148724524|NCT01730040|536463379|FG003|Overall Study|Other than specified|5|||
148724525|NCT01730040|536463380|FG004|Overall Study|Other than specified|5|||
148724526|NCT01730040|536463381|FG005|Overall Study|Other than specified|4|||
148724527|NCT01730040|536463382|FG006|Overall Study|Other than specified|4|||
148724528|NCT01730040|536463376|FG000|Overall Study|Adverse Event|4|||
148724529|NCT01730040|536463377|FG001|Overall Study|Adverse Event|3|||
148724530|NCT01730040|536463378|FG002|Overall Study|Adverse Event|5|||
148724531|NCT01730040|536463379|FG003|Overall Study|Adverse Event|3|||
148724532|NCT01730040|536463380|FG004|Overall Study|Adverse Event|1|||
148724533|NCT01730040|536463381|FG005|Overall Study|Adverse Event|1|||
148724534|NCT01730040|536463382|FG006|Overall Study|Adverse Event|2|||
148724535|NCT01730040|536463376|FG000|Overall Study|Poor compliance to protocol|2|||
148724536|NCT01730040|536463377|FG001|Overall Study|Poor compliance to protocol|4|||
148724537|NCT01730040|536463378|FG002|Overall Study|Poor compliance to protocol|0|||
148724538|NCT01730040|536463379|FG003|Overall Study|Poor compliance to protocol|0|||
148724539|NCT01730040|536463380|FG004|Overall Study|Poor compliance to protocol|0|||
148724540|NCT01730040|536463381|FG005|Overall Study|Poor compliance to protocol|0|||
148724541|NCT01730040|536463382|FG006|Overall Study|Poor compliance to protocol|1|||
148724542|NCT00544817|536463383|FG000|Combined Modality|Lack of Efficacy|2|||
148724543|NCT00544817|536463383|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
148724544|NCT00544817|536463383|FG000|Combined Modality|Adverse Event|2|||
148724545|NCT00544817|536463383|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
148724546|NCT00544817|536463383|FG000|No Treatment Interval|Lack of Efficacy|8|||
148724547|NCT00544817|536463383|FG000|No Treatment Interval|Physician Decision|3|||
148724548|NCT00544817|536463383|FG000|No Treatment Interval|Adverse Event|1|||
148724549|NCT00544817|536463383|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
148724550|NCT00544817|536463383|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
148724551|NCT00544817|536463383|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
148724552|NCT02813421|536463384|FG000|Overall Study|Withdrawal by Subject|1|||
148724553|NCT02813421|536463385|FG001|Overall Study|Withdrawal by Subject|2|||
148724554|NCT02813421|536463384|FG000|Overall Study|Lost to Follow-up|1|||
148724555|NCT02813421|536463385|FG001|Overall Study|Lost to Follow-up|1|||
148724556|NCT00977548|536463386|FG000|Overall Study|Ineligible|4|||
148724557|NCT00977548|536463386|FG000|Overall Study|Adverse Event|8|||
148724558|NCT00977548|536463386|FG000|Overall Study|Withdrawal by Subject|1|||
148724559|NCT04213209|536463393|FG000|Overall Study|Protocol Violation|1|||
148724560|NCT04213209|536463394|FG001|Overall Study|Protocol Violation|0|||
148724561|NCT04213209|536463395|FG002|Overall Study|Protocol Violation|0|||
148724562|NCT04213209|536463396|FG003|Overall Study|Protocol Violation|0|||
148724563|NCT04213209|536463397|FG004|Overall Study|Protocol Violation|0|||
148724564|NCT04213209|536463398|FG005|Overall Study|Protocol Violation|0|||
148724565|NCT02065713|536463406|FG000|Overall Study|Adverse Event|0|||
148724566|NCT02065713|536463407|FG001|Overall Study|Adverse Event|1|||
148724567|NCT02065713|536463406|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148724568|NCT02065713|536463407|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148724569|NCT02791893|536463416|FG000|Blinded Phase|Lost to Follow-up|2|||
148724570|NCT02791893|536463417|FG001|Blinded Phase|Lost to Follow-up|2|||
148724571|NCT02791893|536463416|FG000|Blinded Phase|Withdrawal by Subject|1|||
148724572|NCT02791893|536463417|FG001|Blinded Phase|Withdrawal by Subject|2|||
148724573|NCT02791893|536463416|FG000|Open Label Phase|Lost to Follow-up|3|||
148724574|NCT02791893|536463417|FG001|Open Label Phase|Lost to Follow-up|0|||
148724575|NCT02791893|536463416|FG000|Open Label Phase|Withdrawal by Subject|0|||
148724576|NCT02791893|536463417|FG001|Open Label Phase|Withdrawal by Subject|2|||
148724577|NCT01570283|536463418|FG000|Cohort 1: Dose Level 1|Death|0|||
148724578|NCT01570283|536463419|FG001|Cohort 1: Dose Level 1|Death|1|||
148724579|NCT01570283|536463420|FG002|Cohort 1: Dose Level 1|Death|0|||
148724580|NCT01570283|536463421|FG003|Cohort 1: Dose Level 1|Death|0|||
148724581|NCT01570283|536463422|FG004|Cohort 1: Dose Level 1|Death|0|||
148724582|NCT01570283|536463423|FG005|Cohort 1: Dose Level 1|Death|0|||
148724583|NCT01570283|536463418|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
148724584|NCT01570283|536463419|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
148724585|NCT01570283|536463420|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
148724586|NCT01570283|536463421|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
148724587|NCT01570283|536463422|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
148724588|NCT01570283|536463423|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
148724589|NCT01570283|536463418|FG000|Cohort 2: Dose Level 2|Death|0|||
148724590|NCT01570283|536463419|FG001|Cohort 2: Dose Level 2|Death|0|||
148969913|NCT01068509|537374786|FG002|Overall Study|Withdrew Consent|2|||
148969914|NCT01068509|537374784|FG000|Overall Study|Reason Not Specified|0|||
148969915|NCT01068509|537374785|FG001|Overall Study|Reason Not Specified|1|||
148969916|NCT01068509|537374786|FG002|Overall Study|Reason Not Specified|0|||
148969917|NCT03913091|537374787|FG000|Overall Study|Lost to Follow-up|18|||
148969918|NCT03913091|537374788|FG001|Overall Study|Lost to Follow-up|11|||
148969919|NCT03913091|537374787|FG000|Overall Study|Required additional meds/surgery|1|||
148969920|NCT03913091|537374788|FG001|Overall Study|Required additional meds/surgery|2|||
148969921|NCT03913091|537374787|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
148969922|NCT03913091|537374788|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
148969923|NCT01380184|537374789|FG000|Part 1 (19 Days)|Adverse Event|1|||
148969924|NCT01380184|537374789|FG000|Part 2|Adverse Event|5|||
148969925|NCT01380184|537374789|FG000|Part 2|Disease Progression|8|||
148969926|NCT01380184|537374789|FG000|Part 2|Lost to Follow-up|1|||
148969927|NCT04804813|537374791|FG000|Overall Study|Protocol Violation|2|||
148969928|NCT04804813|537374792|FG001|Overall Study|Protocol Violation|0|||
148969929|NCT04804813|537374791|FG000|Overall Study|Withdrawal by Subject|1|||
148969930|NCT04804813|537374792|FG001|Overall Study|Withdrawal by Subject|0|||
148969931|NCT00560950|537374793|FG000|Overall Study|Lost to Follow-up|1|||
148969932|NCT00560950|537374794|FG001|Overall Study|Lost to Follow-up|0|||
148969933|NCT05308901|537376553|FG000|Overall Study|Death|6|||
148969934|NCT01914666|537376557|FG000|Treatment Period|Lack of Efficacy|0|||
148969935|NCT01914666|537376558|FG001|Treatment Period|Lack of Efficacy|0|||
148969936|NCT01914666|537376559|FG002|Treatment Period|Lack of Efficacy|2|||
148969937|NCT01914666|537376557|FG000|Treatment Period|Adverse Event|10|||
148969938|NCT01914666|537376558|FG001|Treatment Period|Adverse Event|4|||
148969939|NCT01914666|537376559|FG002|Treatment Period|Adverse Event|2|||
148969940|NCT01914666|537376557|FG000|Treatment Period|Withdrawal by Subject|3|||
148969941|NCT01914666|537376558|FG001|Treatment Period|Withdrawal by Subject|2|||
148969942|NCT01914666|537376559|FG002|Treatment Period|Withdrawal by Subject|2|||
148969943|NCT01914666|537376557|FG000|Treatment Period|Physician Decision|0|||
148969944|NCT01914666|537376558|FG001|Treatment Period|Physician Decision|0|||
148969945|NCT01914666|537376559|FG002|Treatment Period|Physician Decision|2|||
148969946|NCT02586012|537376560|FG000|Overall Study|Withdrawal by Subject|1|||
148969947|NCT02586012|537376561|FG001|Overall Study|Withdrawal by Subject|1|||
148969948|NCT02586012|537376562|FG002|Overall Study|Withdrawal by Subject|0|||
148969949|NCT02586012|537376563|FG003|Overall Study|Withdrawal by Subject|1|||
148969950|NCT02586012|537376564|FG004|Overall Study|Withdrawal by Subject|0|||
148969951|NCT02586012|537376565|FG005|Overall Study|Withdrawal by Subject|2|||
148724591|NCT01570283|536463420|FG002|Cohort 2: Dose Level 2|Death|1|||
148724592|NCT01570283|536463421|FG003|Cohort 2: Dose Level 2|Death|0|||
148724593|NCT01570283|536463422|FG004|Cohort 2: Dose Level 2|Death|0|||
148724594|NCT01570283|536463423|FG005|Cohort 2: Dose Level 2|Death|0|||
148724595|NCT01570283|536463418|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
148724596|NCT01570283|536463419|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
148724597|NCT01570283|536463420|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
148724598|NCT01570283|536463421|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
148724599|NCT01570283|536463422|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
148724600|NCT01570283|536463423|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
148724601|NCT01570283|536463418|FG000|Cohort 3: Dose Level 3|Death|0|||
148724602|NCT01570283|536463419|FG001|Cohort 3: Dose Level 3|Death|0|||
148724603|NCT01570283|536463420|FG002|Cohort 3: Dose Level 3|Death|0|||
148724604|NCT01570283|536463421|FG003|Cohort 3: Dose Level 3|Death|0|||
148724605|NCT01570283|536463422|FG004|Cohort 3: Dose Level 3|Death|0|||
148724606|NCT01570283|536463423|FG005|Cohort 3: Dose Level 3|Death|1|||
148724607|NCT01570283|536463418|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
148724608|NCT01570283|536463419|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
148724609|NCT01570283|536463420|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
148724610|NCT01570283|536463421|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
148724611|NCT01570283|536463422|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
148724612|NCT01570283|536463423|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
148724613|NCT01048502|536463429|FG000|Overall Study|Lost to Follow-up|2|||
148724614|NCT01048502|536463430|FG001|Overall Study|Lost to Follow-up|0|||
148724615|NCT01048502|536463431|FG002|Overall Study|Lost to Follow-up|0|||
148816392|NCT05324371|536802853|FG000|Overall Study|Withdrawal by Subject|1|||
148969952|NCT02586012|537376560|FG000|Overall Study|Protocol Violation|0|||
148816393|NCT05324371|536802853|FG000|Overall Study|Death|1|||
148816394|NCT01131585|536802854|FG000|Overall Study|Adverse Event|0|||
148969953|NCT02586012|537376561|FG001|Overall Study|Protocol Violation|0|||
148724616|NCT01048502|536463432|FG003|Overall Study|Lost to Follow-up|0|||
148724617|NCT01048502|536463429|FG000|Overall Study|Adverse Event|1|||
148816395|NCT01131585|536802855|FG001|Overall Study|Adverse Event|2|||
148969954|NCT02586012|537376562|FG002|Overall Study|Protocol Violation|0|||
148969955|NCT02586012|537376563|FG003|Overall Study|Protocol Violation|0|||
148969956|NCT02586012|537376564|FG004|Overall Study|Protocol Violation|0|||
148969957|NCT02586012|537376565|FG005|Overall Study|Protocol Violation|1|||
148969958|NCT02586012|537376560|FG000|Overall Study|study terminated|0|||
148969959|NCT02586012|537376561|FG001|Overall Study|study terminated|2|||
148969960|NCT02586012|537376562|FG002|Overall Study|study terminated|1|||
148969961|NCT02586012|537376563|FG003|Overall Study|study terminated|1|||
148969962|NCT02586012|537376564|FG004|Overall Study|study terminated|1|||
148969963|NCT02586012|537376565|FG005|Overall Study|study terminated|0|||
148969964|NCT03252522|537376566|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
148969965|NCT03252522|537376567|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
148969966|NCT03252522|537376568|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
148969967|NCT03252522|537376566|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
148969968|NCT03252522|537376567|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
148969969|NCT03252522|537376568|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
148969970|NCT03252522|537376566|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
148969971|NCT03252522|537376567|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
148969972|NCT03252522|537376568|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
148969973|NCT03252522|537376566|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
148969974|NCT03252522|537376567|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
148969975|NCT03252522|537376568|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
148969976|NCT03252522|537376566|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
148969977|NCT03252522|537376567|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
148969978|NCT03252522|537376568|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
148969979|NCT03252522|537376566|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
148724618|NCT01048502|536463430|FG001|Overall Study|Adverse Event|0|||
148724619|NCT01048502|536463431|FG002|Overall Study|Adverse Event|0|||
148724620|NCT01048502|536463432|FG003|Overall Study|Adverse Event|0|||
148724621|NCT01048502|536463429|FG000|Overall Study|Withdrawal by Subject|1|||
148724622|NCT01048502|536463430|FG001|Overall Study|Withdrawal by Subject|4|||
148724623|NCT01048502|536463431|FG002|Overall Study|Withdrawal by Subject|5|||
148724624|NCT01048502|536463432|FG003|Overall Study|Withdrawal by Subject|3|||
148724625|NCT01048502|536463429|FG000|Overall Study|Physician Decision|0|||
148724626|NCT01048502|536463430|FG001|Overall Study|Physician Decision|3|||
148724627|NCT01048502|536463431|FG002|Overall Study|Physician Decision|0|||
148724628|NCT01048502|536463432|FG003|Overall Study|Physician Decision|1|||
148724629|NCT00493454|536463434|FG000|Overall Study|Withdrawal by Subject|1|||
148724630|NCT02502734|536463437|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
148724631|NCT02502734|536463438|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
148724632|NCT02502734|536463437|FG000|Washout Period|Adverse Event|1|||
148724633|NCT02502734|536463438|FG001|Washout Period|Adverse Event|0|||
148724634|NCT03095118|536463444|FG000|Overall Study|Adverse Event|1|||
148724635|NCT03095118|536463444|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
148724636|NCT04668274|536463445|FG000|Part 1 Study Period 1|Adverse Event|3|||
148724637|NCT04668274|536463446|FG001|Part 1 Study Period 1|Adverse Event|0|||
148724638|NCT04668274|536463447|FG002|Part 1 Study Period 1|Adverse Event|0|||
148724639|NCT04668274|536463448|FG003|Part 1 Study Period 1|Adverse Event|0|||
148724640|NCT04668274|536463445|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
148724641|NCT04668274|536463446|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
148724642|NCT04668274|536463447|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
148724643|NCT04668274|536463448|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
148724644|NCT04668274|536463445|FG000|Part 1 Study Period 2|Other|0|||
148724645|NCT04668274|536463446|FG001|Part 1 Study Period 2|Other|1|||
148724646|NCT04668274|536463447|FG002|Part 1 Study Period 2|Other|0|||
148724647|NCT04668274|536463448|FG003|Part 1 Study Period 2|Other|0|||
148724648|NCT04668274|536463445|FG000|Part 1 Study Period 3|Adverse Event|0|||
148724649|NCT04668274|536463446|FG001|Part 1 Study Period 3|Adverse Event|0|||
148724650|NCT04668274|536463447|FG002|Part 1 Study Period 3|Adverse Event|1|||
148724651|NCT04668274|536463448|FG003|Part 1 Study Period 3|Adverse Event|0|||
148724652|NCT04668274|536463445|FG000|Part 1 Study Period 3|Other|0|||
148724653|NCT04668274|536463446|FG001|Part 1 Study Period 3|Other|0|||
148969980|NCT03252522|537376567|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
148969981|NCT03252522|537376568|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
148969982|NCT03252522|537376566|FG000|Phase 2: Open Label|Adverse Event|0|||
148969983|NCT03252522|537376567|FG001|Phase 2: Open Label|Adverse Event|0|||
148724654|NCT04668274|536463447|FG002|Part 1 Study Period 3|Other|2|||
148724655|NCT04668274|536463448|FG003|Part 1 Study Period 3|Other|0|||
148969984|NCT03252522|537376568|FG002|Phase 2: Open Label|Adverse Event|2|||
148969985|NCT03252522|537376566|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
148969986|NCT03252522|537376567|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
148724656|NCT04668274|536463445|FG000|Part 2 Study Period 4|Other|0|||
148724657|NCT04668274|536463446|FG001|Part 2 Study Period 4|Other|0|||
148724658|NCT04668274|536463447|FG002|Part 2 Study Period 4|Other|0|||
148724659|NCT04668274|536463448|FG003|Part 2 Study Period 4|Other|1|||
148724660|NCT02363439|536463451|FG000|Overall Study|Lack of Efficacy|4|||
148724661|NCT03827018|536463456|FG000|Overall Study|Adverse Event|1|||
148724662|NCT03827018|536463457|FG001|Overall Study|Adverse Event|0|||
148724663|NCT03827018|536463456|FG000|Overall Study|Withdrawal by Subject|2|||
148969987|NCT03252522|537376568|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
148969988|NCT00071812|537376570|FG000|24-Week Double-Blind Period|Adverse Event|2|||
148969989|NCT00071812|537376571|FG001|24-Week Double-Blind Period|Adverse Event|3|||
148969990|NCT00071812|537376572|FG002|24-Week Double-Blind Period|Adverse Event|4|||
148969991|NCT00071812|537376573|FG003|24-Week Double-Blind Period|Adverse Event|4|||
148969992|NCT00071812|537376570|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
148969993|NCT00071812|537376571|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
148969994|NCT00071812|537376572|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
148969995|NCT00071812|537376573|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
148969996|NCT00071812|537376570|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
148969997|NCT00071812|537376571|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
148969998|NCT00071812|537376572|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
148724664|NCT03827018|536463457|FG001|Overall Study|Withdrawal by Subject|2|||
148724665|NCT03827018|536463456|FG000|Overall Study|Lack of Efficacy|0|||
148724666|NCT03827018|536463457|FG001|Overall Study|Lack of Efficacy|1|||
148724667|NCT04647383|536463458|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
148969999|NCT00071812|537376573|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
148724668|NCT04647383|536463459|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
148724669|NCT04647383|536463460|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
148724670|NCT04647383|536463461|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
148724671|NCT00775528|536463462|FG000|Overall Study|Protocol Violation|1|||
148724672|NCT01884688|536463465|FG000|Overall Study|Screen Failure|2|||
148724673|NCT04099641|536463466|FG000|Overall Study|Death|46|||
148724674|NCT04099641|536463467|FG001|Overall Study|Death|12|||
148724675|NCT04099641|536463466|FG000|Overall Study|Lost to Follow-up|1|||
148724676|NCT04099641|536463467|FG001|Overall Study|Lost to Follow-up|0|||
148724677|NCT04099641|536463466|FG000|Overall Study|Withdrawal by Subject|2|||
148724678|NCT04099641|536463467|FG001|Overall Study|Withdrawal by Subject|0|||
148724679|NCT02470091|536463484|FG000|Overall Study|Withdrawal by Subject|1|||
148724680|NCT02470091|536463485|FG001|Overall Study|Withdrawal by Subject|0|||
148724681|NCT02470091|536463484|FG000|Overall Study|Ineligible|0|||
148724682|NCT02470091|536463485|FG001|Overall Study|Ineligible|2|||
148724683|NCT00303667|536463487|FG000|Overall Study|Death|0|||
148724684|NCT00303667|536463488|FG001|Overall Study|Death|4|||
148724685|NCT01029392|536463489|FG000|Overall Study|Withdrawal by Subject|18|||
148724686|NCT01029392|536463490|FG001|Overall Study|Withdrawal by Subject|11|||
148724687|NCT01029392|536463489|FG000|Overall Study|Physician Decision|2|||
148724688|NCT01029392|536463490|FG001|Overall Study|Physician Decision|0|||
148724689|NCT01103479|536463491|FG000|Overall Study|Up to date with CRC screening|1|||
148724690|NCT01103479|536463492|FG001|Overall Study|Up to date with CRC screening|9|||
148724691|NCT01103479|536463493|FG002|Overall Study|Up to date with CRC screening|12|||
148724692|NCT01103479|536463491|FG000|Overall Study|Family history of CRC|1|||
148724693|NCT01103479|536463492|FG001|Overall Study|Family history of CRC|0|||
148724694|NCT01103479|536463493|FG002|Overall Study|Family history of CRC|2|||
148724695|NCT01103479|536463491|FG000|Overall Study|Active cancer|1|||
148724696|NCT01103479|536463492|FG001|Overall Study|Active cancer|0|||
148724697|NCT01103479|536463493|FG002|Overall Study|Active cancer|0|||
148724698|NCT01103479|536463491|FG000|Overall Study|Saw non-study physician|2|||
148724699|NCT01103479|536463492|FG001|Overall Study|Saw non-study physician|0|||
148724700|NCT01103479|536463493|FG002|Overall Study|Saw non-study physician|0|||
148724701|NCT02549573|536463496|FG000|Overall Study|Withdrawal by Subject|0|||
148724702|NCT02549573|536463497|FG001|Overall Study|Withdrawal by Subject|2|||
148724703|NCT02549573|536463496|FG000|Overall Study|Protocol Violation|0|||
148724704|NCT02549573|536463497|FG001|Overall Study|Protocol Violation|1|||
148724705|NCT02083926|536463498|FG000|Overall Study|Withdrawal by Subject|1|||
148724706|NCT02083926|536463499|FG001|Overall Study|Withdrawal by Subject|0|||
148724707|NCT02610816|536463502|FG000|Phase 1|Withdrawal by Subject|2|||
148724708|NCT02610816|536463503|FG001|Phase 1|Withdrawal by Subject|6|||
148724709|NCT02610816|536463504|FG002|Phase 1|Withdrawal by Subject|0|||
148724710|NCT02610816|536463505|FG003|Phase 1|Withdrawal by Subject|0|||
148724711|NCT02610816|536463502|FG000|Phase 1|Lost to Follow-up|2|||
148724712|NCT02610816|536463503|FG001|Phase 1|Lost to Follow-up|1|||
148724713|NCT02610816|536463504|FG002|Phase 1|Lost to Follow-up|0|||
148724714|NCT02610816|536463505|FG003|Phase 1|Lost to Follow-up|0|||
148724715|NCT02610816|536463502|FG000|Phase 1|Physician Decision|0|||
148724716|NCT02610816|536463503|FG001|Phase 1|Physician Decision|1|||
148724717|NCT02610816|536463504|FG002|Phase 1|Physician Decision|0|||
148970000|NCT00071812|537376570|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
148970001|NCT00071812|537376571|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
148724718|NCT02610816|536463505|FG003|Phase 1|Physician Decision|0|||
148724719|NCT02610816|536463502|FG000|Phase 2|Withdrawal by Subject|0|||
148724720|NCT02610816|536463503|FG001|Phase 2|Withdrawal by Subject|0|||
148724721|NCT02610816|536463504|FG002|Phase 2|Withdrawal by Subject|9|||
148724722|NCT02610816|536463505|FG003|Phase 2|Withdrawal by Subject|3|||
148724723|NCT02610816|536463502|FG000|Phase 2|Lost to Follow-up|0|||
148724724|NCT02610816|536463503|FG001|Phase 2|Lost to Follow-up|0|||
148724725|NCT02610816|536463504|FG002|Phase 2|Lost to Follow-up|2|||
148724726|NCT02610816|536463505|FG003|Phase 2|Lost to Follow-up|0|||
148724727|NCT02610816|536463502|FG000|Phase 2|Physician Decision|0|||
148724728|NCT02610816|536463503|FG001|Phase 2|Physician Decision|0|||
148724729|NCT02610816|536463504|FG002|Phase 2|Physician Decision|0|||
148724730|NCT02610816|536463505|FG003|Phase 2|Physician Decision|2|||
148724731|NCT02610816|536463502|FG000|Phase 2|Pregnancy|0|||
148724732|NCT02610816|536463503|FG001|Phase 2|Pregnancy|0|||
148724733|NCT02610816|536463504|FG002|Phase 2|Pregnancy|0|||
148724734|NCT02610816|536463505|FG003|Phase 2|Pregnancy|1|||
148724735|NCT00384176|536463508|FG000|Overall Study|Death|239|||
148724736|NCT00384176|536463509|FG001|Overall Study|Death|247|||
148724737|NCT00384176|536463510|FG002|Overall Study|Death|105|||
148724738|NCT00384176|536463508|FG000|Overall Study|Withdrawal by Subject|52|||
148724739|NCT00384176|536463509|FG001|Overall Study|Withdrawal by Subject|48|||
148724740|NCT00384176|536463510|FG002|Overall Study|Withdrawal by Subject|22|||
148724741|NCT00384176|536463508|FG000|Overall Study|Lost to Follow-up|16|||
148724742|NCT00384176|536463509|FG001|Overall Study|Lost to Follow-up|18|||
148724743|NCT00384176|536463510|FG002|Overall Study|Lost to Follow-up|4|||
148724744|NCT00384176|536463508|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
148724745|NCT00384176|536463509|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
148724746|NCT00384176|536463510|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
148724747|NCT00384176|536463508|FG000|Overall Study|Longer QTC as Visit 1|1|||
148724748|NCT00384176|536463509|FG001|Overall Study|Longer QTC as Visit 1|0|||
148724749|NCT00384176|536463510|FG002|Overall Study|Longer QTC as Visit 1|0|||
148724750|NCT00384176|536463508|FG000|Overall Study|Toxicity of treatment|1|||
148724751|NCT00384176|536463509|FG001|Overall Study|Toxicity of treatment|0|||
148724752|NCT00384176|536463510|FG002|Overall Study|Toxicity of treatment|0|||
148724753|NCT00384176|536463508|FG000|Overall Study|Did not receive study treatment|0|||
148724754|NCT00384176|536463509|FG001|Overall Study|Did not receive study treatment|1|||
148724755|NCT00384176|536463510|FG002|Overall Study|Did not receive study treatment|1|||
148724756|NCT00384176|536463508|FG000|Overall Study|Physician Decision|0|||
148724757|NCT00384176|536463509|FG001|Overall Study|Physician Decision|2|||
148724758|NCT00384176|536463510|FG002|Overall Study|Physician Decision|0|||
148724759|NCT00384176|536463508|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
148724760|NCT00384176|536463509|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
148724761|NCT00384176|536463510|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
148724762|NCT03078478|536463511|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
148724763|NCT03078478|536463512|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
148724764|NCT03078478|536463511|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
148724765|NCT03078478|536463512|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
148724766|NCT03078478|536463511|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
148724767|NCT03078478|536463512|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
148724768|NCT03078478|536463511|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
148724769|NCT03078478|536463512|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
148724770|NCT03078478|536463511|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
148724771|NCT03078478|536463512|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
148724772|NCT03078478|536463511|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
148724773|NCT03078478|536463512|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
148724774|NCT03078478|536463511|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
148724775|NCT03078478|536463512|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
148724776|NCT03078478|536463511|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
148724777|NCT03078478|536463512|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
148724778|NCT02953678|536463515|FG000|Overall Study|Adverse Event|20|||
148724779|NCT02953678|536463515|FG000|Overall Study|Death|7|||
148724780|NCT02953678|536463515|FG000|Overall Study|Physician Decision|23|||
148724781|NCT02953678|536463515|FG000|Overall Study|Progressive Disease of GVHD|7|||
148724782|NCT02953678|536463515|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
148724783|NCT02953678|536463515|FG000|Overall Study|Withdrawal by participant|3|||
148724784|NCT02953678|536463515|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
148724785|NCT02953678|536463515|FG000|Overall Study|Participants were transferred to commercial product.|3|||
148724786|NCT03064438|536465885|FG000|Overall Study|Lost to Follow-up|1|||
148724787|NCT03064438|536465886|FG001|Overall Study|Lost to Follow-up|0|||
148724788|NCT03064438|536465885|FG000|Overall Study|Withdrawal by Subject|0|||
148724789|NCT03064438|536465886|FG001|Overall Study|Withdrawal by Subject|1|||
148724790|NCT01937351|536465887|FG000|Overall Study|Withdrawal by Subject|4|||
148724791|NCT01937351|536465888|FG001|Overall Study|Withdrawal by Subject|2|||
148724792|NCT01937351|536465887|FG000|Overall Study|Death|1|||
148724793|NCT01937351|536465888|FG001|Overall Study|Death|0|||
148724794|NCT01937351|536465887|FG000|Overall Study|Not treated w device, per protocol fail|4|||
148724795|NCT01937351|536465888|FG001|Overall Study|Not treated w device, per protocol fail|0|||
148724796|NCT01042535|536465889|FG000|Overall Study|disease progression prior to treatment|3|||
148724797|NCT01042535|536465889|FG000|Overall Study|disease progression during treatment|3|||
148724798|NCT01042535|536465889|FG000|Overall Study|complications from other disease|2|||
148724799|NCT00107042|536465892|FG000|Overall Study|Lost to Follow-up|9|||
148724800|NCT00107042|536465893|FG001|Overall Study|Lost to Follow-up|7|||
149234097|NCT01243762|538326389|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
149234098|NCT01243762|538326390|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149234099|NCT01243762|538326391|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149234100|NCT01243762|538326392|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
149234101|NCT01243762|538326393|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
149234102|NCT01243762|538326394|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
149234103|NCT01243762|538326388|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149234104|NCT01243762|538326389|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
149234105|NCT01243762|538326390|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149234106|NCT01243762|538326391|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
149234107|NCT01243762|538326392|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149234108|NCT01243762|538326393|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149234109|NCT01243762|538326394|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
149234110|NCT01243762|538326388|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
149234111|NCT01243762|538326389|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
149234112|NCT01243762|538326390|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
149234113|NCT01243762|538326391|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
149234114|NCT01243762|538326392|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
149234115|NCT01243762|538326393|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
149234116|NCT01243762|538326394|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
149234117|NCT01243762|538326388|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149234118|NCT01243762|538326389|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
149234119|NCT01243762|538326390|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149234120|NCT01243762|538326391|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149234121|NCT01243762|538326392|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149234122|NCT01243762|538326393|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149234123|NCT01243762|538326394|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
149234124|NCT01243762|538326388|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149234125|NCT01243762|538326389|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
149234126|NCT01243762|538326390|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149234127|NCT01243762|538326391|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149234128|NCT01243762|538326392|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149234129|NCT01243762|538326393|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
149234130|NCT01243762|538326394|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
149234131|NCT01243762|538326388|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
149234132|NCT01243762|538326389|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
149234133|NCT01243762|538326390|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
149234134|NCT01243762|538326391|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
149234135|NCT01243762|538326392|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
149234136|NCT01243762|538326393|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
149234137|NCT01243762|538326394|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
149234138|NCT01243762|538326388|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149234139|NCT01243762|538326389|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
149234140|NCT01243762|538326390|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149234141|NCT01243762|538326391|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149234142|NCT01243762|538326392|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
149234143|NCT01243762|538326393|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149234144|NCT01243762|538326394|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
149234145|NCT01243762|538326388|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149234146|NCT01243762|538326389|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149234147|NCT01243762|538326390|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149234148|NCT01243762|538326391|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
149234149|NCT01243762|538326392|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
149234150|NCT01243762|538326393|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
148970002|NCT00071812|537376572|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
149234151|NCT01243762|538326394|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
149234152|NCT02059265|538326395|FG000|Overall Study|Ineligible|4|||
149234153|NCT03605758|538326400|FG000|Overall Study|Lost to Follow-up|2|||
149234154|NCT03605758|538326401|FG001|Overall Study|Lost to Follow-up|1|||
149234155|NCT03605758|538326400|FG000|Overall Study|Illness|0|||
149234156|NCT03605758|538326401|FG001|Overall Study|Illness|1|||
149234157|NCT03605758|538326400|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
149234158|NCT03605758|538326401|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
149234159|NCT04366258|538326408|FG000|Baseline Assessments|Screen Failure|21|||
149234160|NCT04366258|538326408|FG000|Baseline Assessments|Early Termination|3|||
148724801|NCT00107042|536465892|FG000|Overall Study|Withdrawal by Subject|6|||
148970003|NCT00071812|537376573|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
148724802|NCT00107042|536465893|FG001|Overall Study|Withdrawal by Subject|1|||
149234161|NCT02940392|538326413|FG000|Overall Study|Lost to Follow-up|3|||
149234162|NCT02940392|538326413|FG000|Overall Study|Retreatment|3|||
149234163|NCT02940392|538326413|FG000|Overall Study|Death|2|||
149234164|NCT03205046|538326415|FG000|Overall Study|Death|10|||
149234165|NCT03205046|538326416|FG001|Overall Study|Death|6|||
149234166|NCT03205046|538326415|FG000|Overall Study|Withdrawal by Subject|1|||
149234167|NCT03205046|538326416|FG001|Overall Study|Withdrawal by Subject|2|||
149234168|NCT03205046|538326415|FG000|Overall Study|Lost to Follow-up|0|||
149234169|NCT03205046|538326416|FG001|Overall Study|Lost to Follow-up|1|||
149234170|NCT03205046|538326415|FG000|Overall Study|Study terminated by sponsor|2|||
149234171|NCT03205046|538326416|FG001|Overall Study|Study terminated by sponsor|1|||
149234172|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
149234173|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
149234174|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
149234175|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
149234176|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
149234177|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Death|1|||
149234178|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Death|0|||
149234179|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Death|0|||
149234180|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Death|0|||
149234181|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Death|0|||
149234182|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
149234183|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
149234184|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
149234185|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
149234186|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
149234187|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
149234188|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
149234189|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
149234190|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
148724803|NCT00107042|536465892|FG000|Overall Study|Moved out of area|5|||
148724804|NCT00107042|536465893|FG001|Overall Study|Moved out of area|3|||
148724805|NCT00107042|536465892|FG000|Overall Study|Pregnancy|1|||
148724806|NCT00107042|536465893|FG001|Overall Study|Pregnancy|1|||
148724807|NCT00107042|536465892|FG000|Overall Study|Inadvertent enrollment|0|||
148724808|NCT00107042|536465893|FG001|Overall Study|Inadvertent enrollment|1|||
148724809|NCT00107042|536465892|FG000|Overall Study|vaccinated outside window|1|||
148724810|NCT00107042|536465893|FG001|Overall Study|vaccinated outside window|1|||
148724811|NCT00107042|536465892|FG000|Overall Study|Disallowed medications|0|||
148724812|NCT00107042|536465893|FG001|Overall Study|Disallowed medications|2|||
148724813|NCT03919448|536465894|FG000|Overall Study|Withdrawal by Subject|1|||
148724814|NCT03919448|536465895|FG001|Overall Study|Withdrawal by Subject|0|||
148724815|NCT03919448|536465896|FG002|Overall Study|Withdrawal by Subject|0|||
148724816|NCT03438539|536465898|FG000|Overall Study|Lost to Follow-up|8|||
148724817|NCT03438539|536465899|FG001|Overall Study|Lost to Follow-up|4|||
148724818|NCT03438539|536465900|FG002|Overall Study|Lost to Follow-up|10|||
148724819|NCT03438539|536465901|FG003|Overall Study|Lost to Follow-up|9|||
148724820|NCT03438539|536465902|FG004|Overall Study|Lost to Follow-up|3|||
148724821|NCT03438539|536465903|FG005|Overall Study|Lost to Follow-up|8|||
148724822|NCT01221090|536465904|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
148724823|NCT01221090|536465905|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
149234191|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
149234192|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
149234193|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
149234194|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
149234195|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
149234196|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
149234197|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
149234198|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
149234199|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
149234200|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
149234201|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
149234202|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
149234203|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
149234204|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
149234205|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
149234206|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
149234207|NCT00634933|538326417|FG000|Part A: Baseline to Week 24|Other|1|||
149234208|NCT00634933|538326418|FG001|Part A: Baseline to Week 24|Other|8|||
149234209|NCT00634933|538326419|FG002|Part A: Baseline to Week 24|Other|5|||
149234210|NCT00634933|538326420|FG003|Part A: Baseline to Week 24|Other|0|||
149234211|NCT00634933|538326421|FG004|Part A: Baseline to Week 24|Other|0|||
149234212|NCT00634933|538326417|FG000|Between Part A and Part B|Physician Decision|0|||
148724824|NCT01221090|536465906|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
148724825|NCT01221090|536465907|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
149234213|NCT00634933|538326418|FG001|Between Part A and Part B|Physician Decision|1|||
149234214|NCT00634933|538326419|FG002|Between Part A and Part B|Physician Decision|0|||
149234215|NCT00634933|538326420|FG003|Between Part A and Part B|Physician Decision|0|||
149234216|NCT00634933|538326421|FG004|Between Part A and Part B|Physician Decision|0|||
149234217|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
149234218|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
149234219|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
149234220|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
149234221|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
149234222|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
149234223|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
149234224|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
149234225|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
149234226|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
149234227|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
149234228|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
149234229|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
149234230|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
149234231|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
149234232|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
149234233|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
148970004|NCT00071812|537376570|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
149234234|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
148970005|NCT00071812|537376571|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
148970006|NCT00071812|537376572|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
148970007|NCT00071812|537376573|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
148970008|NCT00071812|537376570|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
148970009|NCT00071812|537376571|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
148970010|NCT00071812|537376572|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
148970011|NCT00071812|537376573|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
148970012|NCT00071812|537376570|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
148970013|NCT00071812|537376571|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
148970014|NCT00071812|537376572|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
148970015|NCT00071812|537376573|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
148970016|NCT00071812|537376570|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
148970017|NCT00071812|537376571|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
149234235|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
149234236|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
149234237|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
149234238|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
148970018|NCT00071812|537376572|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
148970019|NCT00071812|537376573|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
148970020|NCT00071812|537376570|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
149234239|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
149234240|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
149234241|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
149234242|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
149234243|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
149234244|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
149234245|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
149234246|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
149234247|NCT00634933|538326417|FG000|Part B: Week 24 to Week 52|Other|0|||
149234248|NCT00634933|538326418|FG001|Part B: Week 24 to Week 52|Other|0|||
149234249|NCT00634933|538326419|FG002|Part B: Week 24 to Week 52|Other|5|||
149234250|NCT00634933|538326420|FG003|Part B: Week 24 to Week 52|Other|0|||
149234251|NCT00634933|538326421|FG004|Part B: Week 24 to Week 52|Other|1|||
149234252|NCT02219477|538326424|FG000|Overall Study|Adverse Event|0|||
148970021|NCT00071812|537376571|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
149234253|NCT02219477|538326425|FG001|Overall Study|Adverse Event|1|||
149234254|NCT02219477|538326426|FG002|Overall Study|Adverse Event|1|||
149234255|NCT02219477|538326424|FG000|Overall Study|Withdrawal by Subject|0|||
149234256|NCT02219477|538326425|FG001|Overall Study|Withdrawal by Subject|1|||
148970022|NCT00071812|537376572|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
148970023|NCT00071812|537376573|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
149234257|NCT02219477|538326426|FG002|Overall Study|Withdrawal by Subject|0|||
148970024|NCT00071812|537376570|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
149234258|NCT03522506|538326427|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149234259|NCT03522506|538326428|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149234260|NCT03522506|538326429|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
149234261|NCT03522506|538326430|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
148970025|NCT00071812|537376571|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
148970026|NCT00071812|537376572|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
148970027|NCT00071812|537376573|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
148970028|NCT01816139|537376574|FG000|Overall Study|Adverse Event|6|||
148970029|NCT01816139|537376575|FG001|Overall Study|Adverse Event|8|||
148970030|NCT01816139|537376574|FG000|Overall Study|Lack of Efficacy|1|||
148970031|NCT01816139|537376575|FG001|Overall Study|Lack of Efficacy|2|||
149234262|NCT03522506|538326427|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149234263|NCT03522506|538326428|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149234264|NCT03522506|538326429|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
149234265|NCT03522506|538326430|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
149234266|NCT05643573|538326431|FG000|Overall Study|Adverse Event|117|||
149234267|NCT05643573|538326432|FG001|Overall Study|Adverse Event|90|||
149234268|NCT05643573|538326431|FG000|Overall Study|Death|53|||
149234269|NCT05643573|538326432|FG001|Overall Study|Death|57|||
149234270|NCT05643573|538326431|FG000|Overall Study|Lost to Follow-up|6|||
149234271|NCT05643573|538326432|FG001|Overall Study|Lost to Follow-up|3|||
149234272|NCT05643573|538326431|FG000|Overall Study|Other|18|||
149234273|NCT05643573|538326432|FG001|Overall Study|Other|15|||
149234274|NCT05643573|538326431|FG000|Overall Study|Outcome event|64|||
149234275|NCT05643573|538326432|FG001|Overall Study|Outcome event|36|||
149234276|NCT05643573|538326431|FG000|Overall Study|Physician Decision|33|||
149234277|NCT05643573|538326432|FG001|Overall Study|Physician Decision|19|||
149234278|NCT05643573|538326431|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
149234279|NCT05643573|538326432|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
149234280|NCT05643573|538326431|FG000|Overall Study|Site terminated by sponsor|10|||
149234281|NCT05643573|538326432|FG001|Overall Study|Site terminated by sponsor|10|||
149234282|NCT05643573|538326431|FG000|Overall Study|Study terminated by sponsor|1|||
149234283|NCT05643573|538326432|FG001|Overall Study|Study terminated by sponsor|0|||
149234284|NCT05643573|538326431|FG000|Overall Study|Withdrawal by Subject|178|||
149234285|NCT05643573|538326432|FG001|Overall Study|Withdrawal by Subject|130|||
149234286|NCT04409262|538326434|FG000|Overall Study|Adverse Event|0|||
149234287|NCT04409262|538326435|FG001|Overall Study|Adverse Event|2|||
149234288|NCT04409262|538326434|FG000|Overall Study|Death|55|||
149234289|NCT04409262|538326435|FG001|Overall Study|Death|97|||
149234290|NCT04409262|538326434|FG000|Overall Study|Lost to Follow-up|12|||
149234291|NCT04409262|538326435|FG001|Overall Study|Lost to Follow-up|23|||
149234292|NCT04409262|538326434|FG000|Overall Study|Lack of Staff|0|||
149234293|NCT04409262|538326435|FG001|Overall Study|Lack of Staff|1|||
149234294|NCT04409262|538326434|FG000|Overall Study|Protocol Violation|3|||
149234295|NCT04409262|538326435|FG001|Overall Study|Protocol Violation|1|||
149234296|NCT04409262|538326434|FG000|Overall Study|Withdrawal by Subject|5|||
149234297|NCT04409262|538326435|FG001|Overall Study|Withdrawal by Subject|10|||
149234298|NCT03205605|538326436|FG000|Overall Study|Withdrawal by Subject|1|||
149234299|NCT02396849|538326437|FG000|Overall Study|Lost to Follow-up|1|||
149234300|NCT02396849|538326438|FG001|Overall Study|Lost to Follow-up|1|||
149234301|NCT02396849|538326437|FG000|Overall Study|Did not tolerate intervention|1|||
149234302|NCT02396849|538326438|FG001|Overall Study|Did not tolerate intervention|1|||
149234303|NCT03328325|538326441|FG000|Overall Study|Lost to Follow-up|4|||
149234304|NCT03328325|538326441|FG000|Overall Study|Physician Decision|1|||
149234305|NCT03328325|538326441|FG000|Overall Study|Withdrawal by Subject|3|||
149234306|NCT03328325|538326441|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
149234307|NCT04794491|538326444|FG000|Overall Study|Adverse Event|1|||
149234308|NCT04794491|538326444|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
149234309|NCT04794491|538326444|FG000|Overall Study|Noncompliance With Study Intervention|1|||
149234310|NCT04794491|538326444|FG000|Overall Study|Withdrawal by Subject|2|||
149234311|NCT00931515|538326445|FG000|Overall Study|Lost to Follow-up|2|||
149234312|NCT00931515|538326446|FG001|Overall Study|Lost to Follow-up|5|||
149234313|NCT03655951|538326447|FG000|Overall Study|Lost to Follow-up|39|||
149234314|NCT03655951|538326448|FG001|Overall Study|Lost to Follow-up|20|||
149234315|NCT03655951|538326447|FG000|Overall Study|Withdrawal by Subject|0|||
149234316|NCT03655951|538326448|FG001|Overall Study|Withdrawal by Subject|1|||
149234317|NCT03145207|538326453|FG000|Overall Study|volunteer started taking allergy shots|1|||
149234318|NCT03145207|538326453|FG000|Overall Study|baseline blood pressure high|1|||
149234319|NCT01396434|538326455|FG000|Overall Study|Lost to Follow-up|1|||
149234320|NCT01396434|538326456|FG001|Overall Study|Lost to Follow-up|0|||
149234321|NCT01396434|538326457|FG002|Overall Study|Lost to Follow-up|0|||
149234322|NCT01396434|538326455|FG000|Overall Study|Other|10|||
149234323|NCT01396434|538326456|FG001|Overall Study|Other|0|||
148970032|NCT01816139|537376574|FG000|Overall Study|Lost to Follow-up|5|||
148970033|NCT01816139|537376575|FG001|Overall Study|Lost to Follow-up|3|||
148970034|NCT01816139|537376574|FG000|Overall Study|Withdrew Consent|6|||
148970035|NCT01816139|537376575|FG001|Overall Study|Withdrew Consent|4|||
149234324|NCT01396434|538326457|FG002|Overall Study|Other|0|||
149234325|NCT00157157|538326460|FG000|Overall Study|Withdrawal by Subject|6|||
149234326|NCT00157157|538326460|FG000|Overall Study|Physician Decision|1|||
149234327|NCT00157157|538326460|FG000|Overall Study|Lost to Follow-up|1|||
149234328|NCT00157157|538326460|FG000|Overall Study|Enrolled in another study|1|||
149234329|NCT00157157|538326460|FG000|Overall Study|Met exclusion criteria|1|||
149234330|NCT00157157|538326460|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
149234331|NCT02260804|538326464|FG000|Induction Study Period|Protocol Violation|2|||
149234332|NCT02260804|538326465|FG001|Induction Study Period|Protocol Violation|0|||
149234333|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
149234334|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
149234335|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
149234336|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
149234337|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
149234338|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
149234339|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
149234340|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
149234341|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
149234342|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
149234343|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
149234344|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
149234345|NCT02260804|538326464|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
149234346|NCT02260804|538326465|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
149234347|NCT02260804|538326464|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
149234348|NCT02260804|538326465|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
149234349|NCT02260804|538326464|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
149234350|NCT02260804|538326465|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
149234351|NCT02260804|538326464|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
149234352|NCT02260804|538326465|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
148970036|NCT01816139|537376574|FG000|Overall Study|Protocol Violation|6|||
148970037|NCT01816139|537376575|FG001|Overall Study|Protocol Violation|3|||
148970038|NCT01816139|537376574|FG000|Overall Study|Reason not Specified|4|||
148970039|NCT01816139|537376575|FG001|Overall Study|Reason not Specified|2|||
148970040|NCT01940120|537376576|FG000|Overall Study|Death|40|||
148970041|NCT01940120|537376576|FG000|Overall Study|Withdrawal by Subject|8|||
148970042|NCT03277846|537376577|FG000|Overall Study|Inpatient stay too brief|12|||
148970043|NCT03277846|537376578|FG001|Overall Study|Inpatient stay too brief|11|||
148970044|NCT03240575|537376579|FG000|Overall Study|Adverse Event|0|||
148970045|NCT03240575|537376580|FG001|Overall Study|Adverse Event|2|||
148970046|NCT03240575|537376581|FG002|Overall Study|Adverse Event|0|||
148970047|NCT03240575|537376582|FG003|Overall Study|Adverse Event|1|||
148816396|NCT01131585|536802854|FG000|Overall Study|Abnormal laboratory value|1|||
148816397|NCT01131585|536802855|FG001|Overall Study|Abnormal laboratory value|0|||
148816398|NCT01131585|536802854|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148816399|NCT01131585|536802855|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
148816400|NCT01131585|536802854|FG000|Overall Study|Protocol Violation|2|||
148816401|NCT01131585|536802855|FG001|Overall Study|Protocol Violation|1|||
148816402|NCT01131585|536802854|FG000|Overall Study|Withdrawal by Subject|3|||
148816403|NCT01131585|536802855|FG001|Overall Study|Withdrawal by Subject|3|||
148816404|NCT01131585|536802854|FG000|Overall Study|Lost to Follow-up|0|||
148816405|NCT01131585|536802855|FG001|Overall Study|Lost to Follow-up|1|||
148816406|NCT01131585|536802854|FG000|Overall Study|Administrative problems|1|||
148816407|NCT01131585|536802855|FG001|Overall Study|Administrative problems|1|||
148816408|NCT01131585|536802854|FG000|Overall Study|Study termination|78|||
148816409|NCT01131585|536802855|FG001|Overall Study|Study termination|32|||
148816410|NCT01786109|536802856|FG000|Overall Study|fail manometry barostat tube placement|1|||
148816411|NCT01786109|536802857|FG001|Overall Study|fail manometry barostat tube placement|0|||
148816412|NCT01786109|536802858|FG002|Overall Study|fail manometry barostat tube placement|0|||
148816413|NCT01786109|536802856|FG000|Overall Study|unrelated illness|0|||
148816414|NCT01786109|536802857|FG001|Overall Study|unrelated illness|0|||
148816415|NCT01786109|536802858|FG002|Overall Study|unrelated illness|1|||
148816416|NCT01786109|536802856|FG000|Overall Study|adverse effects colon preparation|0|||
148816417|NCT01786109|536802857|FG001|Overall Study|adverse effects colon preparation|0|||
148816418|NCT01786109|536802858|FG002|Overall Study|adverse effects colon preparation|1|||
148816419|NCT01068912|536802863|FG000|Overall Study|Adverse Event|2|||
148970048|NCT03240575|537376579|FG000|Overall Study|Withdrawal by Subject|2|||
148970049|NCT03240575|537376580|FG001|Overall Study|Withdrawal by Subject|11|||
148970050|NCT03240575|537376581|FG002|Overall Study|Withdrawal by Subject|0|||
148970051|NCT03240575|537376582|FG003|Overall Study|Withdrawal by Subject|1|||
148970052|NCT03240575|537376579|FG000|Overall Study|Other|0|||
148970053|NCT03240575|537376580|FG001|Overall Study|Other|1|||
148970054|NCT03240575|537376581|FG002|Overall Study|Other|0|||
148970055|NCT03240575|537376582|FG003|Overall Study|Other|0|||
148970056|NCT03568942|537376587|FG000|Overall Study|Family emergency|1|||
148970057|NCT03568942|537376587|FG000|Overall Study|Lost to Follow-up|1|||
148970058|NCT05358821|537376590|FG000|Overall Study|Withdrawal by Subject|0|||
148970059|NCT05358821|537376591|FG001|Overall Study|Withdrawal by Subject|1|||
148970060|NCT05358821|537376592|FG002|Overall Study|Withdrawal by Subject|0|||
148970061|NCT05358821|537376590|FG000|Overall Study|Withdrawal of Consent|0|||
148970062|NCT05358821|537376591|FG001|Overall Study|Withdrawal of Consent|0|||
148970063|NCT05358821|537376592|FG002|Overall Study|Withdrawal of Consent|1|||
148970064|NCT00048542|537376594|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
148970065|NCT00048542|537376595|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
148970066|NCT00048542|537376596|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
148970067|NCT00048542|537376597|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
148970068|NCT00048542|537376598|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
148970069|NCT00048542|537376599|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
148970070|NCT00048542|537376600|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
148970071|NCT00048542|537376601|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
148970072|NCT00048542|537376594|FG000|Double-Blind Phase|Protocol Violation|0|||
148970073|NCT00048542|537376595|FG001|Double-Blind Phase|Protocol Violation|0|||
148970074|NCT00048542|537376596|FG002|Double-Blind Phase|Protocol Violation|1|||
148970075|NCT00048542|537376597|FG003|Double-Blind Phase|Protocol Violation|0|||
148970076|NCT00048542|537376598|FG004|Double-Blind Phase|Protocol Violation|0|||
148970077|NCT00048542|537376599|FG005|Double-Blind Phase|Protocol Violation|0|||
148970078|NCT00048542|537376600|FG006|Double-Blind Phase|Protocol Violation|0|||
148970079|NCT00048542|537376601|FG007|Double-Blind Phase|Protocol Violation|0|||
148970080|NCT00048542|537376594|FG000|Double-Blind Phase|Sponsor request or decision|2|||
148970081|NCT00048542|537376595|FG001|Double-Blind Phase|Sponsor request or decision|0|||
148970082|NCT00048542|537376596|FG002|Double-Blind Phase|Sponsor request or decision|0|||
148970083|NCT00048542|537376597|FG003|Double-Blind Phase|Sponsor request or decision|0|||
148970084|NCT00048542|537376598|FG004|Double-Blind Phase|Sponsor request or decision|0|||
148970085|NCT00048542|537376599|FG005|Double-Blind Phase|Sponsor request or decision|0|||
148970086|NCT00048542|537376600|FG006|Double-Blind Phase|Sponsor request or decision|0|||
148970087|NCT00048542|537376601|FG007|Double-Blind Phase|Sponsor request or decision|0|||
148970088|NCT00048542|537376594|FG000|Double-Blind Phase|Randomized in error|1|||
148970089|NCT00048542|537376595|FG001|Double-Blind Phase|Randomized in error|0|||
148970090|NCT00048542|537376596|FG002|Double-Blind Phase|Randomized in error|0|||
148970091|NCT00048542|537376597|FG003|Double-Blind Phase|Randomized in error|0|||
148970092|NCT00048542|537376598|FG004|Double-Blind Phase|Randomized in error|0|||
148970093|NCT00048542|537376599|FG005|Double-Blind Phase|Randomized in error|0|||
148970094|NCT00048542|537376600|FG006|Double-Blind Phase|Randomized in error|0|||
148970095|NCT00048542|537376601|FG007|Double-Blind Phase|Randomized in error|0|||
148970096|NCT00048542|537376594|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
149025166|NCT04529538|537568047|FG004|Overall Study|Withdrawal by Subject|0|||
148970097|NCT00048542|537376595|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
148970098|NCT00048542|537376596|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
148970099|NCT00048542|537376597|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
148724826|NCT01221090|536465904|FG000|Overall Study|Withdrawal by Subject|0|||
148724827|NCT01221090|536465905|FG001|Overall Study|Withdrawal by Subject|22|||
148724828|NCT01221090|536465906|FG002|Overall Study|Withdrawal by Subject|27|||
148724829|NCT01221090|536465907|FG003|Overall Study|Withdrawal by Subject|2|||
148724830|NCT00440466|536465908|FG000|Overall Study|Death|3|||
148724831|NCT00440466|536465909|FG001|Overall Study|Death|2|||
148724832|NCT00440466|536465910|FG002|Overall Study|Death|9|||
148724833|NCT00440466|536465908|FG000|Overall Study|Adverse Event|3|||
148724834|NCT00440466|536465909|FG001|Overall Study|Adverse Event|4|||
148724835|NCT00440466|536465910|FG002|Overall Study|Adverse Event|11|||
148724836|NCT00440466|536465908|FG000|Overall Study|Lost to Follow-up|1|||
148724837|NCT00440466|536465909|FG001|Overall Study|Lost to Follow-up|0|||
148724838|NCT00440466|536465910|FG002|Overall Study|Lost to Follow-up|2|||
148724839|NCT00440466|536465908|FG000|Overall Study|Physician Decision|2|||
148724840|NCT00440466|536465909|FG001|Overall Study|Physician Decision|0|||
148724841|NCT00440466|536465910|FG002|Overall Study|Physician Decision|1|||
148724842|NCT00440466|536465908|FG000|Overall Study|Protocol Violation|2|||
148724843|NCT00440466|536465909|FG001|Overall Study|Protocol Violation|0|||
148724844|NCT00440466|536465910|FG002|Overall Study|Protocol Violation|4|||
148724845|NCT00440466|536465908|FG000|Overall Study|Withdrawal by Subject|2|||
148724846|NCT00440466|536465909|FG001|Overall Study|Withdrawal by Subject|5|||
148724847|NCT00440466|536465910|FG002|Overall Study|Withdrawal by Subject|9|||
148724848|NCT00440466|536465908|FG000|Overall Study|Began Dialysis|0|||
148724849|NCT00440466|536465909|FG001|Overall Study|Began Dialysis|0|||
148724850|NCT00440466|536465910|FG002|Overall Study|Began Dialysis|1|||
148724851|NCT00440466|536465908|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
148724852|NCT00440466|536465909|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
148724853|NCT00440466|536465910|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
148724854|NCT00655850|536465911|FG000|Overall Study|Death|2|||
148724855|NCT00655850|536465911|FG000|Overall Study|Withdrawal by Subject|1|||
148724856|NCT02459665|536465912|FG000|Overall Study|Withdrawal by Subject|0|||
148724857|NCT02459665|536465913|FG001|Overall Study|Withdrawal by Subject|1|||
148724858|NCT02459665|536465914|FG002|Overall Study|Withdrawal by Subject|1|||
148724859|NCT02459665|536465915|FG003|Overall Study|Withdrawal by Subject|2|||
148724860|NCT01223235|536465916|FG000|Overall Study|Withdrawal by Subject|1|||
148724861|NCT00865098|536465918|FG000|Overall Study|Progressive disease|1|||
148724862|NCT00099268|536465919|FG000|Overall Study|Withdrawal by Subject|46|||
148724863|NCT00099268|536465920|FG001|Overall Study|Withdrawal by Subject|28|||
148724864|NCT00099268|536465919|FG000|Overall Study|Adverse Event|19|||
148724865|NCT00099268|536465920|FG001|Overall Study|Adverse Event|19|||
148724866|NCT00099268|536465919|FG000|Overall Study|Protocol Violation|9|||
148724867|NCT00099268|536465920|FG001|Overall Study|Protocol Violation|8|||
148724868|NCT00099268|536465919|FG000|Overall Study|Lost to Follow-up|6|||
148724869|NCT00099268|536465920|FG001|Overall Study|Lost to Follow-up|4|||
148724870|NCT00099268|536465919|FG000|Overall Study|Lack of Efficacy|5|||
148724871|NCT00099268|536465920|FG001|Overall Study|Lack of Efficacy|18|||
148724872|NCT00099268|536465919|FG000|Overall Study|Administrative problems|4|||
148724873|NCT00099268|536465920|FG001|Overall Study|Administrative problems|4|||
148724874|NCT00099268|536465919|FG000|Overall Study|Death|3|||
148724875|NCT00099268|536465920|FG001|Overall Study|Death|1|||
148724876|NCT01360866|536465921|FG000|Overall Study|Lost to Follow-up|11|||
148724877|NCT01360866|536465922|FG001|Overall Study|Lost to Follow-up|28|||
148724878|NCT01360866|536465923|FG002|Overall Study|Lost to Follow-up|41|||
148724879|NCT01360866|536465924|FG003|Overall Study|Lost to Follow-up|0|||
148724880|NCT01360866|536465921|FG000|Overall Study|Adverse Event|56|||
148724881|NCT01360866|536465922|FG001|Overall Study|Adverse Event|61|||
148724882|NCT01360866|536465923|FG002|Overall Study|Adverse Event|134|||
148724883|NCT01360866|536465924|FG003|Overall Study|Adverse Event|6|||
148724884|NCT01360866|536465921|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
148724885|NCT01360866|536465922|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
148724886|NCT01360866|536465923|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
148970100|NCT00048542|537376598|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
148970101|NCT00048542|537376599|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
148970102|NCT00048542|537376600|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
148970103|NCT00048542|537376601|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
148724887|NCT01360866|536465924|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
148724888|NCT01360866|536465921|FG000|Overall Study|Withdrawn by Investigator|9|||
149025167|NCT04529538|537568048|FG005|Overall Study|Withdrawal by Subject|2|||
149025168|NCT04529538|537568049|FG006|Overall Study|Withdrawal by Subject|3|||
149025169|NCT04529538|537568050|FG007|Overall Study|Withdrawal by Subject|0|||
149025170|NCT04529538|537568043|FG000|Overall Study|Other|0|||
149025171|NCT04529538|537568044|FG001|Overall Study|Other|1|||
148970104|NCT00048542|537376594|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
148970105|NCT00048542|537376595|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
148970106|NCT00048542|537376596|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
148970107|NCT00048542|537376597|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
148970108|NCT00048542|537376598|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
148970109|NCT00048542|537376599|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
148970110|NCT00048542|537376600|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
148970111|NCT00048542|537376601|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
148724889|NCT01360866|536465922|FG001|Overall Study|Withdrawn by Investigator|8|||
148724890|NCT01360866|536465923|FG002|Overall Study|Withdrawn by Investigator|31|||
148970112|NCT00048542|537376594|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
148970113|NCT00048542|537376595|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
148970114|NCT00048542|537376596|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
148970115|NCT00048542|537376597|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
148970116|NCT00048542|537376598|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
148970117|NCT00048542|537376599|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
148970118|NCT00048542|537376600|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
148970119|NCT00048542|537376601|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
148724891|NCT01360866|536465924|FG003|Overall Study|Withdrawn by Investigator|2|||
148970120|NCT00048542|537376594|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
148970121|NCT00048542|537376595|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
149025172|NCT04529538|537568045|FG002|Overall Study|Other|0|||
149025173|NCT04529538|537568046|FG003|Overall Study|Other|0|||
148724892|NCT01360866|536465921|FG000|Overall Study|Withdrawal by participant|79|||
148724893|NCT01360866|536465922|FG001|Overall Study|Withdrawal by participant|89|||
148724894|NCT01360866|536465923|FG002|Overall Study|Withdrawal by participant|168|||
148724895|NCT01360866|536465924|FG003|Overall Study|Withdrawal by participant|8|||
148970122|NCT00048542|537376596|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
148970123|NCT00048542|537376597|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
148970124|NCT00048542|537376598|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
148724896|NCT01360866|536465921|FG000|Overall Study|Protocol Deviation|25|||
148724897|NCT01360866|536465922|FG001|Overall Study|Protocol Deviation|33|||
148724898|NCT01360866|536465923|FG002|Overall Study|Protocol Deviation|61|||
148724899|NCT01360866|536465924|FG003|Overall Study|Protocol Deviation|2|||
148724900|NCT01360866|536465921|FG000|Overall Study|Lack of Efficacy|30|||
148724901|NCT01360866|536465922|FG001|Overall Study|Lack of Efficacy|40|||
148724902|NCT01360866|536465923|FG002|Overall Study|Lack of Efficacy|30|||
148724903|NCT01360866|536465924|FG003|Overall Study|Lack of Efficacy|4|||
148724904|NCT00918463|536465929|FG000|Overall Study|Death|1|||
148724905|NCT00918463|536465929|FG000|Overall Study|Lack of Efficacy|1|||
148970125|NCT00048542|537376599|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
148970126|NCT00048542|537376600|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
149025174|NCT04529538|537568047|FG004|Overall Study|Other|0|||
148724906|NCT01014624|536465933|FG000|Overall Study|Adverse Event|0|||
148970127|NCT00048542|537376601|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
148970128|NCT00048542|537376594|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
148970129|NCT00048542|537376595|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
148970130|NCT00048542|537376596|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
148970131|NCT00048542|537376597|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
148970132|NCT00048542|537376598|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
148970133|NCT00048542|537376599|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
148970134|NCT00048542|537376600|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
148970135|NCT00048542|537376601|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
148970136|NCT00048542|537376594|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
149025175|NCT04529538|537568048|FG005|Overall Study|Other|0|||
149025176|NCT04529538|537568049|FG006|Overall Study|Other|0|||
149025177|NCT04529538|537568050|FG007|Overall Study|Other|0|||
149025178|NCT04529538|537568043|FG000|Overall Study|Adverse Event|0|||
149025179|NCT04529538|537568044|FG001|Overall Study|Adverse Event|0|||
149025180|NCT04529538|537568045|FG002|Overall Study|Adverse Event|0|||
149025181|NCT04529538|537568046|FG003|Overall Study|Adverse Event|1|||
149025182|NCT04529538|537568047|FG004|Overall Study|Adverse Event|0|||
149025183|NCT04529538|537568048|FG005|Overall Study|Adverse Event|0|||
149025184|NCT04529538|537568049|FG006|Overall Study|Adverse Event|0|||
149025185|NCT04529538|537568050|FG007|Overall Study|Adverse Event|0|||
149025186|NCT04529538|537568043|FG000|Overall Study|Protocol Deviation|0|||
149025187|NCT04529538|537568044|FG001|Overall Study|Protocol Deviation|0|||
149025188|NCT04529538|537568045|FG002|Overall Study|Protocol Deviation|0|||
149025189|NCT04529538|537568046|FG003|Overall Study|Protocol Deviation|1|||
149025190|NCT04529538|537568047|FG004|Overall Study|Protocol Deviation|0|||
149025191|NCT04529538|537568048|FG005|Overall Study|Protocol Deviation|0|||
149025192|NCT04529538|537568049|FG006|Overall Study|Protocol Deviation|0|||
149025193|NCT04529538|537568050|FG007|Overall Study|Protocol Deviation|0|||
149025194|NCT04529538|537568043|FG000|Overall Study|Physician Decision|0|||
149025195|NCT04529538|537568044|FG001|Overall Study|Physician Decision|0|||
149025196|NCT04529538|537568045|FG002|Overall Study|Physician Decision|0|||
149025197|NCT04529538|537568046|FG003|Overall Study|Physician Decision|0|||
149025198|NCT04529538|537568047|FG004|Overall Study|Physician Decision|0|||
149025199|NCT04529538|537568048|FG005|Overall Study|Physician Decision|1|||
149025200|NCT04529538|537568049|FG006|Overall Study|Physician Decision|0|||
149025201|NCT04529538|537568050|FG007|Overall Study|Physician Decision|1|||
149025202|NCT01449721|537568051|FG000|Overall Study|Physician Decision|0|||
148970137|NCT00048542|537376595|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
149025203|NCT01449721|537568052|FG001|Overall Study|Physician Decision|1|||
149025204|NCT01449721|537568051|FG000|Overall Study|Physician Decision|0|||
149025205|NCT01449721|537568052|FG001|Overall Study|Physician Decision|1|||
149025206|NCT00114959|537568059|FG000|Overall Study|Lack of Efficacy|6|||
148970138|NCT00048542|537376596|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
149025207|NCT00114959|537568059|FG000|Overall Study|Physician Decision|1|||
149025208|NCT00114959|537568059|FG000|Overall Study|Death|1|||
149025209|NCT03803774|537568060|FG000|Dose Escalation|Withdrawal by Subject|0|||
149025210|NCT03803774|537568061|FG001|Dose Escalation|Withdrawal by Subject|0|||
148970139|NCT00048542|537376597|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
148970140|NCT00048542|537376598|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
148970141|NCT00048542|537376599|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
148970142|NCT00048542|537376600|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
148970143|NCT00048542|537376601|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
148970144|NCT00048542|537376594|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
148970145|NCT00048542|537376595|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
148970146|NCT00048542|537376596|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
148970147|NCT00048542|537376597|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
148970148|NCT00048542|537376598|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
148970149|NCT00048542|537376599|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
148970150|NCT00048542|537376600|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
148970151|NCT00048542|537376601|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
148970152|NCT00048542|537376594|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
148970153|NCT00048542|537376595|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
148970154|NCT00048542|537376596|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
148970155|NCT00048542|537376597|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
148970156|NCT00048542|537376598|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
148970157|NCT00048542|537376599|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
148970158|NCT00048542|537376600|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
148970159|NCT00048542|537376601|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
148970160|NCT00048542|537376594|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
148970161|NCT00048542|537376595|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
148970162|NCT00048542|537376596|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
148970163|NCT00048542|537376597|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
148970164|NCT00048542|537376598|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
148970165|NCT00048542|537376599|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
148970166|NCT00048542|537376600|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
148970167|NCT00048542|537376601|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
148970168|NCT00048542|537376594|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
148970169|NCT00048542|537376595|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
148970170|NCT00048542|537376596|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
148970171|NCT00048542|537376597|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
148970172|NCT00048542|537376598|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
148970173|NCT00048542|537376599|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
148970174|NCT00048542|537376600|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
148970175|NCT00048542|537376601|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
148970176|NCT00048542|537376594|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
148970177|NCT00048542|537376595|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
148970178|NCT00048542|537376596|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
148816420|NCT01068912|536802864|FG001|Overall Study|Adverse Event|3|||
148816421|NCT01068912|536802865|FG002|Overall Study|Adverse Event|2|||
148724907|NCT01014624|536465934|FG001|Overall Study|Adverse Event|1|||
148970179|NCT00048542|537376597|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
148970180|NCT00048542|537376598|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
148970181|NCT00048542|537376599|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
148816422|NCT01068912|536802863|FG000|Overall Study|Withdrawal by Subject|5|||
148816423|NCT01068912|536802864|FG001|Overall Study|Withdrawal by Subject|6|||
148970182|NCT00048542|537376600|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
148970183|NCT00048542|537376601|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
148816424|NCT01068912|536802865|FG002|Overall Study|Withdrawal by Subject|6|||
148816425|NCT01068912|536802863|FG000|Overall Study|Lost to Follow-up|3|||
148816426|NCT01068912|536802864|FG001|Overall Study|Lost to Follow-up|7|||
148816427|NCT01068912|536802865|FG002|Overall Study|Lost to Follow-up|3|||
148970184|NCT02704364|537376603|FG000|Overall Study|Adverse Event|1|||
148970185|NCT02704364|537376604|FG001|Overall Study|Adverse Event|1|||
148724908|NCT01014624|536465933|FG000|Overall Study|Protocol Violation|1|||
148724909|NCT01014624|536465934|FG001|Overall Study|Protocol Violation|0|||
148724910|NCT01014624|536465933|FG000|Overall Study|Withdrawal by Subject|1|||
148724911|NCT01014624|536465934|FG001|Overall Study|Withdrawal by Subject|0|||
148724912|NCT01117337|536465939|FG000|Overall Study|Lost to Follow-up|4|||
148724913|NCT01117337|536465940|FG001|Overall Study|Lost to Follow-up|0|||
148724914|NCT01045993|536465941|FG000|Overall Study|Treated-later found eligibility not met|0|||
148724915|NCT01045993|536465942|FG001|Overall Study|Treated-later found eligibility not met|1|||
148724916|NCT01045993|536465943|FG002|Overall Study|Treated-later found eligibility not met|0|||
148724917|NCT01045993|536465944|FG003|Overall Study|Treated-later found eligibility not met|0|||
148724918|NCT01659736|536465945|FG000|Treatment Period|Adverse Event|1|||
148724919|NCT01659736|536465946|FG001|Treatment Period|Adverse Event|1|||
148724920|NCT01659736|536465945|FG000|Treatment Period|Protocol Violation|3|||
148724921|NCT01659736|536465946|FG001|Treatment Period|Protocol Violation|1|||
148724922|NCT01659736|536465945|FG000|Treatment Period|Withdrawal by Subject|1|||
148724923|NCT01659736|536465946|FG001|Treatment Period|Withdrawal by Subject|0|||
148724924|NCT01659736|536465945|FG000|3-month Follow-up|Lost to Follow-up|0|||
148724925|NCT01659736|536465946|FG001|3-month Follow-up|Lost to Follow-up|1|||
148724926|NCT02462486|536465950|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
148724927|NCT02462486|536465951|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
148724928|NCT02462486|536465952|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
148724929|NCT02462486|536465950|FG000|Overall Study|Adverse Event|53|||
148724930|NCT02462486|536465951|FG001|Overall Study|Adverse Event|48|||
148724931|NCT02462486|536465952|FG002|Overall Study|Adverse Event|21|||
148724932|NCT02462486|536465950|FG000|Overall Study|Lack of Efficacy|6|||
148724933|NCT02462486|536465951|FG001|Overall Study|Lack of Efficacy|12|||
148724934|NCT02462486|536465952|FG002|Overall Study|Lack of Efficacy|3|||
148724935|NCT02462486|536465950|FG000|Overall Study|Lost to Follow-up|3|||
148816428|NCT01068912|536802863|FG000|Overall Study|Protocol Violation|0|||
148816429|NCT01068912|536802864|FG001|Overall Study|Protocol Violation|2|||
148970186|NCT02704364|537376605|FG002|Overall Study|Adverse Event|0|||
148970187|NCT02704364|537376603|FG000|Overall Study|Noncompliance with study drug|1|||
148970188|NCT02704364|537376604|FG001|Overall Study|Noncompliance with study drug|1|||
148970189|NCT02704364|537376605|FG002|Overall Study|Noncompliance with study drug|0|||
148970190|NCT02704364|537376603|FG000|Overall Study|Other|0|||
148970191|NCT02704364|537376604|FG001|Overall Study|Other|1|||
148970192|NCT02704364|537376605|FG002|Overall Study|Other|1|||
148970193|NCT04627064|537376607|FG000|Overall Study|Progressive disease|8|||
148970194|NCT04627064|537376608|FG001|Overall Study|Progressive disease|0|||
148970195|NCT04627064|537376607|FG000|Overall Study|Withdrawal by Subject|2|||
148970196|NCT04627064|537376608|FG001|Overall Study|Withdrawal by Subject|0|||
148970197|NCT04627064|537376607|FG000|Overall Study|Physician Decision|1|||
148970198|NCT04627064|537376608|FG001|Overall Study|Physician Decision|0|||
148970199|NCT04098458|537376611|FG000|Overall Study|Death|1|||
148970200|NCT04098458|537376611|FG000|Overall Study|did not meet study inclusion criteria|3|||
148970201|NCT00006489|537376612|FG000|Overall Study|Adverse Event|3|||
148970202|NCT00006489|537376613|FG001|Overall Study|Adverse Event|2|||
148970203|NCT00006489|537376614|FG002|Overall Study|Adverse Event|4|||
148970204|NCT00006489|537376615|FG003|Overall Study|Adverse Event|3|||
148970205|NCT00006489|537376612|FG000|Overall Study|Withdrawal by Subject|10|||
148970206|NCT00006489|537376613|FG001|Overall Study|Withdrawal by Subject|9|||
148970207|NCT00006489|537376614|FG002|Overall Study|Withdrawal by Subject|9|||
148970208|NCT00006489|537376615|FG003|Overall Study|Withdrawal by Subject|6|||
148970209|NCT00006489|537376612|FG000|Overall Study|Scheduling Conflict|0|||
148970210|NCT00006489|537376613|FG001|Overall Study|Scheduling Conflict|3|||
148970211|NCT00006489|537376614|FG002|Overall Study|Scheduling Conflict|2|||
148970212|NCT00006489|537376615|FG003|Overall Study|Scheduling Conflict|1|||
148970213|NCT00006489|537376612|FG000|Overall Study|Death|0|||
148970214|NCT00006489|537376613|FG001|Overall Study|Death|0|||
148970215|NCT00006489|537376614|FG002|Overall Study|Death|0|||
148970216|NCT00006489|537376615|FG003|Overall Study|Death|1|||
148970217|NCT00578175|537376616|FG000|Overall Study|Adverse Event|0|||
148970218|NCT00578175|537376617|FG001|Overall Study|Adverse Event|1|||
148970219|NCT00578175|537376618|FG002|Overall Study|Adverse Event|1|||
148970220|NCT00578175|537376616|FG000|Overall Study|Other reasons|70|||
148970221|NCT00578175|537376617|FG001|Overall Study|Other reasons|42|||
148970222|NCT00578175|537376618|FG002|Overall Study|Other reasons|23|||
148970223|NCT00235872|537376619|FG000|Overall Study|Adverse Event|34|||
148970224|NCT00235872|537376619|FG000|Overall Study|Death|1|||
148970225|NCT00235872|537376619|FG000|Overall Study|Lost to Follow-up|1|||
148970226|NCT00235872|537376619|FG000|Overall Study|Withdrawal by Subject|50|||
148970227|NCT00235872|537376619|FG000|Overall Study|Administrative reason|61|||
148970228|NCT02852265|537376620|FG000|3-month Follow-up|Lost to Follow-up|1|||
148970229|NCT02852265|537376621|FG001|3-month Follow-up|Lost to Follow-up|1|||
148970230|NCT01800916|537376624|FG000|Test Period 1 (1 Week)|Convex product user|0|||
148970231|NCT01800916|537376625|FG001|Test Period 1 (1 Week)|Convex product user|0|||
148970232|NCT01800916|537376626|FG002|Test Period 1 (1 Week)|Convex product user|0|||
148724936|NCT02462486|536465951|FG001|Overall Study|Lost to Follow-up|4|||
148724937|NCT02462486|536465952|FG002|Overall Study|Lost to Follow-up|2|||
148724938|NCT02462486|536465950|FG000|Overall Study|Withdrawal by Subject|25|||
148724939|NCT02462486|536465951|FG001|Overall Study|Withdrawal by Subject|22|||
148724940|NCT02462486|536465952|FG002|Overall Study|Withdrawal by Subject|19|||
148724941|NCT02462486|536465950|FG000|Overall Study|Protocol Violation|3|||
148724942|NCT02462486|536465951|FG001|Overall Study|Protocol Violation|1|||
148724943|NCT02462486|536465952|FG002|Overall Study|Protocol Violation|1|||
148724944|NCT02462486|536465950|FG000|Overall Study|Reason not Specified|3|||
148724945|NCT02462486|536465951|FG001|Overall Study|Reason not Specified|4|||
148724946|NCT02462486|536465952|FG002|Overall Study|Reason not Specified|3|||
148724947|NCT02310763|536465957|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
148724948|NCT02310763|536465958|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
148724949|NCT02310763|536465959|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
148970233|NCT01800916|537376627|FG003|Test Period 1 (1 Week)|Convex product user|1|||
148970234|NCT01800916|537376628|FG004|Test Period 1 (1 Week)|Convex product user|0|||
148970235|NCT01800916|537376629|FG005|Test Period 1 (1 Week)|Convex product user|0|||
148970236|NCT01800916|537376630|FG006|Test Period 1 (1 Week)|Convex product user|0|||
148970237|NCT01800916|537376631|FG007|Test Period 1 (1 Week)|Convex product user|0|||
148970238|NCT01800916|537376632|FG008|Test Period 1 (1 Week)|Convex product user|0|||
148724950|NCT02310763|536465957|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
148816430|NCT01068912|536802865|FG002|Overall Study|Protocol Violation|0|||
148970239|NCT01800916|537376624|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
148970240|NCT01800916|537376625|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
148970241|NCT01800916|537376626|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
148970242|NCT01800916|537376627|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
148970243|NCT01800916|537376628|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
148970244|NCT01800916|537376629|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
148970245|NCT01800916|537376630|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
148970246|NCT01800916|537376631|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
148970247|NCT01800916|537376632|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
148970248|NCT01232296|537376633|FG000|Overall Study|Adverse Event|24|||
148970249|NCT01232296|537376634|FG001|Overall Study|Adverse Event|12|||
148970250|NCT01232296|537376633|FG000|Overall Study|Physician Decision|1|||
148970251|NCT01232296|537376634|FG001|Overall Study|Physician Decision|1|||
148970252|NCT01232296|537376633|FG000|Overall Study|Progressive disease|43|||
148970253|NCT01232296|537376634|FG001|Overall Study|Progressive disease|61|||
148970254|NCT01232296|537376633|FG000|Overall Study|Study terminated by sponsor|0|||
148970255|NCT01232296|537376634|FG001|Overall Study|Study terminated by sponsor|1|||
148970256|NCT01232296|537376633|FG000|Overall Study|Technical problems|3|||
148970257|NCT01232296|537376634|FG001|Overall Study|Technical problems|0|||
148970258|NCT01232296|537376633|FG000|Overall Study|Subject/guardian decision|10|||
148970259|NCT01232296|537376634|FG001|Overall Study|Subject/guardian decision|2|||
148970260|NCT01232296|537376633|FG000|Overall Study|Death|1|||
148970261|NCT01232296|537376634|FG001|Overall Study|Death|6|||
148724951|NCT02310763|536465958|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
148724952|NCT02310763|536465959|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
148724953|NCT02310763|536465957|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
148724954|NCT02310763|536465958|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
148724955|NCT02310763|536465959|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
148724956|NCT02310763|536465957|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
148724957|NCT02310763|536465958|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
148724958|NCT02310763|536465959|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
148724959|NCT02310763|536465957|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
148724960|NCT02310763|536465958|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
148724961|NCT02310763|536465959|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
148724962|NCT02010255|536465960|FG000|Overall Study|Death|0|||
148724963|NCT02010255|536465961|FG001|Overall Study|Death|1|||
148724964|NCT02010255|536465962|FG002|Overall Study|Death|4|||
148724965|NCT02010255|536465963|FG003|Overall Study|Death|4|||
148724966|NCT02010255|536465964|FG004|Overall Study|Death|2|||
148724967|NCT02010255|536465965|FG005|Overall Study|Death|0|||
148724968|NCT02010255|536465966|FG006|Overall Study|Death|1|||
148724969|NCT02010255|536465967|FG007|Overall Study|Death|1|||
148724970|NCT02010255|536465968|FG008|Overall Study|Death|1|||
148724971|NCT02010255|536465969|FG009|Overall Study|Death|0|||
148724972|NCT02010255|536465970|FG010|Overall Study|Death|1|||
148724973|NCT02010255|536465971|FG011|Overall Study|Death|1|||
148724974|NCT02010255|536465972|FG012|Overall Study|Death|0|||
148724975|NCT02010255|536465973|FG013|Overall Study|Death|0|||
148724976|NCT02010255|536465960|FG000|Overall Study|Lack of Efficacy|4|||
148724977|NCT02010255|536465961|FG001|Overall Study|Lack of Efficacy|1|||
148724978|NCT02010255|536465962|FG002|Overall Study|Lack of Efficacy|2|||
148724979|NCT02010255|536465963|FG003|Overall Study|Lack of Efficacy|1|||
148970262|NCT00937547|537376641|FG000|Overall Study|misdiagnosis|1|||
148970263|NCT00937547|537376642|FG001|Overall Study|misdiagnosis|6|||
148970264|NCT00937547|537376643|FG002|Overall Study|misdiagnosis|7|||
148970265|NCT01234467|537376644|FG000|Overall Study|Adverse Event|3|||
148970266|NCT01234467|537376644|FG000|Overall Study|Death|2|||
148970267|NCT01234467|537376644|FG000|Overall Study|Withdrawal by Subject|2|||
148970268|NCT01234467|537376644|FG000|Overall Study|Disease Progression|2|||
148970269|NCT01234467|537376644|FG000|Overall Study|Clinical deterioration|1|||
148970270|NCT01234467|537376644|FG000|Overall Study|Physician Decision|1|||
148724980|NCT02010255|536465964|FG004|Overall Study|Lack of Efficacy|1|||
148724981|NCT02010255|536465965|FG005|Overall Study|Lack of Efficacy|0|||
148724982|NCT02010255|536465966|FG006|Overall Study|Lack of Efficacy|0|||
148724983|NCT02010255|536465967|FG007|Overall Study|Lack of Efficacy|0|||
148724984|NCT02010255|536465968|FG008|Overall Study|Lack of Efficacy|0|||
148724985|NCT02010255|536465969|FG009|Overall Study|Lack of Efficacy|0|||
148724986|NCT02010255|536465970|FG010|Overall Study|Lack of Efficacy|1|||
148724987|NCT02010255|536465971|FG011|Overall Study|Lack of Efficacy|0|||
148724988|NCT02010255|536465972|FG012|Overall Study|Lack of Efficacy|0|||
148724989|NCT02010255|536465973|FG013|Overall Study|Lack of Efficacy|0|||
148970271|NCT01234467|537376644|FG000|Overall Study|Other complicating disease (stroke)|1|||
148970272|NCT01461096|537376646|FG000|Overall Study|Death|3|||
148724990|NCT02010255|536465960|FG000|Overall Study|Withdrew Consent|1|||
148724991|NCT02010255|536465961|FG001|Overall Study|Withdrew Consent|0|||
148724992|NCT02010255|536465962|FG002|Overall Study|Withdrew Consent|0|||
148724993|NCT02010255|536465963|FG003|Overall Study|Withdrew Consent|1|||
148724994|NCT02010255|536465964|FG004|Overall Study|Withdrew Consent|0|||
148724995|NCT02010255|536465965|FG005|Overall Study|Withdrew Consent|0|||
148724996|NCT02010255|536465966|FG006|Overall Study|Withdrew Consent|0|||
148724997|NCT02010255|536465967|FG007|Overall Study|Withdrew Consent|0|||
148724998|NCT02010255|536465968|FG008|Overall Study|Withdrew Consent|0|||
148724999|NCT02010255|536465969|FG009|Overall Study|Withdrew Consent|0|||
148725000|NCT02010255|536465970|FG010|Overall Study|Withdrew Consent|0|||
148725001|NCT02010255|536465971|FG011|Overall Study|Withdrew Consent|0|||
148725002|NCT02010255|536465972|FG012|Overall Study|Withdrew Consent|0|||
148816431|NCT01068912|536802863|FG000|Overall Study|aggravation influenza|1|||
148725003|NCT02010255|536465973|FG013|Overall Study|Withdrew Consent|0|||
148725004|NCT02010255|536465960|FG000|Overall Study|Adverse Event|1|||
148725005|NCT02010255|536465961|FG001|Overall Study|Adverse Event|0|||
148725006|NCT02010255|536465962|FG002|Overall Study|Adverse Event|0|||
148725007|NCT02010255|536465963|FG003|Overall Study|Adverse Event|0|||
148725008|NCT02010255|536465964|FG004|Overall Study|Adverse Event|0|||
148725009|NCT02010255|536465965|FG005|Overall Study|Adverse Event|0|||
148725010|NCT02010255|536465966|FG006|Overall Study|Adverse Event|0|||
148725011|NCT02010255|536465967|FG007|Overall Study|Adverse Event|0|||
148725012|NCT02010255|536465968|FG008|Overall Study|Adverse Event|0|||
148725013|NCT02010255|536465969|FG009|Overall Study|Adverse Event|0|||
148725014|NCT02010255|536465970|FG010|Overall Study|Adverse Event|0|||
148725015|NCT02010255|536465971|FG011|Overall Study|Adverse Event|0|||
148725016|NCT02010255|536465972|FG012|Overall Study|Adverse Event|0|||
148725017|NCT02010255|536465973|FG013|Overall Study|Adverse Event|0|||
148725018|NCT02010255|536465960|FG000|Overall Study|Lost to Follow-up|0|||
148725019|NCT02010255|536465961|FG001|Overall Study|Lost to Follow-up|0|||
148725020|NCT02010255|536465962|FG002|Overall Study|Lost to Follow-up|1|||
148725021|NCT02010255|536465963|FG003|Overall Study|Lost to Follow-up|0|||
148725022|NCT02010255|536465964|FG004|Overall Study|Lost to Follow-up|1|||
148970273|NCT01461096|537376647|FG001|Overall Study|Death|6|||
148970274|NCT01461096|537376646|FG000|Overall Study|Severe debilitation, unable to continue|1|||
148970275|NCT01461096|537376647|FG001|Overall Study|Severe debilitation, unable to continue|1|||
148970276|NCT01461096|537376646|FG000|Overall Study|Subj not able to get to clinic|15|||
148970277|NCT01461096|537376647|FG001|Overall Study|Subj not able to get to clinic|13|||
148970278|NCT01461096|537376646|FG000|Overall Study|Site is closing|27|||
148970279|NCT01461096|537376647|FG001|Overall Study|Site is closing|30|||
148970280|NCT01461096|537376646|FG000|Overall Study|Withdrawal by Subject|5|||
148970281|NCT01461096|537376647|FG001|Overall Study|Withdrawal by Subject|3|||
148970282|NCT01461096|537376646|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
148970283|NCT01461096|537376647|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
148970284|NCT01461096|537376646|FG000|Overall Study|Lost to Follow-up|8|||
148970285|NCT01461096|537376647|FG001|Overall Study|Lost to Follow-up|4|||
148970286|NCT04889625|537376648|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
148970287|NCT04889625|537376649|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
148970288|NCT04889625|537376648|FG000|Period 1|Subject out of window|0|||
148970289|NCT04889625|537376649|FG001|Period 1|Subject out of window|1|||
148970290|NCT04889625|537376648|FG000|Period 1|Wrong add power dispensed|0|||
148970291|NCT04889625|537376649|FG001|Period 1|Wrong add power dispensed|1|||
148970292|NCT04889625|537376648|FG000|Period 1|Discontinued due to fitting guide error|1|||
148970293|NCT04889625|537376649|FG001|Period 1|Discontinued due to fitting guide error|1|||
148970294|NCT04889625|537376648|FG000|Period 2|Test article no longer available|1|||
148970295|NCT04889625|537376649|FG001|Period 2|Test article no longer available|0|||
148970296|NCT04889625|537376648|FG000|Period 2|Incorrect lens dispensed|1|||
148970297|NCT04889625|537376649|FG001|Period 2|Incorrect lens dispensed|0|||
148970298|NCT04889625|537376648|FG000|Period 2|Wrong add power dispensed|0|||
148970299|NCT04889625|537376649|FG001|Period 2|Wrong add power dispensed|1|||
148970300|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
148970301|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
148970302|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
148970303|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
148970304|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
148970305|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
148970306|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
148970307|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
148970308|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
148970309|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
148970310|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
148970311|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
148970312|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
148970313|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
148970314|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
148970315|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
148970316|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
148970317|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
148970318|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Death|0|||
148970319|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Death|0|||
148970320|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Death|1|||
148970321|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Death|0|||
148970322|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Death|0|||
148970323|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Death|0|||
148970324|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Death|0|||
149025211|NCT03803774|537568062|FG002|Dose Escalation|Withdrawal by Subject|0|||
148725023|NCT02010255|536465965|FG005|Overall Study|Lost to Follow-up|0|||
148970325|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Death|0|||
148970326|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Death|0|||
149025212|NCT03803774|537568063|FG003|Dose Escalation|Withdrawal by Subject|1|||
148725024|NCT02010255|536465966|FG006|Overall Study|Lost to Follow-up|0|||
148725025|NCT02010255|536465967|FG007|Overall Study|Lost to Follow-up|0|||
148725026|NCT02010255|536465968|FG008|Overall Study|Lost to Follow-up|0|||
148725027|NCT02010255|536465969|FG009|Overall Study|Lost to Follow-up|0|||
148725028|NCT02010255|536465970|FG010|Overall Study|Lost to Follow-up|0|||
148725029|NCT02010255|536465971|FG011|Overall Study|Lost to Follow-up|0|||
148725030|NCT02010255|536465972|FG012|Overall Study|Lost to Follow-up|0|||
148725031|NCT02010255|536465973|FG013|Overall Study|Lost to Follow-up|0|||
148725032|NCT02010255|536465960|FG000|Overall Study|Randomized but Not Treated|0|||
148725033|NCT02010255|536465961|FG001|Overall Study|Randomized but Not Treated|0|||
148725034|NCT02010255|536465962|FG002|Overall Study|Randomized but Not Treated|0|||
148725035|NCT02010255|536465963|FG003|Overall Study|Randomized but Not Treated|0|||
148725036|NCT02010255|536465964|FG004|Overall Study|Randomized but Not Treated|0|||
148725037|NCT02010255|536465965|FG005|Overall Study|Randomized but Not Treated|0|||
148725038|NCT02010255|536465966|FG006|Overall Study|Randomized but Not Treated|0|||
148725039|NCT02010255|536465967|FG007|Overall Study|Randomized but Not Treated|0|||
148725040|NCT02010255|536465968|FG008|Overall Study|Randomized but Not Treated|0|||
148725041|NCT02010255|536465969|FG009|Overall Study|Randomized but Not Treated|0|||
148725042|NCT02010255|536465970|FG010|Overall Study|Randomized but Not Treated|0|||
148725043|NCT02010255|536465971|FG011|Overall Study|Randomized but Not Treated|0|||
148725044|NCT02010255|536465972|FG012|Overall Study|Randomized but Not Treated|0|||
148725045|NCT02010255|536465973|FG013|Overall Study|Randomized but Not Treated|1|||
148725046|NCT01351350|536465974|FG000|Overall Study|Disease Progression|5|||
149025213|NCT03803774|537568064|FG004|Dose Escalation|Withdrawal by Subject|0|||
149025214|NCT03212365|537568072|FG000|Overall Study|Discharged prior to Xa level|12|||
149025215|NCT03212365|537568073|FG001|Overall Study|Discharged prior to Xa level|8|||
149025216|NCT03212365|537568072|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
149025217|NCT03212365|537568073|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
149025218|NCT03212365|537568072|FG000|Overall Study|Refused study medication|3|||
149025219|NCT03212365|537568073|FG001|Overall Study|Refused study medication|0|||
149025220|NCT03212365|537568072|FG000|Overall Study|Initiated heparin infusion on floor|1|||
149025221|NCT03212365|537568073|FG001|Overall Study|Initiated heparin infusion on floor|1|||
149025222|NCT03212365|537568072|FG000|Overall Study|Unexpected return to OR|1|||
149025223|NCT03212365|537568073|FG001|Overall Study|Unexpected return to OR|1|||
149025224|NCT03212365|537568072|FG000|Overall Study|Medication distribution error|1|||
149025225|NCT03212365|537568073|FG001|Overall Study|Medication distribution error|0|||
149025226|NCT03212365|537568072|FG000|Overall Study|Required epidural placement|1|||
149025227|NCT03212365|537568073|FG001|Overall Study|Required epidural placement|0|||
149025228|NCT03212365|537568072|FG000|Overall Study|Withdrawal by Subject|0|||
149025229|NCT03212365|537568073|FG001|Overall Study|Withdrawal by Subject|1|||
149025230|NCT03212365|537568072|FG000|Overall Study|developed acute renal failure|0|||
149025231|NCT03212365|537568073|FG001|Overall Study|developed acute renal failure|1|||
149025232|NCT00333138|537568075|FG000|Core Study (6 Months)|Adverse Event|4|||
149025233|NCT00333138|537568076|FG001|Core Study (6 Months)|Adverse Event|5|||
149025234|NCT00333138|537568077|FG002|Core Study (6 Months)|Adverse Event|8|||
149025235|NCT00333138|537568075|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
149025236|NCT00333138|537568076|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
149025237|NCT00333138|537568077|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
149025238|NCT00333138|537568075|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
149025239|NCT00333138|537568076|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
149025240|NCT00333138|537568077|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
149025241|NCT00333138|537568075|FG000|Core Study (6 Months)|Protocol Violation|1|||
149025242|NCT00333138|537568076|FG001|Core Study (6 Months)|Protocol Violation|0|||
149025243|NCT00333138|537568077|FG002|Core Study (6 Months)|Protocol Violation|1|||
149025244|NCT00333138|537568075|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
149025245|NCT00333138|537568076|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
149025246|NCT00333138|537568077|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
149025247|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
149025248|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
149025249|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
149025250|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
148725047|NCT01351350|536465975|FG001|Overall Study|Disease Progression|13|||
148725048|NCT01351350|536465976|FG002|Overall Study|Disease Progression|6|||
148725049|NCT01351350|536465977|FG003|Overall Study|Disease Progression|8|||
148725050|NCT01351350|536465978|FG004|Overall Study|Disease Progression|5|||
148725051|NCT01351350|536465974|FG000|Overall Study|Adverse Event|1|||
148725052|NCT01351350|536465975|FG001|Overall Study|Adverse Event|10|||
148725053|NCT01351350|536465976|FG002|Overall Study|Adverse Event|1|||
148725054|NCT01351350|536465977|FG003|Overall Study|Adverse Event|2|||
149025251|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
148725055|NCT01351350|536465978|FG004|Overall Study|Adverse Event|0|||
148725056|NCT01351350|536465974|FG000|Overall Study|Participant Decision|2|||
148725057|NCT01351350|536465975|FG001|Overall Study|Participant Decision|6|||
148725058|NCT01351350|536465976|FG002|Overall Study|Participant Decision|3|||
148725059|NCT01351350|536465977|FG003|Overall Study|Participant Decision|3|||
148725060|NCT01351350|536465978|FG004|Overall Study|Participant Decision|2|||
148725061|NCT01351350|536465974|FG000|Overall Study|Enrolled but not Treated|0|||
148725062|NCT01351350|536465975|FG001|Overall Study|Enrolled but not Treated|0|||
148725063|NCT01351350|536465976|FG002|Overall Study|Enrolled but not Treated|1|||
148725064|NCT01351350|536465977|FG003|Overall Study|Enrolled but not Treated|0|||
148725065|NCT01351350|536465978|FG004|Overall Study|Enrolled but not Treated|0|||
148725066|NCT00285584|536465987|FG000|Month 3|Lost to Follow-up|3|||
148725067|NCT00285584|536465988|FG001|Month 3|Lost to Follow-up|3|||
148816432|NCT01068912|536802864|FG001|Overall Study|aggravation influenza|1|||
148816433|NCT01068912|536802865|FG002|Overall Study|aggravation influenza|1|||
148816434|NCT01068912|536802863|FG000|Overall Study|other underlying illness|0|||
148816435|NCT01068912|536802864|FG001|Overall Study|other underlying illness|3|||
148816436|NCT01068912|536802865|FG002|Overall Study|other underlying illness|3|||
148816437|NCT02762604|536802866|FG000|Overall Study|Lost to Follow-up|2|||
148816438|NCT02762604|536802867|FG001|Overall Study|Lost to Follow-up|7|||
148816439|NCT02762604|536802866|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
148816440|NCT02762604|536802867|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
148816441|NCT03442569|536802873|FG000|Overall Study|Subject was ineligible after enrollment|1|||
148816442|NCT03010501|536802877|FG000|Study Week 1|Withdrawal by Subject|2|||
148816443|NCT03010501|536802878|FG001|Study Week 1|Withdrawal by Subject|1|||
148816444|NCT03010501|536802879|FG002|Study Week 1|Withdrawal by Subject|0|||
148970327|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
148970328|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
148970329|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
148970330|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
148970331|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
148970332|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
148970333|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
148970334|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
148970335|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
148970336|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
148970337|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
148725068|NCT00285584|536465987|FG000|Month 3|Withdrawal by Subject|1|||
148725069|NCT00285584|536465988|FG001|Month 3|Withdrawal by Subject|0|||
148725070|NCT00285584|536465987|FG000|Month 6|Lost to Follow-up|0|||
148725071|NCT00285584|536465988|FG001|Month 6|Lost to Follow-up|1|||
148725072|NCT01807117|536465994|FG000|Overall Study|Physician Decision|2|||
148725073|NCT01807117|536465994|FG000|Overall Study|Disease diagnosis not a study disease|1|||
148725074|NCT00834899|536465995|FG000|Overall Study|Withdrawal by Subject|1|||
148725075|NCT00834899|536465996|FG001|Overall Study|Withdrawal by Subject|1|||
148725076|NCT02709486|536466002|FG000|Overall Study|Adverse Event|2|||
148725077|NCT02709486|536466003|FG001|Overall Study|Adverse Event|5|||
148970338|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
148970339|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
148970340|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
148970341|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
148970342|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
148970343|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
148970344|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
148970345|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
148970346|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
149025252|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
148816445|NCT03010501|536802880|FG003|Study Week 1|Withdrawal by Subject|2|||
148970347|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
148816446|NCT03010501|536802881|FG004|Study Week 1|Withdrawal by Subject|0|||
148816447|NCT03010501|536802882|FG005|Study Week 1|Withdrawal by Subject|0|||
148970348|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
148970349|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
148970350|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
148970351|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
148970352|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
148970353|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
148970354|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
148970355|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
148816448|NCT03010501|536802877|FG000|Study Week 3|Withdrawal by Subject|0|||
148970356|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
148816449|NCT03010501|536802878|FG001|Study Week 3|Withdrawal by Subject|0|||
148816450|NCT03010501|536802879|FG002|Study Week 3|Withdrawal by Subject|0|||
148816451|NCT03010501|536802880|FG003|Study Week 3|Withdrawal by Subject|1|||
148816452|NCT03010501|536802881|FG004|Study Week 3|Withdrawal by Subject|0|||
148816453|NCT03010501|536802882|FG005|Study Week 3|Withdrawal by Subject|0|||
148816454|NCT03770455|536802884|FG000|Overall Study|Screen failures|3|||
148816455|NCT04937387|536802885|FG000|Overall Study|Adverse Event|1|||
148816456|NCT04937387|536802886|FG001|Overall Study|Adverse Event|0|||
148816457|NCT04937387|536802887|FG002|Overall Study|Adverse Event|2|||
148816458|NCT04937387|536802888|FG003|Overall Study|Adverse Event|0|||
148816459|NCT04937387|536802885|FG000|Overall Study|Lack of Efficacy|1|||
148816460|NCT04937387|536802886|FG001|Overall Study|Lack of Efficacy|0|||
148816461|NCT04937387|536802887|FG002|Overall Study|Lack of Efficacy|0|||
148816462|NCT04937387|536802888|FG003|Overall Study|Lack of Efficacy|1|||
148970357|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
148970358|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
148970359|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
148970360|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
148816463|NCT04937387|536802885|FG000|Overall Study|Withdrawal by Subject|1|||
148816464|NCT04937387|536802886|FG001|Overall Study|Withdrawal by Subject|0|||
148816465|NCT04937387|536802887|FG002|Overall Study|Withdrawal by Subject|1|||
148816466|NCT04937387|536802888|FG003|Overall Study|Withdrawal by Subject|1|||
148816467|NCT04937387|536802885|FG000|Overall Study|Randomized in error|0|||
148816468|NCT04937387|536802886|FG001|Overall Study|Randomized in error|0|||
148970361|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
148970362|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
148970363|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
148970364|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
148970365|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
148970366|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
148970367|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
148970368|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
148970369|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
148970370|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
148970371|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
148970372|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970373|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
148970374|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970375|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970376|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970377|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970378|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970379|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970380|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
148970381|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
148970382|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
148970383|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
148970384|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
148970385|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
148970386|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
148970387|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
148970388|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
148970389|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
148970390|NCT00404352|537376661|FG000|Double Blind (up to 24 Month)|Other|0|||
148970391|NCT00404352|537376662|FG001|Double Blind (up to 24 Month)|Other|1|||
148970392|NCT00404352|537376663|FG002|Double Blind (up to 24 Month)|Other|0|||
148816469|NCT04937387|536802887|FG002|Overall Study|Randomized in error|0|||
148816470|NCT04937387|536802888|FG003|Overall Study|Randomized in error|1|||
148816471|NCT01022580|536803917|FG000|Overall Study|Death|18|||
148816472|NCT01022580|536803918|FG001|Overall Study|Death|22|||
148816473|NCT03439839|536803919|FG000|Overall Study|Death|3|||
148816474|NCT03439839|536803920|FG001|Overall Study|Death|0|||
148816475|NCT00723944|536803926|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
148816476|NCT00723944|536803927|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
148816477|NCT00723944|536803926|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
148816478|NCT00723944|536803927|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
148816479|NCT00723944|536803926|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
148816480|NCT00723944|536803927|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
148816481|NCT01847209|536803928|FG000|Overall Study|Withdrawal by Subject|1|||
148816482|NCT01847209|536803928|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
148816483|NCT04575324|536803931|FG000|Overall Study|Lost to Follow-up|29|||
148816484|NCT04575324|536803932|FG001|Overall Study|Lost to Follow-up|25|||
148816485|NCT04575324|536803931|FG000|Overall Study|Death|1|||
148816486|NCT04575324|536803932|FG001|Overall Study|Death|2|||
149025253|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
149025254|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
149025255|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
149025256|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
149025257|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
149025258|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
149025259|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
149025260|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
149025261|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
149025262|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
149025263|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
149025264|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
149025265|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
149025266|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
149025267|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
149025268|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
148970393|NCT00404352|537376664|FG003|Double Blind (up to 24 Month)|Other|0|||
148970394|NCT00404352|537376665|FG004|Double Blind (up to 24 Month)|Other|0|||
148970395|NCT00404352|537376666|FG005|Double Blind (up to 24 Month)|Other|0|||
148970396|NCT00404352|537376667|FG006|Double Blind (up to 24 Month)|Other|0|||
148970397|NCT00404352|537376668|FG007|Double Blind (up to 24 Month)|Other|0|||
148970398|NCT00404352|537376669|FG008|Double Blind (up to 24 Month)|Other|0|||
148970399|NCT00404352|537376661|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
148970400|NCT00404352|537376662|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
148970401|NCT00404352|537376663|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
148970402|NCT00404352|537376664|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
148970403|NCT00404352|537376665|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
148970404|NCT00404352|537376666|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
148970405|NCT00404352|537376667|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
148970406|NCT00404352|537376668|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
148970407|NCT00404352|537376669|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
148970408|NCT00404352|537376661|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
148970409|NCT00404352|537376662|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
148970410|NCT00404352|537376663|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
148970411|NCT00404352|537376664|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
148970412|NCT00404352|537376665|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
148970413|NCT00404352|537376666|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
148970414|NCT00404352|537376667|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
148970415|NCT00404352|537376668|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
148970416|NCT00404352|537376669|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
148970417|NCT00404352|537376661|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148970418|NCT00404352|537376662|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148970419|NCT00404352|537376663|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148725078|NCT02709486|536466004|FG002|Overall Study|Adverse Event|3|||
148970420|NCT00404352|537376664|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148970421|NCT00404352|537376665|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
148970422|NCT00404352|537376666|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148970423|NCT00404352|537376667|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
149025269|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
149025270|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
149025271|NCT00333138|537568075|FG000|Extension Study (Month6 to End of Study)|Death|0|||
149025272|NCT00333138|537568076|FG001|Extension Study (Month6 to End of Study)|Death|1|||
149025273|NCT00333138|537568077|FG002|Extension Study (Month6 to End of Study)|Death|0|||
149025274|NCT01342887|537568078|FG000|Overall Study|Death|2|||
149025275|NCT04880161|537568080|FG000|Overall Study|Withdrawal by Subject|1|||
149025276|NCT04880161|537568081|FG001|Overall Study|Withdrawal by Subject|0|||
149025277|NCT04880161|537568080|FG000|Overall Study|Lack of Compliance|1|||
149025278|NCT04880161|537568081|FG001|Overall Study|Lack of Compliance|1|||
149025279|NCT04880161|537568080|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
149025280|NCT04880161|537568081|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
149025281|NCT04880161|537568080|FG000|Overall Study|Screen Failure|0|||
149025282|NCT04880161|537568081|FG001|Overall Study|Screen Failure|1|||
149025283|NCT01354106|537568082|FG000|Overall Study|Withdrawal by Subject|2|||
149025284|NCT00231179|537569970|FG000|Overall Study|Lost to Follow-up|21|||
149025285|NCT00231179|537569971|FG001|Overall Study|Lost to Follow-up|21|||
149025286|NCT00231179|537569970|FG000|Overall Study|Withdrawal by Subject|3|||
149025287|NCT00231179|537569971|FG001|Overall Study|Withdrawal by Subject|3|||
149025288|NCT02206685|537569972|FG000|Overall Study|Surgery cancelled/changed|2|||
149025289|NCT02206685|537569973|FG001|Overall Study|Surgery cancelled/changed|3|||
149025290|NCT02206685|537569972|FG000|Overall Study|Withdrawal by Subject|1|||
149025291|NCT02206685|537569973|FG001|Overall Study|Withdrawal by Subject|2|||
149025292|NCT02206685|537569972|FG000|Overall Study|Protocol Violation|2|||
149025293|NCT02206685|537569973|FG001|Overall Study|Protocol Violation|2|||
149025294|NCT01345292|537569974|FG000|Overall Study|Withdrawal by Subject|2|||
149025295|NCT01345292|537569975|FG001|Overall Study|Withdrawal by Subject|0|||
149025296|NCT01345292|537569976|FG002|Overall Study|Withdrawal by Subject|1|||
149025297|NCT05406791|537569980|FG000|Overall Study|Lost to Follow-up|13|||
149025298|NCT05406791|537569981|FG001|Overall Study|Lost to Follow-up|10|||
149025299|NCT02373813|537569982|FG000|Run-In Period|Other, Not Specified|5|||
149025300|NCT02373813|537569983|FG001|Run-In Period|Other, Not Specified|0|||
149025301|NCT02373813|537569984|FG002|Run-In Period|Other, Not Specified|0|||
149025302|NCT02373813|537569985|FG003|Run-In Period|Other, Not Specified|0|||
149025303|NCT02373813|537569982|FG000|Run-In Period|Withdrawal by Subject|16|||
149025304|NCT02373813|537569983|FG001|Run-In Period|Withdrawal by Subject|0|||
149025305|NCT02373813|537569984|FG002|Run-In Period|Withdrawal by Subject|0|||
149025306|NCT02373813|537569985|FG003|Run-In Period|Withdrawal by Subject|0|||
149025307|NCT02373813|537569982|FG000|Run-In Period|Decision by Sponsor|11|||
149025308|NCT02373813|537569983|FG001|Run-In Period|Decision by Sponsor|0|||
149025309|NCT02373813|537569984|FG002|Run-In Period|Decision by Sponsor|0|||
149025310|NCT02373813|537569985|FG003|Run-In Period|Decision by Sponsor|0|||
149025311|NCT02373813|537569982|FG000|Run-In Period|Protocol Violation|75|||
149025312|NCT02373813|537569983|FG001|Run-In Period|Protocol Violation|0|||
149025313|NCT02373813|537569984|FG002|Run-In Period|Protocol Violation|0|||
149025314|NCT02373813|537569985|FG003|Run-In Period|Protocol Violation|0|||
149025315|NCT02373813|537569982|FG000|Run-In Period|Lost to Follow-up|2|||
149025316|NCT02373813|537569983|FG001|Run-In Period|Lost to Follow-up|0|||
149025317|NCT02373813|537569984|FG002|Run-In Period|Lost to Follow-up|0|||
149025318|NCT02373813|537569985|FG003|Run-In Period|Lost to Follow-up|0|||
149025319|NCT02373813|537569982|FG000|Run-In Period|Adverse Event|3|||
149025320|NCT02373813|537569983|FG001|Run-In Period|Adverse Event|0|||
149025321|NCT02373813|537569984|FG002|Run-In Period|Adverse Event|0|||
149025322|NCT02373813|537569985|FG003|Run-In Period|Adverse Event|0|||
149025323|NCT02373813|537569982|FG000|Run-In Period|Noncompliance|1|||
149025324|NCT02373813|537569983|FG001|Run-In Period|Noncompliance|0|||
149025325|NCT02373813|537569984|FG002|Run-In Period|Noncompliance|0|||
149025326|NCT02373813|537569985|FG003|Run-In Period|Noncompliance|0|||
149025327|NCT02373813|537569982|FG000|Run-In Period|Ineligibility Determined|3|||
148725079|NCT02709486|536466002|FG000|Overall Study|Death|0|||
148725080|NCT02709486|536466003|FG001|Overall Study|Death|0|||
148725081|NCT02709486|536466004|FG002|Overall Study|Death|2|||
148725082|NCT02709486|536466002|FG000|Overall Study|Insufficient clinical response|7|||
148725083|NCT02709486|536466003|FG001|Overall Study|Insufficient clinical response|3|||
148725084|NCT02709486|536466004|FG002|Overall Study|Insufficient clinical response|3|||
148725085|NCT02709486|536466002|FG000|Overall Study|Lost to Follow-up|3|||
148725086|NCT02709486|536466003|FG001|Overall Study|Lost to Follow-up|2|||
148725087|NCT02709486|536466004|FG002|Overall Study|Lost to Follow-up|2|||
148725088|NCT02709486|536466002|FG000|Overall Study|Other|0|||
148725089|NCT02709486|536466003|FG001|Overall Study|Other|2|||
148725090|NCT02709486|536466004|FG002|Overall Study|Other|3|||
148725091|NCT02709486|536466002|FG000|Overall Study|Withdrawal by Subject|32|||
148725092|NCT02709486|536466003|FG001|Overall Study|Withdrawal by Subject|22|||
148725093|NCT02709486|536466004|FG002|Overall Study|Withdrawal by Subject|32|||
148725094|NCT00606502|536466009|FG000|Randomization|Randomized but not treated|3|||
148725095|NCT00606502|536466010|FG001|Randomization|Randomized but not treated|0|||
148725096|NCT00606502|536466009|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
148725097|NCT00606502|536466010|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
148725098|NCT02443545|536466017|FG000|Overall Study|Adverse Event|1|||
148725099|NCT02443545|536466018|FG001|Overall Study|Adverse Event|1|||
148725100|NCT02443545|536466017|FG000|Overall Study|Lost to Follow-up|0|||
148725101|NCT02443545|536466018|FG001|Overall Study|Lost to Follow-up|2|||
148725102|NCT02443545|536466017|FG000|Overall Study|Physician Decision|3|||
148725103|NCT02443545|536466018|FG001|Overall Study|Physician Decision|0|||
148725104|NCT02443545|536466017|FG000|Overall Study|Protocol Violation|8|||
148725105|NCT02443545|536466018|FG001|Overall Study|Protocol Violation|1|||
148725106|NCT02443545|536466017|FG000|Overall Study|Pregnancy|1|||
148725107|NCT02443545|536466018|FG001|Overall Study|Pregnancy|1|||
148725108|NCT02443545|536466017|FG000|Overall Study|Withdrawal by Subject|6|||
148725109|NCT02443545|536466018|FG001|Overall Study|Withdrawal by Subject|3|||
148725110|NCT02443545|536466017|FG000|Overall Study|Termination of study|20|||
148725111|NCT02443545|536466018|FG001|Overall Study|Termination of study|11|||
148725112|NCT02139124|536466020|FG000|Overall Study|Adverse Event|2|||
148725113|NCT02139124|536466021|FG001|Overall Study|Adverse Event|0|||
148725114|NCT02139124|536466022|FG002|Overall Study|Adverse Event|1|||
148725115|NCT02139124|536466023|FG003|Overall Study|Adverse Event|2|||
148725116|NCT02139124|536466024|FG004|Overall Study|Adverse Event|5|||
148725117|NCT02139124|536466020|FG000|Overall Study|Withdrawal by Subject|2|||
148725118|NCT02139124|536466021|FG001|Overall Study|Withdrawal by Subject|2|||
148725119|NCT02139124|536466022|FG002|Overall Study|Withdrawal by Subject|2|||
148725120|NCT02139124|536466023|FG003|Overall Study|Withdrawal by Subject|2|||
148725121|NCT02139124|536466024|FG004|Overall Study|Withdrawal by Subject|3|||
148725122|NCT02139124|536466020|FG000|Overall Study|Protocol Violation|0|||
148725123|NCT02139124|536466021|FG001|Overall Study|Protocol Violation|0|||
148725124|NCT02139124|536466022|FG002|Overall Study|Protocol Violation|0|||
148725125|NCT02139124|536466023|FG003|Overall Study|Protocol Violation|1|||
148725126|NCT02139124|536466024|FG004|Overall Study|Protocol Violation|1|||
148725127|NCT02139124|536466020|FG000|Overall Study|non-compliant|1|||
148725128|NCT02139124|536466021|FG001|Overall Study|non-compliant|0|||
148725129|NCT02139124|536466022|FG002|Overall Study|non-compliant|0|||
148725130|NCT02139124|536466023|FG003|Overall Study|non-compliant|2|||
148725131|NCT02139124|536466024|FG004|Overall Study|non-compliant|0|||
148725132|NCT02139124|536466020|FG000|Overall Study|incarceration|0|||
148725133|NCT02139124|536466021|FG001|Overall Study|incarceration|0|||
148725134|NCT02139124|536466022|FG002|Overall Study|incarceration|1|||
148725135|NCT02139124|536466023|FG003|Overall Study|incarceration|0|||
148725136|NCT02139124|536466024|FG004|Overall Study|incarceration|0|||
148725137|NCT02139124|536466020|FG000|Overall Study|subject moved|1|||
148725138|NCT02139124|536466021|FG001|Overall Study|subject moved|0|||
148725139|NCT02139124|536466022|FG002|Overall Study|subject moved|0|||
148725140|NCT02139124|536466023|FG003|Overall Study|subject moved|0|||
148725141|NCT02139124|536466024|FG004|Overall Study|subject moved|0|||
148725142|NCT02139124|536466020|FG000|Overall Study|Lost to Follow-up|3|||
148725143|NCT02139124|536466021|FG001|Overall Study|Lost to Follow-up|2|||
148725144|NCT02139124|536466022|FG002|Overall Study|Lost to Follow-up|0|||
148725145|NCT02139124|536466023|FG003|Overall Study|Lost to Follow-up|5|||
148725146|NCT02139124|536466024|FG004|Overall Study|Lost to Follow-up|4|||
148725147|NCT02691741|536466025|FG000|Overall Study|Adverse Event|0|||
148725148|NCT02691741|536466026|FG001|Overall Study|Adverse Event|2|||
148725149|NCT02691741|536466025|FG000|Overall Study|Lost to Follow-up|1|||
148725150|NCT02691741|536466026|FG001|Overall Study|Lost to Follow-up|0|||
148725151|NCT02691741|536466025|FG000|Overall Study|Physician Decision|0|||
148725152|NCT02691741|536466026|FG001|Overall Study|Physician Decision|1|||
148725153|NCT02691741|536466025|FG000|Overall Study|Withdrawal by Subject|0|||
148725154|NCT02691741|536466026|FG001|Overall Study|Withdrawal by Subject|4|||
148725155|NCT01425528|536466027|FG000|Overall Study|Withdrawal by Subject|1|||
148725156|NCT01425528|536466028|FG001|Overall Study|Withdrawal by Subject|1|||
148725157|NCT00854373|536466029|FG000|Overall Study|Withdrawal by Subject|1|||
148725158|NCT00854373|536466030|FG001|Overall Study|Withdrawal by Subject|3|||
148725159|NCT00854373|536466029|FG000|Overall Study|Forgot to take study drug|1|||
148725160|NCT00854373|536466030|FG001|Overall Study|Forgot to take study drug|1|||
148816487|NCT04575324|536803931|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
148816488|NCT04575324|536803932|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
148816489|NCT02582632|536803933|FG000|Overall Study|Other|1|||
148816490|NCT01771913|536803934|FG000|Overall Study|Withdrawal by Subject|1|||
148816491|NCT01771913|536803935|FG001|Overall Study|Withdrawal by Subject|0|||
148816492|NCT04307394|536803936|FG000|Overall Study|Lost to Follow-up|3|||
148816493|NCT04307394|536803936|FG000|Overall Study|Withdrawal by Subject|2|||
148816494|NCT00416949|536803939|FG000|Overall Study|Patients refused to participate|5|||
148816495|NCT01471574|536803940|FG000|Treatment Period|Lack of Efficacy|12|||
148816496|NCT01471574|536803941|FG001|Treatment Period|Lack of Efficacy|4|||
148816497|NCT01471574|536803942|FG002|Treatment Period|Lack of Efficacy|14|||
148816498|NCT01471574|536803943|FG003|Treatment Period|Lack of Efficacy|1|||
148816499|NCT01471574|536803940|FG000|Treatment Period|Adverse Event|7|||
148816500|NCT01471574|536803941|FG001|Treatment Period|Adverse Event|3|||
148816501|NCT01471574|536803942|FG002|Treatment Period|Adverse Event|6|||
148816502|NCT01471574|536803943|FG003|Treatment Period|Adverse Event|1|||
148816503|NCT01471574|536803940|FG000|Treatment Period|Withdrawal by Subject|5|||
148816504|NCT01471574|536803941|FG001|Treatment Period|Withdrawal by Subject|1|||
148816505|NCT01471574|536803942|FG002|Treatment Period|Withdrawal by Subject|1|||
148816506|NCT01471574|536803943|FG003|Treatment Period|Withdrawal by Subject|0|||
148816507|NCT01471574|536803940|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
148816508|NCT01471574|536803941|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
148816509|NCT01471574|536803942|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
148816510|NCT01471574|536803943|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
148816511|NCT01471574|536803940|FG000|Treatment Period|Lost to Follow-up|1|||
148816512|NCT01471574|536803941|FG001|Treatment Period|Lost to Follow-up|2|||
148816513|NCT01471574|536803942|FG002|Treatment Period|Lost to Follow-up|2|||
148816514|NCT01471574|536803943|FG003|Treatment Period|Lost to Follow-up|0|||
148816515|NCT01471574|536803940|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
148816516|NCT01471574|536803941|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
148816517|NCT01471574|536803942|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
148816518|NCT01471574|536803943|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
148816519|NCT01471574|536803940|FG000|Treatment Period|Other|1|||
148816520|NCT01471574|536803941|FG001|Treatment Period|Other|0|||
148970424|NCT00404352|537376668|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148970425|NCT00404352|537376669|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
148970426|NCT00404352|537376661|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148970427|NCT00404352|537376662|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148970428|NCT00404352|537376663|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148725161|NCT00307931|536466031|FG000|Overall Study|Adverse Event|1|||
148725162|NCT02697773|536466032|FG000|Overall Study|Adverse Event|2|||
148725163|NCT02697773|536466033|FG001|Overall Study|Adverse Event|1|||
148725164|NCT02697773|536466034|FG002|Overall Study|Adverse Event|2|||
148725165|NCT02697773|536466032|FG000|Overall Study|Death|0|||
148725166|NCT02697773|536466033|FG001|Overall Study|Death|0|||
148725167|NCT02697773|536466034|FG002|Overall Study|Death|2|||
148725168|NCT02697773|536466032|FG000|Overall Study|Lack of Efficacy|4|||
148725169|NCT02697773|536466033|FG001|Overall Study|Lack of Efficacy|6|||
148725170|NCT02697773|536466034|FG002|Overall Study|Lack of Efficacy|6|||
148725171|NCT02697773|536466032|FG000|Overall Study|Lost to Follow-up|5|||
148725172|NCT02697773|536466033|FG001|Overall Study|Lost to Follow-up|5|||
148725173|NCT02697773|536466034|FG002|Overall Study|Lost to Follow-up|7|||
148725174|NCT02697773|536466032|FG000|Overall Study|Other|15|||
148725175|NCT02697773|536466033|FG001|Overall Study|Other|11|||
148970429|NCT00404352|537376664|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148970430|NCT00404352|537376665|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148970431|NCT00404352|537376666|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
148970432|NCT00404352|537376667|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148816521|NCT01471574|536803942|FG002|Treatment Period|Other|0|||
148970433|NCT00404352|537376668|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148970434|NCT00404352|537376669|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
148970435|NCT00404352|537376661|FG000|Open Label (up to 24 Month)|Disease progression|0|||
148970436|NCT00404352|537376662|FG001|Open Label (up to 24 Month)|Disease progression|0|||
148816522|NCT01471574|536803943|FG003|Treatment Period|Other|0|||
148970437|NCT00404352|537376663|FG002|Open Label (up to 24 Month)|Disease progression|0|||
148970438|NCT00404352|537376664|FG003|Open Label (up to 24 Month)|Disease progression|1|||
148816523|NCT01471574|536803940|FG000|Follow-up Period|Withdrawal by Subject|3|||
148725176|NCT02697773|536466034|FG002|Overall Study|Other|10|||
148725177|NCT02697773|536466032|FG000|Overall Study|Protocol Violation|1|||
148725178|NCT02697773|536466033|FG001|Overall Study|Protocol Violation|1|||
148725179|NCT02697773|536466034|FG002|Overall Study|Protocol Violation|0|||
148725180|NCT02697773|536466032|FG000|Overall Study|Withdrawal by Subject|10|||
148816524|NCT01471574|536803941|FG001|Follow-up Period|Withdrawal by Subject|0|||
148816525|NCT01471574|536803942|FG002|Follow-up Period|Withdrawal by Subject|3|||
148725181|NCT02697773|536466033|FG001|Overall Study|Withdrawal by Subject|13|||
148970439|NCT00404352|537376665|FG004|Open Label (up to 24 Month)|Disease progression|0|||
148970440|NCT00404352|537376666|FG005|Open Label (up to 24 Month)|Disease progression|0|||
148970441|NCT00404352|537376667|FG006|Open Label (up to 24 Month)|Disease progression|0|||
148970442|NCT00404352|537376668|FG007|Open Label (up to 24 Month)|Disease progression|0|||
148970443|NCT00404352|537376669|FG008|Open Label (up to 24 Month)|Disease progression|0|||
148970444|NCT00404352|537376661|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970445|NCT00404352|537376662|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970446|NCT00404352|537376663|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970447|NCT00404352|537376664|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970448|NCT00404352|537376665|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970449|NCT00404352|537376666|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970450|NCT00404352|537376667|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
148970451|NCT00404352|537376668|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
148970452|NCT00404352|537376669|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
148970453|NCT00404352|537376661|FG000|Open Label Extension (up to 36 Months)|Other|0|||
148970454|NCT00404352|537376662|FG001|Open Label Extension (up to 36 Months)|Other|0|||
148970455|NCT00404352|537376663|FG002|Open Label Extension (up to 36 Months)|Other|0|||
148970456|NCT00404352|537376664|FG003|Open Label Extension (up to 36 Months)|Other|0|||
148970457|NCT00404352|537376665|FG004|Open Label Extension (up to 36 Months)|Other|0|||
148970458|NCT00404352|537376666|FG005|Open Label Extension (up to 36 Months)|Other|0|||
148970459|NCT00404352|537376667|FG006|Open Label Extension (up to 36 Months)|Other|0|||
148970460|NCT00404352|537376668|FG007|Open Label Extension (up to 36 Months)|Other|0|||
148970461|NCT00404352|537376669|FG008|Open Label Extension (up to 36 Months)|Other|2|||
148970462|NCT01479621|537376670|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
148970463|NCT01479621|537376671|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
148970464|NCT01479621|537376672|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
148970465|NCT01479621|537376673|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
148970466|NCT01479621|537376674|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
148970467|NCT01479621|537376675|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
148970468|NCT01479621|537376676|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
148970469|NCT01479621|537376670|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
148970470|NCT01479621|537376671|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
148970471|NCT01479621|537376672|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
148970472|NCT01479621|537376673|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
148970473|NCT01479621|537376674|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
148970474|NCT01479621|537376675|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
148970475|NCT01479621|537376676|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
148970476|NCT01479621|537376670|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
148970477|NCT01479621|537376671|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
148970478|NCT01479621|537376672|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
148970479|NCT01479621|537376673|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
148970480|NCT01479621|537376674|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
148970481|NCT01479621|537376675|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
148970482|NCT01479621|537376676|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
148970483|NCT01479621|537376670|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
148970484|NCT01479621|537376671|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
148970485|NCT01479621|537376672|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
148970486|NCT01479621|537376673|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
148970487|NCT01479621|537376674|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
148970488|NCT01479621|537376675|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
148970489|NCT01479621|537376676|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
148970490|NCT01479621|537376670|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
148970491|NCT01479621|537376671|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
148970492|NCT01479621|537376672|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
148725182|NCT02697773|536466034|FG002|Overall Study|Withdrawal by Subject|13|||
148725183|NCT02697773|536466032|FG000|Overall Study|Randomized but not treated|1|||
148970493|NCT01479621|537376673|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
148970494|NCT01479621|537376674|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
148970495|NCT01479621|537376675|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
148970496|NCT01479621|537376676|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
148970497|NCT01479621|537376670|FG000|Treatment Period|Adverse Event|0|||
149025328|NCT02373813|537569983|FG001|Run-In Period|Ineligibility Determined|0|||
149025329|NCT02373813|537569984|FG002|Run-In Period|Ineligibility Determined|0|||
148725184|NCT02697773|536466033|FG001|Overall Study|Randomized but not treated|1|||
148725185|NCT02697773|536466034|FG002|Overall Study|Randomized but not treated|0|||
148725186|NCT00613834|536466035|FG000|Overall Study|Withdrawal by Subject|0|||
148725187|NCT00613834|536466036|FG001|Overall Study|Withdrawal by Subject|3|||
148725188|NCT00842530|536466037|FG000|Overall Study|Serious adverse event|0|||
149025330|NCT02373813|537569985|FG003|Run-In Period|Ineligibility Determined|0|||
149025331|NCT02373813|537569982|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
149025332|NCT02373813|537569983|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
149025333|NCT02373813|537569984|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
149025334|NCT02373813|537569985|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
149025335|NCT02373813|537569982|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
149025336|NCT02373813|537569983|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
149025337|NCT02373813|537569984|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
149025338|NCT02373813|537569985|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
149025339|NCT02373813|537569982|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149025340|NCT02373813|537569983|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
149025341|NCT02373813|537569984|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
149025342|NCT02373813|537569985|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
149025343|NCT02373813|537569982|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
149025344|NCT02373813|537569983|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
149025345|NCT02373813|537569984|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
149025346|NCT02373813|537569985|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
149025347|NCT01764386|537569987|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
149025348|NCT01764386|537569988|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
149025349|NCT01764386|537569987|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
148725189|NCT00842530|536466038|FG001|Overall Study|Serious adverse event|6|||
148725190|NCT00842530|536466037|FG000|Overall Study|Other adverse event|6|||
148725191|NCT00842530|536466038|FG001|Overall Study|Other adverse event|1|||
148725192|NCT00842530|536466037|FG000|Overall Study|Protocol Violation|32|||
148725193|NCT00842530|536466038|FG001|Overall Study|Protocol Violation|14|||
148725194|NCT00842530|536466037|FG000|Overall Study|Lost to Follow-up|6|||
148725195|NCT00842530|536466038|FG001|Overall Study|Lost to Follow-up|8|||
148725196|NCT00842530|536466037|FG000|Overall Study|Withdrawal by Subject|73|||
148970498|NCT01479621|537376671|FG001|Treatment Period|Adverse Event|0|||
148970499|NCT01479621|537376672|FG002|Treatment Period|Adverse Event|0|||
148970500|NCT01479621|537376673|FG003|Treatment Period|Adverse Event|0|||
148970501|NCT01479621|537376674|FG004|Treatment Period|Adverse Event|1|||
148970502|NCT01479621|537376675|FG005|Treatment Period|Adverse Event|2|||
148970503|NCT01479621|537376676|FG006|Treatment Period|Adverse Event|2|||
148970504|NCT01479621|537376670|FG000|Treatment Period|Withdrawal by Subject|0|||
148970505|NCT01479621|537376671|FG001|Treatment Period|Withdrawal by Subject|4|||
148970506|NCT01479621|537376672|FG002|Treatment Period|Withdrawal by Subject|2|||
148970507|NCT01479621|537376673|FG003|Treatment Period|Withdrawal by Subject|2|||
148970508|NCT01479621|537376674|FG004|Treatment Period|Withdrawal by Subject|5|||
148970509|NCT01479621|537376675|FG005|Treatment Period|Withdrawal by Subject|5|||
148970510|NCT01479621|537376676|FG006|Treatment Period|Withdrawal by Subject|1|||
148970511|NCT01479621|537376670|FG000|Treatment Period|Physician Decision|0|||
148970512|NCT01479621|537376671|FG001|Treatment Period|Physician Decision|0|||
148970513|NCT01479621|537376672|FG002|Treatment Period|Physician Decision|0|||
148970514|NCT01479621|537376673|FG003|Treatment Period|Physician Decision|0|||
148970515|NCT01479621|537376674|FG004|Treatment Period|Physician Decision|1|||
148970516|NCT01479621|537376675|FG005|Treatment Period|Physician Decision|1|||
148970517|NCT01479621|537376676|FG006|Treatment Period|Physician Decision|0|||
148970518|NCT01479621|537376670|FG000|Treatment Period|Non-compliance to study drug|0|||
148970519|NCT01479621|537376671|FG001|Treatment Period|Non-compliance to study drug|1|||
148970520|NCT01479621|537376672|FG002|Treatment Period|Non-compliance to study drug|0|||
148970521|NCT01479621|537376673|FG003|Treatment Period|Non-compliance to study drug|0|||
148970522|NCT01479621|537376674|FG004|Treatment Period|Non-compliance to study drug|0|||
148970523|NCT01479621|537376675|FG005|Treatment Period|Non-compliance to study drug|0|||
148970524|NCT01479621|537376676|FG006|Treatment Period|Non-compliance to study drug|1|||
148970525|NCT01479621|537376670|FG000|Treatment Period|Protocol Violation|0|||
148970526|NCT01479621|537376671|FG001|Treatment Period|Protocol Violation|9|||
148970527|NCT01479621|537376672|FG002|Treatment Period|Protocol Violation|6|||
149025350|NCT01764386|537569988|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
149025351|NCT01764386|537569987|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
148970528|NCT01479621|537376673|FG003|Treatment Period|Protocol Violation|5|||
148970529|NCT01479621|537376674|FG004|Treatment Period|Protocol Violation|2|||
148970530|NCT01479621|537376675|FG005|Treatment Period|Protocol Violation|10|||
148970531|NCT01479621|537376676|FG006|Treatment Period|Protocol Violation|6|||
148970532|NCT01479621|537376670|FG000|Treatment Period|Pregnancy|0|||
148725197|NCT00842530|536466038|FG001|Overall Study|Withdrawal by Subject|28|||
148725198|NCT02939950|536466039|FG000|Overall Study|Lost to Follow-up|13|||
148725199|NCT02939950|536466040|FG001|Overall Study|Lost to Follow-up|16|||
148816526|NCT01471574|536803943|FG003|Follow-up Period|Withdrawal by Subject|1|||
148970533|NCT01479621|537376671|FG001|Treatment Period|Pregnancy|0|||
148970534|NCT01479621|537376672|FG002|Treatment Period|Pregnancy|2|||
149025352|NCT01764386|537569988|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
149025353|NCT01764386|537569987|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
149025354|NCT01764386|537569988|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
149025355|NCT01764386|537569987|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
149025356|NCT01764386|537569988|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
149025357|NCT01764386|537569987|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
149025358|NCT01764386|537569988|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
149025359|NCT01764386|537569987|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
149025360|NCT01764386|537569988|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
149025361|NCT01764386|537569987|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
149025362|NCT01764386|537569988|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
149025363|NCT02788656|537569989|FG000|Overall Study|Withdrawal by Subject|1|||
149025364|NCT02788656|537569990|FG001|Overall Study|Withdrawal by Subject|0|||
148725200|NCT02939950|536466039|FG000|Overall Study|Positive slit lamp findings|0|||
149025365|NCT03169361|537569991|FG000|Overall Study|Protocol Violation|32|||
149025366|NCT02263885|537569992|FG000|Overall Study|Withdrawal by Subject|7|||
149025367|NCT02263885|537569992|FG000|Overall Study|Alternative Treatment|3|||
149025368|NCT02271594|537569993|FG000|Overall Study|Study closed; recruiting failure|19|||
149025369|NCT02271594|537569994|FG001|Overall Study|Study closed; recruiting failure|12|||
149025370|NCT00495469|537569999|FG000|Overall Study|Adverse Event|0|||
149025371|NCT00495469|537570000|FG001|Overall Study|Adverse Event|1|||
149025372|NCT00495469|537570001|FG002|Overall Study|Adverse Event|3|||
149025373|NCT00495469|537570002|FG003|Overall Study|Adverse Event|0|||
149025374|NCT00495469|537570003|FG004|Overall Study|Adverse Event|1|||
149025375|NCT00495469|537570004|FG005|Overall Study|Adverse Event|1|||
149025376|NCT00495469|537570005|FG006|Overall Study|Adverse Event|1|||
149025377|NCT00495469|537569999|FG000|Overall Study|Lost to Follow-up|1|||
149025378|NCT00495469|537570000|FG001|Overall Study|Lost to Follow-up|1|||
149025379|NCT00495469|537570001|FG002|Overall Study|Lost to Follow-up|3|||
149025380|NCT00495469|537570002|FG003|Overall Study|Lost to Follow-up|1|||
149025381|NCT00495469|537570003|FG004|Overall Study|Lost to Follow-up|0|||
149025382|NCT00495469|537570004|FG005|Overall Study|Lost to Follow-up|0|||
149025383|NCT00495469|537570005|FG006|Overall Study|Lost to Follow-up|0|||
149025384|NCT00495469|537569999|FG000|Overall Study|Protocol Violation|0|||
149025385|NCT00495469|537570000|FG001|Overall Study|Protocol Violation|0|||
149025386|NCT00495469|537570001|FG002|Overall Study|Protocol Violation|0|||
149025387|NCT00495469|537570002|FG003|Overall Study|Protocol Violation|0|||
149025388|NCT00495469|537570003|FG004|Overall Study|Protocol Violation|1|||
149025389|NCT00495469|537570004|FG005|Overall Study|Protocol Violation|2|||
149025390|NCT00495469|537570005|FG006|Overall Study|Protocol Violation|0|||
149025391|NCT00495469|537569999|FG000|Overall Study|Withdrawal by Subject|5|||
149025392|NCT00495469|537570000|FG001|Overall Study|Withdrawal by Subject|3|||
149025393|NCT00495469|537570001|FG002|Overall Study|Withdrawal by Subject|1|||
149025394|NCT00495469|537570002|FG003|Overall Study|Withdrawal by Subject|3|||
149025395|NCT00495469|537570003|FG004|Overall Study|Withdrawal by Subject|3|||
149025396|NCT00495469|537570004|FG005|Overall Study|Withdrawal by Subject|2|||
149025397|NCT00495469|537570005|FG006|Overall Study|Withdrawal by Subject|3|||
149025398|NCT00495469|537569999|FG000|Overall Study|Lack of Efficacy|0|||
149025399|NCT00495469|537570000|FG001|Overall Study|Lack of Efficacy|0|||
149025400|NCT00495469|537570001|FG002|Overall Study|Lack of Efficacy|0|||
149025401|NCT00495469|537570002|FG003|Overall Study|Lack of Efficacy|0|||
149025402|NCT00495469|537570003|FG004|Overall Study|Lack of Efficacy|0|||
149025403|NCT00495469|537570004|FG005|Overall Study|Lack of Efficacy|0|||
149025404|NCT00495469|537570005|FG006|Overall Study|Lack of Efficacy|1|||
149025405|NCT00495469|537569999|FG000|Overall Study|Liver function test abnormality|0|||
149025406|NCT00495469|537570000|FG001|Overall Study|Liver function test abnormality|1|||
149025407|NCT00495469|537570001|FG002|Overall Study|Liver function test abnormality|0|||
149025408|NCT00495469|537570002|FG003|Overall Study|Liver function test abnormality|0|||
149025409|NCT00495469|537570003|FG004|Overall Study|Liver function test abnormality|0|||
149025410|NCT00495469|537570004|FG005|Overall Study|Liver function test abnormality|0|||
148725201|NCT02939950|536466040|FG001|Overall Study|Positive slit lamp findings|1|||
148725202|NCT02939950|536466039|FG000|Overall Study|Chalazion upper lid|0|||
148725203|NCT02939950|536466040|FG001|Overall Study|Chalazion upper lid|1|||
148725204|NCT02939950|536466039|FG000|Overall Study|Lack of motivation|0|||
149025411|NCT00495469|537570005|FG006|Overall Study|Liver function test abnormality|0|||
149025412|NCT00495469|537569999|FG000|Overall Study|ST depression at randomisation in ECG|0|||
149025413|NCT00495469|537570000|FG001|Overall Study|ST depression at randomisation in ECG|1|||
149025414|NCT00495469|537570001|FG002|Overall Study|ST depression at randomisation in ECG|0|||
149025415|NCT00495469|537570002|FG003|Overall Study|ST depression at randomisation in ECG|0|||
149025416|NCT00495469|537570003|FG004|Overall Study|ST depression at randomisation in ECG|0|||
149025417|NCT00495469|537570004|FG005|Overall Study|ST depression at randomisation in ECG|0|||
148725205|NCT02939950|536466040|FG001|Overall Study|Lack of motivation|2|||
148725206|NCT02939950|536466039|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
148816527|NCT01471574|536803940|FG000|Follow-up Period|Lost to Follow-up|4|||
148816528|NCT01471574|536803941|FG001|Follow-up Period|Lost to Follow-up|1|||
148816529|NCT01471574|536803942|FG002|Follow-up Period|Lost to Follow-up|3|||
148816530|NCT01471574|536803943|FG003|Follow-up Period|Lost to Follow-up|2|||
148816531|NCT01471574|536803940|FG000|Follow-up Period|Death|0|||
148816532|NCT01471574|536803941|FG001|Follow-up Period|Death|0|||
148816533|NCT01471574|536803942|FG002|Follow-up Period|Death|1|||
148816534|NCT01471574|536803943|FG003|Follow-up Period|Death|0|||
148816535|NCT01471574|536803940|FG000|Follow-up Period|Follow-up no longer required|0|||
148816536|NCT01471574|536803941|FG001|Follow-up Period|Follow-up no longer required|1|||
148816537|NCT01471574|536803942|FG002|Follow-up Period|Follow-up no longer required|0|||
148816538|NCT01471574|536803943|FG003|Follow-up Period|Follow-up no longer required|0|||
148816539|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
148816540|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
148816541|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
148816542|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
148816543|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
148816544|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
148816545|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
148816546|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
148816547|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
148816548|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
148816549|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
148816550|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
148816551|NCT00447278|536803944|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
148816552|NCT00447278|536803945|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
148816553|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
148816554|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
148816555|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
148816556|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
148816557|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
148816558|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
148816559|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
148816560|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
148816561|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
148816562|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
148816563|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
148816564|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
148816565|NCT00447278|536803944|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
148816566|NCT00447278|536803945|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
148816567|NCT03677401|536803946|FG000|Overall Study|Adverse Event|4|||
148816568|NCT03677401|536803947|FG001|Overall Study|Adverse Event|14|||
148816569|NCT03677401|536803946|FG000|Overall Study|Lack of Efficacy|3|||
148816570|NCT03677401|536803947|FG001|Overall Study|Lack of Efficacy|1|||
148816571|NCT03677401|536803946|FG000|Overall Study|Withdrawal by Subject|2|||
148816572|NCT03677401|536803947|FG001|Overall Study|Withdrawal by Subject|2|||
148816573|NCT03677401|536803946|FG000|Overall Study|Sponsor decision|0|||
148816574|NCT03677401|536803947|FG001|Overall Study|Sponsor decision|1|||
148725207|NCT02939950|536466040|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
148725208|NCT02939950|536466039|FG000|Overall Study|Military orders|1|||
148725209|NCT02939950|536466040|FG001|Overall Study|Military orders|0|||
148725210|NCT02939950|536466039|FG000|Overall Study|Participant Relocated|5|||
148725211|NCT02939950|536466040|FG001|Overall Study|Participant Relocated|3|||
148725212|NCT02939950|536466039|FG000|Overall Study|Study related symptoms|8|||
148725213|NCT02939950|536466040|FG001|Overall Study|Study related symptoms|8|||
148725214|NCT02939950|536466039|FG000|Overall Study|Unacceptable lens movement|2|||
148725215|NCT02939950|536466040|FG001|Overall Study|Unacceptable lens movement|0|||
148725216|NCT02939950|536466039|FG000|Overall Study|Protocol Violation|6|||
148725217|NCT02939950|536466040|FG001|Overall Study|Protocol Violation|3|||
148725218|NCT02939950|536466039|FG000|Overall Study|Physician Decision|2|||
148725219|NCT02939950|536466040|FG001|Overall Study|Physician Decision|0|||
148725220|NCT02939950|536466039|FG000|Overall Study|Pregnancy|6|||
148725221|NCT02939950|536466040|FG001|Overall Study|Pregnancy|7|||
148725222|NCT02939950|536466039|FG000|Overall Study|Withdrawal by Subject|12|||
148725223|NCT02939950|536466040|FG001|Overall Study|Withdrawal by Subject|28|||
148725224|NCT02939950|536466039|FG000|Overall Study|Adverse Event|7|||
148725225|NCT02939950|536466040|FG001|Overall Study|Adverse Event|3|||
148725226|NCT02939950|536466039|FG000|Overall Study|Randomized, not dispensed|1|||
148816575|NCT03677401|536803946|FG000|Overall Study|Reason Unspecified|1|||
148725227|NCT02939950|536466040|FG001|Overall Study|Randomized, not dispensed|0|||
148725228|NCT02939950|536466039|FG000|Overall Study|Ineligible at Baseline|2|||
148725229|NCT02939950|536466040|FG001|Overall Study|Ineligible at Baseline|8|||
148725230|NCT02243293|536466041|FG000|Overall Study|Adverse Event|1|||
148725231|NCT02243293|536466042|FG001|Overall Study|Adverse Event|0|||
148725232|NCT02243293|536466043|FG002|Overall Study|Adverse Event|0|||
148725233|NCT02243293|536466044|FG003|Overall Study|Adverse Event|0|||
148725234|NCT02243293|536466045|FG004|Overall Study|Adverse Event|0|||
148725235|NCT02243293|536466046|FG005|Overall Study|Adverse Event|0|||
148725236|NCT02243293|536466047|FG006|Overall Study|Adverse Event|0|||
148725237|NCT02243293|536466048|FG007|Overall Study|Adverse Event|0|||
148725238|NCT02243293|536466049|FG008|Overall Study|Adverse Event|0|||
148725239|NCT02243293|536466050|FG009|Overall Study|Adverse Event|0|||
148725240|NCT02243293|536466051|FG010|Overall Study|Adverse Event|0|||
148725241|NCT02243293|536466052|FG011|Overall Study|Adverse Event|0|||
148725242|NCT02243293|536466053|FG012|Overall Study|Adverse Event|0|||
148725243|NCT02243293|536466054|FG013|Overall Study|Adverse Event|0|||
148725244|NCT02243293|536466055|FG014|Overall Study|Adverse Event|0|||
148725245|NCT02243293|536466056|FG015|Overall Study|Adverse Event|1|||
148725246|NCT02243293|536466057|FG016|Overall Study|Adverse Event|0|||
148725247|NCT02243293|536466058|FG017|Overall Study|Adverse Event|0|||
148725248|NCT02243293|536466059|FG018|Overall Study|Adverse Event|0|||
148725249|NCT02243293|536466060|FG019|Overall Study|Adverse Event|0|||
148725250|NCT02243293|536466061|FG020|Overall Study|Adverse Event|1|||
148725251|NCT02243293|536466062|FG021|Overall Study|Adverse Event|0|||
148725252|NCT02243293|536466041|FG000|Overall Study|Withdrawal by Subject|1|||
148725253|NCT02243293|536466042|FG001|Overall Study|Withdrawal by Subject|0|||
148725254|NCT02243293|536466043|FG002|Overall Study|Withdrawal by Subject|0|||
148725255|NCT02243293|536466044|FG003|Overall Study|Withdrawal by Subject|0|||
148725256|NCT02243293|536466045|FG004|Overall Study|Withdrawal by Subject|0|||
148816576|NCT03677401|536803947|FG001|Overall Study|Reason Unspecified|0|||
149025418|NCT00495469|537570005|FG006|Overall Study|ST depression at randomisation in ECG|0|||
149025419|NCT04454567|537570010|FG000|Overall Study|Study Terminated by Sponsor|1|||
149025420|NCT04454567|537570011|FG001|Overall Study|Study Terminated by Sponsor|1|||
149025421|NCT01123161|537570016|FG000|Overall Study|Lost to Follow-up|1|||
149025422|NCT01123161|537570017|FG001|Overall Study|Lost to Follow-up|0|||
149025423|NCT01123161|537570016|FG000|Overall Study|Withdrawal by Subject|1|||
149025424|NCT01123161|537570017|FG001|Overall Study|Withdrawal by Subject|0|||
149025425|NCT02459964|537570018|FG000|Overall Study|Withdrawal by Subject|0|||
149025426|NCT02459964|537570019|FG001|Overall Study|Withdrawal by Subject|0|||
149025427|NCT02459964|537570020|FG002|Overall Study|Withdrawal by Subject|1|||
149025428|NCT02459964|537570018|FG000|Overall Study|Abnormal EKG changes|0|||
149025429|NCT02459964|537570019|FG001|Overall Study|Abnormal EKG changes|0|||
149025430|NCT02459964|537570020|FG002|Overall Study|Abnormal EKG changes|1|||
149025431|NCT00550732|537570021|FG000|Overall Study|Death|4|||
149025432|NCT00550732|537570021|FG000|Overall Study|Withdrawal by Subject|2|||
149025433|NCT00550732|537570021|FG000|Overall Study|Physician Decision|2|||
149025434|NCT00550732|537570021|FG000|Overall Study|Lost to Follow-up|1|||
149025435|NCT00550732|537570021|FG000|Overall Study|Palliative care|1|||
149025436|NCT00550732|537570021|FG000|Overall Study|Adverse Event|1|||
149025437|NCT00926393|537570023|FG000|Overall Study|Withdrawal by Subject|1|||
149025438|NCT00926393|537570024|FG001|Overall Study|Withdrawal by Subject|2|||
149025439|NCT00926393|537570023|FG000|Overall Study|Adverse Event|1|||
149025440|NCT00926393|537570024|FG001|Overall Study|Adverse Event|1|||
149025441|NCT03302910|537570032|FG000|Overall Study|Protocol Violation|1|||
149025442|NCT03302910|537570033|FG001|Overall Study|Protocol Violation|0|||
149025443|NCT02851511|537570037|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
149025444|NCT02851511|537570038|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
149025445|NCT02851511|537570039|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
149025446|NCT02851511|537570040|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
149025447|NCT02851511|537570037|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
149025448|NCT02851511|537570038|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
149025449|NCT02851511|537570039|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
149025450|NCT02851511|537570040|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
149025451|NCT02851511|537570037|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
149025452|NCT02851511|537570038|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
149025453|NCT02851511|537570039|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
149025454|NCT02851511|537570040|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
149025455|NCT02851511|537570037|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
149025456|NCT02851511|537570038|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
149025457|NCT02851511|537570039|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
149025458|NCT02851511|537570040|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
149025459|NCT02851511|537570037|FG000|Phase I|Physician Decision|0|||
149025460|NCT02851511|537570038|FG001|Phase I|Physician Decision|0|||
149025461|NCT02851511|537570039|FG002|Phase I|Physician Decision|0|||
148725257|NCT02243293|536466046|FG005|Overall Study|Withdrawal by Subject|0|||
148725258|NCT02243293|536466047|FG006|Overall Study|Withdrawal by Subject|0|||
148725259|NCT02243293|536466048|FG007|Overall Study|Withdrawal by Subject|0|||
149025462|NCT02851511|537570040|FG003|Phase I|Physician Decision|1|||
149025463|NCT02851511|537570037|FG000|Phase I|Withdrawal by Subject|2|||
149025464|NCT02851511|537570038|FG001|Phase I|Withdrawal by Subject|1|||
149025465|NCT02851511|537570039|FG002|Phase I|Withdrawal by Subject|0|||
149025466|NCT02851511|537570040|FG003|Phase I|Withdrawal by Subject|3|||
149025467|NCT02851511|537570037|FG000|Phase II|Physician Decision|18|||
149025468|NCT02851511|537570038|FG001|Phase II|Physician Decision|16|||
148725260|NCT02243293|536466049|FG008|Overall Study|Withdrawal by Subject|0|||
148725261|NCT02243293|536466050|FG009|Overall Study|Withdrawal by Subject|1|||
148725262|NCT02243293|536466051|FG010|Overall Study|Withdrawal by Subject|0|||
148970535|NCT01479621|537376673|FG003|Treatment Period|Pregnancy|0|||
148970536|NCT01479621|537376674|FG004|Treatment Period|Pregnancy|0|||
148970537|NCT01479621|537376675|FG005|Treatment Period|Pregnancy|0|||
148970538|NCT01479621|537376676|FG006|Treatment Period|Pregnancy|0|||
148970539|NCT01479621|537376670|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
148970540|NCT01479621|537376671|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
148970541|NCT01479621|537376672|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
148970542|NCT01479621|537376673|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
148970543|NCT01479621|537376674|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
148970544|NCT01479621|537376675|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
148970545|NCT01479621|537376676|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
148970546|NCT01479621|537376670|FG000|Treatment Period|Lost to Follow-up|0|||
148970547|NCT01479621|537376671|FG001|Treatment Period|Lost to Follow-up|0|||
148970548|NCT01479621|537376672|FG002|Treatment Period|Lost to Follow-up|1|||
148970549|NCT01479621|537376673|FG003|Treatment Period|Lost to Follow-up|0|||
148970550|NCT01479621|537376674|FG004|Treatment Period|Lost to Follow-up|2|||
148970551|NCT01479621|537376675|FG005|Treatment Period|Lost to Follow-up|2|||
148970552|NCT01479621|537376676|FG006|Treatment Period|Lost to Follow-up|1|||
148970553|NCT01479621|537376670|FG000|Treatment Period|Met stopping criteria|0|||
148970554|NCT01479621|537376671|FG001|Treatment Period|Met stopping criteria|8|||
148970555|NCT01479621|537376672|FG002|Treatment Period|Met stopping criteria|7|||
148970556|NCT01479621|537376673|FG003|Treatment Period|Met stopping criteria|4|||
148970557|NCT01479621|537376674|FG004|Treatment Period|Met stopping criteria|9|||
148970558|NCT01479621|537376675|FG005|Treatment Period|Met stopping criteria|20|||
148970559|NCT01479621|537376676|FG006|Treatment Period|Met stopping criteria|6|||
148970560|NCT04370691|537376677|FG000|Overall Study|Pending visit|48|||
148970561|NCT04370691|537376677|FG000|Overall Study|Have Not Reached Lower Window|15|||
148970562|NCT04370691|537376677|FG000|Overall Study|Termination|14|||
148970563|NCT04370691|537376677|FG000|Overall Study|Missed or Overdue|10|||
148970564|NCT00606892|537376685|FG000|First Intervention|Protocol Violation|1|||
148970565|NCT00606892|537376686|FG001|First Intervention|Protocol Violation|4|||
148970566|NCT00329407|537376698|FG000|Overall Study|Withdrawal by Subject|1|||
148970567|NCT00978068|537376699|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
148970568|NCT00978068|537376700|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
148970569|NCT00978068|537376699|FG000|Overall Study|Death|1|||
148970570|NCT00978068|537376700|FG001|Overall Study|Death|2|||
148970571|NCT00978068|537376699|FG000|Overall Study|Lost to Follow-up|1|||
148970572|NCT00978068|537376700|FG001|Overall Study|Lost to Follow-up|2|||
148970573|NCT00978068|537376699|FG000|Overall Study|Physician Decision|0|||
148970574|NCT00978068|537376700|FG001|Overall Study|Physician Decision|1|||
148970575|NCT00978068|537376699|FG000|Overall Study|Unable to Comply with Study|0|||
148970576|NCT00978068|537376700|FG001|Overall Study|Unable to Comply with Study|2|||
148970577|NCT01398956|537376703|FG000|Overall Study|Withdrawal by Subject|4|||
148970578|NCT01398956|537376703|FG000|Overall Study|AE, non-serious non-fatal|4|||
148970579|NCT01398956|537376703|FG000|Overall Study|Withdrawal Criteria No.3|1|||
148970580|NCT01398956|537376703|FG000|Overall Study|Subject moved a long distance|1|||
148970581|NCT00451035|537376704|FG000|Overall Study|Disease progression|11|||
148970582|NCT00451035|537376704|FG000|Overall Study|Death|3|||
148970583|NCT00451035|537376704|FG000|Overall Study|New anti-neoplastic therapy|3|||
148970584|NCT03274986|537376705|FG000|Overall Study|Withdrawal by Subject|0|||
148970585|NCT03274986|537376706|FG001|Overall Study|Withdrawal by Subject|1|||
148970586|NCT03274986|537376705|FG000|Overall Study|Lost to Follow-up|0|||
148970587|NCT03274986|537376706|FG001|Overall Study|Lost to Follow-up|1|||
148970588|NCT00603746|537376707|FG000|Overall Study|Adverse Event|2|||
148970589|NCT00603746|537376708|FG001|Overall Study|Adverse Event|3|||
148970590|NCT00603746|537376709|FG002|Overall Study|Adverse Event|0|||
148970591|NCT00603746|537376710|FG003|Overall Study|Adverse Event|1|||
149025469|NCT02851511|537570039|FG002|Phase II|Physician Decision|0|||
148970592|NCT00603746|537376711|FG004|Overall Study|Adverse Event|0|||
148970593|NCT00603746|537376712|FG005|Overall Study|Adverse Event|4|||
148970594|NCT00603746|537376707|FG000|Overall Study|Lack of Efficacy|34|||
148970595|NCT00603746|537376708|FG001|Overall Study|Lack of Efficacy|11|||
148970596|NCT00603746|537376709|FG002|Overall Study|Lack of Efficacy|6|||
148970597|NCT00603746|537376710|FG003|Overall Study|Lack of Efficacy|11|||
148970598|NCT00603746|537376711|FG004|Overall Study|Lack of Efficacy|12|||
148970599|NCT00603746|537376712|FG005|Overall Study|Lack of Efficacy|8|||
148970600|NCT00603746|537376707|FG000|Overall Study|Protocol Violation|0|||
148970601|NCT00603746|537376708|FG001|Overall Study|Protocol Violation|3|||
148970602|NCT00603746|537376709|FG002|Overall Study|Protocol Violation|1|||
148970603|NCT00603746|537376710|FG003|Overall Study|Protocol Violation|0|||
148725263|NCT02243293|536466052|FG011|Overall Study|Withdrawal by Subject|1|||
148725264|NCT02243293|536466053|FG012|Overall Study|Withdrawal by Subject|0|||
148725265|NCT02243293|536466054|FG013|Overall Study|Withdrawal by Subject|0|||
148725266|NCT02243293|536466055|FG014|Overall Study|Withdrawal by Subject|0|||
148725267|NCT02243293|536466056|FG015|Overall Study|Withdrawal by Subject|0|||
148725268|NCT02243293|536466057|FG016|Overall Study|Withdrawal by Subject|0|||
148725269|NCT02243293|536466058|FG017|Overall Study|Withdrawal by Subject|0|||
148725270|NCT02243293|536466059|FG018|Overall Study|Withdrawal by Subject|0|||
148725271|NCT02243293|536466060|FG019|Overall Study|Withdrawal by Subject|0|||
148725272|NCT02243293|536466061|FG020|Overall Study|Withdrawal by Subject|0|||
148725273|NCT02243293|536466062|FG021|Overall Study|Withdrawal by Subject|1|||
148725274|NCT02243293|536466041|FG000|Overall Study|Lost to Follow-up|0|||
148725275|NCT02243293|536466042|FG001|Overall Study|Lost to Follow-up|1|||
148725276|NCT02243293|536466043|FG002|Overall Study|Lost to Follow-up|1|||
148725277|NCT02243293|536466044|FG003|Overall Study|Lost to Follow-up|1|||
148725278|NCT02243293|536466045|FG004|Overall Study|Lost to Follow-up|0|||
148725279|NCT02243293|536466046|FG005|Overall Study|Lost to Follow-up|0|||
148725280|NCT02243293|536466047|FG006|Overall Study|Lost to Follow-up|3|||
148725281|NCT02243293|536466048|FG007|Overall Study|Lost to Follow-up|0|||
148725282|NCT02243293|536466049|FG008|Overall Study|Lost to Follow-up|0|||
148725283|NCT02243293|536466050|FG009|Overall Study|Lost to Follow-up|0|||
148725284|NCT02243293|536466051|FG010|Overall Study|Lost to Follow-up|0|||
148725285|NCT02243293|536466052|FG011|Overall Study|Lost to Follow-up|2|||
148725286|NCT02243293|536466053|FG012|Overall Study|Lost to Follow-up|0|||
148725287|NCT02243293|536466054|FG013|Overall Study|Lost to Follow-up|0|||
148725288|NCT02243293|536466055|FG014|Overall Study|Lost to Follow-up|0|||
148725289|NCT02243293|536466056|FG015|Overall Study|Lost to Follow-up|0|||
148725290|NCT02243293|536466057|FG016|Overall Study|Lost to Follow-up|3|||
148970604|NCT00603746|537376711|FG004|Overall Study|Protocol Violation|1|||
148970605|NCT00603746|537376712|FG005|Overall Study|Protocol Violation|0|||
148725291|NCT02243293|536466058|FG017|Overall Study|Lost to Follow-up|1|||
148725292|NCT02243293|536466059|FG018|Overall Study|Lost to Follow-up|0|||
148725293|NCT02243293|536466060|FG019|Overall Study|Lost to Follow-up|0|||
148725294|NCT02243293|536466061|FG020|Overall Study|Lost to Follow-up|1|||
148725295|NCT02243293|536466062|FG021|Overall Study|Lost to Follow-up|2|||
148725296|NCT02243293|536466041|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
148725297|NCT02243293|536466042|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
148725298|NCT02243293|536466043|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
148725299|NCT02243293|536466044|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
148725300|NCT02243293|536466045|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
148725301|NCT02243293|536466046|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
148725302|NCT02243293|536466047|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
148816577|NCT01177410|536803948|FG000|Overall Study|Adverse Event|0|||
148816578|NCT01177410|536803949|FG001|Overall Study|Adverse Event|2|||
148816579|NCT01177410|536803950|FG002|Overall Study|Adverse Event|2|||
148816580|NCT01177410|536803948|FG000|Overall Study|Withdrawal by Subject|1|||
148816581|NCT01177410|536803949|FG001|Overall Study|Withdrawal by Subject|4|||
148816582|NCT01177410|536803950|FG002|Overall Study|Withdrawal by Subject|3|||
148816583|NCT01177410|536803948|FG000|Overall Study|Lost to Follow-up|0|||
148816584|NCT01177410|536803949|FG001|Overall Study|Lost to Follow-up|1|||
148816585|NCT01177410|536803950|FG002|Overall Study|Lost to Follow-up|0|||
148816586|NCT05950906|536803951|FG000|Overall Study|Adverse Event|0|||
148816587|NCT05950906|536803952|FG001|Overall Study|Adverse Event|0|||
148725303|NCT02243293|536466048|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
148970606|NCT00603746|537376707|FG000|Overall Study|Lost to Follow-up|0|||
148970607|NCT00603746|537376708|FG001|Overall Study|Lost to Follow-up|1|||
148970608|NCT00603746|537376709|FG002|Overall Study|Lost to Follow-up|1|||
148970609|NCT00603746|537376710|FG003|Overall Study|Lost to Follow-up|0|||
148970610|NCT00603746|537376711|FG004|Overall Study|Lost to Follow-up|0|||
148970611|NCT00603746|537376712|FG005|Overall Study|Lost to Follow-up|0|||
148970612|NCT00603746|537376707|FG000|Overall Study|Physician Decision|1|||
148970613|NCT00603746|537376708|FG001|Overall Study|Physician Decision|0|||
148970614|NCT00603746|537376709|FG002|Overall Study|Physician Decision|0|||
148970615|NCT00603746|537376710|FG003|Overall Study|Physician Decision|0|||
148970616|NCT00603746|537376711|FG004|Overall Study|Physician Decision|1|||
148970617|NCT00603746|537376712|FG005|Overall Study|Physician Decision|0|||
148970618|NCT00603746|537376707|FG000|Overall Study|Withdrawal by Subject|1|||
148970619|NCT00603746|537376708|FG001|Overall Study|Withdrawal by Subject|0|||
148970620|NCT00603746|537376709|FG002|Overall Study|Withdrawal by Subject|0|||
148970621|NCT00603746|537376710|FG003|Overall Study|Withdrawal by Subject|1|||
148970622|NCT00603746|537376711|FG004|Overall Study|Withdrawal by Subject|3|||
148970623|NCT00603746|537376712|FG005|Overall Study|Withdrawal by Subject|1|||
148970624|NCT03323658|537376713|FG000|Overall Study|Adverse Event|0|||
148970625|NCT03323658|537376714|FG001|Overall Study|Adverse Event|1|||
148970626|NCT03323658|537376715|FG002|Overall Study|Adverse Event|0|||
148970627|NCT00615056|537376716|FG000|Overall Study|Death|31|||
148970628|NCT00615056|537376717|FG001|Overall Study|Death|31|||
148970629|NCT00615056|537376718|FG002|Overall Study|Death|21|||
148970630|NCT00615056|537376719|FG003|Overall Study|Death|23|||
148970631|NCT00615056|537376716|FG000|Overall Study|Lost to Follow-up|1|||
148970632|NCT00615056|537376717|FG001|Overall Study|Lost to Follow-up|2|||
148970633|NCT00615056|537376718|FG002|Overall Study|Lost to Follow-up|4|||
148970634|NCT00615056|537376719|FG003|Overall Study|Lost to Follow-up|5|||
148970635|NCT00615056|537376716|FG000|Overall Study|Other|13|||
148970636|NCT00615056|537376717|FG001|Overall Study|Other|15|||
148725304|NCT02243293|536466049|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
148725305|NCT02243293|536466050|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
148725306|NCT02243293|536466051|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
148725307|NCT02243293|536466052|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
148725308|NCT02243293|536466053|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
148725309|NCT02243293|536466054|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
148725310|NCT02243293|536466055|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
148725311|NCT02243293|536466056|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
148725312|NCT02243293|536466057|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
148725313|NCT02243293|536466058|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
148725314|NCT02243293|536466059|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
148725315|NCT02243293|536466060|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
148725316|NCT02243293|536466061|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
148725317|NCT02243293|536466062|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
148970637|NCT00615056|537376718|FG002|Overall Study|Other|10|||
148970638|NCT00615056|537376719|FG003|Overall Study|Other|7|||
148970639|NCT00615056|537376716|FG000|Overall Study|Objective progression or relapse|0|||
148725318|NCT02243293|536466041|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
148970640|NCT00615056|537376717|FG001|Overall Study|Objective progression or relapse|2|||
148970641|NCT00615056|537376718|FG002|Overall Study|Objective progression or relapse|0|||
148725319|NCT02243293|536466042|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
148970642|NCT00615056|537376719|FG003|Overall Study|Objective progression or relapse|0|||
148816588|NCT05950906|536803953|FG002|Overall Study|Adverse Event|0|||
148816589|NCT05950906|536803954|FG003|Overall Study|Adverse Event|0|||
148970643|NCT00615056|537376716|FG000|Overall Study|Withdrawal by Subject|0|||
148970644|NCT00615056|537376717|FG001|Overall Study|Withdrawal by Subject|1|||
149025470|NCT02851511|537570040|FG003|Phase II|Physician Decision|0|||
148725320|NCT02243293|536466043|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
148725321|NCT02243293|536466044|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
148725322|NCT02243293|536466045|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
148725323|NCT02243293|536466046|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
148725324|NCT02243293|536466047|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
148725325|NCT02243293|536466048|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
148725326|NCT02243293|536466049|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
148725327|NCT02243293|536466050|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
148725328|NCT02243293|536466051|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
148725329|NCT02243293|536466052|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
148725330|NCT02243293|536466053|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
148725331|NCT02243293|536466054|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
148725332|NCT02243293|536466055|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
148725333|NCT02243293|536466056|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
148725334|NCT02243293|536466057|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
148725335|NCT02243293|536466058|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
148725336|NCT02243293|536466059|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
148725337|NCT02243293|536466060|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
148725338|NCT02243293|536466061|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
148725339|NCT02243293|536466062|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
148725340|NCT03069417|536466063|FG000|Overall Study|Lost to Follow-up|2|||
148725341|NCT03069417|536466064|FG001|Overall Study|Lost to Follow-up|0|||
148725342|NCT03069417|536466063|FG000|Overall Study|Reason Unknown|4|||
148725343|NCT03069417|536466064|FG001|Overall Study|Reason Unknown|7|||
148725344|NCT00440115|536466065|FG000|Overall Study|Death|7|||
148725345|NCT00440115|536466066|FG001|Overall Study|Death|9|||
148725346|NCT00440115|536466067|FG002|Overall Study|Death|5|||
148725347|NCT00440115|536466065|FG000|Overall Study|Incarceration|0|||
148725348|NCT00440115|536466066|FG001|Overall Study|Incarceration|2|||
148725349|NCT00440115|536466067|FG002|Overall Study|Incarceration|1|||
148725350|NCT02377063|536466068|FG000|Overall Study|Non-compliance|5|||
148725351|NCT01524913|536466069|FG000|Overall Study|Lost to Follow-up|4|||
148816590|NCT05950906|536803955|FG004|Overall Study|Adverse Event|0|||
148725352|NCT01524913|536466070|FG001|Overall Study|Lost to Follow-up|0|||
148725353|NCT01524913|536466071|FG002|Overall Study|Lost to Follow-up|0|||
149025471|NCT02851511|537570037|FG000|Phase II|Withdrawal by Subject|18|||
149025472|NCT02851511|537570038|FG001|Phase II|Withdrawal by Subject|16|||
149025473|NCT02851511|537570039|FG002|Phase II|Withdrawal by Subject|0|||
149025474|NCT02851511|537570040|FG003|Phase II|Withdrawal by Subject|0|||
149025475|NCT02851511|537570037|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
149025476|NCT02851511|537570038|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
149025477|NCT02851511|537570039|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
149025478|NCT02851511|537570040|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
149025479|NCT02851511|537570037|FG000|Phase II|Lost to Follow-up|0|||
149025480|NCT02851511|537570038|FG001|Phase II|Lost to Follow-up|1|||
148970645|NCT00615056|537376718|FG002|Overall Study|Withdrawal by Subject|1|||
148970646|NCT00615056|537376719|FG003|Overall Study|Withdrawal by Subject|0|||
148970647|NCT00615056|537376716|FG000|Overall Study|Discontinued by Sponsor|1|||
148970648|NCT00615056|537376717|FG001|Overall Study|Discontinued by Sponsor|0|||
148970649|NCT00615056|537376718|FG002|Overall Study|Discontinued by Sponsor|0|||
148970650|NCT00615056|537376719|FG003|Overall Study|Discontinued by Sponsor|0|||
148970651|NCT00615056|537376716|FG000|Overall Study|Randomized but not treated|3|||
148970652|NCT00615056|537376717|FG001|Overall Study|Randomized but not treated|0|||
148970653|NCT00615056|537376718|FG002|Overall Study|Randomized but not treated|0|||
148970654|NCT00615056|537376719|FG003|Overall Study|Randomized but not treated|0|||
148970655|NCT02357147|537376727|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
148970656|NCT02357147|537376728|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
148970657|NCT02357147|537376727|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
148970658|NCT02357147|537376728|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
148970659|NCT02357147|537376727|FG000|Combination Treatment Phase|Investigator Discretion|1|||
148970660|NCT02357147|537376728|FG001|Combination Treatment Phase|Investigator Discretion|1|||
148970661|NCT02357147|537376727|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
148970662|NCT02357147|537376728|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
148970663|NCT02357147|537376727|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
148970664|NCT02357147|537376728|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
148970665|NCT02357147|537376727|FG000|Combination Treatment Phase|Adverse Event|12|||
148970666|NCT02357147|537376728|FG001|Combination Treatment Phase|Adverse Event|4|||
148970667|NCT02357147|537376727|FG000|Combination Treatment Phase|Death|1|||
148970668|NCT02357147|537376728|FG001|Combination Treatment Phase|Death|1|||
148970669|NCT02357147|537376727|FG000|Combination Treatment Phase|Sponsor Decision|0|||
148970670|NCT02357147|537376728|FG001|Combination Treatment Phase|Sponsor Decision|12|||
148970671|NCT02357147|537376727|FG000|Combination Treatment Phase|Other|1|||
148970672|NCT02357147|537376728|FG001|Combination Treatment Phase|Other|0|||
148970673|NCT02357147|537376727|FG000|Combination Treatment Phase|Not treated|0|||
148970674|NCT02357147|537376728|FG001|Combination Treatment Phase|Not treated|2|||
148970675|NCT02357147|537376727|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
148970676|NCT02357147|537376728|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
148970677|NCT02357147|537376727|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
148970678|NCT02357147|537376728|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
148970679|NCT02357147|537376727|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
148970680|NCT02357147|537376728|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
148970681|NCT02357147|537376727|FG000|Maintenance Treatment Phase|Adverse Event|0|||
148970682|NCT02357147|537376728|FG001|Maintenance Treatment Phase|Adverse Event|3|||
148970683|NCT02357147|537376727|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
148970684|NCT02357147|537376728|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
148970685|NCT02357147|537376727|FG000|Maintenance Treatment Phase|Not Treated|1|||
148970686|NCT02357147|537376728|FG001|Maintenance Treatment Phase|Not Treated|0|||
148970687|NCT02970968|537378079|FG000|Overall Study|Withdrawal by Subject|3|||
148970688|NCT02970968|537378080|FG001|Overall Study|Withdrawal by Subject|3|||
148970689|NCT02970968|537378079|FG000|Overall Study|Adverse Event|1|||
148970690|NCT02970968|537378080|FG001|Overall Study|Adverse Event|2|||
148970691|NCT02970968|537378079|FG000|Overall Study|Lost to Follow-up|1|||
148970692|NCT02970968|537378080|FG001|Overall Study|Lost to Follow-up|1|||
148970693|NCT02970968|537378079|FG000|Overall Study|Non-Compliance|0|||
148970694|NCT02970968|537378080|FG001|Overall Study|Non-Compliance|1|||
148970695|NCT02565381|537378081|FG000|Overall Study|Lost to Follow-up|1|||
149025481|NCT02851511|537570039|FG002|Phase II|Lost to Follow-up|0|||
149025482|NCT02851511|537570040|FG003|Phase II|Lost to Follow-up|0|||
149025483|NCT00051311|537570041|FG000|Overall Study|Starting new study|0|||
149025484|NCT00051311|537570042|FG001|Overall Study|Starting new study|1|||
149025485|NCT00051311|537570041|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
149025486|NCT00051311|537570042|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
149025487|NCT00051311|537570041|FG000|Overall Study|Death of recipient|8|||
149025488|NCT00051311|537570042|FG001|Overall Study|Death of recipient|8|||
149025489|NCT00051311|537570041|FG000|Overall Study|Recipient taken off study|4|||
149025490|NCT00051311|537570042|FG001|Overall Study|Recipient taken off study|4|||
149025491|NCT02256969|537570043|FG000|Overall Study|Screenfailed or withdrew|2|||
149025492|NCT02256969|537570044|FG001|Overall Study|Screenfailed or withdrew|1|||
149025493|NCT02256969|537570045|FG002|Overall Study|Screenfailed or withdrew|1|||
149025494|NCT00953160|537570046|FG000|Overall Study|Lost to Follow-up|23|||
149025495|NCT00953160|537570046|FG000|Overall Study|Withdrawal by Subject|4|||
149025496|NCT01427907|537570047|FG000|Overall Study|Withdrawal by Subject|3|||
149025497|NCT01427907|537570048|FG001|Overall Study|Withdrawal by Subject|4|||
149025498|NCT04337489|537570049|FG000|Overall Study|Withdrawal by Subject|1|||
149025499|NCT00335153|537570054|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
149025500|NCT00335153|537570054|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
149025501|NCT00335153|537570054|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
149025502|NCT00335153|537570054|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
149025503|NCT00335153|537570054|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
149025504|NCT00335153|537570054|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
149025505|NCT00335153|537570054|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
149025506|NCT00335153|537570054|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
149025507|NCT00335153|537570054|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
149025508|NCT00335153|537570054|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
149025509|NCT01113463|537570059|FG000|Overall Study|Physician Decision|5|||
149025510|NCT02478359|537570061|FG000|Overall Study|Disenrolled from health plan|106|||
149025511|NCT02478359|537570062|FG001|Overall Study|Disenrolled from health plan|65|||
149025512|NCT02412761|537570063|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149025513|NCT02412761|537570064|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
148816591|NCT05950906|536803956|FG005|Overall Study|Adverse Event|0|||
148970696|NCT02565381|537378082|FG001|Overall Study|Lost to Follow-up|0|||
148970697|NCT02565381|537378083|FG002|Overall Study|Lost to Follow-up|1|||
148970698|NCT01904604|537378084|FG000|Overall Study|Withdrew before receiving dosing|0|||
148970699|NCT01904604|537378085|FG001|Overall Study|Withdrew before receiving dosing|1|||
148970700|NCT01904604|537378086|FG002|Overall Study|Withdrew before receiving dosing|0|||
148970701|NCT01904604|537378084|FG000|Overall Study|Non-compliance|1|||
148970702|NCT01904604|537378085|FG001|Overall Study|Non-compliance|0|||
148970703|NCT01904604|537378086|FG002|Overall Study|Non-compliance|0|||
148970704|NCT01904604|537378084|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
148970705|NCT01904604|537378085|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
148970706|NCT01904604|537378086|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
148970707|NCT01904604|537378084|FG000|Overall Study|Patch site reactions|1|||
148970708|NCT01904604|537378085|FG001|Overall Study|Patch site reactions|1|||
148970709|NCT01904604|537378086|FG002|Overall Study|Patch site reactions|0|||
148970710|NCT01904604|537378084|FG000|Overall Study|Increased syncope|0|||
148970711|NCT01904604|537378085|FG001|Overall Study|Increased syncope|1|||
148970712|NCT01904604|537378086|FG002|Overall Study|Increased syncope|0|||
148970713|NCT01904604|537378084|FG000|Overall Study|Unrelated illness|0|||
148970714|NCT01904604|537378085|FG001|Overall Study|Unrelated illness|1|||
148970715|NCT01904604|537378086|FG002|Overall Study|Unrelated illness|0|||
148970716|NCT01904604|537378084|FG000|Overall Study|Passed Week 52 OFC|1|||
148970717|NCT01904604|537378085|FG001|Overall Study|Passed Week 52 OFC|0|||
148970718|NCT01904604|537378086|FG002|Overall Study|Passed Week 52 OFC|0|||
148970719|NCT01904604|537378084|FG000|Overall Study|Withdrawal by Subject|1|||
148970720|NCT01904604|537378085|FG001|Overall Study|Withdrawal by Subject|2|||
148970721|NCT01904604|537378086|FG002|Overall Study|Withdrawal by Subject|0|||
148970722|NCT01904604|537378084|FG000|Overall Study|Participant Relocated|1|||
148970723|NCT01904604|537378085|FG001|Overall Study|Participant Relocated|1|||
148970724|NCT01904604|537378086|FG002|Overall Study|Participant Relocated|1|||
149025514|NCT02412761|537570065|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
149025515|NCT02412761|537570066|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149025516|NCT02412761|537570067|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149025517|NCT02412761|537570068|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
149025518|NCT01818700|537570069|FG000|Overall Study|Adverse Event|67|||
149025519|NCT01818700|537570069|FG000|Overall Study|Lack of Efficacy|2|||
148970725|NCT01904604|537378084|FG000|Overall Study|Lost to Follow-up|0|||
148970726|NCT01904604|537378085|FG001|Overall Study|Lost to Follow-up|0|||
148970727|NCT01904604|537378086|FG002|Overall Study|Lost to Follow-up|1|||
148970728|NCT01945489|537378087|FG000|Cycle 1|Adverse Event|2|||
148970729|NCT01945489|537378088|FG001|Cycle 1|Adverse Event|0|||
148816592|NCT05950906|536803957|FG006|Overall Study|Adverse Event|0|||
148816593|NCT05950906|536803958|FG007|Overall Study|Adverse Event|0|||
148816594|NCT05950906|536803959|FG008|Overall Study|Adverse Event|0|||
148816595|NCT05950906|536803960|FG009|Overall Study|Adverse Event|0|||
148816596|NCT05950906|536803961|FG010|Overall Study|Adverse Event|0|||
148816597|NCT05950906|536803962|FG011|Overall Study|Adverse Event|0|||
148816598|NCT05950906|536803963|FG012|Overall Study|Adverse Event|1|||
148816599|NCT05950906|536803964|FG013|Overall Study|Adverse Event|0|||
148816600|NCT05950906|536803951|FG000|Overall Study|Physician Decision|0|||
148816601|NCT05950906|536803952|FG001|Overall Study|Physician Decision|0|||
148816602|NCT05950906|536803953|FG002|Overall Study|Physician Decision|0|||
148816603|NCT05950906|536803954|FG003|Overall Study|Physician Decision|0|||
148816604|NCT05950906|536803955|FG004|Overall Study|Physician Decision|0|||
148816605|NCT05950906|536803956|FG005|Overall Study|Physician Decision|0|||
148816606|NCT05950906|536803957|FG006|Overall Study|Physician Decision|0|||
148816607|NCT05950906|536803958|FG007|Overall Study|Physician Decision|0|||
148816608|NCT05950906|536803959|FG008|Overall Study|Physician Decision|0|||
148816609|NCT05950906|536803960|FG009|Overall Study|Physician Decision|0|||
148816610|NCT05950906|536803961|FG010|Overall Study|Physician Decision|0|||
148816611|NCT05950906|536803962|FG011|Overall Study|Physician Decision|0|||
148816612|NCT05950906|536803963|FG012|Overall Study|Physician Decision|1|||
148816613|NCT05950906|536803964|FG013|Overall Study|Physician Decision|0|||
148816614|NCT03142750|536803970|FG000|Overall Study|Lost to Follow-up|4|||
148816615|NCT03142750|536803971|FG001|Overall Study|Lost to Follow-up|1|||
148816616|NCT02942407|536803972|FG000|Overall Study|Lost to Follow-up|3|||
148816617|NCT02942407|536803973|FG001|Overall Study|Lost to Follow-up|2|||
148816618|NCT02942407|536803972|FG000|Overall Study|Withdrawal by Subject|7|||
148816619|NCT02942407|536803973|FG001|Overall Study|Withdrawal by Subject|9|||
148816620|NCT02942407|536803972|FG000|Overall Study|Death|16|||
148816621|NCT02942407|536803973|FG001|Overall Study|Death|13|||
148816622|NCT00933166|536803974|FG000|Overall Study|Lost to Follow-up|4|||
148816623|NCT00933166|536803974|FG000|Overall Study|Lack of Efficacy|9|||
148816624|NCT00933166|536803974|FG000|Overall Study|Unavailable|4|||
148816625|NCT00933166|536803974|FG000|Overall Study|Withdrawal by Subject|1|||
148816626|NCT04618471|536803975|FG000|Overall Study|Screen Failure|62|||
148816627|NCT04618471|536803975|FG000|Overall Study|Withdrawal by Subject|6|||
148816628|NCT04618471|536803975|FG000|Overall Study|Physician Decision|2|||
148816629|NCT04618471|536803975|FG000|Overall Study|Lost to Follow-up|1|||
148816630|NCT04618471|536803975|FG000|Overall Study|Various other reasons|2|||
148888890|NCT02159066|537072253|FG000|Part I|Termination of participants from the study|3|||
148888891|NCT02159066|537072254|FG001|Part I|Termination of participants from the study|3|||
148970730|NCT01945489|537378087|FG000|Cycle 1|Lost to Follow-up|4|||
148970731|NCT01945489|537378088|FG001|Cycle 1|Lost to Follow-up|0|||
148970732|NCT01945489|537378087|FG000|Cycle 1|Personal Reasons|4|||
148970733|NCT01945489|537378088|FG001|Cycle 1|Personal Reasons|2|||
148970734|NCT01945489|537378087|FG000|Cycle 1|Protocol Violation|0|||
148970735|NCT01945489|537378088|FG001|Cycle 1|Protocol Violation|1|||
148970736|NCT01945489|537378087|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
148970737|NCT01945489|537378088|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
148970738|NCT01945489|537378087|FG000|Cycle 2|Adverse Event|1|||
148970739|NCT01945489|537378088|FG001|Cycle 2|Adverse Event|0|||
148970740|NCT01945489|537378087|FG000|Cycle 2|Lost to Follow-up|0|||
148970741|NCT01945489|537378088|FG001|Cycle 2|Lost to Follow-up|1|||
148970742|NCT04144166|537378092|FG000|Overall Study|Discharged before study start|1|||
148970743|NCT04144166|537378092|FG000|Overall Study|Pregnancy|1|||
148970744|NCT04144166|537378092|FG000|Overall Study|Nail polish could not be removed from finger|1|||
148888892|NCT02159066|537072255|FG002|Part I|Termination of participants from the study|0|||
148888893|NCT02159066|537072256|FG003|Part I|Termination of participants from the study|0|||
148888894|NCT02159066|537072257|FG004|Part I|Termination of participants from the study|0|||
148888895|NCT02159066|537072258|FG005|Part I|Termination of participants from the study|0|||
148888896|NCT02159066|537072253|FG000|Part I|Physician Decision|2|||
148888897|NCT02159066|537072254|FG001|Part I|Physician Decision|9|||
148888898|NCT02159066|537072255|FG002|Part I|Physician Decision|0|||
148888899|NCT02159066|537072256|FG003|Part I|Physician Decision|0|||
148888900|NCT02159066|537072257|FG004|Part I|Physician Decision|0|||
148888901|NCT02159066|537072258|FG005|Part I|Physician Decision|0|||
148888902|NCT02159066|537072253|FG000|Part I|Participant/Guardian Decision|9|||
148888903|NCT02159066|537072254|FG001|Part I|Participant/Guardian Decision|3|||
148888904|NCT02159066|537072255|FG002|Part I|Participant/Guardian Decision|0|||
148888905|NCT02159066|537072256|FG003|Part I|Participant/Guardian Decision|0|||
148888906|NCT02159066|537072257|FG004|Part I|Participant/Guardian Decision|0|||
148888907|NCT02159066|537072258|FG005|Part I|Participant/Guardian Decision|0|||
148888908|NCT02159066|537072253|FG000|Part I|Missing Data|1|||
148888909|NCT02159066|537072254|FG001|Part I|Missing Data|0|||
148888910|NCT02159066|537072255|FG002|Part I|Missing Data|0|||
148888911|NCT02159066|537072256|FG003|Part I|Missing Data|0|||
148888912|NCT02159066|537072257|FG004|Part I|Missing Data|0|||
148888913|NCT02159066|537072258|FG005|Part I|Missing Data|0|||
148888914|NCT02159066|537072253|FG000|Part II|Adverse Event|0|||
148888915|NCT02159066|537072254|FG001|Part II|Adverse Event|0|||
148888916|NCT02159066|537072255|FG002|Part II|Adverse Event|1|||
148888917|NCT02159066|537072256|FG003|Part II|Adverse Event|0|||
148888918|NCT02159066|537072257|FG004|Part II|Adverse Event|1|||
148888919|NCT02159066|537072258|FG005|Part II|Adverse Event|1|||
148888920|NCT02159066|537072253|FG000|Part II|Death|0|||
148888921|NCT02159066|537072254|FG001|Part II|Death|0|||
148888922|NCT02159066|537072255|FG002|Part II|Death|1|||
148888923|NCT02159066|537072256|FG003|Part II|Death|0|||
148888924|NCT02159066|537072257|FG004|Part II|Death|2|||
148888925|NCT02159066|537072258|FG005|Part II|Death|1|||
148888926|NCT02159066|537072253|FG000|Part II|Progressive Disease|0|||
148888927|NCT02159066|537072254|FG001|Part II|Progressive Disease|0|||
148888928|NCT02159066|537072255|FG002|Part II|Progressive Disease|35|||
148888929|NCT02159066|537072256|FG003|Part II|Progressive Disease|1|||
148888930|NCT02159066|537072257|FG004|Part II|Progressive Disease|7|||
148888931|NCT02159066|537072258|FG005|Part II|Progressive Disease|4|||
148888932|NCT02159066|537072253|FG000|Part II|New Therapy for Study Indication|0|||
148888933|NCT02159066|537072254|FG001|Part II|New Therapy for Study Indication|0|||
148888934|NCT02159066|537072255|FG002|Part II|New Therapy for Study Indication|0|||
148888935|NCT02159066|537072256|FG003|Part II|New Therapy for Study Indication|0|||
148888936|NCT02159066|537072257|FG004|Part II|New Therapy for Study Indication|1|||
148888937|NCT02159066|537072258|FG005|Part II|New Therapy for Study Indication|0|||
148888938|NCT02159066|537072253|FG000|Part II|Physician Decision|0|||
148888939|NCT02159066|537072254|FG001|Part II|Physician Decision|0|||
148888940|NCT02159066|537072255|FG002|Part II|Physician Decision|1|||
148888941|NCT02159066|537072256|FG003|Part II|Physician Decision|0|||
148888942|NCT02159066|537072257|FG004|Part II|Physician Decision|0|||
148725354|NCT00702208|536466072|FG000|Overall Study|Lost to Follow-up|28|||
148725355|NCT00702208|536466072|FG000|Overall Study|Did not self-lavage|1|||
148725356|NCT00702208|536466072|FG000|Overall Study|Unsatisfactory colposcopy|2|||
148725357|NCT00402025|536466074|FG000|Overall Study|Adverse Event|0|||
148725358|NCT00402025|536466075|FG001|Overall Study|Adverse Event|0|||
148725359|NCT00402025|536466076|FG002|Overall Study|Adverse Event|2|||
148725360|NCT00402025|536466074|FG000|Overall Study|Death|0|||
148725361|NCT00402025|536466075|FG001|Overall Study|Death|1|||
148816631|NCT04618471|536803975|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
148816632|NCT05774977|536803978|FG000|Overall Study|Withdrawal by Subject|2|||
148816633|NCT00374868|536803979|FG000|Overall Study|Adverse Event|12|||
148816634|NCT00374868|536803979|FG000|Overall Study|Progressive Disease|7|||
148816635|NCT00374868|536803979|FG000|Overall Study|Physician Decision|13|||
148816636|NCT00374868|536803979|FG000|Overall Study|Lost to Follow-up|1|||
148816637|NCT00374868|536803979|FG000|Overall Study|Death|2|||
148816638|NCT00374868|536803979|FG000|Overall Study|Other - Not Specified|1|||
148970745|NCT00697346|537378093|FG000|Overall Study|Adverse Event|4|||
148725362|NCT00402025|536466076|FG002|Overall Study|Death|5|||
148725363|NCT00402025|536466074|FG000|Overall Study|Disease Progression|1|||
149025520|NCT01818700|537570069|FG000|Overall Study|Lost to Follow-up|5|||
149025521|NCT01818700|537570069|FG000|Overall Study|Withdrawal by Subject|27|||
149025522|NCT01818700|537570069|FG000|Overall Study|Protocol Violation|2|||
149025523|NCT01818700|537570069|FG000|Overall Study|Other|1|||
149025524|NCT01417000|537570070|FG000|Overall Study|Death|59|||
149025525|NCT01417000|537570071|FG001|Overall Study|Death|28|||
149025526|NCT01417000|537570070|FG000|Overall Study|Lost to Follow-up|1|||
149025527|NCT01417000|537570071|FG001|Overall Study|Lost to Follow-up|0|||
149025528|NCT01417000|537570070|FG000|Overall Study|Study Terminated by Sponsor|1|||
149025529|NCT01417000|537570071|FG001|Overall Study|Study Terminated by Sponsor|1|||
149025530|NCT00958009|537570072|FG000|Overall Study|Adverse Event|1|||
149025531|NCT00958009|537570072|FG000|Overall Study|Subject found device difficult to use|1|||
149025532|NCT03379233|537570075|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
149025533|NCT03379233|537570076|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
149025534|NCT00848211|537570077|FG000|Overall Study|Protocol Violation|0|||
149025535|NCT00848211|537570078|FG001|Overall Study|Protocol Violation|1|||
149025536|NCT00848211|537570079|FG002|Overall Study|Protocol Violation|1|||
149025537|NCT00848211|537570080|FG003|Overall Study|Protocol Violation|0|||
149025538|NCT00848211|537570077|FG000|Overall Study|Adverse Event|0|||
149025539|NCT00848211|537570078|FG001|Overall Study|Adverse Event|0|||
149025540|NCT00848211|537570079|FG002|Overall Study|Adverse Event|0|||
148725364|NCT00402025|536466075|FG001|Overall Study|Disease Progression|1|||
148725365|NCT00402025|536466076|FG002|Overall Study|Disease Progression|2|||
148725366|NCT00402025|536466074|FG000|Overall Study|Physician Decision|1|||
148725367|NCT00402025|536466075|FG001|Overall Study|Physician Decision|1|||
148725368|NCT00402025|536466076|FG002|Overall Study|Physician Decision|0|||
148725369|NCT00402025|536466074|FG000|Overall Study|Participant Decision|0|||
148725370|NCT00402025|536466075|FG001|Overall Study|Participant Decision|0|||
148725371|NCT00402025|536466076|FG002|Overall Study|Participant Decision|1|||
148725372|NCT01172821|536466086|FG000|Overall Study|Adverse Event|5|||
148725373|NCT01172821|536466087|FG001|Overall Study|Adverse Event|2|||
148725374|NCT01172821|536466088|FG002|Overall Study|Adverse Event|2|||
148725375|NCT01172821|536466089|FG003|Overall Study|Adverse Event|7|||
148725376|NCT01172821|536466086|FG000|Overall Study|Protocol Violation|0|||
148725377|NCT01172821|536466087|FG001|Overall Study|Protocol Violation|2|||
148725378|NCT01172821|536466088|FG002|Overall Study|Protocol Violation|1|||
148725379|NCT01172821|536466089|FG003|Overall Study|Protocol Violation|2|||
148725380|NCT01172821|536466086|FG000|Overall Study|Lost to Follow-up|4|||
148725381|NCT01172821|536466087|FG001|Overall Study|Lost to Follow-up|1|||
148725382|NCT01172821|536466088|FG002|Overall Study|Lost to Follow-up|2|||
148725383|NCT01172821|536466089|FG003|Overall Study|Lost to Follow-up|2|||
148725384|NCT01172821|536466086|FG000|Overall Study|Withdrawal by Subject|2|||
148725385|NCT01172821|536466087|FG001|Overall Study|Withdrawal by Subject|3|||
148725386|NCT01172821|536466088|FG002|Overall Study|Withdrawal by Subject|3|||
148725387|NCT01172821|536466089|FG003|Overall Study|Withdrawal by Subject|3|||
148725388|NCT01172821|536466086|FG000|Overall Study|Other|3|||
148725389|NCT01172821|536466087|FG001|Overall Study|Other|4|||
148725390|NCT01172821|536466088|FG002|Overall Study|Other|5|||
148725391|NCT01172821|536466089|FG003|Overall Study|Other|3|||
148725392|NCT01432574|536468095|FG000|Overall Study|Moved|2|||
148725393|NCT01432574|536468095|FG000|Overall Study|Not interested|1|||
148725394|NCT02516410|536468096|FG000|Overall Study|Adverse Event|0|||
148725395|NCT02516410|536468097|FG001|Overall Study|Adverse Event|1|||
148725396|NCT02516410|536468096|FG000|Overall Study|Withdrawal by Subject|0|||
148725397|NCT02516410|536468097|FG001|Overall Study|Withdrawal by Subject|1|||
148725398|NCT01475253|536468102|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
148725399|NCT01475253|536468103|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
148725400|NCT01475253|536468104|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
148725401|NCT01475253|536468105|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
148725402|NCT01475253|536468102|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
148725403|NCT01475253|536468103|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
148725404|NCT01475253|536468104|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
148725405|NCT01475253|536468105|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
148725406|NCT03135899|536468106|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725407|NCT03135899|536468107|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725408|NCT03135899|536468108|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725409|NCT03135899|536468109|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725410|NCT03135899|536468110|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725411|NCT03135899|536468111|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725412|NCT03135899|536468112|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
148725413|NCT03135899|536468113|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
148725414|NCT03135899|536468106|FG000|Overall Study|Withdrawal by Subject|0|||
148725415|NCT03135899|536468107|FG001|Overall Study|Withdrawal by Subject|0|||
148725416|NCT03135899|536468108|FG002|Overall Study|Withdrawal by Subject|0|||
149025541|NCT00848211|537570080|FG003|Overall Study|Adverse Event|0|||
148725417|NCT03135899|536468109|FG003|Overall Study|Withdrawal by Subject|0|||
149025542|NCT01124617|537570081|FG000|Overall Study|Adverse Event|5|||
148725418|NCT03135899|536468110|FG004|Overall Study|Withdrawal by Subject|0|||
148725419|NCT03135899|536468111|FG005|Overall Study|Withdrawal by Subject|2|||
148725420|NCT03135899|536468112|FG006|Overall Study|Withdrawal by Subject|0|||
148725421|NCT03135899|536468113|FG007|Overall Study|Withdrawal by Subject|0|||
148725422|NCT04146363|536468114|FG000|Induction Period|Adverse Event|1|||
148725423|NCT04146363|536468115|FG001|Induction Period|Adverse Event|2|||
148725424|NCT04146363|536468116|FG002|Induction Period|Adverse Event|0|||
148725425|NCT04146363|536468117|FG003|Induction Period|Adverse Event|0|||
148725426|NCT04146363|536468118|FG004|Induction Period|Adverse Event|0|||
148725427|NCT04146363|536468119|FG005|Induction Period|Adverse Event|0|||
148725428|NCT04146363|536468120|FG006|Induction Period|Adverse Event|0|||
148970746|NCT00697346|537378094|FG001|Overall Study|Adverse Event|5|||
148970747|NCT00697346|537378095|FG002|Overall Study|Adverse Event|0|||
148970748|NCT00697346|537378093|FG000|Overall Study|Progressive Disease|19|||
148970749|NCT00697346|537378094|FG001|Overall Study|Progressive Disease|18|||
148970750|NCT00697346|537378095|FG002|Overall Study|Progressive Disease|0|||
148970751|NCT00697346|537378093|FG000|Overall Study|Symptomatic Deterioration|0|||
148970752|NCT00697346|537378094|FG001|Overall Study|Symptomatic Deterioration|1|||
148970753|NCT00697346|537378095|FG002|Overall Study|Symptomatic Deterioration|0|||
148970754|NCT00697346|537378093|FG000|Overall Study|Withdrawal by Subject|2|||
148970755|NCT00697346|537378094|FG001|Overall Study|Withdrawal by Subject|2|||
148970756|NCT00697346|537378095|FG002|Overall Study|Withdrawal by Subject|0|||
148970757|NCT00697346|537378093|FG000|Overall Study|Reason not Specified|3|||
148970758|NCT00697346|537378094|FG001|Overall Study|Reason not Specified|0|||
148970759|NCT00697346|537378095|FG002|Overall Study|Reason not Specified|1|||
148970760|NCT03643562|537378096|FG000|Overall Study|Adverse Event|1|||
148970761|NCT03643562|537378097|FG001|Overall Study|Adverse Event|0|||
148970762|NCT03643562|537378096|FG000|Overall Study|Lack of Efficacy|0|||
148970763|NCT03643562|537378097|FG001|Overall Study|Lack of Efficacy|1|||
148970764|NCT03643562|537378096|FG000|Overall Study|Physician Decision|0|||
148970765|NCT03643562|537378097|FG001|Overall Study|Physician Decision|1|||
148970766|NCT03643562|537378096|FG000|Overall Study|Study Terminated by Sponsor|2|||
148970767|NCT03643562|537378097|FG001|Overall Study|Study Terminated by Sponsor|10|||
148970768|NCT03643562|537378096|FG000|Overall Study|Withdrawal by Subject|2|||
148970769|NCT03643562|537378097|FG001|Overall Study|Withdrawal by Subject|2|||
148970770|NCT03643562|537378096|FG000|Overall Study|Other than specified|3|||
148970771|NCT03643562|537378097|FG001|Overall Study|Other than specified|2|||
148970772|NCT04145895|537378098|FG000|Overall Study|Physician Decision|2|||
148970773|NCT04145895|537378099|FG001|Overall Study|Physician Decision|0|||
148970774|NCT04145895|537378098|FG000|Overall Study|Withdrawal by Subject|0|||
148970775|NCT04145895|537378099|FG001|Overall Study|Withdrawal by Subject|2|||
148970776|NCT01236755|537378100|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
148970777|NCT01236755|537378100|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
148970778|NCT01236755|537378100|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
148970779|NCT01236755|537378100|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
148970780|NCT01481116|537378101|FG000|Overall Study|Adverse Event|26|||
148970781|NCT01481116|537378102|FG001|Overall Study|Adverse Event|26|||
148970782|NCT01481116|537378103|FG002|Overall Study|Adverse Event|42|||
148970783|NCT01481116|537378101|FG000|Overall Study|Major Protocol Deviation|3|||
148970784|NCT01481116|537378102|FG001|Overall Study|Major Protocol Deviation|7|||
148970785|NCT01481116|537378103|FG002|Overall Study|Major Protocol Deviation|1|||
148970786|NCT01481116|537378101|FG000|Overall Study|Lost to Follow-up|8|||
148725429|NCT04146363|536468121|FG007|Induction Period|Adverse Event|0|||
148725430|NCT04146363|536468122|FG008|Induction Period|Adverse Event|0|||
148725431|NCT04146363|536468123|FG009|Induction Period|Adverse Event|0|||
148725432|NCT04146363|536468124|FG010|Induction Period|Adverse Event|0|||
148725433|NCT04146363|536468114|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
148725434|NCT04146363|536468115|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
148725435|NCT04146363|536468116|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
148725436|NCT04146363|536468117|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
148970787|NCT01481116|537378102|FG001|Overall Study|Lost to Follow-up|12|||
148970788|NCT01481116|537378103|FG002|Overall Study|Lost to Follow-up|11|||
148725437|NCT04146363|536468118|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
148725438|NCT04146363|536468119|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
148725439|NCT04146363|536468120|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
148970789|NCT01481116|537378101|FG000|Overall Study|Withdrawal by Subject|37|||
148970790|NCT01481116|537378102|FG001|Overall Study|Withdrawal by Subject|33|||
148970791|NCT01481116|537378103|FG002|Overall Study|Withdrawal by Subject|37|||
148725440|NCT04146363|536468121|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
148970792|NCT01481116|537378101|FG000|Overall Study|Study Termination|730|||
148725441|NCT04146363|536468122|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
148970793|NCT01481116|537378102|FG001|Overall Study|Study Termination|729|||
148970794|NCT01481116|537378103|FG002|Overall Study|Study Termination|713|||
148970795|NCT01481116|537378101|FG000|Overall Study|Pregnancy|0|||
148970796|NCT01481116|537378102|FG001|Overall Study|Pregnancy|0|||
148970797|NCT01481116|537378103|FG002|Overall Study|Pregnancy|1|||
148970798|NCT01481116|537378101|FG000|Overall Study|Lack of Efficacy|3|||
148970799|NCT01481116|537378102|FG001|Overall Study|Lack of Efficacy|3|||
149025543|NCT01124617|537570082|FG001|Overall Study|Adverse Event|2|||
149025544|NCT01124617|537570081|FG000|Overall Study|Lack of Efficacy|2|||
149025545|NCT01124617|537570082|FG001|Overall Study|Lack of Efficacy|1|||
149025546|NCT01124617|537570081|FG000|Overall Study|Protocol Violation|1|||
149025547|NCT01124617|537570082|FG001|Overall Study|Protocol Violation|1|||
149025548|NCT01124617|537570081|FG000|Overall Study|Withdrawal by Subject|9|||
149025549|NCT01124617|537570082|FG001|Overall Study|Withdrawal by Subject|1|||
148725442|NCT04146363|536468123|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
148725443|NCT04146363|536468124|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
148725444|NCT04146363|536468114|FG000|Induction Period|Lack of Efficacy|7|||
148725445|NCT04146363|536468115|FG001|Induction Period|Lack of Efficacy|2|||
148725446|NCT04146363|536468116|FG002|Induction Period|Lack of Efficacy|0|||
148725447|NCT04146363|536468117|FG003|Induction Period|Lack of Efficacy|0|||
148725448|NCT04146363|536468118|FG004|Induction Period|Lack of Efficacy|0|||
148725449|NCT04146363|536468119|FG005|Induction Period|Lack of Efficacy|0|||
148725450|NCT04146363|536468120|FG006|Induction Period|Lack of Efficacy|0|||
148725451|NCT04146363|536468121|FG007|Induction Period|Lack of Efficacy|0|||
148725452|NCT04146363|536468122|FG008|Induction Period|Lack of Efficacy|0|||
148970800|NCT01481116|537378103|FG002|Overall Study|Lack of Efficacy|1|||
148970801|NCT01481116|537378101|FG000|Overall Study|Contraindications|1|||
148970802|NCT01481116|537378102|FG001|Overall Study|Contraindications|1|||
148970803|NCT01481116|537378103|FG002|Overall Study|Contraindications|0|||
148970804|NCT01481116|537378101|FG000|Overall Study|Other|1|||
148970805|NCT01481116|537378102|FG001|Overall Study|Other|1|||
148970806|NCT01481116|537378103|FG002|Overall Study|Other|0|||
148970807|NCT01481116|537378101|FG000|Overall Study|Participant Started Taking Glipizide|1|||
148970808|NCT01481116|537378102|FG001|Overall Study|Participant Started Taking Glipizide|0|||
148970809|NCT01481116|537378103|FG002|Overall Study|Participant Started Taking Glipizide|0|||
148970810|NCT01481116|537378101|FG000|Overall Study|Participant Moved Out of Area|2|||
148970811|NCT01481116|537378102|FG001|Overall Study|Participant Moved Out of Area|0|||
148970812|NCT01481116|537378103|FG002|Overall Study|Participant Moved Out of Area|1|||
148970813|NCT01481116|537378101|FG000|Overall Study|Participant Moved Out of Country|1|||
148970814|NCT01481116|537378102|FG001|Overall Study|Participant Moved Out of Country|0|||
148970815|NCT01481116|537378103|FG002|Overall Study|Participant Moved Out of Country|1|||
148725453|NCT04146363|536468123|FG009|Induction Period|Lack of Efficacy|0|||
148725454|NCT04146363|536468124|FG010|Induction Period|Lack of Efficacy|0|||
148725455|NCT04146363|536468114|FG000|Induction Period|Lost to Follow-up|1|||
148725456|NCT04146363|536468115|FG001|Induction Period|Lost to Follow-up|4|||
148725457|NCT04146363|536468116|FG002|Induction Period|Lost to Follow-up|0|||
148725458|NCT04146363|536468117|FG003|Induction Period|Lost to Follow-up|0|||
148725459|NCT04146363|536468118|FG004|Induction Period|Lost to Follow-up|0|||
148725460|NCT04146363|536468119|FG005|Induction Period|Lost to Follow-up|0|||
148725461|NCT04146363|536468120|FG006|Induction Period|Lost to Follow-up|0|||
148725462|NCT04146363|536468121|FG007|Induction Period|Lost to Follow-up|0|||
148725463|NCT04146363|536468122|FG008|Induction Period|Lost to Follow-up|0|||
148725464|NCT04146363|536468123|FG009|Induction Period|Lost to Follow-up|0|||
148725465|NCT04146363|536468124|FG010|Induction Period|Lost to Follow-up|0|||
148725466|NCT04146363|536468114|FG000|Induction Period|Positive quantiferon test|0|||
148725467|NCT04146363|536468115|FG001|Induction Period|Positive quantiferon test|1|||
148725468|NCT04146363|536468116|FG002|Induction Period|Positive quantiferon test|0|||
148725469|NCT04146363|536468117|FG003|Induction Period|Positive quantiferon test|0|||
148725470|NCT04146363|536468118|FG004|Induction Period|Positive quantiferon test|0|||
148725471|NCT04146363|536468119|FG005|Induction Period|Positive quantiferon test|0|||
148725472|NCT04146363|536468120|FG006|Induction Period|Positive quantiferon test|0|||
148725473|NCT04146363|536468121|FG007|Induction Period|Positive quantiferon test|0|||
148725474|NCT04146363|536468122|FG008|Induction Period|Positive quantiferon test|0|||
148725475|NCT04146363|536468123|FG009|Induction Period|Positive quantiferon test|0|||
148725476|NCT04146363|536468124|FG010|Induction Period|Positive quantiferon test|0|||
148725477|NCT04146363|536468114|FG000|Induction Period|Protocol Deviation|5|||
148725478|NCT04146363|536468115|FG001|Induction Period|Protocol Deviation|6|||
148725479|NCT04146363|536468116|FG002|Induction Period|Protocol Deviation|0|||
148816639|NCT03325439|536803980|FG000|Overall Study|Ineligibility|3|||
149025550|NCT01124617|537570081|FG000|Overall Study|Other|2|||
149025551|NCT01124617|537570082|FG001|Overall Study|Other|1|||
149025552|NCT00945477|537570083|FG000|Overall Study|Adverse Event|3|||
149025553|NCT00945477|537570083|FG000|Overall Study|Lack of Efficacy|2|||
149025554|NCT00945477|537570083|FG000|Overall Study|Withdrawal by Subject|1|||
148725480|NCT04146363|536468117|FG003|Induction Period|Protocol Deviation|0|||
148725481|NCT04146363|536468118|FG004|Induction Period|Protocol Deviation|0|||
148725482|NCT04146363|536468119|FG005|Induction Period|Protocol Deviation|0|||
148725483|NCT04146363|536468120|FG006|Induction Period|Protocol Deviation|0|||
148725484|NCT04146363|536468121|FG007|Induction Period|Protocol Deviation|0|||
148725485|NCT04146363|536468122|FG008|Induction Period|Protocol Deviation|0|||
148970816|NCT01481116|537378101|FG000|Overall Study|Investigator Decision|3|||
148970817|NCT01481116|537378102|FG001|Overall Study|Investigator Decision|2|||
148970818|NCT01481116|537378103|FG002|Overall Study|Investigator Decision|1|||
148725486|NCT04146363|536468123|FG009|Induction Period|Protocol Deviation|0|||
148725487|NCT04146363|536468124|FG010|Induction Period|Protocol Deviation|0|||
148725488|NCT04146363|536468114|FG000|Induction Period|Withdrawal by Subject|6|||
148725489|NCT04146363|536468115|FG001|Induction Period|Withdrawal by Subject|3|||
148725490|NCT04146363|536468116|FG002|Induction Period|Withdrawal by Subject|0|||
148725491|NCT04146363|536468117|FG003|Induction Period|Withdrawal by Subject|0|||
148725492|NCT04146363|536468118|FG004|Induction Period|Withdrawal by Subject|0|||
148725493|NCT04146363|536468119|FG005|Induction Period|Withdrawal by Subject|0|||
148725494|NCT04146363|536468120|FG006|Induction Period|Withdrawal by Subject|0|||
148725495|NCT04146363|536468121|FG007|Induction Period|Withdrawal by Subject|0|||
148725496|NCT04146363|536468122|FG008|Induction Period|Withdrawal by Subject|0|||
148725497|NCT04146363|536468123|FG009|Induction Period|Withdrawal by Subject|0|||
148725498|NCT04146363|536468124|FG010|Induction Period|Withdrawal by Subject|0|||
148725499|NCT04146363|536468114|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725500|NCT04146363|536468115|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725501|NCT04146363|536468116|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725502|NCT04146363|536468117|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725503|NCT04146363|536468118|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725504|NCT04146363|536468119|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725505|NCT04146363|536468120|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
148725506|NCT04146363|536468121|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
148725507|NCT04146363|536468122|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
148970819|NCT01481116|537378101|FG000|Overall Study|Sponsor Decision|0|||
148970820|NCT01481116|537378102|FG001|Overall Study|Sponsor Decision|1|||
148970821|NCT01481116|537378103|FG002|Overall Study|Sponsor Decision|3|||
148970822|NCT01481116|537378101|FG000|Overall Study|Non-Compliant With Study Drug|0|||
148970823|NCT01481116|537378102|FG001|Overall Study|Non-Compliant With Study Drug|1|||
148970824|NCT01481116|537378103|FG002|Overall Study|Non-Compliant With Study Drug|1|||
148970825|NCT01481116|537378101|FG000|Overall Study|Investigator's Discretion|2|||
148970826|NCT01481116|537378102|FG001|Overall Study|Investigator's Discretion|0|||
148970827|NCT01481116|537378103|FG002|Overall Study|Investigator's Discretion|0|||
148970828|NCT01481116|537378101|FG000|Overall Study|Death|2|||
148970829|NCT01481116|537378102|FG001|Overall Study|Death|1|||
148970830|NCT01481116|537378103|FG002|Overall Study|Death|0|||
148970831|NCT01481116|537378101|FG000|Overall Study|Hypoglycemic Event|4|||
148970832|NCT01481116|537378102|FG001|Overall Study|Hypoglycemic Event|0|||
148970833|NCT01481116|537378103|FG002|Overall Study|Hypoglycemic Event|0|||
148970834|NCT00805935|537378104|FG000|Overall Study|Stimulation Failure|1|||
148970835|NCT00805935|537378105|FG001|Overall Study|Stimulation Failure|5|||
148970836|NCT00805935|537378106|FG002|Overall Study|Stimulation Failure|2|||
148970837|NCT00805935|537378107|FG003|Overall Study|Stimulation Failure|2|||
148970838|NCT00805935|537378104|FG000|Overall Study|Cycle cancelled|0|||
148970839|NCT00805935|537378105|FG001|Overall Study|Cycle cancelled|0|||
148970840|NCT00805935|537378106|FG002|Overall Study|Cycle cancelled|2|||
148970841|NCT00805935|537378107|FG003|Overall Study|Cycle cancelled|0|||
148970842|NCT00805935|537378104|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
148970843|NCT00805935|537378105|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
148970844|NCT00805935|537378106|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
148970845|NCT00805935|537378107|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
148970846|NCT00805935|537378104|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
148970847|NCT00805935|537378105|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
148970848|NCT00805935|537378106|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
148970849|NCT00805935|537378107|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
148970850|NCT00805935|537378104|FG000|Overall Study|Lost to Follow-up|1|||
148970851|NCT00805935|537378105|FG001|Overall Study|Lost to Follow-up|0|||
148970852|NCT00805935|537378106|FG002|Overall Study|Lost to Follow-up|0|||
148970853|NCT00805935|537378107|FG003|Overall Study|Lost to Follow-up|0|||
148970854|NCT00805935|537378104|FG000|Overall Study|No positive serum pregnancy|8|||
148970855|NCT00805935|537378105|FG001|Overall Study|No positive serum pregnancy|7|||
148970856|NCT00805935|537378106|FG002|Overall Study|No positive serum pregnancy|6|||
148970857|NCT00805935|537378107|FG003|Overall Study|No positive serum pregnancy|5|||
148970858|NCT00805935|537378104|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
148970859|NCT00805935|537378105|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
148725508|NCT04146363|536468123|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725509|NCT04146363|536468124|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
148725510|NCT04146363|536468114|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725511|NCT04146363|536468115|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148970860|NCT00805935|537378106|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
148970861|NCT00805935|537378107|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
148970862|NCT00805935|537378104|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
148970863|NCT00805935|537378105|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
148970864|NCT00805935|537378106|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
148970865|NCT00805935|537378107|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
148970866|NCT00805935|537378104|FG000|Overall Study|Biochemical pregnancy|0|||
148970867|NCT00805935|537378105|FG001|Overall Study|Biochemical pregnancy|1|||
148970868|NCT00805935|537378106|FG002|Overall Study|Biochemical pregnancy|0|||
148970869|NCT00805935|537378107|FG003|Overall Study|Biochemical pregnancy|0|||
148970870|NCT00805935|537378104|FG000|Overall Study|Chemical pregnancy|0|||
148970871|NCT00805935|537378105|FG001|Overall Study|Chemical pregnancy|5|||
148970872|NCT00805935|537378106|FG002|Overall Study|Chemical pregnancy|3|||
148970873|NCT00805935|537378107|FG003|Overall Study|Chemical pregnancy|2|||
148970874|NCT00805935|537378104|FG000|Overall Study|Ectopic pregnancy|0|||
148970875|NCT00805935|537378105|FG001|Overall Study|Ectopic pregnancy|0|||
148970876|NCT00805935|537378106|FG002|Overall Study|Ectopic pregnancy|1|||
148970877|NCT00805935|537378107|FG003|Overall Study|Ectopic pregnancy|0|||
148970878|NCT00805935|537378104|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
148970879|NCT00805935|537378105|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
148970880|NCT00805935|537378106|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
148970881|NCT00805935|537378107|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
148970882|NCT02223767|537378112|FG000|Overall Study|Withdrawal by Subject|4|||
148970883|NCT02223767|537378113|FG001|Overall Study|Withdrawal by Subject|4|||
148970884|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
148970885|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
148970886|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
148970887|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
148970888|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
148970889|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
148970890|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
148970891|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
148970892|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
148970893|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
148970894|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
148970895|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
148970896|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
148970897|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
148970898|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
148970899|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
148970900|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
148970901|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
148970902|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
148970903|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
148970904|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
148970905|NCT00934544|537378115|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
148970906|NCT00934544|537378116|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
148970907|NCT00934544|537378117|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
148970908|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
148970909|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
148970910|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
148970911|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
148970912|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
148970913|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
148970914|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
148970915|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
148970916|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
148970917|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
149025555|NCT02825043|537570084|FG000|Overall Study|Lost to Follow-up|4|||
149025556|NCT03582137|537570088|FG000|Overall Study|Adverse Event|1|||
148970918|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
148970919|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
148970920|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
148970921|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
148970922|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
148970923|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
148970924|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
148970925|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
148970926|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
149025557|NCT03582137|537570089|FG001|Overall Study|Adverse Event|0|||
149025558|NCT01253200|537570090|FG000|Overall Study|Death|1|||
149025559|NCT01253200|537570091|FG001|Overall Study|Death|0|||
149025560|NCT01253200|537570092|FG002|Overall Study|Death|0|||
148725512|NCT04146363|536468116|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725513|NCT04146363|536468117|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725514|NCT04146363|536468118|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725515|NCT04146363|536468119|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725516|NCT04146363|536468120|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725517|NCT04146363|536468121|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
148725518|NCT04146363|536468122|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725519|NCT04146363|536468123|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725520|NCT04146363|536468124|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
148725521|NCT04146363|536468114|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725522|NCT04146363|536468115|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725523|NCT04146363|536468116|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725524|NCT04146363|536468117|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725525|NCT04146363|536468118|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725526|NCT04146363|536468119|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725527|NCT04146363|536468120|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
148725528|NCT04146363|536468121|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
148725529|NCT04146363|536468122|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725530|NCT04146363|536468123|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725531|NCT04146363|536468124|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
148725532|NCT04146363|536468114|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725533|NCT04146363|536468115|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725534|NCT04146363|536468116|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
148725535|NCT04146363|536468117|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725536|NCT04146363|536468118|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725537|NCT04146363|536468119|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
148725538|NCT04146363|536468120|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725539|NCT04146363|536468121|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725540|NCT04146363|536468122|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725541|NCT04146363|536468123|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725542|NCT04146363|536468124|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
148725543|NCT04146363|536468114|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725544|NCT04146363|536468115|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725545|NCT04146363|536468116|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725546|NCT04146363|536468117|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725547|NCT04146363|536468118|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
149025561|NCT01253200|537570093|FG003|Overall Study|Death|0|||
149025562|NCT01253200|537570094|FG004|Overall Study|Death|0|||
149025563|NCT01253200|537570090|FG000|Overall Study|Lost to Follow-up|1|||
149025564|NCT01253200|537570091|FG001|Overall Study|Lost to Follow-up|1|||
149025565|NCT01253200|537570092|FG002|Overall Study|Lost to Follow-up|0|||
149025566|NCT01253200|537570093|FG003|Overall Study|Lost to Follow-up|0|||
148725548|NCT04146363|536468119|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
148725549|NCT04146363|536468120|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
148725550|NCT04146363|536468121|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
148725551|NCT04146363|536468122|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725552|NCT04146363|536468123|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725553|NCT04146363|536468124|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
148725554|NCT04146363|536468114|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725555|NCT04146363|536468115|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725556|NCT04146363|536468116|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
148725557|NCT04146363|536468117|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725558|NCT04146363|536468118|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725559|NCT04146363|536468119|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
148725560|NCT04146363|536468120|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
148725561|NCT04146363|536468121|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
148725562|NCT04146363|536468122|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725563|NCT04146363|536468123|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725564|NCT04146363|536468124|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
148725565|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725566|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725567|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
148816640|NCT03188185|536803981|FG000|Stage 1|Adverse Event|4|||
149025567|NCT01253200|537570094|FG004|Overall Study|Lost to Follow-up|0|||
148725568|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
148816641|NCT03188185|536803982|FG001|Stage 1|Adverse Event|12|||
148816642|NCT03188185|536803983|FG002|Stage 1|Adverse Event|0|||
149025568|NCT01253200|537570090|FG000|Overall Study|Withdrawal by Subject|2|||
149025569|NCT01253200|537570091|FG001|Overall Study|Withdrawal by Subject|0|||
149025570|NCT01253200|537570092|FG002|Overall Study|Withdrawal by Subject|0|||
149025571|NCT01253200|537570093|FG003|Overall Study|Withdrawal by Subject|0|||
149025572|NCT01253200|537570094|FG004|Overall Study|Withdrawal by Subject|0|||
149025573|NCT01253200|537570090|FG000|Overall Study|Protocol Violation|1|||
149025574|NCT01253200|537570091|FG001|Overall Study|Protocol Violation|4|||
149025575|NCT01253200|537570092|FG002|Overall Study|Protocol Violation|0|||
149025576|NCT01253200|537570093|FG003|Overall Study|Protocol Violation|0|||
149025577|NCT01253200|537570094|FG004|Overall Study|Protocol Violation|5|||
149025578|NCT01253200|537570090|FG000|Overall Study|intents|10|||
149025579|NCT01253200|537570091|FG001|Overall Study|intents|10|||
149025580|NCT01253200|537570092|FG002|Overall Study|intents|1|||
149025581|NCT01253200|537570093|FG003|Overall Study|intents|3|||
149025582|NCT01253200|537570094|FG004|Overall Study|intents|0|||
149025583|NCT01253200|537570090|FG000|Overall Study|Attempts|6|||
149025584|NCT01253200|537570091|FG001|Overall Study|Attempts|4|||
149025585|NCT01253200|537570092|FG002|Overall Study|Attempts|1|||
149025586|NCT01253200|537570093|FG003|Overall Study|Attempts|2|||
149025587|NCT01253200|537570094|FG004|Overall Study|Attempts|0|||
149025588|NCT02049437|537570095|FG000|Period 1|Adverse Event|1|||
149025589|NCT02049437|537570096|FG001|Period 1|Adverse Event|1|||
149025590|NCT02049437|537570095|FG000|Period 1|Adverse Event|1|||
149025591|NCT02049437|537570096|FG001|Period 1|Adverse Event|0|||
149025592|NCT01027871|537570099|FG000|Overall Study|Physician Decision|1|||
149025593|NCT01027871|537570100|FG001|Overall Study|Physician Decision|5|||
149025594|NCT01027871|537570101|FG002|Overall Study|Physician Decision|0|||
149025595|NCT01027871|537570099|FG000|Overall Study|Protocol Violation|0|||
148725569|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725570|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725571|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725572|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725573|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
148725574|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
148725575|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
148725576|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725577|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725578|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725579|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725580|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725581|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725582|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725583|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
148725584|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
148725585|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
148725586|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
148725587|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725588|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725589|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725590|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725591|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725592|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725593|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725594|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725595|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
148725596|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
148725597|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
148725598|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725599|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725600|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725601|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725602|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725603|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725604|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
149025596|NCT01027871|537570100|FG001|Overall Study|Protocol Violation|2|||
149025597|NCT01027871|537570101|FG002|Overall Study|Protocol Violation|2|||
149025598|NCT01027871|537570099|FG000|Overall Study|Withdrawal by Subject|1|||
149025599|NCT01027871|537570100|FG001|Overall Study|Withdrawal by Subject|2|||
149025600|NCT01027871|537570101|FG002|Overall Study|Withdrawal by Subject|2|||
149025601|NCT01027871|537570099|FG000|Overall Study|Adverse Event|0|||
149025602|NCT01027871|537570100|FG001|Overall Study|Adverse Event|2|||
149025603|NCT01027871|537570101|FG002|Overall Study|Adverse Event|2|||
149025604|NCT01027871|537570099|FG000|Overall Study|Sponsor Decision|0|||
149025605|NCT01027871|537570100|FG001|Overall Study|Sponsor Decision|2|||
148816643|NCT03188185|536803984|FG003|Stage 1|Adverse Event|0|||
148970927|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
148970928|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
148970929|NCT00934544|537378115|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
148970930|NCT00934544|537378116|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
148970931|NCT00934544|537378117|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
148970932|NCT02643251|537378118|FG000|Overall Study|Adverse Event|3|||
148970933|NCT02643251|537378119|FG001|Overall Study|Adverse Event|1|||
148970934|NCT02643251|537378118|FG000|Overall Study|Withdrawal by Subject|2|||
148970935|NCT02643251|537378119|FG001|Overall Study|Withdrawal by Subject|0|||
148970936|NCT02643251|537378118|FG000|Overall Study|Lost to Follow-up|4|||
148970937|NCT02643251|537378119|FG001|Overall Study|Lost to Follow-up|1|||
148970938|NCT02643251|537378118|FG000|Overall Study|Protocol Violation|1|||
148970939|NCT02643251|537378119|FG001|Overall Study|Protocol Violation|0|||
148816644|NCT03188185|536803981|FG000|Stage 1|Lack of Efficacy|0|||
148816645|NCT03188185|536803982|FG001|Stage 1|Lack of Efficacy|2|||
148816646|NCT03188185|536803983|FG002|Stage 1|Lack of Efficacy|0|||
148970940|NCT02643251|537378118|FG000|Overall Study|PI Decision to terminate patient|1|||
148970941|NCT02643251|537378119|FG001|Overall Study|PI Decision to terminate patient|0|||
148970942|NCT00348556|537378120|FG000|Overall Study|Adverse Event|1|||
148970943|NCT00333229|537378123|FG000|Overall Study|Lack of Efficacy|0|||
148725605|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725606|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
148725607|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
148725608|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
148725609|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148725610|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148725611|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148725612|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148725613|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148725614|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148970944|NCT00333229|537378124|FG001|Overall Study|Lack of Efficacy|1|||
148970945|NCT00240071|537378125|FG000|Overall Study|Withdrawal by Subject|3|||
148970946|NCT01466270|537378126|FG000|Overall Study|Withdrawal by Subject|4|||
148970947|NCT01466270|537378127|FG001|Overall Study|Withdrawal by Subject|1|||
148970948|NCT01466270|537378126|FG000|Overall Study|Physician Decision|1|||
148970949|NCT01466270|537378127|FG001|Overall Study|Physician Decision|0|||
148970950|NCT01466270|537378126|FG000|Overall Study|Lost to Follow-up|1|||
148970951|NCT01466270|537378127|FG001|Overall Study|Lost to Follow-up|3|||
148970952|NCT01466270|537378126|FG000|Overall Study|Progression|1|||
148970953|NCT01466270|537378127|FG001|Overall Study|Progression|0|||
148970954|NCT01466270|537378126|FG000|Overall Study|Toxicity|4|||
148970955|NCT01466270|537378127|FG001|Overall Study|Toxicity|1|||
148970956|NCT01466270|537378126|FG000|Overall Study|Multiple|1|||
148970957|NCT01466270|537378127|FG001|Overall Study|Multiple|1|||
148970958|NCT01944059|537378128|FG000|Overall Study|Lost to Follow-up|1|||
148970959|NCT01944059|537378128|FG000|Overall Study|Physician Decision|3|||
148970960|NCT01944059|537378128|FG000|Overall Study|Withdrawal by Subject|1|||
148970961|NCT01944059|537378128|FG000|Overall Study|Adverse Event|2|||
148970962|NCT02821962|537378129|FG000|Overall Study|Lost to Follow-up|2|||
148970963|NCT02821962|537378130|FG001|Overall Study|Lost to Follow-up|0|||
148970964|NCT04206293|537378139|FG000|Overall Study|Consent withdrawal|1|||
148970965|NCT00430092|537378141|FG000|Overall Study|Adverse Event|0|||
148970966|NCT00430092|537378142|FG001|Overall Study|Adverse Event|0|||
148970967|NCT00430092|537378143|FG002|Overall Study|Adverse Event|1|||
148970968|NCT00430092|537378141|FG000|Overall Study|Lack of Efficacy|5|||
148970969|NCT00430092|537378142|FG001|Overall Study|Lack of Efficacy|2|||
148970970|NCT00430092|537378143|FG002|Overall Study|Lack of Efficacy|54|||
148970971|NCT00430092|537378141|FG000|Overall Study|Lost to Follow-up|1|||
148970972|NCT00430092|537378142|FG001|Overall Study|Lost to Follow-up|0|||
148970973|NCT00430092|537378143|FG002|Overall Study|Lost to Follow-up|0|||
148970974|NCT00430092|537378141|FG000|Overall Study|Protocol Violation|0|||
148970975|NCT00430092|537378142|FG001|Overall Study|Protocol Violation|1|||
148970976|NCT00430092|537378143|FG002|Overall Study|Protocol Violation|1|||
148970977|NCT00430092|537378141|FG000|Overall Study|Withdrawal by Subject|0|||
148970978|NCT00430092|537378142|FG001|Overall Study|Withdrawal by Subject|1|||
148970979|NCT00430092|537378143|FG002|Overall Study|Withdrawal by Subject|1|||
148970980|NCT00654381|537378151|FG000|1st Stage|Adverse Event|3|||
148970981|NCT00654381|537378152|FG001|1st Stage|Adverse Event|3|||
148970982|NCT00654381|537378153|FG002|1st Stage|Adverse Event|3|||
148970983|NCT00654381|537378154|FG003|1st Stage|Adverse Event|3|||
148970984|NCT00654381|537378155|FG004|1st Stage|Adverse Event|2|||
148970985|NCT00654381|537378156|FG005|1st Stage|Adverse Event|1|||
148970986|NCT00654381|537378151|FG000|1st Stage|Withdrawal by Subject|0|||
148970987|NCT00654381|537378152|FG001|1st Stage|Withdrawal by Subject|0|||
148970988|NCT00654381|537378153|FG002|1st Stage|Withdrawal by Subject|0|||
148970989|NCT00654381|537378154|FG003|1st Stage|Withdrawal by Subject|1|||
148970990|NCT00654381|537378155|FG004|1st Stage|Withdrawal by Subject|0|||
148970991|NCT00654381|537378156|FG005|1st Stage|Withdrawal by Subject|1|||
148970992|NCT00654381|537378151|FG000|1st Stage|Investigator's decision|0|||
148970993|NCT00654381|537378152|FG001|1st Stage|Investigator's decision|0|||
148970994|NCT00654381|537378153|FG002|1st Stage|Investigator's decision|0|||
148970995|NCT00654381|537378154|FG003|1st Stage|Investigator's decision|1|||
148970996|NCT00654381|537378155|FG004|1st Stage|Investigator's decision|0|||
148970997|NCT00654381|537378156|FG005|1st Stage|Investigator's decision|0|||
148970998|NCT00654381|537378151|FG000|2nd Stage|Adverse Event|2|||
148970999|NCT00654381|537378152|FG001|2nd Stage|Adverse Event|0|||
148971000|NCT00654381|537378153|FG002|2nd Stage|Adverse Event|2|||
148971001|NCT00654381|537378154|FG003|2nd Stage|Adverse Event|3|||
148725615|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148971002|NCT00654381|537378155|FG004|2nd Stage|Adverse Event|7|||
148971003|NCT00654381|537378156|FG005|2nd Stage|Adverse Event|2|||
148971004|NCT00654381|537378151|FG000|2nd Stage|Withdrawal by Subject|0|||
148971005|NCT00654381|537378152|FG001|2nd Stage|Withdrawal by Subject|0|||
148971006|NCT00654381|537378153|FG002|2nd Stage|Withdrawal by Subject|0|||
148971007|NCT00654381|537378154|FG003|2nd Stage|Withdrawal by Subject|0|||
148971008|NCT00654381|537378155|FG004|2nd Stage|Withdrawal by Subject|1|||
148971009|NCT00654381|537378156|FG005|2nd Stage|Withdrawal by Subject|1|||
148971010|NCT00654381|537378151|FG000|2nd Stage|Investigator's decision|0|||
148971011|NCT00654381|537378152|FG001|2nd Stage|Investigator's decision|0|||
149025606|NCT01027871|537570101|FG002|Overall Study|Sponsor Decision|0|||
149025607|NCT01027871|537570099|FG000|Overall Study|Discontinued Prior to Treatment|0|||
149025608|NCT01027871|537570100|FG001|Overall Study|Discontinued Prior to Treatment|0|||
148725616|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
148725617|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
149025609|NCT01027871|537570101|FG002|Overall Study|Discontinued Prior to Treatment|1|||
149025610|NCT03782727|537570102|FG000|Overall Study|Lost to Follow-up|32|||
149025611|NCT04887285|537570105|FG000|Overall Study|Lost to Follow-up|0|||
149025612|NCT04887285|537570106|FG001|Overall Study|Lost to Follow-up|2|||
149025613|NCT04887285|537570107|FG002|Overall Study|Lost to Follow-up|3|||
149025614|NCT04640571|537570108|FG000|Overall Study|Withdrawal by Subject|0|||
149025615|NCT04640571|537570109|FG001|Overall Study|Withdrawal by Subject|0|||
149025616|NCT04640571|537570110|FG002|Overall Study|Withdrawal by Subject|0|||
149025617|NCT04640571|537570111|FG003|Overall Study|Withdrawal by Subject|0|||
149025618|NCT04640571|537570112|FG004|Overall Study|Withdrawal by Subject|0|||
149025619|NCT04640571|537570113|FG005|Overall Study|Withdrawal by Subject|2|||
149025620|NCT04736056|537570116|FG000|Overall Study|Death|0|||
149025621|NCT04736056|537570117|FG001|Overall Study|Death|0|||
149025622|NCT04736056|537570118|FG002|Overall Study|Death|0|||
149025623|NCT04736056|537570119|FG003|Overall Study|Death|1|||
149025624|NCT04736056|537570116|FG000|Overall Study|Lost to Follow-up|1|||
149025625|NCT04736056|537570117|FG001|Overall Study|Lost to Follow-up|0|||
149025626|NCT04736056|537570118|FG002|Overall Study|Lost to Follow-up|1|||
149025627|NCT04736056|537570119|FG003|Overall Study|Lost to Follow-up|1|||
149025628|NCT04736056|537570116|FG000|Overall Study|Withdrawal by Subject|2|||
149025629|NCT04736056|537570117|FG001|Overall Study|Withdrawal by Subject|0|||
149025630|NCT04736056|537570118|FG002|Overall Study|Withdrawal by Subject|0|||
149025631|NCT04736056|537570119|FG003|Overall Study|Withdrawal by Subject|0|||
149025632|NCT04736056|537570116|FG000|Overall Study|Physician Decision|1|||
149025633|NCT04736056|537570117|FG001|Overall Study|Physician Decision|0|||
149025634|NCT04736056|537570118|FG002|Overall Study|Physician Decision|1|||
149025635|NCT04736056|537570119|FG003|Overall Study|Physician Decision|0|||
149025636|NCT02223182|537570120|FG000|Double-Blind Period|Adverse Event|0|||
149025637|NCT02223182|537570121|FG001|Double-Blind Period|Adverse Event|2|||
149025638|NCT02223182|537570122|FG002|Double-Blind Period|Adverse Event|1|||
149025639|NCT02223182|537570123|FG003|Double-Blind Period|Adverse Event|0|||
149025640|NCT02223182|537570120|FG000|Double-Blind Period|Withdrawal by Subject|1|||
149025641|NCT02223182|537570121|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149025642|NCT02223182|537570122|FG002|Double-Blind Period|Withdrawal by Subject|1|||
149025643|NCT02223182|537570123|FG003|Double-Blind Period|Withdrawal by Subject|0|||
149025644|NCT02223182|537570120|FG000|Double-Blind Period|Lost to Follow-up|0|||
149025645|NCT02223182|537570121|FG001|Double-Blind Period|Lost to Follow-up|1|||
149025646|NCT02223182|537570122|FG002|Double-Blind Period|Lost to Follow-up|0|||
149025647|NCT02223182|537570123|FG003|Double-Blind Period|Lost to Follow-up|0|||
149025648|NCT02223182|537570120|FG000|Double-Blind Period|Non Compliance|0|||
149025649|NCT02223182|537570121|FG001|Double-Blind Period|Non Compliance|0|||
149025650|NCT02223182|537570122|FG002|Double-Blind Period|Non Compliance|0|||
149025651|NCT02223182|537570123|FG003|Double-Blind Period|Non Compliance|1|||
149025652|NCT02223182|537570120|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
149025653|NCT02223182|537570121|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
149025654|NCT02223182|537570122|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
149025655|NCT02223182|537570123|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
148725618|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
148725619|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
148725620|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725621|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725622|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725623|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
149025656|NCT02223182|537570120|FG000|Open-Label 500 Period|Adverse Event|1|||
149025657|NCT02223182|537570121|FG001|Open-Label 500 Period|Adverse Event|0|||
149025658|NCT02223182|537570122|FG002|Open-Label 500 Period|Adverse Event|2|||
149025659|NCT02223182|537570123|FG003|Open-Label 500 Period|Adverse Event|1|||
149025660|NCT02223182|537570120|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
148725624|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725625|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725626|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
149025661|NCT02223182|537570121|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
149025662|NCT02223182|537570122|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
149025663|NCT02223182|537570123|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
149025664|NCT02223182|537570120|FG000|Open-Label 500 Period|Physician Decision|0|||
149025665|NCT02223182|537570121|FG001|Open-Label 500 Period|Physician Decision|0|||
149025666|NCT02223182|537570122|FG002|Open-Label 500 Period|Physician Decision|0|||
149025667|NCT02223182|537570123|FG003|Open-Label 500 Period|Physician Decision|1|||
148725627|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725628|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725629|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
148725630|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
148725631|NCT04146363|536468114|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725632|NCT04146363|536468115|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725633|NCT04146363|536468116|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725634|NCT04146363|536468117|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725635|NCT04146363|536468118|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725636|NCT04146363|536468119|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725637|NCT04146363|536468120|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725638|NCT04146363|536468121|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725639|NCT04146363|536468122|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725640|NCT04146363|536468123|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
148725641|NCT04146363|536468124|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
148725642|NCT02914236|536468129|FG000|Overall Study|Lost to Follow-up|1|||
148725643|NCT04776746|536468130|FG000|Overall Study|Study terminated by sponsor|61|||
148725644|NCT04776746|536468130|FG000|Overall Study|Adverse Event|5|||
148725645|NCT04776746|536468130|FG000|Overall Study|Death|4|||
148725646|NCT04776746|536468130|FG000|Overall Study|Lack of Efficacy|3|||
148725647|NCT04776746|536468130|FG000|Overall Study|Noncompliance with study drug|2|||
148725648|NCT04776746|536468130|FG000|Overall Study|Not related to COVID-19|2|||
148725649|NCT00140413|536468135|FG000|Overall Study|Lost to Follow-up|1|||
148725650|NCT00140413|536468136|FG001|Overall Study|Lost to Follow-up|0|||
148725651|NCT00140413|536468135|FG000|Overall Study|Withdrawal by Subject|2|||
148725652|NCT00140413|536468136|FG001|Overall Study|Withdrawal by Subject|0|||
148725653|NCT03702049|536468141|FG000|Overall Study|Lost to Follow-up|4|||
148725654|NCT03702049|536468141|FG000|Overall Study|Physician Decision|1|||
148725655|NCT01715896|536468145|FG000|Overall Study|Lost to Follow-up|0|||
148725656|NCT01715896|536468146|FG001|Overall Study|Lost to Follow-up|2|||
148725657|NCT01715896|536468145|FG000|Overall Study|Withdrawal by Subject|1|||
148725658|NCT01715896|536468146|FG001|Overall Study|Withdrawal by Subject|4|||
148725659|NCT01715896|536468145|FG000|Overall Study|Other|2|||
148725660|NCT01715896|536468146|FG001|Overall Study|Other|5|||
148725661|NCT05506358|536468150|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
148725662|NCT05506358|536468151|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
148725663|NCT05506358|536468152|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
148725664|NCT05506358|536468153|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
148725665|NCT05506358|536468154|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
148725666|NCT05506358|536468150|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
148971012|NCT00654381|537378153|FG002|2nd Stage|Investigator's decision|1|||
148971013|NCT00654381|537378154|FG003|2nd Stage|Investigator's decision|1|||
148971014|NCT00654381|537378155|FG004|2nd Stage|Investigator's decision|0|||
148971015|NCT00654381|537378156|FG005|2nd Stage|Investigator's decision|0|||
148971016|NCT00654381|537378151|FG000|Extension Stage|Adverse Event|1|||
148971017|NCT00654381|537378152|FG001|Extension Stage|Adverse Event|2|||
148971018|NCT00654381|537378153|FG002|Extension Stage|Adverse Event|9|||
148971019|NCT00654381|537378154|FG003|Extension Stage|Adverse Event|7|||
148971020|NCT00654381|537378155|FG004|Extension Stage|Adverse Event|1|||
148971021|NCT00654381|537378156|FG005|Extension Stage|Adverse Event|1|||
148971022|NCT00654381|537378151|FG000|Extension Stage|Protocol Violation|0|||
148971023|NCT00654381|537378152|FG001|Extension Stage|Protocol Violation|0|||
148971024|NCT00654381|537378153|FG002|Extension Stage|Protocol Violation|0|||
148971025|NCT00654381|537378154|FG003|Extension Stage|Protocol Violation|1|||
148971026|NCT00654381|537378155|FG004|Extension Stage|Protocol Violation|0|||
148971027|NCT00654381|537378156|FG005|Extension Stage|Protocol Violation|0|||
148971028|NCT00654381|537378151|FG000|Extension Stage|Lack of Efficacy|0|||
148971029|NCT00654381|537378152|FG001|Extension Stage|Lack of Efficacy|0|||
148971030|NCT00654381|537378153|FG002|Extension Stage|Lack of Efficacy|1|||
148725667|NCT05506358|536468151|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
148725668|NCT05506358|536468152|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
148971031|NCT00654381|537378154|FG003|Extension Stage|Lack of Efficacy|0|||
148971032|NCT00654381|537378155|FG004|Extension Stage|Lack of Efficacy|0|||
148971033|NCT00654381|537378156|FG005|Extension Stage|Lack of Efficacy|0|||
148971034|NCT00654381|537378151|FG000|Extension Stage|Withdrawal by Subject|0|||
148725669|NCT05506358|536468153|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
148725670|NCT05506358|536468154|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
148725671|NCT05506358|536468150|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
149025668|NCT02223182|537570120|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
148971035|NCT00654381|537378152|FG001|Extension Stage|Withdrawal by Subject|0|||
148971036|NCT00654381|537378153|FG002|Extension Stage|Withdrawal by Subject|1|||
148971037|NCT00654381|537378154|FG003|Extension Stage|Withdrawal by Subject|1|||
148971038|NCT00654381|537378155|FG004|Extension Stage|Withdrawal by Subject|1|||
148971039|NCT00654381|537378156|FG005|Extension Stage|Withdrawal by Subject|1|||
148971040|NCT00654381|537378151|FG000|Extension Stage|Closure of the trial site|0|||
148971041|NCT00654381|537378152|FG001|Extension Stage|Closure of the trial site|0|||
148971042|NCT00654381|537378153|FG002|Extension Stage|Closure of the trial site|0|||
148971043|NCT00654381|537378154|FG003|Extension Stage|Closure of the trial site|0|||
148971044|NCT00654381|537378155|FG004|Extension Stage|Closure of the trial site|1|||
148971045|NCT00654381|537378156|FG005|Extension Stage|Closure of the trial site|1|||
148971046|NCT03100825|537378157|FG000|Overall Study|Participant/Guardian Decision|7|||
148971047|NCT03100825|537378157|FG000|Overall Study|Physician Decision|1|||
148971048|NCT00994448|537378159|FG000|Overall Study|Adverse Event|1|||
148971049|NCT00994448|537378160|FG001|Overall Study|Adverse Event|0|||
148971050|NCT00994448|537378159|FG000|Overall Study|Lost to Follow-up|5|||
148971051|NCT00994448|537378160|FG001|Overall Study|Lost to Follow-up|1|||
148971052|NCT00994448|537378159|FG000|Overall Study|Withdrawal by Subject|1|||
148971053|NCT00994448|537378160|FG001|Overall Study|Withdrawal by Subject|1|||
148971054|NCT00994448|537378159|FG000|Overall Study|Physician Decision|1|||
148971055|NCT00994448|537378160|FG001|Overall Study|Physician Decision|0|||
148971056|NCT04164901|537378163|FG000|Overall Study|Withdrawal by Subject|4|||
148971057|NCT04164901|537378164|FG001|Overall Study|Withdrawal by Subject|4|||
148971058|NCT00559962|537378165|FG000|Overall Study|Adverse Event|1|||
148971059|NCT00559962|537378166|FG001|Overall Study|Adverse Event|7|||
148971060|NCT00559962|537378167|FG002|Overall Study|Adverse Event|8|||
148971061|NCT00559962|537378168|FG003|Overall Study|Adverse Event|5|||
148971062|NCT00559962|537378169|FG004|Overall Study|Adverse Event|11|||
148971063|NCT00559962|537378170|FG005|Overall Study|Adverse Event|4|||
148971064|NCT00559962|537378171|FG006|Overall Study|Adverse Event|4|||
148971065|NCT00559962|537378172|FG007|Overall Study|Adverse Event|2|||
148971066|NCT00559962|537378165|FG000|Overall Study|Lost to Follow-up|0|||
148971067|NCT00559962|537378166|FG001|Overall Study|Lost to Follow-up|1|||
148971068|NCT00559962|537378167|FG002|Overall Study|Lost to Follow-up|0|||
148971069|NCT00559962|537378168|FG003|Overall Study|Lost to Follow-up|0|||
148971070|NCT00559962|537378169|FG004|Overall Study|Lost to Follow-up|0|||
148971071|NCT00559962|537378170|FG005|Overall Study|Lost to Follow-up|0|||
148971072|NCT00559962|537378171|FG006|Overall Study|Lost to Follow-up|0|||
148971073|NCT00559962|537378172|FG007|Overall Study|Lost to Follow-up|0|||
148971074|NCT00559962|537378165|FG000|Overall Study|Withdrawal by Subject|1|||
148971075|NCT00559962|537378166|FG001|Overall Study|Withdrawal by Subject|1|||
148971076|NCT00559962|537378167|FG002|Overall Study|Withdrawal by Subject|2|||
148971077|NCT00559962|537378168|FG003|Overall Study|Withdrawal by Subject|0|||
148971078|NCT00559962|537378169|FG004|Overall Study|Withdrawal by Subject|3|||
148971079|NCT00559962|537378170|FG005|Overall Study|Withdrawal by Subject|1|||
148971080|NCT00559962|537378171|FG006|Overall Study|Withdrawal by Subject|0|||
148971081|NCT00559962|537378172|FG007|Overall Study|Withdrawal by Subject|2|||
148971082|NCT00559962|537378165|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
148971083|NCT00559962|537378166|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
148971084|NCT00559962|537378167|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
148971085|NCT00559962|537378168|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
148725672|NCT05506358|536468151|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
148725673|NCT05506358|536468152|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
148725674|NCT05506358|536468153|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
148725675|NCT05506358|536468154|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
148725676|NCT05506358|536468150|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
148971086|NCT00559962|537378169|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
148971087|NCT00559962|537378170|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
148971088|NCT00559962|537378171|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
148971089|NCT00559962|537378172|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
148971090|NCT03047135|537378173|FG000|Overall Study|Still being treated|3|||
148971091|NCT03778931|537378176|FG000|Overall Study|Withdrawal by Subject|12|||
148971092|NCT03778931|537378177|FG001|Overall Study|Withdrawal by Subject|25|||
148971093|NCT03778931|537378176|FG000|Overall Study|Physician Decision|1|||
148971094|NCT03778931|537378177|FG001|Overall Study|Physician Decision|3|||
148971095|NCT03778931|537378176|FG000|Overall Study|Participant Noncompliance|1|||
148971096|NCT03778931|537378177|FG001|Overall Study|Participant Noncompliance|1|||
148971097|NCT03778931|537378176|FG000|Overall Study|Lost to Follow-up|4|||
148971098|NCT03778931|537378177|FG001|Overall Study|Lost to Follow-up|1|||
148971099|NCT03778931|537378176|FG000|Overall Study|Death|69|||
148971100|NCT03778931|537378177|FG001|Overall Study|Death|79|||
148971101|NCT02130765|537378182|FG000|Overall Study|Did not receive treatment|4|||
148971102|NCT02130765|537378183|FG001|Overall Study|Did not receive treatment|0|||
148971103|NCT02130765|537378184|FG002|Overall Study|Did not receive treatment|0|||
148971104|NCT02130765|537378185|FG003|Overall Study|Did not receive treatment|0|||
148971105|NCT01537783|537378191|FG000|Overall Study|Lost to Follow-up|11|||
148971106|NCT01537783|537378192|FG001|Overall Study|Lost to Follow-up|2|||
148971107|NCT03216850|537378193|FG000|Overall Study|Pre-analytical error|6|||
149025669|NCT02223182|537570121|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
149025670|NCT02223182|537570122|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
149025671|NCT02223182|537570123|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
149025672|NCT02223182|537570120|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
149025673|NCT02223182|537570121|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
149025674|NCT02223182|537570122|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
149025675|NCT02223182|537570123|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
149025676|NCT02223182|537570120|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
149025677|NCT02223182|537570121|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
149025678|NCT02223182|537570122|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
149025679|NCT02223182|537570123|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
149025680|NCT02223182|537570120|FG000|Open-Label 300 Period|Non Compliance|0|||
149025681|NCT02223182|537570121|FG001|Open-Label 300 Period|Non Compliance|2|||
149025682|NCT02223182|537570122|FG002|Open-Label 300 Period|Non Compliance|1|||
149025683|NCT02223182|537570123|FG003|Open-Label 300 Period|Non Compliance|0|||
149025684|NCT00663962|537570126|FG000|Overall Study|somnolence|1|||
149025685|NCT00663962|537570127|FG001|Overall Study|somnolence|0|||
149025686|NCT01515319|537570153|FG000|Overall Study|Withdrawal by Subject|0|||
149025687|NCT01515319|537570154|FG001|Overall Study|Withdrawal by Subject|0|||
149025688|NCT01515319|537570155|FG002|Overall Study|Withdrawal by Subject|0|||
149025689|NCT01515319|537570156|FG003|Overall Study|Withdrawal by Subject|0|||
149025690|NCT01515319|537570157|FG004|Overall Study|Withdrawal by Subject|0|||
149025691|NCT01515319|537570158|FG005|Overall Study|Withdrawal by Subject|0|||
149025692|NCT01515319|537570159|FG006|Overall Study|Withdrawal by Subject|1|||
149025693|NCT01515319|537570160|FG007|Overall Study|Withdrawal by Subject|0|||
149025694|NCT01515319|537570161|FG008|Overall Study|Withdrawal by Subject|0|||
149025695|NCT01515319|537570162|FG009|Overall Study|Withdrawal by Subject|0|||
149025696|NCT01515319|537570153|FG000|Overall Study|Adverse Event|0|||
149025697|NCT01515319|537570154|FG001|Overall Study|Adverse Event|0|||
149025698|NCT01515319|537570155|FG002|Overall Study|Adverse Event|0|||
149025699|NCT01515319|537570156|FG003|Overall Study|Adverse Event|0|||
149025700|NCT01515319|537570157|FG004|Overall Study|Adverse Event|0|||
149025701|NCT01515319|537570158|FG005|Overall Study|Adverse Event|0|||
149025702|NCT01515319|537570159|FG006|Overall Study|Adverse Event|0|||
149025703|NCT01515319|537570160|FG007|Overall Study|Adverse Event|0|||
149025704|NCT01515319|537570161|FG008|Overall Study|Adverse Event|3|||
149025705|NCT01515319|537570162|FG009|Overall Study|Adverse Event|0|||
149025706|NCT01515319|537570153|FG000|Overall Study|Protocol Violation|0|||
149025707|NCT01515319|537570154|FG001|Overall Study|Protocol Violation|0|||
149025708|NCT01515319|537570155|FG002|Overall Study|Protocol Violation|0|||
149025709|NCT01515319|537570156|FG003|Overall Study|Protocol Violation|0|||
149025710|NCT01515319|537570157|FG004|Overall Study|Protocol Violation|0|||
149025711|NCT01515319|537570158|FG005|Overall Study|Protocol Violation|0|||
149025712|NCT01515319|537570159|FG006|Overall Study|Protocol Violation|0|||
149025713|NCT01515319|537570160|FG007|Overall Study|Protocol Violation|0|||
149025714|NCT01515319|537570161|FG008|Overall Study|Protocol Violation|2|||
149025715|NCT01515319|537570162|FG009|Overall Study|Protocol Violation|0|||
149025716|NCT02624778|537571857|FG000|Overall Study|Lost to Follow-up|0|||
149025717|NCT02624778|537571858|FG001|Overall Study|Lost to Follow-up|0|||
149025718|NCT02624778|537571859|FG002|Overall Study|Lost to Follow-up|1|||
149025719|NCT02624778|537571860|FG003|Overall Study|Lost to Follow-up|0|||
149025720|NCT02624778|537571861|FG004|Overall Study|Lost to Follow-up|0|||
149025721|NCT02624778|537571862|FG005|Overall Study|Lost to Follow-up|0|||
149025722|NCT02624778|537571863|FG006|Overall Study|Lost to Follow-up|0|||
149025723|NCT02624778|537571864|FG007|Overall Study|Lost to Follow-up|0|||
149025724|NCT02624778|537571865|FG008|Overall Study|Lost to Follow-up|0|||
149025725|NCT02624778|537571857|FG000|Overall Study|Withdrawal by Subject|0|||
149025726|NCT02624778|537571858|FG001|Overall Study|Withdrawal by Subject|1|||
149025727|NCT02624778|537571859|FG002|Overall Study|Withdrawal by Subject|0|||
149025728|NCT02624778|537571860|FG003|Overall Study|Withdrawal by Subject|0|||
149025729|NCT02624778|537571861|FG004|Overall Study|Withdrawal by Subject|0|||
149025730|NCT02624778|537571862|FG005|Overall Study|Withdrawal by Subject|1|||
149025731|NCT02624778|537571863|FG006|Overall Study|Withdrawal by Subject|1|||
149025732|NCT02624778|537571864|FG007|Overall Study|Withdrawal by Subject|1|||
149025733|NCT02624778|537571865|FG008|Overall Study|Withdrawal by Subject|1|||
149025734|NCT02624778|537571857|FG000|Overall Study|Adverse Event|0|||
148816647|NCT03188185|536803984|FG003|Stage 1|Lack of Efficacy|0|||
148816648|NCT03188185|536803981|FG000|Stage 1|Lost to Follow-up|6|||
148816649|NCT03188185|536803982|FG001|Stage 1|Lost to Follow-up|1|||
148816650|NCT03188185|536803983|FG002|Stage 1|Lost to Follow-up|0|||
149025735|NCT02624778|537571858|FG001|Overall Study|Adverse Event|0|||
149025736|NCT02624778|537571859|FG002|Overall Study|Adverse Event|0|||
149025737|NCT02624778|537571860|FG003|Overall Study|Adverse Event|0|||
149025738|NCT02624778|537571861|FG004|Overall Study|Adverse Event|0|||
149025739|NCT02624778|537571862|FG005|Overall Study|Adverse Event|0|||
149025740|NCT02624778|537571863|FG006|Overall Study|Adverse Event|0|||
149025741|NCT02624778|537571864|FG007|Overall Study|Adverse Event|0|||
148816651|NCT03188185|536803984|FG003|Stage 1|Lost to Follow-up|0|||
148816652|NCT03188185|536803981|FG000|Stage 1|Withdrawal by Subject|9|||
148816653|NCT03188185|536803982|FG001|Stage 1|Withdrawal by Subject|0|||
148816654|NCT03188185|536803983|FG002|Stage 1|Withdrawal by Subject|0|||
148816655|NCT03188185|536803984|FG003|Stage 1|Withdrawal by Subject|0|||
148816656|NCT03188185|536803981|FG000|Stage 1|Identified as a professional patient|0|||
148816657|NCT03188185|536803982|FG001|Stage 1|Identified as a professional patient|1|||
148816658|NCT03188185|536803983|FG002|Stage 1|Identified as a professional patient|0|||
148816659|NCT03188185|536803984|FG003|Stage 1|Identified as a professional patient|0|||
148816660|NCT03188185|536803981|FG000|Stage 2|Adverse Event|0|||
148816661|NCT03188185|536803982|FG001|Stage 2|Adverse Event|0|||
148816662|NCT03188185|536803983|FG002|Stage 2|Adverse Event|2|||
148816663|NCT03188185|536803984|FG003|Stage 2|Adverse Event|4|||
148816664|NCT03188185|536803981|FG000|Stage 2|Lack of Efficacy|0|||
148816665|NCT03188185|536803982|FG001|Stage 2|Lack of Efficacy|0|||
148816666|NCT03188185|536803983|FG002|Stage 2|Lack of Efficacy|3|||
148816667|NCT03188185|536803984|FG003|Stage 2|Lack of Efficacy|0|||
148816668|NCT03188185|536803981|FG000|Stage 2|Lost to Follow-up|0|||
148816669|NCT03188185|536803982|FG001|Stage 2|Lost to Follow-up|0|||
148816670|NCT03188185|536803983|FG002|Stage 2|Lost to Follow-up|1|||
148816671|NCT03188185|536803984|FG003|Stage 2|Lost to Follow-up|0|||
148816672|NCT03188185|536803981|FG000|Stage 2|Physician Decision|0|||
148816673|NCT03188185|536803982|FG001|Stage 2|Physician Decision|0|||
148816674|NCT03188185|536803983|FG002|Stage 2|Physician Decision|0|||
148816675|NCT03188185|536803984|FG003|Stage 2|Physician Decision|1|||
148816676|NCT03188185|536803981|FG000|Stage 2|Withdrawal by Subject|0|||
148816677|NCT03188185|536803982|FG001|Stage 2|Withdrawal by Subject|0|||
148816678|NCT03188185|536803983|FG002|Stage 2|Withdrawal by Subject|3|||
148816679|NCT03188185|536803984|FG003|Stage 2|Withdrawal by Subject|1|||
148816680|NCT00774748|536803985|FG000|Overall Study|Lost to Follow-up|3|||
148816681|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
148816682|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
148816683|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
148816684|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
148816685|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
148816686|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
148816687|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
148816688|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
148816689|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
148816690|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
148816691|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
148816692|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
148816693|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
148816694|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
148816695|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
148816696|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
148816697|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
148816698|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
148816699|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
148816700|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
148816701|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
148816702|NCT02337946|536803988|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
148816703|NCT02337946|536803989|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
148816704|NCT02337946|536803990|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
148971108|NCT01116232|537378194|FG000|Overall Study|Progressive diease|4|||
148816705|NCT02337946|536803988|FG000|In-between Period|Without Informed Consent|1|||
148816706|NCT02337946|536803989|FG001|In-between Period|Without Informed Consent|0|||
148816707|NCT02337946|536803990|FG002|In-between Period|Without Informed Consent|0|||
148816708|NCT02337946|536803988|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
148816709|NCT02337946|536803989|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
148816710|NCT02337946|536803990|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
148816711|NCT02337946|536803988|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
148816712|NCT02337946|536803989|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
148816713|NCT02337946|536803990|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
148816714|NCT02337946|536803988|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
148816715|NCT02337946|536803989|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
148816716|NCT02337946|536803990|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
148816717|NCT02337946|536803988|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
148816718|NCT02337946|536803989|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
148816719|NCT02337946|536803990|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
148816720|NCT02337946|536803988|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
148816721|NCT02337946|536803989|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
148816722|NCT02337946|536803990|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
148971109|NCT03554291|537378195|FG000|Overall Study|Death|2|||
148971110|NCT03554291|537378196|FG001|Overall Study|Death|1|||
148971111|NCT03554291|537378195|FG000|Overall Study|Lost to Follow-up|1|||
148971112|NCT03554291|537378196|FG001|Overall Study|Lost to Follow-up|0|||
148971113|NCT03554291|537378195|FG000|Overall Study|Withdrawal by Subject|1|||
148971114|NCT03554291|537378196|FG001|Overall Study|Withdrawal by Subject|0|||
148971115|NCT03554291|537378195|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
148971116|NCT03554291|537378196|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
148725677|NCT05506358|536468151|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
148725678|NCT05506358|536468152|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
148725679|NCT05506358|536468153|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
148725680|NCT05506358|536468154|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
148725681|NCT05506358|536468150|FG000|Overall Study|HbE trait|0|||
148725682|NCT05506358|536468151|FG001|Overall Study|HbE trait|0|||
148725683|NCT05506358|536468152|FG002|Overall Study|HbE trait|0|||
148725684|NCT05506358|536468153|FG003|Overall Study|HbE trait|1|||
148725685|NCT05506358|536468154|FG004|Overall Study|HbE trait|0|||
148725686|NCT02017860|536468158|FG000|Overall Study|Adverse Event|1|||
148725687|NCT02017860|536468158|FG000|Overall Study|Withdrawal by Subject|1|||
148725688|NCT03336242|536468163|FG000|Overall Study|Adverse Event|0|||
148725689|NCT03336242|536468164|FG001|Overall Study|Adverse Event|1|||
148725690|NCT02457611|536468168|FG000|Overall Study|Lost to Follow-up|3|||
148725691|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
148725692|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
148725693|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
148725694|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
148725695|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
148725696|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
148725697|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
148725698|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
148725699|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
148725700|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
148725701|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
148725702|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
148725703|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
148725704|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
148725705|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
148725706|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
148725707|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
148725708|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
148725709|NCT00384293|536468169|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
148725710|NCT00384293|536468170|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
148725711|NCT00384293|536468171|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
148725712|NCT00384293|536468169|FG000|Post-randomization Period|Adverse Event|0|||
148725713|NCT00384293|536468170|FG001|Post-randomization Period|Adverse Event|23|||
148725714|NCT00384293|536468171|FG002|Post-randomization Period|Adverse Event|7|||
148725715|NCT00384293|536468169|FG000|Post-randomization Period|Lost to Follow-up|0|||
148725716|NCT00384293|536468170|FG001|Post-randomization Period|Lost to Follow-up|2|||
148725717|NCT00384293|536468171|FG002|Post-randomization Period|Lost to Follow-up|1|||
148725718|NCT00384293|536468169|FG000|Post-randomization Period|Protocol Violation|0|||
148725719|NCT00384293|536468170|FG001|Post-randomization Period|Protocol Violation|1|||
148725720|NCT00384293|536468171|FG002|Post-randomization Period|Protocol Violation|0|||
148725721|NCT00384293|536468169|FG000|Post-randomization Period|Withdrawal by Subject|0|||
148725722|NCT00384293|536468170|FG001|Post-randomization Period|Withdrawal by Subject|8|||
148725723|NCT00384293|536468171|FG002|Post-randomization Period|Withdrawal by Subject|6|||
148725724|NCT00384293|536468169|FG000|Post-randomization Period|Trial Termination|0|||
148725725|NCT00384293|536468170|FG001|Post-randomization Period|Trial Termination|180|||
148725726|NCT00384293|536468171|FG002|Post-randomization Period|Trial Termination|204|||
148725727|NCT00384293|536468169|FG000|Post-randomization Period|Patient Randomized in Error|0|||
148725728|NCT00384293|536468170|FG001|Post-randomization Period|Patient Randomized in Error|0|||
148725729|NCT00384293|536468171|FG002|Post-randomization Period|Patient Randomized in Error|1|||
148725730|NCT03005067|536468172|FG000|Overall Study|Withdrawal by Subject|3|||
148725731|NCT03005067|536468173|FG001|Overall Study|Withdrawal by Subject|2|||
148725732|NCT03005067|536468172|FG000|Overall Study|Adverse Event|4|||
148725733|NCT03005067|536468173|FG001|Overall Study|Adverse Event|3|||
148725734|NCT03005067|536468172|FG000|Overall Study|Other (reason not specified)|3|||
148725735|NCT03005067|536468173|FG001|Overall Study|Other (reason not specified)|1|||
148816723|NCT02337946|536803988|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
148971117|NCT01524627|537378201|FG000|Overall Study|Physician Decision|0|||
148725736|NCT03005067|536468172|FG000|Overall Study|Protocol Violation|0|||
148725737|NCT03005067|536468173|FG001|Overall Study|Protocol Violation|1|||
148971118|NCT01524627|537378202|FG001|Overall Study|Physician Decision|1|||
148971119|NCT01524627|537378201|FG000|Overall Study|Lost to Follow-up|1|||
148971120|NCT01524627|537378202|FG001|Overall Study|Lost to Follow-up|1|||
148971121|NCT00969553|537378203|FG000|Overall Study|Progressive disease (PD)|2|||
148971122|NCT00969553|537378204|FG001|Overall Study|Progressive disease (PD)|2|||
148971123|NCT00969553|537378205|FG002|Overall Study|Progressive disease (PD)|6|||
148971124|NCT00969553|537378206|FG003|Overall Study|Progressive disease (PD)|9|||
148971125|NCT00969553|537378207|FG004|Overall Study|Progressive disease (PD)|2|||
148971126|NCT00969553|537378208|FG005|Overall Study|Progressive disease (PD)|4|||
148971127|NCT00969553|537378209|FG006|Overall Study|Progressive disease (PD)|2|||
148971128|NCT00969553|537378210|FG007|Overall Study|Progressive disease (PD)|12|||
148971129|NCT00969553|537378211|FG008|Overall Study|Progressive disease (PD)|3|||
148971130|NCT00969553|537378203|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971131|NCT00969553|537378204|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971132|NCT00969553|537378205|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971133|NCT00969553|537378206|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971134|NCT00969553|537378207|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
148971135|NCT00969553|537378208|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971136|NCT00969553|537378209|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971137|NCT00969553|537378210|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971138|NCT00969553|537378211|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
148971139|NCT00969553|537378203|FG000|Overall Study|Other Adverse Event|0|||
148971140|NCT00969553|537378204|FG001|Overall Study|Other Adverse Event|0|||
148971141|NCT00969553|537378205|FG002|Overall Study|Other Adverse Event|0|||
148971142|NCT00969553|537378206|FG003|Overall Study|Other Adverse Event|1|||
148971143|NCT00969553|537378207|FG004|Overall Study|Other Adverse Event|0|||
148971144|NCT00969553|537378208|FG005|Overall Study|Other Adverse Event|0|||
148971145|NCT00969553|537378209|FG006|Overall Study|Other Adverse Event|1|||
148971146|NCT00969553|537378210|FG007|Overall Study|Other Adverse Event|0|||
148971147|NCT00969553|537378211|FG008|Overall Study|Other Adverse Event|0|||
148971148|NCT00969553|537378203|FG000|Overall Study|Refused cont. medication|1|||
148971149|NCT00969553|537378204|FG001|Overall Study|Refused cont. medication|1|||
148971150|NCT00969553|537378205|FG002|Overall Study|Refused cont. medication|0|||
148971151|NCT00969553|537378206|FG003|Overall Study|Refused cont. medication|2|||
148971152|NCT00969553|537378207|FG004|Overall Study|Refused cont. medication|0|||
148971153|NCT00969553|537378208|FG005|Overall Study|Refused cont. medication|0|||
148971154|NCT00969553|537378209|FG006|Overall Study|Refused cont. medication|0|||
148971155|NCT00969553|537378210|FG007|Overall Study|Refused cont. medication|1|||
148971156|NCT00969553|537378211|FG008|Overall Study|Refused cont. medication|0|||
148971157|NCT00969553|537378203|FG000|Overall Study|Not specified above|0|||
148971158|NCT00969553|537378204|FG001|Overall Study|Not specified above|0|||
148971159|NCT00969553|537378205|FG002|Overall Study|Not specified above|0|||
148971160|NCT00969553|537378206|FG003|Overall Study|Not specified above|4|||
148971161|NCT00969553|537378207|FG004|Overall Study|Not specified above|0|||
148971162|NCT00969553|537378208|FG005|Overall Study|Not specified above|0|||
148971163|NCT00969553|537378209|FG006|Overall Study|Not specified above|1|||
148971164|NCT00969553|537378210|FG007|Overall Study|Not specified above|1|||
148971165|NCT00969553|537378211|FG008|Overall Study|Not specified above|0|||
148971166|NCT03350503|537378212|FG000|Overall Study|Adverse Event|5|||
148971167|NCT03350503|537378212|FG000|Overall Study|Withdrawal by Subject|5|||
148971168|NCT03350503|537378212|FG000|Overall Study|Continuation impossible due to move|4|||
148725738|NCT02674386|536468180|FG000|Overall Study|Lost to Follow-up|0|||
148971169|NCT03350503|537378212|FG000|Overall Study|Physician Decision|3|||
148971170|NCT03962543|537378215|FG000|Treatment Phase|Death|0|||
148971171|NCT03962543|537378216|FG001|Treatment Phase|Death|1|||
148971172|NCT03962543|537378215|FG000|Treatment Phase|Withdrawal by Subject|3|||
148971173|NCT03962543|537378216|FG001|Treatment Phase|Withdrawal by Subject|0|||
148971174|NCT03962543|537378215|FG000|Treatment Phase|Adverse Event|3|||
148971175|NCT03962543|537378216|FG001|Treatment Phase|Adverse Event|12|||
148971176|NCT03962543|537378215|FG000|Treatment Phase|Lost to Follow-up|1|||
148971177|NCT03962543|537378216|FG001|Treatment Phase|Lost to Follow-up|2|||
148971178|NCT03962543|537378215|FG000|Treatment Phase|Radiographic PD|9|||
148971179|NCT03962543|537378216|FG001|Treatment Phase|Radiographic PD|3|||
148971180|NCT03962543|537378215|FG000|Treatment Phase|Participant Decision|3|||
148971181|NCT03962543|537378216|FG001|Treatment Phase|Participant Decision|8|||
148971182|NCT03962543|537378215|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
148971183|NCT03962543|537378216|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
148971184|NCT03962543|537378215|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
148971185|NCT03962543|537378216|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
148725739|NCT02674386|536468181|FG001|Overall Study|Lost to Follow-up|1|||
148971186|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
148971187|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
148971188|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
148725740|NCT02674386|536468182|FG002|Overall Study|Lost to Follow-up|1|||
149025742|NCT02624778|537571865|FG008|Overall Study|Adverse Event|2|||
148725741|NCT02674386|536468180|FG000|Overall Study|Withdrawal by Subject|0|||
148725742|NCT02674386|536468181|FG001|Overall Study|Withdrawal by Subject|4|||
148725743|NCT02674386|536468182|FG002|Overall Study|Withdrawal by Subject|0|||
148725744|NCT02674386|536468180|FG000|Overall Study|Other|0|||
148725745|NCT02674386|536468181|FG001|Overall Study|Other|1|||
148725746|NCT02674386|536468182|FG002|Overall Study|Other|0|||
148725747|NCT02674386|536468180|FG000|Overall Study|Enrolled but not evaluated|0|||
148725748|NCT02674386|536468181|FG001|Overall Study|Enrolled but not evaluated|4|||
148971189|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
148971190|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
148971191|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
148971192|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
148971193|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
148971194|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
148971195|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
148971196|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
148971197|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
148971198|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
148971199|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
148971200|NCT03962543|537378215|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
148971201|NCT03962543|537378216|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
148971202|NCT01589822|537379765|FG000|Overall Study|Withdrawal by Subject|1|||
148971203|NCT01589822|537379766|FG001|Overall Study|Withdrawal by Subject|2|||
148971204|NCT01589822|537379767|FG002|Overall Study|Withdrawal by Subject|0|||
148971205|NCT01589822|537379765|FG000|Overall Study|Death|1|||
148971206|NCT01589822|537379766|FG001|Overall Study|Death|0|||
148971207|NCT01589822|537379767|FG002|Overall Study|Death|0|||
148971208|NCT01589822|537379765|FG000|Overall Study|Missed 90 day visit|2|||
148971209|NCT01589822|537379766|FG001|Overall Study|Missed 90 day visit|1|||
148971210|NCT01589822|537379767|FG002|Overall Study|Missed 90 day visit|1|||
148971211|NCT05168475|537379768|FG000|Period 1|Protocol Violation|1|||
148971212|NCT05168475|537379768|FG000|Period 1|IMP shortage|2|||
148971213|NCT05168475|537379768|FG000|Period 1|Not randomised|2|||
148971214|NCT05168475|537379768|FG000|Period 2|IMP shortage|1|||
148971215|NCT04482179|537379769|FG000|Overall Study|Death|1|||
148971216|NCT04482179|537379770|FG001|Overall Study|Death|0|||
148971217|NCT04482179|537379769|FG000|Overall Study|Withdrawal by Subject|1|||
148971218|NCT04482179|537379770|FG001|Overall Study|Withdrawal by Subject|0|||
148725749|NCT02674386|536468182|FG002|Overall Study|Enrolled but not evaluated|0|||
148725750|NCT00351351|536468188|FG000|Overall Study|surgical access pbs; device issues|9|||
148725751|NCT00351351|536468189|FG001|Overall Study|surgical access pbs; device issues|4|||
148725752|NCT03176784|536468191|FG000|Overall Study|Lost to Follow-up|77|||
148725753|NCT03176784|536468192|FG001|Overall Study|Lost to Follow-up|79|||
148725754|NCT03176784|536468193|FG002|Overall Study|Lost to Follow-up|79|||
148725755|NCT03176784|536468194|FG003|Overall Study|Lost to Follow-up|49|||
148725756|NCT03176784|536468191|FG000|Overall Study|Withdrawal by Subject|28|||
148725757|NCT03176784|536468192|FG001|Overall Study|Withdrawal by Subject|34|||
148725758|NCT03176784|536468193|FG002|Overall Study|Withdrawal by Subject|34|||
148725759|NCT03176784|536468194|FG003|Overall Study|Withdrawal by Subject|21|||
148725760|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
148725761|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
148725762|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
148725763|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
148725764|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
148725765|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
148725766|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
148725767|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
148725768|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
148725769|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
148971219|NCT01302964|537379771|FG000|Overall Study|Adverse Event|1|||
148971220|NCT01302964|537379772|FG001|Overall Study|Adverse Event|0|||
148725770|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
148971221|NCT04127786|537379775|FG000|Primary Series|Adverse Event|1|||
148971222|NCT04127786|537379776|FG001|Primary Series|Adverse Event|0|||
148971223|NCT04127786|537379777|FG002|Primary Series|Adverse Event|0|||
148971224|NCT04127786|537379778|FG003|Primary Series|Adverse Event|1|||
148971225|NCT04127786|537379779|FG004|Primary Series|Adverse Event|0|||
148971226|NCT04127786|537379780|FG005|Primary Series|Adverse Event|1|||
148971227|NCT04127786|537379775|FG000|Primary Series|Protocol Violation|5|||
148725771|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
148971228|NCT04127786|537379776|FG001|Primary Series|Protocol Violation|3|||
148971229|NCT04127786|537379777|FG002|Primary Series|Protocol Violation|4|||
148971230|NCT04127786|537379778|FG003|Primary Series|Protocol Violation|3|||
148971231|NCT04127786|537379779|FG004|Primary Series|Protocol Violation|2|||
148971232|NCT04127786|537379780|FG005|Primary Series|Protocol Violation|0|||
148971233|NCT04127786|537379775|FG000|Primary Series|Withdrawal by Subject|0|||
148971234|NCT04127786|537379776|FG001|Primary Series|Withdrawal by Subject|0|||
149025743|NCT02624778|537571857|FG000|Overall Study|Death|0|||
149025744|NCT02624778|537571858|FG001|Overall Study|Death|0|||
148725772|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
148725773|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
148725774|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
148725775|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
148725776|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
148725777|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
148725778|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
148725779|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
148725780|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
148725781|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
148725782|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
148725783|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
148725784|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
148725785|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
148725786|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
148725787|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
148725788|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Death|0|||
148725789|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Death|1|||
148725790|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Death|0|||
148725791|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Death|0|||
148725792|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
148725793|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
148888943|NCT02159066|537072258|FG005|Part II|Physician Decision|0|||
148888944|NCT02159066|537072253|FG000|Part II|Participant/Guardian Decision|0|||
148888945|NCT02159066|537072254|FG001|Part II|Participant/Guardian Decision|0|||
148888946|NCT02159066|537072255|FG002|Part II|Participant/Guardian Decision|0|||
148888947|NCT02159066|537072256|FG003|Part II|Participant/Guardian Decision|0|||
148888948|NCT02159066|537072257|FG004|Part II|Participant/Guardian Decision|2|||
148888949|NCT02159066|537072258|FG005|Part II|Participant/Guardian Decision|0|||
148888950|NCT01135134|537072259|FG000|Overall Study|Adverse Event|1|||
148888951|NCT01135134|537072260|FG001|Overall Study|Adverse Event|1|||
148888952|NCT01135134|537072259|FG000|Overall Study|Did not meet protocol eligibility|1|||
148888953|NCT01135134|537072260|FG001|Overall Study|Did not meet protocol eligibility|0|||
148888954|NCT05470387|537072265|FG000|Overall Study|Protocol Violation|0|||
148888955|NCT05470387|537072266|FG001|Overall Study|Protocol Violation|3|||
148888956|NCT01255423|537072267|FG000|Overall Study|Abnormal Laboratory value|3|||
148888957|NCT01255423|537072268|FG001|Overall Study|Abnormal Laboratory value|2|||
148888958|NCT01255423|537072267|FG000|Overall Study|Use of prohibited medications|0|||
148888959|NCT01255423|537072268|FG001|Overall Study|Use of prohibited medications|1|||
148888960|NCT01858363|537072271|FG000|Overall Study|Death|35|||
148888961|NCT01858363|537072272|FG001|Overall Study|Death|9|||
148888962|NCT01858363|537072271|FG000|Overall Study|Withdrawal by Subject|28|||
148888963|NCT01858363|537072272|FG001|Overall Study|Withdrawal by Subject|14|||
148888964|NCT01858363|537072271|FG000|Overall Study|Lost to Follow-up|13|||
148888965|NCT01858363|537072272|FG001|Overall Study|Lost to Follow-up|3|||
148888966|NCT01859923|537072273|FG000|Overall Study|Adverse Event|0|||
148888967|NCT01859923|537072274|FG001|Overall Study|Adverse Event|0|||
148888968|NCT01859923|537072275|FG002|Overall Study|Adverse Event|1|||
148888969|NCT01859923|537072276|FG003|Overall Study|Adverse Event|1|||
148888970|NCT00057863|537072282|FG000|Overall Study|Death|1|||
148888971|NCT00057863|537072282|FG000|Overall Study|Withdrawal by Subject|2|||
148888972|NCT00764361|537072283|FG000|Overall Study|Withdrawal by Subject|2|||
148888973|NCT00764361|537072284|FG001|Overall Study|Withdrawal by Subject|3|||
148888974|NCT00764361|537072283|FG000|Overall Study|Adverse Event|0|||
148888975|NCT00764361|537072284|FG001|Overall Study|Adverse Event|1|||
148888976|NCT02090426|537072285|FG000|Overall Study|Lost to Follow-up|12|||
148888977|NCT02090426|537072286|FG001|Overall Study|Lost to Follow-up|6|||
148888978|NCT02079038|537072290|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
148888979|NCT02079038|537072291|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
148888980|NCT02079038|537072290|FG000|Modified Intent to Treat Population|Death|1|||
148888981|NCT02079038|537072291|FG001|Modified Intent to Treat Population|Death|0|||
148888982|NCT02079038|537072290|FG000|Completed 6 Months|Lost to Follow-up|2|||
148888983|NCT02079038|537072291|FG001|Completed 6 Months|Lost to Follow-up|1|||
148888984|NCT03480152|537072292|FG000|Phase I|Signed consent. Died before treatment.|1|||
148888985|NCT03480152|537072293|FG001|Phase I|Signed consent. Died before treatment.|0|||
148888986|NCT03480152|537072294|FG002|Phase I|Signed consent. Died before treatment.|0|||
148888987|NCT01308736|537072295|FG000|Overall Study|Did not attend a single session|6|||
148888988|NCT01308736|537072296|FG001|Overall Study|Did not attend a single session|5|||
148888989|NCT03634085|537072297|FG000|Overall Study|Adverse Event|1|||
148888990|NCT03634085|537072298|FG001|Overall Study|Adverse Event|0|||
148888991|NCT03634085|537072297|FG000|Overall Study|Withdrawal by Subject|0|||
148971235|NCT04127786|537379777|FG002|Primary Series|Withdrawal by Subject|0|||
148971236|NCT04127786|537379778|FG003|Primary Series|Withdrawal by Subject|1|||
148971237|NCT04127786|537379779|FG004|Primary Series|Withdrawal by Subject|0|||
148971238|NCT04127786|537379780|FG005|Primary Series|Withdrawal by Subject|0|||
148971239|NCT04127786|537379775|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
148971240|NCT04127786|537379776|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
148971241|NCT04127786|537379777|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
148971242|NCT04127786|537379778|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
148971243|NCT04127786|537379779|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
148971244|NCT04127786|537379780|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
148971245|NCT04127786|537379775|FG000|Booster Phase|Withdrawal by Subject|2|||
148971246|NCT04127786|537379776|FG001|Booster Phase|Withdrawal by Subject|0|||
148971247|NCT04127786|537379777|FG002|Booster Phase|Withdrawal by Subject|0|||
148971248|NCT04127786|537379778|FG003|Booster Phase|Withdrawal by Subject|0|||
148971249|NCT04127786|537379779|FG004|Booster Phase|Withdrawal by Subject|0|||
148971250|NCT04127786|537379780|FG005|Booster Phase|Withdrawal by Subject|0|||
148971251|NCT03569371|537379783|FG000|Overall Study|Lack of Efficacy|1|||
148971252|NCT03569371|537379783|FG000|Overall Study|Lost to Follow-up|1|||
148971253|NCT03569371|537379783|FG000|Overall Study|Adverse Event|1|||
148971254|NCT02347527|537379784|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
148971255|NCT02347527|537379785|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
148971256|NCT02347527|537379786|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
148971257|NCT02347527|537379787|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
148971258|NCT02347527|537379784|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
148971259|NCT02347527|537379785|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
148971260|NCT02347527|537379786|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
148971261|NCT02347527|537379787|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
148971262|NCT02347527|537379784|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
148971263|NCT02347527|537379785|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
148971264|NCT02347527|537379786|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
148971265|NCT02347527|537379787|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
148971266|NCT02347527|537379784|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
148971267|NCT02347527|537379785|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
148971268|NCT02347527|537379786|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
148971269|NCT02347527|537379787|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
148971270|NCT02347527|537379784|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
148971271|NCT02347527|537379785|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
148971272|NCT02347527|537379786|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
148971273|NCT02347527|537379787|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
148971274|NCT00596011|537379788|FG000|Overall Study|Withdrawal by Subject|2|||
148971275|NCT00596011|537379789|FG001|Overall Study|Withdrawal by Subject|3|||
148971276|NCT00596011|537379788|FG000|Overall Study|Adverse Event|11|||
148971277|NCT00596011|537379789|FG001|Overall Study|Adverse Event|7|||
148971278|NCT00192075|537379790|FG000|Overall Study|Disease Progression|23|||
148971279|NCT00192075|537379791|FG001|Overall Study|Disease Progression|6|||
148971280|NCT00192075|537379790|FG000|Overall Study|Adverse Event|1|||
148971281|NCT00192075|537379791|FG001|Overall Study|Adverse Event|3|||
148971282|NCT00192075|537379790|FG000|Overall Study|Death|0|||
148971283|NCT00192075|537379791|FG001|Overall Study|Death|1|||
148971284|NCT00192075|537379790|FG000|Overall Study|Lack of Efficacy|0|||
148971285|NCT00192075|537379791|FG001|Overall Study|Lack of Efficacy|0|||
148971286|NCT00192075|537379790|FG000|Overall Study|Physician Decision|3|||
148971287|NCT00192075|537379791|FG001|Overall Study|Physician Decision|0|||
148971288|NCT00192075|537379790|FG000|Overall Study|Withdrawal by Subject|5|||
148971289|NCT00192075|537379791|FG001|Overall Study|Withdrawal by Subject|5|||
148971290|NCT00192075|537379790|FG000|Overall Study|Patient Non-Compliance|0|||
148971291|NCT00192075|537379791|FG001|Overall Study|Patient Non-Compliance|1|||
148971292|NCT00192075|537379790|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
148971293|NCT00192075|537379791|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
148971294|NCT00192075|537379790|FG000|Overall Study|Other|5|||
148971295|NCT00192075|537379791|FG001|Overall Study|Other|2|||
149025745|NCT02624778|537571859|FG002|Overall Study|Death|0|||
149025746|NCT02624778|537571860|FG003|Overall Study|Death|0|||
148971296|NCT00706966|537379795|FG000|Overall Study|Adverse Event|1|||
148725794|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
148971297|NCT01631474|537379796|FG000|Overall Study|Lost to Follow-up|8|||
148971298|NCT01631474|537379797|FG001|Overall Study|Lost to Follow-up|5|||
148971299|NCT01631474|537379798|FG002|Overall Study|Lost to Follow-up|7|||
149025747|NCT02624778|537571861|FG004|Overall Study|Death|0|||
148971300|NCT01631474|537379799|FG003|Overall Study|Lost to Follow-up|5|||
148971301|NCT01631474|537379800|FG004|Overall Study|Lost to Follow-up|5|||
148971302|NCT01631474|537379796|FG000|Overall Study|Withdrawal by Subject|4|||
148971303|NCT01631474|537379797|FG001|Overall Study|Withdrawal by Subject|4|||
148971304|NCT01631474|537379798|FG002|Overall Study|Withdrawal by Subject|2|||
148971305|NCT01631474|537379799|FG003|Overall Study|Withdrawal by Subject|6|||
148971306|NCT01631474|537379800|FG004|Overall Study|Withdrawal by Subject|5|||
148971307|NCT01631474|537379796|FG000|Overall Study|Lack of Efficacy|2|||
148971308|NCT01631474|537379797|FG001|Overall Study|Lack of Efficacy|2|||
148971309|NCT01631474|537379798|FG002|Overall Study|Lack of Efficacy|0|||
148971310|NCT01631474|537379799|FG003|Overall Study|Lack of Efficacy|0|||
148971311|NCT01631474|537379800|FG004|Overall Study|Lack of Efficacy|2|||
148971312|NCT01631474|537379796|FG000|Overall Study|Noncompliance with Study Drug|0|||
148971313|NCT01631474|537379797|FG001|Overall Study|Noncompliance with Study Drug|0|||
148971314|NCT01631474|537379798|FG002|Overall Study|Noncompliance with Study Drug|0|||
148971315|NCT01631474|537379799|FG003|Overall Study|Noncompliance with Study Drug|0|||
148971316|NCT01631474|537379800|FG004|Overall Study|Noncompliance with Study Drug|1|||
148971317|NCT01631474|537379796|FG000|Overall Study|Adverse Event|0|||
148971318|NCT01631474|537379797|FG001|Overall Study|Adverse Event|1|||
148971319|NCT01631474|537379798|FG002|Overall Study|Adverse Event|0|||
148971320|NCT01631474|537379799|FG003|Overall Study|Adverse Event|0|||
148971321|NCT01631474|537379800|FG004|Overall Study|Adverse Event|0|||
148971322|NCT01467076|537379801|FG000|Overall Study|Lost to Follow-up|1|||
148971323|NCT01467076|537379802|FG001|Overall Study|Lost to Follow-up|0|||
148971324|NCT01467076|537379803|FG002|Overall Study|Lost to Follow-up|0|||
148971325|NCT05288556|537379809|FG000|Overall Study|Protocol Violation|1|||
148971326|NCT05288556|537379809|FG000|Overall Study|Withdrawal by Subject|1|||
148971327|NCT02465528|537379810|FG000|Overall Study|Progressive disease|0|||
148971328|NCT02465528|537379811|FG001|Overall Study|Progressive disease|2|||
148971329|NCT02465528|537379812|FG002|Overall Study|Progressive disease|9|||
148971330|NCT02465528|537379813|FG003|Overall Study|Progressive disease|4|||
148971331|NCT02465528|537379810|FG000|Overall Study|Study terminated by sponsor|1|||
148971332|NCT02465528|537379811|FG001|Overall Study|Study terminated by sponsor|2|||
148971333|NCT02465528|537379812|FG002|Overall Study|Study terminated by sponsor|0|||
149025748|NCT02624778|537571862|FG005|Overall Study|Death|0|||
149025749|NCT02624778|537571863|FG006|Overall Study|Death|1|||
149025750|NCT02624778|537571864|FG007|Overall Study|Death|0|||
149025751|NCT02624778|537571865|FG008|Overall Study|Death|0|||
148725795|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
148725796|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
148725797|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
148725798|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
148725799|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
148725800|NCT02990806|536468195|FG000|Stage 1 (22 Weeks)|Other|1|||
148725801|NCT02990806|536468196|FG001|Stage 1 (22 Weeks)|Other|3|||
148725802|NCT02990806|536468197|FG002|Stage 1 (22 Weeks)|Other|0|||
148725803|NCT02990806|536468198|FG003|Stage 1 (22 Weeks)|Other|0|||
148725804|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
148725805|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
148725806|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
148725807|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
148725808|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Death|1|||
148725809|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Death|0|||
148725810|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Death|0|||
148725811|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Death|0|||
148725812|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
148725813|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
148725814|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
148725815|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
148725816|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
148725817|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
148725818|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
148725819|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
148725820|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
148725821|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
148725822|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
148725823|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
149025752|NCT02624778|537571857|FG000|Overall Study|Physician Decision|0|||
149025753|NCT02624778|537571858|FG001|Overall Study|Physician Decision|0|||
148725824|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
148725825|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
148971334|NCT02465528|537379813|FG003|Overall Study|Study terminated by sponsor|0|||
148971335|NCT02465528|537379810|FG000|Overall Study|Withdrawal by Subject|0|||
148971336|NCT02465528|537379811|FG001|Overall Study|Withdrawal by Subject|0|||
148971337|NCT02465528|537379812|FG002|Overall Study|Withdrawal by Subject|2|||
149025754|NCT02624778|537571859|FG002|Overall Study|Physician Decision|0|||
148971338|NCT02465528|537379813|FG003|Overall Study|Withdrawal by Subject|0|||
148725826|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
148725827|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
148725828|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
148725829|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
148725830|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
148725831|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
148971339|NCT02465528|537379810|FG000|Overall Study|Adverse Event|0|||
148971340|NCT02465528|537379811|FG001|Overall Study|Adverse Event|0|||
148971341|NCT02465528|537379812|FG002|Overall Study|Adverse Event|0|||
148971342|NCT02465528|537379813|FG003|Overall Study|Adverse Event|1|||
148971343|NCT02465528|537379810|FG000|Overall Study|Physician Decision|0|||
148971344|NCT02465528|537379811|FG001|Overall Study|Physician Decision|0|||
148971345|NCT02465528|537379812|FG002|Overall Study|Physician Decision|1|||
148725832|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
148971346|NCT02465528|537379813|FG003|Overall Study|Physician Decision|0|||
148971347|NCT03752619|537379816|FG000|Overall Study|Lost to Follow-up|2|||
148971348|NCT03752619|537379817|FG001|Overall Study|Lost to Follow-up|1|||
148971349|NCT03752619|537379816|FG000|Overall Study|Withdrawal by Subject|1|||
148971350|NCT03752619|537379817|FG001|Overall Study|Withdrawal by Subject|1|||
148971351|NCT03752619|537379816|FG000|Overall Study|Adverse Event|0|||
148971352|NCT03752619|537379817|FG001|Overall Study|Adverse Event|1|||
148971353|NCT05040152|537379818|FG000|Overall Study|Withdrawal by Subject|5|||
148971354|NCT05040152|537379819|FG001|Overall Study|Withdrawal by Subject|0|||
148971355|NCT05040152|537379818|FG000|Overall Study|Lost to Follow-up|0|||
148971356|NCT05040152|537379819|FG001|Overall Study|Lost to Follow-up|2|||
148971357|NCT03907683|537379820|FG000|Overall Study|Pregnancy|1|||
148971358|NCT03907683|537379820|FG000|Overall Study|Withdrawal by Subject|1|||
148971359|NCT03400332|537379821|FG000|Pre-Treatment|Other reasons|0|||
148971360|NCT03400332|537379822|FG001|Pre-Treatment|Other reasons|0|||
148971361|NCT03400332|537379823|FG002|Pre-Treatment|Other reasons|0|||
148971362|NCT03400332|537379824|FG003|Pre-Treatment|Other reasons|0|||
148971363|NCT03400332|537379825|FG004|Pre-Treatment|Other reasons|0|||
148971364|NCT03400332|537379826|FG005|Pre-Treatment|Other reasons|0|||
148971365|NCT03400332|537379827|FG006|Pre-Treatment|Other reasons|0|||
148971366|NCT03400332|537379828|FG007|Pre-Treatment|Other reasons|0|||
148971367|NCT03400332|537379829|FG008|Pre-Treatment|Other reasons|1|||
148971368|NCT03400332|537379821|FG000|Pre-Treatment|No longer met study criteria|0|||
148971369|NCT03400332|537379822|FG001|Pre-Treatment|No longer met study criteria|0|||
148971370|NCT03400332|537379823|FG002|Pre-Treatment|No longer met study criteria|0|||
148971371|NCT03400332|537379824|FG003|Pre-Treatment|No longer met study criteria|0|||
148971372|NCT03400332|537379825|FG004|Pre-Treatment|No longer met study criteria|0|||
148971373|NCT03400332|537379826|FG005|Pre-Treatment|No longer met study criteria|0|||
148971374|NCT03400332|537379827|FG006|Pre-Treatment|No longer met study criteria|0|||
148971375|NCT03400332|537379828|FG007|Pre-Treatment|No longer met study criteria|0|||
148971376|NCT03400332|537379829|FG008|Pre-Treatment|No longer met study criteria|1|||
148971377|NCT03400332|537379821|FG000|Pre-Treatment|Withdrawal by Subject|0|||
148971378|NCT03400332|537379822|FG001|Pre-Treatment|Withdrawal by Subject|0|||
148971379|NCT03400332|537379823|FG002|Pre-Treatment|Withdrawal by Subject|0|||
148971380|NCT03400332|537379824|FG003|Pre-Treatment|Withdrawal by Subject|0|||
148971381|NCT03400332|537379825|FG004|Pre-Treatment|Withdrawal by Subject|0|||
148971382|NCT03400332|537379826|FG005|Pre-Treatment|Withdrawal by Subject|0|||
148971383|NCT03400332|537379827|FG006|Pre-Treatment|Withdrawal by Subject|0|||
148971384|NCT03400332|537379828|FG007|Pre-Treatment|Withdrawal by Subject|0|||
148971385|NCT03400332|537379829|FG008|Pre-Treatment|Withdrawal by Subject|1|||
148971386|NCT03400332|537379821|FG000|Treatment|Participant withdrew consent|2|||
148971387|NCT03400332|537379822|FG001|Treatment|Participant withdrew consent|2|||
148971388|NCT03400332|537379823|FG002|Treatment|Participant withdrew consent|0|||
148971389|NCT03400332|537379824|FG003|Treatment|Participant withdrew consent|0|||
148971390|NCT03400332|537379825|FG004|Treatment|Participant withdrew consent|3|||
148725833|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
148725834|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
148971391|NCT03400332|537379826|FG005|Treatment|Participant withdrew consent|3|||
148971392|NCT03400332|537379827|FG006|Treatment|Participant withdrew consent|1|||
148971393|NCT03400332|537379828|FG007|Treatment|Participant withdrew consent|1|||
148971394|NCT03400332|537379829|FG008|Treatment|Participant withdrew consent|1|||
148971395|NCT03400332|537379821|FG000|Treatment|Other reasons|0|||
148971396|NCT03400332|537379822|FG001|Treatment|Other reasons|1|||
148971397|NCT03400332|537379823|FG002|Treatment|Other reasons|1|||
148971398|NCT03400332|537379824|FG003|Treatment|Other reasons|0|||
148971399|NCT03400332|537379825|FG004|Treatment|Other reasons|3|||
148971400|NCT03400332|537379826|FG005|Treatment|Other reasons|1|||
148971401|NCT03400332|537379827|FG006|Treatment|Other reasons|2|||
148971402|NCT03400332|537379828|FG007|Treatment|Other reasons|0|||
148971403|NCT03400332|537379829|FG008|Treatment|Other reasons|1|||
148971404|NCT03400332|537379821|FG000|Treatment|Lost to Follow-up|0|||
149025755|NCT02624778|537571860|FG003|Overall Study|Physician Decision|0|||
148971405|NCT03400332|537379822|FG001|Treatment|Lost to Follow-up|1|||
148971406|NCT03400332|537379823|FG002|Treatment|Lost to Follow-up|0|||
148971407|NCT03400332|537379824|FG003|Treatment|Lost to Follow-up|0|||
148971408|NCT03400332|537379825|FG004|Treatment|Lost to Follow-up|0|||
148971409|NCT03400332|537379826|FG005|Treatment|Lost to Follow-up|0|||
148971410|NCT03400332|537379827|FG006|Treatment|Lost to Follow-up|0|||
148971411|NCT03400332|537379828|FG007|Treatment|Lost to Follow-up|0|||
148971412|NCT03400332|537379829|FG008|Treatment|Lost to Follow-up|0|||
148971413|NCT03400332|537379821|FG000|Treatment|Death|3|||
148971414|NCT03400332|537379822|FG001|Treatment|Death|1|||
148971415|NCT03400332|537379823|FG002|Treatment|Death|2|||
148971416|NCT03400332|537379824|FG003|Treatment|Death|3|||
148971417|NCT03400332|537379825|FG004|Treatment|Death|6|||
148971418|NCT03400332|537379826|FG005|Treatment|Death|2|||
148971419|NCT03400332|537379827|FG006|Treatment|Death|1|||
148971420|NCT03400332|537379828|FG007|Treatment|Death|3|||
148971421|NCT03400332|537379829|FG008|Treatment|Death|6|||
148971422|NCT04476017|537379833|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
148971423|NCT04476017|537379834|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
148971424|NCT02075840|537379835|FG000|Overall Study|Withdrawal by Subject|13|||
148971425|NCT02075840|537379836|FG001|Overall Study|Withdrawal by Subject|22|||
148971426|NCT02075840|537379835|FG000|Overall Study|Reason not specified|1|||
148971427|NCT02075840|537379836|FG001|Overall Study|Reason not specified|0|||
148971428|NCT02075840|537379835|FG000|Overall Study|Adverse Event|0|||
148971429|NCT02075840|537379836|FG001|Overall Study|Adverse Event|2|||
148971430|NCT02075840|537379835|FG000|Overall Study|Death|35|||
148971431|NCT02075840|537379836|FG001|Overall Study|Death|40|||
148971432|NCT02075840|537379835|FG000|Overall Study|Lost to Follow-up|3|||
148971433|NCT02075840|537379836|FG001|Overall Study|Lost to Follow-up|2|||
148971434|NCT02075840|537379835|FG000|Overall Study|Physician Decision|1|||
148971435|NCT02075840|537379836|FG001|Overall Study|Physician Decision|3|||
148971436|NCT02075840|537379835|FG000|Overall Study|Ongoing at CCOD|99|||
148971437|NCT02075840|537379836|FG001|Overall Study|Ongoing at CCOD|82|||
148971438|NCT03795610|537379838|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
148971439|NCT03795610|537379838|FG000|Overall Study|Withdrawal by Subject|1|||
148971440|NCT03795610|537379838|FG000|Overall Study|Screen Failure (Unknown)|1|||
148971441|NCT02775344|537379839|FG000|Overall Study|No ovarian cyst identified|3|||
148971442|NCT02775344|537379840|FG001|Overall Study|No ovarian cyst identified|2|||
148971443|NCT03909165|537379843|FG000|Overall Study|Physician Decision|0|||
148971444|NCT03909165|537379844|FG001|Overall Study|Physician Decision|1|||
148971445|NCT03909165|537379845|FG002|Overall Study|Physician Decision|0|||
148971446|NCT03909165|537379846|FG003|Overall Study|Physician Decision|0|||
148971447|NCT03909165|537379847|FG004|Overall Study|Physician Decision|0|||
148971448|NCT03909165|537379843|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148971449|NCT03909165|537379844|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148971450|NCT03909165|537379845|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148971451|NCT03909165|537379846|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148971452|NCT03909165|537379847|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148971453|NCT03909165|537379843|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
148971454|NCT03909165|537379844|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
148971455|NCT03909165|537379845|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
148971456|NCT03909165|537379846|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
148725835|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
148725836|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
148725837|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
148725838|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
148725839|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
148725840|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
148725841|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
148725842|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
148725843|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
148971457|NCT03909165|537379847|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
148971458|NCT03909165|537379843|FG000|Overall Study|Previous Drug Exposure|0|||
148971459|NCT03909165|537379844|FG001|Overall Study|Previous Drug Exposure|0|||
148971460|NCT03909165|537379845|FG002|Overall Study|Previous Drug Exposure|1|||
148725844|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
148971461|NCT03909165|537379846|FG003|Overall Study|Previous Drug Exposure|0|||
148971462|NCT03909165|537379847|FG004|Overall Study|Previous Drug Exposure|0|||
148971463|NCT03909165|537379843|FG000|Overall Study|Early Discharge|1|||
148971464|NCT03909165|537379844|FG001|Overall Study|Early Discharge|0|||
148725845|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
148971465|NCT03909165|537379845|FG002|Overall Study|Early Discharge|0|||
148971466|NCT03909165|537379846|FG003|Overall Study|Early Discharge|0|||
148971467|NCT03909165|537379847|FG004|Overall Study|Early Discharge|0|||
148971468|NCT00414661|537379848|FG000|Overall Study|Death|2|||
148971469|NCT00414661|537379849|FG001|Overall Study|Death|5|||
148971470|NCT00414661|537379850|FG002|Overall Study|Death|0|||
148971471|NCT00414661|537379851|FG003|Overall Study|Death|0|||
148725846|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
148725847|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
148725848|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Other|3|||
148725849|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Other|0|||
148725850|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Other|4|||
148971472|NCT00414661|537379848|FG000|Overall Study|Lost to Follow-up|1|||
148971473|NCT00414661|537379849|FG001|Overall Study|Lost to Follow-up|4|||
148971474|NCT00414661|537379850|FG002|Overall Study|Lost to Follow-up|0|||
148971475|NCT00414661|537379851|FG003|Overall Study|Lost to Follow-up|1|||
148971476|NCT00414661|537379848|FG000|Overall Study|Withdrawal by Subject|5|||
148971477|NCT00414661|537379849|FG001|Overall Study|Withdrawal by Subject|2|||
148971478|NCT00414661|537379850|FG002|Overall Study|Withdrawal by Subject|2|||
148971479|NCT00414661|537379851|FG003|Overall Study|Withdrawal by Subject|2|||
148971480|NCT00414661|537379848|FG000|Overall Study|Other|6|||
148971481|NCT00414661|537379849|FG001|Overall Study|Other|3|||
148971482|NCT00414661|537379850|FG002|Overall Study|Other|0|||
148971483|NCT00414661|537379851|FG003|Overall Study|Other|0|||
148971484|NCT01554618|537379863|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
148971485|NCT01554618|537379864|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
148971486|NCT01554618|537379863|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
148971487|NCT01554618|537379864|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
148971488|NCT01554618|537379863|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
148971489|NCT01554618|537379864|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
148971490|NCT01554618|537379863|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
148971491|NCT01554618|537379864|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
148971492|NCT01554618|537379863|FG000|Open-Label Extension Period|Physician Decision|0|||
148971493|NCT01554618|537379864|FG001|Open-Label Extension Period|Physician Decision|1|||
148971494|NCT01554618|537379863|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
148971495|NCT01554618|537379864|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
148971496|NCT00477672|537379865|FG000|Overall Study|Adverse Event|3|||
148971497|NCT00477672|537379866|FG001|Overall Study|Adverse Event|5|||
148971498|NCT00477672|537379867|FG002|Overall Study|Adverse Event|6|||
148971499|NCT00477672|537379865|FG000|Overall Study|Death|0|||
148971500|NCT00477672|537379866|FG001|Overall Study|Death|1|||
148971501|NCT00477672|537379867|FG002|Overall Study|Death|0|||
148971502|NCT00477672|537379865|FG000|Overall Study|Disease progression|0|||
148971503|NCT00477672|537379866|FG001|Overall Study|Disease progression|1|||
148971504|NCT00477672|537379867|FG002|Overall Study|Disease progression|0|||
148971505|NCT00477672|537379865|FG000|Overall Study|Physician Decision|1|||
148971506|NCT00477672|537379866|FG001|Overall Study|Physician Decision|0|||
148971507|NCT00477672|537379867|FG002|Overall Study|Physician Decision|0|||
148725851|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Other|1|||
148725852|NCT02990806|536468195|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
148725853|NCT02990806|536468196|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
148725854|NCT02990806|536468197|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
148725855|NCT02990806|536468198|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
148725856|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
148725857|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
148725858|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
148725859|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
148725860|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
148725861|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
148725862|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
148725863|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
148725864|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
148725865|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
148725866|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
148725867|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
148725868|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
148725869|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
148725870|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
148725871|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
148971508|NCT00477672|537379865|FG000|Overall Study|Protocol noncompliance|0|||
148971509|NCT00477672|537379866|FG001|Overall Study|Protocol noncompliance|2|||
148971510|NCT00477672|537379867|FG002|Overall Study|Protocol noncompliance|0|||
148971511|NCT00477672|537379865|FG000|Overall Study|Consent withdrawn|2|||
148971512|NCT00477672|537379866|FG001|Overall Study|Consent withdrawn|5|||
148971513|NCT00477672|537379867|FG002|Overall Study|Consent withdrawn|10|||
148971514|NCT00477672|537379865|FG000|Overall Study|Discretion of Sponsor|1|||
148971515|NCT00477672|537379866|FG001|Overall Study|Discretion of Sponsor|2|||
148971516|NCT00477672|537379867|FG002|Overall Study|Discretion of Sponsor|0|||
148971517|NCT02722928|537379870|FG000|Overall Study|Standard CT was not as required per prot|5|||
148971518|NCT02722928|537379871|FG001|Overall Study|Standard CT was not as required per prot|13|||
148971519|NCT02722928|537379870|FG000|Overall Study|Required Intraoperative MRI|5|||
148971520|NCT02722928|537379871|FG001|Overall Study|Required Intraoperative MRI|7|||
148971521|NCT02275481|537379872|FG000|Overall Study|Death|2|||
148971522|NCT02275481|537379873|FG001|Overall Study|Death|1|||
148971523|NCT02275481|537379872|FG000|Overall Study|Lost to Follow-up|2|||
148971524|NCT02275481|537379873|FG001|Overall Study|Lost to Follow-up|0|||
148971525|NCT02275481|537379872|FG000|Overall Study|Withdrawal by Subject|3|||
148971526|NCT02275481|537379873|FG001|Overall Study|Withdrawal by Subject|0|||
148971527|NCT02275481|537379872|FG000|Overall Study|all other reasons combined|2|||
148971528|NCT02275481|537379873|FG001|Overall Study|all other reasons combined|1|||
148971529|NCT02275481|537379872|FG000|Overall Study|Physician Decision|0|||
148971530|NCT02275481|537379873|FG001|Overall Study|Physician Decision|1|||
148971531|NCT00717769|537379874|FG000|Overall Study|Adverse Event|9|||
148971532|NCT00717769|537379875|FG001|Overall Study|Adverse Event|6|||
148971533|NCT00717769|537379876|FG002|Overall Study|Adverse Event|1|||
148971534|NCT00717769|537379874|FG000|Overall Study|Lack of compliance|0|||
148971535|NCT00717769|537379875|FG001|Overall Study|Lack of compliance|2|||
148971536|NCT00717769|537379876|FG002|Overall Study|Lack of compliance|0|||
148971537|NCT00717769|537379874|FG000|Overall Study|Lost to Follow-up|3|||
148971538|NCT00717769|537379875|FG001|Overall Study|Lost to Follow-up|4|||
148971539|NCT00717769|537379876|FG002|Overall Study|Lost to Follow-up|0|||
148971540|NCT00717769|537379874|FG000|Overall Study|Lack of Efficacy|1|||
148971541|NCT00717769|537379875|FG001|Overall Study|Lack of Efficacy|2|||
148971542|NCT00717769|537379876|FG002|Overall Study|Lack of Efficacy|0|||
148971543|NCT00717769|537379874|FG000|Overall Study|Protocol Violation|0|||
148971544|NCT00717769|537379875|FG001|Overall Study|Protocol Violation|2|||
148971545|NCT00717769|537379876|FG002|Overall Study|Protocol Violation|0|||
148971546|NCT00717769|537379874|FG000|Overall Study|Sponsor decision|1|||
149025756|NCT02624778|537571861|FG004|Overall Study|Physician Decision|0|||
149025757|NCT02624778|537571862|FG005|Overall Study|Physician Decision|0|||
149025758|NCT02624778|537571863|FG006|Overall Study|Physician Decision|0|||
149025759|NCT02624778|537571864|FG007|Overall Study|Physician Decision|3|||
149025760|NCT02624778|537571865|FG008|Overall Study|Physician Decision|3|||
148725872|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
148725873|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
148725874|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
148725875|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
148725876|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
148725877|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
148725878|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
148725879|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
148725880|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
148725881|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
148725882|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
148725883|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
148725884|NCT02990806|536468195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
148725885|NCT02990806|536468196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
148725886|NCT02990806|536468197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
148725887|NCT02990806|536468198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
148725888|NCT01010750|536468199|FG000|Second Intervention|Adverse Event|0|||
148725889|NCT01010750|536468200|FG001|Second Intervention|Adverse Event|1|||
148725890|NCT01010750|536468201|FG002|Second Intervention|Adverse Event|0|||
148725891|NCT01010750|536468202|FG003|Second Intervention|Adverse Event|0|||
148725892|NCT01010750|536468203|FG004|Second Intervention|Adverse Event|0|||
148725893|NCT01010750|536468204|FG005|Second Intervention|Adverse Event|0|||
148725894|NCT01682148|536468207|FG000|Overall Study|Withdrawal by Subject|2|||
148725895|NCT01682148|536468208|FG001|Overall Study|Withdrawal by Subject|0|||
148725896|NCT01682148|536468207|FG000|Overall Study|Lost to Follow-up|1|||
148725897|NCT01682148|536468208|FG001|Overall Study|Lost to Follow-up|2|||
148725898|NCT01682148|536468207|FG000|Overall Study|Protocol Violation|1|||
148725899|NCT01682148|536468208|FG001|Overall Study|Protocol Violation|1|||
148725900|NCT00171340|536468209|FG000|Overall Study|Adverse Event|46|||
148725901|NCT00171340|536468210|FG001|Overall Study|Adverse Event|42|||
148725902|NCT00171340|536468209|FG000|Overall Study|Lack of Efficacy|29|||
148725903|NCT00171340|536468210|FG001|Overall Study|Lack of Efficacy|41|||
148725904|NCT00171340|536468209|FG000|Overall Study|Protocol Violation|7|||
148971547|NCT00717769|537379875|FG001|Overall Study|Sponsor decision|0|||
148971548|NCT00717769|537379876|FG002|Overall Study|Sponsor decision|10|||
148971549|NCT00717769|537379874|FG000|Overall Study|Withdrew consent|2|||
148971550|NCT00717769|537379875|FG001|Overall Study|Withdrew consent|2|||
148725905|NCT00171340|536468210|FG001|Overall Study|Protocol Violation|8|||
148971551|NCT00717769|537379876|FG002|Overall Study|Withdrew consent|0|||
148971552|NCT02321462|537379878|FG000|Overall Study|Withdrawal by Subject|5|||
148971553|NCT02321462|537379879|FG001|Overall Study|Withdrawal by Subject|2|||
148816724|NCT02337946|536803989|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
148816725|NCT02337946|536803990|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
148816726|NCT02227199|536803991|FG000|Overall Study|Physician Decision|0|||
148816727|NCT02227199|536803992|FG001|Overall Study|Physician Decision|0|||
148816728|NCT02227199|536803993|FG002|Overall Study|Physician Decision|1|||
148816729|NCT02227199|536803991|FG000|Overall Study|Adverse Event|0|||
148816730|NCT02227199|536803992|FG001|Overall Study|Adverse Event|0|||
148816731|NCT02227199|536803993|FG002|Overall Study|Adverse Event|3|||
148816732|NCT03998462|536803995|FG000|Overall Study|Withdrawal by Subject|10|||
148816733|NCT03998462|536803996|FG001|Overall Study|Withdrawal by Subject|4|||
148816734|NCT03998462|536803995|FG000|Overall Study|Lost to Follow-up|1|||
148816735|NCT03998462|536803996|FG001|Overall Study|Lost to Follow-up|0|||
148816736|NCT03998462|536803995|FG000|Overall Study|Technical Difficulties|1|||
148816737|NCT03998462|536803996|FG001|Overall Study|Technical Difficulties|2|||
148816738|NCT05710224|536803997|FG000|Overall Study|Death|1|||
148816739|NCT05710224|536803998|FG001|Overall Study|Death|0|||
148816740|NCT05710224|536803997|FG000|Overall Study|Lost to Follow-up|16|||
148816741|NCT05710224|536803998|FG001|Overall Study|Lost to Follow-up|7|||
148816742|NCT05710224|536803997|FG000|Overall Study|Withdrawal by Subject|4|||
148816743|NCT05710224|536803998|FG001|Overall Study|Withdrawal by Subject|6|||
148816744|NCT05710224|536803997|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148816745|NCT05710224|536803998|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
148816746|NCT05710224|536803997|FG000|Overall Study|Participants Left The City|0|||
148816747|NCT05710224|536803998|FG001|Overall Study|Participants Left The City|2|||
148816748|NCT06061952|536804000|FG000|Overall Study|Withdrawal by Subject|1|||
148816749|NCT06061952|536804001|FG001|Overall Study|Withdrawal by Subject|2|||
148816750|NCT06061952|536804000|FG000|Overall Study|Lost to Follow-up|2|||
148816751|NCT06061952|536804001|FG001|Overall Study|Lost to Follow-up|2|||
148816752|NCT00544882|536804007|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
148816753|NCT00544882|536804008|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
148816754|NCT00544882|536804009|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
148816755|NCT00544882|536804007|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
148816756|NCT00544882|536804008|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
148816757|NCT00544882|536804009|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
148816758|NCT00544882|536804007|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
148816759|NCT00544882|536804008|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
148816760|NCT00544882|536804009|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
148816761|NCT00544882|536804007|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
148816762|NCT00544882|536804008|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
148816763|NCT00544882|536804009|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
148816764|NCT00544882|536804007|FG000|Cycle 3: Follow-up|Noncompliance|0|||
148816765|NCT00544882|536804008|FG001|Cycle 3: Follow-up|Noncompliance|1|||
148816766|NCT00544882|536804009|FG002|Cycle 3: Follow-up|Noncompliance|0|||
148816767|NCT00544882|536804007|FG000|Cycle 3: Follow-up|Pregnancy|0|||
148816768|NCT00544882|536804008|FG001|Cycle 3: Follow-up|Pregnancy|1|||
148816769|NCT00544882|536804009|FG002|Cycle 3: Follow-up|Pregnancy|0|||
148816770|NCT02583269|536804010|FG000|Overall Study|Patient hospitalized prior to start|1|||
148816771|NCT02583269|536804011|FG001|Overall Study|Patient hospitalized prior to start|0|||
148816772|NCT02583269|536804012|FG002|Overall Study|Patient hospitalized prior to start|0|||
148816773|NCT02583269|536804013|FG003|Overall Study|Patient hospitalized prior to start|0|||
148816774|NCT02583269|536804014|FG004|Overall Study|Patient hospitalized prior to start|0|||
148971554|NCT02321462|537379878|FG000|Overall Study|Subject withdrawn before any treatment|1|||
148971555|NCT02321462|537379879|FG001|Overall Study|Subject withdrawn before any treatment|1|||
148971556|NCT00692770|537379892|FG000|Overall Study|Protocol Violation|2|||
148971557|NCT00692770|537379893|FG001|Overall Study|Protocol Violation|7|||
148971558|NCT00692770|537379892|FG000|Overall Study|Withdrawal by Subject|97|||
148971559|NCT00692770|537379893|FG001|Overall Study|Withdrawal by Subject|36|||
148971560|NCT00692770|537379892|FG000|Overall Study|Adverse Event|136|||
148971561|NCT00692770|537379893|FG001|Overall Study|Adverse Event|41|||
148971562|NCT00692770|537379892|FG000|Overall Study|Death|10|||
148971563|NCT00692770|537379893|FG001|Overall Study|Death|5|||
148816775|NCT01039675|536804017|FG000|Overall Study|Adverse Event|0|||
148816776|NCT01039675|536804018|FG001|Overall Study|Adverse Event|2|||
148816777|NCT01039675|536804017|FG000|Overall Study|Lack of Efficacy|0|||
148816778|NCT01039675|536804018|FG001|Overall Study|Lack of Efficacy|2|||
148816779|NCT01039675|536804017|FG000|Overall Study|Withdrawal by Subject|0|||
148816780|NCT01039675|536804018|FG001|Overall Study|Withdrawal by Subject|1|||
148816781|NCT01039675|536804017|FG000|Overall Study|Lost to Follow-up|0|||
148971564|NCT00692770|537379892|FG000|Overall Study|Lost to Follow-up|7|||
148971565|NCT00692770|537379893|FG001|Overall Study|Lost to Follow-up|3|||
148816782|NCT01039675|536804018|FG001|Overall Study|Lost to Follow-up|1|||
148971566|NCT00692770|537379892|FG000|Overall Study|Non-compliant with study medication|11|||
148971567|NCT00692770|537379893|FG001|Overall Study|Non-compliant with study medication|5|||
148816783|NCT01039675|536804017|FG000|Overall Study|Physician Decision|0|||
148971568|NCT00692770|537379892|FG000|Overall Study|Progression by clinical judgment|2|||
148725906|NCT00171340|536468209|FG000|Overall Study|Withdrawal by Subject|22|||
148725907|NCT00171340|536468210|FG001|Overall Study|Withdrawal by Subject|19|||
148725908|NCT00171340|536468209|FG000|Overall Study|Lost to Follow-up|0|||
148725909|NCT00171340|536468210|FG001|Overall Study|Lost to Follow-up|5|||
148725910|NCT00171340|536468209|FG000|Overall Study|Abnormal Laboratory Results|2|||
148725911|NCT00171340|536468210|FG001|Overall Study|Abnormal Laboratory Results|0|||
148725912|NCT00171340|536468209|FG000|Overall Study|Abnormal Test Procedure Results|6|||
148725913|NCT00171340|536468210|FG001|Overall Study|Abnormal Test Procedure Results|11|||
148725914|NCT00171340|536468209|FG000|Overall Study|No Longer Required Study Drug|1|||
148725915|NCT00171340|536468210|FG001|Overall Study|No Longer Required Study Drug|1|||
148725916|NCT00171340|536468209|FG000|Overall Study|Administrative Problems|5|||
148725917|NCT00171340|536468210|FG001|Overall Study|Administrative Problems|2|||
148725918|NCT00171340|536468209|FG000|Overall Study|Death|6|||
148725919|NCT00171340|536468210|FG001|Overall Study|Death|6|||
148725920|NCT01056640|536468211|FG000|Overall Study|Withdrawal by Subject|11|||
148725921|NCT01056640|536468212|FG001|Overall Study|Withdrawal by Subject|8|||
148725922|NCT01056640|536468211|FG000|Overall Study|Death|15|||
148725923|NCT01056640|536468212|FG001|Overall Study|Death|4|||
148725924|NCT01803269|536468213|FG000|Overall Study|Withdrawal by Subject|3|||
148725925|NCT01803269|536468214|FG001|Overall Study|Withdrawal by Subject|0|||
148725926|NCT01803269|536468215|FG002|Overall Study|Withdrawal by Subject|0|||
148725927|NCT01202877|536468221|FG000|Overall Study|Disease Progression|0|||
148725928|NCT01202877|536468222|FG001|Overall Study|Disease Progression|1|||
148725929|NCT01202877|536468223|FG002|Overall Study|Disease Progression|2|||
148725930|NCT01202877|536468221|FG000|Overall Study|Adverse Event|0|||
148725931|NCT01202877|536468222|FG001|Overall Study|Adverse Event|0|||
148725932|NCT01202877|536468223|FG002|Overall Study|Adverse Event|2|||
148725933|NCT01202877|536468221|FG000|Overall Study|Withdrawal by Subject|0|||
148725934|NCT01202877|536468222|FG001|Overall Study|Withdrawal by Subject|0|||
148725935|NCT01202877|536468223|FG002|Overall Study|Withdrawal by Subject|1|||
148725936|NCT01202877|536468221|FG000|Overall Study|Death|0|||
148725937|NCT01202877|536468222|FG001|Overall Study|Death|0|||
148725938|NCT01202877|536468223|FG002|Overall Study|Death|1|||
148725939|NCT00396331|536468224|FG000|Overall Study|Failed to mobilize - no transplant|8|||
148725940|NCT00396331|536468224|FG000|Overall Study|Did not go on to transplant|5|||
148725941|NCT00396331|536468224|FG000|Overall Study|Lost to Follow-up|3|||
148725942|NCT00396331|536468224|FG000|Overall Study|Death|16|||
148725943|NCT00680186|536468225|FG000|Overall Study|Adverse Event|47|||
148725944|NCT00680186|536468226|FG001|Overall Study|Adverse Event|44|||
148725945|NCT00680186|536468225|FG000|Overall Study|Protocol Violation|31|||
148725946|NCT00680186|536468226|FG001|Overall Study|Protocol Violation|26|||
148725947|NCT00680186|536468225|FG000|Overall Study|Lost to Follow-up|11|||
148725948|NCT00680186|536468226|FG001|Overall Study|Lost to Follow-up|6|||
148725949|NCT00680186|536468225|FG000|Overall Study|Withdrawal by Subject|32|||
148725950|NCT00680186|536468226|FG001|Overall Study|Withdrawal by Subject|39|||
148725951|NCT00680186|536468225|FG000|Overall Study|Other|4|||
148725952|NCT00680186|536468226|FG001|Overall Study|Other|1|||
148725953|NCT00873119|536468229|FG000|Overall Study|Patient request|4|||
148725954|NCT00873119|536468230|FG001|Overall Study|Patient request|2|||
148725955|NCT00873119|536468229|FG000|Overall Study|Adverse Event|8|||
148725956|NCT00873119|536468230|FG001|Overall Study|Adverse Event|0|||
148725957|NCT00873119|536468229|FG000|Overall Study|Progressive disease|26|||
148725958|NCT00873119|536468230|FG001|Overall Study|Progressive disease|18|||
148725959|NCT00873119|536468229|FG000|Overall Study|Death|2|||
148725960|NCT00873119|536468230|FG001|Overall Study|Death|1|||
148725961|NCT00873119|536468229|FG000|Overall Study|Other|2|||
148725962|NCT00873119|536468230|FG001|Overall Study|Other|5|||
148725963|NCT00873119|536468229|FG000|Overall Study|Not treated|2|||
148725964|NCT00873119|536468230|FG001|Overall Study|Not treated|0|||
148725965|NCT03648879|536468231|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
148725966|NCT00466726|536468232|FG000|Overall Study|Not evaluable for response|14|||
148725967|NCT00350402|536468233|FG000|Overall Study|Lost to Follow-up|1|||
148816784|NCT01039675|536804018|FG001|Overall Study|Physician Decision|1|||
148816785|NCT02369458|536804020|FG000|Overall Study|Determined to be not eligible|1|||
148725968|NCT00350402|536468234|FG001|Overall Study|Lost to Follow-up|1|||
148725969|NCT01376310|536468235|FG000|Overall Study|Study closed/terminated|1|||
148725970|NCT01376310|536468236|FG001|Overall Study|Study closed/terminated|2|||
148725971|NCT01376310|536468235|FG000|Overall Study|Withdrawal by Subject|8|||
148725972|NCT01376310|536468236|FG001|Overall Study|Withdrawal by Subject|2|||
148725973|NCT01376310|536468235|FG000|Overall Study|Physician Decision|26|||
148725974|NCT01376310|536468236|FG001|Overall Study|Physician Decision|7|||
148971569|NCT00692770|537379893|FG001|Overall Study|Progression by clinical judgment|3|||
148971570|NCT00692770|537379892|FG000|Overall Study|Physician decision not protocol driven|10|||
148971571|NCT00692770|537379893|FG001|Overall Study|Physician decision not protocol driven|14|||
148971572|NCT00692770|537379892|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
148971573|NCT00692770|537379893|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
148971574|NCT00692770|537379892|FG000|Overall Study|Protocol driven decision point|3|||
148971575|NCT00692770|537379893|FG001|Overall Study|Protocol driven decision point|7|||
148725975|NCT01376310|536468235|FG000|Overall Study|Lost to Follow-up|1|||
148971576|NCT00692770|537379892|FG000|Overall Study|Completed all planned assessments|79|||
148971577|NCT00692770|537379893|FG001|Overall Study|Completed all planned assessments|101|||
148971578|NCT00692770|537379892|FG000|Overall Study|Radiological and clinical progression|8|||
148971579|NCT00692770|537379893|FG001|Overall Study|Radiological and clinical progression|8|||
148971580|NCT00692770|537379892|FG000|Overall Study|Clinical endpoint reached|16|||
148971581|NCT00692770|537379893|FG001|Overall Study|Clinical endpoint reached|43|||
148971582|NCT00692770|537379892|FG000|Overall Study|Study terminated by sponsor|2|||
148971583|NCT00692770|537379893|FG001|Overall Study|Study terminated by sponsor|2|||
148971584|NCT00692770|537379892|FG000|Overall Study|Randomized but not treated|3|||
148971585|NCT00692770|537379893|FG001|Overall Study|Randomized but not treated|4|||
148971586|NCT04327986|537379895|FG000|Overall Study|Physician Decision|2|||
148971587|NCT04327986|537379896|FG001|Overall Study|Physician Decision|0|||
148971588|NCT04327986|537379897|FG002|Overall Study|Physician Decision|0|||
148971589|NCT04327986|537379895|FG000|Overall Study|Death|1|||
148971590|NCT04327986|537379896|FG001|Overall Study|Death|0|||
148971591|NCT04327986|537379897|FG002|Overall Study|Death|0|||
148971592|NCT04248816|537379898|FG000|Overall Study|Ineligible post-randomization|7|||
148971593|NCT04248816|537379899|FG001|Overall Study|Ineligible post-randomization|21|||
148971594|NCT04248816|537379900|FG002|Overall Study|Ineligible post-randomization|25|||
148971595|NCT03044197|537379902|FG000|Overall Study|Withdrawal by Subject|3|||
148971596|NCT03044197|537379903|FG001|Overall Study|Withdrawal by Subject|1|||
148971597|NCT00834912|537379904|FG000|Treatment Period 1|Adverse Event|0|||
148971598|NCT00834912|537379905|FG001|Treatment Period 1|Adverse Event|1|||
148971599|NCT00834912|537379906|FG002|Treatment Period 1|Adverse Event|0|||
148971600|NCT00834912|537379907|FG003|Treatment Period 1|Adverse Event|1|||
148971601|NCT00834912|537379908|FG004|Treatment Period 1|Adverse Event|0|||
148971602|NCT00834912|537379909|FG005|Treatment Period 1|Adverse Event|0|||
148971603|NCT00834912|537379904|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148971604|NCT00834912|537379905|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148971605|NCT00834912|537379906|FG002|Treatment Period 2|Withdrawal by Subject|1|||
148971606|NCT00834912|537379907|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148971607|NCT00834912|537379908|FG004|Treatment Period 2|Withdrawal by Subject|1|||
148971608|NCT00834912|537379909|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148971609|NCT00262067|537379912|FG000|Overall Study|Death|190|||
148971610|NCT00262067|537379913|FG001|Overall Study|Death|89|||
148971611|NCT00262067|537379914|FG002|Overall Study|Death|186|||
148971612|NCT00262067|537379915|FG003|Overall Study|Death|99|||
148971613|NCT00262067|537379912|FG000|Overall Study|Lost to Follow-up|5|||
148971614|NCT00262067|537379913|FG001|Overall Study|Lost to Follow-up|4|||
148971615|NCT00262067|537379914|FG002|Overall Study|Lost to Follow-up|7|||
148971616|NCT00262067|537379915|FG003|Overall Study|Lost to Follow-up|5|||
148971617|NCT00262067|537379912|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
148971618|NCT00262067|537379913|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
148971619|NCT00262067|537379914|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
148971620|NCT00262067|537379915|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
148971621|NCT00262067|537379912|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
148971622|NCT00262067|537379913|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
148971623|NCT00262067|537379914|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
148971624|NCT00262067|537379915|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
148971625|NCT03829046|537379916|FG000|Overall Study|Withdrawal by Subject|1|||
148971626|NCT03829046|537379917|FG001|Overall Study|Withdrawal by Subject|0|||
148971627|NCT01399593|537379921|FG000|Overall Study|Physician Decision|1|||
148971628|NCT01399593|537379922|FG001|Overall Study|Physician Decision|0|||
148971629|NCT01399593|537379921|FG000|Overall Study|Adverse Event|1|||
148971630|NCT01399593|537379922|FG001|Overall Study|Adverse Event|0|||
148971631|NCT01399593|537379921|FG000|Overall Study|Death|1|||
148971632|NCT01399593|537379922|FG001|Overall Study|Death|1|||
148971633|NCT01399593|537379921|FG000|Overall Study|Transplantectomy|0|||
148971634|NCT01399593|537379922|FG001|Overall Study|Transplantectomy|1|||
148971635|NCT02849548|537379923|FG000|Overall Study|Lost to Follow-up|1|||
148971636|NCT02849548|537379924|FG001|Overall Study|Lost to Follow-up|2|||
148971637|NCT02849548|537379923|FG000|Overall Study|Protocol Violation|1|||
148971638|NCT02849548|537379924|FG001|Overall Study|Protocol Violation|0|||
148971639|NCT00714259|537379925|FG000|Overall Study|Death|2|||
148971640|NCT01140477|537381779|FG000|Overall Study|Lost to Follow-up|4|||
148971641|NCT01140477|537381780|FG001|Overall Study|Lost to Follow-up|0|||
148971642|NCT01140477|537381779|FG000|Overall Study|Withdrawal by Subject|1|||
148971643|NCT01140477|537381780|FG001|Overall Study|Withdrawal by Subject|4|||
148971644|NCT01140477|537381779|FG000|Overall Study|Surgical complication preventing implant|2|||
148971645|NCT01140477|537381780|FG001|Overall Study|Surgical complication preventing implant|0|||
148971646|NCT01140477|537381779|FG000|Overall Study|Death|1|||
148971647|NCT01140477|537381780|FG001|Overall Study|Death|1|||
148971648|NCT01140477|537381779|FG000|Overall Study|Subject explanted|0|||
148971649|NCT01140477|537381780|FG001|Overall Study|Subject explanted|1|||
148971650|NCT01982253|537381788|FG000|Overall Study|Withdrawal by Subject|1|||
148971651|NCT01982253|537381789|FG001|Overall Study|Withdrawal by Subject|0|||
148971652|NCT01982253|537381790|FG002|Overall Study|Withdrawal by Subject|0|||
148971653|NCT01982253|537381788|FG000|Overall Study|Study terminated by sponsor|1|||
148971654|NCT01982253|537381789|FG001|Overall Study|Study terminated by sponsor|4|||
148725976|NCT01376310|536468236|FG001|Overall Study|Lost to Follow-up|0|||
148725977|NCT02339740|536468239|FG000|Overall Study|Death|1|||
148725978|NCT02339740|536468240|FG001|Overall Study|Death|0|||
148725979|NCT02339740|536468239|FG000|Overall Study|Physician Decision|0|||
148725980|NCT02339740|536468240|FG001|Overall Study|Physician Decision|2|||
148725981|NCT02339740|536468239|FG000|Overall Study|Withdrawal by Subject|5|||
148725982|NCT02339740|536468240|FG001|Overall Study|Withdrawal by Subject|1|||
148725983|NCT02339740|536468239|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
148725984|NCT02339740|536468240|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
148725985|NCT00645944|536468241|FG000|Randomized|Withdrawal by Subject|1|||
148725986|NCT00645944|536468242|FG001|Randomized|Withdrawal by Subject|2|||
148725987|NCT00645944|536468241|FG000|Received Medication|Adverse Event|2|||
148725988|NCT00645944|536468242|FG001|Received Medication|Adverse Event|1|||
148725989|NCT00645944|536468241|FG000|Received Medication|Withdrawal by Subject|1|||
148725990|NCT00645944|536468242|FG001|Received Medication|Withdrawal by Subject|1|||
148725991|NCT00645944|536468241|FG000|Received Medication|Lost to Follow-up|1|||
148725992|NCT00645944|536468242|FG001|Received Medication|Lost to Follow-up|0|||
148725993|NCT00645944|536468241|FG000|Received Medication|Protocol Violation|2|||
148725994|NCT00645944|536468242|FG001|Received Medication|Protocol Violation|1|||
148725995|NCT00706355|536468243|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
148725996|NCT00706355|536468244|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
148725997|NCT00706355|536468245|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
148725998|NCT00706355|536468246|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
148725999|NCT00706355|536468243|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
148726000|NCT00706355|536468244|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
148726001|NCT00706355|536468245|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
148726002|NCT00706355|536468246|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
148726003|NCT00706355|536468243|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
148726004|NCT00706355|536468244|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
148726005|NCT00706355|536468245|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
148726006|NCT00706355|536468246|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
148726007|NCT00706355|536468243|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
148726008|NCT00706355|536468244|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
148726009|NCT00706355|536468245|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
148726010|NCT00706355|536468246|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
148726011|NCT00706355|536468243|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
148726012|NCT00706355|536468244|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
148726013|NCT00706355|536468245|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
148726014|NCT00706355|536468246|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
148971655|NCT01982253|537381790|FG002|Overall Study|Study terminated by sponsor|4|||
148971656|NCT03848845|537381791|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
148971657|NCT03848845|537381792|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
148971658|NCT03848845|537381793|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
148971659|NCT03848845|537381794|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
148971660|NCT03848845|537381791|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
148971661|NCT03848845|537381792|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
148971662|NCT03848845|537381793|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
148971663|NCT03848845|537381794|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
148971664|NCT03848845|537381791|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
148726015|NCT00706355|536468243|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
148726016|NCT00706355|536468244|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
148726017|NCT00706355|536468245|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
148726018|NCT00706355|536468246|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
148726019|NCT00706355|536468243|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
148726020|NCT00706355|536468244|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
148726021|NCT00706355|536468245|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
148726022|NCT00706355|536468246|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
148726023|NCT00706355|536468243|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
148726024|NCT00706355|536468244|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
148971665|NCT03848845|537381792|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
148971666|NCT03848845|537381793|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
148971667|NCT03848845|537381794|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
148971668|NCT03848845|537381791|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
148726025|NCT00706355|536468245|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
148726026|NCT00706355|536468246|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
149025761|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
148816786|NCT02369458|536804021|FG001|Overall Study|Determined to be not eligible|0|||
148816787|NCT03853798|536804022|FG000|Overall Study|Death|0|||
148816788|NCT03853798|536804023|FG001|Overall Study|Death|0|||
148816789|NCT03853798|536804024|FG002|Overall Study|Death|0|||
148816790|NCT03853798|536804025|FG003|Overall Study|Death|0|||
148816791|NCT03853798|536804026|FG004|Overall Study|Death|0|||
148816792|NCT03853798|536804027|FG005|Overall Study|Death|1|||
148816793|NCT03853798|536804028|FG006|Overall Study|Death|0|||
148816794|NCT03853798|536804029|FG007|Overall Study|Death|0|||
148816795|NCT03853798|536804030|FG008|Overall Study|Death|0|||
148816796|NCT03853798|536804022|FG000|Overall Study|Adverse Event|0|||
148816797|NCT03853798|536804023|FG001|Overall Study|Adverse Event|0|||
148816798|NCT03853798|536804024|FG002|Overall Study|Adverse Event|2|||
148816799|NCT03853798|536804025|FG003|Overall Study|Adverse Event|0|||
148816800|NCT03853798|536804026|FG004|Overall Study|Adverse Event|0|||
148816801|NCT03853798|536804027|FG005|Overall Study|Adverse Event|0|||
148816802|NCT03853798|536804028|FG006|Overall Study|Adverse Event|0|||
148816803|NCT03853798|536804029|FG007|Overall Study|Adverse Event|0|||
148816804|NCT03853798|536804030|FG008|Overall Study|Adverse Event|0|||
148816805|NCT03853798|536804022|FG000|Overall Study|Withdrawal by Subject|0|||
148816806|NCT03853798|536804023|FG001|Overall Study|Withdrawal by Subject|1|||
148816807|NCT03853798|536804024|FG002|Overall Study|Withdrawal by Subject|4|||
148816808|NCT03853798|536804025|FG003|Overall Study|Withdrawal by Subject|0|||
148816809|NCT03853798|536804026|FG004|Overall Study|Withdrawal by Subject|0|||
148816810|NCT03853798|536804027|FG005|Overall Study|Withdrawal by Subject|5|||
148816811|NCT03853798|536804028|FG006|Overall Study|Withdrawal by Subject|0|||
148816812|NCT03853798|536804029|FG007|Overall Study|Withdrawal by Subject|0|||
148816813|NCT03853798|536804030|FG008|Overall Study|Withdrawal by Subject|4|||
148816814|NCT03853798|536804022|FG000|Overall Study|Physician Decision|1|||
148816815|NCT03853798|536804023|FG001|Overall Study|Physician Decision|0|||
148816816|NCT03853798|536804024|FG002|Overall Study|Physician Decision|0|||
148816817|NCT03853798|536804025|FG003|Overall Study|Physician Decision|0|||
148816818|NCT03853798|536804026|FG004|Overall Study|Physician Decision|0|||
148816819|NCT03853798|536804027|FG005|Overall Study|Physician Decision|0|||
148816820|NCT03853798|536804028|FG006|Overall Study|Physician Decision|0|||
148816821|NCT03853798|536804029|FG007|Overall Study|Physician Decision|0|||
148816822|NCT03853798|536804030|FG008|Overall Study|Physician Decision|1|||
148816823|NCT03853798|536804022|FG000|Overall Study|Lack of Efficacy|0|||
148816824|NCT03853798|536804023|FG001|Overall Study|Lack of Efficacy|0|||
148816825|NCT03853798|536804024|FG002|Overall Study|Lack of Efficacy|2|||
148816826|NCT03853798|536804025|FG003|Overall Study|Lack of Efficacy|0|||
148816827|NCT03853798|536804026|FG004|Overall Study|Lack of Efficacy|0|||
148816828|NCT03853798|536804027|FG005|Overall Study|Lack of Efficacy|0|||
148816829|NCT03853798|536804028|FG006|Overall Study|Lack of Efficacy|0|||
148816830|NCT03853798|536804029|FG007|Overall Study|Lack of Efficacy|0|||
148816831|NCT03853798|536804030|FG008|Overall Study|Lack of Efficacy|1|||
148816832|NCT03853798|536804022|FG000|Overall Study|Approved Drug Available for Indication|0|||
148816833|NCT03853798|536804023|FG001|Overall Study|Approved Drug Available for Indication|0|||
148816834|NCT03853798|536804024|FG002|Overall Study|Approved Drug Available for Indication|1|||
148816835|NCT03853798|536804025|FG003|Overall Study|Approved Drug Available for Indication|0|||
148816836|NCT03853798|536804026|FG004|Overall Study|Approved Drug Available for Indication|0|||
148816837|NCT03853798|536804027|FG005|Overall Study|Approved Drug Available for Indication|1|||
148816838|NCT03853798|536804028|FG006|Overall Study|Approved Drug Available for Indication|0|||
148816839|NCT03853798|536804029|FG007|Overall Study|Approved Drug Available for Indication|0|||
148816840|NCT03853798|536804030|FG008|Overall Study|Approved Drug Available for Indication|0|||
148816841|NCT03853798|536804022|FG000|Overall Study|Other un-specified|0|||
148816842|NCT03853798|536804023|FG001|Overall Study|Other un-specified|0|||
148816843|NCT03853798|536804024|FG002|Overall Study|Other un-specified|2|||
148816844|NCT03853798|536804025|FG003|Overall Study|Other un-specified|0|||
148816845|NCT03853798|536804026|FG004|Overall Study|Other un-specified|0|||
148816846|NCT03853798|536804027|FG005|Overall Study|Other un-specified|1|||
148816847|NCT03853798|536804028|FG006|Overall Study|Other un-specified|0|||
148816848|NCT03853798|536804029|FG007|Overall Study|Other un-specified|0|||
148816849|NCT03853798|536804030|FG008|Overall Study|Other un-specified|0|||
148816850|NCT02743494|536804031|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
148816851|NCT02743494|536804032|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
148816852|NCT02743494|536804031|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
148816853|NCT02743494|536804032|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
148816854|NCT02743494|536804031|FG000|Treatment Period|Disease recurrence|152|||
148816855|NCT02743494|536804032|FG001|Treatment Period|Disease recurrence|115|||
148816856|NCT02743494|536804031|FG000|Treatment Period|Study drug toxicity|56|||
148816857|NCT02743494|536804032|FG001|Treatment Period|Study drug toxicity|8|||
148816858|NCT02743494|536804031|FG000|Treatment Period|Death|1|||
148816859|NCT02743494|536804032|FG001|Treatment Period|Death|1|||
148816860|NCT02743494|536804031|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
148816861|NCT02743494|536804032|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
148971669|NCT03848845|537381792|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
148971670|NCT03848845|537381793|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
148971671|NCT03848845|537381794|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
148971672|NCT02789176|537381795|FG000|Overall Study|Death|0|||
148971673|NCT02789176|537381796|FG001|Overall Study|Death|0|||
148971674|NCT02789176|537381797|FG002|Overall Study|Death|3|||
148971675|NCT02789176|537381798|FG003|Overall Study|Death|0|||
148971676|NCT02789176|537381795|FG000|Overall Study|Withdrawal by Subject|0|||
148971677|NCT02789176|537381796|FG001|Overall Study|Withdrawal by Subject|0|||
148971678|NCT02789176|537381797|FG002|Overall Study|Withdrawal by Subject|1|||
148971679|NCT02789176|537381798|FG003|Overall Study|Withdrawal by Subject|0|||
148971680|NCT02789176|537381795|FG000|Overall Study|Lost to Follow-up|8|||
148971681|NCT02789176|537381796|FG001|Overall Study|Lost to Follow-up|2|||
148971682|NCT02789176|537381797|FG002|Overall Study|Lost to Follow-up|6|||
148971683|NCT02789176|537381798|FG003|Overall Study|Lost to Follow-up|1|||
148971684|NCT00779675|537381800|FG000|Treatment Period|Adverse Event|87|||
148971685|NCT00779675|537381800|FG000|Treatment Period|Treatment Failure|80|||
148971686|NCT00779675|537381800|FG000|Treatment Period|Transferred to Another Study|38|||
148971687|NCT00779675|537381800|FG000|Treatment Period|Lost to Follow-up|23|||
148971688|NCT00779675|537381800|FG000|Treatment Period|Withdrawal by Subject|46|||
148971689|NCT00779675|537381800|FG000|Treatment Period|Protocol Violation|54|||
148971690|NCT00779675|537381800|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
148971691|NCT00779675|537381800|FG000|Treatment Period|Administrative|3|||
148971692|NCT00779675|537381800|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
148971693|NCT00779675|537381800|FG000|Extended Treatment Period|Protocol Violation|13|||
148971694|NCT00779675|537381800|FG000|Extended Treatment Period|Adverse Event|6|||
148971695|NCT00779675|537381800|FG000|Extended Treatment Period|Treatment Failure|11|||
148971696|NCT00779675|537381800|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
148971697|NCT00779675|537381800|FG000|Extended Treatment Period|Lost to Follow-up|6|||
148971698|NCT01956110|537381812|FG000|Overall Study|Protocol Violation|25|||
148971699|NCT01956110|537381813|FG001|Overall Study|Protocol Violation|11|||
148971700|NCT01956110|537381812|FG000|Overall Study|Adverse Event|9|||
148971701|NCT01956110|537381813|FG001|Overall Study|Adverse Event|10|||
148971702|NCT01956110|537381812|FG000|Overall Study|Personal reasons|1|||
148971703|NCT01956110|537381813|FG001|Overall Study|Personal reasons|1|||
148971704|NCT03325166|537381820|FG000|Overall Study|Adverse Event|1|||
148971705|NCT01633944|537381821|FG000|Open-label Titration Phase|Adverse Event|109|||
148971706|NCT01633944|537381822|FG001|Open-label Titration Phase|Adverse Event|0|||
148971707|NCT01633944|537381823|FG002|Open-label Titration Phase|Adverse Event|0|||
148971708|NCT01633944|537381821|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
148971709|NCT01633944|537381822|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
148971710|NCT01633944|537381823|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
148971711|NCT01633944|537381821|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
148971712|NCT01633944|537381822|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
148971713|NCT01633944|537381823|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
148971714|NCT01633944|537381821|FG000|Open-label Titration Phase|Protocol Violation|24|||
148971715|NCT01633944|537381822|FG001|Open-label Titration Phase|Protocol Violation|0|||
148971716|NCT01633944|537381823|FG002|Open-label Titration Phase|Protocol Violation|0|||
148971717|NCT01633944|537381821|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
148971718|NCT01633944|537381822|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
148971719|NCT01633944|537381823|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
148971720|NCT01633944|537381821|FG000|Open-label Titration Phase|Other|68|||
149025762|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
149025763|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
149025764|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
149025765|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
149025766|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
148971721|NCT01633944|537381822|FG001|Open-label Titration Phase|Other|0|||
148971722|NCT01633944|537381823|FG002|Open-label Titration Phase|Other|0|||
148971723|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Adverse Event|0|||
148971724|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Adverse Event|13|||
148971725|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Adverse Event|7|||
148971726|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
148971727|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
148971728|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
148971729|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148971730|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
148971731|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
148971732|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
148971733|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
148971734|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
148971735|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
148971736|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
148971737|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
148971738|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
148971739|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
148971740|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
148971741|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
148971742|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
148971743|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
148971744|NCT01633944|537381821|FG000|Double-blind Treatment Phase|Other|0|||
148971745|NCT01633944|537381822|FG001|Double-blind Treatment Phase|Other|7|||
148971746|NCT01633944|537381823|FG002|Double-blind Treatment Phase|Other|0|||
148971747|NCT00463060|537381827|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
148971748|NCT00463060|537381827|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
148971749|NCT00701129|537381828|FG000|Overall Study|Death|2|||
148971750|NCT01400841|537381829|FG000|Initial Study Phase (6 Months)|Death|1|||
148971751|NCT01400841|537381829|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
148971752|NCT00910715|537381830|FG000|Overall Study|Lost to Follow-up|22|||
148971753|NCT00910715|537381831|FG001|Overall Study|Lost to Follow-up|26|||
148971754|NCT00910715|537381832|FG002|Overall Study|Lost to Follow-up|0|||
148971755|NCT02884089|537381833|FG000|Period 1|Dosing error|2|||
148971756|NCT02884089|537381834|FG001|Period 1|Dosing error|2|||
148971757|NCT02884089|537381835|FG002|Period 1|Dosing error|0|||
148971758|NCT02884089|537381836|FG003|Period 1|Dosing error|0|||
148971759|NCT02884089|537381833|FG000|Washout Period 1|Lost to Follow-up|0|||
148971760|NCT02884089|537381834|FG001|Washout Period 1|Lost to Follow-up|1|||
148971761|NCT02884089|537381835|FG002|Washout Period 1|Lost to Follow-up|0|||
148971762|NCT02884089|537381836|FG003|Washout Period 1|Lost to Follow-up|1|||
148971763|NCT02884089|537381833|FG000|Washout Period 1|Withdrawal by Subject|0|||
148971764|NCT02884089|537381834|FG001|Washout Period 1|Withdrawal by Subject|1|||
148971765|NCT02884089|537381835|FG002|Washout Period 1|Withdrawal by Subject|0|||
148971766|NCT02884089|537381836|FG003|Washout Period 1|Withdrawal by Subject|0|||
148971767|NCT02884089|537381833|FG000|Period 2|Adverse Event|1|||
148971768|NCT02884089|537381834|FG001|Period 2|Adverse Event|0|||
148971769|NCT02884089|537381835|FG002|Period 2|Adverse Event|0|||
148971770|NCT02884089|537381836|FG003|Period 2|Adverse Event|0|||
148971771|NCT02884089|537381833|FG000|Period 3|Withdrawal by Subject|0|||
148971772|NCT02884089|537381834|FG001|Period 3|Withdrawal by Subject|0|||
148971773|NCT02884089|537381835|FG002|Period 3|Withdrawal by Subject|1|||
148971774|NCT02884089|537381836|FG003|Period 3|Withdrawal by Subject|0|||
148971775|NCT02884089|537381833|FG000|Washout Period 3|Withdrawal by Subject|0|||
148971776|NCT02884089|537381834|FG001|Washout Period 3|Withdrawal by Subject|0|||
148971777|NCT02884089|537381835|FG002|Washout Period 3|Withdrawal by Subject|1|||
148971778|NCT02884089|537381836|FG003|Washout Period 3|Withdrawal by Subject|0|||
148971779|NCT02884089|537381833|FG000|Washout Period 3|Lost to Follow-up|0|||
148971780|NCT02884089|537381834|FG001|Washout Period 3|Lost to Follow-up|0|||
148971781|NCT02884089|537381835|FG002|Washout Period 3|Lost to Follow-up|0|||
148971782|NCT02884089|537381836|FG003|Washout Period 3|Lost to Follow-up|1|||
148971783|NCT02884089|537381833|FG000|Period 4|Withdrawal by Subject|0|||
148971784|NCT02884089|537381834|FG001|Period 4|Withdrawal by Subject|1|||
148971785|NCT02884089|537381835|FG002|Period 4|Withdrawal by Subject|0|||
148971786|NCT02884089|537381836|FG003|Period 4|Withdrawal by Subject|0|||
148971787|NCT02884089|537381833|FG000|Period 4|Lost to Follow-up|1|||
148971788|NCT02884089|537381834|FG001|Period 4|Lost to Follow-up|0|||
148971789|NCT02884089|537381835|FG002|Period 4|Lost to Follow-up|0|||
148971790|NCT02884089|537381836|FG003|Period 4|Lost to Follow-up|0|||
148971791|NCT02884089|537381833|FG000|Follow-up Visit|Withdrawal by Subject|1|||
148971792|NCT02884089|537381834|FG001|Follow-up Visit|Withdrawal by Subject|0|||
148971793|NCT02884089|537381835|FG002|Follow-up Visit|Withdrawal by Subject|0|||
148971794|NCT02884089|537381836|FG003|Follow-up Visit|Withdrawal by Subject|1|||
148971795|NCT03354429|537381837|FG000|Overall Study|Withdrawal by Subject|8|||
148971796|NCT03354429|537381838|FG001|Overall Study|Withdrawal by Subject|7|||
148971797|NCT03354429|537381837|FG000|Overall Study|Lost to Follow-up|1|||
148971798|NCT03354429|537381838|FG001|Overall Study|Lost to Follow-up|0|||
148971799|NCT02624284|537381839|FG000|Overall Study|Withdrawal by Subject|3|||
148971800|NCT02624284|537381840|FG001|Overall Study|Withdrawal by Subject|6|||
148971801|NCT02624284|537381841|FG002|Overall Study|Withdrawal by Subject|3|||
148971802|NCT02624284|537381839|FG000|Overall Study|Protocol Violation|9|||
148971803|NCT02624284|537381840|FG001|Overall Study|Protocol Violation|10|||
148971804|NCT02624284|537381841|FG002|Overall Study|Protocol Violation|7|||
148971805|NCT02624284|537381839|FG000|Overall Study|Revealed exclusionary condition|2|||
148971806|NCT02624284|537381840|FG001|Overall Study|Revealed exclusionary condition|2|||
148971807|NCT02624284|537381841|FG002|Overall Study|Revealed exclusionary condition|0|||
148971808|NCT02624284|537381839|FG000|Overall Study|Adverse Event|0|||
148971809|NCT02624284|537381840|FG001|Overall Study|Adverse Event|0|||
148971810|NCT02624284|537381841|FG002|Overall Study|Adverse Event|1|||
148971811|NCT05923229|537381842|FG000|Overall Study|Withdrawal by Subject|3|||
149025767|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
149025768|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
149025769|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
149025770|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
149025771|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
149025772|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
149025773|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
149025774|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
149025775|NCT04672460|537571866|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
149025776|NCT04672460|537571867|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
149025777|NCT04672460|537571866|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
149025778|NCT04672460|537571867|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
149025779|NCT04672460|537571866|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
149025780|NCT04672460|537571867|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
149025781|NCT04672460|537571866|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
149025782|NCT04672460|537571867|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
149025783|NCT04672460|537571866|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
149025784|NCT04672460|537571867|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
149025785|NCT04672460|537571866|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
149025786|NCT04672460|537571867|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
149025787|NCT04672460|537571866|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
149025788|NCT04672460|537571867|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
149025789|NCT04672460|537571866|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
149025790|NCT04672460|537571867|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
149025791|NCT04672460|537571866|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
149025792|NCT04672460|537571867|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
149025793|NCT04672460|537571866|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
149025794|NCT04672460|537571867|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
148726027|NCT00706355|536468243|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
148726028|NCT00706355|536468244|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
148726029|NCT00706355|536468245|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
148726030|NCT00706355|536468246|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
148726031|NCT04179019|536468249|FG000|Overall Study|Lost to Follow-up|2|||
148726032|NCT04179019|536468249|FG000|Overall Study|Physician Decision|2|||
148726033|NCT04179019|536468249|FG000|Overall Study|Withdrawal by Subject|5|||
148726034|NCT04179019|536468249|FG000|Overall Study|Adverse Event|4|||
148726035|NCT01855048|536468250|FG000|Overall Study|Withdrawal by Subject|0|||
148726036|NCT01855048|536468251|FG001|Overall Study|Withdrawal by Subject|1|||
148726037|NCT01855048|536468252|FG002|Overall Study|Withdrawal by Subject|0|||
148726038|NCT01855048|536468253|FG003|Overall Study|Withdrawal by Subject|0|||
148726039|NCT01855048|536468254|FG004|Overall Study|Withdrawal by Subject|1|||
148726040|NCT01855048|536468255|FG005|Overall Study|Withdrawal by Subject|0|||
148726041|NCT03465436|536468256|FG000|Period 1|Protocol Violation|0|||
148726042|NCT03465436|536468257|FG001|Period 1|Protocol Violation|0|||
148726043|NCT03465436|536468258|FG002|Period 1|Protocol Violation|1|||
148726044|NCT03465436|536468259|FG003|Period 1|Protocol Violation|0|||
148726045|NCT03465436|536468256|FG000|Period 2|Protocol Violation|0|||
148726046|NCT03465436|536468257|FG001|Period 2|Protocol Violation|1|||
148726047|NCT03465436|536468258|FG002|Period 2|Protocol Violation|0|||
148726048|NCT03465436|536468259|FG003|Period 2|Protocol Violation|0|||
148726049|NCT03465436|536468256|FG000|Period 3|Protocol Violation|1|||
148726050|NCT03465436|536468257|FG001|Period 3|Protocol Violation|1|||
148726051|NCT03465436|536468258|FG002|Period 3|Protocol Violation|0|||
148726052|NCT03465436|536468259|FG003|Period 3|Protocol Violation|0|||
148726053|NCT03465436|536468256|FG000|Period 4|Protocol Violation|0|||
149025795|NCT02949271|537571872|FG000|Overall Study|Lack of Efficacy|5|||
148726054|NCT03465436|536468257|FG001|Period 4|Protocol Violation|0|||
148726055|NCT03465436|536468258|FG002|Period 4|Protocol Violation|1|||
148726056|NCT03465436|536468259|FG003|Period 4|Protocol Violation|0|||
148726057|NCT01813071|536468260|FG000|Overall Study|Protocol Violation|0|||
148726058|NCT01813071|536468261|FG001|Overall Study|Protocol Violation|0|||
148726059|NCT01813071|536468262|FG002|Overall Study|Protocol Violation|0|||
149025796|NCT02949271|537571873|FG001|Overall Study|Lack of Efficacy|4|||
148726060|NCT01813071|536468263|FG003|Overall Study|Protocol Violation|0|||
149025797|NCT02949271|537571872|FG000|Overall Study|Lost to Follow-up|3|||
148726061|NCT01813071|536468264|FG004|Overall Study|Protocol Violation|1|||
148726062|NCT01813071|536468265|FG005|Overall Study|Protocol Violation|4|||
148726063|NCT01813071|536468266|FG006|Overall Study|Protocol Violation|2|||
148726064|NCT01813071|536468267|FG007|Overall Study|Protocol Violation|4|||
148726065|NCT01813071|536468268|FG008|Overall Study|Protocol Violation|2|||
148726066|NCT01813071|536468260|FG000|Overall Study|Withdrawal by Subject|0|||
148726067|NCT01813071|536468261|FG001|Overall Study|Withdrawal by Subject|0|||
148816862|NCT02743494|536804031|FG000|Treatment Period|Participant request to discontinue treatment|31|||
148816863|NCT02743494|536804032|FG001|Treatment Period|Participant request to discontinue treatment|5|||
148816864|NCT02743494|536804031|FG000|Treatment Period|Participant withdrew consent|11|||
148816865|NCT02743494|536804032|FG001|Treatment Period|Participant withdrew consent|4|||
148816866|NCT02743494|536804031|FG000|Treatment Period|Lost to Follow-up|0|||
148816867|NCT02743494|536804032|FG001|Treatment Period|Lost to Follow-up|1|||
148816868|NCT02743494|536804031|FG000|Treatment Period|Poor/Non-compliance|2|||
148816869|NCT02743494|536804032|FG001|Treatment Period|Poor/Non-compliance|0|||
148816870|NCT02743494|536804031|FG000|Treatment Period|Other reasons|4|||
148816871|NCT02743494|536804032|FG001|Treatment Period|Other reasons|1|||
148816872|NCT02068794|536805304|FG000|Overall Study|Withdrawal by Subject|0|||
148816873|NCT02068794|536805305|FG001|Overall Study|Withdrawal by Subject|1|||
148816874|NCT02068794|536805306|FG002|Overall Study|Withdrawal by Subject|2|||
148816875|NCT02068794|536805304|FG000|Overall Study|Early Progression|1|||
148816876|NCT02068794|536805305|FG001|Overall Study|Early Progression|0|||
148816877|NCT02068794|536805306|FG002|Overall Study|Early Progression|1|||
148816878|NCT02068794|536805304|FG000|Overall Study|Ineligible|0|||
148816879|NCT02068794|536805305|FG001|Overall Study|Ineligible|0|||
148816880|NCT02068794|536805306|FG002|Overall Study|Ineligible|1|||
148816881|NCT04439175|536805307|FG000|Overall Study|Never started treatment|4|||
148816882|NCT04439175|536805307|FG000|Overall Study|Ineligible|5|||
148816883|NCT04439175|536805307|FG000|Overall Study|Adverse Event|6|||
148816884|NCT04439175|536805307|FG000|Overall Study|Death|4|||
148816885|NCT04439175|536805307|FG000|Overall Study|Disease progression|44|||
148816886|NCT04439175|536805307|FG000|Overall Study|Withdrawal by Subject|4|||
148816887|NCT04439175|536805307|FG000|Overall Study|Alternative Therapy|1|||
148816888|NCT04439175|536805307|FG000|Overall Study|Other|2|||
148816889|NCT01631188|536805308|FG000|Overall Study|Physician Decision|75|||
148816890|NCT03600350|536805309|FG000|Overall Study|Death|1|||
148816891|NCT03600350|536805309|FG000|Overall Study|On Follow Up|18|||
148816892|NCT03695094|536805314|FG000|Overall Study|Adverse Event|1|||
148816893|NCT03695094|536805315|FG001|Overall Study|Adverse Event|1|||
148816894|NCT03695094|536805314|FG000|Overall Study|Withdrawal by Subject|1|||
148816895|NCT03695094|536805315|FG001|Overall Study|Withdrawal by Subject|0|||
148816896|NCT01137812|536805325|FG000|Overall Study|Adverse Event|21|||
148816897|NCT01137812|536805326|FG001|Overall Study|Adverse Event|14|||
148816898|NCT01137812|536805325|FG000|Overall Study|Lost to Follow-up|6|||
148816899|NCT01137812|536805326|FG001|Overall Study|Lost to Follow-up|8|||
148816900|NCT01137812|536805325|FG000|Overall Study|Physician Decision|25|||
148816901|NCT01137812|536805326|FG001|Overall Study|Physician Decision|17|||
148816902|NCT01137812|536805325|FG000|Overall Study|Protocol Violation|5|||
148816903|NCT01137812|536805326|FG001|Overall Study|Protocol Violation|4|||
148816904|NCT01137812|536805325|FG000|Overall Study|Withdrawal by Subject|5|||
148816905|NCT01137812|536805326|FG001|Overall Study|Withdrawal by Subject|13|||
148816906|NCT01137812|536805325|FG000|Overall Study|Death|2|||
148816907|NCT01137812|536805326|FG001|Overall Study|Death|0|||
148816908|NCT01137812|536805325|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
148816909|NCT01137812|536805326|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
148816910|NCT01137812|536805325|FG000|Overall Study|Other|19|||
148816911|NCT01137812|536805326|FG001|Overall Study|Other|27|||
148816912|NCT00845182|536805327|FG000|Overall Study|Lost to Follow-up|3|||
148816913|NCT00845182|536805328|FG001|Overall Study|Lost to Follow-up|3|||
148816914|NCT00845182|536805329|FG002|Overall Study|Lost to Follow-up|4|||
148816915|NCT00845182|536805327|FG000|Overall Study|Adverse Event|0|||
148816916|NCT00845182|536805328|FG001|Overall Study|Adverse Event|1|||
148816917|NCT00845182|536805329|FG002|Overall Study|Adverse Event|1|||
148816918|NCT00845182|536805327|FG000|Overall Study|Physician Decision|0|||
148816919|NCT00845182|536805328|FG001|Overall Study|Physician Decision|0|||
148971812|NCT05923229|537381843|FG001|Overall Study|Withdrawal by Subject|0|||
148971813|NCT05923229|537381842|FG000|Overall Study|Health related|2|||
148971814|NCT05923229|537381843|FG001|Overall Study|Health related|1|||
148971815|NCT03064126|537381844|FG000|Overall Study|Death|40|||
148971816|NCT03064126|537381845|FG001|Overall Study|Death|16|||
148971817|NCT03064126|537381846|FG002|Overall Study|Death|4|||
148971818|NCT03064126|537381847|FG003|Overall Study|Death|2|||
148971819|NCT03064126|537381844|FG000|Overall Study|Withdrawal by Subject|17|||
148971820|NCT03064126|537381845|FG001|Overall Study|Withdrawal by Subject|9|||
148971821|NCT03064126|537381846|FG002|Overall Study|Withdrawal by Subject|0|||
148971822|NCT03064126|537381847|FG003|Overall Study|Withdrawal by Subject|2|||
148816920|NCT00845182|536805329|FG002|Overall Study|Physician Decision|1|||
148816921|NCT04621760|536805330|FG000|Overall Study|Lost to Follow-up|2|||
148816922|NCT04621760|536805331|FG001|Overall Study|Lost to Follow-up|4|||
148816923|NCT04621760|536805330|FG000|Overall Study|Withdrawal by Subject|1|||
148816924|NCT04621760|536805331|FG001|Overall Study|Withdrawal by Subject|0|||
148816925|NCT06262607|536805342|FG000|Overall Study|Physician Decision|0|||
148816926|NCT06262607|536805343|FG001|Overall Study|Physician Decision|1|||
148816927|NCT06262607|536805342|FG000|Overall Study|Withdrawal by Subject|2|||
148816928|NCT06262607|536805343|FG001|Overall Study|Withdrawal by Subject|0|||
148816929|NCT02639559|536805344|FG000|Overall Study|Mobilization failure|0|||
148971823|NCT03064126|537381844|FG000|Overall Study|Lost to Follow-up|7|||
148971824|NCT03064126|537381845|FG001|Overall Study|Lost to Follow-up|3|||
148971825|NCT03064126|537381846|FG002|Overall Study|Lost to Follow-up|0|||
148971826|NCT03064126|537381847|FG003|Overall Study|Lost to Follow-up|0|||
148971827|NCT03064126|537381844|FG000|Overall Study|Adverse Event|2|||
148971828|NCT03064126|537381845|FG001|Overall Study|Adverse Event|0|||
148971829|NCT03064126|537381846|FG002|Overall Study|Adverse Event|0|||
148726068|NCT01813071|536468262|FG002|Overall Study|Withdrawal by Subject|0|||
148726069|NCT01813071|536468263|FG003|Overall Study|Withdrawal by Subject|0|||
148726070|NCT01813071|536468264|FG004|Overall Study|Withdrawal by Subject|0|||
148726071|NCT01813071|536468265|FG005|Overall Study|Withdrawal by Subject|1|||
148726072|NCT01813071|536468266|FG006|Overall Study|Withdrawal by Subject|0|||
148726073|NCT01813071|536468267|FG007|Overall Study|Withdrawal by Subject|0|||
148971830|NCT03064126|537381847|FG003|Overall Study|Adverse Event|0|||
148726074|NCT01813071|536468268|FG008|Overall Study|Withdrawal by Subject|0|||
148726075|NCT01813071|536468260|FG000|Overall Study|Adverse Event|0|||
148726076|NCT01813071|536468261|FG001|Overall Study|Adverse Event|0|||
148726077|NCT01813071|536468262|FG002|Overall Study|Adverse Event|0|||
148726078|NCT01813071|536468263|FG003|Overall Study|Adverse Event|0|||
148726079|NCT01813071|536468264|FG004|Overall Study|Adverse Event|0|||
148726080|NCT01813071|536468265|FG005|Overall Study|Adverse Event|1|||
148726081|NCT01813071|536468266|FG006|Overall Study|Adverse Event|0|||
148726082|NCT01813071|536468267|FG007|Overall Study|Adverse Event|0|||
148726083|NCT01813071|536468268|FG008|Overall Study|Adverse Event|0|||
148726084|NCT01813071|536468260|FG000|Overall Study|Physician Decision|0|||
148726085|NCT01813071|536468261|FG001|Overall Study|Physician Decision|0|||
148726086|NCT01813071|536468262|FG002|Overall Study|Physician Decision|0|||
148726087|NCT01813071|536468263|FG003|Overall Study|Physician Decision|0|||
148726088|NCT01813071|536468264|FG004|Overall Study|Physician Decision|0|||
148726089|NCT01813071|536468265|FG005|Overall Study|Physician Decision|0|||
148726090|NCT01813071|536468266|FG006|Overall Study|Physician Decision|1|||
148726091|NCT01813071|536468267|FG007|Overall Study|Physician Decision|0|||
148726092|NCT01813071|536468268|FG008|Overall Study|Physician Decision|0|||
148726093|NCT01813071|536468260|FG000|Overall Study|Met inc/exc criteria|0|||
148726094|NCT01813071|536468261|FG001|Overall Study|Met inc/exc criteria|0|||
148726095|NCT01813071|536468262|FG002|Overall Study|Met inc/exc criteria|0|||
148726096|NCT01813071|536468263|FG003|Overall Study|Met inc/exc criteria|0|||
148726097|NCT01813071|536468264|FG004|Overall Study|Met inc/exc criteria|0|||
148726098|NCT01813071|536468265|FG005|Overall Study|Met inc/exc criteria|1|||
148726099|NCT01813071|536468266|FG006|Overall Study|Met inc/exc criteria|0|||
148726100|NCT01813071|536468267|FG007|Overall Study|Met inc/exc criteria|1|||
148726101|NCT01813071|536468268|FG008|Overall Study|Met inc/exc criteria|1|||
148726102|NCT01688726|536468272|FG000|Overall Study|Adverse Event|1|||
148726103|NCT01688726|536468273|FG001|Overall Study|Adverse Event|0|||
148726104|NCT01688726|536468272|FG000|Overall Study|Relocated abroad|0|||
148726105|NCT01688726|536468273|FG001|Overall Study|Relocated abroad|1|||
148726106|NCT04553913|536468274|FG000|Overall Study|patient's block resolved prior to PACU|1|||
148726107|NCT04553913|536468274|FG000|Overall Study|did not use the device properly|5|||
148726108|NCT00710749|536468275|FG000|First Intervention|Withdrawal by Subject|1|||
148726109|NCT00710749|536468276|FG001|First Intervention|Withdrawal by Subject|0|||
148726110|NCT02985879|536468278|FG000|Overall Study|Adverse Event|7|||
148726111|NCT02985879|536468279|FG001|Overall Study|Adverse Event|9|||
148726112|NCT02985879|536468280|FG002|Overall Study|Adverse Event|7|||
148726113|NCT02985879|536468278|FG000|Overall Study|Withdrew consent|6|||
148726114|NCT02985879|536468279|FG001|Overall Study|Withdrew consent|8|||
148726115|NCT02985879|536468280|FG002|Overall Study|Withdrew consent|10|||
148726116|NCT02985879|536468278|FG000|Overall Study|Lost to Follow-up|1|||
148726117|NCT02985879|536468279|FG001|Overall Study|Lost to Follow-up|0|||
148726118|NCT02985879|536468280|FG002|Overall Study|Lost to Follow-up|2|||
148726119|NCT02985879|536468278|FG000|Overall Study|Other, not specified|62|||
148726120|NCT02985879|536468279|FG001|Overall Study|Other, not specified|58|||
148726121|NCT02985879|536468280|FG002|Overall Study|Other, not specified|58|||
148726122|NCT04974619|536469892|FG000|Overall Study|Lost to Follow-up|0|||
148726123|NCT04974619|536469893|FG001|Overall Study|Lost to Follow-up|0|||
148726124|NCT04974619|536469894|FG002|Overall Study|Lost to Follow-up|1|||
148726125|NCT04974619|536469892|FG000|Overall Study|Withdrawal by Subject|0|||
148726126|NCT04974619|536469893|FG001|Overall Study|Withdrawal by Subject|0|||
148726127|NCT04974619|536469894|FG002|Overall Study|Withdrawal by Subject|1|||
148726128|NCT04974619|536469892|FG000|Overall Study|Protocol Violation|0|||
148726129|NCT04974619|536469893|FG001|Overall Study|Protocol Violation|1|||
148971831|NCT03064126|537381844|FG000|Overall Study|Physician Decision|3|||
148971832|NCT03064126|537381845|FG001|Overall Study|Physician Decision|0|||
148971833|NCT03064126|537381846|FG002|Overall Study|Physician Decision|0|||
148726130|NCT04974619|536469894|FG002|Overall Study|Protocol Violation|0|||
148726131|NCT03959527|536469901|FG000|Overall Study|Withdrawal by Subject|8|||
148726132|NCT03959527|536469902|FG001|Overall Study|Withdrawal by Subject|3|||
148726133|NCT03959527|536469901|FG000|Overall Study|Lost to Follow-up|31|||
148971834|NCT03064126|537381847|FG003|Overall Study|Physician Decision|0|||
148971835|NCT03064126|537381844|FG000|Overall Study|Other reason for early termination|3|||
148971836|NCT03064126|537381845|FG001|Overall Study|Other reason for early termination|2|||
148971837|NCT03064126|537381846|FG002|Overall Study|Other reason for early termination|0|||
148971838|NCT03064126|537381847|FG003|Overall Study|Other reason for early termination|0|||
148971839|NCT03064126|537381844|FG000|Overall Study|Missed Visit|3|||
148971840|NCT03064126|537381845|FG001|Overall Study|Missed Visit|1|||
148971841|NCT03064126|537381846|FG002|Overall Study|Missed Visit|0|||
148971842|NCT03064126|537381847|FG003|Overall Study|Missed Visit|0|||
148971843|NCT06034496|537381859|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
148726134|NCT03959527|536469902|FG001|Overall Study|Lost to Follow-up|15|||
148726135|NCT03959527|536469901|FG000|Overall Study|Did not meet eligibility criteria|1|||
148726136|NCT03959527|536469902|FG001|Overall Study|Did not meet eligibility criteria|1|||
148726137|NCT03959527|536469901|FG000|Overall Study|Protocol Violation|10|||
148726138|NCT03959527|536469902|FG001|Overall Study|Protocol Violation|5|||
148726139|NCT01688466|536469903|FG000|Overall Study|Withdrawal by Subject|2|||
148726140|NCT01688466|536469904|FG001|Overall Study|Withdrawal by Subject|1|||
148726141|NCT01688466|536469903|FG000|Overall Study|Death|0|||
148726142|NCT01688466|536469904|FG001|Overall Study|Death|1|||
148726143|NCT01688466|536469903|FG000|Overall Study|Adverse Event|0|||
148726144|NCT01688466|536469904|FG001|Overall Study|Adverse Event|4|||
148726145|NCT01688466|536469903|FG000|Overall Study|Not evaluable|0|||
148726146|NCT01688466|536469904|FG001|Overall Study|Not evaluable|1|||
148726147|NCT02658487|536469913|FG000|Overall Study|Death|2|||
148726148|NCT02658487|536469913|FG000|Overall Study|Disease progression|10|||
148726149|NCT02658487|536469913|FG000|Overall Study|Alternative therapy|1|||
148726150|NCT02658487|536469913|FG000|Overall Study|Adverse Event|1|||
148726151|NCT02658487|536469913|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
148726152|NCT02658487|536469913|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
148726153|NCT01885182|536469914|FG000|Overall Study|Adverse Event|11|||
148726154|NCT01885182|536469915|FG001|Overall Study|Adverse Event|13|||
148726155|NCT01885182|536469914|FG000|Overall Study|Withdrawal by Subject|13|||
148726156|NCT01885182|536469915|FG001|Overall Study|Withdrawal by Subject|6|||
148726157|NCT01885182|536469914|FG000|Overall Study|Lost to Follow-up|2|||
148726158|NCT01885182|536469915|FG001|Overall Study|Lost to Follow-up|2|||
148726159|NCT01885182|536469914|FG000|Overall Study|Lack of Efficacy|8|||
148726160|NCT01885182|536469915|FG001|Overall Study|Lack of Efficacy|1|||
148726161|NCT02676284|536469922|FG000|Overall Study|Withdrawal by Subject|1|||
148726162|NCT00708708|536469924|FG000|Overall Study|Another therapy instead of Enbrel|141|||
148726163|NCT00708708|536469924|FG000|Overall Study|Lost to Follow-up|52|||
148726164|NCT00708708|536469924|FG000|Overall Study|Withdrawal by Subject|51|||
148726165|NCT00708708|536469924|FG000|Overall Study|Intolerance|42|||
148726166|NCT00708708|536469924|FG000|Overall Study|Another therapy along with Enbrel|15|||
148726167|NCT00708708|536469924|FG000|Overall Study|Other unspecified|11|||
148726168|NCT00708708|536469924|FG000|Overall Study|Good effectiveness|9|||
148726169|NCT00708708|536469924|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
148726170|NCT00708708|536469924|FG000|Overall Study|Administrative reasons|7|||
148726171|NCT00708708|536469924|FG000|Overall Study|Lack of effectiveness|4|||
148726172|NCT00708708|536469924|FG000|Overall Study|Lack of compliance|3|||
148726173|NCT00708708|536469924|FG000|Overall Study|Pregnancy|3|||
148726174|NCT00708708|536469924|FG000|Overall Study|Adverse Event|3|||
148726175|NCT00708708|536469924|FG000|Overall Study|Missing values|392|||
148726176|NCT00856830|536469925|FG000|Irinotecan & Bendamustine|Death|0|||
148726177|NCT00856830|536469926|FG001|Irinotecan & Bendamustine|Death|0|||
148726178|NCT00856830|536469927|FG002|Irinotecan & Bendamustine|Death|0|||
148726179|NCT00856830|536469928|FG003|Irinotecan & Bendamustine|Death|2|||
148726180|NCT00856830|536469925|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
148726181|NCT00856830|536469926|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
148726182|NCT00856830|536469927|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
148726183|NCT00856830|536469928|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
148726184|NCT01286558|536469931|FG000|Overall Study|Adverse Event|1|||
148726185|NCT01286558|536469932|FG001|Overall Study|Adverse Event|1|||
148726186|NCT01286558|536469931|FG000|Overall Study|Withdrawal by Subject|0|||
148726187|NCT01286558|536469932|FG001|Overall Study|Withdrawal by Subject|1|||
148726188|NCT02694549|536469937|FG000|Overall Study|screen failures|2|||
148726189|NCT01567826|536469938|FG000|Overall Study|Lost to Follow-up|3|||
148726190|NCT01567826|536469939|FG001|Overall Study|Lost to Follow-up|2|||
148726191|NCT03265288|536469944|FG000|Overall Study|Adverse Event|0|||
148726192|NCT03265288|536469945|FG001|Overall Study|Adverse Event|1|||
148726193|NCT03265288|536469944|FG000|Overall Study|Withdrawal by Subject|13|||
148726194|NCT03265288|536469945|FG001|Overall Study|Withdrawal by Subject|5|||
148726195|NCT03265288|536469944|FG000|Overall Study|Drug Withdrawn|3|||
148726196|NCT03265288|536469945|FG001|Overall Study|Drug Withdrawn|3|||
148726197|NCT03265288|536469944|FG000|Overall Study|Any Other Reason|7|||
148816930|NCT02639559|536805345|FG001|Overall Study|Mobilization failure|3|||
148726198|NCT03265288|536469945|FG001|Overall Study|Any Other Reason|3|||
148726199|NCT03575871|536469954|FG000|Overall Study|Adverse Event|5|||
148726200|NCT03575871|536469955|FG001|Overall Study|Adverse Event|5|||
148971844|NCT06034496|537381860|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
148971845|NCT06034496|537381859|FG000|Overall Study|Withdrawal by Subject|5|||
148816931|NCT02639559|536805344|FG000|Overall Study|Issues with vascular acess|1|||
148816932|NCT02639559|536805345|FG001|Overall Study|Issues with vascular acess|0|||
148816933|NCT02969018|536805350|FG000|Overall Study|Adverse Event|2|||
148816934|NCT02969018|536805351|FG001|Overall Study|Adverse Event|4|||
148816935|NCT02969018|536805352|FG002|Overall Study|Adverse Event|1|||
148816936|NCT02969018|536805353|FG003|Overall Study|Adverse Event|2|||
148816937|NCT02969018|536805354|FG004|Overall Study|Adverse Event|0|||
148816938|NCT02969018|536805355|FG005|Overall Study|Adverse Event|1|||
148816939|NCT02969018|536805356|FG006|Overall Study|Adverse Event|2|||
148816940|NCT02969018|536805357|FG007|Overall Study|Adverse Event|0|||
148816941|NCT02969018|536805350|FG000|Overall Study|Lack of Efficacy|0|||
148816942|NCT02969018|536805351|FG001|Overall Study|Lack of Efficacy|1|||
148816943|NCT02969018|536805352|FG002|Overall Study|Lack of Efficacy|0|||
148816944|NCT02969018|536805353|FG003|Overall Study|Lack of Efficacy|0|||
148816945|NCT02969018|536805354|FG004|Overall Study|Lack of Efficacy|1|||
148816946|NCT02969018|536805355|FG005|Overall Study|Lack of Efficacy|1|||
148816947|NCT02969018|536805356|FG006|Overall Study|Lack of Efficacy|1|||
148816948|NCT02969018|536805357|FG007|Overall Study|Lack of Efficacy|1|||
148816949|NCT02969018|536805350|FG000|Overall Study|Lost to Follow-up|1|||
148816950|NCT02969018|536805351|FG001|Overall Study|Lost to Follow-up|2|||
148816951|NCT02969018|536805352|FG002|Overall Study|Lost to Follow-up|2|||
148816952|NCT02969018|536805353|FG003|Overall Study|Lost to Follow-up|0|||
148816953|NCT02969018|536805354|FG004|Overall Study|Lost to Follow-up|1|||
148816954|NCT02969018|536805355|FG005|Overall Study|Lost to Follow-up|1|||
148816955|NCT02969018|536805356|FG006|Overall Study|Lost to Follow-up|0|||
148816956|NCT02969018|536805357|FG007|Overall Study|Lost to Follow-up|1|||
148816957|NCT02969018|536805350|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816958|NCT02969018|536805351|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816959|NCT02969018|536805352|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816960|NCT02969018|536805353|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816961|NCT02969018|536805354|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816962|NCT02969018|536805355|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816963|NCT02969018|536805356|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
148816964|NCT02969018|536805357|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
148816965|NCT02969018|536805350|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148816966|NCT02969018|536805351|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148816967|NCT02969018|536805352|FG002|Overall Study|Non-Compliance With Study Drug|0|||
148816968|NCT02969018|536805353|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148816969|NCT02969018|536805354|FG004|Overall Study|Non-Compliance With Study Drug|0|||
148816970|NCT02969018|536805355|FG005|Overall Study|Non-Compliance With Study Drug|0|||
148816971|NCT02969018|536805356|FG006|Overall Study|Non-Compliance With Study Drug|0|||
148816972|NCT02969018|536805357|FG007|Overall Study|Non-Compliance With Study Drug|0|||
148971846|NCT06034496|537381860|FG001|Overall Study|Withdrawal by Subject|4|||
148971847|NCT02018458|537381861|FG000|Overall Study|Death|4|||
148971848|NCT01428193|537381864|FG000|Overall Study|Physician Decision|1|||
148971849|NCT01428193|537381864|FG000|Overall Study|Elevated screening liver enzymes|1|||
148971850|NCT03762083|537381865|FG000|Overall Study|Withdrawal by Subject|2|||
148971851|NCT03762083|537381865|FG000|Overall Study|Physician Decision|1|||
148971852|NCT02027844|537381866|FG000|Overall Study|Withdrawal by Subject|3|||
148971853|NCT02027844|537381867|FG001|Overall Study|Withdrawal by Subject|2|||
148971854|NCT02027844|537381868|FG002|Overall Study|Withdrawal by Subject|1|||
148971855|NCT02027844|537381866|FG000|Overall Study|Lost to Follow-up|0|||
148971856|NCT02027844|537381867|FG001|Overall Study|Lost to Follow-up|2|||
148971857|NCT02027844|537381868|FG002|Overall Study|Lost to Follow-up|1|||
148971858|NCT02027844|537381866|FG000|Overall Study|Protocol Violation|0|||
148971859|NCT02027844|537381867|FG001|Overall Study|Protocol Violation|2|||
148971860|NCT02027844|537381868|FG002|Overall Study|Protocol Violation|0|||
148971861|NCT02027844|537381866|FG000|Overall Study|Incomlete data|2|||
148971862|NCT02027844|537381867|FG001|Overall Study|Incomlete data|0|||
148971863|NCT02027844|537381868|FG002|Overall Study|Incomlete data|0|||
148971864|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
148971865|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
148971866|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Graft loss|1|||
148816973|NCT02969018|536805350|FG000|Overall Study|Other|0|||
148816974|NCT02969018|536805351|FG001|Overall Study|Other|0|||
148816975|NCT02969018|536805352|FG002|Overall Study|Other|0|||
148971867|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Graft loss|2|||
148971868|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Death|5|||
148816976|NCT02969018|536805353|FG003|Overall Study|Other|1|||
148816977|NCT02969018|536805354|FG004|Overall Study|Other|0|||
148816978|NCT02969018|536805355|FG005|Overall Study|Other|0|||
148816979|NCT02969018|536805356|FG006|Overall Study|Other|0|||
148816980|NCT02969018|536805357|FG007|Overall Study|Other|2|||
148816981|NCT02969018|536805350|FG000|Overall Study|Pregnancy|0|||
148816982|NCT02969018|536805351|FG001|Overall Study|Pregnancy|0|||
148816983|NCT02969018|536805352|FG002|Overall Study|Pregnancy|0|||
148816984|NCT02969018|536805353|FG003|Overall Study|Pregnancy|0|||
148971869|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Death|3|||
149025798|NCT02949271|537571873|FG001|Overall Study|Lost to Follow-up|6|||
149025799|NCT02949271|537571872|FG000|Overall Study|Physician Decision|5|||
149025800|NCT02949271|537571873|FG001|Overall Study|Physician Decision|5|||
149025801|NCT02949271|537571872|FG000|Overall Study|Protocol Violation|6|||
149025802|NCT02949271|537571873|FG001|Overall Study|Protocol Violation|3|||
149025803|NCT02949271|537571872|FG000|Overall Study|Withdrawal by Subject|1|||
149025804|NCT02949271|537571873|FG001|Overall Study|Withdrawal by Subject|0|||
149025805|NCT02949271|537571872|FG000|Overall Study|Delivered prior to intervention|7|||
149025806|NCT02949271|537571873|FG001|Overall Study|Delivered prior to intervention|9|||
149025807|NCT02949271|537571872|FG000|Overall Study|Outside the window for cervical dilation|2|||
149025808|NCT02949271|537571873|FG001|Overall Study|Outside the window for cervical dilation|3|||
149025809|NCT03929302|537571878|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
149025810|NCT03929302|537571879|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
149025811|NCT03929302|537571880|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
149025812|NCT03929302|537571878|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
149025813|NCT03929302|537571879|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
149025814|NCT03929302|537571880|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
149025815|NCT03929302|537571878|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
149025816|NCT03929302|537571879|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
149025817|NCT03929302|537571880|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
149025818|NCT00372567|537571891|FG000|Phase 3 Study|Adverse Event|5|||
149025819|NCT00372567|537571892|FG001|Phase 3 Study|Adverse Event|1|||
149025820|NCT00372567|537571893|FG002|Phase 3 Study|Adverse Event|1|||
149025821|NCT00372567|537571891|FG000|Phase 3 Study|Death|1|||
149025822|NCT00372567|537571892|FG001|Phase 3 Study|Death|1|||
149025823|NCT00372567|537571893|FG002|Phase 3 Study|Death|0|||
149025824|NCT00372567|537571891|FG000|Phase 3 Study|Protocol Violation|0|||
149025825|NCT00372567|537571892|FG001|Phase 3 Study|Protocol Violation|0|||
149025826|NCT00372567|537571893|FG002|Phase 3 Study|Protocol Violation|1|||
149025827|NCT00372567|537571891|FG000|Phase 3 Study|Objective progression or relapse|10|||
149025828|NCT00372567|537571892|FG001|Phase 3 Study|Objective progression or relapse|13|||
149025829|NCT00372567|537571893|FG002|Phase 3 Study|Objective progression or relapse|4|||
149025830|NCT00372567|537571891|FG000|Phase 3 Study|Global deterioration of health status|0|||
149025831|NCT00372567|537571892|FG001|Phase 3 Study|Global deterioration of health status|1|||
149025832|NCT00372567|537571893|FG002|Phase 3 Study|Global deterioration of health status|0|||
149025833|NCT00372567|537571891|FG000|Phase 3 Study|Other|2|||
149025834|NCT00372567|537571892|FG001|Phase 3 Study|Other|2|||
149025835|NCT00372567|537571893|FG002|Phase 3 Study|Other|1|||
149025836|NCT00372567|537571891|FG000|Phase 3 Study|study terminated by sponsor|13|||
149025837|NCT00372567|537571892|FG001|Phase 3 Study|study terminated by sponsor|8|||
149025838|NCT00372567|537571893|FG002|Phase 3 Study|study terminated by sponsor|5|||
149025839|NCT02347943|537571895|FG000|Overall Study|Study was cancelled|140|||
149025840|NCT02347943|537571896|FG001|Overall Study|Study was cancelled|67|||
149025841|NCT02347943|537571897|FG002|Overall Study|Study was cancelled|45|||
149025842|NCT00303303|537571900|FG000|Overall Study|Withdrawal by Subject|0|||
149025843|NCT00303303|537571901|FG001|Overall Study|Withdrawal by Subject|0|||
149025844|NCT00303303|537571902|FG002|Overall Study|Withdrawal by Subject|1|||
149025845|NCT00691028|537571903|FG000|Open-label Period|Adverse Event|0|||
149025846|NCT00691028|537571904|FG001|Open-label Period|Adverse Event|0|||
149025847|NCT00691028|537571905|FG002|Open-label Period|Adverse Event|0|||
149025848|NCT00691028|537571906|FG003|Open-label Period|Adverse Event|16|||
149025849|NCT00691028|537571903|FG000|Open-label Period|Withdrawal by Subject|0|||
149025850|NCT00691028|537571904|FG001|Open-label Period|Withdrawal by Subject|0|||
149025851|NCT00691028|537571905|FG002|Open-label Period|Withdrawal by Subject|0|||
149025852|NCT00691028|537571906|FG003|Open-label Period|Withdrawal by Subject|3|||
149025853|NCT00691028|537571903|FG000|Open-label Period|not come to a hospital|0|||
149025854|NCT00691028|537571904|FG001|Open-label Period|not come to a hospital|0|||
149025855|NCT00691028|537571905|FG002|Open-label Period|not come to a hospital|0|||
148726201|NCT03575871|536469956|FG002|Overall Study|Adverse Event|8|||
148726202|NCT03575871|536469954|FG000|Overall Study|Death|1|||
148726203|NCT03575871|536469955|FG001|Overall Study|Death|0|||
148726204|NCT03575871|536469956|FG002|Overall Study|Death|0|||
148726205|NCT03575871|536469954|FG000|Overall Study|Lack of Efficacy|5|||
148726206|NCT03575871|536469955|FG001|Overall Study|Lack of Efficacy|4|||
149025856|NCT00691028|537571906|FG003|Open-label Period|not come to a hospital|1|||
149025857|NCT00691028|537571903|FG000|Double-blind Period|Adverse Event|8|||
149025858|NCT00691028|537571904|FG001|Double-blind Period|Adverse Event|9|||
149025859|NCT00691028|537571905|FG002|Double-blind Period|Adverse Event|6|||
149025860|NCT00691028|537571906|FG003|Double-blind Period|Adverse Event|0|||
149025861|NCT00691028|537571903|FG000|Double-blind Period|Lack of Efficacy|4|||
149025862|NCT00691028|537571904|FG001|Double-blind Period|Lack of Efficacy|3|||
149025863|NCT00691028|537571905|FG002|Double-blind Period|Lack of Efficacy|2|||
149025864|NCT00691028|537571906|FG003|Double-blind Period|Lack of Efficacy|0|||
149025865|NCT00691028|537571903|FG000|Double-blind Period|Withdrawal by Subject|1|||
148726207|NCT03575871|536469956|FG002|Overall Study|Lack of Efficacy|7|||
148726208|NCT03575871|536469954|FG000|Overall Study|Lost to Follow-up|1|||
148726209|NCT03575871|536469955|FG001|Overall Study|Lost to Follow-up|1|||
148726210|NCT03575871|536469956|FG002|Overall Study|Lost to Follow-up|1|||
148726211|NCT03575871|536469954|FG000|Overall Study|Protocol Deviation|1|||
148726212|NCT03575871|536469955|FG001|Overall Study|Protocol Deviation|1|||
148726213|NCT03575871|536469956|FG002|Overall Study|Protocol Deviation|1|||
148726214|NCT03575871|536469954|FG000|Overall Study|Withdrawal by Subject|6|||
148726215|NCT03575871|536469955|FG001|Overall Study|Withdrawal by Subject|1|||
148726216|NCT03575871|536469956|FG002|Overall Study|Withdrawal by Subject|9|||
148726217|NCT03575871|536469954|FG000|Overall Study|Other than specified|2|||
148726218|NCT03575871|536469955|FG001|Overall Study|Other than specified|2|||
148726219|NCT03575871|536469956|FG002|Overall Study|Other than specified|0|||
148726220|NCT04132336|536469959|FG000|Overall Study|Investigator Decision|0|||
148726221|NCT04132336|536469960|FG001|Overall Study|Investigator Decision|1|||
148726222|NCT04132336|536469961|FG002|Overall Study|Investigator Decision|0|||
148726223|NCT04132336|536469962|FG003|Overall Study|Investigator Decision|0|||
148726224|NCT04132336|536469963|FG004|Overall Study|Investigator Decision|0|||
148726225|NCT04132336|536469964|FG005|Overall Study|Investigator Decision|0|||
148726226|NCT04132336|536469965|FG006|Overall Study|Investigator Decision|0|||
148726227|NCT04319159|536469970|FG000|Overall Study|Screening failure|13|||
148726228|NCT04319159|536469970|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
148726229|NCT04319159|536469970|FG000|Overall Study|Withdrawal by Subject|1|||
148726230|NCT06005597|536469973|FG000|Overall Study|Lost to Follow-up|1|||
148726231|NCT06005597|536469974|FG001|Overall Study|Lost to Follow-up|2|||
148726232|NCT06005597|536469975|FG002|Overall Study|Lost to Follow-up|1|||
148726233|NCT06005597|536469976|FG003|Overall Study|Lost to Follow-up|2|||
148726234|NCT06005597|536469973|FG000|Overall Study|Death|1|||
148726235|NCT06005597|536469974|FG001|Overall Study|Death|1|||
148726236|NCT06005597|536469975|FG002|Overall Study|Death|1|||
148726237|NCT06005597|536469976|FG003|Overall Study|Death|0|||
148726238|NCT02100319|536469980|FG000|Overall Study|Case Report Forms Uncollected|11|||
148726239|NCT02100319|536469980|FG000|Overall Study|Protocol Deviation|5|||
148726240|NCT02370914|536469983|FG000|Overall Study|Protocol Violation|2|||
148726241|NCT00252174|536469985|FG000|Overall Study|Withdrawal by Subject|0|||
148726242|NCT00252174|536469986|FG001|Overall Study|Withdrawal by Subject|1|||
148726243|NCT00252174|536469987|FG002|Overall Study|Withdrawal by Subject|0|||
148726244|NCT02224573|536469988|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
148726245|NCT02224573|536469989|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
148726246|NCT02224573|536469988|FG000|Treatment Phase|Started on Other IMP|1|||
148726247|NCT02224573|536469989|FG001|Treatment Phase|Started on Other IMP|0|||
148726248|NCT02224573|536469988|FG000|Treatment Phase|Participant Discontinued IMP|0|||
148726249|NCT02224573|536469989|FG001|Treatment Phase|Participant Discontinued IMP|1|||
148726250|NCT02224573|536469988|FG000|Treatment Phase|Lack of Efficacy|15|||
148726251|NCT02224573|536469989|FG001|Treatment Phase|Lack of Efficacy|8|||
148726252|NCT02224573|536469988|FG000|Treatment Phase|Began Commercial Product|1|||
148726253|NCT02224573|536469989|FG001|Treatment Phase|Began Commercial Product|0|||
148726254|NCT02224573|536469988|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
148726255|NCT02224573|536469989|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
148726256|NCT02224573|536469988|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
148726257|NCT02224573|536469989|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
148726258|NCT02224573|536469988|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
148726259|NCT02224573|536469989|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
148726260|NCT02224573|536469988|FG000|Treatment Phase|Continued Compassionate Use|1|||
148726261|NCT02224573|536469989|FG001|Treatment Phase|Continued Compassionate Use|0|||
148726262|NCT02224573|536469988|FG000|Treatment Phase|Lack of Efficiency|2|||
148726263|NCT02224573|536469989|FG001|Treatment Phase|Lack of Efficiency|1|||
148726264|NCT02224573|536469988|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
148726265|NCT02224573|536469989|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
148726266|NCT02224573|536469988|FG000|Treatment Phase|Participant Moved|2|||
148726267|NCT02224573|536469989|FG001|Treatment Phase|Participant Moved|0|||
148726268|NCT02224573|536469988|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
148726269|NCT02224573|536469989|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
148726270|NCT02224573|536469988|FG000|Treatment Phase|Refused Medication|1|||
148726271|NCT02224573|536469989|FG001|Treatment Phase|Refused Medication|1|||
148726272|NCT02224573|536469988|FG000|Treatment Phase|Adverse Event|26|||
148726273|NCT02224573|536469989|FG001|Treatment Phase|Adverse Event|38|||
148726274|NCT02224573|536469988|FG000|Treatment Phase|Placed in Group Home|0|||
148726275|NCT02224573|536469989|FG001|Treatment Phase|Placed in Group Home|1|||
148726276|NCT02224573|536469988|FG000|Treatment Phase|Pursued Other Trials|1|||
148726277|NCT02224573|536469989|FG001|Treatment Phase|Pursued Other Trials|0|||
148726278|NCT02224573|536469988|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
148726279|NCT02224573|536469989|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
148726280|NCT02224573|536469988|FG000|Treatment Phase|Lost to Follow-up|2|||
148726281|NCT02224573|536469989|FG001|Treatment Phase|Lost to Follow-up|1|||
148726282|NCT02224573|536469988|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
148726283|NCT02224573|536469989|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
148726284|NCT02224573|536469988|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
148726285|NCT02224573|536469989|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
148726286|NCT02224573|536469988|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
148726287|NCT02224573|536469989|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
148726288|NCT02224573|536469988|FG000|Taper Phase|Adverse Event|1|||
148726289|NCT02224573|536469989|FG001|Taper Phase|Adverse Event|1|||
148726290|NCT02546362|536469990|FG000|4-week Treatment Period|Lost to Follow-up|1|||
148726291|NCT02546362|536469990|FG000|4-week Treatment Period|Change in medication|2|||
148726292|NCT02546362|536469990|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
148726293|NCT02546362|536469990|FG000|12-week Treatment Period|Lost to Follow-up|2|||
148726294|NCT02546362|536469990|FG000|12-week Treatment Period|Change in medication|1|||
148726295|NCT01138826|536469991|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
148726296|NCT01138826|536469992|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
148726297|NCT01138826|536469993|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
148726298|NCT01138826|536469994|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
148726299|NCT01138826|536469995|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
148726300|NCT01138826|536469996|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
148726301|NCT05206448|536469997|FG000|Overall Study|Lost to Follow-up|2|||
148726302|NCT05206448|536469998|FG001|Overall Study|Lost to Follow-up|2|||
148726303|NCT05206448|536469997|FG000|Overall Study|Withdrawal by Subject|2|||
148726304|NCT05206448|536469998|FG001|Overall Study|Withdrawal by Subject|0|||
148726305|NCT05206448|536469997|FG000|Overall Study|found ineligible after randomization|1|||
148726306|NCT05206448|536469998|FG001|Overall Study|found ineligible after randomization|1|||
148726307|NCT05206448|536469997|FG000|Overall Study|unable to complete study due to personal constraints|1|||
148726308|NCT05206448|536469998|FG001|Overall Study|unable to complete study due to personal constraints|0|||
148726309|NCT05206448|536469997|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
148726310|NCT05206448|536469998|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
148726311|NCT01557842|536470003|FG000|Overall Study|Lost to Follow-up|0|||
148726312|NCT01557842|536470004|FG001|Overall Study|Lost to Follow-up|1|||
148726313|NCT01557842|536470003|FG000|Overall Study|Death|1|||
148726314|NCT01557842|536470004|FG001|Overall Study|Death|0|||
148726315|NCT01557842|536470003|FG000|Overall Study|Lack of Efficacy|0|||
148726316|NCT01557842|536470004|FG001|Overall Study|Lack of Efficacy|1|||
148726317|NCT01557842|536470003|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
148726318|NCT01557842|536470004|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
148726319|NCT01557842|536470003|FG000|Overall Study|Study Terminated by Sponsor|3|||
148726320|NCT01557842|536470004|FG001|Overall Study|Study Terminated by Sponsor|4|||
148726321|NCT01557842|536470003|FG000|Overall Study|Not Ablated|2|||
148726322|NCT01557842|536470004|FG001|Overall Study|Not Ablated|0|||
148726323|NCT00754442|536470005|FG000|Overall Study|Withdrawal by Subject|5|||
148726324|NCT00754442|536470006|FG001|Overall Study|Withdrawal by Subject|3|||
148726325|NCT05560763|536470007|FG000|Overall Study|Withdrawal by Subject|4|||
148726326|NCT00296491|536470008|FG000|Overall Study|Low Pollen Counts|18|||
148726327|NCT00296491|536470009|FG001|Overall Study|Low Pollen Counts|26|||
148726328|NCT00296491|536470010|FG002|Overall Study|Low Pollen Counts|25|||
148726329|NCT00296491|536470011|FG003|Overall Study|Low Pollen Counts|16|||
148726330|NCT00296491|536470008|FG000|Overall Study|Protocol Violation|4|||
148726331|NCT00296491|536470009|FG001|Overall Study|Protocol Violation|6|||
148726332|NCT00296491|536470010|FG002|Overall Study|Protocol Violation|2|||
148726333|NCT00296491|536470011|FG003|Overall Study|Protocol Violation|3|||
148726334|NCT00296491|536470008|FG000|Overall Study|Adverse Event|1|||
148726335|NCT00296491|536470009|FG001|Overall Study|Adverse Event|3|||
148726336|NCT00296491|536470010|FG002|Overall Study|Adverse Event|1|||
148726337|NCT00296491|536470011|FG003|Overall Study|Adverse Event|4|||
148726338|NCT00296491|536470008|FG000|Overall Study|Withdrawn due to Asthma|0|||
148726339|NCT00296491|536470009|FG001|Overall Study|Withdrawn due to Asthma|0|||
148726340|NCT00296491|536470010|FG002|Overall Study|Withdrawn due to Asthma|0|||
148726341|NCT00296491|536470011|FG003|Overall Study|Withdrawn due to Asthma|4|||
148726342|NCT00296491|536470008|FG000|Overall Study|Withdrawal by Subject|7|||
148726343|NCT00296491|536470009|FG001|Overall Study|Withdrawal by Subject|3|||
148726344|NCT00296491|536470010|FG002|Overall Study|Withdrawal by Subject|3|||
148726345|NCT00296491|536470011|FG003|Overall Study|Withdrawal by Subject|2|||
148726346|NCT00296491|536470008|FG000|Overall Study|Non-Compliance|12|||
148726347|NCT00296491|536470009|FG001|Overall Study|Non-Compliance|13|||
148726348|NCT00296491|536470010|FG002|Overall Study|Non-Compliance|10|||
148726349|NCT00296491|536470011|FG003|Overall Study|Non-Compliance|14|||
148726350|NCT00296491|536470008|FG000|Overall Study|Lost to Follow-up|0|||
148726351|NCT00296491|536470009|FG001|Overall Study|Lost to Follow-up|2|||
148726352|NCT00296491|536470010|FG002|Overall Study|Lost to Follow-up|2|||
148726353|NCT00296491|536470011|FG003|Overall Study|Lost to Follow-up|0|||
148726354|NCT06972251|536470014|FG000|Overall Study|Withdrawal by Subject|1|||
148726355|NCT06972251|536470015|FG001|Overall Study|Withdrawal by Subject|0|||
148726356|NCT06972251|536470014|FG000|Overall Study|Lost to Follow-up|10|||
148726357|NCT06972251|536470015|FG001|Overall Study|Lost to Follow-up|2|||
149025866|NCT00691028|537571904|FG001|Double-blind Period|Withdrawal by Subject|0|||
149025867|NCT00691028|537571905|FG002|Double-blind Period|Withdrawal by Subject|1|||
149025868|NCT00691028|537571906|FG003|Double-blind Period|Withdrawal by Subject|0|||
149025869|NCT00691028|537571903|FG000|Double-blind Period|not come to a hospital.|0|||
149025870|NCT00691028|537571904|FG001|Double-blind Period|not come to a hospital.|1|||
149025871|NCT00691028|537571905|FG002|Double-blind Period|not come to a hospital.|0|||
149025872|NCT00691028|537571906|FG003|Double-blind Period|not come to a hospital.|0|||
149025873|NCT00058058|537571914|FG000|Overall Study|Withdrawal by Subject|4|||
149025874|NCT00058058|537571914|FG000|Overall Study|Ineligible|20|||
149025875|NCT00058058|537571914|FG000|Overall Study|Claustrophobic|5|||
149025876|NCT00058058|537571914|FG000|Overall Study|technical issues|6|||
149025877|NCT00058058|537571914|FG000|Overall Study|Poor positioning, illness,pain|3|||
149025878|NCT03085017|537571916|FG000|Overall Study|Death|0|||
149025879|NCT03085017|537571917|FG001|Overall Study|Death|3|||
149025880|NCT00582790|537571923|FG000|Overall Study|Rapid progression of disease|1|||
149025881|NCT00372528|537571924|FG000|Overall Study|Lack of Efficacy|1|||
149025882|NCT00372528|537571924|FG000|Overall Study|Adverse Event|1|||
149025883|NCT00372528|537571924|FG000|Overall Study|Study Terminated by Sponsor|18|||
149025884|NCT00372528|537571924|FG000|Overall Study|Other|1|||
149025885|NCT00562965|537571925|FG000|Overall Study|Withdrawal by Subject|0|||
149025886|NCT00562965|537571926|FG001|Overall Study|Withdrawal by Subject|1|||
149025887|NCT00562965|537571925|FG000|Overall Study|Death|2|||
149025888|NCT00562965|537571926|FG001|Overall Study|Death|4|||
149025889|NCT00562965|537571925|FG000|Overall Study|Lost to Follow-up|1|||
149025890|NCT00562965|537571926|FG001|Overall Study|Lost to Follow-up|0|||
149025891|NCT00562965|537571925|FG000|Overall Study|Other|0|||
149025892|NCT00562965|537571926|FG001|Overall Study|Other|1|||
149025893|NCT00965484|537571927|FG000|Overall Study|Protocol Violation|1|||
149025894|NCT00965484|537571927|FG000|Overall Study|Withdrawal by Subject|1|||
149025895|NCT00859014|537571928|FG000|Overall Study|Death|4|||
149025896|NCT00859014|537571928|FG000|Overall Study|Lost to Follow-up|1|||
149025897|NCT00162942|537571929|FG000|Overall Study|Adverse Event|10|||
149025898|NCT00162942|537571930|FG001|Overall Study|Adverse Event|6|||
149025899|NCT00162942|537571929|FG000|Overall Study|Death|1|||
149025900|NCT00162942|537571930|FG001|Overall Study|Death|0|||
149025901|NCT00162942|537571929|FG000|Overall Study|Withdrawal by Subject|3|||
149025902|NCT00162942|537571930|FG001|Overall Study|Withdrawal by Subject|6|||
149025903|NCT00162942|537571929|FG000|Overall Study|Physician Decision|1|||
149025904|NCT00162942|537571930|FG001|Overall Study|Physician Decision|0|||
149025905|NCT00162942|537571929|FG000|Overall Study|Enter Open-Label Study|76|||
149025906|NCT00162942|537571930|FG001|Overall Study|Enter Open-Label Study|35|||
149025907|NCT00162942|537571929|FG000|Overall Study|Alternate Therapy|6|||
149025908|NCT00162942|537571930|FG001|Overall Study|Alternate Therapy|2|||
149025909|NCT00162942|537571929|FG000|Overall Study|Lack of Efficacy|1|||
149025910|NCT00162942|537571930|FG001|Overall Study|Lack of Efficacy|0|||
149025911|NCT00162942|537571929|FG000|Overall Study|Flare During Active Treatment|7|||
149025912|NCT00162942|537571930|FG001|Overall Study|Flare During Active Treatment|3|||
149025913|NCT00162942|537571929|FG000|Overall Study|2 or more consecutive treatments missed|1|||
149025914|NCT00162942|537571930|FG001|Overall Study|2 or more consecutive treatments missed|0|||
149025915|NCT04796935|537571931|FG000|Overall Study|Withdrawal by Subject|0|||
149025916|NCT04796935|537571932|FG001|Overall Study|Withdrawal by Subject|1|||
149025917|NCT04796935|537571931|FG000|Overall Study|Physician Decision|0|||
149025918|NCT04796935|537571932|FG001|Overall Study|Physician Decision|1|||
149025919|NCT04796935|537571931|FG000|Overall Study|Device not available|1|||
149025920|NCT04796935|537571932|FG001|Overall Study|Device not available|0|||
149025921|NCT04796935|537571931|FG000|Overall Study|Trained provider not available|1|||
149025922|NCT04796935|537571932|FG001|Overall Study|Trained provider not available|0|||
149025923|NCT00783718|537571933|FG000|Induction Phase|Adverse Event|4|||
148726358|NCT01790113|536470016|FG000|Overall Study|Adverse Event|2|||
148726359|NCT01790113|536470017|FG001|Overall Study|Adverse Event|7|||
148726360|NCT01790113|536470016|FG000|Overall Study|Study ended due to FDA clearance|1|||
148726361|NCT01790113|536470017|FG001|Overall Study|Study ended due to FDA clearance|68|||
148726362|NCT00949988|536470018|FG000|Overall Study|Withdrawal by Subject|3|||
149025924|NCT00783718|537571934|FG001|Induction Phase|Adverse Event|0|||
148726363|NCT01929395|536470020|FG000|Overall Study|Did not complete - non-related toxicity|1|||
148726364|NCT01929395|536470021|FG001|Overall Study|Did not complete - non-related toxicity|0|||
148816985|NCT02969018|536805354|FG004|Overall Study|Pregnancy|0|||
149025925|NCT00783718|537571935|FG002|Induction Phase|Adverse Event|7|||
149025926|NCT00783718|537571936|FG003|Induction Phase|Adverse Event|0|||
149025927|NCT00783718|537571937|FG004|Induction Phase|Adverse Event|0|||
149025928|NCT00783718|537571938|FG005|Induction Phase|Adverse Event|0|||
149025929|NCT00783718|537571939|FG006|Induction Phase|Adverse Event|0|||
149025930|NCT00783718|537571933|FG000|Induction Phase|Protocol Violation|1|||
149025931|NCT00783718|537571934|FG001|Induction Phase|Protocol Violation|1|||
149025932|NCT00783718|537571935|FG002|Induction Phase|Protocol Violation|6|||
149025933|NCT00783718|537571936|FG003|Induction Phase|Protocol Violation|0|||
148726365|NCT01929395|536470022|FG002|Overall Study|Did not complete - non-related toxicity|0|||
148726366|NCT01929395|536470020|FG000|Overall Study|Withdrawal by Subject|0|||
148726367|NCT01929395|536470021|FG001|Overall Study|Withdrawal by Subject|1|||
148726368|NCT01929395|536470022|FG002|Overall Study|Withdrawal by Subject|0|||
148726369|NCT01929395|536470020|FG000|Overall Study|Screen Fail|0|||
148726370|NCT01929395|536470021|FG001|Overall Study|Screen Fail|0|||
148726371|NCT01929395|536470022|FG002|Overall Study|Screen Fail|1|||
148726372|NCT00484419|536470023|FG000|Overall Study|Adverse Event|3|||
148726373|NCT00484419|536470024|FG001|Overall Study|Adverse Event|0|||
148726374|NCT00484419|536470025|FG002|Overall Study|Adverse Event|0|||
148726375|NCT00484419|536470023|FG000|Overall Study|Lost to Follow-up|1|||
148726376|NCT00484419|536470024|FG001|Overall Study|Lost to Follow-up|0|||
148726377|NCT00484419|536470025|FG002|Overall Study|Lost to Follow-up|2|||
148726378|NCT00484419|536470023|FG000|Overall Study|Withdrawal by Subject|3|||
148726379|NCT00484419|536470024|FG001|Overall Study|Withdrawal by Subject|1|||
148726380|NCT00484419|536470025|FG002|Overall Study|Withdrawal by Subject|1|||
148726381|NCT00484419|536470023|FG000|Overall Study|subject met discontinuation criteria|2|||
148726382|NCT00484419|536470024|FG001|Overall Study|subject met discontinuation criteria|2|||
148726383|NCT00484419|536470025|FG002|Overall Study|subject met discontinuation criteria|4|||
148726384|NCT00484419|536470023|FG000|Overall Study|required restricted medication|1|||
148726385|NCT00484419|536470024|FG001|Overall Study|required restricted medication|0|||
148726386|NCT00484419|536470025|FG002|Overall Study|required restricted medication|1|||
148726387|NCT00484419|536470023|FG000|Overall Study|Physician Decision|1|||
148726388|NCT00484419|536470024|FG001|Overall Study|Physician Decision|1|||
148726389|NCT00484419|536470025|FG002|Overall Study|Physician Decision|1|||
148726390|NCT00484419|536470023|FG000|Overall Study|subject unable to receive medication|1|||
148726391|NCT00484419|536470024|FG001|Overall Study|subject unable to receive medication|0|||
148726392|NCT00484419|536470025|FG002|Overall Study|subject unable to receive medication|0|||
148726393|NCT00484419|536470023|FG000|Overall Study|subject relocated|0|||
148726394|NCT00484419|536470024|FG001|Overall Study|subject relocated|1|||
148726395|NCT00484419|536470025|FG002|Overall Study|subject relocated|0|||
148726396|NCT00484419|536470023|FG000|Overall Study|sponsor decision, randomized in error|0|||
148726397|NCT00484419|536470024|FG001|Overall Study|sponsor decision, randomized in error|0|||
148726398|NCT00484419|536470025|FG002|Overall Study|sponsor decision, randomized in error|2|||
148726399|NCT03604341|536470026|FG000|Overall Study|Withdrawal by Subject|1|||
148726400|NCT03604341|536470027|FG001|Overall Study|Withdrawal by Subject|1|||
148726401|NCT03604341|536470026|FG000|Overall Study|Adverse Event|1|||
148726402|NCT03604341|536470027|FG001|Overall Study|Adverse Event|0|||
148726403|NCT03604341|536470026|FG000|Overall Study|Protocol Violation|0|||
148726404|NCT03604341|536470027|FG001|Overall Study|Protocol Violation|1|||
148726405|NCT01829113|536470029|FG000|Overall Study|Disease Progression|37|||
148726406|NCT01829113|536470030|FG001|Overall Study|Disease Progression|48|||
148726407|NCT01829113|536470029|FG000|Overall Study|Adverse Event|14|||
148726408|NCT01829113|536470030|FG001|Overall Study|Adverse Event|10|||
148726409|NCT01829113|536470029|FG000|Overall Study|Withdrawal by Subject|17|||
148726410|NCT01829113|536470030|FG001|Overall Study|Withdrawal by Subject|10|||
148726411|NCT01829113|536470029|FG000|Overall Study|Death|4|||
148726412|NCT01829113|536470030|FG001|Overall Study|Death|6|||
148726413|NCT01829113|536470029|FG000|Overall Study|Sponsor Decision|1|||
148726414|NCT01829113|536470030|FG001|Overall Study|Sponsor Decision|1|||
148726415|NCT01829113|536470029|FG000|Overall Study|No Study Treatment Received|3|||
148726416|NCT01829113|536470030|FG001|Overall Study|No Study Treatment Received|2|||
148726417|NCT01829113|536470029|FG000|Overall Study|Physician Decision|1|||
148726418|NCT01829113|536470030|FG001|Overall Study|Physician Decision|1|||
148726419|NCT00355472|536470031|FG000|Overall Study|Physician Decision|1|||
148726420|NCT01341587|536470038|FG000|Overall Study|Lost to Follow-up|2|||
148726421|NCT01341587|536470039|FG001|Overall Study|Lost to Follow-up|0|||
148726422|NCT01341587|536470038|FG000|Overall Study|stopped using the meters|2|||
148726423|NCT01341587|536470039|FG001|Overall Study|stopped using the meters|10|||
148726424|NCT03891329|536470040|FG000|Overall Study|Death|5|||
148726425|NCT03891329|536470040|FG000|Overall Study|Lost to Follow-up|4|||
148726426|NCT03891329|536470040|FG000|Overall Study|Physician Decision|4|||
148726427|NCT03891329|536470040|FG000|Overall Study|Device explanted|3|||
148726428|NCT03891329|536470040|FG000|Overall Study|No study device implanted|3|||
148726429|NCT02654587|536470041|FG000|Overall Study|patient alive at end of study|22|||
148726430|NCT02654587|536470042|FG001|Overall Study|patient alive at end of study|8|||
148726431|NCT02654587|536470041|FG000|Overall Study|Withdrawal by Subject|1|||
148726432|NCT02654587|536470042|FG001|Overall Study|Withdrawal by Subject|7|||
148726433|NCT01825837|536470043|FG000|PART I|Withdrawal by Subject|0|||
148726434|NCT01825837|536470044|FG001|PART I|Withdrawal by Subject|0|||
148726435|NCT01825837|536470045|FG002|PART I|Withdrawal by Subject|0|||
148726436|NCT01825837|536470046|FG003|PART I|Withdrawal by Subject|6|||
148726437|NCT01825837|536470043|FG000|PART I|Patient non-compliance|0|||
148726438|NCT01825837|536470044|FG001|PART I|Patient non-compliance|0|||
148726439|NCT01825837|536470045|FG002|PART I|Patient non-compliance|0|||
148726440|NCT01825837|536470046|FG003|PART I|Patient non-compliance|1|||
148726441|NCT01825837|536470043|FG000|PART I|Treatment failure|0|||
148726442|NCT01825837|536470044|FG001|PART I|Treatment failure|0|||
148726443|NCT01825837|536470045|FG002|PART I|Treatment failure|0|||
148726444|NCT01825837|536470046|FG003|PART I|Treatment failure|7|||
148726445|NCT01825837|536470043|FG000|PART I|reason unspecified|0|||
148726446|NCT01825837|536470044|FG001|PART I|reason unspecified|0|||
148726447|NCT01825837|536470045|FG002|PART I|reason unspecified|0|||
148726448|NCT01825837|536470046|FG003|PART I|reason unspecified|3|||
148726449|NCT01825837|536470043|FG000|PART II|Withdrawal by Subject|3|||
148726450|NCT01825837|536470044|FG001|PART II|Withdrawal by Subject|3|||
148726451|NCT01825837|536470045|FG002|PART II|Withdrawal by Subject|7|||
148726452|NCT01825837|536470046|FG003|PART II|Withdrawal by Subject|0|||
148726453|NCT01825837|536470043|FG000|PART II|Patient non-compliance|5|||
148726454|NCT01825837|536470044|FG001|PART II|Patient non-compliance|2|||
148726455|NCT01825837|536470045|FG002|PART II|Patient non-compliance|4|||
148726456|NCT01825837|536470046|FG003|PART II|Patient non-compliance|0|||
148726457|NCT01825837|536470043|FG000|PART II|Adverse Event|3|||
148726458|NCT01825837|536470044|FG001|PART II|Adverse Event|3|||
148726459|NCT01825837|536470045|FG002|PART II|Adverse Event|1|||
148726460|NCT01825837|536470046|FG003|PART II|Adverse Event|0|||
148726461|NCT01825837|536470043|FG000|PART II|Treatment failure|6|||
148726462|NCT01825837|536470044|FG001|PART II|Treatment failure|4|||
148726463|NCT01825837|536470045|FG002|PART II|Treatment failure|5|||
148726464|NCT01825837|536470046|FG003|PART II|Treatment failure|0|||
148726465|NCT01825837|536470043|FG000|PART II|reason unspecified|2|||
148726466|NCT01825837|536470044|FG001|PART II|reason unspecified|2|||
148726467|NCT01825837|536470045|FG002|PART II|reason unspecified|2|||
148726468|NCT01825837|536470046|FG003|PART II|reason unspecified|0|||
148726469|NCT00904748|536470047|FG000|Overall Study|Withdrawal by Subject|1|||
148726470|NCT00904748|536470048|FG001|Overall Study|Withdrawal by Subject|1|||
148726471|NCT00904748|536470049|FG002|Overall Study|Withdrawal by Subject|1|||
148726472|NCT00904748|536470050|FG003|Overall Study|Withdrawal by Subject|2|||
148726473|NCT00904748|536470051|FG004|Overall Study|Withdrawal by Subject|0|||
148726474|NCT00904748|536470052|FG005|Overall Study|Withdrawal by Subject|0|||
148726475|NCT00904748|536470047|FG000|Overall Study|Adverse Event|0|||
148726476|NCT00904748|536470048|FG001|Overall Study|Adverse Event|0|||
148726477|NCT00904748|536470049|FG002|Overall Study|Adverse Event|0|||
148726478|NCT00904748|536470050|FG003|Overall Study|Adverse Event|0|||
148726479|NCT00904748|536470051|FG004|Overall Study|Adverse Event|1|||
148726480|NCT00904748|536470052|FG005|Overall Study|Adverse Event|0|||
148726481|NCT04403763|536470053|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
148726482|NCT04403763|536470054|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
148726483|NCT04403763|536470055|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
148726484|NCT04403763|536470056|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
148726485|NCT04403763|536470057|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
148726486|NCT04403763|536470058|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
148726487|NCT04403763|536470059|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
148726488|NCT04403763|536470053|FG000|Stage 1|Early termination due to PK tube failure|0|||
148726489|NCT04403763|536470054|FG001|Stage 1|Early termination due to PK tube failure|0|||
148726490|NCT04403763|536470055|FG002|Stage 1|Early termination due to PK tube failure|1|||
148726491|NCT04403763|536470056|FG003|Stage 1|Early termination due to PK tube failure|0|||
148726492|NCT04403763|536470057|FG004|Stage 1|Early termination due to PK tube failure|0|||
148726493|NCT04403763|536470058|FG005|Stage 1|Early termination due to PK tube failure|0|||
148726494|NCT04403763|536470059|FG006|Stage 1|Early termination due to PK tube failure|0|||
148726495|NCT04403763|536470053|FG000|Stage 2A|Adverse Event|0|||
148726496|NCT04403763|536470054|FG001|Stage 2A|Adverse Event|0|||
148726497|NCT04403763|536470055|FG002|Stage 2A|Adverse Event|0|||
148971870|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
148971871|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
148971872|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
148971873|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
148971874|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
148971875|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
148971876|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
148971877|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
148971878|NCT00378014|537381869|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
148971879|NCT00378014|537381870|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
148971880|NCT00378014|537381869|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
148971881|NCT00378014|537381870|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
148726498|NCT04403763|536470056|FG003|Stage 2A|Adverse Event|0|||
148726499|NCT04403763|536470057|FG004|Stage 2A|Adverse Event|0|||
148971882|NCT00378014|537381869|FG000|Extension (Month 12 to Month 59)|Death|1|||
148726500|NCT04403763|536470058|FG005|Stage 2A|Adverse Event|0|||
148726501|NCT04403763|536470059|FG006|Stage 2A|Adverse Event|1|||
148726502|NCT01534637|536470060|FG000|Overall Study|Physician Decision|3|||
148726503|NCT01534637|536470060|FG000|Overall Study|Lack of Efficacy|3|||
148726504|NCT01534637|536470060|FG000|Overall Study|Withdrawal by Subject|1|||
148726505|NCT01534637|536470060|FG000|Overall Study|Adverse Event|1|||
148726506|NCT01534637|536470060|FG000|Overall Study|Liver Mets before treatment|1|||
148726507|NCT02377921|536470061|FG000|Overall Study|Subject non-compliance|1|||
148726508|NCT02377921|536470062|FG001|Overall Study|Subject non-compliance|1|||
148726509|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
148726510|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
148726511|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
148726512|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
148726513|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
148726514|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
148726515|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
148726516|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
148726517|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
148726518|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
148726519|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
148726520|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
148726521|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
148726522|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
148726523|NCT02510014|536470065|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
148726524|NCT02510014|536470066|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
148726525|NCT02510014|536470065|FG000|Treatment Period|Adverse Event|11|||
148726526|NCT02510014|536470066|FG001|Treatment Period|Adverse Event|4|||
148726527|NCT02510014|536470065|FG000|Treatment Period|Withdrawal symptoms|3|||
148726528|NCT02510014|536470066|FG001|Treatment Period|Withdrawal symptoms|0|||
148726529|NCT02510014|536470065|FG000|Treatment Period|Lost to Follow-up|80|||
148726530|NCT02510014|536470066|FG001|Treatment Period|Lost to Follow-up|19|||
148726531|NCT02510014|536470065|FG000|Treatment Period|Physician Decision|5|||
148726532|NCT02510014|536470066|FG001|Treatment Period|Physician Decision|0|||
148726533|NCT02510014|536470065|FG000|Treatment Period|Withdrawal by Subject|67|||
148726534|NCT02510014|536470066|FG001|Treatment Period|Withdrawal by Subject|24|||
148726535|NCT02510014|536470065|FG000|Treatment Period|Withdrawn by the investigator|7|||
148726536|NCT02510014|536470066|FG001|Treatment Period|Withdrawn by the investigator|1|||
148726537|NCT02510014|536470065|FG000|Treatment Period|Protocol Violation|4|||
148726538|NCT02510014|536470066|FG001|Treatment Period|Protocol Violation|4|||
148726539|NCT02510014|536470065|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
148726540|NCT02510014|536470066|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
148726541|NCT01020799|536470067|FG000|Overall Study|Adverse Event|4|||
148726542|NCT01020799|536470068|FG001|Overall Study|Adverse Event|3|||
148726543|NCT01020799|536470069|FG002|Overall Study|Adverse Event|2|||
148726544|NCT01020799|536470067|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
148726545|NCT01020799|536470068|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
148726546|NCT01020799|536470069|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
148726547|NCT01020799|536470067|FG000|Overall Study|Protocol Violation|3|||
148726548|NCT01020799|536470068|FG001|Overall Study|Protocol Violation|2|||
148726549|NCT01020799|536470069|FG002|Overall Study|Protocol Violation|0|||
148726550|NCT01020799|536470067|FG000|Overall Study|Withdrawal by Subject|2|||
148726551|NCT01020799|536470068|FG001|Overall Study|Withdrawal by Subject|2|||
148726552|NCT01020799|536470069|FG002|Overall Study|Withdrawal by Subject|3|||
148726553|NCT01020799|536470067|FG000|Overall Study|Lost to Follow-up|6|||
148726554|NCT01020799|536470068|FG001|Overall Study|Lost to Follow-up|4|||
148726555|NCT01020799|536470069|FG002|Overall Study|Lost to Follow-up|2|||
148726556|NCT00233987|536470075|FG000|Overall Study|Withdrawal by Subject|1|||
148726557|NCT00233987|536470075|FG000|Overall Study|Lack of Efficacy|2|||
148726558|NCT00233987|536470075|FG000|Overall Study|Reason Under Review|1|||
148726559|NCT00233987|536470075|FG000|Overall Study|Other - Not Protocol Specified|5|||
148726560|NCT00233987|536470075|FG000|Overall Study|Eligible but No Treatment Received|2|||
148726561|NCT00233987|536470075|FG000|Overall Study|Ineligible|4|||
148726562|NCT03821272|536471748|FG000|Overall Study|Death|1|||
148726563|NCT03821272|536471749|FG001|Overall Study|Death|0|||
148726564|NCT03821272|536471748|FG000|Overall Study|Physician Decision|1|||
148726565|NCT03821272|536471749|FG001|Overall Study|Physician Decision|0|||
148726566|NCT03821272|536471748|FG000|Overall Study|Withdrawal by Subject|1|||
148726567|NCT03821272|536471749|FG001|Overall Study|Withdrawal by Subject|0|||
148726568|NCT05904769|536471750|FG000|Overall Study|Physician Decision|0|||
148726569|NCT05904769|536471751|FG001|Overall Study|Physician Decision|6|||
148726570|NCT05626803|536471754|FG000|Overall Study|Lost to Follow-up|0|||
148726571|NCT05626803|536471755|FG001|Overall Study|Lost to Follow-up|1|||
148726572|NCT05626803|536471756|FG002|Overall Study|Lost to Follow-up|0|||
148726573|NCT05626803|536471757|FG003|Overall Study|Lost to Follow-up|0|||
148726574|NCT01000610|536471760|FG000|Overall Study|Adverse Event|1|||
148726575|NCT01000610|536471760|FG000|Overall Study|Lost to Follow-up|4|||
148726576|NCT01000610|536471760|FG000|Overall Study|Treatment failure|1|||
148726577|NCT01010126|536471761|FG000|Overall Study|Withdrawal by Subject|1|||
148726578|NCT01010126|536471762|FG001|Overall Study|Withdrawal by Subject|0|||
148726579|NCT01010126|536471763|FG002|Overall Study|Withdrawal by Subject|1|||
148726580|NCT01010126|536471764|FG003|Overall Study|Withdrawal by Subject|0|||
148726581|NCT01010126|536471765|FG004|Overall Study|Withdrawal by Subject|3|||
148726582|NCT01010126|536471766|FG005|Overall Study|Withdrawal by Subject|0|||
148726583|NCT00493246|536471769|FG000|Overall Study|Withdrawal by Subject|0|||
148726584|NCT00493246|536471770|FG001|Overall Study|Withdrawal by Subject|0|||
148726585|NCT00493246|536471771|FG002|Overall Study|Withdrawal by Subject|0|||
148726586|NCT00493246|536471772|FG003|Overall Study|Withdrawal by Subject|0|||
148726587|NCT00493246|536471773|FG004|Overall Study|Withdrawal by Subject|1|||
148726588|NCT00493246|536471774|FG005|Overall Study|Withdrawal by Subject|0|||
148726589|NCT00493246|536471775|FG006|Overall Study|Withdrawal by Subject|0|||
148726590|NCT00493246|536471776|FG007|Overall Study|Withdrawal by Subject|0|||
148726591|NCT00493246|536471769|FG000|Overall Study|No access to draw blood|0|||
148726592|NCT00493246|536471770|FG001|Overall Study|No access to draw blood|0|||
148726593|NCT00493246|536471771|FG002|Overall Study|No access to draw blood|0|||
148726594|NCT00493246|536471772|FG003|Overall Study|No access to draw blood|0|||
148726595|NCT00493246|536471773|FG004|Overall Study|No access to draw blood|0|||
148726596|NCT00493246|536471774|FG005|Overall Study|No access to draw blood|1|||
148726597|NCT00493246|536471775|FG006|Overall Study|No access to draw blood|0|||
148726598|NCT00493246|536471776|FG007|Overall Study|No access to draw blood|0|||
148726599|NCT00493246|536471769|FG000|Overall Study|Lost to Follow-up|0|||
148726600|NCT00493246|536471770|FG001|Overall Study|Lost to Follow-up|0|||
148726601|NCT00493246|536471771|FG002|Overall Study|Lost to Follow-up|0|||
148726602|NCT00493246|536471772|FG003|Overall Study|Lost to Follow-up|0|||
148726603|NCT00493246|536471773|FG004|Overall Study|Lost to Follow-up|0|||
148726604|NCT00493246|536471774|FG005|Overall Study|Lost to Follow-up|0|||
148726605|NCT00493246|536471775|FG006|Overall Study|Lost to Follow-up|1|||
148726606|NCT00493246|536471776|FG007|Overall Study|Lost to Follow-up|0|||
148726607|NCT00595335|536471781|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
148726608|NCT00595335|536471782|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
148726609|NCT00595335|536471781|FG000|Baseline to Six Months|Disease Progression|1|||
148726610|NCT00595335|536471782|FG001|Baseline to Six Months|Disease Progression|1|||
148726611|NCT00595335|536471781|FG000|Baseline to Six Months|Adverse Event|1|||
148726612|NCT00595335|536471782|FG001|Baseline to Six Months|Adverse Event|0|||
148726613|NCT00595335|536471781|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
148726614|NCT00595335|536471782|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
148726615|NCT00595335|536471781|FG000|Six Months to Twelve Months|Disease Progression|1|||
148726616|NCT00595335|536471782|FG001|Six Months to Twelve Months|Disease Progression|0|||
148726617|NCT00493779|536471796|FG000|Overall Study|Logistical issue at site|1|||
148726618|NCT01647958|536471797|FG000|Initial Study|Lost to Follow-up|2|||
148726619|NCT01647958|536471798|FG001|Initial Study|Lost to Follow-up|3|||
148726620|NCT01647958|536471797|FG000|Continuation Phase|treatment received during Overall Study|39|||
148726621|NCT01647958|536471798|FG001|Continuation Phase|treatment received during Overall Study|0|||
148726622|NCT01647958|536471797|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
148726623|NCT01647958|536471798|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
148726624|NCT01131299|536471799|FG000|Overall Study|Withdrawal by Subject|4|||
148726625|NCT01131299|536471800|FG001|Overall Study|Withdrawal by Subject|7|||
148726626|NCT01592721|536471808|FG000|Long-term Follow-up|Death|1|||
148726627|NCT03768726|536471811|FG000|Treatment Phase|Adverse Event|2|||
148726628|NCT03768726|536471812|FG001|Treatment Phase|Adverse Event|2|||
148726629|NCT03768726|536471811|FG000|Treatment Phase|Lost to Follow-up|1|||
148971883|NCT00378014|537381870|FG001|Extension (Month 12 to Month 59)|Death|2|||
148971884|NCT00378014|537381869|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
148971885|NCT00378014|537381870|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
148971886|NCT00378014|537381869|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
148971887|NCT00378014|537381870|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
148971888|NCT00378014|537381869|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
148971889|NCT00378014|537381870|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
148971890|NCT00378014|537381869|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
149025934|NCT00783718|537571937|FG004|Induction Phase|Protocol Violation|0|||
149025935|NCT00783718|537571938|FG005|Induction Phase|Protocol Violation|0|||
148726630|NCT03768726|536471812|FG001|Treatment Phase|Lost to Follow-up|0|||
148726631|NCT03768726|536471811|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
148726632|NCT03768726|536471812|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
148726633|NCT03768726|536471811|FG000|Treatment Phase|Withdrawal by Subject|3|||
148726634|NCT03768726|536471812|FG001|Treatment Phase|Withdrawal by Subject|1|||
148971891|NCT00378014|537381870|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
148971892|NCT00727714|537381874|FG000|Overall Study|Lost to Follow-up|2|||
148971893|NCT00325234|537381875|FG000|Overall Study|Adverse Event|10|||
148971894|NCT00325234|537381876|FG001|Overall Study|Adverse Event|7|||
149025936|NCT00783718|537571939|FG006|Induction Phase|Protocol Violation|0|||
148726635|NCT03768726|536471811|FG000|Follow-Up|Adverse Event|2|||
148726636|NCT03768726|536471812|FG001|Follow-Up|Adverse Event|2|||
148726637|NCT03768726|536471811|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
148726638|NCT03768726|536471812|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
149025937|NCT00783718|537571933|FG000|Induction Phase|Lack of Efficacy|5|||
148726639|NCT03768726|536471811|FG000|Follow-Up|Withdrawal by Subject|2|||
148726640|NCT03768726|536471812|FG001|Follow-Up|Withdrawal by Subject|0|||
148726641|NCT03768726|536471811|FG000|Follow-Up|Other|1|||
148726642|NCT03768726|536471812|FG001|Follow-Up|Other|0|||
148726643|NCT01787279|536471814|FG000|Overall Study|Lost to Follow-up|2|||
148726644|NCT01787279|536471814|FG000|Overall Study|Lack of Efficacy|1|||
148726645|NCT02148913|536471815|FG000|Overall Study|Death|0|||
148726646|NCT02148913|536471816|FG001|Overall Study|Death|1|||
148726647|NCT02148913|536471817|FG002|Overall Study|Death|0|||
148726648|NCT02148913|536471818|FG003|Overall Study|Death|0|||
148816986|NCT02969018|536805355|FG005|Overall Study|Pregnancy|1|||
148726649|NCT01287039|536471819|FG000|Overall Study|Noncompliance with study procedures|0|||
148726650|NCT01287039|536471820|FG001|Overall Study|Noncompliance with study procedures|1|||
148816987|NCT02969018|536805356|FG006|Overall Study|Pregnancy|0|||
148816988|NCT02969018|536805357|FG007|Overall Study|Pregnancy|0|||
148816989|NCT02969018|536805350|FG000|Overall Study|Protocol Violation|0|||
148816990|NCT02969018|536805351|FG001|Overall Study|Protocol Violation|0|||
148816991|NCT02969018|536805352|FG002|Overall Study|Protocol Violation|1|||
148816992|NCT02969018|536805353|FG003|Overall Study|Protocol Violation|1|||
148816993|NCT02969018|536805354|FG004|Overall Study|Protocol Violation|0|||
148816994|NCT02969018|536805355|FG005|Overall Study|Protocol Violation|0|||
148816995|NCT02969018|536805356|FG006|Overall Study|Protocol Violation|0|||
148816996|NCT02969018|536805357|FG007|Overall Study|Protocol Violation|0|||
148816997|NCT02969018|536805350|FG000|Overall Study|Withdrawal by Subject|0|||
148816998|NCT02969018|536805351|FG001|Overall Study|Withdrawal by Subject|1|||
148816999|NCT02969018|536805352|FG002|Overall Study|Withdrawal by Subject|2|||
148817000|NCT02969018|536805353|FG003|Overall Study|Withdrawal by Subject|1|||
148817001|NCT02969018|536805354|FG004|Overall Study|Withdrawal by Subject|0|||
148817002|NCT02969018|536805355|FG005|Overall Study|Withdrawal by Subject|4|||
148817003|NCT02969018|536805356|FG006|Overall Study|Withdrawal by Subject|4|||
148817004|NCT02969018|536805357|FG007|Overall Study|Withdrawal by Subject|3|||
148817005|NCT03412890|536805360|FG000|Overall Study|Adverse Event|5|||
148817006|NCT03412890|536805361|FG001|Overall Study|Adverse Event|5|||
148817007|NCT03412890|536805362|FG002|Overall Study|Adverse Event|9|||
148817008|NCT03412890|536805360|FG000|Overall Study|Protocol deviation|2|||
148817009|NCT03412890|536805361|FG001|Overall Study|Protocol deviation|1|||
148817010|NCT03412890|536805362|FG002|Overall Study|Protocol deviation|2|||
148817011|NCT03412890|536805360|FG000|Overall Study|Lost to Follow-up|7|||
148817012|NCT03412890|536805361|FG001|Overall Study|Lost to Follow-up|10|||
148817013|NCT03412890|536805362|FG002|Overall Study|Lost to Follow-up|10|||
148817014|NCT03412890|536805360|FG000|Overall Study|Withdrawal by Subject|9|||
148817015|NCT03412890|536805361|FG001|Overall Study|Withdrawal by Subject|12|||
148817016|NCT03412890|536805362|FG002|Overall Study|Withdrawal by Subject|11|||
148817017|NCT03412890|536805360|FG000|Overall Study|Lack of Efficacy|2|||
148817018|NCT03412890|536805361|FG001|Overall Study|Lack of Efficacy|7|||
148817019|NCT03412890|536805362|FG002|Overall Study|Lack of Efficacy|5|||
148817020|NCT03412890|536805360|FG000|Overall Study|Other|5|||
148817021|NCT03412890|536805361|FG001|Overall Study|Other|6|||
148817022|NCT03412890|536805362|FG002|Overall Study|Other|5|||
148817023|NCT03412890|536805360|FG000|Overall Study|Participants who did not receive any study drug|0|||
148817024|NCT03412890|536805361|FG001|Overall Study|Participants who did not receive any study drug|1|||
148817025|NCT03412890|536805362|FG002|Overall Study|Participants who did not receive any study drug|0|||
148817026|NCT02315625|536805363|FG000|First Intervention|Disease Progression|1|||
148817027|NCT02315625|536805364|FG001|First Intervention|Disease Progression|0|||
148817028|NCT02315625|536805363|FG000|Second Intervention|Physician Decision|2|||
148817029|NCT02315625|536805364|FG001|Second Intervention|Physician Decision|1|||
148817030|NCT02315625|536805363|FG000|Second Intervention|Study closure|1|||
148817031|NCT02315625|536805364|FG001|Second Intervention|Study closure|0|||
148817032|NCT02315625|536805363|FG000|Second Intervention|Disease Progression|1|||
148817033|NCT02315625|536805364|FG001|Second Intervention|Disease Progression|0|||
148817034|NCT05101317|536805365|FG000|Week1-13|Adverse Event|0|||
148817035|NCT05101317|536805366|FG001|Week1-13|Adverse Event|1|||
148726651|NCT01287039|536471819|FG000|Overall Study|Change of location/residence|0|||
148726652|NCT01287039|536471820|FG001|Overall Study|Change of location/residence|3|||
148726653|NCT01287039|536471819|FG000|Overall Study|Elective surgery|0|||
148726654|NCT01287039|536471820|FG001|Overall Study|Elective surgery|1|||
148726655|NCT01287039|536471819|FG000|Overall Study|Protocol Violation|2|||
148726656|NCT01287039|536471820|FG001|Overall Study|Protocol Violation|3|||
148817036|NCT05101317|536805367|FG002|Week1-13|Adverse Event|0|||
148817037|NCT05101317|536805368|FG003|Week1-13|Adverse Event|0|||
148817038|NCT05101317|536805365|FG000|Week1-13|Withdrawal by Subject|0|||
148817039|NCT05101317|536805366|FG001|Week1-13|Withdrawal by Subject|2|||
148817040|NCT05101317|536805367|FG002|Week1-13|Withdrawal by Subject|0|||
148817041|NCT05101317|536805368|FG003|Week1-13|Withdrawal by Subject|0|||
148817042|NCT05101317|536805365|FG000|Week1-13|Early Withdrawl|0|||
148817043|NCT05101317|536805366|FG001|Week1-13|Early Withdrawl|0|||
148817044|NCT05101317|536805367|FG002|Week1-13|Early Withdrawl|0|||
148817045|NCT05101317|536805368|FG003|Week1-13|Early Withdrawl|1|||
148817046|NCT05101317|536805365|FG000|Week 13-25|Lost to Follow-up|0|||
148817047|NCT05101317|536805366|FG001|Week 13-25|Lost to Follow-up|0|||
148726657|NCT01287039|536471819|FG000|Overall Study|Excluded medication taken|1|||
148726658|NCT01287039|536471820|FG001|Overall Study|Excluded medication taken|0|||
148726659|NCT01287039|536471819|FG000|Overall Study|Noncompliance with study medication|0|||
148726660|NCT01287039|536471820|FG001|Overall Study|Noncompliance with study medication|1|||
148726661|NCT01287039|536471819|FG000|Overall Study|Problem with travel|0|||
148726662|NCT01287039|536471820|FG001|Overall Study|Problem with travel|1|||
148726663|NCT01287039|536471819|FG000|Overall Study|Death|1|||
148726664|NCT01287039|536471820|FG001|Overall Study|Death|0|||
148726665|NCT01287039|536471819|FG000|Overall Study|Change of residence|1|||
148726666|NCT01287039|536471820|FG001|Overall Study|Change of residence|0|||
148726667|NCT01287039|536471819|FG000|Overall Study|Adverse Event|7|||
148726668|NCT01287039|536471820|FG001|Overall Study|Adverse Event|4|||
148726669|NCT01287039|536471819|FG000|Overall Study|Withdrawal by Subject|14|||
148726670|NCT01287039|536471820|FG001|Overall Study|Withdrawal by Subject|11|||
148726671|NCT01287039|536471819|FG000|Overall Study|Lost to Follow-up|3|||
148726672|NCT01287039|536471820|FG001|Overall Study|Lost to Follow-up|2|||
148726673|NCT05016622|536471821|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
148726674|NCT05016622|536471821|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
148726675|NCT01304693|536471822|FG000|Overall Study|Adverse Event|0|||
148726676|NCT01304693|536471823|FG001|Overall Study|Adverse Event|0|||
148726677|NCT01304693|536471824|FG002|Overall Study|Adverse Event|0|||
148726678|NCT01304693|536471825|FG003|Overall Study|Adverse Event|0|||
148726679|NCT01304693|536471826|FG004|Overall Study|Adverse Event|1|||
148726680|NCT01304693|536471822|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
148726681|NCT01304693|536471823|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
148726682|NCT01304693|536471824|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
148726683|NCT01304693|536471825|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
148726684|NCT01304693|536471826|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
148726685|NCT03438396|536471828|FG000|Overall Study|Reason Not Specified|9|||
148726686|NCT03438396|536471828|FG000|Overall Study|Withdrawal by Subject|5|||
148726687|NCT03438396|536471828|FG000|Overall Study|Lost to Follow-up|2|||
148726688|NCT03438396|536471828|FG000|Overall Study|Death|85|||
148726689|NCT03438396|536471828|FG000|Overall Study|Not treated|1|||
148726690|NCT00262041|536471829|FG000|Overall Study|Withdrawal by Subject|0|||
148726691|NCT00262041|536471830|FG001|Overall Study|Withdrawal by Subject|3|||
148726692|NCT00262041|536471831|FG002|Overall Study|Withdrawal by Subject|1|||
148726693|NCT00262041|536471829|FG000|Overall Study|Lost to Follow-up|1|||
148726694|NCT00262041|536471830|FG001|Overall Study|Lost to Follow-up|1|||
148726695|NCT00262041|536471831|FG002|Overall Study|Lost to Follow-up|5|||
148726696|NCT00262041|536471829|FG000|Overall Study|Unable to classify|1|||
148726697|NCT00262041|536471830|FG001|Overall Study|Unable to classify|0|||
148726698|NCT00262041|536471831|FG002|Overall Study|Unable to classify|0|||
148726699|NCT03578237|536471832|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
148726700|NCT03578237|536471833|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
148971895|NCT00325234|537381875|FG000|Overall Study|Death due to Study Disease|1|||
148971896|NCT00325234|537381876|FG001|Overall Study|Death due to Study Disease|0|||
148971897|NCT00325234|537381875|FG000|Overall Study|Entry Criteria Not Met|1|||
148971898|NCT00325234|537381876|FG001|Overall Study|Entry Criteria Not Met|2|||
148971899|NCT00325234|537381875|FG000|Overall Study|Subject Decision|6|||
148971900|NCT00325234|537381876|FG001|Overall Study|Subject Decision|8|||
148971901|NCT00325234|537381875|FG000|Overall Study|Physician Decision|17|||
148971902|NCT00325234|537381876|FG001|Overall Study|Physician Decision|12|||
148971903|NCT00325234|537381875|FG000|Overall Study|Progressive Disease|34|||
148971904|NCT00325234|537381876|FG001|Overall Study|Progressive Disease|37|||
148971905|NCT03013543|537381879|FG000|Overall Study|Withdrawal by Subject|0|||
148971906|NCT03013543|537381880|FG001|Overall Study|Withdrawal by Subject|2|||
148971907|NCT03013543|537381881|FG002|Overall Study|Withdrawal by Subject|0|||
148971908|NCT03013543|537381882|FG003|Overall Study|Withdrawal by Subject|5|||
148971909|NCT03013543|537381883|FG004|Overall Study|Withdrawal by Subject|6|||
148971910|NCT03013543|537381884|FG005|Overall Study|Withdrawal by Subject|2|||
148971911|NCT03013543|537381885|FG006|Overall Study|Withdrawal by Subject|3|||
149025938|NCT00783718|537571934|FG001|Induction Phase|Lack of Efficacy|2|||
149025939|NCT00783718|537571935|FG002|Induction Phase|Lack of Efficacy|14|||
148726701|NCT01173471|536471834|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148726702|NCT01173471|536471835|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148726703|NCT01173471|536471836|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
148726704|NCT01173471|536471837|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
148726705|NCT01173471|536471834|FG000|Overall Study|Condition under investigation worsened|2|||
148726706|NCT01173471|536471835|FG001|Overall Study|Condition under investigation worsened|0|||
148726707|NCT01173471|536471836|FG002|Overall Study|Condition under investigation worsened|0|||
148726708|NCT01173471|536471837|FG003|Overall Study|Condition under investigation worsened|0|||
148971912|NCT03013543|537381886|FG007|Overall Study|Withdrawal by Subject|1|||
149025940|NCT00783718|537571936|FG003|Induction Phase|Lack of Efficacy|0|||
148971913|NCT03013543|537381887|FG008|Overall Study|Withdrawal by Subject|0|||
148726709|NCT01173471|536471834|FG000|Overall Study|Lost to Follow-up|0|||
148726710|NCT01173471|536471835|FG001|Overall Study|Lost to Follow-up|0|||
148726711|NCT01173471|536471836|FG002|Overall Study|Lost to Follow-up|1|||
148726712|NCT01173471|536471837|FG003|Overall Study|Lost to Follow-up|0|||
148726713|NCT01173471|536471834|FG000|Overall Study|Reason given as Other|0|||
148726714|NCT01173471|536471835|FG001|Overall Study|Reason given as Other|0|||
148726715|NCT01173471|536471836|FG002|Overall Study|Reason given as Other|1|||
148726716|NCT01173471|536471837|FG003|Overall Study|Reason given as Other|0|||
148726717|NCT02488330|536471838|FG000|Overall Study|Adverse Event|1|||
148726718|NCT02488330|536471838|FG000|Overall Study|Physician Decision|2|||
148726719|NCT02488330|536471838|FG000|Overall Study|Death|2|||
148726720|NCT02488330|536471838|FG000|Overall Study|Disease Progression|3|||
148726721|NCT02488330|536471838|FG000|Overall Study|Study Termination by Sponsor|4|||
148726722|NCT00584844|536471839|FG000|Overall Study|Withdrawal by Subject|59|||
148726723|NCT00584844|536471839|FG000|Overall Study|Screen Failure|20|||
148726724|NCT01642914|536471840|FG000|Overall Study|Adverse Event|11|||
148726725|NCT01642914|536471841|FG001|Overall Study|Adverse Event|7|||
148726726|NCT01642914|536471842|FG002|Overall Study|Adverse Event|15|||
148726727|NCT01642914|536471840|FG000|Overall Study|Lack of Efficacy|9|||
148726728|NCT01642914|536471841|FG001|Overall Study|Lack of Efficacy|4|||
148726729|NCT01642914|536471842|FG002|Overall Study|Lack of Efficacy|2|||
148726730|NCT01642914|536471840|FG000|Overall Study|Protocol Violation|15|||
148726731|NCT01642914|536471841|FG001|Overall Study|Protocol Violation|13|||
148726732|NCT01642914|536471842|FG002|Overall Study|Protocol Violation|6|||
148726733|NCT01642914|536471840|FG000|Overall Study|Withdrawal by Subject|5|||
148726734|NCT01642914|536471841|FG001|Overall Study|Withdrawal by Subject|5|||
148726735|NCT01642914|536471842|FG002|Overall Study|Withdrawal by Subject|10|||
148726736|NCT01642914|536471840|FG000|Overall Study|Lost to Follow-up|5|||
148726737|NCT01642914|536471841|FG001|Overall Study|Lost to Follow-up|3|||
148726738|NCT01642914|536471842|FG002|Overall Study|Lost to Follow-up|7|||
148726739|NCT01642914|536471840|FG000|Overall Study|Other Reason|1|||
148726740|NCT01642914|536471841|FG001|Overall Study|Other Reason|0|||
148726741|NCT01642914|536471842|FG002|Overall Study|Other Reason|0|||
148726742|NCT00171301|536471843|FG000|Overall Study|Death|1|||
148726743|NCT00171301|536471844|FG001|Overall Study|Death|2|||
148726744|NCT00171301|536471843|FG000|Overall Study|Adverse Event|1|||
148726745|NCT00171301|536471844|FG001|Overall Study|Adverse Event|2|||
148726746|NCT00171301|536471843|FG000|Overall Study|Lost to Follow-up|6|||
148726747|NCT00171301|536471844|FG001|Overall Study|Lost to Follow-up|2|||
148726748|NCT00171301|536471843|FG000|Overall Study|Protocol Violation|0|||
148726749|NCT00171301|536471844|FG001|Overall Study|Protocol Violation|2|||
148726750|NCT00171301|536471843|FG000|Overall Study|Withdrawal by Subject|0|||
148726751|NCT00171301|536471844|FG001|Overall Study|Withdrawal by Subject|1|||
148726752|NCT01478828|536471845|FG000|Overall Study|Adverse Event|1|||
148726753|NCT05611996|536471846|FG000|Overall Study|Ineligible|1|||
148726754|NCT05611996|536471846|FG000|Overall Study|Withdrawal by Subject|9|||
148726755|NCT04479475|536471847|FG000|Overall Study|Withdrawal by Subject|7|||
148726756|NCT03451006|536471849|FG000|Overall Study|Withdrawal by Subject|2|||
148726757|NCT03451006|536471850|FG001|Overall Study|Withdrawal by Subject|2|||
148726758|NCT02547766|536471851|FG000|Overall Study|Withdrawal by Subject|1|||
148726759|NCT05444543|536471854|FG000|Overall Study|Withdrawal by Subject|1|||
148726760|NCT05444543|536471855|FG001|Overall Study|Withdrawal by Subject|0|||
148726761|NCT05444543|536471854|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
148726762|NCT05444543|536471855|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
148726763|NCT05444543|536471854|FG000|Overall Study|Adverse Event|0|||
148726764|NCT05444543|536471855|FG001|Overall Study|Adverse Event|1|||
148726765|NCT05444543|536471854|FG000|Overall Study|Family relocating at a distance from study site|0|||
148726766|NCT05444543|536471855|FG001|Overall Study|Family relocating at a distance from study site|1|||
148726767|NCT03847194|536471856|FG000|Overall Study|Lost to Follow-up|2|||
148726768|NCT03847194|536471857|FG001|Overall Study|Lost to Follow-up|5|||
148726769|NCT03847194|536471856|FG000|Overall Study|Withdrawal by Subject|1|||
148726770|NCT03847194|536471857|FG001|Overall Study|Withdrawal by Subject|2|||
148726771|NCT03847194|536471856|FG000|Overall Study|Death|0|||
148726772|NCT03847194|536471857|FG001|Overall Study|Death|1|||
148971914|NCT03013543|537381888|FG009|Overall Study|Withdrawal by Subject|4|||
148971915|NCT03013543|537381879|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
148971916|NCT03013543|537381880|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
148726773|NCT01144403|536471859|FG000|Overall Study|Lost to Follow-up|3|||
148726774|NCT01144403|536471859|FG000|Overall Study|Death|1|||
148726775|NCT01144403|536471859|FG000|Overall Study|Adverse Event|1|||
148726776|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
148726777|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
148726778|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
148726779|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
148726780|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
148726781|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
148971917|NCT03013543|537381881|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
148726782|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
148726783|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
148726784|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
148726785|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
148726786|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
148726787|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
148726788|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
148726789|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
148726790|NCT04740931|536471861|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
148726791|NCT04740931|536471862|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
148726792|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
148726793|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
148726794|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
148726795|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
148726796|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
148726797|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
148726798|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
148726799|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
148726800|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
148726801|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
148726802|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
148726803|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
148726804|NCT04740931|536471861|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
148726805|NCT04740931|536471862|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
148726806|NCT02096588|536471863|FG000|Overall Study|Lack of Efficacy|2|||
148726807|NCT02096588|536471864|FG001|Overall Study|Lack of Efficacy|0|||
148726808|NCT02096588|536471863|FG000|Overall Study|Withdrawal by Subject|0|||
148726809|NCT02096588|536471864|FG001|Overall Study|Withdrawal by Subject|1|||
148726810|NCT01949116|536471871|FG000|Overall Study|Death|2|||
148726811|NCT01949116|536471872|FG001|Overall Study|Death|0|||
148726812|NCT01949116|536471871|FG000|Overall Study|Lost to Follow-up|1|||
148726813|NCT01949116|536471872|FG001|Overall Study|Lost to Follow-up|3|||
148726814|NCT01949116|536471871|FG000|Overall Study|Withdrawal by Subject|5|||
148726815|NCT01949116|536471872|FG001|Overall Study|Withdrawal by Subject|3|||
148726816|NCT01560507|536471881|FG000|Overall Study|Lost to Follow-up|3|||
148726817|NCT01560507|536471882|FG001|Overall Study|Lost to Follow-up|1|||
148726818|NCT01560507|536471883|FG002|Overall Study|Lost to Follow-up|2|||
148726819|NCT01560507|536471881|FG000|Overall Study|Withdrawal by Subject|1|||
148726820|NCT01560507|536471882|FG001|Overall Study|Withdrawal by Subject|1|||
148726821|NCT01560507|536471883|FG002|Overall Study|Withdrawal by Subject|0|||
148726822|NCT01138111|536471884|FG000|Overall Study|Withdrawal by Subject|5|||
148726823|NCT01138111|536471884|FG000|Overall Study|Adverse Event|1|||
148726824|NCT01138111|536471884|FG000|Overall Study|Death|1|||
148726825|NCT01138111|536471884|FG000|Overall Study|Lost to Follow-up|2|||
148726826|NCT00706992|536471885|FG000|Overall Study|Study termination|5|||
148726827|NCT00706992|536471886|FG001|Overall Study|Study termination|5|||
148726828|NCT00706992|536471887|FG002|Overall Study|Study termination|6|||
148726829|NCT00706992|536471888|FG003|Overall Study|Study termination|2|||
148726830|NCT00706992|536471889|FG004|Overall Study|Study termination|3|||
148726831|NCT00706992|536471890|FG005|Overall Study|Study termination|2|||
148726832|NCT00706992|536471891|FG006|Overall Study|Study termination|3|||
148726833|NCT00706992|536471885|FG000|Overall Study|Disease progression before treatment|0|||
148971918|NCT03013543|537381882|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
148971919|NCT03013543|537381883|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
148971920|NCT03013543|537381884|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
148971921|NCT03013543|537381885|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
148971922|NCT03013543|537381886|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
148971923|NCT03013543|537381887|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
148971924|NCT03013543|537381888|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
148971925|NCT03013543|537381879|FG000|Overall Study|Other|0|||
148971926|NCT03013543|537381880|FG001|Overall Study|Other|0|||
148971927|NCT03013543|537381881|FG002|Overall Study|Other|2|||
148971928|NCT03013543|537381882|FG003|Overall Study|Other|0|||
148971929|NCT03013543|537381883|FG004|Overall Study|Other|2|||
148726834|NCT00706992|536471886|FG001|Overall Study|Disease progression before treatment|0|||
148726835|NCT00706992|536471887|FG002|Overall Study|Disease progression before treatment|0|||
148971930|NCT03013543|537381884|FG005|Overall Study|Other|0|||
148971931|NCT03013543|537381885|FG006|Overall Study|Other|0|||
148971932|NCT03013543|537381886|FG007|Overall Study|Other|0|||
148726836|NCT00706992|536471888|FG003|Overall Study|Disease progression before treatment|0|||
148726837|NCT00706992|536471889|FG004|Overall Study|Disease progression before treatment|1|||
148726838|NCT00706992|536471890|FG005|Overall Study|Disease progression before treatment|0|||
148971933|NCT03013543|537381887|FG008|Overall Study|Other|1|||
148971934|NCT03013543|537381888|FG009|Overall Study|Other|0|||
148971935|NCT03013543|537381879|FG000|Overall Study|Adverse Event|0|||
148817048|NCT05101317|536805367|FG002|Week 13-25|Lost to Follow-up|1|||
148817049|NCT05101317|536805368|FG003|Week 13-25|Lost to Follow-up|0|||
148817050|NCT05101317|536805365|FG000|Week 13-25|Withdrawal by Subject|1|||
148817051|NCT05101317|536805366|FG001|Week 13-25|Withdrawal by Subject|1|||
148817052|NCT05101317|536805367|FG002|Week 13-25|Withdrawal by Subject|0|||
148817053|NCT05101317|536805368|FG003|Week 13-25|Withdrawal by Subject|0|||
148817054|NCT05101317|536805365|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
148817055|NCT05101317|536805366|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
148817056|NCT05101317|536805367|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
148817057|NCT05101317|536805368|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
148817058|NCT01327703|536805369|FG000|Second Treatment Period|Adverse Event|1|||
148817059|NCT01327703|536805370|FG001|Second Treatment Period|Adverse Event|1|||
148817060|NCT01327703|536805369|FG000|Second Treatment Period|Protocol Violation|0|||
148817061|NCT01327703|536805370|FG001|Second Treatment Period|Protocol Violation|1|||
148817062|NCT00927082|536805371|FG000|Overall Study|Lost to Follow-up|9|||
148817063|NCT00927082|536805372|FG001|Overall Study|Lost to Follow-up|8|||
148817064|NCT00927082|536805373|FG002|Overall Study|Lost to Follow-up|12|||
148817065|NCT00927082|536805374|FG003|Overall Study|Lost to Follow-up|16|||
148817066|NCT00927082|536805371|FG000|Overall Study|Withdrawal by Subject|3|||
148817067|NCT00927082|536805372|FG001|Overall Study|Withdrawal by Subject|2|||
148817068|NCT00927082|536805373|FG002|Overall Study|Withdrawal by Subject|7|||
148817069|NCT00927082|536805374|FG003|Overall Study|Withdrawal by Subject|2|||
148817070|NCT00927082|536805371|FG000|Overall Study|Death|0|||
148971936|NCT03013543|537381880|FG001|Overall Study|Adverse Event|0|||
148971937|NCT03013543|537381881|FG002|Overall Study|Adverse Event|0|||
148971938|NCT03013543|537381882|FG003|Overall Study|Adverse Event|3|||
148726839|NCT00706992|536471891|FG006|Overall Study|Disease progression before treatment|0|||
148726840|NCT02746627|536471893|FG000|Overall Study|Withdrawal by Subject|1|||
148726841|NCT02746627|536471894|FG001|Overall Study|Withdrawal by Subject|1|||
148726842|NCT02746627|536471895|FG002|Overall Study|Withdrawal by Subject|1|||
148726843|NCT00515034|536471896|FG000|Overall Study|Adverse Event|2|||
148726844|NCT00515034|536471897|FG001|Overall Study|Adverse Event|0|||
148726845|NCT00515034|536471898|FG002|Overall Study|Adverse Event|1|||
148726846|NCT00515034|536471899|FG003|Overall Study|Adverse Event|0|||
148726847|NCT00515034|536471896|FG000|Overall Study|Death|4|||
148726848|NCT00515034|536471897|FG001|Overall Study|Death|2|||
148726849|NCT00515034|536471898|FG002|Overall Study|Death|1|||
148726850|NCT00515034|536471899|FG003|Overall Study|Death|3|||
148726851|NCT00515034|536471896|FG000|Overall Study|Withdrawal by Subject|1|||
148726852|NCT00515034|536471897|FG001|Overall Study|Withdrawal by Subject|0|||
148726853|NCT00515034|536471898|FG002|Overall Study|Withdrawal by Subject|3|||
148726854|NCT00515034|536471899|FG003|Overall Study|Withdrawal by Subject|0|||
148726855|NCT00515034|536471896|FG000|Overall Study|Physician Decision|0|||
148726856|NCT00515034|536471897|FG001|Overall Study|Physician Decision|0|||
148726857|NCT00515034|536471898|FG002|Overall Study|Physician Decision|1|||
148726858|NCT00515034|536471899|FG003|Overall Study|Physician Decision|1|||
148726859|NCT00515034|536471896|FG000|Overall Study|Other|1|||
148726860|NCT00515034|536471897|FG001|Overall Study|Other|0|||
148726861|NCT00515034|536471898|FG002|Overall Study|Other|2|||
148726862|NCT00515034|536471899|FG003|Overall Study|Other|1|||
148726863|NCT02858726|536471900|FG000|Overall Study|Adverse Event|4|||
148726864|NCT02858726|536471901|FG001|Overall Study|Adverse Event|4|||
148726865|NCT02858726|536471902|FG002|Overall Study|Adverse Event|9|||
148726866|NCT02858726|536471903|FG003|Overall Study|Adverse Event|1|||
148726867|NCT02858726|536471900|FG000|Overall Study|Physician Decision|0|||
148726868|NCT02858726|536471901|FG001|Overall Study|Physician Decision|0|||
148726869|NCT02858726|536471902|FG002|Overall Study|Physician Decision|1|||
148726870|NCT02858726|536471903|FG003|Overall Study|Physician Decision|0|||
148726871|NCT02858726|536471900|FG000|Overall Study|Protocol Violation|0|||
148726872|NCT02858726|536471901|FG001|Overall Study|Protocol Violation|0|||
148971939|NCT03013543|537381883|FG004|Overall Study|Adverse Event|2|||
148971940|NCT03013543|537381884|FG005|Overall Study|Adverse Event|1|||
148726873|NCT02858726|536471902|FG002|Overall Study|Protocol Violation|0|||
148726874|NCT02858726|536471903|FG003|Overall Study|Protocol Violation|1|||
148726875|NCT02858726|536471900|FG000|Overall Study|Study Terminated by Sponsor|0|||
148817071|NCT00927082|536805372|FG001|Overall Study|Death|0|||
148817072|NCT00927082|536805373|FG002|Overall Study|Death|1|||
148817073|NCT00927082|536805374|FG003|Overall Study|Death|0|||
148726876|NCT02858726|536471901|FG001|Overall Study|Study Terminated by Sponsor|0|||
148726877|NCT02858726|536471902|FG002|Overall Study|Study Terminated by Sponsor|0|||
148726878|NCT02858726|536471903|FG003|Overall Study|Study Terminated by Sponsor|1|||
148726879|NCT02858726|536471900|FG000|Overall Study|Withdrawal by Subject|1|||
148726880|NCT02858726|536471901|FG001|Overall Study|Withdrawal by Subject|2|||
148726881|NCT02858726|536471902|FG002|Overall Study|Withdrawal by Subject|1|||
148817074|NCT00927082|536805371|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
148817075|NCT00927082|536805372|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
148971941|NCT03013543|537381885|FG006|Overall Study|Adverse Event|3|||
148971942|NCT03013543|537381886|FG007|Overall Study|Adverse Event|8|||
148726882|NCT02858726|536471903|FG003|Overall Study|Withdrawal by Subject|0|||
148726883|NCT02858726|536471900|FG000|Overall Study|Noncompliance|0|||
148726884|NCT02858726|536471901|FG001|Overall Study|Noncompliance|1|||
148726885|NCT02858726|536471902|FG002|Overall Study|Noncompliance|0|||
148726886|NCT02858726|536471903|FG003|Overall Study|Noncompliance|0|||
148726887|NCT01481324|536471909|FG000|Overall Study|Missing Data|0|||
148726888|NCT01481324|536471910|FG001|Overall Study|Missing Data|2|||
148726889|NCT01481324|536471911|FG002|Overall Study|Missing Data|2|||
148726890|NCT01207440|536474096|FG000|Overall Study|Adverse Event|46|||
148726891|NCT01207440|536474097|FG001|Overall Study|Adverse Event|11|||
148726892|NCT01207440|536474098|FG002|Overall Study|Adverse Event|7|||
148726893|NCT01207440|536474099|FG003|Overall Study|Adverse Event|2|||
148726894|NCT01207440|536474100|FG004|Overall Study|Adverse Event|6|||
148726895|NCT01207440|536474101|FG005|Overall Study|Adverse Event|6|||
148726896|NCT01207440|536474102|FG006|Overall Study|Adverse Event|2|||
148726897|NCT01207440|536474096|FG000|Overall Study|Death|6|||
148726898|NCT01207440|536474097|FG001|Overall Study|Death|3|||
148726899|NCT01207440|536474098|FG002|Overall Study|Death|2|||
148726900|NCT01207440|536474099|FG003|Overall Study|Death|2|||
148726901|NCT01207440|536474100|FG004|Overall Study|Death|7|||
148726902|NCT01207440|536474101|FG005|Overall Study|Death|5|||
148726903|NCT01207440|536474102|FG006|Overall Study|Death|1|||
148726904|NCT01207440|536474096|FG000|Overall Study|Lack of Efficacy|13|||
148726905|NCT01207440|536474097|FG001|Overall Study|Lack of Efficacy|2|||
148726906|NCT01207440|536474098|FG002|Overall Study|Lack of Efficacy|5|||
148726907|NCT01207440|536474099|FG003|Overall Study|Lack of Efficacy|1|||
148726908|NCT01207440|536474100|FG004|Overall Study|Lack of Efficacy|2|||
148726909|NCT01207440|536474101|FG005|Overall Study|Lack of Efficacy|3|||
148726910|NCT01207440|536474102|FG006|Overall Study|Lack of Efficacy|0|||
148726911|NCT01207440|536474096|FG000|Overall Study|Lost to Follow-up|0|||
148971943|NCT03013543|537381887|FG008|Overall Study|Adverse Event|0|||
148726912|NCT01207440|536474097|FG001|Overall Study|Lost to Follow-up|0|||
148726913|NCT01207440|536474098|FG002|Overall Study|Lost to Follow-up|2|||
148726914|NCT01207440|536474099|FG003|Overall Study|Lost to Follow-up|1|||
148726915|NCT01207440|536474100|FG004|Overall Study|Lost to Follow-up|0|||
148726916|NCT01207440|536474101|FG005|Overall Study|Lost to Follow-up|0|||
148726917|NCT01207440|536474102|FG006|Overall Study|Lost to Follow-up|0|||
148726918|NCT01207440|536474096|FG000|Overall Study|Non-compliance with Study Drug|3|||
148726919|NCT01207440|536474097|FG001|Overall Study|Non-compliance with Study Drug|0|||
148726920|NCT01207440|536474098|FG002|Overall Study|Non-compliance with Study Drug|1|||
148726921|NCT01207440|536474099|FG003|Overall Study|Non-compliance with Study Drug|0|||
148726922|NCT01207440|536474100|FG004|Overall Study|Non-compliance with Study Drug|0|||
148971944|NCT03013543|537381888|FG009|Overall Study|Adverse Event|2|||
148726923|NCT01207440|536474101|FG005|Overall Study|Non-compliance with Study Drug|0|||
148726924|NCT01207440|536474102|FG006|Overall Study|Non-compliance with Study Drug|0|||
148726925|NCT01207440|536474096|FG000|Overall Study|Physician Decision|6|||
148726926|NCT01207440|536474097|FG001|Overall Study|Physician Decision|5|||
148726927|NCT01207440|536474098|FG002|Overall Study|Physician Decision|5|||
148726928|NCT01207440|536474099|FG003|Overall Study|Physician Decision|0|||
148726929|NCT01207440|536474100|FG004|Overall Study|Physician Decision|1|||
148726930|NCT01207440|536474101|FG005|Overall Study|Physician Decision|0|||
148726931|NCT01207440|536474102|FG006|Overall Study|Physician Decision|0|||
148726932|NCT01207440|536474096|FG000|Overall Study|Progressive Disease|19|||
148726933|NCT01207440|536474097|FG001|Overall Study|Progressive Disease|10|||
148726934|NCT01207440|536474098|FG002|Overall Study|Progressive Disease|19|||
148726935|NCT01207440|536474099|FG003|Overall Study|Progressive Disease|7|||
148726936|NCT01207440|536474100|FG004|Overall Study|Progressive Disease|23|||
148726937|NCT01207440|536474101|FG005|Overall Study|Progressive Disease|27|||
148726938|NCT01207440|536474102|FG006|Overall Study|Progressive Disease|0|||
148726939|NCT01207440|536474096|FG000|Overall Study|Protocol Violation|2|||
148971945|NCT03013543|537381879|FG000|Overall Study|Death|0|||
148971946|NCT03013543|537381880|FG001|Overall Study|Death|0|||
148726940|NCT01207440|536474097|FG001|Overall Study|Protocol Violation|0|||
148726941|NCT01207440|536474098|FG002|Overall Study|Protocol Violation|0|||
148726942|NCT01207440|536474099|FG003|Overall Study|Protocol Violation|0|||
148817076|NCT00927082|536805373|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
148726943|NCT01207440|536474100|FG004|Overall Study|Protocol Violation|0|||
148817077|NCT00927082|536805374|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
148817078|NCT02513563|536805378|FG000|Overall Study|Death|4|||
148726944|NCT01207440|536474101|FG005|Overall Study|Protocol Violation|0|||
148726945|NCT01207440|536474102|FG006|Overall Study|Protocol Violation|0|||
148726946|NCT01207440|536474096|FG000|Overall Study|Site Terminated by Sponsor|69|||
148726947|NCT01207440|536474097|FG001|Overall Study|Site Terminated by Sponsor|19|||
148726948|NCT01207440|536474098|FG002|Overall Study|Site Terminated by Sponsor|12|||
148726949|NCT01207440|536474099|FG003|Overall Study|Site Terminated by Sponsor|2|||
148726950|NCT01207440|536474100|FG004|Overall Study|Site Terminated by Sponsor|3|||
148726951|NCT01207440|536474101|FG005|Overall Study|Site Terminated by Sponsor|0|||
148726952|NCT01207440|536474102|FG006|Overall Study|Site Terminated by Sponsor|2|||
148726953|NCT01207440|536474096|FG000|Overall Study|Withdrawal by Subject|29|||
148971947|NCT03013543|537381881|FG002|Overall Study|Death|0|||
148971948|NCT03013543|537381882|FG003|Overall Study|Death|1|||
148971949|NCT03013543|537381883|FG004|Overall Study|Death|0|||
148726954|NCT01207440|536474097|FG001|Overall Study|Withdrawal by Subject|4|||
148726955|NCT01207440|536474098|FG002|Overall Study|Withdrawal by Subject|5|||
148726956|NCT01207440|536474099|FG003|Overall Study|Withdrawal by Subject|3|||
148726957|NCT01207440|536474100|FG004|Overall Study|Withdrawal by Subject|2|||
148726958|NCT01207440|536474101|FG005|Overall Study|Withdrawal by Subject|2|||
148726959|NCT01207440|536474102|FG006|Overall Study|Withdrawal by Subject|0|||
148726960|NCT01207440|536474096|FG000|Overall Study|Reason Not Specified|10|||
148726961|NCT01207440|536474097|FG001|Overall Study|Reason Not Specified|10|||
148726962|NCT01207440|536474098|FG002|Overall Study|Reason Not Specified|7|||
148726963|NCT01207440|536474099|FG003|Overall Study|Reason Not Specified|0|||
148726964|NCT01207440|536474100|FG004|Overall Study|Reason Not Specified|4|||
148726965|NCT01207440|536474101|FG005|Overall Study|Reason Not Specified|3|||
148726966|NCT01207440|536474102|FG006|Overall Study|Reason Not Specified|0|||
148726967|NCT03341000|536474103|FG000|Overall Study|Adverse Event|1|||
148726968|NCT00380692|536474107|FG000|Study Period II - Double Blind|Adverse Event|1|||
148726969|NCT00380692|536474108|FG001|Study Period II - Double Blind|Adverse Event|0|||
148726970|NCT00380692|536474107|FG000|Study Period II - Double Blind|Protocol Violation|2|||
148726971|NCT00380692|536474108|FG001|Study Period II - Double Blind|Protocol Violation|2|||
148726972|NCT00380692|536474107|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
148726973|NCT00380692|536474108|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
148726974|NCT00380692|536474107|FG000|Study Period II - Double Blind|Physician Decision|0|||
148726975|NCT00380692|536474108|FG001|Study Period II - Double Blind|Physician Decision|1|||
148726976|NCT00380692|536474107|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
148726977|NCT00380692|536474108|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
148726978|NCT00380692|536474107|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
148726979|NCT00380692|536474108|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
148726980|NCT00380692|536474107|FG000|Study Period III - Open Label|Adverse Event|5|||
148726981|NCT00380692|536474108|FG001|Study Period III - Open Label|Adverse Event|3|||
148726982|NCT00380692|536474107|FG000|Study Period III - Open Label|Protocol Violation|0|||
148726983|NCT00380692|536474108|FG001|Study Period III - Open Label|Protocol Violation|0|||
148726984|NCT00380692|536474107|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
148726985|NCT00380692|536474108|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
148726986|NCT00380692|536474107|FG000|Study Period III - Open Label|Physician Decision|0|||
148726987|NCT00380692|536474108|FG001|Study Period III - Open Label|Physician Decision|3|||
148726988|NCT00380692|536474107|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
148726989|NCT00380692|536474108|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
148726990|NCT00380692|536474107|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
148726991|NCT00380692|536474108|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
148726992|NCT02698865|536474111|FG000|Overall Study|Other|11|||
148726993|NCT02698865|536474112|FG001|Overall Study|Other|11|||
148726994|NCT02698865|536474111|FG000|Overall Study|Withdrawal by Subject|20|||
148726995|NCT02698865|536474112|FG001|Overall Study|Withdrawal by Subject|16|||
148726996|NCT02698865|536474111|FG000|Overall Study|Physician Decision|0|||
148726997|NCT02698865|536474112|FG001|Overall Study|Physician Decision|4|||
148726998|NCT02698865|536474111|FG000|Overall Study|Lost to Follow-up|4|||
148726999|NCT02698865|536474112|FG001|Overall Study|Lost to Follow-up|2|||
148727000|NCT03861481|536474113|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
148727001|NCT03861481|536474114|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
148727002|NCT03861481|536474113|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
148727003|NCT03861481|536474114|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
148727004|NCT03861481|536474113|FG000|Overall Study|Relapse|1|||
148727005|NCT03861481|536474114|FG001|Overall Study|Relapse|0|||
148727006|NCT03861481|536474113|FG000|Overall Study|Withdrawal by Subject|0|||
148727007|NCT03861481|536474114|FG001|Overall Study|Withdrawal by Subject|1|||
148727008|NCT03861481|536474113|FG000|Overall Study|Lack of Efficacy|4|||
148727009|NCT03861481|536474114|FG001|Overall Study|Lack of Efficacy|5|||
148727010|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
148727011|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
148727012|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
148727013|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
148727014|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
148727015|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
148727016|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
148971950|NCT03013543|537381884|FG005|Overall Study|Death|0|||
148971951|NCT03013543|537381885|FG006|Overall Study|Death|0|||
148727017|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
148727018|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
148971952|NCT03013543|537381886|FG007|Overall Study|Death|0|||
148971953|NCT03013543|537381887|FG008|Overall Study|Death|0|||
148971954|NCT03013543|537381888|FG009|Overall Study|Death|0|||
148971955|NCT03013543|537381879|FG000|Overall Study|Lack of Efficacy|0|||
148727019|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
148727020|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
148727021|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
148727022|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
148727023|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
148727024|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
148727025|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
148727026|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
148727027|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
148727028|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
148727029|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
148727030|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
148727031|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
148727032|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
148727033|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
148727034|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
148727035|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
148727036|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
148727037|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
148727038|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
148727039|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
148727040|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
148727041|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
148727042|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
148727043|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
148727044|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
148727045|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
148727046|NCT00773734|536474115|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
148727047|NCT00773734|536474116|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
148727048|NCT00773734|536474117|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
148727049|NCT00773734|536474118|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
148727050|NCT00773734|536474119|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
148727051|NCT00773734|536474120|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
148727052|NCT00773734|536474115|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
148727053|NCT00773734|536474116|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
148727054|NCT00773734|536474117|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
148727055|NCT00773734|536474118|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
148727056|NCT00773734|536474119|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
148727057|NCT00773734|536474120|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
148727058|NCT00773734|536474115|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
148727059|NCT00773734|536474116|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
148727060|NCT00773734|536474117|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
148727061|NCT00773734|536474118|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
148727062|NCT00773734|536474119|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
148727063|NCT00773734|536474120|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
148727064|NCT00773734|536474115|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
148727065|NCT00773734|536474116|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
148727066|NCT00773734|536474117|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
148727067|NCT00773734|536474118|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
148727068|NCT00773734|536474119|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
148727069|NCT00773734|536474120|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
148727070|NCT00773734|536474115|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
148727071|NCT00773734|536474116|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
148727072|NCT00773734|536474117|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
148727073|NCT00773734|536474118|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
148727074|NCT00773734|536474119|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
148727075|NCT00773734|536474120|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
148727076|NCT00773734|536474115|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
148727077|NCT00773734|536474116|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
148971956|NCT03013543|537381880|FG001|Overall Study|Lack of Efficacy|0|||
148727078|NCT00773734|536474117|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
148817079|NCT02513563|536805378|FG000|Overall Study|Withdrawal by Subject|4|||
148817080|NCT02513563|536805378|FG000|Overall Study|Physician Decision|1|||
148817081|NCT03674411|536805381|FG000|Overall Study|Non-treatment|4|||
148817082|NCT06038643|536805385|FG000|Overall Study|Withdrawal by Subject|9|||
148971957|NCT03013543|537381881|FG002|Overall Study|Lack of Efficacy|0|||
148971958|NCT03013543|537381882|FG003|Overall Study|Lack of Efficacy|1|||
148971959|NCT03013543|537381883|FG004|Overall Study|Lack of Efficacy|0|||
148971960|NCT03013543|537381884|FG005|Overall Study|Lack of Efficacy|0|||
148971961|NCT03013543|537381885|FG006|Overall Study|Lack of Efficacy|0|||
148971962|NCT03013543|537381886|FG007|Overall Study|Lack of Efficacy|0|||
148971963|NCT03013543|537381887|FG008|Overall Study|Lack of Efficacy|0|||
148971964|NCT03013543|537381888|FG009|Overall Study|Lack of Efficacy|0|||
148971965|NCT03013543|537381879|FG000|Overall Study|Lost to Follow-up|0|||
148971966|NCT03013543|537381880|FG001|Overall Study|Lost to Follow-up|0|||
148971967|NCT03013543|537381881|FG002|Overall Study|Lost to Follow-up|0|||
148971968|NCT03013543|537381882|FG003|Overall Study|Lost to Follow-up|1|||
148971969|NCT03013543|537381883|FG004|Overall Study|Lost to Follow-up|0|||
148971970|NCT03013543|537381884|FG005|Overall Study|Lost to Follow-up|0|||
148971971|NCT03013543|537381885|FG006|Overall Study|Lost to Follow-up|1|||
148971972|NCT03013543|537381886|FG007|Overall Study|Lost to Follow-up|0|||
148971973|NCT03013543|537381887|FG008|Overall Study|Lost to Follow-up|0|||
148971974|NCT03013543|537381888|FG009|Overall Study|Lost to Follow-up|2|||
148971975|NCT03013543|537381879|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148971976|NCT03013543|537381880|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148971977|NCT03013543|537381881|FG002|Overall Study|Non-Compliance With Study Drug|0|||
148971978|NCT03013543|537381882|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148971979|NCT03013543|537381883|FG004|Overall Study|Non-Compliance With Study Drug|0|||
148971980|NCT03013543|537381884|FG005|Overall Study|Non-Compliance With Study Drug|0|||
148727079|NCT00773734|536474118|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
148727080|NCT00773734|536474119|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
148727081|NCT00773734|536474120|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
148727082|NCT00773734|536474115|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
148727083|NCT00773734|536474116|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
148727084|NCT00773734|536474117|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
148727085|NCT00773734|536474118|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
148727086|NCT00773734|536474119|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
148727087|NCT00773734|536474120|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
148727088|NCT00773734|536474115|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
148727089|NCT00773734|536474116|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
148727090|NCT00773734|536474117|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
148727091|NCT00773734|536474118|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
148727092|NCT00773734|536474119|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
148727093|NCT00773734|536474120|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
148727094|NCT00773734|536474115|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
148727095|NCT00773734|536474116|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
148727096|NCT00773734|536474117|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
148727097|NCT00773734|536474118|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
148727098|NCT00773734|536474119|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
148727099|NCT00773734|536474120|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
148727100|NCT00773734|536474115|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
148727101|NCT00773734|536474116|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
148727102|NCT00773734|536474117|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
148727103|NCT00773734|536474118|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
148727104|NCT00773734|536474119|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
148727105|NCT00773734|536474120|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
148727106|NCT00773734|536474115|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
148727107|NCT00773734|536474116|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
148727108|NCT00773734|536474117|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
148727109|NCT00773734|536474118|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
148727110|NCT00773734|536474119|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
148727111|NCT00773734|536474120|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
148727112|NCT00773734|536474115|FG000|Extension: Active Treatment Week 24-52|Other|0|||
148727113|NCT00773734|536474116|FG001|Extension: Active Treatment Week 24-52|Other|0|||
148727114|NCT00773734|536474117|FG002|Extension: Active Treatment Week 24-52|Other|1|||
148727115|NCT00773734|536474118|FG003|Extension: Active Treatment Week 24-52|Other|2|||
148727116|NCT00773734|536474119|FG004|Extension: Active Treatment Week 24-52|Other|0|||
148727117|NCT00773734|536474120|FG005|Extension: Active Treatment Week 24-52|Other|1|||
148727118|NCT00773734|536474115|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
148727119|NCT00773734|536474116|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
148971981|NCT03013543|537381885|FG006|Overall Study|Non-Compliance With Study Drug|0|||
148971982|NCT03013543|537381886|FG007|Overall Study|Non-Compliance With Study Drug|0|||
148971983|NCT03013543|537381887|FG008|Overall Study|Non-Compliance With Study Drug|1|||
148971984|NCT03013543|537381888|FG009|Overall Study|Non-Compliance With Study Drug|0|||
148971985|NCT03013543|537381879|FG000|Overall Study|Physician Decision|0|||
148727120|NCT00773734|536474117|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
148727121|NCT00773734|536474118|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
148727122|NCT00773734|536474119|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
148727123|NCT00773734|536474120|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
148727124|NCT00773734|536474115|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
148727125|NCT00773734|536474116|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
148727126|NCT00773734|536474117|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
148727127|NCT00773734|536474118|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
148727128|NCT00773734|536474119|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
148727129|NCT00773734|536474120|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
148727130|NCT00773734|536474115|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
148727131|NCT00773734|536474116|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
148727132|NCT00773734|536474117|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
148727133|NCT00773734|536474118|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
148727134|NCT00773734|536474119|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
148727135|NCT00773734|536474120|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
148727136|NCT00773734|536474115|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
148727137|NCT00773734|536474116|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
148727138|NCT00773734|536474117|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
148727139|NCT00773734|536474118|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
148727140|NCT00773734|536474119|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
148727141|NCT00773734|536474120|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
148727142|NCT01220297|536474127|FG000|Overall Study|Death|2|||
148727143|NCT01220297|536474127|FG000|Overall Study|Lost to Follow-up|1|||
148727144|NCT02119286|536474129|FG000|Overall Study|Adverse Event|9|||
148727145|NCT02119286|536474130|FG001|Overall Study|Adverse Event|7|||
148727146|NCT02119286|536474131|FG002|Overall Study|Adverse Event|2|||
148727147|NCT02119286|536474129|FG000|Overall Study|Lack of Efficacy|11|||
148727148|NCT02119286|536474130|FG001|Overall Study|Lack of Efficacy|3|||
148727149|NCT02119286|536474131|FG002|Overall Study|Lack of Efficacy|4|||
148727150|NCT02119286|536474129|FG000|Overall Study|Lost to Follow-up|2|||
148727151|NCT02119286|536474130|FG001|Overall Study|Lost to Follow-up|0|||
148727152|NCT02119286|536474131|FG002|Overall Study|Lost to Follow-up|1|||
148727153|NCT02119286|536474129|FG000|Overall Study|Withdrawal by Subject|4|||
148727154|NCT02119286|536474130|FG001|Overall Study|Withdrawal by Subject|1|||
148727155|NCT02119286|536474131|FG002|Overall Study|Withdrawal by Subject|0|||
148727156|NCT04109313|536474132|FG000|Overall Study|Pregnancy|1|||
148727157|NCT04109313|536474132|FG000|Overall Study|Adverse Event|11|||
148727158|NCT04109313|536474132|FG000|Overall Study|Lack of Efficacy|11|||
148727159|NCT04109313|536474132|FG000|Overall Study|Lost to Follow-up|1|||
148727160|NCT04109313|536474132|FG000|Overall Study|Physician Decision|2|||
148727161|NCT04109313|536474132|FG000|Overall Study|Subject Decision|13|||
148727162|NCT04109313|536474132|FG000|Overall Study|Covid-19 situation|2|||
148727163|NCT01272921|536474133|FG000|Overall Study|Protocol Violation|2|||
148727164|NCT01272921|536474134|FG001|Overall Study|Protocol Violation|1|||
148727165|NCT01132664|536474135|FG000|Phase lb|Adverse Event|0|||
148727166|NCT01132664|536474136|FG001|Phase lb|Adverse Event|1|||
148727167|NCT01132664|536474137|FG002|Phase lb|Adverse Event|0|||
148727168|NCT01132664|536474138|FG003|Phase lb|Adverse Event|0|||
148727169|NCT01132664|536474139|FG004|Phase lb|Adverse Event|0|||
148971986|NCT03013543|537381880|FG001|Overall Study|Physician Decision|0|||
148727170|NCT01132664|536474135|FG000|Phase lb|Withdrawal by Subject|1|||
148727171|NCT01132664|536474136|FG001|Phase lb|Withdrawal by Subject|2|||
148727172|NCT01132664|536474137|FG002|Phase lb|Withdrawal by Subject|0|||
148727173|NCT01132664|536474138|FG003|Phase lb|Withdrawal by Subject|0|||
148727174|NCT01132664|536474139|FG004|Phase lb|Withdrawal by Subject|0|||
148727175|NCT01132664|536474135|FG000|Phase lb|Disease Progression|4|||
148727176|NCT01132664|536474136|FG001|Phase lb|Disease Progression|9|||
148727177|NCT01132664|536474137|FG002|Phase lb|Disease Progression|0|||
148727178|NCT01132664|536474138|FG003|Phase lb|Disease Progression|0|||
148727179|NCT01132664|536474139|FG004|Phase lb|Disease Progression|0|||
148727180|NCT01132664|536474135|FG000|Phase ll|Death|0|||
148971987|NCT03013543|537381881|FG002|Overall Study|Physician Decision|0|||
148971988|NCT03013543|537381882|FG003|Overall Study|Physician Decision|0|||
148727181|NCT01132664|536474136|FG001|Phase ll|Death|0|||
148727182|NCT01132664|536474137|FG002|Phase ll|Death|2|||
148727183|NCT01132664|536474138|FG003|Phase ll|Death|0|||
148727184|NCT01132664|536474139|FG004|Phase ll|Death|0|||
148727185|NCT01132664|536474135|FG000|Phase ll|Adverse Event|0|||
148727186|NCT01132664|536474136|FG001|Phase ll|Adverse Event|0|||
148727187|NCT01132664|536474137|FG002|Phase ll|Adverse Event|10|||
148727188|NCT01132664|536474138|FG003|Phase ll|Adverse Event|0|||
148727189|NCT01132664|536474139|FG004|Phase ll|Adverse Event|0|||
148727190|NCT01132664|536474135|FG000|Phase ll|Withdrawal by Subject|0|||
148727191|NCT01132664|536474136|FG001|Phase ll|Withdrawal by Subject|0|||
148727192|NCT01132664|536474137|FG002|Phase ll|Withdrawal by Subject|3|||
148727193|NCT01132664|536474138|FG003|Phase ll|Withdrawal by Subject|0|||
148727194|NCT01132664|536474139|FG004|Phase ll|Withdrawal by Subject|0|||
148971989|NCT03013543|537381883|FG004|Overall Study|Physician Decision|1|||
148817083|NCT06038643|536805386|FG001|Overall Study|Withdrawal by Subject|4|||
148727195|NCT01132664|536474135|FG000|Phase ll|Disease progression|0|||
148727196|NCT01132664|536474136|FG001|Phase ll|Disease progression|0|||
148727197|NCT01132664|536474137|FG002|Phase ll|Disease progression|35|||
148727198|NCT01132664|536474138|FG003|Phase ll|Disease progression|0|||
148727199|NCT01132664|536474139|FG004|Phase ll|Disease progression|0|||
148727200|NCT01132664|536474135|FG000|BM Cohort|Disease progression|0|||
148727201|NCT01132664|536474136|FG001|BM Cohort|Disease progression|0|||
148727202|NCT01132664|536474137|FG002|BM Cohort|Disease progression|0|||
148727203|NCT01132664|536474138|FG003|BM Cohort|Disease progression|3|||
148727204|NCT01132664|536474139|FG004|BM Cohort|Disease progression|4|||
148727205|NCT01132664|536474135|FG000|BM Cohort|Adverse Event|0|||
148727206|NCT01132664|536474136|FG001|BM Cohort|Adverse Event|0|||
148727207|NCT01132664|536474137|FG002|BM Cohort|Adverse Event|0|||
148727208|NCT01132664|536474138|FG003|BM Cohort|Adverse Event|0|||
148727209|NCT01132664|536474139|FG004|BM Cohort|Adverse Event|1|||
148727210|NCT01132664|536474135|FG000|BM Cohort|Withdrawal by Subject|0|||
148727211|NCT01132664|536474136|FG001|BM Cohort|Withdrawal by Subject|0|||
148727212|NCT01132664|536474137|FG002|BM Cohort|Withdrawal by Subject|0|||
148727213|NCT01132664|536474138|FG003|BM Cohort|Withdrawal by Subject|0|||
148727214|NCT01132664|536474139|FG004|BM Cohort|Withdrawal by Subject|1|||
148727215|NCT01996332|536474141|FG000|Overall Study|Adverse Event|117|||
148727216|NCT01996332|536474141|FG000|Overall Study|Lack of Efficacy|1245|||
148727217|NCT01996332|536474141|FG000|Overall Study|Death|264|||
148727218|NCT01996332|536474141|FG000|Overall Study|Protocol Violation|9|||
148727219|NCT01996332|536474141|FG000|Overall Study|Withdrawal by Subject|71|||
148727220|NCT01996332|536474141|FG000|Overall Study|Other|20|||
148727221|NCT01996332|536474141|FG000|Overall Study|Clinical Deterioration|28|||
148727222|NCT01996332|536474141|FG000|Overall Study|Physician Decision|17|||
148727223|NCT01996332|536474141|FG000|Overall Study|Lost to Follow-up|34|||
148727224|NCT02113189|536474142|FG000|Overall Study|Lost to follow up|2|||
148727225|NCT02113189|536474143|FG001|Overall Study|Lost to follow up|1|||
148727226|NCT02113189|536474144|FG002|Overall Study|Lost to follow up|3|||
148727227|NCT02954159|536474145|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
148727228|NCT02954159|536474146|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
148727229|NCT02954159|536474145|FG000|Overall Study|Withdrawal by Subject|0|||
148727230|NCT02954159|536474146|FG001|Overall Study|Withdrawal by Subject|1|||
148727231|NCT02581163|536474148|FG000|Overall Study|Failure to return|15|||
148727232|NCT02581163|536474148|FG000|Overall Study|Insufficient virological response|3|||
148727233|NCT02581163|536474148|FG000|Overall Study|Withdrew consent|1|||
148727234|NCT02581163|536474148|FG000|Overall Study|Death|1|||
148727235|NCT02581163|536474148|FG000|Overall Study|Other, not specified|9|||
148727236|NCT02006628|536474152|FG000|Overall Study|Adverse Event|1|||
148727237|NCT02006628|536474153|FG001|Overall Study|Adverse Event|1|||
148727238|NCT02006628|536474152|FG000|Overall Study|Withdrawal by Subject|2|||
148727239|NCT02006628|536474153|FG001|Overall Study|Withdrawal by Subject|1|||
148727240|NCT01206816|536474156|FG000|Overall Study|Protocol Violation|0|||
148727241|NCT01206816|536474157|FG001|Overall Study|Protocol Violation|0|||
148727242|NCT01206816|536474158|FG002|Overall Study|Protocol Violation|1|||
148727243|NCT01206816|536474159|FG003|Overall Study|Protocol Violation|0|||
148727244|NCT01206816|536474160|FG004|Overall Study|Protocol Violation|0|||
148727245|NCT01206816|536474161|FG005|Overall Study|Protocol Violation|0|||
148727246|NCT01206816|536474162|FG006|Overall Study|Protocol Violation|0|||
148727247|NCT01206816|536474156|FG000|Overall Study|Withdrawal by Subject|0|||
148727248|NCT01206816|536474157|FG001|Overall Study|Withdrawal by Subject|0|||
148727249|NCT01206816|536474158|FG002|Overall Study|Withdrawal by Subject|1|||
148727250|NCT01206816|536474159|FG003|Overall Study|Withdrawal by Subject|0|||
148727251|NCT01206816|536474160|FG004|Overall Study|Withdrawal by Subject|0|||
148727252|NCT01206816|536474161|FG005|Overall Study|Withdrawal by Subject|0|||
148727253|NCT01206816|536474162|FG006|Overall Study|Withdrawal by Subject|0|||
148727254|NCT01206816|536474156|FG000|Overall Study|Progressive disease|3|||
148727255|NCT01206816|536474157|FG001|Overall Study|Progressive disease|3|||
148727256|NCT01206816|536474158|FG002|Overall Study|Progressive disease|13|||
148727257|NCT01206816|536474159|FG003|Overall Study|Progressive disease|3|||
148727258|NCT01206816|536474160|FG004|Overall Study|Progressive disease|3|||
148727259|NCT01206816|536474161|FG005|Overall Study|Progressive disease|16|||
148727260|NCT01206816|536474162|FG006|Overall Study|Progressive disease|3|||
148727261|NCT01206816|536474156|FG000|Overall Study|Other AE|0|||
148727262|NCT01206816|536474157|FG001|Overall Study|Other AE|0|||
148727263|NCT01206816|536474158|FG002|Overall Study|Other AE|4|||
148727264|NCT01206816|536474159|FG003|Overall Study|Other AE|0|||
148727265|NCT01206816|536474160|FG004|Overall Study|Other AE|0|||
148727266|NCT01206816|536474161|FG005|Overall Study|Other AE|3|||
148727267|NCT01206816|536474162|FG006|Overall Study|Other AE|2|||
148727268|NCT01206816|536474156|FG000|Overall Study|other than stated above|0|||
148727269|NCT01206816|536474157|FG001|Overall Study|other than stated above|0|||
148727270|NCT01206816|536474158|FG002|Overall Study|other than stated above|1|||
148727271|NCT01206816|536474159|FG003|Overall Study|other than stated above|0|||
148727272|NCT01206816|536474160|FG004|Overall Study|other than stated above|0|||
148727273|NCT01206816|536474161|FG005|Overall Study|other than stated above|0|||
148727274|NCT01206816|536474162|FG006|Overall Study|other than stated above|1|||
148727275|NCT01939496|536474163|FG000|Overall Study|Adverse Event|2|||
148727276|NCT01939496|536474164|FG001|Overall Study|Adverse Event|0|||
148727277|NCT01939496|536474165|FG002|Overall Study|Adverse Event|0|||
148727278|NCT01939496|536474163|FG000|Overall Study|Lost to Follow-up|1|||
148727279|NCT01939496|536474164|FG001|Overall Study|Lost to Follow-up|1|||
148727280|NCT01939496|536474165|FG002|Overall Study|Lost to Follow-up|0|||
148727281|NCT01939496|536474163|FG000|Overall Study|Physician Decision|1|||
148727282|NCT01939496|536474164|FG001|Overall Study|Physician Decision|0|||
148727283|NCT01939496|536474165|FG002|Overall Study|Physician Decision|0|||
148727284|NCT01939496|536474163|FG000|Overall Study|Protocol Violation|3|||
148727285|NCT01939496|536474164|FG001|Overall Study|Protocol Violation|0|||
148727286|NCT01939496|536474165|FG002|Overall Study|Protocol Violation|0|||
148727287|NCT01939496|536474163|FG000|Overall Study|Withdrawal by Subject|0|||
148727288|NCT01939496|536474164|FG001|Overall Study|Withdrawal by Subject|1|||
148727289|NCT01939496|536474165|FG002|Overall Study|Withdrawal by Subject|1|||
148727290|NCT01939496|536474163|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
148727291|NCT01939496|536474164|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
148727292|NCT01939496|536474165|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
148727293|NCT01939496|536474163|FG000|Overall Study|Other|2|||
148727294|NCT01939496|536474164|FG001|Overall Study|Other|0|||
148727295|NCT01939496|536474165|FG002|Overall Study|Other|1|||
148727296|NCT02384941|536474166|FG000|Overall Study|Adverse Event|11|||
148727297|NCT02384941|536474167|FG001|Overall Study|Adverse Event|13|||
148727298|NCT02384941|536474168|FG002|Overall Study|Adverse Event|17|||
148727299|NCT02384941|536474166|FG000|Overall Study|Lost to Follow-up|3|||
148727300|NCT02384941|536474167|FG001|Overall Study|Lost to Follow-up|2|||
148727301|NCT02384941|536474168|FG002|Overall Study|Lost to Follow-up|1|||
148727302|NCT02384941|536474166|FG000|Overall Study|Non-Compliance With Study Drug|2|||
148727303|NCT02384941|536474167|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148727304|NCT02384941|536474168|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148727305|NCT02384941|536474166|FG000|Overall Study|Physician Decision|1|||
148727306|NCT02384941|536474167|FG001|Overall Study|Physician Decision|1|||
148727307|NCT02384941|536474168|FG002|Overall Study|Physician Decision|0|||
148727308|NCT02384941|536474166|FG000|Overall Study|Protocol Violation|3|||
148727309|NCT02384941|536474167|FG001|Overall Study|Protocol Violation|0|||
148727310|NCT02384941|536474168|FG002|Overall Study|Protocol Violation|0|||
148727311|NCT02384941|536474166|FG000|Overall Study|Withdrawal by Subject|26|||
148727312|NCT02384941|536474167|FG001|Overall Study|Withdrawal by Subject|19|||
148727313|NCT02384941|536474168|FG002|Overall Study|Withdrawal by Subject|20|||
148727314|NCT02384941|536474166|FG000|Overall Study|Pregnancy|0|||
148727315|NCT02384941|536474167|FG001|Overall Study|Pregnancy|0|||
148727316|NCT02384941|536474168|FG002|Overall Study|Pregnancy|1|||
148727317|NCT02384941|536474166|FG000|Overall Study|Other than specified above|4|||
148727318|NCT02384941|536474167|FG001|Overall Study|Other than specified above|0|||
148727319|NCT02384941|536474168|FG002|Overall Study|Other than specified above|1|||
148727320|NCT01705236|536474169|FG000|Overall Study|Lost to Follow-up|1|||
148727321|NCT01705236|536474169|FG000|Overall Study|Administrative problems|2|||
148727322|NCT01705236|536474169|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
148727323|NCT01705236|536474169|FG000|Overall Study|Protocol Violation|3|||
148727324|NCT01705236|536474169|FG000|Overall Study|Abnormal test procedure result(s)|4|||
148727325|NCT01705236|536474169|FG000|Overall Study|Abnormal laboratory value(s)|4|||
148727326|NCT01705236|536474169|FG000|Overall Study|Withdrawal by Subject|5|||
148727327|NCT01705236|536474169|FG000|Overall Study|Adverse Event|5|||
148727328|NCT03028740|536474170|FG000|Overall Study|Did not Receive Study Drug|4|||
148727329|NCT03028740|536474171|FG001|Overall Study|Did not Receive Study Drug|5|||
148727330|NCT03028740|536474170|FG000|Overall Study|Adverse Event|8|||
148727331|NCT03028740|536474171|FG001|Overall Study|Adverse Event|26|||
148727332|NCT03028740|536474170|FG000|Overall Study|Lack of Efficacy|0|||
148727333|NCT03028740|536474171|FG001|Overall Study|Lack of Efficacy|1|||
148727334|NCT03028740|536474170|FG000|Overall Study|Withdrawal by Subject|48|||
148727335|NCT03028740|536474171|FG001|Overall Study|Withdrawal by Subject|101|||
148727336|NCT03028740|536474170|FG000|Overall Study|Lost to Follow-up|30|||
148727337|NCT03028740|536474171|FG001|Overall Study|Lost to Follow-up|54|||
148971990|NCT03013543|537381884|FG005|Overall Study|Physician Decision|0|||
148727338|NCT03028740|536474170|FG000|Overall Study|Physician Decision|4|||
148727339|NCT03028740|536474171|FG001|Overall Study|Physician Decision|11|||
148727340|NCT03028740|536474170|FG000|Overall Study|Protocol Violation|4|||
148727341|NCT03028740|536474171|FG001|Overall Study|Protocol Violation|8|||
148727342|NCT03028740|536474170|FG000|Overall Study|Non-compliance with Study Drug|0|||
148971991|NCT03013543|537381885|FG006|Overall Study|Physician Decision|0|||
148727343|NCT03028740|536474171|FG001|Overall Study|Non-compliance with Study Drug|2|||
148727344|NCT03028740|536474170|FG000|Overall Study|Study Terminated by Sponsor|467|||
148727345|NCT03028740|536474171|FG001|Overall Study|Study Terminated by Sponsor|917|||
148727346|NCT03028740|536474170|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
148727347|NCT03028740|536474171|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
148727348|NCT03028740|536474170|FG000|Overall Study|Reason not Specified|1|||
148971992|NCT03013543|537381886|FG007|Overall Study|Physician Decision|0|||
148727349|NCT03028740|536474171|FG001|Overall Study|Reason not Specified|5|||
148727350|NCT02589522|536474173|FG000|Overall Study|Physician Decision|1|||
148727351|NCT02589522|536474174|FG001|Overall Study|Physician Decision|2|||
148727352|NCT02589522|536474175|FG002|Overall Study|Physician Decision|0|||
148727353|NCT02589522|536474173|FG000|Overall Study|Did not start treatment|1|||
148727354|NCT02589522|536474174|FG001|Overall Study|Did not start treatment|0|||
148727355|NCT02589522|536474175|FG002|Overall Study|Did not start treatment|0|||
148727356|NCT02025010|536474176|FG000|Overall Study|Symptomatic or radiographic progression|36|||
148727357|NCT02025010|536474176|FG000|Overall Study|Adverse Event|6|||
148727358|NCT02025010|536474176|FG000|Overall Study|Physician Decision|7|||
148727359|NCT02025010|536474176|FG000|Overall Study|Withdrawal by Subject|3|||
148727360|NCT02025010|536474176|FG000|Overall Study|Intercurrent illness|3|||
148727361|NCT02025010|536474176|FG000|Overall Study|Patients still on treatment|3|||
148727362|NCT02025010|536474176|FG000|Overall Study|Never initiate the treatment|2|||
148727363|NCT01300052|536474177|FG000|Overall Study|Adverse Event|3|||
148727364|NCT01300052|536474178|FG001|Overall Study|Adverse Event|0|||
148727365|NCT01300052|536474177|FG000|Overall Study|Withdrawal by Subject|2|||
148727366|NCT01300052|536474178|FG001|Overall Study|Withdrawal by Subject|2|||
148727367|NCT01300052|536474177|FG000|Overall Study|Protocol Violation|1|||
148727368|NCT01300052|536474178|FG001|Overall Study|Protocol Violation|1|||
148727369|NCT01231373|536474179|FG000|Overall Study|Withdrew consent prior to randomization|2|||
148727370|NCT01231373|536474180|FG001|Overall Study|Withdrew consent prior to randomization|1|||
148727371|NCT01231373|536474181|FG002|Overall Study|Withdrew consent prior to randomization|0|||
148727372|NCT01231373|536474182|FG003|Overall Study|Withdrew consent prior to randomization|0|||
148727373|NCT01231373|536474179|FG000|Overall Study|Lost to Follow-up|0|||
148727374|NCT01231373|536474180|FG001|Overall Study|Lost to Follow-up|0|||
148727375|NCT01231373|536474181|FG002|Overall Study|Lost to Follow-up|0|||
148727376|NCT01231373|536474182|FG003|Overall Study|Lost to Follow-up|1|||
148727377|NCT01231373|536474179|FG000|Overall Study|Withdrew Consent|1|||
148727378|NCT01231373|536474180|FG001|Overall Study|Withdrew Consent|0|||
148727379|NCT01231373|536474181|FG002|Overall Study|Withdrew Consent|0|||
148727380|NCT01231373|536474182|FG003|Overall Study|Withdrew Consent|0|||
148727381|NCT03253744|536474191|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
148727382|NCT03253744|536474192|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
148727383|NCT03253744|536474193|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
148727384|NCT03253744|536474194|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
148727385|NCT01134627|536474195|FG000|Overall Study|Adverse Event|47|||
148727386|NCT01134627|536474196|FG001|Overall Study|Adverse Event|31|||
148727387|NCT01134627|536474195|FG000|Overall Study|Lost to Follow-up|1|||
148727388|NCT01134627|536474196|FG001|Overall Study|Lost to Follow-up|2|||
148727389|NCT01134627|536474195|FG000|Overall Study|Protocol Violation|3|||
148727390|NCT01134627|536474196|FG001|Overall Study|Protocol Violation|5|||
148727391|NCT01134627|536474195|FG000|Overall Study|Lack of Efficacy|2|||
148727392|NCT01134627|536474196|FG001|Overall Study|Lack of Efficacy|12|||
148727393|NCT01134627|536474195|FG000|Overall Study|Withdrawal by Subject|4|||
148727394|NCT01134627|536474196|FG001|Overall Study|Withdrawal by Subject|3|||
148727395|NCT01134627|536474195|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
148727396|NCT01134627|536474196|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
148727397|NCT01134627|536474195|FG000|Overall Study|Other|11|||
148727398|NCT01134627|536474196|FG001|Overall Study|Other|14|||
148727399|NCT02556307|536474200|FG000|Overall Study|Premature treatment interruption|11|||
148727400|NCT02556307|536474200|FG000|Overall Study|Lost to Follow-up|36|||
148727401|NCT02556307|536474200|FG000|Overall Study|Change to triple therapy|4|||
148727402|NCT02556307|536474200|FG000|Overall Study|Enrolled but not treated|2|||
148727403|NCT03438227|536474201|FG000|Overall Study|Withdrawal by Subject|10|||
148727404|NCT03438227|536474202|FG001|Overall Study|Withdrawal by Subject|5|||
148727405|NCT00293202|536474207|FG000|Overall Study|Withdrawal by Subject|1|||
148727406|NCT00293202|536474208|FG001|Overall Study|Withdrawal by Subject|2|||
148727407|NCT00293202|536474207|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
148727408|NCT00293202|536474208|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
148727409|NCT00293202|536474207|FG000|Overall Study|on-hold due to fistula maturation time|1|||
148727410|NCT00293202|536474208|FG001|Overall Study|on-hold due to fistula maturation time|0|||
148727411|NCT01564459|536474210|FG000|Run-In|Adverse Event|7|||
148727412|NCT01564459|536474211|FG001|Run-In|Adverse Event|0|||
148727413|NCT01564459|536474212|FG002|Run-In|Adverse Event|0|||
148727414|NCT01564459|536474210|FG000|Run-In|Lost to Follow-up|1|||
148727415|NCT01564459|536474211|FG001|Run-In|Lost to Follow-up|0|||
148727416|NCT01564459|536474212|FG002|Run-In|Lost to Follow-up|0|||
148727417|NCT01564459|536474210|FG000|Run-In|Non-compliance with study drug|2|||
148727418|NCT01564459|536474211|FG001|Run-In|Non-compliance with study drug|0|||
148727419|NCT01564459|536474212|FG002|Run-In|Non-compliance with study drug|0|||
148727420|NCT01564459|536474210|FG000|Run-In|Protocol Violation|1|||
148727421|NCT01564459|536474211|FG001|Run-In|Protocol Violation|0|||
148727422|NCT01564459|536474212|FG002|Run-In|Protocol Violation|0|||
148727423|NCT01564459|536474210|FG000|Run-In|Withdrawal by Subject|1|||
148727424|NCT01564459|536474211|FG001|Run-In|Withdrawal by Subject|0|||
148727425|NCT01564459|536474212|FG002|Run-In|Withdrawal by Subject|0|||
149025941|NCT00783718|537571937|FG004|Induction Phase|Lack of Efficacy|0|||
149025942|NCT00783718|537571938|FG005|Induction Phase|Lack of Efficacy|0|||
149025943|NCT00783718|537571939|FG006|Induction Phase|Lack of Efficacy|0|||
149025944|NCT00783718|537571933|FG000|Induction Phase|Withdrawal by Subject|3|||
149025945|NCT00783718|537571934|FG001|Induction Phase|Withdrawal by Subject|4|||
149025946|NCT00783718|537571935|FG002|Induction Phase|Withdrawal by Subject|8|||
149025947|NCT00783718|537571936|FG003|Induction Phase|Withdrawal by Subject|0|||
149025948|NCT00783718|537571937|FG004|Induction Phase|Withdrawal by Subject|0|||
149025949|NCT00783718|537571938|FG005|Induction Phase|Withdrawal by Subject|0|||
149025950|NCT00783718|537571939|FG006|Induction Phase|Withdrawal by Subject|0|||
149025951|NCT00783718|537571933|FG000|Induction Phase|Lost to Follow-up|1|||
149025952|NCT00783718|537571934|FG001|Induction Phase|Lost to Follow-up|0|||
149025953|NCT00783718|537571935|FG002|Induction Phase|Lost to Follow-up|1|||
149025954|NCT00783718|537571936|FG003|Induction Phase|Lost to Follow-up|0|||
149025955|NCT00783718|537571937|FG004|Induction Phase|Lost to Follow-up|0|||
149025956|NCT00783718|537571938|FG005|Induction Phase|Lost to Follow-up|0|||
149025957|NCT00783718|537571939|FG006|Induction Phase|Lost to Follow-up|0|||
148727426|NCT01564459|536474210|FG000|Double-blind Treatment|Adverse Event|0|||
148727427|NCT01564459|536474211|FG001|Double-blind Treatment|Adverse Event|0|||
148727428|NCT01564459|536474212|FG002|Double-blind Treatment|Adverse Event|1|||
148727429|NCT02080832|536474218|FG000|Overall Study|Excluded from analysis by MRI|9|||
148727430|NCT02080832|536474219|FG001|Overall Study|Excluded from analysis by MRI|10|||
148727431|NCT02080832|536474220|FG002|Overall Study|Excluded from analysis by MRI|14|||
148727432|NCT02080832|536474218|FG000|Overall Study|Lost to Follow-up|0|||
148727433|NCT02080832|536474219|FG001|Overall Study|Lost to Follow-up|2|||
148727434|NCT02080832|536474220|FG002|Overall Study|Lost to Follow-up|2|||
148727435|NCT00560937|536474224|FG000|Overall Study|Withdrawal by Subject|0|||
148727436|NCT00560937|536474225|FG001|Overall Study|Withdrawal by Subject|1|||
148727437|NCT00560937|536474224|FG000|Overall Study|Physician Decision|1|||
148727438|NCT00560937|536474225|FG001|Overall Study|Physician Decision|1|||
148727439|NCT01118117|536474226|FG000|Overall Study|Death|8|||
148727440|NCT01118117|536474227|FG001|Overall Study|Death|0|||
148727441|NCT01118117|536474226|FG000|Overall Study|Lost to Follow-up|6|||
148727442|NCT01118117|536474227|FG001|Overall Study|Lost to Follow-up|0|||
148727443|NCT01118117|536474226|FG000|Overall Study|Missed 12 Month Visit|7|||
148727444|NCT01118117|536474227|FG001|Overall Study|Missed 12 Month Visit|0|||
148727445|NCT01660022|536474228|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
148727446|NCT01660022|536474229|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
148727447|NCT01660022|536474230|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
148727448|NCT01660022|536474231|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
148727449|NCT01660022|536474232|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
148727450|NCT01660022|536474233|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
148727451|NCT01660022|536474228|FG000|First Sequence (7 Days)|Adverse Event|0|||
148727452|NCT01660022|536474229|FG001|First Sequence (7 Days)|Adverse Event|0|||
148727453|NCT01660022|536474230|FG002|First Sequence (7 Days)|Adverse Event|0|||
148727454|NCT01660022|536474231|FG003|First Sequence (7 Days)|Adverse Event|0|||
148727455|NCT01660022|536474232|FG004|First Sequence (7 Days)|Adverse Event|1|||
148727456|NCT01660022|536474233|FG005|First Sequence (7 Days)|Adverse Event|3|||
148727457|NCT01660022|536474228|FG000|First Sequence (7 Days)|Protocol Violation|0|||
148727458|NCT01660022|536474229|FG001|First Sequence (7 Days)|Protocol Violation|0|||
148727459|NCT01660022|536474230|FG002|First Sequence (7 Days)|Protocol Violation|0|||
148727460|NCT01660022|536474231|FG003|First Sequence (7 Days)|Protocol Violation|0|||
148727461|NCT01660022|536474232|FG004|First Sequence (7 Days)|Protocol Violation|0|||
148727462|NCT01660022|536474233|FG005|First Sequence (7 Days)|Protocol Violation|1|||
148727463|NCT03545191|536474235|FG000|Overall Study|Death|1|||
148727464|NCT03545191|536474236|FG001|Overall Study|Death|0|||
148727465|NCT03545191|536474237|FG002|Overall Study|Death|0|||
148727466|NCT03545191|536474235|FG000|Overall Study|Adverse Event|4|||
148727467|NCT03545191|536474236|FG001|Overall Study|Adverse Event|2|||
148727468|NCT03545191|536474237|FG002|Overall Study|Adverse Event|7|||
148727469|NCT03545191|536474235|FG000|Overall Study|Other reasons|3|||
148727470|NCT03545191|536474236|FG001|Overall Study|Other reasons|11|||
149025958|NCT00783718|537571933|FG000|Maintenance Phase|Adverse Event|12|||
149025959|NCT00783718|537571934|FG001|Maintenance Phase|Adverse Event|0|||
148727471|NCT03545191|536474237|FG002|Overall Study|Other reasons|8|||
148727472|NCT03545191|536474235|FG000|Overall Study|Withdrawal by Subject|13|||
148727473|NCT03545191|536474236|FG001|Overall Study|Withdrawal by Subject|10|||
148727474|NCT03545191|536474237|FG002|Overall Study|Withdrawal by Subject|12|||
148727475|NCT03545191|536474235|FG000|Overall Study|Lost to Follow-up|1|||
148727476|NCT03545191|536474236|FG001|Overall Study|Lost to Follow-up|2|||
149025960|NCT00783718|537571935|FG002|Maintenance Phase|Adverse Event|0|||
149025961|NCT00783718|537571936|FG003|Maintenance Phase|Adverse Event|15|||
149025962|NCT00783718|537571937|FG004|Maintenance Phase|Adverse Event|7|||
149025963|NCT00783718|537571938|FG005|Maintenance Phase|Adverse Event|6|||
149025964|NCT00783718|537571939|FG006|Maintenance Phase|Adverse Event|16|||
149025965|NCT00783718|537571933|FG000|Maintenance Phase|Protocol Violation|1|||
149025966|NCT00783718|537571934|FG001|Maintenance Phase|Protocol Violation|0|||
148727477|NCT03545191|536474237|FG002|Overall Study|Lost to Follow-up|3|||
148727478|NCT01277718|536474241|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
148727479|NCT01277718|536474242|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
148727480|NCT01277718|536474241|FG000|Period 2 - Second Intervention|Physician Decision|0|||
148727481|NCT01277718|536474242|FG001|Period 2 - Second Intervention|Physician Decision|2|||
148727482|NCT02149121|536474245|FG000|Main Study Period|Lack of Efficacy|2|||
148727483|NCT02149121|536474246|FG001|Main Study Period|Lack of Efficacy|2|||
148727484|NCT02149121|536474247|FG002|Main Study Period|Lack of Efficacy|1|||
148727485|NCT02149121|536474248|FG003|Main Study Period|Lack of Efficacy|0|||
148727486|NCT02149121|536474249|FG004|Main Study Period|Lack of Efficacy|0|||
148727487|NCT02149121|536474250|FG005|Main Study Period|Lack of Efficacy|0|||
148727488|NCT02149121|536474251|FG006|Main Study Period|Lack of Efficacy|0|||
148727489|NCT02149121|536474245|FG000|Main Study Period|Withdrawal by Subject|9|||
148727490|NCT02149121|536474246|FG001|Main Study Period|Withdrawal by Subject|5|||
148727491|NCT02149121|536474247|FG002|Main Study Period|Withdrawal by Subject|1|||
148727492|NCT02149121|536474248|FG003|Main Study Period|Withdrawal by Subject|0|||
148727493|NCT02149121|536474249|FG004|Main Study Period|Withdrawal by Subject|0|||
148727494|NCT02149121|536474250|FG005|Main Study Period|Withdrawal by Subject|0|||
148727495|NCT02149121|536474251|FG006|Main Study Period|Withdrawal by Subject|0|||
148727496|NCT02149121|536474245|FG000|Main Study Period|Adverse Event|2|||
148727497|NCT02149121|536474246|FG001|Main Study Period|Adverse Event|5|||
148727498|NCT02149121|536474247|FG002|Main Study Period|Adverse Event|1|||
148727499|NCT02149121|536474248|FG003|Main Study Period|Adverse Event|0|||
148727500|NCT02149121|536474249|FG004|Main Study Period|Adverse Event|0|||
148727501|NCT02149121|536474250|FG005|Main Study Period|Adverse Event|0|||
148727502|NCT02149121|536474251|FG006|Main Study Period|Adverse Event|0|||
148727503|NCT02149121|536474245|FG000|Main Study Period|Protocol Violation|2|||
148727504|NCT02149121|536474246|FG001|Main Study Period|Protocol Violation|0|||
148727505|NCT02149121|536474247|FG002|Main Study Period|Protocol Violation|0|||
148727506|NCT02149121|536474248|FG003|Main Study Period|Protocol Violation|0|||
148727507|NCT02149121|536474249|FG004|Main Study Period|Protocol Violation|0|||
148727508|NCT02149121|536474250|FG005|Main Study Period|Protocol Violation|0|||
148727509|NCT02149121|536474251|FG006|Main Study Period|Protocol Violation|0|||
148727510|NCT02149121|536474245|FG000|Main Study Period|Lost to Follow-up|2|||
148727511|NCT02149121|536474246|FG001|Main Study Period|Lost to Follow-up|1|||
148727512|NCT02149121|536474247|FG002|Main Study Period|Lost to Follow-up|0|||
148727513|NCT02149121|536474248|FG003|Main Study Period|Lost to Follow-up|0|||
148727514|NCT02149121|536474249|FG004|Main Study Period|Lost to Follow-up|0|||
148727515|NCT02149121|536474250|FG005|Main Study Period|Lost to Follow-up|0|||
148727516|NCT02149121|536474251|FG006|Main Study Period|Lost to Follow-up|0|||
148727517|NCT02149121|536474245|FG000|Main Study Period|Death|1|||
148727518|NCT02149121|536474246|FG001|Main Study Period|Death|0|||
148727519|NCT02149121|536474247|FG002|Main Study Period|Death|0|||
148727520|NCT02149121|536474248|FG003|Main Study Period|Death|0|||
148727521|NCT02149121|536474249|FG004|Main Study Period|Death|0|||
148727522|NCT02149121|536474250|FG005|Main Study Period|Death|0|||
148727523|NCT02149121|536474251|FG006|Main Study Period|Death|0|||
148727524|NCT02149121|536474245|FG000|Main Study Period|Physician Decision|1|||
148727525|NCT02149121|536474246|FG001|Main Study Period|Physician Decision|0|||
148727526|NCT02149121|536474247|FG002|Main Study Period|Physician Decision|0|||
148727527|NCT02149121|536474248|FG003|Main Study Period|Physician Decision|0|||
148727528|NCT02149121|536474249|FG004|Main Study Period|Physician Decision|0|||
148727529|NCT02149121|536474250|FG005|Main Study Period|Physician Decision|0|||
148727530|NCT02149121|536474251|FG006|Main Study Period|Physician Decision|0|||
148727531|NCT02149121|536474245|FG000|Main Study Period|Developed any malignancy|0|||
148727532|NCT02149121|536474246|FG001|Main Study Period|Developed any malignancy|1|||
148727533|NCT02149121|536474247|FG002|Main Study Period|Developed any malignancy|1|||
148727534|NCT02149121|536474248|FG003|Main Study Period|Developed any malignancy|0|||
148727535|NCT02149121|536474249|FG004|Main Study Period|Developed any malignancy|0|||
148727536|NCT02149121|536474250|FG005|Main Study Period|Developed any malignancy|0|||
148817084|NCT06038643|536805385|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
148727537|NCT02149121|536474251|FG006|Main Study Period|Developed any malignancy|0|||
148727538|NCT02149121|536474245|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
148727539|NCT02149121|536474246|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
148817085|NCT06038643|536805386|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
148817086|NCT03369223|536805387|FG000|Overall Study|Lost to Follow-up|0|||
148817087|NCT03369223|536805388|FG001|Overall Study|Lost to Follow-up|0|||
148727540|NCT02149121|536474247|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
148727541|NCT02149121|536474248|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
148727542|NCT02149121|536474249|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
148817088|NCT03369223|536805389|FG002|Overall Study|Lost to Follow-up|0|||
148727543|NCT02149121|536474250|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
148727544|NCT02149121|536474251|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
148727545|NCT02149121|536474245|FG000|Main Study Period|Disease progression|0|||
148817089|NCT03369223|536805390|FG003|Overall Study|Lost to Follow-up|0|||
148727546|NCT02149121|536474246|FG001|Main Study Period|Disease progression|1|||
148727547|NCT02149121|536474247|FG002|Main Study Period|Disease progression|0|||
148727548|NCT02149121|536474248|FG003|Main Study Period|Disease progression|0|||
148727549|NCT02149121|536474249|FG004|Main Study Period|Disease progression|0|||
148727550|NCT02149121|536474250|FG005|Main Study Period|Disease progression|0|||
148727551|NCT02149121|536474251|FG006|Main Study Period|Disease progression|0|||
148727552|NCT02149121|536474245|FG000|Extension Study Period|Withdrawal by Subject|0|||
148727553|NCT02149121|536474246|FG001|Extension Study Period|Withdrawal by Subject|0|||
148727554|NCT02149121|536474247|FG002|Extension Study Period|Withdrawal by Subject|0|||
148727555|NCT02149121|536474248|FG003|Extension Study Period|Withdrawal by Subject|1|||
148727556|NCT02149121|536474249|FG004|Extension Study Period|Withdrawal by Subject|0|||
148727557|NCT02149121|536474250|FG005|Extension Study Period|Withdrawal by Subject|2|||
148727558|NCT02149121|536474251|FG006|Extension Study Period|Withdrawal by Subject|0|||
148727559|NCT03166124|536474260|FG000|Treatment Period 1|Adverse Event|0|||
148727560|NCT03166124|536474261|FG001|Treatment Period 1|Adverse Event|0|||
148727561|NCT03166124|536474262|FG002|Treatment Period 1|Adverse Event|1|||
148727562|NCT03166124|536474263|FG003|Treatment Period 1|Adverse Event|0|||
148727563|NCT03166124|536474260|FG000|Wash-out Period|Withdrawal by Subject|0|||
148727564|NCT03166124|536474261|FG001|Wash-out Period|Withdrawal by Subject|1|||
148727565|NCT03166124|536474262|FG002|Wash-out Period|Withdrawal by Subject|0|||
148727566|NCT03166124|536474263|FG003|Wash-out Period|Withdrawal by Subject|1|||
148727567|NCT03166124|536474260|FG000|Wash-out Period|Adverse Event|0|||
148727568|NCT03166124|536474261|FG001|Wash-out Period|Adverse Event|1|||
148727569|NCT03166124|536474262|FG002|Wash-out Period|Adverse Event|1|||
148727570|NCT03166124|536474263|FG003|Wash-out Period|Adverse Event|0|||
148727571|NCT00788593|536474266|FG000|Placebo Run-in Phase|Adverse Event|2|||
148727572|NCT00788593|536474267|FG001|Placebo Run-in Phase|Adverse Event|0|||
148727573|NCT00788593|536474268|FG002|Placebo Run-in Phase|Adverse Event|0|||
148727574|NCT00788593|536474266|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
148727575|NCT00788593|536474267|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
148727576|NCT00788593|536474268|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
148727577|NCT00788593|536474266|FG000|Placebo Run-in Phase|Protocol Violation|2|||
148727578|NCT00788593|536474267|FG001|Placebo Run-in Phase|Protocol Violation|0|||
148727579|NCT00788593|536474268|FG002|Placebo Run-in Phase|Protocol Violation|0|||
148727580|NCT00788593|536474266|FG000|First Intervention Period|Adverse Event|0|||
148727581|NCT00788593|536474267|FG001|First Intervention Period|Adverse Event|1|||
148727582|NCT00788593|536474268|FG002|First Intervention Period|Adverse Event|0|||
148727583|NCT00788593|536474266|FG000|Second Intervention Period|Lost to Follow-up|0|||
148727584|NCT00788593|536474267|FG001|Second Intervention Period|Lost to Follow-up|1|||
148727585|NCT00788593|536474268|FG002|Second Intervention Period|Lost to Follow-up|0|||
148727586|NCT00788593|536474266|FG000|Second Intervention Period|Other|0|||
148727587|NCT00788593|536474267|FG001|Second Intervention Period|Other|0|||
148727588|NCT00788593|536474268|FG002|Second Intervention Period|Other|1|||
148727589|NCT02655016|536474271|FG000|Overall Study|Disease progression|6|||
148727590|NCT02655016|536474272|FG001|Overall Study|Disease progression|4|||
148727591|NCT02655016|536474271|FG000|Overall Study|Site closed|0|||
148727592|NCT02655016|536474272|FG001|Overall Study|Site closed|1|||
148727593|NCT02655016|536474271|FG000|Overall Study|Death|30|||
148727594|NCT02655016|536474272|FG001|Overall Study|Death|48|||
148727595|NCT02655016|536474271|FG000|Overall Study|Lost to Follow-up|1|||
148727596|NCT02655016|536474272|FG001|Overall Study|Lost to Follow-up|1|||
148727597|NCT02655016|536474271|FG000|Overall Study|Withdrawal by Subject|18|||
148727598|NCT02655016|536474272|FG001|Overall Study|Withdrawal by Subject|36|||
148727599|NCT04459715|536474273|FG000|Overall Study|Adverse Event|3|||
148727600|NCT04459715|536474274|FG001|Overall Study|Adverse Event|3|||
148727601|NCT04459715|536474273|FG000|Overall Study|Death|111|||
148727602|NCT04459715|536474274|FG001|Overall Study|Death|93|||
148727603|NCT04459715|536474273|FG000|Overall Study|Lost to Follow-up|10|||
148727604|NCT04459715|536474274|FG001|Overall Study|Lost to Follow-up|9|||
148727605|NCT04459715|536474273|FG000|Overall Study|Other Reasons|4|||
148727606|NCT04459715|536474274|FG001|Overall Study|Other Reasons|5|||
148727607|NCT04459715|536474273|FG000|Overall Study|PROTOCOL DEVIATION|0|||
148727608|NCT04459715|536474274|FG001|Overall Study|PROTOCOL DEVIATION|1|||
148727609|NCT04459715|536474273|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
148727610|NCT04459715|536474274|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
148727611|NCT04459715|536474273|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
148727612|NCT04459715|536474274|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
148727613|NCT04459715|536474273|FG000|Overall Study|Withdrawal by Subject|22|||
148727614|NCT04459715|536474274|FG001|Overall Study|Withdrawal by Subject|22|||
148727615|NCT00952276|536474275|FG000|Overall Study|Withdrawal by Subject|1|||
148727616|NCT00952276|536474276|FG001|Overall Study|Withdrawal by Subject|0|||
148727617|NCT00952276|536474277|FG002|Overall Study|Withdrawal by Subject|0|||
148727618|NCT00952276|536474278|FG003|Overall Study|Withdrawal by Subject|1|||
148727619|NCT00952276|536474279|FG004|Overall Study|Withdrawal by Subject|0|||
148727620|NCT02427984|536474280|FG000|Overall Study|Lost to Follow-up|13|||
148727621|NCT02427984|536474281|FG001|Overall Study|Lost to Follow-up|5|||
148727622|NCT02427984|536474282|FG002|Overall Study|Lost to Follow-up|18|||
148727623|NCT01744093|536475791|FG000|Overall Study|Withdrawal by Subject|6|||
148727624|NCT01744093|536475792|FG001|Overall Study|Withdrawal by Subject|1|||
148727625|NCT02493777|536475793|FG000|Overall Study|Lost to Follow-up|0|||
148727626|NCT02493777|536475794|FG001|Overall Study|Lost to Follow-up|1|||
148727627|NCT00468728|536475795|FG000|Treatment|criteria for mITT population|4|||
148727628|NCT00468728|536475796|FG001|Treatment|criteria for mITT population|11|||
148727629|NCT00468728|536475795|FG000|Follow-up|mITT failure|34|||
148727630|NCT00468728|536475796|FG001|Follow-up|mITT failure|31|||
148727631|NCT02566993|536475797|FG000|Overall Study|Randomized but not treated|5|||
148727632|NCT02566993|536475798|FG001|Overall Study|Randomized but not treated|16|||
148727633|NCT02566993|536475797|FG000|Overall Study|Progressive disease|213|||
148727634|NCT02566993|536475798|FG001|Overall Study|Progressive disease|152|||
148727635|NCT02566993|536475797|FG000|Overall Study|Withdrawal by Subject|12|||
148727636|NCT02566993|536475798|FG001|Overall Study|Withdrawal by Subject|28|||
148727637|NCT02566993|536475797|FG000|Overall Study|Death|17|||
148727638|NCT02566993|536475798|FG001|Overall Study|Death|23|||
148727639|NCT02566993|536475797|FG000|Overall Study|Physician Decision|10|||
148727640|NCT02566993|536475798|FG001|Overall Study|Physician Decision|17|||
148727641|NCT02566993|536475797|FG000|Overall Study|Study drug-related adverse event|20|||
148727642|NCT02566993|536475798|FG001|Overall Study|Study drug-related adverse event|41|||
148727643|NCT02566993|536475797|FG000|Overall Study|Non study drug-related adverse event|9|||
148727644|NCT02566993|536475798|FG001|Overall Study|Non study drug-related adverse event|9|||
148727645|NCT02566993|536475797|FG000|Overall Study|Symptomatic deterioration|9|||
148727646|NCT02566993|536475798|FG001|Overall Study|Symptomatic deterioration|16|||
148727647|NCT02566993|536475797|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
148727648|NCT02566993|536475798|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
148727649|NCT02566993|536475797|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
148727650|NCT02566993|536475798|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
148727651|NCT02566993|536475797|FG000|Overall Study|Screening failure|2|||
148727652|NCT02566993|536475798|FG001|Overall Study|Screening failure|0|||
148727653|NCT02566993|536475797|FG000|Overall Study|Lost to Follow-up|0|||
148727654|NCT02566993|536475798|FG001|Overall Study|Lost to Follow-up|1|||
148727655|NCT02566993|536475797|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
148727656|NCT02566993|536475798|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
148727657|NCT04572243|536475799|FG000|Core Study: 14 Weeks|Adverse Event|1|||
148727658|NCT04572243|536475800|FG001|Core Study: 14 Weeks|Adverse Event|2|||
148727659|NCT04572243|536475801|FG002|Core Study: 14 Weeks|Adverse Event|0|||
148727660|NCT04572243|536475802|FG003|Core Study: 14 Weeks|Adverse Event|0|||
148727661|NCT04572243|536475799|FG000|Core Study: 14 Weeks|Subject choice|0|||
148727662|NCT04572243|536475800|FG001|Core Study: 14 Weeks|Subject choice|2|||
148727663|NCT04572243|536475801|FG002|Core Study: 14 Weeks|Subject choice|0|||
148727664|NCT04572243|536475802|FG003|Core Study: 14 Weeks|Subject choice|0|||
148727665|NCT04572243|536475799|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
148727666|NCT04572243|536475800|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
148727667|NCT04572243|536475801|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
148727668|NCT04572243|536475802|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
148727669|NCT04572243|536475799|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
148727670|NCT04572243|536475800|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
148727671|NCT04572243|536475801|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
148727672|NCT04572243|536475802|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
148727673|NCT01661881|536475803|FG000|Overall Study|Disease Progression|1|||
148727674|NCT00775606|536475804|FG000|Overall Study|Study sponsor terminated funding|3|||
148727675|NCT00775606|536475805|FG001|Overall Study|Study sponsor terminated funding|0|||
148727676|NCT02278718|536475806|FG000|Overall Study|Adverse Event|1|||
148727677|NCT02278718|536475807|FG001|Overall Study|Adverse Event|0|||
148727678|NCT02278718|536475806|FG000|Overall Study|Lost to Follow-up|2|||
148727679|NCT02278718|536475807|FG001|Overall Study|Lost to Follow-up|4|||
148727680|NCT02278718|536475806|FG000|Overall Study|Withdrawal by Subject|1|||
148727681|NCT02278718|536475807|FG001|Overall Study|Withdrawal by Subject|4|||
148971993|NCT03013543|537381887|FG008|Overall Study|Physician Decision|0|||
148971994|NCT03013543|537381888|FG009|Overall Study|Physician Decision|0|||
148971995|NCT03013543|537381879|FG000|Overall Study|Protocol Violation|0|||
148971996|NCT03013543|537381880|FG001|Overall Study|Protocol Violation|0|||
148971997|NCT03013543|537381881|FG002|Overall Study|Protocol Violation|0|||
148971998|NCT03013543|537381882|FG003|Overall Study|Protocol Violation|0|||
148971999|NCT03013543|537381883|FG004|Overall Study|Protocol Violation|0|||
148972000|NCT03013543|537381884|FG005|Overall Study|Protocol Violation|0|||
148972001|NCT03013543|537381885|FG006|Overall Study|Protocol Violation|0|||
148972002|NCT03013543|537381886|FG007|Overall Study|Protocol Violation|0|||
148972003|NCT03013543|537381887|FG008|Overall Study|Protocol Violation|0|||
148972004|NCT03013543|537381888|FG009|Overall Study|Protocol Violation|1|||
148972005|NCT00323414|537381889|FG000|Overall Study|Withdrawal by Subject|0|||
148972006|NCT00323414|537381890|FG001|Overall Study|Withdrawal by Subject|1|||
148972007|NCT02552316|537381892|FG000|Overall Study|Withdrawal by Subject|1|||
148817090|NCT03369223|536805391|FG004|Overall Study|Lost to Follow-up|0|||
148727682|NCT02278718|536475806|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
148727683|NCT02278718|536475807|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
148727684|NCT02278718|536475806|FG000|Overall Study|Missing|0|||
148727685|NCT02278718|536475807|FG001|Overall Study|Missing|1|||
148727686|NCT04440449|536475808|FG000|Overall Study|Lost to Follow-up|2|||
148727687|NCT04440449|536475809|FG001|Overall Study|Lost to Follow-up|0|||
148727688|NCT03212794|536475810|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
148727689|NCT03212794|536475811|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
148727690|NCT03212794|536475810|FG000|Overall Study|Lost to Follow-up|5|||
148727691|NCT03212794|536475811|FG001|Overall Study|Lost to Follow-up|6|||
148727692|NCT03212794|536475810|FG000|Overall Study|Incarcerated; unable to participate|2|||
148727693|NCT03212794|536475811|FG001|Overall Study|Incarcerated; unable to participate|0|||
148727694|NCT03212794|536475810|FG000|Overall Study|Withdrawal by Subject|1|||
148727695|NCT03212794|536475811|FG001|Overall Study|Withdrawal by Subject|0|||
148727696|NCT03212794|536475810|FG000|Overall Study|Death|0|||
148727697|NCT03212794|536475811|FG001|Overall Study|Death|1|||
148727698|NCT03212794|536475810|FG000|Overall Study|Found to be ineligible after allocation|0|||
148727699|NCT03212794|536475811|FG001|Overall Study|Found to be ineligible after allocation|1|||
148727700|NCT03212794|536475810|FG000|Overall Study|Relocated out of area|2|||
148727701|NCT03212794|536475811|FG001|Overall Study|Relocated out of area|0|||
148817091|NCT03369223|536805392|FG005|Overall Study|Lost to Follow-up|0|||
148817092|NCT03369223|536805393|FG006|Overall Study|Lost to Follow-up|0|||
148817093|NCT03369223|536805394|FG007|Overall Study|Lost to Follow-up|0|||
148817094|NCT03369223|536805395|FG008|Overall Study|Lost to Follow-up|0|||
148817095|NCT03369223|536805396|FG009|Overall Study|Lost to Follow-up|0|||
148817096|NCT03369223|536805397|FG010|Overall Study|Lost to Follow-up|0|||
148817097|NCT03369223|536805398|FG011|Overall Study|Lost to Follow-up|0|||
148817098|NCT03369223|536805399|FG012|Overall Study|Lost to Follow-up|0|||
148817099|NCT03369223|536805400|FG013|Overall Study|Lost to Follow-up|0|||
148817100|NCT03369223|536805401|FG014|Overall Study|Lost to Follow-up|0|||
148817101|NCT03369223|536805402|FG015|Overall Study|Lost to Follow-up|0|||
148817102|NCT03369223|536805403|FG016|Overall Study|Lost to Follow-up|0|||
148817103|NCT03369223|536805404|FG017|Overall Study|Lost to Follow-up|0|||
148817104|NCT03369223|536805405|FG018|Overall Study|Lost to Follow-up|2|||
148817105|NCT03369223|536805406|FG019|Overall Study|Lost to Follow-up|1|||
148817106|NCT03369223|536805387|FG000|Overall Study|Participant no longer meets study criteria|0|||
148817107|NCT03369223|536805388|FG001|Overall Study|Participant no longer meets study criteria|0|||
148817108|NCT03369223|536805389|FG002|Overall Study|Participant no longer meets study criteria|0|||
148817109|NCT03369223|536805390|FG003|Overall Study|Participant no longer meets study criteria|0|||
148817110|NCT03369223|536805391|FG004|Overall Study|Participant no longer meets study criteria|0|||
148817111|NCT03369223|536805392|FG005|Overall Study|Participant no longer meets study criteria|0|||
148817112|NCT03369223|536805393|FG006|Overall Study|Participant no longer meets study criteria|0|||
148817113|NCT03369223|536805394|FG007|Overall Study|Participant no longer meets study criteria|0|||
148817114|NCT03369223|536805395|FG008|Overall Study|Participant no longer meets study criteria|0|||
148817115|NCT03369223|536805396|FG009|Overall Study|Participant no longer meets study criteria|0|||
148817116|NCT03369223|536805397|FG010|Overall Study|Participant no longer meets study criteria|0|||
148817117|NCT03369223|536805398|FG011|Overall Study|Participant no longer meets study criteria|0|||
148817118|NCT03369223|536805399|FG012|Overall Study|Participant no longer meets study criteria|0|||
148817119|NCT03369223|536805400|FG013|Overall Study|Participant no longer meets study criteria|0|||
148817120|NCT03369223|536805401|FG014|Overall Study|Participant no longer meets study criteria|2|||
148817121|NCT03369223|536805402|FG015|Overall Study|Participant no longer meets study criteria|0|||
148817122|NCT03369223|536805403|FG016|Overall Study|Participant no longer meets study criteria|2|||
148817123|NCT03369223|536805404|FG017|Overall Study|Participant no longer meets study criteria|0|||
148817124|NCT03369223|536805405|FG018|Overall Study|Participant no longer meets study criteria|0|||
148817125|NCT03369223|536805406|FG019|Overall Study|Participant no longer meets study criteria|0|||
148817126|NCT03369223|536805387|FG000|Overall Study|Other reasons|0|||
148817127|NCT03369223|536805388|FG001|Overall Study|Other reasons|0|||
148817128|NCT03369223|536805389|FG002|Overall Study|Other reasons|0|||
148817129|NCT03369223|536805390|FG003|Overall Study|Other reasons|0|||
148817130|NCT03369223|536805391|FG004|Overall Study|Other reasons|0|||
148817131|NCT03369223|536805392|FG005|Overall Study|Other reasons|0|||
148727702|NCT01763918|536475812|FG000|Overall Study|Withdrawal by Subject|2|||
148727703|NCT01763918|536475813|FG001|Overall Study|Withdrawal by Subject|1|||
148727704|NCT01763918|536475814|FG002|Overall Study|Withdrawal by Subject|1|||
148727705|NCT01763918|536475815|FG003|Overall Study|Withdrawal by Subject|2|||
148817132|NCT03369223|536805393|FG006|Overall Study|Other reasons|0|||
148817133|NCT03369223|536805394|FG007|Overall Study|Other reasons|0|||
148817134|NCT03369223|536805395|FG008|Overall Study|Other reasons|0|||
148817135|NCT03369223|536805396|FG009|Overall Study|Other reasons|0|||
148817136|NCT03369223|536805397|FG010|Overall Study|Other reasons|0|||
148817137|NCT03369223|536805398|FG011|Overall Study|Other reasons|0|||
148817138|NCT03369223|536805399|FG012|Overall Study|Other reasons|0|||
149025967|NCT00783718|537571935|FG002|Maintenance Phase|Protocol Violation|0|||
149025968|NCT00783718|537571936|FG003|Maintenance Phase|Protocol Violation|0|||
149025969|NCT00783718|537571937|FG004|Maintenance Phase|Protocol Violation|0|||
149025970|NCT00783718|537571938|FG005|Maintenance Phase|Protocol Violation|0|||
149025971|NCT00783718|537571939|FG006|Maintenance Phase|Protocol Violation|2|||
149025972|NCT00783718|537571933|FG000|Maintenance Phase|Lack of Efficacy|83|||
149025973|NCT00783718|537571934|FG001|Maintenance Phase|Lack of Efficacy|0|||
149025974|NCT00783718|537571935|FG002|Maintenance Phase|Lack of Efficacy|0|||
149025975|NCT00783718|537571936|FG003|Maintenance Phase|Lack of Efficacy|61|||
149025976|NCT00783718|537571937|FG004|Maintenance Phase|Lack of Efficacy|31|||
149025977|NCT00783718|537571938|FG005|Maintenance Phase|Lack of Efficacy|33|||
149025978|NCT00783718|537571939|FG006|Maintenance Phase|Lack of Efficacy|155|||
149025979|NCT00783718|537571933|FG000|Maintenance Phase|Withdrawal by Subject|6|||
149025980|NCT00783718|537571934|FG001|Maintenance Phase|Withdrawal by Subject|0|||
149025981|NCT00783718|537571935|FG002|Maintenance Phase|Withdrawal by Subject|0|||
149025982|NCT00783718|537571936|FG003|Maintenance Phase|Withdrawal by Subject|2|||
149025983|NCT00783718|537571937|FG004|Maintenance Phase|Withdrawal by Subject|5|||
149025984|NCT00783718|537571938|FG005|Maintenance Phase|Withdrawal by Subject|2|||
149025985|NCT00783718|537571939|FG006|Maintenance Phase|Withdrawal by Subject|20|||
149025986|NCT00783718|537571933|FG000|Maintenance Phase|Lost to Follow-up|3|||
149025987|NCT00783718|537571934|FG001|Maintenance Phase|Lost to Follow-up|0|||
149025988|NCT00783718|537571935|FG002|Maintenance Phase|Lost to Follow-up|0|||
148727706|NCT01763918|536475812|FG000|Overall Study|Sponsor Decision|4|||
148727707|NCT01763918|536475813|FG001|Overall Study|Sponsor Decision|0|||
148727708|NCT01763918|536475814|FG002|Overall Study|Sponsor Decision|9|||
148727709|NCT01763918|536475815|FG003|Overall Study|Sponsor Decision|0|||
148727710|NCT00897949|536475816|FG000|Overall Study|Adverse Event|1|||
148727711|NCT00897949|536475817|FG001|Overall Study|Adverse Event|1|||
148727712|NCT00897949|536475818|FG002|Overall Study|Adverse Event|0|||
148727713|NCT00897949|536475816|FG000|Overall Study|Lost to Follow-up|0|||
148727714|NCT00897949|536475817|FG001|Overall Study|Lost to Follow-up|2|||
148727715|NCT00897949|536475818|FG002|Overall Study|Lost to Follow-up|1|||
148727716|NCT00897949|536475816|FG000|Overall Study|Protocol Violation|6|||
148727717|NCT00897949|536475817|FG001|Overall Study|Protocol Violation|3|||
148727718|NCT00897949|536475818|FG002|Overall Study|Protocol Violation|1|||
148727719|NCT00897949|536475816|FG000|Overall Study|Withdrawal by Subject|1|||
148727720|NCT00897949|536475817|FG001|Overall Study|Withdrawal by Subject|2|||
148727721|NCT00897949|536475818|FG002|Overall Study|Withdrawal by Subject|0|||
148727722|NCT00897949|536475816|FG000|Overall Study|Patient Uncoorperative|0|||
148727723|NCT00897949|536475817|FG001|Overall Study|Patient Uncoorperative|2|||
148727724|NCT00897949|536475818|FG002|Overall Study|Patient Uncoorperative|1|||
148727725|NCT00897949|536475816|FG000|Overall Study|Lost to Follow-up|30|||
148727726|NCT00897949|536475817|FG001|Overall Study|Lost to Follow-up|23|||
148727727|NCT00897949|536475818|FG002|Overall Study|Lost to Follow-up|17|||
148727728|NCT00897949|536475816|FG000|Overall Study|Withdrawal by Subject|24|||
148727729|NCT00897949|536475817|FG001|Overall Study|Withdrawal by Subject|31|||
148727730|NCT00897949|536475818|FG002|Overall Study|Withdrawal by Subject|17|||
148727731|NCT00897949|536475816|FG000|Overall Study|Abnormal Prestudy Labs|2|||
148727732|NCT00897949|536475817|FG001|Overall Study|Abnormal Prestudy Labs|3|||
148727733|NCT00897949|536475818|FG002|Overall Study|Abnormal Prestudy Labs|4|||
148727734|NCT00897949|536475816|FG000|Overall Study|Abnormal Baseline ECG|2|||
148727735|NCT00897949|536475817|FG001|Overall Study|Abnormal Baseline ECG|2|||
148727736|NCT00897949|536475818|FG002|Overall Study|Abnormal Baseline ECG|4|||
148727737|NCT00897949|536475816|FG000|Overall Study|Need for Concom. Med.|0|||
148727738|NCT00897949|536475817|FG001|Overall Study|Need for Concom. Med.|1|||
148727739|NCT00897949|536475818|FG002|Overall Study|Need for Concom. Med.|1|||
148727740|NCT00897949|536475816|FG000|Overall Study|Lack of Migraine Attack|29|||
148727741|NCT00897949|536475817|FG001|Overall Study|Lack of Migraine Attack|30|||
148727742|NCT00897949|536475818|FG002|Overall Study|Lack of Migraine Attack|19|||
148727743|NCT00897949|536475816|FG000|Overall Study|Did not take study drug|9|||
148727744|NCT00897949|536475817|FG001|Overall Study|Did not take study drug|3|||
148727745|NCT00897949|536475818|FG002|Overall Study|Did not take study drug|4|||
148727746|NCT01553747|536475819|FG000|Overall Study|Protocol Violation|0|||
148727747|NCT01553747|536475820|FG001|Overall Study|Protocol Violation|2|||
148727748|NCT01553747|536475821|FG002|Overall Study|Protocol Violation|0|||
148727749|NCT01553747|536475819|FG000|Overall Study|Voluntarily withdrew|70|||
148727750|NCT01553747|536475820|FG001|Overall Study|Voluntarily withdrew|66|||
148727751|NCT01553747|536475821|FG002|Overall Study|Voluntarily withdrew|74|||
148727752|NCT01553747|536475819|FG000|Overall Study|Adverse event or SAE|32|||
148727753|NCT01553747|536475820|FG001|Overall Study|Adverse event or SAE|28|||
148727754|NCT01553747|536475821|FG002|Overall Study|Adverse event or SAE|19|||
148727755|NCT01553747|536475819|FG000|Overall Study|Physician decision: other|10|||
149025989|NCT00783718|537571936|FG003|Maintenance Phase|Lost to Follow-up|0|||
149025990|NCT00783718|537571937|FG004|Maintenance Phase|Lost to Follow-up|2|||
149025991|NCT00783718|537571938|FG005|Maintenance Phase|Lost to Follow-up|0|||
149025992|NCT00783718|537571939|FG006|Maintenance Phase|Lost to Follow-up|2|||
149025993|NCT01163149|537571943|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
149025994|NCT01163149|537571944|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
149025995|NCT01163149|537571945|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
149025996|NCT01163149|537571943|FG000|Extension Treatment Period|Adverse Event|0|||
149025997|NCT01163149|537571944|FG001|Extension Treatment Period|Adverse Event|1|||
149025998|NCT01163149|537571945|FG002|Extension Treatment Period|Adverse Event|0|||
149025999|NCT01163149|537571943|FG000|Extension Treatment Period|Noncompliance|0|||
149026000|NCT01163149|537571944|FG001|Extension Treatment Period|Noncompliance|0|||
149026001|NCT01163149|537571945|FG002|Extension Treatment Period|Noncompliance|1|||
149026002|NCT01192295|537571946|FG000|Overall Study|Adverse Event|3|||
149026003|NCT01192295|537571947|FG001|Overall Study|Adverse Event|7|||
149026004|NCT01192295|537571946|FG000|Overall Study|Withdrawal by Subject|3|||
149026005|NCT01192295|537571947|FG001|Overall Study|Withdrawal by Subject|4|||
149026006|NCT01192295|537571946|FG000|Overall Study|Lost to Follow-up|0|||
149026007|NCT01192295|537571947|FG001|Overall Study|Lost to Follow-up|1|||
148727756|NCT01553747|536475820|FG001|Overall Study|Physician decision: other|8|||
148727757|NCT01553747|536475821|FG002|Overall Study|Physician decision: other|7|||
148727758|NCT01553747|536475819|FG000|Overall Study|Lost to Follow-up|11|||
148727759|NCT01553747|536475820|FG001|Overall Study|Lost to Follow-up|5|||
148727760|NCT01553747|536475821|FG002|Overall Study|Lost to Follow-up|6|||
148727761|NCT01553747|536475819|FG000|Overall Study|Sponsor decision, specify|7|||
148727762|NCT01553747|536475820|FG001|Overall Study|Sponsor decision, specify|5|||
148817139|NCT03369223|536805400|FG013|Overall Study|Other reasons|1|||
148727763|NCT01553747|536475821|FG002|Overall Study|Sponsor decision, specify|0|||
148727764|NCT01553747|536475819|FG000|Overall Study|Physician decision: lack of efficacy|1|||
148727765|NCT01553747|536475820|FG001|Overall Study|Physician decision: lack of efficacy|5|||
148727766|NCT01553747|536475821|FG002|Overall Study|Physician decision: lack of efficacy|3|||
148727767|NCT00102687|536475822|FG000|Initial Period|Withdrawal by Subject|6|||
148727768|NCT00102687|536475823|FG001|Initial Period|Withdrawal by Subject|3|||
148727769|NCT00102687|536475824|FG002|Initial Period|Withdrawal by Subject|5|||
148727770|NCT00102687|536475825|FG003|Initial Period|Withdrawal by Subject|0|||
148727771|NCT00102687|536475826|FG004|Initial Period|Withdrawal by Subject|0|||
148727772|NCT00102687|536475822|FG000|Initial Period|Adverse Event|4|||
148727773|NCT00102687|536475823|FG001|Initial Period|Adverse Event|7|||
148727774|NCT00102687|536475824|FG002|Initial Period|Adverse Event|9|||
148727775|NCT00102687|536475825|FG003|Initial Period|Adverse Event|0|||
148727776|NCT00102687|536475826|FG004|Initial Period|Adverse Event|0|||
148727777|NCT00102687|536475822|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
148727778|NCT00102687|536475823|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
148727779|NCT00102687|536475824|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
148727780|NCT00102687|536475825|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
148727781|NCT00102687|536475826|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
148727782|NCT00102687|536475822|FG000|Initial Period|Protocol Violation|0|||
148727783|NCT00102687|536475823|FG001|Initial Period|Protocol Violation|0|||
148727784|NCT00102687|536475824|FG002|Initial Period|Protocol Violation|2|||
148727785|NCT00102687|536475825|FG003|Initial Period|Protocol Violation|0|||
148727786|NCT00102687|536475826|FG004|Initial Period|Protocol Violation|0|||
148727787|NCT00102687|536475822|FG000|Initial Period|Physician Decision|2|||
148727788|NCT00102687|536475823|FG001|Initial Period|Physician Decision|9|||
148972008|NCT02552316|537381892|FG000|Overall Study|Withdrawal due to non-compliance|1|||
148972009|NCT02659020|537381893|FG000|Overall Study|Adverse Event|0|||
148972010|NCT02659020|537381894|FG001|Overall Study|Adverse Event|0|||
148972011|NCT02659020|537381895|FG002|Overall Study|Adverse Event|0|||
148972012|NCT02659020|537381896|FG003|Overall Study|Adverse Event|2|||
148972013|NCT02659020|537381897|FG004|Overall Study|Adverse Event|0|||
148972014|NCT02659020|537381898|FG005|Overall Study|Adverse Event|0|||
148972015|NCT02659020|537381899|FG006|Overall Study|Adverse Event|2|||
148972016|NCT02659020|537381893|FG000|Overall Study|Lost to Follow-up|1|||
148972017|NCT02659020|537381894|FG001|Overall Study|Lost to Follow-up|2|||
148972018|NCT02659020|537381895|FG002|Overall Study|Lost to Follow-up|1|||
149026008|NCT01192295|537571946|FG000|Overall Study|Lack of Efficacy|0|||
149026009|NCT01192295|537571947|FG001|Overall Study|Lack of Efficacy|5|||
149026010|NCT01192295|537571946|FG000|Overall Study|Administrative|4|||
149026011|NCT01192295|537571947|FG001|Overall Study|Administrative|6|||
148727789|NCT00102687|536475824|FG002|Initial Period|Physician Decision|6|||
148727790|NCT00102687|536475825|FG003|Initial Period|Physician Decision|0|||
148727791|NCT00102687|536475826|FG004|Initial Period|Physician Decision|0|||
148727792|NCT00102687|536475822|FG000|Initial Period|Sponsor's decision|0|||
148727793|NCT00102687|536475823|FG001|Initial Period|Sponsor's decision|1|||
148727794|NCT00102687|536475824|FG002|Initial Period|Sponsor's decision|1|||
148727795|NCT00102687|536475825|FG003|Initial Period|Sponsor's decision|0|||
148727796|NCT00102687|536475826|FG004|Initial Period|Sponsor's decision|0|||
148817140|NCT03369223|536805401|FG014|Overall Study|Other reasons|2|||
148972019|NCT02659020|537381896|FG003|Overall Study|Lost to Follow-up|6|||
148972020|NCT02659020|537381897|FG004|Overall Study|Lost to Follow-up|1|||
149026012|NCT00630539|537571948|FG000|Overall Study|Adverse Event|1|||
149026013|NCT00630539|537571949|FG001|Overall Study|Adverse Event|3|||
148817141|NCT03369223|536805402|FG015|Overall Study|Other reasons|0|||
148817142|NCT03369223|536805403|FG016|Overall Study|Other reasons|1|||
148817143|NCT03369223|536805404|FG017|Overall Study|Other reasons|0|||
148817144|NCT03369223|536805405|FG018|Overall Study|Other reasons|0|||
148817145|NCT03369223|536805406|FG019|Overall Study|Other reasons|2|||
148817146|NCT03369223|536805387|FG000|Overall Study|Death|0|||
148817147|NCT03369223|536805388|FG001|Overall Study|Death|0|||
148817148|NCT03369223|536805389|FG002|Overall Study|Death|0|||
148817149|NCT03369223|536805390|FG003|Overall Study|Death|0|||
148817150|NCT03369223|536805391|FG004|Overall Study|Death|0|||
148817151|NCT03369223|536805392|FG005|Overall Study|Death|0|||
148817152|NCT03369223|536805393|FG006|Overall Study|Death|0|||
148817153|NCT03369223|536805394|FG007|Overall Study|Death|0|||
148817154|NCT03369223|536805395|FG008|Overall Study|Death|0|||
148817155|NCT03369223|536805396|FG009|Overall Study|Death|0|||
148817156|NCT03369223|536805397|FG010|Overall Study|Death|0|||
148817157|NCT03369223|536805398|FG011|Overall Study|Death|0|||
148817158|NCT03369223|536805399|FG012|Overall Study|Death|0|||
148817159|NCT03369223|536805400|FG013|Overall Study|Death|1|||
148817160|NCT03369223|536805401|FG014|Overall Study|Death|0|||
148817161|NCT03369223|536805402|FG015|Overall Study|Death|0|||
148817162|NCT03369223|536805403|FG016|Overall Study|Death|0|||
148817163|NCT03369223|536805404|FG017|Overall Study|Death|0|||
148817164|NCT03369223|536805405|FG018|Overall Study|Death|1|||
148817165|NCT03369223|536805406|FG019|Overall Study|Death|0|||
148817166|NCT03369223|536805387|FG000|Overall Study|Adverse event unrelated to study drug|0|||
148817167|NCT03369223|536805388|FG001|Overall Study|Adverse event unrelated to study drug|0|||
148817168|NCT03369223|536805389|FG002|Overall Study|Adverse event unrelated to study drug|0|||
148817169|NCT03369223|536805390|FG003|Overall Study|Adverse event unrelated to study drug|0|||
148817170|NCT03369223|536805391|FG004|Overall Study|Adverse event unrelated to study drug|0|||
148817171|NCT03369223|536805392|FG005|Overall Study|Adverse event unrelated to study drug|0|||
148817172|NCT03369223|536805393|FG006|Overall Study|Adverse event unrelated to study drug|1|||
148817173|NCT03369223|536805394|FG007|Overall Study|Adverse event unrelated to study drug|0|||
148817174|NCT03369223|536805395|FG008|Overall Study|Adverse event unrelated to study drug|0|||
148817175|NCT03369223|536805396|FG009|Overall Study|Adverse event unrelated to study drug|1|||
148817176|NCT03369223|536805397|FG010|Overall Study|Adverse event unrelated to study drug|0|||
148817177|NCT03369223|536805398|FG011|Overall Study|Adverse event unrelated to study drug|0|||
148817178|NCT03369223|536805399|FG012|Overall Study|Adverse event unrelated to study drug|0|||
148817179|NCT03369223|536805400|FG013|Overall Study|Adverse event unrelated to study drug|4|||
148817180|NCT03369223|536805401|FG014|Overall Study|Adverse event unrelated to study drug|2|||
148727797|NCT00102687|536475822|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
148727798|NCT00102687|536475823|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
148727799|NCT00102687|536475824|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
148727800|NCT00102687|536475825|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
148727801|NCT00102687|536475826|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
148727802|NCT00102687|536475822|FG000|Initial Period|Death|1|||
148727803|NCT00102687|536475823|FG001|Initial Period|Death|1|||
148727804|NCT00102687|536475824|FG002|Initial Period|Death|1|||
148727805|NCT00102687|536475825|FG003|Initial Period|Death|0|||
148727806|NCT00102687|536475826|FG004|Initial Period|Death|0|||
148727807|NCT00102687|536475822|FG000|Maintenance Period|Withdrawal by Subject|4|||
148727808|NCT00102687|536475823|FG001|Maintenance Period|Withdrawal by Subject|0|||
148727809|NCT00102687|536475824|FG002|Maintenance Period|Withdrawal by Subject|2|||
148727810|NCT00102687|536475825|FG003|Maintenance Period|Withdrawal by Subject|3|||
148727811|NCT00102687|536475826|FG004|Maintenance Period|Withdrawal by Subject|1|||
148727812|NCT00102687|536475822|FG000|Maintenance Period|Adverse Event|1|||
148817181|NCT03369223|536805402|FG015|Overall Study|Adverse event unrelated to study drug|0|||
148817182|NCT03369223|536805403|FG016|Overall Study|Adverse event unrelated to study drug|2|||
149026014|NCT00630539|537571950|FG002|Overall Study|Adverse Event|1|||
148727813|NCT00102687|536475823|FG001|Maintenance Period|Adverse Event|0|||
148727814|NCT00102687|536475824|FG002|Maintenance Period|Adverse Event|0|||
148727815|NCT00102687|536475825|FG003|Maintenance Period|Adverse Event|1|||
149026015|NCT00630539|537571951|FG003|Overall Study|Adverse Event|2|||
148727816|NCT00102687|536475826|FG004|Maintenance Period|Adverse Event|3|||
148727817|NCT00102687|536475822|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
148727818|NCT00102687|536475823|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
148727819|NCT00102687|536475824|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
148817183|NCT03369223|536805404|FG017|Overall Study|Adverse event unrelated to study drug|1|||
148817184|NCT03369223|536805405|FG018|Overall Study|Adverse event unrelated to study drug|3|||
148817185|NCT03369223|536805406|FG019|Overall Study|Adverse event unrelated to study drug|2|||
148817186|NCT03369223|536805387|FG000|Overall Study|Disease progression|6|||
148817187|NCT03369223|536805388|FG001|Overall Study|Disease progression|8|||
148817188|NCT03369223|536805389|FG002|Overall Study|Disease progression|5|||
148817189|NCT03369223|536805390|FG003|Overall Study|Disease progression|1|||
148817190|NCT03369223|536805391|FG004|Overall Study|Disease progression|9|||
148817191|NCT03369223|536805392|FG005|Overall Study|Disease progression|9|||
148727820|NCT00102687|536475825|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
148727821|NCT00102687|536475826|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
148727822|NCT00102687|536475822|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
148727823|NCT00102687|536475823|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
148727824|NCT00102687|536475824|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
148727825|NCT00102687|536475825|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
148727826|NCT00102687|536475826|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
148727827|NCT00102687|536475822|FG000|Maintenance Period|Death|0|||
148727828|NCT00102687|536475823|FG001|Maintenance Period|Death|0|||
148727829|NCT00102687|536475824|FG002|Maintenance Period|Death|0|||
148727830|NCT00102687|536475825|FG003|Maintenance Period|Death|1|||
148727831|NCT00102687|536475826|FG004|Maintenance Period|Death|1|||
148727832|NCT00102687|536475822|FG000|Maintenance Period|Physician Decision|1|||
148727833|NCT00102687|536475823|FG001|Maintenance Period|Physician Decision|2|||
148727834|NCT00102687|536475824|FG002|Maintenance Period|Physician Decision|3|||
148727835|NCT00102687|536475825|FG003|Maintenance Period|Physician Decision|0|||
148727836|NCT00102687|536475826|FG004|Maintenance Period|Physician Decision|4|||
148727837|NCT02408120|536475827|FG000|Overall Study|Withdrawal by Subject|0|||
148727838|NCT02408120|536475828|FG001|Overall Study|Withdrawal by Subject|1|||
148727839|NCT02408120|536475827|FG000|Overall Study|Treatment Refusal|1|||
148727840|NCT02408120|536475828|FG001|Overall Study|Treatment Refusal|0|||
148727841|NCT02408120|536475827|FG000|Overall Study|Received Steroids|1|||
148727842|NCT02408120|536475828|FG001|Overall Study|Received Steroids|1|||
148727843|NCT02408120|536475827|FG000|Overall Study|Discharged same day|1|||
148727844|NCT02408120|536475828|FG001|Overall Study|Discharged same day|1|||
148727845|NCT02408120|536475827|FG000|Overall Study|Did not receive insulin|1|||
148727846|NCT02408120|536475828|FG001|Overall Study|Did not receive insulin|2|||
148727847|NCT00977431|536475834|FG000|Overall Study|Other than listed|1|||
148727848|NCT00977431|536475835|FG001|Overall Study|Other than listed|0|||
148727849|NCT00977431|536475836|FG002|Overall Study|Other than listed|0|||
148727850|NCT00977431|536475837|FG003|Overall Study|Other than listed|0|||
148727851|NCT00977431|536475838|FG004|Overall Study|Other than listed|2|||
148727852|NCT00977431|536475834|FG000|Overall Study|Protocol Violation|0|||
148727853|NCT00977431|536475835|FG001|Overall Study|Protocol Violation|0|||
148727854|NCT00977431|536475836|FG002|Overall Study|Protocol Violation|1|||
148727855|NCT00977431|536475837|FG003|Overall Study|Protocol Violation|0|||
148727856|NCT00977431|536475838|FG004|Overall Study|Protocol Violation|0|||
148727857|NCT00977431|536475834|FG000|Overall Study|Adverse Event|3|||
148727858|NCT00977431|536475835|FG001|Overall Study|Adverse Event|0|||
148727859|NCT00977431|536475836|FG002|Overall Study|Adverse Event|4|||
148727860|NCT00977431|536475837|FG003|Overall Study|Adverse Event|0|||
148727861|NCT00977431|536475838|FG004|Overall Study|Adverse Event|6|||
148727862|NCT00977431|536475834|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
148727863|NCT00977431|536475835|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
148727864|NCT00977431|536475836|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
148727865|NCT00977431|536475837|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
148727866|NCT00977431|536475838|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
148727867|NCT00977431|536475834|FG000|Overall Study|Progressive disease|2|||
148727868|NCT00977431|536475835|FG001|Overall Study|Progressive disease|6|||
148727869|NCT00977431|536475836|FG002|Overall Study|Progressive disease|1|||
148727870|NCT00977431|536475837|FG003|Overall Study|Progressive disease|3|||
148727871|NCT00977431|536475838|FG004|Overall Study|Progressive disease|5|||
148727872|NCT03739138|536475845|FG000|Overall Study|Death|0|||
148727873|NCT03739138|536475846|FG001|Overall Study|Death|7|||
148727874|NCT03739138|536475847|FG002|Overall Study|Death|4|||
148727875|NCT03739138|536475848|FG003|Overall Study|Death|13|||
148727876|NCT03739138|536475849|FG004|Overall Study|Death|0|||
148727877|NCT03739138|536475845|FG000|Overall Study|Lost to Follow-up|0|||
148727878|NCT03739138|536475846|FG001|Overall Study|Lost to Follow-up|0|||
148727879|NCT03739138|536475847|FG002|Overall Study|Lost to Follow-up|1|||
148727880|NCT03739138|536475848|FG003|Overall Study|Lost to Follow-up|0|||
148972021|NCT02659020|537381898|FG005|Overall Study|Lost to Follow-up|5|||
148727881|NCT03739138|536475849|FG004|Overall Study|Lost to Follow-up|0|||
148727882|NCT03739138|536475845|FG000|Overall Study|Study Terminated By Sponsor|0|||
148727883|NCT03739138|536475846|FG001|Overall Study|Study Terminated By Sponsor|0|||
148727884|NCT03739138|536475847|FG002|Overall Study|Study Terminated By Sponsor|0|||
148727885|NCT03739138|536475848|FG003|Overall Study|Study Terminated By Sponsor|4|||
148727886|NCT03739138|536475849|FG004|Overall Study|Study Terminated By Sponsor|0|||
148727887|NCT03739138|536475845|FG000|Overall Study|Withdrawal by Subject|0|||
148727888|NCT03739138|536475846|FG001|Overall Study|Withdrawal by Subject|0|||
148727889|NCT03739138|536475847|FG002|Overall Study|Withdrawal by Subject|0|||
148972022|NCT02659020|537381899|FG006|Overall Study|Lost to Follow-up|0|||
148727890|NCT03739138|536475848|FG003|Overall Study|Withdrawal by Subject|1|||
148727891|NCT03739138|536475849|FG004|Overall Study|Withdrawal by Subject|0|||
148727892|NCT00597116|536475850|FG000|Overall Study|Adverse Event|2|||
148727893|NCT00597116|536475851|FG001|Overall Study|Adverse Event|1|||
148727894|NCT00597116|536475850|FG000|Overall Study|Withdrawal by Subject|0|||
148972023|NCT02659020|537381893|FG000|Overall Study|Physician Decision|0|||
148727895|NCT00597116|536475851|FG001|Overall Study|Withdrawal by Subject|2|||
148727896|NCT00597116|536475850|FG000|Overall Study|Physician Decision|0|||
148727897|NCT00597116|536475851|FG001|Overall Study|Physician Decision|1|||
148727898|NCT00597116|536475850|FG000|Overall Study|Death|0|||
148727899|NCT00597116|536475851|FG001|Overall Study|Death|1|||
148727900|NCT00597116|536475850|FG000|Overall Study|Lost to Follow-up|1|||
148727901|NCT00597116|536475851|FG001|Overall Study|Lost to Follow-up|0|||
148727902|NCT00597116|536475850|FG000|Overall Study|Progressive disease|11|||
148727903|NCT00597116|536475851|FG001|Overall Study|Progressive disease|6|||
148727904|NCT01258101|536475852|FG000|Overall Study|Adverse Event|5|||
148727905|NCT01258101|536475853|FG001|Overall Study|Adverse Event|6|||
148727906|NCT01258101|536475854|FG002|Overall Study|Adverse Event|0|||
148727907|NCT01258101|536475855|FG003|Overall Study|Adverse Event|0|||
148727908|NCT01258101|536475852|FG000|Overall Study|Extra exclusion criterion amended|2|||
148727909|NCT01258101|536475853|FG001|Overall Study|Extra exclusion criterion amended|1|||
148727910|NCT01258101|536475854|FG002|Overall Study|Extra exclusion criterion amended|1|||
148727911|NCT01258101|536475855|FG003|Overall Study|Extra exclusion criterion amended|1|||
148727912|NCT01258101|536475852|FG000|Overall Study|Informed consent has been withdrawn|2|||
148727913|NCT01258101|536475853|FG001|Overall Study|Informed consent has been withdrawn|2|||
148727914|NCT01258101|536475854|FG002|Overall Study|Informed consent has been withdrawn|1|||
148727915|NCT01258101|536475855|FG003|Overall Study|Informed consent has been withdrawn|1|||
148727916|NCT01258101|536475852|FG000|Overall Study|Patient is not able to attend visits|8|||
148727917|NCT01258101|536475853|FG001|Overall Study|Patient is not able to attend visits|9|||
148727918|NCT01258101|536475854|FG002|Overall Study|Patient is not able to attend visits|7|||
148727919|NCT01258101|536475855|FG003|Overall Study|Patient is not able to attend visits|6|||
148727920|NCT01258101|536475852|FG000|Overall Study|Patient´s compliance|4|||
148727921|NCT01258101|536475853|FG001|Overall Study|Patient´s compliance|3|||
148727922|NCT01258101|536475854|FG002|Overall Study|Patient´s compliance|1|||
148727923|NCT01258101|536475855|FG003|Overall Study|Patient´s compliance|2|||
148727924|NCT01258101|536475852|FG000|Overall Study|Lost to Follow-up|5|||
148727925|NCT01258101|536475853|FG001|Overall Study|Lost to Follow-up|5|||
148727926|NCT01258101|536475854|FG002|Overall Study|Lost to Follow-up|0|||
148727927|NCT01258101|536475855|FG003|Overall Study|Lost to Follow-up|6|||
148727928|NCT01258101|536475852|FG000|Overall Study|PCR positive at week 24|0|||
148727929|NCT01258101|536475853|FG001|Overall Study|PCR positive at week 24|0|||
148727930|NCT01258101|536475854|FG002|Overall Study|PCR positive at week 24|0|||
148727931|NCT01258101|536475855|FG003|Overall Study|PCR positive at week 24|1|||
148727932|NCT01258101|536475852|FG000|Overall Study|Other reason|7|||
148727933|NCT01258101|536475853|FG001|Overall Study|Other reason|8|||
148727934|NCT01258101|536475854|FG002|Overall Study|Other reason|1|||
148727935|NCT01258101|536475855|FG003|Overall Study|Other reason|8|||
148727936|NCT00063882|536475856|FG000|Overall Study|Protocol Violation|3|||
148727937|NCT00063882|536475857|FG001|Overall Study|Protocol Violation|3|||
148727938|NCT00063882|536475856|FG000|Overall Study|Withdrawal by Subject|2|||
148727939|NCT00063882|536475857|FG001|Overall Study|Withdrawal by Subject|1|||
148727940|NCT00767520|536475860|FG000|Overall Study|Participants still on treatment|11|||
148727941|NCT00767520|536475861|FG001|Overall Study|Participants still on treatment|15|||
148727942|NCT00767520|536475860|FG000|Overall Study|Randomized in error and Never treated|0|||
148727943|NCT00767520|536475861|FG001|Overall Study|Randomized in error and Never treated|2|||
148727944|NCT01338987|536475864|FG000|Overall Study|enrolled on new protocol|0|||
148727945|NCT01338987|536475865|FG001|Overall Study|enrolled on new protocol|0|||
148727946|NCT01338987|536475866|FG002|Overall Study|enrolled on new protocol|1|||
148727947|NCT01338987|536475867|FG003|Overall Study|enrolled on new protocol|0|||
148727948|NCT01338987|536475868|FG004|Overall Study|enrolled on new protocol|0|||
148727949|NCT01338987|536475864|FG000|Overall Study|Disease progression on study|2|||
148727950|NCT01338987|536475865|FG001|Overall Study|Disease progression on study|1|||
148727951|NCT01338987|536475866|FG002|Overall Study|Disease progression on study|1|||
148727952|NCT01338987|536475867|FG003|Overall Study|Disease progression on study|0|||
148727953|NCT01338987|536475868|FG004|Overall Study|Disease progression on study|0|||
148727954|NCT00058214|536475871|FG000|Overall Study|Adverse Event|1|||
148727955|NCT01470612|536475872|FG000|Overall Study|Adverse Event|20|||
148727956|NCT01470612|536475873|FG001|Overall Study|Adverse Event|80|||
148727957|NCT01470612|536475872|FG000|Overall Study|Death|0|||
148727958|NCT01470612|536475873|FG001|Overall Study|Death|1|||
148727959|NCT01470612|536475872|FG000|Overall Study|Lack of Efficacy|20|||
148727960|NCT01470612|536475873|FG001|Overall Study|Lack of Efficacy|326|||
148727961|NCT01470612|536475872|FG000|Overall Study|Lost to Follow-up|2|||
148727962|NCT01470612|536475873|FG001|Overall Study|Lost to Follow-up|5|||
148727963|NCT01470612|536475872|FG000|Overall Study|Did not meet entrance criteria|0|||
148727964|NCT01470612|536475873|FG001|Overall Study|Did not meet entrance criteria|1|||
148727965|NCT01470612|536475872|FG000|Overall Study|Pregnancy|2|||
148727966|NCT01470612|536475873|FG001|Overall Study|Pregnancy|10|||
148727967|NCT01470612|536475872|FG000|Overall Study|Protocol Violation|2|||
148727968|NCT01470612|536475873|FG001|Overall Study|Protocol Violation|7|||
148727969|NCT01470612|536475872|FG000|Overall Study|Withdrawal by Subject|24|||
148727970|NCT01470612|536475873|FG001|Overall Study|Withdrawal by Subject|79|||
148727971|NCT01470612|536475872|FG000|Overall Study|Other|14|||
148727972|NCT01470612|536475873|FG001|Overall Study|Other|156|||
148727973|NCT03856593|536475879|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
148727974|NCT03856593|536475880|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
148727975|NCT03078582|536475886|FG000|Overall Study|Adverse Event|0|||
148727976|NCT03078582|536475887|FG001|Overall Study|Adverse Event|8|||
148727977|NCT02039414|536475898|FG000|Overall Study|Delivered|1|||
148727978|NCT02039414|536475899|FG001|Overall Study|Delivered|1|||
148727979|NCT02039414|536475898|FG000|Overall Study|Lost to Follow-up|2|||
148727980|NCT02039414|536475899|FG001|Overall Study|Lost to Follow-up|0|||
148727981|NCT02039414|536475898|FG000|Overall Study|Protocol Violation|3|||
148727982|NCT02039414|536475899|FG001|Overall Study|Protocol Violation|1|||
148727983|NCT02972502|536475902|FG000|Overall Study|Lost to Follow-up|3|||
148727984|NCT02972502|536475903|FG001|Overall Study|Lost to Follow-up|1|||
148727985|NCT02972502|536475902|FG000|Overall Study|Withdrawal by Subject|1|||
148727986|NCT02972502|536475903|FG001|Overall Study|Withdrawal by Subject|1|||
148727987|NCT03832738|536475904|FG000|Overall Study|Withdrawal by Subject|6|||
148727988|NCT03832738|536475905|FG001|Overall Study|Withdrawal by Subject|7|||
148727989|NCT03832738|536475906|FG002|Overall Study|Withdrawal by Subject|16|||
148727990|NCT03832738|536475904|FG000|Overall Study|Physician Decision|0|||
148727991|NCT03832738|536475905|FG001|Overall Study|Physician Decision|1|||
148727992|NCT03832738|536475906|FG002|Overall Study|Physician Decision|2|||
148727993|NCT03832738|536475904|FG000|Overall Study|Adverse Event|2|||
148727994|NCT03832738|536475905|FG001|Overall Study|Adverse Event|3|||
148727995|NCT03832738|536475906|FG002|Overall Study|Adverse Event|1|||
148727996|NCT03832738|536475904|FG000|Overall Study|Pregnancy|0|||
148727997|NCT03832738|536475905|FG001|Overall Study|Pregnancy|1|||
148727998|NCT03832738|536475906|FG002|Overall Study|Pregnancy|0|||
148727999|NCT03852459|536475907|FG000|Overall Study|Adverse Event|2|||
148728000|NCT03852459|536475908|FG001|Overall Study|Adverse Event|2|||
148728001|NCT03852459|536475907|FG000|Overall Study|Withdrawal by Subject|1|||
148728002|NCT03852459|536475908|FG001|Overall Study|Withdrawal by Subject|1|||
148728003|NCT00049842|536475909|FG000|Treatment Phase|Adverse Event|47|||
148728004|NCT00049842|536475910|FG001|Treatment Phase|Adverse Event|12|||
148728005|NCT00049842|536475909|FG000|Treatment Phase|Withdrawal by Subject|35|||
148728006|NCT00049842|536475910|FG001|Treatment Phase|Withdrawal by Subject|46|||
148728007|NCT00049842|536475909|FG000|Treatment Phase|Non-compliance with protocol|7|||
148728008|NCT00049842|536475910|FG001|Treatment Phase|Non-compliance with protocol|8|||
148728009|NCT00049842|536475909|FG000|Treatment Phase|Lost to Follow-up|4|||
148728010|NCT00049842|536475910|FG001|Treatment Phase|Lost to Follow-up|8|||
148728011|NCT00049842|536475909|FG000|Treatment Phase|Administrative|0|||
148728012|NCT00049842|536475910|FG001|Treatment Phase|Administrative|3|||
148728013|NCT00049842|536475909|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
148728014|NCT00049842|536475910|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
148728015|NCT00049842|536475909|FG000|Follow-up Phase|Adverse Event|6|||
148728016|NCT00049842|536475910|FG001|Follow-up Phase|Adverse Event|1|||
148728017|NCT00049842|536475909|FG000|Follow-up Phase|Other|1|||
148728018|NCT00049842|536475910|FG001|Follow-up Phase|Other|4|||
148728019|NCT00430950|536475911|FG000|Overall Study|Adverse Event|7|||
148728020|NCT00430950|536475912|FG001|Overall Study|Adverse Event|6|||
148728021|NCT00430950|536475911|FG000|Overall Study|Withdrawal by Subject|1|||
148728022|NCT00430950|536475912|FG001|Overall Study|Withdrawal by Subject|0|||
148728023|NCT00430950|536475911|FG000|Overall Study|concomitant medication,etc.|5|||
148728024|NCT00430950|536475912|FG001|Overall Study|concomitant medication,etc.|7|||
148728025|NCT02442271|536475913|FG000|Overall Study|Adverse Event|1|||
148728026|NCT02442271|536475913|FG000|Overall Study|Withdrew Consent|1|||
148728027|NCT02442271|536475913|FG000|Overall Study|Lost to Follow-up|1|||
148728028|NCT02442271|536475913|FG000|Overall Study|Other|1|||
148728029|NCT00831623|536475919|FG000|Overall Study|Withdrawal by Subject|9|||
148728030|NCT00831623|536475919|FG000|Overall Study|Lost to Follow-up|1|||
148728031|NCT00831623|536475919|FG000|Overall Study|Not 2 years post-treatment|12|||
148728032|NCT00766831|536475921|FG000|Overall Study|Withdrawal by Subject|4|||
148728033|NCT00766831|536475921|FG000|Overall Study|Lost to Follow-up|3|||
148728034|NCT00766831|536475921|FG000|Overall Study|Adverse Event|20|||
148728035|NCT00766831|536475921|FG000|Overall Study|Protocol Violation|15|||
148728036|NCT00766831|536475921|FG000|Overall Study|Physician Decision|5|||
148728037|NCT00766831|536475921|FG000|Overall Study|Withdrawal of consent|26|||
148728038|NCT00766831|536475921|FG000|Overall Study|Non cooperation by participants|14|||
148728039|NCT00766831|536475921|FG000|Overall Study|Other|28|||
148728040|NCT01392326|536475922|FG000|Overall Study|Death|2|||
148728041|NCT01392326|536475923|FG001|Overall Study|Death|0|||
148728042|NCT01392326|536475924|FG002|Overall Study|Death|0|||
148728043|NCT01392326|536475922|FG000|Overall Study|Withdrawal by Subject|12|||
148728044|NCT01392326|536475923|FG001|Overall Study|Withdrawal by Subject|11|||
148728045|NCT01392326|536475924|FG002|Overall Study|Withdrawal by Subject|15|||
148728046|NCT01392326|536475922|FG000|Overall Study|Protocol Violation|2|||
148728047|NCT01392326|536475923|FG001|Overall Study|Protocol Violation|0|||
148728048|NCT01392326|536475924|FG002|Overall Study|Protocol Violation|0|||
148728049|NCT01392326|536475922|FG000|Overall Study|Pregnancy|0|||
148728050|NCT01392326|536475923|FG001|Overall Study|Pregnancy|0|||
148728051|NCT01392326|536475924|FG002|Overall Study|Pregnancy|1|||
148728052|NCT01392326|536475922|FG000|Overall Study|Physician Decision|7|||
148728053|NCT01392326|536475923|FG001|Overall Study|Physician Decision|5|||
148728054|NCT01392326|536475924|FG002|Overall Study|Physician Decision|2|||
148728055|NCT01392326|536475922|FG000|Overall Study|Lost to Follow-up|1|||
148728056|NCT01392326|536475923|FG001|Overall Study|Lost to Follow-up|3|||
148728057|NCT01392326|536475924|FG002|Overall Study|Lost to Follow-up|4|||
148728058|NCT01392326|536475922|FG000|Overall Study|Lack of Efficacy|14|||
148728059|NCT01392326|536475923|FG001|Overall Study|Lack of Efficacy|10|||
148728060|NCT01392326|536475924|FG002|Overall Study|Lack of Efficacy|15|||
148728061|NCT01392326|536475922|FG000|Overall Study|Adverse Event|9|||
148728062|NCT01392326|536475923|FG001|Overall Study|Adverse Event|6|||
148728063|NCT01392326|536475924|FG002|Overall Study|Adverse Event|11|||
148728064|NCT02340221|536475925|FG000|Overall Study|Death|100|||
148728065|NCT02340221|536475926|FG001|Overall Study|Death|197|||
148728066|NCT02340221|536475925|FG000|Overall Study|Withdrawal by Participant|24|||
148728067|NCT02340221|536475926|FG001|Overall Study|Withdrawal by Participant|37|||
148728068|NCT02340221|536475925|FG000|Overall Study|Lost to Follow-up|4|||
148728069|NCT02340221|536475926|FG001|Overall Study|Lost to Follow-up|15|||
148728070|NCT02340221|536475925|FG000|Overall Study|Reason Not Specified|85|||
148728071|NCT02340221|536475926|FG001|Overall Study|Reason Not Specified|165|||
148728072|NCT02340221|536475925|FG000|Overall Study|Study Terminated by Sponsor|1|||
148728073|NCT02340221|536475926|FG001|Overall Study|Study Terminated by Sponsor|3|||
148728074|NCT00518622|536475927|FG000|Overall Study|Lost to Follow-up|0|||
148728075|NCT00518622|536475928|FG001|Overall Study|Lost to Follow-up|0|||
148728076|NCT00518622|536475929|FG002|Overall Study|Lost to Follow-up|1|||
148728077|NCT00518622|536475930|FG003|Overall Study|Lost to Follow-up|0|||
148728078|NCT00518622|536475931|FG004|Overall Study|Lost to Follow-up|0|||
148728079|NCT00518622|536475932|FG005|Overall Study|Lost to Follow-up|0|||
148728080|NCT00518622|536475933|FG006|Overall Study|Lost to Follow-up|0|||
148728081|NCT00518622|536475934|FG007|Overall Study|Lost to Follow-up|0|||
148728082|NCT00518622|536475927|FG000|Overall Study|Study medication taken incorrectly|0|||
148728083|NCT00518622|536475928|FG001|Overall Study|Study medication taken incorrectly|1|||
148728084|NCT00518622|536475929|FG002|Overall Study|Study medication taken incorrectly|0|||
148728085|NCT00518622|536475930|FG003|Overall Study|Study medication taken incorrectly|0|||
148728086|NCT00518622|536475931|FG004|Overall Study|Study medication taken incorrectly|0|||
148728087|NCT00518622|536475932|FG005|Overall Study|Study medication taken incorrectly|0|||
148728088|NCT00518622|536475933|FG006|Overall Study|Study medication taken incorrectly|0|||
148728089|NCT00518622|536475934|FG007|Overall Study|Study medication taken incorrectly|0|||
148728090|NCT03487848|536475935|FG000|Overall Study|Lost to Follow-up|1|||
148728091|NCT00094094|536475936|FG000|Overall Study|Death|2|||
148728092|NCT00094094|536475936|FG000|Overall Study|Lack of Efficacy|23|||
148728093|NCT00094094|536475936|FG000|Overall Study|Adverse Event|7|||
148728094|NCT06029959|536477820|FG000|Overall Study|Physician Decision|6|||
148728095|NCT00003138|536477821|FG000|Step 1|Reasons off treatment not documented|60|||
148728096|NCT00003138|536477822|FG001|Step 1|Reasons off treatment not documented|57|||
148728097|NCT00003138|536477821|FG000|Step 1|Never started treatment|1|||
148728098|NCT00003138|536477822|FG001|Step 1|Never started treatment|0|||
148728099|NCT00003138|536477821|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
148728100|NCT00003138|536477822|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
148728101|NCT00003138|536477821|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
148728102|NCT00003138|536477822|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
148728103|NCT00003138|536477821|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
148728104|NCT00003138|536477822|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
148728105|NCT00003138|536477821|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
148728106|NCT00003138|536477822|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
148728107|NCT04495283|536477823|FG000|Overall Study|Physician Decision|0|||
148728108|NCT04495283|536477824|FG001|Overall Study|Physician Decision|0|||
148728109|NCT04495283|536477825|FG002|Overall Study|Physician Decision|1|||
148728110|NCT04495283|536477823|FG000|Overall Study|Withdrawal by Subject|0|||
148728111|NCT04495283|536477824|FG001|Overall Study|Withdrawal by Subject|1|||
148728112|NCT04495283|536477825|FG002|Overall Study|Withdrawal by Subject|1|||
148972024|NCT02659020|537381894|FG001|Overall Study|Physician Decision|0|||
148972025|NCT02659020|537381895|FG002|Overall Study|Physician Decision|0|||
148972026|NCT02659020|537381896|FG003|Overall Study|Physician Decision|1|||
148972027|NCT02659020|537381897|FG004|Overall Study|Physician Decision|1|||
148972028|NCT02659020|537381898|FG005|Overall Study|Physician Decision|0|||
148972029|NCT02659020|537381899|FG006|Overall Study|Physician Decision|1|||
149026016|NCT00630539|537571948|FG000|Overall Study|Withdrawal by Subject|0|||
148972030|NCT02659020|537381893|FG000|Overall Study|Withdrawal by Subject|2|||
148728113|NCT04495283|536477823|FG000|Overall Study|Other|1|||
148728114|NCT04495283|536477824|FG001|Overall Study|Other|0|||
148972031|NCT02659020|537381894|FG001|Overall Study|Withdrawal by Subject|1|||
148972032|NCT02659020|537381895|FG002|Overall Study|Withdrawal by Subject|0|||
148728115|NCT04495283|536477825|FG002|Overall Study|Other|1|||
148728116|NCT02631876|536477828|FG000|Overall Study|Death|96|||
148728117|NCT02631876|536477829|FG001|Overall Study|Death|50|||
148728118|NCT02631876|536477828|FG000|Overall Study|Investigator's discretion|1|||
148728119|NCT02631876|536477829|FG001|Overall Study|Investigator's discretion|0|||
148728120|NCT02631876|536477828|FG000|Overall Study|Lost to Follow-up|2|||
148728121|NCT02631876|536477829|FG001|Overall Study|Lost to Follow-up|0|||
148728122|NCT02631876|536477828|FG000|Overall Study|Withdrawal by Subject|16|||
148728123|NCT02631876|536477829|FG001|Overall Study|Withdrawal by Subject|9|||
148728124|NCT02631876|536477828|FG000|Overall Study|Other than specified|4|||
148728125|NCT02631876|536477829|FG001|Overall Study|Other than specified|4|||
148728126|NCT01013649|536477832|FG000|First Step|Withdrawal by Subject|36|||
148728127|NCT01013649|536477833|FG001|First Step|Withdrawal by Subject|19|||
148728128|NCT01013649|536477834|FG002|First Step|Withdrawal by Subject|0|||
148728129|NCT01013649|536477835|FG003|First Step|Withdrawal by Subject|0|||
148728130|NCT01013649|536477832|FG000|First Step|Progression|58|||
148728131|NCT01013649|536477833|FG001|First Step|Progression|23|||
148728132|NCT01013649|536477834|FG002|First Step|Progression|0|||
148728133|NCT01013649|536477835|FG003|First Step|Progression|0|||
148728134|NCT01013649|536477832|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
148728135|NCT01013649|536477833|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
148728136|NCT01013649|536477834|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
148728137|NCT01013649|536477835|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
148728138|NCT01013649|536477832|FG000|First Step|Death|3|||
148728139|NCT01013649|536477833|FG001|First Step|Death|4|||
148728140|NCT01013649|536477834|FG002|First Step|Death|0|||
148728141|NCT01013649|536477835|FG003|First Step|Death|0|||
148728142|NCT01013649|536477832|FG000|First Step|Adverse Event|9|||
148728143|NCT01013649|536477833|FG001|First Step|Adverse Event|5|||
148728144|NCT01013649|536477834|FG002|First Step|Adverse Event|0|||
148728145|NCT01013649|536477835|FG003|First Step|Adverse Event|0|||
148728146|NCT01013649|536477832|FG000|First Step|Other|4|||
148728147|NCT01013649|536477833|FG001|First Step|Other|6|||
148728148|NCT01013649|536477834|FG002|First Step|Other|0|||
148728149|NCT01013649|536477835|FG003|First Step|Other|0|||
148728150|NCT04285567|536477836|FG000|Overall Study|Death|3|||
148728151|NCT04285567|536477837|FG001|Overall Study|Death|3|||
148728152|NCT04285567|536477836|FG000|Overall Study|Lost to Follow-up|1|||
148728153|NCT04285567|536477837|FG001|Overall Study|Lost to Follow-up|1|||
148728154|NCT04285567|536477836|FG000|Overall Study|Reason Not Specified|1|||
148728155|NCT04285567|536477837|FG001|Overall Study|Reason Not Specified|1|||
148728156|NCT04285567|536477836|FG000|Overall Study|Physician Decision|2|||
148728157|NCT04285567|536477837|FG001|Overall Study|Physician Decision|1|||
148728158|NCT04285567|536477836|FG000|Overall Study|Withdrawal by Subject|2|||
148728159|NCT04285567|536477837|FG001|Overall Study|Withdrawal by Subject|6|||
148728160|NCT04285567|536477836|FG000|Overall Study|Adverse Event|1|||
148728161|NCT04285567|536477837|FG001|Overall Study|Adverse Event|0|||
148728162|NCT04285567|536477836|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
148728163|NCT04285567|536477837|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
148728164|NCT02091141|536477838|FG000|Overall Study|Death|280|||
148728165|NCT02091141|536477839|FG001|Overall Study|Death|118|||
148728166|NCT02091141|536477840|FG002|Overall Study|Death|46|||
148728167|NCT02091141|536477841|FG003|Overall Study|Death|13|||
148728168|NCT02091141|536477842|FG004|Overall Study|Death|31|||
148728169|NCT02091141|536477843|FG005|Overall Study|Death|16|||
148728170|NCT02091141|536477844|FG006|Overall Study|Death|12|||
148728171|NCT02091141|536477838|FG000|Overall Study|Withdrawal by Subject|21|||
148728172|NCT02091141|536477839|FG001|Overall Study|Withdrawal by Subject|13|||
148728173|NCT02091141|536477840|FG002|Overall Study|Withdrawal by Subject|3|||
148728174|NCT02091141|536477841|FG003|Overall Study|Withdrawal by Subject|2|||
148728175|NCT02091141|536477842|FG004|Overall Study|Withdrawal by Subject|2|||
148728176|NCT02091141|536477843|FG005|Overall Study|Withdrawal by Subject|3|||
148728177|NCT02091141|536477844|FG006|Overall Study|Withdrawal by Subject|0|||
148728178|NCT02091141|536477838|FG000|Overall Study|Lost to Follow-up|21|||
148728179|NCT02091141|536477839|FG001|Overall Study|Lost to Follow-up|5|||
148728180|NCT02091141|536477840|FG002|Overall Study|Lost to Follow-up|1|||
149026017|NCT00630539|537571949|FG001|Overall Study|Withdrawal by Subject|1|||
148728181|NCT02091141|536477841|FG003|Overall Study|Lost to Follow-up|0|||
148728182|NCT02091141|536477842|FG004|Overall Study|Lost to Follow-up|1|||
148728183|NCT02091141|536477843|FG005|Overall Study|Lost to Follow-up|2|||
148728184|NCT02091141|536477844|FG006|Overall Study|Lost to Follow-up|0|||
148728185|NCT02091141|536477838|FG000|Overall Study|Reason Not Specified|6|||
148728186|NCT02091141|536477839|FG001|Overall Study|Reason Not Specified|5|||
148728187|NCT02091141|536477840|FG002|Overall Study|Reason Not Specified|2|||
148728188|NCT02091141|536477841|FG003|Overall Study|Reason Not Specified|0|||
148728189|NCT02091141|536477842|FG004|Overall Study|Reason Not Specified|0|||
148728190|NCT02091141|536477843|FG005|Overall Study|Reason Not Specified|0|||
148728191|NCT02091141|536477844|FG006|Overall Study|Reason Not Specified|1|||
148728192|NCT02091141|536477838|FG000|Overall Study|Study Ended by Sponsor|1|||
148728193|NCT02091141|536477839|FG001|Overall Study|Study Ended by Sponsor|9|||
149026018|NCT00630539|537571950|FG002|Overall Study|Withdrawal by Subject|0|||
149026019|NCT00630539|537571951|FG003|Overall Study|Withdrawal by Subject|1|||
149026020|NCT01700530|537571955|FG000|Overall Study|Withdrawal by Subject|0|||
149026021|NCT01700530|537571956|FG001|Overall Study|Withdrawal by Subject|3|||
149026022|NCT01700530|537571957|FG002|Overall Study|Withdrawal by Subject|1|||
149026023|NCT04833855|537571963|FG000|Overall Study|Decision by sponsor|0|||
149026024|NCT04833855|537571964|FG001|Overall Study|Decision by sponsor|1|||
149026025|NCT04833855|537571965|FG002|Overall Study|Decision by sponsor|0|||
149026026|NCT04833855|537571966|FG003|Overall Study|Decision by sponsor|0|||
149026027|NCT04833855|537571963|FG000|Overall Study|Withdrawal by Subject|4|||
149026028|NCT04833855|537571964|FG001|Overall Study|Withdrawal by Subject|1|||
149026029|NCT04833855|537571965|FG002|Overall Study|Withdrawal by Subject|3|||
149026030|NCT04833855|537571966|FG003|Overall Study|Withdrawal by Subject|1|||
149026031|NCT04833855|537571963|FG000|Overall Study|Lost to Follow-up|1|||
149026032|NCT04833855|537571964|FG001|Overall Study|Lost to Follow-up|0|||
149026033|NCT04833855|537571965|FG002|Overall Study|Lost to Follow-up|2|||
149026034|NCT04833855|537571966|FG003|Overall Study|Lost to Follow-up|2|||
149026035|NCT04833855|537571963|FG000|Overall Study|Protocol specified criteria|0|||
149026036|NCT04833855|537571964|FG001|Overall Study|Protocol specified criteria|0|||
149026037|NCT04833855|537571965|FG002|Overall Study|Protocol specified criteria|2|||
149026038|NCT04833855|537571966|FG003|Overall Study|Protocol specified criteria|1|||
149026039|NCT02806336|537571967|FG000|Overall Study|Physician Decision|1|||
149026040|NCT02806336|537571968|FG001|Overall Study|Physician Decision|0|||
149026041|NCT02806336|537571967|FG000|Overall Study|Withdrawal by Subject|2|||
149026042|NCT02806336|537571968|FG001|Overall Study|Withdrawal by Subject|4|||
149026043|NCT02806336|537571967|FG000|Overall Study|COVID-19 research shut down|3|||
149026044|NCT02806336|537571968|FG001|Overall Study|COVID-19 research shut down|4|||
149026045|NCT02806336|537571967|FG000|Overall Study|Lack of Efficacy|0|||
149026046|NCT02806336|537571968|FG001|Overall Study|Lack of Efficacy|1|||
149026047|NCT02338609|537571972|FG000|Overall Study|Physician Decision|1|||
149026048|NCT02338609|537571972|FG000|Overall Study|Death|1|||
149026049|NCT05705167|537571973|FG000|Overall Study|Randomised but not Treated|0|||
149026050|NCT05705167|537571974|FG001|Overall Study|Randomised but not Treated|2|||
149026051|NCT05705167|537571975|FG002|Overall Study|Randomised but not Treated|0|||
149026052|NCT05705167|537571976|FG003|Overall Study|Randomised but not Treated|7|||
149026053|NCT05705167|537571977|FG004|Overall Study|Randomised but not Treated|0|||
149026054|NCT05705167|537571978|FG005|Overall Study|Randomised but not Treated|0|||
149026055|NCT05705167|537571979|FG006|Overall Study|Randomised but not Treated|0|||
149026056|NCT05705167|537571973|FG000|Overall Study|Death|0|||
149026057|NCT05705167|537571974|FG001|Overall Study|Death|0|||
149026058|NCT05705167|537571975|FG002|Overall Study|Death|3|||
149026059|NCT05705167|537571976|FG003|Overall Study|Death|0|||
149026060|NCT05705167|537571977|FG004|Overall Study|Death|1|||
149026061|NCT05705167|537571978|FG005|Overall Study|Death|1|||
149026062|NCT05705167|537571979|FG006|Overall Study|Death|1|||
149026063|NCT05705167|537571973|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
149026064|NCT05705167|537571974|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
149026065|NCT05705167|537571975|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
149026066|NCT05705167|537571976|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
149026067|NCT05705167|537571977|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
149026068|NCT05705167|537571978|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
149026069|NCT05705167|537571979|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
149026070|NCT02099539|537571982|FG000|Overall Study|Progressive Disease|3|||
149026071|NCT02099539|537571983|FG001|Overall Study|Progressive Disease|2|||
149026072|NCT02099539|537571984|FG002|Overall Study|Progressive Disease|2|||
149026073|NCT02099539|537571985|FG003|Overall Study|Progressive Disease|1|||
149026074|NCT02099539|537571986|FG004|Overall Study|Progressive Disease|4|||
149026075|NCT02099539|537571987|FG005|Overall Study|Progressive Disease|2|||
148728194|NCT02091141|536477840|FG002|Overall Study|Study Ended by Sponsor|0|||
148728195|NCT02091141|536477841|FG003|Overall Study|Study Ended by Sponsor|0|||
148728196|NCT02091141|536477842|FG004|Overall Study|Study Ended by Sponsor|0|||
148728197|NCT02091141|536477843|FG005|Overall Study|Study Ended by Sponsor|0|||
149026076|NCT02099539|537571988|FG006|Overall Study|Progressive Disease|0|||
149026077|NCT02099539|537571982|FG000|Overall Study|Adverse Event|0|||
149026078|NCT02099539|537571983|FG001|Overall Study|Adverse Event|0|||
149026079|NCT02099539|537571984|FG002|Overall Study|Adverse Event|1|||
149026080|NCT02099539|537571985|FG003|Overall Study|Adverse Event|1|||
149026081|NCT02099539|537571986|FG004|Overall Study|Adverse Event|0|||
149026082|NCT02099539|537571987|FG005|Overall Study|Adverse Event|0|||
149026083|NCT02099539|537571988|FG006|Overall Study|Adverse Event|0|||
149026084|NCT02099539|537571982|FG000|Overall Study|Physician Decision|0|||
149026085|NCT02099539|537571983|FG001|Overall Study|Physician Decision|0|||
149026086|NCT02099539|537571984|FG002|Overall Study|Physician Decision|0|||
149026087|NCT02099539|537571985|FG003|Overall Study|Physician Decision|0|||
149026088|NCT02099539|537571986|FG004|Overall Study|Physician Decision|0|||
149026089|NCT02099539|537571987|FG005|Overall Study|Physician Decision|1|||
148817192|NCT03369223|536805393|FG006|Overall Study|Disease progression|4|||
149026090|NCT02099539|537571988|FG006|Overall Study|Physician Decision|0|||
148728198|NCT02091141|536477844|FG006|Overall Study|Study Ended by Sponsor|0|||
148728199|NCT02091141|536477838|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
148728200|NCT02091141|536477839|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
148728201|NCT02091141|536477840|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
148728202|NCT02091141|536477841|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
148728203|NCT02091141|536477842|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
148728204|NCT02091141|536477843|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
148728205|NCT02091141|536477844|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
148728206|NCT04271735|536477845|FG000|Overall Study|Physician Decision|2|||
148728207|NCT04271735|536477846|FG001|Overall Study|Physician Decision|0|||
148728208|NCT00931268|536477849|FG000|Overall Study|Lost to Follow-up|6|||
148728209|NCT02072148|536477850|FG000|Overall Study|withdrew prior to surgery|23|||
148728210|NCT02072148|536477851|FG001|Overall Study|withdrew prior to surgery|0|||
148728211|NCT02072148|536477852|FG002|Overall Study|withdrew prior to surgery|0|||
148728212|NCT02072148|536477850|FG000|Overall Study|Death|0|||
148728213|NCT02072148|536477851|FG001|Overall Study|Death|0|||
148728214|NCT02072148|536477852|FG002|Overall Study|Death|1|||
148728215|NCT02072148|536477850|FG000|Overall Study|Withdrawal by Subject|0|||
148728216|NCT02072148|536477851|FG001|Overall Study|Withdrawal by Subject|13|||
148728217|NCT02072148|536477852|FG002|Overall Study|Withdrawal by Subject|12|||
148728218|NCT00430495|536477854|FG000|Overall Study|Adverse Event|2|||
148728219|NCT00430495|536477855|FG001|Overall Study|Adverse Event|3|||
148728220|NCT00430495|536477856|FG002|Overall Study|Adverse Event|2|||
148728221|NCT00430495|536477857|FG003|Overall Study|Adverse Event|0|||
148728222|NCT00430495|536477854|FG000|Overall Study|Death|0|||
148728223|NCT00430495|536477855|FG001|Overall Study|Death|0|||
148728224|NCT00430495|536477856|FG002|Overall Study|Death|1|||
148728225|NCT00430495|536477857|FG003|Overall Study|Death|0|||
148728226|NCT00430495|536477854|FG000|Overall Study|Lost to Follow-up|0|||
148728227|NCT00430495|536477855|FG001|Overall Study|Lost to Follow-up|1|||
148728228|NCT00430495|536477856|FG002|Overall Study|Lost to Follow-up|4|||
148728229|NCT00430495|536477857|FG003|Overall Study|Lost to Follow-up|0|||
148728230|NCT00430495|536477854|FG000|Overall Study|Protocol Violation|1|||
148728231|NCT00430495|536477855|FG001|Overall Study|Protocol Violation|0|||
148728232|NCT00430495|536477856|FG002|Overall Study|Protocol Violation|1|||
148728233|NCT00430495|536477857|FG003|Overall Study|Protocol Violation|0|||
148728234|NCT00430495|536477854|FG000|Overall Study|Disease Progression|1|||
148728235|NCT00430495|536477855|FG001|Overall Study|Disease Progression|1|||
148728236|NCT00430495|536477856|FG002|Overall Study|Disease Progression|0|||
148728237|NCT00430495|536477857|FG003|Overall Study|Disease Progression|0|||
148728238|NCT00430495|536477854|FG000|Overall Study|Other|8|||
148728239|NCT00430495|536477855|FG001|Overall Study|Other|2|||
148728240|NCT00430495|536477856|FG002|Overall Study|Other|5|||
148728241|NCT00430495|536477857|FG003|Overall Study|Other|4|||
148728242|NCT00430495|536477854|FG000|Overall Study|Randomized but not Treated|2|||
148728243|NCT00430495|536477855|FG001|Overall Study|Randomized but not Treated|0|||
148728244|NCT00430495|536477856|FG002|Overall Study|Randomized but not Treated|0|||
148728245|NCT00430495|536477857|FG003|Overall Study|Randomized but not Treated|0|||
148728246|NCT00158756|536477858|FG000|Overall Study|Withdrawal by Subject|5|||
148728247|NCT00158756|536477859|FG001|Overall Study|Withdrawal by Subject|0|||
148728248|NCT00158756|536477860|FG002|Overall Study|Withdrawal by Subject|6|||
148728249|NCT00158756|536477861|FG003|Overall Study|Withdrawal by Subject|1|||
148728250|NCT00158756|536477862|FG004|Overall Study|Withdrawal by Subject|3|||
148728251|NCT00158756|536477858|FG000|Overall Study|Adverse Event|0|||
148728252|NCT00158756|536477859|FG001|Overall Study|Adverse Event|0|||
148728253|NCT00158756|536477860|FG002|Overall Study|Adverse Event|1|||
148728254|NCT00158756|536477861|FG003|Overall Study|Adverse Event|0|||
148728255|NCT00158756|536477862|FG004|Overall Study|Adverse Event|0|||
148728256|NCT00158756|536477858|FG000|Overall Study|Serious adverse event|0|||
148728257|NCT00158756|536477859|FG001|Overall Study|Serious adverse event|0|||
148728258|NCT00158756|536477860|FG002|Overall Study|Serious adverse event|1|||
148728259|NCT00158756|536477861|FG003|Overall Study|Serious adverse event|0|||
148728260|NCT00158756|536477862|FG004|Overall Study|Serious adverse event|0|||
148728261|NCT02400671|536477863|FG000|Overall Study|Death|5|||
148728262|NCT02400671|536477864|FG001|Overall Study|Death|3|||
148728263|NCT02400671|536477865|FG002|Overall Study|Death|4|||
148728264|NCT02400671|536477863|FG000|Overall Study|Lost to Follow-up|20|||
148728265|NCT02400671|536477864|FG001|Overall Study|Lost to Follow-up|27|||
148728266|NCT02400671|536477865|FG002|Overall Study|Lost to Follow-up|24|||
148728267|NCT02400671|536477863|FG000|Overall Study|Withdrawal by Subject|2|||
148728268|NCT02400671|536477864|FG001|Overall Study|Withdrawal by Subject|2|||
148728269|NCT02400671|536477865|FG002|Overall Study|Withdrawal by Subject|0|||
148728270|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
148728271|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
148728272|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
148728273|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
148728274|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
148728275|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
148728276|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
148728277|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
148728278|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
148728279|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
148728280|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
148728281|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
148728282|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
148728283|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
148728284|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
148728285|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
148728286|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
148728287|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
148728288|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
148728289|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
148728290|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
148728291|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
148728292|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
148728293|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
148728294|NCT01421342|536477866|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
148728295|NCT01421342|536477867|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
148728296|NCT01421342|536477868|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
148728297|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
148728298|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
148728299|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
148728300|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
148728301|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
148728302|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
148728303|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
148728304|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
148728305|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
148728306|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
148728307|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
148728308|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
148728309|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
148728310|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
148728311|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
148728312|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
148728313|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
148728314|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
148728315|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
148728316|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
148728317|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
148728318|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
148728319|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
148728320|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
148728321|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
148728322|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
148728323|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
148728324|NCT01421342|536477866|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
148728325|NCT01421342|536477867|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
148728326|NCT01421342|536477868|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
148728327|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
148728328|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
148728329|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
148728330|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
148728331|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
148728332|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
148728333|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
148728334|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
148728335|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
148728336|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
148728337|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
148728338|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
148817193|NCT03369223|536805394|FG007|Overall Study|Disease progression|6|||
148728339|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
148728340|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
148728341|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
148728342|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
148728343|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
148728344|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
149026091|NCT03473756|537571990|FG000|Overall Study|Withdrawal by Subject|1|||
149026092|NCT03473756|537571991|FG001|Overall Study|Withdrawal by Subject|4|||
149026093|NCT03473756|537571990|FG000|Overall Study|Adverse Event|6|||
149026094|NCT03473756|537571991|FG001|Overall Study|Adverse Event|7|||
149026095|NCT03473756|537571990|FG000|Overall Study|Lack of Efficacy|3|||
148728345|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
148728346|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
148728347|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
148728348|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
148728349|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
148728350|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
148728351|NCT01421342|536477866|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
148728352|NCT01421342|536477867|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
148728353|NCT01421342|536477868|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
148728354|NCT03656874|536477871|FG000|Overall Study|Lost to Follow-up|3|||
148728355|NCT03656874|536477872|FG001|Overall Study|Lost to Follow-up|17|||
148728356|NCT03052322|536477874|FG000|Overall Study|Other un-specified|1|||
148728357|NCT03052322|536477875|FG001|Overall Study|Other un-specified|2|||
148728358|NCT03052322|536477874|FG000|Overall Study|Withdrawal by Subject|10|||
148728359|NCT03052322|536477875|FG001|Overall Study|Withdrawal by Subject|9|||
148728360|NCT03052322|536477874|FG000|Overall Study|Death|0|||
148728361|NCT03052322|536477875|FG001|Overall Study|Death|2|||
148728362|NCT03052322|536477874|FG000|Overall Study|Lack of Efficacy|1|||
148728363|NCT03052322|536477875|FG001|Overall Study|Lack of Efficacy|2|||
148728364|NCT03052322|536477874|FG000|Overall Study|Protocol Violation|1|||
148728365|NCT03052322|536477875|FG001|Overall Study|Protocol Violation|0|||
148728366|NCT03052322|536477874|FG000|Overall Study|Lost to Follow-up|2|||
148728367|NCT03052322|536477875|FG001|Overall Study|Lost to Follow-up|4|||
148728368|NCT03052322|536477874|FG000|Overall Study|Adverse Event|6|||
148728369|NCT03052322|536477875|FG001|Overall Study|Adverse Event|13|||
148728370|NCT00973765|536477876|FG000|Overall Study|Lost to Follow-up|8|||
148728371|NCT00973765|536477877|FG001|Overall Study|Lost to Follow-up|14|||
148728372|NCT01892657|536477880|FG000|Overall Study|Withdrawal by Subject|6|||
148728373|NCT01892657|536477880|FG000|Overall Study|Protocol Violation|12|||
148728374|NCT02712333|536477884|FG000|First Period|Withdrawal by Subject|3|||
148728375|NCT02712333|536477885|FG001|First Period|Withdrawal by Subject|2|||
148728376|NCT03463993|536477886|FG000|Overall Study|Lost to Follow-up|7|||
148728377|NCT03463993|536477887|FG001|Overall Study|Lost to Follow-up|8|||
148728378|NCT03463993|536477886|FG000|Overall Study|Withdrawal by Subject|2|||
148728379|NCT03463993|536477887|FG001|Overall Study|Withdrawal by Subject|0|||
148728380|NCT03463993|536477886|FG000|Overall Study|Protocol Violation|4|||
148728381|NCT03463993|536477887|FG001|Overall Study|Protocol Violation|1|||
148728382|NCT03463993|536477886|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
148728383|NCT03463993|536477887|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
148728384|NCT03463993|536477886|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
148728385|NCT03463993|536477887|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
148728386|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
148728387|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
148728388|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
148728389|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
148728390|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
148728391|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
148728392|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
148728393|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
148728394|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
148728395|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
148728396|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Subject decision|1|||
149026096|NCT03473756|537571991|FG001|Overall Study|Lack of Efficacy|10|||
148728397|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Subject decision|1|||
148728398|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
148728399|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
148728400|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
148728401|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
148728402|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
148728403|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
148728404|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
148728405|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
148728406|NCT00518882|536477894|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
148728407|NCT00518882|536477895|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
148728408|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
148728409|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
148728410|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
148728411|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
148728412|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
148728413|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
148728414|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
148728415|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
148728416|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
148728417|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
148728418|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
148728419|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
148728420|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
148728421|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
148728422|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
148728423|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
148728424|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
148728425|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
148728426|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
148728427|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
148728428|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
148728429|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
148728430|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
148728431|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
148728432|NCT00518882|536477894|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
148728433|NCT00518882|536477895|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
148728434|NCT02696031|536477897|FG000|Up to Week 24|Adverse Event|2|||
148728435|NCT02696031|536477898|FG001|Up to Week 24|Adverse Event|4|||
148728436|NCT02696031|536477899|FG002|Up to Week 24|Adverse Event|2|||
148728437|NCT02696031|536477900|FG003|Up to Week 24|Adverse Event|0|||
148728438|NCT02696031|536477901|FG004|Up to Week 24|Adverse Event|0|||
148728439|NCT02696031|536477902|FG005|Up to Week 24|Adverse Event|0|||
148728440|NCT02696031|536477897|FG000|Up to Week 24|Lack of Efficacy|2|||
148728441|NCT02696031|536477898|FG001|Up to Week 24|Lack of Efficacy|1|||
148728442|NCT02696031|536477899|FG002|Up to Week 24|Lack of Efficacy|2|||
148728443|NCT02696031|536477900|FG003|Up to Week 24|Lack of Efficacy|0|||
148728444|NCT02696031|536477901|FG004|Up to Week 24|Lack of Efficacy|0|||
148728445|NCT02696031|536477902|FG005|Up to Week 24|Lack of Efficacy|0|||
148728446|NCT02696031|536477897|FG000|Up to Week 24|Lost to Follow-up|0|||
148728447|NCT02696031|536477898|FG001|Up to Week 24|Lost to Follow-up|1|||
148728448|NCT02696031|536477899|FG002|Up to Week 24|Lost to Follow-up|1|||
148728449|NCT02696031|536477900|FG003|Up to Week 24|Lost to Follow-up|0|||
148728450|NCT02696031|536477901|FG004|Up to Week 24|Lost to Follow-up|0|||
148728451|NCT02696031|536477902|FG005|Up to Week 24|Lost to Follow-up|0|||
148728452|NCT02696031|536477897|FG000|Up to Week 24|Physician Decision|1|||
148728453|NCT02696031|536477898|FG001|Up to Week 24|Physician Decision|0|||
148728454|NCT02696031|536477899|FG002|Up to Week 24|Physician Decision|1|||
148728455|NCT02696031|536477900|FG003|Up to Week 24|Physician Decision|0|||
148728456|NCT02696031|536477901|FG004|Up to Week 24|Physician Decision|0|||
148728457|NCT02696031|536477902|FG005|Up to Week 24|Physician Decision|0|||
148728458|NCT02696031|536477897|FG000|Up to Week 24|Protocol Violation|1|||
148728459|NCT02696031|536477898|FG001|Up to Week 24|Protocol Violation|0|||
148728460|NCT02696031|536477899|FG002|Up to Week 24|Protocol Violation|0|||
148728461|NCT02696031|536477900|FG003|Up to Week 24|Protocol Violation|0|||
148728462|NCT02696031|536477901|FG004|Up to Week 24|Protocol Violation|0|||
148728463|NCT02696031|536477902|FG005|Up to Week 24|Protocol Violation|0|||
148728464|NCT02696031|536477897|FG000|Up to Week 24|Withdrawal by Subject|4|||
148728465|NCT02696031|536477898|FG001|Up to Week 24|Withdrawal by Subject|1|||
148728466|NCT02696031|536477899|FG002|Up to Week 24|Withdrawal by Subject|5|||
148728467|NCT02696031|536477900|FG003|Up to Week 24|Withdrawal by Subject|0|||
148728468|NCT02696031|536477901|FG004|Up to Week 24|Withdrawal by Subject|0|||
148728469|NCT02696031|536477902|FG005|Up to Week 24|Withdrawal by Subject|0|||
148728470|NCT02696031|536477897|FG000|Up to Week 52|Adverse Event|4|||
148728471|NCT02696031|536477898|FG001|Up to Week 52|Adverse Event|5|||
148728472|NCT02696031|536477899|FG002|Up to Week 52|Adverse Event|3|||
148728473|NCT02696031|536477900|FG003|Up to Week 52|Adverse Event|0|||
148728474|NCT02696031|536477901|FG004|Up to Week 52|Adverse Event|0|||
148728475|NCT02696031|536477902|FG005|Up to Week 52|Adverse Event|0|||
148728476|NCT02696031|536477897|FG000|Up to Week 52|Lack of Efficacy|10|||
149026097|NCT03473756|537571990|FG000|Overall Study|Physician Decision|0|||
148728477|NCT02696031|536477898|FG001|Up to Week 52|Lack of Efficacy|7|||
148728478|NCT02696031|536477899|FG002|Up to Week 52|Lack of Efficacy|11|||
148728479|NCT02696031|536477900|FG003|Up to Week 52|Lack of Efficacy|0|||
148728480|NCT02696031|536477901|FG004|Up to Week 52|Lack of Efficacy|0|||
148728481|NCT02696031|536477902|FG005|Up to Week 52|Lack of Efficacy|0|||
148728482|NCT02696031|536477897|FG000|Up to Week 52|Lost to Follow-up|1|||
148728483|NCT02696031|536477898|FG001|Up to Week 52|Lost to Follow-up|1|||
148728484|NCT02696031|536477899|FG002|Up to Week 52|Lost to Follow-up|1|||
148728485|NCT02696031|536477900|FG003|Up to Week 52|Lost to Follow-up|0|||
148728486|NCT02696031|536477901|FG004|Up to Week 52|Lost to Follow-up|0|||
148728487|NCT02696031|536477902|FG005|Up to Week 52|Lost to Follow-up|0|||
148728488|NCT02696031|536477897|FG000|Up to Week 52|Physician Decision|1|||
148728489|NCT02696031|536477898|FG001|Up to Week 52|Physician Decision|1|||
148728490|NCT02696031|536477899|FG002|Up to Week 52|Physician Decision|2|||
148728491|NCT02696031|536477900|FG003|Up to Week 52|Physician Decision|0|||
148728492|NCT02696031|536477901|FG004|Up to Week 52|Physician Decision|0|||
148728493|NCT02696031|536477902|FG005|Up to Week 52|Physician Decision|0|||
148728494|NCT02696031|536477897|FG000|Up to Week 52|Pregnancy|0|||
148728495|NCT02696031|536477898|FG001|Up to Week 52|Pregnancy|2|||
148728496|NCT02696031|536477899|FG002|Up to Week 52|Pregnancy|0|||
148728497|NCT02696031|536477900|FG003|Up to Week 52|Pregnancy|0|||
148728498|NCT02696031|536477901|FG004|Up to Week 52|Pregnancy|0|||
148728499|NCT02696031|536477902|FG005|Up to Week 52|Pregnancy|0|||
148728500|NCT02696031|536477897|FG000|Up to Week 52|Protocol Violation|1|||
148728501|NCT02696031|536477898|FG001|Up to Week 52|Protocol Violation|0|||
148728502|NCT02696031|536477899|FG002|Up to Week 52|Protocol Violation|0|||
148728503|NCT02696031|536477900|FG003|Up to Week 52|Protocol Violation|0|||
148728504|NCT02696031|536477901|FG004|Up to Week 52|Protocol Violation|0|||
148728505|NCT02696031|536477902|FG005|Up to Week 52|Protocol Violation|0|||
148728506|NCT02696031|536477897|FG000|Up to Week 52|Withdrawal by Subject|12|||
148728507|NCT02696031|536477898|FG001|Up to Week 52|Withdrawal by Subject|3|||
148728508|NCT02696031|536477899|FG002|Up to Week 52|Withdrawal by Subject|9|||
148728509|NCT02696031|536477900|FG003|Up to Week 52|Withdrawal by Subject|0|||
148728510|NCT02696031|536477901|FG004|Up to Week 52|Withdrawal by Subject|0|||
148728511|NCT02696031|536477902|FG005|Up to Week 52|Withdrawal by Subject|0|||
148728512|NCT02696031|536477897|FG000|Up to Week 104|Pregnancy|0|||
148728513|NCT02696031|536477898|FG001|Up to Week 104|Pregnancy|2|||
148728514|NCT02696031|536477899|FG002|Up to Week 104|Pregnancy|1|||
148728515|NCT02696031|536477900|FG003|Up to Week 104|Pregnancy|0|||
148728516|NCT02696031|536477901|FG004|Up to Week 104|Pregnancy|0|||
148728517|NCT02696031|536477902|FG005|Up to Week 104|Pregnancy|0|||
148728518|NCT02696031|536477897|FG000|Up to Week 104|Withdrawal by Subject|15|||
148728519|NCT02696031|536477898|FG001|Up to Week 104|Withdrawal by Subject|10|||
148728520|NCT02696031|536477899|FG002|Up to Week 104|Withdrawal by Subject|16|||
148728521|NCT02696031|536477900|FG003|Up to Week 104|Withdrawal by Subject|0|||
148728522|NCT02696031|536477901|FG004|Up to Week 104|Withdrawal by Subject|0|||
148728523|NCT02696031|536477902|FG005|Up to Week 104|Withdrawal by Subject|0|||
148728524|NCT02696031|536477897|FG000|Up to Week 104|Protocol Violation|1|||
148728525|NCT02696031|536477898|FG001|Up to Week 104|Protocol Violation|0|||
148728526|NCT02696031|536477899|FG002|Up to Week 104|Protocol Violation|0|||
148728527|NCT02696031|536477900|FG003|Up to Week 104|Protocol Violation|0|||
148728528|NCT02696031|536477901|FG004|Up to Week 104|Protocol Violation|0|||
148728529|NCT02696031|536477902|FG005|Up to Week 104|Protocol Violation|0|||
148728530|NCT02696031|536477897|FG000|Up to Week 104|Physician Decision|1|||
148728531|NCT02696031|536477898|FG001|Up to Week 104|Physician Decision|2|||
148728532|NCT02696031|536477899|FG002|Up to Week 104|Physician Decision|3|||
148728533|NCT02696031|536477900|FG003|Up to Week 104|Physician Decision|0|||
148728534|NCT02696031|536477901|FG004|Up to Week 104|Physician Decision|0|||
148728535|NCT02696031|536477902|FG005|Up to Week 104|Physician Decision|0|||
148728536|NCT02696031|536477897|FG000|Up to Week 104|Lost to Follow-up|2|||
148728537|NCT02696031|536477898|FG001|Up to Week 104|Lost to Follow-up|3|||
148728538|NCT02696031|536477899|FG002|Up to Week 104|Lost to Follow-up|1|||
148817194|NCT03369223|536805395|FG008|Overall Study|Disease progression|10|||
148817195|NCT03369223|536805396|FG009|Overall Study|Disease progression|7|||
148728539|NCT02696031|536477900|FG003|Up to Week 104|Lost to Follow-up|0|||
148728540|NCT02696031|536477901|FG004|Up to Week 104|Lost to Follow-up|0|||
148728541|NCT02696031|536477902|FG005|Up to Week 104|Lost to Follow-up|0|||
148728542|NCT02696031|536477897|FG000|Up to Week 104|Lack of Efficacy|13|||
148817196|NCT03369223|536805397|FG010|Overall Study|Disease progression|4|||
148728543|NCT02696031|536477898|FG001|Up to Week 104|Lack of Efficacy|12|||
148728544|NCT02696031|536477899|FG002|Up to Week 104|Lack of Efficacy|11|||
148728545|NCT02696031|536477900|FG003|Up to Week 104|Lack of Efficacy|0|||
148728546|NCT02696031|536477901|FG004|Up to Week 104|Lack of Efficacy|0|||
148728547|NCT02696031|536477902|FG005|Up to Week 104|Lack of Efficacy|0|||
148728548|NCT02696031|536477897|FG000|Up to Week 104|Adverse Event|7|||
148728549|NCT02696031|536477898|FG001|Up to Week 104|Adverse Event|11|||
148728550|NCT02696031|536477899|FG002|Up to Week 104|Adverse Event|5|||
148728551|NCT02696031|536477900|FG003|Up to Week 104|Adverse Event|0|||
148728552|NCT02696031|536477901|FG004|Up to Week 104|Adverse Event|0|||
148728553|NCT02696031|536477902|FG005|Up to Week 104|Adverse Event|0|||
148728554|NCT02696031|536477897|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
148817197|NCT03369223|536805398|FG011|Overall Study|Disease progression|1|||
148728555|NCT02696031|536477898|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
148728556|NCT02696031|536477899|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
148728557|NCT02696031|536477900|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
148728558|NCT02696031|536477901|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
148728559|NCT02696031|536477902|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
148728560|NCT02696031|536477897|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
148728561|NCT02696031|536477898|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
148728562|NCT02696031|536477899|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
148728563|NCT02696031|536477900|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
148728564|NCT02696031|536477901|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
148728565|NCT02696031|536477902|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
148728566|NCT02696031|536477897|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
148728567|NCT02696031|536477898|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
148728568|NCT02696031|536477899|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
148728569|NCT02696031|536477900|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
148728570|NCT02696031|536477901|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
148728571|NCT02696031|536477902|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
148728572|NCT02696031|536477897|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
148728573|NCT02696031|536477898|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
148728574|NCT02696031|536477899|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
148728575|NCT02696031|536477900|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
148728576|NCT02696031|536477901|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
148728577|NCT02696031|536477902|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
148728578|NCT02696031|536477897|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
148728579|NCT02696031|536477898|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
148728580|NCT02696031|536477899|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
148728581|NCT02696031|536477900|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
148728582|NCT02696031|536477901|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
148728583|NCT02696031|536477902|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
148728584|NCT02696031|536477897|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
148728585|NCT02696031|536477898|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
148728586|NCT02696031|536477899|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
148728587|NCT02696031|536477900|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
148728588|NCT02696031|536477901|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
148728589|NCT02696031|536477902|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
148728590|NCT02696031|536477897|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
148728591|NCT02696031|536477898|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
148728592|NCT02696031|536477899|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
148728593|NCT02696031|536477900|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
148728594|NCT02696031|536477901|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
148728595|NCT02696031|536477902|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
148728596|NCT02903238|536477906|FG000|Overall Study|Lost to Follow-up|4|||
148728597|NCT00700817|536477909|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
148728598|NCT00700817|536477910|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
148728599|NCT00700817|536477911|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
148728600|NCT00700817|536477912|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
148728601|NCT00700817|536477913|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
148728602|NCT00700817|536477909|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
148728603|NCT00700817|536477910|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
148728604|NCT00700817|536477911|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
148728605|NCT00700817|536477912|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
148728606|NCT00700817|536477913|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
148728607|NCT00700817|536477909|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
148728608|NCT00700817|536477910|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
148728609|NCT00700817|536477911|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
148728610|NCT00700817|536477912|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
148728611|NCT00700817|536477913|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
148728612|NCT00700817|536477909|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
148728613|NCT00700817|536477910|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
148728614|NCT00700817|536477911|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
148728615|NCT00700817|536477912|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
148728616|NCT00700817|536477913|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
148728617|NCT00700817|536477909|FG000|Week 0-26 (Main Period)|Unclassified|14|||
148728618|NCT00700817|536477910|FG001|Week 0-26 (Main Period)|Unclassified|4|||
148728619|NCT00700817|536477911|FG002|Week 0-26 (Main Period)|Unclassified|8|||
148728620|NCT00700817|536477912|FG003|Week 0-26 (Main Period)|Unclassified|0|||
149026098|NCT03473756|537571991|FG001|Overall Study|Physician Decision|2|||
149026099|NCT03473756|537571990|FG000|Overall Study|End of study treatment|0|||
149026100|NCT03473756|537571991|FG001|Overall Study|End of study treatment|2|||
149026101|NCT03473756|537571990|FG000|Overall Study|Lost to Follow-up|0|||
149026102|NCT03473756|537571991|FG001|Overall Study|Lost to Follow-up|1|||
149026103|NCT03714022|537571992|FG000|Overall Study|Adverse Event|1|||
149026104|NCT03714022|537571993|FG001|Overall Study|Adverse Event|0|||
149026105|NCT03714022|537571992|FG000|Overall Study|Consent withdrawal|0|||
149026106|NCT03714022|537571993|FG001|Overall Study|Consent withdrawal|1|||
149026107|NCT03714022|537571992|FG000|Overall Study|Lost to Follow-up|3|||
149026108|NCT03714022|537571993|FG001|Overall Study|Lost to Follow-up|2|||
149026109|NCT02148718|537571994|FG000|Overall Study|Protocol Violation|26|||
149026110|NCT02148718|537571994|FG000|Overall Study|Discontinued Study Prematurely|5|||
149026111|NCT01007552|537571998|FG000|Overall Study|Withdrawal by Subject|1|||
149026112|NCT04482855|537571999|FG000|Overall Study|Lost to Follow-up|1|||
149026113|NCT04482855|537572000|FG001|Overall Study|Lost to Follow-up|0|||
149026114|NCT04482855|537571999|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
149026115|NCT04482855|537572000|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
149026116|NCT04482855|537571999|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
149026117|NCT04482855|537572000|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
149026118|NCT04438785|537572001|FG000|Overall Study|change of weight, give up intervention|2|||
149026119|NCT04438785|537572002|FG001|Overall Study|change of weight, give up intervention|10|||
149026120|NCT02027935|537572003|FG000|Overall Study|Death|1|||
149026121|NCT02027935|537572003|FG000|Overall Study|Lack of Efficacy|5|||
149026122|NCT02027935|537572003|FG000|Overall Study|Study Closure|1|||
149026123|NCT04873817|537572004|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
149026124|NCT04873817|537572004|FG000|Overall Study|Lost to Follow-up|4|||
149026125|NCT04873817|537572004|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
149026126|NCT04873817|537572004|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
149026127|NCT04873817|537572004|FG000|Overall Study|Other Reasons|3|||
149026128|NCT00924560|537572008|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
149026129|NCT00924560|537572009|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
149026130|NCT00924560|537572010|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
149026131|NCT00924560|537572008|FG000|Overall Study|Non Compliance with the Protocol|20|||
149026132|NCT00924560|537572009|FG001|Overall Study|Non Compliance with the Protocol|15|||
149026133|NCT00924560|537572010|FG002|Overall Study|Non Compliance with the Protocol|4|||
149026134|NCT00924560|537572008|FG000|Overall Study|Physician Decision|2|||
149026135|NCT00924560|537572009|FG001|Overall Study|Physician Decision|3|||
149026136|NCT00924560|537572010|FG002|Overall Study|Physician Decision|4|||
149026137|NCT00924560|537572008|FG000|Overall Study|Withdrawal by Subject|50|||
149026138|NCT00924560|537572009|FG001|Overall Study|Withdrawal by Subject|44|||
149026139|NCT00924560|537572010|FG002|Overall Study|Withdrawal by Subject|18|||
148728621|NCT00700817|536477913|FG004|Week 0-26 (Main Period)|Unclassified|0|||
148728622|NCT00700817|536477909|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
148728623|NCT00700817|536477910|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
148728624|NCT00700817|536477911|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
148728625|NCT00700817|536477912|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
148728626|NCT00700817|536477913|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
148728627|NCT00700817|536477909|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
148728628|NCT00700817|536477910|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
148728629|NCT00700817|536477911|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
148728630|NCT00700817|536477912|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
148728631|NCT00700817|536477913|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
148728632|NCT00700817|536477909|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
148728633|NCT00700817|536477910|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
148728634|NCT00700817|536477911|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
148728635|NCT00700817|536477912|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
148728636|NCT00700817|536477913|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
148728637|NCT00700817|536477909|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
148728638|NCT00700817|536477910|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
148728639|NCT00700817|536477911|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
149026140|NCT00924560|537572008|FG000|Overall Study|Adverse Event|39|||
149026141|NCT00924560|537572009|FG001|Overall Study|Adverse Event|33|||
149026142|NCT00924560|537572010|FG002|Overall Study|Adverse Event|0|||
149026143|NCT00924560|537572008|FG000|Overall Study|Pregnancy|5|||
149026144|NCT00924560|537572009|FG001|Overall Study|Pregnancy|7|||
149026145|NCT00924560|537572010|FG002|Overall Study|Pregnancy|1|||
149026146|NCT00924560|537572008|FG000|Overall Study|Lost to Follow-up|78|||
148728640|NCT00700817|536477912|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
149026147|NCT00924560|537572009|FG001|Overall Study|Lost to Follow-up|94|||
149026148|NCT00924560|537572010|FG002|Overall Study|Lost to Follow-up|45|||
148728641|NCT00700817|536477913|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
148728642|NCT00700817|536477909|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
148728643|NCT00700817|536477910|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
148728644|NCT00700817|536477911|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
148728645|NCT00700817|536477912|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
148728646|NCT00700817|536477913|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
148728647|NCT00700817|536477909|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
148728648|NCT00700817|536477910|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
148728649|NCT00700817|536477911|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
148728650|NCT00700817|536477912|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
148728651|NCT00700817|536477913|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
148728652|NCT00700817|536477909|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
148728653|NCT00700817|536477910|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
148728654|NCT00700817|536477911|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
148728655|NCT00700817|536477912|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
148728656|NCT00700817|536477913|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
148728657|NCT00700817|536477909|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
148817198|NCT03369223|536805399|FG012|Overall Study|Disease progression|1|||
148817199|NCT03369223|536805400|FG013|Overall Study|Disease progression|25|||
148817200|NCT03369223|536805401|FG014|Overall Study|Disease progression|22|||
148817201|NCT03369223|536805402|FG015|Overall Study|Disease progression|2|||
148817202|NCT03369223|536805403|FG016|Overall Study|Disease progression|10|||
148817203|NCT03369223|536805404|FG017|Overall Study|Disease progression|1|||
148817204|NCT03369223|536805405|FG018|Overall Study|Disease progression|18|||
148817205|NCT03369223|536805406|FG019|Overall Study|Disease progression|28|||
148817206|NCT03369223|536805387|FG000|Overall Study|Study drug toxicity|0|||
148817207|NCT03369223|536805388|FG001|Overall Study|Study drug toxicity|1|||
148728658|NCT00700817|536477910|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
148728659|NCT00700817|536477911|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
148728660|NCT00700817|536477912|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
148728661|NCT00700817|536477913|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
148817208|NCT03369223|536805389|FG002|Overall Study|Study drug toxicity|4|||
148817209|NCT03369223|536805390|FG003|Overall Study|Study drug toxicity|0|||
148728662|NCT00700817|536477909|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
148728663|NCT00700817|536477910|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
148728664|NCT00700817|536477911|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
148728665|NCT00700817|536477912|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
148728666|NCT00700817|536477913|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
148728667|NCT00700817|536477909|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
148728668|NCT00700817|536477910|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
148728669|NCT00700817|536477911|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
148728670|NCT00700817|536477912|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
148728671|NCT00700817|536477913|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
148728672|NCT02777918|536477914|FG000|Overall Study|Medical reasons|1|||
148728673|NCT02777918|536477915|FG001|Overall Study|Medical reasons|2|||
148728674|NCT02777918|536477914|FG000|Overall Study|Too busy / stressed|1|||
148728675|NCT02777918|536477915|FG001|Overall Study|Too busy / stressed|1|||
148728676|NCT02777918|536477914|FG000|Overall Study|Withdrawal by Subject|1|||
148728677|NCT02777918|536477915|FG001|Overall Study|Withdrawal by Subject|1|||
148728678|NCT00757848|536477916|FG000|Overall Study|Voluntary discontinuation|1|||
148728679|NCT00757848|536477917|FG001|Overall Study|Voluntary discontinuation|0|||
148728680|NCT00757848|536477916|FG000|Overall Study|Adverse Event|1|||
148728681|NCT00757848|536477917|FG001|Overall Study|Adverse Event|2|||
148817210|NCT03369223|536805391|FG004|Overall Study|Study drug toxicity|1|||
148817211|NCT03369223|536805392|FG005|Overall Study|Study drug toxicity|2|||
148817212|NCT03369223|536805393|FG006|Overall Study|Study drug toxicity|4|||
148817213|NCT03369223|536805394|FG007|Overall Study|Study drug toxicity|2|||
148817214|NCT03369223|536805395|FG008|Overall Study|Study drug toxicity|2|||
148817215|NCT03369223|536805396|FG009|Overall Study|Study drug toxicity|0|||
148817216|NCT03369223|536805397|FG010|Overall Study|Study drug toxicity|6|||
148817217|NCT03369223|536805398|FG011|Overall Study|Study drug toxicity|1|||
148817218|NCT03369223|536805399|FG012|Overall Study|Study drug toxicity|2|||
148728682|NCT00757848|536477916|FG000|Overall Study|Incorrect enrolment|1|||
148728683|NCT00757848|536477917|FG001|Overall Study|Incorrect enrolment|0|||
148728684|NCT00958126|536477925|FG000|Overall Study|Serious Adverse Event|0|||
148728685|NCT00958126|536477926|FG001|Overall Study|Serious Adverse Event|2|||
148728686|NCT00958126|536477927|FG002|Overall Study|Serious Adverse Event|0|||
148728687|NCT00958126|536477928|FG003|Overall Study|Serious Adverse Event|0|||
148817219|NCT03369223|536805400|FG013|Overall Study|Study drug toxicity|19|||
148817220|NCT03369223|536805401|FG014|Overall Study|Study drug toxicity|19|||
148817221|NCT03369223|536805402|FG015|Overall Study|Study drug toxicity|0|||
148817222|NCT03369223|536805403|FG016|Overall Study|Study drug toxicity|18|||
148817223|NCT03369223|536805404|FG017|Overall Study|Study drug toxicity|3|||
148817224|NCT03369223|536805405|FG018|Overall Study|Study drug toxicity|11|||
148817225|NCT03369223|536805406|FG019|Overall Study|Study drug toxicity|7|||
148817226|NCT03369223|536805387|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149026149|NCT00924560|537572008|FG000|Overall Study|Miscellaneous Reasons|13|||
149026150|NCT00924560|537572009|FG001|Overall Study|Miscellaneous Reasons|10|||
148728688|NCT00958126|536477929|FG004|Overall Study|Serious Adverse Event|0|||
148728689|NCT00958126|536477930|FG005|Overall Study|Serious Adverse Event|0|||
148728690|NCT00958126|536477931|FG006|Overall Study|Serious Adverse Event|1|||
148728691|NCT00958126|536477932|FG007|Overall Study|Serious Adverse Event|0|||
148728692|NCT00958126|536477925|FG000|Overall Study|Withdrawal by Subject|0|||
148728693|NCT00958126|536477926|FG001|Overall Study|Withdrawal by Subject|2|||
148728694|NCT00958126|536477927|FG002|Overall Study|Withdrawal by Subject|0|||
148728695|NCT00958126|536477928|FG003|Overall Study|Withdrawal by Subject|0|||
148728696|NCT00958126|536477929|FG004|Overall Study|Withdrawal by Subject|0|||
148817227|NCT03369223|536805388|FG001|Overall Study|Participant request to discontinue study treatment|1|||
148972033|NCT02659020|537381896|FG003|Overall Study|Withdrawal by Subject|3|||
148972034|NCT02659020|537381897|FG004|Overall Study|Withdrawal by Subject|3|||
148972035|NCT02659020|537381898|FG005|Overall Study|Withdrawal by Subject|6|||
148972036|NCT02659020|537381899|FG006|Overall Study|Withdrawal by Subject|3|||
148972037|NCT02659020|537381893|FG000|Overall Study|Progressive Disease|0|||
148972038|NCT02659020|537381894|FG001|Overall Study|Progressive Disease|0|||
148972039|NCT02659020|537381895|FG002|Overall Study|Progressive Disease|0|||
148972040|NCT02659020|537381896|FG003|Overall Study|Progressive Disease|4|||
148972041|NCT02659020|537381897|FG004|Overall Study|Progressive Disease|1|||
148972042|NCT02659020|537381898|FG005|Overall Study|Progressive Disease|0|||
148972043|NCT02659020|537381899|FG006|Overall Study|Progressive Disease|2|||
148972044|NCT04382911|537381900|FG000|Overall Study|unable to be imaged prior to surgery|2|||
148972045|NCT01120210|537381906|FG000|MAIN INFUSION|Adverse Event|1|||
148972046|NCT01120210|537381907|FG001|MAIN INFUSION|Adverse Event|0|||
148972047|NCT01120210|537381906|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
148972048|NCT01120210|537381907|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
148972049|NCT01077960|537381916|FG000|Overall Study|Adverse Event|6|||
148972050|NCT01077960|537381916|FG000|Overall Study|Protocol Violation|3|||
148972051|NCT01077960|537381916|FG000|Overall Study|Lost to Follow-up|5|||
148972052|NCT01077960|537381916|FG000|Overall Study|Subject decision|1|||
148972053|NCT01077960|537381916|FG000|Overall Study|Reason unspecified|1|||
148972054|NCT05619692|537381917|FG000|Overall Study|Adverse Event|2|||
148972055|NCT05619692|537381918|FG001|Overall Study|Adverse Event|2|||
148972056|NCT05619692|537381917|FG000|Overall Study|Withdrawal by Participant|3|||
148972057|NCT05619692|537381918|FG001|Overall Study|Withdrawal by Participant|4|||
148972058|NCT05619692|537381917|FG000|Overall Study|Lost to Follow-up|2|||
148972059|NCT05619692|537381918|FG001|Overall Study|Lost to Follow-up|1|||
148972060|NCT05619692|537381917|FG000|Overall Study|Randomized but not treated|1|||
148972061|NCT05619692|537381918|FG001|Overall Study|Randomized but not treated|3|||
148972062|NCT04049760|537381920|FG000|Overall Study|Withdrawal by Subject|1|||
148972063|NCT02457598|537381921|FG000|Overall Study|Progressive Disease|2|||
148972064|NCT02457598|537381922|FG001|Overall Study|Progressive Disease|2|||
148972065|NCT02457598|537381923|FG002|Overall Study|Progressive Disease|1|||
148972066|NCT02457598|537381924|FG003|Overall Study|Progressive Disease|11|||
148972067|NCT02457598|537381925|FG004|Overall Study|Progressive Disease|7|||
148972068|NCT02457598|537381926|FG005|Overall Study|Progressive Disease|3|||
148972069|NCT02457598|537381927|FG006|Overall Study|Progressive Disease|2|||
148972070|NCT02457598|537381928|FG007|Overall Study|Progressive Disease|1|||
148972071|NCT02457598|537381929|FG008|Overall Study|Progressive Disease|1|||
148972072|NCT02457598|537381930|FG009|Overall Study|Progressive Disease|2|||
148972073|NCT02457598|537381931|FG010|Overall Study|Progressive Disease|45|||
148972074|NCT02457598|537381932|FG011|Overall Study|Progressive Disease|6|||
148972075|NCT02457598|537381933|FG012|Overall Study|Progressive Disease|2|||
148972076|NCT02457598|537381934|FG013|Overall Study|Progressive Disease|2|||
148972077|NCT02457598|537381935|FG014|Overall Study|Progressive Disease|10|||
148972078|NCT02457598|537381936|FG015|Overall Study|Progressive Disease|1|||
148972079|NCT02457598|537381937|FG016|Overall Study|Progressive Disease|1|||
149026151|NCT00924560|537572010|FG002|Overall Study|Miscellaneous Reasons|10|||
148972080|NCT02457598|537381921|FG000|Overall Study|Investigator's Discretion|0|||
148972081|NCT02457598|537381922|FG001|Overall Study|Investigator's Discretion|2|||
148972082|NCT02457598|537381923|FG002|Overall Study|Investigator's Discretion|2|||
148972083|NCT02457598|537381924|FG003|Overall Study|Investigator's Discretion|2|||
148972084|NCT02457598|537381925|FG004|Overall Study|Investigator's Discretion|0|||
148972085|NCT02457598|537381926|FG005|Overall Study|Investigator's Discretion|0|||
148972086|NCT02457598|537381927|FG006|Overall Study|Investigator's Discretion|0|||
148972087|NCT02457598|537381928|FG007|Overall Study|Investigator's Discretion|1|||
148972088|NCT02457598|537381929|FG008|Overall Study|Investigator's Discretion|2|||
148728697|NCT00958126|536477930|FG005|Overall Study|Withdrawal by Subject|0|||
148728698|NCT00958126|536477931|FG006|Overall Study|Withdrawal by Subject|0|||
148728699|NCT00958126|536477932|FG007|Overall Study|Withdrawal by Subject|0|||
148972089|NCT02457598|537381930|FG009|Overall Study|Investigator's Discretion|0|||
148972090|NCT02457598|537381931|FG010|Overall Study|Investigator's Discretion|10|||
148972091|NCT02457598|537381932|FG011|Overall Study|Investigator's Discretion|2|||
148972092|NCT02457598|537381933|FG012|Overall Study|Investigator's Discretion|2|||
148728700|NCT00958126|536477925|FG000|Overall Study|Moved away from study area|0|||
148728701|NCT00958126|536477926|FG001|Overall Study|Moved away from study area|0|||
148728702|NCT00958126|536477927|FG002|Overall Study|Moved away from study area|1|||
148728703|NCT00958126|536477928|FG003|Overall Study|Moved away from study area|1|||
148728704|NCT00958126|536477929|FG004|Overall Study|Moved away from study area|0|||
148728705|NCT00958126|536477930|FG005|Overall Study|Moved away from study area|0|||
148728706|NCT00958126|536477931|FG006|Overall Study|Moved away from study area|0|||
148728707|NCT00958126|536477932|FG007|Overall Study|Moved away from study area|0|||
148728708|NCT00958126|536477925|FG000|Overall Study|Lost to Follow-up|1|||
148728709|NCT00958126|536477926|FG001|Overall Study|Lost to Follow-up|5|||
148728710|NCT00958126|536477927|FG002|Overall Study|Lost to Follow-up|9|||
148728711|NCT00958126|536477928|FG003|Overall Study|Lost to Follow-up|8|||
148728712|NCT00958126|536477929|FG004|Overall Study|Lost to Follow-up|0|||
148728713|NCT00958126|536477930|FG005|Overall Study|Lost to Follow-up|0|||
148728714|NCT00958126|536477931|FG006|Overall Study|Lost to Follow-up|0|||
148728715|NCT00958126|536477932|FG007|Overall Study|Lost to Follow-up|0|||
148728716|NCT00958126|536477925|FG000|Overall Study|Sponsor/Investigator decision|0|||
148728717|NCT00958126|536477926|FG001|Overall Study|Sponsor/Investigator decision|0|||
148728718|NCT00958126|536477927|FG002|Overall Study|Sponsor/Investigator decision|0|||
148728719|NCT00958126|536477928|FG003|Overall Study|Sponsor/Investigator decision|1|||
148728720|NCT00958126|536477929|FG004|Overall Study|Sponsor/Investigator decision|0|||
148728721|NCT00958126|536477930|FG005|Overall Study|Sponsor/Investigator decision|0|||
148728722|NCT00958126|536477931|FG006|Overall Study|Sponsor/Investigator decision|0|||
148728723|NCT00958126|536477932|FG007|Overall Study|Sponsor/Investigator decision|0|||
148728724|NCT00958126|536477925|FG000|Overall Study|Other Reason|0|||
148728725|NCT00958126|536477926|FG001|Overall Study|Other Reason|0|||
148728726|NCT00958126|536477927|FG002|Overall Study|Other Reason|0|||
148728727|NCT00958126|536477928|FG003|Overall Study|Other Reason|1|||
148728728|NCT00958126|536477929|FG004|Overall Study|Other Reason|0|||
148728729|NCT00958126|536477930|FG005|Overall Study|Other Reason|1|||
148728730|NCT00958126|536477931|FG006|Overall Study|Other Reason|0|||
148728731|NCT00958126|536477932|FG007|Overall Study|Other Reason|0|||
148728732|NCT00720226|536477933|FG000|Overall Study|Withdrawal by Subject|7|||
148728733|NCT00720226|536477934|FG001|Overall Study|Withdrawal by Subject|4|||
148728734|NCT03401073|536477935|FG000|Overall Study|Lost to Follow-up|1|||
148728735|NCT03401073|536477936|FG001|Overall Study|Lost to Follow-up|2|||
148728736|NCT00733369|536477937|FG000|Overall Study|Lost to Follow-up|2|||
148728737|NCT00733369|536477938|FG001|Overall Study|Lost to Follow-up|1|||
148728738|NCT00733369|536477937|FG000|Overall Study|Adverse Event|4|||
148728739|NCT00733369|536477938|FG001|Overall Study|Adverse Event|4|||
148728740|NCT00733369|536477937|FG000|Overall Study|Protocol Violation|4|||
148728741|NCT00733369|536477938|FG001|Overall Study|Protocol Violation|4|||
148728742|NCT03977701|536477941|FG000|Overall Study|COVID-19 pandemic|0|||
148728743|NCT03977701|536477942|FG001|Overall Study|COVID-19 pandemic|0|||
148817228|NCT03369223|536805389|FG002|Overall Study|Participant request to discontinue study treatment|0|||
148817229|NCT03369223|536805390|FG003|Overall Study|Participant request to discontinue study treatment|0|||
148817230|NCT03369223|536805391|FG004|Overall Study|Participant request to discontinue study treatment|1|||
148817231|NCT03369223|536805392|FG005|Overall Study|Participant request to discontinue study treatment|1|||
148817232|NCT03369223|536805393|FG006|Overall Study|Participant request to discontinue study treatment|1|||
148817233|NCT03369223|536805394|FG007|Overall Study|Participant request to discontinue study treatment|0|||
148817234|NCT03369223|536805395|FG008|Overall Study|Participant request to discontinue study treatment|0|||
148817235|NCT03369223|536805396|FG009|Overall Study|Participant request to discontinue study treatment|0|||
148817236|NCT03369223|536805397|FG010|Overall Study|Participant request to discontinue study treatment|0|||
148817237|NCT03369223|536805398|FG011|Overall Study|Participant request to discontinue study treatment|0|||
148817238|NCT03369223|536805399|FG012|Overall Study|Participant request to discontinue study treatment|0|||
148817239|NCT03369223|536805400|FG013|Overall Study|Participant request to discontinue study treatment|1|||
148817240|NCT03369223|536805401|FG014|Overall Study|Participant request to discontinue study treatment|1|||
148817241|NCT03369223|536805402|FG015|Overall Study|Participant request to discontinue study treatment|0|||
148817242|NCT03369223|536805403|FG016|Overall Study|Participant request to discontinue study treatment|0|||
148817243|NCT03369223|536805404|FG017|Overall Study|Participant request to discontinue study treatment|0|||
148817244|NCT03369223|536805405|FG018|Overall Study|Participant request to discontinue study treatment|1|||
148817245|NCT03369223|536805406|FG019|Overall Study|Participant request to discontinue study treatment|0|||
148817246|NCT03369223|536805387|FG000|Overall Study|Participant withdrew consent|0|||
148817247|NCT03369223|536805388|FG001|Overall Study|Participant withdrew consent|1|||
148817248|NCT03369223|536805389|FG002|Overall Study|Participant withdrew consent|1|||
148817249|NCT03369223|536805390|FG003|Overall Study|Participant withdrew consent|0|||
148972093|NCT02457598|537381934|FG013|Overall Study|Investigator's Discretion|1|||
148972094|NCT02457598|537381935|FG014|Overall Study|Investigator's Discretion|5|||
149026152|NCT00604786|537572013|FG000|Overall Study|Lost to Follow-up|2|||
148728744|NCT03977701|536477943|FG002|Overall Study|COVID-19 pandemic|0|||
148728745|NCT03977701|536477944|FG003|Overall Study|COVID-19 pandemic|0|||
148728746|NCT03977701|536477945|FG004|Overall Study|COVID-19 pandemic|0|||
148728747|NCT03977701|536477946|FG005|Overall Study|COVID-19 pandemic|1|||
148728748|NCT03977701|536477947|FG006|Overall Study|COVID-19 pandemic|0|||
148728749|NCT03977701|536477948|FG007|Overall Study|COVID-19 pandemic|1|||
148728750|NCT03977701|536477949|FG008|Overall Study|COVID-19 pandemic|0|||
148728751|NCT03977701|536477950|FG009|Overall Study|COVID-19 pandemic|0|||
148728752|NCT01408563|536479475|FG000|Overall Study|Ineligible after consent/ registration|2|||
148728753|NCT02246439|536479481|FG000|Overall Study|Adverse Event|3|||
148728754|NCT02246439|536479482|FG001|Overall Study|Adverse Event|0|||
148728755|NCT02246439|536479481|FG000|Overall Study|Lost to Follow-up|7|||
148728756|NCT02246439|536479482|FG001|Overall Study|Lost to Follow-up|5|||
148728757|NCT02246439|536479481|FG000|Overall Study|Protocol Violation|0|||
148728758|NCT02246439|536479482|FG001|Overall Study|Protocol Violation|2|||
148728759|NCT02246439|536479481|FG000|Overall Study|Physician Decision|0|||
148728760|NCT02246439|536479482|FG001|Overall Study|Physician Decision|1|||
148728761|NCT02246439|536479481|FG000|Overall Study|Unkonwn|1|||
148728762|NCT02246439|536479482|FG001|Overall Study|Unkonwn|3|||
148728763|NCT02246439|536479481|FG000|Overall Study|Withdrawal by Subject|1|||
148728764|NCT02246439|536479482|FG001|Overall Study|Withdrawal by Subject|0|||
148728765|NCT03439852|536479483|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
148728766|NCT03439852|536479484|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
148728767|NCT03439852|536479483|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
148728768|NCT03439852|536479484|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
148728769|NCT03439852|536479483|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
148728770|NCT03439852|536479484|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
148728771|NCT03573505|536479489|FG000|Overall Study|Adverse Event|1|||
148728772|NCT03573505|536479490|FG001|Overall Study|Adverse Event|1|||
148728773|NCT03573505|536479489|FG000|Overall Study|Consent withdrawn|0|||
148728774|NCT03573505|536479490|FG001|Overall Study|Consent withdrawn|1|||
148728775|NCT03573505|536479489|FG000|Overall Study|Disease progression|0|||
148728776|NCT03573505|536479490|FG001|Overall Study|Disease progression|1|||
148728777|NCT03573505|536479489|FG000|Overall Study|Site Terminated by Sponsor|1|||
148728778|NCT03573505|536479490|FG001|Overall Study|Site Terminated by Sponsor|1|||
148728779|NCT03573505|536479489|FG000|Overall Study|Study terminated by sponsor|50|||
148728780|NCT03573505|536479490|FG001|Overall Study|Study terminated by sponsor|45|||
148728781|NCT03573505|536479489|FG000|Overall Study|Reason not specified|0|||
148728782|NCT03573505|536479490|FG001|Overall Study|Reason not specified|1|||
148728783|NCT03573505|536479489|FG000|Overall Study|Death|0|||
148728784|NCT03573505|536479490|FG001|Overall Study|Death|4|||
148728785|NCT04268316|536479491|FG000|Overall Study|Withdrawal by Subject|2|||
148728786|NCT04268316|536479492|FG001|Overall Study|Withdrawal by Subject|1|||
148728787|NCT04268316|536479493|FG002|Overall Study|Withdrawal by Subject|0|||
148728788|NCT02132637|536479494|FG000|Study Period 1|Withdrawal by Subject|0|||
148728789|NCT02132637|536479495|FG001|Study Period 1|Withdrawal by Subject|4|||
148728790|NCT02132637|536479494|FG000|Study Period 1|Physician Decision|1|||
148728791|NCT02132637|536479495|FG001|Study Period 1|Physician Decision|0|||
148728792|NCT02132637|536479494|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
148728793|NCT02132637|536479495|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
148728794|NCT02132637|536479494|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
148728795|NCT02132637|536479495|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
148728796|NCT02145026|536479505|FG000|Overall Study|Adverse Event|2|||
148728797|NCT02145026|536479505|FG000|Overall Study|Death|4|||
148728798|NCT02145026|536479505|FG000|Overall Study|Withdrawal by Subject|2|||
148728799|NCT02145026|536479505|FG000|Overall Study|Physician Decision|4|||
148728800|NCT04920916|536479506|FG000|Phase IIa 60 Day Study|Death|2|||
148728801|NCT04920916|536479507|FG001|Phase IIa 60 Day Study|Death|5|||
148728802|NCT04920916|536479506|FG000|1 Year Follow up (Phone Call)|Death|1|||
148728803|NCT04920916|536479507|FG001|1 Year Follow up (Phone Call)|Death|3|||
148728804|NCT04920916|536479506|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
148728805|NCT04920916|536479507|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
148728806|NCT00076804|536479508|FG000|Overall Study|Death|9|||
148728807|NCT00076804|536479509|FG001|Overall Study|Death|20|||
148728808|NCT00076804|536479508|FG000|Overall Study|Lost to Follow-up|9|||
148728809|NCT00076804|536479509|FG001|Overall Study|Lost to Follow-up|9|||
148728810|NCT00076804|536479508|FG000|Overall Study|Withdrawal by Subject|10|||
148728811|NCT00076804|536479509|FG001|Overall Study|Withdrawal by Subject|8|||
148728812|NCT00076804|536479508|FG000|Overall Study|Early study Closure|32|||
149026153|NCT00604786|537572014|FG001|Overall Study|Lost to Follow-up|0|||
148728813|NCT00076804|536479509|FG001|Overall Study|Early study Closure|32|||
148728814|NCT00354341|536479510|FG000|Overall Study|Adverse Event|1|||
148728815|NCT00354341|536479511|FG001|Overall Study|Adverse Event|0|||
148728816|NCT00354341|536479510|FG000|Overall Study|Death|0|||
148728817|NCT00354341|536479511|FG001|Overall Study|Death|2|||
148728818|NCT00354341|536479510|FG000|Overall Study|Refused treatment|1|||
148728819|NCT00354341|536479511|FG001|Overall Study|Refused treatment|2|||
148728820|NCT00354341|536479510|FG000|Overall Study|Failure to return|0|||
148728821|NCT00354341|536479511|FG001|Overall Study|Failure to return|1|||
148728822|NCT00354341|536479510|FG000|Overall Study|Other|1|||
148728823|NCT00354341|536479511|FG001|Overall Study|Other|2|||
148728824|NCT01901874|536479523|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
149026154|NCT00665561|537572019|FG000|Overall Study|Death recorded on subject summary pages|75|||
149026155|NCT00665561|537572020|FG001|Overall Study|Death recorded on subject summary pages|75|||
149026156|NCT00665561|537572019|FG000|Overall Study|Does not meet entrance criteria|19|||
149026157|NCT00665561|537572020|FG001|Overall Study|Does not meet entrance criteria|21|||
149026158|NCT00665561|537572019|FG000|Overall Study|Lost to Follow-up|203|||
149026159|NCT00665561|537572020|FG001|Overall Study|Lost to Follow-up|264|||
149026160|NCT00665561|537572019|FG000|Overall Study|Withdrawal by Subject|74|||
149026161|NCT00665561|537572020|FG001|Overall Study|Withdrawal by Subject|65|||
149026162|NCT00665561|537572019|FG000|Overall Study|Other|123|||
149026163|NCT00665561|537572020|FG001|Overall Study|Other|108|||
149026164|NCT00665561|537572019|FG000|Overall Study|Site closed|8|||
149026165|NCT00665561|537572020|FG001|Overall Study|Site closed|0|||
149026166|NCT00665561|537572019|FG000|Overall Study|Withdrawn due to pregnancy|0|||
149026167|NCT00665561|537572020|FG001|Overall Study|Withdrawn due to pregnancy|1|||
149026168|NCT02337361|537572021|FG000|3-month Follow-up|Lost to Follow-up|19|||
149026169|NCT02337361|537572022|FG001|3-month Follow-up|Lost to Follow-up|14|||
149026170|NCT02337361|537572021|FG000|6-month Follow-up|Lost to Follow-up|2|||
149026171|NCT02337361|537572022|FG001|6-month Follow-up|Lost to Follow-up|4|||
149026172|NCT01641861|537572023|FG000|Overall Study|Lost to Follow-up|21|||
149026173|NCT01641861|537572024|FG001|Overall Study|Lost to Follow-up|16|||
149026174|NCT01641861|537572023|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
149026175|NCT01641861|537572024|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
149026176|NCT01641861|537572023|FG000|Overall Study|Died due to drowning|0|||
149026177|NCT01641861|537572024|FG001|Overall Study|Died due to drowning|1|||
149026178|NCT00814489|537572025|FG000|Overall Study|Other|2|||
149026179|NCT00814489|537572026|FG001|Overall Study|Other|0|||
149026180|NCT00814489|537572027|FG002|Overall Study|Other|1|||
149026181|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Adverse Event|5|||
149026182|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Adverse Event|13|||
149026183|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Adverse Event|0|||
149026184|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
149026185|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
149026186|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
149026187|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
148728825|NCT01901874|536479523|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
148728826|NCT01901874|536479523|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
148728827|NCT01901874|536479523|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
148728828|NCT01901874|536479523|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
148728829|NCT01901874|536479523|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
148728830|NCT01347866|536479524|FG000|Overall Study|Death|0|||
148728831|NCT01347866|536479525|FG001|Overall Study|Death|0|||
148728832|NCT01347866|536479526|FG002|Overall Study|Death|0|||
148728833|NCT01347866|536479527|FG003|Overall Study|Death|1|||
148728834|NCT01347866|536479528|FG004|Overall Study|Death|2|||
148728835|NCT01347866|536479529|FG005|Overall Study|Death|2|||
148728836|NCT01347866|536479530|FG006|Overall Study|Death|1|||
148728837|NCT01347866|536479531|FG007|Overall Study|Death|0|||
148728838|NCT01347866|536479532|FG008|Overall Study|Death|4|||
148728839|NCT01347866|536479533|FG009|Overall Study|Death|1|||
148728840|NCT01347866|536479534|FG010|Overall Study|Death|3|||
148728841|NCT01347866|536479535|FG011|Overall Study|Death|1|||
148728842|NCT01347866|536479536|FG012|Overall Study|Death|2|||
148728843|NCT01347866|536479537|FG013|Overall Study|Death|0|||
148728844|NCT01347866|536479538|FG014|Overall Study|Death|0|||
148728845|NCT01347866|536479539|FG015|Overall Study|Death|1|||
148728846|NCT01347866|536479540|FG016|Overall Study|Death|0|||
148728847|NCT01347866|536479524|FG000|Overall Study|Lost to Follow-up|0|||
148728848|NCT01347866|536479525|FG001|Overall Study|Lost to Follow-up|0|||
148728849|NCT01347866|536479526|FG002|Overall Study|Lost to Follow-up|0|||
149026188|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
149026189|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
149026190|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
148728850|NCT01347866|536479527|FG003|Overall Study|Lost to Follow-up|0|||
148728851|NCT01347866|536479528|FG004|Overall Study|Lost to Follow-up|0|||
148728852|NCT01347866|536479529|FG005|Overall Study|Lost to Follow-up|0|||
148728853|NCT01347866|536479530|FG006|Overall Study|Lost to Follow-up|0|||
148728854|NCT01347866|536479531|FG007|Overall Study|Lost to Follow-up|1|||
148728855|NCT01347866|536479532|FG008|Overall Study|Lost to Follow-up|1|||
148728856|NCT01347866|536479533|FG009|Overall Study|Lost to Follow-up|0|||
148728857|NCT01347866|536479534|FG010|Overall Study|Lost to Follow-up|0|||
148728858|NCT01347866|536479535|FG011|Overall Study|Lost to Follow-up|0|||
149026191|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
149026192|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
149026193|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
148728859|NCT01347866|536479536|FG012|Overall Study|Lost to Follow-up|0|||
148728860|NCT01347866|536479537|FG013|Overall Study|Lost to Follow-up|0|||
148728861|NCT01347866|536479538|FG014|Overall Study|Lost to Follow-up|0|||
148728862|NCT01347866|536479539|FG015|Overall Study|Lost to Follow-up|0|||
148728863|NCT01347866|536479540|FG016|Overall Study|Lost to Follow-up|0|||
148728864|NCT01347866|536479524|FG000|Overall Study|Other|3|||
148728865|NCT01347866|536479525|FG001|Overall Study|Other|1|||
148728866|NCT01347866|536479526|FG002|Overall Study|Other|1|||
148728867|NCT01347866|536479527|FG003|Overall Study|Other|4|||
148728868|NCT01347866|536479528|FG004|Overall Study|Other|5|||
148728869|NCT01347866|536479529|FG005|Overall Study|Other|0|||
148728870|NCT01347866|536479530|FG006|Overall Study|Other|5|||
148728871|NCT01347866|536479531|FG007|Overall Study|Other|3|||
148728872|NCT01347866|536479532|FG008|Overall Study|Other|22|||
148728873|NCT01347866|536479533|FG009|Overall Study|Other|5|||
148728874|NCT01347866|536479534|FG010|Overall Study|Other|0|||
148728875|NCT01347866|536479535|FG011|Overall Study|Other|3|||
148728876|NCT01347866|536479536|FG012|Overall Study|Other|4|||
148728877|NCT01347866|536479537|FG013|Overall Study|Other|4|||
148728878|NCT01347866|536479538|FG014|Overall Study|Other|2|||
148728879|NCT01347866|536479539|FG015|Overall Study|Other|3|||
148728880|NCT01347866|536479540|FG016|Overall Study|Other|0|||
148728881|NCT01347866|536479524|FG000|Overall Study|Subject refused further follow-up|2|||
148728882|NCT01347866|536479525|FG001|Overall Study|Subject refused further follow-up|0|||
148728883|NCT01347866|536479526|FG002|Overall Study|Subject refused further follow-up|0|||
148728884|NCT01347866|536479527|FG003|Overall Study|Subject refused further follow-up|2|||
148728885|NCT01347866|536479528|FG004|Overall Study|Subject refused further follow-up|0|||
148728886|NCT01347866|536479529|FG005|Overall Study|Subject refused further follow-up|1|||
148728887|NCT01347866|536479530|FG006|Overall Study|Subject refused further follow-up|0|||
148728888|NCT01347866|536479531|FG007|Overall Study|Subject refused further follow-up|0|||
148728889|NCT01347866|536479532|FG008|Overall Study|Subject refused further follow-up|4|||
148728890|NCT01347866|536479533|FG009|Overall Study|Subject refused further follow-up|1|||
148728891|NCT01347866|536479534|FG010|Overall Study|Subject refused further follow-up|0|||
148728892|NCT01347866|536479535|FG011|Overall Study|Subject refused further follow-up|0|||
148728893|NCT01347866|536479536|FG012|Overall Study|Subject refused further follow-up|1|||
148728894|NCT01347866|536479537|FG013|Overall Study|Subject refused further follow-up|3|||
148728895|NCT01347866|536479538|FG014|Overall Study|Subject refused further follow-up|1|||
148728896|NCT01347866|536479539|FG015|Overall Study|Subject refused further follow-up|0|||
148728897|NCT01347866|536479540|FG016|Overall Study|Subject refused further follow-up|2|||
148728898|NCT02429934|536479541|FG000|Overall Study|Withdrawal by Subject|0|||
148728899|NCT02429934|536479542|FG001|Overall Study|Withdrawal by Subject|2|||
148728900|NCT02429934|536479541|FG000|Overall Study|Adverse Event|2|||
148728901|NCT02429934|536479542|FG001|Overall Study|Adverse Event|0|||
148728902|NCT02429934|536479541|FG000|Overall Study|Lost to Follow-up|1|||
148728903|NCT02429934|536479542|FG001|Overall Study|Lost to Follow-up|1|||
148728904|NCT02429934|536479541|FG000|Overall Study|Physician Decision|1|||
148728905|NCT02429934|536479542|FG001|Overall Study|Physician Decision|0|||
148728906|NCT00869024|536479543|FG000|Overall Study|Death|2|||
148728907|NCT00869024|536479544|FG001|Overall Study|Death|3|||
148728908|NCT00869024|536479543|FG000|Overall Study|Lost to Follow-up|0|||
148728909|NCT00869024|536479544|FG001|Overall Study|Lost to Follow-up|1|||
148728910|NCT00869024|536479543|FG000|Overall Study|Protocol Violation|0|||
148728911|NCT00869024|536479544|FG001|Overall Study|Protocol Violation|1|||
148728912|NCT02025751|536479545|FG000|Overall Study|Lost to Follow-up|1|||
148728913|NCT02025751|536479546|FG001|Overall Study|Lost to Follow-up|0|||
148728914|NCT02025751|536479545|FG000|Overall Study|Adverse Event|0|||
148728915|NCT02025751|536479546|FG001|Overall Study|Adverse Event|1|||
148728916|NCT02025751|536479545|FG000|Overall Study|Physician Decision|0|||
148728917|NCT02025751|536479546|FG001|Overall Study|Physician Decision|1|||
148728918|NCT02025751|536479545|FG000|Overall Study|Withdrawal by Subject|0|||
148728919|NCT02025751|536479546|FG001|Overall Study|Withdrawal by Subject|1|||
148728920|NCT00653991|536479547|FG000|3 Month Follow-up|Participant would not respond|150|||
148728921|NCT00653991|536479548|FG001|3 Month Follow-up|Participant would not respond|157|||
148728922|NCT00653991|536479547|FG000|6 Month Follow-up|Participant would not respond|133|||
148728923|NCT00653991|536479548|FG001|6 Month Follow-up|Participant would not respond|141|||
148972095|NCT02457598|537381936|FG015|Overall Study|Investigator's Discretion|0|||
148972096|NCT02457598|537381937|FG016|Overall Study|Investigator's Discretion|0|||
148972097|NCT02457598|537381921|FG000|Overall Study|Study Terminated by Sponsor|0|||
148972098|NCT02457598|537381922|FG001|Overall Study|Study Terminated by Sponsor|1|||
148728924|NCT02181296|536479549|FG000|Overall Study|Lost to Follow-up|7|||
148972099|NCT02457598|537381923|FG002|Overall Study|Study Terminated by Sponsor|0|||
148728925|NCT02181296|536479550|FG001|Overall Study|Lost to Follow-up|6|||
148728926|NCT02939014|536479551|FG000|Overall Study|Lost to Follow-up|1|||
148728927|NCT02939014|536479552|FG001|Overall Study|Lost to Follow-up|0|||
148972100|NCT02457598|537381924|FG003|Overall Study|Study Terminated by Sponsor|4|||
148972101|NCT02457598|537381925|FG004|Overall Study|Study Terminated by Sponsor|1|||
148728928|NCT02939014|536479551|FG000|Overall Study|Death|4|||
148728929|NCT02939014|536479552|FG001|Overall Study|Death|3|||
148728930|NCT01568866|536479553|FG000|Overall Study|Disease Progression|208|||
148728931|NCT01568866|536479554|FG001|Overall Study|Disease Progression|183|||
148728932|NCT01568866|536479553|FG000|Overall Study|Adverse Event|94|||
148728933|NCT01568866|536479554|FG001|Overall Study|Adverse Event|96|||
148728934|NCT01568866|536479553|FG000|Overall Study|Patient Request|55|||
148728935|NCT01568866|536479554|FG001|Overall Study|Patient Request|71|||
148728936|NCT01568866|536479553|FG000|Overall Study|Physician Decision|40|||
148728937|NCT01568866|536479554|FG001|Overall Study|Physician Decision|32|||
148728938|NCT01568866|536479553|FG000|Overall Study|Withdrawal by Subject|19|||
148728939|NCT01568866|536479554|FG001|Overall Study|Withdrawal by Subject|11|||
148728940|NCT01568866|536479553|FG000|Overall Study|Death|10|||
148728941|NCT01568866|536479554|FG001|Overall Study|Death|18|||
148728942|NCT01568866|536479553|FG000|Overall Study|Protocol Non-compliance|2|||
148728943|NCT01568866|536479554|FG001|Overall Study|Protocol Non-compliance|4|||
148728944|NCT01568866|536479553|FG000|Overall Study|Lost to Follow-up|1|||
148728945|NCT01568866|536479554|FG001|Overall Study|Lost to Follow-up|0|||
148728946|NCT01568866|536479553|FG000|Overall Study|Randomized but Not Dosed|9|||
148728947|NCT01568866|536479554|FG001|Overall Study|Randomized but Not Dosed|1|||
148728948|NCT03864042|536479555|FG000|DDI Phase|Adverse Event|2|||
148728949|NCT03864042|536479556|FG001|DDI Phase|Adverse Event|0|||
148728950|NCT03864042|536479557|FG002|DDI Phase|Adverse Event|0|||
148728951|NCT03864042|536479555|FG000|DDI Phase|Physician Decision|1|||
148728952|NCT03864042|536479556|FG001|DDI Phase|Physician Decision|0|||
148728953|NCT03864042|536479557|FG002|DDI Phase|Physician Decision|0|||
148728954|NCT03864042|536479555|FG000|DDI Phase|Progressive Disease|1|||
148728955|NCT03864042|536479556|FG001|DDI Phase|Progressive Disease|0|||
148728956|NCT03864042|536479557|FG002|DDI Phase|Progressive Disease|0|||
148728957|NCT03864042|536479555|FG000|Post-DDI Phase|Adverse Event|5|||
148728958|NCT03864042|536479556|FG001|Post-DDI Phase|Adverse Event|3|||
148728959|NCT03864042|536479557|FG002|Post-DDI Phase|Adverse Event|2|||
148728960|NCT03864042|536479555|FG000|Post-DDI Phase|Progressive Disease|11|||
148728961|NCT03864042|536479556|FG001|Post-DDI Phase|Progressive Disease|6|||
148728962|NCT03864042|536479557|FG002|Post-DDI Phase|Progressive Disease|13|||
148728963|NCT03864042|536479555|FG000|Post-DDI Phase|Discretion of investigator|1|||
148728964|NCT03864042|536479556|FG001|Post-DDI Phase|Discretion of investigator|1|||
148728965|NCT03864042|536479557|FG002|Post-DDI Phase|Discretion of investigator|0|||
148728966|NCT03864042|536479555|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
148728967|NCT03864042|536479556|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
148728968|NCT03864042|536479557|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
148728969|NCT03864042|536479555|FG000|Post-DDI Phase|Withdrawal of consent|1|||
148728970|NCT03864042|536479556|FG001|Post-DDI Phase|Withdrawal of consent|2|||
148728971|NCT03864042|536479557|FG002|Post-DDI Phase|Withdrawal of consent|0|||
148728972|NCT01698775|536479558|FG000|Phase A|Adverse Event|2|||
148728973|NCT01698775|536479559|FG001|Phase A|Adverse Event|1|||
148728974|NCT01698775|536479558|FG000|Phase A|Death|1|||
148728975|NCT01698775|536479559|FG001|Phase A|Death|1|||
148728976|NCT01698775|536479558|FG000|Phase A|Lack of Efficacy|1|||
148728977|NCT01698775|536479559|FG001|Phase A|Lack of Efficacy|0|||
148728978|NCT01698775|536479558|FG000|Phase A|Lost to Follow-up|1|||
148728979|NCT01698775|536479559|FG001|Phase A|Lost to Follow-up|2|||
148728980|NCT01698775|536479558|FG000|Phase A|Protocol Violation|1|||
148728981|NCT01698775|536479559|FG001|Phase A|Protocol Violation|0|||
148728982|NCT01698775|536479558|FG000|Phase A|Withdrawal by Subject|3|||
148728983|NCT01698775|536479559|FG001|Phase A|Withdrawal by Subject|4|||
148728984|NCT01698775|536479558|FG000|Phase A|Kidney [transplant]|0|||
148728985|NCT01698775|536479559|FG001|Phase A|Kidney [transplant]|1|||
148728986|NCT01698775|536479558|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
148728987|NCT01698775|536479559|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
148728988|NCT01698775|536479558|FG000|Phase B|Adverse Event|6|||
148728989|NCT01698775|536479559|FG001|Phase B|Adverse Event|3|||
148728990|NCT01698775|536479558|FG000|Phase B|Death|0|||
148728991|NCT01698775|536479559|FG001|Phase B|Death|1|||
148728992|NCT01698775|536479558|FG000|Phase B|Lack of Efficacy|0|||
148728993|NCT01698775|536479559|FG001|Phase B|Lack of Efficacy|1|||
148728994|NCT01698775|536479558|FG000|Phase B|Lost to Follow-up|0|||
148728995|NCT01698775|536479559|FG001|Phase B|Lost to Follow-up|1|||
148728996|NCT01698775|536479558|FG000|Phase B|Physician Decision|1|||
148728997|NCT01698775|536479559|FG001|Phase B|Physician Decision|1|||
148728998|NCT01698775|536479558|FG000|Phase B|Protocol Violation|1|||
148728999|NCT01698775|536479559|FG001|Phase B|Protocol Violation|1|||
148729000|NCT01698775|536479558|FG000|Phase B|Withdrawal by Subject|6|||
148729001|NCT01698775|536479559|FG001|Phase B|Withdrawal by Subject|2|||
148729002|NCT01244061|536479562|FG000|Overall Study|Death|1|||
148729003|NCT01244061|536479563|FG001|Overall Study|Death|0|||
148729004|NCT01244061|536479562|FG000|Overall Study|Did not meet entrance criteria|1|||
148729005|NCT01244061|536479563|FG001|Overall Study|Did not meet entrance criteria|0|||
148729006|NCT01244061|536479562|FG000|Overall Study|Lack of Efficacy|1|||
148729007|NCT01244061|536479563|FG001|Overall Study|Lack of Efficacy|3|||
148729008|NCT01244061|536479562|FG000|Overall Study|Lost to Follow-up|34|||
148729009|NCT01244061|536479563|FG001|Overall Study|Lost to Follow-up|30|||
148729010|NCT01244061|536479562|FG000|Overall Study|Withdrawal by Subject|29|||
148729011|NCT01244061|536479563|FG001|Overall Study|Withdrawal by Subject|46|||
148729012|NCT01244061|536479562|FG000|Overall Study|Other|8|||
148729013|NCT01244061|536479563|FG001|Overall Study|Other|19|||
148729014|NCT01244061|536479562|FG000|Overall Study|Protocol Violation|1|||
148729015|NCT01244061|536479563|FG001|Overall Study|Protocol Violation|1|||
148729016|NCT01244061|536479562|FG000|Overall Study|Adverse Event|5|||
148729017|NCT01244061|536479563|FG001|Overall Study|Adverse Event|2|||
148729018|NCT01244061|536479562|FG000|Overall Study|Randomized but not treated|2|||
148729019|NCT01244061|536479563|FG001|Overall Study|Randomized but not treated|2|||
148729020|NCT02143583|536479564|FG000|Overall Study|Withdrawal by Subject|1|||
148729021|NCT02143583|536479565|FG001|Overall Study|Withdrawal by Subject|0|||
148729022|NCT02143583|536479566|FG002|Overall Study|Withdrawal by Subject|1|||
148729023|NCT02143583|536479564|FG000|Overall Study|husband illness|0|||
148729024|NCT02143583|536479565|FG001|Overall Study|husband illness|0|||
148729025|NCT02143583|536479566|FG002|Overall Study|husband illness|1|||
148729026|NCT01641133|536479569|FG000|Overall Study|Protocol Violation|0|||
148729027|NCT01641133|536479570|FG001|Overall Study|Protocol Violation|1|||
148729028|NCT01641133|536479571|FG002|Overall Study|Protocol Violation|1|||
148729029|NCT01641133|536479569|FG000|Overall Study|Migrated/moved from study area|5|||
148729030|NCT01641133|536479570|FG001|Overall Study|Migrated/moved from study area|3|||
148729031|NCT01641133|536479571|FG002|Overall Study|Migrated/moved from study area|1|||
148729032|NCT01641133|536479569|FG000|Overall Study|Adverse Event|0|||
148729033|NCT01641133|536479570|FG001|Overall Study|Adverse Event|0|||
148729034|NCT01641133|536479571|FG002|Overall Study|Adverse Event|1|||
148729035|NCT01641133|536479569|FG000|Overall Study|Withdrawal by Subject|5|||
148729036|NCT01641133|536479570|FG001|Overall Study|Withdrawal by Subject|3|||
148729037|NCT01641133|536479571|FG002|Overall Study|Withdrawal by Subject|3|||
148729038|NCT01641133|536479569|FG000|Overall Study|Lost to Follow-up|0|||
148729039|NCT01641133|536479570|FG001|Overall Study|Lost to Follow-up|2|||
148729040|NCT01641133|536479571|FG002|Overall Study|Lost to Follow-up|2|||
148729041|NCT03351231|536479574|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
148729042|NCT03351231|536479574|FG000|Combination Therapy Period|Disease progression|2|||
148729043|NCT03351231|536479574|FG000|Combination Therapy Period|Study drug toxicity|1|||
148729044|NCT03351231|536479574|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
148729045|NCT03351231|536479574|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
148729046|NCT03351231|536479574|FG000|Safety Follow-Up Period|Other reason|2|||
148729047|NCT03499119|536479577|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
148729048|NCT03499119|536479578|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
148729049|NCT03499119|536479579|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
148729050|NCT03499119|536479580|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
148729051|NCT03499119|536479577|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
148729052|NCT03499119|536479578|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
148729053|NCT03499119|536479579|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
148729054|NCT03499119|536479580|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
148729055|NCT03499119|536479577|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
148729056|NCT03499119|536479578|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
148729057|NCT03499119|536479579|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
148729058|NCT03499119|536479580|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
148729059|NCT03499119|536479577|FG000|Optional Extension Phase|Lost to Follow-up|0|||
148729060|NCT03499119|536479578|FG001|Optional Extension Phase|Lost to Follow-up|0|||
148729061|NCT03499119|536479579|FG002|Optional Extension Phase|Lost to Follow-up|0|||
148729062|NCT03499119|536479580|FG003|Optional Extension Phase|Lost to Follow-up|1|||
148729063|NCT03499119|536479577|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
148729064|NCT03499119|536479578|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
148729065|NCT03499119|536479579|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
148729066|NCT03499119|536479580|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
148729067|NCT03499119|536479577|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
148729068|NCT03499119|536479578|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
148729069|NCT03499119|536479579|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
148729070|NCT03499119|536479580|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
148729071|NCT02333487|536479581|FG000|Overall Study|Adverse Event|0|||
148729072|NCT02333487|536479582|FG001|Overall Study|Adverse Event|2|||
148729073|NCT02333487|536479583|FG002|Overall Study|Adverse Event|0|||
148729074|NCT00123955|536479584|FG000|Overall Study|Adverse Event|1|||
148729075|NCT00123955|536479585|FG001|Overall Study|Adverse Event|0|||
148729076|NCT00123955|536479584|FG000|Overall Study|Withdrawal by Subject|4|||
148729077|NCT00123955|536479585|FG001|Overall Study|Withdrawal by Subject|3|||
148729078|NCT00123955|536479584|FG000|Overall Study|Death|0|||
148729079|NCT00123955|536479585|FG001|Overall Study|Death|1|||
148729080|NCT01558297|536479586|FG000|Overall Study|Withdrawal by Subject|2|||
148729081|NCT01558297|536479587|FG001|Overall Study|Withdrawal by Subject|2|||
148729082|NCT01558297|536479588|FG002|Overall Study|Withdrawal by Subject|1|||
148729083|NCT04189445|536481315|FG000|Overall Study|Withdrawal of consent|8|||
148729084|NCT04189445|536481316|FG001|Overall Study|Withdrawal of consent|1|||
148729085|NCT04189445|536481317|FG002|Overall Study|Withdrawal of consent|0|||
148729086|NCT04189445|536481315|FG000|Overall Study|Study Terminated by Sponsor|25|||
148729087|NCT04189445|536481316|FG001|Overall Study|Study Terminated by Sponsor|3|||
148729088|NCT04189445|536481317|FG002|Overall Study|Study Terminated by Sponsor|0|||
148729089|NCT04189445|536481315|FG000|Overall Study|Death|54|||
148729090|NCT04189445|536481316|FG001|Overall Study|Death|24|||
148729091|NCT04189445|536481317|FG002|Overall Study|Death|0|||
148729092|NCT02960893|536481319|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
149026194|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
149026195|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
149026196|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
149026197|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
149026198|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
149026199|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Physician Decision|2|||
149026200|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Physician Decision|3|||
149026201|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Physician Decision|0|||
149026202|NCT01449929|537572028|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
149026203|NCT01449929|537572029|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
149026204|NCT01449929|537572030|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
149026205|NCT01449929|537572028|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
149026206|NCT01449929|537572029|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
149026207|NCT01449929|537572030|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
149026208|NCT01449929|537572028|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
149026209|NCT01449929|537572029|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
149026210|NCT01449929|537572030|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
149026211|NCT01449929|537572028|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
148729093|NCT02960893|536481320|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
148729094|NCT02960893|536481321|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
148729095|NCT02960893|536481322|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
148729096|NCT02960893|536481319|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
148729097|NCT02960893|536481320|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
148729098|NCT02960893|536481321|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
148729099|NCT02960893|536481322|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
148729100|NCT02960893|536481319|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
148729101|NCT02960893|536481320|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
148729102|NCT02960893|536481321|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
148729103|NCT02960893|536481322|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
148729104|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
148729105|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
148729106|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
148729107|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
148729108|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
148729109|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
148729110|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
148729111|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
148729112|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
148729113|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
148729114|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
148729115|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
148729116|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
148729117|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
148729118|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
148729119|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
148729120|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
148729121|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
148729122|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
148729123|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
148729124|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
148729125|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
148729126|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
148729127|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
148729128|NCT02960893|536481319|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
148729129|NCT02960893|536481320|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
148729130|NCT02960893|536481321|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
148817250|NCT03369223|536805391|FG004|Overall Study|Participant withdrew consent|0|||
149026212|NCT01449929|537572029|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
149026213|NCT01449929|537572030|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
149026214|NCT03015740|537572031|FG000|Overall Study|Adverse Event|1|||
149026215|NCT03015740|537572032|FG001|Overall Study|Adverse Event|0|||
149026216|NCT03015740|537572033|FG002|Overall Study|Adverse Event|0|||
149026217|NCT03015740|537572031|FG000|Overall Study|Death|3|||
149026218|NCT03015740|537572032|FG001|Overall Study|Death|5|||
149026219|NCT03015740|537572033|FG002|Overall Study|Death|0|||
148729131|NCT02960893|536481322|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
148729132|NCT05142566|536481323|FG000|Overall Study|Protocol Violation|1|||
148729133|NCT04718194|536481326|FG000|Overall Study|Withdrawal by Subject|3|||
148729134|NCT04718194|536481327|FG001|Overall Study|Withdrawal by Subject|0|||
148729135|NCT04718194|536481326|FG000|Overall Study|Lost to Follow-up|3|||
148729136|NCT04718194|536481327|FG001|Overall Study|Lost to Follow-up|0|||
148729137|NCT04551911|536481330|FG000|Overall Study|Lost to Follow-up|2|||
148729138|NCT04551911|536481331|FG001|Overall Study|Lost to Follow-up|1|||
148729139|NCT04551911|536481330|FG000|Overall Study|Withdrawal by Subject|10|||
148729140|NCT04551911|536481331|FG001|Overall Study|Withdrawal by Subject|10|||
148729141|NCT04551911|536481330|FG000|Overall Study|Did not receive the study drug|3|||
148729142|NCT04551911|536481331|FG001|Overall Study|Did not receive the study drug|4|||
148729143|NCT01215513|536481332|FG000|Overall Study|Not completed CS42|9|||
148729144|NCT01215513|536481332|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
148729145|NCT01215513|536481332|FG000|Overall Study|Adverse event (CS42A)|2|||
148729146|NCT01215513|536481332|FG000|Overall Study|Physician decision (CS42A)|6|||
148729147|NCT01215513|536481332|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
148729148|NCT01215513|536481332|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
148729149|NCT00821873|536481334|FG000|Overall Study|Lost to Follow-up|4|||
148729150|NCT02177136|536481337|FG000|DB Phase|Withdrawal by Subject|2|||
148729151|NCT02177136|536481338|FG001|DB Phase|Withdrawal by Subject|0|||
148729152|NCT02177136|536481339|FG002|DB Phase|Withdrawal by Subject|0|||
148729153|NCT02177136|536481340|FG003|DB Phase|Withdrawal by Subject|0|||
148729154|NCT02177136|536481337|FG000|DB Phase|Discontinued Due to Pruritus|1|||
148729155|NCT02177136|536481338|FG001|DB Phase|Discontinued Due to Pruritus|3|||
148729156|NCT02177136|536481339|FG002|DB Phase|Discontinued Due to Pruritus|0|||
148729157|NCT02177136|536481340|FG003|DB Phase|Discontinued Due to Pruritus|0|||
148729158|NCT02177136|536481337|FG000|DB Phase|Adverse Event|3|||
148729159|NCT02177136|536481338|FG001|DB Phase|Adverse Event|2|||
148729160|NCT02177136|536481339|FG002|DB Phase|Adverse Event|3|||
148729161|NCT02177136|536481340|FG003|DB Phase|Adverse Event|0|||
148729162|NCT02177136|536481337|FG000|DB Phase|Protocol Violation|0|||
148729163|NCT02177136|536481338|FG001|DB Phase|Protocol Violation|0|||
148729164|NCT02177136|536481339|FG002|DB Phase|Protocol Violation|1|||
148729165|NCT02177136|536481340|FG003|DB Phase|Protocol Violation|0|||
148729166|NCT02177136|536481337|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
148729167|NCT02177136|536481338|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
148729168|NCT02177136|536481339|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
148729169|NCT02177136|536481340|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
148729170|NCT02177136|536481337|FG000|LTSE Phase|Withdrawal by Subject|0|||
148729171|NCT02177136|536481338|FG001|LTSE Phase|Withdrawal by Subject|0|||
148729172|NCT02177136|536481339|FG002|LTSE Phase|Withdrawal by Subject|0|||
148729173|NCT02177136|536481340|FG003|LTSE Phase|Withdrawal by Subject|6|||
148729174|NCT02177136|536481337|FG000|LTSE Phase|Adverse Event|0|||
148729175|NCT02177136|536481338|FG001|LTSE Phase|Adverse Event|0|||
148729176|NCT02177136|536481339|FG002|LTSE Phase|Adverse Event|0|||
148729177|NCT02177136|536481340|FG003|LTSE Phase|Adverse Event|10|||
148729178|NCT02177136|536481337|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
148729179|NCT02177136|536481338|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
148729180|NCT02177136|536481339|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
148729181|NCT02177136|536481340|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
148729182|NCT02177136|536481337|FG000|LTSE Phase|Physician Decision|0|||
148729183|NCT02177136|536481338|FG001|LTSE Phase|Physician Decision|0|||
148729184|NCT02177136|536481339|FG002|LTSE Phase|Physician Decision|0|||
148729185|NCT02177136|536481340|FG003|LTSE Phase|Physician Decision|2|||
148729186|NCT02177136|536481337|FG000|LTSE Phase|Lost to Follow-up|0|||
148729187|NCT02177136|536481338|FG001|LTSE Phase|Lost to Follow-up|0|||
148729188|NCT02177136|536481339|FG002|LTSE Phase|Lost to Follow-up|0|||
148729189|NCT02177136|536481340|FG003|LTSE Phase|Lost to Follow-up|1|||
148729190|NCT02177136|536481337|FG000|LTSE Phase|Participant Moved|0|||
148729191|NCT02177136|536481338|FG001|LTSE Phase|Participant Moved|0|||
148729192|NCT02177136|536481339|FG002|LTSE Phase|Participant Moved|0|||
148729193|NCT02177136|536481340|FG003|LTSE Phase|Participant Moved|1|||
148729194|NCT02054130|536481341|FG000|Overall Study|Withdrawal by Subject|4|||
148729195|NCT02054130|536481342|FG001|Overall Study|Withdrawal by Subject|4|||
148729196|NCT02054130|536481343|FG002|Overall Study|Withdrawal by Subject|7|||
148729197|NCT02054130|536481344|FG003|Overall Study|Withdrawal by Subject|10|||
148729198|NCT02054130|536481341|FG000|Overall Study|Death|0|||
148729199|NCT02054130|536481342|FG001|Overall Study|Death|1|||
148729200|NCT02054130|536481343|FG002|Overall Study|Death|0|||
148729201|NCT02054130|536481344|FG003|Overall Study|Death|0|||
148729202|NCT02054130|536481341|FG000|Overall Study|Lost to Follow-up|0|||
148729203|NCT02054130|536481342|FG001|Overall Study|Lost to Follow-up|0|||
148729204|NCT02054130|536481343|FG002|Overall Study|Lost to Follow-up|1|||
148729205|NCT02054130|536481344|FG003|Overall Study|Lost to Follow-up|2|||
148729206|NCT02054130|536481341|FG000|Overall Study|Missed dose|4|||
148729207|NCT02054130|536481342|FG001|Overall Study|Missed dose|6|||
148729208|NCT02054130|536481343|FG002|Overall Study|Missed dose|7|||
148729209|NCT02054130|536481344|FG003|Overall Study|Missed dose|10|||
148729210|NCT01386684|536481345|FG000|Overall Study|Lost to Follow-up|51|||
148729211|NCT01386684|536481345|FG000|Overall Study|Other|51|||
148729212|NCT01386684|536481345|FG000|Overall Study|Death|47|||
148729213|NCT01386684|536481345|FG000|Overall Study|Withdrawal of Consent|44|||
148729214|NCT01386684|536481345|FG000|Overall Study|Alternative Therapy Required|37|||
148729215|NCT01386684|536481345|FG000|Overall Study|Disease Progression|28|||
148729216|NCT01386684|536481345|FG000|Overall Study|Adverse Event|20|||
148729217|NCT01386684|536481345|FG000|Overall Study|Noncompliance|8|||
148729218|NCT01386684|536481345|FG000|Overall Study|Protocol Violation|4|||
148729219|NCT01386684|536481345|FG000|Overall Study|Missing|3|||
148729220|NCT00094458|536481348|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
148729221|NCT00094458|536481349|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
148729222|NCT00094458|536481350|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
148729223|NCT00094458|536481351|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
148729224|NCT00094458|536481352|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
148729225|NCT00094458|536481353|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
148729226|NCT00094458|536481348|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
148729227|NCT00094458|536481349|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
148729228|NCT00094458|536481350|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
148729229|NCT00094458|536481351|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
148729230|NCT00094458|536481352|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
148729231|NCT00094458|536481353|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
148729232|NCT00094458|536481348|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
148729233|NCT00094458|536481349|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
148729234|NCT00094458|536481350|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
148729235|NCT00094458|536481351|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
148729236|NCT00094458|536481352|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
148729237|NCT00094458|536481353|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
148729238|NCT00094458|536481348|FG000|Main Study: Through Week 30|Adverse Event|38|||
148729239|NCT00094458|536481349|FG001|Main Study: Through Week 30|Adverse Event|20|||
148729240|NCT00094458|536481350|FG002|Main Study: Through Week 30|Adverse Event|28|||
148729241|NCT00094458|536481351|FG003|Main Study: Through Week 30|Adverse Event|0|||
148729242|NCT00094458|536481352|FG004|Main Study: Through Week 30|Adverse Event|0|||
148729243|NCT00094458|536481353|FG005|Main Study: Through Week 30|Adverse Event|0|||
148729244|NCT00094458|536481348|FG000|Main Study: Through Week 30|Death|1|||
148729245|NCT00094458|536481349|FG001|Main Study: Through Week 30|Death|0|||
148729246|NCT00094458|536481350|FG002|Main Study: Through Week 30|Death|0|||
148729247|NCT00094458|536481351|FG003|Main Study: Through Week 30|Death|0|||
148729248|NCT00094458|536481352|FG004|Main Study: Through Week 30|Death|0|||
148729249|NCT00094458|536481353|FG005|Main Study: Through Week 30|Death|0|||
148729250|NCT00094458|536481348|FG000|Main Study: Through Week 30|Other|19|||
148729251|NCT00094458|536481349|FG001|Main Study: Through Week 30|Other|16|||
148729252|NCT00094458|536481350|FG002|Main Study: Through Week 30|Other|9|||
148729253|NCT00094458|536481351|FG003|Main Study: Through Week 30|Other|0|||
148729254|NCT00094458|536481352|FG004|Main Study: Through Week 30|Other|0|||
148729255|NCT00094458|536481353|FG005|Main Study: Through Week 30|Other|0|||
148729256|NCT00094458|536481348|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
148729257|NCT00094458|536481349|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
148729258|NCT00094458|536481350|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
148729259|NCT00094458|536481351|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
148729260|NCT00094458|536481352|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
148729261|NCT00094458|536481353|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
148729262|NCT00094458|536481348|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
148729263|NCT00094458|536481349|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
148729264|NCT00094458|536481350|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
148729265|NCT00094458|536481351|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
148729266|NCT00094458|536481352|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
148729267|NCT00094458|536481353|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
148729268|NCT00094458|536481348|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
148972102|NCT02457598|537381926|FG005|Overall Study|Study Terminated by Sponsor|0|||
148972103|NCT02457598|537381927|FG006|Overall Study|Study Terminated by Sponsor|1|||
148972104|NCT02457598|537381928|FG007|Overall Study|Study Terminated by Sponsor|0|||
148972105|NCT02457598|537381929|FG008|Overall Study|Study Terminated by Sponsor|0|||
148972106|NCT02457598|537381930|FG009|Overall Study|Study Terminated by Sponsor|0|||
148972107|NCT02457598|537381931|FG010|Overall Study|Study Terminated by Sponsor|4|||
148729269|NCT00094458|536481349|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
148729270|NCT00094458|536481350|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
148729271|NCT00094458|536481351|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
148729272|NCT00094458|536481352|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
148729273|NCT00094458|536481353|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
148729274|NCT00094458|536481348|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
148972108|NCT02457598|537381932|FG011|Overall Study|Study Terminated by Sponsor|0|||
148972109|NCT02457598|537381933|FG012|Overall Study|Study Terminated by Sponsor|1|||
148729275|NCT00094458|536481349|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
148729276|NCT00094458|536481350|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
148729277|NCT00094458|536481351|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
148729278|NCT00094458|536481352|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
148729279|NCT00094458|536481353|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
148729280|NCT00094458|536481348|FG000|OLE: Open-Label Extension|Adverse Event|0|||
148729281|NCT00094458|536481349|FG001|OLE: Open-Label Extension|Adverse Event|0|||
148729282|NCT00094458|536481350|FG002|OLE: Open-Label Extension|Adverse Event|0|||
148729283|NCT00094458|536481351|FG003|OLE: Open-Label Extension|Adverse Event|0|||
148729284|NCT00094458|536481352|FG004|OLE: Open-Label Extension|Adverse Event|3|||
148729285|NCT00094458|536481353|FG005|OLE: Open-Label Extension|Adverse Event|4|||
148729286|NCT00094458|536481348|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
148729287|NCT00094458|536481349|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
148729288|NCT00094458|536481350|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
148729289|NCT00094458|536481351|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
148729290|NCT00094458|536481352|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
148729291|NCT00094458|536481353|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
148729292|NCT00094458|536481348|FG000|OLE: Open-Label Extension|Patient decision|0|||
148729293|NCT00094458|536481349|FG001|OLE: Open-Label Extension|Patient decision|0|||
148729294|NCT00094458|536481350|FG002|OLE: Open-Label Extension|Patient decision|0|||
148729295|NCT00094458|536481351|FG003|OLE: Open-Label Extension|Patient decision|0|||
148729296|NCT00094458|536481352|FG004|OLE: Open-Label Extension|Patient decision|1|||
148729297|NCT00094458|536481353|FG005|OLE: Open-Label Extension|Patient decision|0|||
148729298|NCT01995266|536481361|FG000|Overall Study|Death|1|||
148729299|NCT01995266|536481361|FG000|Overall Study|Lack of Efficacy|6|||
148729300|NCT01995266|536481361|FG000|Overall Study|Adverse Event|2|||
148729301|NCT03247517|536481362|FG000|Overall Study|Adverse Event|0|||
148729302|NCT03247517|536481363|FG001|Overall Study|Adverse Event|4|||
148729303|NCT03247517|536481364|FG002|Overall Study|Adverse Event|2|||
148729304|NCT03247517|536481362|FG000|Overall Study|Lost to Follow-up|2|||
148729305|NCT03247517|536481363|FG001|Overall Study|Lost to Follow-up|6|||
148729306|NCT03247517|536481364|FG002|Overall Study|Lost to Follow-up|4|||
148729307|NCT03247517|536481362|FG000|Overall Study|Consent withdrawn by caregiver|1|||
148729308|NCT03247517|536481363|FG001|Overall Study|Consent withdrawn by caregiver|4|||
148729309|NCT03247517|536481364|FG002|Overall Study|Consent withdrawn by caregiver|7|||
148729310|NCT03247517|536481362|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
148729311|NCT03247517|536481363|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
148729312|NCT03247517|536481364|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
148729313|NCT03247517|536481362|FG000|Overall Study|Protocol Violation|0|||
148729314|NCT03247517|536481363|FG001|Overall Study|Protocol Violation|2|||
148729315|NCT03247517|536481364|FG002|Overall Study|Protocol Violation|0|||
148729316|NCT03247517|536481362|FG000|Overall Study|Multiple reasons|3|||
148729317|NCT03247517|536481363|FG001|Overall Study|Multiple reasons|1|||
148729318|NCT03247517|536481364|FG002|Overall Study|Multiple reasons|0|||
148729319|NCT03310411|536481365|FG000|Period 1|Adverse Event|0|||
148729320|NCT03310411|536481366|FG001|Period 1|Adverse Event|0|||
148729321|NCT03310411|536481367|FG002|Period 1|Adverse Event|0|||
148729322|NCT03310411|536481368|FG003|Period 1|Adverse Event|1|||
148729323|NCT00619112|536481369|FG000|Overall Study|Adverse Event|1|||
148729324|NCT00619112|536481370|FG001|Overall Study|Adverse Event|2|||
148729325|NCT03623386|536481373|FG000|Overall Study|Protocol Violation|3|||
148729326|NCT03623386|536481374|FG001|Overall Study|Protocol Violation|2|||
148729327|NCT03623386|536481375|FG002|Overall Study|Protocol Violation|0|||
148729328|NCT03623386|536481373|FG000|Overall Study|Physician Decision|1|||
148729329|NCT03623386|536481374|FG001|Overall Study|Physician Decision|1|||
148729330|NCT03623386|536481375|FG002|Overall Study|Physician Decision|0|||
148729331|NCT03623386|536481373|FG000|Overall Study|Lost to Follow-up|0|||
148729332|NCT03623386|536481374|FG001|Overall Study|Lost to Follow-up|2|||
148729333|NCT03623386|536481375|FG002|Overall Study|Lost to Follow-up|0|||
148729334|NCT03623386|536481373|FG000|Overall Study|COVID-19|0|||
148729335|NCT03623386|536481374|FG001|Overall Study|COVID-19|1|||
148729336|NCT03623386|536481375|FG002|Overall Study|COVID-19|0|||
148729337|NCT00729248|536481376|FG000|Overall Study|Physician Decision|2|||
148729338|NCT00515541|536481379|FG000|Overall Study|Physician Decision|0|||
148729339|NCT00515541|536481380|FG001|Overall Study|Physician Decision|2|||
148729340|NCT00515541|536481381|FG002|Overall Study|Physician Decision|0|||
148729341|NCT00515541|536481382|FG003|Overall Study|Physician Decision|1|||
148729342|NCT00515541|536481379|FG000|Overall Study|No show for appointments|0|||
148729343|NCT00515541|536481380|FG001|Overall Study|No show for appointments|1|||
148729344|NCT00515541|536481381|FG002|Overall Study|No show for appointments|0|||
148729345|NCT00515541|536481382|FG003|Overall Study|No show for appointments|2|||
148729346|NCT00515541|536481379|FG000|Overall Study|Withdrawal by Subject|0|||
148729347|NCT00515541|536481380|FG001|Overall Study|Withdrawal by Subject|2|||
148729348|NCT00515541|536481381|FG002|Overall Study|Withdrawal by Subject|0|||
148729349|NCT00515541|536481382|FG003|Overall Study|Withdrawal by Subject|2|||
148729350|NCT02040779|536481384|FG000|Overall Study|Adverse Event|1|||
148729351|NCT02040779|536481385|FG001|Overall Study|Adverse Event|0|||
148729352|NCT02040779|536481386|FG002|Overall Study|Adverse Event|0|||
148729353|NCT02040779|536481384|FG000|Overall Study|Withdrawal by Subject|4|||
148817251|NCT03369223|536805392|FG005|Overall Study|Participant withdrew consent|0|||
148729354|NCT02040779|536481385|FG001|Overall Study|Withdrawal by Subject|1|||
148729355|NCT02040779|536481386|FG002|Overall Study|Withdrawal by Subject|3|||
148729356|NCT02040779|536481384|FG000|Overall Study|Non-compliance|0|||
148729357|NCT02040779|536481385|FG001|Overall Study|Non-compliance|1|||
148729358|NCT02040779|536481386|FG002|Overall Study|Non-compliance|0|||
148729359|NCT02040779|536481384|FG000|Overall Study|Protocol Violation|2|||
148729360|NCT02040779|536481385|FG001|Overall Study|Protocol Violation|1|||
148729361|NCT02040779|536481386|FG002|Overall Study|Protocol Violation|0|||
148729362|NCT02040779|536481384|FG000|Overall Study|Lost to Follow-up|1|||
148729363|NCT02040779|536481385|FG001|Overall Study|Lost to Follow-up|2|||
148729364|NCT02040779|536481386|FG002|Overall Study|Lost to Follow-up|1|||
148729365|NCT02040779|536481384|FG000|Overall Study|Lack of Efficacy|4|||
148729366|NCT02040779|536481385|FG001|Overall Study|Lack of Efficacy|2|||
148729367|NCT02040779|536481386|FG002|Overall Study|Lack of Efficacy|0|||
148729368|NCT00922272|536481389|FG000|Open-label Phase|Adverse Event|5|||
148729369|NCT00922272|536481390|FG001|Open-label Phase|Adverse Event|0|||
148729370|NCT00922272|536481389|FG000|Open-label Phase|Protocol Violation|1|||
148729371|NCT00922272|536481390|FG001|Open-label Phase|Protocol Violation|0|||
148729372|NCT00922272|536481389|FG000|Open-label Phase|Withdrawal by Subject|11|||
148729373|NCT00922272|536481390|FG001|Open-label Phase|Withdrawal by Subject|0|||
148729374|NCT00922272|536481389|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
148729375|NCT00922272|536481390|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
148729376|NCT00922272|536481389|FG000|Open-label Phase|Withdrawal criteria met|5|||
148729377|NCT00922272|536481390|FG001|Open-label Phase|Withdrawal criteria met|0|||
148729378|NCT00922272|536481389|FG000|Double-blind Phase|Adverse Event|1|||
148729379|NCT00922272|536481390|FG001|Double-blind Phase|Adverse Event|1|||
148729380|NCT00922272|536481389|FG000|Double-blind Phase|Withdrawal by Subject|1|||
148729381|NCT00922272|536481390|FG001|Double-blind Phase|Withdrawal by Subject|1|||
148729382|NCT00922272|536481389|FG000|Double-blind Phase|Lost to Follow-up|2|||
148729383|NCT00922272|536481390|FG001|Double-blind Phase|Lost to Follow-up|1|||
148729384|NCT00922272|536481389|FG000|Double-blind Phase|Withdrawal criteria met|1|||
148729385|NCT00922272|536481390|FG001|Double-blind Phase|Withdrawal criteria met|1|||
148729386|NCT00922272|536481389|FG000|Double-blind Phase|Noncompliance|1|||
148729387|NCT00922272|536481390|FG001|Double-blind Phase|Noncompliance|1|||
148729388|NCT00922272|536481389|FG000|Double-blind Phase|Positive urine drug screen|1|||
148729389|NCT00922272|536481390|FG001|Double-blind Phase|Positive urine drug screen|1|||
148729390|NCT03197558|536481397|FG000|Overall Study|Tubes not placed|1|||
148729391|NCT02588950|536481398|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
148729392|NCT02588950|536481399|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
148729393|NCT02588950|536481400|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
148729394|NCT02588950|536481401|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
148729395|NCT02588950|536481398|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
148729396|NCT02588950|536481399|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
148729397|NCT02588950|536481400|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
148729398|NCT02588950|536481401|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
148729399|NCT00866658|536481402|FG000|Overall Study|Adverse Event|5|||
148729400|NCT00866658|536481403|FG001|Overall Study|Adverse Event|14|||
148729401|NCT00866658|536481402|FG000|Overall Study|Lack of Efficacy|2|||
148729402|NCT00866658|536481403|FG001|Overall Study|Lack of Efficacy|1|||
148729403|NCT00866658|536481402|FG000|Overall Study|Withdrawal by Subject|1|||
148729404|NCT00866658|536481403|FG001|Overall Study|Withdrawal by Subject|0|||
148729405|NCT00866658|536481402|FG000|Overall Study|Protocol Violation|1|||
148729406|NCT00866658|536481403|FG001|Overall Study|Protocol Violation|1|||
148729407|NCT00866658|536481402|FG000|Overall Study|Familial and Personal Reasons|4|||
148729408|NCT00866658|536481403|FG001|Overall Study|Familial and Personal Reasons|5|||
148729409|NCT00652028|536481404|FG000|Overall Study|Adverse Event|1|||
148729410|NCT00652028|536481405|FG001|Overall Study|Adverse Event|0|||
148729411|NCT00652028|536481406|FG002|Overall Study|Adverse Event|0|||
148729412|NCT00652028|536481407|FG003|Overall Study|Adverse Event|0|||
148817252|NCT03369223|536805393|FG006|Overall Study|Participant withdrew consent|1|||
148817253|NCT03369223|536805394|FG007|Overall Study|Participant withdrew consent|1|||
148817254|NCT03369223|536805395|FG008|Overall Study|Participant withdrew consent|1|||
148729413|NCT00652028|536481404|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
148729414|NCT00652028|536481405|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
148729415|NCT00652028|536481406|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
148729416|NCT00652028|536481407|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
148729417|NCT00652028|536481404|FG000|Overall Study|Physician Decision|0|||
148729418|NCT00652028|536481405|FG001|Overall Study|Physician Decision|0|||
148729419|NCT00652028|536481406|FG002|Overall Study|Physician Decision|1|||
148729420|NCT00652028|536481407|FG003|Overall Study|Physician Decision|0|||
148729421|NCT02072824|536481408|FG000|Overall Study|Insufficient clinical response|1|||
148729422|NCT02072824|536481409|FG001|Overall Study|Insufficient clinical response|0|||
148729423|NCT02072824|536481410|FG002|Overall Study|Insufficient clinical response|1|||
148729424|NCT02072824|536481408|FG000|Overall Study|No longer willing to participate|1|||
148729425|NCT02072824|536481409|FG001|Overall Study|No longer willing to participate|0|||
148729426|NCT02072824|536481410|FG002|Overall Study|No longer willing to participate|1|||
148729427|NCT02072824|536481408|FG000|Overall Study|Medication error|0|||
148729428|NCT02072824|536481409|FG001|Overall Study|Medication error|1|||
148729429|NCT02072824|536481410|FG002|Overall Study|Medication error|0|||
148729430|NCT02072824|536481408|FG000|Overall Study|Adverse Event|0|||
148729431|NCT02072824|536481409|FG001|Overall Study|Adverse Event|0|||
148729432|NCT02072824|536481410|FG002|Overall Study|Adverse Event|1|||
148729433|NCT02751359|536481411|FG000|Overall Study|Lost to Follow-up|1|||
148729434|NCT02011113|536481415|FG000|Overall Study|Adverse Event|4|||
148729435|NCT02011113|536481415|FG000|Overall Study|Disease Progression (DP)|16|||
148729436|NCT02011113|536481415|FG000|Overall Study|Death|1|||
148729437|NCT02011113|536481415|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
148729438|NCT02011113|536481415|FG000|Overall Study|Investigator's judgement- DP|3|||
148729439|NCT02011113|536481415|FG000|Overall Study|Study terminated by sponsor|11|||
148729440|NCT02669940|536481418|FG000|Overall Study|Failure to return|0|||
148729441|NCT02669940|536481419|FG001|Overall Study|Failure to return|3|||
148729442|NCT02669940|536481418|FG000|Overall Study|Insufficient follow-up data|1|||
148729443|NCT02669940|536481419|FG001|Overall Study|Insufficient follow-up data|0|||
148729444|NCT05065983|536481428|FG000|Overall Study|Lost to Follow-up|2|||
148729445|NCT00986180|536481429|FG000|Overall Study|Adverse Event|21|||
148729446|NCT00986180|536481430|FG001|Overall Study|Adverse Event|23|||
148729447|NCT00986180|536481429|FG000|Overall Study|Lack of Efficacy|4|||
148729448|NCT00986180|536481430|FG001|Overall Study|Lack of Efficacy|3|||
148729449|NCT00986180|536481429|FG000|Overall Study|Lost to Follow-up|5|||
148729450|NCT00986180|536481430|FG001|Overall Study|Lost to Follow-up|7|||
148729451|NCT00986180|536481429|FG000|Overall Study|Physician Decision|1|||
148729452|NCT00986180|536481430|FG001|Overall Study|Physician Decision|3|||
148729453|NCT00986180|536481429|FG000|Overall Study|Protocol Violation|2|||
148729454|NCT00986180|536481430|FG001|Overall Study|Protocol Violation|0|||
148729455|NCT00986180|536481429|FG000|Overall Study|Withdrawal by Subject|1|||
148729456|NCT00986180|536481430|FG001|Overall Study|Withdrawal by Subject|9|||
148729457|NCT00986180|536481429|FG000|Overall Study|Miscellanies|10|||
148729458|NCT00986180|536481430|FG001|Overall Study|Miscellanies|11|||
148729459|NCT04295135|536481433|FG000|Overall Study|Withdrawal by Subject|2|||
148729460|NCT04295135|536481434|FG001|Overall Study|Withdrawal by Subject|1|||
148729461|NCT04295135|536481433|FG000|Overall Study|Subject left organization|8|||
148729462|NCT04295135|536481434|FG001|Overall Study|Subject left organization|4|||
148972110|NCT02457598|537381934|FG013|Overall Study|Study Terminated by Sponsor|0|||
148729463|NCT00003875|536481436|FG000|Overall Study|Screen Failed|1|||
148729464|NCT01546649|536481439|FG000|Overall Study|Adverse Event|4|||
148729465|NCT01546649|536481440|FG001|Overall Study|Adverse Event|5|||
148729466|NCT01546649|536481439|FG000|Overall Study|Protocol Violation|1|||
148729467|NCT01546649|536481440|FG001|Overall Study|Protocol Violation|0|||
148729468|NCT01546649|536481439|FG000|Overall Study|Lack of Efficacy|1|||
148729469|NCT01546649|536481440|FG001|Overall Study|Lack of Efficacy|0|||
148729470|NCT01546649|536481439|FG000|Overall Study|Recurrence|1|||
148729471|NCT01546649|536481440|FG001|Overall Study|Recurrence|1|||
148729472|NCT01546649|536481439|FG000|Overall Study|Discovery of secondary cancer|0|||
148729473|NCT01546649|536481440|FG001|Overall Study|Discovery of secondary cancer|1|||
148729474|NCT01546649|536481439|FG000|Overall Study|Withdrawal by Subject|1|||
148729475|NCT01546649|536481440|FG001|Overall Study|Withdrawal by Subject|2|||
148729476|NCT01621191|536481441|FG000|Overall Study|Adverse Event|9|||
148729477|NCT01621191|536481441|FG000|Overall Study|Withdrawal by Subject|8|||
148729478|NCT01621191|536481441|FG000|Overall Study|Lack of Efficacy|6|||
148729479|NCT01621191|536481441|FG000|Overall Study|Lost to Follow-up|1|||
148729480|NCT01621191|536481441|FG000|Overall Study|Site Removed From Study|1|||
148729481|NCT05420012|536481446|FG000|Overall Study|Lost to Follow-up|0|||
148729482|NCT05420012|536481447|FG001|Overall Study|Lost to Follow-up|1|||
148729483|NCT00038649|536481449|FG000|Overall Study|Adverse Event|9|||
148729484|NCT00942331|536481450|FG000|Overall Study|Did not start treatment|15|||
148729485|NCT00942331|536481451|FG001|Overall Study|Did not start treatment|22|||
148729486|NCT00567476|536481452|FG000|Overall Study|Adverse Event|2|||
148729487|NCT00567476|536481453|FG001|Overall Study|Adverse Event|0|||
148729488|NCT00567476|536481452|FG000|Overall Study|Pregnancy|1|||
148729489|NCT00567476|536481453|FG001|Overall Study|Pregnancy|0|||
148729490|NCT00567476|536481452|FG000|Overall Study|Protocol Violation|4|||
148729491|NCT00567476|536481453|FG001|Overall Study|Protocol Violation|1|||
148729492|NCT00567476|536481452|FG000|Overall Study|Lost to Follow-up|0|||
148729493|NCT00567476|536481453|FG001|Overall Study|Lost to Follow-up|1|||
148729494|NCT00567476|536481452|FG000|Overall Study|Administrative issues|1|||
148729495|NCT00567476|536481453|FG001|Overall Study|Administrative issues|0|||
148729496|NCT00567476|536481452|FG000|Overall Study|Medical Decision|0|||
148729497|NCT00567476|536481453|FG001|Overall Study|Medical Decision|1|||
148729498|NCT00567476|536481452|FG000|Overall Study|Non-adherence to protocol|0|||
148729499|NCT00567476|536481453|FG001|Overall Study|Non-adherence to protocol|1|||
148729500|NCT01491035|536481462|FG000|Overall Study|Lost to Follow-up|0|||
148729501|NCT01491035|536481463|FG001|Overall Study|Lost to Follow-up|0|||
148729502|NCT01491035|536481464|FG002|Overall Study|Lost to Follow-up|0|||
148729503|NCT01491035|536481465|FG003|Overall Study|Lost to Follow-up|0|||
148729504|NCT01491035|536481466|FG004|Overall Study|Lost to Follow-up|1|||
148729505|NCT01491035|536481467|FG005|Overall Study|Lost to Follow-up|0|||
148729506|NCT01491035|536481468|FG006|Overall Study|Lost to Follow-up|0|||
148729507|NCT01491035|536481469|FG007|Overall Study|Lost to Follow-up|0|||
148729508|NCT06204887|536483031|FG000|Overall Study|Lost to Follow-up|3|||
148729509|NCT06204887|536483032|FG001|Overall Study|Lost to Follow-up|4|||
148729510|NCT06204887|536483033|FG002|Overall Study|Lost to Follow-up|1|||
148729511|NCT06204887|536483034|FG003|Overall Study|Lost to Follow-up|6|||
148729512|NCT02522403|536483035|FG000|Overall Study|Lost to Follow-up|2|||
148729513|NCT02522403|536483036|FG001|Overall Study|Lost to Follow-up|2|||
148729514|NCT02522403|536483035|FG000|Overall Study|Withdrawal by Subject|2|||
148729515|NCT02522403|536483036|FG001|Overall Study|Withdrawal by Subject|4|||
148729516|NCT00856973|536483037|FG000|Overall Study|Adverse Event|5|||
148729517|NCT00856973|536483038|FG001|Overall Study|Adverse Event|5|||
148729518|NCT00856973|536483039|FG002|Overall Study|Adverse Event|3|||
148729519|NCT00856973|536483037|FG000|Overall Study|Lost to Follow-up|6|||
148729520|NCT00856973|536483038|FG001|Overall Study|Lost to Follow-up|3|||
148729521|NCT00856973|536483039|FG002|Overall Study|Lost to Follow-up|5|||
148729522|NCT00856973|536483037|FG000|Overall Study|Physician Decision|0|||
148729523|NCT00856973|536483038|FG001|Overall Study|Physician Decision|3|||
148729524|NCT00856973|536483039|FG002|Overall Study|Physician Decision|1|||
148729525|NCT00856973|536483037|FG000|Overall Study|Protocol Violation|1|||
148729526|NCT00856973|536483038|FG001|Overall Study|Protocol Violation|2|||
148729527|NCT00856973|536483039|FG002|Overall Study|Protocol Violation|1|||
148729528|NCT00856973|536483037|FG000|Overall Study|Withdrawal by Subject|13|||
148729529|NCT00856973|536483038|FG001|Overall Study|Withdrawal by Subject|16|||
148729530|NCT00856973|536483039|FG002|Overall Study|Withdrawal by Subject|15|||
148729531|NCT00856973|536483037|FG000|Overall Study|Other|11|||
148972111|NCT02457598|537381935|FG014|Overall Study|Study Terminated by Sponsor|8|||
148972112|NCT02457598|537381936|FG015|Overall Study|Study Terminated by Sponsor|1|||
148729532|NCT00856973|536483038|FG001|Overall Study|Other|12|||
148729533|NCT00856973|536483039|FG002|Overall Study|Other|13|||
148729534|NCT00841906|536483044|FG000|Overall Study|Withdrawal by Subject|2|||
148729535|NCT00841906|536483045|FG001|Overall Study|Withdrawal by Subject|0|||
148729536|NCT01196078|536483046|FG000|Overall Study|Withdrawal by Subject|3|||
148729537|NCT01196078|536483047|FG001|Overall Study|Withdrawal by Subject|5|||
148729538|NCT01196078|536483046|FG000|Overall Study|Adverse Event|4|||
148729539|NCT01196078|536483047|FG001|Overall Study|Adverse Event|4|||
148729540|NCT01196078|536483046|FG000|Overall Study|Protocol Violation|2|||
148729541|NCT01196078|536483047|FG001|Overall Study|Protocol Violation|1|||
148729542|NCT01196078|536483046|FG000|Overall Study|Lack of Efficacy|17|||
148729543|NCT01196078|536483047|FG001|Overall Study|Lack of Efficacy|23|||
148729544|NCT01196078|536483046|FG000|Overall Study|Lost to Follow-up|1|||
148729545|NCT01196078|536483047|FG001|Overall Study|Lost to Follow-up|0|||
148729546|NCT01196078|536483046|FG000|Overall Study|Death|6|||
148729547|NCT01196078|536483047|FG001|Overall Study|Death|4|||
148729548|NCT00127036|536483048|FG000|Overall Study|Insufficient Data for Analysis|6|||
148972113|NCT02457598|537381937|FG016|Overall Study|Study Terminated by Sponsor|0|||
148972114|NCT02457598|537381921|FG000|Overall Study|Adverse Event|0|||
148729549|NCT00127036|536483049|FG001|Overall Study|Insufficient Data for Analysis|11|||
148729550|NCT00127036|536483048|FG000|Overall Study|Screen Failure|2|||
148729551|NCT00127036|536483049|FG001|Overall Study|Screen Failure|0|||
148729552|NCT03001219|536483059|FG000|Proof of Concept|Study Termination by Sponsor|0|||
148729553|NCT03001219|536483060|FG001|Proof of Concept|Study Termination by Sponsor|1|||
148729554|NCT03001219|536483059|FG000|Proof of Concept|Withdrawal by Subject|0|||
148729555|NCT03001219|536483060|FG001|Proof of Concept|Withdrawal by Subject|4|||
148729556|NCT03001219|536483059|FG000|Proof of Concept|Protocol Deviation|0|||
148729557|NCT03001219|536483060|FG001|Proof of Concept|Protocol Deviation|1|||
148729558|NCT03001219|536483059|FG000|Proof of Concept|Adverse Event|1|||
148729559|NCT03001219|536483060|FG001|Proof of Concept|Adverse Event|1|||
148729560|NCT03001219|536483059|FG000|Proof of Concept|Physician Decision|1|||
148729561|NCT03001219|536483060|FG001|Proof of Concept|Physician Decision|0|||
148729562|NCT03001219|536483059|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
148729563|NCT03001219|536483060|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
148729564|NCT03001219|536483059|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
148729565|NCT03001219|536483060|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
148729566|NCT03001219|536483059|FG000|Extension Period Analysis|Physician Decision|0|||
148729567|NCT03001219|536483060|FG001|Extension Period Analysis|Physician Decision|1|||
148729568|NCT03001219|536483059|FG000|Extension Period Analysis|Adverse Event|1|||
148729569|NCT03001219|536483060|FG001|Extension Period Analysis|Adverse Event|1|||
148729570|NCT03001219|536483059|FG000|Extension Period Analysis|Protocol Deviation|0|||
148729571|NCT03001219|536483060|FG001|Extension Period Analysis|Protocol Deviation|1|||
148729572|NCT03001219|536483059|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
148729573|NCT03001219|536483060|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
148729574|NCT01797835|536483061|FG000|Overall Study|Lost to Follow-up|31|||
148729575|NCT01797835|536483062|FG001|Overall Study|Lost to Follow-up|27|||
148729576|NCT01403064|536483063|FG000|Overall Study|Death|0|||
148729577|NCT01403064|536483064|FG001|Overall Study|Death|0|||
148729578|NCT01403064|536483065|FG002|Overall Study|Death|1|||
148729579|NCT01403064|536483066|FG003|Overall Study|Death|1|||
148729580|NCT01403064|536483063|FG000|Overall Study|Withdrawal by Subject|0|||
148729581|NCT01403064|536483064|FG001|Overall Study|Withdrawal by Subject|0|||
148729582|NCT01403064|536483065|FG002|Overall Study|Withdrawal by Subject|1|||
148729583|NCT01403064|536483066|FG003|Overall Study|Withdrawal by Subject|1|||
148729584|NCT01403064|536483063|FG000|Overall Study|Other|1|||
148729585|NCT01403064|536483064|FG001|Overall Study|Other|0|||
148729586|NCT01403064|536483065|FG002|Overall Study|Other|2|||
148729587|NCT01403064|536483066|FG003|Overall Study|Other|1|||
148729588|NCT02528123|536483067|FG000|Overall Study|Lost to Follow-up|1|||
148729589|NCT03733210|536483068|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
148729590|NCT03733210|536483069|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
148729591|NCT03760250|536483070|FG000|Overall Study|Withdrawal by Subject|1|||
148729592|NCT03760250|536483070|FG000|Overall Study|Physician Decision|1|||
148729593|NCT03251963|536483071|FG000|Overall Study|inappropriate Xa level timing|6|||
148729594|NCT03251963|536483072|FG001|Overall Study|inappropriate Xa level timing|3|||
148729595|NCT03251963|536483071|FG000|Overall Study|no peak Xa level drawn|2|||
148729596|NCT03251963|536483072|FG001|Overall Study|no peak Xa level drawn|0|||
148729597|NCT03251963|536483071|FG000|Overall Study|bled prior to Xa level|1|||
148729598|NCT03251963|536483072|FG001|Overall Study|bled prior to Xa level|2|||
148729599|NCT02303041|536483077|FG000|Overall Study|Adverse Event|1|||
148729600|NCT02303041|536483078|FG001|Overall Study|Adverse Event|2|||
148729601|NCT00886288|536483079|FG000|Overall Study|no respect of the 12 weeks period|657|||
148729602|NCT00886288|536483080|FG001|Overall Study|no respect of the 12 weeks period|227|||
148729603|NCT00886288|536483079|FG000|Overall Study|Lost to Follow-up|86|||
148729604|NCT00886288|536483080|FG001|Overall Study|Lost to Follow-up|0|||
148729605|NCT00289874|536483081|FG000|Overall Study|Adverse Event|1|||
148729606|NCT00289874|536483082|FG001|Overall Study|Adverse Event|5|||
148729607|NCT00289874|536483081|FG000|Overall Study|Lost to Follow-up|1|||
148729608|NCT00289874|536483082|FG001|Overall Study|Lost to Follow-up|1|||
148729609|NCT00289874|536483081|FG000|Overall Study|Protocol Violation|3|||
148729610|NCT00289874|536483082|FG001|Overall Study|Protocol Violation|2|||
148729611|NCT00289874|536483081|FG000|Overall Study|Did not meet eligibility|1|||
148729612|NCT00289874|536483082|FG001|Overall Study|Did not meet eligibility|0|||
148729613|NCT00136318|536483085|FG000|Overall Study|Adverse Event|5|||
148729614|NCT00136318|536483086|FG001|Overall Study|Adverse Event|5|||
148729615|NCT00136318|536483085|FG000|Overall Study|Withdrawal by Subject|2|||
148729616|NCT00136318|536483086|FG001|Overall Study|Withdrawal by Subject|2|||
148729617|NCT04355663|536483088|FG000|Overall Study|Physician Decision|2|||
148729618|NCT04355663|536483089|FG001|Overall Study|Physician Decision|7|||
148729619|NCT04355663|536483090|FG002|Overall Study|Physician Decision|0|||
148729620|NCT04355663|536483088|FG000|Overall Study|Adverse Event|0|||
148729621|NCT04355663|536483089|FG001|Overall Study|Adverse Event|0|||
148729622|NCT04355663|536483090|FG002|Overall Study|Adverse Event|1|||
148972115|NCT02457598|537381922|FG001|Overall Study|Adverse Event|1|||
148729623|NCT04355663|536483088|FG000|Overall Study|Withdrawal by Subject|0|||
148729624|NCT04355663|536483089|FG001|Overall Study|Withdrawal by Subject|8|||
148729625|NCT04355663|536483090|FG002|Overall Study|Withdrawal by Subject|3|||
148729626|NCT03395639|536483094|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
148729627|NCT03395639|536483095|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
148729628|NCT03395639|536483096|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
148729629|NCT03395639|536483094|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
148729630|NCT03395639|536483095|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
148729631|NCT03395639|536483096|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
148729632|NCT03395639|536483094|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
148729633|NCT03395639|536483095|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
148729634|NCT03395639|536483096|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
148729635|NCT03395639|536483094|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
148729636|NCT03395639|536483095|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
148729637|NCT03395639|536483096|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
148729638|NCT03395639|536483094|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
148729639|NCT03395639|536483095|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
148972116|NCT02457598|537381923|FG002|Overall Study|Adverse Event|1|||
148972117|NCT02457598|537381924|FG003|Overall Study|Adverse Event|4|||
148972118|NCT02457598|537381925|FG004|Overall Study|Adverse Event|1|||
148972119|NCT02457598|537381926|FG005|Overall Study|Adverse Event|0|||
148972120|NCT02457598|537381927|FG006|Overall Study|Adverse Event|0|||
148972121|NCT02457598|537381928|FG007|Overall Study|Adverse Event|1|||
148972122|NCT02457598|537381929|FG008|Overall Study|Adverse Event|0|||
148972123|NCT02457598|537381930|FG009|Overall Study|Adverse Event|1|||
148972124|NCT02457598|537381931|FG010|Overall Study|Adverse Event|6|||
148972125|NCT02457598|537381932|FG011|Overall Study|Adverse Event|0|||
148972126|NCT02457598|537381933|FG012|Overall Study|Adverse Event|0|||
148972127|NCT02457598|537381934|FG013|Overall Study|Adverse Event|1|||
148972128|NCT02457598|537381935|FG014|Overall Study|Adverse Event|2|||
148972129|NCT02457598|537381936|FG015|Overall Study|Adverse Event|0|||
148972130|NCT02457598|537381937|FG016|Overall Study|Adverse Event|0|||
148972131|NCT02457598|537381921|FG000|Overall Study|Death|0|||
148972132|NCT02457598|537381922|FG001|Overall Study|Death|0|||
148972133|NCT02457598|537381923|FG002|Overall Study|Death|0|||
148972134|NCT02457598|537381924|FG003|Overall Study|Death|3|||
148972135|NCT02457598|537381925|FG004|Overall Study|Death|0|||
148972136|NCT02457598|537381926|FG005|Overall Study|Death|1|||
148972137|NCT02457598|537381927|FG006|Overall Study|Death|0|||
148972138|NCT02457598|537381928|FG007|Overall Study|Death|0|||
148972139|NCT02457598|537381929|FG008|Overall Study|Death|0|||
148972140|NCT02457598|537381930|FG009|Overall Study|Death|0|||
148972141|NCT02457598|537381931|FG010|Overall Study|Death|3|||
148972142|NCT02457598|537381932|FG011|Overall Study|Death|0|||
148972143|NCT02457598|537381933|FG012|Overall Study|Death|0|||
148972144|NCT02457598|537381934|FG013|Overall Study|Death|1|||
148972145|NCT02457598|537381935|FG014|Overall Study|Death|2|||
148972146|NCT02457598|537381936|FG015|Overall Study|Death|0|||
148972147|NCT02457598|537381937|FG016|Overall Study|Death|1|||
148972148|NCT02457598|537381921|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972149|NCT02457598|537381922|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
148972150|NCT02457598|537381923|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972151|NCT02457598|537381924|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
148972152|NCT02457598|537381925|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972153|NCT02457598|537381926|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972154|NCT02457598|537381927|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972155|NCT02457598|537381928|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
148972156|NCT02457598|537381929|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972157|NCT02457598|537381930|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972158|NCT02457598|537381931|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
148972159|NCT02457598|537381932|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972160|NCT02457598|537381933|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972161|NCT02457598|537381934|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
148972162|NCT02457598|537381935|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
148972163|NCT02457598|537381936|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
148972164|NCT02457598|537381937|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
148972165|NCT02457598|537381921|FG000|Overall Study|Withdrew Consent|0|||
148972166|NCT02457598|537381922|FG001|Overall Study|Withdrew Consent|0|||
148972167|NCT02457598|537381923|FG002|Overall Study|Withdrew Consent|0|||
148972168|NCT02457598|537381924|FG003|Overall Study|Withdrew Consent|0|||
148972169|NCT02457598|537381925|FG004|Overall Study|Withdrew Consent|0|||
148729640|NCT03395639|536483096|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
148729641|NCT02595008|536483097|FG000|Overall Study|Enrolled In Error|1|||
148729642|NCT02595008|536483098|FG001|Overall Study|Enrolled In Error|0|||
148729643|NCT03407118|536483099|FG000|Period 2|Withdrawal by Subject|1|||
148729644|NCT03407118|536483100|FG001|Period 2|Withdrawal by Subject|0|||
148729645|NCT02687360|536483107|FG000|Overall Study|Withdrawal by Subject|3|||
148729646|NCT02687360|536483108|FG001|Overall Study|Withdrawal by Subject|0|||
148729647|NCT02999477|536483109|FG000|Overall Study|found ineligible after first dose|0|||
148817255|NCT03369223|536805396|FG009|Overall Study|Participant withdrew consent|0|||
148817256|NCT03369223|536805397|FG010|Overall Study|Participant withdrew consent|0|||
148817257|NCT03369223|536805398|FG011|Overall Study|Participant withdrew consent|1|||
148817258|NCT03369223|536805399|FG012|Overall Study|Participant withdrew consent|0|||
148817259|NCT03369223|536805400|FG013|Overall Study|Participant withdrew consent|0|||
148817260|NCT03369223|536805401|FG014|Overall Study|Participant withdrew consent|3|||
148817261|NCT03369223|536805402|FG015|Overall Study|Participant withdrew consent|0|||
148817262|NCT03369223|536805403|FG016|Overall Study|Participant withdrew consent|1|||
148817263|NCT03369223|536805404|FG017|Overall Study|Participant withdrew consent|0|||
148817264|NCT03369223|536805405|FG018|Overall Study|Participant withdrew consent|4|||
148817265|NCT03369223|536805406|FG019|Overall Study|Participant withdrew consent|2|||
148817266|NCT03369223|536805387|FG000|Overall Study|Randomized but not treated|0|||
148817267|NCT03369223|536805388|FG001|Overall Study|Randomized but not treated|0|||
148817268|NCT03369223|536805389|FG002|Overall Study|Randomized but not treated|0|||
148817269|NCT03369223|536805390|FG003|Overall Study|Randomized but not treated|0|||
148817270|NCT03369223|536805391|FG004|Overall Study|Randomized but not treated|0|||
148817271|NCT03369223|536805392|FG005|Overall Study|Randomized but not treated|0|||
148817272|NCT03369223|536805393|FG006|Overall Study|Randomized but not treated|0|||
148817273|NCT03369223|536805394|FG007|Overall Study|Randomized but not treated|0|||
148817274|NCT03369223|536805395|FG008|Overall Study|Randomized but not treated|0|||
148817275|NCT03369223|536805396|FG009|Overall Study|Randomized but not treated|0|||
148817276|NCT03369223|536805397|FG010|Overall Study|Randomized but not treated|0|||
148817277|NCT03369223|536805398|FG011|Overall Study|Randomized but not treated|0|||
148817278|NCT03369223|536805399|FG012|Overall Study|Randomized but not treated|0|||
148817279|NCT03369223|536805400|FG013|Overall Study|Randomized but not treated|1|||
148817280|NCT03369223|536805401|FG014|Overall Study|Randomized but not treated|1|||
148817281|NCT03369223|536805402|FG015|Overall Study|Randomized but not treated|0|||
148817282|NCT03369223|536805403|FG016|Overall Study|Randomized but not treated|0|||
148817283|NCT03369223|536805404|FG017|Overall Study|Randomized but not treated|0|||
148817284|NCT03369223|536805405|FG018|Overall Study|Randomized but not treated|0|||
148817285|NCT03369223|536805406|FG019|Overall Study|Randomized but not treated|0|||
148817286|NCT01121575|536805407|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
148817287|NCT01121575|536805408|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
148817288|NCT01121575|536805409|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
148817289|NCT01121575|536805410|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
148817290|NCT01121575|536805411|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
148817291|NCT01121575|536805412|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
148817292|NCT01121575|536805407|FG000|Overall Study|Unspecified Reasons|8|||
148817293|NCT01121575|536805408|FG001|Overall Study|Unspecified Reasons|6|||
148817294|NCT01121575|536805409|FG002|Overall Study|Unspecified Reasons|7|||
148817295|NCT01121575|536805410|FG003|Overall Study|Unspecified Reasons|5|||
148817296|NCT01121575|536805411|FG004|Overall Study|Unspecified Reasons|13|||
148817297|NCT01121575|536805412|FG005|Overall Study|Unspecified Reasons|10|||
148817298|NCT01121575|536805407|FG000|Overall Study|Death|6|||
148817299|NCT01121575|536805408|FG001|Overall Study|Death|0|||
148817300|NCT01121575|536805409|FG002|Overall Study|Death|0|||
148817301|NCT01121575|536805410|FG003|Overall Study|Death|1|||
148817302|NCT01121575|536805411|FG004|Overall Study|Death|7|||
148817303|NCT01121575|536805412|FG005|Overall Study|Death|1|||
148817304|NCT00504231|536807236|FG000|Overall Study|Discrepant chart documentation re route|0|||
148817305|NCT00504231|536807237|FG001|Overall Study|Discrepant chart documentation re route|0|||
148817306|NCT00504231|536807238|FG002|Overall Study|Discrepant chart documentation re route|1|||
148729648|NCT02999477|536483110|FG001|Overall Study|found ineligible after first dose|1|||
148729649|NCT02999477|536483109|FG000|Overall Study|Withdrawal by Subject|1|||
148729650|NCT02999477|536483110|FG001|Overall Study|Withdrawal by Subject|1|||
148729651|NCT01846273|536483112|FG000|Overall Study|Adverse Event|9|||
148817307|NCT00504231|536807239|FG003|Overall Study|Discrepant chart documentation re route|0|||
148817308|NCT00835978|536807240|FG000|Overall Study|Death|33|||
148817309|NCT00835978|536807241|FG001|Overall Study|Death|40|||
148817310|NCT00835978|536807242|FG002|Overall Study|Death|49|||
148817311|NCT00835978|536807243|FG003|Overall Study|Death|4|||
148817312|NCT00835978|536807240|FG000|Overall Study|Lost to Follow-up|3|||
148817313|NCT00835978|536807241|FG001|Overall Study|Lost to Follow-up|4|||
148817314|NCT00835978|536807242|FG002|Overall Study|Lost to Follow-up|2|||
148817315|NCT00835978|536807243|FG003|Overall Study|Lost to Follow-up|1|||
148817316|NCT00835978|536807240|FG000|Overall Study|Other|5|||
148817317|NCT00835978|536807241|FG001|Overall Study|Other|1|||
148729652|NCT01846273|536483113|FG001|Overall Study|Adverse Event|7|||
148972170|NCT02457598|537381926|FG005|Overall Study|Withdrew Consent|0|||
148972171|NCT02457598|537381927|FG006|Overall Study|Withdrew Consent|0|||
148972172|NCT02457598|537381928|FG007|Overall Study|Withdrew Consent|2|||
148972173|NCT02457598|537381929|FG008|Overall Study|Withdrew Consent|0|||
148972174|NCT02457598|537381930|FG009|Overall Study|Withdrew Consent|0|||
148972175|NCT02457598|537381931|FG010|Overall Study|Withdrew Consent|3|||
148972176|NCT02457598|537381932|FG011|Overall Study|Withdrew Consent|0|||
148972177|NCT02457598|537381933|FG012|Overall Study|Withdrew Consent|0|||
148729653|NCT01846273|536483114|FG002|Overall Study|Adverse Event|0|||
148729654|NCT01846273|536483112|FG000|Overall Study|Subject withdrew consent|5|||
148729655|NCT01846273|536483113|FG001|Overall Study|Subject withdrew consent|8|||
148729656|NCT01846273|536483114|FG002|Overall Study|Subject withdrew consent|0|||
148729657|NCT01846273|536483112|FG000|Overall Study|Lost to Follow-up|2|||
148729658|NCT01846273|536483113|FG001|Overall Study|Lost to Follow-up|1|||
148729659|NCT01846273|536483114|FG002|Overall Study|Lost to Follow-up|0|||
148729660|NCT01846273|536483112|FG000|Overall Study|Administrative problems|1|||
148729661|NCT01846273|536483113|FG001|Overall Study|Administrative problems|0|||
148729662|NCT01846273|536483114|FG002|Overall Study|Administrative problems|0|||
148729663|NCT01846273|536483112|FG000|Overall Study|Death|2|||
148729664|NCT01846273|536483113|FG001|Overall Study|Death|1|||
148729665|NCT01846273|536483114|FG002|Overall Study|Death|0|||
148972178|NCT02457598|537381934|FG013|Overall Study|Withdrew Consent|1|||
148972179|NCT02457598|537381935|FG014|Overall Study|Withdrew Consent|0|||
148972180|NCT02457598|537381936|FG015|Overall Study|Withdrew Consent|0|||
148972181|NCT02457598|537381937|FG016|Overall Study|Withdrew Consent|0|||
148972182|NCT02457598|537381921|FG000|Overall Study|Unacceptable Toxicity|0|||
148972183|NCT02457598|537381922|FG001|Overall Study|Unacceptable Toxicity|0|||
148972184|NCT02457598|537381923|FG002|Overall Study|Unacceptable Toxicity|0|||
148972185|NCT02457598|537381924|FG003|Overall Study|Unacceptable Toxicity|0|||
148972186|NCT02457598|537381925|FG004|Overall Study|Unacceptable Toxicity|0|||
148972187|NCT02457598|537381926|FG005|Overall Study|Unacceptable Toxicity|0|||
148972188|NCT02457598|537381927|FG006|Overall Study|Unacceptable Toxicity|0|||
148972189|NCT02457598|537381928|FG007|Overall Study|Unacceptable Toxicity|0|||
148972190|NCT02457598|537381929|FG008|Overall Study|Unacceptable Toxicity|0|||
148972191|NCT02457598|537381930|FG009|Overall Study|Unacceptable Toxicity|0|||
148972192|NCT02457598|537381931|FG010|Overall Study|Unacceptable Toxicity|1|||
148972193|NCT02457598|537381932|FG011|Overall Study|Unacceptable Toxicity|0|||
148972194|NCT02457598|537381933|FG012|Overall Study|Unacceptable Toxicity|1|||
148972195|NCT02457598|537381934|FG013|Overall Study|Unacceptable Toxicity|1|||
148972196|NCT02457598|537381935|FG014|Overall Study|Unacceptable Toxicity|1|||
148972197|NCT02457598|537381936|FG015|Overall Study|Unacceptable Toxicity|0|||
148972198|NCT02457598|537381937|FG016|Overall Study|Unacceptable Toxicity|0|||
148972199|NCT02457598|537381921|FG000|Overall Study|Intercurrent Illness|0|||
148972200|NCT02457598|537381922|FG001|Overall Study|Intercurrent Illness|0|||
148972201|NCT02457598|537381923|FG002|Overall Study|Intercurrent Illness|0|||
148972202|NCT02457598|537381924|FG003|Overall Study|Intercurrent Illness|0|||
148972203|NCT02457598|537381925|FG004|Overall Study|Intercurrent Illness|0|||
148972204|NCT02457598|537381926|FG005|Overall Study|Intercurrent Illness|0|||
148972205|NCT02457598|537381927|FG006|Overall Study|Intercurrent Illness|0|||
148972206|NCT02457598|537381928|FG007|Overall Study|Intercurrent Illness|0|||
148972207|NCT02457598|537381929|FG008|Overall Study|Intercurrent Illness|0|||
148972208|NCT02457598|537381930|FG009|Overall Study|Intercurrent Illness|0|||
148972209|NCT02457598|537381931|FG010|Overall Study|Intercurrent Illness|1|||
148972210|NCT02457598|537381932|FG011|Overall Study|Intercurrent Illness|0|||
148972211|NCT02457598|537381933|FG012|Overall Study|Intercurrent Illness|0|||
148729666|NCT01846273|536483112|FG000|Overall Study|Disease Progression|0|||
148729667|NCT01846273|536483113|FG001|Overall Study|Disease Progression|4|||
148729668|NCT01846273|536483114|FG002|Overall Study|Disease Progression|0|||
148729669|NCT01846273|536483112|FG000|Overall Study|Protocol Deviation|2|||
148729670|NCT01846273|536483113|FG001|Overall Study|Protocol Deviation|3|||
148729671|NCT01846273|536483114|FG002|Overall Study|Protocol Deviation|0|||
148729672|NCT01846273|536483112|FG000|Overall Study|Physician Decision|1|||
148729673|NCT01846273|536483113|FG001|Overall Study|Physician Decision|2|||
148729674|NCT01846273|536483114|FG002|Overall Study|Physician Decision|0|||
148729675|NCT00891839|536483115|FG000|Overall Study|Adverse Event|2|||
148729676|NCT00891839|536483115|FG000|Overall Study|Withdrawal by Subject|2|||
148729677|NCT00891839|536483115|FG000|Overall Study|Disease progression|3|||
148729678|NCT02037165|536483116|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
148729679|NCT02037165|536483117|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
148729680|NCT02037165|536483118|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
148729681|NCT02037165|536483119|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
148729682|NCT02037165|536483120|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
148729683|NCT02192164|536483126|FG000|Overall Study|Other|8|||
148729684|NCT02192164|536483126|FG000|Overall Study|Withdrawal by Subject|1|||
148729685|NCT02192164|536483126|FG000|Overall Study|Physician Decision|4|||
148729686|NCT02192164|536483126|FG000|Overall Study|Did not meet the exclusion criteria|1|||
148972212|NCT02457598|537381934|FG013|Overall Study|Intercurrent Illness|0|||
148972213|NCT02457598|537381935|FG014|Overall Study|Intercurrent Illness|0|||
148972214|NCT02457598|537381936|FG015|Overall Study|Intercurrent Illness|0|||
148972215|NCT02457598|537381937|FG016|Overall Study|Intercurrent Illness|0|||
148972216|NCT02457598|537381921|FG000|Overall Study|Protocol Violation|0|||
148972217|NCT02457598|537381922|FG001|Overall Study|Protocol Violation|0|||
148972218|NCT02457598|537381923|FG002|Overall Study|Protocol Violation|0|||
148972219|NCT02457598|537381924|FG003|Overall Study|Protocol Violation|0|||
148972220|NCT02457598|537381925|FG004|Overall Study|Protocol Violation|0|||
148972221|NCT02457598|537381926|FG005|Overall Study|Protocol Violation|0|||
148972222|NCT02457598|537381927|FG006|Overall Study|Protocol Violation|0|||
148972223|NCT02457598|537381928|FG007|Overall Study|Protocol Violation|0|||
148972224|NCT02457598|537381929|FG008|Overall Study|Protocol Violation|0|||
148972225|NCT02457598|537381930|FG009|Overall Study|Protocol Violation|0|||
148972226|NCT02457598|537381931|FG010|Overall Study|Protocol Violation|1|||
148972227|NCT02457598|537381932|FG011|Overall Study|Protocol Violation|0|||
148972228|NCT02457598|537381933|FG012|Overall Study|Protocol Violation|0|||
148972229|NCT02457598|537381934|FG013|Overall Study|Protocol Violation|0|||
148972230|NCT02457598|537381935|FG014|Overall Study|Protocol Violation|0|||
148972231|NCT02457598|537381936|FG015|Overall Study|Protocol Violation|0|||
148972232|NCT02457598|537381937|FG016|Overall Study|Protocol Violation|0|||
148972233|NCT03837899|537381938|FG000|Overall Study|Death|6|||
148972234|NCT03837899|537381939|FG001|Overall Study|Death|8|||
148972235|NCT03837899|537381940|FG002|Overall Study|Death|3|||
148972236|NCT03837899|537381941|FG003|Overall Study|Death|7|||
148972237|NCT03837899|537381942|FG004|Overall Study|Death|8|||
148972238|NCT03837899|537381943|FG005|Overall Study|Death|7|||
148972239|NCT03837899|537381938|FG000|Overall Study|Moved to post-trial access program|0|||
148972240|NCT03837899|537381939|FG001|Overall Study|Moved to post-trial access program|1|||
148972241|NCT03837899|537381940|FG002|Overall Study|Moved to post-trial access program|0|||
148972242|NCT03837899|537381941|FG003|Overall Study|Moved to post-trial access program|0|||
148972243|NCT03837899|537381942|FG004|Overall Study|Moved to post-trial access program|0|||
148972244|NCT03837899|537381943|FG005|Overall Study|Moved to post-trial access program|0|||
148972245|NCT03837899|537381938|FG000|Overall Study|Other|0|||
148972246|NCT03837899|537381939|FG001|Overall Study|Other|0|||
148972247|NCT03837899|537381940|FG002|Overall Study|Other|0|||
148972248|NCT03837899|537381941|FG003|Overall Study|Other|0|||
148972249|NCT03837899|537381942|FG004|Overall Study|Other|0|||
148972250|NCT03837899|537381943|FG005|Overall Study|Other|2|||
148972251|NCT03837899|537381938|FG000|Overall Study|Lost to Follow-up|0|||
148972252|NCT03837899|537381939|FG001|Overall Study|Lost to Follow-up|1|||
148972253|NCT03837899|537381940|FG002|Overall Study|Lost to Follow-up|0|||
148972254|NCT03837899|537381941|FG003|Overall Study|Lost to Follow-up|0|||
148972255|NCT03837899|537381942|FG004|Overall Study|Lost to Follow-up|0|||
148972256|NCT03837899|537381943|FG005|Overall Study|Lost to Follow-up|0|||
148972257|NCT03837899|537381938|FG000|Overall Study|Withdrawal by Subject|0|||
148972258|NCT03837899|537381939|FG001|Overall Study|Withdrawal by Subject|0|||
148972259|NCT03837899|537381940|FG002|Overall Study|Withdrawal by Subject|0|||
148972260|NCT03837899|537381941|FG003|Overall Study|Withdrawal by Subject|1|||
148729687|NCT00851643|536483127|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
148729688|NCT00851643|536483128|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
148729689|NCT00851643|536483129|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
148729690|NCT00851643|536483130|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
148729691|NCT00851643|536483131|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
148729692|NCT00851643|536483132|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
148729693|NCT00851643|536483127|FG000|Base Study (Up to 12 Months)|Other|0|||
148729694|NCT00851643|536483128|FG001|Base Study (Up to 12 Months)|Other|0|||
148729695|NCT00851643|536483129|FG002|Base Study (Up to 12 Months)|Other|0|||
148729696|NCT00851643|536483130|FG003|Base Study (Up to 12 Months)|Other|0|||
148729697|NCT00851643|536483131|FG004|Base Study (Up to 12 Months)|Other|0|||
148729698|NCT00851643|536483132|FG005|Base Study (Up to 12 Months)|Other|1|||
148729699|NCT00851643|536483127|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
148972261|NCT03837899|537381942|FG004|Overall Study|Withdrawal by Subject|0|||
148972262|NCT03837899|537381943|FG005|Overall Study|Withdrawal by Subject|0|||
148972263|NCT03837899|537381938|FG000|Overall Study|Study specific discontinuation criteria|0|||
148972264|NCT03837899|537381939|FG001|Overall Study|Study specific discontinuation criteria|1|||
148972265|NCT03837899|537381940|FG002|Overall Study|Study specific discontinuation criteria|0|||
148972266|NCT03837899|537381941|FG003|Overall Study|Study specific discontinuation criteria|0|||
148972267|NCT03837899|537381942|FG004|Overall Study|Study specific discontinuation criteria|3|||
148972268|NCT03837899|537381943|FG005|Overall Study|Study specific discontinuation criteria|1|||
148972269|NCT00974571|537381944|FG000|Overall Study|Adverse Event|31|||
148972270|NCT00974571|537381945|FG001|Overall Study|Adverse Event|4|||
148972271|NCT00974571|537381946|FG002|Overall Study|Adverse Event|27|||
148972272|NCT00974571|537381944|FG000|Overall Study|Lack of Efficacy|3|||
148972273|NCT00974571|537381945|FG001|Overall Study|Lack of Efficacy|2|||
148972274|NCT00974571|537381946|FG002|Overall Study|Lack of Efficacy|9|||
148972275|NCT00974571|537381944|FG000|Overall Study|Lost to Follow-up|2|||
149026220|NCT03015740|537572031|FG000|Overall Study|Withdrawal by Subject|2|||
149026221|NCT03015740|537572032|FG001|Overall Study|Withdrawal by Subject|0|||
149026222|NCT03015740|537572033|FG002|Overall Study|Withdrawal by Subject|0|||
149026223|NCT03253653|537572038|FG000|Overall Study|Withdrawal by Subject|4|||
149026224|NCT03253653|537572039|FG001|Overall Study|Withdrawal by Subject|1|||
149026225|NCT03253653|537572038|FG000|Overall Study|Protocol Violation|0|||
149026226|NCT03253653|537572039|FG001|Overall Study|Protocol Violation|5|||
149026227|NCT04610684|537574144|FG000|Study Treatment|Withdrawal by Subject|1|||
149026228|NCT04610684|537574144|FG000|Study Treatment|Disease Progression|2|||
149026229|NCT04610684|537574144|FG000|Follow up|Death|2|||
149026230|NCT04610684|537574144|FG000|Follow up|Withdrawal by Subject|1|||
149026231|NCT02153788|537574146|FG000|Overall Study|Physician Decision|2|||
149026232|NCT02153788|537574147|FG001|Overall Study|Physician Decision|1|||
149026233|NCT01876043|537574148|FG000|Overall Study|Death|1|||
149026234|NCT01876043|537574148|FG000|Overall Study|Withdrawal by Subject|1|||
149026235|NCT00079937|537574150|FG000|Overall Study|Adverse Event|2|||
149026236|NCT00079937|537574151|FG001|Overall Study|Adverse Event|1|||
149026237|NCT00079937|537574150|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149026238|NCT00079937|537574151|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149026239|NCT00079937|537574150|FG000|Overall Study|Subject no longer requires study drug|3|||
149026240|NCT00079937|537574151|FG001|Overall Study|Subject no longer requires study drug|0|||
149026241|NCT00079937|537574150|FG000|Overall Study|Protocol Violation|8|||
149026242|NCT00079937|537574151|FG001|Overall Study|Protocol Violation|6|||
149026243|NCT00079937|537574150|FG000|Overall Study|Withdrawal by Subject|21|||
149026244|NCT00079937|537574151|FG001|Overall Study|Withdrawal by Subject|7|||
149026245|NCT00079937|537574150|FG000|Overall Study|Lost to Follow-up|12|||
149026246|NCT00079937|537574151|FG001|Overall Study|Lost to Follow-up|5|||
149026247|NCT00079937|537574150|FG000|Overall Study|Administrative problems|22|||
149026248|NCT00079937|537574151|FG001|Overall Study|Administrative problems|11|||
149026249|NCT05458102|537574154|FG000|Overall Study|Withdrew consent|2|||
149026250|NCT05458102|537574155|FG001|Overall Study|Withdrew consent|0|||
149026251|NCT05458102|537574154|FG000|Overall Study|Adverse Event|1|||
149026252|NCT05458102|537574155|FG001|Overall Study|Adverse Event|0|||
149026253|NCT05458102|537574154|FG000|Overall Study|Enrolled but never treated|1|||
149026254|NCT05458102|537574155|FG001|Overall Study|Enrolled but never treated|0|||
149026255|NCT05458102|537574154|FG000|Overall Study|Protocol Violation|1|||
149026256|NCT05458102|537574155|FG001|Overall Study|Protocol Violation|0|||
149026257|NCT00852475|537574156|FG000|Overall Study|Lost to Follow-up|3|||
149026258|NCT00852475|537574157|FG001|Overall Study|Lost to Follow-up|4|||
149026259|NCT00498186|537574158|FG000|Overall Study|Protocol Violation|10|||
149026260|NCT00498186|537574158|FG000|Overall Study|Lack of Efficacy|31|||
149026261|NCT00498186|537574158|FG000|Overall Study|Adverse Event|89|||
149026262|NCT00498186|537574158|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
149026263|NCT00498186|537574158|FG000|Overall Study|Withdrawal by Subject|18|||
149026264|NCT00498186|537574158|FG000|Overall Study|Lost to Follow-up|3|||
149026265|NCT00498186|537574158|FG000|Overall Study|Other|10|||
149026266|NCT00367237|537574159|FG000|Overall Study|Adverse Event|7|||
149026267|NCT00367237|537574160|FG001|Overall Study|Adverse Event|2|||
149026268|NCT00367237|537574159|FG000|Overall Study|Lost to Follow-up|1|||
149026269|NCT00367237|537574160|FG001|Overall Study|Lost to Follow-up|0|||
149026270|NCT00367237|537574159|FG000|Overall Study|Withdrawal by Subject|0|||
149026271|NCT00367237|537574160|FG001|Overall Study|Withdrawal by Subject|4|||
149026272|NCT00367237|537574159|FG000|Overall Study|Protocol Violation|2|||
148729700|NCT00851643|536483128|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
148729701|NCT00851643|536483129|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
148729702|NCT00851643|536483130|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
148729703|NCT00851643|536483131|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
148729704|NCT00851643|536483132|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
148729705|NCT00851643|536483127|FG000|Extension Study (Up to 36 Months)|Moved|0|||
148729706|NCT00851643|536483128|FG001|Extension Study (Up to 36 Months)|Moved|2|||
148729707|NCT00851643|536483129|FG002|Extension Study (Up to 36 Months)|Moved|1|||
148729708|NCT00851643|536483130|FG003|Extension Study (Up to 36 Months)|Moved|1|||
148729709|NCT00851643|536483131|FG004|Extension Study (Up to 36 Months)|Moved|0|||
148729710|NCT00851643|536483132|FG005|Extension Study (Up to 36 Months)|Moved|1|||
148729711|NCT00359788|536483133|FG000|Overall Study|Adverse Event|11|||
149026273|NCT00367237|537574160|FG001|Overall Study|Protocol Violation|5|||
149026274|NCT01175707|537574161|FG000|Overall Study|Adverse Event|4|||
149026275|NCT01175707|537574162|FG001|Overall Study|Adverse Event|6|||
149026276|NCT04531540|537574171|FG000|Overall Study|Adverse Event|1|||
148729712|NCT00359788|536483134|FG001|Overall Study|Adverse Event|10|||
149026277|NCT04531540|537574171|FG000|Overall Study|Protocol Violation|3|||
149026278|NCT04531540|537574171|FG000|Overall Study|Withdrawal by Subject|4|||
149026279|NCT04531540|537574171|FG000|Overall Study|Found to be Ineligible|1|||
149026280|NCT03239210|537574172|FG000|Overall Study|Lost to Follow-up|2|||
149026281|NCT03239210|537574173|FG001|Overall Study|Lost to Follow-up|2|||
149026282|NCT03239210|537574172|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
148729713|NCT00359788|536483133|FG000|Overall Study|Lack of Efficacy|1|||
149026283|NCT03239210|537574173|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
149026284|NCT03239210|537574172|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
149026285|NCT03239210|537574173|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
149026286|NCT01575860|537574176|FG000|Overall Study|Withdrawal by Subject|1|||
149026287|NCT01575860|537574176|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
149026288|NCT01403987|537574177|FG000|Overall Study|Residents forgot their secret PIN|18|||
149026289|NCT01403987|537574178|FG001|Overall Study|Residents forgot their secret PIN|17|||
149026290|NCT01403987|537574179|FG002|Overall Study|Residents forgot their secret PIN|18|||
149026291|NCT00180674|537574180|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
149026292|NCT00180674|537574180|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
149026293|NCT00278564|537574181|FG000|Overall Study|Lack of Efficacy|4|||
149026294|NCT01094743|537574182|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
149026295|NCT02321540|537574183|FG000|Overall Study|Death|0|||
149026296|NCT02321540|537574184|FG001|Overall Study|Death|1|||
149026297|NCT02321540|537574183|FG000|Overall Study|Progression|3|||
149026298|NCT02321540|537574184|FG001|Overall Study|Progression|9|||
149026299|NCT03606460|537574185|FG000|Overall Study|Lost to Follow-up|1|||
149026300|NCT03606460|537574186|FG001|Overall Study|Lost to Follow-up|8|||
149026301|NCT00003377|537574187|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
149026302|NCT00003377|537574188|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
149026303|NCT00003377|537574189|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
149026304|NCT00003377|537574190|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
149026305|NCT00003377|537574191|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
148729714|NCT00359788|536483134|FG001|Overall Study|Lack of Efficacy|2|||
148729715|NCT00359788|536483133|FG000|Overall Study|Lost to Follow-up|3|||
148729716|NCT00359788|536483134|FG001|Overall Study|Lost to Follow-up|2|||
148729717|NCT00359788|536483133|FG000|Overall Study|Withdrawal by Subject|4|||
148729718|NCT00359788|536483134|FG001|Overall Study|Withdrawal by Subject|1|||
148729719|NCT00359788|536483133|FG000|Overall Study|Protocol Violation|4|||
148729720|NCT00359788|536483134|FG001|Overall Study|Protocol Violation|2|||
148729721|NCT00673933|536483137|FG000|Overall Study|Withdrawal by Subject|2|||
148729722|NCT00673933|536483137|FG000|Overall Study|Lost to Follow-up|1|||
148729723|NCT02220725|536483138|FG000|Overall Study|Lost to Follow-up|0|||
148729724|NCT02220725|536483139|FG001|Overall Study|Lost to Follow-up|0|||
148729725|NCT02220725|536483140|FG002|Overall Study|Lost to Follow-up|0|||
148729726|NCT02220725|536483141|FG003|Overall Study|Lost to Follow-up|1|||
148729727|NCT02220725|536483138|FG000|Overall Study|Withdrawal by Subject|0|||
148729728|NCT02220725|536483139|FG001|Overall Study|Withdrawal by Subject|0|||
148729729|NCT02220725|536483140|FG002|Overall Study|Withdrawal by Subject|0|||
148729730|NCT02220725|536483141|FG003|Overall Study|Withdrawal by Subject|1|||
148729731|NCT04932941|536483142|FG000|Overall Study|Lost to Follow-up|3|||
148729732|NCT04932941|536483143|FG001|Overall Study|Lost to Follow-up|1|||
148729733|NCT04932941|536483142|FG000|Overall Study|Withdrawal by Subject|7|||
148729734|NCT04932941|536483143|FG001|Overall Study|Withdrawal by Subject|4|||
148729735|NCT04932941|536483142|FG000|Overall Study|Other|4|||
148729736|NCT04932941|536483143|FG001|Overall Study|Other|2|||
148729737|NCT00103402|536483144|FG000|Overall Study|Adverse Event|3|||
148729738|NCT00103402|536483145|FG001|Overall Study|Adverse Event|4|||
148729739|NCT00103402|536483144|FG000|Overall Study|Lost to Follow-up|8|||
148729740|NCT00103402|536483145|FG001|Overall Study|Lost to Follow-up|7|||
148729741|NCT00103402|536483144|FG000|Overall Study|Dissatisfied/No longer interested|6|||
148729742|NCT00103402|536483145|FG001|Overall Study|Dissatisfied/No longer interested|6|||
148729743|NCT00103402|536483144|FG000|Overall Study|Personal constraints/Other|5|||
148729744|NCT00103402|536483145|FG001|Overall Study|Personal constraints/Other|0|||
148729745|NCT01393730|536483146|FG000|Overall Study|Withdrawal by Subject|3|||
148729746|NCT01393730|536483146|FG000|Overall Study|Other|2|||
148729747|NCT01393730|536483146|FG000|Overall Study|Adverse Event|1|||
148729748|NCT01673698|536483147|FG000|Overall Study|Lost to Follow-up|51|||
148729749|NCT01673698|536483148|FG001|Overall Study|Lost to Follow-up|13|||
148729750|NCT01297322|536483149|FG000|Overall Study|Lost to Follow-up|1|||
148729751|NCT01297322|536483150|FG001|Overall Study|Lost to Follow-up|0|||
148729752|NCT01297322|536483149|FG000|Overall Study|Withdrawal by Subject|0|||
149026306|NCT00003377|537574187|FG000|Period II|Ureteral stent complications|0|||
149026307|NCT00003377|537574188|FG001|Period II|Ureteral stent complications|0|||
149026308|NCT00003377|537574189|FG002|Period II|Ureteral stent complications|0|||
149026309|NCT00003377|537574190|FG003|Period II|Ureteral stent complications|0|||
149026310|NCT00003377|537574191|FG004|Period II|Ureteral stent complications|1|||
149026311|NCT04541186|537574196|FG000|Main Study|Adverse Event|0|||
149026312|NCT04541186|537574197|FG001|Main Study|Adverse Event|0|||
149026313|NCT04541186|537574198|FG002|Main Study|Adverse Event|4|||
149026314|NCT04541186|537574199|FG003|Main Study|Adverse Event|0|||
148729753|NCT01297322|536483150|FG001|Overall Study|Withdrawal by Subject|1|||
148729754|NCT01297322|536483149|FG000|Overall Study|Protocol Violation|0|||
148729755|NCT01297322|536483150|FG001|Overall Study|Protocol Violation|3|||
148729756|NCT01583218|536483151|FG000|Overall Study|Withdrawal by Subject|43|||
148729757|NCT01583218|536483152|FG001|Overall Study|Withdrawal by Subject|29|||
148729758|NCT01583218|536483151|FG000|Overall Study|Death|206|||
148729759|NCT01583218|536483152|FG001|Overall Study|Death|211|||
148729760|NCT01583218|536483151|FG000|Overall Study|Lost to Follow-up|11|||
148729761|NCT01583218|536483152|FG001|Overall Study|Lost to Follow-up|17|||
148729762|NCT01583218|536483151|FG000|Overall Study|Adverse event or serious adverse event|3|||
148729763|NCT01583218|536483152|FG001|Overall Study|Adverse event or serious adverse event|3|||
148729764|NCT01583218|536483151|FG000|Overall Study|Patient /Family decision|3|||
148729765|NCT01583218|536483152|FG001|Overall Study|Patient /Family decision|0|||
148729766|NCT01583218|536483151|FG000|Overall Study|Cannot contact patient directly|1|||
148729767|NCT01583218|536483152|FG001|Overall Study|Cannot contact patient directly|2|||
148729768|NCT01583218|536483151|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
148729769|NCT01583218|536483152|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
148729770|NCT01583218|536483151|FG000|Overall Study|Patient did not wish to attend visits|0|||
148729771|NCT01583218|536483152|FG001|Overall Study|Patient did not wish to attend visits|1|||
148729772|NCT01583218|536483151|FG000|Overall Study|Patient randomized but not dosed|17|||
148729773|NCT01583218|536483152|FG001|Overall Study|Patient randomized but not dosed|16|||
148729774|NCT01583218|536483151|FG000|Overall Study|Patient was assessed via phone in person|1|||
148729775|NCT01583218|536483152|FG001|Overall Study|Patient was assessed via phone in person|0|||
148729776|NCT01583218|536483151|FG000|Overall Study|Patient deemed ineligible after random|2|||
148729777|NCT01583218|536483152|FG001|Overall Study|Patient deemed ineligible after random|0|||
148729778|NCT01583218|536483151|FG000|Overall Study|Patient was early terminated from study|0|||
148729779|NCT01583218|536483152|FG001|Overall Study|Patient was early terminated from study|1|||
148729780|NCT01583218|536483151|FG000|Overall Study|Patient was randomized due to mistake|1|||
148729781|NCT01583218|536483152|FG001|Overall Study|Patient was randomized due to mistake|0|||
148729782|NCT01583218|536483151|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
148729783|NCT01583218|536483152|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
148729784|NCT01583218|536483151|FG000|Overall Study|Withdraw of consent on day of random|1|||
148729785|NCT01583218|536483152|FG001|Overall Study|Withdraw of consent on day of random|0|||
148729786|NCT02013375|536483155|FG000|Overall Study|Did not engraft|1|||
148729787|NCT02013375|536483155|FG000|Overall Study|Did not engraft|1|||
148729788|NCT00712985|536483156|FG000|Overall Study|1 withdrew prior to start of drug|1|||
148729789|NCT00712985|536483156|FG000|Overall Study|1 patient moved out of state|1|||
148729790|NCT00712985|536483156|FG000|Overall Study|Lack of Efficacy|3|||
148729791|NCT02674061|536483157|FG000|Overall Study|Death|229|||
148729792|NCT02674061|536483158|FG001|Overall Study|Death|77|||
148729793|NCT02674061|536483157|FG000|Overall Study|Lost to Follow-up|3|||
148729794|NCT02674061|536483158|FG001|Overall Study|Lost to Follow-up|3|||
148729795|NCT02674061|536483157|FG000|Overall Study|Withdrawal by Subject|9|||
148729796|NCT02674061|536483158|FG001|Overall Study|Withdrawal by Subject|1|||
148729797|NCT02674061|536483157|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
148729798|NCT02674061|536483158|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
148729799|NCT03334721|536483163|FG000|Overall Study|Withdrawal by Subject|1|||
148729800|NCT03334721|536483164|FG001|Overall Study|Withdrawal by Subject|0|||
148729801|NCT03334721|536483163|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
148729802|NCT03334721|536483164|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
148729803|NCT01663727|536483165|FG000|Overall Study|Death|161|||
148729804|NCT01663727|536483166|FG001|Overall Study|Death|155|||
148729805|NCT01663727|536483165|FG000|Overall Study|Lost to Follow-up|10|||
148729806|NCT01663727|536483166|FG001|Overall Study|Lost to Follow-up|8|||
148729807|NCT01663727|536483165|FG000|Overall Study|Withdrawal by Subject|18|||
148729808|NCT01663727|536483166|FG001|Overall Study|Withdrawal by Subject|25|||
148729809|NCT01663727|536483165|FG000|Overall Study|Study Terminated|51|||
148729810|NCT01663727|536483166|FG001|Overall Study|Study Terminated|50|||
148729811|NCT01663727|536483165|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
148729812|NCT01663727|536483166|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
148729813|NCT01663727|536483165|FG000|Overall Study|Withdrawal prior to dosing.|1|||
148729814|NCT01663727|536483166|FG001|Overall Study|Withdrawal prior to dosing.|0|||
148729815|NCT01902628|536483167|FG000|Overall Study|Withdrawal of participant's consent|7|||
148729816|NCT01902628|536483167|FG000|Overall Study|Adverse Event|41|||
148729817|NCT01902628|536483167|FG000|Overall Study|Lost to Follow-up|35|||
148729818|NCT01232491|536483168|FG000|Overall Study|Adverse Event|13|||
148729819|NCT01232491|536483169|FG001|Overall Study|Adverse Event|8|||
148729820|NCT01232491|536483168|FG000|Overall Study|Lack of Efficacy|1|||
148729821|NCT01232491|536483169|FG001|Overall Study|Lack of Efficacy|5|||
148729822|NCT01232491|536483168|FG000|Overall Study|Protocol Violation|13|||
148729823|NCT01232491|536483169|FG001|Overall Study|Protocol Violation|11|||
148729824|NCT01232491|536483168|FG000|Overall Study|Withdrawal Criteria|12|||
148729825|NCT01232491|536483169|FG001|Overall Study|Withdrawal Criteria|21|||
148729826|NCT01232491|536483168|FG000|Overall Study|Other|21|||
148729827|NCT01232491|536483169|FG001|Overall Study|Other|18|||
148729828|NCT02932228|536483172|FG000|Overall Study|Death|8|||
148729829|NCT02932228|536483173|FG001|Overall Study|Death|23|||
148729830|NCT02932228|536483172|FG000|Overall Study|not eligible upon chart review|2|||
148729831|NCT02932228|536483173|FG001|Overall Study|not eligible upon chart review|5|||
148729832|NCT04556552|536484714|FG000|Overall Study|Lost to Follow-up|1|||
148729833|NCT04556552|536484715|FG001|Overall Study|Lost to Follow-up|0|||
148729834|NCT04556552|536484714|FG000|Overall Study|Claustrophobia|0|||
148729835|NCT04556552|536484715|FG001|Overall Study|Claustrophobia|1|||
148729836|NCT04556552|536484714|FG000|Overall Study|Inability to continue|0|||
148729837|NCT04556552|536484715|FG001|Overall Study|Inability to continue|1|||
148729838|NCT01553279|536484716|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
148729839|NCT01553279|536484717|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
148729840|NCT01553279|536484716|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
148729841|NCT01553279|536484717|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
148729842|NCT01553279|536484716|FG000|Interim Period|Withdrawal by Subject|2|||
148729843|NCT01553279|536484717|FG001|Interim Period|Withdrawal by Subject|2|||
148729844|NCT01553279|536484716|FG000|Interim Period|Lost to Follow-up|1|||
148729845|NCT01553279|536484717|FG001|Interim Period|Lost to Follow-up|0|||
148729846|NCT01553279|536484716|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
148729847|NCT01553279|536484717|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
148729848|NCT01553279|536484716|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
148729849|NCT01553279|536484717|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
148729850|NCT00605865|536484718|FG000|Overall Study|Protocol Violation|115|||
148729851|NCT03955471|536484719|FG000|Overall Study|Death|22|||
148729852|NCT03955471|536484719|FG000|Overall Study|Lost to Follow-up|1|||
148729853|NCT03955471|536484719|FG000|Overall Study|Withdrawal by Subject|6|||
148729854|NCT03955471|536484719|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
148729855|NCT01030341|536484722|FG000|Overall Study|Withdrawal by Subject|1|||
148729856|NCT01030341|536484722|FG000|Overall Study|Lost to Follow-up|2|||
148729857|NCT01884311|536484725|FG000|Overall Study|Withdrawal by Subject|3|||
148729858|NCT01884311|536484725|FG000|Overall Study|withdrew consent due to AEs|1|||
148729859|NCT01884311|536484725|FG000|Overall Study|Precautionary measure|1|||
148729860|NCT02856880|536484726|FG000|Overall Study|Withdrawal of consent|1|||
148729861|NCT00793780|536484727|FG000|Overall Study|Withdrawal by Subject|2|||
148729862|NCT00793780|536484728|FG001|Overall Study|Withdrawal by Subject|1|||
148729863|NCT02858492|536484729|FG000|Overall Study|Withdrawal by Subject|0|||
148729864|NCT02858492|536484730|FG001|Overall Study|Withdrawal by Subject|1|||
148729865|NCT02858492|536484731|FG002|Overall Study|Withdrawal by Subject|0|||
148729866|NCT02858492|536484732|FG003|Overall Study|Withdrawal by Subject|1|||
148729867|NCT02858492|536484729|FG000|Overall Study|Adverse Event|0|||
148729868|NCT02858492|536484730|FG001|Overall Study|Adverse Event|0|||
148729869|NCT02858492|536484731|FG002|Overall Study|Adverse Event|0|||
148729870|NCT02858492|536484732|FG003|Overall Study|Adverse Event|3|||
148729871|NCT02858492|536484729|FG000|Overall Study|Lack of Efficacy|0|||
148729872|NCT02858492|536484730|FG001|Overall Study|Lack of Efficacy|0|||
148729873|NCT02858492|536484731|FG002|Overall Study|Lack of Efficacy|0|||
148729874|NCT02858492|536484732|FG003|Overall Study|Lack of Efficacy|1|||
148729875|NCT02858492|536484729|FG000|Overall Study|Protocol defined stopping criteria|0|||
148729876|NCT02858492|536484730|FG001|Overall Study|Protocol defined stopping criteria|0|||
148729877|NCT02858492|536484731|FG002|Overall Study|Protocol defined stopping criteria|0|||
148729878|NCT02858492|536484732|FG003|Overall Study|Protocol defined stopping criteria|1|||
148729879|NCT00573157|536484733|FG000|Overall Study|Adverse Event|3|||
148729880|NCT00573157|536484734|FG001|Overall Study|Adverse Event|1|||
148729881|NCT00573157|536484733|FG000|Overall Study|Other|1|||
148729882|NCT00573157|536484734|FG001|Overall Study|Other|1|||
148729883|NCT01032018|536484735|FG000|Overall Study|Lost to Follow-up|6|||
148729884|NCT01032018|536484736|FG001|Overall Study|Lost to Follow-up|5|||
148729885|NCT01032018|536484735|FG000|Overall Study|Death|0|||
148729886|NCT01032018|536484736|FG001|Overall Study|Death|1|||
148729887|NCT01248013|536484740|FG000|Overall Study|Withdrawal by Subject|14|||
148729888|NCT01388166|536484743|FG000|Overall Study|Adverse Event|16|||
148729889|NCT01388166|536484743|FG000|Overall Study|Lost to Follow-up|30|||
148729890|NCT01388166|536484743|FG000|Overall Study|Others than specified above|13|||
148729891|NCT02667288|536484748|FG000|Overall Study|Protocol Violation|5|||
148729892|NCT02667288|536484748|FG000|Overall Study|Lost to Follow-up|3|||
148729893|NCT02667288|536484748|FG000|Overall Study|Withdrawal by Subject|5|||
148729894|NCT04397445|536484749|FG000|Overall Study|Withdrawal by Subject|1|||
148729895|NCT04397445|536484750|FG001|Overall Study|Withdrawal by Subject|0|||
148729896|NCT04397445|536484751|FG002|Overall Study|Withdrawal by Subject|0|||
148729897|NCT04397445|536484752|FG003|Overall Study|Withdrawal by Subject|0|||
148729898|NCT01429051|536484753|FG000|Titration Phase|Death|1|||
148729899|NCT01429051|536484753|FG000|Titration Phase|Withdrawal by Subject|7|||
148972276|NCT00974571|537381945|FG001|Overall Study|Lost to Follow-up|1|||
148972277|NCT00974571|537381946|FG002|Overall Study|Lost to Follow-up|2|||
148729900|NCT01429051|536484753|FG000|Titration Phase|Physician Decision|1|||
148729901|NCT01429051|536484753|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
148729902|NCT01429051|536484753|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
148729903|NCT01429051|536484753|FG000|Efficacy Phase|Adverse Event|1|||
148729904|NCT01429051|536484753|FG000|Efficacy Phase|Death|1|||
148729905|NCT01429051|536484753|FG000|Tolerability Phase|Death|5|||
148729906|NCT01429051|536484753|FG000|Tolerability Phase|Adverse Event|2|||
148729907|NCT01429051|536484753|FG000|Tolerability Phase|Withdrawal by Subject|5|||
148729908|NCT01429051|536484753|FG000|Tolerability Phase|Physician Decision|1|||
148729909|NCT01429051|536484753|FG000|Tolerability Phase|Other|2|||
148729910|NCT03921151|536484754|FG000|Overall Study|Withdrawal by Subject|11|||
148729911|NCT03921151|536484755|FG001|Overall Study|Withdrawal by Subject|16|||
148729912|NCT00857792|536484757|FG000|Overall Study|inadequate image quality for analysis|12|||
148729913|NCT02963441|536484767|FG000|Overall Study|Protocol violation or withdrawn|8|||
148729914|NCT02963441|536484767|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
148729915|NCT02963441|536484767|FG000|Overall Study|IDx-DR insufficient quality|33|||
148729916|NCT04688931|536484768|FG000|Overall Study|Adverse Event|4|||
148729917|NCT04688931|536484769|FG001|Overall Study|Adverse Event|1|||
148729918|NCT04688931|536484768|FG000|Overall Study|Withdrawal by Subject|5|||
148729919|NCT04688931|536484769|FG001|Overall Study|Withdrawal by Subject|16|||
148729920|NCT04688931|536484768|FG000|Overall Study|Physician Decision|3|||
148729921|NCT04688931|536484769|FG001|Overall Study|Physician Decision|5|||
148729922|NCT04688931|536484768|FG000|Overall Study|Noncompliance|0|||
148729923|NCT04688931|536484769|FG001|Overall Study|Noncompliance|1|||
148729924|NCT04688931|536484768|FG000|Overall Study|Lost to Follow-up|1|||
148729925|NCT04688931|536484769|FG001|Overall Study|Lost to Follow-up|3|||
148729926|NCT04688931|536484768|FG000|Overall Study|Randomization Error|3|||
148729927|NCT04688931|536484769|FG001|Overall Study|Randomization Error|0|||
148729928|NCT04688931|536484768|FG000|Overall Study|Not Eligible|1|||
148729929|NCT04688931|536484769|FG001|Overall Study|Not Eligible|3|||
148729930|NCT04688931|536484768|FG000|Overall Study|Disease Progression|0|||
148729931|NCT04688931|536484769|FG001|Overall Study|Disease Progression|2|||
148729932|NCT04688931|536484768|FG000|Overall Study|Sponsor Requirement|1|||
148729933|NCT04688931|536484769|FG001|Overall Study|Sponsor Requirement|1|||
148817318|NCT00835978|536807242|FG002|Overall Study|Other|8|||
148817319|NCT00835978|536807243|FG003|Overall Study|Other|0|||
148729934|NCT04688931|536484768|FG000|Overall Study|Other Reason|1|||
148817320|NCT00835978|536807240|FG000|Overall Study|Objective progression or relapse|2|||
148729935|NCT04688931|536484769|FG001|Overall Study|Other Reason|2|||
148972278|NCT00974571|537381944|FG000|Overall Study|Protocol Violation|13|||
148972279|NCT00974571|537381945|FG001|Overall Study|Protocol Violation|4|||
148972280|NCT00974571|537381946|FG002|Overall Study|Protocol Violation|18|||
148972281|NCT00974571|537381944|FG000|Overall Study|Withdrawal by Subject|14|||
148972282|NCT00974571|537381945|FG001|Overall Study|Withdrawal by Subject|5|||
148972283|NCT00974571|537381946|FG002|Overall Study|Withdrawal by Subject|16|||
148972284|NCT00974571|537381944|FG000|Overall Study|Patient Moved|1|||
148972285|NCT00974571|537381945|FG001|Overall Study|Patient Moved|0|||
148972286|NCT00974571|537381946|FG002|Overall Study|Patient Moved|1|||
148972287|NCT00974571|537381944|FG000|Overall Study|Other|4|||
148972288|NCT00974571|537381945|FG001|Overall Study|Other|0|||
148972289|NCT00974571|537381946|FG002|Overall Study|Other|10|||
148972290|NCT02703636|537381948|FG000|Overall Study|Adverse Event|14|||
148972291|NCT02703636|537381948|FG000|Overall Study|Study stopped by sponsor|1|||
148972292|NCT02703636|537381948|FG000|Overall Study|Withdrawal by Subject|1|||
148972293|NCT04011410|537381952|FG000|Overall Study|Withdrawal by Subject|1|||
148972294|NCT01838642|537381953|FG000|Overall Study|Died on study|1|||
148972295|NCT01215227|537381954|FG000|Overall Study|Adverse Event|11|||
148972296|NCT01215227|537381955|FG001|Overall Study|Adverse Event|11|||
148972297|NCT01215227|537381956|FG002|Overall Study|Adverse Event|4|||
148972298|NCT01215227|537381957|FG003|Overall Study|Adverse Event|8|||
148972299|NCT01215227|537381958|FG004|Overall Study|Adverse Event|7|||
148972300|NCT01215227|537381959|FG005|Overall Study|Adverse Event|6|||
148972301|NCT01215227|537381954|FG000|Overall Study|Treatment Failure|8|||
148972302|NCT01215227|537381955|FG001|Overall Study|Treatment Failure|4|||
148972303|NCT01215227|537381956|FG002|Overall Study|Treatment Failure|1|||
148972304|NCT01215227|537381957|FG003|Overall Study|Treatment Failure|5|||
148972305|NCT01215227|537381958|FG004|Overall Study|Treatment Failure|1|||
148972306|NCT01215227|537381959|FG005|Overall Study|Treatment Failure|1|||
148972307|NCT01215227|537381954|FG000|Overall Study|Lost to Follow-up|1|||
148972308|NCT01215227|537381955|FG001|Overall Study|Lost to Follow-up|4|||
148972309|NCT01215227|537381956|FG002|Overall Study|Lost to Follow-up|1|||
148972310|NCT01215227|537381957|FG003|Overall Study|Lost to Follow-up|1|||
148972311|NCT01215227|537381958|FG004|Overall Study|Lost to Follow-up|1|||
148972312|NCT01215227|537381959|FG005|Overall Study|Lost to Follow-up|2|||
148972313|NCT01215227|537381954|FG000|Overall Study|Subject Withdrew Consent|16|||
148972314|NCT01215227|537381955|FG001|Overall Study|Subject Withdrew Consent|20|||
148972315|NCT01215227|537381956|FG002|Overall Study|Subject Withdrew Consent|7|||
148972316|NCT01215227|537381957|FG003|Overall Study|Subject Withdrew Consent|10|||
148972317|NCT01215227|537381958|FG004|Overall Study|Subject Withdrew Consent|11|||
148972318|NCT01215227|537381959|FG005|Overall Study|Subject Withdrew Consent|8|||
148972319|NCT01215227|537381954|FG000|Overall Study|Non-Compliance With Protocol|2|||
148972320|NCT01215227|537381955|FG001|Overall Study|Non-Compliance With Protocol|6|||
148972321|NCT01215227|537381956|FG002|Overall Study|Non-Compliance With Protocol|1|||
148972322|NCT01215227|537381957|FG003|Overall Study|Non-Compliance With Protocol|0|||
148972323|NCT01215227|537381958|FG004|Overall Study|Non-Compliance With Protocol|0|||
148729936|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Adverse Event|9|||
148729937|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Adverse Event|4|||
148729938|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Adverse Event|5|||
148729939|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Adverse Event|9|||
148729940|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Adverse Event|8|||
148729941|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Adverse Event|0|||
148729942|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Adverse Event|0|||
148729943|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
148729944|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
148729945|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
148729946|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
148729947|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
148729948|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
148729949|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
148729950|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Death|1|||
148729951|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Death|1|||
148729952|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Death|1|||
148729953|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Death|1|||
148729954|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Death|0|||
148729955|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Death|0|||
148729956|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Death|0|||
148729957|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
148729958|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
148729959|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
148729960|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
148729961|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
148729962|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
148729963|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
148729964|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
148729965|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
148729966|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
148729967|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
148729968|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
148729969|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
148729970|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
148729971|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
148729972|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
148729973|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
148729974|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
148729975|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
148729976|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
148729977|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
148729978|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Other|2|||
148729979|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Other|9|||
148729980|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Other|9|||
148729981|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Other|3|||
148729982|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Other|2|||
148729983|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Other|0|||
148729984|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Other|0|||
148729985|NCT00361335|536484770|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
148729986|NCT00361335|536484771|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
148729987|NCT00361335|536484772|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
148729988|NCT00361335|536484773|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
148729989|NCT00361335|536484774|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
148729990|NCT00361335|536484775|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
148729991|NCT00361335|536484776|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
148729992|NCT00361335|536484770|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
148729993|NCT00361335|536484771|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
148729994|NCT00361335|536484772|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
148729995|NCT00361335|536484773|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
149026315|NCT04541186|537574200|FG004|Main Study|Adverse Event|0|||
148729996|NCT00361335|536484774|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
149026316|NCT04541186|537574196|FG000|Main Study|Investigator Decision|0|||
149026317|NCT04541186|537574197|FG001|Main Study|Investigator Decision|0|||
149026318|NCT04541186|537574198|FG002|Main Study|Investigator Decision|1|||
148729997|NCT00361335|536484775|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
148729998|NCT00361335|536484776|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
148729999|NCT00361335|536484770|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
148730000|NCT00361335|536484771|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
148730001|NCT00361335|536484772|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
148730002|NCT00361335|536484773|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
148730003|NCT00361335|536484774|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
149026319|NCT04541186|537574199|FG003|Main Study|Investigator Decision|1|||
148730004|NCT00361335|536484775|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
148730005|NCT00361335|536484776|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
148730006|NCT00361335|536484770|FG000|SC Period: Week E0 to Week E24|Death|0|||
148730007|NCT00361335|536484771|FG001|SC Period: Week E0 to Week E24|Death|0|||
148730008|NCT00361335|536484772|FG002|SC Period: Week E0 to Week E24|Death|0|||
148730009|NCT00361335|536484773|FG003|SC Period: Week E0 to Week E24|Death|0|||
148730010|NCT00361335|536484774|FG004|SC Period: Week E0 to Week E24|Death|0|||
148730011|NCT00361335|536484775|FG005|SC Period: Week E0 to Week E24|Death|0|||
148730012|NCT00361335|536484776|FG006|SC Period: Week E0 to Week E24|Death|1|||
148730013|NCT00361335|536484770|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
148730014|NCT00361335|536484771|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
148730015|NCT00361335|536484772|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
148730016|NCT00361335|536484773|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
148730017|NCT00361335|536484774|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
148730018|NCT00361335|536484775|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
148730019|NCT00361335|536484776|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
148730020|NCT00361335|536484770|FG000|SC Period: Week E0 to Week E24|Other|1|||
148730021|NCT00361335|536484771|FG001|SC Period: Week E0 to Week E24|Other|0|||
148730022|NCT00361335|536484772|FG002|SC Period: Week E0 to Week E24|Other|0|||
148730023|NCT00361335|536484773|FG003|SC Period: Week E0 to Week E24|Other|1|||
148730024|NCT00361335|536484774|FG004|SC Period: Week E0 to Week E24|Other|0|||
148730025|NCT00361335|536484775|FG005|SC Period: Week E0 to Week E24|Other|1|||
148730026|NCT00361335|536484776|FG006|SC Period: Week E0 to Week E24|Other|2|||
148730027|NCT00361335|536484770|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
148730028|NCT00361335|536484771|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
148730029|NCT00361335|536484772|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
148730030|NCT00361335|536484773|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
148730031|NCT00361335|536484774|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
148730032|NCT00361335|536484775|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
148730033|NCT00361335|536484776|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
148730034|NCT01765582|536484777|FG000|Overall Study|Other|3|||
148730035|NCT01765582|536484778|FG001|Overall Study|Other|6|||
148730036|NCT01765582|536484779|FG002|Overall Study|Other|9|||
148730037|NCT01765582|536484777|FG000|Overall Study|Lost to Follow-up|2|||
148730038|NCT01765582|536484778|FG001|Overall Study|Lost to Follow-up|2|||
148730039|NCT01765582|536484779|FG002|Overall Study|Lost to Follow-up|1|||
148730040|NCT01765582|536484777|FG000|Overall Study|Death|31|||
148730041|NCT01765582|536484778|FG001|Overall Study|Death|36|||
148730042|NCT01765582|536484779|FG002|Overall Study|Death|33|||
148730043|NCT01765582|536484777|FG000|Overall Study|Sponsor Decision|46|||
148730044|NCT01765582|536484778|FG001|Overall Study|Sponsor Decision|42|||
148730045|NCT01765582|536484779|FG002|Overall Study|Sponsor Decision|42|||
148730046|NCT01765582|536484777|FG000|Overall Study|Withdrawal of Consent|11|||
148730047|NCT01765582|536484778|FG001|Overall Study|Withdrawal of Consent|6|||
148730048|NCT01765582|536484779|FG002|Overall Study|Withdrawal of Consent|10|||
148730049|NCT00616941|536484782|FG000|Overall Study|Progressive Disease|1|||
148730050|NCT00616941|536484783|FG001|Overall Study|Progressive Disease|2|||
148730051|NCT00616941|536484784|FG002|Overall Study|Progressive Disease|1|||
148730052|NCT00616941|536484782|FG000|Overall Study|Adverse Event|0|||
148730053|NCT00616941|536484783|FG001|Overall Study|Adverse Event|1|||
148730054|NCT00616941|536484784|FG002|Overall Study|Adverse Event|1|||
148730055|NCT00616941|536484782|FG000|Overall Study|Subject Non-compliance|0|||
148730056|NCT00616941|536484783|FG001|Overall Study|Subject Non-compliance|0|||
148730057|NCT00616941|536484784|FG002|Overall Study|Subject Non-compliance|1|||
148730058|NCT00616941|536484782|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
148730059|NCT00616941|536484783|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
148730060|NCT00616941|536484784|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
148730061|NCT00616941|536484782|FG000|Overall Study|Vaccination Suspended|0|||
148730062|NCT00616941|536484783|FG001|Overall Study|Vaccination Suspended|0|||
148730063|NCT00616941|536484784|FG002|Overall Study|Vaccination Suspended|3|||
148730064|NCT00714493|536484792|FG000|Overall Study|Adverse Event|11|||
148730065|NCT00714493|536484792|FG000|Overall Study|Death|3|||
148730066|NCT00714493|536484792|FG000|Overall Study|Lack of Efficacy|10|||
148730067|NCT00714493|536484792|FG000|Overall Study|Lost to Follow-up|3|||
148730068|NCT00714493|536484792|FG000|Overall Study|Protocol Violation|12|||
148730069|NCT00714493|536484792|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
148730070|NCT00714493|536484792|FG000|Overall Study|OTHER|2|||
148730071|NCT04505293|536484793|FG000|Overall Study|Lost to Follow-up|2|||
148730072|NCT04505293|536484793|FG000|Overall Study|Withdrawal by Subject|6|||
148730073|NCT04505293|536484793|FG000|Overall Study|CT scan unreadable|277|||
148730074|NCT00506129|536484794|FG000|Overall Study|Disease Progression/Relapse|15|||
148730075|NCT00506129|536484794|FG000|Overall Study|Death|7|||
148730076|NCT01400919|536484798|FG000|Overall Study|Withdrawal by Subject|4|||
148730077|NCT01400919|536484798|FG000|Overall Study|Lost to Follow-up|2|||
148730078|NCT01400919|536484798|FG000|Overall Study|Missed visit|2|||
148730079|NCT00251719|536484799|FG000|Overall Study|Adverse Event|14|||
148730080|NCT00251719|536484800|FG001|Overall Study|Adverse Event|8|||
148730081|NCT00251719|536484801|FG002|Overall Study|Adverse Event|7|||
148730082|NCT00251719|536484799|FG000|Overall Study|Protocol Violation|1|||
148730083|NCT00251719|536484800|FG001|Overall Study|Protocol Violation|1|||
148730084|NCT00251719|536484801|FG002|Overall Study|Protocol Violation|1|||
148730085|NCT00251719|536484799|FG000|Overall Study|Lost to Follow-up|5|||
148730086|NCT00251719|536484800|FG001|Overall Study|Lost to Follow-up|11|||
148730087|NCT00251719|536484801|FG002|Overall Study|Lost to Follow-up|8|||
148730088|NCT00251719|536484799|FG000|Overall Study|Withdrawal by Subject|14|||
148730089|NCT00251719|536484800|FG001|Overall Study|Withdrawal by Subject|12|||
148730090|NCT00251719|536484801|FG002|Overall Study|Withdrawal by Subject|11|||
148730091|NCT00251719|536484799|FG000|Overall Study|Lack of Efficacy|2|||
148730092|NCT00251719|536484800|FG001|Overall Study|Lack of Efficacy|1|||
148730093|NCT00251719|536484801|FG002|Overall Study|Lack of Efficacy|0|||
148730094|NCT00251719|536484799|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
148730095|NCT00251719|536484800|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
148730096|NCT00251719|536484801|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
148730097|NCT00251719|536484799|FG000|Overall Study|Investigator decision|1|||
148730098|NCT00251719|536484800|FG001|Overall Study|Investigator decision|1|||
148730099|NCT00251719|536484801|FG002|Overall Study|Investigator decision|0|||
148730100|NCT00251719|536484799|FG000|Overall Study|Noncompliance|2|||
148730101|NCT00251719|536484800|FG001|Overall Study|Noncompliance|3|||
148730102|NCT00251719|536484801|FG002|Overall Study|Noncompliance|1|||
148730103|NCT00251719|536484799|FG000|Overall Study|Barrett's esophagus|2|||
148730104|NCT00251719|536484800|FG001|Overall Study|Barrett's esophagus|2|||
148730105|NCT00251719|536484801|FG002|Overall Study|Barrett's esophagus|0|||
148730106|NCT01732874|536484804|FG000|Overall Study|Withdrawal by Subject|5|||
148730107|NCT01732874|536484805|FG001|Overall Study|Withdrawal by Subject|1|||
148730108|NCT01732874|536484804|FG000|Overall Study|Death of Infant|3|||
148730109|NCT01732874|536484805|FG001|Overall Study|Death of Infant|2|||
148730110|NCT02923674|536484806|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
148730111|NCT02923674|536484807|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
148730112|NCT02923674|536484808|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
148730113|NCT02923674|536484806|FG000|Overall Study|Lost to Follow-up|7|||
148730114|NCT02923674|536484807|FG001|Overall Study|Lost to Follow-up|12|||
148730115|NCT02923674|536484808|FG002|Overall Study|Lost to Follow-up|7|||
148730116|NCT02923674|536484806|FG000|Overall Study|Problem with intervention|2|||
148730117|NCT02923674|536484807|FG001|Overall Study|Problem with intervention|2|||
148730118|NCT02923674|536484808|FG002|Overall Study|Problem with intervention|1|||
148730119|NCT02923674|536484806|FG000|Overall Study|Adverse Event|3|||
148730120|NCT02923674|536484807|FG001|Overall Study|Adverse Event|1|||
148730121|NCT02923674|536484808|FG002|Overall Study|Adverse Event|1|||
148730122|NCT02923674|536484806|FG000|Overall Study|Withdrawal by Subject|2|||
148730123|NCT02923674|536484807|FG001|Overall Study|Withdrawal by Subject|2|||
148730124|NCT02923674|536484808|FG002|Overall Study|Withdrawal by Subject|2|||
148730125|NCT00557076|536484811|FG000|Overall Study|Unblinding|0|||
148730126|NCT00557076|536484812|FG001|Overall Study|Unblinding|1|||
148730127|NCT00688376|536484813|FG000|Double-Blind Phase|Adverse Event|4|||
148730128|NCT00688376|536484814|FG001|Double-Blind Phase|Adverse Event|4|||
148730129|NCT00688376|536484813|FG000|Double-Blind Phase|Protocol Violation|1|||
148730130|NCT00688376|536484814|FG001|Double-Blind Phase|Protocol Violation|2|||
148730131|NCT00688376|536484813|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
148730132|NCT00688376|536484814|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
148730133|NCT00688376|536484813|FG000|Double-Blind Phase|Not treated|0|||
148730134|NCT00688376|536484814|FG001|Double-Blind Phase|Not treated|1|||
148730135|NCT00688376|536484813|FG000|Blinded Extension Phase|Adverse Event|3|||
148730136|NCT00688376|536484814|FG001|Blinded Extension Phase|Adverse Event|4|||
148730137|NCT00688376|536484813|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
148730138|NCT00688376|536484814|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
148730139|NCT00688376|536484813|FG000|Blinded Extension Phase|Physician Decision|1|||
148730140|NCT00688376|536484814|FG001|Blinded Extension Phase|Physician Decision|0|||
148730141|NCT00688376|536484813|FG000|Blinded Extension Phase|Other|1|||
148730142|NCT00688376|536484814|FG001|Blinded Extension Phase|Other|0|||
148730143|NCT02792959|536484815|FG000|Overall Study|Protocol Violation|1|||
148730144|NCT04392583|536484816|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
148730145|NCT03201250|536484817|FG000|Overall Study|screen failures|3|||
148730146|NCT03201250|536484818|FG001|Overall Study|screen failures|0|||
148730147|NCT03201250|536484819|FG002|Overall Study|screen failures|0|||
148730148|NCT02408068|536484820|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
148730149|NCT02408068|536484821|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
148730150|NCT02408068|536484822|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
148730151|NCT02408068|536484823|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
148730152|NCT02408068|536484824|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
148730153|NCT02408068|536484825|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
148730154|NCT03484117|536484826|FG000|Overall Study|Lost to Follow-up|1|||
148730155|NCT03484117|536484827|FG001|Overall Study|Lost to Follow-up|3|||
148730156|NCT03484117|536484826|FG000|Overall Study|Declined participation in exit assess|1|||
148730157|NCT03484117|536484827|FG001|Overall Study|Declined participation in exit assess|1|||
148730158|NCT01780987|536484828|FG000|Overall Study|Adverse Event|0|||
148730159|NCT01780987|536484829|FG001|Overall Study|Adverse Event|4|||
148730160|NCT01780987|536484828|FG000|Overall Study|Withdrawal by Subject|2|||
148730161|NCT01780987|536484829|FG001|Overall Study|Withdrawal by Subject|0|||
148730162|NCT01780987|536484828|FG000|Overall Study|Request of Changing Hospital|0|||
148730163|NCT01780987|536484829|FG001|Overall Study|Request of Changing Hospital|1|||
148730164|NCT01780987|536484828|FG000|Overall Study|Changing Residence|1|||
148730165|NCT01780987|536484829|FG001|Overall Study|Changing Residence|0|||
148730166|NCT01780987|536484828|FG000|Overall Study|Not Receiving any Study Medication|0|||
148730167|NCT01780987|536484829|FG001|Overall Study|Not Receiving any Study Medication|1|||
148730168|NCT04168190|536484830|FG000|Overall Study|Lost to Follow-up|0|||
148730169|NCT04168190|536484831|FG001|Overall Study|Lost to Follow-up|1|||
148730170|NCT04168190|536484832|FG002|Overall Study|Lost to Follow-up|0|||
148730171|NCT04168190|536484833|FG003|Overall Study|Lost to Follow-up|7|||
148730172|NCT04168190|536484834|FG004|Overall Study|Lost to Follow-up|5|||
148730173|NCT04168190|536484830|FG000|Overall Study|Withdrawal by Subject|1|||
148730174|NCT04168190|536484831|FG001|Overall Study|Withdrawal by Subject|0|||
148730175|NCT04168190|536484832|FG002|Overall Study|Withdrawal by Subject|0|||
148730176|NCT04168190|536484833|FG003|Overall Study|Withdrawal by Subject|2|||
148730177|NCT04168190|536484834|FG004|Overall Study|Withdrawal by Subject|4|||
148730178|NCT04168190|536484830|FG000|Overall Study|Death|0|||
148730179|NCT04168190|536484831|FG001|Overall Study|Death|0|||
148730180|NCT04168190|536484832|FG002|Overall Study|Death|0|||
148730181|NCT04168190|536484833|FG003|Overall Study|Death|1|||
148730182|NCT04168190|536484834|FG004|Overall Study|Death|0|||
148730183|NCT02335983|536484835|FG000|Overall Study|Sponsor Decision|0|||
148730184|NCT02335983|536484836|FG001|Overall Study|Sponsor Decision|0|||
148730185|NCT02335983|536484837|FG002|Overall Study|Sponsor Decision|1|||
148730186|NCT02335983|536484838|FG003|Overall Study|Sponsor Decision|1|||
148730187|NCT02335983|536484839|FG004|Overall Study|Sponsor Decision|0|||
148730188|NCT02335983|536484840|FG005|Overall Study|Sponsor Decision|1|||
148730189|NCT02335983|536484835|FG000|Overall Study|Withdrawal by Subject|3|||
148730190|NCT02335983|536484836|FG001|Overall Study|Withdrawal by Subject|2|||
148730191|NCT02335983|536484837|FG002|Overall Study|Withdrawal by Subject|2|||
148730192|NCT02335983|536484838|FG003|Overall Study|Withdrawal by Subject|1|||
148730193|NCT02335983|536484839|FG004|Overall Study|Withdrawal by Subject|3|||
148730194|NCT02335983|536484840|FG005|Overall Study|Withdrawal by Subject|9|||
148730195|NCT02335983|536484835|FG000|Overall Study|Death|0|||
148730196|NCT02335983|536484836|FG001|Overall Study|Death|0|||
148730197|NCT02335983|536484837|FG002|Overall Study|Death|2|||
148730198|NCT02335983|536484838|FG003|Overall Study|Death|0|||
148730199|NCT02335983|536484839|FG004|Overall Study|Death|0|||
148730200|NCT02335983|536484840|FG005|Overall Study|Death|0|||
148730201|NCT02335983|536484835|FG000|Overall Study|Lost to Follow-up|0|||
148730202|NCT02335983|536484836|FG001|Overall Study|Lost to Follow-up|0|||
148730203|NCT02335983|536484837|FG002|Overall Study|Lost to Follow-up|0|||
148730204|NCT02335983|536484838|FG003|Overall Study|Lost to Follow-up|0|||
148730205|NCT02335983|536484839|FG004|Overall Study|Lost to Follow-up|0|||
148730206|NCT02335983|536484840|FG005|Overall Study|Lost to Follow-up|1|||
148730207|NCT02335983|536484835|FG000|Overall Study|Protocol Specified Criteria|5|||
148730208|NCT02335983|536484836|FG001|Overall Study|Protocol Specified Criteria|7|||
148730209|NCT02335983|536484837|FG002|Overall Study|Protocol Specified Criteria|27|||
148730210|NCT02335983|536484838|FG003|Overall Study|Protocol Specified Criteria|7|||
148730211|NCT02335983|536484839|FG004|Overall Study|Protocol Specified Criteria|5|||
148730212|NCT02335983|536484840|FG005|Overall Study|Protocol Specified Criteria|21|||
148730213|NCT01070771|536484841|FG000|Overall Study|Adverse Event|2|||
148730214|NCT01070771|536484841|FG000|Overall Study|Protocol Violation|1|||
148730215|NCT03127644|536484842|FG000|Overall Study|Study-specific withdrawal criteria|0|||
148730216|NCT03127644|536484843|FG001|Overall Study|Study-specific withdrawal criteria|0|||
148730217|NCT03127644|536484844|FG002|Overall Study|Study-specific withdrawal criteria|2|||
148730218|NCT03835325|536484845|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
148730219|NCT03835325|536484845|FG000|Overall Study|Selection failure|1|||
148730220|NCT01370213|536484846|FG000|Overall Study|Early Death|1|||
148972324|NCT01215227|537381959|FG005|Overall Study|Non-Compliance With Protocol|0|||
148730221|NCT01370213|536484847|FG001|Overall Study|Early Death|0|||
148730222|NCT01370213|536484848|FG002|Overall Study|Early Death|0|||
148730223|NCT01370213|536484846|FG000|Overall Study|Not evaluable|0|||
148972325|NCT01215227|537381954|FG000|Overall Study|Administrative|83|||
148972326|NCT01215227|537381955|FG001|Overall Study|Administrative|73|||
148730224|NCT01370213|536484847|FG001|Overall Study|Not evaluable|2|||
148730225|NCT01370213|536484848|FG002|Overall Study|Not evaluable|0|||
148730226|NCT01550744|536484851|FG000|Open-Label|Lost to Follow-up|7|||
148730227|NCT01550744|536484852|FG001|Open-Label|Lost to Follow-up|0|||
148730228|NCT01550744|536484853|FG002|Open-Label|Lost to Follow-up|0|||
148730229|NCT01550744|536484851|FG000|Open-Label|Withdrawal by Subject|13|||
148730230|NCT01550744|536484852|FG001|Open-Label|Withdrawal by Subject|0|||
148730231|NCT01550744|536484853|FG002|Open-Label|Withdrawal by Subject|0|||
148730232|NCT01550744|536484851|FG000|Open-Label|Adverse Event|11|||
148817321|NCT00835978|536807241|FG001|Overall Study|Objective progression or relapse|0|||
148817322|NCT00835978|536807242|FG002|Overall Study|Objective progression or relapse|1|||
148817323|NCT00835978|536807243|FG003|Overall Study|Objective progression or relapse|0|||
148817324|NCT00835978|536807240|FG000|Overall Study|Adverse Event|1|||
148817325|NCT00835978|536807241|FG001|Overall Study|Adverse Event|0|||
148817326|NCT00835978|536807242|FG002|Overall Study|Adverse Event|1|||
148817327|NCT00835978|536807243|FG003|Overall Study|Adverse Event|0|||
148817328|NCT00835978|536807240|FG000|Overall Study|Withdrawal by Subject|0|||
148817329|NCT00835978|536807241|FG001|Overall Study|Withdrawal by Subject|3|||
148817330|NCT00835978|536807242|FG002|Overall Study|Withdrawal by Subject|0|||
148817331|NCT00835978|536807243|FG003|Overall Study|Withdrawal by Subject|5|||
148817332|NCT00835978|536807240|FG000|Overall Study|Study terminated by sponsor|12|||
148817333|NCT00835978|536807241|FG001|Overall Study|Study terminated by sponsor|8|||
148817334|NCT00835978|536807242|FG002|Overall Study|Study terminated by sponsor|30|||
149026320|NCT04541186|537574200|FG004|Main Study|Investigator Decision|0|||
148730233|NCT01550744|536484852|FG001|Open-Label|Adverse Event|0|||
148730234|NCT01550744|536484853|FG002|Open-Label|Adverse Event|0|||
148730235|NCT01550744|536484851|FG000|Open-Label|Lack of Efficacy|4|||
148730236|NCT01550744|536484852|FG001|Open-Label|Lack of Efficacy|0|||
148730237|NCT01550744|536484853|FG002|Open-Label|Lack of Efficacy|0|||
148730238|NCT01550744|536484851|FG000|Open-Label|Protocol Violation|4|||
148730239|NCT01550744|536484852|FG001|Open-Label|Protocol Violation|0|||
148730240|NCT01550744|536484853|FG002|Open-Label|Protocol Violation|0|||
148730241|NCT01550744|536484851|FG000|Open-Label|Not all 3 study drug injections received|2|||
148730242|NCT01550744|536484852|FG001|Open-Label|Not all 3 study drug injections received|0|||
148730243|NCT01550744|536484853|FG002|Open-Label|Not all 3 study drug injections received|0|||
148730244|NCT01550744|536484851|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
148730245|NCT01550744|536484852|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
148730246|NCT01550744|536484853|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
148730247|NCT01550744|536484851|FG000|Open-Label|Other|1|||
148730248|NCT01550744|536484852|FG001|Open-Label|Other|0|||
148730249|NCT01550744|536484853|FG002|Open-Label|Other|0|||
148730250|NCT01550744|536484851|FG000|Double-Blind|Lost to Follow-up|0|||
148730251|NCT01550744|536484852|FG001|Double-Blind|Lost to Follow-up|6|||
148730252|NCT01550744|536484853|FG002|Double-Blind|Lost to Follow-up|12|||
148730253|NCT01550744|536484851|FG000|Double-Blind|Withdrawal by Subject|0|||
148730254|NCT01550744|536484852|FG001|Double-Blind|Withdrawal by Subject|2|||
148730255|NCT01550744|536484853|FG002|Double-Blind|Withdrawal by Subject|15|||
148730256|NCT01550744|536484851|FG000|Double-Blind|Adverse Event|0|||
148730257|NCT01550744|536484852|FG001|Double-Blind|Adverse Event|4|||
148730258|NCT01550744|536484853|FG002|Double-Blind|Adverse Event|15|||
148730259|NCT01550744|536484851|FG000|Double-Blind|Death|0|||
148730260|NCT01550744|536484852|FG001|Double-Blind|Death|1|||
148730261|NCT01550744|536484853|FG002|Double-Blind|Death|0|||
148730262|NCT01550744|536484851|FG000|Double-Blind|Lack of Efficacy|0|||
148730263|NCT01550744|536484852|FG001|Double-Blind|Lack of Efficacy|2|||
148730264|NCT01550744|536484853|FG002|Double-Blind|Lack of Efficacy|8|||
148730265|NCT01550744|536484851|FG000|Double-Blind|Protocol Violation|0|||
148730266|NCT01550744|536484852|FG001|Double-Blind|Protocol Violation|0|||
148730267|NCT01550744|536484853|FG002|Double-Blind|Protocol Violation|4|||
148730268|NCT01550744|536484851|FG000|Double-Blind|Pregnancy|0|||
148730269|NCT01550744|536484852|FG001|Double-Blind|Pregnancy|0|||
148730270|NCT01550744|536484853|FG002|Double-Blind|Pregnancy|3|||
148730271|NCT01550744|536484851|FG000|Double-Blind|Other|0|||
148730272|NCT01550744|536484852|FG001|Double-Blind|Other|2|||
148730273|NCT01550744|536484853|FG002|Double-Blind|Other|10|||
148730274|NCT00706381|536484855|FG000|Overall Study|Lost to Follow-up|0|||
148730275|NCT00706381|536484856|FG001|Overall Study|Lost to Follow-up|1|||
148730276|NCT00706381|536484857|FG002|Overall Study|Lost to Follow-up|1|||
148730277|NCT00706381|536484858|FG003|Overall Study|Lost to Follow-up|0|||
148730278|NCT00995085|536484862|FG000|Overall Study|Withdrawal by Subject|5|||
148730279|NCT02093221|536484865|FG000|Overall Study|Adverse Event|1|||
148730280|NCT02093221|536484866|FG001|Overall Study|Adverse Event|0|||
148730281|NCT02093221|536484867|FG002|Overall Study|Adverse Event|0|||
148730282|NCT02093221|536484868|FG003|Overall Study|Adverse Event|0|||
148817335|NCT00835978|536807243|FG003|Overall Study|Study terminated by sponsor|0|||
148817336|NCT01105130|536807244|FG000|Overall Study|Withdrawal by Subject|4|||
148817337|NCT01105130|536807245|FG001|Overall Study|Withdrawal by Subject|6|||
148730283|NCT02093221|536484869|FG004|Overall Study|Adverse Event|0|||
148730284|NCT02093221|536484865|FG000|Overall Study|Withdrawal by Subject|1|||
148730285|NCT02093221|536484866|FG001|Overall Study|Withdrawal by Subject|1|||
148730286|NCT02093221|536484867|FG002|Overall Study|Withdrawal by Subject|4|||
148730287|NCT02093221|536484868|FG003|Overall Study|Withdrawal by Subject|1|||
148730288|NCT02093221|536484869|FG004|Overall Study|Withdrawal by Subject|1|||
148730289|NCT02093221|536484865|FG000|Overall Study|Lost to Follow-up|2|||
148730290|NCT02093221|536484866|FG001|Overall Study|Lost to Follow-up|0|||
148817338|NCT01105130|536807246|FG002|Overall Study|Withdrawal by Subject|2|||
148817339|NCT01105130|536807244|FG000|Overall Study|Never Started|2|||
148817340|NCT01105130|536807245|FG001|Overall Study|Never Started|2|||
148972327|NCT01215227|537381956|FG002|Overall Study|Administrative|42|||
148730291|NCT02093221|536484867|FG002|Overall Study|Lost to Follow-up|1|||
148730292|NCT02093221|536484868|FG003|Overall Study|Lost to Follow-up|1|||
148730293|NCT02093221|536484869|FG004|Overall Study|Lost to Follow-up|0|||
148730294|NCT02093221|536484865|FG000|Overall Study|Death|0|||
148730295|NCT02093221|536484866|FG001|Overall Study|Death|1|||
148730296|NCT02093221|536484867|FG002|Overall Study|Death|0|||
148730297|NCT02093221|536484868|FG003|Overall Study|Death|0|||
148730298|NCT02093221|536484869|FG004|Overall Study|Death|0|||
148730299|NCT02093221|536484865|FG000|Overall Study|Protocol Violation|0|||
148730300|NCT02093221|536484866|FG001|Overall Study|Protocol Violation|1|||
148730301|NCT02093221|536484867|FG002|Overall Study|Protocol Violation|0|||
148730302|NCT02093221|536484868|FG003|Overall Study|Protocol Violation|0|||
148730303|NCT02093221|536484869|FG004|Overall Study|Protocol Violation|0|||
148730304|NCT02093221|536484865|FG000|Overall Study|Study termination|6|||
148730305|NCT02093221|536484866|FG001|Overall Study|Study termination|5|||
148730306|NCT02093221|536484867|FG002|Overall Study|Study termination|4|||
148730307|NCT02093221|536484868|FG003|Overall Study|Study termination|6|||
148730308|NCT02093221|536484869|FG004|Overall Study|Study termination|7|||
148730309|NCT03853148|536486289|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
148730310|NCT03853148|536486290|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
148730311|NCT03853148|536486291|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
148730312|NCT03853148|536486292|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
148730313|NCT00090610|536486293|FG000|Overall Study|Withdrawal by Subject|1|||
148730314|NCT00090610|536486294|FG001|Overall Study|Withdrawal by Subject|1|||
148730315|NCT00599521|536486297|FG000|Overall Study|Lack of Efficacy|4|||
148730316|NCT00599521|536486298|FG001|Overall Study|Lack of Efficacy|8|||
148730317|NCT00599521|536486297|FG000|Overall Study|Adverse Event|4|||
148730318|NCT00599521|536486298|FG001|Overall Study|Adverse Event|1|||
148730319|NCT00599521|536486297|FG000|Overall Study|Withdrawal by Subject|28|||
148730320|NCT00599521|536486298|FG001|Overall Study|Withdrawal by Subject|34|||
148730321|NCT00599521|536486297|FG000|Overall Study|Protocol Violation|1|||
148730322|NCT00599521|536486298|FG001|Overall Study|Protocol Violation|1|||
148730323|NCT00599521|536486297|FG000|Overall Study|Lost to Follow-up|23|||
148730324|NCT00599521|536486298|FG001|Overall Study|Lost to Follow-up|23|||
148730325|NCT00599521|536486297|FG000|Overall Study|Pregnancy|0|||
148730326|NCT00599521|536486298|FG001|Overall Study|Pregnancy|2|||
148730327|NCT01293539|536486300|FG000|Overall Study|Physician Decision|1|||
148730328|NCT00609518|536486302|FG000|Overall Study|Death from Study Disease|32|||
148730329|NCT00609518|536486303|FG001|Overall Study|Death from Study Disease|32|||
148730330|NCT00609518|536486302|FG000|Overall Study|Withdrawal by Subject|5|||
148972328|NCT01215227|537381957|FG003|Overall Study|Administrative|24|||
148972329|NCT01215227|537381958|FG004|Overall Study|Administrative|28|||
148972330|NCT01215227|537381959|FG005|Overall Study|Administrative|40|||
148972331|NCT01215227|537381954|FG000|Overall Study|Missing Status|0|||
148972332|NCT01215227|537381955|FG001|Overall Study|Missing Status|1|||
148972333|NCT01215227|537381956|FG002|Overall Study|Missing Status|0|||
148972334|NCT01215227|537381957|FG003|Overall Study|Missing Status|0|||
148972335|NCT01215227|537381958|FG004|Overall Study|Missing Status|0|||
148972336|NCT01215227|537381959|FG005|Overall Study|Missing Status|0|||
148972337|NCT01215227|537381954|FG000|Overall Study|Randomized but not treated|0|||
148972338|NCT01215227|537381955|FG001|Overall Study|Randomized but not treated|0|||
148972339|NCT01215227|537381956|FG002|Overall Study|Randomized but not treated|1|||
148972340|NCT01215227|537381957|FG003|Overall Study|Randomized but not treated|1|||
148972341|NCT01215227|537381958|FG004|Overall Study|Randomized but not treated|0|||
148972342|NCT01215227|537381959|FG005|Overall Study|Randomized but not treated|1|||
148972343|NCT00256698|537381962|FG000|Overall Study|Withdrawal by Subject|7|||
148972344|NCT00256698|537381963|FG001|Overall Study|Withdrawal by Subject|7|||
148972345|NCT00256698|537381962|FG000|Overall Study|Adverse Event|13|||
148972346|NCT00256698|537381963|FG001|Overall Study|Adverse Event|6|||
148972347|NCT00256698|537381962|FG000|Overall Study|Protocol Violation|6|||
148972348|NCT00256698|537381963|FG001|Overall Study|Protocol Violation|5|||
148972349|NCT00256698|537381962|FG000|Overall Study|Lost to Follow-up|1|||
148730331|NCT00609518|536486303|FG001|Overall Study|Withdrawal by Subject|3|||
148730332|NCT00609518|536486302|FG000|Overall Study|Lost to Follow-up|3|||
148730333|NCT00609518|536486303|FG001|Overall Study|Lost to Follow-up|0|||
148730334|NCT00609518|536486302|FG000|Overall Study|Physician Decision|1|||
148730335|NCT00609518|536486303|FG001|Overall Study|Physician Decision|3|||
148730336|NCT00609518|536486302|FG000|Overall Study|Death from Adverse Event|2|||
148730337|NCT00609518|536486303|FG001|Overall Study|Death from Adverse Event|2|||
148730338|NCT05855616|536486304|FG000|Overall Study|Lost to Follow-up|1|||
148730339|NCT05855616|536486305|FG001|Overall Study|Lost to Follow-up|2|||
148730340|NCT04032158|536486306|FG000|Overall Study|Study Termination|2|||
148730341|NCT04032158|536486307|FG001|Overall Study|Study Termination|1|||
148730342|NCT00059787|536486308|FG000|Overall Study|Adverse Event|13|||
148730343|NCT00059787|536486308|FG000|Overall Study|disease progression|2|||
148730344|NCT00059787|536486308|FG000|Overall Study|ineligible|1|||
148972350|NCT00256698|537381963|FG001|Overall Study|Lost to Follow-up|3|||
149026321|NCT04541186|537574196|FG000|Main Study|Withdrawal by Subject|1|||
149026322|NCT04541186|537574197|FG001|Main Study|Withdrawal by Subject|1|||
149026323|NCT04541186|537574198|FG002|Main Study|Withdrawal by Subject|0|||
149026324|NCT04541186|537574199|FG003|Main Study|Withdrawal by Subject|0|||
149026325|NCT04541186|537574200|FG004|Main Study|Withdrawal by Subject|0|||
149026326|NCT04541186|537574196|FG000|Main Study|COVID-19-related Dose Interruption|0|||
149026327|NCT04541186|537574197|FG001|Main Study|COVID-19-related Dose Interruption|0|||
149026328|NCT04541186|537574198|FG002|Main Study|COVID-19-related Dose Interruption|0|||
149026329|NCT04541186|537574199|FG003|Main Study|COVID-19-related Dose Interruption|0|||
149026330|NCT04541186|537574200|FG004|Main Study|COVID-19-related Dose Interruption|1|||
149026331|NCT04541186|537574196|FG000|Main Study|Randomized in Error Not Treated|0|||
149026332|NCT04541186|537574197|FG001|Main Study|Randomized in Error Not Treated|0|||
149026333|NCT04541186|537574198|FG002|Main Study|Randomized in Error Not Treated|1|||
149026334|NCT04541186|537574199|FG003|Main Study|Randomized in Error Not Treated|0|||
149026335|NCT04541186|537574200|FG004|Main Study|Randomized in Error Not Treated|0|||
149026336|NCT04541186|537574196|FG000|Fibrate Expansion Study|Other than Specified|0|||
149026337|NCT04541186|537574197|FG001|Fibrate Expansion Study|Other than Specified|0|||
149026338|NCT04541186|537574198|FG002|Fibrate Expansion Study|Other than Specified|0|||
149026339|NCT04541186|537574199|FG003|Fibrate Expansion Study|Other than Specified|0|||
149026340|NCT04541186|537574200|FG004|Fibrate Expansion Study|Other than Specified|1|||
149026341|NCT03682536|537574201|FG000|Randomization|Withdrawal by Subject|0|||
149026342|NCT03682536|537574202|FG001|Randomization|Withdrawal by Subject|2|||
149026343|NCT03682536|537574201|FG000|Treatment|Other Reasons|8|||
149026344|NCT03682536|537574202|FG001|Treatment|Other Reasons|7|||
149026345|NCT03682536|537574201|FG000|Treatment|Physician Decision|5|||
149026346|NCT03682536|537574202|FG001|Treatment|Physician Decision|5|||
149026347|NCT03682536|537574201|FG000|Treatment|Protocol Violation|1|||
149026348|NCT03682536|537574202|FG001|Treatment|Protocol Violation|0|||
149026349|NCT03682536|537574201|FG000|Treatment|Study Terminated by Sponsor|1|||
149026350|NCT03682536|537574202|FG001|Treatment|Study Terminated by Sponsor|2|||
149026351|NCT03682536|537574201|FG000|Treatment|Lost to Follow-up|0|||
149026352|NCT03682536|537574202|FG001|Treatment|Lost to Follow-up|1|||
148730345|NCT00059787|536486308|FG000|Overall Study|Other|4|||
148730346|NCT04421586|536486310|FG000|Overall Study|Death|0|||
148730347|NCT04421586|536486311|FG001|Overall Study|Death|1|||
148730348|NCT04421586|536486310|FG000|Overall Study|Lost to Follow-up|2|||
148730349|NCT04421586|536486311|FG001|Overall Study|Lost to Follow-up|2|||
149026353|NCT03682536|537574201|FG000|Treatment|Withdrawal by Subject|16|||
149026354|NCT03682536|537574202|FG001|Treatment|Withdrawal by Subject|18|||
149026355|NCT03682536|537574201|FG000|Treatment|Lack of Efficacy|41|||
149026356|NCT03682536|537574202|FG001|Treatment|Lack of Efficacy|68|||
149026357|NCT03682536|537574201|FG000|Treatment|Disease Progression|9|||
148730350|NCT04421586|536486310|FG000|Overall Study|Withdrawn by PI|1|||
148730351|NCT04421586|536486311|FG001|Overall Study|Withdrawn by PI|0|||
148730352|NCT04421586|536486310|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
148730353|NCT04421586|536486311|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
148730354|NCT01968694|536486312|FG000|Washout (1 Month)|Lost to Follow-up|0|||
148730355|NCT01968694|536486313|FG001|Washout (1 Month)|Lost to Follow-up|1|||
148730356|NCT00846521|536486314|FG000|Overall Study|Withdrawal by Subject|5|||
148730357|NCT00846521|536486314|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
148730358|NCT00846521|536486314|FG000|Overall Study|Protocol Violation|1|||
148730359|NCT05070546|536486321|FG000|Overall Study|Death|0|||
148730360|NCT05070546|536486322|FG001|Overall Study|Death|0|||
148730361|NCT05070546|536486323|FG002|Overall Study|Death|0|||
148730362|NCT05070546|536486324|FG003|Overall Study|Death|0|||
148730363|NCT05070546|536486325|FG004|Overall Study|Death|0|||
148730364|NCT05070546|536486326|FG005|Overall Study|Death|1|||
148730365|NCT05070546|536486321|FG000|Overall Study|Lost to Follow-up|8|||
148730366|NCT05070546|536486322|FG001|Overall Study|Lost to Follow-up|2|||
148817341|NCT01105130|536807246|FG002|Overall Study|Never Started|4|||
149026358|NCT03682536|537574202|FG001|Treatment|Disease Progression|7|||
149026359|NCT03682536|537574201|FG000|Treatment|Adverse Event|9|||
149026360|NCT03682536|537574202|FG001|Treatment|Adverse Event|5|||
149026361|NCT03682536|537574201|FG000|Treatment|Death|14|||
149026362|NCT03682536|537574202|FG001|Treatment|Death|13|||
149026363|NCT04824131|537574203|FG000|CAB LA Oral Phase|Adverse Event|1|||
149026364|NCT04824131|537574203|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
149026365|NCT04824131|537574203|FG000|Step 3|Withdrawal by Subject|2|||
149026366|NCT05489224|537574204|FG000|Treatment Period I|Withdrawal by Subject|6|||
149026367|NCT05489224|537574205|FG001|Treatment Period I|Withdrawal by Subject|5|||
148730367|NCT05070546|536486323|FG002|Overall Study|Lost to Follow-up|7|||
148730368|NCT05070546|536486324|FG003|Overall Study|Lost to Follow-up|1|||
148730369|NCT05070546|536486325|FG004|Overall Study|Lost to Follow-up|2|||
148730370|NCT05070546|536486326|FG005|Overall Study|Lost to Follow-up|0|||
148730371|NCT05070546|536486321|FG000|Overall Study|Withdrawal by Subject|1|||
148730372|NCT05070546|536486322|FG001|Overall Study|Withdrawal by Subject|1|||
148730373|NCT05070546|536486323|FG002|Overall Study|Withdrawal by Subject|3|||
148817342|NCT01105130|536807244|FG000|Overall Study|Toxicity|1|||
149026368|NCT05489224|537574206|FG002|Treatment Period I|Withdrawal by Subject|0|||
149026369|NCT05489224|537574204|FG000|Treatment Period I|Adverse Event|3|||
149026370|NCT05489224|537574205|FG001|Treatment Period I|Adverse Event|11|||
149026371|NCT05489224|537574206|FG002|Treatment Period I|Adverse Event|0|||
149026372|NCT05489224|537574204|FG000|Treatment Period I|Lost to Follow-up|0|||
149026373|NCT05489224|537574205|FG001|Treatment Period I|Lost to Follow-up|1|||
149026374|NCT05489224|537574206|FG002|Treatment Period I|Lost to Follow-up|0|||
149026375|NCT05489224|537574204|FG000|Treatment Period I|Physician Decision|0|||
149026376|NCT05489224|537574205|FG001|Treatment Period I|Physician Decision|1|||
149026377|NCT05489224|537574206|FG002|Treatment Period I|Physician Decision|0|||
149026378|NCT05489224|537574204|FG000|Treatment Period II up to Week 32|Ongoing|222|||
149026379|NCT05489224|537574205|FG001|Treatment Period II up to Week 32|Ongoing|107|||
149026380|NCT05489224|537574206|FG002|Treatment Period II up to Week 32|Ongoing|107|||
149026381|NCT05489224|537574204|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
149026382|NCT05489224|537574205|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
149026383|NCT05489224|537574206|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
149026384|NCT05489224|537574204|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
149026385|NCT05489224|537574205|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
149026386|NCT05489224|537574206|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
149026387|NCT03686384|537574208|FG000|Overall Study|Lack of Efficacy|4|||
149026388|NCT03686384|537574209|FG001|Overall Study|Lack of Efficacy|13|||
149026389|NCT03686384|537574208|FG000|Overall Study|Lost to Follow-up|3|||
148730374|NCT05070546|536486324|FG003|Overall Study|Withdrawal by Subject|0|||
148730375|NCT05070546|536486325|FG004|Overall Study|Withdrawal by Subject|0|||
148730376|NCT05070546|536486326|FG005|Overall Study|Withdrawal by Subject|0|||
148730377|NCT05070546|536486321|FG000|Overall Study|Other|0|||
148730378|NCT05070546|536486322|FG001|Overall Study|Other|0|||
148730379|NCT05070546|536486323|FG002|Overall Study|Other|0|||
148730380|NCT05070546|536486324|FG003|Overall Study|Other|0|||
148730381|NCT05070546|536486325|FG004|Overall Study|Other|3|||
148730382|NCT05070546|536486326|FG005|Overall Study|Other|0|||
148730383|NCT05070546|536486321|FG000|Overall Study|Randomized but not vaccinated|1|||
148730384|NCT05070546|536486322|FG001|Overall Study|Randomized but not vaccinated|0|||
148730385|NCT05070546|536486323|FG002|Overall Study|Randomized but not vaccinated|1|||
148730386|NCT05070546|536486324|FG003|Overall Study|Randomized but not vaccinated|1|||
148730387|NCT05070546|536486325|FG004|Overall Study|Randomized but not vaccinated|3|||
148730388|NCT05070546|536486326|FG005|Overall Study|Randomized but not vaccinated|0|||
148730389|NCT00160641|536486332|FG000|Overall Study|Adverse Event|102|||
148730390|NCT00160641|536486332|FG000|Overall Study|Withdrawal by Subject|87|||
148730391|NCT00160641|536486332|FG000|Overall Study|Lost to Follow-up|8|||
148730392|NCT00160641|536486332|FG000|Overall Study|Lack of Efficacy|12|||
148730393|NCT00160641|536486332|FG000|Overall Study|Protocol Violation|3|||
148730394|NCT00160641|536486332|FG000|Overall Study|Other|9|||
148730395|NCT02787408|536486333|FG000|Overall Study|Death|16|||
148730396|NCT02787408|536486333|FG000|Overall Study|Withdrawal by Subject|1|||
148730397|NCT02787408|536486333|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
148730398|NCT01782482|536486334|FG000|Overall Study|Adverse Event|2|||
148730399|NCT01782482|536486335|FG001|Overall Study|Adverse Event|1|||
148730400|NCT01782482|536486334|FG000|Overall Study|Lost to Follow-up|2|||
148730401|NCT01782482|536486335|FG001|Overall Study|Lost to Follow-up|3|||
148730402|NCT01782482|536486334|FG000|Overall Study|Physician Decision|1|||
148730403|NCT01782482|536486335|FG001|Overall Study|Physician Decision|0|||
148730404|NCT01782482|536486334|FG000|Overall Study|Protocol Violation|1|||
148730405|NCT01782482|536486335|FG001|Overall Study|Protocol Violation|0|||
148817343|NCT01105130|536807245|FG001|Overall Study|Toxicity|3|||
148817344|NCT01105130|536807246|FG002|Overall Study|Toxicity|2|||
148817345|NCT01105130|536807244|FG000|Overall Study|Multiple Reasons|3|||
148817346|NCT01105130|536807245|FG001|Overall Study|Multiple Reasons|0|||
148817347|NCT01105130|536807246|FG002|Overall Study|Multiple Reasons|2|||
148730406|NCT01782482|536486334|FG000|Overall Study|Withdrawal by Subject|2|||
148730407|NCT01782482|536486335|FG001|Overall Study|Withdrawal by Subject|3|||
148730408|NCT01782482|536486334|FG000|Overall Study|Randomized in Error|2|||
148817348|NCT01002105|536807247|FG000|Overall Study|Lost to Follow-up|10|||
148817349|NCT01002105|536807248|FG001|Overall Study|Lost to Follow-up|16|||
148817350|NCT01002105|536807247|FG000|Overall Study|non compliance|5|||
149026390|NCT03686384|537574209|FG001|Overall Study|Lost to Follow-up|0|||
149026391|NCT03686384|537574208|FG000|Overall Study|Physician Decision|0|||
149026392|NCT03686384|537574209|FG001|Overall Study|Physician Decision|1|||
149026393|NCT03686384|537574208|FG000|Overall Study|Took prohibited medication|0|||
149026394|NCT03686384|537574209|FG001|Overall Study|Took prohibited medication|1|||
149026395|NCT02820051|537574214|FG000|Overall Study|Lost to Follow-up|7|||
149026396|NCT02820051|537574215|FG001|Overall Study|Lost to Follow-up|4|||
149026397|NCT03008122|537574219|FG000|Overall Study|Physician Decision|3|||
148730409|NCT01782482|536486335|FG001|Overall Study|Randomized in Error|2|||
148817351|NCT01002105|536807248|FG001|Overall Study|non compliance|3|||
148817352|NCT01002105|536807247|FG000|Overall Study|condition worsened|4|||
148817353|NCT01002105|536807248|FG001|Overall Study|condition worsened|2|||
149026398|NCT03008122|537574220|FG001|Overall Study|Physician Decision|2|||
148730410|NCT01782482|536486334|FG000|Overall Study|Habitually wearing toric lens OS|0|||
148730411|NCT01782482|536486335|FG001|Overall Study|Habitually wearing toric lens OS|1|||
148730412|NCT00985712|536486337|FG000|Overall Study|Adverse Event|0|||
148730413|NCT00985712|536486338|FG001|Overall Study|Adverse Event|1|||
148730414|NCT00985712|536486337|FG000|Overall Study|Lost to Follow-up|2|||
148730415|NCT00985712|536486338|FG001|Overall Study|Lost to Follow-up|2|||
148730416|NCT00985712|536486337|FG000|Overall Study|Protocol Violation|0|||
148730417|NCT00985712|536486338|FG001|Overall Study|Protocol Violation|1|||
148730418|NCT00985712|536486337|FG000|Overall Study|Withdrawal by Subject|4|||
148730419|NCT00985712|536486338|FG001|Overall Study|Withdrawal by Subject|1|||
148730420|NCT00985712|536486337|FG000|Overall Study|Sponsor decision|0|||
148817354|NCT01363440|536807249|FG000|Overall Study|Adverse Event|5|||
148817355|NCT01363440|536807250|FG001|Overall Study|Adverse Event|4|||
148972351|NCT00256698|537381962|FG000|Overall Study|disease progression|97|||
148730421|NCT00985712|536486338|FG001|Overall Study|Sponsor decision|2|||
148730422|NCT01194973|536486344|FG000|Screening Period|Screen Failure|3|||
148730423|NCT01194973|536486344|FG000|26 Week Treatment Period|Adverse Event|1|||
148730424|NCT01194973|536486344|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
148730425|NCT01194973|536486344|FG000|26 Week Treatment Period|Pregnancy|1|||
148730426|NCT03096847|536486345|FG000|Overall Study|Other|2|||
148730427|NCT03096847|536486346|FG001|Overall Study|Other|1|||
148730428|NCT03096847|536486347|FG002|Overall Study|Other|2|||
148730429|NCT03096847|536486345|FG000|Overall Study|Lost to Follow-up|1|||
148730430|NCT03096847|536486346|FG001|Overall Study|Lost to Follow-up|0|||
148730431|NCT03096847|536486347|FG002|Overall Study|Lost to Follow-up|1|||
148730432|NCT03096847|536486345|FG000|Overall Study|Death|6|||
148730433|NCT03096847|536486346|FG001|Overall Study|Death|0|||
148730434|NCT03096847|536486347|FG002|Overall Study|Death|2|||
148730435|NCT03096847|536486345|FG000|Overall Study|Protocol Violation|3|||
148730436|NCT03096847|536486346|FG001|Overall Study|Protocol Violation|0|||
148730437|NCT03096847|536486347|FG002|Overall Study|Protocol Violation|6|||
148730438|NCT03096847|536486345|FG000|Overall Study|Physician Decision|12|||
148730439|NCT03096847|536486346|FG001|Overall Study|Physician Decision|2|||
148730440|NCT03096847|536486347|FG002|Overall Study|Physician Decision|8|||
148730441|NCT03096847|536486345|FG000|Overall Study|Withdrawal by Subject|24|||
148730442|NCT03096847|536486346|FG001|Overall Study|Withdrawal by Subject|1|||
148730443|NCT03096847|536486347|FG002|Overall Study|Withdrawal by Subject|12|||
148730444|NCT03096847|536486345|FG000|Overall Study|Adverse Event|72|||
148730445|NCT03096847|536486346|FG001|Overall Study|Adverse Event|6|||
148730446|NCT03096847|536486347|FG002|Overall Study|Adverse Event|28|||
148730447|NCT03096847|536486345|FG000|Overall Study|Progressive disease|97|||
148730448|NCT03096847|536486346|FG001|Overall Study|Progressive disease|10|||
148730449|NCT03096847|536486347|FG002|Overall Study|Progressive disease|78|||
148730450|NCT03096847|536486345|FG000|Overall Study|Non-compliance with study medication|1|||
148730451|NCT03096847|536486346|FG001|Overall Study|Non-compliance with study medication|0|||
148730452|NCT03096847|536486347|FG002|Overall Study|Non-compliance with study medication|0|||
148730453|NCT03096847|536486345|FG000|Overall Study|New therapy for study indication|1|||
148730454|NCT03096847|536486346|FG001|Overall Study|New therapy for study indication|0|||
148730455|NCT03096847|536486347|FG002|Overall Study|New therapy for study indication|1|||
148730456|NCT00359632|536486350|FG000|Overall Study|Death|2|||
148730457|NCT00359632|536486351|FG001|Overall Study|Death|0|||
148730458|NCT00359632|536486350|FG000|Overall Study|Adverse Event|1|||
148730459|NCT00359632|536486351|FG001|Overall Study|Adverse Event|0|||
148730460|NCT00359632|536486350|FG000|Overall Study|Non-compliance with visit schedule|1|||
148730461|NCT00359632|536486351|FG001|Overall Study|Non-compliance with visit schedule|0|||
148730462|NCT01875471|536486352|FG000|Overall Study|Adverse Event|0|||
148730463|NCT01875471|536486353|FG001|Overall Study|Adverse Event|1|||
148730464|NCT01875471|536486352|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
148972352|NCT00256698|537381963|FG001|Overall Study|disease progression|105|||
148972353|NCT00256698|537381962|FG000|Overall Study|still ongoing at data cut-off|41|||
148730465|NCT01875471|536486353|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
148730466|NCT03978091|536486356|FG000|Overall Study|Lost to Follow-up|0|||
148730467|NCT03978091|536486357|FG001|Overall Study|Lost to Follow-up|0|||
148730468|NCT03978091|536486358|FG002|Overall Study|Lost to Follow-up|1|||
148730469|NCT03978091|536486359|FG003|Overall Study|Lost to Follow-up|0|||
148730470|NCT03978091|536486360|FG004|Overall Study|Lost to Follow-up|0|||
148730471|NCT03978091|536486361|FG005|Overall Study|Lost to Follow-up|0|||
148730472|NCT03978091|536486356|FG000|Overall Study|Withdrawal by Subject|0|||
148730473|NCT03978091|536486357|FG001|Overall Study|Withdrawal by Subject|0|||
148730474|NCT03978091|536486358|FG002|Overall Study|Withdrawal by Subject|0|||
148730475|NCT03978091|536486359|FG003|Overall Study|Withdrawal by Subject|1|||
148730476|NCT03978091|536486360|FG004|Overall Study|Withdrawal by Subject|1|||
148730477|NCT03978091|536486361|FG005|Overall Study|Withdrawal by Subject|0|||
148730478|NCT04700280|536486366|FG000|Overall Study|Adverse Event|4|||
148730479|NCT04700280|536486367|FG001|Overall Study|Adverse Event|0|||
148730480|NCT04700280|536486366|FG000|Overall Study|Lack of Efficacy|1|||
148817356|NCT01363440|536807251|FG002|Overall Study|Adverse Event|4|||
148730481|NCT04700280|536486367|FG001|Overall Study|Lack of Efficacy|0|||
148817357|NCT01363440|536807249|FG000|Overall Study|Death|3|||
148730482|NCT04700280|536486366|FG000|Overall Study|Study terminated by sponsor|5|||
148730483|NCT04700280|536486367|FG001|Overall Study|Study terminated by sponsor|3|||
148730484|NCT04700280|536486366|FG000|Overall Study|Other than specified|1|||
148730485|NCT04700280|536486367|FG001|Overall Study|Other than specified|0|||
148730486|NCT01843348|536486368|FG000|Overall Study|Withdrawal by Subject|4|||
148730487|NCT01843348|536486369|FG001|Overall Study|Withdrawal by Subject|16|||
148730488|NCT01843348|536486370|FG002|Overall Study|Withdrawal by Subject|18|||
148730489|NCT01843348|536486368|FG000|Overall Study|Lost to Follow-up|5|||
148730490|NCT01843348|536486369|FG001|Overall Study|Lost to Follow-up|4|||
148730491|NCT01843348|536486370|FG002|Overall Study|Lost to Follow-up|2|||
148730492|NCT01843348|536486368|FG000|Overall Study|Death|5|||
148730493|NCT01843348|536486369|FG001|Overall Study|Death|3|||
148730494|NCT01843348|536486370|FG002|Overall Study|Death|4|||
148730495|NCT01843348|536486368|FG000|Overall Study|Graft loss/retransplantation|5|||
148730496|NCT01843348|536486369|FG001|Overall Study|Graft loss/retransplantation|8|||
148730497|NCT01843348|536486370|FG002|Overall Study|Graft loss/retransplantation|11|||
148730498|NCT01843348|536486368|FG000|Overall Study|Various reasons|4|||
148730499|NCT01843348|536486369|FG001|Overall Study|Various reasons|9|||
148730500|NCT01843348|536486370|FG002|Overall Study|Various reasons|6|||
148730501|NCT00251641|536486371|FG000|Overall Study|Adverse Event|80|||
148730502|NCT00251641|536486372|FG001|Overall Study|Adverse Event|8|||
148730503|NCT00251641|536486371|FG000|Overall Study|Lack of Efficacy|2|||
148730504|NCT00251641|536486372|FG001|Overall Study|Lack of Efficacy|1|||
148730505|NCT00251641|536486371|FG000|Overall Study|Progression of Disease|0|||
148730506|NCT00251641|536486372|FG001|Overall Study|Progression of Disease|2|||
148730507|NCT00251641|536486371|FG000|Overall Study|Lost to Follow-up|3|||
148730508|NCT00251641|536486372|FG001|Overall Study|Lost to Follow-up|3|||
148730509|NCT00251641|536486371|FG000|Overall Study|Withdrawal by Subject|6|||
148730510|NCT00251641|536486372|FG001|Overall Study|Withdrawal by Subject|8|||
148730511|NCT00251641|536486371|FG000|Overall Study|Protocol Violation|10|||
148730512|NCT00251641|536486372|FG001|Overall Study|Protocol Violation|2|||
148730513|NCT00251641|536486371|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
148730514|NCT00251641|536486372|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
148730515|NCT00251641|536486371|FG000|Overall Study|Switched Treatment|9|||
148730516|NCT00251641|536486372|FG001|Overall Study|Switched Treatment|63|||
148730517|NCT00257920|536486373|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
148730518|NCT00257920|536486374|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
148730519|NCT00257920|536486373|FG000|Period: Second Intervention|Other|2|||
148730520|NCT00257920|536486374|FG001|Period: Second Intervention|Other|1|||
148730521|NCT00770692|536486375|FG000|Overall Study|Withdrawal by Subject|7|||
148730522|NCT00770692|536486376|FG001|Overall Study|Withdrawal by Subject|9|||
148730523|NCT00770692|536486377|FG002|Overall Study|Withdrawal by Subject|9|||
148730524|NCT00770692|536486378|FG003|Overall Study|Withdrawal by Subject|6|||
148730525|NCT00770692|536486375|FG000|Overall Study|Adverse Event|3|||
148730526|NCT00770692|536486376|FG001|Overall Study|Adverse Event|0|||
148730527|NCT00770692|536486377|FG002|Overall Study|Adverse Event|4|||
148730528|NCT00770692|536486378|FG003|Overall Study|Adverse Event|4|||
148730529|NCT00770692|536486375|FG000|Overall Study|Investigator judgment|2|||
148730530|NCT00770692|536486376|FG001|Overall Study|Investigator judgment|0|||
148730531|NCT00770692|536486377|FG002|Overall Study|Investigator judgment|1|||
148730532|NCT00770692|536486378|FG003|Overall Study|Investigator judgment|1|||
148730533|NCT00062751|536486379|FG000|Overall Study|Disease progression|24|||
148730534|NCT00062751|536486380|FG001|Overall Study|Disease progression|17|||
148730535|NCT00062751|536486381|FG002|Overall Study|Disease progression|24|||
148730536|NCT00062751|536486382|FG003|Overall Study|Disease progression|2|||
148730537|NCT00062751|536486383|FG004|Overall Study|Disease progression|2|||
148730538|NCT00062751|536486379|FG000|Overall Study|Adverse Event|4|||
148730539|NCT00062751|536486380|FG001|Overall Study|Adverse Event|7|||
148730540|NCT00062751|536486381|FG002|Overall Study|Adverse Event|2|||
148730541|NCT00062751|536486382|FG003|Overall Study|Adverse Event|2|||
148972354|NCT00256698|537381963|FG001|Overall Study|still ongoing at data cut-off|46|||
148972355|NCT00256698|537381962|FG000|Overall Study|withdrawn due to osteoporosis|1|||
148972356|NCT00256698|537381963|FG001|Overall Study|withdrawn due to osteoporosis|0|||
148730542|NCT00062751|536486383|FG004|Overall Study|Adverse Event|2|||
148730543|NCT00062751|536486379|FG000|Overall Study|Other|2|||
148730544|NCT00062751|536486380|FG001|Overall Study|Other|3|||
148730545|NCT00062751|536486381|FG002|Overall Study|Other|1|||
148730546|NCT00062751|536486382|FG003|Overall Study|Other|0|||
148972357|NCT00256698|537381962|FG000|Overall Study|Prematurely Discontinued|1|||
148972358|NCT00256698|537381963|FG001|Overall Study|Prematurely Discontinued|0|||
149005474|NCT03217747|537497893|FG001|Overall Study|Toxicity and progression|0|||
148730547|NCT00062751|536486383|FG004|Overall Study|Other|1|||
148730548|NCT00062751|536486379|FG000|Overall Study|Withdrawal by Subject|1|||
148730549|NCT00062751|536486380|FG001|Overall Study|Withdrawal by Subject|2|||
148730550|NCT00062751|536486381|FG002|Overall Study|Withdrawal by Subject|2|||
148730551|NCT00062751|536486382|FG003|Overall Study|Withdrawal by Subject|1|||
148730552|NCT00062751|536486383|FG004|Overall Study|Withdrawal by Subject|0|||
148730553|NCT00062751|536486379|FG000|Overall Study|Symptomatic deterioration|1|||
149026399|NCT03008122|537574221|FG002|Overall Study|Physician Decision|0|||
149026400|NCT03008122|537574219|FG000|Overall Study|Withdrawal by Subject|1|||
149026401|NCT03008122|537574220|FG001|Overall Study|Withdrawal by Subject|3|||
149026402|NCT03008122|537574221|FG002|Overall Study|Withdrawal by Subject|0|||
149026403|NCT03008122|537574219|FG000|Overall Study|Lost to Follow-up|4|||
149026404|NCT03008122|537574220|FG001|Overall Study|Lost to Follow-up|8|||
149026405|NCT03008122|537574221|FG002|Overall Study|Lost to Follow-up|3|||
148730554|NCT00062751|536486380|FG001|Overall Study|Symptomatic deterioration|1|||
148730555|NCT00062751|536486381|FG002|Overall Study|Symptomatic deterioration|0|||
148730556|NCT00062751|536486382|FG003|Overall Study|Symptomatic deterioration|0|||
148730557|NCT00062751|536486383|FG004|Overall Study|Symptomatic deterioration|1|||
148730558|NCT00062751|536486379|FG000|Overall Study|Death|1|||
148730559|NCT00062751|536486380|FG001|Overall Study|Death|0|||
148730560|NCT00062751|536486381|FG002|Overall Study|Death|1|||
148730561|NCT00062751|536486382|FG003|Overall Study|Death|0|||
148730562|NCT00062751|536486383|FG004|Overall Study|Death|0|||
148730563|NCT03629028|536486384|FG000|Overall Study|Lost to Follow-up|26|||
148730564|NCT03629028|536486385|FG001|Overall Study|Lost to Follow-up|23|||
148730565|NCT03629028|536486384|FG000|Overall Study|Pregnancy|4|||
148730566|NCT03629028|536486385|FG001|Overall Study|Pregnancy|2|||
148730567|NCT03629028|536486384|FG000|Overall Study|intolerance to examination|2|||
148730568|NCT03629028|536486385|FG001|Overall Study|intolerance to examination|0|||
148730569|NCT03097588|536486388|FG000|Overall Study|Adverse Event|1|||
148730570|NCT03828448|536486391|FG000|Overall Study|Sponsor's Discretion|34|||
148730571|NCT05069155|536486392|FG000|Overall Study|Withdrawal by Subject|1|||
148730572|NCT05069155|536486393|FG001|Overall Study|Withdrawal by Subject|3|||
148730573|NCT02206620|536486394|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
148730574|NCT02206620|536486395|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
148730575|NCT02206620|536486394|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
148730576|NCT02206620|536486395|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
148730577|NCT01929031|536486398|FG000|Overall Study|Adverse Event|3|||
148730578|NCT01929031|536486399|FG001|Overall Study|Adverse Event|1|||
148730579|NCT01929031|536486400|FG002|Overall Study|Adverse Event|1|||
148730580|NCT01929031|536486401|FG003|Overall Study|Adverse Event|0|||
148730581|NCT01929031|536486402|FG004|Overall Study|Adverse Event|0|||
148730582|NCT01929031|536486403|FG005|Overall Study|Adverse Event|0|||
148730583|NCT01929031|536486398|FG000|Overall Study|Protocol Violation|1|||
148730584|NCT01929031|536486399|FG001|Overall Study|Protocol Violation|0|||
148730585|NCT01929031|536486400|FG002|Overall Study|Protocol Violation|0|||
148730586|NCT01929031|536486401|FG003|Overall Study|Protocol Violation|0|||
148730587|NCT01929031|536486402|FG004|Overall Study|Protocol Violation|0|||
148730588|NCT01929031|536486403|FG005|Overall Study|Protocol Violation|1|||
148730589|NCT01929031|536486398|FG000|Overall Study|Reason other than specified above|0|||
148730590|NCT01929031|536486399|FG001|Overall Study|Reason other than specified above|1|||
148730591|NCT01929031|536486400|FG002|Overall Study|Reason other than specified above|0|||
148730592|NCT01929031|536486401|FG003|Overall Study|Reason other than specified above|0|||
148730593|NCT01929031|536486402|FG004|Overall Study|Reason other than specified above|1|||
148730594|NCT01929031|536486403|FG005|Overall Study|Reason other than specified above|0|||
148730595|NCT05816200|536486404|FG000|Overall Study|Lost to Follow-up|2|||
148730596|NCT05816200|536486405|FG001|Overall Study|Lost to Follow-up|1|||
148730597|NCT01366443|536486406|FG000|Overall Study|Lost to Follow-up|2|||
148730598|NCT01366443|536486406|FG000|Overall Study|Under 18 yo|1|||
148730599|NCT02394730|536486407|FG000|Overall Study|Lost to Follow-up|1|||
148730600|NCT02394730|536486408|FG001|Overall Study|Lost to Follow-up|0|||
148730601|NCT02394730|536486407|FG000|Overall Study|Withdrawal by Subject|0|||
148730602|NCT02394730|536486408|FG001|Overall Study|Withdrawal by Subject|1|||
148730603|NCT00731549|536486409|FG000|Overall Study|Lost to Follow-up|19|||
148730604|NCT00731549|536486409|FG000|Overall Study|Met withdrawal criteria|24|||
148730605|NCT00731549|536486409|FG000|Overall Study|Physician Decision|16|||
148730606|NCT00731549|536486409|FG000|Overall Study|Withdrawal by Subject|89|||
148730607|NCT00731549|536486409|FG000|Overall Study|Protocol deviation|1|||
148730608|NCT00731549|536486409|FG000|Overall Study|Adverse Event|31|||
148730609|NCT00731549|536486409|FG000|Overall Study|Lack of efficacy with AE|37|||
148730610|NCT00731549|536486409|FG000|Overall Study|Lack of efficacy without AE|6|||
148730611|NCT00588640|536486410|FG000|Overall Study|Physician Decision|1|||
148730612|NCT00588640|536486410|FG000|Overall Study|Ineligible Patient|1|||
148730613|NCT02384850|536486411|FG000|Overall Study|Withdrawal by Subject|2|||
148730614|NCT02384850|536486412|FG001|Overall Study|Withdrawal by Subject|2|||
148730615|NCT00507546|536486413|FG000|Overall Study|Withdrawal by Subject|1|||
148730616|NCT00507546|536486414|FG001|Overall Study|Withdrawal by Subject|0|||
149026406|NCT03008122|537574219|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
148730617|NCT00507546|536486413|FG000|Overall Study|Protocol Violation|1|||
148730618|NCT00507546|536486414|FG001|Overall Study|Protocol Violation|0|||
149026407|NCT03008122|537574220|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
148730619|NCT00507546|536486413|FG000|Overall Study|Physician Decision|0|||
148730620|NCT00507546|536486414|FG001|Overall Study|Physician Decision|1|||
148730621|NCT01111019|536486415|FG000|Overall Study|Withdrew Prematurely|2|||
148972359|NCT04477304|537381965|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
148972360|NCT04477304|537381966|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
148972361|NCT02777125|537381967|FG000|Overall Study|Consent form violation|14|||
148972362|NCT02777125|537381968|FG001|Overall Study|Consent form violation|12|||
148972363|NCT02777125|537381967|FG000|Overall Study|Assent form violation|21|||
148972364|NCT02777125|537381968|FG001|Overall Study|Assent form violation|23|||
148972365|NCT02777125|537381967|FG000|Overall Study|Protocol Violation|8|||
148972366|NCT02777125|537381968|FG001|Overall Study|Protocol Violation|12|||
148972367|NCT00653224|537383381|FG000|Overall Study|Adverse Event|2|||
148972368|NCT00653224|537383382|FG001|Overall Study|Adverse Event|1|||
148972369|NCT00653224|537383381|FG000|Overall Study|Lack of Efficacy|1|||
148972370|NCT00653224|537383382|FG001|Overall Study|Lack of Efficacy|2|||
148972371|NCT00653224|537383381|FG000|Overall Study|Loss of efficacy|1|||
148972372|NCT00653224|537383382|FG001|Overall Study|Loss of efficacy|0|||
148972373|NCT00653224|537383381|FG000|Overall Study|Lost to Follow-up|1|||
148972374|NCT00653224|537383382|FG001|Overall Study|Lost to Follow-up|0|||
148972375|NCT00653224|537383381|FG000|Overall Study|Other|2|||
148972376|NCT00653224|537383382|FG001|Overall Study|Other|4|||
148972377|NCT05723770|537383383|FG000|Overall Study|Lost to Follow-up|4|||
148972378|NCT05723770|537383383|FG000|Overall Study|Withdrawal by Subject|2|||
148972379|NCT02365636|537383386|FG000|Overall Study|Adverse Event|3|||
148972380|NCT02365636|537383387|FG001|Overall Study|Adverse Event|3|||
148972381|NCT02365636|537383388|FG002|Overall Study|Adverse Event|2|||
148972382|NCT02365636|537383386|FG000|Overall Study|Protocol Violation|1|||
148972383|NCT02365636|537383387|FG001|Overall Study|Protocol Violation|4|||
148972384|NCT02365636|537383388|FG002|Overall Study|Protocol Violation|0|||
148972385|NCT02365636|537383386|FG000|Overall Study|Lost to Follow-up|0|||
148972386|NCT02365636|537383387|FG001|Overall Study|Lost to Follow-up|0|||
148972387|NCT02365636|537383388|FG002|Overall Study|Lost to Follow-up|1|||
148972388|NCT02365636|537383386|FG000|Overall Study|Other|2|||
148972389|NCT02365636|537383387|FG001|Overall Study|Other|0|||
148972390|NCT02365636|537383388|FG002|Overall Study|Other|0|||
148972391|NCT00355238|537383389|FG000|Overall Study|Adverse event unrelated to study drug|2|||
148972392|NCT00355238|537383390|FG001|Overall Study|Adverse event unrelated to study drug|2|||
148817358|NCT01363440|536807250|FG001|Overall Study|Death|7|||
148817359|NCT01363440|536807251|FG002|Overall Study|Death|5|||
148817360|NCT01363440|536807249|FG000|Overall Study|Withdrawal by Subject|9|||
148817361|NCT01363440|536807250|FG001|Overall Study|Withdrawal by Subject|11|||
148817362|NCT01363440|536807251|FG002|Overall Study|Withdrawal by Subject|11|||
148817363|NCT01363440|536807249|FG000|Overall Study|Lost to Follow-up|2|||
148817364|NCT01363440|536807250|FG001|Overall Study|Lost to Follow-up|4|||
148817365|NCT01363440|536807251|FG002|Overall Study|Lost to Follow-up|5|||
148817366|NCT01363440|536807249|FG000|Overall Study|Other|4|||
148817367|NCT01363440|536807250|FG001|Overall Study|Other|5|||
148817368|NCT01363440|536807251|FG002|Overall Study|Other|2|||
148817369|NCT01166945|536807252|FG000|Randomized|diagnosed with Group A strep|4|||
148817370|NCT01166945|536807253|FG001|Randomized|diagnosed with Group A strep|4|||
148817371|NCT01166945|536807252|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
148817372|NCT01166945|536807253|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
148817373|NCT01166945|536807252|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
148817374|NCT01166945|536807253|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
148817375|NCT01166945|536807252|FG000|Day 30|Lost to Follow-up|4|||
148817376|NCT01166945|536807253|FG001|Day 30|Lost to Follow-up|3|||
148817377|NCT00552058|536807254|FG000|Overall Study|Adverse Event|8|||
148972393|NCT00355238|537383391|FG002|Overall Study|Adverse event unrelated to study drug|0|||
148972394|NCT00355238|537383392|FG003|Overall Study|Adverse event unrelated to study drug|1|||
148972395|NCT00355238|537383389|FG000|Overall Study|Death|1|||
148730622|NCT01111019|536486415|FG000|Overall Study|Other|1|||
148730623|NCT03512262|536486419|FG000|Overall Study|Adverse Event|8|||
148730624|NCT03512262|536486420|FG001|Overall Study|Adverse Event|3|||
148730625|NCT03512262|536486419|FG000|Overall Study|Death (non-treatment emergent)|1|||
148730626|NCT03512262|536486420|FG001|Overall Study|Death (non-treatment emergent)|0|||
148730627|NCT03512262|536486419|FG000|Overall Study|Withdrawal by Subject|17|||
148730628|NCT03512262|536486420|FG001|Overall Study|Withdrawal by Subject|9|||
148730629|NCT03512262|536486419|FG000|Overall Study|Lost to Follow-up|7|||
148730630|NCT03512262|536486420|FG001|Overall Study|Lost to Follow-up|1|||
148730631|NCT03512262|536486419|FG000|Overall Study|Other than Specified|2|||
148730632|NCT03512262|536486420|FG001|Overall Study|Other than Specified|2|||
148730633|NCT00375492|536486422|FG000|Overall Study|Adverse Event|4|||
148730634|NCT00375492|536486423|FG001|Overall Study|Adverse Event|5|||
148730635|NCT00375492|536486422|FG000|Overall Study|Entry Criteria Not Met|0|||
148730636|NCT00375492|536486423|FG001|Overall Study|Entry Criteria Not Met|1|||
148730637|NCT00375492|536486422|FG000|Overall Study|Loss of Glucose Control|0|||
148730638|NCT00375492|536486423|FG001|Overall Study|Loss of Glucose Control|1|||
148730639|NCT00375492|536486422|FG000|Overall Study|Lost to Follow-up|10|||
148730640|NCT00375492|536486423|FG001|Overall Study|Lost to Follow-up|5|||
148730641|NCT00375492|536486422|FG000|Overall Study|Physician Decision|0|||
148730642|NCT00375492|536486423|FG001|Overall Study|Physician Decision|4|||
148817378|NCT00552058|536807255|FG001|Overall Study|Adverse Event|7|||
148817379|NCT00552058|536807254|FG000|Overall Study|Lack of Efficacy|1|||
148817380|NCT00552058|536807255|FG001|Overall Study|Lack of Efficacy|5|||
148817381|NCT00552058|536807254|FG000|Overall Study|Lost to Follow-up|1|||
148972396|NCT00355238|537383390|FG001|Overall Study|Death|0|||
148972397|NCT00355238|537383391|FG002|Overall Study|Death|0|||
148972398|NCT00355238|537383392|FG003|Overall Study|Death|0|||
148972399|NCT00355238|537383389|FG000|Overall Study|Disease progression|37|||
148972400|NCT00355238|537383390|FG001|Overall Study|Disease progression|36|||
148972401|NCT00355238|537383391|FG002|Overall Study|Disease progression|16|||
148972402|NCT00355238|537383392|FG003|Overall Study|Disease progression|11|||
148972403|NCT00355238|537383389|FG000|Overall Study|Study drug toxicity|11|||
148972404|NCT00355238|537383390|FG001|Overall Study|Study drug toxicity|7|||
148972405|NCT00355238|537383391|FG002|Overall Study|Study drug toxicity|5|||
148972406|NCT00355238|537383392|FG003|Overall Study|Study drug toxicity|2|||
148972407|NCT00355238|537383389|FG000|Overall Study|Participant withdrew consent|3|||
148972408|NCT00355238|537383390|FG001|Overall Study|Participant withdrew consent|1|||
148730643|NCT00375492|536486422|FG000|Overall Study|Protocol Violation|6|||
148730644|NCT00375492|536486423|FG001|Overall Study|Protocol Violation|3|||
148817382|NCT00552058|536807255|FG001|Overall Study|Lost to Follow-up|0|||
148817383|NCT00552058|536807254|FG000|Overall Study|Withdrawal by Subject|4|||
148817384|NCT00552058|536807255|FG001|Overall Study|Withdrawal by Subject|4|||
148972409|NCT00355238|537383391|FG002|Overall Study|Participant withdrew consent|0|||
148972410|NCT00355238|537383392|FG003|Overall Study|Participant withdrew consent|0|||
148972411|NCT00355238|537383389|FG000|Overall Study|Participant request to discontinue study treatment|1|||
148730645|NCT00375492|536486422|FG000|Overall Study|Sponsor Decision|0|||
148972412|NCT00355238|537383390|FG001|Overall Study|Participant request to discontinue study treatment|0|||
148730646|NCT00375492|536486423|FG001|Overall Study|Sponsor Decision|1|||
148817385|NCT00552058|536807254|FG000|Overall Study|Other: Protocol Violation|0|||
148972413|NCT00355238|537383391|FG002|Overall Study|Participant request to discontinue study treatment|1|||
148817386|NCT00552058|536807255|FG001|Overall Study|Other: Protocol Violation|1|||
148817387|NCT00552058|536807254|FG000|Overall Study|Other: Non Compliance|1|||
148817388|NCT00552058|536807255|FG001|Overall Study|Other: Non Compliance|2|||
148817389|NCT00552058|536807254|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
148972414|NCT00355238|537383392|FG003|Overall Study|Participant request to discontinue study treatment|0|||
148972415|NCT01454934|537383393|FG000|Overall Study|Clinical progression|28|||
148972416|NCT01454934|537383394|FG001|Overall Study|Clinical progression|25|||
148730647|NCT00375492|536486422|FG000|Overall Study|Withdrawal by Subject|6|||
148730648|NCT00375492|536486423|FG001|Overall Study|Withdrawal by Subject|6|||
148730649|NCT04062448|536488146|FG000|Overall Study|Lost to Follow-up|1|||
148730650|NCT04062448|536488146|FG000|Overall Study|Withdrawal by Subject|2|||
148730651|NCT03303625|536488147|FG000|Overall Study|Withdrawal by Subject|2|||
148730652|NCT03303625|536488148|FG001|Overall Study|Withdrawal by Subject|0|||
148730653|NCT03303625|536488149|FG002|Overall Study|Withdrawal by Subject|0|||
148730654|NCT03303625|536488150|FG003|Overall Study|Withdrawal by Subject|0|||
148972417|NCT01454934|537383393|FG000|Overall Study|Other|6|||
148730655|NCT04319718|536488151|FG000|Overall Study|Adverse Event|0|||
148730656|NCT04319718|536488152|FG001|Overall Study|Adverse Event|2|||
148730657|NCT04319718|536488151|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
148730658|NCT04319718|536488152|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
148730659|NCT03340064|536488154|FG000|First Period|Adverse Event, non-fatal|2|||
148730660|NCT03340064|536488155|FG001|First Period|Adverse Event, non-fatal|0|||
148730661|NCT03340064|536488154|FG000|First Period|Lack of Efficacy|3|||
148730662|NCT03340064|536488155|FG001|First Period|Lack of Efficacy|0|||
148730663|NCT03340064|536488154|FG000|Second Period|Adverse Event, non-fatal|1|||
148730664|NCT03340064|536488155|FG001|Second Period|Adverse Event, non-fatal|1|||
148730665|NCT03340064|536488154|FG000|Second Period|Lack of Efficacy|11|||
148730666|NCT03340064|536488155|FG001|Second Period|Lack of Efficacy|0|||
148730667|NCT03340064|536488154|FG000|Second Period|Physician Decision|3|||
148730668|NCT03340064|536488155|FG001|Second Period|Physician Decision|0|||
148730669|NCT03340064|536488154|FG000|Second Period|Withdrawal by Subject|2|||
148730670|NCT03340064|536488155|FG001|Second Period|Withdrawal by Subject|1|||
148730671|NCT03340064|536488154|FG000|Second Period|Approved Drug Available For Indication|1|||
148730672|NCT03340064|536488155|FG001|Second Period|Approved Drug Available For Indication|0|||
148730673|NCT03340064|536488154|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
148730674|NCT03340064|536488155|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
148730675|NCT01045421|536488156|FG000|Phase 1|Progressive Disease|0|||
148730676|NCT01045421|536488157|FG001|Phase 1|Progressive Disease|0|||
148730677|NCT01045421|536488158|FG002|Phase 1|Progressive Disease|0|||
148730678|NCT01045421|536488159|FG003|Phase 1|Progressive Disease|0|||
148730679|NCT01045421|536488160|FG004|Phase 1|Progressive Disease|1|||
148730680|NCT01045421|536488161|FG005|Phase 1|Progressive Disease|0|||
148730681|NCT01045421|536488162|FG006|Phase 1|Progressive Disease|0|||
148730682|NCT01045421|536488163|FG007|Phase 1|Progressive Disease|0|||
148730683|NCT01045421|536488164|FG008|Phase 1|Progressive Disease|0|||
148730684|NCT01045421|536488165|FG009|Phase 1|Progressive Disease|0|||
148730685|NCT01045421|536488166|FG010|Phase 1|Progressive Disease|0|||
148730686|NCT01045421|536488156|FG000|Phase 1|Withdrawal by Subject|0|||
148730687|NCT01045421|536488157|FG001|Phase 1|Withdrawal by Subject|0|||
148730688|NCT01045421|536488158|FG002|Phase 1|Withdrawal by Subject|0|||
148730689|NCT01045421|536488159|FG003|Phase 1|Withdrawal by Subject|1|||
148730690|NCT01045421|536488160|FG004|Phase 1|Withdrawal by Subject|0|||
148730691|NCT01045421|536488161|FG005|Phase 1|Withdrawal by Subject|0|||
148730692|NCT01045421|536488162|FG006|Phase 1|Withdrawal by Subject|0|||
148730693|NCT01045421|536488163|FG007|Phase 1|Withdrawal by Subject|0|||
148730694|NCT01045421|536488164|FG008|Phase 1|Withdrawal by Subject|0|||
148730695|NCT01045421|536488165|FG009|Phase 1|Withdrawal by Subject|0|||
148730696|NCT01045421|536488166|FG010|Phase 1|Withdrawal by Subject|0|||
148730697|NCT01045421|536488156|FG000|Phase 2|Progressive Disease|0|||
148730698|NCT01045421|536488157|FG001|Phase 2|Progressive Disease|0|||
148730699|NCT01045421|536488158|FG002|Phase 2|Progressive Disease|0|||
148730700|NCT01045421|536488159|FG003|Phase 2|Progressive Disease|0|||
148730701|NCT01045421|536488160|FG004|Phase 2|Progressive Disease|0|||
148730702|NCT01045421|536488161|FG005|Phase 2|Progressive Disease|0|||
148730703|NCT01045421|536488162|FG006|Phase 2|Progressive Disease|0|||
148730704|NCT01045421|536488163|FG007|Phase 2|Progressive Disease|1|||
148730705|NCT01045421|536488164|FG008|Phase 2|Progressive Disease|1|||
148730706|NCT01045421|536488165|FG009|Phase 2|Progressive Disease|1|||
148730707|NCT01045421|536488166|FG010|Phase 2|Progressive Disease|1|||
148730708|NCT01045421|536488156|FG000|Phase 2|Death|0|||
148730709|NCT01045421|536488157|FG001|Phase 2|Death|0|||
148730710|NCT01045421|536488158|FG002|Phase 2|Death|0|||
148730711|NCT01045421|536488159|FG003|Phase 2|Death|0|||
148730712|NCT01045421|536488160|FG004|Phase 2|Death|0|||
148730713|NCT01045421|536488161|FG005|Phase 2|Death|0|||
148730714|NCT01045421|536488162|FG006|Phase 2|Death|0|||
148730715|NCT01045421|536488163|FG007|Phase 2|Death|1|||
148730716|NCT01045421|536488164|FG008|Phase 2|Death|1|||
148730717|NCT01045421|536488165|FG009|Phase 2|Death|2|||
148730718|NCT01045421|536488166|FG010|Phase 2|Death|0|||
148730719|NCT01045421|536488156|FG000|Phase 2|Other|0|||
148730720|NCT01045421|536488157|FG001|Phase 2|Other|0|||
148730721|NCT01045421|536488158|FG002|Phase 2|Other|0|||
148730722|NCT01045421|536488159|FG003|Phase 2|Other|0|||
148730723|NCT01045421|536488160|FG004|Phase 2|Other|0|||
148730724|NCT01045421|536488161|FG005|Phase 2|Other|0|||
148730725|NCT01045421|536488162|FG006|Phase 2|Other|0|||
148730726|NCT01045421|536488163|FG007|Phase 2|Other|3|||
148730727|NCT01045421|536488164|FG008|Phase 2|Other|0|||
148730728|NCT01045421|536488165|FG009|Phase 2|Other|0|||
148730729|NCT01045421|536488166|FG010|Phase 2|Other|1|||
148730730|NCT02221037|536488167|FG000|Overall Study|Physician Decision|0|||
148730731|NCT02221037|536488168|FG001|Overall Study|Physician Decision|0|||
148730732|NCT02221037|536488169|FG002|Overall Study|Physician Decision|1|||
148730733|NCT02221037|536488170|FG003|Overall Study|Physician Decision|0|||
148730734|NCT00321828|536488171|FG000|Overall Study|Ineligible|3|||
148730735|NCT00321828|536488171|FG000|Overall Study|No follow up data|1|||
148730736|NCT02307266|536488174|FG000|Overall Study|Adverse Event|3|||
148730737|NCT02307266|536488175|FG001|Overall Study|Adverse Event|1|||
148730738|NCT02307266|536488176|FG002|Overall Study|Adverse Event|5|||
148730739|NCT02307266|536488174|FG000|Overall Study|Withdrawal by Subject|2|||
148730740|NCT02307266|536488175|FG001|Overall Study|Withdrawal by Subject|0|||
148730741|NCT02307266|536488176|FG002|Overall Study|Withdrawal by Subject|1|||
148730742|NCT02307266|536488174|FG000|Overall Study|Lost to Follow-up|3|||
148730743|NCT02307266|536488175|FG001|Overall Study|Lost to Follow-up|0|||
148730744|NCT02307266|536488176|FG002|Overall Study|Lost to Follow-up|0|||
148730745|NCT02944383|536488178|FG000|Overall Study|Lost to Follow-up|0|||
148730746|NCT02944383|536488179|FG001|Overall Study|Lost to Follow-up|0|||
148730747|NCT02944383|536488180|FG002|Overall Study|Lost to Follow-up|1|||
148730748|NCT02944383|536488178|FG000|Overall Study|Withdrawal by Subject|1|||
148730749|NCT02944383|536488179|FG001|Overall Study|Withdrawal by Subject|0|||
148730750|NCT02944383|536488180|FG002|Overall Study|Withdrawal by Subject|0|||
148730751|NCT00858143|536488185|FG000|Overall Study|Adverse Event|16|||
148730752|NCT00858143|536488185|FG000|Overall Study|Lack of Efficacy|4|||
148730753|NCT00858143|536488185|FG000|Overall Study|Death|7|||
148730754|NCT00858143|536488185|FG000|Overall Study|Other|23|||
148730755|NCT04710979|536488189|FG000|Overall Study|Lost to Follow-up|2|||
148730756|NCT04710979|536488190|FG001|Overall Study|Lost to Follow-up|4|||
148730757|NCT04710979|536488189|FG000|Overall Study|Withdrawal by Subject|1|||
148730758|NCT04710979|536488190|FG001|Overall Study|Withdrawal by Subject|0|||
148730759|NCT00912093|536488193|FG000|The Controlled Phase|Death|0|||
148730760|NCT00912093|536488194|FG001|The Controlled Phase|Death|1|||
148730761|NCT00912093|536488195|FG002|The Controlled Phase|Death|0|||
148730762|NCT00912093|536488196|FG003|The Controlled Phase|Death|0|||
148730763|NCT00912093|536488197|FG004|The Controlled Phase|Death|0|||
148730764|NCT00912093|536488193|FG000|The Controlled Phase|Medical Condition|0|||
148730765|NCT00912093|536488194|FG001|The Controlled Phase|Medical Condition|1|||
148972418|NCT01454934|537383394|FG001|Overall Study|Other|17|||
148972419|NCT01454934|537383393|FG000|Overall Study|Adverse Event|28|||
148972420|NCT01454934|537383394|FG001|Overall Study|Adverse Event|24|||
148972421|NCT01454934|537383393|FG000|Overall Study|Withdrawn consent|2|||
148972422|NCT01454934|537383394|FG001|Overall Study|Withdrawn consent|5|||
148972423|NCT01454934|537383393|FG000|Overall Study|Withdrawal by Subject|11|||
148972424|NCT01454934|537383394|FG001|Overall Study|Withdrawal by Subject|15|||
148972425|NCT01454934|537383393|FG000|Overall Study|Disease progression|194|||
148972426|NCT01454934|537383394|FG001|Overall Study|Disease progression|181|||
148972427|NCT01454934|537383393|FG000|Overall Study|Lost to Follow-up|0|||
148972428|NCT01454934|537383394|FG001|Overall Study|Lost to Follow-up|1|||
148972429|NCT01454934|537383393|FG000|Overall Study|Not treated|1|||
148972430|NCT01454934|537383394|FG001|Overall Study|Not treated|2|||
148972431|NCT00116558|537383399|FG000|Overall Study|Death|11|||
148972432|NCT00116558|537383400|FG001|Overall Study|Death|5|||
148972433|NCT00116558|537383401|FG002|Overall Study|Death|3|||
148972434|NCT00116558|537383399|FG000|Overall Study|Withdrawal by Subject|17|||
148972435|NCT00116558|537383400|FG001|Overall Study|Withdrawal by Subject|3|||
148972436|NCT00116558|537383401|FG002|Overall Study|Withdrawal by Subject|12|||
148972437|NCT00116558|537383399|FG000|Overall Study|disease progression|3|||
148972438|NCT00116558|537383400|FG001|Overall Study|disease progression|7|||
148730766|NCT00912093|536488195|FG002|The Controlled Phase|Medical Condition|0|||
148730767|NCT00912093|536488196|FG003|The Controlled Phase|Medical Condition|0|||
148730768|NCT00912093|536488197|FG004|The Controlled Phase|Medical Condition|0|||
148730769|NCT00912093|536488193|FG000|The Controlled Phase|Lost to Follow-up|0|||
148730770|NCT00912093|536488194|FG001|The Controlled Phase|Lost to Follow-up|0|||
148730771|NCT00912093|536488195|FG002|The Controlled Phase|Lost to Follow-up|0|||
148730772|NCT00912093|536488196|FG003|The Controlled Phase|Lost to Follow-up|0|||
148730773|NCT00912093|536488197|FG004|The Controlled Phase|Lost to Follow-up|1|||
148972439|NCT00116558|537383401|FG002|Overall Study|disease progression|18|||
148972440|NCT00357370|537383402|FG000|Cohort 2|Lack of Efficacy|0|||
148972441|NCT00357370|537383403|FG001|Cohort 2|Lack of Efficacy|2|||
148730774|NCT00891371|536488200|FG000|Pre-assignment|Inclusion/exclusion|5|||
148730775|NCT00891371|536488200|FG000|Pre-assignment|Consent withdrawal|1|||
148730776|NCT00891371|536488200|FG000|Treatment|Lack of Efficacy|5|||
148730777|NCT00891371|536488200|FG000|Treatment|Adverse Event|2|||
148730778|NCT00891371|536488200|FG000|Treatment|Death|1|||
148972442|NCT00357370|537383404|FG002|Cohort 2|Lack of Efficacy|1|||
148972443|NCT00357370|537383402|FG000|Cohort 2|Adverse Event|1|||
148972444|NCT00357370|537383403|FG001|Cohort 2|Adverse Event|1|||
148730779|NCT00891371|536488200|FG000|Treatment|Lost to Follow-up|1|||
148972445|NCT00357370|537383404|FG002|Cohort 2|Adverse Event|1|||
148730780|NCT00307034|536488201|FG000|Overall Study|Adverse Event|1|||
148730781|NCT00307034|536488202|FG001|Overall Study|Adverse Event|2|||
148730782|NCT00307034|536488201|FG000|Overall Study|Withdrawal by Subject|1|||
148817390|NCT00552058|536807255|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
148817391|NCT00552058|536807254|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
148817392|NCT00552058|536807255|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
148730783|NCT00307034|536488202|FG001|Overall Study|Withdrawal by Subject|2|||
148730784|NCT00307034|536488201|FG000|Overall Study|Lost to Follow-up|0|||
148730785|NCT00307034|536488202|FG001|Overall Study|Lost to Follow-up|3|||
148730786|NCT00450619|536488208|FG000|Overall Study|refused treatment after randomization|2|||
148730787|NCT00450619|536488209|FG001|Overall Study|refused treatment after randomization|0|||
148730788|NCT00450619|536488208|FG000|Overall Study|did not progress; refused further trmt|1|||
148730789|NCT00450619|536488209|FG001|Overall Study|did not progress; refused further trmt|1|||
148730790|NCT00450619|536488208|FG000|Overall Study|Adverse Event|1|||
148730791|NCT00450619|536488209|FG001|Overall Study|Adverse Event|0|||
148730792|NCT02034058|536488210|FG000|Overall Study|Death|3|||
148730793|NCT02836496|536488211|FG000|Overall Study|Adverse Event|2|||
148730794|NCT02836496|536488212|FG001|Overall Study|Adverse Event|1|||
148817393|NCT00552058|536807254|FG000|Overall Study|Other: Positive Stool Result|0|||
148817394|NCT00552058|536807255|FG001|Overall Study|Other: Positive Stool Result|1|||
148817395|NCT00552058|536807254|FG000|Overall Study|Other: Randomized in error|0|||
148817396|NCT00552058|536807255|FG001|Overall Study|Other: Randomized in error|1|||
148817397|NCT00552058|536807254|FG000|Overall Study|Other: Sponsors Decision|0|||
148817398|NCT00552058|536807255|FG001|Overall Study|Other: Sponsors Decision|1|||
148817399|NCT00552058|536807254|FG000|Overall Study|Other: Early Roll Over|1|||
148817400|NCT00552058|536807255|FG001|Overall Study|Other: Early Roll Over|0|||
148817401|NCT03520569|536807256|FG000|Overall Study|Withdrawal by Subject|1|||
148817402|NCT00784927|536807257|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
148730795|NCT02836496|536488211|FG000|Overall Study|Withdrawal by Subject|0|||
148730796|NCT02836496|536488212|FG001|Overall Study|Withdrawal by Subject|1|||
148730797|NCT03914950|536488213|FG000|Overall Study|Physician Decision|54|||
148730798|NCT03052959|536488214|FG000|Overall Study|Lost to Follow-up|4|||
148730799|NCT03052959|536488215|FG001|Overall Study|Lost to Follow-up|5|||
148730800|NCT00140426|536488218|FG000|Overall Study|Withdrawal by Subject|0|||
148730801|NCT00140426|536488219|FG001|Overall Study|Withdrawal by Subject|3|||
148730802|NCT00950963|536488220|FG000|Overall Study|Lost to Follow-up|29|||
148730803|NCT00950963|536488221|FG001|Overall Study|Lost to Follow-up|24|||
148730804|NCT04765384|536488222|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
148730805|NCT04765384|536488223|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
148730806|NCT04765384|536488224|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
148730807|NCT04765384|536488225|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
148730808|NCT04765384|536488226|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
148730809|NCT04765384|536488227|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
148730810|NCT04765384|536488222|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
148730811|NCT04765384|536488223|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
148730812|NCT04765384|536488224|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
148730813|NCT04765384|536488225|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
148730814|NCT04765384|536488226|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
148730815|NCT04765384|536488227|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
148730816|NCT04765384|536488222|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
148730817|NCT04765384|536488223|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
148730818|NCT04765384|536488224|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
148730819|NCT04765384|536488225|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
148730820|NCT04765384|536488226|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
148730821|NCT04765384|536488227|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
148730822|NCT04765384|536488222|FG000|Post-natal: Neonates and Infants|Death|0|||
148730823|NCT04765384|536488223|FG001|Post-natal: Neonates and Infants|Death|0|||
148730824|NCT04765384|536488224|FG002|Post-natal: Neonates and Infants|Death|0|||
148730825|NCT04765384|536488225|FG003|Post-natal: Neonates and Infants|Death|1|||
148730826|NCT04765384|536488226|FG004|Post-natal: Neonates and Infants|Death|0|||
148730827|NCT04765384|536488227|FG005|Post-natal: Neonates and Infants|Death|0|||
148817403|NCT00784927|536807257|FG000|Overall Study|Protocol Violation|1|||
148817404|NCT00784927|536807257|FG000|Overall Study|Ineligible|1|||
148972446|NCT00357370|537383402|FG000|Cohort 2|Lost to Follow-up|0|||
148730828|NCT04765384|536488222|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
148730829|NCT04765384|536488223|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
148730830|NCT04765384|536488224|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
148730831|NCT04765384|536488225|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
148730832|NCT04765384|536488226|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
148730833|NCT04765384|536488227|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
148817405|NCT00471354|536807264|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
148817406|NCT00471354|536807264|FG000|Overall Study|Adverse Event|13|||
148817407|NCT00471354|536807264|FG000|Overall Study|Protocol Violation|12|||
148730834|NCT00629265|536488228|FG000|Overall Study|Lost to Follow-up|4|||
148730835|NCT00629265|536488229|FG001|Overall Study|Lost to Follow-up|5|||
148730836|NCT00629265|536488228|FG000|Overall Study|Withdrawal by Subject|11|||
148730837|NCT00629265|536488229|FG001|Overall Study|Withdrawal by Subject|8|||
148730838|NCT00629265|536488228|FG000|Overall Study|Death|1|||
148730839|NCT00629265|536488229|FG001|Overall Study|Death|0|||
148730840|NCT00629265|536488228|FG000|Overall Study|Adverse Event|2|||
148730841|NCT00629265|536488229|FG001|Overall Study|Adverse Event|0|||
148972447|NCT00357370|537383403|FG001|Cohort 2|Lost to Follow-up|1|||
148730842|NCT00629265|536488228|FG000|Overall Study|HNC Recurrence|4|||
148730843|NCT00629265|536488229|FG001|Overall Study|HNC Recurrence|0|||
148730844|NCT00629265|536488228|FG000|Overall Study|Other CA Requiring Treatment|1|||
148730845|NCT00629265|536488229|FG001|Overall Study|Other CA Requiring Treatment|3|||
148730846|NCT00629265|536488228|FG000|Overall Study|Needed Esophageal Dilation|4|||
148730847|NCT00629265|536488229|FG001|Overall Study|Needed Esophageal Dilation|1|||
148730848|NCT00629265|536488228|FG000|Overall Study|Unrelated Medical Complications|3|||
148730849|NCT00629265|536488229|FG001|Overall Study|Unrelated Medical Complications|1|||
148730850|NCT00629265|536488228|FG000|Overall Study|Unknown Reason|2|||
148730851|NCT00629265|536488229|FG001|Overall Study|Unknown Reason|2|||
148730852|NCT01169532|536488232|FG000|Overall Study|Withdrawal by Subject|1|||
148730853|NCT02032706|536488236|FG000|Overall Study|Did not qualify|5|||
148730854|NCT02032706|536488236|FG000|Overall Study|Protocol Violation|1|||
148730855|NCT02140411|536488237|FG000|Overall Study|Adverse Event|1|||
148972448|NCT00357370|537383404|FG002|Cohort 2|Lost to Follow-up|0|||
148972449|NCT00357370|537383402|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
148972450|NCT00357370|537383403|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
148972451|NCT00357370|537383404|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
148972452|NCT00357370|537383402|FG000|Cohort 2|Withdrawal by Subject|0|||
148972453|NCT00357370|537383403|FG001|Cohort 2|Withdrawal by Subject|2|||
148972454|NCT00357370|537383404|FG002|Cohort 2|Withdrawal by Subject|0|||
148972455|NCT03491150|537383405|FG000|Overall Study|Adverse Event|1|||
148972456|NCT03491150|537383406|FG001|Overall Study|Adverse Event|0|||
148972457|NCT03491150|537383405|FG000|Overall Study|Study Terminated by Sponsor|74|||
148972458|NCT03491150|537383406|FG001|Overall Study|Study Terminated by Sponsor|70|||
148972459|NCT03491150|537383405|FG000|Overall Study|Other|0|||
148972460|NCT03491150|537383406|FG001|Overall Study|Other|1|||
148972461|NCT03491150|537383405|FG000|Overall Study|Withdrawal by Subject|1|||
148972462|NCT03491150|537383406|FG001|Overall Study|Withdrawal by Subject|2|||
148972463|NCT01143090|537383407|FG000|Overall Study|Lack of Efficacy|2|||
148972464|NCT01143090|537383407|FG000|Overall Study|Adverse Event|17|||
148972465|NCT01143090|537383407|FG000|Overall Study|Lost to Follow-up|9|||
148972466|NCT01143090|537383407|FG000|Overall Study|Protocol Violation|2|||
148972467|NCT01143090|537383407|FG000|Overall Study|Withdrawal by Subject|18|||
148972468|NCT01143090|537383407|FG000|Overall Study|Non-compliance with study drug|1|||
148972469|NCT01143090|537383407|FG000|Overall Study|Failure to meet eligibility criteria|1|||
148972470|NCT01143090|537383407|FG000|Overall Study|Administrative|1|||
148972471|NCT02644967|537383419|FG000|Overall Study|Death|26|||
148972472|NCT02644967|537383419|FG000|Overall Study|Physician Decision|1|||
148972473|NCT02644967|537383419|FG000|Overall Study|Withdrawal by Subject|2|||
148972474|NCT02644967|537383419|FG000|Overall Study|Protocol Violation|1|||
148972475|NCT02644967|537383419|FG000|Overall Study|Progressive Disease|1|||
148972476|NCT02644967|537383419|FG000|Overall Study|Study Terminated by Sponsor|4|||
148972477|NCT02287896|537383420|FG000|Second Injection Visit|Withdrawal by Subject|0|||
148972478|NCT02287896|537383421|FG001|Second Injection Visit|Withdrawal by Subject|1|||
148972479|NCT05179421|537383422|FG000|First Infusion Day|Adverse Event|1|||
148972480|NCT05179421|537383423|FG001|First Infusion Day|Adverse Event|0|||
148972481|NCT03746522|537383424|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
148972482|NCT03746522|537383425|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
148972483|NCT03746522|537383426|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
148972484|NCT03746522|537383424|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
148972485|NCT03746522|537383425|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
148972486|NCT03746522|537383426|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
148972487|NCT03746522|537383424|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
148972488|NCT03746522|537383425|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
148972489|NCT03746522|537383426|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
148972490|NCT03746522|537383424|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
148972491|NCT03746522|537383425|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
148730856|NCT04771403|536488241|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
148730857|NCT04771403|536488242|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
148730858|NCT04771403|536488241|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
148817408|NCT00471354|536807264|FG000|Overall Study|Withdrawal by Subject|1|||
148972492|NCT03746522|537383426|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
148972493|NCT03746522|537383424|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
148730859|NCT04771403|536488242|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
148730860|NCT04771403|536488241|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
148730861|NCT04771403|536488242|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
148730862|NCT04771403|536488241|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
148730863|NCT04771403|536488242|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
148730864|NCT04771403|536488241|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
148730865|NCT04771403|536488242|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
148730866|NCT04771403|536488241|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
148730867|NCT04771403|536488242|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
148730868|NCT04771403|536488241|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
148730869|NCT04771403|536488242|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
148730870|NCT04771403|536488241|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
148730871|NCT04771403|536488242|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
148730872|NCT01640873|536488243|FG000|Overall Study|Protocol Violation|2|||
148730873|NCT01640873|536488244|FG001|Overall Study|Protocol Violation|1|||
148730874|NCT02749292|536488248|FG000|Overall Study|Physician Decision|1|||
148730875|NCT02749292|536488249|FG001|Overall Study|Physician Decision|0|||
148730876|NCT02749292|536488248|FG000|Overall Study|Withdrawal by Subject|5|||
148730877|NCT02749292|536488249|FG001|Overall Study|Withdrawal by Subject|7|||
148730878|NCT02749292|536488248|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
148730879|NCT02749292|536488249|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
148730880|NCT02749292|536488248|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
148730881|NCT02749292|536488249|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
148730882|NCT02749292|536488248|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
148730883|NCT02749292|536488249|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
148730884|NCT02749292|536488248|FG000|Overall Study|Adverse Event|4|||
148730885|NCT02749292|536488249|FG001|Overall Study|Adverse Event|1|||
148730886|NCT02749292|536488248|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
148730887|NCT02749292|536488249|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
148730888|NCT02749292|536488248|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
148730889|NCT02749292|536488249|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
148730890|NCT02749292|536488248|FG000|Overall Study|Requiring glucocorticoids|0|||
148730891|NCT02749292|536488249|FG001|Overall Study|Requiring glucocorticoids|3|||
148730892|NCT02749292|536488248|FG000|Overall Study|Cancer|1|||
148730893|NCT02749292|536488249|FG001|Overall Study|Cancer|0|||
148730894|NCT00876018|536488250|FG000|Overall Study|Lost to Follow-up|0|||
148730895|NCT00876018|536488251|FG001|Overall Study|Lost to Follow-up|1|||
148730896|NCT00876018|536488252|FG002|Overall Study|Lost to Follow-up|1|||
148730897|NCT00876018|536488250|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
148730898|NCT00876018|536488251|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
148730899|NCT00876018|536488252|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
148730900|NCT01230892|536488253|FG000|Overall Study|Withdrawal by Subject|1|||
148730901|NCT01230892|536488254|FG001|Overall Study|Withdrawal by Subject|1|||
148730902|NCT01230892|536488253|FG000|Overall Study|Lost to Follow-up|2|||
148730903|NCT01230892|536488254|FG001|Overall Study|Lost to Follow-up|0|||
148730904|NCT00679913|536488255|FG000|Overall Study|Protocol Violation|18|||
148730905|NCT00679913|536488256|FG001|Overall Study|Protocol Violation|13|||
148730906|NCT00725621|536488259|FG000|Overall Study|Adverse Event|25|||
148730907|NCT00725621|536488259|FG000|Overall Study|Lack of Efficacy|46|||
148730908|NCT00725621|536488259|FG000|Overall Study|Withdrawal by Subject|57|||
148730909|NCT00725621|536488259|FG000|Overall Study|Physician Decision|19|||
148730910|NCT00725621|536488259|FG000|Overall Study|Lost to Follow-up|52|||
148730911|NCT00725621|536488259|FG000|Overall Study|Non-compliance|8|||
148730912|NCT00725621|536488259|FG000|Overall Study|Continued treatment by other physician|6|||
148730913|NCT00725621|536488259|FG000|Overall Study|Switched to other study|1|||
148730914|NCT00725621|536488259|FG000|Overall Study|Switched to other drug|1|||
148730915|NCT00725621|536488259|FG000|Overall Study|Prepared for elective surgery|1|||
148730916|NCT00725621|536488259|FG000|Overall Study|Reason not specified|55|||
148730917|NCT01189500|536488260|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
149026408|NCT03008122|537574221|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
148730918|NCT01189500|536488260|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
148730919|NCT01000493|536488261|FG000|Overall Study|Adverse Event|3|||
148730920|NCT01000493|536488262|FG001|Overall Study|Adverse Event|6|||
148730921|NCT01000493|536488261|FG000|Overall Study|Lack of Efficacy|1|||
149026409|NCT03008122|537574219|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
149026410|NCT03008122|537574220|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
149026411|NCT03008122|537574221|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
149026412|NCT03008122|537574219|FG000|Overall Study|Death|0|||
149026413|NCT03008122|537574220|FG001|Overall Study|Death|0|||
149026414|NCT03008122|537574221|FG002|Overall Study|Death|1|||
149026415|NCT01222247|537574222|FG000|Overall Study|Lost to Follow-up|2|||
149026416|NCT01222247|537574223|FG001|Overall Study|Lost to Follow-up|2|||
149026417|NCT02084082|537574224|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
149026418|NCT02084082|537574225|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
149026419|NCT02084082|537574226|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
149026420|NCT02084082|537574227|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
149026421|NCT02084082|537574224|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149026422|NCT02084082|537574225|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149026423|NCT02084082|537574226|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
149026424|NCT02084082|537574227|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
149026425|NCT00832780|537574228|FG000|Overall Study|Death|16|||
149026426|NCT00832780|537574228|FG000|Overall Study|Lost to Follow-up|4|||
149026427|NCT00832780|537574228|FG000|Overall Study|no reason given|2|||
149026428|NCT00832780|537574228|FG000|Overall Study|other complicating condition|2|||
149026429|NCT00832780|537574228|FG000|Overall Study|Physician Decision|1|||
149026430|NCT03289455|537574235|FG000|Overall Study|Death|1|||
149026431|NCT03289455|537574236|FG001|Overall Study|Death|0|||
149026432|NCT03289455|537574237|FG002|Overall Study|Death|0|||
149026433|NCT03289455|537574235|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
149026434|NCT03289455|537574236|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
149026435|NCT03289455|537574237|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
149026436|NCT03289455|537574235|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
149026437|NCT03289455|537574236|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
149026438|NCT03289455|537574237|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
149026439|NCT03289455|537574235|FG000|Overall Study|Progressive disease|3|||
149026440|NCT03289455|537574236|FG001|Overall Study|Progressive disease|4|||
149026441|NCT03289455|537574237|FG002|Overall Study|Progressive disease|5|||
149026442|NCT00333788|537574238|FG000|Overall Study|Adverse Event|44|||
149026443|NCT00333788|537574238|FG000|Overall Study|Lack of Efficacy|80|||
149026444|NCT00333788|537574238|FG000|Overall Study|Lost to Follow-up|2|||
149026445|NCT00333788|537574238|FG000|Overall Study|Withdrawal by Subject|24|||
149026446|NCT00333788|537574238|FG000|Overall Study|Other: Non-compliance|2|||
149026447|NCT00333788|537574238|FG000|Overall Study|Other: Moved|2|||
149026448|NCT00333788|537574238|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
149026449|NCT00333788|537574238|FG000|Overall Study|Other: Investigator decision|1|||
149026450|NCT00333788|537574238|FG000|Overall Study|Other: Quality of life concern|1|||
149026451|NCT00333788|537574238|FG000|Overall Study|Other: Sponsor decision|1|||
149026452|NCT00333788|537574238|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
149026453|NCT00333788|537574238|FG000|Overall Study|Other: Medical monitor decision|1|||
149026454|NCT00333788|537574238|FG000|Overall Study|Other: Physician decision|1|||
149026455|NCT00333788|537574238|FG000|Overall Study|Other: Signed consent for another study|1|||
149026456|NCT02322775|537574244|FG000|Overall Study|Adverse Event|1|||
149026457|NCT02322775|537574245|FG001|Overall Study|Adverse Event|0|||
149026458|NCT02322775|537574244|FG000|Overall Study|Lost to Follow-up|0|||
149026459|NCT02322775|537574245|FG001|Overall Study|Lost to Follow-up|1|||
149026460|NCT02322775|537574244|FG000|Overall Study|Protocol Violation|1|||
149026461|NCT02322775|537574245|FG001|Overall Study|Protocol Violation|0|||
149026462|NCT02322775|537574244|FG000|Overall Study|Withdrawal by Subject|3|||
149026463|NCT02322775|537574245|FG001|Overall Study|Withdrawal by Subject|4|||
149026464|NCT02322775|537574244|FG000|Overall Study|Not willing to perform all FU visits|0|||
149026465|NCT02322775|537574245|FG001|Overall Study|Not willing to perform all FU visits|1|||
148817409|NCT00471354|536807264|FG000|Overall Study|Physician Decision|4|||
148817410|NCT00471354|536807264|FG000|Overall Study|Sponsor Decision|1|||
148817411|NCT00471354|536807264|FG000|Overall Study|Lost to Follow-up|3|||
149026466|NCT02956967|537574246|FG000|Overall Study|Adverse Event|3|||
149026467|NCT02956967|537574246|FG000|Overall Study|Reason non-related to neutropenia|10|||
149026468|NCT02956967|537574246|FG000|Overall Study|Lost to Follow-up|5|||
149026469|NCT02956967|537574246|FG000|Overall Study|Missing|1|||
149026470|NCT02956967|537574246|FG000|Overall Study|Termination of Nivestim administration|29|||
149026471|NCT00764868|537574251|FG000|Overall Study|Adverse Event|18|||
148817412|NCT00471354|536807264|FG000|Overall Study|Lack of Efficacy|5|||
148817413|NCT00471354|536807264|FG000|Overall Study|Patient/Caregiver Decision|12|||
149026472|NCT00764868|537574251|FG000|Overall Study|Withdrawal by Subject|31|||
149026473|NCT00764868|537574251|FG000|Overall Study|Non-compliance|16|||
149026474|NCT00764868|537574251|FG000|Overall Study|Lost to Follow-up|25|||
149026475|NCT00764868|537574251|FG000|Overall Study|Lack of Efficacy|5|||
149026476|NCT00764868|537574251|FG000|Overall Study|Subject moved|7|||
149026477|NCT00764868|537574251|FG000|Overall Study|Pregnancy|3|||
149026478|NCT00764868|537574251|FG000|Overall Study|Prohibited medication|1|||
148817414|NCT02265744|536807265|FG000|Overall Study|Poor/Non-compliance|1|||
148817415|NCT02265744|536807266|FG001|Overall Study|Poor/Non-compliance|1|||
148817416|NCT02265744|536807267|FG002|Overall Study|Poor/Non-compliance|0|||
148817417|NCT02265744|536807268|FG003|Overall Study|Poor/Non-compliance|0|||
148817418|NCT02265744|536807269|FG004|Overall Study|Poor/Non-compliance|2|||
148817419|NCT02265744|536807265|FG000|Overall Study|Lost to Follow-up|0|||
148817420|NCT02265744|536807266|FG001|Overall Study|Lost to Follow-up|0|||
148817421|NCT02265744|536807267|FG002|Overall Study|Lost to Follow-up|0|||
148817422|NCT02265744|536807268|FG003|Overall Study|Lost to Follow-up|1|||
148817423|NCT02265744|536807269|FG004|Overall Study|Lost to Follow-up|0|||
148817424|NCT02265744|536807265|FG000|Overall Study|Death|0|||
148817425|NCT02265744|536807266|FG001|Overall Study|Death|0|||
148817426|NCT02265744|536807267|FG002|Overall Study|Death|0|||
148817427|NCT02265744|536807268|FG003|Overall Study|Death|2|||
148817428|NCT02265744|536807269|FG004|Overall Study|Death|0|||
148817429|NCT02265744|536807265|FG000|Overall Study|Withdrawal by Subject|2|||
148817430|NCT02265744|536807266|FG001|Overall Study|Withdrawal by Subject|0|||
148817431|NCT02265744|536807267|FG002|Overall Study|Withdrawal by Subject|0|||
148817432|NCT02265744|536807268|FG003|Overall Study|Withdrawal by Subject|2|||
148817433|NCT02265744|536807269|FG004|Overall Study|Withdrawal by Subject|0|||
148817434|NCT02265744|536807265|FG000|Overall Study|Participant request to discontinue|2|||
148817435|NCT02265744|536807266|FG001|Overall Study|Participant request to discontinue|2|||
148817436|NCT02265744|536807267|FG002|Overall Study|Participant request to discontinue|2|||
148817437|NCT02265744|536807268|FG003|Overall Study|Participant request to discontinue|0|||
148817438|NCT02265744|536807269|FG004|Overall Study|Participant request to discontinue|0|||
148817439|NCT02265744|536807265|FG000|Overall Study|Adverse Event|8|||
148817440|NCT02265744|536807266|FG001|Overall Study|Adverse Event|4|||
148817441|NCT02265744|536807267|FG002|Overall Study|Adverse Event|9|||
148817442|NCT02265744|536807268|FG003|Overall Study|Adverse Event|8|||
148817443|NCT02265744|536807269|FG004|Overall Study|Adverse Event|2|||
148817444|NCT02265744|536807265|FG000|Overall Study|Lack of Efficacy|2|||
148817445|NCT02265744|536807266|FG001|Overall Study|Lack of Efficacy|4|||
148817446|NCT02265744|536807267|FG002|Overall Study|Lack of Efficacy|3|||
148817447|NCT02265744|536807268|FG003|Overall Study|Lack of Efficacy|4|||
148817448|NCT02265744|536807269|FG004|Overall Study|Lack of Efficacy|5|||
148817449|NCT02265744|536807265|FG000|Overall Study|Reason not provided by Investigator|1|||
148817450|NCT02265744|536807266|FG001|Overall Study|Reason not provided by Investigator|0|||
148817451|NCT02265744|536807267|FG002|Overall Study|Reason not provided by Investigator|0|||
148817452|NCT02265744|536807268|FG003|Overall Study|Reason not provided by Investigator|2|||
148817453|NCT02265744|536807269|FG004|Overall Study|Reason not provided by Investigator|0|||
148817454|NCT02265744|536807265|FG000|Overall Study|Administrative reason by sponsor|3|||
148817455|NCT02265744|536807266|FG001|Overall Study|Administrative reason by sponsor|2|||
148817456|NCT02265744|536807267|FG002|Overall Study|Administrative reason by sponsor|2|||
148817457|NCT02265744|536807268|FG003|Overall Study|Administrative reason by sponsor|3|||
148817458|NCT02265744|536807269|FG004|Overall Study|Administrative reason by sponsor|3|||
148817459|NCT02265744|536807265|FG000|Overall Study|Subject no longer meets study criteria|0|||
148817460|NCT02265744|536807266|FG001|Overall Study|Subject no longer meets study criteria|0|||
148817461|NCT02265744|536807267|FG002|Overall Study|Subject no longer meets study criteria|0|||
148817462|NCT02265744|536807268|FG003|Overall Study|Subject no longer meets study criteria|0|||
148817463|NCT02265744|536807269|FG004|Overall Study|Subject no longer meets study criteria|1|||
148817464|NCT02265744|536807265|FG000|Overall Study|Pregnancy|1|||
148817465|NCT02265744|536807266|FG001|Overall Study|Pregnancy|2|||
148817466|NCT02265744|536807267|FG002|Overall Study|Pregnancy|1|||
148817467|NCT02265744|536807268|FG003|Overall Study|Pregnancy|1|||
148817468|NCT02265744|536807269|FG004|Overall Study|Pregnancy|0|||
148817469|NCT00574951|536807270|FG000|Overall Study|Ineligible - improper prior treatment|1|||
148817470|NCT05161936|536807271|FG000|Overall Study|Study terminated by Sponsor|1|||
148817471|NCT05161936|536807272|FG001|Overall Study|Study terminated by Sponsor|0|||
148817472|NCT05161936|536807273|FG002|Overall Study|Study terminated by Sponsor|0|||
148817473|NCT05161936|536807271|FG000|Overall Study|Withdrawal by Subject|0|||
148817474|NCT05161936|536807272|FG001|Overall Study|Withdrawal by Subject|0|||
148817475|NCT05161936|536807273|FG002|Overall Study|Withdrawal by Subject|1|||
148817476|NCT05278065|536807276|FG000|Overall Study|Withdrawal by Subject|1|||
148817477|NCT05278065|536807277|FG001|Overall Study|Withdrawal by Subject|0|||
148972494|NCT03746522|537383425|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
148817478|NCT02029443|536807278|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
148817479|NCT02029443|536807279|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
148817480|NCT02029443|536807280|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
148817481|NCT02029443|536807281|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
148817482|NCT02029443|536807282|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
148817483|NCT02029443|536807278|FG000|Overall Study|Death|13|||
148817484|NCT02029443|536807279|FG001|Overall Study|Death|2|||
148817485|NCT02029443|536807280|FG002|Overall Study|Death|2|||
148817486|NCT02029443|536807281|FG003|Overall Study|Death|11|||
148817487|NCT02029443|536807282|FG004|Overall Study|Death|2|||
148817488|NCT02029443|536807278|FG000|Overall Study|Lost to Follow-up|1|||
148817489|NCT02029443|536807279|FG001|Overall Study|Lost to Follow-up|0|||
148817490|NCT02029443|536807280|FG002|Overall Study|Lost to Follow-up|1|||
148817491|NCT02029443|536807281|FG003|Overall Study|Lost to Follow-up|1|||
148817492|NCT02029443|536807282|FG004|Overall Study|Lost to Follow-up|0|||
148817493|NCT02029443|536807278|FG000|Overall Study|Started other anti-cancer therapy|17|||
148817494|NCT02029443|536807279|FG001|Overall Study|Started other anti-cancer therapy|4|||
148817495|NCT02029443|536807280|FG002|Overall Study|Started other anti-cancer therapy|7|||
148817496|NCT02029443|536807281|FG003|Overall Study|Started other anti-cancer therapy|9|||
148817497|NCT02029443|536807282|FG004|Overall Study|Started other anti-cancer therapy|3|||
148817498|NCT02029443|536807278|FG000|Overall Study|Withdrawal by Subject|3|||
148817499|NCT02029443|536807279|FG001|Overall Study|Withdrawal by Subject|1|||
148817500|NCT02029443|536807280|FG002|Overall Study|Withdrawal by Subject|1|||
148817501|NCT02029443|536807281|FG003|Overall Study|Withdrawal by Subject|1|||
148817502|NCT02029443|536807282|FG004|Overall Study|Withdrawal by Subject|0|||
148817503|NCT02029443|536807278|FG000|Overall Study|Other|6|||
148817504|NCT02029443|536807279|FG001|Overall Study|Other|6|||
148817505|NCT02029443|536807280|FG002|Overall Study|Other|4|||
148817506|NCT02029443|536807281|FG003|Overall Study|Other|2|||
148817507|NCT02029443|536807282|FG004|Overall Study|Other|0|||
148817508|NCT04999020|536807283|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
148817509|NCT04999020|536807284|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
148817510|NCT04999020|536807285|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
148817511|NCT04999020|536807286|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
148817512|NCT04999020|536807283|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
148817513|NCT04999020|536807284|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
148817514|NCT04999020|536807285|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
148730922|NCT01000493|536488262|FG001|Overall Study|Lack of Efficacy|1|||
148730923|NCT01000493|536488261|FG000|Overall Study|Protocol Violation|1|||
148730924|NCT01000493|536488262|FG001|Overall Study|Protocol Violation|8|||
148730925|NCT01000493|536488261|FG000|Overall Study|Study closed/terminated|25|||
148730926|NCT01000493|536488262|FG001|Overall Study|Study closed/terminated|23|||
148730927|NCT01000493|536488261|FG000|Overall Study|Lost to Follow-up|5|||
148730928|NCT01000493|536488262|FG001|Overall Study|Lost to Follow-up|9|||
148730929|NCT01000493|536488261|FG000|Overall Study|Physician Decision|1|||
148730930|NCT01000493|536488262|FG001|Overall Study|Physician Decision|1|||
148730931|NCT01000493|536488261|FG000|Overall Study|Withdrawal by Subject|3|||
148730932|NCT01000493|536488262|FG001|Overall Study|Withdrawal by Subject|7|||
148730933|NCT01144364|536488267|FG000|Induction Phase|Disease progression|14|||
148730934|NCT01144364|536488268|FG001|Induction Phase|Disease progression|0|||
148730935|NCT01144364|536488269|FG002|Induction Phase|Disease progression|0|||
148730936|NCT01144364|536488267|FG000|Induction Phase|Adverse Event|9|||
148730937|NCT01144364|536488268|FG001|Induction Phase|Adverse Event|0|||
148730938|NCT01144364|536488269|FG002|Induction Phase|Adverse Event|0|||
148730939|NCT01144364|536488267|FG000|Induction Phase|Death|1|||
148730940|NCT01144364|536488268|FG001|Induction Phase|Death|0|||
148730941|NCT01144364|536488269|FG002|Induction Phase|Death|0|||
148730942|NCT01144364|536488267|FG000|Induction Phase|Withdrawal by Subject|1|||
148730943|NCT01144364|536488268|FG001|Induction Phase|Withdrawal by Subject|0|||
148730944|NCT01144364|536488269|FG002|Induction Phase|Withdrawal by Subject|0|||
148730945|NCT01144364|536488267|FG000|Induction Phase|Lost to Follow-up|2|||
148730946|NCT01144364|536488268|FG001|Induction Phase|Lost to Follow-up|0|||
148730947|NCT01144364|536488269|FG002|Induction Phase|Lost to Follow-up|0|||
148730948|NCT01144364|536488267|FG000|Induction Phase|Physician Decision|1|||
148730949|NCT01144364|536488268|FG001|Induction Phase|Physician Decision|0|||
148730950|NCT01144364|536488269|FG002|Induction Phase|Physician Decision|0|||
148730951|NCT01144364|536488267|FG000|Induction Phase|Stable disease|2|||
148730952|NCT01144364|536488268|FG001|Induction Phase|Stable disease|0|||
148730953|NCT01144364|536488269|FG002|Induction Phase|Stable disease|0|||
148730954|NCT01144364|536488267|FG000|Induction Phase|Secondary neoplasia|1|||
148730955|NCT01144364|536488268|FG001|Induction Phase|Secondary neoplasia|0|||
148730956|NCT01144364|536488269|FG002|Induction Phase|Secondary neoplasia|0|||
148730957|NCT01144364|536488267|FG000|Induction Phase|Protocol Violation|1|||
148730958|NCT01144364|536488268|FG001|Induction Phase|Protocol Violation|0|||
148730959|NCT01144364|536488269|FG002|Induction Phase|Protocol Violation|0|||
148730960|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
148730961|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
148730962|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
148730963|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
148730964|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
148730965|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
148730966|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Death|0|||
148730967|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Death|2|||
148730968|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Death|0|||
148817515|NCT04999020|536807286|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
148817516|NCT04999020|536807283|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
148817517|NCT04999020|536807284|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
148817518|NCT04999020|536807285|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
148730969|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
148730970|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
148730971|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
148730972|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
148730973|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
148730974|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
148730975|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
148730976|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
148730977|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
148730978|NCT01144364|536488267|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
148730979|NCT01144364|536488268|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
148730980|NCT01144364|536488269|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
148730981|NCT03456960|536488270|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148730982|NCT03456960|536488271|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148730983|NCT03456960|536488272|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
148730984|NCT03456960|536488273|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
148730985|NCT03456960|536488274|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148730986|NCT03456960|536488275|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
148730987|NCT03456960|536488270|FG000|Period 2 (1 Day)|Adverse Event|1|||
148730988|NCT03456960|536488271|FG001|Period 2 (1 Day)|Adverse Event|0|||
148730989|NCT03456960|536488272|FG002|Period 2 (1 Day)|Adverse Event|0|||
148730990|NCT03456960|536488273|FG003|Period 2 (1 Day)|Adverse Event|1|||
148730991|NCT03456960|536488274|FG004|Period 2 (1 Day)|Adverse Event|0|||
148730992|NCT03456960|536488275|FG005|Period 2 (1 Day)|Adverse Event|0|||
148730993|NCT01346774|536488276|FG000|Overall Study|Did not take a single dose|6|||
148730994|NCT01346774|536488277|FG001|Overall Study|Did not take a single dose|4|||
148730995|NCT01346774|536488276|FG000|Overall Study|Lost to Follow-up|3|||
148730996|NCT01346774|536488277|FG001|Overall Study|Lost to Follow-up|4|||
148730997|NCT01346774|536488276|FG000|Overall Study|Withdrawal by Subject|1|||
148730998|NCT01346774|536488277|FG001|Overall Study|Withdrawal by Subject|4|||
148730999|NCT01346774|536488276|FG000|Overall Study|Protocol Violation|2|||
148731000|NCT01346774|536488277|FG001|Overall Study|Protocol Violation|3|||
148972495|NCT03746522|537383426|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
148972496|NCT01639040|537383427|FG000|Overall Study|Adverse Event|1|||
148972497|NCT01639040|537383428|FG001|Overall Study|Adverse Event|0|||
148972498|NCT00486265|537383432|FG000|Overall Study|Adverse Event|1|||
148972499|NCT00486265|537383432|FG000|Overall Study|Lack of Efficacy|8|||
148972500|NCT01452412|537383433|FG000|Overall Study|Withdrawal by Subject|15|||
148972501|NCT01452412|537383434|FG001|Overall Study|Withdrawal by Subject|11|||
148972502|NCT01452412|537383433|FG000|Overall Study|Adverse Event|4|||
148972503|NCT01452412|537383434|FG001|Overall Study|Adverse Event|3|||
148972504|NCT01452412|537383433|FG000|Overall Study|Lost to Follow-up|5|||
148972505|NCT01452412|537383434|FG001|Overall Study|Lost to Follow-up|3|||
148972506|NCT01452412|537383433|FG000|Overall Study|Death|1|||
148972507|NCT01452412|537383434|FG001|Overall Study|Death|0|||
148972508|NCT01452412|537383433|FG000|Overall Study|Initiated dialysis|1|||
148972509|NCT01452412|537383434|FG001|Overall Study|Initiated dialysis|0|||
148972510|NCT01452412|537383433|FG000|Overall Study|Other|2|||
148972511|NCT01452412|537383434|FG001|Overall Study|Other|0|||
148972512|NCT05132127|537383435|FG000|Overall Study|Adverse Event|1|||
148972513|NCT04697628|537383438|FG000|Overall Study|Withdrawal by Subject|17|||
148972514|NCT04697628|537383439|FG001|Overall Study|Withdrawal by Subject|23|||
148972515|NCT04697628|537383438|FG000|Overall Study|Lost to Follow-up|0|||
148972516|NCT04697628|537383439|FG001|Overall Study|Lost to Follow-up|4|||
148972517|NCT04697628|537383438|FG000|Overall Study|On-going in study|122|||
148972518|NCT04697628|537383439|FG001|Overall Study|On-going in study|91|||
148972519|NCT00393939|537383440|FG000|Overall Study|Protocol Violation|1|||
148972520|NCT00393939|537383441|FG001|Overall Study|Protocol Violation|1|||
148972521|NCT00393939|537383440|FG000|Overall Study|Lost to Follow-up|2|||
148972522|NCT00393939|537383441|FG001|Overall Study|Lost to Follow-up|4|||
148972523|NCT00393939|537383440|FG000|Overall Study|Death|10|||
148972524|NCT00393939|537383441|FG001|Overall Study|Death|4|||
148972525|NCT00393939|537383440|FG000|Overall Study|Sponsor|5|||
148972526|NCT00393939|537383441|FG001|Overall Study|Sponsor|13|||
148972527|NCT00393939|537383440|FG000|Overall Study|Objective progression or relapse|239|||
148731001|NCT01346774|536488276|FG000|Overall Study|Adverse Event|1|||
148731002|NCT01346774|536488277|FG001|Overall Study|Adverse Event|2|||
148731003|NCT00609466|536488285|FG000|Overall Study|Withdrawal by Subject|0|||
148972528|NCT00393939|537383441|FG001|Overall Study|Objective progression or relapse|223|||
148972529|NCT00393939|537383440|FG000|Overall Study|Withdrawal by Subject|2|||
148972530|NCT00393939|537383441|FG001|Overall Study|Withdrawal by Subject|7|||
148972531|NCT00393939|537383440|FG000|Overall Study|Other|37|||
148972532|NCT00393939|537383441|FG001|Overall Study|Other|45|||
148972533|NCT02385799|537383442|FG000|Overall Study|Lost to Follow-up|1|||
148731004|NCT00609466|536488286|FG001|Overall Study|Withdrawal by Subject|1|||
148731005|NCT00609466|536488287|FG002|Overall Study|Withdrawal by Subject|1|||
148731006|NCT00609466|536488285|FG000|Overall Study|Adverse Event|2|||
148731007|NCT00609466|536488286|FG001|Overall Study|Adverse Event|3|||
148731008|NCT00609466|536488287|FG002|Overall Study|Adverse Event|1|||
148731009|NCT00609466|536488285|FG000|Overall Study|Lack of Efficacy|0|||
148731010|NCT00609466|536488286|FG001|Overall Study|Lack of Efficacy|2|||
148731011|NCT00609466|536488287|FG002|Overall Study|Lack of Efficacy|2|||
148731012|NCT01299805|536488288|FG000|Overall Study|Adverse Event|2|||
148731013|NCT01299805|536488289|FG001|Overall Study|Adverse Event|0|||
148731014|NCT03510182|536488290|FG000|Overall Study|Withdrawal by Subject|2|||
148731015|NCT01334710|536488297|FG000|Overall Study|Trial was terminated|3|||
148731016|NCT00290251|536488301|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
148731017|NCT00290251|536488302|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
148731018|NCT00290251|536488303|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
148731019|NCT00290251|536488304|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
148731020|NCT00290251|536488305|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
148731021|NCT00290251|536488306|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
148731022|NCT00290251|536488301|FG000|Treatment 1 (Months 2-4)|headache|0|||
148731023|NCT00290251|536488302|FG001|Treatment 1 (Months 2-4)|headache|0|||
148731024|NCT00290251|536488303|FG002|Treatment 1 (Months 2-4)|headache|0|||
148731025|NCT00290251|536488304|FG003|Treatment 1 (Months 2-4)|headache|0|||
148731026|NCT00290251|536488305|FG004|Treatment 1 (Months 2-4)|headache|1|||
148731027|NCT00290251|536488306|FG005|Treatment 1 (Months 2-4)|headache|0|||
148731028|NCT00290251|536488301|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
148731029|NCT00290251|536488302|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
148731030|NCT00290251|536488303|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
148731031|NCT00290251|536488304|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
148731032|NCT00290251|536488305|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
148731033|NCT00290251|536488306|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
148731034|NCT00852969|536490359|FG000|Overall Study|Adverse Event|0|||
148731035|NCT00852969|536490360|FG001|Overall Study|Adverse Event|1|||
148731036|NCT00852969|536490359|FG000|Overall Study|Lost to Follow-up|0|||
148731037|NCT00852969|536490360|FG001|Overall Study|Lost to Follow-up|1|||
148731038|NCT02358343|536490363|FG000|Screening Intervention|Death|0|||
148731039|NCT02358343|536490364|FG001|Screening Intervention|Death|2|||
148731040|NCT02358343|536490365|FG002|Screening Intervention|Death|0|||
148731041|NCT02358343|536490366|FG003|Screening Intervention|Death|0|||
148731042|NCT02358343|536490367|FG004|Screening Intervention|Death|0|||
148731043|NCT02358343|536490363|FG000|Screening Intervention|Withdrawal by Subject|1|||
148731044|NCT02358343|536490364|FG001|Screening Intervention|Withdrawal by Subject|0|||
148731045|NCT02358343|536490365|FG002|Screening Intervention|Withdrawal by Subject|0|||
148731046|NCT02358343|536490366|FG003|Screening Intervention|Withdrawal by Subject|0|||
148731047|NCT02358343|536490367|FG004|Screening Intervention|Withdrawal by Subject|0|||
148731048|NCT02358343|536490363|FG000|Screening Intervention|Determined Ineligible|5|||
148731049|NCT02358343|536490364|FG001|Screening Intervention|Determined Ineligible|6|||
148731050|NCT02358343|536490365|FG002|Screening Intervention|Determined Ineligible|0|||
148731051|NCT02358343|536490366|FG003|Screening Intervention|Determined Ineligible|0|||
148731052|NCT02358343|536490367|FG004|Screening Intervention|Determined Ineligible|0|||
148731053|NCT02358343|536490363|FG000|Comparative Efficacy Trial / Observation|Death|0|||
148731054|NCT02358343|536490364|FG001|Comparative Efficacy Trial / Observation|Death|0|||
148731055|NCT02358343|536490365|FG002|Comparative Efficacy Trial / Observation|Death|2|||
148731056|NCT02358343|536490366|FG003|Comparative Efficacy Trial / Observation|Death|0|||
148731057|NCT02358343|536490367|FG004|Comparative Efficacy Trial / Observation|Death|0|||
148731058|NCT02358343|536490363|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
148731059|NCT02358343|536490364|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
148731060|NCT02358343|536490365|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
148731061|NCT02358343|536490366|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
148731062|NCT02358343|536490367|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
148731063|NCT02358343|536490363|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
148731064|NCT02358343|536490364|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
148731065|NCT02358343|536490365|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
148731066|NCT02358343|536490366|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
148731067|NCT02358343|536490367|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
148817519|NCT04999020|536807286|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
148817520|NCT04999020|536807283|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
148817521|NCT04999020|536807284|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
148731068|NCT04322149|536490368|FG000|Overall Study|Adverse Event|1|||
148731069|NCT04322149|536490369|FG001|Overall Study|Adverse Event|1|||
148731070|NCT04322149|536490370|FG002|Overall Study|Adverse Event|0|||
148731071|NCT04322149|536490371|FG003|Overall Study|Adverse Event|0|||
148731072|NCT04322149|536490368|FG000|Overall Study|Withdrawal by Subject|0|||
148731073|NCT04322149|536490369|FG001|Overall Study|Withdrawal by Subject|0|||
148731074|NCT04322149|536490370|FG002|Overall Study|Withdrawal by Subject|0|||
148731075|NCT04322149|536490371|FG003|Overall Study|Withdrawal by Subject|2|||
148731076|NCT04322149|536490368|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
148731077|NCT04322149|536490369|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
148731078|NCT04322149|536490370|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
148731079|NCT04322149|536490371|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
148731080|NCT01700049|536490378|FG000|Overall Study|Withdrawal by Subject|1|||
148731081|NCT03084367|536490381|FG000|Overall Study|Lost to Follow-up|32|||
148731082|NCT03084367|536490381|FG000|Overall Study|Withdrawal by Subject|4|||
148731083|NCT03084367|536490381|FG000|Overall Study|Other|1|||
148731084|NCT04325204|536490382|FG000|Overall Study|Death|0|||
148731085|NCT04325204|536490383|FG001|Overall Study|Death|1|||
148731086|NCT04325204|536490382|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
148731087|NCT04325204|536490383|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
148731088|NCT04325204|536490382|FG000|Overall Study|Lost to Follow-up|8|||
148731089|NCT04325204|536490383|FG001|Overall Study|Lost to Follow-up|8|||
148731090|NCT04325204|536490382|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
148731091|NCT04325204|536490383|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
148731092|NCT00270257|536490389|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
148731093|NCT00270257|536490390|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
148731094|NCT01195103|536490391|FG000|Overall Study|Withdrawal by Subject|1|||
148731095|NCT01195103|536490392|FG001|Overall Study|Withdrawal by Subject|0|||
148731096|NCT01195103|536490393|FG002|Overall Study|Withdrawal by Subject|0|||
148731097|NCT02621034|536490394|FG000|Overall Study|Lost to Follow-up|3|||
148731098|NCT02621034|536490395|FG001|Overall Study|Lost to Follow-up|2|||
148731099|NCT02621034|536490396|FG002|Overall Study|Lost to Follow-up|5|||
148731100|NCT03254602|536490403|FG000|Overall Study|Lost to Follow-up|4|||
148731101|NCT02963311|536490406|FG000|Overall Study|Withdrawal by Subject|1|||
148731102|NCT02963311|536490406|FG000|Overall Study|Screen Failure|4|||
148731103|NCT01691820|536490407|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
148731104|NCT01691820|536490408|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
148731105|NCT01691820|536490407|FG000|Overall Study|Migrated/moved from study area|7|||
148731106|NCT01691820|536490408|FG001|Overall Study|Migrated/moved from study area|4|||
148731107|NCT01691820|536490407|FG000|Overall Study|Lost to Follow-up|6|||
148731108|NCT01691820|536490408|FG001|Overall Study|Lost to Follow-up|17|||
148731109|NCT01691820|536490407|FG000|Overall Study|Other (unspecified)|4|||
148731110|NCT01691820|536490408|FG001|Overall Study|Other (unspecified)|1|||
148731111|NCT04442490|536490410|FG000|Overall Study|Withdrawal by Subject|18|||
148731112|NCT04442490|536490411|FG001|Overall Study|Withdrawal by Subject|10|||
148731113|NCT04442490|536490410|FG000|Overall Study|Lost to Follow-up|7|||
148731114|NCT04442490|536490411|FG001|Overall Study|Lost to Follow-up|7|||
148731115|NCT04442490|536490410|FG000|Overall Study|Adverse Event|2|||
148731116|NCT04442490|536490411|FG001|Overall Study|Adverse Event|6|||
148731117|NCT04442490|536490410|FG000|Overall Study|Noncompliance|3|||
148731118|NCT04442490|536490411|FG001|Overall Study|Noncompliance|1|||
148731119|NCT04442490|536490410|FG000|Overall Study|Physician Decision|2|||
148731120|NCT04442490|536490411|FG001|Overall Study|Physician Decision|1|||
148731121|NCT04442490|536490410|FG000|Overall Study|Reason not Specified|2|||
148731122|NCT04442490|536490411|FG001|Overall Study|Reason not Specified|1|||
148731123|NCT04442490|536490410|FG000|Overall Study|Randomized but not Treated|3|||
148731124|NCT04442490|536490411|FG001|Overall Study|Randomized but not Treated|3|||
148731125|NCT02372071|536490423|FG000|Overall Study|Protocol Violation|18|||
148731126|NCT01449279|536490424|FG000|Overall Study|Lack of Efficacy|5|||
148731127|NCT01449279|536490424|FG000|Overall Study|Toxicity|2|||
148731128|NCT03709823|536490425|FG000|Overall Study|Adverse Event|0|||
148731129|NCT03709823|536490426|FG001|Overall Study|Adverse Event|0|||
148731130|NCT03709823|536490427|FG002|Overall Study|Adverse Event|1|||
148731131|NCT03709823|536490428|FG003|Overall Study|Adverse Event|0|||
148731132|NCT03709823|536490429|FG004|Overall Study|Adverse Event|0|||
148731133|NCT03709823|536490430|FG005|Overall Study|Adverse Event|0|||
148731134|NCT03709823|536490425|FG000|Overall Study|Lost to Follow-up|2|||
148731135|NCT03709823|536490426|FG001|Overall Study|Lost to Follow-up|2|||
148731136|NCT03709823|536490427|FG002|Overall Study|Lost to Follow-up|2|||
148731137|NCT03709823|536490428|FG003|Overall Study|Lost to Follow-up|1|||
148731138|NCT03709823|536490429|FG004|Overall Study|Lost to Follow-up|1|||
148731139|NCT03709823|536490430|FG005|Overall Study|Lost to Follow-up|0|||
148731140|NCT03709823|536490425|FG000|Overall Study|Withdrawal by Subject|1|||
148731141|NCT03709823|536490426|FG001|Overall Study|Withdrawal by Subject|3|||
148731142|NCT03709823|536490427|FG002|Overall Study|Withdrawal by Subject|0|||
148731143|NCT03709823|536490428|FG003|Overall Study|Withdrawal by Subject|0|||
148731144|NCT03709823|536490429|FG004|Overall Study|Withdrawal by Subject|0|||
148731145|NCT03709823|536490430|FG005|Overall Study|Withdrawal by Subject|0|||
148731146|NCT03709823|536490425|FG000|Overall Study|Other, Not Specified|0|||
148731147|NCT03709823|536490426|FG001|Overall Study|Other, Not Specified|0|||
149026479|NCT00764868|537574251|FG000|Overall Study|Out of town|1|||
149026480|NCT00764868|537574251|FG000|Overall Study|Misuse and compliance of study drug|1|||
149026481|NCT00764868|537574251|FG000|Overall Study|Subject sent to boarding school|1|||
149026482|NCT00764868|537574251|FG000|Overall Study|Met an exclusion criteria|1|||
149026483|NCT00764868|537574251|FG000|Overall Study|Positive drug screen|2|||
149026484|NCT00764868|537574251|FG000|Overall Study|Sponsor requested withdrawal|1|||
149026485|NCT00783692|537574258|FG000|Induction Phase|Adverse Event|7|||
149026486|NCT00783692|537574259|FG001|Induction Phase|Adverse Event|9|||
149026487|NCT00783692|537574260|FG002|Induction Phase|Adverse Event|24|||
149026488|NCT00783692|537574261|FG003|Induction Phase|Adverse Event|0|||
149026489|NCT00783692|537574262|FG004|Induction Phase|Adverse Event|0|||
149026490|NCT00783692|537574263|FG005|Induction Phase|Adverse Event|0|||
149026491|NCT00783692|537574264|FG006|Induction Phase|Adverse Event|0|||
149026492|NCT00783692|537574258|FG000|Induction Phase|Protocol Violation|0|||
149026493|NCT00783692|537574259|FG001|Induction Phase|Protocol Violation|0|||
149026494|NCT00783692|537574260|FG002|Induction Phase|Protocol Violation|1|||
149026495|NCT00783692|537574261|FG003|Induction Phase|Protocol Violation|0|||
148731148|NCT03709823|536490427|FG002|Overall Study|Other, Not Specified|0|||
148731149|NCT03709823|536490428|FG003|Overall Study|Other, Not Specified|1|||
148731150|NCT03709823|536490429|FG004|Overall Study|Other, Not Specified|0|||
148731151|NCT03709823|536490430|FG005|Overall Study|Other, Not Specified|0|||
148731152|NCT02038907|536490433|FG000|Overall Study|Protocol Violation|0|||
148731153|NCT02038907|536490434|FG001|Overall Study|Protocol Violation|0|||
148731154|NCT02038907|536490435|FG002|Overall Study|Protocol Violation|0|||
148731155|NCT02038907|536490436|FG003|Overall Study|Protocol Violation|0|||
148731156|NCT02038907|536490437|FG004|Overall Study|Protocol Violation|0|||
148731157|NCT02038907|536490438|FG005|Overall Study|Protocol Violation|0|||
148731158|NCT02038907|536490439|FG006|Overall Study|Protocol Violation|0|||
148731159|NCT02038907|536490440|FG007|Overall Study|Protocol Violation|0|||
148731160|NCT02038907|536490441|FG008|Overall Study|Protocol Violation|0|||
148731161|NCT02038907|536490442|FG009|Overall Study|Protocol Violation|0|||
148731162|NCT02038907|536490443|FG010|Overall Study|Protocol Violation|1|||
148731163|NCT02038907|536490444|FG011|Overall Study|Protocol Violation|0|||
148731164|NCT02038907|536490445|FG012|Overall Study|Protocol Violation|0|||
148731165|NCT02038907|536490446|FG013|Overall Study|Protocol Violation|0|||
148731166|NCT02038907|536490433|FG000|Overall Study|Withdrawal by Subject|0|||
148731167|NCT02038907|536490434|FG001|Overall Study|Withdrawal by Subject|0|||
148731168|NCT02038907|536490435|FG002|Overall Study|Withdrawal by Subject|0|||
148731169|NCT02038907|536490436|FG003|Overall Study|Withdrawal by Subject|0|||
148731170|NCT02038907|536490437|FG004|Overall Study|Withdrawal by Subject|0|||
148731171|NCT02038907|536490438|FG005|Overall Study|Withdrawal by Subject|0|||
148731172|NCT02038907|536490439|FG006|Overall Study|Withdrawal by Subject|0|||
148731173|NCT02038907|536490440|FG007|Overall Study|Withdrawal by Subject|0|||
148731174|NCT02038907|536490441|FG008|Overall Study|Withdrawal by Subject|0|||
148731175|NCT02038907|536490442|FG009|Overall Study|Withdrawal by Subject|0|||
148731176|NCT02038907|536490443|FG010|Overall Study|Withdrawal by Subject|1|||
148731177|NCT02038907|536490444|FG011|Overall Study|Withdrawal by Subject|0|||
148731178|NCT02038907|536490445|FG012|Overall Study|Withdrawal by Subject|0|||
148731179|NCT02038907|536490446|FG013|Overall Study|Withdrawal by Subject|0|||
148731180|NCT02618408|536490450|FG000|Overall Study|Withdrawal by Subject|1|||
148731181|NCT02618408|536490451|FG001|Overall Study|Withdrawal by Subject|0|||
148731182|NCT02618408|536490452|FG002|Overall Study|Withdrawal by Subject|4|||
148731183|NCT02618408|536490450|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
148731184|NCT02618408|536490451|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
148731185|NCT02618408|536490452|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
148731186|NCT02618408|536490450|FG000|Overall Study|Lost to Follow-up|4|||
148731187|NCT02618408|536490451|FG001|Overall Study|Lost to Follow-up|2|||
148731188|NCT02618408|536490452|FG002|Overall Study|Lost to Follow-up|6|||
148731189|NCT02618408|536490450|FG000|Overall Study|Adverse Event|4|||
149026496|NCT00783692|537574262|FG004|Induction Phase|Protocol Violation|0|||
149026497|NCT00783692|537574263|FG005|Induction Phase|Protocol Violation|0|||
149026498|NCT00783692|537574264|FG006|Induction Phase|Protocol Violation|0|||
148731190|NCT02618408|536490451|FG001|Overall Study|Adverse Event|0|||
148731191|NCT02618408|536490452|FG002|Overall Study|Adverse Event|10|||
148731192|NCT02618408|536490450|FG000|Overall Study|Physician Decision|1|||
148731193|NCT02618408|536490451|FG001|Overall Study|Physician Decision|1|||
148731194|NCT02618408|536490452|FG002|Overall Study|Physician Decision|2|||
148731195|NCT02618408|536490450|FG000|Overall Study|Protocol Violation|1|||
149026499|NCT00783692|537574258|FG000|Induction Phase|Lack of Efficacy|1|||
148731196|NCT02618408|536490451|FG001|Overall Study|Protocol Violation|1|||
148731197|NCT02618408|536490452|FG002|Overall Study|Protocol Violation|2|||
148731198|NCT02618408|536490450|FG000|Overall Study|Other, Multiple Categories|0|||
148731199|NCT02618408|536490451|FG001|Overall Study|Other, Multiple Categories|0|||
148731200|NCT02618408|536490452|FG002|Overall Study|Other, Multiple Categories|4|||
148731201|NCT01246011|536490453|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
149026500|NCT00783692|537574259|FG001|Induction Phase|Lack of Efficacy|3|||
149026501|NCT00783692|537574260|FG002|Induction Phase|Lack of Efficacy|28|||
148972534|NCT02385799|537383443|FG001|Overall Study|Lost to Follow-up|2|||
148972535|NCT02385799|537383442|FG000|Overall Study|Adverse Event|4|||
148972536|NCT02385799|537383443|FG001|Overall Study|Adverse Event|2|||
148972537|NCT02385799|537383442|FG000|Overall Study|Withdrawal by Subject|0|||
148972538|NCT02385799|537383443|FG001|Overall Study|Withdrawal by Subject|4|||
148972539|NCT03995953|537383444|FG000|Overall Study|Death|3|||
148972540|NCT03995953|537383445|FG001|Overall Study|Death|0|||
148972541|NCT03995953|537383446|FG002|Overall Study|Death|3|||
148972542|NCT03995953|537383447|FG003|Overall Study|Death|0|||
148972543|NCT03995953|537383448|FG004|Overall Study|Death|3|||
148972544|NCT03995953|537383449|FG005|Overall Study|Death|0|||
148972545|NCT03995953|537383450|FG006|Overall Study|Death|0|||
148972546|NCT03995953|537383451|FG007|Overall Study|Death|0|||
148972547|NCT03995953|537383452|FG008|Overall Study|Death|1|||
148731202|NCT01246011|536490454|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
148731203|NCT01246011|536490455|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
148731204|NCT01246011|536490453|FG000|Overall Study|Withdrawal by Subject|0|||
148731205|NCT01246011|536490454|FG001|Overall Study|Withdrawal by Subject|0|||
148731206|NCT01246011|536490455|FG002|Overall Study|Withdrawal by Subject|1|||
148731207|NCT01155024|536490464|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
148731208|NCT01155024|536490465|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
148731209|NCT01155024|536490464|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
148731210|NCT01155024|536490465|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
148731211|NCT01155024|536490464|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
148731212|NCT01155024|536490465|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
148731213|NCT02575911|536490468|FG000|Overall Study|Lost to Follow-up|1|||
148731214|NCT03579966|536490469|FG000|Overall Study|Adverse Event|6|||
148731215|NCT03579966|536490469|FG000|Overall Study|Lost to Follow-up|4|||
148731216|NCT03579966|536490469|FG000|Overall Study|Physician Decision|10|||
148731217|NCT03579966|536490469|FG000|Overall Study|Pregnancy|1|||
148731218|NCT03579966|536490469|FG000|Overall Study|Withdrawal by Subject|16|||
148731219|NCT03579966|536490469|FG000|Overall Study|Study terminated by Sponsor|22|||
148731220|NCT03579966|536490469|FG000|Overall Study|Protocol Violation|1|||
148731221|NCT01340768|536490470|FG000|Overall Study|Lost to Follow-up|10|||
148731222|NCT01340768|536490471|FG001|Overall Study|Lost to Follow-up|4|||
148731223|NCT01340768|536490470|FG000|Overall Study|Withdrawal by Subject|5|||
148731224|NCT01340768|536490471|FG001|Overall Study|Withdrawal by Subject|1|||
148731225|NCT01340768|536490470|FG000|Overall Study|Other|2|||
148731226|NCT01340768|536490471|FG001|Overall Study|Other|0|||
148731227|NCT03321630|536490478|FG000|Overall Study|Adverse Event|1|||
148731228|NCT03321630|536490478|FG000|Overall Study|Investigator Discretion|2|||
148731229|NCT03321630|536490478|FG000|Overall Study|Withdrawal by Subject|1|||
148731230|NCT01675661|536490479|FG000|Overall Study|Lost to Follow-up|22|||
148731231|NCT01675661|536490480|FG001|Overall Study|Lost to Follow-up|23|||
148731232|NCT01675661|536490479|FG000|Overall Study|Practical problems|9|||
148731233|NCT01675661|536490480|FG001|Overall Study|Practical problems|5|||
148731234|NCT01675661|536490479|FG000|Overall Study|Moved away|5|||
148731235|NCT01675661|536490480|FG001|Overall Study|Moved away|6|||
148731236|NCT01675661|536490479|FG000|Overall Study|Withdrawal by Subject|3|||
148731237|NCT01675661|536490480|FG001|Overall Study|Withdrawal by Subject|7|||
148731238|NCT01675661|536490479|FG000|Overall Study|Physician Decision|0|||
148731239|NCT01675661|536490480|FG001|Overall Study|Physician Decision|2|||
148731240|NCT01675661|536490479|FG000|Overall Study|Death|0|||
148731241|NCT01675661|536490480|FG001|Overall Study|Death|1|||
148972548|NCT03995953|537383453|FG009|Overall Study|Death|0|||
148972549|NCT03995953|537383454|FG010|Overall Study|Death|0|||
148972550|NCT03995953|537383455|FG011|Overall Study|Death|0|||
149026502|NCT00783692|537574261|FG003|Induction Phase|Lack of Efficacy|0|||
149026503|NCT00783692|537574262|FG004|Induction Phase|Lack of Efficacy|0|||
149026504|NCT00783692|537574263|FG005|Induction Phase|Lack of Efficacy|0|||
148731242|NCT01675661|536490479|FG000|Overall Study|Other reason|1|||
148731243|NCT01675661|536490480|FG001|Overall Study|Other reason|2|||
148731244|NCT00987389|536490481|FG000|Overall Study|Ineligible|0|||
148972551|NCT03995953|537383444|FG000|Overall Study|Lost to Follow-up|6|||
148972552|NCT03995953|537383445|FG001|Overall Study|Lost to Follow-up|54|||
148731245|NCT00987389|536490482|FG001|Overall Study|Ineligible|3|||
148731246|NCT00987389|536490483|FG002|Overall Study|Ineligible|0|||
148731247|NCT00987389|536490484|FG003|Overall Study|Ineligible|0|||
148972553|NCT03995953|537383446|FG002|Overall Study|Lost to Follow-up|3|||
149026505|NCT00783692|537574264|FG006|Induction Phase|Lack of Efficacy|0|||
149026506|NCT00783692|537574258|FG000|Induction Phase|Withdrawal by Subject|3|||
149026507|NCT00783692|537574259|FG001|Induction Phase|Withdrawal by Subject|9|||
149026508|NCT00783692|537574260|FG002|Induction Phase|Withdrawal by Subject|16|||
149026509|NCT00783692|537574261|FG003|Induction Phase|Withdrawal by Subject|0|||
149026510|NCT00783692|537574262|FG004|Induction Phase|Withdrawal by Subject|0|||
149026511|NCT00783692|537574263|FG005|Induction Phase|Withdrawal by Subject|0|||
149026512|NCT00783692|537574264|FG006|Induction Phase|Withdrawal by Subject|0|||
149026513|NCT00783692|537574258|FG000|Induction Phase|Lost to Follow-up|0|||
149026514|NCT00783692|537574259|FG001|Induction Phase|Lost to Follow-up|0|||
149026515|NCT00783692|537574260|FG002|Induction Phase|Lost to Follow-up|3|||
149026516|NCT00783692|537574261|FG003|Induction Phase|Lost to Follow-up|0|||
149026517|NCT00783692|537574262|FG004|Induction Phase|Lost to Follow-up|0|||
149026518|NCT00783692|537574263|FG005|Induction Phase|Lost to Follow-up|0|||
149026519|NCT00783692|537574264|FG006|Induction Phase|Lost to Follow-up|0|||
149026520|NCT00783692|537574258|FG000|Induction Phase|Other|0|||
149026521|NCT00783692|537574259|FG001|Induction Phase|Other|0|||
149026522|NCT00783692|537574260|FG002|Induction Phase|Other|2|||
149026523|NCT00783692|537574261|FG003|Induction Phase|Other|0|||
149026524|NCT00783692|537574262|FG004|Induction Phase|Other|0|||
149026525|NCT00783692|537574263|FG005|Induction Phase|Other|0|||
149026526|NCT00783692|537574264|FG006|Induction Phase|Other|0|||
149026527|NCT00783692|537574258|FG000|Maintenance Phase|Adverse Event|7|||
149026528|NCT00783692|537574259|FG001|Maintenance Phase|Adverse Event|0|||
149026529|NCT00783692|537574260|FG002|Maintenance Phase|Adverse Event|0|||
149026530|NCT00783692|537574261|FG003|Maintenance Phase|Adverse Event|15|||
149026531|NCT00783692|537574262|FG004|Maintenance Phase|Adverse Event|12|||
149026532|NCT00783692|537574263|FG005|Maintenance Phase|Adverse Event|9|||
149026533|NCT00783692|537574264|FG006|Maintenance Phase|Adverse Event|38|||
149026534|NCT00783692|537574258|FG000|Maintenance Phase|Protocol Violation|0|||
149026535|NCT00783692|537574259|FG001|Maintenance Phase|Protocol Violation|0|||
149026536|NCT00783692|537574260|FG002|Maintenance Phase|Protocol Violation|0|||
149026537|NCT00783692|537574261|FG003|Maintenance Phase|Protocol Violation|1|||
149026538|NCT00783692|537574262|FG004|Maintenance Phase|Protocol Violation|2|||
149026539|NCT00783692|537574263|FG005|Maintenance Phase|Protocol Violation|3|||
149026540|NCT00783692|537574264|FG006|Maintenance Phase|Protocol Violation|4|||
149026541|NCT00783692|537574258|FG000|Maintenance Phase|Lack of Efficacy|79|||
149026542|NCT00783692|537574259|FG001|Maintenance Phase|Lack of Efficacy|0|||
149026543|NCT00783692|537574260|FG002|Maintenance Phase|Lack of Efficacy|0|||
149026544|NCT00783692|537574261|FG003|Maintenance Phase|Lack of Efficacy|64|||
149026545|NCT00783692|537574262|FG004|Maintenance Phase|Lack of Efficacy|58|||
149026546|NCT00783692|537574263|FG005|Maintenance Phase|Lack of Efficacy|48|||
149026547|NCT00783692|537574264|FG006|Maintenance Phase|Lack of Efficacy|177|||
149026548|NCT00783692|537574258|FG000|Maintenance Phase|Withdrawal by Subject|7|||
149026549|NCT00783692|537574259|FG001|Maintenance Phase|Withdrawal by Subject|0|||
149026550|NCT00783692|537574260|FG002|Maintenance Phase|Withdrawal by Subject|0|||
149026551|NCT00783692|537574261|FG003|Maintenance Phase|Withdrawal by Subject|7|||
149026552|NCT00783692|537574262|FG004|Maintenance Phase|Withdrawal by Subject|6|||
149026553|NCT00783692|537574263|FG005|Maintenance Phase|Withdrawal by Subject|9|||
149026554|NCT00783692|537574264|FG006|Maintenance Phase|Withdrawal by Subject|24|||
149026555|NCT00783692|537574258|FG000|Maintenance Phase|Lost to Follow-up|2|||
149026556|NCT00783692|537574259|FG001|Maintenance Phase|Lost to Follow-up|0|||
149026557|NCT00783692|537574260|FG002|Maintenance Phase|Lost to Follow-up|0|||
149026558|NCT00783692|537574261|FG003|Maintenance Phase|Lost to Follow-up|1|||
149026559|NCT00783692|537574262|FG004|Maintenance Phase|Lost to Follow-up|3|||
149026560|NCT00783692|537574263|FG005|Maintenance Phase|Lost to Follow-up|2|||
149026561|NCT00783692|537574264|FG006|Maintenance Phase|Lost to Follow-up|5|||
149026562|NCT00783692|537574258|FG000|Maintenance Phase|Other|0|||
149026563|NCT00783692|537574259|FG001|Maintenance Phase|Other|0|||
149026564|NCT00783692|537574260|FG002|Maintenance Phase|Other|0|||
149026565|NCT00783692|537574261|FG003|Maintenance Phase|Other|1|||
149026566|NCT00783692|537574262|FG004|Maintenance Phase|Other|0|||
149026567|NCT00783692|537574263|FG005|Maintenance Phase|Other|1|||
149026568|NCT00783692|537574264|FG006|Maintenance Phase|Other|1|||
149026569|NCT03005288|537574267|FG000|Overall Study|Withdrawal by Subject|7|||
149026570|NCT03005288|537574268|FG001|Overall Study|Withdrawal by Subject|5|||
149026571|NCT03005288|537574267|FG000|Overall Study|Lost to Follow-up|0|||
149026572|NCT03005288|537574268|FG001|Overall Study|Lost to Follow-up|1|||
149026573|NCT03005288|537574267|FG000|Overall Study|Adverse Event|5|||
149026574|NCT03005288|537574268|FG001|Overall Study|Adverse Event|0|||
149026575|NCT03005288|537574267|FG000|Overall Study|Protocol deviation|0|||
149026576|NCT03005288|537574268|FG001|Overall Study|Protocol deviation|1|||
149026577|NCT03005288|537574267|FG000|Overall Study|Physician Decision|0|||
149026578|NCT03005288|537574268|FG001|Overall Study|Physician Decision|1|||
149026579|NCT00819234|537574273|FG000|Overall Study|Withdrawal by Subject|8|||
148731248|NCT00987389|536490481|FG000|Overall Study|Lost to Follow-up|4|||
148731249|NCT00987389|536490482|FG001|Overall Study|Lost to Follow-up|1|||
148731250|NCT00987389|536490483|FG002|Overall Study|Lost to Follow-up|3|||
148731251|NCT00987389|536490484|FG003|Overall Study|Lost to Follow-up|1|||
148731252|NCT00987389|536490481|FG000|Overall Study|Withdrawal by Subject|4|||
148731253|NCT00987389|536490482|FG001|Overall Study|Withdrawal by Subject|3|||
148731254|NCT00987389|536490483|FG002|Overall Study|Withdrawal by Subject|2|||
148731255|NCT00987389|536490484|FG003|Overall Study|Withdrawal by Subject|1|||
148731256|NCT00987389|536490481|FG000|Overall Study|Withdrawn from Treatment|0|||
148731257|NCT00987389|536490482|FG001|Overall Study|Withdrawn from Treatment|1|||
148731258|NCT00987389|536490483|FG002|Overall Study|Withdrawn from Treatment|0|||
148731259|NCT00987389|536490484|FG003|Overall Study|Withdrawn from Treatment|0|||
148731260|NCT00987389|536490481|FG000|Overall Study|Multiple different reasons|1|||
148731261|NCT00987389|536490482|FG001|Overall Study|Multiple different reasons|0|||
148731262|NCT00987389|536490483|FG002|Overall Study|Multiple different reasons|3|||
148731263|NCT00987389|536490484|FG003|Overall Study|Multiple different reasons|1|||
148731264|NCT02992418|536490487|FG000|Overall Study|Withdrawal by Subject|11|||
148731265|NCT02992418|536490488|FG001|Overall Study|Withdrawal by Subject|12|||
148731266|NCT02992418|536490487|FG000|Overall Study|Non-compliance with the protocol|308|||
148731267|NCT02992418|536490488|FG001|Overall Study|Non-compliance with the protocol|308|||
148731268|NCT02992418|536490487|FG000|Overall Study|Lost to Follow-up|27|||
148731269|NCT02992418|536490488|FG001|Overall Study|Lost to Follow-up|22|||
148731270|NCT00289536|536490489|FG000|Period 3|Lost to Follow-up|0|||
148731271|NCT00289536|536490490|FG001|Period 3|Lost to Follow-up|0|||
148731272|NCT00289536|536490491|FG002|Period 3|Lost to Follow-up|1|||
148731273|NCT03246126|536490492|FG000|Overall Study|Withdrawal by Subject|0|||
148731274|NCT03246126|536490493|FG001|Overall Study|Withdrawal by Subject|1|||
148731275|NCT04465630|536490496|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
148731276|NCT04465630|536490496|FG000|Overall Study|Screen failure|8|||
148731277|NCT04465630|536490496|FG000|Overall Study|Baseline failure|16|||
148731278|NCT01006135|536490497|FG000|Overall Study|Adverse Event|22|||
148731279|NCT01006135|536490497|FG000|Overall Study|Protocol Violation|14|||
148731280|NCT01006135|536490497|FG000|Overall Study|Lost to Follow-up|32|||
148731281|NCT01006135|536490497|FG000|Overall Study|Other|72|||
148731282|NCT01732484|536490499|FG000|Overall Study|Death|7|||
148731283|NCT01732484|536490499|FG000|Overall Study|Lost to Follow-up|14|||
148731284|NCT01732484|536490499|FG000|Overall Study|chronical illness|5|||
148731285|NCT00928707|536490500|FG000|Overall Study|Protocol Violation|1|||
148731286|NCT00928707|536490501|FG001|Overall Study|Protocol Violation|0|||
148731287|NCT00132028|536490502|FG000|Overall Study|Adverse Event|7|||
148731288|NCT00132028|536490502|FG000|Overall Study|Death|2|||
148731289|NCT00132028|536490502|FG000|Overall Study|Lack of Efficacy|11|||
148731290|NCT00132028|536490502|FG000|Overall Study|Withdrawal by Subject|2|||
148731291|NCT00132028|536490502|FG000|Overall Study|not eligible|2|||
148731292|NCT00132028|536490502|FG000|Overall Study|Physician Decision|3|||
148731293|NCT02005887|536490506|FG000|Overall Study|Protocol Violation|0|||
148731294|NCT02005887|536490507|FG001|Overall Study|Protocol Violation|2|||
148731295|NCT01615263|536490516|FG000|Overall Study|Post-randomization exclusion|0|||
148731296|NCT01615263|536490517|FG001|Overall Study|Post-randomization exclusion|2|||
148731297|NCT01321008|536490518|FG000|Overall Study|Early Study Termination|1|||
148731298|NCT02458092|536490519|FG000|Overall Study|Withdrawal by Subject|1|||
148731299|NCT02458092|536490520|FG001|Overall Study|Withdrawal by Subject|0|||
148731300|NCT02989168|536490527|FG000|Overall Study|Withdrawal by Subject|2|||
148731301|NCT02989168|536490528|FG001|Overall Study|Withdrawal by Subject|0|||
148731302|NCT02989168|536490527|FG000|Overall Study|Physician Decision|0|||
148731303|NCT02989168|536490528|FG001|Overall Study|Physician Decision|1|||
148731304|NCT02989168|536490527|FG000|Overall Study|Adverse Event|1|||
148731305|NCT02989168|536490528|FG001|Overall Study|Adverse Event|2|||
148731306|NCT02989168|536490527|FG000|Overall Study|Sponsor stopped study.|1|||
148731307|NCT02989168|536490528|FG001|Overall Study|Sponsor stopped study.|0|||
148731308|NCT00532935|536490529|FG000|Overall Study|Adverse Event|11|||
148731309|NCT00532935|536490530|FG001|Overall Study|Adverse Event|12|||
148731310|NCT00532935|536490529|FG000|Overall Study|Lack of Efficacy|0|||
148731311|NCT00532935|536490530|FG001|Overall Study|Lack of Efficacy|3|||
148731312|NCT00532935|536490529|FG000|Overall Study|Lost to Follow-up|10|||
148731313|NCT00532935|536490530|FG001|Overall Study|Lost to Follow-up|6|||
148731314|NCT00532935|536490529|FG000|Overall Study|Physician Decision|4|||
148731315|NCT00532935|536490530|FG001|Overall Study|Physician Decision|5|||
148731316|NCT00532935|536490529|FG000|Overall Study|Pregnancy|1|||
148731317|NCT00532935|536490530|FG001|Overall Study|Pregnancy|0|||
148731318|NCT00532935|536490529|FG000|Overall Study|Protocol Violation|4|||
148731319|NCT00532935|536490530|FG001|Overall Study|Protocol Violation|2|||
148731320|NCT00532935|536490529|FG000|Overall Study|Withdrawal by Subject|10|||
148731321|NCT00532935|536490530|FG001|Overall Study|Withdrawal by Subject|9|||
148731322|NCT00532935|536490529|FG000|Overall Study|Protocol Specific Criteria|11|||
148731323|NCT00532935|536490530|FG001|Overall Study|Protocol Specific Criteria|15|||
148731324|NCT00456495|536490531|FG000|Overall Study|Physician Decision|2|||
148731325|NCT01301508|536490532|FG000|Overall Study|Withdrawal by Subject|1|||
148731326|NCT01301508|536490533|FG001|Overall Study|Withdrawal by Subject|2|||
148731327|NCT01301508|536490532|FG000|Overall Study|Lost to Follow-up|0|||
148731328|NCT01301508|536490533|FG001|Overall Study|Lost to Follow-up|1|||
148731329|NCT01300923|536490534|FG000|Overall Study|Physician Decision|0|||
148731330|NCT01300923|536490535|FG001|Overall Study|Physician Decision|2|||
148731331|NCT01940497|536490538|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
148731332|NCT01940497|536490539|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
148731333|NCT01940497|536490538|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
148731334|NCT01940497|536490539|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
148731335|NCT01940497|536490538|FG000|Overall Study|Violation of Entry Criteria|1|||
148731336|NCT01940497|536490539|FG001|Overall Study|Violation of Entry Criteria|1|||
148731337|NCT01940497|536490538|FG000|Overall Study|Refused Treatment|1|||
148731338|NCT01940497|536490539|FG001|Overall Study|Refused Treatment|3|||
148731339|NCT01940497|536490538|FG000|Overall Study|Withdrew Consent|6|||
148731340|NCT01940497|536490539|FG001|Overall Study|Withdrew Consent|2|||
148731341|NCT01940497|536490538|FG000|Overall Study|Administrative/Other|1|||
148731342|NCT01940497|536490539|FG001|Overall Study|Administrative/Other|1|||
148731343|NCT02707861|536490540|FG000|Overall Study|Went onto commercial drug|30|||
148731344|NCT02707861|536490541|FG001|Overall Study|Went onto commercial drug|23|||
148731345|NCT02707861|536490540|FG000|Overall Study|Adverse Event|2|||
148731346|NCT02707861|536490541|FG001|Overall Study|Adverse Event|3|||
148731347|NCT02707861|536490540|FG000|Overall Study|Death|5|||
148731348|NCT02707861|536490541|FG001|Overall Study|Death|2|||
148731349|NCT02707861|536490540|FG000|Overall Study|Lack of Efficacy|0|||
148731350|NCT02707861|536490541|FG001|Overall Study|Lack of Efficacy|2|||
148731351|NCT02707861|536490540|FG000|Overall Study|Physician Decision|1|||
148817522|NCT04999020|536807285|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
148817523|NCT04999020|536807286|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
148817524|NCT04999020|536807283|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
148731352|NCT02707861|536490541|FG001|Overall Study|Physician Decision|4|||
148731353|NCT02707861|536490540|FG000|Overall Study|Withdrawal by Subject|2|||
148817525|NCT04999020|536807284|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
148731354|NCT02707861|536490541|FG001|Overall Study|Withdrawal by Subject|1|||
148731355|NCT02707861|536490540|FG000|Overall Study|Lost to Follow-up|1|||
148731356|NCT02707861|536490541|FG001|Overall Study|Lost to Follow-up|3|||
148817526|NCT04999020|536807285|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
148731357|NCT03123861|536490542|FG000|Overall Study|Protocol Violation|1|||
148731358|NCT03123861|536490543|FG001|Overall Study|Protocol Violation|1|||
148731359|NCT03123861|536490542|FG000|Overall Study|Withdrawal by Subject|2|||
148731360|NCT03123861|536490543|FG001|Overall Study|Withdrawal by Subject|2|||
148731361|NCT00448136|536490548|FG000|Overall Study|Death|3|||
148731362|NCT00448136|536490549|FG001|Overall Study|Death|8|||
148731363|NCT00448136|536490548|FG000|Overall Study|Investigator's decision (progression)|1|||
148731364|NCT00448136|536490549|FG001|Overall Study|Investigator's decision (progression)|0|||
148731365|NCT03407430|536490552|FG000|Washout|Protocol Violation|1|||
148731366|NCT03407430|536490553|FG001|Washout|Protocol Violation|0|||
148731367|NCT00922987|536490555|FG000|Overall Study|Insufficient clinical response|1|||
148731368|NCT00922987|536490555|FG000|Overall Study|Protocol Violation|2|||
148731369|NCT00922987|536490555|FG000|Overall Study|Adverse Event|1|||
148731370|NCT04969861|536490558|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
148731371|NCT04969861|536490559|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
148731372|NCT04221789|536492390|FG000|Overall Study|deviation from protoco|22|||
148731373|NCT04221789|536492391|FG001|Overall Study|deviation from protoco|8|||
148731374|NCT04385277|536492392|FG000|Overall Study|Physician Decision|2|||
148731375|NCT04385277|536492392|FG000|Overall Study|Ineligible|1|||
148731376|NCT04385277|536492392|FG000|Overall Study|Patient/Parent Refusal|2|||
148731377|NCT04905290|536492393|FG000|Overall Study|Adverse Event|4|||
148731378|NCT04905290|536492393|FG000|Overall Study|Death|2|||
148731379|NCT04905290|536492393|FG000|Overall Study|Withdrawal by Subject|4|||
148731380|NCT04905290|536492393|FG000|Overall Study|Physician Decision|2|||
148731381|NCT04905290|536492393|FG000|Overall Study|Lost to Follow-up|2|||
148731382|NCT04905290|536492393|FG000|Overall Study|Screen Failure|2|||
148731383|NCT04905290|536492393|FG000|Overall Study|Unsuccessful Procedure|2|||
148731384|NCT05101486|536492394|FG000|Overall Study|Death|1|||
148731385|NCT05101486|536492395|FG001|Overall Study|Death|0|||
148731386|NCT05101486|536492396|FG002|Overall Study|Death|1|||
148731387|NCT05101486|536492394|FG000|Overall Study|Lost to Follow-up|12|||
148731388|NCT05101486|536492395|FG001|Overall Study|Lost to Follow-up|8|||
148731389|NCT05101486|536492396|FG002|Overall Study|Lost to Follow-up|17|||
148731390|NCT05101486|536492394|FG000|Overall Study|Physician Decision|1|||
148731391|NCT05101486|536492395|FG001|Overall Study|Physician Decision|0|||
148731392|NCT05101486|536492396|FG002|Overall Study|Physician Decision|0|||
148731393|NCT05101486|536492394|FG000|Overall Study|Protocol Violation|0|||
148731394|NCT05101486|536492395|FG001|Overall Study|Protocol Violation|0|||
148731395|NCT05101486|536492396|FG002|Overall Study|Protocol Violation|1|||
148731396|NCT05101486|536492394|FG000|Overall Study|Withdrawal by Subject|5|||
148731397|NCT05101486|536492395|FG001|Overall Study|Withdrawal by Subject|2|||
148731398|NCT05101486|536492396|FG002|Overall Study|Withdrawal by Subject|4|||
148731399|NCT05101486|536492394|FG000|Overall Study|Randomized but not vaccinated|1|||
148731400|NCT05101486|536492395|FG001|Overall Study|Randomized but not vaccinated|1|||
148731401|NCT05101486|536492396|FG002|Overall Study|Randomized but not vaccinated|1|||
148731402|NCT03295318|536492397|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
148731403|NCT03295318|536492398|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
148731404|NCT03295318|536492399|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
148731405|NCT03295318|536492397|FG000|Overall Study|Death|1|||
148731406|NCT03295318|536492398|FG001|Overall Study|Death|1|||
148731407|NCT03295318|536492399|FG002|Overall Study|Death|1|||
148731408|NCT03295318|536492397|FG000|Overall Study|Protocol Violation|4|||
148731409|NCT03295318|536492398|FG001|Overall Study|Protocol Violation|3|||
148731410|NCT03295318|536492399|FG002|Overall Study|Protocol Violation|3|||
148731411|NCT03295318|536492397|FG000|Overall Study|Withdrawal by Subject|0|||
148731412|NCT03295318|536492398|FG001|Overall Study|Withdrawal by Subject|0|||
148731413|NCT03295318|536492399|FG002|Overall Study|Withdrawal by Subject|1|||
148731414|NCT03295318|536492397|FG000|Overall Study|Subject discontinued due to travel|0|||
148731415|NCT03295318|536492398|FG001|Overall Study|Subject discontinued due to travel|1|||
148731416|NCT03295318|536492399|FG002|Overall Study|Subject discontinued due to travel|0|||
148731417|NCT03747601|536492400|FG000|Overall Study|COVID halt to visits|4|||
148731418|NCT02788045|536492401|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
148731419|NCT02788045|536492402|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
148731420|NCT02788045|536492403|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
148731421|NCT02788045|536492401|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
148731422|NCT02788045|536492402|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
148731423|NCT02788045|536492403|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
148731424|NCT02788045|536492401|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
148731425|NCT02788045|536492402|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
148731426|NCT02788045|536492403|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
148972554|NCT03995953|537383447|FG003|Overall Study|Lost to Follow-up|32|||
148972555|NCT03995953|537383448|FG004|Overall Study|Lost to Follow-up|5|||
148972556|NCT03995953|537383449|FG005|Overall Study|Lost to Follow-up|44|||
148972557|NCT03995953|537383450|FG006|Overall Study|Lost to Follow-up|0|||
148972558|NCT03995953|537383451|FG007|Overall Study|Lost to Follow-up|31|||
148972559|NCT03995953|537383452|FG008|Overall Study|Lost to Follow-up|8|||
148731427|NCT02788045|536492401|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
148731428|NCT02788045|536492402|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
148731429|NCT02788045|536492403|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
148972560|NCT03995953|537383453|FG009|Overall Study|Lost to Follow-up|36|||
148731430|NCT02788045|536492401|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
148731431|NCT02788045|536492402|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
148731432|NCT02788045|536492403|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
148731433|NCT02788045|536492401|FG000|Main Study (Up to Week 72)|Other|3|||
148731434|NCT02788045|536492402|FG001|Main Study (Up to Week 72)|Other|0|||
148731435|NCT02788045|536492403|FG002|Main Study (Up to Week 72)|Other|0|||
148731436|NCT02788045|536492401|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
148731437|NCT02788045|536492402|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
148731438|NCT02788045|536492403|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
148731439|NCT02788045|536492401|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
148731440|NCT02788045|536492402|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
148731441|NCT02788045|536492403|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
148731442|NCT02788045|536492401|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
148731443|NCT02788045|536492402|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
148731444|NCT02788045|536492403|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
148731445|NCT00144781|536492407|FG000|Overall Study|Adverse Event|0|||
148731446|NCT00144781|536492408|FG001|Overall Study|Adverse Event|1|||
148731447|NCT00144781|536492409|FG002|Overall Study|Adverse Event|0|||
148731448|NCT00144781|536492410|FG003|Overall Study|Adverse Event|0|||
148731449|NCT00144781|536492407|FG000|Overall Study|Non-compliant|0|||
148731450|NCT00144781|536492408|FG001|Overall Study|Non-compliant|1|||
148731451|NCT00144781|536492409|FG002|Overall Study|Non-compliant|0|||
148731452|NCT00144781|536492410|FG003|Overall Study|Non-compliant|0|||
148731453|NCT03696953|536492411|FG000|Overall Study|Withdrawal by Subject|6|||
148731454|NCT03696953|536492412|FG001|Overall Study|Withdrawal by Subject|1|||
148731455|NCT03696953|536492411|FG000|Overall Study|missed GBS swabs|2|||
148731456|NCT03696953|536492412|FG001|Overall Study|missed GBS swabs|2|||
148731457|NCT03696953|536492411|FG000|Overall Study|lost study bottle containing capsules|2|||
148731458|NCT03696953|536492412|FG001|Overall Study|lost study bottle containing capsules|0|||
148731459|NCT03696953|536492411|FG000|Overall Study|Premature birth|1|||
148731460|NCT03696953|536492412|FG001|Overall Study|Premature birth|4|||
148731461|NCT03696953|536492411|FG000|Overall Study|Gestational hypertension|1|||
148731462|NCT03696953|536492412|FG001|Overall Study|Gestational hypertension|1|||
148731463|NCT03696953|536492411|FG000|Overall Study|Gestational diabetes|2|||
148731464|NCT03696953|536492412|FG001|Overall Study|Gestational diabetes|1|||
148731465|NCT03696953|536492411|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
148731466|NCT03696953|536492412|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
148731467|NCT03696953|536492411|FG000|Overall Study|Changed prenatal provider|1|||
148731468|NCT03696953|536492412|FG001|Overall Study|Changed prenatal provider|1|||
148731469|NCT03502707|536492413|FG000|Overall Study|Adverse Event|0|||
148731470|NCT03502707|536492414|FG001|Overall Study|Adverse Event|0|||
148731471|NCT03502707|536492415|FG002|Overall Study|Adverse Event|0|||
148731472|NCT03502707|536492416|FG003|Overall Study|Adverse Event|0|||
148731473|NCT03502707|536492417|FG004|Overall Study|Adverse Event|0|||
148731474|NCT03502707|536492418|FG005|Overall Study|Adverse Event|0|||
148731475|NCT03502707|536492419|FG006|Overall Study|Adverse Event|0|||
148731476|NCT03502707|536492420|FG007|Overall Study|Adverse Event|0|||
148731477|NCT03502707|536492421|FG008|Overall Study|Adverse Event|0|||
148731478|NCT03502707|536492422|FG009|Overall Study|Adverse Event|0|||
148731479|NCT03502707|536492423|FG010|Overall Study|Adverse Event|0|||
148731480|NCT03502707|536492424|FG011|Overall Study|Adverse Event|0|||
148731481|NCT03502707|536492425|FG012|Overall Study|Adverse Event|0|||
148731482|NCT03502707|536492426|FG013|Overall Study|Adverse Event|0|||
148731483|NCT03502707|536492427|FG014|Overall Study|Adverse Event|0|||
148731484|NCT03502707|536492428|FG015|Overall Study|Adverse Event|1|||
148731485|NCT03502707|536492429|FG016|Overall Study|Adverse Event|5|||
148731486|NCT03502707|536492430|FG017|Overall Study|Adverse Event|0|||
148731487|NCT03502707|536492413|FG000|Overall Study|Death|0|||
148731488|NCT03502707|536492414|FG001|Overall Study|Death|0|||
148731489|NCT03502707|536492415|FG002|Overall Study|Death|0|||
148731490|NCT03502707|536492416|FG003|Overall Study|Death|1|||
148731491|NCT03502707|536492417|FG004|Overall Study|Death|0|||
148731492|NCT03502707|536492418|FG005|Overall Study|Death|0|||
148731493|NCT03502707|536492419|FG006|Overall Study|Death|0|||
148731494|NCT03502707|536492420|FG007|Overall Study|Death|0|||
148731495|NCT03502707|536492421|FG008|Overall Study|Death|1|||
148731496|NCT03502707|536492422|FG009|Overall Study|Death|1|||
148731497|NCT03502707|536492423|FG010|Overall Study|Death|0|||
148731498|NCT03502707|536492424|FG011|Overall Study|Death|0|||
148731499|NCT03502707|536492425|FG012|Overall Study|Death|1|||
148731500|NCT03502707|536492426|FG013|Overall Study|Death|0|||
148731501|NCT03502707|536492427|FG014|Overall Study|Death|0|||
148731502|NCT03502707|536492428|FG015|Overall Study|Death|1|||
148731503|NCT03502707|536492429|FG016|Overall Study|Death|0|||
148731504|NCT03502707|536492430|FG017|Overall Study|Death|0|||
148731505|NCT03502707|536492413|FG000|Overall Study|Lost to Follow-up|0|||
148731506|NCT03502707|536492414|FG001|Overall Study|Lost to Follow-up|0|||
148731507|NCT03502707|536492415|FG002|Overall Study|Lost to Follow-up|0|||
148731508|NCT03502707|536492416|FG003|Overall Study|Lost to Follow-up|0|||
148731509|NCT03502707|536492417|FG004|Overall Study|Lost to Follow-up|0|||
148731510|NCT03502707|536492418|FG005|Overall Study|Lost to Follow-up|0|||
148731511|NCT03502707|536492419|FG006|Overall Study|Lost to Follow-up|0|||
148972561|NCT03995953|537383454|FG010|Overall Study|Lost to Follow-up|5|||
148972562|NCT03995953|537383455|FG011|Overall Study|Lost to Follow-up|41|||
148972563|NCT03995953|537383444|FG000|Overall Study|Withdrawal by Subject|4|||
148972564|NCT03995953|537383445|FG001|Overall Study|Withdrawal by Subject|0|||
148972565|NCT03995953|537383446|FG002|Overall Study|Withdrawal by Subject|1|||
148972566|NCT03995953|537383447|FG003|Overall Study|Withdrawal by Subject|0|||
148972567|NCT03995953|537383448|FG004|Overall Study|Withdrawal by Subject|1|||
148972568|NCT03995953|537383449|FG005|Overall Study|Withdrawal by Subject|0|||
148972569|NCT03995953|537383450|FG006|Overall Study|Withdrawal by Subject|1|||
148972570|NCT03995953|537383451|FG007|Overall Study|Withdrawal by Subject|0|||
148972571|NCT03995953|537383452|FG008|Overall Study|Withdrawal by Subject|3|||
148972572|NCT03995953|537383453|FG009|Overall Study|Withdrawal by Subject|0|||
148972573|NCT03995953|537383454|FG010|Overall Study|Withdrawal by Subject|3|||
148972574|NCT03995953|537383455|FG011|Overall Study|Withdrawal by Subject|0|||
148972575|NCT03995953|537383444|FG000|Overall Study|Health Issues|0|||
148972576|NCT03995953|537383445|FG001|Overall Study|Health Issues|0|||
148972577|NCT03995953|537383446|FG002|Overall Study|Health Issues|0|||
148972578|NCT03995953|537383447|FG003|Overall Study|Health Issues|0|||
148972579|NCT03995953|537383448|FG004|Overall Study|Health Issues|1|||
148972580|NCT03995953|537383449|FG005|Overall Study|Health Issues|0|||
148972581|NCT03995953|537383450|FG006|Overall Study|Health Issues|0|||
148972582|NCT03995953|537383451|FG007|Overall Study|Health Issues|0|||
148972583|NCT03995953|537383452|FG008|Overall Study|Health Issues|4|||
148972584|NCT03995953|537383453|FG009|Overall Study|Health Issues|0|||
148972585|NCT03995953|537383454|FG010|Overall Study|Health Issues|0|||
148972586|NCT03995953|537383455|FG011|Overall Study|Health Issues|0|||
148972587|NCT03995953|537383444|FG000|Overall Study|Relocated|11|||
148972588|NCT03995953|537383445|FG001|Overall Study|Relocated|0|||
148972589|NCT03995953|537383446|FG002|Overall Study|Relocated|16|||
148972590|NCT03995953|537383447|FG003|Overall Study|Relocated|0|||
148972591|NCT03995953|537383448|FG004|Overall Study|Relocated|14|||
148972592|NCT03995953|537383449|FG005|Overall Study|Relocated|0|||
148972593|NCT03995953|537383450|FG006|Overall Study|Relocated|16|||
148972594|NCT03995953|537383451|FG007|Overall Study|Relocated|0|||
148972595|NCT03995953|537383452|FG008|Overall Study|Relocated|14|||
148972596|NCT03995953|537383453|FG009|Overall Study|Relocated|0|||
148972597|NCT03995953|537383454|FG010|Overall Study|Relocated|15|||
148972598|NCT03995953|537383455|FG011|Overall Study|Relocated|0|||
148972599|NCT02388997|537383456|FG000|Overall Study|Adverse Event|1|||
148972600|NCT02388997|537383457|FG001|Overall Study|Adverse Event|2|||
148972601|NCT02388997|537383456|FG000|Overall Study|Withdrawal by Subject|2|||
148972602|NCT02388997|537383457|FG001|Overall Study|Withdrawal by Subject|1|||
148972603|NCT02388997|537383456|FG000|Overall Study|Lung function exclusion criteria|0|||
148972604|NCT02388997|537383457|FG001|Overall Study|Lung function exclusion criteria|2|||
148972605|NCT02388997|537383456|FG000|Overall Study|Tested positive for virus during run-in|0|||
148972606|NCT02388997|537383457|FG001|Overall Study|Tested positive for virus during run-in|1|||
148972607|NCT01110915|537383464|FG000|Overall Study|Death|2|||
149026580|NCT00819234|537574274|FG001|Overall Study|Withdrawal by Subject|13|||
149026581|NCT00819234|537574275|FG002|Overall Study|Withdrawal by Subject|6|||
149026582|NCT00819234|537574276|FG003|Overall Study|Withdrawal by Subject|3|||
149026583|NCT00819234|537574277|FG004|Overall Study|Withdrawal by Subject|0|||
148731512|NCT03502707|536492420|FG007|Overall Study|Lost to Follow-up|5|||
148731513|NCT03502707|536492421|FG008|Overall Study|Lost to Follow-up|0|||
148731514|NCT03502707|536492422|FG009|Overall Study|Lost to Follow-up|2|||
148731515|NCT03502707|536492423|FG010|Overall Study|Lost to Follow-up|1|||
148731516|NCT03502707|536492424|FG011|Overall Study|Lost to Follow-up|2|||
148731517|NCT03502707|536492425|FG012|Overall Study|Lost to Follow-up|1|||
148731518|NCT03502707|536492426|FG013|Overall Study|Lost to Follow-up|1|||
148731519|NCT03502707|536492427|FG014|Overall Study|Lost to Follow-up|0|||
148731520|NCT03502707|536492428|FG015|Overall Study|Lost to Follow-up|4|||
148731521|NCT03502707|536492429|FG016|Overall Study|Lost to Follow-up|9|||
148731522|NCT03502707|536492430|FG017|Overall Study|Lost to Follow-up|2|||
148731523|NCT03502707|536492413|FG000|Overall Study|Physician Decision|0|||
148731524|NCT03502707|536492414|FG001|Overall Study|Physician Decision|0|||
148731525|NCT03502707|536492415|FG002|Overall Study|Physician Decision|0|||
148731526|NCT03502707|536492416|FG003|Overall Study|Physician Decision|0|||
148731527|NCT03502707|536492417|FG004|Overall Study|Physician Decision|0|||
148731528|NCT03502707|536492418|FG005|Overall Study|Physician Decision|0|||
148731529|NCT03502707|536492419|FG006|Overall Study|Physician Decision|0|||
148731530|NCT03502707|536492420|FG007|Overall Study|Physician Decision|0|||
148972608|NCT01110915|537383465|FG001|Overall Study|Death|1|||
148972609|NCT01110915|537383464|FG000|Overall Study|Lost to Follow-up|1|||
148972610|NCT01110915|537383465|FG001|Overall Study|Lost to Follow-up|0|||
148972611|NCT01110915|537383464|FG000|Overall Study|Withdrawal by Subject|7|||
148972612|NCT01110915|537383465|FG001|Overall Study|Withdrawal by Subject|1|||
148731531|NCT03502707|536492421|FG008|Overall Study|Physician Decision|2|||
148731532|NCT03502707|536492422|FG009|Overall Study|Physician Decision|1|||
148972613|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
148972614|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
149026584|NCT00819234|537574278|FG005|Overall Study|Withdrawal by Subject|4|||
148731533|NCT03502707|536492423|FG010|Overall Study|Physician Decision|0|||
148731534|NCT03502707|536492424|FG011|Overall Study|Physician Decision|0|||
148731535|NCT03502707|536492425|FG012|Overall Study|Physician Decision|0|||
148731536|NCT03502707|536492426|FG013|Overall Study|Physician Decision|0|||
148731537|NCT03502707|536492427|FG014|Overall Study|Physician Decision|1|||
148731538|NCT03502707|536492428|FG015|Overall Study|Physician Decision|3|||
148731539|NCT03502707|536492429|FG016|Overall Study|Physician Decision|0|||
148731540|NCT03502707|536492430|FG017|Overall Study|Physician Decision|0|||
148731541|NCT03502707|536492413|FG000|Overall Study|Protocol Violation|0|||
148731542|NCT03502707|536492414|FG001|Overall Study|Protocol Violation|0|||
148731543|NCT03502707|536492415|FG002|Overall Study|Protocol Violation|0|||
148731544|NCT03502707|536492416|FG003|Overall Study|Protocol Violation|0|||
148731545|NCT03502707|536492417|FG004|Overall Study|Protocol Violation|0|||
148731546|NCT03502707|536492418|FG005|Overall Study|Protocol Violation|0|||
148731547|NCT03502707|536492419|FG006|Overall Study|Protocol Violation|0|||
148731548|NCT03502707|536492420|FG007|Overall Study|Protocol Violation|0|||
148731549|NCT03502707|536492421|FG008|Overall Study|Protocol Violation|0|||
148731550|NCT03502707|536492422|FG009|Overall Study|Protocol Violation|0|||
148731551|NCT03502707|536492423|FG010|Overall Study|Protocol Violation|0|||
148731552|NCT03502707|536492424|FG011|Overall Study|Protocol Violation|0|||
148731553|NCT03502707|536492425|FG012|Overall Study|Protocol Violation|0|||
148731554|NCT03502707|536492426|FG013|Overall Study|Protocol Violation|0|||
148731555|NCT03502707|536492427|FG014|Overall Study|Protocol Violation|0|||
148731556|NCT03502707|536492428|FG015|Overall Study|Protocol Violation|1|||
148731557|NCT03502707|536492429|FG016|Overall Study|Protocol Violation|0|||
148731558|NCT03502707|536492430|FG017|Overall Study|Protocol Violation|0|||
148731559|NCT03502707|536492413|FG000|Overall Study|Withdrawal by Subject|1|||
148731560|NCT03502707|536492414|FG001|Overall Study|Withdrawal by Subject|1|||
148731561|NCT03502707|536492415|FG002|Overall Study|Withdrawal by Subject|0|||
148731562|NCT03502707|536492416|FG003|Overall Study|Withdrawal by Subject|0|||
148731563|NCT03502707|536492417|FG004|Overall Study|Withdrawal by Subject|0|||
148731564|NCT03502707|536492418|FG005|Overall Study|Withdrawal by Subject|2|||
148731565|NCT03502707|536492419|FG006|Overall Study|Withdrawal by Subject|0|||
148731566|NCT03502707|536492420|FG007|Overall Study|Withdrawal by Subject|3|||
148731567|NCT03502707|536492421|FG008|Overall Study|Withdrawal by Subject|1|||
148731568|NCT03502707|536492422|FG009|Overall Study|Withdrawal by Subject|2|||
148731569|NCT03502707|536492423|FG010|Overall Study|Withdrawal by Subject|12|||
148731570|NCT03502707|536492424|FG011|Overall Study|Withdrawal by Subject|23|||
148731571|NCT03502707|536492425|FG012|Overall Study|Withdrawal by Subject|5|||
148731572|NCT03502707|536492426|FG013|Overall Study|Withdrawal by Subject|3|||
148731573|NCT03502707|536492427|FG014|Overall Study|Withdrawal by Subject|3|||
148731574|NCT03502707|536492428|FG015|Overall Study|Withdrawal by Subject|43|||
148731575|NCT03502707|536492429|FG016|Overall Study|Withdrawal by Subject|44|||
148731576|NCT03502707|536492430|FG017|Overall Study|Withdrawal by Subject|18|||
148731577|NCT03502707|536492413|FG000|Overall Study|Sponsor's Decision|1|||
148731578|NCT03502707|536492414|FG001|Overall Study|Sponsor's Decision|0|||
148731579|NCT03502707|536492415|FG002|Overall Study|Sponsor's Decision|0|||
148731580|NCT03502707|536492416|FG003|Overall Study|Sponsor's Decision|0|||
148731581|NCT03502707|536492417|FG004|Overall Study|Sponsor's Decision|0|||
148731582|NCT03502707|536492418|FG005|Overall Study|Sponsor's Decision|0|||
148731583|NCT03502707|536492419|FG006|Overall Study|Sponsor's Decision|0|||
148731584|NCT03502707|536492420|FG007|Overall Study|Sponsor's Decision|0|||
148731585|NCT03502707|536492421|FG008|Overall Study|Sponsor's Decision|0|||
148731586|NCT03502707|536492422|FG009|Overall Study|Sponsor's Decision|1|||
148731587|NCT03502707|536492423|FG010|Overall Study|Sponsor's Decision|0|||
148731588|NCT03502707|536492424|FG011|Overall Study|Sponsor's Decision|0|||
148731589|NCT03502707|536492425|FG012|Overall Study|Sponsor's Decision|0|||
148731590|NCT03502707|536492426|FG013|Overall Study|Sponsor's Decision|0|||
148731591|NCT03502707|536492427|FG014|Overall Study|Sponsor's Decision|0|||
148731592|NCT03502707|536492428|FG015|Overall Study|Sponsor's Decision|2|||
148972615|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
148972616|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
148972617|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
148731593|NCT03502707|536492429|FG016|Overall Study|Sponsor's Decision|1|||
148731594|NCT03502707|536492430|FG017|Overall Study|Sponsor's Decision|0|||
148731595|NCT03502707|536492413|FG000|Overall Study|Initiated Prohibited Medication|0|||
148731596|NCT03502707|536492414|FG001|Overall Study|Initiated Prohibited Medication|0|||
148731597|NCT03502707|536492415|FG002|Overall Study|Initiated Prohibited Medication|0|||
148731598|NCT03502707|536492416|FG003|Overall Study|Initiated Prohibited Medication|0|||
148731599|NCT03502707|536492417|FG004|Overall Study|Initiated Prohibited Medication|0|||
148731600|NCT03502707|536492418|FG005|Overall Study|Initiated Prohibited Medication|0|||
148972618|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
148972619|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
148731601|NCT03502707|536492419|FG006|Overall Study|Initiated Prohibited Medication|0|||
148731602|NCT03502707|536492420|FG007|Overall Study|Initiated Prohibited Medication|0|||
148731603|NCT03502707|536492421|FG008|Overall Study|Initiated Prohibited Medication|0|||
148731604|NCT03502707|536492422|FG009|Overall Study|Initiated Prohibited Medication|0|||
148731605|NCT03502707|536492423|FG010|Overall Study|Initiated Prohibited Medication|0|||
148731606|NCT03502707|536492424|FG011|Overall Study|Initiated Prohibited Medication|0|||
148731607|NCT03502707|536492425|FG012|Overall Study|Initiated Prohibited Medication|0|||
148731608|NCT03502707|536492426|FG013|Overall Study|Initiated Prohibited Medication|0|||
148731609|NCT03502707|536492427|FG014|Overall Study|Initiated Prohibited Medication|0|||
148731610|NCT03502707|536492428|FG015|Overall Study|Initiated Prohibited Medication|0|||
148731611|NCT03502707|536492429|FG016|Overall Study|Initiated Prohibited Medication|1|||
148731612|NCT03502707|536492430|FG017|Overall Study|Initiated Prohibited Medication|0|||
148731613|NCT03502707|536492413|FG000|Overall Study|Other|0|||
148731614|NCT03502707|536492414|FG001|Overall Study|Other|0|||
148731615|NCT03502707|536492415|FG002|Overall Study|Other|0|||
148731616|NCT03502707|536492416|FG003|Overall Study|Other|0|||
148731617|NCT03502707|536492417|FG004|Overall Study|Other|0|||
148731618|NCT03502707|536492418|FG005|Overall Study|Other|0|||
148731619|NCT03502707|536492419|FG006|Overall Study|Other|0|||
148731620|NCT03502707|536492420|FG007|Overall Study|Other|0|||
148731621|NCT03502707|536492421|FG008|Overall Study|Other|1|||
148731622|NCT03502707|536492422|FG009|Overall Study|Other|1|||
148731623|NCT03502707|536492423|FG010|Overall Study|Other|2|||
148731624|NCT03502707|536492424|FG011|Overall Study|Other|0|||
148731625|NCT03502707|536492425|FG012|Overall Study|Other|0|||
148731626|NCT03502707|536492426|FG013|Overall Study|Other|0|||
148731627|NCT03502707|536492427|FG014|Overall Study|Other|0|||
148731628|NCT03502707|536492428|FG015|Overall Study|Other|4|||
148731629|NCT03502707|536492429|FG016|Overall Study|Other|1|||
148731630|NCT03502707|536492430|FG017|Overall Study|Other|0|||
148731631|NCT03502707|536492413|FG000|Overall Study|Randomized but not vaccinated|0|||
148731632|NCT03502707|536492414|FG001|Overall Study|Randomized but not vaccinated|0|||
148731633|NCT03502707|536492415|FG002|Overall Study|Randomized but not vaccinated|0|||
148731634|NCT03502707|536492416|FG003|Overall Study|Randomized but not vaccinated|0|||
148731635|NCT03502707|536492417|FG004|Overall Study|Randomized but not vaccinated|0|||
148731636|NCT03502707|536492418|FG005|Overall Study|Randomized but not vaccinated|0|||
148731637|NCT03502707|536492419|FG006|Overall Study|Randomized but not vaccinated|0|||
148731638|NCT03502707|536492420|FG007|Overall Study|Randomized but not vaccinated|0|||
148731639|NCT03502707|536492421|FG008|Overall Study|Randomized but not vaccinated|0|||
148731640|NCT03502707|536492422|FG009|Overall Study|Randomized but not vaccinated|0|||
148731641|NCT03502707|536492423|FG010|Overall Study|Randomized but not vaccinated|0|||
148731642|NCT03502707|536492424|FG011|Overall Study|Randomized but not vaccinated|1|||
148731643|NCT03502707|536492425|FG012|Overall Study|Randomized but not vaccinated|0|||
148731644|NCT03502707|536492426|FG013|Overall Study|Randomized but not vaccinated|0|||
148731645|NCT03502707|536492427|FG014|Overall Study|Randomized but not vaccinated|0|||
148731646|NCT03502707|536492428|FG015|Overall Study|Randomized but not vaccinated|0|||
148731647|NCT03502707|536492429|FG016|Overall Study|Randomized but not vaccinated|0|||
148731648|NCT03502707|536492430|FG017|Overall Study|Randomized but not vaccinated|1|||
148731649|NCT00461253|536492431|FG000|Overall Study|Death|985|||
148731650|NCT00461253|536492432|FG001|Overall Study|Death|0|||
148731651|NCT00461253|536492431|FG000|Overall Study|Protocol Violation|613|||
148731652|NCT00461253|536492432|FG001|Overall Study|Protocol Violation|236|||
148731653|NCT00461253|536492431|FG000|Overall Study|no response|2609|||
148731654|NCT00461253|536492432|FG001|Overall Study|no response|11789|||
148731655|NCT00461253|536492431|FG000|Overall Study|administrative|773|||
148731656|NCT00461253|536492432|FG001|Overall Study|administrative|7773|||
148731657|NCT04092894|536492433|FG000|Overall Study|Withdrawal by Subject|2|||
148731658|NCT04092894|536492434|FG001|Overall Study|Withdrawal by Subject|4|||
148731659|NCT04092894|536492433|FG000|Overall Study|Discontinued EEG after randomization|10|||
148731660|NCT04092894|536492434|FG001|Overall Study|Discontinued EEG after randomization|6|||
148731661|NCT00541970|536492435|FG000|Month 7|Protocol Violation|9|||
148731662|NCT00541970|536492436|FG001|Month 7|Protocol Violation|13|||
148731663|NCT00541970|536492437|FG002|Month 7|Protocol Violation|11|||
148731664|NCT00541970|536492438|FG003|Month 7|Protocol Violation|5|||
148972620|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
148972621|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
148972622|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
148731665|NCT00541970|536492435|FG000|Month 12|Adverse Event|0|||
148731666|NCT00541970|536492436|FG001|Month 12|Adverse Event|1|||
148731667|NCT00541970|536492437|FG002|Month 12|Adverse Event|1|||
148731668|NCT00541970|536492438|FG003|Month 12|Adverse Event|1|||
148731669|NCT00541970|536492435|FG000|Month 12|Protocol Violation|12|||
148731670|NCT00541970|536492436|FG001|Month 12|Protocol Violation|21|||
148731671|NCT00541970|536492437|FG002|Month 12|Protocol Violation|20|||
148731672|NCT00541970|536492438|FG003|Month 12|Protocol Violation|15|||
148731673|NCT00541970|536492435|FG000|Month 18|Adverse Event|0|||
148731674|NCT00541970|536492436|FG001|Month 18|Adverse Event|1|||
148731675|NCT00541970|536492437|FG002|Month 18|Adverse Event|1|||
148731676|NCT00541970|536492438|FG003|Month 18|Adverse Event|1|||
148731677|NCT00541970|536492435|FG000|Month 18|Protocol Violation|14|||
148731678|NCT00541970|536492436|FG001|Month 18|Protocol Violation|23|||
148731679|NCT00541970|536492437|FG002|Month 18|Protocol Violation|24|||
148972623|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
148972624|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
148972625|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
148731680|NCT00541970|536492438|FG003|Month 18|Protocol Violation|16|||
148731681|NCT00541970|536492435|FG000|Month 24|Adverse Event|0|||
148731682|NCT00541970|536492436|FG001|Month 24|Adverse Event|1|||
148731683|NCT00541970|536492437|FG002|Month 24|Adverse Event|1|||
148731684|NCT00541970|536492438|FG003|Month 24|Adverse Event|1|||
148731685|NCT00541970|536492435|FG000|Month 24|Protocol Violation|29|||
148731686|NCT00541970|536492436|FG001|Month 24|Protocol Violation|31|||
148731687|NCT00541970|536492437|FG002|Month 24|Protocol Violation|31|||
148731688|NCT00541970|536492438|FG003|Month 24|Protocol Violation|21|||
148731689|NCT00541970|536492435|FG000|Month 36|Protocol Violation|61|||
148731690|NCT00541970|536492436|FG001|Month 36|Protocol Violation|66|||
148731691|NCT00541970|536492437|FG002|Month 36|Protocol Violation|66|||
148731692|NCT00541970|536492438|FG003|Month 36|Protocol Violation|60|||
148731693|NCT00541970|536492435|FG000|Month 48|Withdrawal by Subject|2|||
148731694|NCT00541970|536492436|FG001|Month 48|Withdrawal by Subject|4|||
148731695|NCT00541970|536492437|FG002|Month 48|Withdrawal by Subject|4|||
148731696|NCT00541970|536492438|FG003|Month 48|Withdrawal by Subject|2|||
148731697|NCT00541970|536492435|FG000|Month 48|Other|3|||
148731698|NCT00541970|536492436|FG001|Month 48|Other|1|||
148731699|NCT00541970|536492437|FG002|Month 48|Other|1|||
148731700|NCT00541970|536492438|FG003|Month 48|Other|0|||
148731701|NCT00541970|536492435|FG000|Month 48|Lost to Follow-up|66|||
148731702|NCT00541970|536492436|FG001|Month 48|Lost to Follow-up|68|||
148731703|NCT00541970|536492437|FG002|Month 48|Lost to Follow-up|68|||
148731704|NCT00541970|536492438|FG003|Month 48|Lost to Follow-up|73|||
148731705|NCT00541970|536492435|FG000|Month 60|Protocol Violation|78|||
148731706|NCT00541970|536492436|FG001|Month 60|Protocol Violation|77|||
148731707|NCT00541970|536492437|FG002|Month 60|Protocol Violation|82|||
148731708|NCT00541970|536492438|FG003|Month 60|Protocol Violation|72|||
148731709|NCT00062010|536492439|FG000|Overall Study|Ineligible|3|||
148731710|NCT00807248|536492443|FG000|Overall Study|Adverse Event|1|||
148731711|NCT00807248|536492444|FG001|Overall Study|Adverse Event|2|||
148731712|NCT00807248|536492445|FG002|Overall Study|Adverse Event|2|||
148731713|NCT00807248|536492446|FG003|Overall Study|Adverse Event|6|||
148731714|NCT00807248|536492443|FG000|Overall Study|Lack of Efficacy|14|||
148731715|NCT00807248|536492444|FG001|Overall Study|Lack of Efficacy|4|||
148731716|NCT00807248|536492445|FG002|Overall Study|Lack of Efficacy|8|||
148731717|NCT00807248|536492446|FG003|Overall Study|Lack of Efficacy|3|||
148731718|NCT00807248|536492443|FG000|Overall Study|Protocol Violation|0|||
148731719|NCT00807248|536492444|FG001|Overall Study|Protocol Violation|1|||
148731720|NCT00807248|536492445|FG002|Overall Study|Protocol Violation|1|||
148731721|NCT00807248|536492446|FG003|Overall Study|Protocol Violation|0|||
148731722|NCT00807248|536492443|FG000|Overall Study|Withdrawal of Consent|5|||
148731723|NCT00807248|536492444|FG001|Overall Study|Withdrawal of Consent|5|||
148731724|NCT00807248|536492445|FG002|Overall Study|Withdrawal of Consent|5|||
148731725|NCT00807248|536492446|FG003|Overall Study|Withdrawal of Consent|5|||
148731726|NCT00807248|536492443|FG000|Overall Study|Lost to Follow-up|1|||
148731727|NCT00807248|536492444|FG001|Overall Study|Lost to Follow-up|0|||
148731728|NCT00807248|536492445|FG002|Overall Study|Lost to Follow-up|0|||
148731729|NCT00807248|536492446|FG003|Overall Study|Lost to Follow-up|0|||
148731730|NCT00807248|536492443|FG000|Overall Study|Other Reason|0|||
148731731|NCT00807248|536492444|FG001|Overall Study|Other Reason|0|||
148731732|NCT00807248|536492445|FG002|Overall Study|Other Reason|2|||
148731733|NCT00807248|536492446|FG003|Overall Study|Other Reason|0|||
148731734|NCT02504671|536492448|FG000|Overall Study|Withdrawal by Subject|1|||
148731735|NCT02504671|536492449|FG001|Overall Study|Withdrawal by Subject|5|||
148731736|NCT02504671|536492450|FG002|Overall Study|Withdrawal by Subject|4|||
148731737|NCT02504671|536492451|FG003|Overall Study|Withdrawal by Subject|4|||
148731738|NCT02504671|536492452|FG004|Overall Study|Withdrawal by Subject|5|||
148731739|NCT02504671|536492453|FG005|Overall Study|Withdrawal by Subject|3|||
148731740|NCT02504671|536492448|FG000|Overall Study|Lack of Efficacy|1|||
148731741|NCT02504671|536492449|FG001|Overall Study|Lack of Efficacy|3|||
148972626|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
148731742|NCT02504671|536492450|FG002|Overall Study|Lack of Efficacy|1|||
148731743|NCT02504671|536492451|FG003|Overall Study|Lack of Efficacy|0|||
148731744|NCT02504671|536492452|FG004|Overall Study|Lack of Efficacy|4|||
148731745|NCT02504671|536492453|FG005|Overall Study|Lack of Efficacy|4|||
148731746|NCT02504671|536492448|FG000|Overall Study|Adverse Event|1|||
148731747|NCT02504671|536492449|FG001|Overall Study|Adverse Event|1|||
148731748|NCT02504671|536492450|FG002|Overall Study|Adverse Event|0|||
148731749|NCT02504671|536492451|FG003|Overall Study|Adverse Event|1|||
148731750|NCT02504671|536492452|FG004|Overall Study|Adverse Event|0|||
148731751|NCT02504671|536492453|FG005|Overall Study|Adverse Event|2|||
148731752|NCT02504671|536492448|FG000|Overall Study|Protocol Violation|2|||
148731753|NCT02504671|536492449|FG001|Overall Study|Protocol Violation|1|||
148731754|NCT02504671|536492450|FG002|Overall Study|Protocol Violation|0|||
148972627|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
148731755|NCT02504671|536492451|FG003|Overall Study|Protocol Violation|0|||
148731756|NCT02504671|536492452|FG004|Overall Study|Protocol Violation|0|||
148731757|NCT02504671|536492453|FG005|Overall Study|Protocol Violation|1|||
148731758|NCT02504671|536492448|FG000|Overall Study|Lost to Follow-up|0|||
148731759|NCT02504671|536492449|FG001|Overall Study|Lost to Follow-up|0|||
148731760|NCT02504671|536492450|FG002|Overall Study|Lost to Follow-up|2|||
148731761|NCT02504671|536492451|FG003|Overall Study|Lost to Follow-up|0|||
148731762|NCT02504671|536492452|FG004|Overall Study|Lost to Follow-up|0|||
148731763|NCT02504671|536492453|FG005|Overall Study|Lost to Follow-up|1|||
148731764|NCT02504671|536492448|FG000|Overall Study|Protocol defined stopping criteria|7|||
148731765|NCT02504671|536492449|FG001|Overall Study|Protocol defined stopping criteria|4|||
148731766|NCT02504671|536492450|FG002|Overall Study|Protocol defined stopping criteria|3|||
148731767|NCT02504671|536492451|FG003|Overall Study|Protocol defined stopping criteria|5|||
148731768|NCT02504671|536492452|FG004|Overall Study|Protocol defined stopping criteria|3|||
148731769|NCT02504671|536492453|FG005|Overall Study|Protocol defined stopping criteria|3|||
148731770|NCT01687478|536492454|FG000|Overall Study|Adverse Event|3|||
148731771|NCT01687478|536492455|FG001|Overall Study|Adverse Event|10|||
148731772|NCT01687478|536492454|FG000|Overall Study|Lost to Follow-up|1|||
148731773|NCT01687478|536492455|FG001|Overall Study|Lost to Follow-up|3|||
148731774|NCT01687478|536492454|FG000|Overall Study|Protocol Violation|0|||
148731775|NCT01687478|536492455|FG001|Overall Study|Protocol Violation|2|||
148731776|NCT01687478|536492454|FG000|Overall Study|Withdrawal by Subject|21|||
148731777|NCT01687478|536492455|FG001|Overall Study|Withdrawal by Subject|19|||
148731778|NCT01687478|536492454|FG000|Overall Study|Physician Decision|1|||
148731779|NCT01687478|536492455|FG001|Overall Study|Physician Decision|3|||
148731780|NCT01687478|536492454|FG000|Overall Study|Entry Criteria Not Met|6|||
148731781|NCT01687478|536492455|FG001|Overall Study|Entry Criteria Not Met|2|||
148731782|NCT00577395|536492456|FG000|Overall Study|Study was terminated early by Sponsor|7|||
148731783|NCT00577395|536492457|FG001|Overall Study|Study was terminated early by Sponsor|6|||
148731784|NCT01206101|536492458|FG000|Overall Study|Adverse Event|1|||
148731785|NCT01206101|536492459|FG001|Overall Study|Adverse Event|0|||
148731786|NCT01206101|536492458|FG000|Overall Study|Physician Decision|0|||
148731787|NCT01206101|536492459|FG001|Overall Study|Physician Decision|1|||
148731788|NCT01206101|536492458|FG000|Overall Study|Unclassified|1|||
148731789|NCT01206101|536492459|FG001|Overall Study|Unclassified|0|||
148731790|NCT01859130|536492462|FG000|Overall Study|Death|4|||
148731791|NCT01859130|536492462|FG000|Overall Study|Lost to Follow-up|16|||
148731792|NCT01859130|536492462|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
148731793|NCT01859130|536492462|FG000|Overall Study|Physician Decision|6|||
148731794|NCT01859130|536492462|FG000|Overall Study|Withdrawal by Subject|17|||
148731795|NCT01859130|536492462|FG000|Overall Study|Adverse Event|11|||
148731796|NCT00103311|536492468|FG000|Overall Study|Lost to Follow-up|1|||
148731797|NCT00103311|536492469|FG001|Overall Study|Lost to Follow-up|0|||
148731798|NCT00103311|536492468|FG000|Overall Study|Withdrawal by Subject|2|||
148731799|NCT00103311|536492469|FG001|Overall Study|Withdrawal by Subject|1|||
148731800|NCT00103311|536492468|FG000|Overall Study|Adverse Event|1|||
148731801|NCT00103311|536492469|FG001|Overall Study|Adverse Event|0|||
148731802|NCT03827564|536492470|FG000|Overall Study|Discontinued due to Study Termination|1|||
148731803|NCT03827564|536492471|FG001|Overall Study|Discontinued due to Study Termination|0|||
148731804|NCT02227147|536492472|FG000|Controlled Treatment Period|Adverse Event|4|||
148731805|NCT02227147|536492473|FG001|Controlled Treatment Period|Adverse Event|3|||
148731806|NCT02227147|536492472|FG000|Controlled Treatment Period|Other|2|||
148731807|NCT02227147|536492473|FG001|Controlled Treatment Period|Other|0|||
148731808|NCT02227147|536492472|FG000|Follow-up Period|Other|3|||
148731809|NCT02227147|536492473|FG001|Follow-up Period|Other|5|||
148731810|NCT03347422|536492476|FG000|Part A (26 Weeks)|Adverse Event|3|||
148731811|NCT03347422|536492477|FG001|Part A (26 Weeks)|Adverse Event|0|||
148731812|NCT03347422|536492476|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
148731813|NCT03347422|536492477|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
148731814|NCT03347422|536492476|FG000|Part B (149 Weeks)|Adverse Event|0|||
148731815|NCT03347422|536492477|FG001|Part B (149 Weeks)|Adverse Event|1|||
148731816|NCT03347422|536492476|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
148731817|NCT03347422|536492477|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
148731818|NCT03347422|536492476|FG000|Part B (149 Weeks)|Other|1|||
148731819|NCT03347422|536492477|FG001|Part B (149 Weeks)|Other|0|||
148731820|NCT00158600|536492478|FG000|Overall Study|unable to commit time to study|0|||
148731821|NCT00158600|536492479|FG001|Overall Study|unable to commit time to study|1|||
148731822|NCT00158600|536492478|FG000|Overall Study|Adverse Event|2|||
148731823|NCT00158600|536492479|FG001|Overall Study|Adverse Event|1|||
148731824|NCT00158600|536492478|FG000|Overall Study|Death|1|||
148731825|NCT00158600|536492479|FG001|Overall Study|Death|0|||
148731826|NCT00158600|536492478|FG000|Overall Study|Withdrawal by Subject|2|||
148731827|NCT00158600|536492479|FG001|Overall Study|Withdrawal by Subject|2|||
148731828|NCT01593696|536492480|FG000|Dose Escalation|Progressive Disease|2|||
148731829|NCT01593696|536492481|FG001|Dose Escalation|Progressive Disease|0|||
148731830|NCT01593696|536492482|FG002|Dose Escalation|Progressive Disease|0|||
148731831|NCT01593696|536492483|FG003|Dose Escalation|Progressive Disease|0|||
148731832|NCT01593696|536492480|FG000|Dose Expansion|Fungal infection|0|||
148731833|NCT01593696|536492481|FG001|Dose Expansion|Fungal infection|0|||
148731834|NCT01593696|536492482|FG002|Dose Expansion|Fungal infection|1|||
148731835|NCT01593696|536492483|FG003|Dose Expansion|Fungal infection|0|||
148731836|NCT01936623|536492484|FG000|Overall Study|Lost to Follow-up|0|||
148731837|NCT01936623|536492485|FG001|Overall Study|Lost to Follow-up|5|||
148731838|NCT01249365|536492486|FG000|Overall Study|Lost to Follow-up|1|||
148731839|NCT02397408|536492487|FG000|Overall Study|Physician Decision|4|||
148731840|NCT02397408|536492487|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
148731841|NCT00369655|536492488|FG000|Overall Study|Refusal of further treatment|2|||
148731842|NCT04049617|536492489|FG000|Overall Study|Adverse Event|0|||
148731843|NCT04049617|536492490|FG001|Overall Study|Adverse Event|0|||
148731844|NCT04049617|536492491|FG002|Overall Study|Adverse Event|0|||
148731845|NCT04049617|536492492|FG003|Overall Study|Adverse Event|1|||
148731846|NCT04049617|536492493|FG004|Overall Study|Adverse Event|0|||
148731847|NCT04049617|536492494|FG005|Overall Study|Adverse Event|0|||
148731848|NCT04049617|536492489|FG000|Overall Study|Death|0|||
148731849|NCT04049617|536492490|FG001|Overall Study|Death|0|||
148731850|NCT04049617|536492491|FG002|Overall Study|Death|0|||
148731851|NCT04049617|536492492|FG003|Overall Study|Death|0|||
148731852|NCT04049617|536492493|FG004|Overall Study|Death|0|||
148731853|NCT04049617|536492494|FG005|Overall Study|Death|1|||
148731854|NCT04049617|536492489|FG000|Overall Study|Lost to Follow-up|0|||
148731855|NCT04049617|536492490|FG001|Overall Study|Lost to Follow-up|0|||
148731856|NCT04049617|536492491|FG002|Overall Study|Lost to Follow-up|0|||
148731857|NCT04049617|536492492|FG003|Overall Study|Lost to Follow-up|1|||
148731858|NCT04049617|536492493|FG004|Overall Study|Lost to Follow-up|0|||
148731859|NCT04049617|536492494|FG005|Overall Study|Lost to Follow-up|0|||
148731860|NCT04049617|536492489|FG000|Overall Study|Withdrew consent|0|||
148731861|NCT04049617|536492490|FG001|Overall Study|Withdrew consent|0|||
148731862|NCT04049617|536492491|FG002|Overall Study|Withdrew consent|1|||
148731863|NCT04049617|536492492|FG003|Overall Study|Withdrew consent|0|||
148731864|NCT04049617|536492493|FG004|Overall Study|Withdrew consent|0|||
148731865|NCT04049617|536492494|FG005|Overall Study|Withdrew consent|0|||
148731866|NCT03551496|536492495|FG000|Overall Study|Death|11|||
148731867|NCT03551496|536492496|FG001|Overall Study|Death|7|||
148731868|NCT03551496|536492495|FG000|Overall Study|Withdrawal by Subject|4|||
148731869|NCT03551496|536492496|FG001|Overall Study|Withdrawal by Subject|3|||
148731870|NCT03551496|536492495|FG000|Overall Study|Other Reasons|1|||
148731871|NCT03551496|536492496|FG001|Overall Study|Other Reasons|0|||
148731872|NCT01524679|536492497|FG000|Overall Study|Lost to Follow-up|1|||
148731873|NCT01524679|536492498|FG001|Overall Study|Lost to Follow-up|4|||
148731874|NCT01524679|536492497|FG000|Overall Study|Withdrawal by Subject|4|||
148731875|NCT01524679|536492498|FG001|Overall Study|Withdrawal by Subject|4|||
148731876|NCT01524679|536492497|FG000|Overall Study|Adverse Event|9|||
148731877|NCT01524679|536492498|FG001|Overall Study|Adverse Event|0|||
148731878|NCT01524679|536492497|FG000|Overall Study|Protocol Violation|1|||
148731879|NCT01524679|536492498|FG001|Overall Study|Protocol Violation|0|||
148731880|NCT01524679|536492497|FG000|Overall Study|Lack of Efficacy|2|||
148731881|NCT01524679|536492498|FG001|Overall Study|Lack of Efficacy|0|||
148731882|NCT01524679|536492497|FG000|Overall Study|e.g.wish for children, relocation|6|||
148731883|NCT01524679|536492498|FG001|Overall Study|e.g.wish for children, relocation|1|||
148731884|NCT00801099|536492499|FG000|Overall Study|Lost to Follow-up|101|||
148731885|NCT02149108|536492502|FG000|Overall Study|Not treated|1|||
148731886|NCT02149108|536492503|FG001|Overall Study|Not treated|2|||
148731887|NCT02149108|536492502|FG000|Overall Study|Progressive Disease (PD)|324|||
148731888|NCT02149108|536492503|FG001|Overall Study|Progressive Disease (PD)|318|||
148731889|NCT02149108|536492502|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
148731890|NCT02149108|536492503|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
148731891|NCT02149108|536492502|FG000|Overall Study|Other Adverse Event (AE)|8|||
148731892|NCT02149108|536492503|FG001|Overall Study|Other Adverse Event (AE)|18|||
148731893|NCT02149108|536492502|FG000|Overall Study|Other not defined above|0|||
148731894|NCT02149108|536492503|FG001|Overall Study|Other not defined above|2|||
148731895|NCT02149108|536492502|FG000|Overall Study|Refusal to continue trial medication|15|||
148731896|NCT02149108|536492503|FG001|Overall Study|Refusal to continue trial medication|11|||
148731897|NCT02149108|536492502|FG000|Overall Study|Lost to Follow-up|1|||
148731898|NCT02149108|536492503|FG001|Overall Study|Lost to Follow-up|0|||
148731899|NCT01087489|536492504|FG000|Overall Study|enrolled in another VA study|0|||
148731900|NCT01087489|536492505|FG001|Overall Study|enrolled in another VA study|1|||
148731901|NCT01087489|536492504|FG000|Overall Study|Death|0|||
148731902|NCT01087489|536492505|FG001|Overall Study|Death|1|||
148731903|NCT01087489|536492504|FG000|Overall Study|unable to survey by telephone|0|||
148731904|NCT01087489|536492505|FG001|Overall Study|unable to survey by telephone|1|||
148731905|NCT00893737|536492513|FG000|Overall Study|Adverse Event|4|||
148731906|NCT00893737|536492513|FG000|Overall Study|Withdrawal by Subject|2|||
149026585|NCT00819234|537574279|FG006|Overall Study|Withdrawal by Subject|4|||
148731907|NCT00893737|536492513|FG000|Overall Study|Lost to Follow-up|6|||
148731908|NCT01156142|536492514|FG000|Overall Study|Withdrawal by Subject|8|||
148731909|NCT01156142|536492515|FG001|Overall Study|Withdrawal by Subject|6|||
148731910|NCT01156142|536492514|FG000|Overall Study|Ineligible|0|||
148731911|NCT01156142|536492515|FG001|Overall Study|Ineligible|1|||
148817527|NCT04999020|536807286|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
148972628|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
148972629|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
148972630|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
148972631|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
148972632|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
148972633|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
148972634|NCT02161718|537383468|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
148972635|NCT02161718|537383469|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
148972636|NCT02161718|537383470|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
148972637|NCT02161718|537383468|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
148972638|NCT02161718|537383469|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
148972639|NCT02161718|537383470|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
148972640|NCT02161718|537383468|FG000|Post- Randomization Period|Lost to Follow-up|0|||
148972641|NCT02161718|537383469|FG001|Post- Randomization Period|Lost to Follow-up|9|||
148972642|NCT02161718|537383470|FG002|Post- Randomization Period|Lost to Follow-up|15|||
148972643|NCT02161718|537383468|FG000|Post- Randomization Period|Adverse Event|0|||
148972644|NCT02161718|537383469|FG001|Post- Randomization Period|Adverse Event|9|||
148972645|NCT02161718|537383470|FG002|Post- Randomization Period|Adverse Event|10|||
148972646|NCT02161718|537383468|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
148972647|NCT02161718|537383469|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
148972648|NCT02161718|537383470|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
148972649|NCT02161718|537383468|FG000|Post- Randomization Period|Physician Decision|0|||
148972650|NCT02161718|537383469|FG001|Post- Randomization Period|Physician Decision|2|||
148972651|NCT02161718|537383470|FG002|Post- Randomization Period|Physician Decision|4|||
148972652|NCT02161718|537383468|FG000|Post- Randomization Period|Protocol Violation|0|||
148972653|NCT02161718|537383469|FG001|Post- Randomization Period|Protocol Violation|2|||
148972654|NCT02161718|537383470|FG002|Post- Randomization Period|Protocol Violation|3|||
148817528|NCT04999020|536807283|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
149026586|NCT00819234|537574280|FG007|Overall Study|Withdrawal by Subject|8|||
148817529|NCT04999020|536807284|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
148817530|NCT04999020|536807285|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
148817531|NCT04999020|536807286|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
148817532|NCT04999020|536807283|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
148817533|NCT04999020|536807284|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
148817534|NCT04999020|536807285|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
148817535|NCT04999020|536807286|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
148817536|NCT04999020|536807283|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
148817537|NCT04999020|536807284|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
148817538|NCT04999020|536807285|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
148817539|NCT04999020|536807286|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
148817540|NCT00827242|536807287|FG000|Overall Study|Withdrawal by Subject|2|||
148817541|NCT00827242|536807288|FG001|Overall Study|Withdrawal by Subject|4|||
148817542|NCT00827242|536807287|FG000|Overall Study|Protocol Violation|1|||
148817543|NCT00827242|536807288|FG001|Overall Study|Protocol Violation|3|||
148817544|NCT00827242|536807287|FG000|Overall Study|Lost to Follow-up|0|||
148817545|NCT00827242|536807288|FG001|Overall Study|Lost to Follow-up|3|||
148817546|NCT00827242|536807287|FG000|Overall Study|Adverse Event Excluding Death|2|||
148817547|NCT00827242|536807288|FG001|Overall Study|Adverse Event Excluding Death|1|||
148817548|NCT00827242|536807287|FG000|Overall Study|Entry Criteria Not Met|4|||
148817549|NCT00827242|536807288|FG001|Overall Study|Entry Criteria Not Met|1|||
148817550|NCT00827242|536807287|FG000|Overall Study|Physician Decision|2|||
148817551|NCT00827242|536807288|FG001|Overall Study|Physician Decision|0|||
148817552|NCT00827242|536807287|FG000|Overall Study|Death|1|||
148817553|NCT00827242|536807288|FG001|Overall Study|Death|0|||
148817554|NCT00827242|536807287|FG000|Overall Study|Lack of Efficacy|1|||
148817555|NCT00827242|536807288|FG001|Overall Study|Lack of Efficacy|0|||
148817556|NCT02691663|536807292|FG000|Overall Study|Screen failure after baseline|2|||
148817557|NCT02691663|536807293|FG001|Overall Study|Screen failure after baseline|2|||
148817558|NCT02691663|536807292|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
148817559|NCT02691663|536807293|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
148817560|NCT02691663|536807292|FG000|Overall Study|Withdrawn after Follow up 2|1|||
148817561|NCT02691663|536807293|FG001|Overall Study|Withdrawn after Follow up 2|1|||
148817562|NCT02691663|536807292|FG000|Overall Study|Lost to Follow-up|3|||
148817563|NCT02691663|536807293|FG001|Overall Study|Lost to Follow-up|2|||
148817564|NCT00471107|536807296|FG000|Overall Study|Technical problems/data loss|3|||
148817565|NCT00471107|536807297|FG001|Overall Study|Technical problems/data loss|1|||
148817566|NCT00471107|536807298|FG002|Overall Study|Technical problems/data loss|3|||
148817567|NCT01769443|536807299|FG000|Overall Study|Study closure|1|||
148817568|NCT01769443|536807300|FG001|Overall Study|Study closure|0|||
148817569|NCT03925220|536807301|FG000|Overall Study|Withdrawal by Subject|4|||
148817570|NCT03925220|536807302|FG001|Overall Study|Withdrawal by Subject|4|||
148817571|NCT03925220|536807303|FG002|Overall Study|Withdrawal by Subject|4|||
148817572|NCT03925220|536807304|FG003|Overall Study|Withdrawal by Subject|4|||
148817573|NCT03925220|536807301|FG000|Overall Study|Lost to Follow-up|40|||
148817574|NCT03925220|536807302|FG001|Overall Study|Lost to Follow-up|46|||
148817575|NCT03925220|536807303|FG002|Overall Study|Lost to Follow-up|37|||
148817576|NCT03925220|536807304|FG003|Overall Study|Lost to Follow-up|38|||
148817577|NCT04425018|536807305|FG000|Overall Study|Withdrawal by Subject|1|||
148817578|NCT04425018|536807306|FG001|Overall Study|Withdrawal by Subject|2|||
148817579|NCT01944774|536807307|FG000|Overall Study|Withdrawal by Subject|2|||
148817580|NCT01944774|536807308|FG001|Overall Study|Withdrawal by Subject|3|||
148817581|NCT01944774|536807309|FG002|Overall Study|Withdrawal by Subject|3|||
148817582|NCT01944774|536807307|FG000|Overall Study|Adverse Event|3|||
148817583|NCT01944774|536807308|FG001|Overall Study|Adverse Event|2|||
148817584|NCT01944774|536807309|FG002|Overall Study|Adverse Event|3|||
148817585|NCT01944774|536807307|FG000|Overall Study|Lack of Efficacy|1|||
148817586|NCT01944774|536807308|FG001|Overall Study|Lack of Efficacy|2|||
148817587|NCT01944774|536807309|FG002|Overall Study|Lack of Efficacy|2|||
148817588|NCT01944774|536807307|FG000|Overall Study|Lost to Follow-up|0|||
149026587|NCT00819234|537574281|FG008|Overall Study|Withdrawal by Subject|5|||
149026588|NCT00819234|537574282|FG009|Overall Study|Withdrawal by Subject|3|||
148817589|NCT01944774|536807308|FG001|Overall Study|Lost to Follow-up|1|||
148817590|NCT01944774|536807309|FG002|Overall Study|Lost to Follow-up|0|||
148817591|NCT04828486|536807312|FG000|Overall Study|Adverse Event|2|||
148817592|NCT04828486|536807312|FG000|Overall Study|Death|1|||
148817593|NCT04828486|536807312|FG000|Overall Study|Disease Progression|8|||
148817594|NCT04828486|536807312|FG000|Overall Study|Other Complicating Disease|1|||
148817595|NCT04828486|536807312|FG000|Overall Study|Withdrawal by Subject|1|||
148817596|NCT00866320|536807314|FG000|Overall Study|Withdrawal by Subject|4|||
148817597|NCT00866320|536807314|FG000|Overall Study|Death|2|||
148817598|NCT02063724|536807317|FG000|Overall Study|Disease progression|1|||
148817599|NCT00896233|536807318|FG000|Overall Study|Claustrophobia during MRI|1|||
148817600|NCT02965456|536807319|FG000|Overall Study|Lost to Follow-up|40|||
148817601|NCT02965456|536807320|FG001|Overall Study|Lost to Follow-up|18|||
148731912|NCT03981419|536492516|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
148731913|NCT03981419|536492517|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
148731914|NCT01330459|536492518|FG000|Overall Study|Physician Decision|0|||
148731915|NCT01330459|536492519|FG001|Overall Study|Physician Decision|2|||
148731916|NCT04620135|536492523|FG000|Study Completion|Adverse Event|2|||
148731917|NCT04620135|536492524|FG001|Study Completion|Adverse Event|3|||
148731918|NCT04620135|536492523|FG000|Study Completion|Withdrawal by Subject|2|||
148731919|NCT04620135|536492524|FG001|Study Completion|Withdrawal by Subject|0|||
148731920|NCT02272634|536492525|FG000|Overall Study|Adverse Event|1|||
148731921|NCT02272634|536492526|FG001|Overall Study|Adverse Event|0|||
148731922|NCT02272634|536492527|FG002|Overall Study|Adverse Event|0|||
148731923|NCT02272634|536492525|FG000|Overall Study|Protocol Violation|0|||
148731924|NCT02272634|536492526|FG001|Overall Study|Protocol Violation|0|||
148731925|NCT02272634|536492527|FG002|Overall Study|Protocol Violation|1|||
148731926|NCT02272634|536492525|FG000|Overall Study|Withdrawal by Subject|0|||
148731927|NCT02272634|536492526|FG001|Overall Study|Withdrawal by Subject|1|||
148731928|NCT02272634|536492527|FG002|Overall Study|Withdrawal by Subject|0|||
148731929|NCT01437943|536492529|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
148731930|NCT01437943|536492530|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
148731931|NCT01437943|536492529|FG000|Overall Study|Subject expressed pregnancy plans|1|||
148731932|NCT01437943|536492530|FG001|Overall Study|Subject expressed pregnancy plans|0|||
148731933|NCT01437943|536492529|FG000|Overall Study|Adverse Event|2|||
148731934|NCT01437943|536492530|FG001|Overall Study|Adverse Event|0|||
148731935|NCT01660334|536492535|FG000|Overall Study|Lost to Follow-up|1|||
148731936|NCT00546572|536492536|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
148731937|NCT00546572|536492537|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
148731938|NCT00546572|536492536|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
148731939|NCT00546572|536492537|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
148731940|NCT00546572|536492536|FG000|Vax 1 / Year 0|Protocol Violation|3|||
148731941|NCT00546572|536492537|FG001|Vax 1 / Year 0|Protocol Violation|4|||
148731942|NCT00546572|536492536|FG000|Vax 1 / Year 0|Death|2|||
148731943|NCT00546572|536492537|FG001|Vax 1 / Year 0|Death|2|||
148731944|NCT00546572|536492536|FG000|Vax 1 / Year 0|Adverse Event|0|||
148731945|NCT00546572|536492537|FG001|Vax 1 / Year 0|Adverse Event|1|||
148731946|NCT00546572|536492536|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
148731947|NCT00546572|536492537|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
148731948|NCT00546572|536492536|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
148731949|NCT00546572|536492537|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
148731950|NCT00546572|536492536|FG000|Vax 2 / Year 1|Other|1|||
148731951|NCT00546572|536492537|FG001|Vax 2 / Year 1|Other|1|||
148731952|NCT00546572|536492536|FG000|Vax 2 / Year 1|Adverse Event|1|||
148731953|NCT00546572|536492537|FG001|Vax 2 / Year 1|Adverse Event|0|||
148731954|NCT00546572|536492536|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
148731955|NCT00546572|536492537|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
148731956|NCT03979820|536492538|FG000|Overall Study|Protocol Violation|1|||
148731957|NCT03979820|536492539|FG001|Overall Study|Protocol Violation|0|||
148731958|NCT03979820|536492540|FG002|Overall Study|Protocol Violation|0|||
148731959|NCT03979820|536492541|FG003|Overall Study|Protocol Violation|0|||
148731960|NCT03979820|536492538|FG000|Overall Study|Withdrawal by Subject|0|||
148731961|NCT03979820|536492539|FG001|Overall Study|Withdrawal by Subject|0|||
148731962|NCT03979820|536492540|FG002|Overall Study|Withdrawal by Subject|1|||
148731963|NCT03979820|536492541|FG003|Overall Study|Withdrawal by Subject|0|||
148731964|NCT03979820|536492538|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
148731965|NCT03979820|536492539|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
148731966|NCT03979820|536492540|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
148731967|NCT03979820|536492541|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
148731968|NCT00988065|536492542|FG000|Overall Study|Adverse Event|4|||
148731969|NCT00988065|536492543|FG001|Overall Study|Adverse Event|10|||
148731970|NCT00988065|536492544|FG002|Overall Study|Adverse Event|2|||
148817602|NCT02965456|536807319|FG000|Overall Study|Subject Request|22|||
148817603|NCT02965456|536807320|FG001|Overall Study|Subject Request|13|||
148817604|NCT02965456|536807319|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
148817605|NCT02965456|536807320|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
148731971|NCT00988065|536492542|FG000|Overall Study|Lost to Follow-up|1|||
148731972|NCT00988065|536492543|FG001|Overall Study|Lost to Follow-up|2|||
148731973|NCT00988065|536492544|FG002|Overall Study|Lost to Follow-up|2|||
148731974|NCT00988065|536492542|FG000|Overall Study|Subject withdrew consent|3|||
148731975|NCT00988065|536492543|FG001|Overall Study|Subject withdrew consent|5|||
148731976|NCT00988065|536492544|FG002|Overall Study|Subject withdrew consent|2|||
148731977|NCT00988065|536492542|FG000|Overall Study|Noncompliance with protocol|5|||
148731978|NCT00988065|536492543|FG001|Overall Study|Noncompliance with protocol|6|||
148731979|NCT00988065|536492544|FG002|Overall Study|Noncompliance with protocol|9|||
148731980|NCT01229735|536492545|FG000|Overall Study|Lack of Efficacy|8|||
148731981|NCT01229735|536492546|FG001|Overall Study|Lack of Efficacy|8|||
148817606|NCT02965456|536807319|FG000|Overall Study|Adverse Event|3|||
148731982|NCT01229735|536492545|FG000|Overall Study|Protocol Violation|13|||
148731983|NCT01229735|536492546|FG001|Overall Study|Protocol Violation|8|||
148731984|NCT01229735|536492545|FG000|Overall Study|Lost to Follow-up|0|||
148731985|NCT01229735|536492546|FG001|Overall Study|Lost to Follow-up|2|||
148731986|NCT01229735|536492545|FG000|Overall Study|Withdrawal by Subject|18|||
148731987|NCT01229735|536492546|FG001|Overall Study|Withdrawal by Subject|17|||
148731988|NCT01229735|536492545|FG000|Overall Study|Other Reason|13|||
148731989|NCT01229735|536492546|FG001|Overall Study|Other Reason|10|||
148731990|NCT01229735|536492545|FG000|Overall Study|SAE, non-fatal|0|||
148731991|NCT01229735|536492546|FG001|Overall Study|SAE, non-fatal|4|||
148731992|NCT01229735|536492545|FG000|Overall Study|AE, non-serious non-fatal|13|||
148731993|NCT01229735|536492546|FG001|Overall Study|AE, non-serious non-fatal|17|||
148731994|NCT01229735|536492545|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148731995|NCT01229735|536492546|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
148731996|NCT02130882|536492547|FG000|Overall Study|Withdrawal by Subject|0|||
148731997|NCT02130882|536492548|FG001|Overall Study|Withdrawal by Subject|1|||
148731998|NCT00502801|536492560|FG000|Treatment Period|Withdrawal by Subject|3|||
148731999|NCT00502801|536492560|FG000|Treatment Period|Adverse Event|7|||
148732000|NCT00502801|536492560|FG000|Treatment Period|Death|14|||
148732001|NCT00502801|536492560|FG000|Treatment Period|OTHER|30|||
148732002|NCT00502801|536492560|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
148732003|NCT00502801|536492560|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
148732004|NCT00502801|536492560|FG000|End of Therapy to Test of Cure|Death|3|||
148732005|NCT00502801|536492560|FG000|End of Therapy to Test of Cure|OTHER|2|||
148732006|NCT03176459|536492563|FG000|Overall Study|Lost to Follow-up|5|||
148732007|NCT03176459|536492564|FG001|Overall Study|Lost to Follow-up|7|||
148732008|NCT00446199|536492565|FG000|Overall Study|Adverse Event|7|||
148732009|NCT00446199|536492566|FG001|Overall Study|Adverse Event|4|||
148732010|NCT00446199|536492567|FG002|Overall Study|Adverse Event|6|||
148732011|NCT00446199|536492568|FG003|Overall Study|Adverse Event|4|||
148732012|NCT00446199|536492565|FG000|Overall Study|Lost to Follow-up|4|||
148732013|NCT00446199|536492566|FG001|Overall Study|Lost to Follow-up|5|||
148732014|NCT00446199|536492567|FG002|Overall Study|Lost to Follow-up|2|||
148732015|NCT00446199|536492568|FG003|Overall Study|Lost to Follow-up|6|||
148732016|NCT00446199|536492565|FG000|Overall Study|Protocol Violation|1|||
148732017|NCT00446199|536492566|FG001|Overall Study|Protocol Violation|2|||
148732018|NCT00446199|536492567|FG002|Overall Study|Protocol Violation|1|||
148732019|NCT00446199|536492568|FG003|Overall Study|Protocol Violation|3|||
148732020|NCT00446199|536492565|FG000|Overall Study|Withdrawal by Subject|2|||
148732021|NCT00446199|536492566|FG001|Overall Study|Withdrawal by Subject|5|||
148732022|NCT00446199|536492567|FG002|Overall Study|Withdrawal by Subject|9|||
148732023|NCT00446199|536492568|FG003|Overall Study|Withdrawal by Subject|10|||
148732024|NCT00446199|536492565|FG000|Overall Study|Site termination|2|||
148732025|NCT00446199|536492566|FG001|Overall Study|Site termination|0|||
148732026|NCT00446199|536492567|FG002|Overall Study|Site termination|0|||
148732027|NCT00446199|536492568|FG003|Overall Study|Site termination|1|||
148732028|NCT00446199|536492565|FG000|Overall Study|Randomization in Error|2|||
148732029|NCT00446199|536492566|FG001|Overall Study|Randomization in Error|0|||
148732030|NCT00446199|536492567|FG002|Overall Study|Randomization in Error|1|||
148732031|NCT00446199|536492568|FG003|Overall Study|Randomization in Error|1|||
148732032|NCT00446199|536492565|FG000|Overall Study|Lack of Efficacy|1|||
148732033|NCT00446199|536492566|FG001|Overall Study|Lack of Efficacy|0|||
148732034|NCT00446199|536492567|FG002|Overall Study|Lack of Efficacy|0|||
148732035|NCT00446199|536492568|FG003|Overall Study|Lack of Efficacy|1|||
148732036|NCT00446199|536492565|FG000|Overall Study|Non-compliant with study drug|1|||
148732037|NCT00446199|536492566|FG001|Overall Study|Non-compliant with study drug|0|||
148732038|NCT00446199|536492567|FG002|Overall Study|Non-compliant with study drug|5|||
148732039|NCT00446199|536492568|FG003|Overall Study|Non-compliant with study drug|0|||
148732040|NCT00446199|536492565|FG000|Overall Study|Non-compliant with visit schedule|1|||
148732041|NCT00446199|536492566|FG001|Overall Study|Non-compliant with visit schedule|1|||
148972655|NCT02161718|537383468|FG000|Post- Randomization Period|Lack of Efficacy|0|||
148972656|NCT02161718|537383469|FG001|Post- Randomization Period|Lack of Efficacy|0|||
148732042|NCT00446199|536492567|FG002|Overall Study|Non-compliant with visit schedule|1|||
148732043|NCT00446199|536492568|FG003|Overall Study|Non-compliant with visit schedule|2|||
148732044|NCT00446199|536492565|FG000|Overall Study|Hormone fear|0|||
148732045|NCT00446199|536492566|FG001|Overall Study|Hormone fear|0|||
148732046|NCT00446199|536492567|FG002|Overall Study|Hormone fear|0|||
148732047|NCT00446199|536492568|FG003|Overall Study|Hormone fear|1|||
148732048|NCT00446199|536492565|FG000|Overall Study|Lost interest in study participation|0|||
148732049|NCT00446199|536492566|FG001|Overall Study|Lost interest in study participation|1|||
148732050|NCT00446199|536492567|FG002|Overall Study|Lost interest in study participation|0|||
148732051|NCT00446199|536492568|FG003|Overall Study|Lost interest in study participation|0|||
148972657|NCT02161718|537383470|FG002|Post- Randomization Period|Lack of Efficacy|1|||
148732052|NCT00446199|536492565|FG000|Overall Study|In-/Exclusion criterion violated|2|||
148732053|NCT00446199|536492566|FG001|Overall Study|In-/Exclusion criterion violated|1|||
148817607|NCT02965456|536807320|FG001|Overall Study|Adverse Event|0|||
148972658|NCT02161718|537383468|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
148972659|NCT02161718|537383469|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
148972660|NCT02161718|537383470|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
148972661|NCT02161718|537383468|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
148972662|NCT02161718|537383469|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
148972663|NCT02161718|537383470|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
148972664|NCT02161718|537383468|FG000|Post- Randomization Period|Relocation|0|||
148972665|NCT02161718|537383469|FG001|Post- Randomization Period|Relocation|3|||
148972666|NCT02161718|537383470|FG002|Post- Randomization Period|Relocation|0|||
148972667|NCT02948842|537383479|FG000|Overall Study|Withdrawal by Subject|4|||
148972668|NCT02350309|537383482|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
148972669|NCT02350309|537383483|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
148972670|NCT02350309|537383484|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
148972671|NCT02350309|537383485|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
148972672|NCT02350309|537383486|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
148972673|NCT02350309|537383487|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
148972674|NCT02350309|537383482|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
148972675|NCT02350309|537383483|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
148972676|NCT02350309|537383484|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
148972677|NCT02350309|537383485|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
148972678|NCT02350309|537383486|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
148972679|NCT02350309|537383487|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
148972680|NCT01256710|537383488|FG000|Overall Study|Death|449|||
148972681|NCT01256710|537383488|FG000|Overall Study|System Explant|67|||
148972682|NCT01256710|537383488|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
148972683|NCT01256710|537383488|FG000|Overall Study|Lost to Follow-up|67|||
148972684|NCT01256710|537383488|FG000|Overall Study|Withdrawal by Subject|29|||
148972685|NCT01256710|537383488|FG000|Overall Study|Physician Decision|9|||
148972686|NCT01256710|537383488|FG000|Overall Study|Subject Noncompliance|2|||
148972687|NCT01256710|537383488|FG000|Overall Study|Study Terminated by Sponsor|273|||
148972688|NCT01205165|537383489|FG000|Overall Study|Lost to Follow-up|2|||
148972689|NCT00313612|537383498|FG000|Overall Study|Patient never received treatment|0|||
148972690|NCT00313612|537383499|FG001|Overall Study|Patient never received treatment|1|||
148972691|NCT01557400|537383500|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
148972692|NCT01557400|537383500|FG000|Overall Study|Adverse Event|3|||
148972693|NCT01557400|537383500|FG000|Overall Study|Lost to Follow-up|5|||
148972694|NCT01557400|537383500|FG000|Overall Study|Withdrawal by Subject|9|||
148972695|NCT01393405|537383509|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
148972696|NCT01393405|537383510|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
148972697|NCT01393405|537383511|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
148972698|NCT01393405|537383509|FG000|Induction Period (week1-16)|Adverse Event|16|||
148972699|NCT01393405|537383510|FG001|Induction Period (week1-16)|Adverse Event|0|||
148972700|NCT01393405|537383511|FG002|Induction Period (week1-16)|Adverse Event|0|||
148972701|NCT01393405|537383509|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
148972702|NCT01393405|537383510|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
148972703|NCT01393405|537383511|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
148972704|NCT01393405|537383509|FG000|Maintenance Period Week|Lack of Efficacy|0|||
148972705|NCT01393405|537383510|FG001|Maintenance Period Week|Lack of Efficacy|22|||
148972706|NCT01393405|537383511|FG002|Maintenance Period Week|Lack of Efficacy|22|||
148972707|NCT01393405|537383509|FG000|Maintenance Period Week|Adverse Event|0|||
148972708|NCT01393405|537383510|FG001|Maintenance Period Week|Adverse Event|5|||
148972709|NCT01393405|537383511|FG002|Maintenance Period Week|Adverse Event|2|||
148972710|NCT01393405|537383509|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
148972711|NCT01393405|537383510|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
148972712|NCT01393405|537383511|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
148972713|NCT01393405|537383509|FG000|Maintenance Period Week|Lost to Follow-up|0|||
148972714|NCT01393405|537383510|FG001|Maintenance Period Week|Lost to Follow-up|1|||
148972715|NCT01393405|537383511|FG002|Maintenance Period Week|Lost to Follow-up|0|||
148972716|NCT01434290|537383512|FG000|Overall Study|Protocol Violation|6|||
148972717|NCT01434290|537383513|FG001|Overall Study|Protocol Violation|3|||
148972718|NCT01434290|537383512|FG000|Overall Study|No protocol treatment|2|||
148972719|NCT01434290|537383513|FG001|Overall Study|No protocol treatment|4|||
148972720|NCT02281552|537383514|FG000|Overall Study|Medication error|1|||
148972721|NCT02281552|537383515|FG001|Overall Study|Medication error|0|||
148972722|NCT02281552|537383514|FG000|Overall Study|Insufficient clinical response|0|||
148972723|NCT02281552|537383515|FG001|Overall Study|Insufficient clinical response|1|||
148972724|NCT02281552|537383514|FG000|Overall Study|Adverse Event|3|||
148972725|NCT02281552|537383515|FG001|Overall Study|Adverse Event|9|||
148972726|NCT01224639|537383516|FG000|Overall Study|Withdrawal by Subject|0|||
148972727|NCT01224639|537383517|FG001|Overall Study|Withdrawal by Subject|0|||
148972728|NCT01224639|537383518|FG002|Overall Study|Withdrawal by Subject|0|||
148972729|NCT01224639|537383519|FG003|Overall Study|Withdrawal by Subject|0|||
148972730|NCT01224639|537383520|FG004|Overall Study|Withdrawal by Subject|2|||
149026589|NCT00819234|537574273|FG000|Overall Study|Adverse Event|0|||
149026590|NCT00819234|537574274|FG001|Overall Study|Adverse Event|0|||
149026591|NCT00819234|537574275|FG002|Overall Study|Adverse Event|1|||
149026592|NCT00819234|537574276|FG003|Overall Study|Adverse Event|0|||
149026593|NCT00819234|537574277|FG004|Overall Study|Adverse Event|0|||
149026594|NCT00819234|537574278|FG005|Overall Study|Adverse Event|2|||
149026595|NCT00819234|537574279|FG006|Overall Study|Adverse Event|0|||
149026596|NCT00819234|537574280|FG007|Overall Study|Adverse Event|0|||
149026597|NCT00819234|537574281|FG008|Overall Study|Adverse Event|0|||
149026598|NCT00819234|537574282|FG009|Overall Study|Adverse Event|0|||
149026599|NCT00819234|537574273|FG000|Overall Study|Physician Decision|0|||
149026600|NCT00819234|537574274|FG001|Overall Study|Physician Decision|0|||
149026601|NCT00819234|537574275|FG002|Overall Study|Physician Decision|0|||
149026602|NCT00819234|537574276|FG003|Overall Study|Physician Decision|1|||
149026603|NCT00819234|537574277|FG004|Overall Study|Physician Decision|0|||
149026604|NCT00819234|537574278|FG005|Overall Study|Physician Decision|0|||
149026605|NCT00819234|537574279|FG006|Overall Study|Physician Decision|0|||
149026606|NCT00819234|537574280|FG007|Overall Study|Physician Decision|0|||
149026607|NCT00819234|537574281|FG008|Overall Study|Physician Decision|0|||
149026608|NCT00819234|537574282|FG009|Overall Study|Physician Decision|2|||
149026609|NCT00819234|537574273|FG000|Overall Study|Protocol Violation|0|||
149026610|NCT00819234|537574274|FG001|Overall Study|Protocol Violation|0|||
149026611|NCT00819234|537574275|FG002|Overall Study|Protocol Violation|1|||
149026612|NCT00819234|537574276|FG003|Overall Study|Protocol Violation|0|||
149026613|NCT00819234|537574277|FG004|Overall Study|Protocol Violation|0|||
149026614|NCT00819234|537574278|FG005|Overall Study|Protocol Violation|0|||
149026615|NCT00819234|537574279|FG006|Overall Study|Protocol Violation|0|||
149026616|NCT00819234|537574280|FG007|Overall Study|Protocol Violation|0|||
149026617|NCT00819234|537574281|FG008|Overall Study|Protocol Violation|0|||
149026618|NCT00819234|537574282|FG009|Overall Study|Protocol Violation|0|||
149026619|NCT00819234|537574273|FG000|Overall Study|Lost to Follow-up|2|||
149026620|NCT00819234|537574274|FG001|Overall Study|Lost to Follow-up|2|||
149026621|NCT00819234|537574275|FG002|Overall Study|Lost to Follow-up|0|||
149026622|NCT00819234|537574276|FG003|Overall Study|Lost to Follow-up|2|||
149026623|NCT00819234|537574277|FG004|Overall Study|Lost to Follow-up|1|||
149026624|NCT00819234|537574278|FG005|Overall Study|Lost to Follow-up|1|||
149026625|NCT00819234|537574279|FG006|Overall Study|Lost to Follow-up|1|||
149026626|NCT00819234|537574280|FG007|Overall Study|Lost to Follow-up|1|||
149026627|NCT00819234|537574281|FG008|Overall Study|Lost to Follow-up|1|||
149026628|NCT00819234|537574282|FG009|Overall Study|Lost to Follow-up|2|||
149026629|NCT04011033|537574283|FG000|Overall Study|Physician Decision|2|||
149026630|NCT04011033|537574284|FG001|Overall Study|Physician Decision|3|||
149026631|NCT04011033|537574283|FG000|Overall Study|Withdrawal by Subject|1|||
149026632|NCT04011033|537574284|FG001|Overall Study|Withdrawal by Subject|0|||
149026633|NCT00209274|537574285|FG000|Overall Study|Missed visit|3|||
149026634|NCT00209274|537574286|FG001|Overall Study|Missed visit|2|||
149026635|NCT00209274|537574285|FG000|Overall Study|Death|32|||
149026636|NCT00209274|537574286|FG001|Overall Study|Death|15|||
149026637|NCT00209274|537574285|FG000|Overall Study|Withdrawal by Subject|30|||
149026638|NCT00209274|537574286|FG001|Overall Study|Withdrawal by Subject|15|||
149026639|NCT00209274|537574285|FG000|Overall Study|Randomized not treated (RNT)|6|||
149026640|NCT00209274|537574286|FG001|Overall Study|Randomized not treated (RNT)|15|||
149026641|NCT01394991|537574287|FG000|Overall Study|Adverse Event|0|||
149026642|NCT01394991|537574288|FG001|Overall Study|Adverse Event|4|||
149026643|NCT01394991|537574287|FG000|Overall Study|Lack of Efficacy|5|||
149026644|NCT01394991|537574288|FG001|Overall Study|Lack of Efficacy|7|||
149026645|NCT01394991|537574287|FG000|Overall Study|Lost to Follow-up|6|||
149026646|NCT01394991|537574288|FG001|Overall Study|Lost to Follow-up|8|||
149026647|NCT01394991|537574287|FG000|Overall Study|Physician Decision|1|||
149026648|NCT01394991|537574288|FG001|Overall Study|Physician Decision|3|||
149026649|NCT01394991|537574287|FG000|Overall Study|Protocol Violation|1|||
149026650|NCT01394991|537574288|FG001|Overall Study|Protocol Violation|1|||
149026651|NCT01394991|537574287|FG000|Overall Study|Withdrawal by Subject|20|||
149026652|NCT01394991|537574288|FG001|Overall Study|Withdrawal by Subject|17|||
149026653|NCT01394991|537574287|FG000|Overall Study|Chemotherapy Termination|10|||
149026654|NCT01394991|537574288|FG001|Overall Study|Chemotherapy Termination|15|||
149026655|NCT01394991|537574287|FG000|Overall Study|Disease Progression|7|||
149026656|NCT01394991|537574288|FG001|Overall Study|Disease Progression|7|||
149026657|NCT01394991|537574287|FG000|Overall Study|Prematurely Termination of Trial|9|||
149026658|NCT01394991|537574288|FG001|Overall Study|Prematurely Termination of Trial|10|||
149026659|NCT03073005|537574289|FG000|Overall Study|Death|6|||
149026660|NCT03073005|537574290|FG001|Overall Study|Death|0|||
149026661|NCT03073005|537574291|FG002|Overall Study|Death|7|||
149026662|NCT03073005|537574292|FG003|Overall Study|Death|0|||
149026663|NCT03073005|537574289|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
149026664|NCT03073005|537574290|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
149026665|NCT03073005|537574291|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
149026666|NCT03073005|537574292|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
149026667|NCT03073005|537574289|FG000|Overall Study|Lost to Follow-up|2|||
149026668|NCT03073005|537574290|FG001|Overall Study|Lost to Follow-up|2|||
149026669|NCT03073005|537574291|FG002|Overall Study|Lost to Follow-up|1|||
149026670|NCT03073005|537574292|FG003|Overall Study|Lost to Follow-up|2|||
149026671|NCT03073005|537574289|FG000|Overall Study|Withdrawal by Subject|0|||
149026672|NCT03073005|537574290|FG001|Overall Study|Withdrawal by Subject|4|||
149026673|NCT03073005|537574291|FG002|Overall Study|Withdrawal by Subject|4|||
149026674|NCT03073005|537574292|FG003|Overall Study|Withdrawal by Subject|4|||
149026675|NCT01734811|537574293|FG000|Overall Study|Lost to Follow-up|2|||
149026676|NCT01734811|537574294|FG001|Overall Study|Lost to Follow-up|3|||
149026677|NCT01734811|537574293|FG000|Overall Study|Withdrawal by Subject|2|||
149026678|NCT01734811|537574294|FG001|Overall Study|Withdrawal by Subject|0|||
149026679|NCT02427646|537574295|FG000|Overall Study|Lack of Efficacy|2|||
149026680|NCT02427646|537574296|FG001|Overall Study|Lack of Efficacy|3|||
149026681|NCT02427646|537574295|FG000|Overall Study|Physician Decision|1|||
149026682|NCT02427646|537574296|FG001|Overall Study|Physician Decision|4|||
149026683|NCT02427646|537574295|FG000|Overall Study|Protocol Violation|3|||
149026684|NCT02427646|537574296|FG001|Overall Study|Protocol Violation|3|||
149026685|NCT02427646|537574295|FG000|Overall Study|Bothersome hand weakness|2|||
149026686|NCT02427646|537574296|FG001|Overall Study|Bothersome hand weakness|4|||
149026687|NCT03824236|537574297|FG000|Overall Study|Lost to Follow-up|0|||
149026688|NCT03824236|537574298|FG001|Overall Study|Lost to Follow-up|0|||
149026689|NCT03824236|537574299|FG002|Overall Study|Lost to Follow-up|1|||
149026690|NCT01290094|537574300|FG000|Overall Study|Withdrawal by Subject|1|||
149026691|NCT01290094|537574300|FG000|Overall Study|Lost to Follow-up|5|||
149026692|NCT01101542|537574303|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
148732054|NCT00446199|536492567|FG002|Overall Study|In-/Exclusion criterion violated|2|||
148732055|NCT00446199|536492568|FG003|Overall Study|In-/Exclusion criterion violated|1|||
148732056|NCT00446199|536492565|FG000|Overall Study|Move|0|||
148732057|NCT00446199|536492566|FG001|Overall Study|Move|1|||
148732058|NCT00446199|536492567|FG002|Overall Study|Move|0|||
149026693|NCT01101542|537574303|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
149026694|NCT01101542|537574303|FG000|Year 4 Surveillance Period|Other|287|||
149026695|NCT01101542|537574303|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
149026696|NCT01101542|537574303|FG000|Year 5 Surveillance Period|Pregnancy|1|||
149026697|NCT01101542|537574303|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
149026698|NCT01101542|537574303|FG000|Year 6 Surveillance Period|Pregnancy|1|||
149026699|NCT01101542|537574303|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
148732059|NCT00446199|536492568|FG003|Overall Study|Move|0|||
148732060|NCT06218823|536494954|FG000|Overall Study|Death|3|||
149026700|NCT00701311|537574304|FG000|Overall Study|Lack of Efficacy|3|||
149026701|NCT00701311|537574304|FG000|Overall Study|Adverse Event|3|||
149026702|NCT00701311|537574304|FG000|Overall Study|Withdrawal by Subject|2|||
149026703|NCT01712685|537574305|FG000|Overall Study|pt declined to participate before trmt|1|||
148732061|NCT06218823|536494955|FG001|Overall Study|Death|0|||
148732062|NCT06218823|536494954|FG000|Overall Study|Lost to Follow-up|0|||
148732063|NCT06218823|536494955|FG001|Overall Study|Lost to Follow-up|2|||
148732064|NCT06077487|536494956|FG000|Overall Study|Withdrawal by Subject|0|||
148972731|NCT01224639|537383521|FG005|Overall Study|Withdrawal by Subject|0|||
148972732|NCT01224639|537383522|FG006|Overall Study|Withdrawal by Subject|1|||
148972733|NCT01224639|537383523|FG007|Overall Study|Withdrawal by Subject|1|||
148972734|NCT01224639|537383516|FG000|Overall Study|Adverse Event|0|||
148972735|NCT01224639|537383517|FG001|Overall Study|Adverse Event|0|||
148972736|NCT01224639|537383518|FG002|Overall Study|Adverse Event|0|||
148972737|NCT01224639|537383519|FG003|Overall Study|Adverse Event|0|||
148972738|NCT01224639|537383520|FG004|Overall Study|Adverse Event|0|||
148972739|NCT01224639|537383521|FG005|Overall Study|Adverse Event|0|||
148972740|NCT01224639|537383522|FG006|Overall Study|Adverse Event|0|||
148972741|NCT01224639|537383523|FG007|Overall Study|Adverse Event|1|||
148972742|NCT04365699|537383524|FG000|Overall Study|Death|2|||
148972743|NCT04365699|537383525|FG001|Overall Study|Death|5|||
148972744|NCT04365699|537383526|FG002|Overall Study|Death|15|||
148972745|NCT03925727|537383528|FG000|Overall Study|Adverse Event|4|||
148972746|NCT03925727|537383529|FG001|Overall Study|Adverse Event|0|||
148972747|NCT03925727|537383530|FG002|Overall Study|Adverse Event|3|||
148972748|NCT03925727|537383528|FG000|Overall Study|Protocol Violation|1|||
148972749|NCT03925727|537383529|FG001|Overall Study|Protocol Violation|2|||
148972750|NCT03925727|537383530|FG002|Overall Study|Protocol Violation|2|||
148972751|NCT03925727|537383528|FG000|Overall Study|Withdrawal by Subject|3|||
148972752|NCT03925727|537383529|FG001|Overall Study|Withdrawal by Subject|2|||
148972753|NCT03925727|537383530|FG002|Overall Study|Withdrawal by Subject|4|||
148972754|NCT03925727|537383528|FG000|Overall Study|Administrative Reasons|3|||
148972755|NCT03925727|537383529|FG001|Overall Study|Administrative Reasons|1|||
148972756|NCT03925727|537383530|FG002|Overall Study|Administrative Reasons|2|||
148972757|NCT03925727|537383528|FG000|Overall Study|Randomized in error or Disqualified|8|||
148972758|NCT03925727|537383529|FG001|Overall Study|Randomized in error or Disqualified|1|||
148972759|NCT03925727|537383530|FG002|Overall Study|Randomized in error or Disqualified|7|||
148972760|NCT01574352|537383533|FG000|Overall Study|Withdrawal by Subject|6|||
148972761|NCT01574352|537383534|FG001|Overall Study|Withdrawal by Subject|13|||
148972762|NCT01574352|537383533|FG000|Overall Study|Injury in non-camp related sport|1|||
148972763|NCT01574352|537383534|FG001|Overall Study|Injury in non-camp related sport|0|||
148972764|NCT06425458|537383535|FG000|Overall Study|Removed by study team|2|||
148972765|NCT06425458|537383535|FG000|Overall Study|Lost to Follow-up|5|||
148972766|NCT03945981|537383538|FG000|Overall Study|Lost to Follow-up|12|||
148972767|NCT03945981|537383538|FG000|Overall Study|Physician Decision|4|||
148972768|NCT03945981|537383538|FG000|Overall Study|Withdrawal by Subject|6|||
148972769|NCT03945981|537383538|FG000|Overall Study|Protocol Violation|1|||
148972770|NCT02283788|537383543|FG000|Overall Study|Adverse Event|1|||
148972771|NCT02283788|537383544|FG001|Overall Study|Adverse Event|3|||
148972772|NCT02283788|537383545|FG002|Overall Study|Adverse Event|5|||
148972773|NCT02283788|537383546|FG003|Overall Study|Adverse Event|1|||
148972774|NCT02283788|537383543|FG000|Overall Study|Withdrawal by Subject|0|||
148972775|NCT02283788|537383544|FG001|Overall Study|Withdrawal by Subject|1|||
148972776|NCT02283788|537383545|FG002|Overall Study|Withdrawal by Subject|0|||
148972777|NCT02283788|537383546|FG003|Overall Study|Withdrawal by Subject|1|||
148972778|NCT01101841|537385971|FG000|Overall Study|Adverse Event|15|||
148972779|NCT01101841|537385972|FG001|Overall Study|Adverse Event|15|||
148972780|NCT01101841|537385971|FG000|Overall Study|Lost to Follow-up|9|||
148972781|NCT01101841|537385972|FG001|Overall Study|Lost to Follow-up|3|||
148972782|NCT01101841|537385971|FG000|Overall Study|Withdrawal by Subject|21|||
148972783|NCT01101841|537385972|FG001|Overall Study|Withdrawal by Subject|40|||
148972784|NCT01101841|537385971|FG000|Overall Study|Protocol Violation|1|||
148972785|NCT01101841|537385972|FG001|Overall Study|Protocol Violation|1|||
148972786|NCT01101841|537385971|FG000|Overall Study|Physician Decision|0|||
148972787|NCT01101841|537385972|FG001|Overall Study|Physician Decision|2|||
148732065|NCT06077487|536494957|FG001|Overall Study|Withdrawal by Subject|1|||
148732066|NCT01288053|536494958|FG000|Overall Study|Death|1|||
148972788|NCT01101841|537385971|FG000|Overall Study|Lack of Efficacy|0|||
148972789|NCT01101841|537385972|FG001|Overall Study|Lack of Efficacy|2|||
148972790|NCT01101841|537385971|FG000|Overall Study|Other|0|||
148972791|NCT01101841|537385972|FG001|Overall Study|Other|1|||
148972792|NCT01101841|537385971|FG000|Overall Study|Suicidality Tracking Scale|3|||
148972793|NCT01101841|537385972|FG001|Overall Study|Suicidality Tracking Scale|1|||
148972794|NCT01101841|537385971|FG000|Overall Study|Eligibility Criteria|1|||
148972795|NCT01101841|537385972|FG001|Overall Study|Eligibility Criteria|2|||
148972796|NCT03756558|537385975|FG000|Overall Study|Death|1|||
148972797|NCT03756558|537385975|FG000|Overall Study|Lost to Follow-up|2|||
148732067|NCT03188666|536494959|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
148732068|NCT03188666|536494960|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
148972798|NCT03756558|537385975|FG000|Overall Study|Withdrawal by Subject|2|||
148972799|NCT02896400|537385977|FG000|1 Month Follow-up|Lost to Follow-up|7|||
148972800|NCT02896400|537385978|FG001|1 Month Follow-up|Lost to Follow-up|7|||
148732069|NCT03188666|536494961|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
148732070|NCT03188666|536494962|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
148732071|NCT03188666|536494959|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
148732072|NCT03188666|536494960|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
148732073|NCT03188666|536494961|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
148732074|NCT03188666|536494962|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
148732075|NCT03188666|536494959|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
148732076|NCT03188666|536494960|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
148732077|NCT03188666|536494961|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
148732078|NCT03188666|536494962|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
148732079|NCT03188666|536494959|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
148732080|NCT03188666|536494960|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
148732081|NCT03188666|536494961|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
148732082|NCT03188666|536494962|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
148732083|NCT02068092|536494963|FG000|Overall Study|Physician Decision|2|||
148732084|NCT02068092|536494963|FG000|Overall Study|Adverse Event|2|||
148732085|NCT02068092|536494963|FG000|Overall Study|Lost to Follow-up|4|||
148732086|NCT02068092|536494963|FG000|Overall Study|Withdrawal by Subject|2|||
148732087|NCT02799095|536494964|FG000|Part A|Adverse Event|1|||
148732088|NCT02799095|536494965|FG001|Part A|Adverse Event|0|||
148732089|NCT02799095|536494966|FG002|Part A|Adverse Event|1|||
148732090|NCT02799095|536494967|FG003|Part A|Adverse Event|4|||
148732091|NCT02799095|536494968|FG004|Part A|Adverse Event|1|||
148732092|NCT02799095|536494969|FG005|Part A|Adverse Event|0|||
148732093|NCT02799095|536494970|FG006|Part A|Adverse Event|0|||
148732094|NCT02799095|536494971|FG007|Part A|Adverse Event|0|||
148732095|NCT02799095|536494972|FG008|Part A|Adverse Event|0|||
148732096|NCT02799095|536494973|FG009|Part A|Adverse Event|0|||
148732097|NCT02799095|536494974|FG010|Part A|Adverse Event|0|||
148732098|NCT02799095|536494975|FG011|Part A|Adverse Event|0|||
148732099|NCT02799095|536494976|FG012|Part A|Adverse Event|0|||
148732100|NCT02799095|536494977|FG013|Part A|Adverse Event|0|||
148732101|NCT02799095|536494978|FG014|Part A|Adverse Event|0|||
148732102|NCT02799095|536494979|FG015|Part A|Adverse Event|0|||
148732103|NCT02799095|536494980|FG016|Part A|Adverse Event|0|||
148732104|NCT02799095|536494964|FG000|Part A|Death|0|||
148732105|NCT02799095|536494965|FG001|Part A|Death|0|||
148732106|NCT02799095|536494966|FG002|Part A|Death|0|||
148732107|NCT02799095|536494967|FG003|Part A|Death|0|||
148732108|NCT02799095|536494968|FG004|Part A|Death|0|||
148732109|NCT02799095|536494969|FG005|Part A|Death|0|||
148732110|NCT02799095|536494970|FG006|Part A|Death|3|||
148732111|NCT02799095|536494971|FG007|Part A|Death|0|||
148732112|NCT02799095|536494972|FG008|Part A|Death|0|||
148732113|NCT02799095|536494973|FG009|Part A|Death|0|||
148732114|NCT02799095|536494974|FG010|Part A|Death|0|||
148732115|NCT02799095|536494975|FG011|Part A|Death|0|||
148732116|NCT02799095|536494976|FG012|Part A|Death|0|||
148732117|NCT02799095|536494977|FG013|Part A|Death|0|||
148732118|NCT02799095|536494978|FG014|Part A|Death|0|||
148732119|NCT02799095|536494979|FG015|Part A|Death|0|||
148732120|NCT02799095|536494980|FG016|Part A|Death|0|||
148732121|NCT02799095|536494964|FG000|Part A|Lost to Follow-up|0|||
148732122|NCT02799095|536494965|FG001|Part A|Lost to Follow-up|1|||
148732123|NCT02799095|536494966|FG002|Part A|Lost to Follow-up|0|||
148732124|NCT02799095|536494967|FG003|Part A|Lost to Follow-up|0|||
148732125|NCT02799095|536494968|FG004|Part A|Lost to Follow-up|0|||
148732126|NCT02799095|536494969|FG005|Part A|Lost to Follow-up|0|||
148732127|NCT02799095|536494970|FG006|Part A|Lost to Follow-up|1|||
148732128|NCT02799095|536494971|FG007|Part A|Lost to Follow-up|0|||
148732129|NCT02799095|536494972|FG008|Part A|Lost to Follow-up|0|||
148732130|NCT02799095|536494973|FG009|Part A|Lost to Follow-up|0|||
148732131|NCT02799095|536494974|FG010|Part A|Lost to Follow-up|0|||
148732132|NCT02799095|536494975|FG011|Part A|Lost to Follow-up|0|||
148817608|NCT02965456|536807319|FG000|Overall Study|Noncompliance with Study Drug|1|||
148732133|NCT02799095|536494976|FG012|Part A|Lost to Follow-up|0|||
148732134|NCT02799095|536494977|FG013|Part A|Lost to Follow-up|0|||
148817609|NCT02965456|536807320|FG001|Overall Study|Noncompliance with Study Drug|1|||
148732135|NCT02799095|536494978|FG014|Part A|Lost to Follow-up|0|||
148732136|NCT02799095|536494979|FG015|Part A|Lost to Follow-up|0|||
148732137|NCT02799095|536494980|FG016|Part A|Lost to Follow-up|0|||
148732138|NCT02799095|536494964|FG000|Part A|Progressive Disease|3|||
148732139|NCT02799095|536494965|FG001|Part A|Progressive Disease|3|||
148732140|NCT02799095|536494966|FG002|Part A|Progressive Disease|3|||
148732141|NCT02799095|536494967|FG003|Part A|Progressive Disease|2|||
148732142|NCT02799095|536494968|FG004|Part A|Progressive Disease|2|||
148732143|NCT02799095|536494969|FG005|Part A|Progressive Disease|0|||
148817610|NCT02965456|536807319|FG000|Overall Study|Worsening Condition|0|||
148732144|NCT02799095|536494970|FG006|Part A|Progressive Disease|0|||
148732145|NCT02799095|536494971|FG007|Part A|Progressive Disease|0|||
148732146|NCT02799095|536494972|FG008|Part A|Progressive Disease|0|||
148732147|NCT02799095|536494973|FG009|Part A|Progressive Disease|0|||
148732148|NCT02799095|536494974|FG010|Part A|Progressive Disease|0|||
148732149|NCT02799095|536494975|FG011|Part A|Progressive Disease|0|||
148732150|NCT02799095|536494976|FG012|Part A|Progressive Disease|0|||
148732151|NCT02799095|536494977|FG013|Part A|Progressive Disease|0|||
148732152|NCT02799095|536494978|FG014|Part A|Progressive Disease|0|||
148732153|NCT02799095|536494979|FG015|Part A|Progressive Disease|0|||
148732154|NCT02799095|536494980|FG016|Part A|Progressive Disease|0|||
148732155|NCT02799095|536494964|FG000|Part A|Clinical Progression|1|||
148732156|NCT02799095|536494965|FG001|Part A|Clinical Progression|0|||
148732157|NCT02799095|536494966|FG002|Part A|Clinical Progression|2|||
148732158|NCT02799095|536494967|FG003|Part A|Clinical Progression|1|||
148732159|NCT02799095|536494968|FG004|Part A|Clinical Progression|5|||
148732160|NCT02799095|536494969|FG005|Part A|Clinical Progression|0|||
148732161|NCT02799095|536494970|FG006|Part A|Clinical Progression|0|||
148732162|NCT02799095|536494971|FG007|Part A|Clinical Progression|0|||
148732163|NCT02799095|536494972|FG008|Part A|Clinical Progression|0|||
148732164|NCT02799095|536494973|FG009|Part A|Clinical Progression|0|||
148732165|NCT02799095|536494974|FG010|Part A|Clinical Progression|0|||
148732166|NCT02799095|536494975|FG011|Part A|Clinical Progression|0|||
148732167|NCT02799095|536494976|FG012|Part A|Clinical Progression|0|||
148732168|NCT02799095|536494977|FG013|Part A|Clinical Progression|0|||
148732169|NCT02799095|536494978|FG014|Part A|Clinical Progression|0|||
148732170|NCT02799095|536494979|FG015|Part A|Clinical Progression|0|||
148732171|NCT02799095|536494980|FG016|Part A|Clinical Progression|0|||
148732172|NCT02799095|536494964|FG000|Part A|Protocol Deviation|0|||
148732173|NCT02799095|536494965|FG001|Part A|Protocol Deviation|0|||
148732174|NCT02799095|536494966|FG002|Part A|Protocol Deviation|1|||
148732175|NCT02799095|536494967|FG003|Part A|Protocol Deviation|0|||
148732176|NCT02799095|536494968|FG004|Part A|Protocol Deviation|0|||
148732177|NCT02799095|536494969|FG005|Part A|Protocol Deviation|0|||
148732178|NCT02799095|536494970|FG006|Part A|Protocol Deviation|0|||
148732179|NCT02799095|536494971|FG007|Part A|Protocol Deviation|0|||
148732180|NCT02799095|536494972|FG008|Part A|Protocol Deviation|0|||
148732181|NCT02799095|536494973|FG009|Part A|Protocol Deviation|0|||
148732182|NCT02799095|536494974|FG010|Part A|Protocol Deviation|0|||
148732183|NCT02799095|536494975|FG011|Part A|Protocol Deviation|0|||
148732184|NCT02799095|536494976|FG012|Part A|Protocol Deviation|0|||
148732185|NCT02799095|536494977|FG013|Part A|Protocol Deviation|0|||
148732186|NCT02799095|536494978|FG014|Part A|Protocol Deviation|0|||
148732187|NCT02799095|536494979|FG015|Part A|Protocol Deviation|0|||
148732188|NCT02799095|536494980|FG016|Part A|Protocol Deviation|0|||
148732189|NCT02799095|536494964|FG000|Part A|Withdrawal by Subject|0|||
148732190|NCT02799095|536494965|FG001|Part A|Withdrawal by Subject|0|||
148732191|NCT02799095|536494966|FG002|Part A|Withdrawal by Subject|0|||
148732192|NCT02799095|536494967|FG003|Part A|Withdrawal by Subject|1|||
148732193|NCT02799095|536494968|FG004|Part A|Withdrawal by Subject|3|||
148732194|NCT02799095|536494969|FG005|Part A|Withdrawal by Subject|1|||
148732195|NCT02799095|536494970|FG006|Part A|Withdrawal by Subject|1|||
148732196|NCT02799095|536494971|FG007|Part A|Withdrawal by Subject|0|||
148972801|NCT02896400|537385979|FG002|1 Month Follow-up|Lost to Follow-up|5|||
148972802|NCT02896400|537385980|FG003|1 Month Follow-up|Lost to Follow-up|8|||
148972803|NCT02896400|537385981|FG004|1 Month Follow-up|Lost to Follow-up|9|||
148972804|NCT02896400|537385982|FG005|1 Month Follow-up|Lost to Follow-up|6|||
148972805|NCT02896400|537385983|FG006|1 Month Follow-up|Lost to Follow-up|5|||
148972806|NCT02896400|537385984|FG007|1 Month Follow-up|Lost to Follow-up|6|||
148972807|NCT02896400|537385985|FG008|1 Month Follow-up|Lost to Follow-up|4|||
148972808|NCT02896400|537385986|FG009|1 Month Follow-up|Lost to Follow-up|7|||
148972809|NCT02896400|537385987|FG010|1 Month Follow-up|Lost to Follow-up|5|||
148972810|NCT02896400|537385988|FG011|1 Month Follow-up|Lost to Follow-up|5|||
148972811|NCT02896400|537385989|FG012|1 Month Follow-up|Lost to Follow-up|3|||
148972812|NCT02896400|537385990|FG013|1 Month Follow-up|Lost to Follow-up|4|||
148972813|NCT02896400|537385991|FG014|1 Month Follow-up|Lost to Follow-up|1|||
148972814|NCT02896400|537385992|FG015|1 Month Follow-up|Lost to Follow-up|2|||
148972815|NCT02896400|537385977|FG000|1 Month Follow-up|Death|0|||
148972816|NCT02896400|537385978|FG001|1 Month Follow-up|Death|0|||
148972817|NCT02896400|537385979|FG002|1 Month Follow-up|Death|0|||
148972818|NCT02896400|537385980|FG003|1 Month Follow-up|Death|0|||
148732197|NCT02799095|536494972|FG008|Part A|Withdrawal by Subject|0|||
148732198|NCT02799095|536494973|FG009|Part A|Withdrawal by Subject|0|||
148732199|NCT02799095|536494974|FG010|Part A|Withdrawal by Subject|0|||
148972819|NCT02896400|537385981|FG004|1 Month Follow-up|Death|0|||
148972820|NCT02896400|537385982|FG005|1 Month Follow-up|Death|0|||
148972821|NCT02896400|537385983|FG006|1 Month Follow-up|Death|0|||
148732200|NCT02799095|536494975|FG011|Part A|Withdrawal by Subject|0|||
148732201|NCT02799095|536494976|FG012|Part A|Withdrawal by Subject|0|||
148972822|NCT02896400|537385984|FG007|1 Month Follow-up|Death|0|||
148972823|NCT02896400|537385985|FG008|1 Month Follow-up|Death|0|||
148972824|NCT02896400|537385986|FG009|1 Month Follow-up|Death|0|||
148732202|NCT02799095|536494977|FG013|Part A|Withdrawal by Subject|0|||
148732203|NCT02799095|536494978|FG014|Part A|Withdrawal by Subject|0|||
148732204|NCT02799095|536494979|FG015|Part A|Withdrawal by Subject|0|||
148732205|NCT02799095|536494980|FG016|Part A|Withdrawal by Subject|0|||
148732206|NCT02799095|536494964|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
148732207|NCT02799095|536494965|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
148732208|NCT02799095|536494966|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
148732209|NCT02799095|536494967|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
148732210|NCT02799095|536494968|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
148732211|NCT02799095|536494969|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
148732212|NCT02799095|536494970|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
148732213|NCT02799095|536494971|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
148732214|NCT02799095|536494972|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
148732215|NCT02799095|536494973|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
148732216|NCT02799095|536494974|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
148732217|NCT02799095|536494975|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
148972825|NCT02896400|537385987|FG010|1 Month Follow-up|Death|0|||
148972826|NCT02896400|537385988|FG011|1 Month Follow-up|Death|0|||
148972827|NCT02896400|537385989|FG012|1 Month Follow-up|Death|0|||
148972828|NCT02896400|537385990|FG013|1 Month Follow-up|Death|0|||
148732218|NCT02799095|536494976|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
148732219|NCT02799095|536494977|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
148732220|NCT02799095|536494978|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
148732221|NCT02799095|536494979|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
148732222|NCT02799095|536494980|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
148732223|NCT02799095|536494964|FG000|Part B|Death|0|||
148732224|NCT02799095|536494965|FG001|Part B|Death|0|||
148732225|NCT02799095|536494966|FG002|Part B|Death|0|||
148732226|NCT02799095|536494967|FG003|Part B|Death|0|||
148732227|NCT02799095|536494968|FG004|Part B|Death|0|||
148732228|NCT02799095|536494969|FG005|Part B|Death|0|||
148732229|NCT02799095|536494970|FG006|Part B|Death|0|||
148732230|NCT02799095|536494971|FG007|Part B|Death|7|||
148732231|NCT02799095|536494972|FG008|Part B|Death|7|||
148732232|NCT02799095|536494973|FG009|Part B|Death|0|||
148732233|NCT02799095|536494974|FG010|Part B|Death|0|||
148732234|NCT02799095|536494975|FG011|Part B|Death|0|||
148732235|NCT02799095|536494976|FG012|Part B|Death|0|||
148732236|NCT02799095|536494977|FG013|Part B|Death|0|||
148732237|NCT02799095|536494978|FG014|Part B|Death|0|||
148732238|NCT02799095|536494979|FG015|Part B|Death|0|||
148732239|NCT02799095|536494980|FG016|Part B|Death|0|||
148732240|NCT02799095|536494964|FG000|Part B|Progressive Disease|0|||
148732241|NCT02799095|536494965|FG001|Part B|Progressive Disease|0|||
148732242|NCT02799095|536494966|FG002|Part B|Progressive Disease|0|||
148732243|NCT02799095|536494967|FG003|Part B|Progressive Disease|0|||
148732244|NCT02799095|536494968|FG004|Part B|Progressive Disease|0|||
148732245|NCT02799095|536494969|FG005|Part B|Progressive Disease|0|||
148732246|NCT02799095|536494970|FG006|Part B|Progressive Disease|0|||
148732247|NCT02799095|536494971|FG007|Part B|Progressive Disease|1|||
148732248|NCT02799095|536494972|FG008|Part B|Progressive Disease|0|||
148732249|NCT02799095|536494973|FG009|Part B|Progressive Disease|0|||
148732250|NCT02799095|536494974|FG010|Part B|Progressive Disease|0|||
148732251|NCT02799095|536494975|FG011|Part B|Progressive Disease|0|||
148732252|NCT02799095|536494976|FG012|Part B|Progressive Disease|0|||
148972829|NCT02896400|537385991|FG014|1 Month Follow-up|Death|0|||
148972830|NCT02896400|537385992|FG015|1 Month Follow-up|Death|1|||
148972831|NCT02896400|537385977|FG000|3 Month Follow-up|Lost to Follow-up|6|||
148972832|NCT02896400|537385978|FG001|3 Month Follow-up|Lost to Follow-up|3|||
148972833|NCT02896400|537385979|FG002|3 Month Follow-up|Lost to Follow-up|6|||
148972834|NCT02896400|537385980|FG003|3 Month Follow-up|Lost to Follow-up|11|||
148972835|NCT02896400|537385981|FG004|3 Month Follow-up|Lost to Follow-up|12|||
148972836|NCT02896400|537385982|FG005|3 Month Follow-up|Lost to Follow-up|6|||
148972837|NCT02896400|537385983|FG006|3 Month Follow-up|Lost to Follow-up|4|||
148972838|NCT02896400|537385984|FG007|3 Month Follow-up|Lost to Follow-up|3|||
148972839|NCT02896400|537385985|FG008|3 Month Follow-up|Lost to Follow-up|6|||
148732253|NCT02799095|536494977|FG013|Part B|Progressive Disease|0|||
148732254|NCT02799095|536494978|FG014|Part B|Progressive Disease|0|||
148732255|NCT02799095|536494979|FG015|Part B|Progressive Disease|0|||
148732256|NCT02799095|536494980|FG016|Part B|Progressive Disease|0|||
148732257|NCT02799095|536494964|FG000|Part B|Withdrawal by Subject|0|||
148732258|NCT02799095|536494965|FG001|Part B|Withdrawal by Subject|0|||
148732259|NCT02799095|536494966|FG002|Part B|Withdrawal by Subject|0|||
148732260|NCT02799095|536494967|FG003|Part B|Withdrawal by Subject|0|||
148732261|NCT02799095|536494968|FG004|Part B|Withdrawal by Subject|0|||
148732262|NCT02799095|536494969|FG005|Part B|Withdrawal by Subject|0|||
148732263|NCT02799095|536494970|FG006|Part B|Withdrawal by Subject|0|||
148732264|NCT02799095|536494971|FG007|Part B|Withdrawal by Subject|10|||
148732265|NCT02799095|536494972|FG008|Part B|Withdrawal by Subject|7|||
148732266|NCT02799095|536494973|FG009|Part B|Withdrawal by Subject|0|||
148972840|NCT02896400|537385986|FG009|3 Month Follow-up|Lost to Follow-up|5|||
149026704|NCT01871285|537574306|FG000|First Intervention (1 Day)|Adverse Event|1|||
148732267|NCT02799095|536494974|FG010|Part B|Withdrawal by Subject|0|||
148732268|NCT02799095|536494975|FG011|Part B|Withdrawal by Subject|0|||
148732269|NCT02799095|536494976|FG012|Part B|Withdrawal by Subject|0|||
148732270|NCT02799095|536494977|FG013|Part B|Withdrawal by Subject|0|||
148972841|NCT02896400|537385987|FG010|3 Month Follow-up|Lost to Follow-up|6|||
148972842|NCT02896400|537385988|FG011|3 Month Follow-up|Lost to Follow-up|6|||
148732271|NCT02799095|536494978|FG014|Part B|Withdrawal by Subject|0|||
148732272|NCT02799095|536494979|FG015|Part B|Withdrawal by Subject|0|||
148732273|NCT02799095|536494980|FG016|Part B|Withdrawal by Subject|0|||
148732274|NCT02799095|536494964|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
148972843|NCT02896400|537385989|FG012|3 Month Follow-up|Lost to Follow-up|3|||
148972844|NCT02896400|537385990|FG013|3 Month Follow-up|Lost to Follow-up|5|||
148972845|NCT02896400|537385991|FG014|3 Month Follow-up|Lost to Follow-up|3|||
148972846|NCT02896400|537385992|FG015|3 Month Follow-up|Lost to Follow-up|2|||
148972847|NCT02896400|537385977|FG000|3 Month Follow-up|Death|0|||
148972848|NCT02896400|537385978|FG001|3 Month Follow-up|Death|0|||
148972849|NCT02896400|537385979|FG002|3 Month Follow-up|Death|0|||
148972850|NCT02896400|537385980|FG003|3 Month Follow-up|Death|0|||
148972851|NCT02896400|537385981|FG004|3 Month Follow-up|Death|0|||
148972852|NCT02896400|537385982|FG005|3 Month Follow-up|Death|0|||
148972853|NCT02896400|537385983|FG006|3 Month Follow-up|Death|0|||
148972854|NCT02896400|537385984|FG007|3 Month Follow-up|Death|0|||
148972855|NCT02896400|537385985|FG008|3 Month Follow-up|Death|0|||
148972856|NCT02896400|537385986|FG009|3 Month Follow-up|Death|0|||
148972857|NCT02896400|537385987|FG010|3 Month Follow-up|Death|0|||
148972858|NCT02896400|537385988|FG011|3 Month Follow-up|Death|0|||
148972859|NCT02896400|537385989|FG012|3 Month Follow-up|Death|0|||
148972860|NCT02896400|537385990|FG013|3 Month Follow-up|Death|1|||
148972861|NCT02896400|537385991|FG014|3 Month Follow-up|Death|1|||
148972862|NCT02896400|537385992|FG015|3 Month Follow-up|Death|0|||
148972863|NCT02896400|537385977|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972864|NCT02896400|537385978|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
148972865|NCT02896400|537385979|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972866|NCT02896400|537385980|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972867|NCT02896400|537385981|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
148972868|NCT02896400|537385982|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972869|NCT02896400|537385983|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
148972870|NCT02896400|537385984|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
148972871|NCT02896400|537385985|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972872|NCT02896400|537385986|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972873|NCT02896400|537385987|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
148972874|NCT02896400|537385988|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
148972875|NCT02896400|537385989|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972876|NCT02896400|537385990|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
148972877|NCT02896400|537385991|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
148972878|NCT02896400|537385992|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
148972879|NCT02896400|537385977|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
148972880|NCT02896400|537385978|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
148972881|NCT02896400|537385979|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
148972882|NCT02896400|537385980|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
148972883|NCT02896400|537385981|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
148972884|NCT02896400|537385982|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
148972885|NCT02896400|537385983|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
148972886|NCT02896400|537385984|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
148972887|NCT02896400|537385985|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
148972888|NCT02896400|537385986|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
148972889|NCT02896400|537385987|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
148972890|NCT02896400|537385988|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
148972891|NCT02896400|537385989|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
148972892|NCT02896400|537385990|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
148972893|NCT02896400|537385991|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
148732275|NCT02799095|536494965|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
148732276|NCT02799095|536494966|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
148732277|NCT02799095|536494967|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
148972894|NCT02896400|537385992|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
148972895|NCT02984020|537385993|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
148972896|NCT02984020|537385993|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
148972897|NCT02984020|537385993|FG000|Overall Study|Other significant protocol violation|2|||
148972898|NCT01700179|537385994|FG000|Overall Study|Physician Decision|2|||
148972899|NCT01896895|537385995|FG000|Double-blind MP|Physician Decision|0|||
148972900|NCT01896895|537385996|FG001|Double-blind MP|Physician Decision|0|||
148972901|NCT01896895|537385997|FG002|Double-blind MP|Physician Decision|1|||
148972902|NCT01896895|537385998|FG003|Double-blind MP|Physician Decision|0|||
148972903|NCT01896895|537385995|FG000|Double-blind MP|Withdrawal by Subject|0|||
148817611|NCT02965456|536807320|FG001|Overall Study|Worsening Condition|2|||
148732278|NCT02799095|536494968|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
148732279|NCT02799095|536494969|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
148732280|NCT02799095|536494970|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
148732281|NCT02799095|536494971|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
148732282|NCT02799095|536494972|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
148732283|NCT02799095|536494973|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
148732284|NCT02799095|536494974|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
148732285|NCT02799095|536494975|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
148732286|NCT02799095|536494976|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
148732287|NCT02799095|536494977|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
148732288|NCT02799095|536494978|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
148732289|NCT02799095|536494979|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
148732290|NCT02799095|536494980|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
148732291|NCT02799095|536494964|FG000|Part C|Adverse Event|0|||
148732292|NCT02799095|536494965|FG001|Part C|Adverse Event|0|||
148732293|NCT02799095|536494966|FG002|Part C|Adverse Event|0|||
148732294|NCT02799095|536494967|FG003|Part C|Adverse Event|0|||
148732295|NCT02799095|536494968|FG004|Part C|Adverse Event|0|||
148732296|NCT02799095|536494969|FG005|Part C|Adverse Event|0|||
148732297|NCT02799095|536494970|FG006|Part C|Adverse Event|0|||
148732298|NCT02799095|536494971|FG007|Part C|Adverse Event|0|||
148732299|NCT02799095|536494972|FG008|Part C|Adverse Event|0|||
148732300|NCT02799095|536494973|FG009|Part C|Adverse Event|0|||
148732301|NCT02799095|536494974|FG010|Part C|Adverse Event|3|||
148732302|NCT02799095|536494975|FG011|Part C|Adverse Event|1|||
148732303|NCT02799095|536494976|FG012|Part C|Adverse Event|0|||
148732304|NCT02799095|536494977|FG013|Part C|Adverse Event|1|||
148732305|NCT02799095|536494978|FG014|Part C|Adverse Event|0|||
148732306|NCT02799095|536494979|FG015|Part C|Adverse Event|0|||
148732307|NCT02799095|536494980|FG016|Part C|Adverse Event|0|||
148732308|NCT02799095|536494964|FG000|Part C|Death|0|||
148732309|NCT02799095|536494965|FG001|Part C|Death|0|||
148732310|NCT02799095|536494966|FG002|Part C|Death|0|||
148732311|NCT02799095|536494967|FG003|Part C|Death|0|||
148732312|NCT02799095|536494968|FG004|Part C|Death|0|||
148732313|NCT02799095|536494969|FG005|Part C|Death|0|||
148732314|NCT02799095|536494970|FG006|Part C|Death|0|||
148732315|NCT02799095|536494971|FG007|Part C|Death|0|||
148732316|NCT02799095|536494972|FG008|Part C|Death|0|||
148732317|NCT02799095|536494973|FG009|Part C|Death|0|||
148732318|NCT02799095|536494974|FG010|Part C|Death|7|||
148732319|NCT02799095|536494975|FG011|Part C|Death|5|||
148732320|NCT02799095|536494976|FG012|Part C|Death|6|||
148732321|NCT02799095|536494977|FG013|Part C|Death|8|||
148732322|NCT02799095|536494978|FG014|Part C|Death|1|||
148732323|NCT02799095|536494979|FG015|Part C|Death|8|||
148732324|NCT02799095|536494980|FG016|Part C|Death|1|||
148732325|NCT02799095|536494964|FG000|Part C|Lost to Follow-up|0|||
148732326|NCT02799095|536494965|FG001|Part C|Lost to Follow-up|0|||
148732327|NCT02799095|536494966|FG002|Part C|Lost to Follow-up|0|||
148732328|NCT02799095|536494967|FG003|Part C|Lost to Follow-up|0|||
148732329|NCT02799095|536494968|FG004|Part C|Lost to Follow-up|0|||
148732330|NCT02799095|536494969|FG005|Part C|Lost to Follow-up|0|||
148732331|NCT02799095|536494970|FG006|Part C|Lost to Follow-up|0|||
148732332|NCT02799095|536494971|FG007|Part C|Lost to Follow-up|0|||
148732333|NCT02799095|536494972|FG008|Part C|Lost to Follow-up|0|||
148732334|NCT02799095|536494973|FG009|Part C|Lost to Follow-up|0|||
148732335|NCT02799095|536494974|FG010|Part C|Lost to Follow-up|1|||
148732336|NCT02799095|536494975|FG011|Part C|Lost to Follow-up|1|||
148732337|NCT02799095|536494976|FG012|Part C|Lost to Follow-up|1|||
148732338|NCT02799095|536494977|FG013|Part C|Lost to Follow-up|3|||
148732339|NCT02799095|536494978|FG014|Part C|Lost to Follow-up|0|||
148732340|NCT02799095|536494979|FG015|Part C|Lost to Follow-up|0|||
148732341|NCT02799095|536494980|FG016|Part C|Lost to Follow-up|0|||
148732342|NCT02799095|536494964|FG000|Part C|Progressive Disease|0|||
148732343|NCT02799095|536494965|FG001|Part C|Progressive Disease|0|||
148732344|NCT02799095|536494966|FG002|Part C|Progressive Disease|0|||
148732345|NCT02799095|536494967|FG003|Part C|Progressive Disease|0|||
148732346|NCT02799095|536494968|FG004|Part C|Progressive Disease|0|||
148732347|NCT02799095|536494969|FG005|Part C|Progressive Disease|0|||
148732348|NCT02799095|536494970|FG006|Part C|Progressive Disease|0|||
148732349|NCT02799095|536494971|FG007|Part C|Progressive Disease|0|||
148732350|NCT02799095|536494972|FG008|Part C|Progressive Disease|0|||
148732351|NCT02799095|536494973|FG009|Part C|Progressive Disease|2|||
148732352|NCT02799095|536494974|FG010|Part C|Progressive Disease|13|||
148732353|NCT02799095|536494975|FG011|Part C|Progressive Disease|2|||
148732354|NCT02799095|536494976|FG012|Part C|Progressive Disease|0|||
148732355|NCT02799095|536494977|FG013|Part C|Progressive Disease|1|||
148732356|NCT02799095|536494978|FG014|Part C|Progressive Disease|0|||
148732357|NCT02799095|536494979|FG015|Part C|Progressive Disease|0|||
148732358|NCT02799095|536494980|FG016|Part C|Progressive Disease|0|||
148732359|NCT02799095|536494964|FG000|Part C|Clinical Progression|0|||
148732360|NCT02799095|536494965|FG001|Part C|Clinical Progression|0|||
148732361|NCT02799095|536494966|FG002|Part C|Clinical Progression|0|||
148732362|NCT02799095|536494967|FG003|Part C|Clinical Progression|0|||
148732363|NCT02799095|536494968|FG004|Part C|Clinical Progression|0|||
148972904|NCT01896895|537385996|FG001|Double-blind MP|Withdrawal by Subject|2|||
148972905|NCT01896895|537385997|FG002|Double-blind MP|Withdrawal by Subject|1|||
148972906|NCT01896895|537385998|FG003|Double-blind MP|Withdrawal by Subject|0|||
148972907|NCT01896895|537385995|FG000|Double-blind MP|Lost to Follow-up|1|||
148972908|NCT01896895|537385996|FG001|Double-blind MP|Lost to Follow-up|0|||
148972909|NCT01896895|537385997|FG002|Double-blind MP|Lost to Follow-up|1|||
148972910|NCT01896895|537385998|FG003|Double-blind MP|Lost to Follow-up|0|||
148972911|NCT00667342|537385999|FG000|Overall Study|Protocol Violation|1|||
148972912|NCT00667342|537386000|FG001|Overall Study|Protocol Violation|0|||
148972913|NCT00667342|537386001|FG002|Overall Study|Protocol Violation|0|||
148972914|NCT00667342|537385999|FG000|Overall Study|Withdrawal by Subject|1|||
148972915|NCT00667342|537386000|FG001|Overall Study|Withdrawal by Subject|0|||
148972916|NCT00667342|537386001|FG002|Overall Study|Withdrawal by Subject|0|||
148972917|NCT00667342|537385999|FG000|Overall Study|Physician Decision|3|||
148972918|NCT00667342|537386000|FG001|Overall Study|Physician Decision|0|||
148972919|NCT00667342|537386001|FG002|Overall Study|Physician Decision|0|||
148972920|NCT00667342|537385999|FG000|Overall Study|Relapse or tumor progression|9|||
148972921|NCT00667342|537386000|FG001|Overall Study|Relapse or tumor progression|0|||
148972922|NCT00667342|537386001|FG002|Overall Study|Relapse or tumor progression|7|||
148732364|NCT02799095|536494969|FG005|Part C|Clinical Progression|0|||
148732365|NCT02799095|536494970|FG006|Part C|Clinical Progression|0|||
148732366|NCT02799095|536494971|FG007|Part C|Clinical Progression|0|||
148732367|NCT02799095|536494972|FG008|Part C|Clinical Progression|0|||
148732368|NCT02799095|536494973|FG009|Part C|Clinical Progression|1|||
148732369|NCT02799095|536494974|FG010|Part C|Clinical Progression|3|||
148732370|NCT02799095|536494975|FG011|Part C|Clinical Progression|0|||
148732371|NCT02799095|536494976|FG012|Part C|Clinical Progression|0|||
148732372|NCT02799095|536494977|FG013|Part C|Clinical Progression|1|||
148732373|NCT02799095|536494978|FG014|Part C|Clinical Progression|0|||
148732374|NCT02799095|536494979|FG015|Part C|Clinical Progression|0|||
148732375|NCT02799095|536494980|FG016|Part C|Clinical Progression|0|||
148732376|NCT02799095|536494964|FG000|Part C|Withdrawal by Subject|0|||
148732377|NCT02799095|536494965|FG001|Part C|Withdrawal by Subject|0|||
148732378|NCT02799095|536494966|FG002|Part C|Withdrawal by Subject|0|||
148732379|NCT02799095|536494967|FG003|Part C|Withdrawal by Subject|0|||
148732380|NCT02799095|536494968|FG004|Part C|Withdrawal by Subject|0|||
148732381|NCT02799095|536494969|FG005|Part C|Withdrawal by Subject|0|||
148732382|NCT02799095|536494970|FG006|Part C|Withdrawal by Subject|0|||
148732383|NCT02799095|536494971|FG007|Part C|Withdrawal by Subject|0|||
148732384|NCT02799095|536494972|FG008|Part C|Withdrawal by Subject|0|||
148732385|NCT02799095|536494973|FG009|Part C|Withdrawal by Subject|0|||
148732386|NCT02799095|536494974|FG010|Part C|Withdrawal by Subject|13|||
148732387|NCT02799095|536494975|FG011|Part C|Withdrawal by Subject|15|||
148732388|NCT02799095|536494976|FG012|Part C|Withdrawal by Subject|13|||
148732389|NCT02799095|536494977|FG013|Part C|Withdrawal by Subject|21|||
148732390|NCT02799095|536494978|FG014|Part C|Withdrawal by Subject|0|||
148732391|NCT02799095|536494979|FG015|Part C|Withdrawal by Subject|12|||
148732392|NCT02799095|536494980|FG016|Part C|Withdrawal by Subject|1|||
148732393|NCT02799095|536494964|FG000|Part C|Physician Decision|0|||
148732394|NCT02799095|536494965|FG001|Part C|Physician Decision|0|||
148732395|NCT02799095|536494966|FG002|Part C|Physician Decision|0|||
148732396|NCT02799095|536494967|FG003|Part C|Physician Decision|0|||
148732397|NCT02799095|536494968|FG004|Part C|Physician Decision|0|||
148732398|NCT02799095|536494969|FG005|Part C|Physician Decision|0|||
148732399|NCT02799095|536494970|FG006|Part C|Physician Decision|0|||
148732400|NCT02799095|536494971|FG007|Part C|Physician Decision|0|||
148732401|NCT02799095|536494972|FG008|Part C|Physician Decision|0|||
148732402|NCT02799095|536494973|FG009|Part C|Physician Decision|0|||
148732403|NCT02799095|536494974|FG010|Part C|Physician Decision|1|||
148732404|NCT02799095|536494975|FG011|Part C|Physician Decision|0|||
148732405|NCT02799095|536494976|FG012|Part C|Physician Decision|0|||
148732406|NCT02799095|536494977|FG013|Part C|Physician Decision|0|||
148817612|NCT02965456|536807319|FG000|Overall Study|Lack of Efficacy|1|||
148732407|NCT02799095|536494978|FG014|Part C|Physician Decision|0|||
148732408|NCT02799095|536494979|FG015|Part C|Physician Decision|0|||
148732409|NCT02799095|536494980|FG016|Part C|Physician Decision|0|||
148732410|NCT02799095|536494964|FG000|Part C|Other|0|||
148732411|NCT02799095|536494965|FG001|Part C|Other|0|||
148817613|NCT02965456|536807320|FG001|Overall Study|Lack of Efficacy|0|||
148972923|NCT00667342|537385999|FG000|Overall Study|Adverse Event|0|||
148972924|NCT00667342|537386000|FG001|Overall Study|Adverse Event|0|||
148972925|NCT00667342|537386001|FG002|Overall Study|Adverse Event|1|||
148972926|NCT00667342|537385999|FG000|Overall Study|Ineligible|0|||
148972927|NCT00667342|537386000|FG001|Overall Study|Ineligible|0|||
148732412|NCT02799095|536494966|FG002|Part C|Other|0|||
148732413|NCT02799095|536494967|FG003|Part C|Other|0|||
148732414|NCT02799095|536494968|FG004|Part C|Other|0|||
148732415|NCT02799095|536494969|FG005|Part C|Other|0|||
148732416|NCT02799095|536494970|FG006|Part C|Other|0|||
148732417|NCT02799095|536494971|FG007|Part C|Other|0|||
148732418|NCT02799095|536494972|FG008|Part C|Other|0|||
148732419|NCT02799095|536494973|FG009|Part C|Other|0|||
148817614|NCT02965456|536807319|FG000|Overall Study|Physician Decision|0|||
148972928|NCT00667342|537386001|FG002|Overall Study|Ineligible|1|||
148972929|NCT00646204|537386004|FG000|Overall Study|Adverse Event|3|||
148732420|NCT02799095|536494974|FG010|Part C|Other|0|||
148732421|NCT02799095|536494975|FG011|Part C|Other|2|||
148732422|NCT02799095|536494976|FG012|Part C|Other|2|||
148732423|NCT02799095|536494977|FG013|Part C|Other|0|||
148732424|NCT02799095|536494978|FG014|Part C|Other|0|||
148732425|NCT02799095|536494979|FG015|Part C|Other|0|||
148732426|NCT02799095|536494980|FG016|Part C|Other|0|||
148732427|NCT01933113|536494981|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
148732428|NCT02297438|536494982|FG000|Overall Study|Death|79|||
148732429|NCT02297438|536494983|FG001|Overall Study|Death|86|||
148732430|NCT02297438|536494982|FG000|Overall Study|Lost to Follow-up|9|||
148732431|NCT02297438|536494983|FG001|Overall Study|Lost to Follow-up|7|||
148732432|NCT02297438|536494982|FG000|Overall Study|Withdrawal by Subject|7|||
148732433|NCT02297438|536494983|FG001|Overall Study|Withdrawal by Subject|0|||
148732434|NCT02297438|536494982|FG000|Overall Study|Other|9|||
148732435|NCT02297438|536494983|FG001|Overall Study|Other|5|||
148732436|NCT02297438|536494982|FG000|Overall Study|Ongoing|65|||
148732437|NCT02297438|536494983|FG001|Overall Study|Ongoing|73|||
148732438|NCT02935686|536494985|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
148732439|NCT02935686|536494986|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
148732440|NCT02935686|536494987|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
148732441|NCT02935686|536494988|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
148732442|NCT02935686|536494989|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
148732443|NCT02935686|536494985|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
148732444|NCT02935686|536494986|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
148732445|NCT02935686|536494987|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
148732446|NCT02935686|536494988|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
148732447|NCT02935686|536494989|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
148732448|NCT02935686|536494985|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
148732449|NCT02935686|536494986|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
148732450|NCT02935686|536494987|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
148732451|NCT02935686|536494988|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
148732452|NCT02935686|536494989|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
148732453|NCT02935686|536494985|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
148732454|NCT02935686|536494986|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
148732455|NCT02935686|536494987|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
148732456|NCT02935686|536494988|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
148732457|NCT02935686|536494989|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
148732458|NCT02935686|536494985|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
148732459|NCT02935686|536494986|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
148732460|NCT02935686|536494987|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
148732461|NCT02935686|536494988|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
148732462|NCT02935686|536494989|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
148732463|NCT02935686|536494985|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
148732464|NCT02935686|536494986|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
148732465|NCT02935686|536494987|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
148732466|NCT02935686|536494988|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
148732467|NCT02935686|536494989|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
148732468|NCT02935686|536494985|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
148732469|NCT02935686|536494986|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
148732470|NCT02935686|536494987|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
148732471|NCT02935686|536494988|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
148732472|NCT02935686|536494989|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
148732473|NCT02935686|536494985|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
148732474|NCT02935686|536494986|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
148732475|NCT02935686|536494987|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
148732476|NCT02935686|536494988|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
148732477|NCT02935686|536494989|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
148732478|NCT02935686|536494985|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
148732479|NCT02935686|536494986|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
148732480|NCT02935686|536494987|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
148732481|NCT02935686|536494988|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
148732482|NCT02935686|536494989|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
148732483|NCT02935686|536494985|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
148732484|NCT02935686|536494986|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
148732485|NCT02935686|536494987|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
148732486|NCT02935686|536494988|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
148732487|NCT02935686|536494989|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
148972930|NCT00646204|537386005|FG001|Overall Study|Adverse Event|0|||
148972931|NCT00646204|537386004|FG000|Overall Study|Withdrawal by Subject|1|||
148732488|NCT02935686|536494985|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
148732489|NCT02935686|536494986|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
148732490|NCT02935686|536494987|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
148732491|NCT02935686|536494988|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
148732492|NCT02935686|536494989|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
148732493|NCT00759902|536494992|FG000|Overall Study|Adverse Event|0|||
148732494|NCT00759902|536494993|FG001|Overall Study|Adverse Event|1|||
148732495|NCT02128217|536494994|FG000|Overall Study|Lost to Follow-up|0|||
148732496|NCT02128217|536494995|FG001|Overall Study|Lost to Follow-up|1|||
148732497|NCT05071313|536494998|FG000|Overall Study|Lost to Follow-up|17|||
148732498|NCT05071313|536494999|FG001|Overall Study|Lost to Follow-up|10|||
148732499|NCT05071313|536494998|FG000|Overall Study|Physician Decision|1|||
148732500|NCT05071313|536494999|FG001|Overall Study|Physician Decision|6|||
148732501|NCT05071313|536494998|FG000|Overall Study|Death|1|||
148732502|NCT05071313|536494999|FG001|Overall Study|Death|0|||
148732503|NCT05071313|536494998|FG000|Overall Study|Withdrawal by Subject|10|||
148732504|NCT05071313|536494999|FG001|Overall Study|Withdrawal by Subject|15|||
148732505|NCT05071313|536494998|FG000|Overall Study|Other|1|||
148732506|NCT05071313|536494999|FG001|Overall Study|Other|0|||
148732507|NCT05071313|536494998|FG000|Overall Study|Randomized but not vaccinated|4|||
148732508|NCT05071313|536494999|FG001|Overall Study|Randomized but not vaccinated|2|||
148732509|NCT03107026|536495000|FG000|Overall Study|Adverse Event|2|||
148732510|NCT03107026|536495001|FG001|Overall Study|Adverse Event|14|||
148732511|NCT03107026|536495002|FG002|Overall Study|Adverse Event|23|||
148732512|NCT03107026|536495000|FG000|Overall Study|Lost to Follow-up|12|||
148732513|NCT03107026|536495001|FG001|Overall Study|Lost to Follow-up|12|||
148732514|NCT03107026|536495002|FG002|Overall Study|Lost to Follow-up|13|||
148732515|NCT03107026|536495000|FG000|Overall Study|Protocol Violation|1|||
148732516|NCT03107026|536495001|FG001|Overall Study|Protocol Violation|2|||
148732517|NCT03107026|536495002|FG002|Overall Study|Protocol Violation|0|||
148732518|NCT03107026|536495000|FG000|Overall Study|Pregnancy|1|||
148732519|NCT03107026|536495001|FG001|Overall Study|Pregnancy|0|||
148732520|NCT03107026|536495002|FG002|Overall Study|Pregnancy|0|||
148732521|NCT03107026|536495000|FG000|Overall Study|Withdrawal by Subject|13|||
148732522|NCT03107026|536495001|FG001|Overall Study|Withdrawal by Subject|5|||
148732523|NCT03107026|536495002|FG002|Overall Study|Withdrawal by Subject|17|||
148732524|NCT03107026|536495000|FG000|Overall Study|non compliance with study visits|1|||
148732525|NCT03107026|536495001|FG001|Overall Study|non compliance with study visits|2|||
148732526|NCT03107026|536495002|FG002|Overall Study|non compliance with study visits|0|||
148732527|NCT03107026|536495000|FG000|Overall Study|non-compliance with study drug|2|||
148732528|NCT03107026|536495001|FG001|Overall Study|non-compliance with study drug|2|||
148732529|NCT03107026|536495002|FG002|Overall Study|non-compliance with study drug|3|||
148732530|NCT03107026|536495000|FG000|Overall Study|Physician Decision|0|||
148732531|NCT03107026|536495001|FG001|Overall Study|Physician Decision|1|||
148732532|NCT03107026|536495002|FG002|Overall Study|Physician Decision|0|||
148732533|NCT01183221|536495003|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
148732534|NCT01183221|536495004|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
148732535|NCT00678041|536495007|FG000|Overall Study|Physician Decision|5|||
148732536|NCT00678041|536495008|FG001|Overall Study|Physician Decision|5|||
148732537|NCT03596151|536495009|FG000|Overall Study|Withdrawal by Subject|1|||
148732538|NCT02444793|536495011|FG000|Overall Study|Lost to Follow-up|2|||
148732539|NCT02444793|536495012|FG001|Overall Study|Lost to Follow-up|2|||
148732540|NCT02444793|536495013|FG002|Overall Study|Lost to Follow-up|0|||
148732541|NCT02444793|536495014|FG003|Overall Study|Lost to Follow-up|0|||
148732542|NCT02444793|536495011|FG000|Overall Study|Death|0|||
148732543|NCT02444793|536495012|FG001|Overall Study|Death|3|||
148732544|NCT02444793|536495013|FG002|Overall Study|Death|0|||
148732545|NCT02444793|536495014|FG003|Overall Study|Death|0|||
148732546|NCT02444793|536495011|FG000|Overall Study|Other|0|||
148732547|NCT02444793|536495012|FG001|Overall Study|Other|0|||
148732548|NCT02444793|536495013|FG002|Overall Study|Other|2|||
148732549|NCT02444793|536495014|FG003|Overall Study|Other|0|||
148732550|NCT02444793|536495011|FG000|Overall Study|Objective progression or relapse|9|||
148732551|NCT02444793|536495012|FG001|Overall Study|Objective progression or relapse|1|||
148732552|NCT02444793|536495013|FG002|Overall Study|Objective progression or relapse|2|||
148732553|NCT02444793|536495014|FG003|Overall Study|Objective progression or relapse|3|||
148732554|NCT00210249|536495019|FG000|Overall Study|Lost to Follow-up|5|||
148732555|NCT00210249|536495019|FG000|Overall Study|Protocol Violation|11|||
148732556|NCT03222583|536495020|FG000|Overall Study|Withdrawal by Subject|3|||
148732557|NCT03222583|536495021|FG001|Overall Study|Withdrawal by Subject|3|||
148972932|NCT00646204|537386005|FG001|Overall Study|Withdrawal by Subject|0|||
148972933|NCT00773175|537386006|FG000|Overall Study|Adverse Event|2|||
148972934|NCT00773175|537386007|FG001|Overall Study|Adverse Event|0|||
148972935|NCT00773175|537386006|FG000|Overall Study|Consent Withdrawn|0|||
148732558|NCT03222583|536495020|FG000|Overall Study|Lost to Follow-up|1|||
148732559|NCT03222583|536495021|FG001|Overall Study|Lost to Follow-up|0|||
148732560|NCT03222583|536495020|FG000|Overall Study|Other|1|||
148732561|NCT03222583|536495021|FG001|Overall Study|Other|3|||
148972936|NCT00773175|537386007|FG001|Overall Study|Consent Withdrawn|2|||
148732562|NCT04280705|536495022|FG000|Overall Study|Enrolled but not treated|4|||
148732563|NCT04280705|536495023|FG001|Overall Study|Enrolled but not treated|10|||
148732564|NCT04280705|536495022|FG000|Overall Study|Physician Decision|1|||
148732565|NCT04280705|536495023|FG001|Overall Study|Physician Decision|0|||
148732566|NCT04280705|536495022|FG000|Overall Study|Withdrawal by Subject|7|||
148732567|NCT04280705|536495023|FG001|Overall Study|Withdrawal by Subject|9|||
148732568|NCT04280705|536495022|FG000|Overall Study|Adverse Event|0|||
148732569|NCT04280705|536495023|FG001|Overall Study|Adverse Event|4|||
148732570|NCT04280705|536495022|FG000|Overall Study|Transferred to another hospital|1|||
148732571|NCT04280705|536495023|FG001|Overall Study|Transferred to another hospital|1|||
148732572|NCT02518919|536495026|FG000|Overall Study|Protocol Violation|1|||
148732573|NCT02518919|536495027|FG001|Overall Study|Protocol Violation|1|||
148732574|NCT02518919|536495028|FG002|Overall Study|Protocol Violation|2|||
148732575|NCT04498403|536495029|FG000|Overall Study|Adverse Event|1|||
148732576|NCT04498403|536495030|FG001|Overall Study|Adverse Event|0|||
148732577|NCT04498403|536495029|FG000|Overall Study|Study Terminated By Sponsor|29|||
148732578|NCT04498403|536495030|FG001|Overall Study|Study Terminated By Sponsor|10|||
148732579|NCT01951885|536495031|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
148732580|NCT01951885|536495032|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
148732581|NCT01951885|536495031|FG000|Overall Study|Adverse Event|1|||
148732582|NCT01951885|536495032|FG001|Overall Study|Adverse Event|0|||
148732583|NCT01951885|536495031|FG000|Overall Study|Withdrawal by Subject|0|||
148732584|NCT01951885|536495032|FG001|Overall Study|Withdrawal by Subject|1|||
148732585|NCT01951885|536495031|FG000|Overall Study|ineligible due to a change in donor|0|||
148732586|NCT01951885|536495032|FG001|Overall Study|ineligible due to a change in donor|1|||
148732587|NCT01951885|536495031|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
148732588|NCT01951885|536495032|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
148732589|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Death|89|||
148732590|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Death|193|||
148732591|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Death|198|||
148732592|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
148732593|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
148732594|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
148732595|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
148732596|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
148732597|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
148732598|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
148732599|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
148732600|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
148732601|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
148732602|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
148732603|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
148732604|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
148732605|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
148732606|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
148732607|NCT02031458|536495033|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
148732608|NCT02031458|536495034|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
148732609|NCT02031458|536495035|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
148732610|NCT02031458|536495033|FG000|Baseline to May 8, 2015|Death|36|||
148732611|NCT02031458|536495034|FG001|Baseline to May 8, 2015|Death|87|||
148732612|NCT02031458|536495035|FG002|Baseline to May 8, 2015|Death|100|||
148732613|NCT02031458|536495033|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
148732614|NCT02031458|536495034|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
148732615|NCT02031458|536495035|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
148732616|NCT02031458|536495033|FG000|Baseline to May 8, 2015|Physician Decision|0|||
148732617|NCT02031458|536495034|FG001|Baseline to May 8, 2015|Physician Decision|1|||
148732618|NCT02031458|536495035|FG002|Baseline to May 8, 2015|Physician Decision|0|||
148732619|NCT02031458|536495033|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
148732620|NCT02031458|536495034|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
148732621|NCT02031458|536495035|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
148732622|NCT02031458|536495033|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
148732623|NCT02031458|536495034|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
148732624|NCT02031458|536495035|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
149026705|NCT01871285|537574307|FG001|First Intervention (1 Day)|Adverse Event|0|||
149026706|NCT01871285|537574308|FG002|First Intervention (1 Day)|Adverse Event|0|||
148732625|NCT02031458|536495033|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
148732626|NCT02031458|536495034|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
148732627|NCT02031458|536495035|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
148732628|NCT02031458|536495033|FG000|Baseline to May 8, 2015|On Treatment|43|||
148732629|NCT02031458|536495034|FG001|Baseline to May 8, 2015|On Treatment|81|||
148732630|NCT02031458|536495035|FG002|Baseline to May 8, 2015|On Treatment|73|||
148732631|NCT02031458|536495033|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
148732632|NCT02031458|536495034|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
148732633|NCT02031458|536495035|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
148732634|NCT03188718|536495038|FG000|Overall Study|Participant noncompliance|4|||
148732635|NCT03188718|536495038|FG000|Overall Study|Withdrawal by Subject|1|||
148732636|NCT03188718|536495038|FG000|Overall Study|Device failure|3|||
148732637|NCT02049450|536495039|FG000|Overall Study|Adverse Event|2|||
148732638|NCT02049450|536495039|FG000|Overall Study|Withdrawal by Subject|1|||
148732639|NCT02049450|536495039|FG000|Overall Study|Patients/guardian decision|1|||
148732640|NCT00292188|536495043|FG000|Single-Blind|Adverse Event|14|||
148732641|NCT00292188|536495044|FG001|Single-Blind|Adverse Event|0|||
148732642|NCT00292188|536495045|FG002|Single-Blind|Adverse Event|0|||
148732643|NCT00292188|536495043|FG000|Single-Blind|Lack of Efficacy|2|||
148732644|NCT00292188|536495044|FG001|Single-Blind|Lack of Efficacy|0|||
148732645|NCT00292188|536495045|FG002|Single-Blind|Lack of Efficacy|0|||
148732646|NCT00292188|536495043|FG000|Single-Blind|Laboratory Abnormality|5|||
148732647|NCT00292188|536495044|FG001|Single-Blind|Laboratory Abnormality|0|||
148732648|NCT00292188|536495045|FG002|Single-Blind|Laboratory Abnormality|0|||
148732649|NCT00292188|536495043|FG000|Single-Blind|Lost to Follow-up|3|||
148732650|NCT00292188|536495044|FG001|Single-Blind|Lost to Follow-up|0|||
148732651|NCT00292188|536495045|FG002|Single-Blind|Lost to Follow-up|0|||
148732652|NCT00292188|536495043|FG000|Single-Blind|Other|77|||
148732653|NCT00292188|536495044|FG001|Single-Blind|Other|0|||
148732654|NCT00292188|536495045|FG002|Single-Blind|Other|0|||
148732655|NCT00292188|536495043|FG000|Single-Blind|Withdrawal by Subject|12|||
148732656|NCT00292188|536495044|FG001|Single-Blind|Withdrawal by Subject|0|||
148732657|NCT00292188|536495045|FG002|Single-Blind|Withdrawal by Subject|0|||
148732658|NCT00292188|536495043|FG000|Single-Blind|Did not receive treatment|1|||
148732659|NCT00292188|536495044|FG001|Single-Blind|Did not receive treatment|0|||
148732660|NCT00292188|536495045|FG002|Single-Blind|Did not receive treatment|0|||
148732661|NCT00292188|536495043|FG000|Double-Blind|Adverse Event|0|||
148732662|NCT00292188|536495044|FG001|Double-Blind|Adverse Event|25|||
148732663|NCT00292188|536495045|FG002|Double-Blind|Adverse Event|9|||
148732664|NCT00292188|536495043|FG000|Double-Blind|Lack of Efficacy|0|||
148732665|NCT00292188|536495044|FG001|Double-Blind|Lack of Efficacy|2|||
148732666|NCT00292188|536495045|FG002|Double-Blind|Lack of Efficacy|12|||
148732667|NCT00292188|536495043|FG000|Double-Blind|Lost to Follow-up|0|||
148732668|NCT00292188|536495044|FG001|Double-Blind|Lost to Follow-up|1|||
148732669|NCT00292188|536495045|FG002|Double-Blind|Lost to Follow-up|0|||
148732670|NCT00292188|536495043|FG000|Double-Blind|Other|0|||
148732671|NCT00292188|536495044|FG001|Double-Blind|Other|3|||
148732672|NCT00292188|536495045|FG002|Double-Blind|Other|4|||
148732673|NCT00292188|536495043|FG000|Double-Blind|Withdrawal by Subject|0|||
148732674|NCT00292188|536495044|FG001|Double-Blind|Withdrawal by Subject|0|||
148732675|NCT00292188|536495045|FG002|Double-Blind|Withdrawal by Subject|3|||
148732676|NCT00292188|536495043|FG000|Double-Blind|Laboratory Abnormality|0|||
148732677|NCT00292188|536495044|FG001|Double-Blind|Laboratory Abnormality|0|||
148732678|NCT00292188|536495045|FG002|Double-Blind|Laboratory Abnormality|1|||
148732679|NCT04709835|536495046|FG000|Overall Study|Withdrawal by Subject|0|||
148732680|NCT04709835|536495047|FG001|Overall Study|Withdrawal by Subject|1|||
148732681|NCT04709835|536495048|FG002|Overall Study|Withdrawal by Subject|0|||
148732682|NCT00394524|536495051|FG000|Overall Study|Protocol Violation|2|||
148732683|NCT00394524|536495052|FG001|Overall Study|Protocol Violation|3|||
148732684|NCT00394524|536495051|FG000|Overall Study|Death|1|||
148732685|NCT00394524|536495052|FG001|Overall Study|Death|0|||
148732686|NCT00394524|536495051|FG000|Overall Study|Withdrawal by Subject|0|||
148732687|NCT00394524|536495052|FG001|Overall Study|Withdrawal by Subject|1|||
148732688|NCT01462318|536495053|FG000|Main Study / TP-DI Study|Other|2|||
148732689|NCT01462318|536495054|FG001|Main Study / TP-DI Study|Other|0|||
148732690|NCT01462318|536495055|FG002|Main Study / TP-DI Study|Other|0|||
148732691|NCT01462318|536495053|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
148732692|NCT01462318|536495054|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
148732693|NCT01462318|536495055|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
148732694|NCT01462318|536495053|FG000|Main Study / TP-DI Study|Adverse Event|4|||
148732695|NCT01462318|536495054|FG001|Main Study / TP-DI Study|Adverse Event|0|||
148732696|NCT01462318|536495055|FG002|Main Study / TP-DI Study|Adverse Event|0|||
148732697|NCT01462318|536495053|FG000|Extension Phase|Lost to Follow-up|0|||
148732698|NCT01462318|536495054|FG001|Extension Phase|Lost to Follow-up|0|||
148732699|NCT01462318|536495055|FG002|Extension Phase|Lost to Follow-up|1|||
148732700|NCT01462318|536495053|FG000|Extension Phase|Other|0|||
148732701|NCT01462318|536495054|FG001|Extension Phase|Other|0|||
148732702|NCT01462318|536495055|FG002|Extension Phase|Other|1|||
148732703|NCT01462318|536495053|FG000|Extension Phase|Disease Progression|0|||
148732704|NCT01462318|536495054|FG001|Extension Phase|Disease Progression|0|||
148732705|NCT01462318|536495055|FG002|Extension Phase|Disease Progression|1|||
148732706|NCT01462318|536495053|FG000|Extension Phase|Withdrawal by Subject|0|||
148732707|NCT01462318|536495054|FG001|Extension Phase|Withdrawal by Subject|0|||
148732708|NCT01462318|536495055|FG002|Extension Phase|Withdrawal by Subject|15|||
148732709|NCT01462318|536495053|FG000|Extension Phase|Investigator Decision|0|||
149026707|NCT01871285|537574309|FG003|First Intervention (1 Day)|Adverse Event|0|||
149026708|NCT01871285|537574306|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
149026709|NCT01871285|537574307|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
149026710|NCT01871285|537574308|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
149026711|NCT01871285|537574309|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
149026712|NCT04091672|537576359|FG000|Overall Study|Death|6|||
149026713|NCT04091672|537576360|FG001|Overall Study|Death|6|||
149026714|NCT04091672|537576359|FG000|Overall Study|Lost to Follow-up|7|||
149026715|NCT04091672|537576360|FG001|Overall Study|Lost to Follow-up|7|||
149026716|NCT04091672|537576359|FG000|Overall Study|Withdrawal by Subject|3|||
149026717|NCT04091672|537576360|FG001|Overall Study|Withdrawal by Subject|3|||
149026718|NCT04091672|537576359|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
149026719|NCT04091672|537576360|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
149026720|NCT05296629|537576361|FG000|Overall Study|Withdrawal by Subject|3|||
149026721|NCT05296629|537576362|FG001|Overall Study|Withdrawal by Subject|10|||
149026722|NCT05296629|537576363|FG002|Overall Study|Withdrawal by Subject|4|||
149026723|NCT05296629|537576361|FG000|Overall Study|Lost to Follow-up|2|||
149026724|NCT05296629|537576362|FG001|Overall Study|Lost to Follow-up|7|||
149026725|NCT05296629|537576363|FG002|Overall Study|Lost to Follow-up|1|||
149026726|NCT05296629|537576361|FG000|Overall Study|Adverse Event|0|||
149026727|NCT05296629|537576362|FG001|Overall Study|Adverse Event|4|||
149026728|NCT05296629|537576363|FG002|Overall Study|Adverse Event|2|||
149026729|NCT05296629|537576361|FG000|Overall Study|Protocol Violation|0|||
149026730|NCT05296629|537576362|FG001|Overall Study|Protocol Violation|2|||
149026731|NCT05296629|537576363|FG002|Overall Study|Protocol Violation|0|||
149026732|NCT02268396|537576367|FG000|Overall Study|Adverse Event|3|||
149026733|NCT02268396|537576367|FG000|Overall Study|Administrative|2|||
149026734|NCT02268396|537576367|FG000|Overall Study|Withdrawal by Subject|1|||
149026735|NCT02268396|537576367|FG000|Overall Study|Lost to Follow-up|2|||
149026736|NCT02268396|537576367|FG000|Overall Study|Protocol-Specified Criteria|2|||
149026737|NCT02268396|537576367|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
149026738|NCT01304706|537576370|FG000|Overall Study|Adverse Event|2|||
149026739|NCT01304706|537576370|FG000|Overall Study|Lack of Efficacy|1|||
149026740|NCT01304706|537576370|FG000|Overall Study|Death|3|||
149026741|NCT01304706|537576370|FG000|Overall Study|Withdrawal by Subject|3|||
149026742|NCT01304706|537576370|FG000|Overall Study|Lost to Follow-up|7|||
149026743|NCT01304706|537576370|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
149026744|NCT00359619|537576371|FG000|Overall Study|Adverse Event|0|||
149026745|NCT00359619|537576372|FG001|Overall Study|Adverse Event|0|||
149026746|NCT00359619|537576373|FG002|Overall Study|Adverse Event|1|||
149026747|NCT00359619|537576374|FG003|Overall Study|Adverse Event|0|||
149026748|NCT00359619|537576375|FG004|Overall Study|Adverse Event|0|||
149026749|NCT00359619|537576376|FG005|Overall Study|Adverse Event|0|||
149026750|NCT00359619|537576377|FG006|Overall Study|Adverse Event|1|||
149026751|NCT00359619|537576371|FG000|Overall Study|Withdrawal by Subject|3|||
149026752|NCT00359619|537576372|FG001|Overall Study|Withdrawal by Subject|1|||
149026753|NCT00359619|537576373|FG002|Overall Study|Withdrawal by Subject|4|||
149026754|NCT00359619|537576374|FG003|Overall Study|Withdrawal by Subject|2|||
148972937|NCT00503841|537386008|FG000|Overall Study|All screen failures|44|||
148972938|NCT00326612|537386013|FG000|Overall Study|They did not have a seizure requiring tx|129|||
148972939|NCT00326612|537386014|FG001|Overall Study|They did not have a seizure requiring tx|137|||
148972940|NCT00419562|537386015|FG000|Overall Study|Lost to Follow-up|12|||
148972941|NCT00419562|537386016|FG001|Overall Study|Lost to Follow-up|13|||
148972942|NCT00419562|537386015|FG000|Overall Study|Withdrawal by Subject|20|||
148972943|NCT00419562|537386016|FG001|Overall Study|Withdrawal by Subject|18|||
148972944|NCT00419562|537386015|FG000|Overall Study|Participant Institutionalized|1|||
148972945|NCT00419562|537386016|FG001|Overall Study|Participant Institutionalized|0|||
148972946|NCT00640510|537386017|FG000|Overall Study|Lack of Efficacy|0|||
148972947|NCT00640510|537386018|FG001|Overall Study|Lack of Efficacy|1|||
149026755|NCT00359619|537576375|FG004|Overall Study|Withdrawal by Subject|2|||
149026756|NCT00359619|537576376|FG005|Overall Study|Withdrawal by Subject|0|||
149026757|NCT00359619|537576377|FG006|Overall Study|Withdrawal by Subject|3|||
149026758|NCT00359619|537576371|FG000|Overall Study|Other|1|||
149026759|NCT00359619|537576372|FG001|Overall Study|Other|0|||
149026760|NCT00359619|537576373|FG002|Overall Study|Other|0|||
149026761|NCT00359619|537576374|FG003|Overall Study|Other|0|||
149026762|NCT00359619|537576375|FG004|Overall Study|Other|0|||
148972948|NCT00640510|537386017|FG000|Overall Study|Protocol Violation|1|||
148972949|NCT00640510|537386018|FG001|Overall Study|Protocol Violation|0|||
149026763|NCT00359619|537576376|FG005|Overall Study|Other|0|||
149026764|NCT00359619|537576377|FG006|Overall Study|Other|0|||
149026765|NCT00359619|537576371|FG000|Overall Study|Lost to Follow-up|4|||
149026766|NCT00359619|537576372|FG001|Overall Study|Lost to Follow-up|4|||
149026767|NCT00359619|537576373|FG002|Overall Study|Lost to Follow-up|2|||
148972950|NCT00640510|537386017|FG000|Overall Study|Physician Decision|0|||
149026768|NCT00359619|537576374|FG003|Overall Study|Lost to Follow-up|1|||
149026769|NCT00359619|537576375|FG004|Overall Study|Lost to Follow-up|1|||
149026770|NCT00359619|537576376|FG005|Overall Study|Lost to Follow-up|5|||
148732710|NCT01462318|536495054|FG001|Extension Phase|Investigator Decision|0|||
148732711|NCT01462318|536495055|FG002|Extension Phase|Investigator Decision|5|||
148732712|NCT01462318|536495053|FG000|Extension Phase|Adverse Event|0|||
148732713|NCT01462318|536495054|FG001|Extension Phase|Adverse Event|0|||
148732714|NCT01462318|536495055|FG002|Extension Phase|Adverse Event|22|||
148732715|NCT02238626|536495056|FG000|Overall Study|Adverse Event|3|||
148732716|NCT02238626|536495057|FG001|Overall Study|Adverse Event|5|||
148732717|NCT02238626|536495058|FG002|Overall Study|Adverse Event|0|||
148732718|NCT02238626|536495059|FG003|Overall Study|Adverse Event|3|||
148732719|NCT02238626|536495056|FG000|Overall Study|Lost to Follow-up|2|||
148732720|NCT02238626|536495057|FG001|Overall Study|Lost to Follow-up|4|||
148732721|NCT02238626|536495058|FG002|Overall Study|Lost to Follow-up|2|||
148732722|NCT02238626|536495059|FG003|Overall Study|Lost to Follow-up|2|||
148732723|NCT02238626|536495056|FG000|Overall Study|Withdrawal by Subject|0|||
148732724|NCT02238626|536495057|FG001|Overall Study|Withdrawal by Subject|3|||
148732725|NCT02238626|536495058|FG002|Overall Study|Withdrawal by Subject|0|||
148732726|NCT02238626|536495059|FG003|Overall Study|Withdrawal by Subject|1|||
148732727|NCT02238626|536495056|FG000|Overall Study|Death|0|||
148732728|NCT02238626|536495057|FG001|Overall Study|Death|0|||
148732729|NCT02238626|536495058|FG002|Overall Study|Death|1|||
148732730|NCT02238626|536495059|FG003|Overall Study|Death|1|||
148732731|NCT02238626|536495056|FG000|Overall Study|Other|0|||
148732732|NCT02238626|536495057|FG001|Overall Study|Other|2|||
148732733|NCT02238626|536495058|FG002|Overall Study|Other|0|||
148732734|NCT02238626|536495059|FG003|Overall Study|Other|0|||
148732735|NCT00974974|536495063|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
148732736|NCT00974974|536495064|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
148732737|NCT00974974|536495063|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
148732738|NCT00974974|536495064|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
148732739|NCT00974974|536495063|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
148732740|NCT00974974|536495064|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
148732741|NCT00974974|536495063|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
148732742|NCT00974974|536495064|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
148732743|NCT00974974|536495063|FG000|IR CD-LD Dose Adjustment|Various|0|||
148732744|NCT00974974|536495064|FG001|IR CD-LD Dose Adjustment|Various|9|||
148732745|NCT00974974|536495063|FG000|IPX066 Dose Conversion|Adverse Event|23|||
148732746|NCT00974974|536495064|FG001|IPX066 Dose Conversion|Adverse Event|0|||
148732747|NCT00974974|536495063|FG000|IPX066 Dose Conversion|Death|2|||
148732748|NCT00974974|536495064|FG001|IPX066 Dose Conversion|Death|0|||
148732749|NCT00974974|536495063|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
148732750|NCT00974974|536495064|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
148732751|NCT00974974|536495063|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
148732752|NCT00974974|536495064|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
148732753|NCT00974974|536495063|FG000|IPX066 Dose Conversion|Various|3|||
148732754|NCT00974974|536495064|FG001|IPX066 Dose Conversion|Various|0|||
148732755|NCT00974974|536495063|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
148732756|NCT00974974|536495064|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
148732757|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
148732758|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
148732759|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
148732760|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
148732761|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
148732762|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
148732763|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
148732764|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
148732765|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
148732766|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
148732767|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
148732768|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
148732769|NCT00974974|536495063|FG000|Maintenance - Double Blind Treatment|Various|4|||
148732770|NCT00974974|536495064|FG001|Maintenance - Double Blind Treatment|Various|0|||
148732771|NCT01959035|536495065|FG000|Overall Study|Adverse Event|5|||
148732772|NCT01959035|536495065|FG000|Overall Study|Withdrawal by Subject|4|||
148732773|NCT01959035|536495065|FG000|Overall Study|Lost to Follow-up|1|||
148732774|NCT01959035|536495065|FG000|Overall Study|Other (no primary reason given)|1|||
148732775|NCT04078126|536495073|FG000|Washout|Study put on hold due to COVID-19|0|||
148732776|NCT04078126|536495074|FG001|Washout|Study put on hold due to COVID-19|2|||
148732777|NCT04078126|536495073|FG000|Period 2|Study put on hold due to COVID-19|1|||
148732778|NCT04078126|536495074|FG001|Period 2|Study put on hold due to COVID-19|1|||
148732779|NCT02669758|536495075|FG000|Overall Study|Withdrawal by Subject|43|||
148732780|NCT02669758|536495075|FG000|Overall Study|Lost to Follow-up|19|||
148732781|NCT02669758|536495075|FG000|Overall Study|Adverse Event|16|||
148732782|NCT02669758|536495075|FG000|Overall Study|Non-Compliance with Study Drug|8|||
148732783|NCT02669758|536495075|FG000|Overall Study|Lack of Efficacy|5|||
148732784|NCT02669758|536495075|FG000|Overall Study|Pregnancy|1|||
148972951|NCT00640510|537386018|FG001|Overall Study|Physician Decision|1|||
148972952|NCT01440322|537386019|FG000|Overall Study|Discomfort|2|||
148972953|NCT01440322|537386020|FG001|Overall Study|Discomfort|0|||
148972954|NCT01440322|537386019|FG000|Overall Study|Biomicroscopy|1|||
148972955|NCT01440322|537386020|FG001|Overall Study|Biomicroscopy|0|||
148972956|NCT01440322|537386019|FG000|Overall Study|Symptoms and Problems|1|||
148972957|NCT01440322|537386020|FG001|Overall Study|Symptoms and Problems|0|||
148972958|NCT01440322|537386019|FG000|Overall Study|Unacceptable Subjective Vision|1|||
148972959|NCT01440322|537386020|FG001|Overall Study|Unacceptable Subjective Vision|0|||
148972960|NCT01440322|537386019|FG000|Overall Study|Other Product Related|1|||
148972961|NCT01440322|537386020|FG001|Overall Study|Other Product Related|0|||
148972962|NCT01440322|537386019|FG000|Overall Study|Unrelated Medical Problem|0|||
148972963|NCT01440322|537386020|FG001|Overall Study|Unrelated Medical Problem|1|||
148972964|NCT01440322|537386019|FG000|Overall Study|Other Non-Product Related|1|||
148972965|NCT01440322|537386020|FG001|Overall Study|Other Non-Product Related|0|||
148972966|NCT00770120|537386023|FG000|Overall Study|Progression|31|||
148972967|NCT00770120|537386023|FG000|Overall Study|Adverse Event|11|||
148972968|NCT00770120|537386023|FG000|Overall Study|Not Protocol Specified|11|||
148972969|NCT00770120|537386023|FG000|Overall Study|Death|3|||
148972970|NCT00770120|537386023|FG000|Overall Study|Withdrawal by Subject|2|||
148972971|NCT00770120|537386023|FG000|Overall Study|Ineligible|1|||
148972972|NCT00770120|537386023|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
148972973|NCT00770120|537386023|FG000|Overall Study|Reason under Review|1|||
148972974|NCT02412631|537386024|FG000|Overall Study|Adverse Event|1|||
148972975|NCT02412631|537386025|FG001|Overall Study|Adverse Event|2|||
148972976|NCT02412631|537386024|FG000|Overall Study|Lost to Follow-up|5|||
148972977|NCT02412631|537386025|FG001|Overall Study|Lost to Follow-up|9|||
148972978|NCT02412631|537386024|FG000|Overall Study|Withdrawal by Subject|9|||
148972979|NCT02412631|537386025|FG001|Overall Study|Withdrawal by Subject|3|||
148972980|NCT02412631|537386024|FG000|Overall Study|Early stop by FDA|5|||
148972981|NCT02412631|537386025|FG001|Overall Study|Early stop by FDA|2|||
148972982|NCT02412631|537386024|FG000|Overall Study|Unspecified reason|6|||
148972983|NCT02412631|537386025|FG001|Overall Study|Unspecified reason|8|||
148972984|NCT01782313|537386033|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
148972985|NCT01782313|537386033|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
148972986|NCT01782313|537386033|FG000|Treated Cycle 3|Progressive Disease|21|||
148972987|NCT01782313|537386033|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
148972988|NCT01782313|537386033|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
148972989|NCT01782313|537386033|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
148972990|NCT01782313|537386033|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
148972991|NCT01782313|537386033|FG000|Survival Follow up|Lost to Follow-up|1|||
148972992|NCT00958776|537386034|FG000|Overall Study|Adverse Event|0|||
148972993|NCT00958776|537386035|FG001|Overall Study|Adverse Event|1|||
148972994|NCT00958776|537386034|FG000|Overall Study|Physician Decision|1|||
148972995|NCT00958776|537386035|FG001|Overall Study|Physician Decision|0|||
148972996|NCT00958776|537386034|FG000|Overall Study|Lost to Follow-up|2|||
148972997|NCT00958776|537386035|FG001|Overall Study|Lost to Follow-up|6|||
148972998|NCT00958776|537386034|FG000|Overall Study|Withdrawal by Subject|7|||
148972999|NCT00958776|537386035|FG001|Overall Study|Withdrawal by Subject|16|||
148973000|NCT00958776|537386034|FG000|Overall Study|Protocol Violation|1|||
148973001|NCT00958776|537386035|FG001|Overall Study|Protocol Violation|1|||
148973002|NCT00958776|537386034|FG000|Overall Study|Death|2|||
148973003|NCT00958776|537386035|FG001|Overall Study|Death|1|||
148973004|NCT00958776|537386034|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
148973005|NCT00958776|537386035|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
148973006|NCT00958776|537386034|FG000|Overall Study|Missing|1|||
148973007|NCT00958776|537386035|FG001|Overall Study|Missing|1|||
148973008|NCT00480636|537386036|FG000|Overall Study|Death|12|||
148973009|NCT00480636|537386036|FG000|Overall Study|Lost to Follow-up|4|||
148973010|NCT00480636|537386036|FG000|Overall Study|Other|2|||
148973011|NCT00480636|537386036|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
148732785|NCT02669758|536495075|FG000|Overall Study|Study noncompliance|1|||
148732786|NCT02669758|536495075|FG000|Overall Study|Protocol Violation|1|||
148732787|NCT03402750|536495076|FG000|Overall Study|Lost to Follow-up|2|||
148732788|NCT03402750|536495077|FG001|Overall Study|Lost to Follow-up|1|||
148973012|NCT02583256|537386037|FG000|Overall Study|Withdrawal by Subject|0|||
148973013|NCT02583256|537386038|FG001|Overall Study|Withdrawal by Subject|1|||
149026771|NCT00359619|537576377|FG006|Overall Study|Lost to Follow-up|0|||
149026772|NCT04978363|537576383|FG000|Overall Study|Other medical issues unrelated to the study|0|||
148732789|NCT02981303|536495078|FG000|Overall Study|Progressive Disease|17|||
148973014|NCT02583256|537386039|FG002|Overall Study|Withdrawal by Subject|1|||
148973015|NCT02583256|537386040|FG003|Overall Study|Withdrawal by Subject|0|||
148973016|NCT02583256|537386037|FG000|Overall Study|Lost to Follow-up|1|||
148973017|NCT02583256|537386038|FG001|Overall Study|Lost to Follow-up|1|||
148973018|NCT02583256|537386039|FG002|Overall Study|Lost to Follow-up|0|||
148973019|NCT02583256|537386040|FG003|Overall Study|Lost to Follow-up|1|||
148973020|NCT02583256|537386037|FG000|Overall Study|Administrative/Other|2|||
148973021|NCT02583256|537386038|FG001|Overall Study|Administrative/Other|0|||
148973022|NCT02583256|537386039|FG002|Overall Study|Administrative/Other|1|||
148973023|NCT02583256|537386040|FG003|Overall Study|Administrative/Other|2|||
148973024|NCT02506816|537386047|FG000|Overall Study|Adverse Event|3|||
148973025|NCT02177266|537386048|FG000|Overall Study|Adverse Event|0|||
148973026|NCT02177266|537386049|FG001|Overall Study|Adverse Event|1|||
148973027|NCT02177266|537386048|FG000|Overall Study|Withdrawal by Subject|1|||
148973028|NCT02177266|537386049|FG001|Overall Study|Withdrawal by Subject|0|||
148973029|NCT03019627|537386051|FG000|Overall Study|Adverse Event|8|||
148973030|NCT03019627|537386052|FG001|Overall Study|Adverse Event|0|||
148973031|NCT03019627|537386051|FG000|Overall Study|Unrelated to adverse event|1|||
148973032|NCT03019627|537386052|FG001|Overall Study|Unrelated to adverse event|3|||
148973033|NCT03019627|537386051|FG000|Overall Study|Lost to Follow-up|2|||
148973034|NCT03019627|537386052|FG001|Overall Study|Lost to Follow-up|1|||
148973035|NCT03019627|537386051|FG000|Overall Study|not compliance|2|||
148973036|NCT03019627|537386052|FG001|Overall Study|not compliance|2|||
148973037|NCT03019627|537386051|FG000|Overall Study|Other|2|||
148973038|NCT03019627|537386052|FG001|Overall Study|Other|2|||
148973039|NCT03364049|537386053|FG000|Overall Study|Death|6|||
148973040|NCT03364049|537386054|FG001|Overall Study|Death|4|||
148973041|NCT03364049|537386055|FG002|Overall Study|Death|5|||
148973042|NCT03364049|537386056|FG003|Overall Study|Death|14|||
148973043|NCT03364049|537386053|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
148973044|NCT03364049|537386054|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
148973045|NCT03364049|537386055|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
148973046|NCT03364049|537386056|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
148973047|NCT03364049|537386053|FG000|Overall Study|Withdrawal by Subject|0|||
148973048|NCT03364049|537386054|FG001|Overall Study|Withdrawal by Subject|1|||
148973049|NCT03364049|537386055|FG002|Overall Study|Withdrawal by Subject|1|||
148973050|NCT03364049|537386056|FG003|Overall Study|Withdrawal by Subject|1|||
148973051|NCT00546715|537386057|FG000|Overall Study|Withdrawal by Subject|0|||
148973052|NCT00546715|537386058|FG001|Overall Study|Withdrawal by Subject|1|||
148973053|NCT00546715|537386059|FG002|Overall Study|Withdrawal by Subject|0|||
148973054|NCT00546715|537386060|FG003|Overall Study|Withdrawal by Subject|0|||
148973055|NCT00418691|537386061|FG000|Overall Study|Lost to Follow-up|1|||
148973056|NCT00418691|537386062|FG001|Overall Study|Lost to Follow-up|2|||
148973057|NCT00418691|537386063|FG002|Overall Study|Lost to Follow-up|3|||
148973058|NCT00418691|537386061|FG000|Overall Study|Started new medication voiding entry|0|||
148973059|NCT00418691|537386062|FG001|Overall Study|Started new medication voiding entry|0|||
148973060|NCT00418691|537386063|FG002|Overall Study|Started new medication voiding entry|1|||
148973061|NCT00418691|537386061|FG000|Overall Study|Progressive Disease|1|||
148973062|NCT00418691|537386062|FG001|Overall Study|Progressive Disease|0|||
148973063|NCT00418691|537386063|FG002|Overall Study|Progressive Disease|1|||
148973064|NCT01802775|537386064|FG000|Overall Study|Death|0|||
148973065|NCT01802775|537386065|FG001|Overall Study|Death|3|||
148973066|NCT01802775|537386064|FG000|Overall Study|Reason not provided|0|||
148973067|NCT01802775|537386065|FG001|Overall Study|Reason not provided|1|||
148973068|NCT01802775|537386064|FG000|Overall Study|Physician Decision|1|||
148973069|NCT01802775|537386065|FG001|Overall Study|Physician Decision|0|||
148973070|NCT01802775|537386064|FG000|Overall Study|Adverse Event|1|||
148973071|NCT01802775|537386065|FG001|Overall Study|Adverse Event|1|||
148973072|NCT01802775|537386064|FG000|Overall Study|Withdrawal by Subject|3|||
148973073|NCT01802775|537386065|FG001|Overall Study|Withdrawal by Subject|5|||
148973074|NCT01802775|537386064|FG000|Overall Study|Lost to Follow-up|1|||
148973075|NCT01802775|537386065|FG001|Overall Study|Lost to Follow-up|2|||
148973076|NCT01340976|537386066|FG000|Overall Study|Physician Decision|2|||
148973077|NCT01340976|537386067|FG001|Overall Study|Physician Decision|0|||
148973078|NCT01340976|537386068|FG002|Overall Study|Physician Decision|1|||
148973079|NCT01340976|537386069|FG003|Overall Study|Physician Decision|1|||
148973080|NCT01340976|537386070|FG004|Overall Study|Physician Decision|1|||
148973081|NCT01340976|537386071|FG005|Overall Study|Physician Decision|0|||
148973082|NCT01340976|537386066|FG000|Overall Study|Death|0|||
148973083|NCT01340976|537386067|FG001|Overall Study|Death|1|||
148973084|NCT01340976|537386068|FG002|Overall Study|Death|0|||
148973085|NCT01340976|537386069|FG003|Overall Study|Death|0|||
148973086|NCT01340976|537386070|FG004|Overall Study|Death|0|||
148973087|NCT01340976|537386071|FG005|Overall Study|Death|0|||
148973088|NCT01340976|537386066|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
148973089|NCT01340976|537386067|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
148973090|NCT01340976|537386068|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
148973091|NCT01340976|537386069|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
148973092|NCT01340976|537386070|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
148973093|NCT01340976|537386071|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
148973094|NCT01340976|537386066|FG000|Overall Study|Withdrawal by Subject|0|||
148973095|NCT01340976|537386067|FG001|Overall Study|Withdrawal by Subject|0|||
148973096|NCT01340976|537386068|FG002|Overall Study|Withdrawal by Subject|0|||
148973097|NCT01340976|537386069|FG003|Overall Study|Withdrawal by Subject|1|||
148973098|NCT01340976|537386070|FG004|Overall Study|Withdrawal by Subject|1|||
148973099|NCT01340976|537386071|FG005|Overall Study|Withdrawal by Subject|0|||
148973100|NCT01340976|537386066|FG000|Overall Study|Other anemia treatment|1|||
148973101|NCT01340976|537386067|FG001|Overall Study|Other anemia treatment|0|||
148973102|NCT01340976|537386068|FG002|Overall Study|Other anemia treatment|2|||
148973103|NCT01340976|537386069|FG003|Overall Study|Other anemia treatment|1|||
148973104|NCT01340976|537386070|FG004|Overall Study|Other anemia treatment|0|||
148973105|NCT01340976|537386071|FG005|Overall Study|Other anemia treatment|1|||
148973106|NCT01340976|537386066|FG000|Overall Study|Adverse Event|0|||
148973107|NCT01340976|537386067|FG001|Overall Study|Adverse Event|1|||
148973108|NCT01340976|537386068|FG002|Overall Study|Adverse Event|0|||
148973109|NCT01340976|537386069|FG003|Overall Study|Adverse Event|0|||
148973110|NCT01340976|537386070|FG004|Overall Study|Adverse Event|0|||
148973111|NCT01340976|537386071|FG005|Overall Study|Adverse Event|0|||
148973112|NCT02953821|537386072|FG000|Overall Study|Adverse Event|0|||
148973113|NCT02953821|537386073|FG001|Overall Study|Adverse Event|4|||
148973114|NCT02953821|537386072|FG000|Overall Study|Death|1|||
148973115|NCT02953821|537386073|FG001|Overall Study|Death|0|||
148973116|NCT02953821|537386072|FG000|Overall Study|Progressive Disease|5|||
148973117|NCT02953821|537386073|FG001|Overall Study|Progressive Disease|1|||
148973118|NCT02953821|537386072|FG000|Overall Study|Lost to Follow-up|2|||
148973119|NCT02953821|537386073|FG001|Overall Study|Lost to Follow-up|0|||
148973120|NCT02953821|537386072|FG000|Overall Study|Physician Decision|1|||
148973121|NCT02953821|537386073|FG001|Overall Study|Physician Decision|1|||
148973122|NCT02953821|537386072|FG000|Overall Study|Withdrawal by Subject|3|||
148973123|NCT02953821|537386073|FG001|Overall Study|Withdrawal by Subject|3|||
148973124|NCT02953821|537386072|FG000|Overall Study|Change of address|0|||
148973125|NCT02953821|537386073|FG001|Overall Study|Change of address|1|||
148973126|NCT02953821|537386072|FG000|Overall Study|Lack of Efficacy|1|||
148973127|NCT02953821|537386073|FG001|Overall Study|Lack of Efficacy|0|||
148973128|NCT02953821|537386072|FG000|Overall Study|Out of state for indeterminate time|0|||
148973129|NCT02953821|537386073|FG001|Overall Study|Out of state for indeterminate time|1|||
148973130|NCT02953821|537386072|FG000|Overall Study|No improvement|0|||
148732790|NCT02981303|536495079|FG001|Overall Study|Progressive Disease|37|||
148732791|NCT02981303|536495078|FG000|Overall Study|Adverse Event|1|||
148732792|NCT02981303|536495079|FG001|Overall Study|Adverse Event|4|||
148732793|NCT02981303|536495078|FG000|Overall Study|Withdrawal by Subject|0|||
148732794|NCT02981303|536495079|FG001|Overall Study|Withdrawal by Subject|1|||
148732795|NCT02325518|536495080|FG000|Overall Study|Adverse Event|4|||
148732796|NCT02325518|536495081|FG001|Overall Study|Adverse Event|1|||
148732797|NCT02325518|536495080|FG000|Overall Study|Physician Decision|0|||
148973131|NCT02953821|537386073|FG001|Overall Study|No improvement|1|||
148973132|NCT02953821|537386072|FG000|Overall Study|Refused follow-up visit|2|||
148973133|NCT02953821|537386073|FG001|Overall Study|Refused follow-up visit|1|||
148973134|NCT02103478|537386074|FG000|Overall Study|Adverse Event|0|||
148973135|NCT02103478|537386075|FG001|Overall Study|Adverse Event|0|||
148973136|NCT02103478|537386076|FG002|Overall Study|Adverse Event|1|||
148973137|NCT02103478|537386077|FG003|Overall Study|Adverse Event|1|||
148973138|NCT02103478|537386078|FG004|Overall Study|Adverse Event|2|||
148973139|NCT02103478|537386079|FG005|Overall Study|Adverse Event|1|||
148973140|NCT02103478|537386080|FG006|Overall Study|Adverse Event|0|||
148973141|NCT02103478|537386081|FG007|Overall Study|Adverse Event|0|||
148973142|NCT02103478|537386082|FG008|Overall Study|Adverse Event|0|||
148973143|NCT02103478|537386074|FG000|Overall Study|Death|2|||
148973144|NCT02103478|537386075|FG001|Overall Study|Death|2|||
148973145|NCT02103478|537386076|FG002|Overall Study|Death|1|||
148732798|NCT02325518|536495081|FG001|Overall Study|Physician Decision|1|||
148732799|NCT02325518|536495080|FG000|Overall Study|Withdrawal by Subject|0|||
148732800|NCT02325518|536495081|FG001|Overall Study|Withdrawal by Subject|1|||
148732801|NCT03393806|536495082|FG000|Overall Study|Physician Decision|1|||
148732802|NCT03393806|536495083|FG001|Overall Study|Physician Decision|0|||
148732803|NCT02116608|536495087|FG000|Overall Study|Lost to Follow-up|0|||
148732804|NCT02116608|536495088|FG001|Overall Study|Lost to Follow-up|0|||
148732805|NCT02116608|536495089|FG002|Overall Study|Lost to Follow-up|1|||
148732806|NCT02116608|536495087|FG000|Overall Study|Physician Decision|0|||
148732807|NCT02116608|536495088|FG001|Overall Study|Physician Decision|1|||
148732808|NCT02116608|536495089|FG002|Overall Study|Physician Decision|0|||
148732809|NCT02116608|536495087|FG000|Overall Study|Death|0|||
148732810|NCT02116608|536495088|FG001|Overall Study|Death|1|||
148732811|NCT02116608|536495089|FG002|Overall Study|Death|0|||
148732812|NCT00988442|536495090|FG000|Overall Study|Death|1|||
148732813|NCT00988442|536495091|FG001|Overall Study|Death|2|||
148732814|NCT00988442|536495090|FG000|Overall Study|Lost to Follow-up|0|||
148732815|NCT00988442|536495091|FG001|Overall Study|Lost to Follow-up|1|||
148732816|NCT00988442|536495090|FG000|Overall Study|Early Study Closure|29|||
148732817|NCT00988442|536495091|FG001|Overall Study|Early Study Closure|25|||
148732818|NCT01460901|536495096|FG000|Overall Study|Withdrawal by Subject|2|||
148732819|NCT00895947|536495097|FG000|Overall Study|Adverse Event|3|||
148732820|NCT00895947|536495098|FG001|Overall Study|Adverse Event|4|||
148732821|NCT00895947|536495097|FG000|Overall Study|Lost to Follow-up|3|||
148732822|NCT00895947|536495098|FG001|Overall Study|Lost to Follow-up|4|||
148732823|NCT00895947|536495097|FG000|Overall Study|Protocol Violation|4|||
148732824|NCT00895947|536495098|FG001|Overall Study|Protocol Violation|2|||
148732825|NCT00895947|536495097|FG000|Overall Study|Withdrawal by Subject|2|||
148732826|NCT00895947|536495098|FG001|Overall Study|Withdrawal by Subject|0|||
148732827|NCT00857259|536495105|FG000|Overall Study|Protocol Violation|1|||
148732828|NCT00857259|536495106|FG001|Overall Study|Protocol Violation|0|||
148732829|NCT00857259|536495107|FG002|Overall Study|Protocol Violation|1|||
148732830|NCT02701413|536495108|FG000|Overall Study|Withdrawal by Subject|7|||
148732831|NCT02701413|536495109|FG001|Overall Study|Withdrawal by Subject|11|||
148732832|NCT02138136|536495110|FG000|Overall Study|Protocol Violation|4|||
148732833|NCT02138136|536495110|FG000|Overall Study|Physician Decision|7|||
148732834|NCT02138136|536495110|FG000|Overall Study|Lack of Efficacy|35|||
148732835|NCT02138136|536495110|FG000|Overall Study|Pregnancy|2|||
148732836|NCT02138136|536495110|FG000|Overall Study|Adverse Event|18|||
148732837|NCT02138136|536495110|FG000|Overall Study|Withdrawal by Subject|36|||
148732838|NCT02138136|536495110|FG000|Overall Study|Lost to Follow-up|32|||
148732839|NCT02138136|536495110|FG000|Overall Study|Withdrawn by Sponsor|5|||
148732840|NCT01359644|536495111|FG000|Treatment Period|Lack of Efficacy|0|||
148732841|NCT01359644|536495112|FG001|Treatment Period|Lack of Efficacy|1|||
148732842|NCT01359644|536495113|FG002|Treatment Period|Lack of Efficacy|0|||
148732843|NCT01359644|536495114|FG003|Treatment Period|Lack of Efficacy|0|||
148732844|NCT01359644|536495115|FG004|Treatment Period|Lack of Efficacy|0|||
148732845|NCT01359644|536495116|FG005|Treatment Period|Lack of Efficacy|0|||
148732846|NCT01359644|536495117|FG006|Treatment Period|Lack of Efficacy|0|||
148732847|NCT01359644|536495118|FG007|Treatment Period|Lack of Efficacy|0|||
148732848|NCT01359644|536495119|FG008|Treatment Period|Lack of Efficacy|0|||
148732849|NCT01359644|536495120|FG009|Treatment Period|Lack of Efficacy|0|||
148732850|NCT01359644|536495111|FG000|Treatment Period|Adverse Event|0|||
148732851|NCT01359644|536495112|FG001|Treatment Period|Adverse Event|0|||
148732852|NCT01359644|536495113|FG002|Treatment Period|Adverse Event|1|||
148732853|NCT01359644|536495114|FG003|Treatment Period|Adverse Event|0|||
148732854|NCT01359644|536495115|FG004|Treatment Period|Adverse Event|0|||
148732855|NCT01359644|536495116|FG005|Treatment Period|Adverse Event|1|||
148732856|NCT01359644|536495117|FG006|Treatment Period|Adverse Event|0|||
148732857|NCT01359644|536495118|FG007|Treatment Period|Adverse Event|0|||
148732858|NCT01359644|536495119|FG008|Treatment Period|Adverse Event|0|||
148732859|NCT01359644|536495120|FG009|Treatment Period|Adverse Event|0|||
148732860|NCT01359644|536495111|FG000|Treatment Period|Lost to Follow-up|0|||
148732861|NCT01359644|536495112|FG001|Treatment Period|Lost to Follow-up|0|||
148732862|NCT01359644|536495113|FG002|Treatment Period|Lost to Follow-up|0|||
148732863|NCT01359644|536495114|FG003|Treatment Period|Lost to Follow-up|0|||
148732864|NCT01359644|536495115|FG004|Treatment Period|Lost to Follow-up|0|||
148732865|NCT01359644|536495116|FG005|Treatment Period|Lost to Follow-up|1|||
148732866|NCT01359644|536495117|FG006|Treatment Period|Lost to Follow-up|0|||
148732867|NCT01359644|536495118|FG007|Treatment Period|Lost to Follow-up|0|||
148732868|NCT01359644|536495119|FG008|Treatment Period|Lost to Follow-up|0|||
148732869|NCT01359644|536495120|FG009|Treatment Period|Lost to Follow-up|0|||
148732870|NCT01359644|536495111|FG000|Follow-up Period|Withdrawal by Subject|0|||
148732871|NCT01359644|536495112|FG001|Follow-up Period|Withdrawal by Subject|0|||
148732872|NCT01359644|536495113|FG002|Follow-up Period|Withdrawal by Subject|0|||
148732873|NCT01359644|536495114|FG003|Follow-up Period|Withdrawal by Subject|0|||
148732874|NCT01359644|536495115|FG004|Follow-up Period|Withdrawal by Subject|0|||
148732875|NCT01359644|536495116|FG005|Follow-up Period|Withdrawal by Subject|1|||
148732876|NCT01359644|536495117|FG006|Follow-up Period|Withdrawal by Subject|0|||
148732877|NCT01359644|536495118|FG007|Follow-up Period|Withdrawal by Subject|0|||
148732878|NCT01359644|536495119|FG008|Follow-up Period|Withdrawal by Subject|0|||
148732879|NCT01359644|536495120|FG009|Follow-up Period|Withdrawal by Subject|0|||
148732880|NCT01359644|536495111|FG000|Follow-up Period|Lost to Follow-up|0|||
148732881|NCT01359644|536495112|FG001|Follow-up Period|Lost to Follow-up|0|||
148732882|NCT01359644|536495113|FG002|Follow-up Period|Lost to Follow-up|0|||
148973146|NCT02103478|537386077|FG003|Overall Study|Death|1|||
148973147|NCT02103478|537386078|FG004|Overall Study|Death|5|||
148973148|NCT02103478|537386079|FG005|Overall Study|Death|15|||
148973149|NCT02103478|537386080|FG006|Overall Study|Death|14|||
148973150|NCT02103478|537386081|FG007|Overall Study|Death|10|||
148973151|NCT02103478|537386082|FG008|Overall Study|Death|11|||
148973152|NCT02103478|537386074|FG000|Overall Study|Progressive Disease|2|||
148973153|NCT02103478|537386075|FG001|Overall Study|Progressive Disease|1|||
148973154|NCT02103478|537386076|FG002|Overall Study|Progressive Disease|2|||
148973155|NCT02103478|537386077|FG003|Overall Study|Progressive Disease|0|||
148973156|NCT02103478|537386078|FG004|Overall Study|Progressive Disease|9|||
148973157|NCT02103478|537386079|FG005|Overall Study|Progressive Disease|1|||
148973158|NCT02103478|537386080|FG006|Overall Study|Progressive Disease|2|||
148973159|NCT02103478|537386081|FG007|Overall Study|Progressive Disease|0|||
148973160|NCT02103478|537386082|FG008|Overall Study|Progressive Disease|1|||
148973161|NCT02103478|537386074|FG000|Overall Study|Withdrawal by Subject|2|||
148973162|NCT02103478|537386075|FG001|Overall Study|Withdrawal by Subject|0|||
148973163|NCT02103478|537386076|FG002|Overall Study|Withdrawal by Subject|0|||
148973164|NCT02103478|537386077|FG003|Overall Study|Withdrawal by Subject|4|||
148973165|NCT02103478|537386078|FG004|Overall Study|Withdrawal by Subject|0|||
148973166|NCT02103478|537386079|FG005|Overall Study|Withdrawal by Subject|0|||
148973167|NCT02103478|537386080|FG006|Overall Study|Withdrawal by Subject|1|||
148973168|NCT02103478|537386081|FG007|Overall Study|Withdrawal by Subject|1|||
148973169|NCT02103478|537386082|FG008|Overall Study|Withdrawal by Subject|0|||
148973170|NCT02103478|537386074|FG000|Overall Study|Lost to Follow-up|0|||
148973171|NCT02103478|537386075|FG001|Overall Study|Lost to Follow-up|0|||
148973172|NCT02103478|537386076|FG002|Overall Study|Lost to Follow-up|0|||
148973173|NCT02103478|537386077|FG003|Overall Study|Lost to Follow-up|0|||
148973174|NCT02103478|537386078|FG004|Overall Study|Lost to Follow-up|0|||
148973175|NCT02103478|537386079|FG005|Overall Study|Lost to Follow-up|0|||
148973176|NCT02103478|537386080|FG006|Overall Study|Lost to Follow-up|0|||
148973177|NCT02103478|537386081|FG007|Overall Study|Lost to Follow-up|1|||
148973178|NCT02103478|537386082|FG008|Overall Study|Lost to Follow-up|0|||
148973179|NCT02103478|537386074|FG000|Overall Study|Other|1|||
148973180|NCT02103478|537386075|FG001|Overall Study|Other|3|||
148973181|NCT02103478|537386076|FG002|Overall Study|Other|2|||
148973182|NCT02103478|537386077|FG003|Overall Study|Other|0|||
148973183|NCT02103478|537386078|FG004|Overall Study|Other|3|||
148973184|NCT02103478|537386079|FG005|Overall Study|Other|8|||
148973185|NCT02103478|537386080|FG006|Overall Study|Other|8|||
148973186|NCT02103478|537386081|FG007|Overall Study|Other|4|||
148973187|NCT02103478|537386082|FG008|Overall Study|Other|2|||
148973188|NCT00723606|537386083|FG000|Overall Study|Adverse Event|2|||
148973189|NCT00723606|537386084|FG001|Overall Study|Adverse Event|5|||
148973190|NCT00723606|537386083|FG000|Overall Study|Other|2|||
148973191|NCT00723606|537386084|FG001|Overall Study|Other|0|||
148973192|NCT00723606|537386083|FG000|Overall Study|Withdrawal by Subject|0|||
148973193|NCT00723606|537386084|FG001|Overall Study|Withdrawal by Subject|2|||
148973194|NCT01096784|537386085|FG000|Overall Study|Withdrawal by Subject|2|||
148973195|NCT01096784|537386086|FG001|Overall Study|Withdrawal by Subject|1|||
148973196|NCT01096784|537386085|FG000|Overall Study|Adverse Event|11|||
148973197|NCT01096784|537386086|FG001|Overall Study|Adverse Event|9|||
148973198|NCT01096784|537386085|FG000|Overall Study|Protocol Deviation|2|||
148973199|NCT01096784|537386086|FG001|Overall Study|Protocol Deviation|2|||
148973200|NCT01096784|537386085|FG000|Overall Study|Administrative Decision|0|||
148973201|NCT01096784|537386086|FG001|Overall Study|Administrative Decision|1|||
148973202|NCT01096784|537386085|FG000|Overall Study|Other Unspecified|0|||
148973203|NCT01096784|537386086|FG001|Overall Study|Other Unspecified|1|||
148973204|NCT03761628|537386087|FG000|Overall Study|Withdrawal by Subject|3|||
148973205|NCT03761628|537386087|FG000|Overall Study|Physician Decision|1|||
148973206|NCT03761628|537386087|FG000|Overall Study|Pregnancy|1|||
148973207|NCT03761628|537386087|FG000|Overall Study|Lost to Follow-up|1|||
148973208|NCT02975934|537386090|FG000|Treatment Phase|Never initiated study drug|0|||
148973209|NCT02975934|537386091|FG001|Treatment Phase|Never initiated study drug|5|||
148973210|NCT02975934|537386092|FG002|Treatment Phase|Never initiated study drug|0|||
148973211|NCT03362502|537386093|FG000|Overall Study|Death|0|||
148973212|NCT03362502|537386094|FG001|Overall Study|Death|0|||
148973213|NCT03362502|537386095|FG002|Overall Study|Death|1|||
148973214|NCT00433654|537386098|FG000|Overall Study|Death|4|||
148973215|NCT00433654|537386099|FG001|Overall Study|Death|0|||
148973216|NCT00433654|537386098|FG000|Overall Study|Missed visit|6|||
148973217|NCT00433654|537386099|FG001|Overall Study|Missed visit|3|||
148973218|NCT00433654|537386098|FG000|Overall Study|Subject not yet due for visit|4|||
148973219|NCT00433654|537386099|FG001|Overall Study|Subject not yet due for visit|0|||
148973220|NCT00433654|537386098|FG000|Overall Study|Withdrawal by Subject|1|||
148973221|NCT00433654|537386099|FG001|Overall Study|Withdrawal by Subject|2|||
148973222|NCT03277261|537386100|FG000|Overall Study|Adverse Event|17|||
148973223|NCT03277261|537386101|FG001|Overall Study|Adverse Event|1|||
148973224|NCT03277261|537386100|FG000|Overall Study|Participant Withdrawal of Consent|6|||
148973225|NCT03277261|537386101|FG001|Overall Study|Participant Withdrawal of Consent|15|||
148973226|NCT03277261|537386100|FG000|Overall Study|Investigator / Sponsor Decision|4|||
148973227|NCT03277261|537386101|FG001|Overall Study|Investigator / Sponsor Decision|2|||
148973228|NCT03277261|537386100|FG000|Overall Study|Pregnancy|2|||
148973229|NCT03277261|537386101|FG001|Overall Study|Pregnancy|0|||
148973230|NCT03277261|537386100|FG000|Overall Study|Lost to Follow-up|2|||
148973231|NCT03277261|537386101|FG001|Overall Study|Lost to Follow-up|2|||
148973232|NCT03277261|537386100|FG000|Overall Study|Lack of Efficacy|2|||
148973233|NCT03277261|537386101|FG001|Overall Study|Lack of Efficacy|2|||
148973234|NCT03277261|537386100|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
148973235|NCT03277261|537386101|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
148973236|NCT02043015|537386102|FG000|Overall Study|Lost to Follow-up|4|||
148973237|NCT02043015|537386102|FG000|Overall Study|Withdrawal by Subject|4|||
148973238|NCT02043015|537386102|FG000|Overall Study|Removed once target enrollment reached|15|||
148973239|NCT02043015|537386102|FG000|Overall Study|Participant moved away from study city|4|||
148973240|NCT02043015|537386102|FG000|Overall Study|Incarceration|1|||
148732883|NCT01359644|536495114|FG003|Follow-up Period|Lost to Follow-up|0|||
148732884|NCT01359644|536495115|FG004|Follow-up Period|Lost to Follow-up|0|||
148732885|NCT01359644|536495116|FG005|Follow-up Period|Lost to Follow-up|0|||
148732886|NCT01359644|536495117|FG006|Follow-up Period|Lost to Follow-up|1|||
148732887|NCT01359644|536495118|FG007|Follow-up Period|Lost to Follow-up|2|||
148732888|NCT01359644|536495119|FG008|Follow-up Period|Lost to Follow-up|0|||
148732889|NCT01359644|536495120|FG009|Follow-up Period|Lost to Follow-up|0|||
148732890|NCT00311311|536495122|FG000|Overall Study|Adverse Event|3|||
148732891|NCT00311311|536495123|FG001|Overall Study|Adverse Event|2|||
148732892|NCT00311311|536495122|FG000|Overall Study|Withdrawal by Subject|1|||
148732893|NCT00311311|536495123|FG001|Overall Study|Withdrawal by Subject|1|||
148732894|NCT00311311|536495122|FG000|Overall Study|Noncompliance|0|||
148732895|NCT00311311|536495123|FG001|Overall Study|Noncompliance|1|||
148732896|NCT00311311|536495122|FG000|Overall Study|Study Termination by Sponsor|3|||
148732897|NCT00311311|536495123|FG001|Overall Study|Study Termination by Sponsor|4|||
148732898|NCT00311311|536495122|FG000|Overall Study|Death|1|||
148732899|NCT00311311|536495123|FG001|Overall Study|Death|0|||
148732900|NCT00311311|536495122|FG000|Overall Study|Lack of ancillary assistance|0|||
148732901|NCT00311311|536495123|FG001|Overall Study|Lack of ancillary assistance|1|||
148732902|NCT02685202|536495124|FG000|Overall Study|Lost to Follow-up|9|||
148732903|NCT02615171|536495127|FG000|Overall Study|Lost to Follow-up|2|||
148732904|NCT02615171|536495128|FG001|Overall Study|Lost to Follow-up|1|||
148732905|NCT00741936|536495136|FG000|Overall Study|Lost to Follow-up|1|||
148732906|NCT00741936|536495137|FG001|Overall Study|Lost to Follow-up|1|||
148732907|NCT00741936|536495136|FG000|Overall Study|Adverse Event|3|||
148732908|NCT00741936|536495137|FG001|Overall Study|Adverse Event|4|||
148732909|NCT00741936|536495136|FG000|Overall Study|Pregnancy|0|||
148732910|NCT00741936|536495137|FG001|Overall Study|Pregnancy|1|||
148732911|NCT00741936|536495136|FG000|Overall Study|Protocol Violation|2|||
148732912|NCT00741936|536495137|FG001|Overall Study|Protocol Violation|0|||
148732913|NCT00741936|536495136|FG000|Overall Study|Lack of Efficacy|0|||
148732914|NCT00741936|536495137|FG001|Overall Study|Lack of Efficacy|2|||
148732915|NCT00741936|536495136|FG000|Overall Study|Low compliance|3|||
148732916|NCT00741936|536495137|FG001|Overall Study|Low compliance|0|||
148732917|NCT00369382|536495138|FG000|Overall Study|Death|0|||
148732918|NCT00369382|536495139|FG001|Overall Study|Death|2|||
148732919|NCT00369382|536495138|FG000|Overall Study|Physician Decision|2|||
148732920|NCT00369382|536495139|FG001|Overall Study|Physician Decision|1|||
148732921|NCT00369382|536495138|FG000|Overall Study|Withdrawal by Subject|5|||
148732922|NCT00369382|536495139|FG001|Overall Study|Withdrawal by Subject|0|||
148732923|NCT00369382|536495138|FG000|Overall Study|Randomized, not treated|2|||
148732924|NCT00369382|536495139|FG001|Overall Study|Randomized, not treated|0|||
148732925|NCT00369382|536495138|FG000|Overall Study|Other|1|||
148732926|NCT00369382|536495139|FG001|Overall Study|Other|0|||
148732927|NCT05011123|536497292|FG000|Overall Study|Withdrawal by Subject|4|||
148732928|NCT05011123|536497293|FG001|Overall Study|Withdrawal by Subject|2|||
148732929|NCT05011123|536497292|FG000|Overall Study|Lost to Follow-up|7|||
148732930|NCT05011123|536497293|FG001|Overall Study|Lost to Follow-up|6|||
148732931|NCT05011123|536497292|FG000|Overall Study|Ongoing at the time of DBL date|36|||
148732932|NCT05011123|536497293|FG001|Overall Study|Ongoing at the time of DBL date|10|||
148732933|NCT05011123|536497292|FG000|Overall Study|Randomized but did not receive vaccination|1|||
148973241|NCT01403974|537386103|FG000|Overall Study|Progressive disease according to RECIST|3|||
148973242|NCT01403974|537386104|FG001|Overall Study|Progressive disease according to RECIST|3|||
148973243|NCT01403974|537386105|FG002|Overall Study|Progressive disease according to RECIST|2|||
148973244|NCT01403974|537386106|FG003|Overall Study|Progressive disease according to RECIST|3|||
148973245|NCT01403974|537386107|FG004|Overall Study|Progressive disease according to RECIST|3|||
148732934|NCT05011123|536497293|FG001|Overall Study|Randomized but did not receive vaccination|0|||
148732935|NCT03845296|536497305|FG000|Overall Study|On Treatment|2|||
148732936|NCT03845296|536497306|FG001|Overall Study|On Treatment|1|||
148732937|NCT03845296|536497305|FG000|Overall Study|Adverse Event|4|||
148732938|NCT03845296|536497306|FG001|Overall Study|Adverse Event|11|||
148732939|NCT03845296|536497305|FG000|Overall Study|Refusal unrelated to adverse event|0|||
148732940|NCT03845296|536497306|FG001|Overall Study|Refusal unrelated to adverse event|1|||
148732941|NCT03845296|536497305|FG000|Overall Study|Progression/relapse|14|||
148732942|NCT03845296|536497306|FG001|Overall Study|Progression/relapse|18|||
148732943|NCT03845296|536497305|FG000|Overall Study|Death|4|||
148732944|NCT03845296|536497306|FG001|Overall Study|Death|0|||
148732945|NCT03845296|536497305|FG000|Overall Study|Other - not protocol specified|1|||
148732946|NCT03845296|536497306|FG001|Overall Study|Other - not protocol specified|3|||
148732947|NCT04732221|536497309|FG000|Base Period|Death|2|||
148732948|NCT04732221|536497310|FG001|Base Period|Death|0|||
148732949|NCT04732221|536497311|FG002|Base Period|Death|0|||
148732950|NCT04732221|536497312|FG003|Base Period|Death|0|||
148732951|NCT04732221|536497313|FG004|Base Period|Death|0|||
148732952|NCT04732221|536497314|FG005|Base Period|Death|0|||
148732953|NCT04732221|536497315|FG006|Base Period|Death|0|||
148732954|NCT04732221|536497309|FG000|Base Period|Withdrawal by Subject|0|||
148732955|NCT04732221|536497310|FG001|Base Period|Withdrawal by Subject|1|||
148732956|NCT04732221|536497311|FG002|Base Period|Withdrawal by Subject|1|||
148732957|NCT04732221|536497312|FG003|Base Period|Withdrawal by Subject|0|||
148732958|NCT04732221|536497313|FG004|Base Period|Withdrawal by Subject|0|||
148732959|NCT04732221|536497314|FG005|Base Period|Withdrawal by Subject|0|||
148732960|NCT04732221|536497315|FG006|Base Period|Withdrawal by Subject|0|||
148732961|NCT04732221|536497309|FG000|Extension Period|Adverse Event|0|||
148732962|NCT04732221|536497310|FG001|Extension Period|Adverse Event|0|||
148732963|NCT04732221|536497311|FG002|Extension Period|Adverse Event|0|||
148732964|NCT04732221|536497312|FG003|Extension Period|Adverse Event|0|||
148732965|NCT04732221|536497313|FG004|Extension Period|Adverse Event|0|||
148732966|NCT04732221|536497314|FG005|Extension Period|Adverse Event|1|||
148732967|NCT04732221|536497315|FG006|Extension Period|Adverse Event|0|||
148732968|NCT04732221|536497309|FG000|Extension Period|Death|0|||
148732969|NCT04732221|536497310|FG001|Extension Period|Death|0|||
148732970|NCT04732221|536497311|FG002|Extension Period|Death|0|||
148732971|NCT04732221|536497312|FG003|Extension Period|Death|0|||
148732972|NCT04732221|536497313|FG004|Extension Period|Death|1|||
148732973|NCT04732221|536497314|FG005|Extension Period|Death|0|||
148732974|NCT04732221|536497315|FG006|Extension Period|Death|2|||
148732975|NCT04732221|536497309|FG000|Extension Period|Pregnancy|0|||
148732976|NCT04732221|536497310|FG001|Extension Period|Pregnancy|0|||
148732977|NCT04732221|536497311|FG002|Extension Period|Pregnancy|0|||
148732978|NCT04732221|536497312|FG003|Extension Period|Pregnancy|0|||
148732979|NCT04732221|536497313|FG004|Extension Period|Pregnancy|1|||
148732980|NCT04732221|536497314|FG005|Extension Period|Pregnancy|0|||
148732981|NCT04732221|536497315|FG006|Extension Period|Pregnancy|0|||
148732982|NCT04732221|536497309|FG000|Extension Period|Sponsors Decision|0|||
148732983|NCT04732221|536497310|FG001|Extension Period|Sponsors Decision|0|||
148732984|NCT04732221|536497311|FG002|Extension Period|Sponsors Decision|0|||
148732985|NCT04732221|536497312|FG003|Extension Period|Sponsors Decision|0|||
148732986|NCT04732221|536497313|FG004|Extension Period|Sponsors Decision|41|||
148732987|NCT04732221|536497314|FG005|Extension Period|Sponsors Decision|40|||
148732988|NCT04732221|536497315|FG006|Extension Period|Sponsors Decision|40|||
148732989|NCT04732221|536497309|FG000|Extension Period|Withdrawal by Subject|0|||
148732990|NCT04732221|536497310|FG001|Extension Period|Withdrawal by Subject|0|||
148732991|NCT04732221|536497311|FG002|Extension Period|Withdrawal by Subject|0|||
148732992|NCT04732221|536497312|FG003|Extension Period|Withdrawal by Subject|0|||
148732993|NCT04732221|536497313|FG004|Extension Period|Withdrawal by Subject|1|||
148732994|NCT04732221|536497314|FG005|Extension Period|Withdrawal by Subject|5|||
148732995|NCT04732221|536497315|FG006|Extension Period|Withdrawal by Subject|2|||
148973246|NCT01403974|537386108|FG005|Overall Study|Progressive disease according to RECIST|2|||
148973247|NCT01403974|537386109|FG006|Overall Study|Progressive disease according to RECIST|3|||
148973248|NCT01403974|537386110|FG007|Overall Study|Progressive disease according to RECIST|2|||
148732996|NCT04394351|536497316|FG000|Part A (16 Weeks)|Adverse Event|1|||
148732997|NCT04394351|536497317|FG001|Part A (16 Weeks)|Adverse Event|0|||
148732998|NCT04394351|536497318|FG002|Part A (16 Weeks)|Adverse Event|0|||
148732999|NCT04394351|536497319|FG003|Part A (16 Weeks)|Adverse Event|0|||
148733000|NCT04394351|536497320|FG004|Part A (16 Weeks)|Adverse Event|0|||
148733001|NCT04394351|536497321|FG005|Part A (16 Weeks)|Adverse Event|0|||
148733002|NCT04394351|536497322|FG006|Part A (16 Weeks)|Adverse Event|0|||
148733003|NCT04394351|536497323|FG007|Part A (16 Weeks)|Adverse Event|0|||
148733004|NCT04394351|536497316|FG000|Part A (16 Weeks)|Physician Decision|0|||
148733005|NCT04394351|536497317|FG001|Part A (16 Weeks)|Physician Decision|1|||
148733006|NCT04394351|536497318|FG002|Part A (16 Weeks)|Physician Decision|0|||
148733007|NCT04394351|536497319|FG003|Part A (16 Weeks)|Physician Decision|0|||
148733008|NCT04394351|536497320|FG004|Part A (16 Weeks)|Physician Decision|0|||
148733009|NCT04394351|536497321|FG005|Part A (16 Weeks)|Physician Decision|0|||
148733010|NCT04394351|536497322|FG006|Part A (16 Weeks)|Physician Decision|0|||
148733011|NCT04394351|536497323|FG007|Part A (16 Weeks)|Physician Decision|0|||
148733012|NCT04394351|536497316|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733013|NCT04394351|536497317|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
148733014|NCT04394351|536497318|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733015|NCT04394351|536497319|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733016|NCT04394351|536497320|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733017|NCT04394351|536497321|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733018|NCT04394351|536497322|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733019|NCT04394351|536497323|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
148733020|NCT04394351|536497316|FG000|Part B (36 Weeks)|Adverse Event|0|||
148733021|NCT04394351|536497317|FG001|Part B (36 Weeks)|Adverse Event|0|||
148733022|NCT04394351|536497318|FG002|Part B (36 Weeks)|Adverse Event|0|||
148733023|NCT04394351|536497319|FG003|Part B (36 Weeks)|Adverse Event|0|||
148733024|NCT04394351|536497320|FG004|Part B (36 Weeks)|Adverse Event|0|||
148733025|NCT04394351|536497321|FG005|Part B (36 Weeks)|Adverse Event|0|||
148733026|NCT04394351|536497322|FG006|Part B (36 Weeks)|Adverse Event|1|||
148733027|NCT04394351|536497323|FG007|Part B (36 Weeks)|Adverse Event|0|||
148733028|NCT04394351|536497316|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733029|NCT04394351|536497317|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733030|NCT04394351|536497318|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733031|NCT04394351|536497319|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733032|NCT04394351|536497320|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733033|NCT04394351|536497321|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733034|NCT04394351|536497322|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
148733035|NCT04394351|536497323|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
148733036|NCT04394351|536497316|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733037|NCT04394351|536497317|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733038|NCT04394351|536497318|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733039|NCT04394351|536497319|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733040|NCT04394351|536497320|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733041|NCT04394351|536497321|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733042|NCT04394351|536497322|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
148733043|NCT04394351|536497323|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
148733044|NCT04394351|536497316|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733045|NCT04394351|536497317|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733046|NCT04394351|536497318|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733047|NCT04394351|536497319|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733048|NCT04394351|536497320|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733049|NCT04394351|536497321|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733050|NCT04394351|536497322|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
148733051|NCT04394351|536497323|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
148733052|NCT04394351|536497316|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733053|NCT04394351|536497317|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733054|NCT04394351|536497318|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733055|NCT04394351|536497319|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733056|NCT04394351|536497320|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733057|NCT04394351|536497321|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733058|NCT04394351|536497322|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
148733059|NCT04394351|536497323|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
148733060|NCT05327816|536497328|FG000|Overall Study|Lost to Follow-up|1|||
148733061|NCT05327816|536497329|FG001|Overall Study|Lost to Follow-up|0|||
148733062|NCT05327816|536497330|FG002|Overall Study|Lost to Follow-up|0|||
148733063|NCT05327816|536497331|FG003|Overall Study|Lost to Follow-up|0|||
148733064|NCT05327816|536497332|FG004|Overall Study|Lost to Follow-up|0|||
148733065|NCT05327816|536497333|FG005|Overall Study|Lost to Follow-up|0|||
148733066|NCT05327816|536497334|FG006|Overall Study|Lost to Follow-up|0|||
148733067|NCT05327816|536497335|FG007|Overall Study|Lost to Follow-up|0|||
148733068|NCT05327816|536497336|FG008|Overall Study|Lost to Follow-up|0|||
148733069|NCT05327816|536497337|FG009|Overall Study|Lost to Follow-up|1|||
148733070|NCT05327816|536497338|FG010|Overall Study|Lost to Follow-up|0|||
148733071|NCT05327816|536497328|FG000|Overall Study|Withdrawal by Subject|0|||
148733072|NCT05327816|536497329|FG001|Overall Study|Withdrawal by Subject|0|||
148733073|NCT05327816|536497330|FG002|Overall Study|Withdrawal by Subject|0|||
148733074|NCT05327816|536497331|FG003|Overall Study|Withdrawal by Subject|0|||
148733075|NCT05327816|536497332|FG004|Overall Study|Withdrawal by Subject|1|||
148733076|NCT05327816|536497333|FG005|Overall Study|Withdrawal by Subject|1|||
148733077|NCT05327816|536497334|FG006|Overall Study|Withdrawal by Subject|0|||
148733078|NCT05327816|536497335|FG007|Overall Study|Withdrawal by Subject|0|||
148733079|NCT05327816|536497336|FG008|Overall Study|Withdrawal by Subject|0|||
148733080|NCT05327816|536497337|FG009|Overall Study|Withdrawal by Subject|0|||
148733081|NCT05327816|536497338|FG010|Overall Study|Withdrawal by Subject|0|||
148733082|NCT05327816|536497328|FG000|Overall Study|Study Terminated by Sponsor|11|||
148973249|NCT01403974|537386111|FG008|Overall Study|Progressive disease according to RECIST|6|||
148973250|NCT01403974|537386112|FG009|Overall Study|Progressive disease according to RECIST|2|||
148973251|NCT01403974|537386113|FG010|Overall Study|Progressive disease according to RECIST|3|||
148973252|NCT01403974|537386114|FG011|Overall Study|Progressive disease according to RECIST|2|||
148973253|NCT01403974|537386115|FG012|Overall Study|Progressive disease according to RECIST|2|||
148973254|NCT01403974|537386116|FG013|Overall Study|Progressive disease according to RECIST|3|||
148973255|NCT01403974|537386117|FG014|Overall Study|Progressive disease according to RECIST|1|||
148973256|NCT01403974|537386118|FG015|Overall Study|Progressive disease according to RECIST|8|||
148973257|NCT01403974|537386103|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
148973258|NCT01403974|537386104|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
148973259|NCT01403974|537386105|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
148973260|NCT01403974|537386106|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
148973261|NCT01403974|537386107|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
148973262|NCT01403974|537386108|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
148973263|NCT01403974|537386109|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
148973264|NCT01403974|537386110|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
148973265|NCT01403974|537386111|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
148973266|NCT01403974|537386112|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
148973267|NCT01403974|537386113|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
148973268|NCT01403974|537386114|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
148973269|NCT01403974|537386115|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
148973270|NCT01403974|537386116|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
148973271|NCT01403974|537386117|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
148973272|NCT01403974|537386118|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
148973273|NCT01403974|537386103|FG000|Overall Study|Refused to continue study medication|0|||
148973274|NCT01403974|537386104|FG001|Overall Study|Refused to continue study medication|0|||
148973275|NCT01403974|537386105|FG002|Overall Study|Refused to continue study medication|0|||
148973276|NCT01403974|537386106|FG003|Overall Study|Refused to continue study medication|0|||
148973277|NCT01403974|537386107|FG004|Overall Study|Refused to continue study medication|0|||
148973278|NCT01403974|537386108|FG005|Overall Study|Refused to continue study medication|1|||
148973279|NCT01403974|537386109|FG006|Overall Study|Refused to continue study medication|0|||
148973280|NCT01403974|537386110|FG007|Overall Study|Refused to continue study medication|0|||
148973281|NCT01403974|537386111|FG008|Overall Study|Refused to continue study medication|1|||
148973282|NCT01403974|537386112|FG009|Overall Study|Refused to continue study medication|0|||
148973283|NCT01403974|537386113|FG010|Overall Study|Refused to continue study medication|1|||
148973284|NCT01403974|537386114|FG011|Overall Study|Refused to continue study medication|0|||
148973285|NCT01403974|537386115|FG012|Overall Study|Refused to continue study medication|0|||
148973286|NCT01403974|537386116|FG013|Overall Study|Refused to continue study medication|0|||
148973287|NCT01403974|537386117|FG014|Overall Study|Refused to continue study medication|0|||
148973288|NCT01403974|537386118|FG015|Overall Study|Refused to continue study medication|4|||
148973289|NCT01403974|537386103|FG000|Overall Study|Adverse Event|0|||
148973290|NCT01403974|537386104|FG001|Overall Study|Adverse Event|0|||
148973291|NCT01403974|537386105|FG002|Overall Study|Adverse Event|1|||
148733083|NCT05327816|536497329|FG001|Overall Study|Study Terminated by Sponsor|12|||
148733084|NCT05327816|536497330|FG002|Overall Study|Study Terminated by Sponsor|12|||
148733085|NCT05327816|536497331|FG003|Overall Study|Study Terminated by Sponsor|12|||
148733086|NCT05327816|536497332|FG004|Overall Study|Study Terminated by Sponsor|11|||
148733087|NCT05327816|536497333|FG005|Overall Study|Study Terminated by Sponsor|11|||
148733088|NCT05327816|536497334|FG006|Overall Study|Study Terminated by Sponsor|11|||
148733089|NCT05327816|536497335|FG007|Overall Study|Study Terminated by Sponsor|11|||
148733090|NCT05327816|536497336|FG008|Overall Study|Study Terminated by Sponsor|11|||
148733091|NCT05327816|536497337|FG009|Overall Study|Study Terminated by Sponsor|11|||
148733092|NCT05327816|536497338|FG010|Overall Study|Study Terminated by Sponsor|12|||
148733093|NCT05327816|536497328|FG000|Overall Study|Randomized but not treated|0|||
148733094|NCT05327816|536497329|FG001|Overall Study|Randomized but not treated|0|||
148733095|NCT05327816|536497330|FG002|Overall Study|Randomized but not treated|0|||
148733096|NCT05327816|536497331|FG003|Overall Study|Randomized but not treated|0|||
148733097|NCT05327816|536497332|FG004|Overall Study|Randomized but not treated|0|||
148733098|NCT05327816|536497333|FG005|Overall Study|Randomized but not treated|0|||
148733099|NCT05327816|536497334|FG006|Overall Study|Randomized but not treated|1|||
148733100|NCT05327816|536497335|FG007|Overall Study|Randomized but not treated|1|||
148733101|NCT05327816|536497336|FG008|Overall Study|Randomized but not treated|1|||
148733102|NCT05327816|536497337|FG009|Overall Study|Randomized but not treated|0|||
148733103|NCT05327816|536497338|FG010|Overall Study|Randomized but not treated|0|||
148733104|NCT01106014|536497339|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
148733105|NCT01106014|536497340|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
148733106|NCT01106014|536497339|FG000|Overall Study|Adverse Event|78|||
148733107|NCT01106014|536497340|FG001|Overall Study|Adverse Event|42|||
148733108|NCT01106014|536497339|FG000|Overall Study|Withdrawal by Subject|43|||
148733109|NCT01106014|536497340|FG001|Overall Study|Withdrawal by Subject|37|||
148733110|NCT01106014|536497339|FG000|Overall Study|Administrative reason|7|||
148733111|NCT01106014|536497340|FG001|Overall Study|Administrative reason|6|||
148733112|NCT01106014|536497339|FG000|Overall Study|Lost to Follow-up|2|||
148733113|NCT01106014|536497340|FG001|Overall Study|Lost to Follow-up|3|||
148733114|NCT00658658|536497347|FG000|Overall Study|Withdrawal by Subject|0|||
148733115|NCT00658658|536497348|FG001|Overall Study|Withdrawal by Subject|1|||
148733116|NCT00658658|536497349|FG002|Overall Study|Withdrawal by Subject|0|||
148733117|NCT00658658|536497350|FG003|Overall Study|Withdrawal by Subject|0|||
148733118|NCT00658658|536497351|FG004|Overall Study|Withdrawal by Subject|0|||
148733119|NCT00658658|536497347|FG000|Overall Study|Death|4|||
148733120|NCT00658658|536497348|FG001|Overall Study|Death|0|||
148733121|NCT00658658|536497349|FG002|Overall Study|Death|0|||
148733122|NCT00658658|536497350|FG003|Overall Study|Death|1|||
148733123|NCT00658658|536497351|FG004|Overall Study|Death|1|||
148733124|NCT00658658|536497347|FG000|Overall Study|Disease Progression|0|||
148733125|NCT00658658|536497348|FG001|Overall Study|Disease Progression|1|||
148733126|NCT00658658|536497349|FG002|Overall Study|Disease Progression|0|||
148733127|NCT00658658|536497350|FG003|Overall Study|Disease Progression|1|||
148733128|NCT00658658|536497351|FG004|Overall Study|Disease Progression|3|||
148733129|NCT00658658|536497347|FG000|Overall Study|Protocol-specified Criteria|1|||
148733130|NCT00658658|536497348|FG001|Overall Study|Protocol-specified Criteria|0|||
148733131|NCT00658658|536497349|FG002|Overall Study|Protocol-specified Criteria|0|||
148733132|NCT00658658|536497350|FG003|Overall Study|Protocol-specified Criteria|0|||
148733133|NCT00658658|536497351|FG004|Overall Study|Protocol-specified Criteria|0|||
148733134|NCT00658658|536497347|FG000|Overall Study|Other|0|||
148733135|NCT00658658|536497348|FG001|Overall Study|Other|0|||
148733136|NCT00658658|536497349|FG002|Overall Study|Other|0|||
148733137|NCT00658658|536497350|FG003|Overall Study|Other|0|||
148733138|NCT00658658|536497351|FG004|Overall Study|Other|1|||
148733139|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
148733140|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
148733141|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
148733142|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
148733143|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
148733144|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
148733145|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
148733146|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
148733147|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
148733148|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
148733149|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
148733150|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
148733151|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
148733152|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
148733153|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
148733154|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
148733155|NCT03182244|536497353|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
148733156|NCT03182244|536497354|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
148733157|NCT03182244|536497353|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
148733158|NCT03182244|536497354|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
148733159|NCT03182244|536497353|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
148733160|NCT03182244|536497354|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
148733161|NCT03182244|536497353|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
148733162|NCT03182244|536497354|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
148733163|NCT03182244|536497353|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
148733164|NCT03182244|536497354|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
148733165|NCT00824616|536497355|FG000|Overall Study|Adverse Event|2|||
148733166|NCT00824616|536497356|FG001|Overall Study|Adverse Event|1|||
148733167|NCT00824616|536497355|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
148733168|NCT00824616|536497356|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
148733169|NCT00824616|536497355|FG000|Overall Study|Hyperglycemia|1|||
148733170|NCT00824616|536497356|FG001|Overall Study|Hyperglycemia|1|||
148973292|NCT01403974|537386106|FG003|Overall Study|Adverse Event|0|||
148733171|NCT00824616|536497355|FG000|Overall Study|Lack of Efficacy|2|||
148733172|NCT00824616|536497356|FG001|Overall Study|Lack of Efficacy|1|||
148733173|NCT00824616|536497355|FG000|Overall Study|Lost to Follow-up|0|||
148733174|NCT00824616|536497356|FG001|Overall Study|Lost to Follow-up|1|||
148733175|NCT00824616|536497355|FG000|Overall Study|Withdrawal by Subject|1|||
148973293|NCT01403974|537386107|FG004|Overall Study|Adverse Event|0|||
148733176|NCT00824616|536497356|FG001|Overall Study|Withdrawal by Subject|1|||
148733177|NCT04711902|536497357|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
148733178|NCT04711902|536497358|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
148973294|NCT01403974|537386108|FG005|Overall Study|Adverse Event|0|||
148733179|NCT04711902|536497359|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
148733180|NCT04711902|536497360|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
149026773|NCT04978363|537576384|FG001|Overall Study|Other medical issues unrelated to the study|0|||
149026774|NCT04978363|537576385|FG002|Overall Study|Other medical issues unrelated to the study|0|||
149026775|NCT04978363|537576386|FG003|Overall Study|Other medical issues unrelated to the study|0|||
149026776|NCT04978363|537576387|FG004|Overall Study|Other medical issues unrelated to the study|1|||
149026777|NCT04978363|537576388|FG005|Overall Study|Other medical issues unrelated to the study|0|||
149026778|NCT04978363|537576389|FG006|Overall Study|Other medical issues unrelated to the study|0|||
149026779|NCT04978363|537576390|FG007|Overall Study|Other medical issues unrelated to the study|0|||
149026780|NCT04978363|537576391|FG008|Overall Study|Other medical issues unrelated to the study|0|||
149026781|NCT04978363|537576392|FG009|Overall Study|Other medical issues unrelated to the study|0|||
149026782|NCT04978363|537576393|FG010|Overall Study|Other medical issues unrelated to the study|0|||
149026783|NCT04978363|537576383|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
149026784|NCT04978363|537576384|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
149026785|NCT04978363|537576385|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
149026786|NCT04978363|537576386|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
149026787|NCT04978363|537576387|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
149026788|NCT04978363|537576388|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
149026789|NCT04978363|537576389|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
149026790|NCT04978363|537576390|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
149026791|NCT04978363|537576391|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
149026792|NCT04978363|537576392|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
149026793|NCT04978363|537576393|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
149026794|NCT04978363|537576383|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026795|NCT04978363|537576384|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
149026796|NCT04978363|537576385|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026797|NCT04978363|537576386|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026798|NCT04978363|537576387|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026799|NCT04978363|537576388|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026800|NCT04978363|537576389|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026801|NCT04978363|537576390|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026802|NCT04978363|537576391|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026803|NCT04978363|537576392|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026804|NCT04978363|537576393|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
149026805|NCT01251614|537576394|FG000|Overall Study|Adverse Event|1|||
149026806|NCT01251614|537576395|FG001|Overall Study|Adverse Event|0|||
149026807|NCT01251614|537576396|FG002|Overall Study|Adverse Event|1|||
149026808|NCT01251614|537576394|FG000|Overall Study|Lack of Efficacy|1|||
149026809|NCT01251614|537576395|FG001|Overall Study|Lack of Efficacy|9|||
149026810|NCT01251614|537576396|FG002|Overall Study|Lack of Efficacy|4|||
149026811|NCT01251614|537576394|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
149026812|NCT01251614|537576395|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
149026813|NCT01251614|537576396|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
149026814|NCT01251614|537576394|FG000|Overall Study|Pregnancy|0|||
149026815|NCT01251614|537576395|FG001|Overall Study|Pregnancy|0|||
149026816|NCT01251614|537576396|FG002|Overall Study|Pregnancy|2|||
149026817|NCT01251614|537576394|FG000|Overall Study|Loss of Disease Control|0|||
149026818|NCT01251614|537576395|FG001|Overall Study|Loss of Disease Control|1|||
149026819|NCT01251614|537576396|FG002|Overall Study|Loss of Disease Control|0|||
149026820|NCT01251614|537576394|FG000|Overall Study|Withdrawal by Subject|0|||
149026821|NCT01251614|537576395|FG001|Overall Study|Withdrawal by Subject|2|||
149026822|NCT01251614|537576396|FG002|Overall Study|Withdrawal by Subject|1|||
149026823|NCT01251614|537576394|FG000|Overall Study|Lost to Follow-up|0|||
149026824|NCT01251614|537576395|FG001|Overall Study|Lost to Follow-up|1|||
149026825|NCT01251614|537576396|FG002|Overall Study|Lost to Follow-up|0|||
149026826|NCT00049517|537576397|FG000|Induction|Disease progression|0|||
149026827|NCT00049517|537576398|FG001|Induction|Disease progression|0|||
149026828|NCT00049517|537576399|FG002|Induction|Disease progression|0|||
149026829|NCT00049517|537576400|FG003|Induction|Disease progression|0|||
149026830|NCT00049517|537576401|FG004|Induction|Disease progression|18|||
149026831|NCT00049517|537576402|FG005|Induction|Disease progression|11|||
149026832|NCT00049517|537576397|FG000|Induction|Adverse Event|0|||
149026833|NCT00049517|537576398|FG001|Induction|Adverse Event|0|||
149026834|NCT00049517|537576399|FG002|Induction|Adverse Event|0|||
149026835|NCT00049517|537576400|FG003|Induction|Adverse Event|0|||
149026836|NCT00049517|537576401|FG004|Induction|Adverse Event|5|||
149026837|NCT00049517|537576402|FG005|Induction|Adverse Event|7|||
149026838|NCT00049517|537576397|FG000|Induction|Death|0|||
149026839|NCT00049517|537576398|FG001|Induction|Death|0|||
149026840|NCT00049517|537576399|FG002|Induction|Death|0|||
149026841|NCT00049517|537576400|FG003|Induction|Death|0|||
149026842|NCT00049517|537576401|FG004|Induction|Death|9|||
149026843|NCT00049517|537576402|FG005|Induction|Death|6|||
149026844|NCT00049517|537576397|FG000|Induction|Withdrawal by Subject|0|||
148733181|NCT04711902|536497361|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
148733182|NCT04711902|536497362|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
148733183|NCT00368979|536497364|FG000|Overall Study|Adverse Event|9|||
148733184|NCT00368979|536497365|FG001|Overall Study|Adverse Event|16|||
148733185|NCT00368979|536497364|FG000|Overall Study|Lack of Efficacy|5|||
148733186|NCT00368979|536497365|FG001|Overall Study|Lack of Efficacy|3|||
148733187|NCT00368979|536497364|FG000|Overall Study|Other|3|||
148733188|NCT00368979|536497365|FG001|Overall Study|Other|1|||
148733189|NCT00368979|536497364|FG000|Overall Study|Lost to Follow-up|1|||
148733190|NCT00368979|536497365|FG001|Overall Study|Lost to Follow-up|0|||
148733191|NCT00368979|536497364|FG000|Overall Study|Protocol Violation|2|||
148733192|NCT00368979|536497365|FG001|Overall Study|Protocol Violation|1|||
148733193|NCT00368979|536497364|FG000|Overall Study|Withdrawal by Subject|5|||
148733194|NCT00368979|536497365|FG001|Overall Study|Withdrawal by Subject|9|||
148733195|NCT05183217|536497369|FG000|Overall Study|Withdrawal by Subject|1|||
148733196|NCT05183217|536497370|FG001|Overall Study|Withdrawal by Subject|1|||
148733197|NCT03412396|536497374|FG000|Overall Study|Withdrawal by Subject|2|||
148733198|NCT03412396|536497374|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
148733199|NCT03412396|536497374|FG000|Overall Study|Did not undergo RP|2|||
148733200|NCT01383135|536497381|FG000|Overall Study|Not Scanned / Imaged|1|||
148733201|NCT01383135|536497382|FG001|Overall Study|Not Scanned / Imaged|0|||
148733202|NCT01383135|536497383|FG002|Overall Study|Not Scanned / Imaged|1|||
148733203|NCT01383135|536497384|FG003|Overall Study|Not Scanned / Imaged|0|||
148733204|NCT03167723|536497388|FG000|Overall Study|Protocol Violation|4|||
148733205|NCT03167723|536497389|FG001|Overall Study|Protocol Violation|6|||
148733206|NCT00415194|536497391|FG000|Overall Study|Adverse Event|37|||
148733207|NCT00415194|536497392|FG001|Overall Study|Adverse Event|32|||
148733208|NCT00415194|536497391|FG000|Overall Study|Entry Criteria Not Met|4|||
148733209|NCT00415194|536497392|FG001|Overall Study|Entry Criteria Not Met|8|||
148733210|NCT00415194|536497391|FG000|Overall Study|Lost to Follow-up|1|||
148733211|NCT00415194|536497392|FG001|Overall Study|Lost to Follow-up|0|||
148733212|NCT00415194|536497391|FG000|Overall Study|Physician Decision|10|||
148733213|NCT00415194|536497392|FG001|Overall Study|Physician Decision|16|||
148733214|NCT00415194|536497391|FG000|Overall Study|Progressive Disease|180|||
148733215|NCT00415194|536497392|FG001|Overall Study|Progressive Disease|217|||
148733216|NCT00415194|536497391|FG000|Overall Study|Protocol Violation|4|||
148733217|NCT00415194|536497392|FG001|Overall Study|Protocol Violation|2|||
148733218|NCT00415194|536497391|FG000|Overall Study|Withdrawal by Subject|28|||
148733219|NCT00415194|536497392|FG001|Overall Study|Withdrawal by Subject|21|||
148733220|NCT00415194|536497391|FG000|Overall Study|Death Due to Study Disease|26|||
148733221|NCT00415194|536497392|FG001|Overall Study|Death Due to Study Disease|29|||
148733222|NCT00415194|536497391|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
148733223|NCT00415194|536497392|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
148733224|NCT00415194|536497391|FG000|Overall Study|Death Due to Procedural Related AE|0|||
148733225|NCT00415194|536497392|FG001|Overall Study|Death Due to Procedural Related AE|1|||
148733226|NCT00415194|536497391|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
148733227|NCT00415194|536497392|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
148733228|NCT01297465|536497393|FG000|Overall Study|Lack of Ovarian Response|1|||
148733229|NCT01297465|536497394|FG001|Overall Study|Lack of Ovarian Response|1|||
148733230|NCT01297465|536497393|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
148733231|NCT01297465|536497394|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
148733232|NCT01297465|536497393|FG000|Overall Study|No Oocytes Retrieved|1|||
148733233|NCT01297465|536497394|FG001|Overall Study|No Oocytes Retrieved|1|||
148733234|NCT01297465|536497393|FG000|Overall Study|Poor oocyte quality|0|||
148733235|NCT01297465|536497394|FG001|Overall Study|Poor oocyte quality|1|||
148733236|NCT01297465|536497393|FG000|Overall Study|No Fertilization|6|||
148733237|NCT01297465|536497394|FG001|Overall Study|No Fertilization|4|||
148733238|NCT01297465|536497393|FG000|Overall Study|All Embryos Discarded|0|||
148733239|NCT01297465|536497394|FG001|Overall Study|All Embryos Discarded|1|||
148733240|NCT01297465|536497393|FG000|Overall Study|Intention to Freeze all Embryos|0|||
148733241|NCT01297465|536497394|FG001|Overall Study|Intention to Freeze all Embryos|1|||
148733242|NCT00969540|536497395|FG000|Overall Study|Lost to Follow-up|1|||
148733243|NCT00969540|536497396|FG001|Overall Study|Lost to Follow-up|1|||
148733244|NCT01683838|536497397|FG000|Overall Study|Adverse Event|12|||
148733245|NCT01683838|536497398|FG001|Overall Study|Adverse Event|2|||
148733246|NCT01683838|536497397|FG000|Overall Study|Protocol Violation|3|||
148733247|NCT01683838|536497398|FG001|Overall Study|Protocol Violation|1|||
148733248|NCT01683838|536497397|FG000|Overall Study|Withdrawal by Subject|6|||
148733249|NCT01683838|536497398|FG001|Overall Study|Withdrawal by Subject|5|||
148733250|NCT01683838|536497397|FG000|Overall Study|Lost to Follow-up|1|||
148733251|NCT01683838|536497398|FG001|Overall Study|Lost to Follow-up|1|||
148973295|NCT01403974|537386109|FG006|Overall Study|Adverse Event|0|||
148733252|NCT01683838|536497397|FG000|Overall Study|Other|4|||
148733253|NCT01683838|536497398|FG001|Overall Study|Other|3|||
148733254|NCT01646138|536497399|FG000|Overall Study|Lost to Follow-up|0|||
148733255|NCT01646138|536497400|FG001|Overall Study|Lost to Follow-up|0|||
148733256|NCT01646138|536497401|FG002|Overall Study|Lost to Follow-up|0|||
148733257|NCT01646138|536497402|FG003|Overall Study|Lost to Follow-up|0|||
148733258|NCT01646138|536497403|FG004|Overall Study|Lost to Follow-up|2|||
148733259|NCT03397771|536497404|FG000|Overall Study|2 erroneously randomized, never treated|3|||
148733260|NCT03397771|536497405|FG001|Overall Study|2 erroneously randomized, never treated|1|||
148733261|NCT03397771|536497404|FG000|Overall Study|Withdrawal by Subject|1|||
148733262|NCT03397771|536497405|FG001|Overall Study|Withdrawal by Subject|3|||
148733263|NCT03397771|536497404|FG000|Overall Study|Protocol Violation|2|||
148733264|NCT03397771|536497405|FG001|Overall Study|Protocol Violation|2|||
148733265|NCT03397771|536497404|FG000|Overall Study|Adverse Event|2|||
148733266|NCT03397771|536497405|FG001|Overall Study|Adverse Event|1|||
148733267|NCT02455050|536497409|FG000|Treatment Period 1|Lost to Follow-up|1|||
148733268|NCT02455050|536497410|FG001|Treatment Period 1|Lost to Follow-up|1|||
148733269|NCT02455050|536497411|FG002|Treatment Period 1|Lost to Follow-up|1|||
148733270|NCT02455050|536497412|FG003|Treatment Period 1|Lost to Follow-up|2|||
148733271|NCT02455050|536497409|FG000|Treatment Period 2|Lost to Follow-up|1|||
148733272|NCT02455050|536497410|FG001|Treatment Period 2|Lost to Follow-up|0|||
148733273|NCT02455050|536497411|FG002|Treatment Period 2|Lost to Follow-up|2|||
148733274|NCT02455050|536497412|FG003|Treatment Period 2|Lost to Follow-up|1|||
148733275|NCT01259115|536497415|FG000|Period 1|Adverse Event|1|||
148733276|NCT01259115|536497416|FG001|Period 1|Adverse Event|0|||
148733277|NCT01259115|536497415|FG000|Period 1|Protocol Violation|2|||
148733278|NCT01259115|536497416|FG001|Period 1|Protocol Violation|0|||
148733279|NCT01259115|536497415|FG000|Period 1|Lost to Follow-up|0|||
148733280|NCT01259115|536497416|FG001|Period 1|Lost to Follow-up|1|||
148733281|NCT01259115|536497415|FG000|Period 2|Adverse Event|1|||
148733282|NCT01259115|536497416|FG001|Period 2|Adverse Event|0|||
148733283|NCT01971970|536497417|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
148733284|NCT01971970|536497418|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
148733285|NCT01971970|536497417|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
148733286|NCT01971970|536497418|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
148733287|NCT01971970|536497417|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
148733288|NCT01971970|536497418|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
148733289|NCT01971970|536497417|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
148733290|NCT01971970|536497418|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
148733291|NCT01971970|536497417|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
148733292|NCT01971970|536497418|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
148733293|NCT01971970|536497417|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
148733294|NCT01971970|536497418|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
148733295|NCT01971970|536497417|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
148733296|NCT01971970|536497418|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
148733297|NCT00848107|536497419|FG000|Overall Study|Lost to Follow-up|2|||
148733298|NCT00848107|536497419|FG000|Overall Study|Withdrawal by Subject|8|||
148733299|NCT00848107|536497419|FG000|Overall Study|Adverse Event|9|||
148733300|NCT00848107|536497419|FG000|Overall Study|Death|1|||
148733301|NCT00848107|536497419|FG000|Overall Study|Pregnancy|1|||
148733302|NCT01831765|536497420|FG000|Overall Study|Lack of Efficacy|1|||
148733303|NCT01831765|536497421|FG001|Overall Study|Lack of Efficacy|0|||
148733304|NCT01831765|536497422|FG002|Overall Study|Lack of Efficacy|0|||
148733305|NCT01831765|536497420|FG000|Overall Study|Other, sponsor withdrew subject|0|||
148733306|NCT01831765|536497421|FG001|Overall Study|Other, sponsor withdrew subject|1|||
148733307|NCT01831765|536497422|FG002|Overall Study|Other, sponsor withdrew subject|0|||
148733308|NCT01831765|536497420|FG000|Overall Study|Pregnancy|1|||
148733309|NCT01831765|536497421|FG001|Overall Study|Pregnancy|1|||
148733310|NCT01831765|536497422|FG002|Overall Study|Pregnancy|2|||
148733311|NCT01831765|536497420|FG000|Overall Study|Death|0|||
148733312|NCT01831765|536497421|FG001|Overall Study|Death|1|||
148733313|NCT01831765|536497422|FG002|Overall Study|Death|1|||
148733314|NCT01831765|536497420|FG000|Overall Study|Other, site closed|1|||
148733315|NCT01831765|536497421|FG001|Overall Study|Other, site closed|1|||
148733316|NCT01831765|536497422|FG002|Overall Study|Other, site closed|0|||
148733317|NCT01831765|536497420|FG000|Overall Study|Adverse Event|5|||
148733318|NCT01831765|536497421|FG001|Overall Study|Adverse Event|3|||
148733319|NCT01831765|536497422|FG002|Overall Study|Adverse Event|3|||
148733320|NCT01831765|536497420|FG000|Overall Study|Withdrawal by Subject|22|||
148733321|NCT01831765|536497421|FG001|Overall Study|Withdrawal by Subject|7|||
148733322|NCT01831765|536497422|FG002|Overall Study|Withdrawal by Subject|17|||
148733323|NCT01831765|536497420|FG000|Overall Study|Withdrawal criteria|12|||
149026845|NCT00049517|537576398|FG001|Induction|Withdrawal by Subject|0|||
148733324|NCT01831765|536497421|FG001|Overall Study|Withdrawal criteria|10|||
148733325|NCT01831765|536497422|FG002|Overall Study|Withdrawal criteria|16|||
148733326|NCT01831765|536497420|FG000|Overall Study|Lost to Follow-up|2|||
148733327|NCT01831765|536497421|FG001|Overall Study|Lost to Follow-up|3|||
148733328|NCT01831765|536497422|FG002|Overall Study|Lost to Follow-up|3|||
148733329|NCT00859586|536497423|FG000|Overall Study|Donors|4|||
148733330|NCT02524730|536497424|FG000|Overall Study|Lost to Follow-up|5|||
148733331|NCT02524730|536497424|FG000|Overall Study|Withdrawal by Subject|18|||
148973296|NCT01403974|537386110|FG007|Overall Study|Adverse Event|1|||
148973297|NCT01403974|537386111|FG008|Overall Study|Adverse Event|0|||
148973298|NCT01403974|537386112|FG009|Overall Study|Adverse Event|0|||
148973299|NCT01403974|537386113|FG010|Overall Study|Adverse Event|0|||
148973300|NCT01403974|537386114|FG011|Overall Study|Adverse Event|0|||
148973301|NCT01403974|537386115|FG012|Overall Study|Adverse Event|1|||
148973302|NCT01403974|537386116|FG013|Overall Study|Adverse Event|0|||
148973303|NCT01403974|537386117|FG014|Overall Study|Adverse Event|0|||
148973304|NCT01403974|537386118|FG015|Overall Study|Adverse Event|0|||
148973305|NCT01403974|537386103|FG000|Overall Study|Other than specified|0|||
148973306|NCT01403974|537386104|FG001|Overall Study|Other than specified|0|||
148973307|NCT01403974|537386105|FG002|Overall Study|Other than specified|0|||
148973308|NCT01403974|537386106|FG003|Overall Study|Other than specified|0|||
148973309|NCT01403974|537386107|FG004|Overall Study|Other than specified|0|||
148973310|NCT01403974|537386108|FG005|Overall Study|Other than specified|0|||
148973311|NCT01403974|537386109|FG006|Overall Study|Other than specified|0|||
148973312|NCT01403974|537386110|FG007|Overall Study|Other than specified|0|||
148973313|NCT01403974|537386111|FG008|Overall Study|Other than specified|0|||
148973314|NCT01403974|537386112|FG009|Overall Study|Other than specified|1|||
148973315|NCT01403974|537386113|FG010|Overall Study|Other than specified|0|||
148973316|NCT01403974|537386114|FG011|Overall Study|Other than specified|1|||
148973317|NCT01403974|537386115|FG012|Overall Study|Other than specified|0|||
148973318|NCT01403974|537386116|FG013|Overall Study|Other than specified|0|||
148973319|NCT01403974|537386117|FG014|Overall Study|Other than specified|0|||
148973320|NCT01403974|537386118|FG015|Overall Study|Other than specified|0|||
148973321|NCT01494610|537386121|FG000|Period 1|Withdrawal by Subject|1|||
148973322|NCT01494610|537386122|FG001|Period 1|Withdrawal by Subject|1|||
148973323|NCT01494610|537386121|FG000|Period 3|Adverse Event|1|||
148973324|NCT01494610|537386122|FG001|Period 3|Adverse Event|0|||
148973325|NCT01494610|537386121|FG000|Period 3|Withdrawal by Subject|1|||
148973326|NCT01494610|537386122|FG001|Period 3|Withdrawal by Subject|0|||
148973327|NCT01494610|537386121|FG000|Period 4|Protocol Violation|1|||
148973328|NCT01494610|537386122|FG001|Period 4|Protocol Violation|0|||
148973329|NCT00547703|537386123|FG000|Overall Study|Lost to Follow-up|1|||
148973330|NCT00547703|537386124|FG001|Overall Study|Lost to Follow-up|0|||
148973331|NCT00006184|537386127|FG000|Overall Study|Death|1|||
148973332|NCT00006184|537386128|FG001|Overall Study|Death|0|||
148973333|NCT02681302|537386129|FG000|Overall Study|Withdrawal by Subject|1|||
148973334|NCT02681302|537386130|FG001|Overall Study|Withdrawal by Subject|1|||
148973335|NCT02681302|537386131|FG002|Overall Study|Withdrawal by Subject|0|||
148733332|NCT02524730|536497424|FG000|Overall Study|Death|10|||
148733333|NCT02524730|536497424|FG000|Overall Study|Adverse Event|8|||
148733334|NCT02524730|536497424|FG000|Overall Study|Protocol Violation|1|||
148733335|NCT02524730|536497424|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
148733336|NCT00507130|536497425|FG000|Overall Study|Lost to Follow-up|0|||
148733337|NCT00507130|536497426|FG001|Overall Study|Lost to Follow-up|0|||
148733338|NCT00507130|536497427|FG002|Overall Study|Lost to Follow-up|1|||
148733339|NCT00507130|536497428|FG003|Overall Study|Lost to Follow-up|1|||
148733340|NCT00507130|536497425|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
148733341|NCT00507130|536497426|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
148733342|NCT00507130|536497427|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
148733343|NCT00507130|536497428|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
148733344|NCT00080938|536497435|FG000|Overall Study|Adverse Event|3|||
148733345|NCT00080938|536497435|FG000|Overall Study|Withdrawal by Subject|6|||
148733346|NCT00080938|536497435|FG000|Overall Study|Death|2|||
148733347|NCT00080938|536497435|FG000|Overall Study|Lack of Efficacy|7|||
148733348|NCT00080938|536497435|FG000|Overall Study|other disease|1|||
148733349|NCT00080938|536497435|FG000|Overall Study|Not started protocol therapy|1|||
148733350|NCT00080938|536497435|FG000|Overall Study|Ineligible|4|||
148733351|NCT00706511|536497440|FG000|Overall Study|Withdrawal by Subject|1|||
148733352|NCT00706511|536497441|FG001|Overall Study|Withdrawal by Subject|0|||
148733353|NCT00706511|536497442|FG002|Overall Study|Withdrawal by Subject|0|||
148733354|NCT00706511|536497443|FG003|Overall Study|Withdrawal by Subject|0|||
148733355|NCT02605993|536497444|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
148733356|NCT02605993|536497445|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
148733357|NCT02605993|536497446|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
148733358|NCT02605993|536497447|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
148733359|NCT03493386|536497452|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148733360|NCT03493386|536497453|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
148733361|NCT03493386|536497454|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148733362|NCT03493386|536497455|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
148733363|NCT04645966|536497456|FG000|Vaccination Phase|Adverse Event|1|||
148733364|NCT04645966|536497457|FG001|Vaccination Phase|Adverse Event|0|||
148733365|NCT04645966|536497458|FG002|Vaccination Phase|Adverse Event|0|||
148733366|NCT04645966|536497459|FG003|Vaccination Phase|Adverse Event|0|||
148733367|NCT04645966|536497460|FG004|Vaccination Phase|Adverse Event|0|||
148733368|NCT04645966|536497461|FG005|Vaccination Phase|Adverse Event|0|||
148733369|NCT04645966|536497462|FG006|Vaccination Phase|Adverse Event|1|||
148733370|NCT04645966|536497463|FG007|Vaccination Phase|Adverse Event|0|||
148733371|NCT04645966|536497464|FG008|Vaccination Phase|Adverse Event|0|||
148733372|NCT04645966|536497456|FG000|Vaccination Phase|Death|0|||
148733373|NCT04645966|536497457|FG001|Vaccination Phase|Death|0|||
148733374|NCT04645966|536497458|FG002|Vaccination Phase|Death|0|||
148733375|NCT04645966|536497459|FG003|Vaccination Phase|Death|0|||
148733376|NCT04645966|536497460|FG004|Vaccination Phase|Death|0|||
148733377|NCT04645966|536497461|FG005|Vaccination Phase|Death|1|||
148733378|NCT04645966|536497462|FG006|Vaccination Phase|Death|0|||
148733379|NCT04645966|536497463|FG007|Vaccination Phase|Death|0|||
148733380|NCT04645966|536497464|FG008|Vaccination Phase|Death|0|||
148733381|NCT04645966|536497456|FG000|Vaccination Phase|Protocol Violation|0|||
148733382|NCT04645966|536497457|FG001|Vaccination Phase|Protocol Violation|0|||
148733383|NCT04645966|536497458|FG002|Vaccination Phase|Protocol Violation|0|||
148733384|NCT04645966|536497459|FG003|Vaccination Phase|Protocol Violation|0|||
148733385|NCT04645966|536497460|FG004|Vaccination Phase|Protocol Violation|1|||
148733386|NCT04645966|536497461|FG005|Vaccination Phase|Protocol Violation|0|||
148733387|NCT04645966|536497462|FG006|Vaccination Phase|Protocol Violation|0|||
148733388|NCT04645966|536497463|FG007|Vaccination Phase|Protocol Violation|0|||
148733389|NCT04645966|536497464|FG008|Vaccination Phase|Protocol Violation|0|||
148733390|NCT04645966|536497456|FG000|Vaccination Phase|Study terminated by sponsor|0|||
148733391|NCT04645966|536497457|FG001|Vaccination Phase|Study terminated by sponsor|0|||
148733392|NCT04645966|536497458|FG002|Vaccination Phase|Study terminated by sponsor|14|||
148733393|NCT04645966|536497459|FG003|Vaccination Phase|Study terminated by sponsor|15|||
148733394|NCT04645966|536497460|FG004|Vaccination Phase|Study terminated by sponsor|47|||
148733395|NCT04645966|536497461|FG005|Vaccination Phase|Study terminated by sponsor|43|||
148733396|NCT04645966|536497462|FG006|Vaccination Phase|Study terminated by sponsor|29|||
148733397|NCT04645966|536497463|FG007|Vaccination Phase|Study terminated by sponsor|29|||
148733398|NCT04645966|536497464|FG008|Vaccination Phase|Study terminated by sponsor|12|||
148733399|NCT04645966|536497456|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
148733400|NCT04645966|536497457|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
148733401|NCT04645966|536497458|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
148733402|NCT04645966|536497459|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
148733403|NCT04645966|536497460|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
148733404|NCT04645966|536497461|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
148733405|NCT04645966|536497462|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
148733406|NCT04645966|536497463|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
148733407|NCT04645966|536497464|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
148733408|NCT04645966|536497456|FG000|Vaccination Phase|Other|0|||
148733409|NCT04645966|536497457|FG001|Vaccination Phase|Other|0|||
148733410|NCT04645966|536497458|FG002|Vaccination Phase|Other|0|||
148733411|NCT04645966|536497459|FG003|Vaccination Phase|Other|0|||
148733412|NCT04645966|536497460|FG004|Vaccination Phase|Other|0|||
148733413|NCT04645966|536497461|FG005|Vaccination Phase|Other|2|||
148733414|NCT04645966|536497462|FG006|Vaccination Phase|Other|0|||
148733415|NCT04645966|536497463|FG007|Vaccination Phase|Other|0|||
148733416|NCT04645966|536497464|FG008|Vaccination Phase|Other|0|||
148733417|NCT04645966|536497456|FG000|Vaccination Phase|Lost to Follow-up|0|||
148733418|NCT04645966|536497457|FG001|Vaccination Phase|Lost to Follow-up|0|||
148733419|NCT04645966|536497458|FG002|Vaccination Phase|Lost to Follow-up|0|||
148733420|NCT04645966|536497459|FG003|Vaccination Phase|Lost to Follow-up|0|||
148733421|NCT04645966|536497460|FG004|Vaccination Phase|Lost to Follow-up|0|||
148733422|NCT04645966|536497461|FG005|Vaccination Phase|Lost to Follow-up|0|||
148733423|NCT04645966|536497462|FG006|Vaccination Phase|Lost to Follow-up|0|||
148733424|NCT04645966|536497463|FG007|Vaccination Phase|Lost to Follow-up|1|||
148733425|NCT04645966|536497464|FG008|Vaccination Phase|Lost to Follow-up|0|||
148733426|NCT04645966|536497456|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
148733427|NCT04645966|536497457|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
148733428|NCT04645966|536497458|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
148733429|NCT04645966|536497459|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
148733430|NCT04645966|536497460|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
148733431|NCT04645966|536497461|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
148733432|NCT04645966|536497462|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
148733433|NCT04645966|536497463|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
148733434|NCT04645966|536497464|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
148733435|NCT04645966|536497456|FG000|Follow-up Phase|Lost to Follow-up|0|||
148733436|NCT04645966|536497457|FG001|Follow-up Phase|Lost to Follow-up|0|||
148733437|NCT04645966|536497458|FG002|Follow-up Phase|Lost to Follow-up|0|||
148733438|NCT04645966|536497459|FG003|Follow-up Phase|Lost to Follow-up|0|||
148733439|NCT04645966|536497460|FG004|Follow-up Phase|Lost to Follow-up|0|||
148733440|NCT04645966|536497461|FG005|Follow-up Phase|Lost to Follow-up|0|||
149026846|NCT00049517|537576399|FG002|Induction|Withdrawal by Subject|0|||
148973336|NCT02681302|537386132|FG003|Overall Study|Withdrawal by Subject|0|||
149026847|NCT00049517|537576400|FG003|Induction|Withdrawal by Subject|0|||
149026848|NCT00049517|537576401|FG004|Induction|Withdrawal by Subject|1|||
149026849|NCT00049517|537576402|FG005|Induction|Withdrawal by Subject|3|||
149026850|NCT00049517|537576397|FG000|Induction|Alternative therapy|0|||
149026851|NCT00049517|537576398|FG001|Induction|Alternative therapy|0|||
149026852|NCT00049517|537576399|FG002|Induction|Alternative therapy|0|||
149026853|NCT00049517|537576400|FG003|Induction|Alternative therapy|0|||
149026854|NCT00049517|537576401|FG004|Induction|Alternative therapy|2|||
149026855|NCT00049517|537576402|FG005|Induction|Alternative therapy|2|||
149026856|NCT00049517|537576397|FG000|Induction|Other complicating disease|0|||
149026857|NCT00049517|537576398|FG001|Induction|Other complicating disease|0|||
148733441|NCT04645966|536497462|FG006|Follow-up Phase|Lost to Follow-up|0|||
148733442|NCT04645966|536497463|FG007|Follow-up Phase|Lost to Follow-up|1|||
148733443|NCT04645966|536497464|FG008|Follow-up Phase|Lost to Follow-up|0|||
148733444|NCT05297578|536497477|FG000|Overall Study|Lost to Follow-up|1|||
148733445|NCT05297578|536497478|FG001|Overall Study|Lost to Follow-up|1|||
148733446|NCT05297578|536497479|FG002|Overall Study|Lost to Follow-up|2|||
148733447|NCT05297578|536497480|FG003|Overall Study|Lost to Follow-up|1|||
148733448|NCT05297578|536497477|FG000|Overall Study|Death|0|||
148733449|NCT05297578|536497478|FG001|Overall Study|Death|1|||
148733450|NCT05297578|536497479|FG002|Overall Study|Death|0|||
148733451|NCT05297578|536497480|FG003|Overall Study|Death|0|||
148733452|NCT05297578|536497477|FG000|Overall Study|Withdrawal by Subject|0|||
148733453|NCT05297578|536497478|FG001|Overall Study|Withdrawal by Subject|0|||
148733454|NCT05297578|536497479|FG002|Overall Study|Withdrawal by Subject|1|||
148733455|NCT05297578|536497480|FG003|Overall Study|Withdrawal by Subject|0|||
148733456|NCT00117325|536497481|FG000|Overall Study|Adverse Event|3|||
148733457|NCT00117325|536497482|FG001|Overall Study|Adverse Event|3|||
148733458|NCT00117325|536497481|FG000|Overall Study|Lost to Follow-up|1|||
148733459|NCT00117325|536497482|FG001|Overall Study|Lost to Follow-up|1|||
148733460|NCT00117325|536497481|FG000|Overall Study|Protocol Violation|2|||
148733461|NCT00117325|536497482|FG001|Overall Study|Protocol Violation|3|||
148733462|NCT00117325|536497481|FG000|Overall Study|Withdrawal by Subject|3|||
148733463|NCT00117325|536497482|FG001|Overall Study|Withdrawal by Subject|2|||
148733464|NCT00117325|536497481|FG000|Overall Study|Lack of Efficacy|1|||
148733465|NCT00117325|536497482|FG001|Overall Study|Lack of Efficacy|0|||
148733466|NCT00117325|536497481|FG000|Overall Study|Use of prohibited medicine|1|||
148733467|NCT00117325|536497482|FG001|Overall Study|Use of prohibited medicine|2|||
148733468|NCT00117325|536497481|FG000|Overall Study|Early termination|1|||
148733469|NCT00117325|536497482|FG001|Overall Study|Early termination|1|||
148733470|NCT00117325|536497481|FG000|Overall Study|Admisnitrative|1|||
148733471|NCT00117325|536497482|FG001|Overall Study|Admisnitrative|0|||
148733472|NCT02266134|536497483|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
148733473|NCT02266134|536497484|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
148733474|NCT02266134|536497485|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
148733475|NCT02266134|536497486|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
148733476|NCT02266134|536497483|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
148733477|NCT02266134|536497484|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
148733478|NCT02266134|536497485|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
148733479|NCT02266134|536497486|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
148733480|NCT02266134|536497483|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
148733481|NCT02266134|536497484|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
148733482|NCT02266134|536497485|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
148733483|NCT02266134|536497486|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
148733484|NCT02266134|536497483|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
148733485|NCT02266134|536497484|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
148733486|NCT02266134|536497485|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
148973337|NCT02681302|537386133|FG004|Overall Study|Withdrawal by Subject|1|||
148973338|NCT02681302|537386134|FG005|Overall Study|Withdrawal by Subject|0|||
148973339|NCT02681302|537386129|FG000|Overall Study|Screen Failure|2|||
148973340|NCT02681302|537386130|FG001|Overall Study|Screen Failure|4|||
148973341|NCT02681302|537386131|FG002|Overall Study|Screen Failure|2|||
148973342|NCT02681302|537386132|FG003|Overall Study|Screen Failure|0|||
149026858|NCT00049517|537576399|FG002|Induction|Other complicating disease|0|||
149026859|NCT00049517|537576400|FG003|Induction|Other complicating disease|0|||
148733487|NCT02266134|536497486|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
149026860|NCT00049517|537576401|FG004|Induction|Other complicating disease|3|||
148733488|NCT02266134|536497483|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
148733489|NCT02266134|536497484|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
148733490|NCT02266134|536497485|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
148733491|NCT02266134|536497486|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
148973343|NCT02681302|537386133|FG004|Overall Study|Screen Failure|1|||
148973344|NCT02681302|537386134|FG005|Overall Study|Screen Failure|1|||
148973345|NCT02681302|537386129|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
148973346|NCT02681302|537386130|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
148973347|NCT02681302|537386131|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
148973348|NCT02681302|537386132|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
148973349|NCT02681302|537386133|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
148973350|NCT02681302|537386134|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
148973351|NCT01736696|537386135|FG000|Overall Study|Withdrawal by Subject|0|||
148973352|NCT01736696|537386136|FG001|Overall Study|Withdrawal by Subject|0|||
148973353|NCT01736696|537386137|FG002|Overall Study|Withdrawal by Subject|1|||
148973354|NCT01736696|537386138|FG003|Overall Study|Withdrawal by Subject|0|||
148973355|NCT01736696|537386139|FG004|Overall Study|Withdrawal by Subject|0|||
148973356|NCT01736696|537386140|FG005|Overall Study|Withdrawal by Subject|0|||
148973357|NCT01736696|537386141|FG006|Overall Study|Withdrawal by Subject|0|||
148973358|NCT00838565|537386142|FG000|Overall Study|Withdrawal by Subject|0|||
148973359|NCT00838565|537386143|FG001|Overall Study|Withdrawal by Subject|0|||
148973360|NCT00838565|537386144|FG002|Overall Study|Withdrawal by Subject|1|||
148973361|NCT00838565|537386145|FG003|Overall Study|Withdrawal by Subject|0|||
148973362|NCT00838565|537386146|FG004|Overall Study|Withdrawal by Subject|0|||
148973363|NCT00838565|537386147|FG005|Overall Study|Withdrawal by Subject|2|||
148973364|NCT00838565|537386142|FG000|Overall Study|Other|0|||
148973365|NCT00838565|537386143|FG001|Overall Study|Other|2|||
148973366|NCT00838565|537386144|FG002|Overall Study|Other|0|||
148973367|NCT00838565|537386145|FG003|Overall Study|Other|0|||
148973368|NCT00838565|537386146|FG004|Overall Study|Other|0|||
148973369|NCT00838565|537386147|FG005|Overall Study|Other|0|||
148973370|NCT00838565|537386142|FG000|Overall Study|Randomized but not Treated|0|||
148973371|NCT00838565|537386143|FG001|Overall Study|Randomized but not Treated|1|||
148973372|NCT00838565|537386144|FG002|Overall Study|Randomized but not Treated|0|||
148973373|NCT00838565|537386145|FG003|Overall Study|Randomized but not Treated|0|||
148973374|NCT00838565|537386146|FG004|Overall Study|Randomized but not Treated|0|||
148973375|NCT00838565|537386147|FG005|Overall Study|Randomized but not Treated|0|||
148973376|NCT00458484|537386148|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
148973377|NCT00458484|537386149|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
148973378|NCT00458484|537386150|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
148973379|NCT00458484|537386151|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
148973380|NCT00458484|537386152|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
148973381|NCT00458484|537386153|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
148973382|NCT00458484|537386154|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
148973383|NCT03571516|537386155|FG000|Overall Study|Severe diarrhea|1|||
148973384|NCT03571516|537386156|FG001|Overall Study|Severe diarrhea|0|||
148973385|NCT03571516|537386155|FG000|Overall Study|Withdrawal by Subject|0|||
148973386|NCT03571516|537386156|FG001|Overall Study|Withdrawal by Subject|1|||
148973387|NCT01455012|537386157|FG000|Overall Study|Adverse Event|0|||
148973388|NCT01455012|537386158|FG001|Overall Study|Adverse Event|2|||
148973389|NCT01455012|537386157|FG000|Overall Study|Lack of Efficacy|6|||
148973390|NCT01455012|537386158|FG001|Overall Study|Lack of Efficacy|1|||
148973391|NCT01455012|537386157|FG000|Overall Study|Withdrawal by Subject|3|||
148973392|NCT01455012|537386158|FG001|Overall Study|Withdrawal by Subject|1|||
148973393|NCT01455012|537386157|FG000|Overall Study|Unknown reason|2|||
148973394|NCT01455012|537386158|FG001|Overall Study|Unknown reason|0|||
148973395|NCT02253810|537386160|FG000|Overall Study|Withdrawal by Subject|2|||
148973396|NCT02253810|537386161|FG001|Overall Study|Withdrawal by Subject|1|||
148733492|NCT02266134|536497483|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
148733493|NCT02266134|536497484|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
148733494|NCT02266134|536497485|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
148733495|NCT02266134|536497486|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
148733496|NCT04647721|536497487|FG000|Overall Study|Withdrawal by Subject|0|||
148733497|NCT04647721|536497488|FG001|Overall Study|Withdrawal by Subject|2|||
148733498|NCT04647721|536497487|FG000|Overall Study|Lost to Follow-up|2|||
148733499|NCT04647721|536497488|FG001|Overall Study|Lost to Follow-up|0|||
148733500|NCT01974440|536497489|FG000|Overall Study|Lost to Follow-up|7|||
148733501|NCT01974440|536497490|FG001|Overall Study|Lost to Follow-up|7|||
148733502|NCT01974440|536497489|FG000|Overall Study|Withdrawal by Subject|24|||
148733503|NCT01974440|536497490|FG001|Overall Study|Withdrawal by Subject|20|||
148733504|NCT01974440|536497489|FG000|Overall Study|Sponsor decision|109|||
148733505|NCT01974440|536497490|FG001|Overall Study|Sponsor decision|110|||
148733506|NCT00762437|536497491|FG000|Overall Study|Lost to Follow-up|7|||
148733507|NCT00762437|536497491|FG000|Overall Study|Missed final study visit|11|||
148733508|NCT00762437|536497491|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
148733509|NCT04480710|536497492|FG000|Overall Study|Adverse Event|0|||
148733510|NCT04480710|536497493|FG001|Overall Study|Adverse Event|2|||
148973397|NCT02253810|537386160|FG000|Overall Study|Unknown concomitant procedure|3|||
148733511|NCT04480710|536497494|FG002|Overall Study|Adverse Event|0|||
148733512|NCT04480710|536497495|FG003|Overall Study|Adverse Event|0|||
148733513|NCT04480710|536497492|FG000|Overall Study|Withdrawal by Subject|0|||
148733514|NCT04480710|536497493|FG001|Overall Study|Withdrawal by Subject|1|||
148733515|NCT04480710|536497494|FG002|Overall Study|Withdrawal by Subject|0|||
148733516|NCT04480710|536497495|FG003|Overall Study|Withdrawal by Subject|0|||
148733517|NCT04480710|536497492|FG000|Overall Study|Physician Decision|0|||
148733518|NCT04480710|536497493|FG001|Overall Study|Physician Decision|0|||
148733519|NCT04480710|536497494|FG002|Overall Study|Physician Decision|1|||
148733520|NCT04480710|536497495|FG003|Overall Study|Physician Decision|0|||
148733521|NCT03819049|536497496|FG000|Overall Study|Lost to Follow-up|1|||
148733522|NCT03819049|536497497|FG001|Overall Study|Lost to Follow-up|2|||
148733523|NCT03819049|536497498|FG002|Overall Study|Lost to Follow-up|9|||
148733524|NCT03819049|536497499|FG003|Overall Study|Lost to Follow-up|0|||
148733525|NCT03819049|536497500|FG004|Overall Study|Lost to Follow-up|3|||
148733526|NCT03819049|536497501|FG005|Overall Study|Lost to Follow-up|1|||
148733527|NCT03819049|536497502|FG006|Overall Study|Lost to Follow-up|0|||
148733528|NCT03819049|536497496|FG000|Overall Study|Withdrawal by Subject|0|||
148733529|NCT03819049|536497497|FG001|Overall Study|Withdrawal by Subject|0|||
148733530|NCT03819049|536497498|FG002|Overall Study|Withdrawal by Subject|18|||
148733531|NCT03819049|536497499|FG003|Overall Study|Withdrawal by Subject|0|||
148733532|NCT03819049|536497500|FG004|Overall Study|Withdrawal by Subject|10|||
148733533|NCT03819049|536497501|FG005|Overall Study|Withdrawal by Subject|9|||
148733534|NCT03819049|536497502|FG006|Overall Study|Withdrawal by Subject|1|||
148733535|NCT03819049|536497496|FG000|Overall Study|Ongoing|0|||
148733536|NCT03819049|536497497|FG001|Overall Study|Ongoing|0|||
148733537|NCT03819049|536497498|FG002|Overall Study|Ongoing|75|||
148733538|NCT03819049|536497499|FG003|Overall Study|Ongoing|0|||
148733539|NCT03819049|536497500|FG004|Overall Study|Ongoing|41|||
148733540|NCT03819049|536497501|FG005|Overall Study|Ongoing|0|||
148733541|NCT03819049|536497502|FG006|Overall Study|Ongoing|0|||
148733542|NCT03819049|536497496|FG000|Overall Study|Other|0|||
148733543|NCT03819049|536497497|FG001|Overall Study|Other|0|||
148733544|NCT03819049|536497498|FG002|Overall Study|Other|2|||
148733545|NCT03819049|536497499|FG003|Overall Study|Other|0|||
148733546|NCT03819049|536497500|FG004|Overall Study|Other|0|||
148733547|NCT03819049|536497501|FG005|Overall Study|Other|0|||
148733548|NCT03819049|536497502|FG006|Overall Study|Other|0|||
148733549|NCT03819049|536497496|FG000|Overall Study|Randomized but not vaccinated|0|||
148733550|NCT03819049|536497497|FG001|Overall Study|Randomized but not vaccinated|0|||
148733551|NCT03819049|536497498|FG002|Overall Study|Randomized but not vaccinated|0|||
148733552|NCT03819049|536497499|FG003|Overall Study|Randomized but not vaccinated|1|||
148733553|NCT03819049|536497500|FG004|Overall Study|Randomized but not vaccinated|0|||
148733554|NCT03819049|536497501|FG005|Overall Study|Randomized but not vaccinated|2|||
148733555|NCT03819049|536497502|FG006|Overall Study|Randomized but not vaccinated|1|||
148733556|NCT03819049|536497496|FG000|Overall Study|Physician Decision|0|||
148733557|NCT03819049|536497497|FG001|Overall Study|Physician Decision|0|||
148733558|NCT03819049|536497498|FG002|Overall Study|Physician Decision|0|||
148733559|NCT03819049|536497499|FG003|Overall Study|Physician Decision|0|||
148733560|NCT03819049|536497500|FG004|Overall Study|Physician Decision|0|||
148733561|NCT03819049|536497501|FG005|Overall Study|Physician Decision|0|||
148733562|NCT03819049|536497502|FG006|Overall Study|Physician Decision|1|||
148733563|NCT01986010|536497503|FG000|Overall Study|Adverse Event|0|||
148733564|NCT01986010|536497504|FG001|Overall Study|Adverse Event|1|||
148733565|NCT01986010|536497505|FG002|Overall Study|Adverse Event|0|||
148733566|NCT01986010|536497506|FG003|Overall Study|Adverse Event|0|||
148733567|NCT01986010|536497507|FG004|Overall Study|Adverse Event|0|||
148733568|NCT01986010|536497508|FG005|Overall Study|Adverse Event|0|||
148733569|NCT01986010|536497509|FG006|Overall Study|Adverse Event|0|||
148733570|NCT01986010|536497510|FG007|Overall Study|Adverse Event|0|||
148733571|NCT01986010|536497511|FG008|Overall Study|Adverse Event|0|||
148733572|NCT01986010|536497512|FG009|Overall Study|Adverse Event|0|||
148733573|NCT01986010|536497513|FG010|Overall Study|Adverse Event|0|||
148733574|NCT01986010|536497514|FG011|Overall Study|Adverse Event|0|||
148733575|NCT01986010|536497515|FG012|Overall Study|Adverse Event|0|||
148733576|NCT01986010|536497516|FG013|Overall Study|Adverse Event|0|||
148733577|NCT01986010|536497517|FG014|Overall Study|Adverse Event|0|||
148733578|NCT01986010|536497518|FG015|Overall Study|Adverse Event|1|||
148733579|NCT01986010|536497519|FG016|Overall Study|Adverse Event|0|||
148817615|NCT02965456|536807320|FG001|Overall Study|Physician Decision|1|||
148733580|NCT01986010|536497503|FG000|Overall Study|Lost to Follow-up|2|||
148733581|NCT01986010|536497504|FG001|Overall Study|Lost to Follow-up|1|||
148733582|NCT01986010|536497505|FG002|Overall Study|Lost to Follow-up|2|||
148733583|NCT01986010|536497506|FG003|Overall Study|Lost to Follow-up|2|||
148733584|NCT01986010|536497507|FG004|Overall Study|Lost to Follow-up|2|||
148733585|NCT01986010|536497508|FG005|Overall Study|Lost to Follow-up|2|||
148733586|NCT01986010|536497509|FG006|Overall Study|Lost to Follow-up|0|||
148733587|NCT01986010|536497510|FG007|Overall Study|Lost to Follow-up|0|||
148733588|NCT01986010|536497511|FG008|Overall Study|Lost to Follow-up|4|||
148733589|NCT01986010|536497512|FG009|Overall Study|Lost to Follow-up|2|||
148733590|NCT01986010|536497513|FG010|Overall Study|Lost to Follow-up|0|||
148733591|NCT01986010|536497514|FG011|Overall Study|Lost to Follow-up|1|||
148733592|NCT01986010|536497515|FG012|Overall Study|Lost to Follow-up|1|||
148733593|NCT01986010|536497516|FG013|Overall Study|Lost to Follow-up|1|||
148733594|NCT01986010|536497517|FG014|Overall Study|Lost to Follow-up|2|||
148733595|NCT01986010|536497518|FG015|Overall Study|Lost to Follow-up|0|||
148733596|NCT01986010|536497519|FG016|Overall Study|Lost to Follow-up|0|||
148733597|NCT01986010|536497503|FG000|Overall Study|Physician Decision|0|||
148733598|NCT01986010|536497504|FG001|Overall Study|Physician Decision|0|||
148733599|NCT01986010|536497505|FG002|Overall Study|Physician Decision|0|||
148733600|NCT01986010|536497506|FG003|Overall Study|Physician Decision|0|||
148733601|NCT01986010|536497507|FG004|Overall Study|Physician Decision|0|||
148733602|NCT01986010|536497508|FG005|Overall Study|Physician Decision|0|||
148733603|NCT01986010|536497509|FG006|Overall Study|Physician Decision|0|||
148733604|NCT01986010|536497510|FG007|Overall Study|Physician Decision|0|||
148733605|NCT01986010|536497511|FG008|Overall Study|Physician Decision|0|||
148733606|NCT01986010|536497512|FG009|Overall Study|Physician Decision|0|||
148733607|NCT01986010|536497513|FG010|Overall Study|Physician Decision|0|||
148733608|NCT01986010|536497514|FG011|Overall Study|Physician Decision|0|||
148733609|NCT01986010|536497515|FG012|Overall Study|Physician Decision|0|||
148733610|NCT01986010|536497516|FG013|Overall Study|Physician Decision|0|||
148733611|NCT01986010|536497517|FG014|Overall Study|Physician Decision|1|||
148733612|NCT01986010|536497518|FG015|Overall Study|Physician Decision|0|||
148733613|NCT01986010|536497519|FG016|Overall Study|Physician Decision|0|||
148733614|NCT01986010|536497503|FG000|Overall Study|Withdrawal by Subject|2|||
148733615|NCT01986010|536497504|FG001|Overall Study|Withdrawal by Subject|2|||
148733616|NCT01986010|536497505|FG002|Overall Study|Withdrawal by Subject|3|||
148733617|NCT01986010|536497506|FG003|Overall Study|Withdrawal by Subject|0|||
148733618|NCT01986010|536497507|FG004|Overall Study|Withdrawal by Subject|2|||
148733619|NCT01986010|536497508|FG005|Overall Study|Withdrawal by Subject|4|||
148733620|NCT01986010|536497509|FG006|Overall Study|Withdrawal by Subject|0|||
148733621|NCT01986010|536497510|FG007|Overall Study|Withdrawal by Subject|0|||
148733622|NCT01986010|536497511|FG008|Overall Study|Withdrawal by Subject|0|||
148733623|NCT01986010|536497512|FG009|Overall Study|Withdrawal by Subject|0|||
148733624|NCT01986010|536497513|FG010|Overall Study|Withdrawal by Subject|0|||
148733625|NCT01986010|536497514|FG011|Overall Study|Withdrawal by Subject|2|||
148973398|NCT02253810|537386161|FG001|Overall Study|Unknown concomitant procedure|2|||
148973399|NCT00291668|537386163|FG000|Overall Study|Lack of Efficacy|1|||
148973400|NCT00291668|537386164|FG001|Overall Study|Lack of Efficacy|0|||
148733626|NCT01986010|536497515|FG012|Overall Study|Withdrawal by Subject|0|||
148733627|NCT01986010|536497516|FG013|Overall Study|Withdrawal by Subject|1|||
148973401|NCT00291668|537386165|FG002|Overall Study|Lack of Efficacy|0|||
148973402|NCT00291668|537386163|FG000|Overall Study|SAE, non-fatal|1|||
148733628|NCT01986010|536497517|FG014|Overall Study|Withdrawal by Subject|2|||
148733629|NCT01986010|536497518|FG015|Overall Study|Withdrawal by Subject|0|||
148733630|NCT01986010|536497519|FG016|Overall Study|Withdrawal by Subject|0|||
148733631|NCT01986010|536497503|FG000|Overall Study|Status Not Recorded|2|||
148733632|NCT01986010|536497504|FG001|Overall Study|Status Not Recorded|4|||
148733633|NCT01986010|536497505|FG002|Overall Study|Status Not Recorded|2|||
148733634|NCT01986010|536497506|FG003|Overall Study|Status Not Recorded|0|||
148733635|NCT01986010|536497507|FG004|Overall Study|Status Not Recorded|1|||
148733636|NCT01986010|536497508|FG005|Overall Study|Status Not Recorded|2|||
148733637|NCT01986010|536497509|FG006|Overall Study|Status Not Recorded|0|||
148733638|NCT01986010|536497510|FG007|Overall Study|Status Not Recorded|0|||
148733639|NCT01986010|536497511|FG008|Overall Study|Status Not Recorded|2|||
148733640|NCT01986010|536497512|FG009|Overall Study|Status Not Recorded|1|||
148733641|NCT01986010|536497513|FG010|Overall Study|Status Not Recorded|7|||
148733642|NCT01986010|536497514|FG011|Overall Study|Status Not Recorded|7|||
148733643|NCT01986010|536497515|FG012|Overall Study|Status Not Recorded|9|||
148733644|NCT01986010|536497516|FG013|Overall Study|Status Not Recorded|9|||
148733645|NCT01986010|536497517|FG014|Overall Study|Status Not Recorded|5|||
148817616|NCT02965456|536807319|FG000|Overall Study|Pregnancy|1|||
148973403|NCT00291668|537386164|FG001|Overall Study|SAE, non-fatal|1|||
148973404|NCT00291668|537386165|FG002|Overall Study|SAE, non-fatal|1|||
148973405|NCT00291668|537386163|FG000|Overall Study|AE, non-serious non-fatal|1|||
148973406|NCT00291668|537386164|FG001|Overall Study|AE, non-serious non-fatal|0|||
148973407|NCT00291668|537386165|FG002|Overall Study|AE, non-serious non-fatal|0|||
148973408|NCT00291668|537386163|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148973409|NCT00291668|537386164|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
148973410|NCT00291668|537386165|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
148973411|NCT04656132|537386166|FG000|Overall Study|Lost to Follow-up|4|||
148973412|NCT04656132|537386166|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
148973413|NCT04019041|537386167|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
148973414|NCT04019041|537386168|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
149026861|NCT00049517|537576402|FG005|Induction|Other complicating disease|0|||
148733646|NCT01986010|536497518|FG015|Overall Study|Status Not Recorded|10|||
148733647|NCT01986010|536497519|FG016|Overall Study|Status Not Recorded|4|||
148733648|NCT01335997|536497522|FG000|Period I and II|Adverse Event|63|||
148733649|NCT01335997|536497523|FG001|Period I and II|Adverse Event|43|||
148817617|NCT02965456|536807320|FG001|Overall Study|Pregnancy|0|||
148733650|NCT01335997|536497522|FG000|Period I and II|Noncompliance with Study Drug|1|||
148733651|NCT01335997|536497523|FG001|Period I and II|Noncompliance with Study Drug|1|||
148733652|NCT01335997|536497522|FG000|Period I and II|Lost to Follow-up|3|||
148733653|NCT01335997|536497523|FG001|Period I and II|Lost to Follow-up|5|||
148733654|NCT01335997|536497522|FG000|Period I and II|Withdrawal by Subject|9|||
148733655|NCT01335997|536497523|FG001|Period I and II|Withdrawal by Subject|4|||
148733656|NCT01335997|536497522|FG000|Period I and II|Study Terminated by Sponsor|406|||
148733657|NCT01335997|536497523|FG001|Period I and II|Study Terminated by Sponsor|415|||
148733658|NCT01335997|536497522|FG000|Period I and II|Protocol Violation|9|||
148733659|NCT01335997|536497523|FG001|Period I and II|Protocol Violation|10|||
148733660|NCT01335997|536497522|FG000|Period I and II|Physician Decision|2|||
148733661|NCT01335997|536497523|FG001|Period I and II|Physician Decision|1|||
148733662|NCT01335997|536497522|FG000|Period III|Adverse Event|0|||
148733663|NCT01335997|536497523|FG001|Period III|Adverse Event|2|||
148733664|NCT01335997|536497522|FG000|Period III|Study Terminated by Sponsor|77|||
148733665|NCT01335997|536497523|FG001|Period III|Study Terminated by Sponsor|76|||
148733666|NCT01335997|536497522|FG000|Period III|Protocol Violation|0|||
148733667|NCT01335997|536497523|FG001|Period III|Protocol Violation|1|||
148733668|NCT01335997|536497522|FG000|Period III|Lost to Follow-up|1|||
148733669|NCT01335997|536497523|FG001|Period III|Lost to Follow-up|0|||
148733670|NCT00006721|536499022|FG000|Overall Study|Adverse Event|0|||
148733671|NCT00006721|536499023|FG001|Overall Study|Adverse Event|4|||
148733672|NCT00006721|536499024|FG002|Overall Study|Adverse Event|4|||
148733673|NCT00006721|536499022|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
148733674|NCT00006721|536499023|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
148733675|NCT00006721|536499024|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
148733676|NCT00006721|536499022|FG000|Overall Study|Progression/Relapse|0|||
148733677|NCT00006721|536499023|FG001|Overall Study|Progression/Relapse|1|||
148733678|NCT00006721|536499024|FG002|Overall Study|Progression/Relapse|2|||
148733679|NCT00006721|536499022|FG000|Overall Study|Death|0|||
148733680|NCT00006721|536499023|FG001|Overall Study|Death|1|||
148733681|NCT00006721|536499024|FG002|Overall Study|Death|2|||
148733682|NCT00006721|536499022|FG000|Overall Study|Other - Not Protocol Specified|0|||
148733683|NCT00006721|536499023|FG001|Overall Study|Other - Not Protocol Specified|7|||
148733684|NCT00006721|536499024|FG002|Overall Study|Other - Not Protocol Specified|7|||
148733685|NCT00006721|536499022|FG000|Overall Study|Ineligible|2|||
148733686|NCT00006721|536499023|FG001|Overall Study|Ineligible|12|||
148733687|NCT00006721|536499024|FG002|Overall Study|Ineligible|10|||
148733688|NCT00006721|536499022|FG000|Overall Study|Eligible but no Treatment Received|1|||
148733689|NCT00006721|536499023|FG001|Overall Study|Eligible but no Treatment Received|0|||
148733690|NCT00006721|536499024|FG002|Overall Study|Eligible but no Treatment Received|0|||
148733691|NCT03653507|536499025|FG000|Overall Study|Miscellaneous|28|||
148733692|NCT03653507|536499026|FG001|Overall Study|Miscellaneous|19|||
148733693|NCT03653507|536499025|FG000|Overall Study|Withdrawal by Subject|37|||
148733694|NCT03653507|536499026|FG001|Overall Study|Withdrawal by Subject|22|||
148733695|NCT03653507|536499025|FG000|Overall Study|Protocol Deviation|2|||
148733696|NCT03653507|536499026|FG001|Overall Study|Protocol Deviation|1|||
148733697|NCT03653507|536499025|FG000|Overall Study|Progressive disease|117|||
148733698|NCT03653507|536499026|FG001|Overall Study|Progressive disease|168|||
148733699|NCT03653507|536499025|FG000|Overall Study|Lost to Follow-up|1|||
148733700|NCT03653507|536499026|FG001|Overall Study|Lost to Follow-up|1|||
148733701|NCT03653507|536499025|FG000|Overall Study|Death|25|||
148733702|NCT03653507|536499026|FG001|Overall Study|Death|22|||
148733703|NCT03653507|536499025|FG000|Overall Study|Adverse Event|35|||
148733704|NCT03653507|536499026|FG001|Overall Study|Adverse Event|14|||
148733705|NCT02492880|536499031|FG000|Overall Study|Lost to Follow-up|1|||
148733706|NCT02492880|536499031|FG000|Overall Study|Protocol Violation|1|||
148733707|NCT01200992|536499032|FG000|Overall Study|Study terminated early|35|||
148733708|NCT01200992|536499033|FG001|Overall Study|Study terminated early|41|||
148733709|NCT01200992|536499032|FG000|Overall Study|Randomized but not treated|2|||
148733710|NCT01200992|536499033|FG001|Overall Study|Randomized but not treated|0|||
148733711|NCT00792935|536499034|FG000|Overall Study|Adverse Event|2|||
148817618|NCT02965456|536807319|FG000|Overall Study|Protocol Violation|0|||
148817619|NCT02965456|536807320|FG001|Overall Study|Protocol Violation|1|||
148733712|NCT00792935|536499035|FG001|Overall Study|Adverse Event|1|||
148733713|NCT00792935|536499034|FG000|Overall Study|Lost to Follow-up|0|||
148733714|NCT00792935|536499035|FG001|Overall Study|Lost to Follow-up|1|||
148733715|NCT00792935|536499034|FG000|Overall Study|Protocol Violation|2|||
148733716|NCT00792935|536499035|FG001|Overall Study|Protocol Violation|0|||
148817620|NCT02965456|536807319|FG000|Overall Study|Participant ran out of study drug|0|||
148817621|NCT02965456|536807320|FG001|Overall Study|Participant ran out of study drug|1|||
148817622|NCT04465955|536807321|FG000|Overall Study|Withdrew consent|6|||
148973415|NCT04019041|537386169|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
148733717|NCT00792935|536499034|FG000|Overall Study|Withdrawal by Subject|0|||
148733718|NCT00792935|536499035|FG001|Overall Study|Withdrawal by Subject|1|||
148733719|NCT03186781|536499036|FG000|Overall Study|Lost to Follow-up|0|||
148733720|NCT03186781|536499037|FG001|Overall Study|Lost to Follow-up|0|||
148817623|NCT04465955|536807322|FG001|Overall Study|Withdrew consent|10|||
148817624|NCT04465955|536807323|FG002|Overall Study|Withdrew consent|7|||
148817625|NCT04465955|536807321|FG000|Overall Study|Adverse Event|6|||
148817626|NCT04465955|536807322|FG001|Overall Study|Adverse Event|5|||
148817627|NCT04465955|536807323|FG002|Overall Study|Adverse Event|1|||
148817628|NCT04465955|536807321|FG000|Overall Study|Lost to Follow-up|2|||
148817629|NCT04465955|536807322|FG001|Overall Study|Lost to Follow-up|0|||
148817630|NCT04465955|536807323|FG002|Overall Study|Lost to Follow-up|3|||
148817631|NCT04465955|536807321|FG000|Overall Study|Other|1|||
148817632|NCT04465955|536807322|FG001|Overall Study|Other|1|||
148817633|NCT04465955|536807323|FG002|Overall Study|Other|3|||
148817634|NCT00387127|536807324|FG000|Overall Study|Lost to Follow-up|0|||
148817635|NCT00387127|536807325|FG001|Overall Study|Lost to Follow-up|4|||
148817636|NCT00387127|536807324|FG000|Overall Study|Death|16|||
148817637|NCT00387127|536807325|FG001|Overall Study|Death|16|||
148817638|NCT00387127|536807324|FG000|Overall Study|Physician Decision|0|||
148973416|NCT04019041|537386170|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
148973417|NCT04019041|537386171|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
148973418|NCT04019041|537386172|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
148733721|NCT03186781|536499038|FG002|Overall Study|Lost to Follow-up|1|||
148733722|NCT03186781|536499039|FG003|Overall Study|Lost to Follow-up|0|||
148733723|NCT03186781|536499040|FG004|Overall Study|Lost to Follow-up|1|||
148733724|NCT03186781|536499041|FG005|Overall Study|Lost to Follow-up|0|||
148733725|NCT03186781|536499036|FG000|Overall Study|Moved from Area|0|||
148733726|NCT03186781|536499037|FG001|Overall Study|Moved from Area|0|||
148733727|NCT03186781|536499038|FG002|Overall Study|Moved from Area|0|||
148733728|NCT03186781|536499039|FG003|Overall Study|Moved from Area|0|||
148733729|NCT03186781|536499040|FG004|Overall Study|Moved from Area|1|||
148733730|NCT03186781|536499041|FG005|Overall Study|Moved from Area|0|||
148733731|NCT03186781|536499036|FG000|Overall Study|Withdrawal by Subject|0|||
148733732|NCT03186781|536499037|FG001|Overall Study|Withdrawal by Subject|0|||
148733733|NCT03186781|536499038|FG002|Overall Study|Withdrawal by Subject|0|||
148733734|NCT03186781|536499039|FG003|Overall Study|Withdrawal by Subject|0|||
148733735|NCT03186781|536499040|FG004|Overall Study|Withdrawal by Subject|1|||
148733736|NCT03186781|536499041|FG005|Overall Study|Withdrawal by Subject|0|||
148733737|NCT02622113|536499046|FG000|Overall Study|Adverse Event|4|||
148733738|NCT02622113|536499047|FG001|Overall Study|Adverse Event|4|||
148733739|NCT02622113|536499046|FG000|Overall Study|Physician Decision|0|||
148733740|NCT02622113|536499047|FG001|Overall Study|Physician Decision|1|||
148733741|NCT02622113|536499046|FG000|Overall Study|Withdrawal by Subject|0|||
148733742|NCT02622113|536499047|FG001|Overall Study|Withdrawal by Subject|2|||
148733743|NCT02622113|536499046|FG000|Overall Study|Stopping Criteria|1|||
148733744|NCT02622113|536499047|FG001|Overall Study|Stopping Criteria|3|||
148733745|NCT00667810|536499048|FG000|Overall Study|Adverse Event|13|||
148733746|NCT00667810|536499049|FG001|Overall Study|Adverse Event|14|||
148733747|NCT00667810|536499050|FG002|Overall Study|Adverse Event|19|||
148733748|NCT00667810|536499051|FG003|Overall Study|Adverse Event|1|||
148733749|NCT00667810|536499048|FG000|Overall Study|Death|1|||
148733750|NCT00667810|536499049|FG001|Overall Study|Death|1|||
148733751|NCT00667810|536499050|FG002|Overall Study|Death|3|||
148733752|NCT00667810|536499051|FG003|Overall Study|Death|0|||
148733753|NCT00667810|536499048|FG000|Overall Study|Lack of Efficacy|1|||
148733754|NCT00667810|536499049|FG001|Overall Study|Lack of Efficacy|0|||
148973419|NCT04019041|537386167|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
148973420|NCT04019041|537386168|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
148973421|NCT04019041|537386169|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
148973422|NCT04019041|537386170|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
148973423|NCT04019041|537386171|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
148973424|NCT04019041|537386172|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
148973425|NCT04019041|537386167|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
148973426|NCT04019041|537386168|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
148973427|NCT04019041|537386169|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
148973428|NCT04019041|537386170|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
148973429|NCT04019041|537386171|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
148973430|NCT04019041|537386172|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
148973431|NCT04019041|537386167|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
149026862|NCT00049517|537576397|FG000|Induction|Reasons not reported|0|||
148733755|NCT00667810|536499050|FG002|Overall Study|Lack of Efficacy|2|||
148733756|NCT00667810|536499051|FG003|Overall Study|Lack of Efficacy|0|||
148733757|NCT00667810|536499048|FG000|Overall Study|Lost to Follow-up|1|||
148733758|NCT00667810|536499049|FG001|Overall Study|Lost to Follow-up|4|||
148733759|NCT00667810|536499050|FG002|Overall Study|Lost to Follow-up|2|||
148733760|NCT00667810|536499051|FG003|Overall Study|Lost to Follow-up|0|||
148733761|NCT00667810|536499048|FG000|Overall Study|Physician Decision|1|||
148817639|NCT00387127|536807325|FG001|Overall Study|Physician Decision|1|||
148817640|NCT00387127|536807324|FG000|Overall Study|Withdrawal by Subject|3|||
148817641|NCT00387127|536807325|FG001|Overall Study|Withdrawal by Subject|2|||
148817642|NCT00387127|536807324|FG000|Overall Study|Required by Protocol Amendment #4|12|||
148817643|NCT00387127|536807325|FG001|Overall Study|Required by Protocol Amendment #4|10|||
148817644|NCT00387127|536807324|FG000|Overall Study|Serious Adverse Event|1|||
148817645|NCT00387127|536807325|FG001|Overall Study|Serious Adverse Event|1|||
148817646|NCT00387127|536807324|FG000|Overall Study|Sponsor Unblinded|1|||
148817647|NCT00387127|536807325|FG001|Overall Study|Sponsor Unblinded|0|||
148817648|NCT00812097|536807328|FG000|Overall Study|Death|3|||
148817649|NCT00812097|536807329|FG001|Overall Study|Death|10|||
148817650|NCT00812097|536807330|FG002|Overall Study|Death|3|||
148817651|NCT00812097|536807331|FG003|Overall Study|Death|3|||
148817652|NCT00812097|536807328|FG000|Overall Study|Withdrawal by Subject|14|||
148817653|NCT00812097|536807329|FG001|Overall Study|Withdrawal by Subject|12|||
148817654|NCT00812097|536807330|FG002|Overall Study|Withdrawal by Subject|8|||
148817655|NCT00812097|536807331|FG003|Overall Study|Withdrawal by Subject|2|||
148817656|NCT00812097|536807328|FG000|Overall Study|Lost to Follow-up|90|||
148817657|NCT00812097|536807329|FG001|Overall Study|Lost to Follow-up|14|||
148817658|NCT00812097|536807330|FG002|Overall Study|Lost to Follow-up|17|||
148817659|NCT00812097|536807331|FG003|Overall Study|Lost to Follow-up|5|||
148817660|NCT00812097|536807328|FG000|Overall Study|Explantation of study device(s)|27|||
148817661|NCT00812097|536807329|FG001|Overall Study|Explantation of study device(s)|29|||
148817662|NCT00812097|536807330|FG002|Overall Study|Explantation of study device(s)|14|||
148817663|NCT00812097|536807331|FG003|Overall Study|Explantation of study device(s)|20|||
148817664|NCT00812097|536807328|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
148817665|NCT00812097|536807329|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
148817666|NCT00812097|536807330|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
148817667|NCT00812097|536807331|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
148817668|NCT00317369|536807335|FG000|Overall Study|Adverse Event|2|||
148817669|NCT00317369|536807336|FG001|Overall Study|Adverse Event|1|||
148817670|NCT00317369|536807337|FG002|Overall Study|Adverse Event|0|||
148817671|NCT00317369|536807335|FG000|Overall Study|Lack of Efficacy|0|||
148817672|NCT00317369|536807336|FG001|Overall Study|Lack of Efficacy|1|||
148817673|NCT00317369|536807337|FG002|Overall Study|Lack of Efficacy|1|||
148817674|NCT00317369|536807335|FG000|Overall Study|Withdrawal by Subject|0|||
148817675|NCT00317369|536807336|FG001|Overall Study|Withdrawal by Subject|0|||
148817676|NCT00317369|536807337|FG002|Overall Study|Withdrawal by Subject|1|||
148817677|NCT03573882|536807339|FG000|Overall Study|Study Terminated by Sponsor|22|||
148817678|NCT03573882|536807340|FG001|Overall Study|Study Terminated by Sponsor|17|||
148817679|NCT03573882|536807341|FG002|Overall Study|Study Terminated by Sponsor|18|||
148817680|NCT03573882|536807339|FG000|Overall Study|Withdrawal by Subject|6|||
148733762|NCT00667810|536499049|FG001|Overall Study|Physician Decision|1|||
148733763|NCT00667810|536499050|FG002|Overall Study|Physician Decision|2|||
148733764|NCT00667810|536499051|FG003|Overall Study|Physician Decision|0|||
148733765|NCT00667810|536499048|FG000|Overall Study|Protocol Violation|0|||
148733766|NCT00667810|536499049|FG001|Overall Study|Protocol Violation|2|||
148733767|NCT00667810|536499050|FG002|Overall Study|Protocol Violation|0|||
148733768|NCT00667810|536499051|FG003|Overall Study|Protocol Violation|0|||
148733769|NCT00667810|536499048|FG000|Overall Study|Withdrawal by Subject|14|||
148733770|NCT00667810|536499049|FG001|Overall Study|Withdrawal by Subject|20|||
148733771|NCT00667810|536499050|FG002|Overall Study|Withdrawal by Subject|29|||
148733772|NCT00667810|536499051|FG003|Overall Study|Withdrawal by Subject|1|||
148733773|NCT00667810|536499048|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
148733774|NCT00667810|536499049|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
148733775|NCT00667810|536499050|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
148733776|NCT00667810|536499051|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
148733777|NCT00667810|536499048|FG000|Overall Study|Failed to Return|0|||
148733778|NCT00667810|536499049|FG001|Overall Study|Failed to Return|0|||
148733779|NCT00667810|536499050|FG002|Overall Study|Failed to Return|2|||
148733780|NCT00667810|536499051|FG003|Overall Study|Failed to Return|0|||
148733781|NCT00667810|536499048|FG000|Overall Study|Loss of Caregiver|0|||
148733782|NCT00667810|536499049|FG001|Overall Study|Loss of Caregiver|1|||
148733783|NCT00667810|536499050|FG002|Overall Study|Loss of Caregiver|3|||
148733784|NCT00667810|536499051|FG003|Overall Study|Loss of Caregiver|0|||
148733785|NCT00667810|536499048|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
148733786|NCT00667810|536499049|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
148733787|NCT00667810|536499050|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
148817681|NCT03573882|536807340|FG001|Overall Study|Withdrawal by Subject|11|||
148817682|NCT03573882|536807341|FG002|Overall Study|Withdrawal by Subject|7|||
148817683|NCT03573882|536807339|FG000|Overall Study|Adverse Event|7|||
148817684|NCT03573882|536807340|FG001|Overall Study|Adverse Event|5|||
148733788|NCT00667810|536499051|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
148733789|NCT00667810|536499048|FG000|Overall Study|Other|6|||
148733790|NCT00667810|536499049|FG001|Overall Study|Other|6|||
148733791|NCT00667810|536499050|FG002|Overall Study|Other|5|||
148817685|NCT03573882|536807341|FG002|Overall Study|Adverse Event|6|||
148817686|NCT03573882|536807339|FG000|Overall Study|Lost to Follow-up|2|||
148817687|NCT03573882|536807340|FG001|Overall Study|Lost to Follow-up|5|||
148817688|NCT03573882|536807341|FG002|Overall Study|Lost to Follow-up|3|||
148817689|NCT03573882|536807339|FG000|Overall Study|Physician Decision|4|||
148817690|NCT03573882|536807340|FG001|Overall Study|Physician Decision|3|||
148733792|NCT00667810|536499051|FG003|Overall Study|Other|0|||
148733793|NCT04112173|536499052|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
148733794|NCT01561430|536499053|FG000|Overall Study|Adverse Event|0|||
148733795|NCT01561430|536499054|FG001|Overall Study|Adverse Event|0|||
148733796|NCT01561430|536499055|FG002|Overall Study|Adverse Event|3|||
149026863|NCT00049517|537576398|FG001|Induction|Reasons not reported|0|||
149026864|NCT00049517|537576399|FG002|Induction|Reasons not reported|0|||
149026865|NCT00049517|537576400|FG003|Induction|Reasons not reported|0|||
149026866|NCT00049517|537576401|FG004|Induction|Reasons not reported|22|||
149026867|NCT00049517|537576402|FG005|Induction|Reasons not reported|25|||
149026868|NCT00049517|537576397|FG000|Conditioning/Transplant|Disease progression|14|||
149026869|NCT00049517|537576398|FG001|Conditioning/Transplant|Disease progression|6|||
149026870|NCT00049517|537576399|FG002|Conditioning/Transplant|Disease progression|10|||
149026871|NCT00049517|537576400|FG003|Conditioning/Transplant|Disease progression|6|||
148733797|NCT01561430|536499056|FG003|Overall Study|Adverse Event|1|||
148733798|NCT01561430|536499053|FG000|Overall Study|Withdrawal by Subject|0|||
148733799|NCT01561430|536499054|FG001|Overall Study|Withdrawal by Subject|0|||
148733800|NCT01561430|536499055|FG002|Overall Study|Withdrawal by Subject|1|||
148733801|NCT01561430|536499056|FG003|Overall Study|Withdrawal by Subject|0|||
148733802|NCT01561430|536499053|FG000|Overall Study|Physician Decision|0|||
148733803|NCT01561430|536499054|FG001|Overall Study|Physician Decision|1|||
148733804|NCT01561430|536499055|FG002|Overall Study|Physician Decision|0|||
148733805|NCT01561430|536499056|FG003|Overall Study|Physician Decision|0|||
148733806|NCT01561430|536499053|FG000|Overall Study|Sponsor Decision|1|||
148733807|NCT01561430|536499054|FG001|Overall Study|Sponsor Decision|14|||
148733808|NCT01561430|536499055|FG002|Overall Study|Sponsor Decision|13|||
148733809|NCT01561430|536499056|FG003|Overall Study|Sponsor Decision|12|||
148733810|NCT02731326|536499066|FG000|Overall Study|Withdrawal by Subject|4|||
148733811|NCT02731326|536499067|FG001|Overall Study|Withdrawal by Subject|1|||
148733812|NCT02731326|536499066|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
148733813|NCT02731326|536499067|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
148733814|NCT02731326|536499066|FG000|Overall Study|Discharged without AliveCor|10|||
148733815|NCT02731326|536499067|FG001|Overall Study|Discharged without AliveCor|0|||
148733816|NCT02731326|536499066|FG000|Overall Study|Duplicate Participant|1|||
148733817|NCT02731326|536499067|FG001|Overall Study|Duplicate Participant|1|||
148733818|NCT01442688|536499069|FG000|First Intervention|Withdrawal by Subject|1|||
148733819|NCT01442688|536499070|FG001|First Intervention|Withdrawal by Subject|0|||
148733820|NCT01442688|536499069|FG000|First Intervention|subject incarcerated|1|||
148733821|NCT01442688|536499070|FG001|First Intervention|subject incarcerated|0|||
148733822|NCT01442688|536499069|FG000|Second Intervention|Adverse Event|1|||
148733823|NCT01442688|536499070|FG001|Second Intervention|Adverse Event|0|||
148733824|NCT02643355|536499071|FG000|Overall Study|Withdrawal by Subject|1|||
148733825|NCT02643355|536499072|FG001|Overall Study|Withdrawal by Subject|3|||
148733826|NCT02643355|536499071|FG000|Overall Study|Protocol Violation|0|||
148733827|NCT02643355|536499072|FG001|Overall Study|Protocol Violation|2|||
148733828|NCT00302081|536499075|FG000|Overall Study|Adverse Event|6|||
148733829|NCT00302081|536499076|FG001|Overall Study|Adverse Event|5|||
148733830|NCT00302081|536499077|FG002|Overall Study|Adverse Event|4|||
148733831|NCT00302081|536499075|FG000|Overall Study|Lost to Follow-up|21|||
148733832|NCT00302081|536499076|FG001|Overall Study|Lost to Follow-up|18|||
148733833|NCT00302081|536499077|FG002|Overall Study|Lost to Follow-up|28|||
148733834|NCT00302081|536499075|FG000|Overall Study|Withdrawal by Subject|8|||
148733835|NCT00302081|536499076|FG001|Overall Study|Withdrawal by Subject|12|||
148733836|NCT00302081|536499077|FG002|Overall Study|Withdrawal by Subject|8|||
148733837|NCT00302081|536499075|FG000|Overall Study|Protocol Violation|5|||
148733838|NCT00302081|536499076|FG001|Overall Study|Protocol Violation|1|||
148733839|NCT00302081|536499077|FG002|Overall Study|Protocol Violation|2|||
148733840|NCT00302081|536499075|FG000|Overall Study|Lack of Efficacy|1|||
148733841|NCT00302081|536499076|FG001|Overall Study|Lack of Efficacy|0|||
148733842|NCT00302081|536499077|FG002|Overall Study|Lack of Efficacy|5|||
148733843|NCT00302081|536499075|FG000|Overall Study|Death|2|||
148733844|NCT00302081|536499076|FG001|Overall Study|Death|1|||
148733845|NCT00302081|536499077|FG002|Overall Study|Death|0|||
148733846|NCT00302081|536499075|FG000|Overall Study|Other|13|||
148733847|NCT00302081|536499076|FG001|Overall Study|Other|6|||
148733848|NCT00302081|536499077|FG002|Overall Study|Other|5|||
148733849|NCT04480021|536499078|FG000|Overall Study|Lost to Follow-up|3|||
148733850|NCT04480021|536499079|FG001|Overall Study|Lost to Follow-up|4|||
148733851|NCT05084963|536499080|FG000|Overall Study|Withdrawal by Subject|0|||
148733852|NCT05084963|536499081|FG001|Overall Study|Withdrawal by Subject|0|||
148733853|NCT05084963|536499082|FG002|Overall Study|Withdrawal by Subject|1|||
149026872|NCT00049517|537576401|FG004|Conditioning/Transplant|Disease progression|0|||
149026873|NCT00049517|537576402|FG005|Conditioning/Transplant|Disease progression|0|||
148733854|NCT03569228|536499083|FG000|Overall Study|Withdrawal by PI|0|||
148733855|NCT03569228|536499084|FG001|Overall Study|Withdrawal by PI|0|||
148733856|NCT03569228|536499085|FG002|Overall Study|Withdrawal by PI|2|||
148733857|NCT03569228|536499086|FG003|Overall Study|Withdrawal by PI|2|||
148733858|NCT03569228|536499087|FG004|Overall Study|Withdrawal by PI|1|||
148733859|NCT03569228|536499088|FG005|Overall Study|Withdrawal by PI|0|||
148733860|NCT03569228|536499089|FG006|Overall Study|Withdrawal by PI|0|||
148733861|NCT03569228|536499090|FG007|Overall Study|Withdrawal by PI|0|||
148733862|NCT03569228|536499091|FG008|Overall Study|Withdrawal by PI|0|||
148733863|NCT03569228|536499083|FG000|Overall Study|Lost to Follow-up|0|||
148733864|NCT03569228|536499084|FG001|Overall Study|Lost to Follow-up|0|||
148733865|NCT03569228|536499085|FG002|Overall Study|Lost to Follow-up|0|||
148733866|NCT03569228|536499086|FG003|Overall Study|Lost to Follow-up|0|||
148733867|NCT03569228|536499087|FG004|Overall Study|Lost to Follow-up|0|||
148733868|NCT03569228|536499088|FG005|Overall Study|Lost to Follow-up|0|||
148733869|NCT03569228|536499089|FG006|Overall Study|Lost to Follow-up|0|||
148733870|NCT03569228|536499090|FG007|Overall Study|Lost to Follow-up|0|||
148733871|NCT03569228|536499091|FG008|Overall Study|Lost to Follow-up|1|||
148733872|NCT03569228|536499083|FG000|Overall Study|Screen Fail|2|||
148733873|NCT03569228|536499084|FG001|Overall Study|Screen Fail|2|||
148733874|NCT03569228|536499085|FG002|Overall Study|Screen Fail|1|||
148733875|NCT03569228|536499086|FG003|Overall Study|Screen Fail|1|||
148733876|NCT03569228|536499087|FG004|Overall Study|Screen Fail|1|||
148733877|NCT03569228|536499088|FG005|Overall Study|Screen Fail|3|||
148733878|NCT03569228|536499089|FG006|Overall Study|Screen Fail|1|||
148733879|NCT03569228|536499090|FG007|Overall Study|Screen Fail|5|||
148733880|NCT03569228|536499091|FG008|Overall Study|Screen Fail|2|||
148733881|NCT00536263|536499092|FG000|Overall Study|Adverse Event|5|||
148733882|NCT00536263|536499093|FG001|Overall Study|Adverse Event|5|||
148733883|NCT00536263|536499094|FG002|Overall Study|Adverse Event|7|||
148733884|NCT00536263|536499092|FG000|Overall Study|Lost to Follow-up|3|||
148733885|NCT00536263|536499093|FG001|Overall Study|Lost to Follow-up|4|||
148733886|NCT00536263|536499094|FG002|Overall Study|Lost to Follow-up|4|||
148733887|NCT00536263|536499092|FG000|Overall Study|Subject withdrew - not treatment related|2|||
148733888|NCT00536263|536499093|FG001|Overall Study|Subject withdrew - not treatment related|0|||
148733889|NCT00536263|536499094|FG002|Overall Study|Subject withdrew - not treatment related|5|||
148733890|NCT00536263|536499092|FG000|Overall Study|Subject withdrew - treatment related|0|||
148733891|NCT00536263|536499093|FG001|Overall Study|Subject withdrew - treatment related|3|||
148733892|NCT00536263|536499094|FG002|Overall Study|Subject withdrew - treatment related|2|||
148733893|NCT00536263|536499092|FG000|Overall Study|Noncompliance with protocol|0|||
148733894|NCT00536263|536499093|FG001|Overall Study|Noncompliance with protocol|0|||
148733895|NCT00536263|536499094|FG002|Overall Study|Noncompliance with protocol|1|||
148733896|NCT00536263|536499092|FG000|Overall Study|Did not meet protocol eligibility|1|||
148733897|NCT00536263|536499093|FG001|Overall Study|Did not meet protocol eligibility|2|||
148733898|NCT00536263|536499094|FG002|Overall Study|Did not meet protocol eligibility|2|||
148733899|NCT00826449|536499095|FG000|Overall Study|Disease Progression|4|||
148733900|NCT00826449|536499095|FG000|Overall Study|Withdrawal by Subject|1|||
148733901|NCT02994940|536499098|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
148733902|NCT02994940|536499099|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
148733903|NCT02994940|536499098|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
148733904|NCT02994940|536499099|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
148733905|NCT02994940|536499098|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
148733906|NCT02994940|536499099|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
148733907|NCT01103466|536499100|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
148733908|NCT01103466|536499101|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
148733909|NCT01103466|536499102|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
148733910|NCT01103466|536499100|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
148733911|NCT01103466|536499101|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
148733912|NCT01103466|536499102|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
148733913|NCT01103466|536499100|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
148733914|NCT01103466|536499101|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
148733915|NCT01103466|536499102|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
148733916|NCT01103466|536499100|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
148733917|NCT01103466|536499101|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
148733918|NCT01103466|536499102|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
148733919|NCT01103466|536499100|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
148733920|NCT01103466|536499101|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
148817691|NCT03573882|536807341|FG002|Overall Study|Physician Decision|2|||
148817692|NCT03573882|536807339|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
148817693|NCT03573882|536807340|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
148817694|NCT03573882|536807341|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
148733921|NCT01103466|536499102|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
148733922|NCT01103466|536499100|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
148733923|NCT01103466|536499101|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
148733924|NCT01103466|536499102|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
148733925|NCT02331368|536499107|FG000|Overall Study|Withdrawal by Subject|3|||
148733926|NCT02302859|536499115|FG000|Overall Study|Lost Phone|1|||
148733927|NCT02302859|536499116|FG001|Overall Study|Lost Phone|1|||
148733928|NCT02302859|536499115|FG000|Overall Study|Withdrawal by Subject|0|||
148733929|NCT02302859|536499116|FG001|Overall Study|Withdrawal by Subject|1|||
148733930|NCT01355159|536499121|FG000|Overall Study|Withdrew consent|39|||
148733931|NCT01355159|536499122|FG001|Overall Study|Withdrew consent|47|||
148733932|NCT01355159|536499121|FG000|Overall Study|No primary outcome data|17|||
148733933|NCT01355159|536499122|FG001|Overall Study|No primary outcome data|11|||
148733934|NCT01355159|536499121|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
148733935|NCT01355159|536499122|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
148733936|NCT01355159|536499121|FG000|Overall Study|Early intrauterine fetal death|6|||
149026874|NCT00049517|537576397|FG000|Conditioning/Transplant|Adverse Event|2|||
149026875|NCT00049517|537576398|FG001|Conditioning/Transplant|Adverse Event|1|||
149026876|NCT00049517|537576399|FG002|Conditioning/Transplant|Adverse Event|4|||
148733937|NCT01355159|536499122|FG001|Overall Study|Early intrauterine fetal death|6|||
148733938|NCT02357342|536499123|FG000|First 6 Months|Death|2|||
148733939|NCT02357342|536499124|FG001|First 6 Months|Death|0|||
148733940|NCT01674647|536499125|FG000|Treatment Period|Death|4|||
148733941|NCT01674647|536499126|FG001|Treatment Period|Death|1|||
148733942|NCT01674647|536499125|FG000|Treatment Period|Efficacy outcome reached|0|||
148733943|NCT01674647|536499126|FG001|Treatment Period|Efficacy outcome reached|1|||
148733944|NCT01674647|536499125|FG000|Treatment Period|Physician Decision|3|||
148733945|NCT01674647|536499126|FG001|Treatment Period|Physician Decision|1|||
148733946|NCT01674647|536499125|FG000|Treatment Period|Adverse Event|60|||
148733947|NCT01674647|536499126|FG001|Treatment Period|Adverse Event|22|||
148733948|NCT01674647|536499125|FG000|Treatment Period|Non-compliance with study drug|3|||
148733949|NCT01674647|536499126|FG001|Treatment Period|Non-compliance with study drug|0|||
148733950|NCT01674647|536499125|FG000|Treatment Period|Lost to Follow-up|1|||
148733951|NCT01674647|536499126|FG001|Treatment Period|Lost to Follow-up|1|||
148733952|NCT01674647|536499125|FG000|Treatment Period|Withdrawal by Subject|19|||
148733953|NCT01674647|536499126|FG001|Treatment Period|Withdrawal by Subject|16|||
148733954|NCT01674647|536499125|FG000|Treatment Period|Switching to other therapy|5|||
148733955|NCT01674647|536499126|FG001|Treatment Period|Switching to other therapy|2|||
148733956|NCT01674647|536499125|FG000|Treatment Period|Logistical difficulties|5|||
148733957|NCT01674647|536499126|FG001|Treatment Period|Logistical difficulties|8|||
148733958|NCT01674647|536499125|FG000|Treatment Period|Treatment failure|0|||
148733959|NCT01674647|536499126|FG001|Treatment Period|Treatment failure|14|||
148733960|NCT01674647|536499125|FG000|Treatment Period|Protocol Violation|56|||
148733961|NCT01674647|536499126|FG001|Treatment Period|Protocol Violation|36|||
148733962|NCT01674647|536499125|FG000|30-day Safety Follow-up Period|Death|3|||
148733963|NCT01674647|536499126|FG001|30-day Safety Follow-up Period|Death|2|||
148733964|NCT01674647|536499125|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
148733965|NCT01674647|536499126|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
148733966|NCT01674647|536499125|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
148733967|NCT01674647|536499126|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
148733968|NCT01674647|536499125|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
148733969|NCT01674647|536499126|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
148733970|NCT01674647|536499125|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
148733971|NCT01674647|536499126|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
148733972|NCT01674647|536499125|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
148733973|NCT01674647|536499126|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
148733974|NCT01941940|536499128|FG000|Overall Study|Adverse Event|11|||
148733975|NCT01941940|536499128|FG000|Overall Study|Lost to Follow-up|2|||
148733976|NCT01941940|536499128|FG000|Overall Study|Physician Decision|2|||
148733977|NCT01941940|536499128|FG000|Overall Study|Withdrawal by Subject|15|||
148733978|NCT01941940|536499128|FG000|Overall Study|Death|1|||
148733979|NCT01941940|536499128|FG000|Overall Study|Other|1|||
148733980|NCT01941940|536499128|FG000|Overall Study|Other|1|||
148733981|NCT03212521|536499132|FG000|Overall Study|Adverse Event|1|||
148733982|NCT03212521|536499132|FG000|Overall Study|Lost to Follow-up|4|||
148733983|NCT03212521|536499132|FG000|Overall Study|Withdrawal by Subject|1|||
148733984|NCT03212521|536499132|FG000|Overall Study|Other|1|||
148733985|NCT00444457|536499133|FG000|Infant Series|Other|0|||
148733986|NCT00444457|536499134|FG001|Infant Series|Other|1|||
148733987|NCT00444457|536499135|FG002|Infant Series|Other|0|||
148733988|NCT00444457|536499136|FG003|Infant Series|Other|0|||
148733989|NCT00444457|536499133|FG000|Infant Series|Parent or legal guardian request|18|||
148733990|NCT00444457|536499134|FG001|Infant Series|Parent or legal guardian request|29|||
148733991|NCT00444457|536499135|FG002|Infant Series|Parent or legal guardian request|34|||
148733992|NCT00444457|536499136|FG003|Infant Series|Parent or legal guardian request|14|||
148733993|NCT00444457|536499133|FG000|Infant Series|Lost to Follow-up|10|||
148733994|NCT00444457|536499134|FG001|Infant Series|Lost to Follow-up|11|||
148733995|NCT00444457|536499135|FG002|Infant Series|Lost to Follow-up|7|||
148733996|NCT00444457|536499136|FG003|Infant Series|Lost to Follow-up|6|||
148733997|NCT00444457|536499133|FG000|Infant Series|Protocol Violation|16|||
148733998|NCT00444457|536499134|FG001|Infant Series|Protocol Violation|8|||
148733999|NCT00444457|536499135|FG002|Infant Series|Protocol Violation|6|||
148734000|NCT00444457|536499136|FG003|Infant Series|Protocol Violation|3|||
148817695|NCT03573882|536807339|FG000|Overall Study|Pregnancy|1|||
148817696|NCT03573882|536807340|FG001|Overall Study|Pregnancy|2|||
148817697|NCT03573882|536807341|FG002|Overall Study|Pregnancy|0|||
148817698|NCT03573882|536807339|FG000|Overall Study|Other|4|||
148817699|NCT03573882|536807340|FG001|Overall Study|Other|2|||
148817700|NCT03573882|536807341|FG002|Overall Study|Other|2|||
148817701|NCT02965833|536807343|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
148817702|NCT02965833|536807344|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
148817703|NCT02965833|536807343|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
148817704|NCT02965833|536807344|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
148817705|NCT02965833|536807343|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
148817706|NCT02965833|536807344|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
148817707|NCT02965833|536807343|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
148817708|NCT02965833|536807344|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
148817709|NCT02965833|536807343|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
148817710|NCT02965833|536807344|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
148817711|NCT03370302|536807345|FG000|Dose Escalation Phase|Other|0|||
148817712|NCT03370302|536807346|FG001|Dose Escalation Phase|Other|1|||
148817713|NCT03370302|536807347|FG002|Dose Escalation Phase|Other|1|||
148817714|NCT03370302|536807348|FG003|Dose Escalation Phase|Other|0|||
148817715|NCT03370302|536807349|FG004|Dose Escalation Phase|Other|0|||
148817716|NCT03370302|536807350|FG005|Dose Escalation Phase|Other|0|||
148817717|NCT03370302|536807345|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
148817718|NCT03370302|536807346|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
148817719|NCT03370302|536807347|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
148817720|NCT03370302|536807348|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
148817721|NCT03370302|536807349|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
148817722|NCT03370302|536807350|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
148817723|NCT03370302|536807345|FG000|Dose Escalation Phase|Adverse Event|1|||
148817724|NCT03370302|536807346|FG001|Dose Escalation Phase|Adverse Event|0|||
148817725|NCT03370302|536807347|FG002|Dose Escalation Phase|Adverse Event|2|||
148817726|NCT03370302|536807348|FG003|Dose Escalation Phase|Adverse Event|0|||
148817727|NCT03370302|536807349|FG004|Dose Escalation Phase|Adverse Event|0|||
148817728|NCT03370302|536807350|FG005|Dose Escalation Phase|Adverse Event|0|||
148817729|NCT03370302|536807345|FG000|Dose Escalation Phase|Progressive Disease|2|||
148817730|NCT03370302|536807346|FG001|Dose Escalation Phase|Progressive Disease|4|||
148817731|NCT03370302|536807347|FG002|Dose Escalation Phase|Progressive Disease|2|||
148817732|NCT03370302|536807348|FG003|Dose Escalation Phase|Progressive Disease|0|||
148817733|NCT03370302|536807349|FG004|Dose Escalation Phase|Progressive Disease|3|||
148817734|NCT03370302|536807350|FG005|Dose Escalation Phase|Progressive Disease|1|||
148817735|NCT03370302|536807345|FG000|Dose Expansion Phase|Progressive Disease|0|||
148817736|NCT03370302|536807346|FG001|Dose Expansion Phase|Progressive Disease|0|||
148817737|NCT03370302|536807347|FG002|Dose Expansion Phase|Progressive Disease|0|||
148817738|NCT03370302|536807348|FG003|Dose Expansion Phase|Progressive Disease|6|||
148817739|NCT03370302|536807349|FG004|Dose Expansion Phase|Progressive Disease|0|||
148817740|NCT03370302|536807350|FG005|Dose Expansion Phase|Progressive Disease|0|||
148817741|NCT00250718|536807351|FG000|Overall Study|Death|1|||
148817742|NCT00250718|536807351|FG000|Overall Study|Adverse Event|1|||
148817743|NCT00250718|536807351|FG000|Overall Study|Withdrawal by Subject|1|||
148817744|NCT03407482|536807352|FG000|Overall Study|Adverse Event|12|||
148817745|NCT03407482|536807352|FG000|Overall Study|Disease Relapse|1|||
148817746|NCT03407482|536807352|FG000|Overall Study|Lost to Follow-up|1|||
148817747|NCT03407482|536807352|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148817748|NCT03407482|536807352|FG000|Overall Study|Pregnancy|2|||
148817749|NCT03407482|536807352|FG000|Overall Study|Protocol Violation|1|||
148817750|NCT03407482|536807352|FG000|Overall Study|Study Terminated By Sponsor|106|||
148734001|NCT00444457|536499133|FG000|Infant Series|Failed to return|5|||
148734002|NCT00444457|536499134|FG001|Infant Series|Failed to return|4|||
148734003|NCT00444457|536499135|FG002|Infant Series|Failed to return|4|||
148734004|NCT00444457|536499136|FG003|Infant Series|Failed to return|2|||
148734005|NCT00444457|536499133|FG000|Infant Series|Investigator request|4|||
148734006|NCT00444457|536499134|FG001|Infant Series|Investigator request|3|||
148734007|NCT00444457|536499135|FG002|Infant Series|Investigator request|3|||
148734008|NCT00444457|536499136|FG003|Infant Series|Investigator request|2|||
148734009|NCT00444457|536499133|FG000|Infant Series|Other|0|||
148734010|NCT00444457|536499134|FG001|Infant Series|Other|2|||
148817751|NCT03407482|536807352|FG000|Overall Study|Withdrawal by Subject|6|||
148817752|NCT03407482|536807352|FG000|Overall Study|Data Entry Error|1|||
148817753|NCT05942040|536807353|FG000|Overall Study|No longer employed at study site.|0|||
148817754|NCT05942040|536807354|FG001|Overall Study|No longer employed at study site.|0|||
148817755|NCT05942040|536807355|FG002|Overall Study|No longer employed at study site.|3|||
148734011|NCT00444457|536499135|FG002|Infant Series|Other|4|||
148734012|NCT00444457|536499136|FG003|Infant Series|Other|0|||
148734013|NCT00444457|536499133|FG000|Infant Series|Adverse Event|1|||
148734014|NCT00444457|536499134|FG001|Infant Series|Adverse Event|2|||
148734015|NCT00444457|536499135|FG002|Infant Series|Adverse Event|2|||
148734016|NCT00444457|536499136|FG003|Infant Series|Adverse Event|0|||
148734017|NCT00444457|536499133|FG000|Infant Series|Death|0|||
148734018|NCT00444457|536499134|FG001|Infant Series|Death|1|||
148734019|NCT00444457|536499135|FG002|Infant Series|Death|1|||
148734020|NCT00444457|536499136|FG003|Infant Series|Death|1|||
148734021|NCT00444457|536499133|FG000|After Infant Series|Other|0|||
148817789|NCT04337021|536807359|FG000|Overall Study|Lost to Follow-up|54|||
148817790|NCT04337021|536807360|FG001|Overall Study|Lost to Follow-up|66|||
148817791|NCT01685437|536807365|FG000|Overall Study|Withdrawal by Subject|22|||
148817792|NCT01685437|536807365|FG000|Overall Study|Lost to Follow-up|3|||
148817793|NCT01685437|536807365|FG000|Overall Study|Adverse Event|1|||
148817794|NCT01685437|536807365|FG000|Overall Study|Protocol Violation|4|||
148817795|NCT01685437|536807365|FG000|Overall Study|Unable to make visits due to work|1|||
148817796|NCT03828383|536807376|FG000|Overall Study|Lost to Follow-up|3|||
148817797|NCT03828383|536807377|FG001|Overall Study|Lost to Follow-up|2|||
148817798|NCT03828383|536807376|FG000|Overall Study|Withdrawal by Subject|4|||
148734022|NCT00444457|536499134|FG001|After Infant Series|Other|1|||
148734023|NCT00444457|536499135|FG002|After Infant Series|Other|1|||
148734024|NCT00444457|536499136|FG003|After Infant Series|Other|1|||
148734025|NCT00444457|536499133|FG000|After Infant Series|Parent or legal guardian request|4|||
148734026|NCT00444457|536499134|FG001|After Infant Series|Parent or legal guardian request|11|||
148734027|NCT00444457|536499135|FG002|After Infant Series|Parent or legal guardian request|6|||
148734028|NCT00444457|536499136|FG003|After Infant Series|Parent or legal guardian request|3|||
148734029|NCT00444457|536499133|FG000|After Infant Series|Failed to return|7|||
148734030|NCT00444457|536499134|FG001|After Infant Series|Failed to return|6|||
148734031|NCT00444457|536499135|FG002|After Infant Series|Failed to return|5|||
148734032|NCT00444457|536499136|FG003|After Infant Series|Failed to return|1|||
148734033|NCT00444457|536499133|FG000|After Infant Series|Lost to Follow-up|5|||
148734034|NCT00444457|536499134|FG001|After Infant Series|Lost to Follow-up|5|||
148734035|NCT00444457|536499135|FG002|After Infant Series|Lost to Follow-up|5|||
148734036|NCT00444457|536499136|FG003|After Infant Series|Lost to Follow-up|2|||
148734037|NCT00444457|536499133|FG000|After Infant Series|Protocol Violation|2|||
148734038|NCT00444457|536499134|FG001|After Infant Series|Protocol Violation|4|||
148734039|NCT00444457|536499135|FG002|After Infant Series|Protocol Violation|2|||
148734040|NCT00444457|536499136|FG003|After Infant Series|Protocol Violation|2|||
148734041|NCT00444457|536499133|FG000|After Infant Series|Adverse Event|2|||
148734042|NCT00444457|536499134|FG001|After Infant Series|Adverse Event|2|||
148734043|NCT00444457|536499135|FG002|After Infant Series|Adverse Event|0|||
148817799|NCT03828383|536807377|FG001|Overall Study|Withdrawal by Subject|5|||
148817800|NCT03860584|536807386|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
148734044|NCT00444457|536499136|FG003|After Infant Series|Adverse Event|0|||
148734045|NCT00444457|536499133|FG000|After Infant Series|Investigator request|0|||
148817801|NCT03860584|536807387|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
148973432|NCT04019041|537386168|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
148817802|NCT03860584|536807386|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
148734046|NCT00444457|536499134|FG001|After Infant Series|Investigator request|0|||
148734047|NCT00444457|536499135|FG002|After Infant Series|Investigator request|0|||
148734048|NCT00444457|536499136|FG003|After Infant Series|Investigator request|1|||
148734049|NCT00444457|536499133|FG000|After Infant Series|Other|0|||
148734050|NCT00444457|536499134|FG001|After Infant Series|Other|1|||
148734051|NCT00444457|536499135|FG002|After Infant Series|Other|0|||
148734052|NCT00444457|536499136|FG003|After Infant Series|Other|0|||
148734053|NCT00444457|536499133|FG000|Toddler Dose|Lost to Follow-up|4|||
148734054|NCT00444457|536499134|FG001|Toddler Dose|Lost to Follow-up|1|||
148734055|NCT00444457|536499135|FG002|Toddler Dose|Lost to Follow-up|1|||
148734056|NCT00444457|536499136|FG003|Toddler Dose|Lost to Follow-up|3|||
148734057|NCT00444457|536499133|FG000|Toddler Dose|Failed to return|2|||
148734058|NCT00444457|536499134|FG001|Toddler Dose|Failed to return|2|||
148734059|NCT00444457|536499135|FG002|Toddler Dose|Failed to return|1|||
148734060|NCT00444457|536499136|FG003|Toddler Dose|Failed to return|3|||
148734061|NCT00444457|536499133|FG000|Toddler Dose|Parent or legal guardian request|0|||
148734062|NCT00444457|536499134|FG001|Toddler Dose|Parent or legal guardian request|3|||
148734063|NCT00444457|536499135|FG002|Toddler Dose|Parent or legal guardian request|2|||
148734064|NCT00444457|536499136|FG003|Toddler Dose|Parent or legal guardian request|1|||
148734065|NCT00444457|536499133|FG000|Toddler Dose|Protocol Violation|1|||
148734066|NCT00444457|536499134|FG001|Toddler Dose|Protocol Violation|0|||
148734067|NCT00444457|536499135|FG002|Toddler Dose|Protocol Violation|0|||
148734068|NCT00444457|536499136|FG003|Toddler Dose|Protocol Violation|1|||
148734069|NCT00914459|536499139|FG000|Overall Study|Protocol Violation|0|||
148734070|NCT00914459|536499140|FG001|Overall Study|Protocol Violation|1|||
148734071|NCT00914459|536499139|FG000|Overall Study|Parent/Legal guardian request|1|||
148734072|NCT00914459|536499140|FG001|Overall Study|Parent/Legal guardian request|0|||
148734073|NCT03201211|536499141|FG000|Overall Study|Adverse Event|1|||
148734074|NCT03201211|536499142|FG001|Overall Study|Adverse Event|0|||
148734075|NCT03201211|536499143|FG002|Overall Study|Adverse Event|0|||
148734076|NCT03201211|536499141|FG000|Overall Study|Protocol Violation|1|||
148734077|NCT03201211|536499142|FG001|Overall Study|Protocol Violation|0|||
148734078|NCT03201211|536499143|FG002|Overall Study|Protocol Violation|0|||
148734079|NCT03201211|536499141|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
148734080|NCT03201211|536499142|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
148734081|NCT03201211|536499143|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
148734082|NCT03201211|536499141|FG000|Overall Study|OTHER unknown reasons|0|||
148734083|NCT03201211|536499142|FG001|Overall Study|OTHER unknown reasons|1|||
148734084|NCT03201211|536499143|FG002|Overall Study|OTHER unknown reasons|0|||
148734085|NCT01661179|536499144|FG000|Overall Study|Death|1|||
148734086|NCT01661179|536499144|FG000|Overall Study|Withdrawal by Subject|1|||
148734087|NCT01661179|536499144|FG000|Overall Study|Other Eligibility criteria|4|||
148734088|NCT02041091|536499145|FG000|Treatment|Adverse Event|3|||
148734089|NCT02041091|536499146|FG001|Treatment|Adverse Event|3|||
148734090|NCT02041091|536499145|FG000|Treatment|Withdrawal by Subject|2|||
148734091|NCT02041091|536499146|FG001|Treatment|Withdrawal by Subject|4|||
148734092|NCT02041091|536499145|FG000|Treatment|Physician Decision|1|||
148734093|NCT02041091|536499146|FG001|Treatment|Physician Decision|0|||
148734094|NCT02041091|536499145|FG000|Treatment|Sponsor Decision|15|||
148734095|NCT02041091|536499146|FG001|Treatment|Sponsor Decision|16|||
148734096|NCT02041091|536499145|FG000|Treatment|Lost to Follow-up|1|||
148734097|NCT02041091|536499146|FG001|Treatment|Lost to Follow-up|0|||
148734098|NCT02041091|536499145|FG000|Optional Safety Extension Period|Adverse Event|4|||
148734099|NCT02041091|536499146|FG001|Optional Safety Extension Period|Adverse Event|2|||
148734100|NCT02041091|536499145|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
148734101|NCT02041091|536499146|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
148734102|NCT02041091|536499145|FG000|Optional Safety Extension Period|Protocol Violation|2|||
148734103|NCT02041091|536499146|FG001|Optional Safety Extension Period|Protocol Violation|0|||
148734104|NCT02041091|536499145|FG000|Optional Safety Extension Period|Physician Decision|2|||
148734105|NCT02041091|536499146|FG001|Optional Safety Extension Period|Physician Decision|1|||
148734106|NCT02041091|536499145|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
148734107|NCT02041091|536499146|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
148734108|NCT02041091|536499145|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
148734109|NCT02041091|536499146|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
148734110|NCT01602965|536499147|FG000|Overall Study|Lost to Follow-up|4|||
148734111|NCT01602965|536499148|FG001|Overall Study|Lost to Follow-up|2|||
148734112|NCT03118570|536499149|FG000|Overall Study|Adverse Event|2|||
148734113|NCT03118570|536499150|FG001|Overall Study|Adverse Event|0|||
148734114|NCT03118570|536499151|FG002|Overall Study|Adverse Event|0|||
148734115|NCT03118570|536499152|FG003|Overall Study|Adverse Event|0|||
148734116|NCT03118570|536499153|FG004|Overall Study|Adverse Event|3|||
148734117|NCT03118570|536499149|FG000|Overall Study|Withdrawal by Subject|0|||
148734118|NCT03118570|536499150|FG001|Overall Study|Withdrawal by Subject|1|||
148734119|NCT03118570|536499151|FG002|Overall Study|Withdrawal by Subject|4|||
148734120|NCT03118570|536499152|FG003|Overall Study|Withdrawal by Subject|0|||
148734121|NCT03118570|536499153|FG004|Overall Study|Withdrawal by Subject|1|||
148734122|NCT03118570|536499149|FG000|Overall Study|Lost to Follow-up|2|||
148734123|NCT03118570|536499150|FG001|Overall Study|Lost to Follow-up|3|||
148734124|NCT03118570|536499151|FG002|Overall Study|Lost to Follow-up|1|||
148734125|NCT03118570|536499152|FG003|Overall Study|Lost to Follow-up|0|||
148734126|NCT03118570|536499153|FG004|Overall Study|Lost to Follow-up|1|||
148734127|NCT03118570|536499149|FG000|Overall Study|Other, Not Specified|1|||
148734128|NCT03118570|536499150|FG001|Overall Study|Other, Not Specified|3|||
148734129|NCT03118570|536499151|FG002|Overall Study|Other, Not Specified|0|||
148734130|NCT03118570|536499152|FG003|Overall Study|Other, Not Specified|0|||
148734131|NCT03118570|536499153|FG004|Overall Study|Other, Not Specified|0|||
148734132|NCT02312063|536499157|FG000|Overall Study|Withdrawal by Subject|0|||
148734133|NCT02312063|536499158|FG001|Overall Study|Withdrawal by Subject|1|||
148734134|NCT00321737|536499162|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
148734135|NCT00321737|536499163|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
148734136|NCT00321737|536499164|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
148734137|NCT00321737|536499162|FG000|Overall Study|Adverse Event|11|||
148734138|NCT00321737|536499163|FG001|Overall Study|Adverse Event|3|||
148734139|NCT00321737|536499164|FG002|Overall Study|Adverse Event|6|||
148734140|NCT00321737|536499162|FG000|Overall Study|Lost to Follow-up|5|||
148734141|NCT00321737|536499163|FG001|Overall Study|Lost to Follow-up|5|||
148734142|NCT00321737|536499164|FG002|Overall Study|Lost to Follow-up|6|||
148734143|NCT00321737|536499162|FG000|Overall Study|Withdrawal by Subject|19|||
148734144|NCT00321737|536499163|FG001|Overall Study|Withdrawal by Subject|12|||
148734145|NCT00321737|536499164|FG002|Overall Study|Withdrawal by Subject|17|||
148734146|NCT00321737|536499162|FG000|Overall Study|Protocol Violation|0|||
148734147|NCT00321737|536499163|FG001|Overall Study|Protocol Violation|0|||
148734148|NCT00321737|536499164|FG002|Overall Study|Protocol Violation|1|||
148734149|NCT00321737|536499162|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
148734150|NCT00321737|536499163|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
148734151|NCT00321737|536499164|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
148734152|NCT00321737|536499162|FG000|Overall Study|Possible Barrett's Esophagus|2|||
148734153|NCT00321737|536499163|FG001|Overall Study|Possible Barrett's Esophagus|1|||
148734154|NCT00321737|536499164|FG002|Overall Study|Possible Barrett's Esophagus|1|||
148734155|NCT00321737|536499162|FG000|Overall Study|Therapeutic Failure|6|||
148734156|NCT00321737|536499163|FG001|Overall Study|Therapeutic Failure|0|||
148734157|NCT00321737|536499164|FG002|Overall Study|Therapeutic Failure|2|||
148734158|NCT00321737|536499162|FG000|Overall Study|Pregnancy|0|||
148734159|NCT00321737|536499163|FG001|Overall Study|Pregnancy|2|||
148734160|NCT00321737|536499164|FG002|Overall Study|Pregnancy|0|||
148734161|NCT00321737|536499162|FG000|Overall Study|Noncompliance|2|||
148734162|NCT00321737|536499163|FG001|Overall Study|Noncompliance|0|||
148734163|NCT00321737|536499164|FG002|Overall Study|Noncompliance|0|||
148734164|NCT00321737|536499162|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
148734165|NCT00321737|536499163|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
148734166|NCT00321737|536499164|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
148734167|NCT02283294|536499165|FG000|Overall Study|Lost to Follow-up|1|||
148734168|NCT02283294|536499166|FG001|Overall Study|Lost to Follow-up|1|||
148734169|NCT02283294|536499165|FG000|Overall Study|Withdrawal by Subject|1|||
148734170|NCT02283294|536499166|FG001|Overall Study|Withdrawal by Subject|6|||
148734171|NCT02283294|536499165|FG000|Overall Study|Protocol Violation|1|||
148734172|NCT02283294|536499166|FG001|Overall Study|Protocol Violation|0|||
148734173|NCT02283294|536499165|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
148734174|NCT02283294|536499166|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
148734175|NCT00594646|536499167|FG000|Overall Study|Withdrawal by Subject|1|||
148734176|NCT00594646|536499167|FG000|Overall Study|Lost to Follow-up|15|||
148734177|NCT01769339|536499170|FG000|Overall Study|Lost to Follow-up|42|||
148734178|NCT01769339|536499170|FG000|Overall Study|Adverse Event|1|||
148734179|NCT03548064|536501479|FG000|Overall Study|Withdrawal by Subject|0|||
148734180|NCT03548064|536501480|FG001|Overall Study|Withdrawal by Subject|0|||
148734181|NCT03548064|536501481|FG002|Overall Study|Withdrawal by Subject|0|||
148734182|NCT03548064|536501482|FG003|Overall Study|Withdrawal by Subject|1|||
148734183|NCT03548064|536501483|FG004|Overall Study|Withdrawal by Subject|0|||
148734184|NCT03548064|536501484|FG005|Overall Study|Withdrawal by Subject|0|||
148734185|NCT03548064|536501485|FG006|Overall Study|Withdrawal by Subject|0|||
148734186|NCT03548064|536501486|FG007|Overall Study|Withdrawal by Subject|0|||
148734187|NCT03548064|536501479|FG000|Overall Study|Lost to Follow-up|0|||
148734188|NCT03548064|536501480|FG001|Overall Study|Lost to Follow-up|0|||
148734189|NCT03548064|536501481|FG002|Overall Study|Lost to Follow-up|0|||
148734190|NCT03548064|536501482|FG003|Overall Study|Lost to Follow-up|0|||
149026877|NCT00049517|537576400|FG003|Conditioning/Transplant|Adverse Event|8|||
148734191|NCT03548064|536501483|FG004|Overall Study|Lost to Follow-up|2|||
148734192|NCT03548064|536501484|FG005|Overall Study|Lost to Follow-up|0|||
148734193|NCT03548064|536501485|FG006|Overall Study|Lost to Follow-up|0|||
148734194|NCT03548064|536501486|FG007|Overall Study|Lost to Follow-up|0|||
148734195|NCT03548064|536501479|FG000|Overall Study|Covid-19 Pandemic|0|||
148734196|NCT03548064|536501480|FG001|Overall Study|Covid-19 Pandemic|0|||
148734197|NCT03548064|536501481|FG002|Overall Study|Covid-19 Pandemic|0|||
148734198|NCT03548064|536501482|FG003|Overall Study|Covid-19 Pandemic|0|||
148734199|NCT03548064|536501483|FG004|Overall Study|Covid-19 Pandemic|10|||
148734200|NCT03548064|536501484|FG005|Overall Study|Covid-19 Pandemic|3|||
148734201|NCT03548064|536501485|FG006|Overall Study|Covid-19 Pandemic|0|||
148734202|NCT03548064|536501486|FG007|Overall Study|Covid-19 Pandemic|0|||
148734203|NCT04941729|536501487|FG000|Overall Study|Death|0|||
148734204|NCT04941729|536501488|FG001|Overall Study|Death|1|||
148734205|NCT04941729|536501487|FG000|Overall Study|Study terminated by sponsor|11|||
148734206|NCT04941729|536501488|FG001|Overall Study|Study terminated by sponsor|10|||
148734207|NCT05424042|536501489|FG000|Overall Study|Withdrawal by Subject|2|||
148734208|NCT05424042|536501490|FG001|Overall Study|Withdrawal by Subject|0|||
148734209|NCT05424042|536501491|FG002|Overall Study|Withdrawal by Subject|4|||
148734210|NCT05424042|536501489|FG000|Overall Study|Lost to Follow-up|0|||
148734211|NCT05424042|536501490|FG001|Overall Study|Lost to Follow-up|0|||
148734212|NCT05424042|536501491|FG002|Overall Study|Lost to Follow-up|1|||
148734213|NCT05091307|536501492|FG000|Overall Study|Death|0|||
148734214|NCT05091307|536501493|FG001|Overall Study|Death|0|||
148734215|NCT05091307|536501494|FG002|Overall Study|Death|1|||
148734216|NCT05091307|536501495|FG003|Overall Study|Death|0|||
148734217|NCT05091307|536501492|FG000|Overall Study|Lost to Follow-up|33|||
148734218|NCT05091307|536501493|FG001|Overall Study|Lost to Follow-up|33|||
148734219|NCT05091307|536501494|FG002|Overall Study|Lost to Follow-up|2|||
148734220|NCT05091307|536501495|FG003|Overall Study|Lost to Follow-up|0|||
148734221|NCT05091307|536501492|FG000|Overall Study|Physician Decision|1|||
148734222|NCT05091307|536501493|FG001|Overall Study|Physician Decision|0|||
148734223|NCT05091307|536501494|FG002|Overall Study|Physician Decision|0|||
148734224|NCT05091307|536501495|FG003|Overall Study|Physician Decision|0|||
148734225|NCT05091307|536501492|FG000|Overall Study|Protocol Violation|1|||
148734226|NCT05091307|536501493|FG001|Overall Study|Protocol Violation|0|||
148734227|NCT05091307|536501494|FG002|Overall Study|Protocol Violation|0|||
148734228|NCT05091307|536501495|FG003|Overall Study|Protocol Violation|0|||
148734229|NCT05091307|536501492|FG000|Overall Study|Withdrawal by Subject|16|||
148734230|NCT05091307|536501493|FG001|Overall Study|Withdrawal by Subject|16|||
148734231|NCT05091307|536501494|FG002|Overall Study|Withdrawal by Subject|0|||
148734232|NCT05091307|536501495|FG003|Overall Study|Withdrawal by Subject|1|||
148734233|NCT05091307|536501492|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
148734234|NCT05091307|536501493|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
148734235|NCT05091307|536501494|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
148734236|NCT05091307|536501495|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
148734237|NCT05091307|536501492|FG000|Overall Study|Initiated Prohibited Medication|1|||
148734238|NCT05091307|536501493|FG001|Overall Study|Initiated Prohibited Medication|0|||
148734239|NCT05091307|536501494|FG002|Overall Study|Initiated Prohibited Medication|0|||
148734240|NCT05091307|536501495|FG003|Overall Study|Initiated Prohibited Medication|0|||
148734241|NCT05091307|536501492|FG000|Overall Study|Other|4|||
148734242|NCT05091307|536501493|FG001|Overall Study|Other|4|||
148734243|NCT05091307|536501494|FG002|Overall Study|Other|0|||
148734244|NCT05091307|536501495|FG003|Overall Study|Other|0|||
148734245|NCT05091307|536501492|FG000|Overall Study|Randomized but not vaccinated|0|||
148734246|NCT05091307|536501493|FG001|Overall Study|Randomized but not vaccinated|2|||
148734247|NCT05091307|536501494|FG002|Overall Study|Randomized but not vaccinated|0|||
148734248|NCT05091307|536501495|FG003|Overall Study|Randomized but not vaccinated|0|||
148734249|NCT03611543|536501496|FG000|Overall Study|Withdrawal by Subject|4|||
148734250|NCT03611543|536501497|FG001|Overall Study|Withdrawal by Subject|4|||
148734251|NCT03611543|536501496|FG000|Overall Study|Physician Decision|1|||
148734252|NCT03611543|536501497|FG001|Overall Study|Physician Decision|1|||
148734253|NCT03611543|536501496|FG000|Overall Study|Protocol Violation|2|||
148734254|NCT03611543|536501497|FG001|Overall Study|Protocol Violation|2|||
148734255|NCT03611543|536501496|FG000|Overall Study|Device failure|2|||
148734256|NCT03611543|536501497|FG001|Overall Study|Device failure|2|||
148734257|NCT03611543|536501496|FG000|Overall Study|Missing information|5|||
148734258|NCT03611543|536501497|FG001|Overall Study|Missing information|5|||
148734259|NCT03986138|536501504|FG000|First MRI Examination|Physician Decision|0|||
148734260|NCT03986138|536501505|FG001|First MRI Examination|Physician Decision|1|||
148734261|NCT03986138|536501504|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
148734262|NCT03986138|536501505|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
148734263|NCT03986138|536501504|FG000|Washout|Withdrawal by Subject|4|||
148734264|NCT03986138|536501505|FG001|Washout|Withdrawal by Subject|5|||
148734265|NCT03986138|536501504|FG000|Washout|Lost to Follow-up|0|||
148734266|NCT03986138|536501505|FG001|Washout|Lost to Follow-up|2|||
148734267|NCT03986138|536501504|FG000|Washout|Adverse Event|1|||
148734268|NCT03986138|536501505|FG001|Washout|Adverse Event|1|||
149026878|NCT00049517|537576401|FG004|Conditioning/Transplant|Adverse Event|0|||
148734269|NCT03986138|536501504|FG000|Washout|Other reason|5|||
148734270|NCT03986138|536501505|FG001|Washout|Other reason|5|||
148734271|NCT03986138|536501504|FG000|Second MRI Examination|Withdrawal by Subject|0|||
148734272|NCT03986138|536501505|FG001|Second MRI Examination|Withdrawal by Subject|2|||
148734273|NCT04305587|536501506|FG000|Overall Study|Withdrawal by Subject|0|||
148734274|NCT04305587|536501507|FG001|Overall Study|Withdrawal by Subject|0|||
148734275|NCT04305587|536501508|FG002|Overall Study|Withdrawal by Subject|0|||
148734276|NCT04305587|536501509|FG003|Overall Study|Withdrawal by Subject|1|||
149026879|NCT00049517|537576402|FG005|Conditioning/Transplant|Adverse Event|0|||
149026880|NCT00049517|537576397|FG000|Conditioning/Transplant|Death|1|||
149026881|NCT00049517|537576398|FG001|Conditioning/Transplant|Death|0|||
149026882|NCT00049517|537576399|FG002|Conditioning/Transplant|Death|0|||
149026883|NCT00049517|537576400|FG003|Conditioning/Transplant|Death|2|||
149026884|NCT00049517|537576401|FG004|Conditioning/Transplant|Death|0|||
149026885|NCT00049517|537576402|FG005|Conditioning/Transplant|Death|0|||
149026886|NCT00049517|537576397|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
149026887|NCT00049517|537576398|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
149026888|NCT00049517|537576399|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
149026889|NCT00049517|537576400|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
149026890|NCT00049517|537576401|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
149026891|NCT00049517|537576402|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
149026892|NCT00049517|537576397|FG000|Conditioning/Transplant|Alternative therapy|4|||
149026893|NCT00049517|537576398|FG001|Conditioning/Transplant|Alternative therapy|4|||
149026894|NCT00049517|537576399|FG002|Conditioning/Transplant|Alternative therapy|2|||
149026895|NCT00049517|537576400|FG003|Conditioning/Transplant|Alternative therapy|1|||
149026896|NCT00049517|537576401|FG004|Conditioning/Transplant|Alternative therapy|1|||
148734277|NCT04305587|536501510|FG004|Overall Study|Withdrawal by Subject|0|||
148734278|NCT04305587|536501511|FG005|Overall Study|Withdrawal by Subject|0|||
148734279|NCT04305587|536501512|FG006|Overall Study|Withdrawal by Subject|0|||
148734280|NCT04305587|536501513|FG007|Overall Study|Withdrawal by Subject|0|||
148734281|NCT04305587|536501514|FG008|Overall Study|Withdrawal by Subject|0|||
148734282|NCT01523457|536501515|FG000|Overall Study|Withdrawal by Subject|7|||
148734283|NCT01523457|536501516|FG001|Overall Study|Withdrawal by Subject|2|||
148734284|NCT01367665|536501517|FG000|Overall Study|Death|102|||
148734285|NCT01367665|536501518|FG001|Overall Study|Death|19|||
148734286|NCT01367665|536501517|FG000|Overall Study|Lost to Follow-up|222|||
148734287|NCT01367665|536501518|FG001|Overall Study|Lost to Follow-up|22|||
148734288|NCT01367665|536501517|FG000|Overall Study|Not Done|118|||
148734289|NCT01367665|536501518|FG001|Overall Study|Not Done|14|||
148734290|NCT02752906|536501519|FG000|Overall Study|Protocol Violation|2|||
148734291|NCT02752906|536501520|FG001|Overall Study|Protocol Violation|1|||
148734292|NCT02752906|536501519|FG000|Overall Study|Withdrawal by Subject|2|||
148734293|NCT02752906|536501520|FG001|Overall Study|Withdrawal by Subject|2|||
148734294|NCT02752906|536501519|FG000|Overall Study|Lost to Follow-up|3|||
148734295|NCT02752906|536501520|FG001|Overall Study|Lost to Follow-up|2|||
148734296|NCT01570686|536501526|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148734297|NCT01570686|536501527|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148973433|NCT04019041|537386169|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
148973434|NCT04019041|537386170|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
148973435|NCT04019041|537386171|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
148973436|NCT04019041|537386172|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
148973437|NCT04019041|537386167|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
148973438|NCT04019041|537386168|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
148973439|NCT04019041|537386169|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
148973440|NCT04019041|537386170|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
148973441|NCT04019041|537386171|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
148973442|NCT04019041|537386172|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
148973443|NCT04019041|537386167|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
148973444|NCT04019041|537386168|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
148973445|NCT04019041|537386169|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
148973446|NCT04019041|537386170|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
148973447|NCT04019041|537386171|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
148973448|NCT04019041|537386172|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
148973449|NCT04019041|537386167|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
148973450|NCT04019041|537386168|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
148973451|NCT04019041|537386169|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
148973452|NCT04019041|537386170|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
148973453|NCT04019041|537386171|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
148973454|NCT04019041|537386172|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
148973455|NCT04019041|537386167|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
148973456|NCT04019041|537386168|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
148973457|NCT04019041|537386169|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
148973458|NCT04019041|537386170|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
148973459|NCT04019041|537386171|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
149026897|NCT00049517|537576402|FG005|Conditioning/Transplant|Alternative therapy|0|||
149026898|NCT00049517|537576397|FG000|Conditioning/Transplant|Other complicating disease|2|||
148734298|NCT01570686|536501526|FG000|Overall Study|Administrative problems|0|||
148734299|NCT01570686|536501527|FG001|Overall Study|Administrative problems|1|||
148817803|NCT03860584|536807387|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
148817804|NCT03860584|536807386|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
148817805|NCT03860584|536807387|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
148817806|NCT03860584|536807386|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
148817807|NCT03860584|536807387|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
148817808|NCT03735498|536808396|FG000|Overall Study|Withdrawal by Subject|3|||
148817809|NCT03735498|536808396|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
148817810|NCT03787212|536808398|FG000|Period 1|Study Termination|2|||
148817811|NCT03787212|536808399|FG001|Period 1|Study Termination|2|||
148817812|NCT02014103|536808400|FG000|Overall Study|Protocol Violation|7|||
148817813|NCT02014103|536808401|FG001|Overall Study|Protocol Violation|7|||
148817814|NCT02014103|536808400|FG000|Overall Study|Adverse Event|1|||
148817815|NCT02014103|536808401|FG001|Overall Study|Adverse Event|0|||
148817816|NCT02014103|536808400|FG000|Overall Study|Lost venous access|1|||
148817817|NCT02014103|536808401|FG001|Overall Study|Lost venous access|0|||
148817818|NCT02014103|536808400|FG000|Overall Study|Withdrawal by Subject|0|||
148817819|NCT02014103|536808401|FG001|Overall Study|Withdrawal by Subject|2|||
148817820|NCT05638737|536808402|FG000|Overall Study|Withdrawal by Subject|4|||
148817821|NCT05638737|536808403|FG001|Overall Study|Withdrawal by Subject|7|||
148817822|NCT00327171|536808406|FG000|Overall Study|Did not receive study medication|3|||
148817823|NCT00327171|536808407|FG001|Overall Study|Did not receive study medication|0|||
148817824|NCT00327171|536808406|FG000|Overall Study|Adverse Event|23|||
148817825|NCT00327171|536808407|FG001|Overall Study|Adverse Event|23|||
148817826|NCT00327171|536808406|FG000|Overall Study|Disease progression/lack of efficacy|68|||
148817827|NCT00327171|536808407|FG001|Overall Study|Disease progression/lack of efficacy|69|||
148817828|NCT00327171|536808406|FG000|Overall Study|Investigator/participant request|1|||
148817829|NCT00327171|536808407|FG001|Overall Study|Investigator/participant request|8|||
148817830|NCT00327171|536808406|FG000|Overall Study|Clinical progression|12|||
148817831|NCT00327171|536808407|FG001|Overall Study|Clinical progression|8|||
148817832|NCT00327171|536808406|FG000|Overall Study|Undisclosed history of ischemia|0|||
148817833|NCT00327171|536808407|FG001|Overall Study|Undisclosed history of ischemia|1|||
148817834|NCT00327171|536808406|FG000|Overall Study|Other|1|||
148817835|NCT00327171|536808407|FG001|Overall Study|Other|0|||
148817836|NCT00530075|536808408|FG000|Overall Study|Adverse Event|1|||
148817837|NCT00530075|536808408|FG000|Overall Study|Death|1|||
148817838|NCT00530075|536808408|FG000|Overall Study|Lack of Efficacy|3|||
148817839|NCT00530075|536808408|FG000|Overall Study|Protocol Violation|1|||
148817840|NCT00530075|536808408|FG000|Overall Study|Withdrawal by Subject|1|||
148817841|NCT03422718|536808414|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
148817842|NCT03422718|536808415|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
148817843|NCT03422718|536808416|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
148817844|NCT03422718|536808417|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
148817845|NCT03422718|536808418|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
148817846|NCT03422718|536808419|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
148817847|NCT03422718|536808420|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
148817848|NCT03422718|536808421|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
148817849|NCT03422718|536808414|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
148817850|NCT03422718|536808415|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
148817851|NCT03422718|536808416|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
148734300|NCT01570686|536501526|FG000|Overall Study|Adverse Event|8|||
148734301|NCT01570686|536501527|FG001|Overall Study|Adverse Event|6|||
148734302|NCT01570686|536501526|FG000|Overall Study|Lost to Follow-up|4|||
148734303|NCT01570686|536501527|FG001|Overall Study|Lost to Follow-up|3|||
148734304|NCT01570686|536501526|FG000|Overall Study|Protocol Deviation|3|||
148734305|NCT01570686|536501527|FG001|Overall Study|Protocol Deviation|0|||
148734306|NCT01570686|536501526|FG000|Overall Study|Withdrawal by Subject|4|||
148734307|NCT01570686|536501527|FG001|Overall Study|Withdrawal by Subject|4|||
148734308|NCT01570686|536501526|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148734309|NCT01570686|536501527|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148734310|NCT00505375|536501537|FG000|Overall Study|Death|1|||
148734311|NCT00505375|536501538|FG001|Overall Study|Death|0|||
148734312|NCT00505375|536501537|FG000|Overall Study|Withdrawal by Subject|2|||
148734313|NCT00505375|536501538|FG001|Overall Study|Withdrawal by Subject|2|||
148734314|NCT00505375|536501537|FG000|Overall Study|Lost to Follow-up|0|||
148734315|NCT00505375|536501538|FG001|Overall Study|Lost to Follow-up|2|||
148734316|NCT00505375|536501537|FG000|Overall Study|Pregnancy|1|||
148734317|NCT00505375|536501538|FG001|Overall Study|Pregnancy|0|||
148734318|NCT00505375|536501537|FG000|Overall Study|Travel issues|0|||
148734319|NCT00505375|536501538|FG001|Overall Study|Travel issues|1|||
148734320|NCT04234984|536501540|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
148734321|NCT04234984|536501540|FG000|Follow-up at the Second Time Point|Death|1|||
148734322|NCT04234984|536501540|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
148734323|NCT01055132|536501543|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
148734324|NCT01055132|536501544|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
148734325|NCT01055132|536501543|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
148734326|NCT01055132|536501544|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
148734327|NCT02746471|536501545|FG000|Overall Study|Death|43|||
148734328|NCT02746471|536501545|FG000|Overall Study|Exited before 36 months|1119|||
148734329|NCT02564211|536501546|FG000|Overall Study|Adverse Event|4|||
148734330|NCT00622466|536501548|FG000|Overall Study|Death|1|||
148734331|NCT00622466|536501548|FG000|Overall Study|Adverse Event|1|||
148734332|NCT00622466|536501548|FG000|Overall Study|Withdrawal by Subject|2|||
148734333|NCT04594707|536501549|FG000|Overall Study|Adverse Event|0|||
148734334|NCT04594707|536501550|FG001|Overall Study|Adverse Event|0|||
148734335|NCT04594707|536501551|FG002|Overall Study|Adverse Event|1|||
148817852|NCT03422718|536808417|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
148734336|NCT04594707|536501549|FG000|Overall Study|Death|0|||
148734337|NCT04594707|536501550|FG001|Overall Study|Death|2|||
148817853|NCT03422718|536808418|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
148817854|NCT03422718|536808419|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
148817855|NCT03422718|536808420|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
148817856|NCT03422718|536808421|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
148817857|NCT03422718|536808414|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
148817858|NCT03422718|536808415|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
148817859|NCT03422718|536808416|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
148817860|NCT03422718|536808417|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
148817861|NCT03422718|536808418|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
148817862|NCT03422718|536808419|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
148817863|NCT03422718|536808420|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
148817864|NCT03422718|536808421|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
148817865|NCT03422718|536808414|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
148817866|NCT03422718|536808415|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
148817867|NCT03422718|536808416|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
148817868|NCT03422718|536808417|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
148734338|NCT04594707|536501551|FG002|Overall Study|Death|2|||
148734339|NCT04594707|536501549|FG000|Overall Study|Lung Transplant|0|||
148734340|NCT04594707|536501550|FG001|Overall Study|Lung Transplant|0|||
148734341|NCT04594707|536501551|FG002|Overall Study|Lung Transplant|1|||
148734342|NCT04594707|536501549|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
148734343|NCT04594707|536501550|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
148734344|NCT04594707|536501551|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
148734345|NCT04594707|536501549|FG000|Overall Study|Study Terminated By Sponsor|19|||
148734346|NCT04594707|536501550|FG001|Overall Study|Study Terminated By Sponsor|47|||
148734347|NCT04594707|536501551|FG002|Overall Study|Study Terminated By Sponsor|41|||
148734348|NCT04594707|536501549|FG000|Overall Study|Withdrawal by Subject|1|||
148734349|NCT04594707|536501550|FG001|Overall Study|Withdrawal by Subject|0|||
148734350|NCT04594707|536501551|FG002|Overall Study|Withdrawal by Subject|2|||
148734351|NCT02534844|536501552|FG000|Part B|Withdrawal by Subject|0|||
148734352|NCT02534844|536501553|FG001|Part B|Withdrawal by Subject|0|||
148734353|NCT02534844|536501554|FG002|Part B|Withdrawal by Subject|0|||
148734354|NCT02534844|536501555|FG003|Part B|Withdrawal by Subject|0|||
148734355|NCT02534844|536501556|FG004|Part B|Withdrawal by Subject|2|||
148734356|NCT02534844|536501557|FG005|Part B|Withdrawal by Subject|1|||
148734357|NCT00655876|536501558|FG000|Overall Study|Protocol Violation|9|||
148734358|NCT00655876|536501559|FG001|Overall Study|Protocol Violation|7|||
148734359|NCT00326963|536501560|FG000|Overall Study|Adverse Event|2|||
148734360|NCT00326963|536501560|FG000|Overall Study|Injection site reaction|1|||
148734361|NCT00326963|536501560|FG000|Overall Study|Death|1|||
148734362|NCT00326963|536501560|FG000|Overall Study|Failure to return|10|||
148734363|NCT00326963|536501560|FG000|Overall Study|Withdrawal by Subject|10|||
148734364|NCT00326963|536501560|FG000|Overall Study|Refused treatment / did not cooperate|5|||
148734365|NCT00326963|536501560|FG000|Overall Study|Violation of selection criteria at entry|2|||
148734366|NCT00326963|536501560|FG000|Overall Study|Other protocol violation|1|||
148734367|NCT00326963|536501560|FG000|Overall Study|Administrative / other|1|||
148734368|NCT01468818|536501566|FG000|Overall Study|Death during treatment|2|||
148734369|NCT00338455|536501569|FG000|Overall Study|Death|2|||
148734370|NCT00338455|536501570|FG001|Overall Study|Death|1|||
148734371|NCT00338455|536501569|FG000|Overall Study|Physician Decision|1|||
148734372|NCT00338455|536501570|FG001|Overall Study|Physician Decision|0|||
148734373|NCT01447420|536501575|FG000|Overall Study|Adverse Event|2|||
148734374|NCT01447420|536501576|FG001|Overall Study|Adverse Event|4|||
148734375|NCT01447420|536501577|FG002|Overall Study|Adverse Event|2|||
148734376|NCT01447420|536501575|FG000|Overall Study|Protocol Violation|3|||
148734377|NCT01447420|536501576|FG001|Overall Study|Protocol Violation|3|||
148734378|NCT01447420|536501577|FG002|Overall Study|Protocol Violation|0|||
148734379|NCT01447420|536501575|FG000|Overall Study|Withdrawal by Subject|4|||
148734380|NCT01447420|536501576|FG001|Overall Study|Withdrawal by Subject|1|||
148734381|NCT01447420|536501577|FG002|Overall Study|Withdrawal by Subject|0|||
148734382|NCT01447420|536501575|FG000|Overall Study|Lack of Efficacy|1|||
148734383|NCT01447420|536501576|FG001|Overall Study|Lack of Efficacy|19|||
148734384|NCT01447420|536501577|FG002|Overall Study|Lack of Efficacy|8|||
148734385|NCT04562155|536501579|FG000|Overall Study|COVID-19 pandemic|0|||
148734386|NCT04562155|536501580|FG001|Overall Study|COVID-19 pandemic|0|||
148734387|NCT04562155|536501581|FG002|Overall Study|COVID-19 pandemic|0|||
148734388|NCT04562155|536501582|FG003|Overall Study|COVID-19 pandemic|1|||
148734389|NCT04562155|536501579|FG000|Overall Study|Adverse Event|7|||
148734390|NCT04562155|536501580|FG001|Overall Study|Adverse Event|3|||
148734391|NCT04562155|536501581|FG002|Overall Study|Adverse Event|8|||
148734392|NCT04562155|536501582|FG003|Overall Study|Adverse Event|1|||
148734393|NCT04562155|536501579|FG000|Overall Study|Withdrawal by Subject|3|||
148734394|NCT04562155|536501580|FG001|Overall Study|Withdrawal by Subject|6|||
148734395|NCT04562155|536501581|FG002|Overall Study|Withdrawal by Subject|3|||
148734396|NCT04562155|536501582|FG003|Overall Study|Withdrawal by Subject|3|||
148734397|NCT04562155|536501579|FG000|Overall Study|Participant personal reason|1|||
148734398|NCT04562155|536501580|FG001|Overall Study|Participant personal reason|0|||
148734399|NCT04562155|536501581|FG002|Overall Study|Participant personal reason|2|||
148734400|NCT04562155|536501582|FG003|Overall Study|Participant personal reason|1|||
148734401|NCT00851318|536501583|FG000|Overall Study|Withdrawal by Subject|7|||
148734402|NCT00851318|536501584|FG001|Overall Study|Withdrawal by Subject|1|||
148734403|NCT00851318|536501585|FG002|Overall Study|Withdrawal by Subject|5|||
148734404|NCT00851318|536501586|FG003|Overall Study|Withdrawal by Subject|3|||
148734405|NCT00851318|536501583|FG000|Overall Study|Adverse Event|13|||
148734406|NCT00851318|536501584|FG001|Overall Study|Adverse Event|2|||
148734407|NCT00851318|536501585|FG002|Overall Study|Adverse Event|9|||
148734408|NCT00851318|536501586|FG003|Overall Study|Adverse Event|12|||
148734409|NCT00851318|536501583|FG000|Overall Study|Pregnancy|0|||
148734410|NCT00851318|536501584|FG001|Overall Study|Pregnancy|0|||
148734411|NCT00851318|536501585|FG002|Overall Study|Pregnancy|1|||
148734412|NCT00851318|536501586|FG003|Overall Study|Pregnancy|1|||
148734413|NCT00851318|536501583|FG000|Overall Study|Lack of Efficacy|8|||
148734414|NCT00851318|536501584|FG001|Overall Study|Lack of Efficacy|2|||
148734415|NCT00851318|536501585|FG002|Overall Study|Lack of Efficacy|4|||
148734416|NCT00851318|536501586|FG003|Overall Study|Lack of Efficacy|2|||
148734417|NCT00851318|536501583|FG000|Overall Study|Non-compliance with Study Procedures|2|||
148734418|NCT00851318|536501584|FG001|Overall Study|Non-compliance with Study Procedures|0|||
148734419|NCT00851318|536501585|FG002|Overall Study|Non-compliance with Study Procedures|1|||
148734420|NCT00851318|536501586|FG003|Overall Study|Non-compliance with Study Procedures|0|||
148734421|NCT00851318|536501583|FG000|Overall Study|Physician Decision|0|||
148734422|NCT00851318|536501584|FG001|Overall Study|Physician Decision|0|||
148734423|NCT00851318|536501585|FG002|Overall Study|Physician Decision|1|||
148734424|NCT00851318|536501586|FG003|Overall Study|Physician Decision|1|||
148734425|NCT05961215|536501587|FG000|Overall Study|Withdrawal by Subject|1|||
148734426|NCT01096368|536501589|FG000|Overall Study|Death|0|||
148734427|NCT01096368|536501590|FG001|Overall Study|Death|1|||
148734428|NCT01096368|536501591|FG002|Overall Study|Death|0|||
148734429|NCT01096368|536501592|FG003|Overall Study|Death|0|||
148734430|NCT01096368|536501593|FG004|Overall Study|Death|0|||
148734431|NCT01096368|536501589|FG000|Overall Study|Physician Decision|0|||
148734432|NCT01096368|536501590|FG001|Overall Study|Physician Decision|13|||
148734433|NCT01096368|536501591|FG002|Overall Study|Physician Decision|2|||
148817869|NCT03422718|536808418|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
148817870|NCT03422718|536808419|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
148817871|NCT03422718|536808420|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
148734434|NCT01096368|536501592|FG003|Overall Study|Physician Decision|4|||
148734435|NCT01096368|536501593|FG004|Overall Study|Physician Decision|6|||
148734436|NCT01096368|536501589|FG000|Overall Study|Withdrawal by Subject|0|||
148734437|NCT01096368|536501590|FG001|Overall Study|Withdrawal by Subject|52|||
148734438|NCT01096368|536501591|FG002|Overall Study|Withdrawal by Subject|0|||
148734439|NCT01096368|536501592|FG003|Overall Study|Withdrawal by Subject|10|||
148734440|NCT01096368|536501593|FG004|Overall Study|Withdrawal by Subject|14|||
148734441|NCT01096368|536501589|FG000|Overall Study|Ineligible|0|||
148734442|NCT01096368|536501590|FG001|Overall Study|Ineligible|3|||
148734443|NCT01096368|536501591|FG002|Overall Study|Ineligible|2|||
148734444|NCT01096368|536501592|FG003|Overall Study|Ineligible|0|||
148734445|NCT01096368|536501593|FG004|Overall Study|Ineligible|25|||
148734446|NCT01096368|536501589|FG000|Overall Study|Did not start treatment|0|||
148734447|NCT01096368|536501590|FG001|Overall Study|Did not start treatment|4|||
148734448|NCT01096368|536501591|FG002|Overall Study|Did not start treatment|4|||
148734449|NCT01096368|536501592|FG003|Overall Study|Did not start treatment|0|||
148734450|NCT01096368|536501593|FG004|Overall Study|Did not start treatment|0|||
148734451|NCT01096368|536501589|FG000|Overall Study|Progressive disease|0|||
148734452|NCT01096368|536501590|FG001|Overall Study|Progressive disease|6|||
148734453|NCT01096368|536501591|FG002|Overall Study|Progressive disease|0|||
148734454|NCT01096368|536501592|FG003|Overall Study|Progressive disease|10|||
148734455|NCT01096368|536501593|FG004|Overall Study|Progressive disease|3|||
148734456|NCT01096368|536501589|FG000|Overall Study|Other|0|||
148734457|NCT01096368|536501590|FG001|Overall Study|Other|0|||
148734458|NCT01096368|536501591|FG002|Overall Study|Other|1|||
148734459|NCT01096368|536501592|FG003|Overall Study|Other|0|||
148734460|NCT01096368|536501593|FG004|Overall Study|Other|0|||
148734461|NCT01096368|536501589|FG000|Overall Study|Treated with institutional review|0|||
148734462|NCT01096368|536501590|FG001|Overall Study|Treated with institutional review|0|||
148734463|NCT01096368|536501591|FG002|Overall Study|Treated with institutional review|0|||
148734464|NCT01096368|536501592|FG003|Overall Study|Treated with institutional review|0|||
148734465|NCT01096368|536501593|FG004|Overall Study|Treated with institutional review|1|||
148734466|NCT06354998|536501594|FG000|Overall Study|Withdrawal by Subject|3|||
148734467|NCT06354998|536501595|FG001|Overall Study|Withdrawal by Subject|0|||
148734468|NCT05442866|536501596|FG000|Overall Study|Death|1|||
148734469|NCT05442866|536501596|FG000|Overall Study|Lost to Follow-up|9|||
148734470|NCT05442866|536501596|FG000|Overall Study|Protocol Violation|1|||
148734471|NCT01568320|536501598|FG000|Overall Study|Death|20|||
148734472|NCT01568320|536501598|FG000|Overall Study|Lost to Follow-up|9|||
148734473|NCT01568320|536501598|FG000|Overall Study|Withdrawal by Subject|10|||
148734474|NCT01568320|536501598|FG000|Overall Study|Conversion to open repair|1|||
148734475|NCT01568320|536501598|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
148734476|NCT01616953|536501599|FG000|Overall Study|Lost to Follow-up|1|||
148734477|NCT01616953|536501600|FG001|Overall Study|Lost to Follow-up|0|||
148734478|NCT01616953|536501599|FG000|Overall Study|lack of bone and soft tissue|1|||
148734479|NCT01616953|536501600|FG001|Overall Study|lack of bone and soft tissue|0|||
148734480|NCT00816361|536501602|FG000|Overall Study|Withdrawal by Subject|0|||
148734481|NCT00816361|536501603|FG001|Overall Study|Withdrawal by Subject|0|||
148734482|NCT00816361|536501604|FG002|Overall Study|Withdrawal by Subject|0|||
148734483|NCT00816361|536501605|FG003|Overall Study|Withdrawal by Subject|0|||
148734484|NCT00816361|536501606|FG004|Overall Study|Withdrawal by Subject|1|||
148734485|NCT00816361|536501607|FG005|Overall Study|Withdrawal by Subject|2|||
148734486|NCT00816361|536501608|FG006|Overall Study|Withdrawal by Subject|0|||
148734487|NCT00816361|536501609|FG007|Overall Study|Withdrawal by Subject|2|||
148734488|NCT00816361|536501610|FG008|Overall Study|Withdrawal by Subject|1|||
148734489|NCT00816361|536501602|FG000|Overall Study|Death|4|||
148734490|NCT00816361|536501603|FG001|Overall Study|Death|3|||
148734491|NCT00816361|536501604|FG002|Overall Study|Death|3|||
148734492|NCT00816361|536501605|FG003|Overall Study|Death|3|||
148734493|NCT00816361|536501606|FG004|Overall Study|Death|1|||
148734494|NCT00816361|536501607|FG005|Overall Study|Death|1|||
148734495|NCT00816361|536501608|FG006|Overall Study|Death|3|||
148734496|NCT00816361|536501609|FG007|Overall Study|Death|7|||
148734497|NCT00816361|536501610|FG008|Overall Study|Death|8|||
148817872|NCT03422718|536808421|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
148817873|NCT03422718|536808414|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
148734498|NCT00816361|536501602|FG000|Overall Study|Other|0|||
148734499|NCT00816361|536501603|FG001|Overall Study|Other|0|||
148817874|NCT03422718|536808415|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
148817875|NCT03422718|536808416|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
148734500|NCT00816361|536501604|FG002|Overall Study|Other|0|||
148734501|NCT00816361|536501605|FG003|Overall Study|Other|0|||
148734502|NCT00816361|536501606|FG004|Overall Study|Other|0|||
148734503|NCT00816361|536501607|FG005|Overall Study|Other|0|||
148734504|NCT00816361|536501608|FG006|Overall Study|Other|0|||
148817876|NCT03422718|536808417|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
148817877|NCT03422718|536808418|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
148817878|NCT03422718|536808419|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
148817879|NCT03422718|536808420|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
148817880|NCT03422718|536808421|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
148817881|NCT03422718|536808414|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
148817882|NCT03422718|536808415|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
148817883|NCT03422718|536808416|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
148817884|NCT03422718|536808417|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
148817885|NCT03422718|536808418|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
148817886|NCT03422718|536808419|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
148817887|NCT03422718|536808420|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
148817888|NCT03422718|536808421|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
148817889|NCT00422461|536808423|FG000|Overall Study|Adverse Event|1|||
148817890|NCT00422461|536808424|FG001|Overall Study|Adverse Event|2|||
148817891|NCT00422461|536808425|FG002|Overall Study|Adverse Event|1|||
148817892|NCT00422461|536808426|FG003|Overall Study|Adverse Event|1|||
148817893|NCT00422461|536808423|FG000|Overall Study|Other|0|||
148817894|NCT00422461|536808424|FG001|Overall Study|Other|0|||
148817895|NCT00422461|536808425|FG002|Overall Study|Other|0|||
148817896|NCT00422461|536808426|FG003|Overall Study|Other|2|||
148817897|NCT00422461|536808423|FG000|Overall Study|Participants no longer willing to participate in study|1|||
148817898|NCT00422461|536808424|FG001|Overall Study|Participants no longer willing to participate in study|0|||
148817899|NCT00422461|536808425|FG002|Overall Study|Participants no longer willing to participate in study|0|||
148817900|NCT00422461|536808426|FG003|Overall Study|Participants no longer willing to participate in study|0|||
148817901|NCT00422461|536808423|FG000|Overall Study|Randomized but not treated|1|||
148817902|NCT00422461|536808424|FG001|Overall Study|Randomized but not treated|1|||
148817903|NCT00422461|536808425|FG002|Overall Study|Randomized but not treated|0|||
148817904|NCT00422461|536808426|FG003|Overall Study|Randomized but not treated|0|||
148817905|NCT01795937|536808427|FG000|Overall Study|Withdrawal by Subject|1|||
148817906|NCT01795937|536808428|FG001|Overall Study|Withdrawal by Subject|0|||
148817907|NCT01795937|536808429|FG002|Overall Study|Withdrawal by Subject|0|||
148817908|NCT01795937|536808427|FG000|Overall Study|Physician Decision|0|||
148817909|NCT01795937|536808428|FG001|Overall Study|Physician Decision|1|||
148817910|NCT01795937|536808429|FG002|Overall Study|Physician Decision|0|||
148817911|NCT01028053|536808430|FG000|Overall Study|Screen Failure|113|||
148817912|NCT01028053|536808430|FG000|Overall Study|Patient Request|11|||
148817913|NCT01028053|536808430|FG000|Overall Study|Protocol Violation|1|||
148817914|NCT01028053|536808430|FG000|Overall Study|Physician Decision|2|||
148817915|NCT01028053|536808430|FG000|Overall Study|Technical Problem|1|||
148817916|NCT01028053|536808430|FG000|Overall Study|Terminated by Sponsor|1|||
148817917|NCT01028053|536808430|FG000|Overall Study|Various reasons|4|||
148817918|NCT02965716|536808432|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
148817919|NCT02965716|536808433|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
148817920|NCT02965716|536808432|FG000|Overall Study|Progression/Relapse|8|||
148817921|NCT02965716|536808433|FG001|Overall Study|Progression/Relapse|16|||
148817922|NCT02965716|536808432|FG000|Overall Study|Death|1|||
148817923|NCT02965716|536808433|FG001|Overall Study|Death|0|||
148817924|NCT02965716|536808432|FG000|Overall Study|Not Protocol Specified|1|||
148817925|NCT02965716|536808433|FG001|Overall Study|Not Protocol Specified|3|||
148817926|NCT05558410|536808434|FG000|Overall Study|Adverse Event|1|||
148817927|NCT05558410|536808435|FG001|Overall Study|Adverse Event|2|||
148817928|NCT05558410|536808436|FG002|Overall Study|Adverse Event|0|||
148817929|NCT05558410|536808434|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
148817930|NCT05558410|536808435|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
148817931|NCT05558410|536808436|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
148817932|NCT05558410|536808434|FG000|Overall Study|Lost to Follow-up|10|||
148817933|NCT05558410|536808435|FG001|Overall Study|Lost to Follow-up|17|||
148973460|NCT04019041|537386172|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
148973461|NCT04019041|537386167|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148973462|NCT04019041|537386168|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148973463|NCT04019041|537386169|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148973464|NCT04019041|537386170|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148817934|NCT05558410|536808436|FG002|Overall Study|Lost to Follow-up|19|||
148817935|NCT05558410|536808434|FG000|Overall Study|Death|1|||
148817936|NCT05558410|536808435|FG001|Overall Study|Death|0|||
148973465|NCT04019041|537386171|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
148973466|NCT04019041|537386172|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
148973467|NCT02741115|537386175|FG000|Overall Study|Adverse Event|1|||
148973468|NCT02741115|537386176|FG001|Overall Study|Adverse Event|0|||
148817937|NCT05558410|536808436|FG002|Overall Study|Death|0|||
148817938|NCT05558410|536808434|FG000|Overall Study|Other non-compliance|0|||
148817939|NCT05558410|536808435|FG001|Overall Study|Other non-compliance|1|||
148817940|NCT05558410|536808436|FG002|Overall Study|Other non-compliance|2|||
149026899|NCT00049517|537576398|FG001|Conditioning/Transplant|Other complicating disease|0|||
148734505|NCT00816361|536501609|FG007|Overall Study|Other|0|||
148734506|NCT00816361|536501610|FG008|Overall Study|Other|1|||
148734507|NCT01394952|536501611|FG000|Overall Study|Lost to Follow-up|0|||
148734508|NCT01394952|536501612|FG001|Overall Study|Lost to Follow-up|5|||
148734509|NCT01394952|536501611|FG000|Overall Study|Withdrawal by Subject|10|||
148734510|NCT01394952|536501612|FG001|Overall Study|Withdrawal by Subject|5|||
148734511|NCT01394952|536501611|FG000|Overall Study|Physician Decision|2|||
148734512|NCT01394952|536501612|FG001|Overall Study|Physician Decision|0|||
148734513|NCT01394952|536501611|FG000|Overall Study|Sponsor Decision|5|||
148734514|NCT01394952|536501612|FG001|Overall Study|Sponsor Decision|7|||
148734515|NCT01763684|536501614|FG000|Overall Study|Study terminated early due to low enrollment|126|||
148734516|NCT01763684|536501615|FG001|Overall Study|Study terminated early due to low enrollment|127|||
148734517|NCT01763684|536501614|FG000|Overall Study|Study surgery not performed|7|||
148734518|NCT01763684|536501615|FG001|Overall Study|Study surgery not performed|6|||
149026900|NCT00049517|537576399|FG002|Conditioning/Transplant|Other complicating disease|0|||
149026901|NCT00049517|537576400|FG003|Conditioning/Transplant|Other complicating disease|4|||
149026902|NCT00049517|537576401|FG004|Conditioning/Transplant|Other complicating disease|0|||
149026903|NCT00049517|537576402|FG005|Conditioning/Transplant|Other complicating disease|1|||
149026904|NCT00049517|537576397|FG000|Conditioning/Transplant|Reasons not reported|25|||
149026905|NCT00049517|537576398|FG001|Conditioning/Transplant|Reasons not reported|31|||
149026906|NCT00049517|537576399|FG002|Conditioning/Transplant|Reasons not reported|18|||
149026907|NCT00049517|537576400|FG003|Conditioning/Transplant|Reasons not reported|15|||
149026908|NCT00049517|537576401|FG004|Conditioning/Transplant|Reasons not reported|5|||
149026909|NCT00049517|537576402|FG005|Conditioning/Transplant|Reasons not reported|5|||
149026910|NCT01419717|537576403|FG000|Overall Study|Protocol-specified Criteria|62|||
149026911|NCT01419717|537576403|FG000|Overall Study|Adverse Event|19|||
149026912|NCT01419717|537576403|FG000|Overall Study|Death|17|||
149026913|NCT01419717|537576403|FG000|Overall Study|Withdrawal by Subject|10|||
149026914|NCT01419717|537576403|FG000|Overall Study|Disease Progression|9|||
149026915|NCT01419717|537576403|FG000|Overall Study|Other|4|||
149026916|NCT01419717|537576403|FG000|Overall Study|Lost to Follow-up|2|||
149026917|NCT01419717|537576403|FG000|Overall Study|Administrative Decision|1|||
149026918|NCT01419717|537576403|FG000|Overall Study|Noncompliance|1|||
148734519|NCT02987959|536501616|FG000|Overall Study|Grantor stopped supply of drugs|6|||
148734520|NCT00643565|536501619|FG000|Overall Study|Death|12|||
148734521|NCT00643565|536501620|FG001|Overall Study|Death|11|||
148734522|NCT00643565|536501619|FG000|Overall Study|Withdrawal by Subject|4|||
148734523|NCT00643565|536501620|FG001|Overall Study|Withdrawal by Subject|1|||
148734524|NCT00643565|536501619|FG000|Overall Study|Lost to Follow-up|0|||
148734525|NCT00643565|536501620|FG001|Overall Study|Lost to Follow-up|6|||
148734526|NCT00643565|536501619|FG000|Overall Study|Other|7|||
148734527|NCT00643565|536501620|FG001|Overall Study|Other|8|||
148734528|NCT00643565|536501619|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
148734529|NCT00643565|536501620|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
148734530|NCT00643565|536501619|FG000|Overall Study|Recurrence of Disease|2|||
148734531|NCT00643565|536501620|FG001|Overall Study|Recurrence of Disease|1|||
148734532|NCT00643565|536501619|FG000|Overall Study|Progression of Disease|18|||
148734533|NCT00643565|536501620|FG001|Overall Study|Progression of Disease|14|||
148734534|NCT00643565|536501619|FG000|Overall Study|Protocol Violation|3|||
148734535|NCT00643565|536501620|FG001|Overall Study|Protocol Violation|0|||
148734536|NCT00643565|536501619|FG000|Overall Study|Did Not Cooperate|0|||
148734537|NCT00643565|536501620|FG001|Overall Study|Did Not Cooperate|1|||
148734538|NCT00643565|536501619|FG000|Overall Study|Administrative|22|||
148734539|NCT00643565|536501620|FG001|Overall Study|Administrative|16|||
148734540|NCT00643565|536501619|FG000|Overall Study|Adverse Event|5|||
148734541|NCT00643565|536501620|FG001|Overall Study|Adverse Event|8|||
148734542|NCT03285308|536501625|FG000|Overall Study|Adverse Event|3|||
148734543|NCT03285308|536501626|FG001|Overall Study|Adverse Event|7|||
148734544|NCT03285308|536501625|FG000|Overall Study|Withdrawal by Subject|8|||
148734545|NCT03285308|536501626|FG001|Overall Study|Withdrawal by Subject|9|||
148734546|NCT03285308|536501625|FG000|Overall Study|Lost to Follow-up|3|||
149026919|NCT02857283|537576404|FG000|First Exposure|Withdrawal by Subject|1|||
149026920|NCT02857283|537576405|FG001|First Exposure|Withdrawal by Subject|0|||
148734547|NCT03285308|536501626|FG001|Overall Study|Lost to Follow-up|1|||
148734548|NCT03285308|536501625|FG000|Overall Study|Protocol Deviation|6|||
148734549|NCT03285308|536501626|FG001|Overall Study|Protocol Deviation|5|||
148734550|NCT03285308|536501625|FG000|Overall Study|Reason not Specified|0|||
148734551|NCT03285308|536501626|FG001|Overall Study|Reason not Specified|1|||
149026921|NCT00093795|537576406|FG000|Overall Study|No follow up data|20|||
149026922|NCT00093795|537576407|FG001|Overall Study|No follow up data|16|||
149026923|NCT00093795|537576408|FG002|Overall Study|No follow up data|17|||
148734552|NCT02283983|536501627|FG000|Overall Study|Inclusion criteria not met|0|||
148734553|NCT02283983|536501628|FG001|Overall Study|Inclusion criteria not met|1|||
148734554|NCT02283983|536501627|FG000|Overall Study|Withdrawal by Subject|4|||
148734555|NCT02283983|536501628|FG001|Overall Study|Withdrawal by Subject|2|||
148973469|NCT02741115|537386175|FG000|Overall Study|Lost to Follow-up|7|||
148973470|NCT02741115|537386176|FG001|Overall Study|Lost to Follow-up|4|||
148973471|NCT02741115|537386175|FG000|Overall Study|Withdrawal by Subject|4|||
148973472|NCT02741115|537386176|FG001|Overall Study|Withdrawal by Subject|2|||
148973473|NCT04602624|537386179|FG000|Overall Study|Protocol Deviation|1|||
148973474|NCT04602624|537386179|FG000|Overall Study|Withdrawal by Participant|1|||
148734556|NCT02283983|536501627|FG000|Overall Study|Protocol Violation|0|||
148734557|NCT02283983|536501628|FG001|Overall Study|Protocol Violation|4|||
148734558|NCT02283983|536501627|FG000|Overall Study|Physician Decision|2|||
148734559|NCT02283983|536501628|FG001|Overall Study|Physician Decision|4|||
148734560|NCT02283983|536501627|FG000|Overall Study|Death|1|||
148734561|NCT02283983|536501628|FG001|Overall Study|Death|0|||
148734562|NCT02283983|536501627|FG000|Overall Study|Adverse Event|1|||
148734563|NCT02283983|536501628|FG001|Overall Study|Adverse Event|0|||
148734564|NCT02283983|536501627|FG000|Overall Study|Lost to Follow-up|9|||
148734565|NCT02283983|536501628|FG001|Overall Study|Lost to Follow-up|8|||
148734566|NCT02283983|536501627|FG000|Overall Study|Relapse|1|||
148734567|NCT02283983|536501628|FG001|Overall Study|Relapse|0|||
148734568|NCT03283761|536501629|FG000|Study Treatment|Patient Non-Compliance|1|||
148734569|NCT03283761|536501629|FG000|Study Treatment|Alternative Cancer Therapy|7|||
148734570|NCT03283761|536501629|FG000|Study Treatment|Disease progression|21|||
148734571|NCT03283761|536501629|FG000|Study Treatment|Adverse Event|3|||
148734572|NCT03283761|536501629|FG000|Study Treatment|Withdrawal by Subject|4|||
148734573|NCT03283761|536501629|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
148734574|NCT03283761|536501629|FG000|Study Treatment|Symptomatic Deterioration|1|||
148734575|NCT03283761|536501629|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
148734576|NCT03283761|536501629|FG000|Follow up|Lost to Follow-up|1|||
148734577|NCT03283761|536501629|FG000|Follow up|Symptomatic Deterioration|1|||
148734578|NCT03283761|536501629|FG000|Follow up|Death|29|||
148734579|NCT03283761|536501629|FG000|Follow up|study terminated|4|||
148734580|NCT03283761|536501629|FG000|Follow up|Primary Investigator Withdrawal|1|||
148734581|NCT03283761|536501629|FG000|Follow up|Switched to alternative therapy|1|||
148734582|NCT03283761|536501629|FG000|Follow up|Subject is now in Hospice|1|||
148734583|NCT04453202|536501635|FG000|Overall Study|Adverse Event|0|||
148734584|NCT04453202|536501636|FG001|Overall Study|Adverse Event|0|||
148734585|NCT04453202|536501637|FG002|Overall Study|Adverse Event|0|||
148734586|NCT04453202|536501638|FG003|Overall Study|Adverse Event|0|||
148734587|NCT04453202|536501639|FG004|Overall Study|Adverse Event|0|||
148734588|NCT04453202|536501640|FG005|Overall Study|Adverse Event|0|||
148734589|NCT04453202|536501641|FG006|Overall Study|Adverse Event|1|||
148734590|NCT04453202|536501642|FG007|Overall Study|Adverse Event|0|||
148734591|NCT04453202|536501643|FG008|Overall Study|Adverse Event|0|||
148734592|NCT04453202|536501644|FG009|Overall Study|Adverse Event|0|||
148734593|NCT04453202|536501645|FG010|Overall Study|Adverse Event|0|||
148734594|NCT04453202|536501635|FG000|Overall Study|Death|0|||
148734595|NCT04453202|536501636|FG001|Overall Study|Death|0|||
148734596|NCT04453202|536501637|FG002|Overall Study|Death|0|||
148734597|NCT04453202|536501638|FG003|Overall Study|Death|0|||
148734598|NCT04453202|536501639|FG004|Overall Study|Death|0|||
148734599|NCT04453202|536501640|FG005|Overall Study|Death|0|||
148734600|NCT04453202|536501641|FG006|Overall Study|Death|0|||
148734601|NCT04453202|536501642|FG007|Overall Study|Death|0|||
148734602|NCT04453202|536501643|FG008|Overall Study|Death|0|||
148734603|NCT04453202|536501644|FG009|Overall Study|Death|1|||
148734604|NCT04453202|536501645|FG010|Overall Study|Death|0|||
148734605|NCT04453202|536501635|FG000|Overall Study|Lost to Follow-up|0|||
148734606|NCT04453202|536501636|FG001|Overall Study|Lost to Follow-up|1|||
148734607|NCT04453202|536501637|FG002|Overall Study|Lost to Follow-up|0|||
148734608|NCT04453202|536501638|FG003|Overall Study|Lost to Follow-up|1|||
148734609|NCT04453202|536501639|FG004|Overall Study|Lost to Follow-up|0|||
148734610|NCT04453202|536501640|FG005|Overall Study|Lost to Follow-up|0|||
148734611|NCT04453202|536501641|FG006|Overall Study|Lost to Follow-up|0|||
148734612|NCT04453202|536501642|FG007|Overall Study|Lost to Follow-up|0|||
148734613|NCT04453202|536501643|FG008|Overall Study|Lost to Follow-up|0|||
148973475|NCT00634647|537387761|FG000|Overall Study|death on study|3|||
148734614|NCT04453202|536501644|FG009|Overall Study|Lost to Follow-up|1|||
148734615|NCT04453202|536501645|FG010|Overall Study|Lost to Follow-up|1|||
148734616|NCT04453202|536501635|FG000|Overall Study|Withdrawal by Subject|1|||
148734617|NCT04453202|536501636|FG001|Overall Study|Withdrawal by Subject|2|||
148817941|NCT05558410|536808434|FG000|Overall Study|Sponsor Decision|1|||
148734618|NCT04453202|536501637|FG002|Overall Study|Withdrawal by Subject|1|||
148734619|NCT04453202|536501638|FG003|Overall Study|Withdrawal by Subject|2|||
148734620|NCT04453202|536501639|FG004|Overall Study|Withdrawal by Subject|1|||
148734621|NCT04453202|536501640|FG005|Overall Study|Withdrawal by Subject|1|||
148734622|NCT04453202|536501641|FG006|Overall Study|Withdrawal by Subject|0|||
148734623|NCT04453202|536501642|FG007|Overall Study|Withdrawal by Subject|0|||
148734624|NCT04453202|536501643|FG008|Overall Study|Withdrawal by Subject|0|||
148734625|NCT04453202|536501644|FG009|Overall Study|Withdrawal by Subject|1|||
148734626|NCT04453202|536501645|FG010|Overall Study|Withdrawal by Subject|0|||
149026924|NCT00940017|537576409|FG000|Overall Study|did not meet entrance criteria|3|||
149026925|NCT00940017|537576409|FG000|Overall Study|Adverse Event|1|||
149026926|NCT00613301|537576410|FG000|Overall Study|Adverse Event|49|||
149026927|NCT00613301|537576410|FG000|Overall Study|Lost to Follow-up|88|||
149026928|NCT00613301|537576410|FG000|Overall Study|Withdrawal by Subject|5|||
149026929|NCT00613301|537576410|FG000|Overall Study|Death|6|||
149026930|NCT00613301|537576410|FG000|Overall Study|Lack of Efficacy|13|||
149026931|NCT00613301|537576410|FG000|Overall Study|Physician Decision|2|||
149026932|NCT00613301|537576410|FG000|Overall Study|No data was collected|53|||
149026933|NCT00613301|537576410|FG000|Overall Study|Irregularly enrolled patients|12|||
149026934|NCT01684046|537576413|FG000|Period 1, First 30 Days|Adverse Event|0|||
149026935|NCT01684046|537576414|FG001|Period 1, First 30 Days|Adverse Event|2|||
149026936|NCT02790606|537576426|FG000|Overall Study|Death|27|||
149026937|NCT02790606|537576426|FG000|Overall Study|Lost to Follow-up|4|||
149026938|NCT02790606|537576426|FG000|Overall Study|Physician Decision|3|||
149026939|NCT02790606|537576426|FG000|Overall Study|Withdrawal by Subject|1|||
149026940|NCT02735915|537576427|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
149026941|NCT02735915|537576427|FG000|Overall Study|Withdrawal following SAE|2|||
149026942|NCT02735915|537576427|FG000|Overall Study|Withdrawal by Subject|1|||
149026943|NCT05328973|537576428|FG000|Overall Study|Withdrawal by Subject|0|||
149026944|NCT05328973|537576429|FG001|Overall Study|Withdrawal by Subject|1|||
149026945|NCT02680756|537576436|FG000|Overall Study|Adverse Event|10|||
149026946|NCT02680756|537576437|FG001|Overall Study|Adverse Event|2|||
149026947|NCT02680756|537576436|FG000|Overall Study|Lost to Follow-up|7|||
149026948|NCT02680756|537576437|FG001|Overall Study|Lost to Follow-up|6|||
149026949|NCT02680756|537576436|FG000|Overall Study|Withdrawal by Subject|5|||
149026950|NCT02680756|537576437|FG001|Overall Study|Withdrawal by Subject|5|||
148734627|NCT04453202|536501635|FG000|Overall Study|Adverse Event|0|||
148734628|NCT04453202|536501636|FG001|Overall Study|Adverse Event|0|||
148973476|NCT00634647|537387761|FG000|Overall Study|refused further treatment|3|||
148973477|NCT00634647|537387761|FG000|Overall Study|declined to participate before treatment|1|||
148973478|NCT01207778|537387762|FG000|Overall Study|Lost to Follow-up|0|||
148973479|NCT01207778|537387763|FG001|Overall Study|Lost to Follow-up|3|||
148973480|NCT01207778|537387764|FG002|Overall Study|Lost to Follow-up|3|||
148973481|NCT01433263|537387765|FG000|Overall Study|Adverse Event|3|||
148973482|NCT01433263|537387766|FG001|Overall Study|Adverse Event|1|||
148973483|NCT01433263|537387765|FG000|Overall Study|Death|5|||
148973484|NCT01433263|537387766|FG001|Overall Study|Death|3|||
148973485|NCT01433263|537387765|FG000|Overall Study|Lost to Follow-up|0|||
148973486|NCT01433263|537387766|FG001|Overall Study|Lost to Follow-up|1|||
148973487|NCT01433263|537387765|FG000|Overall Study|Protocol Deviation|1|||
148973488|NCT01433263|537387766|FG001|Overall Study|Protocol Deviation|0|||
148973489|NCT01433263|537387765|FG000|Overall Study|Withdrawal by Subject|10|||
148973490|NCT01433263|537387766|FG001|Overall Study|Withdrawal by Subject|7|||
148973491|NCT00293384|537387772|FG000|Overall Study|Non-compliance|2|||
148973492|NCT00293384|537387772|FG000|Overall Study|Missed dosage/study drug|1|||
148973493|NCT00293384|537387772|FG000|Overall Study|Ineligible|2|||
148973494|NCT04709237|537387774|FG000|Overall Study|Lost to Follow-up|1|||
148973495|NCT04709237|537387775|FG001|Overall Study|Lost to Follow-up|0|||
148973496|NCT04709237|537387776|FG002|Overall Study|Lost to Follow-up|0|||
148973497|NCT02610192|537387777|FG000|Overall Study|Received other treatment|8|||
148973498|NCT02610192|537387777|FG000|Overall Study|Physician Decision|1|||
148973499|NCT01344057|537387779|FG000|Overall Study|Premature Withdrawal|1|||
148973500|NCT00145509|537387780|FG000|Overall Study|Adverse Event|10|||
148973501|NCT00145509|537387781|FG001|Overall Study|Adverse Event|3|||
148973502|NCT00145509|537387780|FG000|Overall Study|Lack of Efficacy|3|||
148973503|NCT00145509|537387781|FG001|Overall Study|Lack of Efficacy|1|||
148734629|NCT04453202|536501637|FG002|Overall Study|Adverse Event|0|||
148734630|NCT04453202|536501638|FG003|Overall Study|Adverse Event|0|||
148734631|NCT04453202|536501639|FG004|Overall Study|Adverse Event|0|||
148734632|NCT04453202|536501640|FG005|Overall Study|Adverse Event|1|||
148734633|NCT04453202|536501641|FG006|Overall Study|Adverse Event|0|||
148734634|NCT04453202|536501642|FG007|Overall Study|Adverse Event|0|||
148973504|NCT00145509|537387780|FG000|Overall Study|Lost to Follow-up|5|||
148973505|NCT00145509|537387781|FG001|Overall Study|Lost to Follow-up|9|||
148973506|NCT00145509|537387780|FG000|Overall Study|Withdrew Consent|2|||
148973507|NCT00145509|537387781|FG001|Overall Study|Withdrew Consent|7|||
148973508|NCT00145509|537387780|FG000|Overall Study|Reason not provided|2|||
148973509|NCT00145509|537387781|FG001|Overall Study|Reason not provided|1|||
149026951|NCT02680756|537576436|FG000|Overall Study|Physician Decision|4|||
149026952|NCT02680756|537576437|FG001|Overall Study|Physician Decision|1|||
149026953|NCT02680756|537576436|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
149026954|NCT02680756|537576437|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
149026955|NCT02680756|537576436|FG000|Overall Study|Blood transfusion for any reason|0|||
148973510|NCT01359592|537387782|FG000|Initial Registration|Adverse Event|1|||
148973511|NCT01359592|537387783|FG001|Initial Registration|Adverse Event|0|||
148973512|NCT01359592|537387784|FG002|Initial Registration|Adverse Event|0|||
148973513|NCT01359592|537387785|FG003|Initial Registration|Adverse Event|0|||
148973514|NCT01359592|537387782|FG000|Initial Registration|Death|1|||
148734635|NCT04453202|536501643|FG008|Overall Study|Adverse Event|0|||
148734636|NCT04453202|536501644|FG009|Overall Study|Adverse Event|0|||
148734637|NCT04453202|536501645|FG010|Overall Study|Adverse Event|0|||
148734638|NCT00424775|536501646|FG000|Overall Study|Adverse Event|2|||
148734639|NCT00424775|536501647|FG001|Overall Study|Adverse Event|0|||
148734640|NCT00424775|536501646|FG000|Overall Study|Lack of Efficacy|1|||
148734641|NCT00424775|536501647|FG001|Overall Study|Lack of Efficacy|0|||
148734642|NCT00681590|536501648|FG000|Overall Study|Withdrawal by Subject|2|||
148734643|NCT00681590|536501649|FG001|Overall Study|Withdrawal by Subject|12|||
148734644|NCT02912650|536501650|FG000|Overall Study|Withdrawal by Subject|1|||
148734645|NCT02912650|536501651|FG001|Overall Study|Withdrawal by Subject|0|||
148734646|NCT02912650|536501652|FG002|Overall Study|Withdrawal by Subject|1|||
148734647|NCT02912650|536501653|FG003|Overall Study|Withdrawal by Subject|5|||
148734648|NCT02912650|536501650|FG000|Overall Study|Adverse Event|0|||
148734649|NCT02912650|536501651|FG001|Overall Study|Adverse Event|0|||
148734650|NCT02912650|536501652|FG002|Overall Study|Adverse Event|1|||
148734651|NCT02912650|536501653|FG003|Overall Study|Adverse Event|0|||
148734652|NCT02562482|536501654|FG000|Overall Study|Enrolled, but did not receive product|4|||
148734653|NCT02562482|536501655|FG001|Overall Study|Enrolled, but did not receive product|0|||
148734654|NCT02562482|536501654|FG000|Overall Study|Lost to Follow-up|9|||
148734655|NCT02562482|536501655|FG001|Overall Study|Lost to Follow-up|6|||
148734656|NCT02562482|536501654|FG000|Overall Study|Moved from area|2|||
148734657|NCT02562482|536501655|FG001|Overall Study|Moved from area|3|||
148734658|NCT02562482|536501654|FG000|Overall Study|Withdrawal by Subject|5|||
148734659|NCT02562482|536501655|FG001|Overall Study|Withdrawal by Subject|3|||
148734660|NCT02562482|536501654|FG000|Overall Study|Physician Decision|1|||
148734661|NCT02562482|536501655|FG001|Overall Study|Physician Decision|3|||
148734662|NCT02562482|536501654|FG000|Overall Study|Illness/Injury unrelated to product|0|||
148734663|NCT02562482|536501655|FG001|Overall Study|Illness/Injury unrelated to product|1|||
148734664|NCT00975286|536501656|FG000|Overall Study|Adverse Event|9|||
148734665|NCT00975286|536501657|FG001|Overall Study|Adverse Event|19|||
148734666|NCT00975286|536501656|FG000|Overall Study|Protocol Violation|1|||
148734667|NCT00975286|536501657|FG001|Overall Study|Protocol Violation|2|||
148734668|NCT00975286|536501656|FG000|Overall Study|Withdrawal by Subject|0|||
148734669|NCT00975286|536501657|FG001|Overall Study|Withdrawal by Subject|2|||
148734670|NCT00975286|536501656|FG000|Overall Study|Familial and Personal Reasons|2|||
148734671|NCT00975286|536501657|FG001|Overall Study|Familial and Personal Reasons|2|||
148734672|NCT00975286|536501656|FG000|Overall Study|Poor Compliance to Protocol|0|||
148734673|NCT00975286|536501657|FG001|Overall Study|Poor Compliance to Protocol|2|||
148734674|NCT00975286|536501656|FG000|Overall Study|Sponsor Decision|0|||
148734675|NCT00975286|536501657|FG001|Overall Study|Sponsor Decision|2|||
148734676|NCT01490866|536501658|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
148734677|NCT01490866|536501658|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
148734678|NCT01490866|536501658|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
148734679|NCT01490866|536501658|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
148734680|NCT01490866|536501658|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
148734681|NCT01490866|536501658|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
148734682|NCT01490866|536501658|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
148734683|NCT01490866|536501658|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
148734684|NCT01490866|536501658|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
148734685|NCT01490866|536501658|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
148734686|NCT01490866|536501658|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
148734687|NCT04135196|536501659|FG000|Overall Study|Lost to Follow-up|8|||
148734688|NCT04135196|536501660|FG001|Overall Study|Lost to Follow-up|7|||
148734689|NCT04135196|536501661|FG002|Overall Study|Lost to Follow-up|8|||
148734690|NCT04135196|536501662|FG003|Overall Study|Lost to Follow-up|9|||
148734691|NCT04135196|536501663|FG004|Overall Study|Lost to Follow-up|1|||
148734692|NCT04135196|536501659|FG000|Overall Study|Pregnancy|0|||
148734693|NCT04135196|536501660|FG001|Overall Study|Pregnancy|0|||
148734694|NCT04135196|536501661|FG002|Overall Study|Pregnancy|1|||
148734695|NCT04135196|536501662|FG003|Overall Study|Pregnancy|0|||
148734696|NCT04135196|536501663|FG004|Overall Study|Pregnancy|0|||
148734697|NCT04135196|536501659|FG000|Overall Study|Withdrawal by Subject|0|||
148734698|NCT04135196|536501660|FG001|Overall Study|Withdrawal by Subject|0|||
148734699|NCT04135196|536501661|FG002|Overall Study|Withdrawal by Subject|0|||
148734700|NCT04135196|536501662|FG003|Overall Study|Withdrawal by Subject|0|||
148734701|NCT04135196|536501663|FG004|Overall Study|Withdrawal by Subject|1|||
148734702|NCT01970865|536501664|FG000|Overall Study|Death|3|||
148734703|NCT01970865|536501665|FG001|Overall Study|Death|2|||
148734704|NCT01970865|536501666|FG002|Overall Study|Death|3|||
148734705|NCT01970865|536501667|FG003|Overall Study|Death|6|||
148734706|NCT01970865|536501668|FG004|Overall Study|Death|9|||
148734707|NCT01970865|536501669|FG005|Overall Study|Death|3|||
148734708|NCT01970865|536501670|FG006|Overall Study|Death|2|||
148734709|NCT01970865|536501671|FG007|Overall Study|Death|3|||
148734710|NCT01970865|536501672|FG008|Overall Study|Death|2|||
148734711|NCT01970865|536501673|FG009|Overall Study|Death|2|||
148734712|NCT01970865|536501674|FG010|Overall Study|Death|8|||
148734713|NCT01970865|536501675|FG011|Overall Study|Death|13|||
148734714|NCT01970865|536501676|FG012|Overall Study|Death|25|||
148734715|NCT01970865|536501677|FG013|Overall Study|Death|46|||
148734716|NCT01970865|536501678|FG014|Overall Study|Death|37|||
148734717|NCT01970865|536501679|FG015|Overall Study|Death|22|||
148734718|NCT01970865|536501680|FG016|Overall Study|Death|1|||
148734719|NCT01970865|536501681|FG017|Overall Study|Death|17|||
148734720|NCT01970865|536501664|FG000|Overall Study|Lost to Follow-up|0|||
148734721|NCT01970865|536501665|FG001|Overall Study|Lost to Follow-up|0|||
148734722|NCT01970865|536501666|FG002|Overall Study|Lost to Follow-up|0|||
148734723|NCT01970865|536501667|FG003|Overall Study|Lost to Follow-up|1|||
148734724|NCT01970865|536501668|FG004|Overall Study|Lost to Follow-up|1|||
148734725|NCT01970865|536501669|FG005|Overall Study|Lost to Follow-up|0|||
148734726|NCT01970865|536501670|FG006|Overall Study|Lost to Follow-up|0|||
148734727|NCT01970865|536501671|FG007|Overall Study|Lost to Follow-up|0|||
148734728|NCT01970865|536501672|FG008|Overall Study|Lost to Follow-up|0|||
148734729|NCT01970865|536501673|FG009|Overall Study|Lost to Follow-up|0|||
148734730|NCT01970865|536501674|FG010|Overall Study|Lost to Follow-up|1|||
148734731|NCT01970865|536501675|FG011|Overall Study|Lost to Follow-up|0|||
148734732|NCT01970865|536501676|FG012|Overall Study|Lost to Follow-up|2|||
148734733|NCT01970865|536501677|FG013|Overall Study|Lost to Follow-up|0|||
148734734|NCT01970865|536501678|FG014|Overall Study|Lost to Follow-up|1|||
148734735|NCT01970865|536501679|FG015|Overall Study|Lost to Follow-up|4|||
148734736|NCT01970865|536501680|FG016|Overall Study|Lost to Follow-up|0|||
148734737|NCT01970865|536501681|FG017|Overall Study|Lost to Follow-up|1|||
148734738|NCT01970865|536501664|FG000|Overall Study|Other|0|||
148734739|NCT01970865|536501665|FG001|Overall Study|Other|1|||
148734740|NCT01970865|536501666|FG002|Overall Study|Other|0|||
148734741|NCT01970865|536501667|FG003|Overall Study|Other|1|||
148734742|NCT01970865|536501668|FG004|Overall Study|Other|1|||
148734743|NCT01970865|536501669|FG005|Overall Study|Other|0|||
148734744|NCT01970865|536501670|FG006|Overall Study|Other|1|||
148734745|NCT01970865|536501671|FG007|Overall Study|Other|0|||
148734746|NCT01970865|536501672|FG008|Overall Study|Other|0|||
148734747|NCT01970865|536501673|FG009|Overall Study|Other|0|||
148734748|NCT01970865|536501674|FG010|Overall Study|Other|2|||
148734749|NCT01970865|536501675|FG011|Overall Study|Other|3|||
148734750|NCT01970865|536501676|FG012|Overall Study|Other|8|||
148734751|NCT01970865|536501677|FG013|Overall Study|Other|3|||
148734752|NCT01970865|536501678|FG014|Overall Study|Other|2|||
148734753|NCT01970865|536501679|FG015|Overall Study|Other|3|||
148734754|NCT01970865|536501680|FG016|Overall Study|Other|0|||
148734755|NCT01970865|536501681|FG017|Overall Study|Other|2|||
148734756|NCT01970865|536501664|FG000|Overall Study|Participant refused further follow-up|0|||
148734757|NCT01970865|536501665|FG001|Overall Study|Participant refused further follow-up|0|||
148734758|NCT01970865|536501666|FG002|Overall Study|Participant refused further follow-up|0|||
148734759|NCT01970865|536501667|FG003|Overall Study|Participant refused further follow-up|2|||
148734760|NCT01970865|536501668|FG004|Overall Study|Participant refused further follow-up|3|||
148734761|NCT01970865|536501669|FG005|Overall Study|Participant refused further follow-up|0|||
148734762|NCT01970865|536501670|FG006|Overall Study|Participant refused further follow-up|0|||
148734763|NCT01970865|536501671|FG007|Overall Study|Participant refused further follow-up|0|||
148734764|NCT01970865|536501672|FG008|Overall Study|Participant refused further follow-up|0|||
148734765|NCT01970865|536501673|FG009|Overall Study|Participant refused further follow-up|0|||
148734766|NCT01970865|536501674|FG010|Overall Study|Participant refused further follow-up|1|||
148734767|NCT01970865|536501675|FG011|Overall Study|Participant refused further follow-up|4|||
148734768|NCT01970865|536501676|FG012|Overall Study|Participant refused further follow-up|7|||
148734769|NCT01970865|536501677|FG013|Overall Study|Participant refused further follow-up|8|||
148734770|NCT01970865|536501678|FG014|Overall Study|Participant refused further follow-up|3|||
148734771|NCT01970865|536501679|FG015|Overall Study|Participant refused further follow-up|11|||
148734772|NCT01970865|536501680|FG016|Overall Study|Participant refused further follow-up|0|||
148734773|NCT01970865|536501681|FG017|Overall Study|Participant refused further follow-up|6|||
148734774|NCT01946191|536501682|FG000|Allocation|Did not complete orientation|1|||
148734775|NCT01946191|536501683|FG001|Allocation|Did not complete orientation|1|||
148734776|NCT01946191|536501682|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
148734777|NCT01946191|536501683|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
148734778|NCT01946191|536501682|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
148734779|NCT01946191|536501683|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
148734780|NCT01946191|536501682|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
148734781|NCT01946191|536501683|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
148734782|NCT01083810|536501684|FG000|Overall Study|Lost to Follow-up|23|||
148734783|NCT01083810|536501685|FG001|Overall Study|Lost to Follow-up|11|||
148734784|NCT01083810|536501686|FG002|Overall Study|Lost to Follow-up|4|||
148734785|NCT01083810|536501684|FG000|Overall Study|Adverse Event|15|||
148734786|NCT01083810|536501685|FG001|Overall Study|Adverse Event|11|||
148734787|NCT01083810|536501686|FG002|Overall Study|Adverse Event|4|||
148734788|NCT01083810|536501684|FG000|Overall Study|Withdrawal by Subject|7|||
148734789|NCT01083810|536501685|FG001|Overall Study|Withdrawal by Subject|2|||
148734790|NCT01083810|536501686|FG002|Overall Study|Withdrawal by Subject|4|||
148973515|NCT01359592|537387783|FG001|Initial Registration|Death|0|||
148973516|NCT01359592|537387784|FG002|Initial Registration|Death|0|||
148973517|NCT01359592|537387785|FG003|Initial Registration|Death|0|||
148973518|NCT01359592|537387782|FG000|Initial Registration|Other reason not protocol specified|1|||
148817942|NCT05558410|536808435|FG001|Overall Study|Sponsor Decision|0|||
148817943|NCT05558410|536808436|FG002|Overall Study|Sponsor Decision|0|||
148817944|NCT05558410|536808434|FG000|Overall Study|Other|1|||
148817945|NCT05558410|536808435|FG001|Overall Study|Other|0|||
148817946|NCT05558410|536808436|FG002|Overall Study|Other|1|||
148817947|NCT00923702|536808439|FG000|Overall Study|Ongoing enrollment|0|||
148817948|NCT00923702|536808440|FG001|Overall Study|Ongoing enrollment|0|||
148817949|NCT00923702|536808441|FG002|Overall Study|Ongoing enrollment|0|||
148817950|NCT00923702|536808442|FG003|Overall Study|Ongoing enrollment|0|||
148817951|NCT00923702|536808443|FG004|Overall Study|Ongoing enrollment|354|||
148817952|NCT01158404|536808444|FG000|Overall Study|Withdrawal by Subject|0|||
148973519|NCT01359592|537387783|FG001|Initial Registration|Other reason not protocol specified|0|||
148973520|NCT01359592|537387784|FG002|Initial Registration|Other reason not protocol specified|0|||
148734791|NCT01083810|536501684|FG000|Overall Study|Reason not reported|6|||
148734792|NCT01083810|536501685|FG001|Overall Study|Reason not reported|1|||
148734793|NCT01083810|536501686|FG002|Overall Study|Reason not reported|1|||
148734794|NCT01083810|536501684|FG000|Overall Study|Non-compliance|4|||
148734795|NCT01083810|536501685|FG001|Overall Study|Non-compliance|7|||
148734796|NCT01083810|536501686|FG002|Overall Study|Non-compliance|2|||
148734797|NCT01083810|536501684|FG000|Overall Study|Simplification|4|||
148734798|NCT01083810|536501685|FG001|Overall Study|Simplification|1|||
148734799|NCT01083810|536501686|FG002|Overall Study|Simplification|0|||
148734800|NCT01083810|536501684|FG000|Overall Study|Death|2|||
148734801|NCT01083810|536501685|FG001|Overall Study|Death|2|||
148734802|NCT01083810|536501686|FG002|Overall Study|Death|3|||
148734803|NCT01083810|536501684|FG000|Overall Study|Co-morbidities|1|||
148734804|NCT01083810|536501685|FG001|Overall Study|Co-morbidities|0|||
148734805|NCT01083810|536501686|FG002|Overall Study|Co-morbidities|0|||
148734806|NCT01083810|536501684|FG000|Overall Study|Participation in study|1|||
148734807|NCT01083810|536501685|FG001|Overall Study|Participation in study|0|||
148734808|NCT01083810|536501686|FG002|Overall Study|Participation in study|0|||
148734809|NCT01083810|536501684|FG000|Overall Study|Therapy break|1|||
148734810|NCT01083810|536501685|FG001|Overall Study|Therapy break|2|||
148734811|NCT01083810|536501686|FG002|Overall Study|Therapy break|2|||
148734812|NCT01083810|536501684|FG000|Overall Study|Virologic failure|1|||
148734813|NCT01083810|536501685|FG001|Overall Study|Virologic failure|8|||
148734814|NCT01083810|536501686|FG002|Overall Study|Virologic failure|0|||
148734815|NCT03071094|536501687|FG000|Overall Study|Death|1|||
148734816|NCT03071094|536501688|FG001|Overall Study|Death|1|||
148734817|NCT03071094|536501687|FG000|Overall Study|Adverse Event|1|||
148734818|NCT03071094|536501688|FG001|Overall Study|Adverse Event|0|||
148734819|NCT01079832|536501691|FG000|Overall Study|Withdrawal by Subject|1|||
148734820|NCT01195272|536501692|FG000|Overall Study|Adverse Event|1|||
148734821|NCT01195272|536501692|FG000|Overall Study|Lack of Efficacy|3|||
148734822|NCT03047473|536505319|FG000|Overall Study|Lost to Follow-up|2|||
148734823|NCT01167257|536505320|FG000|Overall Study|Lost to Follow-up|2|||
148734824|NCT01167257|536505321|FG001|Overall Study|Lost to Follow-up|2|||
148734825|NCT01167257|536505320|FG000|Overall Study|Withdrew consent|1|||
148734826|NCT01167257|536505321|FG001|Overall Study|Withdrew consent|1|||
148734827|NCT03283319|536505323|FG000|Overall Study|Lost to Follow-up|5|||
148734828|NCT03283319|536505324|FG001|Overall Study|Lost to Follow-up|4|||
148734829|NCT03283319|536505325|FG002|Overall Study|Lost to Follow-up|5|||
148734830|NCT03283319|536505326|FG003|Overall Study|Lost to Follow-up|5|||
148734831|NCT03283319|536505327|FG004|Overall Study|Lost to Follow-up|4|||
148734832|NCT03283319|536505328|FG005|Overall Study|Lost to Follow-up|3|||
148734833|NCT03283319|536505323|FG000|Overall Study|Withdrawal by Subject|2|||
148734834|NCT03283319|536505324|FG001|Overall Study|Withdrawal by Subject|2|||
148817953|NCT01158404|536808445|FG001|Overall Study|Withdrawal by Subject|1|||
148973521|NCT01359592|537387785|FG003|Initial Registration|Other reason not protocol specified|0|||
148973522|NCT01359592|537387782|FG000|Initial Registration|Ineligible|26|||
148973523|NCT01359592|537387783|FG001|Initial Registration|Ineligible|0|||
148734835|NCT03283319|536505325|FG002|Overall Study|Withdrawal by Subject|2|||
148973524|NCT01359592|537387784|FG002|Initial Registration|Ineligible|0|||
148734836|NCT03283319|536505326|FG003|Overall Study|Withdrawal by Subject|1|||
148734837|NCT03283319|536505327|FG004|Overall Study|Withdrawal by Subject|0|||
148734838|NCT03283319|536505328|FG005|Overall Study|Withdrawal by Subject|1|||
148734839|NCT03283319|536505323|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
148734840|NCT03283319|536505324|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
148734841|NCT03283319|536505325|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
148817954|NCT01158404|536808446|FG002|Overall Study|Withdrawal by Subject|0|||
148973525|NCT01359592|537387785|FG003|Initial Registration|Ineligible|0|||
148734842|NCT03283319|536505326|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
148734843|NCT03283319|536505327|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
148817955|NCT01158404|536808447|FG003|Overall Study|Withdrawal by Subject|0|||
148734844|NCT03283319|536505328|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
148734845|NCT00721630|536505329|FG000|Overall Study|Participant found to be ineligible|1|||
148734846|NCT02213510|536505331|FG000|Overall Study|Death|0|||
148734847|NCT02213510|536505332|FG001|Overall Study|Death|1|||
148734848|NCT02213510|536505331|FG000|Overall Study|Lost to Follow-up|1|||
148734849|NCT02213510|536505332|FG001|Overall Study|Lost to Follow-up|0|||
148734850|NCT03954834|536505334|FG000|Overall Study|Adverse Event|1|||
148734851|NCT03954834|536505335|FG001|Overall Study|Adverse Event|3|||
148734852|NCT03954834|536505336|FG002|Overall Study|Adverse Event|1|||
148734853|NCT03954834|536505337|FG003|Overall Study|Adverse Event|1|||
148734854|NCT03954834|536505334|FG000|Overall Study|Death|0|||
148734855|NCT03954834|536505335|FG001|Overall Study|Death|0|||
148734856|NCT03954834|536505336|FG002|Overall Study|Death|0|||
148734857|NCT03954834|536505337|FG003|Overall Study|Death|1|||
148734858|NCT03954834|536505334|FG000|Overall Study|Physician Decision|0|||
148734859|NCT03954834|536505335|FG001|Overall Study|Physician Decision|1|||
148734860|NCT03954834|536505336|FG002|Overall Study|Physician Decision|0|||
148734861|NCT03954834|536505337|FG003|Overall Study|Physician Decision|2|||
148734862|NCT03954834|536505334|FG000|Overall Study|Protocol Violation|1|||
148734863|NCT03954834|536505335|FG001|Overall Study|Protocol Violation|0|||
148734864|NCT03954834|536505336|FG002|Overall Study|Protocol Violation|0|||
148734865|NCT03954834|536505337|FG003|Overall Study|Protocol Violation|1|||
148734866|NCT03954834|536505334|FG000|Overall Study|Withdrawal by Subject|2|||
148734867|NCT03954834|536505335|FG001|Overall Study|Withdrawal by Subject|3|||
148734868|NCT03954834|536505336|FG002|Overall Study|Withdrawal by Subject|13|||
148734869|NCT03954834|536505337|FG003|Overall Study|Withdrawal by Subject|6|||
148734870|NCT03954834|536505334|FG000|Overall Study|Participant left the country|0|||
148734871|NCT03954834|536505335|FG001|Overall Study|Participant left the country|0|||
148734872|NCT03954834|536505336|FG002|Overall Study|Participant left the country|1|||
148734873|NCT03954834|536505337|FG003|Overall Study|Participant left the country|0|||
148734874|NCT03954834|536505334|FG000|Overall Study|Lost to Follow-up|3|||
148734875|NCT03954834|536505335|FG001|Overall Study|Lost to Follow-up|2|||
148734876|NCT03954834|536505336|FG002|Overall Study|Lost to Follow-up|3|||
148734877|NCT03954834|536505337|FG003|Overall Study|Lost to Follow-up|5|||
148734878|NCT00372411|536505350|FG000|Overall Study|Withdrawal by Subject|3|||
148734879|NCT00372411|536505351|FG001|Overall Study|Withdrawal by Subject|4|||
148734880|NCT00372411|536505352|FG002|Overall Study|Withdrawal by Subject|1|||
148734881|NCT00372411|536505350|FG000|Overall Study|Death|0|||
148734882|NCT00372411|536505351|FG001|Overall Study|Death|2|||
148734883|NCT00372411|536505352|FG002|Overall Study|Death|1|||
148734884|NCT00372411|536505350|FG000|Overall Study|Lost to Follow-up|1|||
148734885|NCT00372411|536505351|FG001|Overall Study|Lost to Follow-up|1|||
148734886|NCT00372411|536505352|FG002|Overall Study|Lost to Follow-up|1|||
148734887|NCT00372411|536505350|FG000|Overall Study|Adverse Event|1|||
148734888|NCT00372411|536505351|FG001|Overall Study|Adverse Event|1|||
148734889|NCT00372411|536505352|FG002|Overall Study|Adverse Event|0|||
148734890|NCT01398514|536505353|FG000|Overall Study|Adverse Event|1|||
148734891|NCT01398514|536505354|FG001|Overall Study|Adverse Event|0|||
148734892|NCT01398514|536505353|FG000|Overall Study|Non-compliance with study procedures|2|||
148734893|NCT01398514|536505354|FG001|Overall Study|Non-compliance with study procedures|0|||
148734894|NCT01398514|536505353|FG000|Overall Study|Physiologic non-responsiveness|1|||
148734895|NCT01398514|536505354|FG001|Overall Study|Physiologic non-responsiveness|3|||
148734896|NCT01398514|536505353|FG000|Overall Study|Failure to show a conditioned response|4|||
148734897|NCT01398514|536505354|FG001|Overall Study|Failure to show a conditioned response|3|||
148734898|NCT00754650|536505355|FG000|Overall Study|Disease Progression|2|||
148734899|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
148734900|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
148734901|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
148734902|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
148734903|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
148734904|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
148734905|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
148734906|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
148734907|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
148734908|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
148734909|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
148734910|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
148973526|NCT01359592|537387782|FG000|PET-Directed Therapy|Adverse Event|0|||
148973527|NCT01359592|537387783|FG001|PET-Directed Therapy|Adverse Event|0|||
148734911|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
148734912|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
148734913|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
148734914|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
148734915|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
148734916|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
148973528|NCT01359592|537387784|FG002|PET-Directed Therapy|Adverse Event|1|||
148973529|NCT01359592|537387785|FG003|PET-Directed Therapy|Adverse Event|0|||
148973530|NCT01359592|537387782|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
148973531|NCT01359592|537387783|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
148973532|NCT01359592|537387784|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
148973533|NCT01359592|537387785|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
148973534|NCT01359592|537387782|FG000|PET-Directed Therapy|Ineligible|0|||
148973535|NCT01359592|537387783|FG001|PET-Directed Therapy|Ineligible|0|||
148973536|NCT01359592|537387784|FG002|PET-Directed Therapy|Ineligible|24|||
148973537|NCT01359592|537387785|FG003|PET-Directed Therapy|Ineligible|0|||
148973538|NCT00749775|537387792|FG000|Overall Study|Protocol Violation|24|||
148973539|NCT00749775|537387792|FG000|Overall Study|Lost to Follow-up|36|||
148973540|NCT00749775|537387792|FG000|Overall Study|No visit after first day of treatment|44|||
148973541|NCT00749775|537387792|FG000|Overall Study|No drug administration|3|||
148973542|NCT01067352|537387799|FG000|Overall Study|Withdrawal by Subject|1|||
148973543|NCT01067352|537387800|FG001|Overall Study|Withdrawal by Subject|2|||
148973544|NCT01067352|537387801|FG002|Overall Study|Withdrawal by Subject|1|||
148973545|NCT01067352|537387799|FG000|Overall Study|Physician Decision|0|||
148973546|NCT01067352|537387800|FG001|Overall Study|Physician Decision|1|||
148973547|NCT01067352|537387801|FG002|Overall Study|Physician Decision|0|||
148973548|NCT02566759|537387802|FG000|All Parts|Withdrawal by Subject|0|||
148973549|NCT02566759|537387803|FG001|All Parts|Withdrawal by Subject|1|||
148973550|NCT02566759|537387804|FG002|All Parts|Withdrawal by Subject|0|||
148973551|NCT02566759|537387805|FG003|All Parts|Withdrawal by Subject|0|||
148973552|NCT02566759|537387806|FG004|All Parts|Withdrawal by Subject|0|||
148973553|NCT02566759|537387807|FG005|All Parts|Withdrawal by Subject|0|||
148973554|NCT02566759|537387808|FG006|All Parts|Withdrawal by Subject|0|||
148973555|NCT02566759|537387809|FG007|All Parts|Withdrawal by Subject|0|||
148973556|NCT02566759|537387810|FG008|All Parts|Withdrawal by Subject|0|||
148973557|NCT02566759|537387811|FG009|All Parts|Withdrawal by Subject|0|||
148973558|NCT02566759|537387812|FG010|All Parts|Withdrawal by Subject|0|||
148973559|NCT02566759|537387813|FG011|All Parts|Withdrawal by Subject|0|||
148973560|NCT02566759|537387814|FG012|All Parts|Withdrawal by Subject|0|||
148973561|NCT02566759|537387815|FG013|All Parts|Withdrawal by Subject|0|||
148973562|NCT02566759|537387816|FG014|All Parts|Withdrawal by Subject|0|||
148973563|NCT02566759|537387817|FG015|All Parts|Withdrawal by Subject|0|||
148973564|NCT02566759|537387818|FG016|All Parts|Withdrawal by Subject|0|||
148973565|NCT02566759|537387802|FG000|All Parts|Adverse Event|0|||
148973566|NCT02566759|537387803|FG001|All Parts|Adverse Event|0|||
148973567|NCT02566759|537387804|FG002|All Parts|Adverse Event|0|||
148973568|NCT02566759|537387805|FG003|All Parts|Adverse Event|0|||
148973569|NCT02566759|537387806|FG004|All Parts|Adverse Event|0|||
148973570|NCT02566759|537387807|FG005|All Parts|Adverse Event|0|||
148973571|NCT02566759|537387808|FG006|All Parts|Adverse Event|0|||
148973572|NCT02566759|537387809|FG007|All Parts|Adverse Event|0|||
148973573|NCT02566759|537387810|FG008|All Parts|Adverse Event|0|||
148973574|NCT02566759|537387811|FG009|All Parts|Adverse Event|0|||
148973575|NCT02566759|537387812|FG010|All Parts|Adverse Event|0|||
148973576|NCT02566759|537387813|FG011|All Parts|Adverse Event|0|||
148973577|NCT02566759|537387814|FG012|All Parts|Adverse Event|1|||
148973578|NCT02566759|537387815|FG013|All Parts|Adverse Event|3|||
148973579|NCT02566759|537387816|FG014|All Parts|Adverse Event|0|||
148973580|NCT02566759|537387817|FG015|All Parts|Adverse Event|0|||
148973581|NCT02566759|537387818|FG016|All Parts|Adverse Event|0|||
148973582|NCT02566759|537387802|FG000|All Parts|Other|0|||
148973583|NCT02566759|537387803|FG001|All Parts|Other|0|||
148973584|NCT02566759|537387804|FG002|All Parts|Other|0|||
148973585|NCT02566759|537387805|FG003|All Parts|Other|0|||
148973586|NCT02566759|537387806|FG004|All Parts|Other|0|||
148973587|NCT02566759|537387807|FG005|All Parts|Other|0|||
148973588|NCT02566759|537387808|FG006|All Parts|Other|0|||
148973589|NCT02566759|537387809|FG007|All Parts|Other|0|||
148973590|NCT02566759|537387810|FG008|All Parts|Other|0|||
148973591|NCT02566759|537387811|FG009|All Parts|Other|0|||
148973592|NCT02566759|537387812|FG010|All Parts|Other|0|||
148973593|NCT02566759|537387813|FG011|All Parts|Other|0|||
148973594|NCT02566759|537387814|FG012|All Parts|Other|0|||
148973595|NCT02566759|537387815|FG013|All Parts|Other|2|||
148973596|NCT02566759|537387816|FG014|All Parts|Other|0|||
148973597|NCT02566759|537387817|FG015|All Parts|Other|0|||
148973598|NCT02566759|537387818|FG016|All Parts|Other|0|||
148973599|NCT02566759|537387802|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973600|NCT02566759|537387803|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973601|NCT02566759|537387804|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973602|NCT02566759|537387805|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973603|NCT02566759|537387806|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973604|NCT02566759|537387807|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973605|NCT02566759|537387808|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973606|NCT02566759|537387809|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973607|NCT02566759|537387810|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973608|NCT02566759|537387811|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973609|NCT02566759|537387812|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
149026956|NCT02680756|537576437|FG001|Overall Study|Blood transfusion for any reason|1|||
149026957|NCT02680756|537576436|FG000|Overall Study|Death|1|||
149026958|NCT02680756|537576437|FG001|Overall Study|Death|0|||
149026959|NCT02680756|537576436|FG000|Overall Study|Protocol Violation|1|||
149026960|NCT02680756|537576437|FG001|Overall Study|Protocol Violation|0|||
149026961|NCT02680756|537576436|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
149026962|NCT02680756|537576437|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
149026963|NCT02680756|537576436|FG000|Overall Study|None of above or not recorded|3|||
149026964|NCT02680756|537576437|FG001|Overall Study|None of above or not recorded|2|||
149026965|NCT00480441|537576438|FG000|Screening|Not Eligible|37|||
149026966|NCT00480441|537576439|FG001|Screening|Not Eligible|0|||
149026967|NCT00480441|537576440|FG002|Screening|Not Eligible|0|||
148817956|NCT01158404|536808448|FG004|Overall Study|Withdrawal by Subject|3|||
148817957|NCT01158404|536808449|FG005|Overall Study|Withdrawal by Subject|1|||
148973610|NCT02566759|537387813|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973611|NCT02566759|537387814|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973612|NCT02566759|537387815|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973613|NCT02566759|537387816|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973614|NCT02566759|537387817|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
148973615|NCT02566759|537387818|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
148973616|NCT00976898|537387819|FG000|Overall Study|Protocol Violation|1|||
148973617|NCT00976898|537387819|FG000|Overall Study|Adverse Event|1|||
149026968|NCT00480441|537576438|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
149026969|NCT00480441|537576439|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
149026970|NCT00480441|537576440|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
149026971|NCT00480441|537576438|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
148817958|NCT01158404|536808450|FG006|Overall Study|Withdrawal by Subject|0|||
148817959|NCT01158404|536808451|FG007|Overall Study|Withdrawal by Subject|1|||
148817960|NCT01158404|536808444|FG000|Overall Study|Physician Decision|0|||
148817961|NCT01158404|536808445|FG001|Overall Study|Physician Decision|0|||
148817962|NCT01158404|536808446|FG002|Overall Study|Physician Decision|0|||
148817963|NCT01158404|536808447|FG003|Overall Study|Physician Decision|0|||
149026972|NCT00480441|537576439|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
148734917|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
148817964|NCT01158404|536808448|FG004|Overall Study|Physician Decision|0|||
148817965|NCT01158404|536808449|FG005|Overall Study|Physician Decision|0|||
148817966|NCT01158404|536808450|FG006|Overall Study|Physician Decision|0|||
148817967|NCT01158404|536808451|FG007|Overall Study|Physician Decision|1|||
148817968|NCT01158404|536808444|FG000|Overall Study|Progressive Disease|0|||
149026973|NCT00480441|537576440|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
149026974|NCT00480441|537576438|FG000|Baseline Functional MRI|physical contraindication|4|||
148734918|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
148734919|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
148734920|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
148734921|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
148734922|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
148734923|NCT03514641|536505356|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
148734924|NCT03514641|536505357|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
148734925|NCT03514641|536505358|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
148734926|NCT03514641|536505359|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
148734927|NCT03514641|536505356|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
148734928|NCT03514641|536505357|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
148734929|NCT03514641|536505358|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
148734930|NCT03514641|536505359|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
148734931|NCT03514641|536505356|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
148734932|NCT03514641|536505357|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
148734933|NCT03514641|536505358|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
148734934|NCT03514641|536505359|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
148734935|NCT03514641|536505356|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
148734936|NCT03514641|536505357|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
148734937|NCT03514641|536505358|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
148734938|NCT03514641|536505359|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
148734939|NCT03514641|536505356|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
148734940|NCT03514641|536505357|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
148734941|NCT03514641|536505358|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
148734942|NCT03514641|536505359|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
148817969|NCT01158404|536808445|FG001|Overall Study|Progressive Disease|0|||
148817970|NCT01158404|536808446|FG002|Overall Study|Progressive Disease|0|||
148817971|NCT01158404|536808447|FG003|Overall Study|Progressive Disease|0|||
148817972|NCT01158404|536808448|FG004|Overall Study|Progressive Disease|0|||
148817973|NCT01158404|536808449|FG005|Overall Study|Progressive Disease|0|||
148973618|NCT00976898|537387819|FG000|Overall Study|Physician Decision|1|||
148973619|NCT00976898|537387819|FG000|Overall Study|Liver Transplant|1|||
148973620|NCT00976898|537387819|FG000|Overall Study|Progressive Disease|1|||
148973621|NCT05107128|537387820|FG000|Overall Study|Adverse Event|2|||
148973622|NCT05107128|537387821|FG001|Overall Study|Adverse Event|0|||
148973623|NCT05107128|537387820|FG000|Overall Study|Withdrawal by Subject|3|||
148973624|NCT05107128|537387821|FG001|Overall Study|Withdrawal by Subject|3|||
148973625|NCT05107128|537387820|FG000|Overall Study|Withdrawal of Consent|0|||
148973626|NCT05107128|537387821|FG001|Overall Study|Withdrawal of Consent|1|||
148973627|NCT05107128|537387820|FG000|Overall Study|Reason Not Specified|2|||
148973628|NCT05107128|537387821|FG001|Overall Study|Reason Not Specified|0|||
148973629|NCT04649151|537387824|FG000|Overall Study|Pregnancy|0|||
148973630|NCT04649151|537387825|FG001|Overall Study|Pregnancy|0|||
148973631|NCT04649151|537387826|FG002|Overall Study|Pregnancy|0|||
148973632|NCT04649151|537387827|FG003|Overall Study|Pregnancy|0|||
148973633|NCT04649151|537387828|FG004|Overall Study|Pregnancy|3|||
148973634|NCT04649151|537387824|FG000|Overall Study|Physician Decision|10|||
148973635|NCT04649151|537387825|FG001|Overall Study|Physician Decision|0|||
148973636|NCT04649151|537387826|FG002|Overall Study|Physician Decision|0|||
148973637|NCT04649151|537387827|FG003|Overall Study|Physician Decision|1|||
148973638|NCT04649151|537387828|FG004|Overall Study|Physician Decision|1|||
148973639|NCT04649151|537387824|FG000|Overall Study|Protocol Deviation|25|||
148973640|NCT04649151|537387825|FG001|Overall Study|Protocol Deviation|3|||
148973641|NCT04649151|537387826|FG002|Overall Study|Protocol Deviation|0|||
148973642|NCT04649151|537387827|FG003|Overall Study|Protocol Deviation|0|||
148973643|NCT04649151|537387828|FG004|Overall Study|Protocol Deviation|0|||
148973644|NCT04649151|537387824|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
148973645|NCT04649151|537387825|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
148973646|NCT04649151|537387826|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
148973647|NCT04649151|537387827|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
148973648|NCT04649151|537387828|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
148973649|NCT04649151|537387824|FG000|Overall Study|Withdrawal by Subject|370|||
148973650|NCT04649151|537387825|FG001|Overall Study|Withdrawal by Subject|113|||
148973651|NCT04649151|537387826|FG002|Overall Study|Withdrawal by Subject|2|||
148973652|NCT04649151|537387827|FG003|Overall Study|Withdrawal by Subject|7|||
148973653|NCT04649151|537387828|FG004|Overall Study|Withdrawal by Subject|15|||
148973654|NCT04649151|537387824|FG000|Overall Study|Adverse Event|1|||
148973655|NCT04649151|537387825|FG001|Overall Study|Adverse Event|0|||
148973656|NCT04649151|537387826|FG002|Overall Study|Adverse Event|0|||
148973657|NCT04649151|537387827|FG003|Overall Study|Adverse Event|0|||
148973658|NCT04649151|537387828|FG004|Overall Study|Adverse Event|0|||
148973659|NCT04649151|537387824|FG000|Overall Study|Lost to Follow-up|256|||
148973660|NCT04649151|537387825|FG001|Overall Study|Lost to Follow-up|29|||
148973661|NCT04649151|537387826|FG002|Overall Study|Lost to Follow-up|10|||
148973662|NCT04649151|537387827|FG003|Overall Study|Lost to Follow-up|3|||
148973663|NCT04649151|537387828|FG004|Overall Study|Lost to Follow-up|6|||
148973664|NCT04649151|537387824|FG000|Overall Study|Other than specified|59|||
148973665|NCT04649151|537387825|FG001|Overall Study|Other than specified|294|||
148973666|NCT04649151|537387826|FG002|Overall Study|Other than specified|0|||
148973667|NCT04649151|537387827|FG003|Overall Study|Other than specified|0|||
148973668|NCT04649151|537387828|FG004|Overall Study|Other than specified|4|||
148973669|NCT04649151|537387824|FG000|Overall Study|Death|0|||
148973670|NCT04649151|537387825|FG001|Overall Study|Death|0|||
148973671|NCT04649151|537387826|FG002|Overall Study|Death|0|||
148973672|NCT04649151|537387827|FG003|Overall Study|Death|0|||
148973673|NCT04649151|537387828|FG004|Overall Study|Death|1|||
148973674|NCT00499603|537387856|FG000|Overall Study|Adverse Event|0|||
148973675|NCT00499603|537387857|FG001|Overall Study|Adverse Event|1|||
148973676|NCT03323099|537387858|FG000|Overall Study|Withdrawal by Subject|6|||
148973677|NCT03323099|537387859|FG001|Overall Study|Withdrawal by Subject|12|||
148973678|NCT03323099|537387858|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
148734943|NCT03514641|536505356|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
148973679|NCT03323099|537387859|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
148973680|NCT05220397|537387860|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
148973681|NCT05220397|537387861|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
148973682|NCT05220397|537387862|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
148973683|NCT05220397|537387863|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
148973684|NCT05220397|537387864|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
148973685|NCT00207142|537387866|FG000|Induction Phase|Adverse Event|9|||
148973686|NCT00207142|537387867|FG001|Induction Phase|Adverse Event|0|||
148973687|NCT00207142|537387868|FG002|Induction Phase|Adverse Event|0|||
148973688|NCT00207142|537387869|FG003|Induction Phase|Adverse Event|0|||
148973689|NCT00207142|537387866|FG000|Induction Phase|Death|1|||
148973690|NCT00207142|537387867|FG001|Induction Phase|Death|0|||
148973691|NCT00207142|537387868|FG002|Induction Phase|Death|0|||
148973692|NCT00207142|537387869|FG003|Induction Phase|Death|0|||
148973693|NCT00207142|537387866|FG000|Induction Phase|Lack of Efficacy|1|||
148973694|NCT00207142|537387867|FG001|Induction Phase|Lack of Efficacy|0|||
148973695|NCT00207142|537387868|FG002|Induction Phase|Lack of Efficacy|0|||
149026975|NCT00480441|537576439|FG001|Baseline Functional MRI|physical contraindication|0|||
149026976|NCT00480441|537576440|FG002|Baseline Functional MRI|physical contraindication|0|||
149026977|NCT00480441|537576438|FG000|Randomization|Lost to Follow-up|0|||
149026978|NCT00480441|537576439|FG001|Randomization|Lost to Follow-up|7|||
149026979|NCT00480441|537576440|FG002|Randomization|Lost to Follow-up|2|||
149026980|NCT02374957|537576441|FG000|Overall Study|Patient did not complete forms correctly|1|||
149026981|NCT02374957|537576442|FG001|Overall Study|Patient did not complete forms correctly|0|||
149026982|NCT03681691|537576443|FG000|Overall Study|COVID|1|||
149026983|NCT03681691|537576444|FG001|Overall Study|COVID|0|||
149026984|NCT03681691|537576443|FG000|Overall Study|prolonged bleeding|1|||
149026985|NCT03681691|537576444|FG001|Overall Study|prolonged bleeding|0|||
149026986|NCT03681691|537576443|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
149026987|NCT03681691|537576444|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
149026988|NCT00748969|537576445|FG000|Overall Study|Withdrawal by Subject|1|||
149026989|NCT00748969|537576446|FG001|Overall Study|Withdrawal by Subject|0|||
149026990|NCT00748969|537576445|FG000|Overall Study|Withdrawal by Subject|0|||
149026991|NCT00748969|537576446|FG001|Overall Study|Withdrawal by Subject|1|||
149026992|NCT02334306|537576447|FG000|Double-blind Period|Adverse Event|0|||
149026993|NCT02334306|537576448|FG001|Double-blind Period|Adverse Event|1|||
149026994|NCT02334306|537576447|FG000|Double-blind Period|Withdrawal by Subject|1|||
149026995|NCT02334306|537576448|FG001|Double-blind Period|Withdrawal by Subject|1|||
149026996|NCT00465985|537576449|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
149026997|NCT00465985|537576450|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
149026998|NCT00465985|537576449|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
149026999|NCT00465985|537576450|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
149027000|NCT00465985|537576449|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
149027001|NCT00465985|537576450|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
149027002|NCT00465985|537576449|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
149027003|NCT00465985|537576450|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
149027004|NCT01687270|537576451|FG000|Overall Study|Lack of Efficacy|11|||
149027005|NCT01687270|537576451|FG000|Overall Study|Lost to Follow-up|1|||
149027006|NCT03532178|537576452|FG000|First Period|Withdrawal by Subject|1|||
149027007|NCT03532178|537576453|FG001|First Period|Withdrawal by Subject|3|||
149027008|NCT03532178|537576452|FG000|First Period|technical issues in data collection Technical issues|0|||
149027009|NCT03532178|537576453|FG001|First Period|technical issues in data collection Technical issues|1|||
149027010|NCT03532178|537576452|FG000|Second Period|Withdrawal by Subject|1|||
149027011|NCT03532178|537576453|FG001|Second Period|Withdrawal by Subject|1|||
149027012|NCT03532178|537576452|FG000|Second Period|Technical issues|0|||
149027013|NCT03532178|537576453|FG001|Second Period|Technical issues|1|||
149027014|NCT03302156|537576454|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
149027015|NCT03302156|537576455|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
149027016|NCT03302156|537576456|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
149027017|NCT02390557|537576457|FG000|Wave 2|Survey non-respondent|72|||
149027018|NCT02390557|537576458|FG001|Wave 2|Survey non-respondent|41|||
149027019|NCT02390557|537576459|FG002|Wave 2|Survey non-respondent|23|||
149027020|NCT03278028|537576462|FG000|Overall Study|Lost to Follow-up|1|||
149027021|NCT03278028|537576463|FG001|Overall Study|Lost to Follow-up|0|||
149027022|NCT03278028|537576462|FG000|Overall Study|Withdrawal by Subject|3|||
148973696|NCT00207142|537387869|FG003|Induction Phase|Lack of Efficacy|0|||
148973697|NCT00207142|537387866|FG000|Induction Phase|Lost to Follow-up|5|||
148973698|NCT00207142|537387867|FG001|Induction Phase|Lost to Follow-up|0|||
148973699|NCT00207142|537387868|FG002|Induction Phase|Lost to Follow-up|0|||
148973700|NCT00207142|537387869|FG003|Induction Phase|Lost to Follow-up|0|||
148973701|NCT00207142|537387866|FG000|Induction Phase|Physician Decision|2|||
148973702|NCT00207142|537387867|FG001|Induction Phase|Physician Decision|0|||
148973703|NCT00207142|537387868|FG002|Induction Phase|Physician Decision|0|||
148973704|NCT00207142|537387869|FG003|Induction Phase|Physician Decision|0|||
149027023|NCT03278028|537576463|FG001|Overall Study|Withdrawal by Subject|1|||
149027024|NCT03278028|537576462|FG000|Overall Study|Pregnancy|0|||
149027025|NCT03278028|537576463|FG001|Overall Study|Pregnancy|1|||
149027026|NCT03635112|537576464|FG000|Overall Study|Adverse Event|5|||
149027027|NCT03635112|537576465|FG001|Overall Study|Adverse Event|9|||
148734944|NCT03514641|536505357|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
148734945|NCT03514641|536505358|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
148973705|NCT00207142|537387866|FG000|Induction Phase|Poor/noncompliance|2|||
149027028|NCT03635112|537576466|FG002|Overall Study|Adverse Event|14|||
149027029|NCT03635112|537576464|FG000|Overall Study|Lost to Follow-up|1|||
149027030|NCT03635112|537576465|FG001|Overall Study|Lost to Follow-up|0|||
149027031|NCT03635112|537576466|FG002|Overall Study|Lost to Follow-up|1|||
148973706|NCT00207142|537387867|FG001|Induction Phase|Poor/noncompliance|0|||
148973707|NCT00207142|537387868|FG002|Induction Phase|Poor/noncompliance|0|||
148973708|NCT00207142|537387869|FG003|Induction Phase|Poor/noncompliance|0|||
148973709|NCT00207142|537387866|FG000|Induction Phase|Pregnancy|1|||
148973710|NCT00207142|537387867|FG001|Induction Phase|Pregnancy|0|||
148734946|NCT03514641|536505359|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
148734947|NCT01345175|536505360|FG000|Overall Study|Physician Decision|0|||
148734948|NCT01345175|536505361|FG001|Overall Study|Physician Decision|1|||
148734949|NCT01345175|536505360|FG000|Overall Study|Withdrawal by Subject|1|||
148734950|NCT01345175|536505361|FG001|Overall Study|Withdrawal by Subject|1|||
148734951|NCT01345175|536505360|FG000|Overall Study|Failed to complete BFI|3|||
148734952|NCT01345175|536505361|FG001|Overall Study|Failed to complete BFI|2|||
148734953|NCT01345175|536505360|FG000|Overall Study|Stopped taking medication|2|||
148734954|NCT01345175|536505361|FG001|Overall Study|Stopped taking medication|2|||
148734955|NCT02906930|536505364|FG000|Overall Study|Withdrawal by Subject|0|||
148734956|NCT02906930|536505365|FG001|Overall Study|Withdrawal by Subject|5|||
148734957|NCT02906930|536505366|FG002|Overall Study|Withdrawal by Subject|5|||
148734958|NCT02906930|536505367|FG003|Overall Study|Withdrawal by Subject|4|||
148734959|NCT02906930|536505364|FG000|Overall Study|Lost to Follow-up|5|||
148734960|NCT02906930|536505365|FG001|Overall Study|Lost to Follow-up|7|||
148734961|NCT02906930|536505366|FG002|Overall Study|Lost to Follow-up|5|||
148734962|NCT02906930|536505367|FG003|Overall Study|Lost to Follow-up|2|||
148734963|NCT02906930|536505364|FG000|Overall Study|Death|0|||
148734964|NCT02906930|536505365|FG001|Overall Study|Death|0|||
148734965|NCT02906930|536505366|FG002|Overall Study|Death|1|||
148734966|NCT02906930|536505367|FG003|Overall Study|Death|0|||
148734967|NCT02906930|536505364|FG000|Overall Study|Other|1|||
148734968|NCT02906930|536505365|FG001|Overall Study|Other|2|||
148734969|NCT02906930|536505366|FG002|Overall Study|Other|1|||
148734970|NCT02906930|536505367|FG003|Overall Study|Other|2|||
148734971|NCT02570113|536505368|FG000|Overall Study|Withdrawal by Subject|3|||
148734972|NCT00910091|536505369|FG000|Pre-assignment|Withdrawal by Subject|0|||
148734973|NCT00910091|536505370|FG001|Pre-assignment|Withdrawal by Subject|2|||
148734974|NCT00910091|536505369|FG000|Treatment and Survival|Withdrawal by Subject|3|||
148734975|NCT00910091|536505370|FG001|Treatment and Survival|Withdrawal by Subject|4|||
148734976|NCT00910091|536505369|FG000|Treatment and Survival|Adverse Event|1|||
148734977|NCT00910091|536505370|FG001|Treatment and Survival|Adverse Event|0|||
148734978|NCT01908816|536505371|FG000|Overall Study|Subject's no longer requires study drug|0|||
148734979|NCT01908816|536505372|FG001|Overall Study|Subject's no longer requires study drug|0|||
148734980|NCT01908816|536505373|FG002|Overall Study|Subject's no longer requires study drug|0|||
148734981|NCT01908816|536505374|FG003|Overall Study|Subject's no longer requires study drug|1|||
148734982|NCT01908816|536505371|FG000|Overall Study|Protocol deviation|1|||
148734983|NCT01908816|536505372|FG001|Overall Study|Protocol deviation|2|||
148734984|NCT01908816|536505373|FG002|Overall Study|Protocol deviation|1|||
148734985|NCT01908816|536505374|FG003|Overall Study|Protocol deviation|1|||
148734986|NCT01908816|536505371|FG000|Overall Study|Withdrawal by Subject|0|||
148734987|NCT01908816|536505372|FG001|Overall Study|Withdrawal by Subject|4|||
148734988|NCT01908816|536505373|FG002|Overall Study|Withdrawal by Subject|2|||
148734989|NCT01908816|536505374|FG003|Overall Study|Withdrawal by Subject|2|||
148734990|NCT01908816|536505371|FG000|Overall Study|Lost to Follow-up|3|||
148734991|NCT01908816|536505372|FG001|Overall Study|Lost to Follow-up|5|||
148734992|NCT01908816|536505373|FG002|Overall Study|Lost to Follow-up|4|||
148734993|NCT01908816|536505374|FG003|Overall Study|Lost to Follow-up|2|||
148734994|NCT01908816|536505371|FG000|Overall Study|Death|1|||
148734995|NCT01908816|536505372|FG001|Overall Study|Death|0|||
148734996|NCT01908816|536505373|FG002|Overall Study|Death|7|||
148734997|NCT01908816|536505374|FG003|Overall Study|Death|1|||
148734998|NCT01908816|536505371|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148734999|NCT01908816|536505372|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
148735000|NCT01908816|536505373|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
148735001|NCT01908816|536505374|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
148735002|NCT01908816|536505371|FG000|Overall Study|Early termination|87|||
148735003|NCT01908816|536505372|FG001|Overall Study|Early termination|60|||
148735004|NCT01908816|536505373|FG002|Overall Study|Early termination|43|||
148735005|NCT01908816|536505374|FG003|Overall Study|Early termination|28|||
148735006|NCT01007942|536505376|FG000|Overall Study|Adverse Event|29|||
148735007|NCT01007942|536505377|FG001|Overall Study|Adverse Event|14|||
148735008|NCT01007942|536505376|FG000|Overall Study|Abnormal test procedure|0|||
148735009|NCT01007942|536505377|FG001|Overall Study|Abnormal test procedure|1|||
148735010|NCT01007942|536505376|FG000|Overall Study|Disease progression|217|||
148735011|NCT01007942|536505377|FG001|Overall Study|Disease progression|242|||
148735012|NCT01007942|536505376|FG000|Overall Study|New cancer therapy|5|||
148735013|NCT01007942|536505377|FG001|Overall Study|New cancer therapy|1|||
148735014|NCT01007942|536505376|FG000|Overall Study|Protocol Violation|1|||
148735015|NCT01007942|536505377|FG001|Overall Study|Protocol Violation|1|||
148735016|NCT01007942|536505376|FG000|Overall Study|Withdrawal by Subject|19|||
148735017|NCT01007942|536505377|FG001|Overall Study|Withdrawal by Subject|14|||
148735018|NCT01007942|536505376|FG000|Overall Study|Lost to Follow-up|1|||
148735019|NCT01007942|536505377|FG001|Overall Study|Lost to Follow-up|0|||
148735020|NCT01007942|536505376|FG000|Overall Study|Administrative problems|2|||
148735021|NCT01007942|536505377|FG001|Overall Study|Administrative problems|0|||
148735022|NCT01007942|536505376|FG000|Overall Study|Death|3|||
148735023|NCT01007942|536505377|FG001|Overall Study|Death|2|||
148735024|NCT01007942|536505376|FG000|Overall Study|Patients untreated|4|||
148735025|NCT01007942|536505377|FG001|Overall Study|Patients untreated|3|||
148735026|NCT04492020|536505378|FG000|Overall Study|Adverse Event|1|||
148735027|NCT04492020|536505379|FG001|Overall Study|Adverse Event|3|||
148735028|NCT04492020|536505378|FG000|Overall Study|Withdrawal by Subject|4|||
148735029|NCT04492020|536505379|FG001|Overall Study|Withdrawal by Subject|3|||
148735030|NCT04492020|536505378|FG000|Overall Study|Lost to Follow-up|4|||
148735031|NCT04492020|536505379|FG001|Overall Study|Lost to Follow-up|3|||
148735032|NCT04492020|536505378|FG000|Overall Study|Protocol Violation|5|||
148735033|NCT04492020|536505379|FG001|Overall Study|Protocol Violation|2|||
148735034|NCT04492020|536505378|FG000|Overall Study|Lack of Qualifying Event|25|||
148735035|NCT04492020|536505379|FG001|Overall Study|Lack of Qualifying Event|27|||
148735036|NCT04492020|536505378|FG000|Overall Study|Non-compliance with Study Drug|2|||
148735037|NCT04492020|536505379|FG001|Overall Study|Non-compliance with Study Drug|1|||
148735038|NCT04585789|536505380|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
148735039|NCT04585789|536505381|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
148735040|NCT04585789|536505382|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
148735041|NCT04585789|536505380|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
148735042|NCT04585789|536505381|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
148735043|NCT04585789|536505382|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
148735044|NCT01175811|536505383|FG000|Overall Study|Adverse Event|1|||
148735045|NCT01175811|536505384|FG001|Overall Study|Adverse Event|1|||
148735046|NCT01175811|536505383|FG000|Overall Study|Entry criteria not met|3|||
148735047|NCT01175811|536505384|FG001|Overall Study|Entry criteria not met|1|||
148735048|NCT01175811|536505383|FG000|Overall Study|Lack of Efficacy|1|||
148735049|NCT01175811|536505384|FG001|Overall Study|Lack of Efficacy|0|||
148735050|NCT01175811|536505383|FG000|Overall Study|Lost to Follow-up|3|||
148735051|NCT01175811|536505384|FG001|Overall Study|Lost to Follow-up|2|||
148735052|NCT01175811|536505383|FG000|Overall Study|Physician Decision|1|||
148735053|NCT01175811|536505384|FG001|Overall Study|Physician Decision|1|||
148735054|NCT01175811|536505383|FG000|Overall Study|Protocol Violation|1|||
148735055|NCT01175811|536505384|FG001|Overall Study|Protocol Violation|2|||
148735056|NCT01175811|536505383|FG000|Overall Study|Withdrawal by Subject|6|||
148735057|NCT01175811|536505384|FG001|Overall Study|Withdrawal by Subject|7|||
148735058|NCT02628743|536505386|FG000|Overall Study|Other|3|||
148735059|NCT02628743|536505386|FG000|Overall Study|Withdrawal by Subject|50|||
148735060|NCT02628743|536505386|FG000|Overall Study|Study Terminated by Sponsor|76|||
148735061|NCT02628743|536505386|FG000|Overall Study|Physician Decision|2|||
148735062|NCT01059344|536505390|FG000|Overall Study|Adverse Event|12|||
148735063|NCT01059344|536505391|FG001|Overall Study|Adverse Event|30|||
148735064|NCT01059344|536505390|FG000|Overall Study|Withdrawal by Subject|6|||
148735065|NCT01059344|536505391|FG001|Overall Study|Withdrawal by Subject|9|||
148735066|NCT01059344|536505390|FG000|Overall Study|Lost to Follow-up|1|||
148735067|NCT01059344|536505391|FG001|Overall Study|Lost to Follow-up|1|||
148735068|NCT01059344|536505390|FG000|Overall Study|Other|3|||
148735069|NCT01059344|536505391|FG001|Overall Study|Other|6|||
148735070|NCT01739348|536505392|FG000|Part I (Base Study)|Adverse Event|41|||
148735071|NCT01739348|536505393|FG001|Part I (Base Study)|Adverse Event|52|||
148735072|NCT01739348|536505394|FG002|Part I (Base Study)|Adverse Event|8|||
148735073|NCT01739348|536505395|FG003|Part I (Base Study)|Adverse Event|33|||
148735074|NCT01739348|536505392|FG000|Part I (Base Study)|Death|10|||
148735075|NCT01739348|536505393|FG001|Part I (Base Study)|Death|7|||
148735076|NCT01739348|536505394|FG002|Part I (Base Study)|Death|2|||
148735077|NCT01739348|536505395|FG003|Part I (Base Study)|Death|8|||
148735078|NCT01739348|536505392|FG000|Part I (Base Study)|Lack of Efficacy|3|||
148735079|NCT01739348|536505393|FG001|Part I (Base Study)|Lack of Efficacy|8|||
148973711|NCT00207142|537387868|FG002|Induction Phase|Pregnancy|0|||
148973712|NCT00207142|537387869|FG003|Induction Phase|Pregnancy|0|||
148973713|NCT00207142|537387866|FG000|Induction Phase|Subject no longer meets study criteria|3|||
148973714|NCT00207142|537387867|FG001|Induction Phase|Subject no longer meets study criteria|0|||
148973715|NCT00207142|537387868|FG002|Induction Phase|Subject no longer meets study criteria|0|||
148973716|NCT00207142|537387869|FG003|Induction Phase|Subject no longer meets study criteria|0|||
148973717|NCT00207142|537387866|FG000|Induction Phase|Withdrawal by Subject|4|||
148973718|NCT00207142|537387867|FG001|Induction Phase|Withdrawal by Subject|0|||
148735080|NCT01739348|536505394|FG002|Part I (Base Study)|Lack of Efficacy|0|||
148735081|NCT01739348|536505395|FG003|Part I (Base Study)|Lack of Efficacy|7|||
148735082|NCT01739348|536505392|FG000|Part I (Base Study)|Lost to Follow-up|4|||
148735083|NCT01739348|536505393|FG001|Part I (Base Study)|Lost to Follow-up|2|||
148735084|NCT01739348|536505394|FG002|Part I (Base Study)|Lost to Follow-up|4|||
148735085|NCT01739348|536505395|FG003|Part I (Base Study)|Lost to Follow-up|4|||
148735086|NCT01739348|536505392|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
148735087|NCT01739348|536505393|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
148973719|NCT00207142|537387868|FG002|Induction Phase|Withdrawal by Subject|0|||
148735088|NCT01739348|536505394|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
148735089|NCT01739348|536505395|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
148735090|NCT01739348|536505392|FG000|Part I (Base Study)|Physician Decision|10|||
148973720|NCT00207142|537387869|FG003|Induction Phase|Withdrawal by Subject|0|||
148973721|NCT00207142|537387866|FG000|Induction Phase|Incarceration|1|||
148973722|NCT00207142|537387867|FG001|Induction Phase|Incarceration|0|||
148973723|NCT00207142|537387868|FG002|Induction Phase|Incarceration|0|||
148973724|NCT00207142|537387869|FG003|Induction Phase|Incarceration|0|||
148973725|NCT00207142|537387866|FG000|Induction Phase|Missing lab data|1|||
148973726|NCT00207142|537387867|FG001|Induction Phase|Missing lab data|0|||
148973727|NCT00207142|537387868|FG002|Induction Phase|Missing lab data|0|||
148973728|NCT00207142|537387869|FG003|Induction Phase|Missing lab data|0|||
148973729|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
148973730|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
148973731|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
148973732|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
148973733|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
148973734|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
148973735|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
148973736|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
148973737|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
148973738|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
148973739|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
148973740|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
148973741|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
148973742|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
148973743|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
148973744|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
148973745|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
148973746|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
148973747|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
148973748|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
148973749|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
148973750|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
148973751|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
148973752|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
148973753|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
148973754|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
148973755|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
148973756|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
148973757|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Death|0|||
148973758|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Death|0|||
148973759|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Death|0|||
148973760|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Death|1|||
148973761|NCT00207142|537387866|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
148973762|NCT00207142|537387867|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
148735091|NCT01739348|536505393|FG001|Part I (Base Study)|Physician Decision|7|||
148735092|NCT01739348|536505394|FG002|Part I (Base Study)|Physician Decision|1|||
148735093|NCT01739348|536505395|FG003|Part I (Base Study)|Physician Decision|4|||
148735094|NCT01739348|536505392|FG000|Part I (Base Study)|Protocol Violation|2|||
148735095|NCT01739348|536505393|FG001|Part I (Base Study)|Protocol Violation|0|||
148735096|NCT01739348|536505394|FG002|Part I (Base Study)|Protocol Violation|1|||
148735097|NCT01739348|536505395|FG003|Part I (Base Study)|Protocol Violation|2|||
148735098|NCT01739348|536505392|FG000|Part I (Base Study)|Screen Failure|2|||
148735099|NCT01739348|536505393|FG001|Part I (Base Study)|Screen Failure|0|||
148735100|NCT01739348|536505394|FG002|Part I (Base Study)|Screen Failure|0|||
148735101|NCT01739348|536505395|FG003|Part I (Base Study)|Screen Failure|0|||
148735102|NCT01739348|536505392|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
148735103|NCT01739348|536505393|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
148735104|NCT01739348|536505394|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
148973763|NCT00207142|537387868|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
148973764|NCT00207142|537387869|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
148973765|NCT01857063|537387870|FG000|Period 1 (7 Days)|Adverse Event|0|||
148973766|NCT01857063|537387871|FG001|Period 1 (7 Days)|Adverse Event|1|||
148735105|NCT01739348|536505395|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
148735106|NCT01739348|536505392|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
148735107|NCT01739348|536505393|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
148973767|NCT01857063|537387870|FG000|Period 1 (7 Days)|Physician Decision|1|||
148973768|NCT01857063|537387871|FG001|Period 1 (7 Days)|Physician Decision|0|||
148973769|NCT01857063|537387870|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
148973770|NCT01857063|537387871|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
148973771|NCT01857063|537387870|FG000|Period 2 (7 Days)|Adverse Event|2|||
148973772|NCT01857063|537387871|FG001|Period 2 (7 Days)|Adverse Event|1|||
148973773|NCT01857063|537387870|FG000|Period 2 (7 Days)|Physician Decision|1|||
148973774|NCT01857063|537387871|FG001|Period 2 (7 Days)|Physician Decision|1|||
149027032|NCT03635112|537576464|FG000|Overall Study|Physician Decision|5|||
149027033|NCT03635112|537576465|FG001|Overall Study|Physician Decision|7|||
149027034|NCT03635112|537576466|FG002|Overall Study|Physician Decision|5|||
149027035|NCT03635112|537576464|FG000|Overall Study|Protocol Violation|0|||
149027036|NCT03635112|537576465|FG001|Overall Study|Protocol Violation|0|||
149027037|NCT03635112|537576466|FG002|Overall Study|Protocol Violation|1|||
149027038|NCT03635112|537576464|FG000|Overall Study|Study Terminated by Sponsor|11|||
149027039|NCT03635112|537576465|FG001|Overall Study|Study Terminated by Sponsor|17|||
148735108|NCT01739348|536505394|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
148973775|NCT01857063|537387870|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
148973776|NCT01857063|537387871|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
148973777|NCT04958109|537387872|FG000|Overall Study|Withdrawal by Subject|0|||
148973778|NCT04958109|537387873|FG001|Overall Study|Withdrawal by Subject|1|||
148973779|NCT04958109|537387872|FG000|Overall Study|Lost to Follow-up|0|||
148973780|NCT04958109|537387873|FG001|Overall Study|Lost to Follow-up|1|||
148973781|NCT00715793|537387876|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
148973782|NCT00715793|537387877|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
148973783|NCT00715793|537387876|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
148973784|NCT00715793|537387877|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
148973785|NCT00058825|537387878|FG000|Overall Study|Relapse|9|||
148973786|NCT00058825|537387878|FG000|Overall Study|Progressive Disease|5|||
148973787|NCT00058825|537387878|FG000|Overall Study|Graft Failure|5|||
148973788|NCT00058825|537387878|FG000|Overall Study|Death|3|||
148973789|NCT04115358|537387879|FG000|Overall Study|exfoliation|0|||
148973790|NCT04115358|537387880|FG001|Overall Study|exfoliation|0|||
148973791|NCT04115358|537387881|FG002|Overall Study|exfoliation|1|||
148973792|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973793|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
148973794|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
148973795|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
148973796|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973797|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973798|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973799|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973800|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
149027040|NCT03635112|537576466|FG002|Overall Study|Study Terminated by Sponsor|21|||
148735109|NCT01739348|536505395|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
148735110|NCT01739348|536505392|FG000|Part I (Base Study)|Participant Moved|4|||
148735111|NCT01739348|536505393|FG001|Part I (Base Study)|Participant Moved|3|||
148735112|NCT01739348|536505394|FG002|Part I (Base Study)|Participant Moved|1|||
148735113|NCT01739348|536505395|FG003|Part I (Base Study)|Participant Moved|7|||
148735114|NCT01739348|536505392|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
148735115|NCT01739348|536505393|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
148735116|NCT01739348|536505394|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
148735117|NCT01739348|536505395|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
148735118|NCT01739348|536505392|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
148735119|NCT01739348|536505393|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
148735120|NCT01739348|536505394|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
148735121|NCT01739348|536505395|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
148735122|NCT01739348|536505392|FG000|Part II (Extension Study)|Adverse Event|10|||
148735123|NCT01739348|536505393|FG001|Part II (Extension Study)|Adverse Event|11|||
148735124|NCT01739348|536505394|FG002|Part II (Extension Study)|Adverse Event|7|||
148735125|NCT01739348|536505395|FG003|Part II (Extension Study)|Adverse Event|26|||
148735126|NCT01739348|536505392|FG000|Part II (Extension Study)|Death|3|||
148735127|NCT01739348|536505393|FG001|Part II (Extension Study)|Death|3|||
148735128|NCT01739348|536505394|FG002|Part II (Extension Study)|Death|2|||
148735129|NCT01739348|536505395|FG003|Part II (Extension Study)|Death|6|||
148735130|NCT01739348|536505392|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
149027041|NCT03635112|537576464|FG000|Overall Study|Withdrawal by Subject|4|||
149027042|NCT03635112|537576465|FG001|Overall Study|Withdrawal by Subject|9|||
148735131|NCT01739348|536505393|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
148973801|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973802|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973803|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973804|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973805|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973806|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973807|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
149027043|NCT03635112|537576466|FG002|Overall Study|Withdrawal by Subject|7|||
148735132|NCT01739348|536505394|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
148735133|NCT01739348|536505395|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
148973808|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
149027044|NCT03635112|537576464|FG000|Overall Study|Miscellaneous|0|||
149027045|NCT03635112|537576465|FG001|Overall Study|Miscellaneous|0|||
149027046|NCT03635112|537576466|FG002|Overall Study|Miscellaneous|1|||
149027047|NCT03283553|537576470|FG000|Patient Participant Flow|Death|5|||
149027048|NCT03283553|537576471|FG001|Patient Participant Flow|Death|10|||
149027049|NCT03283553|537576470|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
149027050|NCT03283553|537576471|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
149027051|NCT03283553|537576470|FG000|Patient Participant Flow|Lost to Follow-up|1|||
149027052|NCT03283553|537576471|FG001|Patient Participant Flow|Lost to Follow-up|1|||
149027053|NCT03283553|537576470|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
149027054|NCT03283553|537576471|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
149027055|NCT03283553|537576470|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
149027056|NCT03283553|537576471|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
149027057|NCT03283553|537576470|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
149027058|NCT03283553|537576471|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
149027059|NCT03686683|537576472|FG000|Overall Study|Withdrawal by Subject|52|||
149027060|NCT03686683|537576473|FG001|Overall Study|Withdrawal by Subject|32|||
149027061|NCT03686683|537576472|FG000|Overall Study|Lost to Follow-up|23|||
149027062|NCT03686683|537576473|FG001|Overall Study|Lost to Follow-up|19|||
149027063|NCT03686683|537576472|FG000|Overall Study|Adverse Event|1|||
149027064|NCT03686683|537576473|FG001|Overall Study|Adverse Event|0|||
149027065|NCT03686683|537576472|FG000|Overall Study|Death|10|||
149027066|NCT03686683|537576473|FG001|Overall Study|Death|5|||
149027067|NCT03686683|537576472|FG000|Overall Study|Progressive Disease|1|||
149027068|NCT03686683|537576473|FG001|Overall Study|Progressive Disease|1|||
149027069|NCT03686683|537576472|FG000|Overall Study|Noncompliance|1|||
149027070|NCT03686683|537576473|FG001|Overall Study|Noncompliance|0|||
149027071|NCT03686683|537576472|FG000|Overall Study|Physician Decision|1|||
149027072|NCT03686683|537576473|FG001|Overall Study|Physician Decision|1|||
149027073|NCT03686683|537576472|FG000|Overall Study|Screen fail post-randomization|1|||
149027074|NCT03686683|537576473|FG001|Overall Study|Screen fail post-randomization|0|||
149027075|NCT03686683|537576472|FG000|Overall Study|Protocol Violation|3|||
149027076|NCT03686683|537576473|FG001|Overall Study|Protocol Violation|0|||
149027077|NCT03686683|537576472|FG000|Overall Study|No data available|1|||
149027078|NCT03686683|537576473|FG001|Overall Study|No data available|0|||
149027079|NCT03255941|537576474|FG000|Overall Study|Not eligible or refused injection|37|||
149027080|NCT03255941|537576475|FG001|Overall Study|Not eligible or refused injection|44|||
149027081|NCT03255941|537576476|FG002|Overall Study|Not eligible or refused injection|5|||
149027082|NCT03255941|537576477|FG003|Overall Study|Not eligible or refused injection|6|||
148735134|NCT01739348|536505392|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
148735135|NCT01739348|536505393|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
148735136|NCT01739348|536505394|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
148735137|NCT01739348|536505395|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
148735138|NCT01739348|536505392|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
148735139|NCT01739348|536505393|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
148735140|NCT01739348|536505394|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
148735141|NCT01739348|536505395|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
148735142|NCT01739348|536505392|FG000|Part II (Extension Study)|Physician Decision|7|||
148735143|NCT01739348|536505393|FG001|Part II (Extension Study)|Physician Decision|11|||
148735144|NCT01739348|536505394|FG002|Part II (Extension Study)|Physician Decision|6|||
148735145|NCT01739348|536505395|FG003|Part II (Extension Study)|Physician Decision|12|||
148735146|NCT01739348|536505392|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
148735147|NCT01739348|536505393|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
148735148|NCT01739348|536505394|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
148735149|NCT01739348|536505395|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
148735150|NCT01739348|536505392|FG000|Part II (Extension Study)|Participant Moved|3|||
148735151|NCT01739348|536505393|FG001|Part II (Extension Study)|Participant Moved|3|||
148735152|NCT01739348|536505394|FG002|Part II (Extension Study)|Participant Moved|0|||
148735153|NCT01739348|536505395|FG003|Part II (Extension Study)|Participant Moved|3|||
148735154|NCT01739348|536505392|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
148735155|NCT01739348|536505393|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
148735156|NCT01739348|536505394|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
148735157|NCT01739348|536505395|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
149027083|NCT03255941|537576474|FG000|Overall Study|Did not complete exit interview|1|||
149027084|NCT03255941|537576475|FG001|Overall Study|Did not complete exit interview|2|||
149027085|NCT03255941|537576476|FG002|Overall Study|Did not complete exit interview|0|||
149027086|NCT03255941|537576477|FG003|Overall Study|Did not complete exit interview|0|||
149027087|NCT00372060|537576478|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
149027088|NCT00372060|537576479|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
149027089|NCT00372060|537576478|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
149027090|NCT00372060|537576479|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
148735158|NCT01739348|536505392|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
148735159|NCT01739348|536505393|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
148735160|NCT01739348|536505394|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
148735161|NCT01739348|536505395|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
148735162|NCT01085201|536505400|FG000|Overall Study|Scheduling conflict|1|||
148735163|NCT01085201|536505401|FG001|Overall Study|Scheduling conflict|0|||
148735164|NCT01085201|536505402|FG002|Overall Study|Scheduling conflict|1|||
148735165|NCT01085201|536505403|FG003|Overall Study|Scheduling conflict|0|||
148735166|NCT01085201|536505404|FG004|Overall Study|Scheduling conflict|0|||
148973809|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973810|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973811|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973812|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973813|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973814|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973815|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
148973816|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973817|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
148973818|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973819|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973820|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973821|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973822|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973823|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973824|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973825|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973826|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973827|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148735167|NCT01085201|536505400|FG000|Overall Study|Unknown- no study drug|2|||
148735168|NCT01085201|536505401|FG001|Overall Study|Unknown- no study drug|0|||
148735169|NCT01085201|536505402|FG002|Overall Study|Unknown- no study drug|0|||
148735170|NCT01085201|536505403|FG003|Overall Study|Unknown- no study drug|0|||
148735171|NCT01085201|536505404|FG004|Overall Study|Unknown- no study drug|0|||
148735172|NCT01085201|536505400|FG000|Overall Study|Fond ineligible after consent|0|||
148735173|NCT01085201|536505401|FG001|Overall Study|Fond ineligible after consent|1|||
148735174|NCT01085201|536505402|FG002|Overall Study|Fond ineligible after consent|1|||
148735175|NCT01085201|536505403|FG003|Overall Study|Fond ineligible after consent|0|||
148735176|NCT01085201|536505404|FG004|Overall Study|Fond ineligible after consent|0|||
148735177|NCT00528411|536505405|FG000|Overall Study|Adverse Event|4|||
148735178|NCT00528411|536505406|FG001|Overall Study|Adverse Event|0|||
148735179|NCT00528411|536505407|FG002|Overall Study|Adverse Event|1|||
148735180|NCT00528411|536505405|FG000|Overall Study|Incorrect Enrolment|1|||
148735181|NCT00528411|536505406|FG001|Overall Study|Incorrect Enrolment|1|||
148735182|NCT00528411|536505407|FG002|Overall Study|Incorrect Enrolment|0|||
148735183|NCT00528411|536505405|FG000|Overall Study|Severe non-compliance to protocol|0|||
148735184|NCT00528411|536505406|FG001|Overall Study|Severe non-compliance to protocol|1|||
148735185|NCT00528411|536505407|FG002|Overall Study|Severe non-compliance to protocol|0|||
148735186|NCT00528411|536505405|FG000|Overall Study|Prior commitment medication|0|||
148735187|NCT00528411|536505406|FG001|Overall Study|Prior commitment medication|1|||
148735188|NCT00528411|536505407|FG002|Overall Study|Prior commitment medication|0|||
148735189|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
148735190|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
148735191|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
148735192|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
148735193|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
148735194|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
148735195|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
148735196|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
148735197|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
148735198|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735199|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
148973828|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973829|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973830|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973831|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148735200|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735201|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735202|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735203|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735204|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735205|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148735206|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
148973832|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973833|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973834|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148735207|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735208|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
148735209|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735210|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
148735211|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148973835|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973836|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973837|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973838|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148735212|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735213|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735214|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735215|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735216|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148735217|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
148735218|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148973839|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
148973840|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973841|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
148973842|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973843|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973844|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973845|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973846|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973847|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973848|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973849|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973850|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973851|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973852|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973853|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973854|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973855|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973856|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148735219|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
148735220|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148735221|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148735222|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148735223|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148735224|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
148735225|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
148817974|NCT01158404|536808450|FG006|Overall Study|Progressive Disease|1|||
148817975|NCT01158404|536808451|FG007|Overall Study|Progressive Disease|0|||
148817976|NCT01336972|536808454|FG000|Overall Study|Adverse Event|1|||
148817977|NCT01336972|536808455|FG001|Overall Study|Adverse Event|1|||
148817978|NCT01336972|536808456|FG002|Overall Study|Adverse Event|0|||
148817979|NCT02441114|536808461|FG000|Washout2|Withdrawal by Subject|4|||
148817980|NCT04790201|536808465|FG000|Overall Study|Lost to Follow-up|0|||
148817981|NCT04790201|536808466|FG001|Overall Study|Lost to Follow-up|0|||
148817982|NCT04790201|536808467|FG002|Overall Study|Lost to Follow-up|2|||
148817983|NCT04790201|536808465|FG000|Overall Study|Death|0|||
148817984|NCT04790201|536808466|FG001|Overall Study|Death|1|||
148817985|NCT04790201|536808467|FG002|Overall Study|Death|0|||
148817986|NCT04790201|536808465|FG000|Overall Study|Protocol Violation|1|||
148973857|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973858|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973859|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973860|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973861|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148817987|NCT04790201|536808466|FG001|Overall Study|Protocol Violation|0|||
148817988|NCT04790201|536808467|FG002|Overall Study|Protocol Violation|1|||
148735226|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
148735227|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
148735228|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735229|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
148735230|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735231|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735232|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735233|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735234|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735235|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
148735236|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735237|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735238|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735239|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735240|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735241|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735242|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
148735243|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735244|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735245|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735246|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
148735247|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735248|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735249|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735250|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735251|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735252|NCT03893565|536505408|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
148735253|NCT03893565|536505409|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
148735254|NCT03893565|536505410|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
148735255|NCT03893565|536505411|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
148735256|NCT03893565|536505412|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
148735257|NCT03893565|536505413|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
148735258|NCT03893565|536505414|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
148735259|NCT03893565|536505415|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
148735260|NCT03893565|536505416|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
148735261|NCT03893565|536505408|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
148735262|NCT03893565|536505409|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
148735263|NCT03893565|536505410|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
148735264|NCT03893565|536505411|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
148735265|NCT03893565|536505412|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
148735266|NCT03893565|536505413|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
148735267|NCT03893565|536505414|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
148735268|NCT03893565|536505415|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
148735269|NCT03893565|536505416|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
148735270|NCT03893565|536505408|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735271|NCT03893565|536505409|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735272|NCT03893565|536505410|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735273|NCT03893565|536505411|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735274|NCT03893565|536505412|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735275|NCT03893565|536505413|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735276|NCT03893565|536505414|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
148735277|NCT03893565|536505415|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735278|NCT03893565|536505416|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
148735279|NCT03893565|536505408|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735280|NCT03893565|536505409|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735281|NCT03893565|536505410|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735282|NCT03893565|536505411|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735283|NCT03893565|536505412|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735284|NCT03893565|536505413|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
148735285|NCT03893565|536505414|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
148735286|NCT03893565|536505415|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735287|NCT03893565|536505416|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
148735288|NCT03893565|536505408|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
148735289|NCT03893565|536505409|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
148735290|NCT03893565|536505410|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
148735291|NCT03893565|536505411|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
148735292|NCT03893565|536505412|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
148735293|NCT03893565|536505413|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
148735294|NCT03893565|536505414|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
148735295|NCT03893565|536505415|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
148735296|NCT03893565|536505416|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
148735297|NCT03893565|536505408|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735298|NCT03893565|536505409|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735299|NCT03893565|536505410|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735300|NCT03893565|536505411|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735301|NCT03893565|536505412|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735302|NCT03893565|536505413|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735303|NCT03893565|536505414|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735304|NCT03893565|536505415|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
148735305|NCT03893565|536505416|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
148735306|NCT03893565|536505408|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735307|NCT03893565|536505409|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735308|NCT03893565|536505410|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735309|NCT03893565|536505411|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735310|NCT03893565|536505412|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735311|NCT03893565|536505413|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735312|NCT03893565|536505414|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735313|NCT03893565|536505415|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
148735314|NCT03893565|536505416|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
148735315|NCT03893565|536505408|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735316|NCT03893565|536505409|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735317|NCT03893565|536505410|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735318|NCT03893565|536505411|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735319|NCT03893565|536505412|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735320|NCT03893565|536505413|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735321|NCT03893565|536505414|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735322|NCT03893565|536505415|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
148735323|NCT03893565|536505416|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
148735324|NCT03893565|536505408|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735325|NCT03893565|536505409|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735326|NCT03893565|536505410|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735327|NCT03893565|536505411|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735328|NCT03893565|536505412|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735329|NCT03893565|536505413|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735330|NCT03893565|536505414|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735331|NCT03893565|536505415|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
148735332|NCT03893565|536505416|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
148735333|NCT01715571|536505419|FG000|Overall Study|Lost to Follow-up|8|||
148817989|NCT02609633|536808468|FG000|Overall Study|Consent Withdrawn|0|||
148817990|NCT02609633|536808469|FG001|Overall Study|Consent Withdrawn|1|||
148817991|NCT02609633|536808468|FG000|Overall Study|Protocol Deviation|1|||
148817992|NCT02609633|536808469|FG001|Overall Study|Protocol Deviation|0|||
148817993|NCT02609633|536808468|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
148817994|NCT02609633|536808469|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
148817995|NCT02609633|536808468|FG000|Overall Study|Reason not Specified|2|||
148817996|NCT02609633|536808469|FG001|Overall Study|Reason not Specified|1|||
148817997|NCT05762679|536808472|FG000|Overall Study|Withdrawal by Subject|1|||
148817998|NCT05762679|536808472|FG000|Overall Study|No analyzable imaging data|1|||
148817999|NCT03670628|536808473|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
148818000|NCT03670628|536808474|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
148735334|NCT04658095|536505428|FG000|Overall Study|Study terminated|5|||
148735335|NCT04658095|536505429|FG001|Overall Study|Study terminated|1|||
148818001|NCT03670628|536808473|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
148888992|NCT03634085|537072298|FG001|Overall Study|Withdrawal by Subject|2|||
149027091|NCT00372060|537576478|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
148735336|NCT04658095|536505430|FG002|Overall Study|Study terminated|4|||
148735337|NCT05187013|536505431|FG000|Overall Study|Withdrawal by Subject|1|||
148735338|NCT05187013|536505432|FG001|Overall Study|Withdrawal by Subject|1|||
148735339|NCT05187013|536505433|FG002|Overall Study|Withdrawal by Subject|0|||
148735340|NCT05187013|536505431|FG000|Overall Study|Death|0|||
148735341|NCT05187013|536505432|FG001|Overall Study|Death|1|||
148735342|NCT05187013|536505433|FG002|Overall Study|Death|0|||
148735343|NCT05187013|536505431|FG000|Overall Study|Lost to Follow-up|20|||
148735344|NCT05187013|536505432|FG001|Overall Study|Lost to Follow-up|17|||
148735345|NCT05187013|536505433|FG002|Overall Study|Lost to Follow-up|0|||
148735346|NCT05187013|536505431|FG000|Overall Study|Ongoing Participants|3|||
148735347|NCT05187013|536505432|FG001|Overall Study|Ongoing Participants|5|||
148735348|NCT05187013|536505433|FG002|Overall Study|Ongoing Participants|0|||
148735349|NCT02387983|536505434|FG000|Overall Study|Adverse Event|4|||
148735350|NCT02387983|536505434|FG000|Overall Study|Protocol Violation|1|||
148735351|NCT02387983|536505434|FG000|Overall Study|Withdrawal by Subject|2|||
148735352|NCT00077857|536505435|FG000|Overall Study|Adverse Event|30|||
148735353|NCT00077857|536505436|FG001|Overall Study|Adverse Event|32|||
148735354|NCT00077857|536505435|FG000|Overall Study|Death|7|||
148735355|NCT00077857|536505436|FG001|Overall Study|Death|3|||
148735356|NCT00077857|536505435|FG000|Overall Study|Insufficient therapeutic response|112|||
148735357|NCT00077857|536505436|FG001|Overall Study|Insufficient therapeutic response|128|||
148735358|NCT00077857|536505435|FG000|Overall Study|Violation of selection criteria at entry|3|||
148735359|NCT00077857|536505436|FG001|Overall Study|Violation of selection criteria at entry|1|||
148735360|NCT00077857|536505435|FG000|Overall Study|Other protocol violation|0|||
148735361|NCT00077857|536505436|FG001|Overall Study|Other protocol violation|1|||
148735362|NCT00077857|536505435|FG000|Overall Study|Refused treatment|29|||
148735363|NCT00077857|536505436|FG001|Overall Study|Refused treatment|21|||
148735364|NCT00077857|536505435|FG000|Overall Study|Failure to return|5|||
148735365|NCT00077857|536505436|FG001|Overall Study|Failure to return|5|||
148735366|NCT00077857|536505435|FG000|Overall Study|Other|15|||
148735367|NCT00077857|536505436|FG001|Overall Study|Other|13|||
148735368|NCT06187909|536505439|FG000|Overall Study|Withdrawal by Subject|2|||
148735369|NCT06187909|536505440|FG001|Overall Study|Withdrawal by Subject|2|||
148735370|NCT00085423|536505441|FG000|Overall Study|Withdrawal by Subject|1|||
148735371|NCT00085423|536505441|FG000|Overall Study|screen failure|1|||
148735372|NCT04740814|536505442|FG000|Overall Study|Adverse Event|3|||
148735373|NCT04740814|536505442|FG000|Overall Study|Protocol Violation|2|||
148735374|NCT04740814|536505442|FG000|Overall Study|Lost to Follow-up|2|||
148735375|NCT04740814|536505442|FG000|Overall Study|Withdrawal by Subject|3|||
148735376|NCT02440568|536505443|FG000|Overall Study|Death|1|||
148735377|NCT02440568|536505444|FG001|Overall Study|Death|3|||
148735378|NCT02440568|536505445|FG002|Overall Study|Death|4|||
148735379|NCT02440568|536505446|FG003|Overall Study|Death|2|||
148735380|NCT02440568|536505443|FG000|Overall Study|Lack of Efficacy|2|||
148735381|NCT02440568|536505444|FG001|Overall Study|Lack of Efficacy|0|||
148735382|NCT02440568|536505445|FG002|Overall Study|Lack of Efficacy|1|||
148735383|NCT02440568|536505446|FG003|Overall Study|Lack of Efficacy|0|||
148735384|NCT02440568|536505443|FG000|Overall Study|Lost to Follow-up|1|||
148735385|NCT02440568|536505444|FG001|Overall Study|Lost to Follow-up|0|||
148735386|NCT02440568|536505445|FG002|Overall Study|Lost to Follow-up|0|||
148735387|NCT02440568|536505446|FG003|Overall Study|Lost to Follow-up|0|||
148735388|NCT00669071|536505454|FG000|Overall Study|Lost to Follow-up|3|||
148735389|NCT00669071|536505454|FG000|Overall Study|Final visit 40 days out of window|1|||
148735390|NCT04305496|536505455|FG000|Global Cohort|Withdrawal by Subject|13|||
148735391|NCT04305496|536505456|FG001|Global Cohort|Withdrawal by Subject|6|||
148735392|NCT04305496|536505455|FG000|Global Cohort|Physician Decision|1|||
148735393|NCT04305496|536505456|FG001|Global Cohort|Physician Decision|1|||
148735394|NCT04305496|536505455|FG000|Global Cohort|Subjective disease progression|16|||
148735395|NCT04305496|536505456|FG001|Global Cohort|Subjective disease progression|17|||
148735396|NCT04305496|536505455|FG000|Global Cohort|Condition under investigation worsened|209|||
148735397|NCT04305496|536505456|FG001|Global Cohort|Condition under investigation worsened|273|||
148735398|NCT04305496|536505455|FG000|Global Cohort|Protocol Violation|2|||
148735399|NCT04305496|536505456|FG001|Global Cohort|Protocol Violation|0|||
148735400|NCT04305496|536505455|FG000|Global Cohort|Adverse Event|44|||
148735401|NCT04305496|536505456|FG001|Global Cohort|Adverse Event|6|||
148735402|NCT04305496|536505455|FG000|Global Cohort|Death|3|||
148735403|NCT04305496|536505456|FG001|Global Cohort|Death|2|||
148735404|NCT04305496|536505455|FG000|Global Cohort|Any reason not specifically recorded|4|||
148735405|NCT04305496|536505456|FG001|Global Cohort|Any reason not specifically recorded|5|||
148735406|NCT04305496|536505455|FG000|China Cohort|Any reason not specifically recorded|1|||
148735407|NCT04305496|536505456|FG001|China Cohort|Any reason not specifically recorded|1|||
148735408|NCT04305496|536505455|FG000|China Cohort|Adverse Event|8|||
148735409|NCT04305496|536505456|FG001|China Cohort|Adverse Event|2|||
148735410|NCT04305496|536505455|FG000|China Cohort|Condition under investigation worsened|40|||
148735411|NCT04305496|536505456|FG001|China Cohort|Condition under investigation worsened|47|||
148735412|NCT04305496|536505455|FG000|China Cohort|Subjective disease progression|2|||
148735413|NCT04305496|536505456|FG001|China Cohort|Subjective disease progression|2|||
148735414|NCT04305496|536505455|FG000|China Cohort|Withdrawal by Subject|2|||
148735415|NCT04305496|536505456|FG001|China Cohort|Withdrawal by Subject|1|||
148735416|NCT01157897|536505457|FG000|Overall Study|Lost to Follow-up|2|||
148735417|NCT01157897|536505458|FG001|Overall Study|Lost to Follow-up|0|||
148735418|NCT01157897|536505459|FG002|Overall Study|Lost to Follow-up|0|||
148735419|NCT01157897|536505460|FG003|Overall Study|Lost to Follow-up|1|||
148735420|NCT01157897|536505457|FG000|Overall Study|Relocated|0|||
148735421|NCT01157897|536505458|FG001|Overall Study|Relocated|2|||
148735422|NCT01157897|536505459|FG002|Overall Study|Relocated|0|||
148735423|NCT01157897|536505460|FG003|Overall Study|Relocated|0|||
148735424|NCT03276221|536505461|FG000|Overall Study|Lost to Follow-up|6|||
148735425|NCT03276221|536505462|FG001|Overall Study|Lost to Follow-up|2|||
148735426|NCT03276221|536505463|FG002|Overall Study|Lost to Follow-up|0|||
148735427|NCT03276221|536505461|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
148735428|NCT03276221|536505462|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
148735429|NCT03276221|536505463|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
148735430|NCT01791153|536505466|FG000|Part 1: Blinded Period|Adverse Event|7|||
148735431|NCT01791153|536505467|FG001|Part 1: Blinded Period|Adverse Event|3|||
148735432|NCT01791153|536505468|FG002|Part 1: Blinded Period|Adverse Event|2|||
148735433|NCT01791153|536505469|FG003|Part 1: Blinded Period|Adverse Event|0|||
148735434|NCT01791153|536505470|FG004|Part 1: Blinded Period|Adverse Event|0|||
148735435|NCT01791153|536505471|FG005|Part 1: Blinded Period|Adverse Event|0|||
148735436|NCT01791153|536505472|FG006|Part 1: Blinded Period|Adverse Event|0|||
148735437|NCT01791153|536505473|FG007|Part 1: Blinded Period|Adverse Event|0|||
148735438|NCT01791153|536505466|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
148735439|NCT01791153|536505467|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
148735440|NCT01791153|536505468|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
148735441|NCT01791153|536505469|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
148735442|NCT01791153|536505470|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
148735443|NCT01791153|536505471|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
148735444|NCT01791153|536505472|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
148735445|NCT01791153|536505473|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
148735446|NCT01791153|536505466|FG000|Part 1: Blinded Period|Non-Compliance|1|||
148735447|NCT01791153|536505467|FG001|Part 1: Blinded Period|Non-Compliance|0|||
148735448|NCT01791153|536505468|FG002|Part 1: Blinded Period|Non-Compliance|0|||
148735449|NCT01791153|536505469|FG003|Part 1: Blinded Period|Non-Compliance|0|||
148735450|NCT01791153|536505470|FG004|Part 1: Blinded Period|Non-Compliance|0|||
148735451|NCT01791153|536505471|FG005|Part 1: Blinded Period|Non-Compliance|0|||
148735452|NCT01791153|536505472|FG006|Part 1: Blinded Period|Non-Compliance|0|||
148735453|NCT01791153|536505473|FG007|Part 1: Blinded Period|Non-Compliance|0|||
148735454|NCT01791153|536505466|FG000|Part 1: Blinded Period|Physician Decision|0|||
148735455|NCT01791153|536505467|FG001|Part 1: Blinded Period|Physician Decision|0|||
148735456|NCT01791153|536505468|FG002|Part 1: Blinded Period|Physician Decision|0|||
148735457|NCT01791153|536505469|FG003|Part 1: Blinded Period|Physician Decision|1|||
148735458|NCT01791153|536505470|FG004|Part 1: Blinded Period|Physician Decision|0|||
148735459|NCT01791153|536505471|FG005|Part 1: Blinded Period|Physician Decision|0|||
148735460|NCT01791153|536505472|FG006|Part 1: Blinded Period|Physician Decision|0|||
148735461|NCT01791153|536505473|FG007|Part 1: Blinded Period|Physician Decision|0|||
148735462|NCT01791153|536505466|FG000|Part 1: Blinded Period|Protocol Violation|0|||
148735463|NCT01791153|536505467|FG001|Part 1: Blinded Period|Protocol Violation|0|||
148735464|NCT01791153|536505468|FG002|Part 1: Blinded Period|Protocol Violation|0|||
148735465|NCT01791153|536505469|FG003|Part 1: Blinded Period|Protocol Violation|1|||
148735466|NCT01791153|536505470|FG004|Part 1: Blinded Period|Protocol Violation|0|||
148735467|NCT01791153|536505471|FG005|Part 1: Blinded Period|Protocol Violation|0|||
148735468|NCT01791153|536505472|FG006|Part 1: Blinded Period|Protocol Violation|0|||
148735469|NCT01791153|536505473|FG007|Part 1: Blinded Period|Protocol Violation|0|||
148735470|NCT01791153|536505466|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
148735471|NCT01791153|536505467|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
148735472|NCT01791153|536505468|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
148735473|NCT01791153|536505469|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
148735474|NCT01791153|536505470|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
148735475|NCT01791153|536505471|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
148735476|NCT01791153|536505472|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
148735477|NCT01791153|536505473|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
148735478|NCT01791153|536505466|FG000|Part 2: Open-label Period|Adverse Event|0|||
148735479|NCT01791153|536505467|FG001|Part 2: Open-label Period|Adverse Event|0|||
148735480|NCT01791153|536505468|FG002|Part 2: Open-label Period|Adverse Event|0|||
148735481|NCT01791153|536505469|FG003|Part 2: Open-label Period|Adverse Event|0|||
148735482|NCT01791153|536505470|FG004|Part 2: Open-label Period|Adverse Event|0|||
148735483|NCT01791153|536505471|FG005|Part 2: Open-label Period|Adverse Event|1|||
148735484|NCT01791153|536505472|FG006|Part 2: Open-label Period|Adverse Event|1|||
148735485|NCT01791153|536505473|FG007|Part 2: Open-label Period|Adverse Event|2|||
148735486|NCT01791153|536505466|FG000|Part 2: Open-label Period|Death|0|||
148735487|NCT01791153|536505467|FG001|Part 2: Open-label Period|Death|0|||
148735488|NCT01791153|536505468|FG002|Part 2: Open-label Period|Death|0|||
148735489|NCT01791153|536505469|FG003|Part 2: Open-label Period|Death|0|||
148735490|NCT01791153|536505470|FG004|Part 2: Open-label Period|Death|0|||
148735491|NCT01791153|536505471|FG005|Part 2: Open-label Period|Death|1|||
148735492|NCT01791153|536505472|FG006|Part 2: Open-label Period|Death|1|||
148735493|NCT01791153|536505473|FG007|Part 2: Open-label Period|Death|1|||
148735494|NCT01791153|536505466|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
148735495|NCT01791153|536505467|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
148735496|NCT01791153|536505468|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
148735497|NCT01791153|536505469|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
148735498|NCT01791153|536505470|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
148735499|NCT01791153|536505471|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
148735500|NCT01791153|536505472|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
148735501|NCT01791153|536505473|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
148735502|NCT01791153|536505466|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
148735503|NCT01791153|536505467|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
148973862|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973863|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
148973864|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
148973865|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
148973866|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
148973867|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
148973868|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973869|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973870|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973871|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973872|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973873|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973874|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973875|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973876|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973877|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973878|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973879|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973880|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973881|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973882|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973883|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973884|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973885|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973886|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973887|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
148973888|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
148973889|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
148973890|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
148973891|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
148973892|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973893|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973894|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973895|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973896|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973897|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973898|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973899|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973900|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973901|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973902|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973903|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973904|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973905|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973906|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973907|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973908|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973909|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973910|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148973911|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
148735504|NCT01791153|536505468|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
148735505|NCT01791153|536505469|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
148735506|NCT01791153|536505470|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
148735507|NCT01791153|536505471|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
148735508|NCT01791153|536505472|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
148735509|NCT01791153|536505473|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
148735510|NCT01791153|536505466|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
148735511|NCT01791153|536505467|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
148735512|NCT01791153|536505468|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
148735513|NCT01791153|536505469|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
148735514|NCT01791153|536505470|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
148735515|NCT01791153|536505471|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
148735516|NCT01791153|536505472|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
148735517|NCT01791153|536505473|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
148735518|NCT01791153|536505466|FG000|Part 2: Open-label Period|Physician Decision|0|||
148735519|NCT01791153|536505467|FG001|Part 2: Open-label Period|Physician Decision|0|||
148735520|NCT01791153|536505468|FG002|Part 2: Open-label Period|Physician Decision|0|||
148735521|NCT01791153|536505469|FG003|Part 2: Open-label Period|Physician Decision|0|||
148735522|NCT01791153|536505470|FG004|Part 2: Open-label Period|Physician Decision|1|||
148735523|NCT01791153|536505471|FG005|Part 2: Open-label Period|Physician Decision|1|||
148735524|NCT01791153|536505472|FG006|Part 2: Open-label Period|Physician Decision|0|||
148735525|NCT01791153|536505473|FG007|Part 2: Open-label Period|Physician Decision|0|||
148735526|NCT01181271|536505481|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
148735527|NCT01181271|536505481|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
148735528|NCT01181271|536505481|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
148735529|NCT01181271|536505481|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
148735530|NCT01408628|536505482|FG000|Consented|Withdrawal by Subject|12|||
148735531|NCT01408628|536505482|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
148735532|NCT01408628|536505482|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
148735533|NCT01408628|536505482|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
148735534|NCT02980874|536505483|FG000|Overall Study|Adverse Event|2|||
148735535|NCT02980874|536505484|FG001|Overall Study|Adverse Event|7|||
148735536|NCT02980874|536505483|FG000|Overall Study|Withdrawal by Subject|7|||
148735537|NCT02980874|536505484|FG001|Overall Study|Withdrawal by Subject|2|||
148735538|NCT02980874|536505483|FG000|Overall Study|Lost to Follow-up|5|||
148735539|NCT02980874|536505484|FG001|Overall Study|Lost to Follow-up|5|||
148735540|NCT02980874|536505483|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
148735541|NCT02980874|536505484|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
148735542|NCT02980874|536505483|FG000|Overall Study|Unknown study completion status|1|||
148735543|NCT02980874|536505484|FG001|Overall Study|Unknown study completion status|0|||
148735544|NCT02435836|536505485|FG000|Overall Study|Lost to Follow-up|21|||
148735545|NCT02435836|536505485|FG000|Overall Study|Lack of Efficacy|1|||
148735546|NCT02435836|536505485|FG000|Overall Study|Withdrawal by Subject|236|||
148735547|NCT02435836|536505485|FG000|Overall Study|Insufficient Clinical Response|26|||
148735548|NCT02435836|536505485|FG000|Overall Study|Adverse Event|44|||
148735549|NCT02435836|536505485|FG000|Overall Study|Sponsor discontinued trial|167|||
148735550|NCT02435836|536505485|FG000|Overall Study|Noncompliance|27|||
148735551|NCT02435836|536505485|FG000|Overall Study|Protocol Violation|6|||
148735552|NCT02435836|536505485|FG000|Overall Study|Met Withdrawal Criteria|7|||
148735553|NCT02435836|536505485|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
148735554|NCT01121666|536505486|FG000|Overall Study|Protocol Violation|29|||
148735555|NCT01121666|536505487|FG001|Overall Study|Protocol Violation|10|||
148735556|NCT01855074|536505490|FG000|Overall Study|Adverse Event|1|||
148735557|NCT01855074|536505490|FG000|Overall Study|Lost to Follow-up|4|||
148735558|NCT01855074|536505490|FG000|Overall Study|Withdrawal by Subject|8|||
148735559|NCT01855074|536505490|FG000|Overall Study|Started but not treated|1|||
148735560|NCT01629966|536505491|FG000|Overall Study|Pregnancy|0|||
148735561|NCT01629966|536505492|FG001|Overall Study|Pregnancy|1|||
148735562|NCT01629966|536505493|FG002|Overall Study|Pregnancy|0|||
148735563|NCT01629966|536505491|FG000|Overall Study|Lost to Follow-up|10|||
148735564|NCT01629966|536505492|FG001|Overall Study|Lost to Follow-up|13|||
148735565|NCT01629966|536505493|FG002|Overall Study|Lost to Follow-up|9|||
148735566|NCT01629966|536505491|FG000|Overall Study|Withdrawal by Subject|8|||
148735567|NCT01629966|536505492|FG001|Overall Study|Withdrawal by Subject|9|||
148735568|NCT01629966|536505493|FG002|Overall Study|Withdrawal by Subject|16|||
148735569|NCT01629966|536505491|FG000|Overall Study|Protocol Violation|7|||
148735570|NCT01629966|536505492|FG001|Overall Study|Protocol Violation|9|||
148735571|NCT01629966|536505493|FG002|Overall Study|Protocol Violation|7|||
148735572|NCT01629966|536505491|FG000|Overall Study|Lack of Efficacy|5|||
148735573|NCT01629966|536505492|FG001|Overall Study|Lack of Efficacy|2|||
148735574|NCT01629966|536505493|FG002|Overall Study|Lack of Efficacy|4|||
148735575|NCT01629966|536505491|FG000|Overall Study|Adverse Event|11|||
148735576|NCT01629966|536505492|FG001|Overall Study|Adverse Event|18|||
148973912|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973913|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
148973914|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973915|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
148973916|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973917|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973918|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973919|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973920|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973921|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973922|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973923|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973924|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973925|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973926|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973927|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973928|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973929|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973930|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973931|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973932|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973933|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973934|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973935|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
148973936|NCT02346240|537387882|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973937|NCT02346240|537387883|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973938|NCT02346240|537387884|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
148973939|NCT02346240|537387885|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973940|NCT02346240|537387886|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973941|NCT02346240|537387887|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973942|NCT02346240|537387888|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973943|NCT02346240|537387889|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973944|NCT02346240|537387890|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973945|NCT02346240|537387891|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973946|NCT02346240|537387892|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973947|NCT02346240|537387893|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973948|NCT02346240|537387894|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973949|NCT02346240|537387895|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973950|NCT02346240|537387896|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973951|NCT02346240|537387897|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973952|NCT02346240|537387898|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973953|NCT02346240|537387899|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973954|NCT02346240|537387900|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973955|NCT02346240|537387901|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973956|NCT02346240|537387902|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973957|NCT02346240|537387903|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973958|NCT02346240|537387904|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973959|NCT02346240|537387905|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
148973960|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973961|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
149027092|NCT00372060|537576479|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
149027093|NCT00372060|537576478|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
149027094|NCT00372060|537576479|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
149027095|NCT00372060|537576478|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
149027096|NCT00372060|537576479|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
149027097|NCT00372060|537576478|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
149027098|NCT00372060|537576479|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
149027099|NCT01579578|537576491|FG000|Overall Study|Death|4|||
148735577|NCT01629966|536505493|FG002|Overall Study|Adverse Event|30|||
148973962|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973963|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973964|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973965|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973966|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973967|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
148888993|NCT04276233|537072299|FG000|Overall Study|Adverse Event|1|||
148888994|NCT04276233|537072299|FG000|Overall Study|Lost to Follow-up|3|||
148888995|NCT04276233|537072299|FG000|Overall Study|Physician Decision|4|||
148888996|NCT04276233|537072299|FG000|Overall Study|Withdrawal by Subject|2|||
148888997|NCT01946139|537072302|FG000|Overall Study|Withdrawal by Subject|8|||
148888998|NCT01946139|537072302|FG000|Overall Study|ineligible|8|||
148888999|NCT01946139|537072302|FG000|Overall Study|Specimens not available|4|||
148889000|NCT01363700|537072311|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
148889001|NCT01363700|537072312|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
148889002|NCT01363700|537072313|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
148889003|NCT01363700|537072314|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
148889004|NCT01363700|537072315|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
148889005|NCT01454596|537072316|FG000|Overall Study|Death|0|||
148889006|NCT01454596|537072317|FG001|Overall Study|Death|0|||
148889007|NCT01454596|537072318|FG002|Overall Study|Death|0|||
148889008|NCT01454596|537072319|FG003|Overall Study|Death|0|||
148889009|NCT01454596|537072320|FG004|Overall Study|Death|0|||
148889010|NCT01454596|537072321|FG005|Overall Study|Death|0|||
148889011|NCT01454596|537072322|FG006|Overall Study|Death|0|||
148889012|NCT01454596|537072323|FG007|Overall Study|Death|0|||
148889013|NCT01454596|537072324|FG008|Overall Study|Death|0|||
148889014|NCT01454596|537072325|FG009|Overall Study|Death|1|||
148889015|NCT01454596|537072326|FG010|Overall Study|Death|1|||
148889016|NCT01454596|537072327|FG011|Overall Study|Death|0|||
148889017|NCT02721875|537072328|FG000|Overall Study|Progressive disease/relapse|1|||
148889018|NCT02721875|537072329|FG001|Overall Study|Progressive disease/relapse|0|||
148889019|NCT01329978|537072334|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
148889020|NCT01329978|537072335|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
148889021|NCT01329978|537072336|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
148889022|NCT01329978|537072337|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
148889023|NCT01329978|537072338|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
148889024|NCT01329978|537072334|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
148889025|NCT01329978|537072335|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
148889026|NCT01329978|537072336|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
148889027|NCT01329978|537072337|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
148889028|NCT01329978|537072338|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
148889029|NCT01329978|537072334|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
148889030|NCT01329978|537072335|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
148889031|NCT01329978|537072336|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
148889032|NCT01329978|537072337|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
148889033|NCT01329978|537072338|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
148889034|NCT01329978|537072334|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
148889035|NCT01329978|537072335|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
148889036|NCT01329978|537072336|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
148889037|NCT01329978|537072337|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
148889038|NCT01329978|537072338|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
148889039|NCT01329978|537072334|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
148889040|NCT01329978|537072335|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
148889041|NCT01329978|537072336|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
148889042|NCT01329978|537072337|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
148889043|NCT01329978|537072338|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
148889044|NCT01329978|537072334|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
148889045|NCT01329978|537072335|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
148889046|NCT01329978|537072336|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
148889047|NCT01329978|537072337|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
148889048|NCT01329978|537072338|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
148889049|NCT01329978|537072334|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
148889050|NCT01329978|537072335|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
148889051|NCT01329978|537072336|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
148889052|NCT01329978|537072337|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
148889053|NCT01329978|537072338|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
148889054|NCT02800863|537072347|FG000|Overall Study|Adverse Event|14|||
148889055|NCT02800863|537072347|FG000|Overall Study|Another Device Implanted|1|||
148889056|NCT02800863|537072347|FG000|Overall Study|Device Explanted|1|||
148889057|NCT02800863|537072347|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
148889058|NCT02800863|537072347|FG000|Overall Study|Health Issues|1|||
148889059|NCT02800863|537072347|FG000|Overall Study|Insurance Denial|8|||
148889060|NCT02800863|537072347|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
148735578|NCT02991430|536505496|FG000|Treatment Period 1|Adverse Event|1|||
148735579|NCT02991430|536505497|FG001|Treatment Period 1|Adverse Event|0|||
148735580|NCT02991430|536505498|FG002|Treatment Period 1|Adverse Event|2|||
148735581|NCT02991430|536505496|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148735582|NCT02991430|536505497|FG001|Treatment Period 1|Withdrawal by Subject|4|||
148735583|NCT02991430|536505498|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148735584|NCT02991430|536505496|FG000|Treatment Period 2|Study Termination|6|||
148735585|NCT02991430|536505497|FG001|Treatment Period 2|Study Termination|3|||
148735586|NCT02991430|536505498|FG002|Treatment Period 2|Study Termination|3|||
148735587|NCT02991430|536505496|FG000|Treatment Period 2|Lost to Follow-up|0|||
148735588|NCT02991430|536505497|FG001|Treatment Period 2|Lost to Follow-up|0|||
148735589|NCT02991430|536505498|FG002|Treatment Period 2|Lost to Follow-up|1|||
148735590|NCT02991430|536505496|FG000|Post-treatment Observation Period|Study Termination|3|||
148735591|NCT02991430|536505497|FG001|Post-treatment Observation Period|Study Termination|6|||
148735592|NCT02991430|536505498|FG002|Post-treatment Observation Period|Study Termination|5|||
148735593|NCT01150890|536505499|FG000|Overall Study|Other|0|||
148735594|NCT01150890|536505500|FG001|Overall Study|Other|1|||
148735595|NCT01150890|536505501|FG002|Overall Study|Other|0|||
148735596|NCT01150890|536505502|FG003|Overall Study|Other|2|||
148735597|NCT01150890|536505499|FG000|Overall Study|Pregnancy|0|||
148735598|NCT01150890|536505500|FG001|Overall Study|Pregnancy|0|||
148735599|NCT01150890|536505501|FG002|Overall Study|Pregnancy|0|||
148735600|NCT01150890|536505502|FG003|Overall Study|Pregnancy|1|||
148735601|NCT01150890|536505499|FG000|Overall Study|Administrative Decision|4|||
148735602|NCT01150890|536505500|FG001|Overall Study|Administrative Decision|4|||
148735603|NCT01150890|536505501|FG002|Overall Study|Administrative Decision|5|||
148735604|NCT01150890|536505502|FG003|Overall Study|Administrative Decision|6|||
148735605|NCT01150890|536505499|FG000|Overall Study|Ineligibility determined|0|||
148735606|NCT01150890|536505500|FG001|Overall Study|Ineligibility determined|1|||
148735607|NCT01150890|536505501|FG002|Overall Study|Ineligibility determined|0|||
148735608|NCT01150890|536505502|FG003|Overall Study|Ineligibility determined|0|||
148735609|NCT01150890|536505499|FG000|Overall Study|Adverse Event|0|||
148735610|NCT01150890|536505500|FG001|Overall Study|Adverse Event|0|||
148735611|NCT01150890|536505501|FG002|Overall Study|Adverse Event|2|||
148735612|NCT01150890|536505502|FG003|Overall Study|Adverse Event|0|||
148735613|NCT01150890|536505499|FG000|Overall Study|Withdrawal by Subject|0|||
148735614|NCT01150890|536505500|FG001|Overall Study|Withdrawal by Subject|0|||
148735615|NCT01150890|536505501|FG002|Overall Study|Withdrawal by Subject|2|||
148735616|NCT01150890|536505502|FG003|Overall Study|Withdrawal by Subject|1|||
148735617|NCT01150890|536505499|FG000|Overall Study|Disease progression|0|||
148735618|NCT01150890|536505500|FG001|Overall Study|Disease progression|7|||
148735619|NCT01150890|536505501|FG002|Overall Study|Disease progression|3|||
148735620|NCT01150890|536505502|FG003|Overall Study|Disease progression|7|||
148735621|NCT03970837|536505503|FG000|Overall Study|Adverse Event|23|||
148735622|NCT03970837|536505504|FG001|Overall Study|Adverse Event|20|||
148735623|NCT03970837|536505505|FG002|Overall Study|Adverse Event|16|||
148735624|NCT03970837|536505506|FG003|Overall Study|Adverse Event|6|||
148735625|NCT03970837|536505507|FG004|Overall Study|Adverse Event|4|||
148735626|NCT03970837|536505508|FG005|Overall Study|Adverse Event|5|||
148973968|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
148973969|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973970|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973971|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973972|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148735627|NCT03970837|536505509|FG006|Overall Study|Adverse Event|1|||
148735628|NCT03970837|536505510|FG007|Overall Study|Adverse Event|5|||
148735629|NCT03970837|536505511|FG008|Overall Study|Adverse Event|0|||
148735630|NCT03970837|536505512|FG009|Overall Study|Adverse Event|0|||
148735631|NCT03970837|536505513|FG010|Overall Study|Adverse Event|1|||
148735632|NCT03970837|536505514|FG011|Overall Study|Adverse Event|1|||
148818002|NCT03670628|536808474|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
148818003|NCT00997126|536808475|FG000|Overall Study|Physician Decision|7|||
148818004|NCT00997126|536808476|FG001|Overall Study|Physician Decision|11|||
148973973|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
148973974|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
148735633|NCT03970837|536505503|FG000|Overall Study|Lack of Efficacy|14|||
148735634|NCT03970837|536505504|FG001|Overall Study|Lack of Efficacy|12|||
148735635|NCT03970837|536505505|FG002|Overall Study|Lack of Efficacy|1|||
148735636|NCT03970837|536505506|FG003|Overall Study|Lack of Efficacy|2|||
148735637|NCT03970837|536505507|FG004|Overall Study|Lack of Efficacy|3|||
148735638|NCT03970837|536505508|FG005|Overall Study|Lack of Efficacy|4|||
148818005|NCT06042855|536808481|FG000|Overall Study|No Receipt of Study Drug|48|||
148735639|NCT03970837|536505509|FG006|Overall Study|Lack of Efficacy|6|||
148735640|NCT03970837|536505510|FG007|Overall Study|Lack of Efficacy|1|||
148735641|NCT03970837|536505511|FG008|Overall Study|Lack of Efficacy|1|||
148735642|NCT03970837|536505512|FG009|Overall Study|Lack of Efficacy|0|||
148735643|NCT03970837|536505513|FG010|Overall Study|Lack of Efficacy|0|||
148973975|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
148973976|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
148973977|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973978|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973979|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973980|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973981|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973982|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973983|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148973984|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973985|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973986|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973987|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973988|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973989|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973990|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973991|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973992|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973993|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973994|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973995|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973996|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973997|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
148973998|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148973999|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
148974000|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974001|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974002|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974003|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974004|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974005|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974006|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974007|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
148974008|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974009|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974010|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974011|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974012|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974013|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974014|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974015|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974016|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974017|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974018|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974019|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974020|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
149027100|NCT01579578|537576492|FG001|Overall Study|Death|1|||
149027101|NCT01579578|537576491|FG000|Overall Study|Lost to Follow-up|1|||
149027102|NCT01579578|537576492|FG001|Overall Study|Lost to Follow-up|1|||
149027103|NCT01579578|537576491|FG000|Overall Study|Withdrawal by Subject|2|||
148735644|NCT03970837|536505514|FG011|Overall Study|Lack of Efficacy|0|||
148735645|NCT03970837|536505503|FG000|Overall Study|Lost to Follow-up|6|||
148735646|NCT03970837|536505504|FG001|Overall Study|Lost to Follow-up|5|||
148735647|NCT03970837|536505505|FG002|Overall Study|Lost to Follow-up|5|||
148735648|NCT03970837|536505506|FG003|Overall Study|Lost to Follow-up|1|||
148735649|NCT03970837|536505507|FG004|Overall Study|Lost to Follow-up|0|||
148735650|NCT03970837|536505508|FG005|Overall Study|Lost to Follow-up|2|||
148735651|NCT03970837|536505509|FG006|Overall Study|Lost to Follow-up|0|||
148735652|NCT03970837|536505510|FG007|Overall Study|Lost to Follow-up|0|||
148735653|NCT03970837|536505511|FG008|Overall Study|Lost to Follow-up|0|||
148735654|NCT03970837|536505512|FG009|Overall Study|Lost to Follow-up|0|||
148735655|NCT03970837|536505513|FG010|Overall Study|Lost to Follow-up|0|||
148735656|NCT03970837|536505514|FG011|Overall Study|Lost to Follow-up|0|||
148818006|NCT06042855|536808482|FG001|Overall Study|No Receipt of Study Drug|57|||
148735657|NCT03970837|536505503|FG000|Overall Study|Protocol Violation|1|||
148735658|NCT03970837|536505504|FG001|Overall Study|Protocol Violation|0|||
148735659|NCT03970837|536505505|FG002|Overall Study|Protocol Violation|0|||
148735660|NCT03970837|536505506|FG003|Overall Study|Protocol Violation|0|||
148818007|NCT06042855|536808481|FG000|Overall Study|Administratively Withdrawn|59|||
148735661|NCT03970837|536505507|FG004|Overall Study|Protocol Violation|0|||
148735662|NCT03970837|536505508|FG005|Overall Study|Protocol Violation|0|||
148735663|NCT03970837|536505509|FG006|Overall Study|Protocol Violation|0|||
148735664|NCT03970837|536505510|FG007|Overall Study|Protocol Violation|0|||
148735665|NCT03970837|536505511|FG008|Overall Study|Protocol Violation|0|||
148735666|NCT03970837|536505512|FG009|Overall Study|Protocol Violation|0|||
148735667|NCT03970837|536505513|FG010|Overall Study|Protocol Violation|0|||
148735668|NCT03970837|536505514|FG011|Overall Study|Protocol Violation|0|||
148735669|NCT03970837|536505503|FG000|Overall Study|Physician Decision|5|||
148735670|NCT03970837|536505504|FG001|Overall Study|Physician Decision|8|||
148735671|NCT03970837|536505505|FG002|Overall Study|Physician Decision|4|||
148735672|NCT03970837|536505506|FG003|Overall Study|Physician Decision|1|||
148735673|NCT03970837|536505507|FG004|Overall Study|Physician Decision|5|||
148735674|NCT03970837|536505508|FG005|Overall Study|Physician Decision|2|||
148735675|NCT03970837|536505509|FG006|Overall Study|Physician Decision|4|||
148735676|NCT03970837|536505510|FG007|Overall Study|Physician Decision|5|||
148735677|NCT03970837|536505511|FG008|Overall Study|Physician Decision|0|||
148735678|NCT03970837|536505512|FG009|Overall Study|Physician Decision|1|||
148735679|NCT03970837|536505513|FG010|Overall Study|Physician Decision|0|||
148735680|NCT03970837|536505514|FG011|Overall Study|Physician Decision|0|||
148735681|NCT03970837|536505503|FG000|Overall Study|Withdrawal by Subject|32|||
148735682|NCT03970837|536505504|FG001|Overall Study|Withdrawal by Subject|35|||
148735683|NCT03970837|536505505|FG002|Overall Study|Withdrawal by Subject|12|||
148735684|NCT03970837|536505506|FG003|Overall Study|Withdrawal by Subject|8|||
148735685|NCT03970837|536505507|FG004|Overall Study|Withdrawal by Subject|6|||
148735686|NCT03970837|536505508|FG005|Overall Study|Withdrawal by Subject|8|||
148735687|NCT03970837|536505509|FG006|Overall Study|Withdrawal by Subject|2|||
148735688|NCT03970837|536505510|FG007|Overall Study|Withdrawal by Subject|3|||
148735689|NCT03970837|536505511|FG008|Overall Study|Withdrawal by Subject|0|||
148735690|NCT03970837|536505512|FG009|Overall Study|Withdrawal by Subject|0|||
148735691|NCT03970837|536505513|FG010|Overall Study|Withdrawal by Subject|0|||
148735692|NCT03970837|536505514|FG011|Overall Study|Withdrawal by Subject|1|||
148735693|NCT03970837|536505503|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
148735694|NCT03970837|536505504|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
148735695|NCT03970837|536505505|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
148735696|NCT03970837|536505506|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
148735697|NCT03970837|536505507|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
148735698|NCT03970837|536505508|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148735699|NCT03970837|536505509|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148735700|NCT03970837|536505510|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148735701|NCT03970837|536505511|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
148735702|NCT03970837|536505512|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
148735703|NCT03970837|536505513|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
148735704|NCT03970837|536505514|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
148735705|NCT03970837|536505503|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148735706|NCT03970837|536505504|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148735707|NCT03970837|536505505|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148735708|NCT03970837|536505506|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148735709|NCT03970837|536505507|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148735710|NCT03970837|536505508|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148735711|NCT03970837|536505509|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
148735712|NCT03970837|536505510|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
148735713|NCT03970837|536505511|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
148735714|NCT03970837|536505512|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
148735715|NCT03970837|536505513|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
148735716|NCT03970837|536505514|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
148735717|NCT02132754|536505515|FG000|Overall Study|Adverse Event|0|||
148735718|NCT02132754|536505516|FG001|Overall Study|Adverse Event|0|||
148735719|NCT02132754|536505517|FG002|Overall Study|Adverse Event|0|||
148735720|NCT02132754|536505518|FG003|Overall Study|Adverse Event|0|||
148735721|NCT02132754|536505519|FG004|Overall Study|Adverse Event|0|||
148735722|NCT02132754|536505520|FG005|Overall Study|Adverse Event|0|||
148735723|NCT02132754|536505521|FG006|Overall Study|Adverse Event|0|||
148974021|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974022|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
148974023|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148735724|NCT02132754|536505522|FG007|Overall Study|Adverse Event|0|||
148735725|NCT02132754|536505523|FG008|Overall Study|Adverse Event|0|||
148735726|NCT02132754|536505524|FG009|Overall Study|Adverse Event|0|||
148735727|NCT02132754|536505525|FG010|Overall Study|Adverse Event|0|||
148735728|NCT02132754|536505526|FG011|Overall Study|Adverse Event|0|||
148735729|NCT02132754|536505527|FG012|Overall Study|Adverse Event|0|||
148735730|NCT02132754|536505528|FG013|Overall Study|Adverse Event|0|||
148735731|NCT02132754|536505529|FG014|Overall Study|Adverse Event|0|||
148735732|NCT02132754|536505530|FG015|Overall Study|Adverse Event|0|||
148735733|NCT02132754|536505531|FG016|Overall Study|Adverse Event|0|||
148735734|NCT02132754|536505532|FG017|Overall Study|Adverse Event|1|||
148735735|NCT02132754|536505533|FG018|Overall Study|Adverse Event|0|||
148735736|NCT02132754|536505534|FG019|Overall Study|Adverse Event|0|||
148735737|NCT02132754|536505535|FG020|Overall Study|Adverse Event|0|||
148974024|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974025|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974026|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974027|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974028|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974029|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974030|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974031|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148974032|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974033|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974034|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974035|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974036|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974037|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148974038|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148974039|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148974040|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148974041|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974042|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148974043|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
148974044|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974045|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
148974046|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
148974047|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
148974048|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148974049|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974050|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974051|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974052|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974053|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974054|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974055|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148974056|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974057|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974058|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974059|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974060|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974061|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974062|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974063|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974064|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974065|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974066|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974067|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974068|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974069|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
148974070|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
148974071|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
148974072|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
148974073|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974074|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974075|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974076|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974077|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974078|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974079|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
148974080|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974081|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148735738|NCT02132754|536505536|FG021|Overall Study|Adverse Event|0|||
148818008|NCT06042855|536808482|FG001|Overall Study|Administratively Withdrawn|59|||
148735739|NCT02132754|536505537|FG022|Overall Study|Adverse Event|0|||
148735740|NCT02132754|536505538|FG023|Overall Study|Adverse Event|0|||
148735741|NCT02132754|536505539|FG024|Overall Study|Adverse Event|0|||
148735742|NCT02132754|536505540|FG025|Overall Study|Adverse Event|1|||
148735743|NCT02132754|536505541|FG026|Overall Study|Adverse Event|1|||
148735744|NCT02132754|536505542|FG027|Overall Study|Adverse Event|0|||
148735745|NCT02132754|536505543|FG028|Overall Study|Adverse Event|0|||
148735746|NCT02132754|536505544|FG029|Overall Study|Adverse Event|0|||
148735747|NCT02132754|536505545|FG030|Overall Study|Adverse Event|1|||
148735748|NCT02132754|536505546|FG031|Overall Study|Adverse Event|0|||
148735749|NCT02132754|536505547|FG032|Overall Study|Adverse Event|1|||
148735750|NCT02132754|536505548|FG033|Overall Study|Adverse Event|1|||
148735751|NCT02132754|536505515|FG000|Overall Study|Clinical Progression|0|||
148735752|NCT02132754|536505516|FG001|Overall Study|Clinical Progression|0|||
148735753|NCT02132754|536505517|FG002|Overall Study|Clinical Progression|0|||
148735754|NCT02132754|536505518|FG003|Overall Study|Clinical Progression|0|||
148735755|NCT02132754|536505519|FG004|Overall Study|Clinical Progression|0|||
148735756|NCT02132754|536505520|FG005|Overall Study|Clinical Progression|0|||
148735757|NCT02132754|536505521|FG006|Overall Study|Clinical Progression|0|||
148735758|NCT02132754|536505522|FG007|Overall Study|Clinical Progression|0|||
148735759|NCT02132754|536505523|FG008|Overall Study|Clinical Progression|0|||
148735760|NCT02132754|536505524|FG009|Overall Study|Clinical Progression|1|||
148735761|NCT02132754|536505525|FG010|Overall Study|Clinical Progression|0|||
148735762|NCT02132754|536505526|FG011|Overall Study|Clinical Progression|0|||
148735763|NCT02132754|536505527|FG012|Overall Study|Clinical Progression|0|||
148735764|NCT02132754|536505528|FG013|Overall Study|Clinical Progression|0|||
148735765|NCT02132754|536505529|FG014|Overall Study|Clinical Progression|0|||
148735766|NCT02132754|536505530|FG015|Overall Study|Clinical Progression|0|||
148735767|NCT02132754|536505531|FG016|Overall Study|Clinical Progression|1|||
148735768|NCT02132754|536505532|FG017|Overall Study|Clinical Progression|1|||
148818009|NCT01428128|536808487|FG000|Overall Study|Withdrawal by Subject|4|||
148818010|NCT01428128|536808487|FG000|Overall Study|Screen failure by p53|10|||
148818011|NCT01428128|536808487|FG000|Overall Study|Received Neulasta in one cycle|2|||
148735769|NCT02132754|536505533|FG018|Overall Study|Clinical Progression|0|||
148735770|NCT02132754|536505534|FG019|Overall Study|Clinical Progression|1|||
148735771|NCT02132754|536505535|FG020|Overall Study|Clinical Progression|0|||
148818012|NCT01428128|536808487|FG000|Overall Study|Adverse Event|1|||
148818013|NCT05259033|536808496|FG000|Overall Study|Withdrawal by Subject|10|||
148818014|NCT05259033|536808497|FG001|Overall Study|Withdrawal by Subject|5|||
148974082|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974083|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974084|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974085|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974086|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
148974087|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974088|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974089|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974090|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974091|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974092|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974093|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974094|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974095|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974096|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974097|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974098|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974099|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974100|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974101|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974102|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974103|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
148974104|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974105|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974106|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974107|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974108|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974109|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148735772|NCT02132754|536505536|FG021|Overall Study|Clinical Progression|0|||
148735773|NCT02132754|536505537|FG022|Overall Study|Clinical Progression|1|||
148735774|NCT02132754|536505538|FG023|Overall Study|Clinical Progression|0|||
148735775|NCT02132754|536505539|FG024|Overall Study|Clinical Progression|1|||
148735776|NCT02132754|536505540|FG025|Overall Study|Clinical Progression|1|||
148735777|NCT02132754|536505541|FG026|Overall Study|Clinical Progression|0|||
148735778|NCT02132754|536505542|FG027|Overall Study|Clinical Progression|1|||
148735779|NCT02132754|536505543|FG028|Overall Study|Clinical Progression|1|||
148735780|NCT02132754|536505544|FG029|Overall Study|Clinical Progression|0|||
148735781|NCT02132754|536505545|FG030|Overall Study|Clinical Progression|1|||
148735782|NCT02132754|536505546|FG031|Overall Study|Clinical Progression|0|||
148735783|NCT02132754|536505547|FG032|Overall Study|Clinical Progression|0|||
148735784|NCT02132754|536505548|FG033|Overall Study|Clinical Progression|2|||
148735785|NCT02132754|536505515|FG000|Overall Study|Death|0|||
148735786|NCT02132754|536505516|FG001|Overall Study|Death|0|||
148735787|NCT02132754|536505517|FG002|Overall Study|Death|0|||
148735788|NCT02132754|536505518|FG003|Overall Study|Death|0|||
148735789|NCT02132754|536505519|FG004|Overall Study|Death|0|||
148735790|NCT02132754|536505520|FG005|Overall Study|Death|0|||
148735791|NCT02132754|536505521|FG006|Overall Study|Death|0|||
148735792|NCT02132754|536505522|FG007|Overall Study|Death|0|||
148735793|NCT02132754|536505523|FG008|Overall Study|Death|0|||
148735794|NCT02132754|536505524|FG009|Overall Study|Death|0|||
148735795|NCT02132754|536505525|FG010|Overall Study|Death|0|||
148735796|NCT02132754|536505526|FG011|Overall Study|Death|0|||
148735797|NCT02132754|536505527|FG012|Overall Study|Death|0|||
148735798|NCT02132754|536505528|FG013|Overall Study|Death|0|||
148735799|NCT02132754|536505529|FG014|Overall Study|Death|0|||
148735800|NCT02132754|536505530|FG015|Overall Study|Death|1|||
148735801|NCT02132754|536505531|FG016|Overall Study|Death|0|||
148735802|NCT02132754|536505532|FG017|Overall Study|Death|0|||
148735803|NCT02132754|536505533|FG018|Overall Study|Death|0|||
148735804|NCT02132754|536505534|FG019|Overall Study|Death|1|||
148735805|NCT02132754|536505535|FG020|Overall Study|Death|0|||
148735806|NCT02132754|536505536|FG021|Overall Study|Death|1|||
148735807|NCT02132754|536505537|FG022|Overall Study|Death|0|||
148735808|NCT02132754|536505538|FG023|Overall Study|Death|0|||
148735809|NCT02132754|536505539|FG024|Overall Study|Death|0|||
148735810|NCT02132754|536505540|FG025|Overall Study|Death|0|||
148735811|NCT02132754|536505541|FG026|Overall Study|Death|1|||
148735812|NCT02132754|536505542|FG027|Overall Study|Death|0|||
148735813|NCT02132754|536505543|FG028|Overall Study|Death|0|||
148735814|NCT02132754|536505544|FG029|Overall Study|Death|0|||
148735815|NCT02132754|536505545|FG030|Overall Study|Death|0|||
148735816|NCT02132754|536505546|FG031|Overall Study|Death|0|||
148974110|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974111|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974112|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
148974113|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974114|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974115|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
148974116|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974117|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
148974118|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
148974119|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974120|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974121|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974122|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974123|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974124|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974125|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148735817|NCT02132754|536505547|FG032|Overall Study|Death|0|||
148735818|NCT02132754|536505548|FG033|Overall Study|Death|2|||
148735819|NCT02132754|536505515|FG000|Overall Study|Excluded Medication|0|||
148735820|NCT02132754|536505516|FG001|Overall Study|Excluded Medication|0|||
148735821|NCT02132754|536505517|FG002|Overall Study|Excluded Medication|0|||
148735822|NCT02132754|536505518|FG003|Overall Study|Excluded Medication|0|||
148735823|NCT02132754|536505519|FG004|Overall Study|Excluded Medication|0|||
148735824|NCT02132754|536505520|FG005|Overall Study|Excluded Medication|0|||
148735825|NCT02132754|536505521|FG006|Overall Study|Excluded Medication|0|||
148735826|NCT02132754|536505522|FG007|Overall Study|Excluded Medication|0|||
148735827|NCT02132754|536505523|FG008|Overall Study|Excluded Medication|0|||
148735828|NCT02132754|536505524|FG009|Overall Study|Excluded Medication|0|||
148735829|NCT02132754|536505525|FG010|Overall Study|Excluded Medication|0|||
148735830|NCT02132754|536505526|FG011|Overall Study|Excluded Medication|0|||
148735831|NCT02132754|536505527|FG012|Overall Study|Excluded Medication|0|||
148735832|NCT02132754|536505528|FG013|Overall Study|Excluded Medication|0|||
148735833|NCT02132754|536505529|FG014|Overall Study|Excluded Medication|0|||
148735834|NCT02132754|536505530|FG015|Overall Study|Excluded Medication|0|||
148735835|NCT02132754|536505531|FG016|Overall Study|Excluded Medication|0|||
148735836|NCT02132754|536505532|FG017|Overall Study|Excluded Medication|0|||
148735837|NCT02132754|536505533|FG018|Overall Study|Excluded Medication|0|||
148735838|NCT02132754|536505534|FG019|Overall Study|Excluded Medication|0|||
148735839|NCT02132754|536505535|FG020|Overall Study|Excluded Medication|1|||
148735840|NCT02132754|536505536|FG021|Overall Study|Excluded Medication|0|||
148735841|NCT02132754|536505537|FG022|Overall Study|Excluded Medication|0|||
148735842|NCT02132754|536505538|FG023|Overall Study|Excluded Medication|0|||
148735843|NCT02132754|536505539|FG024|Overall Study|Excluded Medication|0|||
148735844|NCT02132754|536505540|FG025|Overall Study|Excluded Medication|0|||
148735845|NCT02132754|536505541|FG026|Overall Study|Excluded Medication|0|||
148735846|NCT02132754|536505542|FG027|Overall Study|Excluded Medication|0|||
148735847|NCT02132754|536505543|FG028|Overall Study|Excluded Medication|0|||
148735848|NCT02132754|536505544|FG029|Overall Study|Excluded Medication|0|||
148735849|NCT02132754|536505545|FG030|Overall Study|Excluded Medication|0|||
148735850|NCT02132754|536505546|FG031|Overall Study|Excluded Medication|0|||
148735851|NCT02132754|536505547|FG032|Overall Study|Excluded Medication|0|||
148735852|NCT02132754|536505548|FG033|Overall Study|Excluded Medication|1|||
148735853|NCT02132754|536505515|FG000|Overall Study|Physician Decision|0|||
148735854|NCT02132754|536505516|FG001|Overall Study|Physician Decision|0|||
148735855|NCT02132754|536505517|FG002|Overall Study|Physician Decision|0|||
148735856|NCT02132754|536505518|FG003|Overall Study|Physician Decision|0|||
148735857|NCT02132754|536505519|FG004|Overall Study|Physician Decision|0|||
148735858|NCT02132754|536505520|FG005|Overall Study|Physician Decision|0|||
148735859|NCT02132754|536505521|FG006|Overall Study|Physician Decision|0|||
148735860|NCT02132754|536505522|FG007|Overall Study|Physician Decision|0|||
148735861|NCT02132754|536505523|FG008|Overall Study|Physician Decision|0|||
148735862|NCT02132754|536505524|FG009|Overall Study|Physician Decision|1|||
148735863|NCT02132754|536505525|FG010|Overall Study|Physician Decision|0|||
148735864|NCT02132754|536505526|FG011|Overall Study|Physician Decision|1|||
148735865|NCT02132754|536505527|FG012|Overall Study|Physician Decision|1|||
148735866|NCT02132754|536505528|FG013|Overall Study|Physician Decision|0|||
148735867|NCT02132754|536505529|FG014|Overall Study|Physician Decision|0|||
148735868|NCT02132754|536505530|FG015|Overall Study|Physician Decision|1|||
148735869|NCT02132754|536505531|FG016|Overall Study|Physician Decision|0|||
148735870|NCT02132754|536505532|FG017|Overall Study|Physician Decision|0|||
148735871|NCT02132754|536505533|FG018|Overall Study|Physician Decision|0|||
148735872|NCT02132754|536505534|FG019|Overall Study|Physician Decision|0|||
148735873|NCT02132754|536505535|FG020|Overall Study|Physician Decision|0|||
148735874|NCT02132754|536505536|FG021|Overall Study|Physician Decision|0|||
148735875|NCT02132754|536505537|FG022|Overall Study|Physician Decision|0|||
148735876|NCT02132754|536505538|FG023|Overall Study|Physician Decision|0|||
148735877|NCT02132754|536505539|FG024|Overall Study|Physician Decision|1|||
148735878|NCT02132754|536505540|FG025|Overall Study|Physician Decision|0|||
148735879|NCT02132754|536505541|FG026|Overall Study|Physician Decision|0|||
148735880|NCT02132754|536505542|FG027|Overall Study|Physician Decision|0|||
148735881|NCT02132754|536505543|FG028|Overall Study|Physician Decision|0|||
148735882|NCT02132754|536505544|FG029|Overall Study|Physician Decision|0|||
148735883|NCT02132754|536505545|FG030|Overall Study|Physician Decision|0|||
148735884|NCT02132754|536505546|FG031|Overall Study|Physician Decision|1|||
148735885|NCT02132754|536505547|FG032|Overall Study|Physician Decision|0|||
148735886|NCT02132754|536505548|FG033|Overall Study|Physician Decision|3|||
148735887|NCT02132754|536505515|FG000|Overall Study|Progressive Disease|1|||
148735888|NCT02132754|536505516|FG001|Overall Study|Progressive Disease|1|||
148735889|NCT02132754|536505517|FG002|Overall Study|Progressive Disease|1|||
148735890|NCT02132754|536505518|FG003|Overall Study|Progressive Disease|1|||
148735891|NCT02132754|536505519|FG004|Overall Study|Progressive Disease|1|||
148735892|NCT02132754|536505520|FG005|Overall Study|Progressive Disease|1|||
148735893|NCT02132754|536505521|FG006|Overall Study|Progressive Disease|1|||
148735894|NCT02132754|536505522|FG007|Overall Study|Progressive Disease|1|||
148735895|NCT02132754|536505523|FG008|Overall Study|Progressive Disease|1|||
148735896|NCT02132754|536505524|FG009|Overall Study|Progressive Disease|3|||
148735897|NCT02132754|536505525|FG010|Overall Study|Progressive Disease|3|||
148735898|NCT02132754|536505526|FG011|Overall Study|Progressive Disease|2|||
148735899|NCT02132754|536505527|FG012|Overall Study|Progressive Disease|2|||
148735900|NCT02132754|536505528|FG013|Overall Study|Progressive Disease|3|||
148735901|NCT02132754|536505529|FG014|Overall Study|Progressive Disease|2|||
148735902|NCT02132754|536505530|FG015|Overall Study|Progressive Disease|1|||
148735903|NCT02132754|536505531|FG016|Overall Study|Progressive Disease|2|||
148735904|NCT02132754|536505532|FG017|Overall Study|Progressive Disease|1|||
148735905|NCT02132754|536505533|FG018|Overall Study|Progressive Disease|3|||
148735906|NCT02132754|536505534|FG019|Overall Study|Progressive Disease|1|||
148735907|NCT02132754|536505535|FG020|Overall Study|Progressive Disease|1|||
148735908|NCT02132754|536505536|FG021|Overall Study|Progressive Disease|3|||
148735909|NCT02132754|536505537|FG022|Overall Study|Progressive Disease|2|||
148735910|NCT02132754|536505538|FG023|Overall Study|Progressive Disease|3|||
148735911|NCT02132754|536505539|FG024|Overall Study|Progressive Disease|0|||
148735912|NCT02132754|536505540|FG025|Overall Study|Progressive Disease|1|||
148735913|NCT02132754|536505541|FG026|Overall Study|Progressive Disease|2|||
148735914|NCT02132754|536505542|FG027|Overall Study|Progressive Disease|1|||
148735915|NCT02132754|536505543|FG028|Overall Study|Progressive Disease|2|||
148735916|NCT02132754|536505544|FG029|Overall Study|Progressive Disease|3|||
148735917|NCT02132754|536505545|FG030|Overall Study|Progressive Disease|1|||
148735918|NCT02132754|536505546|FG031|Overall Study|Progressive Disease|1|||
148735919|NCT02132754|536505547|FG032|Overall Study|Progressive Disease|3|||
148735920|NCT02132754|536505548|FG033|Overall Study|Progressive Disease|6|||
148735921|NCT02132754|536505515|FG000|Overall Study|Screen Failure|0|||
148735922|NCT02132754|536505516|FG001|Overall Study|Screen Failure|0|||
148735923|NCT02132754|536505517|FG002|Overall Study|Screen Failure|0|||
148735924|NCT02132754|536505518|FG003|Overall Study|Screen Failure|0|||
148735925|NCT02132754|536505519|FG004|Overall Study|Screen Failure|0|||
148735926|NCT02132754|536505520|FG005|Overall Study|Screen Failure|0|||
148735927|NCT02132754|536505521|FG006|Overall Study|Screen Failure|0|||
148735928|NCT02132754|536505522|FG007|Overall Study|Screen Failure|0|||
148735929|NCT02132754|536505523|FG008|Overall Study|Screen Failure|0|||
148735930|NCT02132754|536505524|FG009|Overall Study|Screen Failure|0|||
148735931|NCT02132754|536505525|FG010|Overall Study|Screen Failure|0|||
148735932|NCT02132754|536505526|FG011|Overall Study|Screen Failure|0|||
148735933|NCT02132754|536505527|FG012|Overall Study|Screen Failure|0|||
148735934|NCT02132754|536505528|FG013|Overall Study|Screen Failure|0|||
148735935|NCT02132754|536505529|FG014|Overall Study|Screen Failure|0|||
148735936|NCT02132754|536505530|FG015|Overall Study|Screen Failure|0|||
148735937|NCT02132754|536505531|FG016|Overall Study|Screen Failure|0|||
148735938|NCT02132754|536505532|FG017|Overall Study|Screen Failure|0|||
148735939|NCT02132754|536505533|FG018|Overall Study|Screen Failure|0|||
148974126|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974127|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
148974128|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974129|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974130|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974131|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974132|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974133|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974134|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974135|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974136|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974137|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
148974138|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974139|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974140|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974141|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974142|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974143|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974144|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974145|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974146|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974147|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974148|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974149|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974150|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974151|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
148974152|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974153|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974154|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974155|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974156|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974157|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148735940|NCT02132754|536505534|FG019|Overall Study|Screen Failure|1|||
148735941|NCT02132754|536505535|FG020|Overall Study|Screen Failure|0|||
148735942|NCT02132754|536505536|FG021|Overall Study|Screen Failure|1|||
148735943|NCT02132754|536505537|FG022|Overall Study|Screen Failure|0|||
148735944|NCT02132754|536505538|FG023|Overall Study|Screen Failure|0|||
148735945|NCT02132754|536505539|FG024|Overall Study|Screen Failure|0|||
148735946|NCT02132754|536505540|FG025|Overall Study|Screen Failure|0|||
148974158|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974159|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974160|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974161|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974162|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
148974163|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974164|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974165|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974166|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974167|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974168|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974169|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974170|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974171|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974172|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974173|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974174|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974175|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
148974176|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974177|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974178|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974179|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974180|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974181|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974182|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974183|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974184|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974185|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974186|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974187|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974188|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974189|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974190|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
148974191|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974192|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974193|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974194|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974195|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974196|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974197|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974198|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974199|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
148974200|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974201|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974202|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974203|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974204|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974205|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974206|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974207|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974208|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974209|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974210|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974211|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974212|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974213|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974214|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
148974215|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148735947|NCT02132754|536505541|FG026|Overall Study|Screen Failure|0|||
148735948|NCT02132754|536505542|FG027|Overall Study|Screen Failure|0|||
148735949|NCT02132754|536505543|FG028|Overall Study|Screen Failure|0|||
148735950|NCT02132754|536505544|FG029|Overall Study|Screen Failure|0|||
148735951|NCT02132754|536505545|FG030|Overall Study|Screen Failure|0|||
148735952|NCT02132754|536505546|FG031|Overall Study|Screen Failure|0|||
148735953|NCT02132754|536505547|FG032|Overall Study|Screen Failure|0|||
148735954|NCT02132754|536505548|FG033|Overall Study|Screen Failure|0|||
148735955|NCT02132754|536505515|FG000|Overall Study|Transferred to Extension Study|0|||
148735956|NCT02132754|536505516|FG001|Overall Study|Transferred to Extension Study|0|||
148735957|NCT02132754|536505517|FG002|Overall Study|Transferred to Extension Study|0|||
148974216|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974217|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974218|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974219|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974220|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974221|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974222|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974223|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
148974224|NCT02346240|537387882|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974225|NCT02346240|537387883|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974226|NCT02346240|537387884|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974227|NCT02346240|537387885|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974228|NCT02346240|537387886|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974229|NCT02346240|537387887|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974230|NCT02346240|537387888|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974231|NCT02346240|537387889|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974232|NCT02346240|537387890|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974233|NCT02346240|537387891|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974234|NCT02346240|537387892|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974235|NCT02346240|537387893|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974236|NCT02346240|537387894|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974237|NCT02346240|537387895|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974238|NCT02346240|537387896|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
148974239|NCT02346240|537387897|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974240|NCT02346240|537387898|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974241|NCT02346240|537387899|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974242|NCT02346240|537387900|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148735958|NCT02132754|536505518|FG003|Overall Study|Transferred to Extension Study|0|||
148735959|NCT02132754|536505519|FG004|Overall Study|Transferred to Extension Study|0|||
148735960|NCT02132754|536505520|FG005|Overall Study|Transferred to Extension Study|0|||
148974243|NCT02346240|537387901|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974244|NCT02346240|537387902|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974245|NCT02346240|537387903|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974246|NCT02346240|537387904|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974247|NCT02346240|537387905|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
148974248|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974249|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148735961|NCT02132754|536505521|FG006|Overall Study|Transferred to Extension Study|0|||
148735962|NCT02132754|536505522|FG007|Overall Study|Transferred to Extension Study|0|||
148735963|NCT02132754|536505523|FG008|Overall Study|Transferred to Extension Study|0|||
148735964|NCT02132754|536505524|FG009|Overall Study|Transferred to Extension Study|0|||
148735965|NCT02132754|536505525|FG010|Overall Study|Transferred to Extension Study|0|||
148735966|NCT02132754|536505526|FG011|Overall Study|Transferred to Extension Study|0|||
148735967|NCT02132754|536505527|FG012|Overall Study|Transferred to Extension Study|0|||
148735968|NCT02132754|536505528|FG013|Overall Study|Transferred to Extension Study|0|||
148735969|NCT02132754|536505529|FG014|Overall Study|Transferred to Extension Study|0|||
148974250|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974251|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148735970|NCT02132754|536505530|FG015|Overall Study|Transferred to Extension Study|0|||
148735971|NCT02132754|536505531|FG016|Overall Study|Transferred to Extension Study|0|||
148735972|NCT02132754|536505532|FG017|Overall Study|Transferred to Extension Study|0|||
148818015|NCT05259033|536808496|FG000|Overall Study|Lost to Follow-up|1|||
148735973|NCT02132754|536505533|FG018|Overall Study|Transferred to Extension Study|0|||
148735974|NCT02132754|536505534|FG019|Overall Study|Transferred to Extension Study|0|||
148735975|NCT02132754|536505535|FG020|Overall Study|Transferred to Extension Study|0|||
148735976|NCT02132754|536505536|FG021|Overall Study|Transferred to Extension Study|0|||
148735977|NCT02132754|536505537|FG022|Overall Study|Transferred to Extension Study|0|||
148735978|NCT02132754|536505538|FG023|Overall Study|Transferred to Extension Study|0|||
148735979|NCT02132754|536505539|FG024|Overall Study|Transferred to Extension Study|0|||
148735980|NCT02132754|536505540|FG025|Overall Study|Transferred to Extension Study|0|||
148735981|NCT02132754|536505541|FG026|Overall Study|Transferred to Extension Study|0|||
148735982|NCT02132754|536505542|FG027|Overall Study|Transferred to Extension Study|0|||
148735983|NCT02132754|536505543|FG028|Overall Study|Transferred to Extension Study|0|||
148735984|NCT02132754|536505544|FG029|Overall Study|Transferred to Extension Study|0|||
148735985|NCT02132754|536505545|FG030|Overall Study|Transferred to Extension Study|0|||
148735986|NCT02132754|536505546|FG031|Overall Study|Transferred to Extension Study|0|||
148735987|NCT02132754|536505547|FG032|Overall Study|Transferred to Extension Study|0|||
148735988|NCT02132754|536505548|FG033|Overall Study|Transferred to Extension Study|6|||
148735989|NCT02132754|536505515|FG000|Overall Study|Withdrawal by Subject|0|||
148735990|NCT02132754|536505516|FG001|Overall Study|Withdrawal by Subject|0|||
148735991|NCT02132754|536505517|FG002|Overall Study|Withdrawal by Subject|0|||
148735992|NCT02132754|536505518|FG003|Overall Study|Withdrawal by Subject|0|||
148735993|NCT02132754|536505519|FG004|Overall Study|Withdrawal by Subject|0|||
148735994|NCT02132754|536505520|FG005|Overall Study|Withdrawal by Subject|0|||
148735995|NCT02132754|536505521|FG006|Overall Study|Withdrawal by Subject|0|||
148735996|NCT02132754|536505522|FG007|Overall Study|Withdrawal by Subject|0|||
148735997|NCT02132754|536505523|FG008|Overall Study|Withdrawal by Subject|0|||
148735998|NCT02132754|536505524|FG009|Overall Study|Withdrawal by Subject|1|||
148735999|NCT02132754|536505525|FG010|Overall Study|Withdrawal by Subject|0|||
148736000|NCT02132754|536505526|FG011|Overall Study|Withdrawal by Subject|0|||
148736001|NCT02132754|536505527|FG012|Overall Study|Withdrawal by Subject|1|||
148736002|NCT02132754|536505528|FG013|Overall Study|Withdrawal by Subject|0|||
148736003|NCT02132754|536505529|FG014|Overall Study|Withdrawal by Subject|1|||
148736004|NCT02132754|536505530|FG015|Overall Study|Withdrawal by Subject|2|||
148736005|NCT02132754|536505531|FG016|Overall Study|Withdrawal by Subject|1|||
148736006|NCT02132754|536505532|FG017|Overall Study|Withdrawal by Subject|0|||
148736007|NCT02132754|536505533|FG018|Overall Study|Withdrawal by Subject|0|||
148736008|NCT02132754|536505534|FG019|Overall Study|Withdrawal by Subject|0|||
148736009|NCT02132754|536505535|FG020|Overall Study|Withdrawal by Subject|1|||
148736010|NCT02132754|536505536|FG021|Overall Study|Withdrawal by Subject|0|||
148736011|NCT02132754|536505537|FG022|Overall Study|Withdrawal by Subject|0|||
148736012|NCT02132754|536505538|FG023|Overall Study|Withdrawal by Subject|0|||
148736013|NCT02132754|536505539|FG024|Overall Study|Withdrawal by Subject|1|||
148736014|NCT02132754|536505540|FG025|Overall Study|Withdrawal by Subject|0|||
148736015|NCT02132754|536505541|FG026|Overall Study|Withdrawal by Subject|0|||
148736016|NCT02132754|536505542|FG027|Overall Study|Withdrawal by Subject|1|||
148736017|NCT02132754|536505543|FG028|Overall Study|Withdrawal by Subject|0|||
148736018|NCT02132754|536505544|FG029|Overall Study|Withdrawal by Subject|0|||
148736019|NCT02132754|536505545|FG030|Overall Study|Withdrawal by Subject|0|||
148974252|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148736020|NCT02132754|536505546|FG031|Overall Study|Withdrawal by Subject|1|||
148736021|NCT02132754|536505547|FG032|Overall Study|Withdrawal by Subject|0|||
148736022|NCT02132754|536505548|FG033|Overall Study|Withdrawal by Subject|2|||
148736023|NCT03786718|536507403|FG000|Overall Study|Lost to Follow-up|3|||
148736024|NCT03786718|536507403|FG000|Overall Study|Withdrawal by Subject|1|||
148736025|NCT03786718|536507403|FG000|Overall Study|Did not use the intervention|2|||
148736026|NCT03786718|536507403|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
148736027|NCT00552578|536507409|FG000|Overall Study|Lost to Follow-up|1|||
148736028|NCT00552578|536507410|FG001|Overall Study|Lost to Follow-up|1|||
148736029|NCT00470067|536507411|FG000|Overall Study|Death|1|||
148736030|NCT00470067|536507411|FG000|Overall Study|Disease Progression|6|||
148736031|NCT02085135|536507413|FG000|Overall Study|Adverse Event|4|||
148736032|NCT02085135|536507414|FG001|Overall Study|Adverse Event|7|||
148736033|NCT02085135|536507413|FG000|Overall Study|Lost to Follow-up|2|||
148736034|NCT02085135|536507414|FG001|Overall Study|Lost to Follow-up|2|||
148736035|NCT02085135|536507413|FG000|Overall Study|Withdrawal by Subject|3|||
148974253|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148736036|NCT02085135|536507414|FG001|Overall Study|Withdrawal by Subject|0|||
148736037|NCT02085135|536507413|FG000|Overall Study|Lack of Efficacy|2|||
148736038|NCT02085135|536507414|FG001|Overall Study|Lack of Efficacy|0|||
148736039|NCT04091659|536507417|FG000|Overall Study|Protocol Violation|3|||
148736040|NCT04091659|536507418|FG001|Overall Study|Protocol Violation|0|||
148736041|NCT04091659|536507417|FG000|Overall Study|Lost to Follow-up|0|||
148736042|NCT04091659|536507418|FG001|Overall Study|Lost to Follow-up|1|||
148974254|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974255|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148736043|NCT01085734|536507424|FG000|Overall Study|Adverse Event|0|||
148736044|NCT01085734|536507425|FG001|Overall Study|Adverse Event|2|||
148736045|NCT01085734|536507424|FG000|Overall Study|Death|1|||
148736046|NCT01085734|536507425|FG001|Overall Study|Death|0|||
148736047|NCT01085734|536507424|FG000|Overall Study|Lost to Follow-up|0|||
148736048|NCT01085734|536507425|FG001|Overall Study|Lost to Follow-up|1|||
148736049|NCT01085734|536507424|FG000|Overall Study|Withdrawal by Subject|0|||
148736050|NCT01085734|536507425|FG001|Overall Study|Withdrawal by Subject|1|||
148736051|NCT03678285|536507428|FG000|Overall Study|Adverse Event|2|||
148736052|NCT03678285|536507428|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
148736053|NCT03678285|536507428|FG000|Overall Study|Dehydrated prior to start of workout|1|||
148736054|NCT00123474|536507429|FG000|Randomized to Treatment|Randomized, never treated|1|||
148736055|NCT00123474|536507430|FG001|Randomized to Treatment|Randomized, never treated|4|||
148736056|NCT00123474|536507431|FG002|Randomized to Treatment|Randomized, never treated|2|||
148736057|NCT00123474|536507432|FG003|Randomized to Treatment|Randomized, never treated|1|||
148736058|NCT00123474|536507429|FG000|As Treated at Study Closure|not reported when site closed|1|||
148736059|NCT00123474|536507430|FG001|As Treated at Study Closure|not reported when site closed|0|||
148736060|NCT00123474|536507431|FG002|As Treated at Study Closure|not reported when site closed|1|||
148736061|NCT00123474|536507432|FG003|As Treated at Study Closure|not reported when site closed|0|||
148736062|NCT00123474|536507429|FG000|As Treated at Study Closure|Adverse Event|10|||
148736063|NCT00123474|536507430|FG001|As Treated at Study Closure|Adverse Event|4|||
148736064|NCT00123474|536507431|FG002|As Treated at Study Closure|Adverse Event|10|||
148736065|NCT00123474|536507432|FG003|As Treated at Study Closure|Adverse Event|8|||
148736066|NCT00123474|536507429|FG000|As Treated at Study Closure|Disease Progression|35|||
148736067|NCT00123474|536507430|FG001|As Treated at Study Closure|Disease Progression|42|||
148736068|NCT00123474|536507431|FG002|As Treated at Study Closure|Disease Progression|29|||
148736069|NCT00123474|536507432|FG003|As Treated at Study Closure|Disease Progression|27|||
148736070|NCT00123474|536507429|FG000|As Treated at Study Closure|Investigator Request|12|||
148736071|NCT00123474|536507430|FG001|As Treated at Study Closure|Investigator Request|6|||
148736072|NCT00123474|536507431|FG002|As Treated at Study Closure|Investigator Request|7|||
148736073|NCT00123474|536507432|FG003|As Treated at Study Closure|Investigator Request|5|||
148736074|NCT00123474|536507429|FG000|As Treated at Study Closure|non-specified|54|||
148736075|NCT00123474|536507430|FG001|As Treated at Study Closure|non-specified|47|||
148736076|NCT00123474|536507431|FG002|As Treated at Study Closure|non-specified|57|||
148736077|NCT00123474|536507432|FG003|As Treated at Study Closure|non-specified|60|||
148736078|NCT00123474|536507429|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
148736079|NCT00123474|536507430|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
148736080|NCT00123474|536507431|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
148736081|NCT00123474|536507432|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
148736082|NCT00123474|536507429|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
148736083|NCT00123474|536507430|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
148736084|NCT00123474|536507431|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
148736085|NCT00123474|536507432|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
148736086|NCT00616629|536507433|FG000|Overall Study|Protocol Violation|1|||
148736087|NCT00616629|536507434|FG001|Overall Study|Protocol Violation|2|||
148736088|NCT00616629|536507435|FG002|Overall Study|Protocol Violation|1|||
148736089|NCT00616629|536507436|FG003|Overall Study|Protocol Violation|0|||
148736090|NCT00616629|536507437|FG004|Overall Study|Protocol Violation|0|||
148736091|NCT00616629|536507433|FG000|Overall Study|AV-block|1|||
148736092|NCT00616629|536507434|FG001|Overall Study|AV-block|0|||
148736093|NCT00616629|536507435|FG002|Overall Study|AV-block|0|||
148736094|NCT00616629|536507436|FG003|Overall Study|AV-block|0|||
148736095|NCT00616629|536507437|FG004|Overall Study|AV-block|0|||
148736096|NCT02695537|536507451|FG000|Overall Study|Adverse Event|3|||
148736097|NCT02695537|536507451|FG000|Overall Study|Lack of Efficacy|28|||
148736098|NCT02695537|536507451|FG000|Overall Study|Withdrawal by Subject|4|||
148736099|NCT02695537|536507451|FG000|Overall Study|Protocol Violation|3|||
148736100|NCT03870477|536507454|FG000|Overall Study|Early Study Termination|1|||
148736101|NCT02256436|536507457|FG000|Overall Study|Adverse Event|9|||
148736102|NCT02256436|536507458|FG001|Overall Study|Adverse Event|14|||
148736103|NCT02256436|536507457|FG000|Overall Study|Death|216|||
148736104|NCT02256436|536507458|FG001|Overall Study|Death|208|||
148818016|NCT05259033|536808497|FG001|Overall Study|Lost to Follow-up|0|||
148818017|NCT05259033|536808496|FG000|Overall Study|Death|2|||
148818018|NCT05259033|536808497|FG001|Overall Study|Death|0|||
148736105|NCT02256436|536507457|FG000|Overall Study|Lost to Follow-up|1|||
148736106|NCT02256436|536507458|FG001|Overall Study|Lost to Follow-up|2|||
148736107|NCT02256436|536507457|FG000|Overall Study|Physician Decision|1|||
148736108|NCT02256436|536507458|FG001|Overall Study|Physician Decision|0|||
148736109|NCT02256436|536507457|FG000|Overall Study|Protocol Violation|0|||
148818019|NCT01068249|536808498|FG000|Overall Study|Death|1|||
148818020|NCT01068249|536808498|FG000|Overall Study|Withdrawal by Subject|3|||
148818021|NCT00002874|536808505|FG000|Overall Study|Withdrawal by Subject|1|||
148736110|NCT02256436|536507458|FG001|Overall Study|Protocol Violation|1|||
148736111|NCT02256436|536507457|FG000|Overall Study|Withdrawal by Subject|26|||
148736112|NCT02256436|536507458|FG001|Overall Study|Withdrawal by Subject|10|||
148974256|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974257|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974258|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974259|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974260|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974261|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974262|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974263|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974264|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
148974265|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
148974266|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
148974267|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
148974268|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
148974269|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
148974270|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
148974271|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
148974272|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974273|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974274|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974275|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974276|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974277|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974278|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974279|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974280|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974281|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974282|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974283|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974284|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974285|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974286|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974287|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974288|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974289|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974290|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
148974291|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
148974292|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974293|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
148974294|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974295|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
148974296|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974297|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974298|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974299|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974300|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974301|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974302|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148736113|NCT02256436|536507457|FG000|Overall Study|Transferred to Extension Study|11|||
148736114|NCT02256436|536507458|FG001|Overall Study|Transferred to Extension Study|23|||
148736115|NCT02256436|536507457|FG000|Overall Study|Did Not Continue on Extension Study|8|||
148736116|NCT02256436|536507458|FG001|Overall Study|Did Not Continue on Extension Study|12|||
148736117|NCT01696279|536507459|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
148736118|NCT01696279|536507460|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
148736119|NCT01696279|536507461|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
148736120|NCT01696279|536507462|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
148736121|NCT01696279|536507459|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
148736122|NCT01696279|536507460|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
148736123|NCT01696279|536507461|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
148736124|NCT01696279|536507462|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
148736125|NCT01696279|536507459|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
148736126|NCT01696279|536507460|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
148736127|NCT01696279|536507461|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
148974303|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974304|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974305|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974306|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974307|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148736128|NCT01696279|536507462|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
148736129|NCT01696279|536507459|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
148736130|NCT01696279|536507460|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
148736131|NCT01696279|536507461|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
148736132|NCT01696279|536507462|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
148736133|NCT01696279|536507459|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
148736134|NCT01696279|536507460|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
148736135|NCT01696279|536507461|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
148736136|NCT01696279|536507462|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
148736137|NCT01696279|536507459|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
148736138|NCT01696279|536507460|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
148736139|NCT01696279|536507461|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
148736140|NCT01696279|536507462|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
148736141|NCT01696279|536507459|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
148736142|NCT01696279|536507460|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
148736143|NCT01696279|536507461|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
148736144|NCT01696279|536507462|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
148736145|NCT01696279|536507459|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
148736146|NCT01696279|536507460|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
148736147|NCT01696279|536507461|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
148736148|NCT01696279|536507462|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
148736149|NCT01696279|536507459|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
148736150|NCT01696279|536507460|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
148736151|NCT01696279|536507461|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
148736152|NCT01696279|536507462|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
148736153|NCT01696279|536507459|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
148736154|NCT01696279|536507460|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
148736155|NCT01696279|536507461|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
148736156|NCT01696279|536507462|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
148736157|NCT01696279|536507459|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
148736158|NCT01696279|536507460|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
148736159|NCT01696279|536507461|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
148736160|NCT01696279|536507462|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
148736161|NCT05788289|536507463|FG000|Overall Study|Death|3|||
148736162|NCT01584843|536507476|FG000|First Treatment Period|Adverse Event|0|||
148736163|NCT01584843|536507477|FG001|First Treatment Period|Adverse Event|0|||
148736164|NCT01584843|536507478|FG002|First Treatment Period|Adverse Event|1|||
148736165|NCT01584843|536507479|FG003|First Treatment Period|Adverse Event|0|||
148736166|NCT01584843|536507480|FG004|First Treatment Period|Adverse Event|0|||
148736167|NCT01584843|536507481|FG005|First Treatment Period|Adverse Event|0|||
148736168|NCT01584843|536507476|FG000|First Treatment Period|Protocol Violation|0|||
148736169|NCT01584843|536507477|FG001|First Treatment Period|Protocol Violation|0|||
148736170|NCT01584843|536507478|FG002|First Treatment Period|Protocol Violation|0|||
148736171|NCT01584843|536507479|FG003|First Treatment Period|Protocol Violation|0|||
148736172|NCT01584843|536507480|FG004|First Treatment Period|Protocol Violation|0|||
148736173|NCT01584843|536507481|FG005|First Treatment Period|Protocol Violation|1|||
148736174|NCT01584843|536507476|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
148736175|NCT01584843|536507477|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
148736176|NCT01584843|536507478|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
148974308|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974309|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974310|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974311|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974312|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148736177|NCT01584843|536507479|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
148736178|NCT01584843|536507480|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
148736179|NCT01584843|536507481|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
148736180|NCT01584843|536507476|FG000|Second Treatment Period|Withdrawal by Subject|0|||
148736181|NCT01584843|536507477|FG001|Second Treatment Period|Withdrawal by Subject|0|||
148736182|NCT01584843|536507478|FG002|Second Treatment Period|Withdrawal by Subject|0|||
148736183|NCT01584843|536507479|FG003|Second Treatment Period|Withdrawal by Subject|0|||
148736184|NCT01584843|536507480|FG004|Second Treatment Period|Withdrawal by Subject|0|||
148736185|NCT01584843|536507481|FG005|Second Treatment Period|Withdrawal by Subject|1|||
148818022|NCT00002874|536808506|FG001|Overall Study|Withdrawal by Subject|1|||
148736186|NCT04126213|536507484|FG000|Overall Study|Lost to Follow-up|9|||
148736187|NCT04126213|536507485|FG001|Overall Study|Lost to Follow-up|1|||
148736188|NCT04126213|536507486|FG002|Overall Study|Lost to Follow-up|5|||
148736189|NCT04126213|536507487|FG003|Overall Study|Lost to Follow-up|10|||
148736190|NCT04126213|536507488|FG004|Overall Study|Lost to Follow-up|4|||
148736191|NCT04126213|536507489|FG005|Overall Study|Lost to Follow-up|7|||
148736192|NCT04126213|536507484|FG000|Overall Study|Withdrawal by Subject|3|||
148736193|NCT04126213|536507485|FG001|Overall Study|Withdrawal by Subject|2|||
148736194|NCT04126213|536507486|FG002|Overall Study|Withdrawal by Subject|1|||
148736195|NCT04126213|536507487|FG003|Overall Study|Withdrawal by Subject|1|||
148974313|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974314|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
148974315|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974316|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974317|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
148974318|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974319|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148974320|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974321|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974322|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974323|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974324|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974325|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974326|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974327|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974328|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974329|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974330|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974331|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974332|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974333|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974334|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974335|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974336|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974337|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974338|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974339|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974340|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974341|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
148974342|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974343|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
148974344|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974345|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974346|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974347|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974348|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974349|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974350|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974351|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974352|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974353|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974354|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974355|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974356|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974357|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974358|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974359|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974360|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974361|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
148974362|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
148974363|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
148818023|NCT00002874|536808505|FG000|Overall Study|Protocol Violation|44|||
148818024|NCT00002874|536808506|FG001|Overall Study|Protocol Violation|34|||
148974364|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148974365|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
148974366|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
148736196|NCT04126213|536507488|FG004|Overall Study|Withdrawal by Subject|1|||
148736197|NCT04126213|536507489|FG005|Overall Study|Withdrawal by Subject|1|||
148974367|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
148974368|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148736198|NCT04126213|536507484|FG000|Overall Study|Other|0|||
148736199|NCT04126213|536507485|FG001|Overall Study|Other|0|||
148736200|NCT04126213|536507486|FG002|Overall Study|Other|2|||
148736201|NCT04126213|536507487|FG003|Overall Study|Other|2|||
148736202|NCT04126213|536507488|FG004|Overall Study|Other|0|||
148736203|NCT04126213|536507489|FG005|Overall Study|Other|1|||
148736204|NCT04126213|536507484|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148736205|NCT04126213|536507485|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
148736206|NCT04126213|536507486|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148736207|NCT04126213|536507487|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148736208|NCT04126213|536507488|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148736209|NCT04126213|536507489|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
148736210|NCT02853370|536507490|FG000|Overall Study|Physician Decision|1|||
148736211|NCT02853370|536507490|FG000|Overall Study|Lack of Efficacy|2|||
148736212|NCT02853370|536507490|FG000|Overall Study|Death|1|||
148736213|NCT02853370|536507490|FG000|Overall Study|Adverse Event|4|||
148736214|NCT02853370|536507490|FG000|Overall Study|Withdrawal by Subject|3|||
148736215|NCT02317614|536507491|FG000|Overall Study|Lost to Follow-up|1|||
148736216|NCT02317614|536507492|FG001|Overall Study|Lost to Follow-up|1|||
148736217|NCT02317614|536507491|FG000|Overall Study|Withdrawal by Subject|1|||
148736218|NCT02317614|536507492|FG001|Overall Study|Withdrawal by Subject|0|||
148736219|NCT02317614|536507491|FG000|Overall Study|Death|1|||
148736220|NCT02317614|536507492|FG001|Overall Study|Death|1|||
148736221|NCT00750308|536507493|FG000|First Treatment|Adverse Event|0|||
148736222|NCT00750308|536507494|FG001|First Treatment|Adverse Event|1|||
148736223|NCT00750308|536507495|FG002|First Treatment|Adverse Event|0|||
148736224|NCT00750308|536507496|FG003|First Treatment|Adverse Event|0|||
148736225|NCT00750308|536507497|FG004|First Treatment|Adverse Event|0|||
148736226|NCT00750308|536507498|FG005|First Treatment|Adverse Event|0|||
148736227|NCT00750308|536507499|FG006|First Treatment|Adverse Event|0|||
148736228|NCT00750308|536507500|FG007|First Treatment|Adverse Event|0|||
148736229|NCT00750308|536507501|FG008|First Treatment|Adverse Event|0|||
148736230|NCT00750308|536507502|FG009|First Treatment|Adverse Event|0|||
148736231|NCT00750308|536507503|FG010|First Treatment|Adverse Event|1|||
148736232|NCT00750308|536507504|FG011|First Treatment|Adverse Event|1|||
148736233|NCT00750308|536507493|FG000|First Treatment|Withdrawal by Subject|0|||
148736234|NCT00750308|536507494|FG001|First Treatment|Withdrawal by Subject|0|||
148736235|NCT00750308|536507495|FG002|First Treatment|Withdrawal by Subject|0|||
148736236|NCT00750308|536507496|FG003|First Treatment|Withdrawal by Subject|1|||
148736237|NCT00750308|536507497|FG004|First Treatment|Withdrawal by Subject|0|||
148736238|NCT00750308|536507498|FG005|First Treatment|Withdrawal by Subject|0|||
148736239|NCT00750308|536507499|FG006|First Treatment|Withdrawal by Subject|0|||
148736240|NCT00750308|536507500|FG007|First Treatment|Withdrawal by Subject|1|||
148736241|NCT00750308|536507501|FG008|First Treatment|Withdrawal by Subject|0|||
148736242|NCT00750308|536507502|FG009|First Treatment|Withdrawal by Subject|0|||
148736243|NCT00750308|536507503|FG010|First Treatment|Withdrawal by Subject|0|||
148736244|NCT00750308|536507504|FG011|First Treatment|Withdrawal by Subject|0|||
148736245|NCT00750308|536507493|FG000|Second Treatment|Adverse Event|0|||
148736246|NCT00750308|536507494|FG001|Second Treatment|Adverse Event|0|||
148736247|NCT00750308|536507495|FG002|Second Treatment|Adverse Event|0|||
148736248|NCT00750308|536507496|FG003|Second Treatment|Adverse Event|0|||
148736249|NCT00750308|536507497|FG004|Second Treatment|Adverse Event|0|||
148736250|NCT00750308|536507498|FG005|Second Treatment|Adverse Event|1|||
148736251|NCT00750308|536507499|FG006|Second Treatment|Adverse Event|0|||
148736252|NCT00750308|536507500|FG007|Second Treatment|Adverse Event|0|||
148736253|NCT00750308|536507501|FG008|Second Treatment|Adverse Event|1|||
148736254|NCT00750308|536507502|FG009|Second Treatment|Adverse Event|0|||
148974369|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974370|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974371|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974372|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974373|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148736255|NCT00750308|536507503|FG010|Second Treatment|Adverse Event|0|||
148736256|NCT00750308|536507504|FG011|Second Treatment|Adverse Event|0|||
148736257|NCT00750308|536507493|FG000|Second Treatment|Withdrawal by Subject|0|||
148736258|NCT00750308|536507494|FG001|Second Treatment|Withdrawal by Subject|0|||
148736259|NCT00750308|536507495|FG002|Second Treatment|Withdrawal by Subject|0|||
148736260|NCT00750308|536507496|FG003|Second Treatment|Withdrawal by Subject|0|||
148736261|NCT00750308|536507497|FG004|Second Treatment|Withdrawal by Subject|1|||
148736262|NCT00750308|536507498|FG005|Second Treatment|Withdrawal by Subject|0|||
148736263|NCT00750308|536507499|FG006|Second Treatment|Withdrawal by Subject|0|||
148736264|NCT00750308|536507500|FG007|Second Treatment|Withdrawal by Subject|0|||
148736265|NCT00750308|536507501|FG008|Second Treatment|Withdrawal by Subject|0|||
148736266|NCT00750308|536507502|FG009|Second Treatment|Withdrawal by Subject|0|||
148736267|NCT00750308|536507503|FG010|Second Treatment|Withdrawal by Subject|0|||
148736268|NCT00750308|536507504|FG011|Second Treatment|Withdrawal by Subject|0|||
148736269|NCT00750308|536507493|FG000|Third Treatment|Withdrawal by Subject|0|||
148736270|NCT00750308|536507494|FG001|Third Treatment|Withdrawal by Subject|1|||
148736271|NCT00750308|536507495|FG002|Third Treatment|Withdrawal by Subject|0|||
148736272|NCT00750308|536507496|FG003|Third Treatment|Withdrawal by Subject|0|||
148736273|NCT00750308|536507497|FG004|Third Treatment|Withdrawal by Subject|0|||
148736274|NCT00750308|536507498|FG005|Third Treatment|Withdrawal by Subject|0|||
148736275|NCT00750308|536507499|FG006|Third Treatment|Withdrawal by Subject|0|||
148736276|NCT00750308|536507500|FG007|Third Treatment|Withdrawal by Subject|0|||
148736277|NCT00750308|536507501|FG008|Third Treatment|Withdrawal by Subject|0|||
148736278|NCT00750308|536507502|FG009|Third Treatment|Withdrawal by Subject|0|||
148736279|NCT00750308|536507503|FG010|Third Treatment|Withdrawal by Subject|0|||
148736280|NCT00750308|536507504|FG011|Third Treatment|Withdrawal by Subject|0|||
148736281|NCT04156620|536507505|FG000|Overall Study|Adverse event - TP 1|5|||
148736282|NCT04156620|536507506|FG001|Overall Study|Adverse event - TP 1|2|||
148736283|NCT04156620|536507505|FG000|Overall Study|Lost to follow-up TP 1|1|||
148736284|NCT04156620|536507506|FG001|Overall Study|Lost to follow-up TP 1|1|||
148736285|NCT04156620|536507505|FG000|Overall Study|Progressive disease - TP 1|0|||
148736286|NCT04156620|536507506|FG001|Overall Study|Progressive disease - TP 1|1|||
148736287|NCT04156620|536507505|FG000|Overall Study|Subject decision - TP 1|3|||
148736288|NCT04156620|536507506|FG001|Overall Study|Subject decision - TP 1|5|||
148736289|NCT04156620|536507505|FG000|Overall Study|Adverse event - TP 2|5|||
148736290|NCT04156620|536507506|FG001|Overall Study|Adverse event - TP 2|6|||
148736291|NCT04156620|536507505|FG000|Overall Study|Death - TP 2|1|||
148736292|NCT04156620|536507506|FG001|Overall Study|Death - TP 2|0|||
148736293|NCT04156620|536507505|FG000|Overall Study|Lost to follow-up - TP 2|5|||
148736294|NCT04156620|536507506|FG001|Overall Study|Lost to follow-up - TP 2|2|||
148736295|NCT04156620|536507505|FG000|Overall Study|Physician decision - TP 2|4|||
148736296|NCT04156620|536507506|FG001|Overall Study|Physician decision - TP 2|2|||
148736297|NCT04156620|536507505|FG000|Overall Study|Pregnancy - TP 2|1|||
148736298|NCT04156620|536507506|FG001|Overall Study|Pregnancy - TP 2|1|||
148736299|NCT04156620|536507505|FG000|Overall Study|Subject decision - TP 2|11|||
148736300|NCT04156620|536507506|FG001|Overall Study|Subject decision - TP 2|9|||
148736301|NCT04156620|536507505|FG000|Overall Study|New therapy for study indication - TP 2|1|||
148736302|NCT04156620|536507506|FG001|Overall Study|New therapy for study indication - TP 2|0|||
148736303|NCT00513682|536507507|FG000|Washout Phase|Adverse Event|2|||
148736304|NCT02450526|536507508|FG000|DB Period (Cycle 1)|Adverse Event|0|||
148736305|NCT02450526|536507509|FG001|DB Period (Cycle 1)|Adverse Event|0|||
148736306|NCT02450526|536507510|FG002|DB Period (Cycle 1)|Adverse Event|2|||
148736307|NCT02450526|536507511|FG003|DB Period (Cycle 1)|Adverse Event|0|||
148736308|NCT02450526|536507512|FG004|DB Period (Cycle 1)|Adverse Event|0|||
148736309|NCT02450526|536507508|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
148736310|NCT02450526|536507509|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
148736311|NCT02450526|536507510|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
148736312|NCT02450526|536507511|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
148736313|NCT02450526|536507512|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
148736314|NCT02450526|536507508|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
148736315|NCT02450526|536507509|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
148736316|NCT02450526|536507510|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
148736317|NCT02450526|536507511|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
148736318|NCT02450526|536507512|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
148736319|NCT02450526|536507508|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
148736320|NCT02450526|536507509|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
148818025|NCT00504309|536808510|FG000|Overall Study|Death|0|||
148736321|NCT02450526|536507510|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
148818026|NCT00504309|536808511|FG001|Overall Study|Death|0|||
148818027|NCT00504309|536808512|FG002|Overall Study|Death|0|||
148818028|NCT00504309|536808513|FG003|Overall Study|Death|0|||
148818029|NCT00504309|536808514|FG004|Overall Study|Death|1|||
148818030|NCT00504309|536808515|FG005|Overall Study|Death|0|||
148974374|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148736322|NCT02450526|536507511|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
148736323|NCT02450526|536507512|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
148736324|NCT02450526|536507508|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
148736325|NCT02450526|536507509|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
148736326|NCT02450526|536507510|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
148736327|NCT02450526|536507511|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
148736328|NCT02450526|536507512|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
148736329|NCT02450526|536507508|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
148736330|NCT02450526|536507509|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
148736331|NCT02450526|536507510|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
148736332|NCT02450526|536507511|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
148818031|NCT00504309|536808510|FG000|Overall Study|Withdrawal by Subject|0|||
148736333|NCT02450526|536507512|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
148736334|NCT02450526|536507508|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
148736335|NCT02450526|536507509|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
148736336|NCT02450526|536507510|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
148736337|NCT02450526|536507511|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
148736338|NCT02450526|536507512|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
148736339|NCT02450526|536507508|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
148736340|NCT02450526|536507509|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
148736341|NCT02450526|536507510|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
148736342|NCT02450526|536507511|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
148736343|NCT02450526|536507512|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
148736344|NCT01753336|536507513|FG000|Overall Study|Patient decision|12|||
148736345|NCT01753336|536507513|FG000|Overall Study|Lost to Follow-up|3|||
148736346|NCT01753336|536507513|FG000|Overall Study|Physician Decision|2|||
148736347|NCT01753336|536507513|FG000|Overall Study|Sponsor's decision|2|||
148736348|NCT01753336|536507513|FG000|Overall Study|Withdrawal by Subject|1|||
148736349|NCT01672970|536507515|FG000|Overall Study|Lack of Efficacy|12|||
148736350|NCT01672970|536507515|FG000|Overall Study|Adverse Event|18|||
148736351|NCT01672970|536507515|FG000|Overall Study|Withdrawal by Subject|2|||
148736352|NCT01672970|536507515|FG000|Overall Study|Lost to Follow-up|5|||
148736353|NCT01672970|536507515|FG000|Overall Study|Other|9|||
148736354|NCT01672970|536507515|FG000|Overall Study|Enrolled but not treated|1|||
148736355|NCT04568031|536507516|FG000|Overall Study|Lost to Follow-up|1|||
148736356|NCT04568031|536507517|FG001|Overall Study|Lost to Follow-up|0|||
148736357|NCT04568031|536507518|FG002|Overall Study|Lost to Follow-up|0|||
148736358|NCT04568031|536507519|FG003|Overall Study|Lost to Follow-up|0|||
148736359|NCT04568031|536507516|FG000|Overall Study|Physician Decision|1|||
148736360|NCT04568031|536507517|FG001|Overall Study|Physician Decision|0|||
148736361|NCT04568031|536507518|FG002|Overall Study|Physician Decision|1|||
148736362|NCT04568031|536507519|FG003|Overall Study|Physician Decision|0|||
148736363|NCT04568031|536507516|FG000|Overall Study|Withdrawal by Subject|1|||
148736364|NCT04568031|536507517|FG001|Overall Study|Withdrawal by Subject|0|||
148736365|NCT04568031|536507518|FG002|Overall Study|Withdrawal by Subject|4|||
148736366|NCT04568031|536507519|FG003|Overall Study|Withdrawal by Subject|1|||
148736367|NCT04874636|536507520|FG000|Overall Study|Adverse Event|17|||
148736368|NCT04874636|536507521|FG001|Overall Study|Adverse Event|7|||
148736369|NCT04874636|536507520|FG000|Overall Study|Lost to Follow-up|1|||
148736370|NCT04874636|536507521|FG001|Overall Study|Lost to Follow-up|0|||
148736371|NCT04874636|536507520|FG000|Overall Study|Non-Compliance with Study Drug|2|||
148736372|NCT04874636|536507521|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148736373|NCT04874636|536507520|FG000|Overall Study|Physician Decision|1|||
148736374|NCT04874636|536507521|FG001|Overall Study|Physician Decision|0|||
148736375|NCT04874636|536507520|FG000|Overall Study|Withdrawal by Subject|6|||
148736376|NCT04874636|536507521|FG001|Overall Study|Withdrawal by Subject|5|||
148736377|NCT01770392|536507522|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
148736378|NCT03401450|536507523|FG000|Overall Study|Lost to Follow-up|4|||
148736379|NCT03401450|536507524|FG001|Overall Study|Lost to Follow-up|6|||
148736380|NCT03401450|536507523|FG000|Overall Study|Anesthesia plan changed|2|||
148736381|NCT03401450|536507524|FG001|Overall Study|Anesthesia plan changed|2|||
148736382|NCT03401450|536507523|FG000|Overall Study|Did not complete medication diary|4|||
148736383|NCT03401450|536507524|FG001|Overall Study|Did not complete medication diary|2|||
148736384|NCT03401450|536507523|FG000|Overall Study|post surgery medication change|2|||
148736385|NCT03401450|536507524|FG001|Overall Study|post surgery medication change|1|||
148736386|NCT03401450|536507523|FG000|Overall Study|Cancelled surgery|0|||
148736387|NCT03401450|536507524|FG001|Overall Study|Cancelled surgery|2|||
148736388|NCT00228423|536507525|FG000|Overall Study|Adverse Event|2|||
148736389|NCT00228423|536507526|FG001|Overall Study|Adverse Event|5|||
148736390|NCT00228423|536507525|FG000|Overall Study|Withdrawal by Subject|7|||
148736391|NCT00228423|536507526|FG001|Overall Study|Withdrawal by Subject|3|||
148736392|NCT00228423|536507525|FG000|Overall Study|Protocol Violation|1|||
148736393|NCT00228423|536507526|FG001|Overall Study|Protocol Violation|3|||
148736394|NCT00228423|536507525|FG000|Overall Study|Physician Decision|0|||
148736395|NCT00228423|536507526|FG001|Overall Study|Physician Decision|1|||
148736396|NCT03258853|536507543|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
148736397|NCT03258853|536507544|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
148736398|NCT02582866|536507545|FG000|Overall Study|Death|1|||
148736399|NCT02582866|536507545|FG000|Overall Study|Lack of Efficacy|2|||
148736400|NCT02582866|536507545|FG000|Overall Study|Lost to Follow-up|2|||
148736401|NCT02582866|536507545|FG000|Overall Study|Withdrawal by Subject|7|||
148736402|NCT02582866|536507545|FG000|Overall Study|Investigator decision|5|||
148736403|NCT02582866|536507545|FG000|Overall Study|Participant wants to get pregnant|1|||
148736404|NCT02582866|536507545|FG000|Overall Study|Pregnancy|2|||
148736405|NCT02582866|536507545|FG000|Overall Study|Sponsor decision|1|||
148736406|NCT02582866|536507545|FG000|Overall Study|Withdrawal due to personal reasons|1|||
148736407|NCT03567382|536507548|FG000|Overall Study|Lost to Follow-up|1|||
148736408|NCT03567382|536507549|FG001|Overall Study|Lost to Follow-up|21|||
148736409|NCT03567382|536507550|FG002|Overall Study|Lost to Follow-up|1|||
148736410|NCT03567382|536507551|FG003|Overall Study|Lost to Follow-up|21|||
148736411|NCT03567382|536507548|FG000|Overall Study|Withdrawal by Subject|2|||
148974375|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974376|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974377|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974378|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974379|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974380|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974381|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974382|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974383|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974384|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974385|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974386|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
148974387|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
148736412|NCT03567382|536507549|FG001|Overall Study|Withdrawal by Subject|14|||
148736413|NCT03567382|536507550|FG002|Overall Study|Withdrawal by Subject|1|||
148736414|NCT03567382|536507551|FG003|Overall Study|Withdrawal by Subject|12|||
148736415|NCT02011386|536507556|FG000|Overall Study|Non-compliance|2|||
148736416|NCT02011386|536507556|FG000|Overall Study|Lack of Efficacy|3|||
148736417|NCT04555720|536507557|FG000|Overall Study|Lost to Follow-up|2|||
148736418|NCT04555720|536507558|FG001|Overall Study|Lost to Follow-up|0|||
148736419|NCT04555720|536507559|FG002|Overall Study|Lost to Follow-up|0|||
148736420|NCT04555720|536507560|FG003|Overall Study|Lost to Follow-up|0|||
148736421|NCT04555720|536507557|FG000|Overall Study|Withdrawal by Subject|4|||
148736422|NCT04555720|536507558|FG001|Overall Study|Withdrawal by Subject|6|||
148736423|NCT04555720|536507559|FG002|Overall Study|Withdrawal by Subject|0|||
148736424|NCT04555720|536507560|FG003|Overall Study|Withdrawal by Subject|0|||
148736425|NCT03753763|536507561|FG000|Overall Study|Adverse Event|2|||
148736426|NCT03753763|536507562|FG001|Overall Study|Adverse Event|0|||
148736427|NCT03753763|536507561|FG000|Overall Study|Withdrawal by Subject|3|||
148736428|NCT03753763|536507562|FG001|Overall Study|Withdrawal by Subject|1|||
148736429|NCT03753763|536507561|FG000|Overall Study|clinical deterioration|1|||
148736430|NCT03753763|536507562|FG001|Overall Study|clinical deterioration|0|||
148736431|NCT00719849|536507563|FG000|Overall Study|Death|0|||
148736432|NCT00719849|536507564|FG001|Overall Study|Death|1|||
148736433|NCT02201290|536507566|FG000|Overall Study|Withdrawal by Subject|2|||
148736434|NCT02201290|536507566|FG000|Overall Study|Lack of Efficacy|2|||
148736435|NCT02201290|536507566|FG000|Overall Study|Adverse Event|1|||
148736436|NCT03907462|536507567|FG000|Overall Study|Physician Decision|1|||
148736437|NCT03907462|536507568|FG001|Overall Study|Physician Decision|3|||
148736438|NCT03907462|536507569|FG002|Overall Study|Physician Decision|1|||
148736439|NCT03907462|536507567|FG000|Overall Study|Withdrawal by Subject|6|||
148736440|NCT03907462|536507568|FG001|Overall Study|Withdrawal by Subject|3|||
148736441|NCT03907462|536507569|FG002|Overall Study|Withdrawal by Subject|3|||
148736442|NCT03907462|536507567|FG000|Overall Study|Pregnancy|4|||
148736443|NCT03907462|536507568|FG001|Overall Study|Pregnancy|2|||
148736444|NCT03907462|536507569|FG002|Overall Study|Pregnancy|6|||
148736445|NCT03907462|536507567|FG000|Overall Study|Lost to Follow-up|16|||
148736446|NCT03907462|536507568|FG001|Overall Study|Lost to Follow-up|18|||
148736447|NCT03907462|536507569|FG002|Overall Study|Lost to Follow-up|22|||
148736448|NCT00699283|536510206|FG000|Overall Study|Lack of Efficacy|15|||
148736449|NCT00699283|536510207|FG001|Overall Study|Lack of Efficacy|5|||
148736450|NCT00699283|536510206|FG000|Overall Study|Lost to Follow-up|2|||
148736451|NCT00699283|536510207|FG001|Overall Study|Lost to Follow-up|0|||
148974388|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148974389|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
148974390|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
148974391|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
148736452|NCT00699283|536510206|FG000|Overall Study|Withdrawal by Subject|1|||
148736453|NCT00699283|536510207|FG001|Overall Study|Withdrawal by Subject|0|||
148736454|NCT00699283|536510206|FG000|Overall Study|Other Reason|5|||
148736455|NCT00699283|536510207|FG001|Overall Study|Other Reason|1|||
148736456|NCT00699283|536510206|FG000|Overall Study|SAE, non-fatal|1|||
148736457|NCT00699283|536510207|FG001|Overall Study|SAE, non-fatal|1|||
148736458|NCT00699283|536510206|FG000|Overall Study|AE, non-serious non-fatal|8|||
148736459|NCT00699283|536510207|FG001|Overall Study|AE, non-serious non-fatal|1|||
148736460|NCT00699283|536510206|FG000|Overall Study|AE of unknown type|1|||
148736461|NCT00699283|536510207|FG001|Overall Study|AE of unknown type|0|||
148736462|NCT00805675|536510208|FG000|Overall Study|Adverse Event|0|||
148736463|NCT00805675|536510209|FG001|Overall Study|Adverse Event|0|||
148736464|NCT00805675|536510210|FG002|Overall Study|Adverse Event|1|||
148736465|NCT02771795|536510211|FG000|Overall Study|Withdrawal by Subject|47|||
148736466|NCT02771795|536510212|FG001|Overall Study|Withdrawal by Subject|37|||
148736467|NCT02771795|536510211|FG000|Overall Study|Termination by premature discontinuation of study|168|||
148736468|NCT02771795|536510212|FG001|Overall Study|Termination by premature discontinuation of study|185|||
148974392|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974393|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974394|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974395|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148736469|NCT03929757|536510213|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
148736470|NCT03929757|536510214|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
148736471|NCT03929757|536510215|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
148736472|NCT03929757|536510213|FG000|Main Study: Up to Day 365|Other|1|||
148974396|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974397|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974398|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974399|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974400|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974401|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974402|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974403|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974404|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974405|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974406|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974407|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974408|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974409|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974410|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
148974411|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974412|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
148974413|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
148974414|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
148974415|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
148974416|NCT02346240|537387882|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974417|NCT02346240|537387883|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974418|NCT02346240|537387884|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974419|NCT02346240|537387885|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974420|NCT02346240|537387886|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974421|NCT02346240|537387887|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974422|NCT02346240|537387888|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974423|NCT02346240|537387889|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974424|NCT02346240|537387890|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974425|NCT02346240|537387891|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974426|NCT02346240|537387892|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974427|NCT02346240|537387893|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148736473|NCT03929757|536510214|FG001|Main Study: Up to Day 365|Other|0|||
148736474|NCT03929757|536510215|FG002|Main Study: Up to Day 365|Other|0|||
148736475|NCT03929757|536510213|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
148736476|NCT03929757|536510214|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
148736477|NCT03929757|536510215|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
148736478|NCT00114166|536510216|FG000|Overall Study|Wrong primary|0|||
148736479|NCT00114166|536510217|FG001|Overall Study|Wrong primary|1|||
148736480|NCT01154816|536510218|FG000|Overall Study|Withdrawal by Subject|1|||
148736481|NCT01154816|536510219|FG001|Overall Study|Withdrawal by Subject|0|||
148736482|NCT01154816|536510220|FG002|Overall Study|Withdrawal by Subject|0|||
148736483|NCT01154816|536510221|FG003|Overall Study|Withdrawal by Subject|1|||
148736484|NCT01154816|536510222|FG004|Overall Study|Withdrawal by Subject|0|||
148736485|NCT01154816|536510223|FG005|Overall Study|Withdrawal by Subject|0|||
148974428|NCT02346240|537387894|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974429|NCT02346240|537387895|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974430|NCT02346240|537387896|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148736486|NCT01154816|536510224|FG006|Overall Study|Withdrawal by Subject|0|||
148736487|NCT01154816|536510225|FG007|Overall Study|Withdrawal by Subject|0|||
148818032|NCT00504309|536808511|FG001|Overall Study|Withdrawal by Subject|0|||
148818033|NCT00504309|536808512|FG002|Overall Study|Withdrawal by Subject|1|||
148818034|NCT00504309|536808513|FG003|Overall Study|Withdrawal by Subject|0|||
148736488|NCT01154816|536510226|FG008|Overall Study|Withdrawal by Subject|1|||
148736489|NCT01154816|536510227|FG009|Overall Study|Withdrawal by Subject|3|||
148818035|NCT00504309|536808514|FG004|Overall Study|Withdrawal by Subject|0|||
148736490|NCT01154816|536510228|FG010|Overall Study|Withdrawal by Subject|0|||
148736491|NCT01154816|536510229|FG011|Overall Study|Withdrawal by Subject|0|||
148736492|NCT01154816|536510218|FG000|Overall Study|Progressive Disease|13|||
148736493|NCT01154816|536510219|FG001|Overall Study|Progressive Disease|8|||
148736494|NCT01154816|536510220|FG002|Overall Study|Progressive Disease|9|||
148736495|NCT01154816|536510221|FG003|Overall Study|Progressive Disease|9|||
148736496|NCT01154816|536510222|FG004|Overall Study|Progressive Disease|8|||
148736497|NCT01154816|536510223|FG005|Overall Study|Progressive Disease|8|||
148736498|NCT01154816|536510224|FG006|Overall Study|Progressive Disease|5|||
148736499|NCT01154816|536510225|FG007|Overall Study|Progressive Disease|6|||
148736500|NCT01154816|536510226|FG008|Overall Study|Progressive Disease|8|||
148736501|NCT01154816|536510227|FG009|Overall Study|Progressive Disease|6|||
148736502|NCT01154816|536510228|FG010|Overall Study|Progressive Disease|10|||
148736503|NCT01154816|536510229|FG011|Overall Study|Progressive Disease|3|||
148736504|NCT01154816|536510218|FG000|Overall Study|Physician Decision|1|||
148736505|NCT01154816|536510219|FG001|Overall Study|Physician Decision|0|||
148736506|NCT01154816|536510220|FG002|Overall Study|Physician Decision|1|||
148736507|NCT01154816|536510221|FG003|Overall Study|Physician Decision|0|||
148736508|NCT01154816|536510222|FG004|Overall Study|Physician Decision|2|||
148736509|NCT01154816|536510223|FG005|Overall Study|Physician Decision|0|||
148736510|NCT01154816|536510224|FG006|Overall Study|Physician Decision|0|||
148736511|NCT01154816|536510225|FG007|Overall Study|Physician Decision|0|||
148736512|NCT01154816|536510226|FG008|Overall Study|Physician Decision|0|||
148736513|NCT01154816|536510227|FG009|Overall Study|Physician Decision|1|||
148736514|NCT01154816|536510228|FG010|Overall Study|Physician Decision|1|||
148736515|NCT01154816|536510229|FG011|Overall Study|Physician Decision|1|||
148736516|NCT01154816|536510218|FG000|Overall Study|Adverse Event|5|||
148736517|NCT01154816|536510219|FG001|Overall Study|Adverse Event|2|||
148736518|NCT01154816|536510220|FG002|Overall Study|Adverse Event|0|||
148736519|NCT01154816|536510221|FG003|Overall Study|Adverse Event|0|||
148736520|NCT01154816|536510222|FG004|Overall Study|Adverse Event|0|||
148736521|NCT01154816|536510223|FG005|Overall Study|Adverse Event|0|||
148736522|NCT01154816|536510224|FG006|Overall Study|Adverse Event|1|||
148736523|NCT01154816|536510225|FG007|Overall Study|Adverse Event|1|||
148736524|NCT01154816|536510226|FG008|Overall Study|Adverse Event|0|||
148736525|NCT01154816|536510227|FG009|Overall Study|Adverse Event|0|||
148736526|NCT01154816|536510228|FG010|Overall Study|Adverse Event|0|||
148736527|NCT01154816|536510229|FG011|Overall Study|Adverse Event|0|||
148736528|NCT04715932|536510230|FG000|Overall Study|Lost to Follow-up|1|||
148736529|NCT04715932|536510231|FG001|Overall Study|Lost to Follow-up|0|||
148736530|NCT02393248|536510232|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736531|NCT02393248|536510233|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
148736532|NCT02393248|536510234|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736533|NCT02393248|536510235|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736534|NCT02393248|536510236|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736535|NCT02393248|536510237|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
148736536|NCT02393248|536510238|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
148736537|NCT02393248|536510239|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736538|NCT02393248|536510240|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736539|NCT02393248|536510241|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736540|NCT02393248|536510242|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736541|NCT02393248|536510243|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736542|NCT02393248|536510244|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736543|NCT02393248|536510245|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736544|NCT02393248|536510246|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736545|NCT02393248|536510247|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736546|NCT02393248|536510248|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736547|NCT02393248|536510249|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736548|NCT02393248|536510250|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736549|NCT02393248|536510251|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736550|NCT02393248|536510252|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736551|NCT02393248|536510253|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736552|NCT02393248|536510254|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736553|NCT02393248|536510255|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736554|NCT02393248|536510256|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
148736555|NCT02393248|536510232|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736556|NCT02393248|536510233|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
148736557|NCT02393248|536510234|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736558|NCT02393248|536510235|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736559|NCT02393248|536510236|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736560|NCT02393248|536510237|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736561|NCT02393248|536510238|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736562|NCT02393248|536510239|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736563|NCT02393248|536510240|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736564|NCT02393248|536510241|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736565|NCT02393248|536510242|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736566|NCT02393248|536510243|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736567|NCT02393248|536510244|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736568|NCT02393248|536510245|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736569|NCT02393248|536510246|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736570|NCT02393248|536510247|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736571|NCT02393248|536510248|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736572|NCT02393248|536510249|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736573|NCT02393248|536510250|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736574|NCT02393248|536510251|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736575|NCT02393248|536510252|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736576|NCT02393248|536510253|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736577|NCT02393248|536510254|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736578|NCT02393248|536510255|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736579|NCT02393248|536510256|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
148736580|NCT02393248|536510232|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
148736581|NCT02393248|536510233|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
148736582|NCT02393248|536510234|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
148736583|NCT02393248|536510235|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
148736584|NCT02393248|536510236|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
148736585|NCT02393248|536510237|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
148736586|NCT02393248|536510238|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
148736587|NCT02393248|536510239|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
148736588|NCT02393248|536510240|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
148736589|NCT02393248|536510241|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
148736590|NCT02393248|536510242|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
148736591|NCT02393248|536510243|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
148736592|NCT02393248|536510244|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
148736593|NCT02393248|536510245|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
148736594|NCT02393248|536510246|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
148736595|NCT02393248|536510247|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
148736596|NCT02393248|536510248|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
148736597|NCT02393248|536510249|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
148736598|NCT02393248|536510250|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
148736599|NCT02393248|536510251|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
148736600|NCT02393248|536510252|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
148736601|NCT02393248|536510253|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
148736602|NCT02393248|536510254|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
148736603|NCT02393248|536510255|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
148736604|NCT02393248|536510256|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
148736605|NCT02393248|536510232|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
148736606|NCT02393248|536510233|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736607|NCT02393248|536510234|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736608|NCT02393248|536510235|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736609|NCT02393248|536510236|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736610|NCT02393248|536510237|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736611|NCT02393248|536510238|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736612|NCT02393248|536510239|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736613|NCT02393248|536510240|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736614|NCT02393248|536510241|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736615|NCT02393248|536510242|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736616|NCT02393248|536510243|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736617|NCT02393248|536510244|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736618|NCT02393248|536510245|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736619|NCT02393248|536510246|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736620|NCT02393248|536510247|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736621|NCT02393248|536510248|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736622|NCT02393248|536510249|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736623|NCT02393248|536510250|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736624|NCT02393248|536510251|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736625|NCT02393248|536510252|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736626|NCT02393248|536510253|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736627|NCT02393248|536510254|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736628|NCT02393248|536510255|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736629|NCT02393248|536510256|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
148736630|NCT02393248|536510232|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736631|NCT02393248|536510233|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736632|NCT02393248|536510234|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736633|NCT02393248|536510235|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736634|NCT02393248|536510236|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736635|NCT02393248|536510237|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
148736636|NCT02393248|536510238|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
148736637|NCT02393248|536510239|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736638|NCT02393248|536510240|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736639|NCT02393248|536510241|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
148736640|NCT02393248|536510242|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736641|NCT02393248|536510243|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736642|NCT02393248|536510244|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736643|NCT02393248|536510245|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736644|NCT02393248|536510246|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736645|NCT02393248|536510247|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736646|NCT02393248|536510248|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736647|NCT02393248|536510249|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736648|NCT02393248|536510250|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736649|NCT02393248|536510251|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736650|NCT02393248|536510252|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736651|NCT02393248|536510253|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736652|NCT02393248|536510254|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736653|NCT02393248|536510255|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736654|NCT02393248|536510256|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
148736655|NCT02393248|536510232|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736656|NCT02393248|536510233|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736657|NCT02393248|536510234|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736658|NCT02393248|536510235|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736659|NCT02393248|536510236|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736660|NCT02393248|536510237|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736661|NCT02393248|536510238|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
148736662|NCT02393248|536510239|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736663|NCT02393248|536510240|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736664|NCT02393248|536510241|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736665|NCT02393248|536510242|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736666|NCT02393248|536510243|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736667|NCT02393248|536510244|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736668|NCT02393248|536510245|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736669|NCT02393248|536510246|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736670|NCT02393248|536510247|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736671|NCT02393248|536510248|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736672|NCT02393248|536510249|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736673|NCT02393248|536510250|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736674|NCT02393248|536510251|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736675|NCT02393248|536510252|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736676|NCT02393248|536510253|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736677|NCT02393248|536510254|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736678|NCT02393248|536510255|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736679|NCT02393248|536510256|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
148736680|NCT02393248|536510232|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736681|NCT02393248|536510233|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736682|NCT02393248|536510234|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736683|NCT02393248|536510235|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736684|NCT02393248|536510236|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736685|NCT02393248|536510237|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736686|NCT02393248|536510238|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736687|NCT02393248|536510239|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736688|NCT02393248|536510240|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736689|NCT02393248|536510241|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736690|NCT02393248|536510242|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736691|NCT02393248|536510243|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
148736692|NCT02393248|536510244|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
148736693|NCT02393248|536510245|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
148736694|NCT02393248|536510246|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
148736695|NCT02393248|536510247|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736696|NCT02393248|536510248|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736697|NCT02393248|536510249|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736698|NCT02393248|536510250|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736699|NCT02393248|536510251|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736700|NCT02393248|536510252|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736701|NCT02393248|536510253|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736702|NCT02393248|536510254|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736703|NCT02393248|536510255|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736704|NCT02393248|536510256|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
148736705|NCT02393248|536510232|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736706|NCT02393248|536510233|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736707|NCT02393248|536510234|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736708|NCT02393248|536510235|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736709|NCT02393248|536510236|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736710|NCT02393248|536510237|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736711|NCT02393248|536510238|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736712|NCT02393248|536510239|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736713|NCT02393248|536510240|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736714|NCT02393248|536510241|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736715|NCT02393248|536510242|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
148736716|NCT02393248|536510243|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
148736717|NCT02393248|536510244|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736718|NCT02393248|536510245|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736719|NCT02393248|536510246|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736720|NCT02393248|536510247|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736721|NCT02393248|536510248|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736722|NCT02393248|536510249|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736723|NCT02393248|536510250|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736724|NCT02393248|536510251|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736725|NCT02393248|536510252|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736726|NCT02393248|536510253|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736727|NCT02393248|536510254|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736728|NCT02393248|536510255|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736729|NCT02393248|536510256|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
148736730|NCT02393248|536510232|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
148736731|NCT02393248|536510233|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
148736732|NCT02393248|536510234|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
148736733|NCT02393248|536510235|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
148736734|NCT02393248|536510236|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
148736735|NCT02393248|536510237|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
148736736|NCT02393248|536510238|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
148736737|NCT02393248|536510239|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
148736738|NCT02393248|536510240|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
148736739|NCT02393248|536510241|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
148736740|NCT02393248|536510242|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
148736741|NCT02393248|536510243|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
148736742|NCT02393248|536510244|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
148736743|NCT02393248|536510245|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
148736744|NCT02393248|536510246|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
148736745|NCT02393248|536510247|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
148736746|NCT02393248|536510248|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
148736747|NCT02393248|536510249|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
148736748|NCT02393248|536510250|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
148736749|NCT02393248|536510251|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
148736750|NCT02393248|536510252|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
148736751|NCT02393248|536510253|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
148736752|NCT02393248|536510254|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
148974431|NCT02346240|537387897|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148736753|NCT02393248|536510255|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
148736754|NCT02393248|536510256|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
148974432|NCT02346240|537387898|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974433|NCT02346240|537387899|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148736755|NCT02393248|536510232|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736756|NCT02393248|536510233|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736757|NCT02393248|536510234|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736758|NCT02393248|536510235|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736759|NCT02393248|536510236|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736760|NCT02393248|536510237|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736761|NCT02393248|536510238|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736762|NCT02393248|536510239|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736763|NCT02393248|536510240|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736764|NCT02393248|536510241|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736765|NCT02393248|536510242|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736766|NCT02393248|536510243|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
148736767|NCT02393248|536510244|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736768|NCT02393248|536510245|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
148736769|NCT02393248|536510246|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736770|NCT02393248|536510247|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736771|NCT02393248|536510248|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736772|NCT02393248|536510249|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736773|NCT02393248|536510250|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736774|NCT02393248|536510251|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736775|NCT02393248|536510252|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736776|NCT02393248|536510253|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736777|NCT02393248|536510254|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736778|NCT02393248|536510255|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736779|NCT02393248|536510256|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
148736780|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736781|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736782|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736783|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736784|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736785|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736786|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736787|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736788|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736789|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736790|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736791|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736792|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736793|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736794|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736795|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736796|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736797|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736798|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
148736799|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736800|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
148736801|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
148736802|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736803|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
148736804|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
148736805|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Death|0|||
148736806|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Death|0|||
148736807|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Death|0|||
148736808|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Death|0|||
148736809|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Death|0|||
148736810|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Death|0|||
148736811|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Death|0|||
148736812|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Death|0|||
148736813|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Death|0|||
148736814|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Death|0|||
148736815|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Death|0|||
148736816|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Death|0|||
148736817|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Death|0|||
148736818|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Death|0|||
148736819|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Death|0|||
148736820|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Death|1|||
148736821|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Death|7|||
148736822|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Death|5|||
148736823|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Death|5|||
148736824|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Death|3|||
148736825|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Death|7|||
148736826|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Death|5|||
148736827|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Death|6|||
148736828|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Death|3|||
148736829|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Death|0|||
148736830|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736831|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736832|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736833|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736834|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736835|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736836|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736837|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736838|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736839|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736840|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736841|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736842|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736843|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736844|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736845|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736846|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736847|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
148736848|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
148736849|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
148736850|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
148736851|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
148736852|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
148736853|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
148736854|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
148736855|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Disease Progression|0|||
148736856|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Disease Progression|0|||
148736857|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Disease Progression|0|||
148736858|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Disease Progression|0|||
148736859|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Disease Progression|0|||
148736860|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Disease Progression|0|||
148736861|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Disease Progression|0|||
148736862|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Disease Progression|0|||
148736863|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Disease Progression|0|||
148736864|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Disease Progression|0|||
148736865|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Disease Progression|0|||
148736866|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Disease Progression|0|||
148736867|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Disease Progression|0|||
148736868|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Disease Progression|0|||
148736869|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Disease Progression|0|||
148736870|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Disease Progression|0|||
148736871|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Disease Progression|0|||
148736872|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Disease Progression|0|||
148736873|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Disease Progression|0|||
148736874|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Disease Progression|0|||
148736875|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Disease Progression|2|||
148736876|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Disease Progression|1|||
148736877|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Disease Progression|0|||
148736878|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Disease Progression|0|||
148736879|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Disease Progression|0|||
148818036|NCT00504309|536808515|FG005|Overall Study|Withdrawal by Subject|0|||
148818037|NCT03345095|536808516|FG000|Overall Study|Lack of Efficacy|184|||
148818038|NCT03345095|536808517|FG001|Overall Study|Lack of Efficacy|156|||
148818039|NCT03345095|536808516|FG000|Overall Study|Adverse Event|36|||
148818040|NCT03345095|536808517|FG001|Overall Study|Adverse Event|118|||
148736880|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736881|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736882|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736883|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736884|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736885|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736886|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736887|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736888|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736889|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736890|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736891|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736892|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736893|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736894|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736895|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736896|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736897|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736898|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736899|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736900|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
148736901|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
148736902|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736903|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736904|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
148736905|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736906|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736907|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736908|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736909|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736910|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736911|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736912|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736913|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736914|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736915|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736916|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736917|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736918|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736919|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736920|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736921|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736922|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736923|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736924|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736925|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
148736926|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736927|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736928|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736929|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
148736930|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Adverse Event|0|||
148736931|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Adverse Event|0|||
148736932|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Adverse Event|0|||
148736933|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Adverse Event|0|||
148736934|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Adverse Event|0|||
148736935|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Adverse Event|0|||
148818041|NCT03345095|536808516|FG000|Overall Study|Withdrawal by Subject|22|||
148818042|NCT03345095|536808517|FG001|Overall Study|Withdrawal by Subject|59|||
148818043|NCT03345095|536808516|FG000|Overall Study|Physician Decision|3|||
148818044|NCT03345095|536808517|FG001|Overall Study|Physician Decision|18|||
148818045|NCT03345095|536808516|FG000|Overall Study|Death|2|||
148818046|NCT03345095|536808517|FG001|Overall Study|Death|4|||
148818047|NCT03345095|536808516|FG000|Overall Study|Other reasons|2|||
148736936|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Adverse Event|0|||
148736937|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Adverse Event|0|||
148736938|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Adverse Event|0|||
148736939|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Adverse Event|0|||
148736940|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Adverse Event|0|||
148736941|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Adverse Event|0|||
148736942|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Adverse Event|0|||
148818048|NCT03345095|536808517|FG001|Overall Study|Other reasons|11|||
148818049|NCT03345095|536808516|FG000|Overall Study|Protocol Violation|0|||
148818050|NCT03345095|536808517|FG001|Overall Study|Protocol Violation|1|||
148818051|NCT03554473|536810282|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
148818052|NCT03554473|536810283|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
148818053|NCT03554473|536810284|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
148818054|NCT03554473|536810282|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
148818055|NCT03554473|536810283|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
148818056|NCT03554473|536810284|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
148818057|NCT03554473|536810282|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
148818058|NCT03554473|536810283|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
148818059|NCT03554473|536810284|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
148818060|NCT04971837|536810288|FG000|Overall Study|Long Term Illness|1|||
148818061|NCT04971837|536810288|FG000|Overall Study|BMI too low|9|||
148818062|NCT04971837|536810288|FG000|Overall Study|geographic location|1|||
148818063|NCT04971837|536810288|FG000|Overall Study|Discontinued scheduling conflict|1|||
148818064|NCT05206604|536810289|FG000|Overall Study|Non-compliance with study drug|0|||
148974434|NCT02346240|537387900|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
148974435|NCT02346240|537387901|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974436|NCT02346240|537387902|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974437|NCT02346240|537387903|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974438|NCT02346240|537387904|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974439|NCT02346240|537387905|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
148974440|NCT02942017|537387906|FG000|Overall Study|Adverse Event|0|||
148974441|NCT02942017|537387907|FG001|Overall Study|Adverse Event|1|||
148974442|NCT02942017|537387906|FG000|Overall Study|Withdrawal by Subject|0|||
148974443|NCT02942017|537387907|FG001|Overall Study|Withdrawal by Subject|1|||
148974444|NCT02942017|537387906|FG000|Overall Study|Lost to Follow-up|1|||
148974445|NCT02942017|537387907|FG001|Overall Study|Lost to Follow-up|1|||
148974446|NCT02942017|537387906|FG000|Overall Study|Randomized but not dosed|1|||
148974447|NCT02942017|537387907|FG001|Overall Study|Randomized but not dosed|3|||
148974448|NCT04399161|537387908|FG000|Overall Study|Withdrawal by Subject|1|||
148974449|NCT04399161|537387909|FG001|Overall Study|Withdrawal by Subject|0|||
148974450|NCT04399161|537387910|FG002|Overall Study|Withdrawal by Subject|2|||
148974451|NCT04399161|537387908|FG000|Overall Study|Protocol Violation|1|||
148974452|NCT04399161|537387909|FG001|Overall Study|Protocol Violation|2|||
148974453|NCT04399161|537387910|FG002|Overall Study|Protocol Violation|0|||
148974454|NCT03417141|537387911|FG000|Overall Study|Withdrawal by Subject|1|||
148736943|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Adverse Event|0|||
148736944|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Adverse Event|0|||
148736945|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Adverse Event|0|||
148736946|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Adverse Event|0|||
148736947|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Adverse Event|0|||
148736948|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Adverse Event|0|||
148736949|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Adverse Event|0|||
148736950|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Adverse Event|0|||
148736951|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Adverse Event|0|||
148736952|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Adverse Event|0|||
148736953|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Adverse Event|1|||
148736954|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Adverse Event|0|||
148736955|NCT02393248|536510232|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736956|NCT02393248|536510233|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736957|NCT02393248|536510234|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736958|NCT02393248|536510235|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736959|NCT02393248|536510236|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736960|NCT02393248|536510237|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736961|NCT02393248|536510238|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736962|NCT02393248|536510239|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736963|NCT02393248|536510240|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148974455|NCT03417141|537387911|FG000|Overall Study|Protocol Violation|3|||
148974456|NCT04552587|537387915|FG000|Overall Study|Lost to Follow-up|4|||
148974457|NCT01822132|537387916|FG000|Overall Study|Lost to Follow-up|4|||
148974458|NCT01822132|537387917|FG001|Overall Study|Lost to Follow-up|2|||
148974459|NCT03465878|537387920|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
148974460|NCT03465878|537387921|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
148736964|NCT02393248|536510241|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736965|NCT02393248|536510242|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736966|NCT02393248|536510243|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736967|NCT02393248|536510244|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736968|NCT02393248|536510245|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736969|NCT02393248|536510246|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736970|NCT02393248|536510247|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736971|NCT02393248|536510248|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736972|NCT02393248|536510249|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736973|NCT02393248|536510250|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736974|NCT02393248|536510251|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736975|NCT02393248|536510252|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736976|NCT02393248|536510253|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736977|NCT02393248|536510254|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736978|NCT02393248|536510255|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
148736979|NCT02393248|536510256|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
148736980|NCT03560986|536510257|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
148736981|NCT03560986|536510258|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
148736982|NCT03560986|536510257|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
148736983|NCT03560986|536510258|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
148736984|NCT03560986|536510257|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
148736985|NCT03560986|536510258|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
148736986|NCT03560986|536510257|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
148736987|NCT03560986|536510258|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
148736988|NCT03560986|536510257|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
148736989|NCT03560986|536510258|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
148736990|NCT03560986|536510257|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
148736991|NCT03560986|536510258|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
148736992|NCT03560986|536510257|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
148736993|NCT03560986|536510258|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
148736994|NCT02603393|536510259|FG000|Overall Study|Patient/guardian decision|32|||
148736995|NCT02603393|536510260|FG001|Overall Study|Patient/guardian decision|18|||
148736996|NCT02603393|536510259|FG000|Overall Study|Adverse Event|17|||
148736997|NCT02603393|536510260|FG001|Overall Study|Adverse Event|15|||
148736998|NCT02603393|536510259|FG000|Overall Study|Technical problems|4|||
148736999|NCT02603393|536510260|FG001|Overall Study|Technical problems|7|||
148737000|NCT02603393|536510259|FG000|Overall Study|Lack of Efficacy|7|||
148737001|NCT02603393|536510260|FG001|Overall Study|Lack of Efficacy|2|||
148737002|NCT02603393|536510259|FG000|Overall Study|Death|3|||
148737003|NCT02603393|536510260|FG001|Overall Study|Death|4|||
148737004|NCT02603393|536510259|FG000|Overall Study|Physician Decision|3|||
148737005|NCT02603393|536510260|FG001|Overall Study|Physician Decision|3|||
148737006|NCT02603393|536510259|FG000|Overall Study|Protocol deviation|2|||
148737007|NCT02603393|536510260|FG001|Overall Study|Protocol deviation|3|||
148737008|NCT02603393|536510259|FG000|Overall Study|Lost to Follow-up|1|||
148737009|NCT02603393|536510260|FG001|Overall Study|Lost to Follow-up|2|||
148737010|NCT02603393|536510259|FG000|Overall Study|Non-compliance with study treatment|1|||
148737011|NCT02603393|536510260|FG001|Overall Study|Non-compliance with study treatment|0|||
148737012|NCT02603393|536510259|FG000|Overall Study|Sponsor decision|1|||
148737013|NCT02603393|536510260|FG001|Overall Study|Sponsor decision|0|||
148737014|NCT01868893|536510261|FG000|Overall Study|Adverse Event|2|||
148737015|NCT01868893|536510261|FG000|Overall Study|Commercial availability of study drug|17|||
148818065|NCT05206604|536810290|FG001|Overall Study|Non-compliance with study drug|0|||
148818066|NCT05206604|536810291|FG002|Overall Study|Non-compliance with study drug|0|||
148818067|NCT05206604|536810292|FG003|Overall Study|Non-compliance with study drug|0|||
148818068|NCT05206604|536810293|FG004|Overall Study|Non-compliance with study drug|0|||
148818069|NCT05206604|536810294|FG005|Overall Study|Non-compliance with study drug|1|||
148818070|NCT05206604|536810295|FG006|Overall Study|Non-compliance with study drug|0|||
148818071|NCT05206604|536810296|FG007|Overall Study|Non-compliance with study drug|0|||
148818072|NCT00160615|536810297|FG000|Overall Study|Adverse Event|5|||
148818073|NCT00160615|536810298|FG001|Overall Study|Adverse Event|12|||
148818074|NCT00160615|536810297|FG000|Overall Study|Withdrawal by Subject|0|||
148818075|NCT00160615|536810298|FG001|Overall Study|Withdrawal by Subject|2|||
148818076|NCT00160615|536810297|FG000|Overall Study|Lack of Efficacy|11|||
148818077|NCT00160615|536810298|FG001|Overall Study|Lack of Efficacy|23|||
148818078|NCT00160615|536810297|FG000|Overall Study|Patient decision|1|||
148818079|NCT00160615|536810298|FG001|Overall Study|Patient decision|2|||
148818080|NCT00160615|536810297|FG000|Overall Study|Investigator decision|1|||
148818081|NCT00160615|536810298|FG001|Overall Study|Investigator decision|1|||
148737016|NCT01868893|536510261|FG000|Overall Study|Neutropenia|1|||
148737017|NCT01857271|536510262|FG000|Overall Study|Lost to Follow-up|1|||
148974461|NCT03465878|537387922|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
148974462|NCT03465878|537387923|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
148974463|NCT03465878|537387920|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
148974464|NCT03465878|537387921|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
148974465|NCT03465878|537387922|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
148974466|NCT03465878|537387923|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
148974467|NCT03465878|537387920|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
148974468|NCT03465878|537387921|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
148974469|NCT03465878|537387922|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
148974470|NCT03465878|537387923|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
148974471|NCT02540954|537387924|FG000|Overall Study|Physician Decision|3|||
148974472|NCT02540954|537387925|FG001|Overall Study|Physician Decision|1|||
148974473|NCT02540954|537387924|FG000|Overall Study|Withdrawal by Subject|6|||
148974474|NCT02540954|537387925|FG001|Overall Study|Withdrawal by Subject|5|||
148974475|NCT02540954|537387924|FG000|Overall Study|Lost to Follow-up|1|||
148974476|NCT02540954|537387925|FG001|Overall Study|Lost to Follow-up|1|||
148974477|NCT02540954|537387924|FG000|Overall Study|Adverse Event|4|||
148974478|NCT02540954|537387925|FG001|Overall Study|Adverse Event|2|||
148974479|NCT02540954|537387924|FG000|Overall Study|Death|0|||
148974480|NCT02540954|537387925|FG001|Overall Study|Death|3|||
148974481|NCT02540954|537387924|FG000|Overall Study|Treatment failure|1|||
148974482|NCT02540954|537387925|FG001|Overall Study|Treatment failure|0|||
148974483|NCT02540954|537387924|FG000|Overall Study|Other reason|4|||
148974484|NCT02540954|537387925|FG001|Overall Study|Other reason|2|||
148974485|NCT01393743|537387926|FG000|Core Study|Adverse Event|5|||
148974486|NCT01393743|537387927|FG001|Core Study|Adverse Event|9|||
148974487|NCT01393743|537387928|FG002|Core Study|Adverse Event|0|||
148974488|NCT01393743|537387926|FG000|Core Study|Lost to Follow-up|1|||
148974489|NCT01393743|537387927|FG001|Core Study|Lost to Follow-up|1|||
148974490|NCT01393743|537387928|FG002|Core Study|Lost to Follow-up|0|||
148974491|NCT01393743|537387926|FG000|Core Study|Participant's Choice|2|||
148974492|NCT01393743|537387927|FG001|Core Study|Participant's Choice|3|||
148974493|NCT01393743|537387928|FG002|Core Study|Participant's Choice|0|||
148974494|NCT01393743|537387926|FG000|Core Study|Inadequate therapeutic effect|2|||
148974495|NCT01393743|537387927|FG001|Core Study|Inadequate therapeutic effect|0|||
148974496|NCT01393743|537387928|FG002|Core Study|Inadequate therapeutic effect|0|||
148974497|NCT01393743|537387926|FG000|Extension Phase|Adverse Event|0|||
148974498|NCT01393743|537387927|FG001|Extension Phase|Adverse Event|0|||
148974499|NCT01393743|537387928|FG002|Extension Phase|Adverse Event|12|||
148974500|NCT01393743|537387926|FG000|Extension Phase|Lost to Follow-up|0|||
148737018|NCT01783548|536510263|FG000|Overall Study|Adverse Event|8|||
148737019|NCT01783548|536510264|FG001|Overall Study|Adverse Event|4|||
148737020|NCT01783548|536510263|FG000|Overall Study|Withdrawal by Subject|11|||
148737021|NCT01783548|536510264|FG001|Overall Study|Withdrawal by Subject|8|||
148737022|NCT01783548|536510263|FG000|Overall Study|Non-compliance|4|||
148737023|NCT01783548|536510264|FG001|Overall Study|Non-compliance|0|||
148737024|NCT01783548|536510263|FG000|Overall Study|Protocol Violation|2|||
148737025|NCT01783548|536510264|FG001|Overall Study|Protocol Violation|2|||
148737026|NCT01783548|536510263|FG000|Overall Study|Lost to Follow-up|8|||
148737027|NCT01783548|536510264|FG001|Overall Study|Lost to Follow-up|3|||
148737028|NCT01783548|536510263|FG000|Overall Study|Lack of Efficacy|1|||
148737029|NCT01783548|536510264|FG001|Overall Study|Lack of Efficacy|1|||
148737030|NCT03825341|536510265|FG000|Overall Study|Withdrawal by Subject|0|||
148737031|NCT03825341|536510266|FG001|Overall Study|Withdrawal by Subject|1|||
148974501|NCT01393743|537387927|FG001|Extension Phase|Lost to Follow-up|0|||
148974502|NCT01393743|537387928|FG002|Extension Phase|Lost to Follow-up|2|||
148974503|NCT01393743|537387926|FG000|Extension Phase|Participant choice|0|||
148974504|NCT01393743|537387927|FG001|Extension Phase|Participant choice|0|||
148974505|NCT01393743|537387928|FG002|Extension Phase|Participant choice|16|||
148974506|NCT01393743|537387926|FG000|Extension Phase|Inadequate therapeutic effect|0|||
148974507|NCT01393743|537387927|FG001|Extension Phase|Inadequate therapeutic effect|0|||
148974508|NCT01393743|537387928|FG002|Extension Phase|Inadequate therapeutic effect|7|||
148974509|NCT01393743|537387926|FG000|Extension Phase|Withdrawal by Subject|0|||
148974510|NCT01393743|537387927|FG001|Extension Phase|Withdrawal by Subject|0|||
148974511|NCT01393743|537387928|FG002|Extension Phase|Withdrawal by Subject|8|||
148974512|NCT01393743|537387926|FG000|Extension Phase|Pregnancy|0|||
148974513|NCT01393743|537387927|FG001|Extension Phase|Pregnancy|0|||
148974514|NCT01393743|537387928|FG002|Extension Phase|Pregnancy|1|||
148974515|NCT01393743|537387926|FG000|Extension Phase|Other|0|||
148737032|NCT04053465|536510272|FG000|Overall Study|Withdrawal by Subject|4|||
148737033|NCT04053465|536510273|FG001|Overall Study|Withdrawal by Subject|4|||
148737034|NCT01059539|536510274|FG000|Overall Study|Adverse Event|66|||
148737035|NCT01059539|536510274|FG000|Overall Study|Insufficient Therapeutic Response|26|||
148737036|NCT01059539|536510274|FG000|Overall Study|Protocol Violation|55|||
148974516|NCT01393743|537387927|FG001|Extension Phase|Other|0|||
148974517|NCT01393743|537387928|FG002|Extension Phase|Other|14|||
148974518|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
148737037|NCT01059539|536510274|FG000|Overall Study|Withdrawal of Consent|80|||
148737038|NCT01059539|536510274|FG000|Overall Study|Lost to Follow-up|42|||
148737039|NCT01059539|536510274|FG000|Overall Study|Reason Not Specified|2|||
148737040|NCT04228783|536510275|FG000|Overall Study|Adverse Event|1|||
148737041|NCT04228783|536510276|FG001|Overall Study|Adverse Event|0|||
148737042|NCT04228783|536510277|FG002|Overall Study|Adverse Event|2|||
148737043|NCT04228783|536510278|FG003|Overall Study|Adverse Event|0|||
148737044|NCT04228783|536510279|FG004|Overall Study|Adverse Event|0|||
148737045|NCT04228783|536510280|FG005|Overall Study|Adverse Event|1|||
148737046|NCT04228783|536510275|FG000|Overall Study|Death|0|||
148737047|NCT04228783|536510276|FG001|Overall Study|Death|0|||
148737048|NCT04228783|536510277|FG002|Overall Study|Death|0|||
148737049|NCT04228783|536510278|FG003|Overall Study|Death|0|||
148737050|NCT04228783|536510279|FG004|Overall Study|Death|1|||
148737051|NCT04228783|536510280|FG005|Overall Study|Death|0|||
148737052|NCT04228783|536510275|FG000|Overall Study|Lost to Follow-up|36|||
148737053|NCT04228783|536510276|FG001|Overall Study|Lost to Follow-up|36|||
148974519|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
148974520|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
148974521|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
148974522|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
148974523|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
148974524|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
148974525|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
148974526|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
148974527|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
148974528|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
148974529|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
148974530|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
148974531|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
148974532|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
148974533|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
148974534|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
148974535|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
148974536|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
148974537|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
148974538|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Other|3|||
148974539|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Other|0|||
148974540|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Other|2|||
148974541|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Other|2|||
148974542|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Other|7|||
148974543|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974544|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974545|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974546|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
148974547|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974548|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
148974549|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
148974550|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
148974551|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
148974552|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
148974553|NCT00213148|537387929|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
148974554|NCT00213148|537387930|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
148974555|NCT00213148|537387931|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
148974556|NCT00213148|537387932|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
148974557|NCT00213148|537387933|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
148974558|NCT00213148|537387929|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
148974559|NCT00213148|537387930|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
148737054|NCT04228783|536510277|FG002|Overall Study|Lost to Follow-up|28|||
148737055|NCT04228783|536510278|FG003|Overall Study|Lost to Follow-up|6|||
148974560|NCT00213148|537387931|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
148974561|NCT00213148|537387932|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
148974562|NCT00213148|537387933|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
148974563|NCT00213148|537387929|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
148974564|NCT00213148|537387930|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
148974565|NCT00213148|537387931|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
148737056|NCT04228783|536510279|FG004|Overall Study|Lost to Follow-up|14|||
148737057|NCT04228783|536510280|FG005|Overall Study|Lost to Follow-up|3|||
148737058|NCT04228783|536510275|FG000|Overall Study|Physician Decision|1|||
148974566|NCT00213148|537387932|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
148974567|NCT00213148|537387933|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
148974568|NCT00213148|537387929|FG000|Cycle 2 (1 Month)|Other|2|||
148974569|NCT00213148|537387930|FG001|Cycle 2 (1 Month)|Other|1|||
148974570|NCT00213148|537387931|FG002|Cycle 2 (1 Month)|Other|2|||
148974571|NCT00213148|537387932|FG003|Cycle 2 (1 Month)|Other|8|||
148974572|NCT00213148|537387933|FG004|Cycle 2 (1 Month)|Other|7|||
148737059|NCT04228783|536510276|FG001|Overall Study|Physician Decision|2|||
148974573|NCT00213148|537387929|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148737060|NCT04228783|536510277|FG002|Overall Study|Physician Decision|0|||
148737061|NCT04228783|536510278|FG003|Overall Study|Physician Decision|0|||
148737062|NCT04228783|536510279|FG004|Overall Study|Physician Decision|0|||
148737063|NCT04228783|536510280|FG005|Overall Study|Physician Decision|0|||
148737064|NCT04228783|536510275|FG000|Overall Study|Protocol Violation|0|||
148737065|NCT04228783|536510276|FG001|Overall Study|Protocol Violation|0|||
148737066|NCT04228783|536510277|FG002|Overall Study|Protocol Violation|0|||
148737067|NCT04228783|536510278|FG003|Overall Study|Protocol Violation|1|||
148737068|NCT04228783|536510279|FG004|Overall Study|Protocol Violation|0|||
148737069|NCT04228783|536510280|FG005|Overall Study|Protocol Violation|0|||
148737070|NCT04228783|536510275|FG000|Overall Study|Withdrawal by Subject|6|||
148737071|NCT04228783|536510276|FG001|Overall Study|Withdrawal by Subject|10|||
148737072|NCT04228783|536510277|FG002|Overall Study|Withdrawal by Subject|19|||
148737073|NCT04228783|536510278|FG003|Overall Study|Withdrawal by Subject|1|||
148737074|NCT04228783|536510279|FG004|Overall Study|Withdrawal by Subject|2|||
148737075|NCT04228783|536510280|FG005|Overall Study|Withdrawal by Subject|0|||
148737076|NCT04228783|536510275|FG000|Overall Study|Other|4|||
148737077|NCT04228783|536510276|FG001|Overall Study|Other|3|||
148737078|NCT04228783|536510277|FG002|Overall Study|Other|2|||
148737079|NCT04228783|536510278|FG003|Overall Study|Other|1|||
148737080|NCT04228783|536510279|FG004|Overall Study|Other|0|||
148737081|NCT04228783|536510280|FG005|Overall Study|Other|0|||
148737082|NCT00626392|536510281|FG000|Run-in Period|Adverse Event|0|||
148737083|NCT00626392|536510282|FG001|Run-in Period|Adverse Event|0|||
148737084|NCT00626392|536510283|FG002|Run-in Period|Adverse Event|1|||
148737085|NCT00626392|536510284|FG003|Run-in Period|Adverse Event|0|||
148737086|NCT00626392|536510285|FG004|Run-in Period|Adverse Event|1|||
148737087|NCT00626392|536510286|FG005|Run-in Period|Adverse Event|0|||
148737088|NCT00626392|536510281|FG000|Run-in Period|Withdrawal by Subject|0|||
148737089|NCT00626392|536510282|FG001|Run-in Period|Withdrawal by Subject|1|||
148737090|NCT00626392|536510283|FG002|Run-in Period|Withdrawal by Subject|1|||
148737091|NCT00626392|536510284|FG003|Run-in Period|Withdrawal by Subject|1|||
148737092|NCT00626392|536510285|FG004|Run-in Period|Withdrawal by Subject|3|||
148737093|NCT00626392|536510286|FG005|Run-in Period|Withdrawal by Subject|1|||
148737094|NCT00626392|536510281|FG000|Run-in Period|Noncompliance|1|||
148737095|NCT00626392|536510282|FG001|Run-in Period|Noncompliance|0|||
148737096|NCT00626392|536510283|FG002|Run-in Period|Noncompliance|1|||
148737097|NCT00626392|536510284|FG003|Run-in Period|Noncompliance|0|||
148737098|NCT00626392|536510285|FG004|Run-in Period|Noncompliance|0|||
148737099|NCT00626392|536510286|FG005|Run-in Period|Noncompliance|0|||
148737100|NCT00626392|536510281|FG000|Coadministration Period|Adverse Event|3|||
148737101|NCT00626392|536510282|FG001|Coadministration Period|Adverse Event|1|||
148737102|NCT00626392|536510283|FG002|Coadministration Period|Adverse Event|7|||
148737103|NCT00626392|536510284|FG003|Coadministration Period|Adverse Event|4|||
148737104|NCT00626392|536510285|FG004|Coadministration Period|Adverse Event|3|||
148737105|NCT00626392|536510286|FG005|Coadministration Period|Adverse Event|4|||
148737106|NCT00626392|536510281|FG000|Coadministration Period|Withdrawal by Subject|1|||
148737107|NCT00626392|536510282|FG001|Coadministration Period|Withdrawal by Subject|1|||
148737108|NCT00626392|536510283|FG002|Coadministration Period|Withdrawal by Subject|0|||
148737109|NCT00626392|536510284|FG003|Coadministration Period|Withdrawal by Subject|1|||
148737110|NCT00626392|536510285|FG004|Coadministration Period|Withdrawal by Subject|0|||
148737111|NCT00626392|536510286|FG005|Coadministration Period|Withdrawal by Subject|1|||
148737112|NCT00626392|536510281|FG000|Coadministration Period|Protocol Violation|0|||
148737113|NCT00626392|536510282|FG001|Coadministration Period|Protocol Violation|1|||
148737114|NCT00626392|536510283|FG002|Coadministration Period|Protocol Violation|0|||
148737115|NCT00626392|536510284|FG003|Coadministration Period|Protocol Violation|1|||
148974574|NCT00213148|537387930|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
148974575|NCT00213148|537387931|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974576|NCT00213148|537387932|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974577|NCT00213148|537387933|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
148974578|NCT00213148|537387929|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
148974579|NCT00213148|537387930|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
148974580|NCT00213148|537387931|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
148737116|NCT00626392|536510285|FG004|Coadministration Period|Protocol Violation|1|||
148737117|NCT00626392|536510286|FG005|Coadministration Period|Protocol Violation|0|||
148737118|NCT00626392|536510281|FG000|Coadministration Period|Other|0|||
148737119|NCT00626392|536510282|FG001|Coadministration Period|Other|2|||
148737120|NCT00626392|536510283|FG002|Coadministration Period|Other|3|||
148737121|NCT00626392|536510284|FG003|Coadministration Period|Other|1|||
148737122|NCT00626392|536510285|FG004|Coadministration Period|Other|1|||
148737123|NCT00626392|536510286|FG005|Coadministration Period|Other|1|||
148737124|NCT03151811|536510288|FG000|Overall Study|Randomized But Not Treated|18|||
148737125|NCT03151811|536510289|FG001|Overall Study|Randomized But Not Treated|3|||
148737126|NCT03151811|536510288|FG000|Overall Study|Progressive Disease|130|||
148737127|NCT03151811|536510289|FG001|Overall Study|Progressive Disease|170|||
148737128|NCT03151811|536510288|FG000|Overall Study|Adverse Event|49|||
148737129|NCT03151811|536510289|FG001|Overall Study|Adverse Event|40|||
148737130|NCT03151811|536510288|FG000|Overall Study|Lack of Efficacy|6|||
148737131|NCT03151811|536510289|FG001|Overall Study|Lack of Efficacy|8|||
148737132|NCT03151811|536510288|FG000|Overall Study|Physician Decision|21|||
148737133|NCT03151811|536510289|FG001|Overall Study|Physician Decision|9|||
148737134|NCT03151811|536510288|FG000|Overall Study|Withdrawal by Subject|17|||
148737135|NCT03151811|536510289|FG001|Overall Study|Withdrawal by Subject|7|||
148737136|NCT03151811|536510288|FG000|Overall Study|Lost to Follow-up|0|||
148737137|NCT03151811|536510289|FG001|Overall Study|Lost to Follow-up|1|||
148737138|NCT03151811|536510288|FG000|Overall Study|Study Terminated by Sponsor|5|||
148737139|NCT03151811|536510289|FG001|Overall Study|Study Terminated by Sponsor|11|||
148737140|NCT00742924|536510292|FG000|Overall Study|Adverse Event|0|||
148737141|NCT00742924|536510293|FG001|Overall Study|Adverse Event|0|||
148737142|NCT00742924|536510294|FG002|Overall Study|Adverse Event|1|||
148737143|NCT00742924|536510295|FG003|Overall Study|Adverse Event|1|||
148737144|NCT00742924|536510292|FG000|Overall Study|Lack of Efficacy|5|||
148737145|NCT00742924|536510293|FG001|Overall Study|Lack of Efficacy|1|||
148737146|NCT00742924|536510294|FG002|Overall Study|Lack of Efficacy|2|||
148737147|NCT00742924|536510295|FG003|Overall Study|Lack of Efficacy|4|||
148737148|NCT00742924|536510292|FG000|Overall Study|Physician Decision|0|||
148737149|NCT00742924|536510293|FG001|Overall Study|Physician Decision|0|||
148737150|NCT00742924|536510294|FG002|Overall Study|Physician Decision|0|||
148737151|NCT00742924|536510295|FG003|Overall Study|Physician Decision|1|||
148737152|NCT00742924|536510292|FG000|Overall Study|Withdrawal by Subject|0|||
148737153|NCT00742924|536510293|FG001|Overall Study|Withdrawal by Subject|1|||
148737154|NCT00742924|536510294|FG002|Overall Study|Withdrawal by Subject|1|||
148737155|NCT00742924|536510295|FG003|Overall Study|Withdrawal by Subject|0|||
148737156|NCT00660400|536510296|FG000|Overall Study|Lack of insurance approval|1|||
148737157|NCT00660400|536510296|FG000|Overall Study|Suboptimal organ function|1|||
148737158|NCT00660400|536510296|FG000|Overall Study|Intracranial hemorrhage|1|||
148737159|NCT00660400|536510296|FG000|Overall Study|Withdrawal by Subject|1|||
148737160|NCT04005352|536510310|FG000|Overall Study|Adverse Event|4|||
148737161|NCT04005352|536510311|FG001|Overall Study|Adverse Event|5|||
148737162|NCT04005352|536510310|FG000|Overall Study|Death|4|||
148737163|NCT04005352|536510311|FG001|Overall Study|Death|2|||
148737164|NCT04005352|536510310|FG000|Overall Study|Lost to Follow-up|6|||
148737165|NCT04005352|536510311|FG001|Overall Study|Lost to Follow-up|2|||
148737166|NCT04005352|536510310|FG000|Overall Study|Physician Decision|7|||
148737167|NCT04005352|536510311|FG001|Overall Study|Physician Decision|13|||
148737168|NCT04005352|536510310|FG000|Overall Study|Protocol Violation|0|||
148737169|NCT04005352|536510311|FG001|Overall Study|Protocol Violation|1|||
148737170|NCT04005352|536510310|FG000|Overall Study|Withdrawal by Subject|28|||
148737171|NCT04005352|536510311|FG001|Overall Study|Withdrawal by Subject|38|||
148737172|NCT05005312|536510314|FG000|Overall Study|Enrolled, but not treated|0|||
148737173|NCT05005312|536510315|FG001|Overall Study|Enrolled, but not treated|1|||
148737174|NCT01283035|536510316|FG000|Overall Study|Subject later found ineligible|1|||
148737175|NCT02792699|536510317|FG000|Overall Study|Adverse Event|1|||
148737176|NCT02792699|536510318|FG001|Overall Study|Adverse Event|2|||
148737177|NCT02792699|536510319|FG002|Overall Study|Adverse Event|4|||
148737178|NCT02792699|536510317|FG000|Overall Study|Withdrawal by Subject|4|||
148737179|NCT02792699|536510318|FG001|Overall Study|Withdrawal by Subject|4|||
148737180|NCT02792699|536510319|FG002|Overall Study|Withdrawal by Subject|3|||
148737181|NCT02792699|536510317|FG000|Overall Study|Lost to Follow-up|0|||
148737182|NCT02792699|536510318|FG001|Overall Study|Lost to Follow-up|1|||
148737183|NCT02792699|536510319|FG002|Overall Study|Lost to Follow-up|2|||
148737184|NCT02792699|536510317|FG000|Overall Study|Physician Decision|2|||
148737185|NCT02792699|536510318|FG001|Overall Study|Physician Decision|0|||
148737186|NCT02792699|536510319|FG002|Overall Study|Physician Decision|0|||
148737187|NCT02792699|536510317|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
148737188|NCT02792699|536510318|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
148737189|NCT02792699|536510319|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
148818082|NCT00160615|536810297|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
148737190|NCT02792699|536510317|FG000|Overall Study|Other|1|||
148818083|NCT00160615|536810298|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
148818084|NCT00160615|536810297|FG000|Overall Study|Switch to surgical treatment|0|||
148737191|NCT02792699|536510318|FG001|Overall Study|Other|0|||
148737192|NCT02792699|536510319|FG002|Overall Study|Other|0|||
148737193|NCT02970318|536510321|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
148737194|NCT02970318|536510322|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
148737195|NCT02970318|536510323|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
148737196|NCT02970318|536510324|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
148737197|NCT02970318|536510321|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
148737198|NCT02970318|536510322|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
148737199|NCT02970318|536510323|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
148737200|NCT02970318|536510324|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
148737201|NCT02970318|536510321|FG000|Overall for Arm A & Main for Arm B|Death|41|||
148737202|NCT02970318|536510322|FG001|Overall for Arm A & Main for Arm B|Death|33|||
148737203|NCT02970318|536510323|FG002|Overall for Arm A & Main for Arm B|Death|0|||
148737204|NCT02970318|536510324|FG003|Overall for Arm A & Main for Arm B|Death|0|||
148737205|NCT02970318|536510321|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
148737206|NCT02970318|536510322|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
148737207|NCT02970318|536510323|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
148737208|NCT02970318|536510324|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
148737209|NCT02970318|536510321|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
148737210|NCT02970318|536510322|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
148737211|NCT02970318|536510323|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
148737212|NCT02970318|536510324|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
148737213|NCT02970318|536510321|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
148737214|NCT02970318|536510322|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
148737215|NCT02970318|536510323|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
148737216|NCT02970318|536510324|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
148737217|NCT02970318|536510321|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
148737218|NCT02970318|536510322|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
148737219|NCT02970318|536510323|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
148737220|NCT02970318|536510324|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
148737221|NCT02500641|536510325|FG000|Overall Study|Adverse Event|0|||
148818085|NCT00160615|536810298|FG001|Overall Study|Switch to surgical treatment|2|||
148818086|NCT00160615|536810297|FG000|Overall Study|Non-compliance was suspected|0|||
148818087|NCT00160615|536810298|FG001|Overall Study|Non-compliance was suspected|1|||
148818088|NCT00160615|536810297|FG000|Overall Study|Poor compliance|0|||
148818089|NCT00160615|536810298|FG001|Overall Study|Poor compliance|1|||
148818090|NCT03166631|536810299|FG000|Overall Study|Progressive disease|2|||
148818091|NCT03166631|536810300|FG001|Overall Study|Progressive disease|1|||
148818092|NCT03166631|536810301|FG002|Overall Study|Progressive disease|3|||
148818093|NCT03166631|536810302|FG003|Overall Study|Progressive disease|4|||
148818094|NCT03166631|536810303|FG004|Overall Study|Progressive disease|2|||
148818095|NCT03166631|536810304|FG005|Overall Study|Progressive disease|2|||
148818096|NCT03166631|536810305|FG006|Overall Study|Progressive disease|5|||
148818097|NCT03166631|536810306|FG007|Overall Study|Progressive disease|6|||
148818098|NCT03166631|536810307|FG008|Overall Study|Progressive disease|11|||
148818099|NCT03166631|536810308|FG009|Overall Study|Progressive disease|5|||
148818100|NCT03166631|536810309|FG010|Overall Study|Progressive disease|7|||
148818101|NCT03166631|536810299|FG000|Overall Study|Physician Decision|0|||
148818102|NCT03166631|536810300|FG001|Overall Study|Physician Decision|0|||
148818103|NCT03166631|536810301|FG002|Overall Study|Physician Decision|0|||
148818104|NCT03166631|536810302|FG003|Overall Study|Physician Decision|0|||
148818105|NCT03166631|536810303|FG004|Overall Study|Physician Decision|0|||
148818106|NCT03166631|536810304|FG005|Overall Study|Physician Decision|0|||
148818107|NCT03166631|536810305|FG006|Overall Study|Physician Decision|1|||
148818108|NCT03166631|536810306|FG007|Overall Study|Physician Decision|0|||
148818109|NCT03166631|536810307|FG008|Overall Study|Physician Decision|1|||
148818110|NCT03166631|536810308|FG009|Overall Study|Physician Decision|0|||
148818111|NCT03166631|536810309|FG010|Overall Study|Physician Decision|1|||
148818112|NCT03166631|536810299|FG000|Overall Study|Death|0|||
148818113|NCT03166631|536810300|FG001|Overall Study|Death|0|||
148818114|NCT03166631|536810301|FG002|Overall Study|Death|0|||
148818115|NCT03166631|536810302|FG003|Overall Study|Death|0|||
148818116|NCT03166631|536810303|FG004|Overall Study|Death|1|||
148818117|NCT03166631|536810304|FG005|Overall Study|Death|0|||
148818118|NCT03166631|536810305|FG006|Overall Study|Death|1|||
148818119|NCT03166631|536810306|FG007|Overall Study|Death|0|||
148818120|NCT03166631|536810307|FG008|Overall Study|Death|0|||
148818121|NCT03166631|536810308|FG009|Overall Study|Death|0|||
148818122|NCT03166631|536810309|FG010|Overall Study|Death|0|||
148818123|NCT03166631|536810299|FG000|Overall Study|Adverse Event|1|||
148818124|NCT03166631|536810300|FG001|Overall Study|Adverse Event|0|||
148818125|NCT03166631|536810301|FG002|Overall Study|Adverse Event|0|||
148818126|NCT03166631|536810302|FG003|Overall Study|Adverse Event|0|||
148818127|NCT03166631|536810303|FG004|Overall Study|Adverse Event|0|||
148818128|NCT03166631|536810304|FG005|Overall Study|Adverse Event|1|||
148818129|NCT03166631|536810305|FG006|Overall Study|Adverse Event|1|||
148818130|NCT03166631|536810306|FG007|Overall Study|Adverse Event|0|||
148974581|NCT00213148|537387932|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
148818131|NCT03166631|536810307|FG008|Overall Study|Adverse Event|1|||
148818132|NCT03166631|536810308|FG009|Overall Study|Adverse Event|2|||
148818133|NCT03166631|536810309|FG010|Overall Study|Adverse Event|1|||
148818134|NCT03166631|536810299|FG000|Overall Study|Withdrawal by Subject|0|||
148974582|NCT00213148|537387933|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
148737222|NCT02500641|536510326|FG001|Overall Study|Adverse Event|2|||
148818135|NCT03166631|536810300|FG001|Overall Study|Withdrawal by Subject|0|||
148818136|NCT03166631|536810301|FG002|Overall Study|Withdrawal by Subject|0|||
148737223|NCT02500641|536510325|FG000|Overall Study|Withdrawal by Subject|4|||
148737224|NCT02500641|536510326|FG001|Overall Study|Withdrawal by Subject|5|||
148737225|NCT02500641|536510325|FG000|Overall Study|Unable to follow study procedures|3|||
148737226|NCT02500641|536510326|FG001|Overall Study|Unable to follow study procedures|2|||
148737227|NCT02500641|536510325|FG000|Overall Study|Protocol Violation|1|||
148737228|NCT02500641|536510326|FG001|Overall Study|Protocol Violation|2|||
148737229|NCT02500641|536510325|FG000|Overall Study|Lost to Follow-up|1|||
148737230|NCT02500641|536510326|FG001|Overall Study|Lost to Follow-up|0|||
148737231|NCT02500641|536510325|FG000|Overall Study|Sponsor decision|1|||
148737232|NCT02500641|536510326|FG001|Overall Study|Sponsor decision|0|||
148737233|NCT02500641|536510325|FG000|Overall Study|Non compliance to study drug|0|||
148737234|NCT02500641|536510326|FG001|Overall Study|Non compliance to study drug|1|||
148737235|NCT03233230|536510327|FG000|Overall Study|Adverse Event|6|||
148737236|NCT03233230|536510328|FG001|Overall Study|Adverse Event|3|||
148737237|NCT03233230|536510329|FG002|Overall Study|Adverse Event|6|||
148737238|NCT03233230|536510330|FG003|Overall Study|Adverse Event|3|||
148737239|NCT03233230|536510327|FG000|Overall Study|Protocol Violation|1|||
148737240|NCT03233230|536510328|FG001|Overall Study|Protocol Violation|2|||
148737241|NCT03233230|536510329|FG002|Overall Study|Protocol Violation|1|||
148974583|NCT00213148|537387929|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
148737242|NCT03233230|536510330|FG003|Overall Study|Protocol Violation|1|||
148737243|NCT03233230|536510327|FG000|Overall Study|Lack of Efficacy|1|||
148737244|NCT03233230|536510328|FG001|Overall Study|Lack of Efficacy|0|||
148737245|NCT03233230|536510329|FG002|Overall Study|Lack of Efficacy|0|||
148737246|NCT03233230|536510330|FG003|Overall Study|Lack of Efficacy|0|||
148737247|NCT03233230|536510327|FG000|Overall Study|Other|5|||
148737248|NCT03233230|536510328|FG001|Overall Study|Other|5|||
148737249|NCT03233230|536510329|FG002|Overall Study|Other|5|||
148737250|NCT03233230|536510330|FG003|Overall Study|Other|3|||
148737251|NCT03233230|536510327|FG000|Overall Study|Withdrawal by Subject|2|||
148737252|NCT03233230|536510328|FG001|Overall Study|Withdrawal by Subject|2|||
148737253|NCT03233230|536510329|FG002|Overall Study|Withdrawal by Subject|0|||
148737254|NCT03233230|536510330|FG003|Overall Study|Withdrawal by Subject|1|||
148737255|NCT03233230|536510327|FG000|Overall Study|Lost to Follow-up|0|||
148737256|NCT03233230|536510328|FG001|Overall Study|Lost to Follow-up|3|||
148974584|NCT00213148|537387930|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
148818137|NCT03166631|536810302|FG003|Overall Study|Withdrawal by Subject|0|||
148818138|NCT03166631|536810303|FG004|Overall Study|Withdrawal by Subject|0|||
148974585|NCT00213148|537387931|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
148974586|NCT00213148|537387932|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
148974587|NCT00213148|537387933|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
148974588|NCT00213148|537387929|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
148974589|NCT00213148|537387930|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
148974590|NCT00213148|537387931|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
148737257|NCT03233230|536510329|FG002|Overall Study|Lost to Follow-up|0|||
148737258|NCT03233230|536510330|FG003|Overall Study|Lost to Follow-up|0|||
148737259|NCT02196701|536510331|FG000|Overall Study|Adverse Event|1|||
148737260|NCT02196701|536510331|FG000|Overall Study|Lost to Follow-up|1|||
148737261|NCT02196701|536510331|FG000|Overall Study|Non-adherence to Protocol|1|||
148737262|NCT03275064|536510332|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
148737263|NCT03275064|536510333|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
148737264|NCT03275064|536510334|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
148737265|NCT03275064|536510335|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
148974591|NCT00213148|537387932|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
148974592|NCT00213148|537387933|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
148974593|NCT00213148|537387929|FG000|Cycle 3 (1 Month)|Other|0|||
148737266|NCT03275064|536510336|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
148737267|NCT03275064|536510332|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
148737268|NCT03275064|536510333|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
148737269|NCT03275064|536510334|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
148737270|NCT03275064|536510335|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
148737271|NCT03275064|536510336|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
148974594|NCT00213148|537387930|FG001|Cycle 3 (1 Month)|Other|0|||
148974595|NCT00213148|537387931|FG002|Cycle 3 (1 Month)|Other|1|||
148974596|NCT00213148|537387932|FG003|Cycle 3 (1 Month)|Other|1|||
148974597|NCT00213148|537387933|FG004|Cycle 3 (1 Month)|Other|0|||
148974598|NCT01723228|537387934|FG000|Overall Study|Adverse Event|2|||
148737272|NCT03275064|536510332|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
148818139|NCT03166631|536810304|FG005|Overall Study|Withdrawal by Subject|0|||
148974599|NCT01723228|537387935|FG001|Overall Study|Adverse Event|6|||
148737273|NCT03275064|536510333|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
148737274|NCT03275064|536510334|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
148737275|NCT03275064|536510335|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
148737276|NCT03275064|536510336|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
148737277|NCT03275064|536510332|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
148737278|NCT03275064|536510333|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
148737279|NCT03275064|536510334|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
148737280|NCT03275064|536510335|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
148737281|NCT03275064|536510336|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
148737282|NCT03275064|536510332|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
148737283|NCT03275064|536510333|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
148737284|NCT03275064|536510334|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
148737285|NCT03275064|536510335|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
148737286|NCT03275064|536510336|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
148737287|NCT00620555|536510338|FG000|Overall Study|Adverse Event|4|||
148737288|NCT00620555|536510338|FG000|Overall Study|Protocol Violation|2|||
148737289|NCT00620555|536510338|FG000|Overall Study|Lack of Efficacy|12|||
148737290|NCT00620555|536510338|FG000|Overall Study|Withdrawal by Subject|1|||
148737291|NCT00620555|536510338|FG000|Overall Study|Choice of other treatment|1|||
148737292|NCT00620555|536510338|FG000|Overall Study|Visit failure against planned|1|||
148737293|NCT03796039|536510339|FG000|Overall Study|Death|2|||
148737294|NCT03796039|536510340|FG001|Overall Study|Death|1|||
148737295|NCT03796039|536510339|FG000|Overall Study|Withdrawal by Subject|7|||
148737296|NCT03796039|536510340|FG001|Overall Study|Withdrawal by Subject|4|||
148737297|NCT01140503|536510341|FG000|Overall Study|Withdrawal by Subject|1|||
148737298|NCT02927366|536510342|FG000|Overall Study|Adverse Event|1|||
148737299|NCT02927366|536510343|FG001|Overall Study|Adverse Event|0|||
148737300|NCT02927366|536510342|FG000|Overall Study|Patient schedule|1|||
148737301|NCT02927366|536510343|FG001|Overall Study|Patient schedule|0|||
148737302|NCT00587990|536510344|FG000|Overall Study|Death|0|||
148737303|NCT00587990|536510345|FG001|Overall Study|Death|0|||
148737304|NCT00587990|536510346|FG002|Overall Study|Death|1|||
148737305|NCT00206323|536510347|FG000|Overall Study|Lack of Efficacy|4|||
148737306|NCT00206323|536510348|FG001|Overall Study|Lack of Efficacy|1|||
148737307|NCT00206323|536510347|FG000|Overall Study|Adverse Event|1|||
148737308|NCT00206323|536510348|FG001|Overall Study|Adverse Event|1|||
148737309|NCT00206323|536510347|FG000|Overall Study|Lost to Follow-up|1|||
148737310|NCT00206323|536510348|FG001|Overall Study|Lost to Follow-up|1|||
148737311|NCT03334617|536510349|FG000|Overall Study|Adverse Event|0|||
148737312|NCT03334617|536510350|FG001|Overall Study|Adverse Event|0|||
148737313|NCT03334617|536510351|FG002|Overall Study|Adverse Event|0|||
148737314|NCT03334617|536510352|FG003|Overall Study|Adverse Event|0|||
148737315|NCT03334617|536510353|FG004|Overall Study|Adverse Event|0|||
148737316|NCT03334617|536510354|FG005|Overall Study|Adverse Event|0|||
148737317|NCT03334617|536510355|FG006|Overall Study|Adverse Event|0|||
148737318|NCT03334617|536510356|FG007|Overall Study|Adverse Event|0|||
148737319|NCT03334617|536510357|FG008|Overall Study|Adverse Event|1|||
148737320|NCT03334617|536510358|FG009|Overall Study|Adverse Event|0|||
148737321|NCT03334617|536510359|FG010|Overall Study|Adverse Event|0|||
148737322|NCT03334617|536510360|FG011|Overall Study|Adverse Event|0|||
148737323|NCT03334617|536510361|FG012|Overall Study|Adverse Event|1|||
148737324|NCT03334617|536510362|FG013|Overall Study|Adverse Event|0|||
148737325|NCT03334617|536510363|FG014|Overall Study|Adverse Event|0|||
148737326|NCT03334617|536510364|FG015|Overall Study|Adverse Event|0|||
148737327|NCT03334617|536510365|FG016|Overall Study|Adverse Event|0|||
148737328|NCT03334617|536510366|FG017|Overall Study|Adverse Event|0|||
148737329|NCT03334617|536510367|FG018|Overall Study|Adverse Event|0|||
148737330|NCT03334617|536510368|FG019|Overall Study|Adverse Event|0|||
148737331|NCT03334617|536510369|FG020|Overall Study|Adverse Event|0|||
148737332|NCT03334617|536510370|FG021|Overall Study|Adverse Event|0|||
148737333|NCT03334617|536510349|FG000|Overall Study|Death|18|||
148737334|NCT03334617|536510350|FG001|Overall Study|Death|18|||
148737335|NCT03334617|536510351|FG002|Overall Study|Death|20|||
148737336|NCT03334617|536510352|FG003|Overall Study|Death|21|||
148737337|NCT03334617|536510353|FG004|Overall Study|Death|20|||
148737338|NCT03334617|536510354|FG005|Overall Study|Death|16|||
148737339|NCT03334617|536510355|FG006|Overall Study|Death|28|||
148737340|NCT03334617|536510356|FG007|Overall Study|Death|35|||
148737341|NCT03334617|536510357|FG008|Overall Study|Death|47|||
148737342|NCT03334617|536510358|FG009|Overall Study|Death|0|||
148737343|NCT03334617|536510359|FG010|Overall Study|Death|19|||
148737344|NCT03334617|536510360|FG011|Overall Study|Death|6|||
148737345|NCT03334617|536510361|FG012|Overall Study|Death|20|||
148737346|NCT03334617|536510362|FG013|Overall Study|Death|22|||
148737347|NCT03334617|536510363|FG014|Overall Study|Death|17|||
148737348|NCT03334617|536510364|FG015|Overall Study|Death|18|||
148737349|NCT03334617|536510365|FG016|Overall Study|Death|12|||
148737350|NCT03334617|536510366|FG017|Overall Study|Death|15|||
148737351|NCT03334617|536510367|FG018|Overall Study|Death|16|||
148737352|NCT03334617|536510368|FG019|Overall Study|Death|27|||
148737353|NCT03334617|536510369|FG020|Overall Study|Death|14|||
148737354|NCT03334617|536510370|FG021|Overall Study|Death|27|||
148737355|NCT03334617|536510349|FG000|Overall Study|Lost to Follow-up|0|||
148737356|NCT03334617|536510350|FG001|Overall Study|Lost to Follow-up|0|||
148737357|NCT03334617|536510351|FG002|Overall Study|Lost to Follow-up|0|||
148737358|NCT03334617|536510352|FG003|Overall Study|Lost to Follow-up|1|||
148737359|NCT03334617|536510353|FG004|Overall Study|Lost to Follow-up|0|||
148737360|NCT03334617|536510354|FG005|Overall Study|Lost to Follow-up|1|||
148737361|NCT03334617|536510355|FG006|Overall Study|Lost to Follow-up|0|||
148737362|NCT03334617|536510356|FG007|Overall Study|Lost to Follow-up|0|||
148737363|NCT03334617|536510357|FG008|Overall Study|Lost to Follow-up|1|||
148737364|NCT03334617|536510358|FG009|Overall Study|Lost to Follow-up|0|||
148737365|NCT03334617|536510359|FG010|Overall Study|Lost to Follow-up|0|||
148737366|NCT03334617|536510360|FG011|Overall Study|Lost to Follow-up|0|||
148737367|NCT03334617|536510361|FG012|Overall Study|Lost to Follow-up|0|||
148737368|NCT03334617|536510362|FG013|Overall Study|Lost to Follow-up|0|||
148737369|NCT03334617|536510363|FG014|Overall Study|Lost to Follow-up|0|||
148737370|NCT03334617|536510364|FG015|Overall Study|Lost to Follow-up|0|||
148737371|NCT03334617|536510365|FG016|Overall Study|Lost to Follow-up|0|||
148737372|NCT03334617|536510366|FG017|Overall Study|Lost to Follow-up|0|||
148737373|NCT03334617|536510367|FG018|Overall Study|Lost to Follow-up|0|||
148737374|NCT03334617|536510368|FG019|Overall Study|Lost to Follow-up|0|||
148737375|NCT03334617|536510369|FG020|Overall Study|Lost to Follow-up|0|||
148737376|NCT03334617|536510370|FG021|Overall Study|Lost to Follow-up|0|||
148737377|NCT03334617|536510349|FG000|Overall Study|Withdrawal by Subject|0|||
148737378|NCT03334617|536510350|FG001|Overall Study|Withdrawal by Subject|1|||
148737379|NCT03334617|536510351|FG002|Overall Study|Withdrawal by Subject|0|||
148737380|NCT03334617|536510352|FG003|Overall Study|Withdrawal by Subject|0|||
148737381|NCT03334617|536510353|FG004|Overall Study|Withdrawal by Subject|1|||
148737382|NCT03334617|536510354|FG005|Overall Study|Withdrawal by Subject|1|||
148737383|NCT03334617|536510355|FG006|Overall Study|Withdrawal by Subject|1|||
148737384|NCT03334617|536510356|FG007|Overall Study|Withdrawal by Subject|2|||
148737385|NCT03334617|536510357|FG008|Overall Study|Withdrawal by Subject|0|||
148737386|NCT03334617|536510358|FG009|Overall Study|Withdrawal by Subject|0|||
148737387|NCT03334617|536510359|FG010|Overall Study|Withdrawal by Subject|0|||
148737388|NCT03334617|536510360|FG011|Overall Study|Withdrawal by Subject|1|||
148737389|NCT03334617|536510361|FG012|Overall Study|Withdrawal by Subject|1|||
148737390|NCT03334617|536510362|FG013|Overall Study|Withdrawal by Subject|0|||
148737391|NCT03334617|536510363|FG014|Overall Study|Withdrawal by Subject|2|||
148737392|NCT03334617|536510364|FG015|Overall Study|Withdrawal by Subject|1|||
148737393|NCT03334617|536510365|FG016|Overall Study|Withdrawal by Subject|0|||
148737394|NCT03334617|536510366|FG017|Overall Study|Withdrawal by Subject|1|||
148737395|NCT03334617|536510367|FG018|Overall Study|Withdrawal by Subject|1|||
148737396|NCT03334617|536510368|FG019|Overall Study|Withdrawal by Subject|1|||
148737397|NCT03334617|536510369|FG020|Overall Study|Withdrawal by Subject|0|||
148737398|NCT03334617|536510370|FG021|Overall Study|Withdrawal by Subject|1|||
148737399|NCT03334617|536510349|FG000|Overall Study|Other|1|||
148737400|NCT03334617|536510350|FG001|Overall Study|Other|2|||
148737401|NCT03334617|536510351|FG002|Overall Study|Other|0|||
148737402|NCT03334617|536510352|FG003|Overall Study|Other|1|||
148737403|NCT03334617|536510353|FG004|Overall Study|Other|1|||
148737404|NCT03334617|536510354|FG005|Overall Study|Other|0|||
148737405|NCT03334617|536510355|FG006|Overall Study|Other|2|||
148737406|NCT03334617|536510356|FG007|Overall Study|Other|1|||
148737407|NCT03334617|536510357|FG008|Overall Study|Other|8|||
148737408|NCT03334617|536510358|FG009|Overall Study|Other|0|||
148737409|NCT03334617|536510359|FG010|Overall Study|Other|3|||
148737410|NCT03334617|536510360|FG011|Overall Study|Other|1|||
148737411|NCT03334617|536510361|FG012|Overall Study|Other|3|||
148737412|NCT03334617|536510362|FG013|Overall Study|Other|1|||
148737413|NCT03334617|536510363|FG014|Overall Study|Other|1|||
148737414|NCT03334617|536510364|FG015|Overall Study|Other|3|||
148737415|NCT03334617|536510365|FG016|Overall Study|Other|3|||
148737416|NCT03334617|536510366|FG017|Overall Study|Other|3|||
148737417|NCT03334617|536510367|FG018|Overall Study|Other|7|||
148737418|NCT03334617|536510368|FG019|Overall Study|Other|4|||
148737419|NCT03334617|536510369|FG020|Overall Study|Other|1|||
148737420|NCT03334617|536510370|FG021|Overall Study|Other|4|||
148737421|NCT03334617|536510349|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
148737422|NCT03334617|536510350|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
148737423|NCT03334617|536510351|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
148737424|NCT03334617|536510352|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
148737425|NCT03334617|536510353|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
148737426|NCT03334617|536510354|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
148737427|NCT03334617|536510355|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
148737428|NCT03334617|536510356|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
148737429|NCT03334617|536510357|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
148737430|NCT03334617|536510358|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
148737431|NCT03334617|536510359|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
148737432|NCT03334617|536510360|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
148737433|NCT03334617|536510361|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
148737434|NCT03334617|536510362|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
148737435|NCT03334617|536510363|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
148737436|NCT03334617|536510364|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
148737437|NCT03334617|536510365|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
148974600|NCT01723228|537387934|FG000|Overall Study|Withdrawal by Subject|2|||
148974601|NCT01723228|537387935|FG001|Overall Study|Withdrawal by Subject|1|||
148974602|NCT01723228|537387934|FG000|Overall Study|Protocol Violation|0|||
148974603|NCT01723228|537387935|FG001|Overall Study|Protocol Violation|2|||
148737438|NCT03334617|536510366|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
148737439|NCT03334617|536510367|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
148737440|NCT03334617|536510368|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
148737441|NCT03334617|536510369|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
148737442|NCT03334617|536510370|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
148737443|NCT03657342|536510371|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
148737444|NCT03657342|536510372|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
148737445|NCT03657342|536510371|FG000|Overall Study|Withdrawal by Subject|4|||
148737446|NCT03657342|536510372|FG001|Overall Study|Withdrawal by Subject|4|||
148737447|NCT03657342|536510371|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
148737448|NCT03657342|536510372|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
148737449|NCT03657342|536510371|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
148737450|NCT03657342|536510372|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
148737451|NCT00827632|536510373|FG000|Overall Study|Lost to Follow-up|8|||
148737452|NCT00827632|536510374|FG001|Overall Study|Lost to Follow-up|12|||
148737453|NCT00827632|536510373|FG000|Overall Study|Early withdrawal|14|||
148737454|NCT00827632|536510374|FG001|Overall Study|Early withdrawal|11|||
148737455|NCT03734666|536510376|FG000|Overall Study|Other|7|||
148737456|NCT03734666|536510377|FG001|Overall Study|Other|4|||
148737457|NCT03734666|536510376|FG000|Overall Study|Lost to Follow-up|12|||
148737458|NCT03734666|536510377|FG001|Overall Study|Lost to Follow-up|12|||
148737459|NCT01910389|536510379|FG000|Overall Study|Withdrawal by Subject|2|||
148737460|NCT01910389|536510380|FG001|Overall Study|Withdrawal by Subject|0|||
148737461|NCT01910389|536510379|FG000|Overall Study|Study Closed|13|||
148737462|NCT01910389|536510380|FG001|Overall Study|Study Closed|8|||
148737463|NCT01898650|536510382|FG000|Overall Study|the subject would not lie still for imaging|1|||
148737464|NCT03923530|536510384|FG000|Overall Study|Withdrawal by Subject|1|||
148737465|NCT03923530|536510384|FG000|Overall Study|screen failure|3|||
148737466|NCT00407758|536510385|FG000|Overall Study|ineligible -improper prior treatment|1|||
148737467|NCT02722148|536510396|FG000|Overall Study|Lost to Follow-up|2|||
148737468|NCT02722148|536510396|FG000|Overall Study|Non compliant with treatment regimen|3|||
148737469|NCT00855803|536510398|FG000|Overall Study|Death|2|||
148737470|NCT00855803|536510398|FG000|Overall Study|Lost to Follow-up|2|||
148737471|NCT00855803|536510398|FG000|Overall Study|Technical inability to undergo procedure|2|||
148737472|NCT00855803|536510398|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
148737473|NCT00855803|536510398|FG000|Overall Study|Withdrawal by Subject|3|||
148737474|NCT00855803|536510398|FG000|Overall Study|Physician Decision|3|||
148737475|NCT00809159|536510399|FG000|Part 1|Adverse Event|1|||
148974604|NCT01723228|537387934|FG000|Overall Study|Lost to Follow-up|2|||
148974605|NCT01723228|537387935|FG001|Overall Study|Lost to Follow-up|1|||
148974606|NCT01723228|537387934|FG000|Overall Study|Other|2|||
148974607|NCT01723228|537387935|FG001|Overall Study|Other|1|||
148974608|NCT01806896|537387936|FG000|Overall Study|Adverse Event|2|||
148974609|NCT01806896|537387937|FG001|Overall Study|Adverse Event|0|||
148974610|NCT01806896|537387936|FG000|Overall Study|Other|1|||
148737476|NCT00809159|536510400|FG001|Part 1|Adverse Event|1|||
148737477|NCT00809159|536510401|FG002|Part 1|Adverse Event|0|||
148737478|NCT00809159|536510402|FG003|Part 1|Adverse Event|0|||
148737479|NCT00809159|536510403|FG004|Part 1|Adverse Event|0|||
148737480|NCT00809159|536510404|FG005|Part 1|Adverse Event|0|||
148974611|NCT01806896|537387937|FG001|Overall Study|Other|0|||
148974612|NCT02434770|537387938|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
148974613|NCT02434770|537387939|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
148737481|NCT00809159|536510399|FG000|Part 1|Lost to Follow-up|1|||
148737482|NCT00809159|536510400|FG001|Part 1|Lost to Follow-up|0|||
148737483|NCT00809159|536510401|FG002|Part 1|Lost to Follow-up|0|||
148737484|NCT00809159|536510402|FG003|Part 1|Lost to Follow-up|0|||
148737485|NCT00809159|536510403|FG004|Part 1|Lost to Follow-up|0|||
148737486|NCT00809159|536510404|FG005|Part 1|Lost to Follow-up|0|||
148974614|NCT02434770|537387940|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
148974615|NCT02434770|537387938|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
148974616|NCT02434770|537387939|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
148974617|NCT02434770|537387940|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
148737487|NCT00809159|536510399|FG000|Part 1|Withdrawal by Subject|3|||
148737488|NCT00809159|536510400|FG001|Part 1|Withdrawal by Subject|1|||
148737489|NCT00809159|536510401|FG002|Part 1|Withdrawal by Subject|0|||
148737490|NCT00809159|536510402|FG003|Part 1|Withdrawal by Subject|0|||
148737491|NCT00809159|536510403|FG004|Part 1|Withdrawal by Subject|0|||
148737492|NCT00809159|536510404|FG005|Part 1|Withdrawal by Subject|0|||
148737493|NCT00809159|536510399|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
148737494|NCT00809159|536510400|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
148737495|NCT00809159|536510401|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
148737496|NCT00809159|536510402|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
148737497|NCT00809159|536510403|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
148737498|NCT00809159|536510404|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
148737499|NCT00809159|536510399|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
148737500|NCT00809159|536510400|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
148737501|NCT00809159|536510401|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
148737502|NCT00809159|536510402|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
148737503|NCT00809159|536510403|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
148737504|NCT00809159|536510404|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
148737505|NCT00809159|536510399|FG000|Part 1 and 2|Administrative problems|0|||
148737506|NCT00809159|536510400|FG001|Part 1 and 2|Administrative problems|0|||
148737507|NCT00809159|536510401|FG002|Part 1 and 2|Administrative problems|0|||
148737508|NCT00809159|536510402|FG003|Part 1 and 2|Administrative problems|1|||
148737509|NCT00809159|536510403|FG004|Part 1 and 2|Administrative problems|0|||
148737510|NCT00809159|536510404|FG005|Part 1 and 2|Administrative problems|0|||
148737511|NCT00809159|536510399|FG000|Part 1 and 2|Adverse Event|0|||
148737512|NCT00809159|536510400|FG001|Part 1 and 2|Adverse Event|0|||
148737513|NCT00809159|536510401|FG002|Part 1 and 2|Adverse Event|1|||
148737514|NCT00809159|536510402|FG003|Part 1 and 2|Adverse Event|0|||
148737515|NCT00809159|536510403|FG004|Part 1 and 2|Adverse Event|1|||
148737516|NCT00809159|536510404|FG005|Part 1 and 2|Adverse Event|1|||
148737517|NCT00809159|536510399|FG000|Part 1 and 2|Lost to Follow-up|0|||
148737518|NCT00809159|536510400|FG001|Part 1 and 2|Lost to Follow-up|0|||
148737519|NCT00809159|536510401|FG002|Part 1 and 2|Lost to Follow-up|1|||
148737520|NCT00809159|536510402|FG003|Part 1 and 2|Lost to Follow-up|1|||
148737521|NCT00809159|536510403|FG004|Part 1 and 2|Lost to Follow-up|0|||
148737522|NCT00809159|536510404|FG005|Part 1 and 2|Lost to Follow-up|0|||
148737523|NCT00809159|536510399|FG000|Part 1 and 2|Withdrawal by Subject|0|||
148737524|NCT00809159|536510400|FG001|Part 1 and 2|Withdrawal by Subject|0|||
148737525|NCT00809159|536510401|FG002|Part 1 and 2|Withdrawal by Subject|4|||
148737526|NCT00809159|536510402|FG003|Part 1 and 2|Withdrawal by Subject|0|||
148737527|NCT00809159|536510403|FG004|Part 1 and 2|Withdrawal by Subject|0|||
148737528|NCT00809159|536510404|FG005|Part 1 and 2|Withdrawal by Subject|1|||
148737529|NCT04188301|536510409|FG000|Month 3|Lost to Follow-up|0|||
148737530|NCT04188301|536510410|FG001|Month 3|Lost to Follow-up|0|||
148737531|NCT04188301|536510411|FG002|Month 3|Lost to Follow-up|1|||
148737532|NCT04188301|536510409|FG000|Month 12|Lost to Follow-up|0|||
148737533|NCT04188301|536510410|FG001|Month 12|Lost to Follow-up|0|||
148737534|NCT04188301|536510411|FG002|Month 12|Lost to Follow-up|2|||
148737535|NCT04188301|536510409|FG000|Month 12|Death|1|||
148737536|NCT04188301|536510410|FG001|Month 12|Death|1|||
148737537|NCT04188301|536510411|FG002|Month 12|Death|0|||
148737538|NCT04188301|536510409|FG000|Month 18|Lost to Follow-up|6|||
148737539|NCT04188301|536510410|FG001|Month 18|Lost to Follow-up|0|||
148737540|NCT04188301|536510411|FG002|Month 18|Lost to Follow-up|0|||
148737541|NCT01709838|536510414|FG000|Overall Study|Withdrawal by Subject|21|||
148737542|NCT01709838|536510414|FG000|Overall Study|Lost to Follow-up|16|||
148737543|NCT01709838|536510414|FG000|Overall Study|Pregnancy|10|||
148737544|NCT01709838|536510414|FG000|Overall Study|Subject/guardian decision|8|||
148737545|NCT01709838|536510414|FG000|Overall Study|Adverse Event|4|||
148737546|NCT01709838|536510414|FG000|Overall Study|Physician Decision|4|||
148737547|NCT01709838|536510414|FG000|Overall Study|Death|3|||
148737548|NCT01709838|536510414|FG000|Overall Study|Protocol Violation|1|||
148737549|NCT00620659|536510415|FG000|Treatment Period 1|Adverse Event|1|||
148737550|NCT00620659|536510416|FG001|Treatment Period 1|Adverse Event|0|||
148737551|NCT00620659|536510417|FG002|Treatment Period 1|Adverse Event|0|||
148737552|NCT00620659|536510418|FG003|Treatment Period 1|Adverse Event|3|||
148737553|NCT00620659|536510419|FG004|Treatment Period 1|Adverse Event|0|||
148737554|NCT00620659|536510420|FG005|Treatment Period 1|Adverse Event|0|||
148737555|NCT00620659|536510415|FG000|Treatment Period 1|Protocol Violation|1|||
148737556|NCT00620659|536510416|FG001|Treatment Period 1|Protocol Violation|0|||
148737557|NCT00620659|536510417|FG002|Treatment Period 1|Protocol Violation|0|||
148737558|NCT00620659|536510418|FG003|Treatment Period 1|Protocol Violation|0|||
148737559|NCT00620659|536510419|FG004|Treatment Period 1|Protocol Violation|0|||
148737560|NCT00620659|536510420|FG005|Treatment Period 1|Protocol Violation|0|||
148737561|NCT00620659|536510415|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148737562|NCT00620659|536510416|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148737563|NCT00620659|536510417|FG002|Treatment Period 1|Withdrawal by Subject|1|||
148737564|NCT00620659|536510418|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148737565|NCT00620659|536510419|FG004|Treatment Period 1|Withdrawal by Subject|1|||
148737566|NCT00620659|536510420|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148737567|NCT00620659|536510415|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
148737568|NCT00620659|536510416|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
148737569|NCT00620659|536510417|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
148737570|NCT00620659|536510418|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
148737571|NCT00620659|536510419|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
148737572|NCT00620659|536510420|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
148737573|NCT00620659|536510415|FG000|Treatment Period 2|Adverse Event|0|||
148737574|NCT00620659|536510416|FG001|Treatment Period 2|Adverse Event|3|||
148737575|NCT00620659|536510417|FG002|Treatment Period 2|Adverse Event|0|||
148737576|NCT00620659|536510418|FG003|Treatment Period 2|Adverse Event|0|||
148737577|NCT00620659|536510419|FG004|Treatment Period 2|Adverse Event|2|||
148737578|NCT00620659|536510420|FG005|Treatment Period 2|Adverse Event|0|||
148737579|NCT00620659|536510415|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148737580|NCT00620659|536510416|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148737581|NCT00620659|536510417|FG002|Treatment Period 2|Withdrawal by Subject|1|||
148737582|NCT00620659|536510418|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148737583|NCT00620659|536510419|FG004|Treatment Period 2|Withdrawal by Subject|3|||
148737584|NCT00620659|536510420|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148737585|NCT00620659|536510415|FG000|Placebo Washout Period 2|Adverse Event|2|||
148737586|NCT00620659|536510416|FG001|Placebo Washout Period 2|Adverse Event|0|||
148737587|NCT00620659|536510417|FG002|Placebo Washout Period 2|Adverse Event|0|||
148737588|NCT00620659|536510418|FG003|Placebo Washout Period 2|Adverse Event|0|||
148737589|NCT00620659|536510419|FG004|Placebo Washout Period 2|Adverse Event|0|||
148737590|NCT00620659|536510420|FG005|Placebo Washout Period 2|Adverse Event|0|||
148737591|NCT00620659|536510415|FG000|Treatment Period 3|Adverse Event|0|||
148737592|NCT00620659|536510416|FG001|Treatment Period 3|Adverse Event|2|||
148737593|NCT00620659|536510417|FG002|Treatment Period 3|Adverse Event|0|||
148737594|NCT00620659|536510418|FG003|Treatment Period 3|Adverse Event|0|||
148737595|NCT00620659|536510419|FG004|Treatment Period 3|Adverse Event|0|||
148737596|NCT00620659|536510420|FG005|Treatment Period 3|Adverse Event|0|||
148737597|NCT00620659|536510415|FG000|Treatment Period 3|Withdrawal by Subject|0|||
148737598|NCT00620659|536510416|FG001|Treatment Period 3|Withdrawal by Subject|0|||
148737599|NCT00620659|536510417|FG002|Treatment Period 3|Withdrawal by Subject|0|||
148737600|NCT00620659|536510418|FG003|Treatment Period 3|Withdrawal by Subject|1|||
148737601|NCT00620659|536510419|FG004|Treatment Period 3|Withdrawal by Subject|0|||
148737602|NCT00620659|536510420|FG005|Treatment Period 3|Withdrawal by Subject|0|||
148737603|NCT01193127|536510423|FG000|Randomized|Surgery Cancelled|0|||
148737604|NCT01193127|536510424|FG001|Randomized|Surgery Cancelled|0|||
148737605|NCT01193127|536510425|FG002|Randomized|Surgery Cancelled|0|||
148737606|NCT01193127|536510426|FG003|Randomized|Surgery Cancelled|1|||
148737607|NCT01193127|536510423|FG000|Treated|Withdrawal by Subject|0|||
148737608|NCT01193127|536510424|FG001|Treated|Withdrawal by Subject|0|||
148737609|NCT01193127|536510425|FG002|Treated|Withdrawal by Subject|0|||
148737610|NCT01193127|536510426|FG003|Treated|Withdrawal by Subject|1|||
148737611|NCT03246646|536510429|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
148737612|NCT03246646|536510430|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
148737613|NCT03246646|536510429|FG000|Overall Study|Withdrawal by Subject|3|||
148737614|NCT03246646|536510430|FG001|Overall Study|Withdrawal by Subject|0|||
148737615|NCT03246646|536510429|FG000|Overall Study|Lost to Follow-up|7|||
148737616|NCT03246646|536510430|FG001|Overall Study|Lost to Follow-up|0|||
148737617|NCT02352779|536510431|FG000|Overall Study|Personal Issues|1|||
148737618|NCT02352779|536510432|FG001|Overall Study|Personal Issues|1|||
148737619|NCT02352779|536510433|FG002|Overall Study|Personal Issues|0|||
148737620|NCT02352779|536510431|FG000|Overall Study|Too Many Forms|2|||
148737621|NCT02352779|536510432|FG001|Overall Study|Too Many Forms|0|||
148737622|NCT02352779|536510433|FG002|Overall Study|Too Many Forms|0|||
148737623|NCT02352779|536510431|FG000|Overall Study|Feeling Overwhelmed|1|||
148737624|NCT02352779|536510432|FG001|Overall Study|Feeling Overwhelmed|0|||
148737625|NCT02352779|536510433|FG002|Overall Study|Feeling Overwhelmed|0|||
148737626|NCT02352779|536510431|FG000|Overall Study|Disliked Intervention|1|||
148737627|NCT02352779|536510432|FG001|Overall Study|Disliked Intervention|0|||
148737628|NCT02352779|536510433|FG002|Overall Study|Disliked Intervention|0|||
148737629|NCT02352779|536510431|FG000|Overall Study|Changed Mind|1|||
148737630|NCT02352779|536510432|FG001|Overall Study|Changed Mind|0|||
148737631|NCT02352779|536510433|FG002|Overall Study|Changed Mind|0|||
148737632|NCT02352779|536510431|FG000|Overall Study|Study Related Symptoms|1|||
148974618|NCT02434770|537387938|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
148737633|NCT02352779|536510432|FG001|Overall Study|Study Related Symptoms|0|||
148737634|NCT02352779|536510433|FG002|Overall Study|Study Related Symptoms|0|||
148737635|NCT02352779|536510431|FG000|Overall Study|Absence of Symptoms|1|||
148737636|NCT02352779|536510432|FG001|Overall Study|Absence of Symptoms|0|||
148737637|NCT02352779|536510433|FG002|Overall Study|Absence of Symptoms|0|||
148737638|NCT02352779|536510431|FG000|Overall Study|Other Medical Reason|0|||
148737639|NCT02352779|536510432|FG001|Overall Study|Other Medical Reason|0|||
148737640|NCT02352779|536510433|FG002|Overall Study|Other Medical Reason|1|||
148737641|NCT02352779|536510431|FG000|Overall Study|No Reason|0|||
148974619|NCT02434770|537387939|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
148974620|NCT02434770|537387940|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
148974621|NCT02434770|537387938|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
148974622|NCT02434770|537387939|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
148974623|NCT02434770|537387940|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
148974624|NCT02434770|537387938|FG000|Week 1 to Week 18|Death|1|||
148974625|NCT02434770|537387939|FG001|Week 1 to Week 18|Death|0|||
148974626|NCT02434770|537387940|FG002|Week 1 to Week 18|Death|0|||
148974627|NCT02434770|537387938|FG000|Week 18 to Week|Lost to Follow-up|2|||
148974628|NCT02434770|537387939|FG001|Week 18 to Week|Lost to Follow-up|2|||
148974629|NCT02434770|537387940|FG002|Week 18 to Week|Lost to Follow-up|1|||
148974630|NCT02434770|537387938|FG000|Week 18 to Week|Withdrawal by Subject|0|||
148974631|NCT02434770|537387939|FG001|Week 18 to Week|Withdrawal by Subject|0|||
148974632|NCT02434770|537387940|FG002|Week 18 to Week|Withdrawal by Subject|2|||
148974633|NCT02434770|537387938|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
148974634|NCT02434770|537387939|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
148974635|NCT02434770|537387940|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
148974636|NCT00245765|537387941|FG000|Overall Study|Adverse Event|1|||
148974637|NCT00245765|537387942|FG001|Overall Study|Adverse Event|1|||
148974638|NCT00245765|537387943|FG002|Overall Study|Adverse Event|0|||
148974639|NCT00245765|537387941|FG000|Overall Study|Lack of Efficacy|14|||
148974640|NCT00245765|537387942|FG001|Overall Study|Lack of Efficacy|7|||
148974641|NCT00245765|537387943|FG002|Overall Study|Lack of Efficacy|0|||
148974642|NCT00245765|537387941|FG000|Overall Study|Lost to Follow-up|1|||
148974643|NCT00245765|537387942|FG001|Overall Study|Lost to Follow-up|2|||
148974644|NCT00245765|537387943|FG002|Overall Study|Lost to Follow-up|0|||
148974645|NCT00245765|537387941|FG000|Overall Study|Withdrawal by Subject|1|||
148974646|NCT00245765|537387942|FG001|Overall Study|Withdrawal by Subject|0|||
148974647|NCT00245765|537387943|FG002|Overall Study|Withdrawal by Subject|3|||
148974648|NCT00245765|537387941|FG000|Overall Study|Other reason|2|||
148974649|NCT00245765|537387942|FG001|Overall Study|Other reason|0|||
148818140|NCT03166631|536810305|FG006|Overall Study|Withdrawal by Subject|0|||
148818141|NCT03166631|536810306|FG007|Overall Study|Withdrawal by Subject|0|||
148818142|NCT03166631|536810307|FG008|Overall Study|Withdrawal by Subject|1|||
148818143|NCT03166631|536810308|FG009|Overall Study|Withdrawal by Subject|1|||
148818144|NCT03166631|536810309|FG010|Overall Study|Withdrawal by Subject|0|||
148818145|NCT00567580|536810314|FG000|Overall Study|Protocol Violation|28|||
148974650|NCT00245765|537387943|FG002|Overall Study|Other reason|1|||
148974651|NCT00245765|537387941|FG000|Overall Study|Other|13|||
148974652|NCT00245765|537387942|FG001|Overall Study|Other|4|||
148974653|NCT00245765|537387943|FG002|Overall Study|Other|4|||
148974654|NCT03080961|537387944|FG000|Overall Study|Withdrawal by Subject|3|||
148974655|NCT00660348|537387945|FG000|Overall Study|Withdrawal by Subject|1|||
148974656|NCT00660348|537387946|FG001|Overall Study|Withdrawal by Subject|0|||
148974657|NCT01282424|537387952|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
148974658|NCT01282424|537387952|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
148974659|NCT01282424|537387952|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
148974660|NCT01282424|537387952|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
148974661|NCT01282424|537387952|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
148974662|NCT01282424|537387952|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
148974663|NCT01282424|537387952|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
148974664|NCT01282424|537387952|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
148974665|NCT00528528|537387953|FG000|Overall Study|Lost to Follow-up|0|||
148974666|NCT00528528|537387954|FG001|Overall Study|Lost to Follow-up|0|||
148974667|NCT00528528|537387955|FG002|Overall Study|Lost to Follow-up|1|||
148974668|NCT00528528|537387956|FG003|Overall Study|Lost to Follow-up|1|||
148974669|NCT00528528|537387953|FG000|Overall Study|Ineligible to continue the trial|0|||
148974670|NCT00528528|537387954|FG001|Overall Study|Ineligible to continue the trial|0|||
148974671|NCT00528528|537387955|FG002|Overall Study|Ineligible to continue the trial|0|||
148974672|NCT00528528|537387956|FG003|Overall Study|Ineligible to continue the trial|1|||
148974673|NCT00528528|537387953|FG000|Overall Study|Other|0|||
148818146|NCT00567580|536810315|FG001|Overall Study|Protocol Violation|24|||
148818147|NCT00567580|536810316|FG002|Overall Study|Protocol Violation|24|||
148818148|NCT02400736|536810317|FG000|Overall Study|Lost to Follow-up|6|||
148818149|NCT02400736|536810318|FG001|Overall Study|Lost to Follow-up|6|||
148818150|NCT02400736|536810317|FG000|Overall Study|Withdrawal by Subject|2|||
148974674|NCT00528528|537387954|FG001|Overall Study|Other|1|||
148974675|NCT00528528|537387955|FG002|Overall Study|Other|0|||
148974676|NCT00528528|537387956|FG003|Overall Study|Other|0|||
148974677|NCT00528528|537387953|FG000|Overall Study|Withdrawal by Subject|3|||
148974678|NCT00528528|537387954|FG001|Overall Study|Withdrawal by Subject|2|||
148974679|NCT00528528|537387955|FG002|Overall Study|Withdrawal by Subject|1|||
148974680|NCT00528528|537387956|FG003|Overall Study|Withdrawal by Subject|1|||
148974681|NCT00528528|537387953|FG000|Overall Study|Ongoing participant|0|||
148974682|NCT00528528|537387954|FG001|Overall Study|Ongoing participant|0|||
148974683|NCT00528528|537387955|FG002|Overall Study|Ongoing participant|1|||
148974684|NCT00528528|537387956|FG003|Overall Study|Ongoing participant|0|||
148974685|NCT03508219|537387957|FG000|Overall Study|Death|2|||
148974686|NCT03508219|537387957|FG000|Overall Study|Withdrawal by Subject|1|||
148974687|NCT03508219|537387957|FG000|Overall Study|Lost to Follow-up|4|||
148974688|NCT03508219|537387957|FG000|Overall Study|Missed visit|2|||
148974689|NCT04466891|537387958|FG000|Overall Study|Death|60|||
148974690|NCT04466891|537387959|FG001|Overall Study|Death|6|||
148974691|NCT04466891|537387958|FG000|Overall Study|Withdrawal by Subject|8|||
148974692|NCT04466891|537387959|FG001|Overall Study|Withdrawal by Subject|1|||
148974693|NCT04466891|537387958|FG000|Overall Study|Study terminated by sponsor|5|||
148974694|NCT04466891|537387959|FG001|Overall Study|Study terminated by sponsor|0|||
148974695|NCT04466891|537387958|FG000|Overall Study|Lost to Follow-up|2|||
148974696|NCT04466891|537387959|FG001|Overall Study|Lost to Follow-up|0|||
148974697|NCT04466891|537387958|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
148974698|NCT04466891|537387959|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
148974699|NCT00445328|537387960|FG000|Overall Study|Death|0|||
148974700|NCT00445328|537387961|FG001|Overall Study|Death|1|||
148974701|NCT00445328|537387960|FG000|Overall Study|Adverse Event|0|||
148974702|NCT00445328|537387961|FG001|Overall Study|Adverse Event|3|||
148974703|NCT00445328|537387960|FG000|Overall Study|Other|0|||
148974704|NCT00445328|537387961|FG001|Overall Study|Other|2|||
148974705|NCT00445328|537387960|FG000|Overall Study|Withdrawal by Subject|2|||
148974706|NCT00445328|537387961|FG001|Overall Study|Withdrawal by Subject|0|||
148737642|NCT02352779|536510432|FG001|Overall Study|No Reason|0|||
148737643|NCT02352779|536510433|FG002|Overall Study|No Reason|1|||
148737644|NCT00968799|536510438|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
148737645|NCT01104779|536510441|FG000|Overall Study|Protocol Violation|1|||
148737646|NCT01104779|536510442|FG001|Overall Study|Protocol Violation|2|||
148737647|NCT01104779|536510443|FG002|Overall Study|Protocol Violation|2|||
148737648|NCT01104779|536510441|FG000|Overall Study|Lack of Efficacy|26|||
148737649|NCT01104779|536510442|FG001|Overall Study|Lack of Efficacy|12|||
148737650|NCT01104779|536510443|FG002|Overall Study|Lack of Efficacy|13|||
148737651|NCT01104779|536510441|FG000|Overall Study|Adverse Event|13|||
148737652|NCT01104779|536510442|FG001|Overall Study|Adverse Event|14|||
148737653|NCT01104779|536510443|FG002|Overall Study|Adverse Event|13|||
148737654|NCT01104779|536510441|FG000|Overall Study|Did not meet inc/exc criteria|1|||
148737655|NCT01104779|536510442|FG001|Overall Study|Did not meet inc/exc criteria|1|||
148737656|NCT01104779|536510443|FG002|Overall Study|Did not meet inc/exc criteria|1|||
148737657|NCT01104779|536510441|FG000|Overall Study|Other reasons|0|||
148737658|NCT01104779|536510442|FG001|Overall Study|Other reasons|1|||
148737659|NCT01104779|536510443|FG002|Overall Study|Other reasons|0|||
148737660|NCT01104779|536510441|FG000|Overall Study|Lost to Follow-up|2|||
148737661|NCT01104779|536510442|FG001|Overall Study|Lost to Follow-up|0|||
148737662|NCT01104779|536510443|FG002|Overall Study|Lost to Follow-up|1|||
148737663|NCT01104779|536510441|FG000|Overall Study|Withdrawal by Subject|16|||
148737664|NCT01104779|536510442|FG001|Overall Study|Withdrawal by Subject|25|||
148737665|NCT01104779|536510443|FG002|Overall Study|Withdrawal by Subject|32|||
148737666|NCT01372774|536510446|FG000|Overall Study|Withdrawal prior to treatment|4|||
148737667|NCT01372774|536510447|FG001|Overall Study|Withdrawal prior to treatment|5|||
148737668|NCT00389831|536510448|FG000|Overall Study|Lack of Efficacy|0|||
148737669|NCT00389831|536510449|FG001|Overall Study|Lack of Efficacy|2|||
148737670|NCT00389831|536510448|FG000|Overall Study|Did not receive treatment.|0|||
148737671|NCT00389831|536510449|FG001|Overall Study|Did not receive treatment.|2|||
148737672|NCT00389831|536510448|FG000|Overall Study|Other reasons|0|||
148737673|NCT00389831|536510449|FG001|Overall Study|Other reasons|2|||
148737674|NCT00389831|536510448|FG000|Overall Study|Lost to Follow-up|0|||
148737675|NCT00389831|536510449|FG001|Overall Study|Lost to Follow-up|1|||
148737676|NCT04639713|536510454|FG000|Overall Study|Protocol Noncompliance|2|||
148737677|NCT04639713|536510454|FG000|Overall Study|Withdrawal by Subject|1|||
148737678|NCT03190330|536512662|FG000|Overall Study|Adverse Event|2|||
148737679|NCT03190330|536512662|FG000|Overall Study|Death|10|||
148974707|NCT00445328|537387960|FG000|Overall Study|Protocol Violation|1|||
148974708|NCT00445328|537387961|FG001|Overall Study|Protocol Violation|0|||
148974709|NCT00316199|537387962|FG000|Overall Study|Adverse Event|2|||
149027104|NCT01579578|537576492|FG001|Overall Study|Withdrawal by Subject|1|||
148737680|NCT03190330|536512662|FG000|Overall Study|Lost to Follow-up|1|||
148737681|NCT03190330|536512662|FG000|Overall Study|Withdrawal by Subject|6|||
148737682|NCT03190330|536512662|FG000|Overall Study|Progressive Disease|1|||
148737683|NCT02081209|536512663|FG000|Overall Study|Withdrawal by Subject|1|||
148737684|NCT02370329|536512664|FG000|Overall Study|Alternate treatment|1|||
148974710|NCT00316199|537387962|FG000|Overall Study|Death|8|||
148974711|NCT00316199|537387962|FG000|Overall Study|Lost to Follow-up|2|||
148974712|NCT02782949|537387963|FG000|Overall Study|Protocol Violation|1|||
148974713|NCT02782949|537387964|FG001|Overall Study|Protocol Violation|0|||
148737685|NCT02370329|536512664|FG000|Overall Study|Adverse Event|1|||
148737686|NCT02370329|536512664|FG000|Overall Study|Disease progression|3|||
148737687|NCT02370329|536512664|FG000|Overall Study|Physician Decision|2|||
148737688|NCT02370329|536512664|FG000|Overall Study|Study closure|4|||
148974714|NCT02782949|537387963|FG000|Overall Study|Withdrawal by Subject|0|||
148974715|NCT02782949|537387964|FG001|Overall Study|Withdrawal by Subject|1|||
148737689|NCT02022748|536512668|FG000|Overall Study|Adverse Event|1|||
148737690|NCT02022748|536512669|FG001|Overall Study|Adverse Event|1|||
148737691|NCT02022748|536512670|FG002|Overall Study|Adverse Event|0|||
148737692|NCT02022748|536512668|FG000|Overall Study|Withdrawal by Subject|0|||
148737693|NCT02022748|536512669|FG001|Overall Study|Withdrawal by Subject|1|||
148737694|NCT02022748|536512670|FG002|Overall Study|Withdrawal by Subject|0|||
148737695|NCT00633243|536512671|FG000|Overall Study|Withdrawal by Subject|0|||
148737696|NCT00633243|536512672|FG001|Overall Study|Withdrawal by Subject|1|||
148737697|NCT00633243|536512671|FG000|Overall Study|incarceration|0|||
148737698|NCT00633243|536512672|FG001|Overall Study|incarceration|2|||
148737699|NCT00633243|536512671|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
148737700|NCT00633243|536512672|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
148737701|NCT00633243|536512671|FG000|Overall Study|Not comfortable with self-injecting|0|||
148737702|NCT00633243|536512672|FG001|Overall Study|Not comfortable with self-injecting|1|||
148737703|NCT00633243|536512671|FG000|Overall Study|Mental Health--Depression|0|||
148737704|NCT00633243|536512672|FG001|Overall Study|Mental Health--Depression|1|||
148737705|NCT00633243|536512671|FG000|Overall Study|Couldn't tolerate side-effects|1|||
148818151|NCT02400736|536810318|FG001|Overall Study|Withdrawal by Subject|1|||
148818152|NCT02400736|536810317|FG000|Overall Study|Moved from the area|3|||
148818153|NCT02400736|536810318|FG001|Overall Study|Moved from the area|1|||
148818154|NCT02927145|536810320|FG000|Initial Recruitment|Withdrawal by Subject|0|||
148818155|NCT02927145|536810321|FG001|Initial Recruitment|Withdrawal by Subject|1|||
148974716|NCT03316872|537387965|FG000|Overall Study|Death|1|||
148974717|NCT03548584|537389335|FG000|Overall Study|Lost to Follow-up|0|||
148974718|NCT03548584|537389336|FG001|Overall Study|Lost to Follow-up|0|||
148974719|NCT03548584|537389337|FG002|Overall Study|Lost to Follow-up|1|||
148974720|NCT03548584|537389335|FG000|Overall Study|Adverse Event|1|||
148974721|NCT03548584|537389336|FG001|Overall Study|Adverse Event|11|||
148974722|NCT03548584|537389337|FG002|Overall Study|Adverse Event|5|||
148974723|NCT03548584|537389335|FG000|Overall Study|Site Terminated by Sponsor|1|||
148974724|NCT03548584|537389336|FG001|Overall Study|Site Terminated by Sponsor|3|||
148974725|NCT03548584|537389337|FG002|Overall Study|Site Terminated by Sponsor|2|||
148974726|NCT03548584|537389335|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
148974727|NCT03548584|537389336|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
148974728|NCT03548584|537389337|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
148974729|NCT03548584|537389335|FG000|Overall Study|Lack of Efficacy|0|||
148974730|NCT03548584|537389336|FG001|Overall Study|Lack of Efficacy|1|||
148974731|NCT03548584|537389337|FG002|Overall Study|Lack of Efficacy|0|||
148974732|NCT03548584|537389335|FG000|Overall Study|Non-compliance with Study Drug|0|||
148974733|NCT03548584|537389336|FG001|Overall Study|Non-compliance with Study Drug|1|||
148974734|NCT03548584|537389337|FG002|Overall Study|Non-compliance with Study Drug|0|||
148974735|NCT03548584|537389335|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
148974736|NCT03548584|537389336|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
148974737|NCT03548584|537389337|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
148974738|NCT00533949|537389338|FG000|Overall Study|Protocol Violation|12|||
148974739|NCT00533949|537389339|FG001|Overall Study|Protocol Violation|12|||
148818156|NCT02927145|536810322|FG002|Initial Recruitment|Withdrawal by Subject|1|||
148818157|NCT02927145|536810323|FG003|Initial Recruitment|Withdrawal by Subject|4|||
148818158|NCT02927145|536810324|FG004|Initial Recruitment|Withdrawal by Subject|1|||
148818159|NCT02927145|536810325|FG005|Initial Recruitment|Withdrawal by Subject|1|||
148818160|NCT02927145|536810326|FG006|Initial Recruitment|Withdrawal by Subject|0|||
148818161|NCT02927145|536810327|FG007|Initial Recruitment|Withdrawal by Subject|0|||
148818162|NCT02927145|536810328|FG008|Initial Recruitment|Withdrawal by Subject|2|||
148818163|NCT02927145|536810320|FG000|Initial Recruitment|Adverse Event|0|||
148818164|NCT02927145|536810321|FG001|Initial Recruitment|Adverse Event|0|||
148974740|NCT00533949|537389340|FG002|Overall Study|Protocol Violation|9|||
148737706|NCT00633243|536512672|FG001|Overall Study|Couldn't tolerate side-effects|1|||
148737707|NCT00379340|536512674|FG000|Overall Study|Death|0|||
148818165|NCT02927145|536810322|FG002|Initial Recruitment|Adverse Event|0|||
148818166|NCT02927145|536810323|FG003|Initial Recruitment|Adverse Event|0|||
148818167|NCT02927145|536810324|FG004|Initial Recruitment|Adverse Event|2|||
148818168|NCT02927145|536810325|FG005|Initial Recruitment|Adverse Event|0|||
148818169|NCT02927145|536810326|FG006|Initial Recruitment|Adverse Event|0|||
148818170|NCT02927145|536810327|FG007|Initial Recruitment|Adverse Event|0|||
148974741|NCT00533949|537389341|FG003|Overall Study|Protocol Violation|9|||
148974742|NCT00533949|537389338|FG000|Overall Study|Withdrawal by Subject|3|||
148974743|NCT00533949|537389339|FG001|Overall Study|Withdrawal by Subject|2|||
148974744|NCT00533949|537389340|FG002|Overall Study|Withdrawal by Subject|1|||
149027105|NCT01579578|537576491|FG000|Overall Study|Eligibility criteria|3|||
149027106|NCT01579578|537576492|FG001|Overall Study|Eligibility criteria|9|||
148737708|NCT00379340|536512675|FG001|Overall Study|Death|0|||
148818171|NCT02927145|536810328|FG008|Initial Recruitment|Adverse Event|0|||
148818172|NCT02927145|536810320|FG000|Invitation for Additional Challenge|Pregnancy|0|||
148974745|NCT00533949|537389341|FG003|Overall Study|Withdrawal by Subject|1|||
148974746|NCT00727194|537389342|FG000|Screening Period|Low QMG scores|0|||
148737709|NCT00379340|536512676|FG002|Overall Study|Death|0|||
148737710|NCT00379340|536512677|FG003|Overall Study|Death|2|||
148737711|NCT00379340|536512678|FG004|Overall Study|Death|0|||
148737712|NCT00379340|536512674|FG000|Overall Study|Lack of Efficacy|6|||
148737713|NCT00379340|536512675|FG001|Overall Study|Lack of Efficacy|1|||
148737714|NCT00379340|536512676|FG002|Overall Study|Lack of Efficacy|0|||
148737715|NCT00379340|536512677|FG003|Overall Study|Lack of Efficacy|4|||
148737716|NCT00379340|536512678|FG004|Overall Study|Lack of Efficacy|3|||
148737717|NCT00379340|536512674|FG000|Overall Study|Physician Decision|6|||
148737718|NCT00379340|536512675|FG001|Overall Study|Physician Decision|2|||
148737719|NCT00379340|536512676|FG002|Overall Study|Physician Decision|1|||
148737720|NCT00379340|536512677|FG003|Overall Study|Physician Decision|2|||
148737721|NCT00379340|536512678|FG004|Overall Study|Physician Decision|3|||
148737722|NCT00379340|536512674|FG000|Overall Study|Withdrawal by Subject|0|||
148737723|NCT00379340|536512675|FG001|Overall Study|Withdrawal by Subject|0|||
148737724|NCT00379340|536512676|FG002|Overall Study|Withdrawal by Subject|0|||
148737725|NCT00379340|536512677|FG003|Overall Study|Withdrawal by Subject|1|||
148737726|NCT00379340|536512678|FG004|Overall Study|Withdrawal by Subject|0|||
148737727|NCT00379340|536512674|FG000|Overall Study|Refusal of further protocol therapy|1|||
148737728|NCT00379340|536512675|FG001|Overall Study|Refusal of further protocol therapy|0|||
148737729|NCT00379340|536512676|FG002|Overall Study|Refusal of further protocol therapy|1|||
148737730|NCT00379340|536512677|FG003|Overall Study|Refusal of further protocol therapy|1|||
148737731|NCT00379340|536512678|FG004|Overall Study|Refusal of further protocol therapy|7|||
148737732|NCT00379340|536512674|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
148737733|NCT00379340|536512675|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
148737734|NCT00379340|536512676|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
148737735|NCT00379340|536512677|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
148737736|NCT00379340|536512678|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
148737737|NCT00379340|536512674|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
148737738|NCT00379340|536512675|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
148737739|NCT00379340|536512676|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
148737740|NCT00379340|536512677|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
148737741|NCT00379340|536512678|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
148737742|NCT04347122|536512680|FG000|Overall Study|Physician Decision|0|||
148737743|NCT04347122|536512681|FG001|Overall Study|Physician Decision|3|||
148737744|NCT04347122|536512682|FG002|Overall Study|Physician Decision|3|||
148737745|NCT04347122|536512683|FG003|Overall Study|Physician Decision|6|||
148737746|NCT04994483|536512687|FG000|Overall Study|Adverse Event|26|||
148737747|NCT04994483|536512688|FG001|Overall Study|Adverse Event|17|||
148737748|NCT04994483|536512687|FG000|Overall Study|Lost to Follow-up|6|||
148737749|NCT04994483|536512688|FG001|Overall Study|Lost to Follow-up|10|||
148737750|NCT04994483|536512687|FG000|Overall Study|Noncompliance with study drug|8|||
148737751|NCT04994483|536512688|FG001|Overall Study|Noncompliance with study drug|5|||
148737752|NCT04994483|536512687|FG000|Overall Study|Physician Decision|5|||
148737753|NCT04994483|536512688|FG001|Overall Study|Physician Decision|0|||
148737754|NCT04994483|536512687|FG000|Overall Study|Withdrawal by Subject|41|||
148737755|NCT04994483|536512688|FG001|Overall Study|Withdrawal by Subject|38|||
148737756|NCT04994483|536512687|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
148737757|NCT04994483|536512688|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
148737758|NCT04994483|536512687|FG000|Overall Study|Met stopping criteria|1|||
148737759|NCT04994483|536512688|FG001|Overall Study|Met stopping criteria|0|||
148737760|NCT04994483|536512687|FG000|Overall Study|Randomized in error, not treated|4|||
148737761|NCT04994483|536512688|FG001|Overall Study|Randomized in error, not treated|3|||
148737762|NCT04994483|536512687|FG000|Overall Study|Lack of a reliable study partner|0|||
148737763|NCT04994483|536512688|FG001|Overall Study|Lack of a reliable study partner|1|||
148737764|NCT04994483|536512687|FG000|Overall Study|Met MRI exclusion criteria|0|||
148737765|NCT04994483|536512688|FG001|Overall Study|Met MRI exclusion criteria|1|||
148737766|NCT00112866|536512689|FG000|Overall Study|Protocol Violation|1|||
148737767|NCT00112866|536512690|FG001|Overall Study|Protocol Violation|0|||
148737768|NCT00112866|536512689|FG000|Overall Study|did not start treatment post-op|1|||
148737769|NCT00112866|536512690|FG001|Overall Study|did not start treatment post-op|2|||
148737770|NCT04663295|536512693|FG000|Run-in Period|Withdrawal by Subject|3|||
148737771|NCT04663295|536512693|FG000|Overall Study Period|Pregnancy|1|||
148737772|NCT04663295|536512693|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
148737773|NCT00554190|536512694|FG000|Overall Study|Termination forms not completed|10|||
148737774|NCT01502410|536512696|FG000|Overall Study|Adverse Event|1|||
148737775|NCT01502410|536512697|FG001|Overall Study|Adverse Event|2|||
148737776|NCT01502410|536512698|FG002|Overall Study|Adverse Event|0|||
148737777|NCT01502410|536512699|FG003|Overall Study|Adverse Event|0|||
148737778|NCT01502410|536512696|FG000|Overall Study|Lack of Efficacy|7|||
148737779|NCT01502410|536512697|FG001|Overall Study|Lack of Efficacy|7|||
148737780|NCT01502410|536512698|FG002|Overall Study|Lack of Efficacy|0|||
148737781|NCT01502410|536512699|FG003|Overall Study|Lack of Efficacy|0|||
148737782|NCT01502410|536512696|FG000|Overall Study|Physician Decision|0|||
148737783|NCT01502410|536512697|FG001|Overall Study|Physician Decision|1|||
148737784|NCT01502410|536512698|FG002|Overall Study|Physician Decision|0|||
148818173|NCT02927145|536810321|FG001|Invitation for Additional Challenge|Pregnancy|0|||
148818174|NCT02927145|536810322|FG002|Invitation for Additional Challenge|Pregnancy|0|||
148818175|NCT02927145|536810323|FG003|Invitation for Additional Challenge|Pregnancy|0|||
148818176|NCT02927145|536810324|FG004|Invitation for Additional Challenge|Pregnancy|0|||
148818177|NCT02927145|536810325|FG005|Invitation for Additional Challenge|Pregnancy|0|||
148818178|NCT02927145|536810326|FG006|Invitation for Additional Challenge|Pregnancy|1|||
148818179|NCT02927145|536810327|FG007|Invitation for Additional Challenge|Pregnancy|0|||
148818180|NCT02927145|536810328|FG008|Invitation for Additional Challenge|Pregnancy|0|||
148818181|NCT02323334|536810330|FG000|Period 3|Lost to Follow-up|0|||
148818182|NCT02323334|536810331|FG001|Period 3|Lost to Follow-up|0|||
148818183|NCT02323334|536810332|FG002|Period 3|Lost to Follow-up|1|||
148818184|NCT02323334|536810333|FG003|Period 3|Lost to Follow-up|0|||
148818185|NCT02323334|536810334|FG004|Period 3|Lost to Follow-up|0|||
148818186|NCT02323334|536810335|FG005|Period 3|Lost to Follow-up|0|||
148818187|NCT02323334|536810336|FG006|Period 3|Lost to Follow-up|0|||
148818188|NCT02323334|536810337|FG007|Period 3|Lost to Follow-up|0|||
148818189|NCT02323334|536810338|FG008|Period 3|Lost to Follow-up|0|||
148818190|NCT02323334|536810339|FG009|Period 3|Lost to Follow-up|0|||
148818191|NCT02323334|536810340|FG010|Period 3|Lost to Follow-up|0|||
148818192|NCT02323334|536810341|FG011|Period 3|Lost to Follow-up|0|||
148818193|NCT02323334|536810342|FG012|Period 3|Lost to Follow-up|0|||
148818194|NCT02323334|536810343|FG013|Period 3|Lost to Follow-up|0|||
148818195|NCT02323334|536810344|FG014|Period 3|Lost to Follow-up|0|||
148737785|NCT01502410|536512699|FG003|Overall Study|Physician Decision|0|||
148737786|NCT01502410|536512696|FG000|Overall Study|Withdrawal by Subject|2|||
148737787|NCT01502410|536512697|FG001|Overall Study|Withdrawal by Subject|0|||
148737788|NCT01502410|536512698|FG002|Overall Study|Withdrawal by Subject|0|||
148737789|NCT01502410|536512699|FG003|Overall Study|Withdrawal by Subject|0|||
148737790|NCT02903030|536512700|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
148737791|NCT02903030|536512701|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
148737792|NCT04345601|536512702|FG000|Overall Study|Death|0|||
148737793|NCT04345601|536512703|FG001|Overall Study|Death|3|||
148737794|NCT04345601|536512704|FG002|Overall Study|Death|2|||
148737795|NCT04345601|536512702|FG000|Overall Study|Lost to Follow-up|0|||
148737796|NCT04345601|536512703|FG001|Overall Study|Lost to Follow-up|0|||
148737797|NCT04345601|536512704|FG002|Overall Study|Lost to Follow-up|2|||
148737798|NCT03610516|536512705|FG000|Treatment Epoch|Adverse Event|3|||
148737799|NCT03610516|536512706|FG001|Treatment Epoch|Adverse Event|1|||
148737800|NCT03610516|536512705|FG000|Treatment Epoch|Death|1|||
148737801|NCT03610516|536512706|FG001|Treatment Epoch|Death|0|||
148737802|NCT03610516|536512705|FG000|Treatment Epoch|Lack of Efficacy|0|||
148737803|NCT03610516|536512706|FG001|Treatment Epoch|Lack of Efficacy|1|||
148737804|NCT03610516|536512705|FG000|Treatment Epoch|No longer requires treatment|1|||
148737805|NCT03610516|536512706|FG001|Treatment Epoch|No longer requires treatment|0|||
148737806|NCT03610516|536512705|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
148737807|NCT03610516|536512706|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
148737808|NCT03610516|536512705|FG000|Treatment Epoch|Physician Decision|8|||
148737809|NCT03610516|536512706|FG001|Treatment Epoch|Physician Decision|5|||
148737810|NCT03610516|536512705|FG000|Treatment Epoch|Protocol Deviation|1|||
148737811|NCT03610516|536512706|FG001|Treatment Epoch|Protocol Deviation|0|||
148737812|NCT03610516|536512705|FG000|Treatment Epoch|Withdrawal by Subject|3|||
148737813|NCT03610516|536512706|FG001|Treatment Epoch|Withdrawal by Subject|1|||
148737814|NCT03610516|536512705|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
148737815|NCT03610516|536512706|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
148737816|NCT03610516|536512705|FG000|Post-Treatment Follow-up|Death|1|||
148737817|NCT03610516|536512706|FG001|Post-Treatment Follow-up|Death|0|||
148737818|NCT00540293|536512710|FG000|Overall Study|Adverse event related to study drug|10|||
148737819|NCT00540293|536512710|FG000|Overall Study|Adverse event not related to study drug|7|||
148737820|NCT00540293|536512710|FG000|Overall Study|Withdrawal by Subject|6|||
148737821|NCT00540293|536512710|FG000|Overall Study|Protocol violation, & subject schedule|12|||
148737822|NCT03537599|536512711|FG000|Overall Study|Disease Progression|2|||
148818196|NCT02323334|536810345|FG015|Period 3|Lost to Follow-up|0|||
148818197|NCT02323334|536810346|FG016|Period 3|Lost to Follow-up|0|||
148818198|NCT02323334|536810330|FG000|Period 3|Withdrawal by Subject|1|||
148818199|NCT02323334|536810331|FG001|Period 3|Withdrawal by Subject|0|||
148818200|NCT02323334|536810332|FG002|Period 3|Withdrawal by Subject|0|||
148818201|NCT02323334|536810333|FG003|Period 3|Withdrawal by Subject|0|||
148818202|NCT02323334|536810334|FG004|Period 3|Withdrawal by Subject|0|||
148818203|NCT02323334|536810335|FG005|Period 3|Withdrawal by Subject|0|||
148737823|NCT03537599|536512712|FG001|Overall Study|Disease Progression|1|||
148737824|NCT03537599|536512711|FG000|Overall Study|Death|0|||
148737825|NCT03537599|536512712|FG001|Overall Study|Death|1|||
148737826|NCT00325195|536512715|FG000|Randomized|Not dosed|5|||
148737827|NCT00325195|536512716|FG001|Randomized|Not dosed|5|||
148737828|NCT00325195|536512717|FG002|Randomized|Not dosed|3|||
148818204|NCT02323334|536810336|FG006|Period 3|Withdrawal by Subject|0|||
148818205|NCT02323334|536810337|FG007|Period 3|Withdrawal by Subject|0|||
148818206|NCT02323334|536810338|FG008|Period 3|Withdrawal by Subject|0|||
148818207|NCT02323334|536810339|FG009|Period 3|Withdrawal by Subject|0|||
148818208|NCT02323334|536810340|FG010|Period 3|Withdrawal by Subject|0|||
148818209|NCT02323334|536810341|FG011|Period 3|Withdrawal by Subject|0|||
148818210|NCT02323334|536810342|FG012|Period 3|Withdrawal by Subject|0|||
148818211|NCT02323334|536810343|FG013|Period 3|Withdrawal by Subject|0|||
148818212|NCT02323334|536810344|FG014|Period 3|Withdrawal by Subject|0|||
148818213|NCT02323334|536810345|FG015|Period 3|Withdrawal by Subject|0|||
148818214|NCT02323334|536810346|FG016|Period 3|Withdrawal by Subject|0|||
148818215|NCT00266812|536810347|FG000|Overall Study|Disease Progression|9|||
148818216|NCT00266812|536810348|FG001|Overall Study|Disease Progression|3|||
148818217|NCT00266812|536810347|FG000|Overall Study|Death|5|||
148818218|NCT00266812|536810348|FG001|Overall Study|Death|4|||
148737829|NCT00325195|536512715|FG000|Received Intervention: ITT Population|Adverse Event|15|||
148737830|NCT00325195|536512716|FG001|Received Intervention: ITT Population|Adverse Event|17|||
148737831|NCT00325195|536512717|FG002|Received Intervention: ITT Population|Adverse Event|1|||
148737832|NCT00325195|536512715|FG000|Received Intervention: ITT Population|Death|3|||
148737833|NCT00325195|536512716|FG001|Received Intervention: ITT Population|Death|1|||
148737834|NCT00325195|536512717|FG002|Received Intervention: ITT Population|Death|0|||
148737835|NCT00325195|536512715|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
148737836|NCT00325195|536512716|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
148737837|NCT00325195|536512717|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
148737838|NCT00325195|536512715|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
148737839|NCT00325195|536512716|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
148737840|NCT00325195|536512717|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
148737841|NCT00325195|536512715|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
148737842|NCT00325195|536512716|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
148737843|NCT00325195|536512717|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
148737844|NCT00806286|536512718|FG000|Overall Study|Adverse Event|5|||
148737845|NCT00806286|536512719|FG001|Overall Study|Adverse Event|2|||
148818219|NCT00266812|536810347|FG000|Overall Study|Adverse Event|3|||
148818220|NCT00266812|536810348|FG001|Overall Study|Adverse Event|1|||
148818221|NCT00266812|536810347|FG000|Overall Study|Protocol Violation|0|||
148818222|NCT00266812|536810348|FG001|Overall Study|Protocol Violation|1|||
148818223|NCT00266812|536810347|FG000|Overall Study|Withdrawal by Subject|0|||
148818224|NCT00266812|536810348|FG001|Overall Study|Withdrawal by Subject|2|||
148818225|NCT00266812|536810347|FG000|Overall Study|Discontinued before starting study drug|4|||
148818226|NCT00266812|536810348|FG001|Overall Study|Discontinued before starting study drug|0|||
148818227|NCT03309605|536810349|FG000|Overall Study|Adverse Event|0|||
148818228|NCT03309605|536810350|FG001|Overall Study|Adverse Event|0|||
148818229|NCT03309605|536810351|FG002|Overall Study|Adverse Event|0|||
148818230|NCT03309605|536810352|FG003|Overall Study|Adverse Event|1|||
148818231|NCT03309605|536810353|FG004|Overall Study|Adverse Event|0|||
148818232|NCT03309605|536810354|FG005|Overall Study|Adverse Event|0|||
148818233|NCT03309605|536810355|FG006|Overall Study|Adverse Event|2|||
148818234|NCT03309605|536810356|FG007|Overall Study|Adverse Event|1|||
148818235|NCT03309605|536810349|FG000|Overall Study|Withdrawal by Subject|0|||
148818236|NCT03309605|536810350|FG001|Overall Study|Withdrawal by Subject|0|||
148818237|NCT03309605|536810351|FG002|Overall Study|Withdrawal by Subject|0|||
148818238|NCT03309605|536810352|FG003|Overall Study|Withdrawal by Subject|0|||
148818239|NCT03309605|536810353|FG004|Overall Study|Withdrawal by Subject|1|||
148818240|NCT03309605|536810354|FG005|Overall Study|Withdrawal by Subject|0|||
148818241|NCT03309605|536810355|FG006|Overall Study|Withdrawal by Subject|1|||
148974747|NCT00727194|537389343|FG001|Screening Period|Low QMG scores|0|||
148974748|NCT00727194|537389344|FG002|Screening Period|Low QMG scores|6|||
148818242|NCT03309605|536810356|FG007|Overall Study|Withdrawal by Subject|1|||
148818243|NCT01129284|536810357|FG000|Overall Study|Adverse Event|2|||
148818244|NCT01129284|536810358|FG001|Overall Study|Adverse Event|0|||
148818245|NCT01129284|536810359|FG002|Overall Study|Adverse Event|1|||
148818246|NCT01060111|536810360|FG000|Overall Study|Adverse Event|9|||
148818247|NCT01060111|536810361|FG001|Overall Study|Adverse Event|5|||
148818248|NCT01060111|536810362|FG002|Overall Study|Adverse Event|18|||
148818249|NCT01060111|536810360|FG000|Overall Study|Lack of Efficacy|2|||
148818250|NCT01060111|536810361|FG001|Overall Study|Lack of Efficacy|1|||
148818251|NCT01060111|536810362|FG002|Overall Study|Lack of Efficacy|0|||
148818252|NCT01060111|536810360|FG000|Overall Study|Inappropriate participant|5|||
148818253|NCT01060111|536810361|FG001|Overall Study|Inappropriate participant|4|||
148737846|NCT00806286|536512720|FG002|Overall Study|Adverse Event|0|||
148818254|NCT01060111|536810362|FG002|Overall Study|Inappropriate participant|5|||
148818255|NCT01060111|536810360|FG000|Overall Study|Participants' evasion for hospital visit|0|||
148818256|NCT01060111|536810361|FG001|Overall Study|Participants' evasion for hospital visit|3|||
148818257|NCT01060111|536810362|FG002|Overall Study|Participants' evasion for hospital visit|2|||
148818258|NCT01060111|536810360|FG000|Overall Study|Participants' non-cooperation|8|||
148818259|NCT01060111|536810361|FG001|Overall Study|Participants' non-cooperation|6|||
148974749|NCT00727194|537389342|FG000|Screening Period|Lacked AChR antibodies|0|||
148974750|NCT00727194|537389343|FG001|Screening Period|Lacked AChR antibodies|0|||
148974751|NCT00727194|537389344|FG002|Screening Period|Lacked AChR antibodies|5|||
148974752|NCT00727194|537389342|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
148974753|NCT00727194|537389343|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
148974754|NCT00727194|537389344|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
148974755|NCT00727194|537389342|FG000|Screening Period|Severe infections|0|||
148974756|NCT00727194|537389343|FG001|Screening Period|Severe infections|0|||
148974757|NCT00727194|537389344|FG002|Screening Period|Severe infections|2|||
148974758|NCT00727194|537389342|FG000|Screening Period|History of thymoma|0|||
148974759|NCT00727194|537389343|FG001|Screening Period|History of thymoma|0|||
148974760|NCT00727194|537389344|FG002|Screening Period|History of thymoma|1|||
148974761|NCT00727194|537389342|FG000|Treatment Period 2|Lack of Efficacy|0|||
148974762|NCT00727194|537389343|FG001|Treatment Period 2|Lack of Efficacy|1|||
148974763|NCT00727194|537389344|FG002|Treatment Period 2|Lack of Efficacy|0|||
148974764|NCT04269161|537389345|FG000|Overall Study|Change of modality and no longer eligible|3|||
148974765|NCT04269161|537389346|FG001|Overall Study|Change of modality and no longer eligible|3|||
148737847|NCT00806286|536512718|FG000|Overall Study|Disease progression|31|||
148737848|NCT00806286|536512719|FG001|Overall Study|Disease progression|38|||
148737849|NCT00806286|536512720|FG002|Overall Study|Disease progression|1|||
148737850|NCT00806286|536512718|FG000|Overall Study|Death|1|||
148737851|NCT00806286|536512719|FG001|Overall Study|Death|6|||
148737852|NCT00806286|536512720|FG002|Overall Study|Death|0|||
148737853|NCT00806286|536512718|FG000|Overall Study|Lost to Follow-up|0|||
148737854|NCT00806286|536512719|FG001|Overall Study|Lost to Follow-up|1|||
148737855|NCT00806286|536512720|FG002|Overall Study|Lost to Follow-up|0|||
148737856|NCT00806286|536512718|FG000|Overall Study|Withdrawal by Subject|8|||
148737857|NCT00806286|536512719|FG001|Overall Study|Withdrawal by Subject|3|||
148737858|NCT00806286|536512720|FG002|Overall Study|Withdrawal by Subject|1|||
148737859|NCT00806286|536512718|FG000|Overall Study|Physician Decision|2|||
148737860|NCT00806286|536512719|FG001|Overall Study|Physician Decision|2|||
148737861|NCT00806286|536512720|FG002|Overall Study|Physician Decision|0|||
148737862|NCT00806286|536512718|FG000|Overall Study|Due to a variety of reasons|7|||
148737863|NCT00806286|536512719|FG001|Overall Study|Due to a variety of reasons|2|||
148737864|NCT00806286|536512720|FG002|Overall Study|Due to a variety of reasons|1|||
148737865|NCT00977379|536512733|FG000|Overall Study|Withdrawal by Subject|1|||
148737866|NCT00977379|536512734|FG001|Overall Study|Withdrawal by Subject|1|||
148737867|NCT00977379|536512733|FG000|Overall Study|Death|7|||
148737868|NCT00977379|536512734|FG001|Overall Study|Death|9|||
148737869|NCT00977379|536512733|FG000|Overall Study|Premature Study Termination|4|||
148737870|NCT00977379|536512734|FG001|Overall Study|Premature Study Termination|0|||
148737871|NCT00977379|536512733|FG000|Overall Study|Participant Moving House|0|||
148737872|NCT00977379|536512734|FG001|Overall Study|Participant Moving House|1|||
148737873|NCT00977379|536512733|FG000|Overall Study|Randomization Error|0|||
148737874|NCT00977379|536512734|FG001|Overall Study|Randomization Error|1|||
148737875|NCT00699374|536512735|FG000|Overall Study|Death|93|||
148737876|NCT00699374|536512736|FG001|Overall Study|Death|83|||
148737877|NCT00699374|536512735|FG000|Overall Study|Adverse Event|70|||
148737878|NCT00699374|536512736|FG001|Overall Study|Adverse Event|67|||
148737879|NCT00699374|536512735|FG000|Overall Study|Global deterioration of health status|7|||
148737880|NCT00699374|536512736|FG001|Overall Study|Global deterioration of health status|8|||
148737881|NCT00699374|536512735|FG000|Overall Study|Lost to Follow-up|3|||
148737882|NCT00699374|536512736|FG001|Overall Study|Lost to Follow-up|5|||
148737883|NCT00699374|536512735|FG000|Overall Study|Withdrawal by Subject|34|||
148737884|NCT00699374|536512736|FG001|Overall Study|Withdrawal by Subject|44|||
148737885|NCT00699374|536512735|FG000|Overall Study|Objective progression or relapse|281|||
148737886|NCT00699374|536512736|FG001|Overall Study|Objective progression or relapse|277|||
148737887|NCT00699374|536512735|FG000|Overall Study|Other|18|||
148737888|NCT00699374|536512736|FG001|Overall Study|Other|15|||
148737889|NCT00699374|536512735|FG000|Overall Study|Protocol Violation|2|||
148737890|NCT00699374|536512736|FG001|Overall Study|Protocol Violation|6|||
148737891|NCT00699374|536512735|FG000|Overall Study|Study terminated by sponsor|13|||
148737892|NCT00699374|536512736|FG001|Overall Study|Study terminated by sponsor|28|||
148737893|NCT00699374|536512735|FG000|Overall Study|Randomized but not treated|4|||
148737894|NCT00699374|536512736|FG001|Overall Study|Randomized but not treated|2|||
148737895|NCT00699374|536512735|FG000|Overall Study|Died 28 days after last dose|5|||
148737896|NCT00699374|536512736|FG001|Overall Study|Died 28 days after last dose|9|||
148974766|NCT04269161|537389345|FG000|Overall Study|Required procedure outside of NICU|1|||
148974767|NCT04269161|537389346|FG001|Overall Study|Required procedure outside of NICU|0|||
148974768|NCT04269161|537389345|FG000|Overall Study|Equipment issue|1|||
148737897|NCT00593736|536512743|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
148737898|NCT00593736|536512744|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
148737899|NCT00593736|536512745|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
148737900|NCT00593736|536512746|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
148737901|NCT00593736|536512743|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
148974769|NCT04269161|537389346|FG001|Overall Study|Equipment issue|1|||
148974770|NCT01677195|537389347|FG000|Overall Study|Lost to Follow-up|14|||
148974771|NCT01677195|537389348|FG001|Overall Study|Lost to Follow-up|22|||
148974772|NCT01677195|537389349|FG002|Overall Study|Lost to Follow-up|22|||
148974773|NCT01677195|537389347|FG000|Overall Study|Withdrawal by Subject|1|||
148737902|NCT00593736|536512744|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
148737903|NCT00593736|536512745|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
148737904|NCT00593736|536512746|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
148737905|NCT00593736|536512743|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
148737906|NCT00593736|536512744|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
148737907|NCT00593736|536512745|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
148737908|NCT00593736|536512746|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
148737909|NCT00593736|536512743|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
148737910|NCT00593736|536512744|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
148737911|NCT00593736|536512745|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
148737912|NCT00593736|536512746|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
148737913|NCT00593736|536512743|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
148737914|NCT00593736|536512744|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
148737915|NCT00593736|536512745|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
148737916|NCT00593736|536512746|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
148737917|NCT00593736|536512743|FG000|Screening Period and Placebo Run-in|Various|0|||
148737918|NCT00593736|536512744|FG001|Screening Period and Placebo Run-in|Various|0|||
148737919|NCT00593736|536512745|FG002|Screening Period and Placebo Run-in|Various|0|||
148737920|NCT00593736|536512746|FG003|Screening Period and Placebo Run-in|Various|25|||
148737921|NCT00593736|536512743|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
148737922|NCT00593736|536512744|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
148737923|NCT00593736|536512745|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
148737924|NCT00593736|536512746|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
148737925|NCT00593736|536512743|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
148737926|NCT00593736|536512744|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
148737927|NCT00593736|536512745|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
148737928|NCT00593736|536512746|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
148737929|NCT00593736|536512743|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
148737930|NCT00593736|536512744|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
148737931|NCT00593736|536512745|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
148737932|NCT00593736|536512746|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
148737933|NCT00593736|536512743|FG000|Treatment Period and Placebo Run-out|Various|1|||
148737934|NCT00593736|536512744|FG001|Treatment Period and Placebo Run-out|Various|1|||
148737935|NCT00593736|536512745|FG002|Treatment Period and Placebo Run-out|Various|1|||
148737936|NCT00593736|536512746|FG003|Treatment Period and Placebo Run-out|Various|0|||
148737937|NCT04283500|536512749|FG000|Overall Study|Lost to Follow-up|8|||
148737938|NCT04283500|536512749|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
148737939|NCT02006693|536512753|FG000|Overall Study|No Reason Specified|6|||
148737940|NCT02006693|536512754|FG001|Overall Study|No Reason Specified|8|||
148737941|NCT02006693|536512753|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
148737942|NCT02006693|536512754|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
148737943|NCT02006693|536512753|FG000|Overall Study|XEN Implant Explantation|0|||
148737944|NCT02006693|536512754|FG001|Overall Study|XEN Implant Explantation|1|||
148737945|NCT02006693|536512753|FG000|Overall Study|Death|2|||
148737946|NCT02006693|536512754|FG001|Overall Study|Death|2|||
148737947|NCT02006693|536512753|FG000|Overall Study|Lost to Follow-up|4|||
148737948|NCT02006693|536512754|FG001|Overall Study|Lost to Follow-up|1|||
148737949|NCT02006693|536512753|FG000|Overall Study|Patient Decision|4|||
148737950|NCT02006693|536512754|FG001|Overall Study|Patient Decision|0|||
148737951|NCT01119508|536512757|FG000|Overall Study|Adverse Event|56|||
148737952|NCT01119508|536512757|FG000|Overall Study|Withdrawal by Subject|2|||
148737953|NCT01119508|536512757|FG000|Overall Study|Died before tumor response evaluation|1|||
148737954|NCT00265395|536512758|FG000|Overall Study|Adverse Event|3|||
148737955|NCT00265395|536512759|FG001|Overall Study|Adverse Event|6|||
148737956|NCT00265395|536512758|FG000|Overall Study|Lost to Follow-up|2|||
148737957|NCT00265395|536512759|FG001|Overall Study|Lost to Follow-up|1|||
148737958|NCT00265395|536512758|FG000|Overall Study|Withdrawal by Subject|1|||
148737959|NCT00265395|536512759|FG001|Overall Study|Withdrawal by Subject|6|||
148737960|NCT00265395|536512758|FG000|Overall Study|Protocol Violation|2|||
148737961|NCT00265395|536512759|FG001|Overall Study|Protocol Violation|2|||
148737962|NCT00265395|536512758|FG000|Overall Study|Lack of Efficacy|0|||
148737963|NCT00265395|536512759|FG001|Overall Study|Lack of Efficacy|1|||
148737964|NCT00265395|536512758|FG000|Overall Study|Administrative|0|||
148737965|NCT00265395|536512759|FG001|Overall Study|Administrative|1|||
148737966|NCT02563106|536512762|FG000|Overall Study|Withdrawal by Subject|7|||
148737967|NCT02563106|536512763|FG001|Overall Study|Withdrawal by Subject|8|||
148974774|NCT01677195|537389348|FG001|Overall Study|Withdrawal by Subject|0|||
148974775|NCT01677195|537389349|FG002|Overall Study|Withdrawal by Subject|1|||
148737968|NCT02563106|536512762|FG000|Overall Study|Adverse Event|17|||
148737969|NCT02563106|536512763|FG001|Overall Study|Adverse Event|15|||
148737970|NCT02563106|536512762|FG000|Overall Study|Protocol Violation|1|||
148737971|NCT02563106|536512763|FG001|Overall Study|Protocol Violation|0|||
148737972|NCT02563106|536512762|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
148737973|NCT02563106|536512763|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
148737974|NCT02563106|536512762|FG000|Overall Study|Lost to Follow-up|3|||
148737975|NCT02563106|536512763|FG001|Overall Study|Lost to Follow-up|2|||
148737976|NCT02563106|536512762|FG000|Overall Study|Physician Decision|3|||
148737977|NCT02563106|536512763|FG001|Overall Study|Physician Decision|1|||
148737978|NCT02563106|536512762|FG000|Overall Study|Other reason - not specified|2|||
148974776|NCT01677195|537389347|FG000|Overall Study|Adverse Event|6|||
148974777|NCT01677195|537389348|FG001|Overall Study|Adverse Event|4|||
148974778|NCT01677195|537389349|FG002|Overall Study|Adverse Event|1|||
148974779|NCT01677195|537389347|FG000|Overall Study|Physician Decision|1|||
148974780|NCT01677195|537389348|FG001|Overall Study|Physician Decision|2|||
148974781|NCT01677195|537389349|FG002|Overall Study|Physician Decision|2|||
148974782|NCT01677195|537389347|FG000|Overall Study|Pregnancy|0|||
148974783|NCT01677195|537389348|FG001|Overall Study|Pregnancy|1|||
148974784|NCT01677195|537389349|FG002|Overall Study|Pregnancy|0|||
148974785|NCT01677195|537389347|FG000|Overall Study|Protocol Violation|7|||
148974786|NCT01677195|537389348|FG001|Overall Study|Protocol Violation|3|||
148974787|NCT01677195|537389349|FG002|Overall Study|Protocol Violation|4|||
148974788|NCT04368429|537389350|FG000|Overall Study|Adverse Event|1|||
148974789|NCT04368429|537389351|FG001|Overall Study|Adverse Event|0|||
148974790|NCT03633396|537389354|FG000|Overall Study|Withdrawal by Subject|4|||
148974791|NCT03633396|537389355|FG001|Overall Study|Withdrawal by Subject|4|||
148974792|NCT03633396|537389354|FG000|Overall Study|Adverse Event|1|||
148974793|NCT03633396|537389355|FG001|Overall Study|Adverse Event|1|||
148974794|NCT03633396|537389354|FG000|Overall Study|Lack of Efficacy|1|||
148974795|NCT03633396|537389355|FG001|Overall Study|Lack of Efficacy|0|||
148974796|NCT03633396|537389354|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
148974797|NCT03633396|537389355|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
148974798|NCT01012817|537389356|FG000|Overall Study|Withdrawal by Subject|0|||
148974799|NCT01012817|537389357|FG001|Overall Study|Withdrawal by Subject|0|||
148974800|NCT01012817|537389358|FG002|Overall Study|Withdrawal by Subject|0|||
148974801|NCT01012817|537389359|FG003|Overall Study|Withdrawal by Subject|1|||
148974802|NCT01012817|537389360|FG004|Overall Study|Withdrawal by Subject|0|||
148974803|NCT01012817|537389361|FG005|Overall Study|Withdrawal by Subject|0|||
148974804|NCT01012817|537389362|FG006|Overall Study|Withdrawal by Subject|0|||
148974805|NCT01012817|537389363|FG007|Overall Study|Withdrawal by Subject|1|||
148974806|NCT01012817|537389364|FG008|Overall Study|Withdrawal by Subject|0|||
148974807|NCT01012817|537389365|FG009|Overall Study|Withdrawal by Subject|0|||
148974808|NCT01012817|537389366|FG010|Overall Study|Withdrawal by Subject|1|||
148974809|NCT01012817|537389367|FG011|Overall Study|Withdrawal by Subject|1|||
148974810|NCT01012817|537389368|FG012|Overall Study|Withdrawal by Subject|0|||
148974811|NCT01012817|537389369|FG013|Overall Study|Withdrawal by Subject|1|||
148737979|NCT02563106|536512763|FG001|Overall Study|Other reason - not specified|1|||
148737980|NCT04729309|536512764|FG000|Period 1|Subject unable to return for Period 2|3|||
148737981|NCT04729309|536512765|FG001|Period 1|Subject unable to return for Period 2|0|||
148737982|NCT04729309|536512764|FG000|Period 1|Lost to Follow-up|1|||
148737983|NCT04729309|536512765|FG001|Period 1|Lost to Follow-up|0|||
148737984|NCT01212588|536512766|FG000|Overall Study|Physician Decision|0|||
148737985|NCT01212588|536512767|FG001|Overall Study|Physician Decision|1|||
148737986|NCT01212588|536512766|FG000|Overall Study|Protocol Violation|1|||
148737987|NCT01212588|536512767|FG001|Overall Study|Protocol Violation|1|||
148737988|NCT01136967|536512768|FG000|Overall Study|Adverse Event|9|||
148737989|NCT01136967|536512769|FG001|Overall Study|Adverse Event|12|||
148737990|NCT01136967|536512768|FG000|Overall Study|Participant Choice|8|||
148737991|NCT01136967|536512769|FG001|Overall Study|Participant Choice|3|||
148737992|NCT01136967|536512768|FG000|Overall Study|Lost to Follow-up|0|||
148974812|NCT01012817|537389356|FG000|Overall Study|Adverse Event|0|||
148974813|NCT01012817|537389357|FG001|Overall Study|Adverse Event|0|||
148974814|NCT01012817|537389358|FG002|Overall Study|Adverse Event|0|||
148974815|NCT01012817|537389359|FG003|Overall Study|Adverse Event|0|||
148974816|NCT01012817|537389360|FG004|Overall Study|Adverse Event|0|||
148974817|NCT01012817|537389361|FG005|Overall Study|Adverse Event|1|||
148974818|NCT01012817|537389362|FG006|Overall Study|Adverse Event|0|||
148974819|NCT01012817|537389363|FG007|Overall Study|Adverse Event|0|||
148974820|NCT01012817|537389364|FG008|Overall Study|Adverse Event|0|||
148974821|NCT01012817|537389365|FG009|Overall Study|Adverse Event|0|||
148974822|NCT01012817|537389366|FG010|Overall Study|Adverse Event|1|||
148974823|NCT01012817|537389367|FG011|Overall Study|Adverse Event|0|||
148974824|NCT01012817|537389368|FG012|Overall Study|Adverse Event|0|||
148737993|NCT01136967|536512769|FG001|Overall Study|Lost to Follow-up|1|||
148974825|NCT01012817|537389369|FG013|Overall Study|Adverse Event|1|||
148974826|NCT02472756|537389370|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
148737994|NCT01136967|536512768|FG000|Overall Study|Withdrawal by Subject|1|||
148737995|NCT01136967|536512769|FG001|Overall Study|Withdrawal by Subject|2|||
148737996|NCT01136967|536512768|FG000|Overall Study|Clinical Progression|3|||
148737997|NCT01136967|536512769|FG001|Overall Study|Clinical Progression|5|||
148737998|NCT01136967|536512768|FG000|Overall Study|Radiation|1|||
148737999|NCT01136967|536512769|FG001|Overall Study|Radiation|0|||
148738000|NCT01136967|536512768|FG000|Overall Study|Non-compliance|1|||
148738001|NCT01136967|536512769|FG001|Overall Study|Non-compliance|0|||
148738002|NCT01136967|536512768|FG000|Overall Study|Investigator's Choice|1|||
148738003|NCT01136967|536512769|FG001|Overall Study|Investigator's Choice|1|||
148738004|NCT01136967|536512768|FG000|Overall Study|Increase in Lesion Size|0|||
148738005|NCT01136967|536512769|FG001|Overall Study|Increase in Lesion Size|2|||
148738006|NCT01136967|536512768|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
148738007|NCT01136967|536512769|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
148738008|NCT03317834|536512770|FG000|Overall Study|Death|2|||
148738009|NCT03317834|536512770|FG000|Overall Study|Device Revision|5|||
148738010|NCT03317834|536512770|FG000|Overall Study|Withdrawal by Subject|13|||
148738011|NCT03317834|536512770|FG000|Overall Study|Lost to Follow-up|13|||
148738012|NCT01517373|536512774|FG000|Run-in Period|Death|1|||
148738013|NCT01517373|536512775|FG001|Run-in Period|Death|0|||
148738014|NCT01517373|536512776|FG002|Run-in Period|Death|0|||
148738015|NCT01517373|536512777|FG003|Run-in Period|Death|0|||
148738016|NCT01517373|536512778|FG004|Run-in Period|Death|0|||
148738017|NCT01517373|536512779|FG005|Run-in Period|Death|0|||
148738018|NCT01517373|536512774|FG000|Run-in Period|Adverse Event|5|||
148738019|NCT01517373|536512775|FG001|Run-in Period|Adverse Event|0|||
148738020|NCT01517373|536512776|FG002|Run-in Period|Adverse Event|0|||
148738021|NCT01517373|536512777|FG003|Run-in Period|Adverse Event|0|||
148738022|NCT01517373|536512778|FG004|Run-in Period|Adverse Event|0|||
148738023|NCT01517373|536512779|FG005|Run-in Period|Adverse Event|0|||
148738024|NCT01517373|536512774|FG000|Run-in Period|Did not meet eligibility criteria|34|||
148738025|NCT01517373|536512775|FG001|Run-in Period|Did not meet eligibility criteria|0|||
148738026|NCT01517373|536512776|FG002|Run-in Period|Did not meet eligibility criteria|0|||
148738027|NCT01517373|536512777|FG003|Run-in Period|Did not meet eligibility criteria|0|||
148738028|NCT01517373|536512778|FG004|Run-in Period|Did not meet eligibility criteria|0|||
148738029|NCT01517373|536512779|FG005|Run-in Period|Did not meet eligibility criteria|0|||
148738030|NCT01517373|536512774|FG000|Run-in Period|Lost to Follow-up|1|||
148738031|NCT01517373|536512775|FG001|Run-in Period|Lost to Follow-up|0|||
148738032|NCT01517373|536512776|FG002|Run-in Period|Lost to Follow-up|0|||
148738033|NCT01517373|536512777|FG003|Run-in Period|Lost to Follow-up|0|||
148738034|NCT01517373|536512778|FG004|Run-in Period|Lost to Follow-up|0|||
148738035|NCT01517373|536512779|FG005|Run-in Period|Lost to Follow-up|0|||
148738036|NCT01517373|536512774|FG000|Run-in Period|Withdrawal by Subject|12|||
148738037|NCT01517373|536512775|FG001|Run-in Period|Withdrawal by Subject|0|||
148738038|NCT01517373|536512776|FG002|Run-in Period|Withdrawal by Subject|0|||
148738039|NCT01517373|536512777|FG003|Run-in Period|Withdrawal by Subject|0|||
148738040|NCT01517373|536512778|FG004|Run-in Period|Withdrawal by Subject|0|||
148738041|NCT01517373|536512779|FG005|Run-in Period|Withdrawal by Subject|0|||
148738042|NCT01517373|536512774|FG000|Run-in Period|Sponsor Decision|3|||
148738043|NCT01517373|536512775|FG001|Run-in Period|Sponsor Decision|0|||
148738044|NCT01517373|536512776|FG002|Run-in Period|Sponsor Decision|0|||
148738045|NCT01517373|536512777|FG003|Run-in Period|Sponsor Decision|0|||
148738046|NCT01517373|536512778|FG004|Run-in Period|Sponsor Decision|0|||
148738047|NCT01517373|536512779|FG005|Run-in Period|Sponsor Decision|0|||
148738048|NCT01517373|536512774|FG000|Run-in Period|Other|1|||
148738049|NCT01517373|536512775|FG001|Run-in Period|Other|0|||
148738050|NCT01517373|536512776|FG002|Run-in Period|Other|0|||
148738051|NCT01517373|536512777|FG003|Run-in Period|Other|0|||
148738052|NCT01517373|536512778|FG004|Run-in Period|Other|0|||
148738053|NCT01517373|536512779|FG005|Run-in Period|Other|0|||
148738054|NCT01517373|536512774|FG000|Treatment Period|Adverse Event|0|||
148738055|NCT01517373|536512775|FG001|Treatment Period|Adverse Event|0|||
148738056|NCT01517373|536512776|FG002|Treatment Period|Adverse Event|0|||
148738057|NCT01517373|536512777|FG003|Treatment Period|Adverse Event|0|||
148738058|NCT01517373|536512778|FG004|Treatment Period|Adverse Event|0|||
148738059|NCT01517373|536512779|FG005|Treatment Period|Adverse Event|2|||
148738060|NCT01517373|536512774|FG000|Treatment Period|Lost to Follow-up|0|||
148738061|NCT01517373|536512775|FG001|Treatment Period|Lost to Follow-up|0|||
148738062|NCT01517373|536512776|FG002|Treatment Period|Lost to Follow-up|1|||
148738063|NCT01517373|536512777|FG003|Treatment Period|Lost to Follow-up|1|||
148738064|NCT01517373|536512778|FG004|Treatment Period|Lost to Follow-up|0|||
148738065|NCT01517373|536512779|FG005|Treatment Period|Lost to Follow-up|0|||
148738066|NCT01517373|536512774|FG000|Treatment Period|Withdrawal by Subject|0|||
148738067|NCT01517373|536512775|FG001|Treatment Period|Withdrawal by Subject|3|||
148738068|NCT01517373|536512776|FG002|Treatment Period|Withdrawal by Subject|2|||
148738069|NCT01517373|536512777|FG003|Treatment Period|Withdrawal by Subject|2|||
148738070|NCT01517373|536512778|FG004|Treatment Period|Withdrawal by Subject|2|||
148738071|NCT01517373|536512779|FG005|Treatment Period|Withdrawal by Subject|3|||
148738072|NCT01517373|536512774|FG000|Treatment Period|Other|0|||
148738073|NCT01517373|536512775|FG001|Treatment Period|Other|0|||
148974827|NCT02472756|537389370|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
148974828|NCT02472756|537389370|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
148974829|NCT02472756|537389370|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
148974830|NCT02472756|537389370|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
148974831|NCT02143414|537389371|FG000|Induction|Adverse Event|1|||
148974832|NCT02143414|537389372|FG001|Induction|Adverse Event|2|||
148974833|NCT02143414|537389371|FG000|Induction|Death|1|||
148974834|NCT02143414|537389372|FG001|Induction|Death|2|||
148974835|NCT02143414|537389371|FG000|Induction|Patient refusal|1|||
148974836|NCT02143414|537389372|FG001|Induction|Patient refusal|1|||
148974837|NCT02143414|537389371|FG000|Induction|Refractory|1|||
148974838|NCT02143414|537389372|FG001|Induction|Refractory|0|||
148974839|NCT02143414|537389371|FG000|Induction|Began alternative treatment|1|||
148974840|NCT02143414|537389372|FG001|Induction|Began alternative treatment|0|||
148974841|NCT02143414|537389371|FG000|Induction|Ineligible for postremission|5|||
148974842|NCT02143414|537389372|FG001|Induction|Ineligible for postremission|1|||
148974843|NCT02143414|537389371|FG000|Post-remission|Adverse Event|0|||
148974844|NCT02143414|537389372|FG001|Post-remission|Adverse Event|2|||
148974845|NCT02143414|537389371|FG000|Post-remission|Disease progression/relapse|5|||
148974846|NCT02143414|537389372|FG001|Post-remission|Disease progression/relapse|0|||
148974847|NCT02143414|537389371|FG000|Maintenance|Adverse Event|4|||
148974848|NCT02143414|537389372|FG001|Maintenance|Adverse Event|6|||
148974849|NCT02143414|537389371|FG000|Maintenance|Disease progression/relapse|3|||
148974850|NCT02143414|537389372|FG001|Maintenance|Disease progression/relapse|2|||
148974851|NCT02143414|537389371|FG000|Maintenance|Patient refusal|2|||
148974852|NCT02143414|537389372|FG001|Maintenance|Patient refusal|1|||
148738074|NCT01517373|536512776|FG002|Treatment Period|Other|0|||
148738075|NCT01517373|536512777|FG003|Treatment Period|Other|0|||
148738076|NCT01517373|536512778|FG004|Treatment Period|Other|1|||
148738077|NCT01517373|536512779|FG005|Treatment Period|Other|0|||
148738078|NCT01517373|536512774|FG000|Treatment Period|Protocol Violation|0|||
148738079|NCT01517373|536512775|FG001|Treatment Period|Protocol Violation|0|||
148738080|NCT01517373|536512776|FG002|Treatment Period|Protocol Violation|0|||
148738081|NCT01517373|536512777|FG003|Treatment Period|Protocol Violation|0|||
148738082|NCT01517373|536512778|FG004|Treatment Period|Protocol Violation|1|||
148738083|NCT01517373|536512779|FG005|Treatment Period|Protocol Violation|0|||
148738084|NCT01517373|536512774|FG000|Treatment Period|Lack of Efficacy|0|||
148738085|NCT01517373|536512775|FG001|Treatment Period|Lack of Efficacy|1|||
148738086|NCT01517373|536512776|FG002|Treatment Period|Lack of Efficacy|1|||
148738087|NCT01517373|536512777|FG003|Treatment Period|Lack of Efficacy|3|||
148738088|NCT01517373|536512778|FG004|Treatment Period|Lack of Efficacy|2|||
148738089|NCT01517373|536512779|FG005|Treatment Period|Lack of Efficacy|0|||
148738090|NCT01517373|536512774|FG000|Treatment Period|Medication error without AEs|0|||
148738091|NCT01517373|536512775|FG001|Treatment Period|Medication error without AEs|0|||
148738092|NCT01517373|536512776|FG002|Treatment Period|Medication error without AEs|2|||
148738093|NCT01517373|536512777|FG003|Treatment Period|Medication error without AEs|1|||
148738094|NCT01517373|536512778|FG004|Treatment Period|Medication error without AEs|0|||
148738095|NCT01517373|536512779|FG005|Treatment Period|Medication error without AEs|2|||
148738096|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
148738097|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
148738098|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
148738099|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
148738100|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
148738101|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
148738102|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
148738103|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
148738104|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
148738105|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
148738106|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Death|1|||
148738107|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Death|0|||
148738108|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Death|0|||
148738109|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Death|0|||
148974853|NCT02143414|537389371|FG000|Maintenance|Physician Decision|1|||
148974854|NCT02143414|537389372|FG001|Maintenance|Physician Decision|0|||
148974855|NCT02143414|537389371|FG000|Maintenance|Death|0|||
148974856|NCT02143414|537389372|FG001|Maintenance|Death|1|||
148974857|NCT02143414|537389371|FG000|Maintenance|On protocol treatment|0|||
148974858|NCT02143414|537389372|FG001|Maintenance|On protocol treatment|6|||
148974859|NCT00110266|537389376|FG000|Overall Study|Adverse Event|27|||
148974860|NCT00110266|537389376|FG000|Overall Study|Abnormal laboratory value|15|||
148738110|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Death|0|||
148738111|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
148818260|NCT01060111|536810362|FG002|Overall Study|Participants' non-cooperation|6|||
148974861|NCT00110266|537389376|FG000|Overall Study|Withdrawal by Subject|16|||
148974862|NCT00110266|537389376|FG000|Overall Study|Death|17|||
148974863|NCT00110266|537389376|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148974864|NCT00110266|537389376|FG000|Overall Study|Participant condition no longer requires study drug|1|||
148738112|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
148738113|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
148738114|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
148738115|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
148738116|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
148738117|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
148738118|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
148738119|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
148738120|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
148738121|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
148738122|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
148738123|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
148738124|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
148738125|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
148738126|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
148738127|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
148738128|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
148738129|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
148738130|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148738131|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
148738132|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
148738133|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
148738134|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
148738135|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
148738136|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Other|4|||
148738137|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Other|4|||
148738138|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Other|3|||
148738139|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Other|1|||
148738140|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Other|0|||
148738141|NCT01081834|536512784|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
148738142|NCT01081834|536512785|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
148738143|NCT01081834|536512786|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
148738144|NCT01081834|536512787|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
148738145|NCT01081834|536512788|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
148738146|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
148738147|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
148738148|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
148738149|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
148738150|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
148738151|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Death|1|||
148738152|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Death|0|||
148738153|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Death|0|||
148738154|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Death|0|||
148738155|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Death|0|||
148738156|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
148738157|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
148738158|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148738159|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148738160|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148738161|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148738162|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
148738163|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148738164|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148738165|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148738166|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
148738167|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
148738168|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
148738169|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
148738170|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
148738171|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
148738172|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148738173|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
148818261|NCT01060111|536810360|FG000|Overall Study|Adverse event and insufficient effect|0|||
148818262|NCT01060111|536810361|FG001|Overall Study|Adverse event and insufficient effect|1|||
148974865|NCT00978731|537389377|FG000|Overall Study|Death|4|||
148738174|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148738175|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148738176|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
148738177|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
148738178|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
148738179|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
148738180|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
148738181|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Other|4|||
148738182|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Other|5|||
148738183|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Other|4|||
148738184|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Other|0|||
148738185|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Other|0|||
148738186|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
148738187|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
148738188|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
148738189|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
148738190|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
148738191|NCT01081834|536512784|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148738192|NCT01081834|536512785|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
148738193|NCT01081834|536512786|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148738194|NCT01081834|536512787|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148738195|NCT01081834|536512788|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
148738196|NCT01777620|536512789|FG000|Overall Study|Subject Withdrawal|1|||
148738197|NCT01777620|536512790|FG001|Overall Study|Subject Withdrawal|0|||
148738198|NCT01756079|536512802|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
148738199|NCT01756079|536512802|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
148738200|NCT01756079|536512802|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
148738201|NCT01756079|536512802|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
148738202|NCT01756079|536512802|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
148738203|NCT03597529|536512803|FG000|Overall Study|Lost to Follow-up|10|||
148738204|NCT03597529|536512804|FG001|Overall Study|Lost to Follow-up|12|||
148738205|NCT03597529|536512803|FG000|Overall Study|Physician Decision|3|||
148738206|NCT03597529|536512804|FG001|Overall Study|Physician Decision|1|||
148738207|NCT03597529|536512803|FG000|Overall Study|Withdrawal by Subject|6|||
148738208|NCT03597529|536512804|FG001|Overall Study|Withdrawal by Subject|3|||
148738209|NCT03597529|536512803|FG000|Overall Study|Non-compliant with study activities|1|||
148738210|NCT03597529|536512804|FG001|Overall Study|Non-compliant with study activities|2|||
148738211|NCT04015908|536512805|FG000|Overall Study|Lost to Follow-up|0|||
148738212|NCT04015908|536512806|FG001|Overall Study|Lost to Follow-up|1|||
148738213|NCT03464630|536512809|FG000|Overall Study|Lost to Follow-up|62|||
148738214|NCT03464630|536512810|FG001|Overall Study|Lost to Follow-up|52|||
148738215|NCT03464630|536512809|FG000|Overall Study|Withdrawal by Subject|16|||
148738216|NCT03464630|536512810|FG001|Overall Study|Withdrawal by Subject|10|||
148738217|NCT03464630|536512809|FG000|Overall Study|Passive Disengagement|8|||
148738218|NCT03464630|536512810|FG001|Overall Study|Passive Disengagement|4|||
148738219|NCT04524364|536512811|FG000|Overall Study|Physician Decision|3|||
148738220|NCT04524364|536512812|FG001|Overall Study|Physician Decision|6|||
148738221|NCT04524364|536512811|FG000|Overall Study|Adverse Event|0|||
148738222|NCT04524364|536512812|FG001|Overall Study|Adverse Event|1|||
148738223|NCT04524364|536512811|FG000|Overall Study|Investigational device deficiency|0|||
148738224|NCT04524364|536512812|FG001|Overall Study|Investigational device deficiency|1|||
148738225|NCT04524364|536512811|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
148738226|NCT04524364|536512812|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
148738227|NCT04524364|536512811|FG000|Overall Study|Device unavailability|0|||
148738228|NCT04524364|536512812|FG001|Overall Study|Device unavailability|2|||
148738229|NCT04524364|536512811|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
148738230|NCT04524364|536512812|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
148974866|NCT00978731|537389378|FG001|Overall Study|Death|1|||
148974867|NCT00978731|537389379|FG002|Overall Study|Death|1|||
148974868|NCT00978731|537389380|FG003|Overall Study|Death|0|||
148974869|NCT00978731|537389377|FG000|Overall Study|Lost to Follow-up|0|||
148818263|NCT01060111|536810362|FG002|Overall Study|Adverse event and insufficient effect|0|||
148818264|NCT01060111|536810360|FG000|Overall Study|Participants' non-cooperation|1|||
148974870|NCT00978731|537389378|FG001|Overall Study|Lost to Follow-up|0|||
148974871|NCT00978731|537389379|FG002|Overall Study|Lost to Follow-up|0|||
148974872|NCT00978731|537389380|FG003|Overall Study|Lost to Follow-up|1|||
148974873|NCT00978731|537389377|FG000|Overall Study|Adverse Event|5|||
148974874|NCT00978731|537389378|FG001|Overall Study|Adverse Event|2|||
148974875|NCT00978731|537389379|FG002|Overall Study|Adverse Event|0|||
148738231|NCT04524364|536512811|FG000|Overall Study|Low International normalized ratio (INR)|1|||
148738232|NCT04524364|536512812|FG001|Overall Study|Low International normalized ratio (INR)|0|||
148738233|NCT00998309|536512815|FG000|Overall Study|Protocol Violation|4|||
148738234|NCT00735397|536512819|FG000|Overall Study|Adverse Event|194|||
148738235|NCT00735397|536512819|FG000|Overall Study|Lost to Follow-up|33|||
148738236|NCT00735397|536512819|FG000|Overall Study|Participant choice|252|||
148738237|NCT00735397|536512819|FG000|Overall Study|Inadequate therapeutic effect|202|||
148738238|NCT00735397|536512819|FG000|Overall Study|Administrative/Other|502|||
148738239|NCT02865460|536512820|FG000|Overall Study|Adverse Event|1|||
148738240|NCT02865460|536512821|FG001|Overall Study|Adverse Event|0|||
148738241|NCT02865460|536512820|FG000|Overall Study|Withdrawal by Subject|1|||
148738242|NCT02865460|536512821|FG001|Overall Study|Withdrawal by Subject|1|||
148738243|NCT02865460|536512820|FG000|Overall Study|Lost to Follow-up|7|||
148738244|NCT02865460|536512821|FG001|Overall Study|Lost to Follow-up|4|||
148738245|NCT02865460|536512820|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
148738246|NCT02865460|536512821|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
148738247|NCT00380744|536512822|FG000|Overall Study|Death|0|||
148738248|NCT00380744|536512823|FG001|Overall Study|Death|0|||
148738249|NCT00380744|536512824|FG002|Overall Study|Death|0|||
148738250|NCT00380744|536512825|FG003|Overall Study|Death|0|||
148738251|NCT00380744|536512826|FG004|Overall Study|Death|0|||
148738252|NCT00380744|536512827|FG005|Overall Study|Death|0|||
148738253|NCT00380744|536512828|FG006|Overall Study|Death|1|||
148738254|NCT00380744|536512822|FG000|Overall Study|Withdrawal by Subject|1|||
148738255|NCT00380744|536512823|FG001|Overall Study|Withdrawal by Subject|0|||
148738256|NCT00380744|536512824|FG002|Overall Study|Withdrawal by Subject|0|||
148738257|NCT00380744|536512825|FG003|Overall Study|Withdrawal by Subject|0|||
148738258|NCT00380744|536512826|FG004|Overall Study|Withdrawal by Subject|0|||
148738259|NCT00380744|536512827|FG005|Overall Study|Withdrawal by Subject|0|||
148738260|NCT00380744|536512828|FG006|Overall Study|Withdrawal by Subject|0|||
148738261|NCT06077149|536512833|FG000|Overall Study|Death|1|||
148738262|NCT06077149|536512834|FG001|Overall Study|Death|0|||
148738263|NCT06077149|536512833|FG000|Overall Study|Withdrawal by Subject|2|||
148738264|NCT06077149|536512834|FG001|Overall Study|Withdrawal by Subject|0|||
148738265|NCT06077149|536512833|FG000|Overall Study|RSV infection before vaccination|3|||
148738266|NCT06077149|536512834|FG001|Overall Study|RSV infection before vaccination|0|||
148974876|NCT00978731|537389380|FG003|Overall Study|Adverse Event|0|||
148974877|NCT00978731|537389377|FG000|Overall Study|Participant's request|1|||
148738267|NCT04154631|536512836|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
148738268|NCT04154631|536512837|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
148738269|NCT01441947|536512838|FG000|Overall Study|Withdrawal by Subject|3|||
148974878|NCT00978731|537389378|FG001|Overall Study|Participant's request|0|||
148974879|NCT00978731|537389379|FG002|Overall Study|Participant's request|0|||
148974880|NCT00978731|537389380|FG003|Overall Study|Participant's request|0|||
148974881|NCT00978731|537389377|FG000|Overall Study|Administrative reason|3|||
148974882|NCT00978731|537389378|FG001|Overall Study|Administrative reason|3|||
148974883|NCT00978731|537389379|FG002|Overall Study|Administrative reason|1|||
148974884|NCT00978731|537389380|FG003|Overall Study|Administrative reason|0|||
148974885|NCT00978731|537389377|FG000|Overall Study|Deterioration without progression|0|||
148974886|NCT00978731|537389378|FG001|Overall Study|Deterioration without progression|1|||
148974887|NCT00978731|537389379|FG002|Overall Study|Deterioration without progression|0|||
148738270|NCT01441947|536512839|FG001|Overall Study|Withdrawal by Subject|0|||
148738271|NCT02238795|536512840|FG000|Overall Study|Patient without purpura fulminans|1|||
148738272|NCT03384654|536512842|FG000|Overall Study|Withdrawal by Subject|0|||
148738273|NCT03384654|536512843|FG001|Overall Study|Withdrawal by Subject|0|||
148738274|NCT03384654|536512844|FG002|Overall Study|Withdrawal by Subject|1|||
148738275|NCT03384654|536512845|FG003|Overall Study|Withdrawal by Subject|0|||
148738276|NCT05896202|536512848|FG000|Overall Study|Lost to Follow-up|2|||
148974888|NCT00978731|537389380|FG003|Overall Study|Deterioration without progression|0|||
148974889|NCT00978731|537389377|FG000|Overall Study|Disease progression/relapse|5|||
148974890|NCT00978731|537389378|FG001|Overall Study|Disease progression/relapse|4|||
148974891|NCT00978731|537389379|FG002|Overall Study|Disease progression/relapse|2|||
148974892|NCT00978731|537389380|FG003|Overall Study|Disease progression/relapse|2|||
148974893|NCT00978731|537389377|FG000|Overall Study|Study closure|3|||
148974894|NCT00978731|537389378|FG001|Overall Study|Study closure|4|||
148974895|NCT00978731|537389379|FG002|Overall Study|Study closure|1|||
148974896|NCT00978731|537389380|FG003|Overall Study|Study closure|1|||
148974897|NCT00978731|537389377|FG000|Overall Study|No response|1|||
148738277|NCT05896202|536512849|FG001|Overall Study|Lost to Follow-up|2|||
148738278|NCT04669691|536512850|FG000|Overall Study|Death|0|||
148974898|NCT00978731|537389378|FG001|Overall Study|No response|0|||
148738279|NCT04669691|536512851|FG001|Overall Study|Death|1|||
148974899|NCT00978731|537389379|FG002|Overall Study|No response|0|||
148738280|NCT04669691|536512852|FG002|Overall Study|Death|0|||
148738281|NCT04669691|536512853|FG003|Overall Study|Death|0|||
148738282|NCT04669691|536512854|FG004|Overall Study|Death|0|||
148738283|NCT04669691|536512855|FG005|Overall Study|Death|0|||
148738284|NCT00911807|536512856|FG000|Overall Study|Adverse Event|2|||
148738285|NCT00911807|536512857|FG001|Overall Study|Adverse Event|1|||
148738286|NCT00911807|536512858|FG002|Overall Study|Adverse Event|5|||
148738287|NCT00911807|536512856|FG000|Overall Study|Death|0|||
148738288|NCT00911807|536512857|FG001|Overall Study|Death|0|||
148738289|NCT00911807|536512858|FG002|Overall Study|Death|1|||
148738290|NCT00911807|536512856|FG000|Overall Study|Protocol Violation|6|||
148738291|NCT00911807|536512857|FG001|Overall Study|Protocol Violation|4|||
148738292|NCT00911807|536512858|FG002|Overall Study|Protocol Violation|9|||
148738293|NCT00911807|536512856|FG000|Overall Study|Withdrawal by Subject|8|||
148738294|NCT00911807|536512857|FG001|Overall Study|Withdrawal by Subject|10|||
148738295|NCT00911807|536512858|FG002|Overall Study|Withdrawal by Subject|7|||
148738296|NCT00911807|536512856|FG000|Overall Study|Organizational reasons|1|||
148738297|NCT00911807|536512857|FG001|Overall Study|Organizational reasons|3|||
148738298|NCT00911807|536512858|FG002|Overall Study|Organizational reasons|1|||
148738299|NCT03918109|536512862|FG000|Overall Study|Withdrawal by Subject|0|||
148738300|NCT03918109|536512863|FG001|Overall Study|Withdrawal by Subject|0|||
148738301|NCT03918109|536512864|FG002|Overall Study|Withdrawal by Subject|2|||
148738302|NCT03918109|536512865|FG003|Overall Study|Withdrawal by Subject|1|||
148738303|NCT03918109|536512862|FG000|Overall Study|Lost to Follow-up|0|||
148738304|NCT03918109|536512863|FG001|Overall Study|Lost to Follow-up|0|||
148738305|NCT03918109|536512864|FG002|Overall Study|Lost to Follow-up|0|||
148738306|NCT03918109|536512865|FG003|Overall Study|Lost to Follow-up|1|||
148738307|NCT04430855|536512866|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
148738308|NCT04430855|536512867|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
148738309|NCT04430855|536512866|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
148738310|NCT04430855|536512867|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
148738311|NCT04430855|536512866|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
148738312|NCT04430855|536512867|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
148738313|NCT04430855|536512866|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
148738314|NCT04430855|536512867|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
148738315|NCT04430855|536512866|FG000|Period 1 (Weeks 1-12)|Other|0|||
148738316|NCT04430855|536512867|FG001|Period 1 (Weeks 1-12)|Other|1|||
148738317|NCT04430855|536512866|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
148738318|NCT04430855|536512867|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
148738319|NCT04430855|536512866|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
148738320|NCT04430855|536512867|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
148738321|NCT04430855|536512866|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
148738322|NCT04430855|536512867|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
148738323|NCT00186043|536512868|FG000|Overall Study|Lack of Efficacy|1|||
148738324|NCT00186043|536512869|FG001|Overall Study|Lack of Efficacy|3|||
148738325|NCT00186043|536512868|FG000|Overall Study|Lost to Follow-up|4|||
148738326|NCT00186043|536512869|FG001|Overall Study|Lost to Follow-up|6|||
148738327|NCT00186043|536512868|FG000|Overall Study|Withdrawal by Subject|1|||
148738328|NCT00186043|536512869|FG001|Overall Study|Withdrawal by Subject|0|||
148738329|NCT00186043|536512868|FG000|Overall Study|Adverse Event|7|||
148738330|NCT00186043|536512869|FG001|Overall Study|Adverse Event|3|||
148738331|NCT00186043|536512868|FG000|Overall Study|Protocol Violation|2|||
148738332|NCT00186043|536512869|FG001|Overall Study|Protocol Violation|1|||
148738333|NCT00871741|536512870|FG000|Overall Study|Premature study termination|9|||
148738334|NCT00871741|536512871|FG001|Overall Study|Premature study termination|7|||
148738335|NCT05323123|536512872|FG000|Overall Study|Withdrawal by Subject|2|||
148738336|NCT05323123|536512873|FG001|Overall Study|Withdrawal by Subject|1|||
148738337|NCT05323123|536512872|FG000|Overall Study|Lost to Follow-up|4|||
148738338|NCT05323123|536512873|FG001|Overall Study|Lost to Follow-up|2|||
148738339|NCT05323123|536512872|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
148738340|NCT05323123|536512873|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
148738341|NCT05529472|536512874|FG000|Overall Study|Withdrawal by Subject|1|||
148738342|NCT05529472|536512875|FG001|Overall Study|Withdrawal by Subject|1|||
148738343|NCT03589768|536514664|FG000|Overall Study|Death|1|||
148738344|NCT03589768|536514665|FG001|Overall Study|Death|0|||
148738345|NCT03589768|536514666|FG002|Overall Study|Death|8|||
148738346|NCT03589768|536514667|FG003|Overall Study|Death|3|||
148738347|NCT03589768|536514664|FG000|Overall Study|Withdrawal by Subject|2|||
148738348|NCT03589768|536514665|FG001|Overall Study|Withdrawal by Subject|0|||
148818265|NCT01060111|536810361|FG001|Overall Study|Participants' non-cooperation|0|||
148738349|NCT03589768|536514666|FG002|Overall Study|Withdrawal by Subject|0|||
148738350|NCT03589768|536514667|FG003|Overall Study|Withdrawal by Subject|0|||
148738351|NCT03589768|536514664|FG000|Overall Study|Protocol Violation|1|||
148738352|NCT03589768|536514665|FG001|Overall Study|Protocol Violation|0|||
148738353|NCT03589768|536514666|FG002|Overall Study|Protocol Violation|0|||
148738354|NCT03589768|536514667|FG003|Overall Study|Protocol Violation|0|||
148738355|NCT03700385|536514669|FG000|Overall Study|Lost to Follow-up|1|||
148738356|NCT01555671|536514672|FG000|Overall Study|Physician Decision|20|||
148738357|NCT01555671|536514673|FG001|Overall Study|Physician Decision|25|||
148738358|NCT04590040|536514676|FG000|Treatment Period|Lost to Follow-up|2|||
148738359|NCT04590040|536514677|FG001|Treatment Period|Lost to Follow-up|5|||
148738360|NCT04590040|536514678|FG002|Treatment Period|Lost to Follow-up|0|||
148974900|NCT00978731|537389380|FG003|Overall Study|No response|0|||
148974901|NCT03107988|537389381|FG000|Overall Study|Adverse Event|0|||
148974902|NCT03107988|537389382|FG001|Overall Study|Adverse Event|0|||
148974903|NCT03107988|537389383|FG002|Overall Study|Adverse Event|0|||
148974904|NCT03107988|537389384|FG003|Overall Study|Adverse Event|1|||
148974905|NCT03107988|537389385|FG004|Overall Study|Adverse Event|0|||
148974906|NCT03107988|537389386|FG005|Overall Study|Adverse Event|1|||
148974907|NCT03107988|537389387|FG006|Overall Study|Adverse Event|0|||
148974908|NCT03107988|537389388|FG007|Overall Study|Adverse Event|1|||
148974909|NCT03107988|537389389|FG008|Overall Study|Adverse Event|0|||
148974910|NCT03107988|537389390|FG009|Overall Study|Adverse Event|0|||
148974911|NCT03107988|537389391|FG010|Overall Study|Adverse Event|0|||
148974912|NCT03107988|537389392|FG011|Overall Study|Adverse Event|0|||
148974913|NCT03107988|537389393|FG012|Overall Study|Adverse Event|0|||
148974914|NCT03107988|537389381|FG000|Overall Study|Disease Progression or Relapse|1|||
148974915|NCT03107988|537389382|FG001|Overall Study|Disease Progression or Relapse|2|||
148974916|NCT03107988|537389383|FG002|Overall Study|Disease Progression or Relapse|2|||
148974917|NCT03107988|537389384|FG003|Overall Study|Disease Progression or Relapse|5|||
148974918|NCT03107988|537389385|FG004|Overall Study|Disease Progression or Relapse|1|||
148974919|NCT03107988|537389386|FG005|Overall Study|Disease Progression or Relapse|1|||
149027107|NCT01579578|537576491|FG000|Overall Study|Ongoing|3|||
148738361|NCT04590040|536514676|FG000|Treatment Period|Physician Decision|0|||
148738362|NCT04590040|536514677|FG001|Treatment Period|Physician Decision|0|||
148738363|NCT04590040|536514678|FG002|Treatment Period|Physician Decision|2|||
148738364|NCT00000378|536514684|FG000|Overall Study|Lack of Efficacy|16|||
148738365|NCT00000378|536514685|FG001|Overall Study|Lack of Efficacy|14|||
148738366|NCT00631657|536514688|FG000|6-Month Treatment Period|Adverse Event|47|||
148738367|NCT00631657|536514689|FG001|6-Month Treatment Period|Adverse Event|0|||
148974920|NCT03107988|537389387|FG006|Overall Study|Disease Progression or Relapse|0|||
148974921|NCT03107988|537389388|FG007|Overall Study|Disease Progression or Relapse|0|||
148974922|NCT03107988|537389389|FG008|Overall Study|Disease Progression or Relapse|0|||
148974923|NCT03107988|537389390|FG009|Overall Study|Disease Progression or Relapse|1|||
148974924|NCT03107988|537389391|FG010|Overall Study|Disease Progression or Relapse|4|||
148974925|NCT03107988|537389392|FG011|Overall Study|Disease Progression or Relapse|0|||
148974926|NCT03107988|537389393|FG012|Overall Study|Disease Progression or Relapse|0|||
148974927|NCT03107988|537389381|FG000|Overall Study|Ineligible|0|||
148974928|NCT03107988|537389382|FG001|Overall Study|Ineligible|0|||
148974929|NCT03107988|537389383|FG002|Overall Study|Ineligible|0|||
148738368|NCT00631657|536514690|FG002|6-Month Treatment Period|Adverse Event|7|||
148738369|NCT00631657|536514688|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
148738370|NCT00631657|536514689|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
148738371|NCT00631657|536514690|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
148738372|NCT00631657|536514688|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
148738373|NCT00631657|536514689|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
148738374|NCT00631657|536514690|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
148738375|NCT00631657|536514688|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
148738376|NCT00631657|536514689|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
148738377|NCT00631657|536514690|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
148738378|NCT00631657|536514688|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
148738379|NCT00631657|536514689|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
148738380|NCT00631657|536514690|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
148738381|NCT00631657|536514688|FG000|6-Month Treatment Period|Other|16|||
148738382|NCT00631657|536514689|FG001|6-Month Treatment Period|Other|0|||
148738383|NCT00631657|536514690|FG002|6-Month Treatment Period|Other|4|||
148738384|NCT00631657|536514688|FG000|6-Month Treatment Period|Not Treated|2|||
148738385|NCT00631657|536514689|FG001|6-Month Treatment Period|Not Treated|0|||
148738386|NCT00631657|536514690|FG002|6-Month Treatment Period|Not Treated|1|||
148974930|NCT03107988|537389384|FG003|Overall Study|Ineligible|0|||
148974931|NCT03107988|537389385|FG004|Overall Study|Ineligible|0|||
148974932|NCT03107988|537389386|FG005|Overall Study|Ineligible|0|||
148974933|NCT03107988|537389387|FG006|Overall Study|Ineligible|0|||
148974934|NCT03107988|537389388|FG007|Overall Study|Ineligible|0|||
148974935|NCT03107988|537389389|FG008|Overall Study|Ineligible|1|||
148974936|NCT03107988|537389390|FG009|Overall Study|Ineligible|0|||
149027108|NCT01579578|537576492|FG001|Overall Study|Ongoing|0|||
148738387|NCT00631657|536514688|FG000|7-Day Discontinuation Period|Not Treated|1|||
148738388|NCT00631657|536514689|FG001|7-Day Discontinuation Period|Not Treated|1|||
148974937|NCT03107988|537389391|FG010|Overall Study|Ineligible|0|||
148974938|NCT03107988|537389392|FG011|Overall Study|Ineligible|0|||
148974939|NCT03107988|537389393|FG012|Overall Study|Ineligible|0|||
148974940|NCT00548808|537389397|FG000|Overall Study|Lost to Follow-up|9|||
148974941|NCT00548808|537389398|FG001|Overall Study|Lost to Follow-up|3|||
148974942|NCT00548808|537389397|FG000|Overall Study|Protocol Violation|8|||
149027109|NCT03432533|537576493|FG000|Overall Study|Lost to Follow-up|1|||
148974943|NCT00548808|537389398|FG001|Overall Study|Protocol Violation|8|||
148974944|NCT00548808|537389397|FG000|Overall Study|Withdrawal by Subject|8|||
148738389|NCT00631657|536514690|FG002|7-Day Discontinuation Period|Not Treated|1|||
148738390|NCT00631657|536514688|FG000|7-Day Discontinuation Period|Other|1|||
148738391|NCT00631657|536514689|FG001|7-Day Discontinuation Period|Other|0|||
148738392|NCT00631657|536514690|FG002|7-Day Discontinuation Period|Other|0|||
148738393|NCT01284361|536514696|FG000|Overall Study|Withdrawal by Subject|1|||
148738394|NCT01284361|536514696|FG000|Overall Study|Protocol Violation|5|||
148738395|NCT01284361|536514696|FG000|Overall Study|Adverse Event|1|||
148738396|NCT01284361|536514696|FG000|Overall Study|Lost to Follow-up|2|||
148738397|NCT01957397|536514703|FG000|Test Period 1|sudden leakage/small bag|1|||
148738398|NCT01957397|536514704|FG001|Test Period 1|sudden leakage/small bag|1|||
148738399|NCT01957397|536514703|FG000|Test Period 1|Withdrawal by Subject|1|||
148738400|NCT01957397|536514704|FG001|Test Period 1|Withdrawal by Subject|0|||
148738401|NCT01957397|536514703|FG000|Test Period 2|Adverse Event|0|||
148738402|NCT01957397|536514704|FG001|Test Period 2|Adverse Event|1|||
148738403|NCT01957397|536514703|FG000|Test Period 3|Adverse Event|1|||
148738404|NCT01957397|536514704|FG001|Test Period 3|Adverse Event|2|||
148738405|NCT01957397|536514703|FG000|Test Period 3|the adhesive did not work|1|||
148738406|NCT01957397|536514704|FG001|Test Period 3|the adhesive did not work|0|||
148738407|NCT05083585|536514705|FG000|Overall Study|Death|1|||
148738408|NCT05083585|536514706|FG001|Overall Study|Death|1|||
148738409|NCT05083585|536514705|FG000|Overall Study|Lost to Follow-up|1|||
148738410|NCT05083585|536514706|FG001|Overall Study|Lost to Follow-up|1|||
148738411|NCT05083585|536514705|FG000|Overall Study|Withdrawal by Subject|2|||
148738412|NCT05083585|536514706|FG001|Overall Study|Withdrawal by Subject|0|||
148738413|NCT05083585|536514705|FG000|Overall Study|Randomized but not vaccinated|2|||
148738414|NCT05083585|536514706|FG001|Overall Study|Randomized but not vaccinated|0|||
148738415|NCT03469336|536514707|FG000|Overall Study|Adverse Event|1|||
148738416|NCT00686075|536514709|FG000|Overall Study|Withdrawal by Subject|4|||
148738417|NCT00686075|536514710|FG001|Overall Study|Withdrawal by Subject|3|||
148738418|NCT00686075|536514711|FG002|Overall Study|Withdrawal by Subject|3|||
148738419|NCT00686075|536514712|FG003|Overall Study|Withdrawal by Subject|7|||
148738420|NCT00686075|536514713|FG004|Overall Study|Withdrawal by Subject|1|||
148738421|NCT00686075|536514714|FG005|Overall Study|Withdrawal by Subject|0|||
148738422|NCT00686075|536514715|FG006|Overall Study|Withdrawal by Subject|0|||
148738423|NCT00686075|536514716|FG007|Overall Study|Withdrawal by Subject|2|||
148738424|NCT00686075|536514717|FG008|Overall Study|Withdrawal by Subject|4|||
148738425|NCT00686075|536514718|FG009|Overall Study|Withdrawal by Subject|6|||
148738426|NCT00686075|536514709|FG000|Overall Study|Lost to Follow-up|3|||
148738427|NCT00686075|536514710|FG001|Overall Study|Lost to Follow-up|6|||
148738428|NCT00686075|536514711|FG002|Overall Study|Lost to Follow-up|3|||
148738429|NCT00686075|536514712|FG003|Overall Study|Lost to Follow-up|2|||
148738430|NCT00686075|536514713|FG004|Overall Study|Lost to Follow-up|3|||
148738431|NCT00686075|536514714|FG005|Overall Study|Lost to Follow-up|3|||
148738432|NCT00686075|536514715|FG006|Overall Study|Lost to Follow-up|0|||
148738433|NCT00686075|536514716|FG007|Overall Study|Lost to Follow-up|0|||
148738434|NCT00686075|536514717|FG008|Overall Study|Lost to Follow-up|2|||
148738435|NCT00686075|536514718|FG009|Overall Study|Lost to Follow-up|3|||
148738436|NCT00686075|536514709|FG000|Overall Study|Other|1|||
148738437|NCT00686075|536514710|FG001|Overall Study|Other|1|||
148738438|NCT00686075|536514711|FG002|Overall Study|Other|0|||
148738439|NCT00686075|536514712|FG003|Overall Study|Other|0|||
148738440|NCT00686075|536514713|FG004|Overall Study|Other|0|||
148738441|NCT00686075|536514714|FG005|Overall Study|Other|0|||
148738442|NCT00686075|536514715|FG006|Overall Study|Other|0|||
148738443|NCT00686075|536514716|FG007|Overall Study|Other|0|||
148738444|NCT00686075|536514717|FG008|Overall Study|Other|0|||
148738445|NCT00686075|536514718|FG009|Overall Study|Other|1|||
148738446|NCT02740699|536514719|FG000|Overall Study|Lost to Follow-up|5|||
148738447|NCT02740699|536514719|FG000|Overall Study|Withdrawal by Subject|14|||
148738448|NCT02740699|536514719|FG000|Overall Study|Physician Decision|5|||
148738449|NCT02585934|536514721|FG000|Overall Study|Lost to Follow-up|2|||
148738450|NCT02585934|536514722|FG001|Overall Study|Lost to Follow-up|2|||
148738451|NCT02585934|536514721|FG000|Overall Study|Protocol Violation|14|||
148738452|NCT02585934|536514722|FG001|Overall Study|Protocol Violation|11|||
148738453|NCT02585934|536514721|FG000|Overall Study|Adverse Event|21|||
148738454|NCT02585934|536514722|FG001|Overall Study|Adverse Event|22|||
148738455|NCT02585934|536514721|FG000|Overall Study|Physician Decision|3|||
148738456|NCT02585934|536514722|FG001|Overall Study|Physician Decision|2|||
148738457|NCT02585934|536514721|FG000|Overall Study|Withdrawal by Subject|7|||
148738458|NCT02585934|536514722|FG001|Overall Study|Withdrawal by Subject|21|||
148738459|NCT02585934|536514721|FG000|Overall Study|Lack of Efficacy|2|||
148738460|NCT02585934|536514722|FG001|Overall Study|Lack of Efficacy|1|||
148738461|NCT02585934|536514721|FG000|Overall Study|Death|2|||
148738462|NCT02585934|536514722|FG001|Overall Study|Death|0|||
148738463|NCT02585934|536514721|FG000|Overall Study|Caregiver Withdrew Consent|7|||
148738464|NCT02585934|536514722|FG001|Overall Study|Caregiver Withdrew Consent|7|||
149027110|NCT03432533|537576494|FG001|Overall Study|Lost to Follow-up|2|||
148738465|NCT02585934|536514721|FG000|Overall Study|Sponsor Termination|1|||
148738466|NCT02585934|536514722|FG001|Overall Study|Sponsor Termination|2|||
148738467|NCT02585934|536514721|FG000|Overall Study|Another Reason|10|||
148738468|NCT02585934|536514722|FG001|Overall Study|Another Reason|5|||
148738469|NCT04713553|536514723|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
148738470|NCT04713553|536514724|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
148738471|NCT04713553|536514725|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
148738472|NCT04713553|536514726|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
148738473|NCT04713553|536514727|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
148738474|NCT04713553|536514728|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
148738475|NCT04713553|536514729|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
148738476|NCT04713553|536514723|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
148738477|NCT04713553|536514724|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
148738478|NCT04713553|536514725|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
148738479|NCT04713553|536514726|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
148738480|NCT04713553|536514727|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
148738481|NCT04713553|536514728|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
148738482|NCT04713553|536514729|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
148738483|NCT04713553|536514723|FG000|Primary Study (2 Months)|Other|1|||
148738484|NCT04713553|536514724|FG001|Primary Study (2 Months)|Other|2|||
148738485|NCT04713553|536514725|FG002|Primary Study (2 Months)|Other|0|||
148738486|NCT04713553|536514726|FG003|Primary Study (2 Months)|Other|0|||
148738487|NCT04713553|536514727|FG004|Primary Study (2 Months)|Other|1|||
148738488|NCT04713553|536514728|FG005|Primary Study (2 Months)|Other|0|||
148738489|NCT04713553|536514729|FG006|Primary Study (2 Months)|Other|0|||
148974945|NCT00548808|537389398|FG001|Overall Study|Withdrawal by Subject|4|||
148738490|NCT04713553|536514723|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
148738491|NCT04713553|536514724|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
148738492|NCT04713553|536514725|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
148738493|NCT04713553|536514726|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
148738494|NCT04713553|536514727|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
148738495|NCT04713553|536514728|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
148738496|NCT04713553|536514729|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
148738497|NCT04713553|536514723|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
148738498|NCT04713553|536514724|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
148738499|NCT04713553|536514725|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
148738500|NCT04713553|536514726|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
148738501|NCT04713553|536514727|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
148738502|NCT04713553|536514728|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
148738503|NCT04713553|536514729|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
148738504|NCT01359969|536514731|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
148738505|NCT02338193|536514734|FG000|Overall Study|Withdrawal by Subject|0|||
148738506|NCT02338193|536514735|FG001|Overall Study|Withdrawal by Subject|0|||
148738507|NCT02338193|536514736|FG002|Overall Study|Withdrawal by Subject|2|||
148738508|NCT02338193|536514734|FG000|Overall Study|Pregnancy|0|||
148738509|NCT02338193|536514735|FG001|Overall Study|Pregnancy|1|||
148738510|NCT02338193|536514736|FG002|Overall Study|Pregnancy|1|||
148974946|NCT00548808|537389397|FG000|Overall Study|Physician Decision|6|||
148974947|NCT00548808|537389398|FG001|Overall Study|Physician Decision|3|||
148974948|NCT00548808|537389397|FG000|Overall Study|Adverse Event|4|||
148974949|NCT00548808|537389398|FG001|Overall Study|Adverse Event|5|||
148974950|NCT00548808|537389397|FG000|Overall Study|Death|2|||
148974951|NCT00548808|537389398|FG001|Overall Study|Death|0|||
148974952|NCT00548808|537389397|FG000|Overall Study|Entry Criteria Not Met|2|||
148974953|NCT00548808|537389398|FG001|Overall Study|Entry Criteria Not Met|2|||
148974954|NCT00548808|537389397|FG000|Overall Study|Lack of Efficacy|2|||
148974955|NCT00548808|537389398|FG001|Overall Study|Lack of Efficacy|0|||
148974956|NCT00548808|537389397|FG000|Overall Study|Sponsor Decision|1|||
148974957|NCT00548808|537389398|FG001|Overall Study|Sponsor Decision|1|||
148974958|NCT05044234|537389399|FG000|Overall Study|Lost to Follow-up|2|||
148974959|NCT05044234|537389400|FG001|Overall Study|Lost to Follow-up|1|||
148974960|NCT05044234|537389401|FG002|Overall Study|Lost to Follow-up|1|||
148974961|NCT05044234|537389402|FG003|Overall Study|Lost to Follow-up|2|||
148974962|NCT05044234|537389399|FG000|Overall Study|Withdrawal by Subject|6|||
148974963|NCT05044234|537389400|FG001|Overall Study|Withdrawal by Subject|4|||
148974964|NCT05044234|537389401|FG002|Overall Study|Withdrawal by Subject|5|||
148738511|NCT02338193|536514734|FG000|Overall Study|Noncompliant with visits|2|||
148738512|NCT02338193|536514735|FG001|Overall Study|Noncompliant with visits|2|||
148738513|NCT02338193|536514736|FG002|Overall Study|Noncompliant with visits|7|||
148738514|NCT02338193|536514734|FG000|Overall Study|moved out of state|0|||
148738515|NCT02338193|536514735|FG001|Overall Study|moved out of state|1|||
148974965|NCT05044234|537389402|FG003|Overall Study|Withdrawal by Subject|8|||
148974966|NCT05044234|537389399|FG000|Overall Study|Study terminated by Sponsor|21|||
148974967|NCT05044234|537389400|FG001|Overall Study|Study terminated by Sponsor|21|||
148974968|NCT05044234|537389401|FG002|Overall Study|Study terminated by Sponsor|20|||
148974969|NCT05044234|537389402|FG003|Overall Study|Study terminated by Sponsor|14|||
148974970|NCT05044234|537389399|FG000|Overall Study|Other, not specified|0|||
148738516|NCT02338193|536514736|FG002|Overall Study|moved out of state|0|||
148738517|NCT02338193|536514734|FG000|Overall Study|intolerant of side effects|1|||
148738518|NCT02338193|536514735|FG001|Overall Study|intolerant of side effects|0|||
148738519|NCT02338193|536514736|FG002|Overall Study|intolerant of side effects|0|||
148738520|NCT01735955|536514741|FG000|Overall Study|Administrative problems|1|||
148738521|NCT01735955|536514741|FG000|Overall Study|Patient/guardian decision|1|||
148738522|NCT01735955|536514741|FG000|Overall Study|Patient withdrew consent|2|||
148738523|NCT01735955|536514741|FG000|Overall Study|Physician Decision|4|||
148738524|NCT01735955|536514741|FG000|Overall Study|Disease progression|24|||
148738525|NCT01735955|536514741|FG000|Overall Study|Adverse Event|5|||
148738526|NCT02885181|536514742|FG000|Overall Study|Investigator's Discretion|0|||
148738527|NCT02885181|536514743|FG001|Overall Study|Investigator's Discretion|1|||
148738528|NCT02885181|536514744|FG002|Overall Study|Investigator's Discretion|0|||
148738529|NCT02885181|536514745|FG003|Overall Study|Investigator's Discretion|1|||
148738530|NCT02885181|536514742|FG000|Overall Study|Adverse Event|0|||
148738531|NCT02885181|536514743|FG001|Overall Study|Adverse Event|0|||
148738532|NCT02885181|536514744|FG002|Overall Study|Adverse Event|0|||
148738533|NCT02885181|536514745|FG003|Overall Study|Adverse Event|1|||
148738534|NCT02885181|536514742|FG000|Overall Study|Withdrawal by Subject|0|||
148738535|NCT02885181|536514743|FG001|Overall Study|Withdrawal by Subject|0|||
148738536|NCT02885181|536514744|FG002|Overall Study|Withdrawal by Subject|0|||
148738537|NCT02885181|536514745|FG003|Overall Study|Withdrawal by Subject|1|||
148738538|NCT01716715|536514746|FG000|Overall Study|Never Treated|2|||
148738539|NCT01716715|536514747|FG001|Overall Study|Never Treated|4|||
148738540|NCT01161407|536514750|FG000|Overall Study|Protocol Violation|3|||
148738541|NCT01161407|536514751|FG001|Overall Study|Protocol Violation|1|||
148738542|NCT00936897|536514757|FG000|Overall Study|Withdrawal by Subject|9|||
148738543|NCT00936897|536514758|FG001|Overall Study|Withdrawal by Subject|19|||
148818266|NCT01060111|536810362|FG002|Overall Study|Participants' non-cooperation|0|||
148818267|NCT01060111|536810360|FG000|Overall Study|Other|2|||
148818268|NCT01060111|536810361|FG001|Overall Study|Other|3|||
148818269|NCT01060111|536810362|FG002|Overall Study|Other|4|||
148818270|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
148818271|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
148818272|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
148818273|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
148818274|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
148818275|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
148818276|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
148818277|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
148818278|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
148818279|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
148818280|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
148818281|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
148818282|NCT03446573|536810363|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
148818283|NCT03446573|536810364|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
148818284|NCT03446573|536810363|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
148818285|NCT03446573|536810364|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
148818286|NCT03446573|536810363|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
148818287|NCT03446573|536810364|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
148818288|NCT03446573|536810363|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
148818289|NCT03446573|536810364|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
148818290|NCT03446573|536810363|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
148818291|NCT03446573|536810364|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
148818292|NCT03446573|536810363|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
148818293|NCT03446573|536810364|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
148818294|NCT03446573|536810363|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
148818295|NCT03446573|536810364|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
148818296|NCT00625378|536810369|FG000|Overall Study|Adverse Event|22|||
148818297|NCT00625378|536810370|FG001|Overall Study|Adverse Event|0|||
148818298|NCT00625378|536810369|FG000|Overall Study|Withdrawal by Subject|16|||
148818299|NCT00625378|536810370|FG001|Overall Study|Withdrawal by Subject|0|||
148818300|NCT00625378|536810369|FG000|Overall Study|Death|38|||
148974971|NCT05044234|537389400|FG001|Overall Study|Other, not specified|0|||
148974972|NCT05044234|537389401|FG002|Overall Study|Other, not specified|1|||
148738544|NCT00936897|536514757|FG000|Overall Study|Adverse Event|4|||
148738545|NCT00936897|536514758|FG001|Overall Study|Adverse Event|13|||
148738546|NCT00936897|536514757|FG000|Overall Study|Other|3|||
148738547|NCT00936897|536514758|FG001|Overall Study|Other|9|||
148738548|NCT00936897|536514757|FG000|Overall Study|Lost to Follow-up|1|||
148738549|NCT00936897|536514758|FG001|Overall Study|Lost to Follow-up|10|||
148738550|NCT00936897|536514757|FG000|Overall Study|Administrative Decision|1|||
148818301|NCT00625378|536810370|FG001|Overall Study|Death|0|||
148738551|NCT00936897|536514758|FG001|Overall Study|Administrative Decision|2|||
148738552|NCT00936897|536514757|FG000|Overall Study|Protocol Violation|1|||
148738553|NCT00936897|536514758|FG001|Overall Study|Protocol Violation|1|||
148738554|NCT00936897|536514757|FG000|Overall Study|Ineligibility Determined|0|||
148738555|NCT00936897|536514758|FG001|Overall Study|Ineligibility Determined|3|||
148738556|NCT00936897|536514757|FG000|Overall Study|Noncompliance|0|||
148738557|NCT00936897|536514758|FG001|Overall Study|Noncompliance|2|||
148738558|NCT00936897|536514757|FG000|Overall Study|Death|0|||
148738559|NCT00936897|536514758|FG001|Overall Study|Death|1|||
148738560|NCT04058067|536514759|FG000|Overall Study|Adverse Event|2|||
148738561|NCT04058067|536514760|FG001|Overall Study|Adverse Event|0|||
148738562|NCT04058067|536514759|FG000|Overall Study|Death|0|||
148738563|NCT04058067|536514760|FG001|Overall Study|Death|1|||
148738564|NCT04058067|536514759|FG000|Overall Study|Physician Decision|3|||
148738565|NCT04058067|536514760|FG001|Overall Study|Physician Decision|1|||
148738566|NCT04058067|536514759|FG000|Overall Study|Protocol Violation|0|||
148738567|NCT04058067|536514760|FG001|Overall Study|Protocol Violation|1|||
148738568|NCT04058067|536514759|FG000|Overall Study|Withdrawal by Subject|7|||
148738569|NCT04058067|536514760|FG001|Overall Study|Withdrawal by Subject|8|||
148738570|NCT00417170|536514761|FG000|Overall Study|Adverse Event|1|||
148738571|NCT00417170|536514762|FG001|Overall Study|Adverse Event|1|||
148738572|NCT00417170|536514761|FG000|Overall Study|Withdrawal by Subject|1|||
148738573|NCT00417170|536514762|FG001|Overall Study|Withdrawal by Subject|1|||
148738574|NCT00417170|536514761|FG000|Overall Study|Lost to Follow-up|0|||
148738575|NCT00417170|536514762|FG001|Overall Study|Lost to Follow-up|1|||
148818302|NCT00625378|536810369|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
148818303|NCT00625378|536810370|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
148818304|NCT00625378|536810369|FG000|Overall Study|Lost to Follow-up|17|||
148818305|NCT00625378|536810370|FG001|Overall Study|Lost to Follow-up|0|||
148818306|NCT00625378|536810369|FG000|Overall Study|Non-compliant with study medication|3|||
148818307|NCT00625378|536810370|FG001|Overall Study|Non-compliant with study medication|0|||
148818308|NCT00625378|536810369|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
148818309|NCT00625378|536810370|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
148818310|NCT00625378|536810369|FG000|Overall Study|Medical decision|1|||
148818311|NCT00625378|536810370|FG001|Overall Study|Medical decision|0|||
148818312|NCT00625378|536810369|FG000|Overall Study|Multiple toxicities|1|||
148818313|NCT00625378|536810370|FG001|Overall Study|Multiple toxicities|0|||
148818314|NCT00625378|536810369|FG000|Overall Study|New cancer|1|||
148818315|NCT00625378|536810370|FG001|Overall Study|New cancer|0|||
148818316|NCT00625378|536810369|FG000|Overall Study|PTA program|2|||
148818317|NCT00625378|536810370|FG001|Overall Study|PTA program|0|||
148818318|NCT00625378|536810369|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
148818319|NCT00625378|536810370|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
148818320|NCT00625378|536810369|FG000|Overall Study|Sponsor decision|1|||
148818321|NCT00625378|536810370|FG001|Overall Study|Sponsor decision|0|||
148818322|NCT00625378|536810369|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
148818323|NCT00625378|536810370|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
148818324|NCT00625378|536810369|FG000|Overall Study|Switch to commercial drug|6|||
148818325|NCT00625378|536810370|FG001|Overall Study|Switch to commercial drug|1|||
148818326|NCT00625378|536810369|FG000|Overall Study|Missing|2|||
148818327|NCT00625378|536810370|FG001|Overall Study|Missing|0|||
148818328|NCT00625378|536810369|FG000|Overall Study|End of treatment not available|2|||
148818329|NCT00625378|536810370|FG001|Overall Study|End of treatment not available|0|||
148818330|NCT00625378|536810369|FG000|Overall Study|Never treated|2|||
148818331|NCT00625378|536810370|FG001|Overall Study|Never treated|0|||
148818332|NCT04270760|536810371|FG000|Overall Study|Withdrawal by Subject|0|||
148818333|NCT04270760|536810372|FG001|Overall Study|Withdrawal by Subject|1|||
148818334|NCT04270760|536810373|FG002|Overall Study|Withdrawal by Subject|3|||
148818335|NCT04270760|536810374|FG003|Overall Study|Withdrawal by Subject|0|||
148738576|NCT04623086|536514763|FG000|Overall Study|Withdrawal by Subject|0|||
148738577|NCT04623086|536514764|FG001|Overall Study|Withdrawal by Subject|0|||
148738578|NCT04623086|536514765|FG002|Overall Study|Withdrawal by Subject|10|||
148738579|NCT01755767|536514766|FG000|Overall Study|Progressive Disease|8|||
148738580|NCT01755767|536514767|FG001|Overall Study|Progressive Disease|7|||
148738581|NCT01755767|536514768|FG002|Overall Study|Progressive Disease|91|||
148738582|NCT01755767|536514769|FG003|Overall Study|Progressive Disease|43|||
148818336|NCT04270760|536810375|FG004|Overall Study|Withdrawal by Subject|0|||
148818337|NCT04270760|536810371|FG000|Overall Study|Lost to Follow-up|1|||
148818338|NCT04270760|536810372|FG001|Overall Study|Lost to Follow-up|2|||
148818339|NCT04270760|536810373|FG002|Overall Study|Lost to Follow-up|1|||
148818340|NCT04270760|536810374|FG003|Overall Study|Lost to Follow-up|0|||
148818341|NCT04270760|536810375|FG004|Overall Study|Lost to Follow-up|0|||
148738583|NCT01755767|536514766|FG000|Overall Study|Clinical Disease Progression|4|||
148738584|NCT01755767|536514767|FG001|Overall Study|Clinical Disease Progression|2|||
148738585|NCT01755767|536514768|FG002|Overall Study|Clinical Disease Progression|29|||
148738586|NCT01755767|536514769|FG003|Overall Study|Clinical Disease Progression|20|||
148974973|NCT05044234|537389402|FG003|Overall Study|Other, not specified|2|||
148974974|NCT05044234|537389399|FG000|Overall Study|Delayed data entry|0|||
148974975|NCT05044234|537389400|FG001|Overall Study|Delayed data entry|0|||
148974976|NCT05044234|537389401|FG002|Overall Study|Delayed data entry|0|||
148974977|NCT05044234|537389402|FG003|Overall Study|Delayed data entry|1|||
148974978|NCT02940691|537389403|FG000|Overall Study|Lost to Follow-up|5|||
148974979|NCT02940691|537389403|FG000|Overall Study|Incarceration|1|||
148974980|NCT03912233|537389404|FG000|Overall Study|Adverse Event|1|||
148974981|NCT03912233|537389405|FG001|Overall Study|Adverse Event|0|||
148974982|NCT03912233|537389406|FG002|Overall Study|Adverse Event|0|||
148974983|NCT03912233|537389407|FG003|Overall Study|Adverse Event|0|||
148974984|NCT03912233|537389408|FG004|Overall Study|Adverse Event|0|||
148974985|NCT03912233|537389409|FG005|Overall Study|Adverse Event|0|||
148974986|NCT03912233|537389404|FG000|Overall Study|Physician Decision|1|||
148974987|NCT03912233|537389405|FG001|Overall Study|Physician Decision|0|||
148974988|NCT03912233|537389406|FG002|Overall Study|Physician Decision|0|||
148974989|NCT03912233|537389407|FG003|Overall Study|Physician Decision|0|||
148974990|NCT03912233|537389408|FG004|Overall Study|Physician Decision|0|||
148974991|NCT03912233|537389409|FG005|Overall Study|Physician Decision|0|||
148974992|NCT03912233|537389404|FG000|Overall Study|Other|0|||
148974993|NCT03912233|537389405|FG001|Overall Study|Other|0|||
148974994|NCT03912233|537389406|FG002|Overall Study|Other|0|||
148974995|NCT03912233|537389407|FG003|Overall Study|Other|0|||
148974996|NCT03912233|537389408|FG004|Overall Study|Other|7|||
148974997|NCT03912233|537389409|FG005|Overall Study|Other|12|||
148974998|NCT00326911|537389410|FG000|Overall Study|Hospitalization prior to treatment|0|||
148974999|NCT00326911|537389411|FG001|Overall Study|Hospitalization prior to treatment|1|||
148975000|NCT00326911|537389410|FG000|Overall Study|Physician decision prior to treatment|1|||
148975001|NCT00326911|537389411|FG001|Overall Study|Physician decision prior to treatment|0|||
148975002|NCT00326911|537389410|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
148975003|NCT00326911|537389411|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
148975004|NCT01023659|537389415|FG000|Overall Study|Lost to Follow-up|73|||
148975005|NCT01023659|537389416|FG001|Overall Study|Lost to Follow-up|228|||
148975006|NCT01023659|537389417|FG002|Overall Study|Lost to Follow-up|99|||
148975007|NCT04537806|537389418|FG000|Overall Study|Randomized but not treated|1|||
148975008|NCT04537806|537389419|FG001|Overall Study|Randomized but not treated|0|||
148975009|NCT04537806|537389418|FG000|Overall Study|Adverse Event|1|||
148975010|NCT04537806|537389419|FG001|Overall Study|Adverse Event|1|||
148975011|NCT03219333|537389425|FG000|Overall Study|Withdrawal by Subject|9|||
148975012|NCT03219333|537389426|FG001|Overall Study|Withdrawal by Subject|4|||
148975013|NCT03219333|537389425|FG000|Overall Study|Lost to Follow-up|1|||
148975014|NCT03219333|537389426|FG001|Overall Study|Lost to Follow-up|1|||
148975015|NCT03219333|537389425|FG000|Overall Study|Death|104|||
148975016|NCT03219333|537389426|FG001|Overall Study|Death|72|||
148975017|NCT03219333|537389425|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
148975018|NCT03219333|537389426|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
148975019|NCT03219333|537389425|FG000|Overall Study|Other|2|||
148975020|NCT03219333|537389426|FG001|Overall Study|Other|2|||
148975021|NCT01126541|537389427|FG000|Overall Study|Adverse Event|0|||
148975022|NCT01126541|537389428|FG001|Overall Study|Adverse Event|2|||
148975023|NCT01126541|537389429|FG002|Overall Study|Adverse Event|4|||
148738587|NCT01755767|536514766|FG000|Overall Study|Radiographic Disease Progression|9|||
148738588|NCT01755767|536514767|FG001|Overall Study|Radiographic Disease Progression|4|||
148738589|NCT01755767|536514768|FG002|Overall Study|Radiographic Disease Progression|44|||
148738590|NCT01755767|536514769|FG003|Overall Study|Radiographic Disease Progression|27|||
148738591|NCT01755767|536514766|FG000|Overall Study|Adverse Event|6|||
148738592|NCT01755767|536514767|FG001|Overall Study|Adverse Event|0|||
148738593|NCT01755767|536514768|FG002|Overall Study|Adverse Event|28|||
148738594|NCT01755767|536514769|FG003|Overall Study|Adverse Event|11|||
148738595|NCT01755767|536514766|FG000|Overall Study|Death|1|||
148738596|NCT01755767|536514767|FG001|Overall Study|Death|2|||
148738597|NCT01755767|536514768|FG002|Overall Study|Death|15|||
148738598|NCT01755767|536514769|FG003|Overall Study|Death|4|||
148738599|NCT01755767|536514766|FG000|Overall Study|Subject Decision|0|||
148818342|NCT04270760|536810371|FG000|Overall Study|Death|0|||
148818343|NCT04270760|536810372|FG001|Overall Study|Death|0|||
148975024|NCT01126541|537389427|FG000|Overall Study|Death|0|||
148975025|NCT01126541|537389428|FG001|Overall Study|Death|1|||
148975026|NCT01126541|537389429|FG002|Overall Study|Death|0|||
148975027|NCT01126541|537389427|FG000|Overall Study|Lack of Efficacy|6|||
148975028|NCT01126541|537389428|FG001|Overall Study|Lack of Efficacy|1|||
148975029|NCT01126541|537389429|FG002|Overall Study|Lack of Efficacy|11|||
148975030|NCT01126541|537389427|FG000|Overall Study|Lost to Follow-up|1|||
148738600|NCT01755767|536514767|FG001|Overall Study|Subject Decision|0|||
148818344|NCT04270760|536810373|FG002|Overall Study|Death|0|||
148975031|NCT01126541|537389428|FG001|Overall Study|Lost to Follow-up|2|||
148975032|NCT01126541|537389429|FG002|Overall Study|Lost to Follow-up|2|||
148975033|NCT01126541|537389427|FG000|Overall Study|Withdrawal by Subject|2|||
148975034|NCT01126541|537389428|FG001|Overall Study|Withdrawal by Subject|5|||
148738601|NCT01755767|536514768|FG002|Overall Study|Subject Decision|10|||
148738602|NCT01755767|536514769|FG003|Overall Study|Subject Decision|3|||
148738603|NCT01755767|536514766|FG000|Overall Study|Withdrawal by Subject|0|||
148738604|NCT01755767|536514767|FG001|Overall Study|Withdrawal by Subject|0|||
148738605|NCT01755767|536514768|FG002|Overall Study|Withdrawal by Subject|2|||
148738606|NCT01755767|536514769|FG003|Overall Study|Withdrawal by Subject|1|||
148738607|NCT01755767|536514766|FG000|Overall Study|Other|0|||
148738608|NCT01755767|536514767|FG001|Overall Study|Other|0|||
148738609|NCT01755767|536514768|FG002|Overall Study|Other|2|||
148738610|NCT01755767|536514769|FG003|Overall Study|Other|3|||
148738611|NCT01755767|536514766|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
148738612|NCT01755767|536514767|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
148738613|NCT01755767|536514768|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
148738614|NCT01755767|536514769|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
148738615|NCT00191165|536514770|FG000|Overall Study|Adverse Event|2|||
148738616|NCT00191165|536514771|FG001|Overall Study|Adverse Event|0|||
148738617|NCT00191165|536514770|FG000|Overall Study|Protocol Violation|0|||
148738618|NCT00191165|536514771|FG001|Overall Study|Protocol Violation|1|||
148738619|NCT00191165|536514770|FG000|Overall Study|Participant Moved Away|0|||
148738620|NCT00191165|536514771|FG001|Overall Study|Participant Moved Away|1|||
148738621|NCT00715624|536514772|FG000|Overall Study|Adverse Event|12|||
148738622|NCT00715624|536514773|FG001|Overall Study|Adverse Event|37|||
148738623|NCT00715624|536514772|FG000|Overall Study|Lack of Efficacy|11|||
148738624|NCT00715624|536514773|FG001|Overall Study|Lack of Efficacy|11|||
148738625|NCT00715624|536514772|FG000|Overall Study|Lost to Follow-up|1|||
148738626|NCT00715624|536514773|FG001|Overall Study|Lost to Follow-up|2|||
148738627|NCT00715624|536514772|FG000|Overall Study|Protocol Violation|1|||
148738628|NCT00715624|536514773|FG001|Overall Study|Protocol Violation|0|||
148738629|NCT00715624|536514772|FG000|Overall Study|Withdrawal by Subject|11|||
148738630|NCT00715624|536514773|FG001|Overall Study|Withdrawal by Subject|25|||
148738631|NCT00715624|536514772|FG000|Overall Study|Familial and personal reasons|10|||
148738632|NCT00715624|536514773|FG001|Overall Study|Familial and personal reasons|22|||
148738633|NCT00715624|536514772|FG000|Overall Study|Poor compliance|6|||
148738634|NCT00715624|536514773|FG001|Overall Study|Poor compliance|13|||
148738635|NCT00715624|536514772|FG000|Overall Study|Sponsor decision|0|||
148738636|NCT00715624|536514773|FG001|Overall Study|Sponsor decision|4|||
148738637|NCT00715624|536514772|FG000|Overall Study|Incorrect randomization (not treated)|0|||
148738638|NCT00715624|536514773|FG001|Overall Study|Incorrect randomization (not treated)|1|||
148738639|NCT00715624|536514772|FG000|Overall Study|Other|0|||
148738640|NCT00715624|536514773|FG001|Overall Study|Other|1|||
148738641|NCT03200912|536514774|FG000|Overall Study|Adverse Event|3|||
148738642|NCT03200912|536514775|FG001|Overall Study|Adverse Event|0|||
148738643|NCT03200912|536514776|FG002|Overall Study|Adverse Event|0|||
148738644|NCT03200912|536514774|FG000|Overall Study|Withdrawal by Subject|1|||
148738645|NCT03200912|536514775|FG001|Overall Study|Withdrawal by Subject|2|||
148738646|NCT03200912|536514776|FG002|Overall Study|Withdrawal by Subject|4|||
148738647|NCT03200912|536514774|FG000|Overall Study|Non-compliance with study drug|0|||
148738648|NCT03200912|536514775|FG001|Overall Study|Non-compliance with study drug|1|||
148738649|NCT03200912|536514776|FG002|Overall Study|Non-compliance with study drug|0|||
148738650|NCT03196635|536514778|FG000|Overall Study|Withdrawal by Subject|1|||
148738651|NCT00229723|536514781|FG000|Concomitant Phase|Adverse Event|4|||
148738652|NCT00229723|536514782|FG001|Concomitant Phase|Adverse Event|2|||
148738653|NCT00229723|536514783|FG002|Concomitant Phase|Adverse Event|5|||
148738654|NCT00229723|536514784|FG003|Concomitant Phase|Adverse Event|2|||
148975035|NCT01126541|537389429|FG002|Overall Study|Withdrawal by Subject|6|||
148975036|NCT01126541|537389427|FG000|Overall Study|Protocol Violation|0|||
148975037|NCT01126541|537389428|FG001|Overall Study|Protocol Violation|0|||
148975038|NCT01126541|537389429|FG002|Overall Study|Protocol Violation|1|||
148738655|NCT00229723|536514785|FG004|Concomitant Phase|Adverse Event|0|||
148738656|NCT00229723|536514786|FG005|Concomitant Phase|Adverse Event|1|||
148738657|NCT00229723|536514787|FG006|Concomitant Phase|Adverse Event|2|||
148738658|NCT00229723|536514781|FG000|Concomitant Phase|Objective disease progression|0|||
148738659|NCT00229723|536514782|FG001|Concomitant Phase|Objective disease progression|0|||
148738660|NCT00229723|536514783|FG002|Concomitant Phase|Objective disease progression|0|||
148738661|NCT00229723|536514784|FG003|Concomitant Phase|Objective disease progression|0|||
148738662|NCT00229723|536514785|FG004|Concomitant Phase|Objective disease progression|0|||
148738663|NCT00229723|536514786|FG005|Concomitant Phase|Objective disease progression|0|||
148738664|NCT00229723|536514787|FG006|Concomitant Phase|Objective disease progression|0|||
148738665|NCT00229723|536514781|FG000|Concomitant Phase|Clinical progression|0|||
148738666|NCT00229723|536514782|FG001|Concomitant Phase|Clinical progression|0|||
148975039|NCT01126541|537389427|FG000|Overall Study|Administrative reason or other|1|||
148975040|NCT01126541|537389428|FG001|Overall Study|Administrative reason or other|1|||
148738667|NCT00229723|536514783|FG002|Concomitant Phase|Clinical progression|0|||
148738668|NCT00229723|536514784|FG003|Concomitant Phase|Clinical progression|0|||
148738669|NCT00229723|536514785|FG004|Concomitant Phase|Clinical progression|0|||
148738670|NCT00229723|536514786|FG005|Concomitant Phase|Clinical progression|0|||
148975041|NCT01126541|537389429|FG002|Overall Study|Administrative reason or other|2|||
148975042|NCT05459129|537389430|FG000|Overall Study|Death|1|||
148975043|NCT05459129|537389431|FG001|Overall Study|Death|0|||
148975044|NCT05459129|537389430|FG000|Overall Study|Study Terminated By Sponsor|5|||
148975045|NCT05459129|537389431|FG001|Overall Study|Study Terminated By Sponsor|6|||
148975046|NCT04304001|537389432|FG000|Overall Study|Lost to Follow-up|13|||
148975047|NCT04304001|537389433|FG001|Overall Study|Lost to Follow-up|9|||
148975048|NCT04033159|537389437|FG000|Washout Period|Physician Decision|0|||
148975049|NCT04033159|537389438|FG001|Washout Period|Physician Decision|1|||
148975050|NCT04033159|537389439|FG002|Washout Period|Physician Decision|0|||
148975051|NCT04033159|537389437|FG000|Washout Period|Study terminated by Sponsor|0|||
148975052|NCT04033159|537389438|FG001|Washout Period|Study terminated by Sponsor|7|||
148975053|NCT04033159|537389439|FG002|Washout Period|Study terminated by Sponsor|0|||
148975054|NCT04033159|537389437|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
148975055|NCT04033159|537389438|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
148975056|NCT04033159|537389439|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
148975057|NCT04847674|537389442|FG000|Overall Study|Withdrawal by Subject|0|||
148975058|NCT04847674|537389443|FG001|Overall Study|Withdrawal by Subject|1|||
148975059|NCT04847674|537389444|FG002|Overall Study|Withdrawal by Subject|0|||
148975060|NCT04847674|537389442|FG000|Overall Study|Lost to Follow-up|0|||
148975061|NCT04847674|537389443|FG001|Overall Study|Lost to Follow-up|0|||
148975062|NCT04847674|537389444|FG002|Overall Study|Lost to Follow-up|2|||
148975063|NCT04847674|537389442|FG000|Overall Study|Other than specified|21|||
148975064|NCT04847674|537389443|FG001|Overall Study|Other than specified|20|||
148975065|NCT04847674|537389444|FG002|Overall Study|Other than specified|20|||
148975066|NCT03400033|537389445|FG000|Overall Study|Withdrawal by Subject|1|||
148975067|NCT03400033|537389446|FG001|Overall Study|Withdrawal by Subject|2|||
148975068|NCT01524770|537389456|FG000|First Intervention|Withdrawal by Subject|1|||
148975069|NCT01524770|537389457|FG001|First Intervention|Withdrawal by Subject|0|||
148975070|NCT01524770|537389456|FG000|First Intervention|Adverse Event|1|||
148975071|NCT01524770|537389457|FG001|First Intervention|Adverse Event|1|||
148975072|NCT01524770|537389456|FG000|First Intervention|Protocol Violation|1|||
148975073|NCT01524770|537389457|FG001|First Intervention|Protocol Violation|0|||
148975074|NCT02167256|537389459|FG000|Overall Study|Adverse Event|13|||
148975075|NCT02167256|537389460|FG001|Overall Study|Adverse Event|6|||
148975076|NCT02167256|537389459|FG000|Overall Study|Withdrawal by Subject|4|||
148975077|NCT02167256|537389460|FG001|Overall Study|Withdrawal by Subject|4|||
148975078|NCT02167256|537389459|FG000|Overall Study|non-compliance|3|||
148975079|NCT02167256|537389460|FG001|Overall Study|non-compliance|0|||
148975080|NCT02167256|537389459|FG000|Overall Study|Study partner unable to participate|1|||
148975081|NCT02167256|537389460|FG001|Overall Study|Study partner unable to participate|0|||
148975082|NCT02469610|537389461|FG000|Overall Study|Death|1|||
148975083|NCT02469610|537389462|FG001|Overall Study|Death|0|||
148975084|NCT02469610|537389461|FG000|Overall Study|Lost to Follow-up|1|||
148975085|NCT02469610|537389462|FG001|Overall Study|Lost to Follow-up|0|||
148975086|NCT02469610|537389461|FG000|Overall Study|exclusion criteria|2|||
148975087|NCT02469610|537389462|FG001|Overall Study|exclusion criteria|1|||
148975088|NCT00590954|537389465|FG000|Overall Study|Inevaluable|2|||
148975089|NCT04074317|537389470|FG000|Third Period|Withdrawal by Subject|0|||
148975090|NCT04074317|537389471|FG001|Third Period|Withdrawal by Subject|0|||
148975091|NCT04074317|537389472|FG002|Third Period|Withdrawal by Subject|0|||
148975092|NCT04074317|537389473|FG003|Third Period|Withdrawal by Subject|1|||
148975093|NCT04074317|537389474|FG004|Third Period|Withdrawal by Subject|0|||
148975094|NCT04074317|537389475|FG005|Third Period|Withdrawal by Subject|0|||
148975095|NCT03091192|537389476|FG000|Overall Study|Study terminated by sponsor|21|||
148975096|NCT03091192|537389477|FG001|Overall Study|Study terminated by sponsor|14|||
148975097|NCT03091192|537389476|FG000|Overall Study|Death|9|||
148975098|NCT03091192|537389477|FG001|Overall Study|Death|13|||
148738671|NCT00229723|536514787|FG006|Concomitant Phase|Clinical progression|1|||
148738672|NCT00229723|536514781|FG000|Concomitant Phase|Lost to Follow-up|0|||
148738673|NCT00229723|536514782|FG001|Concomitant Phase|Lost to Follow-up|0|||
148975099|NCT03091192|537389476|FG000|Overall Study|Withdrawal by Subject|2|||
148975100|NCT03091192|537389477|FG001|Overall Study|Withdrawal by Subject|0|||
148738674|NCT00229723|536514783|FG002|Concomitant Phase|Lost to Follow-up|0|||
148975101|NCT03091192|537389476|FG000|Overall Study|Lost to Follow-up|1|||
148975102|NCT03091192|537389477|FG001|Overall Study|Lost to Follow-up|0|||
148975103|NCT06023394|537389478|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
148975104|NCT06023394|537389479|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
148975105|NCT06023394|537389478|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
148975106|NCT06023394|537389479|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
148975107|NCT06023394|537389478|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
148975108|NCT06023394|537389479|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
148975109|NCT06023394|537389478|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
148975110|NCT06023394|537389479|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
148975111|NCT02096835|537390762|FG000|Overall Study|Withdrawal by Subject|1|||
148738675|NCT00229723|536514784|FG003|Concomitant Phase|Lost to Follow-up|0|||
148738676|NCT00229723|536514785|FG004|Concomitant Phase|Lost to Follow-up|1|||
148738677|NCT00229723|536514786|FG005|Concomitant Phase|Lost to Follow-up|0|||
148738678|NCT00229723|536514787|FG006|Concomitant Phase|Lost to Follow-up|0|||
148738679|NCT00229723|536514781|FG000|Concomitant Phase|Informed consent withdrawn|3|||
148738680|NCT00229723|536514782|FG001|Concomitant Phase|Informed consent withdrawn|2|||
148738681|NCT00229723|536514783|FG002|Concomitant Phase|Informed consent withdrawn|0|||
148738682|NCT00229723|536514784|FG003|Concomitant Phase|Informed consent withdrawn|2|||
148738683|NCT00229723|536514785|FG004|Concomitant Phase|Informed consent withdrawn|0|||
148738684|NCT00229723|536514786|FG005|Concomitant Phase|Informed consent withdrawn|0|||
148738685|NCT00229723|536514787|FG006|Concomitant Phase|Informed consent withdrawn|0|||
148738686|NCT00229723|536514781|FG000|Concomitant Phase|Severe non-compliance|0|||
148738687|NCT00229723|536514782|FG001|Concomitant Phase|Severe non-compliance|1|||
148738688|NCT00229723|536514783|FG002|Concomitant Phase|Severe non-compliance|0|||
148738689|NCT00229723|536514784|FG003|Concomitant Phase|Severe non-compliance|0|||
148738690|NCT00229723|536514785|FG004|Concomitant Phase|Severe non-compliance|1|||
148738691|NCT00229723|536514786|FG005|Concomitant Phase|Severe non-compliance|0|||
148738692|NCT00229723|536514787|FG006|Concomitant Phase|Severe non-compliance|0|||
148738693|NCT00229723|536514781|FG000|Concomitant Phase|Other|3|||
148738694|NCT00229723|536514782|FG001|Concomitant Phase|Other|0|||
148738695|NCT00229723|536514783|FG002|Concomitant Phase|Other|1|||
148738696|NCT00229723|536514784|FG003|Concomitant Phase|Other|1|||
148738697|NCT00229723|536514785|FG004|Concomitant Phase|Other|0|||
148738698|NCT00229723|536514786|FG005|Concomitant Phase|Other|2|||
148738699|NCT00229723|536514787|FG006|Concomitant Phase|Other|0|||
148738700|NCT00229723|536514781|FG000|Maintenance Phase|Adverse Event|7|||
148738701|NCT00229723|536514782|FG001|Maintenance Phase|Adverse Event|2|||
148738702|NCT00229723|536514783|FG002|Maintenance Phase|Adverse Event|1|||
148738703|NCT00229723|536514784|FG003|Maintenance Phase|Adverse Event|4|||
148738704|NCT00229723|536514785|FG004|Maintenance Phase|Adverse Event|7|||
148738705|NCT00229723|536514786|FG005|Maintenance Phase|Adverse Event|5|||
148738706|NCT00229723|536514787|FG006|Maintenance Phase|Adverse Event|2|||
148738707|NCT00229723|536514781|FG000|Maintenance Phase|Objective disease progression|5|||
148738708|NCT00229723|536514782|FG001|Maintenance Phase|Objective disease progression|5|||
148738709|NCT00229723|536514783|FG002|Maintenance Phase|Objective disease progression|3|||
148738710|NCT00229723|536514784|FG003|Maintenance Phase|Objective disease progression|6|||
148738711|NCT00229723|536514785|FG004|Maintenance Phase|Objective disease progression|2|||
148738712|NCT00229723|536514786|FG005|Maintenance Phase|Objective disease progression|9|||
148738713|NCT00229723|536514787|FG006|Maintenance Phase|Objective disease progression|5|||
148738714|NCT00229723|536514781|FG000|Maintenance Phase|Clinical progression|4|||
148738715|NCT00229723|536514782|FG001|Maintenance Phase|Clinical progression|1|||
148738716|NCT00229723|536514783|FG002|Maintenance Phase|Clinical progression|2|||
148738717|NCT00229723|536514784|FG003|Maintenance Phase|Clinical progression|2|||
148738718|NCT00229723|536514785|FG004|Maintenance Phase|Clinical progression|1|||
148738719|NCT00229723|536514786|FG005|Maintenance Phase|Clinical progression|1|||
148738720|NCT00229723|536514787|FG006|Maintenance Phase|Clinical progression|1|||
148738721|NCT00229723|536514781|FG000|Maintenance Phase|Lost to Follow-up|0|||
148738722|NCT00229723|536514782|FG001|Maintenance Phase|Lost to Follow-up|1|||
148738723|NCT00229723|536514783|FG002|Maintenance Phase|Lost to Follow-up|2|||
148738724|NCT00229723|536514784|FG003|Maintenance Phase|Lost to Follow-up|2|||
148738725|NCT00229723|536514785|FG004|Maintenance Phase|Lost to Follow-up|0|||
148738726|NCT00229723|536514786|FG005|Maintenance Phase|Lost to Follow-up|0|||
148738727|NCT00229723|536514787|FG006|Maintenance Phase|Lost to Follow-up|1|||
148738728|NCT00229723|536514781|FG000|Maintenance Phase|Informed consent withdrawn|1|||
148738729|NCT00229723|536514782|FG001|Maintenance Phase|Informed consent withdrawn|0|||
148738730|NCT00229723|536514783|FG002|Maintenance Phase|Informed consent withdrawn|0|||
148975112|NCT02096835|537390763|FG001|Overall Study|Withdrawal by Subject|0|||
148975113|NCT02096835|537390764|FG002|Overall Study|Withdrawal by Subject|0|||
148738731|NCT00229723|536514784|FG003|Maintenance Phase|Informed consent withdrawn|1|||
148738732|NCT00229723|536514785|FG004|Maintenance Phase|Informed consent withdrawn|1|||
148738733|NCT00229723|536514786|FG005|Maintenance Phase|Informed consent withdrawn|1|||
148738734|NCT00229723|536514787|FG006|Maintenance Phase|Informed consent withdrawn|0|||
148738735|NCT00229723|536514781|FG000|Maintenance Phase|Severe non-compliance|3|||
148738736|NCT00229723|536514782|FG001|Maintenance Phase|Severe non-compliance|1|||
148738737|NCT00229723|536514783|FG002|Maintenance Phase|Severe non-compliance|0|||
148738738|NCT00229723|536514784|FG003|Maintenance Phase|Severe non-compliance|0|||
148738739|NCT00229723|536514785|FG004|Maintenance Phase|Severe non-compliance|1|||
148738740|NCT00229723|536514786|FG005|Maintenance Phase|Severe non-compliance|0|||
148738741|NCT00229723|536514787|FG006|Maintenance Phase|Severe non-compliance|0|||
148738742|NCT00229723|536514781|FG000|Maintenance Phase|Other|5|||
148738743|NCT00229723|536514782|FG001|Maintenance Phase|Other|4|||
148738744|NCT00229723|536514783|FG002|Maintenance Phase|Other|1|||
148738745|NCT00229723|536514784|FG003|Maintenance Phase|Other|2|||
148738746|NCT00229723|536514785|FG004|Maintenance Phase|Other|3|||
148738747|NCT00229723|536514786|FG005|Maintenance Phase|Other|3|||
148738748|NCT00229723|536514787|FG006|Maintenance Phase|Other|1|||
148738749|NCT02677714|536514790|FG000|Overall Study|Withdrawal by Subject|2|||
148738750|NCT02677714|536514791|FG001|Overall Study|Withdrawal by Subject|0|||
148738751|NCT00901576|536514792|FG000|Second Intervention|Withdrawal by Subject|0|||
148738752|NCT00901576|536514793|FG001|Second Intervention|Withdrawal by Subject|0|||
148738753|NCT00901576|536514794|FG002|Second Intervention|Withdrawal by Subject|0|||
148738754|NCT00901576|536514795|FG003|Second Intervention|Withdrawal by Subject|1|||
148738755|NCT00901576|536514796|FG004|Second Intervention|Withdrawal by Subject|0|||
148738756|NCT00901576|536514797|FG005|Second Intervention|Withdrawal by Subject|1|||
148738757|NCT00901576|536514792|FG000|Second Intervention|Physician Decision|1|||
148738758|NCT00901576|536514793|FG001|Second Intervention|Physician Decision|0|||
148738759|NCT00901576|536514794|FG002|Second Intervention|Physician Decision|0|||
148738760|NCT00901576|536514795|FG003|Second Intervention|Physician Decision|0|||
148738761|NCT00901576|536514796|FG004|Second Intervention|Physician Decision|0|||
148738762|NCT00901576|536514797|FG005|Second Intervention|Physician Decision|0|||
148738763|NCT00171951|536514800|FG000|Overall Study|Adverse Event|1|||
148738764|NCT00171951|536514800|FG000|Overall Study|Abnormal Laboratory Values|2|||
148738765|NCT00171951|536514800|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148738766|NCT00171951|536514800|FG000|Overall Study|Participants Withdrew Consent|3|||
148738767|NCT00171951|536514800|FG000|Overall Study|New Cancer Therapy|5|||
148738768|NCT00171951|536514800|FG000|Overall Study|Reason not Specified|2|||
148738769|NCT04159935|536514801|FG000|Overall Study|Study terminated due to COVID-19|1|||
148738770|NCT04159935|536514802|FG001|Overall Study|Study terminated due to COVID-19|3|||
148738771|NCT00724048|536514803|FG000|Overall Study|Adverse Event|1|||
148738772|NCT00724048|536514804|FG001|Overall Study|Adverse Event|1|||
148738773|NCT00724048|536514805|FG002|Overall Study|Adverse Event|1|||
148738774|NCT00724048|536514806|FG003|Overall Study|Adverse Event|0|||
148738775|NCT00724048|536514803|FG000|Overall Study|Lost to Follow-up|0|||
148738776|NCT00724048|536514804|FG001|Overall Study|Lost to Follow-up|1|||
148738777|NCT00724048|536514805|FG002|Overall Study|Lost to Follow-up|0|||
148738778|NCT00724048|536514806|FG003|Overall Study|Lost to Follow-up|0|||
148738779|NCT00724048|536514803|FG000|Overall Study|Withdrawal by Subject|1|||
148738780|NCT00724048|536514804|FG001|Overall Study|Withdrawal by Subject|2|||
148738781|NCT00724048|536514805|FG002|Overall Study|Withdrawal by Subject|1|||
148738782|NCT00724048|536514806|FG003|Overall Study|Withdrawal by Subject|2|||
148738783|NCT00724048|536514803|FG000|Overall Study|Investigator decision|0|||
148738784|NCT00724048|536514804|FG001|Overall Study|Investigator decision|0|||
148738785|NCT00724048|536514805|FG002|Overall Study|Investigator decision|1|||
148738786|NCT00724048|536514806|FG003|Overall Study|Investigator decision|0|||
148738787|NCT00724048|536514803|FG000|Overall Study|Did not tolerate study drug|0|||
148738788|NCT00724048|536514804|FG001|Overall Study|Did not tolerate study drug|0|||
148738789|NCT00724048|536514805|FG002|Overall Study|Did not tolerate study drug|0|||
148738790|NCT00724048|536514806|FG003|Overall Study|Did not tolerate study drug|1|||
148738791|NCT00724048|536514803|FG000|Overall Study|Other than specified|1|||
148738792|NCT00724048|536514804|FG001|Overall Study|Other than specified|1|||
148738793|NCT00724048|536514805|FG002|Overall Study|Other than specified|0|||
148738794|NCT00724048|536514806|FG003|Overall Study|Other than specified|0|||
148738795|NCT01822275|536514808|FG000|Overall Study|Withdrawal by Subject|3|||
148738796|NCT01822275|536514808|FG000|Overall Study|Adverse Event|3|||
148738797|NCT01822275|536514808|FG000|Overall Study|Progression|14|||
148738798|NCT01822275|536514808|FG000|Overall Study|Physician Decision|2|||
148738799|NCT00477295|536514814|FG000|Overall Study|Adverse Event|31|||
148738800|NCT00477295|536514815|FG001|Overall Study|Adverse Event|35|||
148738801|NCT00477295|536514814|FG000|Overall Study|Withdrawal by Subject|35|||
148738802|NCT00477295|536514815|FG001|Overall Study|Withdrawal by Subject|24|||
148738803|NCT00477295|536514814|FG000|Overall Study|Lack of Efficacy|23|||
148738804|NCT00477295|536514815|FG001|Overall Study|Lack of Efficacy|23|||
148738805|NCT00477295|536514814|FG000|Overall Study|Protocol Violation|3|||
148738806|NCT00477295|536514815|FG001|Overall Study|Protocol Violation|8|||
148738807|NCT00477295|536514814|FG000|Overall Study|Physician Decision|4|||
148818345|NCT04270760|536810374|FG003|Overall Study|Death|0|||
148818346|NCT04270760|536810375|FG004|Overall Study|Death|1|||
148738808|NCT00477295|536514815|FG001|Overall Study|Physician Decision|5|||
148738809|NCT00477295|536514814|FG000|Overall Study|Lost to Follow-up|21|||
148738810|NCT00477295|536514815|FG001|Overall Study|Lost to Follow-up|11|||
148738811|NCT00477295|536514814|FG000|Overall Study|Other|4|||
148738812|NCT00477295|536514815|FG001|Overall Study|Other|3|||
148738813|NCT03276780|536514818|FG000|Overall Study|Withdrawal by Subject|5|||
148738814|NCT03276780|536514819|FG001|Overall Study|Withdrawal by Subject|3|||
148738815|NCT03276780|536514818|FG000|Overall Study|Lost to Follow-up|3|||
148738816|NCT03276780|536514819|FG001|Overall Study|Lost to Follow-up|5|||
148738817|NCT03276780|536514818|FG000|Overall Study|Moved out of state|1|||
148738818|NCT03276780|536514819|FG001|Overall Study|Moved out of state|1|||
148738819|NCT03276780|536514818|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
148738820|NCT03276780|536514819|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
148738821|NCT03276780|536514818|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
148738822|NCT03276780|536514819|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
148975114|NCT02096835|537390762|FG000|Overall Study|converted to open procedures|1|||
148975115|NCT02096835|537390763|FG001|Overall Study|converted to open procedures|0|||
148975116|NCT02096835|537390764|FG002|Overall Study|converted to open procedures|0|||
148975117|NCT02096835|537390762|FG000|Overall Study|Lost to Follow-up|1|||
148975118|NCT02096835|537390763|FG001|Overall Study|Lost to Follow-up|0|||
148975119|NCT02096835|537390764|FG002|Overall Study|Lost to Follow-up|1|||
148975120|NCT00023673|537390766|FG000|Overall Study|Ineligible / no protocol treatment|0|||
148975121|NCT00023673|537390767|FG001|Overall Study|Ineligible / no protocol treatment|0|||
148975122|NCT00023673|537390768|FG002|Overall Study|Ineligible / no protocol treatment|0|||
148975123|NCT00023673|537390769|FG003|Overall Study|Ineligible / no protocol treatment|1|||
148975124|NCT00023673|537390766|FG000|Overall Study|Patient withdrew consent|0|||
148975125|NCT00023673|537390767|FG001|Overall Study|Patient withdrew consent|0|||
148975126|NCT00023673|537390768|FG002|Overall Study|Patient withdrew consent|0|||
148975127|NCT00023673|537390769|FG003|Overall Study|Patient withdrew consent|1|||
148975128|NCT04300296|537390774|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
148975129|NCT04300296|537390775|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
148975130|NCT04300296|537390776|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
148975131|NCT04300296|537390777|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
148975132|NCT04300296|537390778|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
148975133|NCT04300296|537390779|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
148975134|NCT04300296|537390774|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
148975135|NCT04300296|537390775|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
148975136|NCT04300296|537390776|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
148975137|NCT04300296|537390777|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
148975138|NCT04300296|537390778|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
148975139|NCT04300296|537390779|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
148975140|NCT04300296|537390774|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
148975141|NCT04300296|537390775|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
148975142|NCT04300296|537390776|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
148975143|NCT04300296|537390777|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
148975144|NCT04300296|537390778|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
148975145|NCT04300296|537390779|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
148975146|NCT04300296|537390774|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
148975147|NCT04300296|537390775|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
148975148|NCT04300296|537390776|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
148975149|NCT04300296|537390777|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
148975150|NCT04300296|537390778|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
148975151|NCT04300296|537390779|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
148975152|NCT04300296|537390774|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
148975153|NCT04300296|537390775|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
148975154|NCT04300296|537390776|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
148975155|NCT04300296|537390777|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
148975156|NCT04300296|537390778|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
148975157|NCT04300296|537390779|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
148975158|NCT04300296|537390774|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
148975159|NCT04300296|537390775|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
148975160|NCT04300296|537390776|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
148738823|NCT02304458|536514820|FG000|Overall Study|Adverse Event|0|||
148738824|NCT02304458|536514821|FG001|Overall Study|Adverse Event|0|||
148738825|NCT02304458|536514822|FG002|Overall Study|Adverse Event|7|||
148738826|NCT02304458|536514823|FG003|Overall Study|Adverse Event|0|||
148738827|NCT02304458|536514824|FG004|Overall Study|Adverse Event|0|||
148738828|NCT02304458|536514825|FG005|Overall Study|Adverse Event|0|||
148738829|NCT02304458|536514826|FG006|Overall Study|Adverse Event|3|||
148738830|NCT02304458|536514827|FG007|Overall Study|Adverse Event|4|||
148738831|NCT02304458|536514820|FG000|Overall Study|Death|0|||
148738832|NCT02304458|536514821|FG001|Overall Study|Death|0|||
148738833|NCT02304458|536514822|FG002|Overall Study|Death|2|||
148738834|NCT02304458|536514823|FG003|Overall Study|Death|0|||
148738835|NCT02304458|536514824|FG004|Overall Study|Death|0|||
148738836|NCT02304458|536514825|FG005|Overall Study|Death|0|||
148738837|NCT02304458|536514826|FG006|Overall Study|Death|1|||
148738838|NCT02304458|536514827|FG007|Overall Study|Death|0|||
148975161|NCT04300296|537390777|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
148975162|NCT04300296|537390778|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
148738839|NCT02304458|536514820|FG000|Overall Study|Lack of Efficacy|4|||
148738840|NCT02304458|536514821|FG001|Overall Study|Lack of Efficacy|6|||
148738841|NCT02304458|536514822|FG002|Overall Study|Lack of Efficacy|38|||
148738842|NCT02304458|536514823|FG003|Overall Study|Lack of Efficacy|5|||
148738843|NCT02304458|536514824|FG004|Overall Study|Lack of Efficacy|6|||
148975163|NCT04300296|537390779|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
148975164|NCT04300296|537390774|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
148975165|NCT04300296|537390775|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
148975166|NCT04300296|537390776|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
148975167|NCT04300296|537390777|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
148975168|NCT04300296|537390778|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
148975169|NCT04300296|537390779|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
148975170|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Adverse Event|9|||
148975171|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Adverse Event|2|||
148975172|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
148975173|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
148975174|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
148975175|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
148975176|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Physician Decision|1|||
148975177|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Physician Decision|1|||
148975178|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Pregnancy|2|||
148975179|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Pregnancy|0|||
148975180|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
148975181|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
148975182|NCT02896127|537390780|FG000|COMPLETED WEEK 52|Technical problems|1|||
148975183|NCT02896127|537390781|FG001|COMPLETED WEEK 52|Technical problems|0|||
148975184|NCT02896127|537390780|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
148975185|NCT02896127|537390781|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
148975186|NCT02896127|537390780|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
148975187|NCT02896127|537390781|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
148975188|NCT02896127|537390780|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
148975189|NCT02896127|537390781|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
148975190|NCT02896127|537390780|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
148975191|NCT02896127|537390781|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
148975192|NCT02896127|537390780|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
148975193|NCT02896127|537390781|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
148975194|NCT00279708|537390782|FG000|Overall Study|Withdrawal by Subject|2|||
148975195|NCT00279708|537390783|FG001|Overall Study|Withdrawal by Subject|3|||
148975196|NCT00279708|537390782|FG000|Overall Study|Adverse Event|1|||
148975197|NCT00279708|537390783|FG001|Overall Study|Adverse Event|1|||
148975198|NCT02477020|537390784|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
148975199|NCT02477020|537390785|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
148975200|NCT02477020|537390784|FG000|Overall Study|Voluntary Withdrawal|7|||
148975201|NCT02477020|537390785|FG001|Overall Study|Voluntary Withdrawal|16|||
148738844|NCT02304458|536514825|FG005|Overall Study|Lack of Efficacy|6|||
148738845|NCT02304458|536514826|FG006|Overall Study|Lack of Efficacy|21|||
148738846|NCT02304458|536514827|FG007|Overall Study|Lack of Efficacy|4|||
148738847|NCT02304458|536514820|FG000|Overall Study|Physician Decision|2|||
148738848|NCT02304458|536514821|FG001|Overall Study|Physician Decision|0|||
148738849|NCT02304458|536514822|FG002|Overall Study|Physician Decision|16|||
148738850|NCT02304458|536514823|FG003|Overall Study|Physician Decision|1|||
148738851|NCT02304458|536514824|FG004|Overall Study|Physician Decision|0|||
148738852|NCT02304458|536514825|FG005|Overall Study|Physician Decision|0|||
148738853|NCT02304458|536514826|FG006|Overall Study|Physician Decision|3|||
148975202|NCT02477020|537390784|FG000|Overall Study|Reason not Specified|3|||
148975203|NCT02477020|537390785|FG001|Overall Study|Reason not Specified|1|||
148975204|NCT02477020|537390784|FG000|Overall Study|Lack of Efficacy|14|||
148975205|NCT02477020|537390785|FG001|Overall Study|Lack of Efficacy|5|||
148975206|NCT00519649|537390786|FG000|Overall Study|Withdrawal by Subject|1|||
148975207|NCT01465802|537390787|FG000|Overall Study|Study terminated by sponsor|1|||
148975208|NCT01465802|537390788|FG001|Overall Study|Study terminated by sponsor|0|||
148975209|NCT01465802|537390789|FG002|Overall Study|Study terminated by sponsor|0|||
148975210|NCT01465802|537390790|FG003|Overall Study|Study terminated by sponsor|1|||
148975211|NCT01465802|537390791|FG004|Overall Study|Study terminated by sponsor|7|||
148975212|NCT01465802|537390787|FG000|Overall Study|Withdrawal by Subject|7|||
148975213|NCT01465802|537390788|FG001|Overall Study|Withdrawal by Subject|7|||
148975214|NCT01465802|537390789|FG002|Overall Study|Withdrawal by Subject|0|||
148738854|NCT02304458|536514827|FG007|Overall Study|Physician Decision|0|||
148738855|NCT02304458|536514820|FG000|Overall Study|Protocol Violation|0|||
148738856|NCT02304458|536514821|FG001|Overall Study|Protocol Violation|0|||
148738857|NCT02304458|536514822|FG002|Overall Study|Protocol Violation|1|||
148975215|NCT01465802|537390790|FG003|Overall Study|Withdrawal by Subject|8|||
148975216|NCT01465802|537390791|FG004|Overall Study|Withdrawal by Subject|1|||
148975217|NCT01465802|537390787|FG000|Overall Study|Lost to Follow-up|1|||
148975218|NCT01465802|537390788|FG001|Overall Study|Lost to Follow-up|1|||
148975219|NCT01465802|537390789|FG002|Overall Study|Lost to Follow-up|0|||
148738858|NCT02304458|536514823|FG003|Overall Study|Protocol Violation|0|||
148738859|NCT02304458|536514824|FG004|Overall Study|Protocol Violation|0|||
148738860|NCT02304458|536514825|FG005|Overall Study|Protocol Violation|0|||
148975220|NCT01465802|537390790|FG003|Overall Study|Lost to Follow-up|0|||
148975221|NCT01465802|537390791|FG004|Overall Study|Lost to Follow-up|0|||
148975222|NCT01465802|537390787|FG000|Overall Study|Reason not specified|9|||
148975223|NCT01465802|537390788|FG001|Overall Study|Reason not specified|4|||
148975224|NCT01465802|537390789|FG002|Overall Study|Reason not specified|0|||
148975225|NCT01465802|537390790|FG003|Overall Study|Reason not specified|10|||
148975226|NCT01465802|537390791|FG004|Overall Study|Reason not specified|2|||
148975227|NCT01465802|537390787|FG000|Overall Study|Death|15|||
148975228|NCT01465802|537390788|FG001|Overall Study|Death|12|||
148975229|NCT01465802|537390789|FG002|Overall Study|Death|0|||
148975230|NCT01465802|537390790|FG003|Overall Study|Death|10|||
148975231|NCT01465802|537390791|FG004|Overall Study|Death|2|||
148975232|NCT01470469|537390792|FG000|Overall Study|Withdrawal by Subject|4|||
148975233|NCT01470469|537390793|FG001|Overall Study|Withdrawal by Subject|6|||
148975234|NCT01470469|537390792|FG000|Overall Study|Lack of Efficacy|1|||
148975235|NCT01470469|537390793|FG001|Overall Study|Lack of Efficacy|7|||
148975236|NCT01470469|537390792|FG000|Overall Study|Adverse Event|0|||
148975237|NCT01470469|537390793|FG001|Overall Study|Adverse Event|7|||
148975238|NCT01470469|537390792|FG000|Overall Study|Lost to Follow-up|2|||
148975239|NCT01470469|537390793|FG001|Overall Study|Lost to Follow-up|2|||
148975240|NCT01470469|537390792|FG000|Overall Study|Protocol Violation|1|||
148975241|NCT01470469|537390793|FG001|Overall Study|Protocol Violation|1|||
148975242|NCT01470469|537390792|FG000|Overall Study|Other|2|||
148975243|NCT01470469|537390793|FG001|Overall Study|Other|1|||
148975244|NCT02504372|537390794|FG000|Overall Study|Death|136|||
148975245|NCT02504372|537390795|FG001|Overall Study|Death|154|||
148975246|NCT02504372|537390794|FG000|Overall Study|Lost to Follow-up|0|||
148975247|NCT02504372|537390795|FG001|Overall Study|Lost to Follow-up|2|||
148975248|NCT02504372|537390794|FG000|Overall Study|Withdrawal of consent|25|||
148975249|NCT02504372|537390795|FG001|Overall Study|Withdrawal of consent|16|||
148975250|NCT02504372|537390794|FG000|Overall Study|Participants ongoing|429|||
148975251|NCT02504372|537390795|FG001|Overall Study|Participants ongoing|415|||
148975252|NCT01502644|537390798|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
148738861|NCT02304458|536514826|FG006|Overall Study|Protocol Violation|0|||
148738862|NCT02304458|536514827|FG007|Overall Study|Protocol Violation|0|||
148738863|NCT02304458|536514820|FG000|Overall Study|Withdrawal by Subject|1|||
148738864|NCT02304458|536514821|FG001|Overall Study|Withdrawal by Subject|0|||
148738865|NCT02304458|536514822|FG002|Overall Study|Withdrawal by Subject|7|||
148738866|NCT02304458|536514823|FG003|Overall Study|Withdrawal by Subject|0|||
148738867|NCT02304458|536514824|FG004|Overall Study|Withdrawal by Subject|0|||
148738868|NCT02304458|536514825|FG005|Overall Study|Withdrawal by Subject|0|||
148738869|NCT02304458|536514826|FG006|Overall Study|Withdrawal by Subject|1|||
148738870|NCT02304458|536514827|FG007|Overall Study|Withdrawal by Subject|0|||
148738871|NCT01425723|536514828|FG000|Overall Study|Lack of Efficacy|0|||
148738872|NCT01425723|536514829|FG001|Overall Study|Lack of Efficacy|1|||
148738873|NCT01425723|536514828|FG000|Overall Study|Withdrawal by Subject|1|||
148738874|NCT01425723|536514829|FG001|Overall Study|Withdrawal by Subject|4|||
148738875|NCT01425723|536514828|FG000|Overall Study|Lost to Follow-up|0|||
148738876|NCT01425723|536514829|FG001|Overall Study|Lost to Follow-up|3|||
148738877|NCT01425723|536514828|FG000|Overall Study|Physician Decision|2|||
148738878|NCT01425723|536514829|FG001|Overall Study|Physician Decision|0|||
148818347|NCT02070991|536810376|FG000|Overall Study|Death|2|||
148818348|NCT02070991|536810377|FG001|Overall Study|Death|0|||
148818349|NCT02070991|536810376|FG000|Overall Study|Withdrawal by Subject|1|||
148975253|NCT01502644|537390799|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
148975254|NCT01502644|537390800|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
148975255|NCT01502644|537390801|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
148975256|NCT01502644|537390798|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
148975257|NCT01502644|537390799|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
148975258|NCT01502644|537390800|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
148975259|NCT01502644|537390801|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
148975260|NCT01502644|537390798|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
148975261|NCT01502644|537390799|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
148975262|NCT01502644|537390800|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
148975263|NCT01502644|537390801|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
148975264|NCT01502644|537390798|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
148975265|NCT01502644|537390799|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
148738879|NCT01425723|536514828|FG000|Overall Study|Other|1|||
148738880|NCT01425723|536514829|FG001|Overall Study|Other|10|||
148738881|NCT00390221|536514830|FG000|Overall Study|Lost to Follow-up|0|||
148738882|NCT00390221|536514831|FG001|Overall Study|Lost to Follow-up|3|||
148738883|NCT00390221|536514832|FG002|Overall Study|Lost to Follow-up|0|||
148738884|NCT00390221|536514830|FG000|Overall Study|Adverse Event|1|||
148738885|NCT00390221|536514831|FG001|Overall Study|Adverse Event|4|||
148975266|NCT01502644|537390800|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
148975267|NCT01502644|537390801|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
148975268|NCT01502644|537390798|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
148975269|NCT01502644|537390799|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
148975270|NCT01502644|537390800|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
148975271|NCT01502644|537390801|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
148975272|NCT02052739|537390804|FG000|Overall Study|Withdrew due to Adverse Event|3|||
148975273|NCT02052739|537390805|FG001|Overall Study|Withdrew due to Adverse Event|0|||
148975274|NCT02052739|537390804|FG000|Overall Study|Participant Died|2|||
148975275|NCT02052739|537390805|FG001|Overall Study|Participant Died|1|||
148975276|NCT01526889|537390806|FG000|Treatment Period|Adverse Event|2|||
148975277|NCT01526889|537390807|FG001|Treatment Period|Adverse Event|0|||
148975278|NCT01526889|537390806|FG000|Treatment Extension Period|Administrative problems|1|||
148975279|NCT01526889|537390807|FG001|Treatment Extension Period|Administrative problems|0|||
148975280|NCT01573624|537390808|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
148975281|NCT01573624|537390809|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
148975282|NCT01573624|537390810|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
148975283|NCT01573624|537390811|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
148975284|NCT01573624|537390812|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
148975285|NCT01573624|537390813|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
148975286|NCT01573624|537390814|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
148975287|NCT01573624|537390808|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
148975288|NCT01573624|537390809|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
148975289|NCT01573624|537390810|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
148975290|NCT01573624|537390811|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
148975291|NCT01573624|537390812|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
148975292|NCT01573624|537390813|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
148975293|NCT01573624|537390814|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
148975294|NCT01573624|537390808|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
148975295|NCT01573624|537390809|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
148975296|NCT01573624|537390810|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
148975297|NCT01573624|537390811|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
148975298|NCT01573624|537390812|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
148975299|NCT01573624|537390813|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
148975300|NCT01573624|537390814|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
148975301|NCT01573624|537390808|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148975302|NCT01573624|537390809|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148975303|NCT01573624|537390810|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148975304|NCT01573624|537390811|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148975305|NCT01573624|537390812|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148975306|NCT01573624|537390813|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
148975307|NCT01573624|537390814|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148975308|NCT01573624|537390808|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
148738886|NCT00390221|536514832|FG002|Overall Study|Adverse Event|3|||
148738887|NCT00390221|536514830|FG000|Overall Study|Investigator Decision|0|||
148738888|NCT00390221|536514831|FG001|Overall Study|Investigator Decision|0|||
148738889|NCT00390221|536514832|FG002|Overall Study|Investigator Decision|1|||
148738890|NCT00390221|536514830|FG000|Overall Study|Withdrawal by Subject|13|||
148738891|NCT00390221|536514831|FG001|Overall Study|Withdrawal by Subject|9|||
148738892|NCT00390221|536514832|FG002|Overall Study|Withdrawal by Subject|7|||
148738893|NCT00390221|536514830|FG000|Overall Study|Subject Non-compliance|1|||
148738894|NCT00390221|536514831|FG001|Overall Study|Subject Non-compliance|0|||
148738895|NCT00390221|536514832|FG002|Overall Study|Subject Non-compliance|2|||
148738896|NCT00390221|536514830|FG000|Overall Study|Other|3|||
148738897|NCT00390221|536514831|FG001|Overall Study|Other|4|||
148738898|NCT00390221|536514832|FG002|Overall Study|Other|2|||
148738899|NCT01565850|536514835|FG000|Overall Study|Adverse Event|0|||
148738900|NCT01565850|536514836|FG001|Overall Study|Adverse Event|1|||
148738901|NCT01565850|536514835|FG000|Overall Study|Lost to Follow-up|12|||
148738902|NCT01565850|536514836|FG001|Overall Study|Lost to Follow-up|4|||
148738903|NCT01565850|536514835|FG000|Overall Study|Investigator's Discretion|2|||
148738904|NCT01565850|536514836|FG001|Overall Study|Investigator's Discretion|1|||
148738905|NCT01565850|536514835|FG000|Overall Study|Participant noncompliance|2|||
148738906|NCT01565850|536514836|FG001|Overall Study|Participant noncompliance|0|||
148738907|NCT01565850|536514835|FG000|Overall Study|Withdrew Consent|4|||
148738908|NCT01565850|536514836|FG001|Overall Study|Withdrew Consent|2|||
148738909|NCT03510598|536516893|FG000|Overall Study|Withdrawal by Subject|1|||
148738910|NCT04240392|536516895|FG000|Overall Study|Withdrawal by Subject|13|||
148738911|NCT04240392|536516896|FG001|Overall Study|Withdrawal by Subject|4|||
148738912|NCT04240392|536516895|FG000|Overall Study|Lost to Follow-up|11|||
148738913|NCT04240392|536516896|FG001|Overall Study|Lost to Follow-up|12|||
148738914|NCT00191113|536516897|FG000|Core Study|Withdrawal by Subject|25|||
148738915|NCT00191113|536516898|FG001|Core Study|Withdrawal by Subject|9|||
148738916|NCT00191113|536516897|FG000|Core Study|Protocol Violation|6|||
148738917|NCT00191113|536516898|FG001|Core Study|Protocol Violation|2|||
148738918|NCT00191113|536516897|FG000|Core Study|Lost to Follow-up|3|||
148738919|NCT00191113|536516898|FG001|Core Study|Lost to Follow-up|0|||
148738920|NCT00191113|536516897|FG000|Core Study|Adverse Event|0|||
148975309|NCT01573624|537390809|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
148975310|NCT01573624|537390810|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
148975311|NCT01573624|537390811|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
148975312|NCT01573624|537390812|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
148738921|NCT00191113|536516898|FG001|Core Study|Adverse Event|2|||
148738922|NCT00191113|536516897|FG000|Core Study|Lack of Efficacy|0|||
148738923|NCT00191113|536516898|FG001|Core Study|Lack of Efficacy|2|||
148738924|NCT00191113|536516897|FG000|Core Study|Death|1|||
148738925|NCT00191113|536516898|FG001|Core Study|Death|0|||
148738926|NCT04241315|536516900|FG000|Overall Study|Withdrawal by Subject|0|||
148738927|NCT04241315|536516901|FG001|Overall Study|Withdrawal by Subject|1|||
148738928|NCT03047330|536516902|FG000|Sleep Block 1|Withdrawal by Subject|3|||
148738929|NCT00663026|536516915|FG000|Overall Study|Lost to Follow-up|1|||
148738930|NCT00663026|536516916|FG001|Overall Study|Lost to Follow-up|0|||
148738931|NCT00663026|536516917|FG002|Overall Study|Lost to Follow-up|0|||
148738932|NCT00663026|536516915|FG000|Overall Study|Other|1|||
148738933|NCT00663026|536516916|FG001|Overall Study|Other|2|||
148738934|NCT00663026|536516917|FG002|Overall Study|Other|0|||
148738935|NCT00663026|536516915|FG000|Overall Study|Adverse Event|0|||
148738936|NCT00663026|536516916|FG001|Overall Study|Adverse Event|2|||
148738937|NCT00663026|536516917|FG002|Overall Study|Adverse Event|3|||
148738938|NCT00663026|536516915|FG000|Overall Study|Caregiver Request|0|||
148738939|NCT00663026|536516916|FG001|Overall Study|Caregiver Request|2|||
148738940|NCT00663026|536516917|FG002|Overall Study|Caregiver Request|0|||
148738941|NCT00663026|536516915|FG000|Overall Study|Withdrawal by Subject|0|||
148738942|NCT00663026|536516916|FG001|Overall Study|Withdrawal by Subject|0|||
148738943|NCT00663026|536516917|FG002|Overall Study|Withdrawal by Subject|1|||
148738944|NCT03783039|536516928|FG000|Overall Study|Death|2|||
148738945|NCT03783039|536516929|FG001|Overall Study|Death|1|||
148738946|NCT00918138|536516930|FG000|Overall Study|Subject withdrew consent|1|||
148738947|NCT00918138|536516931|FG001|Overall Study|Subject withdrew consent|1|||
148738948|NCT00918138|536516930|FG000|Overall Study|Death|1|||
148738949|NCT00918138|536516931|FG001|Overall Study|Death|0|||
148738950|NCT03972163|536516932|FG000|Overall Study|Death|0|||
148738951|NCT03972163|536516933|FG001|Overall Study|Death|1|||
148738952|NCT03400943|536516934|FG000|Treatment Period 1|Adverse Event|0|||
148738953|NCT03400943|536516935|FG001|Treatment Period 1|Adverse Event|0|||
148738954|NCT03400943|536516936|FG002|Treatment Period 1|Adverse Event|0|||
148738955|NCT03400943|536516937|FG003|Treatment Period 1|Adverse Event|1|||
148738956|NCT03400943|536516934|FG000|Treatment Period 1|Lost to Follow-up|1|||
148738957|NCT03400943|536516935|FG001|Treatment Period 1|Lost to Follow-up|0|||
148738958|NCT03400943|536516936|FG002|Treatment Period 1|Lost to Follow-up|0|||
148738959|NCT03400943|536516937|FG003|Treatment Period 1|Lost to Follow-up|0|||
148738960|NCT03400943|536516934|FG000|Treatment Period 1|Protocol Violation|0|||
148738961|NCT03400943|536516935|FG001|Treatment Period 1|Protocol Violation|1|||
148738962|NCT03400943|536516936|FG002|Treatment Period 1|Protocol Violation|1|||
148738963|NCT03400943|536516937|FG003|Treatment Period 1|Protocol Violation|0|||
148738964|NCT03400943|536516934|FG000|Treatment Period 1|Study terminated by sponsor|2|||
148738965|NCT03400943|536516935|FG001|Treatment Period 1|Study terminated by sponsor|0|||
148975313|NCT01573624|537390813|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
148975314|NCT01573624|537390814|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
148738966|NCT03400943|536516936|FG002|Treatment Period 1|Study terminated by sponsor|0|||
148738967|NCT03400943|536516937|FG003|Treatment Period 1|Study terminated by sponsor|1|||
148738968|NCT03400943|536516934|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148738969|NCT03400943|536516935|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148738970|NCT03400943|536516936|FG002|Treatment Period 1|Withdrawal by Subject|3|||
148738971|NCT03400943|536516937|FG003|Treatment Period 1|Withdrawal by Subject|1|||
148738972|NCT03400943|536516934|FG000|Treatment Period 1|Other|2|||
148738973|NCT03400943|536516935|FG001|Treatment Period 1|Other|1|||
148738974|NCT03400943|536516936|FG002|Treatment Period 1|Other|2|||
148738975|NCT03400943|536516937|FG003|Treatment Period 1|Other|2|||
148738976|NCT03400943|536516934|FG000|Post-treatment Period 1|Adverse Event|2|||
148738977|NCT03400943|536516935|FG001|Post-treatment Period 1|Adverse Event|0|||
148738978|NCT03400943|536516936|FG002|Post-treatment Period 1|Adverse Event|0|||
148738979|NCT03400943|536516937|FG003|Post-treatment Period 1|Adverse Event|0|||
148738980|NCT03400943|536516934|FG000|Post-treatment Period 1|Protocol Violation|1|||
148738981|NCT03400943|536516935|FG001|Post-treatment Period 1|Protocol Violation|0|||
148738982|NCT03400943|536516936|FG002|Post-treatment Period 1|Protocol Violation|0|||
148738983|NCT03400943|536516937|FG003|Post-treatment Period 1|Protocol Violation|0|||
148738984|NCT03400943|536516934|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
148738985|NCT03400943|536516935|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
148738986|NCT03400943|536516936|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
148738987|NCT03400943|536516937|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
148738988|NCT03400943|536516934|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
148738989|NCT03400943|536516935|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
148738990|NCT03400943|536516936|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
148738991|NCT03400943|536516937|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
148738992|NCT03400943|536516934|FG000|Post-treatment Period 1|Other|2|||
148738993|NCT03400943|536516935|FG001|Post-treatment Period 1|Other|0|||
148738994|NCT03400943|536516936|FG002|Post-treatment Period 1|Other|4|||
148738995|NCT03400943|536516937|FG003|Post-treatment Period 1|Other|5|||
148738996|NCT03400943|536516934|FG000|Treatment Period 2|Study terminated by sponsor|0|||
148738997|NCT03400943|536516935|FG001|Treatment Period 2|Study terminated by sponsor|1|||
148738998|NCT03400943|536516936|FG002|Treatment Period 2|Study terminated by sponsor|0|||
148738999|NCT03400943|536516937|FG003|Treatment Period 2|Study terminated by sponsor|0|||
148739000|NCT03400943|536516934|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148739001|NCT03400943|536516935|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148739002|NCT03400943|536516936|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148739003|NCT03400943|536516937|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148739004|NCT03400943|536516934|FG000|Treatment Period 2|Other|1|||
148739005|NCT03400943|536516935|FG001|Treatment Period 2|Other|6|||
148739006|NCT03400943|536516936|FG002|Treatment Period 2|Other|0|||
148739007|NCT03400943|536516937|FG003|Treatment Period 2|Other|0|||
148739008|NCT03400943|536516934|FG000|Follow-up Period|Withdrawal by Subject|1|||
148739009|NCT03400943|536516935|FG001|Follow-up Period|Withdrawal by Subject|0|||
148739010|NCT03400943|536516936|FG002|Follow-up Period|Withdrawal by Subject|0|||
148739011|NCT03400943|536516937|FG003|Follow-up Period|Withdrawal by Subject|0|||
148739012|NCT03839823|536516938|FG000|Overall Study|Adverse Event|8|||
148739013|NCT03839823|536516939|FG001|Overall Study|Adverse Event|4|||
148739014|NCT03839823|536516938|FG000|Overall Study|Death|1|||
148739015|NCT03839823|536516939|FG001|Overall Study|Death|0|||
148739016|NCT03839823|536516938|FG000|Overall Study|Physician Decision|1|||
148739017|NCT03839823|536516939|FG001|Overall Study|Physician Decision|5|||
148739018|NCT03839823|536516938|FG000|Overall Study|Progressive Disease (PD)|65|||
148739019|NCT03839823|536516939|FG001|Overall Study|Progressive Disease (PD)|65|||
148739020|NCT03839823|536516938|FG000|Overall Study|Subject Decision|2|||
148739021|NCT03839823|536516939|FG001|Overall Study|Subject Decision|9|||
148739022|NCT03839823|536516938|FG000|Overall Study|Not Treated|0|||
148739023|NCT03839823|536516939|FG001|Overall Study|Not Treated|10|||
148739024|NCT03327792|536516940|FG000|Overall Study|Adverse Event|4|||
148739025|NCT03327792|536516941|FG001|Overall Study|Adverse Event|0|||
148739026|NCT03327792|536516940|FG000|Overall Study|Family/Personal issues|3|||
148739027|NCT03327792|536516941|FG001|Overall Study|Family/Personal issues|2|||
148739028|NCT03327792|536516940|FG000|Overall Study|Lost to Follow-up|0|||
148739029|NCT03327792|536516941|FG001|Overall Study|Lost to Follow-up|1|||
148739030|NCT03511326|536516942|FG000|Overall Study|Withdrawal by Subject|1|||
148739031|NCT01305044|536516945|FG000|Overall Study|Withdrawal by Subject|3|||
148739032|NCT01305044|536516946|FG001|Overall Study|Withdrawal by Subject|6|||
148739033|NCT00849186|536516949|FG000|Overall Study|Adverse Event|2|||
148739034|NCT00849186|536516949|FG000|Overall Study|Withdrawal by Subject|1|||
148739035|NCT00849186|536516949|FG000|Overall Study|not treated|6|||
148739036|NCT00849186|536516949|FG000|Overall Study|Other|1|||
148739037|NCT00492024|536516952|FG000|Treatment|Adverse Event|3|||
148739038|NCT00492024|536516953|FG001|Treatment|Adverse Event|1|||
148739039|NCT00492024|536516952|FG000|Treatment|Lack of Efficacy|21|||
148739040|NCT00492024|536516953|FG001|Treatment|Lack of Efficacy|20|||
148739041|NCT00492024|536516952|FG000|Treatment|Lost to Follow-up|3|||
148739042|NCT00492024|536516953|FG001|Treatment|Lost to Follow-up|1|||
148739043|NCT00492024|536516952|FG000|Treatment|Withdrawal by Subject|2|||
148739044|NCT00492024|536516953|FG001|Treatment|Withdrawal by Subject|0|||
148739045|NCT00492024|536516952|FG000|Follow up|Lack of Efficacy|0|||
148739046|NCT00492024|536516953|FG001|Follow up|Lack of Efficacy|1|||
148739047|NCT00492024|536516952|FG000|Follow up|Lost to Follow-up|1|||
148739048|NCT00492024|536516953|FG001|Follow up|Lost to Follow-up|1|||
148739049|NCT00867503|536516960|FG000|Overall Study|Withdrawal by Subject|1|||
148739050|NCT02704403|536516961|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
148739051|NCT02704403|536516962|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
148739052|NCT02704403|536516961|FG000|Overall Study|Administrative reasons by sponsor|1251|||
148739053|NCT02704403|536516962|FG001|Overall Study|Administrative reasons by sponsor|616|||
148739054|NCT02704403|536516961|FG000|Overall Study|Death|4|||
148739055|NCT02704403|536516962|FG001|Overall Study|Death|3|||
148739056|NCT02704403|536516961|FG000|Overall Study|Endpoint event|52|||
148739057|NCT02704403|536516962|FG001|Overall Study|Endpoint event|24|||
148739058|NCT02704403|536516961|FG000|Overall Study|Lost to Follow-up|22|||
148739059|NCT02704403|536516962|FG001|Overall Study|Lost to Follow-up|11|||
148739060|NCT02704403|536516961|FG000|Overall Study|Protocol Violation|15|||
148739061|NCT02704403|536516962|FG001|Overall Study|Protocol Violation|15|||
148739062|NCT02704403|536516961|FG000|Overall Study|Adverse Event|2|||
148739063|NCT02704403|536516962|FG001|Overall Study|Adverse Event|0|||
148739064|NCT02704403|536516961|FG000|Overall Study|Withdrawal by Subject|85|||
148739065|NCT02704403|536516962|FG001|Overall Study|Withdrawal by Subject|45|||
148739066|NCT02704403|536516961|FG000|Overall Study|Investigator decision|1|||
148739067|NCT02704403|536516962|FG001|Overall Study|Investigator decision|1|||
148739068|NCT02704403|536516961|FG000|Overall Study|Follow-up not possible|1|||
148739069|NCT02704403|536516962|FG001|Overall Study|Follow-up not possible|2|||
148739070|NCT01001988|536516971|FG000|Overall Study|Protocol Violation|84|||
148739071|NCT01001988|536516971|FG000|Overall Study|Withdrawal by Subject|18|||
148739072|NCT01001988|536516971|FG000|Overall Study|Lost to Follow-up|15|||
148739073|NCT01844856|536516972|FG000|Overall Study|Lost to Follow-up|15|||
148739074|NCT01844856|536516973|FG001|Overall Study|Lost to Follow-up|3|||
148739075|NCT01844856|536516972|FG000|Overall Study|Adverse Event|3|||
148739076|NCT01844856|536516973|FG001|Overall Study|Adverse Event|6|||
148739077|NCT01844856|536516972|FG000|Overall Study|Withdrawal by Subject|3|||
148739078|NCT01844856|536516973|FG001|Overall Study|Withdrawal by Subject|2|||
148739079|NCT01844856|536516972|FG000|Overall Study|Noncompliance|2|||
148739080|NCT01844856|536516973|FG001|Overall Study|Noncompliance|3|||
148739081|NCT01844856|536516972|FG000|Overall Study|Enterococcus Resistant|0|||
148739082|NCT01844856|536516973|FG001|Overall Study|Enterococcus Resistant|1|||
148739083|NCT01844856|536516972|FG000|Overall Study|Inadvertently Not Scheduled|1|||
148739084|NCT01844856|536516973|FG001|Overall Study|Inadvertently Not Scheduled|0|||
148739085|NCT01844856|536516972|FG000|Overall Study|Randomized but was a Screen Failure|0|||
148739086|NCT01844856|536516973|FG001|Overall Study|Randomized but was a Screen Failure|1|||
148739087|NCT00927394|536516976|FG000|Overall Study|Adverse Event|14|||
148739088|NCT00927394|536516977|FG001|Overall Study|Adverse Event|9|||
148739089|NCT00927394|536516976|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
148739090|NCT00927394|536516977|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
148739091|NCT00927394|536516976|FG000|Overall Study|Withdrawal by Subject|20|||
148739092|NCT00927394|536516977|FG001|Overall Study|Withdrawal by Subject|24|||
148739093|NCT00927394|536516976|FG000|Overall Study|Lost to Follow-up|8|||
148739094|NCT00927394|536516977|FG001|Overall Study|Lost to Follow-up|14|||
148739095|NCT00927394|536516976|FG000|Overall Study|Administrative Problem|1|||
148739096|NCT00927394|536516977|FG001|Overall Study|Administrative Problem|0|||
148739097|NCT00927394|536516976|FG000|Overall Study|Death|1|||
148739098|NCT00927394|536516977|FG001|Overall Study|Death|1|||
148739099|NCT00927394|536516976|FG000|Overall Study|Protocol deviation|16|||
148739100|NCT00927394|536516977|FG001|Overall Study|Protocol deviation|13|||
148739101|NCT00927394|536516976|FG000|Overall Study|Randomized in error|0|||
148739102|NCT00927394|536516977|FG001|Overall Study|Randomized in error|1|||
148739103|NCT01221363|536516978|FG000|Overall Study|Pregnancy|1|||
148739104|NCT01221363|536516979|FG001|Overall Study|Pregnancy|0|||
148739105|NCT01221363|536516978|FG000|Overall Study|Withdrawal by Subject|11|||
148739106|NCT01221363|536516979|FG001|Overall Study|Withdrawal by Subject|5|||
148739107|NCT04628793|536516980|FG000|Overall Study|Study terminated by sponsor|0|||
148739108|NCT04628793|536516981|FG001|Overall Study|Study terminated by sponsor|0|||
148739109|NCT04628793|536516982|FG002|Overall Study|Study terminated by sponsor|8|||
148739110|NCT04628793|536516980|FG000|Overall Study|Withdrawal by Subject|2|||
148739111|NCT04628793|536516981|FG001|Overall Study|Withdrawal by Subject|3|||
148739112|NCT04628793|536516982|FG002|Overall Study|Withdrawal by Subject|0|||
148739113|NCT04628793|536516980|FG000|Overall Study|Lost to Follow-up|0|||
148739114|NCT04628793|536516981|FG001|Overall Study|Lost to Follow-up|1|||
148739115|NCT04628793|536516982|FG002|Overall Study|Lost to Follow-up|0|||
148739116|NCT01329549|536516986|FG000|Overall Study|Withdrawal by Subject|1|||
148739117|NCT01329549|536516986|FG000|Overall Study|Adverse Event|1|||
148739118|NCT02309138|536516987|FG000|Overall Study|Withdrawal by Subject|44|||
148739119|NCT02309138|536516988|FG001|Overall Study|Withdrawal by Subject|15|||
148739120|NCT02309138|536516987|FG000|Overall Study|Protocol Violation|4|||
148739121|NCT02309138|536516988|FG001|Overall Study|Protocol Violation|2|||
148739122|NCT02309138|536516987|FG000|Overall Study|delivered before visit 2|0|||
148739123|NCT02309138|536516988|FG001|Overall Study|delivered before visit 2|1|||
148739124|NCT03421730|536516989|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739125|NCT03421730|536516990|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
148739126|NCT03421730|536516991|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148818350|NCT02070991|536810377|FG001|Overall Study|Withdrawal by Subject|0|||
148739127|NCT03421730|536516992|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739128|NCT03421730|536516993|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739129|NCT03421730|536516994|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739130|NCT03421730|536516995|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739131|NCT03421730|536516996|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739132|NCT03421730|536516997|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148975315|NCT01573624|537390808|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
148739133|NCT03421730|536516998|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739134|NCT03421730|536516999|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739135|NCT03421730|536517000|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
148739136|NCT03421730|536516989|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739137|NCT03421730|536516990|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739138|NCT03421730|536516991|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739139|NCT03421730|536516992|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739140|NCT03421730|536516993|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
148739141|NCT03421730|536516994|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739142|NCT03421730|536516995|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739143|NCT03421730|536516996|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739144|NCT03421730|536516997|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739145|NCT03421730|536516998|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739146|NCT03421730|536516999|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739147|NCT03421730|536517000|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
148739148|NCT01955083|536517001|FG000|Overall Study|Lost to Follow-up|1|||
148739149|NCT01955083|536517002|FG001|Overall Study|Lost to Follow-up|1|||
148739150|NCT01559389|536517011|FG000|Overall Study|Withdrawal by Subject|20|||
148739151|NCT01559389|536517012|FG001|Overall Study|Withdrawal by Subject|20|||
148739152|NCT02871492|536517013|FG000|Overall Study|Lost to Follow-up|6|||
148739153|NCT02871492|536517014|FG001|Overall Study|Lost to Follow-up|3|||
148739154|NCT02871492|536517015|FG002|Overall Study|Lost to Follow-up|5|||
148739155|NCT02871492|536517013|FG000|Overall Study|Withdrawal by Subject|0|||
148739156|NCT02871492|536517014|FG001|Overall Study|Withdrawal by Subject|0|||
148739157|NCT02871492|536517015|FG002|Overall Study|Withdrawal by Subject|1|||
148739158|NCT04546724|536517016|FG000|Overall Study|Withdrawal by Subject|145|||
148739159|NCT04546724|536517017|FG001|Overall Study|Withdrawal by Subject|41|||
148739160|NCT04546724|536517016|FG000|Overall Study|Adverse Event|1|||
148739161|NCT04546724|536517017|FG001|Overall Study|Adverse Event|1|||
148739162|NCT04546724|536517016|FG000|Overall Study|Lost to Follow-up|186|||
148739163|NCT04546724|536517017|FG001|Overall Study|Lost to Follow-up|63|||
148739164|NCT04546724|536517016|FG000|Overall Study|Physician Decision|8|||
148739165|NCT04546724|536517017|FG001|Overall Study|Physician Decision|2|||
148739166|NCT04546724|536517016|FG000|Overall Study|Death|2|||
148739167|NCT04546724|536517017|FG001|Overall Study|Death|1|||
148739168|NCT04546724|536517016|FG000|Overall Study|subject has been out of town|1|||
148739169|NCT04546724|536517017|FG001|Overall Study|subject has been out of town|0|||
148739170|NCT04546724|536517016|FG000|Overall Study|subject is incarcerated|2|||
148739171|NCT04546724|536517017|FG001|Overall Study|subject is incarcerated|0|||
148739172|NCT04546724|536517016|FG000|Overall Study|subject is relocating|12|||
148739173|NCT04546724|536517017|FG001|Overall Study|subject is relocating|4|||
148739174|NCT04546724|536517016|FG000|Overall Study|Subject in another study|1|||
148739175|NCT04546724|536517017|FG001|Overall Study|Subject in another study|1|||
148739176|NCT03583086|536517018|FG000|Overall Study|Death|2|||
148739177|NCT03583086|536517019|FG001|Overall Study|Death|6|||
148739178|NCT03583086|536517020|FG002|Overall Study|Death|12|||
148739179|NCT03583086|536517021|FG003|Overall Study|Death|10|||
148739180|NCT03583086|536517022|FG004|Overall Study|Death|14|||
148739181|NCT03583086|536517023|FG005|Overall Study|Death|14|||
148739182|NCT03583086|536517024|FG006|Overall Study|Death|4|||
148739183|NCT03583086|536517018|FG000|Overall Study|Withdrawal by Subject|0|||
148739184|NCT03583086|536517019|FG001|Overall Study|Withdrawal by Subject|0|||
148739185|NCT03583086|536517020|FG002|Overall Study|Withdrawal by Subject|1|||
148739186|NCT03583086|536517021|FG003|Overall Study|Withdrawal by Subject|0|||
148739187|NCT03583086|536517022|FG004|Overall Study|Withdrawal by Subject|0|||
148975316|NCT01573624|537390809|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
148975317|NCT01573624|537390810|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
148975318|NCT01573624|537390811|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
148739188|NCT03583086|536517023|FG005|Overall Study|Withdrawal by Subject|0|||
148739189|NCT03583086|536517024|FG006|Overall Study|Withdrawal by Subject|1|||
148739190|NCT03583086|536517018|FG000|Overall Study|Refused follow-up|0|||
148739191|NCT03583086|536517019|FG001|Overall Study|Refused follow-up|0|||
148739192|NCT03583086|536517020|FG002|Overall Study|Refused follow-up|1|||
148739193|NCT03583086|536517021|FG003|Overall Study|Refused follow-up|0|||
148739194|NCT03583086|536517022|FG004|Overall Study|Refused follow-up|1|||
148739195|NCT03583086|536517023|FG005|Overall Study|Refused follow-up|0|||
148739196|NCT03583086|536517024|FG006|Overall Study|Refused follow-up|0|||
148739197|NCT03583086|536517018|FG000|Overall Study|Declining Performance Status|0|||
148739198|NCT03583086|536517019|FG001|Overall Study|Declining Performance Status|0|||
148739199|NCT03583086|536517020|FG002|Overall Study|Declining Performance Status|1|||
148739200|NCT03583086|536517021|FG003|Overall Study|Declining Performance Status|0|||
148739201|NCT03583086|536517022|FG004|Overall Study|Declining Performance Status|0|||
148818351|NCT02448043|536810380|FG000|Overall Study|Withdrawal by Subject|2|||
148818352|NCT02448043|536810381|FG001|Overall Study|Withdrawal by Subject|2|||
148818353|NCT02448043|536810380|FG000|Overall Study|Protocol Violation|1|||
148818354|NCT02448043|536810381|FG001|Overall Study|Protocol Violation|2|||
148818355|NCT04149353|536810390|FG000|Overall Study|Study terminated|1|||
148818356|NCT02068599|536810391|FG000|Overall Study|Adverse Event|4|||
148818357|NCT02068599|536810392|FG001|Overall Study|Adverse Event|1|||
148818358|NCT02068599|536810393|FG002|Overall Study|Adverse Event|1|||
148818359|NCT02068599|536810391|FG000|Overall Study|Withdrawal by Subject|2|||
148818360|NCT02068599|536810392|FG001|Overall Study|Withdrawal by Subject|7|||
148818361|NCT02068599|536810393|FG002|Overall Study|Withdrawal by Subject|5|||
148818362|NCT02068599|536810391|FG000|Overall Study|Protocol Violation|4|||
148818363|NCT02068599|536810392|FG001|Overall Study|Protocol Violation|2|||
148818364|NCT02068599|536810393|FG002|Overall Study|Protocol Violation|3|||
148818365|NCT02068599|536810391|FG000|Overall Study|Lost to Follow-up|1|||
148818366|NCT02068599|536810392|FG001|Overall Study|Lost to Follow-up|0|||
148818367|NCT02068599|536810393|FG002|Overall Study|Lost to Follow-up|0|||
148818368|NCT02068599|536810391|FG000|Overall Study|Lack of Efficacy|0|||
148818369|NCT02068599|536810392|FG001|Overall Study|Lack of Efficacy|0|||
148818370|NCT02068599|536810393|FG002|Overall Study|Lack of Efficacy|3|||
148818371|NCT02068599|536810391|FG000|Overall Study|Noncompliance|0|||
148818372|NCT02068599|536810392|FG001|Overall Study|Noncompliance|0|||
148818373|NCT02068599|536810393|FG002|Overall Study|Noncompliance|1|||
148818374|NCT02958527|536810396|FG000|Overall Study|Not collected CRFs|12|||
148818375|NCT02691572|536810397|FG000|Overall Study|Withdrawal by Subject|1|||
148818376|NCT02691572|536810398|FG001|Overall Study|Withdrawal by Subject|0|||
148818377|NCT02691572|536810397|FG000|Overall Study|Protocol Violation|0|||
148818378|NCT02691572|536810398|FG001|Overall Study|Protocol Violation|1|||
148818379|NCT00699751|536810399|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
148818380|NCT00699751|536810400|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
148818381|NCT00699751|536810399|FG000|Period 1: Without/Before Drug Switch|Death|28|||
148818382|NCT00699751|536810400|FG001|Period 1: Without/Before Drug Switch|Death|29|||
148818383|NCT00699751|536810399|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
148818384|NCT00699751|536810400|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
148818385|NCT00699751|536810399|FG000|Period 1: Without/Before Drug Switch|Other|30|||
148818386|NCT00699751|536810400|FG001|Period 1: Without/Before Drug Switch|Other|20|||
148818387|NCT00699751|536810399|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
148739202|NCT03583086|536517023|FG005|Overall Study|Declining Performance Status|0|||
148739203|NCT03583086|536517024|FG006|Overall Study|Declining Performance Status|0|||
148739204|NCT03583086|536517018|FG000|Overall Study|Still on study|0|||
148739205|NCT03583086|536517019|FG001|Overall Study|Still on study|0|||
148739206|NCT03583086|536517020|FG002|Overall Study|Still on study|0|||
148739207|NCT03583086|536517021|FG003|Overall Study|Still on study|1|||
148739208|NCT03583086|536517022|FG004|Overall Study|Still on study|0|||
148818388|NCT00699751|536810400|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
148818389|NCT00699751|536810399|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
148818390|NCT00699751|536810400|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
148818391|NCT00699751|536810399|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
148818392|NCT00699751|536810400|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
148818393|NCT00699751|536810399|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
148818394|NCT00699751|536810400|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
148818395|NCT01947933|536810401|FG000|Overall Study|Withdrawal by Subject|0|||
148818396|NCT01947933|536810402|FG001|Overall Study|Withdrawal by Subject|0|||
148818397|NCT01947933|536810403|FG002|Overall Study|Withdrawal by Subject|1|||
148818398|NCT01947933|536810404|FG003|Overall Study|Withdrawal by Subject|0|||
148818399|NCT01947933|536810405|FG004|Overall Study|Withdrawal by Subject|0|||
148818400|NCT01947933|536810406|FG005|Overall Study|Withdrawal by Subject|0|||
148818401|NCT01947933|536810407|FG006|Overall Study|Withdrawal by Subject|0|||
148818402|NCT01947933|536810408|FG007|Overall Study|Withdrawal by Subject|0|||
148818403|NCT01947933|536810409|FG008|Overall Study|Withdrawal by Subject|0|||
148818404|NCT01947933|536810401|FG000|Overall Study|Lost to Follow-up|0|||
148818405|NCT01947933|536810402|FG001|Overall Study|Lost to Follow-up|0|||
148818406|NCT01947933|536810403|FG002|Overall Study|Lost to Follow-up|0|||
148818407|NCT01947933|536810404|FG003|Overall Study|Lost to Follow-up|0|||
148818408|NCT01947933|536810405|FG004|Overall Study|Lost to Follow-up|0|||
148818409|NCT01947933|536810406|FG005|Overall Study|Lost to Follow-up|0|||
148818410|NCT01947933|536810407|FG006|Overall Study|Lost to Follow-up|0|||
148818411|NCT01947933|536810408|FG007|Overall Study|Lost to Follow-up|0|||
148818412|NCT01947933|536810409|FG008|Overall Study|Lost to Follow-up|1|||
148739209|NCT03583086|536517023|FG005|Overall Study|Still on study|0|||
148739210|NCT03583086|536517024|FG006|Overall Study|Still on study|1|||
148739211|NCT03583086|536517018|FG000|Overall Study|Disease progression|0|||
148739212|NCT03583086|536517019|FG001|Overall Study|Disease progression|0|||
148818413|NCT00294398|536810410|FG000|Overall Study|Lost to Follow-up|21|||
148818414|NCT00294398|536810411|FG001|Overall Study|Lost to Follow-up|26|||
148818415|NCT00985790|536810412|FG000|Overall Study|Withdrawal by Subject|1|||
148739213|NCT03583086|536517020|FG002|Overall Study|Disease progression|0|||
148739214|NCT03583086|536517021|FG003|Overall Study|Disease progression|0|||
148739215|NCT03583086|536517022|FG004|Overall Study|Disease progression|0|||
148739216|NCT03583086|536517023|FG005|Overall Study|Disease progression|0|||
148739217|NCT03583086|536517024|FG006|Overall Study|Disease progression|1|||
148739218|NCT03583086|536517018|FG000|Overall Study|Undergoing radiation therapy|0|||
148739219|NCT03583086|536517019|FG001|Overall Study|Undergoing radiation therapy|0|||
148975319|NCT01573624|537390812|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
148975320|NCT01573624|537390813|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
148975321|NCT01573624|537390814|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
148975322|NCT01573624|537390808|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
148975323|NCT01573624|537390809|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
148975324|NCT01573624|537390810|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
148975325|NCT01573624|537390811|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
148975326|NCT01573624|537390812|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
148975327|NCT01573624|537390813|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
148975328|NCT01573624|537390814|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
148975329|NCT01573624|537390808|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
148975330|NCT01573624|537390809|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148975331|NCT01573624|537390810|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
148975332|NCT01573624|537390811|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
148975333|NCT01573624|537390812|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148975334|NCT01573624|537390813|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148739220|NCT03583086|536517020|FG002|Overall Study|Undergoing radiation therapy|0|||
148739221|NCT03583086|536517021|FG003|Overall Study|Undergoing radiation therapy|0|||
148739222|NCT03583086|536517022|FG004|Overall Study|Undergoing radiation therapy|0|||
148739223|NCT03583086|536517023|FG005|Overall Study|Undergoing radiation therapy|0|||
148739224|NCT03583086|536517024|FG006|Overall Study|Undergoing radiation therapy|1|||
148739225|NCT03583086|536517018|FG000|Overall Study|Lost to Follow-up|0|||
148739226|NCT03583086|536517019|FG001|Overall Study|Lost to Follow-up|0|||
148739227|NCT03583086|536517020|FG002|Overall Study|Lost to Follow-up|0|||
148739228|NCT03583086|536517021|FG003|Overall Study|Lost to Follow-up|0|||
148739229|NCT03583086|536517022|FG004|Overall Study|Lost to Follow-up|0|||
148739230|NCT03583086|536517023|FG005|Overall Study|Lost to Follow-up|1|||
148739231|NCT03583086|536517024|FG006|Overall Study|Lost to Follow-up|0|||
148739232|NCT03583086|536517018|FG000|Overall Study|Adverse Event|0|||
148739233|NCT03583086|536517019|FG001|Overall Study|Adverse Event|0|||
148739234|NCT03583086|536517020|FG002|Overall Study|Adverse Event|0|||
148739235|NCT03583086|536517021|FG003|Overall Study|Adverse Event|0|||
148739236|NCT03583086|536517022|FG004|Overall Study|Adverse Event|0|||
148739237|NCT03583086|536517023|FG005|Overall Study|Adverse Event|1|||
148739238|NCT03583086|536517024|FG006|Overall Study|Adverse Event|0|||
148739239|NCT00396812|536517028|FG000|Overall Study|Physician Decision|1|||
148739240|NCT03201445|536517030|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
148739241|NCT03201445|536517031|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
148739242|NCT03201445|536517030|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
148739243|NCT03201445|536517031|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
148739244|NCT03201445|536517030|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
148739245|NCT03201445|536517031|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
148739246|NCT03201445|536517030|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
148739247|NCT03201445|536517031|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
148739248|NCT03201445|536517030|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
148739249|NCT03201445|536517031|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
148739250|NCT03201445|536517030|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
148739251|NCT03201445|536517031|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
148739252|NCT03201445|536517030|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
148739253|NCT03201445|536517031|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
148975335|NCT01573624|537390814|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
148739254|NCT03201445|536517030|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
148739255|NCT03201445|536517031|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
148739256|NCT03201445|536517030|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
148739257|NCT03201445|536517031|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
148739258|NCT03201445|536517030|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
148739259|NCT03201445|536517031|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
148739260|NCT03201445|536517030|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
148739261|NCT03201445|536517031|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
148739262|NCT03201445|536517030|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
148739263|NCT03201445|536517031|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
148739264|NCT03201445|536517030|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
148739265|NCT03201445|536517031|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
148739266|NCT03201445|536517030|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
148739267|NCT03201445|536517031|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
148739268|NCT03201445|536517030|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
148739269|NCT03201445|536517031|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
148739270|NCT03201445|536517030|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
148739271|NCT03201445|536517031|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
148739272|NCT03201445|536517030|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
148739273|NCT03201445|536517031|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
148739274|NCT03201445|536517030|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
148739275|NCT03201445|536517031|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
148739276|NCT03201445|536517030|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
148739277|NCT03201445|536517031|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
148739278|NCT03201445|536517030|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
148739279|NCT03201445|536517031|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
148739280|NCT03201445|536517030|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
148739281|NCT03201445|536517031|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
148739282|NCT01346293|536517034|FG000|Overall Study|Protocol Violation|30|||
148739283|NCT01346293|536517035|FG001|Overall Study|Protocol Violation|9|||
148739284|NCT01346293|536517034|FG000|Overall Study|Lost to Follow-up|21|||
148739285|NCT01346293|536517035|FG001|Overall Study|Lost to Follow-up|8|||
148739286|NCT01346293|536517034|FG000|Overall Study|Withdrawal by Subject|15|||
148739287|NCT01346293|536517035|FG001|Overall Study|Withdrawal by Subject|4|||
148739288|NCT01346293|536517034|FG000|Overall Study|Other|1|||
148739289|NCT01346293|536517035|FG001|Overall Study|Other|0|||
148739290|NCT00838435|536517038|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
148739291|NCT00838435|536517038|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
148739292|NCT00838435|536517038|FG000|Part 2 (7 Years)|Adverse Event|2|||
148739293|NCT00838435|536517038|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
148739294|NCT00838435|536517038|FG000|Part 2 (7 Years)|Physician Decision|1|||
148739295|NCT00838435|536517038|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
148739296|NCT00838435|536517038|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
148739297|NCT01341782|536517039|FG000|Overall Study|Adverse Event|1|||
148739298|NCT01341782|536517040|FG001|Overall Study|Adverse Event|1|||
148739299|NCT01341782|536517039|FG000|Overall Study|Withdrawal by Subject|6|||
148739300|NCT01341782|536517040|FG001|Overall Study|Withdrawal by Subject|5|||
148739301|NCT01341782|536517039|FG000|Overall Study|Missed 3 consecutive doses|0|||
148739302|NCT01341782|536517040|FG001|Overall Study|Missed 3 consecutive doses|4|||
148739303|NCT01341782|536517039|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
148739304|NCT01341782|536517040|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
148739305|NCT01341782|536517039|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
148739306|NCT01341782|536517040|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
148739307|NCT01341782|536517039|FG000|Overall Study|Other|5|||
148739308|NCT01341782|536517040|FG001|Overall Study|Other|0|||
148739309|NCT02036775|536517041|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
148739310|NCT02036775|536517042|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
148739311|NCT02036775|536517043|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
148739312|NCT02036775|536517044|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
148739313|NCT02036775|536517045|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
148739314|NCT02036775|536517046|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
148739315|NCT02329847|536517053|FG000|Overall Study|Death|4|||
148739316|NCT02329847|536517054|FG001|Overall Study|Death|4|||
148739317|NCT02329847|536517055|FG002|Overall Study|Death|22|||
148739318|NCT02329847|536517056|FG003|Overall Study|Death|12|||
148739319|NCT02329847|536517057|FG004|Overall Study|Death|20|||
148739320|NCT02329847|536517058|FG005|Overall Study|Death|13|||
148739321|NCT02329847|536517053|FG000|Overall Study|Lost to Follow-up|0|||
148739322|NCT02329847|536517054|FG001|Overall Study|Lost to Follow-up|0|||
148739323|NCT02329847|536517055|FG002|Overall Study|Lost to Follow-up|2|||
148739324|NCT02329847|536517056|FG003|Overall Study|Lost to Follow-up|3|||
148739325|NCT02329847|536517057|FG004|Overall Study|Lost to Follow-up|0|||
148739326|NCT02329847|536517058|FG005|Overall Study|Lost to Follow-up|1|||
148739327|NCT02329847|536517053|FG000|Overall Study|Physician Decision|0|||
148739328|NCT02329847|536517054|FG001|Overall Study|Physician Decision|0|||
148739329|NCT02329847|536517055|FG002|Overall Study|Physician Decision|0|||
148739330|NCT02329847|536517056|FG003|Overall Study|Physician Decision|0|||
148739331|NCT02329847|536517057|FG004|Overall Study|Physician Decision|1|||
148739332|NCT02329847|536517058|FG005|Overall Study|Physician Decision|0|||
148739333|NCT02329847|536517053|FG000|Overall Study|Withdrawal by Subject|2|||
148739334|NCT02329847|536517054|FG001|Overall Study|Withdrawal by Subject|1|||
148739335|NCT02329847|536517055|FG002|Overall Study|Withdrawal by Subject|5|||
148739336|NCT02329847|536517056|FG003|Overall Study|Withdrawal by Subject|7|||
148739337|NCT02329847|536517057|FG004|Overall Study|Withdrawal by Subject|8|||
148975336|NCT01573624|537390808|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
148975337|NCT01573624|537390809|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
148975338|NCT01573624|537390810|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
148975339|NCT01573624|537390811|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
148975340|NCT01573624|537390812|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
148975341|NCT01573624|537390813|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
148975342|NCT01573624|537390814|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
148975343|NCT01573624|537390808|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148975344|NCT01573624|537390809|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148975345|NCT01573624|537390810|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148975346|NCT01573624|537390811|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
148975347|NCT01573624|537390812|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148975348|NCT01573624|537390813|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
148975349|NCT01573624|537390814|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
148975350|NCT01573624|537390808|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975351|NCT01573624|537390809|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975352|NCT01573624|537390810|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975353|NCT01573624|537390811|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975354|NCT01573624|537390812|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975355|NCT01573624|537390813|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975356|NCT01573624|537390814|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975357|NCT01573624|537390808|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
148975358|NCT01573624|537390809|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
148975359|NCT01573624|537390810|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
148975360|NCT01573624|537390811|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
148975361|NCT01573624|537390812|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
148975362|NCT01573624|537390813|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
148975363|NCT01573624|537390814|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
148975364|NCT01573624|537390808|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
148975365|NCT01573624|537390809|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
148975366|NCT01573624|537390810|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
148975367|NCT01573624|537390811|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
148975368|NCT01573624|537390812|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
148975369|NCT01573624|537390813|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
148975370|NCT01573624|537390814|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
148975371|NCT01573624|537390808|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
148975372|NCT01573624|537390809|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
148975373|NCT01573624|537390810|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
148975374|NCT01573624|537390811|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
148975375|NCT01573624|537390812|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
148975376|NCT01573624|537390813|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
148975377|NCT01573624|537390814|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
148739338|NCT02329847|536517058|FG005|Overall Study|Withdrawal by Subject|3|||
148739339|NCT02329847|536517053|FG000|Overall Study|Other|1|||
148739340|NCT02329847|536517054|FG001|Overall Study|Other|2|||
149027111|NCT03432533|537576493|FG000|Overall Study|Withdrawal by Subject|14|||
149027112|NCT03432533|537576494|FG001|Overall Study|Withdrawal by Subject|9|||
148739341|NCT02329847|536517055|FG002|Overall Study|Other|6|||
148739342|NCT02329847|536517056|FG003|Overall Study|Other|13|||
148739343|NCT02329847|536517057|FG004|Overall Study|Other|10|||
148739344|NCT02329847|536517058|FG005|Overall Study|Other|3|||
148739345|NCT03365011|536517061|FG000|Overall Study|Withdrawal by Subject|1|||
148739346|NCT03365011|536517062|FG001|Overall Study|Withdrawal by Subject|2|||
148739347|NCT03582826|536517063|FG000|Overall Study|Lost to Follow-up|39|||
148739348|NCT03582826|536517064|FG001|Overall Study|Lost to Follow-up|0|||
148739349|NCT03582826|536517063|FG000|Overall Study|Withdrawal by Subject|2|||
148739350|NCT03582826|536517064|FG001|Overall Study|Withdrawal by Subject|0|||
148739351|NCT03155945|536517073|FG000|Overall Study|Lost to Follow-up|0|||
148739352|NCT03155945|536517074|FG001|Overall Study|Lost to Follow-up|1|||
148739353|NCT03155945|536517073|FG000|Overall Study|Withdrawal by Subject|0|||
148739354|NCT03155945|536517074|FG001|Overall Study|Withdrawal by Subject|1|||
148739355|NCT03155945|536517073|FG000|Overall Study|Other Reason|0|||
148739356|NCT03155945|536517074|FG001|Overall Study|Other Reason|1|||
148739357|NCT02013674|536517076|FG000|Overall Study|Death|0|||
148739358|NCT02013674|536517077|FG001|Overall Study|Death|1|||
148739359|NCT02013674|536517076|FG000|Overall Study|Lost to Follow-up|1|||
148739360|NCT02013674|536517077|FG001|Overall Study|Lost to Follow-up|0|||
148739361|NCT03433755|536517081|FG000|Overall Study|Lost to Follow-up|1|||
148739362|NCT03433755|536517082|FG001|Overall Study|Lost to Follow-up|0|||
148739363|NCT03433755|536517083|FG002|Overall Study|Lost to Follow-up|0|||
148739364|NCT03433755|536517084|FG003|Overall Study|Lost to Follow-up|0|||
148739365|NCT03433755|536517081|FG000|Overall Study|Decision by Sponsor|1|||
148739366|NCT03433755|536517082|FG001|Overall Study|Decision by Sponsor|0|||
148739367|NCT03433755|536517083|FG002|Overall Study|Decision by Sponsor|0|||
148739368|NCT03433755|536517084|FG003|Overall Study|Decision by Sponsor|0|||
148739369|NCT05065567|536517088|FG000|Overall Study|Lost to Follow-up|10|||
148739370|NCT05065567|536517089|FG001|Overall Study|Lost to Follow-up|9|||
148739371|NCT05065567|536517090|FG002|Overall Study|Lost to Follow-up|6|||
148739372|NCT03665441|536518830|FG000|Overall Study|survival follow up ongoing|23|||
148739373|NCT03665441|536518831|FG001|Overall Study|survival follow up ongoing|0|||
148739374|NCT03665441|536518830|FG000|Overall Study|Patients ongoing on treatment|9|||
148739375|NCT03665441|536518831|FG001|Overall Study|Patients ongoing on treatment|6|||
148739376|NCT03665441|536518830|FG000|Overall Study|Randomized but not treated|7|||
148739377|NCT03665441|536518831|FG001|Overall Study|Randomized but not treated|11|||
148739378|NCT05307510|536518832|FG000|Overall Study|Lost to Follow-up|3|||
148739379|NCT05307510|536518833|FG001|Overall Study|Lost to Follow-up|6|||
148739380|NCT05307510|536518832|FG000|Overall Study|Withdrawal by Subject|0|||
148739381|NCT05307510|536518833|FG001|Overall Study|Withdrawal by Subject|1|||
148739382|NCT04003896|536518837|FG000|Overall Study|Withdrawal by Subject|3|||
148739383|NCT04003896|536518837|FG000|Overall Study|Physician Decision|1|||
148739384|NCT01682863|536518838|FG000|Overall Study|Subject/guardian decision|19|||
148739385|NCT01682863|536518839|FG001|Overall Study|Subject/guardian decision|12|||
148739386|NCT01682863|536518840|FG002|Overall Study|Subject/guardian decision|10|||
148739387|NCT01682863|536518838|FG000|Overall Study|Lost to Follow-up|5|||
148739388|NCT01682863|536518839|FG001|Overall Study|Lost to Follow-up|1|||
148739389|NCT01682863|536518840|FG002|Overall Study|Lost to Follow-up|6|||
148739390|NCT01682863|536518838|FG000|Overall Study|Death|1|||
148739391|NCT01682863|536518839|FG001|Overall Study|Death|3|||
148739392|NCT01682863|536518840|FG002|Overall Study|Death|4|||
148739393|NCT01682863|536518838|FG000|Overall Study|Protocol deviation|1|||
148739394|NCT01682863|536518839|FG001|Overall Study|Protocol deviation|0|||
148739395|NCT01682863|536518840|FG002|Overall Study|Protocol deviation|1|||
148739396|NCT01682863|536518838|FG000|Overall Study|Technical problems|1|||
148739397|NCT01682863|536518839|FG001|Overall Study|Technical problems|0|||
148739398|NCT01682863|536518840|FG002|Overall Study|Technical problems|0|||
148739399|NCT01682863|536518838|FG000|Overall Study|Adverse Event|0|||
148739400|NCT01682863|536518839|FG001|Overall Study|Adverse Event|1|||
148739401|NCT01682863|536518840|FG002|Overall Study|Adverse Event|2|||
148739402|NCT01682863|536518838|FG000|Overall Study|Physician Decision|0|||
148739403|NCT01682863|536518839|FG001|Overall Study|Physician Decision|0|||
148739404|NCT01682863|536518840|FG002|Overall Study|Physician Decision|1|||
148739405|NCT02315196|536518841|FG000|Overall Study|Withdrew consent|9|||
148739406|NCT00837473|536518842|FG000|Overall Study|Lost to Follow-up|1|||
148739407|NCT00837473|536518842|FG000|Overall Study|Withdrawal by Subject|2|||
148739408|NCT01635218|536518843|FG000|Overall Study|Lost to Follow-up|3|||
148739409|NCT01635218|536518844|FG001|Overall Study|Lost to Follow-up|7|||
148739410|NCT01635218|536518845|FG002|Overall Study|Lost to Follow-up|6|||
148739411|NCT00537303|536518846|FG000|Overall Study|Adverse Event|1|||
148739412|NCT00537303|536518847|FG001|Overall Study|Adverse Event|4|||
148739413|NCT00537303|536518846|FG000|Overall Study|Lack of Efficacy|6|||
148739414|NCT00537303|536518847|FG001|Overall Study|Lack of Efficacy|7|||
148739415|NCT00537303|536518846|FG000|Overall Study|Protocol Violation|8|||
148739416|NCT00537303|536518847|FG001|Overall Study|Protocol Violation|4|||
148739417|NCT00537303|536518846|FG000|Overall Study|Withdrawal criteria|3|||
148739418|NCT00537303|536518847|FG001|Overall Study|Withdrawal criteria|3|||
148975378|NCT01573624|537390808|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
148739419|NCT00537303|536518846|FG000|Overall Study|Unclassified|8|||
148739420|NCT00537303|536518847|FG001|Overall Study|Unclassified|7|||
148739421|NCT04576923|536518848|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
148739422|NCT01475097|536518849|FG000|Overall Study|Protocol Violation|1|||
148739423|NCT01475097|536518850|FG001|Overall Study|Protocol Violation|1|||
148739424|NCT01635283|536518852|FG000|Overall Study|Tumor Progression|3|||
148739425|NCT01635283|536518852|FG000|Overall Study|Lost to Follow-up|1|||
148739426|NCT04516759|536518853|FG000|Overall Study|Withdrawal by Subject|1|||
148739427|NCT04516759|536518854|FG001|Overall Study|Withdrawal by Subject|1|||
148739428|NCT04516759|536518853|FG000|Overall Study|Other|0|||
148739429|NCT04516759|536518854|FG001|Overall Study|Other|1|||
148739430|NCT01775189|536518856|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148739431|NCT01775189|536518857|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
148739432|NCT01775189|536518858|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148739433|NCT01775189|536518859|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148739434|NCT01775189|536518860|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148739435|NCT01775189|536518861|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148739436|NCT01775189|536518862|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
148739437|NCT01775189|536518856|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148739438|NCT01775189|536518857|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
148739439|NCT01775189|536518858|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148739440|NCT01775189|536518859|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148739441|NCT01775189|536518860|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148739442|NCT01775189|536518861|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148739443|NCT01775189|536518862|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
148739444|NCT01775189|536518856|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
148739445|NCT01775189|536518857|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
148739446|NCT01775189|536518858|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
148739447|NCT01775189|536518859|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
148739448|NCT01775189|536518860|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
148739449|NCT01775189|536518861|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
148739450|NCT01775189|536518862|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
148739451|NCT01775189|536518856|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
148739452|NCT01775189|536518857|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
148739453|NCT01775189|536518858|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
148739454|NCT01775189|536518859|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
148739455|NCT01775189|536518860|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
148739456|NCT01775189|536518861|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
148739457|NCT01775189|536518862|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
148739458|NCT01775189|536518856|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
148739459|NCT01775189|536518857|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
148739460|NCT01775189|536518858|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
148739461|NCT01775189|536518859|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
148739462|NCT01775189|536518860|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
148739463|NCT01775189|536518861|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
148739464|NCT01775189|536518862|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
148739465|NCT01775189|536518856|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
148739466|NCT01775189|536518857|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
148739467|NCT01775189|536518858|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
148739468|NCT01775189|536518859|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
148739469|NCT01775189|536518860|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
148739470|NCT01775189|536518861|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
148739471|NCT01775189|536518862|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
148739472|NCT01338870|536518872|FG000|Overall Study|Lost to Follow-up|0|||
148739473|NCT01338870|536518873|FG001|Overall Study|Lost to Follow-up|0|||
148739474|NCT01338870|536518874|FG002|Overall Study|Lost to Follow-up|1|||
148739475|NCT01338870|536518875|FG003|Overall Study|Lost to Follow-up|0|||
148739476|NCT01338870|536518876|FG004|Overall Study|Lost to Follow-up|1|||
148739477|NCT01338870|536518877|FG005|Overall Study|Lost to Follow-up|0|||
148739478|NCT01338870|536518872|FG000|Overall Study|Withdrawal by Subject|2|||
148739479|NCT01338870|536518873|FG001|Overall Study|Withdrawal by Subject|3|||
148739480|NCT01338870|536518874|FG002|Overall Study|Withdrawal by Subject|4|||
148739481|NCT01338870|536518875|FG003|Overall Study|Withdrawal by Subject|0|||
148739482|NCT01338870|536518876|FG004|Overall Study|Withdrawal by Subject|0|||
148739483|NCT01338870|536518877|FG005|Overall Study|Withdrawal by Subject|2|||
148739484|NCT01338870|536518872|FG000|Overall Study|Other|3|||
148739485|NCT01338870|536518873|FG001|Overall Study|Other|3|||
148739486|NCT01338870|536518874|FG002|Overall Study|Other|3|||
148739487|NCT01338870|536518875|FG003|Overall Study|Other|2|||
148739488|NCT01338870|536518876|FG004|Overall Study|Other|0|||
148739489|NCT01338870|536518877|FG005|Overall Study|Other|2|||
148739490|NCT01338870|536518872|FG000|Overall Study|Protocol Violation|0|||
148739491|NCT01338870|536518873|FG001|Overall Study|Protocol Violation|2|||
148739492|NCT01338870|536518874|FG002|Overall Study|Protocol Violation|2|||
148739493|NCT01338870|536518875|FG003|Overall Study|Protocol Violation|2|||
148739494|NCT01338870|536518876|FG004|Overall Study|Protocol Violation|1|||
148739495|NCT01338870|536518877|FG005|Overall Study|Protocol Violation|1|||
148975379|NCT01573624|537390809|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
148975380|NCT01573624|537390810|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
148739496|NCT01338870|536518872|FG000|Overall Study|Adverse Event|4|||
148739497|NCT01338870|536518873|FG001|Overall Study|Adverse Event|4|||
148739498|NCT01338870|536518874|FG002|Overall Study|Adverse Event|1|||
148739499|NCT01338870|536518875|FG003|Overall Study|Adverse Event|5|||
148739500|NCT01338870|536518876|FG004|Overall Study|Adverse Event|4|||
148739501|NCT01338870|536518877|FG005|Overall Study|Adverse Event|1|||
148739502|NCT01228019|536518882|FG000|Overall Study|Dose Violation|70|||
148739503|NCT01228019|536518882|FG000|Overall Study|Duplicate enrollment|1|||
148739504|NCT01228019|536518882|FG000|Overall Study|Missing pre-treatment data|72|||
148739505|NCT01228019|536518882|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
148739506|NCT01228019|536518882|FG000|Overall Study|Violation of Entry Criterion|9|||
148739507|NCT01844505|536518883|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
148739508|NCT01844505|536518884|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
148739509|NCT01844505|536518885|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
148739510|NCT01844505|536518883|FG000|Treatment Period|Other Reasons|120|||
148739511|NCT01844505|536518884|FG001|Treatment Period|Other Reasons|136|||
148739512|NCT01844505|536518885|FG002|Treatment Period|Other Reasons|58|||
148739513|NCT01844505|536518883|FG000|Treatment Period|Lost to Follow-up|9|||
148739514|NCT01844505|536518884|FG001|Treatment Period|Lost to Follow-up|11|||
148739515|NCT01844505|536518885|FG002|Treatment Period|Lost to Follow-up|6|||
148739516|NCT01844505|536518883|FG000|Treatment Period|Death|175|||
148739517|NCT01844505|536518884|FG001|Treatment Period|Death|154|||
148818416|NCT00985790|536810413|FG001|Overall Study|Withdrawal by Subject|1|||
148818417|NCT00985790|536810412|FG000|Overall Study|Lost to Follow-up|6|||
148818418|NCT00985790|536810413|FG001|Overall Study|Lost to Follow-up|7|||
148975381|NCT01573624|537390811|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
148975382|NCT01573624|537390812|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
148975383|NCT01573624|537390813|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
148975384|NCT01573624|537390814|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
148975385|NCT01573624|537390808|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
148975386|NCT01573624|537390809|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
148975387|NCT01573624|537390810|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
148975388|NCT01573624|537390811|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
148975389|NCT01573624|537390812|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
148975390|NCT01573624|537390813|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
148975391|NCT01573624|537390814|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
148975392|NCT01573624|537390808|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
148975393|NCT01573624|537390809|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
148975394|NCT01573624|537390810|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
148975395|NCT01573624|537390811|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
148975396|NCT01573624|537390812|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
148975397|NCT01573624|537390813|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
148975398|NCT01573624|537390814|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
148975399|NCT01573624|537390808|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
148975400|NCT01573624|537390809|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
148818419|NCT06100250|536810414|FG000|Overall Study|Lost to Follow-up|5|||
148818420|NCT05537571|536810415|FG000|Overall Study|Withdrawal by Subject|1|||
148818421|NCT05537571|536810416|FG001|Overall Study|Withdrawal by Subject|1|||
148975401|NCT01573624|537390810|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
148975402|NCT01573624|537390811|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
148975403|NCT01573624|537390812|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
148975404|NCT01573624|537390813|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
148975405|NCT01573624|537390814|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
148975406|NCT01573624|537390808|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
148975407|NCT01573624|537390809|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
148975408|NCT01573624|537390810|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
148975409|NCT01573624|537390811|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
148975410|NCT01573624|537390812|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
148975411|NCT01573624|537390813|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
148975412|NCT01573624|537390814|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
148975413|NCT01573624|537390808|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
148975414|NCT01573624|537390809|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
148975415|NCT01573624|537390810|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
148975416|NCT01573624|537390811|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
148975417|NCT01573624|537390812|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
148975418|NCT01573624|537390813|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
148975419|NCT01573624|537390814|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
148975420|NCT01573624|537390808|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148975421|NCT01573624|537390809|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148975422|NCT01573624|537390810|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148739518|NCT01844505|536518885|FG002|Treatment Period|Death|228|||
148818422|NCT05537571|536810417|FG002|Overall Study|Withdrawal by Subject|0|||
148818423|NCT05537571|536810418|FG003|Overall Study|Withdrawal by Subject|0|||
148739519|NCT00128830|536518887|FG000|Overall Study|Adverse Event|10|||
148818424|NCT05537571|536810419|FG004|Overall Study|Withdrawal by Subject|0|||
148739520|NCT00128830|536518887|FG000|Overall Study|Withdrawal by Subject|14|||
148739521|NCT00128830|536518887|FG000|Overall Study|Lost to Follow-up|4|||
148818425|NCT05537571|536810415|FG000|Overall Study|Adverse Event|2|||
148739522|NCT00128830|536518887|FG000|Overall Study|Reached a virologic endpoint|29|||
148739523|NCT00128830|536518887|FG000|Overall Study|Non-compliant|4|||
148739524|NCT00128830|536518887|FG000|Overall Study|Discontinued or ineligible for study|2|||
148739525|NCT00128830|536518887|FG000|Overall Study|Other|9|||
148739526|NCT02730351|536518888|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
148739527|NCT02730351|536518889|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
148739528|NCT02730351|536518888|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
148739529|NCT02730351|536518889|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
148739530|NCT02730351|536518888|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
148739531|NCT02730351|536518889|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
148739532|NCT02730351|536518888|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
148739533|NCT02730351|536518889|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
148739534|NCT02730351|536518888|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
148739535|NCT02730351|536518889|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
148739536|NCT00311402|536518890|FG000|Overall Study|Adverse Event|118|||
148739537|NCT00311402|536518891|FG001|Overall Study|Adverse Event|105|||
148739538|NCT00311402|536518890|FG000|Overall Study|Lost to Follow-up|0|||
148739539|NCT00311402|536518891|FG001|Overall Study|Lost to Follow-up|3|||
148739540|NCT00311402|536518890|FG000|Overall Study|Withdrawal by Subject|17|||
148739541|NCT00311402|536518891|FG001|Overall Study|Withdrawal by Subject|18|||
148739542|NCT00311402|536518890|FG000|Overall Study|Lack of Efficacy|58|||
148739543|NCT00311402|536518891|FG001|Overall Study|Lack of Efficacy|42|||
148739544|NCT00311402|536518890|FG000|Overall Study|Protocol Violation|7|||
148739545|NCT00311402|536518891|FG001|Overall Study|Protocol Violation|6|||
148739546|NCT00311402|536518890|FG000|Overall Study|IRB's rejection etc.|10|||
148739547|NCT00311402|536518891|FG001|Overall Study|IRB's rejection etc.|3|||
148739548|NCT01268501|536518893|FG000|Overall Study|Lost to Follow-up|1|||
148739549|NCT01268501|536518893|FG000|Overall Study|Withdrawal by Subject|3|||
148739550|NCT01268501|536518893|FG000|Overall Study|Unacceptable Subjective Vision|3|||
148739551|NCT01268501|536518893|FG000|Overall Study|Handling Difficulties|2|||
148739552|NCT02754856|536518895|FG000|Overall Study|Withdrawal by Subject|1|||
148739553|NCT04874155|536518898|FG000|Overall Study|Lost to Follow-up|1|||
148739554|NCT04874155|536518899|FG001|Overall Study|Lost to Follow-up|1|||
148739555|NCT04874155|536518898|FG000|Overall Study|Withdrawal by Subject|2|||
148739556|NCT04874155|536518899|FG001|Overall Study|Withdrawal by Subject|2|||
148739557|NCT00530218|536518900|FG000|Overall Study|CMV Not Detected|13|||
148739558|NCT00530218|536518900|FG000|Overall Study|Death|12|||
148739559|NCT00678886|536518903|FG000|Overall Study|Withdrawal by Subject|0|||
148739560|NCT00678886|536518904|FG001|Overall Study|Withdrawal by Subject|0|||
148739561|NCT00678886|536518905|FG002|Overall Study|Withdrawal by Subject|4|||
148739562|NCT00678886|536518906|FG003|Overall Study|Withdrawal by Subject|6|||
148739563|NCT00678886|536518903|FG000|Overall Study|Physician Decision|0|||
148739564|NCT00678886|536518904|FG001|Overall Study|Physician Decision|0|||
148739565|NCT00678886|536518905|FG002|Overall Study|Physician Decision|1|||
148739566|NCT00678886|536518906|FG003|Overall Study|Physician Decision|1|||
148975423|NCT01573624|537390811|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148975424|NCT01573624|537390812|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
148975425|NCT01573624|537390813|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
148975426|NCT01573624|537390814|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
148975427|NCT01573624|537390808|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975428|NCT01573624|537390809|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975429|NCT01573624|537390810|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975430|NCT01573624|537390811|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975431|NCT01573624|537390812|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975432|NCT01573624|537390813|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
148975433|NCT01573624|537390814|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
148975434|NCT01573624|537390808|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
148975435|NCT01573624|537390809|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148975436|NCT01573624|537390810|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148975437|NCT01573624|537390811|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148975438|NCT01573624|537390812|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
148739567|NCT00678886|536518903|FG000|Overall Study|Lost to Follow-up|0|||
148739568|NCT00678886|536518904|FG001|Overall Study|Lost to Follow-up|0|||
148739569|NCT00678886|536518905|FG002|Overall Study|Lost to Follow-up|3|||
148739570|NCT00678886|536518906|FG003|Overall Study|Lost to Follow-up|2|||
148739571|NCT00678886|536518903|FG000|Overall Study|Other|0|||
148739572|NCT00678886|536518904|FG001|Overall Study|Other|0|||
148739573|NCT00678886|536518905|FG002|Overall Study|Other|1|||
148739574|NCT00678886|536518906|FG003|Overall Study|Other|0|||
148739575|NCT03477903|536518907|FG000|Overall Study|Study Terminated by Sponsor|1|||
148739576|NCT01147107|536518908|FG000|Overall Study|Lack of Efficacy|5|||
148739577|NCT01147107|536518909|FG001|Overall Study|Lack of Efficacy|0|||
148739578|NCT01147107|536518908|FG000|Overall Study|Withdrawal by Subject|1|||
148739579|NCT01147107|536518909|FG001|Overall Study|Withdrawal by Subject|1|||
148739580|NCT03496610|536518910|FG000|Overall Study|Lost to Follow-up|3|||
148739581|NCT03496610|536518911|FG001|Overall Study|Lost to Follow-up|2|||
148739582|NCT03496610|536518910|FG000|Overall Study|Physician Decision|1|||
148739583|NCT03496610|536518911|FG001|Overall Study|Physician Decision|0|||
148739584|NCT03496610|536518910|FG000|Overall Study|Withdrawal by Subject|1|||
148739585|NCT03496610|536518911|FG001|Overall Study|Withdrawal by Subject|0|||
148739586|NCT04693416|536518912|FG000|Overall Study|Lost to Follow-up|13|||
148739587|NCT04693416|536518913|FG001|Overall Study|Lost to Follow-up|0|||
148739588|NCT00474266|536518914|FG000|Overall Study|Withdrawal by Subject|7|||
148739589|NCT00474266|536518915|FG001|Overall Study|Withdrawal by Subject|20|||
148739590|NCT00474266|536518916|FG002|Overall Study|Withdrawal by Subject|4|||
148739591|NCT00474266|536518917|FG003|Overall Study|Withdrawal by Subject|7|||
148739592|NCT02774642|536518919|FG000|Overall Study|Lost to Follow-up|9|||
148739593|NCT02774642|536518920|FG001|Overall Study|Lost to Follow-up|7|||
148739594|NCT05330468|536518923|FG000|Overall Study|Death|6|||
148739595|NCT05330468|536518923|FG000|Overall Study|Withdrawal by Subject|4|||
148739596|NCT05330468|536518923|FG000|Overall Study|Lost to Follow-up|4|||
148739597|NCT02365558|536518924|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
148739598|NCT02365558|536518925|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
148739599|NCT02365558|536518924|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
148739600|NCT02365558|536518925|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
148739601|NCT00369317|536518926|FG000|Overall Study|Adverse Event|3|||
148739602|NCT00369317|536518926|FG000|Overall Study|Death|1|||
148739603|NCT00369317|536518926|FG000|Overall Study|Lack of Efficacy|5|||
148739604|NCT00369317|536518926|FG000|Overall Study|Physician Decision|2|||
148739605|NCT00369317|536518926|FG000|Overall Study|Withdrawal by Subject|8|||
148739606|NCT00369317|536518926|FG000|Overall Study|Ineligible|1|||
148739607|NCT06281171|536518933|FG000|Timepoint 2|Lost to Follow-up|6|||
148739608|NCT06281171|536518934|FG001|Timepoint 2|Lost to Follow-up|4|||
148739609|NCT06281171|536518933|FG000|Timepoint 3|Lost to Follow-up|0|||
148739610|NCT06281171|536518934|FG001|Timepoint 3|Lost to Follow-up|5|||
148739611|NCT00073021|536518939|FG000|Overall Study|Protocol Violation|2|||
148739612|NCT00073021|536518940|FG001|Overall Study|Protocol Violation|1|||
148739613|NCT00073021|536518939|FG000|Overall Study|Adverse Event|4|||
148739614|NCT00073021|536518940|FG001|Overall Study|Adverse Event|4|||
148739615|NCT00073021|536518939|FG000|Overall Study|Withdrawal by Subject|6|||
148739616|NCT00073021|536518940|FG001|Overall Study|Withdrawal by Subject|5|||
148739617|NCT00073021|536518939|FG000|Overall Study|Physician Decision|3|||
148739618|NCT00073021|536518940|FG001|Overall Study|Physician Decision|1|||
148739619|NCT00073021|536518939|FG000|Overall Study|Lack of Efficacy|11|||
148739620|NCT00073021|536518940|FG001|Overall Study|Lack of Efficacy|5|||
148739621|NCT01458106|536518941|FG000|Overall Study|Withdrawal by Subject|2|||
148739622|NCT01458106|536518942|FG001|Overall Study|Withdrawal by Subject|0|||
148739623|NCT01458106|536518941|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
148739624|NCT01458106|536518942|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
148739625|NCT01458106|536518941|FG000|Overall Study|Withdrawn Per Protocol|0|||
148739626|NCT01458106|536518942|FG001|Overall Study|Withdrawn Per Protocol|1|||
148739627|NCT03835221|536518943|FG000|Methafilcon A|Withdrawal by Subject|1|||
148739628|NCT00861198|536518945|FG000|Overall Study|SpyGlass Failed|5|||
148739629|NCT02288182|536518946|FG000|Overall Study|Adverse Event|0|||
148739630|NCT02288182|536518947|FG001|Overall Study|Adverse Event|1|||
148739631|NCT02288182|536518946|FG000|Overall Study|Lost to Follow-up|0|||
148739632|NCT02288182|536518947|FG001|Overall Study|Lost to Follow-up|1|||
148818426|NCT05537571|536810416|FG001|Overall Study|Adverse Event|0|||
148818427|NCT05537571|536810417|FG002|Overall Study|Adverse Event|0|||
148975439|NCT01573624|537390813|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
148975440|NCT01573624|537390814|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
148975441|NCT01573624|537390808|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
148975442|NCT01573624|537390809|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
148739633|NCT02823652|536518951|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
148739634|NCT02823652|536518952|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
148739635|NCT02823652|536518953|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
148739636|NCT02823652|536518951|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
148739637|NCT02823652|536518952|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
148739638|NCT02823652|536518953|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
148739639|NCT02823652|536518951|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
148739640|NCT02823652|536518952|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
148739641|NCT02823652|536518953|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
148818428|NCT05537571|536810418|FG003|Overall Study|Adverse Event|0|||
148739642|NCT02823652|536518951|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
148739643|NCT02823652|536518952|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
148739644|NCT02823652|536518953|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
148818429|NCT05537571|536810419|FG004|Overall Study|Adverse Event|0|||
148739645|NCT04619992|536518954|FG000|Overall Study|Withdrawal by Subject|1|||
148739646|NCT04619992|536518955|FG001|Overall Study|Withdrawal by Subject|0|||
148739647|NCT01197755|536518956|FG000|Overall Study|Adverse Event|8|||
148739648|NCT01197755|536518957|FG001|Overall Study|Adverse Event|10|||
148739649|NCT01197755|536518958|FG002|Overall Study|Adverse Event|10|||
148739650|NCT01197755|536518956|FG000|Overall Study|Study-specific discontinuation criteria|2|||
148739651|NCT01197755|536518957|FG001|Overall Study|Study-specific discontinuation criteria|1|||
148739652|NCT01197755|536518958|FG002|Overall Study|Study-specific discontinuation criteria|0|||
148739653|NCT01197755|536518956|FG000|Overall Study|Entered the long-term extension study|18|||
148739654|NCT01197755|536518957|FG001|Overall Study|Entered the long-term extension study|21|||
148739655|NCT01197755|536518958|FG002|Overall Study|Entered the long-term extension study|35|||
148739656|NCT01197755|536518956|FG000|Overall Study|Lack of therapeutic response|0|||
148739657|NCT01197755|536518957|FG001|Overall Study|Lack of therapeutic response|7|||
148739658|NCT01197755|536518958|FG002|Overall Study|Lack of therapeutic response|4|||
148739659|NCT01197755|536518956|FG000|Overall Study|Severe non-compliance to the protocol|2|||
148739660|NCT01197755|536518957|FG001|Overall Study|Severe non-compliance to the protocol|1|||
148739661|NCT01197755|536518958|FG002|Overall Study|Severe non-compliance to the protocol|2|||
148739662|NCT01197755|536518956|FG000|Overall Study|Withdrawal by Subject|1|||
148739663|NCT01197755|536518957|FG001|Overall Study|Withdrawal by Subject|0|||
148975443|NCT01573624|537390810|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
148739664|NCT01197755|536518958|FG002|Overall Study|Withdrawal by Subject|0|||
148739665|NCT01197755|536518956|FG000|Overall Study|Lost to Follow-up|0|||
148739666|NCT01197755|536518957|FG001|Overall Study|Lost to Follow-up|0|||
148739667|NCT01197755|536518958|FG002|Overall Study|Lost to Follow-up|1|||
148739668|NCT01197755|536518956|FG000|Overall Study|eg, change in circumstances|7|||
148975444|NCT01573624|537390811|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
148975445|NCT01573624|537390812|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
148975446|NCT01573624|537390813|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
148975447|NCT01573624|537390814|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
148975448|NCT01573624|537390808|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
148975449|NCT01573624|537390809|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
148975450|NCT01573624|537390810|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
148739669|NCT01197755|536518957|FG001|Overall Study|eg, change in circumstances|3|||
148739670|NCT01197755|536518958|FG002|Overall Study|eg, change in circumstances|2|||
148739671|NCT00499174|536518959|FG000|Overall Study|Physician Decision|78|||
148739672|NCT00499174|536518960|FG001|Overall Study|Physician Decision|9|||
148739673|NCT02269163|536518961|FG000|Overall Study|Lost to Follow-up|1|||
148739674|NCT02269163|536518962|FG001|Overall Study|Lost to Follow-up|0|||
148739675|NCT02269163|536518961|FG000|Overall Study|Major protocol violation|0|||
148739676|NCT02269163|536518962|FG001|Overall Study|Major protocol violation|1|||
148739677|NCT02269163|536518961|FG000|Overall Study|Other|2|||
148739678|NCT02269163|536518962|FG001|Overall Study|Other|2|||
148739679|NCT02269163|536518961|FG000|Overall Study|Withdrawal by Subject|0|||
148739680|NCT02269163|536518962|FG001|Overall Study|Withdrawal by Subject|3|||
148739681|NCT02269163|536518961|FG000|Overall Study|Physician Decision|0|||
148739682|NCT02269163|536518962|FG001|Overall Study|Physician Decision|1|||
148739683|NCT01214915|536518964|FG000|Overall Study|Adverse Event|8|||
148739684|NCT01214915|536518964|FG000|Overall Study|Lack of Efficacy|3|||
148739685|NCT00761865|536518965|FG000|Overall Study|Lost to Follow-up|8|||
148739686|NCT00761865|536518966|FG001|Overall Study|Lost to Follow-up|7|||
148739687|NCT00319982|536518967|FG000|Overall Study|Withdrawal by Subject|1|||
148739688|NCT00319982|536518968|FG001|Overall Study|Withdrawal by Subject|0|||
148739689|NCT00758680|536518969|FG000|Overall Study|Adverse Event|0|||
148739690|NCT00758680|536518970|FG001|Overall Study|Adverse Event|0|||
148739691|NCT00758680|536518971|FG002|Overall Study|Adverse Event|0|||
148739692|NCT00758680|536518972|FG003|Overall Study|Adverse Event|0|||
148739693|NCT00758680|536518973|FG004|Overall Study|Adverse Event|0|||
148739694|NCT00758680|536518974|FG005|Overall Study|Adverse Event|0|||
148975451|NCT01573624|537390811|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
148975452|NCT01573624|537390812|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
149027113|NCT01648283|537576495|FG000|Overall Study|Withdrawal by Subject|14|||
149027114|NCT00578227|537576501|FG000|Overall Study|Lost to Follow-up|0|||
149027115|NCT00578227|537576502|FG001|Overall Study|Lost to Follow-up|1|||
149027116|NCT00578227|537576503|FG002|Overall Study|Lost to Follow-up|1|||
148739695|NCT00758680|536518975|FG006|Overall Study|Adverse Event|0|||
148739696|NCT00758680|536518976|FG007|Overall Study|Adverse Event|1|||
148739697|NCT00758680|536518977|FG008|Overall Study|Adverse Event|0|||
148739698|NCT00758680|536518978|FG009|Overall Study|Adverse Event|1|||
148739699|NCT00758680|536518969|FG000|Overall Study|Laboratory Adverse Event|0|||
148739700|NCT00758680|536518970|FG001|Overall Study|Laboratory Adverse Event|0|||
148739701|NCT00758680|536518971|FG002|Overall Study|Laboratory Adverse Event|0|||
148739702|NCT00758680|536518972|FG003|Overall Study|Laboratory Adverse Event|0|||
148739703|NCT00758680|536518973|FG004|Overall Study|Laboratory Adverse Event|0|||
148739704|NCT00758680|536518974|FG005|Overall Study|Laboratory Adverse Event|0|||
148975453|NCT01573624|537390813|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
148975454|NCT01573624|537390814|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
148975455|NCT01573624|537390808|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
148975456|NCT01573624|537390809|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
148975457|NCT01573624|537390810|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
148975458|NCT01573624|537390811|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
148975459|NCT01573624|537390812|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
148975460|NCT01573624|537390813|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
148975461|NCT01573624|537390814|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
148975462|NCT01573624|537390808|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
148975463|NCT01573624|537390809|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
148975464|NCT01573624|537390810|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
148975465|NCT01573624|537390811|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
148975466|NCT01573624|537390812|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
148975467|NCT01573624|537390813|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
148975468|NCT01573624|537390814|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
148975469|NCT05059600|537390815|FG000|Overall Study|Enrolled but not Treated|10|||
148975470|NCT02519712|537390818|FG000|Overall Study|Disease Relapse|1|||
148975471|NCT02519712|537390818|FG000|Overall Study|Disease Progression|1|||
148975472|NCT02519712|537390818|FG000|Overall Study|Accruals are donors|2|||
148975473|NCT00613509|537390819|FG000|Cycle 1|Adverse Event|2|||
148975474|NCT00613509|537390820|FG001|Cycle 1|Adverse Event|1|||
148975475|NCT00613509|537390819|FG000|Cycle 1|Disease Progression|2|||
148975476|NCT00613509|537390820|FG001|Cycle 1|Disease Progression|6|||
148975477|NCT00613509|537390819|FG000|Cycle 1|Unacceptable Toxicity|1|||
148975478|NCT00613509|537390820|FG001|Cycle 1|Unacceptable Toxicity|0|||
148975479|NCT00613509|537390819|FG000|Cycle 1|Other administrative reason|0|||
148975480|NCT00613509|537390820|FG001|Cycle 1|Other administrative reason|1|||
148975481|NCT00677807|537390823|FG000|Overall Study|Adverse Event|4|||
148975482|NCT00677807|537390824|FG001|Overall Study|Adverse Event|1|||
148975483|NCT00677807|537390825|FG002|Overall Study|Adverse Event|6|||
148975484|NCT00677807|537390823|FG000|Overall Study|Lack of Efficacy|0|||
148975485|NCT00677807|537390824|FG001|Overall Study|Lack of Efficacy|0|||
148975486|NCT00677807|537390825|FG002|Overall Study|Lack of Efficacy|2|||
148975487|NCT00677807|537390823|FG000|Overall Study|Participant no longer needs study drug|0|||
148975488|NCT00677807|537390824|FG001|Overall Study|Participant no longer needs study drug|0|||
148975489|NCT00677807|537390825|FG002|Overall Study|Participant no longer needs study drug|1|||
148975490|NCT00677807|537390823|FG000|Overall Study|Withdrawal by Subject|10|||
148975491|NCT00677807|537390824|FG001|Overall Study|Withdrawal by Subject|3|||
148975492|NCT00677807|537390825|FG002|Overall Study|Withdrawal by Subject|6|||
148975493|NCT00677807|537390823|FG000|Overall Study|Lost to Follow-up|2|||
148975494|NCT00677807|537390824|FG001|Overall Study|Lost to Follow-up|2|||
148975495|NCT00677807|537390825|FG002|Overall Study|Lost to Follow-up|2|||
148975496|NCT00677807|537390823|FG000|Overall Study|Administrative problems|1|||
148975497|NCT00677807|537390824|FG001|Overall Study|Administrative problems|1|||
148975498|NCT00677807|537390825|FG002|Overall Study|Administrative problems|2|||
148975499|NCT00677807|537390823|FG000|Overall Study|Death|0|||
148975500|NCT00677807|537390824|FG001|Overall Study|Death|1|||
148975501|NCT00677807|537390825|FG002|Overall Study|Death|1|||
148975502|NCT00677807|537390823|FG000|Overall Study|Protocol Deviation|1|||
148975503|NCT00677807|537390824|FG001|Overall Study|Protocol Deviation|3|||
148975504|NCT00677807|537390825|FG002|Overall Study|Protocol Deviation|0|||
148975505|NCT00314366|537390830|FG000|Overall Study|not treated due to patient medical condi|1|||
148975506|NCT00314366|537390831|FG001|Overall Study|not treated due to patient medical condi|0|||
149027117|NCT00578227|537576501|FG000|Overall Study|Withdrawal by Subject|5|||
148739705|NCT00758680|536518975|FG006|Overall Study|Laboratory Adverse Event|0|||
148739706|NCT00758680|536518976|FG007|Overall Study|Laboratory Adverse Event|0|||
148739707|NCT00758680|536518977|FG008|Overall Study|Laboratory Adverse Event|1|||
148739708|NCT00758680|536518978|FG009|Overall Study|Laboratory Adverse Event|0|||
148739709|NCT00758680|536518969|FG000|Overall Study|Withdrawal by Subject|0|||
148739710|NCT00758680|536518970|FG001|Overall Study|Withdrawal by Subject|0|||
148739711|NCT00758680|536518971|FG002|Overall Study|Withdrawal by Subject|0|||
148739712|NCT00758680|536518972|FG003|Overall Study|Withdrawal by Subject|0|||
148975507|NCT03467425|537390832|FG000|Overall Study|Adverse Event|9|||
148975508|NCT03467425|537390833|FG001|Overall Study|Adverse Event|9|||
148975509|NCT03467425|537390832|FG000|Overall Study|Lack of Efficacy|3|||
148975510|NCT03467425|537390833|FG001|Overall Study|Lack of Efficacy|1|||
148975511|NCT03467425|537390832|FG000|Overall Study|Protocol Violation|0|||
148975512|NCT03467425|537390833|FG001|Overall Study|Protocol Violation|1|||
148975513|NCT03467425|537390832|FG000|Overall Study|Lost to Follow-up|18|||
148975514|NCT03467425|537390833|FG001|Overall Study|Lost to Follow-up|25|||
148975515|NCT03467425|537390832|FG000|Overall Study|Physician Decision|2|||
148975516|NCT03467425|537390833|FG001|Overall Study|Physician Decision|1|||
148975517|NCT03467425|537390832|FG000|Overall Study|Withdrawal by Subject|15|||
148975518|NCT03467425|537390833|FG001|Overall Study|Withdrawal by Subject|17|||
148975519|NCT01864291|537390834|FG000|Overall Study|need for revision surgery|2|||
148975520|NCT01387607|537390841|FG000|Overall Study|Adverse Event|23|||
148975521|NCT01387607|537390842|FG001|Overall Study|Adverse Event|11|||
148739713|NCT00758680|536518973|FG004|Overall Study|Withdrawal by Subject|0|||
148739714|NCT00758680|536518974|FG005|Overall Study|Withdrawal by Subject|0|||
148739715|NCT00758680|536518975|FG006|Overall Study|Withdrawal by Subject|1|||
148739716|NCT00758680|536518976|FG007|Overall Study|Withdrawal by Subject|0|||
148739717|NCT00758680|536518977|FG008|Overall Study|Withdrawal by Subject|1|||
148739718|NCT00758680|536518978|FG009|Overall Study|Withdrawal by Subject|0|||
148739719|NCT03480386|536518979|FG000|Overall Study|Did not complete measures at 3-months|17|||
148739720|NCT03480386|536518980|FG001|Overall Study|Did not complete measures at 3-months|14|||
148739721|NCT03480386|536518979|FG000|Overall Study|No baseline measures|11|||
148739722|NCT03480386|536518980|FG001|Overall Study|No baseline measures|14|||
148739723|NCT03480386|536518979|FG000|Overall Study|Death|0|||
148739724|NCT03480386|536518980|FG001|Overall Study|Death|5|||
148739725|NCT03480386|536518979|FG000|Overall Study|Withdrawal by Subject|12|||
148739726|NCT03480386|536518980|FG001|Overall Study|Withdrawal by Subject|8|||
148739727|NCT03480386|536518979|FG000|Overall Study|Lost to Follow-up|2|||
148739728|NCT03480386|536518980|FG001|Overall Study|Lost to Follow-up|1|||
148739729|NCT03480386|536518979|FG000|Overall Study|Complicating disease|0|||
148739730|NCT03480386|536518980|FG001|Overall Study|Complicating disease|1|||
148739731|NCT03480386|536518979|FG000|Overall Study|Disease progression|3|||
148739732|NCT03480386|536518980|FG001|Overall Study|Disease progression|0|||
148739733|NCT03480386|536518979|FG000|Overall Study|Became ineligible|0|||
148739734|NCT03480386|536518980|FG001|Overall Study|Became ineligible|2|||
148739735|NCT00574912|536518981|FG000|Overall Study|Could not place IV lines.|3|||
148739736|NCT00574912|536518981|FG000|Overall Study|scheduling conflicts|3|||
148739737|NCT00574912|536518981|FG000|Overall Study|Physician Decision|2|||
148739738|NCT04730349|536518984|FG000|Overall Study|Participant withdrew consent|1|||
148739739|NCT04730349|536518985|FG001|Overall Study|Participant withdrew consent|0|||
148739740|NCT04730349|536518984|FG000|Overall Study|Disease progression|6|||
148739741|NCT04730349|536518985|FG001|Overall Study|Disease progression|4|||
148739742|NCT04730349|536518984|FG000|Overall Study|Study drug toxicity|0|||
148739743|NCT04730349|536518985|FG001|Overall Study|Study drug toxicity|1|||
148739744|NCT02886624|536520611|FG000|12-week Post Treatment Follow-up|Death|1|||
148739745|NCT02886624|536520611|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
148739746|NCT03151408|536520613|FG000|Overall Study|Adverse Event|24|||
148739747|NCT03151408|536520614|FG001|Overall Study|Adverse Event|23|||
148739748|NCT03151408|536520613|FG000|Overall Study|Death|46|||
148739749|NCT03151408|536520614|FG001|Overall Study|Death|26|||
148739750|NCT03151408|536520613|FG000|Overall Study|Physician Decision|13|||
148739751|NCT03151408|536520614|FG001|Overall Study|Physician Decision|19|||
148739752|NCT03151408|536520613|FG000|Overall Study|Withdrawal by Subject|16|||
148739753|NCT03151408|536520614|FG001|Overall Study|Withdrawal by Subject|20|||
148739754|NCT03151408|536520613|FG000|Overall Study|Progressive disease|45|||
148739755|NCT03151408|536520614|FG001|Overall Study|Progressive disease|61|||
148739756|NCT03151408|536520613|FG000|Overall Study|non-compliance by patient|1|||
148739757|NCT03151408|536520614|FG001|Overall Study|non-compliance by patient|0|||
148739758|NCT03151408|536520613|FG000|Overall Study|other reasons|56|||
148739759|NCT03151408|536520614|FG001|Overall Study|other reasons|52|||
148739760|NCT03151408|536520613|FG000|Overall Study|randomized and not treated|2|||
148739761|NCT03151408|536520614|FG001|Overall Study|randomized and not treated|2|||
148739762|NCT03262038|536520619|FG000|Overall Study|Withdrawal by Subject|0|||
148739763|NCT03262038|536520620|FG001|Overall Study|Withdrawal by Subject|1|||
148739764|NCT04933968|536520621|FG000|Overall Study|Adverse Event|0|||
148739765|NCT04933968|536520622|FG001|Overall Study|Adverse Event|0|||
148739766|NCT04933968|536520623|FG002|Overall Study|Adverse Event|1|||
148739767|NCT04933968|536520624|FG003|Overall Study|Adverse Event|1|||
148739768|NCT04933968|536520625|FG004|Overall Study|Adverse Event|0|||
148739769|NCT04933968|536520626|FG005|Overall Study|Adverse Event|0|||
148739770|NCT04933968|536520621|FG000|Overall Study|Lost to Follow-up|1|||
148739771|NCT04933968|536520622|FG001|Overall Study|Lost to Follow-up|0|||
148739772|NCT04933968|536520623|FG002|Overall Study|Lost to Follow-up|1|||
148739773|NCT04933968|536520624|FG003|Overall Study|Lost to Follow-up|0|||
148739774|NCT04933968|536520625|FG004|Overall Study|Lost to Follow-up|0|||
148739775|NCT04933968|536520626|FG005|Overall Study|Lost to Follow-up|0|||
148739776|NCT04933968|536520621|FG000|Overall Study|Randomized not treated|1|||
148818430|NCT05537571|536810415|FG000|Overall Study|Hepatitis A screening result|2|||
148739777|NCT04933968|536520622|FG001|Overall Study|Randomized not treated|0|||
148739778|NCT04933968|536520623|FG002|Overall Study|Randomized not treated|0|||
148739779|NCT04933968|536520624|FG003|Overall Study|Randomized not treated|0|||
148818431|NCT05537571|536810416|FG001|Overall Study|Hepatitis A screening result|0|||
148739780|NCT04933968|536520625|FG004|Overall Study|Randomized not treated|0|||
148739781|NCT04933968|536520626|FG005|Overall Study|Randomized not treated|0|||
148739782|NCT04933968|536520621|FG000|Overall Study|Sponsor terminated study|0|||
148739783|NCT04933968|536520622|FG001|Overall Study|Sponsor terminated study|0|||
148739784|NCT04933968|536520623|FG002|Overall Study|Sponsor terminated study|0|||
148975522|NCT01387607|537390841|FG000|Overall Study|Lack of Efficacy|8|||
148975523|NCT01387607|537390842|FG001|Overall Study|Lack of Efficacy|6|||
148975524|NCT01387607|537390841|FG000|Overall Study|Lost to Follow-up|2|||
148975525|NCT01387607|537390842|FG001|Overall Study|Lost to Follow-up|1|||
148975526|NCT01387607|537390841|FG000|Overall Study|No longer meets eligibility criteria|0|||
148975527|NCT01387607|537390842|FG001|Overall Study|No longer meets eligibility criteria|1|||
148975528|NCT01387607|537390841|FG000|Overall Study|Protocol Violation|1|||
148975529|NCT01387607|537390842|FG001|Overall Study|Protocol Violation|5|||
148975530|NCT01387607|537390841|FG000|Overall Study|Withdrawal by Subject|13|||
148975531|NCT01387607|537390842|FG001|Overall Study|Withdrawal by Subject|14|||
148975532|NCT01387607|537390841|FG000|Overall Study|Other|1|||
148975533|NCT01387607|537390842|FG001|Overall Study|Other|1|||
148818432|NCT05537571|536810417|FG002|Overall Study|Hepatitis A screening result|0|||
148818433|NCT05537571|536810418|FG003|Overall Study|Hepatitis A screening result|0|||
148818434|NCT05537571|536810419|FG004|Overall Study|Hepatitis A screening result|0|||
148739785|NCT04933968|536520624|FG003|Overall Study|Sponsor terminated study|1|||
148818435|NCT05537571|536810415|FG000|Overall Study|Lost to Follow-up|0|||
148818436|NCT05537571|536810416|FG001|Overall Study|Lost to Follow-up|0|||
148818437|NCT05537571|536810417|FG002|Overall Study|Lost to Follow-up|1|||
148818438|NCT05537571|536810418|FG003|Overall Study|Lost to Follow-up|0|||
148818439|NCT05537571|536810419|FG004|Overall Study|Lost to Follow-up|1|||
148818440|NCT04210375|536810422|FG000|Overall Study|Death|0|||
148818441|NCT04210375|536810423|FG001|Overall Study|Death|1|||
148975534|NCT01387607|537390841|FG000|Overall Study|Randomized, not treated|3|||
148739786|NCT04933968|536520625|FG004|Overall Study|Sponsor terminated study|2|||
148739787|NCT04933968|536520626|FG005|Overall Study|Sponsor terminated study|0|||
148739788|NCT04933968|536520621|FG000|Overall Study|Other|0|||
148975535|NCT01387607|537390842|FG001|Overall Study|Randomized, not treated|6|||
148975536|NCT00689481|537390844|FG000|Overall Study|Adverse Event|7|||
148975537|NCT00689481|537390845|FG001|Overall Study|Adverse Event|1|||
148975538|NCT00689481|537390844|FG000|Overall Study|Lost to Follow-up|4|||
148975539|NCT00689481|537390845|FG001|Overall Study|Lost to Follow-up|3|||
148975540|NCT00689481|537390844|FG000|Overall Study|Lack of Efficacy|4|||
148975541|NCT00689481|537390845|FG001|Overall Study|Lack of Efficacy|3|||
148975542|NCT00689481|537390844|FG000|Overall Study|Non-compliance with study treatment|1|||
148975543|NCT00689481|537390845|FG001|Overall Study|Non-compliance with study treatment|1|||
148975544|NCT00689481|537390844|FG000|Overall Study|Withdrawal by Subject|8|||
148975545|NCT00689481|537390845|FG001|Overall Study|Withdrawal by Subject|4|||
148975546|NCT00689481|537390844|FG000|Overall Study|Excluded medication started during study|0|||
148975547|NCT00689481|537390845|FG001|Overall Study|Excluded medication started during study|1|||
148975548|NCT00689481|537390844|FG000|Overall Study|Subject early term, left on vacation|0|||
148975549|NCT00689481|537390845|FG001|Overall Study|Subject early term, left on vacation|1|||
148975550|NCT03337724|537390848|FG000|Overall Study|Reason not Specified|12|||
148975551|NCT03337724|537390849|FG001|Overall Study|Reason not Specified|21|||
148975552|NCT03337724|537390850|FG002|Overall Study|Reason not Specified|9|||
148975553|NCT03337724|537390851|FG003|Overall Study|Reason not Specified|9|||
148739789|NCT04933968|536520622|FG001|Overall Study|Other|0|||
148739790|NCT04933968|536520623|FG002|Overall Study|Other|0|||
148739791|NCT04933968|536520624|FG003|Overall Study|Other|1|||
148739792|NCT04933968|536520625|FG004|Overall Study|Other|0|||
148739793|NCT04933968|536520626|FG005|Overall Study|Other|0|||
148739794|NCT04933968|536520621|FG000|Overall Study|Missing|1|||
148739795|NCT04933968|536520622|FG001|Overall Study|Missing|3|||
148739796|NCT04933968|536520623|FG002|Overall Study|Missing|2|||
148739797|NCT04933968|536520624|FG003|Overall Study|Missing|1|||
148975554|NCT03337724|537390852|FG004|Overall Study|Reason not Specified|29|||
148975555|NCT03337724|537390848|FG000|Overall Study|Withdrawal by Subject|13|||
148975556|NCT03337724|537390849|FG001|Overall Study|Withdrawal by Subject|15|||
148975557|NCT03337724|537390850|FG002|Overall Study|Withdrawal by Subject|4|||
148975558|NCT03337724|537390851|FG003|Overall Study|Withdrawal by Subject|15|||
148975559|NCT03337724|537390852|FG004|Overall Study|Withdrawal by Subject|6|||
148975560|NCT03337724|537390848|FG000|Overall Study|Protocol Deviation|0|||
148975561|NCT03337724|537390849|FG001|Overall Study|Protocol Deviation|1|||
148818442|NCT04210375|536810424|FG002|Overall Study|Death|0|||
148975562|NCT03337724|537390850|FG002|Overall Study|Protocol Deviation|1|||
148975563|NCT03337724|537390851|FG003|Overall Study|Protocol Deviation|1|||
148975564|NCT03337724|537390852|FG004|Overall Study|Protocol Deviation|0|||
148975565|NCT03337724|537390848|FG000|Overall Study|Adverse Event|1|||
148975566|NCT03337724|537390849|FG001|Overall Study|Adverse Event|1|||
148739798|NCT04933968|536520625|FG004|Overall Study|Missing|1|||
148739799|NCT04933968|536520626|FG005|Overall Study|Missing|0|||
148739800|NCT01724489|536520627|FG000|Overall Study|Adverse Event|8|||
148975567|NCT03337724|537390850|FG002|Overall Study|Adverse Event|0|||
148975568|NCT03337724|537390851|FG003|Overall Study|Adverse Event|1|||
148975569|NCT03337724|537390852|FG004|Overall Study|Adverse Event|0|||
148739801|NCT01724489|536520628|FG001|Overall Study|Adverse Event|3|||
148818443|NCT04210375|536810425|FG003|Overall Study|Death|0|||
148818444|NCT04439123|536810426|FG000|Overall Study|Adverse Event|11|||
148818445|NCT04439123|536810426|FG000|Overall Study|Death|1|||
148739802|NCT01724489|536520627|FG000|Overall Study|Surgery, medication|1|||
148739803|NCT01724489|536520628|FG001|Overall Study|Surgery, medication|1|||
148739804|NCT01724489|536520627|FG000|Overall Study|Lost to Follow-up|1|||
148739805|NCT01724489|536520628|FG001|Overall Study|Lost to Follow-up|2|||
148739806|NCT01724489|536520627|FG000|Overall Study|Withdrawal by Subject|6|||
148739807|NCT01724489|536520628|FG001|Overall Study|Withdrawal by Subject|6|||
148739808|NCT01664130|536520631|FG000|Overall Study|competing secondary disease|2|||
148739809|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
148739810|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
148739811|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
148739812|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
148739813|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
148739814|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
148739815|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
148739816|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
148739817|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
148739818|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
148739819|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
148739820|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
148739821|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
148739822|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
148739823|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
148739824|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
148739825|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
148739826|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
148739827|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
148739828|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
148739829|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
148739830|NCT04040192|536520632|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
148739831|NCT04040192|536520633|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
148739832|NCT04040192|536520634|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
148739833|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
148739834|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
148739835|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
148739836|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
148739837|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
148739838|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
148739839|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
148739840|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
148739841|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
148739842|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
148739843|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
148739844|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
148739845|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
148739846|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
148739847|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
148739848|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
148739849|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
148975570|NCT03337724|537390848|FG000|Overall Study|Death|40|||
148975571|NCT03337724|537390849|FG001|Overall Study|Death|89|||
148975572|NCT03337724|537390850|FG002|Overall Study|Death|43|||
148975573|NCT03337724|537390851|FG003|Overall Study|Death|76|||
148975574|NCT03337724|537390852|FG004|Overall Study|Death|50|||
148975575|NCT03337724|537390848|FG000|Overall Study|Lost to Follow-up|5|||
148975576|NCT03337724|537390849|FG001|Overall Study|Lost to Follow-up|5|||
148975577|NCT03337724|537390850|FG002|Overall Study|Lost to Follow-up|4|||
148975578|NCT03337724|537390851|FG003|Overall Study|Lost to Follow-up|7|||
148975579|NCT03337724|537390852|FG004|Overall Study|Lost to Follow-up|4|||
148975580|NCT03337724|537390848|FG000|Overall Study|Physician Decision|16|||
148975581|NCT03337724|537390849|FG001|Overall Study|Physician Decision|34|||
148975582|NCT03337724|537390850|FG002|Overall Study|Physician Decision|14|||
148739850|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
148739851|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
148739852|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
148975583|NCT03337724|537390851|FG003|Overall Study|Physician Decision|34|||
148975584|NCT03337724|537390852|FG004|Overall Study|Physician Decision|13|||
148975585|NCT03337724|537390848|FG000|Overall Study|Progressive Disease|0|||
148975586|NCT03337724|537390849|FG001|Overall Study|Progressive Disease|2|||
148739853|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
148739854|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
148739855|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
148739856|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
148739857|NCT04040192|536520632|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
148739858|NCT04040192|536520633|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
148739859|NCT04040192|536520634|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
148739860|NCT00469144|536520635|FG000|Overall Study|Death|0|||
148739861|NCT00469144|536520636|FG001|Overall Study|Death|1|||
148975587|NCT03337724|537390850|FG002|Overall Study|Progressive Disease|1|||
148975588|NCT03337724|537390851|FG003|Overall Study|Progressive Disease|2|||
148975589|NCT03337724|537390852|FG004|Overall Study|Progressive Disease|0|||
148975590|NCT03337724|537390848|FG000|Overall Study|Symptomatic Deterioration|0|||
148975591|NCT03337724|537390849|FG001|Overall Study|Symptomatic Deterioration|0|||
148975592|NCT03337724|537390850|FG002|Overall Study|Symptomatic Deterioration|0|||
148975593|NCT03337724|537390851|FG003|Overall Study|Symptomatic Deterioration|1|||
148975594|NCT03337724|537390852|FG004|Overall Study|Symptomatic Deterioration|0|||
148975595|NCT00773097|537390853|FG000|Overall Study|Withdrawal by Subject|1|||
148975596|NCT00773097|537390853|FG000|Overall Study|Physician Decision|6|||
148975597|NCT03195478|537390858|FG000|Overall Study|Disease Progression|5|||
148975598|NCT03195478|537390859|FG001|Overall Study|Disease Progression|4|||
148975599|NCT03195478|537390860|FG002|Overall Study|Disease Progression|6|||
148975600|NCT03195478|537390861|FG003|Overall Study|Disease Progression|1|||
148975601|NCT03195478|537390858|FG000|Overall Study|Study Drug Toxicity|2|||
148975602|NCT03195478|537390859|FG001|Overall Study|Study Drug Toxicity|0|||
148975603|NCT03195478|537390860|FG002|Overall Study|Study Drug Toxicity|0|||
148975604|NCT03195478|537390861|FG003|Overall Study|Study Drug Toxicity|1|||
148975605|NCT03195478|537390858|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
148975606|NCT03195478|537390859|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
148975607|NCT03195478|537390860|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
148975608|NCT03195478|537390861|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
148975609|NCT03195478|537390858|FG000|Overall Study|Participant Withdrew Consent|1|||
148975610|NCT03195478|537390859|FG001|Overall Study|Participant Withdrew Consent|0|||
148975611|NCT03195478|537390860|FG002|Overall Study|Participant Withdrew Consent|0|||
148975612|NCT03195478|537390861|FG003|Overall Study|Participant Withdrew Consent|0|||
148975613|NCT03195478|537390858|FG000|Overall Study|Maximum Clinical benefit|0|||
148975614|NCT03195478|537390859|FG001|Overall Study|Maximum Clinical benefit|0|||
148975615|NCT03195478|537390860|FG002|Overall Study|Maximum Clinical benefit|1|||
148975616|NCT03195478|537390861|FG003|Overall Study|Maximum Clinical benefit|0|||
148975617|NCT03195478|537390858|FG000|Overall Study|Other Reasons|0|||
148975618|NCT03195478|537390859|FG001|Overall Study|Other Reasons|0|||
148975619|NCT03195478|537390860|FG002|Overall Study|Other Reasons|1|||
148975620|NCT03195478|537390861|FG003|Overall Study|Other Reasons|0|||
148975621|NCT02742103|537392286|FG000|Overall Study|Protocol Violation|1|||
148975622|NCT02742103|537392287|FG001|Overall Study|Protocol Violation|0|||
148739862|NCT00469144|536520635|FG000|Overall Study|No Response|5|||
148739863|NCT00469144|536520636|FG001|Overall Study|No Response|5|||
148739864|NCT00469144|536520635|FG000|Overall Study|Progressive Disease|1|||
148739865|NCT00469144|536520636|FG001|Overall Study|Progressive Disease|0|||
148739866|NCT01994291|536520637|FG000|Overall Study|Adverse Event|4|||
148739867|NCT01994291|536520638|FG001|Overall Study|Adverse Event|1|||
148739868|NCT01994291|536520639|FG002|Overall Study|Adverse Event|3|||
148739869|NCT01994291|536520637|FG000|Overall Study|Lost to Follow-up|1|||
148739870|NCT01994291|536520638|FG001|Overall Study|Lost to Follow-up|1|||
148739871|NCT01994291|536520639|FG002|Overall Study|Lost to Follow-up|0|||
148739872|NCT01994291|536520637|FG000|Overall Study|Does not meet entrance criteria|1|||
148739873|NCT01994291|536520638|FG001|Overall Study|Does not meet entrance criteria|0|||
148739874|NCT01994291|536520639|FG002|Overall Study|Does not meet entrance criteria|0|||
148739875|NCT01994291|536520637|FG000|Overall Study|Medication error without associated AE|1|||
148739876|NCT01994291|536520638|FG001|Overall Study|Medication error without associated AE|0|||
148739877|NCT01994291|536520639|FG002|Overall Study|Medication error without associated AE|1|||
148739878|NCT01994291|536520637|FG000|Overall Study|Protocol Violation|1|||
148975623|NCT02742103|537392286|FG000|Overall Study|Death|2|||
148975624|NCT02742103|537392287|FG001|Overall Study|Death|2|||
148739879|NCT01994291|536520638|FG001|Overall Study|Protocol Violation|0|||
148739880|NCT01994291|536520639|FG002|Overall Study|Protocol Violation|0|||
148975625|NCT02742103|537392286|FG000|Overall Study|Adverse Event|1|||
148739881|NCT01994291|536520637|FG000|Overall Study|Withdrawal by Subject|6|||
148739882|NCT01994291|536520638|FG001|Overall Study|Withdrawal by Subject|3|||
148739883|NCT01994291|536520639|FG002|Overall Study|Withdrawal by Subject|5|||
148739884|NCT01994291|536520637|FG000|Overall Study|Other|1|||
148975626|NCT02742103|537392287|FG001|Overall Study|Adverse Event|0|||
148975627|NCT02742103|537392286|FG000|Overall Study|Moved to another town|0|||
148739885|NCT01994291|536520638|FG001|Overall Study|Other|2|||
148975628|NCT02742103|537392287|FG001|Overall Study|Moved to another town|1|||
148975629|NCT02742103|537392286|FG000|Overall Study|Withdrawal by Subject|5|||
148739886|NCT01994291|536520639|FG002|Overall Study|Other|0|||
148739887|NCT00856375|536520640|FG000|Overall Study|Other|0|||
148739888|NCT00856375|536520641|FG001|Overall Study|Other|1|||
148739889|NCT00856375|536520640|FG000|Overall Study|Death|32|||
148739890|NCT00856375|536520641|FG001|Overall Study|Death|30|||
148739891|NCT00856375|536520640|FG000|Overall Study|Sponsor Terminated Study|7|||
148739892|NCT00856375|536520641|FG001|Overall Study|Sponsor Terminated Study|7|||
148739893|NCT00856375|536520640|FG000|Overall Study|Withdrawal by Subject|2|||
148739894|NCT00856375|536520641|FG001|Overall Study|Withdrawal by Subject|1|||
148739895|NCT00856375|536520640|FG000|Overall Study|Lost to Follow-up|1|||
148739896|NCT00856375|536520641|FG001|Overall Study|Lost to Follow-up|2|||
148739897|NCT02227446|536520642|FG000|Overall Study|not eligible post randomization|18|||
148739898|NCT02227446|536520643|FG001|Overall Study|not eligible post randomization|29|||
148739899|NCT02227446|536520642|FG000|Overall Study|Withdrawal by Subject|4|||
148739900|NCT02227446|536520643|FG001|Overall Study|Withdrawal by Subject|5|||
148739901|NCT02121392|536520644|FG000|Prior to Intervention|Protocol Violation|40|||
148739902|NCT02121392|536520645|FG001|Prior to Intervention|Protocol Violation|35|||
148739903|NCT02121392|536520644|FG000|Prior to Intervention|Withdrawal by Subject|8|||
148739904|NCT02121392|536520645|FG001|Prior to Intervention|Withdrawal by Subject|6|||
148739905|NCT02121392|536520644|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
148739906|NCT02121392|536520645|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
148739907|NCT02121392|536520644|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
148739908|NCT02121392|536520645|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
148739909|NCT01352416|536520646|FG000|Overall Study|Physician Decision|1|||
148739910|NCT01352416|536520647|FG001|Overall Study|Physician Decision|2|||
148739911|NCT01352416|536520648|FG002|Overall Study|Physician Decision|2|||
148739912|NCT01352416|536520649|FG003|Overall Study|Physician Decision|1|||
148739913|NCT03016975|536520658|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
148739914|NCT03016975|536520659|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
148739915|NCT03016975|536520660|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
148739916|NCT03016975|536520658|FG000|At 6 Months Follow-up|Death|2|||
148739917|NCT03016975|536520659|FG001|At 6 Months Follow-up|Death|0|||
148739918|NCT03016975|536520660|FG002|At 6 Months Follow-up|Death|0|||
148739919|NCT03016975|536520658|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
148739920|NCT03016975|536520659|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
148739921|NCT03016975|536520660|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
148739922|NCT03016975|536520658|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
148739923|NCT03016975|536520659|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
148739924|NCT03016975|536520660|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
148739925|NCT03016975|536520658|FG000|At 6 Months Follow-up|Aborted implant|1|||
148739926|NCT03016975|536520659|FG001|At 6 Months Follow-up|Aborted implant|0|||
148739927|NCT03016975|536520660|FG002|At 6 Months Follow-up|Aborted implant|0|||
148739928|NCT03016975|536520658|FG000|At 2 Year Follow-up|Death|1|||
148739929|NCT03016975|536520659|FG001|At 2 Year Follow-up|Death|0|||
148739930|NCT03016975|536520660|FG002|At 2 Year Follow-up|Death|0|||
148739931|NCT03016975|536520658|FG000|At 3 Year Follow-up|Death|1|||
148739932|NCT03016975|536520659|FG001|At 3 Year Follow-up|Death|0|||
148739933|NCT03016975|536520660|FG002|At 3 Year Follow-up|Death|0|||
148739934|NCT03016975|536520658|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
148739935|NCT03016975|536520659|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
148739936|NCT03016975|536520660|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
148739937|NCT03016975|536520658|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
148739938|NCT03016975|536520659|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
148739939|NCT03016975|536520660|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
148739940|NCT02901548|536520661|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
148739941|NCT02640053|536520665|FG000|Overall Study|Withdrawal by Subject|2|||
148739942|NCT02640053|536520666|FG001|Overall Study|Withdrawal by Subject|1|||
148739943|NCT02640053|536520665|FG000|Overall Study|Adverse Event|1|||
148739944|NCT02640053|536520666|FG001|Overall Study|Adverse Event|1|||
148739945|NCT02640053|536520665|FG000|Overall Study|Alternative Therapy|1|||
148739946|NCT02640053|536520666|FG001|Overall Study|Alternative Therapy|1|||
148739947|NCT02640053|536520665|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
148975630|NCT02742103|537392287|FG001|Overall Study|Withdrawal by Subject|2|||
148739948|NCT02640053|536520666|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
148739949|NCT02348723|536520667|FG000|Overall Study|No ablation|21|||
148739950|NCT02348723|536520668|FG001|Overall Study|No ablation|20|||
148739951|NCT02348723|536520667|FG000|Overall Study|Non-compliant with Protocol|1|||
148975631|NCT04346615|537392290|FG000|Overall Study|Lost to Follow-up|0|||
148975632|NCT04346615|537392291|FG001|Overall Study|Lost to Follow-up|2|||
148975633|NCT04346615|537392290|FG000|Overall Study|Withdrawal by Subject|1|||
148975634|NCT04346615|537392291|FG001|Overall Study|Withdrawal by Subject|0|||
148739952|NCT02348723|536520668|FG001|Overall Study|Non-compliant with Protocol|0|||
148739953|NCT02348723|536520667|FG000|Overall Study|Lost to Follow-up|1|||
148739954|NCT02348723|536520668|FG001|Overall Study|Lost to Follow-up|1|||
148739955|NCT02348723|536520667|FG000|Overall Study|Consent withdrawn|1|||
148975635|NCT04346615|537392290|FG000|Overall Study|Death|5|||
148739956|NCT02348723|536520668|FG001|Overall Study|Consent withdrawn|3|||
148739957|NCT02348723|536520667|FG000|Overall Study|Reason other than specified|1|||
148739958|NCT02348723|536520668|FG001|Overall Study|Reason other than specified|1|||
148739959|NCT02348723|536520667|FG000|Overall Study|Adverse Event|3|||
148739960|NCT02348723|536520668|FG001|Overall Study|Adverse Event|1|||
148739961|NCT02910063|536520671|FG000|Phase 2|Withdrawal by Subject|3|||
148739962|NCT02910063|536520672|FG001|Phase 2|Withdrawal by Subject|0|||
148739963|NCT02910063|536520673|FG002|Phase 2|Withdrawal by Subject|0|||
148739964|NCT02910063|536520671|FG000|Phase 2|Lost to Follow-up|1|||
148739965|NCT02910063|536520672|FG001|Phase 2|Lost to Follow-up|0|||
148739966|NCT02910063|536520673|FG002|Phase 2|Lost to Follow-up|0|||
148739967|NCT02910063|536520671|FG000|Phase 2|Death|24|||
148739968|NCT02910063|536520672|FG001|Phase 2|Death|0|||
148739969|NCT02910063|536520673|FG002|Phase 2|Death|0|||
148739970|NCT04435184|536520674|FG000|Overall Study|follow-up blood draws missing|3|||
148739971|NCT04435184|536520675|FG001|Overall Study|follow-up blood draws missing|5|||
148739972|NCT00426361|536520682|FG000|Overall Study|Lost to Follow-up|3|||
148739973|NCT00426361|536520683|FG001|Overall Study|Lost to Follow-up|2|||
148739974|NCT00426361|536520684|FG002|Overall Study|Lost to Follow-up|5|||
148739975|NCT00426361|536520682|FG000|Overall Study|Withdrawal by Subject|1|||
148739976|NCT00426361|536520683|FG001|Overall Study|Withdrawal by Subject|3|||
148739977|NCT00426361|536520684|FG002|Overall Study|Withdrawal by Subject|0|||
148739978|NCT02828241|536520685|FG000|Overall Study|Adverse Event|7|||
148739979|NCT02828241|536520686|FG001|Overall Study|Adverse Event|2|||
148739980|NCT02828241|536520685|FG000|Overall Study|Protocol Violation|1|||
148739981|NCT02828241|536520686|FG001|Overall Study|Protocol Violation|0|||
148739982|NCT03050060|536520702|FG000|Overall Study|Adverse Event|7|||
148739983|NCT03050060|536520702|FG000|Overall Study|Withdrawal by Subject|1|||
148739984|NCT03050060|536520702|FG000|Overall Study|Progression|7|||
148739985|NCT00510289|536520703|FG000|Overall Study|Withdrawal by Subject|7|||
148739986|NCT00510289|536520703|FG000|Overall Study|Refused bone marrow biopsy|2|||
148739987|NCT00510289|536520703|FG000|Overall Study|Lost to Follow-up|1|||
148739988|NCT00510289|536520703|FG000|Overall Study|Progressed prior to starting drug|2|||
148739989|NCT04428333|536520706|FG000|Overall Study|Physician Decision|5|||
148739990|NCT04428333|536520707|FG001|Overall Study|Physician Decision|6|||
148739991|NCT04428333|536520706|FG000|Overall Study|Withdrawal by Subject|1|||
148739992|NCT04428333|536520707|FG001|Overall Study|Withdrawal by Subject|3|||
148739993|NCT04428333|536520706|FG000|Overall Study|Study Terminated By Sponsor|14|||
148739994|NCT04428333|536520707|FG001|Overall Study|Study Terminated By Sponsor|16|||
148739995|NCT01094886|536520710|FG000|Overall Study|Adverse Event|2|||
148739996|NCT01094886|536520710|FG000|Overall Study|Withdrawal by Subject|5|||
148739997|NCT03866902|536520711|FG000|Overall Study|Lost to Follow-up|98|||
148739998|NCT03866902|536520712|FG001|Overall Study|Lost to Follow-up|82|||
148739999|NCT03866902|536520711|FG000|Overall Study|Pregnancy|18|||
148740000|NCT03866902|536520712|FG001|Overall Study|Pregnancy|24|||
148740001|NCT00371397|536520720|FG000|Session 1|Withdrawal by Subject|1|||
148740002|NCT00371397|536520721|FG001|Session 1|Withdrawal by Subject|0|||
148740003|NCT00371397|536520722|FG002|Session 1|Withdrawal by Subject|0|||
148740004|NCT00371397|536520723|FG003|Session 1|Withdrawal by Subject|0|||
148740005|NCT00371397|536520724|FG004|Session 1|Withdrawal by Subject|0|||
148740006|NCT00371397|536520725|FG005|Session 1|Withdrawal by Subject|0|||
148740007|NCT00371397|536520726|FG006|Session 1|Withdrawal by Subject|0|||
148740008|NCT00371397|536520727|FG007|Session 1|Withdrawal by Subject|1|||
148740009|NCT00371397|536520728|FG008|Session 1|Withdrawal by Subject|0|||
148740010|NCT00371397|536520729|FG009|Session 1|Withdrawal by Subject|0|||
148740011|NCT00371397|536520730|FG010|Session 1|Withdrawal by Subject|0|||
148740012|NCT00371397|536520731|FG011|Session 1|Withdrawal by Subject|0|||
148740013|NCT02377427|536520732|FG000|Part A (Up to Week 20)|Physician Decision|1|||
148740014|NCT02377427|536520733|FG001|Part A (Up to Week 20)|Physician Decision|0|||
148740015|NCT02377427|536520734|FG002|Part A (Up to Week 20)|Physician Decision|0|||
148740016|NCT02377427|536520735|FG003|Part A (Up to Week 20)|Physician Decision|0|||
148740017|NCT02377427|536520736|FG004|Part A (Up to Week 20)|Physician Decision|0|||
148740018|NCT02377427|536520732|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
148740019|NCT02377427|536520733|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
148740020|NCT02377427|536520734|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
148740021|NCT02377427|536520735|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
148740022|NCT02377427|536520736|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
148740023|NCT02377427|536520732|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
148740024|NCT02377427|536520733|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
148740025|NCT02377427|536520734|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
148740026|NCT02377427|536520735|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
148740027|NCT02377427|536520736|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
148740028|NCT02377427|536520732|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
148740029|NCT02377427|536520733|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
148740030|NCT02377427|536520734|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
148740031|NCT02377427|536520735|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
148740032|NCT02377427|536520736|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
148740033|NCT02293863|536520737|FG000|Overall Study|Death|4|||
148740034|NCT02293863|536520738|FG001|Overall Study|Death|6|||
148740035|NCT02293863|536520739|FG002|Overall Study|Death|4|||
148740036|NCT02293863|536520737|FG000|Overall Study|Lost to Follow-up|2|||
148740037|NCT02293863|536520738|FG001|Overall Study|Lost to Follow-up|2|||
148740038|NCT02293863|536520739|FG002|Overall Study|Lost to Follow-up|2|||
148740039|NCT02293863|536520737|FG000|Overall Study|Withdrawal by Subject|3|||
148740040|NCT02293863|536520738|FG001|Overall Study|Withdrawal by Subject|3|||
148740041|NCT02293863|536520739|FG002|Overall Study|Withdrawal by Subject|1|||
148740042|NCT02293863|536520737|FG000|Overall Study|Reason Not Specified|0|||
148740043|NCT02293863|536520738|FG001|Overall Study|Reason Not Specified|2|||
148740044|NCT02293863|536520739|FG002|Overall Study|Reason Not Specified|2|||
148740045|NCT02342639|536520740|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
148740046|NCT02342639|536520741|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
148740047|NCT02342639|536520740|FG000|Overall Study|Protocol Violation|0|||
148740048|NCT02342639|536520741|FG001|Overall Study|Protocol Violation|2|||
148740049|NCT00416884|536520744|FG000|Overall Study|Study terminated due to low accrual|1|||
148740050|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
148740051|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
148740052|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740053|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740054|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740055|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740056|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740057|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740058|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740059|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740060|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740061|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740062|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740063|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
148740064|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
148740065|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
148740066|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740067|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740068|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740069|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740070|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740071|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740072|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740073|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740074|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740075|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740076|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740077|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
148740078|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
148740079|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
148740080|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740081|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740082|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740083|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740084|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740085|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740086|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740087|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740088|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740089|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740090|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148818446|NCT04439123|536810426|FG000|Overall Study|Disease progression|19|||
148818447|NCT04439123|536810426|FG000|Overall Study|Withdrawal by Subject|2|||
148975636|NCT04346615|537392291|FG001|Overall Study|Death|1|||
148975637|NCT04346615|537392290|FG000|Overall Study|Other|0|||
148740091|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
148740092|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
148740093|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
148740094|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740095|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740096|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740097|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740098|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740099|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740100|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740101|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740102|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740103|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740104|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740105|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
148740106|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
148740107|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
148740108|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740109|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740110|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740111|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740112|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740113|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740114|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740115|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740116|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740117|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740118|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740119|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
148740120|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
148740121|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
148740122|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740123|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740124|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740125|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740126|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740127|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740128|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740129|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740130|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740131|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740132|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740133|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
148740134|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
148740135|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
148740136|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740137|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740138|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740139|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740140|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740141|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740142|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148818448|NCT04439123|536810426|FG000|Overall Study|Still on treatment|2|||
148818449|NCT00424008|536810427|FG000|Overall Study|Adverse Event|8|||
148818450|NCT00424008|536810428|FG001|Overall Study|Adverse Event|6|||
148818451|NCT00424008|536810427|FG000|Overall Study|Lack of Efficacy|40|||
148818452|NCT00424008|536810428|FG001|Overall Study|Lack of Efficacy|34|||
148818453|NCT00424008|536810427|FG000|Overall Study|Lost to Follow-up|1|||
148818454|NCT00424008|536810428|FG001|Overall Study|Lost to Follow-up|2|||
148818455|NCT00424008|536810427|FG000|Overall Study|Withdrawal by Subject|5|||
148818456|NCT00424008|536810428|FG001|Overall Study|Withdrawal by Subject|8|||
148818457|NCT00424008|536810427|FG000|Overall Study|Noncompliance with protocol|13|||
148818458|NCT00424008|536810428|FG001|Overall Study|Noncompliance with protocol|7|||
148818459|NCT00424008|536810427|FG000|Overall Study|Did not meet protocol eligibility|16|||
148818460|NCT00424008|536810428|FG001|Overall Study|Did not meet protocol eligibility|21|||
148818461|NCT00424008|536810427|FG000|Overall Study|Administrative|266|||
148818462|NCT00424008|536810428|FG001|Overall Study|Administrative|257|||
148818463|NCT02593864|536810429|FG000|Overall Study|Withdrawal by Subject|3|||
148818464|NCT02593864|536810429|FG000|Overall Study|Lost to Follow-up|3|||
148818465|NCT01405911|536810430|FG000|Overall Study|Pre-treatment lab AE|0|||
148818466|NCT01405911|536810431|FG001|Overall Study|Pre-treatment lab AE|1|||
148818467|NCT01405911|536810432|FG002|Overall Study|Pre-treatment lab AE|0|||
148818468|NCT01405911|536810430|FG000|Overall Study|Lost to Follow-up|0|||
148818469|NCT01405911|536810431|FG001|Overall Study|Lost to Follow-up|1|||
148818470|NCT01405911|536810432|FG002|Overall Study|Lost to Follow-up|0|||
148818471|NCT01405911|536810430|FG000|Overall Study|Protocol Violation|1|||
148818472|NCT01405911|536810431|FG001|Overall Study|Protocol Violation|0|||
148818473|NCT01405911|536810432|FG002|Overall Study|Protocol Violation|0|||
148975638|NCT04346615|537392291|FG001|Overall Study|Other|2|||
148740143|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740144|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740145|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740146|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740147|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
148740148|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
148740149|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
148740150|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740151|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740152|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740153|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740154|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740155|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740156|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740157|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740158|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740159|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740160|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740161|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
148740162|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
148740163|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
148740164|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740165|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740166|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740167|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740168|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740169|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740170|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740171|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740172|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740173|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740174|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740175|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
148740176|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
148740177|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
148740178|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740179|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740180|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740181|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740182|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740183|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740184|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740185|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740186|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740187|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740188|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740189|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
148740190|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
148740191|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
148740192|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740193|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740194|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740195|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740196|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740197|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740198|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740199|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740200|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740201|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148818474|NCT01405911|536810430|FG000|Overall Study|Withdrawal by Subject|3|||
148740202|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740203|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
148740204|NCT03982199|536520745|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
148740205|NCT03982199|536520746|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
148740206|NCT03982199|536520747|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740207|NCT03982199|536520748|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740208|NCT03982199|536520749|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740209|NCT03982199|536520750|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740210|NCT03982199|536520751|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740211|NCT03982199|536520752|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740212|NCT03982199|536520753|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740213|NCT03982199|536520754|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740214|NCT03982199|536520755|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740215|NCT03982199|536520756|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740216|NCT03982199|536520757|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740217|NCT03982199|536520758|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
148740218|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740219|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740220|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740221|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
148740222|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740223|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740224|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740225|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740226|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740227|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740228|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740229|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740230|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740231|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
148740232|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740233|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740234|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
148740235|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740236|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740237|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740238|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740239|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740240|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740241|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740242|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740243|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740244|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740245|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
148740246|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740247|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740248|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
148740249|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740250|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740251|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740252|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740253|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740254|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740255|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740256|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740257|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740258|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740259|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
148740260|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740261|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740262|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
148740263|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
148740264|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740265|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740266|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740267|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740268|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148975639|NCT04346615|537392290|FG000|Overall Study|Randomized not treated|1|||
148975640|NCT04346615|537392291|FG001|Overall Study|Randomized not treated|0|||
148740269|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740270|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740271|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740272|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740273|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
148740274|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740275|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740276|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740277|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
148740278|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740279|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740280|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740281|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740282|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740283|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740284|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740285|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740286|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740287|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
148740288|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740289|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740290|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
148740291|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
148740292|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740293|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740294|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740295|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740296|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740297|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740298|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740299|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740300|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740301|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
148740302|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740303|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740304|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740305|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740306|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740307|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740308|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740309|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740310|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
148740311|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740312|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740313|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740314|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740315|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
148740316|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740317|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740318|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740319|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740320|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740321|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740322|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740323|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740324|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
148740325|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148975641|NCT02349711|537392299|FG000|Overall Study|Withdrawal by Subject|2|||
148975642|NCT02349711|537392300|FG001|Overall Study|Withdrawal by Subject|1|||
148975643|NCT02349711|537392299|FG000|Overall Study|Lost to Follow-up|1|||
148975644|NCT02349711|537392300|FG001|Overall Study|Lost to Follow-up|1|||
148740326|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740327|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740328|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740329|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
148740330|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740331|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740332|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740333|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740334|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740335|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740336|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740337|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740338|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
148740339|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740340|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740341|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740342|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740343|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
148740344|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740345|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740346|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740347|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740348|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740349|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740350|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740351|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740352|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
148740353|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740354|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740355|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740356|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740357|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
148740358|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740359|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740360|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740361|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740362|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740363|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740364|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740365|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740366|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
148740367|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740368|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740369|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740370|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740371|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
148740372|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148818475|NCT01405911|536810431|FG001|Overall Study|Withdrawal by Subject|1|||
148975645|NCT02453594|537392301|FG000|Overall Study|Protocol Violation|0|||
148975646|NCT02453594|537392302|FG001|Overall Study|Protocol Violation|0|||
148975647|NCT02453594|537392303|FG002|Overall Study|Protocol Violation|1|||
148975648|NCT02453594|537392301|FG000|Overall Study|Cohort Was Closed|17|||
148975649|NCT02453594|537392302|FG001|Overall Study|Cohort Was Closed|21|||
148975650|NCT02453594|537392303|FG002|Overall Study|Cohort Was Closed|14|||
148975651|NCT02453594|537392301|FG000|Overall Study|Death|20|||
148975652|NCT02453594|537392302|FG001|Overall Study|Death|24|||
148975653|NCT02453594|537392303|FG002|Overall Study|Death|16|||
148975654|NCT02453594|537392301|FG000|Overall Study|Lost to Follow-up|6|||
148975655|NCT02453594|537392302|FG001|Overall Study|Lost to Follow-up|14|||
148975656|NCT02453594|537392303|FG002|Overall Study|Lost to Follow-up|2|||
148975657|NCT02453594|537392301|FG000|Overall Study|Physician Decision|2|||
148975658|NCT02453594|537392302|FG001|Overall Study|Physician Decision|4|||
148975659|NCT02453594|537392303|FG002|Overall Study|Physician Decision|0|||
148975660|NCT02453594|537392301|FG000|Overall Study|Site Terminated by Sponsor|1|||
148975661|NCT02453594|537392302|FG001|Overall Study|Site Terminated by Sponsor|0|||
148975662|NCT02453594|537392303|FG002|Overall Study|Site Terminated by Sponsor|1|||
148975663|NCT02453594|537392301|FG000|Overall Study|Transitioned to Extension Study|16|||
148740373|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148818476|NCT01405911|536810432|FG002|Overall Study|Withdrawal by Subject|1|||
148818477|NCT06375655|536810433|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
148975664|NCT02453594|537392302|FG001|Overall Study|Transitioned to Extension Study|9|||
148740374|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740375|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740376|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740377|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
148740378|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740379|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
148740380|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
148740381|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740382|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740383|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740384|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740385|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
148740386|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740387|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740388|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740389|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740390|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740391|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740392|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740393|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740394|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
148740395|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740396|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740397|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740398|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740399|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
148740400|NCT03982199|536520745|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740401|NCT03982199|536520746|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740402|NCT03982199|536520747|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740403|NCT03982199|536520748|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740404|NCT03982199|536520749|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740405|NCT03982199|536520750|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
148740406|NCT03982199|536520751|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740407|NCT03982199|536520752|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
148740408|NCT03982199|536520753|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
148740409|NCT03982199|536520754|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740410|NCT03982199|536520755|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740411|NCT03982199|536520756|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740412|NCT03982199|536520757|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740413|NCT03982199|536520758|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
148740414|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740415|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740416|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740417|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740418|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740419|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740420|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740421|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740422|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
148740423|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
148740424|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
148740425|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
148740426|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
148740427|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
148740428|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740429|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740430|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740431|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740432|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740433|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740434|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740435|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740436|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740437|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
148740438|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740439|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740440|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740441|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
148740442|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740443|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740444|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740445|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740446|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740447|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740448|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740449|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740450|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740451|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
149027118|NCT00578227|537576502|FG001|Overall Study|Withdrawal by Subject|1|||
149027119|NCT00578227|537576503|FG002|Overall Study|Withdrawal by Subject|3|||
149027120|NCT00916006|537576508|FG000|Overall Study|Adverse Event|1|||
149027121|NCT00916006|537576509|FG001|Overall Study|Adverse Event|1|||
149027122|NCT00916006|537576508|FG000|Overall Study|Withdrawal by Subject|2|||
149027123|NCT00916006|537576509|FG001|Overall Study|Withdrawal by Subject|5|||
149027124|NCT00916006|537576508|FG000|Overall Study|Protocol Violation|0|||
149027125|NCT00916006|537576509|FG001|Overall Study|Protocol Violation|1|||
148740452|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740453|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740454|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
148740455|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
148740456|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740457|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740458|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740459|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740460|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740461|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740462|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740463|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740464|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740465|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740466|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
148740467|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
148740468|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
148740469|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
148740470|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740471|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740472|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740473|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740474|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740475|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740476|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740477|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740478|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148818478|NCT06375655|536810434|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
149027126|NCT01605136|537576514|FG000|Study Period|Withdrawal by Subject|2|||
149027127|NCT01605136|537576515|FG001|Study Period|Withdrawal by Subject|0|||
148818479|NCT04124965|536810435|FG000|Overall Study|Adverse event, non-fatal|3|||
148818480|NCT04124965|536810436|FG001|Overall Study|Adverse event, non-fatal|1|||
148818481|NCT04124965|536810435|FG000|Overall Study|Withdrawal by Subject|1|||
148818482|NCT04124965|536810436|FG001|Overall Study|Withdrawal by Subject|1|||
148818483|NCT04124965|536810435|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
148818484|NCT04124965|536810436|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
148818485|NCT04124965|536810435|FG000|Overall Study|Pregnancy|1|||
148818486|NCT04124965|536810436|FG001|Overall Study|Pregnancy|0|||
149027128|NCT01605136|537576514|FG000|Study Period|Physician Decision|1|||
149027129|NCT01605136|537576515|FG001|Study Period|Physician Decision|1|||
149027130|NCT01605136|537576514|FG000|Study Period|Lost to Follow-up|0|||
148740479|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740480|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740481|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740482|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
148740483|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
148740484|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740485|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740486|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740487|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740488|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740489|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740490|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740491|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740492|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740493|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740494|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740495|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
148740496|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
148740497|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
148740498|NCT03982199|536520745|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740499|NCT03982199|536520746|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740500|NCT03982199|536520747|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740501|NCT03982199|536520748|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740502|NCT03982199|536520749|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740503|NCT03982199|536520750|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740504|NCT03982199|536520751|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740505|NCT03982199|536520752|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740506|NCT03982199|536520753|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740507|NCT03982199|536520754|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740508|NCT03982199|536520755|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740509|NCT03982199|536520756|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740510|NCT03982199|536520757|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
148740511|NCT03982199|536520758|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
148740512|NCT03395405|536522217|FG000|Overall Study|Death|0|||
148740513|NCT03395405|536522218|FG001|Overall Study|Death|2|||
148740514|NCT03395405|536522217|FG000|Overall Study|Lost to Follow-up|0|||
148740515|NCT03395405|536522218|FG001|Overall Study|Lost to Follow-up|1|||
148740516|NCT03395405|536522217|FG000|Overall Study|Protocol Violation|0|||
148740517|NCT03395405|536522218|FG001|Overall Study|Protocol Violation|1|||
148740518|NCT03395405|536522217|FG000|Overall Study|Withdrawal by Subject|3|||
148740519|NCT03395405|536522218|FG001|Overall Study|Withdrawal by Subject|1|||
148740520|NCT03395405|536522217|FG000|Overall Study|COVID-19 Pandemic|1|||
148740521|NCT03395405|536522218|FG001|Overall Study|COVID-19 Pandemic|0|||
148740522|NCT00450801|536522221|FG000|Overall Study|Death|1|||
148740523|NCT05048329|536522222|FG000|Overall Study|Withdrawal by Subject|1|||
148740524|NCT05048329|536522222|FG000|Overall Study|Screenfail|1|||
148740525|NCT00324649|536522223|FG000|Overall Study|Adverse Event|1|||
148740526|NCT00324649|536522224|FG001|Overall Study|Adverse Event|4|||
148740527|NCT00324649|536522223|FG000|Overall Study|Withdrawal by Subject|0|||
148740528|NCT00324649|536522224|FG001|Overall Study|Withdrawal by Subject|1|||
148740529|NCT00324649|536522223|FG000|Overall Study|Noncompliance|1|||
148740530|NCT00324649|536522224|FG001|Overall Study|Noncompliance|0|||
148740531|NCT01396512|536522227|FG000|Overall Study|Withdrawal by Subject|0|||
148740532|NCT01396512|536522228|FG001|Overall Study|Withdrawal by Subject|1|||
148740533|NCT02152605|536522229|FG000|Overall Study|Adverse Event|6|||
148740534|NCT02152605|536522230|FG001|Overall Study|Adverse Event|8|||
148740535|NCT02152605|536522229|FG000|Overall Study|Lack of Efficacy|7|||
148740536|NCT02152605|536522230|FG001|Overall Study|Lack of Efficacy|4|||
148740537|NCT02152605|536522229|FG000|Overall Study|Protocol deviation|1|||
148740538|NCT02152605|536522230|FG001|Overall Study|Protocol deviation|4|||
148740539|NCT02152605|536522229|FG000|Overall Study|Lost to Follow-up|1|||
148740540|NCT02152605|536522230|FG001|Overall Study|Lost to Follow-up|0|||
148740541|NCT02152605|536522229|FG000|Overall Study|Withdrew consent|4|||
148740542|NCT02152605|536522230|FG001|Overall Study|Withdrew consent|2|||
148740543|NCT01564537|536522235|FG000|Overall Study|Site Terminated by Sponsor|1|||
148740544|NCT01564537|536522236|FG001|Overall Study|Site Terminated by Sponsor|0|||
148740545|NCT01564537|536522235|FG000|Overall Study|Withdrawal by Subject|12|||
148740546|NCT01564537|536522236|FG001|Overall Study|Withdrawal by Subject|14|||
148740547|NCT01564537|536522235|FG000|Overall Study|Lost to Follow-up|7|||
148740548|NCT01564537|536522236|FG001|Overall Study|Lost to Follow-up|3|||
148740549|NCT01564537|536522235|FG000|Overall Study|Reason not specified|81|||
148740550|NCT01564537|536522236|FG001|Overall Study|Reason not specified|82|||
148740551|NCT05776862|536522237|FG000|Overall Study|Adverse Event|0|||
148740552|NCT05776862|536522238|FG001|Overall Study|Adverse Event|1|||
148740553|NCT05776862|536522237|FG000|Overall Study|non-compliance|1|||
148740554|NCT05776862|536522238|FG001|Overall Study|non-compliance|0|||
148740555|NCT02448706|536522239|FG000|Overall Study|Withdrawal by Subject|4|||
148740556|NCT02448706|536522240|FG001|Overall Study|Withdrawal by Subject|3|||
148740557|NCT02448706|536522239|FG000|Overall Study|Protocol Violation|1|||
148740558|NCT02448706|536522240|FG001|Overall Study|Protocol Violation|1|||
148740559|NCT01199471|536522241|FG000|Overall Study|Protocol Violation|4|||
148740560|NCT01199471|536522241|FG000|Overall Study|Withdrawal by Subject|1|||
148740561|NCT01199471|536522241|FG000|Overall Study|Physician Decision|1|||
149027131|NCT01605136|537576515|FG001|Study Period|Lost to Follow-up|2|||
148740562|NCT02065700|536522242|FG000|Overall Study|Adverse Event|165|||
148818487|NCT04124965|536810435|FG000|Overall Study|Sponsor and participant decision|0|||
148818488|NCT04124965|536810436|FG001|Overall Study|Sponsor and participant decision|1|||
148818489|NCT04124965|536810435|FG000|Overall Study|Personal surgery|0|||
148740563|NCT02065700|536522243|FG001|Overall Study|Adverse Event|101|||
148740564|NCT02065700|536522242|FG000|Overall Study|Withdrawal by Subject|90|||
148740565|NCT02065700|536522243|FG001|Overall Study|Withdrawal by Subject|29|||
148740566|NCT02065700|536522242|FG000|Overall Study|Lost to Follow-up|12|||
148740567|NCT02065700|536522243|FG001|Overall Study|Lost to Follow-up|9|||
148740568|NCT02065700|536522242|FG000|Overall Study|Physician Decision|2|||
148740569|NCT02065700|536522243|FG001|Overall Study|Physician Decision|0|||
148740570|NCT02065700|536522242|FG000|Overall Study|Sponsor Request|38|||
148740571|NCT02065700|536522243|FG001|Overall Study|Sponsor Request|15|||
148740572|NCT02065700|536522242|FG000|Overall Study|Treatment Failure|3|||
148740573|NCT02065700|536522243|FG001|Overall Study|Treatment Failure|2|||
148740574|NCT02065700|536522242|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
148740575|NCT02065700|536522243|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
148740576|NCT02065700|536522242|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
148740577|NCT02065700|536522243|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
148740578|NCT02065700|536522242|FG000|Overall Study|Non-compliance with Study Procedures|2|||
148740579|NCT02065700|536522243|FG001|Overall Study|Non-compliance with Study Procedures|0|||
148740580|NCT02065700|536522242|FG000|Overall Study|Not Defined|21|||
148740581|NCT02065700|536522243|FG001|Overall Study|Not Defined|3|||
148740582|NCT00554606|536522246|FG000|Overall Study|Adverse Event|3|||
148740583|NCT00554606|536522246|FG000|Overall Study|Abnormal laboratory values|1|||
148740584|NCT00554606|536522246|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
148740585|NCT00554606|536522246|FG000|Overall Study|Subject withdrew consent|2|||
148740586|NCT00554606|536522246|FG000|Overall Study|Lost to Follow-up|2|||
148740587|NCT00554606|536522246|FG000|Overall Study|Administrative problems|60|||
148740588|NCT00554606|536522246|FG000|Overall Study|Death|1|||
148740589|NCT00554606|536522246|FG000|Overall Study|Protocol deviation|2|||
148818490|NCT04124965|536810436|FG001|Overall Study|Personal surgery|1|||
148818491|NCT04124965|536810435|FG000|Overall Study|Physician Decision|0|||
148818492|NCT04124965|536810436|FG001|Overall Study|Physician Decision|1|||
148818493|NCT02184156|536810437|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
148818494|NCT02184156|536810438|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
148818495|NCT02184156|536810437|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
148818496|NCT02184156|536810438|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
148818497|NCT02114684|536810441|FG000|Overall Study|Death|6|||
148818498|NCT02114684|536810442|FG001|Overall Study|Death|4|||
148818499|NCT02114684|536810441|FG000|Overall Study|Lost to Follow-up|1|||
148818500|NCT02114684|536810442|FG001|Overall Study|Lost to Follow-up|2|||
148818501|NCT02114684|536810441|FG000|Overall Study|Withdrawal by Subject|1|||
148818502|NCT02114684|536810442|FG001|Overall Study|Withdrawal by Subject|2|||
148740590|NCT03323437|536522248|FG000|Overall Study|Withdrawal by Subject|0|||
148818503|NCT02114684|536810441|FG000|Overall Study|Relocation|3|||
148818504|NCT02114684|536810442|FG001|Overall Study|Relocation|1|||
148818505|NCT02114684|536810441|FG000|Overall Study|Rifampicin resistant on culture|0|||
148818506|NCT02114684|536810442|FG001|Overall Study|Rifampicin resistant on culture|1|||
148818507|NCT02114684|536810441|FG000|Overall Study|Patient Incarcerated|1|||
148818508|NCT02114684|536810442|FG001|Overall Study|Patient Incarcerated|0|||
148818509|NCT02530242|536810448|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
148818510|NCT02530242|536810449|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
148818511|NCT00283959|536810450|FG000|Extension Period|Low Compliance|1|||
148818512|NCT01214720|536810453|FG000|Overall Study|Alive and still on treatment|34|||
148818513|NCT01214720|536810454|FG001|Overall Study|Alive and still on treatment|18|||
148818514|NCT01214720|536810453|FG000|Overall Study|Alive and in follow-up|45|||
148818515|NCT01214720|536810454|FG001|Overall Study|Alive and in follow-up|48|||
148818516|NCT01214720|536810453|FG000|Overall Study|Lost to Follow-up|6|||
148818517|NCT01214720|536810454|FG001|Overall Study|Lost to Follow-up|2|||
148740591|NCT03323437|536522249|FG001|Overall Study|Withdrawal by Subject|4|||
148740592|NCT01473524|536522254|FG000|DB Phase|Adverse Event|4|||
148740593|NCT01473524|536522255|FG001|DB Phase|Adverse Event|8|||
148740594|NCT01473524|536522256|FG002|DB Phase|Adverse Event|2|||
148818518|NCT05591755|536810455|FG000|Overall Study|Screen Failure|1|||
148740595|NCT01473524|536522257|FG003|DB Phase|Adverse Event|0|||
148740596|NCT01473524|536522258|FG004|DB Phase|Adverse Event|0|||
148740597|NCT01473524|536522259|FG005|DB Phase|Adverse Event|0|||
148740598|NCT01473524|536522254|FG000|DB Phase|Death|1|||
148740599|NCT01473524|536522255|FG001|DB Phase|Death|0|||
148740600|NCT01473524|536522256|FG002|DB Phase|Death|0|||
148740601|NCT01473524|536522257|FG003|DB Phase|Death|0|||
148740602|NCT01473524|536522258|FG004|DB Phase|Death|0|||
148740603|NCT01473524|536522259|FG005|DB Phase|Death|0|||
148740604|NCT01473524|536522254|FG000|DB Phase|Withdrawal by Subject|2|||
148740605|NCT01473524|536522255|FG001|DB Phase|Withdrawal by Subject|1|||
148740606|NCT01473524|536522256|FG002|DB Phase|Withdrawal by Subject|1|||
148740607|NCT01473524|536522257|FG003|DB Phase|Withdrawal by Subject|0|||
148740608|NCT01473524|536522258|FG004|DB Phase|Withdrawal by Subject|0|||
148740609|NCT01473524|536522259|FG005|DB Phase|Withdrawal by Subject|0|||
148740610|NCT01473524|536522254|FG000|LTSE Phase|Withdrawal by Subject|0|||
148740611|NCT01473524|536522255|FG001|LTSE Phase|Withdrawal by Subject|0|||
148740612|NCT01473524|536522256|FG002|LTSE Phase|Withdrawal by Subject|0|||
148740613|NCT01473524|536522257|FG003|LTSE Phase|Withdrawal by Subject|3|||
148740614|NCT01473524|536522258|FG004|LTSE Phase|Withdrawal by Subject|3|||
148740615|NCT01473524|536522259|FG005|LTSE Phase|Withdrawal by Subject|6|||
148740616|NCT01473524|536522254|FG000|LTSE Phase|Death|0|||
148740617|NCT01473524|536522255|FG001|LTSE Phase|Death|0|||
148740618|NCT01473524|536522256|FG002|LTSE Phase|Death|0|||
148740619|NCT01473524|536522257|FG003|LTSE Phase|Death|0|||
148740620|NCT01473524|536522258|FG004|LTSE Phase|Death|1|||
148740621|NCT01473524|536522259|FG005|LTSE Phase|Death|0|||
148740622|NCT01473524|536522254|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
148740623|NCT01473524|536522255|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
148740624|NCT01473524|536522256|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
148740625|NCT01473524|536522257|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
148740626|NCT01473524|536522258|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
148740627|NCT01473524|536522259|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
148740628|NCT01473524|536522254|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
148740629|NCT01473524|536522255|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
148740630|NCT01473524|536522256|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
148740631|NCT01473524|536522257|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
148740632|NCT01473524|536522258|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
148740633|NCT01473524|536522259|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
148740634|NCT01473524|536522254|FG000|LTSE Phase|Lost to Follow-up|0|||
148740635|NCT01473524|536522255|FG001|LTSE Phase|Lost to Follow-up|0|||
148740636|NCT01473524|536522256|FG002|LTSE Phase|Lost to Follow-up|0|||
148740637|NCT01473524|536522257|FG003|LTSE Phase|Lost to Follow-up|1|||
148740638|NCT01473524|536522258|FG004|LTSE Phase|Lost to Follow-up|3|||
148740639|NCT01473524|536522259|FG005|LTSE Phase|Lost to Follow-up|2|||
148740640|NCT01473524|536522254|FG000|LTSE Phase|Principal Investigator Decision|0|||
148740641|NCT01473524|536522255|FG001|LTSE Phase|Principal Investigator Decision|0|||
148740642|NCT01473524|536522256|FG002|LTSE Phase|Principal Investigator Decision|0|||
148740643|NCT01473524|536522257|FG003|LTSE Phase|Principal Investigator Decision|1|||
148740644|NCT01473524|536522258|FG004|LTSE Phase|Principal Investigator Decision|1|||
148740645|NCT01473524|536522259|FG005|LTSE Phase|Principal Investigator Decision|3|||
148740646|NCT01473524|536522254|FG000|LTSE Phase|Liver Transplantation|0|||
148740647|NCT01473524|536522255|FG001|LTSE Phase|Liver Transplantation|0|||
148740648|NCT01473524|536522256|FG002|LTSE Phase|Liver Transplantation|0|||
148740649|NCT01473524|536522257|FG003|LTSE Phase|Liver Transplantation|0|||
148740650|NCT01473524|536522258|FG004|LTSE Phase|Liver Transplantation|0|||
148740651|NCT01473524|536522259|FG005|LTSE Phase|Liver Transplantation|1|||
148740652|NCT01473524|536522254|FG000|LTSE Phase|Pregnancy|0|||
148740653|NCT01473524|536522255|FG001|LTSE Phase|Pregnancy|0|||
148740654|NCT01473524|536522256|FG002|LTSE Phase|Pregnancy|0|||
148740655|NCT01473524|536522257|FG003|LTSE Phase|Pregnancy|1|||
148740656|NCT01473524|536522258|FG004|LTSE Phase|Pregnancy|0|||
148740657|NCT01473524|536522259|FG005|LTSE Phase|Pregnancy|0|||
148740658|NCT01473524|536522254|FG000|LTSE Phase|Protocol Violation|0|||
148740659|NCT01473524|536522255|FG001|LTSE Phase|Protocol Violation|0|||
148740660|NCT01473524|536522256|FG002|LTSE Phase|Protocol Violation|0|||
148740661|NCT01473524|536522257|FG003|LTSE Phase|Protocol Violation|0|||
148975665|NCT02453594|537392303|FG002|Overall Study|Transitioned to Extension Study|16|||
148740662|NCT01473524|536522258|FG004|LTSE Phase|Protocol Violation|0|||
148740663|NCT01473524|536522259|FG005|LTSE Phase|Protocol Violation|1|||
148740664|NCT02045147|536522261|FG000|Overall Study|Withdrawal by Subject|2|||
148740665|NCT02045147|536522262|FG001|Overall Study|Withdrawal by Subject|0|||
148740666|NCT02045147|536522263|FG002|Overall Study|Withdrawal by Subject|0|||
148740667|NCT02045147|536522264|FG003|Overall Study|Withdrawal by Subject|0|||
148975666|NCT02453594|537392301|FG000|Overall Study|Withdrawal by Subject|7|||
148975667|NCT02453594|537392302|FG001|Overall Study|Withdrawal by Subject|9|||
148740668|NCT02045147|536522265|FG004|Overall Study|Withdrawal by Subject|0|||
148740669|NCT02045147|536522266|FG005|Overall Study|Withdrawal by Subject|0|||
148740670|NCT02045147|536522267|FG006|Overall Study|Withdrawal by Subject|0|||
148740671|NCT02045147|536522268|FG007|Overall Study|Withdrawal by Subject|1|||
148740672|NCT02045147|536522261|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
148740673|NCT02045147|536522262|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
148740674|NCT02045147|536522263|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
148740675|NCT02045147|536522264|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
148740676|NCT02045147|536522265|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
148740677|NCT02045147|536522266|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
148740678|NCT02045147|536522267|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
148740679|NCT02045147|536522268|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
148740680|NCT04839692|536522269|FG000|Overall Study|Withdrawal by Subject|0|||
148740681|NCT04839692|536522270|FG001|Overall Study|Withdrawal by Subject|3|||
148740682|NCT04839692|536522269|FG000|Overall Study|Physician Decision|1|||
148740683|NCT04839692|536522270|FG001|Overall Study|Physician Decision|0|||
148740684|NCT03146962|536522271|FG000|Overall Study|Lost to Follow-up|1|||
148740685|NCT03146962|536522272|FG001|Overall Study|Lost to Follow-up|1|||
148740686|NCT03146962|536522273|FG002|Overall Study|Lost to Follow-up|0|||
148740687|NCT03146962|536522274|FG003|Overall Study|Lost to Follow-up|0|||
148740688|NCT03146962|536522275|FG004|Overall Study|Lost to Follow-up|0|||
148740689|NCT03146962|536522276|FG005|Overall Study|Lost to Follow-up|0|||
148740690|NCT03146962|536522277|FG006|Overall Study|Lost to Follow-up|0|||
148740691|NCT03146962|536522278|FG007|Overall Study|Lost to Follow-up|0|||
148740692|NCT03146962|536522279|FG008|Overall Study|Lost to Follow-up|0|||
148740693|NCT03146962|536522280|FG009|Overall Study|Lost to Follow-up|0|||
148740694|NCT03146962|536522271|FG000|Overall Study|Adverse Event|0|||
148740695|NCT03146962|536522272|FG001|Overall Study|Adverse Event|3|||
148740696|NCT03146962|536522273|FG002|Overall Study|Adverse Event|0|||
148740697|NCT03146962|536522274|FG003|Overall Study|Adverse Event|0|||
148740698|NCT03146962|536522275|FG004|Overall Study|Adverse Event|0|||
148740699|NCT03146962|536522276|FG005|Overall Study|Adverse Event|0|||
148740700|NCT03146962|536522277|FG006|Overall Study|Adverse Event|0|||
148740701|NCT03146962|536522278|FG007|Overall Study|Adverse Event|1|||
148740702|NCT03146962|536522279|FG008|Overall Study|Adverse Event|0|||
148740703|NCT03146962|536522280|FG009|Overall Study|Adverse Event|0|||
148740704|NCT03146962|536522271|FG000|Overall Study|Withdrawal by Subject|0|||
148740705|NCT03146962|536522272|FG001|Overall Study|Withdrawal by Subject|0|||
148740706|NCT03146962|536522273|FG002|Overall Study|Withdrawal by Subject|0|||
148740707|NCT03146962|536522274|FG003|Overall Study|Withdrawal by Subject|0|||
148740708|NCT03146962|536522275|FG004|Overall Study|Withdrawal by Subject|1|||
148740709|NCT03146962|536522276|FG005|Overall Study|Withdrawal by Subject|0|||
148740710|NCT03146962|536522277|FG006|Overall Study|Withdrawal by Subject|0|||
148740711|NCT03146962|536522278|FG007|Overall Study|Withdrawal by Subject|0|||
148740712|NCT03146962|536522279|FG008|Overall Study|Withdrawal by Subject|0|||
148740713|NCT03146962|536522280|FG009|Overall Study|Withdrawal by Subject|0|||
148740714|NCT03146962|536522271|FG000|Overall Study|Death|0|||
148740715|NCT03146962|536522272|FG001|Overall Study|Death|1|||
148740716|NCT03146962|536522273|FG002|Overall Study|Death|0|||
148740717|NCT03146962|536522274|FG003|Overall Study|Death|0|||
148740718|NCT03146962|536522275|FG004|Overall Study|Death|0|||
148740719|NCT03146962|536522276|FG005|Overall Study|Death|0|||
148975668|NCT02453594|537392303|FG002|Overall Study|Withdrawal by Subject|11|||
148975669|NCT02097134|537392304|FG000|Overall Study|Physician Decision|4|||
148975670|NCT02097134|537392304|FG000|Overall Study|Non-Protocol Therapy|1|||
148740720|NCT03146962|536522277|FG006|Overall Study|Death|0|||
148740721|NCT03146962|536522278|FG007|Overall Study|Death|0|||
148740722|NCT03146962|536522279|FG008|Overall Study|Death|0|||
148740723|NCT03146962|536522280|FG009|Overall Study|Death|0|||
148740724|NCT03146962|536522271|FG000|Overall Study|COVID Precautions|1|||
148740725|NCT03146962|536522272|FG001|Overall Study|COVID Precautions|0|||
148740726|NCT03146962|536522273|FG002|Overall Study|COVID Precautions|0|||
148740727|NCT03146962|536522274|FG003|Overall Study|COVID Precautions|0|||
148740728|NCT03146962|536522275|FG004|Overall Study|COVID Precautions|0|||
148740729|NCT03146962|536522276|FG005|Overall Study|COVID Precautions|0|||
148740730|NCT03146962|536522277|FG006|Overall Study|COVID Precautions|0|||
148740731|NCT03146962|536522278|FG007|Overall Study|COVID Precautions|0|||
148740732|NCT03146962|536522279|FG008|Overall Study|COVID Precautions|0|||
148740733|NCT03146962|536522280|FG009|Overall Study|COVID Precautions|0|||
148740734|NCT03146962|536522271|FG000|Overall Study|Physician Decision|0|||
148740735|NCT03146962|536522272|FG001|Overall Study|Physician Decision|0|||
148740736|NCT03146962|536522273|FG002|Overall Study|Physician Decision|0|||
148975671|NCT02097134|537392304|FG000|Overall Study|Progressive Disease|3|||
148740737|NCT03146962|536522274|FG003|Overall Study|Physician Decision|0|||
148740738|NCT03146962|536522275|FG004|Overall Study|Physician Decision|0|||
148740739|NCT03146962|536522276|FG005|Overall Study|Physician Decision|0|||
148740740|NCT03146962|536522277|FG006|Overall Study|Physician Decision|0|||
148740741|NCT03146962|536522278|FG007|Overall Study|Physician Decision|0|||
148740742|NCT03146962|536522279|FG008|Overall Study|Physician Decision|0|||
148740743|NCT03146962|536522280|FG009|Overall Study|Physician Decision|1|||
148740744|NCT03146962|536522271|FG000|Overall Study|Started New Treatment|0|||
148740745|NCT03146962|536522272|FG001|Overall Study|Started New Treatment|1|||
148740746|NCT03146962|536522273|FG002|Overall Study|Started New Treatment|0|||
148740747|NCT03146962|536522274|FG003|Overall Study|Started New Treatment|0|||
148740748|NCT03146962|536522275|FG004|Overall Study|Started New Treatment|0|||
148740749|NCT03146962|536522276|FG005|Overall Study|Started New Treatment|0|||
148740750|NCT03146962|536522277|FG006|Overall Study|Started New Treatment|0|||
148740751|NCT03146962|536522278|FG007|Overall Study|Started New Treatment|0|||
148740752|NCT03146962|536522279|FG008|Overall Study|Started New Treatment|0|||
148740753|NCT03146962|536522280|FG009|Overall Study|Started New Treatment|0|||
148740754|NCT02383810|536522281|FG000|Overall Study|Physician Decision|1|||
148740755|NCT02383810|536522282|FG001|Overall Study|Physician Decision|1|||
148740756|NCT02383810|536522283|FG002|Overall Study|Physician Decision|0|||
148740757|NCT02383810|536522284|FG003|Overall Study|Physician Decision|0|||
148740758|NCT02383810|536522285|FG004|Overall Study|Physician Decision|0|||
148740759|NCT02383810|536522286|FG005|Overall Study|Physician Decision|0|||
148740760|NCT02383810|536522287|FG006|Overall Study|Physician Decision|0|||
148740761|NCT02383810|536522288|FG007|Overall Study|Physician Decision|0|||
148740762|NCT02383810|536522281|FG000|Overall Study|Withdrawal by Subject|2|||
148740763|NCT02383810|536522282|FG001|Overall Study|Withdrawal by Subject|3|||
148740764|NCT02383810|536522283|FG002|Overall Study|Withdrawal by Subject|3|||
148740765|NCT02383810|536522284|FG003|Overall Study|Withdrawal by Subject|3|||
148740766|NCT02383810|536522285|FG004|Overall Study|Withdrawal by Subject|0|||
148740767|NCT02383810|536522286|FG005|Overall Study|Withdrawal by Subject|0|||
148740768|NCT02383810|536522287|FG006|Overall Study|Withdrawal by Subject|0|||
148740769|NCT02383810|536522288|FG007|Overall Study|Withdrawal by Subject|0|||
148740770|NCT02383810|536522281|FG000|Overall Study|Adverse Event|0|||
148740771|NCT02383810|536522282|FG001|Overall Study|Adverse Event|2|||
148740772|NCT02383810|536522283|FG002|Overall Study|Adverse Event|4|||
148740773|NCT02383810|536522284|FG003|Overall Study|Adverse Event|5|||
148740774|NCT02383810|536522285|FG004|Overall Study|Adverse Event|0|||
148740775|NCT02383810|536522286|FG005|Overall Study|Adverse Event|1|||
148740776|NCT02383810|536522287|FG006|Overall Study|Adverse Event|1|||
148740777|NCT02383810|536522288|FG007|Overall Study|Adverse Event|0|||
148740778|NCT02383810|536522281|FG000|Overall Study|Lost to Follow-up|0|||
148740779|NCT02383810|536522282|FG001|Overall Study|Lost to Follow-up|1|||
148740780|NCT02383810|536522283|FG002|Overall Study|Lost to Follow-up|0|||
148740781|NCT02383810|536522284|FG003|Overall Study|Lost to Follow-up|1|||
148740782|NCT02383810|536522285|FG004|Overall Study|Lost to Follow-up|0|||
148740783|NCT02383810|536522286|FG005|Overall Study|Lost to Follow-up|0|||
148740784|NCT02383810|536522287|FG006|Overall Study|Lost to Follow-up|0|||
148740785|NCT02383810|536522288|FG007|Overall Study|Lost to Follow-up|0|||
148740786|NCT02383810|536522281|FG000|Overall Study|other|0|||
148740787|NCT02383810|536522282|FG001|Overall Study|other|0|||
148975672|NCT02097134|537392304|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
148975673|NCT03285646|537392319|FG000|Overall Study|Adverse Event|1|||
148975674|NCT03285646|537392320|FG001|Overall Study|Adverse Event|0|||
148975675|NCT03285646|537392319|FG000|Overall Study|Withdrawal by Subject|10|||
148975676|NCT03285646|537392320|FG001|Overall Study|Withdrawal by Subject|2|||
148975677|NCT03285646|537392319|FG000|Overall Study|Lost to Follow-up|2|||
148975678|NCT03285646|537392320|FG001|Overall Study|Lost to Follow-up|1|||
148975679|NCT03285646|537392319|FG000|Overall Study|Investigator/Sponsor Decision|0|||
148975680|NCT03285646|537392320|FG001|Overall Study|Investigator/Sponsor Decision|1|||
148975681|NCT01434823|537392327|FG000|Overall Study|Incomplete data in medical record|4|||
148740788|NCT02383810|536522283|FG002|Overall Study|other|0|||
148740789|NCT02383810|536522284|FG003|Overall Study|other|2|||
148740790|NCT02383810|536522285|FG004|Overall Study|other|0|||
148740791|NCT02383810|536522286|FG005|Overall Study|other|0|||
148740792|NCT02383810|536522287|FG006|Overall Study|other|0|||
148740793|NCT02383810|536522288|FG007|Overall Study|other|0|||
148975682|NCT01434823|537392328|FG001|Overall Study|Incomplete data in medical record|7|||
148975683|NCT00501540|537392334|FG000|Overall Study|Death|5|||
148740794|NCT02383810|536522281|FG000|Overall Study|subject did not receive study treatment|0|||
148740795|NCT02383810|536522282|FG001|Overall Study|subject did not receive study treatment|1|||
148740796|NCT02383810|536522283|FG002|Overall Study|subject did not receive study treatment|0|||
148740797|NCT02383810|536522284|FG003|Overall Study|subject did not receive study treatment|0|||
148740798|NCT02383810|536522285|FG004|Overall Study|subject did not receive study treatment|0|||
148740799|NCT02383810|536522286|FG005|Overall Study|subject did not receive study treatment|0|||
148740800|NCT02383810|536522287|FG006|Overall Study|subject did not receive study treatment|0|||
148975684|NCT02331446|537392335|FG000|Overall Study|Lost to Follow-up|2|||
148740801|NCT02383810|536522288|FG007|Overall Study|subject did not receive study treatment|0|||
148740802|NCT02861014|536522294|FG000|Primary Analysis|Adverse Event|7|||
148740803|NCT02861014|536522294|FG000|Primary Analysis|Death|1|||
148740804|NCT02861014|536522294|FG000|Primary Analysis|Lack of Efficacy|3|||
148740805|NCT02861014|536522294|FG000|Primary Analysis|Physician Decision|2|||
148740806|NCT02861014|536522294|FG000|Primary Analysis|Pregnancy|4|||
148740807|NCT02861014|536522294|FG000|Primary Analysis|Protocol Violation|2|||
148740808|NCT02861014|536522294|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
148740809|NCT02861014|536522294|FG000|Primary Analysis|Withdrawal by Subject|14|||
148740810|NCT02861014|536522294|FG000|Primary Analysis|Commercial ocrelizumab|3|||
148740811|NCT02861014|536522294|FG000|Safety Follow-up|Adverse Event|1|||
148740812|NCT02861014|536522294|FG000|Safety Follow-up|Pregnancy|1|||
148740813|NCT02861014|536522294|FG000|Safety Follow-up|Withdrawal by Subject|9|||
148740814|NCT02861014|536522294|FG000|Safety Follow-up|Study terminated by sponsor|1|||
148740815|NCT02861014|536522294|FG000|Safety Follow-up|Physician Decision|1|||
148740816|NCT02861014|536522294|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
148740817|NCT02861014|536522294|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
148740818|NCT03247816|536522295|FG000|Overall Study|Adverse Event|12|||
148740819|NCT03247816|536522295|FG000|Overall Study|Physician Decision|3|||
148740820|NCT03247816|536522295|FG000|Overall Study|Lack of Efficacy|1|||
148740821|NCT03247816|536522295|FG000|Overall Study|Lost to Follow-up|10|||
148740822|NCT03247816|536522295|FG000|Overall Study|Missing Feraccru stop date|3|||
148740823|NCT01439009|536522298|FG000|Overall Study|Physician Decision|5|||
148740824|NCT01439009|536522299|FG001|Overall Study|Physician Decision|3|||
148740825|NCT01439009|536522298|FG000|Overall Study|Protocol Violation|2|||
148740826|NCT01439009|536522299|FG001|Overall Study|Protocol Violation|0|||
148740827|NCT01439009|536522298|FG000|Overall Study|Deviation of exclusion criteria|1|||
148740828|NCT01439009|536522299|FG001|Overall Study|Deviation of exclusion criteria|0|||
148740829|NCT00926783|536522300|FG000|Overall Study|Incomplete CFAE Procedures|3|||
148740830|NCT00926783|536522301|FG001|Overall Study|Incomplete CFAE Procedures|3|||
148740831|NCT03257865|536522302|FG000|Overall Study|Adverse Event|4|||
148740832|NCT03257865|536522303|FG001|Overall Study|Adverse Event|8|||
148740833|NCT03257865|536522302|FG000|Overall Study|Lack of Efficacy|1|||
148740834|NCT03257865|536522303|FG001|Overall Study|Lack of Efficacy|2|||
148740835|NCT03257865|536522302|FG000|Overall Study|Non-compliance with Study Drug|0|||
148740836|NCT03257865|536522303|FG001|Overall Study|Non-compliance with Study Drug|2|||
148740837|NCT03257865|536522302|FG000|Overall Study|Withdrawal by Subject|23|||
148740838|NCT03257865|536522303|FG001|Overall Study|Withdrawal by Subject|17|||
148740839|NCT03257865|536522302|FG000|Overall Study|Physician Decision|3|||
148740840|NCT03257865|536522303|FG001|Overall Study|Physician Decision|1|||
148740841|NCT03257865|536522302|FG000|Overall Study|Other|0|||
148740842|NCT03257865|536522303|FG001|Overall Study|Other|1|||
148740843|NCT03257865|536522302|FG000|Overall Study|Lost to Follow-up|4|||
148740844|NCT03257865|536522303|FG001|Overall Study|Lost to Follow-up|4|||
148740845|NCT02278055|536522304|FG000|Overall Study|Adverse Event|1|||
148740846|NCT02278055|536522304|FG000|Overall Study|Lost to Follow-up|1|||
148740847|NCT02278055|536522304|FG000|Overall Study|Withdrawal by Subject|2|||
148740848|NCT02278055|536522304|FG000|Overall Study|Progressive Disease|4|||
148740849|NCT01661062|536522305|FG000|Overall Study|Completed Treatment Off Study|3|||
148740850|NCT01661062|536522305|FG000|Overall Study|Withdrawal by Subject|2|||
148740851|NCT01292226|536522310|FG000|Overall Study|Adverse Event|5|||
148740852|NCT01292226|536522310|FG000|Overall Study|Death|1|||
148740853|NCT01292226|536522310|FG000|Overall Study|Graft loss|1|||
148740854|NCT01292226|536522310|FG000|Overall Study|Protocol Violation|3|||
148740855|NCT01292226|536522310|FG000|Overall Study|Withdrawal by Subject|1|||
148740856|NCT01292226|536522310|FG000|Overall Study|Other|2|||
148740857|NCT04106661|536522311|FG000|Overall Study|Protocol Violation|3|||
148740858|NCT04106661|536522312|FG001|Overall Study|Protocol Violation|0|||
148740859|NCT04106661|536522311|FG000|Overall Study|Scheduling difficulties|1|||
148740860|NCT04106661|536522312|FG001|Overall Study|Scheduling difficulties|1|||
148740861|NCT00233402|536522313|FG000|Overall Study|No pathology data|12|||
148740862|NCT00233402|536522314|FG001|Overall Study|No pathology data|9|||
148740863|NCT00233402|536522313|FG000|Overall Study|No Ta/T1|89|||
148740864|NCT00233402|536522314|FG001|Overall Study|No Ta/T1|94|||
148740865|NCT00233402|536522313|FG000|Overall Study|Lost to follow up etc|3|||
148740866|NCT00233402|536522314|FG001|Overall Study|Lost to follow up etc|21|||
148740867|NCT03503864|536522317|FG000|Overall Study|Protocol Violation|6|||
148740868|NCT03503864|536522317|FG000|Overall Study|Withdrawal by Subject|7|||
148740869|NCT00423319|536522318|FG000|Overall Study|Death|2|||
148740870|NCT00423319|536522319|FG001|Overall Study|Death|0|||
148740871|NCT00423319|536522318|FG000|Overall Study|Adverse Event|93|||
148740872|NCT00423319|536522319|FG001|Overall Study|Adverse Event|112|||
148740873|NCT00423319|536522318|FG000|Overall Study|Withdrawal by Subject|86|||
148740874|NCT00423319|536522319|FG001|Overall Study|Withdrawal by Subject|99|||
148740875|NCT00423319|536522318|FG000|Overall Study|Lost to Follow-up|4|||
148740876|NCT00423319|536522319|FG001|Overall Study|Lost to Follow-up|3|||
148740877|NCT00423319|536522318|FG000|Overall Study|Poor compliance or noncompliance|1|||
148740878|NCT00423319|536522319|FG001|Overall Study|Poor compliance or noncompliance|1|||
148740879|NCT00423319|536522318|FG000|Overall Study|No longer meets study criteria|15|||
148740880|NCT00423319|536522319|FG001|Overall Study|No longer meets study criteria|15|||
148740881|NCT00423319|536522318|FG000|Overall Study|Other|23|||
148740882|NCT00423319|536522319|FG001|Overall Study|Other|22|||
148740883|NCT02639052|536522320|FG000|Overall Study|Lost to Follow-up|1|||
148740884|NCT04572893|536522327|FG000|Part A|Adverse Event|1|||
148740885|NCT04572893|536522328|FG001|Part A|Adverse Event|0|||
148740886|NCT04572893|536522329|FG002|Part A|Adverse Event|0|||
148740887|NCT04572893|536522330|FG003|Part A|Adverse Event|0|||
148740888|NCT04572893|536522331|FG004|Part A|Adverse Event|0|||
148740889|NCT04572893|536522332|FG005|Part A|Adverse Event|0|||
148740890|NCT04572893|536522333|FG006|Part A|Adverse Event|0|||
148740891|NCT04572893|536522327|FG000|Part B|Withdrawal by Subject|0|||
148740892|NCT04572893|536522328|FG001|Part B|Withdrawal by Subject|0|||
148740893|NCT04572893|536522329|FG002|Part B|Withdrawal by Subject|0|||
148740894|NCT04572893|536522330|FG003|Part B|Withdrawal by Subject|0|||
148740895|NCT04572893|536522331|FG004|Part B|Withdrawal by Subject|0|||
148740896|NCT04572893|536522332|FG005|Part B|Withdrawal by Subject|1|||
148740897|NCT04572893|536522333|FG006|Part B|Withdrawal by Subject|0|||
148740898|NCT04572893|536522327|FG000|Part B|Study terminated by sponsor|0|||
148740899|NCT04572893|536522328|FG001|Part B|Study terminated by sponsor|0|||
148740900|NCT04572893|536522329|FG002|Part B|Study terminated by sponsor|0|||
148740901|NCT04572893|536522330|FG003|Part B|Study terminated by sponsor|0|||
148740902|NCT04572893|536522331|FG004|Part B|Study terminated by sponsor|7|||
148740903|NCT04572893|536522332|FG005|Part B|Study terminated by sponsor|5|||
148740904|NCT04572893|536522333|FG006|Part B|Study terminated by sponsor|3|||
148740905|NCT04572893|536522327|FG000|Part B|Lost to Follow-up|0|||
148740906|NCT04572893|536522328|FG001|Part B|Lost to Follow-up|0|||
148740907|NCT04572893|536522329|FG002|Part B|Lost to Follow-up|0|||
148740908|NCT04572893|536522330|FG003|Part B|Lost to Follow-up|0|||
148740909|NCT04572893|536522331|FG004|Part B|Lost to Follow-up|0|||
148740910|NCT04572893|536522332|FG005|Part B|Lost to Follow-up|0|||
148740911|NCT04572893|536522333|FG006|Part B|Lost to Follow-up|1|||
148740912|NCT04572893|536522327|FG000|Part B|Adverse Event|0|||
148740913|NCT04572893|536522328|FG001|Part B|Adverse Event|0|||
148740914|NCT04572893|536522329|FG002|Part B|Adverse Event|0|||
148740915|NCT04572893|536522330|FG003|Part B|Adverse Event|0|||
148740916|NCT04572893|536522331|FG004|Part B|Adverse Event|1|||
148740917|NCT04572893|536522332|FG005|Part B|Adverse Event|1|||
148740918|NCT04572893|536522333|FG006|Part B|Adverse Event|0|||
148740919|NCT04853992|536522334|FG000|Treatment Period A|Adverse Event|0|||
148740920|NCT04853992|536522335|FG001|Treatment Period A|Adverse Event|1|||
148740921|NCT04853992|536522334|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
148740922|NCT04853992|536522335|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
148740923|NCT02351960|536522336|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
148740924|NCT02351960|536522337|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
148740925|NCT02351960|536522336|FG000|Overall Study|Voluntary Withdrawal|5|||
148740926|NCT02351960|536522337|FG001|Overall Study|Voluntary Withdrawal|4|||
148740927|NCT02351960|536522336|FG000|Overall Study|Significant Protocol Deviation|0|||
148740928|NCT02351960|536522337|FG001|Overall Study|Significant Protocol Deviation|5|||
148740929|NCT00638027|536522338|FG000|Overall Study|Adverse Event|0|||
148740930|NCT00638027|536522339|FG001|Overall Study|Adverse Event|2|||
148740931|NCT03014180|536522340|FG000|Overall Study|Protocol Violation|2|||
148740932|NCT01284621|536522341|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
148740933|NCT01284621|536522342|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
148740934|NCT01284621|536522343|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
148740935|NCT01284621|536522344|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
148740936|NCT01284621|536522345|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
148740937|NCT01284621|536522346|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
148740938|NCT02099682|536522349|FG000|Overall Study|Data Not Available|51|||
148740939|NCT02099682|536522349|FG000|Overall Study|Lost to Follow-up|31|||
148740940|NCT02099682|536522349|FG000|Overall Study|Other|29|||
148740941|NCT02802631|536522350|FG000|Overall Study|Withdrawal by Subject|1|||
148740942|NCT02802631|536522351|FG001|Overall Study|Withdrawal by Subject|0|||
148740943|NCT02802631|536522352|FG002|Overall Study|Withdrawal by Subject|0|||
148740944|NCT02802631|536522353|FG003|Overall Study|Withdrawal by Subject|0|||
148740945|NCT02802631|536522354|FG004|Overall Study|Withdrawal by Subject|0|||
148740946|NCT02802631|536522355|FG005|Overall Study|Withdrawal by Subject|0|||
148740947|NCT02802631|536522356|FG006|Overall Study|Withdrawal by Subject|0|||
148740948|NCT02802631|536522357|FG007|Overall Study|Withdrawal by Subject|0|||
148740949|NCT02802631|536522350|FG000|Overall Study|Physician Decision|1|||
148740950|NCT02802631|536522351|FG001|Overall Study|Physician Decision|0|||
148740951|NCT02802631|536522352|FG002|Overall Study|Physician Decision|0|||
148740952|NCT02802631|536522353|FG003|Overall Study|Physician Decision|0|||
148740953|NCT02802631|536522354|FG004|Overall Study|Physician Decision|0|||
148740954|NCT02802631|536522355|FG005|Overall Study|Physician Decision|0|||
148740955|NCT02802631|536522356|FG006|Overall Study|Physician Decision|1|||
148740956|NCT02802631|536522357|FG007|Overall Study|Physician Decision|0|||
148740957|NCT02802631|536522350|FG000|Overall Study|Adverse Event|0|||
148740958|NCT02802631|536522351|FG001|Overall Study|Adverse Event|2|||
148740959|NCT02802631|536522352|FG002|Overall Study|Adverse Event|0|||
148740960|NCT02802631|536522353|FG003|Overall Study|Adverse Event|1|||
148740961|NCT02802631|536522354|FG004|Overall Study|Adverse Event|6|||
148740962|NCT02802631|536522355|FG005|Overall Study|Adverse Event|1|||
148740963|NCT02802631|536522356|FG006|Overall Study|Adverse Event|4|||
148740964|NCT02802631|536522357|FG007|Overall Study|Adverse Event|0|||
148740965|NCT02802631|536522350|FG000|Overall Study|Sponsor Decision|0|||
148740966|NCT02802631|536522351|FG001|Overall Study|Sponsor Decision|0|||
148740967|NCT02802631|536522352|FG002|Overall Study|Sponsor Decision|6|||
148740968|NCT02802631|536522353|FG003|Overall Study|Sponsor Decision|0|||
148740969|NCT02802631|536522354|FG004|Overall Study|Sponsor Decision|2|||
148740970|NCT02802631|536522355|FG005|Overall Study|Sponsor Decision|0|||
148740971|NCT02802631|536522356|FG006|Overall Study|Sponsor Decision|0|||
148740972|NCT02802631|536522357|FG007|Overall Study|Sponsor Decision|4|||
148740973|NCT02212379|536522358|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
148740974|NCT02212379|536522358|FG000|From Baseline to Week 48|Adverse Event|7|||
148740975|NCT02212379|536522358|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
148740976|NCT02212379|536522358|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
148740977|NCT02212379|536522358|FG000|From Week 48 to Week 96|Adverse Event|1|||
148740978|NCT02212379|536522358|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
148740979|NCT00704730|536522359|FG000|Overall Study|Adverse Event|35|||
148740980|NCT00704730|536522360|FG001|Overall Study|Adverse Event|9|||
148740981|NCT00704730|536522359|FG000|Overall Study|Death|11|||
148740982|NCT00704730|536522360|FG001|Overall Study|Death|5|||
148740983|NCT00704730|536522359|FG000|Overall Study|Physician Decision|2|||
148740984|NCT00704730|536522360|FG001|Overall Study|Physician Decision|0|||
148740985|NCT00704730|536522359|FG000|Overall Study|Did not receive drug|5|||
148740986|NCT00704730|536522360|FG001|Overall Study|Did not receive drug|2|||
148740987|NCT00704730|536522359|FG000|Overall Study|Disease progression per PI|58|||
148740988|NCT00704730|536522360|FG001|Overall Study|Disease progression per PI|67|||
148740989|NCT00704730|536522359|FG000|Overall Study|data unavailable|1|||
148740990|NCT00704730|536522360|FG001|Overall Study|data unavailable|0|||
148740991|NCT00704730|536522359|FG000|Overall Study|Withdrawal by Subject|9|||
148740992|NCT00704730|536522360|FG001|Overall Study|Withdrawal by Subject|13|||
148740993|NCT00213135|536524130|FG000|Overall Study|Adverse Event|9|||
148740994|NCT00213135|536524131|FG001|Overall Study|Adverse Event|5|||
148740995|NCT00213135|536524132|FG002|Overall Study|Adverse Event|5|||
148740996|NCT00213135|536524130|FG000|Overall Study|Lost to Follow-up|11|||
148740997|NCT00213135|536524131|FG001|Overall Study|Lost to Follow-up|8|||
148740998|NCT00213135|536524132|FG002|Overall Study|Lost to Follow-up|4|||
148740999|NCT00213135|536524130|FG000|Overall Study|Protocol Violation|4|||
148741000|NCT00213135|536524131|FG001|Overall Study|Protocol Violation|4|||
148741001|NCT00213135|536524132|FG002|Overall Study|Protocol Violation|10|||
148741002|NCT00213135|536524130|FG000|Overall Study|Death|1|||
148741003|NCT00213135|536524131|FG001|Overall Study|Death|1|||
148741004|NCT00213135|536524132|FG002|Overall Study|Death|2|||
148741005|NCT00213135|536524130|FG000|Overall Study|Disease progression|4|||
148741006|NCT00213135|536524131|FG001|Overall Study|Disease progression|5|||
148741007|NCT00213135|536524132|FG002|Overall Study|Disease progression|21|||
148741008|NCT00213135|536524130|FG000|Overall Study|Other|21|||
148741009|NCT00213135|536524131|FG001|Overall Study|Other|12|||
148741010|NCT00213135|536524132|FG002|Overall Study|Other|15|||
148741011|NCT01908907|536524133|FG000|Overall Study|Physician Decision|1|||
148741012|NCT01908907|536524134|FG001|Overall Study|Physician Decision|0|||
148741013|NCT01908907|536524133|FG000|Overall Study|Protocol Violation|1|||
148741014|NCT01908907|536524134|FG001|Overall Study|Protocol Violation|0|||
148741015|NCT00660907|536524135|FG000|Overall Study|Incorrect Enrollment|1|||
148741016|NCT00660907|536524136|FG001|Overall Study|Incorrect Enrollment|1|||
148741017|NCT00660907|536524135|FG000|Overall Study|Adverse Event|33|||
148741018|NCT00660907|536524136|FG001|Overall Study|Adverse Event|19|||
148741019|NCT00660907|536524135|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
148741020|NCT00660907|536524136|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
148741021|NCT00660907|536524135|FG000|Overall Study|Withdrawal by Subject|23|||
148741022|NCT00660907|536524136|FG001|Overall Study|Withdrawal by Subject|32|||
148741023|NCT00660907|536524135|FG000|Overall Study|Lost to Follow-up|3|||
148741024|NCT00660907|536524136|FG001|Overall Study|Lost to Follow-up|3|||
148741025|NCT00660907|536524135|FG000|Overall Study|Poor/Non-Compliance|5|||
148741026|NCT00660907|536524136|FG001|Overall Study|Poor/Non-Compliance|1|||
148741027|NCT00660907|536524135|FG000|Overall Study|Safety|1|||
148741028|NCT00660907|536524136|FG001|Overall Study|Safety|0|||
148741029|NCT00660907|536524135|FG000|Overall Study|Death|1|||
148741030|NCT00660907|536524136|FG001|Overall Study|Death|3|||
148741031|NCT00660907|536524135|FG000|Overall Study|Various|11|||
148741032|NCT00660907|536524136|FG001|Overall Study|Various|8|||
148741033|NCT04975191|536524137|FG000|Overall Study|Protocol Violation|1|||
148741034|NCT04975191|536524138|FG001|Overall Study|Protocol Violation|2|||
148741035|NCT04975191|536524139|FG002|Overall Study|Protocol Violation|2|||
148741036|NCT04975191|536524140|FG003|Overall Study|Protocol Violation|2|||
148741037|NCT04975191|536524137|FG000|Overall Study|Lost to Follow-up|13|||
148741038|NCT04975191|536524138|FG001|Overall Study|Lost to Follow-up|3|||
148741039|NCT04975191|536524139|FG002|Overall Study|Lost to Follow-up|8|||
148741040|NCT04975191|536524140|FG003|Overall Study|Lost to Follow-up|8|||
148741041|NCT00761657|536524141|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
148741042|NCT00761657|536524142|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
148741043|NCT00761657|536524143|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
148741044|NCT00761657|536524144|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
148741045|NCT00761657|536524145|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
148741046|NCT00761657|536524146|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
148741047|NCT00761657|536524147|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
148741048|NCT00761657|536524148|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
148741049|NCT00761657|536524149|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
148741050|NCT00761657|536524141|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741051|NCT00761657|536524142|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741052|NCT00761657|536524143|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
148741053|NCT00761657|536524144|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
148741054|NCT00761657|536524145|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741055|NCT00761657|536524146|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741056|NCT00761657|536524147|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741057|NCT00761657|536524148|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741058|NCT00761657|536524149|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
148741059|NCT00761657|536524141|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
148741060|NCT00761657|536524142|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
148741061|NCT00761657|536524143|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
148741062|NCT00761657|536524144|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
148741063|NCT00761657|536524145|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
148741064|NCT00761657|536524146|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
148741065|NCT00761657|536524147|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
148741066|NCT00761657|536524148|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
148741067|NCT00761657|536524149|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
148741068|NCT00761657|536524141|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
148741069|NCT00761657|536524142|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
148741070|NCT00761657|536524143|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
148741071|NCT00761657|536524144|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
148741072|NCT00761657|536524145|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
148741073|NCT00761657|536524146|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
148741074|NCT00761657|536524147|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
148741075|NCT00761657|536524148|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
148741076|NCT00761657|536524149|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
148741077|NCT00359801|536524159|FG000|Overall Study|Lost to Follow-up|72|||
148741078|NCT00359801|536524160|FG001|Overall Study|Lost to Follow-up|58|||
148741079|NCT00359801|536524159|FG000|Overall Study|Withdrawal by Subject|143|||
148741080|NCT00359801|536524160|FG001|Overall Study|Withdrawal by Subject|96|||
148741081|NCT00359801|536524159|FG000|Overall Study|Other|66|||
148741082|NCT00359801|536524160|FG001|Overall Study|Other|46|||
148741083|NCT00359801|536524159|FG000|Overall Study|Final Status Unknown: missing data|7|||
148741084|NCT00359801|536524160|FG001|Overall Study|Final Status Unknown: missing data|4|||
148741085|NCT00359801|536524159|FG000|Overall Study|Sponsor Decision|17|||
148741086|NCT00359801|536524160|FG001|Overall Study|Sponsor Decision|16|||
148741087|NCT02929056|536524165|FG000|Overall Study|Lost to Follow-up|0|||
148741088|NCT02929056|536524166|FG001|Overall Study|Lost to Follow-up|1|||
148741089|NCT02245412|536524167|FG000|Treatment Period|Death|1|||
148741090|NCT02245412|536524168|FG001|Treatment Period|Death|1|||
148741091|NCT02245412|536524169|FG002|Treatment Period|Death|0|||
148741092|NCT02245412|536524167|FG000|Treatment Period|Physician Decision|1|||
148741093|NCT02245412|536524168|FG001|Treatment Period|Physician Decision|1|||
148741094|NCT02245412|536524169|FG002|Treatment Period|Physician Decision|0|||
148741095|NCT02245412|536524167|FG000|Treatment Period|Withdrawal by Subject|2|||
148741096|NCT02245412|536524168|FG001|Treatment Period|Withdrawal by Subject|1|||
148741097|NCT02245412|536524169|FG002|Treatment Period|Withdrawal by Subject|0|||
148741098|NCT02245412|536524167|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
148741099|NCT02245412|536524168|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
148818519|NCT05591755|536810456|FG001|Overall Study|Screen Failure|0|||
148741100|NCT02245412|536524169|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
148741101|NCT02245412|536524167|FG000|Follow-Up Period|Death|4|||
148741102|NCT02245412|536524168|FG001|Follow-Up Period|Death|2|||
148741103|NCT02245412|536524169|FG002|Follow-Up Period|Death|1|||
148741104|NCT02245412|536524167|FG000|Follow-Up Period|Physician Decision|1|||
148741105|NCT02245412|536524168|FG001|Follow-Up Period|Physician Decision|0|||
148741106|NCT02245412|536524169|FG002|Follow-Up Period|Physician Decision|0|||
148741107|NCT02245412|536524167|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
148741108|NCT02245412|536524168|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
148741109|NCT02245412|536524169|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
148741110|NCT01056289|536524173|FG000|Open-label Phase|Adverse Event|29|||
148741111|NCT01056289|536524174|FG001|Open-label Phase|Adverse Event|0|||
148818520|NCT05591755|536810457|FG002|Overall Study|Screen Failure|0|||
148741112|NCT01056289|536524175|FG002|Open-label Phase|Adverse Event|0|||
148741113|NCT01056289|536524176|FG003|Open-label Phase|Adverse Event|0|||
148741114|NCT01056289|536524173|FG000|Open-label Phase|Lost to Follow-up|30|||
148741115|NCT01056289|536524174|FG001|Open-label Phase|Lost to Follow-up|0|||
148741116|NCT01056289|536524175|FG002|Open-label Phase|Lost to Follow-up|0|||
148741117|NCT01056289|536524176|FG003|Open-label Phase|Lost to Follow-up|0|||
148741118|NCT01056289|536524173|FG000|Open-label Phase|Other|9|||
148741119|NCT01056289|536524174|FG001|Open-label Phase|Other|0|||
148741120|NCT01056289|536524175|FG002|Open-label Phase|Other|0|||
148741121|NCT01056289|536524176|FG003|Open-label Phase|Other|0|||
148741122|NCT01056289|536524173|FG000|Open-label Phase|Protocol Violation|6|||
148741123|NCT01056289|536524174|FG001|Open-label Phase|Protocol Violation|0|||
148741124|NCT01056289|536524175|FG002|Open-label Phase|Protocol Violation|0|||
148741125|NCT01056289|536524176|FG003|Open-label Phase|Protocol Violation|0|||
148741126|NCT01056289|536524173|FG000|Open-label Phase|Withdrawal by Subject|26|||
148741127|NCT01056289|536524174|FG001|Open-label Phase|Withdrawal by Subject|0|||
148741128|NCT01056289|536524175|FG002|Open-label Phase|Withdrawal by Subject|0|||
148741129|NCT01056289|536524176|FG003|Open-label Phase|Withdrawal by Subject|0|||
148741130|NCT01056289|536524173|FG000|Open-label Phase|Lack of Efficacy|18|||
148741131|NCT01056289|536524174|FG001|Open-label Phase|Lack of Efficacy|0|||
148741132|NCT01056289|536524175|FG002|Open-label Phase|Lack of Efficacy|0|||
148741133|NCT01056289|536524176|FG003|Open-label Phase|Lack of Efficacy|0|||
148741134|NCT01056289|536524173|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
148741135|NCT01056289|536524174|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
148741136|NCT01056289|536524175|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
148741137|NCT01056289|536524176|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
148741138|NCT01056289|536524173|FG000|Double-blind Phase|Adverse Event|0|||
148741139|NCT01056289|536524174|FG001|Double-blind Phase|Adverse Event|1|||
148741140|NCT01056289|536524175|FG002|Double-blind Phase|Adverse Event|2|||
148741141|NCT01056289|536524176|FG003|Double-blind Phase|Adverse Event|1|||
148741142|NCT01056289|536524173|FG000|Double-blind Phase|Lost to Follow-up|0|||
148741143|NCT01056289|536524174|FG001|Double-blind Phase|Lost to Follow-up|2|||
148741144|NCT01056289|536524175|FG002|Double-blind Phase|Lost to Follow-up|2|||
148741145|NCT01056289|536524176|FG003|Double-blind Phase|Lost to Follow-up|2|||
148741146|NCT01056289|536524173|FG000|Double-blind Phase|Other|0|||
148741147|NCT01056289|536524174|FG001|Double-blind Phase|Other|0|||
148741148|NCT01056289|536524175|FG002|Double-blind Phase|Other|1|||
148741149|NCT01056289|536524176|FG003|Double-blind Phase|Other|2|||
148741150|NCT01056289|536524173|FG000|Double-blind Phase|Protocol Violation|0|||
148741151|NCT01056289|536524174|FG001|Double-blind Phase|Protocol Violation|0|||
148741152|NCT01056289|536524175|FG002|Double-blind Phase|Protocol Violation|1|||
148741153|NCT01056289|536524176|FG003|Double-blind Phase|Protocol Violation|1|||
148741154|NCT01056289|536524173|FG000|Double-blind Phase|Withdrawal by Subject|0|||
148741155|NCT01056289|536524174|FG001|Double-blind Phase|Withdrawal by Subject|0|||
148741156|NCT01056289|536524175|FG002|Double-blind Phase|Withdrawal by Subject|4|||
148741157|NCT01056289|536524176|FG003|Double-blind Phase|Withdrawal by Subject|2|||
148741158|NCT01056289|536524173|FG000|Double-blind Phase|Discontinuation symptom|0|||
148741159|NCT01056289|536524174|FG001|Double-blind Phase|Discontinuation symptom|1|||
148741160|NCT01056289|536524175|FG002|Double-blind Phase|Discontinuation symptom|2|||
148741161|NCT01056289|536524176|FG003|Double-blind Phase|Discontinuation symptom|2|||
148741162|NCT01056289|536524173|FG000|Double-blind Phase|Physician Decision|0|||
148741163|NCT01056289|536524174|FG001|Double-blind Phase|Physician Decision|0|||
148741164|NCT01056289|536524175|FG002|Double-blind Phase|Physician Decision|1|||
148741165|NCT01056289|536524176|FG003|Double-blind Phase|Physician Decision|0|||
148741166|NCT00402116|536524183|FG000|Overall Study|Jaw infection after surgery-other|1|||
148741167|NCT00402116|536524184|FG001|Overall Study|Jaw infection after surgery-other|0|||
148741168|NCT00402116|536524185|FG002|Overall Study|Jaw infection after surgery-other|0|||
148741169|NCT00402116|536524183|FG000|Overall Study|Withdrawal by Subject|1|||
148741170|NCT00402116|536524184|FG001|Overall Study|Withdrawal by Subject|0|||
148741171|NCT00402116|536524185|FG002|Overall Study|Withdrawal by Subject|5|||
148741172|NCT00402116|536524183|FG000|Overall Study|Treatment completed per protocol|1|||
148741173|NCT00402116|536524184|FG001|Overall Study|Treatment completed per protocol|1|||
148741174|NCT00402116|536524185|FG002|Overall Study|Treatment completed per protocol|2|||
148741175|NCT00402116|536524183|FG000|Overall Study|other complicating disease|0|||
148741176|NCT00402116|536524184|FG001|Overall Study|other complicating disease|0|||
148741177|NCT00402116|536524185|FG002|Overall Study|other complicating disease|2|||
148741178|NCT00402116|536524183|FG000|Overall Study|Disease Progression|0|||
148741179|NCT00402116|536524184|FG001|Overall Study|Disease Progression|4|||
148741180|NCT00402116|536524185|FG002|Overall Study|Disease Progression|38|||
148741181|NCT00402116|536524183|FG000|Overall Study|mistaken thrombocytopenia|0|||
148741182|NCT00402116|536524184|FG001|Overall Study|mistaken thrombocytopenia|0|||
148741183|NCT00402116|536524185|FG002|Overall Study|mistaken thrombocytopenia|1|||
148741184|NCT00402116|536524183|FG000|Overall Study|decline related hyponatremia/tumor|0|||
148741185|NCT00402116|536524184|FG001|Overall Study|decline related hyponatremia/tumor|0|||
148741186|NCT00402116|536524185|FG002|Overall Study|decline related hyponatremia/tumor|1|||
148741187|NCT00402116|536524183|FG000|Overall Study|Adverse Event|0|||
148741188|NCT00402116|536524184|FG001|Overall Study|Adverse Event|1|||
148741189|NCT00402116|536524185|FG002|Overall Study|Adverse Event|6|||
148741190|NCT00270855|536524188|FG000|Overall Study|Withdrawal by Subject|8|||
148741191|NCT00270855|536524189|FG001|Overall Study|Withdrawal by Subject|8|||
148741192|NCT02618759|536524192|FG000|Overall Study|Lost to Follow-up|0|||
148741193|NCT02618759|536524193|FG001|Overall Study|Lost to Follow-up|1|||
148741194|NCT02618759|536524192|FG000|Overall Study|Withdrawal by Subject|1|||
148741195|NCT02618759|536524193|FG001|Overall Study|Withdrawal by Subject|0|||
148741196|NCT02618759|536524192|FG000|Overall Study|Other Reasons|1|||
148741197|NCT02618759|536524193|FG001|Overall Study|Other Reasons|4|||
148741198|NCT02500043|536524196|FG000|Overall Study|Randomized, but not Treated|2|||
148741199|NCT02500043|536524197|FG001|Overall Study|Randomized, but not Treated|2|||
148741200|NCT02500043|536524196|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
148741201|NCT02500043|536524197|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
148741202|NCT02500043|536524196|FG000|Overall Study|Adverse Event|33|||
148741203|NCT02500043|536524197|FG001|Overall Study|Adverse Event|11|||
148741204|NCT02500043|536524196|FG000|Overall Study|Clinical Progression|54|||
148741205|NCT02500043|536524197|FG001|Overall Study|Clinical Progression|35|||
148741206|NCT02500043|536524196|FG000|Overall Study|Radiological Progression|192|||
148741207|NCT02500043|536524197|FG001|Overall Study|Radiological Progression|110|||
148741208|NCT02500043|536524196|FG000|Overall Study|Physician's Decision|11|||
148741209|NCT02500043|536524197|FG001|Overall Study|Physician's Decision|3|||
148741210|NCT02500043|536524196|FG000|Overall Study|Withdrawal by Subject|14|||
148741211|NCT02500043|536524197|FG001|Overall Study|Withdrawal by Subject|4|||
148741212|NCT02500043|536524196|FG000|Overall Study|Death|11|||
148741213|NCT02500043|536524197|FG001|Overall Study|Death|2|||
148741214|NCT02500043|536524196|FG000|Overall Study|Protocol Deviation|1|||
148741215|NCT02500043|536524197|FG001|Overall Study|Protocol Deviation|0|||
148741216|NCT01371747|536524198|FG000|Overall Study|Adverse Event|4|||
148741217|NCT01371747|536524199|FG001|Overall Study|Adverse Event|2|||
148741218|NCT01371747|536524200|FG002|Overall Study|Adverse Event|7|||
148741219|NCT01371747|536524201|FG003|Overall Study|Adverse Event|2|||
148741220|NCT01371747|536524202|FG004|Overall Study|Adverse Event|2|||
148741221|NCT01371747|536524203|FG005|Overall Study|Adverse Event|2|||
148741222|NCT01371747|536524198|FG000|Overall Study|Death|1|||
148741223|NCT01371747|536524199|FG001|Overall Study|Death|0|||
148741224|NCT01371747|536524200|FG002|Overall Study|Death|4|||
148741225|NCT01371747|536524201|FG003|Overall Study|Death|1|||
148741226|NCT01371747|536524202|FG004|Overall Study|Death|2|||
148741227|NCT01371747|536524203|FG005|Overall Study|Death|0|||
148741228|NCT01371747|536524198|FG000|Overall Study|Abnormal Renal Function|0|||
148741229|NCT01371747|536524199|FG001|Overall Study|Abnormal Renal Function|2|||
148741230|NCT01371747|536524200|FG002|Overall Study|Abnormal Renal Function|0|||
148741231|NCT01371747|536524201|FG003|Overall Study|Abnormal Renal Function|1|||
148741232|NCT01371747|536524202|FG004|Overall Study|Abnormal Renal Function|0|||
148741233|NCT01371747|536524203|FG005|Overall Study|Abnormal Renal Function|1|||
148741234|NCT01371747|536524198|FG000|Overall Study|High Serum Potassium Results|1|||
148741235|NCT01371747|536524199|FG001|Overall Study|High Serum Potassium Results|1|||
148741236|NCT01371747|536524200|FG002|Overall Study|High Serum Potassium Results|1|||
148741237|NCT01371747|536524201|FG003|Overall Study|High Serum Potassium Results|2|||
148741238|NCT01371747|536524202|FG004|Overall Study|High Serum Potassium Results|0|||
148741239|NCT01371747|536524203|FG005|Overall Study|High Serum Potassium Results|2|||
148741240|NCT01371747|536524198|FG000|Overall Study|Low Serum Potassium Results|1|||
148741241|NCT01371747|536524199|FG001|Overall Study|Low Serum Potassium Results|1|||
148741242|NCT01371747|536524200|FG002|Overall Study|Low Serum Potassium Results|1|||
148741243|NCT01371747|536524201|FG003|Overall Study|Low Serum Potassium Results|1|||
148741244|NCT01371747|536524202|FG004|Overall Study|Low Serum Potassium Results|0|||
148741245|NCT01371747|536524203|FG005|Overall Study|Low Serum Potassium Results|3|||
148741246|NCT01371747|536524198|FG000|Overall Study|Protocol Violation|0|||
148741247|NCT01371747|536524199|FG001|Overall Study|Protocol Violation|0|||
148741248|NCT01371747|536524200|FG002|Overall Study|Protocol Violation|1|||
148741249|NCT01371747|536524201|FG003|Overall Study|Protocol Violation|0|||
148741250|NCT01371747|536524202|FG004|Overall Study|Protocol Violation|0|||
148741251|NCT01371747|536524203|FG005|Overall Study|Protocol Violation|0|||
148741252|NCT01371747|536524198|FG000|Overall Study|Non-Compliance|3|||
148741253|NCT01371747|536524199|FG001|Overall Study|Non-Compliance|4|||
148741254|NCT01371747|536524200|FG002|Overall Study|Non-Compliance|3|||
148741255|NCT01371747|536524201|FG003|Overall Study|Non-Compliance|0|||
148741256|NCT01371747|536524202|FG004|Overall Study|Non-Compliance|0|||
148741257|NCT01371747|536524203|FG005|Overall Study|Non-Compliance|1|||
148741258|NCT01371747|536524198|FG000|Overall Study|Physician Decision|0|||
148741259|NCT01371747|536524199|FG001|Overall Study|Physician Decision|0|||
148741260|NCT01371747|536524200|FG002|Overall Study|Physician Decision|0|||
148741261|NCT01371747|536524201|FG003|Overall Study|Physician Decision|0|||
148741262|NCT01371747|536524202|FG004|Overall Study|Physician Decision|1|||
148741263|NCT01371747|536524203|FG005|Overall Study|Physician Decision|0|||
148741264|NCT01371747|536524198|FG000|Overall Study|Withdrawal by Subject|6|||
148741265|NCT01371747|536524199|FG001|Overall Study|Withdrawal by Subject|12|||
148741266|NCT01371747|536524200|FG002|Overall Study|Withdrawal by Subject|5|||
148741267|NCT01371747|536524201|FG003|Overall Study|Withdrawal by Subject|2|||
148741268|NCT01371747|536524202|FG004|Overall Study|Withdrawal by Subject|2|||
148741269|NCT01371747|536524203|FG005|Overall Study|Withdrawal by Subject|4|||
148741270|NCT01371747|536524198|FG000|Overall Study|Other Reasons|2|||
148741271|NCT01371747|536524199|FG001|Overall Study|Other Reasons|1|||
148741272|NCT01371747|536524200|FG002|Overall Study|Other Reasons|2|||
148741273|NCT01371747|536524201|FG003|Overall Study|Other Reasons|0|||
148741274|NCT01371747|536524202|FG004|Overall Study|Other Reasons|0|||
148741275|NCT01371747|536524203|FG005|Overall Study|Other Reasons|1|||
148741276|NCT02094417|536524204|FG000|Overall Study|Adverse Event|0|||
148741277|NCT02094417|536524205|FG001|Overall Study|Adverse Event|0|||
148741278|NCT02094417|536524206|FG002|Overall Study|Adverse Event|0|||
148741279|NCT02094417|536524207|FG003|Overall Study|Adverse Event|1|||
148741280|NCT02094417|536524204|FG000|Overall Study|Eligibility criteria|0|||
148741281|NCT02094417|536524205|FG001|Overall Study|Eligibility criteria|1|||
148741282|NCT02094417|536524206|FG002|Overall Study|Eligibility criteria|0|||
148741283|NCT02094417|536524207|FG003|Overall Study|Eligibility criteria|0|||
148741284|NCT02094417|536524204|FG000|Overall Study|No responder|4|||
148741285|NCT02094417|536524205|FG001|Overall Study|No responder|4|||
148741286|NCT02094417|536524206|FG002|Overall Study|No responder|4|||
148741287|NCT02094417|536524207|FG003|Overall Study|No responder|3|||
148741288|NCT02094417|536524204|FG000|Overall Study|Unable to conduct observations or assess|0|||
148741289|NCT02094417|536524205|FG001|Overall Study|Unable to conduct observations or assess|1|||
148741290|NCT02094417|536524206|FG002|Overall Study|Unable to conduct observations or assess|0|||
148741291|NCT02094417|536524207|FG003|Overall Study|Unable to conduct observations or assess|0|||
148741292|NCT02094417|536524204|FG000|Overall Study|Withdrawal by Subject|1|||
148741293|NCT02094417|536524205|FG001|Overall Study|Withdrawal by Subject|2|||
148741294|NCT02094417|536524206|FG002|Overall Study|Withdrawal by Subject|1|||
148741295|NCT02094417|536524207|FG003|Overall Study|Withdrawal by Subject|3|||
148741296|NCT03022084|536524208|FG000|Overall Study|Lost to Follow-up|2|||
148741297|NCT03022084|536524209|FG001|Overall Study|Lost to Follow-up|3|||
148741298|NCT02932306|536524213|FG000|Overall Study|Withdrawal by Subject|16|||
148741299|NCT02932306|536524214|FG001|Overall Study|Withdrawal by Subject|25|||
148741300|NCT02932306|536524213|FG000|Overall Study|Adverse Event|3|||
148741301|NCT02932306|536524214|FG001|Overall Study|Adverse Event|0|||
148741302|NCT02932306|536524213|FG000|Overall Study|Pregnancy|2|||
148741303|NCT02932306|536524214|FG001|Overall Study|Pregnancy|0|||
148741304|NCT02932306|536524213|FG000|Overall Study|Protocol Violation|1|||
148741305|NCT02932306|536524214|FG001|Overall Study|Protocol Violation|1|||
148741306|NCT02932306|536524213|FG000|Overall Study|Noncompliance with Study Drug|1|||
148741307|NCT02932306|536524214|FG001|Overall Study|Noncompliance with Study Drug|1|||
148741308|NCT02932306|536524213|FG000|Overall Study|Lost to Follow-up|36|||
148741309|NCT02932306|536524214|FG001|Overall Study|Lost to Follow-up|40|||
148741310|NCT02932306|536524213|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
148741311|NCT02932306|536524214|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
148741312|NCT02932306|536524213|FG000|Overall Study|Lack of Efficacy|0|||
148741313|NCT02932306|536524214|FG001|Overall Study|Lack of Efficacy|2|||
148741314|NCT02932306|536524213|FG000|Overall Study|Worsening condition|2|||
148741315|NCT02932306|536524214|FG001|Overall Study|Worsening condition|0|||
148741316|NCT02932306|536524213|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
148741317|NCT02932306|536524214|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
148741318|NCT03559400|536524219|FG000|Overall Study|Lost to Follow-up|9|||
148741319|NCT03559400|536524220|FG001|Overall Study|Lost to Follow-up|7|||
148741320|NCT03559400|536524219|FG000|Overall Study|Death|0|||
148741321|NCT03559400|536524220|FG001|Overall Study|Death|2|||
148741322|NCT02119819|536524221|FG000|Overall Study|Adverse Event|3|||
148741323|NCT02119819|536524222|FG001|Overall Study|Adverse Event|1|||
148741324|NCT02119819|536524223|FG002|Overall Study|Adverse Event|2|||
148741325|NCT02119819|536524224|FG003|Overall Study|Adverse Event|3|||
148741326|NCT02119819|536524225|FG004|Overall Study|Adverse Event|0|||
148741327|NCT02119819|536524226|FG005|Overall Study|Adverse Event|1|||
148741328|NCT02119819|536524221|FG000|Overall Study|Lack of Efficacy|0|||
148741329|NCT02119819|536524222|FG001|Overall Study|Lack of Efficacy|0|||
148741330|NCT02119819|536524223|FG002|Overall Study|Lack of Efficacy|0|||
148741331|NCT02119819|536524224|FG003|Overall Study|Lack of Efficacy|0|||
148741332|NCT02119819|536524225|FG004|Overall Study|Lack of Efficacy|0|||
148741333|NCT02119819|536524226|FG005|Overall Study|Lack of Efficacy|1|||
148741334|NCT02119819|536524221|FG000|Overall Study|Lost to Follow-up|0|||
148741335|NCT02119819|536524222|FG001|Overall Study|Lost to Follow-up|0|||
148741336|NCT02119819|536524223|FG002|Overall Study|Lost to Follow-up|1|||
148741337|NCT02119819|536524224|FG003|Overall Study|Lost to Follow-up|2|||
148741338|NCT02119819|536524225|FG004|Overall Study|Lost to Follow-up|1|||
148741339|NCT02119819|536524226|FG005|Overall Study|Lost to Follow-up|2|||
148741340|NCT02119819|536524221|FG000|Overall Study|Physician Decision|1|||
148741341|NCT02119819|536524222|FG001|Overall Study|Physician Decision|1|||
148741342|NCT02119819|536524223|FG002|Overall Study|Physician Decision|0|||
148741343|NCT02119819|536524224|FG003|Overall Study|Physician Decision|0|||
148741344|NCT02119819|536524225|FG004|Overall Study|Physician Decision|0|||
148741345|NCT02119819|536524226|FG005|Overall Study|Physician Decision|1|||
148741346|NCT02119819|536524221|FG000|Overall Study|Withdrawal by Subject|5|||
148741347|NCT02119819|536524222|FG001|Overall Study|Withdrawal by Subject|3|||
148741348|NCT02119819|536524223|FG002|Overall Study|Withdrawal by Subject|0|||
148741349|NCT02119819|536524224|FG003|Overall Study|Withdrawal by Subject|0|||
148741350|NCT02119819|536524225|FG004|Overall Study|Withdrawal by Subject|6|||
148741351|NCT02119819|536524226|FG005|Overall Study|Withdrawal by Subject|10|||
148741352|NCT02119819|536524221|FG000|Overall Study|Jury Duty|0|||
148741353|NCT02119819|536524222|FG001|Overall Study|Jury Duty|0|||
148741354|NCT02119819|536524223|FG002|Overall Study|Jury Duty|1|||
148741355|NCT02119819|536524224|FG003|Overall Study|Jury Duty|0|||
148741356|NCT02119819|536524225|FG004|Overall Study|Jury Duty|0|||
148741357|NCT02119819|536524226|FG005|Overall Study|Jury Duty|0|||
148741358|NCT02119819|536524221|FG000|Overall Study|Protocol Violation|0|||
148741359|NCT02119819|536524222|FG001|Overall Study|Protocol Violation|0|||
148741360|NCT02119819|536524223|FG002|Overall Study|Protocol Violation|0|||
148741361|NCT02119819|536524224|FG003|Overall Study|Protocol Violation|1|||
148741362|NCT02119819|536524225|FG004|Overall Study|Protocol Violation|0|||
148741363|NCT02119819|536524226|FG005|Overall Study|Protocol Violation|0|||
148741364|NCT02119819|536524221|FG000|Overall Study|Left the city to get a job|0|||
148741365|NCT02119819|536524222|FG001|Overall Study|Left the city to get a job|0|||
148741366|NCT02119819|536524223|FG002|Overall Study|Left the city to get a job|0|||
148741367|NCT02119819|536524224|FG003|Overall Study|Left the city to get a job|1|||
148741368|NCT02119819|536524225|FG004|Overall Study|Left the city to get a job|0|||
148741369|NCT02119819|536524226|FG005|Overall Study|Left the city to get a job|0|||
148741370|NCT01544179|536524227|FG000|Overall Study|Death|50|||
148741371|NCT01544179|536524228|FG001|Overall Study|Death|37|||
148741372|NCT01544179|536524227|FG000|Overall Study|Lost to Follow-up|0|||
148741373|NCT01544179|536524228|FG001|Overall Study|Lost to Follow-up|1|||
148741374|NCT01544179|536524227|FG000|Overall Study|Adverse Event|0|||
148741375|NCT01544179|536524228|FG001|Overall Study|Adverse Event|1|||
148741376|NCT01544179|536524227|FG000|Overall Study|Withdrawal by Subject|12|||
148741377|NCT01544179|536524228|FG001|Overall Study|Withdrawal by Subject|7|||
148741378|NCT01544179|536524227|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
148741379|NCT01544179|536524228|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148741380|NCT00049530|536524231|FG000|Overall Study|Lack of Efficacy|25|||
148741381|NCT00049530|536524231|FG000|Overall Study|Adverse Event|2|||
148741382|NCT00049530|536524231|FG000|Overall Study|Death|1|||
148741383|NCT00049530|536524231|FG000|Overall Study|symptomatic deterioration|1|||
148741384|NCT00049530|536524231|FG000|Overall Study|ineligible|3|||
148741385|NCT00282919|536524232|FG000|Overall Study|Lack of Efficacy|4|||
148741386|NCT00282919|536524232|FG000|Overall Study|Withdrawal by Subject|1|||
148741387|NCT00282919|536524232|FG000|Overall Study|Asymptomatic Parasitemia|2|||
148741388|NCT04497948|536524233|FG000|Overall Study|Death|2|||
148741389|NCT00696787|536524234|FG000|Overall Study|Adverse Event|1|||
148741390|NCT00696787|536524235|FG001|Overall Study|Adverse Event|0|||
148741391|NCT00696787|536524236|FG002|Overall Study|Adverse Event|6|||
148741392|NCT00696787|536524234|FG000|Overall Study|Discontinuation by Sponsor|9|||
148741393|NCT00696787|536524235|FG001|Overall Study|Discontinuation by Sponsor|13|||
148741394|NCT00696787|536524236|FG002|Overall Study|Discontinuation by Sponsor|14|||
148741395|NCT00696787|536524234|FG000|Overall Study|Lack of Efficacy|0|||
148741396|NCT00696787|536524235|FG001|Overall Study|Lack of Efficacy|1|||
148741397|NCT00696787|536524236|FG002|Overall Study|Lack of Efficacy|0|||
148741398|NCT00696787|536524234|FG000|Overall Study|Lost to Follow-up|4|||
148741399|NCT00696787|536524235|FG001|Overall Study|Lost to Follow-up|0|||
148741400|NCT00696787|536524236|FG002|Overall Study|Lost to Follow-up|3|||
148741401|NCT00696787|536524234|FG000|Overall Study|Withdrawal by Subject|0|||
148741402|NCT00696787|536524235|FG001|Overall Study|Withdrawal by Subject|3|||
148741403|NCT00696787|536524236|FG002|Overall Study|Withdrawal by Subject|2|||
148741404|NCT00696787|536524234|FG000|Overall Study|Failed to return|1|||
148741405|NCT00696787|536524235|FG001|Overall Study|Failed to return|3|||
148741406|NCT00696787|536524236|FG002|Overall Study|Failed to return|1|||
148741407|NCT01934335|536524244|FG000|Overall Study|Withdrawal by Subject|1|||
148741408|NCT01934335|536524245|FG001|Overall Study|Withdrawal by Subject|1|||
148741409|NCT01421511|536524246|FG000|Overall Study|Lost to Follow-up|11|||
148741410|NCT01421511|536524247|FG001|Overall Study|Lost to Follow-up|14|||
148741411|NCT01421511|536524246|FG000|Overall Study|Randomized but didn't receive study drug|1|||
148741412|NCT01421511|536524247|FG001|Overall Study|Randomized but didn't receive study drug|7|||
148741413|NCT01421511|536524246|FG000|Overall Study|Physician Decision|0|||
148741414|NCT01421511|536524247|FG001|Overall Study|Physician Decision|1|||
148818521|NCT05591755|536810458|FG003|Overall Study|Screen Failure|0|||
148818522|NCT05591755|536810455|FG000|Overall Study|Protocol Violation|0|||
148818523|NCT05591755|536810456|FG001|Overall Study|Protocol Violation|0|||
148818524|NCT05591755|536810457|FG002|Overall Study|Protocol Violation|2|||
148818525|NCT05591755|536810458|FG003|Overall Study|Protocol Violation|0|||
148818526|NCT05591755|536810455|FG000|Overall Study|Withdrawal by Subject|0|||
148818527|NCT05591755|536810456|FG001|Overall Study|Withdrawal by Subject|1|||
148741415|NCT01421511|536524246|FG000|Overall Study|Withdrawal by Subject|6|||
148741416|NCT01421511|536524247|FG001|Overall Study|Withdrawal by Subject|5|||
148741417|NCT01421511|536524246|FG000|Overall Study|Death|1|||
148741418|NCT01421511|536524247|FG001|Overall Study|Death|1|||
148741419|NCT05384171|536524248|FG000|Overall Study|Lost to Follow-up|9|||
148741420|NCT05384171|536524249|FG001|Overall Study|Lost to Follow-up|9|||
148741421|NCT05384171|536524248|FG000|Overall Study|Withdrawal by Subject|3|||
148741422|NCT05384171|536524249|FG001|Overall Study|Withdrawal by Subject|0|||
148741423|NCT01111825|536524250|FG000|Overall Study|Withdrawal by Subject|0|||
148975685|NCT02331446|537392336|FG001|Overall Study|Lost to Follow-up|1|||
148975686|NCT02331446|537392337|FG002|Overall Study|Lost to Follow-up|0|||
148975687|NCT02331446|537392338|FG003|Overall Study|Lost to Follow-up|1|||
148975688|NCT02331446|537392335|FG000|Overall Study|Personal Problem|2|||
148975689|NCT02331446|537392336|FG001|Overall Study|Personal Problem|0|||
148975690|NCT02331446|537392337|FG002|Overall Study|Personal Problem|0|||
148975691|NCT02331446|537392338|FG003|Overall Study|Personal Problem|0|||
148975692|NCT02331446|537392335|FG000|Overall Study|Disease|0|||
148975693|NCT02331446|537392336|FG001|Overall Study|Disease|2|||
148975694|NCT02331446|537392337|FG002|Overall Study|Disease|2|||
148975695|NCT02331446|537392338|FG003|Overall Study|Disease|1|||
148975696|NCT02331446|537392335|FG000|Overall Study|Physician Decision|0|||
148975697|NCT02331446|537392336|FG001|Overall Study|Physician Decision|1|||
148975698|NCT02331446|537392337|FG002|Overall Study|Physician Decision|0|||
148975699|NCT02331446|537392338|FG003|Overall Study|Physician Decision|1|||
148975700|NCT02331446|537392335|FG000|Overall Study|Lost before baseline analysis|0|||
148975701|NCT02331446|537392336|FG001|Overall Study|Lost before baseline analysis|1|||
148975702|NCT02331446|537392337|FG002|Overall Study|Lost before baseline analysis|1|||
148975703|NCT02331446|537392338|FG003|Overall Study|Lost before baseline analysis|0|||
148975704|NCT04879745|537392339|FG000|Overall Study|Lost to Follow-up|4|||
148975705|NCT04879745|537392340|FG001|Overall Study|Lost to Follow-up|1|||
148975706|NCT00120042|537392341|FG000|Overall Study|all completed protocl|0|||
148975707|NCT00120042|537392342|FG001|Overall Study|all completed protocl|0|||
148975708|NCT00120042|537392343|FG002|Overall Study|all completed protocl|0|||
148975709|NCT00796861|537392344|FG000|Overall Study|Withdrawal by Subject|2|||
148975710|NCT00796861|537392344|FG000|Overall Study|Death|2|||
148975711|NCT03852316|537392345|FG000|Overall Study|Protocol Violation|1|||
148975712|NCT03852316|537392345|FG000|Overall Study|Withdrawal by Subject|2|||
148975713|NCT03852316|537392345|FG000|Overall Study|Enrolled but Device not Utilized|1|||
148975714|NCT04532112|537392348|FG000|Overall Study|Adverse Event|3|||
148975715|NCT04532112|537392349|FG001|Overall Study|Adverse Event|0|||
148975716|NCT00529386|537392350|FG000|Overall Study|Lost to Follow-up|1|||
148975717|NCT03592641|537392351|FG000|Overall Study|Withdrawal by Subject|1|||
148975718|NCT03670810|537392354|FG000|Main Study|Adverse Event|37|||
148975719|NCT03670810|537392355|FG001|Main Study|Adverse Event|38|||
148975720|NCT03670810|537392356|FG002|Main Study|Adverse Event|3|||
148975721|NCT03670810|537392357|FG003|Main Study|Adverse Event|4|||
148975722|NCT03670810|537392358|FG004|Main Study|Adverse Event|4|||
148975723|NCT03670810|537392359|FG005|Main Study|Adverse Event|5|||
148975724|NCT03670810|537392360|FG006|Main Study|Adverse Event|0|||
148975725|NCT03670810|537392361|FG007|Main Study|Adverse Event|0|||
148975726|NCT03670810|537392362|FG008|Main Study|Adverse Event|0|||
148975727|NCT03670810|537392354|FG000|Main Study|Lack of Efficacy|8|||
148975728|NCT03670810|537392355|FG001|Main Study|Lack of Efficacy|9|||
148975729|NCT03670810|537392356|FG002|Main Study|Lack of Efficacy|3|||
148975730|NCT03670810|537392357|FG003|Main Study|Lack of Efficacy|4|||
148975731|NCT03670810|537392358|FG004|Main Study|Lack of Efficacy|0|||
148975732|NCT03670810|537392359|FG005|Main Study|Lack of Efficacy|0|||
148975733|NCT03670810|537392360|FG006|Main Study|Lack of Efficacy|0|||
148975734|NCT03670810|537392361|FG007|Main Study|Lack of Efficacy|0|||
148975735|NCT03670810|537392362|FG008|Main Study|Lack of Efficacy|0|||
148975736|NCT03670810|537392354|FG000|Main Study|Lost to Follow-up|9|||
148975737|NCT03670810|537392355|FG001|Main Study|Lost to Follow-up|7|||
148975738|NCT03670810|537392356|FG002|Main Study|Lost to Follow-up|4|||
148975739|NCT03670810|537392357|FG003|Main Study|Lost to Follow-up|6|||
148975740|NCT03670810|537392358|FG004|Main Study|Lost to Follow-up|1|||
148975741|NCT03670810|537392359|FG005|Main Study|Lost to Follow-up|0|||
148975742|NCT03670810|537392360|FG006|Main Study|Lost to Follow-up|0|||
148975743|NCT03670810|537392361|FG007|Main Study|Lost to Follow-up|0|||
148975744|NCT03670810|537392362|FG008|Main Study|Lost to Follow-up|0|||
148975745|NCT03670810|537392354|FG000|Main Study|Non-compliance with Study Drug|0|||
148975746|NCT03670810|537392355|FG001|Main Study|Non-compliance with Study Drug|2|||
149027132|NCT01605136|537576514|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
148975747|NCT03670810|537392356|FG002|Main Study|Non-compliance with Study Drug|3|||
148975748|NCT03670810|537392357|FG003|Main Study|Non-compliance with Study Drug|0|||
148975749|NCT03670810|537392358|FG004|Main Study|Non-compliance with Study Drug|0|||
149027133|NCT01605136|537576515|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
149027134|NCT01072929|537576516|FG000|Overall Study|Adverse Event|8|||
149027135|NCT01072929|537576517|FG001|Overall Study|Adverse Event|11|||
148975750|NCT03670810|537392359|FG005|Main Study|Non-compliance with Study Drug|0|||
148975751|NCT03670810|537392360|FG006|Main Study|Non-compliance with Study Drug|0|||
148975752|NCT03670810|537392361|FG007|Main Study|Non-compliance with Study Drug|1|||
148975753|NCT03670810|537392362|FG008|Main Study|Non-compliance with Study Drug|0|||
148975754|NCT03670810|537392354|FG000|Main Study|Physician Decision|3|||
148975755|NCT03670810|537392355|FG001|Main Study|Physician Decision|0|||
149027136|NCT01072929|537576518|FG002|Overall Study|Adverse Event|2|||
148975756|NCT03670810|537392356|FG002|Main Study|Physician Decision|1|||
148975757|NCT03670810|537392357|FG003|Main Study|Physician Decision|0|||
148975758|NCT03670810|537392358|FG004|Main Study|Physician Decision|0|||
148975759|NCT03670810|537392359|FG005|Main Study|Physician Decision|0|||
148975760|NCT03670810|537392360|FG006|Main Study|Physician Decision|1|||
148975761|NCT03670810|537392361|FG007|Main Study|Physician Decision|1|||
148975762|NCT03670810|537392362|FG008|Main Study|Physician Decision|0|||
148975763|NCT03670810|537392354|FG000|Main Study|Pregnancy|1|||
148975764|NCT03670810|537392355|FG001|Main Study|Pregnancy|2|||
148975765|NCT03670810|537392356|FG002|Main Study|Pregnancy|0|||
148975766|NCT03670810|537392357|FG003|Main Study|Pregnancy|0|||
148975767|NCT03670810|537392358|FG004|Main Study|Pregnancy|0|||
148975768|NCT03670810|537392359|FG005|Main Study|Pregnancy|0|||
148975769|NCT03670810|537392360|FG006|Main Study|Pregnancy|0|||
148975770|NCT03670810|537392361|FG007|Main Study|Pregnancy|0|||
148975771|NCT03670810|537392362|FG008|Main Study|Pregnancy|0|||
148975772|NCT03670810|537392354|FG000|Main Study|Protocol Deviation|2|||
148975773|NCT03670810|537392355|FG001|Main Study|Protocol Deviation|12|||
148975774|NCT03670810|537392356|FG002|Main Study|Protocol Deviation|8|||
148975775|NCT03670810|537392357|FG003|Main Study|Protocol Deviation|4|||
148975776|NCT03670810|537392358|FG004|Main Study|Protocol Deviation|0|||
148975777|NCT03670810|537392359|FG005|Main Study|Protocol Deviation|0|||
148975778|NCT03670810|537392360|FG006|Main Study|Protocol Deviation|0|||
148975779|NCT03670810|537392361|FG007|Main Study|Protocol Deviation|0|||
148975780|NCT03670810|537392362|FG008|Main Study|Protocol Deviation|0|||
148975781|NCT03670810|537392354|FG000|Main Study|Withdrawal by Subject|21|||
148975782|NCT03670810|537392355|FG001|Main Study|Withdrawal by Subject|21|||
148975783|NCT03670810|537392356|FG002|Main Study|Withdrawal by Subject|8|||
148975784|NCT03670810|537392357|FG003|Main Study|Withdrawal by Subject|9|||
148975785|NCT03670810|537392358|FG004|Main Study|Withdrawal by Subject|5|||
148975786|NCT03670810|537392359|FG005|Main Study|Withdrawal by Subject|2|||
148975787|NCT03670810|537392360|FG006|Main Study|Withdrawal by Subject|1|||
148741424|NCT01111825|536524251|FG001|Overall Study|Withdrawal by Subject|0|||
148741425|NCT01111825|536524252|FG002|Overall Study|Withdrawal by Subject|1|||
148741426|NCT01111825|536524253|FG003|Overall Study|Withdrawal by Subject|0|||
148741427|NCT01111825|536524250|FG000|Overall Study|Lost to Follow-up|0|||
148741428|NCT01111825|536524251|FG001|Overall Study|Lost to Follow-up|0|||
148741429|NCT01111825|536524252|FG002|Overall Study|Lost to Follow-up|3|||
148741430|NCT01111825|536524253|FG003|Overall Study|Lost to Follow-up|1|||
148741431|NCT01111825|536524250|FG000|Overall Study|Adverse Event|2|||
148741432|NCT01111825|536524251|FG001|Overall Study|Adverse Event|1|||
148741433|NCT01111825|536524252|FG002|Overall Study|Adverse Event|4|||
148741434|NCT01111825|536524253|FG003|Overall Study|Adverse Event|0|||
148741435|NCT01111825|536524250|FG000|Overall Study|Disease Progression|1|||
148741436|NCT01111825|536524251|FG001|Overall Study|Disease Progression|0|||
148741437|NCT01111825|536524252|FG002|Overall Study|Disease Progression|0|||
148741438|NCT01111825|536524253|FG003|Overall Study|Disease Progression|0|||
148741439|NCT01111825|536524250|FG000|Overall Study|Discontinuation by Sponsor|0|||
148741440|NCT01111825|536524251|FG001|Overall Study|Discontinuation by Sponsor|0|||
148741441|NCT01111825|536524252|FG002|Overall Study|Discontinuation by Sponsor|0|||
148741442|NCT01111825|536524253|FG003|Overall Study|Discontinuation by Sponsor|20|||
148741443|NCT01377987|536524256|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
148741444|NCT01377987|536524257|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
148741445|NCT00195338|536524260|FG000|Overall Study|Lost to Follow-up|2|||
148741446|NCT00195338|536524260|FG000|Overall Study|Adverse Event|5|||
148741447|NCT00195338|536524260|FG000|Overall Study|Lack of Efficacy|1|||
148741448|NCT00195338|536524260|FG000|Overall Study|Early closure of the site|4|||
148741449|NCT00811928|536524261|FG000|Overall Study|AEs and SAEs Including Death|7|||
148741450|NCT00811928|536524262|FG001|Overall Study|AEs and SAEs Including Death|11|||
148741451|NCT00811928|536524261|FG000|Overall Study|Withdrawal by Subject|18|||
148741452|NCT00811928|536524262|FG001|Overall Study|Withdrawal by Subject|12|||
148741453|NCT00811928|536524261|FG000|Overall Study|Did Not Take Study Drug|3|||
148975788|NCT03670810|537392361|FG007|Main Study|Withdrawal by Subject|1|||
148975789|NCT03670810|537392362|FG008|Main Study|Withdrawal by Subject|0|||
148975790|NCT03670810|537392354|FG000|Main Study|Participant did not want to take the three other treatments|1|||
148975791|NCT03670810|537392355|FG001|Main Study|Participant did not want to take the three other treatments|0|||
148975792|NCT03670810|537392356|FG002|Main Study|Participant did not want to take the three other treatments|0|||
148975793|NCT03670810|537392357|FG003|Main Study|Participant did not want to take the three other treatments|0|||
148975794|NCT03670810|537392358|FG004|Main Study|Participant did not want to take the three other treatments|0|||
148741454|NCT00811928|536524262|FG001|Overall Study|Did Not Take Study Drug|0|||
148741455|NCT00811928|536524261|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
148975795|NCT03670810|537392359|FG005|Main Study|Participant did not want to take the three other treatments|0|||
148975796|NCT03670810|537392360|FG006|Main Study|Participant did not want to take the three other treatments|0|||
149027137|NCT01072929|537576516|FG000|Overall Study|Lack of Efficacy|7|||
148741456|NCT00811928|536524262|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
148741457|NCT00811928|536524261|FG000|Overall Study|Investigator Decision|2|||
148741458|NCT00811928|536524262|FG001|Overall Study|Investigator Decision|1|||
148741459|NCT00811928|536524261|FG000|Overall Study|Poor Compliance|2|||
148975797|NCT03670810|537392361|FG007|Main Study|Participant did not want to take the three other treatments|0|||
148975798|NCT03670810|537392362|FG008|Main Study|Participant did not want to take the three other treatments|0|||
148741460|NCT00811928|536524262|FG001|Overall Study|Poor Compliance|5|||
148741461|NCT02087189|536524263|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
148741462|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
148741463|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
148741464|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
148741465|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
148741466|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
148741467|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
148741468|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
148741469|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
148741470|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
148741471|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
148741472|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
148741473|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
148741474|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
148741475|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
148741476|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
148741477|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
148741478|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148741479|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148741480|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148741481|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148741482|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
148741483|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
148741484|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
148741485|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
148741486|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
148741487|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
148741488|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
148741489|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
148741490|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
148741491|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
148741492|NCT03713619|536524264|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
148741493|NCT03713619|536524265|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
148741494|NCT03713619|536524266|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
148741495|NCT03713619|536524267|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
148741496|NCT03713619|536524268|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
148741497|NCT03713619|536524264|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
148741498|NCT03713619|536524265|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
148741499|NCT03713619|536524266|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
148741500|NCT03713619|536524267|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
148741501|NCT03713619|536524268|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
148741502|NCT03713619|536524264|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
148741503|NCT03713619|536524265|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148741504|NCT03713619|536524266|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148741505|NCT03713619|536524267|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
148741506|NCT03713619|536524268|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148741507|NCT03713619|536524264|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
148741508|NCT03713619|536524265|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
148741509|NCT03713619|536524266|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
148741510|NCT03713619|536524267|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
148741511|NCT03713619|536524268|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
148741512|NCT03713619|536524264|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
148741513|NCT03713619|536524265|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
148741514|NCT03713619|536524266|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
148741515|NCT03713619|536524267|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
148741516|NCT03713619|536524268|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
148741517|NCT03713619|536524264|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
148741518|NCT03713619|536524265|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
148741519|NCT03713619|536524266|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
148741520|NCT03713619|536524267|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
148975799|NCT03670810|537392354|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148975800|NCT03670810|537392355|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
148975801|NCT03670810|537392356|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148741521|NCT03713619|536524268|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
148741522|NCT03713619|536524264|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
148975802|NCT03670810|537392357|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148741523|NCT03713619|536524265|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
148741524|NCT03713619|536524266|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
148741525|NCT03713619|536524267|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
148741526|NCT03713619|536524268|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
148741527|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
148741528|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
148741529|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
148741530|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
148741531|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
148741532|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
148741533|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
148741534|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
148741535|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
148741536|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
148741537|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
148741538|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
148741539|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
148741540|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
148741541|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
148741542|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
148741543|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
148741544|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
148741545|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
148741546|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
148741547|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
148741548|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
148741549|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
148741550|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
148741551|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
148741552|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
148741553|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
148741554|NCT02552212|536524271|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
148741555|NCT02552212|536524272|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
148741556|NCT02552212|536524273|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
148741557|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
148741558|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
148741559|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
148741560|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
148741561|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
148741562|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
148741563|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
148741564|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
148741565|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
148741566|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
148741567|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
148741568|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
148741569|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
148741570|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
148741571|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
148741572|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
148741573|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
148741574|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
148741575|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
148741576|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
148741577|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
148741578|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
148741579|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
148741580|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
148741581|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
148741582|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
148741583|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
148741584|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
148741585|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
148741586|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
148741587|NCT02552212|536524271|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
149027138|NCT01072929|537576517|FG001|Overall Study|Lack of Efficacy|4|||
148975803|NCT03670810|537392358|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148741588|NCT02552212|536524272|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
148741589|NCT02552212|536524273|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
148741590|NCT01671332|536524274|FG000|Overall Study|Withdrawal by Subject|1|||
148741591|NCT01671332|536524275|FG001|Overall Study|Withdrawal by Subject|1|||
148741592|NCT05038800|536524277|FG000|Overall Study|Death|1|||
148741593|NCT05038800|536524278|FG001|Overall Study|Death|1|||
148741594|NCT05038800|536524279|FG002|Overall Study|Death|5|||
148741595|NCT05038800|536524280|FG003|Overall Study|Death|3|||
148741596|NCT05038800|536524281|FG004|Overall Study|Death|1|||
148741597|NCT05038800|536524277|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148741598|NCT05038800|536524278|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148741599|NCT05038800|536524279|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148741600|NCT05038800|536524280|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148741601|NCT05038800|536524281|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148741602|NCT05038800|536524277|FG000|Overall Study|Lack of Efficacy|0|||
148741603|NCT05038800|536524278|FG001|Overall Study|Lack of Efficacy|0|||
148741604|NCT05038800|536524279|FG002|Overall Study|Lack of Efficacy|0|||
148741605|NCT05038800|536524280|FG003|Overall Study|Lack of Efficacy|0|||
148741606|NCT05038800|536524281|FG004|Overall Study|Lack of Efficacy|1|||
148741607|NCT00121134|536524282|FG000|Overall Study|Progression of Disease|5|||
148741608|NCT00121134|536524283|FG001|Overall Study|Progression of Disease|3|||
148741609|NCT00121134|536524284|FG002|Overall Study|Progression of Disease|4|||
148741610|NCT00121134|536524285|FG003|Overall Study|Progression of Disease|2|||
148741611|NCT00121134|536524282|FG000|Overall Study|Toxicity|4|||
148741612|NCT00121134|536524283|FG001|Overall Study|Toxicity|7|||
148741613|NCT00121134|536524284|FG002|Overall Study|Toxicity|13|||
148741614|NCT00121134|536524285|FG003|Overall Study|Toxicity|5|||
148741615|NCT00121134|536524282|FG000|Overall Study|Physician Decision|6|||
148741616|NCT00121134|536524283|FG001|Overall Study|Physician Decision|4|||
148741617|NCT00121134|536524284|FG002|Overall Study|Physician Decision|4|||
148741618|NCT00121134|536524285|FG003|Overall Study|Physician Decision|1|||
148741619|NCT00121134|536524282|FG000|Overall Study|Treatment Delay|1|||
148741620|NCT00121134|536524283|FG001|Overall Study|Treatment Delay|0|||
148741621|NCT00121134|536524284|FG002|Overall Study|Treatment Delay|0|||
148741622|NCT00121134|536524285|FG003|Overall Study|Treatment Delay|0|||
148741623|NCT00121134|536524282|FG000|Overall Study|Intercurrent Illness|0|||
148741624|NCT00121134|536524283|FG001|Overall Study|Intercurrent Illness|0|||
148741625|NCT00121134|536524284|FG002|Overall Study|Intercurrent Illness|0|||
148741626|NCT00121134|536524285|FG003|Overall Study|Intercurrent Illness|1|||
148741627|NCT00121134|536524282|FG000|Overall Study|Patient Personal Reasons|0|||
148741628|NCT00121134|536524283|FG001|Overall Study|Patient Personal Reasons|1|||
148741629|NCT00121134|536524284|FG002|Overall Study|Patient Personal Reasons|0|||
148741630|NCT00121134|536524285|FG003|Overall Study|Patient Personal Reasons|0|||
148741631|NCT02533375|536524292|FG000|Overall Study|Lack of Efficacy|3|||
148741632|NCT02533375|536524292|FG000|Overall Study|Adverse Event|2|||
148741633|NCT00673387|536524293|FG000|Overall Study|Withdrawal by Subject|15|||
148741634|NCT00673387|536524294|FG001|Overall Study|Withdrawal by Subject|16|||
148741635|NCT00673387|536524295|FG002|Overall Study|Withdrawal by Subject|20|||
148741636|NCT00673387|536524296|FG003|Overall Study|Withdrawal by Subject|16|||
148741637|NCT00673387|536524297|FG004|Overall Study|Withdrawal by Subject|18|||
148741638|NCT00673387|536524298|FG005|Overall Study|Withdrawal by Subject|21|||
148741639|NCT00673387|536524299|FG006|Overall Study|Withdrawal by Subject|15|||
148975804|NCT03670810|537392359|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148975805|NCT03670810|537392360|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148975806|NCT03670810|537392361|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148975807|NCT03670810|537392362|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
148975808|NCT03670810|537392354|FG000|Main Study|Travel and Coronavirus issues|0|||
148975809|NCT03670810|537392355|FG001|Main Study|Travel and Coronavirus issues|0|||
148975810|NCT03670810|537392356|FG002|Main Study|Travel and Coronavirus issues|0|||
148975811|NCT03670810|537392357|FG003|Main Study|Travel and Coronavirus issues|1|||
148975812|NCT03670810|537392358|FG004|Main Study|Travel and Coronavirus issues|0|||
148975813|NCT03670810|537392359|FG005|Main Study|Travel and Coronavirus issues|0|||
148975814|NCT03670810|537392360|FG006|Main Study|Travel and Coronavirus issues|0|||
148741640|NCT00673387|536524300|FG007|Overall Study|Withdrawal by Subject|21|||
148741641|NCT00673387|536524293|FG000|Overall Study|Adverse Event|3|||
148741642|NCT00673387|536524294|FG001|Overall Study|Adverse Event|1|||
148741643|NCT00673387|536524295|FG002|Overall Study|Adverse Event|5|||
148741644|NCT00673387|536524296|FG003|Overall Study|Adverse Event|2|||
148741645|NCT00673387|536524297|FG004|Overall Study|Adverse Event|6|||
148741646|NCT00673387|536524298|FG005|Overall Study|Adverse Event|2|||
148741647|NCT00673387|536524299|FG006|Overall Study|Adverse Event|5|||
148741648|NCT00673387|536524300|FG007|Overall Study|Adverse Event|5|||
148741649|NCT00673387|536524293|FG000|Overall Study|Physician Decision|0|||
149027139|NCT01072929|537576518|FG002|Overall Study|Lack of Efficacy|0|||
148741650|NCT00673387|536524294|FG001|Overall Study|Physician Decision|0|||
148741651|NCT00673387|536524295|FG002|Overall Study|Physician Decision|0|||
148975815|NCT03670810|537392361|FG007|Main Study|Travel and Coronavirus issues|0|||
148975816|NCT03670810|537392362|FG008|Main Study|Travel and Coronavirus issues|0|||
148975817|NCT03670810|537392354|FG000|Open Label Extension|Protocol Deviation|0|||
148975818|NCT03670810|537392355|FG001|Open Label Extension|Protocol Deviation|0|||
148975819|NCT03670810|537392356|FG002|Open Label Extension|Protocol Deviation|0|||
148975820|NCT03670810|537392357|FG003|Open Label Extension|Protocol Deviation|0|||
148975821|NCT03670810|537392358|FG004|Open Label Extension|Protocol Deviation|0|||
148818528|NCT05591755|536810457|FG002|Overall Study|Withdrawal by Subject|0|||
148818529|NCT05591755|536810458|FG003|Overall Study|Withdrawal by Subject|0|||
148818530|NCT01397747|536810460|FG000|Overall Study|Multitarget DNA test excluded|689|||
148818531|NCT01397747|536810460|FG000|Overall Study|Colonoscopy excluded|304|||
148818532|NCT01397747|536810460|FG000|Overall Study|FIT excluded|34|||
148975822|NCT03670810|537392359|FG005|Open Label Extension|Protocol Deviation|0|||
148975823|NCT03670810|537392360|FG006|Open Label Extension|Protocol Deviation|0|||
148975824|NCT03670810|537392361|FG007|Open Label Extension|Protocol Deviation|0|||
148975825|NCT03670810|537392362|FG008|Open Label Extension|Protocol Deviation|5|||
148975826|NCT03670810|537392354|FG000|Open Label Extension|Death|0|||
148975827|NCT03670810|537392355|FG001|Open Label Extension|Death|0|||
148975828|NCT03670810|537392356|FG002|Open Label Extension|Death|0|||
148975829|NCT03670810|537392357|FG003|Open Label Extension|Death|0|||
148975830|NCT03670810|537392358|FG004|Open Label Extension|Death|0|||
148975831|NCT03670810|537392359|FG005|Open Label Extension|Death|0|||
148975832|NCT03670810|537392360|FG006|Open Label Extension|Death|0|||
148975833|NCT03670810|537392361|FG007|Open Label Extension|Death|0|||
148975834|NCT03670810|537392362|FG008|Open Label Extension|Death|1|||
148975835|NCT03670810|537392354|FG000|Open Label Extension|COVID-19|0|||
148975836|NCT03670810|537392355|FG001|Open Label Extension|COVID-19|0|||
148975837|NCT03670810|537392356|FG002|Open Label Extension|COVID-19|0|||
148975838|NCT03670810|537392357|FG003|Open Label Extension|COVID-19|0|||
148975839|NCT03670810|537392358|FG004|Open Label Extension|COVID-19|0|||
148975840|NCT03670810|537392359|FG005|Open Label Extension|COVID-19|0|||
148975841|NCT03670810|537392360|FG006|Open Label Extension|COVID-19|0|||
148975842|NCT03670810|537392361|FG007|Open Label Extension|COVID-19|0|||
148741652|NCT00673387|536524296|FG003|Overall Study|Physician Decision|0|||
148741653|NCT00673387|536524297|FG004|Overall Study|Physician Decision|0|||
148741654|NCT00673387|536524298|FG005|Overall Study|Physician Decision|5|||
148741655|NCT00673387|536524299|FG006|Overall Study|Physician Decision|1|||
148741656|NCT00673387|536524300|FG007|Overall Study|Physician Decision|1|||
148741657|NCT00673387|536524293|FG000|Overall Study|Protocol Violation|3|||
148741658|NCT00673387|536524294|FG001|Overall Study|Protocol Violation|0|||
148741659|NCT00673387|536524295|FG002|Overall Study|Protocol Violation|1|||
148741660|NCT00673387|536524296|FG003|Overall Study|Protocol Violation|2|||
148741661|NCT00673387|536524297|FG004|Overall Study|Protocol Violation|0|||
148741662|NCT00673387|536524298|FG005|Overall Study|Protocol Violation|1|||
148741663|NCT00673387|536524299|FG006|Overall Study|Protocol Violation|1|||
148741664|NCT00673387|536524300|FG007|Overall Study|Protocol Violation|3|||
148741665|NCT00673387|536524293|FG000|Overall Study|Lost to Follow-up|8|||
148741666|NCT00673387|536524294|FG001|Overall Study|Lost to Follow-up|6|||
148741667|NCT00673387|536524295|FG002|Overall Study|Lost to Follow-up|5|||
148741668|NCT00673387|536524296|FG003|Overall Study|Lost to Follow-up|6|||
148741669|NCT00673387|536524297|FG004|Overall Study|Lost to Follow-up|6|||
148741670|NCT00673387|536524298|FG005|Overall Study|Lost to Follow-up|5|||
148741671|NCT00673387|536524299|FG006|Overall Study|Lost to Follow-up|8|||
148741672|NCT00673387|536524300|FG007|Overall Study|Lost to Follow-up|5|||
148741673|NCT00960115|536524301|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
148741674|NCT00960115|536524302|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
148741675|NCT00418821|536524303|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
148741676|NCT04400682|536524308|FG000|Period 1|Withdrawal by Subject|1|||
148741677|NCT04400682|536524309|FG001|Period 1|Withdrawal by Subject|4|||
148741678|NCT02105974|536524310|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
148741679|NCT02105974|536524311|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
148741680|NCT02105974|536524312|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
148741681|NCT02105974|536524310|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
148741682|NCT02105974|536524311|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
148741683|NCT02105974|536524312|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
148741684|NCT02105974|536524310|FG000|2 Week Run-in Period|Adverse Event|6|||
148741685|NCT02105974|536524311|FG001|2 Week Run-in Period|Adverse Event|0|||
148741686|NCT02105974|536524312|FG002|2 Week Run-in Period|Adverse Event|0|||
148818533|NCT03158311|536810463|FG000|Overall Study|Subject/Guardian Decision|10|||
148818534|NCT03158311|536810464|FG001|Overall Study|Subject/Guardian Decision|6|||
148975843|NCT03670810|537392362|FG008|Open Label Extension|COVID-19|1|||
148975844|NCT03670810|537392354|FG000|Open Label Extension|Lack of Efficacy|0|||
148975845|NCT03670810|537392355|FG001|Open Label Extension|Lack of Efficacy|0|||
148975846|NCT03670810|537392356|FG002|Open Label Extension|Lack of Efficacy|0|||
148975847|NCT03670810|537392357|FG003|Open Label Extension|Lack of Efficacy|0|||
148975848|NCT03670810|537392358|FG004|Open Label Extension|Lack of Efficacy|0|||
148975849|NCT03670810|537392359|FG005|Open Label Extension|Lack of Efficacy|0|||
148975850|NCT03670810|537392360|FG006|Open Label Extension|Lack of Efficacy|0|||
148975851|NCT03670810|537392361|FG007|Open Label Extension|Lack of Efficacy|0|||
148975852|NCT03670810|537392362|FG008|Open Label Extension|Lack of Efficacy|39|||
148975853|NCT03670810|537392354|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
148975854|NCT03670810|537392355|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
148975855|NCT03670810|537392356|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
148975856|NCT03670810|537392357|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
148975857|NCT03670810|537392358|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
148975858|NCT03670810|537392359|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
148975859|NCT03670810|537392360|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
148975860|NCT03670810|537392361|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
148975861|NCT03670810|537392362|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
148975862|NCT03670810|537392354|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975863|NCT03670810|537392355|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975864|NCT03670810|537392356|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975865|NCT03670810|537392357|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975866|NCT03670810|537392358|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975867|NCT03670810|537392359|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975868|NCT03670810|537392360|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975869|NCT03670810|537392361|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
148975870|NCT03670810|537392362|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
148975871|NCT03670810|537392354|FG000|Open Label Extension|Withdrawal by Subject|0|||
148975872|NCT03670810|537392355|FG001|Open Label Extension|Withdrawal by Subject|0|||
148975873|NCT03670810|537392356|FG002|Open Label Extension|Withdrawal by Subject|0|||
148975874|NCT03670810|537392357|FG003|Open Label Extension|Withdrawal by Subject|0|||
148975875|NCT03670810|537392358|FG004|Open Label Extension|Withdrawal by Subject|0|||
148975876|NCT03670810|537392359|FG005|Open Label Extension|Withdrawal by Subject|0|||
148975877|NCT03670810|537392360|FG006|Open Label Extension|Withdrawal by Subject|0|||
148975878|NCT03670810|537392361|FG007|Open Label Extension|Withdrawal by Subject|0|||
148975879|NCT03670810|537392362|FG008|Open Label Extension|Withdrawal by Subject|46|||
148975880|NCT03670810|537392354|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975881|NCT03670810|537392355|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975882|NCT03670810|537392356|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975883|NCT03670810|537392357|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975884|NCT03670810|537392358|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975885|NCT03670810|537392359|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975886|NCT03670810|537392360|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975887|NCT03670810|537392361|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
148975888|NCT03670810|537392362|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
148975889|NCT03670810|537392354|FG000|Open Label Extension|Physician Decision|0|||
148975890|NCT03670810|537392355|FG001|Open Label Extension|Physician Decision|0|||
148975891|NCT03670810|537392356|FG002|Open Label Extension|Physician Decision|0|||
148975892|NCT03670810|537392357|FG003|Open Label Extension|Physician Decision|0|||
148975893|NCT03670810|537392358|FG004|Open Label Extension|Physician Decision|0|||
148975894|NCT03670810|537392359|FG005|Open Label Extension|Physician Decision|0|||
148741687|NCT02105974|536524310|FG000|2 Week Run-in Period|Study closed/terminated|1|||
148741688|NCT02105974|536524311|FG001|2 Week Run-in Period|Study closed/terminated|0|||
148741689|NCT02105974|536524312|FG002|2 Week Run-in Period|Study closed/terminated|0|||
148741690|NCT02105974|536524310|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
148741691|NCT02105974|536524311|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
148975895|NCT03670810|537392360|FG006|Open Label Extension|Physician Decision|0|||
148975896|NCT03670810|537392361|FG007|Open Label Extension|Physician Decision|0|||
148975897|NCT03670810|537392362|FG008|Open Label Extension|Physician Decision|2|||
148975898|NCT03670810|537392354|FG000|Open Label Extension|Non-compliance with study drug|0|||
148975899|NCT03670810|537392355|FG001|Open Label Extension|Non-compliance with study drug|0|||
148975900|NCT03670810|537392356|FG002|Open Label Extension|Non-compliance with study drug|0|||
148975901|NCT03670810|537392357|FG003|Open Label Extension|Non-compliance with study drug|0|||
148975902|NCT03670810|537392358|FG004|Open Label Extension|Non-compliance with study drug|0|||
148975903|NCT03670810|537392359|FG005|Open Label Extension|Non-compliance with study drug|0|||
148975904|NCT03670810|537392360|FG006|Open Label Extension|Non-compliance with study drug|0|||
148975905|NCT03670810|537392361|FG007|Open Label Extension|Non-compliance with study drug|0|||
148975906|NCT03670810|537392362|FG008|Open Label Extension|Non-compliance with study drug|5|||
148741692|NCT02105974|536524312|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
148741693|NCT02105974|536524310|FG000|2 Week Run-in Period|Withdrew consent|23|||
148741694|NCT02105974|536524311|FG001|2 Week Run-in Period|Withdrew consent|0|||
148741695|NCT02105974|536524312|FG002|2 Week Run-in Period|Withdrew consent|0|||
148741696|NCT02105974|536524310|FG000|2 Week Run-in Period|Investigator discretion|8|||
148741697|NCT02105974|536524311|FG001|2 Week Run-in Period|Investigator discretion|0|||
148741698|NCT02105974|536524312|FG002|2 Week Run-in Period|Investigator discretion|0|||
148741699|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
148741700|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
148741701|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
148741702|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
148741703|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
148741704|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
148741705|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
148741706|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
148741707|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
148741708|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
148741709|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
148741710|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
148741711|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
148741712|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
148741713|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
148741714|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
148741715|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
148741716|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
148741717|NCT02105974|536524310|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
148741718|NCT02105974|536524311|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
148741719|NCT02105974|536524312|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
148741720|NCT00477633|536524313|FG000|Overall Study|Did not receive treatment|23|||
148741721|NCT00477633|536524313|FG000|Overall Study|Adverse Event|143|||
148741722|NCT00477633|536524313|FG000|Overall Study|Pregnancy|23|||
148741723|NCT00477633|536524313|FG000|Overall Study|Lost to Follow-up|271|||
148741724|NCT00477633|536524313|FG000|Overall Study|Withdrawal by Subject|149|||
148741725|NCT00477633|536524313|FG000|Overall Study|Protocol Violation|25|||
148741726|NCT00477633|536524313|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
148741727|NCT02968849|536524314|FG000|Overall Study|Death|8|||
148741728|NCT02968849|536524315|FG001|Overall Study|Death|10|||
148741729|NCT02968849|536524314|FG000|Overall Study|Lost to Follow-up|31|||
148741730|NCT02968849|536524315|FG001|Overall Study|Lost to Follow-up|29|||
148741731|NCT02968849|536524314|FG000|Overall Study|Withdrawal by Subject|73|||
148741732|NCT02968849|536524315|FG001|Overall Study|Withdrawal by Subject|64|||
148741733|NCT02968849|536524314|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
148741734|NCT02968849|536524315|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
148741735|NCT02968849|536524314|FG000|Overall Study|Physician Decision|6|||
148741736|NCT02968849|536524315|FG001|Overall Study|Physician Decision|9|||
148741737|NCT02968849|536524314|FG000|Overall Study|Other|16|||
148741738|NCT02968849|536524315|FG001|Overall Study|Other|10|||
148741739|NCT00478244|536526184|FG000|Overall Study|Did not receive transplant|1|||
148741740|NCT02856555|536526185|FG000|Overall Study|Adverse Event|1|||
148741741|NCT02856555|536526186|FG001|Overall Study|Adverse Event|0|||
148741742|NCT02856555|536526187|FG002|Overall Study|Adverse Event|0|||
148741743|NCT02856555|536526185|FG000|Overall Study|Lost to Follow-up|1|||
148741744|NCT02856555|536526186|FG001|Overall Study|Lost to Follow-up|3|||
148741745|NCT02856555|536526187|FG002|Overall Study|Lost to Follow-up|0|||
148741746|NCT02856555|536526185|FG000|Overall Study|Withdrawal by Subject|3|||
148741747|NCT02856555|536526186|FG001|Overall Study|Withdrawal by Subject|0|||
148741748|NCT02856555|536526187|FG002|Overall Study|Withdrawal by Subject|0|||
148741749|NCT02856555|536526185|FG000|Overall Study|Randomized but Never Treated|0|||
148741750|NCT02856555|536526186|FG001|Overall Study|Randomized but Never Treated|1|||
148741751|NCT02856555|536526187|FG002|Overall Study|Randomized but Never Treated|0|||
148741752|NCT00580788|536526191|FG000|Overall Study|Adverse Event|0|||
148741753|NCT00580788|536526192|FG001|Overall Study|Adverse Event|0|||
148741754|NCT00580788|536526193|FG002|Overall Study|Adverse Event|0|||
148741755|NCT00580788|536526194|FG003|Overall Study|Adverse Event|1|||
148741756|NCT03301649|536526197|FG000|Overall Study|Need alternate therapy due to live lice|17|||
148741757|NCT03301649|536526198|FG001|Overall Study|Need alternate therapy due to live lice|25|||
148741758|NCT03301649|536526199|FG002|Overall Study|Need alternate therapy due to live lice|81|||
148741759|NCT03301649|536526197|FG000|Overall Study|Lost to Follow-up|11|||
148741760|NCT03301649|536526198|FG001|Overall Study|Lost to Follow-up|11|||
148741761|NCT03301649|536526199|FG002|Overall Study|Lost to Follow-up|3|||
148741762|NCT03301649|536526197|FG000|Overall Study|Protocol Violation|0|||
148741763|NCT03301649|536526198|FG001|Overall Study|Protocol Violation|1|||
148741764|NCT03301649|536526199|FG002|Overall Study|Protocol Violation|1|||
148741765|NCT03301649|536526197|FG000|Overall Study|Withdrawal by Subject|10|||
148741766|NCT03301649|536526198|FG001|Overall Study|Withdrawal by Subject|4|||
148741767|NCT03301649|536526199|FG002|Overall Study|Withdrawal by Subject|0|||
148741768|NCT03301649|536526197|FG000|Overall Study|Other than specified|5|||
148741769|NCT03301649|536526198|FG001|Overall Study|Other than specified|3|||
148741770|NCT03301649|536526199|FG002|Overall Study|Other than specified|0|||
148741771|NCT01403051|536526200|FG000|Overall Study|Protocol Violation|2|||
148741772|NCT01403051|536526201|FG001|Overall Study|Protocol Violation|0|||
148741773|NCT01403051|536526200|FG000|Overall Study|Death|1|||
148741774|NCT01403051|536526201|FG001|Overall Study|Death|0|||
148741775|NCT01403051|536526200|FG000|Overall Study|Withdrawal by Subject|2|||
148741776|NCT01403051|536526201|FG001|Overall Study|Withdrawal by Subject|1|||
148741777|NCT01403051|536526200|FG000|Overall Study|Lost to Follow-up|5|||
148741778|NCT01403051|536526201|FG001|Overall Study|Lost to Follow-up|5|||
148741779|NCT00887289|536526206|FG000|Overall Study|Lack of Efficacy|14|||
148741780|NCT00887289|536526206|FG000|Overall Study|Adverse Event|27|||
148741781|NCT00887289|536526206|FG000|Overall Study|Withdrawal by Subject|26|||
148741782|NCT00887289|536526206|FG000|Overall Study|Lost to Follow-up|8|||
148741783|NCT00887289|536526206|FG000|Overall Study|Other|20|||
148741784|NCT00509366|536526207|FG000|Overall Study|Not Treated (Screen Failure)|1|||
148741785|NCT00509366|536526208|FG001|Overall Study|Not Treated (Screen Failure)|1|||
148741786|NCT00509366|536526209|FG002|Overall Study|Not Treated (Screen Failure)|1|||
148741787|NCT00509366|536526210|FG003|Overall Study|Not Treated (Screen Failure)|0|||
148741788|NCT00509366|536526211|FG004|Overall Study|Not Treated (Screen Failure)|0|||
148741789|NCT01438996|536526214|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
148741790|NCT01438996|536526215|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
148741791|NCT01438996|536526216|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
148741792|NCT01433549|536526217|FG000|Phase 2: Second Study Product|Adverse Event|0|||
148741793|NCT01433549|536526218|FG001|Phase 2: Second Study Product|Adverse Event|1|||
148741794|NCT01696058|536526223|FG000|Overall Study|Adverse Event|21|||
148741795|NCT01696058|536526224|FG001|Overall Study|Adverse Event|11|||
148741796|NCT01696058|536526223|FG000|Overall Study|Lack of Efficacy|2|||
148741797|NCT01696058|536526224|FG001|Overall Study|Lack of Efficacy|3|||
148741798|NCT01696058|536526223|FG000|Overall Study|Protocol Violation|9|||
148741799|NCT01696058|536526224|FG001|Overall Study|Protocol Violation|3|||
148741800|NCT01696058|536526223|FG000|Overall Study|Lost to Follow-up|2|||
148741801|NCT01696058|536526224|FG001|Overall Study|Lost to Follow-up|5|||
148741802|NCT01696058|536526223|FG000|Overall Study|Withdrawal by Subject|4|||
148741803|NCT01696058|536526224|FG001|Overall Study|Withdrawal by Subject|6|||
148741804|NCT01696058|536526223|FG000|Overall Study|Other reason prematurely discontinued|5|||
148741805|NCT01696058|536526224|FG001|Overall Study|Other reason prematurely discontinued|3|||
148741806|NCT02186834|536526226|FG000|Dose Escalation|Death|0|||
148741807|NCT02186834|536526227|FG001|Dose Escalation|Death|0|||
148741808|NCT02186834|536526228|FG002|Dose Escalation|Death|0|||
148741809|NCT02186834|536526229|FG003|Dose Escalation|Death|1|||
148741810|NCT02186834|536526230|FG004|Dose Escalation|Death|0|||
148741811|NCT02186834|536526231|FG005|Dose Escalation|Death|0|||
148741812|NCT02186834|536526226|FG000|Treatment at RP2D|Died prior to treatment|0|||
148741813|NCT02186834|536526227|FG001|Treatment at RP2D|Died prior to treatment|0|||
148741814|NCT02186834|536526228|FG002|Treatment at RP2D|Died prior to treatment|0|||
148741815|NCT02186834|536526229|FG003|Treatment at RP2D|Died prior to treatment|0|||
148741816|NCT02186834|536526230|FG004|Treatment at RP2D|Died prior to treatment|0|||
148741817|NCT02186834|536526231|FG005|Treatment at RP2D|Died prior to treatment|1|||
148741818|NCT00749892|536526232|FG000|Overall Study|Withdrawal by Subject|3|||
148741819|NCT04581369|536526233|FG000|Overall Study|Death|7|||
148741820|NCT04581369|536526234|FG001|Overall Study|Death|6|||
148741821|NCT04581369|536526235|FG002|Overall Study|Death|0|||
148741822|NCT04581369|536526233|FG000|Overall Study|Lost to Follow-up|7|||
148741823|NCT04581369|536526234|FG001|Overall Study|Lost to Follow-up|3|||
148741824|NCT04581369|536526235|FG002|Overall Study|Lost to Follow-up|0|||
148741825|NCT04581369|536526233|FG000|Overall Study|liver transplant|2|||
148741826|NCT04581369|536526234|FG001|Overall Study|liver transplant|2|||
148741827|NCT04581369|536526235|FG002|Overall Study|liver transplant|0|||
148741828|NCT04581369|536526233|FG000|Overall Study|transitioned to hospice care|0|||
148741829|NCT04581369|536526234|FG001|Overall Study|transitioned to hospice care|5|||
148741830|NCT04581369|536526235|FG002|Overall Study|transitioned to hospice care|0|||
148741831|NCT00780910|536526236|FG000|Overall Study|Adverse Event|2|||
148741832|NCT00106964|536526240|FG000|Overall Study|Lost to Follow-up|8|||
148741833|NCT00106964|536526241|FG001|Overall Study|Lost to Follow-up|6|||
148741834|NCT00106964|536526242|FG002|Overall Study|Lost to Follow-up|2|||
148741835|NCT00106964|536526240|FG000|Overall Study|Pregnancy|2|||
148741836|NCT00106964|536526241|FG001|Overall Study|Pregnancy|3|||
148741837|NCT00106964|536526242|FG002|Overall Study|Pregnancy|2|||
148741838|NCT00106964|536526240|FG000|Overall Study|Death|1|||
148741839|NCT00106964|536526241|FG001|Overall Study|Death|1|||
148741840|NCT00106964|536526242|FG002|Overall Study|Death|0|||
148741841|NCT00106964|536526240|FG000|Overall Study|Incarceration|0|||
148975907|NCT03670810|537392354|FG000|Open Label Extension|Pregnancy|0|||
148741842|NCT00106964|536526241|FG001|Overall Study|Incarceration|1|||
148741843|NCT00106964|536526242|FG002|Overall Study|Incarceration|0|||
148975908|NCT03670810|537392355|FG001|Open Label Extension|Pregnancy|0|||
148975909|NCT03670810|537392356|FG002|Open Label Extension|Pregnancy|0|||
148975910|NCT03670810|537392357|FG003|Open Label Extension|Pregnancy|0|||
148975911|NCT03670810|537392358|FG004|Open Label Extension|Pregnancy|0|||
148975912|NCT03670810|537392359|FG005|Open Label Extension|Pregnancy|0|||
148975913|NCT03670810|537392360|FG006|Open Label Extension|Pregnancy|0|||
148975914|NCT03670810|537392361|FG007|Open Label Extension|Pregnancy|0|||
148975915|NCT03670810|537392362|FG008|Open Label Extension|Pregnancy|3|||
148975916|NCT03670810|537392354|FG000|Open Label Extension|Adverse Event|0|||
148975917|NCT03670810|537392355|FG001|Open Label Extension|Adverse Event|0|||
148975918|NCT03670810|537392356|FG002|Open Label Extension|Adverse Event|0|||
148975919|NCT03670810|537392357|FG003|Open Label Extension|Adverse Event|0|||
148975920|NCT03670810|537392358|FG004|Open Label Extension|Adverse Event|0|||
148975921|NCT03670810|537392359|FG005|Open Label Extension|Adverse Event|0|||
148975922|NCT03670810|537392360|FG006|Open Label Extension|Adverse Event|0|||
148975923|NCT03670810|537392361|FG007|Open Label Extension|Adverse Event|0|||
148975924|NCT03670810|537392362|FG008|Open Label Extension|Adverse Event|24|||
148975925|NCT03670810|537392354|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
148975926|NCT03670810|537392355|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
148975927|NCT03670810|537392356|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
148741844|NCT00106964|536526240|FG000|Overall Study|Site Funding Terminated|0|||
148741845|NCT00106964|536526241|FG001|Overall Study|Site Funding Terminated|1|||
148741846|NCT00106964|536526242|FG002|Overall Study|Site Funding Terminated|1|||
148741847|NCT00106964|536526240|FG000|Overall Study|Failure to adhere|2|||
148741848|NCT00106964|536526241|FG001|Overall Study|Failure to adhere|0|||
148741849|NCT00106964|536526242|FG002|Overall Study|Failure to adhere|0|||
148741850|NCT00106964|536526240|FG000|Overall Study|Did not meet eligibility criteria|0|||
148741851|NCT00106964|536526241|FG001|Overall Study|Did not meet eligibility criteria|2|||
148741852|NCT00106964|536526242|FG002|Overall Study|Did not meet eligibility criteria|2|||
148741853|NCT00106964|536526240|FG000|Overall Study|Required disallowed medication|0|||
148741854|NCT00106964|536526241|FG001|Overall Study|Required disallowed medication|1|||
148741855|NCT00106964|536526242|FG002|Overall Study|Required disallowed medication|0|||
148741856|NCT04746794|536526243|FG000|Overall Study|Did not complete any study assessment|50303|||
148741857|NCT04746794|536526244|FG001|Overall Study|Did not complete any study assessment|44997|||
148741858|NCT03207243|536526245|FG000|Overall Study|Adverse Event|2|||
148741859|NCT03207243|536526246|FG001|Overall Study|Adverse Event|2|||
148741860|NCT03207243|536526245|FG000|Overall Study|Loss of Asthma Control|47|||
148741861|NCT03207243|536526246|FG001|Overall Study|Loss of Asthma Control|31|||
148741862|NCT03207243|536526245|FG000|Overall Study|Withdrawal by Subject|2|||
148741863|NCT03207243|536526246|FG001|Overall Study|Withdrawal by Subject|4|||
148741864|NCT03207243|536526245|FG000|Overall Study|Physician Decision|1|||
148741865|NCT03207243|536526246|FG001|Overall Study|Physician Decision|1|||
148741866|NCT03207243|536526245|FG000|Overall Study|Lost to Follow-up|0|||
148741867|NCT03207243|536526246|FG001|Overall Study|Lost to Follow-up|1|||
148741868|NCT03207243|536526245|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
148741869|NCT03207243|536526246|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
148741870|NCT03207243|536526245|FG000|Overall Study|Protocol Violation|0|||
148741871|NCT03207243|536526246|FG001|Overall Study|Protocol Violation|3|||
148741872|NCT01422187|536526251|FG000|Overall Study|Personal reason|1|||
148975928|NCT03670810|537392357|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
148975929|NCT03670810|537392358|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
148975930|NCT03670810|537392359|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
148975931|NCT03670810|537392360|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
148975932|NCT03670810|537392361|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
148741873|NCT01422187|536526252|FG001|Overall Study|Personal reason|0|||
148741874|NCT01422187|536526253|FG002|Overall Study|Personal reason|0|||
148741875|NCT01422187|536526251|FG000|Overall Study|Lost to Follow-up|0|||
148741876|NCT01422187|536526252|FG001|Overall Study|Lost to Follow-up|1|||
148741877|NCT01422187|536526253|FG002|Overall Study|Lost to Follow-up|0|||
148741878|NCT00168818|536526254|FG000|Overall Study|Adverse Event|23|||
148741879|NCT00168818|536526255|FG001|Overall Study|Adverse Event|29|||
148741880|NCT00168818|536526256|FG002|Overall Study|Adverse Event|31|||
148741881|NCT00168818|536526254|FG000|Overall Study|Protocol Violation|16|||
148741882|NCT00168818|536526255|FG001|Overall Study|Protocol Violation|11|||
148975933|NCT03670810|537392362|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
148741883|NCT00168818|536526256|FG002|Overall Study|Protocol Violation|11|||
148741884|NCT00168818|536526254|FG000|Overall Study|Lost to Follow-up|13|||
148741885|NCT00168818|536526255|FG001|Overall Study|Lost to Follow-up|4|||
148741886|NCT00168818|536526256|FG002|Overall Study|Lost to Follow-up|15|||
148741887|NCT00168818|536526254|FG000|Overall Study|Withdrawal by Subject|43|||
148741888|NCT00168818|536526255|FG001|Overall Study|Withdrawal by Subject|41|||
148741889|NCT00168818|536526256|FG002|Overall Study|Withdrawal by Subject|37|||
148741890|NCT00168818|536526254|FG000|Overall Study|Other|22|||
148741891|NCT00168818|536526255|FG001|Overall Study|Other|24|||
148741892|NCT00168818|536526256|FG002|Overall Study|Other|30|||
148818535|NCT03158311|536810465|FG002|Overall Study|Subject/Guardian Decision|11|||
148818536|NCT03158311|536810463|FG000|Overall Study|Adverse Event|5|||
148818537|NCT03158311|536810464|FG001|Overall Study|Adverse Event|3|||
148818538|NCT03158311|536810465|FG002|Overall Study|Adverse Event|3|||
148818539|NCT03158311|536810463|FG000|Overall Study|Techinical Problems|3|||
148818540|NCT03158311|536810464|FG001|Overall Study|Techinical Problems|1|||
148818541|NCT03158311|536810465|FG002|Overall Study|Techinical Problems|5|||
148818542|NCT03158311|536810463|FG000|Overall Study|Physician Decision|2|||
148818543|NCT03158311|536810464|FG001|Overall Study|Physician Decision|3|||
148818544|NCT03158311|536810465|FG002|Overall Study|Physician Decision|7|||
148818545|NCT03158311|536810463|FG000|Overall Study|Lost to Follow-up|1|||
148818546|NCT03158311|536810464|FG001|Overall Study|Lost to Follow-up|1|||
148818547|NCT03158311|536810465|FG002|Overall Study|Lost to Follow-up|1|||
148818548|NCT03158311|536810463|FG000|Overall Study|Sponsor decision|1|||
148818549|NCT03158311|536810464|FG001|Overall Study|Sponsor decision|0|||
148818550|NCT03158311|536810465|FG002|Overall Study|Sponsor decision|0|||
148818551|NCT03158311|536810463|FG000|Overall Study|Pregnancy|0|||
148818552|NCT03158311|536810464|FG001|Overall Study|Pregnancy|2|||
148818553|NCT03158311|536810465|FG002|Overall Study|Pregnancy|0|||
148818554|NCT03158311|536810463|FG000|Overall Study|Randomized in error|0|||
148818555|NCT03158311|536810464|FG001|Overall Study|Randomized in error|0|||
148818556|NCT03158311|536810465|FG002|Overall Study|Randomized in error|1|||
148818557|NCT02665455|536810466|FG000|Overall Study|Withdrawal by Subject|6|||
148818558|NCT02665455|536810466|FG000|Overall Study|Lost to Follow-up|1|||
148818559|NCT02665455|536810466|FG000|Overall Study|Adverse Event|1|||
148818560|NCT02665455|536810466|FG000|Overall Study|Protocol Violation|1|||
148818561|NCT03011372|536810470|FG000|Overall Study|Death|16|||
148818562|NCT03011372|536810470|FG000|Overall Study|Lost to Follow-up|2|||
148818563|NCT03011372|536810470|FG000|Overall Study|Sponsor Decision|17|||
148818564|NCT03011372|536810470|FG000|Overall Study|Withdrawal by Subject|7|||
148818565|NCT03011372|536810470|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
148818566|NCT03011372|536810470|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
148818567|NCT03011372|536810470|FG000|Overall Study|Sponsor's Decision|2|||
148818568|NCT05865886|536810471|FG000|Overall Study|Serious adverse event|0|||
148818569|NCT05865886|536810472|FG001|Overall Study|Serious adverse event|1|||
148818570|NCT01671059|536810473|FG000|Overall Study|Adverse Event|4|||
148818571|NCT01671059|536810473|FG000|Overall Study|Lack of Efficacy|1|||
148818572|NCT02564978|536810476|FG000|Overall Study|Adverse Event|8|||
148818573|NCT02564978|536810476|FG000|Overall Study|Death|1|||
148818574|NCT02564978|536810476|FG000|Overall Study|Lost to Follow-up|1|||
148818575|NCT02564978|536810476|FG000|Overall Study|Withdrawal by Subject|15|||
148818576|NCT02564978|536810476|FG000|Overall Study|Early Study Closure|2|||
148818577|NCT02564978|536810476|FG000|Overall Study|Other Reason|5|||
148818578|NCT03022630|536812994|FG000|Overall Study|Death|9|||
148818579|NCT03022630|536812995|FG001|Overall Study|Death|7|||
148818580|NCT03022630|536812994|FG000|Overall Study|Withdrawal by Subject|0|||
148818581|NCT03022630|536812995|FG001|Overall Study|Withdrawal by Subject|5|||
148818582|NCT00884949|536812996|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
148818583|NCT00884949|536812996|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
148818584|NCT00382070|536812997|FG000|Overall Study|No follow up data mapped to Other|17|||
148818585|NCT00382070|536812998|FG001|Overall Study|No follow up data mapped to Other|19|||
148818586|NCT00382070|536812997|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
148818587|NCT00382070|536812998|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
148818588|NCT00382070|536812997|FG000|Overall Study|No clinical assessment|9|||
148818589|NCT00382070|536812998|FG001|Overall Study|No clinical assessment|11|||
148818590|NCT00456612|536813000|FG000|Overall Study|Withdrawal by Subject|3|||
148741893|NCT00168818|536526254|FG000|Treatment|Adverse Event|77|||
148741894|NCT00168818|536526255|FG001|Treatment|Adverse Event|89|||
148741895|NCT00168818|536526256|FG002|Treatment|Adverse Event|68|||
148741896|NCT00168818|536526254|FG000|Treatment|Protocol Violation|8|||
148741897|NCT00168818|536526255|FG001|Treatment|Protocol Violation|11|||
148741898|NCT00168818|536526256|FG002|Treatment|Protocol Violation|11|||
148741899|NCT00168818|536526254|FG000|Treatment|Lost to Follow-up|0|||
148741900|NCT00168818|536526255|FG001|Treatment|Lost to Follow-up|2|||
148741901|NCT00168818|536526256|FG002|Treatment|Lost to Follow-up|1|||
148818591|NCT05788328|536813006|FG000|Treatment Period 4 (5 Days)|Other|1|||
148818592|NCT05788328|536813006|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
148818593|NCT00145327|536813012|FG000|Overall Study|Withdrawal by Subject|77|||
148818594|NCT00145327|536813013|FG001|Overall Study|Withdrawal by Subject|72|||
148818595|NCT00145327|536813014|FG002|Overall Study|Withdrawal by Subject|164|||
148818596|NCT00145327|536813012|FG000|Overall Study|Death|26|||
148818597|NCT00145327|536813013|FG001|Overall Study|Death|18|||
148818598|NCT00145327|536813014|FG002|Overall Study|Death|30|||
148818599|NCT00145327|536813012|FG000|Overall Study|Adverse Event|14|||
148818600|NCT00145327|536813013|FG001|Overall Study|Adverse Event|11|||
148818601|NCT00145327|536813014|FG002|Overall Study|Adverse Event|22|||
148818602|NCT00145327|536813012|FG000|Overall Study|Lost to Follow-up|9|||
148741902|NCT00168818|536526254|FG000|Treatment|Withdrawal by Subject|25|||
148741903|NCT00168818|536526255|FG001|Treatment|Withdrawal by Subject|20|||
148741904|NCT00168818|536526256|FG002|Treatment|Withdrawal by Subject|22|||
148741905|NCT00168818|536526254|FG000|Treatment|Other|23|||
148741906|NCT00168818|536526255|FG001|Treatment|Other|29|||
148741907|NCT00168818|536526256|FG002|Treatment|Other|31|||
148741908|NCT00603837|536526259|FG000|Overall Study|Physician Decision|3|||
148741909|NCT00603837|536526260|FG001|Overall Study|Physician Decision|0|||
148741910|NCT04611529|536526261|FG000|2-day Follow up|Lost to Follow-up|5|||
148741911|NCT04611529|536526262|FG001|2-day Follow up|Lost to Follow-up|6|||
148741912|NCT04611529|536526263|FG002|2-day Follow up|Lost to Follow-up|3|||
148741913|NCT02538965|536526269|FG000|Treatment Period|Other = Death due to disease progression|1|||
148741914|NCT02538965|536526269|FG000|Treatment Period|Adverse Event|2|||
148741915|NCT02538965|536526269|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
148741916|NCT02538965|536526269|FG000|Treatment Period|Treatment Failure|9|||
148741917|NCT02538965|536526269|FG000|Treatment Period|Disease Progression|1|||
148741918|NCT02538965|536526269|FG000|Treatment Period|Physician Decision|2|||
148741919|NCT02538965|536526269|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
148741920|NCT02538965|536526269|FG000|Follow-Up Period|Withdrawal by Parent|4|||
148741921|NCT04893018|536526270|FG000|Overall Study|Lost to Follow-up|1|||
148741922|NCT04893018|536526271|FG001|Overall Study|Lost to Follow-up|0|||
148741923|NCT04893018|536526270|FG000|Overall Study|Withdrawal by Subject|2|||
148741924|NCT04893018|536526271|FG001|Overall Study|Withdrawal by Subject|0|||
148741925|NCT04893018|536526270|FG000|Overall Study|Study Terminated|1|||
148741926|NCT04893018|536526271|FG001|Overall Study|Study Terminated|2|||
148741927|NCT00314951|536526274|FG000|Treatment|Didn't meet criteria for mITT population|16|||
148818603|NCT00145327|536813013|FG001|Overall Study|Lost to Follow-up|14|||
148818604|NCT00145327|536813014|FG002|Overall Study|Lost to Follow-up|14|||
148818605|NCT00145327|536813012|FG000|Overall Study|Administrative problems|12|||
148818606|NCT00145327|536813013|FG001|Overall Study|Administrative problems|9|||
148818607|NCT00145327|536813014|FG002|Overall Study|Administrative problems|13|||
148818608|NCT00145327|536813012|FG000|Overall Study|Protocol Violation|2|||
148818609|NCT00145327|536813013|FG001|Overall Study|Protocol Violation|0|||
148818610|NCT00145327|536813014|FG002|Overall Study|Protocol Violation|2|||
148818611|NCT00145327|536813012|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148818612|NCT00145327|536813013|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148818613|NCT00145327|536813014|FG002|Overall Study|Abnormal laboratory value(s)|2|||
148818614|NCT00145327|536813012|FG000|Overall Study|Missing - not stated|1|||
148818615|NCT00145327|536813013|FG001|Overall Study|Missing - not stated|0|||
148741928|NCT00314951|536526275|FG001|Treatment|Didn't meet criteria for mITT population|11|||
148741929|NCT00314951|536526274|FG000|Follow-up|mITT failure|44|||
148741930|NCT00314951|536526275|FG001|Follow-up|mITT failure|34|||
148741931|NCT02015065|536526281|FG000|Overall Study|Death on study|1|||
148741932|NCT02015065|536526282|FG001|Overall Study|Death on study|2|||
148741933|NCT02015065|536526283|FG002|Overall Study|Death on study|1|||
148741934|NCT00468650|536526284|FG000|Overall Study|Lost to Follow-up|4|||
148741935|NCT00468650|536526284|FG000|Overall Study|Withdrawal by Subject|2|||
148741936|NCT00468650|536526284|FG000|Overall Study|Protocol Violation|1|||
148741937|NCT00478426|536526285|FG000|Overall Study|Withdrawal by Subject|1|||
148741938|NCT00789737|536526290|FG000|Overall Study|Withdrawal by Subject|13|||
148741939|NCT00789737|536526291|FG001|Overall Study|Withdrawal by Subject|22|||
148741940|NCT00789737|536526290|FG000|Overall Study|Lost to Follow-up|10|||
148741941|NCT00789737|536526291|FG001|Overall Study|Lost to Follow-up|14|||
148741942|NCT00789737|536526290|FG000|Overall Study|Adverse Event|8|||
148741943|NCT00789737|536526291|FG001|Overall Study|Adverse Event|8|||
148741944|NCT00789737|536526290|FG000|Overall Study|Protocol Violation|3|||
148741945|NCT00789737|536526291|FG001|Overall Study|Protocol Violation|0|||
148741946|NCT00789737|536526290|FG000|Overall Study|Lack of Efficacy|3|||
148741947|NCT00789737|536526291|FG001|Overall Study|Lack of Efficacy|0|||
148741948|NCT00789737|536526290|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
148741949|NCT00789737|536526291|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
148741950|NCT00789737|536526290|FG000|Overall Study|Other|11|||
148741951|NCT00789737|536526291|FG001|Overall Study|Other|7|||
148741952|NCT01189487|536526292|FG000|Overall Study|Lack of Efficacy|2|||
148741953|NCT01189487|536526292|FG000|Overall Study|Adverse Event|1|||
148741954|NCT04630158|536526293|FG000|Overall Study|Adverse Event|1|||
148741955|NCT04630158|536526294|FG001|Overall Study|Adverse Event|1|||
148741956|NCT04630158|536526295|FG002|Overall Study|Adverse Event|1|||
148741957|NCT04630158|536526293|FG000|Overall Study|Physician Decision|0|||
148741958|NCT04630158|536526294|FG001|Overall Study|Physician Decision|2|||
148741959|NCT04630158|536526295|FG002|Overall Study|Physician Decision|0|||
148741960|NCT04630158|536526293|FG000|Overall Study|Protocol Violation|1|||
148741961|NCT04630158|536526294|FG001|Overall Study|Protocol Violation|0|||
148818616|NCT00145327|536813014|FG002|Overall Study|Missing - not stated|1|||
148818617|NCT04027946|536813015|FG000|Overall Study|Screen failures|3|||
148741962|NCT04630158|536526295|FG002|Overall Study|Protocol Violation|1|||
148741963|NCT04630158|536526293|FG000|Overall Study|Withdrawal by Subject|2|||
148741964|NCT04630158|536526294|FG001|Overall Study|Withdrawal by Subject|1|||
148741965|NCT04630158|536526295|FG002|Overall Study|Withdrawal by Subject|2|||
148741966|NCT03136965|536526299|FG000|Overall Study|Lost to Follow-up|0|||
148741967|NCT03136965|536526300|FG001|Overall Study|Lost to Follow-up|1|||
148741968|NCT03136965|536526301|FG002|Overall Study|Lost to Follow-up|0|||
148741969|NCT01210612|536526303|FG000|Overall Study|Withdrawal by Subject|0|||
148741970|NCT01210612|536526304|FG001|Overall Study|Withdrawal by Subject|2|||
148741971|NCT02290223|536526305|FG000|6 Months|Lost to Follow-up|9|||
148741972|NCT02290223|536526306|FG001|6 Months|Lost to Follow-up|6|||
148818618|NCT03315689|536813020|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
148818619|NCT03315689|536813021|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
148818620|NCT03315689|536813020|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
148818621|NCT03315689|536813021|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
148818622|NCT03315689|536813020|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
148818623|NCT03315689|536813021|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
148818624|NCT00864513|536813022|FG000|Overall Study|Withdrawal by Subject|3|||
148818625|NCT03073109|536813023|FG000|Overall Study|Adverse Event|0|||
148818626|NCT03073109|536813024|FG001|Overall Study|Adverse Event|1|||
148818627|NCT03073109|536813023|FG000|Overall Study|Other|2|||
148818628|NCT03073109|536813024|FG001|Overall Study|Other|0|||
148818629|NCT03073109|536813023|FG000|Overall Study|Lost to Follow-up|8|||
148818630|NCT03073109|536813024|FG001|Overall Study|Lost to Follow-up|1|||
148818631|NCT01348698|536813025|FG000|Overall Study|Does not meet lesion size criteria|1|||
148818632|NCT01348698|536813025|FG000|Overall Study|Death|3|||
148818633|NCT01348698|536813025|FG000|Overall Study|PI decision to close study|68|||
148818634|NCT01297244|536813026|FG000|Overall Study|Progressive disease|22|||
148818635|NCT01297244|536813027|FG001|Overall Study|Progressive disease|3|||
148818636|NCT01297244|536813026|FG000|Overall Study|Adverse Event|9|||
148818637|NCT01297244|536813027|FG001|Overall Study|Adverse Event|1|||
148818638|NCT01297244|536813026|FG000|Overall Study|Death|1|||
148818639|NCT01297244|536813027|FG001|Overall Study|Death|1|||
149027140|NCT01072929|537576516|FG000|Overall Study|Withdrawal by Subject|7|||
149027141|NCT01072929|537576517|FG001|Overall Study|Withdrawal by Subject|15|||
149027142|NCT01072929|537576518|FG002|Overall Study|Withdrawal by Subject|3|||
149027143|NCT01072929|537576516|FG000|Overall Study|Protocol Violation|13|||
149027144|NCT01072929|537576517|FG001|Overall Study|Protocol Violation|11|||
149027145|NCT01072929|537576518|FG002|Overall Study|Protocol Violation|2|||
149027146|NCT01072929|537576516|FG000|Overall Study|Lost to Follow-up|8|||
149027147|NCT01072929|537576517|FG001|Overall Study|Lost to Follow-up|4|||
149027148|NCT01072929|537576518|FG002|Overall Study|Lost to Follow-up|1|||
149027149|NCT01072929|537576516|FG000|Overall Study|Noncompliance with study medication|0|||
149027150|NCT01072929|537576517|FG001|Overall Study|Noncompliance with study medication|3|||
149027151|NCT01072929|537576518|FG002|Overall Study|Noncompliance with study medication|0|||
149027152|NCT01072929|537576516|FG000|Overall Study|Noncompliance with study procedures|1|||
149027153|NCT01072929|537576517|FG001|Overall Study|Noncompliance with study procedures|0|||
148741973|NCT02290223|536526305|FG000|6 Months|Withdrawal by Subject|5|||
148741974|NCT02290223|536526306|FG001|6 Months|Withdrawal by Subject|0|||
148741975|NCT02290223|536526305|FG000|6 Months|deceased (not related to study)|2|||
148741976|NCT02290223|536526306|FG001|6 Months|deceased (not related to study)|0|||
148741977|NCT02290223|536526305|FG000|12 Months|Lost to Follow-up|16|||
148741978|NCT02290223|536526306|FG001|12 Months|Lost to Follow-up|10|||
148741979|NCT02290223|536526305|FG000|12 Months|Refusal|0|||
148741980|NCT02290223|536526306|FG001|12 Months|Refusal|1|||
148741981|NCT05293639|536526307|FG000|Overall Study|Withdrawal by Subject|1|||
148741982|NCT05293639|536526308|FG001|Overall Study|Withdrawal by Subject|1|||
148741983|NCT05293639|536526309|FG002|Overall Study|Withdrawal by Subject|2|||
148741984|NCT05293639|536526307|FG000|Overall Study|Death|0|||
148741985|NCT05293639|536526308|FG001|Overall Study|Death|1|||
148741986|NCT05293639|536526309|FG002|Overall Study|Death|0|||
148741987|NCT05293639|536526307|FG000|Overall Study|Lost to Follow-up|0|||
148741988|NCT05293639|536526308|FG001|Overall Study|Lost to Follow-up|0|||
148741989|NCT05293639|536526309|FG002|Overall Study|Lost to Follow-up|5|||
148741990|NCT05293639|536526307|FG000|Overall Study|Other|0|||
148741991|NCT05293639|536526308|FG001|Overall Study|Other|0|||
148818640|NCT01297244|536813026|FG000|Overall Study|Clinical progression|1|||
148818641|NCT01297244|536813027|FG001|Overall Study|Clinical progression|1|||
149027154|NCT01072929|537576518|FG002|Overall Study|Noncompliance with study procedures|1|||
149027155|NCT01072929|537576516|FG000|Overall Study|Other|0|||
148818642|NCT01297244|536813026|FG000|Overall Study|Withdrawal by Subject|2|||
148818643|NCT01297244|536813027|FG001|Overall Study|Withdrawal by Subject|0|||
149027156|NCT01072929|537576517|FG001|Overall Study|Other|3|||
149027157|NCT01072929|537576518|FG002|Overall Study|Other|0|||
148741992|NCT05293639|536526309|FG002|Overall Study|Other|1|||
148741993|NCT00813800|536526315|FG000|Overall Study|Screen Failure after Consent|2|||
148741994|NCT00813800|536526315|FG000|Overall Study|Adverse Event|1|||
148741995|NCT00813800|536526315|FG000|Overall Study|Worsening of depression|2|||
148741996|NCT00813800|536526315|FG000|Overall Study|Physician Decision|1|||
148818644|NCT01875237|536813028|FG000|Overall Study|GVDH before DLI|1|||
148741997|NCT00642278|536526318|FG000|Overall Study|Adverse Event|2|||
148818645|NCT01875237|536813029|FG001|Overall Study|GVDH before DLI|0|||
148818646|NCT01875237|536813028|FG000|Overall Study|DLI cells could not be produced|1|||
148818647|NCT01875237|536813029|FG001|Overall Study|DLI cells could not be produced|0|||
148818648|NCT03558672|536813030|FG000|Overall Study|Study Early Termination|10|||
148818649|NCT00983957|536813033|FG000|Overall Study|Adverse Event|1|||
148818650|NCT00983957|536813033|FG000|Overall Study|Personal Reasons|1|||
148818651|NCT03055195|536813034|FG000|Overall Study|Lack of Efficacy|1|||
148818652|NCT03055195|536813035|FG001|Overall Study|Lack of Efficacy|0|||
148818653|NCT03055195|536813034|FG000|Overall Study|Withdrawal by Subject|6|||
148818654|NCT03055195|536813035|FG001|Overall Study|Withdrawal by Subject|7|||
148818655|NCT03055195|536813034|FG000|Overall Study|Study Terminated by Sponsor|2|||
148818656|NCT03055195|536813035|FG001|Overall Study|Study Terminated by Sponsor|6|||
148818657|NCT03055195|536813034|FG000|Overall Study|Protocol Violation|2|||
148818658|NCT03055195|536813035|FG001|Overall Study|Protocol Violation|1|||
148818659|NCT03055195|536813034|FG000|Overall Study|Physician Decision|1|||
148818660|NCT03055195|536813035|FG001|Overall Study|Physician Decision|0|||
148818661|NCT00986232|536813036|FG000|Overall Study|Adverse Event|1|||
148818662|NCT00986232|536813037|FG001|Overall Study|Adverse Event|2|||
148818663|NCT00986232|536813038|FG002|Overall Study|Adverse Event|3|||
148818664|NCT00986232|536813039|FG003|Overall Study|Adverse Event|0|||
148818665|NCT00986232|536813036|FG000|Overall Study|Lost to Follow-up|19|||
148818666|NCT00986232|536813037|FG001|Overall Study|Lost to Follow-up|12|||
148818667|NCT00986232|536813038|FG002|Overall Study|Lost to Follow-up|12|||
148818668|NCT00986232|536813039|FG003|Overall Study|Lost to Follow-up|7|||
148818669|NCT00986232|536813036|FG000|Overall Study|Protocol Violation|2|||
148818670|NCT00986232|536813037|FG001|Overall Study|Protocol Violation|3|||
148818671|NCT00986232|536813038|FG002|Overall Study|Protocol Violation|0|||
148818672|NCT00986232|536813039|FG003|Overall Study|Protocol Violation|1|||
148818673|NCT00986232|536813036|FG000|Overall Study|Withdrawal by Subject|13|||
148818674|NCT00986232|536813037|FG001|Overall Study|Withdrawal by Subject|16|||
148818675|NCT00986232|536813038|FG002|Overall Study|Withdrawal by Subject|12|||
148818676|NCT00986232|536813039|FG003|Overall Study|Withdrawal by Subject|3|||
148818677|NCT00986232|536813036|FG000|Overall Study|Missed one or more bleeds|13|||
148818678|NCT00986232|536813037|FG001|Overall Study|Missed one or more bleeds|10|||
148818679|NCT00986232|536813038|FG002|Overall Study|Missed one or more bleeds|6|||
148818680|NCT00986232|536813039|FG003|Overall Study|Missed one or more bleeds|7|||
148818681|NCT00986232|536813036|FG000|Overall Study|Incomplete safety follow-up|3|||
148818682|NCT00986232|536813037|FG001|Overall Study|Incomplete safety follow-up|7|||
148818683|NCT00986232|536813038|FG002|Overall Study|Incomplete safety follow-up|2|||
148818684|NCT00986232|536813039|FG003|Overall Study|Incomplete safety follow-up|2|||
148818685|NCT00790933|536813040|FG000|Overall Study|Adverse Event|94|||
148818686|NCT00790933|536813041|FG001|Overall Study|Adverse Event|119|||
148818687|NCT00790933|536813042|FG002|Overall Study|Adverse Event|65|||
148818688|NCT00790933|536813043|FG003|Overall Study|Adverse Event|5|||
148818689|NCT00790933|536813044|FG004|Overall Study|Adverse Event|69|||
148818690|NCT00790933|536813040|FG000|Overall Study|Protocol Violation(s)|8|||
148818691|NCT00790933|536813041|FG001|Overall Study|Protocol Violation(s)|18|||
148818692|NCT00790933|536813042|FG002|Overall Study|Protocol Violation(s)|7|||
148818693|NCT00790933|536813043|FG003|Overall Study|Protocol Violation(s)|0|||
148818694|NCT00790933|536813044|FG004|Overall Study|Protocol Violation(s)|12|||
148818695|NCT00790933|536813040|FG000|Overall Study|Lack of Efficacy|192|||
148818696|NCT00790933|536813041|FG001|Overall Study|Lack of Efficacy|176|||
148818697|NCT00790933|536813042|FG002|Overall Study|Lack of Efficacy|130|||
148818698|NCT00790933|536813043|FG003|Overall Study|Lack of Efficacy|1|||
148818699|NCT00790933|536813044|FG004|Overall Study|Lack of Efficacy|121|||
148818700|NCT00790933|536813040|FG000|Overall Study|Study Terminated by Sponsor|0|||
148818701|NCT00790933|536813041|FG001|Overall Study|Study Terminated by Sponsor|0|||
148818702|NCT00790933|536813042|FG002|Overall Study|Study Terminated by Sponsor|1|||
148818703|NCT00790933|536813043|FG003|Overall Study|Study Terminated by Sponsor|0|||
148818704|NCT00790933|536813044|FG004|Overall Study|Study Terminated by Sponsor|0|||
148818705|NCT00790933|536813040|FG000|Overall Study|Withdrawal by Subject|123|||
148818706|NCT00790933|536813041|FG001|Overall Study|Withdrawal by Subject|120|||
148818707|NCT00790933|536813042|FG002|Overall Study|Withdrawal by Subject|52|||
148975934|NCT03670810|537392354|FG000|Open Label Extension|Lost to Follow-up|0|||
148975935|NCT03670810|537392355|FG001|Open Label Extension|Lost to Follow-up|0|||
148975936|NCT03670810|537392356|FG002|Open Label Extension|Lost to Follow-up|0|||
148975937|NCT03670810|537392357|FG003|Open Label Extension|Lost to Follow-up|0|||
148975938|NCT03670810|537392358|FG004|Open Label Extension|Lost to Follow-up|0|||
148818708|NCT00790933|536813043|FG003|Overall Study|Withdrawal by Subject|6|||
148818709|NCT00790933|536813044|FG004|Overall Study|Withdrawal by Subject|50|||
148818710|NCT00790933|536813040|FG000|Overall Study|Lost to Follow-up|13|||
148975939|NCT03670810|537392359|FG005|Open Label Extension|Lost to Follow-up|0|||
148975940|NCT03670810|537392360|FG006|Open Label Extension|Lost to Follow-up|0|||
148818711|NCT00790933|536813041|FG001|Overall Study|Lost to Follow-up|31|||
148818712|NCT00790933|536813042|FG002|Overall Study|Lost to Follow-up|10|||
148818713|NCT00790933|536813043|FG003|Overall Study|Lost to Follow-up|1|||
148818714|NCT00790933|536813044|FG004|Overall Study|Lost to Follow-up|15|||
148818715|NCT00790933|536813040|FG000|Overall Study|Reason Not Specified|8|||
148818716|NCT00790933|536813041|FG001|Overall Study|Reason Not Specified|16|||
148818717|NCT00790933|536813042|FG002|Overall Study|Reason Not Specified|4|||
148741998|NCT00642278|536526319|FG001|Overall Study|Adverse Event|1|||
148741999|NCT00642278|536526320|FG002|Overall Study|Adverse Event|3|||
148742000|NCT00642278|536526321|FG003|Overall Study|Adverse Event|1|||
148742001|NCT00642278|536526322|FG004|Overall Study|Adverse Event|2|||
148818718|NCT00790933|536813043|FG003|Overall Study|Reason Not Specified|1|||
148818719|NCT00790933|536813044|FG004|Overall Study|Reason Not Specified|9|||
148818720|NCT00875667|536813045|FG000|Overall Study|Adverse Event|29|||
148818721|NCT00875667|536813046|FG001|Overall Study|Adverse Event|10|||
148818722|NCT00875667|536813045|FG000|Overall Study|Withdrawal by Subject|17|||
148818723|NCT00875667|536813046|FG001|Overall Study|Withdrawal by Subject|5|||
148818724|NCT00875667|536813045|FG000|Overall Study|Death|7|||
148818725|NCT00875667|536813046|FG001|Overall Study|Death|2|||
148818726|NCT00875667|536813045|FG000|Overall Study|Protocol Violation|2|||
148818727|NCT00875667|536813046|FG001|Overall Study|Protocol Violation|0|||
148818728|NCT00875667|536813045|FG000|Overall Study|Disease Progression|100|||
148818729|NCT00875667|536813046|FG001|Overall Study|Disease Progression|49|||
148818730|NCT00875667|536813045|FG000|Overall Study|Miscellaneous|12|||
148818731|NCT00875667|536813046|FG001|Overall Study|Miscellaneous|6|||
148818732|NCT00875667|536813045|FG000|Overall Study|Randomized but no Study Drug Given|3|||
148818733|NCT00875667|536813046|FG001|Overall Study|Randomized but no Study Drug Given|1|||
148818734|NCT00894647|536813049|FG000|Overall Study|Adverse Event|5|||
148818735|NCT00894647|536813050|FG001|Overall Study|Adverse Event|4|||
148818736|NCT00894647|536813049|FG000|Overall Study|Withdrawal by Subject|4|||
148818737|NCT00894647|536813050|FG001|Overall Study|Withdrawal by Subject|4|||
148818738|NCT00894647|536813049|FG000|Overall Study|Lost to Follow-up|0|||
148818739|NCT00894647|536813050|FG001|Overall Study|Lost to Follow-up|2|||
148818740|NCT00894647|536813049|FG000|Overall Study|Non-compliance with study procedures|0|||
148818741|NCT00894647|536813050|FG001|Overall Study|Non-compliance with study procedures|2|||
148818742|NCT00894647|536813049|FG000|Overall Study|Other, not due to AE|1|||
148818743|NCT00894647|536813050|FG001|Overall Study|Other, not due to AE|2|||
148818744|NCT01967277|536813051|FG000|Overall Study|Lost to Follow-up|1|||
148818745|NCT01967277|536813052|FG001|Overall Study|Lost to Follow-up|2|||
148818746|NCT01967277|536813051|FG000|Overall Study|Unrelated illness|0|||
148742002|NCT00642278|536526323|FG005|Overall Study|Adverse Event|2|||
148742003|NCT00642278|536526324|FG006|Overall Study|Adverse Event|0|||
148742004|NCT00642278|536526318|FG000|Overall Study|Lack of Efficacy|0|||
148742005|NCT00642278|536526319|FG001|Overall Study|Lack of Efficacy|1|||
148742006|NCT00642278|536526320|FG002|Overall Study|Lack of Efficacy|0|||
148742007|NCT00642278|536526321|FG003|Overall Study|Lack of Efficacy|0|||
148742008|NCT00642278|536526322|FG004|Overall Study|Lack of Efficacy|0|||
148742009|NCT00642278|536526323|FG005|Overall Study|Lack of Efficacy|0|||
148742010|NCT00642278|536526324|FG006|Overall Study|Lack of Efficacy|0|||
148742011|NCT00642278|536526318|FG000|Overall Study|Lost to Follow-up|5|||
148742012|NCT00642278|536526319|FG001|Overall Study|Lost to Follow-up|1|||
148742013|NCT00642278|536526320|FG002|Overall Study|Lost to Follow-up|0|||
148742014|NCT00642278|536526321|FG003|Overall Study|Lost to Follow-up|1|||
148742015|NCT00642278|536526322|FG004|Overall Study|Lost to Follow-up|0|||
148742016|NCT00642278|536526323|FG005|Overall Study|Lost to Follow-up|1|||
148742017|NCT00642278|536526324|FG006|Overall Study|Lost to Follow-up|1|||
148742018|NCT00642278|536526318|FG000|Overall Study|Physician Decision|0|||
148742019|NCT00642278|536526319|FG001|Overall Study|Physician Decision|0|||
148742020|NCT00642278|536526320|FG002|Overall Study|Physician Decision|0|||
148742021|NCT00642278|536526321|FG003|Overall Study|Physician Decision|1|||
148742022|NCT00642278|536526322|FG004|Overall Study|Physician Decision|0|||
148742023|NCT00642278|536526323|FG005|Overall Study|Physician Decision|0|||
148742024|NCT00642278|536526324|FG006|Overall Study|Physician Decision|0|||
148742025|NCT00642278|536526318|FG000|Overall Study|Protocol Violation|0|||
148742026|NCT00642278|536526319|FG001|Overall Study|Protocol Violation|0|||
148742027|NCT00642278|536526320|FG002|Overall Study|Protocol Violation|1|||
148742028|NCT00642278|536526321|FG003|Overall Study|Protocol Violation|1|||
148975941|NCT03670810|537392361|FG007|Open Label Extension|Lost to Follow-up|0|||
148975942|NCT03670810|537392362|FG008|Open Label Extension|Lost to Follow-up|23|||
148975943|NCT04182100|537392363|FG000|Overall Study|Adverse Event|1|||
148742029|NCT00642278|536526322|FG004|Overall Study|Protocol Violation|0|||
148742030|NCT00642278|536526323|FG005|Overall Study|Protocol Violation|1|||
148818747|NCT01967277|536813052|FG001|Overall Study|Unrelated illness|1|||
148818748|NCT01913470|536813056|FG000|Overall Study|Lost to Follow-up|0|||
148975944|NCT04182100|537392363|FG000|Overall Study|Withdrawal by Subject|1|||
148742031|NCT00642278|536526324|FG006|Overall Study|Protocol Violation|2|||
148742032|NCT00642278|536526318|FG000|Overall Study|Withdrawal by Subject|1|||
148742033|NCT00642278|536526319|FG001|Overall Study|Withdrawal by Subject|1|||
148742034|NCT00642278|536526320|FG002|Overall Study|Withdrawal by Subject|1|||
148742035|NCT00642278|536526321|FG003|Overall Study|Withdrawal by Subject|3|||
148742036|NCT00642278|536526322|FG004|Overall Study|Withdrawal by Subject|6|||
148742037|NCT00642278|536526323|FG005|Overall Study|Withdrawal by Subject|2|||
148742038|NCT00642278|536526324|FG006|Overall Study|Withdrawal by Subject|2|||
148818749|NCT01913470|536813057|FG001|Overall Study|Lost to Follow-up|1|||
148818750|NCT01913470|536813056|FG000|Overall Study|Physician Decision|0|||
148818751|NCT01913470|536813057|FG001|Overall Study|Physician Decision|1|||
148742039|NCT00642278|536526318|FG000|Overall Study|Noncompliance with study drug regimen|0|||
148742040|NCT00642278|536526319|FG001|Overall Study|Noncompliance with study drug regimen|0|||
148742041|NCT00642278|536526320|FG002|Overall Study|Noncompliance with study drug regimen|0|||
148742042|NCT00642278|536526321|FG003|Overall Study|Noncompliance with study drug regimen|1|||
148742043|NCT00642278|536526322|FG004|Overall Study|Noncompliance with study drug regimen|0|||
148742044|NCT00642278|536526323|FG005|Overall Study|Noncompliance with study drug regimen|0|||
148742045|NCT00642278|536526324|FG006|Overall Study|Noncompliance with study drug regimen|0|||
148742046|NCT00642278|536526318|FG000|Overall Study|Other|2|||
148742047|NCT00642278|536526319|FG001|Overall Study|Other|1|||
148742048|NCT00642278|536526320|FG002|Overall Study|Other|0|||
148742049|NCT00642278|536526321|FG003|Overall Study|Other|1|||
148742050|NCT00642278|536526322|FG004|Overall Study|Other|0|||
148742051|NCT00642278|536526323|FG005|Overall Study|Other|1|||
148742052|NCT00642278|536526324|FG006|Overall Study|Other|0|||
148742053|NCT00090363|536526325|FG000|Overall Study|Lost to Follow-up|1|||
148742054|NCT00090363|536526326|FG001|Overall Study|Lost to Follow-up|2|||
148742055|NCT00090363|536526327|FG002|Overall Study|Lost to Follow-up|1|||
148742056|NCT00090363|536526325|FG000|Overall Study|Withdrawal by Subject|7|||
148742057|NCT00090363|536526326|FG001|Overall Study|Withdrawal by Subject|7|||
148742058|NCT00090363|536526327|FG002|Overall Study|Withdrawal by Subject|6|||
148742059|NCT00090363|536526325|FG000|Overall Study|Study-specific discontinuation criteria|75|||
148742060|NCT00090363|536526326|FG001|Overall Study|Study-specific discontinuation criteria|74|||
148742061|NCT00090363|536526327|FG002|Overall Study|Study-specific discontinuation criteria|62|||
148742062|NCT00090363|536526325|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148742063|NCT00090363|536526326|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148742064|NCT00090363|536526327|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
148742065|NCT00090363|536526325|FG000|Overall Study|Consent expired|7|||
148742066|NCT00090363|536526326|FG001|Overall Study|Consent expired|10|||
148742067|NCT00090363|536526327|FG002|Overall Study|Consent expired|9|||
148742068|NCT00090363|536526325|FG000|Overall Study|Reasons not specified|2|||
148742069|NCT00090363|536526326|FG001|Overall Study|Reasons not specified|1|||
148742070|NCT00090363|536526327|FG002|Overall Study|Reasons not specified|1|||
148742071|NCT00090363|536526325|FG000|Overall Study|Continuing on study off treatment|14|||
148742072|NCT00090363|536526326|FG001|Overall Study|Continuing on study off treatment|13|||
148742073|NCT00090363|536526327|FG002|Overall Study|Continuing on study off treatment|16|||
148742074|NCT04642365|536526329|FG000|Overall Study|Death|3|||
148742075|NCT04642365|536526330|FG001|Overall Study|Death|2|||
148742076|NCT04642365|536526331|FG002|Overall Study|Death|4|||
148742077|NCT04642365|536526332|FG003|Overall Study|Death|5|||
148742078|NCT04642365|536526333|FG004|Overall Study|Death|5|||
148818752|NCT01913470|536813056|FG000|Overall Study|Withdrawal by Subject|0|||
148818753|NCT01913470|536813057|FG001|Overall Study|Withdrawal by Subject|1|||
148818754|NCT00245570|536813060|FG000|Washout Between Periods III and IV|Adverse Event|0|||
148818755|NCT00245570|536813061|FG001|Washout Between Periods III and IV|Adverse Event|1|||
148818756|NCT00245570|536813062|FG002|Washout Between Periods III and IV|Adverse Event|0|||
148818757|NCT00245570|536813063|FG003|Washout Between Periods III and IV|Adverse Event|0|||
148818758|NCT00245570|536813064|FG004|Washout Between Periods III and IV|Adverse Event|0|||
148818759|NCT00245570|536813065|FG005|Washout Between Periods III and IV|Adverse Event|0|||
148818760|NCT00710970|536813074|FG000|Overall Study|Never took drug|3|||
148818761|NCT01028560|536813075|FG000|Overall Study|Lack of Efficacy|3|||
148818762|NCT01028560|536813076|FG001|Overall Study|Lack of Efficacy|6|||
148818763|NCT01028560|536813075|FG000|Overall Study|Withdrawal by Subject|7|||
148818764|NCT01028560|536813076|FG001|Overall Study|Withdrawal by Subject|12|||
148818765|NCT02153827|536813077|FG000|Overall Study|Lost to Follow-up|3|||
148818766|NCT02153827|536813078|FG001|Overall Study|Lost to Follow-up|9|||
148818767|NCT01960842|536813083|FG000|Overall Study|Adverse Event|1|||
148818768|NCT01960842|536813083|FG000|Overall Study|Withdrawal by Subject|2|||
148742079|NCT04642365|536526334|FG005|Overall Study|Death|3|||
148742080|NCT04642365|536526335|FG006|Overall Study|Death|2|||
148818769|NCT00397930|536813084|FG000|Overall Study|Personal reasons|14|||
148742081|NCT04642365|536526336|FG007|Overall Study|Death|1|||
148742082|NCT04642365|536526329|FG000|Overall Study|Physician Decision|1|||
148742083|NCT04642365|536526330|FG001|Overall Study|Physician Decision|0|||
148742084|NCT04642365|536526331|FG002|Overall Study|Physician Decision|0|||
148742085|NCT04642365|536526332|FG003|Overall Study|Physician Decision|0|||
148818770|NCT00397930|536813085|FG001|Overall Study|Personal reasons|8|||
148818771|NCT00397930|536813084|FG000|Overall Study|Other medical|9|||
148818772|NCT00397930|536813085|FG001|Overall Study|Other medical|4|||
148975945|NCT02375672|537392367|FG000|Overall Study|remain on follow up|20|||
148975946|NCT03921411|537392374|FG000|Overall Study|Withdrawal by Subject|1|||
148975947|NCT03921411|537392374|FG000|Overall Study|Protocol Deviation|2|||
148742086|NCT04642365|536526333|FG004|Overall Study|Physician Decision|0|||
148742087|NCT04642365|536526334|FG005|Overall Study|Physician Decision|0|||
148818773|NCT00397930|536813084|FG000|Overall Study|Unknown reasons|9|||
148818774|NCT00397930|536813085|FG001|Overall Study|Unknown reasons|14|||
148818775|NCT00397930|536813084|FG000|Overall Study|Noncompliant|3|||
148742088|NCT04642365|536526335|FG006|Overall Study|Physician Decision|0|||
148742089|NCT04642365|536526336|FG007|Overall Study|Physician Decision|0|||
148742090|NCT04642365|536526329|FG000|Overall Study|Progressive Disease|1|||
148742091|NCT04642365|536526330|FG001|Overall Study|Progressive Disease|1|||
148742092|NCT04642365|536526331|FG002|Overall Study|Progressive Disease|1|||
148742093|NCT04642365|536526332|FG003|Overall Study|Progressive Disease|0|||
148742094|NCT04642365|536526333|FG004|Overall Study|Progressive Disease|0|||
148742095|NCT04642365|536526334|FG005|Overall Study|Progressive Disease|0|||
148742096|NCT04642365|536526335|FG006|Overall Study|Progressive Disease|1|||
148742097|NCT04642365|536526336|FG007|Overall Study|Progressive Disease|0|||
148742098|NCT04642365|536526329|FG000|Overall Study|Study Terminated By Sponsor|0|||
148742099|NCT04642365|536526330|FG001|Overall Study|Study Terminated By Sponsor|2|||
148742100|NCT04642365|536526331|FG002|Overall Study|Study Terminated By Sponsor|1|||
148742101|NCT04642365|536526332|FG003|Overall Study|Study Terminated By Sponsor|1|||
148742102|NCT04642365|536526333|FG004|Overall Study|Study Terminated By Sponsor|1|||
148742103|NCT04642365|536526334|FG005|Overall Study|Study Terminated By Sponsor|2|||
148742104|NCT04642365|536526335|FG006|Overall Study|Study Terminated By Sponsor|2|||
148742105|NCT04642365|536526336|FG007|Overall Study|Study Terminated By Sponsor|1|||
148742106|NCT04642365|536526329|FG000|Overall Study|Symptomatic Deterioration|1|||
148742107|NCT04642365|536526330|FG001|Overall Study|Symptomatic Deterioration|1|||
148742108|NCT04642365|536526331|FG002|Overall Study|Symptomatic Deterioration|0|||
148742109|NCT04642365|536526332|FG003|Overall Study|Symptomatic Deterioration|0|||
148742110|NCT04642365|536526333|FG004|Overall Study|Symptomatic Deterioration|0|||
148742111|NCT04642365|536526334|FG005|Overall Study|Symptomatic Deterioration|1|||
148742112|NCT04642365|536526335|FG006|Overall Study|Symptomatic Deterioration|0|||
148742113|NCT04642365|536526336|FG007|Overall Study|Symptomatic Deterioration|0|||
148742114|NCT04642365|536526329|FG000|Overall Study|Withdrawal by Subject|0|||
148742115|NCT04642365|536526330|FG001|Overall Study|Withdrawal by Subject|0|||
148742116|NCT04642365|536526331|FG002|Overall Study|Withdrawal by Subject|1|||
148742117|NCT04642365|536526332|FG003|Overall Study|Withdrawal by Subject|1|||
148742118|NCT04642365|536526333|FG004|Overall Study|Withdrawal by Subject|0|||
148742119|NCT04642365|536526334|FG005|Overall Study|Withdrawal by Subject|0|||
148742120|NCT04642365|536526335|FG006|Overall Study|Withdrawal by Subject|2|||
148742121|NCT04642365|536526336|FG007|Overall Study|Withdrawal by Subject|0|||
148742122|NCT04642365|536526329|FG000|Overall Study|Adverse Event|0|||
148742123|NCT04642365|536526330|FG001|Overall Study|Adverse Event|0|||
148742124|NCT04642365|536526331|FG002|Overall Study|Adverse Event|0|||
148742125|NCT04642365|536526332|FG003|Overall Study|Adverse Event|0|||
148742126|NCT04642365|536526333|FG004|Overall Study|Adverse Event|0|||
148742127|NCT04642365|536526334|FG005|Overall Study|Adverse Event|0|||
148742128|NCT04642365|536526335|FG006|Overall Study|Adverse Event|0|||
148742129|NCT04642365|536526336|FG007|Overall Study|Adverse Event|1|||
148742130|NCT02728843|536526337|FG000|Overall Study|Adverse Event|0|||
148742131|NCT02728843|536526338|FG001|Overall Study|Adverse Event|2|||
148742132|NCT02728843|536526339|FG002|Overall Study|Adverse Event|3|||
148742133|NCT02728843|536526340|FG003|Overall Study|Adverse Event|1|||
148742134|NCT02728843|536526341|FG004|Overall Study|Adverse Event|2|||
148742135|NCT02728843|536526337|FG000|Overall Study|Lack of Efficacy|0|||
148742136|NCT02728843|536526338|FG001|Overall Study|Lack of Efficacy|1|||
148742137|NCT02728843|536526339|FG002|Overall Study|Lack of Efficacy|1|||
148742138|NCT02728843|536526340|FG003|Overall Study|Lack of Efficacy|0|||
148742139|NCT02728843|536526341|FG004|Overall Study|Lack of Efficacy|0|||
148742140|NCT02728843|536526337|FG000|Overall Study|Protocol Violation|2|||
148742141|NCT02728843|536526338|FG001|Overall Study|Protocol Violation|0|||
148742142|NCT02728843|536526339|FG002|Overall Study|Protocol Violation|4|||
148742143|NCT02728843|536526340|FG003|Overall Study|Protocol Violation|2|||
148742144|NCT02728843|536526341|FG004|Overall Study|Protocol Violation|2|||
148742145|NCT02728843|536526337|FG000|Overall Study|Withdrawal by Subject|1|||
148742146|NCT02728843|536526338|FG001|Overall Study|Withdrawal by Subject|0|||
148742147|NCT02728843|536526339|FG002|Overall Study|Withdrawal by Subject|0|||
148742148|NCT02728843|536526340|FG003|Overall Study|Withdrawal by Subject|1|||
148742149|NCT02728843|536526341|FG004|Overall Study|Withdrawal by Subject|0|||
148742150|NCT02728843|536526337|FG000|Overall Study|Use of rescue medication|0|||
148742151|NCT02728843|536526338|FG001|Overall Study|Use of rescue medication|2|||
148742152|NCT02728843|536526339|FG002|Overall Study|Use of rescue medication|0|||
148742153|NCT02728843|536526340|FG003|Overall Study|Use of rescue medication|2|||
148742154|NCT02728843|536526341|FG004|Overall Study|Use of rescue medication|1|||
148742155|NCT02478320|536526342|FG000|Overall Study|Adverse Event|2|||
148742156|NCT02478320|536526343|FG001|Overall Study|Adverse Event|0|||
148742157|NCT02478320|536526342|FG000|Overall Study|Death|1|||
148742158|NCT02478320|536526343|FG001|Overall Study|Death|0|||
148742159|NCT02478320|536526342|FG000|Overall Study|Lack of Efficacy|4|||
148742160|NCT02478320|536526343|FG001|Overall Study|Lack of Efficacy|0|||
148742161|NCT02478320|536526342|FG000|Overall Study|Withdrawal by Subject|2|||
148742162|NCT02478320|536526343|FG001|Overall Study|Withdrawal by Subject|0|||
148742163|NCT02478320|536526342|FG000|Overall Study|Screen Failure|3|||
148742164|NCT02478320|536526343|FG001|Overall Study|Screen Failure|0|||
148742165|NCT02092467|536526346|FG000|Overall Study|Death|49|||
148742166|NCT02092467|536526347|FG001|Overall Study|Death|66|||
148742167|NCT02092467|536526348|FG002|Overall Study|Death|38|||
148742168|NCT02092467|536526346|FG000|Overall Study|Lost to Follow-up|38|||
148742169|NCT02092467|536526347|FG001|Overall Study|Lost to Follow-up|35|||
148742170|NCT02092467|536526348|FG002|Overall Study|Lost to Follow-up|40|||
148742171|NCT02092467|536526346|FG000|Overall Study|Global Deterioration of Health Status|1|||
148742172|NCT02092467|536526347|FG001|Overall Study|Global Deterioration of Health Status|0|||
148742173|NCT02092467|536526348|FG002|Overall Study|Global Deterioration of Health Status|0|||
148742174|NCT02092467|536526346|FG000|Overall Study|Other|32|||
148742175|NCT02092467|536526347|FG001|Overall Study|Other|30|||
148742176|NCT02092467|536526348|FG002|Overall Study|Other|24|||
148742177|NCT02092467|536526346|FG000|Overall Study|Withdrawal by Subject|282|||
148742178|NCT02092467|536526347|FG001|Overall Study|Withdrawal by Subject|327|||
148742179|NCT02092467|536526348|FG002|Overall Study|Withdrawal by Subject|289|||
148742180|NCT02092467|536526346|FG000|Overall Study|Randomized but not treated|2|||
148742181|NCT02092467|536526347|FG001|Overall Study|Randomized but not treated|1|||
148742182|NCT02092467|536526348|FG002|Overall Study|Randomized but not treated|7|||
148742183|NCT02952898|536526351|FG000|Overall Study|Withdrawal by Subject|10|||
148742184|NCT02952898|536526352|FG001|Overall Study|Withdrawal by Subject|8|||
148742185|NCT02952898|536526353|FG002|Overall Study|Withdrawal by Subject|8|||
148742186|NCT02952898|536526351|FG000|Overall Study|Adverse Event|8|||
148742187|NCT02952898|536526352|FG001|Overall Study|Adverse Event|8|||
148742188|NCT02952898|536526353|FG002|Overall Study|Adverse Event|3|||
148742189|NCT02952898|536526351|FG000|Overall Study|Lost to Follow-up|3|||
148742190|NCT02952898|536526352|FG001|Overall Study|Lost to Follow-up|2|||
148742191|NCT02952898|536526353|FG002|Overall Study|Lost to Follow-up|2|||
148742192|NCT02952898|536526351|FG000|Overall Study|Non-compliance with study drug|1|||
148742193|NCT02952898|536526352|FG001|Overall Study|Non-compliance with study drug|1|||
148742194|NCT02952898|536526353|FG002|Overall Study|Non-compliance with study drug|2|||
148742195|NCT04844762|536526356|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742196|NCT04844762|536526357|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742197|NCT04844762|536526358|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
148742198|NCT04844762|536526359|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742199|NCT04844762|536526360|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742200|NCT04844762|536526361|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742201|NCT04844762|536526356|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
148742202|NCT04844762|536526357|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
148742203|NCT04844762|536526358|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
148742204|NCT04844762|536526359|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
148742205|NCT04844762|536526360|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
148742206|NCT04844762|536526361|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
148742207|NCT04844762|536526356|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742208|NCT04844762|536526357|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742209|NCT04844762|536526358|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
148742210|NCT04844762|536526359|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
148742211|NCT04844762|536526360|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742212|NCT04844762|536526361|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
148742213|NCT04844762|536526356|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742214|NCT04844762|536526357|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742215|NCT04844762|536526358|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
148742216|NCT04844762|536526359|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
148818776|NCT00397930|536813085|FG001|Overall Study|Noncompliant|2|||
148818777|NCT00397930|536813084|FG000|Overall Study|Too time-consuming|2|||
148742217|NCT04844762|536526360|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
148742218|NCT04844762|536526361|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742219|NCT04844762|536526356|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
148742220|NCT04844762|536526357|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
148742221|NCT04844762|536526358|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742222|NCT04844762|536526359|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742223|NCT04844762|536526360|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742224|NCT04844762|536526361|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742225|NCT04844762|536526356|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
148742226|NCT04844762|536526357|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742227|NCT04844762|536526358|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742228|NCT04844762|536526359|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742229|NCT04844762|536526360|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742230|NCT04844762|536526361|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742231|NCT04844762|536526356|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742232|NCT04844762|536526357|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742233|NCT04844762|536526358|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148818778|NCT00397930|536813085|FG001|Overall Study|Too time-consuming|9|||
148742234|NCT04844762|536526359|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742235|NCT04844762|536526360|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
148742236|NCT04844762|536526361|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
148742237|NCT04844762|536526356|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
148742238|NCT04844762|536526357|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742239|NCT04844762|536526358|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742240|NCT04844762|536526359|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742241|NCT04844762|536526360|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742242|NCT04844762|536526361|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
148742243|NCT04844762|536526356|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
148742244|NCT04844762|536526357|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742245|NCT04844762|536526358|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742246|NCT04844762|536526359|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742247|NCT04844762|536526360|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
148742248|NCT04844762|536526361|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
148742249|NCT04844762|536526356|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
148742250|NCT04844762|536526357|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
148742251|NCT04844762|536526358|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
148742252|NCT04844762|536526359|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
148742253|NCT04844762|536526360|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
148742254|NCT04844762|536526361|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
148742255|NCT04844762|536526356|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
148742256|NCT04844762|536526357|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
148742257|NCT04844762|536526358|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
148742258|NCT04844762|536526359|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
148742259|NCT04844762|536526360|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
148742260|NCT04844762|536526361|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
148742261|NCT01200069|536527926|FG000|Overall Study|Withdrawal by Subject|0|||
148742262|NCT01200069|536527927|FG001|Overall Study|Withdrawal by Subject|1|||
148742263|NCT03408639|536527928|FG000|Overall Study|Death|5|||
148742264|NCT03408639|536527929|FG001|Overall Study|Death|5|||
148742265|NCT03408639|536527928|FG000|Overall Study|Lost to Follow-up|1|||
148742266|NCT03408639|536527929|FG001|Overall Study|Lost to Follow-up|4|||
148742267|NCT03408639|536527928|FG000|Overall Study|Withdrawal by Subject|2|||
148742268|NCT03408639|536527929|FG001|Overall Study|Withdrawal by Subject|7|||
148742269|NCT03408639|536527928|FG000|Overall Study|Physician Decision|3|||
148742270|NCT03408639|536527929|FG001|Overall Study|Physician Decision|6|||
148742271|NCT04998851|536527930|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
148742272|NCT04998851|536527931|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
148742273|NCT04998851|536527930|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
148742274|NCT04998851|536527931|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
148742275|NCT00070499|536527932|FG000|Overall Study|Adverse Event|6|||
148742276|NCT00070499|536527933|FG001|Overall Study|Adverse Event|6|||
148742277|NCT00070499|536527934|FG002|Overall Study|Adverse Event|19|||
148742278|NCT00070499|536527935|FG003|Overall Study|Adverse Event|15|||
148742279|NCT00070499|536527932|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
148742280|NCT00070499|536527933|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
148742281|NCT00070499|536527934|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
148742282|NCT00070499|536527935|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
148742283|NCT00070499|536527932|FG000|Overall Study|Progression/relapse|4|||
148742284|NCT00070499|536527933|FG001|Overall Study|Progression/relapse|2|||
148818779|NCT00397930|536813084|FG000|Overall Study|Started own yoga program|1|||
148818780|NCT00397930|536813085|FG001|Overall Study|Started own yoga program|1|||
148818781|NCT00397930|536813084|FG000|Overall Study|Did not want to be in control group|0|||
148818782|NCT00397930|536813085|FG001|Overall Study|Did not want to be in control group|1|||
148818783|NCT00397930|536813084|FG000|Overall Study|Withdrawal by Subject|0|||
148818784|NCT00397930|536813085|FG001|Overall Study|Withdrawal by Subject|8|||
148742285|NCT00070499|536527934|FG002|Overall Study|Progression/relapse|1|||
148742286|NCT00070499|536527935|FG003|Overall Study|Progression/relapse|4|||
148742287|NCT00070499|536527932|FG000|Overall Study|Death|1|||
148742288|NCT00070499|536527933|FG001|Overall Study|Death|1|||
148742289|NCT00070499|536527934|FG002|Overall Study|Death|1|||
148742290|NCT00070499|536527935|FG003|Overall Study|Death|2|||
148742291|NCT00070499|536527932|FG000|Overall Study|Other - not protocol specified|7|||
148742292|NCT00070499|536527933|FG001|Overall Study|Other - not protocol specified|3|||
148742293|NCT00070499|536527934|FG002|Overall Study|Other - not protocol specified|12|||
148742294|NCT00070499|536527935|FG003|Overall Study|Other - not protocol specified|20|||
148742295|NCT00070499|536527932|FG000|Overall Study|Still on protocol treatment|10|||
148742296|NCT00070499|536527933|FG001|Overall Study|Still on protocol treatment|4|||
148742297|NCT00070499|536527934|FG002|Overall Study|Still on protocol treatment|79|||
148742298|NCT00070499|536527935|FG003|Overall Study|Still on protocol treatment|57|||
148742299|NCT00070499|536527932|FG000|Overall Study|Did not start treatment|1|||
148742300|NCT00070499|536527933|FG001|Overall Study|Did not start treatment|0|||
148742301|NCT00070499|536527934|FG002|Overall Study|Did not start treatment|0|||
148742302|NCT00070499|536527935|FG003|Overall Study|Did not start treatment|2|||
148742303|NCT00070499|536527932|FG000|Overall Study|Not eligible|2|||
148742304|NCT00070499|536527933|FG001|Overall Study|Not eligible|5|||
148742305|NCT00070499|536527934|FG002|Overall Study|Not eligible|3|||
148742306|NCT00070499|536527935|FG003|Overall Study|Not eligible|2|||
148742307|NCT00805467|536527936|FG000|Overall Study|Lack of Efficacy|0|||
148742308|NCT00805467|536527937|FG001|Overall Study|Lack of Efficacy|8|||
148742309|NCT00805467|536527938|FG002|Overall Study|Lack of Efficacy|13|||
148742310|NCT00805467|536527939|FG003|Overall Study|Lack of Efficacy|86|||
148742311|NCT00805467|536527936|FG000|Overall Study|Lost to Follow-up|0|||
148742312|NCT00805467|536527937|FG001|Overall Study|Lost to Follow-up|1|||
148742313|NCT00805467|536527938|FG002|Overall Study|Lost to Follow-up|7|||
148742314|NCT00805467|536527939|FG003|Overall Study|Lost to Follow-up|21|||
148742315|NCT00805467|536527936|FG000|Overall Study|Withdrawal by Subject|0|||
148742316|NCT00805467|536527937|FG001|Overall Study|Withdrawal by Subject|6|||
148742317|NCT00805467|536527938|FG002|Overall Study|Withdrawal by Subject|45|||
148742318|NCT00805467|536527939|FG003|Overall Study|Withdrawal by Subject|50|||
148742319|NCT00805467|536527936|FG000|Overall Study|Protocol Violation|0|||
148742320|NCT00805467|536527937|FG001|Overall Study|Protocol Violation|3|||
148742321|NCT00805467|536527938|FG002|Overall Study|Protocol Violation|0|||
148742322|NCT00805467|536527939|FG003|Overall Study|Protocol Violation|5|||
148742323|NCT00805467|536527936|FG000|Overall Study|Adverse Event|0|||
148742324|NCT00805467|536527937|FG001|Overall Study|Adverse Event|13|||
148742325|NCT00805467|536527938|FG002|Overall Study|Adverse Event|26|||
148742326|NCT00805467|536527939|FG003|Overall Study|Adverse Event|57|||
148742327|NCT00805467|536527936|FG000|Overall Study|Death|0|||
148742328|NCT00805467|536527937|FG001|Overall Study|Death|2|||
148742329|NCT00805467|536527938|FG002|Overall Study|Death|7|||
148742330|NCT00805467|536527939|FG003|Overall Study|Death|5|||
148742331|NCT00805467|536527936|FG000|Overall Study|Physician Decision|0|||
148742332|NCT00805467|536527937|FG001|Overall Study|Physician Decision|1|||
148742333|NCT00805467|536527938|FG002|Overall Study|Physician Decision|2|||
148742334|NCT00805467|536527939|FG003|Overall Study|Physician Decision|6|||
148742335|NCT00805467|536527936|FG000|Overall Study|Not reported|0|||
148742336|NCT00805467|536527937|FG001|Overall Study|Not reported|0|||
148742337|NCT00805467|536527938|FG002|Overall Study|Not reported|3|||
148742338|NCT00805467|536527939|FG003|Overall Study|Not reported|7|||
148742339|NCT00459043|536527940|FG000|Overall Study|Withdrawal by Subject|1|||
148742340|NCT00459043|536527941|FG001|Overall Study|Withdrawal by Subject|0|||
148742341|NCT01392963|536527942|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
148742342|NCT01392963|536527943|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
148742343|NCT01392963|536527942|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
148742344|NCT01392963|536527943|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
148742345|NCT01392963|536527942|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
148742346|NCT01392963|536527943|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
148742347|NCT03156504|536527947|FG000|Overall Study|Withdrawal by Subject|1|||
148742348|NCT03333941|536527948|FG000|Overall Study|Lost to Follow-up|10|||
148742349|NCT03333941|536527948|FG000|Overall Study|Death|2|||
148742350|NCT03333941|536527948|FG000|Overall Study|Adverse Event|1|||
148742351|NCT02549027|536527954|FG000|Washout After Period 4|Withdrawal by Subject|0|||
148742352|NCT02549027|536527955|FG001|Washout After Period 4|Withdrawal by Subject|1|||
148742353|NCT02549027|536527956|FG002|Washout After Period 4|Withdrawal by Subject|1|||
148742354|NCT02549027|536527957|FG003|Washout After Period 4|Withdrawal by Subject|1|||
148742355|NCT02549027|536527958|FG004|Washout After Period 4|Withdrawal by Subject|0|||
148742356|NCT02549027|536527959|FG005|Washout After Period 4|Withdrawal by Subject|0|||
148742357|NCT02549027|536527954|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
148742358|NCT02549027|536527955|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
148742359|NCT02549027|536527956|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
148742360|NCT02549027|536527957|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
148742361|NCT02549027|536527958|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
148742362|NCT02549027|536527959|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
148742363|NCT00875797|536528023|FG000|Overall Study|Protocol Violation|6|||
148742364|NCT00875797|536528024|FG001|Overall Study|Protocol Violation|3|||
148742365|NCT00425373|536528028|FG000|Overall Study|Adverse Event|2|||
148818785|NCT00397930|536813084|FG000|Overall Study|Missing data|0|||
148818786|NCT00397930|536813085|FG001|Overall Study|Missing data|4|||
148975948|NCT03921411|537392374|FG000|Overall Study|Enrolled, but never treated|2|||
148975949|NCT02114879|537392375|FG000|Overall Study|Withdrawal by Subject|9|||
148742366|NCT00425373|536528029|FG001|Overall Study|Adverse Event|2|||
148742367|NCT00425373|536528030|FG002|Overall Study|Adverse Event|0|||
148742368|NCT00425373|536528031|FG003|Overall Study|Adverse Event|1|||
148742369|NCT00425373|536528032|FG004|Overall Study|Adverse Event|4|||
148742370|NCT00425373|536528033|FG005|Overall Study|Adverse Event|6|||
148742371|NCT00425373|536528034|FG006|Overall Study|Adverse Event|2|||
148742372|NCT00425373|536528035|FG007|Overall Study|Adverse Event|3|||
148742373|NCT00425373|536528036|FG008|Overall Study|Adverse Event|8|||
148742374|NCT00425373|536528028|FG000|Overall Study|Lost to Follow-up|0|||
148742375|NCT00425373|536528029|FG001|Overall Study|Lost to Follow-up|1|||
148742376|NCT00425373|536528030|FG002|Overall Study|Lost to Follow-up|0|||
148742377|NCT00425373|536528031|FG003|Overall Study|Lost to Follow-up|0|||
148742378|NCT00425373|536528032|FG004|Overall Study|Lost to Follow-up|1|||
148742379|NCT00425373|536528033|FG005|Overall Study|Lost to Follow-up|0|||
148742380|NCT00425373|536528034|FG006|Overall Study|Lost to Follow-up|0|||
148742381|NCT00425373|536528035|FG007|Overall Study|Lost to Follow-up|0|||
148742382|NCT00425373|536528036|FG008|Overall Study|Lost to Follow-up|0|||
148742383|NCT00425373|536528028|FG000|Overall Study|Protocol Violation|1|||
148742384|NCT00425373|536528029|FG001|Overall Study|Protocol Violation|0|||
148742385|NCT00425373|536528030|FG002|Overall Study|Protocol Violation|1|||
148742386|NCT00425373|536528031|FG003|Overall Study|Protocol Violation|0|||
148742387|NCT00425373|536528032|FG004|Overall Study|Protocol Violation|0|||
148742388|NCT00425373|536528033|FG005|Overall Study|Protocol Violation|0|||
148742389|NCT00425373|536528034|FG006|Overall Study|Protocol Violation|0|||
148742390|NCT00425373|536528035|FG007|Overall Study|Protocol Violation|5|||
148742391|NCT00425373|536528036|FG008|Overall Study|Protocol Violation|3|||
148742392|NCT00425373|536528028|FG000|Overall Study|Withdrawal by Subject|2|||
148742393|NCT00425373|536528029|FG001|Overall Study|Withdrawal by Subject|0|||
148742394|NCT00425373|536528030|FG002|Overall Study|Withdrawal by Subject|2|||
148742395|NCT00425373|536528031|FG003|Overall Study|Withdrawal by Subject|1|||
148742396|NCT00425373|536528032|FG004|Overall Study|Withdrawal by Subject|4|||
148742397|NCT00425373|536528033|FG005|Overall Study|Withdrawal by Subject|0|||
148742398|NCT00425373|536528034|FG006|Overall Study|Withdrawal by Subject|2|||
148742399|NCT00425373|536528035|FG007|Overall Study|Withdrawal by Subject|2|||
148742400|NCT00425373|536528036|FG008|Overall Study|Withdrawal by Subject|2|||
148742401|NCT00425373|536528028|FG000|Overall Study|Lack of Efficacy|0|||
148742402|NCT00425373|536528029|FG001|Overall Study|Lack of Efficacy|0|||
148742403|NCT00425373|536528030|FG002|Overall Study|Lack of Efficacy|0|||
148742404|NCT00425373|536528031|FG003|Overall Study|Lack of Efficacy|0|||
148742405|NCT00425373|536528032|FG004|Overall Study|Lack of Efficacy|1|||
148742406|NCT00425373|536528033|FG005|Overall Study|Lack of Efficacy|3|||
148742407|NCT00425373|536528034|FG006|Overall Study|Lack of Efficacy|3|||
148742408|NCT00425373|536528035|FG007|Overall Study|Lack of Efficacy|0|||
148742409|NCT00425373|536528036|FG008|Overall Study|Lack of Efficacy|5|||
148742410|NCT02960490|536528038|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
148742411|NCT02960490|536528039|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
148742412|NCT02960490|536528040|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742413|NCT02960490|536528041|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742414|NCT02960490|536528042|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742415|NCT02960490|536528043|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742416|NCT02960490|536528044|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742417|NCT02960490|536528045|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742418|NCT02960490|536528046|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742419|NCT02960490|536528047|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
148742420|NCT02960490|536528038|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742421|NCT02960490|536528039|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
148742422|NCT02960490|536528040|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742423|NCT02960490|536528041|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148818787|NCT02391584|536813086|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
148818788|NCT02391584|536813087|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
148818789|NCT02391584|536813086|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
148975950|NCT02114879|537392376|FG001|Overall Study|Withdrawal by Subject|5|||
148975951|NCT02114879|537392375|FG000|Overall Study|Death|6|||
148975952|NCT02114879|537392376|FG001|Overall Study|Death|11|||
148742424|NCT02960490|536528042|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742425|NCT02960490|536528043|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742426|NCT02960490|536528044|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742427|NCT02960490|536528045|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742428|NCT02960490|536528046|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742429|NCT02960490|536528047|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
148742430|NCT02960490|536528038|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
148742431|NCT02960490|536528039|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
148742432|NCT02960490|536528040|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742433|NCT02960490|536528041|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742434|NCT02960490|536528042|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742435|NCT02960490|536528043|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742436|NCT02960490|536528044|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742437|NCT02960490|536528045|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742438|NCT02960490|536528046|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742439|NCT02960490|536528047|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
148742440|NCT02960490|536528038|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
148742441|NCT02960490|536528039|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
148742442|NCT02960490|536528040|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742443|NCT02960490|536528041|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742444|NCT02960490|536528042|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742445|NCT02960490|536528043|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742446|NCT02960490|536528044|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742447|NCT02960490|536528045|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742448|NCT02960490|536528046|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742449|NCT02960490|536528047|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
148742450|NCT02960490|536528038|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742451|NCT02960490|536528039|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742452|NCT02960490|536528040|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
148742453|NCT02960490|536528041|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
148742454|NCT02960490|536528042|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742455|NCT02960490|536528043|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
148742456|NCT02960490|536528044|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742457|NCT02960490|536528045|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742458|NCT02960490|536528046|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742459|NCT02960490|536528047|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
148742460|NCT02960490|536528038|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742461|NCT02960490|536528039|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742462|NCT02960490|536528040|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
148742463|NCT02960490|536528041|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742464|NCT02960490|536528042|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
148742465|NCT02960490|536528043|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742466|NCT02960490|536528044|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742467|NCT02960490|536528045|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742468|NCT02960490|536528046|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742469|NCT02960490|536528047|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
148742470|NCT02960490|536528038|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
148742471|NCT02960490|536528039|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
148742472|NCT02960490|536528040|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
148742473|NCT02960490|536528041|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
148742474|NCT02960490|536528042|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
148742475|NCT02960490|536528043|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
148742476|NCT02960490|536528044|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
148742477|NCT02960490|536528045|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
148742478|NCT02960490|536528046|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
148742479|NCT02960490|536528047|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
148742480|NCT02960490|536528038|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742481|NCT02960490|536528039|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742482|NCT02960490|536528040|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742483|NCT02960490|536528041|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742484|NCT02960490|536528042|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742485|NCT02960490|536528043|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742486|NCT02960490|536528044|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
148742487|NCT02960490|536528045|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
148742488|NCT02960490|536528046|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
148742489|NCT02960490|536528047|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
148742490|NCT02960490|536528038|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742491|NCT02960490|536528039|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742492|NCT02960490|536528040|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742493|NCT02960490|536528041|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148818790|NCT02391584|536813087|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
148742494|NCT02960490|536528042|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742495|NCT02960490|536528043|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742496|NCT02960490|536528044|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742497|NCT02960490|536528045|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
148742498|NCT02960490|536528046|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742499|NCT02960490|536528047|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
148742500|NCT02960490|536528038|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
148742501|NCT02960490|536528039|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
148742502|NCT02960490|536528040|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
148818791|NCT02391584|536813086|FG000|3 Month|Lost to Follow-up|1|||
148818792|NCT02391584|536813087|FG001|3 Month|Lost to Follow-up|0|||
148818793|NCT02391584|536813086|FG000|6 Month|Withdrawal by Subject|1|||
148818794|NCT02391584|536813087|FG001|6 Month|Withdrawal by Subject|0|||
148818795|NCT02391584|536813086|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
148742503|NCT02960490|536528041|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
148742504|NCT02960490|536528042|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
148742505|NCT02960490|536528043|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
148742506|NCT02960490|536528044|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
148742507|NCT02960490|536528045|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
148742508|NCT02960490|536528046|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
148742509|NCT02960490|536528047|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
148742510|NCT02960490|536528038|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742511|NCT02960490|536528039|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742512|NCT02960490|536528040|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742513|NCT02960490|536528041|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742514|NCT02960490|536528042|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742515|NCT02960490|536528043|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742516|NCT02960490|536528044|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
148742517|NCT02960490|536528045|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742518|NCT02960490|536528046|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742519|NCT02960490|536528047|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
148742520|NCT02960490|536528038|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742521|NCT02960490|536528039|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742522|NCT02960490|536528040|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742523|NCT02960490|536528041|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742524|NCT02960490|536528042|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742525|NCT02960490|536528043|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742526|NCT02960490|536528044|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742527|NCT02960490|536528045|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
148742528|NCT02960490|536528046|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742529|NCT02960490|536528047|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
148742530|NCT01590797|536528048|FG000|Overall Study|Adverse Event|4|||
148742531|NCT01590797|536528049|FG001|Overall Study|Adverse Event|3|||
148742532|NCT01590797|536528048|FG000|Overall Study|Lack of Efficacy|0|||
148742533|NCT01590797|536528049|FG001|Overall Study|Lack of Efficacy|2|||
148742534|NCT01590797|536528048|FG000|Overall Study|Lost to Follow-up|0|||
148742535|NCT01590797|536528049|FG001|Overall Study|Lost to Follow-up|1|||
148742536|NCT01590797|536528048|FG000|Overall Study|Protocol Violation|4|||
148742537|NCT01590797|536528049|FG001|Overall Study|Protocol Violation|1|||
148742538|NCT01590797|536528048|FG000|Overall Study|Withdrawal by Subject|7|||
148742539|NCT01590797|536528049|FG001|Overall Study|Withdrawal by Subject|5|||
148742540|NCT01590797|536528048|FG000|Overall Study|Other Protocol Specified Criteria|2|||
148742541|NCT01590797|536528049|FG001|Overall Study|Other Protocol Specified Criteria|4|||
148742542|NCT02910011|536528062|FG000|Overall Study|Physician Decision|2|||
148742543|NCT00920790|536528063|FG000|Overall Study|aggravation of general condition|14|||
148742544|NCT02460679|536528064|FG000|Overall Study|Investigator Decision|1|||
148742545|NCT02460679|536528064|FG000|Overall Study|Withdrawal by Subject|4|||
148742546|NCT04411914|536528065|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
148742547|NCT04411914|536528066|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
148742548|NCT00339144|536528104|FG000|Overall Study|Disease progression|5|||
148742549|NCT00339144|536528105|FG001|Overall Study|Disease progression|2|||
148742550|NCT00339144|536528106|FG002|Overall Study|Disease progression|2|||
148742551|NCT00339144|536528104|FG000|Overall Study|Study drug toxicity|3|||
148818796|NCT02391584|536813087|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
148975953|NCT02114879|537392375|FG000|Overall Study|Lost to Follow-up|4|||
148742552|NCT00339144|536528105|FG001|Overall Study|Study drug toxicity|1|||
148742553|NCT00339144|536528106|FG002|Overall Study|Study drug toxicity|1|||
148742554|NCT00339144|536528104|FG000|Overall Study|Participant's request to discontinuation|1|||
148742555|NCT00339144|536528105|FG001|Overall Study|Participant's request to discontinuation|0|||
148742556|NCT00339144|536528106|FG002|Overall Study|Participant's request to discontinuation|1|||
148742557|NCT03280381|536528107|FG000|Overall Study|Physician Decision|0|||
148742558|NCT03280381|536528108|FG001|Overall Study|Physician Decision|2|||
148975954|NCT02114879|537392376|FG001|Overall Study|Lost to Follow-up|6|||
148742559|NCT02655666|536528111|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
148742560|NCT00895414|536528114|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
148742561|NCT00895414|536528115|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
148742562|NCT00895414|536528114|FG000|First Intervention (14 Days)|Physician Decision|0|||
148742563|NCT00895414|536528115|FG001|First Intervention (14 Days)|Physician Decision|1|||
148742564|NCT02181790|536528118|FG000|Overall Study|study terminated|2|||
148818797|NCT02384460|536813100|FG000|Overall Study|Protocol Violation|0|||
148818798|NCT02384460|536813101|FG001|Overall Study|Protocol Violation|1|||
148742565|NCT02181790|536528119|FG001|Overall Study|study terminated|0|||
148975955|NCT02114879|537392375|FG000|Overall Study|Physician Decision|0|||
148818799|NCT02384460|536813100|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
148818800|NCT02384460|536813101|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
148818801|NCT02384460|536813100|FG000|Overall Study|Adverse Event|5|||
148818802|NCT02384460|536813101|FG001|Overall Study|Adverse Event|2|||
148818803|NCT02384460|536813100|FG000|Overall Study|Withdrawal by Subject|0|||
148818804|NCT02384460|536813101|FG001|Overall Study|Withdrawal by Subject|3|||
148818805|NCT02384460|536813100|FG000|Overall Study|Elective medical treatment|1|||
148818806|NCT02384460|536813101|FG001|Overall Study|Elective medical treatment|0|||
148818807|NCT02384460|536813100|FG000|Overall Study|Non-compliance|1|||
148818808|NCT02384460|536813101|FG001|Overall Study|Non-compliance|0|||
148818809|NCT02400580|536813104|FG000|Overall Study|Withdrawal by Subject|1|||
148818810|NCT02400580|536813105|FG001|Overall Study|Withdrawal by Subject|1|||
148818811|NCT02400580|536813104|FG000|Overall Study|Adverse Event|1|||
148818812|NCT02400580|536813105|FG001|Overall Study|Adverse Event|0|||
148818813|NCT00965094|536813106|FG000|Overall Study|Adverse Event|5|||
148818814|NCT00965094|536813107|FG001|Overall Study|Adverse Event|0|||
148818815|NCT00965094|536813106|FG000|Overall Study|Lost to Follow-up|0|||
148818816|NCT00965094|536813107|FG001|Overall Study|Lost to Follow-up|1|||
148818817|NCT01871727|536813113|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
148818818|NCT01871727|536813114|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
148818819|NCT01871727|536813115|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
148818820|NCT01871727|536813116|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
148818821|NCT01871727|536813117|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
148818822|NCT01871727|536813113|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
148818823|NCT01871727|536813114|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
148818824|NCT01871727|536813115|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
148818825|NCT01871727|536813116|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
148818826|NCT01871727|536813117|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
148818827|NCT01871727|536813113|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
148818828|NCT01871727|536813114|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
148818829|NCT01871727|536813115|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
148818830|NCT01871727|536813116|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
148818831|NCT01871727|536813117|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
148818832|NCT01871727|536813113|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
148818833|NCT01871727|536813114|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
148818834|NCT01871727|536813115|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
148818835|NCT01871727|536813116|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
148818836|NCT01871727|536813117|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
148818837|NCT01871727|536813113|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
148818838|NCT01871727|536813114|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
148818839|NCT01871727|536813115|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
148818840|NCT01871727|536813116|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
148818841|NCT01871727|536813117|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
148818842|NCT01871727|536813113|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
148818843|NCT01871727|536813114|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
148818844|NCT01871727|536813115|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
148818845|NCT01871727|536813116|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
148818846|NCT01871727|536813117|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
148818847|NCT01871727|536813113|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
148818848|NCT01871727|536813114|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
148818849|NCT01871727|536813115|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
148818850|NCT01871727|536813116|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
148818851|NCT01871727|536813117|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
148818852|NCT01263028|536813118|FG000|Overall Study|Withdrawal by Subject|1|||
148818853|NCT01263028|536813118|FG000|Overall Study|Adverse Event|1|||
148818854|NCT01263028|536813118|FG000|Overall Study|Study terminated due to low enrollment.|4|||
148818855|NCT03019588|536813119|FG000|Overall Study|Death|44|||
148818856|NCT03019588|536813120|FG001|Overall Study|Death|46|||
148818857|NCT03019588|536813119|FG000|Overall Study|Study terminated by Sponsor|3|||
148818858|NCT03019588|536813120|FG001|Overall Study|Study terminated by Sponsor|1|||
148818859|NCT00887588|536813121|FG000|Core Period|Death|1|||
148818860|NCT00887588|536813122|FG001|Core Period|Death|1|||
148818861|NCT00887588|536813121|FG000|Core Period|Lost to Follow-up|3|||
148818862|NCT00887588|536813122|FG001|Core Period|Lost to Follow-up|1|||
148818863|NCT00887588|536813121|FG000|Core Period|Withdrawal by Subject|6|||
149027158|NCT02929108|537576519|FG000|Overall Study|Hospice patient death|100|||
148818864|NCT00887588|536813122|FG001|Core Period|Withdrawal by Subject|8|||
148818865|NCT00887588|536813121|FG000|Core Period|Adverse Event|9|||
148818866|NCT00887588|536813122|FG001|Core Period|Adverse Event|11|||
148818867|NCT00887588|536813121|FG000|Extension Period|Adverse Event|4|||
148818868|NCT00887588|536813122|FG001|Extension Period|Adverse Event|4|||
148818869|NCT00887588|536813121|FG000|Extension Period|Death|0|||
148818870|NCT00887588|536813122|FG001|Extension Period|Death|1|||
148742566|NCT02752087|536528122|FG000|Washout|Physician Decision|1|||
148742567|NCT02752087|536528123|FG001|Washout|Physician Decision|0|||
148742568|NCT02458287|536528124|FG000|Overall Study|Adverse Event|0|||
148742569|NCT02458287|536528125|FG001|Overall Study|Adverse Event|0|||
148742570|NCT02458287|536528126|FG002|Overall Study|Adverse Event|0|||
148742571|NCT02458287|536528127|FG003|Overall Study|Adverse Event|1|||
148742572|NCT02458287|536528124|FG000|Overall Study|Lost to Follow-up|0|||
148742573|NCT02458287|536528125|FG001|Overall Study|Lost to Follow-up|1|||
148742574|NCT02458287|536528126|FG002|Overall Study|Lost to Follow-up|1|||
148742575|NCT02458287|536528127|FG003|Overall Study|Lost to Follow-up|0|||
148742576|NCT02458287|536528124|FG000|Overall Study|Protocol Violation|0|||
148742577|NCT02458287|536528125|FG001|Overall Study|Protocol Violation|1|||
148742578|NCT02458287|536528126|FG002|Overall Study|Protocol Violation|0|||
148742579|NCT02458287|536528127|FG003|Overall Study|Protocol Violation|0|||
148742580|NCT02458287|536528124|FG000|Overall Study|Withdrawal by Subject|0|||
148742581|NCT02458287|536528125|FG001|Overall Study|Withdrawal by Subject|2|||
148742582|NCT02458287|536528126|FG002|Overall Study|Withdrawal by Subject|2|||
148742583|NCT02458287|536528127|FG003|Overall Study|Withdrawal by Subject|1|||
148742584|NCT02458287|536528124|FG000|Overall Study|Relocated Out of State|0|||
148742585|NCT02458287|536528125|FG001|Overall Study|Relocated Out of State|0|||
148742586|NCT02458287|536528126|FG002|Overall Study|Relocated Out of State|0|||
148742587|NCT02458287|536528127|FG003|Overall Study|Relocated Out of State|1|||
148742588|NCT00843635|536528128|FG000|Overall Study|Adverse Event|2|||
148742589|NCT00843635|536528129|FG001|Overall Study|Adverse Event|2|||
148742590|NCT00843635|536528130|FG002|Overall Study|Adverse Event|0|||
148742591|NCT01860677|536528131|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
148742592|NCT01860677|536528132|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
148742593|NCT02785952|536528133|FG000|Overall Study|Adverse Event|31|||
148742594|NCT02785952|536528134|FG001|Overall Study|Adverse Event|19|||
148742595|NCT02785952|536528133|FG000|Overall Study|Refusal unrelated to adverse events|10|||
148742596|NCT02785952|536528134|FG001|Overall Study|Refusal unrelated to adverse events|5|||
148742597|NCT02785952|536528133|FG000|Overall Study|Disease progression/relapse|61|||
148742598|NCT02785952|536528134|FG001|Overall Study|Disease progression/relapse|89|||
148742599|NCT02785952|536528133|FG000|Overall Study|Death|11|||
148742600|NCT02785952|536528134|FG001|Overall Study|Death|7|||
148742601|NCT02785952|536528133|FG000|Overall Study|Other- not protocol specified|6|||
148742602|NCT02785952|536528134|FG001|Overall Study|Other- not protocol specified|4|||
148742603|NCT02785952|536528133|FG000|Overall Study|On protocol treatment|6|||
148742604|NCT02785952|536528134|FG001|Overall Study|On protocol treatment|3|||
148742605|NCT01144715|536528135|FG000|Overall Study|Lost to Follow-up|2|||
148742606|NCT01144715|536528136|FG001|Overall Study|Lost to Follow-up|1|||
148742607|NCT01144715|536528135|FG000|Overall Study|Withdrawal by Subject|2|||
148742608|NCT01144715|536528136|FG001|Overall Study|Withdrawal by Subject|1|||
148742609|NCT01144715|536528135|FG000|Overall Study|Adverse Event|0|||
148742610|NCT01144715|536528136|FG001|Overall Study|Adverse Event|1|||
148742611|NCT03553576|536528137|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
148742612|NCT03553576|536528138|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
148742613|NCT03553576|536528137|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
148742614|NCT03553576|536528138|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
148742615|NCT03553576|536528137|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
148742616|NCT03553576|536528138|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
148742617|NCT03553576|536528137|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
148742618|NCT03553576|536528138|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
148742619|NCT03553576|536528137|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
148742620|NCT03553576|536528138|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
148742621|NCT03553576|536528137|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
148742622|NCT03553576|536528138|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
148742623|NCT03553576|536528137|FG000|Overall Study|Physician Decision|2|||
148742624|NCT03553576|536528138|FG001|Overall Study|Physician Decision|5|||
148742625|NCT00351533|536528143|FG000|Overall Study|Extubated before first BAL|1|||
148742626|NCT00351533|536528144|FG001|Overall Study|Extubated before first BAL|0|||
148742627|NCT00351533|536528143|FG000|Overall Study|Lost to Follow-up|1|||
148742628|NCT00351533|536528144|FG001|Overall Study|Lost to Follow-up|3|||
148742629|NCT00351533|536528143|FG000|Overall Study|Physician Decision|0|||
148742630|NCT00351533|536528144|FG001|Overall Study|Physician Decision|1|||
148742631|NCT00351533|536528143|FG000|Overall Study|Withdrawal by Subject|0|||
148742632|NCT00351533|536528144|FG001|Overall Study|Withdrawal by Subject|1|||
148742633|NCT00197496|536528148|FG000|Baseline to Discharge|not interested|1|||
148742634|NCT00197496|536528149|FG001|Baseline to Discharge|not interested|0|||
148818871|NCT00887588|536813121|FG000|Extension Period|Protocol deviation|1|||
148818872|NCT00887588|536813122|FG001|Extension Period|Protocol deviation|0|||
148742635|NCT00197496|536528148|FG000|Baseline to Discharge|MRSA|1|||
148742636|NCT00197496|536528149|FG001|Baseline to Discharge|MRSA|0|||
148742637|NCT00197496|536528148|FG000|Baseline to Discharge|Physician Decision|0|||
148742638|NCT00197496|536528149|FG001|Baseline to Discharge|Physician Decision|1|||
148742639|NCT00197496|536528148|FG000|Baseline to Discharge|Protocol Violation|0|||
148742640|NCT00197496|536528149|FG001|Baseline to Discharge|Protocol Violation|1|||
148742641|NCT00197496|536528148|FG000|Follow-up|Lost to Follow-up|2|||
148742642|NCT00197496|536528149|FG001|Follow-up|Lost to Follow-up|1|||
148742643|NCT00857584|536528150|FG000|Overall Study|Lack of Efficacy|1|||
148742644|NCT00857584|536528151|FG001|Overall Study|Lack of Efficacy|2|||
148742645|NCT00857584|536528150|FG000|Overall Study|Adverse Event|2|||
148742646|NCT00857584|536528151|FG001|Overall Study|Adverse Event|2|||
148742647|NCT00857584|536528150|FG000|Overall Study|Physician Decision|1|||
148742648|NCT00857584|536528151|FG001|Overall Study|Physician Decision|1|||
148742649|NCT00658021|536528153|FG000|28-Week Treatment Period|Adverse Event|3|||
148742650|NCT00658021|536528154|FG001|28-Week Treatment Period|Adverse Event|1|||
148742651|NCT00658021|536528155|FG002|28-Week Treatment Period|Adverse Event|0|||
148742652|NCT00658021|536528153|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
148742653|NCT00658021|536528154|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
148742654|NCT00658021|536528155|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
148742655|NCT00658021|536528153|FG000|28-Week Treatment Period|Protocol Violation|0|||
148742656|NCT00658021|536528154|FG001|28-Week Treatment Period|Protocol Violation|2|||
148742657|NCT00658021|536528155|FG002|28-Week Treatment Period|Protocol Violation|1|||
148742658|NCT00658021|536528153|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
148742659|NCT00658021|536528154|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
148742660|NCT00658021|536528155|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
148742661|NCT00658021|536528153|FG000|28-Week Treatment Period|Physician Decision|1|||
148742662|NCT00658021|536528154|FG001|28-Week Treatment Period|Physician Decision|2|||
148742663|NCT00658021|536528155|FG002|28-Week Treatment Period|Physician Decision|1|||
148742664|NCT00658021|536528153|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
148742665|NCT00658021|536528154|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
148742666|NCT00658021|536528155|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
148742667|NCT00658021|536528153|FG000|28-Week Treatment Period|Loss of glucose control|1|||
148742668|NCT00658021|536528154|FG001|28-Week Treatment Period|Loss of glucose control|1|||
148742669|NCT00658021|536528155|FG002|28-Week Treatment Period|Loss of glucose control|10|||
148742670|NCT00658021|536528153|FG000|28-Week Treatment Period|Other|2|||
148742671|NCT00658021|536528154|FG001|28-Week Treatment Period|Other|3|||
148742672|NCT00658021|536528155|FG002|28-Week Treatment Period|Other|1|||
148742673|NCT00658021|536528153|FG000|28-Week Treatment Period|Did not receive treatment|2|||
148742674|NCT00658021|536528154|FG001|28-Week Treatment Period|Did not receive treatment|0|||
148742675|NCT00658021|536528155|FG002|28-Week Treatment Period|Did not receive treatment|0|||
148742676|NCT00658021|536528153|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
148742677|NCT00658021|536528154|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
148742678|NCT00658021|536528155|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
148742679|NCT00658021|536528153|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
148742680|NCT00658021|536528154|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
148742681|NCT00658021|536528155|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
148742682|NCT01806506|536528156|FG000|Overall Study|Lost to Follow-up|2|||
148742683|NCT01806506|536528157|FG001|Overall Study|Lost to Follow-up|1|||
148742684|NCT02542605|536528160|FG000|Part B: Challenge Phase|Sponsor decision|1|||
148742685|NCT02542605|536528161|FG001|Part B: Challenge Phase|Sponsor decision|0|||
148742686|NCT02542605|536528162|FG002|Part B: Challenge Phase|Sponsor decision|0|||
148742687|NCT02542605|536528160|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
148742688|NCT02542605|536528161|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
148742689|NCT02542605|536528162|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
148742690|NCT04051619|536528163|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
148742691|NCT04051619|536528164|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
148742692|NCT04051619|536528163|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
148742693|NCT04051619|536528164|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
148742694|NCT01924754|536530299|FG000|Overall Study|Lost to Follow-up|1|||
148742695|NCT01924754|536530300|FG001|Overall Study|Lost to Follow-up|2|||
148742696|NCT01924754|536530301|FG002|Overall Study|Lost to Follow-up|1|||
148742697|NCT01924754|536530299|FG000|Overall Study|Pregnancy|0|||
148742698|NCT01924754|536530300|FG001|Overall Study|Pregnancy|1|||
148742699|NCT01924754|536530301|FG002|Overall Study|Pregnancy|2|||
148742700|NCT03132155|536530302|FG000|Overall Study|Lack of Efficacy|6|||
148742701|NCT03132155|536530302|FG000|Overall Study|Lost to Follow-up|1|||
148742702|NCT03132155|536530302|FG000|Overall Study|Withdrawal by Subject|1|||
148742703|NCT02925403|536530308|FG000|Overall Study|Lost to Follow-up|0|||
148742704|NCT02925403|536530309|FG001|Overall Study|Lost to Follow-up|1|||
148742705|NCT02899195|536530310|FG000|Concurrent Durvalumab|Adverse Event|4|||
148742706|NCT02899195|536530310|FG000|Concurrent Durvalumab|Physician Decision|1|||
148742707|NCT02899195|536530310|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
148975956|NCT02114879|537392376|FG001|Overall Study|Physician Decision|2|||
148742708|NCT02899195|536530310|FG000|Concurrent Durvalumab|Progressive Disease|5|||
148742709|NCT02899195|536530310|FG000|Maintenance Durvalumab|Adverse Event|1|||
148742710|NCT02899195|536530310|FG000|Maintenance Durvalumab|Physician Decision|1|||
148742711|NCT02899195|536530310|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
148742712|NCT02899195|536530310|FG000|Maintenance Durvalumab|Progressive Disease|31|||
148742713|NCT04778904|536530311|FG000|Overall Study|Protocol Violation|1|||
148742714|NCT04778904|536530312|FG001|Overall Study|Protocol Violation|0|||
148742715|NCT04778904|536530313|FG002|Overall Study|Protocol Violation|0|||
148742716|NCT04778904|536530314|FG003|Overall Study|Protocol Violation|0|||
148742717|NCT04778904|536530311|FG000|Overall Study|Withdrawal by Subject|0|||
148742718|NCT04778904|536530312|FG001|Overall Study|Withdrawal by Subject|0|||
148742719|NCT04778904|536530313|FG002|Overall Study|Withdrawal by Subject|1|||
148742720|NCT04778904|536530314|FG003|Overall Study|Withdrawal by Subject|0|||
148742721|NCT03452137|536530315|FG000|Overall Study|Death|67|||
148742722|NCT03452137|536530316|FG001|Overall Study|Death|70|||
148742723|NCT03452137|536530315|FG000|Overall Study|Lost to Follow-up|4|||
148742724|NCT03452137|536530316|FG001|Overall Study|Lost to Follow-up|2|||
148742725|NCT03452137|536530315|FG000|Overall Study|Physician Decision|0|||
148742726|NCT03452137|536530316|FG001|Overall Study|Physician Decision|1|||
148742727|NCT03452137|536530315|FG000|Overall Study|Study Terminated by Sponsor|120|||
148742728|NCT03452137|536530316|FG001|Overall Study|Study Terminated by Sponsor|121|||
148742729|NCT03452137|536530315|FG000|Overall Study|Withdrawal by Subject|12|||
148742730|NCT03452137|536530316|FG001|Overall Study|Withdrawal by Subject|9|||
148742731|NCT03772717|536530317|FG000|Overall Study|Withdrawal by Subject|2|||
148742732|NCT02856802|536530318|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
148742733|NCT02856802|536530319|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
148742734|NCT02856802|536530318|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
148742735|NCT02856802|536530319|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
148742736|NCT02856802|536530318|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
148742737|NCT02856802|536530319|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
148742738|NCT02856802|536530318|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
148742739|NCT02856802|536530319|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
148742740|NCT02856802|536530318|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
148742741|NCT02856802|536530319|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
148742742|NCT02856802|536530318|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
148742743|NCT02856802|536530319|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
148742744|NCT04138043|536530320|FG000|Overall Study|Withdrawal by Subject|0|||
148742745|NCT04138043|536530321|FG001|Overall Study|Withdrawal by Subject|1|||
148742746|NCT00587860|536530322|FG000|Overall Study|Lost to Follow-up|2|||
148742747|NCT00587860|536530323|FG001|Overall Study|Lost to Follow-up|2|||
148742748|NCT00587860|536530322|FG000|Overall Study|Withdrawal by Subject|3|||
148742749|NCT00587860|536530323|FG001|Overall Study|Withdrawal by Subject|3|||
148742750|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
148742751|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
148742752|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
148742753|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
148742754|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
148742755|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
148742756|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
148742757|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
148742758|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
148742759|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
148742760|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
148742761|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
148742762|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
148742763|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
148742764|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
148742765|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
148742766|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
148742767|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
148742768|NCT00261443|536530324|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
148742769|NCT00261443|536530325|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
148742770|NCT00261443|536530326|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
148742771|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
148742772|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
148742773|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
148742774|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
148742775|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
148742776|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
148742777|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
148742778|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
148742779|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
148742780|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
148742781|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
148742782|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
148742783|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
148742784|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
148742785|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
148742786|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
148742787|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
148742788|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
148742789|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
148742790|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
148742791|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
148742792|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
148742793|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
148742794|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
148742795|NCT00261443|536530324|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
148742796|NCT00261443|536530325|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
148742797|NCT00261443|536530326|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
148742798|NCT00261443|536530324|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
148742799|NCT00261443|536530325|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
148742800|NCT00261443|536530326|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
148742801|NCT00261443|536530324|FG000|3: Assessment of Relapse|Adverse Event|0|||
148742802|NCT00261443|536530325|FG001|3: Assessment of Relapse|Adverse Event|15|||
148742803|NCT00261443|536530326|FG002|3: Assessment of Relapse|Adverse Event|19|||
148742804|NCT00261443|536530324|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
148742805|NCT00261443|536530325|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
148742806|NCT00261443|536530326|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
148742807|NCT00261443|536530324|FG000|3: Assessment of Relapse|Death|0|||
148742808|NCT00261443|536530325|FG001|3: Assessment of Relapse|Death|0|||
148742809|NCT00261443|536530326|FG002|3: Assessment of Relapse|Death|1|||
148742810|NCT00261443|536530324|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
148742811|NCT00261443|536530325|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
148742812|NCT00261443|536530326|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
148742813|NCT00261443|536530324|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
148742814|NCT00261443|536530325|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
148742815|NCT00261443|536530326|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
148742816|NCT00261443|536530324|FG000|3: Assessment of Relapse|Pregnancy|0|||
148742817|NCT00261443|536530325|FG001|3: Assessment of Relapse|Pregnancy|2|||
148742818|NCT00261443|536530326|FG002|3: Assessment of Relapse|Pregnancy|1|||
148742819|NCT00261443|536530324|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
148742820|NCT00261443|536530325|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
148742821|NCT00261443|536530326|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
148742822|NCT00261443|536530324|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
148742823|NCT00261443|536530325|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
148742824|NCT00261443|536530326|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
148742825|NCT00261443|536530324|FG000|3: Assessment of Relapse|Other Reasons|0|||
148742826|NCT00261443|536530325|FG001|3: Assessment of Relapse|Other Reasons|4|||
148742827|NCT00261443|536530326|FG002|3: Assessment of Relapse|Other Reasons|3|||
148742828|NCT00261443|536530324|FG000|4: Extension Phase|Adverse Event|0|||
148742829|NCT00261443|536530325|FG001|4: Extension Phase|Adverse Event|1|||
148742830|NCT00261443|536530326|FG002|4: Extension Phase|Adverse Event|0|||
148742831|NCT00261443|536530324|FG000|4: Extension Phase|Withdrawal by Subject|0|||
148742832|NCT00261443|536530325|FG001|4: Extension Phase|Withdrawal by Subject|1|||
148742833|NCT00261443|536530326|FG002|4: Extension Phase|Withdrawal by Subject|2|||
148742834|NCT00261443|536530324|FG000|4: Extension Phase|Lost to Follow-up|0|||
148742835|NCT00261443|536530325|FG001|4: Extension Phase|Lost to Follow-up|1|||
148742836|NCT00261443|536530326|FG002|4: Extension Phase|Lost to Follow-up|0|||
148742837|NCT02755649|536530327|FG000|Overall Study|Transitioned into OLE study|99|||
148742838|NCT02755649|536530328|FG001|Overall Study|Transitioned into OLE study|98|||
148742839|NCT02755649|536530329|FG002|Overall Study|Transitioned into OLE study|100|||
148742840|NCT02755649|536530327|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
148742841|NCT02755649|536530328|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
148742842|NCT02755649|536530329|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
148742843|NCT02755649|536530327|FG000|Overall Study|Physician Decision|0|||
148742844|NCT02755649|536530328|FG001|Overall Study|Physician Decision|0|||
148742845|NCT02755649|536530329|FG002|Overall Study|Physician Decision|2|||
148742846|NCT02755649|536530327|FG000|Overall Study|Withdrawal by Subject|0|||
148742847|NCT02755649|536530328|FG001|Overall Study|Withdrawal by Subject|1|||
148818873|NCT00887588|536813121|FG000|Extension Period|Lost to Follow-up|1|||
148818874|NCT00887588|536813122|FG001|Extension Period|Lost to Follow-up|0|||
148742848|NCT02755649|536530329|FG002|Overall Study|Withdrawal by Subject|0|||
148742849|NCT02755649|536530327|FG000|Overall Study|Undecided|1|||
148742850|NCT02755649|536530328|FG001|Overall Study|Undecided|0|||
148742851|NCT02755649|536530329|FG002|Overall Study|Undecided|0|||
148742852|NCT01286753|536530330|FG000|Overall Study|Adverse Event|7|||
148742853|NCT01286753|536530331|FG001|Overall Study|Adverse Event|6|||
148742854|NCT01286753|536530330|FG000|Overall Study|Progression|11|||
148742855|NCT01286753|536530331|FG001|Overall Study|Progression|13|||
148742856|NCT01286753|536530330|FG000|Overall Study|Refused Treatment|1|||
148742857|NCT01286753|536530331|FG001|Overall Study|Refused Treatment|0|||
148742858|NCT01286753|536530330|FG000|Overall Study|Withdrawal of Consent|0|||
148742859|NCT01286753|536530331|FG001|Overall Study|Withdrawal of Consent|2|||
148742860|NCT01286753|536530330|FG000|Overall Study|Discontinued to Join Extension Study|6|||
148742861|NCT01286753|536530331|FG001|Overall Study|Discontinued to Join Extension Study|4|||
148742862|NCT01286753|536530330|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
148742863|NCT01286753|536530331|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
148742864|NCT02126826|536530335|FG000|Overall Study|Withdrawal by Subject|0|||
148742865|NCT02126826|536530336|FG001|Overall Study|Withdrawal by Subject|0|||
148742866|NCT02126826|536530337|FG002|Overall Study|Withdrawal by Subject|0|||
148742867|NCT02126826|536530338|FG003|Overall Study|Withdrawal by Subject|1|||
148742868|NCT02126826|536530339|FG004|Overall Study|Withdrawal by Subject|0|||
148742869|NCT02126826|536530340|FG005|Overall Study|Withdrawal by Subject|0|||
148742870|NCT02126826|536530341|FG006|Overall Study|Withdrawal by Subject|0|||
148742871|NCT03092219|536530342|FG000|Overall Study|Protocol Violation|7|||
148742872|NCT03092219|536530343|FG001|Overall Study|Protocol Violation|4|||
148742873|NCT03278626|536530344|FG000|Overall Study|Death|2|||
148742874|NCT03278626|536530344|FG000|Overall Study|Toxicity|1|||
148742875|NCT03278626|536530344|FG000|Overall Study|Disease Progression|2|||
148742876|NCT04971187|536530345|FG000|Overall Study|Screen failures|2|||
148742877|NCT00591773|536530348|FG000|Overall Study|Adverse Event|9|||
148742878|NCT00591773|536530349|FG001|Overall Study|Adverse Event|9|||
148742879|NCT00591773|536530350|FG002|Overall Study|Adverse Event|6|||
148742880|NCT00591773|536530348|FG000|Overall Study|Protocol Violation|2|||
148742881|NCT00591773|536530349|FG001|Overall Study|Protocol Violation|3|||
148742882|NCT00591773|536530350|FG002|Overall Study|Protocol Violation|0|||
148742883|NCT00591773|536530348|FG000|Overall Study|Lost to Follow-up|1|||
148742884|NCT00591773|536530349|FG001|Overall Study|Lost to Follow-up|4|||
148742885|NCT00591773|536530350|FG002|Overall Study|Lost to Follow-up|1|||
148742886|NCT00591773|536530348|FG000|Overall Study|Withdrawal by Subject|2|||
148742887|NCT00591773|536530349|FG001|Overall Study|Withdrawal by Subject|5|||
148742888|NCT00591773|536530350|FG002|Overall Study|Withdrawal by Subject|3|||
148742889|NCT00591773|536530348|FG000|Overall Study|Lack of Efficacy|1|||
148742890|NCT00591773|536530349|FG001|Overall Study|Lack of Efficacy|2|||
148742891|NCT00591773|536530350|FG002|Overall Study|Lack of Efficacy|2|||
148742892|NCT00591773|536530348|FG000|Overall Study|Other|1|||
148742893|NCT00591773|536530349|FG001|Overall Study|Other|1|||
148742894|NCT00591773|536530350|FG002|Overall Study|Other|4|||
148742895|NCT02135614|536530351|FG000|Overall Study|Randomized but Not Treated|2|||
148742896|NCT02135614|536530352|FG001|Overall Study|Randomized but Not Treated|1|||
148742897|NCT02135614|536530351|FG000|Overall Study|Adverse Event|0|||
148742898|NCT02135614|536530352|FG001|Overall Study|Adverse Event|1|||
148742899|NCT02135614|536530351|FG000|Overall Study|Death|1|||
148742900|NCT02135614|536530352|FG001|Overall Study|Death|0|||
148742901|NCT02135614|536530351|FG000|Overall Study|Investigator's Discretion|0|||
148742902|NCT02135614|536530352|FG001|Overall Study|Investigator's Discretion|1|||
148742903|NCT02135614|536530351|FG000|Overall Study|Withdrew Consent|2|||
148742904|NCT02135614|536530352|FG001|Overall Study|Withdrew Consent|2|||
148742905|NCT02135614|536530351|FG000|Overall Study|Lost to Follow-up|3|||
148742906|NCT02135614|536530352|FG001|Overall Study|Lost to Follow-up|0|||
148742907|NCT02679235|536530359|FG000|Overall Study|Withdrawal by Subject|3|||
148742908|NCT02679235|536530359|FG000|Overall Study|Adverse Event|1|||
148742909|NCT00923273|536530360|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
148742910|NCT00923273|536530361|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
148742911|NCT00923273|536530362|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
148742912|NCT00923273|536530363|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
148742913|NCT00923273|536530364|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
148742914|NCT00923273|536530360|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
148742915|NCT00923273|536530361|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
148742916|NCT00923273|536530362|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
148742917|NCT00923273|536530363|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
148742918|NCT00923273|536530364|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
148742919|NCT00605540|536530365|FG000|Overall Study|Death|15|||
148742920|NCT00605540|536530365|FG000|Overall Study|Lost to Follow-up|23|||
148742921|NCT00264550|536530366|FG000|Overall Study|Death|0|||
148742922|NCT00264550|536530367|FG001|Overall Study|Death|3|||
148742923|NCT00264550|536530368|FG002|Overall Study|Death|0|||
148742924|NCT00264550|536530369|FG003|Overall Study|Death|0|||
148742925|NCT00264550|536530366|FG000|Overall Study|Lost to Follow-up|3|||
148742926|NCT00264550|536530367|FG001|Overall Study|Lost to Follow-up|1|||
148742927|NCT00264550|536530368|FG002|Overall Study|Lost to Follow-up|1|||
148742928|NCT00264550|536530369|FG003|Overall Study|Lost to Follow-up|1|||
148742929|NCT00264550|536530366|FG000|Overall Study|Adverse Event|23|||
148742930|NCT00264550|536530367|FG001|Overall Study|Adverse Event|18|||
148742931|NCT00264550|536530368|FG002|Overall Study|Adverse Event|9|||
148742932|NCT00264550|536530369|FG003|Overall Study|Adverse Event|14|||
148742933|NCT00264550|536530366|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
148742934|NCT00264550|536530367|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
148742935|NCT00264550|536530368|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
148742936|NCT00264550|536530369|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
148742937|NCT00264550|536530366|FG000|Overall Study|Discontinued oral study agent|0|||
148742938|NCT00264550|536530367|FG001|Overall Study|Discontinued oral study agent|1|||
148742939|NCT00264550|536530368|FG002|Overall Study|Discontinued oral study agent|0|||
148742940|NCT00264550|536530369|FG003|Overall Study|Discontinued oral study agent|0|||
148742941|NCT00264550|536530366|FG000|Overall Study|Other|13|||
148742942|NCT00264550|536530367|FG001|Overall Study|Other|7|||
148742943|NCT00264550|536530368|FG002|Overall Study|Other|3|||
148742944|NCT00264550|536530369|FG003|Overall Study|Other|9|||
148742945|NCT02246114|536530370|FG000|Overall Study|miscarriage|1|||
148742946|NCT02246114|536530371|FG001|Overall Study|miscarriage|0|||
148742947|NCT00129389|536530376|FG000|Overall Study|Adverse Event|19|||
148742948|NCT00129389|536530377|FG001|Overall Study|Adverse Event|87|||
148742949|NCT00129389|536530376|FG000|Overall Study|Death|0|||
148742950|NCT00129389|536530377|FG001|Overall Study|Death|1|||
148742951|NCT00129389|536530376|FG000|Overall Study|Lost to Follow-up|2|||
148742952|NCT00129389|536530377|FG001|Overall Study|Lost to Follow-up|1|||
148742953|NCT00129389|536530376|FG000|Overall Study|Physician Decision|0|||
148742954|NCT00129389|536530377|FG001|Overall Study|Physician Decision|4|||
148742955|NCT00129389|536530376|FG000|Overall Study|Protocol Violation|0|||
148742956|NCT00129389|536530377|FG001|Overall Study|Protocol Violation|6|||
148742957|NCT00129389|536530376|FG000|Overall Study|Withdrawal by Subject|9|||
148742958|NCT00129389|536530377|FG001|Overall Study|Withdrawal by Subject|23|||
148742959|NCT00129389|536530376|FG000|Overall Study|Relapse|1|||
148742960|NCT00129389|536530377|FG001|Overall Study|Relapse|0|||
148742961|NCT00129389|536530376|FG000|Overall Study|Not eligible|1|||
148742962|NCT00129389|536530377|FG001|Overall Study|Not eligible|2|||
148742963|NCT00129389|536530376|FG000|Overall Study|Crossed to the other arm|1|||
148742964|NCT00129389|536530377|FG001|Overall Study|Crossed to the other arm|16|||
148742965|NCT00741286|536530381|FG000|Overall Study|Lost to Follow-up|15|||
148742966|NCT00741286|536530382|FG001|Overall Study|Lost to Follow-up|10|||
148742967|NCT00741286|536530381|FG000|Overall Study|Adverse Event|1|||
148742968|NCT00741286|536530382|FG001|Overall Study|Adverse Event|6|||
148742969|NCT00741286|536530381|FG000|Overall Study|Protocol Violation|3|||
148742970|NCT00741286|536530382|FG001|Overall Study|Protocol Violation|2|||
148742971|NCT00741286|536530381|FG000|Overall Study|Primary Outcome|1|||
148742972|NCT00741286|536530382|FG001|Overall Study|Primary Outcome|1|||
148742973|NCT01831258|536530383|FG000|Overall Study|Withdrawal by Subject|2|||
148742974|NCT01831258|536530384|FG001|Overall Study|Withdrawal by Subject|1|||
148742975|NCT01831258|536530383|FG000|Overall Study|Lost to Follow-up|3|||
148742976|NCT01831258|536530384|FG001|Overall Study|Lost to Follow-up|2|||
148742977|NCT02564887|536530393|FG000|Overall Study|Lost to Follow-up|6|||
148742978|NCT02564887|536530394|FG001|Overall Study|Lost to Follow-up|0|||
148742979|NCT01199016|536530395|FG000|Overall Study|No longer meets eligibility criteria|4|||
148742980|NCT01199016|536530395|FG000|Overall Study|Entrance criteria|5|||
148742981|NCT01199016|536530395|FG000|Overall Study|Protocol Violation|9|||
148742982|NCT01199016|536530395|FG000|Overall Study|Other|13|||
148742983|NCT01199016|536530395|FG000|Overall Study|Withdrawal by Subject|21|||
148742984|NCT01199016|536530395|FG000|Overall Study|Lost to Follow-up|25|||
148742985|NCT02842073|536530406|FG000|Overall Study|Withdrawal by Subject|1|||
148742986|NCT01333397|536530409|FG000|Overall Study|Lost to Follow-up|1|||
148742987|NCT01333397|536530410|FG001|Overall Study|Lost to Follow-up|0|||
148742988|NCT01333397|536530411|FG002|Overall Study|Lost to Follow-up|0|||
148742989|NCT01333397|536530412|FG003|Overall Study|Lost to Follow-up|1|||
148742990|NCT01333397|536530413|FG004|Overall Study|Lost to Follow-up|0|||
148742991|NCT01085357|536530414|FG000|Overall Study|Adverse Event|1|||
148742992|NCT01085357|536530415|FG001|Overall Study|Adverse Event|1|||
148742993|NCT01085357|536530414|FG000|Overall Study|Subject Decision|4|||
148742994|NCT01085357|536530415|FG001|Overall Study|Subject Decision|3|||
148742995|NCT01085357|536530414|FG000|Overall Study|Investigator Decision|1|||
148742996|NCT01085357|536530415|FG001|Overall Study|Investigator Decision|1|||
148742997|NCT01085357|536530414|FG000|Overall Study|Death|11|||
148742998|NCT01085357|536530415|FG001|Overall Study|Death|1|||
148742999|NCT01085357|536530414|FG000|Overall Study|Lost to Follow-up|2|||
148743000|NCT01085357|536530415|FG001|Overall Study|Lost to Follow-up|0|||
148818875|NCT00366535|536813123|FG000|First Phase: 12 Weeks|Adverse Event|1|||
148818876|NCT00366535|536813124|FG001|First Phase: 12 Weeks|Adverse Event|3|||
148818877|NCT00366535|536813123|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
148818878|NCT00366535|536813124|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
148818879|NCT00366535|536813123|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
148818880|NCT00366535|536813124|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
148818881|NCT00366535|536813123|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
148818882|NCT00366535|536813124|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
148818883|NCT03753542|536813132|FG000|Overall Study|Lost to Follow-up|9|||
148818884|NCT03753542|536813133|FG001|Overall Study|Lost to Follow-up|14|||
148818885|NCT04180696|536813134|FG000|Overall Study|Death|5|||
148818886|NCT04180696|536813135|FG001|Overall Study|Death|6|||
148818887|NCT04180696|536813134|FG000|Overall Study|Lost to Follow-up|1|||
148818888|NCT04180696|536813135|FG001|Overall Study|Lost to Follow-up|0|||
148818889|NCT04180696|536813134|FG000|Overall Study|Withdrawal by Subject|0|||
148818890|NCT04180696|536813135|FG001|Overall Study|Withdrawal by Subject|1|||
148818891|NCT01033071|536813141|FG000|Overall Study|Adverse Event|28|||
148818892|NCT01033071|536813142|FG001|Overall Study|Adverse Event|51|||
148818893|NCT01033071|536813143|FG002|Overall Study|Adverse Event|26|||
148818894|NCT01033071|536813141|FG000|Overall Study|Protocol Violation|0|||
148818895|NCT01033071|536813142|FG001|Overall Study|Protocol Violation|2|||
148818896|NCT01033071|536813143|FG002|Overall Study|Protocol Violation|1|||
148818897|NCT01033071|536813141|FG000|Overall Study|Lost to Follow-up|4|||
148818898|NCT01033071|536813142|FG001|Overall Study|Lost to Follow-up|5|||
148818899|NCT01033071|536813143|FG002|Overall Study|Lost to Follow-up|5|||
148818900|NCT01033071|536813141|FG000|Overall Study|Withdrawal by Subject|17|||
148818901|NCT01033071|536813142|FG001|Overall Study|Withdrawal by Subject|14|||
148818902|NCT01033071|536813143|FG002|Overall Study|Withdrawal by Subject|11|||
148818903|NCT01033071|536813141|FG000|Overall Study|Lack of Efficacy|0|||
148818904|NCT01033071|536813142|FG001|Overall Study|Lack of Efficacy|1|||
148818905|NCT01033071|536813143|FG002|Overall Study|Lack of Efficacy|1|||
148818906|NCT01033071|536813141|FG000|Overall Study|Other|6|||
148818907|NCT01033071|536813142|FG001|Overall Study|Other|4|||
148818908|NCT01033071|536813143|FG002|Overall Study|Other|3|||
148818909|NCT04289298|536814555|FG000|Overall Study|Lost to Follow-up|5|||
148818910|NCT04289298|536814556|FG001|Overall Study|Lost to Follow-up|0|||
148818911|NCT04289298|536814555|FG000|Overall Study|Withdrawal by Subject|2|||
148818912|NCT04289298|536814556|FG001|Overall Study|Withdrawal by Subject|0|||
148818913|NCT01734928|536814557|FG000|Randomization|Physician Decision|0|||
148818914|NCT01734928|536814558|FG001|Randomization|Physician Decision|1|||
148818915|NCT01734928|536814557|FG000|Randomization|clinical progression|0|||
148818916|NCT01734928|536814558|FG001|Randomization|clinical progression|1|||
148818917|NCT01734928|536814557|FG000|Randomization|progressive disease|0|||
148818918|NCT01734928|536814558|FG001|Randomization|progressive disease|2|||
148818919|NCT01734928|536814557|FG000|Randomization|Withdrew informed consent|0|||
148818920|NCT01734928|536814558|FG001|Randomization|Withdrew informed consent|4|||
148818921|NCT01734928|536814557|FG000|Randomization|Death|1|||
148818922|NCT01734928|536814558|FG001|Randomization|Death|0|||
148818923|NCT01734928|536814557|FG000|Randomization|Randomization error|1|||
148818924|NCT01734928|536814558|FG001|Randomization|Randomization error|0|||
148818925|NCT01734928|536814557|FG000|Randomization|Lost to Follow-up|1|||
148818926|NCT01734928|536814558|FG001|Randomization|Lost to Follow-up|0|||
148818927|NCT01734928|536814557|FG000|Treatment Period|Lost to Follow-up|0|||
148818928|NCT01734928|536814558|FG001|Treatment Period|Lost to Follow-up|2|||
148818929|NCT01734928|536814557|FG000|Treatment Period|Progressive Disease|167|||
148818930|NCT01734928|536814558|FG001|Treatment Period|Progressive Disease|165|||
148818931|NCT01734928|536814557|FG000|Treatment Period|Adverse Event|39|||
148818932|NCT01734928|536814558|FG001|Treatment Period|Adverse Event|52|||
148818933|NCT01734928|536814557|FG000|Treatment Period|Withdrawal of Consent|25|||
148818934|NCT01734928|536814558|FG001|Treatment Period|Withdrawal of Consent|22|||
148818935|NCT01734928|536814557|FG000|Treatment Period|Death|20|||
148818936|NCT01734928|536814558|FG001|Treatment Period|Death|9|||
148818937|NCT01734928|536814557|FG000|Treatment Period|Other Reasons|27|||
148818938|NCT01734928|536814558|FG001|Treatment Period|Other Reasons|19|||
148818939|NCT01734928|536814557|FG000|Treatment Period|Pregnancy|0|||
148818940|NCT01734928|536814558|FG001|Treatment Period|Pregnancy|1|||
148818941|NCT00620035|536814559|FG000|Overall Study|Adverse Event|106|||
148818942|NCT00620035|536814559|FG000|Overall Study|Withdrawal of Informed Consent|1|||
148818943|NCT00620035|536814559|FG000|Overall Study|Other Reason|38|||
148818944|NCT01629563|536814562|FG000|Overall Study|Adverse Event|16|||
148818945|NCT01629563|536814563|FG001|Overall Study|Adverse Event|16|||
148818946|NCT01629563|536814562|FG000|Overall Study|Death|2|||
148818947|NCT01629563|536814563|FG001|Overall Study|Death|0|||
148818948|NCT01629563|536814562|FG000|Overall Study|Lack of Efficacy|2|||
148818949|NCT01629563|536814563|FG001|Overall Study|Lack of Efficacy|3|||
148818950|NCT01629563|536814562|FG000|Overall Study|Lost to Follow-up|1|||
148818951|NCT01629563|536814563|FG001|Overall Study|Lost to Follow-up|0|||
148818952|NCT01629563|536814562|FG000|Overall Study|Pregnancy|1|||
148818953|NCT01629563|536814563|FG001|Overall Study|Pregnancy|2|||
148818954|NCT01629563|536814562|FG000|Overall Study|Protocol Violation|0|||
148818955|NCT01629563|536814563|FG001|Overall Study|Protocol Violation|1|||
148818956|NCT01629563|536814562|FG000|Overall Study|Withdrawal by Subject|27|||
148818957|NCT01629563|536814563|FG001|Overall Study|Withdrawal by Subject|20|||
148818958|NCT01629563|536814562|FG000|Overall Study|surgery|0|||
148818959|NCT01629563|536814563|FG001|Overall Study|surgery|3|||
148818960|NCT01629563|536814562|FG000|Overall Study|Lack of return of menses|12|||
148818961|NCT01629563|536814563|FG001|Overall Study|Lack of return of menses|7|||
148818962|NCT01629563|536814562|FG000|Overall Study|Protocol Violation|0|||
148818963|NCT01629563|536814563|FG001|Overall Study|Protocol Violation|1|||
148818964|NCT02316613|536814566|FG000|Overall Study|Death|63|||
148818965|NCT02316613|536814566|FG000|Overall Study|Lost to Follow-up|9|||
148818966|NCT02316613|536814566|FG000|Overall Study|Lymphoma transformation|2|||
148818967|NCT02316613|536814566|FG000|Overall Study|Participant moved/changed medical team|11|||
148818968|NCT02316613|536814566|FG000|Overall Study|No data and duplicate cases|5|||
148818969|NCT02316613|536814566|FG000|Overall Study|Did not met selection criteria|14|||
148818970|NCT01108796|536814567|FG000|Overall Study|Adverse Event|0|||
148818971|NCT01108796|536814568|FG001|Overall Study|Adverse Event|1|||
148818972|NCT01108796|536814567|FG000|Overall Study|Lost to Follow-up|7|||
148818973|NCT01108796|536814568|FG001|Overall Study|Lost to Follow-up|6|||
148818974|NCT00758043|536814569|FG000|Overall Study|Adverse Event|1|||
148818975|NCT00758043|536814570|FG001|Overall Study|Adverse Event|20|||
148818976|NCT00758043|536814571|FG002|Overall Study|Adverse Event|12|||
148818977|NCT00758043|536814572|FG003|Overall Study|Adverse Event|62|||
148818978|NCT00758043|536814569|FG000|Overall Study|Lack of Efficacy|0|||
148818979|NCT00758043|536814570|FG001|Overall Study|Lack of Efficacy|6|||
148818980|NCT00758043|536814571|FG002|Overall Study|Lack of Efficacy|18|||
148818981|NCT00758043|536814572|FG003|Overall Study|Lack of Efficacy|12|||
148818982|NCT00758043|536814569|FG000|Overall Study|Refused Further Treatment|0|||
148818983|NCT00758043|536814570|FG001|Overall Study|Refused Further Treatment|11|||
148818984|NCT00758043|536814571|FG002|Overall Study|Refused Further Treatment|5|||
148818985|NCT00758043|536814572|FG003|Overall Study|Refused Further Treatment|8|||
148818986|NCT00758043|536814569|FG000|Overall Study|Lost to Follow-up|0|||
148818987|NCT00758043|536814570|FG001|Overall Study|Lost to Follow-up|2|||
148818988|NCT00758043|536814571|FG002|Overall Study|Lost to Follow-up|2|||
148818989|NCT00758043|536814572|FG003|Overall Study|Lost to Follow-up|5|||
148818990|NCT00758043|536814569|FG000|Overall Study|Withdrawal by Subject|0|||
148818991|NCT00758043|536814570|FG001|Overall Study|Withdrawal by Subject|1|||
148818992|NCT00758043|536814571|FG002|Overall Study|Withdrawal by Subject|1|||
148818993|NCT00758043|536814572|FG003|Overall Study|Withdrawal by Subject|4|||
148818994|NCT00758043|536814569|FG000|Overall Study|Required Prohibited Medication|0|||
148818995|NCT00758043|536814570|FG001|Overall Study|Required Prohibited Medication|0|||
148818996|NCT00758043|536814571|FG002|Overall Study|Required Prohibited Medication|1|||
148818997|NCT00758043|536814572|FG003|Overall Study|Required Prohibited Medication|3|||
148818998|NCT00758043|536814569|FG000|Overall Study|Non-Compliant With study Drug|0|||
148818999|NCT00758043|536814570|FG001|Overall Study|Non-Compliant With study Drug|0|||
148819000|NCT00758043|536814571|FG002|Overall Study|Non-Compliant With study Drug|0|||
148819001|NCT00758043|536814572|FG003|Overall Study|Non-Compliant With study Drug|1|||
148819002|NCT00758043|536814569|FG000|Overall Study|Other Reasons|0|||
148819003|NCT00758043|536814570|FG001|Overall Study|Other Reasons|1|||
148819004|NCT00758043|536814571|FG002|Overall Study|Other Reasons|0|||
148819005|NCT00758043|536814572|FG003|Overall Study|Other Reasons|5|||
148819006|NCT01829165|536814579|FG000|Overall Study|Did not complete intervention|2|||
148819007|NCT01829165|536814580|FG001|Overall Study|Did not complete intervention|0|||
148819008|NCT02573467|536814581|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
148819009|NCT02573467|536814582|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
148819010|NCT02573467|536814583|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
148819011|NCT02573467|536814584|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
148819012|NCT02573467|536814581|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
148819013|NCT02573467|536814582|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
148819014|NCT02573467|536814583|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
148819015|NCT02573467|536814584|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
148819016|NCT02573467|536814581|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
148819017|NCT02573467|536814582|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
148819018|NCT02573467|536814583|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
148819019|NCT02573467|536814584|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
148819020|NCT02573467|536814581|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
148975957|NCT03120013|537392379|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
148975958|NCT03120013|537392380|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
148819021|NCT02573467|536814582|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
148819022|NCT02573467|536814583|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
148819023|NCT02573467|536814584|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
148819024|NCT02573467|536814581|FG000|Post-treatment Follow up Epoch|Death|1|||
148819025|NCT02573467|536814582|FG001|Post-treatment Follow up Epoch|Death|1|||
148819026|NCT02573467|536814583|FG002|Post-treatment Follow up Epoch|Death|0|||
148743001|NCT05320887|536530418|FG000|Overall Study|Lost to Follow-up|0|||
148743002|NCT05320887|536530419|FG001|Overall Study|Lost to Follow-up|3|||
148743003|NCT05320887|536530420|FG002|Overall Study|Lost to Follow-up|0|||
148743004|NCT05320887|536530421|FG003|Overall Study|Lost to Follow-up|0|||
148743005|NCT03485365|536530425|FG000|Overall Study|Protocol Violation|0|||
148743006|NCT03485365|536530426|FG001|Overall Study|Protocol Violation|0|||
148743007|NCT03485365|536530427|FG002|Overall Study|Protocol Violation|0|||
148743008|NCT03485365|536530428|FG003|Overall Study|Protocol Violation|1|||
148743009|NCT03485365|536530429|FG004|Overall Study|Protocol Violation|0|||
148743010|NCT03485365|536530430|FG005|Overall Study|Protocol Violation|0|||
148743011|NCT03485365|536530431|FG006|Overall Study|Protocol Violation|1|||
148743012|NCT03485365|536530432|FG007|Overall Study|Protocol Violation|0|||
148743013|NCT03485365|536530433|FG008|Overall Study|Protocol Violation|0|||
148743014|NCT00205803|536530434|FG000|Infant Series|Lost to Follow-up|10|||
148743015|NCT00205803|536530435|FG001|Infant Series|Lost to Follow-up|4|||
148743016|NCT00205803|536530434|FG000|Infant Series|Withdrawal by Subject|2|||
148743017|NCT00205803|536530435|FG001|Infant Series|Withdrawal by Subject|5|||
148743018|NCT00205803|536530434|FG000|Infant Series|Physician Decision|3|||
148743019|NCT00205803|536530435|FG001|Infant Series|Physician Decision|1|||
148743020|NCT00205803|536530434|FG000|Infant Series|Protocol Violation|1|||
148743021|NCT00205803|536530435|FG001|Infant Series|Protocol Violation|0|||
148743022|NCT00205803|536530434|FG000|Infant Series|Lost Kaiser coverage|0|||
148743023|NCT00205803|536530435|FG001|Infant Series|Lost Kaiser coverage|1|||
148743024|NCT00205803|536530434|FG000|Infant Series|Non-compliant|1|||
148743025|NCT00205803|536530435|FG001|Infant Series|Non-compliant|0|||
148743026|NCT00205803|536530434|FG000|Infant Series|Sponsor request|1|||
148743027|NCT00205803|536530435|FG001|Infant Series|Sponsor request|0|||
148743028|NCT00205803|536530434|FG000|After Infant Series|Adverse Event|1|||
148743029|NCT00205803|536530435|FG001|After Infant Series|Adverse Event|1|||
148743030|NCT00205803|536530434|FG000|After Infant Series|Protocol Violation|1|||
148743031|NCT00205803|536530435|FG001|After Infant Series|Protocol Violation|1|||
148743032|NCT00205803|536530434|FG000|After Infant Series|Lost to Follow-up|2|||
148743033|NCT00205803|536530435|FG001|After Infant Series|Lost to Follow-up|1|||
148743034|NCT00205803|536530434|FG000|After Infant Series|Physician Decision|3|||
148743035|NCT00205803|536530435|FG001|After Infant Series|Physician Decision|2|||
148743036|NCT00205803|536530434|FG000|After Infant Series|Withdrawal by Subject|1|||
148743037|NCT00205803|536530435|FG001|After Infant Series|Withdrawal by Subject|4|||
148743038|NCT00205803|536530434|FG000|After Infant Series|Other|10|||
148743039|NCT00205803|536530435|FG001|After Infant Series|Other|4|||
148743040|NCT00205803|536530434|FG000|Toddler Dose|Lost to Follow-up|2|||
148743041|NCT00205803|536530435|FG001|Toddler Dose|Lost to Follow-up|3|||
148743042|NCT03185013|536530436|FG000|Overall Study|Withdrawal by Subject|5|||
148743043|NCT03185013|536530437|FG001|Overall Study|Withdrawal by Subject|3|||
148743044|NCT03185013|536530436|FG000|Overall Study|Adverse Event|1|||
148743045|NCT03185013|536530437|FG001|Overall Study|Adverse Event|0|||
148743046|NCT03185013|536530436|FG000|Overall Study|Progressive Disease|1|||
148743047|NCT03185013|536530437|FG001|Overall Study|Progressive Disease|0|||
148743048|NCT03185013|536530436|FG000|Overall Study|Lost to Follow-up|8|||
148743049|NCT03185013|536530437|FG001|Overall Study|Lost to Follow-up|2|||
148743050|NCT03185013|536530436|FG000|Overall Study|Physician Decision|1|||
148743051|NCT03185013|536530437|FG001|Overall Study|Physician Decision|0|||
148743052|NCT03185013|536530436|FG000|Overall Study|Protocol Deviation|2|||
148743053|NCT03185013|536530437|FG001|Overall Study|Protocol Deviation|0|||
148743054|NCT03185013|536530436|FG000|Overall Study|Reason not Specified|3|||
148743055|NCT03185013|536530437|FG001|Overall Study|Reason not Specified|2|||
148743056|NCT03185013|536530436|FG000|Overall Study|Death|1|||
148743057|NCT03185013|536530437|FG001|Overall Study|Death|0|||
148743058|NCT01104792|536530443|FG000|Overall Study|Adverse Event|77|||
148743059|NCT01104792|536530443|FG000|Overall Study|Insufficient Therapeutic Response|22|||
148743060|NCT01104792|536530443|FG000|Overall Study|Protocol Violation|45|||
148743061|NCT01104792|536530443|FG000|Overall Study|Withdrawal of Consent|179|||
148743062|NCT01104792|536530443|FG000|Overall Study|Lost to Follow-up|43|||
148743063|NCT01104792|536530443|FG000|Overall Study|Reasons Not Specified|27|||
148743064|NCT01104792|536530443|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
148743065|NCT01102374|536530444|FG000|Overall Study|Death|9|||
148743066|NCT01102374|536530445|FG001|Overall Study|Death|13|||
148743067|NCT01102374|536530444|FG000|Overall Study|Lost to Follow-up|7|||
148743068|NCT01102374|536530445|FG001|Overall Study|Lost to Follow-up|6|||
148743069|NCT03255655|536530446|FG000|Overall Study|Lost to Follow-up|7|||
148743070|NCT03255655|536530447|FG001|Overall Study|Lost to Follow-up|4|||
148743071|NCT02056392|536530449|FG000|Overall Study|Lost to Follow-up|0|||
148743072|NCT02056392|536530450|FG001|Overall Study|Lost to Follow-up|1|||
148743073|NCT02056392|536530451|FG002|Overall Study|Lost to Follow-up|2|||
148743074|NCT02056392|536530452|FG003|Overall Study|Lost to Follow-up|0|||
148743075|NCT02056392|536530453|FG004|Overall Study|Lost to Follow-up|0|||
148743076|NCT02056392|536530454|FG005|Overall Study|Lost to Follow-up|0|||
148743077|NCT02056392|536530449|FG000|Overall Study|Protocol Violation|1|||
148743078|NCT02056392|536530450|FG001|Overall Study|Protocol Violation|0|||
148743079|NCT02056392|536530451|FG002|Overall Study|Protocol Violation|1|||
148743080|NCT02056392|536530452|FG003|Overall Study|Protocol Violation|0|||
148819027|NCT02573467|536814584|FG003|Post-treatment Follow up Epoch|Death|1|||
148819028|NCT02573467|536814581|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
148819029|NCT02573467|536814582|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
148819030|NCT02573467|536814583|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
148819031|NCT02573467|536814584|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
148743081|NCT02056392|536530453|FG004|Overall Study|Protocol Violation|0|||
148743082|NCT02056392|536530454|FG005|Overall Study|Protocol Violation|0|||
148743083|NCT02056392|536530449|FG000|Overall Study|Withdrawal by Subject|1|||
148743084|NCT02056392|536530450|FG001|Overall Study|Withdrawal by Subject|0|||
148743085|NCT02056392|536530451|FG002|Overall Study|Withdrawal by Subject|0|||
148743086|NCT02056392|536530452|FG003|Overall Study|Withdrawal by Subject|0|||
148743087|NCT02056392|536530453|FG004|Overall Study|Withdrawal by Subject|1|||
148743088|NCT02056392|536530454|FG005|Overall Study|Withdrawal by Subject|0|||
148743089|NCT02203331|536530463|FG000|Overall Study|Pregnancy|1|||
148743090|NCT02203331|536530464|FG001|Overall Study|Pregnancy|0|||
148743091|NCT02203331|536530465|FG002|Overall Study|Pregnancy|0|||
148743092|NCT02203331|536530466|FG003|Overall Study|Pregnancy|0|||
148743093|NCT02203331|536530467|FG004|Overall Study|Pregnancy|2|||
148743094|NCT02203331|536530468|FG005|Overall Study|Pregnancy|0|||
148743095|NCT02203331|536530463|FG000|Overall Study|Withdrawal by Subject|1|||
148743096|NCT02203331|536530464|FG001|Overall Study|Withdrawal by Subject|0|||
148743097|NCT02203331|536530465|FG002|Overall Study|Withdrawal by Subject|1|||
148743098|NCT02203331|536530466|FG003|Overall Study|Withdrawal by Subject|0|||
148743099|NCT02203331|536530467|FG004|Overall Study|Withdrawal by Subject|0|||
148743100|NCT02203331|536530468|FG005|Overall Study|Withdrawal by Subject|3|||
148743101|NCT02203331|536530463|FG000|Overall Study|Adverse Event|4|||
148743102|NCT02203331|536530464|FG001|Overall Study|Adverse Event|8|||
148743103|NCT02203331|536530465|FG002|Overall Study|Adverse Event|3|||
148743104|NCT02203331|536530466|FG003|Overall Study|Adverse Event|4|||
148743105|NCT02203331|536530467|FG004|Overall Study|Adverse Event|3|||
148743106|NCT02203331|536530468|FG005|Overall Study|Adverse Event|3|||
148743107|NCT02203331|536530463|FG000|Overall Study|Other Reasons|1|||
148743108|NCT02203331|536530464|FG001|Overall Study|Other Reasons|2|||
148743109|NCT02203331|536530465|FG002|Overall Study|Other Reasons|0|||
148743110|NCT02203331|536530466|FG003|Overall Study|Other Reasons|2|||
148743111|NCT02203331|536530467|FG004|Overall Study|Other Reasons|0|||
148743112|NCT02203331|536530468|FG005|Overall Study|Other Reasons|0|||
148743113|NCT02203331|536530463|FG000|Overall Study|Lack of Efficacy|0|||
148743114|NCT02203331|536530464|FG001|Overall Study|Lack of Efficacy|2|||
148743115|NCT02203331|536530465|FG002|Overall Study|Lack of Efficacy|1|||
148743116|NCT02203331|536530466|FG003|Overall Study|Lack of Efficacy|0|||
148743117|NCT02203331|536530467|FG004|Overall Study|Lack of Efficacy|0|||
148743118|NCT02203331|536530468|FG005|Overall Study|Lack of Efficacy|1|||
148743119|NCT02203331|536530463|FG000|Overall Study|Protocol Violation|0|||
148743120|NCT02203331|536530464|FG001|Overall Study|Protocol Violation|2|||
148743121|NCT02203331|536530465|FG002|Overall Study|Protocol Violation|0|||
148743122|NCT02203331|536530466|FG003|Overall Study|Protocol Violation|1|||
148743123|NCT02203331|536530467|FG004|Overall Study|Protocol Violation|1|||
148743124|NCT02203331|536530468|FG005|Overall Study|Protocol Violation|0|||
148743125|NCT02203331|536530463|FG000|Overall Study|Lost to Follow-up|0|||
148743126|NCT02203331|536530464|FG001|Overall Study|Lost to Follow-up|0|||
148743127|NCT02203331|536530465|FG002|Overall Study|Lost to Follow-up|0|||
148743128|NCT02203331|536530466|FG003|Overall Study|Lost to Follow-up|0|||
148743129|NCT02203331|536530467|FG004|Overall Study|Lost to Follow-up|1|||
148743130|NCT02203331|536530468|FG005|Overall Study|Lost to Follow-up|0|||
148743131|NCT02682927|536530471|FG000|Overall Study|Adverse Event|0|||
148743132|NCT02682927|536530472|FG001|Overall Study|Adverse Event|0|||
148743133|NCT02682927|536530473|FG002|Overall Study|Adverse Event|5|||
148819032|NCT02573467|536814581|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
148819033|NCT02573467|536814582|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
148819034|NCT02573467|536814583|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
148819035|NCT02573467|536814584|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
148975959|NCT02152995|537392382|FG000|Overall Study|Withdrawal by Subject|1|||
148975960|NCT02152995|537392383|FG001|Overall Study|Withdrawal by Subject|0|||
148975961|NCT02098109|537392384|FG000|Overall Study|Protocol Violation|3|||
148975962|NCT02098109|537392385|FG001|Overall Study|Protocol Violation|0|||
148743134|NCT02682927|536530474|FG003|Overall Study|Adverse Event|1|||
148743135|NCT02682927|536530475|FG004|Overall Study|Adverse Event|0|||
148743136|NCT02682927|536530476|FG005|Overall Study|Adverse Event|2|||
148743137|NCT02682927|536530471|FG000|Overall Study|Death|0|||
148743138|NCT02682927|536530472|FG001|Overall Study|Death|0|||
148743139|NCT02682927|536530473|FG002|Overall Study|Death|0|||
148743140|NCT02682927|536530474|FG003|Overall Study|Death|1|||
148743141|NCT02682927|536530475|FG004|Overall Study|Death|0|||
148743142|NCT02682927|536530476|FG005|Overall Study|Death|0|||
148743143|NCT02682927|536530471|FG000|Overall Study|Lack of Efficacy|1|||
148819036|NCT02056288|536814595|FG000|In-Hospital Data|Surgery cancelled|1|||
148743144|NCT02682927|536530472|FG001|Overall Study|Lack of Efficacy|0|||
148743145|NCT02682927|536530473|FG002|Overall Study|Lack of Efficacy|0|||
148819037|NCT02056288|536814596|FG001|In-Hospital Data|Surgery cancelled|0|||
148819038|NCT02056288|536814595|FG000|In-Hospital Data|Protocol Violation|3|||
148819039|NCT02056288|536814596|FG001|In-Hospital Data|Protocol Violation|0|||
148819040|NCT02056288|536814595|FG000|In-Hospital Data|Physician Decision|1|||
148819041|NCT02056288|536814596|FG001|In-Hospital Data|Physician Decision|0|||
148819042|NCT02056288|536814595|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
148743146|NCT02682927|536530474|FG003|Overall Study|Lack of Efficacy|1|||
148743147|NCT02682927|536530475|FG004|Overall Study|Lack of Efficacy|0|||
148743148|NCT02682927|536530476|FG005|Overall Study|Lack of Efficacy|0|||
148743149|NCT02682927|536530471|FG000|Overall Study|Other|0|||
148743150|NCT02682927|536530472|FG001|Overall Study|Other|0|||
148743151|NCT02682927|536530473|FG002|Overall Study|Other|0|||
148743152|NCT02682927|536530474|FG003|Overall Study|Other|2|||
148743153|NCT02682927|536530475|FG004|Overall Study|Other|0|||
148743154|NCT02682927|536530476|FG005|Overall Study|Other|0|||
148743155|NCT02682927|536530471|FG000|Overall Study|Withdrawal by Subject|2|||
148743156|NCT02682927|536530472|FG001|Overall Study|Withdrawal by Subject|0|||
148743157|NCT02682927|536530473|FG002|Overall Study|Withdrawal by Subject|1|||
148743158|NCT02682927|536530474|FG003|Overall Study|Withdrawal by Subject|0|||
148743159|NCT02682927|536530475|FG004|Overall Study|Withdrawal by Subject|1|||
148743160|NCT02682927|536530476|FG005|Overall Study|Withdrawal by Subject|1|||
148743161|NCT03462459|536530480|FG000|Overall Study|Death|1|||
148743162|NCT03462459|536530481|FG001|Overall Study|Death|0|||
148743163|NCT03462459|536530480|FG000|Overall Study|Lack of Efficacy|2|||
148743164|NCT03462459|536530481|FG001|Overall Study|Lack of Efficacy|4|||
148743165|NCT03462459|536530480|FG000|Overall Study|Lost to Follow-up|1|||
148743166|NCT03462459|536530481|FG001|Overall Study|Lost to Follow-up|3|||
148743167|NCT03462459|536530480|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
148743168|NCT03462459|536530481|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
148743169|NCT03462459|536530480|FG000|Overall Study|Withdrawal by Subject|3|||
148743170|NCT03462459|536530481|FG001|Overall Study|Withdrawal by Subject|2|||
148743171|NCT03462459|536530480|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
148743172|NCT03462459|536530481|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
148743173|NCT02551666|536530483|FG000|Overall Study|Withdrawal by Subject|1|||
148743174|NCT02551666|536530484|FG001|Overall Study|Withdrawal by Subject|3|||
148743175|NCT01177059|536530485|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
148743176|NCT01177059|536530485|FG000|Overall Study|Withdrew consent|2|||
148743177|NCT01177059|536530485|FG000|Overall Study|Lost to Follow-up|18|||
148743178|NCT04324073|536531844|FG000|Overall Study|withdrew consent|0|||
148819043|NCT02056288|536814596|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
148819044|NCT01441414|536814597|FG000|Overall Study|Participant died|9|||
148819045|NCT01441414|536814597|FG000|Overall Study|Other reasons|3|||
148819046|NCT01441414|536814597|FG000|Overall Study|Study terminated by sponsor|2|||
148819047|NCT01441414|536814597|FG000|Overall Study|Subject refused further follow-up|1|||
148819048|NCT01773889|536814598|FG000|Overall Study|lack of funding|2|||
148819049|NCT04233580|536814599|FG000|Overall Study|Adverse Event|3|||
148819050|NCT04233580|536814600|FG001|Overall Study|Adverse Event|3|||
148819051|NCT04233580|536814599|FG000|Overall Study|Withdrawal by Subject|2|||
148819052|NCT04233580|536814600|FG001|Overall Study|Withdrawal by Subject|1|||
148819053|NCT03123588|536814601|FG000|Overall Study|Study Terminated by Sponsor|2|||
148819054|NCT03123588|536814602|FG001|Overall Study|Study Terminated by Sponsor|5|||
148819055|NCT03123588|536814601|FG000|Overall Study|Withdrawal by Subject|1|||
148819056|NCT03123588|536814602|FG001|Overall Study|Withdrawal by Subject|0|||
148819057|NCT03123588|536814601|FG000|Overall Study|Adverse Event|1|||
148819058|NCT03123588|536814602|FG001|Overall Study|Adverse Event|0|||
148819059|NCT03123588|536814601|FG000|Overall Study|Physician Decision|2|||
148819060|NCT03123588|536814602|FG001|Overall Study|Physician Decision|1|||
148819061|NCT01623752|536814604|FG000|Phase 1 (78 Weeks)|No Data|249|||
148819062|NCT01623752|536814605|FG001|Phase 1 (78 Weeks)|No Data|66|||
148819063|NCT01623752|536814606|FG002|Phase 1 (78 Weeks)|No Data|2|||
148819064|NCT01623752|536814604|FG000|Phase 1 (78 Weeks)|Other|33|||
148819065|NCT01623752|536814605|FG001|Phase 1 (78 Weeks)|Other|20|||
148819066|NCT01623752|536814606|FG002|Phase 1 (78 Weeks)|Other|0|||
148819067|NCT01623752|536814604|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
148819068|NCT01623752|536814605|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
148743179|NCT04324073|536531845|FG001|Overall Study|withdrew consent|4|||
148743180|NCT04324073|536531846|FG002|Overall Study|withdrew consent|2|||
148743181|NCT04324073|536531847|FG003|Overall Study|withdrew consent|8|||
148743182|NCT00369486|536531849|FG000|4-Week Visit|Missed visit|2|||
148743183|NCT00369486|536531850|FG001|4-Week Visit|Missed visit|2|||
148743184|NCT00369486|536531851|FG002|4-Week Visit|Missed visit|0|||
148743185|NCT00369486|536531852|FG003|4-Week Visit|Missed visit|2|||
148743186|NCT00369486|536531853|FG004|4-Week Visit|Missed visit|1|||
148819069|NCT01623752|536814606|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
148819070|NCT01623752|536814604|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
148819071|NCT01623752|536814605|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
148819072|NCT01623752|536814606|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
148819073|NCT01623752|536814604|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
148819074|NCT01623752|536814605|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
148819075|NCT01623752|536814606|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
148819076|NCT01623752|536814604|FG000|Phase 2 (78 Weeks)|Other|5|||
148819077|NCT01623752|536814605|FG001|Phase 2 (78 Weeks)|Other|1|||
148819078|NCT01623752|536814606|FG002|Phase 2 (78 Weeks)|Other|0|||
148819079|NCT01623752|536814604|FG000|Phase 2 (78 Weeks)|No Data|43|||
148819080|NCT01623752|536814605|FG001|Phase 2 (78 Weeks)|No Data|11|||
148819081|NCT01623752|536814606|FG002|Phase 2 (78 Weeks)|No Data|0|||
148819082|NCT01623752|536814604|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
148819083|NCT01623752|536814605|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
148819084|NCT01623752|536814606|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
148819085|NCT01814332|536814608|FG000|Overall Study|Adverse Event|8|||
148819086|NCT01814332|536814609|FG001|Overall Study|Adverse Event|3|||
148819087|NCT01814332|536814608|FG000|Overall Study|Withdrawal by Subject|3|||
148819088|NCT01814332|536814609|FG001|Overall Study|Withdrawal by Subject|8|||
148819089|NCT01814332|536814608|FG000|Overall Study|Protocol Violation|0|||
148819090|NCT01814332|536814609|FG001|Overall Study|Protocol Violation|4|||
148819091|NCT01814332|536814608|FG000|Overall Study|Lost to Follow-up|5|||
148819092|NCT01814332|536814609|FG001|Overall Study|Lost to Follow-up|1|||
148819093|NCT04996264|536814610|FG000|Overall Study|Lost to Follow-up|0|||
148819094|NCT04996264|536814611|FG001|Overall Study|Lost to Follow-up|1|||
148819095|NCT04996264|536814610|FG000|Overall Study|Withdrawal by Subject|4|||
148819096|NCT04996264|536814611|FG001|Overall Study|Withdrawal by Subject|3|||
148819097|NCT04996264|536814610|FG000|Overall Study|1 left AMA|0|||
148819098|NCT04996264|536814611|FG001|Overall Study|1 left AMA|1|||
148819099|NCT04996264|536814610|FG000|Overall Study|Subject changed hospitals|0|||
148819100|NCT04996264|536814611|FG001|Overall Study|Subject changed hospitals|1|||
148819101|NCT04996264|536814610|FG000|Overall Study|unable to complete due to work|0|||
148819102|NCT04996264|536814611|FG001|Overall Study|unable to complete due to work|1|||
148819103|NCT04433975|536814612|FG000|1-month Follow Up|Withdrawal by Subject|1|||
148819104|NCT04433975|536814613|FG001|1-month Follow Up|Withdrawal by Subject|1|||
148819105|NCT04433975|536814612|FG000|1-month Follow Up|Lost to Follow-up|21|||
148819106|NCT04433975|536814613|FG001|1-month Follow Up|Lost to Follow-up|25|||
148819107|NCT04433975|536814612|FG000|3-month Follow Up|Lost to Follow-up|20|||
148819108|NCT04433975|536814613|FG001|3-month Follow Up|Lost to Follow-up|24|||
148819109|NCT04433975|536814612|FG000|3-month Follow Up|Death|1|||
148819110|NCT04433975|536814613|FG001|3-month Follow Up|Death|0|||
148819111|NCT04433975|536814612|FG000|3-month Follow Up|Withdrawal by Subject|2|||
148819112|NCT04433975|536814613|FG001|3-month Follow Up|Withdrawal by Subject|0|||
148819113|NCT04433975|536814612|FG000|6-month Follow Up|Lost to Follow-up|23|||
148819114|NCT04433975|536814613|FG001|6-month Follow Up|Lost to Follow-up|28|||
148819115|NCT04433975|536814612|FG000|6-month Follow Up|Withdrawal by Subject|1|||
148819116|NCT04433975|536814613|FG001|6-month Follow Up|Withdrawal by Subject|1|||
148743187|NCT00369486|536531849|FG000|4-Week Visit|Dropped|0|||
148743188|NCT00369486|536531850|FG001|4-Week Visit|Dropped|0|||
148743189|NCT00369486|536531851|FG002|4-Week Visit|Dropped|1|||
148743190|NCT00369486|536531852|FG003|4-Week Visit|Dropped|0|||
148743191|NCT00369486|536531853|FG004|4-Week Visit|Dropped|0|||
148743192|NCT00369486|536531849|FG000|8-Week Visit|Missed visit|0|||
148743193|NCT00369486|536531850|FG001|8-Week Visit|Missed visit|1|||
148743194|NCT00369486|536531851|FG002|8-Week Visit|Missed visit|0|||
148743195|NCT00369486|536531852|FG003|8-Week Visit|Missed visit|0|||
148743196|NCT00369486|536531853|FG004|8-Week Visit|Missed visit|1|||
148743197|NCT00369486|536531849|FG000|8-Week Visit|Dropped|0|||
148743198|NCT00369486|536531850|FG001|8-Week Visit|Dropped|0|||
148743199|NCT00369486|536531851|FG002|8-Week Visit|Dropped|0|||
148743200|NCT00369486|536531852|FG003|8-Week Visit|Dropped|1|||
148743201|NCT00369486|536531853|FG004|8-Week Visit|Dropped|0|||
148743202|NCT00369486|536531849|FG000|17-Week Visit|Missed visit|0|||
148743203|NCT00369486|536531850|FG001|17-Week Visit|Missed visit|0|||
148819117|NCT04433975|536814612|FG000|9-month Follow Up|Lost to Follow-up|27|||
148819118|NCT04433975|536814613|FG001|9-month Follow Up|Lost to Follow-up|36|||
148819119|NCT04433975|536814612|FG000|9-month Follow Up|Death|0|||
148819120|NCT04433975|536814613|FG001|9-month Follow Up|Death|1|||
148819121|NCT04433975|536814612|FG000|12-month Follow Up|Lost to Follow-up|27|||
148819122|NCT04433975|536814613|FG001|12-month Follow Up|Lost to Follow-up|31|||
148819123|NCT04392635|536814616|FG000|Overall Study|Lost to Follow-up|0|||
148819124|NCT04392635|536814617|FG001|Overall Study|Lost to Follow-up|1|||
148819125|NCT02697422|536814618|FG000|Overall Study|Declined exit survey|9|||
148975963|NCT01565291|537392386|FG000|Overall Study|Withdrawal by Subject|1|||
148743204|NCT00369486|536531851|FG002|17-Week Visit|Missed visit|1|||
148743205|NCT00369486|536531852|FG003|17-Week Visit|Missed visit|1|||
148743206|NCT00369486|536531853|FG004|17-Week Visit|Missed visit|1|||
148743207|NCT00369486|536531849|FG000|34-Week Visit|Dropped|0|||
148743208|NCT00369486|536531850|FG001|34-Week Visit|Dropped|1|||
148743209|NCT00369486|536531851|FG002|34-Week Visit|Dropped|1|||
148819126|NCT02697422|536814619|FG001|Overall Study|Declined exit survey|2|||
148819127|NCT02697422|536814618|FG000|Overall Study|Lost to Follow-up|13|||
148819128|NCT02697422|536814619|FG001|Overall Study|Lost to Follow-up|8|||
148819129|NCT02697422|536814618|FG000|Overall Study|Death|2|||
148975964|NCT01565291|537392387|FG001|Overall Study|Withdrawal by Subject|0|||
148743210|NCT00369486|536531852|FG003|34-Week Visit|Dropped|3|||
148743211|NCT00369486|536531853|FG004|34-Week Visit|Dropped|3|||
148743212|NCT01659125|536531854|FG000|Overall Study|Withdrawal by Subject|2|||
148743213|NCT01659125|536531854|FG000|Overall Study|Lost to Follow-up|7|||
148743214|NCT01659125|536531854|FG000|Overall Study|Technical Problem|1|||
148743215|NCT01659125|536531854|FG000|Overall Study|Time Constraints|2|||
148743216|NCT01659125|536531854|FG000|Overall Study|Failed to Start Treatment|2|||
148743217|NCT01207583|536531856|FG000|Overall Study|Withdrawal by Subject|0|||
148743218|NCT01207583|536531857|FG001|Overall Study|Withdrawal by Subject|3|||
148743219|NCT01207583|536531858|FG002|Overall Study|Withdrawal by Subject|1|||
148743220|NCT01207583|536531856|FG000|Overall Study|Participant failed to return|1|||
148743221|NCT01207583|536531857|FG001|Overall Study|Participant failed to return|0|||
148743222|NCT01207583|536531858|FG002|Overall Study|Participant failed to return|0|||
148743223|NCT01207583|536531856|FG000|Overall Study|Lost to Follow-up|0|||
148743224|NCT01207583|536531857|FG001|Overall Study|Lost to Follow-up|2|||
148743225|NCT01207583|536531858|FG002|Overall Study|Lost to Follow-up|0|||
148743226|NCT02540850|536531859|FG000|Overall Study|Lost to Follow-up|69|||
148743227|NCT02540850|536531860|FG001|Overall Study|Lost to Follow-up|66|||
148743228|NCT02540850|536531861|FG002|Overall Study|Lost to Follow-up|34|||
148743229|NCT02242045|536531862|FG000|Overall Study|Investigator's Discretion|1|||
148743230|NCT02242045|536531862|FG000|Overall Study|Progressive Disease|2|||
148743231|NCT02242045|536531862|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
148743232|NCT02242045|536531862|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
148743233|NCT00576316|536531865|FG000|Overall Study|Adverse Event|9|||
148743234|NCT00576316|536531865|FG000|Overall Study|Withdrawal by Subject|2|||
148743235|NCT00576316|536531865|FG000|Overall Study|Protocol Violation|9|||
148743236|NCT02794246|536531868|FG000|Overall Study|Withdrawal by Subject|2|||
148743237|NCT02794246|536531868|FG000|Overall Study|Physician Decision|4|||
148743238|NCT02648932|536531872|FG000|Overall Study|No transplant|3|||
148743239|NCT02648932|536531873|FG001|Overall Study|No transplant|1|||
148743240|NCT02368314|536531874|FG000|Overall Study|Withdrawal by Subject|2|||
148743241|NCT02368314|536531875|FG001|Overall Study|Withdrawal by Subject|1|||
148743242|NCT02368314|536531874|FG000|Overall Study|Adverse Event|1|||
148743243|NCT02368314|536531875|FG001|Overall Study|Adverse Event|2|||
148743244|NCT03106987|536531876|FG000|Overall Study|Death|37|||
148743245|NCT03106987|536531877|FG001|Overall Study|Death|22|||
148743246|NCT03106987|536531878|FG002|Overall Study|Death|12|||
148743247|NCT03106987|536531879|FG003|Overall Study|Death|8|||
148743248|NCT03106987|536531876|FG000|Overall Study|Lost to Follow-up|2|||
148743249|NCT03106987|536531877|FG001|Overall Study|Lost to Follow-up|0|||
148743250|NCT03106987|536531878|FG002|Overall Study|Lost to Follow-up|2|||
148743251|NCT03106987|536531879|FG003|Overall Study|Lost to Follow-up|2|||
148743252|NCT03106987|536531876|FG000|Overall Study|Withdrawal by Subject|5|||
148743253|NCT03106987|536531877|FG001|Overall Study|Withdrawal by Subject|1|||
148743254|NCT03106987|536531878|FG002|Overall Study|Withdrawal by Subject|4|||
148743255|NCT03106987|536531879|FG003|Overall Study|Withdrawal by Subject|1|||
148743256|NCT03336528|536531880|FG000|Overall Study|Protocol Violation|1|||
148743257|NCT03336528|536531881|FG001|Overall Study|Protocol Violation|1|||
148743258|NCT03336528|536531880|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
148743259|NCT03336528|536531881|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
148743260|NCT03336528|536531880|FG000|Overall Study|Did not receive study medication|1|||
148743261|NCT03336528|536531881|FG001|Overall Study|Did not receive study medication|2|||
148743262|NCT00005957|536531884|FG000|Overall Study|No treated|3|||
148743263|NCT00005957|536531885|FG001|Overall Study|No treated|9|||
148743264|NCT00005957|536531884|FG000|Overall Study|Crossover to the other arm|5|||
148743265|NCT00005957|536531885|FG001|Overall Study|Crossover to the other arm|19|||
148743266|NCT02047734|536531886|FG000|Overall Study|Adverse Event|18|||
148743267|NCT02047734|536531887|FG001|Overall Study|Adverse Event|13|||
148743268|NCT02047734|536531888|FG002|Overall Study|Adverse Event|13|||
148743269|NCT02047734|536531886|FG000|Overall Study|Lack of Efficacy|4|||
148743270|NCT02047734|536531887|FG001|Overall Study|Lack of Efficacy|5|||
148743271|NCT02047734|536531888|FG002|Overall Study|Lack of Efficacy|1|||
148743272|NCT02047734|536531886|FG000|Overall Study|Protocol Violation|3|||
148743273|NCT02047734|536531887|FG001|Overall Study|Protocol Violation|1|||
148743274|NCT02047734|536531888|FG002|Overall Study|Protocol Violation|1|||
148743275|NCT02047734|536531886|FG000|Overall Study|Lost to Follow-up|1|||
148743276|NCT02047734|536531887|FG001|Overall Study|Lost to Follow-up|4|||
148743277|NCT02047734|536531888|FG002|Overall Study|Lost to Follow-up|0|||
148743278|NCT02047734|536531886|FG000|Overall Study|Death|0|||
148743279|NCT02047734|536531887|FG001|Overall Study|Death|1|||
148743280|NCT02047734|536531888|FG002|Overall Study|Death|0|||
148743281|NCT02047734|536531886|FG000|Overall Study|Withdrawal by Subject|30|||
148743282|NCT02047734|536531887|FG001|Overall Study|Withdrawal by Subject|31|||
148743283|NCT02047734|536531888|FG002|Overall Study|Withdrawal by Subject|19|||
148743284|NCT02047734|536531886|FG000|Overall Study|Physician Decision|7|||
148743285|NCT02047734|536531887|FG001|Overall Study|Physician Decision|6|||
148743286|NCT02047734|536531888|FG002|Overall Study|Physician Decision|5|||
148743287|NCT02047734|536531886|FG000|Overall Study|Miscellaneous|2|||
148743288|NCT02047734|536531887|FG001|Overall Study|Miscellaneous|4|||
148743289|NCT02047734|536531888|FG002|Overall Study|Miscellaneous|6|||
148743290|NCT02047734|536531886|FG000|Overall Study|Did Not Receive Study Drug|2|||
148743291|NCT02047734|536531887|FG001|Overall Study|Did Not Receive Study Drug|4|||
148743292|NCT02047734|536531888|FG002|Overall Study|Did Not Receive Study Drug|1|||
148743293|NCT00582010|536531891|FG000|Overall Study|Death|0|||
148743294|NCT00582010|536531892|FG001|Overall Study|Death|1|||
148743295|NCT00958893|536531893|FG000|Overall Study|Study prematurely terminated|4|||
148743296|NCT01994850|536531895|FG000|Overall Study|Physician Decision|1|||
148743297|NCT01994850|536531895|FG000|Overall Study|Withdrawal by Subject|1|||
148743298|NCT00182325|536531900|FG000|Overall Study|Lost to Follow-up|7|||
148743299|NCT00182325|536531901|FG001|Overall Study|Lost to Follow-up|7|||
148743300|NCT00182325|536531900|FG000|Overall Study|Miscarriage|5|||
148743301|NCT00182325|536531901|FG001|Overall Study|Miscarriage|3|||
148743302|NCT00182325|536531900|FG000|Overall Study|Did not complete survey|22|||
148743303|NCT00182325|536531901|FG001|Overall Study|Did not complete survey|43|||
148743304|NCT01420965|536531905|FG000|Overall Study|Withdrawal by Subject|1|||
148743305|NCT01420965|536531906|FG001|Overall Study|Withdrawal by Subject|0|||
148743306|NCT01420965|536531907|FG002|Overall Study|Withdrawal by Subject|0|||
148743307|NCT01420965|536531905|FG000|Overall Study|Adverse Event|0|||
148743308|NCT01420965|536531906|FG001|Overall Study|Adverse Event|1|||
148743309|NCT01420965|536531907|FG002|Overall Study|Adverse Event|0|||
148743310|NCT01890434|536531908|FG000|Overall Study|Adverse Event|8|||
148743311|NCT01890434|536531908|FG000|Overall Study|PCI at external hospital|1|||
148743312|NCT01890434|536531908|FG000|Overall Study|Assessment discrepancy|1|||
148743313|NCT01890434|536531908|FG000|Overall Study|CRC didn't contact participant for FU|1|||
148743314|NCT01890434|536531908|FG000|Overall Study|Could not get whole set of images|1|||
148743315|NCT01890434|536531908|FG000|Overall Study|Decline to return for GSPECT|1|||
148743316|NCT01890434|536531908|FG000|Overall Study|GSPECT at rest was not done|1|||
148743317|NCT01890434|536531908|FG000|Overall Study|Participant didn't complete MRI|1|||
148743318|NCT01890434|536531908|FG000|Overall Study|Uncontactable by phone|1|||
148743319|NCT01890434|536531908|FG000|Overall Study|Moved out of position|1|||
148743320|NCT01890434|536531908|FG000|Overall Study|Unable to contact|1|||
148743321|NCT01890434|536531908|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
148743322|NCT01267994|536531910|FG000|Overall Study|Adverse Event|2|||
148743323|NCT05199090|536531913|FG000|Overall Study|Adverse Event|1|||
148743324|NCT05199090|536531914|FG001|Overall Study|Adverse Event|4|||
148743325|NCT05199090|536531915|FG002|Overall Study|Adverse Event|0|||
148743326|NCT05199090|536531916|FG003|Overall Study|Adverse Event|0|||
148743327|NCT05199090|536531917|FG004|Overall Study|Adverse Event|0|||
148743328|NCT05199090|536531918|FG005|Overall Study|Adverse Event|0|||
148743329|NCT05199090|536531913|FG000|Overall Study|Lost to Follow-up|1|||
148743330|NCT05199090|536531914|FG001|Overall Study|Lost to Follow-up|0|||
148819130|NCT02697422|536814619|FG001|Overall Study|Death|1|||
148819131|NCT02697422|536814618|FG000|Overall Study|Withdrawal by Subject|0|||
148819132|NCT02697422|536814619|FG001|Overall Study|Withdrawal by Subject|1|||
148819133|NCT02697422|536814618|FG000|Overall Study|Physician Decision|1|||
148819134|NCT02697422|536814619|FG001|Overall Study|Physician Decision|1|||
148819135|NCT02697422|536814618|FG000|Overall Study|Exit survey data lost|1|||
148819136|NCT02697422|536814619|FG001|Overall Study|Exit survey data lost|0|||
148819137|NCT03983109|536814621|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
148819138|NCT03983109|536814622|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
148819139|NCT02939781|536814623|FG000|Overall Study|Protocol Violation|8|||
148819140|NCT02939781|536814623|FG000|Overall Study|Withdrawal by Subject|1|||
148819141|NCT01740427|536814626|FG000|Overall Study|Objective Progression or Relapse|286|||
148819142|NCT01740427|536814627|FG001|Overall Study|Objective Progression or Relapse|172|||
148819143|NCT01740427|536814626|FG000|Overall Study|Adverse Event|32|||
148819144|NCT01740427|536814627|FG001|Overall Study|Adverse Event|9|||
148819145|NCT01740427|536814626|FG000|Overall Study|Global Deterioration of Health Status|28|||
148819146|NCT01740427|536814627|FG001|Overall Study|Global Deterioration of Health Status|12|||
148819147|NCT01740427|536814626|FG000|Overall Study|Participant Refused Continued Treatment|27|||
148819148|NCT01740427|536814627|FG001|Overall Study|Participant Refused Continued Treatment|15|||
148819149|NCT01740427|536814626|FG000|Overall Study|Unspecified reasons|52|||
148975965|NCT01365273|537392388|FG000|Overall Study|Lost to Follow-up|1|||
148975966|NCT01365273|537392389|FG001|Overall Study|Lost to Follow-up|0|||
148743331|NCT05199090|536531915|FG002|Overall Study|Lost to Follow-up|1|||
148743332|NCT05199090|536531916|FG003|Overall Study|Lost to Follow-up|4|||
148743333|NCT05199090|536531917|FG004|Overall Study|Lost to Follow-up|0|||
148743334|NCT05199090|536531918|FG005|Overall Study|Lost to Follow-up|5|||
148819150|NCT01740427|536814627|FG001|Overall Study|Unspecified reasons|8|||
148819151|NCT01740427|536814626|FG000|Overall Study|Death|10|||
148743335|NCT05199090|536531913|FG000|Overall Study|Physician Decision|0|||
148743336|NCT05199090|536531914|FG001|Overall Study|Physician Decision|0|||
148819152|NCT01740427|536814627|FG001|Overall Study|Death|3|||
148819153|NCT01740427|536814626|FG000|Overall Study|Protocol Violation|5|||
148819154|NCT01740427|536814627|FG001|Overall Study|Protocol Violation|3|||
148975967|NCT01365273|537392388|FG000|Overall Study|Protocol Violation|0|||
148743337|NCT05199090|536531915|FG002|Overall Study|Physician Decision|0|||
148743338|NCT05199090|536531916|FG003|Overall Study|Physician Decision|0|||
148743339|NCT05199090|536531917|FG004|Overall Study|Physician Decision|0|||
148743340|NCT05199090|536531918|FG005|Overall Study|Physician Decision|1|||
148743341|NCT05199090|536531913|FG000|Overall Study|Study terminated by sponsor|0|||
148743342|NCT05199090|536531914|FG001|Overall Study|Study terminated by sponsor|6|||
148743343|NCT05199090|536531915|FG002|Overall Study|Study terminated by sponsor|0|||
148743344|NCT05199090|536531916|FG003|Overall Study|Study terminated by sponsor|0|||
148743345|NCT05199090|536531917|FG004|Overall Study|Study terminated by sponsor|0|||
148743346|NCT05199090|536531918|FG005|Overall Study|Study terminated by sponsor|5|||
148743347|NCT05199090|536531913|FG000|Overall Study|Subject decision|0|||
148743348|NCT05199090|536531914|FG001|Overall Study|Subject decision|4|||
148743349|NCT05199090|536531915|FG002|Overall Study|Subject decision|0|||
148743350|NCT05199090|536531916|FG003|Overall Study|Subject decision|2|||
148743351|NCT05199090|536531917|FG004|Overall Study|Subject decision|5|||
148743352|NCT05199090|536531918|FG005|Overall Study|Subject decision|2|||
148743353|NCT04868968|536531919|FG000|Overall Study|Lost to Follow-up|1|||
148743354|NCT03276078|536531920|FG000|Overall Study|Adverse Event|1|||
148743355|NCT02552732|536531921|FG000|Overall Study|Lost to Follow-up|2|||
148743356|NCT02552732|536531921|FG000|Overall Study|Physician Decision|1|||
148743357|NCT02552732|536531921|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
148743358|NCT02552732|536531921|FG000|Overall Study|Withdrawal by Subject|6|||
148743359|NCT01275430|536531925|FG000|Overall Study|Adverse Event|1|||
148743360|NCT01275430|536531925|FG000|Overall Study|No Contrast Injection|6|||
148743361|NCT01275430|536531925|FG000|Overall Study|Device Malfunction|1|||
148743362|NCT01275430|536531925|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
148743363|NCT04988087|536531927|FG000|Overall Study|Adverse Event|4|||
148743364|NCT04988087|536531928|FG001|Overall Study|Adverse Event|0|||
148743365|NCT04988087|536531929|FG002|Overall Study|Adverse Event|0|||
148743366|NCT04988087|536531930|FG003|Overall Study|Adverse Event|0|||
148743367|NCT04988087|536531927|FG000|Overall Study|Withdrawal by Subject|1|||
148743368|NCT04988087|536531928|FG001|Overall Study|Withdrawal by Subject|1|||
148743369|NCT04988087|536531929|FG002|Overall Study|Withdrawal by Subject|0|||
148743370|NCT04988087|536531930|FG003|Overall Study|Withdrawal by Subject|0|||
148743371|NCT04988087|536531927|FG000|Overall Study|Technical problems|7|||
148743372|NCT04988087|536531928|FG001|Overall Study|Technical problems|9|||
148743373|NCT04988087|536531929|FG002|Overall Study|Technical problems|1|||
148743374|NCT04988087|536531930|FG003|Overall Study|Technical problems|2|||
148743375|NCT02613182|536531931|FG000|Overall Study|Death|6|||
148743376|NCT02613182|536531931|FG000|Overall Study|Physician Decision|1|||
148743377|NCT02613182|536531931|FG000|Overall Study|Study Terminated by Sponsor|21|||
148743378|NCT02613182|536531931|FG000|Overall Study|Withdrawal by Subject|6|||
148743379|NCT02714426|536531935|FG000|Overall Study|Withdrawal by Subject|2|||
148743380|NCT02714426|536531936|FG001|Overall Study|Withdrawal by Subject|2|||
148743381|NCT00025259|536531937|FG000|Overall Study|Death|1|||
148743382|NCT00025259|536531938|FG001|Overall Study|Death|3|||
148743383|NCT00025259|536531939|FG002|Overall Study|Death|0|||
148743384|NCT00025259|536531940|FG003|Overall Study|Death|3|||
148743385|NCT00025259|536531941|FG004|Overall Study|Death|0|||
148743386|NCT00025259|536531942|FG005|Overall Study|Death|1|||
148743387|NCT00025259|536531943|FG006|Overall Study|Death|2|||
148743388|NCT00025259|536531937|FG000|Overall Study|Lack of Efficacy|2|||
148743389|NCT00025259|536531938|FG001|Overall Study|Lack of Efficacy|46|||
148743390|NCT00025259|536531939|FG002|Overall Study|Lack of Efficacy|60|||
148743391|NCT00025259|536531940|FG003|Overall Study|Lack of Efficacy|78|||
148743392|NCT00025259|536531941|FG004|Overall Study|Lack of Efficacy|11|||
148743393|NCT00025259|536531942|FG005|Overall Study|Lack of Efficacy|30|||
148743394|NCT00025259|536531943|FG006|Overall Study|Lack of Efficacy|38|||
148743395|NCT00025259|536531937|FG000|Overall Study|Lost to Follow-up|2|||
148743396|NCT00025259|536531938|FG001|Overall Study|Lost to Follow-up|9|||
148743397|NCT00025259|536531939|FG002|Overall Study|Lost to Follow-up|13|||
148743398|NCT00025259|536531940|FG003|Overall Study|Lost to Follow-up|13|||
148743399|NCT00025259|536531941|FG004|Overall Study|Lost to Follow-up|1|||
148743400|NCT00025259|536531942|FG005|Overall Study|Lost to Follow-up|3|||
148743401|NCT00025259|536531943|FG006|Overall Study|Lost to Follow-up|1|||
148743402|NCT00025259|536531937|FG000|Overall Study|Physician Decision|12|||
148743403|NCT00025259|536531938|FG001|Overall Study|Physician Decision|1|||
148743404|NCT00025259|536531939|FG002|Overall Study|Physician Decision|0|||
148743405|NCT00025259|536531940|FG003|Overall Study|Physician Decision|5|||
148743406|NCT00025259|536531941|FG004|Overall Study|Physician Decision|4|||
148743407|NCT00025259|536531942|FG005|Overall Study|Physician Decision|2|||
148743408|NCT00025259|536531943|FG006|Overall Study|Physician Decision|1|||
148743409|NCT00025259|536531937|FG000|Overall Study|Protocol Violation|3|||
148743410|NCT00025259|536531938|FG001|Overall Study|Protocol Violation|2|||
148743411|NCT00025259|536531939|FG002|Overall Study|Protocol Violation|2|||
148743412|NCT00025259|536531940|FG003|Overall Study|Protocol Violation|1|||
148743413|NCT00025259|536531941|FG004|Overall Study|Protocol Violation|2|||
148743414|NCT00025259|536531942|FG005|Overall Study|Protocol Violation|1|||
148743415|NCT00025259|536531943|FG006|Overall Study|Protocol Violation|3|||
148743416|NCT00025259|536531937|FG000|Overall Study|Withdrawal by Subject|9|||
148743417|NCT00025259|536531938|FG001|Overall Study|Withdrawal by Subject|27|||
148743418|NCT00025259|536531939|FG002|Overall Study|Withdrawal by Subject|6|||
148743419|NCT00025259|536531940|FG003|Overall Study|Withdrawal by Subject|14|||
148743420|NCT00025259|536531941|FG004|Overall Study|Withdrawal by Subject|11|||
148743421|NCT00025259|536531942|FG005|Overall Study|Withdrawal by Subject|8|||
148743422|NCT00025259|536531943|FG006|Overall Study|Withdrawal by Subject|3|||
148743423|NCT00025259|536531937|FG000|Overall Study|Ineligible|14|||
148743424|NCT00025259|536531938|FG001|Overall Study|Ineligible|1|||
148743425|NCT00025259|536531939|FG002|Overall Study|Ineligible|0|||
148743426|NCT00025259|536531940|FG003|Overall Study|Ineligible|0|||
148743427|NCT00025259|536531941|FG004|Overall Study|Ineligible|6|||
148743428|NCT00025259|536531942|FG005|Overall Study|Ineligible|0|||
148743429|NCT00025259|536531943|FG006|Overall Study|Ineligible|1|||
148743430|NCT00025259|536531937|FG000|Overall Study|Randomization error|1|||
148743431|NCT00025259|536531938|FG001|Overall Study|Randomization error|0|||
148743432|NCT00025259|536531939|FG002|Overall Study|Randomization error|0|||
148743433|NCT00025259|536531940|FG003|Overall Study|Randomization error|0|||
148743434|NCT00025259|536531941|FG004|Overall Study|Randomization error|1|||
148743435|NCT00025259|536531942|FG005|Overall Study|Randomization error|7|||
148743436|NCT00025259|536531943|FG006|Overall Study|Randomization error|2|||
148743437|NCT00025259|536531937|FG000|Overall Study|Adverse Event|1|||
148743438|NCT00025259|536531938|FG001|Overall Study|Adverse Event|0|||
148743439|NCT00025259|536531939|FG002|Overall Study|Adverse Event|0|||
148743440|NCT00025259|536531940|FG003|Overall Study|Adverse Event|0|||
148743441|NCT00025259|536531941|FG004|Overall Study|Adverse Event|0|||
148743442|NCT00025259|536531942|FG005|Overall Study|Adverse Event|0|||
148743443|NCT00025259|536531943|FG006|Overall Study|Adverse Event|0|||
148743444|NCT00863772|536531944|FG000|Overall Study|Adverse Event|1|||
148743445|NCT00863772|536531945|FG001|Overall Study|Adverse Event|4|||
148743446|NCT00863772|536531946|FG002|Overall Study|Adverse Event|0|||
148743447|NCT00863772|536531944|FG000|Overall Study|Lack of Efficacy|4|||
148743448|NCT00863772|536531945|FG001|Overall Study|Lack of Efficacy|2|||
148743449|NCT00863772|536531946|FG002|Overall Study|Lack of Efficacy|4|||
148743450|NCT00863772|536531944|FG000|Overall Study|Lost to Follow-up|5|||
148743451|NCT00863772|536531945|FG001|Overall Study|Lost to Follow-up|1|||
148743452|NCT00863772|536531946|FG002|Overall Study|Lost to Follow-up|1|||
148743453|NCT00863772|536531944|FG000|Overall Study|Protocol Violation|2|||
148743454|NCT00863772|536531945|FG001|Overall Study|Protocol Violation|0|||
148743455|NCT00863772|536531946|FG002|Overall Study|Protocol Violation|2|||
148743456|NCT00863772|536531944|FG000|Overall Study|Withdrawal by Subject|4|||
148743457|NCT00863772|536531945|FG001|Overall Study|Withdrawal by Subject|7|||
148743458|NCT00863772|536531946|FG002|Overall Study|Withdrawal by Subject|5|||
148743459|NCT00863772|536531944|FG000|Overall Study|Study terminated by sponsor|44|||
148743460|NCT00863772|536531945|FG001|Overall Study|Study terminated by sponsor|45|||
148743461|NCT00863772|536531946|FG002|Overall Study|Study terminated by sponsor|36|||
148743462|NCT00863772|536531944|FG000|Overall Study|Entered extension study|6|||
148743463|NCT00863772|536531945|FG001|Overall Study|Entered extension study|4|||
148743464|NCT00863772|536531946|FG002|Overall Study|Entered extension study|9|||
148743465|NCT00863772|536531944|FG000|Overall Study|Other|1|||
148743466|NCT00863772|536531945|FG001|Overall Study|Other|2|||
148743467|NCT00863772|536531946|FG002|Overall Study|Other|4|||
148743468|NCT00863772|536531944|FG000|Overall Study|Randomized but not Treated|1|||
148743469|NCT00863772|536531945|FG001|Overall Study|Randomized but not Treated|0|||
148743470|NCT00863772|536531946|FG002|Overall Study|Randomized but not Treated|0|||
148743471|NCT00086281|536531947|FG000|Phase 1|Adverse Event|0|||
148743472|NCT00086281|536531948|FG001|Phase 1|Adverse Event|0|||
148743473|NCT00086281|536531949|FG002|Phase 1|Adverse Event|0|||
148743474|NCT00086281|536531950|FG003|Phase 1|Adverse Event|0|||
148743475|NCT00086281|536531951|FG004|Phase 1|Adverse Event|0|||
148743476|NCT00086281|536531952|FG005|Phase 1|Adverse Event|0|||
148743477|NCT00086281|536531953|FG006|Phase 1|Adverse Event|0|||
148743478|NCT00086281|536531954|FG007|Phase 1|Adverse Event|0|||
148743479|NCT00086281|536531955|FG008|Phase 1|Adverse Event|0|||
148743480|NCT00086281|536531956|FG009|Phase 1|Adverse Event|1|||
148743481|NCT00086281|536531957|FG010|Phase 1|Adverse Event|2|||
148743482|NCT00086281|536531958|FG011|Phase 1|Adverse Event|1|||
148819155|NCT01740427|536814626|FG000|Overall Study|Lost to Follow-up|3|||
148743483|NCT00086281|536531959|FG012|Phase 1|Adverse Event|1|||
148743484|NCT00086281|536531960|FG013|Phase 1|Adverse Event|1|||
148743485|NCT00086281|536531961|FG014|Phase 1|Adverse Event|2|||
148743486|NCT00086281|536531947|FG000|Phase 1|Protocol Violation|0|||
148743487|NCT00086281|536531948|FG001|Phase 1|Protocol Violation|0|||
148743488|NCT00086281|536531949|FG002|Phase 1|Protocol Violation|0|||
148743489|NCT00086281|536531950|FG003|Phase 1|Protocol Violation|0|||
148819156|NCT01740427|536814627|FG001|Overall Study|Lost to Follow-up|0|||
148743490|NCT00086281|536531951|FG004|Phase 1|Protocol Violation|0|||
148743491|NCT00086281|536531952|FG005|Phase 1|Protocol Violation|0|||
148743492|NCT00086281|536531953|FG006|Phase 1|Protocol Violation|0|||
148743493|NCT00086281|536531954|FG007|Phase 1|Protocol Violation|0|||
148743494|NCT00086281|536531955|FG008|Phase 1|Protocol Violation|0|||
148743495|NCT00086281|536531956|FG009|Phase 1|Protocol Violation|0|||
148819157|NCT01740427|536814626|FG000|Overall Study|Site Terminated by Sponsor|1|||
148743496|NCT00086281|536531957|FG010|Phase 1|Protocol Violation|1|||
148743497|NCT00086281|536531958|FG011|Phase 1|Protocol Violation|0|||
148743498|NCT00086281|536531959|FG012|Phase 1|Protocol Violation|0|||
148743499|NCT00086281|536531960|FG013|Phase 1|Protocol Violation|0|||
148743500|NCT00086281|536531961|FG014|Phase 1|Protocol Violation|0|||
148743501|NCT00086281|536531947|FG000|Phase 1|Serious Adverse Event|0|||
148743502|NCT00086281|536531948|FG001|Phase 1|Serious Adverse Event|0|||
148743503|NCT00086281|536531949|FG002|Phase 1|Serious Adverse Event|0|||
148743504|NCT00086281|536531950|FG003|Phase 1|Serious Adverse Event|0|||
148743505|NCT00086281|536531951|FG004|Phase 1|Serious Adverse Event|0|||
148743506|NCT00086281|536531952|FG005|Phase 1|Serious Adverse Event|0|||
148743507|NCT00086281|536531953|FG006|Phase 1|Serious Adverse Event|0|||
148743508|NCT00086281|536531954|FG007|Phase 1|Serious Adverse Event|0|||
148743509|NCT00086281|536531955|FG008|Phase 1|Serious Adverse Event|0|||
148743510|NCT00086281|536531956|FG009|Phase 1|Serious Adverse Event|0|||
148743511|NCT00086281|536531957|FG010|Phase 1|Serious Adverse Event|0|||
148743512|NCT00086281|536531958|FG011|Phase 1|Serious Adverse Event|0|||
148743513|NCT00086281|536531959|FG012|Phase 1|Serious Adverse Event|0|||
148743514|NCT00086281|536531960|FG013|Phase 1|Serious Adverse Event|0|||
148743515|NCT00086281|536531961|FG014|Phase 1|Serious Adverse Event|1|||
148743516|NCT00086281|536531947|FG000|Phase 2|Adverse Event|0|||
148743517|NCT00086281|536531948|FG001|Phase 2|Adverse Event|0|||
148743518|NCT00086281|536531949|FG002|Phase 2|Adverse Event|0|||
148743519|NCT00086281|536531950|FG003|Phase 2|Adverse Event|0|||
148743520|NCT00086281|536531951|FG004|Phase 2|Adverse Event|0|||
148743521|NCT00086281|536531952|FG005|Phase 2|Adverse Event|0|||
148743522|NCT00086281|536531953|FG006|Phase 2|Adverse Event|0|||
148743523|NCT00086281|536531954|FG007|Phase 2|Adverse Event|0|||
148743524|NCT00086281|536531955|FG008|Phase 2|Adverse Event|0|||
148743525|NCT00086281|536531956|FG009|Phase 2|Adverse Event|0|||
148743526|NCT00086281|536531957|FG010|Phase 2|Adverse Event|0|||
148743527|NCT00086281|536531958|FG011|Phase 2|Adverse Event|0|||
148743528|NCT00086281|536531959|FG012|Phase 2|Adverse Event|1|||
148743529|NCT00086281|536531960|FG013|Phase 2|Adverse Event|1|||
148743530|NCT00086281|536531961|FG014|Phase 2|Adverse Event|0|||
148743531|NCT03456453|536531962|FG000|Overall Study|Withdrawal by Subject|2|||
148743532|NCT03456453|536531963|FG001|Overall Study|Withdrawal by Subject|0|||
148743533|NCT03456453|536531962|FG000|Overall Study|Not released to community|1|||
148743534|NCT03456453|536531963|FG001|Overall Study|Not released to community|5|||
148743535|NCT03456453|536531962|FG000|Overall Study|Lost to Follow-up|0|||
148743536|NCT03456453|536531963|FG001|Overall Study|Lost to Follow-up|2|||
148743537|NCT00896480|536531964|FG000|Overall Study|Disease progression/recurrence|21|||
148743538|NCT02071849|536531967|FG000|6-month Primary Endpoint|Did not receive device|4|||
148743539|NCT02071849|536531967|FG000|6-month Primary Endpoint|Adverse Event|1|||
148743540|NCT02071849|536531967|FG000|2-year Extended Follow-up|Adverse Event|1|||
148743541|NCT00103610|536531970|FG000|Overall Study|Entered Rescue Procedure|10|||
148743542|NCT00103610|536531971|FG001|Overall Study|Entered Rescue Procedure|52|||
148743543|NCT00103610|536531970|FG000|Overall Study|Death|16|||
148743544|NCT00103610|536531971|FG001|Overall Study|Death|12|||
148743545|NCT00103610|536531970|FG000|Overall Study|Elective Withdrawal|4|||
148743546|NCT00103610|536531971|FG001|Overall Study|Elective Withdrawal|0|||
148743547|NCT00103610|536531970|FG000|Overall Study|Lost to Follow-up|3|||
148743548|NCT00103610|536531971|FG001|Overall Study|Lost to Follow-up|1|||
148743549|NCT00103610|536531970|FG000|Overall Study|Adverse Event|2|||
148743550|NCT00103610|536531971|FG001|Overall Study|Adverse Event|2|||
148743551|NCT00103610|536531970|FG000|Overall Study|Other|2|||
148743552|NCT00103610|536531971|FG001|Overall Study|Other|7|||
148743553|NCT00103610|536531970|FG000|Overall Study|Failed mobilization|1|||
148743554|NCT00103610|536531971|FG001|Overall Study|Failed mobilization|5|||
148743555|NCT00103610|536531970|FG000|Overall Study|Noncompliance|0|||
148743556|NCT00103610|536531971|FG001|Overall Study|Noncompliance|1|||
148743557|NCT04784533|536531975|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
148743558|NCT04784533|536531976|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
148743559|NCT04784533|536531977|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743560|NCT04784533|536531978|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743561|NCT04784533|536531979|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148819158|NCT01740427|536814627|FG001|Overall Study|Site Terminated by Sponsor|0|||
148743562|NCT04784533|536531980|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743563|NCT04784533|536531981|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743564|NCT04784533|536531982|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743565|NCT04784533|536531983|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743566|NCT04784533|536531984|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
148743567|NCT04784533|536531975|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
148743568|NCT04784533|536531976|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
148743569|NCT04784533|536531977|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
149027159|NCT02929108|537576520|FG001|Overall Study|Hospice patient death|64|||
148743570|NCT04784533|536531978|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743571|NCT04784533|536531979|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743572|NCT04784533|536531980|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743573|NCT04784533|536531981|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743574|NCT04784533|536531982|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743575|NCT04784533|536531983|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743576|NCT04784533|536531984|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
148743577|NCT04784533|536531975|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743578|NCT04784533|536531976|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
148743579|NCT04784533|536531977|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743580|NCT04784533|536531978|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743581|NCT04784533|536531979|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743582|NCT04784533|536531980|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743583|NCT04784533|536531981|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743584|NCT04784533|536531982|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743585|NCT04784533|536531983|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743586|NCT04784533|536531984|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
148743587|NCT04784533|536531975|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
148743588|NCT04784533|536531976|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743589|NCT04784533|536531977|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743590|NCT04784533|536531978|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743591|NCT04784533|536531979|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743592|NCT04784533|536531980|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743593|NCT04784533|536531981|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743594|NCT04784533|536531982|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743595|NCT04784533|536531983|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743596|NCT04784533|536531984|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
148743597|NCT04784533|536531975|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
148743598|NCT04784533|536531976|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
148743599|NCT04784533|536531977|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743600|NCT04784533|536531978|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743601|NCT04784533|536531979|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743602|NCT04784533|536531980|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743603|NCT04784533|536531981|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743604|NCT04784533|536531982|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743605|NCT04784533|536531983|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743606|NCT04784533|536531984|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
148743607|NCT04784533|536531975|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
148743608|NCT04784533|536531976|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
148743609|NCT04784533|536531977|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743610|NCT04784533|536531978|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743611|NCT04784533|536531979|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743612|NCT04784533|536531980|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743613|NCT04784533|536531981|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743614|NCT04784533|536531982|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743615|NCT04784533|536531983|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743616|NCT04784533|536531984|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
148743617|NCT04784533|536531975|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743618|NCT04784533|536531976|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743619|NCT04784533|536531977|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
148743620|NCT04784533|536531978|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743621|NCT04784533|536531979|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743622|NCT04784533|536531980|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743623|NCT04784533|536531981|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743624|NCT04784533|536531982|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743625|NCT04784533|536531983|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743626|NCT04784533|536531984|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
148743627|NCT04784533|536531975|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743628|NCT04784533|536531976|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743629|NCT04784533|536531977|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743630|NCT04784533|536531978|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743631|NCT04784533|536531979|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743632|NCT04784533|536531980|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743633|NCT04784533|536531981|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743634|NCT04784533|536531982|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743635|NCT04784533|536531983|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
148743636|NCT04784533|536531984|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
148743637|NCT04784533|536531975|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743638|NCT04784533|536531976|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743639|NCT04784533|536531977|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743640|NCT04784533|536531978|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743641|NCT04784533|536531979|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743642|NCT04784533|536531980|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743643|NCT04784533|536531981|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743644|NCT04784533|536531982|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
148743645|NCT04784533|536531983|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
148743646|NCT04784533|536531984|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
148743647|NCT05833139|536533126|FG000|Study Period 2|Adverse Event|1|||
148743648|NCT05013008|536533134|FG000|Overall Study|Exclusion from mBFAS|5|||
148743649|NCT05013008|536533135|FG001|Overall Study|Exclusion from mBFAS|25|||
148743650|NCT01443728|536533136|FG000|Overall Study|Lost to Follow-up|2|||
148743651|NCT01443728|536533137|FG001|Overall Study|Lost to Follow-up|0|||
148743652|NCT01443728|536533136|FG000|Overall Study|Withdrawal by Subject|1|||
148743653|NCT01443728|536533137|FG001|Overall Study|Withdrawal by Subject|1|||
148743654|NCT01443728|536533136|FG000|Overall Study|Adverse Event|0|||
148743655|NCT01443728|536533137|FG001|Overall Study|Adverse Event|2|||
148743656|NCT04981717|536533138|FG000|Overall Study|Protocol Violation|0|||
148743657|NCT04981717|536533139|FG001|Overall Study|Protocol Violation|3|||
148743658|NCT04981717|536533138|FG000|Overall Study|Adverse Event|1|||
148743659|NCT04981717|536533139|FG001|Overall Study|Adverse Event|3|||
148743660|NCT04981717|536533138|FG000|Overall Study|Pregnancy|1|||
148743661|NCT04981717|536533139|FG001|Overall Study|Pregnancy|0|||
148743662|NCT04981717|536533138|FG000|Overall Study|Physician Decision|1|||
148743663|NCT04981717|536533139|FG001|Overall Study|Physician Decision|0|||
148743664|NCT04981717|536533138|FG000|Overall Study|Sponsor Request|157|||
148743665|NCT04981717|536533139|FG001|Overall Study|Sponsor Request|172|||
148743666|NCT04981717|536533138|FG000|Overall Study|Lost to Follow-up|4|||
148743667|NCT04981717|536533139|FG001|Overall Study|Lost to Follow-up|5|||
148743668|NCT04981717|536533138|FG000|Overall Study|Withdrawal by Subject|50|||
148743669|NCT04981717|536533139|FG001|Overall Study|Withdrawal by Subject|37|||
148743670|NCT00974922|536533140|FG000|Overall Study|study terminated|24|||
148743671|NCT00287586|536533141|FG000|Overall Study|Withdrew Consent|19|||
148743672|NCT00287586|536533142|FG001|Overall Study|Withdrew Consent|30|||
148743673|NCT00287586|536533141|FG000|Overall Study|Lost to Follow-up|5|||
148743674|NCT00287586|536533142|FG001|Overall Study|Lost to Follow-up|4|||
148743675|NCT00287586|536533141|FG000|Overall Study|Death|2|||
148743676|NCT00287586|536533142|FG001|Overall Study|Death|3|||
148743677|NCT00287586|536533141|FG000|Overall Study|Elevated Hematocrit|3|||
148743678|NCT00287586|536533142|FG001|Overall Study|Elevated Hematocrit|0|||
148743679|NCT00287586|536533141|FG000|Overall Study|Rash|3|||
148743680|NCT00287586|536533142|FG001|Overall Study|Rash|0|||
148743681|NCT00287586|536533141|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
148743682|NCT00287586|536533142|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
148743683|NCT00287586|536533141|FG000|Overall Study|Stroke|2|||
148743684|NCT00287586|536533142|FG001|Overall Study|Stroke|0|||
148743685|NCT00287586|536533141|FG000|Overall Study|Myocardial Infarction|1|||
148743686|NCT00287586|536533142|FG001|Overall Study|Myocardial Infarction|0|||
148743687|NCT00287586|536533141|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
148743688|NCT00287586|536533142|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
148743689|NCT00287586|536533141|FG000|Overall Study|Cognitive Impairment|1|||
148743690|NCT00287586|536533142|FG001|Overall Study|Cognitive Impairment|0|||
148743691|NCT00287586|536533141|FG000|Overall Study|Pancreatic Cancer|1|||
148743692|NCT00287586|536533142|FG001|Overall Study|Pancreatic Cancer|3|||
148743693|NCT00287586|536533141|FG000|Overall Study|Sleep Apnea|1|||
148819159|NCT05752487|536814628|FG000|Overall Study|Enrolled, not treated|9|||
148819160|NCT05752487|536814628|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
148819161|NCT05752487|536814628|FG000|Overall Study|Withdrawal by Subject|2|||
148975968|NCT01365273|537392389|FG001|Overall Study|Protocol Violation|1|||
148975969|NCT01365273|537392388|FG000|Overall Study|Physician Decision|1|||
148975970|NCT01365273|537392389|FG001|Overall Study|Physician Decision|0|||
148743694|NCT00287586|536533142|FG001|Overall Study|Sleep Apnea|0|||
148743695|NCT00287586|536533141|FG000|Overall Study|Shoulder Pain|1|||
148743696|NCT00287586|536533142|FG001|Overall Study|Shoulder Pain|0|||
148743697|NCT00287586|536533141|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
148743698|NCT00287586|536533142|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
148743699|NCT00287586|536533141|FG000|Overall Study|Nonadherence|1|||
148743700|NCT00287586|536533142|FG001|Overall Study|Nonadherence|1|||
148743701|NCT00287586|536533141|FG000|Overall Study|Enrolled in Another Study|1|||
148743702|NCT00287586|536533142|FG001|Overall Study|Enrolled in Another Study|0|||
148743703|NCT00287586|536533141|FG000|Overall Study|Major Depression|0|||
148743704|NCT00287586|536533142|FG001|Overall Study|Major Depression|2|||
148743705|NCT00287586|536533141|FG000|Overall Study|Lung Cancer|0|||
148975971|NCT04907032|537392391|FG000|Overall Study|Withdrawal by Subject|7|||
148743706|NCT00287586|536533142|FG001|Overall Study|Lung Cancer|2|||
148743707|NCT00287586|536533141|FG000|Overall Study|Elevated IPSS Score|0|||
148743708|NCT00287586|536533142|FG001|Overall Study|Elevated IPSS Score|1|||
148743709|NCT00287586|536533141|FG000|Overall Study|Retroperitoneal Cancer|0|||
148743710|NCT00287586|536533142|FG001|Overall Study|Retroperitoneal Cancer|1|||
148743711|NCT00287586|536533141|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
148743712|NCT00287586|536533142|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
148743713|NCT00287586|536533141|FG000|Overall Study|Mood Swings and Irritability|0|||
148743714|NCT00287586|536533142|FG001|Overall Study|Mood Swings and Irritability|1|||
148743715|NCT00287586|536533141|FG000|Overall Study|Bradycardia|0|||
148743716|NCT00287586|536533142|FG001|Overall Study|Bradycardia|1|||
148743717|NCT00287586|536533141|FG000|Overall Study|Itchy Swollen Eyes|0|||
148743718|NCT00287586|536533142|FG001|Overall Study|Itchy Swollen Eyes|1|||
148743719|NCT00287586|536533141|FG000|Overall Study|Recurrent Melanoma|0|||
148743720|NCT00287586|536533142|FG001|Overall Study|Recurrent Melanoma|1|||
148743721|NCT02640482|536533143|FG000|Overall Study|Lost to Follow-up|3|||
148743722|NCT02640482|536533144|FG001|Overall Study|Lost to Follow-up|0|||
148743723|NCT00113763|536533145|FG000|Overall Study|Adverse Event|5|||
148743724|NCT00113763|536533146|FG001|Overall Study|Adverse Event|2|||
148743725|NCT00113763|536533145|FG000|Overall Study|Disease Progression|28|||
148743726|NCT00113763|536533146|FG001|Overall Study|Disease Progression|14|||
148743727|NCT00113763|536533145|FG000|Overall Study|Lost to Follow-up|10|||
148743728|NCT00113763|536533146|FG001|Overall Study|Lost to Follow-up|0|||
148743729|NCT00113763|536533145|FG000|Overall Study|Withdrawal by Subject|1|||
148743730|NCT00113763|536533146|FG001|Overall Study|Withdrawal by Subject|4|||
148743731|NCT00113763|536533145|FG000|Overall Study|Other|27|||
148743732|NCT00113763|536533146|FG001|Overall Study|Other|6|||
148743733|NCT00113763|536533145|FG000|Overall Study|Non-compliance|1|||
148743734|NCT00113763|536533146|FG001|Overall Study|Non-compliance|0|||
148743735|NCT00113763|536533145|FG000|Overall Study|Ongoing|1|||
148743736|NCT00113763|536533146|FG001|Overall Study|Ongoing|0|||
148743737|NCT00517881|536533147|FG000|Overall Study|Protocol Violation|2|||
148743738|NCT00517881|536533147|FG000|Overall Study|Adverse Event|1|||
148743739|NCT00517881|536533147|FG000|Overall Study|Renal transplantation|2|||
148743740|NCT03743415|536533148|FG000|Overall Study|Death|5|||
148743741|NCT03743415|536533149|FG001|Overall Study|Death|3|||
148743742|NCT03743415|536533150|FG002|Overall Study|Death|1|||
148743743|NCT03743415|536533151|FG003|Overall Study|Death|4|||
148743744|NCT03743415|536533152|FG004|Overall Study|Death|0|||
148743745|NCT03743415|536533153|FG005|Overall Study|Death|0|||
148743746|NCT03743415|536533154|FG006|Overall Study|Death|0|||
148743747|NCT03743415|536533155|FG007|Overall Study|Death|0|||
148743748|NCT03743415|536533156|FG008|Overall Study|Death|1|||
148743749|NCT03743415|536533157|FG009|Overall Study|Death|0|||
148743750|NCT03743415|536533148|FG000|Overall Study|Withdrawal by Subject|1|||
148743751|NCT03743415|536533149|FG001|Overall Study|Withdrawal by Subject|0|||
148743752|NCT03743415|536533150|FG002|Overall Study|Withdrawal by Subject|4|||
148743753|NCT03743415|536533151|FG003|Overall Study|Withdrawal by Subject|5|||
148743754|NCT03743415|536533152|FG004|Overall Study|Withdrawal by Subject|5|||
148743755|NCT03743415|536533153|FG005|Overall Study|Withdrawal by Subject|2|||
148743756|NCT03743415|536533154|FG006|Overall Study|Withdrawal by Subject|2|||
148743757|NCT03743415|536533155|FG007|Overall Study|Withdrawal by Subject|5|||
148743758|NCT03743415|536533156|FG008|Overall Study|Withdrawal by Subject|9|||
148743759|NCT03743415|536533157|FG009|Overall Study|Withdrawal by Subject|10|||
148743760|NCT03743415|536533148|FG000|Overall Study|Lost to Follow-up|2|||
148743761|NCT03743415|536533149|FG001|Overall Study|Lost to Follow-up|0|||
148743762|NCT03743415|536533150|FG002|Overall Study|Lost to Follow-up|2|||
148743763|NCT03743415|536533151|FG003|Overall Study|Lost to Follow-up|1|||
148743764|NCT03743415|536533152|FG004|Overall Study|Lost to Follow-up|1|||
148743765|NCT03743415|536533153|FG005|Overall Study|Lost to Follow-up|0|||
148743766|NCT03743415|536533154|FG006|Overall Study|Lost to Follow-up|1|||
148743767|NCT03743415|536533155|FG007|Overall Study|Lost to Follow-up|4|||
148743768|NCT03743415|536533156|FG008|Overall Study|Lost to Follow-up|13|||
148743769|NCT03743415|536533157|FG009|Overall Study|Lost to Follow-up|13|||
148743770|NCT00094861|536533160|FG000|Overall Study|Adverse Event|5|||
148743771|NCT00094861|536533161|FG001|Overall Study|Adverse Event|2|||
148743772|NCT00094861|536533160|FG000|Overall Study|Withdrawal by Subject|5|||
148743773|NCT00094861|536533161|FG001|Overall Study|Withdrawal by Subject|3|||
148743774|NCT00094861|536533160|FG000|Overall Study|Physician Decision|1|||
148743775|NCT00094861|536533161|FG001|Overall Study|Physician Decision|1|||
148975972|NCT04907032|537392392|FG001|Overall Study|Withdrawal by Subject|1|||
148975973|NCT02705820|537392401|FG000|Overall Study|Death|2|||
148743776|NCT00094861|536533160|FG000|Overall Study|Lost to Follow-up|0|||
148743777|NCT00094861|536533161|FG001|Overall Study|Lost to Follow-up|1|||
148743778|NCT00094861|536533160|FG000|Overall Study|Death|4|||
148743779|NCT00094861|536533161|FG001|Overall Study|Death|2|||
148743780|NCT00094861|536533160|FG000|Overall Study|Other|3|||
148743781|NCT00094861|536533161|FG001|Overall Study|Other|0|||
148743782|NCT02129608|536533166|FG000|Overall Study|Lost to Follow-up|0|||
148743783|NCT02129608|536533167|FG001|Overall Study|Lost to Follow-up|1|||
148743784|NCT02129608|536533168|FG002|Overall Study|Lost to Follow-up|1|||
148743785|NCT02129608|536533166|FG000|Overall Study|Withdrawal by Subject|0|||
148743786|NCT02129608|536533167|FG001|Overall Study|Withdrawal by Subject|0|||
148743787|NCT02129608|536533168|FG002|Overall Study|Withdrawal by Subject|2|||
148743788|NCT03760185|536533169|FG000|Overall Study|Lost to Follow-up|1|||
148743789|NCT03760185|536533170|FG001|Overall Study|Lost to Follow-up|1|||
148743790|NCT02473523|536533171|FG000|Overall Study|Death|1|||
148743791|NCT02473523|536533171|FG000|Overall Study|Lost to Follow-up|1|||
148743792|NCT00976911|536533175|FG000|Overall Study|Withdrawal by Subject|4|||
148743793|NCT00976911|536533176|FG001|Overall Study|Withdrawal by Subject|6|||
148743794|NCT00976911|536533175|FG000|Overall Study|Death|138|||
148743795|NCT00976911|536533176|FG001|Overall Study|Death|126|||
148743796|NCT00976911|536533175|FG000|Overall Study|Adverse Event|0|||
148743797|NCT00976911|536533176|FG001|Overall Study|Adverse Event|1|||
148743798|NCT00976911|536533175|FG000|Overall Study|Protocol Violation|2|||
148743799|NCT00976911|536533176|FG001|Overall Study|Protocol Violation|0|||
148743800|NCT00976911|536533175|FG000|Overall Study|Other|8|||
148743801|NCT00976911|536533176|FG001|Overall Study|Other|9|||
148743802|NCT00976911|536533175|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
148743803|NCT00976911|536533176|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
148743804|NCT01191944|536533177|FG000|Overall Study|Adverse Event|11|||
148743805|NCT01191944|536533178|FG001|Overall Study|Adverse Event|12|||
148743806|NCT01191944|536533177|FG000|Overall Study|Protocol Violation|1|||
148743807|NCT01191944|536533178|FG001|Overall Study|Protocol Violation|2|||
148743808|NCT01191944|536533177|FG000|Overall Study|Withdrawal by Subject|4|||
148743809|NCT01191944|536533178|FG001|Overall Study|Withdrawal by Subject|2|||
148743810|NCT01191944|536533177|FG000|Overall Study|Other|1|||
148743811|NCT01191944|536533178|FG001|Overall Study|Other|3|||
148743812|NCT02954991|536533181|FG000|Overall Study|Death|92|||
148743813|NCT02954991|536533182|FG001|Overall Study|Death|11|||
148743814|NCT02954991|536533183|FG002|Overall Study|Death|2|||
148743815|NCT02954991|536533181|FG000|Overall Study|Lost to Follow-up|3|||
148743816|NCT02954991|536533182|FG001|Overall Study|Lost to Follow-up|2|||
148743817|NCT02954991|536533183|FG002|Overall Study|Lost to Follow-up|0|||
148743818|NCT02954991|536533181|FG000|Overall Study|Withdrawal by Subject|9|||
148743819|NCT02954991|536533182|FG001|Overall Study|Withdrawal by Subject|8|||
148743820|NCT02954991|536533183|FG002|Overall Study|Withdrawal by Subject|1|||
148743821|NCT02954991|536533181|FG000|Overall Study|Study Terminated by Sponsor|18|||
148743822|NCT02954991|536533182|FG001|Overall Study|Study Terminated by Sponsor|10|||
148743823|NCT02954991|536533183|FG002|Overall Study|Study Terminated by Sponsor|1|||
148743824|NCT02954991|536533181|FG000|Overall Study|Miscellaneous|2|||
148743825|NCT02954991|536533182|FG001|Overall Study|Miscellaneous|1|||
148743826|NCT02954991|536533183|FG002|Overall Study|Miscellaneous|1|||
148743827|NCT02552303|536533186|FG000|Allocation|Withdrawal by Subject|2|||
148743828|NCT02552303|536533187|FG001|Allocation|Withdrawal by Subject|1|||
148743829|NCT02552303|536533188|FG002|Allocation|Withdrawal by Subject|1|||
148743830|NCT02552303|536533189|FG003|Allocation|Withdrawal by Subject|1|||
148743831|NCT02552303|536533186|FG000|Allocation|ineligible|1|||
148743832|NCT02552303|536533187|FG001|Allocation|ineligible|1|||
148743833|NCT02552303|536533188|FG002|Allocation|ineligible|0|||
148743834|NCT02552303|536533189|FG003|Allocation|ineligible|0|||
148743835|NCT02552303|536533186|FG000|Follow-Up|Lost to Follow-up|0|||
148743836|NCT02552303|536533187|FG001|Follow-Up|Lost to Follow-up|0|||
148743837|NCT02552303|536533188|FG002|Follow-Up|Lost to Follow-up|1|||
148743838|NCT02552303|536533189|FG003|Follow-Up|Lost to Follow-up|0|||
148743839|NCT02552303|536533186|FG000|Follow-Up|ineligible|0|||
148743840|NCT02552303|536533187|FG001|Follow-Up|ineligible|2|||
148743841|NCT02552303|536533188|FG002|Follow-Up|ineligible|0|||
148743842|NCT02552303|536533189|FG003|Follow-Up|ineligible|0|||
148743843|NCT04602546|536533190|FG000|Overall Study|Training|2|||
148743844|NCT04602546|536533191|FG001|Overall Study|Training|2|||
148743845|NCT04602546|536533192|FG002|Overall Study|Training|1|||
148743846|NCT04602546|536533193|FG003|Overall Study|Training|2|||
148743847|NCT04602546|536533194|FG004|Overall Study|Training|0|||
148743848|NCT04602546|536533190|FG000|Overall Study|Randomized with disqualified data|2|||
148743849|NCT04602546|536533191|FG001|Overall Study|Randomized with disqualified data|0|||
148743850|NCT04602546|536533192|FG002|Overall Study|Randomized with disqualified data|2|||
148743851|NCT04602546|536533193|FG003|Overall Study|Randomized with disqualified data|5|||
148743852|NCT04602546|536533194|FG004|Overall Study|Randomized with disqualified data|3|||
148743853|NCT00253448|536533195|FG000|Overall Study|Withdrawal by Subject|1|||
148743854|NCT02052011|536533197|FG000|Overall Study|Lost to Follow-up|3|||
148743855|NCT02052011|536533198|FG001|Overall Study|Lost to Follow-up|0|||
148743856|NCT02052011|536533197|FG000|Overall Study|Withdrawal by Subject|1|||
148743857|NCT02052011|536533198|FG001|Overall Study|Withdrawal by Subject|2|||
148743858|NCT00000620|536533199|FG000|Overall Study|Death|86|||
148743859|NCT00000620|536533200|FG001|Overall Study|Death|67|||
148743860|NCT00000620|536533201|FG002|Overall Study|Death|112|||
148743861|NCT00000620|536533202|FG003|Overall Study|Death|126|||
148743862|NCT00000620|536533203|FG004|Overall Study|Death|64|||
148743863|NCT00000620|536533204|FG005|Overall Study|Death|77|||
148743864|NCT00000620|536533205|FG006|Overall Study|Death|91|||
148743865|NCT00000620|536533206|FG007|Overall Study|Death|95|||
148743866|NCT00000620|536533199|FG000|Overall Study|Lost to Follow-up|14|||
148743867|NCT00000620|536533200|FG001|Overall Study|Lost to Follow-up|14|||
148743868|NCT00000620|536533201|FG002|Overall Study|Lost to Follow-up|14|||
148743869|NCT00000620|536533202|FG003|Overall Study|Lost to Follow-up|14|||
148743870|NCT00000620|536533203|FG004|Overall Study|Lost to Follow-up|15|||
148743871|NCT00000620|536533204|FG005|Overall Study|Lost to Follow-up|15|||
148743872|NCT00000620|536533205|FG006|Overall Study|Lost to Follow-up|13|||
148743873|NCT00000620|536533206|FG007|Overall Study|Lost to Follow-up|14|||
148743874|NCT00000620|536533199|FG000|Overall Study|Withdrawal by Subject|40|||
148743875|NCT00000620|536533200|FG001|Overall Study|Withdrawal by Subject|27|||
148743876|NCT00000620|536533201|FG002|Overall Study|Withdrawal by Subject|28|||
148743877|NCT00000620|536533202|FG003|Overall Study|Withdrawal by Subject|27|||
148743878|NCT00000620|536533203|FG004|Overall Study|Withdrawal by Subject|30|||
148743879|NCT00000620|536533204|FG005|Overall Study|Withdrawal by Subject|32|||
148743880|NCT00000620|536533205|FG006|Overall Study|Withdrawal by Subject|32|||
148743881|NCT00000620|536533206|FG007|Overall Study|Withdrawal by Subject|21|||
148743882|NCT00000620|536533199|FG000|Overall Study|missed closeout visit|22|||
148743883|NCT00000620|536533200|FG001|Overall Study|missed closeout visit|28|||
148743884|NCT00000620|536533201|FG002|Overall Study|missed closeout visit|16|||
148743885|NCT00000620|536533202|FG003|Overall Study|missed closeout visit|11|||
148743886|NCT00000620|536533203|FG004|Overall Study|missed closeout visit|26|||
148743887|NCT00000620|536533204|FG005|Overall Study|missed closeout visit|28|||
148743888|NCT00000620|536533205|FG006|Overall Study|missed closeout visit|13|||
148743889|NCT00000620|536533206|FG007|Overall Study|missed closeout visit|16|||
148743890|NCT01851330|536533207|FG000|Overall Study|Lack of Efficacy|10|||
148743891|NCT01851330|536533208|FG001|Overall Study|Lack of Efficacy|9|||
148743892|NCT01851330|536533209|FG002|Overall Study|Lack of Efficacy|2|||
148743893|NCT01851330|536533207|FG000|Overall Study|Lost to Follow-up|1|||
148743894|NCT01851330|536533208|FG001|Overall Study|Lost to Follow-up|6|||
148743895|NCT01851330|536533209|FG002|Overall Study|Lost to Follow-up|9|||
148743896|NCT01851330|536533207|FG000|Overall Study|Withdrew Consent|2|||
148743897|NCT01851330|536533208|FG001|Overall Study|Withdrew Consent|1|||
148743898|NCT01851330|536533209|FG002|Overall Study|Withdrew Consent|0|||
148743899|NCT01851330|536533207|FG000|Overall Study|Investigator's Discretion|0|||
148743900|NCT01851330|536533208|FG001|Overall Study|Investigator's Discretion|0|||
148743901|NCT01851330|536533209|FG002|Overall Study|Investigator's Discretion|1|||
148743902|NCT01266031|536533210|FG000|Overall Study|Not treated|0|||
148743903|NCT01266031|536533211|FG001|Overall Study|Not treated|3|||
148743904|NCT01266031|536533212|FG002|Overall Study|Not treated|2|||
148743905|NCT01307111|536533215|FG000|IUD Insertion|Lost to Follow-up|2|||
148743906|NCT01307111|536533216|FG001|IUD Insertion|Lost to Follow-up|0|||
148743907|NCT01307111|536533215|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
148743908|NCT01307111|536533216|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
148743909|NCT02114385|536533222|FG000|Overall Study|Withdrawal by Subject|3|||
148743910|NCT02114385|536533223|FG001|Overall Study|Withdrawal by Subject|2|||
148743911|NCT02114385|536533222|FG000|Overall Study|Lost to Follow-up|0|||
148743912|NCT02114385|536533223|FG001|Overall Study|Lost to Follow-up|6|||
148743913|NCT01174043|536533227|FG000|Overall Study|Disease progression|5|||
148743914|NCT01174043|536533227|FG000|Overall Study|Adverse Event|3|||
148743915|NCT01174043|536533227|FG000|Overall Study|Death|1|||
148743916|NCT01174043|536533227|FG000|Overall Study|Withdrawal by Subject|2|||
148743917|NCT02289456|536533233|FG000|Induction Period|Death|2|||
148743918|NCT02289456|536533233|FG000|Induction Period|Adverse Event|11|||
148743919|NCT02289456|536533233|FG000|Induction Period|Progressive Disease (PD)|4|||
148743920|NCT02289456|536533233|FG000|Induction Period|Symptomatic Deterioration|4|||
148743921|NCT02289456|536533233|FG000|Induction Period|Withdrawal by Subject|2|||
148743922|NCT02289456|536533233|FG000|Induction Period|Miscellaneous|1|||
148743923|NCT02289456|536533233|FG000|Monotherapy Period|Death|1|||
148743924|NCT02289456|536533233|FG000|Monotherapy Period|Adverse Event|1|||
148743925|NCT02289456|536533233|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
148743926|NCT02289456|536533233|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
148743927|NCT02289456|536533233|FG000|Monotherapy Period|Withdrawal by Subject|2|||
148743928|NCT02289456|536533233|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
148743929|NCT02289456|536533233|FG000|Monotherapy Period|Miscellaneous|1|||
148743930|NCT02892149|536533234|FG000|Overall Study|Death|262|||
148975974|NCT02705820|537392401|FG000|Overall Study|Disease Progression|34|||
148975975|NCT02705820|537392401|FG000|Overall Study|Clinical Deterioration|3|||
148975976|NCT02751983|537392402|FG000|Treatment|Stopped ACT, but Remained in study|2|||
148743931|NCT02892149|536533235|FG001|Overall Study|Death|278|||
148743932|NCT02892149|536533234|FG000|Overall Study|Withdrawal by Subject|53|||
148743933|NCT02892149|536533235|FG001|Overall Study|Withdrawal by Subject|47|||
148743934|NCT02892149|536533234|FG000|Overall Study|Lost to Follow-up|37|||
148743935|NCT02892149|536533235|FG001|Overall Study|Lost to Follow-up|31|||
148743936|NCT03489109|536533236|FG000|Overall Study|Lost to Follow-up|1|||
148743937|NCT03489109|536533237|FG001|Overall Study|Lost to Follow-up|2|||
148743938|NCT01547130|536533238|FG000|Overall Study|Lost to Follow-up|9|||
148743939|NCT01547130|536533239|FG001|Overall Study|Lost to Follow-up|5|||
148743940|NCT03968978|536533240|FG000|Overall Study|Adverse Event|1|||
148743941|NCT03968978|536533241|FG001|Overall Study|Adverse Event|0|||
148743942|NCT00908310|536533247|FG000|Overall Study|Death|37|||
148743943|NCT00908310|536533247|FG000|Overall Study|Withdrawal by Subject|7|||
148743944|NCT00908310|536533247|FG000|Overall Study|Lost to Follow-up|7|||
148743945|NCT00908310|536533247|FG000|Overall Study|Screening failure|5|||
148743946|NCT00908310|536533247|FG000|Overall Study|Other reasons|4|||
148743947|NCT01004003|536533248|FG000|Overall Study|Progressive disease|2|||
148743948|NCT01004003|536533249|FG001|Overall Study|Progressive disease|1|||
148743949|NCT01004003|536533250|FG002|Overall Study|Progressive disease|1|||
148743950|NCT01004003|536533251|FG003|Overall Study|Progressive disease|0|||
148743951|NCT01004003|536533252|FG004|Overall Study|Progressive disease|2|||
148743952|NCT01004003|536533253|FG005|Overall Study|Progressive disease|1|||
148743953|NCT01004003|536533254|FG006|Overall Study|Progressive disease|1|||
148743954|NCT01004003|536533255|FG007|Overall Study|Progressive disease|39|||
148743955|NCT01004003|536533256|FG008|Overall Study|Progressive disease|22|||
148743956|NCT01004003|536533248|FG000|Overall Study|Adverse Event|4|||
148743957|NCT01004003|536533249|FG001|Overall Study|Adverse Event|2|||
148743958|NCT01004003|536533250|FG002|Overall Study|Adverse Event|3|||
148743959|NCT01004003|536533251|FG003|Overall Study|Adverse Event|3|||
148743960|NCT01004003|536533252|FG004|Overall Study|Adverse Event|2|||
148743961|NCT01004003|536533253|FG005|Overall Study|Adverse Event|2|||
148743962|NCT01004003|536533254|FG006|Overall Study|Adverse Event|7|||
148743963|NCT01004003|536533255|FG007|Overall Study|Adverse Event|21|||
148743964|NCT01004003|536533256|FG008|Overall Study|Adverse Event|6|||
148743965|NCT01004003|536533248|FG000|Overall Study|Refused to continue taking trial med.|0|||
148743966|NCT01004003|536533249|FG001|Overall Study|Refused to continue taking trial med.|0|||
148743967|NCT01004003|536533250|FG002|Overall Study|Refused to continue taking trial med.|0|||
148743968|NCT01004003|536533251|FG003|Overall Study|Refused to continue taking trial med.|0|||
148743969|NCT01004003|536533252|FG004|Overall Study|Refused to continue taking trial med.|0|||
148743970|NCT01004003|536533253|FG005|Overall Study|Refused to continue taking trial med.|0|||
148743971|NCT01004003|536533254|FG006|Overall Study|Refused to continue taking trial med.|0|||
148743972|NCT01004003|536533255|FG007|Overall Study|Refused to continue taking trial med.|0|||
148743973|NCT01004003|536533256|FG008|Overall Study|Refused to continue taking trial med.|2|||
148743974|NCT01004003|536533248|FG000|Overall Study|Other|0|||
148743975|NCT01004003|536533249|FG001|Overall Study|Other|0|||
148743976|NCT01004003|536533250|FG002|Overall Study|Other|0|||
148743977|NCT01004003|536533251|FG003|Overall Study|Other|0|||
148743978|NCT01004003|536533252|FG004|Overall Study|Other|0|||
148743979|NCT01004003|536533253|FG005|Overall Study|Other|1|||
148743980|NCT01004003|536533254|FG006|Overall Study|Other|0|||
148743981|NCT01004003|536533255|FG007|Overall Study|Other|0|||
148743982|NCT01004003|536533256|FG008|Overall Study|Other|0|||
148743983|NCT00315731|536533259|FG000|Overall Study|Lost to Follow-up|1|||
148743984|NCT00315731|536533259|FG000|Overall Study|Death|5|||
148743985|NCT01680497|536533260|FG000|Overall Study|Lost to Follow-up|2|||
148743986|NCT00725205|536533261|FG000|Overall Study|Adverse Event|22|||
148743987|NCT00725205|536533261|FG000|Overall Study|Investigator Discontinued|1|||
148743988|NCT00725205|536533261|FG000|Overall Study|Non-compliance With Protocol|14|||
148743989|NCT00725205|536533261|FG000|Overall Study|Other|8|||
148743990|NCT00725205|536533261|FG000|Overall Study|Protocol Defined Clinical Event|1|||
148743991|NCT00725205|536533261|FG000|Overall Study|Treatment Failure|41|||
148743992|NCT05819203|536533262|FG000|Overall Study|Protocol Violation|1|||
148743993|NCT05819203|536533263|FG001|Overall Study|Protocol Violation|2|||
148743994|NCT05819203|536533262|FG000|Overall Study|Withdrawal by Subject|1|||
148743995|NCT05819203|536533263|FG001|Overall Study|Withdrawal by Subject|0|||
148743996|NCT04123561|536533266|FG000|Overall Study|Lost to Follow-up|20|||
148743997|NCT04123561|536533267|FG001|Overall Study|Lost to Follow-up|12|||
148743998|NCT04123561|536533268|FG002|Overall Study|Lost to Follow-up|5|||
148743999|NCT04123561|536533266|FG000|Overall Study|Withdrawal by Subject|9|||
148744000|NCT04123561|536533267|FG001|Overall Study|Withdrawal by Subject|7|||
148744001|NCT04123561|536533268|FG002|Overall Study|Withdrawal by Subject|9|||
148744002|NCT04123561|536533266|FG000|Overall Study|Lack of Efficacy|7|||
148819162|NCT01860989|536814631|FG000|Overall Study|Unsatisfactory therapeutic|5|||
148819163|NCT04739709|536814635|FG000|Overall Study|Physician Decision|1|||
148819164|NCT04739709|536814636|FG001|Overall Study|Physician Decision|0|||
148744003|NCT04123561|536533267|FG001|Overall Study|Lack of Efficacy|8|||
148744004|NCT04123561|536533268|FG002|Overall Study|Lack of Efficacy|6|||
148744005|NCT04123561|536533266|FG000|Overall Study|Adverse Event|5|||
148819165|NCT01980888|536814638|FG000|Overall Study|Study Terminated by Sponsor|116|||
148819166|NCT01980888|536814639|FG001|Overall Study|Study Terminated by Sponsor|122|||
148744006|NCT04123561|536533267|FG001|Overall Study|Adverse Event|2|||
148744007|NCT04123561|536533268|FG002|Overall Study|Adverse Event|3|||
148744008|NCT04123561|536533266|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
148744009|NCT04123561|536533267|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
148744010|NCT04123561|536533268|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
148744011|NCT04123561|536533266|FG000|Overall Study|Death|0|||
148744012|NCT04123561|536533267|FG001|Overall Study|Death|0|||
148819167|NCT01980888|536814638|FG000|Overall Study|Withdrew Consent|17|||
148744013|NCT04123561|536533268|FG002|Overall Study|Death|1|||
148744014|NCT04123561|536533266|FG000|Overall Study|Protocol Violation|0|||
148744015|NCT04123561|536533267|FG001|Overall Study|Protocol Violation|1|||
148744016|NCT04123561|536533268|FG002|Overall Study|Protocol Violation|0|||
148744017|NCT01243775|536533269|FG000|Overall Study|Withdrawal by Subject|2|||
148744018|NCT02260570|536535834|FG000|Overall Study|Withdrawal by Subject|2|||
148744019|NCT02260570|536535835|FG001|Overall Study|Withdrawal by Subject|1|||
148744020|NCT02260570|536535834|FG000|Overall Study|Physician Decision|1|||
148744021|NCT02260570|536535835|FG001|Overall Study|Physician Decision|1|||
148744022|NCT03996447|536535836|FG000|First MRI Examination|Adverse Event|2|||
148744023|NCT03996447|536535837|FG001|First MRI Examination|Adverse Event|0|||
148744024|NCT03996447|536535836|FG000|First MRI Examination|Withdrawal by Subject|1|||
148744025|NCT03996447|536535837|FG001|First MRI Examination|Withdrawal by Subject|2|||
148744026|NCT03996447|536535836|FG000|First MRI Examination|Protocol Violation|0|||
148744027|NCT03996447|536535837|FG001|First MRI Examination|Protocol Violation|1|||
148744028|NCT03996447|536535836|FG000|Washout|Adverse Event|2|||
148744029|NCT03996447|536535837|FG001|Washout|Adverse Event|0|||
148744030|NCT03996447|536535836|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
148744031|NCT03996447|536535837|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
148744032|NCT03996447|536535836|FG000|Washout|Withdrawal by Subject|0|||
148744033|NCT03996447|536535837|FG001|Washout|Withdrawal by Subject|1|||
148744034|NCT03996447|536535836|FG000|Washout|Other reason|1|||
148744035|NCT03996447|536535837|FG001|Washout|Other reason|1|||
148744036|NCT01810302|536535845|FG000|Overall Study|Death|1|||
148744037|NCT01810302|536535846|FG001|Overall Study|Death|0|||
148744038|NCT01810302|536535845|FG000|Overall Study|Physician Decision|0|||
148744039|NCT01810302|536535846|FG001|Overall Study|Physician Decision|1|||
148744040|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #1|24|||
148744041|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #1|0|||
148744042|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
148744043|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
148744044|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744045|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744046|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
148744047|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
148744048|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
148744049|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
148744050|NCT03888066|536535847|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744051|NCT03888066|536535848|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744052|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744053|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744054|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
148744055|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
148744056|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744057|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744058|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
148744059|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744060|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #2|5|||
148744061|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #2|0|||
148744062|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
148744063|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
148744064|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
148744065|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
148744066|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
148744067|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
148744068|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #3|11|||
148744069|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #3|0|||
148744070|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
148744071|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
148744072|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
148744073|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
148744074|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744075|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744076|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #4|3|||
148744077|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #4|0|||
148744078|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
148744079|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
148975977|NCT02751983|537392403|FG001|Treatment|Stopped ACT, but Remained in study|0|||
148975978|NCT02751983|537392402|FG000|Treatment|Discharged prior to beginning ACT|2|||
148975979|NCT02751983|537392403|FG001|Treatment|Discharged prior to beginning ACT|0|||
148975980|NCT02751983|537392402|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
148975981|NCT02751983|537392403|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
148744080|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
148744081|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
148744082|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
148744083|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
148744084|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
148744085|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
148744086|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
148744087|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744088|NCT03888066|536535847|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
148819168|NCT01980888|536814639|FG001|Overall Study|Withdrew Consent|6|||
148819169|NCT01980888|536814638|FG000|Overall Study|Investigator's Discretion|8|||
148819170|NCT01980888|536814639|FG001|Overall Study|Investigator's Discretion|3|||
148819171|NCT01980888|536814638|FG000|Overall Study|Non-Compliance with Study Drug|3|||
148819172|NCT01980888|536814639|FG001|Overall Study|Non-Compliance with Study Drug|2|||
148819173|NCT04625972|536814640|FG000|Overall Study|Death|3|||
148819174|NCT04625972|536814641|FG001|Overall Study|Death|2|||
148819175|NCT04625972|536814640|FG000|Overall Study|Lost to Follow-up|82|||
148819176|NCT04625972|536814641|FG001|Overall Study|Lost to Follow-up|38|||
148819177|NCT04625972|536814640|FG000|Overall Study|Physician Decision|2|||
148819178|NCT04625972|536814641|FG001|Overall Study|Physician Decision|0|||
148819179|NCT04625972|536814640|FG000|Overall Study|Protocol Violation|0|||
148819180|NCT04625972|536814641|FG001|Overall Study|Protocol Violation|1|||
148819181|NCT04625972|536814640|FG000|Overall Study|Withdrawal by Subject|37|||
148819182|NCT04625972|536814641|FG001|Overall Study|Withdrawal by Subject|24|||
148819183|NCT04625972|536814640|FG000|Overall Study|Not specified elsewhere|8|||
148819184|NCT04625972|536814641|FG001|Overall Study|Not specified elsewhere|6|||
148819185|NCT00433290|536814642|FG000|Overall Study|Adverse Event|24|||
148819186|NCT00433290|536814643|FG001|Overall Study|Adverse Event|7|||
148819187|NCT00433290|536814642|FG000|Overall Study|Lack of Efficacy|1|||
148819188|NCT00433290|536814643|FG001|Overall Study|Lack of Efficacy|5|||
148819189|NCT00433290|536814642|FG000|Overall Study|Withdrawal by Subject|4|||
148819190|NCT00433290|536814643|FG001|Overall Study|Withdrawal by Subject|2|||
148819191|NCT00433290|536814642|FG000|Overall Study|Protocol Violation|3|||
148819192|NCT00433290|536814643|FG001|Overall Study|Protocol Violation|2|||
148819193|NCT00433290|536814642|FG000|Overall Study|Physician Decision|2|||
148819194|NCT00433290|536814643|FG001|Overall Study|Physician Decision|0|||
148819195|NCT00433290|536814642|FG000|Overall Study|Entry Criteria Not Met|0|||
148819196|NCT00433290|536814643|FG001|Overall Study|Entry Criteria Not Met|1|||
148819197|NCT00433290|536814642|FG000|Overall Study|Lost to Follow-up|1|||
148819198|NCT00433290|536814643|FG001|Overall Study|Lost to Follow-up|0|||
148819199|NCT01483651|536814644|FG000|Overall Study|Withdrawal by Subject|0|||
148819200|NCT01483651|536814645|FG001|Overall Study|Withdrawal by Subject|1|||
148819201|NCT01483651|536814646|FG002|Overall Study|Withdrawal by Subject|1|||
148819202|NCT01483651|536814647|FG003|Overall Study|Withdrawal by Subject|0|||
148819203|NCT01483651|536814648|FG004|Overall Study|Withdrawal by Subject|0|||
148819204|NCT01483651|536814649|FG005|Overall Study|Withdrawal by Subject|1|||
148819205|NCT01018953|536814650|FG000|Overall Study|Adverse Event|2|||
148819206|NCT01018953|536814650|FG000|Overall Study|Withdrawal by Subject|1|||
148819207|NCT01018953|536814650|FG000|Overall Study|Study termination by sponsor|5|||
148819208|NCT00724503|536814651|FG000|Overall Study|Lost to Follow-up|4|||
148819209|NCT00724503|536814652|FG001|Overall Study|Lost to Follow-up|8|||
148819210|NCT00724503|536814651|FG000|Overall Study|Withdrawal by Subject|11|||
148819211|NCT00724503|536814652|FG001|Overall Study|Withdrawal by Subject|23|||
148819212|NCT00724503|536814651|FG000|Overall Study|Death|190|||
148819213|NCT00724503|536814652|FG001|Overall Study|Death|182|||
148819214|NCT00724503|536814651|FG000|Overall Study|Adverse Event|1|||
148819215|NCT00724503|536814652|FG001|Overall Study|Adverse Event|0|||
148819216|NCT00724503|536814651|FG000|Overall Study|Not otherwise specified|4|||
148819217|NCT00724503|536814652|FG001|Overall Study|Not otherwise specified|7|||
148975982|NCT02751983|537392402|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
148819218|NCT01186419|536814655|FG000|Overall Study|Withdrawal by Subject|5|||
148819219|NCT01186419|536814656|FG001|Overall Study|Withdrawal by Subject|3|||
148819220|NCT01186419|536814655|FG000|Overall Study|Adverse Event|1|||
148819221|NCT01186419|536814656|FG001|Overall Study|Adverse Event|2|||
148975983|NCT02751983|537392403|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
148819222|NCT01186419|536814655|FG000|Overall Study|Physician Decision|0|||
148819223|NCT01186419|536814656|FG001|Overall Study|Physician Decision|3|||
148819224|NCT01186419|536814655|FG000|Overall Study|Other|1|||
148819225|NCT01186419|536814656|FG001|Overall Study|Other|1|||
148819226|NCT01928771|536814658|FG000|Overall Study|Adverse Event|6|||
148819227|NCT01928771|536814659|FG001|Overall Study|Adverse Event|5|||
148819228|NCT01928771|536814660|FG002|Overall Study|Adverse Event|1|||
148819229|NCT01928771|536814658|FG000|Overall Study|Death|2|||
148819230|NCT01928771|536814659|FG001|Overall Study|Death|2|||
148819231|NCT01928771|536814660|FG002|Overall Study|Death|2|||
148819232|NCT01928771|536814658|FG000|Overall Study|Lost to Follow-up|5|||
148819233|NCT01928771|536814659|FG001|Overall Study|Lost to Follow-up|6|||
148819234|NCT01928771|536814660|FG002|Overall Study|Lost to Follow-up|3|||
148819235|NCT01928771|536814658|FG000|Overall Study|Withdrawal by Subject|20|||
148819236|NCT01928771|536814659|FG001|Overall Study|Withdrawal by Subject|15|||
148819237|NCT01928771|536814660|FG002|Overall Study|Withdrawal by Subject|17|||
148819238|NCT01928771|536814658|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
148819239|NCT01928771|536814659|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
148819240|NCT01928771|536814660|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
148819241|NCT01928771|536814658|FG000|Overall Study|Other Reasons|9|||
148819242|NCT01928771|536814659|FG001|Overall Study|Other Reasons|9|||
148819243|NCT01928771|536814660|FG002|Overall Study|Other Reasons|14|||
148819244|NCT01928771|536814658|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
148819245|NCT01928771|536814659|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
148819246|NCT01928771|536814660|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
148819247|NCT01937117|536814661|FG000|Overall Study|Disease Progression|7|||
148819248|NCT01937117|536814661|FG000|Overall Study|Physician Decision|4|||
148819249|NCT01937117|536814661|FG000|Overall Study|Adverse Event|2|||
148819250|NCT01407367|536814662|FG000|Overall Study|Death|24|||
148819251|NCT01407367|536814663|FG001|Overall Study|Death|32|||
148819252|NCT01407367|536814662|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
148819253|NCT01407367|536814663|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
148819254|NCT01407367|536814662|FG000|Overall Study|Withdrawal by Subject|4|||
148819255|NCT01407367|536814663|FG001|Overall Study|Withdrawal by Subject|15|||
148819256|NCT01407367|536814662|FG000|Overall Study|Lost to Follow-up|0|||
148819257|NCT01407367|536814663|FG001|Overall Study|Lost to Follow-up|2|||
148819258|NCT01245062|536814665|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
148819259|NCT01245062|536814666|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
148819260|NCT01245062|536814667|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
148819261|NCT01245062|536814665|FG000|Randomization and Crossover Phase|Physician Decision|2|||
148819262|NCT01245062|536814666|FG001|Randomization and Crossover Phase|Physician Decision|4|||
148819263|NCT01245062|536814667|FG002|Randomization and Crossover Phase|Physician Decision|0|||
148819264|NCT01245062|536814665|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
148819265|NCT01245062|536814666|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
148819266|NCT01245062|536814667|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
148819267|NCT01245062|536814665|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
148819268|NCT01245062|536814666|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
148819269|NCT01245062|536814667|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
148819270|NCT01245062|536814665|FG000|Cross-over Phase|Lost to Follow-up|0|||
148819271|NCT01245062|536814666|FG001|Cross-over Phase|Lost to Follow-up|0|||
148819272|NCT01245062|536814667|FG002|Cross-over Phase|Lost to Follow-up|1|||
148819273|NCT01245062|536814665|FG000|Cross-over Phase|Physician Decision|0|||
148819274|NCT01245062|536814666|FG001|Cross-over Phase|Physician Decision|0|||
148819275|NCT01245062|536814667|FG002|Cross-over Phase|Physician Decision|1|||
148819276|NCT01245062|536814665|FG000|Cross-over Phase|Withdrew Consent|0|||
148819277|NCT01245062|536814666|FG001|Cross-over Phase|Withdrew Consent|0|||
148819278|NCT01245062|536814667|FG002|Cross-over Phase|Withdrew Consent|4|||
148819279|NCT01245062|536814665|FG000|Cross-over Phase|Study closed/ terminated|0|||
148819280|NCT01245062|536814666|FG001|Cross-over Phase|Study closed/ terminated|0|||
148819281|NCT01245062|536814667|FG002|Cross-over Phase|Study closed/ terminated|11|||
148819282|NCT06025695|536814668|FG000|Overall Study|Adverse Event|5|||
148819283|NCT06025695|536814669|FG001|Overall Study|Adverse Event|6|||
148819284|NCT06025695|536814668|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
148819285|NCT06025695|536814669|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
148819286|NCT06025695|536814668|FG000|Overall Study|Other|23|||
148819287|NCT06025695|536814669|FG001|Overall Study|Other|19|||
148819288|NCT06025695|536814668|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
148819289|NCT06025695|536814669|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
148819290|NCT05762744|536814670|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
148819291|NCT05762744|536814671|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
148819292|NCT05762744|536814670|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
148889061|NCT02800863|537072347|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
148889062|NCT02800863|537072347|FG000|Overall Study|Screen Failure|1|||
148889063|NCT02800863|537072347|FG000|Overall Study|Sponsor Request|6|||
148889064|NCT02800863|537072347|FG000|Overall Study|Death|3|||
148889065|NCT02800863|537072347|FG000|Overall Study|Subject Implant at Another Facility|1|||
148889066|NCT02800863|537072347|FG000|Overall Study|Lost to Follow-up|26|||
148819293|NCT05762744|536814671|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
148819294|NCT01560416|536814675|FG000|Randomized Phase|Crossover Participants|7|||
148819295|NCT01560416|536814676|FG001|Randomized Phase|Crossover Participants|0|||
148819296|NCT00853047|536814680|FG000|Core Phase|Participant Request|0|||
148819297|NCT00853047|536814681|FG001|Core Phase|Participant Request|0|||
148819298|NCT00853047|536814682|FG002|Core Phase|Participant Request|0|||
148819299|NCT00853047|536814683|FG003|Core Phase|Participant Request|1|||
148819300|NCT00853047|536814684|FG004|Core Phase|Participant Request|0|||
148819301|NCT00853047|536814685|FG005|Core Phase|Participant Request|0|||
148819302|NCT00853047|536814680|FG000|Open-Label Extension Phase|Participant Request|0|||
148819303|NCT00853047|536814681|FG001|Open-Label Extension Phase|Participant Request|0|||
148819304|NCT00853047|536814682|FG002|Open-Label Extension Phase|Participant Request|0|||
148819305|NCT00853047|536814683|FG003|Open-Label Extension Phase|Participant Request|0|||
148819306|NCT00853047|536814684|FG004|Open-Label Extension Phase|Participant Request|0|||
148819307|NCT00853047|536814685|FG005|Open-Label Extension Phase|Participant Request|7|||
148819308|NCT00853047|536814680|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
148819309|NCT00853047|536814681|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
148819310|NCT00853047|536814682|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
148819311|NCT00853047|536814683|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
148744089|NCT03888066|536535848|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
148744090|NCT03888066|536535847|FG000|Run-in Phase|AE (Adverse Event)|17|||
148744091|NCT03888066|536535848|FG001|Run-in Phase|AE (Adverse Event)|0|||
148744092|NCT03888066|536535847|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
148744093|NCT03888066|536535848|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
148744094|NCT03888066|536535847|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744095|NCT03888066|536535848|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744096|NCT03888066|536535847|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
148744097|NCT03888066|536535848|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744098|NCT03888066|536535847|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
148744099|NCT03888066|536535848|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
148744100|NCT03888066|536535847|FG000|Run-in Phase|Withdrawal by Subject|43|||
148744101|NCT03888066|536535848|FG001|Run-in Phase|Withdrawal by Subject|0|||
148744102|NCT03888066|536535847|FG000|Run-in Phase|AE; Physician Decision|1|||
148744103|NCT03888066|536535848|FG001|Run-in Phase|AE; Physician Decision|0|||
148744104|NCT03888066|536535847|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
148744105|NCT03888066|536535848|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
148744106|NCT03888066|536535847|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
148744107|NCT03888066|536535848|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
148744108|NCT03888066|536535847|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
148744109|NCT03888066|536535848|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
148744110|NCT03888066|536535847|FG000|Run-in Phase|Death|1|||
148744111|NCT03888066|536535848|FG001|Run-in Phase|Death|0|||
148744112|NCT03888066|536535847|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
148744113|NCT03888066|536535848|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
148744114|NCT03888066|536535847|FG000|Run-in Phase|Physician Decision|1|||
148744115|NCT03888066|536535848|FG001|Run-in Phase|Physician Decision|0|||
148744116|NCT03888066|536535847|FG000|Run-in Phase|Protocol Violation|13|||
148744117|NCT03888066|536535848|FG001|Run-in Phase|Protocol Violation|0|||
148744118|NCT03888066|536535847|FG000|Run-in Phase|Sponsor Request|34|||
148744119|NCT03888066|536535848|FG001|Run-in Phase|Sponsor Request|0|||
148744120|NCT03888066|536535847|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
148744121|NCT03888066|536535848|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
148744122|NCT03888066|536535847|FG000|Run-in Phase|Withdrawal Of Consent|1|||
148744123|NCT03888066|536535848|FG001|Run-in Phase|Withdrawal Of Consent|0|||
148744124|NCT03888066|536535847|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
148744125|NCT03888066|536535848|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
148744126|NCT03888066|536535847|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
148744127|NCT03888066|536535848|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
148744128|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
148744129|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
148744130|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
148744131|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
148744132|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
148744133|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
148744134|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
148744135|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
148744136|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
148744137|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
148819312|NCT00853047|536814684|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
148819313|NCT00853047|536814685|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
148819314|NCT00853047|536814680|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
148819315|NCT00853047|536814681|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
148819316|NCT00853047|536814682|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
148819317|NCT00853047|536814683|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
148819318|NCT00853047|536814684|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
148819319|NCT00853047|536814685|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
148819320|NCT00853047|536814680|FG000|Open-Label Extension Phase|Investigator Decision|0|||
148819321|NCT00853047|536814681|FG001|Open-Label Extension Phase|Investigator Decision|0|||
148819322|NCT00853047|536814682|FG002|Open-Label Extension Phase|Investigator Decision|0|||
148819323|NCT00853047|536814683|FG003|Open-Label Extension Phase|Investigator Decision|0|||
148819324|NCT00853047|536814684|FG004|Open-Label Extension Phase|Investigator Decision|0|||
148819325|NCT00853047|536814685|FG005|Open-Label Extension Phase|Investigator Decision|1|||
148819326|NCT00853047|536814680|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
148819327|NCT00853047|536814681|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
148819328|NCT00853047|536814682|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
148819329|NCT00853047|536814683|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
148819330|NCT00853047|536814684|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
148819331|NCT00853047|536814685|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
148819332|NCT01695772|536814689|FG000|Overall Study|Withdrawal by Subject|18|||
148819333|NCT01695772|536814689|FG000|Overall Study|Progressive Disease|8|||
148819334|NCT01695772|536814689|FG000|Overall Study|Investigator Decision|5|||
148819335|NCT01695772|536814689|FG000|Overall Study|Lost to Follow-up|4|||
148819336|NCT01695772|536814689|FG000|Overall Study|Protocol Violation|2|||
148819337|NCT01695772|536814689|FG000|Overall Study|Unspecified Reason|1|||
148819338|NCT00004859|536814690|FG000|Overall Study|Lack of Efficacy|43|||
148819339|NCT00004859|536814691|FG001|Overall Study|Lack of Efficacy|113|||
148819340|NCT00004859|536814690|FG000|Overall Study|Adverse Event|31|||
148819341|NCT00004859|536814691|FG001|Overall Study|Adverse Event|93|||
148744138|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
148744139|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
148744140|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
148744141|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
148744142|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
148744143|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
148744144|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
148744145|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
148744146|NCT03888066|536535847|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
148819342|NCT00004859|536814690|FG000|Overall Study|Death|5|||
148819343|NCT00004859|536814691|FG001|Overall Study|Death|5|||
148819344|NCT00004859|536814690|FG000|Overall Study|Withdrawal by Subject|7|||
148819345|NCT00004859|536814691|FG001|Overall Study|Withdrawal by Subject|33|||
148819346|NCT00004859|536814690|FG000|Overall Study|Protocol Violation|2|||
148819347|NCT00004859|536814691|FG001|Overall Study|Protocol Violation|2|||
148819348|NCT00004859|536814690|FG000|Overall Study|other disease|0|||
148819349|NCT00004859|536814691|FG001|Overall Study|other disease|3|||
148819350|NCT00004859|536814690|FG000|Overall Study|error|3|||
148819351|NCT00004859|536814691|FG001|Overall Study|error|1|||
148819352|NCT00004859|536814690|FG000|Overall Study|missing data|14|||
148819353|NCT00004859|536814691|FG001|Overall Study|missing data|11|||
148819354|NCT00004859|536814690|FG000|Overall Study|Other|13|||
148819355|NCT00004859|536814691|FG001|Overall Study|Other|21|||
148819356|NCT04073407|536814692|FG000|Part 1|Withdrawal by Subject|1|||
148819357|NCT04073407|536814693|FG001|Part 1|Withdrawal by Subject|0|||
148819358|NCT04073407|536814692|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
148819359|NCT04073407|536814693|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
148819360|NCT04073407|536814692|FG000|Part 2|Withdrawal by Subject|0|||
148819361|NCT04073407|536814693|FG001|Part 2|Withdrawal by Subject|1|||
148819362|NCT01778985|536816280|FG000|Overall Study|Lost to Follow-up|1|||
148819363|NCT01778985|536816281|FG001|Overall Study|Lost to Follow-up|0|||
148819364|NCT01778985|536816280|FG000|Overall Study|Physician Decision|2|||
148819365|NCT01778985|536816281|FG001|Overall Study|Physician Decision|2|||
148819366|NCT01778985|536816280|FG000|Overall Study|Protocol Violation|4|||
148819367|NCT01778985|536816281|FG001|Overall Study|Protocol Violation|1|||
148819368|NCT00088881|536816284|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
148819369|NCT00088881|536816284|FG000|Step 1 - R-CHOP|Adverse Event|1|||
149027160|NCT02929108|537576521|FG002|Overall Study|Hospice patient death|28|||
148819370|NCT00088881|536816284|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
148819371|NCT00088881|536816284|FG000|Step 1 - R-CHOP|Physician Decision|1|||
148819372|NCT00088881|536816284|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
148819373|NCT00088881|536816284|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
148819374|NCT00088881|536816284|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
148819375|NCT02370394|536816292|FG000|Overall Study|Lost to Follow-up|2|||
148744147|NCT03888066|536535848|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
148744148|NCT02207634|536535849|FG000|Overall Study|Withdrawal by Subject|21|||
148744149|NCT02207634|536535850|FG001|Overall Study|Withdrawal by Subject|31|||
148744150|NCT02207634|536535849|FG000|Overall Study|Lost to Follow-up|1|||
148744151|NCT02207634|536535850|FG001|Overall Study|Lost to Follow-up|0|||
148744152|NCT02077140|536535851|FG000|Overall Study|Lost to Follow-up|4|||
148744153|NCT02077140|536535852|FG001|Overall Study|Lost to Follow-up|1|||
148744154|NCT02077140|536535853|FG002|Overall Study|Lost to Follow-up|2|||
148744155|NCT02077140|536535854|FG003|Overall Study|Lost to Follow-up|2|||
148744156|NCT02077140|536535855|FG004|Overall Study|Lost to Follow-up|3|||
148744157|NCT02077140|536535851|FG000|Overall Study|Withdrawal by Subject|0|||
148819376|NCT02370394|536816293|FG001|Overall Study|Lost to Follow-up|1|||
148819377|NCT02370394|536816292|FG000|Overall Study|Withdrawal by Subject|0|||
148819378|NCT02370394|536816293|FG001|Overall Study|Withdrawal by Subject|1|||
148819379|NCT03684057|536816294|FG000|Overall Study|Withdrawal by Subject|4|||
148819380|NCT03684057|536816295|FG001|Overall Study|Withdrawal by Subject|5|||
148819381|NCT02545127|536816296|FG000|Overall Study|Lost to Follow-up|1|||
148819382|NCT02545127|536816297|FG001|Overall Study|Lost to Follow-up|0|||
148819383|NCT03197935|536816298|FG000|Overall Study|Death due to any cause|26|||
148819384|NCT03197935|536816299|FG001|Overall Study|Death due to any cause|15|||
148819385|NCT03197935|536816298|FG000|Overall Study|Lost to Follow-up|3|||
148819386|NCT03197935|536816299|FG001|Overall Study|Lost to Follow-up|5|||
148819387|NCT03197935|536816298|FG000|Overall Study|Physician Decision|2|||
148819388|NCT03197935|536816299|FG001|Overall Study|Physician Decision|1|||
148819389|NCT03197935|536816298|FG000|Overall Study|Withdrawal by Subject|16|||
148819390|NCT03197935|536816299|FG001|Overall Study|Withdrawal by Subject|8|||
148819391|NCT00960856|536816301|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
148819392|NCT00960856|536816302|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
148819393|NCT00960856|536816303|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
148819394|NCT00960856|536816304|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
148819395|NCT00960856|536816301|FG000|Washout Period of 7 Days|Adverse Event|0|||
148819396|NCT00960856|536816302|FG001|Washout Period of 7 Days|Adverse Event|0|||
148819397|NCT00960856|536816303|FG002|Washout Period of 7 Days|Adverse Event|1|||
148819398|NCT00960856|536816304|FG003|Washout Period of 7 Days|Adverse Event|0|||
148819399|NCT05938010|536816306|FG000|Overall Study|Lost to Follow-up|2|||
148819400|NCT00985192|536816307|FG000|Overall Study|Withdrawal by Subject|1|||
148819401|NCT00985192|536816307|FG000|Overall Study|Disease Progression|1|||
148819402|NCT00985192|536816307|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
148819403|NCT02595749|536816310|FG000|Overall Study|Withdrawal by Subject|12|||
148819404|NCT02595749|536816311|FG001|Overall Study|Withdrawal by Subject|7|||
148819405|NCT00669331|536816312|FG000|Randomisation to First Dose|Adverse Event|1|||
148819406|NCT00669331|536816313|FG001|Randomisation to First Dose|Adverse Event|0|||
148819407|NCT00669331|536816312|FG000|Randomisation to First Dose|Protocol Violation|1|||
148819408|NCT00669331|536816313|FG001|Randomisation to First Dose|Protocol Violation|0|||
148819409|NCT00669331|536816312|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
148819410|NCT00669331|536816313|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
148819411|NCT00669331|536816312|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
148819412|NCT00669331|536816313|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
148819413|NCT00669331|536816312|FG000|Randomisation to First Dose|Death|1|||
148819414|NCT00669331|536816313|FG001|Randomisation to First Dose|Death|0|||
148819415|NCT00669331|536816312|FG000|Randomisation to First Dose|Sponsor decision|0|||
148819416|NCT00669331|536816313|FG001|Randomisation to First Dose|Sponsor decision|1|||
148819417|NCT00669331|536816312|FG000|Randomisation to First Dose|Randomised in error|3|||
148819418|NCT00669331|536816313|FG001|Randomisation to First Dose|Randomised in error|10|||
148819419|NCT00669331|536816312|FG000|Blinded Treatment Period|Adverse Event|16|||
148819420|NCT00669331|536816313|FG001|Blinded Treatment Period|Adverse Event|10|||
148819421|NCT00669331|536816312|FG000|Blinded Treatment Period|Protocol Violation|1|||
148819422|NCT00669331|536816313|FG001|Blinded Treatment Period|Protocol Violation|1|||
148819423|NCT00669331|536816312|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
148819424|NCT00669331|536816313|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
148819425|NCT00669331|536816312|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
148819426|NCT00669331|536816313|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
148819427|NCT00669331|536816312|FG000|Blinded Treatment Period|Death|0|||
148819428|NCT00669331|536816313|FG001|Blinded Treatment Period|Death|2|||
148819429|NCT00669331|536816312|FG000|Blinded Treatment Period|Physician Decision|3|||
148819430|NCT00669331|536816313|FG001|Blinded Treatment Period|Physician Decision|3|||
148744158|NCT02077140|536535852|FG001|Overall Study|Withdrawal by Subject|1|||
148744159|NCT02077140|536535853|FG002|Overall Study|Withdrawal by Subject|0|||
148744160|NCT02077140|536535854|FG003|Overall Study|Withdrawal by Subject|2|||
148819431|NCT00669331|536816312|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
148819432|NCT00669331|536816313|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
148819433|NCT01454063|536816314|FG000|Randomized|Adverse Event|1|||
148819434|NCT01454063|536816315|FG001|Randomized|Adverse Event|1|||
148819435|NCT01454063|536816314|FG000|Randomized|Protocol Violation|0|||
148819436|NCT01454063|536816315|FG001|Randomized|Protocol Violation|1|||
148744161|NCT02077140|536535855|FG004|Overall Study|Withdrawal by Subject|2|||
148744162|NCT00451204|536535856|FG000|Overall Study|Adverse Event|4|||
148744163|NCT00451204|536535857|FG001|Overall Study|Adverse Event|6|||
148744164|NCT00451204|536535856|FG000|Overall Study|Lack of Efficacy|4|||
148744165|NCT00451204|536535857|FG001|Overall Study|Lack of Efficacy|4|||
148744166|NCT00451204|536535856|FG000|Overall Study|Lost to Follow-up|4|||
148744167|NCT00451204|536535857|FG001|Overall Study|Lost to Follow-up|4|||
148744168|NCT00451204|536535856|FG000|Overall Study|Protocol Violation|1|||
148744169|NCT00451204|536535857|FG001|Overall Study|Protocol Violation|0|||
148744170|NCT00451204|536535856|FG000|Overall Study|Patient refusal|8|||
148744171|NCT00451204|536535857|FG001|Overall Study|Patient refusal|4|||
148744172|NCT00451204|536535856|FG000|Overall Study|Other|1|||
148744173|NCT00451204|536535857|FG001|Overall Study|Other|2|||
148744174|NCT00230178|536535860|FG000|Overall Study|Adverse Event|1|||
148744175|NCT00230178|536535861|FG001|Overall Study|Adverse Event|5|||
148744176|NCT00230178|536535862|FG002|Overall Study|Adverse Event|2|||
148744177|NCT00230178|536535860|FG000|Overall Study|Withdrawal by Subject|0|||
148744178|NCT00230178|536535861|FG001|Overall Study|Withdrawal by Subject|0|||
148744179|NCT00230178|536535862|FG002|Overall Study|Withdrawal by Subject|1|||
148744180|NCT00230178|536535860|FG000|Overall Study|Various other reasons|3|||
148744181|NCT00230178|536535861|FG001|Overall Study|Various other reasons|2|||
148744182|NCT00230178|536535862|FG002|Overall Study|Various other reasons|4|||
148744183|NCT01753297|536535863|FG000|Overall Study|Lost to Follow-up|7|||
148744184|NCT01753297|536535864|FG001|Overall Study|Lost to Follow-up|2|||
148744185|NCT01753297|536535863|FG000|Overall Study|Withdrawal by Subject|26|||
148744186|NCT01753297|536535864|FG001|Overall Study|Withdrawal by Subject|23|||
148744187|NCT01753297|536535863|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
148744188|NCT01753297|536535864|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
148744189|NCT01753297|536535863|FG000|Overall Study|Death|0|||
148744190|NCT01753297|536535864|FG001|Overall Study|Death|2|||
148744191|NCT01753297|536535863|FG000|Overall Study|Did not attend end of study visit|7|||
148744192|NCT01753297|536535864|FG001|Overall Study|Did not attend end of study visit|8|||
148744193|NCT01275729|536535865|FG000|Overall Study|Death|3|||
148744194|NCT01275729|536535865|FG000|Overall Study|Withdrawal by Subject|1|||
148744195|NCT02252406|536535866|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
148744196|NCT02252406|536535867|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
148744197|NCT02252406|536535866|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
148744198|NCT02252406|536535867|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
148744199|NCT02252406|536535866|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
148744200|NCT02252406|536535867|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
148744201|NCT02252406|536535866|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
148744202|NCT02252406|536535867|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
148744203|NCT02252406|536535866|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
148744204|NCT02252406|536535867|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
148744205|NCT00447876|536535868|FG000|Overall Study|Withdrawal by Subject|1|||
148744206|NCT00447876|536535869|FG001|Overall Study|Withdrawal by Subject|4|||
148744207|NCT00447876|536535868|FG000|Overall Study|Lost to Follow-up|1|||
148744208|NCT00447876|536535869|FG001|Overall Study|Lost to Follow-up|0|||
148744209|NCT00447876|536535868|FG000|Overall Study|Deterioration of symptomology|1|||
148744210|NCT00447876|536535869|FG001|Overall Study|Deterioration of symptomology|0|||
148744211|NCT02533180|536535870|FG000|Overall Study|Death|0|||
148744212|NCT02533180|536535871|FG001|Overall Study|Death|2|||
148744213|NCT02533180|536535870|FG000|Overall Study|Lost to Follow-up|0|||
148744214|NCT02533180|536535871|FG001|Overall Study|Lost to Follow-up|1|||
148744215|NCT02533180|536535870|FG000|Overall Study|Physician Decision|0|||
148744216|NCT02533180|536535871|FG001|Overall Study|Physician Decision|1|||
148744217|NCT02533180|536535870|FG000|Overall Study|Withdrawal by Subject|2|||
148744218|NCT02533180|536535871|FG001|Overall Study|Withdrawal by Subject|5|||
148744219|NCT02533180|536535870|FG000|Overall Study|Screen Failure|37|||
148744220|NCT02533180|536535871|FG001|Overall Study|Screen Failure|0|||
148744221|NCT02533180|536535870|FG000|Overall Study|Protocol Deviation|0|||
148744222|NCT02533180|536535871|FG001|Overall Study|Protocol Deviation|1|||
148744223|NCT02533180|536535870|FG000|Overall Study|Non-compliance|0|||
148744224|NCT02533180|536535871|FG001|Overall Study|Non-compliance|1|||
148819437|NCT01562444|536816320|FG000|Overall Study|Did not meet entry criteria|2|||
148744225|NCT01609023|536535872|FG000|Overall Study|Lack of Efficacy|3|||
148744226|NCT01609023|536535872|FG000|Overall Study|Withdrawal by Subject|4|||
148744227|NCT01609023|536535872|FG000|Overall Study|Lost to Follow-up|8|||
148744228|NCT01609023|536535872|FG000|Overall Study|Toxicity|3|||
148744229|NCT01609023|536535872|FG000|Overall Study|Disease progression|10|||
148744230|NCT01609023|536535872|FG000|Overall Study|Physician Decision|2|||
148744231|NCT01609023|536535872|FG000|Overall Study|Death|2|||
148744232|NCT01609023|536535872|FG000|Overall Study|Personal reasons|1|||
148744233|NCT04172597|536535876|FG000|Overall Study|Disease Progression|0|||
148819438|NCT01562444|536816321|FG001|Overall Study|Did not meet entry criteria|0|||
148744234|NCT04172597|536535877|FG001|Overall Study|Disease Progression|0|||
148744235|NCT04172597|536535878|FG002|Overall Study|Disease Progression|0|||
148975984|NCT02751983|537392402|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
148975985|NCT02751983|537392403|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
148975986|NCT00989833|537392404|FG000|Overall Study|Lost to Follow-up|0|||
148975987|NCT00989833|537392405|FG001|Overall Study|Lost to Follow-up|1|||
148744236|NCT04172597|536535879|FG003|Overall Study|Disease Progression|0|||
148744237|NCT04172597|536535880|FG004|Overall Study|Disease Progression|1|||
148744238|NCT03717012|536535895|FG000|Overall Study|Due to trial termination|1|||
148744239|NCT03717012|536535896|FG001|Overall Study|Due to trial termination|2|||
148744240|NCT03717012|536535895|FG000|Overall Study|Protocol Violation|0|||
148744241|NCT03717012|536535896|FG001|Overall Study|Protocol Violation|2|||
148744242|NCT03717012|536535895|FG000|Overall Study|Adverse Event|0|||
148744243|NCT03717012|536535896|FG001|Overall Study|Adverse Event|1|||
148744244|NCT03717012|536535895|FG000|Overall Study|Lung transplant|0|||
148744245|NCT03717012|536535896|FG001|Overall Study|Lung transplant|1|||
148744246|NCT00789035|536535897|FG000|Overall Study|Adverse Event|0|||
148744247|NCT00789035|536535898|FG001|Overall Study|Adverse Event|2|||
148744248|NCT00789035|536535899|FG002|Overall Study|Adverse Event|0|||
148744249|NCT00789035|536535900|FG003|Overall Study|Adverse Event|1|||
148744250|NCT00789035|536535901|FG004|Overall Study|Adverse Event|3|||
148744251|NCT00789035|536535897|FG000|Overall Study|Lack of Efficacy|3|||
148744252|NCT00789035|536535898|FG001|Overall Study|Lack of Efficacy|0|||
148744253|NCT00789035|536535899|FG002|Overall Study|Lack of Efficacy|0|||
148744254|NCT00789035|536535900|FG003|Overall Study|Lack of Efficacy|0|||
148744255|NCT00789035|536535901|FG004|Overall Study|Lack of Efficacy|2|||
148744256|NCT00789035|536535897|FG000|Overall Study|Protocol Violation|1|||
148744257|NCT00789035|536535898|FG001|Overall Study|Protocol Violation|0|||
148744258|NCT00789035|536535899|FG002|Overall Study|Protocol Violation|0|||
148744259|NCT00789035|536535900|FG003|Overall Study|Protocol Violation|0|||
148744260|NCT00789035|536535901|FG004|Overall Study|Protocol Violation|0|||
148744261|NCT00789035|536535897|FG000|Overall Study|Withdrawal by Subject|0|||
148744262|NCT00789035|536535898|FG001|Overall Study|Withdrawal by Subject|2|||
148744263|NCT00789035|536535899|FG002|Overall Study|Withdrawal by Subject|0|||
148744264|NCT00789035|536535900|FG003|Overall Study|Withdrawal by Subject|0|||
148744265|NCT00789035|536535901|FG004|Overall Study|Withdrawal by Subject|0|||
148744266|NCT00789035|536535897|FG000|Overall Study|Other reason not defined above|2|||
148744267|NCT00789035|536535898|FG001|Overall Study|Other reason not defined above|3|||
148744268|NCT00789035|536535899|FG002|Overall Study|Other reason not defined above|1|||
148744269|NCT00789035|536535900|FG003|Overall Study|Other reason not defined above|0|||
148744270|NCT00789035|536535901|FG004|Overall Study|Other reason not defined above|1|||
148744271|NCT01520870|536535902|FG000|Overall Study|Withdrawal by Subject|2|||
148744272|NCT02463357|536535903|FG000|Overall Study|Withdrawal by Subject|1|||
148744273|NCT02463357|536535904|FG001|Overall Study|Withdrawal by Subject|0|||
148744274|NCT02463357|536535905|FG002|Overall Study|Withdrawal by Subject|0|||
148744275|NCT02463357|536535906|FG003|Overall Study|Withdrawal by Subject|0|||
148744276|NCT02463357|536535907|FG004|Overall Study|Withdrawal by Subject|0|||
148744277|NCT02463357|536535903|FG000|Overall Study|Withdrawal by Subject|0|||
148744278|NCT02463357|536535904|FG001|Overall Study|Withdrawal by Subject|0|||
148744279|NCT02463357|536535905|FG002|Overall Study|Withdrawal by Subject|0|||
148744280|NCT02463357|536535906|FG003|Overall Study|Withdrawal by Subject|0|||
148744281|NCT02463357|536535907|FG004|Overall Study|Withdrawal by Subject|1|||
148744282|NCT01371539|536535910|FG000|Period One: One Week|Lost to Follow-up|0|||
148744283|NCT01371539|536535911|FG001|Period One: One Week|Lost to Follow-up|1|||
148744284|NCT01371539|536535910|FG000|Period Two: One Week|Lost to Follow-up|0|||
148744285|NCT01371539|536535911|FG001|Period Two: One Week|Lost to Follow-up|1|||
148744286|NCT01371539|536535910|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
148744287|NCT01371539|536535911|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
148744288|NCT01371539|536535910|FG000|Period Two: One Week|Time/job conflict|0|||
148744289|NCT01371539|536535911|FG001|Period Two: One Week|Time/job conflict|1|||
148744290|NCT01399658|536535912|FG000|Overall Study|Ineligible|1|||
148744291|NCT01399658|536535912|FG000|Overall Study|Machine Technical Issue|3|||
148744292|NCT01399658|536535912|FG000|Overall Study|Alternative therapy|1|||
148744293|NCT01399658|536535912|FG000|Overall Study|No reason given|1|||
148744294|NCT02620579|536535918|FG000|Overall Study|Physician Decision|0|||
148744295|NCT02620579|536535919|FG001|Overall Study|Physician Decision|0|||
148744296|NCT02620579|536535920|FG002|Overall Study|Physician Decision|0|||
148744297|NCT02620579|536535921|FG003|Overall Study|Physician Decision|1|||
148744298|NCT02620579|536535918|FG000|Overall Study|Withdrawal by Subject|0|||
148744299|NCT02620579|536535919|FG001|Overall Study|Withdrawal by Subject|1|||
148744300|NCT02620579|536535920|FG002|Overall Study|Withdrawal by Subject|1|||
148744301|NCT02620579|536535921|FG003|Overall Study|Withdrawal by Subject|0|||
148744302|NCT00796107|536535922|FG000|Overall Study|Lack of Efficacy|1|||
148744303|NCT00796107|536535922|FG000|Overall Study|Progressive Disease|5|||
148744304|NCT02681510|536535923|FG000|Overall Study|Withdrawal by Subject|1|||
148744305|NCT02681510|536535923|FG000|Overall Study|Lost to Follow-up|9|||
148744306|NCT01721317|536535925|FG000|Overall Study|Study Closed / Terminated|2|||
148975988|NCT00989833|537392406|FG002|Overall Study|Lost to Follow-up|0|||
148744307|NCT01721317|536535926|FG001|Overall Study|Study Closed / Terminated|2|||
148819439|NCT01562444|536816322|FG002|Overall Study|Did not meet entry criteria|3|||
148819440|NCT01562444|536816320|FG000|Overall Study|Did not comply with blood draw schedule|1|||
148819441|NCT01562444|536816321|FG001|Overall Study|Did not comply with blood draw schedule|0|||
148819442|NCT01562444|536816322|FG002|Overall Study|Did not comply with blood draw schedule|1|||
148819443|NCT01562444|536816320|FG000|Overall Study|Unavailable serological results|0|||
148819444|NCT01562444|536816321|FG001|Overall Study|Unavailable serological results|2|||
148819445|NCT01562444|536816322|FG002|Overall Study|Unavailable serological results|2|||
148819446|NCT01562444|536816320|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
148819447|NCT01562444|536816321|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
148819448|NCT01562444|536816322|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
148819449|NCT01562444|536816320|FG000|Overall Study|Protocol forbidden medication|1|||
148819450|NCT01562444|536816321|FG001|Overall Study|Protocol forbidden medication|0|||
148819451|NCT01562444|536816322|FG002|Overall Study|Protocol forbidden medication|0|||
148819452|NCT03387046|536816330|FG000|Overall Study|Adverse Event|1|||
148819453|NCT03387046|536816331|FG001|Overall Study|Adverse Event|1|||
148819454|NCT00509600|536816332|FG000|Overall Study|Adverse Event|1|||
148819455|NCT02568423|536816335|FG000|Overall Study|Lost to Follow-up|0|||
148819456|NCT02568423|536816336|FG001|Overall Study|Lost to Follow-up|2|||
148819457|NCT02568423|536816337|FG002|Overall Study|Lost to Follow-up|0|||
148819458|NCT02568423|536816338|FG003|Overall Study|Lost to Follow-up|0|||
148819459|NCT02568423|536816339|FG004|Overall Study|Lost to Follow-up|0|||
148819460|NCT02568423|536816340|FG005|Overall Study|Lost to Follow-up|0|||
148819461|NCT02568423|536816341|FG006|Overall Study|Lost to Follow-up|0|||
148819462|NCT02568423|536816342|FG007|Overall Study|Lost to Follow-up|0|||
148819463|NCT02568423|536816335|FG000|Overall Study|Physician Decision|0|||
148819464|NCT02568423|536816336|FG001|Overall Study|Physician Decision|0|||
148819465|NCT02568423|536816337|FG002|Overall Study|Physician Decision|0|||
148819466|NCT02568423|536816338|FG003|Overall Study|Physician Decision|0|||
148819467|NCT02568423|536816339|FG004|Overall Study|Physician Decision|0|||
148819468|NCT02568423|536816340|FG005|Overall Study|Physician Decision|1|||
148819469|NCT02568423|536816341|FG006|Overall Study|Physician Decision|0|||
148819470|NCT02568423|536816342|FG007|Overall Study|Physician Decision|0|||
148819471|NCT03794544|536816345|FG000|Overall Study|Withdrawal by Subject|1|||
148819472|NCT03794544|536816346|FG001|Overall Study|Withdrawal by Subject|1|||
148819473|NCT03794544|536816347|FG002|Overall Study|Withdrawal by Subject|0|||
148819474|NCT03794544|536816348|FG003|Overall Study|Withdrawal by Subject|0|||
148819475|NCT03794544|536816345|FG000|Overall Study|Death|0|||
148819476|NCT03794544|536816346|FG001|Overall Study|Death|0|||
148819477|NCT03794544|536816347|FG002|Overall Study|Death|0|||
148819478|NCT03794544|536816348|FG003|Overall Study|Death|1|||
148819479|NCT03794544|536816345|FG000|Overall Study|Lost to Follow-up|0|||
148819480|NCT03794544|536816346|FG001|Overall Study|Lost to Follow-up|1|||
148819481|NCT03794544|536816347|FG002|Overall Study|Lost to Follow-up|1|||
148819482|NCT03794544|536816348|FG003|Overall Study|Lost to Follow-up|0|||
148819483|NCT03794544|536816345|FG000|Overall Study|Other|0|||
148819484|NCT03794544|536816346|FG001|Overall Study|Other|1|||
148819485|NCT03794544|536816347|FG002|Overall Study|Other|0|||
148819486|NCT03794544|536816348|FG003|Overall Study|Other|0|||
148819487|NCT01027416|536816349|FG000|Overall Study|Withdrawal by Subject|0|||
148819488|NCT01027416|536816350|FG001|Overall Study|Withdrawal by Subject|1|||
148819489|NCT01027416|536816349|FG000|Overall Study|Physician Decision|1|||
148819490|NCT01027416|536816350|FG001|Overall Study|Physician Decision|4|||
148819491|NCT00421733|536816351|FG000|Overall Study|Adverse Event|4|||
148819492|NCT00421733|536816352|FG001|Overall Study|Adverse Event|9|||
148819493|NCT00421733|536816353|FG002|Overall Study|Adverse Event|2|||
148819494|NCT00421733|536816351|FG000|Overall Study|Lost to Follow-up|1|||
148819495|NCT00421733|536816352|FG001|Overall Study|Lost to Follow-up|2|||
148819496|NCT00421733|536816353|FG002|Overall Study|Lost to Follow-up|4|||
148819497|NCT00421733|536816351|FG000|Overall Study|Withdrawal by Subject|1|||
148819498|NCT00421733|536816352|FG001|Overall Study|Withdrawal by Subject|2|||
148819499|NCT00421733|536816353|FG002|Overall Study|Withdrawal by Subject|7|||
148819500|NCT00421733|536816351|FG000|Overall Study|Death|0|||
148819501|NCT00421733|536816352|FG001|Overall Study|Death|3|||
148819502|NCT00421733|536816353|FG002|Overall Study|Death|0|||
148819503|NCT00421733|536816351|FG000|Overall Study|Required dialysis|1|||
148819504|NCT00421733|536816352|FG001|Overall Study|Required dialysis|0|||
148819505|NCT00421733|536816353|FG002|Overall Study|Required dialysis|0|||
148819506|NCT00421733|536816351|FG000|Overall Study|Administrative|2|||
148819507|NCT00421733|536816352|FG001|Overall Study|Administrative|0|||
148819508|NCT00421733|536816353|FG002|Overall Study|Administrative|0|||
148819509|NCT00421733|536816351|FG000|Overall Study|Did not satisfy entry criteria|1|||
148819510|NCT00421733|536816352|FG001|Overall Study|Did not satisfy entry criteria|3|||
148819511|NCT00421733|536816353|FG002|Overall Study|Did not satisfy entry criteria|2|||
148819512|NCT00421733|536816351|FG000|Overall Study|Sponsor request|1|||
149027161|NCT02929108|537576522|FG003|Overall Study|Hospice patient death|46|||
148819513|NCT00421733|536816352|FG001|Overall Study|Sponsor request|0|||
148819514|NCT00421733|536816353|FG002|Overall Study|Sponsor request|3|||
148819515|NCT00421733|536816351|FG000|Overall Study|Protocol deviation|4|||
148975989|NCT00989833|537392404|FG000|Overall Study|Protocol Violation|1|||
148975990|NCT00989833|537392405|FG001|Overall Study|Protocol Violation|2|||
148744308|NCT01721317|536535925|FG000|Overall Study|Physician Decision|0|||
148744309|NCT01721317|536535926|FG001|Overall Study|Physician Decision|1|||
148744310|NCT01721317|536535925|FG000|Overall Study|Withdrawal by Subject|0|||
148744311|NCT01721317|536535926|FG001|Overall Study|Withdrawal by Subject|1|||
148744312|NCT00378573|536535935|FG000|Treatment Period|Adverse Event|9|||
148744313|NCT00378573|536535935|FG000|Treatment Period|Physician Decision|1|||
148744314|NCT00378573|536535935|FG000|Treatment Period|Withdrawal by Subject|2|||
148744315|NCT00378573|536535935|FG000|Treatment Period|Disease Progression|4|||
148744316|NCT00378573|536535935|FG000|Treatment Period|Sponsor decision to close study|1|||
148744317|NCT00378573|536535935|FG000|Follow-up|Death|12|||
148744318|NCT00378573|536535935|FG000|Follow-up|Lost to Follow-up|1|||
148744319|NCT00378573|536535935|FG000|Follow-up|Withdrawal by Subject|1|||
148744320|NCT02806024|536535936|FG000|Overall Study|Night Delivery|1|||
148744321|NCT02806024|536535937|FG001|Overall Study|Night Delivery|1|||
148744322|NCT02806024|536535936|FG000|Overall Study|DVT during antepartum admission|0|||
148744323|NCT02806024|536535937|FG001|Overall Study|DVT during antepartum admission|1|||
148744324|NCT01098474|536535938|FG000|Active Phase|Other|0|||
148744325|NCT01098474|536535939|FG001|Active Phase|Other|0|||
148744326|NCT01098474|536535940|FG002|Active Phase|Other|3|||
148744327|NCT01098474|536535941|FG003|Active Phase|Other|0|||
148744328|NCT01098474|536535942|FG004|Active Phase|Other|0|||
148744329|NCT01098474|536535943|FG005|Active Phase|Other|0|||
148744330|NCT01098474|536535938|FG000|Active Phase|Withdrawal by Subject|1|||
148744331|NCT01098474|536535939|FG001|Active Phase|Withdrawal by Subject|1|||
148744332|NCT01098474|536535940|FG002|Active Phase|Withdrawal by Subject|2|||
148744333|NCT01098474|536535941|FG003|Active Phase|Withdrawal by Subject|0|||
148744334|NCT01098474|536535942|FG004|Active Phase|Withdrawal by Subject|0|||
148744335|NCT01098474|536535943|FG005|Active Phase|Withdrawal by Subject|0|||
148744336|NCT01098474|536535938|FG000|Active Phase|Lost to Follow-up|1|||
148744337|NCT01098474|536535939|FG001|Active Phase|Lost to Follow-up|0|||
148744338|NCT01098474|536535940|FG002|Active Phase|Lost to Follow-up|0|||
148744339|NCT01098474|536535941|FG003|Active Phase|Lost to Follow-up|0|||
148744340|NCT01098474|536535942|FG004|Active Phase|Lost to Follow-up|0|||
148744341|NCT01098474|536535943|FG005|Active Phase|Lost to Follow-up|0|||
148744342|NCT01098474|536535938|FG000|Follow Up Phase|Travelled out of study area|0|||
148744343|NCT01098474|536535939|FG001|Follow Up Phase|Travelled out of study area|0|||
148744344|NCT01098474|536535940|FG002|Follow Up Phase|Travelled out of study area|0|||
148744345|NCT01098474|536535941|FG003|Follow Up Phase|Travelled out of study area|0|||
148744346|NCT01098474|536535942|FG004|Follow Up Phase|Travelled out of study area|1|||
148744347|NCT01098474|536535943|FG005|Follow Up Phase|Travelled out of study area|0|||
148744348|NCT01098474|536535938|FG000|Follow Up Phase|Other|0|||
148744349|NCT01098474|536535939|FG001|Follow Up Phase|Other|0|||
148744350|NCT01098474|536535940|FG002|Follow Up Phase|Other|0|||
148744351|NCT01098474|536535941|FG003|Follow Up Phase|Other|0|||
148744352|NCT01098474|536535942|FG004|Follow Up Phase|Other|0|||
148744353|NCT01098474|536535943|FG005|Follow Up Phase|Other|4|||
148744354|NCT01098474|536535938|FG000|Follow Up Phase|Withdrawal by Subject|0|||
148744355|NCT01098474|536535939|FG001|Follow Up Phase|Withdrawal by Subject|0|||
148744356|NCT01098474|536535940|FG002|Follow Up Phase|Withdrawal by Subject|0|||
148744357|NCT01098474|536535941|FG003|Follow Up Phase|Withdrawal by Subject|2|||
148744358|NCT01098474|536535942|FG004|Follow Up Phase|Withdrawal by Subject|0|||
148744359|NCT01098474|536535943|FG005|Follow Up Phase|Withdrawal by Subject|1|||
148744360|NCT01098474|536535938|FG000|Follow Up Phase|Lost to Follow-up|0|||
148744361|NCT01098474|536535939|FG001|Follow Up Phase|Lost to Follow-up|0|||
148744362|NCT01098474|536535940|FG002|Follow Up Phase|Lost to Follow-up|0|||
148744363|NCT01098474|536535941|FG003|Follow Up Phase|Lost to Follow-up|0|||
148744364|NCT01098474|536535942|FG004|Follow Up Phase|Lost to Follow-up|1|||
148744365|NCT01098474|536535943|FG005|Follow Up Phase|Lost to Follow-up|0|||
148744366|NCT03993379|536535944|FG000|Overall Study|The study was terminated early due to business decision.|0|||
148744367|NCT03993379|536535945|FG001|Overall Study|The study was terminated early due to business decision.|2|||
148744368|NCT03993379|536535946|FG002|Overall Study|The study was terminated early due to business decision.|0|||
148744369|NCT03993379|536535947|FG003|Overall Study|The study was terminated early due to business decision.|0|||
148744370|NCT03993379|536535944|FG000|Overall Study|Withdrawal by Subject|0|||
148744371|NCT03993379|536535945|FG001|Overall Study|Withdrawal by Subject|1|||
148744372|NCT03993379|536535946|FG002|Overall Study|Withdrawal by Subject|0|||
148744373|NCT03993379|536535947|FG003|Overall Study|Withdrawal by Subject|0|||
148744374|NCT00711880|536535953|FG000|Overall Study|Adverse Event|11|||
148744375|NCT00711880|536535954|FG001|Overall Study|Adverse Event|2|||
148744376|NCT00711880|536535953|FG000|Overall Study|Patient non-compliance|1|||
148744377|NCT00711880|536535954|FG001|Overall Study|Patient non-compliance|0|||
148744378|NCT00711880|536535953|FG000|Overall Study|Lack of Efficacy|1|||
148744379|NCT00711880|536535954|FG001|Overall Study|Lack of Efficacy|5|||
148744380|NCT00704132|536535955|FG000|Overall Study|Clinical Adverse Experience|1|||
148744381|NCT00704132|536535956|FG001|Overall Study|Clinical Adverse Experience|0|||
148744382|NCT00704132|536535955|FG000|Overall Study|Lack of Efficacy|0|||
148744383|NCT00704132|536535956|FG001|Overall Study|Lack of Efficacy|1|||
148744384|NCT00704132|536535955|FG000|Overall Study|Withdrawal by Subject|0|||
148744385|NCT00704132|536535956|FG001|Overall Study|Withdrawal by Subject|1|||
148744386|NCT03348163|536535957|FG000|Overall Study|Withdrawal by Subject|2|||
148744387|NCT03348163|536535958|FG001|Overall Study|Withdrawal by Subject|0|||
148744388|NCT04841577|536535959|FG000|Overall Study|Adverse Event|5|||
148744389|NCT04841577|536535960|FG001|Overall Study|Adverse Event|10|||
148744390|NCT04841577|536535959|FG000|Overall Study|Lost to Follow-up|8|||
148744391|NCT04841577|536535960|FG001|Overall Study|Lost to Follow-up|7|||
148744392|NCT04841577|536535959|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
148744393|NCT04841577|536535960|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
148744394|NCT04841577|536535959|FG000|Overall Study|Other|0|||
148744395|NCT04841577|536535960|FG001|Overall Study|Other|1|||
148744396|NCT00652340|536535965|FG000|Overall Study|Had not progressed.|4|||
148744397|NCT00652340|536535966|FG001|Overall Study|Had not progressed.|3|||
148744398|NCT03682107|536535967|FG000|Overall Study|Withdrawal by Subject|0|||
148744399|NCT03682107|536535968|FG001|Overall Study|Withdrawal by Subject|1|||
148744400|NCT03682107|536535969|FG002|Overall Study|Withdrawal by Subject|0|||
148744401|NCT03682107|536535970|FG003|Overall Study|Withdrawal by Subject|0|||
148744402|NCT03682107|536535971|FG004|Overall Study|Withdrawal by Subject|0|||
148744403|NCT00879411|536535972|FG000|Overall Study|lost to follow-up (non-AE)|162|||
148744404|NCT03837743|536535981|FG000|Overall Study|Adverse Event|1|||
148744405|NCT03837743|536535981|FG000|Overall Study|Withdrawal by Subject|2|||
148744406|NCT00252239|536535982|FG000|Overall Study|Withdrawal by Subject|1|||
148744407|NCT00252239|536535983|FG001|Overall Study|Withdrawal by Subject|0|||
148744408|NCT00252239|536535984|FG002|Overall Study|Withdrawal by Subject|0|||
148744409|NCT00252239|536535985|FG003|Overall Study|Withdrawal by Subject|1|||
148744410|NCT00252239|536535982|FG000|Overall Study|Lost to Follow-up|0|||
148744411|NCT00252239|536535983|FG001|Overall Study|Lost to Follow-up|0|||
148744412|NCT00252239|536535984|FG002|Overall Study|Lost to Follow-up|2|||
148744413|NCT00252239|536535985|FG003|Overall Study|Lost to Follow-up|0|||
148744414|NCT02257385|536535987|FG000|Overall Study|Adverse Event|12|||
148744415|NCT02257385|536535988|FG001|Overall Study|Adverse Event|8|||
148744416|NCT02257385|536535987|FG000|Overall Study|Lack of Efficacy|1|||
148744417|NCT02257385|536535988|FG001|Overall Study|Lack of Efficacy|2|||
148744418|NCT02257385|536535987|FG000|Overall Study|Protocol Violation|5|||
148744419|NCT02257385|536535988|FG001|Overall Study|Protocol Violation|7|||
148744420|NCT02257385|536535987|FG000|Overall Study|Lost to Follow-up|0|||
148744421|NCT02257385|536535988|FG001|Overall Study|Lost to Follow-up|1|||
148744422|NCT02257385|536535987|FG000|Overall Study|Withdrawal by Subject|4|||
148744423|NCT02257385|536535988|FG001|Overall Study|Withdrawal by Subject|4|||
148744424|NCT03597464|536536001|FG000|Overall Study|Withdrawal by Subject|4|||
148744425|NCT03597464|536536002|FG001|Overall Study|Withdrawal by Subject|5|||
148744426|NCT03597464|536536001|FG000|Overall Study|Lost to Follow-up|3|||
148744427|NCT03597464|536536002|FG001|Overall Study|Lost to Follow-up|1|||
148744428|NCT03597464|536536001|FG000|Overall Study|Pregnancy|3|||
148744429|NCT03597464|536536002|FG001|Overall Study|Pregnancy|1|||
148744430|NCT03597464|536536001|FG000|Overall Study|Lack of Efficacy|2|||
148744431|NCT03597464|536536002|FG001|Overall Study|Lack of Efficacy|0|||
148744432|NCT03597464|536536001|FG000|Overall Study|Physician Decision|2|||
148744433|NCT03597464|536536002|FG001|Overall Study|Physician Decision|2|||
148744434|NCT03597464|536536001|FG000|Overall Study|Protocol Violation|1|||
148744435|NCT03597464|536536002|FG001|Overall Study|Protocol Violation|1|||
148819516|NCT00421733|536816352|FG001|Overall Study|Protocol deviation|7|||
148819517|NCT00421733|536816353|FG002|Overall Study|Protocol deviation|2|||
148819518|NCT00120250|536816354|FG000|Overall Study|Lost to Follow-up|1|||
148819519|NCT00120250|536816355|FG001|Overall Study|Lost to Follow-up|1|||
148819520|NCT00120250|536816354|FG000|Overall Study|Protocol Violation|0|||
148819521|NCT00120250|536816355|FG001|Overall Study|Protocol Violation|1|||
148744436|NCT03597464|536536001|FG000|Overall Study|Adverse Event|0|||
148744437|NCT03597464|536536002|FG001|Overall Study|Adverse Event|2|||
148744438|NCT03597464|536536001|FG000|Overall Study|Death|0|||
148744439|NCT03597464|536536002|FG001|Overall Study|Death|3|||
148744440|NCT01374269|536536006|FG000|Overall Study|Withdrawal by Subject|4|||
148744441|NCT01374269|536536007|FG001|Overall Study|Withdrawal by Subject|0|||
148744442|NCT01374269|536536006|FG000|Overall Study|Lost to Follow-up|1|||
148744443|NCT01374269|536536007|FG001|Overall Study|Lost to Follow-up|3|||
148744444|NCT01374269|536536006|FG000|Overall Study|closed research|1|||
148744445|NCT01374269|536536007|FG001|Overall Study|closed research|2|||
148744446|NCT03316547|536536013|FG000|Overall Study|Death|3|||
148744447|NCT03316547|536536014|FG001|Overall Study|Death|1|||
148744448|NCT03316547|536536013|FG000|Overall Study|Lost to Follow-up|6|||
148819522|NCT00720083|536816356|FG000|Overall Study|Ineligible|1|||
148819523|NCT00720083|536816357|FG001|Overall Study|Ineligible|2|||
148819524|NCT00103506|536816360|FG000|Overall Study|Study closed by sponsor|34|||
148744449|NCT03316547|536536014|FG001|Overall Study|Lost to Follow-up|6|||
148744450|NCT03316547|536536013|FG000|Overall Study|Withdrawal by Subject|3|||
148744451|NCT03316547|536536014|FG001|Overall Study|Withdrawal by Subject|2|||
148744452|NCT03316547|536536013|FG000|Overall Study|Transfer to another hospital|6|||
148819525|NCT00103506|536816361|FG001|Overall Study|Study closed by sponsor|37|||
148819526|NCT00103506|536816360|FG000|Overall Study|Death|257|||
148819527|NCT00103506|536816361|FG001|Overall Study|Death|253|||
148819528|NCT00103506|536816360|FG000|Overall Study|Lost to Follow-up|13|||
148819529|NCT00103506|536816361|FG001|Overall Study|Lost to Follow-up|13|||
148819530|NCT00103506|536816360|FG000|Overall Study|Withdrawal by Subject|18|||
148819531|NCT00103506|536816361|FG001|Overall Study|Withdrawal by Subject|21|||
148819532|NCT00585585|536816362|FG000|Overall Study|Adverse Event|1|||
148819533|NCT01433978|536816365|FG000|Core Study|Adverse Event, Non-Fatal|0|||
148819534|NCT01433978|536816366|FG001|Core Study|Adverse Event, Non-Fatal|1|||
148819535|NCT01433978|536816367|FG002|Core Study|Adverse Event, Non-Fatal|0|||
148819536|NCT01433978|536816365|FG000|Core Study|Lack of Efficacy|5|||
148819537|NCT01433978|536816366|FG001|Core Study|Lack of Efficacy|1|||
148819538|NCT01433978|536816367|FG002|Core Study|Lack of Efficacy|0|||
148819539|NCT01433978|536816365|FG000|Core Study|Study Terminated by Sponsor|6|||
148819540|NCT01433978|536816366|FG001|Core Study|Study Terminated by Sponsor|9|||
148819541|NCT01433978|536816367|FG002|Core Study|Study Terminated by Sponsor|0|||
148819542|NCT01433978|536816365|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
148819543|NCT01433978|536816366|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
148819544|NCT01433978|536816367|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
148819545|NCT01433978|536816365|FG000|Extension Phase|Lack of Efficacy|0|||
148819546|NCT01433978|536816366|FG001|Extension Phase|Lack of Efficacy|0|||
148819547|NCT01433978|536816367|FG002|Extension Phase|Lack of Efficacy|1|||
148819548|NCT01433978|536816365|FG000|Extension Phase|Study Terminated by Sponsor|0|||
148819549|NCT01433978|536816366|FG001|Extension Phase|Study Terminated by Sponsor|0|||
148819550|NCT01433978|536816367|FG002|Extension Phase|Study Terminated by Sponsor|4|||
148819551|NCT03954938|536816368|FG000|Overall Study|Withdrawal by Subject|2|||
148819552|NCT03954938|536816368|FG000|Overall Study|Adverse Event|1|||
148819553|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
148819554|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
148819555|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
148819556|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
148819557|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
148819558|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
148819559|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
148819560|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
148819561|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
148819562|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
148819563|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
148819564|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
148819565|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
148819566|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
148819567|NCT00976391|536816369|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
148819568|NCT00976391|536816370|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
148819569|NCT00976391|536816369|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
148819570|NCT00976391|536816370|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
148819571|NCT00976391|536816369|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
148819572|NCT00976391|536816370|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
148819573|NCT00976391|536816369|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
148819574|NCT00976391|536816370|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
148819575|NCT00976391|536816369|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
148819576|NCT00976391|536816370|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
148819577|NCT00976391|536816369|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
148819578|NCT00976391|536816370|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
148819579|NCT00976391|536816369|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
148819580|NCT00976391|536816370|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
148819581|NCT02565186|536816371|FG000|Overall Study|Adverse Event|113|||
148819582|NCT02565186|536816372|FG001|Overall Study|Adverse Event|148|||
148819583|NCT02565186|536816371|FG000|Overall Study|Lost to Follow-up|102|||
148819584|NCT02565186|536816372|FG001|Overall Study|Lost to Follow-up|93|||
148819585|NCT02565186|536816371|FG000|Overall Study|Non-Compliance|57|||
148819586|NCT02565186|536816372|FG001|Overall Study|Non-Compliance|55|||
148819587|NCT02565186|536816371|FG000|Overall Study|Withdrawal by Subject|229|||
148819588|NCT02565186|536816372|FG001|Overall Study|Withdrawal by Subject|214|||
148819589|NCT02565186|536816371|FG000|Overall Study|Physician Decision|18|||
148819590|NCT02565186|536816372|FG001|Overall Study|Physician Decision|16|||
148819591|NCT02565186|536816371|FG000|Overall Study|Sponsor Request|5|||
148975991|NCT00989833|537392406|FG002|Overall Study|Protocol Violation|1|||
148819592|NCT02565186|536816372|FG001|Overall Study|Sponsor Request|9|||
148819593|NCT02565186|536816371|FG000|Overall Study|Missing|1|||
148819594|NCT02565186|536816372|FG001|Overall Study|Missing|0|||
148819595|NCT02565186|536816371|FG000|Overall Study|Did Not Receive Study Drug|55|||
148819596|NCT02565186|536816372|FG001|Overall Study|Did Not Receive Study Drug|86|||
148819597|NCT00617903|536816373|FG000|Overall Study|Withdrawal by Subject|2|||
148819598|NCT00617903|536816374|FG001|Overall Study|Withdrawal by Subject|3|||
148819599|NCT00617903|536816373|FG000|Overall Study|Lost to Follow-up|1|||
148819600|NCT00617903|536816374|FG001|Overall Study|Lost to Follow-up|1|||
148819601|NCT00617903|536816373|FG000|Overall Study|Lack of Efficacy|0|||
148819602|NCT00617903|536816374|FG001|Overall Study|Lack of Efficacy|1|||
148819603|NCT00617903|536816373|FG000|Overall Study|Adverse Event|0|||
148819604|NCT00617903|536816374|FG001|Overall Study|Adverse Event|1|||
148819605|NCT00617903|536816373|FG000|Overall Study|noncompliance|0|||
148819606|NCT00617903|536816374|FG001|Overall Study|noncompliance|1|||
148819607|NCT01371565|536816375|FG000|Overall Study|Withdrawal by Subject|1|||
148819608|NCT01371565|536816375|FG000|Overall Study|Death|1|||
148819609|NCT01371565|536816375|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
148819610|NCT04676646|536816376|FG000|Open-label Run-in Phase|Adverse Event|3|||
148819611|NCT04676646|536816377|FG001|Open-label Run-in Phase|Adverse Event|0|||
148819612|NCT04676646|536816378|FG002|Open-label Run-in Phase|Adverse Event|0|||
148819613|NCT04676646|536816376|FG000|Open-label Run-in Phase|Death|3|||
148819614|NCT04676646|536816377|FG001|Open-label Run-in Phase|Death|0|||
148819615|NCT04676646|536816378|FG002|Open-label Run-in Phase|Death|0|||
148819616|NCT04676646|536816376|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
148819617|NCT04676646|536816377|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
148819618|NCT04676646|536816378|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
148819619|NCT04676646|536816376|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
148819620|NCT04676646|536816377|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
148819621|NCT04676646|536816378|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
148819622|NCT04676646|536816376|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
148819623|NCT04676646|536816377|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
148819624|NCT04676646|536816378|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
148819625|NCT04676646|536816376|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
148819626|NCT04676646|536816377|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
148819627|NCT04676646|536816378|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
148819628|NCT04676646|536816376|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
148819629|NCT04676646|536816377|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
148819630|NCT04676646|536816378|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
148819631|NCT04676646|536816376|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
148819632|NCT04676646|536816377|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
148819633|NCT04676646|536816378|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
148819634|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
148819635|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
148819636|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
148819637|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Death|0|||
148819638|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Death|1|||
148819639|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Death|2|||
148819640|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
148819641|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
148819642|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
148819643|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
148819644|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
148819645|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
148819646|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
148819647|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
148819648|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
148819649|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
148819650|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
148819651|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
148819652|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
148819653|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
148819654|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
148975992|NCT00989833|537392404|FG000|Overall Study|Withdrawal by Subject|0|||
148975993|NCT00989833|537392405|FG001|Overall Study|Withdrawal by Subject|0|||
148975994|NCT00989833|537392406|FG002|Overall Study|Withdrawal by Subject|1|||
148975995|NCT00989833|537392404|FG000|Overall Study|Incorrectly randomized|1|||
148975996|NCT00989833|537392405|FG001|Overall Study|Incorrectly randomized|0|||
148975997|NCT00989833|537392406|FG002|Overall Study|Incorrectly randomized|0|||
148975998|NCT00308711|537392407|FG000|Overall Study|Withdrawal by Subject|1|||
148975999|NCT00308711|537392408|FG001|Overall Study|Withdrawal by Subject|0|||
149027162|NCT02929108|537576523|FG004|Overall Study|Hospice patient death|55|||
149027163|NCT02929108|537576524|FG005|Overall Study|Hospice patient death|28|||
149027164|NCT02929108|537576525|FG006|Overall Study|Hospice patient death|78|||
149027165|NCT01008748|537576526|FG000|Overall Study|Lost to Follow-up|80|||
149027166|NCT01008748|537576526|FG000|Overall Study|Other|1|||
149027167|NCT00052962|537576527|FG000|Overall Study|Not evaluable|0|||
148744453|NCT03316547|536536014|FG001|Overall Study|Transfer to another hospital|4|||
148744454|NCT00996892|536536015|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
148744455|NCT00996892|536536016|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
148744456|NCT00996892|536536017|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
148744457|NCT00996892|536536018|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
148744458|NCT00996892|536536019|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
148744459|NCT00996892|536536020|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
148744460|NCT00996892|536536021|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
148744461|NCT00996892|536536022|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
148744462|NCT00996892|536536023|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
148744463|NCT00996892|536536024|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
148744464|NCT00996892|536536025|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
148744465|NCT00996892|536536026|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
148744466|NCT00996892|536536027|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
148744467|NCT00996892|536536028|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
148744468|NCT00996892|536536029|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
148744469|NCT00996892|536536030|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
148744470|NCT00996892|536536031|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
148744471|NCT00996892|536536032|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
148744472|NCT00996892|536536033|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
148744473|NCT00996892|536536034|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
148744474|NCT00996892|536536015|FG000|Dose-Escalation Stage 1|Death|1|||
148744475|NCT00996892|536536016|FG001|Dose-Escalation Stage 1|Death|0|||
148744476|NCT00996892|536536017|FG002|Dose-Escalation Stage 1|Death|0|||
148744477|NCT00996892|536536018|FG003|Dose-Escalation Stage 1|Death|0|||
148744478|NCT00996892|536536019|FG004|Dose-Escalation Stage 1|Death|0|||
148744479|NCT00996892|536536020|FG005|Dose-Escalation Stage 1|Death|1|||
148744480|NCT00996892|536536021|FG006|Dose-Escalation Stage 1|Death|0|||
148744481|NCT00996892|536536022|FG007|Dose-Escalation Stage 1|Death|0|||
148744482|NCT00996892|536536023|FG008|Dose-Escalation Stage 1|Death|0|||
148744483|NCT00996892|536536024|FG009|Dose-Escalation Stage 1|Death|0|||
148744484|NCT00996892|536536025|FG010|Dose-Escalation Stage 1|Death|0|||
148744485|NCT00996892|536536026|FG011|Dose-Escalation Stage 1|Death|0|||
148744486|NCT00996892|536536027|FG012|Dose-Escalation Stage 1|Death|0|||
148744487|NCT00996892|536536028|FG013|Dose-Escalation Stage 1|Death|0|||
148744488|NCT00996892|536536029|FG014|Dose-Escalation Stage 1|Death|0|||
148744489|NCT00996892|536536030|FG015|Dose-Escalation Stage 1|Death|0|||
148744490|NCT00996892|536536031|FG016|Dose-Escalation Stage 1|Death|0|||
148744491|NCT00996892|536536032|FG017|Dose-Escalation Stage 1|Death|0|||
148744492|NCT00996892|536536033|FG018|Dose-Escalation Stage 1|Death|0|||
148744493|NCT00996892|536536034|FG019|Dose-Escalation Stage 1|Death|0|||
148744494|NCT00996892|536536015|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
148744495|NCT00996892|536536016|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
148744496|NCT00996892|536536017|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
148744497|NCT00996892|536536018|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
148744498|NCT00996892|536536019|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
148744499|NCT00996892|536536020|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
148744500|NCT00996892|536536021|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
148744501|NCT00996892|536536022|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
148744502|NCT00996892|536536023|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
148744503|NCT00996892|536536024|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
148744504|NCT00996892|536536025|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
148744505|NCT00996892|536536026|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
148744506|NCT00996892|536536027|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
148744507|NCT00996892|536536028|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
148744508|NCT00996892|536536029|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
148744509|NCT00996892|536536030|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
148744510|NCT00996892|536536031|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
148744511|NCT00996892|536536032|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
148744512|NCT00996892|536536033|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
148744513|NCT00996892|536536034|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
148744514|NCT00996892|536536015|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744515|NCT00996892|536536016|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
148744516|NCT00996892|536536017|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744517|NCT00996892|536536018|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
149027168|NCT00052962|537576528|FG001|Overall Study|Not evaluable|2|||
148744518|NCT00996892|536536019|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
148744519|NCT00996892|536536020|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
148744520|NCT00996892|536536021|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
148744521|NCT00996892|536536022|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744522|NCT00996892|536536023|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744523|NCT00996892|536536024|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744524|NCT00996892|536536025|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744525|NCT00996892|536536026|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744526|NCT00996892|536536027|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744527|NCT00996892|536536028|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744528|NCT00996892|536536029|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744529|NCT00996892|536536030|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744530|NCT00996892|536536031|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744531|NCT00996892|536536032|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744532|NCT00996892|536536033|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744533|NCT00996892|536536034|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
148744534|NCT00996892|536536015|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
148744535|NCT00996892|536536016|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
148744536|NCT00996892|536536017|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
148744537|NCT00996892|536536018|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
148744538|NCT00996892|536536019|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
148744539|NCT00996892|536536020|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
148744540|NCT00996892|536536021|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
148744541|NCT00996892|536536022|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
148744542|NCT00996892|536536023|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
148744543|NCT00996892|536536024|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
148744544|NCT00996892|536536025|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
148744545|NCT00996892|536536026|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
148744546|NCT00996892|536536027|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
148744547|NCT00996892|536536028|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
148744548|NCT00996892|536536029|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
148744549|NCT00996892|536536030|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
148744550|NCT00996892|536536031|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
148744551|NCT00996892|536536032|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
148744552|NCT00996892|536536033|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
148744553|NCT00996892|536536034|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
148744554|NCT00996892|536536015|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
148744555|NCT00996892|536536016|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
148744556|NCT00996892|536536017|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
148744557|NCT00996892|536536018|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
148744558|NCT00996892|536536019|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
148744559|NCT00996892|536536020|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
148744560|NCT00996892|536536021|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
148744561|NCT00996892|536536022|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
148744562|NCT00996892|536536023|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
148744563|NCT00996892|536536024|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
148744564|NCT00996892|536536025|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
148744565|NCT00996892|536536026|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
148744566|NCT00996892|536536027|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
148744567|NCT00996892|536536028|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
148744568|NCT00996892|536536029|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
148744569|NCT00996892|536536030|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
148744570|NCT00996892|536536031|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
148744571|NCT00996892|536536032|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
148744572|NCT00996892|536536033|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
148744573|NCT00996892|536536034|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
148744574|NCT00996892|536536015|FG000|Dose-Escalation Stage 1A|Death|0|||
148744575|NCT00996892|536536016|FG001|Dose-Escalation Stage 1A|Death|0|||
148744576|NCT00996892|536536017|FG002|Dose-Escalation Stage 1A|Death|0|||
148744577|NCT00996892|536536018|FG003|Dose-Escalation Stage 1A|Death|0|||
148744578|NCT00996892|536536019|FG004|Dose-Escalation Stage 1A|Death|0|||
148744579|NCT00996892|536536020|FG005|Dose-Escalation Stage 1A|Death|0|||
148744580|NCT00996892|536536021|FG006|Dose-Escalation Stage 1A|Death|0|||
148744581|NCT00996892|536536022|FG007|Dose-Escalation Stage 1A|Death|0|||
148744582|NCT00996892|536536023|FG008|Dose-Escalation Stage 1A|Death|0|||
148744583|NCT00996892|536536024|FG009|Dose-Escalation Stage 1A|Death|2|||
148744584|NCT00996892|536536025|FG010|Dose-Escalation Stage 1A|Death|0|||
148744585|NCT00996892|536536026|FG011|Dose-Escalation Stage 1A|Death|1|||
148744586|NCT00996892|536536027|FG012|Dose-Escalation Stage 1A|Death|1|||
148744587|NCT00996892|536536028|FG013|Dose-Escalation Stage 1A|Death|0|||
148744588|NCT00996892|536536029|FG014|Dose-Escalation Stage 1A|Death|0|||
148744589|NCT00996892|536536030|FG015|Dose-Escalation Stage 1A|Death|0|||
148744590|NCT00996892|536536031|FG016|Dose-Escalation Stage 1A|Death|0|||
148744591|NCT00996892|536536032|FG017|Dose-Escalation Stage 1A|Death|0|||
148744592|NCT00996892|536536033|FG018|Dose-Escalation Stage 1A|Death|0|||
148744593|NCT00996892|536536034|FG019|Dose-Escalation Stage 1A|Death|0|||
148744594|NCT00996892|536536015|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
148744595|NCT00996892|536536016|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
148744596|NCT00996892|536536017|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
148744597|NCT00996892|536536018|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
148744598|NCT00996892|536536019|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
148744599|NCT00996892|536536020|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
148744600|NCT00996892|536536021|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
148744601|NCT00996892|536536022|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
148744602|NCT00996892|536536023|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
148744603|NCT00996892|536536024|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
148744604|NCT00996892|536536025|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
148744605|NCT00996892|536536026|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
148744606|NCT00996892|536536027|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
148744607|NCT00996892|536536028|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
148744608|NCT00996892|536536029|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
148744609|NCT00996892|536536030|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
148744610|NCT00996892|536536031|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
148744611|NCT00996892|536536032|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
148744612|NCT00996892|536536033|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
148744613|NCT00996892|536536034|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
148744614|NCT00996892|536536015|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744615|NCT00996892|536536016|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744616|NCT00996892|536536017|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744617|NCT00996892|536536018|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744618|NCT00996892|536536019|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744619|NCT00996892|536536020|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744620|NCT00996892|536536021|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744621|NCT00996892|536536022|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744622|NCT00996892|536536023|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744623|NCT00996892|536536024|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
148744624|NCT00996892|536536025|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
148744625|NCT00996892|536536026|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
148744626|NCT00996892|536536027|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
148744627|NCT00996892|536536028|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744628|NCT00996892|536536029|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744629|NCT00996892|536536030|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744630|NCT00996892|536536031|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744631|NCT00996892|536536032|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744632|NCT00996892|536536033|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744633|NCT00996892|536536034|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
148744634|NCT00996892|536536015|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
148744635|NCT00996892|536536016|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
148744636|NCT00996892|536536017|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
148744637|NCT00996892|536536018|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
148744638|NCT00996892|536536019|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
148744639|NCT00996892|536536020|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
148744640|NCT00996892|536536021|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
148744641|NCT00996892|536536022|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
148744642|NCT00996892|536536023|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
148744643|NCT00996892|536536024|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
148744644|NCT00996892|536536025|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
148744645|NCT00996892|536536026|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
148744646|NCT00996892|536536027|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
148744647|NCT00996892|536536028|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
148744648|NCT00996892|536536029|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
148744649|NCT00996892|536536030|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
149027169|NCT00052962|537576527|FG000|Overall Study|Not randomized/not evaluable|1|||
148744650|NCT00996892|536536031|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
148744651|NCT00996892|536536032|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
148744652|NCT00996892|536536033|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
148744653|NCT00996892|536536034|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
148744654|NCT00996892|536536015|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
148744655|NCT00996892|536536016|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
148744656|NCT00996892|536536017|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
148744657|NCT00996892|536536018|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
148744658|NCT00996892|536536019|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
148744659|NCT00996892|536536020|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
148744660|NCT00996892|536536021|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
148744661|NCT00996892|536536022|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
148744662|NCT00996892|536536023|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
148744663|NCT00996892|536536024|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
148744664|NCT00996892|536536025|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
148819655|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
148819656|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
148744665|NCT00996892|536536026|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
148744666|NCT00996892|536536027|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
148744667|NCT00996892|536536028|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
148744668|NCT00996892|536536029|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
148744669|NCT00996892|536536030|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
148744670|NCT00996892|536536031|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
148744671|NCT00996892|536536032|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
148744672|NCT00996892|536536033|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
148744673|NCT00996892|536536034|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
148744674|NCT00996892|536536015|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
148744675|NCT00996892|536536016|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
148744676|NCT00996892|536536017|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
148744677|NCT00996892|536536018|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
148744678|NCT00996892|536536019|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
148744679|NCT00996892|536536020|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
148744680|NCT00996892|536536021|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
148744681|NCT00996892|536536022|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
148744682|NCT00996892|536536023|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
148744683|NCT00996892|536536024|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
148744684|NCT00996892|536536025|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
148744685|NCT00996892|536536026|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
148744686|NCT00996892|536536027|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
148744687|NCT00996892|536536028|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
148744688|NCT00996892|536536029|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
148744689|NCT00996892|536536030|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
148744690|NCT00996892|536536031|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
148744691|NCT00996892|536536032|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
148744692|NCT00996892|536536033|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
148744693|NCT00996892|536536034|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
148744694|NCT00996892|536536015|FG000|Expansion Stage 2|Adverse Event|0|||
148744695|NCT00996892|536536016|FG001|Expansion Stage 2|Adverse Event|0|||
148744696|NCT00996892|536536017|FG002|Expansion Stage 2|Adverse Event|0|||
148744697|NCT00996892|536536018|FG003|Expansion Stage 2|Adverse Event|0|||
148744698|NCT00996892|536536019|FG004|Expansion Stage 2|Adverse Event|0|||
148744699|NCT00996892|536536020|FG005|Expansion Stage 2|Adverse Event|0|||
148744700|NCT00996892|536536021|FG006|Expansion Stage 2|Adverse Event|0|||
148744701|NCT00996892|536536022|FG007|Expansion Stage 2|Adverse Event|0|||
148744702|NCT00996892|536536023|FG008|Expansion Stage 2|Adverse Event|0|||
148744703|NCT00996892|536536024|FG009|Expansion Stage 2|Adverse Event|0|||
148744704|NCT00996892|536536025|FG010|Expansion Stage 2|Adverse Event|0|||
148744705|NCT00996892|536536026|FG011|Expansion Stage 2|Adverse Event|0|||
148744706|NCT00996892|536536027|FG012|Expansion Stage 2|Adverse Event|0|||
148744707|NCT00996892|536536028|FG013|Expansion Stage 2|Adverse Event|0|||
148819657|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
148819658|NCT04676646|536816376|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
148819659|NCT04676646|536816377|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
148819660|NCT04676646|536816378|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
148819661|NCT02217982|536816379|FG000|Overall Study|Trial discontinued|1|||
148819662|NCT02217982|536816380|FG001|Overall Study|Trial discontinued|0|||
148819663|NCT02217982|536816379|FG000|Overall Study|Adverse Event|0|||
148819664|NCT02217982|536816380|FG001|Overall Study|Adverse Event|1|||
148819665|NCT05156125|536816381|FG000|Overall Study|Lack of Efficacy|1|||
148819666|NCT05156125|536816382|FG001|Overall Study|Lack of Efficacy|1|||
148819667|NCT05156125|536816383|FG002|Overall Study|Lack of Efficacy|1|||
148819668|NCT05156125|536816381|FG000|Overall Study|Physician Decision|0|||
148976000|NCT00308711|537392409|FG002|Overall Study|Withdrawal by Subject|1|||
148976001|NCT00308711|537392407|FG000|Overall Study|Protocol Violation|0|||
148976002|NCT00308711|537392408|FG001|Overall Study|Protocol Violation|1|||
148976003|NCT00308711|537392409|FG002|Overall Study|Protocol Violation|1|||
148976004|NCT00308711|537392407|FG000|Overall Study|Lost to Follow-up|0|||
148744708|NCT00996892|536536029|FG014|Expansion Stage 2|Adverse Event|0|||
148744709|NCT00996892|536536030|FG015|Expansion Stage 2|Adverse Event|0|||
148744710|NCT00996892|536536031|FG016|Expansion Stage 2|Adverse Event|0|||
148744711|NCT00996892|536536032|FG017|Expansion Stage 2|Adverse Event|0|||
148744712|NCT00996892|536536033|FG018|Expansion Stage 2|Adverse Event|3|||
148744713|NCT00996892|536536034|FG019|Expansion Stage 2|Adverse Event|0|||
148744714|NCT00996892|536536015|FG000|Expansion Stage 2|Death|0|||
148744715|NCT00996892|536536016|FG001|Expansion Stage 2|Death|0|||
148744716|NCT00996892|536536017|FG002|Expansion Stage 2|Death|0|||
148744717|NCT00996892|536536018|FG003|Expansion Stage 2|Death|0|||
148976005|NCT00308711|537392408|FG001|Overall Study|Lost to Follow-up|1|||
148976006|NCT00308711|537392409|FG002|Overall Study|Lost to Follow-up|0|||
148744718|NCT00996892|536536019|FG004|Expansion Stage 2|Death|0|||
148744719|NCT00996892|536536020|FG005|Expansion Stage 2|Death|0|||
148744720|NCT00996892|536536021|FG006|Expansion Stage 2|Death|0|||
148744721|NCT00996892|536536022|FG007|Expansion Stage 2|Death|0|||
148744722|NCT00996892|536536023|FG008|Expansion Stage 2|Death|0|||
148744723|NCT00996892|536536024|FG009|Expansion Stage 2|Death|0|||
148744724|NCT00996892|536536025|FG010|Expansion Stage 2|Death|0|||
148744725|NCT00996892|536536026|FG011|Expansion Stage 2|Death|0|||
148744726|NCT00996892|536536027|FG012|Expansion Stage 2|Death|0|||
148744727|NCT00996892|536536028|FG013|Expansion Stage 2|Death|0|||
148744728|NCT00996892|536536029|FG014|Expansion Stage 2|Death|0|||
148744729|NCT00996892|536536030|FG015|Expansion Stage 2|Death|0|||
148744730|NCT00996892|536536031|FG016|Expansion Stage 2|Death|0|||
148744731|NCT00996892|536536032|FG017|Expansion Stage 2|Death|0|||
148744732|NCT00996892|536536033|FG018|Expansion Stage 2|Death|2|||
148744733|NCT00996892|536536034|FG019|Expansion Stage 2|Death|0|||
148744734|NCT00996892|536536015|FG000|Expansion Stage 2|Physician Decision|0|||
148744735|NCT00996892|536536016|FG001|Expansion Stage 2|Physician Decision|0|||
148744736|NCT00996892|536536017|FG002|Expansion Stage 2|Physician Decision|0|||
148744737|NCT00996892|536536018|FG003|Expansion Stage 2|Physician Decision|0|||
148744738|NCT00996892|536536019|FG004|Expansion Stage 2|Physician Decision|0|||
148744739|NCT00996892|536536020|FG005|Expansion Stage 2|Physician Decision|0|||
148744740|NCT00996892|536536021|FG006|Expansion Stage 2|Physician Decision|0|||
148744741|NCT00996892|536536022|FG007|Expansion Stage 2|Physician Decision|0|||
148744742|NCT00996892|536536023|FG008|Expansion Stage 2|Physician Decision|0|||
148819669|NCT05156125|536816382|FG001|Overall Study|Physician Decision|0|||
148819670|NCT05156125|536816383|FG002|Overall Study|Physician Decision|1|||
148819671|NCT05156125|536816381|FG000|Overall Study|Non-compliance|0|||
148819672|NCT05156125|536816382|FG001|Overall Study|Non-compliance|1|||
148819673|NCT05156125|536816383|FG002|Overall Study|Non-compliance|1|||
148819674|NCT05156125|536816381|FG000|Overall Study|Withdrawal by Subject|0|||
148819675|NCT05156125|536816382|FG001|Overall Study|Withdrawal by Subject|0|||
148819676|NCT05156125|536816383|FG002|Overall Study|Withdrawal by Subject|1|||
148819677|NCT05156125|536816381|FG000|Overall Study|Adverse Event|2|||
148819678|NCT05156125|536816382|FG001|Overall Study|Adverse Event|1|||
148819679|NCT05156125|536816383|FG002|Overall Study|Adverse Event|0|||
148819680|NCT05987540|536816391|FG000|Overall Study|Withdrawal by Subject|2|||
148819681|NCT05987540|536816391|FG000|Overall Study|Death|1|||
148819682|NCT05987540|536816391|FG000|Overall Study|Study Termination|1|||
148819683|NCT05987540|536816391|FG000|Overall Study|Adverse Event|2|||
148819684|NCT01421134|536816392|FG000|Overall Study|Adverse Event|3|||
148819685|NCT01421134|536816393|FG001|Overall Study|Adverse Event|5|||
148819686|NCT01421134|536816392|FG000|Overall Study|Lack of Efficacy|2|||
148819687|NCT01421134|536816393|FG001|Overall Study|Lack of Efficacy|4|||
148819688|NCT01421134|536816392|FG000|Overall Study|Protocol Violation|0|||
148819689|NCT01421134|536816393|FG001|Overall Study|Protocol Violation|3|||
148819690|NCT01421134|536816392|FG000|Overall Study|Withdrawal by Subject|1|||
148819691|NCT01421134|536816393|FG001|Overall Study|Withdrawal by Subject|1|||
148819692|NCT01421134|536816392|FG000|Overall Study|Administrative|0|||
148819693|NCT01421134|536816393|FG001|Overall Study|Administrative|1|||
148819694|NCT01421134|536816392|FG000|Overall Study|Lost to Follow-up|1|||
148819695|NCT01421134|536816393|FG001|Overall Study|Lost to Follow-up|1|||
148819696|NCT02959892|536816394|FG000|Overall Study|PET tracer synthesis failure|1|||
148819697|NCT02959892|536816395|FG001|Overall Study|PET tracer synthesis failure|0|||
148819698|NCT02959892|536816394|FG000|Overall Study|Study termination|0|||
148976007|NCT00308711|537392407|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
148976008|NCT00308711|537392408|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
148744743|NCT00996892|536536024|FG009|Expansion Stage 2|Physician Decision|0|||
148744744|NCT00996892|536536025|FG010|Expansion Stage 2|Physician Decision|0|||
148744745|NCT00996892|536536026|FG011|Expansion Stage 2|Physician Decision|0|||
148744746|NCT00996892|536536027|FG012|Expansion Stage 2|Physician Decision|0|||
148744747|NCT00996892|536536028|FG013|Expansion Stage 2|Physician Decision|0|||
148744748|NCT00996892|536536029|FG014|Expansion Stage 2|Physician Decision|0|||
148744749|NCT00996892|536536030|FG015|Expansion Stage 2|Physician Decision|0|||
148744750|NCT00996892|536536031|FG016|Expansion Stage 2|Physician Decision|0|||
148744751|NCT00996892|536536032|FG017|Expansion Stage 2|Physician Decision|0|||
148744752|NCT00996892|536536033|FG018|Expansion Stage 2|Physician Decision|1|||
148744753|NCT00996892|536536034|FG019|Expansion Stage 2|Physician Decision|0|||
148819699|NCT02959892|536816395|FG001|Overall Study|Study termination|1|||
148819700|NCT02061592|536816396|FG000|Period 1|Withdrawal by Subject|1|||
148819701|NCT02061592|536816397|FG001|Period 1|Withdrawal by Subject|0|||
148819702|NCT02061592|536816396|FG000|Period 1|Protocol Violation|1|||
148819703|NCT02061592|536816397|FG001|Period 1|Protocol Violation|0|||
148976009|NCT00308711|537392409|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
148744754|NCT00996892|536536015|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
148744755|NCT00996892|536536016|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
148744756|NCT00996892|536536017|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
148744757|NCT00996892|536536018|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
148819704|NCT02061592|536816396|FG000|Period 2|Lost to Follow-up|0|||
148819705|NCT02061592|536816397|FG001|Period 2|Lost to Follow-up|1|||
148819706|NCT03338023|536816398|FG000|Overall Study|Withdrawal by Subject|3|||
148819707|NCT03338023|536816399|FG001|Overall Study|Withdrawal by Subject|4|||
148819708|NCT03338023|536816398|FG000|Overall Study|Protocol Violation|3|||
148819709|NCT03338023|536816399|FG001|Overall Study|Protocol Violation|3|||
148819710|NCT03338023|536816398|FG000|Overall Study|Lost to Follow-up|2|||
148819711|NCT03338023|536816399|FG001|Overall Study|Lost to Follow-up|1|||
148976010|NCT00308711|537392407|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
148976011|NCT00308711|537392408|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
148976012|NCT00308711|537392409|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
148744758|NCT00996892|536536019|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
148744759|NCT00996892|536536020|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
148744760|NCT00996892|536536021|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
148744761|NCT00996892|536536022|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
148744762|NCT00996892|536536023|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
148744763|NCT00996892|536536024|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
148744764|NCT00996892|536536025|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
148744765|NCT00996892|536536026|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
148744766|NCT00996892|536536027|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
148744767|NCT00996892|536536028|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
148744768|NCT00996892|536536029|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
148744769|NCT00996892|536536030|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
148744770|NCT00996892|536536031|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
148744771|NCT00996892|536536032|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
148744772|NCT00996892|536536033|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
148744773|NCT00996892|536536034|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
148744774|NCT00996892|536536015|FG000|Expansion Stage 2|Disease Progression|0|||
148744775|NCT00996892|536536016|FG001|Expansion Stage 2|Disease Progression|0|||
148744776|NCT00996892|536536017|FG002|Expansion Stage 2|Disease Progression|0|||
148744777|NCT00996892|536536018|FG003|Expansion Stage 2|Disease Progression|0|||
148744778|NCT00996892|536536019|FG004|Expansion Stage 2|Disease Progression|0|||
148744779|NCT00996892|536536020|FG005|Expansion Stage 2|Disease Progression|0|||
148744780|NCT00996892|536536021|FG006|Expansion Stage 2|Disease Progression|0|||
148744781|NCT00996892|536536022|FG007|Expansion Stage 2|Disease Progression|0|||
148744782|NCT00996892|536536023|FG008|Expansion Stage 2|Disease Progression|0|||
148744783|NCT00996892|536536024|FG009|Expansion Stage 2|Disease Progression|0|||
148744784|NCT00996892|536536025|FG010|Expansion Stage 2|Disease Progression|0|||
148744785|NCT00996892|536536026|FG011|Expansion Stage 2|Disease Progression|0|||
148744786|NCT00996892|536536027|FG012|Expansion Stage 2|Disease Progression|0|||
148744787|NCT00996892|536536028|FG013|Expansion Stage 2|Disease Progression|0|||
148744788|NCT00996892|536536029|FG014|Expansion Stage 2|Disease Progression|0|||
148744789|NCT00996892|536536030|FG015|Expansion Stage 2|Disease Progression|0|||
148744790|NCT00996892|536536031|FG016|Expansion Stage 2|Disease Progression|0|||
148744791|NCT00996892|536536032|FG017|Expansion Stage 2|Disease Progression|0|||
148744792|NCT00996892|536536033|FG018|Expansion Stage 2|Disease Progression|28|||
148744793|NCT00996892|536536034|FG019|Expansion Stage 2|Disease Progression|0|||
148744794|NCT00996892|536536015|FG000|Expansion Stage 2A|Adverse Event|0|||
148744795|NCT00996892|536536016|FG001|Expansion Stage 2A|Adverse Event|0|||
148744796|NCT00996892|536536017|FG002|Expansion Stage 2A|Adverse Event|0|||
148744797|NCT00996892|536536018|FG003|Expansion Stage 2A|Adverse Event|0|||
148744798|NCT00996892|536536019|FG004|Expansion Stage 2A|Adverse Event|0|||
148744799|NCT00996892|536536020|FG005|Expansion Stage 2A|Adverse Event|0|||
148744800|NCT00996892|536536021|FG006|Expansion Stage 2A|Adverse Event|0|||
148744801|NCT00996892|536536022|FG007|Expansion Stage 2A|Adverse Event|0|||
148744802|NCT00996892|536536023|FG008|Expansion Stage 2A|Adverse Event|0|||
148744803|NCT00996892|536536024|FG009|Expansion Stage 2A|Adverse Event|0|||
148744804|NCT00996892|536536025|FG010|Expansion Stage 2A|Adverse Event|0|||
148744805|NCT00996892|536536026|FG011|Expansion Stage 2A|Adverse Event|0|||
148744806|NCT00996892|536536027|FG012|Expansion Stage 2A|Adverse Event|0|||
148744807|NCT00996892|536536028|FG013|Expansion Stage 2A|Adverse Event|0|||
148744808|NCT00996892|536536029|FG014|Expansion Stage 2A|Adverse Event|0|||
148744809|NCT00996892|536536030|FG015|Expansion Stage 2A|Adverse Event|0|||
148744810|NCT00996892|536536031|FG016|Expansion Stage 2A|Adverse Event|0|||
148744811|NCT00996892|536536032|FG017|Expansion Stage 2A|Adverse Event|0|||
148744812|NCT00996892|536536033|FG018|Expansion Stage 2A|Adverse Event|0|||
148744813|NCT00996892|536536034|FG019|Expansion Stage 2A|Adverse Event|8|||
148744814|NCT00996892|536536015|FG000|Expansion Stage 2A|Physician Decision|0|||
148744815|NCT00996892|536536016|FG001|Expansion Stage 2A|Physician Decision|0|||
148744816|NCT00996892|536536017|FG002|Expansion Stage 2A|Physician Decision|0|||
148744817|NCT00996892|536536018|FG003|Expansion Stage 2A|Physician Decision|0|||
148744818|NCT00996892|536536019|FG004|Expansion Stage 2A|Physician Decision|0|||
148744819|NCT00996892|536536020|FG005|Expansion Stage 2A|Physician Decision|0|||
148819712|NCT03338023|536816398|FG000|Overall Study|Physician Decision|1|||
148976013|NCT01420081|537392412|FG000|Overall Study|Death|1|||
148744820|NCT00996892|536536021|FG006|Expansion Stage 2A|Physician Decision|0|||
148744821|NCT00996892|536536022|FG007|Expansion Stage 2A|Physician Decision|0|||
148819713|NCT03338023|536816399|FG001|Overall Study|Physician Decision|2|||
148819714|NCT00685698|536816400|FG000|Overall Study|Withdrawal by Subject|1|||
148819715|NCT00685698|536816400|FG000|Overall Study|Protocol Violation|6|||
148819716|NCT00685698|536816400|FG000|Overall Study|Adverse Event|3|||
148819717|NCT00685698|536816400|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
148819718|NCT00685698|536816400|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
148819719|NCT00685698|536816400|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
148819720|NCT02030418|536816404|FG000|Overall Study|Death|78|||
148819721|NCT02030418|536816404|FG000|Overall Study|Missed 12-Month Visit|9|||
148819722|NCT02030418|536816404|FG000|Overall Study|Withdrawn|57|||
148819723|NCT00724893|536816405|FG000|Overall Study|Adverse Event|76|||
148819724|NCT00724893|536816406|FG001|Overall Study|Adverse Event|142|||
148819725|NCT00724893|536816405|FG000|Overall Study|Withdrawal by Subject|0|||
148819726|NCT00724893|536816406|FG001|Overall Study|Withdrawal by Subject|1|||
148819727|NCT00724893|536816405|FG000|Overall Study|Lack of virologic response|94|||
148819728|NCT00724893|536816406|FG001|Overall Study|Lack of virologic response|202|||
148819729|NCT00724893|536816405|FG000|Overall Study|Reason not specified|193|||
148819730|NCT00724893|536816406|FG001|Overall Study|Reason not specified|7|||
148819731|NCT00724893|536816405|FG000|Overall Study|Patient choice|0|||
148819732|NCT00724893|536816406|FG001|Overall Study|Patient choice|26|||
148819733|NCT00724893|536816405|FG000|Overall Study|Geographic reasons|0|||
148819734|NCT00724893|536816406|FG001|Overall Study|Geographic reasons|11|||
148819735|NCT00724893|536816405|FG000|Overall Study|Incarceration|0|||
148819736|NCT00724893|536816406|FG001|Overall Study|Incarceration|9|||
148819737|NCT00724893|536816405|FG000|Overall Study|Substance abuse|0|||
148819738|NCT00724893|536816406|FG001|Overall Study|Substance abuse|3|||
148819739|NCT00724893|536816405|FG000|Overall Study|Financial reasons|0|||
148819740|NCT00724893|536816406|FG001|Overall Study|Financial reasons|2|||
148819741|NCT00724893|536816405|FG000|Overall Study|Assigned shorter treatment|0|||
148819742|NCT00724893|536816406|FG001|Overall Study|Assigned shorter treatment|2|||
148819743|NCT00724893|536816405|FG000|Overall Study|Lost to Follow-up|0|||
148819744|NCT00724893|536816406|FG001|Overall Study|Lost to Follow-up|52|||
148819745|NCT00724893|536816405|FG000|Overall Study|Unknown, missing data|1|||
148819746|NCT00724893|536816406|FG001|Overall Study|Unknown, missing data|1|||
148819747|NCT01290731|536816409|FG000|Overall Study|Withdrawal by Subject|1|||
148819748|NCT01279200|536816410|FG000|Overall Study|Withdrawal by Subject|1|||
148819749|NCT01279200|536816411|FG001|Overall Study|Withdrawal by Subject|3|||
148819750|NCT01279200|536816410|FG000|Overall Study|Patient withdrawal due to high cost|0|||
148819751|NCT01279200|536816411|FG001|Overall Study|Patient withdrawal due to high cost|1|||
148819752|NCT01279200|536816410|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
148976014|NCT01420081|537392413|FG001|Overall Study|Death|0|||
148744822|NCT00996892|536536023|FG008|Expansion Stage 2A|Physician Decision|0|||
148744823|NCT00996892|536536024|FG009|Expansion Stage 2A|Physician Decision|0|||
148744824|NCT00996892|536536025|FG010|Expansion Stage 2A|Physician Decision|0|||
148744825|NCT00996892|536536026|FG011|Expansion Stage 2A|Physician Decision|0|||
148744826|NCT00996892|536536027|FG012|Expansion Stage 2A|Physician Decision|0|||
148744827|NCT00996892|536536028|FG013|Expansion Stage 2A|Physician Decision|0|||
148744828|NCT00996892|536536029|FG014|Expansion Stage 2A|Physician Decision|0|||
148744829|NCT00996892|536536030|FG015|Expansion Stage 2A|Physician Decision|0|||
148744830|NCT00996892|536536031|FG016|Expansion Stage 2A|Physician Decision|0|||
148744831|NCT00996892|536536032|FG017|Expansion Stage 2A|Physician Decision|0|||
148744832|NCT00996892|536536033|FG018|Expansion Stage 2A|Physician Decision|0|||
148744833|NCT00996892|536536034|FG019|Expansion Stage 2A|Physician Decision|2|||
148744834|NCT00996892|536536015|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
148744835|NCT00996892|536536016|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
148744836|NCT00996892|536536017|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
148744837|NCT00996892|536536018|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
148744838|NCT00996892|536536019|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
148744839|NCT00996892|536536020|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
148744840|NCT00996892|536536021|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
148744841|NCT00996892|536536022|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
148744842|NCT00996892|536536023|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
148744843|NCT00996892|536536024|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
148744844|NCT00996892|536536025|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
148744845|NCT00996892|536536026|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
148744846|NCT00996892|536536027|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
148744847|NCT00996892|536536028|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
148744848|NCT00996892|536536029|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
148744849|NCT00996892|536536030|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
148819753|NCT01279200|536816411|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
148819754|NCT01279200|536816410|FG000|Overall Study|ultrasound screening failure|0|||
148819755|NCT01279200|536816411|FG001|Overall Study|ultrasound screening failure|1|||
148819756|NCT01279200|536816410|FG000|Overall Study|Lost to Follow-up|0|||
148819757|NCT01279200|536816411|FG001|Overall Study|Lost to Follow-up|1|||
148819758|NCT01279200|536816410|FG000|Overall Study|Adverse Event|1|||
148819759|NCT01279200|536816411|FG001|Overall Study|Adverse Event|0|||
148976015|NCT01420081|537392414|FG002|Overall Study|Death|8|||
148976016|NCT01420081|537392415|FG003|Overall Study|Death|0|||
148744850|NCT00996892|536536031|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
148744851|NCT00996892|536536032|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
148744852|NCT00996892|536536033|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
148744853|NCT00996892|536536034|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
148744854|NCT00996892|536536015|FG000|Expansion Stage 2A|Disease Progression|0|||
148744855|NCT00996892|536536016|FG001|Expansion Stage 2A|Disease Progression|0|||
148744856|NCT00996892|536536017|FG002|Expansion Stage 2A|Disease Progression|0|||
148744857|NCT00996892|536536018|FG003|Expansion Stage 2A|Disease Progression|0|||
148744858|NCT00996892|536536019|FG004|Expansion Stage 2A|Disease Progression|0|||
148744859|NCT00996892|536536020|FG005|Expansion Stage 2A|Disease Progression|0|||
148744860|NCT00996892|536536021|FG006|Expansion Stage 2A|Disease Progression|0|||
148744861|NCT00996892|536536022|FG007|Expansion Stage 2A|Disease Progression|0|||
148744862|NCT00996892|536536023|FG008|Expansion Stage 2A|Disease Progression|0|||
148744863|NCT00996892|536536024|FG009|Expansion Stage 2A|Disease Progression|0|||
148744864|NCT00996892|536536025|FG010|Expansion Stage 2A|Disease Progression|0|||
148744865|NCT00996892|536536026|FG011|Expansion Stage 2A|Disease Progression|0|||
148744866|NCT00996892|536536027|FG012|Expansion Stage 2A|Disease Progression|0|||
148744867|NCT00996892|536536028|FG013|Expansion Stage 2A|Disease Progression|0|||
148744868|NCT00996892|536536029|FG014|Expansion Stage 2A|Disease Progression|0|||
148744869|NCT00996892|536536030|FG015|Expansion Stage 2A|Disease Progression|0|||
148744870|NCT00996892|536536031|FG016|Expansion Stage 2A|Disease Progression|0|||
148744871|NCT00996892|536536032|FG017|Expansion Stage 2A|Disease Progression|0|||
148744872|NCT00996892|536536033|FG018|Expansion Stage 2A|Disease Progression|0|||
148744873|NCT00996892|536536034|FG019|Expansion Stage 2A|Disease Progression|31|||
148744874|NCT01653912|536536035|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
148744875|NCT01653912|536536036|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
148744876|NCT01653912|536536037|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
148744877|NCT01653912|536536038|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
148744878|NCT01653912|536536039|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
148744879|NCT01653912|536536040|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
148744880|NCT01653912|536536035|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
148744881|NCT01653912|536536036|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
148744882|NCT01653912|536536037|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
148744883|NCT01653912|536536038|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
148744884|NCT01653912|536536039|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
148744885|NCT01653912|536536040|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
148744886|NCT01653912|536536035|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
148744887|NCT01653912|536536036|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
148744888|NCT01653912|536536037|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
148744889|NCT01653912|536536038|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
148744890|NCT01653912|536536039|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
148744891|NCT01653912|536536040|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
148744892|NCT01653912|536536035|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744893|NCT01653912|536536036|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744894|NCT01653912|536536037|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744895|NCT01653912|536536038|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
148744896|NCT01653912|536536039|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744897|NCT01653912|536536040|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744898|NCT01653912|536536035|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
148744899|NCT01653912|536536036|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
148744900|NCT01653912|536536037|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
148744901|NCT01653912|536536038|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
148744902|NCT01653912|536536039|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
148744903|NCT01653912|536536040|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
148744904|NCT01653912|536536035|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
148744905|NCT01653912|536536036|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
148744906|NCT01653912|536536037|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
148744907|NCT01653912|536536038|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
148744908|NCT01653912|536536039|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
148744909|NCT01653912|536536040|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
148744910|NCT01653912|536536035|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744911|NCT01653912|536536036|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744912|NCT01653912|536536037|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744913|NCT01653912|536536038|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744914|NCT01653912|536536039|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
148744915|NCT01653912|536536040|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
148744916|NCT00708227|536536041|FG000|Overall Study|Physician Decision|0|||
148744917|NCT00708227|536536042|FG001|Overall Study|Physician Decision|3|||
148744918|NCT00708227|536536043|FG002|Overall Study|Physician Decision|1|||
148744919|NCT00708227|536536044|FG003|Overall Study|Physician Decision|2|||
148744920|NCT00708227|536536041|FG000|Overall Study|Withdrawal by Subject|1|||
148819760|NCT01399099|536816412|FG000|Overall Study|Lost to Follow-up|14|||
148976017|NCT01420081|537392416|FG004|Overall Study|Death|7|||
148976018|NCT01420081|537392417|FG005|Overall Study|Death|12|||
148744921|NCT00708227|536536042|FG001|Overall Study|Withdrawal by Subject|2|||
148744922|NCT00708227|536536043|FG002|Overall Study|Withdrawal by Subject|0|||
148744923|NCT00708227|536536044|FG003|Overall Study|Withdrawal by Subject|1|||
148744924|NCT00278889|536536045|FG000|Overall Study|Withdrawal by Subject|0|||
148744925|NCT00278889|536536046|FG001|Overall Study|Withdrawal by Subject|5|||
148744926|NCT00278889|536536047|FG002|Overall Study|Withdrawal by Subject|3|||
148744927|NCT00278889|536536045|FG000|Overall Study|Lost to Follow-up|1|||
148744928|NCT00278889|536536046|FG001|Overall Study|Lost to Follow-up|1|||
148744929|NCT00278889|536536047|FG002|Overall Study|Lost to Follow-up|0|||
148744930|NCT00278889|536536045|FG000|Overall Study|Death|24|||
148744931|NCT00278889|536536046|FG001|Overall Study|Death|21|||
148744932|NCT00278889|536536047|FG002|Overall Study|Death|17|||
148744933|NCT04007991|536536048|FG000|Overall Study|Withdrawal by Subject|1|||
148744934|NCT04007991|536536049|FG001|Overall Study|Withdrawal by Subject|1|||
148744935|NCT04007991|536536048|FG000|Overall Study|Physician Decision|1|||
148744936|NCT04007991|536536049|FG001|Overall Study|Physician Decision|1|||
148744937|NCT04007991|536536048|FG000|Overall Study|Non-compliance with Study Drug|0|||
148744938|NCT04007991|536536049|FG001|Overall Study|Non-compliance with Study Drug|1|||
148744939|NCT04007991|536536048|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
148744940|NCT04007991|536536049|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
148744941|NCT04007991|536536048|FG000|Overall Study|Adverse event, non-fatal|5|||
148744942|NCT04007991|536536049|FG001|Overall Study|Adverse event, non-fatal|0|||
148744943|NCT04007991|536536048|FG000|Overall Study|Lost to Follow-up|2|||
148744944|NCT04007991|536536049|FG001|Overall Study|Lost to Follow-up|1|||
148744945|NCT01987479|536536050|FG000|Overall Study|Protocol Violation|1|||
148744946|NCT01987479|536536050|FG000|Overall Study|Physician Decision|2|||
148744947|NCT01987479|536536050|FG000|Overall Study|Participant/legal guardian decision|1|||
148744948|NCT01987479|536536050|FG000|Overall Study|Other|5|||
148744949|NCT01987479|536536050|FG000|Overall Study|Lost to Follow-up|1|||
148744950|NCT01987479|536536050|FG000|Overall Study|Adverse Event|7|||
148744951|NCT03654599|536536051|FG000|Overall Study|Lost to Follow-up|14|||
148744952|NCT03654599|536536052|FG001|Overall Study|Lost to Follow-up|12|||
148744953|NCT03654599|536536051|FG000|Overall Study|Death|8|||
148744954|NCT03654599|536536052|FG001|Overall Study|Death|6|||
148744955|NCT03654599|536536051|FG000|Overall Study|Withdrawal by Subject|6|||
148744956|NCT03654599|536536052|FG001|Overall Study|Withdrawal by Subject|4|||
148744957|NCT04042376|536536053|FG000|Overall Study|Withdrawal by Subject|1|||
148744958|NCT04042376|536536053|FG000|Overall Study|Death|3|||
148744959|NCT01762800|536538182|FG000|Overall Study|Adverse Event|8|||
148744960|NCT01762800|536538183|FG001|Overall Study|Adverse Event|13|||
148744961|NCT01762800|536538182|FG000|Overall Study|Lack of Efficacy|3|||
148744962|NCT01762800|536538183|FG001|Overall Study|Lack of Efficacy|2|||
148744963|NCT01762800|536538182|FG000|Overall Study|Study Closed/Terminated|0|||
148744964|NCT01762800|536538183|FG001|Overall Study|Study Closed/Terminated|1|||
148744965|NCT01762800|536538182|FG000|Overall Study|Physician Decision|1|||
148744966|NCT01762800|536538183|FG001|Overall Study|Physician Decision|1|||
148744967|NCT01762800|536538182|FG000|Overall Study|Withdrawal by Subject|7|||
148744968|NCT01762800|536538183|FG001|Overall Study|Withdrawal by Subject|4|||
148744969|NCT02847260|536538184|FG000|Overall Study|Adverse Event|3|||
148744970|NCT02847260|536538184|FG000|Overall Study|Withdrawal by Subject|2|||
148744971|NCT02847260|536538184|FG000|Overall Study|Clinical Deterioration|1|||
148744972|NCT02847260|536538184|FG000|Overall Study|Physician Decision|1|||
148744973|NCT02699684|536538185|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
148744974|NCT02699684|536538186|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
148744975|NCT00492778|536538189|FG000|Overall Study|Ineligible by Pathology Review|8|||
148744976|NCT00492778|536538190|FG001|Overall Study|Ineligible by Pathology Review|1|||
148744977|NCT00362336|536538193|FG000|Overall Study|Serious Adverse Event|1|||
148744978|NCT00362336|536538194|FG001|Overall Study|Serious Adverse Event|0|||
148744979|NCT00362336|536538195|FG002|Overall Study|Serious Adverse Event|1|||
148976019|NCT01420081|537392418|FG006|Overall Study|Death|0|||
148976020|NCT01420081|537392419|FG007|Overall Study|Death|1|||
148976021|NCT01420081|537392420|FG008|Overall Study|Death|1|||
148744980|NCT00362336|536538193|FG000|Overall Study|Protocol Violation|0|||
148744981|NCT00362336|536538194|FG001|Overall Study|Protocol Violation|0|||
148744982|NCT00362336|536538195|FG002|Overall Study|Protocol Violation|1|||
148744983|NCT00362336|536538193|FG000|Overall Study|Lost to Follow-up|6|||
148744984|NCT00362336|536538194|FG001|Overall Study|Lost to Follow-up|4|||
148744985|NCT00362336|536538195|FG002|Overall Study|Lost to Follow-up|0|||
148744986|NCT00362336|536538193|FG000|Overall Study|Withdrawal by Subject|3|||
148744987|NCT00362336|536538194|FG001|Overall Study|Withdrawal by Subject|3|||
148976022|NCT01420081|537392412|FG000|Overall Study|Lost to Follow-up|0|||
148744988|NCT00362336|536538195|FG002|Overall Study|Withdrawal by Subject|1|||
148744989|NCT04414618|536538196|FG000|Overall Study|Death|3|||
148976023|NCT01420081|537392413|FG001|Overall Study|Lost to Follow-up|0|||
148976024|NCT01420081|537392414|FG002|Overall Study|Lost to Follow-up|0|||
148976025|NCT01420081|537392415|FG003|Overall Study|Lost to Follow-up|0|||
148976026|NCT01420081|537392416|FG004|Overall Study|Lost to Follow-up|1|||
148976027|NCT01420081|537392417|FG005|Overall Study|Lost to Follow-up|1|||
148744990|NCT04414618|536538197|FG001|Overall Study|Death|3|||
148744991|NCT04414618|536538196|FG000|Overall Study|Withdrawal by Subject|2|||
148744992|NCT04414618|536538197|FG001|Overall Study|Withdrawal by Subject|1|||
148744993|NCT04414618|536538196|FG000|Overall Study|Lost to Follow-up|2|||
148744994|NCT04414618|536538197|FG001|Overall Study|Lost to Follow-up|3|||
148744995|NCT04414618|536538196|FG000|Overall Study|Physician Decision|1|||
148744996|NCT04414618|536538197|FG001|Overall Study|Physician Decision|0|||
148744997|NCT00658879|536538198|FG000|Overall Study|Protocol Violation|1|||
148744998|NCT02640690|536538199|FG000|Overall Study|Lost to Follow-up|7|||
148744999|NCT02640690|536538200|FG001|Overall Study|Lost to Follow-up|7|||
148745000|NCT02640690|536538199|FG000|Overall Study|Withdrawal by Subject|16|||
148745001|NCT02640690|536538200|FG001|Overall Study|Withdrawal by Subject|20|||
148745002|NCT02640690|536538199|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
148745003|NCT02640690|536538200|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
148745004|NCT01118975|536538201|FG000|Overall Study|Adverse Event|0|||
148745005|NCT01118975|536538202|FG001|Overall Study|Adverse Event|1|||
148745006|NCT01645787|536538203|FG000|Washout (2 Weeks)|Adverse Event|1|||
148745007|NCT01645787|536538204|FG001|Washout (2 Weeks)|Adverse Event|0|||
148745008|NCT04315506|536538213|FG000|Overall Study|Lost to Follow-up|74|||
148745009|NCT04315506|536538214|FG001|Overall Study|Lost to Follow-up|82|||
148745010|NCT04315506|536538213|FG000|Overall Study|Withdrawal by Subject|8|||
148745011|NCT04315506|536538214|FG001|Overall Study|Withdrawal by Subject|8|||
148745012|NCT04315506|536538213|FG000|Overall Study|Physician Decision|0|||
148745013|NCT04315506|536538214|FG001|Overall Study|Physician Decision|1|||
148745014|NCT02661217|536538215|FG000|Overall Study|Physician Decision|12|||
148745015|NCT02661217|536538216|FG001|Overall Study|Physician Decision|15|||
148745016|NCT02661217|536538215|FG000|Overall Study|Lost to Follow-up|1|||
148745017|NCT02661217|536538216|FG001|Overall Study|Lost to Follow-up|4|||
148745018|NCT02661217|536538215|FG000|Overall Study|Protocol Deviation|0|||
148745019|NCT02661217|536538216|FG001|Overall Study|Protocol Deviation|4|||
148745020|NCT02661217|536538215|FG000|Overall Study|Non-compliance with study treatment|5|||
148745021|NCT02661217|536538216|FG001|Overall Study|Non-compliance with study treatment|5|||
148745022|NCT02661217|536538215|FG000|Overall Study|Death|21|||
148745023|NCT02661217|536538216|FG001|Overall Study|Death|15|||
148745024|NCT02661217|536538215|FG000|Overall Study|Adverse Event|10|||
148745025|NCT02661217|536538216|FG001|Overall Study|Adverse Event|8|||
148745026|NCT02661217|536538215|FG000|Overall Study|Withdrawal by Subject|15|||
148745027|NCT02661217|536538216|FG001|Overall Study|Withdrawal by Subject|19|||
148745028|NCT02661217|536538215|FG000|Overall Study|Did not enter follow-up epoch|7|||
148745029|NCT02661217|536538216|FG001|Overall Study|Did not enter follow-up epoch|10|||
148745030|NCT02661217|536538215|FG000|Overall Study|Death - no study drug received|1|||
148745031|NCT02661217|536538216|FG001|Overall Study|Death - no study drug received|2|||
148745032|NCT02661217|536538215|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
148745033|NCT02661217|536538216|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
148745034|NCT00626561|536538234|FG000|Overall Study|Withdrawal by Subject|2|||
148745035|NCT00626561|536538234|FG000|Overall Study|Disease Progression|2|||
148745036|NCT00442962|536538235|FG000|Overall Study|Pregnancy|1|||
148745037|NCT00442962|536538235|FG000|Overall Study|Lost to Follow-up|7|||
148745038|NCT00356525|536538241|FG000|Overall Study|Progressive Disease|8|||
148745039|NCT00356525|536538242|FG001|Overall Study|Progressive Disease|5|||
148745040|NCT00356525|536538243|FG002|Overall Study|Progressive Disease|4|||
148745041|NCT00356525|536538244|FG003|Overall Study|Progressive Disease|2|||
148745042|NCT00356525|536538241|FG000|Overall Study|Adverse Event|1|||
148745043|NCT00356525|536538242|FG001|Overall Study|Adverse Event|3|||
148745044|NCT00356525|536538243|FG002|Overall Study|Adverse Event|1|||
148745045|NCT00356525|536538244|FG003|Overall Study|Adverse Event|1|||
148745046|NCT00356525|536538241|FG000|Overall Study|Lost to Follow-up|1|||
148745047|NCT00356525|536538242|FG001|Overall Study|Lost to Follow-up|0|||
148745048|NCT00356525|536538243|FG002|Overall Study|Lost to Follow-up|0|||
148976028|NCT01420081|537392418|FG006|Overall Study|Lost to Follow-up|0|||
148976029|NCT01420081|537392419|FG007|Overall Study|Lost to Follow-up|0|||
148745049|NCT00356525|536538244|FG003|Overall Study|Lost to Follow-up|0|||
148745050|NCT00356525|536538241|FG000|Overall Study|Physician Decision|2|||
148745051|NCT00356525|536538242|FG001|Overall Study|Physician Decision|2|||
148745052|NCT00356525|536538243|FG002|Overall Study|Physician Decision|2|||
148819761|NCT01399099|536816412|FG000|Overall Study|Physician Decision|1|||
148819762|NCT01399099|536816412|FG000|Overall Study|Protocol Violation|1|||
148976030|NCT01420081|537392420|FG008|Overall Study|Lost to Follow-up|0|||
148745053|NCT00356525|536538244|FG003|Overall Study|Physician Decision|1|||
148745054|NCT00356525|536538241|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
148745055|NCT00356525|536538242|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
148745056|NCT00356525|536538243|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
148745057|NCT00356525|536538244|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
148745058|NCT00356525|536538241|FG000|Overall Study|Withdrawal by Subject|1|||
148745059|NCT00356525|536538242|FG001|Overall Study|Withdrawal by Subject|1|||
148745060|NCT00356525|536538243|FG002|Overall Study|Withdrawal by Subject|0|||
148976031|NCT01420081|537392412|FG000|Overall Study|Study Terminated by Sponsor|2|||
148819763|NCT01399099|536816412|FG000|Overall Study|Skin Irritation|13|||
148819764|NCT01399099|536816412|FG000|Overall Study|Infection|1|||
148819765|NCT01399099|536816412|FG000|Overall Study|Miscellaneous|4|||
148819766|NCT01179516|536816413|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
148819767|NCT01179516|536816414|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
148819768|NCT01179516|536816415|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
148819769|NCT01179516|536816413|FG000|Overall Study|Lack of Efficacy|4|||
148819770|NCT01179516|536816414|FG001|Overall Study|Lack of Efficacy|2|||
148819771|NCT01179516|536816415|FG002|Overall Study|Lack of Efficacy|0|||
148819772|NCT01179516|536816413|FG000|Overall Study|Noncompliance with Study Drug|2|||
148819773|NCT01179516|536816414|FG001|Overall Study|Noncompliance with Study Drug|0|||
148819774|NCT01179516|536816415|FG002|Overall Study|Noncompliance with Study Drug|1|||
148819775|NCT01179516|536816413|FG000|Overall Study|Protocol Deviations|4|||
148819776|NCT01179516|536816414|FG001|Overall Study|Protocol Deviations|3|||
148819777|NCT01179516|536816415|FG002|Overall Study|Protocol Deviations|3|||
148819778|NCT01179516|536816413|FG000|Overall Study|Withdrawal of Consent|2|||
148819779|NCT01179516|536816414|FG001|Overall Study|Withdrawal of Consent|6|||
148819780|NCT01179516|536816415|FG002|Overall Study|Withdrawal of Consent|10|||
148819781|NCT01179516|536816413|FG000|Overall Study|Lost to Follow-up|7|||
148819782|NCT01179516|536816414|FG001|Overall Study|Lost to Follow-up|7|||
148819783|NCT01179516|536816415|FG002|Overall Study|Lost to Follow-up|3|||
148819784|NCT01179516|536816413|FG000|Overall Study|Other|2|||
148819785|NCT01179516|536816414|FG001|Overall Study|Other|0|||
148819786|NCT01179516|536816415|FG002|Overall Study|Other|2|||
148819787|NCT02583477|536816419|FG000|Overall Study|Adverse Event|0|||
148819788|NCT02583477|536816420|FG001|Overall Study|Adverse Event|2|||
148819789|NCT02583477|536816419|FG000|Overall Study|Death|1|||
148819790|NCT02583477|536816420|FG001|Overall Study|Death|16|||
148819791|NCT02583477|536816419|FG000|Overall Study|Study terminated|2|||
148819792|NCT02583477|536816420|FG001|Overall Study|Study terminated|2|||
148819793|NCT05507450|536816421|FG000|Overall Study|Death|0|||
148819794|NCT05507450|536816422|FG001|Overall Study|Death|0|||
148819795|NCT05507450|536816423|FG002|Overall Study|Death|1|||
148819796|NCT05507450|536816424|FG003|Overall Study|Death|0|||
148819797|NCT05507450|536816421|FG000|Overall Study|Lost to Follow-up|22|||
148819798|NCT05507450|536816422|FG001|Overall Study|Lost to Follow-up|20|||
148819799|NCT05507450|536816423|FG002|Overall Study|Lost to Follow-up|20|||
148819800|NCT05507450|536816424|FG003|Overall Study|Lost to Follow-up|7|||
148819801|NCT05507450|536816421|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148819802|NCT05507450|536816422|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
148819803|NCT05507450|536816423|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148819804|NCT05507450|536816424|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148819805|NCT05507450|536816421|FG000|Overall Study|Withdrawal by Subject|4|||
148819806|NCT05507450|536816422|FG001|Overall Study|Withdrawal by Subject|11|||
148819807|NCT05507450|536816423|FG002|Overall Study|Withdrawal by Subject|7|||
148819808|NCT05507450|536816424|FG003|Overall Study|Withdrawal by Subject|3|||
149027170|NCT00052962|537576528|FG001|Overall Study|Not randomized/not evaluable|0|||
149027171|NCT01414166|537576530|FG000|Overall Study|Adverse Event|10|||
148819809|NCT05507450|536816421|FG000|Overall Study|Participant left the country|0|||
148819810|NCT05507450|536816422|FG001|Overall Study|Participant left the country|0|||
148819811|NCT05507450|536816423|FG002|Overall Study|Participant left the country|1|||
148819812|NCT05507450|536816424|FG003|Overall Study|Participant left the country|0|||
148819813|NCT03501277|536816425|FG000|Intervention Period 1 (4 Days)|Other|0|||
148819814|NCT03501277|536816426|FG001|Intervention Period 1 (4 Days)|Other|0|||
148819815|NCT03501277|536816427|FG002|Intervention Period 1 (4 Days)|Other|1|||
148819816|NCT03501277|536816428|FG003|Intervention Period 1 (4 Days)|Other|0|||
148819817|NCT03501277|536816425|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
148819818|NCT03501277|536816426|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
148819819|NCT03501277|536816427|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
148819820|NCT03501277|536816428|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
148819821|NCT03501277|536816425|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
149027172|NCT01414166|537576531|FG001|Overall Study|Adverse Event|2|||
149027173|NCT01414166|537576530|FG000|Overall Study|Lost to Follow-up|4|||
149027174|NCT01414166|537576531|FG001|Overall Study|Lost to Follow-up|1|||
148819822|NCT03501277|536816426|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
148819823|NCT03501277|536816427|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
148819824|NCT03501277|536816428|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
148819825|NCT03501277|536816425|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
148819826|NCT03501277|536816426|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
148819827|NCT03501277|536816427|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
148819828|NCT03501277|536816428|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
148819829|NCT00356421|536816431|FG000|Overall Study|Lack of Efficacy|3|||
148819830|NCT00356421|536816432|FG001|Overall Study|Lack of Efficacy|0|||
148819831|NCT00356421|536816431|FG000|Overall Study|Withdrawal by Subject|9|||
148819832|NCT00356421|536816432|FG001|Overall Study|Withdrawal by Subject|2|||
149027175|NCT01414166|537576530|FG000|Overall Study|Non-compliance with study drug|2|||
148819833|NCT00356421|536816431|FG000|Overall Study|Related to study drug|15|||
148819834|NCT00356421|536816432|FG001|Overall Study|Related to study drug|12|||
148819835|NCT00356421|536816431|FG000|Overall Study|Not related to study drug|5|||
148819836|NCT00356421|536816432|FG001|Overall Study|Not related to study drug|3|||
148819837|NCT05089357|536816433|FG000|Overall Study|Withdrawal by Subject|23|||
148819838|NCT05089357|536816433|FG000|Overall Study|Lost to Follow-up|6|||
148819839|NCT05089357|536816433|FG000|Overall Study|Medical reason|1|||
148819840|NCT05089357|536816433|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
148819841|NCT05089357|536816433|FG000|Overall Study|Pregnancy|2|||
148819842|NCT01452347|536816440|FG000|Overall Study|Adverse Event|2|||
148819843|NCT01452347|536816441|FG001|Overall Study|Adverse Event|1|||
148819844|NCT01452347|536816440|FG000|Overall Study|Non compliance protocol|2|||
148819845|NCT01452347|536816441|FG001|Overall Study|Non compliance protocol|0|||
148819846|NCT01452347|536816440|FG000|Overall Study|Lost to Follow-up|2|||
148819847|NCT01452347|536816441|FG001|Overall Study|Lost to Follow-up|0|||
148819848|NCT01452347|536816440|FG000|Overall Study|Withdrawal by Subject|3|||
148819849|NCT01452347|536816441|FG001|Overall Study|Withdrawal by Subject|3|||
148819850|NCT01452347|536816440|FG000|Overall Study|Not treated|6|||
148819851|NCT01452347|536816441|FG001|Overall Study|Not treated|3|||
148819852|NCT01452347|536816440|FG000|Overall Study|Other reason not defined above|2|||
148819853|NCT01452347|536816441|FG001|Overall Study|Other reason not defined above|0|||
148819854|NCT02082483|536818063|FG000|Overall Study|Lost to Follow-up|1|||
148819855|NCT02082483|536818064|FG001|Overall Study|Lost to Follow-up|1|||
148819856|NCT02082483|536818063|FG000|Overall Study|Withdrawal by Subject|2|||
148819857|NCT02082483|536818064|FG001|Overall Study|Withdrawal by Subject|1|||
148819858|NCT02082483|536818063|FG000|Overall Study|Physician Decision|1|||
148819859|NCT02082483|536818064|FG001|Overall Study|Physician Decision|1|||
148819860|NCT02082483|536818063|FG000|Overall Study|Death|2|||
148819861|NCT02082483|536818064|FG001|Overall Study|Death|3|||
148819862|NCT02181621|536818065|FG000|Overall Study|Adverse Event|1|||
148819863|NCT02181621|536818066|FG001|Overall Study|Adverse Event|0|||
148745061|NCT00356525|536538244|FG003|Overall Study|Withdrawal by Subject|3|||
148745062|NCT00356525|536538241|FG000|Overall Study|Death|0|||
148745063|NCT00356525|536538242|FG001|Overall Study|Death|0|||
148745064|NCT00356525|536538243|FG002|Overall Study|Death|0|||
148745065|NCT00356525|536538244|FG003|Overall Study|Death|1|||
148745066|NCT00356525|536538241|FG000|Overall Study|Sponsor Decision|0|||
148745067|NCT00356525|536538242|FG001|Overall Study|Sponsor Decision|0|||
148745068|NCT00356525|536538243|FG002|Overall Study|Sponsor Decision|0|||
148745069|NCT00356525|536538244|FG003|Overall Study|Sponsor Decision|1|||
148745070|NCT00214383|536538247|FG000|Overall Study|Lost to Follow-up|16|||
148745071|NCT00214383|536538248|FG001|Overall Study|Lost to Follow-up|26|||
148745072|NCT01038297|536538249|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
148745073|NCT01038297|536538250|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
148745074|NCT01038297|536538251|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
148745075|NCT01822366|536538252|FG000|Overall Study|Lost to Follow-up|5|||
148745076|NCT01822366|536538253|FG001|Overall Study|Lost to Follow-up|1|||
148745077|NCT01822366|536538254|FG002|Overall Study|Lost to Follow-up|5|||
148745078|NCT01822366|536538255|FG003|Overall Study|Lost to Follow-up|1|||
148745079|NCT01822366|536538252|FG000|Overall Study|Withdrawal by Subject|0|||
148745080|NCT01822366|536538253|FG001|Overall Study|Withdrawal by Subject|6|||
148745081|NCT01822366|536538254|FG002|Overall Study|Withdrawal by Subject|0|||
148745082|NCT01822366|536538255|FG003|Overall Study|Withdrawal by Subject|6|||
148745083|NCT01822366|536538252|FG000|Overall Study|Partial Intervention Completion|0|||
148745084|NCT01822366|536538253|FG001|Overall Study|Partial Intervention Completion|15|||
148745085|NCT01822366|536538254|FG002|Overall Study|Partial Intervention Completion|0|||
148745086|NCT01822366|536538255|FG003|Overall Study|Partial Intervention Completion|15|||
148745087|NCT00384930|536538256|FG000|Overall Study|Adverse Event|5|||
148745088|NCT00384930|536538257|FG001|Overall Study|Adverse Event|4|||
148745089|NCT00384930|536538258|FG002|Overall Study|Adverse Event|12|||
148745090|NCT00384930|536538259|FG003|Overall Study|Adverse Event|11|||
148819864|NCT02181621|536818065|FG000|Overall Study|Previously Enrolled|0|||
148819865|NCT02181621|536818066|FG001|Overall Study|Previously Enrolled|1|||
148819866|NCT02181621|536818065|FG000|Overall Study|Enrollment Hold|1|||
148819867|NCT02181621|536818066|FG001|Overall Study|Enrollment Hold|1|||
148819868|NCT00762788|536818067|FG000|Overall Study|Lost to Follow-up|26|||
148819869|NCT00762788|536818068|FG001|Overall Study|Lost to Follow-up|37|||
148819870|NCT00762788|536818069|FG002|Overall Study|Lost to Follow-up|21|||
148819871|NCT00762788|536818070|FG003|Overall Study|Lost to Follow-up|26|||
148745091|NCT00384930|536538260|FG004|Overall Study|Adverse Event|14|||
148819872|NCT00762788|536818071|FG004|Overall Study|Lost to Follow-up|13|||
148819873|NCT00762788|536818072|FG005|Overall Study|Lost to Follow-up|21|||
148819874|NCT01783015|536818073|FG000|Blinded Treatment|Adverse Event|0|||
148819875|NCT01783015|536818074|FG001|Blinded Treatment|Adverse Event|1|||
148745092|NCT00384930|536538256|FG000|Overall Study|Entry Criteria Not Met|2|||
148745093|NCT00384930|536538257|FG001|Overall Study|Entry Criteria Not Met|6|||
148745094|NCT00384930|536538258|FG002|Overall Study|Entry Criteria Not Met|7|||
148745095|NCT00384930|536538259|FG003|Overall Study|Entry Criteria Not Met|8|||
148819876|NCT01783015|536818075|FG002|Blinded Treatment|Adverse Event|0|||
148819877|NCT01783015|536818073|FG000|Blinded Treatment|Protocol Violation|0|||
148819878|NCT01783015|536818074|FG001|Blinded Treatment|Protocol Violation|1|||
148819879|NCT01783015|536818075|FG002|Blinded Treatment|Protocol Violation|0|||
148819880|NCT01783015|536818073|FG000|Blinded Treatment|Withdrawal by Subject|0|||
148819881|NCT01783015|536818074|FG001|Blinded Treatment|Withdrawal by Subject|1|||
148819882|NCT01783015|536818075|FG002|Blinded Treatment|Withdrawal by Subject|0|||
148819883|NCT01783015|536818073|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
148819884|NCT01783015|536818074|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
148819885|NCT01783015|536818075|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
148819886|NCT01783015|536818073|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
148819887|NCT01783015|536818074|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
148819888|NCT01783015|536818075|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
148819889|NCT01524705|536818078|FG000|Overall Study|Adverse Event|2|||
148819890|NCT01524705|536818079|FG001|Overall Study|Adverse Event|0|||
148819891|NCT01524705|536818078|FG000|Overall Study|Death|1|||
148819892|NCT01524705|536818079|FG001|Overall Study|Death|0|||
148819893|NCT01524705|536818078|FG000|Overall Study|Lost to Follow-up|0|||
148819894|NCT01524705|536818079|FG001|Overall Study|Lost to Follow-up|1|||
148819895|NCT01524705|536818078|FG000|Overall Study|Withdrawal by Subject|0|||
148819896|NCT01524705|536818079|FG001|Overall Study|Withdrawal by Subject|1|||
148819897|NCT01524705|536818078|FG000|Overall Study|Pancreatic Cancer|0|||
148819898|NCT01524705|536818079|FG001|Overall Study|Pancreatic Cancer|1|||
148819899|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
148819900|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
148819901|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
148819902|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
148819903|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
148819904|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
148819905|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
148819906|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
148819907|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
148819908|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
148819909|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
148819910|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
148819911|NCT01243424|536818080|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
148819912|NCT01243424|536818081|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
148819913|NCT01243424|536818080|FG000|Discontinuation From Treatment|Not treated|5|||
148819914|NCT01243424|536818081|FG001|Discontinuation From Treatment|Not treated|4|||
148819915|NCT01243424|536818080|FG000|Discontinuation From Treatment|Adverse Event|457|||
148819916|NCT01243424|536818081|FG001|Discontinuation From Treatment|Adverse Event|523|||
148819917|NCT01243424|536818080|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
148819918|NCT01243424|536818081|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
148819919|NCT01243424|536818080|FG000|Discontinuation From Treatment|Protocol Violation|46|||
148819920|NCT01243424|536818081|FG001|Discontinuation From Treatment|Protocol Violation|47|||
148819921|NCT01243424|536818080|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
148819922|NCT01243424|536818081|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
148819923|NCT01243424|536818080|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
148819924|NCT01243424|536818081|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
148819925|NCT01243424|536818080|FG000|Discontinuation From Treatment|Other than listed above|230|||
148745096|NCT00384930|536538260|FG004|Overall Study|Entry Criteria Not Met|4|||
148745097|NCT00384930|536538256|FG000|Overall Study|Lack of Efficacy|1|||
148745098|NCT00384930|536538257|FG001|Overall Study|Lack of Efficacy|1|||
148745099|NCT00384930|536538258|FG002|Overall Study|Lack of Efficacy|2|||
148745100|NCT00384930|536538259|FG003|Overall Study|Lack of Efficacy|1|||
148745101|NCT00384930|536538260|FG004|Overall Study|Lack of Efficacy|2|||
148745102|NCT00384930|536538256|FG000|Overall Study|Lost to Follow-up|5|||
148745103|NCT00384930|536538257|FG001|Overall Study|Lost to Follow-up|3|||
148745104|NCT00384930|536538258|FG002|Overall Study|Lost to Follow-up|0|||
148745105|NCT00384930|536538259|FG003|Overall Study|Lost to Follow-up|4|||
148745106|NCT00384930|536538260|FG004|Overall Study|Lost to Follow-up|6|||
148745107|NCT00384930|536538256|FG000|Overall Study|Physician Decision|0|||
148745108|NCT00384930|536538257|FG001|Overall Study|Physician Decision|1|||
148745109|NCT00384930|536538258|FG002|Overall Study|Physician Decision|1|||
148745110|NCT00384930|536538259|FG003|Overall Study|Physician Decision|0|||
148745111|NCT00384930|536538260|FG004|Overall Study|Physician Decision|1|||
148819926|NCT01243424|536818081|FG001|Discontinuation From Treatment|Other than listed above|211|||
148819927|NCT01160744|536818088|FG000|Overall Study|Withdrawal by Subject|11|||
148819928|NCT01160744|536818089|FG001|Overall Study|Withdrawal by Subject|5|||
148819929|NCT01160744|536818090|FG002|Overall Study|Withdrawal by Subject|6|||
148745112|NCT00384930|536538256|FG000|Overall Study|Protocol Violation|1|||
148745113|NCT00384930|536538257|FG001|Overall Study|Protocol Violation|0|||
148745114|NCT00384930|536538258|FG002|Overall Study|Protocol Violation|1|||
148745115|NCT00384930|536538259|FG003|Overall Study|Protocol Violation|6|||
148745116|NCT00384930|536538260|FG004|Overall Study|Protocol Violation|4|||
148745117|NCT00384930|536538256|FG000|Overall Study|Sponsor Decision|3|||
148745118|NCT00384930|536538257|FG001|Overall Study|Sponsor Decision|4|||
148745119|NCT00384930|536538258|FG002|Overall Study|Sponsor Decision|0|||
148745120|NCT00384930|536538259|FG003|Overall Study|Sponsor Decision|5|||
148745121|NCT00384930|536538260|FG004|Overall Study|Sponsor Decision|0|||
148745122|NCT00384930|536538256|FG000|Overall Study|Withdrawal by Subject|9|||
148745123|NCT00384930|536538257|FG001|Overall Study|Withdrawal by Subject|7|||
148745124|NCT00384930|536538258|FG002|Overall Study|Withdrawal by Subject|7|||
148745125|NCT00384930|536538259|FG003|Overall Study|Withdrawal by Subject|6|||
148745126|NCT00384930|536538260|FG004|Overall Study|Withdrawal by Subject|16|||
148745127|NCT00384930|536538256|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
148745128|NCT00384930|536538257|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
148745129|NCT00384930|536538258|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
148745130|NCT00384930|536538259|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
148745131|NCT00384930|536538260|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
148745132|NCT01449370|536538265|FG000|Overall Study|Disease Progression|5|||
148745133|NCT01449370|536538266|FG001|Overall Study|Disease Progression|4|||
148976032|NCT01420081|537392413|FG001|Overall Study|Study Terminated by Sponsor|1|||
148976033|NCT01420081|537392414|FG002|Overall Study|Study Terminated by Sponsor|1|||
148976034|NCT01420081|537392415|FG003|Overall Study|Study Terminated by Sponsor|3|||
148976035|NCT01420081|537392416|FG004|Overall Study|Study Terminated by Sponsor|11|||
148976036|NCT01420081|537392417|FG005|Overall Study|Study Terminated by Sponsor|7|||
148976037|NCT01420081|537392418|FG006|Overall Study|Study Terminated by Sponsor|3|||
148976038|NCT01420081|537392419|FG007|Overall Study|Study Terminated by Sponsor|2|||
148976039|NCT01420081|537392420|FG008|Overall Study|Study Terminated by Sponsor|2|||
148976040|NCT01420081|537392412|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
148976041|NCT01420081|537392413|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
148976042|NCT01420081|537392414|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
148976043|NCT01420081|537392415|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
148976044|NCT01420081|537392416|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
148976045|NCT01420081|537392417|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
148976046|NCT01420081|537392418|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
149027176|NCT01414166|537576531|FG001|Overall Study|Non-compliance with study drug|0|||
148745134|NCT01449370|536538267|FG002|Overall Study|Disease Progression|8|||
148745135|NCT01449370|536538268|FG003|Overall Study|Disease Progression|3|||
148745136|NCT01449370|536538269|FG004|Overall Study|Disease Progression|3|||
148745137|NCT01449370|536538270|FG005|Overall Study|Disease Progression|3|||
148745138|NCT01449370|536538271|FG006|Overall Study|Disease Progression|3|||
148745139|NCT01449370|536538272|FG007|Overall Study|Disease Progression|2|||
148745140|NCT01449370|536538273|FG008|Overall Study|Disease Progression|9|||
148745141|NCT01449370|536538274|FG009|Overall Study|Disease Progression|1|||
148745142|NCT01449370|536538275|FG010|Overall Study|Disease Progression|3|||
148745143|NCT01449370|536538276|FG011|Overall Study|Disease Progression|3|||
148745144|NCT01449370|536538277|FG012|Overall Study|Disease Progression|2|||
148745145|NCT01449370|536538278|FG013|Overall Study|Disease Progression|8|||
148745146|NCT01449370|536538279|FG014|Overall Study|Disease Progression|3|||
148745147|NCT01449370|536538280|FG015|Overall Study|Disease Progression|1|||
148745148|NCT01449370|536538281|FG016|Overall Study|Disease Progression|4|||
148745149|NCT01449370|536538282|FG017|Overall Study|Disease Progression|3|||
148745150|NCT01449370|536538283|FG018|Overall Study|Disease Progression|1|||
148745151|NCT01449370|536538284|FG019|Overall Study|Disease Progression|2|||
148745152|NCT01449370|536538285|FG020|Overall Study|Disease Progression|5|||
148745153|NCT01449370|536538286|FG021|Overall Study|Disease Progression|2|||
148745154|NCT01449370|536538287|FG022|Overall Study|Disease Progression|3|||
148745155|NCT01449370|536538288|FG023|Overall Study|Disease Progression|7|||
148745156|NCT01449370|536538289|FG024|Overall Study|Disease Progression|3|||
148745157|NCT01449370|536538265|FG000|Overall Study|Adverse Event|1|||
148745158|NCT01449370|536538266|FG001|Overall Study|Adverse Event|2|||
148745159|NCT01449370|536538267|FG002|Overall Study|Adverse Event|0|||
148745160|NCT01449370|536538268|FG003|Overall Study|Adverse Event|1|||
148745161|NCT01449370|536538269|FG004|Overall Study|Adverse Event|0|||
148745162|NCT01449370|536538270|FG005|Overall Study|Adverse Event|0|||
148745163|NCT01449370|536538271|FG006|Overall Study|Adverse Event|0|||
148745164|NCT01449370|536538272|FG007|Overall Study|Adverse Event|0|||
148745165|NCT01449370|536538273|FG008|Overall Study|Adverse Event|1|||
148745166|NCT01449370|536538274|FG009|Overall Study|Adverse Event|1|||
148745167|NCT01449370|536538275|FG010|Overall Study|Adverse Event|0|||
148745168|NCT01449370|536538276|FG011|Overall Study|Adverse Event|0|||
148976047|NCT01420081|537392419|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
148976048|NCT01420081|537392420|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
148745169|NCT01449370|536538277|FG012|Overall Study|Adverse Event|0|||
148745170|NCT01449370|536538278|FG013|Overall Study|Adverse Event|2|||
148745171|NCT01449370|536538279|FG014|Overall Study|Adverse Event|0|||
148745172|NCT01449370|536538280|FG015|Overall Study|Adverse Event|1|||
148745173|NCT01449370|536538281|FG016|Overall Study|Adverse Event|0|||
148745174|NCT01449370|536538282|FG017|Overall Study|Adverse Event|0|||
148745175|NCT01449370|536538283|FG018|Overall Study|Adverse Event|1|||
148745176|NCT01449370|536538284|FG019|Overall Study|Adverse Event|1|||
148745177|NCT01449370|536538285|FG020|Overall Study|Adverse Event|0|||
148745178|NCT01449370|536538286|FG021|Overall Study|Adverse Event|1|||
148745179|NCT01449370|536538287|FG022|Overall Study|Adverse Event|0|||
148745180|NCT01449370|536538288|FG023|Overall Study|Adverse Event|1|||
148745181|NCT01449370|536538289|FG024|Overall Study|Adverse Event|3|||
148745182|NCT01449370|536538265|FG000|Overall Study|Participant Decision|0|||
148745183|NCT01449370|536538266|FG001|Overall Study|Participant Decision|0|||
148745184|NCT01449370|536538267|FG002|Overall Study|Participant Decision|0|||
148745185|NCT01449370|536538268|FG003|Overall Study|Participant Decision|0|||
148745186|NCT01449370|536538269|FG004|Overall Study|Participant Decision|0|||
148745187|NCT01449370|536538270|FG005|Overall Study|Participant Decision|0|||
148745188|NCT01449370|536538271|FG006|Overall Study|Participant Decision|0|||
148745189|NCT01449370|536538272|FG007|Overall Study|Participant Decision|1|||
148745190|NCT01449370|536538273|FG008|Overall Study|Participant Decision|1|||
148745191|NCT01449370|536538274|FG009|Overall Study|Participant Decision|0|||
148745192|NCT01449370|536538275|FG010|Overall Study|Participant Decision|0|||
148745193|NCT01449370|536538276|FG011|Overall Study|Participant Decision|0|||
148745194|NCT01449370|536538277|FG012|Overall Study|Participant Decision|1|||
148745195|NCT01449370|536538278|FG013|Overall Study|Participant Decision|1|||
148745196|NCT01449370|536538279|FG014|Overall Study|Participant Decision|0|||
148745197|NCT01449370|536538280|FG015|Overall Study|Participant Decision|1|||
148745198|NCT01449370|536538281|FG016|Overall Study|Participant Decision|3|||
148745199|NCT01449370|536538282|FG017|Overall Study|Participant Decision|0|||
148745200|NCT01449370|536538283|FG018|Overall Study|Participant Decision|1|||
148745201|NCT01449370|536538284|FG019|Overall Study|Participant Decision|0|||
148745202|NCT01449370|536538285|FG020|Overall Study|Participant Decision|0|||
148745203|NCT01449370|536538286|FG021|Overall Study|Participant Decision|1|||
148745204|NCT01449370|536538287|FG022|Overall Study|Participant Decision|0|||
148745205|NCT01449370|536538288|FG023|Overall Study|Participant Decision|0|||
148745206|NCT01449370|536538289|FG024|Overall Study|Participant Decision|1|||
148745207|NCT01449370|536538265|FG000|Overall Study|Lost to Follow-up|0|||
148745208|NCT01449370|536538266|FG001|Overall Study|Lost to Follow-up|0|||
148745209|NCT01449370|536538267|FG002|Overall Study|Lost to Follow-up|0|||
148745210|NCT01449370|536538268|FG003|Overall Study|Lost to Follow-up|0|||
148745211|NCT01449370|536538269|FG004|Overall Study|Lost to Follow-up|0|||
148745212|NCT01449370|536538270|FG005|Overall Study|Lost to Follow-up|0|||
148745213|NCT01449370|536538271|FG006|Overall Study|Lost to Follow-up|0|||
148745214|NCT01449370|536538272|FG007|Overall Study|Lost to Follow-up|0|||
148745215|NCT01449370|536538273|FG008|Overall Study|Lost to Follow-up|0|||
148745216|NCT01449370|536538274|FG009|Overall Study|Lost to Follow-up|0|||
148745217|NCT01449370|536538275|FG010|Overall Study|Lost to Follow-up|0|||
148745218|NCT01449370|536538276|FG011|Overall Study|Lost to Follow-up|0|||
148745219|NCT01449370|536538277|FG012|Overall Study|Lost to Follow-up|0|||
148745220|NCT01449370|536538278|FG013|Overall Study|Lost to Follow-up|0|||
148745221|NCT01449370|536538279|FG014|Overall Study|Lost to Follow-up|0|||
148745222|NCT01449370|536538280|FG015|Overall Study|Lost to Follow-up|0|||
148745223|NCT01449370|536538281|FG016|Overall Study|Lost to Follow-up|0|||
148745224|NCT01449370|536538282|FG017|Overall Study|Lost to Follow-up|0|||
148745225|NCT01449370|536538283|FG018|Overall Study|Lost to Follow-up|0|||
148745226|NCT01449370|536538284|FG019|Overall Study|Lost to Follow-up|0|||
148745227|NCT01449370|536538285|FG020|Overall Study|Lost to Follow-up|1|||
148745228|NCT01449370|536538286|FG021|Overall Study|Lost to Follow-up|0|||
148745229|NCT01449370|536538287|FG022|Overall Study|Lost to Follow-up|0|||
148745230|NCT01449370|536538288|FG023|Overall Study|Lost to Follow-up|0|||
148745231|NCT01449370|536538289|FG024|Overall Study|Lost to Follow-up|0|||
148745232|NCT01449370|536538265|FG000|Overall Study|Other|0|||
148745233|NCT01449370|536538266|FG001|Overall Study|Other|0|||
148745234|NCT01449370|536538267|FG002|Overall Study|Other|0|||
148745235|NCT01449370|536538268|FG003|Overall Study|Other|0|||
148745236|NCT01449370|536538269|FG004|Overall Study|Other|0|||
148745237|NCT01449370|536538270|FG005|Overall Study|Other|0|||
148745238|NCT01449370|536538271|FG006|Overall Study|Other|0|||
148745239|NCT01449370|536538272|FG007|Overall Study|Other|0|||
148745240|NCT01449370|536538273|FG008|Overall Study|Other|1|||
148745241|NCT01449370|536538274|FG009|Overall Study|Other|1|||
148745242|NCT01449370|536538275|FG010|Overall Study|Other|0|||
148745243|NCT01449370|536538276|FG011|Overall Study|Other|0|||
148745244|NCT01449370|536538277|FG012|Overall Study|Other|0|||
148745245|NCT01449370|536538278|FG013|Overall Study|Other|0|||
148745246|NCT01449370|536538279|FG014|Overall Study|Other|0|||
148745247|NCT01449370|536538280|FG015|Overall Study|Other|0|||
148745248|NCT01449370|536538281|FG016|Overall Study|Other|0|||
148745249|NCT01449370|536538282|FG017|Overall Study|Other|0|||
148745250|NCT01449370|536538283|FG018|Overall Study|Other|0|||
148745251|NCT01449370|536538284|FG019|Overall Study|Other|0|||
148745252|NCT01449370|536538285|FG020|Overall Study|Other|0|||
148745253|NCT01449370|536538286|FG021|Overall Study|Other|0|||
148745254|NCT01449370|536538287|FG022|Overall Study|Other|1|||
148745255|NCT01449370|536538288|FG023|Overall Study|Other|1|||
148745256|NCT01449370|536538289|FG024|Overall Study|Other|0|||
148745257|NCT01449370|536538265|FG000|Overall Study|Medication Prohibited by Protocol|0|||
148745258|NCT01449370|536538266|FG001|Overall Study|Medication Prohibited by Protocol|0|||
148745259|NCT01449370|536538267|FG002|Overall Study|Medication Prohibited by Protocol|0|||
148745260|NCT01449370|536538268|FG003|Overall Study|Medication Prohibited by Protocol|0|||
148745261|NCT01449370|536538269|FG004|Overall Study|Medication Prohibited by Protocol|0|||
148745262|NCT01449370|536538270|FG005|Overall Study|Medication Prohibited by Protocol|0|||
148745263|NCT01449370|536538271|FG006|Overall Study|Medication Prohibited by Protocol|0|||
148745264|NCT01449370|536538272|FG007|Overall Study|Medication Prohibited by Protocol|0|||
148745265|NCT01449370|536538273|FG008|Overall Study|Medication Prohibited by Protocol|0|||
148745266|NCT01449370|536538274|FG009|Overall Study|Medication Prohibited by Protocol|0|||
148745267|NCT01449370|536538275|FG010|Overall Study|Medication Prohibited by Protocol|0|||
148745268|NCT01449370|536538276|FG011|Overall Study|Medication Prohibited by Protocol|0|||
148745269|NCT01449370|536538277|FG012|Overall Study|Medication Prohibited by Protocol|0|||
148745270|NCT01449370|536538278|FG013|Overall Study|Medication Prohibited by Protocol|0|||
148745271|NCT01449370|536538279|FG014|Overall Study|Medication Prohibited by Protocol|0|||
148745272|NCT01449370|536538280|FG015|Overall Study|Medication Prohibited by Protocol|0|||
148745273|NCT01449370|536538281|FG016|Overall Study|Medication Prohibited by Protocol|0|||
148745274|NCT01449370|536538282|FG017|Overall Study|Medication Prohibited by Protocol|0|||
148745275|NCT01449370|536538283|FG018|Overall Study|Medication Prohibited by Protocol|0|||
148745276|NCT01449370|536538284|FG019|Overall Study|Medication Prohibited by Protocol|0|||
148745277|NCT01449370|536538285|FG020|Overall Study|Medication Prohibited by Protocol|0|||
148745278|NCT01449370|536538286|FG021|Overall Study|Medication Prohibited by Protocol|0|||
148745279|NCT01449370|536538287|FG022|Overall Study|Medication Prohibited by Protocol|0|||
148745280|NCT01449370|536538288|FG023|Overall Study|Medication Prohibited by Protocol|1|||
148745281|NCT01449370|536538289|FG024|Overall Study|Medication Prohibited by Protocol|0|||
148745282|NCT01449370|536538265|FG000|Overall Study|Death|0|||
148745283|NCT01449370|536538266|FG001|Overall Study|Death|0|||
148745284|NCT01449370|536538267|FG002|Overall Study|Death|0|||
148745285|NCT01449370|536538268|FG003|Overall Study|Death|0|||
148745286|NCT01449370|536538269|FG004|Overall Study|Death|0|||
148745287|NCT01449370|536538270|FG005|Overall Study|Death|0|||
148745288|NCT01449370|536538271|FG006|Overall Study|Death|0|||
148745289|NCT01449370|536538272|FG007|Overall Study|Death|0|||
148745290|NCT01449370|536538273|FG008|Overall Study|Death|0|||
148745291|NCT01449370|536538274|FG009|Overall Study|Death|0|||
148745292|NCT01449370|536538275|FG010|Overall Study|Death|0|||
148745293|NCT01449370|536538276|FG011|Overall Study|Death|0|||
148745294|NCT01449370|536538277|FG012|Overall Study|Death|0|||
148819930|NCT01160744|536818091|FG003|Overall Study|Withdrawal by Subject|4|||
148819931|NCT01160744|536818088|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
148819932|NCT01160744|536818089|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
148819933|NCT01160744|536818090|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
148819934|NCT01160744|536818091|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
148819935|NCT00500110|536818094|FG000|Overall Study|Withdrawal by Subject|3|||
148819936|NCT02421510|536818100|FG000|Overall Study|Other|4|||
148819937|NCT02421510|536818101|FG001|Overall Study|Other|2|||
148819938|NCT02421510|536818102|FG002|Overall Study|Other|3|||
148819939|NCT02421510|536818100|FG000|Overall Study|Protocol Violation|1|||
148819940|NCT02421510|536818101|FG001|Overall Study|Protocol Violation|2|||
148819941|NCT02421510|536818102|FG002|Overall Study|Protocol Violation|0|||
148819942|NCT02421510|536818100|FG000|Overall Study|Death|1|||
148819943|NCT02421510|536818101|FG001|Overall Study|Death|0|||
148819944|NCT02421510|536818102|FG002|Overall Study|Death|0|||
148819945|NCT02421510|536818100|FG000|Overall Study|Noncompliance with study drug|1|||
148819946|NCT02421510|536818101|FG001|Overall Study|Noncompliance with study drug|0|||
148819947|NCT02421510|536818102|FG002|Overall Study|Noncompliance with study drug|0|||
148819948|NCT02421510|536818100|FG000|Overall Study|Physician Decision|1|||
148819949|NCT02421510|536818101|FG001|Overall Study|Physician Decision|1|||
148819950|NCT02421510|536818102|FG002|Overall Study|Physician Decision|3|||
148819951|NCT02421510|536818100|FG000|Overall Study|Adverse Event|9|||
148819952|NCT02421510|536818101|FG001|Overall Study|Adverse Event|10|||
148819953|NCT02421510|536818102|FG002|Overall Study|Adverse Event|18|||
148745295|NCT01449370|536538278|FG013|Overall Study|Death|0|||
148745296|NCT01449370|536538279|FG014|Overall Study|Death|0|||
148745297|NCT01449370|536538280|FG015|Overall Study|Death|0|||
148745298|NCT01449370|536538281|FG016|Overall Study|Death|0|||
148819954|NCT02421510|536818100|FG000|Overall Study|Pregnancy|1|||
148819955|NCT02421510|536818101|FG001|Overall Study|Pregnancy|1|||
148819956|NCT02421510|536818102|FG002|Overall Study|Pregnancy|0|||
148745299|NCT01449370|536538282|FG017|Overall Study|Death|0|||
148745300|NCT01449370|536538283|FG018|Overall Study|Death|0|||
148819957|NCT02421510|536818100|FG000|Overall Study|Withdrawal by Subject|14|||
148819958|NCT02421510|536818101|FG001|Overall Study|Withdrawal by Subject|18|||
148819959|NCT02421510|536818102|FG002|Overall Study|Withdrawal by Subject|12|||
148745301|NCT01449370|536538284|FG019|Overall Study|Death|0|||
148745302|NCT01449370|536538285|FG020|Overall Study|Death|0|||
148745303|NCT01449370|536538286|FG021|Overall Study|Death|0|||
148745304|NCT01449370|536538287|FG022|Overall Study|Death|0|||
148745305|NCT01449370|536538288|FG023|Overall Study|Death|0|||
148745306|NCT01449370|536538289|FG024|Overall Study|Death|1|||
148745307|NCT01685840|536538290|FG000|Overall Study|Death|77|||
148745308|NCT01685840|536538291|FG001|Overall Study|Death|66|||
148745309|NCT01685840|536538290|FG000|Overall Study|Lost to Follow-up|27|||
148745310|NCT01685840|536538291|FG001|Overall Study|Lost to Follow-up|25|||
148745311|NCT01685840|536538290|FG000|Overall Study|Physician Decision|3|||
148745312|NCT01685840|536538291|FG001|Overall Study|Physician Decision|7|||
148745313|NCT01685840|536538290|FG000|Overall Study|Withdrawal by Subject|14|||
148745314|NCT01685840|536538291|FG001|Overall Study|Withdrawal by Subject|17|||
148745315|NCT01685840|536538290|FG000|Overall Study|Futility|197|||
148745316|NCT01685840|536538291|FG001|Overall Study|Futility|200|||
148745317|NCT01685840|536538290|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
148745318|NCT01685840|536538291|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
148745319|NCT00710866|536538292|FG000|Overall Study|Protocol Violation|5|||
148745320|NCT00710866|536538293|FG001|Overall Study|Protocol Violation|4|||
148745321|NCT00710866|536538292|FG000|Overall Study|Withdrawal by Subject|2|||
148745322|NCT00710866|536538293|FG001|Overall Study|Withdrawal by Subject|1|||
148745323|NCT00710866|536538292|FG000|Overall Study|Lost to Follow-up|1|||
148745324|NCT00710866|536538293|FG001|Overall Study|Lost to Follow-up|0|||
148745325|NCT00710866|536538292|FG000|Overall Study|Failed to meet eligibility|1|||
148745326|NCT00710866|536538293|FG001|Overall Study|Failed to meet eligibility|1|||
148745327|NCT00534404|536538296|FG000|Overall Study|Death|0|||
148745328|NCT00534404|536538297|FG001|Overall Study|Death|0|||
148745329|NCT00534404|536538298|FG002|Overall Study|Death|2|||
148745330|NCT00534404|536538296|FG000|Overall Study|Withdrawal by Subject|8|||
148745331|NCT00534404|536538297|FG001|Overall Study|Withdrawal by Subject|2|||
148745332|NCT00534404|536538298|FG002|Overall Study|Withdrawal by Subject|38|||
148745333|NCT00534404|536538296|FG000|Overall Study|Removed by study staff|2|||
148745334|NCT00534404|536538297|FG001|Overall Study|Removed by study staff|3|||
148745335|NCT00534404|536538298|FG002|Overall Study|Removed by study staff|1|||
148745336|NCT00534404|536538296|FG000|Overall Study|Lost to Follow-up|170|||
148745337|NCT00534404|536538297|FG001|Overall Study|Lost to Follow-up|138|||
148745338|NCT00534404|536538298|FG002|Overall Study|Lost to Follow-up|201|||
148745339|NCT02996487|536538301|FG000|Overall Study|Lost to Follow-up|1|||
148745340|NCT02996487|536538302|FG001|Overall Study|Lost to Follow-up|1|||
148745341|NCT02996487|536538303|FG002|Overall Study|Lost to Follow-up|0|||
148745342|NCT02996487|536538301|FG000|Overall Study|Death|0|||
148745343|NCT02996487|536538302|FG001|Overall Study|Death|1|||
148745344|NCT02996487|536538303|FG002|Overall Study|Death|0|||
148745345|NCT02996487|536538301|FG000|Overall Study|Withdrawal by Subject|2|||
148745346|NCT02996487|536538302|FG001|Overall Study|Withdrawal by Subject|3|||
148745347|NCT02996487|536538303|FG002|Overall Study|Withdrawal by Subject|0|||
148745348|NCT02027428|536538304|FG000|Induction|Never treated|7|||
148745349|NCT02027428|536538305|FG001|Induction|Never treated|0|||
148745350|NCT02027428|536538306|FG002|Induction|Never treated|0|||
148745351|NCT02027428|536538304|FG000|Induction|Progressive disease|77|||
148745352|NCT02027428|536538305|FG001|Induction|Progressive disease|0|||
148745353|NCT02027428|536538306|FG002|Induction|Progressive disease|0|||
148745354|NCT02027428|536538304|FG000|Induction|Adverse Event|51|||
148745355|NCT02027428|536538305|FG001|Induction|Adverse Event|0|||
148745356|NCT02027428|536538306|FG002|Induction|Adverse Event|0|||
148745357|NCT02027428|536538304|FG000|Induction|Withdrawal by Subject|22|||
148745358|NCT02027428|536538305|FG001|Induction|Withdrawal by Subject|0|||
148745359|NCT02027428|536538306|FG002|Induction|Withdrawal by Subject|0|||
148745360|NCT02027428|536538304|FG000|Induction|Death|21|||
148745361|NCT02027428|536538305|FG001|Induction|Death|0|||
148745362|NCT02027428|536538306|FG002|Induction|Death|0|||
148745363|NCT02027428|536538304|FG000|Induction|Symptomatic deterioration|16|||
148745364|NCT02027428|536538305|FG001|Induction|Symptomatic deterioration|0|||
148745365|NCT02027428|536538306|FG002|Induction|Symptomatic deterioration|0|||
148745366|NCT02027428|536538304|FG000|Induction|Study terminated by sponsor|12|||
148745367|NCT02027428|536538305|FG001|Induction|Study terminated by sponsor|0|||
148745368|NCT02027428|536538306|FG002|Induction|Study terminated by sponsor|0|||
148745369|NCT02027428|536538304|FG000|Induction|Protocol Violation|1|||
148745370|NCT02027428|536538305|FG001|Induction|Protocol Violation|0|||
148745371|NCT02027428|536538306|FG002|Induction|Protocol Violation|0|||
148745372|NCT02027428|536538304|FG000|Induction|Miscellaneous|14|||
148745373|NCT02027428|536538305|FG001|Induction|Miscellaneous|0|||
148745374|NCT02027428|536538306|FG002|Induction|Miscellaneous|0|||
148745375|NCT02027428|536538304|FG000|Induction|Induction Treatment Ongoing|4|||
148819960|NCT02421510|536818100|FG000|Overall Study|Lost to Follow-up|1|||
148745376|NCT02027428|536538305|FG001|Induction|Induction Treatment Ongoing|0|||
148745377|NCT02027428|536538306|FG002|Induction|Induction Treatment Ongoing|0|||
148745378|NCT02027428|536538304|FG000|Maintenance|Death|0|||
148745379|NCT02027428|536538305|FG001|Maintenance|Death|3|||
148745380|NCT02027428|536538306|FG002|Maintenance|Death|2|||
148745381|NCT02027428|536538304|FG000|Maintenance|Adverse Event|0|||
148745382|NCT02027428|536538305|FG001|Maintenance|Adverse Event|21|||
148745383|NCT02027428|536538306|FG002|Maintenance|Adverse Event|1|||
148745384|NCT02027428|536538304|FG000|Maintenance|Progressive disease|0|||
148745385|NCT02027428|536538305|FG001|Maintenance|Progressive disease|84|||
148745386|NCT02027428|536538306|FG002|Maintenance|Progressive disease|47|||
148745387|NCT02027428|536538304|FG000|Maintenance|Symptomatic deterioration|0|||
148745388|NCT02027428|536538305|FG001|Maintenance|Symptomatic deterioration|4|||
148745389|NCT02027428|536538306|FG002|Maintenance|Symptomatic deterioration|1|||
148745390|NCT02027428|536538304|FG000|Maintenance|Withdrawal by Subject|0|||
148745391|NCT02027428|536538305|FG001|Maintenance|Withdrawal by Subject|6|||
148745392|NCT02027428|536538306|FG002|Maintenance|Withdrawal by Subject|5|||
148745393|NCT02027428|536538304|FG000|Maintenance|Protocol Violation|0|||
148745394|NCT02027428|536538305|FG001|Maintenance|Protocol Violation|0|||
148745395|NCT02027428|536538306|FG002|Maintenance|Protocol Violation|1|||
148745396|NCT02027428|536538304|FG000|Maintenance|Other|0|||
148745397|NCT02027428|536538305|FG001|Maintenance|Other|6|||
148745398|NCT02027428|536538306|FG002|Maintenance|Other|3|||
148745399|NCT02027428|536538304|FG000|Survival Follow-up|Death|0|||
148745400|NCT02027428|536538305|FG001|Survival Follow-up|Death|78|||
148745401|NCT02027428|536538306|FG002|Survival Follow-up|Death|45|||
148745402|NCT02027428|536538304|FG000|Survival Follow-up|Lost to Follow-up|0|||
148745403|NCT02027428|536538305|FG001|Survival Follow-up|Lost to Follow-up|1|||
148745404|NCT02027428|536538306|FG002|Survival Follow-up|Lost to Follow-up|1|||
148745405|NCT02676765|536538307|FG000|Overall Study|Lost to Follow-up|0|||
148745406|NCT02676765|536538308|FG001|Overall Study|Lost to Follow-up|1|||
148745407|NCT03340974|536538309|FG000|Completion of Study -Long Term Follow up|Death|8|||
148745408|NCT03340974|536538310|FG001|Completion of Study -Long Term Follow up|Death|5|||
148745409|NCT03340974|536538311|FG002|Completion of Study -Long Term Follow up|Death|5|||
148745410|NCT03340974|536538312|FG003|Completion of Study -Long Term Follow up|Death|7|||
148745411|NCT03340974|536538309|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
148745412|NCT03340974|536538310|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
148745413|NCT03340974|536538311|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
148745414|NCT03340974|536538312|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
148745415|NCT03340974|536538309|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
148745416|NCT03340974|536538310|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
148745417|NCT03340974|536538311|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
148745418|NCT03340974|536538312|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
148745419|NCT03340974|536538309|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
148745420|NCT03340974|536538310|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
148745421|NCT03340974|536538311|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
148745422|NCT03340974|536538312|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
148745423|NCT01128543|536538316|FG000|Overall Study|Withdrawal by Subject|3|||
148745424|NCT01128543|536538316|FG000|Overall Study|Protocol Violation|1|||
148745425|NCT02374346|536538317|FG000|Overall Study|operated or discharged during weekend|48|||
148745426|NCT04487067|536538324|FG000|Overall Study|Adverse Event|3|||
148745427|NCT04487067|536538324|FG000|Overall Study|Death Other Than Progressive Disease|60|||
148745428|NCT04487067|536538324|FG000|Overall Study|Death Due To Progressive Disease|40|||
148745429|NCT04487067|536538324|FG000|Overall Study|Lost to Follow-up|3|||
148745430|NCT04487067|536538324|FG000|Overall Study|Progressive Disease|1|||
148745431|NCT04487067|536538324|FG000|Overall Study|Protocol Violation|3|||
148745432|NCT04487067|536538324|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
148745433|NCT04487067|536538324|FG000|Overall Study|Withdrawal by Subject|15|||
148745434|NCT03097991|536538325|FG000|Overall Study|Didn't meet study criteria|8|||
148745435|NCT03097991|536538326|FG001|Overall Study|Didn't meet study criteria|0|||
148745436|NCT03097991|536538325|FG000|Overall Study|Withdrawal by Subject|12|||
148745437|NCT03097991|536538326|FG001|Overall Study|Withdrawal by Subject|6|||
148745438|NCT03097991|536538325|FG000|Overall Study|Death of Baby|3|||
148745439|NCT03097991|536538326|FG001|Overall Study|Death of Baby|1|||
148745440|NCT03097991|536538325|FG000|Overall Study|Lost to Follow-up|24|||
148745441|NCT03097991|536538326|FG001|Overall Study|Lost to Follow-up|38|||
148745442|NCT03097991|536538325|FG000|Overall Study|Adverse Event|3|||
148745443|NCT03097991|536538326|FG001|Overall Study|Adverse Event|5|||
148976049|NCT01420081|537392412|FG000|Overall Study|Other Reasons|0|||
148745444|NCT00246324|536538327|FG000|Overall Study|Withdrawal by Subject|1|||
148745445|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
148745446|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
148745447|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
148745448|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Death|1|||
148745449|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Death|3|||
148745450|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Death|1|||
148745451|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
148976050|NCT01420081|537392413|FG001|Overall Study|Other Reasons|0|||
148745452|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
148745453|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
148745454|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
148745455|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
148745456|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
148745457|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
148745458|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
148745459|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
148745460|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
148745461|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
148745462|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
148745463|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
148745464|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
148745465|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
148745466|NCT00299130|536538328|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
148745467|NCT00299130|536538329|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
148745468|NCT00299130|536538330|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
148745469|NCT00299130|536538328|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
148745470|NCT00299130|536538329|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
148745471|NCT00299130|536538330|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
148745472|NCT00299130|536538328|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
148745473|NCT00299130|536538329|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
148745474|NCT00299130|536538330|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
148745475|NCT00299130|536538328|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
148745476|NCT00299130|536538329|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
148745477|NCT00299130|536538330|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
148745478|NCT00299130|536538328|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
148745479|NCT00299130|536538329|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
148745480|NCT00299130|536538330|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
148745481|NCT00299130|536538328|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
148745482|NCT00299130|536538329|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
148745483|NCT00299130|536538330|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
148745484|NCT00299130|536538328|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
148745485|NCT00299130|536538329|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
148745486|NCT00299130|536538330|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
148745487|NCT00299130|536538328|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
148745488|NCT00299130|536538329|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
148745489|NCT00299130|536538330|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
148745490|NCT00299130|536538328|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
148745491|NCT00299130|536538329|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
148745492|NCT00299130|536538330|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
148745493|NCT00299130|536538328|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
148745494|NCT00299130|536538329|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
148745495|NCT00299130|536538330|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
148745496|NCT00259272|536538336|FG000|Overall Study|Adverse Event|2|||
148745497|NCT00259272|536538337|FG001|Overall Study|Adverse Event|1|||
148745498|NCT00259272|536538338|FG002|Overall Study|Adverse Event|0|||
148745499|NCT00259272|536538339|FG003|Overall Study|Adverse Event|3|||
148745500|NCT00259272|536538336|FG000|Overall Study|Lack of Efficacy|5|||
148745501|NCT00259272|536538337|FG001|Overall Study|Lack of Efficacy|1|||
148745502|NCT00259272|536538338|FG002|Overall Study|Lack of Efficacy|2|||
148745503|NCT00259272|536538339|FG003|Overall Study|Lack of Efficacy|6|||
148745504|NCT00259272|536538336|FG000|Overall Study|Physician Decision|1|||
148745505|NCT00259272|536538337|FG001|Overall Study|Physician Decision|2|||
148745506|NCT00259272|536538338|FG002|Overall Study|Physician Decision|1|||
148745507|NCT00259272|536538339|FG003|Overall Study|Physician Decision|3|||
148745508|NCT00259272|536538336|FG000|Overall Study|Protocol Violation|2|||
148745509|NCT00259272|536538337|FG001|Overall Study|Protocol Violation|0|||
148745510|NCT00259272|536538338|FG002|Overall Study|Protocol Violation|0|||
148745511|NCT00259272|536538339|FG003|Overall Study|Protocol Violation|1|||
148745512|NCT00259272|536538336|FG000|Overall Study|Sponsor Decision|0|||
148745513|NCT00259272|536538337|FG001|Overall Study|Sponsor Decision|1|||
148745514|NCT00259272|536538338|FG002|Overall Study|Sponsor Decision|0|||
148745515|NCT00259272|536538339|FG003|Overall Study|Sponsor Decision|0|||
148745516|NCT00259272|536538336|FG000|Overall Study|Withdrawal by Subject|4|||
148745517|NCT00259272|536538337|FG001|Overall Study|Withdrawal by Subject|2|||
148745518|NCT00259272|536538338|FG002|Overall Study|Withdrawal by Subject|2|||
148745519|NCT00259272|536538339|FG003|Overall Study|Withdrawal by Subject|7|||
148745520|NCT00259272|536538336|FG000|Overall Study|Lost to Follow-up|1|||
148745521|NCT00259272|536538337|FG001|Overall Study|Lost to Follow-up|0|||
148745522|NCT00259272|536538338|FG002|Overall Study|Lost to Follow-up|0|||
148745523|NCT00259272|536538339|FG003|Overall Study|Lost to Follow-up|1|||
148745524|NCT03301623|536538340|FG000|Overall Study|Death|3|||
148819961|NCT02421510|536818101|FG001|Overall Study|Lost to Follow-up|1|||
148745525|NCT03301623|536538341|FG001|Overall Study|Death|1|||
148745526|NCT03301623|536538340|FG000|Overall Study|Withdrawal by Subject|11|||
148745527|NCT03301623|536538341|FG001|Overall Study|Withdrawal by Subject|13|||
148745528|NCT03301623|536538340|FG000|Overall Study|Lost to Follow-up|3|||
148745529|NCT03301623|536538341|FG001|Overall Study|Lost to Follow-up|1|||
148745530|NCT02516553|536538342|FG000|Overall Study|Progressive disease|2|||
148745531|NCT02516553|536538343|FG001|Overall Study|Progressive disease|2|||
148745532|NCT02516553|536538344|FG002|Overall Study|Progressive disease|3|||
148745533|NCT02516553|536538345|FG003|Overall Study|Progressive disease|5|||
148745534|NCT02516553|536538346|FG004|Overall Study|Progressive disease|3|||
148745535|NCT02516553|536538347|FG005|Overall Study|Progressive disease|0|||
148745536|NCT02516553|536538348|FG006|Overall Study|Progressive disease|5|||
148745537|NCT02516553|536538349|FG007|Overall Study|Progressive disease|5|||
148745538|NCT02516553|536538350|FG008|Overall Study|Progressive disease|11|||
148745539|NCT02516553|536538351|FG009|Overall Study|Progressive disease|3|||
148745540|NCT02516553|536538352|FG010|Overall Study|Progressive disease|10|||
148745541|NCT02516553|536538353|FG011|Overall Study|Progressive disease|8|||
148745542|NCT02516553|536538354|FG012|Overall Study|Progressive disease|8|||
148745543|NCT02516553|536538355|FG013|Overall Study|Progressive disease|2|||
148745544|NCT02516553|536538356|FG014|Overall Study|Progressive disease|2|||
148745545|NCT02516553|536538357|FG015|Overall Study|Progressive disease|2|||
148745546|NCT02516553|536538358|FG016|Overall Study|Progressive disease|1|||
148745547|NCT02516553|536538359|FG017|Overall Study|Progressive disease|9|||
148745548|NCT02516553|536538360|FG018|Overall Study|Progressive disease|12|||
148745549|NCT02516553|536538361|FG019|Overall Study|Progressive disease|7|||
148745550|NCT02516553|536538362|FG020|Overall Study|Progressive disease|16|||
148745551|NCT02516553|536538363|FG021|Overall Study|Progressive disease|18|||
148745552|NCT02516553|536538342|FG000|Overall Study|Dose limiting toxicity|0|||
148745553|NCT02516553|536538343|FG001|Overall Study|Dose limiting toxicity|0|||
148745554|NCT02516553|536538344|FG002|Overall Study|Dose limiting toxicity|0|||
148745555|NCT02516553|536538345|FG003|Overall Study|Dose limiting toxicity|0|||
148745556|NCT02516553|536538346|FG004|Overall Study|Dose limiting toxicity|3|||
148745557|NCT02516553|536538347|FG005|Overall Study|Dose limiting toxicity|1|||
148745558|NCT02516553|536538348|FG006|Overall Study|Dose limiting toxicity|1|||
148745559|NCT02516553|536538349|FG007|Overall Study|Dose limiting toxicity|0|||
148745560|NCT02516553|536538350|FG008|Overall Study|Dose limiting toxicity|1|||
148745561|NCT02516553|536538351|FG009|Overall Study|Dose limiting toxicity|0|||
148745562|NCT02516553|536538352|FG010|Overall Study|Dose limiting toxicity|0|||
148745563|NCT02516553|536538353|FG011|Overall Study|Dose limiting toxicity|1|||
148745564|NCT02516553|536538354|FG012|Overall Study|Dose limiting toxicity|0|||
148745565|NCT02516553|536538355|FG013|Overall Study|Dose limiting toxicity|1|||
148745566|NCT02516553|536538356|FG014|Overall Study|Dose limiting toxicity|0|||
148745567|NCT02516553|536538357|FG015|Overall Study|Dose limiting toxicity|0|||
148745568|NCT02516553|536538358|FG016|Overall Study|Dose limiting toxicity|1|||
148745569|NCT02516553|536538359|FG017|Overall Study|Dose limiting toxicity|1|||
148745570|NCT02516553|536538360|FG018|Overall Study|Dose limiting toxicity|0|||
148745571|NCT02516553|536538361|FG019|Overall Study|Dose limiting toxicity|2|||
148745572|NCT02516553|536538362|FG020|Overall Study|Dose limiting toxicity|0|||
148745573|NCT02516553|536538363|FG021|Overall Study|Dose limiting toxicity|0|||
148745574|NCT02516553|536538342|FG000|Overall Study|Other Adverse Events|0|||
148745575|NCT02516553|536538343|FG001|Overall Study|Other Adverse Events|0|||
148745576|NCT02516553|536538344|FG002|Overall Study|Other Adverse Events|0|||
148745577|NCT02516553|536538345|FG003|Overall Study|Other Adverse Events|1|||
148745578|NCT02516553|536538346|FG004|Overall Study|Other Adverse Events|0|||
148745579|NCT02516553|536538347|FG005|Overall Study|Other Adverse Events|1|||
148745580|NCT02516553|536538348|FG006|Overall Study|Other Adverse Events|0|||
148819962|NCT02421510|536818102|FG002|Overall Study|Lost to Follow-up|0|||
148819963|NCT02852434|536818103|FG000|Overall Study|Withdrawal by Subject|0|||
148819964|NCT02852434|536818104|FG001|Overall Study|Withdrawal by Subject|1|||
148745581|NCT02516553|536538349|FG007|Overall Study|Other Adverse Events|0|||
148745582|NCT02516553|536538350|FG008|Overall Study|Other Adverse Events|0|||
148745583|NCT02516553|536538351|FG009|Overall Study|Other Adverse Events|1|||
148745584|NCT02516553|536538352|FG010|Overall Study|Other Adverse Events|3|||
148819965|NCT02852434|536818103|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
148745585|NCT02516553|536538353|FG011|Overall Study|Other Adverse Events|2|||
148745586|NCT02516553|536538354|FG012|Overall Study|Other Adverse Events|0|||
148745587|NCT02516553|536538355|FG013|Overall Study|Other Adverse Events|1|||
148745588|NCT02516553|536538356|FG014|Overall Study|Other Adverse Events|0|||
148745589|NCT02516553|536538357|FG015|Overall Study|Other Adverse Events|0|||
148819966|NCT02852434|536818104|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
148745590|NCT02516553|536538358|FG016|Overall Study|Other Adverse Events|0|||
148819967|NCT01717859|536818109|FG000|Overall Study|Adverse Event|5|||
148819968|NCT01717859|536818109|FG000|Overall Study|Moved out of state|1|||
148745591|NCT02516553|536538359|FG017|Overall Study|Other Adverse Events|2|||
148745592|NCT02516553|536538360|FG018|Overall Study|Other Adverse Events|1|||
148745593|NCT02516553|536538361|FG019|Overall Study|Other Adverse Events|2|||
149027177|NCT01414166|537576530|FG000|Overall Study|Physician Decision|2|||
149027178|NCT01414166|537576531|FG001|Overall Study|Physician Decision|0|||
149027179|NCT01414166|537576530|FG000|Overall Study|Protocol Violation|2|||
149027180|NCT01414166|537576531|FG001|Overall Study|Protocol Violation|0|||
148745594|NCT02516553|536538362|FG020|Overall Study|Other Adverse Events|2|||
148745595|NCT02516553|536538363|FG021|Overall Study|Other Adverse Events|1|||
148745596|NCT02516553|536538342|FG000|Overall Study|Refused to continue trial medication|0|||
148745597|NCT02516553|536538343|FG001|Overall Study|Refused to continue trial medication|0|||
148745598|NCT02516553|536538344|FG002|Overall Study|Refused to continue trial medication|0|||
148745599|NCT02516553|536538345|FG003|Overall Study|Refused to continue trial medication|0|||
148745600|NCT02516553|536538346|FG004|Overall Study|Refused to continue trial medication|0|||
148745601|NCT02516553|536538347|FG005|Overall Study|Refused to continue trial medication|0|||
148745602|NCT02516553|536538348|FG006|Overall Study|Refused to continue trial medication|0|||
148745603|NCT02516553|536538349|FG007|Overall Study|Refused to continue trial medication|0|||
148745604|NCT02516553|536538350|FG008|Overall Study|Refused to continue trial medication|0|||
148745605|NCT02516553|536538351|FG009|Overall Study|Refused to continue trial medication|0|||
148745606|NCT02516553|536538352|FG010|Overall Study|Refused to continue trial medication|1|||
148745607|NCT02516553|536538353|FG011|Overall Study|Refused to continue trial medication|0|||
148745608|NCT02516553|536538354|FG012|Overall Study|Refused to continue trial medication|0|||
148745609|NCT02516553|536538355|FG013|Overall Study|Refused to continue trial medication|0|||
148745610|NCT02516553|536538356|FG014|Overall Study|Refused to continue trial medication|0|||
148745611|NCT02516553|536538357|FG015|Overall Study|Refused to continue trial medication|0|||
148745612|NCT02516553|536538358|FG016|Overall Study|Refused to continue trial medication|0|||
148745613|NCT02516553|536538359|FG017|Overall Study|Refused to continue trial medication|0|||
148745614|NCT02516553|536538360|FG018|Overall Study|Refused to continue trial medication|1|||
148745615|NCT02516553|536538361|FG019|Overall Study|Refused to continue trial medication|0|||
148745616|NCT02516553|536538362|FG020|Overall Study|Refused to continue trial medication|0|||
148745617|NCT02516553|536538363|FG021|Overall Study|Refused to continue trial medication|1|||
148745618|NCT02516553|536538342|FG000|Overall Study|other reasons than listed|0|||
148745619|NCT02516553|536538343|FG001|Overall Study|other reasons than listed|0|||
148745620|NCT02516553|536538344|FG002|Overall Study|other reasons than listed|0|||
148745621|NCT02516553|536538345|FG003|Overall Study|other reasons than listed|0|||
148745622|NCT02516553|536538346|FG004|Overall Study|other reasons than listed|0|||
148745623|NCT02516553|536538347|FG005|Overall Study|other reasons than listed|0|||
148745624|NCT02516553|536538348|FG006|Overall Study|other reasons than listed|0|||
148745625|NCT02516553|536538349|FG007|Overall Study|other reasons than listed|1|||
148745626|NCT02516553|536538350|FG008|Overall Study|other reasons than listed|1|||
148745627|NCT02516553|536538351|FG009|Overall Study|other reasons than listed|0|||
148745628|NCT02516553|536538352|FG010|Overall Study|other reasons than listed|1|||
148745629|NCT02516553|536538353|FG011|Overall Study|other reasons than listed|1|||
148745630|NCT02516553|536538354|FG012|Overall Study|other reasons than listed|0|||
148745631|NCT02516553|536538355|FG013|Overall Study|other reasons than listed|0|||
148745632|NCT02516553|536538356|FG014|Overall Study|other reasons than listed|0|||
148745633|NCT02516553|536538357|FG015|Overall Study|other reasons than listed|0|||
148745634|NCT02516553|536538358|FG016|Overall Study|other reasons than listed|0|||
148745635|NCT02516553|536538359|FG017|Overall Study|other reasons than listed|0|||
148745636|NCT02516553|536538360|FG018|Overall Study|other reasons than listed|0|||
148745637|NCT02516553|536538361|FG019|Overall Study|other reasons than listed|0|||
148745638|NCT02516553|536538362|FG020|Overall Study|other reasons than listed|2|||
148745639|NCT02516553|536538363|FG021|Overall Study|other reasons than listed|2|||
148745640|NCT04614246|536538365|FG000|Overall Study|Adverse Event|0|||
148745641|NCT04614246|536538366|FG001|Overall Study|Adverse Event|1|||
148745642|NCT04614246|536538367|FG002|Overall Study|Adverse Event|1|||
148745643|NCT04614246|536538368|FG003|Overall Study|Adverse Event|2|||
148745644|NCT04614246|536538369|FG004|Overall Study|Adverse Event|1|||
149027181|NCT01414166|537576530|FG000|Overall Study|Study terminated by Sponsor|68|||
148745645|NCT04614246|536538365|FG000|Overall Study|Lost to Follow-up|0|||
148745646|NCT04614246|536538366|FG001|Overall Study|Lost to Follow-up|1|||
149027182|NCT01414166|537576531|FG001|Overall Study|Study terminated by Sponsor|75|||
149027183|NCT01414166|537576530|FG000|Overall Study|Withdrawal by Subject|3|||
148745647|NCT04614246|536538367|FG002|Overall Study|Lost to Follow-up|0|||
148745648|NCT04614246|536538368|FG003|Overall Study|Lost to Follow-up|1|||
148745649|NCT04614246|536538369|FG004|Overall Study|Lost to Follow-up|3|||
148745650|NCT04614246|536538365|FG000|Overall Study|Other reason|0|||
148745651|NCT04614246|536538366|FG001|Overall Study|Other reason|1|||
148745652|NCT04614246|536538367|FG002|Overall Study|Other reason|2|||
148745653|NCT04614246|536538368|FG003|Overall Study|Other reason|0|||
148745654|NCT04614246|536538369|FG004|Overall Study|Other reason|0|||
148745655|NCT04614246|536538365|FG000|Overall Study|Withdrawal by Subject|4|||
148745656|NCT04614246|536538366|FG001|Overall Study|Withdrawal by Subject|2|||
148745657|NCT04614246|536538367|FG002|Overall Study|Withdrawal by Subject|4|||
148745658|NCT04614246|536538368|FG003|Overall Study|Withdrawal by Subject|3|||
149027184|NCT01414166|537576531|FG001|Overall Study|Withdrawal by Subject|5|||
148976051|NCT01420081|537392414|FG002|Overall Study|Other Reasons|1|||
148976052|NCT01420081|537392415|FG003|Overall Study|Other Reasons|0|||
148976053|NCT01420081|537392416|FG004|Overall Study|Other Reasons|0|||
148976054|NCT01420081|537392417|FG005|Overall Study|Other Reasons|0|||
148976055|NCT01420081|537392418|FG006|Overall Study|Other Reasons|0|||
148976056|NCT01420081|537392419|FG007|Overall Study|Other Reasons|0|||
148976057|NCT01420081|537392420|FG008|Overall Study|Other Reasons|0|||
148745659|NCT04614246|536538369|FG004|Overall Study|Withdrawal by Subject|4|||
148745660|NCT04614246|536538365|FG000|Overall Study|Physician Decision|0|||
148745661|NCT04614246|536538366|FG001|Overall Study|Physician Decision|2|||
148745662|NCT04614246|536538367|FG002|Overall Study|Physician Decision|1|||
148745663|NCT04614246|536538368|FG003|Overall Study|Physician Decision|0|||
148745664|NCT04614246|536538369|FG004|Overall Study|Physician Decision|0|||
148745665|NCT04614246|536538365|FG000|Overall Study|Study terminated by sponsor|10|||
148745666|NCT04614246|536538366|FG001|Overall Study|Study terminated by sponsor|15|||
148745667|NCT04614246|536538367|FG002|Overall Study|Study terminated by sponsor|12|||
148745668|NCT04614246|536538368|FG003|Overall Study|Study terminated by sponsor|13|||
148745669|NCT04614246|536538369|FG004|Overall Study|Study terminated by sponsor|9|||
148745670|NCT04614246|536538365|FG000|Overall Study|Pregnancy|2|||
148745671|NCT04614246|536538366|FG001|Overall Study|Pregnancy|0|||
148745672|NCT04614246|536538367|FG002|Overall Study|Pregnancy|1|||
148745673|NCT04614246|536538368|FG003|Overall Study|Pregnancy|0|||
148745674|NCT04614246|536538369|FG004|Overall Study|Pregnancy|0|||
148745675|NCT00340678|536538371|FG000|Overall Study|Lost to Follow-up|1|||
148745676|NCT00340678|536538372|FG001|Overall Study|Lost to Follow-up|0|||
148745677|NCT00340678|536538373|FG002|Overall Study|Lost to Follow-up|0|||
148745678|NCT00340678|536538374|FG003|Overall Study|Lost to Follow-up|0|||
148745679|NCT05314816|536538377|FG000|Overall Study|Lost to Follow-up|5|||
148745680|NCT05314816|536538378|FG001|Overall Study|Lost to Follow-up|0|||
148745681|NCT05314816|536538379|FG002|Overall Study|Lost to Follow-up|1|||
148745682|NCT05314816|536538377|FG000|Overall Study|Protocol Violation|13|||
148745683|NCT05314816|536538378|FG001|Overall Study|Protocol Violation|8|||
148745684|NCT05314816|536538379|FG002|Overall Study|Protocol Violation|0|||
148745685|NCT02017015|536540566|FG000|Overall Study|Adverse Event|9|||
148745686|NCT02017015|536540566|FG000|Overall Study|Withdrawal by Subject|21|||
148745687|NCT02017015|536540566|FG000|Overall Study|Death|4|||
148745688|NCT02017015|536540566|FG000|Overall Study|Progressive Disease|31|||
148745689|NCT02017015|536540566|FG000|Overall Study|Non-compliance with study drug|2|||
148745690|NCT02017015|536540566|FG000|Overall Study|Physician Decision|2|||
148745691|NCT00459355|536540569|FG000|Overall Study|Subject no longer met inc criteria|20|||
148745692|NCT00459355|536540570|FG001|Overall Study|Subject no longer met inc criteria|18|||
148745693|NCT01173120|536540572|FG000|Overall Study|Lack of Efficacy|2|||
148745694|NCT01173120|536540572|FG000|Overall Study|Lost to Follow-up|1|||
148745695|NCT01173120|536540572|FG000|Overall Study|Participant Decision|2|||
148745696|NCT01173120|536540572|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
148745697|NCT01173120|536540572|FG000|Overall Study|Switch-Participant Decision|12|||
148745698|NCT01173120|536540572|FG000|Overall Study|Switch-Difficulty With Device|12|||
148745699|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
148745700|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
148745701|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
148745702|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
148745703|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
148745704|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
148745705|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
148745706|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
148745707|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
148745708|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
148745709|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
148745710|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
148745711|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
148745712|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
148745713|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
148745714|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
148745715|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
148745716|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
148745717|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
148976058|NCT00414388|537392421|FG000|Overall Study|Adverse Event|1|||
148745718|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
148745719|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
148745720|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
148745721|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
148745722|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
148745723|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
148745724|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
148745725|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
148976059|NCT02318693|537392423|FG000|Overall Study|Protocol Violation|0|||
148976060|NCT02318693|537392424|FG001|Overall Study|Protocol Violation|1|||
148745726|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
148745727|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
148745728|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
148745729|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
148745730|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
148745731|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
148745732|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
148745733|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
148745734|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
148745735|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
148745736|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
148745737|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
148745738|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
148745739|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745740|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745741|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745742|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
148745743|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745744|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745745|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745746|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745747|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745748|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
148745749|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
148745750|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
148745751|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
148745752|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
148745753|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
148745754|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
148745755|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
148745756|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
148745757|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
148745758|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
148745759|NCT03104400|536540573|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745760|NCT03104400|536540574|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745761|NCT03104400|536540575|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745762|NCT03104400|536540576|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
148745763|NCT03104400|536540577|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745764|NCT03104400|536540578|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745765|NCT03104400|536540579|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745766|NCT03104400|536540580|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745767|NCT03104400|536540581|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745768|NCT03104400|536540582|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
148745769|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
148745770|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
148745771|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
148745772|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
148745773|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
148745774|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
148745775|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
148745776|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
148745777|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
148745778|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
148745779|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
148745780|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
148745781|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
148745782|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
148745783|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
148745784|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
148745785|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
148745786|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
148745787|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
148745788|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
148745789|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
148745790|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
148976061|NCT00025883|537392425|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
148976062|NCT00025883|537392425|FG000|Overall Study|no baseline data|1|||
148976063|NCT00025883|537392425|FG000|Overall Study|Death|1|||
148745791|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
148745792|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
148745793|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
148976064|NCT00025883|537392425|FG000|Overall Study|Adverse Event|1|||
148745794|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
148745795|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
148745796|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
148745797|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
148745798|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
148745799|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
148745800|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
148745801|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
148745802|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
148745803|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
148745804|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
148745805|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
148745806|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
148745807|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
148745808|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
148745809|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745810|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745811|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745812|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745813|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745814|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745815|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
148745816|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
148745817|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
148745818|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
148745819|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745820|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745821|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745822|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745823|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745824|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745825|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745826|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
148745827|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
148745828|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
148745829|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
148745830|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
148745831|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
148745832|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
148745833|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
148745834|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
148745835|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
148745836|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
148745837|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
148745838|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
148745839|NCT03104400|536540573|FG000|Period 2 Week 56 - 260)|Other|0|||
148745840|NCT03104400|536540574|FG001|Period 2 Week 56 - 260)|Other|0|||
148745841|NCT03104400|536540575|FG002|Period 2 Week 56 - 260)|Other|0|||
148745842|NCT03104400|536540576|FG003|Period 2 Week 56 - 260)|Other|0|||
148745843|NCT03104400|536540577|FG004|Period 2 Week 56 - 260)|Other|0|||
148819969|NCT01717859|536818109|FG000|Overall Study|Patient concerned about mental health|1|||
148819970|NCT01717859|536818109|FG000|Overall Study|Lost to Follow-up|1|||
148819971|NCT01717859|536818109|FG000|Overall Study|Withdrawal by Subject|2|||
148976065|NCT00025883|537392425|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
148976066|NCT00218543|537392426|FG000|Overall Study|Lost to Follow-up|8|||
148976067|NCT00218543|537392426|FG000|Overall Study|relocated|1|||
148976068|NCT00218543|537392426|FG000|Overall Study|Withdrawal by Subject|1|||
148976069|NCT00218543|537392426|FG000|Overall Study|Physician Decision|3|||
148976070|NCT00218543|537392426|FG000|Overall Study|Adverse Event|2|||
148976071|NCT02448875|537392427|FG000|Overall Study|Adverse Event|2|||
148976072|NCT02448875|537392428|FG001|Overall Study|Adverse Event|1|||
148976073|NCT02448875|537392429|FG002|Overall Study|Adverse Event|0|||
148976074|NCT02448875|537392427|FG000|Overall Study|Lost to Follow-up|1|||
148745844|NCT03104400|536540578|FG005|Period 2 Week 56 - 260)|Other|0|||
148745845|NCT03104400|536540579|FG006|Period 2 Week 56 - 260)|Other|0|||
148745846|NCT03104400|536540580|FG007|Period 2 Week 56 - 260)|Other|0|||
148745847|NCT03104400|536540581|FG008|Period 2 Week 56 - 260)|Other|1|||
148745848|NCT03104400|536540582|FG009|Period 2 Week 56 - 260)|Other|1|||
148745849|NCT02013817|536540583|FG000|Overall Study|Adverse Event|12|||
148745850|NCT02013817|536540583|FG000|Overall Study|Withdrawal by Subject|4|||
148745851|NCT02013817|536540583|FG000|Overall Study|Death|2|||
148819972|NCT01755637|536818110|FG000|Period 1|Adverse Event|0|||
148976075|NCT02448875|537392428|FG001|Overall Study|Lost to Follow-up|0|||
148976076|NCT02448875|537392429|FG002|Overall Study|Lost to Follow-up|0|||
148745852|NCT02013817|536540583|FG000|Overall Study|Other|9|||
148745853|NCT02906358|536540584|FG000|Overall Study|Withdrawal by Subject|10|||
148745854|NCT02906358|536540585|FG001|Overall Study|Withdrawal by Subject|7|||
148745855|NCT02906358|536540584|FG000|Overall Study|Lost to Follow-up|12|||
148745856|NCT02906358|536540585|FG001|Overall Study|Lost to Follow-up|15|||
148745857|NCT01145508|536540586|FG000|Overall Study|Adverse Event|1|||
148745858|NCT01145508|536540587|FG001|Overall Study|Adverse Event|0|||
148745859|NCT01145508|536540586|FG000|Overall Study|Death|1|||
148745860|NCT01145508|536540587|FG001|Overall Study|Death|0|||
148745861|NCT01145508|536540586|FG000|Overall Study|Physician Decision|2|||
148745862|NCT01145508|536540587|FG001|Overall Study|Physician Decision|1|||
148745863|NCT01145508|536540586|FG000|Overall Study|Never started treatment|1|||
148745864|NCT01145508|536540587|FG001|Overall Study|Never started treatment|1|||
148745865|NCT02111603|536540597|FG000|Overall Study|Withdrawal by Subject|1|||
148745866|NCT01582152|536540598|FG000|Overall Study|Disease Progression|4|||
148745867|NCT01582152|536540599|FG001|Overall Study|Disease Progression|5|||
148745868|NCT01582152|536540598|FG000|Overall Study|Adverse Event|2|||
148745869|NCT01582152|536540599|FG001|Overall Study|Adverse Event|1|||
148745870|NCT03055624|536540600|FG000|Overall Study|Study closed|9|||
148745871|NCT00799825|536540612|FG000|Overall Study|Adverse Event|1|||
148745872|NCT00799825|536540612|FG000|Overall Study|Withdrawal by Subject|6|||
148745873|NCT00799825|536540612|FG000|Overall Study|Lost to Follow-up|38|||
148745874|NCT00799825|536540612|FG000|Overall Study|Pregnancy|3|||
148745875|NCT00794339|536540613|FG000|Overall Study|Withdrawal by Subject|3|||
148745876|NCT00794339|536540613|FG000|Overall Study|Ineligible|4|||
148745877|NCT00794339|536540613|FG000|Overall Study|Tx prior to ATSM|3|||
148745878|NCT00794339|536540613|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
148745879|NCT00794339|536540613|FG000|Overall Study|Tx not per protocol|1|||
148745880|NCT01611857|536540614|FG000|Overall Study|Withdrawal by Subject|0|||
148745881|NCT01611857|536540615|FG001|Overall Study|Withdrawal by Subject|2|||
148745882|NCT02439970|536540619|FG000|Overall Study|Study Terminated|2|||
148745883|NCT02439970|536540620|FG001|Overall Study|Study Terminated|3|||
148745884|NCT02952586|536540621|FG000|Lead-In Phase (7 Days)|Death|0|||
148745885|NCT02952586|536540622|FG001|Lead-In Phase (7 Days)|Death|1|||
148745886|NCT02952586|536540621|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
148745887|NCT02952586|536540622|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
148745888|NCT02952586|536540621|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
148745889|NCT02952586|536540622|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
148745890|NCT02952586|536540621|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
148745891|NCT02952586|536540622|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
148745892|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
148745893|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
148745894|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
148745895|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
148745896|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
148745897|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
148745898|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
148745899|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
148745900|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
148745901|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
148745902|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
148745903|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
148745904|NCT02952586|536540621|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
148745905|NCT02952586|536540622|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
148745906|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Death|3|||
148745907|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Death|8|||
148745908|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
148745909|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
148745910|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
148745911|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
148745912|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
148745913|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
148745914|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
148745915|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
148745916|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
148745917|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
148745918|NCT02952586|536540621|FG000|CRT for Cisplatin (63 Days)|Other|1|||
148745919|NCT02952586|536540622|FG001|CRT for Cisplatin (63 Days)|Other|1|||
148745920|NCT02952586|536540621|FG000|CRT for IMRT (63 Days)|Death|5|||
148745921|NCT02952586|536540622|FG001|CRT for IMRT (63 Days)|Death|8|||
148745922|NCT02952586|536540621|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
148745923|NCT02952586|536540622|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
148745924|NCT02952586|536540621|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
148819973|NCT01755637|536818111|FG001|Period 1|Adverse Event|1|||
148745925|NCT02952586|536540622|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
148745926|NCT02952586|536540621|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
148745927|NCT02952586|536540622|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
148745928|NCT02952586|536540621|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
148745929|NCT02952586|536540622|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
148745930|NCT02952586|536540621|FG000|CRT for IMRT (63 Days)|Other|1|||
148745931|NCT02952586|536540622|FG001|CRT for IMRT (63 Days)|Other|0|||
148745932|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Death|17|||
148745933|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Death|11|||
148745934|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
148745935|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
148745936|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
148745937|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
148745938|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
148745939|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
148745940|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
148745941|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
148745942|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
148745943|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
148745944|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
148745945|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
148745946|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
148745947|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
148745948|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Other|2|||
148745949|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Other|1|||
148745950|NCT02952586|536540621|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
148745951|NCT02952586|536540622|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
148745952|NCT02952586|536540621|FG000|Follow-Up Phase (90 Days)|Death|12|||
148745953|NCT02952586|536540622|FG001|Follow-Up Phase (90 Days)|Death|10|||
148745954|NCT02952586|536540621|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
148745955|NCT02952586|536540622|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
148745956|NCT02952586|536540621|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
148745957|NCT02952586|536540622|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
148745958|NCT02952586|536540621|FG000|Follow-Up Phase (90 Days)|Other|7|||
148745959|NCT02952586|536540622|FG001|Follow-Up Phase (90 Days)|Other|5|||
148745960|NCT02952586|536540621|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
148745961|NCT02952586|536540622|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
148745962|NCT02952586|536540621|FG000|LT Follow-up (up to 45 Months)|Death|51|||
148745963|NCT02952586|536540622|FG001|LT Follow-up (up to 45 Months)|Death|31|||
148745964|NCT02952586|536540621|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
148745965|NCT02952586|536540622|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
148745966|NCT02952586|536540621|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
148745967|NCT02952586|536540622|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
148745968|NCT02952586|536540621|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
148745969|NCT02952586|536540622|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
148745970|NCT02075515|536540626|FG000|Overall Study|Serious Adverse Event|1|||
148745971|NCT02075515|536540627|FG001|Overall Study|Serious Adverse Event|1|||
148745972|NCT02075515|536540628|FG002|Overall Study|Serious Adverse Event|1|||
148745973|NCT02075515|536540626|FG000|Overall Study|Non-Serious Adverse Event|0|||
148745974|NCT02075515|536540627|FG001|Overall Study|Non-Serious Adverse Event|1|||
148745975|NCT02075515|536540628|FG002|Overall Study|Non-Serious Adverse Event|0|||
148745976|NCT02075515|536540626|FG000|Overall Study|Withdrawal by Subject|2|||
148745977|NCT02075515|536540627|FG001|Overall Study|Withdrawal by Subject|0|||
148745978|NCT02075515|536540628|FG002|Overall Study|Withdrawal by Subject|1|||
148745979|NCT02075515|536540626|FG000|Overall Study|Lost to Follow-up|1|||
149027185|NCT01823341|537576537|FG000|Overall Study|Failed run-in|7|||
148745980|NCT02075515|536540627|FG001|Overall Study|Lost to Follow-up|3|||
148745981|NCT02075515|536540628|FG002|Overall Study|Lost to Follow-up|6|||
148745982|NCT00741338|536540631|FG000|Overall Study|Adverse Event|0|||
148745983|NCT00741338|536540632|FG001|Overall Study|Adverse Event|1|||
148745984|NCT03593395|536540633|FG000|Overall Study|Lost to Follow-up|48|||
148745985|NCT03593395|536540634|FG001|Overall Study|Lost to Follow-up|3|||
148745986|NCT03593395|536540633|FG000|Overall Study|Withdrawal by Subject|5|||
148745987|NCT03593395|536540634|FG001|Overall Study|Withdrawal by Subject|24|||
148745988|NCT03593395|536540633|FG000|Overall Study|Death|2|||
148745989|NCT03593395|536540634|FG001|Overall Study|Death|3|||
148745990|NCT03593395|536540633|FG000|Overall Study|Physician Decision|0|||
148745991|NCT03593395|536540634|FG001|Overall Study|Physician Decision|6|||
148745992|NCT03593395|536540633|FG000|Overall Study|Participant Relocated|19|||
148745993|NCT03593395|536540634|FG001|Overall Study|Participant Relocated|3|||
148745994|NCT03593395|536540633|FG000|Overall Study|No Information|1|||
148745995|NCT03593395|536540634|FG001|Overall Study|No Information|7|||
148745996|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
148745997|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
148745998|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
148745999|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
148746000|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
148746001|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
148746002|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
148746003|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
148746004|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
148746005|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
148746006|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
148746007|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
148746008|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
148746009|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
148746010|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
148746011|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
148746012|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
148746013|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
148746014|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
148746015|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
148746016|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
148746017|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148746018|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
148746019|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148746020|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
148746021|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
148746022|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
148746023|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
148746024|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
148746025|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
148746026|NCT03713632|536540635|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
148746027|NCT03713632|536540636|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
148746028|NCT03713632|536540637|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
148746029|NCT03713632|536540638|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
148746030|NCT03713632|536540639|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
148746031|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
148746032|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
148746033|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
148746034|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
148746035|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
148746036|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
148746037|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
148746038|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
148746039|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
148746040|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
148746041|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
148746042|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
148746043|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
148746044|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
148746045|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
148746046|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
148746047|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
148746048|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
148746049|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
148746050|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
148746051|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
148746052|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
148746053|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
148746054|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
148746055|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
148746056|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
148746057|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
148746058|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
148746059|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
148746060|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
148746061|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Death|0|||
148746062|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Death|1|||
148746063|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Death|0|||
148746064|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Death|0|||
148746065|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Death|0|||
148746066|NCT03713632|536540635|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148746067|NCT03713632|536540636|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
148746068|NCT03713632|536540637|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148746069|NCT03713632|536540638|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148746070|NCT03713632|536540639|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
148746071|NCT01524978|536540640|FG000|Overall Study|Other|16|||
148746072|NCT01524978|536540641|FG001|Overall Study|Other|2|||
148746073|NCT01524978|536540642|FG002|Overall Study|Other|1|||
148746074|NCT01524978|536540643|FG003|Overall Study|Other|2|||
148746075|NCT01524978|536540644|FG004|Overall Study|Other|1|||
148746076|NCT01524978|536540645|FG005|Overall Study|Other|3|||
148746077|NCT01524978|536540646|FG006|Overall Study|Other|17|||
148746078|NCT01524978|536540647|FG007|Overall Study|Other|1|||
148746079|NCT01524978|536540648|FG008|Overall Study|Other|2|||
148746080|NCT01524978|536540649|FG009|Overall Study|Other|2|||
148746081|NCT01524978|536540650|FG010|Overall Study|Other|5|||
148746082|NCT01524978|536540640|FG000|Overall Study|Withdrawal by Subject|12|||
148746083|NCT01524978|536540641|FG001|Overall Study|Withdrawal by Subject|0|||
148746084|NCT01524978|536540642|FG002|Overall Study|Withdrawal by Subject|1|||
148746085|NCT01524978|536540643|FG003|Overall Study|Withdrawal by Subject|1|||
148746086|NCT01524978|536540644|FG004|Overall Study|Withdrawal by Subject|3|||
148746087|NCT01524978|536540645|FG005|Overall Study|Withdrawal by Subject|1|||
148746088|NCT01524978|536540646|FG006|Overall Study|Withdrawal by Subject|6|||
148746089|NCT01524978|536540647|FG007|Overall Study|Withdrawal by Subject|2|||
148746090|NCT01524978|536540648|FG008|Overall Study|Withdrawal by Subject|4|||
148746091|NCT01524978|536540649|FG009|Overall Study|Withdrawal by Subject|0|||
148746092|NCT01524978|536540650|FG010|Overall Study|Withdrawal by Subject|5|||
148746093|NCT01524978|536540640|FG000|Overall Study|Lost to Follow-up|0|||
148746094|NCT01524978|536540641|FG001|Overall Study|Lost to Follow-up|0|||
148746095|NCT01524978|536540642|FG002|Overall Study|Lost to Follow-up|3|||
148746096|NCT01524978|536540643|FG003|Overall Study|Lost to Follow-up|0|||
148746097|NCT01524978|536540644|FG004|Overall Study|Lost to Follow-up|1|||
148746098|NCT01524978|536540645|FG005|Overall Study|Lost to Follow-up|1|||
148746099|NCT01524978|536540646|FG006|Overall Study|Lost to Follow-up|2|||
148746100|NCT01524978|536540647|FG007|Overall Study|Lost to Follow-up|0|||
148746101|NCT01524978|536540648|FG008|Overall Study|Lost to Follow-up|1|||
148746102|NCT01524978|536540649|FG009|Overall Study|Lost to Follow-up|1|||
148746103|NCT01524978|536540650|FG010|Overall Study|Lost to Follow-up|1|||
148746104|NCT01524978|536540640|FG000|Overall Study|Death|34|||
148746105|NCT01524978|536540641|FG001|Overall Study|Death|2|||
148746106|NCT01524978|536540642|FG002|Overall Study|Death|5|||
148746107|NCT01524978|536540643|FG003|Overall Study|Death|24|||
148746108|NCT01524978|536540644|FG004|Overall Study|Death|4|||
148746109|NCT01524978|536540645|FG005|Overall Study|Death|4|||
148746110|NCT01524978|536540646|FG006|Overall Study|Death|1|||
148746111|NCT01524978|536540647|FG007|Overall Study|Death|9|||
148746112|NCT01524978|536540648|FG008|Overall Study|Death|5|||
148746113|NCT01524978|536540649|FG009|Overall Study|Death|6|||
148746114|NCT01524978|536540650|FG010|Overall Study|Death|17|||
148746115|NCT02165735|536540658|FG000|Overall Study|Lost to Follow-up|12|||
148746116|NCT02165735|536540659|FG001|Overall Study|Lost to Follow-up|10|||
148746117|NCT02165735|536540658|FG000|Overall Study|Withdrawal by Subject|3|||
148746118|NCT02165735|536540659|FG001|Overall Study|Withdrawal by Subject|0|||
148746119|NCT02165735|536540658|FG000|Overall Study|Participant indicated lack of time|1|||
148746120|NCT02165735|536540659|FG001|Overall Study|Participant indicated lack of time|3|||
148746121|NCT02165735|536540658|FG000|Overall Study|Protocol Violation|0|||
148746122|NCT02165735|536540659|FG001|Overall Study|Protocol Violation|1|||
148746123|NCT03066258|536540660|FG000|Overall Study|Death|1|||
148746124|NCT03066258|536540661|FG001|Overall Study|Death|0|||
148746125|NCT03066258|536540662|FG002|Overall Study|Death|0|||
148746126|NCT03066258|536540663|FG003|Overall Study|Death|0|||
148746127|NCT03066258|536540664|FG004|Overall Study|Death|1|||
148746128|NCT02784795|536540665|FG000|Overall Study|Progressive Disease|2|||
148746129|NCT02784795|536540666|FG001|Overall Study|Progressive Disease|1|||
148746130|NCT02784795|536540667|FG002|Overall Study|Progressive Disease|1|||
148746131|NCT02784795|536540668|FG003|Overall Study|Progressive Disease|0|||
148746132|NCT02784795|536540669|FG004|Overall Study|Progressive Disease|2|||
148746133|NCT02784795|536540670|FG005|Overall Study|Progressive Disease|0|||
148746134|NCT02784795|536540671|FG006|Overall Study|Progressive Disease|2|||
148746135|NCT02784795|536540672|FG007|Overall Study|Progressive Disease|0|||
148746136|NCT02784795|536540673|FG008|Overall Study|Progressive Disease|0|||
148746137|NCT02784795|536540674|FG009|Overall Study|Progressive Disease|0|||
148746138|NCT02784795|536540675|FG010|Overall Study|Progressive Disease|1|||
148746139|NCT02784795|536540676|FG011|Overall Study|Progressive Disease|0|||
148746140|NCT02784795|536540665|FG000|Overall Study|Adverse Event|1|||
148746141|NCT02784795|536540666|FG001|Overall Study|Adverse Event|0|||
148746142|NCT02784795|536540667|FG002|Overall Study|Adverse Event|0|||
148746143|NCT02784795|536540668|FG003|Overall Study|Adverse Event|1|||
148746144|NCT02784795|536540669|FG004|Overall Study|Adverse Event|0|||
148819974|NCT04389671|536818112|FG000|Overall Study|Death|7|||
148819975|NCT00899847|536818113|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
148819976|NCT02287025|536818114|FG000|Overall Study|Not treated|2|||
148819977|NCT02287025|536818115|FG001|Overall Study|Not treated|0|||
148819978|NCT02287025|536818114|FG000|Overall Study|Progression of disease|3|||
148819979|NCT02287025|536818115|FG001|Overall Study|Progression of disease|2|||
148819980|NCT02287025|536818114|FG000|Overall Study|Adverse Event|2|||
148819981|NCT02287025|536818115|FG001|Overall Study|Adverse Event|4|||
148819982|NCT02287025|536818114|FG000|Overall Study|Withdrawal by Subject|2|||
148819983|NCT02287025|536818115|FG001|Overall Study|Withdrawal by Subject|2|||
148819984|NCT02287025|536818114|FG000|Overall Study|Screening failed|1|||
148819985|NCT02287025|536818115|FG001|Overall Study|Screening failed|1|||
148819986|NCT04053452|536818116|FG000|Overall Study|Withdrawal by Subject|1|||
148819987|NCT04053452|536818117|FG001|Overall Study|Withdrawal by Subject|0|||
148819988|NCT04053452|536818116|FG000|Overall Study|Time restraint due to inpatient needs|1|||
148819989|NCT04053452|536818117|FG001|Overall Study|Time restraint due to inpatient needs|2|||
148819990|NCT01149538|536818125|FG000|Overall Study|Lost to Follow-up|0|||
148819991|NCT01149538|536818126|FG001|Overall Study|Lost to Follow-up|1|||
148819992|NCT01149538|536818125|FG000|Overall Study|Withdrawal by Subject|5|||
148819993|NCT01149538|536818126|FG001|Overall Study|Withdrawal by Subject|3|||
148819994|NCT00888849|536818127|FG000|Overall Study|Death|4|||
148819995|NCT00888849|536818128|FG001|Overall Study|Death|7|||
148819996|NCT00888849|536818127|FG000|Overall Study|Lost to Follow-up|1|||
148819997|NCT00888849|536818128|FG001|Overall Study|Lost to Follow-up|2|||
148819998|NCT05064800|536818129|FG000|Period 3|Withdrawal by Subject|0|||
148819999|NCT05064800|536818130|FG001|Period 3|Withdrawal by Subject|0|||
148820000|NCT05064800|536818131|FG002|Period 3|Withdrawal by Subject|0|||
148820001|NCT05064800|536818132|FG003|Period 3|Withdrawal by Subject|0|||
148820002|NCT05064800|536818133|FG004|Period 3|Withdrawal by Subject|1|||
148820003|NCT05064800|536818134|FG005|Period 3|Withdrawal by Subject|0|||
148820004|NCT00629239|536818135|FG000|Overall Study|Adverse Event|7|||
148820005|NCT00629239|536818136|FG001|Overall Study|Adverse Event|4|||
148820006|NCT00629239|536818135|FG000|Overall Study|Physician Decision|1|||
148820007|NCT00629239|536818136|FG001|Overall Study|Physician Decision|0|||
148820008|NCT01181128|536818137|FG000|Overall Study|Withdrawal by Subject|2|||
148820009|NCT01181128|536818138|FG001|Overall Study|Withdrawal by Subject|2|||
148820010|NCT01181128|536818139|FG002|Overall Study|Withdrawal by Subject|0|||
148820011|NCT01181128|536818137|FG000|Overall Study|Death|1|||
148820012|NCT01181128|536818138|FG001|Overall Study|Death|0|||
148820013|NCT01181128|536818139|FG002|Overall Study|Death|0|||
148820014|NCT01181128|536818137|FG000|Overall Study|Physician Decision|2|||
148820015|NCT01181128|536818138|FG001|Overall Study|Physician Decision|0|||
148820016|NCT01181128|536818139|FG002|Overall Study|Physician Decision|0|||
148820017|NCT01181128|536818137|FG000|Overall Study|Adverse Event|0|||
148820018|NCT01181128|536818138|FG001|Overall Study|Adverse Event|2|||
148820019|NCT01181128|536818139|FG002|Overall Study|Adverse Event|0|||
148820020|NCT01181128|536818137|FG000|Overall Study|Other|1|||
148820021|NCT01181128|536818138|FG001|Overall Study|Other|1|||
148820022|NCT01181128|536818139|FG002|Overall Study|Other|1|||
148820023|NCT01851369|536818142|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820024|NCT01851369|536818143|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820025|NCT01851369|536818144|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820026|NCT01851369|536818145|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820027|NCT01851369|536818146|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820028|NCT01851369|536818147|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
148820029|NCT01851369|536818148|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820030|NCT01851369|536818149|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820031|NCT01851369|536818150|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820032|NCT01851369|536818151|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820033|NCT01851369|536818152|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820034|NCT01851369|536818153|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
149027186|NCT01823341|537576537|FG000|Overall Study|Withdrawal by Subject|7|||
149027187|NCT01823341|537576537|FG000|Overall Study|Adverse Event|1|||
148820035|NCT01851369|536818154|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
148820036|NCT00183391|536818155|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
148820037|NCT00183391|536818156|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
148820038|NCT00183391|536818155|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
148820039|NCT00183391|536818156|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
148820040|NCT02336503|536818159|FG000|Overall Study|Lost to Follow-up|0|||
148820041|NCT02336503|536818160|FG001|Overall Study|Lost to Follow-up|3|||
148820042|NCT02336503|536818161|FG002|Overall Study|Lost to Follow-up|0|||
148820043|NCT02336503|536818162|FG003|Overall Study|Lost to Follow-up|2|||
148820044|NCT02336503|536818159|FG000|Overall Study|Withdrawal by Subject|2|||
149027188|NCT05174065|537576538|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
148820045|NCT02336503|536818160|FG001|Overall Study|Withdrawal by Subject|0|||
148820046|NCT02336503|536818161|FG002|Overall Study|Withdrawal by Subject|0|||
148746145|NCT02784795|536540670|FG005|Overall Study|Adverse Event|0|||
148746146|NCT02784795|536540671|FG006|Overall Study|Adverse Event|1|||
148746147|NCT02784795|536540672|FG007|Overall Study|Adverse Event|0|||
148746148|NCT02784795|536540673|FG008|Overall Study|Adverse Event|0|||
148746149|NCT02784795|536540674|FG009|Overall Study|Adverse Event|0|||
148746150|NCT02784795|536540675|FG010|Overall Study|Adverse Event|0|||
148746151|NCT02784795|536540676|FG011|Overall Study|Adverse Event|2|||
148746152|NCT02784795|536540665|FG000|Overall Study|Withdrawal by Subject|1|||
148746153|NCT02784795|536540666|FG001|Overall Study|Withdrawal by Subject|0|||
148746154|NCT02784795|536540667|FG002|Overall Study|Withdrawal by Subject|2|||
148746155|NCT02784795|536540668|FG003|Overall Study|Withdrawal by Subject|1|||
148746156|NCT02784795|536540669|FG004|Overall Study|Withdrawal by Subject|3|||
148746157|NCT02784795|536540670|FG005|Overall Study|Withdrawal by Subject|0|||
148746158|NCT02784795|536540671|FG006|Overall Study|Withdrawal by Subject|0|||
148746159|NCT02784795|536540672|FG007|Overall Study|Withdrawal by Subject|1|||
148746160|NCT02784795|536540673|FG008|Overall Study|Withdrawal by Subject|0|||
148746161|NCT02784795|536540674|FG009|Overall Study|Withdrawal by Subject|0|||
148746162|NCT02784795|536540675|FG010|Overall Study|Withdrawal by Subject|0|||
148746163|NCT02784795|536540676|FG011|Overall Study|Withdrawal by Subject|2|||
148746164|NCT02784795|536540665|FG000|Overall Study|Death|0|||
148746165|NCT02784795|536540666|FG001|Overall Study|Death|0|||
148746166|NCT02784795|536540667|FG002|Overall Study|Death|0|||
148746167|NCT02784795|536540668|FG003|Overall Study|Death|0|||
148746168|NCT02784795|536540669|FG004|Overall Study|Death|1|||
148746169|NCT02784795|536540670|FG005|Overall Study|Death|0|||
148746170|NCT02784795|536540671|FG006|Overall Study|Death|0|||
148746171|NCT02784795|536540672|FG007|Overall Study|Death|0|||
148746172|NCT02784795|536540673|FG008|Overall Study|Death|0|||
148746173|NCT02784795|536540674|FG009|Overall Study|Death|0|||
148746174|NCT02784795|536540675|FG010|Overall Study|Death|0|||
148746175|NCT02784795|536540676|FG011|Overall Study|Death|0|||
148746176|NCT02784795|536540665|FG000|Overall Study|Physician Decision|0|||
148746177|NCT02784795|536540666|FG001|Overall Study|Physician Decision|0|||
148746178|NCT02784795|536540667|FG002|Overall Study|Physician Decision|0|||
148746179|NCT02784795|536540668|FG003|Overall Study|Physician Decision|0|||
148746180|NCT02784795|536540669|FG004|Overall Study|Physician Decision|0|||
148746181|NCT02784795|536540670|FG005|Overall Study|Physician Decision|0|||
148746182|NCT02784795|536540671|FG006|Overall Study|Physician Decision|1|||
148746183|NCT02784795|536540672|FG007|Overall Study|Physician Decision|0|||
148746184|NCT02784795|536540673|FG008|Overall Study|Physician Decision|0|||
148746185|NCT02784795|536540674|FG009|Overall Study|Physician Decision|0|||
148746186|NCT02784795|536540675|FG010|Overall Study|Physician Decision|0|||
148746187|NCT02784795|536540676|FG011|Overall Study|Physician Decision|0|||
148746188|NCT00595309|536540679|FG000|Overall Study|Lost to Follow-up|1|||
148746189|NCT00595309|536540679|FG000|Overall Study|planned vaccination against yellow fever|1|||
148746190|NCT00595309|536540679|FG000|Overall Study|acute infection after V0|1|||
148746191|NCT00595309|536540679|FG000|Overall Study|personal reason|1|||
148746192|NCT00101283|536540680|FG000|Overall Study|Withdrawal by Subject|0|||
148746193|NCT00101283|536540681|FG001|Overall Study|Withdrawal by Subject|1|||
148746194|NCT00101283|536540680|FG000|Overall Study|Insurance Refusal|0|||
148746195|NCT00101283|536540681|FG001|Overall Study|Insurance Refusal|1|||
148746196|NCT00101283|536540680|FG000|Overall Study|Prostate Cancer Recurrence|0|||
148746197|NCT00101283|536540681|FG001|Overall Study|Prostate Cancer Recurrence|1|||
148746198|NCT02797171|536540682|FG000|Overall Study|Lost to Follow-up|2|||
148746199|NCT02797171|536540683|FG001|Overall Study|Lost to Follow-up|0|||
148746200|NCT02797171|536540684|FG002|Overall Study|Lost to Follow-up|2|||
148746201|NCT02797171|536540685|FG003|Overall Study|Lost to Follow-up|1|||
148746202|NCT02797171|536540686|FG004|Overall Study|Lost to Follow-up|2|||
148746203|NCT02797171|536540687|FG005|Overall Study|Lost to Follow-up|0|||
148746204|NCT02797171|536540682|FG000|Overall Study|Withdrawal by Subject|1|||
148746205|NCT02797171|536540683|FG001|Overall Study|Withdrawal by Subject|1|||
148746206|NCT02797171|536540684|FG002|Overall Study|Withdrawal by Subject|0|||
148746207|NCT02797171|536540685|FG003|Overall Study|Withdrawal by Subject|0|||
148746208|NCT02797171|536540686|FG004|Overall Study|Withdrawal by Subject|0|||
148746209|NCT02797171|536540687|FG005|Overall Study|Withdrawal by Subject|0|||
148746210|NCT02797171|536540682|FG000|Overall Study|Protocol Violation|1|||
148746211|NCT02797171|536540683|FG001|Overall Study|Protocol Violation|0|||
148746212|NCT02797171|536540684|FG002|Overall Study|Protocol Violation|0|||
148746213|NCT02797171|536540685|FG003|Overall Study|Protocol Violation|0|||
148820047|NCT02336503|536818162|FG003|Overall Study|Withdrawal by Subject|4|||
148746214|NCT02797171|536540686|FG004|Overall Study|Protocol Violation|0|||
148746215|NCT02797171|536540687|FG005|Overall Study|Protocol Violation|0|||
148746216|NCT02797171|536540682|FG000|Overall Study|Participant unable to adhere|0|||
148746217|NCT02797171|536540683|FG001|Overall Study|Participant unable to adhere|1|||
148746218|NCT02797171|536540684|FG002|Overall Study|Participant unable to adhere|0|||
148746219|NCT02797171|536540685|FG003|Overall Study|Participant unable to adhere|0|||
148746220|NCT02797171|536540686|FG004|Overall Study|Participant unable to adhere|0|||
148820048|NCT02336503|536818159|FG000|Overall Study|Adverse Event|0|||
148746221|NCT02797171|536540687|FG005|Overall Study|Participant unable to adhere|0|||
148746222|NCT02797171|536540682|FG000|Overall Study|Not Randomized|0|||
148746223|NCT02797171|536540683|FG001|Overall Study|Not Randomized|0|||
148746224|NCT02797171|536540684|FG002|Overall Study|Not Randomized|0|||
148746225|NCT02797171|536540685|FG003|Overall Study|Not Randomized|0|||
148746226|NCT02797171|536540686|FG004|Overall Study|Not Randomized|0|||
148746227|NCT02797171|536540687|FG005|Overall Study|Not Randomized|1|||
148746228|NCT01372748|536540690|FG000|Overall Study|Lost to Follow-up|16|||
148746229|NCT01372748|536540691|FG001|Overall Study|Lost to Follow-up|34|||
148746230|NCT01372748|536540690|FG000|Overall Study|Withdrawal by Subject|7|||
148746231|NCT01372748|536540691|FG001|Overall Study|Withdrawal by Subject|5|||
148746232|NCT00134901|536540692|FG000|Overall Study|Lost to Follow-up|5|||
148746233|NCT00134901|536540693|FG001|Overall Study|Lost to Follow-up|5|||
148746234|NCT00134901|536540692|FG000|Overall Study|discontinued intervention|12|||
148746235|NCT00134901|536540693|FG001|Overall Study|discontinued intervention|10|||
148746236|NCT00606632|536540694|FG000|Overall Study|Withdrawal by Subject|13|||
148746237|NCT00606632|536540694|FG000|Overall Study|Miscellaneous reasons|9|||
148746238|NCT03908437|536540695|FG000|Overall Study|Death|0|||
148746239|NCT03908437|536540696|FG001|Overall Study|Death|1|||
148746240|NCT03908437|536540695|FG000|Overall Study|Lost to Follow-up|31|||
148746241|NCT03908437|536540696|FG001|Overall Study|Lost to Follow-up|24|||
148746242|NCT04238650|536540697|FG000|Overall Study|Withdrawal by Subject|0|||
148746243|NCT04238650|536540698|FG001|Overall Study|Withdrawal by Subject|1|||
148746244|NCT03633825|536540699|FG000|Enrollment|Did not post on network|5066|||
148746245|NCT03633825|536540700|FG001|Enrollment|Did not post on network|5080|||
148746246|NCT03633825|536540699|FG000|Enrollment|Post not classified as crisis|13967|||
148746247|NCT03633825|536540700|FG001|Enrollment|Post not classified as crisis|13757|||
148746248|NCT03633825|536540699|FG000|Follow up|Lost to Follow-up|478|||
148746249|NCT03633825|536540700|FG001|Follow up|Lost to Follow-up|450|||
148746250|NCT02756208|536540701|FG000|Overall Study|Withdrawal by Subject|1|||
148746251|NCT02756208|536540702|FG001|Overall Study|Withdrawal by Subject|0|||
148746252|NCT02756208|536540703|FG002|Overall Study|Withdrawal by Subject|1|||
148746253|NCT02756208|536540704|FG003|Overall Study|Withdrawal by Subject|3|||
148746254|NCT02756208|536540701|FG000|Overall Study|Lost to Follow-up|3|||
148746255|NCT02756208|536540702|FG001|Overall Study|Lost to Follow-up|1|||
148746256|NCT02756208|536540703|FG002|Overall Study|Lost to Follow-up|1|||
148746257|NCT02756208|536540704|FG003|Overall Study|Lost to Follow-up|1|||
148746258|NCT02756208|536540701|FG000|Overall Study|Physician Decision|1|||
148746259|NCT02756208|536540702|FG001|Overall Study|Physician Decision|0|||
148746260|NCT02756208|536540703|FG002|Overall Study|Physician Decision|0|||
148746261|NCT02756208|536540704|FG003|Overall Study|Physician Decision|0|||
148746262|NCT02756208|536540701|FG000|Overall Study|Protocol Violation|0|||
148746263|NCT02756208|536540702|FG001|Overall Study|Protocol Violation|1|||
148746264|NCT02756208|536540703|FG002|Overall Study|Protocol Violation|0|||
148746265|NCT02756208|536540704|FG003|Overall Study|Protocol Violation|0|||
148746266|NCT02585778|536540705|FG000|Overall Study|Adverse Event|17|||
148746267|NCT02585778|536540706|FG001|Overall Study|Adverse Event|4|||
148746268|NCT02585778|536540705|FG000|Overall Study|Participant did not wish to continue|9|||
148746269|NCT02585778|536540706|FG001|Overall Study|Participant did not wish to continue|4|||
148746270|NCT02585778|536540705|FG000|Overall Study|Poor compliance to study protocol|0|||
148746271|NCT02585778|536540706|FG001|Overall Study|Poor compliance to study protocol|2|||
148746272|NCT02585778|536540705|FG000|Overall Study|Death|0|||
148746273|NCT02585778|536540706|FG001|Overall Study|Death|1|||
148746274|NCT02585778|536540705|FG000|Overall Study|Randomized but not treated|1|||
148746275|NCT02585778|536540706|FG001|Overall Study|Randomized but not treated|2|||
148746276|NCT02585778|536540705|FG000|Overall Study|Other than specified above|6|||
148746277|NCT02585778|536540706|FG001|Overall Study|Other than specified above|2|||
148746278|NCT05246670|536540707|FG000|Overall Study|Withdrawal by Subject|2|||
148746279|NCT05246670|536540708|FG001|Overall Study|Withdrawal by Subject|3|||
148746280|NCT05246670|536540709|FG002|Overall Study|Withdrawal by Subject|0|||
148746281|NCT05246670|536540710|FG003|Overall Study|Withdrawal by Subject|1|||
148746282|NCT05246670|536540707|FG000|Overall Study|Adverse Event|0|||
148746283|NCT05246670|536540708|FG001|Overall Study|Adverse Event|0|||
148746284|NCT05246670|536540709|FG002|Overall Study|Adverse Event|1|||
148746285|NCT05246670|536540710|FG003|Overall Study|Adverse Event|0|||
148746286|NCT05246670|536540707|FG000|Overall Study|Physician Decision|1|||
148746287|NCT05246670|536540708|FG001|Overall Study|Physician Decision|0|||
148746288|NCT05246670|536540709|FG002|Overall Study|Physician Decision|0|||
148746289|NCT05246670|536540710|FG003|Overall Study|Physician Decision|0|||
148746290|NCT05246670|536540707|FG000|Overall Study|Protocol Violation|1|||
148746291|NCT05246670|536540708|FG001|Overall Study|Protocol Violation|0|||
148746292|NCT05246670|536540709|FG002|Overall Study|Protocol Violation|0|||
148746293|NCT05246670|536540710|FG003|Overall Study|Protocol Violation|0|||
148746294|NCT04152291|536540711|FG000|Overall Study|Covid-19 restrictions|27|||
148746295|NCT04152291|536540711|FG000|Overall Study|Withdrawal by Subject|3|||
148746296|NCT03597295|536540712|FG000|Overall Study|Death|70|||
148746297|NCT03597295|536540712|FG000|Overall Study|Lost to Follow-up|7|||
148820049|NCT02336503|536818160|FG001|Overall Study|Adverse Event|0|||
148820050|NCT02336503|536818161|FG002|Overall Study|Adverse Event|1|||
148820051|NCT02336503|536818162|FG003|Overall Study|Adverse Event|0|||
148820052|NCT02460380|536818163|FG000|Overall Study|Withdrawal by Subject|10|||
148820053|NCT02460380|536818164|FG001|Overall Study|Withdrawal by Subject|5|||
148820054|NCT00395512|536818165|FG000|Overall Study|Adverse Event|3|||
148820055|NCT00395512|536818166|FG001|Overall Study|Adverse Event|8|||
148820056|NCT00395512|536818167|FG002|Overall Study|Adverse Event|6|||
148820057|NCT00395512|536818168|FG003|Overall Study|Adverse Event|6|||
148820058|NCT00395512|536818165|FG000|Overall Study|Protocol Violation|2|||
148820059|NCT00395512|536818166|FG001|Overall Study|Protocol Violation|3|||
148820060|NCT00395512|536818167|FG002|Overall Study|Protocol Violation|6|||
148820061|NCT00395512|536818168|FG003|Overall Study|Protocol Violation|7|||
148820062|NCT00395512|536818165|FG000|Overall Study|Lost to Follow-up|2|||
148820063|NCT00395512|536818166|FG001|Overall Study|Lost to Follow-up|6|||
148820064|NCT00395512|536818167|FG002|Overall Study|Lost to Follow-up|5|||
148820065|NCT00395512|536818168|FG003|Overall Study|Lost to Follow-up|5|||
148820066|NCT00395512|536818165|FG000|Overall Study|Withdrawal by Subject|6|||
148820067|NCT00395512|536818166|FG001|Overall Study|Withdrawal by Subject|5|||
148820068|NCT00395512|536818167|FG002|Overall Study|Withdrawal by Subject|5|||
148820069|NCT00395512|536818168|FG003|Overall Study|Withdrawal by Subject|12|||
148820070|NCT00395512|536818165|FG000|Overall Study|Physician Decision|6|||
148820071|NCT00395512|536818166|FG001|Overall Study|Physician Decision|4|||
148820072|NCT00395512|536818167|FG002|Overall Study|Physician Decision|2|||
148820073|NCT00395512|536818168|FG003|Overall Study|Physician Decision|2|||
148820074|NCT00395512|536818165|FG000|Overall Study|Other|1|||
148820075|NCT00395512|536818166|FG001|Overall Study|Other|1|||
148820076|NCT00395512|536818167|FG002|Overall Study|Other|0|||
148820077|NCT00395512|536818168|FG003|Overall Study|Other|0|||
148820078|NCT00395512|536818165|FG000|Overall Study|Hyperglycemic Rescue|18|||
148820079|NCT00395512|536818166|FG001|Overall Study|Hyperglycemic Rescue|10|||
148820080|NCT00395512|536818167|FG002|Overall Study|Hyperglycemic Rescue|4|||
148820081|NCT00395512|536818168|FG003|Overall Study|Hyperglycemic Rescue|6|||
148820082|NCT01478087|536818171|FG000|Overall Study|due to sponsor closing study|1|||
148820083|NCT05436288|536818177|FG000|Overall Study|Lost to Follow-up|1|||
148820084|NCT05436288|536818177|FG000|Overall Study|Adverse Event|1|||
148746298|NCT05124691|536540713|FG000|Phase II|Eligibility criteria|0|||
148746299|NCT05124691|536540714|FG001|Phase II|Eligibility criteria|1|||
148746300|NCT05124691|536540715|FG002|Phase II|Eligibility criteria|0|||
148746301|NCT05124691|536540713|FG000|Phase II|Withdrawal by Subject|6|||
148746302|NCT05124691|536540714|FG001|Phase II|Withdrawal by Subject|2|||
148746303|NCT05124691|536540715|FG002|Phase II|Withdrawal by Subject|3|||
148746304|NCT05124691|536540713|FG000|Phase III|Withdrawal by Subject|6|||
148746305|NCT05124691|536540714|FG001|Phase III|Withdrawal by Subject|4|||
148746306|NCT05124691|536540715|FG002|Phase III|Withdrawal by Subject|4|||
148746307|NCT05124691|536540713|FG000|Phase III|Lost to Follow-up|1|||
148746308|NCT05124691|536540714|FG001|Phase III|Lost to Follow-up|0|||
148746309|NCT05124691|536540715|FG002|Phase III|Lost to Follow-up|0|||
148746310|NCT05211726|536540716|FG000|Overall Study|Withdrawal by Subject|2|||
148746311|NCT05211726|536540717|FG001|Overall Study|Withdrawal by Subject|3|||
148746312|NCT05211726|536540716|FG000|Overall Study|Protocol Violation|0|||
148746313|NCT05211726|536540717|FG001|Overall Study|Protocol Violation|1|||
148746314|NCT03509467|536540718|FG000|Overall Study|Withdrawal by Subject|5|||
148746315|NCT03509467|536540719|FG001|Overall Study|Withdrawal by Subject|1|||
148820085|NCT01873833|536818183|FG000|Overall Study|Withdrawal by Subject|1|||
148820086|NCT04146909|536818186|FG000|Overall Study|Withdrawal by Subject|3|||
148820087|NCT04146909|536818186|FG000|Overall Study|Did not qualify after consented|1|||
148820088|NCT01860404|536818187|FG000|Overall Study|Lost to Follow-up|3|||
148820089|NCT01860404|536818188|FG001|Overall Study|Lost to Follow-up|4|||
148976077|NCT02448875|537392427|FG000|Overall Study|Investigator Decision|3|||
148976078|NCT02448875|537392428|FG001|Overall Study|Investigator Decision|0|||
148976079|NCT02448875|537392429|FG002|Overall Study|Investigator Decision|1|||
148746316|NCT03509467|536540720|FG002|Overall Study|Withdrawal by Subject|6|||
148746317|NCT03509467|536540721|FG003|Overall Study|Withdrawal by Subject|7|||
148820090|NCT01860404|536818189|FG002|Overall Study|Lost to Follow-up|1|||
148820091|NCT01860404|536818190|FG003|Overall Study|Lost to Follow-up|6|||
148820092|NCT01860404|536818191|FG004|Overall Study|Lost to Follow-up|4|||
148976080|NCT02448875|537392427|FG000|Overall Study|Withdrawal by Subject|1|||
148820093|NCT01860404|536818187|FG000|Overall Study|Withdrawal by Subject|0|||
148976081|NCT02448875|537392428|FG001|Overall Study|Withdrawal by Subject|0|||
148976082|NCT02448875|537392429|FG002|Overall Study|Withdrawal by Subject|0|||
148746318|NCT03509467|536540722|FG004|Overall Study|Withdrawal by Subject|10|||
148746319|NCT03509467|536540723|FG005|Overall Study|Withdrawal by Subject|10|||
148746320|NCT03509467|536540724|FG006|Overall Study|Withdrawal by Subject|10|||
148746321|NCT03509467|536540725|FG007|Overall Study|Withdrawal by Subject|10|||
148746322|NCT03509467|536540718|FG000|Overall Study|Death|0|||
148746323|NCT03509467|536540719|FG001|Overall Study|Death|0|||
148820094|NCT01860404|536818188|FG001|Overall Study|Withdrawal by Subject|0|||
148820095|NCT01860404|536818189|FG002|Overall Study|Withdrawal by Subject|4|||
148820096|NCT01860404|536818190|FG003|Overall Study|Withdrawal by Subject|0|||
148746324|NCT03509467|536540720|FG002|Overall Study|Death|2|||
148746325|NCT03509467|536540721|FG003|Overall Study|Death|2|||
148746326|NCT03509467|536540722|FG004|Overall Study|Death|1|||
148746327|NCT03509467|536540723|FG005|Overall Study|Death|0|||
148746328|NCT03509467|536540724|FG006|Overall Study|Death|1|||
148746329|NCT03509467|536540725|FG007|Overall Study|Death|0|||
148746330|NCT03509467|536540718|FG000|Overall Study|Proxy Withdrawal|0|||
148746331|NCT03509467|536540719|FG001|Overall Study|Proxy Withdrawal|0|||
148746332|NCT03509467|536540720|FG002|Overall Study|Proxy Withdrawal|0|||
148746333|NCT03509467|536540721|FG003|Overall Study|Proxy Withdrawal|0|||
148746334|NCT03509467|536540722|FG004|Overall Study|Proxy Withdrawal|0|||
148746335|NCT03509467|536540723|FG005|Overall Study|Proxy Withdrawal|0|||
148746336|NCT03509467|536540724|FG006|Overall Study|Proxy Withdrawal|0|||
148746337|NCT03509467|536540725|FG007|Overall Study|Proxy Withdrawal|1|||
148746338|NCT00428116|536540726|FG000|Overall Study|Death|1|||
148746339|NCT00428116|536540727|FG001|Overall Study|Death|0|||
148746340|NCT00428116|536540726|FG000|Overall Study|Withdrawal by Subject|1|||
148746341|NCT00428116|536540727|FG001|Overall Study|Withdrawal by Subject|0|||
148746342|NCT00428116|536540726|FG000|Overall Study|Lost to Follow-up|1|||
148746343|NCT00428116|536540727|FG001|Overall Study|Lost to Follow-up|0|||
148746344|NCT01141205|536540728|FG000|Overall Study|Physician Decision|1|||
148746345|NCT01141205|536540729|FG001|Overall Study|Physician Decision|1|||
148746346|NCT01141205|536540728|FG000|Overall Study|Lost to Follow-up|1|||
148746347|NCT01141205|536540729|FG001|Overall Study|Lost to Follow-up|0|||
148746348|NCT01141205|536540728|FG000|Overall Study|Withdrawal by Subject|1|||
148746349|NCT01141205|536540729|FG001|Overall Study|Withdrawal by Subject|1|||
148746350|NCT00396565|536540736|FG000|Overall Study|Physician Decision|3|||
148746351|NCT00396565|536540737|FG001|Overall Study|Physician Decision|1|||
148746352|NCT00396565|536540738|FG002|Overall Study|Physician Decision|2|||
148746353|NCT00396565|536540736|FG000|Overall Study|Adverse Event|5|||
148746354|NCT00396565|536540737|FG001|Overall Study|Adverse Event|13|||
148746355|NCT00396565|536540738|FG002|Overall Study|Adverse Event|3|||
148746356|NCT00396565|536540736|FG000|Overall Study|Withdrawal by Subject|8|||
148746357|NCT00396565|536540737|FG001|Overall Study|Withdrawal by Subject|13|||
148746358|NCT00396565|536540738|FG002|Overall Study|Withdrawal by Subject|1|||
148746359|NCT00396565|536540736|FG000|Overall Study|Lack of Efficacy|32|||
148746360|NCT00396565|536540737|FG001|Overall Study|Lack of Efficacy|64|||
148746361|NCT00396565|536540738|FG002|Overall Study|Lack of Efficacy|11|||
148746362|NCT01098487|536540739|FG000|Overall Study|Adverse Event|22|||
148746363|NCT01098487|536540739|FG000|Overall Study|Lack of Efficacy|11|||
148746364|NCT01098487|536540739|FG000|Overall Study|Withdrawal by Subject|7|||
148746365|NCT01098487|536540739|FG000|Overall Study|Lost to Follow-up|3|||
148746366|NCT01098487|536540739|FG000|Overall Study|Physician Decision|1|||
148746367|NCT00345631|536540740|FG000|Overall Study|Withdrawal by Subject|1|||
148746368|NCT00345631|536540741|FG001|Overall Study|Withdrawal by Subject|0|||
148746369|NCT00345631|536540742|FG002|Overall Study|Withdrawal by Subject|1|||
148746370|NCT00345631|536540740|FG000|Overall Study|Adverse Event|0|||
148746371|NCT00345631|536540741|FG001|Overall Study|Adverse Event|1|||
148746372|NCT00345631|536540742|FG002|Overall Study|Adverse Event|0|||
148746373|NCT00345631|536540740|FG000|Overall Study|Lost to Follow-up|3|||
148746374|NCT00345631|536540741|FG001|Overall Study|Lost to Follow-up|7|||
148746375|NCT00345631|536540742|FG002|Overall Study|Lost to Follow-up|4|||
148746376|NCT00345631|536540740|FG000|Overall Study|Other reasons|0|||
148746377|NCT00345631|536540741|FG001|Overall Study|Other reasons|0|||
148746378|NCT00345631|536540742|FG002|Overall Study|Other reasons|1|||
148746379|NCT01885195|536540745|FG000|Overall Study|Adverse Event|29|||
148746380|NCT01885195|536540745|FG000|Overall Study|Death|1|||
148746381|NCT01885195|536540745|FG000|Overall Study|Disease Progression|67|||
148746382|NCT01885195|536540745|FG000|Overall Study|Protocol Deviation|2|||
148746383|NCT01885195|536540745|FG000|Overall Study|Physician Decision|3|||
148746384|NCT01885195|536540745|FG000|Overall Study|Patient/guardian decision|8|||
148746385|NCT03390426|536540746|FG000|Overall Study|Protocol Violation|0|||
148746386|NCT03390426|536540747|FG001|Overall Study|Protocol Violation|1|||
148746387|NCT03052127|536540750|FG000|Overall Study|Withdrawal by Subject|0|||
148746388|NCT03052127|536540751|FG001|Overall Study|Withdrawal by Subject|0|||
148746389|NCT03052127|536540752|FG002|Overall Study|Withdrawal by Subject|0|||
148746390|NCT03052127|536540753|FG003|Overall Study|Withdrawal by Subject|0|||
148746391|NCT03052127|536540754|FG004|Overall Study|Withdrawal by Subject|0|||
148746392|NCT03052127|536540755|FG005|Overall Study|Withdrawal by Subject|0|||
148746393|NCT03052127|536540756|FG006|Overall Study|Withdrawal by Subject|0|||
148746394|NCT03052127|536540757|FG007|Overall Study|Withdrawal by Subject|1|||
148746395|NCT03052127|536540758|FG008|Overall Study|Withdrawal by Subject|1|||
148746396|NCT03052127|536540759|FG009|Overall Study|Withdrawal by Subject|1|||
148746397|NCT03052127|536540760|FG010|Overall Study|Withdrawal by Subject|0|||
148746398|NCT03052127|536540761|FG011|Overall Study|Withdrawal by Subject|0|||
148746399|NCT03052127|536540750|FG000|Overall Study|Discontinuation by Sponsor|0|||
148746400|NCT03052127|536540751|FG001|Overall Study|Discontinuation by Sponsor|0|||
148746401|NCT03052127|536540752|FG002|Overall Study|Discontinuation by Sponsor|0|||
148746402|NCT03052127|536540753|FG003|Overall Study|Discontinuation by Sponsor|0|||
148746403|NCT03052127|536540754|FG004|Overall Study|Discontinuation by Sponsor|0|||
148746404|NCT03052127|536540755|FG005|Overall Study|Discontinuation by Sponsor|0|||
148746405|NCT03052127|536540756|FG006|Overall Study|Discontinuation by Sponsor|0|||
148746406|NCT03052127|536540757|FG007|Overall Study|Discontinuation by Sponsor|0|||
148746407|NCT03052127|536540758|FG008|Overall Study|Discontinuation by Sponsor|4|||
148746408|NCT03052127|536540759|FG009|Overall Study|Discontinuation by Sponsor|2|||
148746409|NCT03052127|536540760|FG010|Overall Study|Discontinuation by Sponsor|5|||
148746410|NCT03052127|536540761|FG011|Overall Study|Discontinuation by Sponsor|13|||
148746411|NCT03052127|536540750|FG000|Overall Study|Inability to comply with trial requirements|0|||
148746412|NCT03052127|536540751|FG001|Overall Study|Inability to comply with trial requirements|0|||
148746413|NCT03052127|536540752|FG002|Overall Study|Inability to comply with trial requirements|1|||
148746414|NCT03052127|536540753|FG003|Overall Study|Inability to comply with trial requirements|0|||
148746415|NCT03052127|536540754|FG004|Overall Study|Inability to comply with trial requirements|0|||
148746416|NCT03052127|536540755|FG005|Overall Study|Inability to comply with trial requirements|0|||
148746417|NCT03052127|536540756|FG006|Overall Study|Inability to comply with trial requirements|0|||
148746418|NCT03052127|536540757|FG007|Overall Study|Inability to comply with trial requirements|0|||
148746419|NCT03052127|536540758|FG008|Overall Study|Inability to comply with trial requirements|0|||
148746420|NCT03052127|536540759|FG009|Overall Study|Inability to comply with trial requirements|0|||
148746421|NCT03052127|536540760|FG010|Overall Study|Inability to comply with trial requirements|0|||
148746422|NCT03052127|536540761|FG011|Overall Study|Inability to comply with trial requirements|0|||
148746423|NCT03052127|536540750|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
148746424|NCT03052127|536540751|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746425|NCT03052127|536540752|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746426|NCT03052127|536540753|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746427|NCT03052127|536540754|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
148746428|NCT03052127|536540755|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
148746429|NCT03052127|536540756|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
148746430|NCT03052127|536540757|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746431|NCT03052127|536540758|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746432|NCT03052127|536540759|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746433|NCT03052127|536540760|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746434|NCT03052127|536540761|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
148746435|NCT02521376|536540762|FG000|Overall Study|Enrolled, But Not Treated|1|||
148746436|NCT02521376|536540763|FG001|Overall Study|Enrolled, But Not Treated|0|||
148746437|NCT02521376|536540764|FG002|Overall Study|Enrolled, But Not Treated|0|||
148746438|NCT02521376|536540765|FG003|Overall Study|Enrolled, But Not Treated|0|||
148746439|NCT02759692|536540766|FG000|Period 1|Test article no longer available|1|||
148746440|NCT02759692|536540767|FG001|Period 1|Test article no longer available|1|||
148746441|NCT02759692|536540766|FG000|Period 1|No longer meets eligibility criteria.|1|||
148746442|NCT02759692|536540767|FG001|Period 1|No longer meets eligibility criteria.|0|||
148746443|NCT02759692|536540766|FG000|Period 1|Miss-Randomized|1|||
148746444|NCT02759692|536540767|FG001|Period 1|Miss-Randomized|1|||
148746445|NCT02759692|536540766|FG000|Period 2|Lost to Follow-up|1|||
148746446|NCT02759692|536540767|FG001|Period 2|Lost to Follow-up|0|||
148746447|NCT02759692|536540766|FG000|Period 2|Test article no longer available|0|||
148746448|NCT02759692|536540767|FG001|Period 2|Test article no longer available|1|||
148746449|NCT01954745|536540773|FG000|Overall Study|Radiological Progression|11|||
148746450|NCT01954745|536540773|FG000|Overall Study|Clinical Progression|5|||
148746451|NCT01954745|536540773|FG000|Overall Study|Adverse Event|2|||
148746452|NCT01954745|536540773|FG000|Overall Study|Death|1|||
148746453|NCT05292183|536542473|FG000|Overall Study|Adverse Event|1|||
148746454|NCT03922529|536542478|FG000|Overall Study|Withdrawal by Subject|13|||
148746455|NCT03922529|536542479|FG001|Overall Study|Withdrawal by Subject|12|||
148746456|NCT03922529|536542478|FG000|Overall Study|Death|7|||
148746457|NCT03922529|536542479|FG001|Overall Study|Death|12|||
148746458|NCT03922529|536542478|FG000|Overall Study|Lost to Follow-up|12|||
148746459|NCT03922529|536542479|FG001|Overall Study|Lost to Follow-up|19|||
148746460|NCT03922529|536542478|FG000|Overall Study|Adverse Event|1|||
148746461|NCT03922529|536542479|FG001|Overall Study|Adverse Event|0|||
148746462|NCT03922529|536542478|FG000|Overall Study|Death after withdrawal|1|||
148746463|NCT03922529|536542479|FG001|Overall Study|Death after withdrawal|0|||
148746464|NCT03922529|536542478|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
148746465|NCT03922529|536542479|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
148746466|NCT03922529|536542478|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
148746467|NCT03922529|536542479|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
148746468|NCT01277601|536542480|FG000|Overall Study|Adverse Event|5|||
148746469|NCT01277601|536542481|FG001|Overall Study|Adverse Event|3|||
148746470|NCT01277601|536542482|FG002|Overall Study|Adverse Event|0|||
148746471|NCT01277601|536542483|FG003|Overall Study|Adverse Event|7|||
148746472|NCT01277601|536542480|FG000|Overall Study|Withdrawal by Subject|18|||
148746473|NCT01277601|536542481|FG001|Overall Study|Withdrawal by Subject|21|||
148746474|NCT01277601|536542482|FG002|Overall Study|Withdrawal by Subject|8|||
148820097|NCT01860404|536818191|FG004|Overall Study|Withdrawal by Subject|0|||
148820098|NCT00676689|536818192|FG000|Overall Study|Screen Failure|2|||
148820099|NCT00676689|536818192|FG000|Overall Study|Death|2|||
148820100|NCT00676689|536818192|FG000|Overall Study|Lost to Follow-up|4|||
148820101|NCT00676689|536818192|FG000|Overall Study|Physician Decision|1|||
148820102|NCT00676689|536818192|FG000|Overall Study|Withdrawal by Subject|3|||
148820103|NCT00676689|536818192|FG000|Overall Study|Continuing FU|49|||
148820104|NCT00567112|536818194|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
148820105|NCT00567112|536818195|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
148820106|NCT00567112|536818196|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
148820107|NCT00567112|536818194|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
148820108|NCT00567112|536818195|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
148820109|NCT00567112|536818196|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
148820110|NCT00567112|536818194|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
148820111|NCT00567112|536818195|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
148820112|NCT00567112|536818196|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
148820113|NCT00421993|536818199|FG000|Overall Study|Withdrawal by Subject|22|||
148820114|NCT00421993|536818200|FG001|Overall Study|Withdrawal by Subject|23|||
148820115|NCT00421993|536818201|FG002|Overall Study|Withdrawal by Subject|23|||
148820116|NCT00421993|536818202|FG003|Overall Study|Withdrawal by Subject|24|||
148820117|NCT00421993|536818199|FG000|Overall Study|Lost to Follow-up|18|||
148820118|NCT00421993|536818200|FG001|Overall Study|Lost to Follow-up|19|||
148820119|NCT00421993|536818201|FG002|Overall Study|Lost to Follow-up|22|||
148820120|NCT00421993|536818202|FG003|Overall Study|Lost to Follow-up|20|||
148820121|NCT00421993|536818199|FG000|Overall Study|Adverse Event|11|||
148820122|NCT00421993|536818200|FG001|Overall Study|Adverse Event|1|||
148820123|NCT00421993|536818201|FG002|Overall Study|Adverse Event|6|||
148820124|NCT00421993|536818202|FG003|Overall Study|Adverse Event|4|||
148820125|NCT00421993|536818199|FG000|Overall Study|Protocol Violation|2|||
148820126|NCT00421993|536818200|FG001|Overall Study|Protocol Violation|2|||
148820127|NCT00421993|536818201|FG002|Overall Study|Protocol Violation|0|||
148820128|NCT00421993|536818202|FG003|Overall Study|Protocol Violation|1|||
148820129|NCT00421993|536818199|FG000|Overall Study|Lack of Efficacy|0|||
148820130|NCT00421993|536818200|FG001|Overall Study|Lack of Efficacy|3|||
148820131|NCT00421993|536818201|FG002|Overall Study|Lack of Efficacy|0|||
148820132|NCT00421993|536818202|FG003|Overall Study|Lack of Efficacy|5|||
148820133|NCT00421993|536818199|FG000|Overall Study|Pregnancy|0|||
148820134|NCT00421993|536818200|FG001|Overall Study|Pregnancy|1|||
148820135|NCT00421993|536818201|FG002|Overall Study|Pregnancy|1|||
148820136|NCT00421993|536818202|FG003|Overall Study|Pregnancy|2|||
148820137|NCT00421993|536818199|FG000|Overall Study|Subject transportation issues|0|||
148820138|NCT00421993|536818200|FG001|Overall Study|Subject transportation issues|0|||
148820139|NCT00421993|536818201|FG002|Overall Study|Subject transportation issues|0|||
148820140|NCT00421993|536818202|FG003|Overall Study|Subject transportation issues|1|||
148820141|NCT02547935|536818203|FG000|Overall Study|Other|0|||
148820142|NCT02547935|536818204|FG001|Overall Study|Other|1|||
148820143|NCT02547935|536818205|FG002|Overall Study|Other|0|||
148820144|NCT02547935|536818203|FG000|Overall Study|Withdrawal by Subject|2|||
148820145|NCT02547935|536818204|FG001|Overall Study|Withdrawal by Subject|3|||
148820146|NCT02547935|536818205|FG002|Overall Study|Withdrawal by Subject|4|||
148820147|NCT02547935|536818203|FG000|Overall Study|Screen Failure|2|||
148820148|NCT02547935|536818204|FG001|Overall Study|Screen Failure|0|||
148820149|NCT02547935|536818205|FG002|Overall Study|Screen Failure|0|||
148820150|NCT02547935|536818203|FG000|Overall Study|Physician Decision|0|||
148820151|NCT02547935|536818204|FG001|Overall Study|Physician Decision|1|||
148820152|NCT02547935|536818205|FG002|Overall Study|Physician Decision|0|||
148820153|NCT02547935|536818203|FG000|Overall Study|Lost to Follow-up|0|||
148820154|NCT02547935|536818204|FG001|Overall Study|Lost to Follow-up|2|||
148820155|NCT02547935|536818205|FG002|Overall Study|Lost to Follow-up|1|||
148820156|NCT02547935|536818203|FG000|Overall Study|Death|1|||
148820157|NCT02547935|536818204|FG001|Overall Study|Death|1|||
148820158|NCT02547935|536818205|FG002|Overall Study|Death|0|||
148820159|NCT01301092|536818206|FG000|Overall Study|Lost to Follow-up|0|||
148820160|NCT01301092|536818207|FG001|Overall Study|Lost to Follow-up|0|||
148820161|NCT01301092|536818208|FG002|Overall Study|Lost to Follow-up|1|||
148820162|NCT01350973|536818209|FG000|Overall Study|Adverse Event|4|||
149027189|NCT05174065|537576539|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
148820163|NCT01350973|536818210|FG001|Overall Study|Adverse Event|7|||
148820164|NCT01350973|536818211|FG002|Overall Study|Adverse Event|7|||
148820165|NCT01350973|536818209|FG000|Overall Study|Voluntary Withdrawal|2|||
148820166|NCT01350973|536818210|FG001|Overall Study|Voluntary Withdrawal|1|||
148820167|NCT01350973|536818211|FG002|Overall Study|Voluntary Withdrawal|1|||
148820168|NCT03738215|536818212|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
148820169|NCT03738215|536818213|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
148820170|NCT03738215|536818214|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
148820171|NCT03738215|536818212|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
148820172|NCT03738215|536818213|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
149027190|NCT05174065|537576540|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
149027191|NCT05174065|537576538|FG000|Placebo-controlled Period|Other|0|||
149027192|NCT05174065|537576539|FG001|Placebo-controlled Period|Other|1|||
149027193|NCT05174065|537576540|FG002|Placebo-controlled Period|Other|0|||
149027194|NCT05174065|537576538|FG000|Placebo-controlled Period|Adverse Event|1|||
149027195|NCT05174065|537576539|FG001|Placebo-controlled Period|Adverse Event|1|||
149027196|NCT05174065|537576540|FG002|Placebo-controlled Period|Adverse Event|0|||
149027197|NCT05174065|537576538|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
149027198|NCT05174065|537576539|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
149027199|NCT05174065|537576540|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
148746475|NCT01277601|536542483|FG003|Overall Study|Withdrawal by Subject|17|||
148746476|NCT01277601|536542480|FG000|Overall Study|Lost to Follow-up|7|||
148746477|NCT01277601|536542481|FG001|Overall Study|Lost to Follow-up|9|||
148746478|NCT01277601|536542482|FG002|Overall Study|Lost to Follow-up|4|||
148746479|NCT01277601|536542483|FG003|Overall Study|Lost to Follow-up|2|||
148746480|NCT01277601|536542480|FG000|Overall Study|Physician Decision|3|||
148746481|NCT01277601|536542481|FG001|Overall Study|Physician Decision|5|||
148746482|NCT01277601|536542482|FG002|Overall Study|Physician Decision|1|||
148746483|NCT01277601|536542483|FG003|Overall Study|Physician Decision|6|||
148746484|NCT01277601|536542480|FG000|Overall Study|Pregnancy|2|||
148746485|NCT01277601|536542481|FG001|Overall Study|Pregnancy|2|||
148746486|NCT01277601|536542482|FG002|Overall Study|Pregnancy|4|||
148746487|NCT01277601|536542483|FG003|Overall Study|Pregnancy|1|||
148746488|NCT01277601|536542480|FG000|Overall Study|Noncompliance with Study Drug|1|||
148746489|NCT01277601|536542481|FG001|Overall Study|Noncompliance with Study Drug|3|||
148746490|NCT01277601|536542482|FG002|Overall Study|Noncompliance with Study Drug|2|||
148746491|NCT01277601|536542483|FG003|Overall Study|Noncompliance with Study Drug|0|||
148746492|NCT01277601|536542480|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
148746493|NCT01277601|536542481|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
148746494|NCT01277601|536542482|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
148746495|NCT01277601|536542483|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
148746496|NCT01277601|536542480|FG000|Overall Study|Protocol Violation|0|||
148746497|NCT01277601|536542481|FG001|Overall Study|Protocol Violation|2|||
148746498|NCT01277601|536542482|FG002|Overall Study|Protocol Violation|5|||
148746499|NCT01277601|536542483|FG003|Overall Study|Protocol Violation|0|||
148746500|NCT01277601|536542480|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
148746501|NCT01277601|536542481|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
148746502|NCT01277601|536542482|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
148746503|NCT01277601|536542483|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
148746504|NCT04034927|536542484|FG000|Overall Study|Adverse Event|4|||
148746505|NCT04034927|536542485|FG001|Overall Study|Adverse Event|9|||
148746506|NCT04034927|536542484|FG000|Overall Study|Death|0|||
148746507|NCT04034927|536542485|FG001|Overall Study|Death|1|||
148746508|NCT04034927|536542484|FG000|Overall Study|Withdrawal by Subject|0|||
148746509|NCT04034927|536542485|FG001|Overall Study|Withdrawal by Subject|3|||
148746510|NCT04034927|536542484|FG000|Overall Study|Still on Treatment|2|||
148746511|NCT04034927|536542485|FG001|Overall Study|Still on Treatment|1|||
148746512|NCT04034927|536542484|FG000|Overall Study|Other|1|||
148746513|NCT04034927|536542485|FG001|Overall Study|Other|1|||
148746514|NCT02291510|536542486|FG000|Overall Study|Adverse Event|0|||
148746515|NCT02291510|536542487|FG001|Overall Study|Adverse Event|0|||
148746516|NCT02291510|536542488|FG002|Overall Study|Adverse Event|0|||
148746517|NCT02291510|536542489|FG003|Overall Study|Adverse Event|1|||
148746518|NCT04856930|536542493|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
148746519|NCT04856930|536542494|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
148746520|NCT04856930|536542495|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
148746521|NCT04856930|536542493|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
148746522|NCT04856930|536542494|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
148746523|NCT04856930|536542495|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
148746524|NCT04856930|536542493|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
148746525|NCT04856930|536542494|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
148746526|NCT04856930|536542495|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
148746527|NCT04856930|536542493|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
148746528|NCT04856930|536542494|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
148746529|NCT04856930|536542495|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
148746530|NCT04856930|536542493|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
148746531|NCT04856930|536542494|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
148746532|NCT04856930|536542495|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
148746533|NCT04856930|536542493|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
148746534|NCT04856930|536542494|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
148746535|NCT04856930|536542495|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
148746536|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
149027200|NCT05174065|537576538|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
148820173|NCT03738215|536818214|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
148820174|NCT03738215|536818212|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
148820175|NCT03738215|536818213|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
148820176|NCT03738215|536818214|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
148820177|NCT03738215|536818212|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
148820178|NCT03738215|536818213|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
148820179|NCT03738215|536818214|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
148820180|NCT03738215|536818212|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
148820181|NCT03738215|536818213|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
148820182|NCT03738215|536818214|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
148820183|NCT03738215|536818212|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
148820184|NCT03738215|536818213|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
148820185|NCT03738215|536818214|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
148820186|NCT03738215|536818212|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
148820187|NCT03738215|536818213|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
148820188|NCT03738215|536818214|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
148820189|NCT03738215|536818212|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
148820190|NCT03738215|536818213|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
148820191|NCT03738215|536818214|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
148820192|NCT03738215|536818212|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
148820193|NCT03738215|536818213|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
148820194|NCT03738215|536818214|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
148820195|NCT03738215|536818212|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
148820196|NCT03738215|536818213|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
148820197|NCT03738215|536818214|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
148820198|NCT02638493|536818215|FG000|Overall Study|Inability to provide semen samples|2|||
148820199|NCT02638493|536818216|FG001|Overall Study|Inability to provide semen samples|0|||
148820200|NCT02638493|536818217|FG002|Overall Study|Inability to provide semen samples|0|||
148820201|NCT02724644|536819979|FG000|Overall Study|Adverse Event|7|||
148820202|NCT02724644|536819980|FG001|Overall Study|Adverse Event|1|||
148820203|NCT02724644|536819979|FG000|Overall Study|Lost to Follow-up|6|||
148820204|NCT02724644|536819980|FG001|Overall Study|Lost to Follow-up|2|||
148820205|NCT02724644|536819979|FG000|Overall Study|Withdrawal by Subject|7|||
148820206|NCT02724644|536819980|FG001|Overall Study|Withdrawal by Subject|1|||
148820207|NCT02724644|536819979|FG000|Overall Study|Administrative|1|||
148820208|NCT02724644|536819980|FG001|Overall Study|Administrative|0|||
148820209|NCT04193176|536819981|FG000|Overall Study|Withdrawal by Subject|6|||
148820210|NCT04193176|536819982|FG001|Overall Study|Withdrawal by Subject|10|||
148746537|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
148746538|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
148746539|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
148746540|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
148746541|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
148746542|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
148746543|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
148746544|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
148746545|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
148746546|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
148746547|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
148746548|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
148746549|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
148746550|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
148746551|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
148746552|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
148746553|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
148746554|NCT04856930|536542493|FG000|Extension Period (16 Weeks)|Other than specified|0|||
148746555|NCT04856930|536542494|FG001|Extension Period (16 Weeks)|Other than specified|0|||
148746556|NCT04856930|536542495|FG002|Extension Period (16 Weeks)|Other than specified|1|||
148746557|NCT04856930|536542493|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
148746558|NCT04856930|536542494|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
148820211|NCT00944645|536819983|FG000|Period 2|Adverse Event|1|||
148820212|NCT00944645|536819984|FG001|Period 2|Adverse Event|0|||
148746559|NCT04856930|536542495|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
148746560|NCT04856930|536542493|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
148820213|NCT00944645|536819983|FG000|Period 2|Lost to Follow-up|0|||
148820214|NCT00944645|536819984|FG001|Period 2|Lost to Follow-up|3|||
148820215|NCT00944645|536819983|FG000|Period 2|Withdrawal by Subject|7|||
148820216|NCT00944645|536819984|FG001|Period 2|Withdrawal by Subject|6|||
148820217|NCT01245751|536819988|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
148820218|NCT01245751|536819989|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
148820219|NCT01245751|536819990|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
148820220|NCT01245751|536819991|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
148820221|NCT01245751|536819988|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
148820222|NCT01245751|536819989|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
148820223|NCT01245751|536819990|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
148820224|NCT01245751|536819991|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
148820225|NCT01245751|536819988|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
148820226|NCT01245751|536819989|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
148820227|NCT01245751|536819990|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
148820228|NCT01245751|536819991|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
148820229|NCT00289978|536819993|FG000|Overall Study|Withdrawal by Subject|31|||
148820230|NCT00289978|536819994|FG001|Overall Study|Withdrawal by Subject|17|||
148820231|NCT00289978|536819995|FG002|Overall Study|Withdrawal by Subject|28|||
148820232|NCT00289978|536819993|FG000|Overall Study|Adverse Event|22|||
148820233|NCT00289978|536819994|FG001|Overall Study|Adverse Event|13|||
148820234|NCT00289978|536819995|FG002|Overall Study|Adverse Event|18|||
148820235|NCT00289978|536819993|FG000|Overall Study|Lack of Efficacy|13|||
148820236|NCT00289978|536819994|FG001|Overall Study|Lack of Efficacy|6|||
148820237|NCT00289978|536819995|FG002|Overall Study|Lack of Efficacy|25|||
148820238|NCT00289978|536819993|FG000|Overall Study|Abnormal laboratory value(s)|20|||
148820239|NCT00289978|536819994|FG001|Overall Study|Abnormal laboratory value(s)|9|||
148820240|NCT00289978|536819995|FG002|Overall Study|Abnormal laboratory value(s)|1|||
148820241|NCT00289978|536819993|FG000|Overall Study|Lost to Follow-up|3|||
148820242|NCT00289978|536819994|FG001|Overall Study|Lost to Follow-up|5|||
148820243|NCT00289978|536819995|FG002|Overall Study|Lost to Follow-up|7|||
148820244|NCT00289978|536819993|FG000|Overall Study|Protocol Violation|5|||
148820245|NCT00289978|536819994|FG001|Overall Study|Protocol Violation|5|||
148820246|NCT00289978|536819995|FG002|Overall Study|Protocol Violation|4|||
148820247|NCT00289978|536819993|FG000|Overall Study|Abnormal test procedure result(s)|2|||
148820248|NCT00289978|536819994|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148820249|NCT00289978|536819995|FG002|Overall Study|Abnormal test procedure result(s)|1|||
148820250|NCT00289978|536819993|FG000|Overall Study|Death|1|||
148820251|NCT00289978|536819994|FG001|Overall Study|Death|0|||
148820252|NCT00289978|536819995|FG002|Overall Study|Death|2|||
148820253|NCT01058005|536819998|FG000|Overall Study|Adverse Event|0|||
148820254|NCT01058005|536819999|FG001|Overall Study|Adverse Event|2|||
148820255|NCT01058005|536820000|FG002|Overall Study|Adverse Event|1|||
148820256|NCT01058005|536819998|FG000|Overall Study|Physician Decision|2|||
148820257|NCT01058005|536819999|FG001|Overall Study|Physician Decision|2|||
148820258|NCT01058005|536820000|FG002|Overall Study|Physician Decision|0|||
148820259|NCT01058005|536819998|FG000|Overall Study|Withdrawal by Subject|4|||
148820260|NCT01058005|536819999|FG001|Overall Study|Withdrawal by Subject|5|||
148746561|NCT04856930|536542494|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
148746562|NCT04856930|536542495|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
148746563|NCT04856930|536542493|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
148746564|NCT04856930|536542494|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
148746565|NCT04856930|536542495|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
148746566|NCT04856930|536542493|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
148746567|NCT04856930|536542494|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
148746568|NCT04856930|536542495|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
148746569|NCT01009814|536542503|FG000|Overall Study|No longer met study criteria|1|||
148746570|NCT01009814|536542504|FG001|Overall Study|No longer met study criteria|1|||
148746571|NCT01009814|536542505|FG002|Overall Study|No longer met study criteria|0|||
148746572|NCT01009814|536542506|FG003|Overall Study|No longer met study criteria|0|||
148746573|NCT01009814|536542507|FG004|Overall Study|No longer met study criteria|0|||
148746574|NCT00618371|536542508|FG000|Overall Study|Withdrawal by Subject|2|||
148746575|NCT03965689|536542509|FG000|Overall Study|Too sick to get study intervention|2|||
148746576|NCT01214655|536542510|FG000|Part A|Progressive Disease|7|||
148746577|NCT01214655|536542511|FG001|Part A|Progressive Disease|0|||
148746578|NCT01214655|536542512|FG002|Part A|Progressive Disease|0|||
148746579|NCT01214655|536542510|FG000|Part A|Physician Decision|1|||
148746580|NCT01214655|536542511|FG001|Part A|Physician Decision|0|||
148746581|NCT01214655|536542512|FG002|Part A|Physician Decision|0|||
148746582|NCT01214655|536542510|FG000|Part B|Progressive disease|0|||
148820261|NCT01058005|536820000|FG002|Overall Study|Withdrawal by Subject|11|||
148820262|NCT01058005|536819998|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
148820263|NCT01058005|536819999|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
148820264|NCT01058005|536820000|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
148820265|NCT01058005|536819998|FG000|Overall Study|Reason Missing|5|||
148820266|NCT01058005|536819999|FG001|Overall Study|Reason Missing|3|||
148820267|NCT01058005|536820000|FG002|Overall Study|Reason Missing|1|||
148820268|NCT00122187|536820001|FG000|Overall Study|Withdrew because of resource limitations|2|||
148820269|NCT00122187|536820002|FG001|Overall Study|Withdrew because of resource limitations|2|||
148820270|NCT03528577|536820006|FG000|Sequence 1|Failed Spirometry|1|||
148746583|NCT01214655|536542511|FG001|Part B|Progressive disease|10|||
148746584|NCT01214655|536542512|FG002|Part B|Progressive disease|0|||
148746585|NCT01214655|536542510|FG000|Part B|Death|0|||
148820271|NCT03528577|536820006|FG000|Sequence 1|Restricted medication|1|||
148820272|NCT03528577|536820006|FG000|Sequence 2|Adverse Event|1|||
148820273|NCT03528577|536820006|FG000|Sequence 2|Withdrawal by Subject|1|||
148820274|NCT03528577|536820006|FG000|Sequence 2|Failed Spirometry|1|||
148820275|NCT03528577|536820006|FG000|Sequence 3|Failed Spirometry|1|||
148820276|NCT03528577|536820006|FG000|Sequence 4|Failed Spirometry|2|||
148820277|NCT03528577|536820006|FG000|Sequence 4|Adverse Event|1|||
148820278|NCT04882215|536820007|FG000|Overall Study|Withdrawal by Subject|5|||
148820279|NCT04882215|536820008|FG001|Overall Study|Withdrawal by Subject|0|||
148820280|NCT04098302|536820011|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
148820281|NCT04098302|536820012|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
148820282|NCT04098302|536820013|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
148820283|NCT04098302|536820014|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
148820284|NCT04098302|536820011|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
148820285|NCT04098302|536820012|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
148820286|NCT04098302|536820013|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
148820287|NCT04098302|536820014|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
148820288|NCT04098302|536820011|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
148820289|NCT04098302|536820012|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
148820290|NCT04098302|536820013|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
148820291|NCT04098302|536820014|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
148820292|NCT04098302|536820011|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
148820293|NCT04098302|536820012|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
148820294|NCT04098302|536820013|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
148820295|NCT04098302|536820014|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
148820296|NCT04098302|536820011|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
148820297|NCT04098302|536820012|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
148820298|NCT04098302|536820013|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
148820299|NCT04098302|536820014|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
148820300|NCT04098302|536820011|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
148820301|NCT04098302|536820012|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
148820302|NCT04098302|536820013|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
148820303|NCT04098302|536820014|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
148820304|NCT04098302|536820011|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
148820305|NCT04098302|536820012|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
148820306|NCT04098302|536820013|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
148820307|NCT04098302|536820014|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
148820308|NCT04098302|536820011|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
148820309|NCT04098302|536820012|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
148820310|NCT04098302|536820013|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
148820311|NCT04098302|536820014|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
148820312|NCT05061706|536820017|FG000|Overall Study|Adverse Event|29|||
148820313|NCT05061706|536820018|FG001|Overall Study|Adverse Event|1|||
148820314|NCT05061706|536820017|FG000|Overall Study|Lack of Efficacy|0|||
148820315|NCT05061706|536820018|FG001|Overall Study|Lack of Efficacy|1|||
148820316|NCT05061706|536820017|FG000|Overall Study|Lost to Follow-up|2|||
148820317|NCT05061706|536820018|FG001|Overall Study|Lost to Follow-up|2|||
148820318|NCT05061706|536820017|FG000|Overall Study|Protocol Violation|3|||
148820319|NCT05061706|536820018|FG001|Overall Study|Protocol Violation|1|||
148820320|NCT05061706|536820017|FG000|Overall Study|Withdrawal by Subject|3|||
148820321|NCT05061706|536820018|FG001|Overall Study|Withdrawal by Subject|9|||
148820322|NCT01668537|536820023|FG000|Overall Study|Request to Discontinue Prematurely|1|||
148820323|NCT01668537|536820024|FG001|Overall Study|Request to Discontinue Prematurely|1|||
148820324|NCT01668537|536820023|FG000|Overall Study|Subject unwilling/unable to comply|5|||
148820325|NCT01668537|536820024|FG001|Overall Study|Subject unwilling/unable to comply|0|||
148820326|NCT01668537|536820023|FG000|Overall Study|Reason Precludes Participation|1|||
148820327|NCT01668537|536820024|FG001|Overall Study|Reason Precludes Participation|0|||
148820328|NCT01668537|536820023|FG000|Overall Study|Lost to Follow-up|13|||
148746586|NCT01214655|536542511|FG001|Part B|Death|1|||
148746587|NCT01214655|536542512|FG002|Part B|Death|0|||
148746588|NCT01214655|536542510|FG000|Part B|Withdrawal by Subject|0|||
148746589|NCT01214655|536542511|FG001|Part B|Withdrawal by Subject|2|||
148746590|NCT01214655|536542512|FG002|Part B|Withdrawal by Subject|0|||
148746591|NCT01214655|536542510|FG000|Part C|Progressive Disease|0|||
148820329|NCT01668537|536820024|FG001|Overall Study|Lost to Follow-up|6|||
148820330|NCT01668537|536820023|FG000|Overall Study|Other|2|||
148820331|NCT01668537|536820024|FG001|Overall Study|Other|3|||
148820332|NCT01543503|536820027|FG000|Overall Study|Lost to Follow-up|32|||
148820333|NCT01543503|536820028|FG001|Overall Study|Lost to Follow-up|36|||
148820334|NCT01543503|536820027|FG000|Overall Study|Adverse Event|9|||
148820335|NCT01543503|536820028|FG001|Overall Study|Adverse Event|13|||
148820336|NCT01543503|536820027|FG000|Overall Study|Lack of Efficacy|4|||
148820337|NCT01543503|536820028|FG001|Overall Study|Lack of Efficacy|16|||
148820338|NCT01543503|536820027|FG000|Overall Study|Participant withdrew informed consent|8|||
148820339|NCT01543503|536820028|FG001|Overall Study|Participant withdrew informed consent|10|||
148820340|NCT01543503|536820027|FG000|Overall Study|Change of jobs|0|||
148820341|NCT01543503|536820028|FG001|Overall Study|Change of jobs|1|||
148820342|NCT01543503|536820027|FG000|Overall Study|Intolerance to the biologic treatment|0|||
148820343|NCT01543503|536820028|FG001|Overall Study|Intolerance to the biologic treatment|1|||
148820344|NCT01543503|536820027|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
148820345|NCT01543503|536820028|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
148820346|NCT01543503|536820027|FG000|Overall Study|Participant did not complete last visit|0|||
148820347|NCT01543503|536820028|FG001|Overall Study|Participant did not complete last visit|2|||
148820348|NCT01543503|536820027|FG000|Overall Study|Refused to continue treatment|7|||
148820349|NCT01543503|536820028|FG001|Overall Study|Refused to continue treatment|0|||
148820350|NCT01543503|536820027|FG000|Overall Study|Incorrect medication received|1|||
148820351|NCT01543503|536820028|FG001|Overall Study|Incorrect medication received|0|||
148820352|NCT01543503|536820027|FG000|Overall Study|Participant moved to another city|2|||
148820353|NCT01543503|536820028|FG001|Overall Study|Participant moved to another city|0|||
148820354|NCT01543503|536820027|FG000|Overall Study|Participant will not return for visits|0|||
148820355|NCT01543503|536820028|FG001|Overall Study|Participant will not return for visits|2|||
148820356|NCT01543503|536820027|FG000|Overall Study|Participant transferred to another city|1|||
148820357|NCT01543503|536820028|FG001|Overall Study|Participant transferred to another city|0|||
148820358|NCT01543503|536820027|FG000|Overall Study|Participant moved to Scotland|1|||
148820359|NCT01543503|536820028|FG001|Overall Study|Participant moved to Scotland|0|||
148820360|NCT01543503|536820027|FG000|Overall Study|Participant decision to stop treatment|1|||
148820361|NCT01543503|536820028|FG001|Overall Study|Participant decision to stop treatment|0|||
148820362|NCT01543503|536820027|FG000|Overall Study|Investigator did not wish to participate|1|||
148820363|NCT01543503|536820028|FG001|Overall Study|Investigator did not wish to participate|1|||
148820364|NCT01543503|536820027|FG000|Overall Study|Participant recruited after closing date|0|||
148820365|NCT01543503|536820028|FG001|Overall Study|Participant recruited after closing date|1|||
148820366|NCT01543503|536820027|FG000|Overall Study|Site stopped participation|5|||
148820367|NCT01543503|536820028|FG001|Overall Study|Site stopped participation|1|||
148820368|NCT01543503|536820027|FG000|Overall Study|Participant did not attend a visit|1|||
148820369|NCT01543503|536820028|FG001|Overall Study|Participant did not attend a visit|0|||
148820370|NCT01543503|536820027|FG000|Overall Study|Moved to other rheumatologic site|0|||
148820371|NCT01543503|536820028|FG001|Overall Study|Moved to other rheumatologic site|1|||
148820372|NCT01543503|536820027|FG000|Overall Study|Participant consented to another study|0|||
148820373|NCT01543503|536820028|FG001|Overall Study|Participant consented to another study|2|||
148746592|NCT01214655|536542511|FG001|Part C|Progressive Disease|0|||
148746593|NCT01214655|536542512|FG002|Part C|Progressive Disease|5|||
148746594|NCT01214655|536542510|FG000|Part C|Death|0|||
148746595|NCT01214655|536542511|FG001|Part C|Death|0|||
148746596|NCT01214655|536542512|FG002|Part C|Death|1|||
148746597|NCT01214655|536542510|FG000|Part C|Physician Decision|0|||
148746598|NCT01214655|536542511|FG001|Part C|Physician Decision|0|||
148746599|NCT01214655|536542512|FG002|Part C|Physician Decision|1|||
148746600|NCT01434810|536542513|FG000|Overall Study|Did not receive treatment|11|||
148746601|NCT01434810|536542514|FG001|Overall Study|Did not receive treatment|3|||
148746602|NCT01434810|536542513|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
148746603|NCT01434810|536542514|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
148746604|NCT02437903|536542515|FG000|Overall Study|Adverse Event|1|||
148746605|NCT02437903|536542515|FG000|Overall Study|Withdrawal by Subject|1|||
148746606|NCT02437903|536542515|FG000|Overall Study|Lost to Follow-up|3|||
148746607|NCT04974749|536542522|FG000|Overall Study|Withdrawal by Subject|2|||
148746608|NCT04974749|536542522|FG000|Overall Study|Gestation|1|||
148746609|NCT01121562|536542523|FG000|Overall Study|Objective progression or relapse|8|||
148746610|NCT01121562|536542523|FG000|Overall Study|Withdrawal by Subject|1|||
148746611|NCT01121562|536542523|FG000|Overall Study|Adverse Event|1|||
148746612|NCT01121562|536542523|FG000|Overall Study|Sponsor Decision|1|||
148746613|NCT01121562|536542523|FG000|Overall Study|Met study discontinuation criteria|1|||
148746614|NCT02540083|536542529|FG000|Overall Study|Withdrawal by Subject|16|||
148746615|NCT02301390|536542532|FG000|Overall Study|Withdrawal by Subject|3|||
148746616|NCT02301390|536542533|FG001|Overall Study|Withdrawal by Subject|5|||
148746617|NCT02301390|536542532|FG000|Overall Study|Protocol Violation|1|||
148746618|NCT02301390|536542533|FG001|Overall Study|Protocol Violation|0|||
148746619|NCT02301390|536542532|FG000|Overall Study|Physician Decision|1|||
148820374|NCT01543503|536820027|FG000|Overall Study|Participant went to United States|1|||
148820375|NCT01543503|536820028|FG001|Overall Study|Participant went to United States|0|||
148820376|NCT01543503|536820027|FG000|Overall Study|Screen failure|1|||
148746620|NCT02301390|536542533|FG001|Overall Study|Physician Decision|0|||
148746621|NCT02301390|536542532|FG000|Overall Study|Lost to Follow-up|0|||
148746622|NCT02301390|536542533|FG001|Overall Study|Lost to Follow-up|1|||
148820377|NCT01543503|536820028|FG001|Overall Study|Screen failure|0|||
148820378|NCT00052715|536820029|FG000|Overall Study|wrong histology|1|||
148820379|NCT01936974|536820030|FG000|Overall Study|Physician Decision|2|||
148820380|NCT01936974|536820031|FG001|Overall Study|Physician Decision|5|||
148820381|NCT04584554|536820034|FG000|Overall Study|Withdrawal by Subject|2|||
148820382|NCT04584554|536820035|FG001|Overall Study|Withdrawal by Subject|2|||
148820383|NCT03767894|536820040|FG000|Overall Study|Withdrawal by Subject|1|||
148820384|NCT02280499|536820043|FG000|Overall Study|Death|14|||
148820385|NCT02280499|536820043|FG000|Overall Study|Lost to Follow-up|42|||
148820386|NCT02280499|536820043|FG000|Overall Study|Adverse Event|5|||
148820387|NCT01436500|536820045|FG000|Overall Study|Death|1|||
148820388|NCT01436500|536820046|FG001|Overall Study|Death|0|||
148820389|NCT01436500|536820047|FG002|Overall Study|Death|0|||
148820390|NCT01436500|536820048|FG003|Overall Study|Death|0|||
148820391|NCT01436500|536820049|FG004|Overall Study|Death|0|||
148820392|NCT01436500|536820045|FG000|Overall Study|Adverse Event|0|||
148820393|NCT01436500|536820046|FG001|Overall Study|Adverse Event|2|||
148820394|NCT01436500|536820047|FG002|Overall Study|Adverse Event|2|||
148820395|NCT01436500|536820048|FG003|Overall Study|Adverse Event|0|||
148820396|NCT01436500|536820049|FG004|Overall Study|Adverse Event|1|||
148746623|NCT02301390|536542532|FG000|Overall Study|Death|2|||
148746624|NCT02301390|536542533|FG001|Overall Study|Death|2|||
148746625|NCT02301390|536542532|FG000|Overall Study|Procedure not completed|0|||
148746626|NCT02301390|536542533|FG001|Overall Study|Procedure not completed|4|||
148746627|NCT02301390|536542532|FG000|Overall Study|Missed multiple visits|1|||
148746628|NCT02301390|536542533|FG001|Overall Study|Missed multiple visits|1|||
148746629|NCT02301390|536542532|FG000|Overall Study|study terminated|2|||
148746630|NCT02301390|536542533|FG001|Overall Study|study terminated|0|||
148746631|NCT00185588|536542534|FG000|Overall Study|Adverse Event|3|||
148746632|NCT00185588|536542535|FG001|Overall Study|Adverse Event|1|||
148746633|NCT00185588|536542536|FG002|Overall Study|Adverse Event|4|||
148746634|NCT00185588|536542537|FG003|Overall Study|Adverse Event|2|||
148746635|NCT00185588|536542534|FG000|Overall Study|Lost to Follow-up|0|||
148746636|NCT00185588|536542535|FG001|Overall Study|Lost to Follow-up|0|||
148746637|NCT00185588|536542536|FG002|Overall Study|Lost to Follow-up|1|||
148746638|NCT00185588|536542537|FG003|Overall Study|Lost to Follow-up|2|||
148746639|NCT00185588|536542534|FG000|Overall Study|Withdrawal by Subject|0|||
148746640|NCT00185588|536542535|FG001|Overall Study|Withdrawal by Subject|1|||
148746641|NCT00185588|536542536|FG002|Overall Study|Withdrawal by Subject|0|||
148746642|NCT00185588|536542537|FG003|Overall Study|Withdrawal by Subject|0|||
148746643|NCT00185588|536542534|FG000|Overall Study|Physician Decision|0|||
148746644|NCT00185588|536542535|FG001|Overall Study|Physician Decision|0|||
148746645|NCT00185588|536542536|FG002|Overall Study|Physician Decision|1|||
148746646|NCT00185588|536542537|FG003|Overall Study|Physician Decision|0|||
148746647|NCT02604407|536542538|FG000|Overall Study|Adverse Event|0|||
148746648|NCT02604407|536542539|FG001|Overall Study|Adverse Event|7|||
148746649|NCT02604407|536542540|FG002|Overall Study|Adverse Event|5|||
148746650|NCT02604407|536542538|FG000|Overall Study|Protocol Violation|2|||
148746651|NCT02604407|536542539|FG001|Overall Study|Protocol Violation|0|||
148746652|NCT02604407|536542540|FG002|Overall Study|Protocol Violation|0|||
148746653|NCT02604407|536542538|FG000|Overall Study|Withdrawal by Subject|3|||
148746654|NCT02604407|536542539|FG001|Overall Study|Withdrawal by Subject|3|||
148746655|NCT02604407|536542540|FG002|Overall Study|Withdrawal by Subject|5|||
148746656|NCT02604407|536542538|FG000|Overall Study|Lost to Follow-up|2|||
148746657|NCT02604407|536542539|FG001|Overall Study|Lost to Follow-up|1|||
148746658|NCT02604407|536542540|FG002|Overall Study|Lost to Follow-up|2|||
148746659|NCT02604407|536542538|FG000|Overall Study|Lack of Efficacy|1|||
148746660|NCT02604407|536542539|FG001|Overall Study|Lack of Efficacy|0|||
148746661|NCT02604407|536542540|FG002|Overall Study|Lack of Efficacy|0|||
148746662|NCT02604407|536542538|FG000|Overall Study|Other|3|||
148820397|NCT01436500|536820045|FG000|Overall Study|Withdrawal by Subject|0|||
148820398|NCT01436500|536820046|FG001|Overall Study|Withdrawal by Subject|0|||
148820399|NCT01436500|536820047|FG002|Overall Study|Withdrawal by Subject|2|||
148820400|NCT01436500|536820048|FG003|Overall Study|Withdrawal by Subject|0|||
148820401|NCT01436500|536820049|FG004|Overall Study|Withdrawal by Subject|2|||
148746663|NCT02604407|536542539|FG001|Overall Study|Other|1|||
148746664|NCT02604407|536542540|FG002|Overall Study|Other|4|||
148746665|NCT00398866|536542541|FG000|Overall Study|Adverse Event|1|||
148820402|NCT01436500|536820045|FG000|Overall Study|Physician Decision|0|||
148820403|NCT01436500|536820046|FG001|Overall Study|Physician Decision|0|||
148746666|NCT00398866|536542542|FG001|Overall Study|Adverse Event|0|||
148746667|NCT00398866|536542543|FG002|Overall Study|Adverse Event|0|||
148820404|NCT01436500|536820047|FG002|Overall Study|Physician Decision|1|||
148820405|NCT01436500|536820048|FG003|Overall Study|Physician Decision|0|||
148820406|NCT01436500|536820049|FG004|Overall Study|Physician Decision|0|||
148820407|NCT01436500|536820045|FG000|Overall Study|liver transplant|1|||
148746668|NCT00398866|536542541|FG000|Overall Study|Lack of Efficacy|0|||
148746669|NCT00398866|536542542|FG001|Overall Study|Lack of Efficacy|0|||
148746670|NCT00398866|536542543|FG002|Overall Study|Lack of Efficacy|1|||
148746671|NCT00398866|536542541|FG000|Overall Study|Lost to Follow-up|7|||
148820408|NCT01436500|536820046|FG001|Overall Study|liver transplant|0|||
148976083|NCT01282216|537392430|FG000|Overall Study|Graft failure|0|||
148746672|NCT00398866|536542542|FG001|Overall Study|Lost to Follow-up|6|||
148746673|NCT00398866|536542543|FG002|Overall Study|Lost to Follow-up|4|||
148746674|NCT00398866|536542541|FG000|Overall Study|Withdrawal by Subject|5|||
148746675|NCT00398866|536542542|FG001|Overall Study|Withdrawal by Subject|1|||
148746676|NCT00398866|536542543|FG002|Overall Study|Withdrawal by Subject|2|||
148746677|NCT00398866|536542541|FG000|Overall Study|Unable to complete requirements of study|1|||
148746678|NCT00398866|536542542|FG001|Overall Study|Unable to complete requirements of study|1|||
148746679|NCT00398866|536542543|FG002|Overall Study|Unable to complete requirements of study|1|||
148746680|NCT02481869|536542546|FG000|Overall Study|Lost to Follow-up|3|||
148976084|NCT01282216|537392431|FG001|Overall Study|Graft failure|0|||
148746681|NCT02481869|536542547|FG001|Overall Study|Lost to Follow-up|4|||
148746682|NCT02481869|536542546|FG000|Overall Study|Withdrawal by Subject|2|||
148746683|NCT02481869|536542547|FG001|Overall Study|Withdrawal by Subject|0|||
148746684|NCT00191191|536542550|FG000|Overall Study|Entry Criteria Exclusion|2|||
148746685|NCT00191191|536542551|FG001|Overall Study|Entry Criteria Exclusion|0|||
148746686|NCT00191191|536542550|FG000|Overall Study|Treated with Another Systemic Agent|1|||
148746687|NCT00191191|536542551|FG001|Overall Study|Treated with Another Systemic Agent|1|||
148746688|NCT00191191|536542550|FG000|Overall Study|Adverse Event|11|||
148746689|NCT00191191|536542551|FG001|Overall Study|Adverse Event|21|||
148746690|NCT00191191|536542550|FG000|Overall Study|Progressive Disease|84|||
148746691|NCT00191191|536542551|FG001|Overall Study|Progressive Disease|72|||
148746692|NCT00191191|536542550|FG000|Overall Study|Toxicity After Dose Reduction|7|||
148746693|NCT00191191|536542551|FG001|Overall Study|Toxicity After Dose Reduction|8|||
148746694|NCT00191191|536542550|FG000|Overall Study|Family/Caregiver Decision|5|||
148746695|NCT00191191|536542551|FG001|Overall Study|Family/Caregiver Decision|7|||
148746696|NCT00191191|536542550|FG000|Overall Study|Lost to Follow-up|1|||
148746697|NCT00191191|536542551|FG001|Overall Study|Lost to Follow-up|0|||
148746698|NCT00191191|536542550|FG000|Overall Study|Physician Decision|3|||
148746699|NCT00191191|536542551|FG001|Overall Study|Physician Decision|2|||
148746700|NCT00191191|536542550|FG000|Overall Study|Good Clinical Practice Violation|0|||
148746701|NCT00191191|536542551|FG001|Overall Study|Good Clinical Practice Violation|1|||
148746702|NCT04289363|536542552|FG000|Overall Study|Lost to Follow-up|14|||
148746703|NCT04289363|536542553|FG001|Overall Study|Lost to Follow-up|0|||
148746704|NCT03790657|536542554|FG000|Overall Study|Adverse Event|1|||
148746705|NCT03790657|536542555|FG001|Overall Study|Adverse Event|1|||
148746706|NCT03790657|536542554|FG000|Overall Study|Withdrawal by Subject|1|||
148746707|NCT03790657|536542555|FG001|Overall Study|Withdrawal by Subject|1|||
148746708|NCT03971474|536542556|FG000|Overall Study|Adverse Event|11|||
148746709|NCT03971474|536542557|FG001|Overall Study|Adverse Event|7|||
148746710|NCT03971474|536542556|FG000|Overall Study|Refusal unrelated to adverse event|5|||
148746711|NCT03971474|536542557|FG001|Overall Study|Refusal unrelated to adverse event|1|||
148746712|NCT03971474|536542556|FG000|Overall Study|Progression/relapse|40|||
148746713|NCT03971474|536542557|FG001|Overall Study|Progression/relapse|47|||
148746714|NCT03971474|536542556|FG000|Overall Study|Death|6|||
148746715|NCT03971474|536542557|FG001|Overall Study|Death|3|||
148746716|NCT03971474|536542556|FG000|Overall Study|Other - not protocol specified|5|||
148746717|NCT03971474|536542557|FG001|Overall Study|Other - not protocol specified|4|||
148746718|NCT03971474|536542556|FG000|Overall Study|On treatment|0|||
148746719|NCT03971474|536542557|FG001|Overall Study|On treatment|7|||
148746720|NCT02370238|536542558|FG000|Overall Study|Death|42|||
148746721|NCT02370238|536542559|FG001|Overall Study|Death|35|||
148746722|NCT02370238|536542558|FG000|Overall Study|Lost to Follow-up|1|||
148746723|NCT02370238|536542559|FG001|Overall Study|Lost to Follow-up|3|||
148746724|NCT02370238|536542558|FG000|Overall Study|Withdrawal by Subject|2|||
148746725|NCT02370238|536542559|FG001|Overall Study|Withdrawal by Subject|6|||
148746726|NCT02370238|536542558|FG000|Overall Study|Other|2|||
148746727|NCT02370238|536542559|FG001|Overall Study|Other|1|||
148746728|NCT01807065|536542560|FG000|Overall Study|Receive no sip-T due to IV access|1|||
148746729|NCT01807065|536542561|FG001|Overall Study|Receive no sip-T due to IV access|1|||
148746730|NCT01153425|536542562|FG000|Overall Study|Withdrawal by Subject|3|||
148746731|NCT01153425|536542563|FG001|Overall Study|Withdrawal by Subject|3|||
148746732|NCT01482312|536542564|FG000|Period 1, 90 Minutes of Wear|Other|1|||
148746733|NCT01482312|536542565|FG001|Period 1, 90 Minutes of Wear|Other|0|||
148746734|NCT01482312|536542566|FG002|Period 1, 90 Minutes of Wear|Other|0|||
148746735|NCT01482312|536542564|FG000|Period 2, 90 Minutes of Wear|Other|1|||
148746736|NCT01482312|536542565|FG001|Period 2, 90 Minutes of Wear|Other|0|||
148746737|NCT01482312|536542566|FG002|Period 2, 90 Minutes of Wear|Other|0|||
148746738|NCT01699815|536542567|FG000|Overall Study|Protocol Violation|4|||
148746739|NCT01699815|536542568|FG001|Overall Study|Protocol Violation|7|||
148746740|NCT01699815|536542567|FG000|Overall Study|record could not be located|1|||
148976085|NCT01282216|537392432|FG002|Overall Study|Graft failure|3|||
148976086|NCT01282216|537392433|FG003|Overall Study|Graft failure|2|||
148746741|NCT01699815|536542568|FG001|Overall Study|record could not be located|0|||
148746742|NCT01699815|536542567|FG000|Overall Study|Adverse Event|0|||
148746743|NCT01699815|536542568|FG001|Overall Study|Adverse Event|1|||
148746744|NCT01295320|536542569|FG000|Overall Study|Adverse Event|2|||
148746745|NCT01295320|536542569|FG000|Overall Study|Lost to Follow-up|4|||
148746746|NCT01295320|536542569|FG000|Overall Study|Withdrawal by Subject|2|||
148746747|NCT01295320|536542569|FG000|Overall Study|Subject was bedridden|1|||
148746748|NCT01295320|536542569|FG000|Overall Study|Unable to travel|1|||
148746749|NCT04759768|536542570|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
148746750|NCT04759768|536542571|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
148746751|NCT04759768|536542570|FG000|Washout (7 Days)|Physician Decision|0|||
148746752|NCT04759768|536542571|FG001|Washout (7 Days)|Physician Decision|1|||
148746753|NCT04324021|536542575|FG000|Overall Study|Adverse Event|1|||
148746754|NCT04324021|536542576|FG001|Overall Study|Adverse Event|0|||
148746755|NCT04324021|536542577|FG002|Overall Study|Adverse Event|0|||
148746756|NCT04324021|536542575|FG000|Overall Study|Lack of Efficacy|0|||
148746757|NCT04324021|536542576|FG001|Overall Study|Lack of Efficacy|0|||
148746758|NCT04324021|536542577|FG002|Overall Study|Lack of Efficacy|1|||
148746759|NCT04324021|536542575|FG000|Overall Study|Death|1|||
148746760|NCT04324021|536542576|FG001|Overall Study|Death|1|||
148746761|NCT04324021|536542577|FG002|Overall Study|Death|0|||
148746762|NCT02006732|536542578|FG000|Overall Study|Adverse Event|10|||
148746763|NCT02006732|536542579|FG001|Overall Study|Adverse Event|7|||
148746764|NCT02006732|536542580|FG002|Overall Study|Adverse Event|4|||
148746765|NCT02006732|536542581|FG003|Overall Study|Adverse Event|2|||
148746766|NCT02006732|536542578|FG000|Overall Study|Lack of Efficacy|6|||
148746767|NCT02006732|536542579|FG001|Overall Study|Lack of Efficacy|3|||
148746768|NCT02006732|536542580|FG002|Overall Study|Lack of Efficacy|1|||
148746769|NCT02006732|536542581|FG003|Overall Study|Lack of Efficacy|1|||
148746770|NCT02006732|536542578|FG000|Overall Study|Protocol Violation|1|||
148746771|NCT02006732|536542579|FG001|Overall Study|Protocol Violation|1|||
148746772|NCT02006732|536542580|FG002|Overall Study|Protocol Violation|0|||
148746773|NCT02006732|536542581|FG003|Overall Study|Protocol Violation|0|||
148746774|NCT02006732|536542578|FG000|Overall Study|Lost to Follow-up|0|||
148746775|NCT02006732|536542579|FG001|Overall Study|Lost to Follow-up|1|||
148746776|NCT02006732|536542580|FG002|Overall Study|Lost to Follow-up|0|||
148746777|NCT02006732|536542581|FG003|Overall Study|Lost to Follow-up|0|||
148746778|NCT02006732|536542578|FG000|Overall Study|Withdrawal by Subject|3|||
148746779|NCT02006732|536542579|FG001|Overall Study|Withdrawal by Subject|0|||
148746780|NCT02006732|536542580|FG002|Overall Study|Withdrawal by Subject|4|||
148746781|NCT02006732|536542581|FG003|Overall Study|Withdrawal by Subject|1|||
148746782|NCT03516513|536542584|FG000|Overall Study|Withdrawal by Subject|2|||
148746783|NCT03516513|536542585|FG001|Overall Study|Withdrawal by Subject|2|||
148746784|NCT03516513|536542586|FG002|Overall Study|Withdrawal by Subject|0|||
148746785|NCT03516513|536542587|FG003|Overall Study|Withdrawal by Subject|0|||
148746786|NCT01130597|536542593|FG000|Overall Study|Protocol-specified (High K+)|1|||
148746787|NCT01130597|536542593|FG000|Overall Study|Adverse Event|4|||
148746788|NCT01130597|536542593|FG000|Overall Study|Death|1|||
148746789|NCT01130597|536542593|FG000|Overall Study|Protocol Violation|1|||
148746790|NCT03371459|536542594|FG000|Washout|Lost to Follow-up|0|||
148746791|NCT03371459|536542595|FG001|Washout|Lost to Follow-up|1|||
148746792|NCT01589497|536542596|FG000|Overall Study|Withdrawal by Subject|0|||
148746793|NCT01589497|536542597|FG001|Overall Study|Withdrawal by Subject|1|||
148746794|NCT01589497|536542598|FG002|Overall Study|Withdrawal by Subject|0|||
148746795|NCT01589497|536542599|FG003|Overall Study|Withdrawal by Subject|1|||
148746796|NCT01589497|536542596|FG000|Overall Study|Death|1|||
148746797|NCT01589497|536542597|FG001|Overall Study|Death|0|||
148746798|NCT01589497|536542598|FG002|Overall Study|Death|0|||
148746799|NCT01589497|536542599|FG003|Overall Study|Death|0|||
148746800|NCT01589497|536542596|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
148746801|NCT01589497|536542597|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
148746802|NCT01589497|536542598|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
148746803|NCT01589497|536542599|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
148746804|NCT03694327|536542602|FG000|Overall Study|Lost to Follow-up|13|||
148746805|NCT03694327|536542603|FG001|Overall Study|Lost to Follow-up|23|||
148746806|NCT01496976|536544239|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
148746807|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
148746808|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
148746809|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
148746810|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
148746811|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
148746812|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
148746813|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
148746814|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
148746815|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
148746816|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
148746817|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
148976087|NCT01282216|537392430|FG000|Overall Study|Physician Decision|0|||
148746818|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
148746819|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
148746820|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
148820409|NCT01436500|536820047|FG002|Overall Study|liver transplant|0|||
148820410|NCT01436500|536820048|FG003|Overall Study|liver transplant|0|||
148820411|NCT01436500|536820049|FG004|Overall Study|liver transplant|0|||
148820412|NCT01436500|536820045|FG000|Overall Study|initiation of dialysis|0|||
148820413|NCT01436500|536820046|FG001|Overall Study|initiation of dialysis|0|||
148820414|NCT01436500|536820047|FG002|Overall Study|initiation of dialysis|0|||
148820415|NCT01436500|536820048|FG003|Overall Study|initiation of dialysis|0|||
148820416|NCT01436500|536820049|FG004|Overall Study|initiation of dialysis|1|||
148820417|NCT01436500|536820045|FG000|Overall Study|discontinued study drug|1|||
148820418|NCT01436500|536820046|FG001|Overall Study|discontinued study drug|0|||
148820419|NCT01436500|536820047|FG002|Overall Study|discontinued study drug|0|||
148820420|NCT01436500|536820048|FG003|Overall Study|discontinued study drug|0|||
148820421|NCT01436500|536820049|FG004|Overall Study|discontinued study drug|0|||
148820422|NCT01436500|536820045|FG000|Overall Study|Other|0|||
148820423|NCT01436500|536820046|FG001|Overall Study|Other|1|||
148820424|NCT01436500|536820047|FG002|Overall Study|Other|0|||
148820425|NCT01436500|536820048|FG003|Overall Study|Other|1|||
148820426|NCT01436500|536820049|FG004|Overall Study|Other|0|||
148820427|NCT04560309|536820058|FG000|Overall Study|Meet drop out criteria|1|||
148820428|NCT04560309|536820059|FG001|Overall Study|Meet drop out criteria|1|||
148820429|NCT05085405|536820060|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
148820430|NCT05085405|536820061|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
148820431|NCT05085405|536820062|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
148820432|NCT05085405|536820063|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
148820433|NCT05085405|536820064|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
148820434|NCT05085405|536820065|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
148820435|NCT05085405|536820060|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
148820436|NCT05085405|536820061|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
148820437|NCT05085405|536820062|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
148820438|NCT05085405|536820063|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
148820439|NCT05085405|536820064|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
148820440|NCT05085405|536820065|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
148820441|NCT03808909|536820068|FG000|Overall Study|Lost to Follow-up|3|||
148820442|NCT03808909|536820069|FG001|Overall Study|Lost to Follow-up|0|||
148820443|NCT01827943|536820070|FG000|Overall Study|Protocol Violation|8|||
148820444|NCT01827943|536820070|FG000|Overall Study|Never treated because of an rapid progression|1|||
148820445|NCT00501085|536820071|FG000|Overall Study|Lost to Follow-up|195|||
148820446|NCT00501085|536820071|FG000|Overall Study|Withdrawal by Subject|34|||
148820447|NCT00501085|536820071|FG000|Overall Study|Subject Decision|1|||
148820448|NCT00501085|536820071|FG000|Overall Study|Revision Surgery|7|||
148820449|NCT00501085|536820071|FG000|Overall Study|Explantation Surgery|26|||
148820450|NCT00501085|536820071|FG000|Overall Study|Adverse Event|4|||
148820451|NCT00501085|536820071|FG000|Overall Study|Non-Compliance|24|||
148820452|NCT00501085|536820071|FG000|Overall Study|Study closed by sponsor|109|||
148820453|NCT00501085|536820071|FG000|Overall Study|Other loss to follow-up|32|||
148820454|NCT01487161|536820072|FG000|Overall Study|Adverse Event|1|||
148820455|NCT01487161|536820073|FG001|Overall Study|Adverse Event|0|||
148820456|NCT01487161|536820074|FG002|Overall Study|Adverse Event|0|||
148820457|NCT01487161|536820075|FG003|Overall Study|Adverse Event|0|||
148820458|NCT01487161|536820072|FG000|Overall Study|Withdrawal by Subject|1|||
148820459|NCT01487161|536820073|FG001|Overall Study|Withdrawal by Subject|1|||
148820460|NCT01487161|536820074|FG002|Overall Study|Withdrawal by Subject|1|||
148820461|NCT01487161|536820075|FG003|Overall Study|Withdrawal by Subject|2|||
148820462|NCT01487161|536820072|FG000|Overall Study|missing data|0|||
148820463|NCT01487161|536820073|FG001|Overall Study|missing data|1|||
148820464|NCT01487161|536820074|FG002|Overall Study|missing data|0|||
148820465|NCT01487161|536820075|FG003|Overall Study|missing data|0|||
148820466|NCT00663351|536820076|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
148820467|NCT00663351|536820077|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
148820468|NCT00663351|536820076|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
148820469|NCT00663351|536820077|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
148820470|NCT00663351|536820076|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
148820471|NCT00663351|536820077|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
148820472|NCT00663351|536820076|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
148820473|NCT00663351|536820077|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
148820474|NCT00663351|536820076|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
148820475|NCT00663351|536820077|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
148820476|NCT00663351|536820076|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
148820477|NCT00663351|536820077|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
148820478|NCT03113136|536820078|FG000|Overall Study|Lost to Follow-up|22|||
148820479|NCT03113136|536820079|FG001|Overall Study|Lost to Follow-up|47|||
148820480|NCT03113136|536820080|FG002|Overall Study|Lost to Follow-up|54|||
148746821|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
148746822|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
148746823|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
148746824|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
148746825|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
148746826|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
148746827|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
148746828|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
148746829|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
148746830|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
148746831|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
148746832|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
148746833|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
148746834|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
148746835|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
148746836|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
148746837|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
148746838|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
148746839|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
148746840|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
148746841|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
148746842|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
148746843|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
148746844|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
148746845|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
148746846|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
148746847|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
148746848|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
148746849|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
148746850|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
148746851|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
148746852|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
148746853|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746854|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746855|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746856|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746857|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746858|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746859|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746860|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
148746861|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746862|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
148746863|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746864|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746865|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746866|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746867|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746868|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746869|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746870|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746871|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746872|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
148746873|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746874|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746875|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746876|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746877|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746878|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
148746879|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
148746880|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746881|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746882|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746883|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148820481|NCT03113136|536820078|FG000|Overall Study|Withdrawal by Subject|4|||
148746884|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746885|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746886|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746887|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
148746888|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
148746889|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746890|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746891|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746892|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746893|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746894|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746895|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746896|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
148746897|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
148746898|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746899|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746900|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746901|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746902|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746903|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746904|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746905|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
148746906|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746907|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
148746908|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
148746909|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746910|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746911|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746912|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746913|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746914|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
148746915|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
148746916|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
148746917|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746918|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746919|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746920|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746921|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746922|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746923|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
148746924|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746925|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
148746926|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746927|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746928|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746929|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746930|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746931|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746932|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
148746933|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746934|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
148746935|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746936|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746937|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746938|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746939|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746940|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746941|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
148746942|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746943|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148820482|NCT03113136|536820079|FG001|Overall Study|Withdrawal by Subject|13|||
148820483|NCT03113136|536820080|FG002|Overall Study|Withdrawal by Subject|14|||
148820484|NCT03113136|536820078|FG000|Overall Study|Ineligible|0|||
148820485|NCT03113136|536820079|FG001|Overall Study|Ineligible|2|||
148820486|NCT03113136|536820080|FG002|Overall Study|Ineligible|1|||
148820487|NCT03113136|536820078|FG000|Overall Study|Study Team Decision|1|||
148820488|NCT03113136|536820079|FG001|Overall Study|Study Team Decision|4|||
148820489|NCT03113136|536820080|FG002|Overall Study|Study Team Decision|0|||
148820490|NCT04689009|536820085|FG000|Overall Study|Adverse Event|1|||
148820491|NCT04689009|536820086|FG001|Overall Study|Adverse Event|0|||
148820492|NCT04689009|536820085|FG000|Overall Study|Lost to Follow-up|1|||
148820493|NCT04689009|536820086|FG001|Overall Study|Lost to Follow-up|2|||
148820494|NCT04689009|536820085|FG000|Overall Study|Withdrawal by Subject|4|||
148820495|NCT04689009|536820086|FG001|Overall Study|Withdrawal by Subject|3|||
148820496|NCT04689009|536820085|FG000|Overall Study|Protocol Violation|1|||
148820497|NCT04689009|536820086|FG001|Overall Study|Protocol Violation|0|||
148820498|NCT02362412|536820087|FG000|Treatment Period III|Lost to Follow-up|0|||
148820499|NCT02362412|536820088|FG001|Treatment Period III|Lost to Follow-up|1|||
148820500|NCT00977561|536820091|FG000|Overall Study|Death|3|||
148820501|NCT00977561|536820092|FG001|Overall Study|Death|2|||
148820502|NCT00977561|536820091|FG000|Overall Study|Study terminated|0|||
148820503|NCT00977561|536820092|FG001|Overall Study|Study terminated|2|||
148820504|NCT00977561|536820091|FG000|Overall Study|Other|2|||
148820505|NCT00977561|536820092|FG001|Overall Study|Other|0|||
148820506|NCT02187055|536820093|FG000|Overall Study|Lack of Efficacy|10|||
148820507|NCT02187055|536820094|FG001|Overall Study|Lack of Efficacy|3|||
148820508|NCT02187055|536820095|FG002|Overall Study|Lack of Efficacy|7|||
148820509|NCT02187055|536820093|FG000|Overall Study|Lost to Follow-up|2|||
148746944|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
148746945|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746946|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746947|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746948|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746949|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746950|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
148746951|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746952|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746953|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
148746954|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746955|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148820510|NCT02187055|536820094|FG001|Overall Study|Lost to Follow-up|7|||
148820511|NCT02187055|536820095|FG002|Overall Study|Lost to Follow-up|3|||
148820512|NCT02187055|536820093|FG000|Overall Study|No longer meets eligibility criteria|0|||
148820513|NCT02187055|536820094|FG001|Overall Study|No longer meets eligibility criteria|2|||
148820514|NCT02187055|536820095|FG002|Overall Study|No longer meets eligibility criteria|0|||
148820515|NCT02187055|536820093|FG000|Overall Study|No longer willing to participate|6|||
148820516|NCT02187055|536820094|FG001|Overall Study|No longer willing to participate|8|||
148820517|NCT02187055|536820095|FG002|Overall Study|No longer willing to participate|10|||
148820518|NCT02187055|536820093|FG000|Overall Study|Other|5|||
148820519|NCT02187055|536820094|FG001|Overall Study|Other|6|||
148820520|NCT02187055|536820095|FG002|Overall Study|Other|3|||
148820521|NCT02187055|536820093|FG000|Overall Study|Protocol Violation|9|||
148820522|NCT02187055|536820094|FG001|Overall Study|Protocol Violation|9|||
148820523|NCT02187055|536820095|FG002|Overall Study|Protocol Violation|4|||
148820524|NCT02187055|536820093|FG000|Overall Study|Pregnancy|3|||
148820525|NCT02187055|536820094|FG001|Overall Study|Pregnancy|1|||
148820526|NCT02187055|536820095|FG002|Overall Study|Pregnancy|0|||
148820527|NCT02187055|536820093|FG000|Overall Study|Withdrawal by Subject|11|||
148820528|NCT02187055|536820094|FG001|Overall Study|Withdrawal by Subject|11|||
148820529|NCT02187055|536820095|FG002|Overall Study|Withdrawal by Subject|11|||
148820530|NCT02187055|536820093|FG000|Overall Study|Adverse Event|21|||
148820531|NCT02187055|536820094|FG001|Overall Study|Adverse Event|26|||
148820532|NCT02187055|536820095|FG002|Overall Study|Adverse Event|36|||
148820533|NCT02187055|536820093|FG000|Overall Study|Death|2|||
148820534|NCT02187055|536820094|FG001|Overall Study|Death|0|||
148820535|NCT02187055|536820095|FG002|Overall Study|Death|0|||
148820536|NCT01666314|536820098|FG000|Overall Study|Adverse Event|3|||
148820537|NCT01666314|536820099|FG001|Overall Study|Adverse Event|13|||
148820538|NCT01666314|536820100|FG002|Overall Study|Adverse Event|7|||
148820539|NCT01666314|536820101|FG003|Overall Study|Adverse Event|7|||
148976088|NCT01282216|537392431|FG001|Overall Study|Physician Decision|0|||
148976089|NCT01282216|537392432|FG002|Overall Study|Physician Decision|11|||
148820540|NCT01666314|536820098|FG000|Overall Study|Progressive Disease|11|||
148820541|NCT01666314|536820099|FG001|Overall Study|Progressive Disease|9|||
148820542|NCT01666314|536820100|FG002|Overall Study|Progressive Disease|19|||
148820543|NCT01666314|536820101|FG003|Overall Study|Progressive Disease|20|||
148820544|NCT01666314|536820098|FG000|Overall Study|Symptomatic Deterioration|1|||
148746956|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746957|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746958|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746959|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
148746960|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746961|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746962|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
148746963|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746964|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746965|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746966|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746967|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746968|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
148746969|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746970|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746971|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746972|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746973|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746974|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746975|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
148746976|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746977|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
148746978|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
148746979|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
148746980|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746981|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746982|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746983|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746984|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746985|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746986|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
148746987|NCT03598790|536544240|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746988|NCT03598790|536544241|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746989|NCT03598790|536544242|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
148746990|NCT03598790|536544243|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746991|NCT03598790|536544244|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746992|NCT03598790|536544245|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746993|NCT03598790|536544246|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746994|NCT03598790|536544247|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746995|NCT03598790|536544248|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
148746996|NCT03598790|536544240|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
148746997|NCT03598790|536544241|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
148746998|NCT03598790|536544242|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
148746999|NCT03598790|536544243|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
148747000|NCT03598790|536544244|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
148747001|NCT03598790|536544245|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
148747002|NCT03598790|536544246|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
148747003|NCT03598790|536544247|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
148747004|NCT03598790|536544248|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
148747005|NCT03598790|536544240|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747006|NCT03598790|536544241|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747007|NCT03598790|536544242|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747008|NCT03598790|536544243|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
148747009|NCT03598790|536544244|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747010|NCT03598790|536544245|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747011|NCT03598790|536544246|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747012|NCT03598790|536544247|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747013|NCT03598790|536544248|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
148747014|NCT03598790|536544240|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747015|NCT03598790|536544241|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747016|NCT03598790|536544242|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747017|NCT03598790|536544243|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
148747018|NCT03598790|536544244|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747019|NCT03598790|536544245|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747020|NCT03598790|536544246|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747021|NCT03598790|536544247|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747022|NCT03598790|536544248|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
148747023|NCT03598790|536544240|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747024|NCT03598790|536544241|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747025|NCT03598790|536544242|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747026|NCT03598790|536544243|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
148747027|NCT03598790|536544244|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
148747028|NCT03598790|536544245|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747029|NCT03598790|536544246|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747030|NCT03598790|536544247|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747031|NCT03598790|536544248|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
148747032|NCT03598790|536544240|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747033|NCT03598790|536544241|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747034|NCT03598790|536544242|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747035|NCT03598790|536544243|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
148747036|NCT03598790|536544244|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747037|NCT03598790|536544245|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747038|NCT03598790|536544246|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747039|NCT03598790|536544247|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747040|NCT03598790|536544248|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
148747041|NCT05929651|536544254|FG000|Overall Study|Protocol Deviation|1|||
148747042|NCT05929651|536544254|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
148747043|NCT02731638|536544255|FG000|Overall Study|Lost to Follow-up|6|||
148747044|NCT02731638|536544256|FG001|Overall Study|Lost to Follow-up|9|||
148747045|NCT04158245|536544257|FG000|Overall Study|Lost to Follow-up|1|||
148747046|NCT02454608|536544258|FG000|Double-Blind Period|Lack of Efficacy|0|||
148747047|NCT02454608|536544259|FG001|Double-Blind Period|Lack of Efficacy|2|||
148747048|NCT02454608|536544260|FG002|Double-Blind Period|Lack of Efficacy|0|||
148747049|NCT02454608|536544258|FG000|Open Label Period|Lost to Follow-up|0|||
148747050|NCT02454608|536544259|FG001|Open Label Period|Lost to Follow-up|0|||
148747051|NCT02454608|536544260|FG002|Open Label Period|Lost to Follow-up|11|||
148747052|NCT02454608|536544258|FG000|Open Label Period|Withdrawal by Subject|0|||
148747053|NCT02454608|536544259|FG001|Open Label Period|Withdrawal by Subject|0|||
148747054|NCT02454608|536544260|FG002|Open Label Period|Withdrawal by Subject|8|||
148747055|NCT01433055|536544265|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
148747056|NCT01433055|536544266|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
148747057|NCT01433055|536544265|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
148747058|NCT01433055|536544266|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
148747059|NCT00678210|536544267|FG000|Overall Study|Adverse Event|1|||
148747060|NCT00678210|536544268|FG001|Overall Study|Adverse Event|2|||
148747061|NCT00678210|536544269|FG002|Overall Study|Adverse Event|3|||
148747062|NCT00678210|536544270|FG003|Overall Study|Adverse Event|3|||
148747063|NCT00678210|536544267|FG000|Overall Study|Lack of Efficacy|2|||
148747064|NCT00678210|536544268|FG001|Overall Study|Lack of Efficacy|3|||
148747065|NCT00678210|536544269|FG002|Overall Study|Lack of Efficacy|1|||
148747066|NCT00678210|536544270|FG003|Overall Study|Lack of Efficacy|9|||
148747067|NCT00678210|536544267|FG000|Overall Study|Lost to Follow-up|4|||
148747068|NCT00678210|536544268|FG001|Overall Study|Lost to Follow-up|2|||
148747069|NCT00678210|536544269|FG002|Overall Study|Lost to Follow-up|0|||
148747070|NCT00678210|536544270|FG003|Overall Study|Lost to Follow-up|1|||
148747071|NCT00678210|536544267|FG000|Overall Study|Withdrawal by Subject|3|||
148747072|NCT00678210|536544268|FG001|Overall Study|Withdrawal by Subject|4|||
148747073|NCT00678210|536544269|FG002|Overall Study|Withdrawal by Subject|1|||
148747074|NCT00678210|536544270|FG003|Overall Study|Withdrawal by Subject|7|||
148747075|NCT00678210|536544267|FG000|Overall Study|Other|1|||
148747076|NCT00678210|536544268|FG001|Overall Study|Other|0|||
148747077|NCT00678210|536544269|FG002|Overall Study|Other|1|||
148747078|NCT00678210|536544270|FG003|Overall Study|Other|0|||
148747079|NCT04825912|536544271|FG000|Overall Study|Death|3|||
148747080|NCT04825912|536544271|FG000|Overall Study|Withdrawal by Subject|1|||
148747081|NCT02090725|536544272|FG000|Overall Study|Withdrawal by Subject|1|||
148747082|NCT02090725|536544272|FG000|Overall Study|participants moved from area|3|||
148747083|NCT05256134|536544276|FG000|Overall Study|Study Terminated by Sponsor|11|||
148820545|NCT01666314|536820099|FG001|Overall Study|Symptomatic Deterioration|0|||
148820546|NCT01666314|536820100|FG002|Overall Study|Symptomatic Deterioration|2|||
148820547|NCT01666314|536820101|FG003|Overall Study|Symptomatic Deterioration|0|||
148820548|NCT01666314|536820098|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
148820549|NCT01666314|536820099|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
148820550|NCT01666314|536820100|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
148820551|NCT01666314|536820101|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
148820552|NCT01666314|536820098|FG000|Overall Study|Withdrawal by Subject|1|||
148820553|NCT01666314|536820099|FG001|Overall Study|Withdrawal by Subject|1|||
148820554|NCT01666314|536820100|FG002|Overall Study|Withdrawal by Subject|2|||
148820555|NCT01666314|536820101|FG003|Overall Study|Withdrawal by Subject|3|||
148820556|NCT01666314|536820098|FG000|Overall Study|Reason not Specified|10|||
148820557|NCT01666314|536820099|FG001|Overall Study|Reason not Specified|7|||
148820558|NCT01666314|536820100|FG002|Overall Study|Reason not Specified|5|||
148820559|NCT01666314|536820101|FG003|Overall Study|Reason not Specified|5|||
148820560|NCT03462563|536820104|FG000|Overall Study|Death|1|||
148820561|NCT03462563|536820105|FG001|Overall Study|Death|1|||
148820562|NCT03462563|536820104|FG000|Overall Study|Termination of study|2|||
148820563|NCT03462563|536820105|FG001|Overall Study|Termination of study|1|||
148820564|NCT03462563|536820104|FG000|Overall Study|Adverse Event|1|||
148820565|NCT03462563|536820105|FG001|Overall Study|Adverse Event|3|||
148820566|NCT03462563|536820104|FG000|Overall Study|Unspecified reason|10|||
148820567|NCT03462563|536820105|FG001|Overall Study|Unspecified reason|12|||
148820568|NCT03462563|536820104|FG000|Overall Study|Physician Decision|1|||
148820569|NCT03462563|536820105|FG001|Overall Study|Physician Decision|0|||
148820570|NCT05737745|536820106|FG000|Overall Study|Withdrawal by Subject|0|||
148820571|NCT05737745|536820107|FG001|Overall Study|Withdrawal by Subject|6|||
148820572|NCT05737745|536820108|FG002|Overall Study|Withdrawal by Subject|1|||
148820573|NCT02021318|536820109|FG000|Overall Study|Adverse Event|2|||
148820574|NCT02021318|536820110|FG001|Overall Study|Adverse Event|1|||
148820575|NCT02021318|536820109|FG000|Overall Study|Death|33|||
148820576|NCT02021318|536820110|FG001|Overall Study|Death|34|||
148820577|NCT02021318|536820109|FG000|Overall Study|Lost to Follow-up|3|||
148820578|NCT02021318|536820110|FG001|Overall Study|Lost to Follow-up|3|||
148820579|NCT02021318|536820109|FG000|Overall Study|Progressive Disease|0|||
148820580|NCT02021318|536820110|FG001|Overall Study|Progressive Disease|1|||
148820581|NCT02021318|536820109|FG000|Overall Study|Withdrawal by Subject|30|||
148820582|NCT02021318|536820110|FG001|Overall Study|Withdrawal by Subject|18|||
148820583|NCT02021318|536820109|FG000|Overall Study|Physician Decision|3|||
148820584|NCT02021318|536820110|FG001|Overall Study|Physician Decision|3|||
148820585|NCT02021318|536820109|FG000|Overall Study|Miscellaneous|2|||
148820586|NCT02021318|536820110|FG001|Overall Study|Miscellaneous|3|||
148820587|NCT02569242|536820111|FG000|Overall Study|Death|1|||
148820588|NCT02569242|536820112|FG001|Overall Study|Death|0|||
148820589|NCT02569242|536820111|FG000|Overall Study|Withdrawal by Subject|0|||
148820590|NCT02569242|536820112|FG001|Overall Study|Withdrawal by Subject|1|||
148820591|NCT00689052|536820113|FG000|Overall Study|Adverse Event|4|||
148820592|NCT00689052|536820114|FG001|Overall Study|Adverse Event|6|||
148820593|NCT00689052|536820113|FG000|Overall Study|Protocol Violation|1|||
148820594|NCT00689052|536820114|FG001|Overall Study|Protocol Violation|0|||
148820595|NCT00689052|536820113|FG000|Overall Study|Lost to Follow-up|2|||
148820596|NCT00689052|536820114|FG001|Overall Study|Lost to Follow-up|0|||
148820597|NCT00689052|536820113|FG000|Overall Study|Withdrawal by Subject|2|||
148820598|NCT00689052|536820114|FG001|Overall Study|Withdrawal by Subject|0|||
148820599|NCT00689052|536820113|FG000|Overall Study|Early termination of the trial|22|||
148820600|NCT00689052|536820114|FG001|Overall Study|Early termination of the trial|24|||
148820601|NCT04796207|536820117|FG000|Overall Study|Lost to Follow-up|7|||
148820602|NCT04796207|536820118|FG001|Overall Study|Lost to Follow-up|2|||
148820603|NCT03003468|536820119|FG000|Overall Study|Withdrawal by Subject|0|||
148820604|NCT03003468|536820120|FG001|Overall Study|Withdrawal by Subject|0|||
148820605|NCT03003468|536820121|FG002|Overall Study|Withdrawal by Subject|1|||
148820606|NCT03003468|536820119|FG000|Overall Study|No measurable lesions|0|||
148820607|NCT03003468|536820120|FG001|Overall Study|No measurable lesions|0|||
148820608|NCT03003468|536820121|FG002|Overall Study|No measurable lesions|1|||
148820609|NCT02405962|536820122|FG000|Overall Study|Lost to Follow-up|1|||
148820610|NCT02405962|536820123|FG001|Overall Study|Lost to Follow-up|4|||
148820611|NCT02405962|536820122|FG000|Overall Study|A participant has moved to another place|0|||
148820612|NCT02405962|536820123|FG001|Overall Study|A participant has moved to another place|1|||
148820613|NCT00165698|536820124|FG000|Overall Study|Adverse Event|2|||
148976090|NCT01282216|537392433|FG003|Overall Study|Physician Decision|0|||
148976091|NCT01282216|537392430|FG000|Overall Study|Relapse|0|||
148976092|NCT01282216|537392431|FG001|Overall Study|Relapse|0|||
148820614|NCT00165698|536820125|FG001|Overall Study|Adverse Event|10|||
148820615|NCT00165698|536820124|FG000|Overall Study|Lost to Follow-up|2|||
148820616|NCT00165698|536820125|FG001|Overall Study|Lost to Follow-up|2|||
148820617|NCT00165698|536820124|FG000|Overall Study|Withdrawal by Subject|2|||
148820618|NCT00165698|536820125|FG001|Overall Study|Withdrawal by Subject|1|||
148820619|NCT00165698|536820124|FG000|Overall Study|Protocol Violation|1|||
148820620|NCT00165698|536820125|FG001|Overall Study|Protocol Violation|0|||
148820621|NCT00165698|536820124|FG000|Overall Study|Not Taken/Lost the medicine|1|||
148820622|NCT00165698|536820125|FG001|Overall Study|Not Taken/Lost the medicine|2|||
148820623|NCT03601052|536820126|FG000|Overall Study|Lost to Follow-up|2|||
148820624|NCT00837330|536820127|FG000|Overall Study|Lost to Follow-up|1|||
148820625|NCT00837330|536820128|FG001|Overall Study|Lost to Follow-up|3|||
148820626|NCT00086307|536820139|FG000|Overall Study|Lack of Efficacy|1|||
148820627|NCT00086307|536820140|FG001|Overall Study|Lack of Efficacy|1|||
148820628|NCT00086307|536820141|FG002|Overall Study|Lack of Efficacy|2|||
148820629|NCT00086307|536820139|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
148820630|NCT00086307|536820140|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
148747084|NCT05256134|536544277|FG001|Overall Study|Study Terminated by Sponsor|10|||
148747085|NCT05256134|536544276|FG000|Overall Study|Withdrawal by Subject|1|||
148747086|NCT05256134|536544277|FG001|Overall Study|Withdrawal by Subject|3|||
148747087|NCT01383707|536544286|FG000|Overall Study|Consent withdrawal|6|||
148747088|NCT01383707|536544286|FG000|Overall Study|Death|19|||
148747089|NCT01383707|536544286|FG000|Overall Study|Other|8|||
148747090|NCT01383707|536544286|FG000|Overall Study|Sponsor's decision|2|||
148747091|NCT01383707|536544286|FG000|Overall Study|Adverse Event|14|||
148747092|NCT01383707|536544286|FG000|Overall Study|Progressive disease|23|||
148747093|NCT01977417|536544288|FG000|Overall Study|Adverse Event|1|||
148747094|NCT01977417|536544289|FG001|Overall Study|Adverse Event|0|||
148747095|NCT01977417|536544288|FG000|Overall Study|Withdrawal by Subject|2|||
148820631|NCT00086307|536820141|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
148820632|NCT00086307|536820139|FG000|Overall Study|Nausea and headaches|0|||
148820633|NCT00086307|536820140|FG001|Overall Study|Nausea and headaches|0|||
148820634|NCT00086307|536820141|FG002|Overall Study|Nausea and headaches|1|||
148820635|NCT00086307|536820139|FG000|Overall Study|Constipation and sleepiness|0|||
148820636|NCT00086307|536820140|FG001|Overall Study|Constipation and sleepiness|0|||
148820637|NCT00086307|536820141|FG002|Overall Study|Constipation and sleepiness|1|||
148820638|NCT00086307|536820139|FG000|Overall Study|Suicidal ideation|0|||
148820639|NCT00086307|536820140|FG001|Overall Study|Suicidal ideation|0|||
148747096|NCT01977417|536544289|FG001|Overall Study|Withdrawal by Subject|4|||
148747097|NCT01977417|536544288|FG000|Overall Study|Female enrollment goal met|0|||
148747098|NCT01977417|536544289|FG001|Overall Study|Female enrollment goal met|2|||
148747099|NCT01692626|536544290|FG000|Overall Study|Death|0|||
148747100|NCT01692626|536544291|FG001|Overall Study|Death|1|||
148747101|NCT01692626|536544290|FG000|Overall Study|Adverse Event|2|||
148747102|NCT01692626|536544291|FG001|Overall Study|Adverse Event|3|||
148747103|NCT01692626|536544290|FG000|Overall Study|Protocol Violation|1|||
148747104|NCT01692626|536544291|FG001|Overall Study|Protocol Violation|2|||
148747105|NCT01692626|536544290|FG000|Overall Study|Withdrawal by Subject|1|||
148747106|NCT01692626|536544291|FG001|Overall Study|Withdrawal by Subject|0|||
148747107|NCT00855894|536544292|FG000|Overall Study|Death|31|||
148747108|NCT00855894|536544292|FG000|Overall Study|Patient's decision|1|||
148747109|NCT00855894|536544292|FG000|Overall Study|Disease progression|1|||
148747110|NCT02794870|536544299|FG000|Overall Study|Withdrawal by Subject|2|||
148747111|NCT02794870|536544300|FG001|Overall Study|Withdrawal by Subject|0|||
148747112|NCT00616421|536544301|FG000|Overall Study|Withdrawal by Subject|9|||
148747113|NCT00616421|536544302|FG001|Overall Study|Withdrawal by Subject|11|||
148747114|NCT00616421|536544303|FG002|Overall Study|Withdrawal by Subject|8|||
148747115|NCT00616421|536544301|FG000|Overall Study|Lost to Follow-up|12|||
148747116|NCT00616421|536544302|FG001|Overall Study|Lost to Follow-up|26|||
148747117|NCT00616421|536544303|FG002|Overall Study|Lost to Follow-up|30|||
148747118|NCT00616421|536544301|FG000|Overall Study|Inappropriate enrollment|3|||
148820640|NCT00086307|536820141|FG002|Overall Study|Suicidal ideation|1|||
148820641|NCT00086307|536820139|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
148820642|NCT00086307|536820140|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
148820643|NCT00086307|536820141|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
148820644|NCT00086307|536820139|FG000|Overall Study|Withdrawal by Subject|0|||
148820645|NCT00086307|536820140|FG001|Overall Study|Withdrawal by Subject|0|||
148820646|NCT00086307|536820141|FG002|Overall Study|Withdrawal by Subject|2|||
148820647|NCT01727154|536820145|FG000|Overall Study|Death|17|||
148820648|NCT01727154|536820145|FG000|Overall Study|Withdrawal by Subject|14|||
148820649|NCT01727154|536820145|FG000|Overall Study|Subject Withdrew Consent|18|||
148820650|NCT01727154|536820145|FG000|Overall Study|Study Terminated|6|||
148820651|NCT01727154|536820145|FG000|Overall Study|No Discontinuation Documentation|4|||
148820652|NCT00003474|536820146|FG000|Overall Study|Not Evaluable|14|||
148747119|NCT00616421|536544302|FG001|Overall Study|Inappropriate enrollment|0|||
148747120|NCT00616421|536544303|FG002|Overall Study|Inappropriate enrollment|1|||
148747121|NCT00616421|536544301|FG000|Overall Study|Administrative reason|1|||
148747122|NCT00616421|536544302|FG001|Overall Study|Administrative reason|0|||
148747123|NCT00616421|536544303|FG002|Overall Study|Administrative reason|0|||
148820653|NCT03020888|536820147|FG000|Overall Study|Physician Decision|4|||
148747124|NCT00616421|536544301|FG000|Overall Study|Protocol Violation|0|||
148747125|NCT00616421|536544302|FG001|Overall Study|Protocol Violation|1|||
148747126|NCT00616421|536544303|FG002|Overall Study|Protocol Violation|2|||
148820654|NCT03020888|536820147|FG000|Overall Study|Withdrawal by Subject|6|||
148820655|NCT03020888|536820147|FG000|Overall Study|Insurance coverage|2|||
148820656|NCT03020888|536820147|FG000|Overall Study|Lost to Follow-up|1|||
148820657|NCT01184118|536820148|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
148820658|NCT01184118|536820148|FG000|Overall Study|No physiologic confirmation of asthma|8|||
148820659|NCT01184118|536820148|FG000|Overall Study|FEV1 <60% predicted|2|||
148820660|NCT01184118|536820148|FG000|Overall Study|Exclusionary medical condition|2|||
148820661|NCT01184118|536820148|FG000|Overall Study|Withdrawal by Subject|5|||
148820662|NCT01198548|536820156|FG000|Overall Study|Disease Progression|9|||
148820663|NCT01198548|536820156|FG000|Overall Study|Administrative Decision|1|||
148820664|NCT02186171|536820157|FG000|Overall Study|Withdrawal by Subject|1|||
148820665|NCT02186171|536820158|FG001|Overall Study|Withdrawal by Subject|9|||
148820666|NCT02186171|536820157|FG000|Overall Study|Lost to Follow-up|2|||
148820667|NCT02186171|536820158|FG001|Overall Study|Lost to Follow-up|2|||
148820668|NCT02186171|536820157|FG000|Overall Study|Death|1|||
148820669|NCT02186171|536820158|FG001|Overall Study|Death|2|||
148820670|NCT02186171|536820157|FG000|Overall Study|Protocol-specified Criteria|0|||
148820671|NCT02186171|536820158|FG001|Overall Study|Protocol-specified Criteria|2|||
148820672|NCT02015104|536820160|FG000|Overall Study|Withdrew consent after first dose drug|1|||
148820673|NCT02015104|536820161|FG001|Overall Study|Withdrew consent after first dose drug|0|||
148820674|NCT02015104|536820160|FG000|Overall Study|Withdrew consent prior to treatment|0|||
148820675|NCT02015104|536820161|FG001|Overall Study|Withdrew consent prior to treatment|1|||
148820676|NCT03334175|536820162|FG000|Overall Study|Lost to Follow-up|0|||
148820677|NCT03334175|536820163|FG001|Overall Study|Lost to Follow-up|1|||
148820678|NCT03882801|536822314|FG000|Period 1|Adverse Event|0|||
148820679|NCT03882801|536822315|FG001|Period 1|Adverse Event|1|||
148820680|NCT03882801|536822314|FG000|Period 1|Non-compliance with study drug|1|||
148820681|NCT03882801|536822315|FG001|Period 1|Non-compliance with study drug|1|||
148820682|NCT03882801|536822314|FG000|Period 1|Never treated with study drug|1|||
148820683|NCT03882801|536822315|FG001|Period 1|Never treated with study drug|0|||
148820684|NCT03882801|536822314|FG000|Washout Period|Physician Decision|0|||
148820685|NCT03882801|536822315|FG001|Washout Period|Physician Decision|1|||
148820686|NCT03882801|536822314|FG000|Period 2|Non-compliance with study drug|0|||
148820687|NCT03882801|536822315|FG001|Period 2|Non-compliance with study drug|1|||
148820688|NCT03928704|536822319|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
148820689|NCT03928704|536822320|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
148820690|NCT03928704|536822321|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
148820691|NCT03928704|536822322|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
148820692|NCT03928704|536822323|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
148820693|NCT03928704|536822324|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
148820694|NCT03928704|536822319|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
148820695|NCT03928704|536822320|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
148820696|NCT03928704|536822321|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
148820697|NCT03928704|536822322|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
148820698|NCT03928704|536822323|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
148820699|NCT03928704|536822324|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
148820700|NCT03928704|536822319|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
148820701|NCT03928704|536822320|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
148820702|NCT03928704|536822321|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
148820703|NCT03928704|536822322|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
148820704|NCT03928704|536822323|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
148820705|NCT03928704|536822324|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
148820706|NCT03928704|536822319|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
148820707|NCT03928704|536822320|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
148820708|NCT03928704|536822321|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
148820709|NCT03928704|536822322|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
148820710|NCT03928704|536822323|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
148820711|NCT03928704|536822324|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
148820712|NCT03928704|536822319|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
148820713|NCT03928704|536822320|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
148820714|NCT03928704|536822321|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
148820715|NCT03928704|536822322|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
148820716|NCT03928704|536822323|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
148820717|NCT03928704|536822324|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
148820718|NCT03928704|536822319|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
148820719|NCT03928704|536822320|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
148820720|NCT03928704|536822321|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
148820721|NCT03928704|536822322|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
148820722|NCT03928704|536822323|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
148820723|NCT03928704|536822324|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
148820724|NCT03928704|536822319|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
148820725|NCT03928704|536822320|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
148820726|NCT03928704|536822321|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
148820727|NCT03928704|536822322|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
148820728|NCT03928704|536822323|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
148820729|NCT03928704|536822324|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
148820730|NCT03928704|536822319|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
148820731|NCT03928704|536822320|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
148820732|NCT03928704|536822321|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
148820733|NCT03928704|536822322|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
148820734|NCT03928704|536822323|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
148820735|NCT03928704|536822324|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
148820736|NCT03928704|536822319|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
148820737|NCT03928704|536822320|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
148820738|NCT03928704|536822321|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
148820739|NCT03928704|536822322|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
148820740|NCT03928704|536822323|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
148820741|NCT03928704|536822324|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
148820742|NCT03928704|536822319|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
148820743|NCT03928704|536822320|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
148820744|NCT03928704|536822321|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
148820745|NCT03928704|536822322|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
148820746|NCT03928704|536822323|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
148820747|NCT03928704|536822324|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
148820748|NCT01428713|536822329|FG000|Overall Study|Non-compliance|2|||
148820749|NCT01428713|536822330|FG001|Overall Study|Non-compliance|2|||
148820750|NCT01428713|536822329|FG000|Overall Study|Withdrawal by Subject|1|||
148820751|NCT01428713|536822330|FG001|Overall Study|Withdrawal by Subject|1|||
148820752|NCT01428713|536822329|FG000|Overall Study|Adverse Event|0|||
148820753|NCT01428713|536822330|FG001|Overall Study|Adverse Event|2|||
148820754|NCT02930941|536822331|FG000|Overall Study|Lost to Follow-up|1|||
148820755|NCT02930941|536822332|FG001|Overall Study|Lost to Follow-up|2|||
148820756|NCT00903344|536822335|FG000|Overall Study|Pregnancy|2|||
148820757|NCT00903344|536822336|FG001|Overall Study|Pregnancy|3|||
148820758|NCT00903344|536822335|FG000|Overall Study|Lost to Follow-up|3|||
148820759|NCT00903344|536822336|FG001|Overall Study|Lost to Follow-up|0|||
148820760|NCT00585169|536822339|FG000|Overall Study|Withdrawal by Subject|1|||
148820761|NCT03055221|536822351|FG000|Overall Study|Adverse Event|2|||
148820762|NCT03055221|536822351|FG000|Overall Study|Withdrawal by Subject|4|||
148820763|NCT03055221|536822351|FG000|Overall Study|Death|6|||
148820764|NCT03055221|536822351|FG000|Overall Study|Physician Decision|1|||
148820765|NCT03055221|536822351|FG000|Overall Study|Study terminated by Sponsor|3|||
148820766|NCT03055221|536822351|FG000|Overall Study|Lost to Follow-up|4|||
148820767|NCT01964560|536822356|FG000|Overall Study|Adverse Event|23|||
148820768|NCT01964560|536822356|FG000|Overall Study|Lack of Efficacy|46|||
148820769|NCT01964560|536822356|FG000|Overall Study|Protocol deviation|2|||
148820770|NCT01964560|536822356|FG000|Overall Study|Lost to Follow-up|4|||
148820771|NCT01964560|536822356|FG000|Overall Study|Withdrawal by Subject|64|||
148820772|NCT01964560|536822356|FG000|Overall Study|Surgery-hemispherotomy|1|||
148820773|NCT01964560|536822356|FG000|Overall Study|Surgery|1|||
148820774|NCT01964560|536822356|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
148820775|NCT01964560|536822356|FG000|Overall Study|Patient and Investigator choice|1|||
148820776|NCT01964560|536822356|FG000|Overall Study|Patient was prescribed CBD|1|||
148820777|NCT01964560|536822356|FG000|Overall Study|Participant moved to another country|1|||
148820778|NCT01301001|536822357|FG000|First Intervention|Lost to Follow-up|4|||
148820779|NCT01301001|536822358|FG001|First Intervention|Lost to Follow-up|4|||
148820780|NCT01301001|536822357|FG000|First Intervention|Withdrawal by Subject|1|||
148820781|NCT01301001|536822358|FG001|First Intervention|Withdrawal by Subject|4|||
148820782|NCT01301001|536822357|FG000|First Intervention|Adverse Event|5|||
148820783|NCT01301001|536822358|FG001|First Intervention|Adverse Event|0|||
148820784|NCT01301001|536822357|FG000|First Intervention|Protocol Violation|0|||
148820785|NCT01301001|536822358|FG001|First Intervention|Protocol Violation|1|||
148820786|NCT01301001|536822357|FG000|Second Intervention|Adverse Event|2|||
148820787|NCT01301001|536822358|FG001|Second Intervention|Adverse Event|0|||
148820788|NCT01301001|536822357|FG000|Second Intervention|Withdrawal by Subject|2|||
148820789|NCT01301001|536822358|FG001|Second Intervention|Withdrawal by Subject|0|||
148820790|NCT02301429|536822365|FG000|Overall Study|not acceptable vascular anatomy|3|||
148820791|NCT01502072|536822366|FG000|Overall Study|Withdrawal by Subject|1|||
148820792|NCT01502072|536822367|FG001|Overall Study|Withdrawal by Subject|0|||
148820793|NCT01502072|536822368|FG002|Overall Study|Withdrawal by Subject|0|||
148820794|NCT01502072|536822366|FG000|Overall Study|Death|0|||
148820795|NCT01502072|536822367|FG001|Overall Study|Death|1|||
148820796|NCT01502072|536822368|FG002|Overall Study|Death|0|||
148820797|NCT04535362|536822382|FG000|Overall Study|Lost to Follow-up|3|||
148820798|NCT04535362|536822383|FG001|Overall Study|Lost to Follow-up|1|||
148820799|NCT03791060|536822384|FG000|Overall Study|Withdrawal by Subject|1|||
148820800|NCT02018887|536822387|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
148820801|NCT02018887|536822388|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820802|NCT02018887|536822389|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820803|NCT02018887|536822390|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820804|NCT02018887|536822391|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820805|NCT02018887|536822392|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820806|NCT02018887|536822393|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148747127|NCT00616421|536544301|FG000|Overall Study|Unable to classify|1|||
148747128|NCT00616421|536544302|FG001|Overall Study|Unable to classify|0|||
148747129|NCT00616421|536544303|FG002|Overall Study|Unable to classify|0|||
148747130|NCT01495702|536544304|FG000|Randomized Phase|Randomized But Not Treated|1|||
148747131|NCT01495702|536544305|FG001|Randomized Phase|Randomized But Not Treated|4|||
148747132|NCT01495702|536544304|FG000|Randomized Phase|Adverse Event|2|||
148747133|NCT01495702|536544305|FG001|Randomized Phase|Adverse Event|2|||
148747134|NCT01495702|536544304|FG000|Randomized Phase|Death|1|||
148747135|NCT01495702|536544305|FG001|Randomized Phase|Death|0|||
148747136|NCT01495702|536544304|FG000|Randomized Phase|Lack of Efficacy|2|||
148747137|NCT01495702|536544305|FG001|Randomized Phase|Lack of Efficacy|0|||
148747138|NCT01495702|536544304|FG000|Randomized Phase|Investigators Discretion|2|||
148747139|NCT01495702|536544305|FG001|Randomized Phase|Investigators Discretion|0|||
148747140|NCT01495702|536544304|FG000|Randomized Phase|Withdrew Consent|10|||
148747141|NCT01495702|536544305|FG001|Randomized Phase|Withdrew Consent|18|||
148747142|NCT01495702|536544304|FG000|Randomized Phase|Lost to Follow-up|4|||
148747143|NCT01495702|536544305|FG001|Randomized Phase|Lost to Follow-up|3|||
148747144|NCT01495702|536544304|FG000|Randomized Phase|Participant Noncompliance|1|||
148747145|NCT01495702|536544305|FG001|Randomized Phase|Participant Noncompliance|0|||
148747146|NCT01495702|536544304|FG000|Randomized Phase|Protocol Violation|3|||
148747147|NCT01495702|536544305|FG001|Randomized Phase|Protocol Violation|1|||
148747148|NCT01427608|536544306|FG000|Overall Study|Death|1|||
148747149|NCT01427608|536544307|FG001|Overall Study|Death|0|||
148747150|NCT01427608|536544306|FG000|Overall Study|Withdrawal by Subject|7|||
148747151|NCT01427608|536544307|FG001|Overall Study|Withdrawal by Subject|3|||
148747152|NCT01427608|536544306|FG000|Overall Study|Relapsed-all cause|13|||
148747153|NCT01427608|536544307|FG001|Overall Study|Relapsed-all cause|34|||
148747154|NCT01427608|536544306|FG000|Overall Study|Events not attributed to study meds|0|||
148747155|NCT01427608|536544307|FG001|Overall Study|Events not attributed to study meds|1|||
148747156|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
148747157|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
148747158|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
148747159|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
148747160|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
148747161|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
148747162|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
148747163|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
148747164|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
148747165|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
148747166|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
148747167|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
148747168|NCT02422797|536544308|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
148747169|NCT02422797|536544309|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
148747170|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
148747171|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
148747172|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
148747173|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
148747174|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
148820807|NCT02018887|536822394|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820808|NCT02018887|536822395|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820809|NCT02018887|536822396|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820810|NCT02018887|536822397|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
148820811|NCT02018887|536822387|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148820812|NCT02018887|536822388|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148820813|NCT02018887|536822389|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148747175|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
148747176|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
148747177|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
148747178|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
148820814|NCT02018887|536822390|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148820815|NCT02018887|536822391|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
148747179|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
148747180|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
148747181|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
148747182|NCT02422797|536544308|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
148747183|NCT02422797|536544309|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
148747184|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
148747185|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
148747186|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
148747187|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
148747188|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
148747189|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
148747190|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
148747191|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
148747192|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
148747193|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
148747194|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
148747195|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
148747196|NCT02422797|536544308|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
148747197|NCT02422797|536544309|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
148747198|NCT04071405|536544310|FG000|Overall Study|Protocol Violation|3|||
148747199|NCT05445492|536544315|FG000|Overall Study|Physician Decision|1|||
148747200|NCT03126435|536544320|FG000|Overall Study|Death|90|||
148747201|NCT03126435|536544321|FG001|Overall Study|Death|84|||
148747202|NCT03126435|536544320|FG000|Overall Study|Lost to Follow-up|4|||
148747203|NCT03126435|536544321|FG001|Overall Study|Lost to Follow-up|3|||
148747204|NCT03126435|536544320|FG000|Overall Study|Physician Decision|0|||
148747205|NCT03126435|536544321|FG001|Overall Study|Physician Decision|1|||
148747206|NCT03126435|536544320|FG000|Overall Study|Withdrawal by Subject|6|||
148747207|NCT03126435|536544321|FG001|Overall Study|Withdrawal by Subject|12|||
148747208|NCT03126435|536544320|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
148747209|NCT03126435|536544321|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
148747210|NCT03154125|536544328|FG000|Overall Study|Lost to Follow-up|11|||
148747211|NCT03154125|536544329|FG001|Overall Study|Lost to Follow-up|11|||
148747212|NCT03154125|536544330|FG002|Overall Study|Lost to Follow-up|0|||
148747213|NCT03154125|536544328|FG000|Overall Study|Withdrawal by Subject|49|||
148747214|NCT03154125|536544329|FG001|Overall Study|Withdrawal by Subject|55|||
148747215|NCT03154125|536544330|FG002|Overall Study|Withdrawal by Subject|8|||
148747216|NCT03154125|536544328|FG000|Overall Study|Physician Decision|13|||
148747217|NCT03154125|536544329|FG001|Overall Study|Physician Decision|6|||
148747218|NCT03154125|536544330|FG002|Overall Study|Physician Decision|0|||
148747219|NCT03154125|536544328|FG000|Overall Study|Protocol Violation|3|||
148747220|NCT03154125|536544329|FG001|Overall Study|Protocol Violation|5|||
148747221|NCT03154125|536544330|FG002|Overall Study|Protocol Violation|0|||
148747222|NCT00810511|536544331|FG000|Overall Study|Protocol Violation|0|||
148747223|NCT00810511|536544332|FG001|Overall Study|Protocol Violation|1|||
148747224|NCT00810511|536544331|FG000|Overall Study|Lack of Efficacy|9|||
148747225|NCT00810511|536544332|FG001|Overall Study|Lack of Efficacy|1|||
148747226|NCT00810511|536544331|FG000|Overall Study|death in the family|0|||
148747227|NCT00810511|536544332|FG001|Overall Study|death in the family|1|||
148747228|NCT00810511|536544331|FG000|Overall Study|Lost to Follow-up|1|||
148747229|NCT00810511|536544332|FG001|Overall Study|Lost to Follow-up|0|||
148747230|NCT00810511|536544331|FG000|Overall Study|deposits on contact lens|0|||
148747231|NCT00810511|536544332|FG001|Overall Study|deposits on contact lens|1|||
148747232|NCT00462904|536544333|FG000|Overall Study|Lost to Follow-up|1|||
148747233|NCT02508935|536544334|FG000|Overall Study|Withdrawal by Subject|1|||
148747234|NCT02508935|536544334|FG000|Overall Study|Withdrawal by Caregiver|8|||
148747235|NCT02508935|536544334|FG000|Overall Study|Pain Score <4|1|||
148747236|NCT02508935|536544334|FG000|Overall Study|Emesis|3|||
148747237|NCT02508935|536544334|FG000|Overall Study|Adverse Event|3|||
148747238|NCT02508935|536544334|FG000|Overall Study|Protocol Violation|1|||
148747239|NCT02508935|536544334|FG000|Overall Study|Physician Decision|1|||
148747240|NCT02508935|536544334|FG000|Overall Study|Trial terminated by sponsor|5|||
148747241|NCT04877457|536544337|FG000|Overall Study|Early termination of study due to low enrollment|2|||
148747242|NCT04877457|536544338|FG001|Overall Study|Early termination of study due to low enrollment|1|||
148747243|NCT02211417|536544339|FG000|Overall Study|Withdrawal by Subject|11|||
148747244|NCT02211417|536544340|FG001|Overall Study|Withdrawal by Subject|8|||
148820816|NCT02018887|536822392|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148976093|NCT01282216|537392432|FG002|Overall Study|Relapse|17|||
148747245|NCT02211417|536544339|FG000|Overall Study|Protocol Violation|1|||
148747246|NCT02211417|536544340|FG001|Overall Study|Protocol Violation|0|||
148747247|NCT02211417|536544339|FG000|Overall Study|Pregnancy|0|||
148976094|NCT01282216|537392433|FG003|Overall Study|Relapse|6|||
148976095|NCT01282216|537392430|FG000|Overall Study|Death|0|||
148820817|NCT02018887|536822393|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
148820818|NCT02018887|536822394|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
148820819|NCT02018887|536822395|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148820820|NCT02018887|536822396|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148820821|NCT02018887|536822397|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
148820822|NCT02018887|536822387|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
148820823|NCT02018887|536822388|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
148820824|NCT02018887|536822389|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
148820825|NCT02018887|536822390|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
148820826|NCT02018887|536822391|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
148820827|NCT02018887|536822392|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
148820828|NCT02018887|536822393|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
148820829|NCT02018887|536822394|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
148820830|NCT02018887|536822395|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
148820831|NCT02018887|536822396|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
148820832|NCT02018887|536822397|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
148820833|NCT02018887|536822387|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
148820834|NCT02018887|536822388|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
148820835|NCT02018887|536822389|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
148820836|NCT02018887|536822390|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
148820837|NCT02018887|536822391|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
148820838|NCT02018887|536822392|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
148820839|NCT02018887|536822393|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
148820840|NCT02018887|536822394|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
148820841|NCT02018887|536822395|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
148820842|NCT02018887|536822396|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
148820843|NCT02018887|536822397|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
148820844|NCT01145222|536822398|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
148820845|NCT01145222|536822399|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
148820846|NCT01145222|536822400|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
148820847|NCT01145222|536822401|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
148820848|NCT01145222|536822398|FG000|Overall Study|Poor bowel preparation|0|||
148820849|NCT01145222|536822399|FG001|Overall Study|Poor bowel preparation|0|||
148820850|NCT01145222|536822400|FG002|Overall Study|Poor bowel preparation|0|||
148820851|NCT01145222|536822401|FG003|Overall Study|Poor bowel preparation|1|||
148820852|NCT00927186|536822402|FG000|12 Months Primary Study|Adverse Event|5|||
148820853|NCT00927186|536822403|FG001|12 Months Primary Study|Adverse Event|2|||
148820854|NCT00927186|536822402|FG000|12 Months Primary Study|Lost to Follow-up|1|||
148820855|NCT00927186|536822403|FG001|12 Months Primary Study|Lost to Follow-up|0|||
148820856|NCT00927186|536822402|FG000|12 Months Primary Study|Protocol Violation|0|||
148820857|NCT00927186|536822403|FG001|12 Months Primary Study|Protocol Violation|1|||
148820858|NCT00927186|536822402|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
148820859|NCT00927186|536822403|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
148820860|NCT00604383|536822404|FG000|Overall Study|Withdrawal by Subject|33|||
148820861|NCT00604383|536822405|FG001|Overall Study|Withdrawal by Subject|31|||
148820862|NCT00604383|536822404|FG000|Overall Study|Lost to Follow-up|24|||
148820863|NCT00604383|536822405|FG001|Overall Study|Lost to Follow-up|19|||
148820864|NCT00604383|536822404|FG000|Overall Study|Death|14|||
148820865|NCT00604383|536822405|FG001|Overall Study|Death|22|||
148820866|NCT00604383|536822404|FG000|Overall Study|Adverse Event|16|||
148820867|NCT00604383|536822405|FG001|Overall Study|Adverse Event|9|||
148820868|NCT00604383|536822404|FG000|Overall Study|Physician Decision|0|||
148820869|NCT00604383|536822405|FG001|Overall Study|Physician Decision|3|||
148820870|NCT01698008|536822406|FG000|Overall Study|Withdrawal by Subject|1|||
148820871|NCT01698008|536822407|FG001|Overall Study|Withdrawal by Subject|2|||
148820872|NCT01011283|536822411|FG000|Overall Study|Adverse Event|4|||
148820873|NCT01011283|536822412|FG001|Overall Study|Adverse Event|2|||
148820874|NCT01011283|536822411|FG000|Overall Study|Progressive Disease|0|||
148820875|NCT01011283|536822412|FG001|Overall Study|Progressive Disease|2|||
148820876|NCT01011283|536822411|FG000|Overall Study|Terminated by Sponsor|5|||
148820877|NCT01011283|536822412|FG001|Overall Study|Terminated by Sponsor|5|||
148820878|NCT01011283|536822411|FG000|Overall Study|Other|2|||
148820879|NCT01011283|536822412|FG001|Overall Study|Other|2|||
148976096|NCT01282216|537392431|FG001|Overall Study|Death|0|||
148820880|NCT00799864|536822417|FG000|Overall Study|Participant reached a virologic endpoint|9|||
148820881|NCT00799864|536822418|FG001|Overall Study|Participant reached a virologic endpoint|2|||
148820882|NCT00799864|536822419|FG002|Overall Study|Participant reached a virologic endpoint|2|||
148820883|NCT00799864|536822420|FG003|Overall Study|Participant reached a virologic endpoint|0|||
148820884|NCT00799864|536822421|FG004|Overall Study|Participant reached a virologic endpoint|0|||
148820885|NCT00799864|536822417|FG000|Overall Study|Other|2|||
148820886|NCT00799864|536822418|FG001|Overall Study|Other|1|||
148820887|NCT00799864|536822419|FG002|Overall Study|Other|0|||
148820888|NCT00799864|536822420|FG003|Overall Study|Other|0|||
148820889|NCT00799864|536822421|FG004|Overall Study|Other|0|||
148889067|NCT02800863|537072347|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
148747248|NCT02211417|536544340|FG001|Overall Study|Pregnancy|1|||
148747249|NCT02211417|536544339|FG000|Overall Study|Lost to Follow-up|2|||
148747250|NCT02211417|536544340|FG001|Overall Study|Lost to Follow-up|3|||
148747251|NCT02211417|536544339|FG000|Overall Study|Adverse Event|1|||
148747252|NCT02211417|536544340|FG001|Overall Study|Adverse Event|4|||
148747253|NCT01198132|536544341|FG000|Overall Study|Withdrawal by Subject|4|||
148747254|NCT01198132|536544342|FG001|Overall Study|Withdrawal by Subject|5|||
148747255|NCT01198132|536544341|FG000|Overall Study|Physician Decision|5|||
148747256|NCT01198132|536544342|FG001|Overall Study|Physician Decision|4|||
148747257|NCT01198132|536544341|FG000|Overall Study|Other Unspecified|3|||
148747258|NCT01198132|536544342|FG001|Overall Study|Other Unspecified|6|||
148747259|NCT01198132|536544341|FG000|Overall Study|Lack of Efficacy|2|||
148747260|NCT01198132|536544342|FG001|Overall Study|Lack of Efficacy|3|||
148747261|NCT01198132|536544341|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
148747262|NCT01198132|536544342|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
148747263|NCT01198132|536544341|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
148747264|NCT01198132|536544342|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
148747265|NCT01198132|536544341|FG000|Overall Study|Adverse Event|0|||
148747266|NCT01198132|536544342|FG001|Overall Study|Adverse Event|1|||
148747267|NCT01198132|536544341|FG000|Overall Study|Protocol Violation|1|||
148747268|NCT01198132|536544342|FG001|Overall Study|Protocol Violation|0|||
148747269|NCT01755091|536544343|FG000|Overall Study|Withdrawal by Subject|6|||
148747270|NCT01755091|536544344|FG001|Overall Study|Withdrawal by Subject|1|||
148747271|NCT01755091|536544345|FG002|Overall Study|Withdrawal by Subject|3|||
148747272|NCT01755091|536544343|FG000|Overall Study|Adverse Event|1|||
148747273|NCT01755091|536544344|FG001|Overall Study|Adverse Event|1|||
148747274|NCT01755091|536544345|FG002|Overall Study|Adverse Event|1|||
148747275|NCT01755091|536544343|FG000|Overall Study|Lost to Follow-up|1|||
148747276|NCT01755091|536544344|FG001|Overall Study|Lost to Follow-up|0|||
148747277|NCT01755091|536544345|FG002|Overall Study|Lost to Follow-up|1|||
148747278|NCT01755091|536544343|FG000|Overall Study|Physician Decision|1|||
148747279|NCT01755091|536544344|FG001|Overall Study|Physician Decision|1|||
148747280|NCT01755091|536544345|FG002|Overall Study|Physician Decision|2|||
148747281|NCT03071276|536544346|FG000|Overall Study|Adverse Event|1|||
148747282|NCT03071276|536544346|FG000|Overall Study|Lack of Efficacy|14|||
148747283|NCT02185053|536544347|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
148747284|NCT02185053|536544348|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
148747285|NCT02185053|536544349|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
148747286|NCT02185053|536544347|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
148747287|NCT02185053|536544348|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
148747288|NCT02185053|536544349|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
148747289|NCT02185053|536544347|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
148747290|NCT02185053|536544348|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
148747291|NCT02185053|536544349|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
148747292|NCT02185053|536544347|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
148747293|NCT02185053|536544348|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
148747294|NCT02185053|536544349|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
148747295|NCT02185053|536544347|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
148747296|NCT02185053|536544348|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
148747297|NCT02185053|536544349|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
148747298|NCT02185053|536544347|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
148747299|NCT02185053|536544348|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
148747300|NCT02185053|536544349|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
148747301|NCT02185053|536544347|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
148747302|NCT02185053|536544348|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
148747303|NCT02185053|536544349|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
148747304|NCT02185053|536544347|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
148747305|NCT02185053|536544348|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
148747306|NCT02185053|536544349|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
148747307|NCT00307437|536544350|FG000|Controlled Period|Adverse Event|7|||
148976097|NCT01282216|537392432|FG002|Overall Study|Death|2|||
148976098|NCT01282216|537392433|FG003|Overall Study|Death|0|||
148976099|NCT02908529|537392435|FG000|Overall Study|Lost to Follow-up|0|||
148747308|NCT00307437|536544351|FG001|Controlled Period|Adverse Event|2|||
148747309|NCT00307437|536544352|FG002|Controlled Period|Adverse Event|5|||
148747310|NCT00307437|536544353|FG003|Controlled Period|Adverse Event|0|||
148747311|NCT00307437|536544354|FG004|Controlled Period|Adverse Event|0|||
148747312|NCT00307437|536544355|FG005|Controlled Period|Adverse Event|0|||
148747313|NCT00307437|536544356|FG006|Controlled Period|Adverse Event|0|||
148747314|NCT00307437|536544350|FG000|Controlled Period|Death|0|||
148747315|NCT00307437|536544351|FG001|Controlled Period|Death|0|||
148976100|NCT02908529|537392436|FG001|Overall Study|Lost to Follow-up|2|||
148747316|NCT00307437|536544352|FG002|Controlled Period|Death|1|||
148747317|NCT00307437|536544353|FG003|Controlled Period|Death|0|||
148820890|NCT04865978|536822422|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
148820891|NCT04865978|536822423|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
148820892|NCT02181738|536822429|FG000|Overall Study|Participant Withdrew Consent|2|||
148820893|NCT02181738|536822430|FG001|Overall Study|Participant Withdrew Consent|1|||
148820894|NCT02181738|536822431|FG002|Overall Study|Participant Withdrew Consent|1|||
148820895|NCT02181738|536822432|FG003|Overall Study|Participant Withdrew Consent|1|||
148820896|NCT02181738|536822429|FG000|Overall Study|Lost to Follow-up|1|||
148820897|NCT02181738|536822430|FG001|Overall Study|Lost to Follow-up|2|||
148820898|NCT02181738|536822431|FG002|Overall Study|Lost to Follow-up|1|||
148820899|NCT02181738|536822432|FG003|Overall Study|Lost to Follow-up|1|||
148820900|NCT02181738|536822429|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
148820901|NCT02181738|536822430|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
148820902|NCT02181738|536822431|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
148820903|NCT02181738|536822432|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
148820904|NCT02181738|536822429|FG000|Overall Study|Poor/Non-Compliance|1|||
148820905|NCT02181738|536822430|FG001|Overall Study|Poor/Non-Compliance|0|||
148820906|NCT02181738|536822431|FG002|Overall Study|Poor/Non-Compliance|2|||
148820907|NCT02181738|536822432|FG003|Overall Study|Poor/Non-Compliance|1|||
148820908|NCT02181738|536822429|FG000|Overall Study|Disease Progression|28|||
148820909|NCT02181738|536822430|FG001|Overall Study|Disease Progression|35|||
148820910|NCT02181738|536822431|FG002|Overall Study|Disease Progression|40|||
148820911|NCT02181738|536822432|FG003|Overall Study|Disease Progression|0|||
148820912|NCT02181738|536822429|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
148820913|NCT02181738|536822430|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
148820914|NCT02181738|536822431|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
148820915|NCT02181738|536822432|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
148820916|NCT02181738|536822429|FG000|Overall Study|Study Drug Toxicity|6|||
148820917|NCT02181738|536822430|FG001|Overall Study|Study Drug Toxicity|11|||
148820918|NCT02181738|536822431|FG002|Overall Study|Study Drug Toxicity|8|||
148820919|NCT02181738|536822432|FG003|Overall Study|Study Drug Toxicity|1|||
148820920|NCT02181738|536822429|FG000|Overall Study|Other Reasons|14|||
148820921|NCT02181738|536822430|FG001|Overall Study|Other Reasons|16|||
148820922|NCT02181738|536822431|FG002|Overall Study|Other Reasons|28|||
148820923|NCT02181738|536822432|FG003|Overall Study|Other Reasons|0|||
148820924|NCT02181738|536822429|FG000|Overall Study|Maximum Clinical Benefit|3|||
148820925|NCT02181738|536822430|FG001|Overall Study|Maximum Clinical Benefit|0|||
148820926|NCT02181738|536822431|FG002|Overall Study|Maximum Clinical Benefit|1|||
148820927|NCT02181738|536822432|FG003|Overall Study|Maximum Clinical Benefit|0|||
148820928|NCT02181738|536822429|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
148820929|NCT02181738|536822430|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
148820930|NCT02181738|536822431|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
148820931|NCT02181738|536822432|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
148820932|NCT00191152|536822433|FG000|Initial Treatment|Adverse Event|43|||
148820933|NCT00191152|536822434|FG001|Initial Treatment|Adverse Event|67|||
148820934|NCT00191152|536822433|FG000|Initial Treatment|Physician Decision|40|||
148820935|NCT00191152|536822434|FG001|Initial Treatment|Physician Decision|31|||
148820936|NCT00191152|536822433|FG000|Initial Treatment|Withdrawal by Subject|40|||
148820937|NCT00191152|536822434|FG001|Initial Treatment|Withdrawal by Subject|28|||
148820938|NCT00191152|536822433|FG000|Initial Treatment|Lost to Follow-up|0|||
148820939|NCT00191152|536822434|FG001|Initial Treatment|Lost to Follow-up|6|||
148820940|NCT00191152|536822433|FG000|Initial Treatment|Other|18|||
148820941|NCT00191152|536822434|FG001|Initial Treatment|Other|21|||
148820942|NCT00191152|536822433|FG000|Crossover Treatment|Adverse Event|8|||
148820943|NCT00191152|536822434|FG001|Crossover Treatment|Adverse Event|8|||
148820944|NCT00191152|536822433|FG000|Crossover Treatment|Physician Decision|7|||
148820945|NCT00191152|536822434|FG001|Crossover Treatment|Physician Decision|7|||
148820946|NCT00191152|536822433|FG000|Crossover Treatment|Withdrawal by Subject|6|||
148820947|NCT00191152|536822434|FG001|Crossover Treatment|Withdrawal by Subject|9|||
148820948|NCT00191152|536822433|FG000|Crossover Treatment|Lost to Follow-up|2|||
148976101|NCT03238911|537392446|FG000|Overall Study|Withdrawal by Subject|1|||
148976102|NCT03238911|537392447|FG001|Overall Study|Withdrawal by Subject|2|||
148976103|NCT03238911|537392446|FG000|Overall Study|Lost to Follow-up|2|||
148976104|NCT03238911|537392447|FG001|Overall Study|Lost to Follow-up|1|||
148976105|NCT02239536|537392448|FG000|Overall Study|Non-neoplastic polyp|23|||
148976106|NCT02239536|537392449|FG001|Overall Study|Non-neoplastic polyp|17|||
148976107|NCT01038778|537392450|FG000|Overall Study|Withdrawal by Subject|0|||
148820949|NCT00191152|536822434|FG001|Crossover Treatment|Lost to Follow-up|1|||
148820950|NCT00191152|536822433|FG000|Crossover Treatment|Other|4|||
148820951|NCT00191152|536822434|FG001|Crossover Treatment|Other|3|||
148820952|NCT00114777|536822435|FG000|Randomization to Month 36|Death|10|||
148820953|NCT00114777|536822436|FG001|Randomization to Month 36|Death|4|||
148820954|NCT00114777|536822437|FG002|Randomization to Month 36|Death|3|||
148820955|NCT00114777|536822435|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
148820956|NCT00114777|536822436|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
148747318|NCT00307437|536544354|FG004|Controlled Period|Death|0|||
148747319|NCT00307437|536544355|FG005|Controlled Period|Death|0|||
148747320|NCT00307437|536544356|FG006|Controlled Period|Death|0|||
148747321|NCT00307437|536544350|FG000|Controlled Period|Lack of Efficacy|2|||
148747322|NCT00307437|536544351|FG001|Controlled Period|Lack of Efficacy|0|||
148747323|NCT00307437|536544352|FG002|Controlled Period|Lack of Efficacy|0|||
148747324|NCT00307437|536544353|FG003|Controlled Period|Lack of Efficacy|0|||
148747325|NCT00307437|536544354|FG004|Controlled Period|Lack of Efficacy|0|||
148747326|NCT00307437|536544355|FG005|Controlled Period|Lack of Efficacy|0|||
148747327|NCT00307437|536544356|FG006|Controlled Period|Lack of Efficacy|0|||
148747328|NCT00307437|536544350|FG000|Controlled Period|Lost to Follow-up|2|||
148747329|NCT00307437|536544351|FG001|Controlled Period|Lost to Follow-up|3|||
148747330|NCT00307437|536544352|FG002|Controlled Period|Lost to Follow-up|0|||
148747331|NCT00307437|536544353|FG003|Controlled Period|Lost to Follow-up|0|||
148747332|NCT00307437|536544354|FG004|Controlled Period|Lost to Follow-up|0|||
148747333|NCT00307437|536544355|FG005|Controlled Period|Lost to Follow-up|0|||
148747334|NCT00307437|536544356|FG006|Controlled Period|Lost to Follow-up|0|||
148747335|NCT00307437|536544350|FG000|Controlled Period|Other|5|||
148747336|NCT00307437|536544351|FG001|Controlled Period|Other|1|||
148747337|NCT00307437|536544352|FG002|Controlled Period|Other|3|||
148747338|NCT00307437|536544353|FG003|Controlled Period|Other|0|||
148747339|NCT00307437|536544354|FG004|Controlled Period|Other|0|||
148747340|NCT00307437|536544355|FG005|Controlled Period|Other|0|||
148747341|NCT00307437|536544356|FG006|Controlled Period|Other|0|||
148747342|NCT00307437|536544350|FG000|After Controlled Period|Adverse Event|0|||
148747343|NCT00307437|536544351|FG001|After Controlled Period|Adverse Event|0|||
148747344|NCT00307437|536544352|FG002|After Controlled Period|Adverse Event|0|||
148747345|NCT00307437|536544353|FG003|After Controlled Period|Adverse Event|18|||
148747346|NCT00307437|536544354|FG004|After Controlled Period|Adverse Event|16|||
148747347|NCT00307437|536544355|FG005|After Controlled Period|Adverse Event|31|||
148747348|NCT00307437|536544356|FG006|After Controlled Period|Adverse Event|40|||
148747349|NCT00307437|536544350|FG000|After Controlled Period|Death|0|||
148747350|NCT00307437|536544351|FG001|After Controlled Period|Death|0|||
148747351|NCT00307437|536544352|FG002|After Controlled Period|Death|0|||
148747352|NCT00307437|536544353|FG003|After Controlled Period|Death|3|||
148747353|NCT00307437|536544354|FG004|After Controlled Period|Death|1|||
148747354|NCT00307437|536544355|FG005|After Controlled Period|Death|1|||
148747355|NCT00307437|536544356|FG006|After Controlled Period|Death|3|||
148747356|NCT00307437|536544350|FG000|After Controlled Period|Lack of Efficacy|0|||
148747357|NCT00307437|536544351|FG001|After Controlled Period|Lack of Efficacy|0|||
148747358|NCT00307437|536544352|FG002|After Controlled Period|Lack of Efficacy|0|||
148747359|NCT00307437|536544353|FG003|After Controlled Period|Lack of Efficacy|15|||
148747360|NCT00307437|536544354|FG004|After Controlled Period|Lack of Efficacy|17|||
148747361|NCT00307437|536544355|FG005|After Controlled Period|Lack of Efficacy|37|||
148747362|NCT00307437|536544356|FG006|After Controlled Period|Lack of Efficacy|24|||
148747363|NCT00307437|536544350|FG000|After Controlled Period|Lost to Follow-up|0|||
148747364|NCT00307437|536544351|FG001|After Controlled Period|Lost to Follow-up|0|||
148747365|NCT00307437|536544352|FG002|After Controlled Period|Lost to Follow-up|0|||
148747366|NCT00307437|536544353|FG003|After Controlled Period|Lost to Follow-up|7|||
148747367|NCT00307437|536544354|FG004|After Controlled Period|Lost to Follow-up|12|||
148747368|NCT00307437|536544355|FG005|After Controlled Period|Lost to Follow-up|13|||
148747369|NCT00307437|536544356|FG006|After Controlled Period|Lost to Follow-up|18|||
148747370|NCT00307437|536544350|FG000|After Controlled Period|Other|0|||
148747371|NCT00307437|536544351|FG001|After Controlled Period|Other|0|||
148747372|NCT00307437|536544352|FG002|After Controlled Period|Other|0|||
148747373|NCT00307437|536544353|FG003|After Controlled Period|Other|15|||
148747374|NCT00307437|536544354|FG004|After Controlled Period|Other|9|||
148747375|NCT00307437|536544355|FG005|After Controlled Period|Other|40|||
148747376|NCT00307437|536544356|FG006|After Controlled Period|Other|28|||
148747377|NCT00338728|536544362|FG000|Overall Study|Screen Failure|14|||
148747378|NCT02933255|536544369|FG000|Overall Study|Discontinued due to study closure.|1|||
148747379|NCT02933255|536544370|FG001|Overall Study|Discontinued due to study closure.|0|||
148747380|NCT04380961|536544371|FG000|Overall Study|Lost to Follow-up|17|||
148747381|NCT04380961|536544372|FG001|Overall Study|Lost to Follow-up|11|||
148747382|NCT04380961|536544371|FG000|Overall Study|Withdrawal by Subject|3|||
148747383|NCT04380961|536544372|FG001|Overall Study|Withdrawal by Subject|0|||
148747384|NCT04380961|536544371|FG000|Overall Study|Death|22|||
148747385|NCT04380961|536544372|FG001|Overall Study|Death|16|||
148747386|NCT04380961|536544371|FG000|Overall Study|Other|1|||
148747387|NCT04380961|536544372|FG001|Overall Study|Other|0|||
148747388|NCT04380961|536544371|FG000|Overall Study|Randomized but Not Treated|1|||
148747389|NCT04380961|536544372|FG001|Overall Study|Randomized but Not Treated|2|||
148747390|NCT04803305|536544373|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
148747391|NCT04803305|536544374|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
148747392|NCT04803305|536544373|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
148747393|NCT04803305|536544374|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
148747394|NCT04803305|536544373|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
148747395|NCT04803305|536544374|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
148747396|NCT04803305|536544373|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
148747397|NCT04803305|536544374|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
148747398|NCT04803305|536544373|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
148747399|NCT04803305|536544374|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
148747400|NCT04803305|536544373|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
148747401|NCT04803305|536544374|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
148747402|NCT04803305|536544373|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
148747403|NCT04803305|536544374|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
148747404|NCT04803305|536544373|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
148747405|NCT04803305|536544374|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
148747406|NCT01862484|536544376|FG000|Overall Study|Lack of Efficacy|1|||
148747407|NCT01862484|536544377|FG001|Overall Study|Lack of Efficacy|1|||
148747408|NCT01862484|536544376|FG000|Overall Study|Lost to Follow-up|1|||
148747409|NCT01862484|536544377|FG001|Overall Study|Lost to Follow-up|2|||
148747410|NCT01862484|536544376|FG000|Overall Study|Protocol Violation|0|||
148747411|NCT01862484|536544377|FG001|Overall Study|Protocol Violation|2|||
148747412|NCT01862484|536544376|FG000|Overall Study|Withdrawal by Subject|0|||
148747413|NCT01862484|536544377|FG001|Overall Study|Withdrawal by Subject|3|||
148747414|NCT00721227|536544378|FG000|Overall Study|Lost to Follow-up|3|||
148747415|NCT00721227|536544379|FG001|Overall Study|Lost to Follow-up|0|||
148747416|NCT00721227|536544378|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
148747417|NCT00721227|536544379|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
148747418|NCT03207867|536544380|FG000|Overall Study|Adverse Event|1|||
148747419|NCT03207867|536544381|FG001|Overall Study|Adverse Event|0|||
148747420|NCT03207867|536544382|FG002|Overall Study|Adverse Event|1|||
148747421|NCT03207867|536544383|FG003|Overall Study|Adverse Event|0|||
148747422|NCT03207867|536544384|FG004|Overall Study|Adverse Event|0|||
148747423|NCT03207867|536544385|FG005|Overall Study|Adverse Event|2|||
148747424|NCT03207867|536544386|FG006|Overall Study|Adverse Event|1|||
148747425|NCT03207867|536544387|FG007|Overall Study|Adverse Event|1|||
148747426|NCT03207867|536544388|FG008|Overall Study|Adverse Event|2|||
148747427|NCT03207867|536544389|FG009|Overall Study|Adverse Event|2|||
148747428|NCT03207867|536544390|FG010|Overall Study|Adverse Event|0|||
148747429|NCT03207867|536544391|FG011|Overall Study|Adverse Event|0|||
148747430|NCT03207867|536544392|FG012|Overall Study|Adverse Event|0|||
148747431|NCT03207867|536544393|FG013|Overall Study|Adverse Event|0|||
148747432|NCT03207867|536544394|FG014|Overall Study|Adverse Event|0|||
148747433|NCT03207867|536544395|FG015|Overall Study|Adverse Event|0|||
148747434|NCT03207867|536544396|FG016|Overall Study|Adverse Event|3|||
148747435|NCT03207867|536544397|FG017|Overall Study|Adverse Event|1|||
148747436|NCT03207867|536544398|FG018|Overall Study|Adverse Event|2|||
148747437|NCT03207867|536544399|FG019|Overall Study|Adverse Event|1|||
148747438|NCT03207867|536544400|FG020|Overall Study|Adverse Event|0|||
148747439|NCT03207867|536544401|FG021|Overall Study|Adverse Event|0|||
148747440|NCT03207867|536544402|FG022|Overall Study|Adverse Event|0|||
148747441|NCT03207867|536544403|FG023|Overall Study|Adverse Event|0|||
148747442|NCT03207867|536544380|FG000|Overall Study|Death|0|||
148747443|NCT03207867|536544381|FG001|Overall Study|Death|0|||
148747444|NCT03207867|536544382|FG002|Overall Study|Death|0|||
148747445|NCT03207867|536544383|FG003|Overall Study|Death|0|||
148747446|NCT03207867|536544384|FG004|Overall Study|Death|0|||
148747447|NCT03207867|536544385|FG005|Overall Study|Death|1|||
148747448|NCT03207867|536544386|FG006|Overall Study|Death|0|||
148747449|NCT03207867|536544387|FG007|Overall Study|Death|3|||
148747450|NCT03207867|536544388|FG008|Overall Study|Death|1|||
148747451|NCT03207867|536544389|FG009|Overall Study|Death|2|||
148747452|NCT03207867|536544390|FG010|Overall Study|Death|0|||
148747453|NCT03207867|536544391|FG011|Overall Study|Death|1|||
148747454|NCT03207867|536544392|FG012|Overall Study|Death|0|||
148747455|NCT03207867|536544393|FG013|Overall Study|Death|1|||
148747456|NCT03207867|536544394|FG014|Overall Study|Death|0|||
148747457|NCT03207867|536544395|FG015|Overall Study|Death|0|||
148976108|NCT01038778|537392451|FG001|Overall Study|Withdrawal by Subject|2|||
148747458|NCT03207867|536544396|FG016|Overall Study|Death|0|||
148747459|NCT03207867|536544397|FG017|Overall Study|Death|2|||
148747460|NCT03207867|536544398|FG018|Overall Study|Death|0|||
148747461|NCT03207867|536544399|FG019|Overall Study|Death|1|||
148747462|NCT03207867|536544400|FG020|Overall Study|Death|0|||
148747463|NCT03207867|536544401|FG021|Overall Study|Death|0|||
148747464|NCT03207867|536544402|FG022|Overall Study|Death|0|||
148747465|NCT03207867|536544403|FG023|Overall Study|Death|0|||
148747466|NCT03207867|536544380|FG000|Overall Study|Physician Decision|3|||
148747467|NCT03207867|536544381|FG001|Overall Study|Physician Decision|5|||
148747468|NCT03207867|536544382|FG002|Overall Study|Physician Decision|0|||
148747469|NCT03207867|536544383|FG003|Overall Study|Physician Decision|3|||
148747470|NCT03207867|536544384|FG004|Overall Study|Physician Decision|2|||
148747471|NCT03207867|536544385|FG005|Overall Study|Physician Decision|0|||
148747472|NCT03207867|536544386|FG006|Overall Study|Physician Decision|0|||
148747473|NCT03207867|536544387|FG007|Overall Study|Physician Decision|0|||
148747474|NCT03207867|536544388|FG008|Overall Study|Physician Decision|4|||
148747475|NCT03207867|536544389|FG009|Overall Study|Physician Decision|2|||
148747476|NCT03207867|536544390|FG010|Overall Study|Physician Decision|0|||
148747477|NCT03207867|536544391|FG011|Overall Study|Physician Decision|4|||
148747478|NCT03207867|536544392|FG012|Overall Study|Physician Decision|0|||
148747479|NCT03207867|536544393|FG013|Overall Study|Physician Decision|0|||
148747480|NCT03207867|536544394|FG014|Overall Study|Physician Decision|2|||
148747481|NCT03207867|536544395|FG015|Overall Study|Physician Decision|1|||
148747482|NCT03207867|536544396|FG016|Overall Study|Physician Decision|1|||
148747483|NCT03207867|536544397|FG017|Overall Study|Physician Decision|2|||
148747484|NCT03207867|536544398|FG018|Overall Study|Physician Decision|1|||
148747485|NCT03207867|536544399|FG019|Overall Study|Physician Decision|3|||
148747486|NCT03207867|536544400|FG020|Overall Study|Physician Decision|0|||
148747487|NCT03207867|536544401|FG021|Overall Study|Physician Decision|0|||
148747488|NCT03207867|536544402|FG022|Overall Study|Physician Decision|0|||
148747489|NCT03207867|536544403|FG023|Overall Study|Physician Decision|0|||
148747490|NCT03207867|536544380|FG000|Overall Study|Progressive Disease|7|||
148747491|NCT03207867|536544381|FG001|Overall Study|Progressive Disease|7|||
148747492|NCT03207867|536544382|FG002|Overall Study|Progressive Disease|9|||
148747493|NCT03207867|536544383|FG003|Overall Study|Progressive Disease|10|||
148747494|NCT03207867|536544384|FG004|Overall Study|Progressive Disease|11|||
148747495|NCT03207867|536544385|FG005|Overall Study|Progressive Disease|10|||
148747496|NCT03207867|536544386|FG006|Overall Study|Progressive Disease|9|||
148747497|NCT03207867|536544387|FG007|Overall Study|Progressive Disease|8|||
148747498|NCT03207867|536544388|FG008|Overall Study|Progressive Disease|19|||
148747499|NCT03207867|536544389|FG009|Overall Study|Progressive Disease|23|||
148747500|NCT03207867|536544390|FG010|Overall Study|Progressive Disease|2|||
148747501|NCT03207867|536544391|FG011|Overall Study|Progressive Disease|24|||
148747502|NCT03207867|536544392|FG012|Overall Study|Progressive Disease|3|||
148747503|NCT03207867|536544393|FG013|Overall Study|Progressive Disease|11|||
148747504|NCT03207867|536544394|FG014|Overall Study|Progressive Disease|9|||
148747505|NCT03207867|536544395|FG015|Overall Study|Progressive Disease|5|||
148747506|NCT03207867|536544396|FG016|Overall Study|Progressive Disease|10|||
148747507|NCT03207867|536544397|FG017|Overall Study|Progressive Disease|14|||
148747508|NCT03207867|536544398|FG018|Overall Study|Progressive Disease|13|||
148747509|NCT03207867|536544399|FG019|Overall Study|Progressive Disease|14|||
148747510|NCT03207867|536544400|FG020|Overall Study|Progressive Disease|6|||
148747511|NCT03207867|536544401|FG021|Overall Study|Progressive Disease|3|||
148747512|NCT03207867|536544402|FG022|Overall Study|Progressive Disease|3|||
148747513|NCT03207867|536544403|FG023|Overall Study|Progressive Disease|3|||
148747514|NCT03207867|536544380|FG000|Overall Study|Patient/guardian Decision|0|||
148747515|NCT03207867|536544381|FG001|Overall Study|Patient/guardian Decision|0|||
148747516|NCT03207867|536544382|FG002|Overall Study|Patient/guardian Decision|1|||
148747517|NCT03207867|536544383|FG003|Overall Study|Patient/guardian Decision|1|||
148747518|NCT03207867|536544384|FG004|Overall Study|Patient/guardian Decision|1|||
148747519|NCT03207867|536544385|FG005|Overall Study|Patient/guardian Decision|2|||
148747520|NCT03207867|536544386|FG006|Overall Study|Patient/guardian Decision|1|||
148747521|NCT03207867|536544387|FG007|Overall Study|Patient/guardian Decision|0|||
148747522|NCT03207867|536544388|FG008|Overall Study|Patient/guardian Decision|1|||
148747523|NCT03207867|536544389|FG009|Overall Study|Patient/guardian Decision|0|||
148747524|NCT03207867|536544390|FG010|Overall Study|Patient/guardian Decision|0|||
148747525|NCT03207867|536544391|FG011|Overall Study|Patient/guardian Decision|1|||
148747526|NCT03207867|536544392|FG012|Overall Study|Patient/guardian Decision|0|||
148747527|NCT03207867|536544393|FG013|Overall Study|Patient/guardian Decision|1|||
148747528|NCT03207867|536544394|FG014|Overall Study|Patient/guardian Decision|2|||
148747529|NCT03207867|536544395|FG015|Overall Study|Patient/guardian Decision|0|||
148747530|NCT03207867|536544396|FG016|Overall Study|Patient/guardian Decision|1|||
148747531|NCT03207867|536544397|FG017|Overall Study|Patient/guardian Decision|3|||
148747532|NCT03207867|536544398|FG018|Overall Study|Patient/guardian Decision|4|||
148747533|NCT03207867|536544399|FG019|Overall Study|Patient/guardian Decision|1|||
148747534|NCT03207867|536544400|FG020|Overall Study|Patient/guardian Decision|0|||
148747535|NCT03207867|536544401|FG021|Overall Study|Patient/guardian Decision|0|||
148747536|NCT03207867|536544402|FG022|Overall Study|Patient/guardian Decision|0|||
149027201|NCT05174065|537576539|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
149027202|NCT05174065|537576540|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
148747537|NCT03207867|536544403|FG023|Overall Study|Patient/guardian Decision|0|||
148747538|NCT05938621|536546352|FG000|Overall Study|Lost to Follow-up|1|||
148747539|NCT05938621|536546353|FG001|Overall Study|Lost to Follow-up|5|||
148747540|NCT05938621|536546354|FG002|Overall Study|Lost to Follow-up|2|||
148747541|NCT05938621|536546355|FG003|Overall Study|Lost to Follow-up|2|||
148747542|NCT01059786|536546357|FG000|Overall Study|Did not receive 6 cycles.|0|||
148747543|NCT01059786|536546358|FG001|Overall Study|Did not receive 6 cycles.|0|||
148747544|NCT01059786|536546359|FG002|Overall Study|Did not receive 6 cycles.|4|||
148747545|NCT01059786|536546360|FG003|Overall Study|Did not receive 6 cycles.|1|||
148820957|NCT00114777|536822437|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
148747546|NCT01059786|536546361|FG004|Overall Study|Did not receive 6 cycles.|0|||
148747547|NCT04205812|536546362|FG000|Randomized Treatment Period|Ongoing|28|||
148747548|NCT04205812|536546363|FG001|Randomized Treatment Period|Ongoing|138|||
148747549|NCT04205812|536546362|FG000|Randomized Treatment Period|Death|94|||
148747550|NCT04205812|536546363|FG001|Randomized Treatment Period|Death|226|||
148747551|NCT04205812|536546362|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
148747552|NCT04205812|536546363|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
148747553|NCT04205812|536546362|FG000|Randomized Treatment Period|Physician Decision|1|||
148747554|NCT04205812|536546363|FG001|Randomized Treatment Period|Physician Decision|4|||
148747555|NCT04205812|536546362|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
148747556|NCT04205812|536546363|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
148747557|NCT04205812|536546362|FG000|Randomized Treatment Period|Progressive Disease|0|||
148747558|NCT04205812|536546363|FG001|Randomized Treatment Period|Progressive Disease|1|||
148747559|NCT04205812|536546362|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
148747560|NCT04205812|536546363|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
148747561|NCT04205812|536546362|FG000|Monotherapy Treatment Period|Ongoing|17|||
148747562|NCT04205812|536546363|FG001|Monotherapy Treatment Period|Ongoing|0|||
148747563|NCT04205812|536546362|FG000|Monotherapy Treatment Period|Death|39|||
148747564|NCT04205812|536546363|FG001|Monotherapy Treatment Period|Death|0|||
148747565|NCT04205812|536546362|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
148747566|NCT04205812|536546363|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
148747567|NCT04205812|536546362|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
148747568|NCT04205812|536546363|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
148747569|NCT04559347|536546364|FG000|Overall Study|Death|1|||
148747570|NCT04559347|536546365|FG001|Overall Study|Death|0|||
148747571|NCT04559347|536546364|FG000|Overall Study|Thoracotomy conversion|1|||
148747572|NCT04559347|536546365|FG001|Overall Study|Thoracotomy conversion|1|||
148747573|NCT04559347|536546364|FG000|Overall Study|Provider unavailable|2|||
148747574|NCT04559347|536546365|FG001|Overall Study|Provider unavailable|1|||
148747575|NCT04559347|536546364|FG000|Overall Study|Other|2|||
148747576|NCT04559347|536546365|FG001|Overall Study|Other|1|||
148747577|NCT00371033|536546366|FG000|Overall Study|Lost to Follow-up|3|||
148747578|NCT00371033|536546367|FG001|Overall Study|Lost to Follow-up|2|||
148747579|NCT00371033|536546366|FG000|Overall Study|No longer interested|2|||
148747580|NCT00371033|536546367|FG001|Overall Study|No longer interested|0|||
148747581|NCT00371033|536546366|FG000|Overall Study|Uknown|3|||
148747582|NCT00371033|536546367|FG001|Overall Study|Uknown|1|||
148747583|NCT05026177|536546370|FG000|Overall Study|Adverse Event|33|||
148747584|NCT05026177|536546371|FG001|Overall Study|Adverse Event|33|||
148747585|NCT05026177|536546372|FG002|Overall Study|Adverse Event|17|||
148747586|NCT05026177|536546370|FG000|Overall Study|Lost to Follow-up|7|||
148747587|NCT05026177|536546371|FG001|Overall Study|Lost to Follow-up|6|||
148747588|NCT05026177|536546372|FG002|Overall Study|Lost to Follow-up|8|||
148747589|NCT05026177|536546370|FG000|Overall Study|Noncompliance with study drug|6|||
148747590|NCT05026177|536546371|FG001|Overall Study|Noncompliance with study drug|2|||
148747591|NCT05026177|536546372|FG002|Overall Study|Noncompliance with study drug|1|||
148747592|NCT05026177|536546370|FG000|Overall Study|Physician Decision|4|||
148747593|NCT05026177|536546371|FG001|Overall Study|Physician Decision|1|||
148747594|NCT05026177|536546372|FG002|Overall Study|Physician Decision|0|||
148747595|NCT05026177|536546370|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
148747596|NCT05026177|536546371|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
148747597|NCT05026177|536546372|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
148747598|NCT05026177|536546370|FG000|Overall Study|Withdrawal by Subject|53|||
148747599|NCT05026177|536546371|FG001|Overall Study|Withdrawal by Subject|51|||
148747600|NCT05026177|536546372|FG002|Overall Study|Withdrawal by Subject|55|||
148747601|NCT05026177|536546370|FG000|Overall Study|Protocol Violation|0|||
148747602|NCT05026177|536546371|FG001|Overall Study|Protocol Violation|1|||
148747603|NCT05026177|536546372|FG002|Overall Study|Protocol Violation|0|||
148747604|NCT05026177|536546370|FG000|Overall Study|Study terminated by sponsor|70|||
148747605|NCT05026177|536546371|FG001|Overall Study|Study terminated by sponsor|74|||
148747606|NCT05026177|536546372|FG002|Overall Study|Study terminated by sponsor|67|||
148747607|NCT05026177|536546370|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
148747608|NCT05026177|536546371|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
148747609|NCT05026177|536546372|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
148747610|NCT05026177|536546370|FG000|Overall Study|Starting alternative treatment|0|||
148747611|NCT05026177|536546371|FG001|Overall Study|Starting alternative treatment|1|||
148747612|NCT05026177|536546372|FG002|Overall Study|Starting alternative treatment|1|||
148747613|NCT05026177|536546370|FG000|Overall Study|Noncompliance with study procedures|0|||
148747614|NCT05026177|536546371|FG001|Overall Study|Noncompliance with study procedures|1|||
148747615|NCT05026177|536546372|FG002|Overall Study|Noncompliance with study procedures|1|||
148747616|NCT05026177|536546370|FG000|Overall Study|Met stopping criteria|0|||
148747617|NCT05026177|536546371|FG001|Overall Study|Met stopping criteria|0|||
148747618|NCT05026177|536546372|FG002|Overall Study|Met stopping criteria|1|||
148747619|NCT05026177|536546370|FG000|Overall Study|Health issues preventing continuation|0|||
148747620|NCT05026177|536546371|FG001|Overall Study|Health issues preventing continuation|0|||
148747621|NCT05026177|536546372|FG002|Overall Study|Health issues preventing continuation|1|||
148747622|NCT05026177|536546370|FG000|Overall Study|Randomized in error, not treated|0|||
148820958|NCT00114777|536822435|FG000|Randomization to Month 36|Lack of Efficacy|19|||
148820959|NCT00114777|536822436|FG001|Randomization to Month 36|Lack of Efficacy|15|||
148820960|NCT00114777|536822437|FG002|Randomization to Month 36|Lack of Efficacy|17|||
148820961|NCT00114777|536822435|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
148820962|NCT00114777|536822436|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
148820963|NCT00114777|536822437|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
148820964|NCT00114777|536822435|FG000|Randomization to Month 36|Adverse Event|34|||
148820965|NCT00114777|536822436|FG001|Randomization to Month 36|Adverse Event|35|||
148820966|NCT00114777|536822437|FG002|Randomization to Month 36|Adverse Event|44|||
148820967|NCT00114777|536822435|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
148820968|NCT00114777|536822436|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
148820969|NCT00114777|536822437|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
148820970|NCT00114777|536822435|FG000|Randomization to Month 36|Other|9|||
148820971|NCT00114777|536822436|FG001|Randomization to Month 36|Other|3|||
148820972|NCT00114777|536822437|FG002|Randomization to Month 36|Other|12|||
148820973|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Death|8|||
148747623|NCT05026177|536546371|FG001|Overall Study|Randomized in error, not treated|0|||
148747624|NCT05026177|536546372|FG002|Overall Study|Randomized in error, not treated|2|||
148747625|NCT03816878|536546379|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
148747626|NCT03816878|536546380|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
148820974|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Death|13|||
148820975|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Death|7|||
148820976|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
148820977|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
148820978|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
148820979|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
148820980|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
148820981|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
148820982|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
148820983|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
148820984|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
148820985|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
148820986|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
148820987|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
148820988|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
148820989|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
148820990|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
148820991|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
148820992|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
148820993|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
148820994|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
148820995|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
148820996|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
148820997|NCT00114777|536822435|FG000|Long-Term Extension to Month 84|Other|2|||
148820998|NCT00114777|536822436|FG001|Long-Term Extension to Month 84|Other|0|||
148820999|NCT00114777|536822437|FG002|Long-Term Extension to Month 84|Other|2|||
148821000|NCT04477486|536822441|FG000|Overall Study|Death|2|||
148821001|NCT04477486|536822441|FG000|Overall Study|Ongoing at Time of Analysis|11|||
148821002|NCT04576949|536822443|FG000|Overall Study|Adverse Event|1|||
148821003|NCT04576949|536822444|FG001|Overall Study|Adverse Event|3|||
148821004|NCT04576949|536822445|FG002|Overall Study|Adverse Event|2|||
148821005|NCT04576949|536822443|FG000|Overall Study|Withdrawal by Subject|41|||
148976109|NCT01038778|537392452|FG002|Overall Study|Withdrawal by Subject|3|||
148976110|NCT05645432|537392453|FG000|Overall Study|Withdrawal by Subject|1|||
148747627|NCT03816878|536546379|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
148747628|NCT03816878|536546380|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
148747629|NCT03355469|536546381|FG000|Overall Study|COVID-19|3|||
148747630|NCT03355469|536546382|FG001|Overall Study|COVID-19|2|||
148747631|NCT03355469|536546383|FG002|Overall Study|COVID-19|3|||
148747632|NCT03355469|536546384|FG003|Overall Study|COVID-19|3|||
148747633|NCT03355469|536546381|FG000|Overall Study|Lost to Follow-up|1|||
148747634|NCT03355469|536546382|FG001|Overall Study|Lost to Follow-up|0|||
148747635|NCT03355469|536546383|FG002|Overall Study|Lost to Follow-up|1|||
148747636|NCT03355469|536546384|FG003|Overall Study|Lost to Follow-up|0|||
148747637|NCT03355469|536546381|FG000|Overall Study|Withdrawal by Subject|2|||
148747638|NCT03355469|536546382|FG001|Overall Study|Withdrawal by Subject|1|||
148747639|NCT03355469|536546383|FG002|Overall Study|Withdrawal by Subject|0|||
148747640|NCT03355469|536546384|FG003|Overall Study|Withdrawal by Subject|3|||
148821006|NCT04576949|536822444|FG001|Overall Study|Withdrawal by Subject|26|||
148821007|NCT04576949|536822445|FG002|Overall Study|Withdrawal by Subject|18|||
148821008|NCT04576949|536822443|FG000|Overall Study|Physician Decision|3|||
148747641|NCT05626231|536546385|FG000|Provider Enrollment|Worked part-time|4|||
148747642|NCT05626231|536546385|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
148747643|NCT05626231|536546385|FG000|Provider Enrollment|Non-clinical employee|1|||
148747644|NCT05626231|536546385|FG000|Provider Enrollment|Provider does not see clients|3|||
148747645|NCT05626231|536546385|FG000|Provider Enrollment|Other|5|||
148747646|NCT03765788|536546387|FG000|Overall Study|Subject decision|2|||
148747647|NCT03765788|536546388|FG001|Overall Study|Subject decision|3|||
148747648|NCT03765788|536546387|FG000|Overall Study|Physician Decision|2|||
148747649|NCT03765788|536546388|FG001|Overall Study|Physician Decision|4|||
148747650|NCT03765788|536546387|FG000|Overall Study|Death|0|||
148747651|NCT03765788|536546388|FG001|Overall Study|Death|1|||
148747652|NCT03765788|536546387|FG000|Overall Study|Lost to Follow-up|1|||
148747653|NCT03765788|536546388|FG001|Overall Study|Lost to Follow-up|0|||
148747654|NCT03203850|536546389|FG000|Overall Study|Subject/guardian decision|4|||
148747655|NCT03203850|536546390|FG001|Overall Study|Subject/guardian decision|3|||
148747656|NCT03203850|536546389|FG000|Overall Study|Adverse Event|3|||
148747657|NCT03203850|536546390|FG001|Overall Study|Adverse Event|0|||
148747658|NCT03203850|536546389|FG000|Overall Study|Death|1|||
148747659|NCT03203850|536546390|FG001|Overall Study|Death|0|||
148747660|NCT02717455|536546391|FG000|Overall Study|Adverse Event|1|||
148747661|NCT02717455|536546392|FG001|Overall Study|Adverse Event|0|||
148747662|NCT02717455|536546393|FG002|Overall Study|Adverse Event|0|||
148747663|NCT02717455|536546394|FG003|Overall Study|Adverse Event|2|||
148747664|NCT02717455|536546395|FG004|Overall Study|Adverse Event|2|||
148747665|NCT02717455|536546396|FG005|Overall Study|Adverse Event|2|||
148747666|NCT02717455|536546391|FG000|Overall Study|Withdrawal by Subject|1|||
148747667|NCT02717455|536546392|FG001|Overall Study|Withdrawal by Subject|1|||
148747668|NCT02717455|536546393|FG002|Overall Study|Withdrawal by Subject|0|||
148747669|NCT02717455|536546394|FG003|Overall Study|Withdrawal by Subject|2|||
148747670|NCT02717455|536546395|FG004|Overall Study|Withdrawal by Subject|2|||
148747671|NCT02717455|536546396|FG005|Overall Study|Withdrawal by Subject|1|||
148747672|NCT02717455|536546391|FG000|Overall Study|Death|1|||
148747673|NCT02717455|536546392|FG001|Overall Study|Death|0|||
148747674|NCT02717455|536546393|FG002|Overall Study|Death|0|||
148747675|NCT02717455|536546394|FG003|Overall Study|Death|0|||
148747676|NCT02717455|536546395|FG004|Overall Study|Death|1|||
148747677|NCT02717455|536546396|FG005|Overall Study|Death|0|||
148747678|NCT02717455|536546391|FG000|Overall Study|Did not receive study drug|0|||
148747679|NCT02717455|536546392|FG001|Overall Study|Did not receive study drug|0|||
148747680|NCT02717455|536546393|FG002|Overall Study|Did not receive study drug|0|||
148747681|NCT02717455|536546394|FG003|Overall Study|Did not receive study drug|1|||
148747682|NCT02717455|536546395|FG004|Overall Study|Did not receive study drug|0|||
148747683|NCT02717455|536546396|FG005|Overall Study|Did not receive study drug|1|||
148747684|NCT02717455|536546391|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
148747685|NCT02717455|536546392|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
148747686|NCT02717455|536546393|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
148747687|NCT02717455|536546394|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
148747688|NCT02717455|536546395|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
148747689|NCT02717455|536546396|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
148747690|NCT02717455|536546391|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
148747691|NCT02717455|536546392|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
148747692|NCT02717455|536546393|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
148747693|NCT02717455|536546394|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
148747694|NCT02717455|536546395|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
148747695|NCT02717455|536546396|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
148747696|NCT00733005|536546399|FG000|Overall Study|Adverse Event|0|||
148747697|NCT00733005|536546400|FG001|Overall Study|Adverse Event|1|||
148747698|NCT00733005|536546399|FG000|Overall Study|Treatment Failure|0|||
148747699|NCT00733005|536546400|FG001|Overall Study|Treatment Failure|1|||
148747700|NCT00733005|536546399|FG000|Overall Study|Withdrawal by Subject|0|||
148747701|NCT00733005|536546400|FG001|Overall Study|Withdrawal by Subject|1|||
148747702|NCT00733005|536546399|FG000|Overall Study|Protocol Violation|2|||
148747703|NCT00733005|536546400|FG001|Overall Study|Protocol Violation|0|||
148747704|NCT01769456|536546401|FG000|Overall Study|Lost to Follow-up|19|||
148747705|NCT01769456|536546401|FG000|Overall Study|Withdrawal by Subject|3|||
148747706|NCT01769456|536546401|FG000|Overall Study|Did not receive PCC intervention|6|||
148747707|NCT01769456|536546401|FG000|Overall Study|Moved out of the area|3|||
148747708|NCT01769456|536546401|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
148747709|NCT01769456|536546401|FG000|Overall Study|Parental request to youth to withdraw|1|||
148747710|NCT02465398|536546408|FG000|Overall Study|Death|7|||
148747711|NCT02465398|536546408|FG000|Overall Study|Revision|7|||
148747712|NCT02465398|536546408|FG000|Overall Study|did not receive study device|1|||
148747713|NCT02465398|536546408|FG000|Overall Study|Withdrawal by Subject|1|||
148747714|NCT02465398|536546408|FG000|Overall Study|Lost to Follow-up|14|||
148747715|NCT05244122|536546413|FG000|Overall Study|Withdrawal by Subject|318|||
148747716|NCT02969382|536546416|FG000|Overall Study|Adverse Event|8|||
148747717|NCT02969382|536546417|FG001|Overall Study|Adverse Event|10|||
148747718|NCT02969382|536546416|FG000|Overall Study|Lack of Efficacy|4|||
148747719|NCT02969382|536546417|FG001|Overall Study|Lack of Efficacy|5|||
148747720|NCT02969382|536546416|FG000|Overall Study|Death|0|||
148747721|NCT02969382|536546417|FG001|Overall Study|Death|1|||
148747722|NCT02969382|536546416|FG000|Overall Study|PROTOCOL DEVIATION|0|||
148747723|NCT02969382|536546417|FG001|Overall Study|PROTOCOL DEVIATION|1|||
148747724|NCT02969382|536546416|FG000|Overall Study|Withdrawal by Subject|14|||
148747725|NCT02969382|536546417|FG001|Overall Study|Withdrawal by Subject|9|||
148747726|NCT01625988|536546429|FG000|Overall Study|Lost to Follow-up|5|||
148747727|NCT01625988|536546430|FG001|Overall Study|Lost to Follow-up|6|||
148747728|NCT01625988|536546429|FG000|Overall Study|Withdrawal by Subject|8|||
148747729|NCT01625988|536546430|FG001|Overall Study|Withdrawal by Subject|3|||
148747730|NCT01625988|536546429|FG000|Overall Study|Adverse Event|0|||
148747731|NCT01625988|536546430|FG001|Overall Study|Adverse Event|1|||
148747732|NCT01625988|536546429|FG000|Overall Study|Lack of Efficacy|0|||
148747733|NCT01625988|536546430|FG001|Overall Study|Lack of Efficacy|1|||
148747734|NCT01625988|536546429|FG000|Overall Study|Randomized Inappropriately|1|||
148747735|NCT01625988|536546430|FG001|Overall Study|Randomized Inappropriately|0|||
148747736|NCT01625988|536546429|FG000|Overall Study|Protocol Violation|0|||
148747737|NCT01625988|536546430|FG001|Overall Study|Protocol Violation|2|||
148747738|NCT01937871|536546432|FG000|Overall Study|Adverse Event|6|||
148747739|NCT01937871|536546433|FG001|Overall Study|Adverse Event|6|||
148747740|NCT01937871|536546434|FG002|Overall Study|Adverse Event|2|||
148747741|NCT01937871|536546432|FG000|Overall Study|Lost to Follow-up|8|||
148747742|NCT01937871|536546433|FG001|Overall Study|Lost to Follow-up|2|||
148747743|NCT01937871|536546434|FG002|Overall Study|Lost to Follow-up|4|||
148747744|NCT01937871|536546432|FG000|Overall Study|Withdrawal by Subject|9|||
148747745|NCT01937871|536546433|FG001|Overall Study|Withdrawal by Subject|6|||
148747746|NCT01937871|536546434|FG002|Overall Study|Withdrawal by Subject|4|||
148747747|NCT01937871|536546432|FG000|Overall Study|Physician Decision|0|||
148747748|NCT01937871|536546433|FG001|Overall Study|Physician Decision|1|||
148747749|NCT01937871|536546434|FG002|Overall Study|Physician Decision|0|||
148747750|NCT01937871|536546432|FG000|Overall Study|Entry Criteria Not Met|1|||
148747751|NCT01937871|536546433|FG001|Overall Study|Entry Criteria Not Met|2|||
148747752|NCT01937871|536546434|FG002|Overall Study|Entry Criteria Not Met|1|||
148747753|NCT00799058|536546435|FG000|Overall Study|Withdrawal by Subject|2|||
148747754|NCT00799058|536546436|FG001|Overall Study|Withdrawal by Subject|2|||
148747755|NCT00799058|536546437|FG002|Overall Study|Withdrawal by Subject|2|||
148747756|NCT00799058|536546435|FG000|Overall Study|Lost to Follow-up|1|||
148747757|NCT00799058|536546436|FG001|Overall Study|Lost to Follow-up|2|||
148747758|NCT00799058|536546437|FG002|Overall Study|Lost to Follow-up|1|||
148747759|NCT00799058|536546435|FG000|Overall Study|Adverse Event|0|||
148747760|NCT00799058|536546436|FG001|Overall Study|Adverse Event|2|||
148747761|NCT00799058|536546437|FG002|Overall Study|Adverse Event|0|||
148747762|NCT00799058|536546435|FG000|Overall Study|Pregnancy|1|||
148747763|NCT00799058|536546436|FG001|Overall Study|Pregnancy|0|||
148747764|NCT00799058|536546437|FG002|Overall Study|Pregnancy|0|||
148747765|NCT00799058|536546435|FG000|Overall Study|Not adherent|3|||
148747766|NCT00799058|536546436|FG001|Overall Study|Not adherent|2|||
148747767|NCT00799058|536546437|FG002|Overall Study|Not adherent|1|||
148747768|NCT00799058|536546435|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
148747769|NCT00799058|536546436|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
148747770|NCT00799058|536546437|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
148747771|NCT00799058|536546435|FG000|Overall Study|IP dispensing error|1|||
148747772|NCT00799058|536546436|FG001|Overall Study|IP dispensing error|0|||
148747773|NCT00799058|536546437|FG002|Overall Study|IP dispensing error|0|||
148747774|NCT00799058|536546435|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
148747775|NCT00799058|536546436|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
148747776|NCT00799058|536546437|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
148747777|NCT00799058|536546435|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
148747778|NCT00799058|536546436|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
148747779|NCT00799058|536546437|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
148747780|NCT00799058|536546435|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
148747781|NCT00799058|536546436|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
148747782|NCT00799058|536546437|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
148747783|NCT00799058|536546435|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
148747784|NCT00799058|536546436|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
148747785|NCT00799058|536546437|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
148747786|NCT02088697|536546438|FG000|Period I|Physician Decision|1|||
148747787|NCT02088697|536546439|FG001|Period I|Physician Decision|4|||
148747788|NCT02088697|536546438|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
148821009|NCT04576949|536822444|FG001|Overall Study|Physician Decision|0|||
148821010|NCT04576949|536822445|FG002|Overall Study|Physician Decision|0|||
148821011|NCT04576949|536822443|FG000|Overall Study|Death|0|||
148821012|NCT04576949|536822444|FG001|Overall Study|Death|1|||
148821013|NCT04576949|536822445|FG002|Overall Study|Death|0|||
148821014|NCT04576949|536822443|FG000|Overall Study|Lost to Follow-up|29|||
148821015|NCT04576949|536822444|FG001|Overall Study|Lost to Follow-up|37|||
148821016|NCT04576949|536822445|FG002|Overall Study|Lost to Follow-up|24|||
148821017|NCT04576949|536822443|FG000|Overall Study|Other, Not Specified|2|||
148821018|NCT04576949|536822444|FG001|Overall Study|Other, Not Specified|3|||
148821019|NCT04576949|536822445|FG002|Overall Study|Other, Not Specified|1|||
148821020|NCT04576949|536822443|FG000|Overall Study|Other|1|||
148821021|NCT04576949|536822444|FG001|Overall Study|Other|0|||
148821022|NCT04576949|536822445|FG002|Overall Study|Other|0|||
148821023|NCT03511066|536822451|FG000|Overall Study|Withdrawal by Subject|1|||
148821024|NCT03511066|536822452|FG001|Overall Study|Withdrawal by Subject|2|||
148821025|NCT03511066|536822453|FG002|Overall Study|Withdrawal by Subject|3|||
148821026|NCT03511066|536822451|FG000|Overall Study|Lost to Follow-up|2|||
148821027|NCT03511066|536822452|FG001|Overall Study|Lost to Follow-up|3|||
148821028|NCT03511066|536822453|FG002|Overall Study|Lost to Follow-up|0|||
148821029|NCT04193527|536822456|FG000|Overall Study|Other|1|||
148821030|NCT04193527|536822457|FG001|Overall Study|Other|1|||
148821031|NCT04193527|536822458|FG002|Overall Study|Other|0|||
148821032|NCT03336866|536822459|FG000|Overall Study|Lost to Follow-up|2|||
148821033|NCT03336866|536822460|FG001|Overall Study|Lost to Follow-up|0|||
148821034|NCT03336866|536822461|FG002|Overall Study|Lost to Follow-up|3|||
148821035|NCT03336866|536822459|FG000|Overall Study|Withdrawal by Subject|1|||
148821036|NCT03336866|536822460|FG001|Overall Study|Withdrawal by Subject|1|||
148821037|NCT03336866|536822461|FG002|Overall Study|Withdrawal by Subject|0|||
148821038|NCT03336866|536822459|FG000|Overall Study|Noncompliance with clinic house rules|0|||
148821039|NCT03336866|536822460|FG001|Overall Study|Noncompliance with clinic house rules|0|||
148821040|NCT03336866|536822461|FG002|Overall Study|Noncompliance with clinic house rules|1|||
148821041|NCT01125748|536822464|FG000|Overall Study|Adverse Event|0|||
148821042|NCT01125748|536822465|FG001|Overall Study|Adverse Event|2|||
148821043|NCT01125748|536822464|FG000|Overall Study|Lost to Follow-up|0|||
148821044|NCT01125748|536822465|FG001|Overall Study|Lost to Follow-up|1|||
148821045|NCT01125748|536822464|FG000|Overall Study|Physician Decision|8|||
148821046|NCT01125748|536822465|FG001|Overall Study|Physician Decision|7|||
148821047|NCT01125748|536822464|FG000|Overall Study|Patient Decision to Withdraw|2|||
148821048|NCT01125748|536822465|FG001|Overall Study|Patient Decision to Withdraw|4|||
148821049|NCT01751685|536822466|FG000|6-mo Followup|Missed study visit|1|||
148821050|NCT01751685|536822467|FG001|6-mo Followup|Missed study visit|0|||
148821051|NCT01751685|536822466|FG000|6-mo Followup|Withdrawal by Subject|2|||
148821052|NCT01751685|536822467|FG001|6-mo Followup|Withdrawal by Subject|2|||
148821053|NCT01751685|536822466|FG000|6-mo Followup|Lost to Follow-up|0|||
148821054|NCT01751685|536822467|FG001|6-mo Followup|Lost to Follow-up|1|||
148821055|NCT01751685|536822466|FG000|12-mo Followup|Lost to Follow-up|5|||
148821056|NCT01751685|536822467|FG001|12-mo Followup|Lost to Follow-up|0|||
148821057|NCT01028391|536822468|FG000|Overall Study|Adverse Event|4|||
148821058|NCT01028391|536822469|FG001|Overall Study|Adverse Event|0|||
148821059|NCT01028391|536822468|FG000|Overall Study|Lack of Efficacy|0|||
148821060|NCT01028391|536822469|FG001|Overall Study|Lack of Efficacy|2|||
148821061|NCT01028391|536822468|FG000|Overall Study|Lost to Follow-up|3|||
148821062|NCT01028391|536822469|FG001|Overall Study|Lost to Follow-up|4|||
148821063|NCT01028391|536822468|FG000|Overall Study|Physician Decision|0|||
148821064|NCT01028391|536822469|FG001|Overall Study|Physician Decision|1|||
148821065|NCT01028391|536822468|FG000|Overall Study|Withdrawal by Subject|6|||
148821066|NCT01028391|536822469|FG001|Overall Study|Withdrawal by Subject|3|||
148821067|NCT01028391|536822468|FG000|Overall Study|Needed excluded medication|1|||
148821068|NCT01028391|536822469|FG001|Overall Study|Needed excluded medication|1|||
148821069|NCT01107457|536822470|FG000|Part A|Adverse Event|1|||
148821070|NCT01107457|536822471|FG001|Part A|Adverse Event|2|||
148821071|NCT01107457|536822472|FG002|Part A|Adverse Event|1|||
148821072|NCT01107457|536822473|FG003|Part A|Adverse Event|0|||
148821073|NCT01107457|536822474|FG004|Part A|Adverse Event|0|||
148821074|NCT01107457|536822475|FG005|Part A|Adverse Event|0|||
148821075|NCT01107457|536822470|FG000|Part A|Withdrawal by Subject|3|||
148821076|NCT01107457|536822471|FG001|Part A|Withdrawal by Subject|3|||
148821077|NCT01107457|536822472|FG002|Part A|Withdrawal by Subject|0|||
148821078|NCT01107457|536822473|FG003|Part A|Withdrawal by Subject|3|||
148821079|NCT01107457|536822474|FG004|Part A|Withdrawal by Subject|1|||
148821080|NCT01107457|536822475|FG005|Part A|Withdrawal by Subject|0|||
148821081|NCT01107457|536822470|FG000|Part A|Lost to Follow-up|0|||
148821082|NCT01107457|536822471|FG001|Part A|Lost to Follow-up|1|||
148821083|NCT01107457|536822472|FG002|Part A|Lost to Follow-up|0|||
148821084|NCT01107457|536822473|FG003|Part A|Lost to Follow-up|0|||
148821085|NCT01107457|536822474|FG004|Part A|Lost to Follow-up|0|||
148821086|NCT01107457|536822475|FG005|Part A|Lost to Follow-up|0|||
148821087|NCT01107457|536822470|FG000|Part A|Lack of Efficacy|1|||
148821088|NCT01107457|536822471|FG001|Part A|Lack of Efficacy|0|||
148821089|NCT01107457|536822472|FG002|Part A|Lack of Efficacy|0|||
148821090|NCT01107457|536822473|FG003|Part A|Lack of Efficacy|0|||
148821091|NCT01107457|536822474|FG004|Part A|Lack of Efficacy|0|||
148821092|NCT01107457|536822475|FG005|Part A|Lack of Efficacy|0|||
148821093|NCT01107457|536822470|FG000|Part A|Protocol Violation|0|||
148821094|NCT01107457|536822471|FG001|Part A|Protocol Violation|1|||
148821095|NCT01107457|536822472|FG002|Part A|Protocol Violation|0|||
148821096|NCT01107457|536822473|FG003|Part A|Protocol Violation|0|||
148821097|NCT01107457|536822474|FG004|Part A|Protocol Violation|0|||
148821098|NCT01107457|536822475|FG005|Part A|Protocol Violation|0|||
148821099|NCT01107457|536822470|FG000|Part B and C|Adverse Event|0|||
148821100|NCT01107457|536822471|FG001|Part B and C|Adverse Event|0|||
148821101|NCT01107457|536822472|FG002|Part B and C|Adverse Event|0|||
148821102|NCT01107457|536822473|FG003|Part B and C|Adverse Event|0|||
148821103|NCT01107457|536822474|FG004|Part B and C|Adverse Event|0|||
148821104|NCT01107457|536822475|FG005|Part B and C|Adverse Event|12|||
148821105|NCT01107457|536822470|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
148821106|NCT01107457|536822471|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
148821107|NCT01107457|536822472|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
148821108|NCT01107457|536822473|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
148821109|NCT01107457|536822474|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
148821110|NCT01107457|536822475|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
148821111|NCT01107457|536822470|FG000|Part B and C|Physician Decision|0|||
148821112|NCT01107457|536822471|FG001|Part B and C|Physician Decision|0|||
148821113|NCT01107457|536822472|FG002|Part B and C|Physician Decision|0|||
148821114|NCT01107457|536822473|FG003|Part B and C|Physician Decision|0|||
148821115|NCT01107457|536822474|FG004|Part B and C|Physician Decision|0|||
148821116|NCT01107457|536822475|FG005|Part B and C|Physician Decision|3|||
148821117|NCT01107457|536822470|FG000|Part B and C|Lack of Efficacy|0|||
148821118|NCT01107457|536822471|FG001|Part B and C|Lack of Efficacy|0|||
148821119|NCT01107457|536822472|FG002|Part B and C|Lack of Efficacy|0|||
148821120|NCT01107457|536822473|FG003|Part B and C|Lack of Efficacy|0|||
148821121|NCT01107457|536822474|FG004|Part B and C|Lack of Efficacy|0|||
148821122|NCT01107457|536822475|FG005|Part B and C|Lack of Efficacy|7|||
148821123|NCT01107457|536822470|FG000|Part B and C|Lost to Follow-up|0|||
148821124|NCT01107457|536822471|FG001|Part B and C|Lost to Follow-up|0|||
148821125|NCT01107457|536822472|FG002|Part B and C|Lost to Follow-up|0|||
148821126|NCT01107457|536822473|FG003|Part B and C|Lost to Follow-up|0|||
148821127|NCT01107457|536822474|FG004|Part B and C|Lost to Follow-up|0|||
148821128|NCT01107457|536822475|FG005|Part B and C|Lost to Follow-up|10|||
148821129|NCT01107457|536822470|FG000|Part B and C|Protocol Violation|0|||
148821130|NCT01107457|536822471|FG001|Part B and C|Protocol Violation|0|||
148821131|NCT01107457|536822472|FG002|Part B and C|Protocol Violation|0|||
148821132|NCT01107457|536822473|FG003|Part B and C|Protocol Violation|0|||
148821133|NCT01107457|536822474|FG004|Part B and C|Protocol Violation|0|||
148821134|NCT01107457|536822475|FG005|Part B and C|Protocol Violation|1|||
148821135|NCT01107457|536822470|FG000|Part B and C|Sponsor Decision|0|||
148821136|NCT01107457|536822471|FG001|Part B and C|Sponsor Decision|0|||
148821137|NCT01107457|536822472|FG002|Part B and C|Sponsor Decision|0|||
148821138|NCT01107457|536822473|FG003|Part B and C|Sponsor Decision|0|||
148821139|NCT01107457|536822474|FG004|Part B and C|Sponsor Decision|0|||
148821140|NCT01107457|536822475|FG005|Part B and C|Sponsor Decision|66|||
148821141|NCT01107457|536822470|FG000|Part B and C|Withdrawal by Subject|0|||
148821142|NCT01107457|536822471|FG001|Part B and C|Withdrawal by Subject|0|||
148821143|NCT01107457|536822472|FG002|Part B and C|Withdrawal by Subject|0|||
148821144|NCT01107457|536822473|FG003|Part B and C|Withdrawal by Subject|0|||
148821145|NCT01107457|536822474|FG004|Part B and C|Withdrawal by Subject|0|||
148821146|NCT01107457|536822475|FG005|Part B and C|Withdrawal by Subject|16|||
148821147|NCT01107457|536822470|FG000|Part B and C|Clinical Relapse|0|||
148821148|NCT01107457|536822471|FG001|Part B and C|Clinical Relapse|0|||
148821149|NCT01107457|536822472|FG002|Part B and C|Clinical Relapse|0|||
148821150|NCT01107457|536822473|FG003|Part B and C|Clinical Relapse|0|||
148821151|NCT01107457|536822474|FG004|Part B and C|Clinical Relapse|0|||
149027203|NCT05174065|537576538|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
148821152|NCT01107457|536822475|FG005|Part B and C|Clinical Relapse|4|||
149027204|NCT05174065|537576539|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
148821153|NCT00694161|536822476|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
148821154|NCT00694161|536822476|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
148821155|NCT00694161|536822476|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
148821156|NCT00694122|536822477|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
148821157|NCT00694122|536822478|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
148821158|NCT00694122|536822477|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
148821159|NCT00694122|536822478|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
148821160|NCT00694122|536822477|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
148821161|NCT00694122|536822478|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
148821162|NCT00105508|536822479|FG000|Overall Study|Prephase Dropout|1|||
148821163|NCT00105508|536822480|FG001|Overall Study|Prephase Dropout|0|||
148821164|NCT00105508|536822479|FG000|Overall Study|Adverse Event|16|||
148976111|NCT01610700|537394444|FG000|Overall Study|Adverse Event|3|||
148976112|NCT01610700|537394445|FG001|Overall Study|Adverse Event|1|||
148747789|NCT02088697|536546439|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
148747790|NCT02652949|536546440|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
148747791|NCT02652949|536546440|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
148747792|NCT02652949|536546440|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
148747793|NCT02652949|536546440|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
148747794|NCT02652949|536546440|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
148747795|NCT02652949|536546440|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
148747796|NCT02652949|536546440|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
148747797|NCT02652949|536546440|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
148747798|NCT02652949|536546440|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
148747799|NCT02652949|536546440|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
148747800|NCT02652949|536546440|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
148747801|NCT02652949|536546440|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
148747802|NCT02652949|536546440|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
148747803|NCT02652949|536546440|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
148747804|NCT02652949|536546440|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
148747805|NCT02652949|536546440|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
148747806|NCT02652949|536546440|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
148747807|NCT00699816|536546441|FG000|Overall Study|Protocol Violation|1|||
148747808|NCT00699816|536546442|FG001|Overall Study|Protocol Violation|3|||
148747809|NCT01569295|536546443|FG000|Overall Study|Progressive Disease|75|||
148747810|NCT01569295|536546444|FG001|Overall Study|Progressive Disease|139|||
148747811|NCT01569295|536546443|FG000|Overall Study|Adverse Event|39|||
148747812|NCT01569295|536546444|FG001|Overall Study|Adverse Event|14|||
148747813|NCT01569295|536546443|FG000|Overall Study|Withdrawal by Subject|25|||
148747814|NCT01569295|536546444|FG001|Overall Study|Withdrawal by Subject|12|||
148747815|NCT01569295|536546443|FG000|Overall Study|Death|19|||
148747816|NCT01569295|536546444|FG001|Overall Study|Death|15|||
148747817|NCT01569295|536546443|FG000|Overall Study|Physician Decision|13|||
148747818|NCT01569295|536546444|FG001|Overall Study|Physician Decision|18|||
148747819|NCT01569295|536546443|FG000|Overall Study|Study Terminated by Sponsor|24|||
148747820|NCT01569295|536546444|FG001|Overall Study|Study Terminated by Sponsor|2|||
148747821|NCT01569295|536546443|FG000|Overall Study|Other Reason not Specified|3|||
148747822|NCT01569295|536546444|FG001|Overall Study|Other Reason not Specified|5|||
148747823|NCT01569295|536546443|FG000|Overall Study|Non-Compliance with Study Drug|6|||
148747824|NCT01569295|536546444|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148747825|NCT01569295|536546443|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
148747826|NCT01569295|536546444|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
148747827|NCT01569295|536546443|FG000|Overall Study|Lost to Follow-up|1|||
148747828|NCT01569295|536546444|FG001|Overall Study|Lost to Follow-up|1|||
148747829|NCT02455518|536546448|FG000|Overall Study|Protocol Violation|0|||
148747830|NCT02455518|536546449|FG001|Overall Study|Protocol Violation|1|||
148747831|NCT02455518|536546450|FG002|Overall Study|Protocol Violation|1|||
148747832|NCT02455518|536546451|FG003|Overall Study|Protocol Violation|3|||
148747833|NCT02125877|536546452|FG000|Overall Study|Physician Decision|1|||
148747834|NCT02125877|536546453|FG001|Overall Study|Physician Decision|0|||
148747835|NCT02125877|536546452|FG000|Overall Study|Death|0|||
148747836|NCT02125877|536546453|FG001|Overall Study|Death|1|||
148747837|NCT02125877|536546452|FG000|Overall Study|Administrative problems|0|||
148747838|NCT02125877|536546453|FG001|Overall Study|Administrative problems|1|||
148747839|NCT02125877|536546452|FG000|Overall Study|Participant/guardian decision|0|||
148747840|NCT02125877|536546453|FG001|Overall Study|Participant/guardian decision|2|||
148747841|NCT02125877|536546452|FG000|Overall Study|Withdrawal by Subject|2|||
148747842|NCT02125877|536546453|FG001|Overall Study|Withdrawal by Subject|1|||
148747843|NCT02125877|536546452|FG000|Overall Study|Protocol deviation|4|||
148747844|NCT02125877|536546453|FG001|Overall Study|Protocol deviation|1|||
148747845|NCT02125877|536546452|FG000|Overall Study|Adverse Event|6|||
148747846|NCT02125877|536546453|FG001|Overall Study|Adverse Event|4|||
148747847|NCT01973595|536546454|FG000|Washout|Withdrawal by Subject|1|||
148747848|NCT01973595|536546455|FG001|Washout|Withdrawal by Subject|0|||
148747849|NCT01973595|536546456|FG002|Washout|Withdrawal by Subject|1|||
148747850|NCT01973595|536546457|FG003|Washout|Withdrawal by Subject|0|||
148747851|NCT04759703|536546463|FG000|Overall Study|Withdrawal by Subject|4|||
148747852|NCT04759703|536546464|FG001|Overall Study|Withdrawal by Subject|9|||
148747853|NCT04759703|536546463|FG000|Overall Study|Adverse Event|1|||
148747854|NCT04759703|536546464|FG001|Overall Study|Adverse Event|0|||
148747855|NCT04759703|536546463|FG000|Overall Study|Lost to Follow-up|2|||
148747856|NCT04759703|536546464|FG001|Overall Study|Lost to Follow-up|0|||
148747857|NCT03138655|536546471|FG000|Overall Study|Adverse Event|2|||
148747858|NCT03138655|536546472|FG001|Overall Study|Adverse Event|1|||
148747859|NCT03138655|536546473|FG002|Overall Study|Adverse Event|2|||
148747860|NCT03138655|536546474|FG003|Overall Study|Adverse Event|1|||
148976113|NCT01610700|537394444|FG000|Overall Study|Withdrawal by Subject|0|||
148747861|NCT03138655|536546475|FG004|Overall Study|Adverse Event|1|||
148747862|NCT03138655|536546476|FG005|Overall Study|Adverse Event|4|||
148747863|NCT03138655|536546477|FG006|Overall Study|Adverse Event|2|||
148747864|NCT03138655|536546478|FG007|Overall Study|Adverse Event|2|||
148747865|NCT03138655|536546471|FG000|Overall Study|Withdrawal by Subject|0|||
148747866|NCT03138655|536546472|FG001|Overall Study|Withdrawal by Subject|1|||
148747867|NCT03138655|536546473|FG002|Overall Study|Withdrawal by Subject|0|||
148747868|NCT03138655|536546474|FG003|Overall Study|Withdrawal by Subject|0|||
148747869|NCT03138655|536546475|FG004|Overall Study|Withdrawal by Subject|0|||
148747870|NCT03138655|536546476|FG005|Overall Study|Withdrawal by Subject|0|||
148747871|NCT03138655|536546477|FG006|Overall Study|Withdrawal by Subject|1|||
148747872|NCT03138655|536546478|FG007|Overall Study|Withdrawal by Subject|0|||
148821165|NCT00105508|536822480|FG001|Overall Study|Adverse Event|19|||
148821166|NCT00105508|536822479|FG000|Overall Study|Insufficient Efficacy|1|||
148821167|NCT00105508|536822480|FG001|Overall Study|Insufficient Efficacy|0|||
148821168|NCT00105508|536822479|FG000|Overall Study|Withdrawal by Subject|10|||
148821169|NCT00105508|536822480|FG001|Overall Study|Withdrawal by Subject|6|||
148821170|NCT00105508|536822479|FG000|Overall Study|Lost to Follow-up|3|||
148821171|NCT00105508|536822480|FG001|Overall Study|Lost to Follow-up|0|||
148821172|NCT00105508|536822479|FG000|Overall Study|Protocol Violation|1|||
148821173|NCT00105508|536822480|FG001|Overall Study|Protocol Violation|2|||
148821174|NCT00105508|536822479|FG000|Overall Study|Other|8|||
148821175|NCT00105508|536822480|FG001|Overall Study|Other|9|||
148821176|NCT00683384|536822481|FG000|Overall Study|Death|1|||
148821177|NCT00683384|536822481|FG000|Overall Study|Adverse Event|1|||
148821178|NCT00120874|536822482|FG000|Overall Study|Death|0|||
148821179|NCT00120874|536822483|FG001|Overall Study|Death|1|||
148821180|NCT00300495|536822490|FG000|Overall Study|Protocol Violation|4|||
148821181|NCT00300495|536822491|FG001|Overall Study|Protocol Violation|1|||
148821182|NCT01348490|536822492|FG000|Overall Study|Death|1|||
148821183|NCT01348490|536822492|FG000|Overall Study|Adverse Event|3|||
148821184|NCT01348490|536822492|FG000|Overall Study|Consent withdrawn|7|||
148821185|NCT01348490|536822492|FG000|Overall Study|Disease progression|3|||
148821186|NCT01348490|536822492|FG000|Overall Study|Lost to Follow-up|1|||
148821187|NCT01348490|536822492|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
148821188|NCT01348490|536822492|FG000|Overall Study|Other Unspecified|8|||
148821189|NCT03834883|536822499|FG000|Second Treatment|Withdrawal by Subject|1|||
148821190|NCT03834883|536822500|FG001|Second Treatment|Withdrawal by Subject|0|||
148821191|NCT03834883|536822501|FG002|Second Treatment|Withdrawal by Subject|0|||
148821192|NCT03834883|536822502|FG003|Second Treatment|Withdrawal by Subject|0|||
148821193|NCT03834883|536822499|FG000|Second Treatment|COVID-19 pandemic|1|||
148821194|NCT03834883|536822500|FG001|Second Treatment|COVID-19 pandemic|0|||
148821195|NCT03834883|536822501|FG002|Second Treatment|COVID-19 pandemic|1|||
148821196|NCT03834883|536822502|FG003|Second Treatment|COVID-19 pandemic|1|||
148821197|NCT01030900|536822503|FG000|Overall Study|Not treated due to congestive heart failure|1|||
148821198|NCT01030900|536822503|FG000|Overall Study|Not treated due to rapid disease|1|||
148821199|NCT01179399|536822504|FG000|Overall Study|Adverse Event|1|||
148821200|NCT01179399|536822504|FG000|Overall Study|Lack of Efficacy|30|||
148821201|NCT01179399|536822504|FG000|Overall Study|Withdrawal by Subject|1|||
148821202|NCT00441896|536822505|FG000|Overall Study|Withdrawal by Subject|0|||
148821203|NCT00441896|536822506|FG001|Overall Study|Withdrawal by Subject|0|||
148821204|NCT00441896|536822507|FG002|Overall Study|Withdrawal by Subject|0|||
148821205|NCT00441896|536822508|FG003|Overall Study|Withdrawal by Subject|1|||
148821206|NCT00441896|536822509|FG004|Overall Study|Withdrawal by Subject|0|||
148821207|NCT00441896|536822510|FG005|Overall Study|Withdrawal by Subject|0|||
148821208|NCT00441896|536822511|FG006|Overall Study|Withdrawal by Subject|0|||
148821209|NCT00441896|536822512|FG007|Overall Study|Withdrawal by Subject|0|||
148821210|NCT00441896|536822513|FG008|Overall Study|Withdrawal by Subject|0|||
148821211|NCT00441896|536822514|FG009|Overall Study|Withdrawal by Subject|0|||
149027205|NCT05174065|537576540|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
149027206|NCT00689104|537576541|FG000|Overall Study|Eligibility criterion not met|5|||
148747873|NCT03138655|536546471|FG000|Overall Study|Reason not Specified|1|||
148747874|NCT03138655|536546472|FG001|Overall Study|Reason not Specified|0|||
148747875|NCT03138655|536546473|FG002|Overall Study|Reason not Specified|0|||
149027207|NCT00689104|537576542|FG001|Overall Study|Eligibility criterion not met|8|||
149027208|NCT00689104|537576543|FG002|Overall Study|Eligibility criterion not met|0|||
148747876|NCT03138655|536546474|FG003|Overall Study|Reason not Specified|2|||
148747877|NCT03138655|536546475|FG004|Overall Study|Reason not Specified|1|||
148747878|NCT03138655|536546476|FG005|Overall Study|Reason not Specified|1|||
148821212|NCT00441896|536822505|FG000|Overall Study|Other|0|||
148821213|NCT00441896|536822506|FG001|Overall Study|Other|0|||
148821214|NCT00441896|536822507|FG002|Overall Study|Other|0|||
148821215|NCT00441896|536822508|FG003|Overall Study|Other|0|||
148821216|NCT00441896|536822509|FG004|Overall Study|Other|1|||
148821217|NCT00441896|536822510|FG005|Overall Study|Other|0|||
148821218|NCT00441896|536822511|FG006|Overall Study|Other|0|||
148821219|NCT00441896|536822512|FG007|Overall Study|Other|0|||
148821220|NCT00441896|536822513|FG008|Overall Study|Other|0|||
148821221|NCT00441896|536822514|FG009|Overall Study|Other|0|||
148821222|NCT03572218|536822515|FG000|Overall Study|Lost to Follow-up|3|||
148821223|NCT03572218|536822516|FG001|Overall Study|Lost to Follow-up|2|||
148821224|NCT03572218|536822515|FG000|Overall Study|No longer available for study visits|2|||
148821225|NCT03572218|536822516|FG001|Overall Study|No longer available for study visits|1|||
148821226|NCT03572218|536822515|FG000|Overall Study|No longer interested|1|||
148821227|NCT03572218|536822516|FG001|Overall Study|No longer interested|2|||
148821228|NCT01793129|536824486|FG000|Overall Study|Lost to Follow-up|3|||
148821229|NCT01793129|536824487|FG001|Overall Study|Lost to Follow-up|7|||
148821230|NCT01793129|536824486|FG000|Overall Study|Withdrawal by Subject|0|||
148821231|NCT01793129|536824487|FG001|Overall Study|Withdrawal by Subject|2|||
148821232|NCT01567085|536824490|FG000|Overall Study|Death|6|||
148821233|NCT01567085|536824490|FG000|Overall Study|Adverse Event|6|||
148821234|NCT01567085|536824490|FG000|Overall Study|Lost to Follow-up|3|||
148821235|NCT01567085|536824490|FG000|Overall Study|Graft loss|2|||
148821236|NCT01567085|536824490|FG000|Overall Study|Renal transplantectomy|1|||
148821237|NCT01567085|536824490|FG000|Overall Study|Returned to chronic dialysis|1|||
148821238|NCT01567085|536824490|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
148821239|NCT03537729|536824495|FG000|Overall Study|Death|2|||
148821240|NCT03537729|536824496|FG001|Overall Study|Death|2|||
148821241|NCT03537729|536824497|FG002|Overall Study|Death|7|||
148821242|NCT03537729|536824495|FG000|Overall Study|Withdrawal by Subject|3|||
148821243|NCT03537729|536824496|FG001|Overall Study|Withdrawal by Subject|3|||
148821244|NCT03537729|536824497|FG002|Overall Study|Withdrawal by Subject|0|||
148821245|NCT03537729|536824495|FG000|Overall Study|Subject Moved|8|||
148821246|NCT03537729|536824496|FG001|Overall Study|Subject Moved|5|||
148821247|NCT03537729|536824497|FG002|Overall Study|Subject Moved|4|||
148821248|NCT03537729|536824495|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
148821249|NCT03537729|536824496|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
148821250|NCT03537729|536824497|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
148821251|NCT03537729|536824495|FG000|Overall Study|COVID-19 Site Restrictions|11|||
148821252|NCT03537729|536824496|FG001|Overall Study|COVID-19 Site Restrictions|15|||
148821253|NCT03537729|536824497|FG002|Overall Study|COVID-19 Site Restrictions|18|||
148821254|NCT03537729|536824495|FG000|Overall Study|Decline in Health|5|||
148821255|NCT03537729|536824496|FG001|Overall Study|Decline in Health|9|||
148821256|NCT03537729|536824497|FG002|Overall Study|Decline in Health|4|||
148821257|NCT03537729|536824495|FG000|Overall Study|Determined Ineligible|0|||
148821258|NCT03537729|536824496|FG001|Overall Study|Determined Ineligible|0|||
148821259|NCT03537729|536824497|FG002|Overall Study|Determined Ineligible|1|||
148821260|NCT00284934|536824498|FG000|Overall Study|Adverse Event|1|||
148821261|NCT00284934|536824499|FG001|Overall Study|Adverse Event|2|||
148821262|NCT00284934|536824498|FG000|Overall Study|Other reasons|3|||
148821263|NCT00284934|536824499|FG001|Overall Study|Other reasons|1|||
148821264|NCT00454142|536824500|FG000|Overall Study|Withdrawal by Subject|1|||
148821265|NCT01748552|536824508|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
148821266|NCT01748552|536824509|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
149027209|NCT00689104|537576544|FG003|Overall Study|Eligibility criterion not met|4|||
149027210|NCT00689104|537576541|FG000|Overall Study|Adverse Event|13|||
149027211|NCT00689104|537576542|FG001|Overall Study|Adverse Event|25|||
149027212|NCT00689104|537576543|FG002|Overall Study|Adverse Event|16|||
149027213|NCT00689104|537576544|FG003|Overall Study|Adverse Event|24|||
149027214|NCT00689104|537576541|FG000|Overall Study|Lack of Efficacy|5|||
149027215|NCT00689104|537576542|FG001|Overall Study|Lack of Efficacy|6|||
149027216|NCT00689104|537576543|FG002|Overall Study|Lack of Efficacy|2|||
149027217|NCT00689104|537576544|FG003|Overall Study|Lack of Efficacy|3|||
149027218|NCT00689104|537576541|FG000|Overall Study|Withdrawal by Subject|12|||
149027219|NCT00689104|537576542|FG001|Overall Study|Withdrawal by Subject|11|||
149027220|NCT00689104|537576543|FG002|Overall Study|Withdrawal by Subject|18|||
149027221|NCT00689104|537576544|FG003|Overall Study|Withdrawal by Subject|11|||
149027222|NCT00689104|537576541|FG000|Overall Study|Lost to Follow-up|4|||
149027223|NCT00689104|537576542|FG001|Overall Study|Lost to Follow-up|3|||
149027224|NCT00689104|537576543|FG002|Overall Study|Lost to Follow-up|2|||
149027225|NCT00689104|537576544|FG003|Overall Study|Lost to Follow-up|5|||
148821267|NCT01748552|536824510|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
148821268|NCT01748552|536824511|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
149027226|NCT00689104|537576541|FG000|Overall Study|Protocol Violation|2|||
149027227|NCT00689104|537576542|FG001|Overall Study|Protocol Violation|3|||
148821269|NCT01748552|536824512|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
149027228|NCT00689104|537576543|FG002|Overall Study|Protocol Violation|5|||
148821270|NCT01748552|536824513|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
148821271|NCT01748552|536824514|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
148821272|NCT01748552|536824515|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
148821273|NCT01748552|536824516|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
148821274|NCT01748552|536824517|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
148821275|NCT01748552|536824518|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
148747879|NCT03138655|536546477|FG006|Overall Study|Reason not Specified|0|||
148747880|NCT03138655|536546478|FG007|Overall Study|Reason not Specified|0|||
148747881|NCT02800642|536546479|FG000|Overall Study|Death|3|||
148747882|NCT02800642|536546479|FG000|Overall Study|Other|10|||
148747883|NCT02800642|536546479|FG000|Overall Study|Physician Decision|2|||
148747884|NCT02800642|536546479|FG000|Overall Study|Adverse Event|6|||
148747885|NCT02800642|536546479|FG000|Overall Study|Withdrawal by Subject|3|||
148747886|NCT02800642|536546479|FG000|Overall Study|Lost to Follow-up|1|||
148747887|NCT04868500|536546480|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
148747888|NCT04868500|536546481|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
148747889|NCT04868500|536546480|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
148747890|NCT04868500|536546481|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
148747891|NCT02859142|536546482|FG000|Overall Study|Adverse Event|1|||
148747892|NCT02859142|536546483|FG001|Overall Study|Adverse Event|2|||
148747893|NCT02859142|536546482|FG000|Overall Study|Lost to Follow-up|1|||
148747894|NCT02859142|536546483|FG001|Overall Study|Lost to Follow-up|4|||
148747895|NCT02859142|536546482|FG000|Overall Study|Withdrawal by Subject|2|||
148747896|NCT02859142|536546483|FG001|Overall Study|Withdrawal by Subject|0|||
148747897|NCT02859142|536546482|FG000|Overall Study|Scheduling difficulties|0|||
148747898|NCT02859142|536546483|FG001|Overall Study|Scheduling difficulties|3|||
148747899|NCT03290079|536546484|FG000|Overall Study|Death|2|||
148747900|NCT01941498|536546488|FG000|Overall Study|Relocated out of state|1|||
148747901|NCT05299528|536546491|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
148747902|NCT05299528|536546492|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
148747903|NCT05299528|536546493|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
148747904|NCT05299528|536546494|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
148747905|NCT05299528|536546495|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
148747906|NCT05299528|536546496|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
148747907|NCT05299528|536546497|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
148747908|NCT05299528|536546491|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
148747909|NCT05299528|536546492|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
148747910|NCT05299528|536546493|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
148747911|NCT05299528|536546494|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
148747912|NCT05299528|536546495|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
148747913|NCT05299528|536546496|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
148747914|NCT05299528|536546497|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
148747915|NCT05299528|536546491|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
148747916|NCT05299528|536546492|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
148747917|NCT05299528|536546493|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
148747918|NCT05299528|536546494|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
148747919|NCT05299528|536546495|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
148747920|NCT05299528|536546496|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
148747921|NCT05299528|536546497|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
148747922|NCT00490841|536546498|FG000|Overall Study|Death|5|||
148747923|NCT00490841|536546498|FG000|Overall Study|Withdrawal by Subject|4|||
148747924|NCT00490841|536546498|FG000|Overall Study|Lost to Follow-up|1|||
148747925|NCT00490841|536546498|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
148747926|NCT01277211|536546499|FG000|Overall Study|Adverse Event|60|||
148747927|NCT01277211|536546500|FG001|Overall Study|Adverse Event|22|||
148747928|NCT01277211|536546499|FG000|Overall Study|Pregnancy|9|||
148747929|NCT01277211|536546500|FG001|Overall Study|Pregnancy|4|||
148747930|NCT01277211|536546499|FG000|Overall Study|Lost to Follow-up|14|||
148747931|NCT01277211|536546500|FG001|Overall Study|Lost to Follow-up|9|||
148747932|NCT01277211|536546499|FG000|Overall Study|Did not wish to continue|17|||
148747933|NCT01277211|536546500|FG001|Overall Study|Did not wish to continue|0|||
148747934|NCT01277211|536546499|FG000|Overall Study|Withdrew Consent|9|||
148747935|NCT01277211|536546500|FG001|Overall Study|Withdrew Consent|9|||
148747936|NCT01277211|536546499|FG000|Overall Study|Non-compliance with protocol|13|||
148747937|NCT01277211|536546500|FG001|Overall Study|Non-compliance with protocol|4|||
148747938|NCT01277211|536546499|FG000|Overall Study|Did not meet protocol eligibility|1|||
148747939|NCT01277211|536546500|FG001|Overall Study|Did not meet protocol eligibility|0|||
148747940|NCT01277211|536546499|FG000|Overall Study|Administrative|3|||
148747941|NCT01277211|536546500|FG001|Overall Study|Administrative|0|||
148747942|NCT01277211|536546499|FG000|Overall Study|Pregnancy wish|0|||
148821276|NCT01748552|536824519|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
148747943|NCT01277211|536546500|FG001|Overall Study|Pregnancy wish|2|||
148747944|NCT01277211|536546499|FG000|Overall Study|Discontinued prior to treatment|24|||
148747945|NCT01277211|536546500|FG001|Overall Study|Discontinued prior to treatment|13|||
148747946|NCT03452943|536546501|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
148747947|NCT03452943|536546502|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
148747948|NCT03452943|536546501|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
148747949|NCT03452943|536546502|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
148747950|NCT03452943|536546501|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
148747951|NCT03452943|536546502|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
148747952|NCT03452943|536546501|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
148747953|NCT03452943|536546502|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
148747954|NCT03452943|536546501|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
148747955|NCT03452943|536546502|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
148747956|NCT03452943|536546501|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
148747957|NCT03452943|536546502|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
148747958|NCT01107197|536546507|FG000|Overall Study|Death|12|||
148747959|NCT01107197|536546508|FG001|Overall Study|Death|10|||
148747960|NCT01107197|536546507|FG000|Overall Study|Lost to Follow-up|5|||
148747961|NCT01107197|536546508|FG001|Overall Study|Lost to Follow-up|8|||
148747962|NCT01107197|536546507|FG000|Overall Study|Withdrawal by Subject|3|||
148747963|NCT01107197|536546508|FG001|Overall Study|Withdrawal by Subject|5|||
148747964|NCT04697069|536546509|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
148747965|NCT04697069|536546510|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
148747966|NCT04697069|536546509|FG000|Overall Study|Study termination|2|||
148747967|NCT04697069|536546510|FG001|Overall Study|Study termination|1|||
148747968|NCT05180227|536546511|FG000|Overall Study|Hypertension at screening|1|||
148747969|NCT05180227|536546511|FG000|Overall Study|Lost to Follow-up|1|||
148747970|NCT02779855|536546512|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
148747971|NCT02779855|536546513|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
148747972|NCT02779855|536546514|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
148747973|NCT01301729|536546515|FG000|Overall Study|Withdrawal by Subject|2|||
148747974|NCT01301729|536546515|FG000|Overall Study|Participant did not Return for Treatment|1|||
148747975|NCT01301729|536546515|FG000|Overall Study|Violated Selection Criteria|1|||
148747976|NCT05794503|536546516|FG000|Overall Study|Operation Cancelled|2|||
148747977|NCT05794503|536546517|FG001|Overall Study|Operation Cancelled|0|||
148747978|NCT05794503|536546516|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
148747979|NCT05794503|536546517|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
148747980|NCT05794503|536546516|FG000|Overall Study|Protocol Violation|1|||
148747981|NCT05794503|536546517|FG001|Overall Study|Protocol Violation|0|||
148747982|NCT00509795|536546518|FG000|Overall Study|Adverse Event|4|||
148747983|NCT00509795|536546519|FG001|Overall Study|Adverse Event|3|||
148747984|NCT00509795|536546520|FG002|Overall Study|Adverse Event|5|||
148747985|NCT00509795|536546521|FG003|Overall Study|Adverse Event|4|||
148747986|NCT00509795|536546518|FG000|Overall Study|Death|3|||
148747987|NCT00509795|536546519|FG001|Overall Study|Death|1|||
148747988|NCT00509795|536546520|FG002|Overall Study|Death|2|||
148747989|NCT00509795|536546521|FG003|Overall Study|Death|7|||
148747990|NCT00509795|536546518|FG000|Overall Study|Lack of Efficacy|0|||
148747991|NCT00509795|536546519|FG001|Overall Study|Lack of Efficacy|0|||
148747992|NCT00509795|536546520|FG002|Overall Study|Lack of Efficacy|2|||
148747993|NCT00509795|536546521|FG003|Overall Study|Lack of Efficacy|2|||
148747994|NCT00509795|536546518|FG000|Overall Study|Lost to Follow-up|1|||
148747995|NCT00509795|536546519|FG001|Overall Study|Lost to Follow-up|2|||
148747996|NCT00509795|536546520|FG002|Overall Study|Lost to Follow-up|4|||
148747997|NCT00509795|536546521|FG003|Overall Study|Lost to Follow-up|4|||
148747998|NCT00509795|536546518|FG000|Overall Study|OTHER|1|||
148747999|NCT00509795|536546519|FG001|Overall Study|OTHER|0|||
148748000|NCT00509795|536546520|FG002|Overall Study|OTHER|4|||
148748001|NCT00509795|536546521|FG003|Overall Study|OTHER|1|||
148748002|NCT00509795|536546518|FG000|Overall Study|Protocol Violation|3|||
148748003|NCT00509795|536546519|FG001|Overall Study|Protocol Violation|0|||
148748004|NCT00509795|536546520|FG002|Overall Study|Protocol Violation|3|||
148748005|NCT00509795|536546521|FG003|Overall Study|Protocol Violation|1|||
148748006|NCT00509795|536546518|FG000|Overall Study|Withdrawal by Subject|10|||
148748007|NCT00509795|536546519|FG001|Overall Study|Withdrawal by Subject|5|||
148748008|NCT00509795|536546520|FG002|Overall Study|Withdrawal by Subject|7|||
148748009|NCT00509795|536546521|FG003|Overall Study|Withdrawal by Subject|8|||
148748010|NCT00143247|536546523|FG000|Overall Study|Death|8|||
149027229|NCT00689104|537576544|FG003|Overall Study|Protocol Violation|3|||
148748011|NCT00143247|536546523|FG000|Overall Study|Adverse Event|19|||
148748012|NCT00143247|536546523|FG000|Overall Study|Lack of Efficacy|3|||
148748013|NCT00143247|536546523|FG000|Overall Study|Withdrawal by Subject|55|||
148748014|NCT00143247|536546523|FG000|Overall Study|Study terminated by sponsor|31|||
148748015|NCT00143247|536546523|FG000|Overall Study|Protocol Violation|15|||
148748016|NCT00143247|536546523|FG000|Overall Study|Lost to Follow-up|12|||
148748017|NCT00143247|536546523|FG000|Overall Study|following inaccurate lab adverse event|1|||
148748018|NCT00143247|536546523|FG000|Overall Study|Other|12|||
148748019|NCT02766283|536546524|FG000|Overall Study|Lost to Follow-up|27|||
148748020|NCT00805961|536546525|FG000|Modality Therapy|Withdrawal by Subject|1|||
148748021|NCT00805961|536546525|FG000|Modality Therapy|Adverse Event|1|||
148748022|NCT00805961|536546525|FG000|Modality Therapy|Disease Progression|2|||
148748023|NCT00805961|536546525|FG000|Treatment-Free Interval|Adverse Event|3|||
148748024|NCT00805961|536546525|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
148748025|NCT00805961|536546525|FG000|Treatment-Free Interval|Physician Decision|1|||
148748026|NCT00805961|536546525|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
148748027|NCT00805961|536546525|FG000|Maintenance Treatment|Lack of Efficacy|13|||
148748028|NCT00805961|536546525|FG000|Maintenance Treatment|Intercurrent Illness|7|||
148748029|NCT00805961|536546525|FG000|Maintenance Treatment|Adverse Event|6|||
148748030|NCT00805961|536546525|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
148748031|NCT00805961|536546525|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
148748032|NCT00805961|536546525|FG000|Maintenance Treatment|Withdrawn Consent|1|||
148748033|NCT00912912|536546526|FG000|Overall Study|Withdrawal by Subject|1|||
148748034|NCT00912912|536546526|FG000|Overall Study|Disease Progression|3|||
148748035|NCT00306995|536546527|FG000|Study Part I|Withdrawal by Subject|0|||
148748036|NCT00306995|536546528|FG001|Study Part I|Withdrawal by Subject|0|||
148748037|NCT00306995|536546529|FG002|Study Part I|Withdrawal by Subject|0|||
148748038|NCT00306995|536546530|FG003|Study Part I|Withdrawal by Subject|0|||
148748039|NCT00306995|536546531|FG004|Study Part I|Withdrawal by Subject|0|||
148748040|NCT00306995|536546532|FG005|Study Part I|Withdrawal by Subject|0|||
148748041|NCT00306995|536546533|FG006|Study Part I|Withdrawal by Subject|1|||
148748042|NCT00306995|536546527|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
148748043|NCT00306995|536546528|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
148748044|NCT00306995|536546529|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
148748045|NCT00306995|536546530|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
148748046|NCT00306995|536546531|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
148748047|NCT00306995|536546532|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
148748048|NCT00306995|536546533|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
148748049|NCT05422625|536546534|FG000|Overall Study|Withdrawal by Subject|1|||
148748050|NCT05422625|536546535|FG001|Overall Study|Withdrawal by Subject|0|||
148748051|NCT01290302|536547917|FG000|Overall Study|Adverse Event|2|||
148748052|NCT01290302|536547918|FG001|Overall Study|Adverse Event|0|||
148748053|NCT01290302|536547917|FG000|Overall Study|Withdrawal by Subject|1|||
148748054|NCT01290302|536547918|FG001|Overall Study|Withdrawal by Subject|0|||
148748055|NCT01290302|536547917|FG000|Overall Study|Physician Decision|0|||
148748056|NCT01290302|536547918|FG001|Overall Study|Physician Decision|2|||
148748057|NCT01290302|536547917|FG000|Overall Study|Expiration of time for screening window|1|||
148748058|NCT01290302|536547918|FG001|Overall Study|Expiration of time for screening window|0|||
148748059|NCT00615199|536547921|FG000|Overall Study|Adverse Event|3|||
148748060|NCT00615199|536547922|FG001|Overall Study|Adverse Event|1|||
148748061|NCT00615199|536547923|FG002|Overall Study|Adverse Event|1|||
148748062|NCT00615199|536547924|FG003|Overall Study|Adverse Event|0|||
148748063|NCT00615199|536547921|FG000|Overall Study|Lack of Efficacy|2|||
148748064|NCT00615199|536547922|FG001|Overall Study|Lack of Efficacy|0|||
148748065|NCT00615199|536547923|FG002|Overall Study|Lack of Efficacy|0|||
148748066|NCT00615199|536547924|FG003|Overall Study|Lack of Efficacy|1|||
148748067|NCT00615199|536547921|FG000|Overall Study|Lost to Follow-up|1|||
148748068|NCT00615199|536547922|FG001|Overall Study|Lost to Follow-up|0|||
148748069|NCT00615199|536547923|FG002|Overall Study|Lost to Follow-up|0|||
148748070|NCT00615199|536547924|FG003|Overall Study|Lost to Follow-up|0|||
148748071|NCT00615199|536547921|FG000|Overall Study|Other|0|||
148748072|NCT00615199|536547922|FG001|Overall Study|Other|0|||
148748073|NCT00615199|536547923|FG002|Overall Study|Other|0|||
148748074|NCT00615199|536547924|FG003|Overall Study|Other|1|||
148748075|NCT00615199|536547921|FG000|Overall Study|Withdrawal by Subject|2|||
148748076|NCT00615199|536547922|FG001|Overall Study|Withdrawal by Subject|1|||
148748077|NCT00615199|536547923|FG002|Overall Study|Withdrawal by Subject|0|||
148748078|NCT00615199|536547924|FG003|Overall Study|Withdrawal by Subject|0|||
148748079|NCT02653625|536547925|FG000|Overall Study|Adverse Event|1|||
148748080|NCT02653625|536547925|FG000|Overall Study|Non-compliance with Study Drug|1|||
148748081|NCT02653625|536547925|FG000|Overall Study|Protocol Violation|1|||
148748082|NCT02653625|536547925|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
148748083|NCT00064987|536547928|FG000|Overall Study|Physician Decision|3|||
148748084|NCT00064987|536547929|FG001|Overall Study|Physician Decision|0|||
148748085|NCT04152863|536547930|FG000|Overall Study|Death|13|||
148748086|NCT04152863|536547931|FG001|Overall Study|Death|12|||
148748087|NCT04152863|536547932|FG002|Overall Study|Death|7|||
148748088|NCT04152863|536547930|FG000|Overall Study|Physician Decision|1|||
148748089|NCT04152863|536547931|FG001|Overall Study|Physician Decision|1|||
148748090|NCT04152863|536547932|FG002|Overall Study|Physician Decision|1|||
148748091|NCT04152863|536547930|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
148748092|NCT04152863|536547931|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
148748093|NCT04152863|536547932|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
148748094|NCT04152863|536547930|FG000|Overall Study|Withdrawal by Subject|2|||
148748095|NCT04152863|536547931|FG001|Overall Study|Withdrawal by Subject|1|||
148748096|NCT04152863|536547932|FG002|Overall Study|Withdrawal by Subject|3|||
148748097|NCT01644617|536547933|FG000|Overall Study|Withdrawal by Subject|3|||
148748098|NCT01644617|536547934|FG001|Overall Study|Withdrawal by Subject|4|||
148821277|NCT01748552|536824508|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821278|NCT01748552|536824509|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821279|NCT01748552|536824510|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821280|NCT01748552|536824511|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821281|NCT01748552|536824512|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821282|NCT01748552|536824513|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821283|NCT01748552|536824514|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
148821284|NCT01748552|536824515|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
148821285|NCT01748552|536824516|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
148821286|NCT01748552|536824517|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821287|NCT01748552|536824518|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821288|NCT01748552|536824519|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
148821289|NCT00504556|536824520|FG000|Overall Study|Adverse Event|11|||
148821290|NCT00504556|536824521|FG001|Overall Study|Adverse Event|11|||
148821291|NCT00504556|536824522|FG002|Overall Study|Adverse Event|14|||
148821292|NCT00504556|536824523|FG003|Overall Study|Adverse Event|13|||
148821293|NCT00504556|536824524|FG004|Overall Study|Adverse Event|5|||
148821294|NCT00504556|536824520|FG000|Overall Study|Death|3|||
148821295|NCT00504556|536824521|FG001|Overall Study|Death|3|||
148821296|NCT00504556|536824522|FG002|Overall Study|Death|1|||
148821297|NCT00504556|536824523|FG003|Overall Study|Death|0|||
148821298|NCT00504556|536824524|FG004|Overall Study|Death|2|||
148821299|NCT00504556|536824520|FG000|Overall Study|Protocol Violation|1|||
148821300|NCT00504556|536824521|FG001|Overall Study|Protocol Violation|3|||
148821301|NCT00504556|536824522|FG002|Overall Study|Protocol Violation|2|||
148821302|NCT00504556|536824523|FG003|Overall Study|Protocol Violation|1|||
148821303|NCT00504556|536824524|FG004|Overall Study|Protocol Violation|2|||
148821304|NCT00504556|536824520|FG000|Overall Study|Lost to Follow-up|0|||
148821305|NCT00504556|536824521|FG001|Overall Study|Lost to Follow-up|0|||
148821306|NCT00504556|536824522|FG002|Overall Study|Lost to Follow-up|1|||
148821307|NCT00504556|536824523|FG003|Overall Study|Lost to Follow-up|1|||
148821308|NCT00504556|536824524|FG004|Overall Study|Lost to Follow-up|1|||
148821309|NCT00504556|536824520|FG000|Overall Study|Withdrawal by Subject|16|||
148821310|NCT00504556|536824521|FG001|Overall Study|Withdrawal by Subject|16|||
148821311|NCT00504556|536824522|FG002|Overall Study|Withdrawal by Subject|7|||
148821312|NCT00504556|536824523|FG003|Overall Study|Withdrawal by Subject|8|||
148821313|NCT00504556|536824524|FG004|Overall Study|Withdrawal by Subject|12|||
148821314|NCT00504556|536824520|FG000|Overall Study|administrative reasons|0|||
148821315|NCT00504556|536824521|FG001|Overall Study|administrative reasons|2|||
148821316|NCT00504556|536824522|FG002|Overall Study|administrative reasons|2|||
148821317|NCT00504556|536824523|FG003|Overall Study|administrative reasons|1|||
148821318|NCT00504556|536824524|FG004|Overall Study|administrative reasons|2|||
148821319|NCT00504556|536824520|FG000|Overall Study|did not meet entry criteria|2|||
148821320|NCT00504556|536824521|FG001|Overall Study|did not meet entry criteria|0|||
148821321|NCT00504556|536824522|FG002|Overall Study|did not meet entry criteria|1|||
148821322|NCT00504556|536824523|FG003|Overall Study|did not meet entry criteria|1|||
148821323|NCT00504556|536824524|FG004|Overall Study|did not meet entry criteria|0|||
148821324|NCT00504556|536824520|FG000|Overall Study|data monitor committee decision|0|||
148821325|NCT00504556|536824521|FG001|Overall Study|data monitor committee decision|0|||
148821326|NCT00504556|536824522|FG002|Overall Study|data monitor committee decision|0|||
148821327|NCT00504556|536824523|FG003|Overall Study|data monitor committee decision|100|||
148821328|NCT00504556|536824524|FG004|Overall Study|data monitor committee decision|0|||
148821329|NCT00504556|536824520|FG000|Overall Study|Other|2|||
148821330|NCT00504556|536824521|FG001|Overall Study|Other|2|||
148821331|NCT00504556|536824522|FG002|Overall Study|Other|2|||
148821332|NCT00504556|536824523|FG003|Overall Study|Other|3|||
148821333|NCT00504556|536824524|FG004|Overall Study|Other|0|||
148821334|NCT00504556|536824520|FG000|Overall Study|not in safety analysis set|0|||
148821335|NCT00504556|536824521|FG001|Overall Study|not in safety analysis set|1|||
148821336|NCT00504556|536824522|FG002|Overall Study|not in safety analysis set|1|||
148976114|NCT01610700|537394445|FG001|Overall Study|Withdrawal by Subject|1|||
148976115|NCT01610700|537394444|FG000|Overall Study|subject took one dose of street cannabis|0|||
148976116|NCT01610700|537394445|FG001|Overall Study|subject took one dose of street cannabis|1|||
148976117|NCT02652624|537394448|FG000|Randomized Phase|Pregnancy|3|||
148821337|NCT00504556|536824523|FG003|Overall Study|not in safety analysis set|0|||
148821338|NCT00504556|536824524|FG004|Overall Study|not in safety analysis set|1|||
148821339|NCT00676052|536824525|FG000|Overall Study|Adverse Event|0|||
148821340|NCT00676052|536824526|FG001|Overall Study|Adverse Event|1|||
148821341|NCT00676052|536824527|FG002|Overall Study|Adverse Event|1|||
148821342|NCT00676052|536824528|FG003|Overall Study|Adverse Event|2|||
148821343|NCT00676052|536824529|FG004|Overall Study|Adverse Event|2|||
148821344|NCT00676052|536824530|FG005|Overall Study|Adverse Event|2|||
148821345|NCT00676052|536824525|FG000|Overall Study|Lack of Efficacy|2|||
148821346|NCT00676052|536824526|FG001|Overall Study|Lack of Efficacy|2|||
148976118|NCT02652624|537394449|FG001|Randomized Phase|Pregnancy|1|||
148748099|NCT01644617|536547935|FG002|Overall Study|Withdrawal by Subject|1|||
148748100|NCT01644617|536547933|FG000|Overall Study|Lost to Follow-up|0|||
148748101|NCT01644617|536547934|FG001|Overall Study|Lost to Follow-up|1|||
148748102|NCT01644617|536547935|FG002|Overall Study|Lost to Follow-up|0|||
148748103|NCT01644617|536547933|FG000|Overall Study|Adverse Event|3|||
148748104|NCT01644617|536547934|FG001|Overall Study|Adverse Event|0|||
148748105|NCT01644617|536547935|FG002|Overall Study|Adverse Event|6|||
148748106|NCT02276807|536547936|FG000|Overall Study|Withdrawal by Subject|8|||
148748107|NCT02276807|536547937|FG001|Overall Study|Withdrawal by Subject|7|||
148748108|NCT02276807|536547936|FG000|Overall Study|Lost to Follow-up|10|||
148748109|NCT02276807|536547937|FG001|Overall Study|Lost to Follow-up|10|||
148748110|NCT00247676|536547949|FG000|Overall Study|Death|5|||
148748111|NCT00247676|536547949|FG000|Overall Study|Adverse Event|11|||
148748112|NCT00247676|536547949|FG000|Overall Study|Lack of Efficacy|15|||
148748113|NCT00247676|536547949|FG000|Overall Study|Other|3|||
148748114|NCT00247676|536547949|FG000|Overall Study|Withdrawal by Subject|2|||
148748115|NCT04342819|536547950|FG000|Overall Study|Declined|4|||
148748116|NCT04342819|536547950|FG000|Overall Study|Not meeeting selection criteria|1|||
148748117|NCT00911300|536547952|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
148748118|NCT00911300|536547953|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
148748119|NCT00911300|536547952|FG000|Overall Study|Death|1|||
148748120|NCT00911300|536547953|FG001|Overall Study|Death|0|||
148748121|NCT00911300|536547952|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
148748122|NCT00911300|536547953|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
148748123|NCT00911300|536547952|FG000|Overall Study|Adverse Event|14|||
148748124|NCT00911300|536547953|FG001|Overall Study|Adverse Event|6|||
148748125|NCT00911300|536547952|FG000|Overall Study|Protocol Violation|3|||
148748126|NCT00911300|536547953|FG001|Overall Study|Protocol Violation|2|||
148748127|NCT00911300|536547952|FG000|Overall Study|Consent Withdrawn|4|||
148748128|NCT00911300|536547953|FG001|Overall Study|Consent Withdrawn|12|||
148748129|NCT00911300|536547952|FG000|Overall Study|Coronary Angiography Performed|1|||
148748130|NCT00911300|536547953|FG001|Overall Study|Coronary Angiography Performed|0|||
148748131|NCT00911300|536547952|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
148748132|NCT00911300|536547953|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
148748133|NCT00911300|536547952|FG000|Overall Study|Received Commercial Treatment|1|||
148748134|NCT00911300|536547953|FG001|Overall Study|Received Commercial Treatment|0|||
148748135|NCT00911300|536547952|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
148748136|NCT00911300|536547953|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
148748137|NCT00911300|536547952|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
148748138|NCT00911300|536547953|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
148748139|NCT00911300|536547952|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
148748140|NCT00911300|536547953|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
148748141|NCT00911300|536547952|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
148748142|NCT00911300|536547953|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
148748143|NCT00911300|536547952|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
148748144|NCT00911300|536547953|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
148748145|NCT00911300|536547952|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
148748146|NCT00911300|536547953|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
148748147|NCT00911300|536547952|FG000|Overall Study|International Normalized Ratio Too High|0|||
148748148|NCT00911300|536547953|FG001|Overall Study|International Normalized Ratio Too High|1|||
148748149|NCT00911300|536547952|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
148748150|NCT00911300|536547953|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
148748151|NCT00911300|536547952|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
148748152|NCT00911300|536547953|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
148748153|NCT00911300|536547952|FG000|Overall Study|Physician Decision|0|||
148748154|NCT00911300|536547953|FG001|Overall Study|Physician Decision|1|||
148748155|NCT00911300|536547952|FG000|Overall Study|Treatment Stopped by Mistake|0|||
148748156|NCT00911300|536547953|FG001|Overall Study|Treatment Stopped by Mistake|1|||
148748157|NCT00911300|536547952|FG000|Overall Study|Randomized; No Study Medication Received|0|||
148748158|NCT00911300|536547953|FG001|Overall Study|Randomized; No Study Medication Received|2|||
148748159|NCT02287922|536547954|FG000|Overall Study|Adverse Event|1|||
148821347|NCT00676052|536824527|FG002|Overall Study|Lack of Efficacy|1|||
148821348|NCT00676052|536824528|FG003|Overall Study|Lack of Efficacy|1|||
148748160|NCT02287922|536547955|FG001|Overall Study|Adverse Event|1|||
148748161|NCT02287922|536547956|FG002|Overall Study|Adverse Event|3|||
148748162|NCT02287922|536547957|FG003|Overall Study|Adverse Event|4|||
148748163|NCT02287922|536547954|FG000|Overall Study|Withdrawal by Subject|1|||
148748164|NCT02287922|536547955|FG001|Overall Study|Withdrawal by Subject|1|||
148748165|NCT02287922|536547956|FG002|Overall Study|Withdrawal by Subject|1|||
148748166|NCT02287922|536547957|FG003|Overall Study|Withdrawal by Subject|2|||
148748167|NCT02287922|536547954|FG000|Overall Study|Lost to Follow-up|0|||
148748168|NCT02287922|536547955|FG001|Overall Study|Lost to Follow-up|0|||
148821349|NCT00676052|536824529|FG004|Overall Study|Lack of Efficacy|2|||
148821350|NCT00676052|536824530|FG005|Overall Study|Lack of Efficacy|1|||
148821351|NCT00676052|536824525|FG000|Overall Study|Protocol Violation|5|||
148821352|NCT00676052|536824526|FG001|Overall Study|Protocol Violation|3|||
148821353|NCT00676052|536824527|FG002|Overall Study|Protocol Violation|2|||
148821354|NCT00676052|536824528|FG003|Overall Study|Protocol Violation|2|||
148821355|NCT00676052|536824529|FG004|Overall Study|Protocol Violation|1|||
148821356|NCT00676052|536824530|FG005|Overall Study|Protocol Violation|2|||
148821357|NCT00676052|536824525|FG000|Overall Study|Lost to Follow-up|0|||
148821358|NCT00676052|536824526|FG001|Overall Study|Lost to Follow-up|0|||
148821359|NCT00676052|536824527|FG002|Overall Study|Lost to Follow-up|0|||
148821360|NCT00676052|536824528|FG003|Overall Study|Lost to Follow-up|0|||
148821361|NCT00676052|536824529|FG004|Overall Study|Lost to Follow-up|1|||
148821362|NCT00676052|536824530|FG005|Overall Study|Lost to Follow-up|0|||
148821363|NCT00676052|536824525|FG000|Overall Study|Physician Decision|1|||
148821364|NCT00676052|536824526|FG001|Overall Study|Physician Decision|1|||
148821365|NCT00676052|536824527|FG002|Overall Study|Physician Decision|1|||
148821366|NCT00676052|536824528|FG003|Overall Study|Physician Decision|0|||
148821367|NCT00676052|536824529|FG004|Overall Study|Physician Decision|0|||
148821368|NCT00676052|536824530|FG005|Overall Study|Physician Decision|1|||
148821369|NCT00676052|536824525|FG000|Overall Study|Withdrawal by Subject|1|||
148821370|NCT00676052|536824526|FG001|Overall Study|Withdrawal by Subject|0|||
148821371|NCT00676052|536824527|FG002|Overall Study|Withdrawal by Subject|1|||
148821372|NCT00676052|536824528|FG003|Overall Study|Withdrawal by Subject|0|||
148821373|NCT00676052|536824529|FG004|Overall Study|Withdrawal by Subject|0|||
148821374|NCT00676052|536824530|FG005|Overall Study|Withdrawal by Subject|0|||
148821375|NCT00710554|536824536|FG000|Overall Study|Adverse Event|24|||
148821376|NCT00710554|536824537|FG001|Overall Study|Adverse Event|7|||
148821377|NCT00710554|536824536|FG000|Overall Study|Withdrawal by Subject|7|||
148821378|NCT00710554|536824537|FG001|Overall Study|Withdrawal by Subject|3|||
148821379|NCT00710554|536824536|FG000|Overall Study|Lost to Follow-up|7|||
148821380|NCT00710554|536824537|FG001|Overall Study|Lost to Follow-up|1|||
148821381|NCT00710554|536824536|FG000|Overall Study|Lack of Efficacy|11|||
148821382|NCT00710554|536824537|FG001|Overall Study|Lack of Efficacy|12|||
148821383|NCT00710554|536824536|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
148821384|NCT00710554|536824537|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
148821385|NCT01093885|536824538|FG000|Overall Study|Adverse Event|4|||
148821386|NCT01093885|536824538|FG000|Overall Study|Lost to Follow-up|1|||
148821387|NCT01560988|536824539|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
148821388|NCT01560988|536824540|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
148821389|NCT01560988|536824539|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
148821390|NCT01560988|536824540|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
148821391|NCT01560988|536824539|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
148821392|NCT01560988|536824540|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
148821393|NCT01975285|536824544|FG000|Overall Study|Failed Block and follow up|2|||
148821394|NCT01975285|536824545|FG001|Overall Study|Failed Block and follow up|2|||
148821395|NCT03774810|536824546|FG000|Phase 1|Lack of Efficacy|21|||
148821396|NCT03774810|536824547|FG001|Phase 1|Lack of Efficacy|0|||
148821397|NCT03774810|536824548|FG002|Phase 1|Lack of Efficacy|0|||
148821398|NCT03774810|536824549|FG003|Phase 1|Lack of Efficacy|0|||
148821399|NCT03774810|536824550|FG004|Phase 1|Lack of Efficacy|0|||
148821400|NCT03774810|536824546|FG000|Phase 1|Withdrawal by Subject|9|||
148821401|NCT03774810|536824547|FG001|Phase 1|Withdrawal by Subject|0|||
148821402|NCT03774810|536824548|FG002|Phase 1|Withdrawal by Subject|0|||
148821403|NCT03774810|536824549|FG003|Phase 1|Withdrawal by Subject|0|||
148821404|NCT03774810|536824550|FG004|Phase 1|Withdrawal by Subject|0|||
148821405|NCT03774810|536824546|FG000|Phase 1|Lost to Follow-up|2|||
148821406|NCT03774810|536824547|FG001|Phase 1|Lost to Follow-up|0|||
148821407|NCT03774810|536824548|FG002|Phase 1|Lost to Follow-up|0|||
148821408|NCT03774810|536824549|FG003|Phase 1|Lost to Follow-up|0|||
148821409|NCT03774810|536824550|FG004|Phase 1|Lost to Follow-up|0|||
148821410|NCT03774810|536824546|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
148821411|NCT03774810|536824547|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
148821412|NCT03774810|536824548|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
148821413|NCT03774810|536824549|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
148821414|NCT03774810|536824550|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
148821415|NCT03774810|536824546|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
148821416|NCT03774810|536824547|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
148821417|NCT03774810|536824548|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
148821418|NCT03774810|536824549|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
148821419|NCT03774810|536824550|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
148821420|NCT03774810|536824546|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
148821421|NCT03774810|536824547|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
148821422|NCT03774810|536824548|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
148821423|NCT03774810|536824549|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
148821424|NCT03774810|536824550|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
148821425|NCT03774810|536824546|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
148821426|NCT03774810|536824547|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
148821427|NCT03774810|536824548|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
148821428|NCT03774810|536824549|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
148748169|NCT02287922|536547956|FG002|Overall Study|Lost to Follow-up|1|||
148976119|NCT02652624|537394448|FG000|Randomized Phase|Investigator's Discretion|0|||
148976120|NCT02652624|537394449|FG001|Randomized Phase|Investigator's Discretion|2|||
148748170|NCT02287922|536547957|FG003|Overall Study|Lost to Follow-up|0|||
148748171|NCT02287922|536547954|FG000|Overall Study|Sponsor's decision|0|||
148748172|NCT02287922|536547955|FG001|Overall Study|Sponsor's decision|0|||
148748173|NCT02287922|536547956|FG002|Overall Study|Sponsor's decision|0|||
148748174|NCT02287922|536547957|FG003|Overall Study|Sponsor's decision|1|||
148748175|NCT02287922|536547954|FG000|Overall Study|Other|1|||
148748176|NCT02287922|536547955|FG001|Overall Study|Other|0|||
148748177|NCT02287922|536547956|FG002|Overall Study|Other|2|||
148748178|NCT02287922|536547957|FG003|Overall Study|Other|0|||
148748179|NCT00668317|536547958|FG000|Overall Study|Adverse Event|2|||
148748180|NCT03668808|536547964|FG000|First Intervention|Withdrawal by Subject|2|||
148748181|NCT03668808|536547965|FG001|First Intervention|Withdrawal by Subject|2|||
148748182|NCT00280735|536547968|FG000|Overall Study|Adverse Event|5|||
148748183|NCT00280735|536547968|FG000|Overall Study|Lack of Efficacy|3|||
148748184|NCT00280735|536547968|FG000|Overall Study|Withdrawal by Subject|8|||
148748185|NCT00280735|536547968|FG000|Overall Study|Intercurrent Illness|2|||
148748186|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
148748187|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Death|1|||
148748188|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
148748189|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
148748190|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
148748191|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
148748192|NCT02001987|536547970|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
148748193|NCT02001987|536547970|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
148748194|NCT02001987|536547970|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
148748195|NCT02001987|536547970|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
148748196|NCT02001987|536547970|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
148748197|NCT02001987|536547970|FG000|LTE Period (52 Weeks)|Other|3|||
148748198|NCT01965860|536547971|FG000|Overall Study|Pregnancy|1|||
148748199|NCT01965860|536547972|FG001|Overall Study|Pregnancy|0|||
148748200|NCT01965860|536547973|FG002|Overall Study|Pregnancy|1|||
148748201|NCT01965860|536547971|FG000|Overall Study|Logistics|1|||
148748202|NCT01965860|536547972|FG001|Overall Study|Logistics|0|||
148748203|NCT01965860|536547973|FG002|Overall Study|Logistics|0|||
148748204|NCT02064296|536547977|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
148748205|NCT02064296|536547978|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
148748206|NCT02064296|536547979|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
148748207|NCT02064296|536547977|FG000|Intervention|Withdrawal by Subject|0|||
148748208|NCT02064296|536547978|FG001|Intervention|Withdrawal by Subject|1|||
148748209|NCT02064296|536547979|FG002|Intervention|Withdrawal by Subject|2|||
148748210|NCT04186845|536547988|FG000|Overall Study|Death|2|||
148748211|NCT04186845|536547988|FG000|Overall Study|Lost to Follow-up|1|||
148748212|NCT04186845|536547988|FG000|Overall Study|Physician Decision|1|||
148748213|NCT04186845|536547988|FG000|Overall Study|Protocol Violation|1|||
148748214|NCT04186845|536547988|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
148748215|NCT04186845|536547988|FG000|Overall Study|Biopsy ordered but not done|1|||
148748216|NCT04186845|536547988|FG000|Overall Study|It was previously confirmed|1|||
148748217|NCT04186845|536547988|FG000|Overall Study|Patient cancelled scheduled scans|2|||
148748218|NCT04186845|536547988|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
148748219|NCT04186845|536547988|FG000|Overall Study|Subject refused confirmatory imaging|1|||
148748220|NCT04186845|536547988|FG000|Overall Study|Too small to biopsy|1|||
148748221|NCT05061420|536547989|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
148748222|NCT05061420|536547990|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
148748223|NCT05061420|536547991|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
148748224|NCT05061420|536547989|FG000|Overall Study|Progressive disease|11|||
148748225|NCT05061420|536547990|FG001|Overall Study|Progressive disease|15|||
148748226|NCT05061420|536547991|FG002|Overall Study|Progressive disease|14|||
148748227|NCT05061420|536547989|FG000|Overall Study|Withdrawal by Subject|2|||
148748228|NCT05061420|536547990|FG001|Overall Study|Withdrawal by Subject|0|||
148748229|NCT05061420|536547991|FG002|Overall Study|Withdrawal by Subject|1|||
148976121|NCT02652624|537394448|FG000|Randomized Phase|Death|0|||
148748230|NCT05061420|536547989|FG000|Overall Study|Not related to COVID-19|2|||
148748231|NCT05061420|536547990|FG001|Overall Study|Not related to COVID-19|0|||
148748232|NCT05061420|536547991|FG002|Overall Study|Not related to COVID-19|0|||
148748233|NCT01814553|536547992|FG000|Overall Study|PD per clinical progression|6|||
148748234|NCT01814553|536547993|FG001|Overall Study|PD per clinical progression|8|||
148748235|NCT01814553|536547992|FG000|Overall Study|Other Adverse Event|4|||
148748236|NCT01814553|536547993|FG001|Overall Study|Other Adverse Event|5|||
148748237|NCT01814553|536547992|FG000|Overall Study|Withdrawal by Subject|1|||
148748238|NCT01814553|536547993|FG001|Overall Study|Withdrawal by Subject|1|||
148748239|NCT01814553|536547992|FG000|Overall Study|Other than stated|7|||
148748240|NCT01814553|536547993|FG001|Overall Study|Other than stated|8|||
148821429|NCT03774810|536824550|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
148821430|NCT03774810|536824546|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
148821431|NCT03774810|536824547|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
148821432|NCT03774810|536824548|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
148821433|NCT03774810|536824549|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
148821434|NCT03774810|536824550|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
148821435|NCT03774810|536824546|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
148821436|NCT03774810|536824547|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
148821437|NCT03774810|536824548|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
148821438|NCT03774810|536824549|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
148821439|NCT03774810|536824550|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
148821440|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
148821441|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
148821442|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
148821443|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
148821444|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
148821445|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
148821446|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
148821447|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
148821448|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
148821449|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
148821450|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
148821451|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
148821452|NCT00290758|536824555|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
148821453|NCT00290758|536824556|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
148821454|NCT00290758|536824555|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
148821455|NCT00290758|536824556|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
148821456|NCT03994120|536824558|FG000|Overall Study|Lost to Follow-up|3|||
148821457|NCT03994120|536824559|FG001|Overall Study|Lost to Follow-up|1|||
148821458|NCT01111292|536824560|FG000|Treatment|Physician Decision|1|||
148821459|NCT01111292|536824561|FG001|Treatment|Physician Decision|1|||
148821460|NCT02619812|536824562|FG000|Overall Study|Withdrawal by Subject|0|||
148821461|NCT02619812|536824563|FG001|Overall Study|Withdrawal by Subject|0|||
148821462|NCT02619812|536824564|FG002|Overall Study|Withdrawal by Subject|1|||
148821463|NCT02619812|536824565|FG003|Overall Study|Withdrawal by Subject|2|||
148821464|NCT01096186|536824566|FG000|Overall Study|Adverse Event|16|||
148821465|NCT01096186|536824566|FG000|Overall Study|Death|4|||
148821466|NCT01096186|536824566|FG000|Overall Study|Lack of Efficacy|4|||
148821467|NCT01096186|536824566|FG000|Overall Study|Lost to Follow-up|2|||
148821468|NCT01096186|536824566|FG000|Overall Study|Withdrawal by Subject|22|||
148821469|NCT01096186|536824566|FG000|Overall Study|Physician Decision|1|||
148821470|NCT01096186|536824566|FG000|Overall Study|Noncompliance with study drug|1|||
148821471|NCT05587998|536824572|FG000|Overall Study|Withdrawal by Subject|1|||
148821472|NCT05587998|536824573|FG001|Overall Study|Withdrawal by Subject|1|||
148821473|NCT05587998|536824572|FG000|Overall Study|Not treated|3|||
148821474|NCT05587998|536824573|FG001|Overall Study|Not treated|1|||
148821475|NCT05587998|536824572|FG000|Overall Study|Non-compliance with study procedures|0|||
148821476|NCT05587998|536824573|FG001|Overall Study|Non-compliance with study procedures|1|||
148821477|NCT04263532|536824578|FG000|Overall Study|Withdrawal by Subject|2|||
148821478|NCT04263532|536824579|FG001|Overall Study|Withdrawal by Subject|0|||
148821479|NCT03892915|536824580|FG000|Overall Study|Lost to Follow-up|6|||
148821480|NCT03892915|536824581|FG001|Overall Study|Lost to Follow-up|12|||
148821481|NCT03892915|536824580|FG000|Overall Study|Death|0|||
148821482|NCT03892915|536824581|FG001|Overall Study|Death|2|||
148821483|NCT03892915|536824580|FG000|Overall Study|Withdrawal by Subject|1|||
148821484|NCT03892915|536824581|FG001|Overall Study|Withdrawal by Subject|1|||
148821485|NCT03892915|536824580|FG000|Overall Study|unsuccessful delivery|13|||
148821486|NCT03892915|536824581|FG001|Overall Study|unsuccessful delivery|18|||
148821487|NCT01210443|536824583|FG000|Overall Study|Study terminated by sponsor|2|||
148821488|NCT02807181|536824584|FG000|Overall Study|Death|28|||
148821489|NCT02807181|536824585|FG001|Overall Study|Death|24|||
148821490|NCT02807181|536824584|FG000|Overall Study|Withdrawal by Subject|1|||
148821491|NCT02807181|536824585|FG001|Overall Study|Withdrawal by Subject|1|||
148821492|NCT02807181|536824584|FG000|Overall Study|Lost to Follow-up|0|||
148821493|NCT02807181|536824585|FG001|Overall Study|Lost to Follow-up|2|||
148976122|NCT02652624|537394449|FG001|Randomized Phase|Death|1|||
148976123|NCT02652624|537394448|FG000|Randomized Phase|Lost to Follow-up|0|||
148821494|NCT02807181|536824584|FG000|Overall Study|Subject decision|1|||
148821495|NCT02807181|536824585|FG001|Overall Study|Subject decision|0|||
148821496|NCT02807181|536824584|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
148821497|NCT02807181|536824585|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
148748241|NCT00447993|536547996|FG000|Overall Study|Lost to Follow-up|0|||
148748242|NCT00447993|536547997|FG001|Overall Study|Lost to Follow-up|0|||
148748243|NCT00447993|536547998|FG002|Overall Study|Lost to Follow-up|2|||
148748244|NCT00447993|536547999|FG003|Overall Study|Lost to Follow-up|2|||
148748245|NCT00447993|536547996|FG000|Overall Study|Withdrawal by Subject|0|||
148748246|NCT00447993|536547997|FG001|Overall Study|Withdrawal by Subject|0|||
148748247|NCT00447993|536547998|FG002|Overall Study|Withdrawal by Subject|2|||
148748248|NCT00447993|536547999|FG003|Overall Study|Withdrawal by Subject|2|||
148748249|NCT02503787|536548004|FG000|Enrollment|Withdrawal by Subject|6|||
148748250|NCT02503787|536548004|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
148748251|NCT02503787|536548004|FG000|Enrollment|Physician Decision|2|||
148748252|NCT02503787|536548004|FG000|Enrollment|Insurance issue|2|||
148748253|NCT02503787|536548004|FG000|Enrollment|Lost to Follow-up|1|||
148748254|NCT02503787|536548004|FG000|Enrollment|Study closure|1|||
148748255|NCT02503787|536548004|FG000|Enrollment|Adverse Event|1|||
148748256|NCT02503787|536548004|FG000|Enrollment|Protocol Violation|1|||
148748257|NCT02503787|536548004|FG000|Enrollment|Inability to implant system|1|||
148748258|NCT02503787|536548004|FG000|Enrollment|Unable to be programmed|1|||
148748259|NCT02503787|536548004|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
148748260|NCT02503787|536548004|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
148748261|NCT02503787|536548004|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
148748262|NCT02503787|536548004|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
148748263|NCT02503787|536548004|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
148748264|NCT02503787|536548004|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
148748265|NCT04700137|536548005|FG000|Overall Study|Lost to Follow-up|1|||
148748266|NCT04700137|536548006|FG001|Overall Study|Lost to Follow-up|6|||
148748267|NCT04700137|536548007|FG002|Overall Study|Lost to Follow-up|1|||
148748268|NCT04700137|536548008|FG003|Overall Study|Lost to Follow-up|1|||
148748269|NCT04700137|536548005|FG000|Overall Study|Withdrawal by Subject|0|||
148748270|NCT04700137|536548006|FG001|Overall Study|Withdrawal by Subject|0|||
148748271|NCT04700137|536548007|FG002|Overall Study|Withdrawal by Subject|1|||
148748272|NCT04700137|536548008|FG003|Overall Study|Withdrawal by Subject|0|||
148748273|NCT04700137|536548005|FG000|Overall Study|Death|0|||
148748274|NCT04700137|536548006|FG001|Overall Study|Death|0|||
148748275|NCT04700137|536548007|FG002|Overall Study|Death|1|||
148748276|NCT04700137|536548008|FG003|Overall Study|Death|0|||
148748277|NCT04787627|536548009|FG000|Overall Study|Withdrawal by Subject|3|||
148748278|NCT04787627|536548010|FG001|Overall Study|Withdrawal by Subject|0|||
148748279|NCT04787627|536548009|FG000|Overall Study|Physician Decision|2|||
148748280|NCT04787627|536548010|FG001|Overall Study|Physician Decision|0|||
148748281|NCT04787627|536548009|FG000|Overall Study|Excluded|0|||
148748282|NCT04787627|536548010|FG001|Overall Study|Excluded|1|||
148748283|NCT00548093|536548011|FG000|Overall Study|Death|33|||
148748284|NCT00548093|536548012|FG001|Overall Study|Death|13|||
148748285|NCT00548093|536548011|FG000|Overall Study|Lost to Follow-up|3|||
148748286|NCT00548093|536548012|FG001|Overall Study|Lost to Follow-up|1|||
148748287|NCT00548093|536548011|FG000|Overall Study|Objective progression or relapse|1|||
148748288|NCT00548093|536548012|FG001|Overall Study|Objective progression or relapse|1|||
148748289|NCT00548093|536548011|FG000|Overall Study|Other|11|||
148748290|NCT00548093|536548012|FG001|Overall Study|Other|1|||
148748291|NCT00548093|536548011|FG000|Overall Study|Withdrawal by Subject|1|||
148748292|NCT00548093|536548012|FG001|Overall Study|Withdrawal by Subject|0|||
148748293|NCT00548093|536548011|FG000|Overall Study|Completed post-treatment follow-up|1|||
148748294|NCT00548093|536548012|FG001|Overall Study|Completed post-treatment follow-up|0|||
148748295|NCT02924727|536548015|FG000|Overall Study|Withdrawal by Subject|2|||
148748296|NCT02924727|536548016|FG001|Overall Study|Withdrawal by Subject|4|||
148748297|NCT02924727|536548015|FG000|Overall Study|Lost to Follow-up|2|||
148748298|NCT02924727|536548016|FG001|Overall Study|Lost to Follow-up|5|||
148748299|NCT02924727|536548015|FG000|Overall Study|Death|221|||
148748300|NCT02924727|536548016|FG001|Overall Study|Death|247|||
148748301|NCT02924727|536548015|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
148748302|NCT02924727|536548016|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
148748303|NCT01464931|536548021|FG000|Overall Study|Withdrawal by Subject|1|||
148748304|NCT01464931|536548022|FG001|Overall Study|Withdrawal by Subject|0|||
148748305|NCT01982812|536548023|FG000|Overall Study|Death|1|||
148748306|NCT01982812|536548024|FG001|Overall Study|Death|5|||
148748307|NCT01982812|536548023|FG000|Overall Study|Adverse Event|0|||
148748308|NCT01982812|536548024|FG001|Overall Study|Adverse Event|5|||
148748309|NCT00174954|536548025|FG000|Overall Study|Adverse Event|2|||
148748310|NCT00174954|536548025|FG000|Overall Study|No tophi found in MRI|1|||
148748311|NCT00174954|536548025|FG000|Overall Study|Physician Decision|1|||
148748312|NCT00993421|536548029|FG000|Overall Study|Adverse Event|2|||
148748313|NCT00993421|536548030|FG001|Overall Study|Adverse Event|7|||
148748314|NCT00993421|536548031|FG002|Overall Study|Adverse Event|6|||
148748315|NCT00993421|536548032|FG003|Overall Study|Adverse Event|9|||
148748316|NCT00993421|536548033|FG004|Overall Study|Adverse Event|5|||
148748317|NCT00993421|536548034|FG005|Overall Study|Adverse Event|7|||
148748318|NCT00993421|536548035|FG006|Overall Study|Adverse Event|1|||
148821498|NCT02807181|536824584|FG000|Overall Study|In Study|3|||
148821499|NCT02807181|536824585|FG001|Overall Study|In Study|3|||
148821500|NCT02807181|536824584|FG000|Overall Study|Post Progression|3|||
148748319|NCT00993421|536548029|FG000|Overall Study|Sponsor Decision|36|||
148748320|NCT00993421|536548030|FG001|Overall Study|Sponsor Decision|31|||
148821501|NCT02807181|536824585|FG001|Overall Study|Post Progression|2|||
148821502|NCT01078545|536824587|FG000|Overall Study|Lost to Follow-up|13|||
148821503|NCT01078545|536824587|FG000|Overall Study|Physician Decision|6|||
148821504|NCT01078545|536824587|FG000|Overall Study|Withdrawal by Subject|3|||
148821505|NCT01078545|536824587|FG000|Overall Study|Death|3|||
148821506|NCT01078545|536824587|FG000|Overall Study|Participant moved to another physician|1|||
148821507|NCT02497755|536824588|FG000|Overall Study|Protocol Violation|1|||
148821508|NCT02497755|536824589|FG001|Overall Study|Protocol Violation|0|||
148821509|NCT01774370|536824592|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
148821510|NCT01774370|536824592|FG000|Overall Study|Administered prior to the contract date|4|||
148821511|NCT01774370|536824592|FG000|Overall Study|Subjects of contraindications|34|||
148821512|NCT01774370|536824592|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
148821513|NCT01774370|536824592|FG000|Overall Study|Follow-up failure|34|||
148821514|NCT00514917|536824593|FG000|Overall Study|Death|4|||
148821515|NCT00514917|536824594|FG001|Overall Study|Death|10|||
148821516|NCT00514917|536824593|FG000|Overall Study|Protocol Violation|1|||
148821517|NCT00514917|536824594|FG001|Overall Study|Protocol Violation|0|||
148821518|NCT00514917|536824593|FG000|Overall Study|Lost to Follow-up|4|||
148821519|NCT00514917|536824594|FG001|Overall Study|Lost to Follow-up|3|||
148821520|NCT00514917|536824593|FG000|Overall Study|Withdrawal by Subject|18|||
148821521|NCT00514917|536824594|FG001|Overall Study|Withdrawal by Subject|16|||
148821522|NCT00514917|536824593|FG000|Overall Study|Discontinued due to study closure|88|||
148821523|NCT00514917|536824594|FG001|Overall Study|Discontinued due to study closure|81|||
148821524|NCT00514917|536824593|FG000|Overall Study|Undefined|11|||
148821525|NCT00514917|536824594|FG001|Overall Study|Undefined|5|||
148821526|NCT04243837|536824595|FG000|Overall Study|Adverse Event|2|||
148821527|NCT04243837|536824596|FG001|Overall Study|Adverse Event|1|||
148821528|NCT04243837|536824595|FG000|Overall Study|Withdrawal by Subject|4|||
148821529|NCT04243837|536824596|FG001|Overall Study|Withdrawal by Subject|2|||
148821530|NCT04243837|536824595|FG000|Overall Study|Covid-19 lock down|1|||
148821531|NCT04243837|536824596|FG001|Overall Study|Covid-19 lock down|0|||
148821532|NCT04243837|536824595|FG000|Overall Study|Study Terminated by Sponsor|11|||
148821533|NCT04243837|536824596|FG001|Overall Study|Study Terminated by Sponsor|12|||
148748321|NCT00993421|536548031|FG002|Overall Study|Sponsor Decision|28|||
148748322|NCT00993421|536548032|FG003|Overall Study|Sponsor Decision|30|||
148748323|NCT00993421|536548033|FG004|Overall Study|Sponsor Decision|38|||
148748324|NCT00993421|536548034|FG005|Overall Study|Sponsor Decision|30|||
148748325|NCT00993421|536548035|FG006|Overall Study|Sponsor Decision|29|||
148748326|NCT00993421|536548029|FG000|Overall Study|Lost to Follow-up|3|||
148748327|NCT00993421|536548030|FG001|Overall Study|Lost to Follow-up|5|||
148748328|NCT00993421|536548031|FG002|Overall Study|Lost to Follow-up|5|||
148748329|NCT00993421|536548032|FG003|Overall Study|Lost to Follow-up|0|||
148748330|NCT00993421|536548033|FG004|Overall Study|Lost to Follow-up|0|||
148748331|NCT00993421|536548034|FG005|Overall Study|Lost to Follow-up|0|||
148748332|NCT00993421|536548035|FG006|Overall Study|Lost to Follow-up|6|||
148748333|NCT00993421|536548029|FG000|Overall Study|Withdrawal by Subject|3|||
148748334|NCT00993421|536548030|FG001|Overall Study|Withdrawal by Subject|2|||
148748335|NCT00993421|536548031|FG002|Overall Study|Withdrawal by Subject|3|||
148748336|NCT00993421|536548032|FG003|Overall Study|Withdrawal by Subject|3|||
148821534|NCT02829957|536824600|FG000|Overall Study|Lost to Follow-up|2|||
148821535|NCT02829957|536824601|FG001|Overall Study|Lost to Follow-up|1|||
148821536|NCT01663987|536824604|FG000|Overall Study|Adverse Event|7|||
148821537|NCT01663987|536824605|FG001|Overall Study|Adverse Event|2|||
148821538|NCT01663987|536824604|FG000|Overall Study|Lost to Follow-up|1|||
148821539|NCT01663987|536824605|FG001|Overall Study|Lost to Follow-up|1|||
148821540|NCT01663987|536824604|FG000|Overall Study|Withdrawal by Subject|2|||
148821541|NCT01663987|536824605|FG001|Overall Study|Withdrawal by Subject|3|||
148821542|NCT01663987|536824604|FG000|Overall Study|Other reason not defined above|3|||
148748337|NCT00993421|536548033|FG004|Overall Study|Withdrawal by Subject|3|||
148821543|NCT01663987|536824605|FG001|Overall Study|Other reason not defined above|0|||
148821544|NCT00309244|536824611|FG000|Overall Study|Adverse Event|29|||
148821545|NCT00309244|536824612|FG001|Overall Study|Adverse Event|12|||
148821546|NCT00309244|536824611|FG000|Overall Study|Lost to Follow-up|6|||
148821547|NCT00309244|536824612|FG001|Overall Study|Lost to Follow-up|22|||
148821548|NCT00309244|536824611|FG000|Overall Study|Physician Decision|5|||
148821549|NCT00309244|536824612|FG001|Overall Study|Physician Decision|8|||
148821550|NCT00309244|536824611|FG000|Overall Study|Protocol Violation|6|||
148821551|NCT00309244|536824612|FG001|Overall Study|Protocol Violation|3|||
148821552|NCT00309244|536824611|FG000|Overall Study|Withdrawal by Subject|50|||
148748338|NCT00993421|536548034|FG005|Overall Study|Withdrawal by Subject|5|||
148748339|NCT00993421|536548035|FG006|Overall Study|Withdrawal by Subject|3|||
148748340|NCT00993421|536548029|FG000|Overall Study|Death|0|||
148748341|NCT00993421|536548030|FG001|Overall Study|Death|0|||
148748342|NCT00993421|536548031|FG002|Overall Study|Death|0|||
148821553|NCT00309244|536824612|FG001|Overall Study|Withdrawal by Subject|32|||
148821554|NCT00309244|536824611|FG000|Overall Study|Various|7|||
148821555|NCT00309244|536824612|FG001|Overall Study|Various|7|||
148821556|NCT00309244|536824611|FG000|Overall Study|Randomized but not dosed|11|||
148821557|NCT00309244|536824612|FG001|Overall Study|Randomized but not dosed|12|||
148821558|NCT00309244|536824611|FG000|Overall Study|Death|4|||
148821559|NCT00309244|536824612|FG001|Overall Study|Death|1|||
148821560|NCT02945046|536824613|FG000|Overall Study|Adverse Event|1|||
148821561|NCT02945046|536824614|FG001|Overall Study|Adverse Event|0|||
148821562|NCT02945046|536824615|FG002|Overall Study|Adverse Event|2|||
148821563|NCT02945046|536824613|FG000|Overall Study|Withdrawal by Subject|3|||
148821564|NCT02945046|536824614|FG001|Overall Study|Withdrawal by Subject|3|||
148821565|NCT02945046|536824615|FG002|Overall Study|Withdrawal by Subject|3|||
148821566|NCT02945046|536824613|FG000|Overall Study|Protocol Violation|2|||
148821567|NCT02945046|536824614|FG001|Overall Study|Protocol Violation|3|||
148821568|NCT02945046|536824615|FG002|Overall Study|Protocol Violation|2|||
148821569|NCT02945046|536824613|FG000|Overall Study|Lost to Follow-up|1|||
148821570|NCT02945046|536824614|FG001|Overall Study|Lost to Follow-up|1|||
148821571|NCT02945046|536824615|FG002|Overall Study|Lost to Follow-up|0|||
148821572|NCT02945046|536824613|FG000|Overall Study|Lack of Efficacy|1|||
148821573|NCT02945046|536824614|FG001|Overall Study|Lack of Efficacy|2|||
148821574|NCT02945046|536824615|FG002|Overall Study|Lack of Efficacy|1|||
148821575|NCT02945046|536824613|FG000|Overall Study|Other than specified|5|||
148821576|NCT02945046|536824614|FG001|Overall Study|Other than specified|4|||
148821577|NCT02945046|536824615|FG002|Overall Study|Other than specified|7|||
148821578|NCT00545948|536824617|FG000|Overall Study|Not Treated|1|||
148821579|NCT00545948|536824618|FG001|Overall Study|Not Treated|1|||
148821580|NCT00545948|536824619|FG002|Overall Study|Not Treated|7|||
148821581|NCT03467945|536824620|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148821582|NCT03467945|536824621|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148821583|NCT03467945|536824622|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148821584|NCT03467945|536824623|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148821585|NCT03467945|536824620|FG000|Treatment Period 3|Withdrawal by Subject|1|||
148821586|NCT03467945|536824621|FG001|Treatment Period 3|Withdrawal by Subject|0|||
148821587|NCT03467945|536824622|FG002|Treatment Period 3|Withdrawal by Subject|2|||
148821588|NCT03467945|536824623|FG003|Treatment Period 3|Withdrawal by Subject|1|||
148821589|NCT00541775|536824634|FG000|Overall Study|Adverse Event|3|||
148821590|NCT00541775|536824635|FG001|Overall Study|Adverse Event|2|||
148821591|NCT00541775|536824636|FG002|Overall Study|Adverse Event|1|||
148821592|NCT00541775|536824634|FG000|Overall Study|Lack of Efficacy|0|||
148821593|NCT00541775|536824635|FG001|Overall Study|Lack of Efficacy|0|||
148821594|NCT00541775|536824636|FG002|Overall Study|Lack of Efficacy|3|||
148821595|NCT00541775|536824634|FG000|Overall Study|Lost to Follow-up|0|||
148821596|NCT00541775|536824635|FG001|Overall Study|Lost to Follow-up|0|||
148821597|NCT00541775|536824636|FG002|Overall Study|Lost to Follow-up|2|||
148976124|NCT02652624|537394449|FG001|Randomized Phase|Lost to Follow-up|1|||
148976125|NCT02652624|537394448|FG000|Extension Phase|Lost to Follow-up|3|||
148976126|NCT02652624|537394449|FG001|Extension Phase|Lost to Follow-up|1|||
148976127|NCT02652624|537394448|FG000|Extension Phase|Pregnancy|1|||
148976128|NCT02652624|537394449|FG001|Extension Phase|Pregnancy|1|||
148976129|NCT02652624|537394448|FG000|Extension Phase|Adverse Event|0|||
148976130|NCT02652624|537394449|FG001|Extension Phase|Adverse Event|1|||
148821598|NCT00541775|536824634|FG000|Overall Study|Protocol Violation|1|||
148821599|NCT00541775|536824635|FG001|Overall Study|Protocol Violation|0|||
148821600|NCT00541775|536824636|FG002|Overall Study|Protocol Violation|0|||
148821601|NCT00541775|536824634|FG000|Overall Study|Withdrawal by Subject and Other|5|||
148821602|NCT00541775|536824635|FG001|Overall Study|Withdrawal by Subject and Other|0|||
148821603|NCT00541775|536824636|FG002|Overall Study|Withdrawal by Subject and Other|2|||
148821604|NCT00032487|536824637|FG000|Overall Study|Withdrawal by Subject|67|||
148821605|NCT00032487|536824638|FG001|Overall Study|Withdrawal by Subject|43|||
148821606|NCT00032487|536824637|FG000|Overall Study|Adverse Event|3|||
148821607|NCT00032487|536824638|FG001|Overall Study|Adverse Event|7|||
148821608|NCT00032487|536824637|FG000|Overall Study|Lost to Follow-up|57|||
148976131|NCT02652624|537394448|FG000|Extension Phase|Withdrew Consent|0|||
148976132|NCT02652624|537394449|FG001|Extension Phase|Withdrew Consent|1|||
148821609|NCT00032487|536824638|FG001|Overall Study|Lost to Follow-up|58|||
148821610|NCT00032487|536824637|FG000|Overall Study|Had other reason|12|||
148821611|NCT00032487|536824638|FG001|Overall Study|Had other reason|12|||
148821612|NCT04913675|536824640|FG000|Main Study (Up to Week 36)|Death|0|||
148821613|NCT04913675|536824641|FG001|Main Study (Up to Week 36)|Death|2|||
148821614|NCT04913675|536824642|FG002|Main Study (Up to Week 36)|Death|2|||
148821615|NCT04913675|536824643|FG003|Main Study (Up to Week 36)|Death|0|||
148821616|NCT04913675|536824640|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
148821617|NCT04913675|536824641|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
148821618|NCT04913675|536824642|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
148821619|NCT04913675|536824643|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
148821620|NCT04913675|536824640|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
148976133|NCT01049919|537394450|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
148748343|NCT00993421|536548032|FG003|Overall Study|Death|0|||
148748344|NCT00993421|536548033|FG004|Overall Study|Death|0|||
148748345|NCT00993421|536548034|FG005|Overall Study|Death|0|||
148748346|NCT00993421|536548035|FG006|Overall Study|Death|1|||
148748347|NCT00993421|536548029|FG000|Overall Study|Entry Criteria Exclusion|0|||
148748348|NCT00993421|536548030|FG001|Overall Study|Entry Criteria Exclusion|0|||
148748349|NCT00993421|536548031|FG002|Overall Study|Entry Criteria Exclusion|1|||
148748350|NCT00993421|536548032|FG003|Overall Study|Entry Criteria Exclusion|3|||
148748351|NCT00993421|536548033|FG004|Overall Study|Entry Criteria Exclusion|0|||
148748352|NCT00993421|536548034|FG005|Overall Study|Entry Criteria Exclusion|1|||
148748353|NCT00993421|536548035|FG006|Overall Study|Entry Criteria Exclusion|0|||
148748354|NCT00993421|536548029|FG000|Overall Study|Physician Decision|0|||
148748355|NCT00993421|536548030|FG001|Overall Study|Physician Decision|0|||
148748356|NCT00993421|536548031|FG002|Overall Study|Physician Decision|0|||
148748357|NCT00993421|536548032|FG003|Overall Study|Physician Decision|0|||
148748358|NCT00993421|536548033|FG004|Overall Study|Physician Decision|0|||
148748359|NCT00993421|536548034|FG005|Overall Study|Physician Decision|1|||
148748360|NCT00993421|536548035|FG006|Overall Study|Physician Decision|1|||
148748361|NCT00993421|536548029|FG000|Overall Study|Protocol Violation|0|||
148748362|NCT00993421|536548030|FG001|Overall Study|Protocol Violation|0|||
148748363|NCT00993421|536548031|FG002|Overall Study|Protocol Violation|0|||
148748364|NCT00993421|536548032|FG003|Overall Study|Protocol Violation|0|||
148748365|NCT00993421|536548033|FG004|Overall Study|Protocol Violation|0|||
148748366|NCT00993421|536548034|FG005|Overall Study|Protocol Violation|2|||
148748367|NCT00993421|536548035|FG006|Overall Study|Protocol Violation|1|||
148748368|NCT00352417|536548038|FG000|Overall Study|Adverse Event|1|||
148748369|NCT00352417|536548039|FG001|Overall Study|Adverse Event|0|||
148748370|NCT00352417|536548038|FG000|Overall Study|Protocol Violation|0|||
148748371|NCT00352417|536548039|FG001|Overall Study|Protocol Violation|2|||
148748372|NCT00352417|536548038|FG000|Overall Study|Withdrawal by Subject|1|||
148748373|NCT00352417|536548039|FG001|Overall Study|Withdrawal by Subject|2|||
148748374|NCT00352417|536548038|FG000|Overall Study|Lost to Follow-up|1|||
148748375|NCT00352417|536548039|FG001|Overall Study|Lost to Follow-up|0|||
148748376|NCT00352417|536548038|FG000|Overall Study|Schedule Change|2|||
148748377|NCT00352417|536548039|FG001|Overall Study|Schedule Change|1|||
148748378|NCT02447744|536548040|FG000|Overall Study|Withdrawal by Subject|3|||
148748379|NCT02447744|536548041|FG001|Overall Study|Withdrawal by Subject|1|||
148748380|NCT02447744|536548040|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
148748381|NCT02447744|536548041|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
148748382|NCT02498613|536550437|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
148748383|NCT02498613|536550438|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
148748384|NCT02498613|536550439|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
148748385|NCT02498613|536550440|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
148748386|NCT02498613|536550437|FG000|Overall Study|Withdrawal by Subject|3|||
148748387|NCT02498613|536550438|FG001|Overall Study|Withdrawal by Subject|1|||
148748388|NCT02498613|536550439|FG002|Overall Study|Withdrawal by Subject|0|||
148748389|NCT02498613|536550440|FG003|Overall Study|Withdrawal by Subject|0|||
148748390|NCT05109611|536550442|FG000|Overall Study|Adverse Event|13|||
148748391|NCT05109611|536550443|FG001|Overall Study|Adverse Event|10|||
148748392|NCT05109611|536550442|FG000|Overall Study|Withdrawal by Subject|1|||
148748393|NCT05109611|536550443|FG001|Overall Study|Withdrawal by Subject|0|||
148748394|NCT05109611|536550442|FG000|Overall Study|Lost to Follow-up|1|||
148748395|NCT05109611|536550443|FG001|Overall Study|Lost to Follow-up|2|||
148748396|NCT05109611|536550442|FG000|Overall Study|Protocol Violation|0|||
148748397|NCT05109611|536550443|FG001|Overall Study|Protocol Violation|4|||
148748398|NCT05109611|536550442|FG000|Overall Study|Information unavailable|1|||
148748399|NCT05109611|536550443|FG001|Overall Study|Information unavailable|1|||
148748400|NCT03573830|536550446|FG000|Overall Study|Dropped without completing treatment|0|||
148748401|NCT03573830|536550447|FG001|Overall Study|Dropped without completing treatment|7|||
148821621|NCT04913675|536824641|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
149027230|NCT00689104|537576541|FG000|Overall Study|Randomized but never received study drug|2|||
149027231|NCT00689104|537576542|FG001|Overall Study|Randomized but never received study drug|1|||
149027232|NCT00689104|537576543|FG002|Overall Study|Randomized but never received study drug|1|||
148748402|NCT03573830|536550446|FG000|Overall Study|Lost to Follow-up|4|||
148748403|NCT03573830|536550447|FG001|Overall Study|Lost to Follow-up|0|||
148748404|NCT00233948|536550448|FG000|Overall Study|Adverse Event|1|||
148748405|NCT00233948|536550449|FG001|Overall Study|Adverse Event|0|||
148748406|NCT00233948|536550450|FG002|Overall Study|Adverse Event|0|||
148748407|NCT00233948|536550451|FG003|Overall Study|Adverse Event|0|||
148748408|NCT00233948|536550452|FG004|Overall Study|Adverse Event|0|||
148748409|NCT00233948|536550453|FG005|Overall Study|Adverse Event|0|||
148748410|NCT03284723|536550454|FG000|Overall Study|Death|0|||
148748411|NCT03284723|536550455|FG001|Overall Study|Death|0|||
148748412|NCT03284723|536550456|FG002|Overall Study|Death|0|||
148748413|NCT03284723|536550457|FG003|Overall Study|Death|1|||
148748414|NCT03284723|536550458|FG004|Overall Study|Death|0|||
148748415|NCT03284723|536550459|FG005|Overall Study|Death|0|||
148748416|NCT03284723|536550460|FG006|Overall Study|Death|1|||
148821622|NCT04913675|536824642|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
148821623|NCT04913675|536824643|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
148821624|NCT04913675|536824640|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
148821625|NCT04913675|536824641|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
148821626|NCT04913675|536824642|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
148821627|NCT04913675|536824643|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
148821628|NCT04913675|536824640|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
148821629|NCT04913675|536824641|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
148821630|NCT04913675|536824642|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
148821631|NCT04913675|536824643|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
148821632|NCT02975700|536824644|FG000|Overall Study|Adverse Event|1|||
148821633|NCT02975700|536824644|FG000|Overall Study|Progressive disease|3|||
148821634|NCT02975700|536824644|FG000|Overall Study|Failed screening criteria|2|||
148821635|NCT01541254|536824645|FG000|Overall Study|Withdrawal by Subject|1|||
148821636|NCT01541254|536824645|FG000|Overall Study|excluded - metal allergy|1|||
148821637|NCT01541254|536824645|FG000|Overall Study|enrolled after study closed|1|||
148748417|NCT03284723|536550461|FG007|Overall Study|Death|0|||
148748418|NCT03284723|536550462|FG008|Overall Study|Death|0|||
148748419|NCT03284723|536550463|FG009|Overall Study|Death|2|||
148748420|NCT03284723|536550464|FG010|Overall Study|Death|1|||
148748421|NCT03284723|536550465|FG011|Overall Study|Death|0|||
148748422|NCT03284723|536550454|FG000|Overall Study|Lost to Follow-up|0|||
148748423|NCT03284723|536550455|FG001|Overall Study|Lost to Follow-up|0|||
148748424|NCT03284723|536550456|FG002|Overall Study|Lost to Follow-up|0|||
148748425|NCT03284723|536550457|FG003|Overall Study|Lost to Follow-up|0|||
148748426|NCT03284723|536550458|FG004|Overall Study|Lost to Follow-up|0|||
148748427|NCT03284723|536550459|FG005|Overall Study|Lost to Follow-up|2|||
148748428|NCT03284723|536550460|FG006|Overall Study|Lost to Follow-up|1|||
148748429|NCT03284723|536550461|FG007|Overall Study|Lost to Follow-up|0|||
148748430|NCT03284723|536550462|FG008|Overall Study|Lost to Follow-up|0|||
148748431|NCT03284723|536550463|FG009|Overall Study|Lost to Follow-up|2|||
148748432|NCT03284723|536550464|FG010|Overall Study|Lost to Follow-up|0|||
148748433|NCT03284723|536550465|FG011|Overall Study|Lost to Follow-up|0|||
148748434|NCT03284723|536550454|FG000|Overall Study|Study Terminated By Sponsor|0|||
148748435|NCT03284723|536550455|FG001|Overall Study|Study Terminated By Sponsor|0|||
148748436|NCT03284723|536550456|FG002|Overall Study|Study Terminated By Sponsor|0|||
148748437|NCT03284723|536550457|FG003|Overall Study|Study Terminated By Sponsor|0|||
148748438|NCT03284723|536550458|FG004|Overall Study|Study Terminated By Sponsor|1|||
148748439|NCT03284723|536550459|FG005|Overall Study|Study Terminated By Sponsor|0|||
148748440|NCT03284723|536550460|FG006|Overall Study|Study Terminated By Sponsor|0|||
148748441|NCT03284723|536550461|FG007|Overall Study|Study Terminated By Sponsor|0|||
148748442|NCT03284723|536550462|FG008|Overall Study|Study Terminated By Sponsor|1|||
148748443|NCT03284723|536550463|FG009|Overall Study|Study Terminated By Sponsor|1|||
148748444|NCT03284723|536550464|FG010|Overall Study|Study Terminated By Sponsor|1|||
148748445|NCT03284723|536550465|FG011|Overall Study|Study Terminated By Sponsor|1|||
148748446|NCT03284723|536550454|FG000|Overall Study|Withdrawal by Subject|0|||
148748447|NCT03284723|536550455|FG001|Overall Study|Withdrawal by Subject|0|||
148748448|NCT03284723|536550456|FG002|Overall Study|Withdrawal by Subject|0|||
148748449|NCT03284723|536550457|FG003|Overall Study|Withdrawal by Subject|0|||
148748450|NCT03284723|536550458|FG004|Overall Study|Withdrawal by Subject|5|||
148748451|NCT03284723|536550459|FG005|Overall Study|Withdrawal by Subject|3|||
148748452|NCT03284723|536550460|FG006|Overall Study|Withdrawal by Subject|1|||
148748453|NCT03284723|536550461|FG007|Overall Study|Withdrawal by Subject|0|||
148748454|NCT03284723|536550462|FG008|Overall Study|Withdrawal by Subject|6|||
148748455|NCT03284723|536550463|FG009|Overall Study|Withdrawal by Subject|0|||
148748456|NCT03284723|536550464|FG010|Overall Study|Withdrawal by Subject|3|||
148748457|NCT03284723|536550465|FG011|Overall Study|Withdrawal by Subject|1|||
148748458|NCT03284723|536550454|FG000|Overall Study|Other|1|||
148748459|NCT03284723|536550455|FG001|Overall Study|Other|0|||
148748460|NCT03284723|536550456|FG002|Overall Study|Other|1|||
148821638|NCT01541254|536824645|FG000|Overall Study|GI bleed prior to procedure|1|||
148821639|NCT01541254|536824645|FG000|Overall Study|stent not required|1|||
148821640|NCT01541254|536824645|FG000|Overall Study|alternate stent used|1|||
149027233|NCT00689104|537576544|FG003|Overall Study|Randomized but never received study drug|0|||
149027234|NCT00689104|537576541|FG000|Overall Study|Physician Decision|1|||
149027235|NCT00689104|537576542|FG001|Overall Study|Physician Decision|0|||
148748461|NCT03284723|536550457|FG003|Overall Study|Other|0|||
148748462|NCT03284723|536550458|FG004|Overall Study|Other|1|||
148748463|NCT03284723|536550459|FG005|Overall Study|Other|0|||
148748464|NCT03284723|536550460|FG006|Overall Study|Other|0|||
148748465|NCT03284723|536550461|FG007|Overall Study|Other|0|||
148748466|NCT03284723|536550462|FG008|Overall Study|Other|0|||
149027236|NCT00689104|537576543|FG002|Overall Study|Physician Decision|0|||
148748467|NCT03284723|536550463|FG009|Overall Study|Other|0|||
148748468|NCT03284723|536550464|FG010|Overall Study|Other|1|||
148748469|NCT03284723|536550465|FG011|Overall Study|Other|0|||
148748470|NCT03284723|536550454|FG000|Overall Study|Adverse Event|0|||
148748471|NCT03284723|536550455|FG001|Overall Study|Adverse Event|0|||
148976134|NCT01049919|537394451|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
148976135|NCT01049919|537394450|FG000|Overall Study|Withdrawal by Subject|5|||
148748472|NCT03284723|536550456|FG002|Overall Study|Adverse Event|0|||
148748473|NCT03284723|536550457|FG003|Overall Study|Adverse Event|0|||
148748474|NCT03284723|536550458|FG004|Overall Study|Adverse Event|0|||
148748475|NCT03284723|536550459|FG005|Overall Study|Adverse Event|0|||
148748476|NCT03284723|536550460|FG006|Overall Study|Adverse Event|0|||
148748477|NCT03284723|536550461|FG007|Overall Study|Adverse Event|0|||
148748478|NCT03284723|536550462|FG008|Overall Study|Adverse Event|1|||
148748479|NCT03284723|536550463|FG009|Overall Study|Adverse Event|0|||
148748480|NCT03284723|536550464|FG010|Overall Study|Adverse Event|0|||
148748481|NCT03284723|536550465|FG011|Overall Study|Adverse Event|0|||
148748482|NCT00764881|536550466|FG000|Overall Study|Adverse Event|5|||
148748483|NCT00764881|536550467|FG001|Overall Study|Adverse Event|1|||
148748484|NCT00764881|536550466|FG000|Overall Study|Withdrawal by Subject|1|||
148748485|NCT00764881|536550467|FG001|Overall Study|Withdrawal by Subject|3|||
148748486|NCT00764881|536550466|FG000|Overall Study|Protocol Violation|2|||
148748487|NCT00764881|536550467|FG001|Overall Study|Protocol Violation|2|||
148748488|NCT00764881|536550466|FG000|Overall Study|Lost to Follow-up|2|||
148748489|NCT00764881|536550467|FG001|Overall Study|Lost to Follow-up|0|||
148748490|NCT00764881|536550466|FG000|Overall Study|Noncompliant|1|||
148748491|NCT00764881|536550467|FG001|Overall Study|Noncompliant|0|||
148748492|NCT00764881|536550466|FG000|Overall Study|Accidentally discontinued study drug|1|||
148748493|NCT00764881|536550467|FG001|Overall Study|Accidentally discontinued study drug|0|||
148748494|NCT00764881|536550466|FG000|Overall Study|Wished to become pregnant|1|||
148748495|NCT00764881|536550467|FG001|Overall Study|Wished to become pregnant|0|||
148748496|NCT00764881|536550466|FG000|Overall Study|Carcinoma detected|1|||
148748497|NCT00764881|536550467|FG001|Overall Study|Carcinoma detected|0|||
148748498|NCT00764881|536550466|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
148748499|NCT00764881|536550467|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
148748500|NCT00764881|536550466|FG000|Overall Study|no treatment or no observation|2|||
148748501|NCT00764881|536550467|FG001|Overall Study|no treatment or no observation|2|||
148748502|NCT01567462|536550471|FG000|Overall Study|Withdrawal by Subject|4|||
148748503|NCT01567462|536550472|FG001|Overall Study|Withdrawal by Subject|7|||
148748504|NCT00886015|536550475|FG000|Overall Study|Death|0|||
148748505|NCT00886015|536550476|FG001|Overall Study|Death|2|||
148748506|NCT00196326|536550477|FG000|Overall Study|Did not meet protocol requirements|64|||
148748507|NCT00196326|536550477|FG000|Overall Study|Non-compliance with the protocol|81|||
148748508|NCT00196326|536550477|FG000|Overall Study|Physician Decision|3|||
148748509|NCT00196326|536550477|FG000|Overall Study|Withdrawal by Subject|225|||
148748510|NCT00196326|536550477|FG000|Overall Study|Adverse Event|253|||
148748511|NCT00196326|536550477|FG000|Overall Study|Pregnancy|34|||
148748512|NCT00196326|536550477|FG000|Overall Study|Lost to Follow-up|304|||
148748513|NCT00196326|536550477|FG000|Overall Study|Other|22|||
148748514|NCT01473407|536550478|FG000|Overall Study|Physician Decision|1|||
148748515|NCT01473407|536550479|FG001|Overall Study|Physician Decision|4|||
148748516|NCT01473407|536550478|FG000|Overall Study|Lost to Follow-up|10|||
148748517|NCT01473407|536550479|FG001|Overall Study|Lost to Follow-up|4|||
148748518|NCT01473407|536550478|FG000|Overall Study|Adverse Event|8|||
148748519|NCT01473407|536550479|FG001|Overall Study|Adverse Event|8|||
148748520|NCT01473407|536550478|FG000|Overall Study|Randomization Error|3|||
148748521|NCT01473407|536550479|FG001|Overall Study|Randomization Error|1|||
148748522|NCT01473407|536550478|FG000|Overall Study|Withdrawal by Subject|4|||
148748523|NCT01473407|536550479|FG001|Overall Study|Withdrawal by Subject|7|||
148748524|NCT01473407|536550478|FG000|Overall Study|Kidney Transplant|7|||
148748525|NCT01473407|536550479|FG001|Overall Study|Kidney Transplant|6|||
148748526|NCT01473407|536550478|FG000|Overall Study|Vacation/Travel|1|||
148748527|NCT01473407|536550479|FG001|Overall Study|Vacation/Travel|1|||
148748528|NCT01473407|536550478|FG000|Overall Study|Elevated Hemoglobin|1|||
148748529|NCT01473407|536550479|FG001|Overall Study|Elevated Hemoglobin|0|||
148748530|NCT01473407|536550478|FG000|Overall Study|Patient Received Aranesp|1|||
148748531|NCT01473407|536550479|FG001|Overall Study|Patient Received Aranesp|0|||
148748532|NCT01473407|536550478|FG000|Overall Study|Patient Lost Green Card Status|1|||
148748533|NCT01473407|536550479|FG001|Overall Study|Patient Lost Green Card Status|0|||
148748534|NCT01473407|536550478|FG000|Overall Study|Temperature Excursion|2|||
148748535|NCT01473407|536550479|FG001|Overall Study|Temperature Excursion|3|||
148748536|NCT01473407|536550478|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
148748537|NCT01473407|536550479|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
148748538|NCT01473407|536550478|FG000|Overall Study|Sponsor's Decision|10|||
148748539|NCT01473407|536550479|FG001|Overall Study|Sponsor's Decision|10|||
148748540|NCT01473407|536550478|FG000|Overall Study|Site Closure|1|||
148748541|NCT01473407|536550479|FG001|Overall Study|Site Closure|0|||
148748542|NCT05223920|536550480|FG000|Overall Study|Adverse Event|6|||
148748543|NCT05223920|536550481|FG001|Overall Study|Adverse Event|3|||
148748544|NCT05223920|536550480|FG000|Overall Study|Death|2|||
148748545|NCT05223920|536550481|FG001|Overall Study|Death|0|||
148748546|NCT05223920|536550480|FG000|Overall Study|Disease Progression|1|||
148748547|NCT05223920|536550481|FG001|Overall Study|Disease Progression|2|||
148748548|NCT05223920|536550480|FG000|Overall Study|Physician Decision|1|||
148748549|NCT05223920|536550481|FG001|Overall Study|Physician Decision|2|||
148748550|NCT05223920|536550480|FG000|Overall Study|Sponsor decision|11|||
148748551|NCT05223920|536550481|FG001|Overall Study|Sponsor decision|9|||
148748552|NCT05223920|536550480|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
148748553|NCT05223920|536550481|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
148748554|NCT05223920|536550480|FG000|Overall Study|Subject decision|1|||
148748555|NCT05223920|536550481|FG001|Overall Study|Subject decision|0|||
148748556|NCT05223920|536550480|FG000|Overall Study|Withdrawal by Subject|1|||
148748557|NCT05223920|536550481|FG001|Overall Study|Withdrawal by Subject|6|||
148748558|NCT00369941|536550482|FG000|Overall Study|Never Treated|1|||
148748559|NCT00369941|536550483|FG001|Overall Study|Never Treated|2|||
148748560|NCT00369941|536550482|FG000|Overall Study|Adverse Event|14|||
148748561|NCT00369941|536550483|FG001|Overall Study|Adverse Event|28|||
148748562|NCT00369941|536550482|FG000|Overall Study|Lack of Efficacy|6|||
148748563|NCT00369941|536550483|FG001|Overall Study|Lack of Efficacy|10|||
148748564|NCT00369941|536550482|FG000|Overall Study|Lost to Follow-up|12|||
148748565|NCT00369941|536550483|FG001|Overall Study|Lost to Follow-up|22|||
148748566|NCT00369941|536550482|FG000|Overall Study|Protocol Violation|5|||
148748567|NCT00369941|536550483|FG001|Overall Study|Protocol Violation|3|||
148748568|NCT00369941|536550482|FG000|Overall Study|Withdrawal by Subject|5|||
148748569|NCT00369941|536550483|FG001|Overall Study|Withdrawal by Subject|18|||
148748570|NCT00369941|536550482|FG000|Overall Study|Pregnancy|4|||
148748571|NCT00369941|536550483|FG001|Overall Study|Pregnancy|2|||
148748572|NCT00369941|536550482|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
148748573|NCT00369941|536550483|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
148748574|NCT00369941|536550482|FG000|Overall Study|Moved|11|||
148748575|NCT00369941|536550483|FG001|Overall Study|Moved|5|||
148748576|NCT00369941|536550482|FG000|Overall Study|Treatment with Prohibited Medication|3|||
148748577|NCT00369941|536550483|FG001|Overall Study|Treatment with Prohibited Medication|1|||
148748578|NCT00369941|536550482|FG000|Overall Study|Employment Interfered with Study Visits|1|||
148748579|NCT00369941|536550483|FG001|Overall Study|Employment Interfered with Study Visits|0|||
148748580|NCT00369941|536550482|FG000|Overall Study|Study Site Terminated|2|||
148748581|NCT00369941|536550483|FG001|Overall Study|Study Site Terminated|0|||
148748582|NCT00369941|536550482|FG000|Overall Study|Miscellaneous|3|||
148748583|NCT00369941|536550483|FG001|Overall Study|Miscellaneous|3|||
148748584|NCT01027702|536550484|FG000|Overall Study|Received subsequent therapy|1|||
148748585|NCT01027702|536550485|FG001|Overall Study|Received subsequent therapy|2|||
148748586|NCT01027702|536550486|FG002|Overall Study|Received subsequent therapy|0|||
148748587|NCT01027702|536550487|FG003|Overall Study|Received subsequent therapy|4|||
148748588|NCT01027702|536550488|FG004|Overall Study|Received subsequent therapy|1|||
148748589|NCT01027702|536550489|FG005|Overall Study|Received subsequent therapy|0|||
148748590|NCT01027702|536550490|FG006|Overall Study|Received subsequent therapy|1|||
148748591|NCT01027702|536550484|FG000|Overall Study|Death|0|||
148748592|NCT01027702|536550485|FG001|Overall Study|Death|0|||
148748593|NCT01027702|536550486|FG002|Overall Study|Death|1|||
148748594|NCT01027702|536550487|FG003|Overall Study|Death|0|||
148748595|NCT01027702|536550488|FG004|Overall Study|Death|0|||
148748596|NCT01027702|536550489|FG005|Overall Study|Death|0|||
148748597|NCT01027702|536550490|FG006|Overall Study|Death|0|||
148748598|NCT00403585|536550491|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
148748599|NCT00403585|536550491|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
148748600|NCT00403585|536550491|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
148748601|NCT02964312|536550494|FG000|Overall Study|Lost to Follow-up|28|||
148748602|NCT02964312|536550494|FG000|Overall Study|Withdrawal by Subject|11|||
148748603|NCT02964312|536550494|FG000|Overall Study|Lack of Efficacy|10|||
148748604|NCT02964312|536550494|FG000|Overall Study|Did not consent to long-term FU|14|||
148748605|NCT02964312|536550494|FG000|Overall Study|Death|1|||
148748606|NCT02862730|536550503|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
148748607|NCT02862730|536550504|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
148976136|NCT01049919|537394451|FG001|Overall Study|Withdrawal by Subject|0|||
148976137|NCT01049919|537394450|FG000|Overall Study|Lost to Follow-up|6|||
148748608|NCT02862730|536550505|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
148748609|NCT02862730|536550506|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
148748610|NCT02862730|536550507|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
148748611|NCT02862730|536550508|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
148748612|NCT02862730|536550509|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
148748613|NCT02862730|536550503|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
148748614|NCT02862730|536550504|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
148748615|NCT02862730|536550505|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
148748616|NCT02862730|536550506|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
148748617|NCT02862730|536550507|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
148748618|NCT02862730|536550508|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
148748619|NCT02862730|536550509|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
148821641|NCT01227395|536824647|FG000|Overall Study|Protocol Violation|0|||
148821642|NCT01227395|536824648|FG001|Overall Study|Protocol Violation|1|||
148821643|NCT03259308|536824653|FG000|Overall Study|Adverse Event|5|||
148821644|NCT03259308|536824654|FG001|Overall Study|Adverse Event|4|||
148821645|NCT03259308|536824655|FG002|Overall Study|Adverse Event|1|||
148821646|NCT03259308|536824653|FG000|Overall Study|Withdrawal by Subject|2|||
148821647|NCT03259308|536824654|FG001|Overall Study|Withdrawal by Subject|1|||
148821648|NCT03259308|536824655|FG002|Overall Study|Withdrawal by Subject|3|||
148821649|NCT03259308|536824653|FG000|Overall Study|Lost to Follow-up|0|||
148821650|NCT03259308|536824654|FG001|Overall Study|Lost to Follow-up|0|||
148821651|NCT03259308|536824655|FG002|Overall Study|Lost to Follow-up|1|||
148821652|NCT03259308|536824653|FG000|Overall Study|Pregnancy|0|||
148821653|NCT03259308|536824654|FG001|Overall Study|Pregnancy|0|||
148821654|NCT03259308|536824655|FG002|Overall Study|Pregnancy|1|||
148821655|NCT03259308|536824653|FG000|Overall Study|Protocol Deviation|0|||
148821656|NCT03259308|536824654|FG001|Overall Study|Protocol Deviation|3|||
148821657|NCT03259308|536824655|FG002|Overall Study|Protocol Deviation|0|||
148821658|NCT03259308|536824653|FG000|Overall Study|Lack of Efficacy|0|||
148821659|NCT03259308|536824654|FG001|Overall Study|Lack of Efficacy|0|||
148821660|NCT03259308|536824655|FG002|Overall Study|Lack of Efficacy|1|||
148821661|NCT03632720|536824660|FG000|Overall Study|Adverse Event|2|||
148821662|NCT03632720|536824661|FG001|Overall Study|Adverse Event|0|||
148821663|NCT03632720|536824662|FG002|Overall Study|Adverse Event|0|||
148821664|NCT03632720|536824660|FG000|Overall Study|Lost to Follow-up|0|||
148821665|NCT03632720|536824661|FG001|Overall Study|Lost to Follow-up|1|||
148821666|NCT03632720|536824662|FG002|Overall Study|Lost to Follow-up|0|||
148821667|NCT03632720|536824660|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
148821668|NCT03632720|536824661|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
148821669|NCT03632720|536824662|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
148821670|NCT03632720|536824660|FG000|Overall Study|Screen failure|0|||
148821671|NCT03632720|536824661|FG001|Overall Study|Screen failure|1|||
148821672|NCT03632720|536824662|FG002|Overall Study|Screen failure|0|||
148976138|NCT01049919|537394451|FG001|Overall Study|Lost to Follow-up|1|||
148976139|NCT01049919|537394450|FG000|Overall Study|Physician Decision|2|||
148976140|NCT01049919|537394451|FG001|Overall Study|Physician Decision|0|||
148976141|NCT01049919|537394450|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
148748620|NCT02862730|536550503|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
148748621|NCT02862730|536550504|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
148748622|NCT02862730|536550505|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
148748623|NCT02862730|536550506|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
148748624|NCT02862730|536550507|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
148748625|NCT02862730|536550508|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
148748626|NCT02862730|536550509|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
148748627|NCT02862730|536550503|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
148748628|NCT02862730|536550504|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
148748629|NCT02862730|536550505|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
148748630|NCT02862730|536550506|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
148748631|NCT02862730|536550507|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
148748632|NCT02862730|536550508|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
148748633|NCT02862730|536550509|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
148748634|NCT03685344|536550510|FG000|Overall Study|Withdrawal by Subject|1|||
148748635|NCT03685344|536550511|FG001|Overall Study|Withdrawal by Subject|1|||
148748636|NCT03685344|536550512|FG002|Overall Study|Withdrawal by Subject|2|||
148748637|NCT03685344|536550513|FG003|Overall Study|Withdrawal by Subject|0|||
148748638|NCT03685344|536550510|FG000|Overall Study|Physician Decision|1|||
148748639|NCT03685344|536550511|FG001|Overall Study|Physician Decision|1|||
148748640|NCT03685344|536550512|FG002|Overall Study|Physician Decision|5|||
148748641|NCT03685344|536550513|FG003|Overall Study|Physician Decision|0|||
148748642|NCT03685344|536550510|FG000|Overall Study|Death|1|||
148821673|NCT01117350|536824664|FG000|Comparative Period|Not Treated|5|||
148821674|NCT01117350|536824665|FG001|Comparative Period|Not Treated|8|||
148821675|NCT01117350|536824664|FG000|Comparative Period|Adverse Event|6|||
148821676|NCT01117350|536824665|FG001|Comparative Period|Adverse Event|33|||
148821677|NCT01117350|536824664|FG000|Comparative Period|Lost to Follow-up|11|||
148821678|NCT01117350|536824665|FG001|Comparative Period|Lost to Follow-up|7|||
148821679|NCT01117350|536824664|FG000|Comparative Period|Withdrawal by Subject|9|||
148821680|NCT01117350|536824665|FG001|Comparative Period|Withdrawal by Subject|13|||
148821681|NCT01117350|536824664|FG000|Comparative Period|Protocol Violation|8|||
148748643|NCT03685344|536550511|FG001|Overall Study|Death|1|||
148821682|NCT01117350|536824665|FG001|Comparative Period|Protocol Violation|12|||
148748644|NCT03685344|536550512|FG002|Overall Study|Death|0|||
148821683|NCT01117350|536824664|FG000|Comparative Period|Lack of Efficacy|1|||
148821684|NCT01117350|536824665|FG001|Comparative Period|Lack of Efficacy|0|||
148821685|NCT01117350|536824664|FG000|Comparative Period|Physician Decision|0|||
148821686|NCT01117350|536824665|FG001|Comparative Period|Physician Decision|1|||
148821687|NCT01117350|536824664|FG000|Comparative Period|Move to another city/country|2|||
148821688|NCT01117350|536824665|FG001|Comparative Period|Move to another city/country|1|||
148748645|NCT03685344|536550513|FG003|Overall Study|Death|0|||
148748646|NCT02121652|536550516|FG000|Overall Study|Lost to Follow-up|2|||
148748647|NCT02121652|536550517|FG001|Overall Study|Lost to Follow-up|1|||
148748648|NCT02121652|536550516|FG000|Overall Study|Death|1|||
148748649|NCT02121652|536550517|FG001|Overall Study|Death|0|||
148748650|NCT02121652|536550516|FG000|Overall Study|Withdrawal by Subject|3|||
148748651|NCT02121652|536550517|FG001|Overall Study|Withdrawal by Subject|3|||
148748652|NCT00261950|536550519|FG000|Overall Study|Lost to Follow-up|2|||
148748653|NCT00261950|536550519|FG000|Overall Study|Death|6|||
148748654|NCT00261950|536550519|FG000|Overall Study|Withdrawal by Subject|5|||
148748655|NCT00261950|536550519|FG000|Overall Study|Other|1|||
148748656|NCT00261950|536550519|FG000|Overall Study|Physician Decision|1|||
148748657|NCT00261950|536550519|FG000|Overall Study|Protocol specified Criteria|11|||
148748658|NCT01023035|536550520|FG000|Treatment Period|Adverse Event|27|||
148748659|NCT01023035|536550521|FG001|Treatment Period|Adverse Event|32|||
148748660|NCT01023035|536550522|FG002|Treatment Period|Adverse Event|50|||
148748661|NCT01023035|536550520|FG000|Treatment Period|Non-Medical Reasons|19|||
148748662|NCT01023035|536550521|FG001|Treatment Period|Non-Medical Reasons|22|||
148748663|NCT01023035|536550522|FG002|Treatment Period|Non-Medical Reasons|44|||
148748664|NCT01023035|536550520|FG000|Treatment Period|Treatment Failure|26|||
148748665|NCT01023035|536550521|FG001|Treatment Period|Treatment Failure|31|||
148748666|NCT01023035|536550522|FG002|Treatment Period|Treatment Failure|24|||
148748667|NCT01023035|536550520|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
148748668|NCT01023035|536550521|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
148748669|NCT01023035|536550522|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
148748670|NCT01023035|536550520|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
148748671|NCT01023035|536550521|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
148748672|NCT01023035|536550522|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
148748673|NCT00445432|536550527|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
148748674|NCT00445432|536550528|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
148748675|NCT00445432|536550529|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
148748676|NCT00445432|536550530|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
148748677|NCT00445432|536550527|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
148748678|NCT00445432|536550528|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
148748679|NCT00445432|536550529|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
148748680|NCT00445432|536550530|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
148748681|NCT00445432|536550527|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
148748682|NCT00445432|536550528|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
148748683|NCT00445432|536550529|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
148748684|NCT00445432|536550530|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
148748685|NCT00445432|536550527|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
148748686|NCT00445432|536550528|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
148748687|NCT00445432|536550529|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
148748688|NCT00445432|536550530|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
148748689|NCT00445432|536550527|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
148748690|NCT00445432|536550528|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
148748691|NCT00445432|536550529|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
148748692|NCT00445432|536550530|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
148748693|NCT00445432|536550527|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
148748694|NCT00445432|536550528|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
148748695|NCT00445432|536550529|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
148748696|NCT00445432|536550530|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
148748697|NCT00445432|536550527|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
148748698|NCT00445432|536550528|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
148748699|NCT00445432|536550529|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
148748700|NCT00445432|536550530|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
148748701|NCT02789137|536550531|FG000|Overall Study|Dropped out/Died|58|||
148748702|NCT01090414|536550532|FG000|Study 101-99|Progressive Disease|28|||
148821689|NCT01117350|536824664|FG000|Extension Period|Not included in extension, not treated|0|||
148821690|NCT01117350|536824665|FG001|Extension Period|Not included in extension, not treated|50|||
148821691|NCT01117350|536824664|FG000|Extension Period|Adverse Event|0|||
148748703|NCT01090414|536550533|FG001|Study 101-99|Progressive Disease|48|||
148748704|NCT01090414|536550534|FG002|Study 101-99|Progressive Disease|10|||
148748705|NCT01090414|536550535|FG003|Study 101-99|Progressive Disease|4|||
148748706|NCT01090414|536550532|FG000|Study 101-99|Adverse Event|10|||
148748707|NCT01090414|536550533|FG001|Study 101-99|Adverse Event|28|||
148821692|NCT01117350|536824665|FG001|Extension Period|Adverse Event|2|||
148821693|NCT01117350|536824664|FG000|Extension Period|Protocol Violation|0|||
148821694|NCT01117350|536824665|FG001|Extension Period|Protocol Violation|2|||
148821695|NCT01117350|536824664|FG000|Extension Period|Lost to Follow-up|0|||
148748708|NCT01090414|536550534|FG002|Study 101-99|Adverse Event|18|||
148821696|NCT01117350|536824665|FG001|Extension Period|Lost to Follow-up|2|||
149027237|NCT00689104|537576544|FG003|Overall Study|Physician Decision|0|||
148748709|NCT01090414|536550535|FG003|Study 101-99|Adverse Event|0|||
148748710|NCT01090414|536550532|FG000|Study 101-99|Investigator Request|1|||
148748711|NCT01090414|536550533|FG001|Study 101-99|Investigator Request|11|||
148748712|NCT01090414|536550534|FG002|Study 101-99|Investigator Request|4|||
148748713|NCT01090414|536550535|FG003|Study 101-99|Investigator Request|0|||
148748714|NCT01090414|536550532|FG000|Study 101-99|Death|3|||
148748715|NCT01090414|536550533|FG001|Study 101-99|Death|8|||
148748716|NCT01090414|536550534|FG002|Study 101-99|Death|1|||
148748717|NCT01090414|536550535|FG003|Study 101-99|Death|0|||
148748718|NCT01090414|536550532|FG000|Study 101-99|Sponsor Discontinued Study|0|||
148748719|NCT01090414|536550533|FG001|Study 101-99|Sponsor Discontinued Study|7|||
148748720|NCT01090414|536550534|FG002|Study 101-99|Sponsor Discontinued Study|5|||
148748721|NCT01090414|536550535|FG003|Study 101-99|Sponsor Discontinued Study|0|||
148748722|NCT01090414|536550532|FG000|Study 101-99|Other (Unknown Reasons)|3|||
148748723|NCT01090414|536550533|FG001|Study 101-99|Other (Unknown Reasons)|3|||
148748724|NCT01090414|536550534|FG002|Study 101-99|Other (Unknown Reasons)|0|||
148748725|NCT01090414|536550535|FG003|Study 101-99|Other (Unknown Reasons)|0|||
148748726|NCT01090414|536550532|FG000|Study 101-99|Withdrew Consent|0|||
148748727|NCT01090414|536550533|FG001|Study 101-99|Withdrew Consent|2|||
148748728|NCT01090414|536550534|FG002|Study 101-99|Withdrew Consent|3|||
148748729|NCT01090414|536550535|FG003|Study 101-99|Withdrew Consent|1|||
148748730|NCT01090414|536550532|FG000|Study 101-99|Participant Request|3|||
148748731|NCT01090414|536550533|FG001|Study 101-99|Participant Request|1|||
148748732|NCT01090414|536550534|FG002|Study 101-99|Participant Request|0|||
148748733|NCT01090414|536550535|FG003|Study 101-99|Participant Request|0|||
148748734|NCT03594071|536550536|FG000|Overall Study|Re-operation|3|||
148748735|NCT03594071|536550536|FG000|Overall Study|Missed visit|2|||
148748736|NCT05219448|536550537|FG000|Overall Study|Lost to Follow-up|9|||
148748737|NCT05219448|536550538|FG001|Overall Study|Lost to Follow-up|0|||
148748738|NCT03022370|536550539|FG000|Overall Study|Death|6|||
148748739|NCT03022370|536550540|FG001|Overall Study|Death|12|||
148748740|NCT03022370|536550539|FG000|Overall Study|Lost to Follow-up|174|||
148748741|NCT03022370|536550540|FG001|Overall Study|Lost to Follow-up|109|||
148748742|NCT00560391|536550541|FG000|Overall Study|Still on treatment|0|||
148748743|NCT00560391|536550542|FG001|Overall Study|Still on treatment|0|||
148748744|NCT00560391|536550543|FG002|Overall Study|Still on treatment|0|||
148748745|NCT00560391|536550544|FG003|Overall Study|Still on treatment|1|||
148748746|NCT00560391|536550545|FG004|Overall Study|Still on treatment|2|||
148748747|NCT01526655|536550546|FG000|Overall Study|Withdrawal by Subject|0|||
148748748|NCT01526655|536550547|FG001|Overall Study|Withdrawal by Subject|1|||
148748749|NCT04753216|536550548|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
148748750|NCT04753216|536550548|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
148748751|NCT04753216|536550548|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
148748752|NCT01895777|536550549|FG000|Overall Study|Adverse Event|1|||
148748753|NCT01895777|536550550|FG001|Overall Study|Adverse Event|2|||
148748754|NCT01895777|536550549|FG000|Overall Study|Lost to Follow-up|2|||
148748755|NCT01895777|536550550|FG001|Overall Study|Lost to Follow-up|0|||
148748756|NCT01895777|536550549|FG000|Overall Study|Not treated|1|||
148748757|NCT01895777|536550550|FG001|Overall Study|Not treated|0|||
148748758|NCT01895777|536550549|FG000|Overall Study|Other reasons|3|||
148748759|NCT01895777|536550550|FG001|Overall Study|Other reasons|2|||
149027238|NCT00689104|537576541|FG000|Overall Study|Non-compliance with study procedures|0|||
149027239|NCT00689104|537576542|FG001|Overall Study|Non-compliance with study procedures|0|||
149027240|NCT00689104|537576543|FG002|Overall Study|Non-compliance with study procedures|1|||
149027241|NCT00689104|537576544|FG003|Overall Study|Non-compliance with study procedures|0|||
149027242|NCT02753530|537576546|FG000|Overall Study|Adverse Event|7|||
149027243|NCT02753530|537576547|FG001|Overall Study|Adverse Event|1|||
149027244|NCT02753530|537576546|FG000|Overall Study|Death|0|||
149027245|NCT02753530|537576547|FG001|Overall Study|Death|1|||
149027246|NCT02753530|537576546|FG000|Overall Study|Physician Decision|0|||
149027247|NCT02753530|537576547|FG001|Overall Study|Physician Decision|1|||
149027248|NCT02753530|537576546|FG000|Overall Study|Protocol Violation|1|||
149027249|NCT02753530|537576547|FG001|Overall Study|Protocol Violation|0|||
148748760|NCT01895777|536550549|FG000|Overall Study|Non-compliance with the CTP|2|||
148748761|NCT01895777|536550550|FG001|Overall Study|Non-compliance with the CTP|1|||
149027250|NCT02753530|537576546|FG000|Overall Study|Withdrawal by Subject|4|||
149027251|NCT02753530|537576547|FG001|Overall Study|Withdrawal by Subject|3|||
149027252|NCT01221181|537576555|FG000|Overall Study|Lost to Follow-up|1|||
148748762|NCT02288325|536550563|FG000|Run-in Period|Adverse Event|48|||
149027253|NCT00429793|537576556|FG000|Overall Study|Improper pre-protocol treatment|3|||
148748763|NCT02288325|536550564|FG001|Run-in Period|Adverse Event|0|||
148821697|NCT01117350|536824664|FG000|Extension Period|Withdrawal by Subject|0|||
149027254|NCT00429793|537576556|FG000|Overall Study|Required test not done|1|||
149027255|NCT00429793|537576556|FG000|Overall Study|Never treated|1|||
149027256|NCT00429793|537576556|FG000|Overall Study|Non-measurable|1|||
148748764|NCT02288325|536550565|FG002|Run-in Period|Adverse Event|0|||
148748765|NCT02288325|536550563|FG000|Run-in Period|Lack of Efficacy|16|||
148748766|NCT02288325|536550564|FG001|Run-in Period|Lack of Efficacy|0|||
148748767|NCT02288325|536550565|FG002|Run-in Period|Lack of Efficacy|0|||
148748768|NCT02288325|536550563|FG000|Run-in Period|Withdrawal of Consent|28|||
148748769|NCT02288325|536550564|FG001|Run-in Period|Withdrawal of Consent|0|||
148748770|NCT02288325|536550565|FG002|Run-in Period|Withdrawal of Consent|0|||
148748771|NCT02288325|536550563|FG000|Run-in Period|Lost to Follow-up|25|||
148748772|NCT02288325|536550564|FG001|Run-in Period|Lost to Follow-up|0|||
148748773|NCT02288325|536550565|FG002|Run-in Period|Lost to Follow-up|0|||
148748774|NCT02288325|536550563|FG000|Run-in Period|Protocol Violation|17|||
148748775|NCT02288325|536550564|FG001|Run-in Period|Protocol Violation|0|||
148748776|NCT02288325|536550565|FG002|Run-in Period|Protocol Violation|0|||
148748777|NCT02288325|536550563|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
148748778|NCT02288325|536550564|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
148748779|NCT02288325|536550565|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
148748780|NCT02288325|536550563|FG000|Run-in Period|Reason not Specified|8|||
148748781|NCT02288325|536550564|FG001|Run-in Period|Reason not Specified|0|||
148748782|NCT02288325|536550565|FG002|Run-in Period|Reason not Specified|0|||
148748783|NCT02288325|536550563|FG000|Stabilization Period|Adverse Event|13|||
148748784|NCT02288325|536550564|FG001|Stabilization Period|Adverse Event|0|||
148748785|NCT02288325|536550565|FG002|Stabilization Period|Adverse Event|0|||
148748786|NCT02288325|536550563|FG000|Stabilization Period|Lack of Efficacy|22|||
148748787|NCT02288325|536550564|FG001|Stabilization Period|Lack of Efficacy|0|||
148748788|NCT02288325|536550565|FG002|Stabilization Period|Lack of Efficacy|0|||
148748789|NCT02288325|536550563|FG000|Stabilization Period|Withdrawal of Consent|23|||
148748790|NCT02288325|536550564|FG001|Stabilization Period|Withdrawal of Consent|0|||
148748791|NCT02288325|536550565|FG002|Stabilization Period|Withdrawal of Consent|0|||
148748792|NCT02288325|536550563|FG000|Stabilization Period|Lost to Follow-up|12|||
148748793|NCT02288325|536550564|FG001|Stabilization Period|Lost to Follow-up|0|||
148748794|NCT02288325|536550565|FG002|Stabilization Period|Lost to Follow-up|0|||
148748795|NCT02288325|536550563|FG000|Stabilization Period|Protocol Violation|8|||
148748796|NCT02288325|536550564|FG001|Stabilization Period|Protocol Violation|0|||
148748797|NCT02288325|536550565|FG002|Stabilization Period|Protocol Violation|0|||
148748798|NCT02288325|536550563|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
148748799|NCT02288325|536550564|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
148748800|NCT02288325|536550565|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
148748801|NCT02288325|536550563|FG000|Stabilization Period|Reason not Specified|15|||
148748802|NCT02288325|536550564|FG001|Stabilization Period|Reason not Specified|0|||
148748803|NCT02288325|536550565|FG002|Stabilization Period|Reason not Specified|0|||
148748804|NCT02288325|536550563|FG000|Double-blind Treatment Period|Adverse Event|0|||
148748805|NCT02288325|536550564|FG001|Double-blind Treatment Period|Adverse Event|2|||
148748806|NCT02288325|536550565|FG002|Double-blind Treatment Period|Adverse Event|5|||
148748807|NCT02288325|536550563|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
148748808|NCT02288325|536550564|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
148748809|NCT02288325|536550565|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
148748810|NCT02288325|536550563|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
148748811|NCT02288325|536550564|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
148748812|NCT02288325|536550565|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
148748813|NCT02288325|536550563|FG000|Double-blind Treatment Period|Protocol Violation|0|||
148748814|NCT02288325|536550564|FG001|Double-blind Treatment Period|Protocol Violation|1|||
148748815|NCT02288325|536550565|FG002|Double-blind Treatment Period|Protocol Violation|2|||
148748816|NCT02288325|536550563|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
148748817|NCT02288325|536550564|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
148748818|NCT02288325|536550565|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
148748819|NCT02288325|536550563|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
148748820|NCT02288325|536550564|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
148748821|NCT02288325|536550565|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
148748822|NCT03607487|536550570|FG000|Overall Study|Withdrawal by Subject|2|||
148748823|NCT03607487|536550571|FG001|Overall Study|Withdrawal by Subject|0|||
148748824|NCT03607487|536550572|FG002|Overall Study|Withdrawal by Subject|0|||
148748825|NCT03607487|536550573|FG003|Overall Study|Withdrawal by Subject|1|||
148748826|NCT01884337|536550574|FG000|Treatment|Adverse Event|2|||
148748827|NCT01884337|536550575|FG001|Treatment|Adverse Event|2|||
148748828|NCT01884337|536550574|FG000|Treatment|Subj. request to discont. treatment|2|||
148748829|NCT01884337|536550575|FG001|Treatment|Subj. request to discont. treatment|0|||
148748830|NCT01884337|536550574|FG000|Follow-up Period|Lost to Follow-up|1|||
148748831|NCT01884337|536550575|FG001|Follow-up Period|Lost to Follow-up|1|||
148748832|NCT04223752|536550588|FG000|Overall Study|Participant enrolled in error|0|||
148748833|NCT04223752|536550589|FG001|Overall Study|Participant enrolled in error|0|||
148748834|NCT04223752|536550590|FG002|Overall Study|Participant enrolled in error|0|||
148821698|NCT01117350|536824665|FG001|Extension Period|Withdrawal by Subject|3|||
148748835|NCT04223752|536550591|FG003|Overall Study|Participant enrolled in error|0|||
148748836|NCT04223752|536550592|FG004|Overall Study|Participant enrolled in error|1|||
148748837|NCT04223752|536550588|FG000|Overall Study|Death|0|||
148748838|NCT04223752|536550589|FG001|Overall Study|Death|0|||
148748839|NCT04223752|536550590|FG002|Overall Study|Death|0|||
148748840|NCT04223752|536550591|FG003|Overall Study|Death|2|||
148748841|NCT04223752|536550592|FG004|Overall Study|Death|1|||
148748842|NCT04138823|536550593|FG000|Overall Study|Clinical disease progression|0|||
148748843|NCT04138823|536550594|FG001|Overall Study|Clinical disease progression|0|||
148748844|NCT04138823|536550595|FG002|Overall Study|Clinical disease progression|1|||
148748845|NCT04138823|536550593|FG000|Overall Study|Objective disease progression|3|||
148748846|NCT04138823|536550594|FG001|Overall Study|Objective disease progression|2|||
148748847|NCT04138823|536550595|FG002|Overall Study|Objective disease progression|5|||
148748848|NCT04036110|536550596|FG000|Overall Study|Lost to Follow-up|3|||
148748849|NCT04036110|536550597|FG001|Overall Study|Lost to Follow-up|2|||
148748850|NCT04036110|536550598|FG002|Overall Study|Lost to Follow-up|1|||
148748851|NCT04036110|536550596|FG000|Overall Study|Study Suspended|4|||
148748852|NCT04036110|536550597|FG001|Overall Study|Study Suspended|5|||
148748853|NCT04036110|536550598|FG002|Overall Study|Study Suspended|1|||
148748854|NCT02466685|536550599|FG000|Overall Study|Adverse Event|5|||
148748855|NCT02466685|536550600|FG001|Overall Study|Adverse Event|2|||
148748856|NCT02466685|536550599|FG000|Overall Study|Lost to Follow-up|1|||
148748857|NCT02466685|536550600|FG001|Overall Study|Lost to Follow-up|1|||
148748858|NCT02466685|536550599|FG000|Overall Study|Withdrawal by Subject|1|||
148748859|NCT02466685|536550600|FG001|Overall Study|Withdrawal by Subject|0|||
148748860|NCT02466685|536550599|FG000|Overall Study|Physician Decision|1|||
148748861|NCT02466685|536550600|FG001|Overall Study|Physician Decision|1|||
148748862|NCT02593110|536550601|FG000|Overall Study|Withdrawal by Subject|0|||
148748863|NCT02593110|536550602|FG001|Overall Study|Withdrawal by Subject|3|||
148748864|NCT02593110|536550603|FG002|Overall Study|Withdrawal by Subject|3|||
148748865|NCT02593110|536550604|FG003|Overall Study|Withdrawal by Subject|2|||
148748866|NCT02593110|536550601|FG000|Overall Study|Death|0|||
148748867|NCT02593110|536550602|FG001|Overall Study|Death|0|||
148748868|NCT02593110|536550603|FG002|Overall Study|Death|1|||
148748869|NCT02593110|536550604|FG003|Overall Study|Death|0|||
148748870|NCT03548337|536550605|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
148748871|NCT03548337|536550606|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
148748872|NCT03548337|536550605|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
148748873|NCT03548337|536550606|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
148748874|NCT03548337|536550605|FG000|Infant Series|Lost to Follow-up|2|||
148748875|NCT03548337|536550606|FG001|Infant Series|Lost to Follow-up|1|||
148748876|NCT03548337|536550605|FG000|Infant Series|Adverse Event|0|||
148748877|NCT03548337|536550606|FG001|Infant Series|Adverse Event|2|||
148748878|NCT03548337|536550605|FG000|Infant Series|Randomized but Not Vaccinated|1|||
148748879|NCT03548337|536550606|FG001|Infant Series|Randomized but Not Vaccinated|0|||
148748880|NCT03548337|536550605|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
148748881|NCT03548337|536550606|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
148748882|NCT01911273|536550609|FG000|Overall Study|Progression of Disease|1|||
148748883|NCT01911273|536550610|FG001|Overall Study|Progression of Disease|0|||
148748884|NCT01911273|536550609|FG000|Overall Study|Withdrawal by Subject|0|||
148748885|NCT01911273|536550610|FG001|Overall Study|Withdrawal by Subject|2|||
148748886|NCT00839254|536550612|FG000|Overall Study|Protocol Violation|0|||
148748887|NCT00839254|536550613|FG001|Overall Study|Protocol Violation|1|||
148748888|NCT00839254|536550614|FG002|Overall Study|Protocol Violation|1|||
148748889|NCT00839254|536550615|FG003|Overall Study|Protocol Violation|1|||
148748890|NCT00839254|536550616|FG004|Overall Study|Protocol Violation|0|||
148748891|NCT00839254|536550617|FG005|Overall Study|Protocol Violation|0|||
148748892|NCT00839254|536550618|FG006|Overall Study|Protocol Violation|1|||
148748893|NCT00839254|536550619|FG007|Overall Study|Protocol Violation|2|||
148748894|NCT00839254|536550612|FG000|Overall Study|Physician Decision|0|||
148748895|NCT00839254|536550613|FG001|Overall Study|Physician Decision|1|||
148748896|NCT00839254|536550614|FG002|Overall Study|Physician Decision|0|||
148748897|NCT00839254|536550615|FG003|Overall Study|Physician Decision|0|||
148748898|NCT00839254|536550616|FG004|Overall Study|Physician Decision|0|||
148748899|NCT00839254|536550617|FG005|Overall Study|Physician Decision|0|||
148748900|NCT00839254|536550618|FG006|Overall Study|Physician Decision|0|||
148748901|NCT00839254|536550619|FG007|Overall Study|Physician Decision|1|||
148748902|NCT00839254|536550612|FG000|Overall Study|Wrong treatment number allocation|0|||
148748903|NCT00839254|536550613|FG001|Overall Study|Wrong treatment number allocation|1|||
148748904|NCT00839254|536550614|FG002|Overall Study|Wrong treatment number allocation|0|||
148748905|NCT00839254|536550615|FG003|Overall Study|Wrong treatment number allocation|0|||
148748906|NCT00839254|536550616|FG004|Overall Study|Wrong treatment number allocation|0|||
148748907|NCT00839254|536550617|FG005|Overall Study|Wrong treatment number allocation|1|||
148748908|NCT00839254|536550618|FG006|Overall Study|Wrong treatment number allocation|0|||
148748909|NCT00839254|536550619|FG007|Overall Study|Wrong treatment number allocation|0|||
148748910|NCT00839254|536550612|FG000|Overall Study|Adverse Event|12|||
148748911|NCT00839254|536550613|FG001|Overall Study|Adverse Event|6|||
148748912|NCT00839254|536550614|FG002|Overall Study|Adverse Event|3|||
148748913|NCT00839254|536550615|FG003|Overall Study|Adverse Event|5|||
148748914|NCT00839254|536550616|FG004|Overall Study|Adverse Event|2|||
148748915|NCT00839254|536550617|FG005|Overall Study|Adverse Event|1|||
148821699|NCT01117350|536824664|FG000|Extension Period|Lack of Efficacy|0|||
148821700|NCT01117350|536824665|FG001|Extension Period|Lack of Efficacy|2|||
148821701|NCT01117350|536824664|FG000|Extension Period|Inclusion criteria not respected|0|||
148821702|NCT01117350|536824665|FG001|Extension Period|Inclusion criteria not respected|1|||
148821703|NCT01117350|536824664|FG000|Extension Period|Prohibited medication|0|||
148821704|NCT01117350|536824665|FG001|Extension Period|Prohibited medication|1|||
148821705|NCT01049828|536824667|FG000|Overall Study|Claustrophibia and Frustration|2|||
148821706|NCT00290238|536824668|FG000|Overall Study|Study terminated|27|||
148821707|NCT00290238|536824669|FG001|Overall Study|Study terminated|27|||
148821708|NCT00290238|536824668|FG000|Overall Study|Lost to Follow-up|0|||
148821709|NCT00290238|536824669|FG001|Overall Study|Lost to Follow-up|1|||
148821710|NCT00290238|536824668|FG000|Overall Study|Withdrawal by Subject|15|||
148821711|NCT00290238|536824669|FG001|Overall Study|Withdrawal by Subject|13|||
148821712|NCT03312114|536826581|FG000|Overall Study|All the five enrolled dropped out of the|5|||
148821713|NCT03607695|536826584|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
148821714|NCT03607695|536826584|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
148821715|NCT02741193|536826585|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
148821716|NCT02741193|536826585|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
148821717|NCT02502383|536826586|FG000|Overall Study|Lost to Follow-up|130|||
148821718|NCT02502383|536826587|FG001|Overall Study|Lost to Follow-up|131|||
148821719|NCT02502383|536826586|FG000|Overall Study|Withdrawal by Subject|31|||
148821720|NCT02502383|536826587|FG001|Overall Study|Withdrawal by Subject|24|||
148821721|NCT00527748|536826589|FG000|Overall Study|Other|3|||
148821722|NCT01346709|536826596|FG000|Overall Study|Protocol Violation|35|||
148821723|NCT01346709|536826596|FG000|Overall Study|Lost to Follow-up|31|||
148821724|NCT01346709|536826596|FG000|Overall Study|Missing data in candidate risk factor|285|||
148821725|NCT04821245|536826604|FG000|Overall Study|Withdrawal by Subject|3|||
148821726|NCT04821245|536826604|FG000|Overall Study|Physician Decision|1|||
148821727|NCT04821245|536826604|FG000|Overall Study|Protocol Violation|5|||
148821728|NCT00605657|536826605|FG000|Overall Study|Adverse Event|1|||
148821729|NCT00605657|536826605|FG000|Overall Study|Protocol Violation|1|||
148821730|NCT02773537|536826608|FG000|Overall Study|Lost to Follow-up|0|||
148821731|NCT02773537|536826609|FG001|Overall Study|Lost to Follow-up|1|||
148821732|NCT02773537|536826610|FG002|Overall Study|Lost to Follow-up|4|||
148821733|NCT01840163|536826611|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
148821734|NCT01840163|536826612|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
148821735|NCT01840163|536826611|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
148821736|NCT01840163|536826612|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
148821737|NCT01840163|536826611|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
148821738|NCT01840163|536826612|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
148821739|NCT00662038|536826613|FG000|Overall Study|Reason not specified|3|||
148821740|NCT00662038|536826613|FG000|Overall Study|Withdrawn consent|22|||
148821741|NCT00662038|536826613|FG000|Overall Study|Withdrawal by Subject|83|||
148821742|NCT00662038|536826613|FG000|Overall Study|Sponsor decision|1|||
148821743|NCT00662038|536826613|FG000|Overall Study|Physician Decision|19|||
148821744|NCT00662038|536826613|FG000|Overall Study|Lung transplantation|44|||
148821745|NCT00662038|536826613|FG000|Overall Study|Lost to Follow-up|1|||
148821746|NCT00662038|536826613|FG000|Overall Study|Death|95|||
148821747|NCT00662038|536826613|FG000|Overall Study|Adverse Event|358|||
148821748|NCT00662038|536826613|FG000|Overall Study|Continued treatment|5|||
148821749|NCT00397046|536826614|FG000|Overall Study|Disease Progression|3|||
148821750|NCT00397046|536826615|FG001|Overall Study|Disease Progression|3|||
148821751|NCT00397046|536826616|FG002|Overall Study|Disease Progression|10|||
148821752|NCT00397046|536826617|FG003|Overall Study|Disease Progression|5|||
148821753|NCT03021005|536826621|FG000|Overall Study|Lost to Follow-up|39|||
148821754|NCT03021005|536826622|FG001|Overall Study|Lost to Follow-up|26|||
148821755|NCT00337194|536826623|FG000|Overall Study|Adverse Event|5|||
148821756|NCT00337194|536826624|FG001|Overall Study|Adverse Event|1|||
148821757|NCT00337194|536826623|FG000|Overall Study|Death|2|||
148748916|NCT00839254|536550618|FG006|Overall Study|Adverse Event|0|||
148748917|NCT00839254|536550619|FG007|Overall Study|Adverse Event|1|||
148748918|NCT00839254|536550612|FG000|Overall Study|Withdrawal by Subject|87|||
148748919|NCT00839254|536550613|FG001|Overall Study|Withdrawal by Subject|53|||
148748920|NCT00839254|536550614|FG002|Overall Study|Withdrawal by Subject|54|||
148748921|NCT00839254|536550615|FG003|Overall Study|Withdrawal by Subject|32|||
148748922|NCT00839254|536550616|FG004|Overall Study|Withdrawal by Subject|27|||
148748923|NCT00839254|536550617|FG005|Overall Study|Withdrawal by Subject|15|||
148748924|NCT00839254|536550618|FG006|Overall Study|Withdrawal by Subject|22|||
148748925|NCT00839254|536550619|FG007|Overall Study|Withdrawal by Subject|9|||
148748926|NCT00839254|536550612|FG000|Overall Study|Wrong group allocation|0|||
148748927|NCT00839254|536550613|FG001|Overall Study|Wrong group allocation|0|||
148748928|NCT00839254|536550614|FG002|Overall Study|Wrong group allocation|0|||
148748929|NCT00839254|536550615|FG003|Overall Study|Wrong group allocation|0|||
148748930|NCT00839254|536550616|FG004|Overall Study|Wrong group allocation|0|||
148748931|NCT00839254|536550617|FG005|Overall Study|Wrong group allocation|0|||
148748932|NCT00839254|536550618|FG006|Overall Study|Wrong group allocation|1|||
148748933|NCT00839254|536550619|FG007|Overall Study|Wrong group allocation|0|||
148748934|NCT00839254|536550612|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
148748935|NCT00839254|536550613|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
148748936|NCT00839254|536550614|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
148748937|NCT00839254|536550615|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
148748938|NCT00839254|536550616|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
148748939|NCT00839254|536550617|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
148748940|NCT00839254|536550618|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
148748941|NCT00839254|536550619|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
148748942|NCT00839254|536550612|FG000|Overall Study|Withdrawn due to non-compliance|2|||
148748943|NCT00839254|536550613|FG001|Overall Study|Withdrawn due to non-compliance|0|||
148748944|NCT00839254|536550614|FG002|Overall Study|Withdrawn due to non-compliance|0|||
148748945|NCT00839254|536550615|FG003|Overall Study|Withdrawn due to non-compliance|0|||
148748946|NCT00839254|536550616|FG004|Overall Study|Withdrawn due to non-compliance|0|||
148748947|NCT00839254|536550617|FG005|Overall Study|Withdrawn due to non-compliance|0|||
148748948|NCT00839254|536550618|FG006|Overall Study|Withdrawn due to non-compliance|0|||
148748949|NCT00839254|536550619|FG007|Overall Study|Withdrawn due to non-compliance|0|||
148748950|NCT00839254|536550612|FG000|Overall Study|Lost to Follow-up|51|||
148748951|NCT00839254|536550613|FG001|Overall Study|Lost to Follow-up|30|||
148748952|NCT00839254|536550614|FG002|Overall Study|Lost to Follow-up|32|||
148748953|NCT00839254|536550615|FG003|Overall Study|Lost to Follow-up|24|||
148748954|NCT00839254|536550616|FG004|Overall Study|Lost to Follow-up|8|||
148748955|NCT00839254|536550617|FG005|Overall Study|Lost to Follow-up|8|||
148748956|NCT00839254|536550618|FG006|Overall Study|Lost to Follow-up|4|||
148748957|NCT00839254|536550619|FG007|Overall Study|Lost to Follow-up|2|||
148748958|NCT02215967|536550627|FG000|Overall Study|Patient became ineligible for treatment|0|||
148748959|NCT02215967|536550628|FG001|Overall Study|Patient became ineligible for treatment|0|||
148748960|NCT02215967|536550629|FG002|Overall Study|Patient became ineligible for treatment|0|||
148748961|NCT02215967|536550630|FG003|Overall Study|Patient became ineligible for treatment|3|||
148748962|NCT02215967|536550627|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
148748963|NCT02215967|536550628|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
148748964|NCT02215967|536550629|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
148748965|NCT02215967|536550630|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
148748966|NCT03514017|536550631|FG000|Overall Study|Death|1|||
148748967|NCT03514017|536550631|FG000|Overall Study|Adverse Event|1|||
148748968|NCT02738138|536552236|FG000|Overall Study|Adverse Event|0|||
148748969|NCT02738138|536552237|FG001|Overall Study|Adverse Event|1|||
148748970|NCT02738138|536552236|FG000|Overall Study|Lost to Follow-up|2|||
148748971|NCT02738138|536552237|FG001|Overall Study|Lost to Follow-up|0|||
148748972|NCT02738138|536552236|FG000|Overall Study|Other - not further specified|1|||
148748973|NCT02738138|536552237|FG001|Overall Study|Other - not further specified|0|||
148748974|NCT00666328|536552248|FG000|Overall Study|Death|2|||
148748975|NCT00666328|536552248|FG000|Overall Study|Lost to Follow-up|2|||
148748976|NCT00666328|536552248|FG000|Overall Study|No longer met eligibility criteria|1|||
148748977|NCT03571828|536552249|FG000|Overall Study|Withdrawal by Subject|1|||
148748978|NCT03571828|536552250|FG001|Overall Study|Withdrawal by Subject|0|||
148748979|NCT03571828|536552249|FG000|Overall Study|Decision by sponsor|5|||
148748980|NCT03571828|536552250|FG001|Overall Study|Decision by sponsor|1|||
148748981|NCT03571828|536552249|FG000|Overall Study|Death|2|||
148748982|NCT03571828|536552250|FG001|Overall Study|Death|0|||
148748983|NCT02829918|536552255|FG000|Overall Study|Death|2|||
148748984|NCT02829918|536552255|FG000|Overall Study|Withdrawal by Subject|4|||
148748985|NCT02829918|536552255|FG000|Overall Study|Adverse Event|1|||
148748986|NCT02829918|536552255|FG000|Overall Study|Progression|1|||
148748987|NCT02441686|536552259|FG000|Induction|Adverse Event|4|||
148748988|NCT02441686|536552259|FG000|Induction|Complicating disease|1|||
148748989|NCT02441686|536552259|FG000|Induction|Physician Decision|1|||
148821758|NCT00337194|536826624|FG001|Overall Study|Death|0|||
148821759|NCT00337194|536826623|FG000|Overall Study|Withdrawal by Subject|1|||
148821760|NCT00337194|536826624|FG001|Overall Study|Withdrawal by Subject|0|||
148821761|NCT00337194|536826623|FG000|Overall Study|Disease progression|1|||
148821762|NCT00337194|536826624|FG001|Overall Study|Disease progression|2|||
148821763|NCT00337194|536826623|FG000|Overall Study|Subsequent non-protocol therapy|3|||
148748990|NCT02441686|536552259|FG000|Induction|Withdrawal by Subject|1|||
148748991|NCT02441686|536552259|FG000|Induction|Did not receive treatment|1|||
148748992|NCT02441686|536552259|FG000|Maintenance|Remaining on Treatment|23|||
148821764|NCT00337194|536826624|FG001|Overall Study|Subsequent non-protocol therapy|1|||
149027257|NCT01211665|537578520|FG000|Overall Study|Withdrawal by Subject|1|||
148748993|NCT02441686|536552259|FG000|Maintenance|Physician Decision|1|||
148748994|NCT02441686|536552259|FG000|Maintenance|Adverse Event|3|||
148748995|NCT02441686|536552259|FG000|Maintenance|Progressive Disease|10|||
148748996|NCT02441686|536552259|FG000|Maintenance|Withdrawal by Subject|1|||
148748997|NCT03762239|536552260|FG000|Overall Study|Appointment to the doctor|1|||
148748998|NCT03762239|536552261|FG001|Overall Study|Appointment to the doctor|1|||
148748999|NCT04471428|536552262|FG000|Overall Study|Withdrawal by Subject|29|||
148749000|NCT04471428|536552263|FG001|Overall Study|Withdrawal by Subject|1|||
148749001|NCT04471428|536552262|FG000|Overall Study|Physician Decision|0|||
148749002|NCT04471428|536552263|FG001|Overall Study|Physician Decision|1|||
148749003|NCT04471428|536552262|FG000|Overall Study|Reason Not Specified|0|||
148749004|NCT04471428|536552263|FG001|Overall Study|Reason Not Specified|2|||
148749005|NCT04471428|536552262|FG000|Overall Study|Death|106|||
148749006|NCT04471428|536552263|FG001|Overall Study|Death|114|||
148749007|NCT04471428|536552262|FG000|Overall Study|Ongoing in the study|45|||
148749008|NCT04471428|536552263|FG001|Overall Study|Ongoing in the study|68|||
148749009|NCT03151304|536552264|FG000|Overall Study|Termination of study by Sponsor|23|||
148749010|NCT03151304|536552264|FG000|Overall Study|missing|3|||
148749011|NCT03151304|536552264|FG000|Overall Study|Withdrawal by Subject|8|||
148749012|NCT03151304|536552264|FG000|Overall Study|multiple reasons|30|||
148749013|NCT02565511|536552266|FG000|Overall Study|Study terminated by Sponsor|35|||
148749014|NCT02565511|536552267|FG001|Overall Study|Study terminated by Sponsor|22|||
148749015|NCT02565511|536552268|FG002|Overall Study|Study terminated by Sponsor|235|||
148749016|NCT02565511|536552269|FG003|Overall Study|Study terminated by Sponsor|156|||
148749017|NCT02565511|536552266|FG000|Overall Study|Withdrawal by Subject|3|||
148749018|NCT02565511|536552267|FG001|Overall Study|Withdrawal by Subject|0|||
148749019|NCT02565511|536552268|FG002|Overall Study|Withdrawal by Subject|12|||
148749020|NCT02565511|536552269|FG003|Overall Study|Withdrawal by Subject|5|||
148749021|NCT02565511|536552266|FG000|Overall Study|Adverse Event|0|||
148749022|NCT02565511|536552267|FG001|Overall Study|Adverse Event|0|||
148749023|NCT02565511|536552268|FG002|Overall Study|Adverse Event|1|||
148749024|NCT02565511|536552269|FG003|Overall Study|Adverse Event|1|||
148749025|NCT02565511|536552266|FG000|Overall Study|Lost to Follow-up|4|||
148749026|NCT02565511|536552267|FG001|Overall Study|Lost to Follow-up|1|||
148976142|NCT01049919|537394451|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
148976143|NCT01049919|537394450|FG000|Overall Study|Early study termination by sponsor.|2|||
148976144|NCT01049919|537394451|FG001|Overall Study|Early study termination by sponsor.|0|||
148976145|NCT02984995|537394452|FG000|Overall Study|Required stem cell transplant|13|||
148976146|NCT02984995|537394453|FG001|Overall Study|Required stem cell transplant|2|||
148749027|NCT02565511|536552268|FG002|Overall Study|Lost to Follow-up|0|||
148749028|NCT02565511|536552269|FG003|Overall Study|Lost to Follow-up|1|||
148749029|NCT02565511|536552266|FG000|Overall Study|Physician Decision|0|||
148749030|NCT02565511|536552267|FG001|Overall Study|Physician Decision|0|||
148749031|NCT02565511|536552268|FG002|Overall Study|Physician Decision|0|||
148749032|NCT02565511|536552269|FG003|Overall Study|Physician Decision|1|||
148749033|NCT02565511|536552266|FG000|Overall Study|Protocol deviation|0|||
148749034|NCT02565511|536552267|FG001|Overall Study|Protocol deviation|0|||
148749035|NCT02565511|536552268|FG002|Overall Study|Protocol deviation|3|||
148749036|NCT02565511|536552269|FG003|Overall Study|Protocol deviation|0|||
148749037|NCT01137071|536552270|FG000|Overall Study|Disease Progression|11|||
148749038|NCT01137071|536552270|FG000|Overall Study|Withdrawal by Subject|2|||
148749039|NCT01137071|536552270|FG000|Overall Study|Wrongly Included|1|||
148749040|NCT04807400|536552271|FG000|Overall Study|Adverse Event|2|||
148749041|NCT04807400|536552272|FG001|Overall Study|Adverse Event|3|||
148749042|NCT04807400|536552273|FG002|Overall Study|Adverse Event|3|||
148976147|NCT02984995|537394452|FG000|Overall Study|Progressive disease|11|||
148976148|NCT02984995|537394453|FG001|Overall Study|Progressive disease|1|||
148976149|NCT02984995|537394452|FG000|Overall Study|Adverse Event|1|||
148976150|NCT02984995|537394453|FG001|Overall Study|Adverse Event|0|||
148976151|NCT04354831|537394454|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
148976152|NCT04354831|537394455|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
148976153|NCT02939404|537394456|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
148749043|NCT04807400|536552271|FG000|Overall Study|Death|2|||
148749044|NCT04807400|536552272|FG001|Overall Study|Death|0|||
148749045|NCT04807400|536552273|FG002|Overall Study|Death|0|||
148749046|NCT04807400|536552271|FG000|Overall Study|Lost to Follow-up|8|||
148976154|NCT02939404|537394457|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
148749047|NCT04807400|536552272|FG001|Overall Study|Lost to Follow-up|6|||
148749048|NCT04807400|536552273|FG002|Overall Study|Lost to Follow-up|6|||
148976155|NCT02939404|537394456|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
148976156|NCT02939404|537394457|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
148976157|NCT06640829|537394464|FG000|Overall Study|Withdrawal by Subject|1|||
148976158|NCT06640829|537394464|FG000|Overall Study|Lost to Follow-up|1|||
148976159|NCT01350128|537394465|FG000|Overall Study|Withdrawal by Subject|3|||
148749049|NCT04807400|536552271|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148749050|NCT04807400|536552272|FG001|Overall Study|Non-Compliance With Study Drug|4|||
148749051|NCT04807400|536552273|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148976160|NCT01350128|537394465|FG000|Overall Study|Protocol discontinuation criteria|8|||
148749052|NCT04807400|536552271|FG000|Overall Study|Participant Decision|20|||
148749053|NCT04807400|536552272|FG001|Overall Study|Participant Decision|19|||
148749054|NCT04807400|536552273|FG002|Overall Study|Participant Decision|26|||
148749055|NCT04807400|536552271|FG000|Overall Study|Physician Decision|0|||
148749056|NCT04807400|536552272|FG001|Overall Study|Physician Decision|1|||
148749057|NCT04807400|536552273|FG002|Overall Study|Physician Decision|0|||
148821765|NCT03188705|536826625|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
148821766|NCT03188705|536826625|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
148821767|NCT04914000|536826631|FG000|Overall Study|Lost to Follow-up|8|||
148821768|NCT04914000|536826631|FG000|Overall Study|Withdrawal by Subject|1|||
148821769|NCT03225989|536826633|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
148821770|NCT03225989|536826634|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
148821771|NCT03225989|536826635|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
148821772|NCT03225989|536826633|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
148821773|NCT03225989|536826634|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
148821774|NCT03225989|536826635|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
148821775|NCT03225989|536826633|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
148821776|NCT03225989|536826634|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
148821777|NCT03225989|536826635|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
148821778|NCT03225989|536826633|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
148821779|NCT03225989|536826634|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
148821780|NCT03225989|536826635|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
148821781|NCT03225989|536826633|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
148821782|NCT03225989|536826634|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
148821783|NCT03225989|536826635|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
148821784|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
148821785|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
148821786|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
148821787|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
148821788|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
148821789|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
148821790|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
148821791|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
148821792|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
148821793|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
148821794|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
148821795|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
148821796|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
148821797|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
148821798|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
148821799|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
148821800|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
148821801|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
148821802|NCT03225989|536826633|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
148821803|NCT03225989|536826634|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
148821804|NCT03225989|536826635|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
148821805|NCT03093870|536826636|FG000|Overall Study|Withdrawal by Subject|2|||
148821806|NCT03093870|536826637|FG001|Overall Study|Withdrawal by Subject|6|||
148821807|NCT03093870|536826638|FG002|Overall Study|Withdrawal by Subject|5|||
148821808|NCT03093870|536826636|FG000|Overall Study|Death|1|||
148821809|NCT03093870|536826637|FG001|Overall Study|Death|35|||
148821810|NCT03093870|536826638|FG002|Overall Study|Death|35|||
148821811|NCT03093870|536826636|FG000|Overall Study|Radiographic disease progression|10|||
148821812|NCT03093870|536826637|FG001|Overall Study|Radiographic disease progression|0|||
148821813|NCT03093870|536826638|FG002|Overall Study|Radiographic disease progression|0|||
148821814|NCT03093870|536826636|FG000|Overall Study|Clinical disease progression|1|||
148821815|NCT03093870|536826637|FG001|Overall Study|Clinical disease progression|0|||
148821816|NCT03093870|536826638|FG002|Overall Study|Clinical disease progression|0|||
148821817|NCT03093870|536826636|FG000|Overall Study|Physician Decision|2|||
148821818|NCT03093870|536826637|FG001|Overall Study|Physician Decision|0|||
148821819|NCT03093870|536826638|FG002|Overall Study|Physician Decision|0|||
148821820|NCT03093870|536826636|FG000|Overall Study|Adverse Event|7|||
148821821|NCT03093870|536826637|FG001|Overall Study|Adverse Event|0|||
148821822|NCT03093870|536826638|FG002|Overall Study|Adverse Event|0|||
148821823|NCT03093870|536826636|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
148821824|NCT03093870|536826637|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
148976161|NCT01350128|537394465|FG000|Overall Study|Physician Decision|1|||
148976162|NCT01350128|537394465|FG000|Overall Study|Lost to Follow-up|2|||
148976163|NCT01859715|537394468|FG000|Overall Study|No 2nd VAS|16|||
148821825|NCT03093870|536826638|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
148821826|NCT03093870|536826636|FG000|Overall Study|Lost to Follow-up|0|||
148821827|NCT03093870|536826637|FG001|Overall Study|Lost to Follow-up|0|||
148821828|NCT03093870|536826638|FG002|Overall Study|Lost to Follow-up|1|||
148976164|NCT01859715|537394469|FG001|Overall Study|No 2nd VAS|8|||
148976165|NCT01859715|537394470|FG002|Overall Study|No 2nd VAS|23|||
149027258|NCT01211665|537578521|FG001|Overall Study|Withdrawal by Subject|0|||
149027259|NCT01211665|537578520|FG000|Overall Study|Death|1|||
148749058|NCT04807400|536552271|FG000|Overall Study|Protocol Violation|4|||
148749059|NCT04807400|536552272|FG001|Overall Study|Protocol Violation|3|||
148749060|NCT04807400|536552273|FG002|Overall Study|Protocol Violation|7|||
148749061|NCT04807400|536552271|FG000|Overall Study|Withdrawal by Subject|13|||
148749062|NCT04807400|536552272|FG001|Overall Study|Withdrawal by Subject|9|||
148749063|NCT04807400|536552273|FG002|Overall Study|Withdrawal by Subject|20|||
148749064|NCT04807400|536552271|FG000|Overall Study|Mis-randomized|1|||
148749065|NCT04807400|536552272|FG001|Overall Study|Mis-randomized|0|||
148749066|NCT04807400|536552273|FG002|Overall Study|Mis-randomized|0|||
148749067|NCT03656744|536552274|FG000|Overall Study|Adverse Event|1|||
148749068|NCT03656744|536552275|FG001|Overall Study|Adverse Event|4|||
148749069|NCT03656744|536552276|FG002|Overall Study|Adverse Event|1|||
148749070|NCT03656744|536552274|FG000|Overall Study|Protocol Violation|1|||
148749071|NCT03656744|536552275|FG001|Overall Study|Protocol Violation|0|||
148749072|NCT03656744|536552276|FG002|Overall Study|Protocol Violation|0|||
148749073|NCT03656744|536552274|FG000|Overall Study|Lost to Follow-up|2|||
148749074|NCT03656744|536552275|FG001|Overall Study|Lost to Follow-up|2|||
148749075|NCT03656744|536552276|FG002|Overall Study|Lost to Follow-up|0|||
148749076|NCT03656744|536552274|FG000|Overall Study|Withdrawal by Subject|0|||
148749077|NCT03656744|536552275|FG001|Overall Study|Withdrawal by Subject|1|||
148749078|NCT03656744|536552276|FG002|Overall Study|Withdrawal by Subject|0|||
148749079|NCT03656744|536552274|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
148749080|NCT03656744|536552275|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
148749081|NCT03656744|536552276|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
148749082|NCT01332292|536552280|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
148749083|NCT01332292|536552281|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
148749084|NCT01332292|536552280|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
148749085|NCT01332292|536552281|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
148749086|NCT01332292|536552280|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
148749087|NCT01332292|536552281|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
148749088|NCT03910673|536552283|FG000|Overall Study|Adverse Event|0|||
148749089|NCT03910673|536552284|FG001|Overall Study|Adverse Event|0|||
148749090|NCT03910673|536552285|FG002|Overall Study|Adverse Event|0|||
148749091|NCT03910673|536552286|FG003|Overall Study|Adverse Event|2|||
148749092|NCT03910673|536552287|FG004|Overall Study|Adverse Event|0|||
148749093|NCT00098774|536552288|FG000|Overall Study|Adverse Event|2|||
148749094|NCT00098774|536552288|FG000|Overall Study|Disease Progression|9|||
148749095|NCT00098774|536552288|FG000|Overall Study|Withdrawal by Subject|1|||
148749096|NCT00098774|536552288|FG000|Overall Study|Failed (to respond) during induction|4|||
148749097|NCT00098774|536552288|FG000|Overall Study|Physician Decision|2|||
148749098|NCT00796757|536552289|FG000|Overall Study|Withdrawal by Subject|14|||
148749099|NCT00796757|536552289|FG000|Overall Study|Death|61|||
148749100|NCT00796757|536552289|FG000|Overall Study|Protocol Violation|1|||
148749101|NCT00796757|536552289|FG000|Overall Study|Participant noncompliance|1|||
148749102|NCT00796757|536552289|FG000|Overall Study|Investigator's decision|2|||
148749103|NCT00796757|536552289|FG000|Overall Study|Other|7|||
148749104|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
148749105|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Off-label use|283|||
148749106|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
148749107|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
148749108|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
148749109|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
148749110|NCT01070953|536552290|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
148749111|NCT01070953|536552290|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
148749112|NCT01070953|536552290|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
148749113|NCT01070953|536552290|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
148749114|NCT02359994|536552292|FG000|Overall Population Study|Adverse Event|1|||
148749115|NCT02359994|536552293|FG001|Overall Population Study|Adverse Event|1|||
148749116|NCT02359994|536552292|FG000|Overall Population Study|Death|1|||
148749117|NCT02359994|536552293|FG001|Overall Population Study|Death|5|||
148749118|NCT02359994|536552292|FG000|Overall Population Study|Lost to Follow-up|1|||
148749119|NCT02359994|536552293|FG001|Overall Population Study|Lost to Follow-up|1|||
148749120|NCT02359994|536552292|FG000|Overall Population Study|Withdrawal by Subject|1|||
148749121|NCT02359994|536552293|FG001|Overall Population Study|Withdrawal by Subject|0|||
148749122|NCT02359994|536552292|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
148749123|NCT02359994|536552293|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
148749124|NCT02359994|536552292|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
148749125|NCT02359994|536552293|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
149027260|NCT01211665|537578521|FG001|Overall Study|Death|0|||
148749126|NCT02359994|536552292|FG000|Extended Oncology 24-Month Survival|Death|19|||
148749127|NCT02359994|536552293|FG001|Extended Oncology 24-Month Survival|Death|21|||
148749128|NCT02359994|536552292|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
148749129|NCT02359994|536552293|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
148749130|NCT04597632|536552294|FG000|Overall Study|Withdrawal by Subject|10|||
148749131|NCT04597632|536552294|FG000|Overall Study|Lost to Follow-up|1|||
148749132|NCT04597632|536552294|FG000|Overall Study|Death|1|||
148749133|NCT04597632|536552294|FG000|Overall Study|Adverse Event|5|||
148749134|NCT01823835|536552295|FG000|Overall Study|Adverse Event|0|||
148749135|NCT01823835|536552296|FG001|Overall Study|Adverse Event|0|||
148749136|NCT01823835|536552297|FG002|Overall Study|Adverse Event|0|||
148749137|NCT01823835|536552298|FG003|Overall Study|Adverse Event|0|||
148749138|NCT01823835|536552299|FG004|Overall Study|Adverse Event|1|||
148749139|NCT01823835|536552300|FG005|Overall Study|Adverse Event|0|||
148749140|NCT01823835|536552301|FG006|Overall Study|Adverse Event|1|||
148749141|NCT01823835|536552302|FG007|Overall Study|Adverse Event|0|||
148749142|NCT01823835|536552303|FG008|Overall Study|Adverse Event|0|||
148749143|NCT01823835|536552304|FG009|Overall Study|Adverse Event|0|||
148749144|NCT01823835|536552305|FG010|Overall Study|Adverse Event|1|||
148749145|NCT01823835|536552306|FG011|Overall Study|Adverse Event|2|||
148749146|NCT01823835|536552307|FG012|Overall Study|Adverse Event|0|||
148749147|NCT01823835|536552308|FG013|Overall Study|Adverse Event|0|||
148749148|NCT01823835|536552309|FG014|Overall Study|Adverse Event|0|||
148749149|NCT01823835|536552295|FG000|Overall Study|Physician Decision|0|||
148749150|NCT01823835|536552296|FG001|Overall Study|Physician Decision|0|||
148749151|NCT01823835|536552297|FG002|Overall Study|Physician Decision|0|||
148749152|NCT01823835|536552298|FG003|Overall Study|Physician Decision|0|||
148749153|NCT01823835|536552299|FG004|Overall Study|Physician Decision|0|||
148749154|NCT01823835|536552300|FG005|Overall Study|Physician Decision|0|||
148749155|NCT01823835|536552301|FG006|Overall Study|Physician Decision|0|||
148749156|NCT01823835|536552302|FG007|Overall Study|Physician Decision|0|||
148749157|NCT01823835|536552303|FG008|Overall Study|Physician Decision|0|||
148749158|NCT01823835|536552304|FG009|Overall Study|Physician Decision|0|||
148749159|NCT01823835|536552305|FG010|Overall Study|Physician Decision|0|||
148749160|NCT01823835|536552306|FG011|Overall Study|Physician Decision|2|||
148749161|NCT01823835|536552307|FG012|Overall Study|Physician Decision|0|||
148749162|NCT01823835|536552308|FG013|Overall Study|Physician Decision|0|||
148749163|NCT01823835|536552309|FG014|Overall Study|Physician Decision|0|||
148749164|NCT01823835|536552295|FG000|Overall Study|Progressive Disease|3|||
148749165|NCT01823835|536552296|FG001|Overall Study|Progressive Disease|4|||
148749166|NCT01823835|536552297|FG002|Overall Study|Progressive Disease|3|||
148749167|NCT01823835|536552298|FG003|Overall Study|Progressive Disease|6|||
148749168|NCT01823835|536552299|FG004|Overall Study|Progressive Disease|4|||
148749169|NCT01823835|536552300|FG005|Overall Study|Progressive Disease|6|||
148749170|NCT01823835|536552301|FG006|Overall Study|Progressive Disease|5|||
148749171|NCT01823835|536552302|FG007|Overall Study|Progressive Disease|3|||
148749172|NCT01823835|536552303|FG008|Overall Study|Progressive Disease|3|||
148749173|NCT01823835|536552304|FG009|Overall Study|Progressive Disease|18|||
148749174|NCT01823835|536552305|FG010|Overall Study|Progressive Disease|8|||
148749175|NCT01823835|536552306|FG011|Overall Study|Progressive Disease|46|||
148749176|NCT01823835|536552307|FG012|Overall Study|Progressive Disease|18|||
148749177|NCT01823835|536552308|FG013|Overall Study|Progressive Disease|4|||
148749178|NCT01823835|536552309|FG014|Overall Study|Progressive Disease|6|||
148749179|NCT01823835|536552295|FG000|Overall Study|Study Termination|0|||
148749180|NCT01823835|536552296|FG001|Overall Study|Study Termination|0|||
148749181|NCT01823835|536552297|FG002|Overall Study|Study Termination|0|||
148749182|NCT01823835|536552298|FG003|Overall Study|Study Termination|0|||
148749183|NCT01823835|536552299|FG004|Overall Study|Study Termination|1|||
148749184|NCT01823835|536552300|FG005|Overall Study|Study Termination|0|||
148749185|NCT01823835|536552301|FG006|Overall Study|Study Termination|0|||
148749186|NCT01823835|536552302|FG007|Overall Study|Study Termination|0|||
148749187|NCT01823835|536552303|FG008|Overall Study|Study Termination|0|||
148749188|NCT01823835|536552304|FG009|Overall Study|Study Termination|0|||
148749189|NCT01823835|536552305|FG010|Overall Study|Study Termination|0|||
148749190|NCT01823835|536552306|FG011|Overall Study|Study Termination|1|||
148749191|NCT01823835|536552307|FG012|Overall Study|Study Termination|0|||
148749192|NCT01823835|536552308|FG013|Overall Study|Study Termination|0|||
148749193|NCT01823835|536552309|FG014|Overall Study|Study Termination|0|||
148749194|NCT01823835|536552295|FG000|Overall Study|Withdrawal by Subject|0|||
148749195|NCT01823835|536552296|FG001|Overall Study|Withdrawal by Subject|0|||
148749196|NCT01823835|536552297|FG002|Overall Study|Withdrawal by Subject|1|||
148749197|NCT01823835|536552298|FG003|Overall Study|Withdrawal by Subject|0|||
148749198|NCT01823835|536552299|FG004|Overall Study|Withdrawal by Subject|0|||
148749199|NCT01823835|536552300|FG005|Overall Study|Withdrawal by Subject|0|||
148749200|NCT01823835|536552301|FG006|Overall Study|Withdrawal by Subject|0|||
148749201|NCT01823835|536552302|FG007|Overall Study|Withdrawal by Subject|0|||
148749202|NCT01823835|536552303|FG008|Overall Study|Withdrawal by Subject|0|||
148749203|NCT01823835|536552304|FG009|Overall Study|Withdrawal by Subject|1|||
148749204|NCT01823835|536552305|FG010|Overall Study|Withdrawal by Subject|1|||
148749205|NCT01823835|536552306|FG011|Overall Study|Withdrawal by Subject|2|||
148749206|NCT01823835|536552307|FG012|Overall Study|Withdrawal by Subject|1|||
148749207|NCT01823835|536552308|FG013|Overall Study|Withdrawal by Subject|0|||
148749208|NCT01823835|536552309|FG014|Overall Study|Withdrawal by Subject|0|||
148749209|NCT03017612|536552312|FG000|Overall Study|Adverse Event|2|||
148749210|NCT01320150|536552313|FG000|Overall Study|Protocol Violation|15|||
148749211|NCT01320150|536552313|FG000|Overall Study|Withdrawal by Subject|5|||
148749212|NCT01320150|536552313|FG000|Overall Study|Death|2|||
148749213|NCT01320150|536552313|FG000|Overall Study|Lost to Follow-up|44|||
148749214|NCT04895982|536552314|FG000|Overall Study|Withdrawal by Subject|0|||
148749215|NCT04895982|536552315|FG001|Overall Study|Withdrawal by Subject|0|||
148749216|NCT04895982|536552316|FG002|Overall Study|Withdrawal by Subject|0|||
148749217|NCT04895982|536552317|FG003|Overall Study|Withdrawal by Subject|0|||
148749218|NCT04895982|536552318|FG004|Overall Study|Withdrawal by Subject|0|||
148749219|NCT04895982|536552319|FG005|Overall Study|Withdrawal by Subject|1|||
148749220|NCT04895982|536552320|FG006|Overall Study|Withdrawal by Subject|1|||
148749221|NCT04895982|536552321|FG007|Overall Study|Withdrawal by Subject|0|||
148749222|NCT04895982|536552322|FG008|Overall Study|Withdrawal by Subject|0|||
148749223|NCT04895982|536552323|FG009|Overall Study|Withdrawal by Subject|1|||
148749224|NCT04895982|536552324|FG010|Overall Study|Withdrawal by Subject|0|||
148749225|NCT04895982|536552325|FG011|Overall Study|Withdrawal by Subject|1|||
148749226|NCT04895982|536552314|FG000|Overall Study|Withdrawal by parent/guardian|2|||
148749227|NCT04895982|536552315|FG001|Overall Study|Withdrawal by parent/guardian|3|||
148749228|NCT04895982|536552316|FG002|Overall Study|Withdrawal by parent/guardian|3|||
148749229|NCT04895982|536552317|FG003|Overall Study|Withdrawal by parent/guardian|1|||
148749230|NCT04895982|536552318|FG004|Overall Study|Withdrawal by parent/guardian|3|||
148749231|NCT04895982|536552319|FG005|Overall Study|Withdrawal by parent/guardian|2|||
148749232|NCT04895982|536552320|FG006|Overall Study|Withdrawal by parent/guardian|1|||
148749233|NCT04895982|536552321|FG007|Overall Study|Withdrawal by parent/guardian|0|||
148749234|NCT04895982|536552322|FG008|Overall Study|Withdrawal by parent/guardian|3|||
148749235|NCT04895982|536552323|FG009|Overall Study|Withdrawal by parent/guardian|0|||
148749236|NCT04895982|536552324|FG010|Overall Study|Withdrawal by parent/guardian|0|||
148749237|NCT04895982|536552325|FG011|Overall Study|Withdrawal by parent/guardian|0|||
148749238|NCT04895982|536552314|FG000|Overall Study|Other|0|||
148749239|NCT04895982|536552315|FG001|Overall Study|Other|0|||
148749240|NCT04895982|536552316|FG002|Overall Study|Other|1|||
148749241|NCT04895982|536552317|FG003|Overall Study|Other|1|||
148749242|NCT04895982|536552318|FG004|Overall Study|Other|0|||
148749243|NCT04895982|536552319|FG005|Overall Study|Other|0|||
148749244|NCT04895982|536552320|FG006|Overall Study|Other|0|||
148749245|NCT04895982|536552321|FG007|Overall Study|Other|0|||
148749246|NCT04895982|536552322|FG008|Overall Study|Other|0|||
148749247|NCT04895982|536552323|FG009|Overall Study|Other|1|||
148749248|NCT04895982|536552324|FG010|Overall Study|Other|0|||
148749249|NCT04895982|536552325|FG011|Overall Study|Other|0|||
148749250|NCT04895982|536552314|FG000|Overall Study|Protocol Violation|0|||
148749251|NCT04895982|536552315|FG001|Overall Study|Protocol Violation|0|||
148749252|NCT04895982|536552316|FG002|Overall Study|Protocol Violation|1|||
148749253|NCT04895982|536552317|FG003|Overall Study|Protocol Violation|1|||
148749254|NCT04895982|536552318|FG004|Overall Study|Protocol Violation|1|||
148749255|NCT04895982|536552319|FG005|Overall Study|Protocol Violation|0|||
148749256|NCT04895982|536552320|FG006|Overall Study|Protocol Violation|0|||
148749257|NCT04895982|536552321|FG007|Overall Study|Protocol Violation|1|||
148749258|NCT04895982|536552322|FG008|Overall Study|Protocol Violation|0|||
148749259|NCT04895982|536552323|FG009|Overall Study|Protocol Violation|0|||
148749260|NCT04895982|536552324|FG010|Overall Study|Protocol Violation|0|||
148749261|NCT04895982|536552325|FG011|Overall Study|Protocol Violation|0|||
148749262|NCT04895982|536552314|FG000|Overall Study|Lost to Follow-up|0|||
148749263|NCT04895982|536552315|FG001|Overall Study|Lost to Follow-up|0|||
148749264|NCT04895982|536552316|FG002|Overall Study|Lost to Follow-up|1|||
148749265|NCT04895982|536552317|FG003|Overall Study|Lost to Follow-up|0|||
148749266|NCT04895982|536552318|FG004|Overall Study|Lost to Follow-up|0|||
148749267|NCT04895982|536552319|FG005|Overall Study|Lost to Follow-up|1|||
148749268|NCT04895982|536552320|FG006|Overall Study|Lost to Follow-up|0|||
148749269|NCT04895982|536552321|FG007|Overall Study|Lost to Follow-up|0|||
148749270|NCT04895982|536552322|FG008|Overall Study|Lost to Follow-up|1|||
148749271|NCT04895982|536552323|FG009|Overall Study|Lost to Follow-up|0|||
148749272|NCT04895982|536552324|FG010|Overall Study|Lost to Follow-up|0|||
148749273|NCT04895982|536552325|FG011|Overall Study|Lost to Follow-up|0|||
148749274|NCT04895982|536552314|FG000|Overall Study|Refused further study procedures|0|||
148749275|NCT04895982|536552315|FG001|Overall Study|Refused further study procedures|0|||
148749276|NCT04895982|536552316|FG002|Overall Study|Refused further study procedures|1|||
148749277|NCT04895982|536552317|FG003|Overall Study|Refused further study procedures|0|||
148749278|NCT04895982|536552318|FG004|Overall Study|Refused further study procedures|0|||
148749279|NCT04895982|536552319|FG005|Overall Study|Refused further study procedures|0|||
148749280|NCT04895982|536552320|FG006|Overall Study|Refused further study procedures|0|||
148749281|NCT04895982|536552321|FG007|Overall Study|Refused further study procedures|0|||
148749282|NCT04895982|536552322|FG008|Overall Study|Refused further study procedures|0|||
148749283|NCT04895982|536552323|FG009|Overall Study|Refused further study procedures|0|||
148749284|NCT04895982|536552324|FG010|Overall Study|Refused further study procedures|0|||
148749285|NCT04895982|536552325|FG011|Overall Study|Refused further study procedures|0|||
148749286|NCT00919854|536552326|FG000|Overall Study|Adverse Event|1|||
148749287|NCT00985491|536552331|FG000|Overall Study|Adverse Event|8|||
148749288|NCT00985491|536552331|FG000|Overall Study|device migration|7|||
148749289|NCT00985491|536552331|FG000|Overall Study|Withdrawal by Subject|1|||
148749290|NCT00985491|536552331|FG000|Overall Study|implant failure|3|||
148749291|NCT01893346|536552332|FG000|Overall Study|Lost to Follow-up|0|||
148749292|NCT01893346|536552333|FG001|Overall Study|Lost to Follow-up|1|||
148749293|NCT01893346|536552334|FG002|Overall Study|Lost to Follow-up|0|||
148749294|NCT01893346|536552335|FG003|Overall Study|Lost to Follow-up|0|||
148749295|NCT01893346|536552332|FG000|Overall Study|Protocol Violation|1|||
148749296|NCT01893346|536552333|FG001|Overall Study|Protocol Violation|0|||
148749297|NCT01893346|536552334|FG002|Overall Study|Protocol Violation|0|||
148749298|NCT01893346|536552335|FG003|Overall Study|Protocol Violation|0|||
148749299|NCT01893346|536552332|FG000|Overall Study|Withdrawal by Subject|2|||
148749300|NCT01893346|536552333|FG001|Overall Study|Withdrawal by Subject|0|||
148749301|NCT01893346|536552334|FG002|Overall Study|Withdrawal by Subject|0|||
148749302|NCT01893346|536552335|FG003|Overall Study|Withdrawal by Subject|0|||
148749303|NCT00489827|536552342|FG000|Overall Study|Intraoperative exclusion criteria|1|||
148749304|NCT00489827|536552343|FG001|Overall Study|Intraoperative exclusion criteria|1|||
148749305|NCT00489827|536552342|FG000|Overall Study|Intraoperative exclusion criteria|1|||
148749306|NCT00489827|536552343|FG001|Overall Study|Intraoperative exclusion criteria|1|||
148749307|NCT02296931|536552344|FG000|Overall Study|Protocol Violation|0|||
148749308|NCT02296931|536552345|FG001|Overall Study|Protocol Violation|2|||
148749309|NCT01590277|536552346|FG000|Overall Study|Withdrawal by Subject|3|||
148749310|NCT01590277|536552346|FG000|Overall Study|Withdrawal by Subject|2|||
148749311|NCT01590277|536552346|FG000|Overall Study|Withdrawal by Subject|1|||
148749312|NCT01590277|536552346|FG000|Overall Study|Withdrawal by Subject|1|||
148749313|NCT04386616|536552347|FG000|Overall Study|Death|22|||
148749314|NCT04386616|536552348|FG001|Overall Study|Death|22|||
148749315|NCT04386616|536552349|FG002|Overall Study|Death|21|||
148749316|NCT04386616|536552347|FG000|Overall Study|Lost to Follow-up|5|||
148749317|NCT04386616|536552348|FG001|Overall Study|Lost to Follow-up|8|||
148749318|NCT04386616|536552349|FG002|Overall Study|Lost to Follow-up|6|||
148749319|NCT04386616|536552347|FG000|Overall Study|Withdrawal by Subject|2|||
148749320|NCT04386616|536552348|FG001|Overall Study|Withdrawal by Subject|4|||
148749321|NCT04386616|536552349|FG002|Overall Study|Withdrawal by Subject|1|||
148749322|NCT04386616|536552347|FG000|Overall Study|Adverse Event|1|||
148749323|NCT04386616|536552348|FG001|Overall Study|Adverse Event|1|||
148749324|NCT04386616|536552349|FG002|Overall Study|Adverse Event|0|||
148749325|NCT01377012|536552350|FG000|Core Study|Study terminated by Sponsor|47|||
148749326|NCT01377012|536552351|FG001|Core Study|Study terminated by Sponsor|54|||
148749327|NCT01377012|536552352|FG002|Core Study|Study terminated by Sponsor|46|||
148749328|NCT01377012|536552350|FG000|Core Study|Technical problems|1|||
148749329|NCT01377012|536552351|FG001|Core Study|Technical problems|0|||
148749330|NCT01377012|536552352|FG002|Core Study|Technical problems|0|||
148749331|NCT01377012|536552350|FG000|Core Study|Withdrawal by Subject|15|||
148749332|NCT01377012|536552351|FG001|Core Study|Withdrawal by Subject|23|||
148749333|NCT01377012|536552352|FG002|Core Study|Withdrawal by Subject|18|||
148749334|NCT01377012|536552350|FG000|Core Study|Protocol Violation|7|||
148749335|NCT01377012|536552351|FG001|Core Study|Protocol Violation|3|||
148749336|NCT01377012|536552352|FG002|Core Study|Protocol Violation|2|||
148749337|NCT01377012|536552350|FG000|Core Study|Pregnancy|0|||
148749338|NCT01377012|536552351|FG001|Core Study|Pregnancy|0|||
148749339|NCT01377012|536552352|FG002|Core Study|Pregnancy|1|||
148749340|NCT01377012|536552350|FG000|Core Study|Physician Decision|5|||
148749341|NCT01377012|536552351|FG001|Core Study|Physician Decision|4|||
148749342|NCT01377012|536552352|FG002|Core Study|Physician Decision|10|||
148749343|NCT01377012|536552350|FG000|Core Study|Non-Compliant with study treatment|0|||
148749344|NCT01377012|536552351|FG001|Core Study|Non-Compliant with study treatment|0|||
148749345|NCT01377012|536552352|FG002|Core Study|Non-Compliant with study treatment|1|||
148749346|NCT01377012|536552350|FG000|Core Study|No Longer require treatment|0|||
148821829|NCT00601107|536826639|FG000|Overall Study|Adverse Event|0|||
148821830|NCT00601107|536826640|FG001|Overall Study|Adverse Event|1|||
148821831|NCT00601107|536826641|FG002|Overall Study|Adverse Event|3|||
148749347|NCT01377012|536552351|FG001|Core Study|No Longer require treatment|0|||
148749348|NCT01377012|536552352|FG002|Core Study|No Longer require treatment|1|||
148749349|NCT01377012|536552350|FG000|Core Study|Lost to Follow-up|7|||
148749350|NCT01377012|536552351|FG001|Core Study|Lost to Follow-up|5|||
148749351|NCT01377012|536552352|FG002|Core Study|Lost to Follow-up|4|||
148749352|NCT01377012|536552350|FG000|Core Study|Lack of Efficacy|41|||
148749353|NCT01377012|536552351|FG001|Core Study|Lack of Efficacy|28|||
148749354|NCT01377012|536552352|FG002|Core Study|Lack of Efficacy|37|||
148749355|NCT01377012|536552350|FG000|Core Study|Death|1|||
148749356|NCT01377012|536552351|FG001|Core Study|Death|1|||
148749357|NCT01377012|536552352|FG002|Core Study|Death|1|||
148749358|NCT01377012|536552350|FG000|Core Study|Adverse Event|10|||
148976166|NCT01252290|537394471|FG000|Overall Study|Withdrawal by Subject|1|||
148976167|NCT02075437|537394476|FG000|Overall Study|Withdrawal by Subject|5|||
148976168|NCT02075437|537394476|FG000|Overall Study|Lost to Follow-up|1|||
148976169|NCT04439240|537394477|FG000|Overall Study|Ineligible|2|||
148976170|NCT04439240|537394477|FG000|Overall Study|Never started treatment|2|||
148749359|NCT01377012|536552351|FG001|Core Study|Adverse Event|14|||
148749360|NCT01377012|536552352|FG002|Core Study|Adverse Event|13|||
148749361|NCT01377012|536552350|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
148749362|NCT01377012|536552351|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
148749363|NCT01377012|536552352|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
148749364|NCT01377012|536552350|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
148749365|NCT01377012|536552351|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
148749366|NCT01377012|536552352|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
148749367|NCT01377012|536552350|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
148749368|NCT01377012|536552351|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
148749369|NCT01377012|536552352|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
148749370|NCT01377012|536552350|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
148749371|NCT01377012|536552351|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
148749372|NCT01377012|536552352|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
148749373|NCT01377012|536552350|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
148749374|NCT01377012|536552351|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
148749375|NCT01377012|536552352|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
148749376|NCT01377012|536552350|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
148749377|NCT01377012|536552351|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
148749378|NCT01377012|536552352|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
148749379|NCT01632280|536552379|FG000|Overall Study|Withdrawal by Subject|1|||
148749380|NCT01632280|536552380|FG001|Overall Study|Withdrawal by Subject|0|||
148749381|NCT03086551|536552383|FG000|First Intervention|Failure to meet inclusion criterion|1|||
148749382|NCT03086551|536552384|FG001|First Intervention|Failure to meet inclusion criterion|0|||
148749383|NCT03086551|536552383|FG000|First Intervention|Lost to Follow-up|0|||
148749384|NCT03086551|536552384|FG001|First Intervention|Lost to Follow-up|1|||
148749385|NCT03086551|536552383|FG000|Washout|Lost to Follow-up|1|||
148749386|NCT03086551|536552384|FG001|Washout|Lost to Follow-up|2|||
148749387|NCT03086551|536552383|FG000|Washout|Withdrawal by Subject|2|||
148749388|NCT03086551|536552384|FG001|Washout|Withdrawal by Subject|1|||
148749389|NCT03736031|536552385|FG000|Overall Study|Death|2|||
148749390|NCT03736031|536552386|FG001|Overall Study|Death|4|||
148749391|NCT03736031|536552385|FG000|Overall Study|Lost to Follow-up|21|||
148749392|NCT03736031|536552386|FG001|Overall Study|Lost to Follow-up|2|||
148749393|NCT03736031|536552385|FG000|Overall Study|Withdrawal by Subject|9|||
148749394|NCT03736031|536552386|FG001|Overall Study|Withdrawal by Subject|0|||
148749395|NCT05022212|536552387|FG000|Overall Study|Lost to Follow-up|0|||
148749396|NCT05022212|536552388|FG001|Overall Study|Lost to Follow-up|2|||
148749397|NCT00451178|536552389|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
148749398|NCT00451178|536552390|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
148749399|NCT00451178|536552389|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
148749400|NCT00451178|536552390|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
148749401|NCT00451178|536552389|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
148749402|NCT00451178|536552390|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
148749403|NCT00451178|536552389|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
148749404|NCT00451178|536552390|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
148749405|NCT00451178|536552389|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
148749406|NCT00451178|536552390|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
148749407|NCT00451178|536552389|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
148749408|NCT00451178|536552390|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
148749409|NCT00451178|536552389|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
148749410|NCT00451178|536552390|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
148749411|NCT00451178|536552389|FG000|Prior to Maintenance Therapy|PD|2|||
148749412|NCT00451178|536552390|FG001|Prior to Maintenance Therapy|PD|0|||
148749413|NCT00451178|536552389|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
148749414|NCT00451178|536552390|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
148749415|NCT00451178|536552389|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
148749416|NCT00451178|536552390|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
148976171|NCT04439240|537394477|FG000|Overall Study|Adverse Event|12|||
148976172|NCT04439240|537394477|FG000|Overall Study|Death|2|||
148976173|NCT04439240|537394477|FG000|Overall Study|Disease progression|25|||
148749417|NCT00451178|536552389|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
148749418|NCT00451178|536552390|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
148749419|NCT00451178|536552389|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
148749420|NCT00451178|536552390|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
148976174|NCT04439240|537394477|FG000|Overall Study|Other diseases|2|||
148976175|NCT04439240|537394477|FG000|Overall Study|Withdrawal by Subject|3|||
149027261|NCT01456780|537578522|FG000|Overall Study|Lost to Follow-up|3|||
149027262|NCT01456780|537578523|FG001|Overall Study|Lost to Follow-up|3|||
149027263|NCT01456780|537578524|FG002|Overall Study|Lost to Follow-up|0|||
148749421|NCT00451178|536552389|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
148749422|NCT00451178|536552390|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
148749423|NCT00451178|536552389|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
148749424|NCT00451178|536552390|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
148749425|NCT00451178|536552389|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
148749426|NCT00451178|536552390|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
148749427|NCT02729909|536552391|FG000|Overall Study|Lost to Follow-up|0|||
148749428|NCT02729909|536552392|FG001|Overall Study|Lost to Follow-up|1|||
148749429|NCT02729909|536552391|FG000|Overall Study|Lack of Efficacy|0|||
148749430|NCT02729909|536552392|FG001|Overall Study|Lack of Efficacy|2|||
148749431|NCT02729909|536552391|FG000|Overall Study|Significant Protocol Deviation|0|||
148749432|NCT02729909|536552392|FG001|Overall Study|Significant Protocol Deviation|2|||
148749433|NCT02729909|536552391|FG000|Overall Study|Voluntary Withdrawal|1|||
148749434|NCT02729909|536552392|FG001|Overall Study|Voluntary Withdrawal|0|||
148749435|NCT01260701|536552393|FG000|Overall Study|Adverse Event|9|||
148749436|NCT01260701|536552393|FG000|Overall Study|Withdrawal by Subject|2|||
148749437|NCT01260701|536552393|FG000|Overall Study|Progression|53|||
148749438|NCT01260701|536552393|FG000|Overall Study|Death|2|||
148749439|NCT01260701|536552393|FG000|Overall Study|Not protocol specified|3|||
148749440|NCT01260701|536552393|FG000|Overall Study|Under review|1|||
148749441|NCT01260701|536552393|FG000|Overall Study|Ineligible|4|||
148749442|NCT01260701|536552393|FG000|Overall Study|Did not begin protocol therapy|1|||
148749443|NCT06419907|536554181|FG000|Overall Study|Protocol Violation|0|||
148749444|NCT06419907|536554182|FG001|Overall Study|Protocol Violation|3|||
148749445|NCT06419907|536554183|FG002|Overall Study|Protocol Violation|0|||
148749446|NCT06419907|536554184|FG003|Overall Study|Protocol Violation|1|||
148749447|NCT06419907|536554181|FG000|Overall Study|Lost to Follow-up|0|||
148749448|NCT06419907|536554182|FG001|Overall Study|Lost to Follow-up|0|||
148749449|NCT06419907|536554183|FG002|Overall Study|Lost to Follow-up|2|||
148749450|NCT06419907|536554184|FG003|Overall Study|Lost to Follow-up|1|||
148749451|NCT03130777|536554185|FG000|Overall Study|Death|0|||
148749452|NCT03130777|536554186|FG001|Overall Study|Death|1|||
148749453|NCT03130777|536554185|FG000|Overall Study|Did not meet eligibility criteria|1|||
148749454|NCT03130777|536554186|FG001|Overall Study|Did not meet eligibility criteria|0|||
148749455|NCT02586688|536554187|FG000|Overall Study|Lost to Follow-up|2|||
148749456|NCT02586688|536554188|FG001|Overall Study|Lost to Follow-up|1|||
148749457|NCT02586688|536554187|FG000|Overall Study|Withdrawal by Subject|1|||
148749458|NCT02586688|536554188|FG001|Overall Study|Withdrawal by Subject|1|||
148749459|NCT02586688|536554187|FG000|Overall Study|Adverse Event|3|||
148749460|NCT02586688|536554188|FG001|Overall Study|Adverse Event|1|||
148749461|NCT04856917|536554189|FG000|Overall Study|Withdrawal by Subject|4|||
148749462|NCT04856917|536554190|FG001|Overall Study|Withdrawal by Subject|3|||
148749463|NCT04856917|536554191|FG002|Overall Study|Withdrawal by Subject|1|||
148749464|NCT04856917|536554189|FG000|Overall Study|Lost to Follow-up|3|||
148749465|NCT04856917|536554190|FG001|Overall Study|Lost to Follow-up|1|||
148749466|NCT04856917|536554191|FG002|Overall Study|Lost to Follow-up|1|||
148749467|NCT04856917|536554189|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
148749468|NCT04856917|536554190|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
148749469|NCT04856917|536554191|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
148749470|NCT04856917|536554189|FG000|Overall Study|Other|1|||
148749471|NCT04856917|536554190|FG001|Overall Study|Other|1|||
148749472|NCT04856917|536554191|FG002|Overall Study|Other|0|||
148749473|NCT06195930|536554197|FG000|Overall Study|Adverse Event|4|||
148749474|NCT03631199|536554198|FG000|Overall Study|Progressive disease|9|||
148821832|NCT00601107|536826642|FG003|Overall Study|Adverse Event|0|||
148821833|NCT00601107|536826639|FG000|Overall Study|Withdrawal by Subject|5|||
148821834|NCT00601107|536826640|FG001|Overall Study|Withdrawal by Subject|4|||
148821835|NCT00601107|536826641|FG002|Overall Study|Withdrawal by Subject|7|||
148821836|NCT00601107|536826642|FG003|Overall Study|Withdrawal by Subject|4|||
148821837|NCT00601107|536826639|FG000|Overall Study|Lost to Follow-up|3|||
148821838|NCT00601107|536826640|FG001|Overall Study|Lost to Follow-up|3|||
148821839|NCT00601107|536826641|FG002|Overall Study|Lost to Follow-up|0|||
148821840|NCT00601107|536826642|FG003|Overall Study|Lost to Follow-up|3|||
148821841|NCT00601107|536826639|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
148749475|NCT03631199|536554199|FG001|Overall Study|Progressive disease|5|||
148749476|NCT03631199|536554200|FG002|Overall Study|Progressive disease|5|||
148749477|NCT03631199|536554201|FG003|Overall Study|Progressive disease|149|||
148749478|NCT03631199|536554202|FG004|Overall Study|Progressive disease|148|||
148749479|NCT03631199|536554198|FG000|Overall Study|Physician Decision|0|||
148749480|NCT03631199|536554199|FG001|Overall Study|Physician Decision|2|||
148749481|NCT03631199|536554200|FG002|Overall Study|Physician Decision|3|||
148749482|NCT03631199|536554201|FG003|Overall Study|Physician Decision|19|||
148749483|NCT03631199|536554202|FG004|Overall Study|Physician Decision|13|||
148749484|NCT03631199|536554198|FG000|Overall Study|Adverse Event|1|||
149027264|NCT05349864|537578531|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
148749485|NCT03631199|536554199|FG001|Overall Study|Adverse Event|1|||
148749486|NCT03631199|536554200|FG002|Overall Study|Adverse Event|0|||
148749487|NCT03631199|536554201|FG003|Overall Study|Adverse Event|28|||
148749488|NCT03631199|536554202|FG004|Overall Study|Adverse Event|29|||
148749489|NCT03631199|536554198|FG000|Overall Study|Death|0|||
148749490|NCT03631199|536554199|FG001|Overall Study|Death|1|||
148749491|NCT03631199|536554200|FG002|Overall Study|Death|0|||
148749492|NCT03631199|536554201|FG003|Overall Study|Death|35|||
148749493|NCT03631199|536554202|FG004|Overall Study|Death|48|||
148749494|NCT03631199|536554198|FG000|Overall Study|Subject decision|0|||
148749495|NCT03631199|536554199|FG001|Overall Study|Subject decision|1|||
148749496|NCT03631199|536554200|FG002|Overall Study|Subject decision|0|||
148749497|NCT03631199|536554201|FG003|Overall Study|Subject decision|12|||
148749498|NCT03631199|536554202|FG004|Overall Study|Subject decision|12|||
148749499|NCT03631199|536554198|FG000|Overall Study|No treated|0|||
148749500|NCT03631199|536554199|FG001|Overall Study|No treated|0|||
148749501|NCT03631199|536554200|FG002|Overall Study|No treated|0|||
148749502|NCT03631199|536554201|FG003|Overall Study|No treated|0|||
148749503|NCT03631199|536554202|FG004|Overall Study|No treated|1|||
148749504|NCT03631199|536554198|FG000|Overall Study|Treatment ongoing|0|||
148749505|NCT03631199|536554199|FG001|Overall Study|Treatment ongoing|1|||
148749506|NCT03631199|536554200|FG002|Overall Study|Treatment ongoing|1|||
148749507|NCT03631199|536554201|FG003|Overall Study|Treatment ongoing|76|||
148749508|NCT03631199|536554202|FG004|Overall Study|Treatment ongoing|71|||
148749509|NCT03631199|536554198|FG000|Overall Study|Guardian decision|0|||
148749510|NCT03631199|536554199|FG001|Overall Study|Guardian decision|0|||
148749511|NCT03631199|536554200|FG002|Overall Study|Guardian decision|0|||
148749512|NCT03631199|536554201|FG003|Overall Study|Guardian decision|1|||
148749513|NCT03631199|536554202|FG004|Overall Study|Guardian decision|1|||
148749514|NCT03999996|536554203|FG000|Prior to Booster|Adverse Event|2|||
148749515|NCT03999996|536554204|FG001|Prior to Booster|Adverse Event|0|||
148749516|NCT03999996|536554205|FG002|Prior to Booster|Adverse Event|0|||
148749517|NCT03999996|536554206|FG003|Prior to Booster|Adverse Event|0|||
148749518|NCT03999996|536554203|FG000|Prior to Booster|Lost to Follow-up|17|||
148749519|NCT03999996|536554204|FG001|Prior to Booster|Lost to Follow-up|22|||
148749520|NCT03999996|536554205|FG002|Prior to Booster|Lost to Follow-up|0|||
148749521|NCT03999996|536554206|FG003|Prior to Booster|Lost to Follow-up|0|||
148749522|NCT03999996|536554203|FG000|Prior to Booster|Withdrawal of Consent|51|||
148749523|NCT03999996|536554204|FG001|Prior to Booster|Withdrawal of Consent|8|||
148749524|NCT03999996|536554205|FG002|Prior to Booster|Withdrawal of Consent|0|||
148749525|NCT03999996|536554206|FG003|Prior to Booster|Withdrawal of Consent|0|||
148749526|NCT03999996|536554203|FG000|Prior to Booster|Death|0|||
148749527|NCT03999996|536554204|FG001|Prior to Booster|Death|1|||
148749528|NCT03999996|536554205|FG002|Prior to Booster|Death|0|||
148749529|NCT03999996|536554206|FG003|Prior to Booster|Death|0|||
148749530|NCT03999996|536554203|FG000|Prior to Booster|Reason Not Specified|27|||
148749531|NCT03999996|536554204|FG001|Prior to Booster|Reason Not Specified|4|||
148749532|NCT03999996|536554205|FG002|Prior to Booster|Reason Not Specified|0|||
148749533|NCT03999996|536554206|FG003|Prior to Booster|Reason Not Specified|0|||
148749534|NCT03999996|536554203|FG000|Booster Phase|Lost to Follow-up|0|||
148749535|NCT03999996|536554204|FG001|Booster Phase|Lost to Follow-up|0|||
148749536|NCT03999996|536554205|FG002|Booster Phase|Lost to Follow-up|3|||
148749537|NCT03999996|536554206|FG003|Booster Phase|Lost to Follow-up|3|||
148749538|NCT03999996|536554203|FG000|Booster Phase|Withdrawal of Consent|0|||
148749539|NCT03999996|536554204|FG001|Booster Phase|Withdrawal of Consent|0|||
148749540|NCT03999996|536554205|FG002|Booster Phase|Withdrawal of Consent|0|||
148749541|NCT03999996|536554206|FG003|Booster Phase|Withdrawal of Consent|1|||
148749542|NCT03999996|536554203|FG000|Booster Phase|Reason Not Specified|0|||
148749543|NCT03999996|536554204|FG001|Booster Phase|Reason Not Specified|0|||
148749544|NCT03999996|536554205|FG002|Booster Phase|Reason Not Specified|0|||
148749545|NCT03999996|536554206|FG003|Booster Phase|Reason Not Specified|1|||
148749546|NCT03690388|536554207|FG000|Overall Study|Adverse Event|8|||
148749547|NCT03690388|536554208|FG001|Overall Study|Adverse Event|1|||
148749548|NCT03690388|536554207|FG000|Overall Study|Radiographic Progression|14|||
148749549|NCT03690388|536554208|FG001|Overall Study|Radiographic Progression|29|||
148749550|NCT03690388|536554207|FG000|Overall Study|Clinical deterioration|10|||
148749551|NCT03690388|536554208|FG001|Overall Study|Clinical deterioration|6|||
148749552|NCT03690388|536554207|FG000|Overall Study|Withdrawal by Subject|2|||
148749553|NCT03690388|536554208|FG001|Overall Study|Withdrawal by Subject|0|||
148749554|NCT03690388|536554207|FG000|Overall Study|Lack of Efficacy|1|||
148749555|NCT03690388|536554208|FG001|Overall Study|Lack of Efficacy|0|||
148749556|NCT03690388|536554207|FG000|Overall Study|Lost to Follow-up|1|||
148749557|NCT03690388|536554208|FG001|Overall Study|Lost to Follow-up|0|||
148749558|NCT00266630|536554213|FG000|Overall Study|Adverse Event|8|||
148749559|NCT00266630|536554214|FG001|Overall Study|Adverse Event|6|||
148749560|NCT00266630|536554213|FG000|Overall Study|Lack of Efficacy|1|||
148749561|NCT00266630|536554214|FG001|Overall Study|Lack of Efficacy|4|||
148749562|NCT00266630|536554213|FG000|Overall Study|Entry Criteria not met|1|||
148749563|NCT00266630|536554214|FG001|Overall Study|Entry Criteria not met|0|||
148749564|NCT00266630|536554213|FG000|Overall Study|Protocol Violation|1|||
148821842|NCT00601107|536826640|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
148821843|NCT00601107|536826641|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
148821844|NCT00601107|536826642|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
148821845|NCT00601107|536826639|FG000|Overall Study|Worsening of Psoriasis|4|||
148821846|NCT00601107|536826640|FG001|Overall Study|Worsening of Psoriasis|1|||
148821847|NCT00601107|536826641|FG002|Overall Study|Worsening of Psoriasis|1|||
148821848|NCT00601107|536826642|FG003|Overall Study|Worsening of Psoriasis|4|||
148821849|NCT00601107|536826639|FG000|Overall Study|Undefined|1|||
148821850|NCT00601107|536826640|FG001|Overall Study|Undefined|0|||
148821851|NCT00601107|536826641|FG002|Overall Study|Undefined|1|||
148821852|NCT00601107|536826642|FG003|Overall Study|Undefined|0|||
148821853|NCT02453191|536826643|FG000|Overall Study|Withdrawal by Subject|1|||
148821854|NCT03364686|536826644|FG000|Overall Study|Physician Decision|2|||
148821855|NCT01520714|536826645|FG000|Overall Study|Protocol Violation|0|||
148821856|NCT01520714|536826646|FG001|Overall Study|Protocol Violation|3|||
148821857|NCT01520714|536826645|FG000|Overall Study|Adverse Event|0|||
148821858|NCT01520714|536826646|FG001|Overall Study|Adverse Event|2|||
148821859|NCT01520714|536826645|FG000|Overall Study|Lack of Efficacy|0|||
148821860|NCT01520714|536826646|FG001|Overall Study|Lack of Efficacy|1|||
148821861|NCT01986751|536826652|FG000|Overall Study|improperly consented|10|||
148821862|NCT01986751|536826653|FG001|Overall Study|improperly consented|2|||
148821863|NCT03566550|536826654|FG000|Overall Study|Withdrawal by Subject|0|||
148821864|NCT03566550|536826655|FG001|Overall Study|Withdrawal by Subject|1|||
148821865|NCT00063999|536826657|FG000|Overall Study|Withdrawal by Subject|1|||
148821866|NCT00063999|536826658|FG001|Overall Study|Withdrawal by Subject|0|||
148821867|NCT00063999|536826657|FG000|Overall Study|Ineligible|44|||
148821868|NCT00063999|536826658|FG001|Overall Study|Ineligible|24|||
148821869|NCT01489358|536826662|FG000|Overall Study|Lost to Follow-up|0|||
148976176|NCT04439240|537394477|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
148976177|NCT04439240|537394477|FG000|Overall Study|Symptomatic decline|1|||
148976178|NCT04439240|537394477|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
148976179|NCT04439240|537394477|FG000|Overall Study|Clinical progression|1|||
148976180|NCT00813124|537394479|FG000|Overall Study|Death|2|||
148976181|NCT00813124|537394479|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
148976182|NCT00813124|537394479|FG000|Overall Study|Withdrawal by Subject|1|||
148976183|NCT00767676|537394480|FG000|Overall Study|Investigator error|54|||
148976184|NCT00079274|537394483|FG000|Overall Study|Withdrawal by Subject|111|||
148976185|NCT00079274|537394484|FG001|Overall Study|Withdrawal by Subject|10|||
148749565|NCT00266630|536554214|FG001|Overall Study|Protocol Violation|3|||
148749566|NCT00266630|536554213|FG000|Overall Study|Physician Decision|1|||
148749567|NCT00266630|536554214|FG001|Overall Study|Physician Decision|2|||
148749568|NCT00266630|536554213|FG000|Overall Study|Withdrawal by Subject|10|||
148749569|NCT00266630|536554214|FG001|Overall Study|Withdrawal by Subject|2|||
148749570|NCT00266630|536554213|FG000|Overall Study|Lost to Follow-up|1|||
148749571|NCT00266630|536554214|FG001|Overall Study|Lost to Follow-up|0|||
148749572|NCT00266630|536554213|FG000|Overall Study|Other|19|||
148749573|NCT00266630|536554214|FG001|Overall Study|Other|11|||
148749574|NCT05377749|536554219|FG000|3 Weeks|Lost to Follow-up|2|||
148749575|NCT05377749|536554220|FG001|3 Weeks|Lost to Follow-up|4|||
148749576|NCT05377749|536554219|FG000|3 Weeks|Withdrawal by Subject|1|||
148749577|NCT05377749|536554220|FG001|3 Weeks|Withdrawal by Subject|1|||
148749578|NCT04909853|536554221|FG000|Part 1|Assigned but not treated|0|||
148749579|NCT04909853|536554222|FG001|Part 1|Assigned but not treated|0|||
148749580|NCT04909853|536554223|FG002|Part 1|Assigned but not treated|1|||
148749581|NCT04909853|536554224|FG003|Part 1|Assigned but not treated|0|||
148749582|NCT04909853|536554221|FG000|Part 2|Adverse Event|0|||
148749583|NCT04909853|536554222|FG001|Part 2|Adverse Event|0|||
148749584|NCT04909853|536554223|FG002|Part 2|Adverse Event|0|||
148749585|NCT04909853|536554224|FG003|Part 2|Adverse Event|1|||
148749586|NCT02548156|536554227|FG000|Washout Period 1|Lost to Follow-up|0|||
148749587|NCT02548156|536554228|FG001|Washout Period 1|Lost to Follow-up|0|||
148749588|NCT02548156|536554229|FG002|Washout Period 1|Lost to Follow-up|0|||
148821870|NCT01489358|536826663|FG001|Overall Study|Lost to Follow-up|0|||
148821871|NCT01489358|536826664|FG002|Overall Study|Lost to Follow-up|2|||
148821872|NCT03722030|536826665|FG000|Overall Study|Withdrawal by Subject|1|||
148821873|NCT03722030|536826666|FG001|Overall Study|Withdrawal by Subject|0|||
148749589|NCT02548156|536554230|FG003|Washout Period 1|Lost to Follow-up|0|||
148821874|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Adverse Event|14|||
148821875|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Adverse Event|27|||
148821876|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Adverse Event|60|||
148821877|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Adverse Event|0|||
148821878|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Adverse Event|0|||
148821879|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Pregnancy|0|||
148821880|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Pregnancy|7|||
148976186|NCT00079274|537394485|FG002|Overall Study|Withdrawal by Subject|12|||
148749590|NCT02548156|536554231|FG004|Washout Period 1|Lost to Follow-up|1|||
148821881|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Pregnancy|9|||
148749591|NCT02548156|536554232|FG005|Washout Period 1|Lost to Follow-up|0|||
148749592|NCT00444587|536554245|FG000|Overall Study|Death|2|||
148749593|NCT00444587|536554246|FG001|Overall Study|Death|1|||
148749594|NCT00444587|536554245|FG000|Overall Study|Progression of the disease|73|||
148749595|NCT00444587|536554246|FG001|Overall Study|Progression of the disease|8|||
148749596|NCT00444587|536554245|FG000|Overall Study|Refused treatment/did not cooperate|4|||
148749597|NCT00444587|536554246|FG001|Overall Study|Refused treatment/did not cooperate|1|||
148749598|NCT00444587|536554245|FG000|Overall Study|Investigator decision|3|||
148749599|NCT00444587|536554246|FG001|Overall Study|Investigator decision|0|||
148749600|NCT00444587|536554245|FG000|Overall Study|Protocol Violation|1|||
148749601|NCT00444587|536554246|FG001|Overall Study|Protocol Violation|0|||
148749602|NCT00444587|536554245|FG000|Overall Study|Missing|0|||
148749603|NCT00444587|536554246|FG001|Overall Study|Missing|5|||
148749604|NCT01720225|536554255|FG000|Overall Study|Withdrawal by Subject|0|||
148749605|NCT01720225|536554256|FG001|Overall Study|Withdrawal by Subject|1|||
148749606|NCT01720225|536554255|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
148749607|NCT01720225|536554256|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
148749608|NCT00661193|536554260|FG000|Overall Study|Adverse Event|2|||
148749609|NCT00661193|536554261|FG001|Overall Study|Adverse Event|1|||
148749610|NCT00661193|536554260|FG000|Overall Study|Withdrawal by Subject|3|||
148749611|NCT00661193|536554261|FG001|Overall Study|Withdrawal by Subject|1|||
148749612|NCT00661193|536554260|FG000|Overall Study|Progression|27|||
148749613|NCT00661193|536554261|FG001|Overall Study|Progression|24|||
148749614|NCT00661193|536554260|FG000|Overall Study|Not protocol specified|1|||
148749615|NCT00661193|536554261|FG001|Overall Study|Not protocol specified|0|||
148749616|NCT01811472|536554262|FG000|Overall Study|Adverse Event|1|||
148749617|NCT01811472|536554263|FG001|Overall Study|Adverse Event|0|||
148749618|NCT01811472|536554264|FG002|Overall Study|Adverse Event|4|||
148749619|NCT01811472|536554262|FG000|Overall Study|Lost to Follow-up|0|||
148749620|NCT01811472|536554263|FG001|Overall Study|Lost to Follow-up|0|||
148749621|NCT01811472|536554264|FG002|Overall Study|Lost to Follow-up|1|||
148749622|NCT01811472|536554262|FG000|Overall Study|Subject/guardian decision|1|||
148749623|NCT01811472|536554263|FG001|Overall Study|Subject/guardian decision|0|||
148749624|NCT01811472|536554264|FG002|Overall Study|Subject/guardian decision|0|||
148749625|NCT03288714|536554265|FG000|Overall Study|Lost to Follow-up|2|||
148749626|NCT03288714|536554266|FG001|Overall Study|Lost to Follow-up|1|||
148749627|NCT03288714|536554265|FG000|Overall Study|Non-compliance with study schedule|2|||
148749628|NCT03288714|536554266|FG001|Overall Study|Non-compliance with study schedule|0|||
148749629|NCT03288714|536554265|FG000|Overall Study|Withdrawal by Subject|3|||
148749630|NCT03288714|536554266|FG001|Overall Study|Withdrawal by Subject|1|||
148749631|NCT03288714|536554265|FG000|Overall Study|Clinical Worsening|2|||
148749632|NCT03288714|536554266|FG001|Overall Study|Clinical Worsening|1|||
148749633|NCT03288714|536554265|FG000|Overall Study|Adverse Event|1|||
148749634|NCT03288714|536554266|FG001|Overall Study|Adverse Event|0|||
148749635|NCT03280264|536554267|FG000|Overall Study|Adverse Event|1|||
148749636|NCT03280264|536554267|FG000|Overall Study|Physician Decision|1|||
148749637|NCT03280264|536554267|FG000|Overall Study|Withdrawal by Subject|1|||
148749638|NCT00524420|536554275|FG000|Overall Study|Lack of Efficacy|1|||
148749639|NCT00524420|536554276|FG001|Overall Study|Lack of Efficacy|0|||
148749640|NCT00577863|536554277|FG000|Overall Study|Adverse Event|4|||
148749641|NCT00577863|536554278|FG001|Overall Study|Adverse Event|2|||
148749642|NCT00577863|536554277|FG000|Overall Study|Death|1|||
148749643|NCT00577863|536554278|FG001|Overall Study|Death|0|||
148749644|NCT00577863|536554277|FG000|Overall Study|Lost to Follow-up|2|||
148749645|NCT00577863|536554278|FG001|Overall Study|Lost to Follow-up|2|||
148749646|NCT00577863|536554277|FG000|Overall Study|Entry Criteria Exclusion|1|||
148749647|NCT00577863|536554278|FG001|Overall Study|Entry Criteria Exclusion|0|||
148749648|NCT00577863|536554277|FG000|Overall Study|Withdrawal by Subject|0|||
148749649|NCT00577863|536554278|FG001|Overall Study|Withdrawal by Subject|2|||
148749650|NCT00577863|536554277|FG000|Overall Study|Sponsor Decision|2|||
148749651|NCT00577863|536554278|FG001|Overall Study|Sponsor Decision|7|||
148749652|NCT00577863|536554277|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
148749653|NCT00577863|536554278|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
148749654|NCT03639779|536554291|FG000|Overall Study|Lost to Follow-up|1|||
148749655|NCT02932462|536554294|FG000|Overall Study|Adverse Event|1|||
148749656|NCT02932462|536554295|FG001|Overall Study|Adverse Event|2|||
148749657|NCT02932462|536554294|FG000|Overall Study|Lost to Follow-up|4|||
148749658|NCT02932462|536554295|FG001|Overall Study|Lost to Follow-up|1|||
148749659|NCT02932462|536554294|FG000|Overall Study|Protocol Violation|0|||
148749660|NCT02932462|536554295|FG001|Overall Study|Protocol Violation|5|||
148749661|NCT02932462|536554294|FG000|Overall Study|Withdrawal by Subject|1|||
148749662|NCT02932462|536554295|FG001|Overall Study|Withdrawal by Subject|4|||
148749663|NCT02932462|536554294|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148749664|NCT02932462|536554295|FG001|Overall Study|Non-Compliance With Study Drug|1|||
148749665|NCT02932462|536554294|FG000|Overall Study|Progressive Disease|1|||
148749666|NCT02932462|536554295|FG001|Overall Study|Progressive Disease|0|||
148749667|NCT02413229|536554296|FG000|Overall Study|Adverse Event|0|||
148749668|NCT02413229|536554297|FG001|Overall Study|Adverse Event|0|||
148821882|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Pregnancy|0|||
148749669|NCT02413229|536554298|FG002|Overall Study|Adverse Event|0|||
148749670|NCT02413229|536554299|FG003|Overall Study|Adverse Event|1|||
148749671|NCT02413229|536554300|FG004|Overall Study|Adverse Event|0|||
148749672|NCT02413229|536554301|FG005|Overall Study|Adverse Event|0|||
148749673|NCT02413229|536554302|FG006|Overall Study|Adverse Event|0|||
148749674|NCT02413229|536554303|FG007|Overall Study|Adverse Event|1|||
148749675|NCT02413229|536554296|FG000|Overall Study|Lost to Follow-up|0|||
148749676|NCT02413229|536554297|FG001|Overall Study|Lost to Follow-up|0|||
148749677|NCT02413229|536554298|FG002|Overall Study|Lost to Follow-up|1|||
148749678|NCT02413229|536554299|FG003|Overall Study|Lost to Follow-up|0|||
148749679|NCT02413229|536554300|FG004|Overall Study|Lost to Follow-up|2|||
148749680|NCT02413229|536554301|FG005|Overall Study|Lost to Follow-up|0|||
148749681|NCT02413229|536554302|FG006|Overall Study|Lost to Follow-up|0|||
148749682|NCT02413229|536554303|FG007|Overall Study|Lost to Follow-up|0|||
148749683|NCT02413229|536554296|FG000|Overall Study|Withdrawal by Subject|1|||
148749684|NCT02413229|536554297|FG001|Overall Study|Withdrawal by Subject|1|||
148749685|NCT02413229|536554298|FG002|Overall Study|Withdrawal by Subject|0|||
148749686|NCT02413229|536554299|FG003|Overall Study|Withdrawal by Subject|0|||
148749687|NCT02413229|536554300|FG004|Overall Study|Withdrawal by Subject|1|||
148749688|NCT02413229|536554301|FG005|Overall Study|Withdrawal by Subject|0|||
148749689|NCT02413229|536554302|FG006|Overall Study|Withdrawal by Subject|0|||
148749690|NCT02413229|536554303|FG007|Overall Study|Withdrawal by Subject|2|||
148749691|NCT02413229|536554296|FG000|Overall Study|Progressive Disease|0|||
148749692|NCT02413229|536554297|FG001|Overall Study|Progressive Disease|0|||
148749693|NCT02413229|536554298|FG002|Overall Study|Progressive Disease|0|||
148749694|NCT02413229|536554299|FG003|Overall Study|Progressive Disease|0|||
148749695|NCT02413229|536554300|FG004|Overall Study|Progressive Disease|0|||
148749696|NCT02413229|536554301|FG005|Overall Study|Progressive Disease|0|||
148749697|NCT02413229|536554302|FG006|Overall Study|Progressive Disease|0|||
148749698|NCT02413229|536554303|FG007|Overall Study|Progressive Disease|1|||
148749699|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Other|34|||
148749700|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Other|0|||
148749701|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Other|0|||
148749702|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Other|0|||
148749703|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Death|14|||
148749704|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Death|0|||
148749705|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Death|0|||
148749706|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Death|0|||
148749707|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
148749708|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
148749709|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
148749710|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
148749711|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
148749712|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
148749713|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
148749714|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
148749715|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
148749716|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
148749717|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
148749718|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
148749719|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
148749720|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
148749721|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
148749722|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
148749723|NCT01995513|536554304|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
148749724|NCT01995513|536554305|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
148749725|NCT01995513|536554306|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
148749726|NCT01995513|536554307|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
148749727|NCT01995513|536554304|FG000|Period 1: Second Open Label Treatment|Other|0|||
148749728|NCT01995513|536554305|FG001|Period 1: Second Open Label Treatment|Other|2|||
148749729|NCT01995513|536554306|FG002|Period 1: Second Open Label Treatment|Other|0|||
148749730|NCT01995513|536554307|FG003|Period 1: Second Open Label Treatment|Other|0|||
148749731|NCT01995513|536554304|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
149027265|NCT05349864|537578532|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
148749732|NCT01995513|536554305|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
148749733|NCT01995513|536554306|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
148749734|NCT01995513|536554307|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
148749735|NCT01995513|536554304|FG000|Period 2: Double Blind Treatment|Death|0|||
148749736|NCT01995513|536554305|FG001|Period 2: Double Blind Treatment|Death|0|||
148749737|NCT01995513|536554306|FG002|Period 2: Double Blind Treatment|Death|0|||
148749738|NCT01995513|536554307|FG003|Period 2: Double Blind Treatment|Death|1|||
148749739|NCT01995513|536554304|FG000|Period 2: Double Blind Treatment|Other|0|||
148749740|NCT01995513|536554305|FG001|Period 2: Double Blind Treatment|Other|0|||
148749741|NCT01995513|536554306|FG002|Period 2: Double Blind Treatment|Other|3|||
148749742|NCT01995513|536554307|FG003|Period 2: Double Blind Treatment|Other|3|||
148749743|NCT01995513|536554304|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
148749744|NCT01995513|536554305|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
148749745|NCT01995513|536554306|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
148749746|NCT01995513|536554307|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
148749747|NCT01995513|536554304|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
148749748|NCT01995513|536554305|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
148749749|NCT01995513|536554306|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
148749750|NCT01995513|536554307|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
148749751|NCT01995513|536554304|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
148749752|NCT01995513|536554305|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
148749753|NCT01995513|536554306|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
148749754|NCT01995513|536554307|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
148749755|NCT01995513|536554304|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
148749756|NCT01995513|536554305|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
148749757|NCT01995513|536554306|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
148749758|NCT01995513|536554307|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
148749759|NCT01232452|536554308|FG000|Overall Study|Adverse Event|17|||
148749760|NCT01232452|536554309|FG001|Overall Study|Adverse Event|15|||
148749761|NCT01232452|536554308|FG000|Overall Study|Withdrawal by Subject|11|||
148749762|NCT01232452|536554309|FG001|Overall Study|Withdrawal by Subject|8|||
148749763|NCT01232452|536554308|FG000|Overall Study|Physician Decision|8|||
148749764|NCT01232452|536554309|FG001|Overall Study|Physician Decision|12|||
148749765|NCT01232452|536554308|FG000|Overall Study|Protocol entry criterion not met|0|||
148749766|NCT01232452|536554309|FG001|Overall Study|Protocol entry criterion not met|2|||
148749767|NCT01232452|536554308|FG000|Overall Study|Sponsor Decision|3|||
148749768|NCT01232452|536554309|FG001|Overall Study|Sponsor Decision|1|||
148749769|NCT01232452|536554308|FG000|Overall Study|Protocol Violation|0|||
148749770|NCT01232452|536554309|FG001|Overall Study|Protocol Violation|1|||
148749771|NCT01750190|536554320|FG000|Overall Study|Adverse Event|47|||
148749772|NCT01750190|536554321|FG001|Overall Study|Adverse Event|19|||
148749773|NCT01750190|536554320|FG000|Overall Study|Death|38|||
148749774|NCT01750190|536554321|FG001|Overall Study|Death|11|||
148749775|NCT01750190|536554320|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
148749776|NCT01750190|536554321|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
148749777|NCT01750190|536554320|FG000|Overall Study|Lost to Follow-up|28|||
148749778|NCT01750190|536554321|FG001|Overall Study|Lost to Follow-up|7|||
148749779|NCT01750190|536554320|FG000|Overall Study|Physician Decision|16|||
148749780|NCT01750190|536554321|FG001|Overall Study|Physician Decision|17|||
148749781|NCT01750190|536554320|FG000|Overall Study|Protocol Violation|6|||
148749782|NCT01750190|536554321|FG001|Overall Study|Protocol Violation|5|||
148749783|NCT01750190|536554320|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
148749784|NCT01750190|536554321|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
148749785|NCT01750190|536554320|FG000|Overall Study|Withdrawal by Subject|83|||
148749786|NCT01750190|536554321|FG001|Overall Study|Withdrawal by Subject|89|||
148749787|NCT01750190|536554320|FG000|Overall Study|Kidney Transplant|8|||
148749788|NCT01750190|536554321|FG001|Overall Study|Kidney Transplant|4|||
148749789|NCT01750190|536554320|FG000|Overall Study|Dialysis|22|||
148749790|NCT01750190|536554321|FG001|Overall Study|Dialysis|8|||
148749791|NCT01750190|536554320|FG000|Overall Study|Other than Specified|13|||
148749792|NCT01750190|536554321|FG001|Overall Study|Other than Specified|4|||
148749793|NCT02955212|536554322|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
148749794|NCT02955212|536554323|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
148749795|NCT02955212|536554322|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
148749796|NCT02955212|536554323|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
148749797|NCT02955212|536554322|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
148749798|NCT02955212|536554323|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
148749799|NCT02955212|536554322|FG000|Period 1: Double-blind Treatment Period|Other|3|||
148749800|NCT02955212|536554323|FG001|Period 1: Double-blind Treatment Period|Other|2|||
148749801|NCT02955212|536554322|FG000|Period 2: Open-label Extension|Adverse Event|11|||
148749802|NCT02955212|536554323|FG001|Period 2: Open-label Extension|Adverse Event|7|||
148749803|NCT02955212|536554322|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
148976187|NCT00079274|537394486|FG003|Overall Study|Withdrawal by Subject|163|||
148976188|NCT00079274|537394487|FG004|Overall Study|Withdrawal by Subject|7|||
148749804|NCT02955212|536554323|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
148749805|NCT02955212|536554322|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
148749806|NCT02955212|536554323|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
148976189|NCT00079274|537394488|FG005|Overall Study|Withdrawal by Subject|8|||
148976190|NCT00079274|537394489|FG006|Overall Study|Withdrawal by Subject|0|||
148821883|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Pregnancy|0|||
148821884|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
148821885|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
148821886|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
148821887|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
148749807|NCT02955212|536554322|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
148749808|NCT02955212|536554323|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
148749809|NCT02955212|536554322|FG000|Period 2: Open-label Extension|Other|2|||
148821888|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
148821889|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
148821890|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
148821891|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
148821892|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
148821893|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
148821894|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Death|1|||
148821895|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Death|2|||
148821896|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Death|2|||
148821897|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Death|0|||
148821898|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Death|0|||
148821899|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
148821900|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
148821901|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
148821902|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
148821903|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
148821904|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
148821905|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
148821906|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
148821907|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
148821908|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
148821909|NCT00098293|536826667|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
148821910|NCT00098293|536826668|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
148821911|NCT00098293|536826669|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
148821912|NCT00098293|536826670|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
148821913|NCT00098293|536826671|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
148821914|NCT00098293|536826667|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
148821915|NCT00098293|536826668|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
148821916|NCT00098293|536826669|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
148821917|NCT00098293|536826670|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
148821918|NCT00098293|536826671|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
148821919|NCT00098293|536826667|FG000|Open-label (OL) Phase|Adverse Event|0|||
148821920|NCT00098293|536826668|FG001|Open-label (OL) Phase|Adverse Event|3|||
148749810|NCT02955212|536554323|FG001|Period 2: Open-label Extension|Other|4|||
148749811|NCT02009722|536554324|FG000|Overall Study|Protocol Violation|1|||
148749812|NCT02009722|536554325|FG001|Overall Study|Protocol Violation|2|||
148749813|NCT02009722|536554324|FG000|Overall Study|Did not receive intervention|0|||
148749814|NCT02009722|536554325|FG001|Overall Study|Did not receive intervention|1|||
148749815|NCT02454933|536554330|FG000|Overall Study|Progressive disease|10|||
148749816|NCT02454933|536554331|FG001|Overall Study|Progressive disease|7|||
148749817|NCT02454933|536554330|FG000|Overall Study|Adverse Event|1|||
148749818|NCT02454933|536554331|FG001|Overall Study|Adverse Event|1|||
148749819|NCT02454933|536554330|FG000|Overall Study|Withdrawal by Subject|0|||
148749820|NCT02454933|536554331|FG001|Overall Study|Withdrawal by Subject|3|||
148821921|NCT00098293|536826669|FG002|Open-label (OL) Phase|Adverse Event|7|||
148821922|NCT00098293|536826670|FG003|Open-label (OL) Phase|Adverse Event|6|||
148821923|NCT00098293|536826671|FG004|Open-label (OL) Phase|Adverse Event|0|||
148821924|NCT00098293|536826667|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
148821925|NCT00098293|536826668|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
148821926|NCT00098293|536826669|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
148821927|NCT00098293|536826670|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
148821928|NCT00098293|536826671|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
148821929|NCT00098293|536826667|FG000|Open-label (OL) Phase|Pregnancy|0|||
148821930|NCT00098293|536826668|FG001|Open-label (OL) Phase|Pregnancy|1|||
148821931|NCT00098293|536826669|FG002|Open-label (OL) Phase|Pregnancy|0|||
148821932|NCT00098293|536826670|FG003|Open-label (OL) Phase|Pregnancy|3|||
148821933|NCT00098293|536826671|FG004|Open-label (OL) Phase|Pregnancy|0|||
148821934|NCT00098293|536826667|FG000|Open-label (OL) Phase|Protocol Violation|0|||
148821935|NCT00098293|536826668|FG001|Open-label (OL) Phase|Protocol Violation|6|||
148821936|NCT00098293|536826669|FG002|Open-label (OL) Phase|Protocol Violation|13|||
148821937|NCT00098293|536826670|FG003|Open-label (OL) Phase|Protocol Violation|16|||
148821938|NCT00098293|536826671|FG004|Open-label (OL) Phase|Protocol Violation|0|||
148821939|NCT00098293|536826667|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
148821940|NCT00098293|536826668|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
148821941|NCT00098293|536826669|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
148749821|NCT02454933|536554330|FG000|Overall Study|Lost to Follow-up|1|||
148749822|NCT02454933|536554331|FG001|Overall Study|Lost to Follow-up|0|||
148749823|NCT02071225|536554334|FG000|Overall Study|Withdrawal of Consent|2|||
148749824|NCT02071225|536554334|FG000|Overall Study|Protocol Deviation|1|||
148749825|NCT02071225|536554334|FG000|Overall Study|Lost to Follow-up|2|||
148749826|NCT02071225|536554334|FG000|Overall Study|Death|25|||
148749827|NCT01342081|536554335|FG000|Overall Study|Did not receive allocated intervention|0|||
148749828|NCT01342081|536554336|FG001|Overall Study|Did not receive allocated intervention|0|||
148749829|NCT01342081|536554337|FG002|Overall Study|Did not receive allocated intervention|1|||
148749830|NCT01342081|536554335|FG000|Overall Study|Adverse Event|1|||
148749831|NCT01342081|536554336|FG001|Overall Study|Adverse Event|0|||
148749832|NCT01342081|536554337|FG002|Overall Study|Adverse Event|0|||
148749833|NCT01342081|536554335|FG000|Overall Study|Physician Decision|0|||
148749834|NCT01342081|536554336|FG001|Overall Study|Physician Decision|1|||
148749835|NCT01342081|536554337|FG002|Overall Study|Physician Decision|0|||
148749836|NCT01342081|536554335|FG000|Overall Study|Withdrawal by Subject|1|||
148749837|NCT01342081|536554336|FG001|Overall Study|Withdrawal by Subject|1|||
148749838|NCT01342081|536554337|FG002|Overall Study|Withdrawal by Subject|0|||
148749839|NCT03934541|536554344|FG000|Overall Study|Study Terminated by Sponsor|0|||
148749840|NCT03934541|536554345|FG001|Overall Study|Study Terminated by Sponsor|1|||
148749841|NCT03934541|536554346|FG002|Overall Study|Study Terminated by Sponsor|0|||
148749842|NCT03934541|536554347|FG003|Overall Study|Study Terminated by Sponsor|0|||
148749843|NCT03142191|536554348|FG000|Placebo Controlled Period|Death|0|||
148749844|NCT03142191|536554349|FG001|Placebo Controlled Period|Death|1|||
148749845|NCT03142191|536554350|FG002|Placebo Controlled Period|Death|1|||
148749846|NCT03142191|536554351|FG003|Placebo Controlled Period|Death|0|||
148749847|NCT03142191|536554352|FG004|Placebo Controlled Period|Death|0|||
148749848|NCT03142191|536554348|FG000|Placebo Controlled Period|Adverse Event|4|||
148749849|NCT03142191|536554349|FG001|Placebo Controlled Period|Adverse Event|5|||
148749850|NCT03142191|536554350|FG002|Placebo Controlled Period|Adverse Event|1|||
148749851|NCT03142191|536554351|FG003|Placebo Controlled Period|Adverse Event|0|||
148749852|NCT03142191|536554352|FG004|Placebo Controlled Period|Adverse Event|0|||
148749853|NCT03142191|536554348|FG000|Placebo Controlled Period|Progressive Disease|1|||
148749854|NCT03142191|536554349|FG001|Placebo Controlled Period|Progressive Disease|0|||
148749855|NCT03142191|536554350|FG002|Placebo Controlled Period|Progressive Disease|1|||
148749856|NCT03142191|536554351|FG003|Placebo Controlled Period|Progressive Disease|0|||
148749857|NCT03142191|536554352|FG004|Placebo Controlled Period|Progressive Disease|0|||
148749858|NCT03142191|536554348|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
148749859|NCT03142191|536554349|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
148749860|NCT03142191|536554350|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
148749861|NCT03142191|536554351|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
148749862|NCT03142191|536554352|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
148749863|NCT03142191|536554348|FG000|Placebo Controlled Period|Other Reasons|1|||
148749864|NCT03142191|536554349|FG001|Placebo Controlled Period|Other Reasons|0|||
148749865|NCT03142191|536554350|FG002|Placebo Controlled Period|Other Reasons|0|||
148749866|NCT03142191|536554351|FG003|Placebo Controlled Period|Other Reasons|0|||
148749867|NCT03142191|536554352|FG004|Placebo Controlled Period|Other Reasons|0|||
148749868|NCT03142191|536554348|FG000|Active Treatment Extension Period|Death|2|||
148749869|NCT03142191|536554349|FG001|Active Treatment Extension Period|Death|1|||
148749870|NCT03142191|536554350|FG002|Active Treatment Extension Period|Death|1|||
148749871|NCT03142191|536554351|FG003|Active Treatment Extension Period|Death|1|||
148749872|NCT03142191|536554352|FG004|Active Treatment Extension Period|Death|0|||
148749873|NCT03142191|536554348|FG000|Active Treatment Extension Period|Adverse Event|6|||
148749874|NCT03142191|536554349|FG001|Active Treatment Extension Period|Adverse Event|5|||
148749875|NCT03142191|536554350|FG002|Active Treatment Extension Period|Adverse Event|4|||
148749876|NCT03142191|536554351|FG003|Active Treatment Extension Period|Adverse Event|1|||
148749877|NCT03142191|536554352|FG004|Active Treatment Extension Period|Adverse Event|0|||
149027266|NCT02333630|537578533|FG000|Overall Study|Lost to Follow-up|5|||
148749878|NCT03142191|536554348|FG000|Active Treatment Extension Period|Progressive Disease|10|||
148749879|NCT03142191|536554349|FG001|Active Treatment Extension Period|Progressive Disease|5|||
148749880|NCT03142191|536554350|FG002|Active Treatment Extension Period|Progressive Disease|4|||
148749881|NCT03142191|536554351|FG003|Active Treatment Extension Period|Progressive Disease|1|||
148749882|NCT03142191|536554352|FG004|Active Treatment Extension Period|Progressive Disease|2|||
148749883|NCT03142191|536554348|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
148749884|NCT03142191|536554349|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
148749885|NCT03142191|536554350|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
148749886|NCT03142191|536554351|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
148749887|NCT03142191|536554352|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
148749888|NCT03142191|536554348|FG000|Active Treatment Extension Period|Physician Decision|2|||
148749889|NCT03142191|536554349|FG001|Active Treatment Extension Period|Physician Decision|0|||
148749890|NCT03142191|536554350|FG002|Active Treatment Extension Period|Physician Decision|0|||
148821942|NCT00098293|536826670|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
148749891|NCT03142191|536554351|FG003|Active Treatment Extension Period|Physician Decision|0|||
148749892|NCT03142191|536554352|FG004|Active Treatment Extension Period|Physician Decision|0|||
148749893|NCT03142191|536554348|FG000|Active Treatment Extension Period|Other Reasons|3|||
148749894|NCT03142191|536554349|FG001|Active Treatment Extension Period|Other Reasons|3|||
148749895|NCT03142191|536554350|FG002|Active Treatment Extension Period|Other Reasons|3|||
148749896|NCT03142191|536554351|FG003|Active Treatment Extension Period|Other Reasons|8|||
148749897|NCT03142191|536554352|FG004|Active Treatment Extension Period|Other Reasons|3|||
148749898|NCT03142191|536554348|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
148749899|NCT03142191|536554349|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
148749900|NCT03142191|536554350|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
148749901|NCT03142191|536554351|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
148749902|NCT03142191|536554352|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
148749903|NCT01130493|536554357|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
148749904|NCT01130493|536554358|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
148749905|NCT01130493|536554359|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
148749906|NCT01130493|536554357|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
148749907|NCT01130493|536554358|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
148749908|NCT01130493|536554359|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
148749909|NCT01130493|536554357|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
148749910|NCT01130493|536554358|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
148749911|NCT01130493|536554359|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
148749912|NCT01130493|536554357|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
148749913|NCT01130493|536554358|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
148749914|NCT01130493|536554359|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
148749915|NCT01130493|536554357|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
148749916|NCT01130493|536554358|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
148749917|NCT01130493|536554359|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
148749918|NCT01130493|536554357|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
148749919|NCT01130493|536554358|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
148749920|NCT01130493|536554359|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
148749921|NCT01130493|536554357|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
148749922|NCT01130493|536554358|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
148749923|NCT01130493|536554359|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
148749924|NCT01130493|536554357|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
148749925|NCT01130493|536554358|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
148749926|NCT01130493|536554359|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
148749927|NCT01130493|536554357|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
148749928|NCT01130493|536554358|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
148749929|NCT01130493|536554359|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
148749930|NCT01130493|536554357|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
148749931|NCT01130493|536554358|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
148749932|NCT01130493|536554359|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
148749933|NCT01130493|536554357|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
148749934|NCT01130493|536554358|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
148749935|NCT01130493|536554359|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
148749936|NCT01130493|536554357|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
148749937|NCT01130493|536554358|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
148749938|NCT01130493|536554359|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
148749939|NCT01130493|536554357|FG000|Part 2: OLE|Adverse Event|0|||
148749940|NCT01130493|536554358|FG001|Part 2: OLE|Adverse Event|2|||
148749941|NCT01130493|536554359|FG002|Part 2: OLE|Adverse Event|1|||
148749942|NCT01130493|536554357|FG000|Part 2: OLE|Withdrawal by Subject|0|||
148749943|NCT01130493|536554358|FG001|Part 2: OLE|Withdrawal by Subject|1|||
148749944|NCT01130493|536554359|FG002|Part 2: OLE|Withdrawal by Subject|4|||
148749945|NCT00879086|536554362|FG000|Overall Study|Adverse Event|3|||
148749946|NCT00879086|536554363|FG001|Overall Study|Adverse Event|15|||
148749947|NCT00879086|536554362|FG000|Overall Study|Participant choice|2|||
148749948|NCT00879086|536554363|FG001|Overall Study|Participant choice|2|||
148749949|NCT00879086|536554362|FG000|Overall Study|Progression of disease|40|||
148749950|NCT00879086|536554363|FG001|Overall Study|Progression of disease|26|||
148749951|NCT00879086|536554362|FG000|Overall Study|Withdrawal of consent|2|||
148749952|NCT00879086|536554363|FG001|Overall Study|Withdrawal of consent|1|||
149027267|NCT02333630|537578534|FG001|Overall Study|Lost to Follow-up|2|||
148749953|NCT00879086|536554362|FG000|Overall Study|Other|4|||
148749954|NCT00879086|536554363|FG001|Overall Study|Other|6|||
148749955|NCT00879086|536554362|FG000|Overall Study|Death|1|||
148749956|NCT00879086|536554363|FG001|Overall Study|Death|2|||
148749957|NCT02969044|536554364|FG000|Overall Study|Withdrawal by Subject|2|||
148749958|NCT02969044|536554365|FG001|Overall Study|Withdrawal by Subject|6|||
148749959|NCT02969044|536554364|FG000|Overall Study|Adverse Event|3|||
148749960|NCT02969044|536554365|FG001|Overall Study|Adverse Event|0|||
148749961|NCT04728802|536554366|FG000|Overall Study|Withdrawal by Subject|4|||
148749962|NCT04728802|536554367|FG001|Overall Study|Withdrawal by Subject|20|||
148749963|NCT04728802|536554366|FG000|Overall Study|Physician Decision|7|||
148749964|NCT04728802|536554367|FG001|Overall Study|Physician Decision|7|||
148749965|NCT04728802|536554366|FG000|Overall Study|Protocol Violation|10|||
148749966|NCT04728802|536554367|FG001|Overall Study|Protocol Violation|4|||
148749967|NCT04728802|536554366|FG000|Overall Study|Transfer|1|||
148749968|NCT04728802|536554367|FG001|Overall Study|Transfer|0|||
148749969|NCT04728802|536554366|FG000|Overall Study|Death|4|||
148749970|NCT04728802|536554367|FG001|Overall Study|Death|5|||
148749971|NCT04728802|536554366|FG000|Overall Study|Other|3|||
148749972|NCT04728802|536554367|FG001|Overall Study|Other|0|||
148749973|NCT04650204|536554368|FG000|Overall Study|Study was Terminated|2|||
148749974|NCT04650204|536554369|FG001|Overall Study|Study was Terminated|1|||
148749975|NCT01330303|536554370|FG000|Period 1|Adverse Event|1|||
148749976|NCT01330303|536554371|FG001|Period 1|Adverse Event|0|||
148749977|NCT01330303|536554370|FG000|Period 1|Protocol Violation|0|||
148749978|NCT01330303|536554371|FG001|Period 1|Protocol Violation|1|||
148749979|NCT01330303|536554370|FG000|Period 1|Withdrawal by Subject|0|||
148749980|NCT01330303|536554371|FG001|Period 1|Withdrawal by Subject|1|||
148749981|NCT05221320|536556108|FG000|Overall Study|Lack of Efficacy|3|||
148749982|NCT05221320|536556109|FG001|Overall Study|Lack of Efficacy|7|||
148749983|NCT05221320|536556110|FG002|Overall Study|Lack of Efficacy|10|||
148749984|NCT05221320|536556111|FG003|Overall Study|Lack of Efficacy|1|||
148749985|NCT05221320|536556112|FG004|Overall Study|Lack of Efficacy|0|||
148749986|NCT05221320|536556113|FG005|Overall Study|Lack of Efficacy|0|||
148749987|NCT05221320|536556108|FG000|Overall Study|Physician Decision|1|||
148749988|NCT05221320|536556109|FG001|Overall Study|Physician Decision|0|||
148749989|NCT05221320|536556110|FG002|Overall Study|Physician Decision|3|||
148749990|NCT05221320|536556111|FG003|Overall Study|Physician Decision|1|||
148749991|NCT05221320|536556112|FG004|Overall Study|Physician Decision|0|||
148749992|NCT05221320|536556113|FG005|Overall Study|Physician Decision|0|||
148749993|NCT05221320|536556108|FG000|Overall Study|Withdrawal by Subject|0|||
148749994|NCT05221320|536556109|FG001|Overall Study|Withdrawal by Subject|3|||
148749995|NCT05221320|536556110|FG002|Overall Study|Withdrawal by Subject|1|||
148749996|NCT05221320|536556111|FG003|Overall Study|Withdrawal by Subject|0|||
148749997|NCT05221320|536556112|FG004|Overall Study|Withdrawal by Subject|0|||
148749998|NCT05221320|536556113|FG005|Overall Study|Withdrawal by Subject|0|||
148749999|NCT05221320|536556108|FG000|Overall Study|Death|0|||
148750000|NCT05221320|536556109|FG001|Overall Study|Death|5|||
148750001|NCT05221320|536556110|FG002|Overall Study|Death|6|||
148750002|NCT05221320|536556111|FG003|Overall Study|Death|0|||
148750003|NCT05221320|536556112|FG004|Overall Study|Death|1|||
148750004|NCT05221320|536556113|FG005|Overall Study|Death|0|||
148750005|NCT06473519|536556114|FG000|Overall Study|Lost to Follow-up|2|||
148750006|NCT06473519|536556115|FG001|Overall Study|Lost to Follow-up|5|||
148750007|NCT06473519|536556114|FG000|Overall Study|Withdrawal by Subject|1|||
148750008|NCT06473519|536556115|FG001|Overall Study|Withdrawal by Subject|4|||
148750009|NCT06473519|536556114|FG000|Overall Study|Randomized but not vaccinated|1|||
148750010|NCT06473519|536556115|FG001|Overall Study|Randomized but not vaccinated|2|||
148750011|NCT02514447|536556119|FG000|Overall Study|Withdrawal by Subject|3|||
148750012|NCT02514447|536556120|FG001|Overall Study|Withdrawal by Subject|1|||
148750013|NCT02514447|536556121|FG002|Overall Study|Withdrawal by Subject|1|||
148750014|NCT02514447|536556122|FG003|Overall Study|Withdrawal by Subject|0|||
148750015|NCT02514447|536556123|FG004|Overall Study|Withdrawal by Subject|0|||
148750016|NCT02514447|536556124|FG005|Overall Study|Withdrawal by Subject|0|||
148750017|NCT02514447|536556125|FG006|Overall Study|Withdrawal by Subject|0|||
148750018|NCT02514447|536556126|FG007|Overall Study|Withdrawal by Subject|1|||
148750019|NCT02514447|536556127|FG008|Overall Study|Withdrawal by Subject|1|||
148750020|NCT02514447|536556119|FG000|Overall Study|Death|24|||
148750021|NCT02514447|536556120|FG001|Overall Study|Death|28|||
148750022|NCT02514447|536556121|FG002|Overall Study|Death|29|||
148750023|NCT02514447|536556122|FG003|Overall Study|Death|0|||
148750024|NCT02514447|536556123|FG004|Overall Study|Death|3|||
148750025|NCT02514447|536556124|FG005|Overall Study|Death|4|||
148750026|NCT02514447|536556125|FG006|Overall Study|Death|8|||
148750027|NCT02514447|536556126|FG007|Overall Study|Death|6|||
148750028|NCT02514447|536556127|FG008|Overall Study|Death|5|||
148750029|NCT02514447|536556119|FG000|Overall Study|Lost to Follow-up|1|||
148750030|NCT02514447|536556120|FG001|Overall Study|Lost to Follow-up|0|||
148750031|NCT02514447|536556121|FG002|Overall Study|Lost to Follow-up|0|||
148750032|NCT02514447|536556122|FG003|Overall Study|Lost to Follow-up|0|||
148750033|NCT02514447|536556123|FG004|Overall Study|Lost to Follow-up|0|||
148750034|NCT02514447|536556124|FG005|Overall Study|Lost to Follow-up|0|||
148750035|NCT02514447|536556125|FG006|Overall Study|Lost to Follow-up|0|||
148750036|NCT02514447|536556126|FG007|Overall Study|Lost to Follow-up|0|||
148750037|NCT02514447|536556127|FG008|Overall Study|Lost to Follow-up|1|||
148750038|NCT02514447|536556119|FG000|Overall Study|Sponsor Termination of Study|0|||
148750039|NCT02514447|536556120|FG001|Overall Study|Sponsor Termination of Study|1|||
148750040|NCT02514447|536556121|FG002|Overall Study|Sponsor Termination of Study|1|||
148750041|NCT02514447|536556122|FG003|Overall Study|Sponsor Termination of Study|0|||
148750042|NCT02514447|536556123|FG004|Overall Study|Sponsor Termination of Study|0|||
148750043|NCT02514447|536556124|FG005|Overall Study|Sponsor Termination of Study|0|||
148750044|NCT02514447|536556125|FG006|Overall Study|Sponsor Termination of Study|0|||
148750045|NCT02514447|536556126|FG007|Overall Study|Sponsor Termination of Study|0|||
148750046|NCT02514447|536556127|FG008|Overall Study|Sponsor Termination of Study|0|||
148750047|NCT02514447|536556119|FG000|Overall Study|Study completion per Investigator|1|||
148750048|NCT02514447|536556120|FG001|Overall Study|Study completion per Investigator|0|||
148750049|NCT02514447|536556121|FG002|Overall Study|Study completion per Investigator|1|||
148750050|NCT02514447|536556122|FG003|Overall Study|Study completion per Investigator|2|||
148750051|NCT02514447|536556123|FG004|Overall Study|Study completion per Investigator|0|||
148750052|NCT02514447|536556124|FG005|Overall Study|Study completion per Investigator|0|||
148750053|NCT02514447|536556125|FG006|Overall Study|Study completion per Investigator|0|||
148750054|NCT02514447|536556126|FG007|Overall Study|Study completion per Investigator|0|||
148750055|NCT02514447|536556127|FG008|Overall Study|Study completion per Investigator|1|||
148750056|NCT03560037|536556130|FG000|Overall Study|Protocol Violation|1|||
148750057|NCT03560037|536556131|FG001|Overall Study|Protocol Violation|0|||
148750058|NCT03560037|536556130|FG000|Overall Study|Physician Decision|0|||
148750059|NCT03560037|536556131|FG001|Overall Study|Physician Decision|1|||
149027268|NCT00984282|537578535|FG000|Double Blind Treatment|Adverse Event|40|||
149027269|NCT00984282|537578536|FG001|Double Blind Treatment|Adverse Event|6|||
149027270|NCT00984282|537578535|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
149027271|NCT00984282|537578536|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
149027272|NCT00984282|537578535|FG000|Double Blind Treatment|Physician Decision|1|||
149027273|NCT00984282|537578536|FG001|Double Blind Treatment|Physician Decision|2|||
149027274|NCT00984282|537578535|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
149027275|NCT00984282|537578536|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
149027276|NCT00984282|537578535|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
149027277|NCT00984282|537578536|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
149027278|NCT00984282|537578535|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
149027279|NCT00984282|537578536|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
149027280|NCT00984282|537578535|FG000|Double Blind Treatment|Lost to Follow-up|3|||
148750060|NCT03620708|536556132|FG000|Overall Study|Lost to Follow-up|1|||
148750061|NCT03620708|536556133|FG001|Overall Study|Lost to Follow-up|1|||
148750062|NCT03620708|536556134|FG002|Overall Study|Lost to Follow-up|2|||
148750063|NCT03620708|536556132|FG000|Overall Study|Withdrawal by Subject|0|||
148750064|NCT03620708|536556133|FG001|Overall Study|Withdrawal by Subject|0|||
148750065|NCT03620708|536556134|FG002|Overall Study|Withdrawal by Subject|1|||
148750066|NCT05168202|536556135|FG000|Overall Study|Progressive Disease|4|||
148750067|NCT05168202|536556136|FG001|Overall Study|Progressive Disease|4|||
148750068|NCT05168202|536556137|FG002|Overall Study|Progressive Disease|2|||
148750069|NCT05168202|536556138|FG003|Overall Study|Progressive Disease|3|||
148750070|NCT05168202|536556139|FG004|Overall Study|Progressive Disease|2|||
148750071|NCT05168202|536556140|FG005|Overall Study|Progressive Disease|3|||
148750072|NCT05168202|536556141|FG006|Overall Study|Progressive Disease|2|||
148750073|NCT05168202|536556135|FG000|Overall Study|Adverse Event|2|||
148750074|NCT05168202|536556136|FG001|Overall Study|Adverse Event|1|||
148750075|NCT05168202|536556137|FG002|Overall Study|Adverse Event|4|||
148750076|NCT05168202|536556138|FG003|Overall Study|Adverse Event|4|||
148750077|NCT05168202|536556139|FG004|Overall Study|Adverse Event|3|||
148750078|NCT05168202|536556140|FG005|Overall Study|Adverse Event|2|||
148750079|NCT05168202|536556141|FG006|Overall Study|Adverse Event|0|||
148750080|NCT05168202|536556135|FG000|Overall Study|Lack of Efficacy|0|||
149027281|NCT00984282|537578536|FG001|Double Blind Treatment|Lost to Follow-up|0|||
149027282|NCT00984282|537578535|FG000|Double Blind Treatment|Death|8|||
149027283|NCT00984282|537578536|FG001|Double Blind Treatment|Death|4|||
149027284|NCT00984282|537578535|FG000|Double Blind Treatment|Not treated|0|||
149027285|NCT00984282|537578536|FG001|Double Blind Treatment|Not treated|1|||
149027286|NCT00984282|537578535|FG000|Double Blind Treatment|Switched to commercial drug|6|||
148750081|NCT05168202|536556136|FG001|Overall Study|Lack of Efficacy|1|||
148750082|NCT05168202|536556137|FG002|Overall Study|Lack of Efficacy|1|||
148750083|NCT05168202|536556138|FG003|Overall Study|Lack of Efficacy|0|||
148750084|NCT05168202|536556139|FG004|Overall Study|Lack of Efficacy|1|||
148750085|NCT05168202|536556140|FG005|Overall Study|Lack of Efficacy|2|||
148750086|NCT05168202|536556141|FG006|Overall Study|Lack of Efficacy|2|||
148750087|NCT05168202|536556135|FG000|Overall Study|Withdrawal by Subject|0|||
148750088|NCT05168202|536556136|FG001|Overall Study|Withdrawal by Subject|0|||
148750089|NCT05168202|536556137|FG002|Overall Study|Withdrawal by Subject|1|||
148750090|NCT05168202|536556138|FG003|Overall Study|Withdrawal by Subject|1|||
148750091|NCT05168202|536556139|FG004|Overall Study|Withdrawal by Subject|1|||
148750092|NCT05168202|536556140|FG005|Overall Study|Withdrawal by Subject|1|||
148750093|NCT05168202|536556141|FG006|Overall Study|Withdrawal by Subject|0|||
148750094|NCT05168202|536556135|FG000|Overall Study|Disease Relapse|0|||
148750095|NCT05168202|536556136|FG001|Overall Study|Disease Relapse|1|||
148750096|NCT05168202|536556137|FG002|Overall Study|Disease Relapse|0|||
148750097|NCT05168202|536556138|FG003|Overall Study|Disease Relapse|1|||
148750098|NCT05168202|536556139|FG004|Overall Study|Disease Relapse|1|||
148750099|NCT05168202|536556140|FG005|Overall Study|Disease Relapse|0|||
148750100|NCT05168202|536556141|FG006|Overall Study|Disease Relapse|0|||
148750101|NCT05168202|536556135|FG000|Overall Study|Other Reasons|0|||
148750102|NCT05168202|536556136|FG001|Overall Study|Other Reasons|0|||
148750103|NCT05168202|536556137|FG002|Overall Study|Other Reasons|0|||
148750104|NCT05168202|536556138|FG003|Overall Study|Other Reasons|0|||
148750105|NCT05168202|536556139|FG004|Overall Study|Other Reasons|0|||
148750106|NCT05168202|536556140|FG005|Overall Study|Other Reasons|2|||
148750107|NCT05168202|536556141|FG006|Overall Study|Other Reasons|1|||
148750108|NCT05168202|536556135|FG000|Overall Study|Physician Decision|0|||
148750109|NCT05168202|536556136|FG001|Overall Study|Physician Decision|1|||
148750110|NCT05168202|536556137|FG002|Overall Study|Physician Decision|1|||
148750111|NCT05168202|536556138|FG003|Overall Study|Physician Decision|0|||
148750112|NCT05168202|536556139|FG004|Overall Study|Physician Decision|0|||
148750113|NCT05168202|536556140|FG005|Overall Study|Physician Decision|0|||
148750114|NCT05168202|536556141|FG006|Overall Study|Physician Decision|0|||
148750115|NCT05168202|536556135|FG000|Overall Study|Study Terminated by Sponsor|0|||
148750116|NCT05168202|536556136|FG001|Overall Study|Study Terminated by Sponsor|0|||
148750117|NCT05168202|536556137|FG002|Overall Study|Study Terminated by Sponsor|0|||
148750118|NCT05168202|536556138|FG003|Overall Study|Study Terminated by Sponsor|1|||
148750119|NCT05168202|536556139|FG004|Overall Study|Study Terminated by Sponsor|0|||
148750120|NCT05168202|536556140|FG005|Overall Study|Study Terminated by Sponsor|0|||
148750121|NCT05168202|536556141|FG006|Overall Study|Study Terminated by Sponsor|0|||
148750122|NCT04011722|536556145|FG000|30 Days|Death|5|||
148750123|NCT04011722|536556146|FG001|30 Days|Death|1|||
148750124|NCT04011722|536556145|FG000|1 Year|Death|13|||
148750125|NCT04011722|536556146|FG001|1 Year|Death|5|||
148750126|NCT04011722|536556145|FG000|1 Year|Withdrawal by Subject|8|||
148750127|NCT04011722|536556146|FG001|1 Year|Withdrawal by Subject|2|||
148750128|NCT04011722|536556145|FG000|1 Year|Missed Visit|6|||
148750129|NCT04011722|536556146|FG001|1 Year|Missed Visit|1|||
148750130|NCT04011722|536556145|FG000|1 Year|Pending Visit|0|||
148750131|NCT04011722|536556146|FG001|1 Year|Pending Visit|11|||
148750132|NCT04011722|536556145|FG000|1 Year|Not Yet Due|0|||
148750133|NCT04011722|536556146|FG001|1 Year|Not Yet Due|9|||
148750134|NCT04011722|536556145|FG000|2 Year|Death|16|||
148750135|NCT04011722|536556146|FG001|2 Year|Death|1|||
148750136|NCT04011722|536556145|FG000|2 Year|Withdrawal by Subject|10|||
148750137|NCT04011722|536556146|FG001|2 Year|Withdrawal by Subject|1|||
148750138|NCT04011722|536556145|FG000|2 Year|Missed Visit|9|||
148750139|NCT04011722|536556146|FG001|2 Year|Missed Visit|0|||
148750140|NCT04011722|536556145|FG000|2 Year|Visit Pending|1|||
148750141|NCT04011722|536556146|FG001|2 Year|Visit Pending|3|||
148750142|NCT04011722|536556145|FG000|2 Year|Not Yet Due|43|||
148750143|NCT04011722|536556146|FG001|2 Year|Not Yet Due|54|||
148750144|NCT04011722|536556145|FG000|3 Year|Death|10|||
148750145|NCT04011722|536556146|FG001|3 Year|Death|0|||
148750146|NCT04011722|536556145|FG000|3 Year|Withdrawal by Subject|2|||
148750147|NCT04011722|536556146|FG001|3 Year|Withdrawal by Subject|0|||
148750148|NCT04011722|536556145|FG000|3 Year|Missed Visit|2|||
148750149|NCT04011722|536556146|FG001|3 Year|Missed Visit|0|||
148821943|NCT00098293|536826671|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
148821944|NCT00098293|536826667|FG000|Open-label (OL) Phase|Death|0|||
148821945|NCT00098293|536826668|FG001|Open-label (OL) Phase|Death|2|||
148750150|NCT04011722|536556145|FG000|3 Year|Pending Visit|34|||
148750151|NCT04011722|536556146|FG001|3 Year|Pending Visit|0|||
148750152|NCT04011722|536556145|FG000|3 Year|Not Yet Due|99|||
148750153|NCT04011722|536556146|FG001|3 Year|Not Yet Due|0|||
148750154|NCT00077207|536556147|FG000|Overall Study|Adverse Event|5|||
148750155|NCT00077207|536556147|FG000|Overall Study|Lack of Efficacy|12|||
148750156|NCT00077207|536556147|FG000|Overall Study|Physician Decision|6|||
148750157|NCT00077207|536556147|FG000|Overall Study|Withdrawal by Subject|6|||
148821946|NCT00098293|536826669|FG002|Open-label (OL) Phase|Death|3|||
148976191|NCT00079274|537394483|FG000|Overall Study|Adverse Event|130|||
148976192|NCT00079274|537394484|FG001|Overall Study|Adverse Event|8|||
148976193|NCT00079274|537394485|FG002|Overall Study|Adverse Event|8|||
148976194|NCT00079274|537394486|FG003|Overall Study|Adverse Event|184|||
148750158|NCT00077207|536556147|FG000|Overall Study|Ineligible|1|||
148750159|NCT03052751|536556149|FG000|Dosing Period 1|Adverse Event|0|||
148750160|NCT03052751|536556150|FG001|Dosing Period 1|Adverse Event|1|||
148750161|NCT03052751|536556151|FG002|Dosing Period 1|Adverse Event|0|||
148750162|NCT03052751|536556152|FG003|Dosing Period 1|Adverse Event|0|||
148750163|NCT03052751|536556153|FG004|Dosing Period 1|Adverse Event|0|||
148750164|NCT03052751|536556154|FG005|Dosing Period 1|Adverse Event|0|||
148750165|NCT03052751|536556149|FG000|Dosing Period 2|Adverse Event|0|||
148750166|NCT03052751|536556150|FG001|Dosing Period 2|Adverse Event|0|||
148750167|NCT03052751|536556151|FG002|Dosing Period 2|Adverse Event|3|||
148750168|NCT03052751|536556152|FG003|Dosing Period 2|Adverse Event|0|||
148750169|NCT03052751|536556153|FG004|Dosing Period 2|Adverse Event|0|||
148821947|NCT00098293|536826670|FG003|Open-label (OL) Phase|Death|0|||
148750170|NCT03052751|536556154|FG005|Dosing Period 2|Adverse Event|0|||
148750171|NCT03052751|536556149|FG000|Observation Period|Adverse Event|0|||
148750172|NCT03052751|536556150|FG001|Observation Period|Adverse Event|0|||
148750173|NCT03052751|536556151|FG002|Observation Period|Adverse Event|0|||
148750174|NCT03052751|536556152|FG003|Observation Period|Adverse Event|0|||
148750175|NCT03052751|536556153|FG004|Observation Period|Adverse Event|1|||
148750176|NCT03052751|536556154|FG005|Observation Period|Adverse Event|0|||
148750177|NCT01973439|536556155|FG000|Overall Study|Lost samples from one PK Day|2|||
148750178|NCT01973439|536556155|FG000|Overall Study|Vomiting after commencing once daily|1|||
148750179|NCT01973439|536556155|FG000|Overall Study|PK curve incomplete|2|||
148750180|NCT02232984|536556156|FG000|Overall Study|Withdrawal by Subject|5|||
148750181|NCT02232984|536556156|FG000|Overall Study|Death|1|||
148750182|NCT02232984|536556156|FG000|Overall Study|Investigator withdrawal|10|||
148750183|NCT02232984|536556156|FG000|Overall Study|Device implant unsuccessful|53|||
148750184|NCT02232984|536556156|FG000|Overall Study|not disclosed by site|7|||
148750185|NCT02232984|536556156|FG000|Overall Study|Protocol Violation|1|||
148750186|NCT00769379|536556157|FG000|Overall Study|No follow up data mapped to Other.|3|||
148750187|NCT00769379|536556158|FG001|Overall Study|No follow up data mapped to Other.|13|||
148750188|NCT02673775|536556159|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
148750189|NCT02673775|536556160|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
148750190|NCT02673775|536556159|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
148750191|NCT02673775|536556160|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
148750192|NCT02673775|536556159|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
148750193|NCT02673775|536556160|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
148750194|NCT02673775|536556159|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
148750195|NCT02673775|536556160|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
148750196|NCT00535405|536556161|FG000|Overall Study|Adverse Event|6|||
148750197|NCT00535405|536556162|FG001|Overall Study|Adverse Event|8|||
148750198|NCT00535405|536556163|FG002|Overall Study|Adverse Event|3|||
148750199|NCT00535405|536556164|FG003|Overall Study|Adverse Event|8|||
148750200|NCT00535405|536556165|FG004|Overall Study|Adverse Event|6|||
148750201|NCT00535405|536556161|FG000|Overall Study|Lost to Follow-up|1|||
148750202|NCT00535405|536556162|FG001|Overall Study|Lost to Follow-up|3|||
148750203|NCT00535405|536556163|FG002|Overall Study|Lost to Follow-up|3|||
148750204|NCT00535405|536556164|FG003|Overall Study|Lost to Follow-up|2|||
148750205|NCT00535405|536556165|FG004|Overall Study|Lost to Follow-up|1|||
148750206|NCT00535405|536556161|FG000|Overall Study|Physician Decision|3|||
148750207|NCT00535405|536556162|FG001|Overall Study|Physician Decision|2|||
148750208|NCT00535405|536556163|FG002|Overall Study|Physician Decision|0|||
148750209|NCT00535405|536556164|FG003|Overall Study|Physician Decision|1|||
148750210|NCT00535405|536556165|FG004|Overall Study|Physician Decision|1|||
148750211|NCT00535405|536556161|FG000|Overall Study|Protocol Violation|2|||
148750212|NCT00535405|536556162|FG001|Overall Study|Protocol Violation|2|||
148750213|NCT00535405|536556163|FG002|Overall Study|Protocol Violation|2|||
148750214|NCT00535405|536556164|FG003|Overall Study|Protocol Violation|1|||
148750215|NCT00535405|536556165|FG004|Overall Study|Protocol Violation|0|||
148750216|NCT00535405|536556161|FG000|Overall Study|Withdrawal by Subject|5|||
148750217|NCT00535405|536556162|FG001|Overall Study|Withdrawal by Subject|11|||
148750218|NCT00535405|536556163|FG002|Overall Study|Withdrawal by Subject|10|||
148750219|NCT00535405|536556164|FG003|Overall Study|Withdrawal by Subject|10|||
148750220|NCT00535405|536556165|FG004|Overall Study|Withdrawal by Subject|8|||
148750221|NCT03519087|536556166|FG000|Clinic Evaluation|Physician Decision|15|||
148750222|NCT03519087|536556167|FG001|Clinic Evaluation|Physician Decision|18|||
148750223|NCT03519087|536556168|FG002|Clinic Evaluation|Physician Decision|0|||
148750224|NCT03519087|536556169|FG003|Clinic Evaluation|Physician Decision|0|||
148750225|NCT03519087|536556170|FG004|Clinic Evaluation|Physician Decision|0|||
148750226|NCT03519087|536556166|FG000|Clinic Evaluation|Protocol Violation|1|||
148750227|NCT03519087|536556167|FG001|Clinic Evaluation|Protocol Violation|0|||
148750228|NCT03519087|536556168|FG002|Clinic Evaluation|Protocol Violation|0|||
148750229|NCT03519087|536556169|FG003|Clinic Evaluation|Protocol Violation|0|||
148750230|NCT03519087|536556170|FG004|Clinic Evaluation|Protocol Violation|0|||
148750231|NCT03519087|536556166|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
148750232|NCT03519087|536556167|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
148750233|NCT03519087|536556168|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
148750234|NCT03519087|536556169|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
148750235|NCT03519087|536556170|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
148750236|NCT03519087|536556166|FG000|Re-randomization for Treatment|Not appropriate|2|||
148750237|NCT03519087|536556167|FG001|Re-randomization for Treatment|Not appropriate|3|||
148750238|NCT03519087|536556168|FG002|Re-randomization for Treatment|Not appropriate|0|||
148750239|NCT03519087|536556169|FG003|Re-randomization for Treatment|Not appropriate|0|||
148750240|NCT03519087|536556170|FG004|Re-randomization for Treatment|Not appropriate|0|||
148750241|NCT03519087|536556166|FG000|Laboratory Testing|Lost to Follow-up|0|||
148821948|NCT00098293|536826671|FG004|Open-label (OL) Phase|Death|0|||
148750242|NCT03519087|536556167|FG001|Laboratory Testing|Lost to Follow-up|0|||
148821949|NCT00098293|536826667|FG000|Supplemental Phase (SP)|Death|0|||
148750243|NCT03519087|536556168|FG002|Laboratory Testing|Lost to Follow-up|2|||
148750244|NCT03519087|536556169|FG003|Laboratory Testing|Lost to Follow-up|3|||
148750245|NCT03519087|536556170|FG004|Laboratory Testing|Lost to Follow-up|6|||
148750246|NCT03519087|536556166|FG000|Laboratory Testing|Protocol Violation|0|||
148750247|NCT03519087|536556167|FG001|Laboratory Testing|Protocol Violation|0|||
148750248|NCT03519087|536556168|FG002|Laboratory Testing|Protocol Violation|0|||
148750249|NCT03519087|536556169|FG003|Laboratory Testing|Protocol Violation|1|||
148750250|NCT03519087|536556170|FG004|Laboratory Testing|Protocol Violation|0|||
148750251|NCT03076775|536556171|FG000|Overall Study|Lost to Follow-up|1|||
148750252|NCT03076775|536556172|FG001|Overall Study|Lost to Follow-up|0|||
148750253|NCT00104572|536556173|FG000|Overall Study|Withdrawal by Subject|3|||
148750254|NCT00104572|536556174|FG001|Overall Study|Withdrawal by Subject|3|||
148750255|NCT00104572|536556175|FG002|Overall Study|Withdrawal by Subject|0|||
148750256|NCT02290405|536556176|FG000|Overall Study|Withdrawal by Subject|1|||
148750257|NCT02290405|536556177|FG001|Overall Study|Withdrawal by Subject|0|||
148750258|NCT02016183|536556178|FG000|Overall Study|Case Report Forms Uncollected|13|||
148750259|NCT02016183|536556178|FG000|Overall Study|Protocol Violation|52|||
148750260|NCT00770328|536556190|FG000|Overall Study|Adverse Event|11|||
148750261|NCT00770328|536556191|FG001|Overall Study|Adverse Event|2|||
148750262|NCT00770328|536556190|FG000|Overall Study|Lost to Follow-up|2|||
148750263|NCT00770328|536556191|FG001|Overall Study|Lost to Follow-up|2|||
148750264|NCT03164616|536556196|FG000|Overall Study|Death|250|||
148750265|NCT03164616|536556197|FG001|Overall Study|Death|264|||
148750266|NCT03164616|536556198|FG002|Overall Study|Death|279|||
148750267|NCT03164616|536556196|FG000|Overall Study|Lost to Follow-up|2|||
148750268|NCT03164616|536556197|FG001|Overall Study|Lost to Follow-up|2|||
148750269|NCT03164616|536556198|FG002|Overall Study|Lost to Follow-up|2|||
148750270|NCT03164616|536556196|FG000|Overall Study|Withdrawal by Subject|6|||
148750271|NCT03164616|536556197|FG001|Overall Study|Withdrawal by Subject|7|||
148750272|NCT03164616|536556198|FG002|Overall Study|Withdrawal by Subject|16|||
148750273|NCT02123446|536556199|FG000|Washout Period (1 Day)|Physician Decision|1|||
148750274|NCT02123446|536556200|FG001|Washout Period (1 Day)|Physician Decision|0|||
148750275|NCT04388553|536556201|FG000|Overall Study|Protocol Violation|1|||
148750276|NCT04388553|536556202|FG001|Overall Study|Protocol Violation|0|||
148750277|NCT04604795|536556203|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
148750278|NCT04604795|536556204|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
148750279|NCT04604795|536556205|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750280|NCT04604795|536556206|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750281|NCT04604795|536556207|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750282|NCT04604795|536556208|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750283|NCT04604795|536556209|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750284|NCT04604795|536556210|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750285|NCT04604795|536556211|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750286|NCT04604795|536556212|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
148750287|NCT04604795|536556203|FG000|Part B: Up to Day 14|Adverse Event|0|||
148750288|NCT04604795|536556204|FG001|Part B: Up to Day 14|Adverse Event|0|||
148750289|NCT04604795|536556205|FG002|Part B: Up to Day 14|Adverse Event|0|||
148750290|NCT04604795|536556206|FG003|Part B: Up to Day 14|Adverse Event|0|||
148750291|NCT04604795|536556207|FG004|Part B: Up to Day 14|Adverse Event|2|||
148750292|NCT04604795|536556208|FG005|Part B: Up to Day 14|Adverse Event|1|||
148750293|NCT04604795|536556209|FG006|Part B: Up to Day 14|Adverse Event|0|||
148750294|NCT04604795|536556210|FG007|Part B: Up to Day 14|Adverse Event|0|||
148750295|NCT04604795|536556211|FG008|Part B: Up to Day 14|Adverse Event|0|||
148750296|NCT04604795|536556212|FG009|Part B: Up to Day 14|Adverse Event|0|||
148750297|NCT04604795|536556203|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750298|NCT04604795|536556204|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750299|NCT04604795|536556205|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750300|NCT04604795|536556206|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750301|NCT04604795|536556207|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750302|NCT04604795|536556208|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750303|NCT04604795|536556209|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750304|NCT04604795|536556210|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
149027287|NCT00984282|537578536|FG001|Double Blind Treatment|Switched to commercial drug|1|||
148750305|NCT04604795|536556211|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
148750306|NCT04604795|536556212|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
148750307|NCT04604795|536556203|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750308|NCT04604795|536556204|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750309|NCT04604795|536556205|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750310|NCT04604795|536556206|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750311|NCT04604795|536556207|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750312|NCT04604795|536556208|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750313|NCT04604795|536556209|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750314|NCT04604795|536556210|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750315|NCT04604795|536556211|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
148750316|NCT04604795|536556212|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
148750317|NCT04604795|536556203|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750318|NCT04604795|536556204|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750319|NCT04604795|536556205|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750320|NCT04604795|536556206|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750321|NCT04604795|536556207|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750322|NCT04604795|536556208|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148976195|NCT00079274|537394487|FG004|Overall Study|Adverse Event|7|||
148976196|NCT00079274|537394488|FG005|Overall Study|Adverse Event|8|||
148750323|NCT04604795|536556209|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750324|NCT04604795|536556210|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750325|NCT04604795|536556211|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
148750326|NCT04604795|536556212|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
148750327|NCT04604795|536556203|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750328|NCT04604795|536556204|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750329|NCT04604795|536556205|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750330|NCT04604795|536556206|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750331|NCT04604795|536556207|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750332|NCT04604795|536556208|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750333|NCT04604795|536556209|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750334|NCT04604795|536556210|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750335|NCT04604795|536556211|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
148750336|NCT04604795|536556212|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
148750337|NCT01957176|536556217|FG000|Overall Study|Adverse Event|2|||
148750338|NCT01957176|536556218|FG001|Overall Study|Adverse Event|0|||
148750339|NCT01957176|536556217|FG000|Overall Study|Physician Decision|2|||
148750340|NCT01957176|536556218|FG001|Overall Study|Physician Decision|1|||
148750341|NCT01957176|536556217|FG000|Overall Study|Withdrawal by Subject|1|||
148750342|NCT01957176|536556218|FG001|Overall Study|Withdrawal by Subject|0|||
148750343|NCT02517463|536556219|FG000|Overall Study|Lost to Follow-up|5|||
148750344|NCT02517463|536556220|FG001|Overall Study|Lost to Follow-up|2|||
148750345|NCT03180645|536556221|FG000|Overall Study|Adverse Event|0|||
148750346|NCT03180645|536556222|FG001|Overall Study|Adverse Event|1|||
148750347|NCT03180645|536556223|FG002|Overall Study|Adverse Event|2|||
148750348|NCT01512160|536556224|FG000|Overall Study|Lost to Follow-up|1|||
148750349|NCT01512160|536556225|FG001|Overall Study|Lost to Follow-up|0|||
148750350|NCT01512160|536556226|FG002|Overall Study|Lost to Follow-up|0|||
148750351|NCT01512160|536556227|FG003|Overall Study|Lost to Follow-up|0|||
148750352|NCT01512160|536556224|FG000|Overall Study|Withdrawal by Subject|1|||
148750353|NCT01512160|536556225|FG001|Overall Study|Withdrawal by Subject|0|||
148750354|NCT01512160|536556226|FG002|Overall Study|Withdrawal by Subject|0|||
148750355|NCT01512160|536556227|FG003|Overall Study|Withdrawal by Subject|1|||
148750356|NCT00866359|536556231|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
148750357|NCT00866359|536556232|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
148750358|NCT00866359|536556233|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
148750359|NCT00866359|536556234|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
148750360|NCT00866359|536556231|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
148750361|NCT00866359|536556232|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
148750362|NCT00866359|536556233|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
148750363|NCT00866359|536556234|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
148750364|NCT00866359|536556231|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
148976197|NCT00079274|537394489|FG006|Overall Study|Adverse Event|0|||
148976198|NCT00079274|537394483|FG000|Overall Study|Recurrence|21|||
148976199|NCT00079274|537394484|FG001|Overall Study|Recurrence|0|||
148976200|NCT00079274|537394485|FG002|Overall Study|Recurrence|1|||
148750365|NCT00866359|536556232|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
148750366|NCT00866359|536556233|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
148750367|NCT00866359|536556234|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
148750368|NCT00866359|536556231|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
148750369|NCT00866359|536556232|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
148976201|NCT00079274|537394486|FG003|Overall Study|Recurrence|15|||
148750370|NCT00866359|536556233|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
148750371|NCT00866359|536556234|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
148750372|NCT00866359|536556231|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
148750373|NCT00866359|536556232|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
148750374|NCT00866359|536556233|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
148750375|NCT00866359|536556234|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
148976202|NCT00079274|537394487|FG004|Overall Study|Recurrence|0|||
148976203|NCT00079274|537394488|FG005|Overall Study|Recurrence|2|||
148976204|NCT00079274|537394489|FG006|Overall Study|Recurrence|0|||
148976205|NCT00079274|537394483|FG000|Overall Study|Alternate Treatment|6|||
148821950|NCT00098293|536826668|FG001|Supplemental Phase (SP)|Death|0|||
148821951|NCT00098293|536826669|FG002|Supplemental Phase (SP)|Death|0|||
148821952|NCT00098293|536826670|FG003|Supplemental Phase (SP)|Death|0|||
148821953|NCT00098293|536826671|FG004|Supplemental Phase (SP)|Death|1|||
148821954|NCT00098293|536826667|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
148821955|NCT00098293|536826668|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
148976206|NCT00079274|537394484|FG001|Overall Study|Alternate Treatment|1|||
148750376|NCT00866359|536556231|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
148750377|NCT00866359|536556232|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
148750378|NCT00866359|536556233|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
148750379|NCT00866359|536556234|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
148750380|NCT01625091|536556235|FG000|Intervention|Death|1|||
148750381|NCT01625091|536556236|FG001|Intervention|Death|1|||
148750382|NCT01625091|536556235|FG000|Intervention|Withdrawal by Subject|4|||
148750383|NCT01625091|536556236|FG001|Intervention|Withdrawal by Subject|1|||
148750384|NCT01625091|536556235|FG000|Intervention|Adverse Event|0|||
148750385|NCT01625091|536556236|FG001|Intervention|Adverse Event|2|||
148750386|NCT01625091|536556235|FG000|Intervention|Lost to Follow-up|4|||
148750387|NCT01625091|536556236|FG001|Intervention|Lost to Follow-up|4|||
148750388|NCT01625091|536556235|FG000|Intervention|Study termination|2|||
148750389|NCT01625091|536556236|FG001|Intervention|Study termination|3|||
148750390|NCT01625091|536556235|FG000|Post-intervention|Death|0|||
148750391|NCT01625091|536556236|FG001|Post-intervention|Death|1|||
148750392|NCT01625091|536556235|FG000|Post-intervention|Lost to Follow-up|2|||
148750393|NCT01625091|536556236|FG001|Post-intervention|Lost to Follow-up|0|||
148750394|NCT01625091|536556235|FG000|Post-intervention|Study termination|2|||
148750395|NCT01625091|536556236|FG001|Post-intervention|Study termination|1|||
148750396|NCT00768248|536556243|FG000|Overall Study|Research coordinator didn't collect data|1|||
148750397|NCT00768248|536556244|FG001|Overall Study|Research coordinator didn't collect data|1|||
148750398|NCT01547390|536556245|FG000|Overall Study|Withdrawal by Subject|10|||
148750399|NCT01547390|536556246|FG001|Overall Study|Withdrawal by Subject|7|||
148750400|NCT01547390|536556245|FG000|Overall Study|termination of pregnancy|0|||
148750401|NCT01547390|536556246|FG001|Overall Study|termination of pregnancy|1|||
148750402|NCT01547390|536556245|FG000|Overall Study|Lost to Follow-up|0|||
148750403|NCT01547390|536556246|FG001|Overall Study|Lost to Follow-up|2|||
148750404|NCT01547390|536556245|FG000|Overall Study|Adverse Event|3|||
148750405|NCT01547390|536556246|FG001|Overall Study|Adverse Event|0|||
148750406|NCT01959295|536556249|FG000|Overall Study|Adverse Event|2|||
148750407|NCT01959295|536556250|FG001|Overall Study|Adverse Event|0|||
148750408|NCT01959295|536556249|FG000|Overall Study|Lost to Follow-up|0|||
148750409|NCT01959295|536556250|FG001|Overall Study|Lost to Follow-up|2|||
148750410|NCT01959295|536556249|FG000|Overall Study|Physician Decision|2|||
148750411|NCT01959295|536556250|FG001|Overall Study|Physician Decision|3|||
148750412|NCT01959295|536556249|FG000|Overall Study|Protocol Violation|16|||
148750413|NCT01959295|536556250|FG001|Overall Study|Protocol Violation|5|||
148750414|NCT01959295|536556249|FG000|Overall Study|Withdrawal by Subject|3|||
148750415|NCT01959295|536556250|FG001|Overall Study|Withdrawal by Subject|1|||
148750416|NCT01959295|536556249|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
148750417|NCT01959295|536556250|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
148750418|NCT04917861|536556252|FG000|Main Study (196 Days)|Adverse Event|0|||
148750419|NCT04917861|536556253|FG001|Main Study (196 Days)|Adverse Event|1|||
148750420|NCT04917861|536556254|FG002|Main Study (196 Days)|Adverse Event|0|||
148750421|NCT04917861|536556255|FG003|Main Study (196 Days)|Adverse Event|0|||
148750422|NCT04917861|536556252|FG000|Main Study (196 Days)|Death|0|||
148750423|NCT04917861|536556253|FG001|Main Study (196 Days)|Death|0|||
148750424|NCT04917861|536556254|FG002|Main Study (196 Days)|Death|0|||
148750425|NCT04917861|536556255|FG003|Main Study (196 Days)|Death|1|||
148750426|NCT04917861|536556252|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
148750427|NCT04917861|536556253|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
148750428|NCT04917861|536556254|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
148750429|NCT04917861|536556255|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
148750430|NCT04917861|536556252|FG000|Main Study (196 Days)|Physician Decision|0|||
148750431|NCT04917861|536556253|FG001|Main Study (196 Days)|Physician Decision|0|||
148750432|NCT04917861|536556254|FG002|Main Study (196 Days)|Physician Decision|0|||
148750433|NCT04917861|536556255|FG003|Main Study (196 Days)|Physician Decision|1|||
148750434|NCT04917861|536556252|FG000|Main Study (196 Days)|Pregnancy|1|||
148750435|NCT04917861|536556253|FG001|Main Study (196 Days)|Pregnancy|1|||
148750436|NCT04917861|536556254|FG002|Main Study (196 Days)|Pregnancy|0|||
148821956|NCT00098293|536826669|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
148821957|NCT00098293|536826670|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
148821958|NCT00098293|536826671|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
148821959|NCT00098293|536826667|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
148750437|NCT04917861|536556255|FG003|Main Study (196 Days)|Pregnancy|0|||
148750438|NCT04917861|536556252|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
148750439|NCT04917861|536556253|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
148821960|NCT00098293|536826668|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
148821961|NCT00098293|536826669|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
148821962|NCT00098293|536826670|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
148821963|NCT00098293|536826671|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
148821964|NCT00098293|536826667|FG000|Supplemental Phase (SP)|Other|0|||
148821965|NCT00098293|536826668|FG001|Supplemental Phase (SP)|Other|0|||
148821966|NCT00098293|536826669|FG002|Supplemental Phase (SP)|Other|0|||
148821967|NCT00098293|536826670|FG003|Supplemental Phase (SP)|Other|0|||
148821968|NCT00098293|536826671|FG004|Supplemental Phase (SP)|Other|22|||
148821969|NCT00754559|536826674|FG000|Overall Study|Adverse Event|15|||
148821970|NCT00754559|536826674|FG000|Overall Study|Protocol Violation|11|||
148821971|NCT00754559|536826674|FG000|Overall Study|Lack of Efficacy|10|||
148821972|NCT00754559|536826674|FG000|Overall Study|Lost to Follow-up|2|||
148821973|NCT00754559|536826674|FG000|Overall Study|Administrative reason|1|||
148821974|NCT00754559|536826674|FG000|Overall Study|Other|5|||
148821975|NCT00754559|536826674|FG000|Overall Study|Withdrawal by Subject|3|||
148821976|NCT00345592|536826675|FG000|Overall Study|Death|14|||
148821977|NCT00345592|536826676|FG001|Overall Study|Death|16|||
148821978|NCT00345592|536826675|FG000|Overall Study|Withdrawal by Subject|11|||
148821979|NCT00345592|536826676|FG001|Overall Study|Withdrawal by Subject|8|||
148821980|NCT04000724|536826678|FG000|Overall Study|Withdrawal by Subject|5|||
148821981|NCT04000724|536826679|FG001|Overall Study|Withdrawal by Subject|3|||
148821982|NCT04000724|536826680|FG002|Overall Study|Withdrawal by Subject|4|||
148821983|NCT04000724|536826678|FG000|Overall Study|Lost to Follow-up|11|||
148821984|NCT04000724|536826679|FG001|Overall Study|Lost to Follow-up|7|||
148821985|NCT04000724|536826680|FG002|Overall Study|Lost to Follow-up|13|||
148821986|NCT00455455|536826681|FG000|Washout|Withdrawal by Subject|0|||
148821987|NCT00455455|536826682|FG001|Washout|Withdrawal by Subject|1|||
148821988|NCT00455455|536826681|FG000|Washout|Withdrawal by Subject|1|||
148821989|NCT00455455|536826682|FG001|Washout|Withdrawal by Subject|0|||
148821990|NCT01370538|536826683|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
148821991|NCT01370538|536826684|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
148821992|NCT01370538|536826683|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148821993|NCT01370538|536826684|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
148821994|NCT01370538|536826683|FG000|Overall Study|Adverse Event|1|||
148821995|NCT01370538|536826684|FG001|Overall Study|Adverse Event|0|||
148821996|NCT01370538|536826683|FG000|Overall Study|Protocol Violation|8|||
148821997|NCT01370538|536826684|FG001|Overall Study|Protocol Violation|5|||
148821998|NCT01370538|536826683|FG000|Overall Study|Development of study specific withdrawal|1|||
148821999|NCT01370538|536826684|FG001|Overall Study|Development of study specific withdrawal|1|||
148822000|NCT01370538|536826683|FG000|Overall Study|Lost to follow up|6|||
148822001|NCT01370538|536826684|FG001|Overall Study|Lost to follow up|10|||
148822002|NCT03335566|536826685|FG000|Overall Study|Adverse Event|0|||
148822003|NCT03335566|536826686|FG001|Overall Study|Adverse Event|1|||
148822004|NCT03335566|536826685|FG000|Overall Study|Lost to Follow-up|1|||
148822005|NCT03335566|536826686|FG001|Overall Study|Lost to Follow-up|0|||
148822006|NCT03335566|536826685|FG000|Overall Study|Technical Problems|1|||
148822007|NCT03335566|536826686|FG001|Overall Study|Technical Problems|0|||
148822008|NCT03335566|536826685|FG000|Overall Study|Protocol Violation|1|||
148822009|NCT03335566|536826686|FG001|Overall Study|Protocol Violation|0|||
148822010|NCT03335566|536826685|FG000|Overall Study|Other than specified above|1|||
148822011|NCT03335566|536826686|FG001|Overall Study|Other than specified above|2|||
148822012|NCT01084135|536826687|FG000|20 Week|Physician Decision|0|||
148822013|NCT01084135|536826688|FG001|20 Week|Physician Decision|1|||
148822014|NCT02675452|536826690|FG000|Overall Study|Sponsor decision|0|||
148822015|NCT02675452|536826691|FG001|Overall Study|Sponsor decision|0|||
148822016|NCT02675452|536826692|FG002|Overall Study|Sponsor decision|0|||
148822017|NCT02675452|536826693|FG003|Overall Study|Sponsor decision|0|||
148822018|NCT02675452|536826694|FG004|Overall Study|Sponsor decision|0|||
148822019|NCT02675452|536826695|FG005|Overall Study|Sponsor decision|0|||
148822020|NCT02675452|536826696|FG006|Overall Study|Sponsor decision|0|||
148822021|NCT02675452|536826697|FG007|Overall Study|Sponsor decision|0|||
148822022|NCT02675452|536826698|FG008|Overall Study|Sponsor decision|0|||
148822023|NCT02675452|536826699|FG009|Overall Study|Sponsor decision|1|||
148822024|NCT02675452|536826700|FG010|Overall Study|Sponsor decision|0|||
148822025|NCT02675452|536826701|FG011|Overall Study|Sponsor decision|0|||
148822026|NCT02675452|536826702|FG012|Overall Study|Sponsor decision|0|||
148822027|NCT02675452|536826703|FG013|Overall Study|Sponsor decision|2|||
148822028|NCT02675452|536826704|FG014|Overall Study|Sponsor decision|1|||
148822029|NCT02675452|536826705|FG015|Overall Study|Sponsor decision|0|||
148822030|NCT02675452|536826706|FG016|Overall Study|Sponsor decision|1|||
148822031|NCT02675452|536826707|FG017|Overall Study|Sponsor decision|0|||
148822032|NCT02675452|536826708|FG018|Overall Study|Sponsor decision|0|||
148822033|NCT02675452|536826709|FG019|Overall Study|Sponsor decision|0|||
148822034|NCT02675452|536826710|FG020|Overall Study|Sponsor decision|0|||
148822035|NCT02675452|536826711|FG021|Overall Study|Sponsor decision|0|||
148822036|NCT02675452|536826712|FG022|Overall Study|Sponsor decision|0|||
148822037|NCT02675452|536826713|FG023|Overall Study|Sponsor decision|0|||
148822038|NCT02675452|536826714|FG024|Overall Study|Sponsor decision|0|||
148822039|NCT02675452|536826715|FG025|Overall Study|Sponsor decision|0|||
148822040|NCT02675452|536826716|FG026|Overall Study|Sponsor decision|2|||
148822041|NCT02675452|536826717|FG027|Overall Study|Sponsor decision|0|||
148822042|NCT02675452|536826718|FG028|Overall Study|Sponsor decision|0|||
148822043|NCT02675452|536826690|FG000|Overall Study|Withdrawal by Subject|0|||
148822044|NCT02675452|536826691|FG001|Overall Study|Withdrawal by Subject|0|||
148822045|NCT02675452|536826692|FG002|Overall Study|Withdrawal by Subject|0|||
148822046|NCT02675452|536826693|FG003|Overall Study|Withdrawal by Subject|0|||
148822047|NCT02675452|536826694|FG004|Overall Study|Withdrawal by Subject|0|||
148822048|NCT02675452|536826695|FG005|Overall Study|Withdrawal by Subject|0|||
148822049|NCT02675452|536826696|FG006|Overall Study|Withdrawal by Subject|0|||
148822050|NCT02675452|536826697|FG007|Overall Study|Withdrawal by Subject|0|||
148822051|NCT02675452|536826698|FG008|Overall Study|Withdrawal by Subject|0|||
148822052|NCT02675452|536826699|FG009|Overall Study|Withdrawal by Subject|1|||
148822053|NCT02675452|536826700|FG010|Overall Study|Withdrawal by Subject|0|||
148822054|NCT02675452|536826701|FG011|Overall Study|Withdrawal by Subject|1|||
148822055|NCT02675452|536826702|FG012|Overall Study|Withdrawal by Subject|0|||
148822056|NCT02675452|536826703|FG013|Overall Study|Withdrawal by Subject|1|||
148822057|NCT02675452|536826704|FG014|Overall Study|Withdrawal by Subject|1|||
148822058|NCT02675452|536826705|FG015|Overall Study|Withdrawal by Subject|0|||
148822059|NCT02675452|536826706|FG016|Overall Study|Withdrawal by Subject|2|||
148822060|NCT02675452|536826707|FG017|Overall Study|Withdrawal by Subject|0|||
148822061|NCT02675452|536826708|FG018|Overall Study|Withdrawal by Subject|0|||
148822062|NCT02675452|536826709|FG019|Overall Study|Withdrawal by Subject|0|||
148822063|NCT02675452|536826710|FG020|Overall Study|Withdrawal by Subject|0|||
148822064|NCT02675452|536826711|FG021|Overall Study|Withdrawal by Subject|0|||
148822065|NCT02675452|536826712|FG022|Overall Study|Withdrawal by Subject|3|||
148822066|NCT02675452|536826713|FG023|Overall Study|Withdrawal by Subject|0|||
148822067|NCT02675452|536826714|FG024|Overall Study|Withdrawal by Subject|1|||
148822068|NCT02675452|536826715|FG025|Overall Study|Withdrawal by Subject|0|||
148822069|NCT02675452|536826716|FG026|Overall Study|Withdrawal by Subject|1|||
148822070|NCT02675452|536826717|FG027|Overall Study|Withdrawal by Subject|3|||
148822071|NCT02675452|536826718|FG028|Overall Study|Withdrawal by Subject|4|||
148822072|NCT02675452|536826690|FG000|Overall Study|Death|0|||
148822073|NCT02675452|536826691|FG001|Overall Study|Death|0|||
148822074|NCT02675452|536826692|FG002|Overall Study|Death|1|||
148822075|NCT02675452|536826693|FG003|Overall Study|Death|0|||
148822076|NCT02675452|536826694|FG004|Overall Study|Death|0|||
148822077|NCT02675452|536826695|FG005|Overall Study|Death|1|||
148822078|NCT02675452|536826696|FG006|Overall Study|Death|0|||
148822079|NCT02675452|536826697|FG007|Overall Study|Death|0|||
148822080|NCT02675452|536826698|FG008|Overall Study|Death|1|||
148822081|NCT02675452|536826699|FG009|Overall Study|Death|0|||
148822082|NCT02675452|536826700|FG010|Overall Study|Death|0|||
148822083|NCT02675452|536826701|FG011|Overall Study|Death|0|||
148822084|NCT02675452|536826702|FG012|Overall Study|Death|1|||
148822085|NCT02675452|536826703|FG013|Overall Study|Death|0|||
148822086|NCT02675452|536826704|FG014|Overall Study|Death|0|||
148822087|NCT02675452|536826705|FG015|Overall Study|Death|2|||
148822088|NCT02675452|536826706|FG016|Overall Study|Death|0|||
148822089|NCT02675452|536826707|FG017|Overall Study|Death|0|||
148822090|NCT02675452|536826708|FG018|Overall Study|Death|4|||
148822091|NCT02675452|536826709|FG019|Overall Study|Death|3|||
148822092|NCT02675452|536826710|FG020|Overall Study|Death|3|||
148822093|NCT02675452|536826711|FG021|Overall Study|Death|3|||
148822094|NCT02675452|536826712|FG022|Overall Study|Death|7|||
148822095|NCT02675452|536826713|FG023|Overall Study|Death|5|||
148822096|NCT02675452|536826714|FG024|Overall Study|Death|3|||
148822097|NCT02675452|536826715|FG025|Overall Study|Death|4|||
148822098|NCT02675452|536826716|FG026|Overall Study|Death|7|||
148822099|NCT02675452|536826717|FG027|Overall Study|Death|6|||
148822100|NCT02675452|536826718|FG028|Overall Study|Death|9|||
148822101|NCT02675452|536826690|FG000|Overall Study|Lost to Follow-up|0|||
148822102|NCT02675452|536826691|FG001|Overall Study|Lost to Follow-up|1|||
148822103|NCT02675452|536826692|FG002|Overall Study|Lost to Follow-up|0|||
148822104|NCT02675452|536826693|FG003|Overall Study|Lost to Follow-up|0|||
148822105|NCT02675452|536826694|FG004|Overall Study|Lost to Follow-up|0|||
148822106|NCT02675452|536826695|FG005|Overall Study|Lost to Follow-up|0|||
148822107|NCT02675452|536826696|FG006|Overall Study|Lost to Follow-up|0|||
148976207|NCT00079274|537394485|FG002|Overall Study|Alternate Treatment|0|||
148976208|NCT00079274|537394486|FG003|Overall Study|Alternate Treatment|3|||
148976209|NCT00079274|537394487|FG004|Overall Study|Alternate Treatment|0|||
148822108|NCT02675452|536826697|FG007|Overall Study|Lost to Follow-up|0|||
148822109|NCT02675452|536826698|FG008|Overall Study|Lost to Follow-up|0|||
148822110|NCT02675452|536826699|FG009|Overall Study|Lost to Follow-up|0|||
148822111|NCT02675452|536826700|FG010|Overall Study|Lost to Follow-up|0|||
148822112|NCT02675452|536826701|FG011|Overall Study|Lost to Follow-up|0|||
148822113|NCT02675452|536826702|FG012|Overall Study|Lost to Follow-up|1|||
148822114|NCT02675452|536826703|FG013|Overall Study|Lost to Follow-up|0|||
148822115|NCT02675452|536826704|FG014|Overall Study|Lost to Follow-up|0|||
148822116|NCT02675452|536826705|FG015|Overall Study|Lost to Follow-up|0|||
148822117|NCT02675452|536826706|FG016|Overall Study|Lost to Follow-up|0|||
148822118|NCT02675452|536826707|FG017|Overall Study|Lost to Follow-up|0|||
148750440|NCT04917861|536556254|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
148750441|NCT04917861|536556255|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
148750442|NCT04917861|536556252|FG000|Main Study (196 Days)|Other Than Specified|1|||
148750443|NCT04917861|536556253|FG001|Main Study (196 Days)|Other Than Specified|0|||
148750444|NCT04917861|536556254|FG002|Main Study (196 Days)|Other Than Specified|1|||
148750445|NCT04917861|536556255|FG003|Main Study (196 Days)|Other Than Specified|2|||
148750446|NCT04917861|536556252|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
148750447|NCT04917861|536556253|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
148750448|NCT04917861|536556254|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
148750449|NCT04917861|536556255|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
148750450|NCT04917861|536556252|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
148750451|NCT04917861|536556253|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
148750452|NCT04917861|536556254|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
148750453|NCT04917861|536556255|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
148750454|NCT04917861|536556252|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
148750455|NCT04917861|536556253|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
148750456|NCT04917861|536556254|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
148750457|NCT04917861|536556255|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
148750458|NCT04917861|536556252|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
148750459|NCT04917861|536556253|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
148750460|NCT04917861|536556254|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
148750461|NCT04917861|536556255|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
148750462|NCT04917861|536556252|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
148750463|NCT04917861|536556253|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
148750464|NCT04917861|536556254|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
148750465|NCT04917861|536556255|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
148750466|NCT04917861|536556252|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
148750467|NCT04917861|536556253|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
148750468|NCT04917861|536556254|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
148750469|NCT04917861|536556255|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
148750470|NCT01128179|536556256|FG000|Overall Study|Death|1|||
148750471|NCT01128179|536556257|FG001|Overall Study|Death|0|||
148750472|NCT01128179|536556256|FG000|Overall Study|Protocol Violation|1|||
148750473|NCT01128179|536556257|FG001|Overall Study|Protocol Violation|0|||
148750474|NCT02694328|536556258|FG000|Overall Study|Adverse Event|27|||
148750475|NCT02694328|536556259|FG001|Overall Study|Adverse Event|33|||
148750476|NCT02694328|536556258|FG000|Overall Study|Withdrawal by Subject|27|||
148750477|NCT02694328|536556259|FG001|Overall Study|Withdrawal by Subject|23|||
148750478|NCT02694328|536556258|FG000|Overall Study|Lost to Follow-up|26|||
148750479|NCT02694328|536556259|FG001|Overall Study|Lost to Follow-up|22|||
148750480|NCT02694328|536556258|FG000|Overall Study|Noncompliant with study drug|11|||
148750481|NCT02694328|536556259|FG001|Overall Study|Noncompliant with study drug|8|||
148750482|NCT02694328|536556258|FG000|Overall Study|Incarceration|1|||
148750483|NCT02694328|536556259|FG001|Overall Study|Incarceration|1|||
148750484|NCT02694328|536556258|FG000|Overall Study|Lack of Efficacy|1|||
148750485|NCT02694328|536556259|FG001|Overall Study|Lack of Efficacy|2|||
148750486|NCT02694328|536556258|FG000|Overall Study|Pregnancy|1|||
148750487|NCT02694328|536556259|FG001|Overall Study|Pregnancy|1|||
148750488|NCT02694328|536556258|FG000|Overall Study|Protocol Violation|6|||
148750489|NCT02694328|536556259|FG001|Overall Study|Protocol Violation|5|||
148750490|NCT02694328|536556258|FG000|Overall Study|Abnormal Laboratory Value|0|||
148750491|NCT02694328|536556259|FG001|Overall Study|Abnormal Laboratory Value|3|||
148750492|NCT00720382|536556263|FG000|Overall Study|Adverse Event|54|||
148750493|NCT00720382|536556264|FG001|Overall Study|Adverse Event|17|||
148750494|NCT00720382|536556263|FG000|Overall Study|Lack of Efficacy|18|||
148750495|NCT00720382|536556264|FG001|Overall Study|Lack of Efficacy|7|||
148750496|NCT00720382|536556263|FG000|Overall Study|Non-Compliance|15|||
148750497|NCT00720382|536556264|FG001|Overall Study|Non-Compliance|5|||
148750498|NCT00720382|536556263|FG000|Overall Study|Withdrawal by Subject|47|||
148750499|NCT00720382|536556264|FG001|Overall Study|Withdrawal by Subject|11|||
148750500|NCT00720382|536556263|FG000|Overall Study|Lost to Follow-up|28|||
148750501|NCT00720382|536556264|FG001|Overall Study|Lost to Follow-up|14|||
148750502|NCT00720382|536556263|FG000|Overall Study|administrative|14|||
148750503|NCT00720382|536556264|FG001|Overall Study|administrative|5|||
148750504|NCT05192889|536556265|FG000|Block 1: All Eligible Patients|Death|2|||
148750505|NCT05192889|536556266|FG001|Block 1: All Eligible Patients|Death|0|||
148822119|NCT02675452|536826708|FG018|Overall Study|Lost to Follow-up|0|||
148822120|NCT02675452|536826709|FG019|Overall Study|Lost to Follow-up|0|||
148822121|NCT02675452|536826710|FG020|Overall Study|Lost to Follow-up|0|||
148750506|NCT05192889|536556267|FG002|Block 1: All Eligible Patients|Death|0|||
148750507|NCT05192889|536556265|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
148750508|NCT05192889|536556266|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
148976210|NCT00079274|537394488|FG005|Overall Study|Alternate Treatment|0|||
148822122|NCT02675452|536826711|FG021|Overall Study|Lost to Follow-up|0|||
148750509|NCT05192889|536556267|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
148750510|NCT05192889|536556265|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
148750511|NCT05192889|536556266|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
148750512|NCT05192889|536556267|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
148750513|NCT03300817|536558041|FG000|Overall Study|Withdrawal by Subject|1|||
148750514|NCT03300817|536558041|FG000|Overall Study|Adverse Event|1|||
148750515|NCT03300817|536558041|FG000|Overall Study|Subject Found to be Ineligible|2|||
148750516|NCT00265759|536558042|FG000|Overall Study|Withdrawal by Subject|0|||
148750517|NCT00265759|536558043|FG001|Overall Study|Withdrawal by Subject|1|||
148750518|NCT00265759|536558044|FG002|Overall Study|Withdrawal by Subject|2|||
148750519|NCT00265759|536558045|FG003|Overall Study|Withdrawal by Subject|2|||
148750520|NCT00265759|536558042|FG000|Overall Study|Cancel|0|||
148750521|NCT00265759|536558043|FG001|Overall Study|Cancel|0|||
148750522|NCT00265759|536558044|FG002|Overall Study|Cancel|0|||
148750523|NCT00265759|536558045|FG003|Overall Study|Cancel|3|||
148750524|NCT00265759|536558042|FG000|Overall Study|Ineligible|0|||
148750525|NCT00265759|536558043|FG001|Overall Study|Ineligible|0|||
148750526|NCT00265759|536558044|FG002|Overall Study|Ineligible|0|||
148750527|NCT00265759|536558045|FG003|Overall Study|Ineligible|1|||
148750528|NCT00265759|536558042|FG000|Overall Study|Bilateral disease|0|||
148750529|NCT00265759|536558043|FG001|Overall Study|Bilateral disease|0|||
148750530|NCT00265759|536558044|FG002|Overall Study|Bilateral disease|0|||
148750531|NCT00265759|536558045|FG003|Overall Study|Bilateral disease|2|||
148750532|NCT00265759|536558042|FG000|Overall Study|Discontinued due to intolerability|0|||
148750533|NCT00265759|536558043|FG001|Overall Study|Discontinued due to intolerability|0|||
148750534|NCT00265759|536558044|FG002|Overall Study|Discontinued due to intolerability|0|||
148750535|NCT00265759|536558045|FG003|Overall Study|Discontinued due to intolerability|1|||
148750536|NCT03729596|536558047|FG000|Overall Study|Death|3|||
148750537|NCT03729596|536558048|FG001|Overall Study|Death|5|||
148750538|NCT03729596|536558049|FG002|Overall Study|Death|4|||
148750539|NCT03729596|536558050|FG003|Overall Study|Death|1|||
148750540|NCT03729596|536558051|FG004|Overall Study|Death|0|||
148750541|NCT03729596|536558052|FG005|Overall Study|Death|34|||
148750542|NCT03729596|536558053|FG006|Overall Study|Death|18|||
148750543|NCT03729596|536558054|FG007|Overall Study|Death|14|||
148750544|NCT03729596|536558055|FG008|Overall Study|Death|19|||
148750545|NCT03729596|536558056|FG009|Overall Study|Death|9|||
148750546|NCT03729596|536558047|FG000|Overall Study|Lost to Follow-up|0|||
148750547|NCT03729596|536558048|FG001|Overall Study|Lost to Follow-up|0|||
148750548|NCT03729596|536558049|FG002|Overall Study|Lost to Follow-up|0|||
148750549|NCT03729596|536558050|FG003|Overall Study|Lost to Follow-up|0|||
148750550|NCT03729596|536558051|FG004|Overall Study|Lost to Follow-up|0|||
148750551|NCT03729596|536558052|FG005|Overall Study|Lost to Follow-up|0|||
148750552|NCT03729596|536558053|FG006|Overall Study|Lost to Follow-up|1|||
148750553|NCT03729596|536558054|FG007|Overall Study|Lost to Follow-up|0|||
148750554|NCT03729596|536558055|FG008|Overall Study|Lost to Follow-up|0|||
148750555|NCT03729596|536558056|FG009|Overall Study|Lost to Follow-up|1|||
148750556|NCT03729596|536558047|FG000|Overall Study|protocol amendment|0|||
148750557|NCT03729596|536558048|FG001|Overall Study|protocol amendment|1|||
148750558|NCT03729596|536558049|FG002|Overall Study|protocol amendment|3|||
148750559|NCT03729596|536558050|FG003|Overall Study|protocol amendment|6|||
148822123|NCT02675452|536826712|FG022|Overall Study|Lost to Follow-up|0|||
148822124|NCT02675452|536826713|FG023|Overall Study|Lost to Follow-up|0|||
148750560|NCT03729596|536558051|FG004|Overall Study|protocol amendment|5|||
148750561|NCT03729596|536558052|FG005|Overall Study|protocol amendment|0|||
148750562|NCT03729596|536558053|FG006|Overall Study|protocol amendment|0|||
148750563|NCT03729596|536558054|FG007|Overall Study|protocol amendment|0|||
148750564|NCT03729596|536558055|FG008|Overall Study|protocol amendment|0|||
148750565|NCT03729596|536558056|FG009|Overall Study|protocol amendment|0|||
148750566|NCT03729596|536558047|FG000|Overall Study|Withdrawal by Subject|0|||
148750567|NCT03729596|536558048|FG001|Overall Study|Withdrawal by Subject|0|||
148750568|NCT03729596|536558049|FG002|Overall Study|Withdrawal by Subject|0|||
148750569|NCT03729596|536558050|FG003|Overall Study|Withdrawal by Subject|0|||
148750570|NCT03729596|536558051|FG004|Overall Study|Withdrawal by Subject|0|||
148750571|NCT03729596|536558052|FG005|Overall Study|Withdrawal by Subject|4|||
148750572|NCT03729596|536558053|FG006|Overall Study|Withdrawal by Subject|2|||
148822125|NCT02675452|536826714|FG024|Overall Study|Lost to Follow-up|0|||
148750573|NCT03729596|536558054|FG007|Overall Study|Withdrawal by Subject|3|||
148750574|NCT03729596|536558055|FG008|Overall Study|Withdrawal by Subject|2|||
148750575|NCT03729596|536558056|FG009|Overall Study|Withdrawal by Subject|3|||
148750576|NCT03729596|536558047|FG000|Overall Study|study terminated by sponsor|0|||
148750577|NCT03729596|536558048|FG001|Overall Study|study terminated by sponsor|0|||
148750578|NCT03729596|536558049|FG002|Overall Study|study terminated by sponsor|0|||
148750579|NCT03729596|536558050|FG003|Overall Study|study terminated by sponsor|0|||
148750580|NCT03729596|536558051|FG004|Overall Study|study terminated by sponsor|1|||
148750581|NCT03729596|536558052|FG005|Overall Study|study terminated by sponsor|3|||
148750582|NCT03729596|536558053|FG006|Overall Study|study terminated by sponsor|0|||
148750583|NCT03729596|536558054|FG007|Overall Study|study terminated by sponsor|1|||
148750584|NCT03729596|536558055|FG008|Overall Study|study terminated by sponsor|0|||
148822126|NCT02675452|536826715|FG025|Overall Study|Lost to Follow-up|0|||
149027288|NCT00984282|537578535|FG000|Double Blind Treatment|protocol driven decision point|1|||
149027289|NCT00984282|537578536|FG001|Double Blind Treatment|protocol driven decision point|1|||
149027290|NCT00984282|537578535|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
149027291|NCT00984282|537578536|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
148750585|NCT03729596|536558056|FG009|Overall Study|study terminated by sponsor|0|||
148750586|NCT03713593|536558057|FG000|Overall Study|Sponsor Decision|73|||
148750587|NCT03713593|536558058|FG001|Overall Study|Sponsor Decision|41|||
148750588|NCT03713593|536558057|FG000|Overall Study|Lost to Follow-up|2|||
148750589|NCT03713593|536558058|FG001|Overall Study|Lost to Follow-up|1|||
148750590|NCT03713593|536558057|FG000|Overall Study|Death|314|||
148750591|NCT03713593|536558058|FG001|Overall Study|Death|349|||
148750592|NCT03713593|536558057|FG000|Overall Study|Withdrawal by Subject|6|||
148750593|NCT03713593|536558058|FG001|Overall Study|Withdrawal by Subject|8|||
148750594|NCT05061134|536558059|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
148750595|NCT05061134|536558060|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
148750596|NCT05061134|536558061|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
148750597|NCT05061134|536558059|FG000|Overall Study|Subject not treated|0|||
148750598|NCT05061134|536558060|FG001|Overall Study|Subject not treated|0|||
148750599|NCT05061134|536558061|FG002|Overall Study|Subject not treated|2|||
148750600|NCT05061134|536558059|FG000|Overall Study|Other|0|||
148750601|NCT05061134|536558060|FG001|Overall Study|Other|0|||
148750602|NCT05061134|536558061|FG002|Overall Study|Other|9|||
148750603|NCT05061134|536558059|FG000|Overall Study|Withdrawal by Subject|9|||
148750604|NCT05061134|536558060|FG001|Overall Study|Withdrawal by Subject|8|||
148750605|NCT05061134|536558061|FG002|Overall Study|Withdrawal by Subject|5|||
148750606|NCT05061134|536558059|FG000|Overall Study|Study Terminated by Sponsor|22|||
148750607|NCT05061134|536558060|FG001|Overall Study|Study Terminated by Sponsor|14|||
148750608|NCT05061134|536558061|FG002|Overall Study|Study Terminated by Sponsor|7|||
148750609|NCT05061134|536558059|FG000|Overall Study|Progressive Disease|1|||
148750610|NCT05061134|536558060|FG001|Overall Study|Progressive Disease|2|||
148750611|NCT05061134|536558061|FG002|Overall Study|Progressive Disease|0|||
148750612|NCT05061134|536558059|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
148750613|NCT05061134|536558060|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
148750614|NCT05061134|536558061|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
148750615|NCT05061134|536558059|FG000|Overall Study|Lost to Follow-up|1|||
148750616|NCT05061134|536558060|FG001|Overall Study|Lost to Follow-up|0|||
148750617|NCT05061134|536558061|FG002|Overall Study|Lost to Follow-up|0|||
148750618|NCT05061134|536558059|FG000|Overall Study|Physician Decision|1|||
148750619|NCT05061134|536558060|FG001|Overall Study|Physician Decision|1|||
148750620|NCT05061134|536558061|FG002|Overall Study|Physician Decision|0|||
148750621|NCT05061134|536558059|FG000|Overall Study|Disease progression|1|||
148750622|NCT05061134|536558060|FG001|Overall Study|Disease progression|0|||
148750623|NCT05061134|536558061|FG002|Overall Study|Disease progression|0|||
148750624|NCT05061134|536558059|FG000|Overall Study|Death|43|||
148750625|NCT05061134|536558060|FG001|Overall Study|Death|23|||
148750626|NCT05061134|536558061|FG002|Overall Study|Death|14|||
148750627|NCT05061134|536558059|FG000|Overall Study|Database lock|2|||
148750628|NCT05061134|536558060|FG001|Overall Study|Database lock|0|||
148750629|NCT05061134|536558061|FG002|Overall Study|Database lock|0|||
148750630|NCT00001521|536558062|FG000|Overall Study|Withdrawal by Subject|3|||
148750631|NCT00001521|536558063|FG001|Overall Study|Withdrawal by Subject|3|||
148750632|NCT00001521|536558062|FG000|Overall Study|Physician Decision|1|||
148750633|NCT00001521|536558063|FG001|Overall Study|Physician Decision|1|||
148750634|NCT00001521|536558062|FG000|Overall Study|Noncompliant|6|||
148750635|NCT00001521|536558063|FG001|Overall Study|Noncompliant|3|||
148750636|NCT03176134|536558064|FG000|Overall Study|Lost to Follow-up|0|||
148750637|NCT03176134|536558065|FG001|Overall Study|Lost to Follow-up|2|||
148750638|NCT03176134|536558066|FG002|Overall Study|Lost to Follow-up|0|||
148750639|NCT03176134|536558067|FG003|Overall Study|Lost to Follow-up|0|||
148750640|NCT03176134|536558068|FG004|Overall Study|Lost to Follow-up|0|||
148750641|NCT03176134|536558069|FG005|Overall Study|Lost to Follow-up|0|||
148750642|NCT03176134|536558070|FG006|Overall Study|Lost to Follow-up|0|||
148750643|NCT03176134|536558071|FG007|Overall Study|Lost to Follow-up|0|||
148750644|NCT03176134|536558064|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
148750645|NCT03176134|536558065|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148750646|NCT03176134|536558066|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
148750647|NCT03176134|536558067|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
148750648|NCT03176134|536558068|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
148750649|NCT03176134|536558069|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
148750650|NCT03176134|536558070|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
148750651|NCT03176134|536558071|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
148750652|NCT03410056|536558076|FG000|Overall Study|Decision by Sponsor|0|||
148750653|NCT03410056|536558077|FG001|Overall Study|Decision by Sponsor|0|||
148750654|NCT03410056|536558078|FG002|Overall Study|Decision by Sponsor|3|||
148750655|NCT03410056|536558079|FG003|Overall Study|Decision by Sponsor|0|||
148750656|NCT03410056|536558080|FG004|Overall Study|Decision by Sponsor|0|||
148750657|NCT03410056|536558081|FG005|Overall Study|Decision by Sponsor|0|||
148750658|NCT03410056|536558082|FG006|Overall Study|Decision by Sponsor|0|||
148750659|NCT03410056|536558076|FG000|Overall Study|Withdrawal by Subject|0|||
148750660|NCT03410056|536558077|FG001|Overall Study|Withdrawal by Subject|2|||
148750661|NCT03410056|536558078|FG002|Overall Study|Withdrawal by Subject|5|||
148750662|NCT03410056|536558079|FG003|Overall Study|Withdrawal by Subject|5|||
148750663|NCT03410056|536558080|FG004|Overall Study|Withdrawal by Subject|0|||
148976211|NCT00079274|537394489|FG006|Overall Study|Alternate Treatment|0|||
148750664|NCT03410056|536558081|FG005|Overall Study|Withdrawal by Subject|0|||
148750665|NCT03410056|536558082|FG006|Overall Study|Withdrawal by Subject|0|||
148750666|NCT01499095|536558087|FG000|Overall Study|Randomized But Not Treated|1|||
148750667|NCT01499095|536558088|FG001|Overall Study|Randomized But Not Treated|1|||
148750668|NCT01499095|536558087|FG000|Overall Study|Adverse Event|12|||
148750669|NCT01499095|536558088|FG001|Overall Study|Adverse Event|7|||
148750670|NCT01499095|536558087|FG000|Overall Study|Lack of Efficacy|2|||
148750671|NCT01499095|536558088|FG001|Overall Study|Lack of Efficacy|1|||
148750672|NCT01499095|536558087|FG000|Overall Study|Protocol Violation|6|||
148750673|NCT01499095|536558088|FG001|Overall Study|Protocol Violation|7|||
148750674|NCT01499095|536558087|FG000|Overall Study|Received Rescue Therapy|32|||
148750675|NCT01499095|536558088|FG001|Overall Study|Received Rescue Therapy|40|||
148750676|NCT01499095|536558087|FG000|Overall Study|Diverse Reasons|22|||
148750677|NCT01499095|536558088|FG001|Overall Study|Diverse Reasons|25|||
148750678|NCT01499095|536558087|FG000|Overall Study|Lost to Follow-up|6|||
148750679|NCT01499095|536558088|FG001|Overall Study|Lost to Follow-up|4|||
148750680|NCT01499095|536558087|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
148750681|NCT01499095|536558088|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
148750682|NCT01499095|536558087|FG000|Overall Study|Hypoglycemia|3|||
148750683|NCT01499095|536558088|FG001|Overall Study|Hypoglycemia|1|||
148750684|NCT01499095|536558087|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
148750685|NCT01499095|536558088|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
148750686|NCT01499095|536558087|FG000|Overall Study|Change in Injection Schedule|2|||
148750687|NCT01499095|536558088|FG001|Overall Study|Change in Injection Schedule|0|||
148750688|NCT01499095|536558087|FG000|Overall Study|Perceived Lack of Efficacy|1|||
148750689|NCT01499095|536558088|FG001|Overall Study|Perceived Lack of Efficacy|1|||
148750690|NCT00443729|536558089|FG000|Overall Study|Never Treated|0|||
148750691|NCT00443729|536558090|FG001|Overall Study|Never Treated|1|||
148750692|NCT00443729|536558089|FG000|Overall Study|Lack of Efficacy|4|||
148750693|NCT00443729|536558090|FG001|Overall Study|Lack of Efficacy|2|||
148750694|NCT00443729|536558089|FG000|Overall Study|Lost to Follow-up|0|||
148750695|NCT00443729|536558090|FG001|Overall Study|Lost to Follow-up|1|||
148750696|NCT00443729|536558089|FG000|Overall Study|Physician Decision|2|||
148750697|NCT00443729|536558090|FG001|Overall Study|Physician Decision|1|||
148750698|NCT00443729|536558089|FG000|Overall Study|Protocol Violation|1|||
148750699|NCT00443729|536558090|FG001|Overall Study|Protocol Violation|1|||
148750700|NCT00443729|536558089|FG000|Overall Study|Withdrawal by Subject|3|||
148750701|NCT00443729|536558090|FG001|Overall Study|Withdrawal by Subject|1|||
148750702|NCT04182490|536558092|FG000|Overall Study|Withdrawal by Subject|3|||
148750703|NCT04182490|536558093|FG001|Overall Study|Withdrawal by Subject|3|||
148750704|NCT04182490|536558092|FG000|Overall Study|Lost to Follow-up|0|||
148750705|NCT04182490|536558093|FG001|Overall Study|Lost to Follow-up|1|||
148750706|NCT04182490|536558092|FG000|Overall Study|Physician Decision|0|||
148750707|NCT04182490|536558093|FG001|Overall Study|Physician Decision|1|||
148750708|NCT04882241|536558094|FG000|Overall Study|Ongoing in study|46|||
148750709|NCT04882241|536558095|FG001|Overall Study|Ongoing in study|48|||
148750710|NCT04882241|536558096|FG002|Overall Study|Ongoing in study|0|||
148750711|NCT04882241|536558097|FG003|Overall Study|Ongoing in study|0|||
148750712|NCT04882241|536558094|FG000|Overall Study|Death|13|||
148750713|NCT04882241|536558095|FG001|Overall Study|Death|13|||
148750714|NCT04882241|536558096|FG002|Overall Study|Death|0|||
148750715|NCT04882241|536558097|FG003|Overall Study|Death|0|||
148750716|NCT01349192|536558103|FG000|Overall Study|Protocol Violation|0|||
148750717|NCT01349192|536558104|FG001|Overall Study|Protocol Violation|1|||
148750718|NCT01349192|536558103|FG000|Overall Study|Withdrawal by Subject|0|||
148750719|NCT01349192|536558104|FG001|Overall Study|Withdrawal by Subject|2|||
148750720|NCT01349192|536558103|FG000|Overall Study|Lost to Follow-up|1|||
148750721|NCT01349192|536558104|FG001|Overall Study|Lost to Follow-up|3|||
148750722|NCT01349192|536558103|FG000|Overall Study|Failure to adhere to Protocol|2|||
148750723|NCT01349192|536558104|FG001|Overall Study|Failure to adhere to Protocol|0|||
148750724|NCT02038010|536558108|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
148750725|NCT02038010|536558109|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
148750726|NCT02038010|536558110|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
148750727|NCT02038010|536558111|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
148750728|NCT02038010|536558108|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
148750729|NCT02038010|536558109|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
148822127|NCT02675452|536826716|FG026|Overall Study|Lost to Follow-up|1|||
148822128|NCT02675452|536826717|FG027|Overall Study|Lost to Follow-up|0|||
148822129|NCT02675452|536826718|FG028|Overall Study|Lost to Follow-up|0|||
148822130|NCT02675452|536826690|FG000|Overall Study|Other|0|||
148822131|NCT02675452|536826691|FG001|Overall Study|Other|0|||
148822132|NCT02675452|536826692|FG002|Overall Study|Other|0|||
148822133|NCT02675452|536826693|FG003|Overall Study|Other|0|||
148822134|NCT02675452|536826694|FG004|Overall Study|Other|0|||
148822135|NCT02675452|536826695|FG005|Overall Study|Other|0|||
148822136|NCT02675452|536826696|FG006|Overall Study|Other|0|||
148822137|NCT02675452|536826697|FG007|Overall Study|Other|0|||
148822138|NCT02675452|536826698|FG008|Overall Study|Other|0|||
148822139|NCT02675452|536826699|FG009|Overall Study|Other|0|||
148822140|NCT02675452|536826700|FG010|Overall Study|Other|0|||
148822141|NCT02675452|536826701|FG011|Overall Study|Other|0|||
148822142|NCT02675452|536826702|FG012|Overall Study|Other|0|||
148822143|NCT02675452|536826703|FG013|Overall Study|Other|0|||
148822144|NCT02675452|536826704|FG014|Overall Study|Other|0|||
148822145|NCT02675452|536826705|FG015|Overall Study|Other|0|||
148822146|NCT02675452|536826706|FG016|Overall Study|Other|0|||
148822147|NCT02675452|536826707|FG017|Overall Study|Other|0|||
148822148|NCT02675452|536826708|FG018|Overall Study|Other|0|||
148822149|NCT02675452|536826709|FG019|Overall Study|Other|0|||
148822150|NCT02675452|536826710|FG020|Overall Study|Other|0|||
148822151|NCT02675452|536826711|FG021|Overall Study|Other|0|||
148822152|NCT02675452|536826712|FG022|Overall Study|Other|0|||
148822153|NCT02675452|536826713|FG023|Overall Study|Other|0|||
148822154|NCT02675452|536826714|FG024|Overall Study|Other|0|||
148822155|NCT02675452|536826715|FG025|Overall Study|Other|0|||
148822156|NCT02675452|536826716|FG026|Overall Study|Other|1|||
148822157|NCT02675452|536826717|FG027|Overall Study|Other|0|||
148822158|NCT02675452|536826718|FG028|Overall Study|Other|0|||
148822159|NCT04595370|536826721|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
148822160|NCT04595370|536826722|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
148822161|NCT04595370|536826723|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
148822162|NCT04595370|536826724|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
148822163|NCT04595370|536826725|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
148822164|NCT04595370|536826726|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
148822165|NCT04595370|536826721|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
148822166|NCT04595370|536826722|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
148822167|NCT04595370|536826723|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
148822168|NCT04595370|536826724|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
148750730|NCT02038010|536558110|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
148750731|NCT02038010|536558111|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
148750732|NCT02038010|536558108|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
148750733|NCT02038010|536558109|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
148750734|NCT02038010|536558110|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
148750735|NCT02038010|536558111|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
148750736|NCT02038010|536558108|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
148750737|NCT02038010|536558109|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
148750738|NCT02038010|536558110|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
148750739|NCT02038010|536558111|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
148750740|NCT02038010|536558108|FG000|Follow Up|Death|4|||
148750741|NCT02038010|536558109|FG001|Follow Up|Death|3|||
148750742|NCT02038010|536558110|FG002|Follow Up|Death|0|||
148750743|NCT02038010|536558111|FG003|Follow Up|Death|0|||
148750744|NCT02038010|536558108|FG000|Follow Up|Other|3|||
148750745|NCT02038010|536558109|FG001|Follow Up|Other|0|||
148750746|NCT02038010|536558110|FG002|Follow Up|Other|0|||
148750747|NCT02038010|536558111|FG003|Follow Up|Other|0|||
148750748|NCT02262325|536558112|FG000|Overall Study|Death|16|||
148750749|NCT02262325|536558112|FG000|Overall Study|Lost to Follow-up|1|||
148750750|NCT02815995|536558113|FG000|Overall Study|Disease Progression|3|||
148822169|NCT04595370|536826725|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
148822170|NCT04595370|536826726|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
148822171|NCT04595370|536826721|FG000|Overall Study|Adverse Event|0|||
148822172|NCT04595370|536826722|FG001|Overall Study|Adverse Event|4|||
148976212|NCT00079274|537394483|FG000|Overall Study|Other Medical Problems|6|||
148750751|NCT02815995|536558114|FG001|Overall Study|Disease Progression|7|||
148750752|NCT02815995|536558115|FG002|Overall Study|Disease Progression|2|||
148750753|NCT02815995|536558116|FG003|Overall Study|Disease Progression|4|||
148750754|NCT02815995|536558117|FG004|Overall Study|Disease Progression|3|||
148750755|NCT02815995|536558118|FG005|Overall Study|Disease Progression|9|||
148822173|NCT04595370|536826723|FG002|Overall Study|Adverse Event|3|||
148822174|NCT04595370|536826724|FG003|Overall Study|Adverse Event|1|||
148822175|NCT04595370|536826725|FG004|Overall Study|Adverse Event|1|||
148822176|NCT04595370|536826726|FG005|Overall Study|Adverse Event|1|||
148750756|NCT02815995|536558119|FG006|Overall Study|Disease Progression|3|||
148750757|NCT02815995|536558120|FG007|Overall Study|Disease Progression|1|||
148750758|NCT02815995|536558113|FG000|Overall Study|Adverse Event|1|||
148750759|NCT02815995|536558114|FG001|Overall Study|Adverse Event|2|||
148750760|NCT02815995|536558115|FG002|Overall Study|Adverse Event|2|||
148750761|NCT02815995|536558116|FG003|Overall Study|Adverse Event|0|||
148750762|NCT02815995|536558117|FG004|Overall Study|Adverse Event|0|||
148750763|NCT02815995|536558118|FG005|Overall Study|Adverse Event|1|||
148750764|NCT02815995|536558119|FG006|Overall Study|Adverse Event|0|||
148750765|NCT02815995|536558120|FG007|Overall Study|Adverse Event|0|||
148750766|NCT02815995|536558113|FG000|Overall Study|Pregnancy|0|||
148750767|NCT02815995|536558114|FG001|Overall Study|Pregnancy|0|||
148750768|NCT02815995|536558115|FG002|Overall Study|Pregnancy|0|||
148750769|NCT02815995|536558116|FG003|Overall Study|Pregnancy|0|||
148750770|NCT02815995|536558117|FG004|Overall Study|Pregnancy|0|||
148750771|NCT02815995|536558118|FG005|Overall Study|Pregnancy|0|||
148750772|NCT02815995|536558119|FG006|Overall Study|Pregnancy|1|||
148750773|NCT02815995|536558120|FG007|Overall Study|Pregnancy|0|||
148750774|NCT01071915|536558121|FG000|Overall Study|Adverse Event|3|||
148750775|NCT01071915|536558121|FG000|Overall Study|Physician Decision|2|||
148750776|NCT01071915|536558121|FG000|Overall Study|Withdrawal by Subject|2|||
148750777|NCT01071915|536558121|FG000|Overall Study|Miscellaneous Reasons|2|||
148750778|NCT01125189|536558122|FG000|Treatment Period|Lack of Efficacy|15|||
148750779|NCT01125189|536558123|FG001|Treatment Period|Lack of Efficacy|18|||
148750780|NCT01125189|536558124|FG002|Treatment Period|Lack of Efficacy|25|||
148750781|NCT01125189|536558122|FG000|Treatment Period|Adverse Event|7|||
148750782|NCT01125189|536558123|FG001|Treatment Period|Adverse Event|8|||
148750783|NCT01125189|536558124|FG002|Treatment Period|Adverse Event|8|||
148750784|NCT01125189|536558122|FG000|Treatment Period|Withdrawal by Subject|3|||
148750785|NCT01125189|536558123|FG001|Treatment Period|Withdrawal by Subject|1|||
148750786|NCT01125189|536558124|FG002|Treatment Period|Withdrawal by Subject|1|||
148750787|NCT01125189|536558122|FG000|Treatment Period|Death|1|||
148750788|NCT01125189|536558123|FG001|Treatment Period|Death|0|||
148750789|NCT01125189|536558124|FG002|Treatment Period|Death|0|||
148750790|NCT01125189|536558122|FG000|Treatment Period|Lost to Follow-up|1|||
148750791|NCT01125189|536558123|FG001|Treatment Period|Lost to Follow-up|2|||
148750792|NCT01125189|536558124|FG002|Treatment Period|Lost to Follow-up|1|||
148750793|NCT01125189|536558122|FG000|Treatment Period|Poor compliance/noncompliance|0|||
148750794|NCT01125189|536558123|FG001|Treatment Period|Poor compliance/noncompliance|1|||
148750795|NCT01125189|536558124|FG002|Treatment Period|Poor compliance/noncompliance|0|||
148750796|NCT01125189|536558122|FG000|Treatment Period|Participants requested to discontinue|1|||
148750797|NCT01125189|536558123|FG001|Treatment Period|Participants requested to discontinue|3|||
148750798|NCT01125189|536558124|FG002|Treatment Period|Participants requested to discontinue|4|||
148750799|NCT01125189|536558122|FG000|Treatment Period|Other reasons|1|||
148750800|NCT01125189|536558123|FG001|Treatment Period|Other reasons|1|||
148750801|NCT01125189|536558124|FG002|Treatment Period|Other reasons|0|||
148750802|NCT01125189|536558122|FG000|Treatment Period|Completed 24 week treatment period only|2|||
148750803|NCT01125189|536558123|FG001|Treatment Period|Completed 24 week treatment period only|1|||
148750804|NCT01125189|536558124|FG002|Treatment Period|Completed 24 week treatment period only|2|||
148750805|NCT01125189|536558122|FG000|Follow up Period|Withdrawal by Subject|3|||
148750806|NCT01125189|536558123|FG001|Follow up Period|Withdrawal by Subject|2|||
148750807|NCT01125189|536558124|FG002|Follow up Period|Withdrawal by Subject|5|||
148750808|NCT01125189|536558122|FG000|Follow up Period|Death|1|||
148750809|NCT01125189|536558123|FG001|Follow up Period|Death|0|||
148750810|NCT01125189|536558124|FG002|Follow up Period|Death|0|||
148750811|NCT01125189|536558122|FG000|Follow up Period|Lost to Follow-up|12|||
148750812|NCT01125189|536558123|FG001|Follow up Period|Lost to Follow-up|9|||
148750813|NCT01125189|536558124|FG002|Follow up Period|Lost to Follow-up|6|||
148750814|NCT01125189|536558122|FG000|Follow up Period|Other reasons|4|||
148750815|NCT01125189|536558123|FG001|Follow up Period|Other reasons|4|||
148750816|NCT01125189|536558124|FG002|Follow up Period|Other reasons|5|||
148750817|NCT00114140|536558125|FG000|Overall Study|Protocol Violation|7|||
148750818|NCT00110396|536558126|FG000|Overall Study|Adverse Event|15|||
148750819|NCT00110396|536558126|FG000|Overall Study|Lost to Follow-up|1|||
148750820|NCT00110396|536558126|FG000|Overall Study|Administration of plasmapheresis|1|||
148750821|NCT00110396|536558126|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
148750822|NCT00110396|536558126|FG000|Overall Study|Lack of Efficacy|1|||
148750823|NCT00110396|536558126|FG000|Overall Study|Decided not to continue treatment|1|||
148750824|NCT00110396|536558126|FG000|Overall Study|Patient non-compliance|1|||
148750825|NCT00110396|536558126|FG000|Overall Study|Patient refused to continue|1|||
148750826|NCT00110396|536558126|FG000|Overall Study|Patient refused to participate|1|||
148750827|NCT00110396|536558126|FG000|Overall Study|Patient will|1|||
148750828|NCT00110396|536558126|FG000|Overall Study|Patient's decision|1|||
148750829|NCT00110396|536558126|FG000|Overall Study|Participation in MS vaccine study|1|||
148750830|NCT00110396|536558126|FG000|Overall Study|Pregnancy|1|||
148750831|NCT00110396|536558126|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
148750832|NCT00110396|536558126|FG000|Overall Study|Protocol Violation|2|||
148750833|NCT00110396|536558126|FG000|Overall Study|Patient refused to come back|1|||
148750834|NCT00110396|536558126|FG000|Overall Study|The patient has refused|2|||
148750835|NCT00110396|536558126|FG000|Overall Study|The patient has refused to visit site|1|||
148750836|NCT00110396|536558126|FG000|Overall Study|Patient is to be administered copaxone|1|||
148750837|NCT00245466|536558129|FG000|Overall Study|Adverse Event|2|||
148750838|NCT00245466|536558130|FG001|Overall Study|Adverse Event|8|||
148750839|NCT00245466|536558131|FG002|Overall Study|Adverse Event|4|||
148750840|NCT00245466|536558129|FG000|Overall Study|Low prostate specific antigen suppr|16|||
148750841|NCT00245466|536558130|FG001|Overall Study|Low prostate specific antigen suppr|14|||
148750842|NCT00245466|536558131|FG002|Overall Study|Low prostate specific antigen suppr|5|||
148750843|NCT00245466|536558129|FG000|Overall Study|Insufficient testosterone suppr|12|||
148750844|NCT00245466|536558130|FG001|Overall Study|Insufficient testosterone suppr|12|||
148750845|NCT00245466|536558131|FG002|Overall Study|Insufficient testosterone suppr|21|||
148750846|NCT00245466|536558129|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
148750847|NCT00245466|536558130|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
148750848|NCT00245466|536558131|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
148750849|NCT00245466|536558129|FG000|Overall Study|Withdrawal by Subject|2|||
148750850|NCT00245466|536558130|FG001|Overall Study|Withdrawal by Subject|2|||
148750851|NCT00245466|536558131|FG002|Overall Study|Withdrawal by Subject|1|||
148750852|NCT00245466|536558129|FG000|Overall Study|Lost to Follow-up|3|||
148750853|NCT00245466|536558130|FG001|Overall Study|Lost to Follow-up|0|||
148750854|NCT00245466|536558131|FG002|Overall Study|Lost to Follow-up|0|||
148750855|NCT00245466|536558129|FG000|Overall Study|Disease progression|0|||
148750856|NCT00245466|536558130|FG001|Overall Study|Disease progression|3|||
148750857|NCT00245466|536558131|FG002|Overall Study|Disease progression|1|||
148750858|NCT00245466|536558129|FG000|Overall Study|Protocol Violation|1|||
148750859|NCT00245466|536558130|FG001|Overall Study|Protocol Violation|2|||
148750860|NCT00245466|536558131|FG002|Overall Study|Protocol Violation|2|||
148750861|NCT00245466|536558129|FG000|Overall Study|Death|0|||
148750862|NCT00245466|536558130|FG001|Overall Study|Death|2|||
148750863|NCT00245466|536558131|FG002|Overall Study|Death|0|||
148750864|NCT00245466|536558129|FG000|Overall Study|Administrative reasons|0|||
148750865|NCT00245466|536558130|FG001|Overall Study|Administrative reasons|1|||
148750866|NCT00245466|536558131|FG002|Overall Study|Administrative reasons|0|||
148750867|NCT04194645|536558136|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750868|NCT04194645|536558137|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750869|NCT04194645|536558138|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750870|NCT04194645|536558139|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750871|NCT04194645|536558140|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750872|NCT04194645|536558141|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750873|NCT04194645|536558142|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750874|NCT04194645|536558143|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750875|NCT04194645|536558144|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750876|NCT04194645|536558145|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
148750877|NCT04194645|536558146|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750878|NCT04194645|536558147|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750879|NCT04194645|536558148|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750880|NCT04194645|536558149|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750881|NCT04194645|536558150|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
148750882|NCT00940316|536558153|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
148750883|NCT00940316|536558154|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
148750884|NCT00940316|536558155|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
148750885|NCT00940316|536558153|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
148750886|NCT00940316|536558154|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
148750887|NCT00940316|536558155|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
148750888|NCT00940316|536558153|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
148750889|NCT00940316|536558154|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
148750890|NCT00940316|536558155|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
148750891|NCT00940316|536558153|FG000|Treated After Cycle 5|Adverse Event|0|||
148750892|NCT00940316|536558154|FG001|Treated After Cycle 5|Adverse Event|0|||
148750893|NCT00940316|536558155|FG002|Treated After Cycle 5|Adverse Event|1|||
148750894|NCT00940316|536558153|FG000|Treated After Cycle 5|Progressive disease|0|||
148750895|NCT00940316|536558154|FG001|Treated After Cycle 5|Progressive disease|1|||
148750896|NCT00940316|536558155|FG002|Treated After Cycle 5|Progressive disease|0|||
148750897|NCT02324582|536558156|FG000|Overall Study|Screen Failures|0|||
148750898|NCT02324582|536558157|FG001|Overall Study|Screen Failures|5|||
148750899|NCT00996489|536558160|FG000|Overall Study|Device failure|45|||
148750900|NCT00996489|536558160|FG000|Overall Study|Discontinued|116|||
148750901|NCT00129545|536558163|FG000|Overall Study|Death|5|||
148750902|NCT00129545|536558164|FG001|Overall Study|Death|60|||
148750903|NCT00129545|536558165|FG002|Overall Study|Death|44|||
148750904|NCT00129545|536558163|FG000|Overall Study|Withdrawal by Subject|3|||
148750905|NCT00129545|536558164|FG001|Overall Study|Withdrawal by Subject|18|||
148750906|NCT00129545|536558165|FG002|Overall Study|Withdrawal by Subject|44|||
148976213|NCT00079274|537394484|FG001|Overall Study|Other Medical Problems|1|||
148750907|NCT00129545|536558163|FG000|Overall Study|Lost to Follow-up|2|||
148750908|NCT00129545|536558164|FG001|Overall Study|Lost to Follow-up|22|||
148750909|NCT00129545|536558165|FG002|Overall Study|Lost to Follow-up|13|||
148750910|NCT00129545|536558163|FG000|Overall Study|Physician Decision|0|||
148750911|NCT00129545|536558164|FG001|Overall Study|Physician Decision|3|||
148750912|NCT00129545|536558165|FG002|Overall Study|Physician Decision|10|||
148750913|NCT00129545|536558163|FG000|Overall Study|Device not implanted|16|||
148750914|NCT00129545|536558164|FG001|Overall Study|Device not implanted|61|||
148750915|NCT00129545|536558165|FG002|Overall Study|Device not implanted|0|||
148750916|NCT03541317|536558173|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
148750917|NCT03541317|536558174|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
148750918|NCT03541317|536558175|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
148750919|NCT03541317|536558176|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
148750920|NCT03541317|536558177|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
148750921|NCT03541317|536558178|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
148750922|NCT02286843|536558179|FG000|Overall Study|Not Treated|4|||
148750923|NCT02286843|536558179|FG000|Overall Study|Protocol Violation|1|||
148750924|NCT02286843|536558179|FG000|Overall Study|Withdrawal by Subject|1|||
148750925|NCT02536846|536558180|FG000|Overall Study|Withdrawal by Subject|1|||
148750926|NCT04502212|536558188|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
148750927|NCT04502212|536558188|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
148750928|NCT00111241|536558189|FG000|Overall Study|Lost to Follow-up|1|||
148750929|NCT00111241|536558190|FG001|Overall Study|Lost to Follow-up|0|||
148750930|NCT00111241|536558189|FG000|Overall Study|Withdrawal by Subject|4|||
148750931|NCT00111241|536558190|FG001|Overall Study|Withdrawal by Subject|0|||
148750932|NCT00111241|536558189|FG000|Overall Study|Protocol Violation|9|||
148750933|NCT00111241|536558190|FG001|Overall Study|Protocol Violation|8|||
148750934|NCT00111241|536558189|FG000|Overall Study|Adverse Event|1|||
148750935|NCT00111241|536558190|FG001|Overall Study|Adverse Event|0|||
148750936|NCT02096744|536558201|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
148750937|NCT02096744|536558202|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
148750938|NCT02096744|536558201|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
148750939|NCT02096744|536558202|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
148750940|NCT02096744|536558201|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
148750941|NCT02096744|536558202|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
148750942|NCT02445963|536558205|FG000|Overall Study|Lost to Follow-up|1|||
148750943|NCT02445963|536558206|FG001|Overall Study|Lost to Follow-up|0|||
148750944|NCT02445963|536558207|FG002|Overall Study|Lost to Follow-up|0|||
148750945|NCT02445963|536558208|FG003|Overall Study|Lost to Follow-up|0|||
148750946|NCT02445963|536558205|FG000|Overall Study|Change in employment|1|||
148750947|NCT02445963|536558206|FG001|Overall Study|Change in employment|0|||
148750948|NCT02445963|536558207|FG002|Overall Study|Change in employment|0|||
148750949|NCT02445963|536558208|FG003|Overall Study|Change in employment|0|||
148750950|NCT02445963|536558205|FG000|Overall Study|Symptoms post-vaccination|0|||
148750951|NCT02445963|536558206|FG001|Overall Study|Symptoms post-vaccination|0|||
148750952|NCT02445963|536558207|FG002|Overall Study|Symptoms post-vaccination|1|||
148750953|NCT02445963|536558208|FG003|Overall Study|Symptoms post-vaccination|0|||
148750954|NCT01449812|536558212|FG000|Overall Study|Migrated/moved from study area|1|||
148750955|NCT01449812|536558213|FG001|Overall Study|Migrated/moved from study area|0|||
148750956|NCT01449812|536558214|FG002|Overall Study|Migrated/moved from study area|0|||
148750957|NCT01449812|536558212|FG000|Overall Study|Withdrawal by Subject|0|||
148750958|NCT01449812|536558213|FG001|Overall Study|Withdrawal by Subject|0|||
148750959|NCT01449812|536558214|FG002|Overall Study|Withdrawal by Subject|1|||
148750960|NCT01449812|536558212|FG000|Overall Study|Lost to Follow-up|1|||
148750961|NCT01449812|536558213|FG001|Overall Study|Lost to Follow-up|0|||
148750962|NCT01449812|536558214|FG002|Overall Study|Lost to Follow-up|0|||
148750963|NCT03449446|536558215|FG000|Overall Study|Randomized but Never Treated|0|||
148750964|NCT03449446|536558216|FG001|Overall Study|Randomized but Never Treated|0|||
148750965|NCT03449446|536558217|FG002|Overall Study|Randomized but Never Treated|1|||
148750966|NCT03449446|536558218|FG003|Overall Study|Randomized but Never Treated|1|||
148750967|NCT03449446|536558219|FG004|Overall Study|Randomized but Never Treated|1|||
148750968|NCT03449446|536558220|FG005|Overall Study|Randomized but Never Treated|0|||
148750969|NCT03449446|536558221|FG006|Overall Study|Randomized but Never Treated|0|||
148750970|NCT03449446|536558215|FG000|Overall Study|Unknown Reason|33|||
148976214|NCT00079274|537394485|FG002|Overall Study|Other Medical Problems|0|||
148750971|NCT03449446|536558216|FG001|Overall Study|Unknown Reason|1|||
148750972|NCT03449446|536558217|FG002|Overall Study|Unknown Reason|1|||
148750973|NCT03449446|536558218|FG003|Overall Study|Unknown Reason|1|||
148976215|NCT00079274|537394486|FG003|Overall Study|Other Medical Problems|7|||
148976216|NCT00079274|537394487|FG004|Overall Study|Other Medical Problems|0|||
148976217|NCT00079274|537394488|FG005|Overall Study|Other Medical Problems|0|||
148822177|NCT04595370|536826721|FG000|Overall Study|Withdrawal of Consent|1|||
148976218|NCT00079274|537394489|FG006|Overall Study|Other Medical Problems|0|||
148822178|NCT04595370|536826722|FG001|Overall Study|Withdrawal of Consent|1|||
148822179|NCT04595370|536826723|FG002|Overall Study|Withdrawal of Consent|1|||
148822180|NCT04595370|536826724|FG003|Overall Study|Withdrawal of Consent|0|||
148822181|NCT04595370|536826725|FG004|Overall Study|Withdrawal of Consent|0|||
148822182|NCT04595370|536826726|FG005|Overall Study|Withdrawal of Consent|0|||
148822183|NCT04595370|536826721|FG000|Overall Study|Death|0|||
148822184|NCT04595370|536826722|FG001|Overall Study|Death|1|||
148822185|NCT04595370|536826723|FG002|Overall Study|Death|0|||
148822186|NCT04595370|536826724|FG003|Overall Study|Death|0|||
148822187|NCT04595370|536826725|FG004|Overall Study|Death|1|||
148822188|NCT04595370|536826726|FG005|Overall Study|Death|0|||
148822189|NCT04595370|536826721|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148822190|NCT04595370|536826722|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148822191|NCT04595370|536826723|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
148822192|NCT04595370|536826724|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148822193|NCT04595370|536826725|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148822194|NCT04595370|536826726|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148822195|NCT04595370|536826721|FG000|Overall Study|Withdrawal by Subject|0|||
148822196|NCT04595370|536826722|FG001|Overall Study|Withdrawal by Subject|0|||
148822197|NCT04595370|536826723|FG002|Overall Study|Withdrawal by Subject|1|||
148822198|NCT04595370|536826724|FG003|Overall Study|Withdrawal by Subject|0|||
148822199|NCT04595370|536826725|FG004|Overall Study|Withdrawal by Subject|2|||
148822200|NCT04595370|536826726|FG005|Overall Study|Withdrawal by Subject|0|||
148822201|NCT04595370|536826721|FG000|Overall Study|Lost to Follow-up|0|||
148822202|NCT04595370|536826722|FG001|Overall Study|Lost to Follow-up|0|||
148822203|NCT04595370|536826723|FG002|Overall Study|Lost to Follow-up|0|||
148822204|NCT04595370|536826724|FG003|Overall Study|Lost to Follow-up|0|||
148822205|NCT04595370|536826725|FG004|Overall Study|Lost to Follow-up|1|||
148822206|NCT04595370|536826726|FG005|Overall Study|Lost to Follow-up|0|||
148822207|NCT04595370|536826721|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
148822208|NCT04595370|536826722|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
148822209|NCT04595370|536826723|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
148822210|NCT04595370|536826724|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
148822211|NCT04595370|536826725|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
148822212|NCT04595370|536826726|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
148822213|NCT05660538|536826727|FG000|Overall Study|Adverse Event|0|||
148822214|NCT05660538|536826728|FG001|Overall Study|Adverse Event|0|||
148822215|NCT05660538|536826729|FG002|Overall Study|Adverse Event|1|||
148822216|NCT05660538|536826730|FG003|Overall Study|Adverse Event|0|||
148822217|NCT05660538|536826727|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
148822218|NCT05660538|536826728|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
148822219|NCT05660538|536826729|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
148822220|NCT05660538|536826730|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
148822221|NCT05660538|536826727|FG000|Overall Study|Lost to Follow-up|0|||
148822222|NCT05660538|536826728|FG001|Overall Study|Lost to Follow-up|0|||
148822223|NCT05660538|536826729|FG002|Overall Study|Lost to Follow-up|1|||
148822224|NCT05660538|536826730|FG003|Overall Study|Lost to Follow-up|1|||
148822225|NCT05660538|536826727|FG000|Overall Study|Death|0|||
148822226|NCT05660538|536826728|FG001|Overall Study|Death|0|||
148822227|NCT05660538|536826729|FG002|Overall Study|Death|1|||
148822228|NCT05660538|536826730|FG003|Overall Study|Death|0|||
148822229|NCT05660538|536826727|FG000|Overall Study|Physician Decision|0|||
148822230|NCT05660538|536826728|FG001|Overall Study|Physician Decision|0|||
148976219|NCT00079274|537394483|FG000|Overall Study|Death|4|||
148976220|NCT00079274|537394484|FG001|Overall Study|Death|0|||
148750974|NCT03449446|536558219|FG004|Overall Study|Unknown Reason|2|||
148750975|NCT03449446|536558220|FG005|Overall Study|Unknown Reason|2|||
148750976|NCT03449446|536558221|FG006|Overall Study|Unknown Reason|0|||
148750977|NCT03449446|536558215|FG000|Overall Study|Withdrew Consent|1|||
148750978|NCT03449446|536558216|FG001|Overall Study|Withdrew Consent|3|||
148750979|NCT03449446|536558217|FG002|Overall Study|Withdrew Consent|1|||
148750980|NCT03449446|536558218|FG003|Overall Study|Withdrew Consent|4|||
148750981|NCT03449446|536558219|FG004|Overall Study|Withdrew Consent|4|||
148750982|NCT03449446|536558220|FG005|Overall Study|Withdrew Consent|4|||
148822231|NCT05660538|536826729|FG002|Overall Study|Physician Decision|0|||
148822232|NCT05660538|536826730|FG003|Overall Study|Physician Decision|1|||
148822233|NCT05660538|536826727|FG000|Overall Study|Sponsor Decision|1|||
148822234|NCT05660538|536826728|FG001|Overall Study|Sponsor Decision|0|||
148822235|NCT05660538|536826729|FG002|Overall Study|Sponsor Decision|0|||
148976221|NCT00079274|537394485|FG002|Overall Study|Death|1|||
148822236|NCT05660538|536826730|FG003|Overall Study|Sponsor Decision|0|||
148822237|NCT05660538|536826727|FG000|Overall Study|Other|1|||
148822238|NCT05660538|536826728|FG001|Overall Study|Other|0|||
148750983|NCT03449446|536558221|FG006|Overall Study|Withdrew Consent|1|||
148822239|NCT05660538|536826729|FG002|Overall Study|Other|0|||
148822240|NCT05660538|536826730|FG003|Overall Study|Other|1|||
148822241|NCT05660538|536826727|FG000|Overall Study|Randomized but did not receive study drug|1|||
148822242|NCT05660538|536826728|FG001|Overall Study|Randomized but did not receive study drug|0|||
148822243|NCT05660538|536826729|FG002|Overall Study|Randomized but did not receive study drug|0|||
148822244|NCT05660538|536826730|FG003|Overall Study|Randomized but did not receive study drug|1|||
148822245|NCT05660538|536826727|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
148822246|NCT05660538|536826728|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
148822247|NCT05660538|536826729|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
148822248|NCT05660538|536826730|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
148822249|NCT04518410|536826731|FG000|Overall Study|Lost to Follow-up|1|||
148822250|NCT04518410|536826732|FG001|Overall Study|Lost to Follow-up|1|||
148822251|NCT04518410|536826733|FG002|Overall Study|Lost to Follow-up|8|||
148822252|NCT04518410|536826734|FG003|Overall Study|Lost to Follow-up|5|||
148822253|NCT04518410|536826735|FG004|Overall Study|Lost to Follow-up|92|||
148822254|NCT04518410|536826736|FG005|Overall Study|Lost to Follow-up|25|||
148822255|NCT04518410|536826737|FG006|Overall Study|Lost to Follow-up|25|||
148822256|NCT04518410|536826738|FG007|Overall Study|Lost to Follow-up|3|||
148822257|NCT04518410|536826739|FG008|Overall Study|Lost to Follow-up|2|||
148822258|NCT04518410|536826740|FG009|Overall Study|Lost to Follow-up|13|||
148822259|NCT04518410|536826741|FG010|Overall Study|Lost to Follow-up|9|||
148822260|NCT04518410|536826742|FG011|Overall Study|Lost to Follow-up|13|||
148822261|NCT04518410|536826743|FG012|Overall Study|Lost to Follow-up|9|||
148822262|NCT04518410|536826744|FG013|Overall Study|Lost to Follow-up|13|||
148822263|NCT04518410|536826745|FG014|Overall Study|Lost to Follow-up|8|||
148822264|NCT04518410|536826746|FG015|Overall Study|Lost to Follow-up|10|||
148822265|NCT04518410|536826747|FG016|Overall Study|Lost to Follow-up|6|||
148822266|NCT04518410|536826748|FG017|Overall Study|Lost to Follow-up|13|||
148822267|NCT04518410|536826749|FG018|Overall Study|Lost to Follow-up|21|||
148822268|NCT04518410|536826750|FG019|Overall Study|Lost to Follow-up|6|||
148822269|NCT04518410|536826751|FG020|Overall Study|Lost to Follow-up|7|||
148822270|NCT04518410|536826752|FG021|Overall Study|Lost to Follow-up|21|||
148822271|NCT04518410|536826753|FG022|Overall Study|Lost to Follow-up|1|||
148822272|NCT04518410|536826754|FG023|Overall Study|Lost to Follow-up|7|||
148822273|NCT04518410|536826755|FG024|Overall Study|Lost to Follow-up|6|||
148822274|NCT04518410|536826731|FG000|Overall Study|Withdrawal by Subject|1|||
148822275|NCT04518410|536826732|FG001|Overall Study|Withdrawal by Subject|2|||
148822276|NCT04518410|536826733|FG002|Overall Study|Withdrawal by Subject|2|||
148822277|NCT04518410|536826734|FG003|Overall Study|Withdrawal by Subject|3|||
148822278|NCT04518410|536826735|FG004|Overall Study|Withdrawal by Subject|20|||
148822279|NCT04518410|536826736|FG005|Overall Study|Withdrawal by Subject|20|||
148822280|NCT04518410|536826737|FG006|Overall Study|Withdrawal by Subject|25|||
148822281|NCT04518410|536826738|FG007|Overall Study|Withdrawal by Subject|6|||
148822282|NCT04518410|536826739|FG008|Overall Study|Withdrawal by Subject|1|||
148822283|NCT04518410|536826740|FG009|Overall Study|Withdrawal by Subject|12|||
148822284|NCT04518410|536826741|FG010|Overall Study|Withdrawal by Subject|5|||
148822285|NCT04518410|536826742|FG011|Overall Study|Withdrawal by Subject|7|||
148822286|NCT04518410|536826743|FG012|Overall Study|Withdrawal by Subject|2|||
148822287|NCT04518410|536826744|FG013|Overall Study|Withdrawal by Subject|13|||
148822288|NCT04518410|536826745|FG014|Overall Study|Withdrawal by Subject|4|||
148822289|NCT04518410|536826746|FG015|Overall Study|Withdrawal by Subject|9|||
148822290|NCT04518410|536826747|FG016|Overall Study|Withdrawal by Subject|0|||
148822291|NCT04518410|536826748|FG017|Overall Study|Withdrawal by Subject|15|||
148822292|NCT04518410|536826749|FG018|Overall Study|Withdrawal by Subject|12|||
148822293|NCT04518410|536826750|FG019|Overall Study|Withdrawal by Subject|9|||
148822294|NCT04518410|536826751|FG020|Overall Study|Withdrawal by Subject|14|||
148822295|NCT04518410|536826752|FG021|Overall Study|Withdrawal by Subject|3|||
148822296|NCT04518410|536826753|FG022|Overall Study|Withdrawal by Subject|2|||
148822297|NCT04518410|536826754|FG023|Overall Study|Withdrawal by Subject|9|||
148822298|NCT04518410|536826755|FG024|Overall Study|Withdrawal by Subject|8|||
148822299|NCT04518410|536826731|FG000|Overall Study|Other|1|||
148822300|NCT04518410|536826732|FG001|Overall Study|Other|0|||
148822301|NCT04518410|536826733|FG002|Overall Study|Other|0|||
148822302|NCT04518410|536826734|FG003|Overall Study|Other|1|||
148822303|NCT04518410|536826735|FG004|Overall Study|Other|6|||
148822304|NCT04518410|536826736|FG005|Overall Study|Other|6|||
148822305|NCT04518410|536826737|FG006|Overall Study|Other|5|||
148822306|NCT04518410|536826738|FG007|Overall Study|Other|2|||
148822307|NCT04518410|536826739|FG008|Overall Study|Other|0|||
148822308|NCT04518410|536826740|FG009|Overall Study|Other|1|||
148822309|NCT04518410|536826741|FG010|Overall Study|Other|0|||
148822310|NCT04518410|536826742|FG011|Overall Study|Other|2|||
148822311|NCT04518410|536826743|FG012|Overall Study|Other|0|||
148822312|NCT04518410|536826744|FG013|Overall Study|Other|0|||
148822313|NCT04518410|536826745|FG014|Overall Study|Other|0|||
148822314|NCT04518410|536826746|FG015|Overall Study|Other|3|||
149027292|NCT00984282|537578535|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
148822315|NCT04518410|536826747|FG016|Overall Study|Other|1|||
148750984|NCT03449446|536558215|FG000|Overall Study|Adverse Event|1|||
148750985|NCT03449446|536558216|FG001|Overall Study|Adverse Event|2|||
148750986|NCT03449446|536558217|FG002|Overall Study|Adverse Event|1|||
148750987|NCT03449446|536558218|FG003|Overall Study|Adverse Event|0|||
148750988|NCT03449446|536558219|FG004|Overall Study|Adverse Event|0|||
148750989|NCT03449446|536558220|FG005|Overall Study|Adverse Event|2|||
148750990|NCT03449446|536558221|FG006|Overall Study|Adverse Event|0|||
148750991|NCT03449446|536558215|FG000|Overall Study|Lost to Follow-up|0|||
148750992|NCT03449446|536558216|FG001|Overall Study|Lost to Follow-up|0|||
148750993|NCT03449446|536558217|FG002|Overall Study|Lost to Follow-up|2|||
148750994|NCT03449446|536558218|FG003|Overall Study|Lost to Follow-up|1|||
148750995|NCT03449446|536558219|FG004|Overall Study|Lost to Follow-up|3|||
148750996|NCT03449446|536558220|FG005|Overall Study|Lost to Follow-up|0|||
148750997|NCT03449446|536558221|FG006|Overall Study|Lost to Follow-up|0|||
148750998|NCT03449446|536558215|FG000|Overall Study|Investigator's Discretion|0|||
148750999|NCT03449446|536558216|FG001|Overall Study|Investigator's Discretion|1|||
148751000|NCT03449446|536558217|FG002|Overall Study|Investigator's Discretion|1|||
148751001|NCT03449446|536558218|FG003|Overall Study|Investigator's Discretion|2|||
148751002|NCT03449446|536558219|FG004|Overall Study|Investigator's Discretion|0|||
148751003|NCT03449446|536558220|FG005|Overall Study|Investigator's Discretion|0|||
148751004|NCT03449446|536558221|FG006|Overall Study|Investigator's Discretion|0|||
148751005|NCT03449446|536558215|FG000|Overall Study|Non Compliance with Study Drug|1|||
148751006|NCT03449446|536558216|FG001|Overall Study|Non Compliance with Study Drug|0|||
148751007|NCT03449446|536558217|FG002|Overall Study|Non Compliance with Study Drug|0|||
148751008|NCT03449446|536558218|FG003|Overall Study|Non Compliance with Study Drug|0|||
148751009|NCT03449446|536558219|FG004|Overall Study|Non Compliance with Study Drug|0|||
148751010|NCT03449446|536558220|FG005|Overall Study|Non Compliance with Study Drug|0|||
148751011|NCT03449446|536558221|FG006|Overall Study|Non Compliance with Study Drug|0|||
148751012|NCT03449446|536558215|FG000|Overall Study|Protocol Violation|0|||
148751013|NCT03449446|536558216|FG001|Overall Study|Protocol Violation|0|||
148751014|NCT03449446|536558217|FG002|Overall Study|Protocol Violation|0|||
148751015|NCT03449446|536558218|FG003|Overall Study|Protocol Violation|0|||
148751016|NCT03449446|536558219|FG004|Overall Study|Protocol Violation|1|||
148751017|NCT03449446|536558220|FG005|Overall Study|Protocol Violation|1|||
148751018|NCT03449446|536558221|FG006|Overall Study|Protocol Violation|0|||
148751019|NCT03449446|536558215|FG000|Overall Study|Death|0|||
148751020|NCT03449446|536558216|FG001|Overall Study|Death|0|||
148751021|NCT03449446|536558217|FG002|Overall Study|Death|0|||
148751022|NCT03449446|536558218|FG003|Overall Study|Death|0|||
148751023|NCT03449446|536558219|FG004|Overall Study|Death|1|||
148751024|NCT03449446|536558220|FG005|Overall Study|Death|0|||
148751025|NCT03449446|536558221|FG006|Overall Study|Death|0|||
148751026|NCT02108912|536558226|FG000|Overall Study|Lost to Follow-up|1|||
148751027|NCT02108912|536558227|FG001|Overall Study|Lost to Follow-up|1|||
148751028|NCT02108912|536558226|FG000|Overall Study|lack of transportation|1|||
148751029|NCT02108912|536558227|FG001|Overall Study|lack of transportation|0|||
148751030|NCT02108912|536558226|FG000|Overall Study|high blood pressure|1|||
148751031|NCT02108912|536558227|FG001|Overall Study|high blood pressure|0|||
148751032|NCT00625872|536558230|FG000|Overall Study|Withdrawal by Subject|1|||
148751033|NCT00625872|536558231|FG001|Overall Study|Withdrawal by Subject|0|||
148751034|NCT00625872|536558230|FG000|Overall Study|Does not meet inclusion criteria|1|||
148751035|NCT00625872|536558231|FG001|Overall Study|Does not meet inclusion criteria|0|||
148751036|NCT00625872|536558230|FG000|Overall Study|Terminated by sponsor|2|||
148751037|NCT00625872|536558231|FG001|Overall Study|Terminated by sponsor|5|||
148751038|NCT00625872|536558230|FG000|Overall Study|Randomized but not treated|0|||
148751039|NCT00625872|536558231|FG001|Overall Study|Randomized but not treated|1|||
148751040|NCT04208750|536558232|FG000|Overall Study|Lost to Follow-up|16|||
148751041|NCT04208750|536558233|FG001|Overall Study|Lost to Follow-up|15|||
148751042|NCT02201277|536558237|FG000|Overall Study|Death|3|||
148751043|NCT02201277|536558238|FG001|Overall Study|Death|4|||
148751044|NCT02201277|536558237|FG000|Overall Study|Lost to Follow-up|2|||
148751045|NCT02201277|536558238|FG001|Overall Study|Lost to Follow-up|1|||
148751046|NCT02201277|536558237|FG000|Overall Study|Failed retrieval|1|||
148751047|NCT02201277|536558238|FG001|Overall Study|Failed retrieval|0|||
148751048|NCT02201277|536558237|FG000|Overall Study|Physician Decision|1|||
148751049|NCT02201277|536558238|FG001|Overall Study|Physician Decision|0|||
148751050|NCT02905032|536558239|FG000|Overall Study|Withdrawal by Subject|2|||
148751051|NCT02905032|536558240|FG001|Overall Study|Withdrawal by Subject|0|||
148751052|NCT02905032|536558241|FG002|Overall Study|Withdrawal by Subject|0|||
148751053|NCT02905032|536558239|FG000|Overall Study|Protocol Violation|6|||
148751054|NCT02905032|536558240|FG001|Overall Study|Protocol Violation|12|||
148751055|NCT02905032|536558241|FG002|Overall Study|Protocol Violation|0|||
148751056|NCT00739063|536558242|FG000|Overall Study|Screen failures|8|||
148751057|NCT02163057|536558243|FG000|Overall Study|Participant Refusal to Continue|2|||
148751058|NCT02163057|536558244|FG001|Overall Study|Participant Refusal to Continue|2|||
148751059|NCT02163057|536558243|FG000|Overall Study|Participant Significant Noncompliance|0|||
148751060|NCT02163057|536558244|FG001|Overall Study|Participant Significant Noncompliance|1|||
148751061|NCT02163057|536558243|FG000|Overall Study|Progression of Disease|1|||
148976222|NCT00079274|537394486|FG003|Overall Study|Death|15|||
148976223|NCT00079274|537394487|FG004|Overall Study|Death|0|||
148976224|NCT00079274|537394488|FG005|Overall Study|Death|0|||
148976225|NCT00079274|537394489|FG006|Overall Study|Death|0|||
148976226|NCT00079274|537394483|FG000|Overall Study|Cytogenetic resistance|0|||
148976227|NCT00079274|537394484|FG001|Overall Study|Cytogenetic resistance|0|||
148976228|NCT00079274|537394485|FG002|Overall Study|Cytogenetic resistance|0|||
148976229|NCT00079274|537394486|FG003|Overall Study|Cytogenetic resistance|2|||
148976230|NCT00079274|537394487|FG004|Overall Study|Cytogenetic resistance|0|||
149027293|NCT00984282|537578536|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
148751062|NCT02163057|536558244|FG001|Overall Study|Progression of Disease|2|||
148751063|NCT02603146|536560443|FG000|Overall Study|Lost to Follow-up|5|||
148751064|NCT02603146|536560444|FG001|Overall Study|Lost to Follow-up|6|||
148751065|NCT02603146|536560443|FG000|Overall Study|Withdrawal by Subject|8|||
148751066|NCT02603146|536560444|FG001|Overall Study|Withdrawal by Subject|10|||
148751067|NCT02603146|536560443|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
148751068|NCT02603146|536560444|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
148751069|NCT02603146|536560443|FG000|Overall Study|Participant moved|2|||
148751070|NCT02603146|536560444|FG001|Overall Study|Participant moved|0|||
148751071|NCT02603146|536560443|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
148751072|NCT02603146|536560444|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
148751073|NCT00782626|536560451|FG000|Overall Study|Adverse Event|1|||
148751074|NCT00782626|536560451|FG000|Overall Study|Progressive Disease|5|||
148751075|NCT00782626|536560451|FG000|Overall Study|Other Complicating Disease|1|||
148751076|NCT04054765|536560452|FG000|Baseline|Withdrawal by Subject|5|||
148751077|NCT04054765|536560453|FG001|Baseline|Withdrawal by Subject|3|||
148751078|NCT04054765|536560452|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
148751079|NCT04054765|536560453|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
148751080|NCT04054765|536560452|FG000|3-month Follow up|Withdrawal by Subject|0|||
148751081|NCT04054765|536560453|FG001|3-month Follow up|Withdrawal by Subject|3|||
148751082|NCT04054765|536560452|FG000|6-month Follow up|Lost to Follow-up|32|||
148751083|NCT04054765|536560453|FG001|6-month Follow up|Lost to Follow-up|32|||
148751084|NCT03718832|536560457|FG000|Analysis Sample|Withdrawal by Subject|18|||
148751085|NCT03718832|536560458|FG001|Analysis Sample|Withdrawal by Subject|15|||
148751086|NCT03718832|536560457|FG000|Analysis Sample|Legal hold on data|1|||
148751087|NCT03718832|536560458|FG001|Analysis Sample|Legal hold on data|0|||
148751088|NCT03718832|536560457|FG000|Analysis Sample|Participant from treated household|0|||
148751089|NCT03718832|536560458|FG001|Analysis Sample|Participant from treated household|1|||
148751090|NCT03718832|536560457|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
148751091|NCT03718832|536560458|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
148751092|NCT01996241|536560459|FG000|Overall Study|Lost to Follow-up|252|||
148751093|NCT01996241|536560460|FG001|Overall Study|Lost to Follow-up|235|||
148751094|NCT01068262|536560463|FG000|Overall Study|Adverse Event|2|||
148751095|NCT01068262|536560464|FG001|Overall Study|Adverse Event|0|||
148751096|NCT01068262|536560465|FG002|Overall Study|Adverse Event|1|||
148751097|NCT01068262|536560466|FG003|Overall Study|Adverse Event|0|||
148751098|NCT01068262|536560463|FG000|Overall Study|Protocol Violation|1|||
148751099|NCT01068262|536560464|FG001|Overall Study|Protocol Violation|0|||
148751100|NCT01068262|536560465|FG002|Overall Study|Protocol Violation|0|||
148751101|NCT01068262|536560466|FG003|Overall Study|Protocol Violation|0|||
148751102|NCT01068262|536560463|FG000|Overall Study|Withdrawal by Subject|0|||
148751103|NCT01068262|536560464|FG001|Overall Study|Withdrawal by Subject|1|||
148751104|NCT01068262|536560465|FG002|Overall Study|Withdrawal by Subject|0|||
148751105|NCT01068262|536560466|FG003|Overall Study|Withdrawal by Subject|0|||
148751106|NCT00470535|536560471|FG000|Overall Study|Disease Progression|13|||
148751107|NCT00470535|536560471|FG000|Overall Study|Withdrawal by Subject|1|||
148751108|NCT00470535|536560471|FG000|Overall Study|Adverse Event|1|||
148751109|NCT00470535|536560471|FG000|Overall Study|Death|1|||
148751110|NCT00470535|536560471|FG000|Overall Study|Other|2|||
148751111|NCT05024747|536560475|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
148751112|NCT05024747|536560476|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
148751113|NCT05024747|536560475|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
148751114|NCT05024747|536560476|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
148751115|NCT05024747|536560475|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
148751116|NCT05024747|536560476|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
148751117|NCT04428034|536560477|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
148751118|NCT01431079|536560484|FG000|Overall Study|Lost to Follow-up|35|||
148751119|NCT01431079|536560485|FG001|Overall Study|Lost to Follow-up|39|||
148976231|NCT00079274|537394488|FG005|Overall Study|Cytogenetic resistance|0|||
149027294|NCT00984282|537578535|FG000|Open-label Treatment|Adverse Event|20|||
148751120|NCT04747470|536560486|FG000|Overall Study|Death|0|||
148751121|NCT04747470|536560487|FG001|Overall Study|Death|3|||
148751122|NCT04747470|536560488|FG002|Overall Study|Death|2|||
148976232|NCT00079274|537394489|FG006|Overall Study|Cytogenetic resistance|0|||
148976233|NCT00079274|537394483|FG000|Overall Study|Other|43|||
148976234|NCT00079274|537394484|FG001|Overall Study|Other|7|||
149027295|NCT00984282|537578536|FG001|Open-label Treatment|Adverse Event|30|||
149027296|NCT00984282|537578535|FG000|Open-label Treatment|Withdrawal by Subject|6|||
149027297|NCT00984282|537578536|FG001|Open-label Treatment|Withdrawal by Subject|21|||
149027298|NCT00984282|537578535|FG000|Open-label Treatment|Death|7|||
149027299|NCT00984282|537578536|FG001|Open-label Treatment|Death|15|||
149027300|NCT00984282|537578535|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
148751123|NCT04747470|536560489|FG003|Overall Study|Death|2|||
148751124|NCT04747470|536560490|FG004|Overall Study|Death|2|||
148751125|NCT04747470|536560491|FG005|Overall Study|Death|0|||
148751126|NCT04747470|536560492|FG006|Overall Study|Death|0|||
148751127|NCT04747470|536560493|FG007|Overall Study|Death|0|||
148751128|NCT04747470|536560494|FG008|Overall Study|Death|0|||
148751129|NCT04747470|536560495|FG009|Overall Study|Death|0|||
148751130|NCT04747470|536560496|FG010|Overall Study|Death|0|||
148751131|NCT04747470|536560486|FG000|Overall Study|Withdrew Consent|0|||
148751132|NCT04747470|536560487|FG001|Overall Study|Withdrew Consent|0|||
148751133|NCT04747470|536560488|FG002|Overall Study|Withdrew Consent|0|||
148751134|NCT04747470|536560489|FG003|Overall Study|Withdrew Consent|1|||
148751135|NCT04747470|536560490|FG004|Overall Study|Withdrew Consent|0|||
148751136|NCT04747470|536560491|FG005|Overall Study|Withdrew Consent|0|||
148751137|NCT04747470|536560492|FG006|Overall Study|Withdrew Consent|0|||
148751138|NCT04747470|536560493|FG007|Overall Study|Withdrew Consent|0|||
148751139|NCT04747470|536560494|FG008|Overall Study|Withdrew Consent|0|||
148751140|NCT04747470|536560495|FG009|Overall Study|Withdrew Consent|0|||
148751141|NCT04747470|536560496|FG010|Overall Study|Withdrew Consent|0|||
148751142|NCT04747470|536560486|FG000|Overall Study|Study Terminated by Sponsor|0|||
148751143|NCT04747470|536560487|FG001|Overall Study|Study Terminated by Sponsor|0|||
148751144|NCT04747470|536560488|FG002|Overall Study|Study Terminated by Sponsor|1|||
148751145|NCT04747470|536560489|FG003|Overall Study|Study Terminated by Sponsor|0|||
148751146|NCT04747470|536560490|FG004|Overall Study|Study Terminated by Sponsor|2|||
148751147|NCT04747470|536560491|FG005|Overall Study|Study Terminated by Sponsor|0|||
148751148|NCT04747470|536560492|FG006|Overall Study|Study Terminated by Sponsor|0|||
148751149|NCT04747470|536560493|FG007|Overall Study|Study Terminated by Sponsor|0|||
148751150|NCT04747470|536560494|FG008|Overall Study|Study Terminated by Sponsor|0|||
148751151|NCT04747470|536560495|FG009|Overall Study|Study Terminated by Sponsor|0|||
148751152|NCT04747470|536560496|FG010|Overall Study|Study Terminated by Sponsor|0|||
148751153|NCT04720053|536560500|FG000|Overall Study|Lost to Follow-up|12|||
148751154|NCT01960257|536560501|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
148751155|NCT01960257|536560502|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
148751156|NCT01960257|536560503|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
148751157|NCT01960257|536560501|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
148751158|NCT01960257|536560502|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
148751159|NCT01960257|536560503|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
148751160|NCT01960257|536560501|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
148751161|NCT01960257|536560502|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
148751162|NCT01960257|536560503|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
148751163|NCT01942993|536560504|FG000|Overall Study|Lost to Follow-up|1|||
148751164|NCT01942993|536560504|FG000|Overall Study|Physician Decision|1|||
148751165|NCT01350271|536560508|FG000|Overall Study|Lost to Follow-up|21|||
148751166|NCT01350271|536560509|FG001|Overall Study|Lost to Follow-up|17|||
148751167|NCT01350271|536560510|FG002|Overall Study|Lost to Follow-up|26|||
148751168|NCT02906670|536560511|FG000|Cohort 1, QW|Radiological Progression|1|||
148751169|NCT02906670|536560512|FG001|Cohort 1, QW|Radiological Progression|0|||
148751170|NCT02906670|536560513|FG002|Cohort 1, QW|Radiological Progression|0|||
148751171|NCT02906670|536560514|FG003|Cohort 1, QW|Radiological Progression|0|||
148751172|NCT02906670|536560515|FG004|Cohort 1, QW|Radiological Progression|0|||
148751173|NCT02906670|536560516|FG005|Cohort 1, QW|Radiological Progression|0|||
148751174|NCT02906670|536560517|FG006|Cohort 1, QW|Radiological Progression|0|||
148751175|NCT02906670|536560518|FG007|Cohort 1, QW|Radiological Progression|0|||
148751176|NCT02906670|536560519|FG008|Cohort 1, QW|Radiological Progression|0|||
148751177|NCT02906670|536560520|FG009|Cohort 1, QW|Radiological Progression|0|||
148751178|NCT02906670|536560511|FG000|Cohort 2, QW|Radiological Progression|0|||
148751179|NCT02906670|536560512|FG001|Cohort 2, QW|Radiological Progression|1|||
148751180|NCT02906670|536560513|FG002|Cohort 2, QW|Radiological Progression|0|||
148751181|NCT02906670|536560514|FG003|Cohort 2, QW|Radiological Progression|0|||
148751182|NCT02906670|536560515|FG004|Cohort 2, QW|Radiological Progression|0|||
148751183|NCT02906670|536560516|FG005|Cohort 2, QW|Radiological Progression|0|||
148751184|NCT02906670|536560517|FG006|Cohort 2, QW|Radiological Progression|0|||
148822316|NCT04518410|536826748|FG017|Overall Study|Other|1|||
148751185|NCT02906670|536560518|FG007|Cohort 2, QW|Radiological Progression|0|||
148751186|NCT02906670|536560519|FG008|Cohort 2, QW|Radiological Progression|0|||
148751187|NCT02906670|536560520|FG009|Cohort 2, QW|Radiological Progression|0|||
148751188|NCT02906670|536560511|FG000|Cohort 3, QW|Radiological Progression|0|||
148751189|NCT02906670|536560512|FG001|Cohort 3, QW|Radiological Progression|0|||
148751190|NCT02906670|536560513|FG002|Cohort 3, QW|Radiological Progression|2|||
148751191|NCT02906670|536560514|FG003|Cohort 3, QW|Radiological Progression|0|||
148751192|NCT02906670|536560515|FG004|Cohort 3, QW|Radiological Progression|0|||
148822317|NCT04518410|536826749|FG018|Overall Study|Other|1|||
148822318|NCT04518410|536826750|FG019|Overall Study|Other|0|||
149027301|NCT00984282|537578536|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
149027302|NCT00984282|537578535|FG000|Open-label Treatment|Lost to Follow-up|1|||
149027303|NCT00984282|537578536|FG001|Open-label Treatment|Lost to Follow-up|1|||
149027304|NCT00984282|537578535|FG000|Open-label Treatment|Patient convenience|1|||
149027305|NCT00984282|537578536|FG001|Open-label Treatment|Patient convenience|0|||
149027306|NCT00984282|537578535|FG000|Open-label Treatment|Non-compliant with study medication|1|||
149027307|NCT00984282|537578536|FG001|Open-label Treatment|Non-compliant with study medication|0|||
149027308|NCT00984282|537578535|FG000|Open-label Treatment|Target lesion removed|0|||
149027309|NCT00984282|537578536|FG001|Open-label Treatment|Target lesion removed|1|||
149027310|NCT00984282|537578535|FG000|Open-label Treatment|Protocol driven decision point|1|||
149027311|NCT00984282|537578536|FG001|Open-label Treatment|Protocol driven decision point|1|||
149027312|NCT00984282|537578535|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
149027313|NCT00984282|537578536|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
149027314|NCT00984282|537578535|FG000|Open-label Treatment|Switched to commercial drug|6|||
149027315|NCT00984282|537578536|FG001|Open-label Treatment|Switched to commercial drug|7|||
149027316|NCT00984282|537578535|FG000|Open-label Treatment|Physician Decision|1|||
149027317|NCT00984282|537578536|FG001|Open-label Treatment|Physician Decision|0|||
149027318|NCT00984282|537578535|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
148751193|NCT02906670|536560516|FG005|Cohort 3, QW|Radiological Progression|0|||
149027319|NCT00984282|537578536|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
149027320|NCT00984282|537578535|FG000|Long Term Follow-up|Death|27|||
149027321|NCT00984282|537578536|FG001|Long Term Follow-up|Death|68|||
149027322|NCT00984282|537578535|FG000|Long Term Follow-up|Lost to Follow-up|3|||
149027323|NCT00984282|537578536|FG001|Long Term Follow-up|Lost to Follow-up|6|||
149027324|NCT00984282|537578535|FG000|Long Term Follow-up|Protocol driven decision point|25|||
149027325|NCT00984282|537578536|FG001|Long Term Follow-up|Protocol driven decision point|26|||
149027326|NCT00984282|537578535|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
149027327|NCT00984282|537578536|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
149027328|NCT00984282|537578535|FG000|Long Term Follow-up|Switched to commercial drug|4|||
149027329|NCT00984282|537578536|FG001|Long Term Follow-up|Switched to commercial drug|2|||
148751194|NCT02906670|536560517|FG006|Cohort 3, QW|Radiological Progression|0|||
148751195|NCT02906670|536560518|FG007|Cohort 3, QW|Radiological Progression|0|||
148751196|NCT02906670|536560519|FG008|Cohort 3, QW|Radiological Progression|0|||
148751197|NCT02906670|536560520|FG009|Cohort 3, QW|Radiological Progression|0|||
148751198|NCT02906670|536560511|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751199|NCT02906670|536560512|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751200|NCT02906670|536560513|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
148751201|NCT02906670|536560514|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751202|NCT02906670|536560515|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751203|NCT02906670|536560516|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751204|NCT02906670|536560517|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751205|NCT02906670|536560518|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751206|NCT02906670|536560519|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751207|NCT02906670|536560520|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
148751208|NCT02906670|536560511|FG000|Cohort 4, Q2W|Radiological Progression|0|||
148751209|NCT02906670|536560512|FG001|Cohort 4, Q2W|Radiological Progression|0|||
148751210|NCT02906670|536560513|FG002|Cohort 4, Q2W|Radiological Progression|0|||
148751211|NCT02906670|536560514|FG003|Cohort 4, Q2W|Radiological Progression|0|||
148751212|NCT02906670|536560515|FG004|Cohort 4, Q2W|Radiological Progression|0|||
148751213|NCT02906670|536560516|FG005|Cohort 4, Q2W|Radiological Progression|1|||
148751214|NCT02906670|536560517|FG006|Cohort 4, Q2W|Radiological Progression|0|||
148751215|NCT02906670|536560518|FG007|Cohort 4, Q2W|Radiological Progression|0|||
148751216|NCT02906670|536560519|FG008|Cohort 4, Q2W|Radiological Progression|0|||
148751217|NCT02906670|536560520|FG009|Cohort 4, Q2W|Radiological Progression|0|||
148751218|NCT02906670|536560511|FG000|Cohort 4, Q2W|Clinical Progression|0|||
148751219|NCT02906670|536560512|FG001|Cohort 4, Q2W|Clinical Progression|0|||
148751220|NCT02906670|536560513|FG002|Cohort 4, Q2W|Clinical Progression|0|||
148751221|NCT02906670|536560514|FG003|Cohort 4, Q2W|Clinical Progression|0|||
148751222|NCT02906670|536560515|FG004|Cohort 4, Q2W|Clinical Progression|0|||
148751223|NCT02906670|536560516|FG005|Cohort 4, Q2W|Clinical Progression|2|||
148751224|NCT02906670|536560517|FG006|Cohort 4, Q2W|Clinical Progression|0|||
148751225|NCT02906670|536560518|FG007|Cohort 4, Q2W|Clinical Progression|0|||
148822319|NCT04518410|536826751|FG020|Overall Study|Other|1|||
149027330|NCT00984282|537578535|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
149027331|NCT00984282|537578536|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
149027332|NCT02223793|537578537|FG000|Overall Study|Lost to Follow-up|10|||
148751226|NCT02906670|536560519|FG008|Cohort 4, Q2W|Clinical Progression|0|||
148751227|NCT02906670|536560520|FG009|Cohort 4, Q2W|Clinical Progression|0|||
148751228|NCT02906670|536560511|FG000|Cohort 5, Q2W|Radiological Progression|0|||
148751229|NCT02906670|536560512|FG001|Cohort 5, Q2W|Radiological Progression|0|||
148822320|NCT04518410|536826752|FG021|Overall Study|Other|0|||
148751230|NCT02906670|536560513|FG002|Cohort 5, Q2W|Radiological Progression|0|||
148751231|NCT02906670|536560514|FG003|Cohort 5, Q2W|Radiological Progression|0|||
148751232|NCT02906670|536560515|FG004|Cohort 5, Q2W|Radiological Progression|0|||
148751233|NCT02906670|536560516|FG005|Cohort 5, Q2W|Radiological Progression|0|||
148751234|NCT02906670|536560517|FG006|Cohort 5, Q2W|Radiological Progression|4|||
148751235|NCT02906670|536560518|FG007|Cohort 5, Q2W|Radiological Progression|0|||
148751236|NCT02906670|536560519|FG008|Cohort 5, Q2W|Radiological Progression|0|||
148751237|NCT02906670|536560520|FG009|Cohort 5, Q2W|Radiological Progression|0|||
148751238|NCT02906670|536560511|FG000|Cohort 5, Q2W|Clinical Progression|0|||
148751239|NCT02906670|536560512|FG001|Cohort 5, Q2W|Clinical Progression|0|||
148751240|NCT02906670|536560513|FG002|Cohort 5, Q2W|Clinical Progression|0|||
148751241|NCT02906670|536560514|FG003|Cohort 5, Q2W|Clinical Progression|0|||
148751242|NCT02906670|536560515|FG004|Cohort 5, Q2W|Clinical Progression|0|||
148751243|NCT02906670|536560516|FG005|Cohort 5, Q2W|Clinical Progression|0|||
148751244|NCT02906670|536560517|FG006|Cohort 5, Q2W|Clinical Progression|1|||
148751245|NCT02906670|536560518|FG007|Cohort 5, Q2W|Clinical Progression|0|||
148751246|NCT02906670|536560519|FG008|Cohort 5, Q2W|Clinical Progression|0|||
148751247|NCT02906670|536560520|FG009|Cohort 5, Q2W|Clinical Progression|0|||
148751248|NCT02906670|536560511|FG000|Cohort 5, Q2W|Adverse Event|0|||
148751249|NCT02906670|536560512|FG001|Cohort 5, Q2W|Adverse Event|0|||
148751250|NCT02906670|536560513|FG002|Cohort 5, Q2W|Adverse Event|0|||
148751251|NCT02906670|536560514|FG003|Cohort 5, Q2W|Adverse Event|0|||
148751252|NCT02906670|536560515|FG004|Cohort 5, Q2W|Adverse Event|0|||
148751253|NCT02906670|536560516|FG005|Cohort 5, Q2W|Adverse Event|0|||
148751254|NCT02906670|536560517|FG006|Cohort 5, Q2W|Adverse Event|1|||
148751255|NCT02906670|536560518|FG007|Cohort 5, Q2W|Adverse Event|0|||
148751256|NCT02906670|536560519|FG008|Cohort 5, Q2W|Adverse Event|0|||
148751257|NCT02906670|536560520|FG009|Cohort 5, Q2W|Adverse Event|0|||
148751258|NCT02906670|536560511|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751259|NCT02906670|536560512|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751260|NCT02906670|536560513|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751261|NCT02906670|536560514|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751262|NCT02906670|536560515|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751263|NCT02906670|536560516|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751264|NCT02906670|536560517|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
148751265|NCT02906670|536560518|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751266|NCT02906670|536560519|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751267|NCT02906670|536560520|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
148751268|NCT02906670|536560511|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
148751269|NCT02906670|536560512|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
148751270|NCT02906670|536560513|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
148751271|NCT02906670|536560514|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
148751272|NCT02906670|536560515|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
148751273|NCT02906670|536560516|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
148751274|NCT02906670|536560517|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
148751275|NCT02906670|536560518|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
148751276|NCT02906670|536560519|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
148751277|NCT02906670|536560520|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
148751278|NCT02906670|536560511|FG000|Cohort 5P, Q2W|Adverse Event|0|||
148751279|NCT02906670|536560512|FG001|Cohort 5P, Q2W|Adverse Event|0|||
148751280|NCT02906670|536560513|FG002|Cohort 5P, Q2W|Adverse Event|0|||
148751281|NCT02906670|536560514|FG003|Cohort 5P, Q2W|Adverse Event|0|||
148751282|NCT02906670|536560515|FG004|Cohort 5P, Q2W|Adverse Event|0|||
148751283|NCT02906670|536560516|FG005|Cohort 5P, Q2W|Adverse Event|0|||
148751284|NCT02906670|536560517|FG006|Cohort 5P, Q2W|Adverse Event|0|||
148751285|NCT02906670|536560518|FG007|Cohort 5P, Q2W|Adverse Event|1|||
148751286|NCT02906670|536560519|FG008|Cohort 5P, Q2W|Adverse Event|0|||
148751287|NCT02906670|536560520|FG009|Cohort 5P, Q2W|Adverse Event|0|||
148751288|NCT02906670|536560511|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
148751289|NCT02906670|536560512|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
148751290|NCT02906670|536560513|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
148751291|NCT02906670|536560514|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
148751292|NCT02906670|536560515|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
148751293|NCT02906670|536560516|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
148751294|NCT02906670|536560517|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
148751295|NCT02906670|536560518|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
148751296|NCT02906670|536560519|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
148751297|NCT02906670|536560520|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
148751298|NCT02906670|536560511|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
148751299|NCT02906670|536560512|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
148751300|NCT02906670|536560513|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
148751301|NCT02906670|536560514|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
148751302|NCT02906670|536560515|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
148751303|NCT02906670|536560516|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
148751304|NCT02906670|536560517|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
148751305|NCT02906670|536560518|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
148751306|NCT02906670|536560519|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
148751307|NCT02906670|536560520|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
148751308|NCT02906670|536560511|FG000|Cohort 4P, QW|Radiological Progression|0|||
148751309|NCT02906670|536560512|FG001|Cohort 4P, QW|Radiological Progression|0|||
148751310|NCT02906670|536560513|FG002|Cohort 4P, QW|Radiological Progression|0|||
148751311|NCT02906670|536560514|FG003|Cohort 4P, QW|Radiological Progression|3|||
148751312|NCT02906670|536560515|FG004|Cohort 4P, QW|Radiological Progression|0|||
148751313|NCT02906670|536560516|FG005|Cohort 4P, QW|Radiological Progression|0|||
148751314|NCT02906670|536560517|FG006|Cohort 4P, QW|Radiological Progression|0|||
148751315|NCT02906670|536560518|FG007|Cohort 4P, QW|Radiological Progression|0|||
148751316|NCT02906670|536560519|FG008|Cohort 4P, QW|Radiological Progression|0|||
148751317|NCT02906670|536560520|FG009|Cohort 4P, QW|Radiological Progression|0|||
148751318|NCT02906670|536560511|FG000|Cohort 7P, Q2W|Adverse Event|0|||
148751319|NCT02906670|536560512|FG001|Cohort 7P, Q2W|Adverse Event|0|||
148751320|NCT02906670|536560513|FG002|Cohort 7P, Q2W|Adverse Event|0|||
148751321|NCT02906670|536560514|FG003|Cohort 7P, Q2W|Adverse Event|0|||
148751322|NCT02906670|536560515|FG004|Cohort 7P, Q2W|Adverse Event|0|||
148751323|NCT02906670|536560516|FG005|Cohort 7P, Q2W|Adverse Event|0|||
148751324|NCT02906670|536560517|FG006|Cohort 7P, Q2W|Adverse Event|0|||
148751325|NCT02906670|536560518|FG007|Cohort 7P, Q2W|Adverse Event|0|||
148751326|NCT02906670|536560519|FG008|Cohort 7P, Q2W|Adverse Event|0|||
148751327|NCT02906670|536560520|FG009|Cohort 7P, Q2W|Adverse Event|1|||
148751328|NCT02906670|536560511|FG000|Cohort 7P, Q2W|Physician Decision|0|||
148751329|NCT02906670|536560512|FG001|Cohort 7P, Q2W|Physician Decision|0|||
148751330|NCT02906670|536560513|FG002|Cohort 7P, Q2W|Physician Decision|0|||
148751331|NCT02906670|536560514|FG003|Cohort 7P, Q2W|Physician Decision|0|||
148751332|NCT02906670|536560515|FG004|Cohort 7P, Q2W|Physician Decision|0|||
148751333|NCT02906670|536560516|FG005|Cohort 7P, Q2W|Physician Decision|0|||
148751334|NCT02906670|536560517|FG006|Cohort 7P, Q2W|Physician Decision|0|||
148751335|NCT02906670|536560518|FG007|Cohort 7P, Q2W|Physician Decision|0|||
148751336|NCT02906670|536560519|FG008|Cohort 7P, Q2W|Physician Decision|0|||
148751337|NCT02906670|536560520|FG009|Cohort 7P, Q2W|Physician Decision|1|||
148751338|NCT02906670|536560511|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751339|NCT02906670|536560512|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751340|NCT02906670|536560513|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751341|NCT02906670|536560514|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751342|NCT02906670|536560515|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751343|NCT02906670|536560516|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751344|NCT02906670|536560517|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751345|NCT02906670|536560518|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751346|NCT02906670|536560519|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
148751347|NCT02906670|536560520|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
148751348|NCT02906670|536560511|FG000|Cohort 5P, QW|Radiological Progression|0|||
148751349|NCT02906670|536560512|FG001|Cohort 5P, QW|Radiological Progression|0|||
148751350|NCT02906670|536560513|FG002|Cohort 5P, QW|Radiological Progression|0|||
148751351|NCT02906670|536560514|FG003|Cohort 5P, QW|Radiological Progression|0|||
148751352|NCT02906670|536560515|FG004|Cohort 5P, QW|Radiological Progression|3|||
148751353|NCT02906670|536560516|FG005|Cohort 5P, QW|Radiological Progression|0|||
148751354|NCT02906670|536560517|FG006|Cohort 5P, QW|Radiological Progression|0|||
148751355|NCT02906670|536560518|FG007|Cohort 5P, QW|Radiological Progression|0|||
148751356|NCT02906670|536560519|FG008|Cohort 5P, QW|Radiological Progression|0|||
148751357|NCT02906670|536560520|FG009|Cohort 5P, QW|Radiological Progression|0|||
148751358|NCT03749330|536560521|FG000|Overall Study|Clinicians left work in the CICU|0|||
148751359|NCT03749330|536560522|FG001|Overall Study|Clinicians left work in the CICU|2|||
148751360|NCT03749330|536560523|FG002|Overall Study|Clinicians left work in the CICU|0|||
148751361|NCT03749330|536560524|FG003|Overall Study|Clinicians left work in the CICU|0|||
148751362|NCT03749330|536560525|FG004|Overall Study|Clinicians left work in the CICU|0|||
148751363|NCT03749330|536560526|FG005|Overall Study|Clinicians left work in the CICU|0|||
148751364|NCT03908125|536560527|FG000|Overall Study|Withdrawal by Subject|92|||
148751365|NCT03908125|536560527|FG000|Overall Study|Lost to Follow-up|8|||
148751366|NCT02414958|536560528|FG000|Overall Study|Adverse Event|6|||
148751367|NCT02414958|536560529|FG001|Overall Study|Adverse Event|6|||
148751368|NCT02414958|536560530|FG002|Overall Study|Adverse Event|3|||
148751369|NCT02414958|536560528|FG000|Overall Study|Protocol Violation|10|||
148751370|NCT02414958|536560529|FG001|Overall Study|Protocol Violation|3|||
148751371|NCT02414958|536560530|FG002|Overall Study|Protocol Violation|1|||
148751372|NCT02414958|536560528|FG000|Overall Study|Lost to Follow-up|7|||
148751373|NCT02414958|536560529|FG001|Overall Study|Lost to Follow-up|4|||
148751374|NCT02414958|536560530|FG002|Overall Study|Lost to Follow-up|0|||
148751375|NCT02414958|536560528|FG000|Overall Study|Withdrawal by Subject|5|||
148976235|NCT00079274|537394485|FG002|Overall Study|Other|5|||
148751376|NCT02414958|536560529|FG001|Overall Study|Withdrawal by Subject|3|||
148751377|NCT02414958|536560530|FG002|Overall Study|Withdrawal by Subject|5|||
148751378|NCT02414958|536560528|FG000|Overall Study|Other than specified|4|||
148751379|NCT02414958|536560529|FG001|Overall Study|Other than specified|4|||
148751380|NCT02414958|536560530|FG002|Overall Study|Other than specified|5|||
148976236|NCT00079274|537394486|FG003|Overall Study|Other|55|||
149027333|NCT02223793|537578538|FG001|Overall Study|Lost to Follow-up|1|||
149027334|NCT02223793|537578539|FG002|Overall Study|Lost to Follow-up|2|||
149027335|NCT02223793|537578537|FG000|Overall Study|Withdrawal by Subject|3|||
149027336|NCT02223793|537578538|FG001|Overall Study|Withdrawal by Subject|2|||
149027337|NCT02223793|537578539|FG002|Overall Study|Withdrawal by Subject|3|||
149027338|NCT02223793|537578537|FG000|Overall Study|Moved/studycenter unable to participate|4|||
149027339|NCT02223793|537578538|FG001|Overall Study|Moved/studycenter unable to participate|6|||
149027340|NCT02223793|537578539|FG002|Overall Study|Moved/studycenter unable to participate|8|||
149027341|NCT00315055|537578540|FG000|Overall Study|Protocol Violation|2|||
149027342|NCT00315055|537578541|FG001|Overall Study|Protocol Violation|4|||
149027343|NCT00315055|537578540|FG000|Overall Study|Lost to Follow-up|1|||
149027344|NCT00315055|537578541|FG001|Overall Study|Lost to Follow-up|1|||
149027345|NCT02359435|537578542|FG000|Overall Study|Lost to Follow-up|4|||
149027346|NCT02359435|537578543|FG001|Overall Study|Lost to Follow-up|4|||
149027347|NCT00463151|537578547|FG000|Overall Study|Adverse Event|0|||
149027348|NCT00463151|537578548|FG001|Overall Study|Adverse Event|0|||
149027349|NCT00463151|537578549|FG002|Overall Study|Adverse Event|1|||
149027350|NCT00463151|537578550|FG003|Overall Study|Adverse Event|0|||
149027351|NCT00463151|537578547|FG000|Overall Study|Lack of Efficacy|2|||
149027352|NCT00463151|537578548|FG001|Overall Study|Lack of Efficacy|5|||
149027353|NCT00463151|537578549|FG002|Overall Study|Lack of Efficacy|2|||
149027354|NCT00463151|537578550|FG003|Overall Study|Lack of Efficacy|5|||
149027355|NCT00463151|537578547|FG000|Overall Study|Protocol Violation|0|||
149027356|NCT00463151|537578548|FG001|Overall Study|Protocol Violation|0|||
149027357|NCT00463151|537578549|FG002|Overall Study|Protocol Violation|0|||
149027358|NCT00463151|537578550|FG003|Overall Study|Protocol Violation|1|||
148751381|NCT03885661|536560532|FG000|Overall Study|Withdrawal by Subject|0|||
148751382|NCT03885661|536560533|FG001|Overall Study|Withdrawal by Subject|1|||
148751383|NCT03885661|536560532|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
148751384|NCT03885661|536560533|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
148751385|NCT05064397|536560534|FG000|Overall Study|Adverse Event|4|||
148751386|NCT05064397|536560534|FG000|Overall Study|Lack of Efficacy|12|||
148751387|NCT05064397|536560534|FG000|Overall Study|Withdrawal by Subject|3|||
148751388|NCT05064397|536560534|FG000|Overall Study|Lost to Follow-up|1|||
148751389|NCT05064397|536560534|FG000|Overall Study|Other reasons|3|||
148751390|NCT00344448|536560537|FG000|Screening|Withdrawal by Subject|0|||
148751391|NCT00344448|536560538|FG001|Screening|Withdrawal by Subject|1|||
148751392|NCT00344448|536560537|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
148751393|NCT00344448|536560538|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
148751394|NCT00344448|536560537|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
148751395|NCT00344448|536560538|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
148751396|NCT00344448|536560537|FG000|Open Label|Withdrawal by Subject|1|||
148751397|NCT00344448|536560538|FG001|Open Label|Withdrawal by Subject|1|||
148751398|NCT00344448|536560537|FG000|Open Label|Study terminated|1|||
148751399|NCT00344448|536560538|FG001|Open Label|Study terminated|0|||
148751400|NCT01783886|536560541|FG000|Overall Study|Lost to Follow-up|0|||
148751401|NCT01783886|536560542|FG001|Overall Study|Lost to Follow-up|3|||
148751402|NCT01783886|536560543|FG002|Overall Study|Lost to Follow-up|0|||
148751403|NCT01783886|536560541|FG000|Overall Study|Protocol deviation|0|||
148751404|NCT01783886|536560542|FG001|Overall Study|Protocol deviation|0|||
148751405|NCT01783886|536560543|FG002|Overall Study|Protocol deviation|2|||
148751406|NCT01783886|536560541|FG000|Overall Study|Withdrawal of consent by participant|1|||
148751407|NCT01783886|536560542|FG001|Overall Study|Withdrawal of consent by participant|3|||
148751408|NCT01783886|536560543|FG002|Overall Study|Withdrawal of consent by participant|4|||
149027359|NCT00463151|537578547|FG000|Overall Study|Withdrawal by Subject|0|||
149027360|NCT00463151|537578548|FG001|Overall Study|Withdrawal by Subject|0|||
149027361|NCT00463151|537578549|FG002|Overall Study|Withdrawal by Subject|0|||
149027362|NCT00463151|537578550|FG003|Overall Study|Withdrawal by Subject|1|||
149027363|NCT05349084|537578551|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
149027364|NCT00972543|537578552|FG000|Overall Study|Adverse Event|1|||
149027365|NCT00972543|537578553|FG001|Overall Study|Adverse Event|0|||
149027366|NCT00972543|537578552|FG000|Overall Study|Early study termination by sponsor|4|||
149027367|NCT00972543|537578553|FG001|Overall Study|Early study termination by sponsor|1|||
149027368|NCT00293462|537578554|FG000|Overall Study|Withdrawal by Subject|4|||
149027369|NCT00293462|537578555|FG001|Overall Study|Withdrawal by Subject|3|||
149027370|NCT00293462|537578556|FG002|Overall Study|Withdrawal by Subject|8|||
149027371|NCT00293462|537578554|FG000|Overall Study|Death|1|||
149027372|NCT00293462|537578555|FG001|Overall Study|Death|0|||
148751409|NCT01783886|536560541|FG000|Overall Study|Adverse Event|4|||
148751410|NCT01783886|536560542|FG001|Overall Study|Adverse Event|5|||
148751411|NCT01783886|536560543|FG002|Overall Study|Adverse Event|4|||
149027373|NCT00293462|537578556|FG002|Overall Study|Death|0|||
149027374|NCT00293462|537578554|FG000|Overall Study|Lost to Follow-up|0|||
149027375|NCT00293462|537578555|FG001|Overall Study|Lost to Follow-up|1|||
148751412|NCT01640249|536560544|FG000|Period 1|Withdrawal by Subject|1|||
148751413|NCT01640249|536560545|FG001|Period 1|Withdrawal by Subject|0|||
148751414|NCT01640249|536560546|FG002|Period 1|Withdrawal by Subject|0|||
148751415|NCT01640249|536560547|FG003|Period 1|Withdrawal by Subject|0|||
148751416|NCT01640249|536560548|FG004|Period 1|Withdrawal by Subject|0|||
148751417|NCT01640249|536560549|FG005|Period 1|Withdrawal by Subject|1|||
148751418|NCT01640249|536560550|FG006|Period 1|Withdrawal by Subject|0|||
148751419|NCT02273388|536560551|FG000|Overall Study|Adverse Event|0|||
148751420|NCT02273388|536560552|FG001|Overall Study|Adverse Event|0|||
148751421|NCT02273388|536560553|FG002|Overall Study|Adverse Event|0|||
148751422|NCT02273388|536560554|FG003|Overall Study|Adverse Event|0|||
148751423|NCT02273388|536560555|FG004|Overall Study|Adverse Event|0|||
148751424|NCT02273388|536560556|FG005|Overall Study|Adverse Event|0|||
148751425|NCT02273388|536560557|FG006|Overall Study|Adverse Event|1|||
148751426|NCT02273388|536560558|FG007|Overall Study|Adverse Event|2|||
148751427|NCT02273388|536560559|FG008|Overall Study|Adverse Event|0|||
148751428|NCT02273388|536560560|FG009|Overall Study|Adverse Event|0|||
148751429|NCT02273388|536560561|FG010|Overall Study|Adverse Event|0|||
148751430|NCT02273388|536560562|FG011|Overall Study|Adverse Event|0|||
148751431|NCT02273388|536560551|FG000|Overall Study|Adverse Event study disease worse|4|||
148751432|NCT02273388|536560552|FG001|Overall Study|Adverse Event study disease worse|3|||
148751433|NCT02273388|536560553|FG002|Overall Study|Adverse Event study disease worse|3|||
148751434|NCT02273388|536560554|FG003|Overall Study|Adverse Event study disease worse|2|||
148751435|NCT02273388|536560555|FG004|Overall Study|Adverse Event study disease worse|4|||
148751436|NCT02273388|536560556|FG005|Overall Study|Adverse Event study disease worse|3|||
148751437|NCT02273388|536560557|FG006|Overall Study|Adverse Event study disease worse|14|||
148751438|NCT02273388|536560558|FG007|Overall Study|Adverse Event study disease worse|6|||
148751439|NCT02273388|536560559|FG008|Overall Study|Adverse Event study disease worse|6|||
148751440|NCT02273388|536560560|FG009|Overall Study|Adverse Event study disease worse|5|||
148751441|NCT02273388|536560561|FG010|Overall Study|Adverse Event study disease worse|10|||
148751442|NCT02273388|536560562|FG011|Overall Study|Adverse Event study disease worse|1|||
148751443|NCT02273388|536560551|FG000|Overall Study|Sponsor decision|0|||
148751444|NCT02273388|536560552|FG001|Overall Study|Sponsor decision|0|||
148751445|NCT02273388|536560553|FG002|Overall Study|Sponsor decision|0|||
148751446|NCT02273388|536560554|FG003|Overall Study|Sponsor decision|0|||
148751447|NCT02273388|536560555|FG004|Overall Study|Sponsor decision|0|||
148751448|NCT02273388|536560556|FG005|Overall Study|Sponsor decision|0|||
148751449|NCT02273388|536560557|FG006|Overall Study|Sponsor decision|0|||
148751450|NCT02273388|536560558|FG007|Overall Study|Sponsor decision|0|||
148751451|NCT02273388|536560559|FG008|Overall Study|Sponsor decision|0|||
148751452|NCT02273388|536560560|FG009|Overall Study|Sponsor decision|0|||
148751453|NCT02273388|536560561|FG010|Overall Study|Sponsor decision|0|||
148751454|NCT02273388|536560562|FG011|Overall Study|Sponsor decision|1|||
148751455|NCT01855828|536560563|FG000|Overall Study|Adverse Event|1|||
148751456|NCT01855828|536560563|FG000|Overall Study|Withdrawal by Subject|1|||
148751457|NCT04239027|536560564|FG000|Overall Study|Adverse Event|4|||
148751458|NCT04239027|536560564|FG000|Overall Study|Withdrawal by Subject|9|||
148751459|NCT04239027|536560564|FG000|Overall Study|Death|1|||
148751460|NCT04239027|536560564|FG000|Overall Study|Physician Decision|9|||
148751461|NCT04239027|536560564|FG000|Overall Study|Lost to Follow-up|2|||
148751462|NCT04239027|536560564|FG000|Overall Study|Lack of Efficacy|1|||
148751463|NCT01184079|536560565|FG000|Overall Study|Lost to Follow-up|14|||
148751464|NCT01184079|536560566|FG001|Overall Study|Lost to Follow-up|2|||
148751465|NCT03172494|536560567|FG000|Overall Study|Adverse Event|5|||
148751466|NCT03172494|536560568|FG001|Overall Study|Adverse Event|1|||
148751467|NCT03172494|536560569|FG002|Overall Study|Adverse Event|15|||
148751468|NCT03172494|536560567|FG000|Overall Study|Protocol Violation|3|||
148751469|NCT03172494|536560568|FG001|Overall Study|Protocol Violation|2|||
148751470|NCT03172494|536560569|FG002|Overall Study|Protocol Violation|1|||
148751471|NCT03172494|536560567|FG000|Overall Study|Lack of Efficacy|0|||
148751472|NCT03172494|536560568|FG001|Overall Study|Lack of Efficacy|0|||
148751473|NCT03172494|536560569|FG002|Overall Study|Lack of Efficacy|4|||
148751474|NCT03172494|536560567|FG000|Overall Study|Pregnancy|0|||
148751475|NCT03172494|536560568|FG001|Overall Study|Pregnancy|1|||
148822321|NCT04518410|536826753|FG022|Overall Study|Other|1|||
148976237|NCT00079274|537394487|FG004|Overall Study|Other|1|||
148976238|NCT00079274|537394488|FG005|Overall Study|Other|2|||
148751476|NCT03172494|536560569|FG002|Overall Study|Pregnancy|0|||
148751477|NCT03172494|536560567|FG000|Overall Study|Withdrawal by Subject|10|||
148751478|NCT03172494|536560568|FG001|Overall Study|Withdrawal by Subject|8|||
148751479|NCT03172494|536560569|FG002|Overall Study|Withdrawal by Subject|8|||
148751480|NCT03172494|536560567|FG000|Overall Study|Severe hypoglycaemic episode|0|||
148751481|NCT03172494|536560568|FG001|Overall Study|Severe hypoglycaemic episode|0|||
148751482|NCT03172494|536560569|FG002|Overall Study|Severe hypoglycaemic episode|1|||
148751483|NCT03172494|536560567|FG000|Overall Study|Non-compliance towards treatment|2|||
148751484|NCT03172494|536560568|FG001|Overall Study|Non-compliance towards treatment|0|||
148751485|NCT03172494|536560569|FG002|Overall Study|Non-compliance towards treatment|0|||
148751486|NCT04233073|536560570|FG000|Overall Study|Death|5|||
148751487|NCT00143390|536560571|FG000|Overall Study|Death|2|||
148751488|NCT00143390|536560572|FG001|Overall Study|Death|0|||
148822322|NCT04518410|536826754|FG023|Overall Study|Other|2|||
148751489|NCT00143390|536560571|FG000|Overall Study|Not meeting entry criteria|2|||
148751490|NCT00143390|536560572|FG001|Overall Study|Not meeting entry criteria|5|||
148751491|NCT00143390|536560571|FG000|Overall Study|Withdrawal by Subject|4|||
148751492|NCT00143390|536560572|FG001|Overall Study|Withdrawal by Subject|4|||
148751493|NCT00143390|536560571|FG000|Overall Study|Progressive disease|119|||
148751494|NCT00143390|536560572|FG001|Overall Study|Progressive disease|115|||
148751495|NCT00143390|536560571|FG000|Overall Study|Protocol Violation|2|||
148751496|NCT00143390|536560572|FG001|Overall Study|Protocol Violation|0|||
148751497|NCT00143390|536560571|FG000|Overall Study|Study termination|10|||
148751498|NCT00143390|536560572|FG001|Overall Study|Study termination|15|||
148751499|NCT00143390|536560571|FG000|Overall Study|Adverse Event|9|||
148751500|NCT00143390|536560572|FG001|Overall Study|Adverse Event|8|||
148751501|NCT00143390|536560571|FG000|Overall Study|Other|1|||
148751502|NCT00143390|536560572|FG001|Overall Study|Other|2|||
148751503|NCT02764151|536560575|FG000|Overall Study|Subject refused further follow-up|0|||
148751504|NCT02764151|536560576|FG001|Overall Study|Subject refused further follow-up|0|||
148751505|NCT02764151|536560577|FG002|Overall Study|Subject refused further follow-up|0|||
148751506|NCT02764151|536560578|FG003|Overall Study|Subject refused further follow-up|1|||
148751507|NCT02764151|536560575|FG000|Overall Study|Other|0|||
148751508|NCT02764151|536560576|FG001|Overall Study|Other|0|||
148751509|NCT02764151|536560577|FG002|Overall Study|Other|0|||
148751510|NCT02764151|536560578|FG003|Overall Study|Other|2|||
148751511|NCT01450683|536560579|FG000|Overall Study|Adverse Event|2|||
148751512|NCT01523002|536560585|FG000|Period 1|Withdrawal by Subject|1|||
148751513|NCT01523002|536560586|FG001|Period 1|Withdrawal by Subject|3|||
148751514|NCT01523002|536560585|FG000|Period 1|Lost to Follow-up|1|||
148751515|NCT01523002|536560586|FG001|Period 1|Lost to Follow-up|0|||
148751516|NCT01523002|536560585|FG000|Period 1|Adverse Event|0|||
148751517|NCT01523002|536560586|FG001|Period 1|Adverse Event|8|||
148751518|NCT01523002|536560585|FG000|Period 2|Withdrawal by Subject|4|||
148751519|NCT01523002|536560586|FG001|Period 2|Withdrawal by Subject|1|||
148751520|NCT01523002|536560585|FG000|Period 2|Adverse Event|2|||
148751521|NCT01523002|536560586|FG001|Period 2|Adverse Event|5|||
148751522|NCT01523002|536560585|FG000|Period 3|Withdrawal by Subject|1|||
148751523|NCT01523002|536560586|FG001|Period 3|Withdrawal by Subject|0|||
148751524|NCT01523002|536560585|FG000|Period 3|Adverse Event|3|||
148751525|NCT01523002|536560586|FG001|Period 3|Adverse Event|0|||
148751526|NCT01256502|536560587|FG000|Overall Study|Had scaffold removed|4|||
148751527|NCT01256502|536560587|FG000|Overall Study|Personal reasons|5|||
148751528|NCT01256502|536560587|FG000|Overall Study|Protocol deviation|1|||
148751529|NCT00852202|536560590|FG000|Overall Study|Adverse Event|2|||
148751530|NCT00852202|536560591|FG001|Overall Study|Adverse Event|3|||
148751531|NCT00852202|536560592|FG002|Overall Study|Adverse Event|7|||
148751532|NCT00852202|536560590|FG000|Overall Study|Lack of Efficacy|4|||
148751533|NCT00852202|536560591|FG001|Overall Study|Lack of Efficacy|1|||
148751534|NCT00852202|536560592|FG002|Overall Study|Lack of Efficacy|2|||
148751535|NCT00852202|536560590|FG000|Overall Study|Protocol Violation|2|||
148751536|NCT00852202|536560591|FG001|Overall Study|Protocol Violation|2|||
148751537|NCT00852202|536560592|FG002|Overall Study|Protocol Violation|7|||
148751538|NCT00852202|536560590|FG000|Overall Study|Withdrawal by Subject|3|||
148751539|NCT00852202|536560591|FG001|Overall Study|Withdrawal by Subject|1|||
148751540|NCT00852202|536560592|FG002|Overall Study|Withdrawal by Subject|2|||
148751541|NCT00852202|536560590|FG000|Overall Study|Lost to Follow-up|5|||
148751542|NCT00852202|536560591|FG001|Overall Study|Lost to Follow-up|5|||
148751543|NCT00852202|536560592|FG002|Overall Study|Lost to Follow-up|6|||
148751544|NCT00852202|536560590|FG000|Overall Study|pregnancy,moving away and surgery|1|||
148751545|NCT00852202|536560591|FG001|Overall Study|pregnancy,moving away and surgery|0|||
148751546|NCT00852202|536560592|FG002|Overall Study|pregnancy,moving away and surgery|2|||
148751547|NCT04779879|536560598|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
148751548|NCT04779879|536560599|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
148751549|NCT04779879|536560600|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
148751550|NCT04779879|536560601|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
148751551|NCT04779879|536560602|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
148751552|NCT04779879|536560603|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
148751553|NCT04779879|536560598|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
148751554|NCT04779879|536560599|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
148751555|NCT04779879|536560600|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
148751556|NCT04779879|536560601|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
148751557|NCT04779879|536560602|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
148751558|NCT04779879|536560603|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
148751559|NCT04779879|536560598|FG000|Part C: Up to Week 36|Death|0|||
148751560|NCT04779879|536560599|FG001|Part C: Up to Week 36|Death|0|||
148751561|NCT04779879|536560600|FG002|Part C: Up to Week 36|Death|0|||
148751562|NCT04779879|536560601|FG003|Part C: Up to Week 36|Death|0|||
148751563|NCT04779879|536560602|FG004|Part C: Up to Week 36|Death|0|||
148751564|NCT04779879|536560603|FG005|Part C: Up to Week 36|Death|1|||
148751565|NCT04779879|536560598|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
148751566|NCT04779879|536560599|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
148751567|NCT04779879|536560600|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
148751568|NCT04779879|536560601|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
148751569|NCT04779879|536560602|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
148751570|NCT04779879|536560603|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
148751571|NCT05101343|536560604|FG000|Overall Study|Withdrawal by Subject|2|||
148751572|NCT05101343|536560605|FG001|Overall Study|Withdrawal by Subject|1|||
148751573|NCT02854527|536560606|FG000|Overall Study|Adverse Event|0|||
148751574|NCT02854527|536560607|FG001|Overall Study|Adverse Event|0|||
148751575|NCT02854527|536560608|FG002|Overall Study|Adverse Event|0|||
148751576|NCT02854527|536560609|FG003|Overall Study|Adverse Event|0|||
148751577|NCT02854527|536560610|FG004|Overall Study|Adverse Event|1|||
148751578|NCT02854527|536560611|FG005|Overall Study|Adverse Event|0|||
148751579|NCT02854527|536560612|FG006|Overall Study|Adverse Event|0|||
148751580|NCT02854527|536560613|FG007|Overall Study|Adverse Event|0|||
148751581|NCT02854527|536560614|FG008|Overall Study|Adverse Event|0|||
148751582|NCT02854527|536560615|FG009|Overall Study|Adverse Event|0|||
148751583|NCT02854527|536560606|FG000|Overall Study|Lost to Follow-up|0|||
148751584|NCT02854527|536560607|FG001|Overall Study|Lost to Follow-up|0|||
148751585|NCT02854527|536560608|FG002|Overall Study|Lost to Follow-up|0|||
148751586|NCT02854527|536560609|FG003|Overall Study|Lost to Follow-up|1|||
148751587|NCT02854527|536560610|FG004|Overall Study|Lost to Follow-up|0|||
148751588|NCT02854527|536560611|FG005|Overall Study|Lost to Follow-up|0|||
148751589|NCT02854527|536560612|FG006|Overall Study|Lost to Follow-up|0|||
148751590|NCT02854527|536560613|FG007|Overall Study|Lost to Follow-up|0|||
148751591|NCT02854527|536560614|FG008|Overall Study|Lost to Follow-up|0|||
148751592|NCT02854527|536560615|FG009|Overall Study|Lost to Follow-up|0|||
148751593|NCT01682811|536560618|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
148751594|NCT01682811|536560619|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
148751595|NCT01682811|536560620|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
148751596|NCT01682811|536560621|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
148751597|NCT01682811|536560622|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
148751598|NCT01682811|536560623|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
148751599|NCT01682811|536560624|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
148751600|NCT01682811|536560618|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
148751601|NCT01682811|536560619|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
148751602|NCT01682811|536560620|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
148751603|NCT01682811|536560621|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
148751604|NCT01682811|536560622|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
148751605|NCT01682811|536560623|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
148751606|NCT01682811|536560624|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
148751607|NCT01682811|536560618|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
148751608|NCT01682811|536560619|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
148751609|NCT01682811|536560620|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
148751610|NCT01682811|536560621|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
148751611|NCT01682811|536560622|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
148751612|NCT01682811|536560623|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
148751613|NCT01682811|536560624|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
148751614|NCT01682811|536560618|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
148751615|NCT01682811|536560619|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
148751616|NCT01682811|536560620|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
148751617|NCT01682811|536560621|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
148751618|NCT01682811|536560622|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
148751619|NCT01682811|536560623|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
148751620|NCT01682811|536560624|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
148822323|NCT04518410|536826755|FG024|Overall Study|Other|2|||
148822324|NCT04518410|536826731|FG000|Overall Study|Protocol Violation|0|||
148822325|NCT04518410|536826732|FG001|Overall Study|Protocol Violation|0|||
148822326|NCT04518410|536826733|FG002|Overall Study|Protocol Violation|0|||
148822327|NCT04518410|536826734|FG003|Overall Study|Protocol Violation|2|||
148822328|NCT04518410|536826735|FG004|Overall Study|Protocol Violation|17|||
148822329|NCT04518410|536826736|FG005|Overall Study|Protocol Violation|1|||
148822330|NCT04518410|536826737|FG006|Overall Study|Protocol Violation|2|||
148822331|NCT04518410|536826738|FG007|Overall Study|Protocol Violation|1|||
148822332|NCT04518410|536826739|FG008|Overall Study|Protocol Violation|0|||
148822333|NCT04518410|536826740|FG009|Overall Study|Protocol Violation|0|||
148822334|NCT04518410|536826741|FG010|Overall Study|Protocol Violation|0|||
148822335|NCT04518410|536826742|FG011|Overall Study|Protocol Violation|0|||
148822336|NCT04518410|536826743|FG012|Overall Study|Protocol Violation|0|||
148822337|NCT04518410|536826744|FG013|Overall Study|Protocol Violation|0|||
148822338|NCT04518410|536826745|FG014|Overall Study|Protocol Violation|0|||
148822339|NCT04518410|536826746|FG015|Overall Study|Protocol Violation|0|||
148822340|NCT04518410|536826747|FG016|Overall Study|Protocol Violation|1|||
148822341|NCT04518410|536826748|FG017|Overall Study|Protocol Violation|1|||
148822342|NCT04518410|536826749|FG018|Overall Study|Protocol Violation|0|||
148822343|NCT04518410|536826750|FG019|Overall Study|Protocol Violation|0|||
148822344|NCT04518410|536826751|FG020|Overall Study|Protocol Violation|1|||
148822345|NCT04518410|536826752|FG021|Overall Study|Protocol Violation|2|||
148751621|NCT06082843|536562846|FG000|Overall Study|Withdrawal by Subject|0|||
148751622|NCT06082843|536562847|FG001|Overall Study|Withdrawal by Subject|2|||
148751623|NCT06082843|536562846|FG000|Overall Study|Study terminated by sponsor|12|||
148751624|NCT06082843|536562847|FG001|Overall Study|Study terminated by sponsor|8|||
148751625|NCT04358081|536562849|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
148751626|NCT04358081|536562850|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
148751627|NCT04358081|536562851|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
148751628|NCT04358081|536562849|FG000|Treatment Phase of Study|Adverse Event|1|||
148751629|NCT04358081|536562850|FG001|Treatment Phase of Study|Adverse Event|0|||
148751630|NCT04358081|536562851|FG002|Treatment Phase of Study|Adverse Event|1|||
148751631|NCT04358081|536562849|FG000|Treatment Phase of Study|Physician Decision|2|||
148751632|NCT04358081|536562850|FG001|Treatment Phase of Study|Physician Decision|0|||
148751633|NCT04358081|536562851|FG002|Treatment Phase of Study|Physician Decision|1|||
148751634|NCT04358081|536562849|FG000|Treatment Phase of Study|Protocol Violation|1|||
148751635|NCT04358081|536562850|FG001|Treatment Phase of Study|Protocol Violation|0|||
148751636|NCT04358081|536562851|FG002|Treatment Phase of Study|Protocol Violation|0|||
148751637|NCT04358081|536562849|FG000|Study Completion Phase|Death|0|||
148751638|NCT04358081|536562850|FG001|Study Completion Phase|Death|0|||
148751639|NCT04358081|536562851|FG002|Study Completion Phase|Death|1|||
148751640|NCT04358081|536562849|FG000|Study Completion Phase|Lost to Follow-up|1|||
148751641|NCT04358081|536562850|FG001|Study Completion Phase|Lost to Follow-up|0|||
148751642|NCT04358081|536562851|FG002|Study Completion Phase|Lost to Follow-up|1|||
148751643|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
148751644|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
148751645|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
148751646|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
148751647|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
148751648|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
148751649|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
148751650|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
148751651|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
148751652|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
148751653|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
148751654|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
148751655|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
148751656|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
148751657|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
148751658|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
148751659|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
148751660|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
148751661|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
148751662|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
148751663|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
148751664|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
148751665|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
148751666|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
148751667|NCT01130532|536562852|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
148751668|NCT01130532|536562853|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
148751669|NCT01130532|536562854|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
148751670|NCT01130532|536562855|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
148751671|NCT01130532|536562852|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
148751672|NCT01130532|536562853|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
148751673|NCT01130532|536562854|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
148751674|NCT01130532|536562855|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
148751675|NCT01130532|536562852|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
148751676|NCT01130532|536562853|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
148751677|NCT01130532|536562854|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
148751678|NCT01130532|536562855|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
148751679|NCT01130532|536562852|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
148751680|NCT01130532|536562853|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
148751681|NCT01130532|536562854|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
148751682|NCT01130532|536562855|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
148751683|NCT01130532|536562852|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
148751684|NCT01130532|536562853|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
148751685|NCT01130532|536562854|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
148751686|NCT01130532|536562855|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
149027376|NCT00293462|537578556|FG002|Overall Study|Lost to Follow-up|0|||
148751687|NCT02762929|536562856|FG000|Overall Study|Adverse Event|0|||
149027377|NCT00293462|537578554|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
148751688|NCT02762929|536562857|FG001|Overall Study|Adverse Event|0|||
148751689|NCT02762929|536562858|FG002|Overall Study|Adverse Event|0|||
148751690|NCT02762929|536562859|FG003|Overall Study|Adverse Event|1|||
148751691|NCT02762929|536562860|FG004|Overall Study|Adverse Event|0|||
148822346|NCT04518410|536826753|FG022|Overall Study|Protocol Violation|0|||
148751692|NCT02762929|536562861|FG005|Overall Study|Adverse Event|0|||
148751693|NCT02762929|536562856|FG000|Overall Study|Lost to Follow-up|1|||
148751694|NCT02762929|536562857|FG001|Overall Study|Lost to Follow-up|2|||
148751695|NCT02762929|536562858|FG002|Overall Study|Lost to Follow-up|0|||
148751696|NCT02762929|536562859|FG003|Overall Study|Lost to Follow-up|1|||
148751697|NCT02762929|536562860|FG004|Overall Study|Lost to Follow-up|0|||
148751698|NCT02762929|536562861|FG005|Overall Study|Lost to Follow-up|0|||
148751699|NCT02762929|536562856|FG000|Overall Study|Withdrawal by Subject|0|||
148751700|NCT02762929|536562857|FG001|Overall Study|Withdrawal by Subject|1|||
148751701|NCT02762929|536562858|FG002|Overall Study|Withdrawal by Subject|0|||
148751702|NCT02762929|536562859|FG003|Overall Study|Withdrawal by Subject|0|||
148751703|NCT02762929|536562860|FG004|Overall Study|Withdrawal by Subject|0|||
148751704|NCT02762929|536562861|FG005|Overall Study|Withdrawal by Subject|0|||
148751705|NCT02762929|536562856|FG000|Overall Study|exclusionary medication disclosed late|0|||
148751706|NCT02762929|536562857|FG001|Overall Study|exclusionary medication disclosed late|0|||
148751707|NCT02762929|536562858|FG002|Overall Study|exclusionary medication disclosed late|0|||
148751708|NCT02762929|536562859|FG003|Overall Study|exclusionary medication disclosed late|1|||
148751709|NCT02762929|536562860|FG004|Overall Study|exclusionary medication disclosed late|0|||
148751710|NCT02762929|536562861|FG005|Overall Study|exclusionary medication disclosed late|0|||
148751711|NCT02656303|536562862|FG000|Overall Study|Adverse Event|3|||
148751712|NCT02656303|536562863|FG001|Overall Study|Adverse Event|2|||
148751713|NCT02656303|536562864|FG002|Overall Study|Adverse Event|0|||
148751714|NCT02656303|536562862|FG000|Overall Study|Death|12|||
148751715|NCT02656303|536562863|FG001|Overall Study|Death|4|||
148751716|NCT02656303|536562864|FG002|Overall Study|Death|1|||
148751717|NCT02656303|536562862|FG000|Overall Study|Lack of Efficacy|1|||
148751718|NCT02656303|536562863|FG001|Overall Study|Lack of Efficacy|0|||
148751719|NCT02656303|536562864|FG002|Overall Study|Lack of Efficacy|0|||
148751720|NCT02656303|536562862|FG000|Overall Study|Non-Compliance with Study|1|||
148751721|NCT02656303|536562863|FG001|Overall Study|Non-Compliance with Study|1|||
148751722|NCT02656303|536562864|FG002|Overall Study|Non-Compliance with Study|0|||
148751723|NCT02656303|536562862|FG000|Overall Study|Investigator Decision|2|||
148751724|NCT02656303|536562863|FG001|Overall Study|Investigator Decision|1|||
148751725|NCT02656303|536562864|FG002|Overall Study|Investigator Decision|0|||
148751726|NCT02656303|536562862|FG000|Overall Study|Progressive Disease|25|||
148751727|NCT02656303|536562863|FG001|Overall Study|Progressive Disease|14|||
148751728|NCT02656303|536562864|FG002|Overall Study|Progressive Disease|10|||
148751729|NCT02656303|536562862|FG000|Overall Study|Study Terminated by Sponsor|20|||
148751730|NCT02656303|536562863|FG001|Overall Study|Study Terminated by Sponsor|7|||
148976239|NCT00079274|537394489|FG006|Overall Study|Other|0|||
148976240|NCT00617240|537394492|FG000|Overall Study|Lack of Efficacy|1|||
148976241|NCT00617240|537394493|FG001|Overall Study|Lack of Efficacy|0|||
148976242|NCT01611259|537394494|FG000|Overall Study|Physician Decision|1|||
148976243|NCT01611259|537394494|FG000|Overall Study|Lack of Efficacy|2|||
148976244|NCT01611259|537394494|FG000|Overall Study|Adverse Event|4|||
148976245|NCT01611259|537394494|FG000|Overall Study|Withdrawal by Subject|7|||
148976246|NCT04936685|537394495|FG000|Overall Study|Protocol Violation|1|||
148976247|NCT04936685|537394496|FG001|Overall Study|Protocol Violation|0|||
148976248|NCT03969212|537394497|FG000|Overall Study|Adverse Event|1|||
148976249|NCT03969212|537394498|FG001|Overall Study|Adverse Event|0|||
148976250|NCT03969212|537394499|FG002|Overall Study|Adverse Event|0|||
148976251|NCT03969212|537394500|FG003|Overall Study|Adverse Event|0|||
148976252|NCT03969212|537394497|FG000|Overall Study|Lost to Follow-up|2|||
148976253|NCT03969212|537394498|FG001|Overall Study|Lost to Follow-up|2|||
148976254|NCT03969212|537394499|FG002|Overall Study|Lost to Follow-up|2|||
148976255|NCT03969212|537394500|FG003|Overall Study|Lost to Follow-up|2|||
148976256|NCT03969212|537394497|FG000|Overall Study|Protocol Violation|0|||
148976257|NCT03969212|537394498|FG001|Overall Study|Protocol Violation|0|||
148976258|NCT03969212|537394499|FG002|Overall Study|Protocol Violation|0|||
148976259|NCT03969212|537394500|FG003|Overall Study|Protocol Violation|1|||
148976260|NCT03969212|537394497|FG000|Overall Study|Withdrawal by Subject|7|||
148976261|NCT03969212|537394498|FG001|Overall Study|Withdrawal by Subject|13|||
148976262|NCT03969212|537394499|FG002|Overall Study|Withdrawal by Subject|5|||
148976263|NCT03969212|537394500|FG003|Overall Study|Withdrawal by Subject|11|||
148976264|NCT03969212|537394497|FG000|Overall Study|Physician Decision|0|||
148976265|NCT03969212|537394498|FG001|Overall Study|Physician Decision|0|||
148976266|NCT03969212|537394499|FG002|Overall Study|Physician Decision|1|||
148976267|NCT03969212|537394500|FG003|Overall Study|Physician Decision|0|||
148976268|NCT03969212|537394497|FG000|Overall Study|Reason not Specified|22|||
148976269|NCT03969212|537394498|FG001|Overall Study|Reason not Specified|23|||
148976270|NCT03969212|537394499|FG002|Overall Study|Reason not Specified|28|||
148976271|NCT03969212|537394500|FG003|Overall Study|Reason not Specified|26|||
148976272|NCT00280566|537394504|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
148976273|NCT00280566|537394505|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
148976274|NCT00280566|537394506|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
148976275|NCT00280566|537394504|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
149027378|NCT00293462|537578555|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
148976276|NCT00280566|537394505|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
148751731|NCT02656303|536562864|FG002|Overall Study|Study Terminated by Sponsor|5|||
148751732|NCT02656303|536562862|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
148751733|NCT02656303|536562863|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
148751734|NCT02656303|536562864|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
148751735|NCT02656303|536562862|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
148751736|NCT02656303|536562863|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
148751737|NCT02656303|536562864|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
148751738|NCT02656303|536562862|FG000|Overall Study|Reason not Specified|1|||
148751739|NCT02656303|536562863|FG001|Overall Study|Reason not Specified|1|||
148751740|NCT02656303|536562864|FG002|Overall Study|Reason not Specified|2|||
148751741|NCT03041311|536562867|FG000|Overall Study|Death|39|||
148751742|NCT03041311|536562868|FG001|Overall Study|Death|42|||
148751743|NCT03041311|536562867|FG000|Overall Study|Lost to Follow-up|0|||
148751744|NCT03041311|536562868|FG001|Overall Study|Lost to Follow-up|1|||
148751745|NCT03041311|536562867|FG000|Overall Study|Withdrawal by Subject|8|||
148751746|NCT03041311|536562868|FG001|Overall Study|Withdrawal by Subject|5|||
148751747|NCT03041311|536562867|FG000|Overall Study|Sponsor Terminated Study|2|||
148751748|NCT03041311|536562868|FG001|Overall Study|Sponsor Terminated Study|4|||
148751749|NCT03041311|536562867|FG000|Overall Study|Disease Progression|3|||
148751750|NCT03041311|536562868|FG001|Overall Study|Disease Progression|1|||
148751751|NCT03041311|536562867|FG000|Overall Study|Randomized in error, did not receive drug|2|||
148751752|NCT03041311|536562868|FG001|Overall Study|Randomized in error, did not receive drug|0|||
148751753|NCT01842438|536562869|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
148751754|NCT01842438|536562870|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
148751755|NCT01842438|536562869|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
148751756|NCT01842438|536562870|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
148751757|NCT01842438|536562869|FG000|T2: 6month Follow-up|Death|0|||
148751758|NCT01842438|536562870|FG001|T2: 6month Follow-up|Death|1|||
148751759|NCT02366689|536562876|FG000|Overall Study|Withdrawal by Subject|1|||
148751760|NCT02366689|536562877|FG001|Overall Study|Withdrawal by Subject|0|||
148751761|NCT02366689|536562878|FG002|Overall Study|Withdrawal by Subject|1|||
148751762|NCT02366689|536562876|FG000|Overall Study|Lost to Follow-up|3|||
148751763|NCT02366689|536562877|FG001|Overall Study|Lost to Follow-up|2|||
148751764|NCT02366689|536562878|FG002|Overall Study|Lost to Follow-up|0|||
148751765|NCT02366689|536562876|FG000|Overall Study|Pregnancy|0|||
148751766|NCT02366689|536562877|FG001|Overall Study|Pregnancy|1|||
148751767|NCT02366689|536562878|FG002|Overall Study|Pregnancy|1|||
148751768|NCT01290068|536562879|FG000|Overall Study|Adverse Event|1|||
148751769|NCT01290068|536562880|FG001|Overall Study|Adverse Event|3|||
148751770|NCT01290068|536562879|FG000|Overall Study|Lost to Follow-up|3|||
148751771|NCT01290068|536562880|FG001|Overall Study|Lost to Follow-up|0|||
148751772|NCT01290068|536562879|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
148751773|NCT01290068|536562880|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
148751774|NCT01290068|536562879|FG000|Overall Study|Other|3|||
148751775|NCT01290068|536562880|FG001|Overall Study|Other|1|||
148751776|NCT03283566|536562884|FG000|Overall Study|Lost to Follow-up|1|||
148751777|NCT03283566|536562885|FG001|Overall Study|Lost to Follow-up|2|||
148751778|NCT00853099|536562889|FG000|Double-blind Period|Adverse Event|7|||
148751779|NCT00853099|536562890|FG001|Double-blind Period|Adverse Event|9|||
148751780|NCT00853099|536562891|FG002|Double-blind Period|Adverse Event|13|||
148751781|NCT00853099|536562892|FG003|Double-blind Period|Adverse Event|0|||
148751782|NCT00853099|536562889|FG000|Double-blind Period|Withdrawal by Subject|2|||
148751783|NCT00853099|536562890|FG001|Double-blind Period|Withdrawal by Subject|3|||
148751784|NCT00853099|536562891|FG002|Double-blind Period|Withdrawal by Subject|0|||
148751785|NCT00853099|536562892|FG003|Double-blind Period|Withdrawal by Subject|0|||
148751786|NCT00853099|536562889|FG000|Double-blind Period|Lack of Efficacy|14|||
148751787|NCT00853099|536562890|FG001|Double-blind Period|Lack of Efficacy|17|||
148751788|NCT00853099|536562891|FG002|Double-blind Period|Lack of Efficacy|16|||
148751789|NCT00853099|536562892|FG003|Double-blind Period|Lack of Efficacy|0|||
148751790|NCT00853099|536562889|FG000|Double-blind Period|Other|0|||
148751791|NCT00853099|536562890|FG001|Double-blind Period|Other|0|||
148751792|NCT00853099|536562891|FG002|Double-blind Period|Other|1|||
148751793|NCT00853099|536562892|FG003|Double-blind Period|Other|0|||
148751794|NCT00853099|536562889|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
148751795|NCT00853099|536562890|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
148751796|NCT00853099|536562891|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
148976277|NCT00280566|537394506|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
148751797|NCT00853099|536562892|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
148751798|NCT00853099|536562889|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
148751799|NCT00853099|536562890|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
148751800|NCT00853099|536562891|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
148751801|NCT00853099|536562892|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
148751802|NCT00853099|536562889|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
149027379|NCT00293462|537578556|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
149027380|NCT00293462|537578554|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
149027381|NCT00293462|537578555|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
149027382|NCT00293462|537578556|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
149027383|NCT00293462|537578554|FG000|Overall Study|Refuse Radiation Treatment|1|||
149027384|NCT00293462|537578555|FG001|Overall Study|Refuse Radiation Treatment|0|||
149027385|NCT00293462|537578556|FG002|Overall Study|Refuse Radiation Treatment|0|||
149027386|NCT00293462|537578554|FG000|Overall Study|No Show|0|||
149027387|NCT00293462|537578555|FG001|Overall Study|No Show|0|||
149027388|NCT00293462|537578556|FG002|Overall Study|No Show|1|||
149027389|NCT00293462|537578554|FG000|Overall Study|Went back to his home country|0|||
149027390|NCT00293462|537578555|FG001|Overall Study|Went back to his home country|0|||
148751803|NCT00853099|536562890|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
148751804|NCT00853099|536562891|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
148751805|NCT00853099|536562892|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
148751806|NCT00853099|536562889|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
148751807|NCT00853099|536562890|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
148751808|NCT00853099|536562891|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
148751809|NCT00853099|536562892|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
148751810|NCT00853099|536562889|FG000|Double-blind + Open-label Periods|Other|0|||
148751811|NCT00853099|536562890|FG001|Double-blind + Open-label Periods|Other|0|||
148751812|NCT00853099|536562891|FG002|Double-blind + Open-label Periods|Other|0|||
148751813|NCT00853099|536562892|FG003|Double-blind + Open-label Periods|Other|6|||
148751814|NCT02719184|536562897|FG000|Overall Study|Other than listed|1|||
148751815|NCT02719184|536562898|FG001|Overall Study|Other than listed|12|||
148751816|NCT02719184|536562899|FG002|Overall Study|Other than listed|13|||
148751817|NCT02719184|536562900|FG003|Overall Study|Other than listed|22|||
148751818|NCT02719184|536562901|FG004|Overall Study|Other than listed|9|||
148751819|NCT02719184|536562897|FG000|Overall Study|Withdrawal by Subject|5|||
148751820|NCT02719184|536562898|FG001|Overall Study|Withdrawal by Subject|3|||
148751821|NCT02719184|536562899|FG002|Overall Study|Withdrawal by Subject|6|||
148751822|NCT02719184|536562900|FG003|Overall Study|Withdrawal by Subject|6|||
148751823|NCT02719184|536562901|FG004|Overall Study|Withdrawal by Subject|0|||
148751824|NCT02719184|536562897|FG000|Overall Study|Lost to Follow-up|0|||
148751825|NCT02719184|536562898|FG001|Overall Study|Lost to Follow-up|4|||
148751826|NCT02719184|536562899|FG002|Overall Study|Lost to Follow-up|1|||
148751827|NCT02719184|536562900|FG003|Overall Study|Lost to Follow-up|3|||
148751828|NCT02719184|536562901|FG004|Overall Study|Lost to Follow-up|0|||
148751829|NCT02719184|536562897|FG000|Overall Study|Protocol Violation|0|||
148751830|NCT02719184|536562898|FG001|Overall Study|Protocol Violation|3|||
148751831|NCT02719184|536562899|FG002|Overall Study|Protocol Violation|0|||
148751832|NCT02719184|536562900|FG003|Overall Study|Protocol Violation|2|||
148751833|NCT02719184|536562901|FG004|Overall Study|Protocol Violation|0|||
148751834|NCT02719184|536562897|FG000|Overall Study|Adverse Event|0|||
148751835|NCT02719184|536562898|FG001|Overall Study|Adverse Event|0|||
148751836|NCT02719184|536562899|FG002|Overall Study|Adverse Event|0|||
148751837|NCT02719184|536562900|FG003|Overall Study|Adverse Event|3|||
148751838|NCT02719184|536562901|FG004|Overall Study|Adverse Event|0|||
148751839|NCT04108299|536562903|FG000|Overall Study|Not interested in participating|2|||
148751840|NCT04108299|536562904|FG001|Overall Study|Not interested in participating|1|||
148751841|NCT04108299|536562905|FG002|Overall Study|Not interested in participating|2|||
148751842|NCT04108299|536562906|FG003|Overall Study|Not interested in participating|1|||
148751843|NCT04123405|536562907|FG000|Overall Study|Adverse Event|1|||
148751844|NCT04123405|536562908|FG001|Overall Study|Adverse Event|2|||
148751845|NCT04123405|536562909|FG002|Overall Study|Adverse Event|3|||
148751846|NCT04123405|536562910|FG003|Overall Study|Adverse Event|3|||
148751847|NCT04123405|536562907|FG000|Overall Study|Exclusion criteria met|1|||
149027391|NCT00293462|537578556|FG002|Overall Study|Went back to his home country|1|||
149027392|NCT00293462|537578554|FG000|Overall Study|Blood clot after chemotherapy|0|||
149027393|NCT00293462|537578555|FG001|Overall Study|Blood clot after chemotherapy|0|||
149027394|NCT00293462|537578556|FG002|Overall Study|Blood clot after chemotherapy|1|||
148751848|NCT04123405|536562908|FG001|Overall Study|Exclusion criteria met|2|||
148751849|NCT04123405|536562909|FG002|Overall Study|Exclusion criteria met|0|||
148751850|NCT04123405|536562910|FG003|Overall Study|Exclusion criteria met|2|||
148751851|NCT04123405|536562907|FG000|Overall Study|Withdrawal by Subject|1|||
148751852|NCT04123405|536562908|FG001|Overall Study|Withdrawal by Subject|3|||
148751853|NCT04123405|536562909|FG002|Overall Study|Withdrawal by Subject|0|||
148751854|NCT04123405|536562910|FG003|Overall Study|Withdrawal by Subject|2|||
148751855|NCT04123405|536562907|FG000|Overall Study|Contact to subject lost|0|||
148751856|NCT04123405|536562908|FG001|Overall Study|Contact to subject lost|0|||
148751857|NCT04123405|536562909|FG002|Overall Study|Contact to subject lost|0|||
148751858|NCT04123405|536562910|FG003|Overall Study|Contact to subject lost|1|||
148751859|NCT04123405|536562907|FG000|Overall Study|screening failure|1|||
148751860|NCT04123405|536562908|FG001|Overall Study|screening failure|0|||
148822347|NCT04518410|536826754|FG023|Overall Study|Protocol Violation|3|||
148822348|NCT04518410|536826755|FG024|Overall Study|Protocol Violation|0|||
148822349|NCT04518410|536826731|FG000|Overall Study|Death|0|||
148822350|NCT04518410|536826732|FG001|Overall Study|Death|0|||
148822351|NCT04518410|536826733|FG002|Overall Study|Death|0|||
148822352|NCT04518410|536826734|FG003|Overall Study|Death|0|||
148822353|NCT04518410|536826735|FG004|Overall Study|Death|12|||
148822354|NCT04518410|536826736|FG005|Overall Study|Death|2|||
148822355|NCT04518410|536826737|FG006|Overall Study|Death|11|||
148822356|NCT04518410|536826738|FG007|Overall Study|Death|0|||
148822357|NCT04518410|536826739|FG008|Overall Study|Death|1|||
148822358|NCT04518410|536826740|FG009|Overall Study|Death|0|||
148822359|NCT04518410|536826741|FG010|Overall Study|Death|0|||
148822360|NCT04518410|536826742|FG011|Overall Study|Death|0|||
148822361|NCT04518410|536826743|FG012|Overall Study|Death|0|||
148822362|NCT04518410|536826744|FG013|Overall Study|Death|1|||
148822363|NCT04518410|536826745|FG014|Overall Study|Death|1|||
148822364|NCT04518410|536826746|FG015|Overall Study|Death|0|||
148822365|NCT04518410|536826747|FG016|Overall Study|Death|0|||
148822366|NCT04518410|536826748|FG017|Overall Study|Death|1|||
148822367|NCT04518410|536826749|FG018|Overall Study|Death|4|||
148822368|NCT04518410|536826750|FG019|Overall Study|Death|4|||
148822369|NCT04518410|536826751|FG020|Overall Study|Death|1|||
148822370|NCT04518410|536826752|FG021|Overall Study|Death|0|||
148822371|NCT04518410|536826753|FG022|Overall Study|Death|0|||
148822372|NCT04518410|536826754|FG023|Overall Study|Death|0|||
148822373|NCT04518410|536826755|FG024|Overall Study|Death|0|||
148822374|NCT04518410|536826731|FG000|Overall Study|Requirement to start alternative therapy|0|||
148822375|NCT04518410|536826732|FG001|Overall Study|Requirement to start alternative therapy|0|||
148822376|NCT04518410|536826733|FG002|Overall Study|Requirement to start alternative therapy|1|||
148822377|NCT04518410|536826734|FG003|Overall Study|Requirement to start alternative therapy|0|||
148822378|NCT04518410|536826735|FG004|Overall Study|Requirement to start alternative therapy|0|||
148822379|NCT04518410|536826736|FG005|Overall Study|Requirement to start alternative therapy|0|||
148822380|NCT04518410|536826737|FG006|Overall Study|Requirement to start alternative therapy|0|||
148822381|NCT04518410|536826738|FG007|Overall Study|Requirement to start alternative therapy|0|||
148822382|NCT04518410|536826739|FG008|Overall Study|Requirement to start alternative therapy|0|||
148822383|NCT04518410|536826740|FG009|Overall Study|Requirement to start alternative therapy|0|||
148822384|NCT04518410|536826741|FG010|Overall Study|Requirement to start alternative therapy|0|||
148822385|NCT04518410|536826742|FG011|Overall Study|Requirement to start alternative therapy|0|||
148822386|NCT04518410|536826743|FG012|Overall Study|Requirement to start alternative therapy|0|||
148822387|NCT04518410|536826744|FG013|Overall Study|Requirement to start alternative therapy|0|||
148822388|NCT04518410|536826745|FG014|Overall Study|Requirement to start alternative therapy|0|||
148822389|NCT04518410|536826746|FG015|Overall Study|Requirement to start alternative therapy|0|||
148822390|NCT04518410|536826747|FG016|Overall Study|Requirement to start alternative therapy|0|||
148822391|NCT04518410|536826748|FG017|Overall Study|Requirement to start alternative therapy|0|||
148822392|NCT04518410|536826749|FG018|Overall Study|Requirement to start alternative therapy|0|||
148976278|NCT00280566|537394504|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
148976279|NCT00280566|537394505|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
148976280|NCT00280566|537394506|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
148976281|NCT00280566|537394504|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
148976282|NCT00280566|537394505|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
148976283|NCT00280566|537394506|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
148976284|NCT00280566|537394504|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
148976285|NCT00280566|537394505|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
148976286|NCT00280566|537394506|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
148976287|NCT00280566|537394504|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
148976288|NCT00280566|537394505|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
148976289|NCT00280566|537394506|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
148976290|NCT00280566|537394504|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
148976291|NCT00280566|537394505|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
149027395|NCT00293462|537578554|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
148822393|NCT04518410|536826750|FG019|Overall Study|Requirement to start alternative therapy|0|||
148822394|NCT04518410|536826751|FG020|Overall Study|Requirement to start alternative therapy|0|||
148822395|NCT04518410|536826752|FG021|Overall Study|Requirement to start alternative therapy|0|||
148822396|NCT04518410|536826753|FG022|Overall Study|Requirement to start alternative therapy|0|||
148822397|NCT04518410|536826754|FG023|Overall Study|Requirement to start alternative therapy|0|||
148822398|NCT04518410|536826755|FG024|Overall Study|Requirement to start alternative therapy|0|||
148822399|NCT04518410|536826731|FG000|Overall Study|Randomized but not treated|0|||
148822400|NCT04518410|536826732|FG001|Overall Study|Randomized but not treated|0|||
148822401|NCT04518410|536826733|FG002|Overall Study|Randomized but not treated|0|||
148822402|NCT04518410|536826734|FG003|Overall Study|Randomized but not treated|2|||
148822403|NCT04518410|536826735|FG004|Overall Study|Randomized but not treated|6|||
148822404|NCT04518410|536826736|FG005|Overall Study|Randomized but not treated|4|||
148822405|NCT04518410|536826737|FG006|Overall Study|Randomized but not treated|3|||
148976292|NCT00280566|537394506|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
148822406|NCT04518410|536826738|FG007|Overall Study|Randomized but not treated|3|||
148822407|NCT04518410|536826739|FG008|Overall Study|Randomized but not treated|0|||
148822408|NCT04518410|536826740|FG009|Overall Study|Randomized but not treated|4|||
148822409|NCT04518410|536826741|FG010|Overall Study|Randomized but not treated|0|||
148822410|NCT04518410|536826742|FG011|Overall Study|Randomized but not treated|0|||
148822411|NCT04518410|536826743|FG012|Overall Study|Randomized but not treated|1|||
148822412|NCT04518410|536826744|FG013|Overall Study|Randomized but not treated|3|||
148822413|NCT04518410|536826745|FG014|Overall Study|Randomized but not treated|3|||
148822414|NCT04518410|536826746|FG015|Overall Study|Randomized but not treated|3|||
148822415|NCT04518410|536826747|FG016|Overall Study|Randomized but not treated|4|||
148822416|NCT04518410|536826748|FG017|Overall Study|Randomized but not treated|5|||
148822417|NCT04518410|536826749|FG018|Overall Study|Randomized but not treated|4|||
148822418|NCT04518410|536826750|FG019|Overall Study|Randomized but not treated|0|||
148822419|NCT04518410|536826751|FG020|Overall Study|Randomized but not treated|0|||
148822420|NCT04518410|536826752|FG021|Overall Study|Randomized but not treated|5|||
148822421|NCT04518410|536826753|FG022|Overall Study|Randomized but not treated|0|||
148822422|NCT04518410|536826754|FG023|Overall Study|Randomized but not treated|3|||
148822423|NCT04518410|536826755|FG024|Overall Study|Randomized but not treated|1|||
148822424|NCT04518410|536826731|FG000|Overall Study|Screen Fail but Randomized|0|||
148822425|NCT04518410|536826732|FG001|Overall Study|Screen Fail but Randomized|0|||
148822426|NCT04518410|536826733|FG002|Overall Study|Screen Fail but Randomized|0|||
148822427|NCT04518410|536826734|FG003|Overall Study|Screen Fail but Randomized|0|||
148822428|NCT04518410|536826735|FG004|Overall Study|Screen Fail but Randomized|2|||
148822429|NCT04518410|536826736|FG005|Overall Study|Screen Fail but Randomized|0|||
148822430|NCT04518410|536826737|FG006|Overall Study|Screen Fail but Randomized|0|||
148822431|NCT04518410|536826738|FG007|Overall Study|Screen Fail but Randomized|0|||
148822432|NCT04518410|536826739|FG008|Overall Study|Screen Fail but Randomized|0|||
148751861|NCT04123405|536562909|FG002|Overall Study|screening failure|0|||
148751862|NCT04123405|536562910|FG003|Overall Study|screening failure|0|||
148751863|NCT00662649|536562912|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
148751864|NCT00662649|536562913|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
148751865|NCT00662649|536562914|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
148751866|NCT00662649|536562915|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
148751867|NCT00662649|536562916|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
148751868|NCT00662649|536562912|FG000|Core Study (24 Months)|Adverse Event|22|||
148751869|NCT00662649|536562913|FG001|Core Study (24 Months)|Adverse Event|13|||
148751870|NCT00662649|536562914|FG002|Core Study (24 Months)|Adverse Event|18|||
148751871|NCT00662649|536562915|FG003|Core Study (24 Months)|Adverse Event|0|||
148751872|NCT00662649|536562916|FG004|Core Study (24 Months)|Adverse Event|0|||
148751873|NCT00662649|536562912|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
148751874|NCT00662649|536562913|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
148751875|NCT00662649|536562914|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
148751876|NCT00662649|536562915|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
148751877|NCT00662649|536562916|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
148751878|NCT00662649|536562912|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
148751879|NCT00662649|536562913|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
148751880|NCT00662649|536562914|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
148751881|NCT00662649|536562915|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
148751882|NCT00662649|536562916|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
148751883|NCT00662649|536562912|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
148751884|NCT00662649|536562913|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
148751885|NCT00662649|536562914|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
148751886|NCT00662649|536562915|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
148751887|NCT00662649|536562916|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
148751888|NCT00662649|536562912|FG000|Core Study (24 Months)|Protocol Violation|5|||
148751889|NCT00662649|536562913|FG001|Core Study (24 Months)|Protocol Violation|5|||
148751890|NCT00662649|536562914|FG002|Core Study (24 Months)|Protocol Violation|4|||
148751891|NCT00662649|536562915|FG003|Core Study (24 Months)|Protocol Violation|0|||
148751892|NCT00662649|536562916|FG004|Core Study (24 Months)|Protocol Violation|0|||
148751893|NCT00662649|536562912|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
148751894|NCT00662649|536562913|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
148822433|NCT04518410|536826740|FG009|Overall Study|Screen Fail but Randomized|0|||
148822434|NCT04518410|536826741|FG010|Overall Study|Screen Fail but Randomized|0|||
148822435|NCT04518410|536826742|FG011|Overall Study|Screen Fail but Randomized|0|||
148822436|NCT04518410|536826743|FG012|Overall Study|Screen Fail but Randomized|0|||
148822437|NCT04518410|536826744|FG013|Overall Study|Screen Fail but Randomized|0|||
148822438|NCT04518410|536826745|FG014|Overall Study|Screen Fail but Randomized|0|||
148751895|NCT00662649|536562914|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
148751896|NCT00662649|536562915|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
148751897|NCT00662649|536562916|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
148822439|NCT04518410|536826746|FG015|Overall Study|Screen Fail but Randomized|0|||
148822440|NCT04518410|536826747|FG016|Overall Study|Screen Fail but Randomized|0|||
148822441|NCT04518410|536826748|FG017|Overall Study|Screen Fail but Randomized|0|||
148751898|NCT00662649|536562912|FG000|Core Study (24 Months)|Death|1|||
148751899|NCT00662649|536562913|FG001|Core Study (24 Months)|Death|0|||
148751900|NCT00662649|536562914|FG002|Core Study (24 Months)|Death|2|||
148751901|NCT00662649|536562915|FG003|Core Study (24 Months)|Death|0|||
148751902|NCT00662649|536562916|FG004|Core Study (24 Months)|Death|0|||
148751903|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
148751904|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
148751905|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
148751906|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
148751907|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
148751908|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
148751909|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
148751910|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
148751911|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
148751912|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
148751913|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
148751914|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
148751915|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
148751916|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
148751917|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
148751918|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
148751919|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
148751920|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
148751921|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
148751922|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
148751923|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
148751924|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
148751925|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
148751926|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
148751927|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
148751928|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
148751929|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
148751930|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
148751931|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
148751932|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
148751933|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
148751934|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
148751935|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
148751936|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
148751937|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
148751938|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
148751939|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
148751940|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
148751941|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
148751942|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
148751943|NCT00662649|536562912|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
148751944|NCT00662649|536562913|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
148751945|NCT00662649|536562914|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
148751946|NCT00662649|536562915|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
148751947|NCT00662649|536562916|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
148751948|NCT01026194|536562917|FG000|Period 1：Double Blind Period|Adverse Event|2|||
148751949|NCT01026194|536562918|FG001|Period 1：Double Blind Period|Adverse Event|1|||
148751950|NCT01026194|536562917|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
148751951|NCT01026194|536562918|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
148751952|NCT01026194|536562917|FG000|Period 1：Double Blind Period|Physician Decision|0|||
148751953|NCT01026194|536562918|FG001|Period 1：Double Blind Period|Physician Decision|4|||
148751954|NCT01026194|536562917|FG000|Period 2：Open-label Period|Adverse Event|4|||
148751955|NCT01026194|536562918|FG001|Period 2：Open-label Period|Adverse Event|5|||
148751956|NCT01026194|536562917|FG000|Period 2：Open-label Period|Physician Decision|3|||
148751957|NCT01026194|536562918|FG001|Period 2：Open-label Period|Physician Decision|1|||
148751958|NCT01026194|536562917|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
149027396|NCT00293462|537578555|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
148751959|NCT01026194|536562918|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
148751960|NCT02556801|536562921|FG000|Overall Study|Lost to Follow-up|1|||
148751961|NCT02556801|536562922|FG001|Overall Study|Lost to Follow-up|0|||
148751962|NCT02556801|536562923|FG002|Overall Study|Lost to Follow-up|2|||
148822442|NCT04518410|536826749|FG018|Overall Study|Screen Fail but Randomized|0|||
148822443|NCT04518410|536826750|FG019|Overall Study|Screen Fail but Randomized|0|||
148822444|NCT04518410|536826751|FG020|Overall Study|Screen Fail but Randomized|0|||
148822445|NCT04518410|536826752|FG021|Overall Study|Screen Fail but Randomized|0|||
148822446|NCT04518410|536826753|FG022|Overall Study|Screen Fail but Randomized|0|||
148822447|NCT04518410|536826754|FG023|Overall Study|Screen Fail but Randomized|0|||
148822448|NCT04518410|536826755|FG024|Overall Study|Screen Fail but Randomized|0|||
148822449|NCT04518410|536826731|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148822450|NCT04518410|536826732|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148822451|NCT04518410|536826733|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148822452|NCT04518410|536826734|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148822453|NCT04518410|536826735|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
148822454|NCT04518410|536826736|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
148822455|NCT04518410|536826737|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
148822456|NCT04518410|536826738|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
148822457|NCT04518410|536826739|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
148822458|NCT04518410|536826740|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
148822459|NCT04518410|536826741|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
148822460|NCT04518410|536826742|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148822461|NCT04518410|536826743|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148976293|NCT00280566|537394504|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
148976294|NCT00280566|537394505|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
148976295|NCT00280566|537394506|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
148976296|NCT00280566|537394504|FG000|Period 2 Double Blind|Adverse Event|0|||
148751963|NCT02556801|536562924|FG003|Overall Study|Lost to Follow-up|0|||
148751964|NCT02556801|536562921|FG000|Overall Study|Withdrawal by Subject|1|||
148751965|NCT02556801|536562922|FG001|Overall Study|Withdrawal by Subject|1|||
148751966|NCT02556801|536562923|FG002|Overall Study|Withdrawal by Subject|1|||
148751967|NCT02556801|536562924|FG003|Overall Study|Withdrawal by Subject|0|||
148751968|NCT02556801|536562921|FG000|Overall Study|Protocol Violation|0|||
148751969|NCT02556801|536562922|FG001|Overall Study|Protocol Violation|3|||
148751970|NCT02556801|536562923|FG002|Overall Study|Protocol Violation|1|||
148751971|NCT02556801|536562924|FG003|Overall Study|Protocol Violation|1|||
148751972|NCT02556801|536562921|FG000|Overall Study|Adverse Event|0|||
148751973|NCT02556801|536562922|FG001|Overall Study|Adverse Event|2|||
148751974|NCT02556801|536562923|FG002|Overall Study|Adverse Event|0|||
148751975|NCT02556801|536562924|FG003|Overall Study|Adverse Event|3|||
148751976|NCT02556801|536562921|FG000|Overall Study|Pregnancy|0|||
148751977|NCT02556801|536562922|FG001|Overall Study|Pregnancy|1|||
148751978|NCT02556801|536562923|FG002|Overall Study|Pregnancy|0|||
148751979|NCT02556801|536562924|FG003|Overall Study|Pregnancy|0|||
148751980|NCT02556801|536562921|FG000|Overall Study|Personal reasons patient|0|||
148751981|NCT02556801|536562922|FG001|Overall Study|Personal reasons patient|0|||
148751982|NCT02556801|536562923|FG002|Overall Study|Personal reasons patient|0|||
148751983|NCT02556801|536562924|FG003|Overall Study|Personal reasons patient|1|||
148751984|NCT02515331|536562927|FG000|Overall Study|Withdrawal by Subject|0|||
148751985|NCT02515331|536562928|FG001|Overall Study|Withdrawal by Subject|0|||
148751986|NCT02515331|536562929|FG002|Overall Study|Withdrawal by Subject|1|||
148751987|NCT02515331|536562927|FG000|Overall Study|Protocol deviation|0|||
148751988|NCT02515331|536562928|FG001|Overall Study|Protocol deviation|0|||
148751989|NCT02515331|536562929|FG002|Overall Study|Protocol deviation|3|||
148751990|NCT02515331|536562927|FG000|Overall Study|Adverse Event|2|||
148751991|NCT02515331|536562928|FG001|Overall Study|Adverse Event|0|||
148751992|NCT02515331|536562929|FG002|Overall Study|Adverse Event|0|||
148751993|NCT00124748|536562930|FG000|Overall Study|Adverse Event|8|||
148751994|NCT00124748|536562931|FG001|Overall Study|Adverse Event|39|||
148751995|NCT00124748|536562930|FG000|Overall Study|Abnormal laboratory Value|2|||
148751996|NCT00124748|536562931|FG001|Overall Study|Abnormal laboratory Value|2|||
148751997|NCT00124748|536562930|FG000|Overall Study|Abnormal Procedure|0|||
148751998|NCT00124748|536562931|FG001|Overall Study|Abnormal Procedure|1|||
148751999|NCT00124748|536562930|FG000|Overall Study|Lack of Efficacy|20|||
148752000|NCT00124748|536562931|FG001|Overall Study|Lack of Efficacy|41|||
148752001|NCT00124748|536562930|FG000|Overall Study|No longer requires study drug|1|||
148752002|NCT00124748|536562931|FG001|Overall Study|No longer requires study drug|1|||
148752003|NCT00124748|536562930|FG000|Overall Study|Protocol Violation|3|||
148752004|NCT00124748|536562931|FG001|Overall Study|Protocol Violation|1|||
148752005|NCT00124748|536562930|FG000|Overall Study|Withdrawal by Subject|5|||
148752006|NCT00124748|536562931|FG001|Overall Study|Withdrawal by Subject|15|||
148752007|NCT00124748|536562930|FG000|Overall Study|Lost to Follow-up|2|||
148752008|NCT00124748|536562931|FG001|Overall Study|Lost to Follow-up|7|||
148752009|NCT00124748|536562930|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
148752010|NCT00124748|536562931|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
148752011|NCT00124748|536562930|FG000|Overall Study|Death|1|||
148752012|NCT00124748|536562931|FG001|Overall Study|Death|3|||
148752013|NCT00322712|536562932|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
148752014|NCT04176250|536562937|FG000|Overall Study|Adverse Event|0|||
148752015|NCT04176250|536562938|FG001|Overall Study|Adverse Event|1|||
148752016|NCT04176250|536562939|FG002|Overall Study|Adverse Event|0|||
148752017|NCT04176250|536562940|FG003|Overall Study|Adverse Event|1|||
148752018|NCT04176250|536562941|FG004|Overall Study|Adverse Event|0|||
148752019|NCT04176250|536562942|FG005|Overall Study|Adverse Event|1|||
148752020|NCT04176250|536562937|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
148752021|NCT04176250|536562938|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
148752022|NCT04176250|536562939|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
148752023|NCT04176250|536562940|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
148752024|NCT04176250|536562941|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
148752025|NCT04176250|536562942|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
148752026|NCT04176250|536562937|FG000|Overall Study|Withdrawal by Subject|0|||
148752027|NCT04176250|536562938|FG001|Overall Study|Withdrawal by Subject|0|||
148752028|NCT04176250|536562939|FG002|Overall Study|Withdrawal by Subject|0|||
148752029|NCT04176250|536562940|FG003|Overall Study|Withdrawal by Subject|0|||
148752030|NCT04176250|536562941|FG004|Overall Study|Withdrawal by Subject|0|||
148752031|NCT04176250|536562942|FG005|Overall Study|Withdrawal by Subject|1|||
148752032|NCT04176250|536562937|FG000|Overall Study|Randomized in error|0|||
148752033|NCT04176250|536562938|FG001|Overall Study|Randomized in error|0|||
148752034|NCT04176250|536562939|FG002|Overall Study|Randomized in error|0|||
148752035|NCT04176250|536562940|FG003|Overall Study|Randomized in error|0|||
148752036|NCT04176250|536562941|FG004|Overall Study|Randomized in error|1|||
148752037|NCT04176250|536562942|FG005|Overall Study|Randomized in error|0|||
148752038|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
148752039|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
148752040|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
148752041|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752042|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
148752043|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
148752044|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752045|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752046|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752047|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752048|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752049|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752050|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752051|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752052|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752053|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752054|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
148752055|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
148752056|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752057|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
148752058|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
148752059|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
148752060|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
148752061|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752062|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752063|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752064|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752065|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148822462|NCT04518410|536826744|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
148822463|NCT04518410|536826745|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
148752066|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752067|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752068|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752069|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752070|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752071|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
148752072|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
148752073|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
148752074|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
148752075|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
148752076|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
148752077|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
148752078|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752079|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752080|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752081|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752082|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752083|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752084|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752085|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752086|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752087|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752088|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
148752089|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752090|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
148752091|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
148752092|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752093|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
148752094|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
148752095|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752096|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752097|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752098|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752099|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752100|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752101|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752102|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752103|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752104|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752105|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
148752106|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752107|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752108|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
148752109|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
148752110|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752111|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752112|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752113|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752114|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752115|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752116|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752117|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752118|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752119|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752120|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752121|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752122|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
148752123|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752124|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752125|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752126|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752127|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
148752128|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752129|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752130|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752131|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752132|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752133|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752134|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752135|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752136|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752137|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752138|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148976297|NCT00280566|537394505|FG001|Period 2 Double Blind|Adverse Event|11|||
148752139|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
148752140|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752141|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
148752142|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752143|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752144|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752145|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752146|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752147|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752148|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752149|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752150|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752151|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752152|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752153|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752154|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752155|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752156|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
148752157|NCT00758524|536562943|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752158|NCT00758524|536562944|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
148752159|NCT00758524|536562945|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752160|NCT00758524|536562946|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752161|NCT00758524|536562947|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752162|NCT00758524|536562948|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752163|NCT00758524|536562949|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752164|NCT00758524|536562950|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752165|NCT00758524|536562951|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752166|NCT00758524|536562952|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752167|NCT00758524|536562953|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752168|NCT00758524|536562954|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752169|NCT00758524|536562955|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752170|NCT00758524|536562956|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752171|NCT00758524|536562957|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752172|NCT00758524|536562958|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752173|NCT00758524|536562959|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
148752174|NCT00758524|536562943|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752175|NCT00758524|536562944|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752176|NCT00758524|536562945|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752177|NCT00758524|536562946|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752178|NCT00758524|536562947|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752179|NCT00758524|536562948|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752180|NCT00758524|536562949|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752181|NCT00758524|536562950|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752182|NCT00758524|536562951|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
148752183|NCT00758524|536562952|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752184|NCT00758524|536562953|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752185|NCT00758524|536562954|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752186|NCT00758524|536562955|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752187|NCT00758524|536562956|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752188|NCT00758524|536562957|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752189|NCT00758524|536562958|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752190|NCT00758524|536562959|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
148752191|NCT00758524|536562943|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752192|NCT00758524|536562944|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752193|NCT00758524|536562945|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752194|NCT00758524|536562946|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752195|NCT00758524|536562947|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752196|NCT00758524|536562948|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752197|NCT00758524|536562949|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
148976298|NCT00280566|537394506|FG002|Period 2 Double Blind|Adverse Event|15|||
148976299|NCT00280566|537394504|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
148976300|NCT00280566|537394505|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
148752198|NCT00758524|536562950|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752199|NCT00758524|536562951|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752200|NCT00758524|536562952|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752201|NCT00758524|536562953|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752202|NCT00758524|536562954|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752203|NCT00758524|536562955|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752204|NCT00758524|536562956|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752205|NCT00758524|536562957|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752206|NCT00758524|536562958|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752207|NCT00758524|536562959|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
148752208|NCT01202175|536562973|FG000|Overall Study|Lost to Follow-up|2|||
148752209|NCT01202175|536562973|FG000|Overall Study|Withdrawal by Subject|1|||
148752210|NCT01202175|536562973|FG000|Overall Study|Adverse Event|2|||
148752211|NCT02790437|536562974|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
148752212|NCT02790437|536562975|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
148752213|NCT02790437|536562974|FG000|Overall Study|Adverse Event|1|||
148752214|NCT02790437|536562975|FG001|Overall Study|Adverse Event|0|||
148752215|NCT02790437|536562974|FG000|Overall Study|Withdrawal by Subject|1|||
148752216|NCT02790437|536562975|FG001|Overall Study|Withdrawal by Subject|0|||
148752217|NCT04688671|536562976|FG000|Overall Study|Adverse Event|3|||
148752218|NCT04688671|536562977|FG001|Overall Study|Adverse Event|1|||
148752219|NCT04688671|536562976|FG000|Overall Study|Withdrawal by Subject|3|||
148752220|NCT04688671|536562977|FG001|Overall Study|Withdrawal by Subject|1|||
148752221|NCT04688671|536562976|FG000|Overall Study|Lack of Efficacy|1|||
148752222|NCT04688671|536562977|FG001|Overall Study|Lack of Efficacy|1|||
148752223|NCT04688671|536562976|FG000|Overall Study|Protocol Violation|1|||
148752224|NCT04688671|536562977|FG001|Overall Study|Protocol Violation|0|||
148752225|NCT04688671|536562976|FG000|Overall Study|Lost to Follow-up|0|||
148752226|NCT04688671|536562977|FG001|Overall Study|Lost to Follow-up|1|||
148752227|NCT01626690|536562978|FG000|Overall Study|Protocol Violation|1|||
148752228|NCT01626690|536562979|FG001|Overall Study|Protocol Violation|0|||
148752229|NCT01626690|536562978|FG000|Overall Study|Adverse Event|1|||
148752230|NCT01626690|536562979|FG001|Overall Study|Adverse Event|0|||
148752231|NCT02676882|536562980|FG000|Overall Study|Adverse Event|1|||
148752232|NCT02676882|536562981|FG001|Overall Study|Adverse Event|0|||
148752233|NCT02676882|536562980|FG000|Overall Study|Lost to Follow-up|1|||
148752234|NCT02676882|536562981|FG001|Overall Study|Lost to Follow-up|0|||
148752235|NCT02676882|536562980|FG000|Overall Study|Withdrawal by Subject|1|||
148752236|NCT02676882|536562981|FG001|Overall Study|Withdrawal by Subject|2|||
148752237|NCT01518322|536562982|FG000|Overall Study|FeNO measurement was missing|13|||
148752238|NCT01269918|536562983|FG000|Overall Study|Did not receive study drug|0|||
148752239|NCT01269918|536562984|FG001|Overall Study|Did not receive study drug|3|||
148752240|NCT00856193|536562988|FG000|Period 2|Abnormal test procedure results|0|||
148752241|NCT00856193|536562989|FG001|Period 2|Abnormal test procedure results|1|||
148752242|NCT00856193|536562988|FG000|Period 2|Lost to Follow-up|0|||
148752243|NCT00856193|536562989|FG001|Period 2|Lost to Follow-up|1|||
148752244|NCT04542057|536562992|FG000|Overall Study|Death|3|||
148752245|NCT04542057|536562993|FG001|Overall Study|Death|1|||
148752246|NCT04542057|536562992|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
148752247|NCT04542057|536562993|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
148752248|NCT04542057|536562992|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
148752249|NCT04542057|536562993|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
148752250|NCT04542057|536562992|FG000|Overall Study|Adverse Event|15|||
148752251|NCT04542057|536562993|FG001|Overall Study|Adverse Event|6|||
148752252|NCT04542057|536562992|FG000|Overall Study|COVID-19 adverse event|6|||
148752253|NCT04542057|536562993|FG001|Overall Study|COVID-19 adverse event|4|||
148752254|NCT04542057|536562992|FG000|Overall Study|Lack of Efficacy|2|||
148752255|NCT04542057|536562993|FG001|Overall Study|Lack of Efficacy|5|||
148752256|NCT04542057|536562992|FG000|Overall Study|Study terminated by sponsor|1|||
148889068|NCT02800863|537072347|FG000|Overall Study|Subject and/or Family Request|64|||
148752257|NCT04542057|536562993|FG001|Overall Study|Study terminated by sponsor|0|||
148752258|NCT04542057|536562992|FG000|Overall Study|Investigator discretion|2|||
148752259|NCT04542057|536562993|FG001|Overall Study|Investigator discretion|1|||
148752260|NCT04542057|536562992|FG000|Overall Study|Withdrawal by Subject|52|||
148752261|NCT04542057|536562993|FG001|Overall Study|Withdrawal by Subject|30|||
148752262|NCT04542057|536562992|FG000|Overall Study|Lost to Follow-up|8|||
148752263|NCT04542057|536562993|FG001|Overall Study|Lost to Follow-up|11|||
148752264|NCT04542057|536562992|FG000|Overall Study|Other|2|||
148752265|NCT04542057|536562993|FG001|Overall Study|Other|2|||
148752266|NCT03404674|536562994|FG000|Overall Study|Inability to Attend Future Visits|0|||
148752267|NCT03404674|536562995|FG001|Overall Study|Inability to Attend Future Visits|1|||
148752268|NCT03404674|536562996|FG002|Overall Study|Inability to Attend Future Visits|1|||
148752269|NCT03404674|536562997|FG003|Overall Study|Inability to Attend Future Visits|0|||
148752270|NCT03404674|536562998|FG004|Overall Study|Inability to Attend Future Visits|0|||
148889069|NCT02800863|537072347|FG000|Overall Study|Trial Failure|81|||
148752271|NCT03404674|536562999|FG005|Overall Study|Inability to Attend Future Visits|0|||
148752272|NCT03404674|536562994|FG000|Overall Study|Behavioral Problems|0|||
148752273|NCT03404674|536562995|FG001|Overall Study|Behavioral Problems|0|||
148752274|NCT03404674|536562996|FG002|Overall Study|Behavioral Problems|1|||
148752275|NCT03404674|536562997|FG003|Overall Study|Behavioral Problems|0|||
148752276|NCT03404674|536562998|FG004|Overall Study|Behavioral Problems|0|||
148752277|NCT03404674|536562999|FG005|Overall Study|Behavioral Problems|0|||
148752278|NCT03404674|536562994|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
148752279|NCT03404674|536562995|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
148752280|NCT03404674|536562996|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
148752281|NCT03404674|536562997|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
148752282|NCT03404674|536562998|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
148752283|NCT03404674|536562999|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
148752284|NCT04660331|536563000|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
148752285|NCT04660331|536563001|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
148752286|NCT04660331|536563002|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
148752287|NCT01487525|536563003|FG000|Overall Study|Withdrawal by Subject|0|||
148752288|NCT01487525|536563004|FG001|Overall Study|Withdrawal by Subject|1|||
148752289|NCT01870778|536563005|FG000|Overall Study|Withdrawal by Subject|8|||
148752290|NCT01870778|536563006|FG001|Overall Study|Withdrawal by Subject|7|||
148752291|NCT01870778|536563005|FG000|Overall Study|Lost to Follow-up|0|||
148752292|NCT01870778|536563006|FG001|Overall Study|Lost to Follow-up|2|||
148752293|NCT00065156|536563007|FG000|Overall Study|Adverse Event|37|||
148752294|NCT00065156|536563007|FG000|Overall Study|Lack of Efficacy|52|||
148752295|NCT00065156|536563007|FG000|Overall Study|Withdrawal by Subject|8|||
148752296|NCT00065156|536563007|FG000|Overall Study|Lost to Follow-up|1|||
148752297|NCT00065156|536563007|FG000|Overall Study|Death|11|||
148752298|NCT00065156|536563007|FG000|Overall Study|Study Closed by Sponsor|2|||
148752299|NCT00065156|536563007|FG000|Overall Study|Disease Progression|7|||
148752300|NCT00065156|536563007|FG000|Overall Study|Investigator Decision|2|||
148752301|NCT00065156|536563007|FG000|Overall Study|Non-Compliance|2|||
148752302|NCT00065156|536563007|FG000|Overall Study|Loss of Response|1|||
148752303|NCT00065156|536563007|FG000|Overall Study|Secondary Malign Disease|1|||
148752304|NCT01215136|536563008|FG000|Overall Study|Adverse Event|2|||
148752305|NCT01215136|536563009|FG001|Overall Study|Adverse Event|9|||
148752306|NCT01215136|536563008|FG000|Overall Study|Disease Progression|3|||
148752307|NCT01215136|536563009|FG001|Overall Study|Disease Progression|14|||
148752308|NCT01215136|536563008|FG000|Overall Study|Symptomatic Deterioration|1|||
148752309|NCT01215136|536563009|FG001|Overall Study|Symptomatic Deterioration|1|||
148752310|NCT01215136|536563008|FG000|Overall Study|Death|0|||
148752311|NCT01215136|536563009|FG001|Overall Study|Death|2|||
148752312|NCT01215136|536563008|FG000|Overall Study|Withdrawal by Subject|0|||
148752313|NCT01215136|536563009|FG001|Overall Study|Withdrawal by Subject|1|||
148752314|NCT02308124|536563010|FG000|Overall Study|Lost to Follow-up|6|||
148752315|NCT02308124|536563011|FG001|Overall Study|Lost to Follow-up|6|||
148752316|NCT02308124|536563012|FG002|Overall Study|Lost to Follow-up|6|||
148752317|NCT02308124|536563010|FG000|Overall Study|Adverse Event|0|||
148752318|NCT02308124|536563011|FG001|Overall Study|Adverse Event|2|||
148752319|NCT02308124|536563012|FG002|Overall Study|Adverse Event|2|||
148752320|NCT01329900|536563028|FG000|Overall Study|Elevated creatinine/renal function|1|||
148752321|NCT01866098|536563029|FG000|Overall Study|Lost to Follow-up|11|||
148752322|NCT01866098|536563030|FG001|Overall Study|Lost to Follow-up|18|||
148752323|NCT01866098|536563031|FG002|Overall Study|Lost to Follow-up|13|||
148752324|NCT01866098|536563029|FG000|Overall Study|Physician Decision|0|||
148752325|NCT01866098|536563030|FG001|Overall Study|Physician Decision|1|||
148752326|NCT01866098|536563031|FG002|Overall Study|Physician Decision|2|||
148752327|NCT01866098|536563029|FG000|Overall Study|Adverse Event|1|||
148752328|NCT01866098|536563030|FG001|Overall Study|Adverse Event|5|||
148752329|NCT01866098|536563031|FG002|Overall Study|Adverse Event|4|||
148752330|NCT01866098|536563029|FG000|Overall Study|Protocol Violation|1|||
148752331|NCT01866098|536563030|FG001|Overall Study|Protocol Violation|0|||
148752332|NCT01866098|536563031|FG002|Overall Study|Protocol Violation|0|||
148752333|NCT01866098|536563029|FG000|Overall Study|Withdrawal by Subject|1|||
148752334|NCT01866098|536563030|FG001|Overall Study|Withdrawal by Subject|2|||
148752335|NCT01866098|536563031|FG002|Overall Study|Withdrawal by Subject|0|||
148752336|NCT01866098|536563029|FG000|Overall Study|Unrelated Hospitalization|2|||
148752337|NCT01866098|536563030|FG001|Overall Study|Unrelated Hospitalization|0|||
148752338|NCT01866098|536563031|FG002|Overall Study|Unrelated Hospitalization|1|||
148752339|NCT01866098|536563029|FG000|Overall Study|Non-compliance|1|||
148752340|NCT01866098|536563030|FG001|Overall Study|Non-compliance|0|||
148752341|NCT01866098|536563031|FG002|Overall Study|Non-compliance|1|||
148752342|NCT01866098|536563029|FG000|Overall Study|Pregnancy|2|||
148752343|NCT01866098|536563030|FG001|Overall Study|Pregnancy|0|||
148752344|NCT01866098|536563031|FG002|Overall Study|Pregnancy|0|||
148752345|NCT01866098|536563029|FG000|Overall Study|Death|0|||
148752346|NCT01866098|536563030|FG001|Overall Study|Death|1|||
148752347|NCT01866098|536563031|FG002|Overall Study|Death|0|||
148822464|NCT04518410|536826746|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
148822465|NCT04518410|536826747|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
148822466|NCT04518410|536826748|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
148822467|NCT04518410|536826749|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
148822468|NCT04518410|536826750|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
148822469|NCT04518410|536826751|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
148822470|NCT04518410|536826752|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
148822471|NCT04518410|536826753|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
148822472|NCT04518410|536826754|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
148822473|NCT04518410|536826755|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
148822474|NCT04518410|536826731|FG000|Overall Study|Dual Enrolled Subject|0|||
148822475|NCT04518410|536826732|FG001|Overall Study|Dual Enrolled Subject|0|||
148822476|NCT04518410|536826733|FG002|Overall Study|Dual Enrolled Subject|0|||
148822477|NCT04518410|536826734|FG003|Overall Study|Dual Enrolled Subject|0|||
148822478|NCT04518410|536826735|FG004|Overall Study|Dual Enrolled Subject|0|||
148822479|NCT04518410|536826736|FG005|Overall Study|Dual Enrolled Subject|0|||
148822480|NCT04518410|536826737|FG006|Overall Study|Dual Enrolled Subject|0|||
148822481|NCT04518410|536826738|FG007|Overall Study|Dual Enrolled Subject|0|||
148822482|NCT04518410|536826739|FG008|Overall Study|Dual Enrolled Subject|0|||
148822483|NCT04518410|536826740|FG009|Overall Study|Dual Enrolled Subject|0|||
148822484|NCT04518410|536826741|FG010|Overall Study|Dual Enrolled Subject|0|||
148822485|NCT04518410|536826742|FG011|Overall Study|Dual Enrolled Subject|0|||
148822486|NCT04518410|536826743|FG012|Overall Study|Dual Enrolled Subject|0|||
148822487|NCT04518410|536826744|FG013|Overall Study|Dual Enrolled Subject|0|||
148822488|NCT04518410|536826745|FG014|Overall Study|Dual Enrolled Subject|0|||
148822489|NCT04518410|536826746|FG015|Overall Study|Dual Enrolled Subject|0|||
148822490|NCT04518410|536826747|FG016|Overall Study|Dual Enrolled Subject|0|||
148822491|NCT04518410|536826748|FG017|Overall Study|Dual Enrolled Subject|1|||
148822492|NCT04518410|536826749|FG018|Overall Study|Dual Enrolled Subject|0|||
148822493|NCT04518410|536826750|FG019|Overall Study|Dual Enrolled Subject|0|||
148822494|NCT04518410|536826751|FG020|Overall Study|Dual Enrolled Subject|0|||
148822495|NCT04518410|536826752|FG021|Overall Study|Dual Enrolled Subject|0|||
148822496|NCT04518410|536826753|FG022|Overall Study|Dual Enrolled Subject|0|||
148822497|NCT04518410|536826754|FG023|Overall Study|Dual Enrolled Subject|0|||
148822498|NCT04518410|536826755|FG024|Overall Study|Dual Enrolled Subject|0|||
148822499|NCT02218268|536826756|FG000|24 Hour Washout|Physician Decision|11|||
148822500|NCT02218268|536826757|FG001|24 Hour Washout|Physician Decision|9|||
148822501|NCT03651336|536826758|FG000|Overall Study|Withdrawal by Subject|4|||
148822502|NCT01341990|536826759|FG000|Overall Study|Adverse Event|0|||
148822503|NCT01341990|536826760|FG001|Overall Study|Adverse Event|1|||
148822504|NCT01341990|536826759|FG000|Overall Study|Torn Study Lens|1|||
148822505|NCT01341990|536826760|FG001|Overall Study|Torn Study Lens|0|||
148822506|NCT01341990|536826759|FG000|Overall Study|Withdrawal by Subject|2|||
148822507|NCT01341990|536826760|FG001|Overall Study|Withdrawal by Subject|0|||
148822508|NCT02487199|536826767|FG000|Overall Study|Withdrew Consent|0|||
148822509|NCT02487199|536826768|FG001|Overall Study|Withdrew Consent|1|||
148822510|NCT01213251|536828534|FG000|Overall Study|Death|2|||
148822511|NCT01213251|536828535|FG001|Overall Study|Death|1|||
148976301|NCT00280566|537394506|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
148976302|NCT00280566|537394504|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
148976303|NCT00280566|537394505|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
148976304|NCT00280566|537394506|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
148976305|NCT00280566|537394504|FG000|Period 2 Double Blind|miscellaneous|0|||
148976306|NCT00280566|537394505|FG001|Period 2 Double Blind|miscellaneous|10|||
148976307|NCT00280566|537394506|FG002|Period 2 Double Blind|miscellaneous|5|||
148976308|NCT01147653|537394507|FG000|Year 2|Withdrawal by Subject|2|||
148976309|NCT01147653|537394508|FG001|Year 2|Withdrawal by Subject|3|||
148976310|NCT00353366|537394509|FG000|Overall Study|Adverse Event|8|||
148976311|NCT00353366|537394509|FG000|Overall Study|Protocol Violation|12|||
148822512|NCT01213251|536828536|FG002|Overall Study|Death|2|||
148822513|NCT01213251|536828534|FG000|Overall Study|Exit|3|||
148822514|NCT01213251|536828535|FG001|Overall Study|Exit|2|||
148822515|NCT01213251|536828536|FG002|Overall Study|Exit|8|||
148822516|NCT01213251|536828534|FG000|Overall Study|Protocol Violation|1|||
148822517|NCT01213251|536828535|FG001|Overall Study|Protocol Violation|1|||
148822518|NCT01213251|536828536|FG002|Overall Study|Protocol Violation|0|||
148822519|NCT01213251|536828534|FG000|Overall Study|Missed 18-Month Follow-up|0|||
148822520|NCT01213251|536828535|FG001|Overall Study|Missed 18-Month Follow-up|0|||
148822521|NCT01213251|536828536|FG002|Overall Study|Missed 18-Month Follow-up|1|||
148822522|NCT00520572|536828541|FG000|Overall Study|Adverse Event|9|||
148752348|NCT00489255|536563045|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
148752349|NCT00489255|536563046|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
148752350|NCT00489255|536563045|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
148752351|NCT00489255|536563046|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
148752352|NCT00489255|536563045|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
148752353|NCT00489255|536563046|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
148752354|NCT00489255|536563045|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
148752355|NCT00489255|536563046|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
148752356|NCT00489255|536563045|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
148752357|NCT00489255|536563046|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
148752358|NCT00489255|536563045|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
148752359|NCT00489255|536563046|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
148752360|NCT00489255|536563045|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
148752361|NCT00489255|536563046|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
148752362|NCT00489255|536563045|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
148752363|NCT00489255|536563046|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
148752364|NCT00489255|536563045|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
148752365|NCT00489255|536563046|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
148752366|NCT00489255|536563045|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
148752367|NCT00489255|536563046|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
148752368|NCT01982955|536563049|FG000|Overall Study|Randomized but not treated|0|||
148752369|NCT01982955|536563050|FG001|Overall Study|Randomized but not treated|0|||
148752370|NCT01982955|536563051|FG002|Overall Study|Randomized but not treated|0|||
148752371|NCT01982955|536563052|FG003|Overall Study|Randomized but not treated|1|||
148752372|NCT01982955|536563053|FG004|Overall Study|Randomized but not treated|0|||
148752373|NCT02721732|536564923|FG000|Overall Study|Adverse Event|2|||
148752374|NCT02721732|536564924|FG001|Overall Study|Adverse Event|0|||
148752375|NCT02721732|536564925|FG002|Overall Study|Adverse Event|2|||
148752376|NCT02721732|536564926|FG003|Overall Study|Adverse Event|0|||
148752377|NCT02721732|536564927|FG004|Overall Study|Adverse Event|1|||
148752378|NCT02721732|536564928|FG005|Overall Study|Adverse Event|0|||
148752379|NCT02721732|536564929|FG006|Overall Study|Adverse Event|1|||
148752380|NCT02721732|536564930|FG007|Overall Study|Adverse Event|0|||
148752381|NCT02721732|536564931|FG008|Overall Study|Adverse Event|1|||
148752382|NCT02721732|536564932|FG009|Overall Study|Adverse Event|1|||
148752383|NCT02721732|536564923|FG000|Overall Study|Death|0|||
148752384|NCT02721732|536564924|FG001|Overall Study|Death|0|||
148752385|NCT02721732|536564925|FG002|Overall Study|Death|0|||
148752386|NCT02721732|536564926|FG003|Overall Study|Death|0|||
148752387|NCT02721732|536564927|FG004|Overall Study|Death|1|||
148752388|NCT02721732|536564928|FG005|Overall Study|Death|0|||
148752389|NCT02721732|536564929|FG006|Overall Study|Death|1|||
148752390|NCT02721732|536564930|FG007|Overall Study|Death|0|||
148752391|NCT02721732|536564931|FG008|Overall Study|Death|0|||
148752392|NCT02721732|536564932|FG009|Overall Study|Death|1|||
148752393|NCT02721732|536564923|FG000|Overall Study|Lack of Efficacy|12|||
148752394|NCT02721732|536564924|FG001|Overall Study|Lack of Efficacy|11|||
148752395|NCT02721732|536564925|FG002|Overall Study|Lack of Efficacy|18|||
148752396|NCT02721732|536564926|FG003|Overall Study|Lack of Efficacy|5|||
148752397|NCT02721732|536564927|FG004|Overall Study|Lack of Efficacy|21|||
148752398|NCT02721732|536564928|FG005|Overall Study|Lack of Efficacy|2|||
148752399|NCT02721732|536564929|FG006|Overall Study|Lack of Efficacy|8|||
148752400|NCT02721732|536564930|FG007|Overall Study|Lack of Efficacy|11|||
148752401|NCT02721732|536564931|FG008|Overall Study|Lack of Efficacy|10|||
148752402|NCT02721732|536564932|FG009|Overall Study|Lack of Efficacy|20|||
148752403|NCT02721732|536564923|FG000|Overall Study|Physician Decision|0|||
148752404|NCT02721732|536564924|FG001|Overall Study|Physician Decision|0|||
148752405|NCT02721732|536564925|FG002|Overall Study|Physician Decision|1|||
148752406|NCT02721732|536564926|FG003|Overall Study|Physician Decision|0|||
148752407|NCT02721732|536564927|FG004|Overall Study|Physician Decision|0|||
148752408|NCT02721732|536564928|FG005|Overall Study|Physician Decision|0|||
148752409|NCT02721732|536564929|FG006|Overall Study|Physician Decision|0|||
148752410|NCT02721732|536564930|FG007|Overall Study|Physician Decision|0|||
148752411|NCT02721732|536564931|FG008|Overall Study|Physician Decision|0|||
148752412|NCT02721732|536564932|FG009|Overall Study|Physician Decision|0|||
148752413|NCT02721732|536564923|FG000|Overall Study|Withdrawal by Subject|1|||
148752414|NCT02721732|536564924|FG001|Overall Study|Withdrawal by Subject|0|||
148752415|NCT02721732|536564925|FG002|Overall Study|Withdrawal by Subject|0|||
148752416|NCT02721732|536564926|FG003|Overall Study|Withdrawal by Subject|0|||
148752417|NCT02721732|536564927|FG004|Overall Study|Withdrawal by Subject|3|||
148752418|NCT02721732|536564928|FG005|Overall Study|Withdrawal by Subject|0|||
148752419|NCT02721732|536564929|FG006|Overall Study|Withdrawal by Subject|1|||
148752420|NCT02721732|536564930|FG007|Overall Study|Withdrawal by Subject|1|||
148752421|NCT02721732|536564931|FG008|Overall Study|Withdrawal by Subject|0|||
148752422|NCT02721732|536564932|FG009|Overall Study|Withdrawal by Subject|1|||
148752423|NCT02721732|536564923|FG000|Overall Study|Participant Choice|1|||
148752424|NCT02721732|536564924|FG001|Overall Study|Participant Choice|0|||
148752425|NCT02721732|536564925|FG002|Overall Study|Participant Choice|0|||
148822523|NCT00520572|536828542|FG001|Overall Study|Adverse Event|3|||
148822524|NCT00520572|536828543|FG002|Overall Study|Adverse Event|6|||
148822525|NCT00520572|536828544|FG003|Overall Study|Adverse Event|9|||
148822526|NCT00520572|536828545|FG004|Overall Study|Adverse Event|7|||
148822527|NCT00520572|536828546|FG005|Overall Study|Adverse Event|2|||
148822528|NCT00520572|536828541|FG000|Overall Study|Withdrawal by Subject|0|||
148822529|NCT00520572|536828542|FG001|Overall Study|Withdrawal by Subject|9|||
148822530|NCT00520572|536828543|FG002|Overall Study|Withdrawal by Subject|5|||
148822531|NCT00520572|536828544|FG003|Overall Study|Withdrawal by Subject|2|||
148822532|NCT00520572|536828545|FG004|Overall Study|Withdrawal by Subject|2|||
148822533|NCT00520572|536828546|FG005|Overall Study|Withdrawal by Subject|0|||
148822534|NCT00520572|536828541|FG000|Overall Study|Protocol Violation|0|||
148822535|NCT00520572|536828542|FG001|Overall Study|Protocol Violation|0|||
148822536|NCT00520572|536828543|FG002|Overall Study|Protocol Violation|1|||
148822537|NCT00520572|536828544|FG003|Overall Study|Protocol Violation|0|||
148822538|NCT00520572|536828545|FG004|Overall Study|Protocol Violation|0|||
148822539|NCT00520572|536828546|FG005|Overall Study|Protocol Violation|0|||
148822540|NCT00520572|536828541|FG000|Overall Study|Lack of Efficacy|1|||
148822541|NCT00520572|536828542|FG001|Overall Study|Lack of Efficacy|1|||
148822542|NCT00520572|536828543|FG002|Overall Study|Lack of Efficacy|1|||
148822543|NCT00520572|536828544|FG003|Overall Study|Lack of Efficacy|2|||
148822544|NCT00520572|536828545|FG004|Overall Study|Lack of Efficacy|1|||
148822545|NCT00520572|536828546|FG005|Overall Study|Lack of Efficacy|0|||
148822546|NCT00520572|536828541|FG000|Overall Study|Lost to Follow-up|0|||
148822547|NCT00520572|536828542|FG001|Overall Study|Lost to Follow-up|0|||
148822548|NCT00520572|536828543|FG002|Overall Study|Lost to Follow-up|0|||
148822549|NCT00520572|536828544|FG003|Overall Study|Lost to Follow-up|0|||
148822550|NCT00520572|536828545|FG004|Overall Study|Lost to Follow-up|1|||
148822551|NCT00520572|536828546|FG005|Overall Study|Lost to Follow-up|0|||
148822552|NCT00520572|536828541|FG000|Overall Study|Incorrect enrollment|1|||
148822553|NCT00520572|536828542|FG001|Overall Study|Incorrect enrollment|0|||
148822554|NCT00520572|536828543|FG002|Overall Study|Incorrect enrollment|1|||
148822555|NCT00520572|536828544|FG003|Overall Study|Incorrect enrollment|0|||
148822556|NCT00520572|536828545|FG004|Overall Study|Incorrect enrollment|1|||
148822557|NCT00520572|536828546|FG005|Overall Study|Incorrect enrollment|0|||
148822558|NCT00520572|536828541|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
148822559|NCT00520572|536828542|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
148822560|NCT00520572|536828543|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
148822561|NCT00520572|536828544|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
148822562|NCT00520572|536828545|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
148822563|NCT00520572|536828546|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
148822564|NCT00520572|536828541|FG000|Overall Study|Long break in taking Medication|0|||
148822565|NCT00520572|536828542|FG001|Overall Study|Long break in taking Medication|0|||
148822566|NCT00520572|536828543|FG002|Overall Study|Long break in taking Medication|0|||
148822567|NCT00520572|536828544|FG003|Overall Study|Long break in taking Medication|1|||
148822568|NCT00520572|536828545|FG004|Overall Study|Long break in taking Medication|0|||
148822569|NCT00520572|536828546|FG005|Overall Study|Long break in taking Medication|0|||
148822570|NCT00520572|536828541|FG000|Overall Study|Did not receive Treatment|1|||
148822571|NCT00520572|536828542|FG001|Overall Study|Did not receive Treatment|0|||
148822572|NCT00520572|536828543|FG002|Overall Study|Did not receive Treatment|1|||
148822573|NCT00520572|536828544|FG003|Overall Study|Did not receive Treatment|0|||
148822574|NCT00520572|536828545|FG004|Overall Study|Did not receive Treatment|0|||
148752426|NCT02721732|536564926|FG003|Overall Study|Participant Choice|0|||
148752427|NCT02721732|536564927|FG004|Overall Study|Participant Choice|0|||
148752428|NCT02721732|536564928|FG005|Overall Study|Participant Choice|0|||
148752429|NCT02721732|536564929|FG006|Overall Study|Participant Choice|0|||
148752430|NCT02721732|536564930|FG007|Overall Study|Participant Choice|0|||
148752431|NCT02721732|536564931|FG008|Overall Study|Participant Choice|0|||
148752432|NCT02721732|536564932|FG009|Overall Study|Participant Choice|1|||
148752433|NCT02721732|536564923|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752434|NCT02721732|536564924|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148822575|NCT00520572|536828546|FG005|Overall Study|Did not receive Treatment|0|||
148822576|NCT02802865|536828549|FG000|Overall Study|Pregnancy|1|||
148822577|NCT02802865|536828550|FG001|Overall Study|Pregnancy|1|||
148822578|NCT02802865|536828549|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
148822579|NCT02802865|536828550|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
148822580|NCT01803737|536828554|FG000|Overall Study|Lack of Time|1|||
148822581|NCT01803737|536828555|FG001|Overall Study|Lack of Time|0|||
148822582|NCT01803737|536828554|FG000|Overall Study|Medical Reason|0|||
148822583|NCT01803737|536828555|FG001|Overall Study|Medical Reason|1|||
148822584|NCT01803737|536828554|FG000|Overall Study|Lost to Follow-up|0|||
148822585|NCT01803737|536828555|FG001|Overall Study|Lost to Follow-up|2|||
148822586|NCT01529112|536828556|FG000|Overall Study|Adverse Event|2|||
148822587|NCT01529112|536828557|FG001|Overall Study|Adverse Event|0|||
148822588|NCT01529112|536828556|FG000|Overall Study|Death|59|||
148822589|NCT01529112|536828557|FG001|Overall Study|Death|38|||
148752435|NCT02721732|536564925|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
148752436|NCT02721732|536564926|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752437|NCT02721732|536564927|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752438|NCT02721732|536564928|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752439|NCT02721732|536564929|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752440|NCT02721732|536564930|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752441|NCT02721732|536564931|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752442|NCT02721732|536564932|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
148752443|NCT02721732|536564923|FG000|Overall Study|Progression and withdrew consent|1|||
148752444|NCT02721732|536564924|FG001|Overall Study|Progression and withdrew consent|1|||
148752445|NCT02721732|536564925|FG002|Overall Study|Progression and withdrew consent|0|||
148752446|NCT02721732|536564926|FG003|Overall Study|Progression and withdrew consent|0|||
148752447|NCT02721732|536564927|FG004|Overall Study|Progression and withdrew consent|0|||
148752448|NCT02721732|536564928|FG005|Overall Study|Progression and withdrew consent|0|||
148752449|NCT02721732|536564929|FG006|Overall Study|Progression and withdrew consent|0|||
148752450|NCT02721732|536564930|FG007|Overall Study|Progression and withdrew consent|0|||
148752451|NCT02721732|536564931|FG008|Overall Study|Progression and withdrew consent|0|||
148752452|NCT02721732|536564932|FG009|Overall Study|Progression and withdrew consent|1|||
148752453|NCT02721732|536564923|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
148752454|NCT02721732|536564924|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
148752455|NCT02721732|536564925|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
148752456|NCT02721732|536564926|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
148752457|NCT02721732|536564927|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
148752458|NCT02721732|536564928|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
148752459|NCT02721732|536564929|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
148752460|NCT02721732|536564930|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
148752461|NCT02721732|536564931|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
148752462|NCT02721732|536564932|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
148752463|NCT02848001|536564935|FG000|Overall Study|other reasons|0|||
148752464|NCT02848001|536564936|FG001|Overall Study|other reasons|0|||
148752465|NCT02848001|536564937|FG002|Overall Study|other reasons|1|||
148752466|NCT02848001|536564938|FG003|Overall Study|other reasons|0|||
148752467|NCT02848001|536564939|FG004|Overall Study|other reasons|4|||
148752468|NCT02848001|536564940|FG005|Overall Study|other reasons|1|||
148752469|NCT02848001|536564941|FG006|Overall Study|other reasons|0|||
148752470|NCT02848001|536564942|FG007|Overall Study|other reasons|2|||
148752471|NCT02848001|536564943|FG008|Overall Study|other reasons|2|||
148752472|NCT02848001|536564944|FG009|Overall Study|other reasons|3|||
148752473|NCT02848001|536564945|FG010|Overall Study|other reasons|0|||
148752474|NCT02848001|536564946|FG011|Overall Study|other reasons|1|||
148752475|NCT02848001|536564947|FG012|Overall Study|other reasons|1|||
148752476|NCT02848001|536564948|FG013|Overall Study|other reasons|0|||
148752477|NCT02848001|536564949|FG014|Overall Study|other reasons|0|||
148752478|NCT02848001|536564950|FG015|Overall Study|other reasons|2|||
148752479|NCT02848001|536564951|FG016|Overall Study|other reasons|1|||
148752480|NCT02848001|536564935|FG000|Overall Study|Lack of Efficacy|0|||
148752481|NCT02848001|536564936|FG001|Overall Study|Lack of Efficacy|1|||
148752482|NCT02848001|536564937|FG002|Overall Study|Lack of Efficacy|1|||
148752483|NCT02848001|536564938|FG003|Overall Study|Lack of Efficacy|2|||
148752484|NCT02848001|536564939|FG004|Overall Study|Lack of Efficacy|3|||
148752485|NCT02848001|536564940|FG005|Overall Study|Lack of Efficacy|0|||
148752486|NCT02848001|536564941|FG006|Overall Study|Lack of Efficacy|1|||
148752487|NCT02848001|536564942|FG007|Overall Study|Lack of Efficacy|0|||
148752488|NCT02848001|536564943|FG008|Overall Study|Lack of Efficacy|0|||
148752489|NCT02848001|536564944|FG009|Overall Study|Lack of Efficacy|1|||
148752490|NCT02848001|536564945|FG010|Overall Study|Lack of Efficacy|0|||
148752491|NCT02848001|536564946|FG011|Overall Study|Lack of Efficacy|2|||
148752492|NCT02848001|536564947|FG012|Overall Study|Lack of Efficacy|0|||
148752493|NCT02848001|536564948|FG013|Overall Study|Lack of Efficacy|2|||
148752494|NCT02848001|536564949|FG014|Overall Study|Lack of Efficacy|2|||
148752495|NCT02848001|536564950|FG015|Overall Study|Lack of Efficacy|0|||
148752496|NCT02848001|536564951|FG016|Overall Study|Lack of Efficacy|0|||
148976312|NCT00353366|537394509|FG000|Overall Study|Withdrawal by Subject|12|||
148976313|NCT00353366|537394509|FG000|Overall Study|Lost to Follow-up|92|||
148976314|NCT00353366|537394509|FG000|Overall Study|Other|19|||
148976315|NCT01302392|537394510|FG000|Overall Study|Lost to Follow-up|1|||
148752497|NCT02848001|536564935|FG000|Overall Study|Progressive Disease|2|||
148752498|NCT02848001|536564936|FG001|Overall Study|Progressive Disease|1|||
148752499|NCT02848001|536564937|FG002|Overall Study|Progressive Disease|0|||
148752500|NCT02848001|536564938|FG003|Overall Study|Progressive Disease|4|||
148752501|NCT02848001|536564939|FG004|Overall Study|Progressive Disease|3|||
148752502|NCT02848001|536564940|FG005|Overall Study|Progressive Disease|0|||
148976316|NCT01302392|537394511|FG001|Overall Study|Lost to Follow-up|0|||
148752503|NCT02848001|536564941|FG006|Overall Study|Progressive Disease|4|||
148752504|NCT02848001|536564942|FG007|Overall Study|Progressive Disease|1|||
148752505|NCT02848001|536564943|FG008|Overall Study|Progressive Disease|0|||
148752506|NCT02848001|536564944|FG009|Overall Study|Progressive Disease|2|||
148752507|NCT02848001|536564945|FG010|Overall Study|Progressive Disease|3|||
148752508|NCT02848001|536564946|FG011|Overall Study|Progressive Disease|2|||
148752509|NCT02848001|536564947|FG012|Overall Study|Progressive Disease|1|||
148752510|NCT02848001|536564948|FG013|Overall Study|Progressive Disease|0|||
148752511|NCT02848001|536564949|FG014|Overall Study|Progressive Disease|2|||
148752512|NCT02848001|536564950|FG015|Overall Study|Progressive Disease|4|||
148752513|NCT02848001|536564951|FG016|Overall Study|Progressive Disease|0|||
148752514|NCT02848001|536564935|FG000|Overall Study|Adverse Event|0|||
148752515|NCT02848001|536564936|FG001|Overall Study|Adverse Event|0|||
148752516|NCT02848001|536564937|FG002|Overall Study|Adverse Event|0|||
148752517|NCT02848001|536564938|FG003|Overall Study|Adverse Event|0|||
148752518|NCT02848001|536564939|FG004|Overall Study|Adverse Event|2|||
148752519|NCT02848001|536564940|FG005|Overall Study|Adverse Event|0|||
148752520|NCT02848001|536564941|FG006|Overall Study|Adverse Event|0|||
148752521|NCT02848001|536564942|FG007|Overall Study|Adverse Event|0|||
148752522|NCT02848001|536564943|FG008|Overall Study|Adverse Event|0|||
148752523|NCT02848001|536564944|FG009|Overall Study|Adverse Event|1|||
148752524|NCT02848001|536564945|FG010|Overall Study|Adverse Event|0|||
148752525|NCT02848001|536564946|FG011|Overall Study|Adverse Event|1|||
148752526|NCT02848001|536564947|FG012|Overall Study|Adverse Event|1|||
148752527|NCT02848001|536564948|FG013|Overall Study|Adverse Event|0|||
148752528|NCT02848001|536564949|FG014|Overall Study|Adverse Event|2|||
148752529|NCT02848001|536564950|FG015|Overall Study|Adverse Event|0|||
148752530|NCT02848001|536564951|FG016|Overall Study|Adverse Event|0|||
148752531|NCT02848001|536564935|FG000|Overall Study|Death|0|||
148752532|NCT02848001|536564936|FG001|Overall Study|Death|0|||
148752533|NCT02848001|536564937|FG002|Overall Study|Death|0|||
148752534|NCT02848001|536564938|FG003|Overall Study|Death|1|||
148752535|NCT02848001|536564939|FG004|Overall Study|Death|3|||
148752536|NCT02848001|536564940|FG005|Overall Study|Death|1|||
148752537|NCT02848001|536564941|FG006|Overall Study|Death|2|||
148752538|NCT02848001|536564942|FG007|Overall Study|Death|3|||
148752539|NCT02848001|536564943|FG008|Overall Study|Death|4|||
148752540|NCT02848001|536564944|FG009|Overall Study|Death|1|||
148752541|NCT02848001|536564945|FG010|Overall Study|Death|0|||
148752542|NCT02848001|536564946|FG011|Overall Study|Death|1|||
148752543|NCT02848001|536564947|FG012|Overall Study|Death|3|||
148752544|NCT02848001|536564948|FG013|Overall Study|Death|0|||
148752545|NCT02848001|536564949|FG014|Overall Study|Death|2|||
148752546|NCT02848001|536564950|FG015|Overall Study|Death|3|||
148752547|NCT02848001|536564951|FG016|Overall Study|Death|0|||
148752548|NCT02848001|536564935|FG000|Overall Study|Physician Decision|0|||
148752549|NCT02848001|536564936|FG001|Overall Study|Physician Decision|0|||
148752550|NCT02848001|536564937|FG002|Overall Study|Physician Decision|0|||
148752551|NCT02848001|536564938|FG003|Overall Study|Physician Decision|0|||
148752552|NCT02848001|536564939|FG004|Overall Study|Physician Decision|0|||
148752553|NCT02848001|536564940|FG005|Overall Study|Physician Decision|0|||
148752554|NCT02848001|536564941|FG006|Overall Study|Physician Decision|0|||
148752555|NCT02848001|536564942|FG007|Overall Study|Physician Decision|0|||
148752556|NCT02848001|536564943|FG008|Overall Study|Physician Decision|1|||
148752557|NCT02848001|536564944|FG009|Overall Study|Physician Decision|1|||
148752558|NCT02848001|536564945|FG010|Overall Study|Physician Decision|0|||
148752559|NCT02848001|536564946|FG011|Overall Study|Physician Decision|0|||
148752560|NCT02848001|536564947|FG012|Overall Study|Physician Decision|2|||
148752561|NCT02848001|536564948|FG013|Overall Study|Physician Decision|0|||
148752562|NCT02848001|536564949|FG014|Overall Study|Physician Decision|0|||
148752563|NCT02848001|536564950|FG015|Overall Study|Physician Decision|0|||
148752564|NCT02848001|536564951|FG016|Overall Study|Physician Decision|0|||
148752565|NCT02848001|536564935|FG000|Overall Study|Withdrawal by Subject|0|||
148752566|NCT02848001|536564936|FG001|Overall Study|Withdrawal by Subject|0|||
148752567|NCT02848001|536564937|FG002|Overall Study|Withdrawal by Subject|0|||
148752568|NCT02848001|536564938|FG003|Overall Study|Withdrawal by Subject|0|||
148752569|NCT02848001|536564939|FG004|Overall Study|Withdrawal by Subject|0|||
148752570|NCT02848001|536564940|FG005|Overall Study|Withdrawal by Subject|1|||
148752571|NCT02848001|536564941|FG006|Overall Study|Withdrawal by Subject|1|||
148752572|NCT02848001|536564942|FG007|Overall Study|Withdrawal by Subject|1|||
148752573|NCT02848001|536564943|FG008|Overall Study|Withdrawal by Subject|0|||
148752574|NCT02848001|536564944|FG009|Overall Study|Withdrawal by Subject|0|||
148752575|NCT02848001|536564945|FG010|Overall Study|Withdrawal by Subject|0|||
148752576|NCT02848001|536564946|FG011|Overall Study|Withdrawal by Subject|0|||
148752577|NCT02848001|536564947|FG012|Overall Study|Withdrawal by Subject|0|||
148752578|NCT02848001|536564948|FG013|Overall Study|Withdrawal by Subject|0|||
148752579|NCT02848001|536564949|FG014|Overall Study|Withdrawal by Subject|0|||
148752580|NCT02848001|536564950|FG015|Overall Study|Withdrawal by Subject|0|||
148752581|NCT02848001|536564951|FG016|Overall Study|Withdrawal by Subject|0|||
148752582|NCT01368497|536564955|FG000|Overall Study|Lost to Follow-up|2|||
148752583|NCT00118157|536564957|FG000|Overall Study|Adverse Event|2|||
148976317|NCT01302392|537394510|FG000|Overall Study|Withdrawal by Subject|6|||
148976318|NCT01302392|537394511|FG001|Overall Study|Withdrawal by Subject|1|||
148752584|NCT00118157|536564957|FG000|Overall Study|Death|8|||
148752585|NCT00118157|536564957|FG000|Overall Study|Withdrawal by Subject|2|||
148752586|NCT00696423|536564958|FG000|Overall Study|Lost to Follow-up|0|||
148752587|NCT00696423|536564959|FG001|Overall Study|Lost to Follow-up|5|||
148752588|NCT03989102|536564960|FG000|Year 1|Withdrawal by Subject|6|||
148752589|NCT03989102|536564961|FG001|Year 1|Withdrawal by Subject|2|||
148752590|NCT03989102|536564962|FG002|Year 1|Withdrawal by Subject|7|||
148752591|NCT03989102|536564960|FG000|Year 1|Lost to Follow-up|5|||
148752592|NCT03989102|536564961|FG001|Year 1|Lost to Follow-up|2|||
148752593|NCT03989102|536564962|FG002|Year 1|Lost to Follow-up|5|||
148752594|NCT03989102|536564960|FG000|Year 1|Subject met withdrawal criteria|1|||
148752595|NCT03989102|536564961|FG001|Year 1|Subject met withdrawal criteria|0|||
148752596|NCT03989102|536564962|FG002|Year 1|Subject met withdrawal criteria|1|||
148752597|NCT03989102|536564960|FG000|Year 2|Lost to Follow-up|7|||
148752598|NCT03989102|536564961|FG001|Year 2|Lost to Follow-up|3|||
148752599|NCT03989102|536564962|FG002|Year 2|Lost to Follow-up|4|||
148752600|NCT03989102|536564960|FG000|Year 2|Withdrawal by Subject|3|||
148752601|NCT03989102|536564961|FG001|Year 2|Withdrawal by Subject|1|||
148752602|NCT03989102|536564962|FG002|Year 2|Withdrawal by Subject|2|||
148752603|NCT03989102|536564960|FG000|Year 2|Subject non-compliant|3|||
148752604|NCT03989102|536564961|FG001|Year 2|Subject non-compliant|2|||
148752605|NCT03989102|536564962|FG002|Year 2|Subject non-compliant|0|||
148752606|NCT03989102|536564960|FG000|Year 2|Travel|1|||
148752607|NCT03989102|536564961|FG001|Year 2|Travel|0|||
148752608|NCT03989102|536564962|FG002|Year 2|Travel|1|||
148752609|NCT03989102|536564960|FG000|Year 2|P16 missing|4|||
148752610|NCT03989102|536564961|FG001|Year 2|P16 missing|2|||
148752611|NCT03989102|536564962|FG002|Year 2|P16 missing|1|||
148752612|NCT03989102|536564960|FG000|Year 2|P11 missing|1|||
148752613|NCT03989102|536564961|FG001|Year 2|P11 missing|3|||
148752614|NCT03989102|536564962|FG002|Year 2|P11 missing|7|||
148752615|NCT03989102|536564960|FG000|Year 2|Definitive displacement outside the study site|0|||
148752616|NCT03989102|536564961|FG001|Year 2|Definitive displacement outside the study site|1|||
148752617|NCT03989102|536564962|FG002|Year 2|Definitive displacement outside the study site|0|||
148752618|NCT03989102|536564960|FG000|Year 2|Subject missed last study visit|0|||
148752619|NCT03989102|536564961|FG001|Year 2|Subject missed last study visit|1|||
148752620|NCT03989102|536564962|FG002|Year 2|Subject missed last study visit|0|||
148752621|NCT03989102|536564960|FG000|Year 2|Death|0|||
148752622|NCT03989102|536564961|FG001|Year 2|Death|1|||
148752623|NCT03989102|536564962|FG002|Year 2|Death|0|||
148752624|NCT03989102|536564960|FG000|Year 2|Subject not reachable|0|||
148752625|NCT03989102|536564961|FG001|Year 2|Subject not reachable|0|||
148752626|NCT03989102|536564962|FG002|Year 2|Subject not reachable|1|||
148752627|NCT03989102|536564960|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
148752628|NCT03989102|536564961|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
148752629|NCT03989102|536564962|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
148752630|NCT03989102|536564960|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
148752631|NCT03989102|536564961|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
148752632|NCT03989102|536564962|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
148752633|NCT03989102|536564960|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
148752634|NCT03989102|536564961|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
148752635|NCT03989102|536564962|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
148752636|NCT03989102|536564960|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
148752637|NCT03989102|536564961|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
148752638|NCT03989102|536564962|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
148752639|NCT03989102|536564960|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
148752640|NCT03989102|536564961|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
148752641|NCT03989102|536564962|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
148752642|NCT03989102|536564960|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
148976319|NCT00259857|537394512|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
148752643|NCT03989102|536564961|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
148976320|NCT00259857|537394513|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
148976321|NCT00259857|537394512|FG000|24 Months Treatment|Lost to Follow-up|0|||
148752644|NCT03989102|536564962|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
148752645|NCT00818766|536564966|FG000|Overall Study|Could not be Contacted on Day 28|11|||
148752646|NCT00818766|536564967|FG001|Overall Study|Could not be Contacted on Day 28|10|||
148752647|NCT00818766|536564966|FG000|Overall Study|Death|1|||
148752648|NCT00818766|536564967|FG001|Overall Study|Death|0|||
148752649|NCT00818766|536564966|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
148752650|NCT00818766|536564967|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
148752651|NCT04515147|536564968|FG000|Overall Study|Withdrawal by Subject|1|||
148976322|NCT00259857|537394513|FG001|24 Months Treatment|Lost to Follow-up|3|||
148976323|NCT00670228|537394514|FG000|Overall Study|Adverse Event|1|||
148752652|NCT04515147|536564969|FG001|Overall Study|Withdrawal by Subject|0|||
148752653|NCT04515147|536564970|FG002|Overall Study|Withdrawal by Subject|10|||
148752654|NCT04515147|536564971|FG003|Overall Study|Withdrawal by Subject|18|||
148752655|NCT04515147|536564972|FG004|Overall Study|Withdrawal by Subject|1|||
148752656|NCT04515147|536564973|FG005|Overall Study|Withdrawal by Subject|8|||
148752657|NCT04515147|536564968|FG000|Overall Study|Lost to Follow-up|0|||
148752658|NCT04515147|536564969|FG001|Overall Study|Lost to Follow-up|1|||
148752659|NCT04515147|536564970|FG002|Overall Study|Lost to Follow-up|5|||
148752660|NCT04515147|536564971|FG003|Overall Study|Lost to Follow-up|6|||
148752661|NCT04515147|536564972|FG004|Overall Study|Lost to Follow-up|2|||
148752662|NCT04515147|536564973|FG005|Overall Study|Lost to Follow-up|1|||
148752663|NCT04515147|536564968|FG000|Overall Study|Adverse Event|0|||
148752664|NCT04515147|536564969|FG001|Overall Study|Adverse Event|0|||
148752665|NCT04515147|536564970|FG002|Overall Study|Adverse Event|0|||
148752666|NCT04515147|536564971|FG003|Overall Study|Adverse Event|2|||
148752667|NCT04515147|536564972|FG004|Overall Study|Adverse Event|0|||
148752668|NCT04515147|536564973|FG005|Overall Study|Adverse Event|0|||
148752669|NCT04515147|536564968|FG000|Overall Study|Miscellaneous|0|||
148752670|NCT04515147|536564969|FG001|Overall Study|Miscellaneous|0|||
148752671|NCT04515147|536564970|FG002|Overall Study|Miscellaneous|0|||
148752672|NCT04515147|536564971|FG003|Overall Study|Miscellaneous|1|||
148752673|NCT04515147|536564972|FG004|Overall Study|Miscellaneous|0|||
148752674|NCT04515147|536564973|FG005|Overall Study|Miscellaneous|1|||
148752675|NCT02760004|536564974|FG000|Overall Study|Lost to Follow-up|13|||
148752676|NCT02760004|536564975|FG001|Overall Study|Lost to Follow-up|22|||
148752677|NCT00970593|536564978|FG000|Overall Study|Adverse Event|1|||
148752678|NCT00970593|536564979|FG001|Overall Study|Adverse Event|1|||
148752679|NCT00970593|536564980|FG002|Overall Study|Adverse Event|0|||
148752680|NCT00970593|536564981|FG003|Overall Study|Adverse Event|0|||
148752681|NCT00970593|536564982|FG004|Overall Study|Adverse Event|0|||
148752682|NCT00970593|536564983|FG005|Overall Study|Adverse Event|0|||
148752683|NCT00970593|536564984|FG006|Overall Study|Adverse Event|0|||
148752684|NCT00970593|536564978|FG000|Overall Study|Discontinuation of study by sponsor|0|||
148752685|NCT00970593|536564979|FG001|Overall Study|Discontinuation of study by sponsor|0|||
148752686|NCT00970593|536564980|FG002|Overall Study|Discontinuation of study by sponsor|5|||
148752687|NCT00970593|536564981|FG003|Overall Study|Discontinuation of study by sponsor|0|||
148752688|NCT00970593|536564982|FG004|Overall Study|Discontinuation of study by sponsor|0|||
148752689|NCT00970593|536564983|FG005|Overall Study|Discontinuation of study by sponsor|0|||
148752690|NCT00970593|536564984|FG006|Overall Study|Discontinuation of study by sponsor|2|||
148752691|NCT00970593|536564978|FG000|Overall Study|Withdrawal by Subject|0|||
148822590|NCT01529112|536828556|FG000|Overall Study|Protocol Violation|1|||
148822591|NCT01529112|536828557|FG001|Overall Study|Protocol Violation|0|||
148822592|NCT01529112|536828556|FG000|Overall Study|Withdrawal by Subject|7|||
148822593|NCT01529112|536828557|FG001|Overall Study|Withdrawal by Subject|3|||
148822594|NCT01530256|536828559|FG000|Overall Study|Death|2|||
148822595|NCT02004275|536828560|FG000|Phase 1|Ineligible|0|||
148822596|NCT02004275|536828561|FG001|Phase 1|Ineligible|0|||
148822597|NCT02004275|536828562|FG002|Phase 1|Ineligible|0|||
148822598|NCT02004275|536828563|FG003|Phase 1|Ineligible|1|||
148822599|NCT02004275|536828564|FG004|Phase 1|Ineligible|1|||
148822600|NCT02004275|536828565|FG005|Phase 1|Ineligible|0|||
148822601|NCT02004275|536828560|FG000|Phase 1|Protocol Violation|0|||
148822602|NCT02004275|536828561|FG001|Phase 1|Protocol Violation|0|||
148822603|NCT02004275|536828562|FG002|Phase 1|Protocol Violation|0|||
148822604|NCT02004275|536828563|FG003|Phase 1|Protocol Violation|1|||
148822605|NCT02004275|536828564|FG004|Phase 1|Protocol Violation|0|||
148822606|NCT02004275|536828565|FG005|Phase 1|Protocol Violation|5|||
148822607|NCT02004275|536828560|FG000|Phase 2 Part 1|Ineligible|6|||
148822608|NCT02004275|536828561|FG001|Phase 2 Part 1|Ineligible|9|||
148822609|NCT02004275|536828562|FG002|Phase 2 Part 1|Ineligible|0|||
148822610|NCT02004275|536828563|FG003|Phase 2 Part 1|Ineligible|0|||
148822611|NCT02004275|536828564|FG004|Phase 2 Part 1|Ineligible|0|||
148822612|NCT02004275|536828565|FG005|Phase 2 Part 1|Ineligible|0|||
148822613|NCT02004275|536828560|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
148752692|NCT00970593|536564979|FG001|Overall Study|Withdrawal by Subject|0|||
148752693|NCT00970593|536564980|FG002|Overall Study|Withdrawal by Subject|1|||
148752694|NCT00970593|536564981|FG003|Overall Study|Withdrawal by Subject|0|||
148752695|NCT00970593|536564982|FG004|Overall Study|Withdrawal by Subject|0|||
148752696|NCT00970593|536564983|FG005|Overall Study|Withdrawal by Subject|0|||
148752697|NCT00970593|536564984|FG006|Overall Study|Withdrawal by Subject|0|||
148752698|NCT00545714|536564991|FG000|Induction Phase (6 Months)|Physician Decision|3|||
148752699|NCT00545714|536564991|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
148752700|NCT00545714|536564991|FG000|Induction Phase (6 Months)|Disease Progression|1|||
148822614|NCT02004275|536828561|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
148822615|NCT02004275|536828562|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
148822616|NCT02004275|536828563|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
148822617|NCT02004275|536828564|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
148822618|NCT02004275|536828565|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
148822619|NCT04621786|536828566|FG000|Overall Study|Lost to Follow-up|9|||
148822620|NCT04621786|536828566|FG000|Overall Study|Protocol Violation|3|||
148752701|NCT00545714|536564991|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
148752702|NCT00545714|536564991|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
148752703|NCT00545714|536564991|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
148752704|NCT00545714|536564991|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
148752705|NCT00545714|536564991|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
148752706|NCT00545714|536564991|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
148752707|NCT00545714|536564991|FG000|Maintenance Phase (36 Months)|Death|2|||
148752708|NCT03889886|536564994|FG000|Overall Study|Other|0|||
148752709|NCT03889886|536564995|FG001|Overall Study|Other|1|||
148752710|NCT03889886|536564996|FG002|Overall Study|Other|0|||
148752711|NCT03889886|536564997|FG003|Overall Study|Other|1|||
148752712|NCT03889886|536564994|FG000|Overall Study|Withdrawal by Subject|0|||
148752713|NCT03889886|536564995|FG001|Overall Study|Withdrawal by Subject|0|||
148752714|NCT03889886|536564996|FG002|Overall Study|Withdrawal by Subject|1|||
148752715|NCT03889886|536564997|FG003|Overall Study|Withdrawal by Subject|0|||
148752716|NCT03889886|536564994|FG000|Overall Study|Adverse Event|0|||
148752717|NCT03889886|536564995|FG001|Overall Study|Adverse Event|0|||
148752718|NCT03889886|536564996|FG002|Overall Study|Adverse Event|0|||
148752719|NCT03889886|536564997|FG003|Overall Study|Adverse Event|6|||
148752720|NCT00276484|536564998|FG000|Overall Study|Adverse Event|4|||
148752721|NCT00276484|536564999|FG001|Overall Study|Adverse Event|7|||
148752722|NCT00276484|536564998|FG000|Overall Study|Lost to Follow-up|1|||
148752723|NCT00276484|536564999|FG001|Overall Study|Lost to Follow-up|1|||
148752724|NCT00276484|536564998|FG000|Overall Study|Protocol Violation|0|||
148752725|NCT00276484|536564999|FG001|Overall Study|Protocol Violation|1|||
148752726|NCT00276484|536564998|FG000|Overall Study|Withdrawal by Subject|4|||
148752727|NCT00276484|536564999|FG001|Overall Study|Withdrawal by Subject|3|||
148752728|NCT00276484|536564998|FG000|Overall Study|Could not take time off work|0|||
148752729|NCT00276484|536564999|FG001|Overall Study|Could not take time off work|1|||
148752730|NCT03624192|536565013|FG000|Overall Study|Lost to Follow-up|1|||
148752731|NCT03624192|536565014|FG001|Overall Study|Lost to Follow-up|1|||
148752732|NCT00100828|536565017|FG000|Overall Study|Physician Decision|6|||
148752733|NCT01176513|536565018|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
148752734|NCT04583735|536565019|FG000|Double-masked Treatment Period|Adverse Event|0|||
148752735|NCT04583735|536565020|FG001|Double-masked Treatment Period|Adverse Event|1|||
148752736|NCT04583735|536565019|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
148752737|NCT04583735|536565020|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
148752738|NCT04583735|536565019|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
148752739|NCT04583735|536565020|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
148752740|NCT04583735|536565019|FG000|Open-label Treatment Period|Adverse Event|1|||
148752741|NCT04583735|536565020|FG001|Open-label Treatment Period|Adverse Event|1|||
148752742|NCT04583735|536565019|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
148752743|NCT04583735|536565020|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
148752744|NCT04583735|536565019|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
148752745|NCT04583735|536565020|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
148752746|NCT00786409|536565023|FG000|Overall Study|Withdrawal by Subject|2|||
148752747|NCT00786409|536565023|FG000|Overall Study|Adverse Event|2|||
148752748|NCT00786409|536565023|FG000|Overall Study|Pregnancy|2|||
148752749|NCT00786409|536565023|FG000|Overall Study|Lost to Follow-up|1|||
148752750|NCT00610129|536565024|FG000|Overall Study|Not treated since patients ineligible|3|||
148752751|NCT01042093|536565027|FG000|Overall Study|Protocol Violation|2|||
148752752|NCT01042093|536565028|FG001|Overall Study|Protocol Violation|2|||
148752753|NCT01042093|536565029|FG002|Overall Study|Protocol Violation|2|||
148752754|NCT01042093|536565030|FG003|Overall Study|Protocol Violation|3|||
148752755|NCT01042093|536565027|FG000|Overall Study|Withdrawal by Subject|0|||
148752756|NCT01042093|536565028|FG001|Overall Study|Withdrawal by Subject|0|||
148752757|NCT01042093|536565029|FG002|Overall Study|Withdrawal by Subject|0|||
148752758|NCT01042093|536565030|FG003|Overall Study|Withdrawal by Subject|1|||
148752759|NCT04331808|536565031|FG000|Overall Study|Withdrew consent|1|||
148752760|NCT04331808|536565032|FG001|Overall Study|Withdrew consent|0|||
148752761|NCT04331808|536565033|FG002|Overall Study|Withdrew consent|2|||
148752762|NCT04331808|536565034|FG003|Overall Study|Withdrew consent|3|||
148752763|NCT00952731|536565035|FG000|Overall Study|Drug supply expired|1|||
148752764|NCT00952731|536565036|FG001|Overall Study|Drug supply expired|0|||
148752765|NCT00243412|536565038|FG000|Overall Study|Death|0|||
148752766|NCT00243412|536565039|FG001|Overall Study|Death|1|||
148752767|NCT00243412|536565038|FG000|Overall Study|Adverse Event|4|||
148822621|NCT00292370|536828567|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
148752768|NCT00243412|536565039|FG001|Overall Study|Adverse Event|2|||
148752769|NCT00243412|536565038|FG000|Overall Study|Lost to Follow-up|0|||
148752770|NCT00243412|536565039|FG001|Overall Study|Lost to Follow-up|1|||
148752771|NCT00243412|536565038|FG000|Overall Study|Physician Decision|1|||
148752772|NCT00243412|536565039|FG001|Overall Study|Physician Decision|1|||
148752773|NCT00243412|536565038|FG000|Overall Study|Withdrawal by Subject|4|||
148752774|NCT00243412|536565039|FG001|Overall Study|Withdrawal by Subject|5|||
148752775|NCT00243412|536565038|FG000|Overall Study|Other|1|||
148752776|NCT00243412|536565039|FG001|Overall Study|Other|1|||
148822622|NCT00292370|536828568|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
148822623|NCT00292370|536828569|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
148822624|NCT00292370|536828567|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
148822625|NCT00292370|536828568|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
148822626|NCT00292370|536828569|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
148822627|NCT00292370|536828567|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
148822628|NCT00292370|536828568|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
148822629|NCT00292370|536828569|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
148822630|NCT00292370|536828567|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
148822631|NCT00292370|536828568|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
148822632|NCT00292370|536828569|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
148822633|NCT00292370|536828567|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
148822634|NCT00292370|536828568|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
148822635|NCT00292370|536828569|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
148822636|NCT00292370|536828567|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
148822637|NCT00292370|536828568|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
148822638|NCT00292370|536828569|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
148822639|NCT00378560|536828574|FG000|Overall Study|Adverse Event|1|||
148822640|NCT00378560|536828575|FG001|Overall Study|Adverse Event|0|||
148822641|NCT00378560|536828574|FG000|Overall Study|Lost to Follow-up|24|||
148822642|NCT00378560|536828575|FG001|Overall Study|Lost to Follow-up|29|||
148822643|NCT00378560|536828574|FG000|Overall Study|Protocol Violation|2|||
148822644|NCT00378560|536828575|FG001|Overall Study|Protocol Violation|0|||
148822645|NCT00378560|536828574|FG000|Overall Study|Withdrawal by Subject|17|||
148822646|NCT00378560|536828575|FG001|Overall Study|Withdrawal by Subject|21|||
148822647|NCT00378560|536828574|FG000|Overall Study|Moved|4|||
148822648|NCT00378560|536828575|FG001|Overall Study|Moved|3|||
148822649|NCT00378560|536828574|FG000|Overall Study|Pregnancy|7|||
148822650|NCT00378560|536828575|FG001|Overall Study|Pregnancy|5|||
148822651|NCT00378560|536828574|FG000|Overall Study|Laboratory test values abnormal|1|||
148822652|NCT00378560|536828575|FG001|Overall Study|Laboratory test values abnormal|0|||
148822653|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
148822654|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
148822655|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
148822656|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
148822657|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
148822658|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
148822659|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
148822660|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
148822661|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
148822662|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
148822663|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
148822664|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
148822665|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Other|6|||
148822666|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Other|3|||
148822667|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Other|0|||
148822668|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
148822669|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
148822670|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
148822671|NCT03636269|536828577|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
148822672|NCT03636269|536828578|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
148822673|NCT03636269|536828579|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
148822674|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Adverse Event|0|||
148822675|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Adverse Event|0|||
148822676|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Adverse Event|21|||
148822677|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
148822678|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
148822679|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
148822680|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
148822681|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
148822682|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
148822683|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
148822684|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
148822685|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
148822686|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Administrative|0|||
148976324|NCT00670228|537394515|FG001|Overall Study|Adverse Event|0|||
148822687|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Administrative|0|||
148822688|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Administrative|36|||
148822689|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Other|0|||
148752777|NCT00041132|536565040|FG000|Overall Study|Adverse Event|19|||
148752778|NCT00041132|536565040|FG000|Overall Study|Death|1|||
148752779|NCT00041132|536565040|FG000|Overall Study|Not Eligible|7|||
148752780|NCT00041132|536565040|FG000|Overall Study|Withdrawal by Subject|1|||
148752781|NCT00041132|536565040|FG000|Overall Study|Physician Decision|2|||
148752782|NCT01808573|536565044|FG000|Overall Study|Death|212|||
148752783|NCT01808573|536565045|FG001|Overall Study|Death|240|||
148752784|NCT01808573|536565044|FG000|Overall Study|Withdrawal by Subject|12|||
148752785|NCT01808573|536565045|FG001|Overall Study|Withdrawal by Subject|10|||
148752786|NCT01808573|536565044|FG000|Overall Study|Lost to Follow-up|3|||
148752787|NCT01808573|536565045|FG001|Overall Study|Lost to Follow-up|0|||
148752788|NCT01808573|536565044|FG000|Overall Study|Discontinuation of study by sponsor|79|||
148752789|NCT01808573|536565045|FG001|Overall Study|Discontinuation of study by sponsor|64|||
148752790|NCT01808573|536565044|FG000|Overall Study|Randomized in Error|1|||
148752791|NCT01808573|536565045|FG001|Overall Study|Randomized in Error|0|||
148752792|NCT00995774|536565046|FG000|Training Period 2|Withdrawal by Subject|2|||
148752793|NCT00995774|536565047|FG001|Training Period 2|Withdrawal by Subject|0|||
148752794|NCT03953612|536565050|FG000|Overall Study|Randomized but did not start|1|||
148752795|NCT03953612|536565051|FG001|Overall Study|Randomized but did not start|1|||
148752796|NCT03953612|536565052|FG002|Overall Study|Randomized but did not start|1|||
148752797|NCT03953612|536565050|FG000|Overall Study|Withdrawal by Subject|2|||
148752798|NCT03953612|536565051|FG001|Overall Study|Withdrawal by Subject|1|||
148752799|NCT03953612|536565052|FG002|Overall Study|Withdrawal by Subject|0|||
148752800|NCT03485352|536565053|FG000|Overall Study|Lost to Follow-up|9|||
148752801|NCT00141778|536565064|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
148752802|NCT00141778|536565065|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
148752803|NCT00141778|536565066|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
148752804|NCT00141778|536565064|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
148752805|NCT00141778|536565065|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
148752806|NCT00141778|536565066|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
148752807|NCT00141778|536565064|FG000|Started Study Medication|Withdrawal by Subject|0|||
148752808|NCT00141778|536565065|FG001|Started Study Medication|Withdrawal by Subject|2|||
148752809|NCT00141778|536565066|FG002|Started Study Medication|Withdrawal by Subject|0|||
148752810|NCT00141778|536565064|FG000|Started Study Medication|Difficulty Swallowing|0|||
148752811|NCT00141778|536565065|FG001|Started Study Medication|Difficulty Swallowing|1|||
148752812|NCT00141778|536565066|FG002|Started Study Medication|Difficulty Swallowing|0|||
148752813|NCT00141778|536565064|FG000|Started Study Medication|Chest Discomfort|0|||
148752814|NCT00141778|536565065|FG001|Started Study Medication|Chest Discomfort|0|||
148752815|NCT00141778|536565066|FG002|Started Study Medication|Chest Discomfort|1|||
148752816|NCT03493685|536566306|FG000|Overall Study|Death|4|||
148752817|NCT03493685|536566307|FG001|Overall Study|Death|3|||
148752818|NCT03493685|536566306|FG000|Overall Study|Lost to Follow-up|3|||
148752819|NCT03493685|536566307|FG001|Overall Study|Lost to Follow-up|2|||
148752820|NCT03493685|536566306|FG000|Overall Study|Physician Decision|2|||
148752821|NCT03493685|536566307|FG001|Overall Study|Physician Decision|0|||
148752822|NCT03493685|536566306|FG000|Overall Study|Withdrawal by Subject|7|||
148752823|NCT03493685|536566307|FG001|Overall Study|Withdrawal by Subject|11|||
148752824|NCT04452669|536566308|FG000|Overall Study|Death|1|||
148752825|NCT04452669|536566309|FG001|Overall Study|Death|4|||
148752826|NCT05126693|536566310|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
148752827|NCT05126693|536566311|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
148752828|NCT05126693|536566310|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
148752829|NCT05126693|536566311|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
148752830|NCT05126693|536566310|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
148752831|NCT05126693|536566311|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
148752832|NCT05525520|536566312|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
148752833|NCT05525520|536566313|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
148752834|NCT05525520|536566312|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
148752835|NCT05525520|536566313|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
148752836|NCT05878093|536566316|FG000|Overall Study|Withdrawal by Subject|3|||
148752837|NCT05878093|536566317|FG001|Overall Study|Withdrawal by Subject|1|||
148752838|NCT04100018|536566321|FG000|Pre-Treatment Period|Not Reported|0|||
148976325|NCT00670228|537394514|FG000|Overall Study|Death or MACE|0|||
148976326|NCT00670228|537394515|FG001|Overall Study|Death or MACE|1|||
148752839|NCT04100018|536566322|FG001|Pre-Treatment Period|Not Reported|4|||
148752840|NCT04100018|536566321|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
148752841|NCT04100018|536566322|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
148752842|NCT04100018|536566321|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
148752843|NCT04100018|536566322|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
148752844|NCT04100018|536566321|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
148752845|NCT04100018|536566322|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
148752846|NCT04100018|536566321|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
148822690|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Other|0|||
148976327|NCT00670228|537394514|FG000|Overall Study|Not treated|2|||
148976328|NCT00670228|537394515|FG001|Overall Study|Not treated|2|||
148752847|NCT04100018|536566322|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
148752848|NCT04100018|536566321|FG000|Treatment Period|Ongoing Treatment|1|||
148752849|NCT04100018|536566322|FG001|Treatment Period|Ongoing Treatment|0|||
148752850|NCT04100018|536566321|FG000|Treatment Period|Other Reason|26|||
148752851|NCT04100018|536566322|FG001|Treatment Period|Other Reason|37|||
148752852|NCT04100018|536566321|FG000|Treatment Period|Completed treatment as per protocol|1|||
148752853|NCT04100018|536566322|FG001|Treatment Period|Completed treatment as per protocol|2|||
148752854|NCT04100018|536566321|FG000|Treatment Period|Maximum clinical benefit|3|||
148752855|NCT04100018|536566322|FG001|Treatment Period|Maximum clinical benefit|0|||
148752856|NCT04100018|536566321|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
148752857|NCT04100018|536566322|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
148752858|NCT04100018|536566321|FG000|Treatment Period|Study drug toxicity|67|||
148752859|NCT04100018|536566322|FG001|Treatment Period|Study drug toxicity|28|||
148752860|NCT04100018|536566321|FG000|Treatment Period|Disease Progression|284|||
148752861|NCT04100018|536566322|FG001|Treatment Period|Disease Progression|327|||
148752862|NCT04100018|536566321|FG000|Treatment Period|Administrative reasons by sponsor|16|||
148752863|NCT04100018|536566322|FG001|Treatment Period|Administrative reasons by sponsor|30|||
148752864|NCT04100018|536566321|FG000|Treatment Period|Poor/Non-Compliance|1|||
148752865|NCT04100018|536566322|FG001|Treatment Period|Poor/Non-Compliance|0|||
148752866|NCT04100018|536566321|FG000|Treatment Period|Lost to Follow-up|2|||
148752867|NCT04100018|536566322|FG001|Treatment Period|Lost to Follow-up|2|||
148752868|NCT04100018|536566321|FG000|Treatment Period|Death|16|||
148752869|NCT04100018|536566322|FG001|Treatment Period|Death|11|||
148752870|NCT04100018|536566321|FG000|Treatment Period|Participant withdrew consent|10|||
148752871|NCT04100018|536566322|FG001|Treatment Period|Participant withdrew consent|10|||
148752872|NCT04100018|536566321|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
148752873|NCT04100018|536566322|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
148752874|NCT04100018|536566321|FG000|Treatment Period|Adverse Event|14|||
148752875|NCT04100018|536566322|FG001|Treatment Period|Adverse Event|6|||
148752876|NCT04100018|536566321|FG000|Treatment Period|Lack of Efficacy|4|||
148752877|NCT04100018|536566322|FG001|Treatment Period|Lack of Efficacy|2|||
148752878|NCT00711243|536566323|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
148752879|NCT00711243|536566324|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
148752880|NCT00711243|536566325|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
148752881|NCT00711243|536566326|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
148752882|NCT00711243|536566327|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
148752883|NCT00711243|536566328|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
148752884|NCT00711243|536566323|FG000|Reached First Response/4 Cycles|Death|0|||
148752885|NCT00711243|536566324|FG001|Reached First Response/4 Cycles|Death|0|||
148752886|NCT00711243|536566325|FG002|Reached First Response/4 Cycles|Death|0|||
148752887|NCT00711243|536566326|FG003|Reached First Response/4 Cycles|Death|0|||
148752888|NCT00711243|536566327|FG004|Reached First Response/4 Cycles|Death|0|||
148752889|NCT00711243|536566328|FG005|Reached First Response/4 Cycles|Death|2|||
148752890|NCT00711243|536566323|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
148752891|NCT00711243|536566324|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
148752892|NCT00711243|536566325|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
148752893|NCT00711243|536566326|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
148752894|NCT00711243|536566327|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
148752895|NCT00711243|536566328|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
148752896|NCT00711243|536566323|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
148752897|NCT00711243|536566324|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
148752898|NCT00711243|536566325|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
148752899|NCT00711243|536566326|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
148752900|NCT00711243|536566327|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
148752901|NCT00711243|536566328|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
148752902|NCT00711243|536566323|FG000|Treated Cycle 5 After First Response|Death|0|||
148752903|NCT00711243|536566324|FG001|Treated Cycle 5 After First Response|Death|0|||
148752904|NCT00711243|536566325|FG002|Treated Cycle 5 After First Response|Death|0|||
148752905|NCT00711243|536566326|FG003|Treated Cycle 5 After First Response|Death|0|||
148752906|NCT00711243|536566327|FG004|Treated Cycle 5 After First Response|Death|0|||
148752907|NCT00711243|536566328|FG005|Treated Cycle 5 After First Response|Death|2|||
148752908|NCT00711243|536566323|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
148752909|NCT00711243|536566324|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
148752910|NCT00711243|536566325|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
148752911|NCT00711243|536566326|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
148822691|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Other|9|||
148822692|NCT03636269|536828577|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
148822693|NCT03636269|536828578|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
148752912|NCT00711243|536566327|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
148752913|NCT00711243|536566328|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
148752914|NCT00711243|536566323|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
148752915|NCT00711243|536566324|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
148752916|NCT00711243|536566325|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
148752917|NCT00711243|536566326|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
148752918|NCT00711243|536566327|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
148752919|NCT00711243|536566328|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
148752920|NCT05989672|536566329|FG000|Overall Study|Adverse Event|3|||
148752921|NCT05989672|536566330|FG001|Overall Study|Adverse Event|0|||
148752922|NCT05989672|536566331|FG002|Overall Study|Adverse Event|0|||
148752923|NCT01962103|536566335|FG000|Phase 1|Adverse Event|4|||
148752924|NCT01962103|536566336|FG001|Phase 1|Adverse Event|0|||
148752925|NCT01962103|536566337|FG002|Phase 1|Adverse Event|2|||
148752926|NCT01962103|536566338|FG003|Phase 1|Adverse Event|1|||
148752927|NCT01962103|536566339|FG004|Phase 1|Adverse Event|2|||
148752928|NCT01962103|536566340|FG005|Phase 1|Adverse Event|2|||
148752929|NCT01962103|536566341|FG006|Phase 1|Adverse Event|0|||
148752930|NCT01962103|536566342|FG007|Phase 1|Adverse Event|0|||
148752931|NCT01962103|536566343|FG008|Phase 1|Adverse Event|0|||
148752932|NCT01962103|536566335|FG000|Phase 1|Progressive Disease|8|||
148752933|NCT01962103|536566336|FG001|Phase 1|Progressive Disease|6|||
148752934|NCT01962103|536566337|FG002|Phase 1|Progressive Disease|8|||
148752935|NCT01962103|536566338|FG003|Phase 1|Progressive Disease|4|||
148752936|NCT01962103|536566339|FG004|Phase 1|Progressive Disease|5|||
148752937|NCT01962103|536566340|FG005|Phase 1|Progressive Disease|4|||
148752938|NCT01962103|536566341|FG006|Phase 1|Progressive Disease|0|||
148752939|NCT01962103|536566342|FG007|Phase 1|Progressive Disease|0|||
148752940|NCT01962103|536566343|FG008|Phase 1|Progressive Disease|0|||
148752941|NCT01962103|536566335|FG000|Phase 1|Withdrawal by Subject|0|||
148752942|NCT01962103|536566336|FG001|Phase 1|Withdrawal by Subject|0|||
148752943|NCT01962103|536566337|FG002|Phase 1|Withdrawal by Subject|0|||
148752944|NCT01962103|536566338|FG003|Phase 1|Withdrawal by Subject|2|||
148752945|NCT01962103|536566339|FG004|Phase 1|Withdrawal by Subject|0|||
148752946|NCT01962103|536566340|FG005|Phase 1|Withdrawal by Subject|0|||
148752947|NCT01962103|536566341|FG006|Phase 1|Withdrawal by Subject|0|||
148752948|NCT01962103|536566342|FG007|Phase 1|Withdrawal by Subject|0|||
148752949|NCT01962103|536566343|FG008|Phase 1|Withdrawal by Subject|0|||
148752950|NCT01962103|536566335|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
148752951|NCT01962103|536566336|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
148752952|NCT01962103|536566337|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
148752953|NCT01962103|536566338|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
148752954|NCT01962103|536566339|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
148752955|NCT01962103|536566340|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
148752956|NCT01962103|536566341|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
148752957|NCT01962103|536566342|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
148752958|NCT01962103|536566343|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
148752959|NCT01962103|536566335|FG000|Phase 1|Physician Decision|0|||
148752960|NCT01962103|536566336|FG001|Phase 1|Physician Decision|0|||
148752961|NCT01962103|536566337|FG002|Phase 1|Physician Decision|0|||
148752962|NCT01962103|536566338|FG003|Phase 1|Physician Decision|1|||
148752963|NCT01962103|536566339|FG004|Phase 1|Physician Decision|0|||
148752964|NCT01962103|536566340|FG005|Phase 1|Physician Decision|0|||
148752965|NCT01962103|536566341|FG006|Phase 1|Physician Decision|0|||
148752966|NCT01962103|536566342|FG007|Phase 1|Physician Decision|0|||
148752967|NCT01962103|536566343|FG008|Phase 1|Physician Decision|0|||
148752968|NCT01962103|536566335|FG000|Phase 1|Symptomatic Deterioration|3|||
148752969|NCT01962103|536566336|FG001|Phase 1|Symptomatic Deterioration|2|||
148752970|NCT01962103|536566337|FG002|Phase 1|Symptomatic Deterioration|2|||
148752971|NCT01962103|536566338|FG003|Phase 1|Symptomatic Deterioration|2|||
148752972|NCT01962103|536566339|FG004|Phase 1|Symptomatic Deterioration|1|||
148752973|NCT01962103|536566340|FG005|Phase 1|Symptomatic Deterioration|1|||
148752974|NCT01962103|536566341|FG006|Phase 1|Symptomatic Deterioration|0|||
148752975|NCT01962103|536566342|FG007|Phase 1|Symptomatic Deterioration|0|||
148752976|NCT01962103|536566343|FG008|Phase 1|Symptomatic Deterioration|0|||
148752977|NCT01962103|536566335|FG000|Phase 1|Miscellaneous|1|||
148752978|NCT01962103|536566336|FG001|Phase 1|Miscellaneous|0|||
148752979|NCT01962103|536566337|FG002|Phase 1|Miscellaneous|0|||
148752980|NCT01962103|536566338|FG003|Phase 1|Miscellaneous|0|||
148752981|NCT01962103|536566339|FG004|Phase 1|Miscellaneous|0|||
148752982|NCT01962103|536566340|FG005|Phase 1|Miscellaneous|0|||
148752983|NCT01962103|536566341|FG006|Phase 1|Miscellaneous|0|||
148752984|NCT01962103|536566342|FG007|Phase 1|Miscellaneous|0|||
148752985|NCT01962103|536566343|FG008|Phase 1|Miscellaneous|0|||
148752986|NCT01962103|536566335|FG000|Phase 2|Adverse Event|0|||
148752987|NCT01962103|536566336|FG001|Phase 2|Adverse Event|0|||
148752988|NCT01962103|536566337|FG002|Phase 2|Adverse Event|0|||
148752989|NCT01962103|536566338|FG003|Phase 2|Adverse Event|0|||
148752990|NCT01962103|536566339|FG004|Phase 2|Adverse Event|0|||
148752991|NCT01962103|536566340|FG005|Phase 2|Adverse Event|0|||
148752992|NCT01962103|536566341|FG006|Phase 2|Adverse Event|1|||
148752993|NCT01962103|536566342|FG007|Phase 2|Adverse Event|0|||
148822694|NCT03636269|536828579|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
148822695|NCT00493285|536828583|FG000|Overall Study|Lost to Follow-up|0|||
148822696|NCT00493285|536828584|FG001|Overall Study|Lost to Follow-up|0|||
148822697|NCT00493285|536828585|FG002|Overall Study|Lost to Follow-up|0|||
148822698|NCT00493285|536828586|FG003|Overall Study|Lost to Follow-up|0|||
148822699|NCT00493285|536828587|FG004|Overall Study|Lost to Follow-up|1|||
148822700|NCT00493285|536828588|FG005|Overall Study|Lost to Follow-up|0|||
148822701|NCT01174459|536828589|FG000|Overall Study|case report form (CRF) not collected|5|||
148822702|NCT00981175|536828596|FG000|Primary Dose Vaccination|Adverse Event|1|||
148822703|NCT00981175|536828597|FG001|Primary Dose Vaccination|Adverse Event|0|||
148822704|NCT00981175|536828596|FG000|Primary Dose Vaccination|Protocol Violation|0|||
148822705|NCT00981175|536828597|FG001|Primary Dose Vaccination|Protocol Violation|1|||
148822706|NCT00981175|536828596|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
148752994|NCT01962103|536566343|FG008|Phase 2|Adverse Event|3|||
148752995|NCT01962103|536566335|FG000|Phase 2|Progressive Disease|0|||
148752996|NCT01962103|536566336|FG001|Phase 2|Progressive Disease|0|||
148752997|NCT01962103|536566337|FG002|Phase 2|Progressive Disease|0|||
148752998|NCT01962103|536566338|FG003|Phase 2|Progressive Disease|0|||
148752999|NCT01962103|536566339|FG004|Phase 2|Progressive Disease|0|||
148753000|NCT01962103|536566340|FG005|Phase 2|Progressive Disease|0|||
148753001|NCT01962103|536566341|FG006|Phase 2|Progressive Disease|11|||
148753002|NCT01962103|536566342|FG007|Phase 2|Progressive Disease|12|||
148753003|NCT01962103|536566343|FG008|Phase 2|Progressive Disease|11|||
148753004|NCT01962103|536566335|FG000|Phase 2|Symptomatic Deterioration|0|||
148753005|NCT01962103|536566336|FG001|Phase 2|Symptomatic Deterioration|0|||
148753006|NCT01962103|536566337|FG002|Phase 2|Symptomatic Deterioration|0|||
148753007|NCT01962103|536566338|FG003|Phase 2|Symptomatic Deterioration|0|||
148753008|NCT01962103|536566339|FG004|Phase 2|Symptomatic Deterioration|0|||
148753009|NCT01962103|536566340|FG005|Phase 2|Symptomatic Deterioration|0|||
148753010|NCT01962103|536566341|FG006|Phase 2|Symptomatic Deterioration|2|||
148753011|NCT01962103|536566342|FG007|Phase 2|Symptomatic Deterioration|2|||
148753012|NCT01962103|536566343|FG008|Phase 2|Symptomatic Deterioration|0|||
148753013|NCT01321749|536566344|FG000|Overall Study|Lost to Follow-up|4|||
148753014|NCT01321749|536566345|FG001|Overall Study|Lost to Follow-up|11|||
148753015|NCT01321749|536566344|FG000|Overall Study|Protocol Violation|4|||
148753016|NCT01321749|536566345|FG001|Overall Study|Protocol Violation|7|||
148753017|NCT01321749|536566344|FG000|Overall Study|Withdrawal by Subject|5|||
148753018|NCT01321749|536566345|FG001|Overall Study|Withdrawal by Subject|4|||
148753019|NCT04179838|536566349|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
148753020|NCT04179838|536566350|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
148753021|NCT04179838|536566349|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
148753022|NCT04179838|536566350|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
148753023|NCT02763046|536566355|FG000|Overall Study|Adverse Event|5|||
148753024|NCT02763046|536566356|FG001|Overall Study|Adverse Event|4|||
148753025|NCT02763046|536566357|FG002|Overall Study|Adverse Event|0|||
148753026|NCT02763046|536566355|FG000|Overall Study|Lack of Efficacy|1|||
148753027|NCT02763046|536566356|FG001|Overall Study|Lack of Efficacy|1|||
148753028|NCT02763046|536566357|FG002|Overall Study|Lack of Efficacy|3|||
148753029|NCT02763046|536566355|FG000|Overall Study|Physician Decision|1|||
148753030|NCT02763046|536566356|FG001|Overall Study|Physician Decision|0|||
148753031|NCT02763046|536566357|FG002|Overall Study|Physician Decision|1|||
148753032|NCT02763046|536566355|FG000|Overall Study|Subject/guardian decision|2|||
148753033|NCT02763046|536566356|FG001|Overall Study|Subject/guardian decision|0|||
148753034|NCT02763046|536566357|FG002|Overall Study|Subject/guardian decision|4|||
148753035|NCT00086684|536566360|FG000|Overall Study|Adverse Event|12|||
148822707|NCT00981175|536828597|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
148976329|NCT00670228|537394514|FG000|Overall Study|Not meeting the selection criteria|2|||
148753036|NCT00086684|536566361|FG001|Overall Study|Adverse Event|17|||
148753037|NCT00086684|536566362|FG002|Overall Study|Adverse Event|14|||
148753038|NCT00086684|536566360|FG000|Overall Study|Lack of Efficacy|6|||
148822708|NCT00981175|536828596|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
148822709|NCT00981175|536828597|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
148822710|NCT01750281|536828598|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
148822711|NCT01750281|536828599|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
148976330|NCT00670228|537394515|FG001|Overall Study|Not meeting the selection criteria|0|||
148753039|NCT00086684|536566361|FG001|Overall Study|Lack of Efficacy|6|||
148753040|NCT00086684|536566362|FG002|Overall Study|Lack of Efficacy|5|||
148753041|NCT00086684|536566360|FG000|Overall Study|Lost to Follow-up|15|||
148822712|NCT01750281|536828600|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
148822713|NCT01750281|536828598|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
148822714|NCT01750281|536828599|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
148753042|NCT00086684|536566361|FG001|Overall Study|Lost to Follow-up|8|||
148753043|NCT00086684|536566362|FG002|Overall Study|Lost to Follow-up|10|||
148753044|NCT00086684|536566360|FG000|Overall Study|Protocol Violation|8|||
148753045|NCT00086684|536566361|FG001|Overall Study|Protocol Violation|3|||
148753046|NCT00086684|536566362|FG002|Overall Study|Protocol Violation|0|||
148753047|NCT00086684|536566360|FG000|Overall Study|Withdrawal by Subject|0|||
148822715|NCT01750281|536828600|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
148822716|NCT01750281|536828598|FG000|Overall Study|Did not receive treatment|0|||
148822717|NCT01750281|536828599|FG001|Overall Study|Did not receive treatment|1|||
148822718|NCT01750281|536828600|FG002|Overall Study|Did not receive treatment|0|||
148822719|NCT04189588|536828601|FG000|Overall Study|Death|0|||
148822720|NCT04189588|536828602|FG001|Overall Study|Death|1|||
148822721|NCT04189588|536828601|FG000|Overall Study|Lost to Follow-up|0|||
148822722|NCT04189588|536828602|FG001|Overall Study|Lost to Follow-up|1|||
148822723|NCT01658735|536828611|FG000|Overall Study|Lack of Efficacy|1|||
148822724|NCT01658735|536828612|FG001|Overall Study|Lack of Efficacy|0|||
148822725|NCT01658735|536828613|FG002|Overall Study|Lack of Efficacy|1|||
148822726|NCT01658735|536828611|FG000|Overall Study|Lost to Follow-up|1|||
148822727|NCT01658735|536828612|FG001|Overall Study|Lost to Follow-up|1|||
148822728|NCT01658735|536828613|FG002|Overall Study|Lost to Follow-up|0|||
148822729|NCT01658735|536828611|FG000|Overall Study|Protocol Violation|0|||
148822730|NCT01658735|536828612|FG001|Overall Study|Protocol Violation|1|||
148822731|NCT01658735|536828613|FG002|Overall Study|Protocol Violation|0|||
148822732|NCT01658735|536828611|FG000|Overall Study|Withdrawal by Subject|3|||
148822733|NCT01658735|536828612|FG001|Overall Study|Withdrawal by Subject|5|||
148822734|NCT01658735|536828613|FG002|Overall Study|Withdrawal by Subject|3|||
148822735|NCT03757715|536828614|FG000|Overall Study|Lost to Follow-up|4|||
148822736|NCT03757715|536828615|FG001|Overall Study|Lost to Follow-up|9|||
148822737|NCT03757715|536828614|FG000|Overall Study|Withdrawal by Subject|1|||
148822738|NCT03757715|536828615|FG001|Overall Study|Withdrawal by Subject|1|||
148822739|NCT03156621|536828616|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
148822740|NCT03156621|536828617|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
148822741|NCT03156621|536828616|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
148822742|NCT03156621|536828617|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
148822743|NCT03302936|536828618|FG000|Overall Study|Protocol Violation|3|||
148822744|NCT03302936|536828619|FG001|Overall Study|Protocol Violation|4|||
148822745|NCT01122680|536828620|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
148822746|NCT01122680|536828621|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
148822747|NCT01122680|536828622|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
148822748|NCT01122680|536828623|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
148822749|NCT01122680|536828620|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
148822750|NCT01122680|536828621|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
148822751|NCT01122680|536828622|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
148822752|NCT01122680|536828623|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
148822753|NCT01122680|536828620|FG000|Period 1 (4 Weeks)|Other|1|||
148822754|NCT01122680|536828621|FG001|Period 1 (4 Weeks)|Other|1|||
148822755|NCT01122680|536828622|FG002|Period 1 (4 Weeks)|Other|0|||
148822756|NCT01122680|536828623|FG003|Period 1 (4 Weeks)|Other|0|||
148822757|NCT01122680|536828620|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
148753048|NCT00086684|536566361|FG001|Overall Study|Withdrawal by Subject|4|||
148753049|NCT00086684|536566362|FG002|Overall Study|Withdrawal by Subject|10|||
148753050|NCT00086684|536566360|FG000|Overall Study|NONCOMPLIANCE|5|||
148753051|NCT00086684|536566361|FG001|Overall Study|NONCOMPLIANCE|7|||
148753052|NCT00086684|536566362|FG002|Overall Study|NONCOMPLIANCE|6|||
148753053|NCT00086684|536566360|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148753054|NCT00086684|536566361|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
148753055|NCT00086684|536566362|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
148753056|NCT00086684|536566360|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
148753057|NCT00086684|536566361|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
148753058|NCT00086684|536566362|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
148753059|NCT00086684|536566360|FG000|Overall Study|Other|4|||
148753060|NCT00086684|536566361|FG001|Overall Study|Other|2|||
148822758|NCT01122680|536828621|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
148822759|NCT01122680|536828622|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
148822760|NCT01122680|536828623|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
148822761|NCT01122680|536828620|FG000|Period 2 (4 Weeks)|Other|1|||
148753061|NCT00086684|536566362|FG002|Overall Study|Other|3|||
148753062|NCT01067105|536566365|FG000|Overall Study|Adverse Event|14|||
148822762|NCT01122680|536828621|FG001|Period 2 (4 Weeks)|Other|0|||
148822763|NCT01122680|536828622|FG002|Period 2 (4 Weeks)|Other|0|||
148822764|NCT01122680|536828623|FG003|Period 2 (4 Weeks)|Other|0|||
148822765|NCT01122680|536828620|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
148822766|NCT01122680|536828621|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
148822767|NCT01122680|536828622|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
148822768|NCT01122680|536828623|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
148753063|NCT01067105|536566365|FG000|Overall Study|Protocol Violation|48|||
148753064|NCT01067105|536566365|FG000|Overall Study|Withdrawal by Subject|36|||
148753065|NCT01067105|536566365|FG000|Overall Study|Lost to Follow-up|6|||
148822769|NCT01122680|536828620|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148822770|NCT01122680|536828621|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
148822771|NCT01122680|536828622|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148822772|NCT01122680|536828623|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
148822773|NCT00756444|536828633|FG000|Overall Study|Adverse Event|1|||
148822774|NCT00756444|536828634|FG001|Overall Study|Adverse Event|1|||
148822775|NCT00756444|536828633|FG000|Overall Study|Withdrawal by Subject|6|||
148753066|NCT01067105|536566365|FG000|Overall Study|Physician Decision|6|||
148753067|NCT01067105|536566365|FG000|Overall Study|Other|31|||
148753068|NCT01495000|536566366|FG000|Overall Study|Lost to Follow-up|2|||
148753069|NCT01495000|536566367|FG001|Overall Study|Lost to Follow-up|2|||
148753070|NCT01495000|536566366|FG000|Overall Study|Protocol Violation|1|||
148753071|NCT01495000|536566367|FG001|Overall Study|Protocol Violation|0|||
148753072|NCT01495000|536566366|FG000|Overall Study|Withdrawal by Subject|10|||
148753073|NCT01495000|536566367|FG001|Overall Study|Withdrawal by Subject|10|||
148753074|NCT02070965|536566368|FG000|Overall Study|Lost to Follow-up|0|||
148753075|NCT02070965|536566369|FG001|Overall Study|Lost to Follow-up|1|||
148753076|NCT02070965|536566370|FG002|Overall Study|Lost to Follow-up|0|||
148753077|NCT02070965|536566368|FG000|Overall Study|Withdrawal by Subject|1|||
148753078|NCT02070965|536566369|FG001|Overall Study|Withdrawal by Subject|1|||
148753079|NCT02070965|536566370|FG002|Overall Study|Withdrawal by Subject|1|||
148753080|NCT02070965|536566368|FG000|Overall Study|Subject moved|1|||
148753081|NCT02070965|536566369|FG001|Overall Study|Subject moved|0|||
148753082|NCT02070965|536566370|FG002|Overall Study|Subject moved|0|||
148753083|NCT00942357|536566379|FG000|Overall Study|Ineligible|37|||
148753084|NCT00942357|536566380|FG001|Overall Study|Ineligible|40|||
148753085|NCT03347110|536566383|FG000|Overall Study|Other (Participant is incarcerated)|1|||
148753086|NCT03347110|536566383|FG000|Overall Study|Withdrawal by Subject|9|||
148753087|NCT03347110|536566383|FG000|Overall Study|Lost to Follow-up|1|||
148753088|NCT03347110|536566383|FG000|Overall Study|Lack of Efficacy|2|||
148753089|NCT03347110|536566383|FG000|Overall Study|Adverse Event, non-fatal|9|||
148753090|NCT02105467|536566386|FG000|Period 1|Lost to Follow-up|1|||
148753091|NCT02105467|536566387|FG001|Period 1|Lost to Follow-up|0|||
148753092|NCT02105467|536566386|FG000|Period 1|Death|1|||
148753093|NCT02105467|536566387|FG001|Period 1|Death|0|||
148753094|NCT02105467|536566386|FG000|Period 2|Lost to Follow-up|1|||
148753095|NCT02105467|536566387|FG001|Period 2|Lost to Follow-up|0|||
148753096|NCT02105467|536566386|FG000|Period 2|Death|1|||
148753097|NCT02105467|536566387|FG001|Period 2|Death|0|||
148753098|NCT02105467|536566386|FG000|Period 2|Withdrawal by Subject|0|||
148753099|NCT02105467|536566387|FG001|Period 2|Withdrawal by Subject|2|||
148753100|NCT02105467|536566386|FG000|Period 3|Lost to Follow-up|0|||
148753101|NCT02105467|536566387|FG001|Period 3|Lost to Follow-up|1|||
148753102|NCT01321879|536566389|FG000|Overall Study|Lack of Efficacy|5|||
148753103|NCT01321879|536566389|FG000|Overall Study|Adverse Event|5|||
148753104|NCT01321879|536566389|FG000|Overall Study|Death|3|||
148753105|NCT01321879|536566389|FG000|Overall Study|Withdrawal by Subject|1|||
148753106|NCT00958828|536566391|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
148753107|NCT00958828|536566392|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
148753108|NCT00958828|536566391|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
148753109|NCT00958828|536566392|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
148753110|NCT00811733|536566393|FG000|Overall Study|Investigator Discretion|10|||
148753111|NCT00811733|536566394|FG001|Overall Study|Investigator Discretion|8|||
148753112|NCT00811733|536566393|FG000|Overall Study|Withdrawal by Subject|1|||
148753113|NCT00811733|536566394|FG001|Overall Study|Withdrawal by Subject|2|||
148753114|NCT00793871|536566395|FG000|Overall Study|Death|50|||
148753115|NCT00793871|536566395|FG000|Overall Study|Lost to Follow-up|3|||
148753116|NCT00793871|536566395|FG000|Overall Study|Study terminated by the Sponsor|7|||
148753117|NCT02500589|536566396|FG000|Overall Study|Withdrawal by Subject|11|||
148753118|NCT02500589|536566397|FG001|Overall Study|Withdrawal by Subject|14|||
148753119|NCT02500589|536566396|FG000|Overall Study|Lost to Follow-up|10|||
148753120|NCT02500589|536566397|FG001|Overall Study|Lost to Follow-up|12|||
148753121|NCT02500589|536566396|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
148753122|NCT02500589|536566397|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
148753123|NCT02500589|536566396|FG000|Overall Study|Death|7|||
148753124|NCT02500589|536566397|FG001|Overall Study|Death|5|||
148753125|NCT00307086|536566402|FG000|Overall Study|ineligible|5|||
148753126|NCT00262028|536566403|FG000|Overall Study|Withdrawal by Subject|6|||
148753127|NCT00262028|536566404|FG001|Overall Study|Withdrawal by Subject|3|||
148753128|NCT00262028|536566405|FG002|Overall Study|Withdrawal by Subject|6|||
148753129|NCT00262028|536566406|FG003|Overall Study|Withdrawal by Subject|5|||
148753130|NCT00262028|536566407|FG004|Overall Study|Withdrawal by Subject|2|||
148753131|NCT00262028|536566408|FG005|Overall Study|Withdrawal by Subject|3|||
148753132|NCT00262028|536566409|FG006|Overall Study|Withdrawal by Subject|5|||
148753133|NCT00262028|536566410|FG007|Overall Study|Withdrawal by Subject|7|||
148753134|NCT00262028|536566411|FG008|Overall Study|Withdrawal by Subject|2|||
148753135|NCT00262028|536566403|FG000|Overall Study|Lost to Follow-up|7|||
148753136|NCT00262028|536566404|FG001|Overall Study|Lost to Follow-up|7|||
148753137|NCT00262028|536566405|FG002|Overall Study|Lost to Follow-up|5|||
148753138|NCT00262028|536566406|FG003|Overall Study|Lost to Follow-up|5|||
148753139|NCT00262028|536566407|FG004|Overall Study|Lost to Follow-up|4|||
148753140|NCT00262028|536566408|FG005|Overall Study|Lost to Follow-up|3|||
148753141|NCT00262028|536566409|FG006|Overall Study|Lost to Follow-up|3|||
148753142|NCT00262028|536566410|FG007|Overall Study|Lost to Follow-up|5|||
148753143|NCT00262028|536566411|FG008|Overall Study|Lost to Follow-up|6|||
148753144|NCT00262028|536566403|FG000|Overall Study|Administrative Reason|11|||
148753145|NCT00262028|536566404|FG001|Overall Study|Administrative Reason|14|||
148753146|NCT00262028|536566405|FG002|Overall Study|Administrative Reason|9|||
148753147|NCT00262028|536566406|FG003|Overall Study|Administrative Reason|12|||
148753148|NCT00262028|536566407|FG004|Overall Study|Administrative Reason|6|||
148753149|NCT00262028|536566408|FG005|Overall Study|Administrative Reason|7|||
148753150|NCT00262028|536566409|FG006|Overall Study|Administrative Reason|4|||
148753151|NCT00262028|536566410|FG007|Overall Study|Administrative Reason|6|||
148753152|NCT00262028|536566411|FG008|Overall Study|Administrative Reason|10|||
148753153|NCT00262028|536566403|FG000|Overall Study|Protocol Violation|0|||
148753154|NCT00262028|536566404|FG001|Overall Study|Protocol Violation|0|||
148753155|NCT00262028|536566405|FG002|Overall Study|Protocol Violation|0|||
148753156|NCT00262028|536566406|FG003|Overall Study|Protocol Violation|1|||
148753157|NCT00262028|536566407|FG004|Overall Study|Protocol Violation|0|||
148753158|NCT00262028|536566408|FG005|Overall Study|Protocol Violation|0|||
148753159|NCT00262028|536566409|FG006|Overall Study|Protocol Violation|0|||
148753160|NCT00262028|536566410|FG007|Overall Study|Protocol Violation|0|||
148753161|NCT00262028|536566411|FG008|Overall Study|Protocol Violation|0|||
148753162|NCT00262028|536566403|FG000|Overall Study|Unable to classify|0|||
148753163|NCT00262028|536566404|FG001|Overall Study|Unable to classify|3|||
148753164|NCT00262028|536566405|FG002|Overall Study|Unable to classify|0|||
148753165|NCT00262028|536566406|FG003|Overall Study|Unable to classify|0|||
148753166|NCT00262028|536566407|FG004|Overall Study|Unable to classify|0|||
148753167|NCT00262028|536566408|FG005|Overall Study|Unable to classify|0|||
148753168|NCT00262028|536566409|FG006|Overall Study|Unable to classify|0|||
148753169|NCT00262028|536566410|FG007|Overall Study|Unable to classify|0|||
148753170|NCT00262028|536566411|FG008|Overall Study|Unable to classify|1|||
148753171|NCT01125917|536566412|FG000|Overall Study|Adverse Event|43|||
148753172|NCT01125917|536566412|FG000|Overall Study|Lost to Follow-up|23|||
148753173|NCT01125917|536566412|FG000|Overall Study|Withdrawal by Subject|31|||
148753174|NCT01125917|536566412|FG000|Overall Study|Administrative|223|||
148753175|NCT01125917|536566412|FG000|Overall Study|Lack of Efficacy|19|||
148753176|NCT04421131|536566413|FG000|Overall Study|Lost to Follow-up|1|||
148753177|NCT04421131|536566413|FG000|Overall Study|Protocol Violation|2|||
148753178|NCT04421131|536566413|FG000|Overall Study|App crashed|5|||
148753179|NCT01197911|536566414|FG000|Overall Study|Adverse Event|0|||
148753180|NCT01197911|536566415|FG001|Overall Study|Adverse Event|0|||
148753181|NCT01197911|536566416|FG002|Overall Study|Adverse Event|1|||
148753182|NCT02553772|536566422|FG000|Overall Study|Adverse Event|2|||
148753183|NCT02553772|536566423|FG001|Overall Study|Adverse Event|3|||
148753184|NCT02553772|536566422|FG000|Overall Study|Lost to Follow-up|2|||
148753185|NCT02553772|536566423|FG001|Overall Study|Lost to Follow-up|1|||
148753186|NCT02553772|536566422|FG000|Overall Study|Withdrawal of Consent|1|||
148753187|NCT02553772|536566423|FG001|Overall Study|Withdrawal of Consent|1|||
148753188|NCT02553772|536566422|FG000|Overall Study|Lack of Efficacy|1|||
148753189|NCT02553772|536566423|FG001|Overall Study|Lack of Efficacy|0|||
148753190|NCT02553772|536566422|FG000|Overall Study|Other Miscellaneous Reasons|0|||
148753191|NCT02553772|536566423|FG001|Overall Study|Other Miscellaneous Reasons|1|||
148753192|NCT05724589|536566424|FG000|Overall Study|Lost to Follow-up|1|||
148753193|NCT04075487|536568461|FG000|Overall Study|Withdrawal by Subject|1|||
148753194|NCT05016960|536568464|FG000|Overall Study|Withdrawal by Subject|1|||
148753195|NCT05016960|536568465|FG001|Overall Study|Withdrawal by Subject|9|||
148753196|NCT05655546|536568468|FG000|Overall Study|Withdrawal by Subject|2|||
148753197|NCT05655546|536568469|FG001|Overall Study|Withdrawal by Subject|4|||
148753198|NCT04576507|536568476|FG000|Overall Study|Adverse Event|4|||
148753199|NCT04576507|536568476|FG000|Overall Study|Withdrawal by Subject|1|||
148753200|NCT04467840|536568477|FG000|Overall Study|Death|35|||
148753201|NCT04467840|536568478|FG001|Overall Study|Death|39|||
148753202|NCT04467840|536568477|FG000|Overall Study|Withdrawal by Subject|8|||
148753203|NCT04467840|536568478|FG001|Overall Study|Withdrawal by Subject|4|||
148753204|NCT04467840|536568477|FG000|Overall Study|Adverse Event|2|||
148753205|NCT04467840|536568478|FG001|Overall Study|Adverse Event|0|||
148753206|NCT04467840|536568477|FG000|Overall Study|Lost to Follow-up|1|||
148753207|NCT04467840|536568478|FG001|Overall Study|Lost to Follow-up|3|||
148753208|NCT04467840|536568477|FG000|Overall Study|Physician Decision|1|||
148753209|NCT04467840|536568478|FG001|Overall Study|Physician Decision|0|||
148753210|NCT04467840|536568477|FG000|Overall Study|Other|1|||
148753211|NCT04467840|536568478|FG001|Overall Study|Other|5|||
148753212|NCT04467840|536568477|FG000|Overall Study|Missing study completion status|3|||
148753213|NCT04467840|536568478|FG001|Overall Study|Missing study completion status|1|||
148753214|NCT05201794|536568481|FG000|Overall Study|Withdrawal by Subject|13|||
148753215|NCT05201794|536568482|FG001|Overall Study|Withdrawal by Subject|12|||
148753216|NCT05201794|536568483|FG002|Overall Study|Withdrawal by Subject|14|||
148753217|NCT05201794|536568484|FG003|Overall Study|Withdrawal by Subject|0|||
148753218|NCT05201794|536568481|FG000|Overall Study|Adverse Event|5|||
148753219|NCT05201794|536568482|FG001|Overall Study|Adverse Event|5|||
148753220|NCT05201794|536568483|FG002|Overall Study|Adverse Event|4|||
148753221|NCT05201794|536568484|FG003|Overall Study|Adverse Event|0|||
148753222|NCT05201794|536568481|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
148822776|NCT00756444|536828634|FG001|Overall Study|Withdrawal by Subject|8|||
148822777|NCT00756444|536828633|FG000|Overall Study|Lost to Follow-up|0|||
148822778|NCT00756444|536828634|FG001|Overall Study|Lost to Follow-up|1|||
148822779|NCT00756444|536828633|FG000|Overall Study|Death|5|||
148822780|NCT00756444|536828634|FG001|Overall Study|Death|4|||
148822781|NCT00756444|536828633|FG000|Overall Study|Disease Progression|2|||
148822782|NCT00756444|536828634|FG001|Overall Study|Disease Progression|7|||
148822783|NCT00756444|536828633|FG000|Overall Study|Ineligibility Determined|1|||
148822784|NCT00756444|536828634|FG001|Overall Study|Ineligibility Determined|0|||
148822785|NCT02264821|536828636|FG000|Overall Study|Protocol Violation|1|||
148822786|NCT02264821|536828637|FG001|Overall Study|Protocol Violation|3|||
148822787|NCT02264821|536828638|FG002|Overall Study|Protocol Violation|6|||
148822788|NCT00552279|536828639|FG000|Overall Study|Adverse Event|0|||
148822789|NCT00552279|536828640|FG001|Overall Study|Adverse Event|1|||
148822790|NCT00552279|536828639|FG000|Overall Study|Withdrawal by Subject|12|||
148822791|NCT00552279|536828640|FG001|Overall Study|Withdrawal by Subject|1|||
148822792|NCT00552279|536828639|FG000|Overall Study|Lost to Follow-up|1|||
148822793|NCT00552279|536828640|FG001|Overall Study|Lost to Follow-up|0|||
148822794|NCT00552279|536828639|FG000|Overall Study|Other|1|||
148822795|NCT00552279|536828640|FG001|Overall Study|Other|1|||
148822796|NCT03142334|536828642|FG000|Overall Study|Death|18|||
148822797|NCT03142334|536828643|FG001|Overall Study|Death|33|||
148822798|NCT03142334|536828642|FG000|Overall Study|Withdrawal by Subject|15|||
148822799|NCT03142334|536828643|FG001|Overall Study|Withdrawal by Subject|11|||
148822800|NCT03142334|536828642|FG000|Overall Study|Ongoing on trial follow up|463|||
148822801|NCT03142334|536828643|FG001|Overall Study|Ongoing on trial follow up|454|||
148822802|NCT01217047|536828644|FG000|Overall Study|Lost to Follow-up|0|||
148822803|NCT01217047|536828645|FG001|Overall Study|Lost to Follow-up|1|||
148822804|NCT01217047|536828646|FG002|Overall Study|Lost to Follow-up|0|||
148822805|NCT03835117|536828647|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
148822806|NCT03835117|536828648|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
148822807|NCT06083493|536828649|FG000|Overall Study|Technical issues with the interventional device|2|||
148822808|NCT06083493|536828650|FG001|Overall Study|Technical issues with the interventional device|2|||
148822809|NCT06083493|536828649|FG000|Overall Study|Performed incorrect visual task|1|||
148822810|NCT06083493|536828650|FG001|Overall Study|Performed incorrect visual task|0|||
148822811|NCT06083493|536828649|FG000|Overall Study|Insufficient baseline performance|0|||
148822812|NCT06083493|536828650|FG001|Overall Study|Insufficient baseline performance|1|||
148822813|NCT04034056|536828651|FG000|Overall Study|Withdrawal by Subject|2|||
148822814|NCT04034056|536828651|FG000|Overall Study|Reason Not Specified|13|||
148822815|NCT04034056|536828651|FG000|Overall Study|Adverse Event|56|||
148822816|NCT01530997|536828652|FG000|Overall Study|Physician Decision|1|||
148822817|NCT01530997|536828652|FG000|Overall Study|Withdrawal by Subject|1|||
148822818|NCT01362270|536828654|FG000|Overall Study|Withdrawal by Subject|1|||
148822819|NCT01362270|536828655|FG001|Overall Study|Withdrawal by Subject|0|||
148822820|NCT01362270|536828654|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
148822821|NCT01362270|536828655|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
148822822|NCT01362270|536828654|FG000|Overall Study|Met excl. criteria before 1st session|1|||
148822823|NCT01362270|536828655|FG001|Overall Study|Met excl. criteria before 1st session|1|||
148822824|NCT02318277|536828656|FG000|Overall Study|Physician Decision|0|||
148822825|NCT02318277|536828657|FG001|Overall Study|Physician Decision|0|||
148822826|NCT02318277|536828658|FG002|Overall Study|Physician Decision|0|||
148822827|NCT02318277|536828659|FG003|Overall Study|Physician Decision|0|||
148822828|NCT02318277|536828660|FG004|Overall Study|Physician Decision|0|||
148822829|NCT02318277|536828661|FG005|Overall Study|Physician Decision|0|||
148822830|NCT02318277|536828662|FG006|Overall Study|Physician Decision|0|||
148822831|NCT02318277|536828663|FG007|Overall Study|Physician Decision|1|||
148822832|NCT02318277|536828656|FG000|Overall Study|Other|0|||
148822833|NCT02318277|536828657|FG001|Overall Study|Other|0|||
148822834|NCT02318277|536828658|FG002|Overall Study|Other|0|||
148822835|NCT02318277|536828659|FG003|Overall Study|Other|0|||
148822836|NCT02318277|536828660|FG004|Overall Study|Other|0|||
148822837|NCT02318277|536828661|FG005|Overall Study|Other|0|||
148822838|NCT02318277|536828662|FG006|Overall Study|Other|1|||
148822839|NCT02318277|536828663|FG007|Overall Study|Other|0|||
148822840|NCT02318277|536828656|FG000|Overall Study|Withdrawal by Subject|0|||
148822841|NCT02318277|536828657|FG001|Overall Study|Withdrawal by Subject|0|||
148822842|NCT02318277|536828658|FG002|Overall Study|Withdrawal by Subject|1|||
148822843|NCT02318277|536828659|FG003|Overall Study|Withdrawal by Subject|0|||
148822844|NCT02318277|536828660|FG004|Overall Study|Withdrawal by Subject|1|||
148822845|NCT02318277|536828661|FG005|Overall Study|Withdrawal by Subject|1|||
148822846|NCT02318277|536828662|FG006|Overall Study|Withdrawal by Subject|6|||
148822847|NCT02318277|536828663|FG007|Overall Study|Withdrawal by Subject|14|||
148822848|NCT02318277|536828656|FG000|Overall Study|Participant trial terminated by sponsor|0|||
148822849|NCT02318277|536828657|FG001|Overall Study|Participant trial terminated by sponsor|0|||
148822850|NCT02318277|536828658|FG002|Overall Study|Participant trial terminated by sponsor|1|||
148822851|NCT02318277|536828659|FG003|Overall Study|Participant trial terminated by sponsor|0|||
148822852|NCT02318277|536828660|FG004|Overall Study|Participant trial terminated by sponsor|1|||
148822853|NCT02318277|536828661|FG005|Overall Study|Participant trial terminated by sponsor|2|||
148822854|NCT02318277|536828662|FG006|Overall Study|Participant trial terminated by sponsor|5|||
148822855|NCT02318277|536828663|FG007|Overall Study|Participant trial terminated by sponsor|16|||
148822856|NCT02318277|536828656|FG000|Overall Study|Lost to Follow-up|1|||
148822857|NCT02318277|536828657|FG001|Overall Study|Lost to Follow-up|0|||
148822858|NCT02318277|536828658|FG002|Overall Study|Lost to Follow-up|1|||
148822859|NCT02318277|536828659|FG003|Overall Study|Lost to Follow-up|0|||
148822860|NCT02318277|536828660|FG004|Overall Study|Lost to Follow-up|0|||
148822861|NCT02318277|536828661|FG005|Overall Study|Lost to Follow-up|0|||
148822862|NCT02318277|536828662|FG006|Overall Study|Lost to Follow-up|3|||
148822863|NCT02318277|536828663|FG007|Overall Study|Lost to Follow-up|4|||
148822864|NCT02318277|536828656|FG000|Overall Study|Death|5|||
148822865|NCT02318277|536828657|FG001|Overall Study|Death|3|||
148822866|NCT02318277|536828658|FG002|Overall Study|Death|1|||
148822867|NCT02318277|536828659|FG003|Overall Study|Death|4|||
148822868|NCT02318277|536828660|FG004|Overall Study|Death|6|||
148822869|NCT02318277|536828661|FG005|Overall Study|Death|5|||
148822870|NCT02318277|536828662|FG006|Overall Study|Death|34|||
148822871|NCT02318277|536828663|FG007|Overall Study|Death|58|||
148822872|NCT02318277|536828656|FG000|Overall Study|Transitioned to Hospice|0|||
148822873|NCT02318277|536828657|FG001|Overall Study|Transitioned to Hospice|0|||
148822874|NCT02318277|536828658|FG002|Overall Study|Transitioned to Hospice|0|||
148822875|NCT02318277|536828659|FG003|Overall Study|Transitioned to Hospice|0|||
148822876|NCT02318277|536828660|FG004|Overall Study|Transitioned to Hospice|0|||
148822877|NCT02318277|536828661|FG005|Overall Study|Transitioned to Hospice|1|||
148822878|NCT02318277|536828662|FG006|Overall Study|Transitioned to Hospice|0|||
148822879|NCT02318277|536828663|FG007|Overall Study|Transitioned to Hospice|0|||
148822880|NCT01968785|536828674|FG000|Overall Study|Withdrawal by Subject|1|||
148822881|NCT01968785|536828675|FG001|Overall Study|Withdrawal by Subject|0|||
148753223|NCT05201794|536568482|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
148753224|NCT05201794|536568483|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
148753225|NCT05201794|536568484|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148753226|NCT05201794|536568481|FG000|Overall Study|Non-Compliance With Study Drug|2|||
148753227|NCT05201794|536568482|FG001|Overall Study|Non-Compliance With Study Drug|3|||
148753228|NCT05201794|536568483|FG002|Overall Study|Non-Compliance With Study Drug|3|||
148753229|NCT05201794|536568484|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148753230|NCT05201794|536568481|FG000|Overall Study|Physician Decision|1|||
148753231|NCT05201794|536568482|FG001|Overall Study|Physician Decision|3|||
148753232|NCT05201794|536568483|FG002|Overall Study|Physician Decision|2|||
148753233|NCT05201794|536568484|FG003|Overall Study|Physician Decision|0|||
148822882|NCT03518203|536828676|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
148822883|NCT03518203|536828676|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
148822884|NCT02366130|536828677|FG000|Overall Study|Withdrawal by Subject|3|||
148822885|NCT02366130|536828677|FG000|Overall Study|Ineligible|6|||
148822886|NCT01065766|536828678|FG000|Overall Study|Assessed before the contracted date|1|||
148822887|NCT01065766|536828678|FG000|Overall Study|Contraindication to administration|6|||
148822888|NCT01065766|536828678|FG000|Overall Study|Violated dosage/administration|25|||
148822889|NCT04223687|536828679|FG000|Overall Study|Missing primary outcome|1|||
148822890|NCT04223687|536828680|FG001|Overall Study|Missing primary outcome|0|||
148822891|NCT01608308|536828684|FG000|Overall Study|pretreatment medical and billing reasons|0|||
148822892|NCT01608308|536828685|FG001|Overall Study|pretreatment medical and billing reasons|2|||
148822893|NCT00286455|536828687|FG000|Overall Study|Hyperglycemia rescue|19|||
148822894|NCT00286455|536828688|FG001|Overall Study|Hyperglycemia rescue|13|||
148822895|NCT00286455|536828689|FG002|Overall Study|Hyperglycemia rescue|10|||
148822896|NCT00286455|536828687|FG000|Overall Study|Adverse Event|1|||
148822897|NCT00286455|536828688|FG001|Overall Study|Adverse Event|3|||
148822898|NCT00286455|536828689|FG002|Overall Study|Adverse Event|2|||
148822899|NCT00286455|536828687|FG000|Overall Study|Lost to Follow-up|0|||
148822900|NCT00286455|536828688|FG001|Overall Study|Lost to Follow-up|3|||
148753234|NCT05201794|536568481|FG000|Overall Study|Lost to Follow-up|2|||
148753235|NCT05201794|536568482|FG001|Overall Study|Lost to Follow-up|2|||
148753236|NCT05201794|536568483|FG002|Overall Study|Lost to Follow-up|0|||
148753237|NCT05201794|536568484|FG003|Overall Study|Lost to Follow-up|0|||
148822901|NCT00286455|536828689|FG002|Overall Study|Lost to Follow-up|3|||
148822902|NCT00286455|536828687|FG000|Overall Study|Physician Decision|3|||
148822903|NCT00286455|536828688|FG001|Overall Study|Physician Decision|0|||
148822904|NCT00286455|536828689|FG002|Overall Study|Physician Decision|2|||
148822905|NCT00286455|536828687|FG000|Overall Study|Protocol Violation|1|||
148753238|NCT05201794|536568481|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
148822906|NCT00286455|536828688|FG001|Overall Study|Protocol Violation|1|||
148753239|NCT05201794|536568482|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
148753240|NCT05201794|536568483|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
148753241|NCT05201794|536568484|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
148753242|NCT05201794|536568481|FG000|Overall Study|Protocol Violation|2|||
148753243|NCT05201794|536568482|FG001|Overall Study|Protocol Violation|0|||
148822907|NCT00286455|536828689|FG002|Overall Study|Protocol Violation|0|||
148822908|NCT00286455|536828687|FG000|Overall Study|Participant Non-compliance|1|||
148822909|NCT00286455|536828688|FG001|Overall Study|Participant Non-compliance|0|||
148822910|NCT00286455|536828689|FG002|Overall Study|Participant Non-compliance|0|||
148822911|NCT00286455|536828687|FG000|Overall Study|Withdrawal by Subject|0|||
149027397|NCT00293462|537578556|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
149027398|NCT00293462|537578554|FG000|Overall Study|Possible Tracheostomy leakage|0|||
149027399|NCT00293462|537578555|FG001|Overall Study|Possible Tracheostomy leakage|1|||
149027400|NCT00293462|537578556|FG002|Overall Study|Possible Tracheostomy leakage|0|||
148753244|NCT05201794|536568483|FG002|Overall Study|Protocol Violation|1|||
148753245|NCT05201794|536568484|FG003|Overall Study|Protocol Violation|0|||
148822912|NCT00286455|536828688|FG001|Overall Study|Withdrawal by Subject|8|||
148822913|NCT00286455|536828689|FG002|Overall Study|Withdrawal by Subject|7|||
148822914|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
148753246|NCT05201794|536568481|FG000|Overall Study|Death|1|||
148753247|NCT05201794|536568482|FG001|Overall Study|Death|0|||
148753248|NCT05201794|536568483|FG002|Overall Study|Death|0|||
148753249|NCT05201794|536568484|FG003|Overall Study|Death|0|||
148753250|NCT05201794|536568481|FG000|Overall Study|Site Terminated By Sponsor|0|||
148753251|NCT05201794|536568482|FG001|Overall Study|Site Terminated By Sponsor|1|||
148753252|NCT05201794|536568483|FG002|Overall Study|Site Terminated By Sponsor|0|||
148753253|NCT05201794|536568484|FG003|Overall Study|Site Terminated By Sponsor|0|||
148753254|NCT05201794|536568481|FG000|Overall Study|Other|3|||
148753255|NCT05201794|536568482|FG001|Overall Study|Other|3|||
148753256|NCT05201794|536568483|FG002|Overall Study|Other|3|||
148753257|NCT05201794|536568484|FG003|Overall Study|Other|0|||
148753258|NCT05201794|536568481|FG000|Overall Study|Randomized But Not Treated|1|||
148753259|NCT05201794|536568482|FG001|Overall Study|Randomized But Not Treated|2|||
148753260|NCT05201794|536568483|FG002|Overall Study|Randomized But Not Treated|1|||
148753261|NCT05201794|536568484|FG003|Overall Study|Randomized But Not Treated|0|||
148753262|NCT04653454|536568487|FG000|Overall Study|Withdrawal by Subject|1|||
148753263|NCT04653454|536568487|FG000|Overall Study|Physician Decision|40|||
148753264|NCT02203357|536568491|FG000|Overall Study|Lost to Follow-up|58|||
148753265|NCT02203357|536568492|FG001|Overall Study|Lost to Follow-up|66|||
148753266|NCT02203357|536568493|FG002|Overall Study|Lost to Follow-up|70|||
148753267|NCT02439216|536568494|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
148753268|NCT02439216|536568495|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753269|NCT02439216|536568496|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753270|NCT02439216|536568497|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753271|NCT02439216|536568498|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753272|NCT02439216|536568499|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753273|NCT02439216|536568500|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753274|NCT02439216|536568501|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753275|NCT02439216|536568502|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
148753276|NCT02439216|536568494|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753277|NCT02439216|536568495|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753278|NCT02439216|536568496|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753279|NCT02439216|536568497|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753280|NCT02439216|536568498|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753281|NCT02439216|536568499|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753282|NCT02439216|536568500|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753283|NCT02439216|536568501|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
148753284|NCT02439216|536568502|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
148753285|NCT02439216|536568494|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753286|NCT02439216|536568495|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753287|NCT02439216|536568496|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753288|NCT02439216|536568497|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753289|NCT02439216|536568498|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753290|NCT02439216|536568499|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753291|NCT02439216|536568500|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
148753292|NCT02439216|536568501|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
148753293|NCT02439216|536568502|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
148822915|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
148822916|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
148822917|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
148753294|NCT02439216|536568494|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148753295|NCT02439216|536568495|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148822918|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
148822919|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
148822920|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
148753296|NCT02439216|536568496|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148822921|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
148822922|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
148822923|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
148822924|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
148822925|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
148822926|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
148822927|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
148822928|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
148822929|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
148822930|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
148822931|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
148822932|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
148822933|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
148822934|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
148822935|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
148822936|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
148822937|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
148822938|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
148822939|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
148822940|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
148822941|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
148822942|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
148822943|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
148822944|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
148822945|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
148822946|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
148822947|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
148822948|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
148822949|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
148822950|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
148822951|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
148822952|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
148822953|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
148822954|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
148822955|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
148822956|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
148822957|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
148822958|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
148822959|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
148822960|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
148822961|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
148822962|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
148822963|NCT01557244|536830717|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
148822964|NCT01557244|536830718|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
148822965|NCT01557244|536830719|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
148822966|NCT01557244|536830720|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
148822967|NCT01557244|536830721|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
148822968|NCT01557244|536830722|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
148822969|NCT01557244|536830723|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
148822970|NCT01557244|536830717|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
148822971|NCT01557244|536830718|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
148822972|NCT01557244|536830719|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
148822973|NCT01557244|536830720|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
148822974|NCT01557244|536830721|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
148822975|NCT01557244|536830722|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
148822976|NCT01557244|536830723|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
148822977|NCT01557244|536830717|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
148822978|NCT01557244|536830718|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
148822979|NCT01557244|536830719|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
148822980|NCT01557244|536830720|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
148822981|NCT01557244|536830721|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
148753297|NCT02439216|536568497|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148753298|NCT02439216|536568498|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148753299|NCT02439216|536568499|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148753300|NCT02439216|536568500|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148753301|NCT02439216|536568501|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
148753302|NCT02439216|536568502|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
148753303|NCT02439216|536568494|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753304|NCT02439216|536568495|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753305|NCT02439216|536568496|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753306|NCT02439216|536568497|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753307|NCT02439216|536568498|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753308|NCT02439216|536568499|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753309|NCT02439216|536568500|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
148753310|NCT02439216|536568501|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
148753311|NCT02439216|536568502|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
148753312|NCT02094300|536568503|FG000|Overall Study|Death|7|||
148753313|NCT02094300|536568503|FG000|Overall Study|Lost to Follow-up|10|||
148753314|NCT02094300|536568503|FG000|Overall Study|Still be eligible for follow-up|3|||
148753315|NCT02493660|536568508|FG000|Overall Study|Physician Decision|0|||
148753316|NCT02493660|536568509|FG001|Overall Study|Physician Decision|1|||
148753317|NCT02493660|536568508|FG000|Overall Study|Adverse Event|4|||
148753318|NCT02493660|536568509|FG001|Overall Study|Adverse Event|2|||
148753319|NCT02493660|536568508|FG000|Overall Study|Withdrawal by Subject|2|||
148753320|NCT02493660|536568509|FG001|Overall Study|Withdrawal by Subject|3|||
148753321|NCT02493660|536568508|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
148753322|NCT02493660|536568509|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
148753323|NCT02493660|536568508|FG000|Overall Study|Protocol Violation|0|||
148753324|NCT02493660|536568509|FG001|Overall Study|Protocol Violation|1|||
148753325|NCT02493660|536568508|FG000|Overall Study|Death|0|||
148753326|NCT02493660|536568509|FG001|Overall Study|Death|1|||
148753327|NCT02493660|536568508|FG000|Overall Study|Lost to Follow-up|2|||
148753328|NCT02493660|536568509|FG001|Overall Study|Lost to Follow-up|4|||
148753329|NCT01050530|536568512|FG000|Overall Study|Adverse Event|6|||
148753330|NCT01050530|536568513|FG001|Overall Study|Adverse Event|3|||
148753331|NCT01050530|536568512|FG000|Overall Study|Lack of Efficacy|1|||
148753332|NCT01050530|536568513|FG001|Overall Study|Lack of Efficacy|4|||
148753333|NCT01050530|536568512|FG000|Overall Study|Withdrawal by Subject|0|||
148753334|NCT01050530|536568513|FG001|Overall Study|Withdrawal by Subject|3|||
148753335|NCT01050530|536568512|FG000|Overall Study|Protocol Violation|1|||
148753336|NCT01050530|536568513|FG001|Overall Study|Protocol Violation|0|||
148753337|NCT02288312|536568514|FG000|Overall Study|Pregnancy|1|||
148753338|NCT02288312|536568515|FG001|Overall Study|Pregnancy|0|||
148753339|NCT02288312|536568516|FG002|Overall Study|Pregnancy|0|||
148753340|NCT01276041|536568519|FG000|Overall Study|Adverse Event|2|||
148753341|NCT01276041|536568519|FG000|Overall Study|Protocol Violation|1|||
148753342|NCT00725491|536568520|FG000|Overall Study|Adverse Event|3|||
148753343|NCT00725491|536568521|FG001|Overall Study|Adverse Event|2|||
148753344|NCT00725491|536568520|FG000|Overall Study|Pregnancy|0|||
148753345|NCT00725491|536568521|FG001|Overall Study|Pregnancy|3|||
148753346|NCT00725491|536568520|FG000|Overall Study|Risk for hyperstimulation|2|||
148753347|NCT00725491|536568521|FG001|Overall Study|Risk for hyperstimulation|9|||
148753348|NCT00725491|536568520|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
148753349|NCT00725491|536568521|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
148753350|NCT00725491|536568520|FG000|Overall Study|Fertilization failure|0|||
148753351|NCT00725491|536568521|FG001|Overall Study|Fertilization failure|1|||
148753352|NCT00725491|536568520|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
148753353|NCT00725491|536568521|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
148753354|NCT01778530|536568530|FG000|Overall Study|Progression on study|1|||
148753355|NCT01778530|536568530|FG000|Overall Study|Adverse event/side effect|1|||
148753356|NCT03472014|536568531|FG000|Overall Study|Lost to Follow-up|4|||
148753357|NCT02394600|536568534|FG000|Overall Study|Adverse Event|3|||
148753358|NCT02394600|536568535|FG001|Overall Study|Adverse Event|0|||
148753359|NCT02394600|536568534|FG000|Overall Study|Lost to Follow-up|0|||
148753360|NCT02394600|536568535|FG001|Overall Study|Lost to Follow-up|1|||
148753361|NCT02394600|536568534|FG000|Overall Study|Withdrawal by Subject|0|||
148753362|NCT02394600|536568535|FG001|Overall Study|Withdrawal by Subject|1|||
148976331|NCT05267054|537394516|FG000|Overall Study|Death|13|||
148976332|NCT05267054|537394517|FG001|Overall Study|Death|14|||
148976333|NCT05267054|537394516|FG000|Overall Study|Study Ended by Sponsor|9|||
148753363|NCT02394600|536568534|FG000|Overall Study|Protocol Violation|1|||
148753364|NCT02394600|536568535|FG001|Overall Study|Protocol Violation|0|||
148753365|NCT02569801|536568536|FG000|Overall Study|Withdrawal by Subject|9|||
148753366|NCT02569801|536568537|FG001|Overall Study|Withdrawal by Subject|9|||
148753367|NCT02569801|536568536|FG000|Overall Study|Sponsor Decision|13|||
148753368|NCT02569801|536568537|FG001|Overall Study|Sponsor Decision|14|||
148753369|NCT02569801|536568536|FG000|Overall Study|Progressive Disease|2|||
148753370|NCT02569801|536568537|FG001|Overall Study|Progressive Disease|7|||
148753371|NCT02569801|536568536|FG000|Overall Study|Lost to Follow-up|0|||
148753372|NCT02569801|536568537|FG001|Overall Study|Lost to Follow-up|1|||
148753373|NCT02569801|536568536|FG000|Overall Study|Death|12|||
148753374|NCT02569801|536568537|FG001|Overall Study|Death|4|||
148753375|NCT00428246|536568538|FG000|Overall Study|Withdrawal by Subject|0|||
148753376|NCT00428246|536568539|FG001|Overall Study|Withdrawal by Subject|0|||
148753377|NCT00428246|536568540|FG002|Overall Study|Withdrawal by Subject|1|||
148753378|NCT00428246|536568538|FG000|Overall Study|Adverse Event|1|||
148753379|NCT00428246|536568539|FG001|Overall Study|Adverse Event|0|||
148753380|NCT00428246|536568540|FG002|Overall Study|Adverse Event|0|||
148753381|NCT03442751|536568542|FG000|Overall Study|Withdrawal by Subject|3|||
148753382|NCT03442751|536568543|FG001|Overall Study|Withdrawal by Subject|1|||
148753383|NCT03442751|536568542|FG000|Overall Study|Lost to Follow-up|3|||
148753384|NCT03442751|536568543|FG001|Overall Study|Lost to Follow-up|0|||
148753385|NCT01928472|536568544|FG000|Overall Study|Death|0|||
148753386|NCT01928472|536568545|FG001|Overall Study|Death|0|||
148753387|NCT01928472|536568546|FG002|Overall Study|Death|1|||
148753388|NCT01928472|536568547|FG003|Overall Study|Death|0|||
148753389|NCT01928472|536568544|FG000|Overall Study|Withdrawal by Subject|4|||
148753390|NCT01928472|536568545|FG001|Overall Study|Withdrawal by Subject|4|||
148753391|NCT01928472|536568546|FG002|Overall Study|Withdrawal by Subject|1|||
148753392|NCT01928472|536568547|FG003|Overall Study|Withdrawal by Subject|2|||
148753393|NCT01928472|536568544|FG000|Overall Study|Lost to Follow-up|2|||
148753394|NCT01928472|536568545|FG001|Overall Study|Lost to Follow-up|3|||
148753395|NCT01928472|536568546|FG002|Overall Study|Lost to Follow-up|4|||
148753396|NCT01928472|536568547|FG003|Overall Study|Lost to Follow-up|0|||
148753397|NCT01928472|536568544|FG000|Overall Study|Administrative Reason|2|||
148753398|NCT01928472|536568545|FG001|Overall Study|Administrative Reason|1|||
148753399|NCT01928472|536568546|FG002|Overall Study|Administrative Reason|0|||
148753400|NCT01928472|536568547|FG003|Overall Study|Administrative Reason|0|||
148753401|NCT01928472|536568544|FG000|Overall Study|Unclassified|0|||
148753402|NCT01928472|536568545|FG001|Overall Study|Unclassified|0|||
148753403|NCT01928472|536568546|FG002|Overall Study|Unclassified|1|||
148753404|NCT01928472|536568547|FG003|Overall Study|Unclassified|0|||
148753405|NCT01308424|536568551|FG000|Baseline Eligibility|Screen Failures|71|||
148753406|NCT01308424|536568552|FG001|Baseline Eligibility|Screen Failures|0|||
148753407|NCT01308424|536568553|FG002|Baseline Eligibility|Screen Failures|0|||
148753408|NCT01308424|536568551|FG000|Randomization|Adverse Event|0|||
148753409|NCT01308424|536568552|FG001|Randomization|Adverse Event|1|||
148753410|NCT01308424|536568553|FG002|Randomization|Adverse Event|1|||
148753411|NCT01308424|536568551|FG000|Randomization|Lost to Follow-up|0|||
148753412|NCT01308424|536568552|FG001|Randomization|Lost to Follow-up|1|||
148753413|NCT01308424|536568553|FG002|Randomization|Lost to Follow-up|0|||
148753414|NCT01308424|536568551|FG000|Randomization|Physician Decision|0|||
148753415|NCT01308424|536568552|FG001|Randomization|Physician Decision|1|||
148753416|NCT01308424|536568553|FG002|Randomization|Physician Decision|1|||
148753417|NCT00948155|536568554|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
148753418|NCT00948155|536568555|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
148753419|NCT00948155|536568554|FG000|Washout 14 Days|Lost to Follow-up|1|||
148753420|NCT00948155|536568555|FG001|Washout 14 Days|Lost to Follow-up|2|||
148753421|NCT05767905|536568556|FG000|Overall Study|Adverse Event|0|||
148753422|NCT05767905|536568557|FG001|Overall Study|Adverse Event|0|||
148753423|NCT05767905|536568558|FG002|Overall Study|Adverse Event|1|||
148753424|NCT03125798|536568562|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
148753425|NCT03125798|536568563|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
148753426|NCT03125798|536568562|FG000|Overall Study|Conversion to thoracotomy|7|||
148753427|NCT03125798|536568563|FG001|Overall Study|Conversion to thoracotomy|7|||
148753428|NCT02635984|536568564|FG000|Overall Study|Lost to Follow-up|2|||
148753429|NCT02635984|536568565|FG001|Overall Study|Lost to Follow-up|4|||
148753430|NCT02635984|536568564|FG000|Overall Study|Study Arm Closed|1|||
148753431|NCT02635984|536568565|FG001|Overall Study|Study Arm Closed|0|||
148753432|NCT00312338|536568570|FG000|Overall Study|Adverse Event|7|||
148753433|NCT00312338|536568571|FG001|Overall Study|Adverse Event|2|||
148753434|NCT00312338|536568570|FG000|Overall Study|Lost to Follow-up|9|||
148753435|NCT00312338|536568571|FG001|Overall Study|Lost to Follow-up|1|||
148753436|NCT00312338|536568570|FG000|Overall Study|Withdrawal by Subject|4|||
148753437|NCT00312338|536568571|FG001|Overall Study|Withdrawal by Subject|0|||
148753438|NCT00312338|536568570|FG000|Overall Study|Subsequent infection|2|||
148753439|NCT00312338|536568571|FG001|Overall Study|Subsequent infection|0|||
148753440|NCT01515423|536568572|FG000|Open Label Phase|Adverse Event|57|||
148753441|NCT01515423|536568573|FG001|Open Label Phase|Adverse Event|0|||
148753442|NCT01515423|536568574|FG002|Open Label Phase|Adverse Event|0|||
148753443|NCT01515423|536568572|FG000|Open Label Phase|Death|2|||
148753444|NCT01515423|536568573|FG001|Open Label Phase|Death|0|||
148753445|NCT01515423|536568574|FG002|Open Label Phase|Death|0|||
148753446|NCT01515423|536568572|FG000|Open Label Phase|Lack of Efficacy|117|||
148753447|NCT01515423|536568573|FG001|Open Label Phase|Lack of Efficacy|0|||
148753448|NCT01515423|536568574|FG002|Open Label Phase|Lack of Efficacy|0|||
148753449|NCT01515423|536568572|FG000|Open Label Phase|Lost to Follow-up|21|||
148753450|NCT01515423|536568573|FG001|Open Label Phase|Lost to Follow-up|0|||
148753451|NCT01515423|536568574|FG002|Open Label Phase|Lost to Follow-up|0|||
148753452|NCT01515423|536568572|FG000|Open Label Phase|Withdrawal by Subject|118|||
148753453|NCT01515423|536568573|FG001|Open Label Phase|Withdrawal by Subject|0|||
148753454|NCT01515423|536568574|FG002|Open Label Phase|Withdrawal by Subject|0|||
148753455|NCT01515423|536568572|FG000|Open Label Phase|excluded from DB Phase|70|||
148753456|NCT01515423|536568573|FG001|Open Label Phase|excluded from DB Phase|0|||
148753457|NCT01515423|536568574|FG002|Open Label Phase|excluded from DB Phase|0|||
148753458|NCT01515423|536568572|FG000|Open Label Phase|Other|28|||
148753459|NCT01515423|536568573|FG001|Open Label Phase|Other|0|||
148753460|NCT01515423|536568574|FG002|Open Label Phase|Other|0|||
148753461|NCT01515423|536568572|FG000|DOUBLE BLIND|Adverse Event|0|||
148753462|NCT01515423|536568573|FG001|DOUBLE BLIND|Adverse Event|15|||
148753463|NCT01515423|536568574|FG002|DOUBLE BLIND|Adverse Event|13|||
148753464|NCT01515423|536568572|FG000|DOUBLE BLIND|Death|0|||
148753465|NCT01515423|536568573|FG001|DOUBLE BLIND|Death|1|||
148753466|NCT01515423|536568574|FG002|DOUBLE BLIND|Death|2|||
148753467|NCT01515423|536568572|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
148753468|NCT01515423|536568573|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
148753469|NCT01515423|536568574|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
148753470|NCT01515423|536568572|FG000|DOUBLE BLIND|Pregnancy|0|||
148753471|NCT01515423|536568573|FG001|DOUBLE BLIND|Pregnancy|2|||
148753472|NCT01515423|536568574|FG002|DOUBLE BLIND|Pregnancy|0|||
148753473|NCT01515423|536568572|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
148753474|NCT01515423|536568573|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
148753475|NCT01515423|536568574|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
148753476|NCT01515423|536568572|FG000|DOUBLE BLIND|Other|0|||
148753477|NCT01515423|536568573|FG001|DOUBLE BLIND|Other|6|||
148753478|NCT01515423|536568574|FG002|DOUBLE BLIND|Other|12|||
148753479|NCT01515423|536568572|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
148753480|NCT01515423|536568573|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
148753481|NCT01515423|536568574|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
148753482|NCT00613171|536568586|FG000|Overall Study|Adverse Event|7|||
148753483|NCT00613171|536568586|FG000|Overall Study|Withdrawal by Subject|3|||
148753484|NCT00613171|536568586|FG000|Overall Study|Reason not Specified|4|||
148753485|NCT02501928|536568587|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
148753486|NCT02501928|536568588|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
148753487|NCT02501928|536568589|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
148753488|NCT02501928|536568590|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
148753489|NCT02501928|536568591|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
148753490|NCT02501928|536568592|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
148753491|NCT00951496|536568595|FG000|Overall Study|Did not initiate study treatment|10|||
148753492|NCT00951496|536568596|FG001|Overall Study|Did not initiate study treatment|8|||
148753493|NCT00951496|536568597|FG002|Overall Study|Did not initiate study treatment|13|||
148753494|NCT00838526|536568599|FG000|Overall Study|Adverse Event|3|||
148753495|NCT00838526|536568600|FG001|Overall Study|Adverse Event|12|||
148753496|NCT00838526|536568599|FG000|Overall Study|Lost to Follow-up|4|||
148753497|NCT00838526|536568600|FG001|Overall Study|Lost to Follow-up|12|||
148753498|NCT00838526|536568599|FG000|Overall Study|Withdrawal by Subject|4|||
148753499|NCT00838526|536568600|FG001|Overall Study|Withdrawal by Subject|5|||
148753500|NCT00838526|536568599|FG000|Overall Study|Lack of Efficacy|2|||
148753501|NCT00838526|536568600|FG001|Overall Study|Lack of Efficacy|3|||
148753502|NCT00838526|536568599|FG000|Overall Study|Other|11|||
148753503|NCT00838526|536568600|FG001|Overall Study|Other|7|||
148753504|NCT01526057|536568601|FG000|Overall Study|Withdrawal by Subject|3|||
148753505|NCT01526057|536568602|FG001|Overall Study|Withdrawal by Subject|2|||
148753506|NCT01526057|536568603|FG002|Overall Study|Withdrawal by Subject|2|||
148753507|NCT01526057|536568601|FG000|Overall Study|Adverse Event|3|||
148753508|NCT01526057|536568602|FG001|Overall Study|Adverse Event|1|||
148753509|NCT01526057|536568603|FG002|Overall Study|Adverse Event|1|||
148753510|NCT01526057|536568601|FG000|Overall Study|Death|1|||
148753511|NCT01526057|536568602|FG001|Overall Study|Death|0|||
148753512|NCT01526057|536568603|FG002|Overall Study|Death|0|||
148753513|NCT01526057|536568601|FG000|Overall Study|Lost to Follow-up|1|||
148753514|NCT01526057|536568602|FG001|Overall Study|Lost to Follow-up|0|||
148753515|NCT01526057|536568603|FG002|Overall Study|Lost to Follow-up|1|||
148753516|NCT01526057|536568601|FG000|Overall Study|Other|1|||
148753517|NCT01526057|536568602|FG001|Overall Study|Other|0|||
148753518|NCT01526057|536568603|FG002|Overall Study|Other|1|||
148753519|NCT01526057|536568601|FG000|Overall Study|Protocol Violation|0|||
148753520|NCT01526057|536568602|FG001|Overall Study|Protocol Violation|0|||
148753521|NCT01526057|536568603|FG002|Overall Study|Protocol Violation|1|||
148753522|NCT01169350|536568614|FG000|Overall Study|Physician Decision|3|||
148753523|NCT01169350|536568614|FG000|Overall Study|Lost to Follow-up|2|||
148753524|NCT04870710|536568616|FG000|Overall Study|Lost to Follow-up|3|||
148753525|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
148753526|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
148753527|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
148753528|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
148753529|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
148753530|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
148753531|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
148753532|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
148753533|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
148753534|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
148753535|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
148753536|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
148753537|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
148753538|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
148753539|NCT04338022|536568617|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
148753540|NCT04338022|536568618|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
148753541|NCT04338022|536568617|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
148753542|NCT04338022|536568618|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
148753543|NCT04338022|536568617|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
148753544|NCT04338022|536568618|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
148753545|NCT04338022|536568617|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
148753546|NCT04338022|536568618|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
148753547|NCT04338022|536568617|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
148753548|NCT04338022|536568618|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
148753549|NCT04338022|536568617|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
148753550|NCT04338022|536568618|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
148753551|NCT04338022|536568617|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
148753552|NCT04338022|536568618|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
148753553|NCT02466321|536568620|FG000|Overall Study|Death|26|||
148753554|NCT02466321|536568620|FG000|Overall Study|Revision|6|||
148753555|NCT02466321|536568620|FG000|Overall Study|Lost to Follow-up|60|||
148753556|NCT02466321|536568620|FG000|Overall Study|Did not receive study device|1|||
148753557|NCT01461538|536568628|FG000|Overall Study|Death|15|||
148753558|NCT01461538|536568629|FG001|Overall Study|Death|6|||
148753559|NCT01461538|536568630|FG002|Overall Study|Death|2|||
148753560|NCT01461538|536568628|FG000|Overall Study|Study Stopped by Sponsor|2|||
148753561|NCT01461538|536568629|FG001|Overall Study|Study Stopped by Sponsor|1|||
148753562|NCT01461538|536568630|FG002|Overall Study|Study Stopped by Sponsor|0|||
148753563|NCT01461538|536568628|FG000|Overall Study|Withdrawal by Subject|1|||
148753564|NCT01461538|536568629|FG001|Overall Study|Withdrawal by Subject|1|||
148753565|NCT01461538|536568630|FG002|Overall Study|Withdrawal by Subject|0|||
148753566|NCT03552380|536568631|FG000|Study Treatment|Disease Progression|3|||
148753567|NCT03552380|536568632|FG001|Study Treatment|Disease Progression|4|||
148753568|NCT03552380|536568631|FG000|Study Treatment|Adverse Event|2|||
148753569|NCT03552380|536568632|FG001|Study Treatment|Adverse Event|2|||
148753570|NCT03552380|536568631|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
148753571|NCT03552380|536568632|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
148753572|NCT03552380|536568631|FG000|Follow up|Death|3|||
148753573|NCT03552380|536568632|FG001|Follow up|Death|4|||
148753574|NCT03552380|536568631|FG000|Follow up|Site IRB terminated|0|||
148753575|NCT03552380|536568632|FG001|Follow up|Site IRB terminated|1|||
148753576|NCT03447743|536568633|FG000|Overall Study|Withdrawal by Subject|2|||
148753577|NCT03447743|536568633|FG000|Overall Study|Lost to Follow-up|3|||
148753578|NCT03447743|536568633|FG000|Overall Study|Adverse Event|1|||
148753579|NCT03447743|536568633|FG000|Overall Study|Did not meet criteria to continue|1|||
148753580|NCT02461160|536568634|FG000|Overall Study|Lost to Follow-up|0|||
148753581|NCT02461160|536568635|FG001|Overall Study|Lost to Follow-up|0|||
148753582|NCT02461160|536568636|FG002|Overall Study|Lost to Follow-up|0|||
148753583|NCT02461160|536568637|FG003|Overall Study|Lost to Follow-up|0|||
148753584|NCT02461160|536568638|FG004|Overall Study|Lost to Follow-up|0|||
148753585|NCT02461160|536568639|FG005|Overall Study|Lost to Follow-up|0|||
148753586|NCT02461160|536568640|FG006|Overall Study|Lost to Follow-up|0|||
148753587|NCT02461160|536568641|FG007|Overall Study|Lost to Follow-up|1|||
148753588|NCT02461160|536568642|FG008|Overall Study|Lost to Follow-up|0|||
148753589|NCT02461160|536568643|FG009|Overall Study|Lost to Follow-up|0|||
148753590|NCT02461160|536568644|FG010|Overall Study|Lost to Follow-up|0|||
148753591|NCT02461160|536568645|FG011|Overall Study|Lost to Follow-up|0|||
148753592|NCT02461160|536568646|FG012|Overall Study|Lost to Follow-up|0|||
148753593|NCT00725283|536569982|FG000|Overall Study|Missing Code|3|||
148753594|NCT00725283|536569982|FG000|Overall Study|Death|5|||
148753595|NCT00725283|536569982|FG000|Overall Study|Other|6|||
148753596|NCT00725283|536569982|FG000|Overall Study|Withdrawal by Subject|10|||
148753597|NCT01866826|536569983|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
148753598|NCT01866826|536569984|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
148753599|NCT01866826|536569983|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
148753600|NCT01866826|536569984|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
148753601|NCT01866826|536569983|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
148753602|NCT01866826|536569984|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
148753603|NCT00116779|536569985|FG000|Overall Study|Adverse Event|4|||
148753604|NCT00116779|536569986|FG001|Overall Study|Adverse Event|2|||
148753605|NCT00116779|536569985|FG000|Overall Study|Protocol Violation|1|||
148753606|NCT00116779|536569986|FG001|Overall Study|Protocol Violation|4|||
148753607|NCT00116779|536569985|FG000|Overall Study|Withdrawal by Subject|4|||
148753608|NCT00116779|536569986|FG001|Overall Study|Withdrawal by Subject|1|||
148753609|NCT00116779|536569985|FG000|Overall Study|Inadequate testosterone suppression|7|||
148753610|NCT00116779|536569986|FG001|Overall Study|Inadequate testosterone suppression|9|||
148753611|NCT00116779|536569985|FG000|Overall Study|Physician Decision|3|||
148753612|NCT00116779|536569986|FG001|Overall Study|Physician Decision|1|||
148753613|NCT00116779|536569985|FG000|Overall Study|Elevated PSA levels|2|||
148753614|NCT00116779|536569986|FG001|Overall Study|Elevated PSA levels|2|||
148753615|NCT02687451|536569987|FG000|Overall Study|Withdrawal by Subject|1|||
148753616|NCT02687451|536569988|FG001|Overall Study|Withdrawal by Subject|0|||
148753617|NCT02687451|536569989|FG002|Overall Study|Withdrawal by Subject|0|||
148753618|NCT02687451|536569990|FG003|Overall Study|Withdrawal by Subject|0|||
148753619|NCT02687451|536569991|FG004|Overall Study|Withdrawal by Subject|0|||
148753620|NCT02687451|536569992|FG005|Overall Study|Withdrawal by Subject|1|||
148753621|NCT00707239|536569993|FG000|Overall Study|Adverse Event|5|||
148753622|NCT00707239|536569994|FG001|Overall Study|Adverse Event|3|||
148753623|NCT00707239|536569995|FG002|Overall Study|Adverse Event|2|||
148753624|NCT00707239|536569993|FG000|Overall Study|Death|3|||
148753625|NCT00707239|536569994|FG001|Overall Study|Death|1|||
148753626|NCT00707239|536569995|FG002|Overall Study|Death|3|||
148753627|NCT00707239|536569993|FG000|Overall Study|Physician Decision|1|||
148753628|NCT00707239|536569994|FG001|Overall Study|Physician Decision|1|||
148753629|NCT00707239|536569995|FG002|Overall Study|Physician Decision|2|||
148753630|NCT00707239|536569993|FG000|Overall Study|Protocol Violation|0|||
148753631|NCT00707239|536569994|FG001|Overall Study|Protocol Violation|0|||
148753632|NCT00707239|536569995|FG002|Overall Study|Protocol Violation|1|||
148753633|NCT00707239|536569993|FG000|Overall Study|Lack of Efficacy|1|||
148753634|NCT00707239|536569994|FG001|Overall Study|Lack of Efficacy|2|||
148753635|NCT00707239|536569995|FG002|Overall Study|Lack of Efficacy|0|||
148753636|NCT00707239|536569993|FG000|Overall Study|Randomized, but not treated|1|||
148753637|NCT00707239|536569994|FG001|Overall Study|Randomized, but not treated|1|||
148753638|NCT00707239|536569995|FG002|Overall Study|Randomized, but not treated|1|||
148753639|NCT00707239|536569993|FG000|Overall Study|Other|8|||
148753640|NCT00707239|536569994|FG001|Overall Study|Other|3|||
148753641|NCT00707239|536569995|FG002|Overall Study|Other|5|||
148753642|NCT00711087|536570000|FG000|Overall Study|Lost to Follow-up|1|||
148753643|NCT00711087|536570001|FG001|Overall Study|Lost to Follow-up|0|||
148753644|NCT03652051|536570002|FG000|Stage 1|Adverse Event|0|||
148753645|NCT03652051|536570003|FG001|Stage 1|Adverse Event|5|||
148753646|NCT03652051|536570004|FG002|Stage 1|Adverse Event|7|||
148753647|NCT03652051|536570005|FG003|Stage 1|Adverse Event|1|||
148753648|NCT03652051|536570002|FG000|Stage 1|Withdrawal by Subject|0|||
148753649|NCT03652051|536570003|FG001|Stage 1|Withdrawal by Subject|0|||
148753650|NCT03652051|536570004|FG002|Stage 1|Withdrawal by Subject|1|||
148753651|NCT03652051|536570005|FG003|Stage 1|Withdrawal by Subject|0|||
148753652|NCT03652051|536570002|FG000|Stage 2|Adverse Event|0|||
148753653|NCT03652051|536570003|FG001|Stage 2|Adverse Event|2|||
148753654|NCT03652051|536570004|FG002|Stage 2|Adverse Event|1|||
148753655|NCT03652051|536570005|FG003|Stage 2|Adverse Event|0|||
148753656|NCT03652051|536570002|FG000|Stage 2|Protocol Violation|0|||
148753657|NCT03652051|536570003|FG001|Stage 2|Protocol Violation|1|||
148753658|NCT03652051|536570004|FG002|Stage 2|Protocol Violation|6|||
148753659|NCT03652051|536570005|FG003|Stage 2|Protocol Violation|0|||
148753660|NCT03652051|536570002|FG000|Stage 2|Lost to Follow-up|0|||
148753661|NCT03652051|536570003|FG001|Stage 2|Lost to Follow-up|2|||
149027401|NCT00293462|537578554|FG000|Overall Study|Low radiation dose in oral cavity|0|||
148753662|NCT03652051|536570004|FG002|Stage 2|Lost to Follow-up|0|||
148753663|NCT03652051|536570005|FG003|Stage 2|Lost to Follow-up|3|||
148753664|NCT03652051|536570002|FG000|Stage 2|Withdrawal by Subject|0|||
148753665|NCT03652051|536570003|FG001|Stage 2|Withdrawal by Subject|11|||
148753666|NCT03652051|536570004|FG002|Stage 2|Withdrawal by Subject|9|||
148753667|NCT03652051|536570005|FG003|Stage 2|Withdrawal by Subject|3|||
148753668|NCT01958437|536570006|FG000|Overall Study|Incidental MRI findings|0|||
148753669|NCT01958437|536570007|FG001|Overall Study|Incidental MRI findings|0|||
148753670|NCT01958437|536570008|FG002|Overall Study|Incidental MRI findings|1|||
148753671|NCT01958437|536570009|FG003|Overall Study|Incidental MRI findings|1|||
148753672|NCT02603887|536570015|FG000|Stage 1|Adverse Event|4|||
148753673|NCT02603887|536570015|FG000|Stage 1|Disease progression|1|||
148753674|NCT02603887|536570015|FG000|Stage 2|FDA guidance|1|||
148753675|NCT04620746|536570016|FG000|Overall Study|Adverse Event|2|||
148753676|NCT04620746|536570017|FG001|Overall Study|Adverse Event|0|||
148753677|NCT04620746|536570016|FG000|Overall Study|Uniterpretable skin test|1|||
148753678|NCT04620746|536570017|FG001|Overall Study|Uniterpretable skin test|0|||
148976334|NCT05267054|537394517|FG001|Overall Study|Study Ended by Sponsor|13|||
148976335|NCT05267054|537394516|FG000|Overall Study|Lost to Follow-up|1|||
148976336|NCT05267054|537394517|FG001|Overall Study|Lost to Follow-up|1|||
148976337|NCT05267054|537394516|FG000|Overall Study|Withdrawal by Subject|1|||
148753679|NCT04620746|536570016|FG000|Overall Study|Withdrawal by Subject|0|||
148753680|NCT04620746|536570017|FG001|Overall Study|Withdrawal by Subject|1|||
148753681|NCT03473925|536570018|FG000|Overall Study|Death|48|||
148753682|NCT03473925|536570019|FG001|Overall Study|Death|44|||
148753683|NCT03473925|536570018|FG000|Overall Study|Sponsor Decision|2|||
148753684|NCT03473925|536570019|FG001|Overall Study|Sponsor Decision|7|||
148753685|NCT03473925|536570018|FG000|Overall Study|Withdrawal by Subject|1|||
148753686|NCT03473925|536570019|FG001|Overall Study|Withdrawal by Subject|3|||
148753687|NCT03473925|536570018|FG000|Overall Study|Not Treated|1|||
148753688|NCT03473925|536570019|FG001|Overall Study|Not Treated|1|||
148753689|NCT03411863|536570020|FG000|Overall Study|Withdrawal by Subject|3|||
148753690|NCT03411863|536570021|FG001|Overall Study|Withdrawal by Subject|1|||
148753691|NCT03411863|536570020|FG000|Overall Study|Physician Decision|0|||
148753692|NCT03411863|536570021|FG001|Overall Study|Physician Decision|1|||
148753693|NCT03535740|536570024|FG000|Overall Study|Death|44|||
148753694|NCT03535740|536570024|FG000|Overall Study|Lost to Follow-up|1|||
148753695|NCT03535740|536570024|FG000|Overall Study|Withdrawal by Subject|13|||
148753696|NCT03535740|536570024|FG000|Overall Study|Site terminated by Sponsor|45|||
148753697|NCT05198518|536570027|FG000|Screening Visit|Deemed unable to participate|58|||
148753698|NCT05198518|536570028|FG001|Screening Visit|Deemed unable to participate|0|||
148753699|NCT05198518|536570029|FG002|Screening Visit|Deemed unable to participate|0|||
148753700|NCT01841593|536570032|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
148753701|NCT01841593|536570033|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
148753702|NCT01841593|536570032|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
148753703|NCT01841593|536570033|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
148753704|NCT00124917|536570034|FG000|Overall Study|Physician Decision|3|||
148753705|NCT03518008|536570035|FG000|Period 2, Second Week of Wear|Family emergency|0|||
148753706|NCT03518008|536570036|FG001|Period 2, Second Week of Wear|Family emergency|1|||
148753707|NCT03164551|536570037|FG000|Overall Study|Imaging discontinued prior completion|8|||
148753708|NCT03164551|536570038|FG001|Overall Study|Imaging discontinued prior completion|0|||
148753709|NCT03164551|536570037|FG000|Overall Study|Participant was non-compliant|1|||
148753710|NCT03164551|536570038|FG001|Overall Study|Participant was non-compliant|0|||
148753711|NCT03164551|536570037|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
148753712|NCT03164551|536570038|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
148753713|NCT03164551|536570037|FG000|Overall Study|Other|8|||
148753714|NCT03164551|536570038|FG001|Overall Study|Other|2|||
148753715|NCT02189837|536570043|FG000|Overall Study|Withdrawal by Subject|2|||
148753716|NCT02189837|536570044|FG001|Overall Study|Withdrawal by Subject|1|||
148753717|NCT02189837|536570045|FG002|Overall Study|Withdrawal by Subject|3|||
148753718|NCT02189837|536570046|FG003|Overall Study|Withdrawal by Subject|1|||
148753719|NCT02189837|536570043|FG000|Overall Study|Sponsor Decision|0|||
148753720|NCT02189837|536570044|FG001|Overall Study|Sponsor Decision|0|||
148753721|NCT02189837|536570045|FG002|Overall Study|Sponsor Decision|0|||
148753722|NCT02189837|536570046|FG003|Overall Study|Sponsor Decision|1|||
148753723|NCT02198963|536570050|FG000|Overall Study|Adverse Event|1|||
148753724|NCT02198963|536570050|FG000|Overall Study|Withdrawal by Subject|6|||
148753725|NCT01876446|536570051|FG000|Overall Study|Death|0|||
148753726|NCT01876446|536570052|FG001|Overall Study|Death|1|||
148753727|NCT01876446|536570051|FG000|Overall Study|Withdrawal by Subject|1|||
148753728|NCT01876446|536570052|FG001|Overall Study|Withdrawal by Subject|2|||
148753729|NCT01876446|536570051|FG000|Overall Study|Physician Decision|1|||
148753730|NCT01876446|536570052|FG001|Overall Study|Physician Decision|3|||
148753731|NCT00822692|536570062|FG000|Overall Study|Lost to Follow-up|17|||
148976338|NCT05267054|537394517|FG001|Overall Study|Withdrawal by Subject|1|||
148976339|NCT01552226|537394523|FG000|Overall Study|Withdrawal by Subject|4|||
148976340|NCT01552226|537394524|FG001|Overall Study|Withdrawal by Subject|4|||
148753732|NCT00822692|536570063|FG001|Overall Study|Lost to Follow-up|25|||
148976341|NCT03604692|537394525|FG000|Overall Study|Investigator's Decision|0|||
148753733|NCT03281876|536570065|FG000|Overall Study|Adverse Event|4|||
148753734|NCT03281876|536570066|FG001|Overall Study|Adverse Event|15|||
148753735|NCT03281876|536570065|FG000|Overall Study|Lost to Follow-up|1|||
148753736|NCT03281876|536570066|FG001|Overall Study|Lost to Follow-up|4|||
148753737|NCT03281876|536570065|FG000|Overall Study|Withdrawal by Subject|11|||
148753738|NCT03281876|536570066|FG001|Overall Study|Withdrawal by Subject|15|||
148753739|NCT03281876|536570065|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
148976342|NCT03604692|537394526|FG001|Overall Study|Investigator's Decision|0|||
148753740|NCT03281876|536570066|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148753741|NCT03281876|536570065|FG000|Overall Study|OTHER|5|||
148753742|NCT03281876|536570066|FG001|Overall Study|OTHER|5|||
148753743|NCT02208089|536570067|FG000|Overall Study|Withdrawal by Subject|1|||
148753744|NCT02208089|536570068|FG001|Overall Study|Withdrawal by Subject|0|||
148753745|NCT02208089|536570067|FG000|Overall Study|Lost to Follow-up|6|||
148753746|NCT02208089|536570068|FG001|Overall Study|Lost to Follow-up|0|||
148753747|NCT00683657|536570071|FG000|Overall Study|Adverse Event|0|||
148753748|NCT00683657|536570072|FG001|Overall Study|Adverse Event|1|||
148753749|NCT00683657|536570071|FG000|Overall Study|Subject Withdrew Consent|1|||
148753750|NCT00683657|536570072|FG001|Overall Study|Subject Withdrew Consent|0|||
148753751|NCT03200717|536570078|FG000|Overall Study|Progressive disease|24|||
148753752|NCT03200717|536570079|FG001|Overall Study|Progressive disease|5|||
148753753|NCT03200717|536570078|FG000|Overall Study|Adverse Event|11|||
148753754|NCT03200717|536570079|FG001|Overall Study|Adverse Event|8|||
148753755|NCT03200717|536570078|FG000|Overall Study|Physician Decision|3|||
148753756|NCT03200717|536570079|FG001|Overall Study|Physician Decision|2|||
148753757|NCT03200717|536570078|FG000|Overall Study|Death|2|||
148753758|NCT03200717|536570079|FG001|Overall Study|Death|0|||
148753759|NCT03200717|536570078|FG000|Overall Study|Subject/Guardian Decision|1|||
148753760|NCT03200717|536570079|FG001|Overall Study|Subject/Guardian Decision|0|||
148753761|NCT03629184|536570080|FG000|Overall Study|Withdrawal by Subject|2|||
148753762|NCT03629184|536570081|FG001|Overall Study|Withdrawal by Subject|1|||
148753763|NCT03629184|536570080|FG000|Overall Study|Physician Decision|1|||
148753764|NCT03629184|536570081|FG001|Overall Study|Physician Decision|0|||
148753765|NCT02046603|536570083|FG000|Overall Study|Other|11|||
148753766|NCT02046603|536570084|FG001|Overall Study|Other|66|||
148753767|NCT02046603|536570083|FG000|Overall Study|Protocol Violation|0|||
148753768|NCT02046603|536570084|FG001|Overall Study|Protocol Violation|1|||
148753769|NCT02046603|536570083|FG000|Overall Study|Participant/legal guardian decision|1|||
148753770|NCT02046603|536570084|FG001|Overall Study|Participant/legal guardian decision|3|||
148753771|NCT02046603|536570083|FG000|Overall Study|Physician Decision|2|||
148753772|NCT02046603|536570084|FG001|Overall Study|Physician Decision|1|||
148753773|NCT02046603|536570083|FG000|Overall Study|Lost to Follow-up|1|||
148753774|NCT02046603|536570084|FG001|Overall Study|Lost to Follow-up|2|||
148753775|NCT02046603|536570083|FG000|Overall Study|Death|0|||
148753776|NCT02046603|536570084|FG001|Overall Study|Death|1|||
148753777|NCT02046603|536570083|FG000|Overall Study|Adverse Event|0|||
148753778|NCT02046603|536570084|FG001|Overall Study|Adverse Event|1|||
148753779|NCT01112059|536570085|FG000|Overall Study|Withdrawal by Subject|1|||
148753780|NCT01112059|536570086|FG001|Overall Study|Withdrawal by Subject|0|||
148753781|NCT03567980|536570089|FG000|Overall Study|Adverse Event|1|||
148753782|NCT02575833|536570090|FG000|Overall Study|Withdrawal by Subject|0|||
148753783|NCT02575833|536570091|FG001|Overall Study|Withdrawal by Subject|1|||
148753784|NCT02575833|536570090|FG000|Overall Study|Lost to Follow-up|1|||
148753785|NCT02575833|536570091|FG001|Overall Study|Lost to Follow-up|0|||
148753786|NCT02633787|536570092|FG000|Overall Study|Withdrawal by Subject|1|||
148753787|NCT01742897|536570093|FG000|Overall Study|Adverse Event|3|||
148753788|NCT01742897|536570093|FG000|Overall Study|Withdrawal by Subject|1|||
148753789|NCT01742897|536570093|FG000|Overall Study|Other|1|||
148753790|NCT00967330|536570096|FG000|Overall Study|Protocol Violation|3|||
148753791|NCT00967330|536570097|FG001|Overall Study|Protocol Violation|4|||
148753792|NCT00967330|536570096|FG000|Overall Study|Regular|10|||
148753793|NCT00967330|536570097|FG001|Overall Study|Regular|3|||
148753794|NCT00967330|536570096|FG000|Overall Study|Withdrawal by Subject|6|||
148753795|NCT00967330|536570097|FG001|Overall Study|Withdrawal by Subject|0|||
148753796|NCT00967330|536570096|FG000|Overall Study|Lost to Follow-up|1|||
148753797|NCT00967330|536570097|FG001|Overall Study|Lost to Follow-up|1|||
148753798|NCT00967330|536570096|FG000|Overall Study|Death|102|||
148753799|NCT00967330|536570097|FG001|Overall Study|Death|51|||
148753800|NCT00967330|536570096|FG000|Overall Study|Severe protocol deviation|0|||
148753801|NCT00967330|536570097|FG001|Overall Study|Severe protocol deviation|1|||
148753802|NCT00349973|536570101|FG000|Overall Study|Adverse Event|3|||
148753803|NCT00349973|536570102|FG001|Overall Study|Adverse Event|3|||
148753804|NCT00349973|536570101|FG000|Overall Study|Withdrawal by Subject|1|||
148753805|NCT00349973|536570102|FG001|Overall Study|Withdrawal by Subject|0|||
148753806|NCT05620082|536570103|FG000|Overall Study|Discharged before study end|1|||
148753807|NCT05620082|536570104|FG001|Overall Study|Discharged before study end|4|||
148753808|NCT05620082|536570105|FG002|Overall Study|Discharged before study end|0|||
148753809|NCT05620082|536570103|FG000|Overall Study|Moved to a different ward|1|||
148753810|NCT05620082|536570104|FG001|Overall Study|Moved to a different ward|0|||
148753811|NCT05620082|536570105|FG002|Overall Study|Moved to a different ward|0|||
148753812|NCT05620082|536570103|FG000|Overall Study|Feeling too unwell|1|||
148753813|NCT05620082|536570104|FG001|Overall Study|Feeling too unwell|0|||
148753814|NCT05620082|536570105|FG002|Overall Study|Feeling too unwell|0|||
148753815|NCT01557504|536571698|FG000|Overall Study|Physician Decision|1|||
148753816|NCT01557504|536571699|FG001|Overall Study|Physician Decision|0|||
148753817|NCT02750618|536571702|FG000|Overall Study|Withdrawal by Subject|1|||
148753818|NCT02572570|536571703|FG000|Overall Study|Study Terminated|27|||
148753819|NCT01417156|536571704|FG000|Overall Study|Adverse Event|12|||
148753820|NCT01417156|536571704|FG000|Overall Study|Protocol Violation|2|||
148753821|NCT01103180|536571708|FG000|Overall Study|Withdrawal by Subject|8|||
148753822|NCT01103180|536571709|FG001|Overall Study|Withdrawal by Subject|13|||
148753823|NCT01103180|536571708|FG000|Overall Study|Lost to Follow-up|13|||
148753824|NCT01103180|536571709|FG001|Overall Study|Lost to Follow-up|7|||
148753825|NCT01103180|536571708|FG000|Overall Study|Physician Decision|1|||
148753826|NCT01103180|536571709|FG001|Overall Study|Physician Decision|0|||
148753827|NCT01103180|536571708|FG000|Overall Study|Protocol Violation|0|||
148753828|NCT01103180|536571709|FG001|Overall Study|Protocol Violation|1|||
148753829|NCT00742209|536571713|FG000|Overall Study|Adverse Event|11|||
148753830|NCT00742209|536571714|FG001|Overall Study|Adverse Event|4|||
148753831|NCT00742209|536571715|FG002|Overall Study|Adverse Event|17|||
148753832|NCT00742209|536571716|FG003|Overall Study|Adverse Event|16|||
148753833|NCT00742209|536571717|FG004|Overall Study|Adverse Event|13|||
148753834|NCT00742209|536571713|FG000|Overall Study|Participant Withdrew Consent|8|||
148753835|NCT00742209|536571714|FG001|Overall Study|Participant Withdrew Consent|4|||
148753836|NCT00742209|536571715|FG002|Overall Study|Participant Withdrew Consent|14|||
148753837|NCT00742209|536571716|FG003|Overall Study|Participant Withdrew Consent|7|||
148753838|NCT00742209|536571717|FG004|Overall Study|Participant Withdrew Consent|4|||
148753839|NCT00742209|536571713|FG000|Overall Study|Protocol Violation|6|||
148753840|NCT00742209|536571714|FG001|Overall Study|Protocol Violation|5|||
148753841|NCT00742209|536571715|FG002|Overall Study|Protocol Violation|4|||
148753842|NCT00742209|536571716|FG003|Overall Study|Protocol Violation|5|||
148753843|NCT00742209|536571717|FG004|Overall Study|Protocol Violation|3|||
148753844|NCT00742209|536571713|FG000|Overall Study|Lost to Follow-up|3|||
148753845|NCT00742209|536571714|FG001|Overall Study|Lost to Follow-up|4|||
148753846|NCT00742209|536571715|FG002|Overall Study|Lost to Follow-up|5|||
148753847|NCT00742209|536571716|FG003|Overall Study|Lost to Follow-up|5|||
148753848|NCT00742209|536571717|FG004|Overall Study|Lost to Follow-up|3|||
148753849|NCT00742209|536571713|FG000|Overall Study|Lack of Efficacy|6|||
148753850|NCT00742209|536571714|FG001|Overall Study|Lack of Efficacy|1|||
148753851|NCT00742209|536571715|FG002|Overall Study|Lack of Efficacy|1|||
148753852|NCT00742209|536571716|FG003|Overall Study|Lack of Efficacy|3|||
148753853|NCT00742209|536571717|FG004|Overall Study|Lack of Efficacy|1|||
148753854|NCT00742209|536571713|FG000|Overall Study|Investigator Discretion|0|||
148753855|NCT00742209|536571714|FG001|Overall Study|Investigator Discretion|0|||
148753856|NCT00742209|536571715|FG002|Overall Study|Investigator Discretion|5|||
148753857|NCT00742209|536571716|FG003|Overall Study|Investigator Discretion|1|||
148753858|NCT00742209|536571717|FG004|Overall Study|Investigator Discretion|1|||
148753859|NCT00882518|536571718|FG000|Overall Study|Adverse Event|9|||
148753860|NCT00882518|536571719|FG001|Overall Study|Adverse Event|18|||
148753861|NCT00882518|536571718|FG000|Overall Study|Withdrawal by Subject|9|||
148753862|NCT00882518|536571719|FG001|Overall Study|Withdrawal by Subject|13|||
148753863|NCT00882518|536571718|FG000|Overall Study|Lack of Efficacy|12|||
148753864|NCT00882518|536571719|FG001|Overall Study|Lack of Efficacy|9|||
148753865|NCT00882518|536571718|FG000|Overall Study|Severe non-compliance to protocol|3|||
148753866|NCT00882518|536571719|FG001|Overall Study|Severe non-compliance to protocol|1|||
148753867|NCT00882518|536571718|FG000|Overall Study|Incorrect enrolment|4|||
148753868|NCT00882518|536571719|FG001|Overall Study|Incorrect enrolment|2|||
148753869|NCT00882518|536571718|FG000|Overall Study|Central lab closure for National day|1|||
148753870|NCT00882518|536571719|FG001|Overall Study|Central lab closure for National day|0|||
148753871|NCT00882518|536571718|FG000|Overall Study|Allocating random number by mistake|0|||
148753872|NCT00882518|536571719|FG001|Overall Study|Allocating random number by mistake|1|||
148753873|NCT03238651|536571720|FG000|Overall Study|Other|0|||
148753874|NCT03238651|536571721|FG001|Overall Study|Other|0|||
148753875|NCT03238651|536571722|FG002|Overall Study|Other|0|||
148753876|NCT03238651|536571723|FG003|Overall Study|Other|0|||
148753877|NCT03238651|536571724|FG004|Overall Study|Other|1|||
148753878|NCT03238651|536571720|FG000|Overall Study|Progressive Disease|2|||
148753879|NCT03238651|536571721|FG001|Overall Study|Progressive Disease|2|||
148753880|NCT03238651|536571722|FG002|Overall Study|Progressive Disease|2|||
148753881|NCT03238651|536571723|FG003|Overall Study|Progressive Disease|2|||
148753882|NCT03238651|536571724|FG004|Overall Study|Progressive Disease|0|||
148753883|NCT03238651|536571720|FG000|Overall Study|Withdrawal by Subject|0|||
148753884|NCT03238651|536571721|FG001|Overall Study|Withdrawal by Subject|1|||
148753885|NCT03238651|536571722|FG002|Overall Study|Withdrawal by Subject|0|||
148753886|NCT03238651|536571723|FG003|Overall Study|Withdrawal by Subject|1|||
148753887|NCT03238651|536571724|FG004|Overall Study|Withdrawal by Subject|0|||
148753888|NCT03238651|536571720|FG000|Overall Study|Adverse Event|1|||
148753889|NCT03238651|536571721|FG001|Overall Study|Adverse Event|3|||
148753890|NCT03238651|536571722|FG002|Overall Study|Adverse Event|2|||
148753891|NCT03238651|536571723|FG003|Overall Study|Adverse Event|0|||
148753892|NCT03238651|536571724|FG004|Overall Study|Adverse Event|0|||
148753893|NCT03743051|536571725|FG000|Overall Study|Adverse Event|5|||
148753894|NCT03743051|536571726|FG001|Overall Study|Adverse Event|9|||
148753895|NCT03743051|536571725|FG000|Overall Study|Death|27|||
148753896|NCT03743051|536571726|FG001|Overall Study|Death|26|||
148753897|NCT03743051|536571725|FG000|Overall Study|Lost to Follow-up|4|||
148753898|NCT03743051|536571726|FG001|Overall Study|Lost to Follow-up|8|||
148753899|NCT03743051|536571725|FG000|Overall Study|Withdrawal by Subject|32|||
148753900|NCT03743051|536571726|FG001|Overall Study|Withdrawal by Subject|19|||
148753901|NCT03743051|536571725|FG000|Overall Study|Physician Decision|10|||
148753902|NCT03743051|536571726|FG001|Overall Study|Physician Decision|15|||
148753903|NCT03743051|536571725|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
148753904|NCT03743051|536571726|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
148753905|NCT00840749|536571729|FG000|Overall Study|Death|1|||
148753906|NCT00840749|536571730|FG001|Overall Study|Death|2|||
148753907|NCT00840749|536571729|FG000|Overall Study|not treated on study arm|11|||
148753908|NCT00840749|536571730|FG001|Overall Study|not treated on study arm|11|||
148753909|NCT00840749|536571729|FG000|Overall Study|study closed|19|||
148753910|NCT00840749|536571730|FG001|Overall Study|study closed|14|||
148753911|NCT01113892|536571735|FG000|Overall Study|Lost to Follow-up|2|||
148753912|NCT01113892|536571736|FG001|Overall Study|Lost to Follow-up|2|||
148753913|NCT01113892|536571735|FG000|Overall Study|Withdrawal by Subject|1|||
148753914|NCT01113892|536571736|FG001|Overall Study|Withdrawal by Subject|1|||
148753915|NCT01113892|536571735|FG000|Overall Study|Death|2|||
148753916|NCT01113892|536571736|FG001|Overall Study|Death|4|||
148753917|NCT01113892|536571735|FG000|Overall Study|Graft no longer evaluable|9|||
148753918|NCT01113892|536571736|FG001|Overall Study|Graft no longer evaluable|9|||
148753919|NCT04886596|536571737|FG000|Overall Study|Adverse Event|442|||
148753920|NCT04886596|536571738|FG001|Overall Study|Adverse Event|441|||
148753921|NCT04886596|536571737|FG000|Overall Study|Lost to Follow-up|448|||
148753922|NCT04886596|536571738|FG001|Overall Study|Lost to Follow-up|465|||
148753923|NCT04886596|536571737|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
148753924|NCT04886596|536571738|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
148753925|NCT04886596|536571737|FG000|Overall Study|Migrated/moved from the study area|201|||
148753926|NCT04886596|536571738|FG001|Overall Study|Migrated/moved from the study area|184|||
148753927|NCT04886596|536571737|FG000|Overall Study|Other|298|||
148753928|NCT04886596|536571738|FG001|Overall Study|Other|326|||
148753929|NCT02766335|536571739|FG000|Initial Registration|Adverse Event|6|||
148753930|NCT02766335|536571740|FG001|Initial Registration|Adverse Event|3|||
148753931|NCT02766335|536571741|FG002|Initial Registration|Adverse Event|0|||
148753932|NCT02766335|536571739|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
148753933|NCT02766335|536571740|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
148753934|NCT02766335|536571741|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
148753935|NCT02766335|536571739|FG000|Initial Registration|Progression/relapse|49|||
148753936|NCT02766335|536571740|FG001|Initial Registration|Progression/relapse|15|||
148753937|NCT02766335|536571741|FG002|Initial Registration|Progression/relapse|0|||
148753938|NCT02766335|536571739|FG000|Initial Registration|Death|1|||
148753939|NCT02766335|536571740|FG001|Initial Registration|Death|3|||
148753940|NCT02766335|536571741|FG002|Initial Registration|Death|0|||
148753941|NCT02766335|536571739|FG000|Initial Registration|not protocol specified|1|||
148753942|NCT02766335|536571740|FG001|Initial Registration|not protocol specified|9|||
148753943|NCT02766335|536571741|FG002|Initial Registration|not protocol specified|0|||
148753944|NCT02766335|536571739|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
148753945|NCT02766335|536571740|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
148753946|NCT02766335|536571741|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
148753947|NCT02766335|536571739|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
148753948|NCT02766335|536571740|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
148753949|NCT02766335|536571741|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
148753950|NCT03645863|536571743|FG000|Overall Study|Withdrawal by Subject|1|||
148753951|NCT03645863|536571744|FG001|Overall Study|Withdrawal by Subject|0|||
148753952|NCT03645863|536571745|FG002|Overall Study|Withdrawal by Subject|0|||
148753953|NCT02756611|536571746|FG000|Overall Study|Death|70|||
148753954|NCT02756611|536571746|FG000|Overall Study|Withdrawal by Subject|2|||
148753955|NCT02756611|536571746|FG000|Overall Study|Lost to Follow-up|3|||
148753956|NCT02756611|536571746|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
148753957|NCT02756611|536571746|FG000|Overall Study|Other|10|||
148753958|NCT00476190|536571754|FG000|Overall Study|Ineligible|1|||
148753959|NCT00476190|536571755|FG001|Overall Study|Ineligible|1|||
148753960|NCT00476190|536571754|FG000|Overall Study|Induction Death|2|||
148753961|NCT00476190|536571755|FG001|Overall Study|Induction Death|0|||
148753962|NCT00476190|536571754|FG000|Overall Study|Induction Failure|2|||
148753963|NCT00476190|536571755|FG001|Overall Study|Induction Failure|4|||
148753964|NCT00476190|536571754|FG000|Overall Study|Lost to Follow-up|1|||
148753965|NCT00476190|536571755|FG001|Overall Study|Lost to Follow-up|0|||
148822982|NCT01557244|536830722|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
148822983|NCT01557244|536830723|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
148753966|NCT00476190|536571754|FG000|Overall Study|Relapse/Progression|5|||
148753967|NCT00476190|536571755|FG001|Overall Study|Relapse/Progression|2|||
148753968|NCT00476190|536571754|FG000|Overall Study|Remission Death|0|||
148753969|NCT00476190|536571755|FG001|Overall Study|Remission Death|1|||
148753970|NCT00476190|536571754|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
148753971|NCT00476190|536571755|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
148753972|NCT00476190|536571754|FG000|Overall Study|Withdrawal by Subject|6|||
148753973|NCT00476190|536571755|FG001|Overall Study|Withdrawal by Subject|2|||
148753974|NCT00476190|536571754|FG000|Overall Study|Other|9|||
148753975|NCT00476190|536571755|FG001|Overall Study|Other|10|||
148753976|NCT04782076|536571758|FG000|Overall Study|Family Emergency|1|||
148753977|NCT02860546|536571763|FG000|Overall Study|Clinical Progression|6|||
148753978|NCT02860546|536571763|FG000|Overall Study|Radiological Progression|12|||
148753979|NCT00281957|536571764|FG000|Overall Study|Adverse Event|7|||
148753980|NCT00281957|536571765|FG001|Overall Study|Adverse Event|2|||
148753981|NCT00281957|536571764|FG000|Overall Study|Death|1|||
148753982|NCT00281957|536571765|FG001|Overall Study|Death|0|||
148753983|NCT00281957|536571764|FG000|Overall Study|Progression/relapse|47|||
148753984|NCT00281957|536571765|FG001|Overall Study|Progression/relapse|35|||
148753985|NCT00281957|536571764|FG000|Overall Study|Not protocol specified|8|||
148753986|NCT00281957|536571765|FG001|Overall Study|Not protocol specified|1|||
148753987|NCT00281957|536571764|FG000|Overall Study|Not eligible|1|||
148753988|NCT00281957|536571765|FG001|Overall Study|Not eligible|2|||
148753989|NCT00281957|536571764|FG000|Overall Study|Did not start treatment|3|||
148753990|NCT00281957|536571765|FG001|Overall Study|Did not start treatment|1|||
148753991|NCT00281957|536571764|FG000|Overall Study|Refusal unrelated to adverse events|0|||
148753992|NCT00281957|536571765|FG001|Overall Study|Refusal unrelated to adverse events|1|||
148753993|NCT02443740|536571766|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
148753994|NCT02443740|536571767|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
148753995|NCT02443740|536571768|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
148753996|NCT02443740|536571769|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
148753997|NCT02443740|536571770|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
148753998|NCT02443740|536571771|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
148753999|NCT02443740|536571772|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
148754000|NCT02443740|536571773|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
148754001|NCT02443740|536571774|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
148754002|NCT02443740|536571775|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
148754003|NCT02443740|536571776|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
148754004|NCT02443740|536571766|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
148754005|NCT02443740|536571767|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754006|NCT02443740|536571768|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754007|NCT02443740|536571769|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754008|NCT02443740|536571770|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754009|NCT02443740|536571771|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754010|NCT02443740|536571772|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
148754011|NCT02443740|536571773|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754012|NCT02443740|536571774|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754013|NCT02443740|536571775|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754014|NCT02443740|536571776|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
148754015|NCT02443740|536571766|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754016|NCT02443740|536571767|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754017|NCT02443740|536571768|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754018|NCT02443740|536571769|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754019|NCT02443740|536571770|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754020|NCT02443740|536571771|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
148754021|NCT02443740|536571772|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754022|NCT02443740|536571773|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754023|NCT02443740|536571774|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754024|NCT02443740|536571775|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754025|NCT02443740|536571776|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
148754026|NCT00456300|536571777|FG000|Overall Study|Adverse Event|1|||
148754027|NCT00456300|536571778|FG001|Overall Study|Adverse Event|0|||
148754028|NCT02452476|536571780|FG000|Overall Study|Death|4|||
148754029|NCT02452476|536571781|FG001|Overall Study|Death|7|||
148754030|NCT02452476|536571780|FG000|Overall Study|Lost to Follow-up|1|||
148754031|NCT02452476|536571781|FG001|Overall Study|Lost to Follow-up|1|||
148754032|NCT02452476|536571780|FG000|Overall Study|Physician Decision|1|||
148754033|NCT02452476|536571781|FG001|Overall Study|Physician Decision|1|||
148754034|NCT02452476|536571780|FG000|Overall Study|Not treated|5|||
148754035|NCT02452476|536571781|FG001|Overall Study|Not treated|1|||
148754036|NCT01074944|536571782|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
148754037|NCT01074944|536571783|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
148754038|NCT01074944|536571784|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
148754039|NCT01074944|536571785|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
148754040|NCT01074944|536571786|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
148754041|NCT01074944|536571782|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
148754042|NCT01074944|536571783|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
148754043|NCT01074944|536571784|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
148754044|NCT01074944|536571785|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
148754045|NCT01074944|536571786|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
148754046|NCT01074944|536571782|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
148754047|NCT01074944|536571783|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
148754048|NCT01074944|536571784|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
148754049|NCT01074944|536571785|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
148754050|NCT01074944|536571786|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
148754051|NCT01074944|536571782|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
148754052|NCT01074944|536571783|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
148754053|NCT01074944|536571784|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
148754054|NCT01074944|536571785|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
148754055|NCT01074944|536571786|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
148754056|NCT01074944|536571782|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
148754057|NCT01074944|536571783|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
148754058|NCT01074944|536571784|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
148754059|NCT01074944|536571785|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
148754060|NCT01074944|536571786|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
148754061|NCT01074944|536571782|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
148754062|NCT01074944|536571783|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
148754063|NCT01074944|536571784|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
148754064|NCT01074944|536571785|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
148754065|NCT01074944|536571786|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
148754066|NCT01074944|536571782|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
148754067|NCT01074944|536571783|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
148754068|NCT01074944|536571784|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
148754069|NCT01074944|536571785|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
148754070|NCT01074944|536571786|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
148754071|NCT01074944|536571782|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
148754072|NCT01074944|536571783|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
148754073|NCT01074944|536571784|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
148754074|NCT01074944|536571785|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
148754075|NCT01074944|536571786|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
148754076|NCT01074944|536571782|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
148754077|NCT01074944|536571783|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
148754078|NCT01074944|536571784|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
148754079|NCT01074944|536571785|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
148754080|NCT01074944|536571786|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
148754081|NCT01074944|536571782|FG000|Long Term Treatment|Adverse Event|0|||
148754082|NCT01074944|536571783|FG001|Long Term Treatment|Adverse Event|0|||
148754083|NCT01074944|536571784|FG002|Long Term Treatment|Adverse Event|0|||
148754084|NCT01074944|536571785|FG003|Long Term Treatment|Adverse Event|3|||
148754085|NCT01074944|536571786|FG004|Long Term Treatment|Adverse Event|0|||
148754086|NCT01074944|536571782|FG000|Long Term Treatment|Lost to Follow-up|0|||
148754087|NCT01074944|536571783|FG001|Long Term Treatment|Lost to Follow-up|0|||
148754088|NCT01074944|536571784|FG002|Long Term Treatment|Lost to Follow-up|0|||
148754089|NCT01074944|536571785|FG003|Long Term Treatment|Lost to Follow-up|2|||
148754090|NCT01074944|536571786|FG004|Long Term Treatment|Lost to Follow-up|0|||
148754091|NCT01074944|536571782|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
148754092|NCT01074944|536571783|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
148754093|NCT01074944|536571784|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
148754094|NCT01074944|536571785|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
148754095|NCT01074944|536571786|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
148754096|NCT01074944|536571782|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
148754097|NCT01074944|536571783|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
148754098|NCT01074944|536571784|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
148754099|NCT01074944|536571785|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
148754100|NCT01074944|536571786|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
148754101|NCT01074944|536571782|FG000|Long Term Treatment|Withdrawal by Subject|0|||
148754102|NCT01074944|536571783|FG001|Long Term Treatment|Withdrawal by Subject|0|||
148754103|NCT01074944|536571784|FG002|Long Term Treatment|Withdrawal by Subject|0|||
148754104|NCT01074944|536571785|FG003|Long Term Treatment|Withdrawal by Subject|2|||
148754105|NCT01074944|536571786|FG004|Long Term Treatment|Withdrawal by Subject|0|||
148822984|NCT01557244|536830717|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
148822985|NCT01557244|536830718|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
148754106|NCT01074944|536571782|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
148754107|NCT01074944|536571783|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
148754108|NCT01074944|536571784|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
148822986|NCT01557244|536830719|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
148822987|NCT01557244|536830720|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
148754109|NCT01074944|536571785|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
148754110|NCT01074944|536571786|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
148754111|NCT01074944|536571782|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
148754112|NCT01074944|536571783|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
148754113|NCT01074944|536571784|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
148754114|NCT01074944|536571785|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
148754115|NCT01074944|536571786|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
148754116|NCT02348112|536571788|FG000|Overall Study|Withdrawal by Subject|32|||
148754117|NCT02348112|536571789|FG001|Overall Study|Withdrawal by Subject|29|||
148754118|NCT02348112|536571788|FG000|Overall Study|Lost to Follow-up|24|||
148754119|NCT02348112|536571789|FG001|Overall Study|Lost to Follow-up|20|||
148754120|NCT02348112|536571788|FG000|Overall Study|Physician Decision|17|||
148754121|NCT02348112|536571789|FG001|Overall Study|Physician Decision|15|||
148754122|NCT02348112|536571788|FG000|Overall Study|Site closed due to PI leaving|0|||
148754123|NCT02348112|536571789|FG001|Overall Study|Site closed due to PI leaving|30|||
148754124|NCT02348112|536571788|FG000|Overall Study|Sponsor withdrawal|0|||
148754125|NCT02348112|536571789|FG001|Overall Study|Sponsor withdrawal|7|||
148754126|NCT02348112|536571788|FG000|Overall Study|Death|0|||
148754127|NCT02348112|536571789|FG001|Overall Study|Death|1|||
148754128|NCT01998841|536571794|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
148754129|NCT01998841|536571795|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
148754130|NCT01998841|536571796|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
148754131|NCT01998841|536571797|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
148754132|NCT01998841|536571798|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
148754133|NCT01998841|536571794|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
148754134|NCT01998841|536571795|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
148754135|NCT01998841|536571796|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
148754136|NCT01998841|536571797|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
148754137|NCT01998841|536571798|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
148754138|NCT02586155|536571799|FG000|Overall Study|Adverse Event|2|||
148754139|NCT02586155|536571800|FG001|Overall Study|Adverse Event|3|||
148754140|NCT02586155|536571799|FG000|Overall Study|Withdrawal by Subject|31|||
148754141|NCT02586155|536571800|FG001|Overall Study|Withdrawal by Subject|24|||
148754142|NCT02586155|536571799|FG000|Overall Study|Lost to Follow-up|7|||
148754143|NCT02586155|536571800|FG001|Overall Study|Lost to Follow-up|13|||
148754144|NCT02586155|536571799|FG000|Overall Study|Death|61|||
148754145|NCT02586155|536571800|FG001|Overall Study|Death|72|||
148754146|NCT02586155|536571799|FG000|Overall Study|Other reasons|26|||
148754147|NCT02586155|536571800|FG001|Overall Study|Other reasons|15|||
148754148|NCT00972595|536571801|FG000|Period 1|Adverse Event|1|||
148754149|NCT00972595|536571802|FG001|Period 1|Adverse Event|0|||
148754150|NCT02072980|536571804|FG000|Period 2, Second Wear|Adverse Event|0|||
148754151|NCT02072980|536571805|FG001|Period 2, Second Wear|Adverse Event|1|||
148754152|NCT03367819|536571808|FG000|Overall Study|Adverse Event|4|||
148754153|NCT03367819|536571809|FG001|Overall Study|Adverse Event|4|||
148754154|NCT03367819|536571808|FG000|Overall Study|Progressive Disease|15|||
148754155|NCT03367819|536571809|FG001|Overall Study|Progressive Disease|13|||
148754156|NCT03367819|536571808|FG000|Overall Study|Withdrawal by Subject|1|||
148754157|NCT03367819|536571809|FG001|Overall Study|Withdrawal by Subject|0|||
148754158|NCT03367819|536571808|FG000|Overall Study|Other|4|||
148754159|NCT03367819|536571809|FG001|Overall Study|Other|2|||
148754160|NCT00550459|536571810|FG000|Overall Study|Adverse Event|0|||
148754161|NCT00550459|536571811|FG001|Overall Study|Adverse Event|2|||
148754162|NCT00550459|536571810|FG000|Overall Study|Withdrawal by Subject|1|||
148754163|NCT00550459|536571811|FG001|Overall Study|Withdrawal by Subject|1|||
148754164|NCT02404805|536571812|FG000|Overall Study|Withdrawal by Subject|1|||
148754165|NCT02404805|536571813|FG001|Overall Study|Withdrawal by Subject|0|||
148754166|NCT02404805|536571814|FG002|Overall Study|Withdrawal by Subject|0|||
148754167|NCT02404805|536571815|FG003|Overall Study|Withdrawal by Subject|0|||
148754168|NCT02404805|536571816|FG004|Overall Study|Withdrawal by Subject|0|||
148754169|NCT02404805|536571817|FG005|Overall Study|Withdrawal by Subject|0|||
148754170|NCT04211831|536571818|FG000|Overall Study|Withdrawal by Subject|4|||
148754171|NCT04211831|536571819|FG001|Overall Study|Withdrawal by Subject|1|||
148754172|NCT04211831|536571820|FG002|Overall Study|Withdrawal by Subject|1|||
148754173|NCT04211831|536571818|FG000|Overall Study|Protocol Violation|0|||
148822988|NCT01557244|536830721|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
148822989|NCT01557244|536830722|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
149027402|NCT00293462|537578555|FG001|Overall Study|Low radiation dose in oral cavity|1|||
148754174|NCT04211831|536571819|FG001|Overall Study|Protocol Violation|0|||
149027403|NCT00293462|537578556|FG002|Overall Study|Low radiation dose in oral cavity|0|||
149027404|NCT00293462|537578554|FG000|Overall Study|Physician Decision|0|||
148754175|NCT04211831|536571820|FG002|Overall Study|Protocol Violation|1|||
148754176|NCT04211831|536571818|FG000|Overall Study|Adverse Event|0|||
148754177|NCT04211831|536571819|FG001|Overall Study|Adverse Event|1|||
148754178|NCT04211831|536571820|FG002|Overall Study|Adverse Event|0|||
148754179|NCT04211831|536571818|FG000|Overall Study|Lack of Efficacy|0|||
148754180|NCT04211831|536571819|FG001|Overall Study|Lack of Efficacy|0|||
148754181|NCT04211831|536571820|FG002|Overall Study|Lack of Efficacy|1|||
148754182|NCT04211831|536571818|FG000|Overall Study|Lost to Follow-up|0|||
148754183|NCT04211831|536571819|FG001|Overall Study|Lost to Follow-up|0|||
148754184|NCT04211831|536571820|FG002|Overall Study|Lost to Follow-up|2|||
148754185|NCT04211831|536571818|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
148754186|NCT04211831|536571819|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
148754187|NCT04211831|536571820|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
148754188|NCT04211831|536571818|FG000|Overall Study|Other|0|||
148754189|NCT04211831|536571819|FG001|Overall Study|Other|1|||
148754190|NCT04211831|536571820|FG002|Overall Study|Other|0|||
148754191|NCT02698163|536571821|FG000|Overall Study|Lost to Follow-up|0|||
148754192|NCT02698163|536571822|FG001|Overall Study|Lost to Follow-up|1|||
148754193|NCT05373108|536571823|FG000|Overall Study|Withdrawal by Subject|2|||
148754194|NCT01133067|536571824|FG000|Overall Study|Death|136|||
148754195|NCT01133067|536571824|FG000|Overall Study|Lost to Follow-up|3|||
148754196|NCT00752128|536571825|FG000|Overall Study|Withdrawal by Subject|4|||
148754197|NCT04135937|536571829|FG000|Overall Study|Lost to Follow-up|2|||
148754198|NCT04135937|536571829|FG000|Overall Study|Withdrawal by Subject|1|||
148754199|NCT02548143|536571830|FG000|Overall Study|Adverse Event|1|||
148754200|NCT02548143|536571831|FG001|Overall Study|Adverse Event|0|||
148754201|NCT02548143|536571830|FG000|Overall Study|Withdrawal by Subject|0|||
148754202|NCT02548143|536571831|FG001|Overall Study|Withdrawal by Subject|1|||
148754203|NCT04871776|536571832|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
148754204|NCT04871776|536571833|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
148754205|NCT04871776|536571834|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
148754206|NCT04871776|536571832|FG000|Overall Study|Did not meet eligibility criteria|1|||
148754207|NCT04871776|536571833|FG001|Overall Study|Did not meet eligibility criteria|1|||
148754208|NCT04871776|536571834|FG002|Overall Study|Did not meet eligibility criteria|1|||
148754209|NCT00625820|536571844|FG000|Overall Study|Withdrawal by Subject|1|||
148754210|NCT01168232|536574011|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
148754211|NCT01168232|536574011|FG000|Overall Study|Ineligible- Wrong cell type|6|||
148754212|NCT01168232|536574011|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
148754213|NCT04510090|536574014|FG000|FE-HS|Withdrawal by Subject|0|||
148754214|NCT04510090|536574015|FG001|FE-HS|Withdrawal by Subject|0|||
148754215|NCT04510090|536574016|FG002|FE-HS|Withdrawal by Subject|0|||
148754216|NCT04510090|536574017|FG003|FE-HS|Withdrawal by Subject|0|||
148754217|NCT04510090|536574018|FG004|FE-HS|Withdrawal by Subject|1|||
148754218|NCT04510090|536574019|FG005|FE-HS|Withdrawal by Subject|0|||
148754219|NCT04510090|536574020|FG006|FE-HS|Withdrawal by Subject|0|||
148754220|NCT04510090|536574021|FG007|FE-HS|Withdrawal by Subject|0|||
148754221|NCT01749826|536574022|FG000|Overall Study|Study Terminated|20|||
148754222|NCT01749826|536574023|FG001|Overall Study|Study Terminated|0|||
148754223|NCT01922037|536574024|FG000|Overall Study|Withdrawal by Subject|2|||
148754224|NCT01922037|536574025|FG001|Overall Study|Withdrawal by Subject|44|||
148754225|NCT01922037|536574024|FG000|Overall Study|Adverse Event|1|||
148754226|NCT01922037|536574025|FG001|Overall Study|Adverse Event|7|||
148754227|NCT01922037|536574024|FG000|Overall Study|Death|0|||
148754228|NCT01922037|536574025|FG001|Overall Study|Death|5|||
148754229|NCT01922037|536574024|FG000|Overall Study|Pregnancy|0|||
148754230|NCT01922037|536574025|FG001|Overall Study|Pregnancy|2|||
148754231|NCT01922037|536574024|FG000|Overall Study|Participant non-compliance|4|||
148754232|NCT01922037|536574025|FG001|Overall Study|Participant non-compliance|46|||
148754233|NCT01922037|536574024|FG000|Overall Study|Investigator/Sponsor decision|1|||
148754234|NCT01922037|536574025|FG001|Overall Study|Investigator/Sponsor decision|4|||
148754235|NCT01922037|536574024|FG000|Overall Study|Other unspecified|2|||
148754236|NCT01922037|536574025|FG001|Overall Study|Other unspecified|66|||
148754237|NCT05085834|536574026|FG000|Overall Study|Lost to Follow-up|9|||
148754238|NCT05085834|536574027|FG001|Overall Study|Lost to Follow-up|2|||
148754239|NCT05085834|536574026|FG000|Overall Study|Adverse Event|6|||
148822990|NCT01557244|536830723|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
148754240|NCT05085834|536574027|FG001|Overall Study|Adverse Event|0|||
148754241|NCT05085834|536574026|FG000|Overall Study|Death|1|||
148754242|NCT05085834|536574027|FG001|Overall Study|Death|0|||
148754243|NCT05085834|536574026|FG000|Overall Study|Inability to swallow the pill|0|||
148754244|NCT05085834|536574027|FG001|Overall Study|Inability to swallow the pill|1|||
148822991|NCT01557244|536830717|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
148754245|NCT03657797|536574033|FG000|Overall Study|Lost to Follow-up|0|||
148754246|NCT03657797|536574034|FG001|Overall Study|Lost to Follow-up|1|||
148822992|NCT01557244|536830718|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
148754247|NCT03657797|536574035|FG002|Overall Study|Lost to Follow-up|1|||
148754248|NCT03657797|536574036|FG003|Overall Study|Lost to Follow-up|0|||
148754249|NCT03657797|536574033|FG000|Overall Study|Physician Decision|0|||
148754250|NCT03657797|536574034|FG001|Overall Study|Physician Decision|1|||
148754251|NCT03657797|536574035|FG002|Overall Study|Physician Decision|0|||
148754252|NCT03657797|536574036|FG003|Overall Study|Physician Decision|0|||
148754253|NCT03657797|536574033|FG000|Overall Study|Withdrawal by Subject|0|||
148754254|NCT03657797|536574034|FG001|Overall Study|Withdrawal by Subject|1|||
148754255|NCT03657797|536574035|FG002|Overall Study|Withdrawal by Subject|2|||
148754256|NCT03657797|536574036|FG003|Overall Study|Withdrawal by Subject|0|||
148754257|NCT03657797|536574033|FG000|Overall Study|Adverse Event|0|||
148754258|NCT03657797|536574034|FG001|Overall Study|Adverse Event|0|||
148754259|NCT03657797|536574035|FG002|Overall Study|Adverse Event|2|||
148754260|NCT03657797|536574036|FG003|Overall Study|Adverse Event|0|||
148754261|NCT00413699|536574037|FG000|Initial Period|Death|25|||
148754262|NCT00413699|536574038|FG001|Initial Period|Death|30|||
148754263|NCT00413699|536574039|FG002|Initial Period|Death|0|||
148754264|NCT00413699|536574037|FG000|Initial Period|Lack of Efficacy|59|||
148754265|NCT00413699|536574038|FG001|Initial Period|Lack of Efficacy|115|||
148754266|NCT00413699|536574039|FG002|Initial Period|Lack of Efficacy|0|||
148754267|NCT00413699|536574037|FG000|Initial Period|Lost to Follow-up|31|||
148754268|NCT00413699|536574038|FG001|Initial Period|Lost to Follow-up|101|||
148754269|NCT00413699|536574039|FG002|Initial Period|Lost to Follow-up|0|||
148754270|NCT00413699|536574037|FG000|Initial Period|Protocol Violation|38|||
148754271|NCT00413699|536574038|FG001|Initial Period|Protocol Violation|89|||
148754272|NCT00413699|536574039|FG002|Initial Period|Protocol Violation|0|||
148754273|NCT00413699|536574037|FG000|Initial Period|Pregnancy|10|||
148754274|NCT00413699|536574038|FG001|Initial Period|Pregnancy|8|||
148754275|NCT00413699|536574039|FG002|Initial Period|Pregnancy|0|||
148754276|NCT00413699|536574037|FG000|Initial Period|Did not meet entrance criteria|2|||
148754277|NCT00413699|536574038|FG001|Initial Period|Did not meet entrance criteria|2|||
148754278|NCT00413699|536574039|FG002|Initial Period|Did not meet entrance criteria|0|||
148754279|NCT00413699|536574037|FG000|Initial Period|Medication error without adverse event|0|||
148754280|NCT00413699|536574038|FG001|Initial Period|Medication error without adverse event|1|||
148754281|NCT00413699|536574039|FG002|Initial Period|Medication error without adverse event|0|||
148754282|NCT00413699|536574037|FG000|Initial Period|Study terminated by Sponsor|0|||
148754283|NCT00413699|536574038|FG001|Initial Period|Study terminated by Sponsor|1|||
148754284|NCT00413699|536574039|FG002|Initial Period|Study terminated by Sponsor|0|||
148754285|NCT00413699|536574037|FG000|Initial Period|Other|67|||
148754286|NCT00413699|536574038|FG001|Initial Period|Other|211|||
148754287|NCT00413699|536574039|FG002|Initial Period|Other|0|||
148754288|NCT00413699|536574037|FG000|Initial Period|Adverse event related to study drug|178|||
148754289|NCT00413699|536574038|FG001|Initial Period|Adverse event related to study drug|527|||
148754290|NCT00413699|536574039|FG002|Initial Period|Adverse event related to study drug|0|||
148754291|NCT00413699|536574037|FG000|Initial Period|Adverse event not related to study drug|113|||
148754292|NCT00413699|536574038|FG001|Initial Period|Adverse event not related to study drug|248|||
148754293|NCT00413699|536574039|FG002|Initial Period|Adverse event not related to study drug|0|||
148754294|NCT00413699|536574037|FG000|Initial Period|Missing end of study page|0|||
148754295|NCT00413699|536574038|FG001|Initial Period|Missing end of study page|4|||
148754296|NCT00413699|536574039|FG002|Initial Period|Missing end of study page|0|||
148754297|NCT00413699|536574037|FG000|Initial Period|No longer willing to participate|116|||
148754298|NCT00413699|536574038|FG001|Initial Period|No longer willing to participate|368|||
148754299|NCT00413699|536574039|FG002|Initial Period|No longer willing to participate|0|||
148754300|NCT00413699|536574037|FG000|Extension Period|No Longer Willing to Participate|0|||
148754301|NCT00413699|536574038|FG001|Extension Period|No Longer Willing to Participate|0|||
148754302|NCT00413699|536574039|FG002|Extension Period|No Longer Willing to Participate|2|||
148754303|NCT00413699|536574037|FG000|Extension Period|Protocol Violation|0|||
148754304|NCT00413699|536574038|FG001|Extension Period|Protocol Violation|0|||
148754305|NCT00413699|536574039|FG002|Extension Period|Protocol Violation|1|||
148754306|NCT00413699|536574037|FG000|Extension Period|Adverse Event|0|||
148754307|NCT00413699|536574038|FG001|Extension Period|Adverse Event|0|||
148754308|NCT00413699|536574039|FG002|Extension Period|Adverse Event|2|||
148754309|NCT02115269|536574040|FG000|Overall Study|Lost to Follow-up|43|||
148754310|NCT02115269|536574040|FG000|Overall Study|Did not complete patient diary|3|||
148754311|NCT02115269|536574040|FG000|Overall Study|Moved to another city|7|||
148754312|NCT02115269|536574040|FG000|Overall Study|Withdrawal by Subject|2|||
148754313|NCT02115269|536574040|FG000|Overall Study|Didn't take study drug|2|||
148754314|NCT02810457|536574041|FG000|Overall Study|Randomised but no treatment received|2|||
148754315|NCT02810457|536574042|FG001|Overall Study|Randomised but no treatment received|1|||
148754316|NCT02810457|536574041|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
148754317|NCT02810457|536574042|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
148754318|NCT02810457|536574041|FG000|Overall Study|Adverse Event|37|||
148754319|NCT02810457|536574042|FG001|Overall Study|Adverse Event|43|||
148754320|NCT02810457|536574041|FG000|Overall Study|Patient decision|31|||
148754321|NCT02810457|536574042|FG001|Overall Study|Patient decision|35|||
148754322|NCT02810457|536574041|FG000|Overall Study|Patient lost to follow-up|2|||
148754323|NCT02810457|536574042|FG001|Overall Study|Patient lost to follow-up|2|||
148754324|NCT02810457|536574041|FG000|Overall Study|Death|39|||
148754325|NCT02810457|536574042|FG001|Overall Study|Death|28|||
148754326|NCT02810457|536574041|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
148754327|NCT02810457|536574042|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
148754328|NCT02810457|536574041|FG000|Overall Study|Clinical progression|15|||
148754329|NCT02810457|536574042|FG001|Overall Study|Clinical progression|16|||
148754330|NCT02810457|536574041|FG000|Overall Study|Investigator decision|3|||
148754331|NCT02810457|536574042|FG001|Overall Study|Investigator decision|2|||
148754332|NCT02810457|536574041|FG000|Overall Study|Patient ineligibility|3|||
148754333|NCT02810457|536574042|FG001|Overall Study|Patient ineligibility|0|||
148754334|NCT02810457|536574041|FG000|Overall Study|Miscalculated PD|1|||
148754335|NCT02810457|536574042|FG001|Overall Study|Miscalculated PD|0|||
148754336|NCT02810457|536574041|FG000|Overall Study|Physician Decision|0|||
148754337|NCT02810457|536574042|FG001|Overall Study|Physician Decision|1|||
148754338|NCT03642262|536574043|FG000|Period 1|Withdrawal by Subject|1|||
148754339|NCT03642262|536574044|FG001|Period 1|Withdrawal by Subject|1|||
148754340|NCT03642262|536574043|FG000|Period 1|Adverse Event|0|||
148754341|NCT03642262|536574044|FG001|Period 1|Adverse Event|1|||
148754342|NCT02440464|536574047|FG000|Overall Study|Withdrawal by Subject|3|||
148754343|NCT02440464|536574048|FG001|Overall Study|Withdrawal by Subject|2|||
148754344|NCT02058069|536574051|FG000|Overall Study|Exclusion due to implant size|5|||
148754345|NCT02058069|536574051|FG000|Overall Study|Withdrawal by Subject|6|||
148754346|NCT02222922|536574052|FG000|Overall Study|Death|0|||
148754347|NCT02222922|536574053|FG001|Overall Study|Death|0|||
148754348|NCT02222922|536574054|FG002|Overall Study|Death|0|||
148754349|NCT02222922|536574055|FG003|Overall Study|Death|0|||
148754350|NCT02222922|536574056|FG004|Overall Study|Death|13|||
148754351|NCT02222922|536574057|FG005|Overall Study|Death|0|||
148754352|NCT02222922|536574058|FG006|Overall Study|Death|0|||
148754353|NCT02222922|536574059|FG007|Overall Study|Death|0|||
148754354|NCT02222922|536574060|FG008|Overall Study|Death|2|||
148754355|NCT02222922|536574052|FG000|Overall Study|Lost to Follow-up|0|||
148754356|NCT02222922|536574053|FG001|Overall Study|Lost to Follow-up|0|||
148754357|NCT02222922|536574054|FG002|Overall Study|Lost to Follow-up|1|||
148754358|NCT02222922|536574055|FG003|Overall Study|Lost to Follow-up|0|||
148754359|NCT02222922|536574056|FG004|Overall Study|Lost to Follow-up|9|||
148754360|NCT02222922|536574057|FG005|Overall Study|Lost to Follow-up|1|||
148754361|NCT02222922|536574058|FG006|Overall Study|Lost to Follow-up|0|||
148754362|NCT02222922|536574059|FG007|Overall Study|Lost to Follow-up|0|||
148754363|NCT02222922|536574060|FG008|Overall Study|Lost to Follow-up|0|||
148754364|NCT02222922|536574052|FG000|Overall Study|Other|0|||
148754365|NCT02222922|536574053|FG001|Overall Study|Other|0|||
148754366|NCT02222922|536574054|FG002|Overall Study|Other|0|||
148754367|NCT02222922|536574055|FG003|Overall Study|Other|2|||
148754368|NCT02222922|536574056|FG004|Overall Study|Other|10|||
148754369|NCT02222922|536574057|FG005|Overall Study|Other|2|||
148754370|NCT02222922|536574058|FG006|Overall Study|Other|2|||
148754371|NCT02222922|536574059|FG007|Overall Study|Other|4|||
148754372|NCT02222922|536574060|FG008|Overall Study|Other|1|||
148754373|NCT02222922|536574052|FG000|Overall Study|Participant refused further follow-up|1|||
148754374|NCT02222922|536574053|FG001|Overall Study|Participant refused further follow-up|0|||
148754375|NCT02222922|536574054|FG002|Overall Study|Participant refused further follow-up|0|||
148754376|NCT02222922|536574055|FG003|Overall Study|Participant refused further follow-up|1|||
148754377|NCT02222922|536574056|FG004|Overall Study|Participant refused further follow-up|6|||
148754378|NCT02222922|536574057|FG005|Overall Study|Participant refused further follow-up|0|||
148754379|NCT02222922|536574058|FG006|Overall Study|Participant refused further follow-up|0|||
148754380|NCT02222922|536574059|FG007|Overall Study|Participant refused further follow-up|0|||
148754381|NCT02222922|536574060|FG008|Overall Study|Participant refused further follow-up|3|||
148754382|NCT02002221|536574067|FG000|Overall Study|Adverse Event|2|||
148754383|NCT02002221|536574068|FG001|Overall Study|Adverse Event|1|||
148754384|NCT02002221|536574067|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148754385|NCT02002221|536574068|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148754386|NCT02002221|536574067|FG000|Overall Study|Patient withdrew consent|0|||
148754387|NCT02002221|536574068|FG001|Overall Study|Patient withdrew consent|1|||
148754388|NCT00897715|536574073|FG000|Overall Study|Lost to Follow-up|0|||
148754389|NCT00897715|536574074|FG001|Overall Study|Lost to Follow-up|1|||
148754390|NCT00897715|536574073|FG000|Overall Study|Physician Decision|1|||
148754391|NCT00897715|536574074|FG001|Overall Study|Physician Decision|0|||
148754392|NCT00897715|536574073|FG000|Overall Study|increased risk of infection|1|||
148754393|NCT00897715|536574074|FG001|Overall Study|increased risk of infection|0|||
148754394|NCT00513240|536574076|FG000|Overall Study|Did not have intended surgery|3|||
148754395|NCT00513240|536574077|FG001|Overall Study|Did not have intended surgery|0|||
148754396|NCT00513240|536574076|FG000|Overall Study|Death|3|||
148754397|NCT00513240|536574077|FG001|Overall Study|Death|3|||
148754398|NCT00513240|536574076|FG000|Overall Study|Withdrawal by Subject|7|||
148754399|NCT00513240|536574077|FG001|Overall Study|Withdrawal by Subject|4|||
148754400|NCT02714218|536574078|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148754401|NCT02714218|536574079|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
148754402|NCT02714218|536574080|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148976343|NCT03604692|537394527|FG002|Overall Study|Investigator's Decision|0|||
148976344|NCT03604692|537394528|FG003|Overall Study|Investigator's Decision|1|||
148976345|NCT03604692|537394529|FG004|Overall Study|Investigator's Decision|0|||
148976346|NCT03604692|537394530|FG005|Overall Study|Investigator's Decision|7|||
148976347|NCT03604692|537394525|FG000|Overall Study|Withdrawal by Subject|0|||
148976348|NCT03604692|537394526|FG001|Overall Study|Withdrawal by Subject|0|||
148754403|NCT02714218|536574078|FG000|Pre-Treatment Period|Other reasons|0|||
148754404|NCT02714218|536574079|FG001|Pre-Treatment Period|Other reasons|1|||
148754405|NCT02714218|536574080|FG002|Pre-Treatment Period|Other reasons|0|||
148754406|NCT02714218|536574078|FG000|Treatment Period|Disease Progression|55|||
148754407|NCT02714218|536574079|FG001|Treatment Period|Disease Progression|52|||
148754408|NCT02714218|536574080|FG002|Treatment Period|Disease Progression|14|||
148754409|NCT02714218|536574078|FG000|Treatment Period|Study drug toxicity|46|||
148754410|NCT02714218|536574079|FG001|Treatment Period|Study drug toxicity|70|||
148754411|NCT02714218|536574080|FG002|Treatment Period|Study drug toxicity|6|||
148754412|NCT02714218|536574078|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
148754413|NCT02714218|536574079|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
148754414|NCT02714218|536574080|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
148754415|NCT02714218|536574078|FG000|Treatment Period|Request to discontinue treatment|1|||
148754416|NCT02714218|536574079|FG001|Treatment Period|Request to discontinue treatment|4|||
148754417|NCT02714218|536574080|FG002|Treatment Period|Request to discontinue treatment|1|||
148754418|NCT02714218|536574078|FG000|Treatment Period|Participant withdrew consent|2|||
148754419|NCT02714218|536574079|FG001|Treatment Period|Participant withdrew consent|2|||
148754420|NCT02714218|536574080|FG002|Treatment Period|Participant withdrew consent|0|||
148754421|NCT02714218|536574078|FG000|Treatment Period|Maximum clinical benefit|4|||
148754422|NCT02714218|536574079|FG001|Treatment Period|Maximum clinical benefit|2|||
148754423|NCT02714218|536574080|FG002|Treatment Period|Maximum clinical benefit|0|||
148754424|NCT02714218|536574078|FG000|Treatment Period|Administrative reason by sponsor|2|||
148754425|NCT02714218|536574079|FG001|Treatment Period|Administrative reason by sponsor|1|||
148754426|NCT02714218|536574080|FG002|Treatment Period|Administrative reason by sponsor|0|||
148754427|NCT02714218|536574078|FG000|Treatment Period|Other reasons|6|||
148754428|NCT02714218|536574079|FG001|Treatment Period|Other reasons|6|||
148754429|NCT02714218|536574080|FG002|Treatment Period|Other reasons|0|||
148754430|NCT02714218|536574078|FG000|Treatment Period|Completed treatment as per protocol|36|||
148754431|NCT02714218|536574079|FG001|Treatment Period|Completed treatment as per protocol|27|||
148754432|NCT02714218|536574080|FG002|Treatment Period|Completed treatment as per protocol|3|||
148754433|NCT02714218|536574078|FG000|Treatment Period|Not reported|9|||
148754434|NCT02714218|536574079|FG001|Treatment Period|Not reported|6|||
148754435|NCT02714218|536574080|FG002|Treatment Period|Not reported|0|||
148754436|NCT01930162|536574083|FG000|Overall Study|Abnormal test procedure result(s)|4|||
148754437|NCT01930162|536574083|FG000|Overall Study|Death|1|||
148754438|NCT02550561|536574084|FG000|Overall Study|Lost to Follow-up|5|||
148754439|NCT02550561|536574084|FG000|Overall Study|Withdrawal by Subject|1|||
148754440|NCT01960413|536574088|FG000|Overall Study|Withdrawal by Subject|1|||
148754441|NCT01960413|536574089|FG001|Overall Study|Withdrawal by Subject|1|||
148754442|NCT01960413|536574088|FG000|Overall Study|Physician Decision|1|||
148754443|NCT01960413|536574089|FG001|Overall Study|Physician Decision|0|||
148754444|NCT01960413|536574088|FG000|Overall Study|Lost to Follow-up|2|||
148754445|NCT01960413|536574089|FG001|Overall Study|Lost to Follow-up|0|||
148754446|NCT00791778|536574090|FG000|Double-blind Treatment|Adverse Event|49|||
148754447|NCT00791778|536574091|FG001|Double-blind Treatment|Adverse Event|9|||
148754448|NCT00791778|536574090|FG000|Double-blind Treatment|Physician Decision|6|||
148754449|NCT00791778|536574091|FG001|Double-blind Treatment|Physician Decision|26|||
148754450|NCT00791778|536574090|FG000|Double-blind Treatment|Protocol Violation|0|||
148754451|NCT00791778|536574091|FG001|Double-blind Treatment|Protocol Violation|4|||
148754452|NCT00791778|536574090|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
148754453|NCT00791778|536574091|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
148754454|NCT00791778|536574090|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
148754455|NCT00791778|536574091|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
148754456|NCT00791778|536574090|FG000|Follow-up|Withdrawal by Subject|3|||
148754457|NCT00791778|536574091|FG001|Follow-up|Withdrawal by Subject|0|||
148754458|NCT00791778|536574090|FG000|Follow-up|Lost to Follow-up|2|||
148754459|NCT00791778|536574091|FG001|Follow-up|Lost to Follow-up|1|||
148754460|NCT00931411|536574094|FG000|First Intervention - 42 Days|Adverse Event|2|||
148754461|NCT00931411|536574095|FG001|First Intervention - 42 Days|Adverse Event|3|||
148754462|NCT00931411|536574094|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
148754463|NCT00931411|536574095|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
148754464|NCT00931411|536574094|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
148754465|NCT00931411|536574095|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
148976349|NCT03604692|537394527|FG002|Overall Study|Withdrawal by Subject|0|||
148976350|NCT03604692|537394528|FG003|Overall Study|Withdrawal by Subject|0|||
148976351|NCT03604692|537394529|FG004|Overall Study|Withdrawal by Subject|0|||
148976352|NCT03604692|537394530|FG005|Overall Study|Withdrawal by Subject|2|||
148976353|NCT03604692|537394525|FG000|Overall Study|Progressive Disease|1|||
148754466|NCT01949662|536574096|FG000|Overall Study|Death|9|||
148754467|NCT01949662|536574097|FG001|Overall Study|Death|7|||
148754468|NCT01949662|536574096|FG000|Overall Study|Discharged before an agitation event|8|||
148754469|NCT01949662|536574097|FG001|Overall Study|Discharged before an agitation event|3|||
148754470|NCT01949662|536574096|FG000|Overall Study|Dropped out|1|||
148754471|NCT01949662|536574097|FG001|Overall Study|Dropped out|3|||
148754472|NCT01949662|536574096|FG000|Overall Study|Ineligible|0|||
148754473|NCT01949662|536574097|FG001|Overall Study|Ineligible|1|||
148754474|NCT02291237|536574098|FG000|Overall Study|Study Terminated by Sponsor|72|||
148754475|NCT02291237|536574099|FG001|Overall Study|Study Terminated by Sponsor|67|||
148754476|NCT02291237|536574098|FG000|Overall Study|Adverse Event|1|||
148754477|NCT02291237|536574099|FG001|Overall Study|Adverse Event|3|||
148754478|NCT02291237|536574098|FG000|Overall Study|Investigator's Discretion|0|||
148754479|NCT02291237|536574099|FG001|Overall Study|Investigator's Discretion|3|||
148754480|NCT02291237|536574098|FG000|Overall Study|Withdrew Consent|11|||
148754481|NCT02291237|536574099|FG001|Overall Study|Withdrew Consent|11|||
148754482|NCT02291237|536574098|FG000|Overall Study|Lost to Follow-up|0|||
148754483|NCT02291237|536574099|FG001|Overall Study|Lost to Follow-up|2|||
148754484|NCT02291237|536574098|FG000|Overall Study|Subject Required Prohibited Medication|2|||
148754485|NCT02291237|536574099|FG001|Overall Study|Subject Required Prohibited Medication|0|||
148754486|NCT00729937|536574102|FG000|Overall Study|Lost to Follow-up|49|||
148754487|NCT00729937|536574103|FG001|Overall Study|Lost to Follow-up|58|||
148754488|NCT00729937|536574104|FG002|Overall Study|Lost to Follow-up|18|||
148754489|NCT00729937|536574105|FG003|Overall Study|Lost to Follow-up|33|||
148754490|NCT00729937|536574106|FG004|Overall Study|Lost to Follow-up|18|||
148754491|NCT00729937|536574107|FG005|Overall Study|Lost to Follow-up|23|||
148754492|NCT00729937|536574102|FG000|Overall Study|Physician Decision|7|||
148754493|NCT00729937|536574103|FG001|Overall Study|Physician Decision|16|||
148754494|NCT00729937|536574104|FG002|Overall Study|Physician Decision|2|||
148754495|NCT00729937|536574105|FG003|Overall Study|Physician Decision|0|||
148754496|NCT00729937|536574106|FG004|Overall Study|Physician Decision|5|||
148754497|NCT00729937|536574107|FG005|Overall Study|Physician Decision|8|||
148754498|NCT00729937|536574102|FG000|Overall Study|Death|1|||
148754499|NCT00729937|536574103|FG001|Overall Study|Death|0|||
148754500|NCT00729937|536574104|FG002|Overall Study|Death|1|||
148754501|NCT00729937|536574105|FG003|Overall Study|Death|0|||
148754502|NCT00729937|536574106|FG004|Overall Study|Death|0|||
148754503|NCT00729937|536574107|FG005|Overall Study|Death|1|||
148754504|NCT00729937|536574102|FG000|Overall Study|Withdrawal by Subject|3|||
148754505|NCT00729937|536574103|FG001|Overall Study|Withdrawal by Subject|5|||
148754506|NCT00729937|536574104|FG002|Overall Study|Withdrawal by Subject|6|||
148754507|NCT00729937|536574105|FG003|Overall Study|Withdrawal by Subject|0|||
148754508|NCT00729937|536574106|FG004|Overall Study|Withdrawal by Subject|4|||
148754509|NCT00729937|536574107|FG005|Overall Study|Withdrawal by Subject|2|||
148754510|NCT00729937|536574102|FG000|Overall Study|Randomized but not treated|12|||
148754511|NCT00729937|536574103|FG001|Overall Study|Randomized but not treated|6|||
148754512|NCT00729937|536574104|FG002|Overall Study|Randomized but not treated|1|||
148754513|NCT00729937|536574105|FG003|Overall Study|Randomized but not treated|0|||
148754514|NCT00729937|536574106|FG004|Overall Study|Randomized but not treated|1|||
148754515|NCT00729937|536574107|FG005|Overall Study|Randomized but not treated|3|||
148754516|NCT00729937|536574102|FG000|Overall Study|Did not meet eligibility criteria|2|||
148754517|NCT00729937|536574103|FG001|Overall Study|Did not meet eligibility criteria|1|||
148754518|NCT00729937|536574104|FG002|Overall Study|Did not meet eligibility criteria|0|||
148754519|NCT00729937|536574105|FG003|Overall Study|Did not meet eligibility criteria|0|||
148754520|NCT00729937|536574106|FG004|Overall Study|Did not meet eligibility criteria|0|||
148754521|NCT00729937|536574107|FG005|Overall Study|Did not meet eligibility criteria|0|||
148754522|NCT00729937|536574102|FG000|Overall Study|Incarcerated|0|||
148754523|NCT00729937|536574103|FG001|Overall Study|Incarcerated|2|||
148754524|NCT00729937|536574104|FG002|Overall Study|Incarcerated|1|||
148754525|NCT00729937|536574105|FG003|Overall Study|Incarcerated|1|||
148754526|NCT00729937|536574106|FG004|Overall Study|Incarcerated|0|||
148754527|NCT00729937|536574107|FG005|Overall Study|Incarcerated|0|||
148754528|NCT01478373|536574109|FG000|Treatment Phase|Protocol Violation|1|||
148754529|NCT01478373|536574109|FG000|Survival Phase|Adverse Event|8|||
148754530|NCT01478373|536574109|FG000|Survival Phase|Protocol Violation|1|||
148754531|NCT01478373|536574109|FG000|Survival Phase|crossover to another study|2|||
148754532|NCT01478373|536574109|FG000|Survival Phase|Progressive Disease|27|||
148754533|NCT01408043|536574112|FG000|Overall Study|unable to collect cells|1|||
148754534|NCT02552121|536574115|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
148754535|NCT02552121|536574116|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754536|NCT02552121|536574117|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754537|NCT02552121|536574118|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754538|NCT02552121|536574119|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754539|NCT02552121|536574120|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754540|NCT02552121|536574121|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754541|NCT02552121|536574122|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
148754542|NCT02552121|536574115|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
148754543|NCT02552121|536574116|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754544|NCT02552121|536574117|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754545|NCT02552121|536574118|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754546|NCT02552121|536574119|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754547|NCT02552121|536574120|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754548|NCT02552121|536574121|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754549|NCT02552121|536574122|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
148754550|NCT02552121|536574115|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754551|NCT02552121|536574116|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
148754552|NCT02552121|536574117|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754553|NCT02552121|536574118|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754554|NCT02552121|536574119|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754555|NCT02552121|536574120|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754556|NCT02552121|536574121|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754557|NCT02552121|536574122|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
148754558|NCT02552121|536574115|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754559|NCT02552121|536574116|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
148754560|NCT02552121|536574117|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754561|NCT02552121|536574118|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754562|NCT02552121|536574119|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754563|NCT02552121|536574120|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754564|NCT02552121|536574121|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754565|NCT02552121|536574122|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
148754566|NCT02552121|536574115|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754567|NCT02552121|536574116|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
148754568|NCT02552121|536574117|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754569|NCT02552121|536574118|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754570|NCT02552121|536574119|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754571|NCT02552121|536574120|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754572|NCT02552121|536574121|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754573|NCT02552121|536574122|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
148754574|NCT02552121|536574115|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754575|NCT02552121|536574116|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
148754576|NCT02552121|536574117|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754577|NCT02552121|536574118|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754578|NCT02552121|536574119|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754579|NCT02552121|536574120|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754580|NCT02552121|536574121|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754581|NCT02552121|536574122|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
148754582|NCT02552121|536574115|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
148754583|NCT02552121|536574116|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
148754584|NCT02552121|536574117|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
148754585|NCT02552121|536574118|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
148754586|NCT02552121|536574119|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
148754587|NCT02552121|536574120|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
148754588|NCT02552121|536574121|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
148754589|NCT02552121|536574122|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
148754590|NCT02552121|536574115|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
148754591|NCT02552121|536574116|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
148754592|NCT02552121|536574117|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
148754593|NCT02552121|536574118|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
148754594|NCT02552121|536574119|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
148754595|NCT02552121|536574120|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
148754596|NCT02552121|536574121|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
148754597|NCT02552121|536574122|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
148754598|NCT02552121|536574115|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
148754599|NCT02552121|536574116|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
148754600|NCT02552121|536574117|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
148754601|NCT02552121|536574118|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
148754602|NCT02552121|536574119|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
148754603|NCT02552121|536574120|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
148754604|NCT02552121|536574121|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
148754605|NCT02552121|536574122|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
148754606|NCT02552121|536574115|FG000|Part 2: Cohort Expansion|Death|0|||
148754607|NCT02552121|536574116|FG001|Part 2: Cohort Expansion|Death|0|||
149027405|NCT00293462|537578555|FG001|Overall Study|Physician Decision|1|||
148754608|NCT02552121|536574117|FG002|Part 2: Cohort Expansion|Death|1|||
148754609|NCT02552121|536574118|FG003|Part 2: Cohort Expansion|Death|0|||
148754610|NCT02552121|536574119|FG004|Part 2: Cohort Expansion|Death|0|||
148754611|NCT02552121|536574120|FG005|Part 2: Cohort Expansion|Death|0|||
148754612|NCT02552121|536574121|FG006|Part 2: Cohort Expansion|Death|0|||
148754613|NCT02552121|536574122|FG007|Part 2: Cohort Expansion|Death|0|||
148754614|NCT01522456|536574123|FG000|Overall Study|Adverse Event|2|||
148754615|NCT01522456|536574123|FG000|Overall Study|Lost to Follow-up|2|||
148754616|NCT01522456|536574123|FG000|Overall Study|Withdrawal by Subject|2|||
148754617|NCT01522456|536574123|FG000|Overall Study|Pregnancy|1|||
148754618|NCT01522456|536574123|FG000|Overall Study|Tolerability Assessment|1|||
148754619|NCT04052620|536574124|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
148754620|NCT04052620|536574125|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
148754621|NCT04052620|536574124|FG000|Overall Study|Withdrawal by Subject|1|||
148754622|NCT04052620|536574125|FG001|Overall Study|Withdrawal by Subject|0|||
148754623|NCT04052620|536574124|FG000|Overall Study|Lost to Follow-up|1|||
148754624|NCT04052620|536574125|FG001|Overall Study|Lost to Follow-up|1|||
148754625|NCT04052620|536574124|FG000|Overall Study|Adverse Event|1|||
148754626|NCT04052620|536574125|FG001|Overall Study|Adverse Event|0|||
148754627|NCT04052620|536574124|FG000|Overall Study|Subject did not meet study Criteria|0|||
148754628|NCT04052620|536574125|FG001|Overall Study|Subject did not meet study Criteria|1|||
148754629|NCT04052620|536574124|FG000|Overall Study|Screened failure, randomized by mistake|0|||
148754630|NCT04052620|536574125|FG001|Overall Study|Screened failure, randomized by mistake|1|||
148754631|NCT04052620|536574124|FG000|Overall Study|Personal reasons|2|||
148754632|NCT04052620|536574125|FG001|Overall Study|Personal reasons|4|||
148754633|NCT04052620|536574124|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
148754634|NCT04052620|536574125|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
148754635|NCT02201784|536574127|FG000|Overall Study|Failure to achieve adequate block|2|||
148754636|NCT02201784|536574128|FG001|Overall Study|Failure to achieve adequate block|0|||
148754637|NCT00193050|536574129|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
148754638|NCT00193050|536574129|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
148754639|NCT00193050|536574129|FG000|Neoadjuvant Treatment|Physician Decision|2|||
148754640|NCT00193050|536574129|FG000|Neoadjuvant Treatment|Adverse Event|2|||
148754641|NCT00193050|536574129|FG000|Adjuvant|Physician Decision|5|||
148754642|NCT00193050|536574129|FG000|Adjuvant|Intercurrent Hospitalization|3|||
148754643|NCT00193050|536574129|FG000|Adjuvant|Lack of Efficacy|2|||
148754644|NCT02431364|536574130|FG000|Overall Study|Adverse Event|0|||
148754645|NCT02431364|536574131|FG001|Overall Study|Adverse Event|1|||
148754646|NCT02431364|536574132|FG002|Overall Study|Adverse Event|0|||
148754647|NCT02431364|536574133|FG003|Overall Study|Adverse Event|0|||
148754648|NCT02431364|536574134|FG004|Overall Study|Adverse Event|0|||
148754649|NCT02431364|536574130|FG000|Overall Study|Randomized but never treated|0|||
148754650|NCT02431364|536574131|FG001|Overall Study|Randomized but never treated|0|||
148754651|NCT02431364|536574132|FG002|Overall Study|Randomized but never treated|0|||
148754652|NCT02431364|536574133|FG003|Overall Study|Randomized but never treated|1|||
148754653|NCT02431364|536574134|FG004|Overall Study|Randomized but never treated|0|||
148754654|NCT00061932|536574135|FG000|Overall Study|Withdrawal by Subject|13|||
148754655|NCT00061932|536574136|FG001|Overall Study|Withdrawal by Subject|4|||
148754656|NCT00916383|536574137|FG000|Overall Study|Adverse Event|1|||
148754657|NCT00916383|536574137|FG000|Overall Study|Death|1|||
148754658|NCT00916383|536574137|FG000|Overall Study|Protocol Violation|1|||
148754659|NCT02899962|536574138|FG000|Open-label Phase|Adverse Event|2|||
148754660|NCT02899962|536574139|FG001|Open-label Phase|Adverse Event|0|||
148754661|NCT02899962|536574140|FG002|Open-label Phase|Adverse Event|0|||
148754662|NCT02899962|536574138|FG000|Open-label Phase|Lost to Follow-up|9|||
148754663|NCT02899962|536574139|FG001|Open-label Phase|Lost to Follow-up|0|||
148754664|NCT02899962|536574140|FG002|Open-label Phase|Lost to Follow-up|0|||
148754665|NCT02899962|536574138|FG000|Open-label Phase|Other reasons|9|||
148754666|NCT02899962|536574139|FG001|Open-label Phase|Other reasons|0|||
148754667|NCT02899962|536574140|FG002|Open-label Phase|Other reasons|0|||
148754668|NCT02899962|536574138|FG000|Open-label Phase|Withdrawal by Subject|7|||
148754669|NCT02899962|536574139|FG001|Open-label Phase|Withdrawal by Subject|0|||
148754670|NCT02899962|536574140|FG002|Open-label Phase|Withdrawal by Subject|0|||
148754671|NCT02899962|536574138|FG000|Maintenance Phase|Adverse Event|0|||
148754672|NCT02899962|536574139|FG001|Maintenance Phase|Adverse Event|2|||
148754673|NCT02899962|536574140|FG002|Maintenance Phase|Adverse Event|1|||
148754674|NCT02899962|536574138|FG000|Maintenance Phase|Death|0|||
148754675|NCT02899962|536574139|FG001|Maintenance Phase|Death|0|||
148754676|NCT02899962|536574140|FG002|Maintenance Phase|Death|1|||
148754677|NCT02899962|536574138|FG000|Maintenance Phase|Lack of Efficacy|0|||
148754678|NCT02899962|536574139|FG001|Maintenance Phase|Lack of Efficacy|20|||
148754679|NCT02899962|536574140|FG002|Maintenance Phase|Lack of Efficacy|16|||
148754680|NCT02899962|536574138|FG000|Maintenance Phase|Lost to Follow-up|0|||
148754681|NCT02899962|536574139|FG001|Maintenance Phase|Lost to Follow-up|12|||
148754682|NCT02899962|536574140|FG002|Maintenance Phase|Lost to Follow-up|14|||
148754683|NCT02899962|536574138|FG000|Maintenance Phase|Other reasons|0|||
148754684|NCT02899962|536574139|FG001|Maintenance Phase|Other reasons|9|||
148754685|NCT02899962|536574140|FG002|Maintenance Phase|Other reasons|13|||
148754686|NCT02899962|536574138|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
148754687|NCT02899962|536574139|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
148754688|NCT02899962|536574140|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
148754689|NCT02899962|536574138|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
148754690|NCT02899962|536574139|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
148754691|NCT02899962|536574140|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
148754692|NCT02899962|536574138|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148754693|NCT02899962|536574139|FG001|Maintenance Phase|Withdrawal by Subject|30|||
148754694|NCT02899962|536574140|FG002|Maintenance Phase|Withdrawal by Subject|36|||
148754695|NCT00258960|536574141|FG000|Overall Study|Death|2|||
148754696|NCT00258960|536574141|FG000|Overall Study|Disease Progression|7|||
148754697|NCT00258960|536574141|FG000|Overall Study|Adverse Event|4|||
148754698|NCT00258960|536574141|FG000|Overall Study|Physician Decision|1|||
148754699|NCT00258960|536574141|FG000|Overall Study|Withdrawal by Subject|1|||
148754700|NCT00258960|536574141|FG000|Overall Study|Mistake|2|||
148754701|NCT00473590|536574142|FG000|Overall Study|Adverse Event|3|||
148754702|NCT00473590|536574143|FG001|Overall Study|Adverse Event|3|||
148754703|NCT00473590|536574142|FG000|Overall Study|Death|4|||
148754704|NCT00473590|536574143|FG001|Overall Study|Death|2|||
148754705|NCT00473590|536574142|FG000|Overall Study|Progression not resulting in death|24|||
148754706|NCT00473590|536574143|FG001|Overall Study|Progression not resulting in death|20|||
148754707|NCT00473590|536574142|FG000|Overall Study|Non-protocol-specified therapy|7|||
148754708|NCT00473590|536574143|FG001|Overall Study|Non-protocol-specified therapy|5|||
148754709|NCT00473590|536574142|FG000|Overall Study|Physician Decision|2|||
148754710|NCT00473590|536574143|FG001|Overall Study|Physician Decision|4|||
148754711|NCT00473590|536574142|FG000|Overall Study|Withdrawal by Subject|5|||
148754712|NCT00473590|536574143|FG001|Overall Study|Withdrawal by Subject|3|||
148754713|NCT00473590|536574142|FG000|Overall Study|Other|0|||
148754714|NCT00473590|536574143|FG001|Overall Study|Other|1|||
148754715|NCT01245283|536574146|FG000|Overall Study|Lost to Follow-up|14|||
148754716|NCT01245283|536574147|FG001|Overall Study|Lost to Follow-up|11|||
148754717|NCT01245283|536574148|FG002|Overall Study|Lost to Follow-up|11|||
148754718|NCT01610492|536574157|FG000|Overall Study|Adverse Event|1|||
148754719|NCT01610492|536574157|FG000|Overall Study|Lack of Efficacy|3|||
148754720|NCT01610492|536574157|FG000|Overall Study|Other: Reached stopping criteria|1|||
148754721|NCT01610492|536574157|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
148754722|NCT03093259|536574159|FG000|Overall Study|Adverse Event|1|||
148754723|NCT03093259|536574160|FG001|Overall Study|Adverse Event|0|||
148754724|NCT03093259|536574159|FG000|Overall Study|Withdrawal by Subject|1|||
148754725|NCT03093259|536574160|FG001|Overall Study|Withdrawal by Subject|0|||
148754726|NCT01757275|536574161|FG000|Overall Study|Lost to Follow-up|1|||
148754727|NCT01757275|536574162|FG001|Overall Study|Lost to Follow-up|2|||
148754728|NCT01757275|536574161|FG000|Overall Study|Adverse Event|3|||
148754729|NCT01757275|536574162|FG001|Overall Study|Adverse Event|3|||
148754730|NCT01757275|536574161|FG000|Overall Study|Withdrawal by Subject|2|||
148754731|NCT01757275|536574162|FG001|Overall Study|Withdrawal by Subject|4|||
148754732|NCT01757275|536574161|FG000|Overall Study|Not treated|3|||
148754733|NCT01757275|536574162|FG001|Overall Study|Not treated|4|||
148754734|NCT01821807|536574163|FG000|Overall Study|Lost to Follow-up|3|||
148754735|NCT01821807|536574164|FG001|Overall Study|Lost to Follow-up|1|||
148754736|NCT01401452|536574166|FG000|Overall Study|Adverse reaction|9|||
148754737|NCT01401452|536574166|FG000|Overall Study|Lost to Follow-up|12|||
148754738|NCT01401452|536574166|FG000|Overall Study|Lack of Efficacy|30|||
148754739|NCT01401452|536574166|FG000|Overall Study|Participant developed breast cancer|1|||
148754740|NCT01401452|536574166|FG000|Overall Study|Tx stopped due to financial reasons|1|||
148754741|NCT01401452|536574166|FG000|Overall Study|Tx stopped by psychiatrist|1|||
148754742|NCT01401452|536574166|FG000|Overall Study|No more visits within the 36 wk followup|4|||
148754743|NCT01401452|536574166|FG000|Overall Study|Subject did not come to follow up visits|2|||
148754744|NCT01401452|536574166|FG000|Overall Study|Subject didn't return for routine visits|1|||
148754745|NCT01401452|536574166|FG000|Overall Study|Subject moved to another city|1|||
148754746|NCT01401452|536574166|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
148754747|NCT01401452|536574166|FG000|Overall Study|Psoriatic arthritis|1|||
148822993|NCT01557244|536830719|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
148822994|NCT01557244|536830720|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
148976354|NCT03604692|537394526|FG001|Overall Study|Progressive Disease|0|||
148754748|NCT01401452|536574166|FG000|Overall Study|Participant stopped Tx|2|||
148754749|NCT01401452|536574166|FG000|Overall Study|Discontinuation for personal reasons|1|||
148754750|NCT01401452|536574166|FG000|Overall Study|Treatment failure|1|||
148754751|NCT01401452|536574166|FG000|Overall Study|Unsatisfactory output|1|||
148754752|NCT01401452|536574166|FG000|Overall Study|Subject withdrew because of Tx success|1|||
148754753|NCT01401452|536574166|FG000|Overall Study|Subject chose to discontinue treatment|1|||
148754754|NCT01401452|536574166|FG000|Overall Study|Participant withdrew consent|1|||
148754755|NCT00584454|536574167|FG000|Overall Study|Adverse Event|1|||
148754756|NCT00584454|536574167|FG000|Overall Study|Relocation|1|||
148754757|NCT00584454|536574167|FG000|Overall Study|Clinical Hold|2|||
148754758|NCT01459783|536574169|FG000|Baseline to 6 Months|Death|1|||
148754759|NCT01459783|536574170|FG001|Baseline to 6 Months|Death|0|||
148754760|NCT01459783|536574169|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
148754761|NCT01459783|536574170|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
148754762|NCT01459783|536574169|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
148754763|NCT01459783|536574170|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
148754764|NCT01459783|536574169|FG000|6 Months to 12 Months|Death|0|||
148754765|NCT01459783|536574170|FG001|6 Months to 12 Months|Death|1|||
148754766|NCT01459783|536574169|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
148754767|NCT01459783|536574170|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
148754768|NCT01459783|536574169|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
148754769|NCT01459783|536574170|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
148754770|NCT01459783|536574169|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
148754771|NCT01459783|536574170|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
148754772|NCT02601014|536574171|FG000|Overall Study|Adverse Event|3|||
148754773|NCT02601014|536574172|FG001|Overall Study|Adverse Event|3|||
148754774|NCT02601014|536574171|FG000|Overall Study|Death|3|||
148754775|NCT02601014|536574172|FG001|Overall Study|Death|1|||
148754776|NCT02601014|536574171|FG000|Overall Study|Disease progression|4|||
148754777|NCT02601014|536574172|FG001|Overall Study|Disease progression|8|||
148754778|NCT00445146|536574175|FG000|Overall Study|Withdrew Consent|29|||
148754779|NCT00445146|536574175|FG000|Overall Study|Lack of Efficacy|28|||
148754780|NCT00445146|536574175|FG000|Overall Study|Investigator's Discretion|22|||
148754781|NCT00445146|536574175|FG000|Overall Study|Adverse Event|13|||
148754782|NCT00445146|536574175|FG000|Overall Study|Lost to Follow-up|13|||
148754783|NCT00445146|536574175|FG000|Overall Study|Death|9|||
148754784|NCT00445146|536574175|FG000|Overall Study|Protocol Violation|4|||
148754785|NCT00445146|536574175|FG000|Overall Study|Pregnancy|1|||
148754786|NCT06389487|536574178|FG000|Overall Study|Lost to Follow-up|9|||
148754787|NCT06389487|536574179|FG001|Overall Study|Lost to Follow-up|5|||
148754788|NCT06389487|536574180|FG002|Overall Study|Lost to Follow-up|13|||
148754789|NCT06389487|536574178|FG000|Overall Study|Protocol Violation|0|||
148754790|NCT06389487|536574179|FG001|Overall Study|Protocol Violation|0|||
148754791|NCT06389487|536574180|FG002|Overall Study|Protocol Violation|2|||
148754792|NCT06389487|536574178|FG000|Overall Study|Withdrawal by Subject|2|||
148754793|NCT06389487|536574179|FG001|Overall Study|Withdrawal by Subject|2|||
148754794|NCT06389487|536574180|FG002|Overall Study|Withdrawal by Subject|1|||
148754795|NCT06389487|536574178|FG000|Overall Study|Other|1|||
148754796|NCT06389487|536574179|FG001|Overall Study|Other|0|||
148754797|NCT06389487|536574180|FG002|Overall Study|Other|1|||
148754798|NCT00858273|536574181|FG000|Overall Study|Protocol Violation|3|||
148754799|NCT00858273|536574182|FG001|Overall Study|Protocol Violation|5|||
148754800|NCT00070564|536576520|FG000|Overall Study|Progression|2|||
148754801|NCT00070564|536576521|FG001|Overall Study|Progression|4|||
148754802|NCT00070564|536576522|FG002|Overall Study|Progression|7|||
148754803|NCT00070564|536576523|FG003|Overall Study|Progression|7|||
148754804|NCT00070564|536576524|FG004|Overall Study|Progression|1|||
148754805|NCT00070564|536576525|FG005|Overall Study|Progression|0|||
148754806|NCT00070564|536576520|FG000|Overall Study|Delinquent|1|||
148754807|NCT00070564|536576521|FG001|Overall Study|Delinquent|4|||
148754808|NCT00070564|536576522|FG002|Overall Study|Delinquent|2|||
148754809|NCT00070564|536576523|FG003|Overall Study|Delinquent|0|||
148754810|NCT00070564|536576524|FG004|Overall Study|Delinquent|0|||
148754811|NCT00070564|536576525|FG005|Overall Study|Delinquent|0|||
148754812|NCT00070564|536576520|FG000|Overall Study|Adverse Event|150|||
148754813|NCT00070564|536576521|FG001|Overall Study|Adverse Event|142|||
148754814|NCT00070564|536576522|FG002|Overall Study|Adverse Event|120|||
148754815|NCT00070564|536576523|FG003|Overall Study|Adverse Event|108|||
148754816|NCT00070564|536576524|FG004|Overall Study|Adverse Event|63|||
148754817|NCT00070564|536576525|FG005|Overall Study|Adverse Event|36|||
148754818|NCT00070564|536576520|FG000|Overall Study|Death|4|||
148754819|NCT00070564|536576521|FG001|Overall Study|Death|1|||
148976355|NCT03604692|537394527|FG002|Overall Study|Progressive Disease|1|||
148976356|NCT03604692|537394528|FG003|Overall Study|Progressive Disease|0|||
148976357|NCT03604692|537394529|FG004|Overall Study|Progressive Disease|3|||
148976358|NCT03604692|537394530|FG005|Overall Study|Progressive Disease|4|||
148754820|NCT00070564|536576522|FG002|Overall Study|Death|5|||
148754821|NCT00070564|536576523|FG003|Overall Study|Death|3|||
148754822|NCT00070564|536576524|FG004|Overall Study|Death|0|||
148754823|NCT00070564|536576525|FG005|Overall Study|Death|1|||
148754824|NCT00070564|536576520|FG000|Overall Study|Other, not protocol specified|17|||
148754825|NCT00070564|536576521|FG001|Overall Study|Other, not protocol specified|15|||
148754826|NCT00070564|536576522|FG002|Overall Study|Other, not protocol specified|14|||
148754827|NCT00070564|536576523|FG003|Overall Study|Other, not protocol specified|19|||
148754828|NCT00070564|536576524|FG004|Overall Study|Other, not protocol specified|6|||
148754829|NCT00070564|536576525|FG005|Overall Study|Other, not protocol specified|7|||
148976359|NCT03604692|537394525|FG000|Overall Study|Difficulty Coming into Site|0|||
148976360|NCT03604692|537394526|FG001|Overall Study|Difficulty Coming into Site|0|||
148754830|NCT00070564|536576520|FG000|Overall Study|Withdrawal by Subject|26|||
148754831|NCT00070564|536576521|FG001|Overall Study|Withdrawal by Subject|37|||
148754832|NCT00070564|536576522|FG002|Overall Study|Withdrawal by Subject|23|||
148754833|NCT00070564|536576523|FG003|Overall Study|Withdrawal by Subject|30|||
148754834|NCT00070564|536576524|FG004|Overall Study|Withdrawal by Subject|8|||
148754835|NCT00070564|536576525|FG005|Overall Study|Withdrawal by Subject|8|||
148754836|NCT00070564|536576520|FG000|Overall Study|Not reported|0|||
148754837|NCT00070564|536576521|FG001|Overall Study|Not reported|0|||
148754838|NCT00070564|536576522|FG002|Overall Study|Not reported|0|||
148754839|NCT00070564|536576523|FG003|Overall Study|Not reported|0|||
148754840|NCT00070564|536576524|FG004|Overall Study|Not reported|1|||
148754841|NCT00070564|536576525|FG005|Overall Study|Not reported|0|||
148754842|NCT04796961|536576526|FG000|Overall Study|Lost to Follow-up|10|||
148754843|NCT04796961|536576526|FG000|Overall Study|Withdrawal by Subject|3|||
148754844|NCT04796961|536576526|FG000|Overall Study|Left Organization|10|||
148754845|NCT03018288|536576527|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
148754846|NCT03018288|536576528|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
148754847|NCT03018288|536576529|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
148754848|NCT03018288|536576530|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
148754849|NCT03018288|536576527|FG000|Overall Study|Participant withdrew consent.|0|||
148754850|NCT03018288|536576528|FG001|Overall Study|Participant withdrew consent.|0|||
148754851|NCT03018288|536576529|FG002|Overall Study|Participant withdrew consent.|1|||
148754852|NCT03018288|536576530|FG003|Overall Study|Participant withdrew consent.|0|||
148754853|NCT03018288|536576527|FG000|Overall Study|Switched to alternative treatment.|0|||
148754854|NCT03018288|536576528|FG001|Overall Study|Switched to alternative treatment.|0|||
148754855|NCT03018288|536576529|FG002|Overall Study|Switched to alternative treatment.|1|||
148754856|NCT03018288|536576530|FG003|Overall Study|Switched to alternative treatment.|0|||
148754857|NCT03018288|536576527|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
148754858|NCT03018288|536576528|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
148754859|NCT03018288|536576529|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
148754860|NCT03018288|536576530|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
148754861|NCT03018288|536576527|FG000|Overall Study|Screen failures|0|||
148754862|NCT03018288|536576528|FG001|Overall Study|Screen failures|0|||
148754863|NCT03018288|536576529|FG002|Overall Study|Screen failures|0|||
148754864|NCT03018288|536576530|FG003|Overall Study|Screen failures|51|||
148754865|NCT03018288|536576527|FG000|Overall Study|Chose treatment outside of UNC|0|||
148754866|NCT03018288|536576528|FG001|Overall Study|Chose treatment outside of UNC|0|||
148754867|NCT03018288|536576529|FG002|Overall Study|Chose treatment outside of UNC|0|||
148754868|NCT03018288|536576530|FG003|Overall Study|Chose treatment outside of UNC|1|||
148754869|NCT03018288|536576527|FG000|Overall Study|Unable to comply with protocol requirements|1|||
148754870|NCT03018288|536576528|FG001|Overall Study|Unable to comply with protocol requirements|1|||
148754871|NCT03018288|536576529|FG002|Overall Study|Unable to comply with protocol requirements|0|||
148754872|NCT03018288|536576530|FG003|Overall Study|Unable to comply with protocol requirements|1|||
148754873|NCT03018288|536576527|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
148754874|NCT03018288|536576528|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
148754875|NCT03018288|536576529|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
148754876|NCT03018288|536576530|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
148754877|NCT03018288|536576527|FG000|Overall Study|Physician Decision|0|||
148754878|NCT03018288|536576528|FG001|Overall Study|Physician Decision|0|||
148754879|NCT03018288|536576529|FG002|Overall Study|Physician Decision|0|||
148754880|NCT03018288|536576530|FG003|Overall Study|Physician Decision|1|||
148754881|NCT01490086|536576534|FG000|Overall Study|Consent withdrawn|4|||
148754882|NCT01490086|536576535|FG001|Overall Study|Consent withdrawn|4|||
148754883|NCT01490086|536576536|FG002|Overall Study|Consent withdrawn|3|||
148754884|NCT01490086|536576537|FG003|Overall Study|Consent withdrawn|0|||
148754885|NCT01490086|536576538|FG004|Overall Study|Consent withdrawn|1|||
148754886|NCT01490086|536576534|FG000|Overall Study|Non-compliance|0|||
148754887|NCT01490086|536576535|FG001|Overall Study|Non-compliance|1|||
148754888|NCT01490086|536576536|FG002|Overall Study|Non-compliance|0|||
148754889|NCT01490086|536576537|FG003|Overall Study|Non-compliance|0|||
148754890|NCT01490086|536576538|FG004|Overall Study|Non-compliance|0|||
148754891|NCT01490086|536576534|FG000|Overall Study|Abnormal laboratory findings|1|||
148754892|NCT01490086|536576535|FG001|Overall Study|Abnormal laboratory findings|0|||
148754893|NCT01490086|536576536|FG002|Overall Study|Abnormal laboratory findings|0|||
148754894|NCT01490086|536576537|FG003|Overall Study|Abnormal laboratory findings|0|||
148754895|NCT01490086|536576538|FG004|Overall Study|Abnormal laboratory findings|0|||
149027406|NCT00293462|537578556|FG002|Overall Study|Physician Decision|0|||
148754896|NCT01490086|536576534|FG000|Overall Study|Lost to Follow-up|0|||
148754897|NCT01490086|536576535|FG001|Overall Study|Lost to Follow-up|0|||
148754898|NCT01490086|536576536|FG002|Overall Study|Lost to Follow-up|0|||
148754899|NCT01490086|536576537|FG003|Overall Study|Lost to Follow-up|0|||
148754900|NCT01490086|536576538|FG004|Overall Study|Lost to Follow-up|1|||
148754901|NCT01490086|536576534|FG000|Overall Study|Physician Decision|3|||
148754902|NCT01490086|536576535|FG001|Overall Study|Physician Decision|4|||
148754903|NCT01490086|536576536|FG002|Overall Study|Physician Decision|2|||
148754904|NCT01490086|536576537|FG003|Overall Study|Physician Decision|3|||
148754905|NCT01490086|536576538|FG004|Overall Study|Physician Decision|1|||
148754906|NCT01490086|536576534|FG000|Overall Study|Adverse Event|0|||
148754907|NCT01490086|536576535|FG001|Overall Study|Adverse Event|0|||
148754908|NCT01490086|536576536|FG002|Overall Study|Adverse Event|1|||
148754909|NCT01490086|536576537|FG003|Overall Study|Adverse Event|2|||
148754910|NCT01490086|536576538|FG004|Overall Study|Adverse Event|0|||
148754911|NCT01490086|536576534|FG000|Overall Study|Lack of Efficacy|0|||
148754912|NCT01490086|536576535|FG001|Overall Study|Lack of Efficacy|3|||
148754913|NCT01490086|536576536|FG002|Overall Study|Lack of Efficacy|1|||
148754914|NCT01490086|536576537|FG003|Overall Study|Lack of Efficacy|0|||
148754915|NCT01490086|536576538|FG004|Overall Study|Lack of Efficacy|8|||
148754916|NCT01490086|536576534|FG000|Overall Study|Worsening of symptoms|0|||
148754917|NCT01490086|536576535|FG001|Overall Study|Worsening of symptoms|1|||
148754918|NCT01490086|536576536|FG002|Overall Study|Worsening of symptoms|0|||
148754919|NCT01490086|536576537|FG003|Overall Study|Worsening of symptoms|1|||
148754920|NCT01490086|536576538|FG004|Overall Study|Worsening of symptoms|0|||
148754921|NCT01490086|536576534|FG000|Overall Study|Subject uncontrollable and abusive|0|||
148754922|NCT01490086|536576535|FG001|Overall Study|Subject uncontrollable and abusive|1|||
148754923|NCT01490086|536576536|FG002|Overall Study|Subject uncontrollable and abusive|0|||
148754924|NCT01490086|536576537|FG003|Overall Study|Subject uncontrollable and abusive|0|||
148754925|NCT01490086|536576538|FG004|Overall Study|Subject uncontrollable and abusive|0|||
148754926|NCT01490086|536576534|FG000|Overall Study|Subject left hospital|0|||
148754927|NCT01490086|536576535|FG001|Overall Study|Subject left hospital|1|||
148754928|NCT01490086|536576536|FG002|Overall Study|Subject left hospital|0|||
148754929|NCT01490086|536576537|FG003|Overall Study|Subject left hospital|1|||
148754930|NCT01490086|536576538|FG004|Overall Study|Subject left hospital|0|||
148754931|NCT05825404|536576539|FG000|First Intervention (Weeks 2-5)|Death|0|||
148754932|NCT05825404|536576540|FG001|First Intervention (Weeks 2-5)|Death|1|||
148754933|NCT05825404|536576539|FG000|Second Intervention (Weeks 8-11)|Death|0|||
148754934|NCT05825404|536576540|FG001|Second Intervention (Weeks 8-11)|Death|1|||
148754935|NCT01127256|536576541|FG000|Overall Study|Adverse Event|13|||
148754936|NCT01127256|536576542|FG001|Overall Study|Adverse Event|13|||
148754937|NCT01127256|536576541|FG000|Overall Study|Lack of Efficacy|4|||
148754938|NCT01127256|536576542|FG001|Overall Study|Lack of Efficacy|0|||
148754939|NCT01127256|536576541|FG000|Overall Study|Lost to Follow-up|16|||
148754940|NCT01127256|536576542|FG001|Overall Study|Lost to Follow-up|17|||
148754941|NCT01127256|536576541|FG000|Overall Study|Withdrawal by Subject|5|||
148754942|NCT01127256|536576542|FG001|Overall Study|Withdrawal by Subject|9|||
148754943|NCT01127256|536576541|FG000|Overall Study|Protocol Violation|1|||
148754944|NCT01127256|536576542|FG001|Overall Study|Protocol Violation|0|||
148754945|NCT00679211|536576543|FG000|Overall Study|Progressive disease|82|||
148754946|NCT00679211|536576543|FG000|Overall Study|Adverse Event|7|||
148754947|NCT00679211|536576543|FG000|Overall Study|Withdrawal by Subject|2|||
148754948|NCT00679211|536576543|FG000|Overall Study|Physician Decision|5|||
148754949|NCT00679211|536576543|FG000|Overall Study|Refused to undergo protocol procedures|1|||
148754950|NCT00679211|536576543|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
148754951|NCT00679211|536576543|FG000|Overall Study|Other|1|||
148754952|NCT00931528|536576544|FG000|Overall Study|Protocol Violation|9|||
148754953|NCT00931528|536576545|FG001|Overall Study|Protocol Violation|12|||
148754954|NCT00931528|536576544|FG000|Overall Study|Withdrawal by Subject|4|||
148754955|NCT00931528|536576545|FG001|Overall Study|Withdrawal by Subject|12|||
148754956|NCT00931528|536576544|FG000|Overall Study|Lost to Follow-up|6|||
148754957|NCT00931528|536576545|FG001|Overall Study|Lost to Follow-up|13|||
148754958|NCT00931528|536576544|FG000|Overall Study|Assessment outside of Time Frame|22|||
148754959|NCT00931528|536576545|FG001|Overall Study|Assessment outside of Time Frame|23|||
148754960|NCT01730053|536576546|FG000|Overall Study|Participant moved|0|||
148754961|NCT01730053|536576547|FG001|Overall Study|Participant moved|0|||
148754962|NCT01730053|536576548|FG002|Overall Study|Participant moved|1|||
148754963|NCT01730053|536576549|FG003|Overall Study|Participant moved|0|||
148754964|NCT01730053|536576550|FG004|Overall Study|Participant moved|0|||
148754965|NCT01730053|536576551|FG005|Overall Study|Participant moved|0|||
148754966|NCT01730053|536576546|FG000|Overall Study|Physician Decision|0|||
148754967|NCT01730053|536576547|FG001|Overall Study|Physician Decision|0|||
148754968|NCT01730053|536576548|FG002|Overall Study|Physician Decision|0|||
148754969|NCT01730053|536576549|FG003|Overall Study|Physician Decision|1|||
148754970|NCT01730053|536576550|FG004|Overall Study|Physician Decision|0|||
148754971|NCT01730053|536576551|FG005|Overall Study|Physician Decision|0|||
148754972|NCT01730053|536576546|FG000|Overall Study|Adverse Event|2|||
148754973|NCT01730053|536576547|FG001|Overall Study|Adverse Event|6|||
148754974|NCT01730053|536576548|FG002|Overall Study|Adverse Event|3|||
148754975|NCT01730053|536576549|FG003|Overall Study|Adverse Event|3|||
148754976|NCT01730053|536576550|FG004|Overall Study|Adverse Event|2|||
148754977|NCT01730053|536576551|FG005|Overall Study|Adverse Event|2|||
148754978|NCT01730053|536576546|FG000|Overall Study|Poor compliance to protocol|1|||
148754979|NCT01730053|536576547|FG001|Overall Study|Poor compliance to protocol|2|||
148754980|NCT01730053|536576548|FG002|Overall Study|Poor compliance to protocol|2|||
148754981|NCT01730053|536576549|FG003|Overall Study|Poor compliance to protocol|0|||
148754982|NCT01730053|536576550|FG004|Overall Study|Poor compliance to protocol|0|||
148754983|NCT01730053|536576551|FG005|Overall Study|Poor compliance to protocol|2|||
148754984|NCT01730053|536576546|FG000|Overall Study|Other than specified|2|||
148754985|NCT01730053|536576547|FG001|Overall Study|Other than specified|6|||
148754986|NCT01730053|536576548|FG002|Overall Study|Other than specified|5|||
148754987|NCT01730053|536576549|FG003|Overall Study|Other than specified|4|||
148754988|NCT01730053|536576550|FG004|Overall Study|Other than specified|7|||
148754989|NCT01730053|536576551|FG005|Overall Study|Other than specified|9|||
148754990|NCT01470248|536576552|FG000|Overall Study|Withdrawal by Subject|1|||
148754991|NCT05842967|536576555|FG000|Period 1: SSA|Adverse Event|1|||
148754992|NCT05842967|536576556|FG001|Period 1: SSA|Adverse Event|1|||
148754993|NCT05842967|536576557|FG002|Period 1: SSA|Adverse Event|0|||
148754994|NCT05842967|536576558|FG003|Period 1: SSA|Adverse Event|0|||
148754995|NCT05842967|536576555|FG000|Period 1: SSA|Death|1|||
148754996|NCT05842967|536576556|FG001|Period 1: SSA|Death|0|||
148754997|NCT05842967|536576557|FG002|Period 1: SSA|Death|0|||
148754998|NCT05842967|536576558|FG003|Period 1: SSA|Death|0|||
148754999|NCT05842967|536576555|FG000|Period 1: SSA|Lost to Follow-up|16|||
148755000|NCT05842967|536576556|FG001|Period 1: SSA|Lost to Follow-up|4|||
148755001|NCT05842967|536576557|FG002|Period 1: SSA|Lost to Follow-up|0|||
148755002|NCT05842967|536576558|FG003|Period 1: SSA|Lost to Follow-up|0|||
148755003|NCT05842967|536576555|FG000|Period 1: SSA|Physician Decision|1|||
148755004|NCT05842967|536576556|FG001|Period 1: SSA|Physician Decision|0|||
148755005|NCT05842967|536576557|FG002|Period 1: SSA|Physician Decision|0|||
148755006|NCT05842967|536576558|FG003|Period 1: SSA|Physician Decision|0|||
148755007|NCT05842967|536576555|FG000|Period 1: SSA|Withdrawal by Subject|2|||
148755008|NCT05842967|536576556|FG001|Period 1: SSA|Withdrawal by Subject|2|||
148755009|NCT05842967|536576557|FG002|Period 1: SSA|Withdrawal by Subject|0|||
148755010|NCT05842967|536576558|FG003|Period 1: SSA|Withdrawal by Subject|0|||
148755011|NCT05842967|536576555|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
148755012|NCT05842967|536576556|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
148755013|NCT05842967|536576557|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
148755014|NCT05842967|536576558|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
148755015|NCT05842967|536576555|FG000|Period 2: SSB|Adverse Event|0|||
148755016|NCT05842967|536576556|FG001|Period 2: SSB|Adverse Event|0|||
148755017|NCT05842967|536576557|FG002|Period 2: SSB|Adverse Event|2|||
148755018|NCT05842967|536576558|FG003|Period 2: SSB|Adverse Event|0|||
148755019|NCT05842967|536576555|FG000|Period 2: SSB|Lost to Follow-up|0|||
148755020|NCT05842967|536576556|FG001|Period 2: SSB|Lost to Follow-up|0|||
148755021|NCT05842967|536576557|FG002|Period 2: SSB|Lost to Follow-up|4|||
148755022|NCT05842967|536576558|FG003|Period 2: SSB|Lost to Follow-up|3|||
148755023|NCT05842967|536576555|FG000|Period 2: SSB|Withdrawal by Subject|0|||
148755024|NCT05842967|536576556|FG001|Period 2: SSB|Withdrawal by Subject|0|||
148755025|NCT05842967|536576557|FG002|Period 2: SSB|Withdrawal by Subject|1|||
148755026|NCT05842967|536576558|FG003|Period 2: SSB|Withdrawal by Subject|0|||
148755027|NCT05842967|536576555|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
148755028|NCT05842967|536576556|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
148755029|NCT05842967|536576557|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
148755030|NCT05842967|536576558|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
148755031|NCT05842967|536576555|FG000|Period 2: SSB|Protocol Violation|0|||
148755032|NCT05842967|536576556|FG001|Period 2: SSB|Protocol Violation|0|||
148755033|NCT05842967|536576557|FG002|Period 2: SSB|Protocol Violation|0|||
148755034|NCT05842967|536576558|FG003|Period 2: SSB|Protocol Violation|1|||
148755035|NCT03103087|536576559|FG000|Overall Study|Did not receive any study drug|1|||
148755036|NCT03103087|536576560|FG001|Overall Study|Did not receive any study drug|0|||
148755037|NCT03103087|536576561|FG002|Overall Study|Did not receive any study drug|0|||
148755038|NCT03103087|536576559|FG000|Overall Study|Protocol Violation|1|||
148755039|NCT03103087|536576560|FG001|Overall Study|Protocol Violation|2|||
148755040|NCT03103087|536576561|FG002|Overall Study|Protocol Violation|1|||
148755041|NCT03103087|536576559|FG000|Overall Study|Lack of Efficacy|2|||
148755042|NCT03103087|536576560|FG001|Overall Study|Lack of Efficacy|1|||
148755043|NCT03103087|536576561|FG002|Overall Study|Lack of Efficacy|1|||
148755044|NCT03103087|536576559|FG000|Overall Study|Pregnancy|0|||
148755045|NCT03103087|536576560|FG001|Overall Study|Pregnancy|0|||
148755046|NCT03103087|536576561|FG002|Overall Study|Pregnancy|1|||
148755047|NCT03103087|536576559|FG000|Overall Study|Adverse Event|2|||
148755048|NCT03103087|536576560|FG001|Overall Study|Adverse Event|15|||
149027407|NCT00688688|537578557|FG000|Overall Study|Eligibility criterion not met|7|||
148755049|NCT03103087|536576561|FG002|Overall Study|Adverse Event|6|||
148755050|NCT03103087|536576559|FG000|Overall Study|Withdrawal by Subject|13|||
148755051|NCT03103087|536576560|FG001|Overall Study|Withdrawal by Subject|6|||
148755052|NCT03103087|536576561|FG002|Overall Study|Withdrawal by Subject|6|||
148755053|NCT03103087|536576559|FG000|Overall Study|Lost to Follow-up|4|||
148755054|NCT03103087|536576560|FG001|Overall Study|Lost to Follow-up|2|||
148755055|NCT03103087|536576561|FG002|Overall Study|Lost to Follow-up|7|||
148755056|NCT03103087|536576559|FG000|Overall Study|Other reason not reported|1|||
148755057|NCT03103087|536576560|FG001|Overall Study|Other reason not reported|3|||
148755058|NCT03103087|536576561|FG002|Overall Study|Other reason not reported|5|||
148755059|NCT03511105|536576563|FG000|Overall Study|Adverse Event|1|||
148755060|NCT03511105|536576564|FG001|Overall Study|Adverse Event|0|||
148755061|NCT03511105|536576563|FG000|Overall Study|Withdrew consent|1|||
148755062|NCT03511105|536576564|FG001|Overall Study|Withdrew consent|0|||
148755063|NCT01402570|536576567|FG000|Overall Study|Adverse Event|1|||
148755064|NCT02019472|536576570|FG000|Overall Study|Adverse Event|14|||
148755065|NCT02019472|536576571|FG001|Overall Study|Adverse Event|23|||
148755066|NCT02019472|536576572|FG002|Overall Study|Adverse Event|17|||
148755067|NCT02019472|536576570|FG000|Overall Study|Death|0|||
148755068|NCT02019472|536576571|FG001|Overall Study|Death|1|||
148755069|NCT02019472|536576572|FG002|Overall Study|Death|1|||
148755070|NCT02019472|536576570|FG000|Overall Study|Lack of Efficacy|7|||
148755071|NCT02019472|536576571|FG001|Overall Study|Lack of Efficacy|4|||
148755072|NCT02019472|536576572|FG002|Overall Study|Lack of Efficacy|4|||
148755073|NCT02019472|536576570|FG000|Overall Study|Lost to Follow-up|0|||
148755074|NCT02019472|536576571|FG001|Overall Study|Lost to Follow-up|2|||
148755075|NCT02019472|536576572|FG002|Overall Study|Lost to Follow-up|1|||
148755076|NCT02019472|536576570|FG000|Overall Study|Physician Decision|1|||
148755077|NCT02019472|536576571|FG001|Overall Study|Physician Decision|2|||
148755078|NCT02019472|536576572|FG002|Overall Study|Physician Decision|0|||
148755079|NCT02019472|536576570|FG000|Overall Study|Pregnancy|1|||
148755080|NCT02019472|536576571|FG001|Overall Study|Pregnancy|2|||
148755081|NCT02019472|536576572|FG002|Overall Study|Pregnancy|2|||
148755082|NCT02019472|536576570|FG000|Overall Study|Withdrawal by Subject|11|||
148755083|NCT02019472|536576571|FG001|Overall Study|Withdrawal by Subject|10|||
148755084|NCT02019472|536576572|FG002|Overall Study|Withdrawal by Subject|11|||
148755085|NCT02019472|536576570|FG000|Overall Study|Other|3|||
148755086|NCT02019472|536576571|FG001|Overall Study|Other|8|||
148755087|NCT02019472|536576572|FG002|Overall Study|Other|6|||
148755088|NCT00513695|536576573|FG000|Overall Study|Discontinued therapy|2|||
148755089|NCT00513695|536576573|FG000|Overall Study|Progression prior to surgery|3|||
148755090|NCT02157935|536576574|FG000|Overall Study|Withdrawal by Subject|25|||
148755091|NCT02157935|536576575|FG001|Overall Study|Withdrawal by Subject|39|||
148755092|NCT02157935|536576574|FG000|Overall Study|Screen failure|1|||
148755093|NCT02157935|536576575|FG001|Overall Study|Screen failure|2|||
148755094|NCT02157935|536576574|FG000|Overall Study|Protocol Violation|1|||
148755095|NCT02157935|536576575|FG001|Overall Study|Protocol Violation|0|||
148755096|NCT02157935|536576574|FG000|Overall Study|Progressive disease|0|||
148755097|NCT02157935|536576575|FG001|Overall Study|Progressive disease|2|||
148755098|NCT02157935|536576574|FG000|Overall Study|Other|5|||
148755099|NCT02157935|536576575|FG001|Overall Study|Other|12|||
148755100|NCT02157935|536576574|FG000|Overall Study|Lack of Efficacy|0|||
148755101|NCT02157935|536576575|FG001|Overall Study|Lack of Efficacy|1|||
148755102|NCT02157935|536576574|FG000|Overall Study|Death|4|||
148755103|NCT02157935|536576575|FG001|Overall Study|Death|4|||
148755104|NCT02157935|536576574|FG000|Overall Study|Adverse Event|3|||
148755105|NCT02157935|536576575|FG001|Overall Study|Adverse Event|5|||
148755106|NCT01173523|536576582|FG000|Overall Study|Clinical Progression|1|||
148755107|NCT01173523|536576583|FG001|Overall Study|Clinical Progression|1|||
148755108|NCT01173523|536576582|FG000|Overall Study|Progressive Disease|10|||
148755109|NCT01173523|536576583|FG001|Overall Study|Progressive Disease|8|||
148755110|NCT01173523|536576582|FG000|Overall Study|Other|2|||
148755111|NCT01173523|536576583|FG001|Overall Study|Other|3|||
148755112|NCT04429503|536576588|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
148755113|NCT04429503|536576589|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
148755114|NCT04429503|536576590|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
148755115|NCT04429503|536576591|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
148755116|NCT04429503|536576592|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
148755117|NCT04429503|536576593|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
148755118|NCT04429503|536576588|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
148755119|NCT04429503|536576589|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
148755120|NCT04429503|536576590|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
148755121|NCT04429503|536576591|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
148822995|NCT01557244|536830721|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
148822996|NCT01557244|536830722|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
148822997|NCT01557244|536830723|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
148755122|NCT04429503|536576592|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
148755123|NCT04429503|536576593|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
148822998|NCT01313676|536830724|FG000|Overall Study|Adverse Event|395|||
148822999|NCT01313676|536830725|FG001|Overall Study|Adverse Event|365|||
148755124|NCT04429503|536576588|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
148823000|NCT01313676|536830726|FG002|Overall Study|Adverse Event|372|||
148755125|NCT04429503|536576589|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
148755126|NCT04429503|536576590|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
148755127|NCT04429503|536576591|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
148755128|NCT04429503|536576592|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
148755129|NCT04429503|536576593|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
148755130|NCT04429503|536576588|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
148755131|NCT04429503|536576589|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
148755132|NCT04429503|536576590|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
148755133|NCT04429503|536576591|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
148755134|NCT04429503|536576592|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
148755135|NCT04429503|536576593|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
148755136|NCT04429503|536576588|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
148755137|NCT04429503|536576589|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
148755138|NCT04429503|536576590|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
148755139|NCT04429503|536576591|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
148755140|NCT04429503|536576592|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
148755141|NCT04429503|536576593|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
148755142|NCT04429503|536576588|FG000|Main Study (Up to Wk 96)|Death|9|||
148755143|NCT04429503|536576589|FG001|Main Study (Up to Wk 96)|Death|18|||
148755144|NCT04429503|536576590|FG002|Main Study (Up to Wk 96)|Death|5|||
148755145|NCT04429503|536576591|FG003|Main Study (Up to Wk 96)|Death|0|||
148755146|NCT04429503|536576592|FG004|Main Study (Up to Wk 96)|Death|0|||
148755147|NCT04429503|536576593|FG005|Main Study (Up to Wk 96)|Death|0|||
148755148|NCT04429503|536576588|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
148755149|NCT04429503|536576589|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
148755150|NCT04429503|536576590|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
148755151|NCT04429503|536576591|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
148755152|NCT04429503|536576592|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
148755153|NCT04429503|536576593|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
148755154|NCT04429503|536576588|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
148755155|NCT04429503|536576589|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
148755156|NCT04429503|536576590|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
148755157|NCT04429503|536576591|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
148755158|NCT04429503|536576592|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
148755159|NCT04429503|536576593|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
148755160|NCT04429503|536576588|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
148755161|NCT04429503|536576589|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
148755162|NCT04429503|536576590|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
148755163|NCT04429503|536576591|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
148755164|NCT04429503|536576592|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
148755165|NCT04429503|536576593|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
148755166|NCT04429503|536576588|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
148755167|NCT04429503|536576589|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
148755168|NCT04429503|536576590|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
148755169|NCT04429503|536576591|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
148755170|NCT04429503|536576592|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
148755171|NCT04429503|536576593|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
148755172|NCT04429503|536576588|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
148755173|NCT04429503|536576589|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
148755174|NCT04429503|536576590|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
148755175|NCT04429503|536576591|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
148755176|NCT04429503|536576592|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
148755177|NCT04429503|536576593|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
148755178|NCT04429503|536576588|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
148755179|NCT04429503|536576589|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
148755180|NCT04429503|536576590|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
148755181|NCT04429503|536576591|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
148755182|NCT04429503|536576592|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
148755183|NCT04429503|536576593|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
148755184|NCT05516108|536576594|FG000|Overall Study|Time Commitment|3|||
148755185|NCT05516108|536576595|FG001|Overall Study|Time Commitment|1|||
148755186|NCT05516108|536576594|FG000|Overall Study|Reason Unknown|2|||
148755187|NCT05516108|536576595|FG001|Overall Study|Reason Unknown|4|||
148755188|NCT00709995|536576596|FG000|Overall Study|Adverse Event|4|||
148755189|NCT00709995|536576597|FG001|Overall Study|Adverse Event|2|||
148755190|NCT00709995|536576596|FG000|Overall Study|Withdrawal by Subject|1|||
148755191|NCT00709995|536576597|FG001|Overall Study|Withdrawal by Subject|3|||
148755192|NCT02003209|536576605|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
148755193|NCT02003209|536576606|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
148755194|NCT00638508|536576607|FG000|Overall Study|Physician Decision|5|||
148755195|NCT00638508|536576608|FG001|Overall Study|Physician Decision|2|||
148755196|NCT00485264|536576609|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
148755197|NCT00485264|536576610|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
148755198|NCT00485264|536576611|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
148755199|NCT00485264|536576612|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
148755200|NCT00485264|536576613|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
148755201|NCT00485264|536576614|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
148755202|NCT00485264|536576609|FG000|Overall Study|Death|1|||
148755203|NCT00485264|536576610|FG001|Overall Study|Death|0|||
148755204|NCT00485264|536576611|FG002|Overall Study|Death|0|||
148755205|NCT00485264|536576612|FG003|Overall Study|Death|0|||
148755206|NCT00485264|536576613|FG004|Overall Study|Death|1|||
148755207|NCT00485264|536576614|FG005|Overall Study|Death|0|||
148755208|NCT00485264|536576609|FG000|Overall Study|Adverse Event|1|||
148755209|NCT00485264|536576610|FG001|Overall Study|Adverse Event|0|||
148755210|NCT00485264|536576611|FG002|Overall Study|Adverse Event|2|||
148755211|NCT00485264|536576612|FG003|Overall Study|Adverse Event|3|||
148755212|NCT00485264|536576613|FG004|Overall Study|Adverse Event|1|||
148755213|NCT00485264|536576614|FG005|Overall Study|Adverse Event|3|||
148755214|NCT00485264|536576609|FG000|Overall Study|Pregnancy|4|||
148755215|NCT00485264|536576610|FG001|Overall Study|Pregnancy|0|||
148755216|NCT00485264|536576611|FG002|Overall Study|Pregnancy|0|||
148755217|NCT00485264|536576612|FG003|Overall Study|Pregnancy|0|||
148755218|NCT00485264|536576613|FG004|Overall Study|Pregnancy|0|||
148755219|NCT00485264|536576614|FG005|Overall Study|Pregnancy|0|||
148755220|NCT00485264|536576609|FG000|Overall Study|Disallowed Medication|0|||
148755221|NCT00485264|536576610|FG001|Overall Study|Disallowed Medication|0|||
148755222|NCT00485264|536576611|FG002|Overall Study|Disallowed Medication|0|||
148755223|NCT00485264|536576612|FG003|Overall Study|Disallowed Medication|0|||
148755224|NCT00485264|536576613|FG004|Overall Study|Disallowed Medication|0|||
148755225|NCT00485264|536576614|FG005|Overall Study|Disallowed Medication|1|||
148755226|NCT00485264|536576609|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
148755227|NCT00485264|536576610|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
148755228|NCT00485264|536576611|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
148755229|NCT00485264|536576612|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
148755230|NCT00485264|536576613|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
148755231|NCT00485264|536576614|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
148755232|NCT00485264|536576609|FG000|Overall Study|Lack of Efficacy|0|||
148755233|NCT00485264|536576610|FG001|Overall Study|Lack of Efficacy|1|||
148755234|NCT00485264|536576611|FG002|Overall Study|Lack of Efficacy|0|||
148755235|NCT00485264|536576612|FG003|Overall Study|Lack of Efficacy|0|||
148755236|NCT00485264|536576613|FG004|Overall Study|Lack of Efficacy|0|||
148755237|NCT00485264|536576614|FG005|Overall Study|Lack of Efficacy|0|||
148755238|NCT00485264|536576609|FG000|Overall Study|Guardian Consent Withdrawn|1|||
148755239|NCT00485264|536576610|FG001|Overall Study|Guardian Consent Withdrawn|0|||
148755240|NCT00485264|536576611|FG002|Overall Study|Guardian Consent Withdrawn|0|||
148755241|NCT00485264|536576612|FG003|Overall Study|Guardian Consent Withdrawn|0|||
148755242|NCT00485264|536576613|FG004|Overall Study|Guardian Consent Withdrawn|1|||
148755243|NCT00485264|536576614|FG005|Overall Study|Guardian Consent Withdrawn|0|||
148755244|NCT00485264|536576609|FG000|Overall Study|Physician Decision|0|||
148755245|NCT00485264|536576610|FG001|Overall Study|Physician Decision|2|||
148755246|NCT00485264|536576611|FG002|Overall Study|Physician Decision|0|||
148755247|NCT00485264|536576612|FG003|Overall Study|Physician Decision|0|||
148755248|NCT00485264|536576613|FG004|Overall Study|Physician Decision|0|||
148755249|NCT00485264|536576614|FG005|Overall Study|Physician Decision|0|||
148755250|NCT00485264|536576609|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
148755251|NCT00485264|536576610|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
148976361|NCT03604692|537394527|FG002|Overall Study|Difficulty Coming into Site|0|||
148976362|NCT03604692|537394528|FG003|Overall Study|Difficulty Coming into Site|0|||
148976363|NCT03604692|537394529|FG004|Overall Study|Difficulty Coming into Site|0|||
148976364|NCT03604692|537394530|FG005|Overall Study|Difficulty Coming into Site|1|||
148755252|NCT00485264|536576611|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
148755253|NCT00485264|536576612|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
148976365|NCT03604692|537394525|FG000|Overall Study|Death|0|||
148755254|NCT00485264|536576613|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
148755255|NCT00485264|536576614|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
148755256|NCT00485264|536576609|FG000|Overall Study|Not Able to Attend Clinic|5|||
148976366|NCT03604692|537394526|FG001|Overall Study|Death|0|||
148755257|NCT00485264|536576610|FG001|Overall Study|Not Able to Attend Clinic|0|||
148755258|NCT00485264|536576611|FG002|Overall Study|Not Able to Attend Clinic|0|||
148755259|NCT00485264|536576612|FG003|Overall Study|Not Able to Attend Clinic|1|||
148755260|NCT00485264|536576613|FG004|Overall Study|Not Able to Attend Clinic|1|||
148755261|NCT00485264|536576614|FG005|Overall Study|Not Able to Attend Clinic|2|||
148755262|NCT00485264|536576609|FG000|Overall Study|Non-Compliant|17|||
148755263|NCT00485264|536576610|FG001|Overall Study|Non-Compliant|2|||
148755264|NCT00485264|536576611|FG002|Overall Study|Non-Compliant|1|||
148755265|NCT00485264|536576612|FG003|Overall Study|Non-Compliant|0|||
148976367|NCT03604692|537394527|FG002|Overall Study|Death|1|||
148755266|NCT00485264|536576613|FG004|Overall Study|Non-Compliant|1|||
148755267|NCT00485264|536576614|FG005|Overall Study|Non-Compliant|0|||
148976368|NCT03604692|537394528|FG003|Overall Study|Death|0|||
148976369|NCT03604692|537394529|FG004|Overall Study|Death|0|||
148976370|NCT03604692|537394530|FG005|Overall Study|Death|0|||
148976371|NCT03604692|537394525|FG000|Overall Study|Drug Intolerance|0|||
148755268|NCT00485264|536576609|FG000|Overall Study|Lost to Follow-up|2|||
148755269|NCT00485264|536576610|FG001|Overall Study|Lost to Follow-up|1|||
148755270|NCT00485264|536576611|FG002|Overall Study|Lost to Follow-up|1|||
148755271|NCT00485264|536576612|FG003|Overall Study|Lost to Follow-up|0|||
148755272|NCT00485264|536576613|FG004|Overall Study|Lost to Follow-up|0|||
148755273|NCT00485264|536576614|FG005|Overall Study|Lost to Follow-up|1|||
148755274|NCT00485264|536576609|FG000|Overall Study|Other Reason|3|||
148755275|NCT00485264|536576610|FG001|Overall Study|Other Reason|0|||
148755276|NCT00485264|536576611|FG002|Overall Study|Other Reason|0|||
148755277|NCT00485264|536576612|FG003|Overall Study|Other Reason|0|||
148755278|NCT00485264|536576613|FG004|Overall Study|Other Reason|0|||
148755279|NCT00485264|536576614|FG005|Overall Study|Other Reason|0|||
148755280|NCT03500198|536576615|FG000|Overall Study|Lost to Follow-up|0|||
148755281|NCT03500198|536576616|FG001|Overall Study|Lost to Follow-up|1|||
148755282|NCT01514461|536576617|FG000|Overall Study|Adverse Event|2|||
148755283|NCT01514461|536576618|FG001|Overall Study|Adverse Event|1|||
148755284|NCT01514461|536576619|FG002|Overall Study|Adverse Event|3|||
148755285|NCT01514461|536576617|FG000|Overall Study|Physician Decision|1|||
148755286|NCT01514461|536576618|FG001|Overall Study|Physician Decision|1|||
148755287|NCT01514461|536576619|FG002|Overall Study|Physician Decision|0|||
148755288|NCT01514461|536576617|FG000|Overall Study|Patient/guardian decision|1|||
148755289|NCT01514461|536576618|FG001|Overall Study|Patient/guardian decision|1|||
148755290|NCT01514461|536576619|FG002|Overall Study|Patient/guardian decision|1|||
148755291|NCT01514461|536576617|FG000|Overall Study|Death|1|||
148755292|NCT01514461|536576618|FG001|Overall Study|Death|0|||
148755293|NCT01514461|536576619|FG002|Overall Study|Death|0|||
148755294|NCT03499067|536576620|FG000|First Intervention|Physician Decision|2|||
148755295|NCT03499067|536576621|FG001|First Intervention|Physician Decision|1|||
148755296|NCT03499067|536576620|FG000|First Intervention|Withdrawal by Subject|3|||
148755297|NCT03499067|536576621|FG001|First Intervention|Withdrawal by Subject|6|||
148755298|NCT00324987|536576627|FG000|Overall Study|Adverse Event|2|||
148755299|NCT00324987|536576628|FG001|Overall Study|Adverse Event|1|||
148755300|NCT00324987|536576627|FG000|Overall Study|Withdrawal by Subject|1|||
148755301|NCT00324987|536576628|FG001|Overall Study|Withdrawal by Subject|1|||
148755302|NCT00324987|536576627|FG000|Overall Study|Progression|1|||
148755303|NCT00324987|536576628|FG001|Overall Study|Progression|1|||
148755304|NCT00324987|536576627|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
148755305|NCT00324987|536576628|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
148755306|NCT02392481|536576629|FG000|Overall Study|Adverse Event|0|||
148755307|NCT02392481|536576630|FG001|Overall Study|Adverse Event|0|||
148755308|NCT02392481|536576631|FG002|Overall Study|Adverse Event|1|||
148755309|NCT02392481|536576632|FG003|Overall Study|Adverse Event|2|||
148755310|NCT02392481|536576629|FG000|Overall Study|Withdrawal by Subject|0|||
148755311|NCT02392481|536576630|FG001|Overall Study|Withdrawal by Subject|0|||
148755312|NCT02392481|536576631|FG002|Overall Study|Withdrawal by Subject|1|||
148755313|NCT02392481|536576632|FG003|Overall Study|Withdrawal by Subject|0|||
148755314|NCT03565900|536576634|FG000|Overall Study|Disposition Unknown|4|||
148755315|NCT03565900|536576635|FG001|Overall Study|Disposition Unknown|1|||
148755316|NCT03565900|536576634|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
148755317|NCT03565900|536576635|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
148755318|NCT03565900|536576634|FG000|Overall Study|Withdrawal by Subject|4|||
148755319|NCT03565900|536576635|FG001|Overall Study|Withdrawal by Subject|5|||
148755320|NCT03565900|536576634|FG000|Overall Study|Randomized By Mistake|0|||
148755321|NCT03565900|536576635|FG001|Overall Study|Randomized By Mistake|2|||
148755322|NCT03565900|536576634|FG000|Overall Study|Physician Decision|7|||
148755323|NCT03565900|536576635|FG001|Overall Study|Physician Decision|11|||
148755324|NCT03565900|536576634|FG000|Overall Study|Death|9|||
148755325|NCT03565900|536576635|FG001|Overall Study|Death|7|||
148755326|NCT01254643|536576636|FG000|Overall Study|Withdrawal by Subject|1|||
148755327|NCT03359850|536576637|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
148755328|NCT03359850|536576638|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
148755329|NCT03359850|536576637|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
148755330|NCT03359850|536576638|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
148755331|NCT03359850|536576637|FG000|Extension Phase (Up to 28 Months)|Death|2|||
148755332|NCT03359850|536576638|FG001|Extension Phase (Up to 28 Months)|Death|4|||
148755333|NCT03359850|536576637|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
148755334|NCT03359850|536576638|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
148755335|NCT03359850|536576637|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
148755336|NCT03359850|536576638|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
148755337|NCT03817125|536576653|FG000|Overall Study|Adverse Event|1|||
148755338|NCT03817125|536576654|FG001|Overall Study|Adverse Event|0|||
148755339|NCT03817125|536576653|FG000|Overall Study|Physician Decision|0|||
148755340|NCT03817125|536576654|FG001|Overall Study|Physician Decision|1|||
148755341|NCT03817125|536576653|FG000|Overall Study|Lack of Efficacy|1|||
148755342|NCT03817125|536576654|FG001|Overall Study|Lack of Efficacy|5|||
148755343|NCT00942084|536576655|FG000|Overall Study|Death|2|||
148755344|NCT01037218|536576658|FG000|Overall Study|Adverse Event|4|||
148755345|NCT01037218|536576659|FG001|Overall Study|Adverse Event|2|||
148755346|NCT01037218|536576660|FG002|Overall Study|Adverse Event|2|||
148755347|NCT01037218|536576661|FG003|Overall Study|Adverse Event|1|||
148755348|NCT01037218|536576658|FG000|Overall Study|Lack of Efficacy|0|||
148755349|NCT01037218|536576659|FG001|Overall Study|Lack of Efficacy|2|||
148755350|NCT01037218|536576660|FG002|Overall Study|Lack of Efficacy|1|||
148755351|NCT01037218|536576661|FG003|Overall Study|Lack of Efficacy|5|||
148755352|NCT01037218|536576658|FG000|Overall Study|Lost to Follow-up|3|||
148755353|NCT01037218|536576659|FG001|Overall Study|Lost to Follow-up|5|||
148755354|NCT01037218|536576660|FG002|Overall Study|Lost to Follow-up|4|||
148755355|NCT01037218|536576661|FG003|Overall Study|Lost to Follow-up|2|||
148755356|NCT01037218|536576658|FG000|Overall Study|Withdrawal by Subject|6|||
148755357|NCT01037218|536576659|FG001|Overall Study|Withdrawal by Subject|7|||
148755358|NCT01037218|536576660|FG002|Overall Study|Withdrawal by Subject|7|||
148755359|NCT01037218|536576661|FG003|Overall Study|Withdrawal by Subject|4|||
148755360|NCT01037218|536576658|FG000|Overall Study|Partner Withdrew Consent|0|||
148755361|NCT01037218|536576659|FG001|Overall Study|Partner Withdrew Consent|3|||
148755362|NCT01037218|536576660|FG002|Overall Study|Partner Withdrew Consent|2|||
148755363|NCT01037218|536576661|FG003|Overall Study|Partner Withdrew Consent|1|||
148755364|NCT01037218|536576658|FG000|Overall Study|Protocol Violation|0|||
148755365|NCT01037218|536576659|FG001|Overall Study|Protocol Violation|0|||
148755366|NCT01037218|536576660|FG002|Overall Study|Protocol Violation|2|||
148755367|NCT01037218|536576661|FG003|Overall Study|Protocol Violation|2|||
148755368|NCT01037218|536576658|FG000|Overall Study|Various|3|||
148755369|NCT01037218|536576659|FG001|Overall Study|Various|2|||
148755370|NCT01037218|536576660|FG002|Overall Study|Various|3|||
148755371|NCT01037218|536576661|FG003|Overall Study|Various|1|||
148755372|NCT02568072|536576662|FG000|Overall Study|Unavailable for appointment|23|||
148755373|NCT02568072|536576662|FG000|Overall Study|Unable to contact|3|||
148755374|NCT02568072|536576662|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
148755375|NCT02568072|536576662|FG000|Overall Study|Withdrawal by Subject|1|||
148755376|NCT02568072|536576662|FG000|Overall Study|Sustained injury, marathon not run|24|||
148755377|NCT01199939|536576663|FG000|Overall Study|Adverse Event|4|||
148755378|NCT01199939|536576663|FG000|Overall Study|Protocol Violation|3|||
148755379|NCT01199939|536576663|FG000|Overall Study|Lost to Follow-up|2|||
148755380|NCT01199939|536576663|FG000|Overall Study|Reached a virologic endpoint|4|||
148755381|NCT02137252|536576666|FG000|Overall Study|trial terminated early|2|||
148755382|NCT02137252|536576667|FG001|Overall Study|trial terminated early|1|||
148755383|NCT00063934|536576669|FG000|Overall Study|Ineligible|1|||
148755384|NCT02285361|536576673|FG000|Overall Study|Protocol Violation|43|||
148755385|NCT02285361|536576673|FG000|Overall Study|Lost to Follow-up|5|||
148755386|NCT02285361|536576673|FG000|Overall Study|Not taken GIOTRIF|2|||
148755387|NCT02285361|536576673|FG000|Overall Study|Consented prior to the contract date|1|||
148755388|NCT01283464|536576674|FG000|Overall Study|Lost to Follow-up|0|||
148755389|NCT01283464|536576675|FG001|Overall Study|Lost to Follow-up|1|||
148755390|NCT01283464|536576674|FG000|Overall Study|Withdrawal by Subject|1|||
148755391|NCT01283464|536576675|FG001|Overall Study|Withdrawal by Subject|0|||
148755392|NCT01283464|536576674|FG000|Overall Study|Physician Decision|1|||
148755393|NCT01283464|536576675|FG001|Overall Study|Physician Decision|0|||
148755394|NCT03051100|536576676|FG000|Overall Study|Withdrawal by Subject|1|||
148755395|NCT03051100|536576677|FG001|Overall Study|Withdrawal by Subject|0|||
148755396|NCT01778855|536576678|FG000|Overall Study|Death|0|||
148755397|NCT01778855|536576679|FG001|Overall Study|Death|1|||
148755398|NCT02059135|536576680|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
148755399|NCT02059135|536576681|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
148755400|NCT02059135|536576680|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
148755401|NCT02059135|536576681|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
148755402|NCT02059135|536576680|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
148755403|NCT02059135|536576681|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
148755404|NCT02059135|536576680|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
148755405|NCT02059135|536576681|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
148755406|NCT02059135|536576680|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
148755407|NCT02059135|536576681|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
148755408|NCT02059135|536576680|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
148755409|NCT02059135|536576681|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
148755410|NCT02059135|536576680|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
148755411|NCT02059135|536576681|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
148755412|NCT02059135|536576680|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
148755413|NCT02059135|536576681|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
148755414|NCT05317312|536576682|FG000|Overall Study|Withdrawal by Subject|0|||
148755415|NCT05317312|536576683|FG001|Overall Study|Withdrawal by Subject|1|||
148755416|NCT05317312|536576684|FG002|Overall Study|Withdrawal by Subject|0|||
148755417|NCT05317312|536576685|FG003|Overall Study|Withdrawal by Subject|0|||
148755418|NCT05317312|536576682|FG000|Overall Study|Lost to Follow-up|0|||
148755419|NCT05317312|536576683|FG001|Overall Study|Lost to Follow-up|0|||
148755420|NCT05317312|536576684|FG002|Overall Study|Lost to Follow-up|0|||
148755421|NCT05317312|536576685|FG003|Overall Study|Lost to Follow-up|1|||
148755422|NCT05317312|536576682|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
148755423|NCT05317312|536576683|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
148755424|NCT05317312|536576684|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
148755425|NCT05317312|536576685|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
148755426|NCT02289729|536576686|FG000|Overall Study|Lack of Efficacy|3|||
148755427|NCT02289729|536576686|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
148755428|NCT02289729|536576686|FG000|Overall Study|Withdrawal by Subject|1|||
148755429|NCT02289729|536576686|FG000|Overall Study|Death|1|||
148755430|NCT03326193|536576687|FG000|Overall Study|Sponsor decision|35|||
148755431|NCT01964976|536576690|FG000|Overall Study|Protocol Violation|31|||
148755432|NCT01168427|536576691|FG000|Overall Study|Patient exited prior to implant|1|||
148755433|NCT00397514|536576692|FG000|Overall Study|Withdrawal by Subject|1|||
148755434|NCT00397514|536576692|FG000|Overall Study|Pacing wire malfunction|1|||
148755435|NCT00397514|536576692|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
148755436|NCT00397514|536576692|FG000|Overall Study|early extubation|2|||
148755437|NCT00397514|536576692|FG000|Overall Study|poor echocardiographic windows|1|||
148755438|NCT01256879|536576693|FG000|Overall Study|Withdrawal by Subject|1|||
148755439|NCT00640315|536576694|FG000|Overall Study|Withdrawal by Subject|0|||
148755440|NCT00640315|536576695|FG001|Overall Study|Withdrawal by Subject|1|||
148755441|NCT00725920|536576697|FG000|Overall Study|Lack of Efficacy|3|||
148755442|NCT00725920|536576698|FG001|Overall Study|Lack of Efficacy|6|||
148755443|NCT02623725|536576699|FG000|Overall Study|Non compliance with protocol|9|||
148755444|NCT02623725|536576700|FG001|Overall Study|Non compliance with protocol|3|||
148755445|NCT02623725|536576699|FG000|Overall Study|Serious adverse event|0|||
148755446|NCT02623725|536576700|FG001|Overall Study|Serious adverse event|2|||
148755447|NCT02623725|536576699|FG000|Overall Study|Withdrawal by Subject|7|||
148755448|NCT02623725|536576700|FG001|Overall Study|Withdrawal by Subject|1|||
148755449|NCT03918629|536576701|FG000|Overall Study|Adverse Event|19|||
148755450|NCT03918629|536576702|FG001|Overall Study|Adverse Event|20|||
148755451|NCT03918629|536576701|FG000|Overall Study|Death|14|||
148755452|NCT03918629|536576702|FG001|Overall Study|Death|7|||
148755453|NCT03918629|536576701|FG000|Overall Study|Lost to Follow-up|36|||
148755454|NCT03918629|536576702|FG001|Overall Study|Lost to Follow-up|28|||
148755455|NCT03918629|536576701|FG000|Overall Study|Physician Decision|1|||
148755456|NCT03918629|536576702|FG001|Overall Study|Physician Decision|0|||
148755457|NCT03918629|536576701|FG000|Overall Study|Protocol Violation|7|||
148755458|NCT03918629|536576702|FG001|Overall Study|Protocol Violation|4|||
148755459|NCT03918629|536576701|FG000|Overall Study|Withdrawal by Subject|47|||
148755460|NCT03918629|536576702|FG001|Overall Study|Withdrawal by Subject|47|||
148755461|NCT03918629|536576701|FG000|Overall Study|Other|7|||
148755462|NCT03918629|536576702|FG001|Overall Study|Other|11|||
148755463|NCT03918629|536576701|FG000|Overall Study|Randomized but not vaccinated|2|||
148755464|NCT03918629|536576702|FG001|Overall Study|Randomized but not vaccinated|1|||
148755465|NCT02456740|536576703|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
148755466|NCT02456740|536576704|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
148755467|NCT02456740|536576705|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
148755468|NCT02456740|536576706|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
148755469|NCT02456740|536576707|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
148755470|NCT02456740|536576708|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
148755471|NCT02456740|536576709|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
148755472|NCT02456740|536576710|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
148755473|NCT02456740|536576711|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
148823001|NCT01313676|536830727|FG003|Overall Study|Adverse Event|333|||
148823002|NCT01313676|536830724|FG000|Overall Study|Lack of Efficacy|98|||
148823003|NCT01313676|536830725|FG001|Overall Study|Lack of Efficacy|90|||
148823004|NCT01313676|536830726|FG002|Overall Study|Lack of Efficacy|65|||
148823005|NCT01313676|536830727|FG003|Overall Study|Lack of Efficacy|46|||
148823006|NCT01313676|536830724|FG000|Overall Study|Protocol Violation|37|||
148823007|NCT01313676|536830725|FG001|Overall Study|Protocol Violation|44|||
148823008|NCT01313676|536830726|FG002|Overall Study|Protocol Violation|46|||
148823009|NCT01313676|536830727|FG003|Overall Study|Protocol Violation|44|||
148823010|NCT01313676|536830724|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
148755474|NCT02456740|536576703|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
148755475|NCT02456740|536576704|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
148755476|NCT02456740|536576705|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
148755477|NCT02456740|536576706|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
148755478|NCT02456740|536576707|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
148755479|NCT02456740|536576708|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
148755480|NCT02456740|536576709|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
148823011|NCT01313676|536830725|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
148976372|NCT03604692|537394526|FG001|Overall Study|Drug Intolerance|0|||
148976373|NCT03604692|537394527|FG002|Overall Study|Drug Intolerance|0|||
148755481|NCT02456740|536576710|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
148755482|NCT02456740|536576711|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
148755483|NCT02456740|536576703|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
148755484|NCT02456740|536576704|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
148755485|NCT02456740|536576705|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
148755486|NCT02456740|536576706|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
148755487|NCT02456740|536576707|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
148755488|NCT02456740|536576708|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
148755489|NCT02456740|536576709|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
148755490|NCT02456740|536576710|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
148755491|NCT02456740|536576711|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
148755492|NCT02456740|536576703|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
148755493|NCT02456740|536576704|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
148755494|NCT02456740|536576705|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
148755495|NCT02456740|536576706|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
148755496|NCT02456740|536576707|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
148755497|NCT02456740|536576708|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
148755498|NCT02456740|536576709|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
148755499|NCT02456740|536576710|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
148755500|NCT02456740|536576711|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
148755501|NCT02456740|536576703|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
148755502|NCT02456740|536576704|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
148755503|NCT02456740|536576705|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
148755504|NCT02456740|536576706|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
148755505|NCT02456740|536576707|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
148755506|NCT02456740|536576708|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
148755507|NCT02456740|536576709|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
148755508|NCT02456740|536576710|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
148755509|NCT02456740|536576711|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
148755510|NCT02456740|536576703|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755511|NCT02456740|536576704|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755512|NCT02456740|536576705|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755513|NCT02456740|536576706|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755514|NCT02456740|536576707|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755515|NCT02456740|536576708|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755516|NCT02456740|536576709|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755517|NCT02456740|536576710|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
148755518|NCT02456740|536576711|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
148755519|NCT02456740|536576703|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
148755520|NCT02456740|536576704|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
148755521|NCT02456740|536576705|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
148755522|NCT02456740|536576706|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
148755523|NCT02456740|536576707|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
148755524|NCT02456740|536576708|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
148755525|NCT02456740|536576709|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
148755526|NCT02456740|536576710|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
148755527|NCT02456740|536576711|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
148755528|NCT01891864|536576715|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
148755529|NCT01891864|536576716|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
148755530|NCT01891864|536576717|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
148755531|NCT01891864|536576718|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
148755532|NCT01891864|536576719|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
148755533|NCT01891864|536576720|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
148976374|NCT03604692|537394528|FG003|Overall Study|Drug Intolerance|1|||
148976375|NCT03604692|537394529|FG004|Overall Study|Drug Intolerance|0|||
148755534|NCT01891864|536576715|FG000|Treatment Period 1|Physician Decision|0|||
148755535|NCT01891864|536576716|FG001|Treatment Period 1|Physician Decision|1|||
148755536|NCT01891864|536576717|FG002|Treatment Period 1|Physician Decision|0|||
148755537|NCT01891864|536576718|FG003|Treatment Period 1|Physician Decision|0|||
148823012|NCT01313676|536830726|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
148976376|NCT03604692|537394530|FG005|Overall Study|Drug Intolerance|0|||
148976377|NCT03604692|537394525|FG000|Overall Study|Noncompliance with follow-up visit|0|||
148976378|NCT03604692|537394526|FG001|Overall Study|Noncompliance with follow-up visit|0|||
148976379|NCT03604692|537394527|FG002|Overall Study|Noncompliance with follow-up visit|0|||
148976380|NCT03604692|537394528|FG003|Overall Study|Noncompliance with follow-up visit|1|||
148755538|NCT01891864|536576719|FG004|Treatment Period 1|Physician Decision|0|||
148755539|NCT01891864|536576720|FG005|Treatment Period 1|Physician Decision|0|||
148755540|NCT01891864|536576715|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
148755541|NCT01891864|536576716|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
148755542|NCT01891864|536576717|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
148755543|NCT01891864|536576718|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
148755544|NCT01891864|536576719|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
148755545|NCT01891864|536576720|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
148755546|NCT01891864|536576715|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
148755547|NCT01891864|536576716|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
148755548|NCT01891864|536576717|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
148755549|NCT01891864|536576718|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
148755550|NCT01891864|536576719|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
148755551|NCT01891864|536576720|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
148755552|NCT01891864|536576715|FG000|Treatment Period 1|Withdrawal by Subject|2|||
148755553|NCT01891864|536576716|FG001|Treatment Period 1|Withdrawal by Subject|5|||
148755554|NCT01891864|536576717|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148755555|NCT01891864|536576718|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148755556|NCT01891864|536576719|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148755557|NCT01891864|536576720|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148755558|NCT01891864|536576715|FG000|Treatment Period 1|Lost to Follow-up|1|||
148755559|NCT01891864|536576716|FG001|Treatment Period 1|Lost to Follow-up|0|||
148755560|NCT01891864|536576717|FG002|Treatment Period 1|Lost to Follow-up|0|||
148755561|NCT01891864|536576718|FG003|Treatment Period 1|Lost to Follow-up|0|||
148755562|NCT01891864|536576719|FG004|Treatment Period 1|Lost to Follow-up|0|||
148755563|NCT01891864|536576720|FG005|Treatment Period 1|Lost to Follow-up|0|||
148755564|NCT01891864|536576715|FG000|Treatment Period 2|Protocol Violation|0|||
148755565|NCT01891864|536576716|FG001|Treatment Period 2|Protocol Violation|0|||
148755566|NCT01891864|536576717|FG002|Treatment Period 2|Protocol Violation|0|||
148755567|NCT01891864|536576718|FG003|Treatment Period 2|Protocol Violation|1|||
148755568|NCT01891864|536576719|FG004|Treatment Period 2|Protocol Violation|0|||
148755569|NCT01891864|536576720|FG005|Treatment Period 2|Protocol Violation|0|||
148755570|NCT01891864|536576715|FG000|Treatment Period 2|Physician Decision|0|||
148755571|NCT01891864|536576716|FG001|Treatment Period 2|Physician Decision|0|||
148755572|NCT01891864|536576717|FG002|Treatment Period 2|Physician Decision|1|||
148755573|NCT01891864|536576718|FG003|Treatment Period 2|Physician Decision|0|||
148755574|NCT01891864|536576719|FG004|Treatment Period 2|Physician Decision|0|||
148755575|NCT01891864|536576720|FG005|Treatment Period 2|Physician Decision|0|||
148755576|NCT01891864|536576715|FG000|Treatment Period 2|Site Termination|0|||
148755577|NCT01891864|536576716|FG001|Treatment Period 2|Site Termination|0|||
148755578|NCT01891864|536576717|FG002|Treatment Period 2|Site Termination|1|||
148755579|NCT01891864|536576718|FG003|Treatment Period 2|Site Termination|2|||
148755580|NCT01891864|536576719|FG004|Treatment Period 2|Site Termination|0|||
148755581|NCT01891864|536576720|FG005|Treatment Period 2|Site Termination|0|||
148755582|NCT01891864|536576715|FG000|Treatment Period 2|Lack of Efficacy|0|||
148755583|NCT01891864|536576716|FG001|Treatment Period 2|Lack of Efficacy|0|||
148755584|NCT01891864|536576717|FG002|Treatment Period 2|Lack of Efficacy|1|||
148755585|NCT01891864|536576718|FG003|Treatment Period 2|Lack of Efficacy|0|||
148755586|NCT01891864|536576719|FG004|Treatment Period 2|Lack of Efficacy|1|||
148755587|NCT01891864|536576720|FG005|Treatment Period 2|Lack of Efficacy|0|||
148755588|NCT01891864|536576715|FG000|Treatment Period 2|Adverse Event|0|||
148755589|NCT01891864|536576716|FG001|Treatment Period 2|Adverse Event|0|||
148755590|NCT01891864|536576717|FG002|Treatment Period 2|Adverse Event|1|||
148755591|NCT01891864|536576718|FG003|Treatment Period 2|Adverse Event|2|||
148755592|NCT01891864|536576719|FG004|Treatment Period 2|Adverse Event|0|||
148755593|NCT01891864|536576720|FG005|Treatment Period 2|Adverse Event|4|||
148755594|NCT01891864|536576715|FG000|Treatment Period 2|Termination of Site|0|||
148755595|NCT01891864|536576716|FG001|Treatment Period 2|Termination of Site|0|||
148976381|NCT03604692|537394529|FG004|Overall Study|Noncompliance with follow-up visit|0|||
148976382|NCT03604692|537394530|FG005|Overall Study|Noncompliance with follow-up visit|0|||
148976383|NCT03604692|537394525|FG000|Overall Study|Not Treated|0|||
148976384|NCT03604692|537394526|FG001|Overall Study|Not Treated|0|||
148823013|NCT01313676|536830727|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
148755596|NCT01891864|536576717|FG002|Treatment Period 2|Termination of Site|0|||
148755597|NCT01891864|536576718|FG003|Treatment Period 2|Termination of Site|0|||
148976385|NCT03604692|537394527|FG002|Overall Study|Not Treated|0|||
148976386|NCT03604692|537394528|FG003|Overall Study|Not Treated|0|||
148755598|NCT01891864|536576719|FG004|Treatment Period 2|Termination of Site|2|||
148755599|NCT01891864|536576720|FG005|Treatment Period 2|Termination of Site|0|||
148976387|NCT03604692|537394529|FG004|Overall Study|Not Treated|1|||
148976388|NCT03604692|537394530|FG005|Overall Study|Not Treated|0|||
148755600|NCT01891864|536576715|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148755601|NCT01891864|536576716|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148755602|NCT01891864|536576717|FG002|Treatment Period 2|Withdrawal by Subject|3|||
148755603|NCT01891864|536576718|FG003|Treatment Period 2|Withdrawal by Subject|4|||
148755604|NCT01891864|536576719|FG004|Treatment Period 2|Withdrawal by Subject|1|||
148755605|NCT01891864|536576720|FG005|Treatment Period 2|Withdrawal by Subject|1|||
148755606|NCT01891864|536576715|FG000|Extension Period|Lack of Efficacy|0|||
148755607|NCT01891864|536576716|FG001|Extension Period|Lack of Efficacy|0|||
148755608|NCT01891864|536576717|FG002|Extension Period|Lack of Efficacy|0|||
148755609|NCT01891864|536576718|FG003|Extension Period|Lack of Efficacy|1|||
148755610|NCT01891864|536576719|FG004|Extension Period|Lack of Efficacy|1|||
148755611|NCT01891864|536576720|FG005|Extension Period|Lack of Efficacy|0|||
148755612|NCT01891864|536576715|FG000|Extension Period|Pregnancy|0|||
148755613|NCT01891864|536576716|FG001|Extension Period|Pregnancy|0|||
148755614|NCT01891864|536576717|FG002|Extension Period|Pregnancy|1|||
148755615|NCT01891864|536576718|FG003|Extension Period|Pregnancy|0|||
148755616|NCT01891864|536576719|FG004|Extension Period|Pregnancy|0|||
148755617|NCT01891864|536576720|FG005|Extension Period|Pregnancy|0|||
148755618|NCT01891864|536576715|FG000|Extension Period|Adverse Event|0|||
148755619|NCT01891864|536576716|FG001|Extension Period|Adverse Event|0|||
148755620|NCT01891864|536576717|FG002|Extension Period|Adverse Event|4|||
148755621|NCT01891864|536576718|FG003|Extension Period|Adverse Event|2|||
148755622|NCT01891864|536576719|FG004|Extension Period|Adverse Event|2|||
148755623|NCT01891864|536576720|FG005|Extension Period|Adverse Event|0|||
148755624|NCT01891864|536576715|FG000|Extension Period|Withdrawal by Subject|0|||
148755625|NCT01891864|536576716|FG001|Extension Period|Withdrawal by Subject|0|||
148755626|NCT01891864|536576717|FG002|Extension Period|Withdrawal by Subject|1|||
148755627|NCT01891864|536576718|FG003|Extension Period|Withdrawal by Subject|2|||
148755628|NCT01891864|536576719|FG004|Extension Period|Withdrawal by Subject|4|||
148755629|NCT01891864|536576720|FG005|Extension Period|Withdrawal by Subject|0|||
148755630|NCT01891864|536576715|FG000|Extension Period|Lost to Follow-up|0|||
148755631|NCT01891864|536576716|FG001|Extension Period|Lost to Follow-up|0|||
148755632|NCT01891864|536576717|FG002|Extension Period|Lost to Follow-up|2|||
148755633|NCT01891864|536576718|FG003|Extension Period|Lost to Follow-up|0|||
148755634|NCT01891864|536576719|FG004|Extension Period|Lost to Follow-up|0|||
148755635|NCT01891864|536576720|FG005|Extension Period|Lost to Follow-up|0|||
148755636|NCT04720105|536576721|FG000|Overall Study|Lack of Efficacy|1|||
148755637|NCT04720105|536576721|FG000|Overall Study|Lost to Follow-up|1|||
148755638|NCT04720105|536576721|FG000|Overall Study|Withdrawal by Subject|3|||
148755639|NCT02892331|536576722|FG000|Overall Study|Withdrawal by Subject|0|||
148755640|NCT02892331|536576723|FG001|Overall Study|Withdrawal by Subject|1|||
148755641|NCT02892331|536576724|FG002|Overall Study|Withdrawal by Subject|1|||
148755642|NCT02892331|536576722|FG000|Overall Study|Sick family member|0|||
148755643|NCT02892331|536576723|FG001|Overall Study|Sick family member|0|||
148755644|NCT02892331|536576724|FG002|Overall Study|Sick family member|1|||
148755645|NCT02892331|536576722|FG000|Overall Study|Corona virus pandemic|1|||
148755646|NCT02892331|536576723|FG001|Overall Study|Corona virus pandemic|0|||
148755647|NCT02892331|536576724|FG002|Overall Study|Corona virus pandemic|1|||
148755648|NCT02892331|536576722|FG000|Overall Study|Lost to Follow-up|1|||
148755649|NCT02892331|536576723|FG001|Overall Study|Lost to Follow-up|0|||
148755650|NCT02892331|536576724|FG002|Overall Study|Lost to Follow-up|1|||
148755651|NCT02892331|536576722|FG000|Overall Study|Blood pressure was too elevated|0|||
148755652|NCT02892331|536576723|FG001|Overall Study|Blood pressure was too elevated|1|||
148755653|NCT02892331|536576724|FG002|Overall Study|Blood pressure was too elevated|0|||
148755654|NCT02892331|536576722|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
148755655|NCT02892331|536576723|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
148755656|NCT02892331|536576724|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
148755657|NCT00982657|536576725|FG000|Overall Study|Death|1|||
148755658|NCT00982657|536576726|FG001|Overall Study|Death|0|||
148755659|NCT00982657|536576727|FG002|Overall Study|Death|1|||
148755660|NCT00982657|536576728|FG003|Overall Study|Death|1|||
148755661|NCT00982657|536576725|FG000|Overall Study|Withdrawal by Subject|0|||
148755662|NCT00982657|536576726|FG001|Overall Study|Withdrawal by Subject|0|||
148755663|NCT00982657|536576727|FG002|Overall Study|Withdrawal by Subject|1|||
148755664|NCT00982657|536576728|FG003|Overall Study|Withdrawal by Subject|3|||
149027408|NCT00688688|537578558|FG001|Overall Study|Eligibility criterion not met|7|||
149027409|NCT00688688|537578559|FG002|Overall Study|Eligibility criterion not met|10|||
149027410|NCT00688688|537578557|FG000|Overall Study|Adverse Event|52|||
148755665|NCT00982657|536576725|FG000|Overall Study|Other|0|||
148755666|NCT00982657|536576726|FG001|Overall Study|Other|0|||
148755667|NCT00982657|536576727|FG002|Overall Study|Other|0|||
148755668|NCT00982657|536576728|FG003|Overall Study|Other|4|||
148755669|NCT00982657|536576725|FG000|Overall Study|On going at date of cut-off|0|||
148755670|NCT00982657|536576726|FG001|Overall Study|On going at date of cut-off|0|||
148755671|NCT00982657|536576727|FG002|Overall Study|On going at date of cut-off|0|||
148755672|NCT00982657|536576728|FG003|Overall Study|On going at date of cut-off|1|||
148755673|NCT02325973|536578857|FG000|Overall Study|Death|5|||
148755674|NCT02325973|536578857|FG000|Overall Study|Withdrawal by subject or investigator|16|||
148755675|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
148755676|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
148755677|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
148755678|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
148755679|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
148755680|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
148755681|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
148755682|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
148755683|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
148755684|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
148755685|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
148755686|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
148755687|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
148755688|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
148755689|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
148755690|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
148755691|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
148755692|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
148755693|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
148755694|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
148755695|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
148755696|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
148755697|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
148755698|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
148755699|NCT02513160|536578858|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
148755700|NCT02513160|536578859|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
148755701|NCT02513160|536578860|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
148755702|NCT02513160|536578861|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
148755703|NCT02513160|536578858|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
148755704|NCT02513160|536578859|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
148755705|NCT02513160|536578860|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
148755706|NCT02513160|536578861|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
148755707|NCT02513160|536578858|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
148755708|NCT02513160|536578859|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
148755709|NCT02513160|536578860|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
148755710|NCT02513160|536578861|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
148755711|NCT02513160|536578858|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
148755712|NCT02513160|536578859|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
148755713|NCT02513160|536578860|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
148755714|NCT02513160|536578861|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
148755715|NCT02513160|536578858|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
148755716|NCT02513160|536578859|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
148755717|NCT02513160|536578860|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
148755718|NCT02513160|536578861|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
148755719|NCT02513160|536578858|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
148755720|NCT02513160|536578859|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
148755721|NCT02513160|536578860|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
148755722|NCT02513160|536578861|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
148755723|NCT03428958|536578865|FG000|Overall Study|Adverse Event|0|||
148823014|NCT01313676|536830724|FG000|Overall Study|Study Closed/terminated|7|||
148755724|NCT03428958|536578866|FG001|Overall Study|Adverse Event|0|||
148755725|NCT03428958|536578867|FG002|Overall Study|Adverse Event|0|||
148755726|NCT03428958|536578868|FG003|Overall Study|Adverse Event|1|||
148755727|NCT03428958|536578869|FG004|Overall Study|Adverse Event|0|||
148755728|NCT03428958|536578870|FG005|Overall Study|Adverse Event|2|||
148823015|NCT01313676|536830725|FG001|Overall Study|Study Closed/terminated|6|||
148823016|NCT01313676|536830726|FG002|Overall Study|Study Closed/terminated|9|||
148823017|NCT01313676|536830727|FG003|Overall Study|Study Closed/terminated|9|||
148823018|NCT01313676|536830724|FG000|Overall Study|Lost to Follow-up|0|||
148823019|NCT01313676|536830725|FG001|Overall Study|Lost to Follow-up|0|||
148823020|NCT01313676|536830726|FG002|Overall Study|Lost to Follow-up|1|||
148823021|NCT01313676|536830727|FG003|Overall Study|Lost to Follow-up|0|||
148976389|NCT00637195|537394534|FG000|Overall Study|Lost to Follow-up|1|||
148976390|NCT00637195|537394535|FG001|Overall Study|Lost to Follow-up|0|||
148976391|NCT00637195|537394534|FG000|Overall Study|Other|2|||
148976392|NCT00637195|537394535|FG001|Overall Study|Other|0|||
148976393|NCT00637195|537394534|FG000|Overall Study|Withdrawal by Subject|0|||
148976394|NCT00637195|537394535|FG001|Overall Study|Withdrawal by Subject|1|||
148976395|NCT01469065|537394538|FG000|Overall Study|Lack of Efficacy|0|||
148823022|NCT01313676|536830724|FG000|Overall Study|Physician Decision|53|||
148823023|NCT01313676|536830725|FG001|Overall Study|Physician Decision|64|||
148823024|NCT01313676|536830726|FG002|Overall Study|Physician Decision|62|||
148823025|NCT01313676|536830727|FG003|Overall Study|Physician Decision|48|||
148823026|NCT01313676|536830724|FG000|Overall Study|Decision by Participant or Proxy|643|||
148823027|NCT01313676|536830725|FG001|Overall Study|Decision by Participant or Proxy|527|||
148823028|NCT01313676|536830726|FG002|Overall Study|Decision by Participant or Proxy|515|||
148823029|NCT01313676|536830727|FG003|Overall Study|Decision by Participant or Proxy|492|||
148823030|NCT01313676|536830724|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
148823031|NCT01313676|536830725|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
148823032|NCT01313676|536830726|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
148823033|NCT01313676|536830727|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
148823034|NCT01313676|536830724|FG000|Overall Study|Investigator Site Closed|12|||
148823035|NCT01313676|536830725|FG001|Overall Study|Investigator Site Closed|11|||
148823036|NCT01313676|536830726|FG002|Overall Study|Investigator Site Closed|15|||
148823037|NCT01313676|536830727|FG003|Overall Study|Investigator Site Closed|10|||
148823038|NCT01313676|536830724|FG000|Overall Study|Missing|1|||
148823039|NCT01313676|536830725|FG001|Overall Study|Missing|1|||
148823040|NCT01313676|536830726|FG002|Overall Study|Missing|1|||
148823041|NCT01313676|536830727|FG003|Overall Study|Missing|0|||
148823042|NCT01862029|536830732|FG000|Overall Study|Physician Decision|1|||
148755729|NCT03428958|536578871|FG006|Overall Study|Adverse Event|1|||
148755730|NCT03428958|536578872|FG007|Overall Study|Adverse Event|0|||
148755731|NCT03428958|536578873|FG008|Overall Study|Adverse Event|0|||
148755732|NCT03428958|536578874|FG009|Overall Study|Adverse Event|0|||
148755733|NCT03428958|536578875|FG010|Overall Study|Adverse Event|0|||
148755734|NCT03428958|536578876|FG011|Overall Study|Adverse Event|0|||
148755735|NCT03428958|536578877|FG012|Overall Study|Adverse Event|0|||
148755736|NCT03428958|536578878|FG013|Overall Study|Adverse Event|0|||
148755737|NCT03428958|536578879|FG014|Overall Study|Adverse Event|0|||
148755738|NCT03428958|536578880|FG015|Overall Study|Adverse Event|0|||
148755739|NCT03428958|536578881|FG016|Overall Study|Adverse Event|0|||
148755740|NCT03428958|536578865|FG000|Overall Study|Clinical Progression|2|||
148755741|NCT03428958|536578866|FG001|Overall Study|Clinical Progression|3|||
148755742|NCT03428958|536578867|FG002|Overall Study|Clinical Progression|2|||
148755743|NCT03428958|536578868|FG003|Overall Study|Clinical Progression|1|||
148755744|NCT03428958|536578869|FG004|Overall Study|Clinical Progression|0|||
148755745|NCT03428958|536578870|FG005|Overall Study|Clinical Progression|2|||
148755746|NCT03428958|536578871|FG006|Overall Study|Clinical Progression|0|||
148755747|NCT03428958|536578872|FG007|Overall Study|Clinical Progression|0|||
148755748|NCT03428958|536578873|FG008|Overall Study|Clinical Progression|0|||
148755749|NCT03428958|536578874|FG009|Overall Study|Clinical Progression|0|||
148755750|NCT03428958|536578875|FG010|Overall Study|Clinical Progression|0|||
148755751|NCT03428958|536578876|FG011|Overall Study|Clinical Progression|0|||
148755752|NCT03428958|536578877|FG012|Overall Study|Clinical Progression|0|||
148755753|NCT03428958|536578878|FG013|Overall Study|Clinical Progression|0|||
148755754|NCT03428958|536578879|FG014|Overall Study|Clinical Progression|0|||
148755755|NCT03428958|536578880|FG015|Overall Study|Clinical Progression|0|||
148755756|NCT03428958|536578881|FG016|Overall Study|Clinical Progression|0|||
148755757|NCT03428958|536578865|FG000|Overall Study|Progression per RECIST|6|||
148755758|NCT03428958|536578866|FG001|Overall Study|Progression per RECIST|6|||
148755759|NCT03428958|536578867|FG002|Overall Study|Progression per RECIST|7|||
148755760|NCT03428958|536578868|FG003|Overall Study|Progression per RECIST|4|||
148755761|NCT03428958|536578869|FG004|Overall Study|Progression per RECIST|0|||
148755762|NCT03428958|536578870|FG005|Overall Study|Progression per RECIST|7|||
148755763|NCT03428958|536578871|FG006|Overall Study|Progression per RECIST|8|||
148755764|NCT03428958|536578872|FG007|Overall Study|Progression per RECIST|0|||
148755765|NCT03428958|536578873|FG008|Overall Study|Progression per RECIST|0|||
148755766|NCT03428958|536578874|FG009|Overall Study|Progression per RECIST|0|||
148755767|NCT03428958|536578875|FG010|Overall Study|Progression per RECIST|0|||
148755768|NCT03428958|536578876|FG011|Overall Study|Progression per RECIST|0|||
148755769|NCT03428958|536578877|FG012|Overall Study|Progression per RECIST|1|||
148755770|NCT03428958|536578878|FG013|Overall Study|Progression per RECIST|0|||
148755771|NCT03428958|536578879|FG014|Overall Study|Progression per RECIST|0|||
148755772|NCT03428958|536578880|FG015|Overall Study|Progression per RECIST|0|||
148755773|NCT03428958|536578881|FG016|Overall Study|Progression per RECIST|0|||
148755774|NCT03428958|536578865|FG000|Overall Study|Death|2|||
148823043|NCT03931785|536830733|FG000|Overall Study|Lost to Follow-up|4|||
148823044|NCT03931785|536830734|FG001|Overall Study|Lost to Follow-up|1|||
148823045|NCT03931785|536830735|FG002|Overall Study|Lost to Follow-up|4|||
148976396|NCT01469065|537394539|FG001|Overall Study|Lack of Efficacy|0|||
148976397|NCT01469065|537394540|FG002|Overall Study|Lack of Efficacy|0|||
148755775|NCT03428958|536578866|FG001|Overall Study|Death|2|||
148755776|NCT03428958|536578867|FG002|Overall Study|Death|0|||
148755777|NCT03428958|536578868|FG003|Overall Study|Death|0|||
148755778|NCT03428958|536578869|FG004|Overall Study|Death|0|||
148823046|NCT03931785|536830736|FG003|Overall Study|Lost to Follow-up|3|||
148823047|NCT03931785|536830733|FG000|Overall Study|Adverse Event|1|||
148755779|NCT03428958|536578870|FG005|Overall Study|Death|7|||
148755780|NCT03428958|536578871|FG006|Overall Study|Death|9|||
148755781|NCT03428958|536578872|FG007|Overall Study|Death|6|||
148755782|NCT03428958|536578873|FG008|Overall Study|Death|0|||
148755783|NCT03428958|536578874|FG009|Overall Study|Death|0|||
148755784|NCT03428958|536578875|FG010|Overall Study|Death|3|||
148755785|NCT03428958|536578876|FG011|Overall Study|Death|0|||
148755786|NCT03428958|536578877|FG012|Overall Study|Death|4|||
148755787|NCT03428958|536578878|FG013|Overall Study|Death|0|||
148755788|NCT03428958|536578879|FG014|Overall Study|Death|0|||
148755789|NCT03428958|536578880|FG015|Overall Study|Death|0|||
148755790|NCT03428958|536578881|FG016|Overall Study|Death|0|||
148755791|NCT03428958|536578865|FG000|Overall Study|Lost to Follow-up|0|||
148755792|NCT03428958|536578866|FG001|Overall Study|Lost to Follow-up|0|||
148755793|NCT03428958|536578867|FG002|Overall Study|Lost to Follow-up|0|||
148755794|NCT03428958|536578868|FG003|Overall Study|Lost to Follow-up|0|||
148755795|NCT03428958|536578869|FG004|Overall Study|Lost to Follow-up|0|||
148755796|NCT03428958|536578870|FG005|Overall Study|Lost to Follow-up|1|||
148755797|NCT03428958|536578871|FG006|Overall Study|Lost to Follow-up|1|||
148755798|NCT03428958|536578872|FG007|Overall Study|Lost to Follow-up|0|||
148755799|NCT03428958|536578873|FG008|Overall Study|Lost to Follow-up|0|||
148755800|NCT03428958|536578874|FG009|Overall Study|Lost to Follow-up|0|||
148755801|NCT03428958|536578875|FG010|Overall Study|Lost to Follow-up|0|||
148755802|NCT03428958|536578876|FG011|Overall Study|Lost to Follow-up|0|||
148755803|NCT03428958|536578877|FG012|Overall Study|Lost to Follow-up|0|||
148755804|NCT03428958|536578878|FG013|Overall Study|Lost to Follow-up|0|||
148755805|NCT03428958|536578879|FG014|Overall Study|Lost to Follow-up|0|||
148755806|NCT03428958|536578880|FG015|Overall Study|Lost to Follow-up|0|||
148755807|NCT03428958|536578881|FG016|Overall Study|Lost to Follow-up|0|||
148755808|NCT03428958|536578865|FG000|Overall Study|Physician/Sponsor Decision|1|||
148755809|NCT03428958|536578866|FG001|Overall Study|Physician/Sponsor Decision|0|||
148755810|NCT03428958|536578867|FG002|Overall Study|Physician/Sponsor Decision|1|||
148755811|NCT03428958|536578868|FG003|Overall Study|Physician/Sponsor Decision|0|||
148755812|NCT03428958|536578869|FG004|Overall Study|Physician/Sponsor Decision|0|||
148755813|NCT03428958|536578870|FG005|Overall Study|Physician/Sponsor Decision|2|||
148755814|NCT03428958|536578871|FG006|Overall Study|Physician/Sponsor Decision|2|||
148755815|NCT03428958|536578872|FG007|Overall Study|Physician/Sponsor Decision|2|||
148755816|NCT03428958|536578873|FG008|Overall Study|Physician/Sponsor Decision|0|||
148755817|NCT03428958|536578874|FG009|Overall Study|Physician/Sponsor Decision|0|||
148755818|NCT03428958|536578875|FG010|Overall Study|Physician/Sponsor Decision|2|||
148755819|NCT03428958|536578876|FG011|Overall Study|Physician/Sponsor Decision|0|||
148755820|NCT03428958|536578877|FG012|Overall Study|Physician/Sponsor Decision|4|||
148755821|NCT03428958|536578878|FG013|Overall Study|Physician/Sponsor Decision|0|||
148755822|NCT03428958|536578879|FG014|Overall Study|Physician/Sponsor Decision|0|||
148755823|NCT03428958|536578880|FG015|Overall Study|Physician/Sponsor Decision|0|||
148755824|NCT03428958|536578881|FG016|Overall Study|Physician/Sponsor Decision|0|||
148755825|NCT03428958|536578865|FG000|Overall Study|Withdrawal by Subject|0|||
148755826|NCT03428958|536578866|FG001|Overall Study|Withdrawal by Subject|0|||
148755827|NCT03428958|536578867|FG002|Overall Study|Withdrawal by Subject|2|||
148755828|NCT03428958|536578868|FG003|Overall Study|Withdrawal by Subject|0|||
148755829|NCT03428958|536578869|FG004|Overall Study|Withdrawal by Subject|0|||
148755830|NCT03428958|536578870|FG005|Overall Study|Withdrawal by Subject|2|||
148755831|NCT03428958|536578871|FG006|Overall Study|Withdrawal by Subject|4|||
148755832|NCT03428958|536578872|FG007|Overall Study|Withdrawal by Subject|1|||
148755833|NCT03428958|536578873|FG008|Overall Study|Withdrawal by Subject|0|||
148755834|NCT03428958|536578874|FG009|Overall Study|Withdrawal by Subject|0|||
148755835|NCT03428958|536578875|FG010|Overall Study|Withdrawal by Subject|0|||
148755836|NCT03428958|536578876|FG011|Overall Study|Withdrawal by Subject|0|||
148755837|NCT03428958|536578877|FG012|Overall Study|Withdrawal by Subject|0|||
148755838|NCT03428958|536578878|FG013|Overall Study|Withdrawal by Subject|0|||
148755839|NCT03428958|536578879|FG014|Overall Study|Withdrawal by Subject|0|||
148755840|NCT03428958|536578880|FG015|Overall Study|Withdrawal by Subject|0|||
148755841|NCT03428958|536578881|FG016|Overall Study|Withdrawal by Subject|0|||
148755842|NCT03874117|536578882|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
148755843|NCT03874117|536578883|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
148755844|NCT03874117|536578882|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
148755845|NCT03874117|536578883|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
148755846|NCT03874117|536578882|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
148755847|NCT03874117|536578883|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148755848|NCT03874117|536578882|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
148755849|NCT03874117|536578883|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
148755850|NCT03874117|536578882|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148755851|NCT03874117|536578883|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
148755852|NCT05012098|536578884|FG000|Overall Study|Disease progression|5|||
148755853|NCT05012098|536578885|FG001|Overall Study|Disease progression|2|||
148755854|NCT05012098|536578884|FG000|Overall Study|Adverse Event|1|||
148823048|NCT03931785|536830734|FG001|Overall Study|Adverse Event|0|||
148823049|NCT03931785|536830735|FG002|Overall Study|Adverse Event|3|||
148823050|NCT03931785|536830736|FG003|Overall Study|Adverse Event|4|||
148823051|NCT03931785|536830733|FG000|Overall Study|Protocol Violation|0|||
148823052|NCT03931785|536830734|FG001|Overall Study|Protocol Violation|1|||
148823053|NCT03931785|536830735|FG002|Overall Study|Protocol Violation|0|||
148823054|NCT03931785|536830736|FG003|Overall Study|Protocol Violation|0|||
148823055|NCT03931785|536830733|FG000|Overall Study|Noncompliance With Study drug|0|||
148823056|NCT03931785|536830734|FG001|Overall Study|Noncompliance With Study drug|1|||
148823057|NCT03931785|536830735|FG002|Overall Study|Noncompliance With Study drug|0|||
148823058|NCT03931785|536830736|FG003|Overall Study|Noncompliance With Study drug|0|||
148823059|NCT03931785|536830733|FG000|Overall Study|Other Not specified|0|||
148823060|NCT03931785|536830734|FG001|Overall Study|Other Not specified|2|||
148823061|NCT03931785|536830735|FG002|Overall Study|Other Not specified|2|||
148823062|NCT03931785|536830736|FG003|Overall Study|Other Not specified|2|||
148823063|NCT03931785|536830733|FG000|Overall Study|Withdrawal by Subject|0|||
148823064|NCT03931785|536830734|FG001|Overall Study|Withdrawal by Subject|2|||
148823065|NCT03931785|536830735|FG002|Overall Study|Withdrawal by Subject|4|||
148823066|NCT03931785|536830736|FG003|Overall Study|Withdrawal by Subject|1|||
148823067|NCT03931785|536830733|FG000|Overall Study|Pregnancy|0|||
148823068|NCT03931785|536830734|FG001|Overall Study|Pregnancy|0|||
148823069|NCT03931785|536830735|FG002|Overall Study|Pregnancy|0|||
148823070|NCT03931785|536830736|FG003|Overall Study|Pregnancy|1|||
148823071|NCT03548415|536830738|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
148823072|NCT03548415|536830739|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
148823073|NCT03548415|536830740|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
148823074|NCT03548415|536830741|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
148823075|NCT03548415|536830742|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
148823076|NCT04605588|536830743|FG000|Overall Study|Withdrawal by Subject|1|||
148823077|NCT04605588|536830744|FG001|Overall Study|Withdrawal by Subject|0|||
148823078|NCT01230814|536830745|FG000|Overall Study|Lost to Follow-up|11|||
148823079|NCT01230814|536830746|FG001|Overall Study|Lost to Follow-up|3|||
148823080|NCT01230814|536830745|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
148823081|NCT01230814|536830746|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
148823082|NCT02533674|536830751|FG000|Dose Level I|Progressive disease|1|||
148823083|NCT02533674|536830752|FG001|Dose Level I|Progressive disease|0|||
148823084|NCT02533674|536830753|FG002|Dose Level I|Progressive disease|0|||
148823085|NCT02533674|536830754|FG003|Dose Level I|Progressive disease|0|||
148823086|NCT02533674|536830755|FG004|Dose Level I|Progressive disease|0|||
148823087|NCT02533674|536830756|FG005|Dose Level I|Progressive disease|0|||
148823088|NCT02533674|536830757|FG006|Dose Level I|Progressive disease|0|||
148823089|NCT02533674|536830758|FG007|Dose Level I|Progressive disease|0|||
148823090|NCT02533674|536830751|FG000|Dose Level I|Withdrawal by Subject|1|||
148823091|NCT02533674|536830752|FG001|Dose Level I|Withdrawal by Subject|0|||
148823092|NCT02533674|536830753|FG002|Dose Level I|Withdrawal by Subject|0|||
148823093|NCT02533674|536830754|FG003|Dose Level I|Withdrawal by Subject|0|||
148823094|NCT02533674|536830755|FG004|Dose Level I|Withdrawal by Subject|0|||
148823095|NCT02533674|536830756|FG005|Dose Level I|Withdrawal by Subject|0|||
148823096|NCT02533674|536830757|FG006|Dose Level I|Withdrawal by Subject|0|||
148823097|NCT02533674|536830758|FG007|Dose Level I|Withdrawal by Subject|0|||
148823098|NCT02533674|536830751|FG000|Dose Level I|Physician Decision|1|||
148823099|NCT02533674|536830752|FG001|Dose Level I|Physician Decision|0|||
148823100|NCT02533674|536830753|FG002|Dose Level I|Physician Decision|0|||
148823101|NCT02533674|536830754|FG003|Dose Level I|Physician Decision|0|||
148823102|NCT02533674|536830755|FG004|Dose Level I|Physician Decision|0|||
148823103|NCT02533674|536830756|FG005|Dose Level I|Physician Decision|0|||
148976398|NCT01469065|537394541|FG003|Overall Study|Lack of Efficacy|0|||
148976399|NCT01469065|537394542|FG004|Overall Study|Lack of Efficacy|1|||
148976400|NCT01469065|537394538|FG000|Overall Study|Other|0|||
148976401|NCT01469065|537394539|FG001|Overall Study|Other|1|||
148976402|NCT01469065|537394540|FG002|Overall Study|Other|0|||
148976403|NCT01469065|537394541|FG003|Overall Study|Other|0|||
148976404|NCT01469065|537394542|FG004|Overall Study|Other|0|||
148976405|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
149027411|NCT00688688|537578558|FG001|Overall Study|Adverse Event|51|||
149027412|NCT00688688|537578559|FG002|Overall Study|Adverse Event|50|||
148823104|NCT02533674|536830757|FG006|Dose Level I|Physician Decision|0|||
148976406|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
148976407|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
149027413|NCT00688688|537578557|FG000|Overall Study|Lack of Efficacy|34|||
148823105|NCT02533674|536830758|FG007|Dose Level I|Physician Decision|0|||
148823106|NCT02533674|536830751|FG000|Dose Level I|Death|1|||
148823107|NCT02533674|536830752|FG001|Dose Level I|Death|0|||
148823108|NCT02533674|536830753|FG002|Dose Level I|Death|0|||
148823109|NCT02533674|536830754|FG003|Dose Level I|Death|0|||
148823110|NCT02533674|536830755|FG004|Dose Level I|Death|0|||
148823111|NCT02533674|536830756|FG005|Dose Level I|Death|0|||
149027414|NCT00688688|537578558|FG001|Overall Study|Lack of Efficacy|25|||
148755855|NCT05012098|536578885|FG001|Overall Study|Adverse Event|0|||
148755856|NCT05012098|536578884|FG000|Overall Study|Withdrawal by Subject|1|||
148755857|NCT05012098|536578885|FG001|Overall Study|Withdrawal by Subject|0|||
148755858|NCT05012098|536578884|FG000|Overall Study|Discontinuation per protocol|1|||
148755859|NCT05012098|536578885|FG001|Overall Study|Discontinuation per protocol|0|||
148755860|NCT05258773|536578886|FG000|Overall Study|Screen Failure|1|||
148755861|NCT05258773|536578887|FG001|Overall Study|Screen Failure|1|||
148755862|NCT05258773|536578886|FG000|Overall Study|Adverse Event|1|||
148755863|NCT05258773|536578887|FG001|Overall Study|Adverse Event|0|||
148755864|NCT05258773|536578886|FG000|Overall Study|Withdrawal by Subject|0|||
148755865|NCT05258773|536578887|FG001|Overall Study|Withdrawal by Subject|1|||
148755866|NCT04815083|536578888|FG000|Overall Study|Physician Decision|1|||
148755867|NCT04815083|536578888|FG000|Overall Study|Study pause|2|||
148755868|NCT04815083|536578888|FG000|Overall Study|Screening failure|4|||
148755869|NCT05364931|536578893|FG000|Overall Study|Adverse Event|0|||
148755870|NCT05364931|536578894|FG001|Overall Study|Adverse Event|2|||
148755871|NCT05364931|536578895|FG002|Overall Study|Adverse Event|1|||
148755872|NCT05364931|536578896|FG003|Overall Study|Adverse Event|0|||
148755873|NCT05364931|536578893|FG000|Overall Study|Lost to Follow-up|1|||
148755874|NCT05364931|536578894|FG001|Overall Study|Lost to Follow-up|0|||
148755875|NCT05364931|536578895|FG002|Overall Study|Lost to Follow-up|0|||
148755876|NCT05364931|536578896|FG003|Overall Study|Lost to Follow-up|0|||
148755877|NCT05364931|536578893|FG000|Overall Study|Withdrawal by Subject|1|||
148755878|NCT05364931|536578894|FG001|Overall Study|Withdrawal by Subject|1|||
148755879|NCT05364931|536578895|FG002|Overall Study|Withdrawal by Subject|3|||
148755880|NCT05364931|536578896|FG003|Overall Study|Withdrawal by Subject|2|||
148755881|NCT05364931|536578893|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
148755882|NCT05364931|536578894|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
148755883|NCT05364931|536578895|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
148755884|NCT05364931|536578896|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
148755885|NCT05364931|536578893|FG000|Overall Study|Discontinued|1|||
148755886|NCT05364931|536578894|FG001|Overall Study|Discontinued|0|||
148755887|NCT05364931|536578895|FG002|Overall Study|Discontinued|0|||
148755888|NCT05364931|536578896|FG003|Overall Study|Discontinued|0|||
148755889|NCT02243605|536578897|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
148755890|NCT02243605|536578898|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
148755891|NCT02243605|536578897|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
148755892|NCT02243605|536578898|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
148755893|NCT02243605|536578897|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
148755894|NCT02243605|536578898|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
148755895|NCT02243605|536578897|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
148755896|NCT02243605|536578898|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
148755897|NCT02243605|536578897|FG000|Stage 2 - Final Analysis Population|Progression|0|||
148755898|NCT02243605|536578898|FG001|Stage 2 - Final Analysis Population|Progression|1|||
148755899|NCT00075816|536578899|FG000|Overall Study|Did not undergo transplantation|14|||
148755900|NCT00075816|536578900|FG001|Overall Study|Did not undergo transplantation|11|||
148755901|NCT01823328|536578901|FG000|Overall Study|Withdrawal by Subject|8|||
148755902|NCT01823328|536578902|FG001|Overall Study|Withdrawal by Subject|6|||
148755903|NCT03192488|536578903|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
148755904|NCT03192488|536578904|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
148755905|NCT03192488|536578905|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
148755906|NCT03192488|536578906|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
148755907|NCT03192488|536578907|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
148755908|NCT03192488|536578908|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
148755909|NCT03192488|536578903|FG000|Third Intervention (d1)|Adverse Event|0|||
148755910|NCT03192488|536578904|FG001|Third Intervention (d1)|Adverse Event|0|||
148755911|NCT03192488|536578905|FG002|Third Intervention (d1)|Adverse Event|0|||
148755912|NCT03192488|536578906|FG003|Third Intervention (d1)|Adverse Event|0|||
148755913|NCT03192488|536578907|FG004|Third Intervention (d1)|Adverse Event|1|||
148755914|NCT03192488|536578908|FG005|Third Intervention (d1)|Adverse Event|0|||
148755915|NCT03588910|536578910|FG000|Overall Study|Withdrawal by Subject|1|||
148755916|NCT03588910|536578911|FG001|Overall Study|Withdrawal by Subject|0|||
148755917|NCT03588910|536578910|FG000|Overall Study|Allergy|2|||
148755918|NCT03588910|536578911|FG001|Overall Study|Allergy|0|||
148755919|NCT03588910|536578910|FG000|Overall Study|Protocol Violation|0|||
148755920|NCT03588910|536578911|FG001|Overall Study|Protocol Violation|3|||
148755921|NCT03588910|536578910|FG000|Overall Study|Did not complete Day 1 Survey|5|||
148755922|NCT03588910|536578911|FG001|Overall Study|Did not complete Day 1 Survey|10|||
148755923|NCT03588910|536578910|FG000|Overall Study|Did not complete Day 7 Survey|5|||
148755924|NCT03588910|536578911|FG001|Overall Study|Did not complete Day 7 Survey|2|||
148755925|NCT02547428|536578912|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
148755926|NCT02547428|536578913|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
148823112|NCT02533674|536830757|FG006|Dose Level I|Death|0|||
148755927|NCT02547428|536578912|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
148755928|NCT02547428|536578913|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
148755929|NCT02547428|536578912|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
148755930|NCT02547428|536578913|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
148755931|NCT02547428|536578912|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
148755932|NCT02547428|536578913|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
148755933|NCT02547428|536578912|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
148755934|NCT02547428|536578913|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
148755935|NCT02547428|536578912|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
148755936|NCT02547428|536578913|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
148755937|NCT02547428|536578912|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
148755938|NCT02547428|536578913|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
148755939|NCT02547428|536578912|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
148755940|NCT02547428|536578913|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
148755941|NCT01892501|536578914|FG000|Overall Study|Protocol Violation|2|||
148755942|NCT01892501|536578914|FG000|Overall Study|Puncture not carried out|9|||
148755943|NCT01892501|536578914|FG000|Overall Study|Radiological monitoring not carried out|5|||
148755944|NCT01892501|536578914|FG000|Overall Study|Non-contributory histological result|12|||
148755945|NCT02302833|536578916|FG000|Overall Study|Lost to Follow-up|3|||
148755946|NCT03664232|536578921|FG000|Overall Study|Withdrawal by Subject|0|||
148755947|NCT03664232|536578922|FG001|Overall Study|Withdrawal by Subject|1|||
148755948|NCT03664232|536578923|FG002|Overall Study|Withdrawal by Subject|0|||
148755949|NCT03664232|536578924|FG003|Overall Study|Withdrawal by Subject|1|||
148755950|NCT03664232|536578921|FG000|Overall Study|Adverse Event|0|||
148755951|NCT03664232|536578922|FG001|Overall Study|Adverse Event|0|||
148755952|NCT03664232|536578923|FG002|Overall Study|Adverse Event|1|||
148755953|NCT03664232|536578924|FG003|Overall Study|Adverse Event|0|||
148755954|NCT03664232|536578921|FG000|Overall Study|Other-Non-compliance with study drug|0|||
148755955|NCT03664232|536578922|FG001|Overall Study|Other-Non-compliance with study drug|1|||
148755956|NCT03664232|536578923|FG002|Overall Study|Other-Non-compliance with study drug|0|||
148755957|NCT03664232|536578924|FG003|Overall Study|Other-Non-compliance with study drug|2|||
148755958|NCT03664232|536578921|FG000|Overall Study|Other-Unspecified|0|||
148755959|NCT03664232|536578922|FG001|Overall Study|Other-Unspecified|3|||
148755960|NCT03664232|536578923|FG002|Overall Study|Other-Unspecified|0|||
148755961|NCT03664232|536578924|FG003|Overall Study|Other-Unspecified|1|||
148755962|NCT03664232|536578921|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
148755963|NCT03664232|536578922|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
148755964|NCT03664232|536578923|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
148755965|NCT03664232|536578924|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
148755966|NCT02717507|536578925|FG000|Overall Study|Lost to Follow-up|5|||
148755967|NCT02717507|536578926|FG001|Overall Study|Lost to Follow-up|8|||
148755968|NCT02717507|536578925|FG000|Overall Study|Pregnancy|1|||
148755969|NCT02717507|536578926|FG001|Overall Study|Pregnancy|1|||
148755970|NCT02717507|536578925|FG000|Overall Study|Protocol Violation|2|||
148755971|NCT02717507|536578926|FG001|Overall Study|Protocol Violation|2|||
148755972|NCT02717507|536578925|FG000|Overall Study|Withdrawal by Subject|20|||
148755973|NCT02717507|536578926|FG001|Overall Study|Withdrawal by Subject|20|||
148755974|NCT02717507|536578925|FG000|Overall Study|Relapse|1|||
148755975|NCT02717507|536578926|FG001|Overall Study|Relapse|1|||
148755976|NCT02717507|536578925|FG000|Overall Study|Cardiac Event|2|||
148755977|NCT02717507|536578926|FG001|Overall Study|Cardiac Event|6|||
148755978|NCT05017246|536578927|FG000|Overall Study|Withdrawal by Subject|5|||
148755979|NCT05017246|536578928|FG001|Overall Study|Withdrawal by Subject|3|||
148755980|NCT05017246|536578927|FG000|Overall Study|Determined to be ineligible|0|||
148755981|NCT05017246|536578928|FG001|Overall Study|Determined to be ineligible|1|||
148755982|NCT05017246|536578927|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
148755983|NCT05017246|536578928|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
148755984|NCT05017246|536578927|FG000|Overall Study|Technical failure|1|||
148755985|NCT05017246|536578928|FG001|Overall Study|Technical failure|3|||
148755986|NCT01439802|536578929|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
148755987|NCT01439802|536578929|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
148755988|NCT00654095|536578930|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
148755989|NCT00654095|536578930|FG000|Overall Study|Elevated triglyceride level (2)|1|||
148755990|NCT00654095|536578930|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
148976408|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
148976409|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
149027415|NCT00688688|537578559|FG002|Overall Study|Lack of Efficacy|45|||
148755991|NCT00654095|536578930|FG000|Overall Study|Adverse Event|11|||
148755992|NCT00654095|536578930|FG000|Overall Study|Withdrawal by Subject|5|||
148755993|NCT00654095|536578930|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
148755994|NCT00654095|536578930|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
148823113|NCT02533674|536830758|FG007|Dose Level I|Death|0|||
148823114|NCT02533674|536830751|FG000|Dose Level I|Never Treated|1|||
148823115|NCT02533674|536830752|FG001|Dose Level I|Never Treated|0|||
148823116|NCT02533674|536830753|FG002|Dose Level I|Never Treated|0|||
148823117|NCT02533674|536830754|FG003|Dose Level I|Never Treated|0|||
148823118|NCT02533674|536830755|FG004|Dose Level I|Never Treated|0|||
148823119|NCT02533674|536830756|FG005|Dose Level I|Never Treated|0|||
148755995|NCT00654095|536578930|FG000|Overall Study|Did not meet inclusion criteria|1|||
148755996|NCT00595621|536578931|FG000|Open Label Run in|Adverse Event|1|||
148755997|NCT00595621|536578932|FG001|Open Label Run in|Adverse Event|0|||
148755998|NCT00595621|536578931|FG000|Open Label Run in|Physician Decision|1|||
148755999|NCT00595621|536578932|FG001|Open Label Run in|Physician Decision|0|||
148756000|NCT00595621|536578931|FG000|Open Label Run in|Withdrawal by Subject|1|||
148756001|NCT00595621|536578932|FG001|Open Label Run in|Withdrawal by Subject|0|||
148756002|NCT00595621|536578931|FG000|Randomization and Study|Adverse Event|2|||
148756003|NCT00595621|536578932|FG001|Randomization and Study|Adverse Event|0|||
148756004|NCT00595621|536578931|FG000|Randomization and Study|Withdrawal by Subject|0|||
148756005|NCT00595621|536578932|FG001|Randomization and Study|Withdrawal by Subject|1|||
148756006|NCT02502149|536578933|FG000|Intermediate|Discontinued prematurely|1|||
148756007|NCT02502149|536578934|FG001|Intermediate|Discontinued prematurely|0|||
148756008|NCT02502149|536578935|FG002|Intermediate|Discontinued prematurely|0|||
148756009|NCT02502149|536578936|FG003|Intermediate|Discontinued prematurely|0|||
148756010|NCT02502149|536578937|FG004|Intermediate|Discontinued prematurely|0|||
148756011|NCT02548832|536578938|FG000|Overall Study|Lost to Follow-up|2|||
148756012|NCT02548832|536578939|FG001|Overall Study|Lost to Follow-up|2|||
148756013|NCT02548832|536578940|FG002|Overall Study|Lost to Follow-up|2|||
148756014|NCT02968576|536578941|FG000|Overall Study|Pregnancy|0|||
148756015|NCT02968576|536578942|FG001|Overall Study|Pregnancy|1|||
148756016|NCT01998919|536578948|FG000|Overall Study|Death|2|||
148756017|NCT01998919|536578949|FG001|Overall Study|Death|2|||
148756018|NCT01998919|536578948|FG000|Overall Study|Adverse Event|0|||
148756019|NCT01998919|536578949|FG001|Overall Study|Adverse Event|5|||
148756020|NCT01998919|536578948|FG000|Overall Study|Disease progression|31|||
148756021|NCT01998919|536578949|FG001|Overall Study|Disease progression|22|||
148756022|NCT01998919|536578948|FG000|Overall Study|Withdrawal by Subject|2|||
148756023|NCT01998919|536578949|FG001|Overall Study|Withdrawal by Subject|4|||
148756024|NCT01998919|536578948|FG000|Overall Study|Lost to Follow-up|2|||
148756025|NCT01998919|536578949|FG001|Overall Study|Lost to Follow-up|0|||
148756026|NCT01998919|536578948|FG000|Overall Study|Other|5|||
148756027|NCT01998919|536578949|FG001|Overall Study|Other|2|||
148756028|NCT02383017|536578950|FG000|Overall Study|Injury Sustained Outside Study|1|||
148756029|NCT02383017|536578951|FG001|Overall Study|Injury Sustained Outside Study|0|||
148756030|NCT02383017|536578950|FG000|Overall Study|Compliance|3|||
148756031|NCT02383017|536578951|FG001|Overall Study|Compliance|2|||
148756032|NCT02383017|536578950|FG000|Overall Study|Found to be Hypogonadal|1|||
148756033|NCT02383017|536578951|FG001|Overall Study|Found to be Hypogonadal|0|||
148756034|NCT01068860|536578952|FG000|Overall Study|Withdrawal by Subject|0|||
148756035|NCT01068860|536578953|FG001|Overall Study|Withdrawal by Subject|0|||
148756036|NCT01068860|536578954|FG002|Overall Study|Withdrawal by Subject|0|||
148756037|NCT01068860|536578955|FG003|Overall Study|Withdrawal by Subject|0|||
148756038|NCT01068860|536578956|FG004|Overall Study|Withdrawal by Subject|0|||
148756039|NCT01068860|536578957|FG005|Overall Study|Withdrawal by Subject|2|||
148756040|NCT01068860|536578958|FG006|Overall Study|Withdrawal by Subject|0|||
148756041|NCT01068860|536578959|FG007|Overall Study|Withdrawal by Subject|0|||
148756042|NCT01068860|536578960|FG008|Overall Study|Withdrawal by Subject|0|||
148756043|NCT01068860|536578961|FG009|Overall Study|Withdrawal by Subject|3|||
148756044|NCT01068860|536578952|FG000|Overall Study|Administrative problems; misrandomized|0|||
148756045|NCT01068860|536578953|FG001|Overall Study|Administrative problems; misrandomized|0|||
148756046|NCT01068860|536578954|FG002|Overall Study|Administrative problems; misrandomized|0|||
148756047|NCT01068860|536578955|FG003|Overall Study|Administrative problems; misrandomized|1|||
148823120|NCT02533674|536830757|FG006|Dose Level I|Never Treated|0|||
148823121|NCT02533674|536830758|FG007|Dose Level I|Never Treated|0|||
148823122|NCT02533674|536830751|FG000|Dose Level II|Progressive disease|0|||
148823123|NCT02533674|536830752|FG001|Dose Level II|Progressive disease|3|||
148823124|NCT02533674|536830753|FG002|Dose Level II|Progressive disease|0|||
148756048|NCT01068860|536578956|FG004|Overall Study|Administrative problems; misrandomized|0|||
148756049|NCT01068860|536578957|FG005|Overall Study|Administrative problems; misrandomized|0|||
148756050|NCT01068860|536578958|FG006|Overall Study|Administrative problems; misrandomized|0|||
148756051|NCT01068860|536578959|FG007|Overall Study|Administrative problems; misrandomized|0|||
148756052|NCT01068860|536578960|FG008|Overall Study|Administrative problems; misrandomized|0|||
148823125|NCT02533674|536830754|FG003|Dose Level II|Progressive disease|0|||
148823126|NCT02533674|536830755|FG004|Dose Level II|Progressive disease|0|||
148823127|NCT02533674|536830756|FG005|Dose Level II|Progressive disease|0|||
148756053|NCT01068860|536578961|FG009|Overall Study|Administrative problems; misrandomized|1|||
148756054|NCT01068860|536578952|FG000|Overall Study|Lost to Follow-up|0|||
148756055|NCT01068860|536578953|FG001|Overall Study|Lost to Follow-up|1|||
148756056|NCT01068860|536578954|FG002|Overall Study|Lost to Follow-up|0|||
148823128|NCT02533674|536830757|FG006|Dose Level II|Progressive disease|0|||
148756057|NCT01068860|536578955|FG003|Overall Study|Lost to Follow-up|0|||
148756058|NCT01068860|536578956|FG004|Overall Study|Lost to Follow-up|0|||
148756059|NCT01068860|536578957|FG005|Overall Study|Lost to Follow-up|0|||
148756060|NCT01068860|536578958|FG006|Overall Study|Lost to Follow-up|0|||
148976410|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
148976411|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
148976412|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
148976413|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
148756061|NCT01068860|536578959|FG007|Overall Study|Lost to Follow-up|0|||
148756062|NCT01068860|536578960|FG008|Overall Study|Lost to Follow-up|0|||
148756063|NCT01068860|536578961|FG009|Overall Study|Lost to Follow-up|0|||
148756064|NCT00927589|536578962|FG000|Overall Study|Death|1|||
148756065|NCT00927589|536578962|FG000|Overall Study|Physician Decision|1|||
148756066|NCT00927589|536578962|FG000|Overall Study|Withdrawal by Subject|3|||
148756067|NCT00927589|536578962|FG000|Overall Study|Adverse Event|2|||
148756068|NCT00927589|536578962|FG000|Overall Study|Disease Progression|8|||
148756069|NCT00927589|536578962|FG000|Overall Study|Non-compliance|1|||
148756070|NCT05263908|536578964|FG000|Overall Study|No informed consent for publication of study results|397|||
148756071|NCT05263908|536578964|FG000|Overall Study|CRF not collected|1|||
148756072|NCT03711188|536578967|FG000|Overall Study|Disease progression|11|||
148756073|NCT03711188|536578967|FG000|Overall Study|Adverse Event|1|||
148756074|NCT01433471|536578968|FG000|Overall Study|Withdrawal by Subject|0|||
148756075|NCT01433471|536578969|FG001|Overall Study|Withdrawal by Subject|1|||
148756076|NCT03875508|536578970|FG000|Overall Study|Adverse Event|1|||
148756077|NCT03875508|536578970|FG000|Overall Study|Lost to Follow-up|8|||
148756078|NCT03875508|536578970|FG000|Overall Study|Lack of Efficacy|1|||
148756079|NCT03875508|536578970|FG000|Overall Study|Other, not specified|2|||
148756080|NCT04341363|536578971|FG000|Overall Study|Adverse Event|1|||
148756081|NCT04341363|536578971|FG000|Overall Study|Withdrawal by Subject|1|||
148756082|NCT02069015|536578972|FG000|Overall Study|Lost to Follow-up|39|||
148756083|NCT02069015|536578973|FG001|Overall Study|Lost to Follow-up|32|||
148756084|NCT02069015|536578972|FG000|Overall Study|Withdrawal by Subject|1|||
148756085|NCT02069015|536578973|FG001|Overall Study|Withdrawal by Subject|1|||
148756086|NCT03335475|536578974|FG000|Overall Study|Did not wear accelerometer|4|||
148756087|NCT03335475|536578975|FG001|Overall Study|Did not wear accelerometer|0|||
148756088|NCT03335475|536578974|FG000|Overall Study|Withdrawal by Subject|0|||
148823129|NCT02533674|536830758|FG007|Dose Level II|Progressive disease|0|||
148823130|NCT02533674|536830751|FG000|Dose Level II|Withdrawal by Subject|0|||
148823131|NCT02533674|536830752|FG001|Dose Level II|Withdrawal by Subject|1|||
148823132|NCT02533674|536830753|FG002|Dose Level II|Withdrawal by Subject|0|||
148823133|NCT02533674|536830754|FG003|Dose Level II|Withdrawal by Subject|0|||
148823134|NCT02533674|536830755|FG004|Dose Level II|Withdrawal by Subject|0|||
148823135|NCT02533674|536830756|FG005|Dose Level II|Withdrawal by Subject|0|||
148823136|NCT02533674|536830757|FG006|Dose Level II|Withdrawal by Subject|0|||
148823137|NCT02533674|536830758|FG007|Dose Level II|Withdrawal by Subject|0|||
148823138|NCT02533674|536830751|FG000|Dose Level II|Treatment-related AE|0|||
148823139|NCT02533674|536830752|FG001|Dose Level II|Treatment-related AE|1|||
148823140|NCT02533674|536830753|FG002|Dose Level II|Treatment-related AE|0|||
148823141|NCT02533674|536830754|FG003|Dose Level II|Treatment-related AE|0|||
148823142|NCT02533674|536830755|FG004|Dose Level II|Treatment-related AE|0|||
148823143|NCT02533674|536830756|FG005|Dose Level II|Treatment-related AE|0|||
148823144|NCT02533674|536830757|FG006|Dose Level II|Treatment-related AE|0|||
148823145|NCT02533674|536830758|FG007|Dose Level II|Treatment-related AE|0|||
148823146|NCT02533674|536830751|FG000|Dose Level II|Physician Decision|0|||
148823147|NCT02533674|536830752|FG001|Dose Level II|Physician Decision|1|||
148976414|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
148976415|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
148976416|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
148976417|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
148976418|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
148756089|NCT03335475|536578975|FG001|Overall Study|Withdrawal by Subject|1|||
148756090|NCT03305848|536578976|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
148756091|NCT03305848|536578976|FG000|Overall Study|Physician Decision|2|||
148756092|NCT00789854|536578979|FG000|Overall Study|Adverse Event|28|||
148756093|NCT00789854|536578980|FG001|Overall Study|Adverse Event|23|||
148823148|NCT02533674|536830753|FG002|Dose Level II|Physician Decision|0|||
148823149|NCT02533674|536830754|FG003|Dose Level II|Physician Decision|0|||
148823150|NCT02533674|536830755|FG004|Dose Level II|Physician Decision|0|||
148823151|NCT02533674|536830756|FG005|Dose Level II|Physician Decision|0|||
148823152|NCT02533674|536830757|FG006|Dose Level II|Physician Decision|0|||
148823153|NCT02533674|536830758|FG007|Dose Level II|Physician Decision|0|||
148823154|NCT02533674|536830751|FG000|Dose Level II|Non-treatment-related AE|0|||
148823155|NCT02533674|536830752|FG001|Dose Level II|Non-treatment-related AE|1|||
148756094|NCT00789854|536578981|FG002|Overall Study|Adverse Event|18|||
148756095|NCT00789854|536578979|FG000|Overall Study|Lost to Follow-up|1|||
148756096|NCT00789854|536578980|FG001|Overall Study|Lost to Follow-up|1|||
148976419|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
148976420|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
148976421|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
148976422|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
148756097|NCT00789854|536578981|FG002|Overall Study|Lost to Follow-up|4|||
148756098|NCT00789854|536578979|FG000|Overall Study|Withdrawal by Subject|9|||
148756099|NCT00789854|536578980|FG001|Overall Study|Withdrawal by Subject|6|||
148756100|NCT00789854|536578981|FG002|Overall Study|Withdrawal by Subject|17|||
148756101|NCT00789854|536578979|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
148756102|NCT00789854|536578980|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
148756103|NCT00789854|536578981|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
148756104|NCT00789854|536578979|FG000|Overall Study|Severe non-compliance to the protocol|3|||
148756105|NCT00789854|536578980|FG001|Overall Study|Severe non-compliance to the protocol|0|||
148756106|NCT00789854|536578981|FG002|Overall Study|Severe non-compliance to the protocol|0|||
148756107|NCT00789854|536578979|FG000|Overall Study|Safety reasons|0|||
148756108|NCT00789854|536578980|FG001|Overall Study|Safety reasons|0|||
148756109|NCT00789854|536578981|FG002|Overall Study|Safety reasons|2|||
148756110|NCT00789854|536578979|FG000|Overall Study|Other|6|||
148756111|NCT00789854|536578980|FG001|Overall Study|Other|0|||
148756112|NCT00789854|536578981|FG002|Overall Study|Other|5|||
148756113|NCT00923013|536578982|FG000|Overall Study|Refused further treatment|0|||
148756114|NCT00923013|536578983|FG001|Overall Study|Refused further treatment|1|||
148756115|NCT00923013|536578984|FG002|Overall Study|Refused further treatment|2|||
148756116|NCT00923013|536578985|FG003|Overall Study|Refused further treatment|0|||
148756117|NCT00923013|536578986|FG004|Overall Study|Refused further treatment|0|||
148756118|NCT00923013|536578987|FG005|Overall Study|Refused further treatment|0|||
148756119|NCT00923013|536578982|FG000|Overall Study|Switched to alternative treatment|0|||
148756120|NCT00923013|536578983|FG001|Overall Study|Switched to alternative treatment|1|||
148756121|NCT00923013|536578984|FG002|Overall Study|Switched to alternative treatment|0|||
148756122|NCT00923013|536578985|FG003|Overall Study|Switched to alternative treatment|0|||
148756123|NCT00923013|536578986|FG004|Overall Study|Switched to alternative treatment|0|||
148756124|NCT00923013|536578987|FG005|Overall Study|Switched to alternative treatment|0|||
148756125|NCT00923013|536578982|FG000|Overall Study|Death on study|2|||
148756126|NCT00923013|536578983|FG001|Overall Study|Death on study|2|||
148756127|NCT00923013|536578984|FG002|Overall Study|Death on study|0|||
148756128|NCT00923013|536578985|FG003|Overall Study|Death on study|1|||
148756129|NCT00923013|536578986|FG004|Overall Study|Death on study|0|||
148756130|NCT00923013|536578987|FG005|Overall Study|Death on study|0|||
148756131|NCT05366010|536578990|FG000|Overall Study|Withdrawal by Subject|1|||
148756132|NCT05366010|536578990|FG000|Overall Study|Protocol Violation|1|||
148756133|NCT05366010|536578990|FG000|Overall Study|Lost to Follow-up|2|||
148756134|NCT05366010|536578990|FG000|Overall Study|Screen Failure|2|||
148756135|NCT02224157|536578991|FG000|Overall Study|Severe non-compliance to protocol|2|||
148756136|NCT02224157|536578992|FG001|Overall Study|Severe non-compliance to protocol|2|||
148756137|NCT02224157|536578991|FG000|Overall Study|Other|13|||
148756138|NCT02224157|536578992|FG001|Overall Study|Other|10|||
148756139|NCT02224157|536578991|FG000|Overall Study|Subject decision|58|||
148756140|NCT02224157|536578992|FG001|Overall Study|Subject decision|50|||
148756141|NCT02224157|536578991|FG000|Overall Study|Prematurely closed site|4|||
148756142|NCT02224157|536578992|FG001|Overall Study|Prematurely closed site|2|||
148756143|NCT02224157|536578991|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
148756144|NCT02224157|536578992|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
148756145|NCT02224157|536578991|FG000|Overall Study|Lost to Follow-up|27|||
148756146|NCT02224157|536578992|FG001|Overall Study|Lost to Follow-up|35|||
148756147|NCT02224157|536578991|FG000|Overall Study|Death|1|||
148756148|NCT02224157|536578992|FG001|Overall Study|Death|1|||
148756149|NCT02224157|536578991|FG000|Overall Study|Adverse Event|1|||
148756150|NCT02224157|536578992|FG001|Overall Study|Adverse Event|3|||
148756151|NCT05906628|536578993|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
148756152|NCT05906628|536578994|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
148756153|NCT05906628|536578993|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
148756154|NCT05906628|536578994|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
148976423|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
148976424|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
148976425|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
148756155|NCT05906628|536578993|FG000|16-Week DBVC Period|Protocol Violation|4|||
148756156|NCT05906628|536578994|FG001|16-Week DBVC Period|Protocol Violation|2|||
148756157|NCT05906628|536578993|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
148756158|NCT05906628|536578994|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
148756159|NCT05906628|536578993|FG000|16-Week OLE Period|Death|1|||
148756160|NCT05906628|536578994|FG001|16-Week OLE Period|Death|0|||
148756161|NCT05906628|536578993|FG000|16-Week OLE Period|Lost to Follow-up|1|||
148756162|NCT05906628|536578994|FG001|16-Week OLE Period|Lost to Follow-up|1|||
148756163|NCT05906628|536578993|FG000|16-Week OLE Period|Protocol Violation|0|||
148756164|NCT05906628|536578994|FG001|16-Week OLE Period|Protocol Violation|1|||
148823156|NCT02533674|536830753|FG002|Dose Level II|Non-treatment-related AE|0|||
148823157|NCT02533674|536830754|FG003|Dose Level II|Non-treatment-related AE|0|||
148823158|NCT02533674|536830755|FG004|Dose Level II|Non-treatment-related AE|0|||
148756165|NCT05906628|536578993|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
148756166|NCT05906628|536578994|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
148756167|NCT00837148|536578995|FG000|Overall Study|Adverse Event|1|||
148756168|NCT00837148|536578995|FG000|Overall Study|Death|1|||
148756169|NCT02301169|536578996|FG000|Overall Study|Adverse Event|1|||
148756170|NCT02301169|536578997|FG001|Overall Study|Adverse Event|0|||
148756171|NCT01422213|536578998|FG000|Overall Study|Adverse Event|8|||
148756172|NCT01422213|536578999|FG001|Overall Study|Adverse Event|7|||
148756173|NCT01422213|536579000|FG002|Overall Study|Adverse Event|11|||
148756174|NCT01422213|536578998|FG000|Overall Study|Lack of Efficacy|10|||
148756175|NCT01422213|536578999|FG001|Overall Study|Lack of Efficacy|2|||
148756176|NCT01422213|536579000|FG002|Overall Study|Lack of Efficacy|2|||
148756177|NCT01422213|536578998|FG000|Overall Study|Non-compliance with study drug|0|||
148756178|NCT01422213|536578999|FG001|Overall Study|Non-compliance with study drug|1|||
148756179|NCT01422213|536579000|FG002|Overall Study|Non-compliance with study drug|0|||
148756180|NCT01422213|536578998|FG000|Overall Study|Protocol Violation|0|||
148756181|NCT01422213|536578999|FG001|Overall Study|Protocol Violation|2|||
148756182|NCT01422213|536579000|FG002|Overall Study|Protocol Violation|4|||
148756183|NCT01422213|536578998|FG000|Overall Study|Withdrawal of Consent|7|||
148756184|NCT01422213|536578999|FG001|Overall Study|Withdrawal of Consent|3|||
148756185|NCT01422213|536579000|FG002|Overall Study|Withdrawal of Consent|5|||
148756186|NCT01422213|536578998|FG000|Overall Study|Lost to Follow-up|3|||
148756187|NCT01422213|536578999|FG001|Overall Study|Lost to Follow-up|3|||
148756188|NCT01422213|536579000|FG002|Overall Study|Lost to Follow-up|5|||
148756189|NCT01422213|536578998|FG000|Overall Study|Administrative or Other Reason(s)|5|||
148756190|NCT01422213|536578999|FG001|Overall Study|Administrative or Other Reason(s)|4|||
148756191|NCT01422213|536579000|FG002|Overall Study|Administrative or Other Reason(s)|2|||
148756192|NCT03762265|536579003|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
148756193|NCT03762265|536579004|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
148756194|NCT03762265|536579003|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
148756195|NCT03762265|536579004|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
148756196|NCT03762265|536579003|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
148756197|NCT03762265|536579004|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
148756198|NCT03762265|536579003|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
148756199|NCT03762265|536579004|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
148756200|NCT03762265|536579003|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
148756201|NCT03762265|536579004|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
148756202|NCT03762265|536579003|FG000|BT Period: Weeks 1 to 37|Other|0|||
148756203|NCT03762265|536579004|FG001|BT Period: Weeks 1 to 37|Other|1|||
148756204|NCT03762265|536579003|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
148756205|NCT03762265|536579004|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
148756206|NCT03762265|536579003|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
148756207|NCT03762265|536579004|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
148756208|NCT03762265|536579003|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
148756209|NCT03762265|536579004|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
148756210|NCT03762265|536579003|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
148756211|NCT03762265|536579004|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
148756212|NCT03762265|536579003|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
148756213|NCT03762265|536579004|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
148756214|NCT03762265|536579003|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
148756215|NCT03762265|536579004|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
148756216|NCT03762265|536579003|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
148756217|NCT03762265|536579004|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
148756218|NCT03762265|536579003|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
148756219|NCT03762265|536579004|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
148756220|NCT03762265|536579003|FG000|LTE Period: Weeks 61 to 109|Other|1|||
148756221|NCT03762265|536579004|FG001|LTE Period: Weeks 61 to 109|Other|0|||
148756222|NCT02857816|536579005|FG000|Overall Study|Screen Failure|33|||
148756223|NCT02857816|536579005|FG000|Overall Study|Withdrawal by Subject|4|||
148823159|NCT02533674|536830756|FG005|Dose Level II|Non-treatment-related AE|0|||
148823160|NCT02533674|536830757|FG006|Dose Level II|Non-treatment-related AE|0|||
148756224|NCT02857816|536579005|FG000|Overall Study|Lost to Follow-up|1|||
148756225|NCT00470470|536579006|FG000|Overall Study|Adverse Event|2|||
148756226|NCT00470470|536579006|FG000|Overall Study|Death|2|||
148756227|NCT00470470|536579006|FG000|Overall Study|Not treated|1|||
148823161|NCT02533674|536830758|FG007|Dose Level II|Non-treatment-related AE|0|||
148756228|NCT01149863|536579007|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
148756229|NCT02286713|536579011|FG000|One Week Follow-Up|Death|1|||
148756230|NCT02286713|536579012|FG001|One Week Follow-Up|Death|0|||
148823162|NCT02533674|536830751|FG000|Dose Level III|Progressive disease|0|||
148823163|NCT02533674|536830752|FG001|Dose Level III|Progressive disease|0|||
148823164|NCT02533674|536830753|FG002|Dose Level III|Progressive disease|2|||
148823165|NCT02533674|536830754|FG003|Dose Level III|Progressive disease|0|||
148823166|NCT02533674|536830755|FG004|Dose Level III|Progressive disease|0|||
148823167|NCT02533674|536830756|FG005|Dose Level III|Progressive disease|0|||
148823168|NCT02533674|536830757|FG006|Dose Level III|Progressive disease|0|||
148823169|NCT02533674|536830758|FG007|Dose Level III|Progressive disease|0|||
148823170|NCT02533674|536830751|FG000|Dose Level III|Withdrawal by Subject|0|||
148823171|NCT02533674|536830752|FG001|Dose Level III|Withdrawal by Subject|0|||
148823172|NCT02533674|536830753|FG002|Dose Level III|Withdrawal by Subject|1|||
148823173|NCT02533674|536830754|FG003|Dose Level III|Withdrawal by Subject|0|||
148823174|NCT02533674|536830755|FG004|Dose Level III|Withdrawal by Subject|0|||
148823175|NCT02533674|536830756|FG005|Dose Level III|Withdrawal by Subject|0|||
148823176|NCT02533674|536830757|FG006|Dose Level III|Withdrawal by Subject|0|||
148823177|NCT02533674|536830758|FG007|Dose Level III|Withdrawal by Subject|0|||
148823178|NCT02533674|536830751|FG000|Dose Level III|Treatment-related AE|0|||
148823179|NCT02533674|536830752|FG001|Dose Level III|Treatment-related AE|0|||
148823180|NCT02533674|536830753|FG002|Dose Level III|Treatment-related AE|1|||
148823181|NCT02533674|536830754|FG003|Dose Level III|Treatment-related AE|0|||
148823182|NCT02533674|536830755|FG004|Dose Level III|Treatment-related AE|0|||
148823183|NCT02533674|536830756|FG005|Dose Level III|Treatment-related AE|0|||
148823184|NCT02533674|536830757|FG006|Dose Level III|Treatment-related AE|0|||
148823185|NCT02533674|536830758|FG007|Dose Level III|Treatment-related AE|0|||
148823186|NCT02533674|536830751|FG000|Dose Level IV|Progressive disease|0|||
148823187|NCT02533674|536830752|FG001|Dose Level IV|Progressive disease|0|||
148823188|NCT02533674|536830753|FG002|Dose Level IV|Progressive disease|0|||
148823189|NCT02533674|536830754|FG003|Dose Level IV|Progressive disease|3|||
148823190|NCT02533674|536830755|FG004|Dose Level IV|Progressive disease|0|||
148823191|NCT02533674|536830756|FG005|Dose Level IV|Progressive disease|0|||
148823192|NCT02533674|536830757|FG006|Dose Level IV|Progressive disease|0|||
148823193|NCT02533674|536830758|FG007|Dose Level IV|Progressive disease|0|||
148823194|NCT02533674|536830751|FG000|Dose Level IV|Withdrawal by Subject|0|||
148823195|NCT02533674|536830752|FG001|Dose Level IV|Withdrawal by Subject|0|||
148823196|NCT02533674|536830753|FG002|Dose Level IV|Withdrawal by Subject|0|||
148823197|NCT02533674|536830754|FG003|Dose Level IV|Withdrawal by Subject|1|||
148823198|NCT02533674|536830755|FG004|Dose Level IV|Withdrawal by Subject|0|||
148823199|NCT02533674|536830756|FG005|Dose Level IV|Withdrawal by Subject|0|||
148756231|NCT02286713|536579011|FG000|One Week Follow-Up|Lost to Follow-up|17|||
148756232|NCT02286713|536579012|FG001|One Week Follow-Up|Lost to Follow-up|21|||
148756233|NCT02286713|536579011|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
148756234|NCT02286713|536579012|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
148756235|NCT02286713|536579011|FG000|Three Month Follow-Up|Death|1|||
148756236|NCT02286713|536579012|FG001|Three Month Follow-Up|Death|1|||
148756237|NCT02286713|536579011|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
148756238|NCT02286713|536579012|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
148756239|NCT02286713|536579011|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
148756240|NCT02286713|536579012|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
148756241|NCT02286713|536579011|FG000|Six Month Follow-Up|Death|2|||
148756242|NCT02286713|536579012|FG001|Six Month Follow-Up|Death|0|||
148756243|NCT02286713|536579011|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
148756244|NCT02286713|536579012|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
148756245|NCT02654054|536579013|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
148756246|NCT02654054|536579014|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
148756247|NCT02654054|536579015|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
148823200|NCT02533674|536830757|FG006|Dose Level IV|Withdrawal by Subject|0|||
148823201|NCT02533674|536830758|FG007|Dose Level IV|Withdrawal by Subject|0|||
148823202|NCT02533674|536830751|FG000|Dose Level IV|Physician Decision|0|||
148823203|NCT02533674|536830752|FG001|Dose Level IV|Physician Decision|0|||
148823204|NCT02533674|536830753|FG002|Dose Level IV|Physician Decision|0|||
148823205|NCT02533674|536830754|FG003|Dose Level IV|Physician Decision|1|||
148823206|NCT02533674|536830755|FG004|Dose Level IV|Physician Decision|0|||
148823207|NCT02533674|536830756|FG005|Dose Level IV|Physician Decision|0|||
148823208|NCT02533674|536830757|FG006|Dose Level IV|Physician Decision|0|||
148823209|NCT02533674|536830758|FG007|Dose Level IV|Physician Decision|0|||
148823210|NCT02533674|536830751|FG000|Dose Level V|Progressive disease|0|||
148823211|NCT02533674|536830752|FG001|Dose Level V|Progressive disease|0|||
149027416|NCT00688688|537578557|FG000|Overall Study|Withdrawal by Subject|66|||
148756248|NCT02654054|536579013|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
148756249|NCT02654054|536579014|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
148756250|NCT02654054|536579015|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
148823212|NCT02533674|536830753|FG002|Dose Level V|Progressive disease|0|||
148823213|NCT02533674|536830754|FG003|Dose Level V|Progressive disease|0|||
148823214|NCT02533674|536830755|FG004|Dose Level V|Progressive disease|3|||
148823215|NCT02533674|536830756|FG005|Dose Level V|Progressive disease|0|||
148823216|NCT02533674|536830757|FG006|Dose Level V|Progressive disease|0|||
148823217|NCT02533674|536830758|FG007|Dose Level V|Progressive disease|0|||
148823218|NCT02533674|536830751|FG000|Dose Level V|Withdrawal by Subject|0|||
148823219|NCT02533674|536830752|FG001|Dose Level V|Withdrawal by Subject|0|||
149027417|NCT00688688|537578558|FG001|Overall Study|Withdrawal by Subject|75|||
148756251|NCT02654054|536579013|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
148756252|NCT02654054|536579014|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
148756253|NCT02654054|536579015|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
148756254|NCT02654054|536579013|FG000|Post-Treatment Follow-Up Period|Other|1|||
148756255|NCT02654054|536579014|FG001|Post-Treatment Follow-Up Period|Other|0|||
148756256|NCT02654054|536579015|FG002|Post-Treatment Follow-Up Period|Other|4|||
148756257|NCT02654054|536579013|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
148756258|NCT02654054|536579014|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
148756259|NCT02654054|536579015|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
148756260|NCT06018129|536579020|FG000|Overall Study|Death|1|||
148756261|NCT06018129|536579021|FG001|Overall Study|Death|1|||
148756262|NCT06018129|536579022|FG002|Overall Study|Death|2|||
148756263|NCT06018129|536579020|FG000|Overall Study|Sponsor Decision|2|||
148756264|NCT06018129|536579021|FG001|Overall Study|Sponsor Decision|2|||
148756265|NCT06018129|536579022|FG002|Overall Study|Sponsor Decision|1|||
148756266|NCT03832686|536579023|FG000|Overall Study|Lost to Follow-up|6|||
148756267|NCT03832686|536579024|FG001|Overall Study|Lost to Follow-up|9|||
148756268|NCT03832686|536579023|FG000|Overall Study|Discontinued Intervention|5|||
148756269|NCT03832686|536579024|FG001|Overall Study|Discontinued Intervention|4|||
148756270|NCT02235454|536579025|FG000|Overall Study|Withdrawal by Subject|2|||
148756271|NCT03323398|536579026|FG000|Overall Study|Other than Specified|0|||
148756272|NCT03323398|536579027|FG001|Overall Study|Other than Specified|1|||
148756273|NCT03323398|536579028|FG002|Overall Study|Other than Specified|2|||
148756274|NCT03323398|536579029|FG003|Overall Study|Other than Specified|0|||
148756275|NCT03323398|536579030|FG004|Overall Study|Other than Specified|0|||
148756276|NCT03323398|536579031|FG005|Overall Study|Other than Specified|0|||
148756277|NCT03323398|536579032|FG006|Overall Study|Other than Specified|1|||
148756278|NCT03323398|536579033|FG007|Overall Study|Other than Specified|0|||
148756279|NCT03323398|536579034|FG008|Overall Study|Other than Specified|2|||
148756280|NCT03323398|536579026|FG000|Overall Study|Lost to Follow-up|1|||
148756281|NCT03323398|536579027|FG001|Overall Study|Lost to Follow-up|2|||
148756282|NCT03323398|536579028|FG002|Overall Study|Lost to Follow-up|1|||
148756283|NCT03323398|536579029|FG003|Overall Study|Lost to Follow-up|0|||
148756284|NCT03323398|536579030|FG004|Overall Study|Lost to Follow-up|0|||
148756285|NCT03323398|536579031|FG005|Overall Study|Lost to Follow-up|0|||
148756286|NCT03323398|536579032|FG006|Overall Study|Lost to Follow-up|0|||
148756287|NCT03323398|536579033|FG007|Overall Study|Lost to Follow-up|0|||
148756288|NCT03323398|536579034|FG008|Overall Study|Lost to Follow-up|0|||
148756289|NCT03323398|536579026|FG000|Overall Study|Death|4|||
148756290|NCT03323398|536579027|FG001|Overall Study|Death|6|||
148756291|NCT03323398|536579028|FG002|Overall Study|Death|2|||
148756292|NCT03323398|536579029|FG003|Overall Study|Death|2|||
148756293|NCT03323398|536579030|FG004|Overall Study|Death|1|||
148756294|NCT03323398|536579031|FG005|Overall Study|Death|2|||
148756295|NCT03323398|536579032|FG006|Overall Study|Death|0|||
148756296|NCT03323398|536579033|FG007|Overall Study|Death|0|||
148756297|NCT03323398|536579034|FG008|Overall Study|Death|6|||
148756298|NCT03323398|536579026|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
148756299|NCT03323398|536579027|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
148756300|NCT03323398|536579028|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
148756301|NCT03323398|536579029|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
148756302|NCT03323398|536579030|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
148756303|NCT03323398|536579031|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
148756304|NCT03323398|536579032|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
148756305|NCT03323398|536579033|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
148756306|NCT03323398|536579034|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
148756307|NCT03323398|536579026|FG000|Overall Study|Withdrawal by Subject|2|||
148756308|NCT03323398|536579027|FG001|Overall Study|Withdrawal by Subject|1|||
148756309|NCT03323398|536579028|FG002|Overall Study|Withdrawal by Subject|3|||
148756310|NCT03323398|536579029|FG003|Overall Study|Withdrawal by Subject|0|||
148756311|NCT03323398|536579030|FG004|Overall Study|Withdrawal by Subject|0|||
148756312|NCT03323398|536579031|FG005|Overall Study|Withdrawal by Subject|1|||
148756313|NCT03323398|536579032|FG006|Overall Study|Withdrawal by Subject|0|||
148756314|NCT03323398|536579033|FG007|Overall Study|Withdrawal by Subject|0|||
148756315|NCT03323398|536579034|FG008|Overall Study|Withdrawal by Subject|0|||
148756316|NCT03323398|536579026|FG000|Overall Study|Participant was Put on Hospice|0|||
148756317|NCT03323398|536579027|FG001|Overall Study|Participant was Put on Hospice|0|||
148756318|NCT03323398|536579028|FG002|Overall Study|Participant was Put on Hospice|0|||
148756319|NCT03323398|536579029|FG003|Overall Study|Participant was Put on Hospice|0|||
148756320|NCT03323398|536579030|FG004|Overall Study|Participant was Put on Hospice|0|||
148756321|NCT03323398|536579031|FG005|Overall Study|Participant was Put on Hospice|0|||
148756322|NCT03323398|536579032|FG006|Overall Study|Participant was Put on Hospice|1|||
148756323|NCT03323398|536579033|FG007|Overall Study|Participant was Put on Hospice|0|||
148756324|NCT03323398|536579034|FG008|Overall Study|Participant was Put on Hospice|0|||
148756325|NCT03323398|536579026|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
148756326|NCT03323398|536579027|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
148756327|NCT03323398|536579028|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
148756328|NCT03323398|536579029|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
148756329|NCT03323398|536579030|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
148756330|NCT03323398|536579031|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
148756331|NCT03323398|536579032|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
148756332|NCT03323398|536579033|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
148756333|NCT03323398|536579034|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
148756334|NCT03641469|536579035|FG000|Overall Study|Ineligible|2|||
148756335|NCT03641469|536579035|FG000|Overall Study|Withdrawal by Subject|5|||
148756336|NCT03641469|536579035|FG000|Overall Study|Physician Decision|1|||
148756337|NCT03641469|536579035|FG000|Overall Study|Protocol Violation|1|||
148756338|NCT03641469|536579035|FG000|Overall Study|Lost to Follow-up|2|||
148756339|NCT05479435|536579036|FG000|Overall Study|Withdrawal by Subject|1|||
148756340|NCT05479435|536579037|FG001|Overall Study|Withdrawal by Subject|0|||
148756341|NCT05479435|536579038|FG002|Overall Study|Withdrawal by Subject|0|||
148756342|NCT05479435|536579036|FG000|Overall Study|Covid 19|0|||
148756343|NCT05479435|536579037|FG001|Overall Study|Covid 19|0|||
148756344|NCT05479435|536579038|FG002|Overall Study|Covid 19|2|||
148756345|NCT00955617|536579041|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
148756346|NCT00955617|536579042|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
148756347|NCT00955617|536579041|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
148756348|NCT00955617|536579042|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
148756349|NCT00955617|536579041|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
148756350|NCT00955617|536579042|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
148756351|NCT00955617|536579041|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
148756352|NCT00955617|536579042|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
148756353|NCT04199104|536580544|FG000|Overall Study|Death|148|||
148756354|NCT04199104|536580545|FG001|Overall Study|Death|134|||
148756355|NCT04199104|536580544|FG000|Overall Study|Lost to Follow-up|1|||
148756356|NCT04199104|536580545|FG001|Overall Study|Lost to Follow-up|1|||
148756357|NCT04199104|536580544|FG000|Overall Study|Withdrawal by Subject|4|||
148756358|NCT04199104|536580545|FG001|Overall Study|Withdrawal by Subject|4|||
148756359|NCT04199104|536580544|FG000|Overall Study|Participants Ongoing|103|||
148756360|NCT04199104|536580545|FG001|Overall Study|Participants Ongoing|116|||
148756361|NCT04563754|536580548|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
148756362|NCT04563754|536580549|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
148756363|NCT04563754|536580550|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
148756364|NCT04563754|536580548|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
148756365|NCT04563754|536580549|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
148756366|NCT04563754|536580550|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
148756367|NCT04563754|536580548|FG000|Follow up|Lost to Follow-up|61|||
148756368|NCT04563754|536580549|FG001|Follow up|Lost to Follow-up|23|||
148756369|NCT04563754|536580550|FG002|Follow up|Lost to Follow-up|5|||
148756370|NCT04563754|536580548|FG000|Follow up|Death|0|||
148756371|NCT04563754|536580549|FG001|Follow up|Death|2|||
148756372|NCT04563754|536580550|FG002|Follow up|Death|0|||
148756373|NCT04563754|536580548|FG000|Follow up|Ongoing|0|||
148756374|NCT04563754|536580549|FG001|Follow up|Ongoing|28|||
148756375|NCT04563754|536580550|FG002|Follow up|Ongoing|0|||
148756376|NCT04023396|536580551|FG000|Overall Study|Adverse Event|16|||
148756377|NCT04023396|536580551|FG000|Overall Study|Death|1|||
148756378|NCT04023396|536580551|FG000|Overall Study|Lost to Follow-up|1|||
148756379|NCT04023396|536580551|FG000|Overall Study|Withdrawal by Subject|14|||
148756380|NCT04023396|536580551|FG000|Overall Study|Pregnancy|4|||
148756381|NCT04023396|536580551|FG000|Overall Study|Lack of Efficacy|3|||
148756382|NCT04023396|536580551|FG000|Overall Study|Physician Decision|4|||
148756383|NCT04023396|536580551|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
148756384|NCT04075825|536580554|FG000|Overall Study|Withdrawal by Subject|6|||
148756385|NCT04075825|536580555|FG001|Overall Study|Withdrawal by Subject|8|||
148756386|NCT04075825|536580554|FG000|Overall Study|Physician Decision|3|||
148756387|NCT04075825|536580555|FG001|Overall Study|Physician Decision|1|||
148756388|NCT04075825|536580554|FG000|Overall Study|Lost to Follow-up|5|||
148756389|NCT04075825|536580555|FG001|Overall Study|Lost to Follow-up|1|||
148756390|NCT04075825|536580554|FG000|Overall Study|Participation in New Clinical Trial|1|||
148756391|NCT04075825|536580555|FG001|Overall Study|Participation in New Clinical Trial|1|||
148756392|NCT04075825|536580554|FG000|Overall Study|Reason Not Specified|2|||
148756393|NCT04075825|536580555|FG001|Overall Study|Reason Not Specified|2|||
148756394|NCT02861586|536580559|FG000|Overall Study|Withdrawal by Subject|1|||
148756395|NCT02861586|536580560|FG001|Overall Study|Withdrawal by Subject|2|||
148756396|NCT02861586|536580561|FG002|Overall Study|Withdrawal by Subject|0|||
149027418|NCT00688688|537578559|FG002|Overall Study|Withdrawal by Subject|65|||
149027419|NCT00688688|537578557|FG000|Overall Study|Lost to Follow-up|14|||
148823220|NCT02533674|536830753|FG002|Dose Level V|Withdrawal by Subject|0|||
148823221|NCT02533674|536830754|FG003|Dose Level V|Withdrawal by Subject|0|||
148823222|NCT02533674|536830755|FG004|Dose Level V|Withdrawal by Subject|1|||
148823223|NCT02533674|536830756|FG005|Dose Level V|Withdrawal by Subject|0|||
148823224|NCT02533674|536830757|FG006|Dose Level V|Withdrawal by Subject|0|||
148823225|NCT02533674|536830758|FG007|Dose Level V|Withdrawal by Subject|0|||
148823226|NCT02533674|536830751|FG000|Dose Level V|Physician Decision|0|||
148823227|NCT02533674|536830752|FG001|Dose Level V|Physician Decision|0|||
148823228|NCT02533674|536830753|FG002|Dose Level V|Physician Decision|0|||
148823229|NCT02533674|536830754|FG003|Dose Level V|Physician Decision|0|||
148823230|NCT02533674|536830755|FG004|Dose Level V|Physician Decision|1|||
148823231|NCT02533674|536830756|FG005|Dose Level V|Physician Decision|0|||
148823232|NCT02533674|536830757|FG006|Dose Level V|Physician Decision|0|||
148823233|NCT02533674|536830758|FG007|Dose Level V|Physician Decision|0|||
148823234|NCT02533674|536830751|FG000|Dose Level VI|Progressive disease|0|||
148823235|NCT02533674|536830752|FG001|Dose Level VI|Progressive disease|0|||
148823236|NCT02533674|536830753|FG002|Dose Level VI|Progressive disease|0|||
148823237|NCT02533674|536830754|FG003|Dose Level VI|Progressive disease|0|||
148823238|NCT02533674|536830755|FG004|Dose Level VI|Progressive disease|0|||
148823239|NCT02533674|536830756|FG005|Dose Level VI|Progressive disease|7|||
148976426|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
148976427|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
148976428|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
148976429|NCT04542070|537394543|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
148976430|NCT04542070|537394544|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
148976431|NCT04542070|537394545|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
148976432|NCT04542070|537394546|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
148976433|NCT04542070|537394543|FG000|Maintenance + Extension Period|Adverse Event|10|||
148756397|NCT02861586|536580562|FG003|Overall Study|Withdrawal by Subject|0|||
148756398|NCT02861586|536580563|FG004|Overall Study|Withdrawal by Subject|0|||
148756399|NCT02861586|536580564|FG005|Overall Study|Withdrawal by Subject|1|||
148756400|NCT02861586|536580565|FG006|Overall Study|Withdrawal by Subject|1|||
148756401|NCT02861586|536580566|FG007|Overall Study|Withdrawal by Subject|0|||
148756402|NCT02861586|536580559|FG000|Overall Study|Lost to Follow-up|3|||
148756403|NCT02861586|536580560|FG001|Overall Study|Lost to Follow-up|1|||
148756404|NCT02861586|536580561|FG002|Overall Study|Lost to Follow-up|1|||
148756405|NCT02861586|536580562|FG003|Overall Study|Lost to Follow-up|0|||
148756406|NCT02861586|536580563|FG004|Overall Study|Lost to Follow-up|0|||
148756407|NCT02861586|536580564|FG005|Overall Study|Lost to Follow-up|3|||
148756408|NCT02861586|536580565|FG006|Overall Study|Lost to Follow-up|0|||
148756409|NCT02861586|536580566|FG007|Overall Study|Lost to Follow-up|0|||
148756410|NCT02861586|536580559|FG000|Overall Study|Adverse Event|0|||
148756411|NCT02861586|536580560|FG001|Overall Study|Adverse Event|0|||
148756412|NCT02861586|536580561|FG002|Overall Study|Adverse Event|0|||
148756413|NCT02861586|536580562|FG003|Overall Study|Adverse Event|0|||
148756414|NCT02861586|536580563|FG004|Overall Study|Adverse Event|0|||
148756415|NCT02861586|536580564|FG005|Overall Study|Adverse Event|1|||
148756416|NCT02861586|536580565|FG006|Overall Study|Adverse Event|0|||
148756417|NCT02861586|536580566|FG007|Overall Study|Adverse Event|0|||
148756418|NCT04581824|536580568|FG000|Overall Study|Lost to Follow-up|1|||
148756419|NCT04581824|536580569|FG001|Overall Study|Lost to Follow-up|0|||
148756420|NCT04581824|536580568|FG000|Overall Study|Withdrawal by Subject|2|||
148756421|NCT04581824|536580569|FG001|Overall Study|Withdrawal by Subject|7|||
148756422|NCT04581824|536580568|FG000|Overall Study|Study terminated by sponsor|37|||
148756423|NCT04581824|536580569|FG001|Overall Study|Study terminated by sponsor|23|||
148756424|NCT04796909|536580570|FG000|Overall Study|Withdrawal by Subject|1|||
148756425|NCT04796909|536580571|FG001|Overall Study|Withdrawal by Subject|1|||
148756426|NCT02832687|536580572|FG000|Overall Study|Adverse Event|0|||
148756427|NCT02832687|536580573|FG001|Overall Study|Adverse Event|2|||
148756428|NCT00210210|536580574|FG000|Overall Study|Withdrawal by Subject|3|||
148756429|NCT00210210|536580575|FG001|Overall Study|Withdrawal by Subject|2|||
148756430|NCT00210210|536580574|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
148756431|NCT00210210|536580575|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
148756432|NCT04231825|536580576|FG000|Overall Study|Protocol Violation|3|||
148756433|NCT04231825|536580577|FG001|Overall Study|Protocol Violation|3|||
148756434|NCT04231825|536580576|FG000|Overall Study|Lost to Follow-up|0|||
148756435|NCT04231825|536580577|FG001|Overall Study|Lost to Follow-up|1|||
148756436|NCT01662635|536580578|FG000|Overall Study|scarce samples for evaluation|30|||
148756437|NCT01651117|536580583|FG000|Overall Study|Death|2|||
148823240|NCT02533674|536830757|FG006|Dose Level VI|Progressive disease|0|||
148823241|NCT02533674|536830758|FG007|Dose Level VI|Progressive disease|0|||
148823242|NCT02533674|536830751|FG000|Dose Level VI|Withdrawal by Subject|0|||
148823243|NCT02533674|536830752|FG001|Dose Level VI|Withdrawal by Subject|0|||
148823244|NCT02533674|536830753|FG002|Dose Level VI|Withdrawal by Subject|0|||
148823245|NCT02533674|536830754|FG003|Dose Level VI|Withdrawal by Subject|0|||
148823246|NCT02533674|536830755|FG004|Dose Level VI|Withdrawal by Subject|0|||
148823247|NCT02533674|536830756|FG005|Dose Level VI|Withdrawal by Subject|1|||
148823248|NCT02533674|536830757|FG006|Dose Level VI|Withdrawal by Subject|0|||
148823249|NCT02533674|536830758|FG007|Dose Level VI|Withdrawal by Subject|0|||
148823250|NCT02533674|536830751|FG000|Dose Level VI|Treatment-related AE|0|||
148823251|NCT02533674|536830752|FG001|Dose Level VI|Treatment-related AE|0|||
148823252|NCT02533674|536830753|FG002|Dose Level VI|Treatment-related AE|0|||
148823253|NCT02533674|536830754|FG003|Dose Level VI|Treatment-related AE|0|||
148823254|NCT02533674|536830755|FG004|Dose Level VI|Treatment-related AE|0|||
148823255|NCT02533674|536830756|FG005|Dose Level VI|Treatment-related AE|1|||
148823256|NCT02533674|536830757|FG006|Dose Level VI|Treatment-related AE|0|||
148823257|NCT02533674|536830758|FG007|Dose Level VI|Treatment-related AE|0|||
148823258|NCT02533674|536830751|FG000|Dose Level VII|Progressive disease|0|||
148823259|NCT02533674|536830752|FG001|Dose Level VII|Progressive disease|0|||
148823260|NCT02533674|536830753|FG002|Dose Level VII|Progressive disease|0|||
148823261|NCT02533674|536830754|FG003|Dose Level VII|Progressive disease|0|||
148823262|NCT02533674|536830755|FG004|Dose Level VII|Progressive disease|0|||
148823263|NCT02533674|536830756|FG005|Dose Level VII|Progressive disease|0|||
148823264|NCT02533674|536830757|FG006|Dose Level VII|Progressive disease|10|||
148823265|NCT02533674|536830758|FG007|Dose Level VII|Progressive disease|0|||
148823266|NCT02533674|536830751|FG000|Dose Level VII|Withdrawal by Subject|0|||
148823267|NCT02533674|536830752|FG001|Dose Level VII|Withdrawal by Subject|0|||
148823268|NCT02533674|536830753|FG002|Dose Level VII|Withdrawal by Subject|0|||
148823269|NCT02533674|536830754|FG003|Dose Level VII|Withdrawal by Subject|0|||
148823270|NCT02533674|536830755|FG004|Dose Level VII|Withdrawal by Subject|0|||
148823271|NCT02533674|536830756|FG005|Dose Level VII|Withdrawal by Subject|0|||
148823272|NCT02533674|536830757|FG006|Dose Level VII|Withdrawal by Subject|3|||
148823273|NCT02533674|536830758|FG007|Dose Level VII|Withdrawal by Subject|0|||
148823274|NCT02533674|536830751|FG000|Dose Level VII|Treatment-related AE|0|||
148823275|NCT02533674|536830752|FG001|Dose Level VII|Treatment-related AE|0|||
148823276|NCT02533674|536830753|FG002|Dose Level VII|Treatment-related AE|0|||
148823277|NCT02533674|536830754|FG003|Dose Level VII|Treatment-related AE|0|||
148823278|NCT02533674|536830755|FG004|Dose Level VII|Treatment-related AE|0|||
148823279|NCT02533674|536830756|FG005|Dose Level VII|Treatment-related AE|0|||
148823280|NCT02533674|536830757|FG006|Dose Level VII|Treatment-related AE|1|||
148823281|NCT02533674|536830758|FG007|Dose Level VII|Treatment-related AE|0|||
148823282|NCT02533674|536830751|FG000|Dose Level VII|Death|0|||
148823283|NCT02533674|536830752|FG001|Dose Level VII|Death|0|||
148823284|NCT02533674|536830753|FG002|Dose Level VII|Death|0|||
148823285|NCT02533674|536830754|FG003|Dose Level VII|Death|0|||
148823286|NCT02533674|536830755|FG004|Dose Level VII|Death|0|||
148823287|NCT02533674|536830756|FG005|Dose Level VII|Death|0|||
148823288|NCT02533674|536830757|FG006|Dose Level VII|Death|2|||
148823289|NCT02533674|536830758|FG007|Dose Level VII|Death|0|||
148823290|NCT02533674|536830751|FG000|Dose Level VIII|Progressive disease|0|||
148823291|NCT02533674|536830752|FG001|Dose Level VIII|Progressive disease|0|||
148823292|NCT02533674|536830753|FG002|Dose Level VIII|Progressive disease|0|||
148823293|NCT02533674|536830754|FG003|Dose Level VIII|Progressive disease|0|||
148823294|NCT02533674|536830755|FG004|Dose Level VIII|Progressive disease|0|||
148823295|NCT02533674|536830756|FG005|Dose Level VIII|Progressive disease|0|||
148823296|NCT02533674|536830757|FG006|Dose Level VIII|Progressive disease|0|||
148823297|NCT02533674|536830758|FG007|Dose Level VIII|Progressive disease|3|||
148823298|NCT02533674|536830751|FG000|Dose Level VIII|Withdrawal by Subject|0|||
148823299|NCT02533674|536830752|FG001|Dose Level VIII|Withdrawal by Subject|0|||
148823300|NCT02533674|536830753|FG002|Dose Level VIII|Withdrawal by Subject|0|||
148823301|NCT02533674|536830754|FG003|Dose Level VIII|Withdrawal by Subject|0|||
148823302|NCT02533674|536830755|FG004|Dose Level VIII|Withdrawal by Subject|0|||
148823303|NCT02533674|536830756|FG005|Dose Level VIII|Withdrawal by Subject|0|||
148823304|NCT02533674|536830757|FG006|Dose Level VIII|Withdrawal by Subject|0|||
148823305|NCT02533674|536830758|FG007|Dose Level VIII|Withdrawal by Subject|1|||
148823306|NCT02533674|536830751|FG000|Dose Level VIII|Treatment-related AE|0|||
148823307|NCT02533674|536830752|FG001|Dose Level VIII|Treatment-related AE|0|||
148823308|NCT02533674|536830753|FG002|Dose Level VIII|Treatment-related AE|0|||
148823309|NCT02533674|536830754|FG003|Dose Level VIII|Treatment-related AE|0|||
148976434|NCT04542070|537394544|FG001|Maintenance + Extension Period|Adverse Event|2|||
148976435|NCT04542070|537394545|FG002|Maintenance + Extension Period|Adverse Event|0|||
148976436|NCT04542070|537394546|FG003|Maintenance + Extension Period|Adverse Event|0|||
148823310|NCT02533674|536830755|FG004|Dose Level VIII|Treatment-related AE|0|||
148823311|NCT02533674|536830756|FG005|Dose Level VIII|Treatment-related AE|0|||
148823312|NCT02533674|536830757|FG006|Dose Level VIII|Treatment-related AE|0|||
148823313|NCT02533674|536830758|FG007|Dose Level VIII|Treatment-related AE|1|||
148823314|NCT02533674|536830751|FG000|Dose Level VIII|Never treated|0|||
148823315|NCT02533674|536830752|FG001|Dose Level VIII|Never treated|0|||
148823316|NCT02533674|536830753|FG002|Dose Level VIII|Never treated|0|||
148823317|NCT02533674|536830754|FG003|Dose Level VIII|Never treated|0|||
148823318|NCT02533674|536830755|FG004|Dose Level VIII|Never treated|0|||
148823319|NCT02533674|536830756|FG005|Dose Level VIII|Never treated|0|||
148823320|NCT02533674|536830757|FG006|Dose Level VIII|Never treated|0|||
148823321|NCT02533674|536830758|FG007|Dose Level VIII|Never treated|1|||
148756438|NCT01651117|536580584|FG001|Overall Study|Death|3|||
148756439|NCT01651117|536580585|FG002|Overall Study|Death|2|||
148756440|NCT01651117|536580586|FG003|Overall Study|Death|2|||
148756441|NCT02088177|536580589|FG000|Overall Study|Lost to Follow-up|3|||
148756442|NCT01641640|536580591|FG000|Overall Study|Enrolled but not treated|1|||
148823322|NCT02365064|536830762|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
148823323|NCT02365064|536830763|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
148756443|NCT01641640|536580591|FG000|Overall Study|Efficacy failure|29|||
148756444|NCT01641640|536580591|FG000|Overall Study|Lost to Follow-up|3|||
148756445|NCT01641640|536580591|FG000|Overall Study|Withdrawal by Subject|2|||
148756446|NCT01641640|536580591|FG000|Overall Study|Adverse Event|1|||
148756447|NCT01234350|536580593|FG000|Overall Study|Adverse Event|277|||
148756448|NCT01234350|536580594|FG001|Overall Study|Adverse Event|92|||
148756449|NCT01234350|536580593|FG000|Overall Study|Withdrawal by Subject|61|||
148756450|NCT01234350|536580594|FG001|Overall Study|Withdrawal by Subject|36|||
148756451|NCT01234350|536580593|FG000|Overall Study|Lost to Follow-up|115|||
148756452|NCT01234350|536580594|FG001|Overall Study|Lost to Follow-up|47|||
148756453|NCT01234350|536580593|FG000|Overall Study|Covers a diverse set of reasons|234|||
148756454|NCT01234350|536580594|FG001|Overall Study|Covers a diverse set of reasons|92|||
148756455|NCT00289848|536580595|FG000|Overall Study|Adverse Event|6|||
148823324|NCT02365064|536830762|FG000|Overall Study|Withdrawal by Subject|6|||
148823325|NCT02365064|536830763|FG001|Overall Study|Withdrawal by Subject|9|||
148823326|NCT02365064|536830762|FG000|Overall Study|Treatment intolerance|2|||
148823327|NCT02365064|536830763|FG001|Overall Study|Treatment intolerance|4|||
148823328|NCT02123511|536830764|FG000|Overall Study|Cancelled treatment|1|||
148823329|NCT02123511|536830765|FG001|Overall Study|Cancelled treatment|0|||
148823330|NCT02123511|536830764|FG000|Overall Study|Incomplete data|1|||
148823331|NCT02123511|536830765|FG001|Overall Study|Incomplete data|3|||
148823332|NCT02123511|536830764|FG000|Overall Study|Ineligible|0|||
148823333|NCT02123511|536830765|FG001|Overall Study|Ineligible|1|||
148823334|NCT00458705|536830766|FG000|Overall Study|Adverse Event|4|||
148823335|NCT00458705|536830766|FG000|Overall Study|Not Treated|1|||
148823336|NCT01379937|536830767|FG000|Overall Study|Protocol Violation|0|||
148823337|NCT01379937|536830768|FG001|Overall Study|Protocol Violation|0|||
148823338|NCT01379937|536830769|FG002|Overall Study|Protocol Violation|0|||
148823339|NCT01379937|536830770|FG003|Overall Study|Protocol Violation|1|||
148823340|NCT01379937|536830767|FG000|Overall Study|Consent withdrawal|0|||
148756456|NCT00289848|536580596|FG001|Overall Study|Adverse Event|4|||
148756457|NCT00289848|536580595|FG000|Overall Study|Death|1|||
148756458|NCT00289848|536580596|FG001|Overall Study|Death|0|||
148756459|NCT00289848|536580595|FG000|Overall Study|Lack of Efficacy|20|||
148756460|NCT00289848|536580596|FG001|Overall Study|Lack of Efficacy|24|||
148756461|NCT00289848|536580595|FG000|Overall Study|Lost to Follow-up|3|||
148756462|NCT00289848|536580596|FG001|Overall Study|Lost to Follow-up|1|||
148756463|NCT00289848|536580595|FG000|Overall Study|Protocol Violation|5|||
148756464|NCT00289848|536580596|FG001|Overall Study|Protocol Violation|2|||
148756465|NCT00289848|536580595|FG000|Overall Study|Withdrawal by Subject|5|||
148756466|NCT00289848|536580596|FG001|Overall Study|Withdrawal by Subject|11|||
148756467|NCT00289848|536580595|FG000|Overall Study|Patient Moved|6|||
148756468|NCT00289848|536580596|FG001|Overall Study|Patient Moved|2|||
148756469|NCT00289848|536580595|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
148756470|NCT00289848|536580596|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
148756471|NCT02792517|536580604|FG000|Overall Study|Withdrawal by Subject|10|||
148756472|NCT02792517|536580604|FG000|Overall Study|Decision by Sponsor|7|||
148756473|NCT02792517|536580604|FG000|Overall Study|Lost to Follow-up|3|||
148756474|NCT01894919|536580605|FG000|Overall Study|Withdrawal by Subject|1|||
148756475|NCT01894919|536580606|FG001|Overall Study|Withdrawal by Subject|0|||
148756476|NCT01894919|536580607|FG002|Overall Study|Withdrawal by Subject|0|||
148756477|NCT01894919|536580608|FG003|Overall Study|Withdrawal by Subject|0|||
148823341|NCT01379937|536830768|FG001|Overall Study|Consent withdrawal|1|||
148823342|NCT01379937|536830769|FG002|Overall Study|Consent withdrawal|0|||
148823343|NCT01379937|536830770|FG003|Overall Study|Consent withdrawal|0|||
148823344|NCT01379937|536830767|FG000|Overall Study|Lost to Follow-up|1|||
148823345|NCT01379937|536830768|FG001|Overall Study|Lost to Follow-up|2|||
148823346|NCT01379937|536830769|FG002|Overall Study|Lost to Follow-up|2|||
148823347|NCT01379937|536830770|FG003|Overall Study|Lost to Follow-up|0|||
148823348|NCT04985682|536830771|FG000|Overall Study|Withdrawal by Subject|1|||
148823349|NCT03016403|536830772|FG000|Baseline|Death|5|||
148756478|NCT01894919|536580609|FG004|Overall Study|Withdrawal by Subject|1|||
148756479|NCT01894919|536580610|FG005|Overall Study|Withdrawal by Subject|0|||
148823350|NCT03016403|536830773|FG001|Baseline|Death|8|||
148823351|NCT03016403|536830774|FG002|Baseline|Death|1|||
148823352|NCT03016403|536830775|FG003|Baseline|Death|0|||
148823353|NCT03016403|536830772|FG000|Baseline|Withdrawal by Subject|2|||
148823354|NCT03016403|536830773|FG001|Baseline|Withdrawal by Subject|8|||
148823355|NCT03016403|536830774|FG002|Baseline|Withdrawal by Subject|4|||
148823356|NCT03016403|536830775|FG003|Baseline|Withdrawal by Subject|10|||
148823357|NCT03016403|536830772|FG000|Baseline|Lost to Follow-up|9|||
148756480|NCT01894919|536580611|FG006|Overall Study|Withdrawal by Subject|0|||
148756481|NCT01894919|536580612|FG007|Overall Study|Withdrawal by Subject|0|||
148756482|NCT01894919|536580613|FG008|Overall Study|Withdrawal by Subject|0|||
148756483|NCT01894919|536580614|FG009|Overall Study|Withdrawal by Subject|1|||
148756484|NCT01894919|536580615|FG010|Overall Study|Withdrawal by Subject|1|||
148756485|NCT01894919|536580616|FG011|Overall Study|Withdrawal by Subject|0|||
148756486|NCT01894919|536580617|FG012|Overall Study|Withdrawal by Subject|0|||
148756487|NCT01894919|536580605|FG000|Overall Study|Adverse Event|0|||
148756488|NCT01894919|536580606|FG001|Overall Study|Adverse Event|0|||
148756489|NCT01894919|536580607|FG002|Overall Study|Adverse Event|0|||
148756490|NCT01894919|536580608|FG003|Overall Study|Adverse Event|0|||
148756491|NCT01894919|536580609|FG004|Overall Study|Adverse Event|0|||
148756492|NCT01894919|536580610|FG005|Overall Study|Adverse Event|0|||
148756493|NCT01894919|536580611|FG006|Overall Study|Adverse Event|0|||
148756494|NCT01894919|536580612|FG007|Overall Study|Adverse Event|0|||
148756495|NCT01894919|536580613|FG008|Overall Study|Adverse Event|0|||
148756496|NCT01894919|536580614|FG009|Overall Study|Adverse Event|0|||
148756497|NCT01894919|536580615|FG010|Overall Study|Adverse Event|1|||
148756498|NCT01894919|536580616|FG011|Overall Study|Adverse Event|0|||
148756499|NCT01894919|536580617|FG012|Overall Study|Adverse Event|0|||
148756500|NCT01894919|536580605|FG000|Overall Study|Other-Unspecified|1|||
148756501|NCT01894919|536580606|FG001|Overall Study|Other-Unspecified|0|||
148756502|NCT01894919|536580607|FG002|Overall Study|Other-Unspecified|0|||
148756503|NCT01894919|536580608|FG003|Overall Study|Other-Unspecified|0|||
148756504|NCT01894919|536580609|FG004|Overall Study|Other-Unspecified|0|||
148756505|NCT01894919|536580610|FG005|Overall Study|Other-Unspecified|0|||
148756506|NCT01894919|536580611|FG006|Overall Study|Other-Unspecified|0|||
148756507|NCT01894919|536580612|FG007|Overall Study|Other-Unspecified|0|||
148756508|NCT01894919|536580613|FG008|Overall Study|Other-Unspecified|0|||
148756509|NCT01894919|536580614|FG009|Overall Study|Other-Unspecified|0|||
148756510|NCT01894919|536580615|FG010|Overall Study|Other-Unspecified|0|||
148756511|NCT01894919|536580616|FG011|Overall Study|Other-Unspecified|0|||
148756512|NCT01894919|536580617|FG012|Overall Study|Other-Unspecified|0|||
148756513|NCT01894919|536580605|FG000|Overall Study|Lost to Follow-up|0|||
148756514|NCT01894919|536580606|FG001|Overall Study|Lost to Follow-up|0|||
148756515|NCT01894919|536580607|FG002|Overall Study|Lost to Follow-up|0|||
148756516|NCT01894919|536580608|FG003|Overall Study|Lost to Follow-up|0|||
148756517|NCT01894919|536580609|FG004|Overall Study|Lost to Follow-up|2|||
148756518|NCT01894919|536580610|FG005|Overall Study|Lost to Follow-up|0|||
148756519|NCT01894919|536580611|FG006|Overall Study|Lost to Follow-up|0|||
148756520|NCT01894919|536580612|FG007|Overall Study|Lost to Follow-up|0|||
148756521|NCT01894919|536580613|FG008|Overall Study|Lost to Follow-up|0|||
148756522|NCT01894919|536580614|FG009|Overall Study|Lost to Follow-up|0|||
148756523|NCT01894919|536580615|FG010|Overall Study|Lost to Follow-up|0|||
148756524|NCT01894919|536580616|FG011|Overall Study|Lost to Follow-up|0|||
148756525|NCT01894919|536580617|FG012|Overall Study|Lost to Follow-up|0|||
148756526|NCT02570308|536580620|FG000|Overall Study|Death|1|||
148756527|NCT02570308|536580621|FG001|Overall Study|Death|5|||
148756528|NCT02570308|536580622|FG002|Overall Study|Death|4|||
148756529|NCT02570308|536580623|FG003|Overall Study|Death|4|||
148756530|NCT02570308|536580624|FG004|Overall Study|Death|69|||
148756531|NCT02570308|536580620|FG000|Overall Study|Lost to Follow-up|0|||
148756532|NCT02570308|536580621|FG001|Overall Study|Lost to Follow-up|0|||
148756533|NCT02570308|536580622|FG002|Overall Study|Lost to Follow-up|0|||
148756534|NCT02570308|536580623|FG003|Overall Study|Lost to Follow-up|0|||
148756535|NCT02570308|536580624|FG004|Overall Study|Lost to Follow-up|2|||
148756536|NCT02570308|536580620|FG000|Overall Study|Withdrawal by Subject|0|||
148756537|NCT02570308|536580621|FG001|Overall Study|Withdrawal by Subject|0|||
148823358|NCT03016403|536830773|FG001|Baseline|Lost to Follow-up|11|||
148823359|NCT03016403|536830774|FG002|Baseline|Lost to Follow-up|6|||
148823360|NCT03016403|536830775|FG003|Baseline|Lost to Follow-up|24|||
148756538|NCT02570308|536580622|FG002|Overall Study|Withdrawal by Subject|0|||
148756539|NCT02570308|536580623|FG003|Overall Study|Withdrawal by Subject|0|||
148823361|NCT03016403|536830772|FG000|6-week Follow-up|Death|1|||
148823362|NCT03016403|536830773|FG001|6-week Follow-up|Death|4|||
148976437|NCT04542070|537394543|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
148976438|NCT04542070|537394544|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
148756540|NCT02570308|536580624|FG004|Overall Study|Withdrawal by Subject|1|||
148756541|NCT02570308|536580620|FG000|Overall Study|Other|0|||
148823363|NCT03016403|536830774|FG002|6-week Follow-up|Death|0|||
148756542|NCT02570308|536580621|FG001|Overall Study|Other|0|||
148756543|NCT02570308|536580622|FG002|Overall Study|Other|0|||
148756544|NCT02570308|536580623|FG003|Overall Study|Other|0|||
148756545|NCT02570308|536580624|FG004|Overall Study|Other|2|||
148756546|NCT02411656|536580627|FG000|Overall Study|Adverse Event|4|||
148756547|NCT02411656|536580627|FG000|Overall Study|Clinical Progression|33|||
148756548|NCT06481709|536580628|FG000|Overall Study|Withdrawal by Subject|0|||
148756549|NCT06481709|536580629|FG001|Overall Study|Withdrawal by Subject|0|||
148756550|NCT06481709|536580630|FG002|Overall Study|Withdrawal by Subject|2|||
148756551|NCT06481709|536580631|FG003|Overall Study|Withdrawal by Subject|0|||
148823364|NCT03016403|536830775|FG003|6-week Follow-up|Death|0|||
148823365|NCT03016403|536830772|FG000|6-week Follow-up|Lost to Follow-up|2|||
148823366|NCT03016403|536830773|FG001|6-week Follow-up|Lost to Follow-up|7|||
148823367|NCT03016403|536830774|FG002|6-week Follow-up|Lost to Follow-up|4|||
148823368|NCT03016403|536830775|FG003|6-week Follow-up|Lost to Follow-up|8|||
148823369|NCT03016403|536830772|FG000|6-week Follow-up|Withdrawal by Subject|0|||
148823370|NCT03016403|536830773|FG001|6-week Follow-up|Withdrawal by Subject|2|||
148823371|NCT03016403|536830774|FG002|6-week Follow-up|Withdrawal by Subject|0|||
148823372|NCT03016403|536830775|FG003|6-week Follow-up|Withdrawal by Subject|1|||
148823373|NCT03016403|536830772|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
148823374|NCT03016403|536830773|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
148823375|NCT03016403|536830774|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
148823376|NCT03016403|536830775|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
148823377|NCT03016403|536830772|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
148823378|NCT03016403|536830773|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
148823379|NCT03016403|536830774|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
148823380|NCT03016403|536830775|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
148823381|NCT03016403|536830772|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
148823382|NCT03016403|536830773|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
148823383|NCT03016403|536830774|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
148823384|NCT03016403|536830775|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
148823385|NCT05463705|536830776|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
148823386|NCT05463705|536830777|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
148823387|NCT05463705|536830778|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
148823388|NCT05463705|536830779|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
148823389|NCT05463705|536830780|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
148823390|NCT05463705|536830781|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
148823391|NCT00079781|536830782|FG000|Pre-implant Period|Withdrawal by Subject|2|||
148823392|NCT00079781|536830783|FG001|Pre-implant Period|Withdrawal by Subject|0|||
148823393|NCT00079781|536830784|FG002|Pre-implant Period|Withdrawal by Subject|0|||
148823394|NCT00079781|536830782|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
148823395|NCT00079781|536830783|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
148823396|NCT00079781|536830784|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
148823397|NCT00079781|536830782|FG000|Follow-up Period|Withdrawal by Subject|3|||
148823398|NCT00079781|536830783|FG001|Follow-up Period|Withdrawal by Subject|0|||
148823399|NCT00079781|536830784|FG002|Follow-up Period|Withdrawal by Subject|1|||
148823400|NCT00079781|536830782|FG000|Follow-up Period|Lost to Follow-up|1|||
148823401|NCT00079781|536830783|FG001|Follow-up Period|Lost to Follow-up|0|||
148823402|NCT00079781|536830784|FG002|Follow-up Period|Lost to Follow-up|0|||
148823403|NCT00079781|536830782|FG000|Follow-up Period|Death|0|||
148823404|NCT00079781|536830783|FG001|Follow-up Period|Death|0|||
148823405|NCT00079781|536830784|FG002|Follow-up Period|Death|1|||
148823406|NCT00225758|536830785|FG000|Overall Study|Adverse Event|4|||
148823407|NCT00621322|536830786|FG000|Overall Study|Lost to Follow-up|0|||
148823408|NCT00621322|536830787|FG001|Overall Study|Lost to Follow-up|0|||
148823409|NCT00621322|536830788|FG002|Overall Study|Lost to Follow-up|0|||
148823410|NCT00621322|536830789|FG003|Overall Study|Lost to Follow-up|0|||
148823411|NCT00621322|536830790|FG004|Overall Study|Lost to Follow-up|1|||
148823412|NCT00621322|536830791|FG005|Overall Study|Lost to Follow-up|0|||
148823413|NCT00621322|536830786|FG000|Overall Study|Physician Decision|0|||
148823414|NCT00621322|536830787|FG001|Overall Study|Physician Decision|0|||
148823415|NCT00621322|536830788|FG002|Overall Study|Physician Decision|1|||
148823416|NCT00621322|536830789|FG003|Overall Study|Physician Decision|1|||
148823417|NCT00621322|536830790|FG004|Overall Study|Physician Decision|0|||
148823418|NCT00621322|536830791|FG005|Overall Study|Physician Decision|0|||
148823419|NCT00621322|536830786|FG000|Overall Study|Withdrawal by Subject|0|||
148823420|NCT00621322|536830787|FG001|Overall Study|Withdrawal by Subject|0|||
148823421|NCT00621322|536830788|FG002|Overall Study|Withdrawal by Subject|0|||
148823422|NCT00621322|536830789|FG003|Overall Study|Withdrawal by Subject|1|||
148823423|NCT00621322|536830790|FG004|Overall Study|Withdrawal by Subject|0|||
148823424|NCT00621322|536830791|FG005|Overall Study|Withdrawal by Subject|2|||
148823425|NCT00621322|536830786|FG000|Overall Study|Migrated/moved from study area|1|||
148823426|NCT00621322|536830787|FG001|Overall Study|Migrated/moved from study area|0|||
148823427|NCT00621322|536830788|FG002|Overall Study|Migrated/moved from study area|1|||
148823428|NCT00621322|536830789|FG003|Overall Study|Migrated/moved from study area|1|||
148823429|NCT00621322|536830790|FG004|Overall Study|Migrated/moved from study area|0|||
148823430|NCT00621322|536830791|FG005|Overall Study|Migrated/moved from study area|2|||
148823431|NCT00576407|536830792|FG000|Overall Study|Death|7|||
148976439|NCT04542070|537394545|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
148823432|NCT00576407|536830792|FG000|Overall Study|Physician Decision|1|||
148823433|NCT04641975|536830793|FG000|Overall Study|Protocol Violation|1|||
148823434|NCT04641975|536830794|FG001|Overall Study|Protocol Violation|2|||
148823435|NCT04641975|536830795|FG002|Overall Study|Protocol Violation|0|||
148823436|NCT04641975|536830796|FG003|Overall Study|Protocol Violation|0|||
148756552|NCT05921903|536580632|FG000|Overall Study|Unsolicited non-SAE|0|||
148756553|NCT05921903|536580633|FG001|Overall Study|Unsolicited non-SAE|1|||
148756554|NCT05921903|536580634|FG002|Overall Study|Unsolicited non-SAE|0|||
148756555|NCT05921903|536580632|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
148756556|NCT05921903|536580633|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
148756557|NCT05921903|536580634|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
148756558|NCT05921903|536580632|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
148756559|NCT05921903|536580633|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
148756560|NCT05921903|536580634|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
148756561|NCT01108718|536580635|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
148756562|NCT01108718|536580636|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
148756563|NCT01060072|536580639|FG000|Overall Study|Adverse Event|1|||
148756564|NCT01060072|536580640|FG001|Overall Study|Adverse Event|1|||
148756565|NCT01060072|536580639|FG000|Overall Study|Physician Decision|0|||
148756566|NCT01060072|536580640|FG001|Overall Study|Physician Decision|2|||
148756567|NCT01060072|536580639|FG000|Overall Study|Protocol Violation|0|||
148756568|NCT01060072|536580640|FG001|Overall Study|Protocol Violation|1|||
148756569|NCT01060072|536580639|FG000|Overall Study|Acute cholecystitis|1|||
148756570|NCT01060072|536580640|FG001|Overall Study|Acute cholecystitis|0|||
148756571|NCT01060072|536580639|FG000|Overall Study|Excluded Medications|0|||
148756572|NCT01060072|536580640|FG001|Overall Study|Excluded Medications|1|||
148756573|NCT01320293|536580646|FG000|Overall Study|Lack of Efficacy|1|||
148756574|NCT01320293|536580646|FG000|Overall Study|Adverse Event|1|||
148756575|NCT01532934|536580647|FG000|Overall Study|Lost to Follow-up|11|||
148756576|NCT01532934|536580648|FG001|Overall Study|Lost to Follow-up|11|||
148756577|NCT01532934|536580647|FG000|Overall Study|In controlled environment|3|||
148756578|NCT01532934|536580648|FG001|Overall Study|In controlled environment|2|||
148756579|NCT01147068|536580649|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
148756580|NCT01147068|536580650|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
148756581|NCT01147068|536580651|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
148756582|NCT01147068|536580652|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
148756583|NCT01147068|536580653|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
148756584|NCT01147068|536580654|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
148756585|NCT01147068|536580655|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
148756586|NCT01147068|536580649|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
148756587|NCT01147068|536580650|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
148756588|NCT01147068|536580651|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
148756589|NCT01147068|536580652|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
148756590|NCT01147068|536580653|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
148756591|NCT01147068|536580654|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
148756592|NCT01147068|536580655|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
148756593|NCT01147068|536580649|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
148756594|NCT01147068|536580650|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
148756595|NCT01147068|536580651|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
148756596|NCT01147068|536580652|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
148756597|NCT01147068|536580653|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
148756598|NCT01147068|536580654|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
148756599|NCT01147068|536580655|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
148756600|NCT01147068|536580649|FG000|Subjects That Received 2nd Dose|Other|0|||
148756601|NCT01147068|536580650|FG001|Subjects That Received 2nd Dose|Other|3|||
148756602|NCT01147068|536580651|FG002|Subjects That Received 2nd Dose|Other|3|||
148756603|NCT01147068|536580652|FG003|Subjects That Received 2nd Dose|Other|0|||
148756604|NCT01147068|536580653|FG004|Subjects That Received 2nd Dose|Other|1|||
148756605|NCT01147068|536580654|FG005|Subjects That Received 2nd Dose|Other|0|||
148756606|NCT01147068|536580655|FG006|Subjects That Received 2nd Dose|Other|0|||
148756607|NCT01147068|536580649|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
148756608|NCT01147068|536580650|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
148756609|NCT01147068|536580651|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
148756610|NCT01147068|536580652|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
148756611|NCT01147068|536580653|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
148756612|NCT01147068|536580654|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
148756613|NCT01147068|536580655|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
148756614|NCT01147068|536580649|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
148756615|NCT01147068|536580650|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
148756616|NCT01147068|536580651|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
148756617|NCT01147068|536580652|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
148756618|NCT01147068|536580653|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
148756619|NCT01147068|536580654|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
148756620|NCT01147068|536580655|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
148756621|NCT01147068|536580649|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
148756622|NCT01147068|536580650|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
148756623|NCT01147068|536580651|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
148756624|NCT01147068|536580652|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
148756625|NCT01147068|536580653|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
148756626|NCT01147068|536580654|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
148756627|NCT01147068|536580655|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
148756628|NCT03181633|536580658|FG000|Overall Study|Withdrawal by Subject|1|||
148756629|NCT03181633|536580658|FG000|Overall Study|Missing follow-up visit|1|||
148756630|NCT01597778|536580661|FG000|Overall Study|Death|7|||
148756631|NCT01597778|536580662|FG001|Overall Study|Death|10|||
148756632|NCT01597778|536580661|FG000|Overall Study|Withdrawal by Subject|3|||
148756633|NCT01597778|536580662|FG001|Overall Study|Withdrawal by Subject|4|||
148756634|NCT01597778|536580661|FG000|Overall Study|Adverse Event|1|||
148756635|NCT01597778|536580662|FG001|Overall Study|Adverse Event|1|||
148756636|NCT01597778|536580661|FG000|Overall Study|Protocol Violation|1|||
148756637|NCT01597778|536580662|FG001|Overall Study|Protocol Violation|11|||
148756638|NCT01597778|536580661|FG000|Overall Study|Transplanted off protocol|2|||
148756639|NCT01597778|536580662|FG001|Overall Study|Transplanted off protocol|3|||
148756640|NCT00699998|536580671|FG000|Overall Study|Withdrawal by Subject|194|||
148756641|NCT00699998|536580672|FG001|Overall Study|Withdrawal by Subject|83|||
148756642|NCT00699998|536580673|FG002|Overall Study|Withdrawal by Subject|202|||
148756643|NCT00699998|536580674|FG003|Overall Study|Withdrawal by Subject|80|||
148756644|NCT00699998|536580671|FG000|Overall Study|Physician Decision|3|||
148756645|NCT00699998|536580672|FG001|Overall Study|Physician Decision|2|||
148756646|NCT00699998|536580673|FG002|Overall Study|Physician Decision|1|||
148756647|NCT00699998|536580674|FG003|Overall Study|Physician Decision|1|||
148756648|NCT00699998|536580671|FG000|Overall Study|Lost to Follow-up|2|||
148756649|NCT00699998|536580672|FG001|Overall Study|Lost to Follow-up|1|||
148756650|NCT00699998|536580673|FG002|Overall Study|Lost to Follow-up|3|||
148756651|NCT00699998|536580674|FG003|Overall Study|Lost to Follow-up|1|||
148756652|NCT01406574|536580675|FG000|Overall Study|Adverse Event|0|||
148756653|NCT01406574|536580676|FG001|Overall Study|Adverse Event|0|||
148756654|NCT01406574|536580677|FG002|Overall Study|Adverse Event|1|||
148756655|NCT01406574|536580678|FG003|Overall Study|Adverse Event|3|||
148756656|NCT01406574|536580675|FG000|Overall Study|Physician Decision|0|||
148756657|NCT01406574|536580676|FG001|Overall Study|Physician Decision|0|||
148756658|NCT01406574|536580677|FG002|Overall Study|Physician Decision|0|||
148756659|NCT01406574|536580678|FG003|Overall Study|Physician Decision|1|||
148756660|NCT01406574|536580675|FG000|Overall Study|Withdrawal by Subject|0|||
148756661|NCT01406574|536580676|FG001|Overall Study|Withdrawal by Subject|1|||
148756662|NCT01406574|536580677|FG002|Overall Study|Withdrawal by Subject|0|||
148756663|NCT01406574|536580678|FG003|Overall Study|Withdrawal by Subject|0|||
148756664|NCT01406574|536580675|FG000|Overall Study|Definite progression of primary disease|1|||
148756665|NCT01406574|536580676|FG001|Overall Study|Definite progression of primary disease|0|||
148756666|NCT01406574|536580677|FG002|Overall Study|Definite progression of primary disease|0|||
148756667|NCT01406574|536580678|FG003|Overall Study|Definite progression of primary disease|0|||
148756668|NCT00946920|536580685|FG000|Overall Study|Withdrawal by Subject|28|||
148756669|NCT00946920|536580686|FG001|Overall Study|Withdrawal by Subject|15|||
148756670|NCT00946920|536580685|FG000|Overall Study|Lost to Follow-up|2|||
148756671|NCT00946920|536580686|FG001|Overall Study|Lost to Follow-up|2|||
148756672|NCT00946920|536580685|FG000|Overall Study|Physician Decision|5|||
148756673|NCT00946920|536580686|FG001|Overall Study|Physician Decision|2|||
148756674|NCT00946920|536580685|FG000|Overall Study|Adverse Event|41|||
148756675|NCT00946920|536580686|FG001|Overall Study|Adverse Event|14|||
148756676|NCT00946920|536580685|FG000|Overall Study|Protocol Violation|16|||
148756677|NCT00946920|536580686|FG001|Overall Study|Protocol Violation|8|||
148756678|NCT00946920|536580685|FG000|Overall Study|Miscellaneous reasons|18|||
148756679|NCT00946920|536580686|FG001|Overall Study|Miscellaneous reasons|3|||
148756680|NCT04740918|536580687|FG000|Overall Study|Study Terminated by Sponsor|41|||
148756681|NCT04740918|536580688|FG001|Overall Study|Study Terminated by Sponsor|32|||
148756682|NCT04740918|536580687|FG000|Overall Study|Death|3|||
148756683|NCT04740918|536580688|FG001|Overall Study|Death|6|||
148756684|NCT04740918|536580687|FG000|Overall Study|Withdrawal by Subject|5|||
148756685|NCT04740918|536580688|FG001|Overall Study|Withdrawal by Subject|4|||
148756686|NCT04740918|536580687|FG000|Overall Study|Lost to Follow-up|1|||
148756687|NCT04740918|536580688|FG001|Overall Study|Lost to Follow-up|3|||
148756688|NCT04740918|536580687|FG000|Overall Study|Progressive disease|0|||
148756689|NCT04740918|536580688|FG001|Overall Study|Progressive disease|1|||
148756690|NCT04314037|536580692|FG000|Treatment Period 2|Adverse Event|1|||
148756691|NCT04314037|536580693|FG001|Treatment Period 2|Adverse Event|0|||
148756692|NCT04314037|536580692|FG000|Treatment Period 3|Protocol Violation|1|||
148756693|NCT04314037|536580693|FG001|Treatment Period 3|Protocol Violation|0|||
148756694|NCT04314037|536580692|FG000|Treatment Period 3|Adverse Event|0|||
148756695|NCT04314037|536580693|FG001|Treatment Period 3|Adverse Event|1|||
148756696|NCT00273182|536580695|FG000|Overall Study|Death|450|||
148756697|NCT00273182|536580695|FG000|Overall Study|Lost to Follow-up|88|||
148756698|NCT00273182|536580695|FG000|Overall Study|Withdrawal by Subject|257|||
148756699|NCT00273182|536580695|FG000|Overall Study|Device/System Explant|154|||
148756700|NCT00273182|536580695|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
148756701|NCT00856492|536580696|FG000|Overall Study|Ineligible or withdrew consent|1|||
148756702|NCT00856492|536580697|FG001|Overall Study|Ineligible or withdrew consent|1|||
148756703|NCT00856492|536580698|FG002|Overall Study|Ineligible or withdrew consent|2|||
148756704|NCT01609790|536580699|FG000|Overall Study|Protocol Violation|1|||
148756705|NCT01609790|536580700|FG001|Overall Study|Protocol Violation|7|||
148756706|NCT01609790|536580701|FG002|Overall Study|Protocol Violation|8|||
148756707|NCT03879135|536581983|FG000|Overall Study|Physician Decision|0|||
148756708|NCT03879135|536581984|FG001|Overall Study|Physician Decision|0|||
148756709|NCT03879135|536581985|FG002|Overall Study|Physician Decision|0|||
148756710|NCT03879135|536581986|FG003|Overall Study|Physician Decision|1|||
148756711|NCT03879135|536581987|FG004|Overall Study|Physician Decision|0|||
148756712|NCT03879135|536581988|FG005|Overall Study|Physician Decision|0|||
148756713|NCT03879135|536581983|FG000|Overall Study|Withdrawal by Subject|0|||
148756714|NCT03879135|536581984|FG001|Overall Study|Withdrawal by Subject|0|||
148756715|NCT03879135|536581985|FG002|Overall Study|Withdrawal by Subject|0|||
148756716|NCT03879135|536581986|FG003|Overall Study|Withdrawal by Subject|0|||
148756717|NCT03879135|536581987|FG004|Overall Study|Withdrawal by Subject|0|||
148756718|NCT03879135|536581988|FG005|Overall Study|Withdrawal by Subject|1|||
148756719|NCT03879135|536581983|FG000|Overall Study|Site Closed by Sponsor|0|||
148756720|NCT03879135|536581984|FG001|Overall Study|Site Closed by Sponsor|0|||
148756721|NCT03879135|536581985|FG002|Overall Study|Site Closed by Sponsor|0|||
148756722|NCT03879135|536581986|FG003|Overall Study|Site Closed by Sponsor|1|||
148756723|NCT03879135|536581987|FG004|Overall Study|Site Closed by Sponsor|1|||
148756724|NCT03879135|536581988|FG005|Overall Study|Site Closed by Sponsor|0|||
148756725|NCT04162847|536581989|FG000|Overall Study|Withdrawal by Subject|7|||
148756726|NCT04162847|536581990|FG001|Overall Study|Withdrawal by Subject|1|||
148756727|NCT03985800|536581991|FG000|Overall Study|Death|1|||
148756728|NCT03985800|536581992|FG001|Overall Study|Death|2|||
148756729|NCT03985800|536581991|FG000|Overall Study|Withdrawal by Subject|3|||
148756730|NCT03985800|536581992|FG001|Overall Study|Withdrawal by Subject|6|||
148756731|NCT03985800|536581991|FG000|Overall Study|Protocol Violation|2|||
148756732|NCT03985800|536581992|FG001|Overall Study|Protocol Violation|0|||
148756733|NCT06025721|536581995|FG000|Overall Study|Physician Decision|1|||
148756734|NCT06025721|536581995|FG000|Overall Study|Protocol Violation|1|||
148756735|NCT06025721|536581995|FG000|Overall Study|Incarceration|1|||
148756736|NCT04173507|536581996|FG000|Overall Study|On Treatment|3|||
148756737|NCT04173507|536581996|FG000|Overall Study|Adverse Event|3|||
148756738|NCT04173507|536581996|FG000|Overall Study|Progression/Relapse|34|||
148756739|NCT04173507|536581996|FG000|Overall Study|Death|2|||
148756740|NCT00370552|536581997|FG000|Overall Study|Adverse Event|2|||
148756741|NCT00370552|536581998|FG001|Overall Study|Adverse Event|2|||
148756742|NCT00370552|536581999|FG002|Overall Study|Adverse Event|2|||
148756743|NCT00370552|536581997|FG000|Overall Study|Disease progression|23|||
148756744|NCT00370552|536581998|FG001|Overall Study|Disease progression|23|||
148756745|NCT00370552|536581999|FG002|Overall Study|Disease progression|15|||
148756746|NCT00370552|536581997|FG000|Overall Study|Maximum clinical benefit|3|||
148756747|NCT00370552|536581998|FG001|Overall Study|Maximum clinical benefit|5|||
148756748|NCT00370552|536581999|FG002|Overall Study|Maximum clinical benefit|5|||
148756749|NCT00370552|536581997|FG000|Overall Study|Poor or noncompliance|0|||
148756750|NCT00370552|536581998|FG001|Overall Study|Poor or noncompliance|0|||
148756751|NCT00370552|536581999|FG002|Overall Study|Poor or noncompliance|1|||
148756752|NCT00370552|536581997|FG000|Overall Study|Study drug toxicity|11|||
148756753|NCT00370552|536581998|FG001|Overall Study|Study drug toxicity|8|||
148756754|NCT00370552|536581999|FG002|Overall Study|Study drug toxicity|6|||
148756755|NCT00370552|536581997|FG000|Overall Study|Withdrawal by Subject|2|||
148823437|NCT04641975|536830793|FG000|Overall Study|Adverse Event|0|||
149027420|NCT00688688|537578558|FG001|Overall Study|Lost to Follow-up|7|||
149027421|NCT00688688|537578559|FG002|Overall Study|Lost to Follow-up|7|||
149027422|NCT00688688|537578557|FG000|Overall Study|Protocol Violation|6|||
149027423|NCT00688688|537578558|FG001|Overall Study|Protocol Violation|9|||
149027424|NCT00688688|537578559|FG002|Overall Study|Protocol Violation|11|||
149027425|NCT00688688|537578557|FG000|Overall Study|Randomized but never received study drug|1|||
148756756|NCT00370552|536581998|FG001|Overall Study|Withdrawal by Subject|0|||
148756757|NCT00370552|536581999|FG002|Overall Study|Withdrawal by Subject|1|||
148756758|NCT00370552|536581997|FG000|Overall Study|Still on treatment|1|||
148756759|NCT00370552|536581998|FG001|Overall Study|Still on treatment|3|||
148823438|NCT04641975|536830794|FG001|Overall Study|Adverse Event|0|||
148756760|NCT00370552|536581999|FG002|Overall Study|Still on treatment|2|||
148756761|NCT00370552|536581997|FG000|Overall Study|Never treated|1|||
148756762|NCT00370552|536581998|FG001|Overall Study|Never treated|0|||
148756763|NCT00370552|536581999|FG002|Overall Study|Never treated|0|||
148756764|NCT00370552|536581997|FG000|Overall Study|Physician Decision|1|||
148756765|NCT00370552|536581998|FG001|Overall Study|Physician Decision|1|||
149027426|NCT00688688|537578558|FG001|Overall Study|Randomized but never received study drug|0|||
149027427|NCT00688688|537578559|FG002|Overall Study|Randomized but never received study drug|0|||
149027428|NCT00688688|537578557|FG000|Overall Study|Non-compliance with study procedures|5|||
149027429|NCT00688688|537578558|FG001|Overall Study|Non-compliance with study procedures|3|||
149027430|NCT00688688|537578559|FG002|Overall Study|Non-compliance with study procedures|4|||
149027431|NCT00688688|537578557|FG000|Overall Study|Taking exclusionary medications|1|||
149027432|NCT00688688|537578558|FG001|Overall Study|Taking exclusionary medications|0|||
149027433|NCT00688688|537578559|FG002|Overall Study|Taking exclusionary medications|0|||
149027434|NCT00688688|537578557|FG000|Overall Study|Site closure|0|||
149027435|NCT00688688|537578558|FG001|Overall Study|Site closure|1|||
149027436|NCT00688688|537578559|FG002|Overall Study|Site closure|0|||
149027437|NCT00688688|537578557|FG000|Overall Study|Violation of exclusion criterion|0|||
149027438|NCT00688688|537578558|FG001|Overall Study|Violation of exclusion criterion|1|||
149027439|NCT00688688|537578559|FG002|Overall Study|Violation of exclusion criterion|0|||
149027440|NCT04296942|537578560|FG000|Overall Study|Study closure by sponsor|1|||
149027441|NCT04296942|537578561|FG001|Overall Study|Study closure by sponsor|0|||
149027442|NCT04296942|537578562|FG002|Overall Study|Study closure by sponsor|0|||
149027443|NCT01004263|537578563|FG000|Overall Study|Adverse Event|15|||
149027444|NCT01004263|537578563|FG000|Overall Study|Withdrawal by Subject|58|||
148756766|NCT00370552|536581999|FG002|Overall Study|Physician Decision|0|||
148756767|NCT00370552|536581997|FG000|Overall Study|Investigator decision|2|||
148756768|NCT00370552|536581998|FG001|Overall Study|Investigator decision|1|||
148756769|NCT00370552|536581999|FG002|Overall Study|Investigator decision|0|||
148756770|NCT00370552|536581997|FG000|Overall Study|High risk of allergic reaction|0|||
148756771|NCT00370552|536581998|FG001|Overall Study|High risk of allergic reaction|1|||
148756772|NCT00370552|536581999|FG002|Overall Study|High risk of allergic reaction|0|||
148756773|NCT00370552|536581997|FG000|Overall Study|Planned radiation for palliation|0|||
148756774|NCT00370552|536581998|FG001|Overall Study|Planned radiation for palliation|1|||
148756775|NCT00370552|536581999|FG002|Overall Study|Planned radiation for palliation|0|||
148756776|NCT01062425|536582007|FG000|Overall Study|Protocol Violation|3|||
148756777|NCT01062425|536582008|FG001|Overall Study|Protocol Violation|6|||
148756778|NCT03534687|536582012|FG000|Overall Study|Lost to Follow-up|7|||
148756779|NCT03534687|536582013|FG001|Overall Study|Lost to Follow-up|2|||
148756780|NCT03428152|536582014|FG000|Overall Study|Physician Decision|4|||
148756781|NCT03428152|536582015|FG001|Overall Study|Physician Decision|2|||
148756782|NCT03428152|536582014|FG000|Overall Study|Protocol Violation|3|||
148756783|NCT03428152|536582015|FG001|Overall Study|Protocol Violation|5|||
148756784|NCT03428152|536582014|FG000|Overall Study|Lack of Efficacy|0|||
148756785|NCT03428152|536582015|FG001|Overall Study|Lack of Efficacy|4|||
148756786|NCT00395629|536582016|FG000|Core Study|Adverse Event|0|||
148756787|NCT00395629|536582017|FG001|Core Study|Adverse Event|3|||
148756788|NCT00395629|536582018|FG002|Core Study|Adverse Event|4|||
148756789|NCT00395629|536582016|FG000|Core Study|Abnormal laboratory value(s)|0|||
148756790|NCT00395629|536582017|FG001|Core Study|Abnormal laboratory value(s)|0|||
148756791|NCT00395629|536582018|FG002|Core Study|Abnormal laboratory value(s)|1|||
148756792|NCT00395629|536582016|FG000|Core Study|Protocol Violation|1|||
148756793|NCT00395629|536582017|FG001|Core Study|Protocol Violation|0|||
148756794|NCT00395629|536582018|FG002|Core Study|Protocol Violation|0|||
148756795|NCT00395629|536582016|FG000|Core Study|Withdrawal by Subject|0|||
148756796|NCT00395629|536582017|FG001|Core Study|Withdrawal by Subject|1|||
148756797|NCT00395629|536582018|FG002|Core Study|Withdrawal by Subject|1|||
148756798|NCT00395629|536582016|FG000|Core Study|Lost to Follow-up|0|||
148756799|NCT00395629|536582017|FG001|Core Study|Lost to Follow-up|0|||
148756800|NCT00395629|536582018|FG002|Core Study|Lost to Follow-up|1|||
148756801|NCT00395629|536582016|FG000|Extension Study|Adverse Event|0|||
148756802|NCT00395629|536582017|FG001|Extension Study|Adverse Event|0|||
148756803|NCT00395629|536582018|FG002|Extension Study|Adverse Event|2|||
148756804|NCT00395629|536582016|FG000|Extension Study|Administrative problems|0|||
148756805|NCT00395629|536582017|FG001|Extension Study|Administrative problems|0|||
148756806|NCT00395629|536582018|FG002|Extension Study|Administrative problems|1|||
148756807|NCT01686373|536582019|FG000|Overall Study|Lost to Follow-up|3|||
148756808|NCT01686373|536582020|FG001|Overall Study|Lost to Follow-up|0|||
148756809|NCT01686373|536582019|FG000|Overall Study|Withdrawal by Subject|0|||
148756810|NCT01686373|536582020|FG001|Overall Study|Withdrawal by Subject|1|||
148756811|NCT01686373|536582019|FG000|Overall Study|Adverse Event|0|||
148756812|NCT01686373|536582020|FG001|Overall Study|Adverse Event|1|||
148756813|NCT01836471|536582027|FG000|Overall Study|Pregnancy|1|||
148756814|NCT01836471|536582028|FG001|Overall Study|Pregnancy|0|||
148756815|NCT01836471|536582029|FG002|Overall Study|Pregnancy|0|||
148756816|NCT01836471|536582030|FG003|Overall Study|Pregnancy|0|||
148756817|NCT01836471|536582031|FG004|Overall Study|Pregnancy|0|||
148756818|NCT01836471|536582027|FG000|Overall Study|Withdrawal by Subject|3|||
148756819|NCT01836471|536582028|FG001|Overall Study|Withdrawal by Subject|4|||
148756820|NCT01836471|536582029|FG002|Overall Study|Withdrawal by Subject|1|||
148823439|NCT04641975|536830795|FG002|Overall Study|Adverse Event|1|||
148823440|NCT04641975|536830796|FG003|Overall Study|Adverse Event|1|||
148756821|NCT01836471|536582030|FG003|Overall Study|Withdrawal by Subject|0|||
148823441|NCT04641975|536830793|FG000|Overall Study|Withdrawal by Subject|1|||
148823442|NCT04641975|536830794|FG001|Overall Study|Withdrawal by Subject|0|||
149027445|NCT01004263|537578563|FG000|Overall Study|Protocol Violation|10|||
148756822|NCT01836471|536582031|FG004|Overall Study|Withdrawal by Subject|2|||
148756823|NCT01836471|536582027|FG000|Overall Study|Physician Decision|0|||
148756824|NCT01836471|536582028|FG001|Overall Study|Physician Decision|1|||
148756825|NCT01836471|536582029|FG002|Overall Study|Physician Decision|0|||
148756826|NCT01836471|536582030|FG003|Overall Study|Physician Decision|0|||
148756827|NCT01836471|536582031|FG004|Overall Study|Physician Decision|0|||
148756828|NCT01836471|536582027|FG000|Overall Study|Lost to Follow-up|0|||
148756829|NCT01836471|536582028|FG001|Overall Study|Lost to Follow-up|0|||
148756830|NCT01836471|536582029|FG002|Overall Study|Lost to Follow-up|0|||
148756831|NCT01836471|536582030|FG003|Overall Study|Lost to Follow-up|1|||
148756832|NCT01836471|536582031|FG004|Overall Study|Lost to Follow-up|1|||
148756833|NCT01836471|536582027|FG000|Overall Study|Adverse Event|6|||
148756834|NCT01836471|536582028|FG001|Overall Study|Adverse Event|3|||
148756835|NCT01836471|536582029|FG002|Overall Study|Adverse Event|1|||
148756836|NCT01836471|536582030|FG003|Overall Study|Adverse Event|1|||
148756837|NCT01836471|536582031|FG004|Overall Study|Adverse Event|2|||
148756838|NCT01836471|536582027|FG000|Overall Study|Non compliance with tx|1|||
148756839|NCT01836471|536582028|FG001|Overall Study|Non compliance with tx|1|||
148756840|NCT01836471|536582029|FG002|Overall Study|Non compliance with tx|0|||
148756841|NCT01836471|536582030|FG003|Overall Study|Non compliance with tx|0|||
148756842|NCT01836471|536582031|FG004|Overall Study|Non compliance with tx|0|||
148756843|NCT00314340|536582033|FG000|Overall Study|lost interest|1|||
148756844|NCT05506046|536582034|FG000|Overall Study|Lost to Follow-up|89|||
148756845|NCT05506046|536582035|FG001|Overall Study|Lost to Follow-up|101|||
148756846|NCT05506046|536582036|FG002|Overall Study|Lost to Follow-up|102|||
148756847|NCT05506046|536582037|FG003|Overall Study|Lost to Follow-up|99|||
148756848|NCT00191477|536582038|FG000|Overall Study|Tumor Recurrence|49|||
148756849|NCT00191477|536582039|FG001|Overall Study|Tumor Recurrence|48|||
148756850|NCT00191477|536582038|FG000|Overall Study|Death, Study Disease|1|||
148756851|NCT00191477|536582039|FG001|Overall Study|Death, Study Disease|1|||
148756852|NCT00191477|536582038|FG000|Overall Study|Death, Other Cause|3|||
148756853|NCT00191477|536582039|FG001|Overall Study|Death, Other Cause|6|||
148756854|NCT00191477|536582038|FG000|Overall Study|Lost to Follow-up|23|||
148756855|NCT00191477|536582039|FG001|Overall Study|Lost to Follow-up|21|||
148756856|NCT00191477|536582038|FG000|Overall Study|Protocol Violation|1|||
148756857|NCT00191477|536582039|FG001|Overall Study|Protocol Violation|1|||
148756858|NCT00191477|536582038|FG000|Overall Study|Treatment Change|2|||
148756859|NCT00191477|536582039|FG001|Overall Study|Treatment Change|0|||
148756860|NCT00191477|536582038|FG000|Overall Study|Withdrawal by Subject|2|||
148756861|NCT00191477|536582039|FG001|Overall Study|Withdrawal by Subject|0|||
148756862|NCT00191477|536582038|FG000|Overall Study|Other|2|||
148756863|NCT00191477|536582039|FG001|Overall Study|Other|0|||
148756864|NCT00191477|536582038|FG000|Overall Study|Not Eligible|41|||
148756865|NCT00191477|536582039|FG001|Overall Study|Not Eligible|38|||
148756866|NCT00191477|536582038|FG000|Overall Study|Pathological Specimen Lost|1|||
148756867|NCT00191477|536582039|FG001|Overall Study|Pathological Specimen Lost|0|||
148756868|NCT00191477|536582038|FG000|Overall Study|Discontinued Prior to Instillation|13|||
148756869|NCT00191477|536582039|FG001|Overall Study|Discontinued Prior to Instillation|14|||
148756870|NCT03776357|536582046|FG000|Overall Study|Lost to Follow-up|3|||
148756871|NCT01286467|536582049|FG000|Overall Study|Death|1|||
148756872|NCT01286467|536582050|FG001|Overall Study|Death|1|||
148756873|NCT01286467|536582051|FG002|Overall Study|Death|1|||
148756874|NCT01286467|536582052|FG003|Overall Study|Death|0|||
148756875|NCT01286467|536582049|FG000|Overall Study|Lost to Follow-up|0|||
148756876|NCT01286467|536582050|FG001|Overall Study|Lost to Follow-up|0|||
148756877|NCT01286467|536582051|FG002|Overall Study|Lost to Follow-up|0|||
148756878|NCT01286467|536582052|FG003|Overall Study|Lost to Follow-up|1|||
148756879|NCT01286467|536582049|FG000|Overall Study|Withdrawal by Subject|0|||
148756880|NCT01286467|536582050|FG001|Overall Study|Withdrawal by Subject|0|||
148756881|NCT01286467|536582051|FG002|Overall Study|Withdrawal by Subject|1|||
148756882|NCT01286467|536582052|FG003|Overall Study|Withdrawal by Subject|0|||
148756883|NCT01286467|536582049|FG000|Overall Study|Physician Decision|0|||
148756884|NCT01286467|536582050|FG001|Overall Study|Physician Decision|0|||
148756885|NCT01286467|536582051|FG002|Overall Study|Physician Decision|0|||
148756886|NCT01286467|536582052|FG003|Overall Study|Physician Decision|1|||
148756887|NCT01286467|536582049|FG000|Overall Study|Disease progression|3|||
148756888|NCT01286467|536582050|FG001|Overall Study|Disease progression|2|||
148756889|NCT01286467|536582051|FG002|Overall Study|Disease progression|2|||
148756890|NCT01286467|536582052|FG003|Overall Study|Disease progression|3|||
148756891|NCT01286467|536582049|FG000|Overall Study|Adverse Event|0|||
148756892|NCT01286467|536582050|FG001|Overall Study|Adverse Event|1|||
148823443|NCT04641975|536830795|FG002|Overall Study|Withdrawal by Subject|0|||
148756893|NCT01286467|536582051|FG002|Overall Study|Adverse Event|2|||
148756894|NCT01286467|536582052|FG003|Overall Study|Adverse Event|3|||
148756895|NCT01286467|536582049|FG000|Overall Study|Study drug stop longer than 14 days|0|||
148756896|NCT01286467|536582050|FG001|Overall Study|Study drug stop longer than 14 days|0|||
148756897|NCT01286467|536582051|FG002|Overall Study|Study drug stop longer than 14 days|1|||
148756898|NCT01286467|536582052|FG003|Overall Study|Study drug stop longer than 14 days|0|||
148756899|NCT01058642|536582053|FG000|Treatment Period 1|Adverse Event|0|||
148823444|NCT04641975|536830796|FG003|Overall Study|Withdrawal by Subject|0|||
148823445|NCT01259024|536830798|FG000|Overall Study|Physician Decision|1|||
148823446|NCT01657500|536830799|FG000|Overall Study|set impropperly matched|3|||
148823447|NCT01657500|536830800|FG001|Overall Study|set impropperly matched|3|||
148823448|NCT01657500|536830799|FG000|Overall Study|Lost to Follow-up|2|||
148823449|NCT01657500|536830800|FG001|Overall Study|Lost to Follow-up|2|||
148823450|NCT00564070|536830803|FG000|Overall Study|Lost to Follow-up|9|||
148823451|NCT00564070|536830804|FG001|Overall Study|Lost to Follow-up|7|||
148823452|NCT00564070|536830803|FG000|Overall Study|Worsening depression, referred to care|3|||
148823453|NCT00564070|536830804|FG001|Overall Study|Worsening depression, referred to care|0|||
148823454|NCT01655069|536830805|FG000|Overall Study|Physician Decision|0|||
148823455|NCT01655069|536830806|FG001|Overall Study|Physician Decision|0|||
148823456|NCT01655069|536830807|FG002|Overall Study|Physician Decision|0|||
148823457|NCT01655069|536830808|FG003|Overall Study|Physician Decision|1|||
148823458|NCT01655069|536830805|FG000|Overall Study|Adverse Event|6|||
148823459|NCT01655069|536830806|FG001|Overall Study|Adverse Event|7|||
148823460|NCT01655069|536830807|FG002|Overall Study|Adverse Event|2|||
148823461|NCT01655069|536830808|FG003|Overall Study|Adverse Event|3|||
148823462|NCT01655069|536830805|FG000|Overall Study|Lack of Efficacy|0|||
148823463|NCT01655069|536830806|FG001|Overall Study|Lack of Efficacy|1|||
148823464|NCT01655069|536830807|FG002|Overall Study|Lack of Efficacy|0|||
148823465|NCT01655069|536830808|FG003|Overall Study|Lack of Efficacy|0|||
148823466|NCT01655069|536830805|FG000|Overall Study|No Treatment Needed|0|||
148823467|NCT01655069|536830806|FG001|Overall Study|No Treatment Needed|1|||
148823468|NCT01655069|536830807|FG002|Overall Study|No Treatment Needed|0|||
148823469|NCT01655069|536830808|FG003|Overall Study|No Treatment Needed|0|||
148823470|NCT01655069|536830805|FG000|Overall Study|Withdrawal by Subject|2|||
148823471|NCT01655069|536830806|FG001|Overall Study|Withdrawal by Subject|3|||
148823472|NCT01655069|536830807|FG002|Overall Study|Withdrawal by Subject|0|||
148823473|NCT01655069|536830808|FG003|Overall Study|Withdrawal by Subject|0|||
148823474|NCT02346370|536830809|FG000|Overall Study|Not treated|1|||
148823475|NCT02346370|536830810|FG001|Overall Study|Not treated|0|||
148823476|NCT02346370|536830811|FG002|Overall Study|Not treated|0|||
148823477|NCT02346370|536830809|FG000|Overall Study|Withdrawal of consent|1|||
148823478|NCT02346370|536830810|FG001|Overall Study|Withdrawal of consent|0|||
148823479|NCT02346370|536830811|FG002|Overall Study|Withdrawal of consent|0|||
148823480|NCT02346370|536830809|FG000|Overall Study|Death|1|||
148823481|NCT02346370|536830810|FG001|Overall Study|Death|3|||
148823482|NCT02346370|536830811|FG002|Overall Study|Death|1|||
148823483|NCT02346370|536830809|FG000|Overall Study|Sponsor discontinued study|5|||
148823484|NCT02346370|536830810|FG001|Overall Study|Sponsor discontinued study|0|||
148823485|NCT02346370|536830811|FG002|Overall Study|Sponsor discontinued study|2|||
148823486|NCT02346370|536830809|FG000|Overall Study|Radiologic progression|0|||
148823487|NCT02346370|536830810|FG001|Overall Study|Radiologic progression|0|||
148823488|NCT02346370|536830811|FG002|Overall Study|Radiologic progression|1|||
148823489|NCT02346370|536830809|FG000|Overall Study|Physician Decision|0|||
148823490|NCT02346370|536830810|FG001|Overall Study|Physician Decision|1|||
148823491|NCT02346370|536830811|FG002|Overall Study|Physician Decision|0|||
148823492|NCT06399471|536830812|FG000|Overall Study|Withdrawal by Subject|1|||
148823493|NCT05529173|536830813|FG000|Overall Study|Physician Decision|3|||
148823494|NCT05529173|536830814|FG001|Overall Study|Physician Decision|6|||
148823495|NCT05529173|536830813|FG000|Overall Study|Sample shipment delay more than one day|4|||
148823496|NCT05529173|536830814|FG001|Overall Study|Sample shipment delay more than one day|0|||
148823497|NCT00609973|536830815|FG000|Overall Study|Adverse Event|2|||
148823498|NCT00609973|536830816|FG001|Overall Study|Adverse Event|1|||
148823499|NCT00609973|536830815|FG000|Overall Study|Protocol Violation|4|||
148823500|NCT00609973|536830816|FG001|Overall Study|Protocol Violation|3|||
148823501|NCT00609973|536830815|FG000|Overall Study|Lost to Follow-up|2|||
148823502|NCT00609973|536830816|FG001|Overall Study|Lost to Follow-up|1|||
148823503|NCT00609973|536830815|FG000|Overall Study|Withdrawal by Subject|0|||
148823504|NCT00609973|536830816|FG001|Overall Study|Withdrawal by Subject|1|||
148823505|NCT01691482|536830818|FG000|Treatment Period 2|Adverse Event|0|||
148823506|NCT01691482|536830819|FG001|Treatment Period 2|Adverse Event|1|||
148823507|NCT01691482|536830818|FG000|Treatment Period 2|Protocol Violation|1|||
148823508|NCT01691482|536830819|FG001|Treatment Period 2|Protocol Violation|1|||
148823509|NCT00407030|536830822|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
148823510|NCT00407030|536830823|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
148823511|NCT00407030|536830824|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
148823512|NCT00407030|536830822|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
148756900|NCT01058642|536582054|FG001|Treatment Period 1|Adverse Event|1|||
148756901|NCT01058642|536582055|FG002|Treatment Period 1|Adverse Event|1|||
148756902|NCT01058642|536582056|FG003|Treatment Period 1|Adverse Event|0|||
148756903|NCT01058642|536582053|FG000|Treatment Period 1|Physician Decision|0|||
148756904|NCT01058642|536582054|FG001|Treatment Period 1|Physician Decision|0|||
148756905|NCT01058642|536582055|FG002|Treatment Period 1|Physician Decision|1|||
148756906|NCT01058642|536582056|FG003|Treatment Period 1|Physician Decision|0|||
148756907|NCT01058642|536582053|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148823513|NCT00407030|536830823|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
148823514|NCT00407030|536830824|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
148823515|NCT00407030|536830822|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
148823516|NCT00407030|536830823|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
148823517|NCT00407030|536830824|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
148823518|NCT00407030|536830822|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
148823519|NCT00407030|536830823|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
148823520|NCT00407030|536830824|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
148823521|NCT00407030|536830822|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
148823522|NCT00407030|536830823|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
148823523|NCT00407030|536830824|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
148823524|NCT00407030|536830822|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
148823525|NCT00407030|536830823|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
148823526|NCT00407030|536830824|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
148823527|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
148823528|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
148823529|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
148823530|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
148823531|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
148823532|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
148823533|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
148823534|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
148823535|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
148823536|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
148823537|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
148823538|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
148823539|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
148823540|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
148823541|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
148823542|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
148823543|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
148823544|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
148823545|NCT00407030|536830822|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
148823546|NCT00407030|536830823|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
148823547|NCT00407030|536830824|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
148823548|NCT00736476|536830827|FG000|Overall Study|Adverse Event|1|||
148823549|NCT00736476|536830828|FG001|Overall Study|Adverse Event|0|||
148823550|NCT01796470|536830829|FG000|Overall Study|Adverse Event|4|||
148823551|NCT01796470|536830830|FG001|Overall Study|Adverse Event|2|||
148823552|NCT01796470|536830831|FG002|Overall Study|Adverse Event|2|||
148823553|NCT01796470|536830832|FG003|Overall Study|Adverse Event|1|||
148823554|NCT01796470|536830833|FG004|Overall Study|Adverse Event|3|||
148823555|NCT01796470|536830829|FG000|Overall Study|Death|2|||
148823556|NCT01796470|536830830|FG001|Overall Study|Death|0|||
148823557|NCT01796470|536830831|FG002|Overall Study|Death|0|||
148823558|NCT01796470|536830832|FG003|Overall Study|Death|0|||
148823559|NCT01796470|536830833|FG004|Overall Study|Death|1|||
148823560|NCT01796470|536830829|FG000|Overall Study|Initiated New Therapy|9|||
148823561|NCT01796470|536830830|FG001|Overall Study|Initiated New Therapy|0|||
148823562|NCT01796470|536830831|FG002|Overall Study|Initiated New Therapy|0|||
148823563|NCT01796470|536830832|FG003|Overall Study|Initiated New Therapy|0|||
148823564|NCT01796470|536830833|FG004|Overall Study|Initiated New Therapy|2|||
148823565|NCT01796470|536830829|FG000|Overall Study|Lost to Follow-up|0|||
148823566|NCT01796470|536830830|FG001|Overall Study|Lost to Follow-up|1|||
148823567|NCT01796470|536830831|FG002|Overall Study|Lost to Follow-up|0|||
148823568|NCT01796470|536830832|FG003|Overall Study|Lost to Follow-up|0|||
148823569|NCT01796470|536830833|FG004|Overall Study|Lost to Follow-up|0|||
148823570|NCT01796470|536830829|FG000|Overall Study|Physician Decision|5|||
148823571|NCT01796470|536830830|FG001|Overall Study|Physician Decision|4|||
148823572|NCT01796470|536830831|FG002|Overall Study|Physician Decision|1|||
148823573|NCT01796470|536830832|FG003|Overall Study|Physician Decision|0|||
148823574|NCT01796470|536830833|FG004|Overall Study|Physician Decision|1|||
148823575|NCT01796470|536830829|FG000|Overall Study|Progressive Disease|7|||
148823576|NCT01796470|536830830|FG001|Overall Study|Progressive Disease|7|||
148823577|NCT01796470|536830831|FG002|Overall Study|Progressive Disease|3|||
148823578|NCT01796470|536830832|FG003|Overall Study|Progressive Disease|2|||
148823579|NCT01796470|536830833|FG004|Overall Study|Progressive Disease|0|||
148823580|NCT01796470|536830829|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
148823581|NCT01796470|536830830|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
148823582|NCT01796470|536830831|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
148823583|NCT01796470|536830832|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
148823584|NCT01796470|536830833|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
148823585|NCT01796470|536830829|FG000|Overall Study|Withdrawal by Subject|7|||
148756908|NCT01058642|536582054|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148756909|NCT01058642|536582055|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148756910|NCT01058642|536582056|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148756911|NCT01058642|536582053|FG000|Treatment Period 1|Lack of Efficacy|0|||
148756912|NCT01058642|536582054|FG001|Treatment Period 1|Lack of Efficacy|0|||
148756913|NCT01058642|536582055|FG002|Treatment Period 1|Lack of Efficacy|0|||
148756914|NCT01058642|536582056|FG003|Treatment Period 1|Lack of Efficacy|1|||
148756915|NCT01058642|536582053|FG000|Treatment Period 1|Protocol Violation|0|||
148756916|NCT01058642|536582054|FG001|Treatment Period 1|Protocol Violation|0|||
148756917|NCT01058642|536582055|FG002|Treatment Period 1|Protocol Violation|0|||
148756918|NCT01058642|536582056|FG003|Treatment Period 1|Protocol Violation|1|||
148756919|NCT01058642|536582053|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
148756920|NCT01058642|536582054|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
148756921|NCT01058642|536582055|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
148756922|NCT01058642|536582056|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
148756923|NCT03751098|536582062|FG000|Overall Study|Withdrawal by Subject|0|||
148756924|NCT03751098|536582063|FG001|Overall Study|Withdrawal by Subject|1|||
148756925|NCT01306305|536582073|FG000|Overall Study|Lost to Follow-up|1|||
148756926|NCT01306305|536582074|FG001|Overall Study|Lost to Follow-up|0|||
148756927|NCT01306305|536582073|FG000|Overall Study|Withdrew consent|1|||
148756928|NCT01306305|536582074|FG001|Overall Study|Withdrew consent|0|||
148756929|NCT04030299|536582075|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
148756930|NCT04030299|536582075|FG000|Overall Study|Withdrawal by Subject|3|||
148756931|NCT04616612|536582076|FG000|Overall Study|Lost to Follow-up|6|||
148756932|NCT04616612|536582077|FG001|Overall Study|Lost to Follow-up|3|||
148756933|NCT02964247|536582080|FG000|Overall Study|Lost to Follow-up|2|||
148756934|NCT02964247|536582081|FG001|Overall Study|Lost to Follow-up|0|||
148756935|NCT02964247|536582080|FG000|Overall Study|Withdrawal by Subject|1|||
148756936|NCT02964247|536582081|FG001|Overall Study|Withdrawal by Subject|2|||
148756937|NCT03759392|536582082|FG000|Overall Study|Adverse Event|12|||
148756938|NCT03759392|536582083|FG001|Overall Study|Adverse Event|4|||
148756939|NCT03759392|536582082|FG000|Overall Study|Death|2|||
148756940|NCT03759392|536582083|FG001|Overall Study|Death|1|||
148756941|NCT03759392|536582082|FG000|Overall Study|Withdrawal by Subject|2|||
148756942|NCT03759392|536582083|FG001|Overall Study|Withdrawal by Subject|0|||
148756943|NCT03759392|536582082|FG000|Overall Study|Protocol Violation|2|||
148756944|NCT03759392|536582083|FG001|Overall Study|Protocol Violation|0|||
148756945|NCT03759392|536582082|FG000|Overall Study|Physician Decision|0|||
148756946|NCT03759392|536582083|FG001|Overall Study|Physician Decision|1|||
148756947|NCT03759392|536582082|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
148756948|NCT03759392|536582083|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
148756949|NCT03759392|536582082|FG000|Overall Study|No longer able to take medicines|1|||
148756950|NCT03759392|536582083|FG001|Overall Study|No longer able to take medicines|0|||
148756951|NCT03759392|536582082|FG000|Overall Study|Stopped taking study drug|1|||
148756952|NCT03759392|536582083|FG001|Overall Study|Stopped taking study drug|0|||
148756953|NCT01288079|536582084|FG000|Overall Study|Withdrawal by Subject|2|||
148756954|NCT01288079|536582085|FG001|Overall Study|Withdrawal by Subject|4|||
148756955|NCT01288079|536582086|FG002|Overall Study|Withdrawal by Subject|1|||
148756956|NCT01288079|536582087|FG003|Overall Study|Withdrawal by Subject|0|||
148756957|NCT01288079|536582084|FG000|Overall Study|Adverse Event|2|||
148756958|NCT01288079|536582085|FG001|Overall Study|Adverse Event|1|||
148756959|NCT01288079|536582086|FG002|Overall Study|Adverse Event|2|||
148756960|NCT01288079|536582087|FG003|Overall Study|Adverse Event|3|||
148756961|NCT01288079|536582084|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
148756962|NCT01288079|536582085|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
148756963|NCT01288079|536582086|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
148756964|NCT01288079|536582087|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
148756965|NCT01288079|536582084|FG000|Overall Study|Condition under Investigation Worsened|0|||
148756966|NCT01288079|536582085|FG001|Overall Study|Condition under Investigation Worsened|0|||
148756967|NCT01288079|536582086|FG002|Overall Study|Condition under Investigation Worsened|0|||
148756968|NCT01288079|536582087|FG003|Overall Study|Condition under Investigation Worsened|1|||
148756969|NCT01288079|536582084|FG000|Overall Study|Lack of Efficacy|2|||
148756970|NCT01288079|536582085|FG001|Overall Study|Lack of Efficacy|2|||
148756971|NCT01288079|536582086|FG002|Overall Study|Lack of Efficacy|0|||
148756972|NCT01288079|536582087|FG003|Overall Study|Lack of Efficacy|2|||
148756973|NCT01288079|536582084|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
148756974|NCT01288079|536582085|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
148756975|NCT01288079|536582086|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
148756976|NCT01288079|536582087|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
148823586|NCT01796470|536830830|FG001|Overall Study|Withdrawal by Subject|0|||
148823587|NCT01796470|536830831|FG002|Overall Study|Withdrawal by Subject|0|||
148756977|NCT01288079|536582084|FG000|Overall Study|Lost to Follow-up|1|||
148756978|NCT01288079|536582085|FG001|Overall Study|Lost to Follow-up|1|||
148756979|NCT01288079|536582086|FG002|Overall Study|Lost to Follow-up|1|||
148756980|NCT01288079|536582087|FG003|Overall Study|Lost to Follow-up|0|||
148756981|NCT01288079|536582084|FG000|Overall Study|Other or Study Termination|11|||
148756982|NCT01288079|536582085|FG001|Overall Study|Other or Study Termination|15|||
148756983|NCT01288079|536582086|FG002|Overall Study|Other or Study Termination|14|||
148756984|NCT01288079|536582087|FG003|Overall Study|Other or Study Termination|8|||
148756985|NCT01530464|536582088|FG000|Washout (24h)|Withdrawal by Subject|1|||
148756986|NCT01530464|536582089|FG001|Washout (24h)|Withdrawal by Subject|0|||
148756987|NCT01530464|536582088|FG000|Washout (24h)|Withdrawal by Subject|0|||
148756988|NCT01530464|536582089|FG001|Washout (24h)|Withdrawal by Subject|1|||
148756989|NCT01709500|536582090|FG000|Overall Study|Randomized but not treated|0|||
148756990|NCT01709500|536582091|FG001|Overall Study|Randomized but not treated|1|||
148756991|NCT01709500|536582090|FG000|Overall Study|Adverse Event|5|||
148756992|NCT01709500|536582091|FG001|Overall Study|Adverse Event|1|||
148756993|NCT01709500|536582090|FG000|Overall Study|Poor compliance to protocol|2|||
148756994|NCT01709500|536582091|FG001|Overall Study|Poor compliance to protocol|1|||
148756995|NCT01709500|536582090|FG000|Overall Study|Other|3|||
148756996|NCT01709500|536582091|FG001|Overall Study|Other|1|||
148756997|NCT01709500|536582090|FG000|Overall Study|Related to IMP administration|1|||
148756998|NCT01709500|536582091|FG001|Overall Study|Related to IMP administration|0|||
148756999|NCT01709500|536582090|FG000|Overall Study|Treatment ongoing|156|||
148757000|NCT01709500|536582091|FG001|Overall Study|Treatment ongoing|78|||
148757001|NCT00420420|536582092|FG000|Overall Study|Adverse Event|5|||
148757002|NCT00420420|536582093|FG001|Overall Study|Adverse Event|3|||
148757003|NCT00420420|536582092|FG000|Overall Study|Protocol Violation|1|||
148757004|NCT00420420|536582093|FG001|Overall Study|Protocol Violation|1|||
148757005|NCT00420420|536582092|FG000|Overall Study|Withdrawal by Subject|1|||
148757006|NCT00420420|536582093|FG001|Overall Study|Withdrawal by Subject|0|||
148757007|NCT00420420|536582092|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
148757008|NCT00420420|536582093|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
148757009|NCT02208362|536582094|FG000|Overall Study|Participant did not complete treatment|0|||
148757010|NCT02208362|536582095|FG001|Overall Study|Participant did not complete treatment|1|||
148757011|NCT02208362|536582096|FG002|Overall Study|Participant did not complete treatment|0|||
148757012|NCT02208362|536582097|FG003|Overall Study|Participant did not complete treatment|0|||
148757013|NCT02208362|536582098|FG004|Overall Study|Participant did not complete treatment|0|||
148757014|NCT02208362|536582099|FG005|Overall Study|Participant did not complete treatment|0|||
148757015|NCT02208362|536582100|FG006|Overall Study|Participant did not complete treatment|1|||
148757016|NCT02208362|536582101|FG007|Overall Study|Participant did not complete treatment|1|||
148757017|NCT02208362|536582102|FG008|Overall Study|Participant did not complete treatment|2|||
148757018|NCT02208362|536582103|FG009|Overall Study|Participant did not complete treatment|0|||
148757019|NCT02208362|536582104|FG010|Overall Study|Participant did not complete treatment|1|||
148757020|NCT02208362|536582105|FG011|Overall Study|Participant did not complete treatment|0|||
148757021|NCT02208362|536582094|FG000|Overall Study|Participant received disallowed treatment|0|||
148757022|NCT02208362|536582095|FG001|Overall Study|Participant received disallowed treatment|0|||
148757023|NCT02208362|536582096|FG002|Overall Study|Participant received disallowed treatment|0|||
148757024|NCT02208362|536582097|FG003|Overall Study|Participant received disallowed treatment|0|||
148757025|NCT02208362|536582098|FG004|Overall Study|Participant received disallowed treatment|0|||
148757026|NCT02208362|536582099|FG005|Overall Study|Participant received disallowed treatment|0|||
148757027|NCT02208362|536582100|FG006|Overall Study|Participant received disallowed treatment|0|||
148757028|NCT02208362|536582101|FG007|Overall Study|Participant received disallowed treatment|0|||
148757029|NCT02208362|536582102|FG008|Overall Study|Participant received disallowed treatment|1|||
148757030|NCT02208362|536582103|FG009|Overall Study|Participant received disallowed treatment|0|||
148757031|NCT02208362|536582104|FG010|Overall Study|Participant received disallowed treatment|0|||
148757032|NCT02208362|536582105|FG011|Overall Study|Participant received disallowed treatment|0|||
148757033|NCT00739882|536583915|FG000|Double-blind Period|Adverse Event|1|||
148757034|NCT00739882|536583916|FG001|Double-blind Period|Adverse Event|2|||
148757035|NCT00739882|536583915|FG000|Double-blind Period|Protocol Violation|1|||
148757036|NCT00739882|536583916|FG001|Double-blind Period|Protocol Violation|0|||
148757037|NCT00739882|536583915|FG000|Double-blind Period|Lack of Efficacy|1|||
148757038|NCT00739882|536583916|FG001|Double-blind Period|Lack of Efficacy|1|||
148757039|NCT00739882|536583915|FG000|Double-blind Period|Other|16|||
148757040|NCT00739882|536583916|FG001|Double-blind Period|Other|8|||
148757041|NCT00739882|536583915|FG000|Open-label Period|Adverse Event|1|||
148757042|NCT00739882|536583916|FG001|Open-label Period|Adverse Event|0|||
148757043|NCT00739882|536583915|FG000|Open-label Period|Other|9|||
148757044|NCT00739882|536583916|FG001|Open-label Period|Other|5|||
148757045|NCT04021914|536583917|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
148757046|NCT02844543|536583918|FG000|Overall Study|Withdrawal by Subject|4|||
148757047|NCT02844543|536583918|FG000|Overall Study|Did not meet eligibility criteria|1|||
148757048|NCT00955409|536583919|FG000|Overall Study|Lack of Efficacy|1|||
148757049|NCT00955409|536583920|FG001|Overall Study|Lack of Efficacy|0|||
148757050|NCT00955409|536583921|FG002|Overall Study|Lack of Efficacy|0|||
148757051|NCT00955409|536583922|FG003|Overall Study|Lack of Efficacy|0|||
148976440|NCT04542070|537394546|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
148757052|NCT00955409|536583923|FG004|Overall Study|Lack of Efficacy|0|||
148757053|NCT00955409|536583924|FG005|Overall Study|Lack of Efficacy|0|||
148757054|NCT00955409|536583925|FG006|Overall Study|Lack of Efficacy|0|||
148757055|NCT00955409|536583926|FG007|Overall Study|Lack of Efficacy|0|||
148757056|NCT00955409|536583927|FG008|Overall Study|Lack of Efficacy|0|||
148757057|NCT00955409|536583928|FG009|Overall Study|Lack of Efficacy|0|||
148757058|NCT00955409|536583919|FG000|Overall Study|Withdrawal by Subject|1|||
148757059|NCT00955409|536583920|FG001|Overall Study|Withdrawal by Subject|0|||
148757060|NCT00955409|536583921|FG002|Overall Study|Withdrawal by Subject|5|||
148757061|NCT00955409|536583922|FG003|Overall Study|Withdrawal by Subject|2|||
148757062|NCT00955409|536583923|FG004|Overall Study|Withdrawal by Subject|0|||
148757063|NCT00955409|536583924|FG005|Overall Study|Withdrawal by Subject|0|||
148757064|NCT00955409|536583925|FG006|Overall Study|Withdrawal by Subject|2|||
148757065|NCT00955409|536583926|FG007|Overall Study|Withdrawal by Subject|0|||
148757066|NCT00955409|536583927|FG008|Overall Study|Withdrawal by Subject|1|||
148757067|NCT00955409|536583928|FG009|Overall Study|Withdrawal by Subject|0|||
148757068|NCT00955409|536583919|FG000|Overall Study|Caregiver Request|2|||
148757069|NCT00955409|536583920|FG001|Overall Study|Caregiver Request|0|||
148757070|NCT00955409|536583921|FG002|Overall Study|Caregiver Request|6|||
148757071|NCT00955409|536583922|FG003|Overall Study|Caregiver Request|5|||
148757072|NCT00955409|536583923|FG004|Overall Study|Caregiver Request|0|||
148757073|NCT00955409|536583924|FG005|Overall Study|Caregiver Request|2|||
148757074|NCT00955409|536583925|FG006|Overall Study|Caregiver Request|3|||
148757075|NCT00955409|536583926|FG007|Overall Study|Caregiver Request|1|||
148757076|NCT00955409|536583927|FG008|Overall Study|Caregiver Request|3|||
148757077|NCT00955409|536583928|FG009|Overall Study|Caregiver Request|0|||
148757078|NCT00955409|536583919|FG000|Overall Study|Investigator Request|0|||
148757079|NCT00955409|536583920|FG001|Overall Study|Investigator Request|0|||
148757080|NCT00955409|536583921|FG002|Overall Study|Investigator Request|1|||
148757081|NCT00955409|536583922|FG003|Overall Study|Investigator Request|0|||
148757082|NCT00955409|536583923|FG004|Overall Study|Investigator Request|0|||
148757083|NCT00955409|536583924|FG005|Overall Study|Investigator Request|0|||
148757084|NCT00955409|536583925|FG006|Overall Study|Investigator Request|0|||
148757085|NCT00955409|536583926|FG007|Overall Study|Investigator Request|0|||
148757086|NCT00955409|536583927|FG008|Overall Study|Investigator Request|0|||
148757087|NCT00955409|536583928|FG009|Overall Study|Investigator Request|0|||
148757088|NCT00955409|536583919|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
148757089|NCT00955409|536583920|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
148757090|NCT00955409|536583921|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
148757091|NCT00955409|536583922|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
148757092|NCT00955409|536583923|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
148757093|NCT00955409|536583924|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
148757094|NCT00955409|536583925|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
148757095|NCT00955409|536583926|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
148757096|NCT00955409|536583927|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
148757097|NCT00955409|536583928|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
148757098|NCT00955409|536583919|FG000|Overall Study|Lost to Follow-up|0|||
148757099|NCT00955409|536583920|FG001|Overall Study|Lost to Follow-up|0|||
148757100|NCT00955409|536583921|FG002|Overall Study|Lost to Follow-up|1|||
148757101|NCT00955409|536583922|FG003|Overall Study|Lost to Follow-up|0|||
148757102|NCT00955409|536583923|FG004|Overall Study|Lost to Follow-up|0|||
148757103|NCT00955409|536583924|FG005|Overall Study|Lost to Follow-up|0|||
148757104|NCT00955409|536583925|FG006|Overall Study|Lost to Follow-up|1|||
148757105|NCT00955409|536583926|FG007|Overall Study|Lost to Follow-up|0|||
148757106|NCT00955409|536583927|FG008|Overall Study|Lost to Follow-up|0|||
148757107|NCT00955409|536583928|FG009|Overall Study|Lost to Follow-up|0|||
148757108|NCT00955409|536583919|FG000|Overall Study|Failed to Return|2|||
148757109|NCT00955409|536583920|FG001|Overall Study|Failed to Return|0|||
148757110|NCT00955409|536583921|FG002|Overall Study|Failed to Return|0|||
148757111|NCT00955409|536583922|FG003|Overall Study|Failed to Return|0|||
148757112|NCT00955409|536583923|FG004|Overall Study|Failed to Return|0|||
148757113|NCT00955409|536583924|FG005|Overall Study|Failed to Return|0|||
148757114|NCT00955409|536583925|FG006|Overall Study|Failed to Return|0|||
148757115|NCT00955409|536583926|FG007|Overall Study|Failed to Return|2|||
148757116|NCT00955409|536583927|FG008|Overall Study|Failed to Return|0|||
148757117|NCT00955409|536583928|FG009|Overall Study|Failed to Return|0|||
148757118|NCT00955409|536583919|FG000|Overall Study|Adverse Event (AE)|2|||
148757119|NCT00955409|536583920|FG001|Overall Study|Adverse Event (AE)|0|||
148976441|NCT04542070|537394543|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
148757120|NCT00955409|536583921|FG002|Overall Study|Adverse Event (AE)|0|||
148757121|NCT00955409|536583922|FG003|Overall Study|Adverse Event (AE)|0|||
148757122|NCT00955409|536583923|FG004|Overall Study|Adverse Event (AE)|0|||
148757123|NCT00955409|536583924|FG005|Overall Study|Adverse Event (AE)|1|||
148757124|NCT00955409|536583925|FG006|Overall Study|Adverse Event (AE)|2|||
148757125|NCT00955409|536583926|FG007|Overall Study|Adverse Event (AE)|0|||
148757126|NCT00955409|536583927|FG008|Overall Study|Adverse Event (AE)|2|||
148757127|NCT00955409|536583928|FG009|Overall Study|Adverse Event (AE)|0|||
148976442|NCT04542070|537394544|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
148757128|NCT00955409|536583919|FG000|Overall Study|Reason not Specified|2|||
148757129|NCT00955409|536583920|FG001|Overall Study|Reason not Specified|1|||
148757130|NCT00955409|536583921|FG002|Overall Study|Reason not Specified|13|||
148757131|NCT00955409|536583922|FG003|Overall Study|Reason not Specified|1|||
148757132|NCT00955409|536583923|FG004|Overall Study|Reason not Specified|2|||
148757133|NCT00955409|536583924|FG005|Overall Study|Reason not Specified|0|||
148757134|NCT00955409|536583925|FG006|Overall Study|Reason not Specified|16|||
148757135|NCT00955409|536583926|FG007|Overall Study|Reason not Specified|0|||
148757136|NCT00955409|536583927|FG008|Overall Study|Reason not Specified|8|||
148757137|NCT00955409|536583928|FG009|Overall Study|Reason not Specified|1|||
148757138|NCT00803790|536583929|FG000|Period 1|Adverse Event|0|||
148757139|NCT00803790|536583930|FG001|Period 1|Adverse Event|1|||
148757140|NCT00803790|536583931|FG002|Period 1|Adverse Event|0|||
148757141|NCT00803790|536583932|FG003|Period 1|Adverse Event|0|||
148757142|NCT00803790|536583929|FG000|Period 1|Lost to Follow-up|1|||
148757143|NCT00803790|536583930|FG001|Period 1|Lost to Follow-up|2|||
148757144|NCT00803790|536583931|FG002|Period 1|Lost to Follow-up|0|||
148757145|NCT00803790|536583932|FG003|Period 1|Lost to Follow-up|0|||
148757146|NCT00803790|536583929|FG000|Period 1|Withdrawal by Subject|8|||
148757147|NCT00803790|536583930|FG001|Period 1|Withdrawal by Subject|6|||
148757148|NCT00803790|536583931|FG002|Period 1|Withdrawal by Subject|0|||
148757149|NCT00803790|536583932|FG003|Period 1|Withdrawal by Subject|0|||
148757150|NCT00803790|536583929|FG000|Period 1|positive drug screen or personal reasons|0|||
148757151|NCT00803790|536583930|FG001|Period 1|positive drug screen or personal reasons|3|||
148757152|NCT00803790|536583931|FG002|Period 1|positive drug screen or personal reasons|0|||
148757153|NCT00803790|536583932|FG003|Period 1|positive drug screen or personal reasons|4|||
148757154|NCT00803790|536583929|FG000|Period 1|Protocol Violation|0|||
148757155|NCT00803790|536583930|FG001|Period 1|Protocol Violation|0|||
148757156|NCT00803790|536583931|FG002|Period 1|Protocol Violation|1|||
148757157|NCT00803790|536583932|FG003|Period 1|Protocol Violation|0|||
148757158|NCT00803790|536583929|FG000|Period 2|Adverse Event|0|||
148757159|NCT00803790|536583930|FG001|Period 2|Adverse Event|0|||
148757160|NCT00803790|536583931|FG002|Period 2|Adverse Event|1|||
148757161|NCT00803790|536583932|FG003|Period 2|Adverse Event|1|||
148757162|NCT00803790|536583929|FG000|Period 2|Withdrawal by Subject|1|||
148757163|NCT00803790|536583930|FG001|Period 2|Withdrawal by Subject|0|||
148757164|NCT00803790|536583931|FG002|Period 2|Withdrawal by Subject|0|||
148757165|NCT00803790|536583932|FG003|Period 2|Withdrawal by Subject|0|||
148757166|NCT00803790|536583929|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
148757167|NCT00803790|536583930|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
148757168|NCT00803790|536583931|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
148757169|NCT00803790|536583932|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
148757170|NCT04710576|536583933|FG000|Overall Study|Participants still in the study|73|||
148757171|NCT04710576|536583934|FG001|Overall Study|Participants still in the study|70|||
148757172|NCT04710576|536583935|FG002|Overall Study|Participants still in the study|60|||
148757173|NCT04710576|536583933|FG000|Overall Study|Death|2|||
148757174|NCT04710576|536583934|FG001|Overall Study|Death|7|||
148757175|NCT04710576|536583935|FG002|Overall Study|Death|12|||
148757176|NCT04710576|536583933|FG000|Overall Study|Withdrawal by Subject|4|||
148757177|NCT04710576|536583934|FG001|Overall Study|Withdrawal by Subject|3|||
148757178|NCT04710576|536583935|FG002|Overall Study|Withdrawal by Subject|7|||
148757179|NCT04710576|536583933|FG000|Overall Study|Sponsor decision|1|||
148757180|NCT04710576|536583934|FG001|Overall Study|Sponsor decision|0|||
148757181|NCT04710576|536583935|FG002|Overall Study|Sponsor decision|0|||
148757182|NCT02068508|536583938|FG000|Overall Study|Case report forms uncollected|27|||
148757183|NCT02068508|536583938|FG000|Overall Study|Patient did not visit the study site|1|||
148757184|NCT02068508|536583938|FG000|Overall Study|Protocol Violation|4|||
148757185|NCT00813150|536583939|FG000|Treatment Period|Adverse Event|16|||
148757186|NCT00813150|536583940|FG001|Treatment Period|Adverse Event|15|||
148757187|NCT00813150|536583939|FG000|Treatment Period|Death|2|||
148757188|NCT00813150|536583940|FG001|Treatment Period|Death|0|||
148757189|NCT00813150|536583939|FG000|Treatment Period|Progressive disease|1|||
148757190|NCT00813150|536583940|FG001|Treatment Period|Progressive disease|0|||
148757191|NCT00813150|536583939|FG000|Treatment Period|Complete response|0|||
148757192|NCT00813150|536583940|FG001|Treatment Period|Complete response|1|||
148757193|NCT00813150|536583939|FG000|Treatment Period|Stable disease|1|||
148757194|NCT00813150|536583940|FG001|Treatment Period|Stable disease|2|||
148757195|NCT00813150|536583939|FG000|Treatment Period|Protocol Violation|3|||
148757196|NCT00813150|536583940|FG001|Treatment Period|Protocol Violation|4|||
148757197|NCT00813150|536583939|FG000|Treatment Period|Withdrawal by Subject|5|||
148757198|NCT00813150|536583940|FG001|Treatment Period|Withdrawal by Subject|3|||
148757199|NCT00813150|536583939|FG000|Treatment Period|Non compliance|0|||
148757200|NCT00813150|536583940|FG001|Treatment Period|Non compliance|1|||
148757201|NCT00813150|536583939|FG000|Treatment Period|Reason not specified|3|||
148757202|NCT00813150|536583940|FG001|Treatment Period|Reason not specified|4|||
148757203|NCT00813150|536583939|FG000|Treatment Period|Data not available|1|||
148757204|NCT00813150|536583940|FG001|Treatment Period|Data not available|2|||
148757205|NCT00813150|536583939|FG000|Long Term Follow-up|Death|0|||
148823588|NCT01796470|536830832|FG003|Overall Study|Withdrawal by Subject|0|||
148823589|NCT01796470|536830833|FG004|Overall Study|Withdrawal by Subject|1|||
148823590|NCT00147537|536830834|FG000|Phase 1b|Death|0|||
148823591|NCT00147537|536830835|FG001|Phase 1b|Death|1|||
148823592|NCT00147537|536830836|FG002|Phase 1b|Death|2|||
148823593|NCT00147537|536830837|FG003|Phase 1b|Death|1|||
148823594|NCT00147537|536830838|FG004|Phase 1b|Death|2|||
148823595|NCT00147537|536830839|FG005|Phase 1b|Death|2|||
148823596|NCT00147537|536830840|FG006|Phase 1b|Death|1|||
148823597|NCT00147537|536830841|FG007|Phase 1b|Death|3|||
148823598|NCT00147537|536830842|FG008|Phase 1b|Death|9|||
148823599|NCT00147537|536830843|FG009|Phase 1b|Death|0|||
148823600|NCT00147537|536830844|FG010|Phase 1b|Death|0|||
148823601|NCT00147537|536830834|FG000|Phase 1b|Lost to Follow-up|2|||
148823602|NCT00147537|536830835|FG001|Phase 1b|Lost to Follow-up|1|||
148823603|NCT00147537|536830836|FG002|Phase 1b|Lost to Follow-up|0|||
148823604|NCT00147537|536830837|FG003|Phase 1b|Lost to Follow-up|0|||
148823605|NCT00147537|536830838|FG004|Phase 1b|Lost to Follow-up|0|||
148823606|NCT00147537|536830839|FG005|Phase 1b|Lost to Follow-up|0|||
148823607|NCT00147537|536830840|FG006|Phase 1b|Lost to Follow-up|2|||
148823608|NCT00147537|536830841|FG007|Phase 1b|Lost to Follow-up|0|||
148823609|NCT00147537|536830842|FG008|Phase 1b|Lost to Follow-up|1|||
148823610|NCT00147537|536830843|FG009|Phase 1b|Lost to Follow-up|0|||
148823611|NCT00147537|536830844|FG010|Phase 1b|Lost to Follow-up|0|||
148823612|NCT00147537|536830834|FG000|Phase 1b|Other|0|||
148823613|NCT00147537|536830835|FG001|Phase 1b|Other|0|||
148823614|NCT00147537|536830836|FG002|Phase 1b|Other|2|||
148823615|NCT00147537|536830837|FG003|Phase 1b|Other|1|||
148823616|NCT00147537|536830838|FG004|Phase 1b|Other|1|||
148823617|NCT00147537|536830839|FG005|Phase 1b|Other|1|||
148823618|NCT00147537|536830840|FG006|Phase 1b|Other|14|||
148823619|NCT00147537|536830841|FG007|Phase 1b|Other|4|||
148823620|NCT00147537|536830842|FG008|Phase 1b|Other|4|||
148757206|NCT00813150|536583940|FG001|Long Term Follow-up|Death|4|||
148757207|NCT00813150|536583939|FG000|Long Term Follow-up|Other|0|||
148757208|NCT00813150|536583940|FG001|Long Term Follow-up|Other|3|||
148757209|NCT00813150|536583939|FG000|Long Term Follow-up|Lost to Follow-up|2|||
148757210|NCT00813150|536583940|FG001|Long Term Follow-up|Lost to Follow-up|0|||
148757211|NCT00813150|536583939|FG000|Long Term Follow-up|Progression/Relapse|22|||
148757212|NCT00813150|536583940|FG001|Long Term Follow-up|Progression/Relapse|24|||
148757213|NCT05423093|536583948|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
148757214|NCT05423093|536583948|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
148757215|NCT05423093|536583948|FG000|Attended Intervention Session|Lost to Follow-up|3|||
148757216|NCT05423093|536583948|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
148757217|NCT05423093|536583948|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
148757218|NCT03593525|536583949|FG000|Overall Study|Withdrawal by Subject|1|||
148757219|NCT03593525|536583950|FG001|Overall Study|Withdrawal by Subject|0|||
148757220|NCT03593525|536583949|FG000|Overall Study|Lost to Follow-up|7|||
148757221|NCT03593525|536583950|FG001|Overall Study|Lost to Follow-up|5|||
148757222|NCT02445248|536583958|FG000|Overall Study|Death|45|||
148757223|NCT02445248|536583959|FG001|Overall Study|Death|12|||
148757224|NCT02445248|536583958|FG000|Overall Study|Progressive disease|13|||
148757225|NCT02445248|536583959|FG001|Overall Study|Progressive disease|1|||
148757226|NCT02445248|536583958|FG000|Overall Study|Subject decision|8|||
148757227|NCT02445248|536583959|FG001|Overall Study|Subject decision|0|||
148757228|NCT02445248|536583958|FG000|Overall Study|Physician Decision|5|||
148757229|NCT02445248|536583959|FG001|Overall Study|Physician Decision|0|||
148757230|NCT02445248|536583958|FG000|Overall Study|Adverse Event|1|||
148757231|NCT02445248|536583959|FG001|Overall Study|Adverse Event|0|||
148757232|NCT02445248|536583958|FG000|Overall Study|Lost to Follow-up|1|||
148823621|NCT00147537|536830843|FG009|Phase 1b|Other|0|||
148823622|NCT00147537|536830844|FG010|Phase 1b|Other|0|||
148823623|NCT00147537|536830834|FG000|Phase 1b|Withdrawal by Subject|0|||
148757233|NCT02445248|536583959|FG001|Overall Study|Lost to Follow-up|0|||
148757234|NCT01217112|536583960|FG000|Overall Study|Adverse Event|0|||
148757235|NCT01217112|536583961|FG001|Overall Study|Adverse Event|2|||
148757236|NCT01217112|536583962|FG002|Overall Study|Adverse Event|0|||
148757237|NCT01217112|536583963|FG003|Overall Study|Adverse Event|2|||
148757238|NCT01217112|536583964|FG004|Overall Study|Adverse Event|0|||
148823624|NCT00147537|536830835|FG001|Phase 1b|Withdrawal by Subject|0|||
148823625|NCT00147537|536830836|FG002|Phase 1b|Withdrawal by Subject|0|||
148823626|NCT00147537|536830837|FG003|Phase 1b|Withdrawal by Subject|0|||
148823627|NCT00147537|536830838|FG004|Phase 1b|Withdrawal by Subject|0|||
148823628|NCT00147537|536830839|FG005|Phase 1b|Withdrawal by Subject|0|||
148823629|NCT00147537|536830840|FG006|Phase 1b|Withdrawal by Subject|0|||
148823630|NCT00147537|536830841|FG007|Phase 1b|Withdrawal by Subject|0|||
148823631|NCT00147537|536830842|FG008|Phase 1b|Withdrawal by Subject|2|||
148823632|NCT00147537|536830843|FG009|Phase 1b|Withdrawal by Subject|0|||
148823633|NCT00147537|536830844|FG010|Phase 1b|Withdrawal by Subject|0|||
148823634|NCT00147537|536830834|FG000|Phase 1b|Randomized but not treated|0|||
148823635|NCT00147537|536830835|FG001|Phase 1b|Randomized but not treated|0|||
148823636|NCT00147537|536830836|FG002|Phase 1b|Randomized but not treated|0|||
148823637|NCT00147537|536830837|FG003|Phase 1b|Randomized but not treated|0|||
148823638|NCT00147537|536830838|FG004|Phase 1b|Randomized but not treated|0|||
148823639|NCT00147537|536830839|FG005|Phase 1b|Randomized but not treated|0|||
148757239|NCT01217112|536583960|FG000|Overall Study|Withdrawal by Subject|0|||
148757240|NCT01217112|536583961|FG001|Overall Study|Withdrawal by Subject|0|||
148757241|NCT01217112|536583962|FG002|Overall Study|Withdrawal by Subject|1|||
148757242|NCT01217112|536583963|FG003|Overall Study|Withdrawal by Subject|0|||
148757243|NCT01217112|536583964|FG004|Overall Study|Withdrawal by Subject|0|||
148757244|NCT01217112|536583960|FG000|Overall Study|Physician Decision|0|||
148757245|NCT01217112|536583961|FG001|Overall Study|Physician Decision|0|||
148757246|NCT01217112|536583962|FG002|Overall Study|Physician Decision|0|||
148757247|NCT01217112|536583963|FG003|Overall Study|Physician Decision|0|||
148757248|NCT01217112|536583964|FG004|Overall Study|Physician Decision|1|||
148757249|NCT02596971|536583965|FG000|Overall Study|Death|5|||
148757250|NCT02596971|536583966|FG001|Overall Study|Death|1|||
148757251|NCT02596971|536583967|FG002|Overall Study|Death|5|||
148757252|NCT02596971|536583965|FG000|Overall Study|Withdrawal by Subject|5|||
148757253|NCT02596971|536583966|FG001|Overall Study|Withdrawal by Subject|1|||
148757254|NCT02596971|536583967|FG002|Overall Study|Withdrawal by Subject|4|||
148757255|NCT01401361|536583970|FG000|Overall Study|Withdrawal by Subject|16|||
148757256|NCT01401361|536583970|FG000|Overall Study|Lack of Efficacy|6|||
148757257|NCT01401361|536583970|FG000|Overall Study|Physician Decision|1|||
148757258|NCT01401361|536583970|FG000|Overall Study|Lost to Follow-up|3|||
148757259|NCT01401361|536583970|FG000|Overall Study|Subject/family decision post procedure|2|||
148757260|NCT00595920|536583973|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
148757261|NCT00351468|536583974|FG000|Overall Study|Adverse Event|42|||
148757262|NCT00351468|536583974|FG000|Overall Study|Withdrawal by Subject|39|||
148757263|NCT00351468|536583974|FG000|Overall Study|Various -follow up w clinical team|39|||
148757264|NCT00351468|536583974|FG000|Overall Study|Lack of Efficacy|32|||
148757265|NCT00351468|536583974|FG000|Overall Study|Non-compliance|8|||
148757266|NCT00351468|536583974|FG000|Overall Study|Lost to Follow-up|4|||
148757267|NCT00351468|536583974|FG000|Overall Study|Protocol Violation|3|||
148757268|NCT00611923|536583975|FG000|Overall Study|Withdrawal by Subject|2|||
148757269|NCT00611923|536583976|FG001|Overall Study|Withdrawal by Subject|2|||
148757270|NCT04565145|536583977|FG000|Overall Study|Withdrawal by Subject|1|||
148757271|NCT04565145|536583978|FG001|Overall Study|Withdrawal by Subject|1|||
148757272|NCT03096314|536583979|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
148757273|NCT03096314|536583980|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
148757274|NCT00471822|536583981|FG000|Overall Study|Protocol Violation|2|||
148757275|NCT02764762|536583982|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
148757276|NCT02764762|536583982|FG000|Overall Study|Lost to Follow-up|4|||
148757277|NCT02764762|536583982|FG000|Overall Study|Voluntary Withdrawal|8|||
148757278|NCT02764762|536583982|FG000|Overall Study|Site Termination|1|||
148757279|NCT02764762|536583982|FG000|Overall Study|Lack of Efficacy|16|||
148757280|NCT02764762|536583982|FG000|Overall Study|Reason not Specified|1|||
148757281|NCT03318861|536583986|FG000|Overall Study|Death|2|||
148757282|NCT03318861|536583987|FG001|Overall Study|Death|3|||
148757283|NCT03318861|536583988|FG002|Overall Study|Death|3|||
148757284|NCT03318861|536583989|FG003|Overall Study|Death|2|||
148757285|NCT03318861|536583990|FG004|Overall Study|Death|2|||
148757286|NCT03318861|536583986|FG000|Overall Study|Enrolled But Never Treated|0|||
148757287|NCT03318861|536583987|FG001|Overall Study|Enrolled But Never Treated|1|||
148757288|NCT03318861|536583988|FG002|Overall Study|Enrolled But Never Treated|0|||
148757289|NCT03318861|536583989|FG003|Overall Study|Enrolled But Never Treated|1|||
148757290|NCT03318861|536583990|FG004|Overall Study|Enrolled But Never Treated|1|||
148757291|NCT03318861|536583986|FG000|Overall Study|Informed Consent Withdraw|0|||
148757292|NCT03318861|536583987|FG001|Overall Study|Informed Consent Withdraw|0|||
148757293|NCT03318861|536583988|FG002|Overall Study|Informed Consent Withdraw|0|||
148757294|NCT03318861|536583989|FG003|Overall Study|Informed Consent Withdraw|1|||
148757295|NCT03318861|536583990|FG004|Overall Study|Informed Consent Withdraw|0|||
148757296|NCT03318861|536583986|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
148757297|NCT03318861|536583987|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
148757298|NCT03318861|536583988|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
148757299|NCT03318861|536583989|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
148757300|NCT03318861|536583990|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
148757301|NCT00917852|536583991|FG000|Overall Study|Death|6|||
148757302|NCT00471081|536583992|FG000|Active Phase|Protocol Violation|1|||
148757303|NCT00471081|536583993|FG001|Active Phase|Protocol Violation|1|||
148757304|NCT00471081|536583992|FG000|Active Phase|Withdrawal by Subject|0|||
148823640|NCT00147537|536830840|FG006|Phase 1b|Randomized but not treated|1|||
149027446|NCT01004263|537578563|FG000|Overall Study|Lost to Follow-up|64|||
148823641|NCT00147537|536830841|FG007|Phase 1b|Randomized but not treated|0|||
148823642|NCT00147537|536830842|FG008|Phase 1b|Randomized but not treated|1|||
148757305|NCT00471081|536583993|FG001|Active Phase|Withdrawal by Subject|3|||
148757306|NCT00471081|536583992|FG000|Active Phase|Lost to Follow-up|0|||
148757307|NCT00471081|536583993|FG001|Active Phase|Lost to Follow-up|1|||
148757308|NCT00471081|536583992|FG000|Active Phase|Lost health plan/insurance|1|||
148757309|NCT00471081|536583993|FG001|Active Phase|Lost health plan/insurance|8|||
148757310|NCT00471081|536583992|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
148757311|NCT00471081|536583993|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
148757312|NCT00471081|536583992|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
148757313|NCT00471081|536583993|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
148757314|NCT00471081|536583992|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
148757315|NCT00471081|536583993|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
148757316|NCT05486091|536583994|FG000|Overall Study|Withdrawal by Subject|1|||
148757317|NCT05486091|536583994|FG000|Overall Study|Lost to Follow-up|2|||
148757318|NCT00957801|536583995|FG000|Overall Study|Withdrawal by Subject|0|||
148757319|NCT00957801|536583996|FG001|Overall Study|Withdrawal by Subject|0|||
148757320|NCT00957801|536583997|FG002|Overall Study|Withdrawal by Subject|0|||
148757321|NCT00957801|536583998|FG003|Overall Study|Withdrawal by Subject|1|||
148757322|NCT02626026|536584002|FG000|Overall Study|Randomized but Never Treated|0|||
148757323|NCT02626026|536584003|FG001|Overall Study|Randomized but Never Treated|0|||
148757324|NCT02626026|536584004|FG002|Overall Study|Randomized but Never Treated|0|||
148757325|NCT02626026|536584005|FG003|Overall Study|Randomized but Never Treated|0|||
148757326|NCT02626026|536584006|FG004|Overall Study|Randomized but Never Treated|1|||
148757327|NCT02626026|536584007|FG005|Overall Study|Randomized but Never Treated|0|||
148757328|NCT01592786|536584008|FG000|Overall Study|Adverse Event|60|||
148757329|NCT01592786|536584008|FG000|Overall Study|Lack of Efficacy|19|||
148757330|NCT01592786|536584008|FG000|Overall Study|Protocol Violation|14|||
148757331|NCT01592786|536584008|FG000|Overall Study|Withdrawal by Subject|23|||
148757332|NCT01592786|536584008|FG000|Overall Study|Lost to Follow-up|19|||
148757333|NCT01592786|536584008|FG000|Overall Study|Other|3|||
148757334|NCT01909934|536584009|FG000|Overall Study|Withdrawal by Subject|3|||
148757335|NCT01909934|536584009|FG000|Overall Study|Lost to Follow-up|1|||
148757336|NCT01909934|536584009|FG000|Overall Study|Death|25|||
148757337|NCT01909934|536584009|FG000|Overall Study|Withdrawal of Informed Consent|1|||
148757338|NCT01909934|536584009|FG000|Overall Study|Reason Not Specified|1|||
148757339|NCT03810092|536584010|FG000|Overall Study|no ground support|17|||
148757340|NCT03810092|536584010|FG000|Overall Study|ADL not done at J0|16|||
148757341|NCT03810092|536584010|FG000|Overall Study|No hemoglobin measure at J5|27|||
148757342|NCT04578535|536584012|FG000|Overall Study|Lost to Follow-up|1|||
148757343|NCT04578535|536584013|FG001|Overall Study|Lost to Follow-up|0|||
148757344|NCT04578535|536584014|FG002|Overall Study|Lost to Follow-up|0|||
148757345|NCT04578535|536584015|FG003|Overall Study|Lost to Follow-up|1|||
148757346|NCT04578535|536584016|FG004|Overall Study|Lost to Follow-up|0|||
148757347|NCT04578535|536584017|FG005|Overall Study|Lost to Follow-up|2|||
148757348|NCT04578535|536584012|FG000|Overall Study|Pregnancy|1|||
148757349|NCT04578535|536584013|FG001|Overall Study|Pregnancy|0|||
148757350|NCT04578535|536584014|FG002|Overall Study|Pregnancy|0|||
148757351|NCT04578535|536584015|FG003|Overall Study|Pregnancy|0|||
148757352|NCT04578535|536584016|FG004|Overall Study|Pregnancy|0|||
148757353|NCT04578535|536584017|FG005|Overall Study|Pregnancy|0|||
148757354|NCT04578535|536584012|FG000|Overall Study|Withdrawal by Subject|0|||
148757355|NCT04578535|536584013|FG001|Overall Study|Withdrawal by Subject|0|||
148757356|NCT04578535|536584014|FG002|Overall Study|Withdrawal by Subject|0|||
148757357|NCT04578535|536584015|FG003|Overall Study|Withdrawal by Subject|1|||
148757358|NCT04578535|536584016|FG004|Overall Study|Withdrawal by Subject|1|||
148757359|NCT04578535|536584017|FG005|Overall Study|Withdrawal by Subject|5|||
148757360|NCT04578535|536584012|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
148757361|NCT04578535|536584013|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
148757362|NCT04578535|536584014|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
148757363|NCT04578535|536584015|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
148757364|NCT04578535|536584016|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
148757365|NCT04578535|536584017|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
148757366|NCT00235755|536584018|FG000|4-Week Titration Phase|Adverse Event|6|||
148757367|NCT00235755|536584019|FG001|4-Week Titration Phase|Adverse Event|14|||
148757368|NCT00235755|536584020|FG002|4-Week Titration Phase|Adverse Event|20|||
148757369|NCT00235755|536584018|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
148757370|NCT00235755|536584019|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
148757371|NCT00235755|536584020|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
148757372|NCT00235755|536584018|FG000|4-Week Titration Phase|Protocol Violation|2|||
148757373|NCT00235755|536584019|FG001|4-Week Titration Phase|Protocol Violation|2|||
149027447|NCT01004263|537578563|FG000|Overall Study|Lack of Efficacy|13|||
149027448|NCT01004263|537578563|FG000|Overall Study|Pregnancy|2|||
148757374|NCT00235755|536584020|FG002|4-Week Titration Phase|Protocol Violation|1|||
148757375|NCT00235755|536584018|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
148757376|NCT00235755|536584019|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
148757377|NCT00235755|536584020|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
149027449|NCT01004263|537578563|FG000|Overall Study|Physician Decision|15|||
148757378|NCT00235755|536584018|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
148757379|NCT00235755|536584019|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
149027450|NCT01004263|537578563|FG000|Overall Study|Lack of Qualifying Event|2|||
148823643|NCT00147537|536830843|FG009|Phase 1b|Randomized but not treated|0|||
148823644|NCT00147537|536830844|FG010|Phase 1b|Randomized but not treated|0|||
148823645|NCT00147537|536830834|FG000|Phase 2|Death|0|||
148823646|NCT00147537|536830835|FG001|Phase 2|Death|0|||
148823647|NCT00147537|536830836|FG002|Phase 2|Death|0|||
148823648|NCT00147537|536830837|FG003|Phase 2|Death|0|||
148823649|NCT00147537|536830838|FG004|Phase 2|Death|0|||
148823650|NCT00147537|536830839|FG005|Phase 2|Death|0|||
148823651|NCT00147537|536830840|FG006|Phase 2|Death|0|||
148823652|NCT00147537|536830841|FG007|Phase 2|Death|0|||
148823653|NCT00147537|536830842|FG008|Phase 2|Death|0|||
148823654|NCT00147537|536830843|FG009|Phase 2|Death|85|||
148823655|NCT00147537|536830844|FG010|Phase 2|Death|31|||
148823656|NCT00147537|536830834|FG000|Phase 2|Lost to Follow-up|0|||
148823657|NCT00147537|536830835|FG001|Phase 2|Lost to Follow-up|0|||
148823658|NCT00147537|536830836|FG002|Phase 2|Lost to Follow-up|0|||
148823659|NCT00147537|536830837|FG003|Phase 2|Lost to Follow-up|0|||
148823660|NCT00147537|536830838|FG004|Phase 2|Lost to Follow-up|0|||
148823661|NCT00147537|536830839|FG005|Phase 2|Lost to Follow-up|0|||
148823662|NCT00147537|536830840|FG006|Phase 2|Lost to Follow-up|0|||
148823663|NCT00147537|536830841|FG007|Phase 2|Lost to Follow-up|0|||
148823664|NCT00147537|536830842|FG008|Phase 2|Lost to Follow-up|0|||
148823665|NCT00147537|536830843|FG009|Phase 2|Lost to Follow-up|12|||
148823666|NCT00147537|536830844|FG010|Phase 2|Lost to Follow-up|4|||
148823667|NCT00147537|536830834|FG000|Phase 2|Other|0|||
148823668|NCT00147537|536830835|FG001|Phase 2|Other|0|||
148823669|NCT00147537|536830836|FG002|Phase 2|Other|0|||
148823670|NCT00147537|536830837|FG003|Phase 2|Other|0|||
148823671|NCT00147537|536830838|FG004|Phase 2|Other|0|||
148823672|NCT00147537|536830839|FG005|Phase 2|Other|0|||
148823673|NCT00147537|536830840|FG006|Phase 2|Other|0|||
148823674|NCT00147537|536830841|FG007|Phase 2|Other|0|||
148823675|NCT00147537|536830842|FG008|Phase 2|Other|0|||
148823676|NCT00147537|536830843|FG009|Phase 2|Other|47|||
148823677|NCT00147537|536830844|FG010|Phase 2|Other|12|||
148823678|NCT00147537|536830834|FG000|Phase 2|Withdrawal by Subject|0|||
148823679|NCT00147537|536830835|FG001|Phase 2|Withdrawal by Subject|0|||
148823680|NCT00147537|536830836|FG002|Phase 2|Withdrawal by Subject|0|||
148823681|NCT00147537|536830837|FG003|Phase 2|Withdrawal by Subject|0|||
148823682|NCT00147537|536830838|FG004|Phase 2|Withdrawal by Subject|0|||
148823683|NCT00147537|536830839|FG005|Phase 2|Withdrawal by Subject|0|||
148823684|NCT00147537|536830840|FG006|Phase 2|Withdrawal by Subject|0|||
148823685|NCT00147537|536830841|FG007|Phase 2|Withdrawal by Subject|0|||
148823686|NCT00147537|536830842|FG008|Phase 2|Withdrawal by Subject|0|||
148823687|NCT00147537|536830843|FG009|Phase 2|Withdrawal by Subject|16|||
148823688|NCT00147537|536830844|FG010|Phase 2|Withdrawal by Subject|4|||
148823689|NCT00147537|536830834|FG000|Phase 2|Randomized but not treated|0|||
148757380|NCT00235755|536584020|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
148757381|NCT00235755|536584018|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
148757382|NCT00235755|536584019|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
148757383|NCT00235755|536584020|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
148757384|NCT00235755|536584018|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
148757385|NCT00235755|536584019|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
148757386|NCT00235755|536584020|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
148757387|NCT00235755|536584018|FG000|12-Week Maintenance Phase|Adverse Event|8|||
148757388|NCT00235755|536584019|FG001|12-Week Maintenance Phase|Adverse Event|12|||
148757389|NCT00235755|536584020|FG002|12-Week Maintenance Phase|Adverse Event|26|||
148757390|NCT00235755|536584018|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
148757391|NCT00235755|536584019|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
148757392|NCT00235755|536584020|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
148823690|NCT00147537|536830835|FG001|Phase 2|Randomized but not treated|0|||
148823691|NCT00147537|536830836|FG002|Phase 2|Randomized but not treated|0|||
148823692|NCT00147537|536830837|FG003|Phase 2|Randomized but not treated|0|||
148823693|NCT00147537|536830838|FG004|Phase 2|Randomized but not treated|0|||
148823694|NCT00147537|536830839|FG005|Phase 2|Randomized but not treated|0|||
148823695|NCT00147537|536830840|FG006|Phase 2|Randomized but not treated|0|||
148823696|NCT00147537|536830841|FG007|Phase 2|Randomized but not treated|0|||
148823697|NCT00147537|536830842|FG008|Phase 2|Randomized but not treated|0|||
148823698|NCT00147537|536830843|FG009|Phase 2|Randomized but not treated|1|||
148823699|NCT00147537|536830844|FG010|Phase 2|Randomized but not treated|1|||
148823700|NCT01927861|536830845|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
148823701|NCT01927861|536830846|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
148823702|NCT01927861|536830845|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
148823703|NCT01927861|536830846|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
148823704|NCT00468546|536830848|FG000|Week 24 Analysis|Lack of Efficacy|83|||
148823705|NCT00468546|536830849|FG001|Week 24 Analysis|Lack of Efficacy|37|||
148823706|NCT00468546|536830848|FG000|Week 24 Analysis|Refused treatment|5|||
148823707|NCT00468546|536830849|FG001|Week 24 Analysis|Refused treatment|5|||
148823708|NCT00468546|536830848|FG000|Week 24 Analysis|Adverse Event|1|||
148823709|NCT00468546|536830849|FG001|Week 24 Analysis|Adverse Event|8|||
148823710|NCT00468546|536830848|FG000|Week 24 Analysis|Failure to return|3|||
148823711|NCT00468546|536830849|FG001|Week 24 Analysis|Failure to return|4|||
148823712|NCT00468546|536830848|FG000|Week 24 Analysis|Rescue therapy|2|||
148823713|NCT00468546|536830849|FG001|Week 24 Analysis|Rescue therapy|0|||
148823714|NCT00468546|536830848|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
148823715|NCT00468546|536830849|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
148823716|NCT00468546|536830848|FG000|Week 24 Analysis|Due to clinical hold|1|||
148823717|NCT00468546|536830849|FG001|Week 24 Analysis|Due to clinical hold|0|||
148823718|NCT00468546|536830848|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
148823719|NCT00468546|536830849|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
148823720|NCT00468546|536830848|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
148823721|NCT00468546|536830849|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
148823722|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
148823723|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
148823724|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Death|1|||
148823725|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Death|0|||
148823726|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
148823727|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
148823728|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
148823729|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
148823730|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
148823731|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
148823732|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
148823733|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
148823734|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
148823735|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
148823736|NCT00468546|536830848|FG000|Week 24 to Week 104 Analysis|Other|17|||
148823737|NCT00468546|536830849|FG001|Week 24 to Week 104 Analysis|Other|14|||
148823738|NCT00472641|536830850|FG000|Overall Study|Lack of Efficacy|3|||
148823739|NCT00472641|536830850|FG000|Overall Study|Adverse Event|3|||
148823740|NCT00472641|536830850|FG000|Overall Study|Lost to Follow-up|1|||
148823741|NCT02006654|536830851|FG000|Overall Study|Withdrawal before treatment|4|||
148757393|NCT00235755|536584018|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
148757394|NCT00235755|536584019|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
148757395|NCT00235755|536584020|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
148757396|NCT00235755|536584018|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
148757397|NCT00235755|536584019|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
148757398|NCT00235755|536584020|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
148757399|NCT00235755|536584018|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
148757400|NCT00235755|536584019|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
148757401|NCT00235755|536584020|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
148757402|NCT00235755|536584018|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
148757403|NCT00235755|536584019|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
148757404|NCT00235755|536584020|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
148757405|NCT03839628|536584021|FG000|Overall Study|Withdrawal by Subject|1|||
148757406|NCT00991887|536584023|FG000|Overall Study|Lost to Follow-up|2|||
148757407|NCT00991887|536584024|FG001|Overall Study|Lost to Follow-up|1|||
148757408|NCT02387840|536584025|FG000|Overall Study|Death|0|||
148757409|NCT02387840|536584026|FG001|Overall Study|Death|0|||
148757410|NCT02387840|536584027|FG002|Overall Study|Death|0|||
148757411|NCT02387840|536584028|FG003|Overall Study|Death|0|||
148757412|NCT02387840|536584029|FG004|Overall Study|Death|0|||
148757413|NCT02387840|536584030|FG005|Overall Study|Death|1|||
148757414|NCT03170544|536584031|FG000|Part 1|Lost to Follow-up|1|||
148757415|NCT03170544|536584032|FG001|Part 1|Lost to Follow-up|0|||
148757416|NCT03170544|536584033|FG002|Part 1|Lost to Follow-up|0|||
148823742|NCT02006654|536830852|FG001|Overall Study|Withdrawal before treatment|2|||
148823743|NCT02006654|536830851|FG000|Overall Study|Adverse Event|16|||
148823744|NCT02006654|536830852|FG001|Overall Study|Adverse Event|17|||
148823745|NCT02006654|536830851|FG000|Overall Study|Death|1|||
148823746|NCT02006654|536830852|FG001|Overall Study|Death|0|||
148823747|NCT02006654|536830851|FG000|Overall Study|Withdrawal by Subject|14|||
148823748|NCT02006654|536830852|FG001|Overall Study|Withdrawal by Subject|12|||
148823749|NCT02006654|536830851|FG000|Overall Study|Protocol Violation|5|||
148757417|NCT03170544|536584034|FG003|Part 1|Lost to Follow-up|0|||
148757418|NCT03170544|536584035|FG004|Part 1|Lost to Follow-up|0|||
148757419|NCT03170544|536584036|FG005|Part 1|Lost to Follow-up|0|||
148757420|NCT03170544|536584037|FG006|Part 1|Lost to Follow-up|0|||
148757421|NCT03170544|536584038|FG007|Part 1|Lost to Follow-up|0|||
148823750|NCT02006654|536830852|FG001|Overall Study|Protocol Violation|8|||
148823751|NCT02006654|536830851|FG000|Overall Study|Lost to Follow-up|1|||
148823752|NCT02006654|536830852|FG001|Overall Study|Lost to Follow-up|0|||
148757422|NCT03170544|536584039|FG008|Part 1|Lost to Follow-up|0|||
148823753|NCT02006654|536830851|FG000|Overall Study|patient's will|2|||
148823754|NCT02006654|536830852|FG001|Overall Study|patient's will|1|||
148823755|NCT02006654|536830851|FG000|Overall Study|insufficient compliance|1|||
148757423|NCT03170544|536584040|FG009|Part 1|Lost to Follow-up|0|||
148757424|NCT03170544|536584041|FG010|Part 1|Lost to Follow-up|0|||
148757425|NCT03170544|536584042|FG011|Part 1|Lost to Follow-up|0|||
148757426|NCT03170544|536584031|FG000|Part 1|Not treated|0|||
148757427|NCT03170544|536584032|FG001|Part 1|Not treated|0|||
148757428|NCT03170544|536584033|FG002|Part 1|Not treated|0|||
148757429|NCT03170544|536584034|FG003|Part 1|Not treated|1|||
148757430|NCT03170544|536584035|FG004|Part 1|Not treated|0|||
148757431|NCT03170544|536584036|FG005|Part 1|Not treated|0|||
148757432|NCT03170544|536584037|FG006|Part 1|Not treated|0|||
148757433|NCT03170544|536584038|FG007|Part 1|Not treated|0|||
148757434|NCT03170544|536584039|FG008|Part 1|Not treated|0|||
148757435|NCT03170544|536584040|FG009|Part 1|Not treated|0|||
148757436|NCT03170544|536584041|FG010|Part 1|Not treated|0|||
148757437|NCT03170544|536584042|FG011|Part 1|Not treated|0|||
148757438|NCT03539302|536584049|FG000|Overall Study|Spontaneous cardio version|0|||
148757439|NCT03539302|536584050|FG001|Overall Study|Spontaneous cardio version|0|||
148757440|NCT03539302|536584051|FG002|Overall Study|Spontaneous cardio version|0|||
148757441|NCT03539302|536584052|FG003|Overall Study|Spontaneous cardio version|0|||
148757442|NCT03539302|536584053|FG004|Overall Study|Spontaneous cardio version|0|||
148757443|NCT03539302|536584054|FG005|Overall Study|Spontaneous cardio version|1|||
148757444|NCT03539302|536584055|FG006|Overall Study|Spontaneous cardio version|1|||
148757445|NCT02107131|536584062|FG000|Overall Study|Lost to Follow-up|4|||
148757446|NCT02107131|536584063|FG001|Overall Study|Lost to Follow-up|4|||
148757447|NCT02107131|536584062|FG000|Overall Study|Physician Decision|1|||
148757448|NCT02107131|536584063|FG001|Overall Study|Physician Decision|0|||
148757449|NCT02107131|536584062|FG000|Overall Study|Withdrawal by Subject|2|||
148757450|NCT02107131|536584063|FG001|Overall Study|Withdrawal by Subject|0|||
148757451|NCT02107131|536584062|FG000|Overall Study|mental instability|1|||
148757452|NCT02107131|536584063|FG001|Overall Study|mental instability|0|||
148757453|NCT02107131|536584062|FG000|Overall Study|Death|0|||
148757454|NCT02107131|536584063|FG001|Overall Study|Death|1|||
148757455|NCT02107131|536584062|FG000|Overall Study|Protocol Violation|0|||
148757456|NCT02107131|536584063|FG001|Overall Study|Protocol Violation|4|||
148757457|NCT02362360|536584071|FG000|Period 1|Lack of Efficacy|1|||
148757458|NCT02362360|536584072|FG001|Period 1|Lack of Efficacy|0|||
148757459|NCT02362360|536584071|FG000|Period 1|Withdrawal by Subject|2|||
148757460|NCT02362360|536584072|FG001|Period 1|Withdrawal by Subject|1|||
148757461|NCT00868530|536584073|FG000|Overall Study|Adverse Event|3|||
148757462|NCT00868530|536584073|FG000|Overall Study|Lost to Follow-up|1|||
148757463|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Adverse Event|7|||
148757464|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
148757465|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Non-compliance|3|||
148757466|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Other|17|||
148757467|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Physician Decision|2|||
148757468|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Pregnancy|1|||
148757469|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
148757470|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
148757471|NCT05207865|536585807|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
148757472|NCT05207865|536585807|FG000|Follow-up Phase|Lost to Follow-up|1|||
148757473|NCT05207865|536585807|FG000|Follow-up Phase|Non-compliance|1|||
148757474|NCT05207865|536585807|FG000|Follow-up Phase|Not reported|2|||
148757475|NCT05207865|536585807|FG000|Follow-up Phase|Not collected|11|||
148757476|NCT01415518|536585808|FG000|Overall Study|Withdrawal by Subject|2|||
148757477|NCT01415518|536585809|FG001|Overall Study|Withdrawal by Subject|12|||
148757478|NCT01415518|536585808|FG000|Overall Study|Protocol Violation|6|||
148757479|NCT01415518|536585809|FG001|Overall Study|Protocol Violation|8|||
148757480|NCT01415518|536585808|FG000|Overall Study|Lost to Follow-up|3|||
148757481|NCT01415518|536585809|FG001|Overall Study|Lost to Follow-up|5|||
148757482|NCT01415518|536585808|FG000|Overall Study|Adverse Event|3|||
148757483|NCT01415518|536585809|FG001|Overall Study|Adverse Event|4|||
148757484|NCT01415518|536585808|FG000|Overall Study|Death|1|||
148757485|NCT01415518|536585809|FG001|Overall Study|Death|1|||
148757486|NCT01415518|536585808|FG000|Overall Study|Condition under Investigation Worsened|1|||
148757487|NCT01415518|536585809|FG001|Overall Study|Condition under Investigation Worsened|1|||
148757488|NCT04570670|536585811|FG000|Overall Study|Withdrawal by Subject|1|||
148757489|NCT04570670|536585812|FG001|Overall Study|Withdrawal by Subject|0|||
148757490|NCT02844933|536585813|FG000|Overall Study|Discontinued due to premature termination of study|3|||
148757491|NCT02844933|536585814|FG001|Overall Study|Discontinued due to premature termination of study|2|||
148757492|NCT01479465|536585815|FG000|Overall Study|Disease Progression|9|||
148757493|NCT01479465|536585816|FG001|Overall Study|Disease Progression|61|||
148757494|NCT01479465|536585817|FG002|Overall Study|Disease Progression|65|||
148757495|NCT01479465|536585818|FG003|Overall Study|Disease Progression|70|||
148757496|NCT01479465|536585815|FG000|Overall Study|Study Discontinued by Sponsor|0|||
148757497|NCT01479465|536585816|FG001|Overall Study|Study Discontinued by Sponsor|7|||
148757498|NCT01479465|536585817|FG002|Overall Study|Study Discontinued by Sponsor|5|||
148757499|NCT01479465|536585818|FG003|Overall Study|Study Discontinued by Sponsor|3|||
148757500|NCT01479465|536585815|FG000|Overall Study|Adverse Event|0|||
148823756|NCT02006654|536830852|FG001|Overall Study|insufficient compliance|0|||
148823757|NCT02006654|536830851|FG000|Overall Study|worsening cognitive condition|0|||
148823758|NCT02006654|536830852|FG001|Overall Study|worsening cognitive condition|1|||
148823759|NCT02006654|536830851|FG000|Overall Study|faecal incontinence|0|||
148823760|NCT02006654|536830852|FG001|Overall Study|faecal incontinence|1|||
148823761|NCT02006654|536830851|FG000|Overall Study|mood disorder|0|||
148823762|NCT02006654|536830852|FG001|Overall Study|mood disorder|1|||
148823763|NCT02006654|536830851|FG000|Overall Study|disallowed medication|1|||
148823764|NCT02006654|536830852|FG001|Overall Study|disallowed medication|0|||
148823765|NCT02006654|536830851|FG000|Overall Study|moving out of state|0|||
148823766|NCT02006654|536830852|FG001|Overall Study|moving out of state|1|||
148823767|NCT02991859|536830855|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823768|NCT02991859|536830856|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
148823769|NCT02991859|536830857|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823770|NCT02991859|536830858|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823771|NCT02991859|536830859|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
148823772|NCT02991859|536830860|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823773|NCT02991859|536830861|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823774|NCT02991859|536830862|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823775|NCT02991859|536830863|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823776|NCT02991859|536830864|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823777|NCT02991859|536830865|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823778|NCT02991859|536830866|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823779|NCT02991859|536830867|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823780|NCT02991859|536830868|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823781|NCT02991859|536830869|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823782|NCT02991859|536830870|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823783|NCT02991859|536830871|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
148823784|NCT02991859|536830855|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823785|NCT02991859|536830856|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823786|NCT02991859|536830857|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823787|NCT02991859|536830858|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823788|NCT02991859|536830859|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823789|NCT02991859|536830860|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823790|NCT02991859|536830861|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823791|NCT02991859|536830862|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823792|NCT02991859|536830863|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823793|NCT02991859|536830864|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823794|NCT02991859|536830865|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823795|NCT02991859|536830866|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823796|NCT02991859|536830867|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
148976443|NCT04542070|537394545|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
148976444|NCT04542070|537394546|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
148976445|NCT04542070|537394543|FG000|Maintenance + Extension Period|Physician Decision|1|||
148976446|NCT04542070|537394544|FG001|Maintenance + Extension Period|Physician Decision|1|||
148757501|NCT01479465|536585816|FG001|Overall Study|Adverse Event|3|||
148757502|NCT01479465|536585817|FG002|Overall Study|Adverse Event|6|||
148757503|NCT01479465|536585818|FG003|Overall Study|Adverse Event|4|||
148757504|NCT01479465|536585815|FG000|Overall Study|Investigator Discretion|1|||
148757505|NCT01479465|536585816|FG001|Overall Study|Investigator Discretion|4|||
148757506|NCT01479465|536585817|FG002|Overall Study|Investigator Discretion|2|||
148757507|NCT01479465|536585818|FG003|Overall Study|Investigator Discretion|4|||
148757508|NCT01479465|536585815|FG000|Overall Study|Subject Request|1|||
148757509|NCT01479465|536585816|FG001|Overall Study|Subject Request|3|||
148757510|NCT01479465|536585817|FG002|Overall Study|Subject Request|4|||
148757511|NCT01479465|536585818|FG003|Overall Study|Subject Request|2|||
148757512|NCT01479465|536585815|FG000|Overall Study|Subject Withdrew Consent|0|||
148757513|NCT01479465|536585816|FG001|Overall Study|Subject Withdrew Consent|5|||
148757514|NCT01479465|536585817|FG002|Overall Study|Subject Withdrew Consent|2|||
148757515|NCT01479465|536585818|FG003|Overall Study|Subject Withdrew Consent|1|||
148757516|NCT01479465|536585815|FG000|Overall Study|Protocol Violation|0|||
148757517|NCT01479465|536585816|FG001|Overall Study|Protocol Violation|1|||
148757518|NCT01479465|536585817|FG002|Overall Study|Protocol Violation|1|||
148757519|NCT01479465|536585818|FG003|Overall Study|Protocol Violation|0|||
148757520|NCT01479465|536585815|FG000|Overall Study|Death|0|||
148757521|NCT01479465|536585816|FG001|Overall Study|Death|0|||
148823797|NCT02991859|536830868|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
148823798|NCT02991859|536830869|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823799|NCT02991859|536830870|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823800|NCT02991859|536830871|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
148823801|NCT02991859|536830855|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823802|NCT02991859|536830856|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823803|NCT02991859|536830857|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823804|NCT02991859|536830858|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823805|NCT02991859|536830859|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823806|NCT02991859|536830860|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
148823807|NCT02991859|536830861|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823808|NCT02991859|536830862|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823809|NCT02991859|536830863|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823810|NCT02991859|536830864|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823811|NCT02991859|536830865|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823812|NCT02991859|536830866|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823813|NCT02991859|536830867|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823814|NCT02991859|536830868|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823815|NCT02991859|536830869|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823816|NCT02991859|536830870|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823817|NCT02991859|536830871|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
148823818|NCT02991859|536830855|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823819|NCT02991859|536830856|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823820|NCT02991859|536830857|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823821|NCT02991859|536830858|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823822|NCT02991859|536830859|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823823|NCT02991859|536830860|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823824|NCT02991859|536830861|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823825|NCT02991859|536830862|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823826|NCT02991859|536830863|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823827|NCT02991859|536830864|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
148823828|NCT02991859|536830865|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823829|NCT02991859|536830866|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823830|NCT02991859|536830867|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823831|NCT02991859|536830868|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823832|NCT02991859|536830869|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823833|NCT02991859|536830870|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823834|NCT02991859|536830871|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
148823835|NCT02991859|536830855|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823836|NCT02991859|536830856|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823837|NCT02991859|536830857|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823838|NCT02991859|536830858|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823839|NCT02991859|536830859|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823840|NCT02991859|536830860|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823841|NCT02991859|536830861|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823842|NCT02991859|536830862|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823843|NCT02991859|536830863|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
148823844|NCT02991859|536830864|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148757522|NCT01479465|536585817|FG002|Overall Study|Death|0|||
148757523|NCT01479465|536585818|FG003|Overall Study|Death|1|||
148757524|NCT01479465|536585815|FG000|Overall Study|Lost to Follow-up|0|||
148757525|NCT01479465|536585816|FG001|Overall Study|Lost to Follow-up|0|||
148757526|NCT01479465|536585817|FG002|Overall Study|Lost to Follow-up|1|||
148757527|NCT01479465|536585818|FG003|Overall Study|Lost to Follow-up|0|||
148757528|NCT02393950|536585826|FG000|Overall Study|Adverse Event|1|||
148757529|NCT02393950|536585827|FG001|Overall Study|Adverse Event|0|||
148757530|NCT02393950|536585826|FG000|Overall Study|Withdrawal by Subject|0|||
148757531|NCT02393950|536585827|FG001|Overall Study|Withdrawal by Subject|1|||
148757532|NCT04335123|536585828|FG000|Overall Study|Withdrawal by Subject|2|||
148757533|NCT04335123|536585829|FG001|Overall Study|Withdrawal by Subject|0|||
148757534|NCT04335123|536585828|FG000|Overall Study|Physician Decision|2|||
148757535|NCT04335123|536585829|FG001|Overall Study|Physician Decision|0|||
148757536|NCT04067050|536585830|FG000|One Month|Lost to Follow-up|4|||
148757537|NCT04067050|536585831|FG001|One Month|Lost to Follow-up|0|||
148757538|NCT04067050|536585830|FG000|Two Month|Lost to Follow-up|1|||
148757539|NCT04067050|536585831|FG001|Two Month|Lost to Follow-up|0|||
148757540|NCT04067050|536585830|FG000|Two Month|Adverse Event|1|||
148757541|NCT04067050|536585831|FG001|Two Month|Adverse Event|0|||
148757542|NCT00460603|536585838|FG000|Phase 1|Death|1|||
148757543|NCT00460603|536585839|FG001|Phase 1|Death|0|||
148757544|NCT00460603|536585840|FG002|Phase 1|Death|0|||
148823845|NCT02991859|536830865|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148757545|NCT00460603|536585841|FG003|Phase 1|Death|2|||
148757546|NCT00460603|536585842|FG004|Phase 1|Death|0|||
148757547|NCT00460603|536585843|FG005|Phase 1|Death|0|||
148757548|NCT00460603|536585844|FG006|Phase 1|Death|0|||
148757549|NCT00460603|536585845|FG007|Phase 1|Death|0|||
148757550|NCT00460603|536585846|FG008|Phase 1|Death|1|||
148757551|NCT00460603|536585847|FG009|Phase 1|Death|0|||
148757552|NCT00460603|536585848|FG010|Phase 1|Death|0|||
148757553|NCT00460603|536585849|FG011|Phase 1|Death|0|||
148757554|NCT00460603|536585838|FG000|Phase 1|Adverse Event|3|||
148757555|NCT00460603|536585839|FG001|Phase 1|Adverse Event|1|||
148757556|NCT00460603|536585840|FG002|Phase 1|Adverse Event|1|||
148757557|NCT00460603|536585841|FG003|Phase 1|Adverse Event|2|||
148757558|NCT00460603|536585842|FG004|Phase 1|Adverse Event|0|||
148757559|NCT00460603|536585843|FG005|Phase 1|Adverse Event|0|||
148757560|NCT00460603|536585844|FG006|Phase 1|Adverse Event|3|||
148757561|NCT00460603|536585845|FG007|Phase 1|Adverse Event|0|||
148757562|NCT00460603|536585846|FG008|Phase 1|Adverse Event|4|||
148757563|NCT00460603|536585847|FG009|Phase 1|Adverse Event|0|||
148757564|NCT00460603|536585848|FG010|Phase 1|Adverse Event|0|||
148757565|NCT00460603|536585849|FG011|Phase 1|Adverse Event|0|||
148757566|NCT00460603|536585838|FG000|Phase 1|Lack of Efficacy|1|||
148757567|NCT00460603|536585839|FG001|Phase 1|Lack of Efficacy|0|||
148757568|NCT00460603|536585840|FG002|Phase 1|Lack of Efficacy|1|||
148757569|NCT00460603|536585841|FG003|Phase 1|Lack of Efficacy|2|||
148757570|NCT00460603|536585842|FG004|Phase 1|Lack of Efficacy|2|||
148757571|NCT00460603|536585843|FG005|Phase 1|Lack of Efficacy|2|||
148757572|NCT00460603|536585844|FG006|Phase 1|Lack of Efficacy|2|||
148757573|NCT00460603|536585845|FG007|Phase 1|Lack of Efficacy|2|||
148757574|NCT00460603|536585846|FG008|Phase 1|Lack of Efficacy|11|||
148757575|NCT00460603|536585847|FG009|Phase 1|Lack of Efficacy|0|||
148757576|NCT00460603|536585848|FG010|Phase 1|Lack of Efficacy|0|||
148757577|NCT00460603|536585849|FG011|Phase 1|Lack of Efficacy|0|||
148757578|NCT00460603|536585838|FG000|Phase 1|Withdrawal by Subject|1|||
148757579|NCT00460603|536585839|FG001|Phase 1|Withdrawal by Subject|2|||
148757580|NCT00460603|536585840|FG002|Phase 1|Withdrawal by Subject|1|||
148757581|NCT00460603|536585841|FG003|Phase 1|Withdrawal by Subject|1|||
148757582|NCT00460603|536585842|FG004|Phase 1|Withdrawal by Subject|3|||
148757583|NCT00460603|536585843|FG005|Phase 1|Withdrawal by Subject|0|||
148757584|NCT00460603|536585844|FG006|Phase 1|Withdrawal by Subject|1|||
148757585|NCT00460603|536585845|FG007|Phase 1|Withdrawal by Subject|0|||
148757586|NCT00460603|536585846|FG008|Phase 1|Withdrawal by Subject|2|||
148757587|NCT00460603|536585847|FG009|Phase 1|Withdrawal by Subject|0|||
148757588|NCT00460603|536585848|FG010|Phase 1|Withdrawal by Subject|0|||
148757589|NCT00460603|536585849|FG011|Phase 1|Withdrawal by Subject|0|||
148757590|NCT00460603|536585838|FG000|Phase 1|Other|0|||
148757591|NCT00460603|536585839|FG001|Phase 1|Other|3|||
148757592|NCT00460603|536585840|FG002|Phase 1|Other|1|||
148757593|NCT00460603|536585841|FG003|Phase 1|Other|1|||
148757594|NCT00460603|536585842|FG004|Phase 1|Other|1|||
148757595|NCT00460603|536585843|FG005|Phase 1|Other|2|||
148757596|NCT00460603|536585844|FG006|Phase 1|Other|0|||
148757597|NCT00460603|536585845|FG007|Phase 1|Other|1|||
148757598|NCT00460603|536585846|FG008|Phase 1|Other|0|||
148757599|NCT00460603|536585847|FG009|Phase 1|Other|0|||
148757600|NCT00460603|536585848|FG010|Phase 1|Other|0|||
148757601|NCT00460603|536585849|FG011|Phase 1|Other|0|||
148757602|NCT00460603|536585838|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757603|NCT00460603|536585839|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757604|NCT00460603|536585840|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757605|NCT00460603|536585841|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757606|NCT00460603|536585842|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757607|NCT00460603|536585843|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757608|NCT00460603|536585844|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757609|NCT00460603|536585845|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757610|NCT00460603|536585846|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757611|NCT00460603|536585847|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
148757612|NCT00460603|536585848|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757613|NCT00460603|536585849|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
148757614|NCT00460603|536585838|FG000|Phase 2|Adverse Event|0|||
148757615|NCT00460603|536585839|FG001|Phase 2|Adverse Event|0|||
148757616|NCT00460603|536585840|FG002|Phase 2|Adverse Event|0|||
148757617|NCT00460603|536585841|FG003|Phase 2|Adverse Event|0|||
148757618|NCT00460603|536585842|FG004|Phase 2|Adverse Event|0|||
148757619|NCT00460603|536585843|FG005|Phase 2|Adverse Event|0|||
148757620|NCT00460603|536585844|FG006|Phase 2|Adverse Event|0|||
148757621|NCT00460603|536585845|FG007|Phase 2|Adverse Event|0|||
148757622|NCT00460603|536585846|FG008|Phase 2|Adverse Event|0|||
148757623|NCT00460603|536585847|FG009|Phase 2|Adverse Event|12|||
148757624|NCT00460603|536585848|FG010|Phase 2|Adverse Event|9|||
148757625|NCT00460603|536585849|FG011|Phase 2|Adverse Event|10|||
148757626|NCT00460603|536585838|FG000|Phase 2|Death|0|||
148757627|NCT00460603|536585839|FG001|Phase 2|Death|0|||
148823846|NCT02991859|536830866|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148757628|NCT00460603|536585840|FG002|Phase 2|Death|0|||
148757629|NCT00460603|536585841|FG003|Phase 2|Death|0|||
148757630|NCT00460603|536585842|FG004|Phase 2|Death|0|||
148757631|NCT00460603|536585843|FG005|Phase 2|Death|0|||
148757632|NCT00460603|536585844|FG006|Phase 2|Death|0|||
148757633|NCT00460603|536585845|FG007|Phase 2|Death|0|||
148757634|NCT00460603|536585846|FG008|Phase 2|Death|0|||
148757635|NCT00460603|536585847|FG009|Phase 2|Death|4|||
148757636|NCT00460603|536585848|FG010|Phase 2|Death|2|||
148757637|NCT00460603|536585849|FG011|Phase 2|Death|2|||
148757638|NCT00460603|536585838|FG000|Phase 2|Protocol Violation|0|||
148757639|NCT00460603|536585839|FG001|Phase 2|Protocol Violation|0|||
148757640|NCT00460603|536585840|FG002|Phase 2|Protocol Violation|0|||
148757641|NCT00460603|536585841|FG003|Phase 2|Protocol Violation|0|||
148757642|NCT00460603|536585842|FG004|Phase 2|Protocol Violation|0|||
148757643|NCT00460603|536585843|FG005|Phase 2|Protocol Violation|0|||
148757644|NCT00460603|536585844|FG006|Phase 2|Protocol Violation|0|||
148757645|NCT00460603|536585845|FG007|Phase 2|Protocol Violation|0|||
148757646|NCT00460603|536585846|FG008|Phase 2|Protocol Violation|0|||
148757647|NCT00460603|536585847|FG009|Phase 2|Protocol Violation|1|||
148757648|NCT00460603|536585848|FG010|Phase 2|Protocol Violation|1|||
148757649|NCT00460603|536585849|FG011|Phase 2|Protocol Violation|0|||
148757650|NCT00460603|536585838|FG000|Phase 2|Lost to Follow-up|0|||
148757651|NCT00460603|536585839|FG001|Phase 2|Lost to Follow-up|0|||
148757652|NCT00460603|536585840|FG002|Phase 2|Lost to Follow-up|0|||
148757653|NCT00460603|536585841|FG003|Phase 2|Lost to Follow-up|0|||
148757654|NCT00460603|536585842|FG004|Phase 2|Lost to Follow-up|0|||
148757655|NCT00460603|536585843|FG005|Phase 2|Lost to Follow-up|0|||
148757656|NCT00460603|536585844|FG006|Phase 2|Lost to Follow-up|0|||
148757657|NCT00460603|536585845|FG007|Phase 2|Lost to Follow-up|0|||
148757658|NCT00460603|536585846|FG008|Phase 2|Lost to Follow-up|0|||
148757659|NCT00460603|536585847|FG009|Phase 2|Lost to Follow-up|1|||
148757660|NCT00460603|536585848|FG010|Phase 2|Lost to Follow-up|0|||
148757661|NCT00460603|536585849|FG011|Phase 2|Lost to Follow-up|0|||
148757662|NCT00460603|536585838|FG000|Phase 2|Other|0|||
148757663|NCT00460603|536585839|FG001|Phase 2|Other|0|||
148757664|NCT00460603|536585840|FG002|Phase 2|Other|0|||
148757665|NCT00460603|536585841|FG003|Phase 2|Other|0|||
148757666|NCT00460603|536585842|FG004|Phase 2|Other|0|||
148757667|NCT00460603|536585843|FG005|Phase 2|Other|0|||
148757668|NCT00460603|536585844|FG006|Phase 2|Other|0|||
148757669|NCT00460603|536585845|FG007|Phase 2|Other|0|||
148757670|NCT00460603|536585846|FG008|Phase 2|Other|0|||
148757671|NCT00460603|536585847|FG009|Phase 2|Other|6|||
148757672|NCT00460603|536585848|FG010|Phase 2|Other|16|||
148757673|NCT00460603|536585849|FG011|Phase 2|Other|7|||
148757674|NCT00460603|536585838|FG000|Phase 2|Objective Progression or Relapse|0|||
148757675|NCT00460603|536585839|FG001|Phase 2|Objective Progression or Relapse|0|||
148757676|NCT00460603|536585840|FG002|Phase 2|Objective Progression or Relapse|0|||
148757677|NCT00460603|536585841|FG003|Phase 2|Objective Progression or Relapse|0|||
148757678|NCT00460603|536585842|FG004|Phase 2|Objective Progression or Relapse|0|||
148757679|NCT00460603|536585843|FG005|Phase 2|Objective Progression or Relapse|0|||
148757680|NCT00460603|536585844|FG006|Phase 2|Objective Progression or Relapse|0|||
148757681|NCT00460603|536585845|FG007|Phase 2|Objective Progression or Relapse|0|||
148757682|NCT00460603|536585846|FG008|Phase 2|Objective Progression or Relapse|0|||
148757683|NCT00460603|536585847|FG009|Phase 2|Objective Progression or Relapse|9|||
148757684|NCT00460603|536585848|FG010|Phase 2|Objective Progression or Relapse|10|||
148757685|NCT00460603|536585849|FG011|Phase 2|Objective Progression or Relapse|17|||
148757686|NCT00460603|536585838|FG000|Phase 2|Global Deterioration of Health Status|0|||
148757687|NCT00460603|536585839|FG001|Phase 2|Global Deterioration of Health Status|0|||
148757688|NCT00460603|536585840|FG002|Phase 2|Global Deterioration of Health Status|0|||
148757689|NCT00460603|536585841|FG003|Phase 2|Global Deterioration of Health Status|0|||
148757690|NCT00460603|536585842|FG004|Phase 2|Global Deterioration of Health Status|0|||
148757691|NCT00460603|536585843|FG005|Phase 2|Global Deterioration of Health Status|0|||
148757692|NCT00460603|536585844|FG006|Phase 2|Global Deterioration of Health Status|0|||
148757693|NCT00460603|536585845|FG007|Phase 2|Global Deterioration of Health Status|0|||
148823847|NCT02991859|536830867|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823848|NCT02991859|536830868|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823849|NCT02991859|536830869|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823850|NCT02991859|536830870|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823851|NCT02991859|536830871|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
148823852|NCT03520387|536830876|FG000|Pre-Randomization|Withdrawal by Subject|1|||
148823853|NCT03520387|536830877|FG001|Pre-Randomization|Withdrawal by Subject|0|||
148823854|NCT03520387|536830878|FG002|Pre-Randomization|Withdrawal by Subject|0|||
148823855|NCT03520387|536830879|FG003|Pre-Randomization|Withdrawal by Subject|0|||
148823856|NCT03520387|536830880|FG004|Pre-Randomization|Withdrawal by Subject|0|||
148976447|NCT04542070|537394545|FG002|Maintenance + Extension Period|Physician Decision|0|||
148976448|NCT04542070|537394546|FG003|Maintenance + Extension Period|Physician Decision|0|||
148757694|NCT00460603|536585846|FG008|Phase 2|Global Deterioration of Health Status|0|||
148757695|NCT00460603|536585847|FG009|Phase 2|Global Deterioration of Health Status|0|||
148757696|NCT00460603|536585848|FG010|Phase 2|Global Deterioration of Health Status|1|||
148757697|NCT00460603|536585849|FG011|Phase 2|Global Deterioration of Health Status|0|||
148757698|NCT00460603|536585838|FG000|Phase 2|Withdrawal by Subject|0|||
148757699|NCT00460603|536585839|FG001|Phase 2|Withdrawal by Subject|0|||
148757700|NCT00460603|536585840|FG002|Phase 2|Withdrawal by Subject|0|||
148757701|NCT00460603|536585841|FG003|Phase 2|Withdrawal by Subject|0|||
148757702|NCT00460603|536585842|FG004|Phase 2|Withdrawal by Subject|0|||
148757703|NCT00460603|536585843|FG005|Phase 2|Withdrawal by Subject|0|||
148757704|NCT00460603|536585844|FG006|Phase 2|Withdrawal by Subject|0|||
148757705|NCT00460603|536585845|FG007|Phase 2|Withdrawal by Subject|0|||
148757706|NCT00460603|536585846|FG008|Phase 2|Withdrawal by Subject|0|||
148757707|NCT00460603|536585847|FG009|Phase 2|Withdrawal by Subject|5|||
148757708|NCT00460603|536585848|FG010|Phase 2|Withdrawal by Subject|4|||
148757709|NCT00460603|536585849|FG011|Phase 2|Withdrawal by Subject|5|||
148757710|NCT00460603|536585838|FG000|Phase 2|Randomized, but not treated|0|||
148757711|NCT00460603|536585839|FG001|Phase 2|Randomized, but not treated|0|||
148757712|NCT00460603|536585840|FG002|Phase 2|Randomized, but not treated|0|||
148757713|NCT00460603|536585841|FG003|Phase 2|Randomized, but not treated|0|||
148757714|NCT00460603|536585842|FG004|Phase 2|Randomized, but not treated|0|||
148757715|NCT00460603|536585843|FG005|Phase 2|Randomized, but not treated|0|||
148757716|NCT00460603|536585844|FG006|Phase 2|Randomized, but not treated|0|||
148757717|NCT00460603|536585845|FG007|Phase 2|Randomized, but not treated|0|||
148757718|NCT00460603|536585846|FG008|Phase 2|Randomized, but not treated|0|||
148757719|NCT00460603|536585847|FG009|Phase 2|Randomized, but not treated|3|||
148757720|NCT00460603|536585848|FG010|Phase 2|Randomized, but not treated|0|||
148757721|NCT00460603|536585849|FG011|Phase 2|Randomized, but not treated|0|||
148757722|NCT03003962|536585850|FG000|Overall Study|Withdrawal by Subject|5|||
148757723|NCT03003962|536585851|FG001|Overall Study|Withdrawal by Subject|17|||
148757724|NCT03003962|536585850|FG000|Overall Study|Death|274|||
148757725|NCT03003962|536585851|FG001|Overall Study|Death|277|||
148757726|NCT03003962|536585850|FG000|Overall Study|Participants ongoing at DCO|55|||
148757727|NCT03003962|536585851|FG001|Overall Study|Participants ongoing at DCO|40|||
148757728|NCT03871543|536585852|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
148757729|NCT03871543|536585852|FG000|Period 1|Investigator Error|1|||
148757730|NCT03871543|536585852|FG000|Period 1|Protocol Violation|2|||
148757731|NCT03871543|536585852|FG000|Period 1|COVID-19 Related|1|||
148757732|NCT03871543|536585852|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
148757733|NCT03871543|536585852|FG000|Period 1|Withdrawal by Subject|10|||
148757734|NCT03871543|536585852|FG000|Period 2|Adverse Event|1|||
148757735|NCT03871543|536585852|FG000|Period 2|Withdrawal by Subject|1|||
148757736|NCT01082328|536585855|FG000|Overall Study|Adverse Event|1|||
148757737|NCT00031590|536585856|FG000|Overall Study|Adverse Event|1|||
148757738|NCT00031590|536585856|FG000|Overall Study|Withdrawal by parents|2|||
148757739|NCT00777296|536585857|FG000|Overall Study|Adverse Event|0|||
148757740|NCT00777296|536585858|FG001|Overall Study|Adverse Event|1|||
148757741|NCT00777296|536585859|FG002|Overall Study|Adverse Event|0|||
148757742|NCT00777296|536585860|FG003|Overall Study|Adverse Event|1|||
148757743|NCT00777296|536585857|FG000|Overall Study|Withdrawal by Subject|1|||
148757744|NCT00777296|536585858|FG001|Overall Study|Withdrawal by Subject|0|||
148757745|NCT00777296|536585859|FG002|Overall Study|Withdrawal by Subject|0|||
148757746|NCT00777296|536585860|FG003|Overall Study|Withdrawal by Subject|0|||
148757747|NCT00777296|536585857|FG000|Overall Study|CRF form not completed|0|||
148757748|NCT00777296|536585858|FG001|Overall Study|CRF form not completed|0|||
148757749|NCT00777296|536585859|FG002|Overall Study|CRF form not completed|2|||
148757750|NCT00777296|536585860|FG003|Overall Study|CRF form not completed|0|||
148757751|NCT01139125|536585861|FG000|Overall Study|Withdrawal by Subject|1|||
148757752|NCT01198470|536585862|FG000|Overall Study|Adverse Event|2|||
148757753|NCT02949973|536585863|FG000|Overall Study|Physician Decision|1|||
148757754|NCT00586703|536585864|FG000|Overall Study|Death|12|||
148757755|NCT00806403|536585867|FG000|Overall Study|Death|4|||
148757756|NCT00806403|536585868|FG001|Overall Study|Death|3|||
148757757|NCT01882985|536585869|FG000|Overall Study|Lost to Follow-up|1|||
148757758|NCT01882985|536585869|FG000|Overall Study|Withdrawal by Subject|1|||
148757759|NCT00765102|536585870|FG000|Overall Study|Progressive disease|18|||
148757760|NCT00765102|536585870|FG000|Overall Study|Adverse Event|6|||
148757761|NCT00765102|536585870|FG000|Overall Study|Physician Decision|4|||
148757762|NCT00765102|536585870|FG000|Overall Study|Withdrawal by Subject|2|||
148757763|NCT00765102|536585870|FG000|Overall Study|Protocol Violation|1|||
148757764|NCT04129125|536585877|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
148757765|NCT04129125|536585877|FG000|Overall Study|Study device was not used|3|||
148757766|NCT03267212|536585880|FG000|First Intervention|Lost to Follow-up|0|||
148757767|NCT03267212|536585881|FG001|First Intervention|Lost to Follow-up|2|||
148757768|NCT03267212|536585880|FG000|First Intervention|Withdrawal by Subject|1|||
148757769|NCT03267212|536585881|FG001|First Intervention|Withdrawal by Subject|1|||
148757770|NCT03267212|536585880|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
148757771|NCT03267212|536585881|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
148757772|NCT04383327|536585884|FG000|Overall Study|Lost to Follow-up|112|||
148757773|NCT04383327|536585885|FG001|Overall Study|Lost to Follow-up|14|||
148757774|NCT04383327|536585886|FG002|Overall Study|Lost to Follow-up|78|||
148757775|NCT04383327|536585887|FG003|Overall Study|Lost to Follow-up|13|||
148757776|NCT04383327|536585888|FG004|Overall Study|Lost to Follow-up|110|||
148757777|NCT04383327|536585889|FG005|Overall Study|Lost to Follow-up|13|||
148757778|NCT04383327|536585890|FG006|Overall Study|Lost to Follow-up|74|||
148757779|NCT04383327|536585891|FG007|Overall Study|Lost to Follow-up|13|||
148757780|NCT04383327|536585892|FG008|Overall Study|Lost to Follow-up|78|||
148823857|NCT03520387|536830876|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
148823858|NCT03520387|536830877|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
148823859|NCT03520387|536830878|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
148823860|NCT03520387|536830879|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
148823861|NCT03520387|536830880|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
148823862|NCT01945242|536830881|FG000|Overall Study|Physician Decision|3|||
148823863|NCT01945242|536830882|FG001|Overall Study|Physician Decision|3|||
148823864|NCT05652140|536830883|FG000|Overall Study|Lost to Follow-up|7|||
148823865|NCT05652140|536830884|FG001|Overall Study|Lost to Follow-up|16|||
148823866|NCT05652140|536830885|FG002|Overall Study|Lost to Follow-up|22|||
148823867|NCT05652140|536830886|FG003|Overall Study|Lost to Follow-up|31|||
148823868|NCT01016015|536830890|FG000|Overall Study|Not Treated|3|||
148823869|NCT01016015|536830890|FG000|Overall Study|Withdrawal by Subject|1|||
148823870|NCT01016015|536830890|FG000|Overall Study|Adverse Event|15|||
148823871|NCT03163264|536830891|FG000|Overall Study|Withdrawal by Subject|13|||
148823872|NCT03163264|536830892|FG001|Overall Study|Withdrawal by Subject|3|||
148823873|NCT03163264|536830893|FG002|Overall Study|Withdrawal by Subject|4|||
148823874|NCT03163264|536830894|FG003|Overall Study|Withdrawal by Subject|2|||
148823875|NCT03163264|536830891|FG000|Overall Study|Lost to Follow-up|17|||
148823876|NCT03163264|536830892|FG001|Overall Study|Lost to Follow-up|20|||
148823877|NCT03163264|536830893|FG002|Overall Study|Lost to Follow-up|0|||
148823878|NCT03163264|536830894|FG003|Overall Study|Lost to Follow-up|0|||
148757781|NCT04383327|536585893|FG009|Overall Study|Lost to Follow-up|10|||
148823879|NCT03163264|536830891|FG000|Overall Study|Death|0|||
148823880|NCT03163264|536830892|FG001|Overall Study|Death|2|||
148757782|NCT04383327|536585894|FG010|Overall Study|Lost to Follow-up|160|||
148757783|NCT04383327|536585895|FG011|Overall Study|Lost to Follow-up|13|||
148757784|NCT05691712|536585896|FG000|Overall Study|Adverse Event|0|||
148757785|NCT05691712|536585897|FG001|Overall Study|Adverse Event|1|||
148757786|NCT05691712|536585898|FG002|Overall Study|Adverse Event|2|||
148757787|NCT05691712|536585899|FG003|Overall Study|Adverse Event|1|||
148757788|NCT05691712|536585896|FG000|Overall Study|Withdrawal by Subject|2|||
148757789|NCT05691712|536585897|FG001|Overall Study|Withdrawal by Subject|3|||
148757790|NCT05691712|536585898|FG002|Overall Study|Withdrawal by Subject|3|||
148757791|NCT05691712|536585899|FG003|Overall Study|Withdrawal by Subject|1|||
148757792|NCT05691712|536585896|FG000|Overall Study|Death|1|||
148757793|NCT05691712|536585897|FG001|Overall Study|Death|0|||
148757794|NCT05691712|536585898|FG002|Overall Study|Death|0|||
148757795|NCT05691712|536585899|FG003|Overall Study|Death|0|||
148757796|NCT05691712|536585896|FG000|Overall Study|Pregnancy|0|||
148757797|NCT05691712|536585897|FG001|Overall Study|Pregnancy|1|||
148757798|NCT05691712|536585898|FG002|Overall Study|Pregnancy|0|||
148757799|NCT05691712|536585899|FG003|Overall Study|Pregnancy|0|||
148757800|NCT05691712|536585896|FG000|Overall Study|Assigned Treatment by Mistake|1|||
148757801|NCT05691712|536585897|FG001|Overall Study|Assigned Treatment by Mistake|0|||
148757802|NCT05691712|536585898|FG002|Overall Study|Assigned Treatment by Mistake|0|||
148757803|NCT05691712|536585899|FG003|Overall Study|Assigned Treatment by Mistake|1|||
148757804|NCT05303194|536585900|FG000|Overall Study|Lost to Follow-up|1|||
148757805|NCT05303194|536585901|FG001|Overall Study|Lost to Follow-up|1|||
148757806|NCT05303194|536585900|FG000|Overall Study|Withdrawal by Subject|0|||
148757807|NCT05303194|536585901|FG001|Overall Study|Withdrawal by Subject|1|||
148757808|NCT04837196|536585911|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
148757809|NCT04837196|536585912|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
148757810|NCT04837196|536585913|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
148757811|NCT04837196|536585914|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
148757812|NCT04837196|536585915|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
148757813|NCT04837196|536585911|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
148757814|NCT04837196|536585912|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
148757815|NCT04837196|536585913|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
148757816|NCT04837196|536585914|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
148757817|NCT04837196|536585915|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
148823881|NCT03163264|536830893|FG002|Overall Study|Death|0|||
148823882|NCT03163264|536830894|FG003|Overall Study|Death|0|||
148823883|NCT04648241|536830895|FG000|Overall Study|Lost to Follow-up|1|||
148823884|NCT04648241|536830896|FG001|Overall Study|Lost to Follow-up|0|||
148823885|NCT02057666|536830897|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
148757818|NCT04837196|536585911|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
148757819|NCT04837196|536585912|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
148757820|NCT04837196|536585913|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
148757821|NCT04837196|536585914|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
148757822|NCT04837196|536585915|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
148823886|NCT02057666|536830898|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
148823887|NCT02057666|536830897|FG000|Double Blind Treatment Period|Poor tolerability|7|||
148823888|NCT02057666|536830898|FG001|Double Blind Treatment Period|Poor tolerability|2|||
148757823|NCT04837196|536585911|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
148757824|NCT04837196|536585912|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
148757825|NCT04837196|536585913|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
148757826|NCT04837196|536585914|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
148757827|NCT04837196|536585915|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
148757828|NCT04837196|536585911|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
148757829|NCT04837196|536585912|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
148757830|NCT04837196|536585913|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
148757831|NCT04837196|536585914|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
148757832|NCT04837196|536585915|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
148757833|NCT05271175|536585916|FG000|One Week Follow up|Lost to Follow-up|10|||
148757834|NCT05271175|536585917|FG001|One Week Follow up|Lost to Follow-up|7|||
148757835|NCT05271175|536585918|FG002|One Week Follow up|Lost to Follow-up|5|||
148757836|NCT05271175|536585916|FG000|One Month Follow up|Lost to Follow-up|12|||
148757837|NCT05271175|536585917|FG001|One Month Follow up|Lost to Follow-up|7|||
148757838|NCT05271175|536585918|FG002|One Month Follow up|Lost to Follow-up|9|||
148757839|NCT05271175|536585916|FG000|Six Months Follow up|Lost to Follow-up|8|||
148757840|NCT05271175|536585917|FG001|Six Months Follow up|Lost to Follow-up|2|||
148757841|NCT05271175|536585918|FG002|Six Months Follow up|Lost to Follow-up|2|||
148757842|NCT01289678|536585919|FG000|Overall Study|Physician Decision|6|||
148757843|NCT00226499|536585920|FG000|Overall Study|Adverse Event|10|||
148757844|NCT00226499|536585921|FG001|Overall Study|Adverse Event|6|||
148757845|NCT00226499|536585922|FG002|Overall Study|Adverse Event|3|||
148757846|NCT00226499|536585920|FG000|Overall Study|Others|1064|||
148757847|NCT00226499|536585921|FG001|Overall Study|Others|1066|||
148757848|NCT00226499|536585922|FG002|Overall Study|Others|356|||
148757849|NCT04564092|536585923|FG000|Overall Study|Withdrawal by Subject|1|||
148757850|NCT02859337|536585924|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
148757851|NCT02859337|536585925|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
148757852|NCT02859337|536585926|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
148757853|NCT02859337|536585924|FG000|Overall Study|Withdrawal by Subject|3|||
148757854|NCT02859337|536585925|FG001|Overall Study|Withdrawal by Subject|1|||
148757855|NCT02859337|536585926|FG002|Overall Study|Withdrawal by Subject|0|||
148757856|NCT02859337|536585924|FG000|Overall Study|Lost to Follow-up|1|||
148757857|NCT02859337|536585925|FG001|Overall Study|Lost to Follow-up|0|||
148757858|NCT02859337|536585926|FG002|Overall Study|Lost to Follow-up|0|||
148757859|NCT04146012|536585927|FG000|Overall Study|Study Terminated|30|||
148757860|NCT04146012|536585928|FG001|Overall Study|Study Terminated|15|||
148757861|NCT01546025|536585929|FG000|Overall Study|Lost to Follow-up|0|||
148757862|NCT01546025|536585930|FG001|Overall Study|Lost to Follow-up|1|||
148757863|NCT02729025|536585934|FG000|Overall Study|Sponsor Decision|0|||
148757864|NCT02729025|536585935|FG001|Overall Study|Sponsor Decision|1|||
148757865|NCT02546986|536587477|FG000|Treatment Period|Progressive Disease|20|||
148757866|NCT02546986|536587478|FG001|Treatment Period|Progressive Disease|22|||
148757867|NCT02546986|536587477|FG000|Treatment Period|Adverse Event|14|||
148757868|NCT02546986|536587478|FG001|Treatment Period|Adverse Event|6|||
148757869|NCT02546986|536587477|FG000|Treatment Period|Symptomatic Deterioration|4|||
148757870|NCT02546986|536587478|FG001|Treatment Period|Symptomatic Deterioration|3|||
148757871|NCT02546986|536587477|FG000|Treatment Period|Death|3|||
148757872|NCT02546986|536587478|FG001|Treatment Period|Death|4|||
148757873|NCT02546986|536587477|FG000|Treatment Period|Physician Decision|1|||
148757874|NCT02546986|536587478|FG001|Treatment Period|Physician Decision|2|||
148757875|NCT02546986|536587477|FG000|Treatment Period|Protocol Violation|1|||
148757876|NCT02546986|536587478|FG001|Treatment Period|Protocol Violation|0|||
148757877|NCT02546986|536587477|FG000|Treatment Period|Withdrawal by Subject|1|||
148757878|NCT02546986|536587478|FG001|Treatment Period|Withdrawal by Subject|1|||
148757879|NCT02546986|536587477|FG000|Treatment Period|Non-compliance with Study Drug|0|||
148757880|NCT02546986|536587478|FG001|Treatment Period|Non-compliance with Study Drug|1|||
148757881|NCT02546986|536587477|FG000|Treatment Period|Study Terminated by Sponsor|0|||
148757882|NCT02546986|536587478|FG001|Treatment Period|Study Terminated by Sponsor|1|||
148823889|NCT02057666|536830897|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
148757883|NCT02546986|536587477|FG000|Treatment Period|Miscellaneous|7|||
148757884|NCT02546986|536587478|FG001|Treatment Period|Miscellaneous|9|||
148757885|NCT02546986|536587477|FG000|Survival Follow-Up Phase|Missing Status|3|||
148757886|NCT02546986|536587478|FG001|Survival Follow-Up Phase|Missing Status|5|||
148976449|NCT04542070|537394543|FG000|Maintenance + Extension Period|Protocol Violation|2|||
148757887|NCT02546986|536587477|FG000|Survival Follow-Up Phase|Death|18|||
148757888|NCT02546986|536587478|FG001|Survival Follow-Up Phase|Death|12|||
148757889|NCT02546986|536587477|FG000|Survival Follow-Up Phase|Alive|13|||
148757890|NCT02546986|536587478|FG001|Survival Follow-Up Phase|Alive|16|||
148757891|NCT02546986|536587477|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
148757892|NCT02546986|536587478|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
148757893|NCT03349060|536587479|FG000|Overall Study|Adverse Event|9|||
148757894|NCT03349060|536587480|FG001|Overall Study|Adverse Event|9|||
148757895|NCT03349060|536587481|FG002|Overall Study|Adverse Event|7|||
148757896|NCT03349060|536587479|FG000|Overall Study|Lack of Efficacy|1|||
148757897|NCT03349060|536587480|FG001|Overall Study|Lack of Efficacy|0|||
148757898|NCT03349060|536587481|FG002|Overall Study|Lack of Efficacy|2|||
148757899|NCT03349060|536587479|FG000|Overall Study|Lost to Follow-up|2|||
148757900|NCT03349060|536587480|FG001|Overall Study|Lost to Follow-up|1|||
148757901|NCT03349060|536587481|FG002|Overall Study|Lost to Follow-up|1|||
148757902|NCT03349060|536587479|FG000|Overall Study|Protocol Violation|2|||
148757903|NCT03349060|536587480|FG001|Overall Study|Protocol Violation|2|||
148757904|NCT03349060|536587481|FG002|Overall Study|Protocol Violation|1|||
148757905|NCT03349060|536587479|FG000|Overall Study|Withdrawal by Subject|5|||
148757906|NCT03349060|536587480|FG001|Overall Study|Withdrawal by Subject|3|||
148757907|NCT03349060|536587481|FG002|Overall Study|Withdrawal by Subject|4|||
148757908|NCT03349060|536587479|FG000|Overall Study|Medication error,no linked adverse event|0|||
148757909|NCT03349060|536587480|FG001|Overall Study|Medication error,no linked adverse event|0|||
148757910|NCT03349060|536587481|FG002|Overall Study|Medication error,no linked adverse event|1|||
148757911|NCT03349060|536587479|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
148757912|NCT03349060|536587480|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
148757913|NCT03349060|536587481|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
148757914|NCT03349060|536587479|FG000|Overall Study|Other|2|||
148757915|NCT03349060|536587480|FG001|Overall Study|Other|1|||
148757916|NCT03349060|536587481|FG002|Overall Study|Other|0|||
148757917|NCT00485732|536587482|FG000|Overall Study|Protocol Violation|1|||
148757918|NCT00485732|536587483|FG001|Overall Study|Protocol Violation|3|||
148757919|NCT00485732|536587482|FG000|Overall Study|Withdrawal by Subject|5|||
148757920|NCT00485732|536587483|FG001|Overall Study|Withdrawal by Subject|4|||
148757921|NCT00485732|536587482|FG000|Overall Study|Lost to Follow-up|2|||
148757922|NCT00485732|536587483|FG001|Overall Study|Lost to Follow-up|2|||
148757923|NCT05573464|536587484|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
148757924|NCT05573464|536587485|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
148757925|NCT05573464|536587484|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
148757926|NCT05573464|536587485|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
148757927|NCT05573464|536587484|FG000|12-week Treatment Period|Protocol Violation|3|||
148757928|NCT05573464|536587485|FG001|12-week Treatment Period|Protocol Violation|1|||
148757929|NCT05573464|536587484|FG000|12-week Treatment Period|Physician Decision|1|||
148757930|NCT05573464|536587485|FG001|12-week Treatment Period|Physician Decision|2|||
148757931|NCT05573464|536587484|FG000|12-week Treatment Period|Lost to Follow-up|2|||
148757932|NCT05573464|536587485|FG001|12-week Treatment Period|Lost to Follow-up|0|||
148757933|NCT05573464|536587484|FG000|12-week Treatment Period|Adverse Event|20|||
148757934|NCT05573464|536587485|FG001|12-week Treatment Period|Adverse Event|9|||
148757935|NCT05573464|536587484|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
148757936|NCT05573464|536587485|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
148757937|NCT05573464|536587484|FG000|12-week Treatment Period|Randomised, not treated|0|||
148757938|NCT05573464|536587485|FG001|12-week Treatment Period|Randomised, not treated|1|||
148757939|NCT05573464|536587484|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
148757940|NCT05573464|536587485|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
148757941|NCT05573464|536587484|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
148757942|NCT05573464|536587485|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
148757943|NCT05573464|536587484|FG000|52-week Treatment Period|Protocol Violation|1|||
148757944|NCT05573464|536587485|FG001|52-week Treatment Period|Protocol Violation|1|||
148757945|NCT05573464|536587484|FG000|52-week Treatment Period|Physician Decision|2|||
148757946|NCT05573464|536587485|FG001|52-week Treatment Period|Physician Decision|2|||
148757947|NCT05573464|536587484|FG000|52-week Treatment Period|Lost to Follow-up|1|||
148757948|NCT05573464|536587485|FG001|52-week Treatment Period|Lost to Follow-up|1|||
148757949|NCT05573464|536587484|FG000|52-week Treatment Period|Adverse Event|11|||
148757950|NCT05573464|536587485|FG001|52-week Treatment Period|Adverse Event|8|||
148757951|NCT05573464|536587484|FG000|52-week Treatment Period|Death|1|||
148757952|NCT05573464|536587485|FG001|52-week Treatment Period|Death|1|||
148757953|NCT05734157|536587486|FG000|Overall Study|Death|3|||
148757954|NCT05734157|536587486|FG000|Overall Study|Withdrawal by Subject|2|||
148757955|NCT05734157|536587486|FG000|Overall Study|Lost to Follow-up|1|||
148757956|NCT05734157|536587486|FG000|Overall Study|Telephone call|3|||
148757957|NCT04846569|536587487|FG000|Overall Study|Withdrawal by Subject|3|||
148757958|NCT04846569|536587488|FG001|Overall Study|Withdrawal by Subject|1|||
148757959|NCT02512302|536587489|FG000|Period 1|Adverse Event|0|||
148757960|NCT02512302|536587490|FG001|Period 1|Adverse Event|1|||
148757961|NCT02512302|536587491|FG002|Period 1|Adverse Event|0|||
148757962|NCT02512302|536587492|FG003|Period 1|Adverse Event|0|||
148757963|NCT02512302|536587493|FG004|Period 1|Adverse Event|0|||
148757964|NCT02512302|536587494|FG005|Period 1|Adverse Event|0|||
148757965|NCT02512302|536587495|FG006|Period 1|Adverse Event|0|||
148757966|NCT02512302|536587496|FG007|Period 1|Adverse Event|0|||
148757967|NCT02512302|536587497|FG008|Period 1|Adverse Event|0|||
148757968|NCT02512302|536587498|FG009|Period 1|Adverse Event|0|||
148757969|NCT02512302|536587489|FG000|Period 2|Adverse Event|0|||
148823890|NCT02057666|536830898|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
148823891|NCT02057666|536830897|FG000|Double Blind Treatment Period|Physician Decision|1|||
148823892|NCT02057666|536830898|FG001|Double Blind Treatment Period|Physician Decision|0|||
148823893|NCT02057666|536830897|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
148823894|NCT02057666|536830898|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
148823895|NCT02057666|536830897|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
148823896|NCT02057666|536830898|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
148823897|NCT02057666|536830897|FG000|Double Blind Treatment Period|Sponsor's request|70|||
148823898|NCT02057666|536830898|FG001|Double Blind Treatment Period|Sponsor's request|34|||
148823899|NCT02057666|536830897|FG000|Open-Label Treatment Period|Poor tolerability|0|||
148823900|NCT02057666|536830898|FG001|Open-Label Treatment Period|Poor tolerability|1|||
148823901|NCT02057666|536830897|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
148823902|NCT02057666|536830898|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
148823903|NCT02057666|536830897|FG000|Open-Label Treatment Period|Sponsor's request|0|||
148823904|NCT02057666|536830898|FG001|Open-Label Treatment Period|Sponsor's request|4|||
148823905|NCT05661734|536830899|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
148823906|NCT05661734|536830899|FG000|Overall Study|Lost to Follow-up|13|||
148823907|NCT05661734|536830899|FG000|Overall Study|Enrolled but not dosed|2|||
148823908|NCT01569763|536832264|FG000|Overall Study|Lack of Efficacy|2|||
148823909|NCT01569763|536832265|FG001|Overall Study|Lack of Efficacy|7|||
148823910|NCT01569763|536832264|FG000|Overall Study|Adverse Event|1|||
148823911|NCT01569763|536832265|FG001|Overall Study|Adverse Event|0|||
148823912|NCT02730169|536832266|FG000|Overall Study|Protocol Violation|1|||
148823913|NCT02730169|536832267|FG001|Overall Study|Protocol Violation|0|||
148823914|NCT02730169|536832268|FG002|Overall Study|Protocol Violation|0|||
148823915|NCT02730169|536832269|FG003|Overall Study|Protocol Violation|1|||
148823916|NCT02730169|536832266|FG000|Overall Study|Adverse Event|2|||
148823917|NCT02730169|536832267|FG001|Overall Study|Adverse Event|3|||
148823918|NCT02730169|536832268|FG002|Overall Study|Adverse Event|3|||
148823919|NCT02730169|536832269|FG003|Overall Study|Adverse Event|0|||
148823920|NCT02730169|536832266|FG000|Overall Study|Adverse Event of Special Interest|0|||
148823921|NCT02730169|536832267|FG001|Overall Study|Adverse Event of Special Interest|1|||
148823922|NCT02730169|536832268|FG002|Overall Study|Adverse Event of Special Interest|2|||
148823923|NCT02730169|536832269|FG003|Overall Study|Adverse Event of Special Interest|0|||
148823924|NCT02730169|536832266|FG000|Overall Study|Withdrawal by Subject|6|||
148823925|NCT02730169|536832267|FG001|Overall Study|Withdrawal by Subject|11|||
148823926|NCT02730169|536832268|FG002|Overall Study|Withdrawal by Subject|6|||
148823927|NCT02730169|536832269|FG003|Overall Study|Withdrawal by Subject|8|||
148823928|NCT02730169|536832266|FG000|Overall Study|Lost to Follow-up|5|||
148823929|NCT02730169|536832267|FG001|Overall Study|Lost to Follow-up|6|||
148823930|NCT02730169|536832268|FG002|Overall Study|Lost to Follow-up|5|||
148823931|NCT02730169|536832269|FG003|Overall Study|Lost to Follow-up|6|||
148823932|NCT02730169|536832266|FG000|Overall Study|Other|0|||
148823933|NCT02730169|536832267|FG001|Overall Study|Other|0|||
148823934|NCT02730169|536832268|FG002|Overall Study|Other|1|||
148823935|NCT02730169|536832269|FG003|Overall Study|Other|1|||
148823936|NCT03004183|536832270|FG000|Overall Study|Adverse Event|7|||
148823937|NCT03004183|536832270|FG000|Overall Study|Lost to Follow-up|1|||
148823938|NCT03004183|536832270|FG000|Overall Study|Physician Decision|40|||
148823939|NCT03004183|536832270|FG000|Overall Study|Withdrawal by Subject|1|||
148823940|NCT03004183|536832270|FG000|Overall Study|COVID-19|1|||
148823941|NCT03681093|536832271|FG000|Overall Study|Subject decision|0|||
148976450|NCT04542070|537394544|FG001|Maintenance + Extension Period|Protocol Violation|5|||
148976451|NCT04542070|537394545|FG002|Maintenance + Extension Period|Protocol Violation|0|||
148976452|NCT04542070|537394546|FG003|Maintenance + Extension Period|Protocol Violation|0|||
148976453|NCT04542070|537394543|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
148976454|NCT04542070|537394544|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
148757970|NCT02512302|536587490|FG001|Period 2|Adverse Event|0|||
148757971|NCT02512302|536587491|FG002|Period 2|Adverse Event|0|||
148757972|NCT02512302|536587492|FG003|Period 2|Adverse Event|0|||
148757973|NCT02512302|536587493|FG004|Period 2|Adverse Event|0|||
148757974|NCT02512302|536587494|FG005|Period 2|Adverse Event|0|||
148757975|NCT02512302|536587495|FG006|Period 2|Adverse Event|0|||
148757976|NCT02512302|536587496|FG007|Period 2|Adverse Event|0|||
148757977|NCT02512302|536587497|FG008|Period 2|Adverse Event|0|||
148757978|NCT02512302|536587498|FG009|Period 2|Adverse Event|1|||
148757979|NCT02512302|536587489|FG000|Period 3|Lost to Follow-up|0|||
148757980|NCT02512302|536587490|FG001|Period 3|Lost to Follow-up|0|||
148757981|NCT02512302|536587491|FG002|Period 3|Lost to Follow-up|1|||
148823942|NCT03681093|536832272|FG001|Overall Study|Subject decision|2|||
148823943|NCT03681093|536832273|FG002|Overall Study|Subject decision|1|||
148757982|NCT02512302|536587492|FG003|Period 3|Lost to Follow-up|0|||
148823944|NCT02529488|536832274|FG000|Overall Study|Adverse Event|1|||
148823945|NCT02529488|536832274|FG000|Overall Study|Death|3|||
148823946|NCT02698787|536832275|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
148823947|NCT02698787|536832276|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
148823948|NCT01882829|536832280|FG000|Overall Study|Adverse Event|4|||
148823949|NCT01882829|536832280|FG000|Overall Study|Protocol Violation|1|||
148823950|NCT01882829|536832280|FG000|Overall Study|Withdrawal by Subject|1|||
148823951|NCT02469961|536832286|FG000|Overall Study|Physician Decision|4|||
148823952|NCT02469961|536832287|FG001|Overall Study|Physician Decision|1|||
148823953|NCT00326495|536832288|FG000|Overall Study|Switched to alternative treatment|1|||
148823954|NCT00326495|536832288|FG000|Overall Study|Disease progression before treatment|1|||
148823955|NCT00326495|536832288|FG000|Overall Study|Refused further treatment|2|||
148823956|NCT00326495|536832288|FG000|Overall Study|Subject off study before assessment|1|||
148823957|NCT02933151|536832289|FG000|Overall Study|Lost to Follow-up|19|||
148823958|NCT02933151|536832290|FG001|Overall Study|Lost to Follow-up|18|||
148823959|NCT02933151|536832289|FG000|Overall Study|Death|1732|||
148823960|NCT02933151|536832290|FG001|Overall Study|Death|1827|||
148823961|NCT02933151|536832289|FG000|Overall Study|Transplant|210|||
148823962|NCT02933151|536832290|FG001|Overall Study|Transplant|278|||
148976455|NCT04542070|537394545|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
148976456|NCT04542070|537394546|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
148976457|NCT04542070|537394543|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
148976458|NCT04542070|537394544|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
148976459|NCT04542070|537394545|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
148757983|NCT02512302|536587493|FG004|Period 3|Lost to Follow-up|0|||
148757984|NCT02512302|536587494|FG005|Period 3|Lost to Follow-up|0|||
148757985|NCT02512302|536587495|FG006|Period 3|Lost to Follow-up|0|||
148757986|NCT02512302|536587496|FG007|Period 3|Lost to Follow-up|0|||
148757987|NCT02512302|536587497|FG008|Period 3|Lost to Follow-up|0|||
148757988|NCT02512302|536587498|FG009|Period 3|Lost to Follow-up|0|||
148757989|NCT02512302|536587489|FG000|Period 4|Adverse Event|0|||
148757990|NCT02512302|536587490|FG001|Period 4|Adverse Event|0|||
148757991|NCT02512302|536587491|FG002|Period 4|Adverse Event|0|||
148757992|NCT02512302|536587492|FG003|Period 4|Adverse Event|0|||
148757993|NCT02512302|536587493|FG004|Period 4|Adverse Event|0|||
148757994|NCT02512302|536587494|FG005|Period 4|Adverse Event|0|||
148757995|NCT02512302|536587495|FG006|Period 4|Adverse Event|1|||
148757996|NCT02512302|536587496|FG007|Period 4|Adverse Event|0|||
148757997|NCT02512302|536587497|FG008|Period 4|Adverse Event|0|||
148757998|NCT02512302|536587498|FG009|Period 4|Adverse Event|0|||
148757999|NCT02342678|536587502|FG000|Overall Study|Lost to Follow-up|0|||
148758000|NCT02342678|536587503|FG001|Overall Study|Lost to Follow-up|1|||
148758001|NCT02342678|536587502|FG000|Overall Study|Too busy to complete study|0|||
148758002|NCT02342678|536587503|FG001|Overall Study|Too busy to complete study|2|||
148758003|NCT02342678|536587502|FG000|Overall Study|Family illness/emergency|0|||
148758004|NCT02342678|536587503|FG001|Overall Study|Family illness/emergency|1|||
148758005|NCT02342678|536587502|FG000|Overall Study|Illness/medical reason|1|||
148758006|NCT02342678|536587503|FG001|Overall Study|Illness/medical reason|1|||
148758007|NCT00350207|536587504|FG000|Overall Study|Adverse Event|5|||
148758008|NCT00350207|536587505|FG001|Overall Study|Adverse Event|2|||
148758009|NCT00350207|536587506|FG002|Overall Study|Adverse Event|2|||
148758010|NCT00350207|536587504|FG000|Overall Study|Lack of Efficacy|1|||
148758011|NCT00350207|536587505|FG001|Overall Study|Lack of Efficacy|0|||
148758012|NCT00350207|536587506|FG002|Overall Study|Lack of Efficacy|2|||
148758013|NCT00350207|536587504|FG000|Overall Study|Lost to Follow-up|1|||
148758014|NCT00350207|536587505|FG001|Overall Study|Lost to Follow-up|0|||
148758015|NCT00350207|536587506|FG002|Overall Study|Lost to Follow-up|1|||
148758016|NCT00350207|536587504|FG000|Overall Study|Withdrawal by Subject|0|||
148758017|NCT00350207|536587505|FG001|Overall Study|Withdrawal by Subject|1|||
148758018|NCT00350207|536587506|FG002|Overall Study|Withdrawal by Subject|1|||
148758019|NCT00350207|536587504|FG000|Overall Study|Other|1|||
148758020|NCT00350207|536587505|FG001|Overall Study|Other|3|||
148758021|NCT00350207|536587506|FG002|Overall Study|Other|1|||
148758022|NCT03214224|536587507|FG000|Overall Study|Protocol Violation|1|||
148758023|NCT03214224|536587507|FG000|Overall Study|Withdrawal by Subject|2|||
148758024|NCT03214224|536587507|FG000|Overall Study|Practice controls or therapists|6|||
148823963|NCT02933151|536832289|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
148823964|NCT02933151|536832290|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
148758025|NCT03802825|536587508|FG000|Overall Study|Lost to follow-up for intervention|12|||
148758026|NCT03802825|536587509|FG001|Overall Study|Lost to follow-up for intervention|3|||
148758027|NCT03802825|536587508|FG000|Overall Study|Received only 1 component of intervention|0|||
148758028|NCT03802825|536587509|FG001|Overall Study|Received only 1 component of intervention|13|||
148758029|NCT01051960|536587516|FG000|Overall Study|Adverse Event|1|||
148758030|NCT00360282|536587517|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
148758031|NCT00360282|536587518|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
148758032|NCT00360282|536587519|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
148758033|NCT00360282|536587520|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
148758034|NCT00360282|536587517|FG000|Second Intervention|Adverse Event|0|||
148823965|NCT02933151|536832289|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
148823966|NCT02933151|536832290|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
148823967|NCT02933151|536832289|FG000|Overall Study|Recovered Kidney Function|47|||
148976460|NCT04542070|537394546|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
148976461|NCT04542070|537394543|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
148976462|NCT04542070|537394544|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
148976463|NCT04542070|537394545|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
148976464|NCT04542070|537394546|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
148976465|NCT04542070|537394543|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
148758035|NCT00360282|536587518|FG001|Second Intervention|Adverse Event|1|||
148758036|NCT00360282|536587519|FG002|Second Intervention|Adverse Event|0|||
148758037|NCT00360282|536587520|FG003|Second Intervention|Adverse Event|0|||
148758038|NCT04537078|536587523|FG000|Overall Study|Protocol Violation|3|||
148758039|NCT04537078|536587524|FG001|Overall Study|Protocol Violation|2|||
148758040|NCT04537078|536587523|FG000|Overall Study|Lost to Follow-up|1|||
148758041|NCT04537078|536587524|FG001|Overall Study|Lost to Follow-up|0|||
148758042|NCT04537078|536587523|FG000|Overall Study|Withdrawal by Subject|0|||
148758043|NCT04537078|536587524|FG001|Overall Study|Withdrawal by Subject|1|||
148758044|NCT01293695|536587528|FG000|Overall Study|Withdrawal by Subject|7|||
148758045|NCT01293695|536587529|FG001|Overall Study|Withdrawal by Subject|1|||
148758046|NCT01293695|536587528|FG000|Overall Study|Lost to Follow-up|8|||
148758047|NCT01293695|536587529|FG001|Overall Study|Lost to Follow-up|6|||
148758048|NCT01568892|536587532|FG000|Open-label Phase|Adverse Event|2|||
148758049|NCT01568892|536587533|FG001|Open-label Phase|Adverse Event|0|||
148758050|NCT01568892|536587532|FG000|Open-label Phase|Lack of Efficacy|4|||
148758051|NCT01568892|536587533|FG001|Open-label Phase|Lack of Efficacy|2|||
148758052|NCT01568892|536587532|FG000|Open-label Phase|Lost to Follow-up|0|||
148758053|NCT01568892|536587533|FG001|Open-label Phase|Lost to Follow-up|1|||
148758054|NCT02375971|536587540|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
148758055|NCT02375971|536587541|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
148758056|NCT02375971|536587542|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
148758057|NCT02375971|536587540|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
148758058|NCT02375971|536587541|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
148758059|NCT02375971|536587542|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
148758060|NCT02375971|536587540|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
148758061|NCT02375971|536587541|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
148758062|NCT02375971|536587542|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
148758063|NCT02375971|536587540|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
148758064|NCT02375971|536587541|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
148758065|NCT02375971|536587542|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
148758066|NCT02375971|536587540|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
148758067|NCT02375971|536587541|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
148758068|NCT02375971|536587542|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
148758069|NCT02375971|536587540|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
148758070|NCT02375971|536587541|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
148758071|NCT02375971|536587542|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
148758072|NCT02375971|536587540|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
148758073|NCT02375971|536587541|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
148758074|NCT02375971|536587542|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
148758075|NCT02375971|536587540|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
148758076|NCT02375971|536587541|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
148758077|NCT02375971|536587542|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
148758078|NCT02755103|536587543|FG000|Overall Study|Lost to Follow-up|17|||
148758079|NCT02755103|536587544|FG001|Overall Study|Lost to Follow-up|15|||
148758080|NCT02755103|536587543|FG000|Overall Study|Death|0|||
148758081|NCT02755103|536587544|FG001|Overall Study|Death|1|||
148758082|NCT02755103|536587543|FG000|Overall Study|Physician Decision|0|||
148758083|NCT02755103|536587544|FG001|Overall Study|Physician Decision|1|||
148758084|NCT02755103|536587543|FG000|Overall Study|Pregnancy|0|||
148758085|NCT02755103|536587544|FG001|Overall Study|Pregnancy|1|||
148758086|NCT02755103|536587543|FG000|Overall Study|Withdrawal by Subject|3|||
148758087|NCT02755103|536587544|FG001|Overall Study|Withdrawal by Subject|0|||
148758088|NCT04177095|536587545|FG000|Overall Study|Withdrawal by Subject|3|||
148758089|NCT04177095|536587545|FG000|Overall Study|Screen Failure|3|||
148758090|NCT04177095|536587545|FG000|Overall Study|Problems with the Trugraf assay|1|||
148758091|NCT00658723|536587546|FG000|Overall Study|Lost to Follow-up|0|||
148758092|NCT00658723|536587547|FG001|Overall Study|Lost to Follow-up|2|||
148758093|NCT00658723|536587548|FG002|Overall Study|Lost to Follow-up|2|||
148758094|NCT00658723|536587546|FG000|Overall Study|Death|2|||
148758095|NCT00658723|536587547|FG001|Overall Study|Death|1|||
148758096|NCT00658723|536587548|FG002|Overall Study|Death|4|||
148976466|NCT04542070|537394544|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
148976467|NCT04542070|537394545|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
148976468|NCT04542070|537394546|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
148758097|NCT00658723|536587546|FG000|Overall Study|Scheduling Issue|1|||
148758098|NCT00658723|536587547|FG001|Overall Study|Scheduling Issue|1|||
148758099|NCT00658723|536587548|FG002|Overall Study|Scheduling Issue|0|||
148823968|NCT02933151|536832290|FG001|Overall Study|Recovered Kidney Function|29|||
148823969|NCT00394472|536832291|FG000|Overall Study|Protocol Violation|1|||
148823970|NCT00394472|536832292|FG001|Overall Study|Protocol Violation|3|||
148823971|NCT00394472|536832291|FG000|Overall Study|incorrect enrolment|4|||
148823972|NCT00394472|536832292|FG001|Overall Study|incorrect enrolment|2|||
148823973|NCT00394472|536832291|FG000|Overall Study|Adverse Event|4|||
148823974|NCT00394472|536832292|FG001|Overall Study|Adverse Event|2|||
148823975|NCT00394472|536832291|FG000|Overall Study|Withdrawal by Subject|0|||
148823976|NCT00394472|536832292|FG001|Overall Study|Withdrawal by Subject|2|||
148823977|NCT00394472|536832291|FG000|Overall Study|Physician Decision|0|||
148823978|NCT00394472|536832292|FG001|Overall Study|Physician Decision|1|||
148823979|NCT00394472|536832291|FG000|Overall Study|Lost to Follow-up|0|||
148823980|NCT00394472|536832292|FG001|Overall Study|Lost to Follow-up|1|||
148823981|NCT02462057|536832305|FG000|Overall Study|Left Vitality|32|||
148823982|NCT02462057|536832306|FG001|Overall Study|Left Vitality|27|||
148823983|NCT02462057|536832307|FG002|Overall Study|Left Vitality|23|||
148823984|NCT02462057|536832308|FG003|Overall Study|Left Vitality|35|||
148823985|NCT02462057|536832309|FG004|Overall Study|Left Vitality|33|||
148823986|NCT02462057|536832305|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
148823987|NCT02462057|536832306|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
148823988|NCT02462057|536832307|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
148823989|NCT02462057|536832308|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
148823990|NCT02462057|536832309|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
148823991|NCT02105012|536832315|FG000|Overall Study|Withdrawal by Subject|11|||
148823992|NCT02105012|536832315|FG000|Overall Study|Protocol Specified Criteria|9|||
148823993|NCT02105012|536832315|FG000|Overall Study|Lost to Follow-up|4|||
148823994|NCT02105012|536832315|FG000|Overall Study|Protocol Violation|4|||
148823995|NCT02105012|536832315|FG000|Overall Study|Physician Decision|3|||
148823996|NCT02105012|536832315|FG000|Overall Study|Adverse Event|1|||
148823997|NCT02105012|536832315|FG000|Overall Study|Lack of Efficacy|1|||
148823998|NCT00474968|536832322|FG000|Overall Study|Withdrawal by Subject|8|||
148823999|NCT00474968|536832323|FG001|Overall Study|Withdrawal by Subject|7|||
148824000|NCT00474968|536832322|FG000|Overall Study|Protocol Violation|9|||
148824001|NCT00474968|536832323|FG001|Overall Study|Protocol Violation|8|||
148824002|NCT00474968|536832322|FG000|Overall Study|Sample not collected|1|||
148824003|NCT00474968|536832323|FG001|Overall Study|Sample not collected|1|||
148824004|NCT00215553|536832324|FG000|Overall Study|Adverse Event|0|||
148824005|NCT00215553|536832325|FG001|Overall Study|Adverse Event|1|||
148824006|NCT00215553|536832326|FG002|Overall Study|Adverse Event|2|||
148824007|NCT00215553|536832327|FG003|Overall Study|Adverse Event|1|||
148824008|NCT00215553|536832328|FG004|Overall Study|Adverse Event|2|||
148824009|NCT00215553|536832329|FG005|Overall Study|Adverse Event|6|||
148824010|NCT00215553|536832330|FG006|Overall Study|Adverse Event|0|||
148824011|NCT01429623|536832331|FG000|Overall Study|Death|1|||
148824012|NCT01429623|536832332|FG001|Overall Study|Death|0|||
148824013|NCT01429623|536832331|FG000|Overall Study|Adverse Event|7|||
148976469|NCT04542070|537394543|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
148976470|NCT04542070|537394544|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
148976471|NCT04542070|537394545|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
148976472|NCT04542070|537394546|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
148824014|NCT01429623|536832332|FG001|Overall Study|Adverse Event|14|||
148824015|NCT01429623|536832331|FG000|Overall Study|Withdrawal by Subject|19|||
148824016|NCT01429623|536832332|FG001|Overall Study|Withdrawal by Subject|13|||
148824017|NCT01429623|536832331|FG000|Overall Study|Physician Decision|2|||
148824018|NCT01429623|536832332|FG001|Overall Study|Physician Decision|3|||
148824019|NCT01429623|536832331|FG000|Overall Study|Protocol Violation|3|||
148824020|NCT01429623|536832332|FG001|Overall Study|Protocol Violation|2|||
148824021|NCT01429623|536832331|FG000|Overall Study|Assorted|1|||
148824022|NCT01429623|536832332|FG001|Overall Study|Assorted|2|||
148824023|NCT01429623|536832331|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
148976473|NCT04542070|537394543|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
148976474|NCT04542070|537394544|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
148976475|NCT04542070|537394545|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
148976476|NCT04542070|537394546|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
148824024|NCT01429623|536832332|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
148824025|NCT01429623|536832331|FG000|Overall Study|No post baseline data|4|||
148824026|NCT01429623|536832332|FG001|Overall Study|No post baseline data|4|||
148824027|NCT05345405|536832333|FG000|Overall Study|Withdrawal by Subject|2|||
148824028|NCT05345405|536832334|FG001|Overall Study|Withdrawal by Subject|0|||
148824029|NCT05345405|536832335|FG002|Overall Study|Withdrawal by Subject|0|||
148824030|NCT05345405|536832333|FG000|Overall Study|Did not meet eligibility criteria|0|||
148824031|NCT05345405|536832334|FG001|Overall Study|Did not meet eligibility criteria|2|||
148824032|NCT05345405|536832335|FG002|Overall Study|Did not meet eligibility criteria|0|||
148824033|NCT05345405|536832333|FG000|Overall Study|Lost to Follow-up|0|||
148824034|NCT05345405|536832334|FG001|Overall Study|Lost to Follow-up|0|||
148824035|NCT05345405|536832335|FG002|Overall Study|Lost to Follow-up|1|||
148824036|NCT03071965|536832337|FG000|Overall Study|Adverse Event|0|||
148824037|NCT03071965|536832338|FG001|Overall Study|Adverse Event|0|||
148824038|NCT03071965|536832339|FG002|Overall Study|Adverse Event|1|||
148824039|NCT03071965|536832340|FG003|Overall Study|Adverse Event|0|||
148824040|NCT03071965|536832337|FG000|Overall Study|Death|0|||
148824041|NCT03071965|536832338|FG001|Overall Study|Death|0|||
148824042|NCT03071965|536832339|FG002|Overall Study|Death|1|||
148824043|NCT03071965|536832340|FG003|Overall Study|Death|1|||
148824044|NCT03071965|536832337|FG000|Overall Study|COVID-19|0|||
148824045|NCT03071965|536832338|FG001|Overall Study|COVID-19|1|||
148824046|NCT03071965|536832339|FG002|Overall Study|COVID-19|0|||
148824047|NCT03071965|536832340|FG003|Overall Study|COVID-19|1|||
148824048|NCT03071965|536832337|FG000|Overall Study|Other Health Reason|0|||
148824049|NCT03071965|536832338|FG001|Overall Study|Other Health Reason|0|||
148824050|NCT03071965|536832339|FG002|Overall Study|Other Health Reason|0|||
148824051|NCT03071965|536832340|FG003|Overall Study|Other Health Reason|1|||
148824052|NCT00986102|536832341|FG000|Overall Study|Lost to Follow-up|0|||
148824053|NCT00986102|536832342|FG001|Overall Study|Lost to Follow-up|1|||
148824054|NCT00986102|536832343|FG002|Overall Study|Lost to Follow-up|0|||
148824055|NCT00986102|536832344|FG003|Overall Study|Lost to Follow-up|1|||
148824056|NCT00986102|536832341|FG000|Overall Study|Withdrawal by Subject|1|||
148824057|NCT00986102|536832342|FG001|Overall Study|Withdrawal by Subject|1|||
148824058|NCT00986102|536832343|FG002|Overall Study|Withdrawal by Subject|0|||
148824059|NCT00986102|536832344|FG003|Overall Study|Withdrawal by Subject|0|||
148824060|NCT04135352|536832346|FG000|Overall Study|Not treated-randomization error|0|||
148824061|NCT04135352|536832347|FG001|Overall Study|Not treated-randomization error|0|||
148824062|NCT04135352|536832348|FG002|Overall Study|Not treated-randomization error|1|||
148824063|NCT04135352|536832349|FG003|Overall Study|Not treated-randomization error|0|||
148824064|NCT04135352|536832350|FG004|Overall Study|Not treated-randomization error|0|||
148824065|NCT04135352|536832351|FG005|Overall Study|Not treated-randomization error|0|||
148824066|NCT04135352|536832352|FG006|Overall Study|Not treated-randomization error|0|||
148824067|NCT04135352|536832353|FG007|Overall Study|Not treated-randomization error|0|||
148824068|NCT04135352|536832346|FG000|Overall Study|Withdrawal by Subject|0|||
148824069|NCT04135352|536832347|FG001|Overall Study|Withdrawal by Subject|0|||
148824070|NCT04135352|536832348|FG002|Overall Study|Withdrawal by Subject|2|||
148824071|NCT04135352|536832349|FG003|Overall Study|Withdrawal by Subject|0|||
148824072|NCT04135352|536832350|FG004|Overall Study|Withdrawal by Subject|0|||
148824073|NCT04135352|536832351|FG005|Overall Study|Withdrawal by Subject|0|||
148824074|NCT04135352|536832352|FG006|Overall Study|Withdrawal by Subject|0|||
148824075|NCT04135352|536832353|FG007|Overall Study|Withdrawal by Subject|0|||
148824076|NCT04135352|536832346|FG000|Overall Study|Sponsor Decision|0|||
148824077|NCT04135352|536832347|FG001|Overall Study|Sponsor Decision|0|||
148824078|NCT04135352|536832348|FG002|Overall Study|Sponsor Decision|2|||
148824079|NCT04135352|536832349|FG003|Overall Study|Sponsor Decision|5|||
148824080|NCT04135352|536832350|FG004|Overall Study|Sponsor Decision|1|||
148824081|NCT04135352|536832351|FG005|Overall Study|Sponsor Decision|4|||
148824082|NCT04135352|536832352|FG006|Overall Study|Sponsor Decision|0|||
148824083|NCT04135352|536832353|FG007|Overall Study|Sponsor Decision|0|||
148824084|NCT04135352|536832346|FG000|Overall Study|Physician Decision|0|||
148824085|NCT04135352|536832347|FG001|Overall Study|Physician Decision|0|||
148824086|NCT04135352|536832348|FG002|Overall Study|Physician Decision|1|||
148824087|NCT04135352|536832349|FG003|Overall Study|Physician Decision|0|||
148976477|NCT04542070|537394543|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
148824088|NCT04135352|536832350|FG004|Overall Study|Physician Decision|1|||
148824089|NCT04135352|536832351|FG005|Overall Study|Physician Decision|0|||
148824090|NCT04135352|536832352|FG006|Overall Study|Physician Decision|0|||
148824091|NCT04135352|536832353|FG007|Overall Study|Physician Decision|0|||
148824092|NCT04135352|536832346|FG000|Overall Study|Death|3|||
148824093|NCT04135352|536832347|FG001|Overall Study|Death|4|||
148824094|NCT04135352|536832348|FG002|Overall Study|Death|7|||
148824095|NCT04135352|536832349|FG003|Overall Study|Death|0|||
148824096|NCT04135352|536832350|FG004|Overall Study|Death|3|||
148976478|NCT04542070|537394544|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
148824097|NCT04135352|536832351|FG005|Overall Study|Death|1|||
148824098|NCT04135352|536832352|FG006|Overall Study|Death|0|||
148824099|NCT04135352|536832353|FG007|Overall Study|Death|0|||
148824100|NCT01392495|536832356|FG000|Overall Study|Death|3|||
148824101|NCT01392495|536832356|FG000|Overall Study|Administrative problems|8|||
148824102|NCT01392495|536832356|FG000|Overall Study|Withdrawal by Subject|2|||
148824103|NCT01392495|536832356|FG000|Overall Study|Adverse Event|3|||
148824104|NCT00819832|536832359|FG000|Overall Study|Sponsor Termination of Study|3|||
148824105|NCT00819832|536832360|FG001|Overall Study|Sponsor Termination of Study|0|||
148824106|NCT00819832|536832361|FG002|Overall Study|Sponsor Termination of Study|0|||
148824107|NCT00819832|536832362|FG003|Overall Study|Sponsor Termination of Study|0|||
148824108|NCT00819832|536832363|FG004|Overall Study|Sponsor Termination of Study|0|||
148824109|NCT00819832|536832364|FG005|Overall Study|Sponsor Termination of Study|0|||
148824110|NCT01309100|536832365|FG000|Overall Study|Protocol Violation|1|||
148824111|NCT01309100|536832365|FG000|Overall Study|Positive Slit lamp finding|1|||
148758100|NCT00658723|536587546|FG000|Overall Study|Withdrawal by Subject|1|||
148758101|NCT00658723|536587547|FG001|Overall Study|Withdrawal by Subject|0|||
148758102|NCT00658723|536587548|FG002|Overall Study|Withdrawal by Subject|1|||
148758103|NCT03876743|536587549|FG000|Overall Study|Lost to Follow-up|6|||
148758104|NCT03876743|536587550|FG001|Overall Study|Lost to Follow-up|4|||
148758105|NCT03876743|536587551|FG002|Overall Study|Lost to Follow-up|4|||
148758106|NCT03876743|536587552|FG003|Overall Study|Lost to Follow-up|7|||
148758107|NCT03889418|536587553|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
148758108|NCT03889418|536587554|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758109|NCT03889418|536587555|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758110|NCT03889418|536587556|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758111|NCT03889418|536587557|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758112|NCT03889418|536587558|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758113|NCT03889418|536587559|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758114|NCT03889418|536587560|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758115|NCT03889418|536587561|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758116|NCT03889418|536587562|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
148758117|NCT03889418|536587553|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758118|NCT03889418|536587554|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
148758119|NCT03889418|536587555|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
148758120|NCT03889418|536587556|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758121|NCT03889418|536587557|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758122|NCT03889418|536587558|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758123|NCT03889418|536587559|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758124|NCT03889418|536587560|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758125|NCT03889418|536587561|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758126|NCT03889418|536587562|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
148758127|NCT03889418|536587553|FG000|October-December 2019 (Month 7-9)|Death|0|||
148758128|NCT03889418|536587554|FG001|October-December 2019 (Month 7-9)|Death|0|||
148758129|NCT03889418|536587555|FG002|October-December 2019 (Month 7-9)|Death|0|||
148758130|NCT03889418|536587556|FG003|October-December 2019 (Month 7-9)|Death|0|||
148758131|NCT03889418|536587557|FG004|October-December 2019 (Month 7-9)|Death|0|||
148758132|NCT03889418|536587558|FG005|October-December 2019 (Month 7-9)|Death|0|||
148758133|NCT03889418|536587559|FG006|October-December 2019 (Month 7-9)|Death|0|||
148758134|NCT03889418|536587560|FG007|October-December 2019 (Month 7-9)|Death|0|||
148758135|NCT03889418|536587561|FG008|October-December 2019 (Month 7-9)|Death|1|||
148758136|NCT03889418|536587562|FG009|October-December 2019 (Month 7-9)|Death|0|||
148758137|NCT03889418|536587553|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758138|NCT03889418|536587554|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758139|NCT03889418|536587555|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758140|NCT03889418|536587556|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
148758141|NCT03889418|536587557|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758142|NCT03889418|536587558|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758143|NCT03889418|536587559|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758144|NCT03889418|536587560|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
148758145|NCT03889418|536587561|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758146|NCT03889418|536587562|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
148758147|NCT03889418|536587553|FG000|April - June 2020 (Month 13-15)|Death|0|||
148758148|NCT03889418|536587554|FG001|April - June 2020 (Month 13-15)|Death|1|||
148758149|NCT03889418|536587555|FG002|April - June 2020 (Month 13-15)|Death|0|||
148758150|NCT03889418|536587556|FG003|April - June 2020 (Month 13-15)|Death|0|||
148758151|NCT03889418|536587557|FG004|April - June 2020 (Month 13-15)|Death|0|||
148758152|NCT03889418|536587558|FG005|April - June 2020 (Month 13-15)|Death|0|||
148758153|NCT03889418|536587559|FG006|April - June 2020 (Month 13-15)|Death|0|||
148758154|NCT03889418|536587560|FG007|April - June 2020 (Month 13-15)|Death|0|||
148758155|NCT03889418|536587561|FG008|April - June 2020 (Month 13-15)|Death|0|||
148758156|NCT03889418|536587562|FG009|April - June 2020 (Month 13-15)|Death|0|||
148758157|NCT03889418|536587553|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758158|NCT03889418|536587554|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758159|NCT03889418|536587555|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758160|NCT03889418|536587556|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
148758161|NCT03889418|536587557|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758162|NCT03889418|536587558|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758163|NCT03889418|536587559|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758164|NCT03889418|536587560|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758165|NCT03889418|536587561|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148758166|NCT03889418|536587562|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
148824112|NCT01452789|536832368|FG000|Overall Study|Withdrawal by Subject|3|||
148758167|NCT03889418|536587553|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
148758168|NCT03889418|536587554|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
148976479|NCT04542070|537394545|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
148976480|NCT04542070|537394546|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
148976481|NCT01813019|537394552|FG000|Overall Study|Adverse Event|0|||
148976482|NCT01813019|537394553|FG001|Overall Study|Adverse Event|3|||
148976483|NCT01813019|537394552|FG000|Overall Study|Withdrawal by Subject|3|||
148976484|NCT01813019|537394553|FG001|Overall Study|Withdrawal by Subject|2|||
148758169|NCT03889418|536587555|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
148758170|NCT03889418|536587556|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
148758171|NCT03889418|536587557|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
148758172|NCT03889418|536587558|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
148758173|NCT03889418|536587559|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
148758174|NCT03889418|536587560|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
148758175|NCT03889418|536587561|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
148758176|NCT03889418|536587562|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
148758177|NCT03889418|536587553|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
148758178|NCT03889418|536587554|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
148758179|NCT03889418|536587555|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
148758180|NCT03889418|536587556|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
148758181|NCT03889418|536587557|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
148758182|NCT03889418|536587558|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
148758183|NCT03889418|536587559|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
148758184|NCT03889418|536587560|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
148758185|NCT03889418|536587561|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
148758186|NCT03889418|536587562|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
148758187|NCT00380874|536587568|FG000|Overall Study|Adverse Event|7|||
148758188|NCT00380874|536587569|FG001|Overall Study|Adverse Event|7|||
148758189|NCT00380874|536587568|FG000|Overall Study|Death|1|||
148758190|NCT00380874|536587569|FG001|Overall Study|Death|0|||
148758191|NCT00380874|536587568|FG000|Overall Study|Withdrawal by Subject|2|||
148758192|NCT00380874|536587569|FG001|Overall Study|Withdrawal by Subject|1|||
148758193|NCT00380874|536587568|FG000|Overall Study|Not related to study drug|3|||
148758194|NCT00380874|536587569|FG001|Overall Study|Not related to study drug|2|||
148758195|NCT03380429|536587570|FG000|Overall Study|Physician Decision|0|||
148758196|NCT03380429|536587571|FG001|Overall Study|Physician Decision|1|||
148758197|NCT03380429|536587572|FG002|Overall Study|Physician Decision|0|||
148758198|NCT03380429|536587573|FG003|Overall Study|Physician Decision|1|||
148758199|NCT03380429|536587574|FG004|Overall Study|Physician Decision|1|||
148758200|NCT03380429|536587570|FG000|Overall Study|Withdrawal by Subject|3|||
148758201|NCT03380429|536587571|FG001|Overall Study|Withdrawal by Subject|3|||
148758202|NCT03380429|536587572|FG002|Overall Study|Withdrawal by Subject|5|||
148758203|NCT03380429|536587573|FG003|Overall Study|Withdrawal by Subject|2|||
148758204|NCT03380429|536587574|FG004|Overall Study|Withdrawal by Subject|1|||
148758205|NCT03380429|536587570|FG000|Overall Study|Lost to Follow-up|0|||
148758206|NCT03380429|536587571|FG001|Overall Study|Lost to Follow-up|2|||
148758207|NCT03380429|536587572|FG002|Overall Study|Lost to Follow-up|4|||
148758208|NCT03380429|536587573|FG003|Overall Study|Lost to Follow-up|3|||
148758209|NCT03380429|536587574|FG004|Overall Study|Lost to Follow-up|1|||
148758210|NCT03380429|536587570|FG000|Overall Study|Protocol Violation|1|||
148758211|NCT03380429|536587571|FG001|Overall Study|Protocol Violation|0|||
148758212|NCT03380429|536587572|FG002|Overall Study|Protocol Violation|1|||
148758213|NCT03380429|536587573|FG003|Overall Study|Protocol Violation|0|||
148758214|NCT03380429|536587574|FG004|Overall Study|Protocol Violation|1|||
148758215|NCT03380429|536587570|FG000|Overall Study|Lack of Efficacy|0|||
148758216|NCT03380429|536587571|FG001|Overall Study|Lack of Efficacy|0|||
148758217|NCT03380429|536587572|FG002|Overall Study|Lack of Efficacy|0|||
148758218|NCT03380429|536587573|FG003|Overall Study|Lack of Efficacy|2|||
148758219|NCT03380429|536587574|FG004|Overall Study|Lack of Efficacy|1|||
148758220|NCT03380429|536587570|FG000|Overall Study|Adverse Event|1|||
148758221|NCT03380429|536587571|FG001|Overall Study|Adverse Event|1|||
148758222|NCT03380429|536587572|FG002|Overall Study|Adverse Event|1|||
148758223|NCT03380429|536587573|FG003|Overall Study|Adverse Event|2|||
148758224|NCT03380429|536587574|FG004|Overall Study|Adverse Event|0|||
148758225|NCT01707290|536587581|FG000|Overall Study|Adverse event (AE)|1|||
148758226|NCT01707290|536587582|FG001|Overall Study|Adverse event (AE)|0|||
148758227|NCT01707290|536587581|FG000|Overall Study|Physician Decision|1|||
148758228|NCT01707290|536587582|FG001|Overall Study|Physician Decision|0|||
148758229|NCT01707290|536587581|FG000|Overall Study|Lost to Follow-up|3|||
148758230|NCT01707290|536587582|FG001|Overall Study|Lost to Follow-up|0|||
148976485|NCT01813019|537394552|FG000|Overall Study|administrative problems|2|||
148758231|NCT01707290|536587581|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
148758232|NCT01707290|536587582|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
148758233|NCT01707290|536587581|FG000|Overall Study|Commercial drug available|60|||
148758234|NCT01707290|536587582|FG001|Overall Study|Commercial drug available|1|||
148824113|NCT01452789|536832369|FG001|Overall Study|Withdrawal by Subject|2|||
148758235|NCT01707290|536587581|FG000|Overall Study|Other unspecified|17|||
148758236|NCT01707290|536587582|FG001|Overall Study|Other unspecified|0|||
148758237|NCT02314026|536587583|FG000|Overall Study|Protocol Violation|28|||
148758238|NCT01139775|536587584|FG000|Overall Study|Adverse Event|0|||
148758239|NCT01139775|536587585|FG001|Overall Study|Adverse Event|6|||
148758240|NCT01139775|536587586|FG002|Overall Study|Adverse Event|2|||
148758241|NCT01139775|536587584|FG000|Overall Study|Protocol Violation|0|||
148758242|NCT01139775|536587585|FG001|Overall Study|Protocol Violation|5|||
148758243|NCT01139775|536587586|FG002|Overall Study|Protocol Violation|0|||
148758244|NCT01139775|536587584|FG000|Overall Study|Withdrawal by Subject|1|||
148758245|NCT01139775|536587585|FG001|Overall Study|Withdrawal by Subject|0|||
148758246|NCT01139775|536587586|FG002|Overall Study|Withdrawal by Subject|2|||
148758247|NCT01139775|536587584|FG000|Overall Study|Physician Decision|0|||
148758248|NCT01139775|536587585|FG001|Overall Study|Physician Decision|2|||
148758249|NCT01139775|536587586|FG002|Overall Study|Physician Decision|2|||
148758250|NCT04760626|536587587|FG000|Overall Study|Withdrawal by Subject|24|||
148758251|NCT04760626|536587588|FG001|Overall Study|Withdrawal by Subject|20|||
148758252|NCT04760626|536587587|FG000|Overall Study|Lost to Follow-up|14|||
148758253|NCT04760626|536587588|FG001|Overall Study|Lost to Follow-up|19|||
148758254|NCT04760626|536587587|FG000|Overall Study|Physician Decision|3|||
148758255|NCT04760626|536587588|FG001|Overall Study|Physician Decision|5|||
148758256|NCT04760626|536587587|FG000|Overall Study|Death|3|||
148758257|NCT04760626|536587588|FG001|Overall Study|Death|6|||
148758258|NCT04760626|536587587|FG000|Overall Study|Site closure|1|||
148758259|NCT04760626|536587588|FG001|Overall Study|Site closure|0|||
148758260|NCT03193853|536587589|FG000|Overall Study|Death|6|||
148758261|NCT01787292|536587590|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
148758262|NCT01787292|536587591|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
148758263|NCT01787292|536587590|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
148758264|NCT01787292|536587591|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
148758265|NCT01827111|536587592|FG000|Overall Study|Disease Progression|1|||
148758266|NCT02962648|536587593|FG000|Overall Study|Withdrawal by Subject|3|||
148758267|NCT02962648|536587593|FG000|Overall Study|Lost to Follow-up|3|||
148758268|NCT02962648|536587593|FG000|Overall Study|Physician Decision|1|||
148758269|NCT02962648|536587593|FG000|Overall Study|Subject had problems with transportation|2|||
148758270|NCT01213966|536587594|FG000|Overall Study|Protocol Violation|1|||
148758271|NCT01213966|536587595|FG001|Overall Study|Protocol Violation|0|||
148758272|NCT01213966|536587596|FG002|Overall Study|Protocol Violation|3|||
148758273|NCT01213966|536587597|FG003|Overall Study|Protocol Violation|1|||
148758274|NCT00740636|536587604|FG000|Overall Study|Adverse Event|0|||
148758275|NCT00740636|536587605|FG001|Overall Study|Adverse Event|2|||
148758276|NCT00740636|536587604|FG000|Overall Study|Patient Ineligible|0|||
148758277|NCT00740636|536587605|FG001|Overall Study|Patient Ineligible|1|||
148758278|NCT00740636|536587604|FG000|Overall Study|Patient Not Treated|0|||
148758279|NCT00740636|536587605|FG001|Overall Study|Patient Not Treated|1|||
148758280|NCT00740636|536587604|FG000|Overall Study|Progressive Disease|1|||
148758281|NCT00740636|536587605|FG001|Overall Study|Progressive Disease|0|||
148758282|NCT00740636|536587604|FG000|Overall Study|Death|1|||
148758283|NCT00740636|536587605|FG001|Overall Study|Death|0|||
148758284|NCT02174627|536587608|FG000|Overall Study|Missing|0|||
148758285|NCT02174627|536587609|FG001|Overall Study|Missing|1|||
148758286|NCT02174627|536587608|FG000|Overall Study|Incorrect enrolment before randomization|0|||
148758287|NCT02174627|536587609|FG001|Overall Study|Incorrect enrolment before randomization|1|||
148758288|NCT02174627|536587608|FG000|Overall Study|Participant decision|84|||
148758289|NCT02174627|536587609|FG001|Overall Study|Participant decision|128|||
148758290|NCT00682786|536587612|FG000|Overall Study|Withdrawal by Subject|2|||
148758291|NCT00682786|536587613|FG001|Overall Study|Withdrawal by Subject|2|||
148758292|NCT00682786|536587612|FG000|Overall Study|Did not receive irinotecan|0|||
148758293|NCT00682786|536587613|FG001|Overall Study|Did not receive irinotecan|1|||
148758294|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
148758295|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
148758296|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
148758297|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
148758298|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
148758299|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
148758300|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
148758301|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
148758302|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
148758303|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
148758304|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
148758305|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
148758306|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
148758307|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
148758308|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
148758309|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
148976486|NCT01813019|537394553|FG001|Overall Study|administrative problems|0|||
148976487|NCT01813019|537394552|FG000|Overall Study|Protocol Deviation|2|||
148976488|NCT01813019|537394553|FG001|Overall Study|Protocol Deviation|1|||
148976489|NCT01696032|537394554|FG000|Overall Study|Withdrawal by Subject|0|||
148976490|NCT01696032|537394555|FG001|Overall Study|Withdrawal by Subject|0|||
148976491|NCT01696032|537394556|FG002|Overall Study|Withdrawal by Subject|1|||
148976492|NCT01696032|537394557|FG003|Overall Study|Withdrawal by Subject|2|||
148758310|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
148758311|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
148824114|NCT01089543|536832370|FG000|Overall Study|Withdrawal by Subject|2|||
148824115|NCT01089543|536832371|FG001|Overall Study|Withdrawal by Subject|3|||
148824116|NCT01089543|536832372|FG002|Overall Study|Withdrawal by Subject|3|||
148824117|NCT01089543|536832373|FG003|Overall Study|Withdrawal by Subject|1|||
148824118|NCT01089543|536832370|FG000|Overall Study|Physician Decision|1|||
148824119|NCT01089543|536832371|FG001|Overall Study|Physician Decision|0|||
148824120|NCT01089543|536832372|FG002|Overall Study|Physician Decision|0|||
148824121|NCT01089543|536832373|FG003|Overall Study|Physician Decision|1|||
148824122|NCT01089543|536832370|FG000|Overall Study|Adverse Event|0|||
148824123|NCT01089543|536832371|FG001|Overall Study|Adverse Event|1|||
148824124|NCT01089543|536832372|FG002|Overall Study|Adverse Event|0|||
148824125|NCT01089543|536832373|FG003|Overall Study|Adverse Event|0|||
148824126|NCT01905267|536832376|FG000|Overall Study|Physician Decision|2|||
148824127|NCT01905267|536832377|FG001|Overall Study|Physician Decision|2|||
148824128|NCT03438656|536832378|FG000|Overall Study|Lost to Follow-up|2|||
148824129|NCT02489045|536832379|FG000|Overall Study|unable to collect usable data|53|||
148758312|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
148758313|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
148758314|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
148758315|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
148758316|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
148758317|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
148758318|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
148758319|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
148758320|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
148758321|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
148758322|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
148758323|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
148758324|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
148758325|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
148758326|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758327|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758328|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
148758329|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758330|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758331|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758332|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
148758333|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758334|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
148758335|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
148758336|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
148758337|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
148758338|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
148758339|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
148758340|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
148758341|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
148758342|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
148758343|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
148758344|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
148824130|NCT02489045|536832379|FG000|Follow-up|Lost to Follow-up|10|||
148824131|NCT00930176|536832385|FG000|Overall Study|Death|1|||
148824132|NCT01108055|536832386|FG000|Overall Study|Ineligible|11|||
148824133|NCT01108055|536832386|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
148824134|NCT03339453|536832387|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
148824135|NCT03339453|536832388|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
148976493|NCT01696032|537394554|FG000|Overall Study|Death|14|||
148976494|NCT01696032|537394555|FG001|Overall Study|Death|4|||
148976495|NCT01696032|537394556|FG002|Overall Study|Death|43|||
148824136|NCT00362609|536832389|FG000|Overall Study|Withdrawal by Subject|0|||
148824137|NCT00362609|536832390|FG001|Overall Study|Withdrawal by Subject|1|||
148824138|NCT00362609|536832389|FG000|Overall Study|Protocol Violation|0|||
148824139|NCT00362609|536832390|FG001|Overall Study|Protocol Violation|1|||
148824140|NCT00236197|536832396|FG000|Overall Study|Withdrawal by Subject|3|||
148824141|NCT00236197|536832397|FG001|Overall Study|Withdrawal by Subject|2|||
148824142|NCT00236197|536832396|FG000|Overall Study|Lost to Follow-up|1|||
148824143|NCT00236197|536832397|FG001|Overall Study|Lost to Follow-up|5|||
148824144|NCT00236197|536832396|FG000|Overall Study|Protocol Violation|0|||
148824145|NCT00236197|536832397|FG001|Overall Study|Protocol Violation|3|||
148824146|NCT00236197|536832396|FG000|Overall Study|Medication non-compliance|1|||
148824147|NCT00236197|536832397|FG001|Overall Study|Medication non-compliance|2|||
148824148|NCT00236197|536832396|FG000|Overall Study|Other|0|||
148824149|NCT00236197|536832397|FG001|Overall Study|Other|2|||
148824150|NCT00682435|536832400|FG000|Overall Study|Insufficient data|5|||
148824151|NCT00682435|536832400|FG000|Overall Study|Erroneously enrolled twice|2|||
148824152|NCT01800058|536832401|FG000|Overall Study|Lost to Follow-up|1|||
148824153|NCT00800384|536832402|FG000|Overall Study|Withdrawal by Subject|24|||
148824154|NCT00800384|536832403|FG001|Overall Study|Withdrawal by Subject|17|||
148824155|NCT00800384|536832402|FG000|Overall Study|Lost to Follow-up|17|||
148824156|NCT00800384|536832403|FG001|Overall Study|Lost to Follow-up|26|||
148824157|NCT05486065|536832404|FG000|Overall Study|Withdrawal by Subject|1|||
148824158|NCT05486065|536832405|FG001|Overall Study|Withdrawal by Subject|5|||
148824159|NCT05486065|536832406|FG002|Overall Study|Withdrawal by Subject|4|||
148824160|NCT05486065|536832407|FG003|Overall Study|Withdrawal by Subject|3|||
148824161|NCT05486065|536832404|FG000|Overall Study|Lost to Follow-up|4|||
148824162|NCT05486065|536832405|FG001|Overall Study|Lost to Follow-up|2|||
148824163|NCT05486065|536832406|FG002|Overall Study|Lost to Follow-up|2|||
148824164|NCT05486065|536832407|FG003|Overall Study|Lost to Follow-up|2|||
148824165|NCT05486065|536832404|FG000|Overall Study|Physician Decision|0|||
148824166|NCT05486065|536832405|FG001|Overall Study|Physician Decision|1|||
148824167|NCT05486065|536832406|FG002|Overall Study|Physician Decision|1|||
148824168|NCT05486065|536832407|FG003|Overall Study|Physician Decision|0|||
148824169|NCT05486065|536832404|FG000|Overall Study|Failure to meet randomization criteria|0|||
148824170|NCT05486065|536832405|FG001|Overall Study|Failure to meet randomization criteria|0|||
148824171|NCT05486065|536832406|FG002|Overall Study|Failure to meet randomization criteria|0|||
148824172|NCT05486065|536832407|FG003|Overall Study|Failure to meet randomization criteria|1|||
148824173|NCT01064622|536832408|FG000|Randomized Phase II|Withdrawal by Subject|2|||
148824174|NCT01064622|536832409|FG001|Randomized Phase II|Withdrawal by Subject|2|||
148824175|NCT01064622|536832408|FG000|Randomized Phase II|Protocol Violation|0|||
148824176|NCT01064622|536832409|FG001|Randomized Phase II|Protocol Violation|1|||
148824177|NCT06868667|536832410|FG000|Overall Study|Death|0|||
148824178|NCT06868667|536832411|FG001|Overall Study|Death|4|||
148824179|NCT06868667|536832410|FG000|Overall Study|Lost to Follow-up|0|||
148824180|NCT06868667|536832411|FG001|Overall Study|Lost to Follow-up|1|||
148824181|NCT06868667|536832410|FG000|Overall Study|Withdrawal by Subject|1|||
148824182|NCT06868667|536832411|FG001|Overall Study|Withdrawal by Subject|0|||
148824183|NCT06868667|536832410|FG000|Overall Study|Ongoing|9|||
148758345|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
148758346|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
148758347|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
148758348|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
148758349|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
148758350|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148758351|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
148758352|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148758353|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148758354|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148758355|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148824184|NCT06868667|536832411|FG001|Overall Study|Ongoing|9|||
148758356|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148758357|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
148824185|NCT05330429|536832414|FG000|Overall Study|Study Terminated by Sponsor|4|||
148824186|NCT05330429|536832415|FG001|Overall Study|Study Terminated by Sponsor|33|||
148824187|NCT05330429|536832416|FG002|Overall Study|Study Terminated by Sponsor|12|||
148824188|NCT05330429|536832414|FG000|Overall Study|Death|5|||
148824189|NCT05330429|536832415|FG001|Overall Study|Death|2|||
148824190|NCT05330429|536832416|FG002|Overall Study|Death|4|||
148824191|NCT05330429|536832414|FG000|Overall Study|Withdrew Consent|0|||
148824192|NCT05330429|536832415|FG001|Overall Study|Withdrew Consent|5|||
148824193|NCT05330429|536832416|FG002|Overall Study|Withdrew Consent|4|||
148824194|NCT05330429|536832414|FG000|Overall Study|Investigator's Discretion|0|||
148824195|NCT05330429|536832415|FG001|Overall Study|Investigator's Discretion|1|||
148824196|NCT05330429|536832416|FG002|Overall Study|Investigator's Discretion|3|||
148824197|NCT05330429|536832414|FG000|Overall Study|Subject Decision|1|||
148824198|NCT05330429|536832415|FG001|Overall Study|Subject Decision|2|||
148824199|NCT05330429|536832416|FG002|Overall Study|Subject Decision|0|||
148824200|NCT05330429|536832414|FG000|Overall Study|Lost to Follow-up|0|||
148824201|NCT05330429|536832415|FG001|Overall Study|Lost to Follow-up|1|||
148824202|NCT05330429|536832416|FG002|Overall Study|Lost to Follow-up|0|||
148824203|NCT01245049|536832417|FG000|Overall Study|Migrated/moved from study area|0|||
148824204|NCT01245049|536832418|FG001|Overall Study|Migrated/moved from study area|1|||
148824205|NCT01245049|536832417|FG000|Overall Study|Withdrawal by Subject|0|||
148824206|NCT01245049|536832418|FG001|Overall Study|Withdrawal by Subject|1|||
148824207|NCT01245049|536832417|FG000|Overall Study|Lost to Follow-up|1|||
148824208|NCT01245049|536832418|FG001|Overall Study|Lost to Follow-up|2|||
148824209|NCT02151604|536832419|FG000|Overall Study|Lost to Follow-up|3|||
148824210|NCT02151604|536832419|FG000|Overall Study|Withdrawal by Subject|2|||
148824211|NCT02151604|536832419|FG000|Overall Study|Physician Decision|3|||
148824212|NCT02151604|536832419|FG000|Overall Study|Death|1|||
148824213|NCT04495478|536832421|FG000|Overall Study|Withdrawal by Subject|0|||
148824214|NCT04495478|536832422|FG001|Overall Study|Withdrawal by Subject|0|||
148824215|NCT04495478|536832423|FG002|Overall Study|Withdrawal by Subject|0|||
148824216|NCT04495478|536832424|FG003|Overall Study|Withdrawal by Subject|1|||
148824217|NCT04495478|536832425|FG004|Overall Study|Withdrawal by Subject|0|||
148824218|NCT04495478|536832426|FG005|Overall Study|Withdrawal by Subject|0|||
148824219|NCT04495478|536832427|FG006|Overall Study|Withdrawal by Subject|0|||
148824220|NCT04495478|536832421|FG000|Overall Study|Physician Decision|0|||
148824221|NCT04495478|536832422|FG001|Overall Study|Physician Decision|1|||
148824222|NCT04495478|536832423|FG002|Overall Study|Physician Decision|0|||
148824223|NCT04495478|536832424|FG003|Overall Study|Physician Decision|0|||
148824224|NCT04495478|536832425|FG004|Overall Study|Physician Decision|1|||
148824225|NCT04495478|536832426|FG005|Overall Study|Physician Decision|0|||
148824226|NCT04495478|536832427|FG006|Overall Study|Physician Decision|0|||
148824227|NCT00655746|536832428|FG000|Overall Study|Withdrawal by Subject|1|||
148824228|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
148824229|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
148824230|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
148824231|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Adverse Event|5|||
148824232|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Adverse Event|1|||
148824233|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Adverse Event|0|||
148824234|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
148824235|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
148824236|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
148824237|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Death|8|||
148824238|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Death|24|||
148824239|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Death|0|||
148824240|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
148824241|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
148824242|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
148824243|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
148824244|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
148824245|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
148824246|NCT02931539|536832429|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
148889316|NCT00101686|537074377|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
148889317|NCT00101686|537074378|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
148889318|NCT00101686|537074379|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
148889319|NCT00101686|537074380|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
148889320|NCT00101686|537074371|FG000|Overall Study|unacceptable toxicity|3|||
148889321|NCT00101686|537074372|FG001|Overall Study|unacceptable toxicity|9|||
148889322|NCT00101686|537074373|FG002|Overall Study|unacceptable toxicity|10|||
148889323|NCT00101686|537074374|FG003|Overall Study|unacceptable toxicity|6|||
148889324|NCT00101686|537074375|FG004|Overall Study|unacceptable toxicity|16|||
148889325|NCT00101686|537074376|FG005|Overall Study|unacceptable toxicity|10|||
148889326|NCT00101686|537074377|FG006|Overall Study|unacceptable toxicity|4|||
148889327|NCT00101686|537074378|FG007|Overall Study|unacceptable toxicity|2|||
148889328|NCT00101686|537074379|FG008|Overall Study|unacceptable toxicity|1|||
148889329|NCT00101686|537074380|FG009|Overall Study|unacceptable toxicity|4|||
148889330|NCT00101686|537074371|FG000|Overall Study|Randomized but did not receive treament|1|||
148889331|NCT00101686|537074372|FG001|Overall Study|Randomized but did not receive treament|6|||
148889332|NCT00101686|537074373|FG002|Overall Study|Randomized but did not receive treament|2|||
148889333|NCT00101686|537074374|FG003|Overall Study|Randomized but did not receive treament|2|||
148889334|NCT00101686|537074375|FG004|Overall Study|Randomized but did not receive treament|2|||
148889335|NCT00101686|537074376|FG005|Overall Study|Randomized but did not receive treament|2|||
148889336|NCT00101686|537074377|FG006|Overall Study|Randomized but did not receive treament|0|||
148889337|NCT00101686|537074378|FG007|Overall Study|Randomized but did not receive treament|1|||
148824247|NCT02931539|536832430|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
148824248|NCT02931539|536832431|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
148824249|NCT02931539|536832429|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
148824250|NCT02931539|536832430|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
148824251|NCT02931539|536832431|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
148824252|NCT03178942|536832432|FG000|Overall Study|Withdrawal by Subject|2|||
148824253|NCT03178942|536832433|FG001|Overall Study|Withdrawal by Subject|0|||
148824254|NCT03178942|536832432|FG000|Overall Study|Lost to Follow-up|1|||
148824255|NCT03178942|536832433|FG001|Overall Study|Lost to Follow-up|2|||
148824256|NCT01926509|536834439|FG000|Overall Study|vital sign met discontinuation criteria|1|||
148824257|NCT01926509|536834440|FG001|Overall Study|vital sign met discontinuation criteria|0|||
148824258|NCT01926509|536834441|FG002|Overall Study|vital sign met discontinuation criteria|0|||
148824259|NCT01926509|536834442|FG003|Overall Study|vital sign met discontinuation criteria|0|||
148824260|NCT03635996|536834446|FG000|Overall Study|Study terminated by Sponsor|94|||
148824261|NCT03635996|536834446|FG000|Overall Study|Withdrawal by Subject|20|||
148824262|NCT03635996|536834446|FG000|Overall Study|Ablation|26|||
148824263|NCT03635996|536834446|FG000|Overall Study|Adverse Event|7|||
148824264|NCT03635996|536834446|FG000|Overall Study|Physician Decision|3|||
148824265|NCT03635996|536834446|FG000|Overall Study|Prohibited medication|5|||
148824266|NCT03635996|536834446|FG000|Overall Study|Did not meet eligibility criteria|5|||
148824267|NCT03635996|536834446|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
148824268|NCT03635996|536834446|FG000|Overall Study|Protocol Violation|1|||
148824269|NCT03635996|536834446|FG000|Overall Study|Lost to Follow-up|1|||
148824270|NCT02821000|536834447|FG000|Overall Study|Death|89|||
148824271|NCT02821000|536834447|FG000|Overall Study|Sponsor Decision|12|||
148824272|NCT02821000|536834447|FG000|Overall Study|Withdrawal by Subject|2|||
148824273|NCT04359680|536834448|FG000|Overall Study|Withdrawal by Subject|29|||
148824274|NCT04359680|536834449|FG001|Overall Study|Withdrawal by Subject|24|||
148824275|NCT04359680|536834448|FG000|Overall Study|Adverse Event|6|||
148824276|NCT04359680|536834449|FG001|Overall Study|Adverse Event|2|||
148824277|NCT04359680|536834448|FG000|Overall Study|Lost to Follow-up|56|||
148824278|NCT04359680|536834449|FG001|Overall Study|Lost to Follow-up|59|||
148824279|NCT04359680|536834448|FG000|Overall Study|Protocol Violation|3|||
148824280|NCT04359680|536834449|FG001|Overall Study|Protocol Violation|5|||
148824281|NCT04359680|536834448|FG000|Overall Study|Physician Decision|1|||
148824282|NCT04359680|536834449|FG001|Overall Study|Physician Decision|1|||
148824283|NCT04359680|536834448|FG000|Overall Study|Sponsor Decision|0|||
148824284|NCT04359680|536834449|FG001|Overall Study|Sponsor Decision|1|||
148824285|NCT03211858|536834450|FG000|Overall Study|Adverse Event|8|||
148824286|NCT03211858|536834451|FG001|Overall Study|Adverse Event|6|||
148824287|NCT03211858|536834450|FG000|Overall Study|Lack of Efficacy|0|||
148824288|NCT03211858|536834451|FG001|Overall Study|Lack of Efficacy|4|||
148824289|NCT03211858|536834450|FG000|Overall Study|Poor compliance to protocol|6|||
148824290|NCT03211858|536834451|FG001|Overall Study|Poor compliance to protocol|2|||
148824291|NCT03211858|536834450|FG000|Overall Study|Non-serious Hypoglycemia|1|||
148824292|NCT03211858|536834451|FG001|Overall Study|Non-serious Hypoglycemia|0|||
148824293|NCT03211858|536834450|FG000|Overall Study|Other than specified above|22|||
148758358|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758359|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758360|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758361|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758362|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
148758363|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758364|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758365|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
148758366|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148824294|NCT03211858|536834451|FG001|Overall Study|Other than specified above|21|||
148824295|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
148824296|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
148824297|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
148824298|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
148824299|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
148824300|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
148824301|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
148824302|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
148824303|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
148824304|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
148824305|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
148824306|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
148824307|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
148758367|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758368|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758369|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758370|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758371|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
148758372|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758373|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
148758374|NCT03896503|536589110|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
148758375|NCT03896503|536589111|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
148758376|NCT03896503|536589112|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
148758377|NCT03896503|536589113|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
148758378|NCT03896503|536589114|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
148758379|NCT03896503|536589115|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
148758380|NCT03896503|536589116|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
148758381|NCT03896503|536589117|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
148758382|NCT00437021|536589118|FG000|Overall Study|Adverse Event|0|||
148758383|NCT00437021|536589119|FG001|Overall Study|Adverse Event|0|||
148758384|NCT00437021|536589120|FG002|Overall Study|Adverse Event|0|||
148758385|NCT00437021|536589121|FG003|Overall Study|Adverse Event|0|||
148758386|NCT00437021|536589122|FG004|Overall Study|Adverse Event|0|||
148758387|NCT00437021|536589123|FG005|Overall Study|Adverse Event|0|||
148758388|NCT00437021|536589124|FG006|Overall Study|Adverse Event|1|||
148758389|NCT00437021|536589125|FG007|Overall Study|Adverse Event|0|||
148758390|NCT00437021|536589126|FG008|Overall Study|Adverse Event|0|||
148758391|NCT00437021|536589127|FG009|Overall Study|Adverse Event|0|||
148758392|NCT00437021|536589128|FG010|Overall Study|Adverse Event|0|||
148758393|NCT00437021|536589129|FG011|Overall Study|Adverse Event|0|||
148758394|NCT00437021|536589118|FG000|Overall Study|Lost to Follow-up|0|||
148758395|NCT00437021|536589119|FG001|Overall Study|Lost to Follow-up|3|||
148758396|NCT00437021|536589120|FG002|Overall Study|Lost to Follow-up|0|||
148758397|NCT00437021|536589121|FG003|Overall Study|Lost to Follow-up|0|||
148758398|NCT00437021|536589122|FG004|Overall Study|Lost to Follow-up|0|||
148758399|NCT00437021|536589123|FG005|Overall Study|Lost to Follow-up|2|||
148758400|NCT00437021|536589124|FG006|Overall Study|Lost to Follow-up|0|||
148758401|NCT00437021|536589125|FG007|Overall Study|Lost to Follow-up|1|||
148758402|NCT00437021|536589126|FG008|Overall Study|Lost to Follow-up|0|||
148758403|NCT00437021|536589127|FG009|Overall Study|Lost to Follow-up|0|||
148758404|NCT00437021|536589128|FG010|Overall Study|Lost to Follow-up|0|||
148758405|NCT00437021|536589129|FG011|Overall Study|Lost to Follow-up|0|||
148758406|NCT00437021|536589118|FG000|Overall Study|Withdrawal by Subject|2|||
148758407|NCT00437021|536589119|FG001|Overall Study|Withdrawal by Subject|1|||
148758408|NCT00437021|536589120|FG002|Overall Study|Withdrawal by Subject|0|||
148758409|NCT00437021|536589121|FG003|Overall Study|Withdrawal by Subject|0|||
148758410|NCT00437021|536589122|FG004|Overall Study|Withdrawal by Subject|0|||
148758411|NCT00437021|536589123|FG005|Overall Study|Withdrawal by Subject|0|||
148758412|NCT00437021|536589124|FG006|Overall Study|Withdrawal by Subject|0|||
148758413|NCT00437021|536589125|FG007|Overall Study|Withdrawal by Subject|0|||
148758414|NCT00437021|536589126|FG008|Overall Study|Withdrawal by Subject|0|||
148758415|NCT00437021|536589127|FG009|Overall Study|Withdrawal by Subject|0|||
148758416|NCT00437021|536589128|FG010|Overall Study|Withdrawal by Subject|0|||
148758417|NCT00437021|536589129|FG011|Overall Study|Withdrawal by Subject|0|||
148758418|NCT04632927|536589132|FG000|Overall Study|Adverse Event|0|||
148758419|NCT04632927|536589133|FG001|Overall Study|Adverse Event|1|||
148758420|NCT04632927|536589132|FG000|Overall Study|Lack of Efficacy|0|||
148758421|NCT04632927|536589133|FG001|Overall Study|Lack of Efficacy|4|||
148758422|NCT04632927|536589132|FG000|Overall Study|Loss of efficacy|0|||
148758423|NCT04632927|536589133|FG001|Overall Study|Loss of efficacy|1|||
148758424|NCT04632927|536589132|FG000|Overall Study|Non-compliance with study drug|0|||
148758425|NCT04632927|536589133|FG001|Overall Study|Non-compliance with study drug|1|||
148758426|NCT04632927|536589132|FG000|Overall Study|Physician Decision|0|||
148758427|NCT04632927|536589133|FG001|Overall Study|Physician Decision|1|||
148758428|NCT04632927|536589132|FG000|Overall Study|Subject decision|0|||
148758429|NCT04632927|536589133|FG001|Overall Study|Subject decision|1|||
148758430|NCT04632927|536589132|FG000|Overall Study|Withdrawal by Subject|0|||
148758431|NCT04632927|536589133|FG001|Overall Study|Withdrawal by Subject|1|||
148758432|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
148758433|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
148758434|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
148758435|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
148758436|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
148758437|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
148758438|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
148824308|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
148824309|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
148824310|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
148824311|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
148824312|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
148824313|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
148824314|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
148824315|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
148824316|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
148824317|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
148824318|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
148824319|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
148824320|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
148824321|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
148824322|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
148824323|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
148824324|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
148824325|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
148824326|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
148824327|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
148824328|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
148824329|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
148824330|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
148824331|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
148824332|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
148824333|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
148824334|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
148824335|NCT02596893|536834452|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
148824336|NCT02596893|536834453|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
148824337|NCT02596893|536834454|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
148824338|NCT02596893|536834455|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
148824339|NCT03280615|536834456|FG000|Overall Study|Lost to Follow-up|1|||
148824340|NCT03280615|536834457|FG001|Overall Study|Lost to Follow-up|2|||
148824341|NCT03280615|536834456|FG000|Overall Study|Adverse Event|1|||
148824342|NCT03280615|536834457|FG001|Overall Study|Adverse Event|1|||
148824343|NCT03280615|536834456|FG000|Overall Study|Withdrawal by Subject|2|||
148824344|NCT03280615|536834457|FG001|Overall Study|Withdrawal by Subject|2|||
148824345|NCT00004228|536834460|FG000|Overall Study|Adverse Event|0|||
148824346|NCT00004228|536834461|FG001|Overall Study|Adverse Event|1|||
148824347|NCT00004228|536834462|FG002|Overall Study|Adverse Event|0|||
148824348|NCT00004228|536834463|FG003|Overall Study|Adverse Event|0|||
148824349|NCT00004228|536834464|FG004|Overall Study|Adverse Event|1|||
148824350|NCT00004228|536834465|FG005|Overall Study|Adverse Event|0|||
148824351|NCT00004228|536834466|FG006|Overall Study|Adverse Event|0|||
148824352|NCT00004228|536834460|FG000|Overall Study|Death|0|||
148824353|NCT00004228|536834461|FG001|Overall Study|Death|1|||
148824354|NCT00004228|536834462|FG002|Overall Study|Death|2|||
148824355|NCT00004228|536834463|FG003|Overall Study|Death|0|||
148824356|NCT00004228|536834464|FG004|Overall Study|Death|1|||
148824357|NCT00004228|536834465|FG005|Overall Study|Death|0|||
148824358|NCT00004228|536834466|FG006|Overall Study|Death|0|||
148824359|NCT00004228|536834460|FG000|Overall Study|Lack of Efficacy|1|||
148824360|NCT00004228|536834461|FG001|Overall Study|Lack of Efficacy|6|||
148824361|NCT00004228|536834462|FG002|Overall Study|Lack of Efficacy|5|||
148976496|NCT01696032|537394557|FG003|Overall Study|Death|18|||
148976497|NCT01696032|537394554|FG000|Overall Study|Lost to Follow-up|0|||
148976498|NCT01696032|537394555|FG001|Overall Study|Lost to Follow-up|1|||
148976499|NCT01696032|537394556|FG002|Overall Study|Lost to Follow-up|0|||
148976500|NCT01696032|537394557|FG003|Overall Study|Lost to Follow-up|0|||
148976501|NCT01696032|537394554|FG000|Overall Study|Database lock|0|||
148976502|NCT01696032|537394555|FG001|Overall Study|Database lock|1|||
148976503|NCT01696032|537394556|FG002|Overall Study|Database lock|7|||
148824362|NCT00004228|536834463|FG003|Overall Study|Lack of Efficacy|3|||
148976504|NCT01696032|537394557|FG003|Overall Study|Database lock|2|||
148976505|NCT00376168|537394560|FG000|Overall Study|Adverse Event|1|||
148824363|NCT00004228|536834464|FG004|Overall Study|Lack of Efficacy|9|||
148824364|NCT00004228|536834465|FG005|Overall Study|Lack of Efficacy|8|||
148976506|NCT00376168|537394561|FG001|Overall Study|Adverse Event|1|||
148976507|NCT00376168|537394560|FG000|Overall Study|Pregnancy|1|||
148824365|NCT00004228|536834466|FG006|Overall Study|Lack of Efficacy|4|||
148824366|NCT00004228|536834460|FG000|Overall Study|Lost to Follow-up|0|||
148824367|NCT00004228|536834461|FG001|Overall Study|Lost to Follow-up|0|||
148824368|NCT00004228|536834462|FG002|Overall Study|Lost to Follow-up|1|||
148976508|NCT00376168|537394561|FG001|Overall Study|Pregnancy|0|||
148824369|NCT00004228|536834463|FG003|Overall Study|Lost to Follow-up|0|||
148824370|NCT00004228|536834464|FG004|Overall Study|Lost to Follow-up|0|||
148824371|NCT00004228|536834465|FG005|Overall Study|Lost to Follow-up|0|||
148824372|NCT00004228|536834466|FG006|Overall Study|Lost to Follow-up|0|||
148824373|NCT00004228|536834460|FG000|Overall Study|Physician Decision|1|||
148824374|NCT00004228|536834461|FG001|Overall Study|Physician Decision|0|||
148824375|NCT00004228|536834462|FG002|Overall Study|Physician Decision|3|||
148824376|NCT00004228|536834463|FG003|Overall Study|Physician Decision|2|||
148824377|NCT00004228|536834464|FG004|Overall Study|Physician Decision|1|||
148824378|NCT00004228|536834465|FG005|Overall Study|Physician Decision|1|||
148824379|NCT00004228|536834466|FG006|Overall Study|Physician Decision|1|||
148824380|NCT00004228|536834460|FG000|Overall Study|Protocol Violation|0|||
148824381|NCT00004228|536834461|FG001|Overall Study|Protocol Violation|5|||
148824382|NCT00004228|536834462|FG002|Overall Study|Protocol Violation|2|||
148824383|NCT00004228|536834463|FG003|Overall Study|Protocol Violation|1|||
148824384|NCT00004228|536834464|FG004|Overall Study|Protocol Violation|1|||
148824385|NCT00004228|536834465|FG005|Overall Study|Protocol Violation|2|||
148824386|NCT00004228|536834466|FG006|Overall Study|Protocol Violation|0|||
148824387|NCT00004228|536834460|FG000|Overall Study|Withdrawal by Subject|3|||
148824388|NCT00004228|536834461|FG001|Overall Study|Withdrawal by Subject|0|||
148824389|NCT00004228|536834462|FG002|Overall Study|Withdrawal by Subject|1|||
148824390|NCT00004228|536834463|FG003|Overall Study|Withdrawal by Subject|0|||
148824391|NCT00004228|536834464|FG004|Overall Study|Withdrawal by Subject|2|||
148824392|NCT00004228|536834465|FG005|Overall Study|Withdrawal by Subject|1|||
148824393|NCT00004228|536834466|FG006|Overall Study|Withdrawal by Subject|2|||
148824394|NCT00004228|536834460|FG000|Overall Study|Other|0|||
148824395|NCT00004228|536834461|FG001|Overall Study|Other|0|||
148824396|NCT00004228|536834462|FG002|Overall Study|Other|1|||
148824397|NCT00004228|536834463|FG003|Overall Study|Other|0|||
148824398|NCT00004228|536834464|FG004|Overall Study|Other|0|||
148824399|NCT00004228|536834465|FG005|Overall Study|Other|0|||
148824400|NCT00004228|536834466|FG006|Overall Study|Other|0|||
148824401|NCT00004228|536834460|FG000|Overall Study|ineligible|4|||
148824402|NCT00004228|536834461|FG001|Overall Study|ineligible|2|||
148824403|NCT00004228|536834462|FG002|Overall Study|ineligible|4|||
148824404|NCT00004228|536834463|FG003|Overall Study|ineligible|1|||
148824405|NCT00004228|536834464|FG004|Overall Study|ineligible|1|||
148824406|NCT00004228|536834465|FG005|Overall Study|ineligible|2|||
148824407|NCT00004228|536834466|FG006|Overall Study|ineligible|5|||
148824408|NCT01013870|536834469|FG000|Overall Study|Lost to Follow-up|1|||
148824409|NCT01013870|536834470|FG001|Overall Study|Lost to Follow-up|3|||
148824410|NCT01386645|536834471|FG000|Overall Study|Physician Decision|0|||
148824411|NCT01386645|536834472|FG001|Overall Study|Physician Decision|0|||
148824412|NCT01386645|536834473|FG002|Overall Study|Physician Decision|1|||
148824413|NCT01386645|536834471|FG000|Overall Study|Withdrawal by Subject|0|||
148824414|NCT01386645|536834472|FG001|Overall Study|Withdrawal by Subject|1|||
148824415|NCT01386645|536834473|FG002|Overall Study|Withdrawal by Subject|1|||
148824416|NCT00432991|536834474|FG000|Overall Study|Protocol Violation|7|||
148824417|NCT00432991|536834475|FG001|Overall Study|Protocol Violation|12|||
148824418|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
148824419|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
149027451|NCT01770860|537578564|FG000|Overall Study|Withdrawal by Subject|4|||
149027452|NCT01770860|537578564|FG000|Overall Study|Lost to Follow-up|1|||
148824420|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
148824421|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
148824422|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
148824423|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
148824424|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
148824425|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
148824426|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
148824427|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
148824428|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
148824429|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
149027453|NCT01770860|537578564|FG000|Overall Study|Administrative decision made by the PI|1|||
148824430|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
148824431|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
148824432|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
148824433|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
148824434|NCT01755156|536834476|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
148824435|NCT01755156|536834477|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
148824436|NCT01755156|536834476|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
148824437|NCT01755156|536834477|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
148824438|NCT01755156|536834476|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
148824439|NCT01755156|536834477|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
148824440|NCT03048019|536834478|FG000|Overall Study|Adverse Event|1|||
148824441|NCT03048019|536834479|FG001|Overall Study|Adverse Event|0|||
148824442|NCT00862277|536834480|FG000|Overall Study|Protocol Violation|1|||
148824443|NCT00862277|536834481|FG001|Overall Study|Protocol Violation|2|||
148824444|NCT00862277|536834482|FG002|Overall Study|Protocol Violation|5|||
148824445|NCT00382863|536834483|FG000|Overall Study|Death|9|||
148824446|NCT00382863|536834484|FG001|Overall Study|Death|9|||
148824447|NCT00382863|536834483|FG000|Overall Study|Lost to Follow-up|1|||
148824448|NCT00382863|536834484|FG001|Overall Study|Lost to Follow-up|2|||
148824449|NCT00382863|536834483|FG000|Overall Study|Withdrawal by Subject|5|||
148824450|NCT00382863|536834484|FG001|Overall Study|Withdrawal by Subject|25|||
148824451|NCT01292473|536834485|FG000|Overall Study|Adverse Event|1|||
148824452|NCT01292473|536834486|FG001|Overall Study|Adverse Event|0|||
148824453|NCT01292473|536834487|FG002|Overall Study|Adverse Event|1|||
148824454|NCT01292473|536834488|FG003|Overall Study|Adverse Event|1|||
148824455|NCT01292473|536834485|FG000|Overall Study|Lost to Follow-up|1|||
148824456|NCT01292473|536834486|FG001|Overall Study|Lost to Follow-up|1|||
148824457|NCT01292473|536834487|FG002|Overall Study|Lost to Follow-up|2|||
148824458|NCT01292473|536834488|FG003|Overall Study|Lost to Follow-up|2|||
148824459|NCT01292473|536834485|FG000|Overall Study|Withdrawal by Subject|3|||
148824460|NCT01292473|536834486|FG001|Overall Study|Withdrawal by Subject|4|||
148824461|NCT01292473|536834487|FG002|Overall Study|Withdrawal by Subject|3|||
148824462|NCT01292473|536834488|FG003|Overall Study|Withdrawal by Subject|3|||
148824463|NCT01292473|536834485|FG000|Overall Study|Physician Decision|0|||
148824464|NCT01292473|536834486|FG001|Overall Study|Physician Decision|1|||
148824465|NCT01292473|536834487|FG002|Overall Study|Physician Decision|0|||
148824466|NCT01292473|536834488|FG003|Overall Study|Physician Decision|0|||
148824467|NCT01292473|536834485|FG000|Overall Study|Disease Progression|0|||
148824468|NCT01292473|536834486|FG001|Overall Study|Disease Progression|1|||
148824469|NCT01292473|536834487|FG002|Overall Study|Disease Progression|3|||
148824470|NCT01292473|536834488|FG003|Overall Study|Disease Progression|6|||
148824471|NCT04432298|536834489|FG000|Overall Study|Other than specified|1|||
148824472|NCT04432298|536834490|FG001|Overall Study|Other than specified|0|||
148824473|NCT04432298|536834489|FG000|Overall Study|Lost to Follow-up|0|||
148824474|NCT04432298|536834490|FG001|Overall Study|Lost to Follow-up|1|||
148824475|NCT04432298|536834489|FG000|Overall Study|Death|3|||
148824476|NCT04432298|536834490|FG001|Overall Study|Death|2|||
148824477|NCT04432298|536834489|FG000|Overall Study|Withdrawal by Subject|2|||
148824478|NCT04432298|536834490|FG001|Overall Study|Withdrawal by Subject|0|||
148824479|NCT02451007|536834491|FG000|Overall Study|Withdrawal by Subject|4|||
148824480|NCT02451007|536834491|FG000|Overall Study|Adverse Event|1|||
148824481|NCT02451007|536834491|FG000|Overall Study|Disease Progression|2|||
148824482|NCT00348374|536834492|FG000|Overall Study|Adverse Event|1|||
148824483|NCT00348374|536834493|FG001|Overall Study|Adverse Event|4|||
148824484|NCT00348374|536834492|FG000|Overall Study|Lost to Follow-up|1|||
148824485|NCT00348374|536834493|FG001|Overall Study|Lost to Follow-up|3|||
148824486|NCT00348374|536834492|FG000|Overall Study|Withdrawal by Subject|5|||
148824487|NCT00348374|536834493|FG001|Overall Study|Withdrawal by Subject|5|||
148824488|NCT00348374|536834492|FG000|Overall Study|Other|11|||
148824489|NCT00348374|536834493|FG001|Overall Study|Other|12|||
148824490|NCT00348374|536834492|FG000|Overall Study|ongoing at date of cutoff|1|||
148824491|NCT00348374|536834493|FG001|Overall Study|ongoing at date of cutoff|1|||
148824492|NCT00348374|536834492|FG000|Overall Study|randomized but did not receive treatment|0|||
148824493|NCT00348374|536834493|FG001|Overall Study|randomized but did not receive treatment|7|||
148824494|NCT02595437|536834501|FG000|Triferic Via IV|Withdrawal by Subject|1|||
148824495|NCT01423084|536834505|FG000|Overall Study|Adverse Event|0|||
148824496|NCT01423084|536834506|FG001|Overall Study|Adverse Event|1|||
148824497|NCT01423084|536834505|FG000|Overall Study|Withdrawal by Subject|2|||
148824498|NCT01423084|536834506|FG001|Overall Study|Withdrawal by Subject|3|||
148824499|NCT02180672|536834508|FG000|Overall Study|Lost to Follow-up|5|||
148824500|NCT02180672|536834509|FG001|Overall Study|Lost to Follow-up|7|||
148824501|NCT03574389|536834510|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
148824502|NCT03574389|536834511|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
148824503|NCT03574389|536834512|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
148824504|NCT03574389|536834513|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
148824505|NCT03574389|536834514|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
148824506|NCT03574389|536834515|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
148824507|NCT03574389|536834516|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
148824508|NCT03574389|536834510|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
148976509|NCT01020019|537394562|FG000|Overall Study|Lost to Follow-up|21|||
148976510|NCT01020019|537394563|FG001|Overall Study|Lost to Follow-up|18|||
148976511|NCT01020019|537394562|FG000|Overall Study|Adverse Event|1|||
148824509|NCT03574389|536834511|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
148824510|NCT03574389|536834512|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
148824511|NCT03574389|536834513|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
148824512|NCT03574389|536834514|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
148824513|NCT03574389|536834515|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
148824514|NCT03574389|536834516|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
148824515|NCT03574389|536834510|FG000|Vaccination Period|Other|6|||
148824516|NCT03574389|536834511|FG001|Vaccination Period|Other|0|||
148824517|NCT03574389|536834512|FG002|Vaccination Period|Other|0|||
148758439|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
148758440|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
148758441|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
148758442|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
148758443|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
148758444|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
148758445|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
148758446|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
148758447|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
148758448|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
148758449|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
148758450|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
148758451|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
148758452|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
148758453|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
148758454|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
148758455|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
148758456|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
148758457|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
148758458|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
148758459|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
148758460|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
148758461|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
148758462|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
148758463|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
148758464|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
148758465|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
148758466|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
148758467|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
148758468|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
148758469|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
148758470|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
148758471|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
148758472|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
148758473|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
148758474|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
148758475|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
148758476|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
148758477|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
148758478|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
148758479|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
148758480|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
148758481|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
148758482|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
148758483|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
148758484|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Site closed|0|||
148758485|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Site closed|0|||
148758486|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Site closed|1|||
148758487|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Site closed|0|||
148758488|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
148758489|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
148758490|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
148758491|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
148758492|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
148758493|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
148758494|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
148758495|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
148758496|NCT00838903|536589134|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
148758497|NCT00838903|536589135|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
148758498|NCT00838903|536589136|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
148758499|NCT00838903|536589137|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
148758500|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
148758501|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
148976512|NCT01020019|537394563|FG001|Overall Study|Adverse Event|5|||
148976513|NCT01020019|537394562|FG000|Overall Study|not interested in treatment|4|||
148976514|NCT01020019|537394563|FG001|Overall Study|not interested in treatment|4|||
148824518|NCT03574389|536834513|FG003|Vaccination Period|Other|0|||
148824519|NCT03574389|536834514|FG004|Vaccination Period|Other|0|||
148824520|NCT03574389|536834515|FG005|Vaccination Period|Other|0|||
148758502|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
148758503|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
148758504|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
148758505|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
148758506|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
148758507|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
148758508|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
148758509|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
148758510|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
148758511|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
148758512|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
148758513|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
148758514|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
148758515|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
148758516|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
148758517|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
148758518|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
148758519|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
148758520|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
148758521|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
148758522|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
148758523|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
148758524|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
148758525|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
148758526|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
148758527|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
148758528|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
148758529|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
148758530|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
148758531|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
148758532|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
148758533|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
148758534|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
148758535|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
148758536|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
148758537|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
148758538|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
148758539|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
148758540|NCT00838903|536589134|FG000|Follow-up Period (8 Weeks)|Missing|1|||
148758541|NCT00838903|536589135|FG001|Follow-up Period (8 Weeks)|Missing|2|||
148758542|NCT00838903|536589136|FG002|Follow-up Period (8 Weeks)|Missing|1|||
148758543|NCT00838903|536589137|FG003|Follow-up Period (8 Weeks)|Missing|1|||
148758544|NCT04225715|536589138|FG000|Overall Study|Reason not Specified|1|||
148758545|NCT04225715|536589139|FG001|Overall Study|Reason not Specified|0|||
148758546|NCT04225715|536589140|FG002|Overall Study|Reason not Specified|0|||
148758547|NCT04225715|536589141|FG003|Overall Study|Reason not Specified|0|||
148758548|NCT04225715|536589142|FG004|Overall Study|Reason not Specified|0|||
148758549|NCT04225715|536589143|FG005|Overall Study|Reason not Specified|0|||
148758550|NCT04225715|536589144|FG006|Overall Study|Reason not Specified|0|||
148758551|NCT04225715|536589145|FG007|Overall Study|Reason not Specified|0|||
148758552|NCT04225715|536589146|FG008|Overall Study|Reason not Specified|0|||
148758553|NCT04225715|536589138|FG000|Overall Study|Protocol Violation|1|||
148758554|NCT04225715|536589139|FG001|Overall Study|Protocol Violation|0|||
148758555|NCT04225715|536589140|FG002|Overall Study|Protocol Violation|0|||
148758556|NCT04225715|536589141|FG003|Overall Study|Protocol Violation|0|||
148758557|NCT04225715|536589142|FG004|Overall Study|Protocol Violation|0|||
148758558|NCT04225715|536589143|FG005|Overall Study|Protocol Violation|9|||
148758559|NCT04225715|536589144|FG006|Overall Study|Protocol Violation|0|||
148758560|NCT04225715|536589145|FG007|Overall Study|Protocol Violation|0|||
148758561|NCT04225715|536589146|FG008|Overall Study|Protocol Violation|0|||
148976515|NCT01020019|537394562|FG000|Overall Study|moving|0|||
148976516|NCT01020019|537394563|FG001|Overall Study|moving|2|||
148976517|NCT05091528|537394564|FG000|Overall Study|Study Termination by Sponsor|0|||
148976518|NCT05091528|537394565|FG001|Overall Study|Study Termination by Sponsor|1|||
148758562|NCT04225715|536589138|FG000|Overall Study|Withdrawal by Subject|4|||
148758563|NCT04225715|536589139|FG001|Overall Study|Withdrawal by Subject|1|||
148758564|NCT04225715|536589140|FG002|Overall Study|Withdrawal by Subject|1|||
148758565|NCT04225715|536589141|FG003|Overall Study|Withdrawal by Subject|0|||
148824521|NCT03574389|536834516|FG006|Vaccination Period|Other|0|||
148824522|NCT03574389|536834510|FG000|Vaccination Period|Adverse Event|0|||
148824523|NCT03574389|536834511|FG001|Vaccination Period|Adverse Event|1|||
148824524|NCT03574389|536834512|FG002|Vaccination Period|Adverse Event|0|||
148824525|NCT03574389|536834513|FG003|Vaccination Period|Adverse Event|0|||
148976519|NCT05091528|537394566|FG002|Overall Study|Study Termination by Sponsor|0|||
148976520|NCT05091528|537394567|FG003|Overall Study|Study Termination by Sponsor|1|||
148758566|NCT04225715|536589142|FG004|Overall Study|Withdrawal by Subject|3|||
148758567|NCT04225715|536589143|FG005|Overall Study|Withdrawal by Subject|1|||
148758568|NCT04225715|536589144|FG006|Overall Study|Withdrawal by Subject|1|||
148758569|NCT04225715|536589145|FG007|Overall Study|Withdrawal by Subject|1|||
148758570|NCT04225715|536589146|FG008|Overall Study|Withdrawal by Subject|0|||
148758571|NCT04225715|536589138|FG000|Overall Study|Adverse Event|0|||
148758572|NCT04225715|536589139|FG001|Overall Study|Adverse Event|0|||
148758573|NCT04225715|536589140|FG002|Overall Study|Adverse Event|0|||
148758574|NCT04225715|536589141|FG003|Overall Study|Adverse Event|0|||
148758575|NCT04225715|536589142|FG004|Overall Study|Adverse Event|0|||
148758576|NCT04225715|536589143|FG005|Overall Study|Adverse Event|0|||
148758577|NCT04225715|536589144|FG006|Overall Study|Adverse Event|0|||
148758578|NCT04225715|536589145|FG007|Overall Study|Adverse Event|0|||
148758579|NCT04225715|536589146|FG008|Overall Study|Adverse Event|1|||
148758580|NCT04225715|536589138|FG000|Overall Study|Arm Terminated By Sponsor|0|||
148758581|NCT04225715|536589139|FG001|Overall Study|Arm Terminated By Sponsor|0|||
148758582|NCT04225715|536589140|FG002|Overall Study|Arm Terminated By Sponsor|0|||
148758583|NCT04225715|536589141|FG003|Overall Study|Arm Terminated By Sponsor|0|||
148758584|NCT04225715|536589142|FG004|Overall Study|Arm Terminated By Sponsor|0|||
148758585|NCT04225715|536589143|FG005|Overall Study|Arm Terminated By Sponsor|0|||
148758586|NCT04225715|536589144|FG006|Overall Study|Arm Terminated By Sponsor|0|||
148758587|NCT04225715|536589145|FG007|Overall Study|Arm Terminated By Sponsor|17|||
148758588|NCT04225715|536589146|FG008|Overall Study|Arm Terminated By Sponsor|18|||
148758589|NCT00683618|536589147|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
148758590|NCT00683618|536589148|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
148758591|NCT00683618|536589149|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
148758592|NCT00683618|536589147|FG000|Randomised Treatment Period|Protocol Violation|0|||
148758593|NCT00683618|536589148|FG001|Randomised Treatment Period|Protocol Violation|1|||
148758594|NCT00683618|536589149|FG002|Randomised Treatment Period|Protocol Violation|0|||
148758595|NCT00683618|536589147|FG000|Randomised Treatment Period|Adverse Event|2|||
148758596|NCT00683618|536589148|FG001|Randomised Treatment Period|Adverse Event|0|||
148758597|NCT00683618|536589149|FG002|Randomised Treatment Period|Adverse Event|2|||
148758598|NCT00683618|536589147|FG000|Randomised Treatment Period|Reason not provided|0|||
148758599|NCT00683618|536589148|FG001|Randomised Treatment Period|Reason not provided|0|||
148758600|NCT00683618|536589149|FG002|Randomised Treatment Period|Reason not provided|2|||
148758601|NCT00683618|536589147|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
148758602|NCT00683618|536589148|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
148758603|NCT00683618|536589149|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
148758604|NCT00683618|536589147|FG000|Extension Treatment Period|Adverse Event|1|||
148758605|NCT00683618|536589148|FG001|Extension Treatment Period|Adverse Event|0|||
148758606|NCT00683618|536589149|FG002|Extension Treatment Period|Adverse Event|0|||
148758607|NCT00683618|536589147|FG000|Extension Treatment Period|Protocol Violation|1|||
148758608|NCT00683618|536589148|FG001|Extension Treatment Period|Protocol Violation|0|||
148758609|NCT00683618|536589149|FG002|Extension Treatment Period|Protocol Violation|0|||
148758610|NCT01002989|536589150|FG000|Overall Study|exclusion criteria, no consent|5|||
148758611|NCT01611935|536589151|FG000|Overall Study|Family Declined Participation|1|||
148758612|NCT01611935|536589152|FG001|Overall Study|Family Declined Participation|0|||
148758613|NCT05177484|536589155|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
148758614|NCT05177484|536589156|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
148758615|NCT05177484|536589155|FG000|Overall Study|Inadvertently withdrawn|3|||
148758616|NCT05177484|536589156|FG001|Overall Study|Inadvertently withdrawn|1|||
148758617|NCT05177484|536589155|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
148758618|NCT05177484|536589156|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
148976521|NCT02214121|537394568|FG000|Part A|Patient decision|2|||
148976522|NCT02214121|537394569|FG001|Part A|Patient decision|0|||
148976523|NCT02214121|537394570|FG002|Part A|Patient decision|0|||
148976524|NCT02214121|537394568|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
148976525|NCT02214121|537394569|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
148758619|NCT02549859|536589157|FG000|Long-term 60 Hz DBS|Study Closed|1|||
148758620|NCT00729612|536589158|FG000|Overall Study|Non evaluable for response|10|||
148758621|NCT04878432|536589161|FG000|Overall Study|Adverse Event|1|||
148758622|NCT04878432|536589161|FG000|Overall Study|Death|2|||
148758623|NCT04878432|536589161|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
148758624|NCT04878432|536589161|FG000|Overall Study|Withdrawal by Subject|6|||
148758625|NCT04878432|536589161|FG000|Overall Study|Progressive Disease|7|||
148758626|NCT04878432|536589161|FG000|Overall Study|New Therapy for Study Indication|7|||
148758627|NCT04878432|536589161|FG000|Overall Study|Physician Decision|11|||
148758628|NCT03922321|536589162|FG000|Overall Study|Participant Moved|1|||
148824526|NCT03574389|536834514|FG004|Vaccination Period|Adverse Event|0|||
148976526|NCT02214121|537394570|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
148976527|NCT02214121|537394568|FG000|Part A|Other|1|||
148976528|NCT02214121|537394569|FG001|Part A|Other|0|||
148976529|NCT02214121|537394570|FG002|Part A|Other|0|||
148976530|NCT02214121|537394568|FG000|Part B|Patient decision|0|||
148976531|NCT02214121|537394569|FG001|Part B|Patient decision|1|||
148976532|NCT02214121|537394570|FG002|Part B|Patient decision|0|||
148976533|NCT02214121|537394568|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
148976534|NCT02214121|537394569|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
148976535|NCT02214121|537394570|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
148976536|NCT02214121|537394568|FG000|Part B|Lost to Follow-up|0|||
148976537|NCT02214121|537394569|FG001|Part B|Lost to Follow-up|0|||
148758629|NCT03922321|536589162|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
148758630|NCT00495391|536589163|FG000|Overall Study|Lack of Efficacy|34|||
148758631|NCT00495391|536589164|FG001|Overall Study|Lack of Efficacy|18|||
148758632|NCT00495391|536589163|FG000|Overall Study|Withdrawal by Subject|2|||
148758633|NCT00495391|536589164|FG001|Overall Study|Withdrawal by Subject|3|||
148758634|NCT02712320|536589165|FG000|Overall Study|Lost to Follow-up|1|||
148758635|NCT02712320|536589165|FG000|Overall Study|Withdrawal by Subject|1|||
148758636|NCT02712320|536589165|FG000|Overall Study|Transferred to another facility|1|||
148758637|NCT02712320|536589165|FG000|Overall Study|Treating with the prohibited medications|2|||
148758638|NCT00444535|536589166|FG000|Overall Study|Withdrawal by Subject|5|||
148758639|NCT00444535|536589166|FG000|Overall Study|Physician Decision|5|||
148758640|NCT00444535|536589166|FG000|Overall Study|progressive disease|1|||
148758641|NCT00444535|536589166|FG000|Overall Study|Adverse Event|2|||
148758642|NCT01704495|536589170|FG000|Subjects Randomized|Other Reason|3|||
148758643|NCT01704495|536589171|FG001|Subjects Randomized|Other Reason|2|||
148758644|NCT01704495|536589172|FG002|Subjects Randomized|Other Reason|3|||
148758645|NCT01704495|536589173|FG003|Subjects Randomized|Other Reason|2|||
148758646|NCT01704495|536589170|FG000|Subjects Randomized|Discontinuation criteria met|4|||
148758647|NCT01704495|536589171|FG001|Subjects Randomized|Discontinuation criteria met|2|||
148758648|NCT01704495|536589172|FG002|Subjects Randomized|Discontinuation criteria met|2|||
148758649|NCT01704495|536589173|FG003|Subjects Randomized|Discontinuation criteria met|0|||
148758650|NCT01704495|536589170|FG000|Subjects Randomized|Adverse Event|8|||
148758651|NCT01704495|536589171|FG001|Subjects Randomized|Adverse Event|2|||
148758652|NCT01704495|536589172|FG002|Subjects Randomized|Adverse Event|0|||
148758653|NCT01704495|536589173|FG003|Subjects Randomized|Adverse Event|7|||
148758654|NCT01704495|536589170|FG000|Subjects Randomized|Withdrawal by Subject|5|||
148758655|NCT01704495|536589171|FG001|Subjects Randomized|Withdrawal by Subject|5|||
148758656|NCT01704495|536589172|FG002|Subjects Randomized|Withdrawal by Subject|5|||
148758657|NCT01704495|536589173|FG003|Subjects Randomized|Withdrawal by Subject|5|||
148758658|NCT01704495|536589170|FG000|Subjects Randomized|Protocol Violation|1|||
148758659|NCT01704495|536589171|FG001|Subjects Randomized|Protocol Violation|1|||
148758660|NCT01704495|536589172|FG002|Subjects Randomized|Protocol Violation|2|||
148758661|NCT01704495|536589173|FG003|Subjects Randomized|Protocol Violation|0|||
148758662|NCT01704495|536589170|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
148758663|NCT01704495|536589171|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
148758664|NCT01704495|536589172|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
148758665|NCT01704495|536589173|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
148758666|NCT01704495|536589170|FG000|Optional Safety Extension|Adverse Event|0|||
148758667|NCT01704495|536589171|FG001|Optional Safety Extension|Adverse Event|4|||
148758668|NCT01704495|536589172|FG002|Optional Safety Extension|Adverse Event|0|||
148758669|NCT01704495|536589173|FG003|Optional Safety Extension|Adverse Event|1|||
148758670|NCT01704495|536589170|FG000|Optional Safety Extension|Other reason|27|||
148758671|NCT01704495|536589171|FG001|Optional Safety Extension|Other reason|29|||
148758672|NCT01704495|536589172|FG002|Optional Safety Extension|Other reason|30|||
148758673|NCT01704495|536589173|FG003|Optional Safety Extension|Other reason|28|||
148758674|NCT01704495|536589170|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
148824527|NCT03574389|536834515|FG005|Vaccination Period|Adverse Event|0|||
148976538|NCT02214121|537394570|FG002|Part B|Lost to Follow-up|1|||
148976539|NCT01541826|537394571|FG000|Overall Study|Lost to Follow-up|2|||
148758675|NCT01704495|536589171|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
148758676|NCT01704495|536589172|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
148824528|NCT03574389|536834516|FG006|Vaccination Period|Adverse Event|0|||
148976540|NCT01541826|537394572|FG001|Overall Study|Lost to Follow-up|3|||
148976541|NCT01541826|537394573|FG002|Overall Study|Lost to Follow-up|0|||
148976542|NCT01541826|537394571|FG000|Overall Study|Withdrawal by Subject|2|||
148758677|NCT01704495|536589173|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
148758678|NCT00832455|536589178|FG000|Overall Study|Adverse Event|13|||
148976543|NCT01541826|537394572|FG001|Overall Study|Withdrawal by Subject|0|||
148976544|NCT01541826|537394573|FG002|Overall Study|Withdrawal by Subject|0|||
148976545|NCT01527292|537394579|FG000|Overall Study|Physician Decision|0|||
148976546|NCT01527292|537394580|FG001|Overall Study|Physician Decision|3|||
148758679|NCT00832455|536589178|FG000|Overall Study|Lost to Follow-up|26|||
148758680|NCT00832455|536589178|FG000|Overall Study|Protocol Violation|4|||
148824529|NCT03574389|536834510|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
148976547|NCT00006916|537394581|FG000|Overall Study|Device not inserted|4|||
148824530|NCT03574389|536834511|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
148824531|NCT03574389|536834512|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
148824532|NCT03574389|536834513|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
148824533|NCT03574389|536834514|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
148824534|NCT03574389|536834515|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
148824535|NCT03574389|536834516|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
148824536|NCT02070380|536834523|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
148824537|NCT02070380|536834524|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
148824538|NCT02070380|536834525|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
148824539|NCT02070380|536834526|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
148824540|NCT02070380|536834523|FG000|Second Injection|Image sets missing or technically inadeq|0|||
148824541|NCT02070380|536834524|FG001|Second Injection|Image sets missing or technically inadeq|1|||
148824542|NCT02070380|536834525|FG002|Second Injection|Image sets missing or technically inadeq|0|||
148824543|NCT02070380|536834526|FG003|Second Injection|Image sets missing or technically inadeq|0|||
148824544|NCT02070380|536834523|FG000|Second Injection|Protocol Violation|0|||
148824545|NCT02070380|536834524|FG001|Second Injection|Protocol Violation|1|||
148824546|NCT02070380|536834525|FG002|Second Injection|Protocol Violation|1|||
148824547|NCT02070380|536834526|FG003|Second Injection|Protocol Violation|5|||
148824548|NCT01133977|536834529|FG000|Overall Study|Adverse Event|0|||
148824549|NCT01133977|536834530|FG001|Overall Study|Adverse Event|0|||
148824550|NCT01133977|536834531|FG002|Overall Study|Adverse Event|1|||
148824551|NCT01133977|536834532|FG003|Overall Study|Adverse Event|0|||
148824552|NCT01133977|536834533|FG004|Overall Study|Adverse Event|0|||
148824553|NCT01133977|536834529|FG000|Overall Study|Death|1|||
148824554|NCT01133977|536834530|FG001|Overall Study|Death|1|||
148824555|NCT01133977|536834531|FG002|Overall Study|Death|1|||
148824556|NCT01133977|536834532|FG003|Overall Study|Death|7|||
148824557|NCT01133977|536834533|FG004|Overall Study|Death|3|||
148824558|NCT01133977|536834529|FG000|Overall Study|Started a New Line of Therapy|2|||
148824559|NCT01133977|536834530|FG001|Overall Study|Started a New Line of Therapy|6|||
148824560|NCT01133977|536834531|FG002|Overall Study|Started a New Line of Therapy|4|||
148976548|NCT00006916|537394581|FG000|Overall Study|Complication of device insertion|1|||
148976549|NCT00558103|537394582|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
148824561|NCT01133977|536834532|FG003|Overall Study|Started a New Line of Therapy|25|||
148824562|NCT01133977|536834533|FG004|Overall Study|Started a New Line of Therapy|33|||
148824563|NCT01133977|536834529|FG000|Overall Study|Lost to Follow-up|0|||
148824564|NCT01133977|536834530|FG001|Overall Study|Lost to Follow-up|0|||
148824565|NCT01133977|536834531|FG002|Overall Study|Lost to Follow-up|0|||
148824566|NCT01133977|536834532|FG003|Overall Study|Lost to Follow-up|2|||
148824567|NCT01133977|536834533|FG004|Overall Study|Lost to Follow-up|1|||
148824568|NCT01133977|536834529|FG000|Overall Study|Withdrawal by Subject|0|||
148824569|NCT01133977|536834530|FG001|Overall Study|Withdrawal by Subject|0|||
148824570|NCT01133977|536834531|FG002|Overall Study|Withdrawal by Subject|0|||
148824571|NCT01133977|536834532|FG003|Overall Study|Withdrawal by Subject|5|||
148824572|NCT01133977|536834533|FG004|Overall Study|Withdrawal by Subject|1|||
148824573|NCT01682603|536834534|FG000|Overall Study|Lost to Follow-up|3|||
148824574|NCT01791205|536834535|FG000|Phase II|Lack of Efficacy|6|||
148824575|NCT01791205|536834536|FG001|Phase II|Lack of Efficacy|0|||
148824576|NCT01791205|536834535|FG000|Phase II|Adverse Event|2|||
148824577|NCT01791205|536834536|FG001|Phase II|Adverse Event|0|||
148824578|NCT01791205|536834535|FG000|Phase II|Safety|1|||
148824579|NCT01791205|536834536|FG001|Phase II|Safety|0|||
148824580|NCT01791205|536834535|FG000|Phase II|Lost to Follow-up|1|||
148824581|NCT01791205|536834536|FG001|Phase II|Lost to Follow-up|0|||
148824582|NCT01791205|536834535|FG000|Phase II|Remission of disease|1|||
148824583|NCT01791205|536834536|FG001|Phase II|Remission of disease|0|||
148824584|NCT01791205|536834535|FG000|Phase II|Physician's decision|1|||
148824585|NCT01791205|536834536|FG001|Phase II|Physician's decision|0|||
148824586|NCT01908699|536834537|FG000|Overall Study|Adverse Event|8|||
148976550|NCT00558103|537394583|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
148976551|NCT00558103|537394584|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
148976552|NCT00558103|537394585|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
148976553|NCT00558103|537394586|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
148976554|NCT00558103|537394587|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
148824587|NCT01908699|536834538|FG001|Overall Study|Adverse Event|12|||
148824588|NCT01908699|536834537|FG000|Overall Study|Lack of Efficacy|2|||
148824589|NCT01908699|536834538|FG001|Overall Study|Lack of Efficacy|2|||
148824590|NCT01908699|536834537|FG000|Overall Study|Lost to Follow-up|2|||
148824591|NCT01908699|536834538|FG001|Overall Study|Lost to Follow-up|4|||
148824592|NCT01908699|536834537|FG000|Overall Study|Physician Decision|8|||
148824593|NCT01908699|536834538|FG001|Overall Study|Physician Decision|8|||
148824594|NCT01908699|536834537|FG000|Overall Study|Withdrawal by Subject|15|||
148824595|NCT01908699|536834538|FG001|Overall Study|Withdrawal by Subject|10|||
148824596|NCT01908699|536834537|FG000|Overall Study|Pregnancy|0|||
148824597|NCT01908699|536834538|FG001|Overall Study|Pregnancy|1|||
148824598|NCT01908699|536834537|FG000|Overall Study|Randomized in Error|1|||
148824599|NCT01908699|536834538|FG001|Overall Study|Randomized in Error|0|||
148824600|NCT01908699|536834537|FG000|Overall Study|Death|9|||
148824601|NCT01908699|536834538|FG001|Overall Study|Death|12|||
148824602|NCT01908699|536834537|FG000|Overall Study|Progressive Disease|30|||
148824603|NCT01908699|536834538|FG001|Overall Study|Progressive Disease|29|||
148824604|NCT01697501|536834539|FG000|Overall Study|Protocol Violation|2|||
148824605|NCT02242903|536834540|FG000|Overall Study|Withdrawal by Subject|1|||
148824606|NCT02242903|536834541|FG001|Overall Study|Withdrawal by Subject|0|||
148824607|NCT02242903|536834542|FG002|Overall Study|Withdrawal by Subject|0|||
148824608|NCT02242903|536834543|FG003|Overall Study|Withdrawal by Subject|0|||
148824609|NCT02242903|536834544|FG004|Overall Study|Withdrawal by Subject|0|||
148824610|NCT02242903|536834545|FG005|Overall Study|Withdrawal by Subject|0|||
148824611|NCT02242903|536834546|FG006|Overall Study|Withdrawal by Subject|0|||
148824612|NCT01896986|536834549|FG000|Overall Study|samples lost|14|||
148824613|NCT01896986|536834550|FG001|Overall Study|samples lost|23|||
148824614|NCT00281580|536834552|FG000|Overall Study|Adverse Event|2|||
148824615|NCT00281580|536834553|FG001|Overall Study|Adverse Event|0|||
148824616|NCT00281580|536834554|FG002|Overall Study|Adverse Event|2|||
148824617|NCT00281580|536834555|FG003|Overall Study|Adverse Event|4|||
148824618|NCT00281580|536834556|FG004|Overall Study|Adverse Event|1|||
148824619|NCT00281580|536834557|FG005|Overall Study|Adverse Event|0|||
148824620|NCT00281580|536834558|FG006|Overall Study|Adverse Event|1|||
148824621|NCT00281580|536834559|FG007|Overall Study|Adverse Event|0|||
148824622|NCT00281580|536834560|FG008|Overall Study|Adverse Event|1|||
148824623|NCT00281580|536834561|FG009|Overall Study|Adverse Event|6|||
148824624|NCT00281580|536834562|FG010|Overall Study|Adverse Event|0|||
148824625|NCT00281580|536834563|FG011|Overall Study|Adverse Event|5|||
148824626|NCT00281580|536834564|FG012|Overall Study|Adverse Event|8|||
148824627|NCT00281580|536834565|FG013|Overall Study|Adverse Event|2|||
148824628|NCT00281580|536834566|FG014|Overall Study|Adverse Event|3|||
148824629|NCT00281580|536834567|FG015|Overall Study|Adverse Event|3|||
148824630|NCT00281580|536834552|FG000|Overall Study|Protocol Violation|0|||
148824631|NCT00281580|536834553|FG001|Overall Study|Protocol Violation|0|||
148824632|NCT00281580|536834554|FG002|Overall Study|Protocol Violation|1|||
148824633|NCT00281580|536834555|FG003|Overall Study|Protocol Violation|1|||
148824634|NCT00281580|536834556|FG004|Overall Study|Protocol Violation|0|||
148824635|NCT00281580|536834557|FG005|Overall Study|Protocol Violation|0|||
148824636|NCT00281580|536834558|FG006|Overall Study|Protocol Violation|1|||
148824637|NCT00281580|536834559|FG007|Overall Study|Protocol Violation|0|||
148824638|NCT00281580|536834560|FG008|Overall Study|Protocol Violation|2|||
148824639|NCT00281580|536834561|FG009|Overall Study|Protocol Violation|0|||
148824640|NCT00281580|536834562|FG010|Overall Study|Protocol Violation|1|||
148824641|NCT00281580|536834563|FG011|Overall Study|Protocol Violation|2|||
148824642|NCT00281580|536834564|FG012|Overall Study|Protocol Violation|0|||
148824643|NCT00281580|536834565|FG013|Overall Study|Protocol Violation|1|||
148824644|NCT00281580|536834566|FG014|Overall Study|Protocol Violation|1|||
148824645|NCT00281580|536834567|FG015|Overall Study|Protocol Violation|3|||
148824646|NCT00281580|536834552|FG000|Overall Study|Withdrawal by Subject|3|||
148824647|NCT00281580|536834553|FG001|Overall Study|Withdrawal by Subject|0|||
148824648|NCT00281580|536834554|FG002|Overall Study|Withdrawal by Subject|1|||
148824649|NCT00281580|536834555|FG003|Overall Study|Withdrawal by Subject|1|||
148824650|NCT00281580|536834556|FG004|Overall Study|Withdrawal by Subject|1|||
148824651|NCT00281580|536834557|FG005|Overall Study|Withdrawal by Subject|2|||
148824652|NCT00281580|536834558|FG006|Overall Study|Withdrawal by Subject|2|||
148824653|NCT00281580|536834559|FG007|Overall Study|Withdrawal by Subject|0|||
148824654|NCT00281580|536834560|FG008|Overall Study|Withdrawal by Subject|1|||
148824655|NCT00281580|536834561|FG009|Overall Study|Withdrawal by Subject|4|||
148824656|NCT00281580|536834562|FG010|Overall Study|Withdrawal by Subject|1|||
148824657|NCT00281580|536834563|FG011|Overall Study|Withdrawal by Subject|1|||
148824658|NCT00281580|536834564|FG012|Overall Study|Withdrawal by Subject|2|||
148824659|NCT00281580|536834565|FG013|Overall Study|Withdrawal by Subject|2|||
149027454|NCT01528709|537578565|FG000|Overall Study|Death|2|||
149027455|NCT01528709|537578566|FG001|Overall Study|Death|0|||
149027456|NCT01528709|537578565|FG000|Overall Study|Withdrawal by Subject|10|||
148824660|NCT00281580|536834566|FG014|Overall Study|Withdrawal by Subject|1|||
149027457|NCT01528709|537578566|FG001|Overall Study|Withdrawal by Subject|15|||
148824661|NCT00281580|536834567|FG015|Overall Study|Withdrawal by Subject|5|||
148824662|NCT00281580|536834552|FG000|Overall Study|Lack of Efficacy|2|||
148824663|NCT00281580|536834553|FG001|Overall Study|Lack of Efficacy|1|||
148824664|NCT00281580|536834554|FG002|Overall Study|Lack of Efficacy|1|||
148824665|NCT00281580|536834555|FG003|Overall Study|Lack of Efficacy|6|||
148824666|NCT00281580|536834556|FG004|Overall Study|Lack of Efficacy|2|||
148824667|NCT00281580|536834557|FG005|Overall Study|Lack of Efficacy|0|||
148824668|NCT00281580|536834558|FG006|Overall Study|Lack of Efficacy|0|||
148824669|NCT00281580|536834559|FG007|Overall Study|Lack of Efficacy|0|||
148824670|NCT00281580|536834560|FG008|Overall Study|Lack of Efficacy|0|||
148824671|NCT00281580|536834561|FG009|Overall Study|Lack of Efficacy|0|||
148824672|NCT00281580|536834562|FG010|Overall Study|Lack of Efficacy|0|||
148824673|NCT00281580|536834563|FG011|Overall Study|Lack of Efficacy|1|||
148824674|NCT00281580|536834564|FG012|Overall Study|Lack of Efficacy|0|||
149027458|NCT01528709|537578565|FG000|Overall Study|allergy|1|||
148824675|NCT00281580|536834565|FG013|Overall Study|Lack of Efficacy|2|||
148824676|NCT00281580|536834566|FG014|Overall Study|Lack of Efficacy|1|||
148824677|NCT00281580|536834567|FG015|Overall Study|Lack of Efficacy|0|||
148824678|NCT00281580|536834552|FG000|Overall Study|Lost to Follow-up|0|||
148824679|NCT00281580|536834553|FG001|Overall Study|Lost to Follow-up|0|||
148824680|NCT00281580|536834554|FG002|Overall Study|Lost to Follow-up|0|||
148824681|NCT00281580|536834555|FG003|Overall Study|Lost to Follow-up|3|||
148824682|NCT00281580|536834556|FG004|Overall Study|Lost to Follow-up|0|||
148824683|NCT00281580|536834557|FG005|Overall Study|Lost to Follow-up|1|||
148824684|NCT00281580|536834558|FG006|Overall Study|Lost to Follow-up|0|||
148824685|NCT00281580|536834559|FG007|Overall Study|Lost to Follow-up|1|||
148824686|NCT00281580|536834560|FG008|Overall Study|Lost to Follow-up|2|||
148824687|NCT00281580|536834561|FG009|Overall Study|Lost to Follow-up|1|||
148824688|NCT00281580|536834562|FG010|Overall Study|Lost to Follow-up|1|||
148824689|NCT00281580|536834563|FG011|Overall Study|Lost to Follow-up|0|||
148824690|NCT00281580|536834564|FG012|Overall Study|Lost to Follow-up|1|||
148824691|NCT00281580|536834565|FG013|Overall Study|Lost to Follow-up|0|||
148824692|NCT00281580|536834566|FG014|Overall Study|Lost to Follow-up|0|||
148824693|NCT00281580|536834567|FG015|Overall Study|Lost to Follow-up|0|||
148824694|NCT00281580|536834552|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
148824695|NCT00281580|536834553|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
148824696|NCT00281580|536834554|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
148824697|NCT00281580|536834555|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
148824698|NCT00281580|536834556|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
148824699|NCT00281580|536834557|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
148824700|NCT00281580|536834558|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
148824701|NCT00281580|536834559|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
148824702|NCT00281580|536834560|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
148824703|NCT00281580|536834561|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
148824704|NCT00281580|536834562|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
148824705|NCT00281580|536834563|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
148824706|NCT00281580|536834564|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
148824707|NCT00281580|536834565|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
148824708|NCT00281580|536834566|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
148824709|NCT00281580|536834567|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
148824710|NCT01550965|536834568|FG000|Overall Study|Adverse Event|26|||
148824711|NCT01550965|536834568|FG000|Overall Study|Withdrawal by Subject|10|||
148824712|NCT01550965|536834568|FG000|Overall Study|Lost to Follow-up|2|||
148824713|NCT01550965|536834568|FG000|Overall Study|Lack of Efficacy|59|||
148824714|NCT01550965|536834568|FG000|Overall Study|Other|13|||
148824715|NCT01696214|536834571|FG000|Overall Study|Lost to Follow-up|1|||
148824716|NCT01696214|536834572|FG001|Overall Study|Lost to Follow-up|0|||
148824717|NCT01696214|536834573|FG002|Overall Study|Lost to Follow-up|0|||
148824718|NCT01696214|536834574|FG003|Overall Study|Lost to Follow-up|0|||
148824719|NCT01063881|536834576|FG000|Overall Study|Adverse Event|12|||
148824720|NCT01063881|536834577|FG001|Overall Study|Adverse Event|2|||
148824721|NCT01063881|536834578|FG002|Overall Study|Adverse Event|0|||
148824722|NCT01063881|536834576|FG000|Overall Study|Lost to Follow-up|13|||
148824723|NCT01063881|536834577|FG001|Overall Study|Lost to Follow-up|7|||
148824724|NCT01063881|536834578|FG002|Overall Study|Lost to Follow-up|1|||
148824725|NCT01063881|536834576|FG000|Overall Study|Withdrawal by Subject|25|||
148824726|NCT01063881|536834577|FG001|Overall Study|Withdrawal by Subject|1|||
148824727|NCT01063881|536834578|FG002|Overall Study|Withdrawal by Subject|0|||
148824728|NCT01063881|536834576|FG000|Overall Study|Reason for not completed not specified|5|||
148824729|NCT01063881|536834577|FG001|Overall Study|Reason for not completed not specified|1|||
148824730|NCT01063881|536834578|FG002|Overall Study|Reason for not completed not specified|0|||
148824731|NCT01340170|536834579|FG000|Overall Study|Lost to Follow-up|2|||
148824732|NCT01340170|536834580|FG001|Overall Study|Lost to Follow-up|4|||
148824733|NCT01340170|536834581|FG002|Overall Study|Lost to Follow-up|0|||
148824734|NCT01340170|536834579|FG000|Overall Study|Implant failure|1|||
148824735|NCT01340170|536834580|FG001|Overall Study|Implant failure|3|||
148824736|NCT01340170|536834581|FG002|Overall Study|Implant failure|0|||
148824737|NCT00066170|536834582|FG000|Overall Study|Adverse Event|2|||
148824738|NCT00066170|536834583|FG001|Overall Study|Adverse Event|4|||
148824739|NCT00066170|536834584|FG002|Overall Study|Adverse Event|1|||
148824740|NCT00066170|536834585|FG003|Overall Study|Adverse Event|7|||
148824741|NCT00066170|536834582|FG000|Overall Study|Serious Adverse Event|0|||
148824742|NCT00066170|536834583|FG001|Overall Study|Serious Adverse Event|0|||
148976555|NCT00558103|537394582|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
148976556|NCT00558103|537394583|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
148824743|NCT00066170|536834584|FG002|Overall Study|Serious Adverse Event|1|||
148824744|NCT00066170|536834585|FG003|Overall Study|Serious Adverse Event|1|||
148824745|NCT00066170|536834582|FG000|Overall Study|Lost to Follow-up|0|||
148824746|NCT00066170|536834583|FG001|Overall Study|Lost to Follow-up|1|||
148824747|NCT00066170|536834584|FG002|Overall Study|Lost to Follow-up|0|||
148824748|NCT00066170|536834585|FG003|Overall Study|Lost to Follow-up|0|||
148824749|NCT00066170|536834582|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
148824750|NCT00066170|536834583|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
148824751|NCT00066170|536834584|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
148824752|NCT00066170|536834585|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
148824753|NCT00066170|536834582|FG000|Overall Study|Protocol Violation|3|||
148824754|NCT00066170|536834583|FG001|Overall Study|Protocol Violation|0|||
148824755|NCT00066170|536834584|FG002|Overall Study|Protocol Violation|0|||
148824756|NCT00066170|536834585|FG003|Overall Study|Protocol Violation|0|||
148824757|NCT00066170|536834582|FG000|Overall Study|Other|1|||
148824758|NCT00066170|536834583|FG001|Overall Study|Other|5|||
148824759|NCT00066170|536834584|FG002|Overall Study|Other|2|||
148824760|NCT00066170|536834585|FG003|Overall Study|Other|0|||
148824761|NCT01248468|536834587|FG000|Overall Study|Administrative problem|1|||
148824762|NCT01248468|536834588|FG001|Overall Study|Administrative problem|0|||
148824763|NCT01248468|536834589|FG002|Overall Study|Administrative problem|0|||
148824764|NCT01248468|536834587|FG000|Overall Study|Lost to Follow-up|9|||
148824765|NCT01248468|536834588|FG001|Overall Study|Lost to Follow-up|12|||
148824766|NCT01248468|536834589|FG002|Overall Study|Lost to Follow-up|4|||
148824767|NCT01248468|536834587|FG000|Overall Study|Pregnancy|1|||
148824768|NCT01248468|536834588|FG001|Overall Study|Pregnancy|0|||
148824769|NCT01248468|536834589|FG002|Overall Study|Pregnancy|0|||
148824770|NCT01248468|536834587|FG000|Overall Study|Withdrawal by Subject|4|||
148824771|NCT01248468|536834588|FG001|Overall Study|Withdrawal by Subject|2|||
148824772|NCT01248468|536834589|FG002|Overall Study|Withdrawal by Subject|0|||
148824773|NCT04128228|536834593|FG000|Overall Study|Withdrawal by Subject|3|||
148824774|NCT04128228|536834594|FG001|Overall Study|Withdrawal by Subject|3|||
148824775|NCT04128228|536834595|FG002|Overall Study|Withdrawal by Subject|0|||
148824776|NCT04128228|536834596|FG003|Overall Study|Withdrawal by Subject|0|||
148824777|NCT04128228|536834593|FG000|Overall Study|noncompliance|2|||
148824778|NCT04128228|536834594|FG001|Overall Study|noncompliance|2|||
148824779|NCT04128228|536834595|FG002|Overall Study|noncompliance|0|||
148824780|NCT04128228|536834596|FG003|Overall Study|noncompliance|0|||
148824781|NCT04401293|536834597|FG000|Overall Study|Withdrawal by Subject|1|||
148824782|NCT04401293|536834598|FG001|Overall Study|Withdrawal by Subject|3|||
148824783|NCT01026038|536834599|FG000|Overall Study|Lost to Follow-up|1|||
148824784|NCT01026038|536834600|FG001|Overall Study|Lost to Follow-up|1|||
148824785|NCT01026038|536834601|FG002|Overall Study|Lost to Follow-up|0|||
148824786|NCT03679884|536834602|FG000|Overall Study|Other|12|||
148824787|NCT03679884|536834603|FG001|Overall Study|Other|12|||
148824788|NCT03679884|536834604|FG002|Overall Study|Other|12|||
148824789|NCT03679884|536834605|FG003|Overall Study|Other|7|||
148824790|NCT03679884|536834606|FG004|Overall Study|Other|8|||
148824791|NCT03679884|536834602|FG000|Overall Study|Lack of Efficacy|15|||
148824792|NCT03679884|536834603|FG001|Overall Study|Lack of Efficacy|29|||
148824793|NCT03679884|536834604|FG002|Overall Study|Lack of Efficacy|13|||
148824794|NCT03679884|536834605|FG003|Overall Study|Lack of Efficacy|29|||
148824795|NCT03679884|536834606|FG004|Overall Study|Lack of Efficacy|10|||
148824796|NCT03679884|536834602|FG000|Overall Study|Death|1|||
148824797|NCT03679884|536834603|FG001|Overall Study|Death|0|||
148824798|NCT03679884|536834604|FG002|Overall Study|Death|0|||
148824799|NCT03679884|536834605|FG003|Overall Study|Death|0|||
148824800|NCT03679884|536834606|FG004|Overall Study|Death|0|||
148824801|NCT03679884|536834602|FG000|Overall Study|Adverse Event|2|||
148824802|NCT03679884|536834603|FG001|Overall Study|Adverse Event|10|||
148824803|NCT03679884|536834604|FG002|Overall Study|Adverse Event|9|||
148824804|NCT03679884|536834605|FG003|Overall Study|Adverse Event|6|||
148824805|NCT03679884|536834606|FG004|Overall Study|Adverse Event|6|||
148824806|NCT03679884|536834602|FG000|Overall Study|Withdrawal by Subject|12|||
148824807|NCT03679884|536834603|FG001|Overall Study|Withdrawal by Subject|23|||
148824808|NCT03679884|536834604|FG002|Overall Study|Withdrawal by Subject|8|||
148824809|NCT03679884|536834605|FG003|Overall Study|Withdrawal by Subject|8|||
148824810|NCT03679884|536834606|FG004|Overall Study|Withdrawal by Subject|9|||
148824811|NCT03679884|536834602|FG000|Overall Study|Lost to Follow-up|1|||
148824812|NCT03679884|536834603|FG001|Overall Study|Lost to Follow-up|4|||
148976557|NCT00558103|537394584|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
148824813|NCT03679884|536834604|FG002|Overall Study|Lost to Follow-up|2|||
148824814|NCT03679884|536834605|FG003|Overall Study|Lost to Follow-up|0|||
148824815|NCT03679884|536834606|FG004|Overall Study|Lost to Follow-up|3|||
148976558|NCT00558103|537394585|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
148824816|NCT02774278|536834607|FG000|Overall Study|Lack of Efficacy|199|||
148976559|NCT00558103|537394586|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
149027459|NCT01528709|537578566|FG001|Overall Study|allergy|0|||
148824817|NCT02774278|536834607|FG000|Overall Study|Death|29|||
148824818|NCT02774278|536834607|FG000|Overall Study|Adverse event/intercurrent illness|16|||
148824819|NCT02774278|536834607|FG000|Overall Study|Refused treatment/did not cooperate|9|||
148824820|NCT02774278|536834607|FG000|Overall Study|Administrative reasons|6|||
148824821|NCT02774278|536834607|FG000|Overall Study|Withdrawal by Subject|3|||
148824822|NCT02774278|536834607|FG000|Overall Study|Protocol Violation|2|||
148824823|NCT03760666|536834618|FG000|Overall Study|Adverse Event|2|||
148824824|NCT03760666|536834619|FG001|Overall Study|Adverse Event|4|||
148976560|NCT00558103|537394587|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
148976561|NCT00558103|537394582|FG000|Randomized Treatment Phase|Disease Progression|1|||
148976562|NCT00558103|537394583|FG001|Randomized Treatment Phase|Disease Progression|0|||
148976563|NCT00558103|537394584|FG002|Randomized Treatment Phase|Disease Progression|1|||
148976564|NCT00558103|537394585|FG003|Randomized Treatment Phase|Disease Progression|0|||
148976565|NCT00558103|537394586|FG004|Randomized Treatment Phase|Disease Progression|0|||
148976566|NCT00558103|537394587|FG005|Randomized Treatment Phase|Disease Progression|0|||
148976567|NCT00558103|537394582|FG000|Randomized Treatment Phase|Adverse Event|0|||
148976568|NCT00558103|537394583|FG001|Randomized Treatment Phase|Adverse Event|0|||
149027460|NCT01237678|537578567|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
149027461|NCT01237678|537578568|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
148758681|NCT00832455|536589178|FG000|Overall Study|Withdrawal by Subject|17|||
148758682|NCT00832455|536589178|FG000|Overall Study|Screening Failure|2|||
148758683|NCT00832455|536589178|FG000|Overall Study|Stopped Medication|4|||
148758684|NCT00832455|536589178|FG000|Overall Study|Parent misunderstood study|1|||
148758685|NCT00832455|536589178|FG000|Overall Study|Parent dissatisfied|1|||
148758686|NCT00832455|536589178|FG000|Overall Study|No improvement|3|||
148758687|NCT00832455|536589178|FG000|Overall Study|Patient moved|1|||
148758688|NCT00092118|536589181|FG000|Overall Study|Adverse Event|35|||
148758689|NCT00092118|536589182|FG001|Overall Study|Adverse Event|32|||
148758690|NCT00092118|536589181|FG000|Overall Study|Lack of Efficacy|12|||
148758691|NCT00092118|536589182|FG001|Overall Study|Lack of Efficacy|14|||
148758692|NCT00092118|536589181|FG000|Overall Study|Lost to Follow-up|4|||
148758693|NCT00092118|536589182|FG001|Overall Study|Lost to Follow-up|3|||
148758694|NCT00092118|536589181|FG000|Overall Study|Protocol Violation|23|||
148758695|NCT00092118|536589182|FG001|Overall Study|Protocol Violation|25|||
148758696|NCT00092118|536589181|FG000|Overall Study|Withdrawal by Subject|4|||
148758697|NCT00092118|536589182|FG001|Overall Study|Withdrawal by Subject|10|||
148758698|NCT00092118|536589181|FG000|Overall Study|Other|6|||
148758699|NCT00092118|536589182|FG001|Overall Study|Other|5|||
148758700|NCT02172664|536589190|FG000|Overall Study|Lost to Follow-up|4|||
148758701|NCT02172664|536589191|FG001|Overall Study|Lost to Follow-up|4|||
148758702|NCT02172664|536589190|FG000|Overall Study|Death|1|||
148758703|NCT02172664|536589191|FG001|Overall Study|Death|1|||
148758704|NCT02172664|536589190|FG000|Overall Study|Moved out of area|1|||
148758705|NCT02172664|536589191|FG001|Overall Study|Moved out of area|1|||
148758706|NCT02946463|536589194|FG000|Primary Evaluation Period|Physician Decision|0|||
148758707|NCT02946463|536589195|FG001|Primary Evaluation Period|Physician Decision|1|||
148758708|NCT02946463|536589196|FG002|Primary Evaluation Period|Physician Decision|0|||
148758709|NCT02946463|536589197|FG003|Primary Evaluation Period|Physician Decision|0|||
148758710|NCT02946463|536589194|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
148758711|NCT02946463|536589195|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
148758712|NCT02946463|536589196|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
148758713|NCT02946463|536589197|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
148758714|NCT02946463|536589194|FG000|Extension Period|Death|4|||
148758715|NCT02946463|536589195|FG001|Extension Period|Death|4|||
148758716|NCT02946463|536589196|FG002|Extension Period|Death|0|||
148758717|NCT02946463|536589197|FG003|Extension Period|Death|0|||
148758718|NCT02946463|536589194|FG000|Extension Period|Withdrawal by Subject|4|||
148758719|NCT02946463|536589195|FG001|Extension Period|Withdrawal by Subject|3|||
148758720|NCT02946463|536589196|FG002|Extension Period|Withdrawal by Subject|0|||
148758721|NCT02946463|536589197|FG003|Extension Period|Withdrawal by Subject|0|||
148758722|NCT02946463|536589194|FG000|Extension Period|Other than specified|2|||
148758723|NCT02946463|536589195|FG001|Extension Period|Other than specified|3|||
148758724|NCT02946463|536589196|FG002|Extension Period|Other than specified|2|||
148758725|NCT02946463|536589197|FG003|Extension Period|Other than specified|0|||
148758726|NCT02946463|536589194|FG000|Extension Period|Physician Decision|1|||
148758727|NCT02946463|536589195|FG001|Extension Period|Physician Decision|4|||
148758728|NCT02946463|536589196|FG002|Extension Period|Physician Decision|0|||
148758729|NCT02946463|536589197|FG003|Extension Period|Physician Decision|0|||
148758730|NCT02946463|536589194|FG000|Extension Period|Pregnancy|3|||
148758731|NCT02946463|536589195|FG001|Extension Period|Pregnancy|1|||
148758732|NCT02946463|536589196|FG002|Extension Period|Pregnancy|0|||
148758733|NCT02946463|536589197|FG003|Extension Period|Pregnancy|0|||
148758734|NCT02946463|536589194|FG000|Extension Period|Adverse Event|1|||
148758735|NCT02946463|536589195|FG001|Extension Period|Adverse Event|2|||
148758736|NCT02946463|536589196|FG002|Extension Period|Adverse Event|0|||
148758737|NCT02946463|536589197|FG003|Extension Period|Adverse Event|0|||
148758738|NCT02946463|536589194|FG000|Extension Period|Lost to Follow-up|1|||
148758739|NCT02946463|536589195|FG001|Extension Period|Lost to Follow-up|0|||
148758740|NCT02946463|536589196|FG002|Extension Period|Lost to Follow-up|0|||
148758741|NCT02946463|536589197|FG003|Extension Period|Lost to Follow-up|0|||
148758742|NCT00468819|536589201|FG000|Overall Study|Withdrawal by Subject|4|||
148758743|NCT00468819|536589202|FG001|Overall Study|Withdrawal by Subject|0|||
148758744|NCT00468819|536589203|FG002|Overall Study|Withdrawal by Subject|1|||
148758745|NCT00468819|536589201|FG000|Overall Study|Lost to Follow-up|0|||
148758746|NCT00468819|536589202|FG001|Overall Study|Lost to Follow-up|0|||
148976569|NCT00558103|537394584|FG002|Randomized Treatment Phase|Adverse Event|0|||
148976570|NCT00558103|537394585|FG003|Randomized Treatment Phase|Adverse Event|1|||
148976571|NCT00558103|537394586|FG004|Randomized Treatment Phase|Adverse Event|1|||
148976572|NCT00558103|537394587|FG005|Randomized Treatment Phase|Adverse Event|0|||
148976573|NCT00558103|537394582|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
148976574|NCT00558103|537394583|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
148824825|NCT03760666|536834620|FG002|Overall Study|Adverse Event|1|||
148824826|NCT03760666|536834618|FG000|Overall Study|AML Disease Progression|3|||
148824827|NCT03760666|536834619|FG001|Overall Study|AML Disease Progression|3|||
148824828|NCT03760666|536834620|FG002|Overall Study|AML Disease Progression|0|||
148824829|NCT03760666|536834618|FG000|Overall Study|Physician Decision|0|||
148824830|NCT03760666|536834619|FG001|Overall Study|Physician Decision|3|||
148824831|NCT03760666|536834620|FG002|Overall Study|Physician Decision|0|||
148824832|NCT03760666|536834618|FG000|Overall Study|Withdrawal by Subject|0|||
148824833|NCT03760666|536834619|FG001|Overall Study|Withdrawal by Subject|1|||
148824834|NCT03760666|536834620|FG002|Overall Study|Withdrawal by Subject|0|||
148824835|NCT02946996|536834628|FG000|Overall Study|non-evaluable|3|||
148824836|NCT02946996|536834629|FG001|Overall Study|non-evaluable|6|||
148824837|NCT02946996|536834630|FG002|Overall Study|non-evaluable|5|||
148824838|NCT00450749|536834631|FG000|Overall Study|Withdrawal by Subject|0|||
148824839|NCT00450749|536834632|FG001|Overall Study|Withdrawal by Subject|0|||
148824840|NCT00450749|536834633|FG002|Overall Study|Withdrawal by Subject|2|||
148824841|NCT00450749|536834631|FG000|Overall Study|Noncompliant|0|||
148824842|NCT00450749|536834632|FG001|Overall Study|Noncompliant|1|||
148824843|NCT00450749|536834633|FG002|Overall Study|Noncompliant|0|||
148976575|NCT00558103|537394584|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
148976576|NCT00558103|537394585|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
148976577|NCT00558103|537394586|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
148976578|NCT00558103|537394587|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
148976579|NCT00558103|537394582|FG000|Monotherapy Extension Phase|Disease Progression|0|||
148758747|NCT00468819|536589203|FG002|Overall Study|Lost to Follow-up|1|||
148758748|NCT00468819|536589201|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
148758749|NCT00468819|536589202|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
148758750|NCT00468819|536589203|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
148758751|NCT03296527|536589206|FG000|Overall Study|Adverse Event|15|||
148758752|NCT03296527|536589207|FG001|Overall Study|Adverse Event|33|||
148758753|NCT03296527|536589206|FG000|Overall Study|Protocol Deviation|4|||
148758754|NCT03296527|536589207|FG001|Overall Study|Protocol Deviation|0|||
148758755|NCT03296527|536589206|FG000|Overall Study|Participant withdrew consent|3|||
148758756|NCT03296527|536589207|FG001|Overall Study|Participant withdrew consent|1|||
148758757|NCT03296527|536589206|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
148758758|NCT03296527|536589207|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
148758759|NCT03296527|536589206|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
148758760|NCT03296527|536589207|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
148758761|NCT03296527|536589206|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
148758762|NCT03296527|536589207|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
148758763|NCT03296527|536589206|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
148758764|NCT03296527|536589207|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
148758765|NCT03296527|536589206|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
148758766|NCT03296527|536589207|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
148758767|NCT01597973|536589208|FG000|Overall Study|Found ineligible before study medication started|4|||
148758768|NCT01597973|536589209|FG001|Overall Study|Found ineligible before study medication started|2|||
148758769|NCT01597973|536589208|FG000|Overall Study|Eligible pathogen not confirmed|14|||
148758770|NCT01597973|536589209|FG001|Overall Study|Eligible pathogen not confirmed|15|||
148758771|NCT01597973|536589208|FG000|Overall Study|LAR not authorized to consent|0|||
148758772|NCT01597973|536589209|FG001|Overall Study|LAR not authorized to consent|1|||
148758773|NCT01597973|536589208|FG000|Overall Study|Ineligible due to early seizures|1|||
148758774|NCT01597973|536589209|FG001|Overall Study|Ineligible due to early seizures|0|||
148758775|NCT01597973|536589208|FG000|Overall Study|Ineligible due to non-target infection|1|||
148758776|NCT01597973|536589209|FG001|Overall Study|Ineligible due to non-target infection|1|||
148758777|NCT02723344|536589210|FG000|Overall Study|Lost to Follow-up|0|||
148758778|NCT02723344|536589211|FG001|Overall Study|Lost to Follow-up|4|||
148824844|NCT06097273|536834636|FG000|Overall Study|Death|2|||
148824845|NCT06097273|536834637|FG001|Overall Study|Death|1|||
148824846|NCT06097273|536834638|FG002|Overall Study|Death|2|||
148976580|NCT00558103|537394583|FG001|Monotherapy Extension Phase|Disease Progression|0|||
148758779|NCT01326845|536589213|FG000|Overall Study|Administrative Problems|5|||
148758780|NCT01326845|536589214|FG001|Overall Study|Administrative Problems|2|||
148758781|NCT01326845|536589213|FG000|Overall Study|Adverse Event|1|||
148824847|NCT06097273|536834639|FG003|Overall Study|Death|2|||
148824848|NCT06097273|536834636|FG000|Overall Study|Lost to Follow-up|27|||
148824849|NCT06097273|536834637|FG001|Overall Study|Lost to Follow-up|18|||
148976581|NCT00558103|537394584|FG002|Monotherapy Extension Phase|Disease Progression|0|||
148976582|NCT00558103|537394585|FG003|Monotherapy Extension Phase|Disease Progression|0|||
148976583|NCT00558103|537394586|FG004|Monotherapy Extension Phase|Disease Progression|0|||
148976584|NCT00558103|537394587|FG005|Monotherapy Extension Phase|Disease Progression|8|||
148976585|NCT03385239|537394590|FG000|Overall Study|Voluntary Withdrawal|2|||
148976586|NCT03385239|537394591|FG001|Overall Study|Voluntary Withdrawal|3|||
148976587|NCT03385239|537394592|FG002|Overall Study|Voluntary Withdrawal|2|||
148976588|NCT03385239|537394593|FG003|Overall Study|Voluntary Withdrawal|3|||
148976589|NCT03385239|537394594|FG004|Overall Study|Voluntary Withdrawal|0|||
148976590|NCT03385239|537394590|FG000|Overall Study|Adverse Event|0|||
148976591|NCT03385239|537394591|FG001|Overall Study|Adverse Event|0|||
148976592|NCT03385239|537394592|FG002|Overall Study|Adverse Event|1|||
148976593|NCT03385239|537394593|FG003|Overall Study|Adverse Event|0|||
148976594|NCT03385239|537394594|FG004|Overall Study|Adverse Event|0|||
148976595|NCT03385239|537394590|FG000|Overall Study|Other|0|||
148976596|NCT03385239|537394591|FG001|Overall Study|Other|0|||
148976597|NCT03385239|537394592|FG002|Overall Study|Other|0|||
148976598|NCT03385239|537394593|FG003|Overall Study|Other|1|||
148976599|NCT03385239|537394594|FG004|Overall Study|Other|0|||
148976600|NCT03139916|537394596|FG000|Overall Study|Withdrawal by Subject|2|||
148976601|NCT03139916|537394596|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
148976602|NCT00678561|537394597|FG000|Overall Study|Adverse Event|0|||
148976603|NCT00678561|537394598|FG001|Overall Study|Adverse Event|1|||
148976604|NCT00678561|537394599|FG002|Overall Study|Adverse Event|1|||
148976605|NCT00678561|537394600|FG003|Overall Study|Adverse Event|0|||
148976606|NCT00678561|537394601|FG004|Overall Study|Adverse Event|1|||
148976607|NCT00678561|537394602|FG005|Overall Study|Adverse Event|0|||
148976608|NCT00678561|537394603|FG006|Overall Study|Adverse Event|0|||
148976609|NCT00678561|537394604|FG007|Overall Study|Adverse Event|0|||
148976610|NCT00678561|537394597|FG000|Overall Study|Protocol Violation|0|||
148976611|NCT00678561|537394598|FG001|Overall Study|Protocol Violation|0|||
148976612|NCT00678561|537394599|FG002|Overall Study|Protocol Violation|0|||
148976613|NCT00678561|537394600|FG003|Overall Study|Protocol Violation|0|||
148976614|NCT00678561|537394601|FG004|Overall Study|Protocol Violation|1|||
148976615|NCT00678561|537394602|FG005|Overall Study|Protocol Violation|1|||
148976616|NCT00678561|537394603|FG006|Overall Study|Protocol Violation|0|||
148976617|NCT00678561|537394604|FG007|Overall Study|Protocol Violation|0|||
148976618|NCT00678561|537394597|FG000|Overall Study|Withdrawal by Subject|0|||
148976619|NCT00678561|537394598|FG001|Overall Study|Withdrawal by Subject|0|||
148976620|NCT00678561|537394599|FG002|Overall Study|Withdrawal by Subject|0|||
148976621|NCT00678561|537394600|FG003|Overall Study|Withdrawal by Subject|0|||
148976622|NCT00678561|537394601|FG004|Overall Study|Withdrawal by Subject|0|||
148976623|NCT00678561|537394602|FG005|Overall Study|Withdrawal by Subject|0|||
148976624|NCT00678561|537394603|FG006|Overall Study|Withdrawal by Subject|0|||
148976625|NCT00678561|537394604|FG007|Overall Study|Withdrawal by Subject|1|||
148976626|NCT00700011|537394605|FG000|Overall Study|Death|0|||
148976627|NCT00700011|537394606|FG001|Overall Study|Death|1|||
148976628|NCT00004031|537394607|FG000|Overall Study|Adverse Event|5|||
148976629|NCT00004031|537394608|FG001|Overall Study|Adverse Event|0|||
148976630|NCT00004031|537394607|FG000|Overall Study|Refusal unrelated to adverse events|2|||
148976631|NCT00004031|537394608|FG001|Overall Study|Refusal unrelated to adverse events|11|||
148976632|NCT00004031|537394607|FG000|Overall Study|Progression/relapse|9|||
148976633|NCT00004031|537394608|FG001|Overall Study|Progression/relapse|4|||
148976634|NCT00004031|537394607|FG000|Overall Study|Death|3|||
148976635|NCT00004031|537394608|FG001|Overall Study|Death|1|||
148976636|NCT00004031|537394607|FG000|Overall Study|Other- not protocol specified|3|||
148758782|NCT01326845|536589214|FG001|Overall Study|Adverse Event|0|||
148758783|NCT01326845|536589213|FG000|Overall Study|Misisng|1|||
148758784|NCT01326845|536589214|FG001|Overall Study|Misisng|3|||
148758785|NCT02524847|536589215|FG000|Overall Study|Adverse Event|4|||
148758786|NCT02524847|536589215|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
148758787|NCT02524847|536589215|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
148758788|NCT02524847|536589215|FG000|Overall Study|Death|1|||
148758789|NCT02524847|536589215|FG000|Overall Study|Reason not Specified|1|||
148758790|NCT04352101|536589216|FG000|Overall Study|Physician Decision|2|||
148758791|NCT04352101|536589217|FG001|Overall Study|Physician Decision|1|||
148758792|NCT00908544|536589224|FG000|Overall Study|Withdrawal by Subject|2|||
148976637|NCT00004031|537394608|FG001|Overall Study|Other- not protocol specified|3|||
149027462|NCT01237678|537578569|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
148758793|NCT00908544|536589225|FG001|Overall Study|Withdrawal by Subject|4|||
148758794|NCT00908544|536589224|FG000|Overall Study|Lack of Efficacy|0|||
148976638|NCT00004031|537394607|FG000|Overall Study|Reason under review|3|||
148976639|NCT00004031|537394608|FG001|Overall Study|Reason under review|2|||
148976640|NCT01451424|537394609|FG000|Overall Study|Withdrawal by Subject|1|||
148976641|NCT01451424|537394610|FG001|Overall Study|Withdrawal by Subject|1|||
148976642|NCT01451424|537394611|FG002|Overall Study|Withdrawal by Subject|0|||
148758795|NCT00908544|536589225|FG001|Overall Study|Lack of Efficacy|1|||
148758796|NCT00908544|536589224|FG000|Overall Study|Pregnancy|1|||
148824850|NCT06097273|536834638|FG002|Overall Study|Lost to Follow-up|36|||
148824851|NCT06097273|536834639|FG003|Overall Study|Lost to Follow-up|31|||
148824852|NCT06097273|536834636|FG000|Overall Study|Physician Decision|0|||
148824853|NCT06097273|536834637|FG001|Overall Study|Physician Decision|1|||
148824854|NCT06097273|536834638|FG002|Overall Study|Physician Decision|0|||
148824855|NCT06097273|536834639|FG003|Overall Study|Physician Decision|3|||
148824856|NCT06097273|536834636|FG000|Overall Study|Protocol Violation|1|||
148824857|NCT06097273|536834637|FG001|Overall Study|Protocol Violation|1|||
148824858|NCT06097273|536834638|FG002|Overall Study|Protocol Violation|2|||
148824859|NCT06097273|536834639|FG003|Overall Study|Protocol Violation|1|||
148824860|NCT06097273|536834636|FG000|Overall Study|Withdrawal by Subject|14|||
148824861|NCT06097273|536834637|FG001|Overall Study|Withdrawal by Subject|11|||
148824862|NCT06097273|536834638|FG002|Overall Study|Withdrawal by Subject|14|||
148824863|NCT06097273|536834639|FG003|Overall Study|Withdrawal by Subject|15|||
148824864|NCT06097273|536834636|FG000|Overall Study|Other Than Specified|7|||
148824865|NCT06097273|536834637|FG001|Overall Study|Other Than Specified|3|||
148824866|NCT06097273|536834638|FG002|Overall Study|Other Than Specified|11|||
148824867|NCT06097273|536834639|FG003|Overall Study|Other Than Specified|6|||
148824868|NCT01832038|536836119|FG000|Overall Study|Death|5|||
148824869|NCT01832038|536836119|FG000|Overall Study|Adverse Event|50|||
148824870|NCT01832038|536836119|FG000|Overall Study|Lack of Efficacy|81|||
148824871|NCT01832038|536836119|FG000|Overall Study|Protocol Violation|7|||
148824872|NCT01832038|536836119|FG000|Overall Study|Lost to Follow-up|10|||
148824873|NCT01832038|536836119|FG000|Overall Study|Withdrawal by Subject|49|||
148824874|NCT01832038|536836119|FG000|Overall Study|Visit non-compliance|2|||
148824875|NCT01832038|536836119|FG000|Overall Study|Subject refused to return visit|2|||
148824876|NCT01832038|536836119|FG000|Overall Study|Not convenient to come back to site|2|||
148824877|NCT01832038|536836119|FG000|Overall Study|Participant was asked to quit|5|||
148824878|NCT01832038|536836119|FG000|Overall Study|Back home|1|||
148824879|NCT01832038|536836119|FG000|Overall Study|Pregnancy|1|||
148824880|NCT01832038|536836119|FG000|Overall Study|Low compliance|3|||
148824881|NCT01832038|536836119|FG000|Overall Study|Prohibit procedure|2|||
148824882|NCT01832038|536836119|FG000|Overall Study|Not possible to visit the hospital|1|||
148824883|NCT01832038|536836119|FG000|Overall Study|Changes of implementation system|3|||
148824884|NCT01832038|536836119|FG000|Overall Study|Plan to pregnancy|7|||
148824885|NCT01832038|536836119|FG000|Overall Study|Bad mood and has suicidal thought|1|||
148824886|NCT01832038|536836119|FG000|Overall Study|Prohibited concomitant medication|1|||
148824887|NCT01832038|536836119|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
148824888|NCT01832038|536836119|FG000|Overall Study|Subject considered the efficacy was poor|1|||
148824889|NCT02255279|536836122|FG000|Overall Study|Lost to Follow-up|2|||
148824890|NCT02255279|536836123|FG001|Overall Study|Lost to Follow-up|2|||
148824891|NCT02255279|536836122|FG000|Overall Study|Protocol Violation|0|||
148824892|NCT02255279|536836123|FG001|Overall Study|Protocol Violation|1|||
148824893|NCT02255279|536836122|FG000|Overall Study|Withdrawal by Subject|3|||
148824894|NCT02255279|536836123|FG001|Overall Study|Withdrawal by Subject|6|||
148824895|NCT02457546|536836127|FG000|Overall Study|Other reasons|4|||
148824896|NCT02457546|536836128|FG001|Overall Study|Other reasons|1|||
148824897|NCT02457546|536836127|FG000|Overall Study|Refused to complete study/procedures|1|||
148824898|NCT02457546|536836128|FG001|Overall Study|Refused to complete study/procedures|1|||
148824899|NCT02457546|536836127|FG000|Overall Study|Lost to Follow-up|4|||
148824900|NCT02457546|536836128|FG001|Overall Study|Lost to Follow-up|1|||
148824901|NCT02457546|536836127|FG000|Overall Study|Adverse Event|0|||
148824902|NCT02457546|536836128|FG001|Overall Study|Adverse Event|1|||
148824903|NCT01897896|536836129|FG000|Overall Study|Death|1|||
148976643|NCT01451424|537394612|FG003|Overall Study|Withdrawal by Subject|2|||
148976644|NCT01451424|537394609|FG000|Overall Study|Lost to Follow-up|0|||
148976645|NCT01451424|537394610|FG001|Overall Study|Lost to Follow-up|1|||
148976646|NCT01451424|537394611|FG002|Overall Study|Lost to Follow-up|0|||
148976647|NCT01451424|537394612|FG003|Overall Study|Lost to Follow-up|1|||
148824904|NCT01897896|536836130|FG001|Overall Study|Death|0|||
148824905|NCT01897896|536836129|FG000|Overall Study|Adverse Event|11|||
148824906|NCT01897896|536836130|FG001|Overall Study|Adverse Event|1|||
148824907|NCT01897896|536836129|FG000|Overall Study|Lost to Follow-up|1|||
148824908|NCT01897896|536836130|FG001|Overall Study|Lost to Follow-up|0|||
148824909|NCT01897896|536836129|FG000|Overall Study|Non-compliance with study drug dosing|1|||
148824910|NCT01897896|536836130|FG001|Overall Study|Non-compliance with study drug dosing|1|||
148824911|NCT01897896|536836129|FG000|Overall Study|Withdrawal by Subject|7|||
148976648|NCT01451424|537394609|FG000|Overall Study|Physician Decision|0|||
148976649|NCT01451424|537394610|FG001|Overall Study|Physician Decision|0|||
148976650|NCT01451424|537394611|FG002|Overall Study|Physician Decision|1|||
148824912|NCT01897896|536836130|FG001|Overall Study|Withdrawal by Subject|1|||
148824913|NCT01897896|536836129|FG000|Overall Study|Require drug that interfere with study|1|||
148976651|NCT01451424|537394612|FG003|Overall Study|Physician Decision|1|||
148824914|NCT01897896|536836130|FG001|Overall Study|Require drug that interfere with study|4|||
148824915|NCT01897896|536836129|FG000|Overall Study|Protocol Violation|1|||
148824916|NCT01897896|536836130|FG001|Overall Study|Protocol Violation|1|||
148976652|NCT01451424|537394609|FG000|Overall Study|Adverse Event|0|||
148758797|NCT00908544|536589225|FG001|Overall Study|Pregnancy|0|||
148758798|NCT00908544|536589224|FG000|Overall Study|Relocation abroad|1|||
148758799|NCT00908544|536589225|FG001|Overall Study|Relocation abroad|1|||
148758800|NCT00908544|536589224|FG000|Overall Study|Unable to visit sutdy center|1|||
148758801|NCT00908544|536589225|FG001|Overall Study|Unable to visit sutdy center|0|||
148758802|NCT04762160|536589226|FG000|Overall Study|Study terminated early due to business reasons|5|||
148758803|NCT01591096|536589228|FG000|Overall Study|Adverse Event|1|||
148758804|NCT01831635|536589229|FG000|Overall Study|Withdrawal by Subject|0|||
148758805|NCT01831635|536589230|FG001|Overall Study|Withdrawal by Subject|2|||
148758806|NCT01831635|536589231|FG002|Overall Study|Withdrawal by Subject|0|||
148758807|NCT05142722|536590918|FG000|Overall Study|Lost to Follow-up|16|||
148758808|NCT05142722|536590919|FG001|Overall Study|Lost to Follow-up|38|||
148758809|NCT05142722|536590918|FG000|Overall Study|Withdrawal by Subject|20|||
148758810|NCT05142722|536590919|FG001|Overall Study|Withdrawal by Subject|27|||
148758811|NCT05142722|536590918|FG000|Overall Study|Death|11|||
148758812|NCT05142722|536590919|FG001|Overall Study|Death|17|||
148758813|NCT05142722|536590918|FG000|Overall Study|Physician Decision|0|||
148758814|NCT05142722|536590919|FG001|Overall Study|Physician Decision|1|||
148758815|NCT05142722|536590918|FG000|Overall Study|Participant Moved Away|0|||
148758816|NCT05142722|536590919|FG001|Overall Study|Participant Moved Away|2|||
148758817|NCT05142722|536590918|FG000|Overall Study|Adverse Event|2|||
148758818|NCT05142722|536590919|FG001|Overall Study|Adverse Event|1|||
148758819|NCT02141438|536590920|FG000|Overall Study|Death|1308|||
148758820|NCT02141438|536590920|FG000|Overall Study|Lost to Follow-up|84|||
148758821|NCT02141438|536590920|FG000|Overall Study|Withdrawal by Subject|52|||
148758822|NCT02141438|536590920|FG000|Overall Study|Physician Decision|1|||
148758823|NCT02141438|536590920|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
148758824|NCT01880554|536590921|FG000|Overall Study|Protocol Violation|14|||
148758825|NCT01880554|536590921|FG000|Overall Study|Simon's design requirements|2|||
148758826|NCT05161481|536590922|FG000|Overall Study|Withdrawal of consent|0|||
148758827|NCT05161481|536590923|FG001|Overall Study|Withdrawal of consent|1|||
148758828|NCT05161481|536590924|FG002|Overall Study|Withdrawal of consent|1|||
148758829|NCT05161481|536590922|FG000|Overall Study|Study terminated by sponsor|3|||
148758830|NCT05161481|536590923|FG001|Overall Study|Study terminated by sponsor|3|||
148758831|NCT05161481|536590924|FG002|Overall Study|Study terminated by sponsor|2|||
148758832|NCT05161481|536590922|FG000|Overall Study|Adverse Event|3|||
148758833|NCT05161481|536590923|FG001|Overall Study|Adverse Event|0|||
148758834|NCT05161481|536590924|FG002|Overall Study|Adverse Event|6|||
148758835|NCT05161481|536590922|FG000|Overall Study|Randomised in error and was not treated|1|||
148758836|NCT05161481|536590923|FG001|Overall Study|Randomised in error and was not treated|0|||
148758837|NCT05161481|536590924|FG002|Overall Study|Randomised in error and was not treated|0|||
148758838|NCT05161481|536590922|FG000|Overall Study|Subject decision|0|||
148758839|NCT05161481|536590923|FG001|Overall Study|Subject decision|0|||
148758840|NCT05161481|536590924|FG002|Overall Study|Subject decision|1|||
148758841|NCT00529087|536590927|FG000|Overall Study|Adverse Event|10|||
148758842|NCT00529087|536590928|FG001|Overall Study|Adverse Event|13|||
148758843|NCT00529087|536590929|FG002|Overall Study|Adverse Event|4|||
148758844|NCT00529087|536590927|FG000|Overall Study|Lost to Follow-up|6|||
148758845|NCT00529087|536590928|FG001|Overall Study|Lost to Follow-up|4|||
148758846|NCT00529087|536590929|FG002|Overall Study|Lost to Follow-up|1|||
148758847|NCT00529087|536590927|FG000|Overall Study|Protocol Violation|8|||
148758848|NCT00529087|536590928|FG001|Overall Study|Protocol Violation|7|||
148758849|NCT00529087|536590929|FG002|Overall Study|Protocol Violation|6|||
148758850|NCT00529087|536590927|FG000|Overall Study|Withdrawal by Subject|3|||
148758851|NCT00529087|536590928|FG001|Overall Study|Withdrawal by Subject|3|||
148758852|NCT00529087|536590929|FG002|Overall Study|Withdrawal by Subject|3|||
148758853|NCT00529087|536590927|FG000|Overall Study|Protocol deviation|1|||
148758854|NCT00529087|536590928|FG001|Overall Study|Protocol deviation|1|||
148758855|NCT00529087|536590929|FG002|Overall Study|Protocol deviation|2|||
148758856|NCT02954601|536590930|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
148758857|NCT02954601|536590931|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
148758858|NCT02954601|536590932|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
148758859|NCT02954601|536590933|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
148758860|NCT00318474|536590934|FG000|Overall Study|Adverse Event|1|||
148758861|NCT00318474|536590935|FG001|Overall Study|Adverse Event|1|||
148758862|NCT00318474|536590934|FG000|Overall Study|Lost to Follow-up|0|||
148758863|NCT00318474|536590935|FG001|Overall Study|Lost to Follow-up|1|||
148758864|NCT00318474|536590934|FG000|Overall Study|Pregnancy|0|||
148758865|NCT00318474|536590935|FG001|Overall Study|Pregnancy|2|||
148758866|NCT00318474|536590934|FG000|Overall Study|Protocol Violation|1|||
148758867|NCT00318474|536590935|FG001|Overall Study|Protocol Violation|0|||
148824917|NCT01897896|536836129|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
148758868|NCT00318474|536590934|FG000|Overall Study|Withdrawal by Subject|3|||
148758869|NCT00318474|536590935|FG001|Overall Study|Withdrawal by Subject|2|||
148758870|NCT00318474|536590934|FG000|Overall Study|Fall in GFR|3|||
148758871|NCT00318474|536590935|FG001|Overall Study|Fall in GFR|3|||
148758872|NCT00318474|536590934|FG000|Overall Study|Post-therapy hyperflycemia|0|||
148824918|NCT01897896|536836130|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
148824919|NCT01897896|536836129|FG000|Overall Study|Caregiver can no longer participate|0|||
148824920|NCT01897896|536836130|FG001|Overall Study|Caregiver can no longer participate|2|||
148824921|NCT01897896|536836129|FG000|Overall Study|Other than specified|2|||
148824922|NCT01897896|536836130|FG001|Overall Study|Other than specified|1|||
148824923|NCT00363467|536836131|FG000|Overall Study|Physician Decision|1|||
148824924|NCT05069415|536836132|FG000|Overall Study|Withdrawal by Subject|2|||
148824925|NCT05069415|536836133|FG001|Overall Study|Withdrawal by Subject|0|||
148824926|NCT05069415|536836132|FG000|Overall Study|Adverse Event|2|||
148824927|NCT05069415|536836133|FG001|Overall Study|Adverse Event|0|||
148824928|NCT00101400|536836134|FG000|Survival Follow-Up|Alive|7|||
148824929|NCT03160573|536836135|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
148824930|NCT03160573|536836136|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
148824931|NCT03160573|536836137|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
148824932|NCT03160573|536836138|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
148824933|NCT03142451|536836139|FG000|Overall Study|Adverse Event|5|||
148824934|NCT03142451|536836140|FG001|Overall Study|Adverse Event|2|||
148824935|NCT03142451|536836139|FG000|Overall Study|Lost to Follow-up|25|||
148824936|NCT03142451|536836140|FG001|Overall Study|Lost to Follow-up|8|||
148824937|NCT03142451|536836139|FG000|Overall Study|Participant request|24|||
148824938|NCT03142451|536836140|FG001|Overall Study|Participant request|12|||
148824939|NCT03142451|536836139|FG000|Overall Study|Protocol Violation|3|||
148824940|NCT03142451|536836140|FG001|Overall Study|Protocol Violation|1|||
148824941|NCT03142451|536836139|FG000|Overall Study|Other|1|||
148824942|NCT03142451|536836140|FG001|Overall Study|Other|1|||
148758873|NCT00318474|536590935|FG001|Overall Study|Post-therapy hyperflycemia|1|||
148758874|NCT00318474|536590934|FG000|Overall Study|Trial terminated|10|||
148758875|NCT00318474|536590935|FG001|Overall Study|Trial terminated|7|||
148758876|NCT01735916|536590944|FG000|Overall Study|Subject not eligible to be randomized|11|||
148758877|NCT01735916|536590945|FG001|Overall Study|Subject not eligible to be randomized|0|||
148758878|NCT01735916|536590946|FG002|Overall Study|Subject not eligible to be randomized|0|||
148758879|NCT01735916|536590944|FG000|Overall Study|Early termination of study by sponsor|4|||
148758880|NCT01735916|536590945|FG001|Overall Study|Early termination of study by sponsor|19|||
148758881|NCT01735916|536590946|FG002|Overall Study|Early termination of study by sponsor|7|||
148758882|NCT01735916|536590944|FG000|Overall Study|Withdrawal by Subject|3|||
148758883|NCT01735916|536590945|FG001|Overall Study|Withdrawal by Subject|0|||
148758884|NCT01735916|536590946|FG002|Overall Study|Withdrawal by Subject|0|||
148758885|NCT00708552|536590951|FG000|Overall Study|Adverse Event|10|||
148758886|NCT00708552|536590952|FG001|Overall Study|Adverse Event|3|||
148758887|NCT00708552|536590953|FG002|Overall Study|Adverse Event|4|||
148758888|NCT00708552|536590954|FG003|Overall Study|Adverse Event|6|||
148758889|NCT00708552|536590951|FG000|Overall Study|Lack of Efficacy|0|||
148758890|NCT00708552|536590952|FG001|Overall Study|Lack of Efficacy|4|||
148758891|NCT00708552|536590953|FG002|Overall Study|Lack of Efficacy|1|||
148758892|NCT00708552|536590954|FG003|Overall Study|Lack of Efficacy|0|||
148758893|NCT00708552|536590951|FG000|Overall Study|Protocol Violation|0|||
148758894|NCT00708552|536590952|FG001|Overall Study|Protocol Violation|0|||
148758895|NCT00708552|536590953|FG002|Overall Study|Protocol Violation|2|||
148758896|NCT00708552|536590954|FG003|Overall Study|Protocol Violation|4|||
148758897|NCT00708552|536590951|FG000|Overall Study|Lost to Follow-up|4|||
148758898|NCT00708552|536590952|FG001|Overall Study|Lost to Follow-up|2|||
148758899|NCT00708552|536590953|FG002|Overall Study|Lost to Follow-up|0|||
148758900|NCT00708552|536590954|FG003|Overall Study|Lost to Follow-up|1|||
148758901|NCT00708552|536590951|FG000|Overall Study|Physician Decision|1|||
148758902|NCT00708552|536590952|FG001|Overall Study|Physician Decision|2|||
148758903|NCT00708552|536590953|FG002|Overall Study|Physician Decision|0|||
148758904|NCT00708552|536590954|FG003|Overall Study|Physician Decision|0|||
148758905|NCT00708552|536590951|FG000|Overall Study|Withdrawal by Subject|12|||
148824943|NCT00090402|536836141|FG000|Overall Study|Death|1|||
148824944|NCT00090402|536836142|FG001|Overall Study|Death|1|||
148824945|NCT00090402|536836143|FG002|Overall Study|Death|0|||
148824946|NCT00090402|536836141|FG000|Overall Study|subject moved|0|||
148824947|NCT00090402|536836142|FG001|Overall Study|subject moved|1|||
148824948|NCT00090402|536836143|FG002|Overall Study|subject moved|0|||
148824949|NCT00090402|536836141|FG000|Overall Study|stopped taking study medication|1|||
148824950|NCT00090402|536836142|FG001|Overall Study|stopped taking study medication|0|||
148824951|NCT00090402|536836143|FG002|Overall Study|stopped taking study medication|1|||
148824952|NCT01052428|536836148|FG000|Overall Study|Death|1|||
148824953|NCT01052428|536836149|FG001|Overall Study|Death|0|||
148824954|NCT01052428|536836148|FG000|Overall Study|Withdrawal by Subject|0|||
148824955|NCT01052428|536836149|FG001|Overall Study|Withdrawal by Subject|1|||
148824956|NCT02168439|536836150|FG000|Overall Study|Protocol Violation|0|||
148824957|NCT02168439|536836151|FG001|Overall Study|Protocol Violation|2|||
148824958|NCT03400787|536836152|FG000|Overall Study|Lost to Follow-up|1|||
148824959|NCT03400787|536836153|FG001|Overall Study|Lost to Follow-up|0|||
148824960|NCT03400787|536836152|FG000|Overall Study|Death|1|||
148824961|NCT03400787|536836153|FG001|Overall Study|Death|0|||
148758906|NCT00708552|536590952|FG001|Overall Study|Withdrawal by Subject|7|||
148824962|NCT03400787|536836152|FG000|Overall Study|Protocol Violation|0|||
148824963|NCT03400787|536836153|FG001|Overall Study|Protocol Violation|2|||
148824964|NCT03400787|536836152|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
148824965|NCT03400787|536836153|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
148824966|NCT02402907|536836158|FG000|Overall Study|Delivered vaginally|9|||
148824967|NCT02402907|536836159|FG001|Overall Study|Delivered vaginally|3|||
148824968|NCT02402907|536836158|FG000|Overall Study|Delivered outside of Sinai|1|||
148824969|NCT02402907|536836159|FG001|Overall Study|Delivered outside of Sinai|1|||
148824970|NCT02402907|536836158|FG000|Overall Study|Lost to follow up after C-Section|10|||
148824971|NCT02402907|536836159|FG001|Overall Study|Lost to follow up after C-Section|23|||
148824972|NCT00449787|536836160|FG000|Overall Study|Lost to Follow-up|10|||
148824973|NCT00449787|536836161|FG001|Overall Study|Lost to Follow-up|8|||
148824974|NCT00449787|536836160|FG000|Overall Study|Did not require medication|95|||
148824975|NCT00449787|536836161|FG001|Overall Study|Did not require medication|92|||
148824976|NCT01716559|536836162|FG000|Overall Study|Adverse Event|11|||
148824977|NCT01716559|536836162|FG000|Overall Study|Death|21|||
148824978|NCT01716559|536836162|FG000|Overall Study|Withdrawal by Subject|4|||
148824979|NCT01716559|536836162|FG000|Overall Study|Other withdrawal reason|75|||
148824980|NCT00661687|536836168|FG000|Overall Study|Study related symptoms and complaints|5|||
148824981|NCT00661687|536836168|FG000|Overall Study|Positive slit lamp findings|4|||
148824982|NCT00661687|536836168|FG000|Overall Study|Inability to maintain wearing schedule|3|||
148824983|NCT00661687|536836168|FG000|Overall Study|Physician Decision|1|||
148824984|NCT00661687|536836168|FG000|Overall Study|Adverse Event|2|||
148824985|NCT02837952|536836169|FG000|Overall Study|Adverse Event|0|||
148824986|NCT02837952|536836170|FG001|Overall Study|Adverse Event|1|||
148824987|NCT02837952|536836169|FG000|Overall Study|Withdrawal by Subject|4|||
148824988|NCT02837952|536836170|FG001|Overall Study|Withdrawal by Subject|5|||
148824989|NCT02837952|536836169|FG000|Overall Study|Medication Error|1|||
148824990|NCT02837952|536836170|FG001|Overall Study|Medication Error|0|||
148824991|NCT01362530|536836171|FG000|Base Study (Cycle 1)|Adverse Event|2|||
148824992|NCT01362530|536836172|FG001|Base Study (Cycle 1)|Adverse Event|0|||
148758907|NCT00708552|536590953|FG002|Overall Study|Withdrawal by Subject|8|||
148758908|NCT00708552|536590954|FG003|Overall Study|Withdrawal by Subject|10|||
148758909|NCT03971071|536590956|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
148758910|NCT03971071|536590957|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
148758911|NCT03971071|536590958|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
148758912|NCT03971071|536590959|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
148758913|NCT03971071|536590960|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
148758914|NCT03971071|536590956|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
148758915|NCT03971071|536590957|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
148758916|NCT03971071|536590958|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
148758917|NCT03971071|536590959|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
148758918|NCT03971071|536590960|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
148758919|NCT03971071|536590956|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
148758920|NCT03971071|536590957|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
148758921|NCT03971071|536590958|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
148758922|NCT03971071|536590959|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
148758923|NCT03971071|536590960|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
148758924|NCT03971071|536590956|FG000|Open-label Treatment Period|Sponsor decision|0|||
148758925|NCT03971071|536590957|FG001|Open-label Treatment Period|Sponsor decision|0|||
148758926|NCT03971071|536590958|FG002|Open-label Treatment Period|Sponsor decision|0|||
148758927|NCT03971071|536590959|FG003|Open-label Treatment Period|Sponsor decision|0|||
148758928|NCT03971071|536590960|FG004|Open-label Treatment Period|Sponsor decision|1|||
148758929|NCT03971071|536590956|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
148824993|NCT01362530|536836171|FG000|Base Study (Cycle 1)|Physician Decision|0|||
148824994|NCT01362530|536836172|FG001|Base Study (Cycle 1)|Physician Decision|1|||
148824995|NCT01362530|536836171|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
148824996|NCT01362530|536836172|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
148824997|NCT01362530|536836171|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
148824998|NCT01362530|536836172|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
148824999|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
148825000|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
148825001|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
148825002|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
148825003|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
148758930|NCT03971071|536590957|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
148825004|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
148825005|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
148825006|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
148825007|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
148825008|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
148825009|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
148825010|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
148825011|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
148825012|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
148825013|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
148825014|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
148825015|NCT01362530|536836171|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
148825016|NCT01362530|536836172|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
148825017|NCT05166902|536836173|FG000|First Intervention|Lost to Follow-up|0|||
148825018|NCT05166902|536836174|FG001|First Intervention|Lost to Follow-up|1|||
148825019|NCT02771145|536836179|FG000|Overall Study|Adverse Event|3|||
148825020|NCT02771145|536836179|FG000|Overall Study|Lost to Follow-up|1|||
148825021|NCT00276380|536836180|FG000|Overall Study|Adverse Event|5|||
148825022|NCT00276380|536836181|FG001|Overall Study|Adverse Event|3|||
148825023|NCT00276380|536836180|FG000|Overall Study|Lost to Follow-up|1|||
148825024|NCT00276380|536836181|FG001|Overall Study|Lost to Follow-up|1|||
148825025|NCT00276380|536836180|FG000|Overall Study|Withdrawal by Subject|3|||
148825026|NCT00276380|536836181|FG001|Overall Study|Withdrawal by Subject|6|||
148825027|NCT00276380|536836180|FG000|Overall Study|Death|5|||
148825028|NCT00276380|536836181|FG001|Overall Study|Death|3|||
148825029|NCT00276380|536836180|FG000|Overall Study|Abnormal aPPT Levels|0|||
148825030|NCT00276380|536836181|FG001|Overall Study|Abnormal aPPT Levels|1|||
148825031|NCT01651208|536836186|FG000|Overall Study|Lost to Follow-up|14|||
148825032|NCT01651208|536836187|FG001|Overall Study|Lost to Follow-up|16|||
148825033|NCT02067156|536836191|FG000|Overall Study|Lost to Follow-up|4|||
148825034|NCT03473301|536836192|FG000|Overall Study|Protocol Violation|4|||
148825035|NCT03473301|536836193|FG001|Overall Study|Protocol Violation|0|||
148825036|NCT03473301|536836194|FG002|Overall Study|Protocol Violation|0|||
148825037|NCT03473301|536836192|FG000|Overall Study|Withdrawal by Subject|0|||
148825038|NCT03473301|536836193|FG001|Overall Study|Withdrawal by Subject|1|||
148825039|NCT03473301|536836194|FG002|Overall Study|Withdrawal by Subject|0|||
148825040|NCT03473301|536836192|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
148825041|NCT03473301|536836193|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
148825042|NCT03473301|536836194|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
148825043|NCT04829214|536836195|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
148825044|NCT04829214|536836196|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
148825045|NCT04829214|536836195|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
148825046|NCT04829214|536836196|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
148825047|NCT02965976|536836197|FG000|Overall Study|Withdrawal by Subject|2|||
148825048|NCT02965976|536836198|FG001|Overall Study|Withdrawal by Subject|0|||
148825049|NCT01370642|536836199|FG000|Overall Study|Adverse Event|2|||
148825050|NCT01370642|536836200|FG001|Overall Study|Adverse Event|1|||
148825051|NCT01370642|536836201|FG002|Overall Study|Adverse Event|1|||
148825052|NCT01370642|536836199|FG000|Overall Study|Detectable HCV RNA|0|||
148825053|NCT01370642|536836200|FG001|Overall Study|Detectable HCV RNA|0|||
148758931|NCT03971071|536590958|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
148758932|NCT03971071|536590959|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
148758933|NCT03971071|536590960|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
148758934|NCT03971071|536590956|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
148758935|NCT03971071|536590957|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
148758936|NCT03971071|536590958|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
148758937|NCT03971071|536590959|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
148758938|NCT03971071|536590960|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
148758939|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
148758940|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
148758941|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
148758942|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
148758943|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
148758944|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758945|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148825054|NCT01370642|536836201|FG002|Overall Study|Detectable HCV RNA|22|||
148825055|NCT01370642|536836199|FG000|Overall Study|Lost to Follow-up|0|||
148825056|NCT01370642|536836200|FG001|Overall Study|Lost to Follow-up|0|||
148825057|NCT01370642|536836201|FG002|Overall Study|Lost to Follow-up|1|||
148825058|NCT01370642|536836199|FG000|Overall Study|Physician Decision|4|||
148825059|NCT01370642|536836200|FG001|Overall Study|Physician Decision|1|||
148825060|NCT01370642|536836201|FG002|Overall Study|Physician Decision|2|||
148825061|NCT01370642|536836199|FG000|Overall Study|Withdrawal by Subject|2|||
148758946|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758947|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758948|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758949|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758950|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758951|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758952|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758953|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
148758954|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
148758955|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
148758956|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
148758957|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
148758958|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
148758959|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758960|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758961|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758962|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758963|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758964|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758965|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758966|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758967|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758968|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
148758969|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
148758970|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
148758971|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
148758972|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
148758973|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
148758974|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758975|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758976|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758977|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758978|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758979|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758980|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758981|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758982|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758983|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
148758984|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
148758985|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
148758986|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
148758987|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
148758988|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
148758989|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758990|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758991|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758992|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758993|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758994|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758995|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758996|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758997|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758998|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
148758999|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
148976653|NCT01451424|537394610|FG001|Overall Study|Adverse Event|0|||
148976654|NCT01451424|537394611|FG002|Overall Study|Adverse Event|0|||
148976655|NCT01451424|537394612|FG003|Overall Study|Adverse Event|1|||
148976656|NCT02920983|537394613|FG000|Dispense 1|Unacceptable Lens Fit|0|||
148976657|NCT02920983|537394614|FG001|Dispense 1|Unacceptable Lens Fit|0|||
148976658|NCT02920983|537394615|FG002|Dispense 1|Unacceptable Lens Fit|0|||
148759000|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759001|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
148759002|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
148759003|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
148759004|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759005|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759006|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759007|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759008|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759009|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759010|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759011|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759012|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759013|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
148759014|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759015|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759016|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759017|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
148759018|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759019|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759020|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759021|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759022|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
148825062|NCT01370642|536836200|FG001|Overall Study|Withdrawal by Subject|4|||
148825063|NCT01370642|536836201|FG002|Overall Study|Withdrawal by Subject|3|||
148825064|NCT00987935|536836208|FG000|Overall Study|Progressive disease|3|||
148825065|NCT00987935|536836209|FG001|Overall Study|Progressive disease|2|||
148825066|NCT00987935|536836210|FG002|Overall Study|Progressive disease|3|||
148825067|NCT00987935|536836211|FG003|Overall Study|Progressive disease|2|||
148825068|NCT00987935|536836212|FG004|Overall Study|Progressive disease|5|||
148825069|NCT00987935|536836213|FG005|Overall Study|Progressive disease|3|||
148825070|NCT00987935|536836214|FG006|Overall Study|Progressive disease|9|||
148825071|NCT00987935|536836215|FG007|Overall Study|Progressive disease|48|||
148825072|NCT00987935|536836216|FG008|Overall Study|Progressive disease|23|||
148825073|NCT00987935|536836208|FG000|Overall Study|Adverse Event|0|||
148825074|NCT00987935|536836209|FG001|Overall Study|Adverse Event|1|||
148825075|NCT00987935|536836210|FG002|Overall Study|Adverse Event|0|||
148825076|NCT00987935|536836211|FG003|Overall Study|Adverse Event|1|||
148825077|NCT00987935|536836212|FG004|Overall Study|Adverse Event|1|||
148825078|NCT00987935|536836213|FG005|Overall Study|Adverse Event|0|||
148825079|NCT00987935|536836214|FG006|Overall Study|Adverse Event|2|||
148825080|NCT00987935|536836215|FG007|Overall Study|Adverse Event|10|||
148825081|NCT00987935|536836216|FG008|Overall Study|Adverse Event|6|||
148825082|NCT00987935|536836208|FG000|Overall Study|Refused to continue taking trial med.|1|||
148825083|NCT00987935|536836209|FG001|Overall Study|Refused to continue taking trial med.|0|||
148825084|NCT00987935|536836210|FG002|Overall Study|Refused to continue taking trial med.|0|||
148825085|NCT00987935|536836211|FG003|Overall Study|Refused to continue taking trial med.|0|||
148825086|NCT00987935|536836212|FG004|Overall Study|Refused to continue taking trial med.|1|||
148825087|NCT00987935|536836213|FG005|Overall Study|Refused to continue taking trial med.|0|||
148825088|NCT00987935|536836214|FG006|Overall Study|Refused to continue taking trial med.|4|||
148825089|NCT00987935|536836215|FG007|Overall Study|Refused to continue taking trial med.|4|||
148825090|NCT00987935|536836216|FG008|Overall Study|Refused to continue taking trial med.|2|||
148825091|NCT00987935|536836208|FG000|Overall Study|Reason other than those specified above|0|||
148825092|NCT00987935|536836209|FG001|Overall Study|Reason other than those specified above|0|||
148825093|NCT00987935|536836210|FG002|Overall Study|Reason other than those specified above|0|||
148825094|NCT00987935|536836211|FG003|Overall Study|Reason other than those specified above|0|||
148825095|NCT00987935|536836212|FG004|Overall Study|Reason other than those specified above|0|||
148825096|NCT00987935|536836213|FG005|Overall Study|Reason other than those specified above|0|||
148825097|NCT00987935|536836214|FG006|Overall Study|Reason other than those specified above|0|||
148825098|NCT00987935|536836215|FG007|Overall Study|Reason other than those specified above|0|||
148825099|NCT00987935|536836216|FG008|Overall Study|Reason other than those specified above|1|||
148825100|NCT00452530|536836217|FG000|Overall Study|Death|1|||
148825101|NCT00452530|536836218|FG001|Overall Study|Death|0|||
148825102|NCT00452530|536836217|FG000|Overall Study|Adverse Event|40|||
148825103|NCT00452530|536836218|FG001|Overall Study|Adverse Event|44|||
148825104|NCT00452530|536836217|FG000|Overall Study|Withdrawal by Subject|68|||
148825105|NCT00452530|536836218|FG001|Overall Study|Withdrawal by Subject|57|||
148759023|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
148825106|NCT00452530|536836217|FG000|Overall Study|Lost to Follow-up|1|||
148825107|NCT00452530|536836218|FG001|Overall Study|Lost to Follow-up|0|||
148825108|NCT00452530|536836217|FG000|Overall Study|Poor compliance/noncompliance|1|||
148976659|NCT02920983|537394616|FG003|Dispense 1|Unacceptable Lens Fit|0|||
148976660|NCT02920983|537394617|FG004|Dispense 1|Unacceptable Lens Fit|1|||
148976661|NCT02920983|537394618|FG005|Dispense 1|Unacceptable Lens Fit|0|||
148976662|NCT02920983|537394613|FG000|Dispense 2|Unscceptable lens fit|1|||
148976663|NCT02920983|537394614|FG001|Dispense 2|Unscceptable lens fit|0|||
148976664|NCT02920983|537394615|FG002|Dispense 2|Unscceptable lens fit|0|||
148976665|NCT02920983|537394616|FG003|Dispense 2|Unscceptable lens fit|0|||
148976666|NCT02920983|537394617|FG004|Dispense 2|Unscceptable lens fit|1|||
148976667|NCT02920983|537394618|FG005|Dispense 2|Unscceptable lens fit|0|||
148976668|NCT02920983|537394613|FG000|Dispense 3|Unacceptable Lens Fit|1|||
148976669|NCT02920983|537394614|FG001|Dispense 3|Unacceptable Lens Fit|1|||
148976670|NCT02920983|537394615|FG002|Dispense 3|Unacceptable Lens Fit|0|||
148976671|NCT02920983|537394616|FG003|Dispense 3|Unacceptable Lens Fit|0|||
148976672|NCT02920983|537394617|FG004|Dispense 3|Unacceptable Lens Fit|1|||
148976673|NCT02920983|537394618|FG005|Dispense 3|Unacceptable Lens Fit|0|||
148976674|NCT02553421|537394619|FG000|Overall Study|Lost to Follow-up|21|||
148976675|NCT02553421|537394620|FG001|Overall Study|Lost to Follow-up|1|||
148976676|NCT02553421|537394619|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
148976677|NCT02553421|537394620|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
148976678|NCT02553421|537394619|FG000|Overall Study|Improper Device Placement|3|||
148976679|NCT02553421|537394620|FG001|Overall Study|Improper Device Placement|0|||
148976680|NCT04740034|537394622|FG000|Overall Study|Death|0|||
148976681|NCT04740034|537394623|FG001|Overall Study|Death|1|||
148976682|NCT04740034|537394624|FG002|Overall Study|Death|2|||
148976683|NCT04740034|537394625|FG003|Overall Study|Death|3|||
148976684|NCT04740034|537394626|FG004|Overall Study|Death|4|||
148976685|NCT04740034|537394627|FG005|Overall Study|Death|4|||
148976686|NCT04740034|537394628|FG006|Overall Study|Death|2|||
148976687|NCT04740034|537394629|FG007|Overall Study|Death|2|||
148976688|NCT04740034|537394630|FG008|Overall Study|Death|2|||
148976689|NCT04740034|537394631|FG009|Overall Study|Death|4|||
148976690|NCT04740034|537394632|FG010|Overall Study|Death|0|||
148976691|NCT04740034|537394622|FG000|Overall Study|Lost to Follow-up|0|||
148976692|NCT04740034|537394623|FG001|Overall Study|Lost to Follow-up|0|||
148976693|NCT04740034|537394624|FG002|Overall Study|Lost to Follow-up|0|||
148976694|NCT04740034|537394625|FG003|Overall Study|Lost to Follow-up|1|||
148976695|NCT04740034|537394626|FG004|Overall Study|Lost to Follow-up|2|||
148976696|NCT04740034|537394627|FG005|Overall Study|Lost to Follow-up|2|||
148976697|NCT04740034|537394628|FG006|Overall Study|Lost to Follow-up|0|||
148976698|NCT04740034|537394629|FG007|Overall Study|Lost to Follow-up|0|||
148976699|NCT04740034|537394630|FG008|Overall Study|Lost to Follow-up|0|||
148976700|NCT04740034|537394631|FG009|Overall Study|Lost to Follow-up|1|||
148976701|NCT04740034|537394632|FG010|Overall Study|Lost to Follow-up|0|||
148976702|NCT04740034|537394622|FG000|Overall Study|Withdrawal by Subject|1|||
148759024|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759025|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759026|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759027|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759028|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
148759029|NCT03334435|536590961|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759030|NCT03334435|536590962|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
148759031|NCT03334435|536590963|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
148976703|NCT04740034|537394623|FG001|Overall Study|Withdrawal by Subject|0|||
148976704|NCT04740034|537394624|FG002|Overall Study|Withdrawal by Subject|0|||
148976705|NCT04740034|537394625|FG003|Overall Study|Withdrawal by Subject|0|||
148976706|NCT04740034|537394626|FG004|Overall Study|Withdrawal by Subject|0|||
148976707|NCT04740034|537394627|FG005|Overall Study|Withdrawal by Subject|0|||
148976708|NCT04740034|537394628|FG006|Overall Study|Withdrawal by Subject|0|||
148976709|NCT04740034|537394629|FG007|Overall Study|Withdrawal by Subject|1|||
148976710|NCT04740034|537394630|FG008|Overall Study|Withdrawal by Subject|0|||
148976711|NCT04740034|537394631|FG009|Overall Study|Withdrawal by Subject|1|||
148976712|NCT04740034|537394632|FG010|Overall Study|Withdrawal by Subject|0|||
148976713|NCT04740034|537394622|FG000|Overall Study|Decision by sponsor|0|||
148976714|NCT04740034|537394623|FG001|Overall Study|Decision by sponsor|0|||
148976715|NCT04740034|537394624|FG002|Overall Study|Decision by sponsor|1|||
148976716|NCT04740034|537394625|FG003|Overall Study|Decision by sponsor|0|||
148976717|NCT04740034|537394626|FG004|Overall Study|Decision by sponsor|0|||
148976718|NCT04740034|537394627|FG005|Overall Study|Decision by sponsor|0|||
148976719|NCT04740034|537394628|FG006|Overall Study|Decision by sponsor|1|||
148976720|NCT04740034|537394629|FG007|Overall Study|Decision by sponsor|2|||
148976721|NCT04740034|537394630|FG008|Overall Study|Decision by sponsor|1|||
148976722|NCT04740034|537394631|FG009|Overall Study|Decision by sponsor|1|||
148976723|NCT04740034|537394632|FG010|Overall Study|Decision by sponsor|2|||
148976724|NCT01105533|537396437|FG000|Overall Study|Death|0|||
148976725|NCT01105533|537396438|FG001|Overall Study|Death|0|||
148976726|NCT01105533|537396439|FG002|Overall Study|Death|0|||
148976727|NCT01105533|537396440|FG003|Overall Study|Death|0|||
148759032|NCT03334435|536590964|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
148976728|NCT01105533|537396441|FG004|Overall Study|Death|1|||
148976729|NCT01105533|537396442|FG005|Overall Study|Death|0|||
148976730|NCT01105533|537396443|FG006|Overall Study|Death|0|||
148759033|NCT03334435|536590965|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
148759034|NCT03334435|536590966|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759035|NCT03334435|536590967|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759036|NCT03334435|536590968|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759037|NCT03334435|536590969|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759038|NCT03334435|536590970|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759039|NCT03334435|536590971|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759040|NCT03334435|536590972|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759041|NCT03334435|536590973|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759042|NCT03334435|536590974|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759043|NCT03334435|536590975|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
148759044|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
148759045|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
148759046|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
148759047|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
148759048|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
148759049|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
148759050|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
148759051|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
148759052|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
148759053|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
148759054|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
148759055|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
148759056|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
148759057|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
148759058|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
148759059|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
148759060|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
148759061|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
148759062|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
148759063|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
148759064|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
148759065|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
148759066|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
148759067|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
148759068|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
148759069|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
148759070|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
148759071|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
148759072|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
148759073|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
148759074|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
148759075|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
148759076|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
148759077|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
148759078|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
148759079|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
148759080|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
148759081|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
148759082|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
148759083|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
148759084|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
148759085|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
148759086|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
148759087|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
148759088|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
148759089|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
148759090|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
148759091|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
148759092|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
148759093|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
148759094|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
148759095|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
148759096|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
148759097|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
148759098|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
148759099|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
148759100|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
148759101|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
148759102|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
148759103|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
148759104|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759105|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759106|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759107|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759108|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759109|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759110|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
148759111|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
148759112|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
148759113|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
148759114|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
148759115|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
148759116|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
148759117|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
148759118|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
148759119|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759120|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759121|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759122|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759123|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759124|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759125|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759126|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759127|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759128|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759129|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759130|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
148759131|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759132|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
148759133|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
148759134|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759135|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759136|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759137|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759138|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759139|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
148759140|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759141|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759142|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759143|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759144|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759145|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759146|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759147|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
148759148|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
148759149|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759150|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759151|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759152|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759153|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759154|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
148759155|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
148976731|NCT01105533|537396444|FG007|Overall Study|Death|0|||
148976732|NCT01105533|537396445|FG008|Overall Study|Death|0|||
148976733|NCT01105533|537396437|FG000|Overall Study|Lack of Efficacy|1|||
148976734|NCT01105533|537396438|FG001|Overall Study|Lack of Efficacy|1|||
148759156|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
148759157|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
148759158|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
148759159|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
148759160|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
148759161|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759162|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759163|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
148759164|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759165|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759166|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759167|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759168|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759169|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
148759170|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
148759171|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759172|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759173|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759174|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
148759175|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
148759176|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
148759177|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
148759178|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
148759179|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759180|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759181|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759182|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759183|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759184|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
148759185|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759186|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759187|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759188|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759189|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
148759190|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759191|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759192|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
148759193|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
148759194|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759195|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759196|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759197|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759198|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759199|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759200|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759201|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
148759202|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
148759203|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759204|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
148759205|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
148759206|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
148759207|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759208|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
148759209|NCT03334435|536590961|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759210|NCT03334435|536590962|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759211|NCT03334435|536590963|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759212|NCT03334435|536590964|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759213|NCT03334435|536590965|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759214|NCT03334435|536590966|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759215|NCT03334435|536590967|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759216|NCT03334435|536590968|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759217|NCT03334435|536590969|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759218|NCT03334435|536590970|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759219|NCT03334435|536590971|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759220|NCT03334435|536590972|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
148759221|NCT03334435|536590973|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
148759222|NCT03334435|536590974|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
148759223|NCT03334435|536590975|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
148759224|NCT01620138|536590976|FG000|Overall Study|Withdrawal by Subject|3|||
148759225|NCT01620138|536590977|FG001|Overall Study|Withdrawal by Subject|0|||
148759226|NCT01620138|536590976|FG000|Overall Study|Lack of Efficacy|1|||
148759227|NCT01620138|536590977|FG001|Overall Study|Lack of Efficacy|0|||
148759228|NCT01620138|536590976|FG000|Overall Study|Adverse Event|2|||
148759229|NCT01620138|536590977|FG001|Overall Study|Adverse Event|0|||
148759230|NCT03922308|536590978|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
148759231|NCT03922308|536590979|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
148759232|NCT03922308|536590980|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
148759233|NCT03922308|536590978|FG000|Overall Study|Lost to Follow-up|1|||
148759234|NCT03922308|536590979|FG001|Overall Study|Lost to Follow-up|0|||
148759235|NCT03922308|536590980|FG002|Overall Study|Lost to Follow-up|0|||
148759236|NCT03922308|536590978|FG000|Overall Study|Reason not Specified|0|||
148759237|NCT03922308|536590979|FG001|Overall Study|Reason not Specified|2|||
148759238|NCT03922308|536590980|FG002|Overall Study|Reason not Specified|1|||
148759239|NCT05005507|536590981|FG000|Overall Study|Premature termination of study|1|||
148759240|NCT01697748|536590983|FG000|Overall Study|ineligible skin incision|1|||
148759241|NCT01697748|536590984|FG001|Overall Study|ineligible skin incision|2|||
148759242|NCT01697748|536590983|FG000|Overall Study|ineligible uterine incision|4|||
148759243|NCT01697748|536590984|FG001|Overall Study|ineligible uterine incision|1|||
148759244|NCT01697748|536590983|FG000|Overall Study|Lost to Follow-up|53|||
148759245|NCT01697748|536590984|FG001|Overall Study|Lost to Follow-up|65|||
148759246|NCT01256450|536590986|FG000|Open-label Titration|Adverse Event|39|||
148759247|NCT01256450|536590987|FG001|Open-label Titration|Adverse Event|0|||
148759248|NCT01256450|536590988|FG002|Open-label Titration|Adverse Event|0|||
148759249|NCT01256450|536590986|FG000|Open-label Titration|Lost to Follow-up|7|||
148759250|NCT01256450|536590987|FG001|Open-label Titration|Lost to Follow-up|0|||
148759251|NCT01256450|536590988|FG002|Open-label Titration|Lost to Follow-up|0|||
148759252|NCT01256450|536590986|FG000|Open-label Titration|Lack of analgesic effect|30|||
148759253|NCT01256450|536590987|FG001|Open-label Titration|Lack of analgesic effect|0|||
148759254|NCT01256450|536590988|FG002|Open-label Titration|Lack of analgesic effect|0|||
148759255|NCT01256450|536590986|FG000|Open-label Titration|Non-compliance|9|||
148759256|NCT01256450|536590987|FG001|Open-label Titration|Non-compliance|0|||
148759257|NCT01256450|536590988|FG002|Open-label Titration|Non-compliance|0|||
148759258|NCT01256450|536590986|FG000|Open-label Titration|Screen failure|1|||
148759259|NCT01256450|536590987|FG001|Open-label Titration|Screen failure|0|||
148759260|NCT01256450|536590988|FG002|Open-label Titration|Screen failure|0|||
148759261|NCT01256450|536590986|FG000|Open-label Titration|Other|13|||
148759262|NCT01256450|536590987|FG001|Open-label Titration|Other|0|||
148759263|NCT01256450|536590988|FG002|Open-label Titration|Other|0|||
148759264|NCT01256450|536590986|FG000|Double-blind Treatment|Adverse Event|0|||
148759265|NCT01256450|536590987|FG001|Double-blind Treatment|Adverse Event|8|||
148759266|NCT01256450|536590988|FG002|Double-blind Treatment|Adverse Event|6|||
148759267|NCT01256450|536590986|FG000|Double-blind Treatment|Lost to Follow-up|0|||
148759268|NCT01256450|536590987|FG001|Double-blind Treatment|Lost to Follow-up|1|||
148759269|NCT01256450|536590988|FG002|Double-blind Treatment|Lost to Follow-up|7|||
148759270|NCT01256450|536590986|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
148759271|NCT01256450|536590987|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
148759272|NCT01256450|536590988|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
148759273|NCT01256450|536590986|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
148759274|NCT01256450|536590987|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
148759275|NCT01256450|536590988|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
148759276|NCT01256450|536590986|FG000|Double-blind Treatment|Non-compliance|0|||
148759277|NCT01256450|536590987|FG001|Double-blind Treatment|Non-compliance|5|||
148759278|NCT01256450|536590988|FG002|Double-blind Treatment|Non-compliance|4|||
148759279|NCT01256450|536590986|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
148759280|NCT01256450|536590987|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
148825109|NCT00452530|536836218|FG001|Overall Study|Poor compliance/noncompliance|2|||
148825110|NCT00452530|536836217|FG000|Overall Study|No longer met study criteria|18|||
148825111|NCT00452530|536836218|FG001|Overall Study|No longer met study criteria|22|||
148759281|NCT01256450|536590988|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
148759282|NCT01256450|536590986|FG000|Double-blind Treatment|Other|0|||
148759283|NCT01256450|536590987|FG001|Double-blind Treatment|Other|9|||
148759284|NCT01256450|536590988|FG002|Double-blind Treatment|Other|12|||
148759285|NCT03866512|536590989|FG000|Overall Study|Lost to Follow-up|1|||
148759286|NCT03866512|536590990|FG001|Overall Study|Lost to Follow-up|2|||
148759287|NCT03866512|536590991|FG002|Overall Study|Lost to Follow-up|1|||
148759288|NCT03866512|536590989|FG000|Overall Study|Cannulation issues|0|||
148759289|NCT03866512|536590990|FG001|Overall Study|Cannulation issues|1|||
148759290|NCT03866512|536590991|FG002|Overall Study|Cannulation issues|2|||
148759291|NCT02556775|536591001|FG000|Overall Study|Withdrawal by Subject|1|||
148825112|NCT00452530|536836217|FG000|Overall Study|Other|7|||
148825113|NCT00452530|536836218|FG001|Overall Study|Other|11|||
149027463|NCT01237678|537578567|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
149027464|NCT01237678|537578568|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
149027465|NCT01237678|537578569|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
148759292|NCT02556775|536591002|FG001|Overall Study|Withdrawal by Subject|0|||
148759293|NCT02556775|536591003|FG002|Overall Study|Withdrawal by Subject|1|||
148759294|NCT02556775|536591004|FG003|Overall Study|Withdrawal by Subject|0|||
148759295|NCT02556775|536591001|FG000|Overall Study|Lost to Follow-up|1|||
148759296|NCT02556775|536591002|FG001|Overall Study|Lost to Follow-up|0|||
148759297|NCT02556775|536591003|FG002|Overall Study|Lost to Follow-up|0|||
148759298|NCT02556775|536591004|FG003|Overall Study|Lost to Follow-up|0|||
148759299|NCT02792062|536591007|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
148759300|NCT02792062|536591008|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
148759301|NCT02792062|536591009|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
148759302|NCT02792062|536591010|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
148759303|NCT02792062|536591011|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
148759304|NCT02792062|536591012|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
148759305|NCT02025725|536591015|FG000|Overall Study|Adverse Event|5|||
148759306|NCT02025725|536591016|FG001|Overall Study|Adverse Event|0|||
148759307|NCT02025725|536591015|FG000|Overall Study|Lost to Follow-up|2|||
148759308|NCT02025725|536591016|FG001|Overall Study|Lost to Follow-up|0|||
148759309|NCT02025725|536591015|FG000|Overall Study|Protocol Violation|1|||
148759310|NCT02025725|536591016|FG001|Overall Study|Protocol Violation|1|||
148759311|NCT02025725|536591015|FG000|Overall Study|Withdrawal by Subject|3|||
148759312|NCT02025725|536591016|FG001|Overall Study|Withdrawal by Subject|2|||
148759313|NCT02025725|536591015|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
148759314|NCT02025725|536591016|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
148759315|NCT05581641|536591017|FG000|Overall Study|Withdrawal by Subject|0|||
148759316|NCT05581641|536591018|FG001|Overall Study|Withdrawal by Subject|1|||
148759317|NCT05581641|536591019|FG002|Overall Study|Withdrawal by Subject|3|||
148759318|NCT05581641|536591020|FG003|Overall Study|Withdrawal by Subject|1|||
148759319|NCT05581641|536591017|FG000|Overall Study|Lost to Follow-up|0|||
148759320|NCT05581641|536591018|FG001|Overall Study|Lost to Follow-up|1|||
148759321|NCT05581641|536591019|FG002|Overall Study|Lost to Follow-up|0|||
148759322|NCT05581641|536591020|FG003|Overall Study|Lost to Follow-up|1|||
148759323|NCT05581641|536591017|FG000|Overall Study|Protocol Violation|1|||
148759324|NCT05581641|536591018|FG001|Overall Study|Protocol Violation|0|||
148759325|NCT05581641|536591019|FG002|Overall Study|Protocol Violation|0|||
148759326|NCT05581641|536591020|FG003|Overall Study|Protocol Violation|0|||
148759327|NCT05581641|536591017|FG000|Overall Study|Other|1|||
148759328|NCT05581641|536591018|FG001|Overall Study|Other|0|||
148759329|NCT05581641|536591019|FG002|Overall Study|Other|2|||
148759330|NCT05581641|536591020|FG003|Overall Study|Other|1|||
148759331|NCT01924689|536591021|FG000|Overall Study|Death|0|||
148759332|NCT01924689|536591022|FG001|Overall Study|Death|1|||
148759333|NCT01924689|536591023|FG002|Overall Study|Death|0|||
148759334|NCT01924689|536591024|FG003|Overall Study|Death|1|||
148759335|NCT01924689|536591025|FG004|Overall Study|Death|0|||
148759336|NCT01924689|536591026|FG005|Overall Study|Death|0|||
148759337|NCT01924689|536591021|FG000|Overall Study|Disease progression|0|||
148759338|NCT01924689|536591022|FG001|Overall Study|Disease progression|0|||
148759339|NCT01924689|536591023|FG002|Overall Study|Disease progression|2|||
148759340|NCT01924689|536591024|FG003|Overall Study|Disease progression|0|||
148759341|NCT01924689|536591025|FG004|Overall Study|Disease progression|3|||
148759342|NCT01924689|536591026|FG005|Overall Study|Disease progression|2|||
148759343|NCT01924689|536591021|FG000|Overall Study|New therapy or study|3|||
148759344|NCT01924689|536591022|FG001|Overall Study|New therapy or study|2|||
148759345|NCT01924689|536591023|FG002|Overall Study|New therapy or study|1|||
148825114|NCT03888482|536836219|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
148825115|NCT03888482|536836220|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
148825116|NCT03888482|536836219|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
148825117|NCT03888482|536836220|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
148825118|NCT03721107|536836221|FG000|Overall Study|Adverse Event|1|||
148825119|NCT03721107|536836222|FG001|Overall Study|Adverse Event|1|||
148825120|NCT03721107|536836223|FG002|Overall Study|Adverse Event|6|||
148825121|NCT03721107|536836224|FG003|Overall Study|Adverse Event|5|||
148759346|NCT01924689|536591024|FG003|Overall Study|New therapy or study|4|||
148759347|NCT01924689|536591025|FG004|Overall Study|New therapy or study|2|||
148759348|NCT01924689|536591026|FG005|Overall Study|New therapy or study|0|||
148759349|NCT01924689|536591021|FG000|Overall Study|Withdrawal of consent|0|||
148759350|NCT01924689|536591022|FG001|Overall Study|Withdrawal of consent|0|||
148759351|NCT01924689|536591023|FG002|Overall Study|Withdrawal of consent|1|||
148825122|NCT03721107|536836221|FG000|Overall Study|Lost to Follow-up|2|||
148825123|NCT03721107|536836222|FG001|Overall Study|Lost to Follow-up|0|||
148759352|NCT01924689|536591024|FG003|Overall Study|Withdrawal of consent|1|||
148759353|NCT01924689|536591025|FG004|Overall Study|Withdrawal of consent|0|||
148825124|NCT03721107|536836223|FG002|Overall Study|Lost to Follow-up|3|||
148759354|NCT01924689|536591026|FG005|Overall Study|Withdrawal of consent|0|||
148759355|NCT01924689|536591021|FG000|Overall Study|Other|0|||
148759356|NCT01924689|536591022|FG001|Overall Study|Other|0|||
148759357|NCT01924689|536591023|FG002|Overall Study|Other|0|||
148759358|NCT01924689|536591024|FG003|Overall Study|Other|0|||
148759359|NCT01924689|536591025|FG004|Overall Study|Other|1|||
148759360|NCT01924689|536591026|FG005|Overall Study|Other|0|||
148759361|NCT02492867|536591027|FG000|Overall Study|Alternate therapy|1|||
148759362|NCT02492867|536591027|FG000|Overall Study|Withdrawal by Subject|2|||
148759363|NCT02492867|536591027|FG000|Overall Study|Disease progression after treatment started|1|||
148759364|NCT02492867|536591027|FG000|Overall Study|Death|1|||
148759365|NCT00122382|536591030|FG000|Double-Blind Study|Adverse Event|9|||
148759366|NCT00122382|536591031|FG001|Double-Blind Study|Adverse Event|11|||
148759367|NCT00122382|536591032|FG002|Double-Blind Study|Adverse Event|0|||
148759368|NCT00122382|536591030|FG000|Double-Blind Study|Death|2|||
148759369|NCT00122382|536591031|FG001|Double-Blind Study|Death|2|||
148759370|NCT00122382|536591032|FG002|Double-Blind Study|Death|0|||
148759371|NCT00122382|536591030|FG000|Double-Blind Study|Lack of Efficacy|0|||
148759372|NCT00122382|536591031|FG001|Double-Blind Study|Lack of Efficacy|8|||
148759373|NCT00122382|536591032|FG002|Double-Blind Study|Lack of Efficacy|0|||
148759374|NCT00122382|536591030|FG000|Double-Blind Study|Lost to Follow-up|2|||
148759375|NCT00122382|536591031|FG001|Double-Blind Study|Lost to Follow-up|1|||
148759376|NCT00122382|536591032|FG002|Double-Blind Study|Lost to Follow-up|0|||
148759377|NCT00122382|536591030|FG000|Double-Blind Study|Pregnancy|2|||
148759378|NCT00122382|536591031|FG001|Double-Blind Study|Pregnancy|0|||
148759379|NCT00122382|536591032|FG002|Double-Blind Study|Pregnancy|0|||
148759380|NCT00122382|536591030|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
148759381|NCT00122382|536591031|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
148759382|NCT00122382|536591032|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
148759383|NCT00122382|536591030|FG000|Double-Blind Study|Withdrawal of Consent|7|||
148759384|NCT00122382|536591031|FG001|Double-Blind Study|Withdrawal of Consent|3|||
148759385|NCT00122382|536591032|FG002|Double-Blind Study|Withdrawal of Consent|0|||
148759386|NCT00122382|536591030|FG000|Double-Blind Study|Protocol Violation|1|||
148759387|NCT00122382|536591031|FG001|Double-Blind Study|Protocol Violation|0|||
148759388|NCT00122382|536591032|FG002|Double-Blind Study|Protocol Violation|0|||
148759389|NCT00122382|536591030|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
148759390|NCT00122382|536591031|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
148759391|NCT00122382|536591032|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
148759392|NCT00122382|536591030|FG000|Double-Blind Study|Randomized but not treated|0|||
148759393|NCT00122382|536591031|FG001|Double-Blind Study|Randomized but not treated|2|||
148759394|NCT00122382|536591032|FG002|Double-Blind Study|Randomized but not treated|0|||
148759395|NCT00122382|536591030|FG000|Open-Label Study|Adverse Event|0|||
148759396|NCT00122382|536591031|FG001|Open-Label Study|Adverse Event|0|||
148759397|NCT00122382|536591032|FG002|Open-Label Study|Adverse Event|11|||
148759398|NCT00122382|536591030|FG000|Open-Label Study|Death|0|||
148759399|NCT00122382|536591031|FG001|Open-Label Study|Death|0|||
148759400|NCT00122382|536591032|FG002|Open-Label Study|Death|2|||
148759401|NCT00122382|536591030|FG000|Open-Label Study|Lack of Efficacy|0|||
148759402|NCT00122382|536591031|FG001|Open-Label Study|Lack of Efficacy|0|||
148759403|NCT00122382|536591032|FG002|Open-Label Study|Lack of Efficacy|3|||
148759404|NCT00122382|536591030|FG000|Open-Label Study|Lost to Follow-up|0|||
148759405|NCT00122382|536591031|FG001|Open-Label Study|Lost to Follow-up|0|||
148759406|NCT00122382|536591032|FG002|Open-Label Study|Lost to Follow-up|3|||
148759407|NCT00122382|536591030|FG000|Open-Label Study|Pregnancy|0|||
148759408|NCT00122382|536591031|FG001|Open-Label Study|Pregnancy|0|||
148759409|NCT00122382|536591032|FG002|Open-Label Study|Pregnancy|2|||
148759410|NCT00122382|536591030|FG000|Open-Label Study|Poor/Non-Compliance|0|||
148759411|NCT00122382|536591031|FG001|Open-Label Study|Poor/Non-Compliance|0|||
148759412|NCT00122382|536591032|FG002|Open-Label Study|Poor/Non-Compliance|1|||
148759413|NCT00122382|536591030|FG000|Open-Label Study|Withdrawal of Consent|0|||
148976735|NCT01105533|537396439|FG002|Overall Study|Lack of Efficacy|3|||
148976736|NCT01105533|537396440|FG003|Overall Study|Lack of Efficacy|3|||
148976737|NCT01105533|537396441|FG004|Overall Study|Lack of Efficacy|4|||
148759414|NCT00122382|536591031|FG001|Open-Label Study|Withdrawal of Consent|0|||
148759415|NCT00122382|536591032|FG002|Open-Label Study|Withdrawal of Consent|4|||
148759416|NCT03644342|536591035|FG000|Overall Study|Adverse Event|2|||
148759417|NCT03644342|536591036|FG001|Overall Study|Adverse Event|0|||
148759418|NCT03644342|536591035|FG000|Overall Study|Protocol Violation|0|||
148759419|NCT03644342|536591036|FG001|Overall Study|Protocol Violation|1|||
148759420|NCT00359424|536591037|FG000|Overall Study|Death|99|||
148759421|NCT00359424|536591038|FG001|Overall Study|Death|58|||
148759422|NCT00359424|536591037|FG000|Overall Study|Lost to Follow-up|19|||
148759423|NCT00359424|536591038|FG001|Overall Study|Lost to Follow-up|7|||
148759424|NCT00359424|536591037|FG000|Overall Study|Withdrawal by Subject|10|||
148759425|NCT00359424|536591038|FG001|Overall Study|Withdrawal by Subject|2|||
148759426|NCT00359424|536591037|FG000|Overall Study|follow up not conducted|2|||
148759427|NCT00359424|536591038|FG001|Overall Study|follow up not conducted|0|||
148759428|NCT02462603|536591039|FG000|Overall Study|Investigator Decision|1|||
148759429|NCT02462603|536591039|FG000|Overall Study|Non-Compliance|1|||
148759430|NCT02462603|536591039|FG000|Overall Study|Withdrawal by Subject|2|||
148759431|NCT00848718|536591040|FG000|Overall Study|Adverse Event|2|||
148759432|NCT00848718|536591041|FG001|Overall Study|Adverse Event|2|||
148759433|NCT00848718|536591042|FG002|Overall Study|Adverse Event|1|||
148759434|NCT00848718|536591043|FG003|Overall Study|Adverse Event|1|||
148759435|NCT00848718|536591044|FG004|Overall Study|Adverse Event|1|||
148759436|NCT00848718|536591045|FG005|Overall Study|Adverse Event|0|||
148759437|NCT00848718|536591046|FG006|Overall Study|Adverse Event|0|||
148759438|NCT00848718|536591047|FG007|Overall Study|Adverse Event|1|||
148759439|NCT00848718|536591048|FG008|Overall Study|Adverse Event|1|||
148759440|NCT00848718|536591049|FG009|Overall Study|Adverse Event|0|||
148759441|NCT00848718|536591050|FG010|Overall Study|Adverse Event|0|||
148759442|NCT00848718|536591051|FG011|Overall Study|Adverse Event|0|||
148759443|NCT00848718|536591052|FG012|Overall Study|Adverse Event|2|||
148759444|NCT00848718|536591040|FG000|Overall Study|Lack of Efficacy|0|||
148759445|NCT00848718|536591041|FG001|Overall Study|Lack of Efficacy|0|||
148759446|NCT00848718|536591042|FG002|Overall Study|Lack of Efficacy|1|||
148759447|NCT00848718|536591043|FG003|Overall Study|Lack of Efficacy|0|||
148759448|NCT00848718|536591044|FG004|Overall Study|Lack of Efficacy|0|||
148759449|NCT00848718|536591045|FG005|Overall Study|Lack of Efficacy|0|||
148759450|NCT00848718|536591046|FG006|Overall Study|Lack of Efficacy|1|||
148759451|NCT00848718|536591047|FG007|Overall Study|Lack of Efficacy|0|||
148759452|NCT00848718|536591048|FG008|Overall Study|Lack of Efficacy|0|||
148759453|NCT00848718|536591049|FG009|Overall Study|Lack of Efficacy|0|||
148759454|NCT00848718|536591050|FG010|Overall Study|Lack of Efficacy|0|||
148759455|NCT00848718|536591051|FG011|Overall Study|Lack of Efficacy|0|||
148759456|NCT00848718|536591052|FG012|Overall Study|Lack of Efficacy|0|||
148759457|NCT00848718|536591040|FG000|Overall Study|Physician Decision|0|||
148759458|NCT00848718|536591041|FG001|Overall Study|Physician Decision|1|||
148759459|NCT00848718|536591042|FG002|Overall Study|Physician Decision|0|||
148759460|NCT00848718|536591043|FG003|Overall Study|Physician Decision|0|||
148759461|NCT00848718|536591044|FG004|Overall Study|Physician Decision|1|||
148759462|NCT00848718|536591045|FG005|Overall Study|Physician Decision|1|||
148759463|NCT00848718|536591046|FG006|Overall Study|Physician Decision|0|||
148759464|NCT00848718|536591047|FG007|Overall Study|Physician Decision|0|||
148759465|NCT00848718|536591048|FG008|Overall Study|Physician Decision|1|||
148759466|NCT00848718|536591049|FG009|Overall Study|Physician Decision|2|||
148759467|NCT00848718|536591050|FG010|Overall Study|Physician Decision|0|||
148759468|NCT00848718|536591051|FG011|Overall Study|Physician Decision|0|||
148759469|NCT00848718|536591052|FG012|Overall Study|Physician Decision|1|||
148759470|NCT00848718|536591040|FG000|Overall Study|Progressive disease before treatment|1|||
148759471|NCT00848718|536591041|FG001|Overall Study|Progressive disease before treatment|5|||
148759472|NCT00848718|536591042|FG002|Overall Study|Progressive disease before treatment|1|||
148759473|NCT00848718|536591043|FG003|Overall Study|Progressive disease before treatment|3|||
148759474|NCT00848718|536591044|FG004|Overall Study|Progressive disease before treatment|4|||
148759475|NCT00848718|536591045|FG005|Overall Study|Progressive disease before treatment|4|||
148759476|NCT00848718|536591046|FG006|Overall Study|Progressive disease before treatment|2|||
148759477|NCT00848718|536591047|FG007|Overall Study|Progressive disease before treatment|1|||
148759478|NCT00848718|536591048|FG008|Overall Study|Progressive disease before treatment|2|||
148759479|NCT00848718|536591049|FG009|Overall Study|Progressive disease before treatment|7|||
148759480|NCT00848718|536591050|FG010|Overall Study|Progressive disease before treatment|3|||
148759481|NCT00848718|536591051|FG011|Overall Study|Progressive disease before treatment|6|||
148759482|NCT00848718|536591052|FG012|Overall Study|Progressive disease before treatment|2|||
148759483|NCT00848718|536591040|FG000|Overall Study|Protocol Violation|0|||
148759484|NCT00848718|536591041|FG001|Overall Study|Protocol Violation|1|||
148759485|NCT00848718|536591042|FG002|Overall Study|Protocol Violation|0|||
148759486|NCT00848718|536591043|FG003|Overall Study|Protocol Violation|0|||
148759487|NCT00848718|536591044|FG004|Overall Study|Protocol Violation|0|||
148759488|NCT00848718|536591045|FG005|Overall Study|Protocol Violation|0|||
148759489|NCT00848718|536591046|FG006|Overall Study|Protocol Violation|0|||
148759490|NCT00848718|536591047|FG007|Overall Study|Protocol Violation|1|||
148759491|NCT00848718|536591048|FG008|Overall Study|Protocol Violation|0|||
148759492|NCT00848718|536591049|FG009|Overall Study|Protocol Violation|0|||
148759493|NCT00848718|536591050|FG010|Overall Study|Protocol Violation|0|||
148759494|NCT00848718|536591051|FG011|Overall Study|Protocol Violation|0|||
148759495|NCT00848718|536591052|FG012|Overall Study|Protocol Violation|1|||
148759496|NCT00848718|536591040|FG000|Overall Study|Withdrawal by Subject|1|||
148759497|NCT00848718|536591041|FG001|Overall Study|Withdrawal by Subject|0|||
148759498|NCT00848718|536591042|FG002|Overall Study|Withdrawal by Subject|0|||
148759499|NCT00848718|536591043|FG003|Overall Study|Withdrawal by Subject|1|||
148759500|NCT00848718|536591044|FG004|Overall Study|Withdrawal by Subject|0|||
148759501|NCT00848718|536591045|FG005|Overall Study|Withdrawal by Subject|0|||
148759502|NCT00848718|536591046|FG006|Overall Study|Withdrawal by Subject|0|||
148759503|NCT00848718|536591047|FG007|Overall Study|Withdrawal by Subject|0|||
148759504|NCT00848718|536591048|FG008|Overall Study|Withdrawal by Subject|0|||
148759505|NCT00848718|536591049|FG009|Overall Study|Withdrawal by Subject|0|||
148825125|NCT03721107|536836224|FG003|Overall Study|Lost to Follow-up|0|||
148825126|NCT03721107|536836221|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
148825127|NCT03721107|536836222|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
148825128|NCT03721107|536836223|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
148825129|NCT03721107|536836224|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
148825130|NCT03721107|536836221|FG000|Overall Study|Physician Decision|0|||
148825131|NCT03721107|536836222|FG001|Overall Study|Physician Decision|1|||
148825132|NCT03721107|536836223|FG002|Overall Study|Physician Decision|0|||
148825133|NCT03721107|536836224|FG003|Overall Study|Physician Decision|0|||
148825134|NCT03721107|536836221|FG000|Overall Study|Pregnancy|0|||
148825135|NCT03721107|536836222|FG001|Overall Study|Pregnancy|0|||
148825136|NCT03721107|536836223|FG002|Overall Study|Pregnancy|1|||
148825137|NCT03721107|536836224|FG003|Overall Study|Pregnancy|0|||
148825138|NCT03721107|536836221|FG000|Overall Study|Withdrawal by Subject|1|||
148825139|NCT03721107|536836222|FG001|Overall Study|Withdrawal by Subject|1|||
148825140|NCT03721107|536836223|FG002|Overall Study|Withdrawal by Subject|5|||
148825141|NCT03721107|536836224|FG003|Overall Study|Withdrawal by Subject|5|||
148825142|NCT03721107|536836221|FG000|Overall Study|Other|1|||
148825143|NCT03721107|536836222|FG001|Overall Study|Other|0|||
148825144|NCT03721107|536836223|FG002|Overall Study|Other|0|||
148825145|NCT03721107|536836224|FG003|Overall Study|Other|1|||
148825146|NCT02294019|536836225|FG000|Overall Study|Adverse Event|2|||
148825147|NCT02294019|536836225|FG000|Overall Study|Protocol Violation|68|||
148825148|NCT02294019|536836225|FG000|Overall Study|Lost to Follow-up|31|||
148825149|NCT02294019|536836225|FG000|Overall Study|Other|1|||
148825150|NCT02294019|536836225|FG000|Overall Study|Withdrawal by Subject|1|||
148825151|NCT01189227|536836227|FG000|Overall Study|Study terminated due to low accrual|6|||
148825152|NCT01189227|536836228|FG001|Overall Study|Study terminated due to low accrual|3|||
148825153|NCT00563316|536836229|FG000|Overall Study|Adverse Event|2|||
148825154|NCT00563316|536836229|FG000|Overall Study|Physician Decision|1|||
148825155|NCT00563316|536836229|FG000|Overall Study|Lost to Follow-up|2|||
148825156|NCT00563316|536836229|FG000|Overall Study|Death|1|||
148825157|NCT00563316|536836229|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
148825158|NCT00563316|536836229|FG000|Overall Study|Other|1|||
148825159|NCT00425854|536836231|FG000|Overall Study|Progressive Disease|19|||
148825160|NCT00425854|536836232|FG001|Overall Study|Progressive Disease|12|||
148825161|NCT00425854|536836231|FG000|Overall Study|Dose reduction toxicity AE|8|||
148825162|NCT00425854|536836232|FG001|Overall Study|Dose reduction toxicity AE|7|||
148825163|NCT00425854|536836231|FG000|Overall Study|Other Adverse Event|2|||
148825164|NCT00425854|536836232|FG001|Overall Study|Other Adverse Event|2|||
148825165|NCT01630811|536836238|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
148825166|NCT01630811|536836239|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
148825167|NCT04818086|536836242|FG000|Overall Study|Physician Decision|1|||
148825168|NCT04818086|536836243|FG001|Overall Study|Physician Decision|0|||
148825169|NCT04818086|536836242|FG000|Overall Study|Withdrawal by Subject|0|||
148825170|NCT04818086|536836243|FG001|Overall Study|Withdrawal by Subject|1|||
148825171|NCT06048705|536836245|FG000|Overall Study|Physician Decision|1|||
148825172|NCT06048705|536836246|FG001|Overall Study|Physician Decision|0|||
148825173|NCT06048705|536836247|FG002|Overall Study|Physician Decision|0|||
148825174|NCT06048705|536836245|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
148825175|NCT06048705|536836246|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
148825176|NCT06048705|536836247|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
148825177|NCT06048705|536836245|FG000|Overall Study|Death prior to lymphodepletion|0|||
148825178|NCT06048705|536836246|FG001|Overall Study|Death prior to lymphodepletion|0|||
148825179|NCT06048705|536836247|FG002|Overall Study|Death prior to lymphodepletion|1|||
148825180|NCT00968968|536836252|FG000|Overall Study|Study closed/terminated|10|||
148825181|NCT00968968|536836253|FG001|Overall Study|Study closed/terminated|10|||
148825182|NCT00968968|536836252|FG000|Overall Study|Protocol defined stopping criteria|3|||
148825183|NCT00968968|536836253|FG001|Overall Study|Protocol defined stopping criteria|1|||
148825184|NCT00968968|536836252|FG000|Overall Study|Withdrawal by Subject|2|||
148825185|NCT00968968|536836253|FG001|Overall Study|Withdrawal by Subject|0|||
148825186|NCT00968968|536836252|FG000|Overall Study|Physician Decision|1|||
148825187|NCT00968968|536836253|FG001|Overall Study|Physician Decision|2|||
148825188|NCT00968968|536836252|FG000|Overall Study|Lost to Follow-up|0|||
148825189|NCT00968968|536836253|FG001|Overall Study|Lost to Follow-up|1|||
148825190|NCT01185366|536836254|FG000|First Line Therapy|Insurance Coverage Denied|1|||
148825191|NCT01185366|536836255|FG001|First Line Therapy|Insurance Coverage Denied|1|||
148825192|NCT01185366|536836254|FG000|First Line Therapy|Withdrawal by Subject|1|||
148825193|NCT01185366|536836255|FG001|First Line Therapy|Withdrawal by Subject|0|||
148825194|NCT01185366|536836254|FG000|First Line Therapy|Lack of Metastatic Site|1|||
148825195|NCT01185366|536836255|FG001|First Line Therapy|Lack of Metastatic Site|0|||
148825196|NCT01185366|536836254|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
148825197|NCT01185366|536836255|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
148825198|NCT01185366|536836254|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
148825199|NCT01185366|536836255|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
148825200|NCT01185366|536836254|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
148759506|NCT00848718|536591050|FG010|Overall Study|Withdrawal by Subject|1|||
148759507|NCT00848718|536591051|FG011|Overall Study|Withdrawal by Subject|0|||
148759508|NCT00848718|536591052|FG012|Overall Study|Withdrawal by Subject|0|||
148976738|NCT01105533|537396442|FG005|Overall Study|Lack of Efficacy|5|||
148976739|NCT01105533|537396443|FG006|Overall Study|Lack of Efficacy|3|||
148976740|NCT01105533|537396444|FG007|Overall Study|Lack of Efficacy|2|||
148976741|NCT01105533|537396445|FG008|Overall Study|Lack of Efficacy|9|||
148976742|NCT01105533|537396437|FG000|Overall Study|Adverse Event|0|||
148976743|NCT01105533|537396438|FG001|Overall Study|Adverse Event|0|||
148976744|NCT01105533|537396439|FG002|Overall Study|Adverse Event|0|||
148976745|NCT01105533|537396440|FG003|Overall Study|Adverse Event|0|||
148976746|NCT01105533|537396441|FG004|Overall Study|Adverse Event|1|||
148976747|NCT01105533|537396442|FG005|Overall Study|Adverse Event|2|||
148976748|NCT01105533|537396443|FG006|Overall Study|Adverse Event|2|||
148976749|NCT01105533|537396444|FG007|Overall Study|Adverse Event|0|||
148976750|NCT01105533|537396445|FG008|Overall Study|Adverse Event|1|||
148976751|NCT01105533|537396437|FG000|Overall Study|Other|0|||
148976752|NCT01105533|537396438|FG001|Overall Study|Other|0|||
148976753|NCT01105533|537396439|FG002|Overall Study|Other|0|||
148976754|NCT01105533|537396440|FG003|Overall Study|Other|0|||
148976755|NCT01105533|537396441|FG004|Overall Study|Other|1|||
148976756|NCT01105533|537396442|FG005|Overall Study|Other|0|||
148976757|NCT01105533|537396443|FG006|Overall Study|Other|3|||
148976758|NCT01105533|537396444|FG007|Overall Study|Other|1|||
148976759|NCT01105533|537396445|FG008|Overall Study|Other|2|||
148976760|NCT01105533|537396437|FG000|Overall Study|Physician Decision|0|||
148976761|NCT01105533|537396438|FG001|Overall Study|Physician Decision|0|||
148976762|NCT01105533|537396439|FG002|Overall Study|Physician Decision|0|||
148976763|NCT01105533|537396440|FG003|Overall Study|Physician Decision|0|||
148976764|NCT01105533|537396441|FG004|Overall Study|Physician Decision|0|||
148976765|NCT01105533|537396442|FG005|Overall Study|Physician Decision|0|||
148976766|NCT01105533|537396443|FG006|Overall Study|Physician Decision|0|||
148976767|NCT01105533|537396444|FG007|Overall Study|Physician Decision|1|||
148976768|NCT01105533|537396445|FG008|Overall Study|Physician Decision|0|||
148976769|NCT01639001|537396451|FG000|Overall Study|Refused further follow-up|9|||
148976770|NCT01639001|537396452|FG001|Overall Study|Refused further follow-up|12|||
148976771|NCT01639001|537396451|FG000|Overall Study|Lost to Follow-up|3|||
148976772|NCT01639001|537396452|FG001|Overall Study|Lost to Follow-up|0|||
148976773|NCT01639001|537396451|FG000|Overall Study|Death|62|||
148976774|NCT01639001|537396452|FG001|Overall Study|Death|61|||
148976775|NCT01639001|537396451|FG000|Overall Study|Randomized but not treated|0|||
148976776|NCT01639001|537396452|FG001|Overall Study|Randomized but not treated|2|||
148976777|NCT01639001|537396451|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
148976778|NCT01639001|537396452|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
148976779|NCT00679341|537396454|FG000|Overall Study|Disease progression|42|||
148976780|NCT00679341|537396455|FG001|Overall Study|Disease progression|36|||
148976781|NCT00679341|537396454|FG000|Overall Study|Adverse Event|5|||
148976782|NCT00679341|537396455|FG001|Overall Study|Adverse Event|6|||
148976783|NCT00679341|537396454|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
148976784|NCT00679341|537396455|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
148976785|NCT00679341|537396454|FG000|Overall Study|Death|1|||
148976786|NCT00679341|537396455|FG001|Overall Study|Death|1|||
148976787|NCT00679341|537396454|FG000|Overall Study|Other|1|||
148976788|NCT00679341|537396455|FG001|Overall Study|Other|0|||
148976789|NCT00679341|537396454|FG000|Overall Study|Physician Decision|1|||
148976790|NCT00679341|537396455|FG001|Overall Study|Physician Decision|0|||
148976791|NCT00679341|537396454|FG000|Overall Study|Not treated|0|||
148976792|NCT00679341|537396455|FG001|Overall Study|Not treated|2|||
148976793|NCT00679341|537396454|FG000|Overall Study|Physician/patient decision to withdraw|0|||
148759509|NCT00848718|536591040|FG000|Overall Study|Progressive disease during treatment|3|||
148976794|NCT00679341|537396455|FG001|Overall Study|Physician/patient decision to withdraw|6|||
148976795|NCT02649972|537396456|FG000|Overall Study|Not treated|1|||
148976796|NCT00306592|537396457|FG000|Overall Study|Adverse Event|8|||
148976797|NCT00306592|537396458|FG001|Overall Study|Adverse Event|15|||
148976798|NCT00306592|537396457|FG000|Overall Study|Lost to Follow-up|1|||
148976799|NCT00306592|537396458|FG001|Overall Study|Lost to Follow-up|0|||
148976800|NCT00306592|537396457|FG000|Overall Study|Noncompliance|0|||
148976801|NCT00306592|537396458|FG001|Overall Study|Noncompliance|2|||
148976802|NCT00306592|537396457|FG000|Overall Study|Persistent Antibodies|6|||
148976803|NCT00306592|537396458|FG001|Overall Study|Persistent Antibodies|3|||
148976804|NCT00306592|537396457|FG000|Overall Study|Voluntary|10|||
148976805|NCT00306592|537396458|FG001|Overall Study|Voluntary|6|||
148976806|NCT00306592|537396457|FG000|Overall Study|Other|5|||
148976807|NCT00306592|537396458|FG001|Overall Study|Other|10|||
148976808|NCT00306592|537396457|FG000|Overall Study|Other|1|||
149027466|NCT01237678|537578567|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
148759510|NCT00848718|536591041|FG001|Overall Study|Progressive disease during treatment|0|||
148976809|NCT00306592|537396458|FG001|Overall Study|Other|2|||
148976810|NCT00306592|537396457|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
148825201|NCT01185366|536836255|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
148825202|NCT01185366|536836254|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
148825203|NCT01185366|536836255|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
148825204|NCT02792257|536836258|FG000|Overall Study|Lost to Follow-up|3|||
148825205|NCT02792257|536836259|FG001|Overall Study|Lost to Follow-up|4|||
148825206|NCT02792257|536836258|FG000|Overall Study|Allergy|0|||
148825207|NCT02792257|536836259|FG001|Overall Study|Allergy|1|||
148825208|NCT02792257|536836258|FG000|Overall Study|Protocol Violation|2|||
148825209|NCT02792257|536836259|FG001|Overall Study|Protocol Violation|0|||
148825210|NCT02792257|536836258|FG000|Overall Study|Excessive Agitation|0|||
148825211|NCT02792257|536836259|FG001|Overall Study|Excessive Agitation|1|||
148825212|NCT02792257|536836258|FG000|Overall Study|Not Feeling Well|0|||
148825213|NCT02792257|536836259|FG001|Overall Study|Not Feeling Well|1|||
148825214|NCT00537082|536836260|FG000|Overall Study|Adverse Event|6|||
148825215|NCT00537082|536836261|FG001|Overall Study|Adverse Event|6|||
148825216|NCT00537082|536836262|FG002|Overall Study|Adverse Event|3|||
148825217|NCT00537082|536836260|FG000|Overall Study|Protocol Violation|0|||
148825218|NCT00537082|536836261|FG001|Overall Study|Protocol Violation|2|||
148825219|NCT00537082|536836262|FG002|Overall Study|Protocol Violation|1|||
148825220|NCT00537082|536836260|FG000|Overall Study|Lack of Efficacy|0|||
148825221|NCT00537082|536836261|FG001|Overall Study|Lack of Efficacy|0|||
148825222|NCT00537082|536836262|FG002|Overall Study|Lack of Efficacy|2|||
148825223|NCT00537082|536836260|FG000|Overall Study|Withdrawal by Subject|0|||
148825224|NCT00537082|536836261|FG001|Overall Study|Withdrawal by Subject|1|||
148825225|NCT00537082|536836262|FG002|Overall Study|Withdrawal by Subject|0|||
148825226|NCT00537082|536836260|FG000|Overall Study|Discontinued before initiating treatment|3|||
148825227|NCT00537082|536836261|FG001|Overall Study|Discontinued before initiating treatment|0|||
148825228|NCT00537082|536836262|FG002|Overall Study|Discontinued before initiating treatment|0|||
148825229|NCT02568254|536836263|FG000|Period 2|Adverse Event|0|||
148825230|NCT02568254|536836264|FG001|Period 2|Adverse Event|0|||
148825231|NCT02568254|536836265|FG002|Period 2|Adverse Event|1|||
148825232|NCT02568254|536836266|FG003|Period 2|Adverse Event|0|||
148825233|NCT02568254|536836267|FG004|Period 2|Adverse Event|0|||
148825234|NCT02568254|536836268|FG005|Period 2|Adverse Event|0|||
148825235|NCT02568254|536836263|FG000|Period 3|Unstatisfactory Lens fitting|0|||
148825236|NCT02568254|536836264|FG001|Period 3|Unstatisfactory Lens fitting|0|||
148825237|NCT02568254|536836265|FG002|Period 3|Unstatisfactory Lens fitting|0|||
148825238|NCT02568254|536836266|FG003|Period 3|Unstatisfactory Lens fitting|0|||
148825239|NCT02568254|536836267|FG004|Period 3|Unstatisfactory Lens fitting|1|||
148825240|NCT02568254|536836268|FG005|Period 3|Unstatisfactory Lens fitting|0|||
148825241|NCT03061214|536836271|FG000|Overall Study|Withdrawal by Subject|21|||
148825242|NCT03061214|536836272|FG001|Overall Study|Withdrawal by Subject|26|||
148825243|NCT03061214|536836273|FG002|Overall Study|Withdrawal by Subject|9|||
148825244|NCT03061214|536836271|FG000|Overall Study|Lost to Follow-up|3|||
148825245|NCT03061214|536836272|FG001|Overall Study|Lost to Follow-up|1|||
148825246|NCT03061214|536836273|FG002|Overall Study|Lost to Follow-up|1|||
148825247|NCT03061214|536836271|FG000|Overall Study|Death|1|||
148825248|NCT03061214|536836272|FG001|Overall Study|Death|1|||
148825249|NCT03061214|536836273|FG002|Overall Study|Death|0|||
148825250|NCT01027754|536838390|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
148825251|NCT01027754|536838391|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
148825252|NCT01027754|536838390|FG000|Overall Study|Withdrawal by Subject|0|||
148825253|NCT01027754|536838391|FG001|Overall Study|Withdrawal by Subject|5|||
148825254|NCT02562040|536838392|FG000|Overall Study|Lost to Follow-up|20|||
148825255|NCT02562040|536838393|FG001|Overall Study|Lost to Follow-up|28|||
148825256|NCT02562040|536838392|FG000|Overall Study|Withdrawal by Subject|8|||
148825257|NCT02562040|536838393|FG001|Overall Study|Withdrawal by Subject|7|||
148825258|NCT02562040|536838392|FG000|Overall Study|Adverse Event|1|||
148825259|NCT02562040|536838393|FG001|Overall Study|Adverse Event|0|||
148825260|NCT00368849|536838394|FG000|Overall Study|Withdrawal by Subject|0|||
148825261|NCT00368849|536838395|FG001|Overall Study|Withdrawal by Subject|1|||
148825262|NCT00368849|536838394|FG000|Overall Study|Physician Decision|0|||
148825263|NCT00368849|536838395|FG001|Overall Study|Physician Decision|1|||
148825264|NCT01902303|536838399|FG000|Overall Study|Adverse Event|0|||
148825265|NCT01902303|536838400|FG001|Overall Study|Adverse Event|1|||
148825266|NCT01902303|536838399|FG000|Overall Study|Lost to Follow-up|0|||
148825267|NCT01902303|536838400|FG001|Overall Study|Lost to Follow-up|1|||
148825268|NCT01902303|536838399|FG000|Overall Study|Protocol Violation|2|||
148825269|NCT01902303|536838400|FG001|Overall Study|Protocol Violation|2|||
148825270|NCT01902303|536838399|FG000|Overall Study|subject lost investigational product|0|||
148825271|NCT01902303|536838400|FG001|Overall Study|subject lost investigational product|1|||
148825272|NCT01902303|536838399|FG000|Overall Study|Did not develop a cold sore|21|||
148825273|NCT01902303|536838400|FG001|Overall Study|Did not develop a cold sore|19|||
148825274|NCT01699685|536838401|FG000|Period 1|Adverse Event|1|||
148825275|NCT01699685|536838402|FG001|Period 1|Adverse Event|1|||
148825276|NCT01699685|536838401|FG000|Period 1|Medical or ethical, noncompliance|2|||
148825277|NCT01699685|536838402|FG001|Period 1|Medical or ethical, noncompliance|0|||
148825278|NCT01699685|536838401|FG000|Period 1|Other|0|||
148976811|NCT00306592|537396458|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
148976812|NCT04101526|537396459|FG000|Overall Study|Did not complete all sleep diary entries|0|||
148976813|NCT04101526|537396460|FG001|Overall Study|Did not complete all sleep diary entries|1|||
148976814|NCT00424372|537396461|FG000|Overall Study|Death|1|||
148976815|NCT00424372|537396461|FG000|Overall Study|Adverse Event|18|||
148976816|NCT00424372|537396461|FG000|Overall Study|Lack of Efficacy|6|||
148976817|NCT00424372|537396461|FG000|Overall Study|Withdrawal by Subject|4|||
148976818|NCT00424372|537396461|FG000|Overall Study|Protocol Violation|1|||
148976819|NCT00424372|537396461|FG000|Overall Study|Health deterioration|1|||
148976820|NCT02488629|537396462|FG000|Overall Study|Lack of Efficacy|3|||
148976821|NCT02488629|537396463|FG001|Overall Study|Lack of Efficacy|1|||
148759511|NCT00848718|536591042|FG002|Overall Study|Progressive disease during treatment|3|||
148759512|NCT00848718|536591043|FG003|Overall Study|Progressive disease during treatment|0|||
148759513|NCT00848718|536591044|FG004|Overall Study|Progressive disease during treatment|0|||
148759514|NCT00848718|536591045|FG005|Overall Study|Progressive disease during treatment|0|||
148759515|NCT00848718|536591046|FG006|Overall Study|Progressive disease during treatment|0|||
148759516|NCT00848718|536591047|FG007|Overall Study|Progressive disease during treatment|2|||
148759517|NCT00848718|536591048|FG008|Overall Study|Progressive disease during treatment|0|||
148759518|NCT00848718|536591049|FG009|Overall Study|Progressive disease during treatment|0|||
148759519|NCT00848718|536591050|FG010|Overall Study|Progressive disease during treatment|0|||
148759520|NCT00848718|536591051|FG011|Overall Study|Progressive disease during treatment|0|||
148759521|NCT00848718|536591052|FG012|Overall Study|Progressive disease during treatment|2|||
148759522|NCT02389829|536591058|FG000|Overall Study|Lost to Follow-up|0|||
148759523|NCT02389829|536591059|FG001|Overall Study|Lost to Follow-up|1|||
148759524|NCT00571727|536591060|FG000|Overall Study|Did not enter in this study|1|||
148759525|NCT00571727|536591060|FG000|Overall Study|Non-compliance|4|||
148759526|NCT00571727|536591060|FG000|Overall Study|Lost to Follow-up|30|||
148759527|NCT00571727|536591060|FG000|Overall Study|Poor growth|1|||
148759528|NCT00571727|536591060|FG000|Overall Study|Parent/patient decision|2|||
148759529|NCT00571727|536591060|FG000|Overall Study|Participant transferred to commercial drug|14|||
148759530|NCT00571727|536591060|FG000|Overall Study|Unable to provide study drug|6|||
148759531|NCT00571727|536591060|FG000|Overall Study|On-treatment at end of study|8|||
148759532|NCT03817190|536591061|FG000|Overall Study|Early Termination|13|||
148759533|NCT03817190|536591062|FG001|Overall Study|Early Termination|20|||
148759534|NCT03817190|536591061|FG000|Overall Study|Adverse Event|10|||
148759535|NCT03817190|536591062|FG001|Overall Study|Adverse Event|17|||
148759536|NCT03817190|536591061|FG000|Overall Study|Withdrawal by Subject|12|||
148759537|NCT03817190|536591062|FG001|Overall Study|Withdrawal by Subject|8|||
148759538|NCT03817190|536591061|FG000|Overall Study|Lost to Follow-up|11|||
148759539|NCT03817190|536591062|FG001|Overall Study|Lost to Follow-up|7|||
148759540|NCT03817190|536591061|FG000|Overall Study|Lack of Efficacy|7|||
148759541|NCT03817190|536591062|FG001|Overall Study|Lack of Efficacy|5|||
148759542|NCT03817190|536591061|FG000|Overall Study|Investigator Decision|5|||
148759543|NCT03817190|536591062|FG001|Overall Study|Investigator Decision|1|||
148759544|NCT03817190|536591061|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
148759545|NCT03817190|536591062|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
148759546|NCT03817190|536591061|FG000|Overall Study|Lack of Contact|1|||
148759547|NCT03817190|536591062|FG001|Overall Study|Lack of Contact|0|||
148759548|NCT03817190|536591061|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
148759549|NCT03817190|536591062|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
148759550|NCT05514873|536591063|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
148759551|NCT05514873|536591063|FG000|Main Treatment Period|Adverse Event|2|||
148759552|NCT05514873|536591063|FG000|Extension Treatment Period|Lost to Follow-up|3|||
148759553|NCT03525678|536591066|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
148759554|NCT03525678|536591067|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
148759555|NCT03525678|536591068|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
148759556|NCT03525678|536591069|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
148759557|NCT03525678|536591070|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
148759558|NCT03525678|536591066|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
148976822|NCT02488629|537396464|FG002|Overall Study|Lack of Efficacy|0|||
148976823|NCT02488629|537396465|FG003|Overall Study|Lack of Efficacy|0|||
148976824|NCT02488629|537396462|FG000|Overall Study|Withdrawal by Subject|0|||
149027467|NCT01237678|537578568|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
148759559|NCT03525678|536591067|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
148759560|NCT03525678|536591068|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
148759561|NCT03525678|536591069|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
148759562|NCT03525678|536591070|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
148759563|NCT03525678|536591066|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
148825279|NCT01699685|536838402|FG001|Period 1|Other|1|||
148976825|NCT02488629|537396463|FG001|Overall Study|Withdrawal by Subject|1|||
148976826|NCT02488629|537396464|FG002|Overall Study|Withdrawal by Subject|0|||
148825280|NCT01699685|536838401|FG000|Period 1|Patient request|0|||
148825281|NCT01699685|536838402|FG001|Period 1|Patient request|1|||
148825282|NCT01699685|536838401|FG000|Period 2|Lost to Follow-up|1|||
148825283|NCT01699685|536838402|FG001|Period 2|Lost to Follow-up|0|||
148825284|NCT05058456|536838403|FG000|Overall Study|Death|1|||
148825285|NCT05058456|536838403|FG000|Overall Study|End of Study data not yet due for release|34|||
148825286|NCT01654250|536838404|FG000|Overall Study|Lost to Follow-up|1|||
148825287|NCT01654250|536838405|FG001|Overall Study|Lost to Follow-up|0|||
148825288|NCT03810365|536838407|FG000|Overall Study|Lost to Follow-up|2|||
148825289|NCT03810365|536838408|FG001|Overall Study|Lost to Follow-up|2|||
148825290|NCT03810365|536838407|FG000|Overall Study|Withdrawal by Subject|4|||
148825291|NCT03810365|536838408|FG001|Overall Study|Withdrawal by Subject|5|||
148825292|NCT00107614|536838413|FG000|Overall Study|Physician Decision|10|||
148825293|NCT00107614|536838413|FG000|Overall Study|Death|2|||
148825294|NCT01730729|536838429|FG000|Overall Study|Adverse Event|1|||
148825295|NCT01730729|536838429|FG000|Overall Study|Death|1|||
148825296|NCT01730729|536838429|FG000|Overall Study|Progressive Disease|12|||
148825297|NCT00871000|536838430|FG000|Overall Study|Withdrawal by Subject|1|||
148825298|NCT00871000|536838431|FG001|Overall Study|Withdrawal by Subject|0|||
148825299|NCT02094885|536838434|FG000|Overall Study|Death|1|||
148825300|NCT02094885|536838435|FG001|Overall Study|Death|5|||
148825301|NCT02094885|536838434|FG000|Overall Study|Withdrawn due to age|1|||
148825302|NCT02094885|536838435|FG001|Overall Study|Withdrawn due to age|0|||
148825303|NCT02003898|536838436|FG000|Overall Study|Death|3|||
148825304|NCT02003898|536838436|FG000|Overall Study|Lost to Follow-up|12|||
148825305|NCT02003898|536838436|FG000|Overall Study|Withdrawal by Subject|52|||
148825306|NCT01537432|536838437|FG000|Overall Study|Lost to Follow-up|3|||
148825307|NCT01537432|536838438|FG001|Overall Study|Lost to Follow-up|1|||
148825308|NCT01537432|536838437|FG000|Overall Study|Withdrawal by Subject|0|||
148825309|NCT01537432|536838438|FG001|Overall Study|Withdrawal by Subject|1|||
148825310|NCT01537432|536838437|FG000|Overall Study|Administrative problems|1|||
148825311|NCT01537432|536838438|FG001|Overall Study|Administrative problems|0|||
148825312|NCT01537432|536838437|FG000|Overall Study|Adverse Event|1|||
148825313|NCT01537432|536838438|FG001|Overall Study|Adverse Event|0|||
148825314|NCT01537432|536838437|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148825315|NCT01537432|536838438|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148825316|NCT01998477|536838439|FG000|Overall Study|Lost to Follow-up|4|||
148825317|NCT01998477|536838440|FG001|Overall Study|Lost to Follow-up|5|||
148825318|NCT01998477|536838439|FG000|Overall Study|Withdrawal by Subject|6|||
148825319|NCT01998477|536838440|FG001|Overall Study|Withdrawal by Subject|0|||
148825320|NCT00779909|536838441|FG000|Overall Study|Lost to Follow-up|1|||
148825321|NCT00779909|536838442|FG001|Overall Study|Lost to Follow-up|0|||
148825322|NCT00779909|536838443|FG002|Overall Study|Lost to Follow-up|0|||
148825323|NCT00779909|536838444|FG003|Overall Study|Lost to Follow-up|1|||
148825324|NCT00779909|536838441|FG000|Overall Study|Withdrawal by Subject|0|||
148825325|NCT00779909|536838442|FG001|Overall Study|Withdrawal by Subject|1|||
148825326|NCT00779909|536838443|FG002|Overall Study|Withdrawal by Subject|0|||
148825327|NCT00779909|536838444|FG003|Overall Study|Withdrawal by Subject|0|||
148825328|NCT03436420|536838445|FG000|Overall Study|Lack of Efficacy|3|||
148825329|NCT01061710|536838446|FG000|Overall Study|Protocol Violation|14|||
148825330|NCT00159874|536838447|FG000|Overall Study|Adverse Event|2|||
148825331|NCT00159874|536838448|FG001|Overall Study|Adverse Event|2|||
148825332|NCT00159874|536838449|FG002|Overall Study|Adverse Event|5|||
148825333|NCT00159874|536838450|FG003|Overall Study|Adverse Event|1|||
148825334|NCT00159874|536838451|FG004|Overall Study|Adverse Event|1|||
148825335|NCT00159874|536838452|FG005|Overall Study|Adverse Event|2|||
148825336|NCT00159874|536838453|FG006|Overall Study|Adverse Event|0|||
148825337|NCT00159874|536838447|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
148976827|NCT02488629|537396465|FG003|Overall Study|Withdrawal by Subject|0|||
148976828|NCT00654628|537396466|FG000|6-week Active Treatment Period|Adverse Event|9|||
148976829|NCT00654628|537396466|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
148976830|NCT00654628|537396466|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
148976831|NCT00654628|537396466|FG000|6-week Active Treatment Period|Out of window period|1|||
148976832|NCT00654628|537396466|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
148825338|NCT00159874|536838448|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
148825339|NCT00159874|536838449|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
148825340|NCT00159874|536838450|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
148825341|NCT00159874|536838451|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
148825342|NCT00159874|536838452|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
148825343|NCT00159874|536838453|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
148825344|NCT00159874|536838447|FG000|Overall Study|Lack of Efficacy|2|||
148825345|NCT00159874|536838448|FG001|Overall Study|Lack of Efficacy|0|||
148825346|NCT00159874|536838449|FG002|Overall Study|Lack of Efficacy|1|||
148825347|NCT00159874|536838450|FG003|Overall Study|Lack of Efficacy|1|||
148825348|NCT00159874|536838451|FG004|Overall Study|Lack of Efficacy|0|||
148825349|NCT00159874|536838452|FG005|Overall Study|Lack of Efficacy|3|||
148825350|NCT00159874|536838453|FG006|Overall Study|Lack of Efficacy|0|||
148976833|NCT00654628|537396466|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
148976834|NCT00912405|537396469|FG000|Overall Study|Lost to Follow-up|5|||
148976835|NCT00953329|537396470|FG000|Overall Study|Lack of Efficacy|1|||
148976836|NCT01797536|537396471|FG000|Overall Study|Adverse Event|0|||
148976837|NCT01797536|537396472|FG001|Overall Study|Adverse Event|1|||
148976838|NCT01797536|537396473|FG002|Overall Study|Adverse Event|0|||
148976839|NCT01797536|537396474|FG003|Overall Study|Adverse Event|0|||
148976840|NCT02039427|537396484|FG000|Overall Study|Duration of surgery > 3h|1|||
148976841|NCT02039427|537396485|FG001|Overall Study|Duration of surgery > 3h|1|||
148976842|NCT02039427|537396486|FG002|Overall Study|Duration of surgery > 3h|0|||
148976843|NCT02039427|537396487|FG003|Overall Study|Duration of surgery > 3h|0|||
148976844|NCT02039427|537396484|FG000|Overall Study|Withdrawal on concent|0|||
148976845|NCT02039427|537396485|FG001|Overall Study|Withdrawal on concent|0|||
148976846|NCT02039427|537396486|FG002|Overall Study|Withdrawal on concent|0|||
148976847|NCT02039427|537396487|FG003|Overall Study|Withdrawal on concent|1|||
148976848|NCT02039427|537396484|FG000|Overall Study|Cancellation of surgery|0|||
148976849|NCT02039427|537396485|FG001|Overall Study|Cancellation of surgery|0|||
148976850|NCT02039427|537396486|FG002|Overall Study|Cancellation of surgery|1|||
148976851|NCT02039427|537396487|FG003|Overall Study|Cancellation of surgery|0|||
148976852|NCT02039427|537396484|FG000|Overall Study|Loss of follow - up|1|||
148976853|NCT02039427|537396485|FG001|Overall Study|Loss of follow - up|0|||
148976854|NCT02039427|537396486|FG002|Overall Study|Loss of follow - up|2|||
148976855|NCT02039427|537396487|FG003|Overall Study|Loss of follow - up|4|||
148976856|NCT02039427|537396484|FG000|Overall Study|Steroid Use|1|||
148976857|NCT02039427|537396485|FG001|Overall Study|Steroid Use|0|||
148976858|NCT02039427|537396486|FG002|Overall Study|Steroid Use|0|||
148976859|NCT02039427|537396487|FG003|Overall Study|Steroid Use|0|||
148976860|NCT00844545|537396488|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
148976861|NCT00844545|537396488|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
148976862|NCT00844545|537396488|FG000|Extension Treatment Period|Adverse Event|2|||
148976863|NCT00844545|537396488|FG000|Post Treatment Period|Withdrawal by Subject|1|||
148976864|NCT01532687|537396495|FG000|Overall Study|Death|2|||
148976865|NCT01532687|537396496|FG001|Overall Study|Death|0|||
148976866|NCT01532687|537396495|FG000|Overall Study|Adverse Event|6|||
148976867|NCT01532687|537396496|FG001|Overall Study|Adverse Event|1|||
148976868|NCT01532687|537396495|FG000|Overall Study|Withdrawal by Subject|1|||
148976869|NCT01532687|537396496|FG001|Overall Study|Withdrawal by Subject|0|||
148976870|NCT01532687|537396495|FG000|Overall Study|Physician Decision|2|||
148976871|NCT01532687|537396496|FG001|Overall Study|Physician Decision|1|||
148976872|NCT01532687|537396495|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
148976873|NCT01532687|537396496|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
148976874|NCT00403455|537396497|FG000|Overall Study|Withdrawal by Subject|1|||
148976875|NCT03160703|537396498|FG000|Overall Study|Withdrawal by Subject|0|||
148976876|NCT03160703|537396499|FG001|Overall Study|Withdrawal by Subject|0|||
148976877|NCT03160703|537396500|FG002|Overall Study|Withdrawal by Subject|0|||
148976878|NCT03160703|537396501|FG003|Overall Study|Withdrawal by Subject|1|||
148976879|NCT00226941|537396508|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
148976880|NCT00226941|537396509|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
148976881|NCT00226941|537396510|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
148976882|NCT00226941|537396511|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
148976883|NCT00226941|537396508|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
148976884|NCT00226941|537396509|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
148759564|NCT03525678|536591067|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
148825351|NCT00159874|536838447|FG000|Overall Study|Lost to Follow-up|1|||
148976885|NCT00226941|537396510|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
148976886|NCT00226941|537396511|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
148976887|NCT01513291|537396512|FG000|Treatment Period|Adverse Event|8|||
148976888|NCT01513291|537396513|FG001|Treatment Period|Adverse Event|4|||
148976889|NCT01513291|537396514|FG002|Treatment Period|Adverse Event|0|||
148976890|NCT01513291|537396515|FG003|Treatment Period|Adverse Event|0|||
148976891|NCT01513291|537396516|FG004|Treatment Period|Adverse Event|0|||
148976892|NCT01513291|537396512|FG000|Treatment Period|Lack of Efficacy|3|||
148976893|NCT01513291|537396513|FG001|Treatment Period|Lack of Efficacy|0|||
148976894|NCT01513291|537396514|FG002|Treatment Period|Lack of Efficacy|0|||
148976895|NCT01513291|537396515|FG003|Treatment Period|Lack of Efficacy|0|||
148976896|NCT01513291|537396516|FG004|Treatment Period|Lack of Efficacy|0|||
148976897|NCT01513291|537396512|FG000|Treatment Period|Lost to Follow-up|2|||
148976898|NCT01513291|537396513|FG001|Treatment Period|Lost to Follow-up|3|||
148976899|NCT01513291|537396514|FG002|Treatment Period|Lost to Follow-up|0|||
148976900|NCT01513291|537396515|FG003|Treatment Period|Lost to Follow-up|0|||
148976901|NCT01513291|537396516|FG004|Treatment Period|Lost to Follow-up|0|||
148976902|NCT01513291|537396512|FG000|Treatment Period|Physician Decision|1|||
148976903|NCT01513291|537396513|FG001|Treatment Period|Physician Decision|0|||
148976904|NCT01513291|537396514|FG002|Treatment Period|Physician Decision|0|||
148976905|NCT01513291|537396515|FG003|Treatment Period|Physician Decision|0|||
148976906|NCT01513291|537396516|FG004|Treatment Period|Physician Decision|0|||
148825352|NCT00159874|536838448|FG001|Overall Study|Lost to Follow-up|0|||
148825353|NCT00159874|536838449|FG002|Overall Study|Lost to Follow-up|3|||
148825354|NCT00159874|536838450|FG003|Overall Study|Lost to Follow-up|0|||
148825355|NCT00159874|536838451|FG004|Overall Study|Lost to Follow-up|1|||
148825356|NCT00159874|536838452|FG005|Overall Study|Lost to Follow-up|2|||
148825357|NCT00159874|536838453|FG006|Overall Study|Lost to Follow-up|1|||
148825358|NCT00159874|536838447|FG000|Overall Study|Other|8|||
148825359|NCT00159874|536838448|FG001|Overall Study|Other|8|||
148825360|NCT00159874|536838449|FG002|Overall Study|Other|8|||
148825361|NCT00159874|536838450|FG003|Overall Study|Other|0|||
148825362|NCT00159874|536838451|FG004|Overall Study|Other|2|||
148825363|NCT00159874|536838452|FG005|Overall Study|Other|1|||
148825364|NCT00159874|536838453|FG006|Overall Study|Other|3|||
148825365|NCT00159874|536838447|FG000|Overall Study|Protocol Violation|0|||
148825366|NCT00159874|536838448|FG001|Overall Study|Protocol Violation|5|||
148825367|NCT00159874|536838449|FG002|Overall Study|Protocol Violation|2|||
148825368|NCT00159874|536838450|FG003|Overall Study|Protocol Violation|0|||
148825369|NCT00159874|536838451|FG004|Overall Study|Protocol Violation|0|||
148825370|NCT00159874|536838452|FG005|Overall Study|Protocol Violation|0|||
148825371|NCT00159874|536838453|FG006|Overall Study|Protocol Violation|0|||
148825372|NCT00159874|536838447|FG000|Overall Study|Death|3|||
148825373|NCT00159874|536838448|FG001|Overall Study|Death|8|||
148825374|NCT00159874|536838449|FG002|Overall Study|Death|15|||
148825375|NCT00159874|536838450|FG003|Overall Study|Death|0|||
148825376|NCT00159874|536838451|FG004|Overall Study|Death|1|||
148825377|NCT00159874|536838452|FG005|Overall Study|Death|2|||
148825378|NCT00159874|536838453|FG006|Overall Study|Death|0|||
148825379|NCT00159874|536838447|FG000|Overall Study|Withdrawal by Subject|2|||
148825380|NCT00159874|536838448|FG001|Overall Study|Withdrawal by Subject|6|||
148825381|NCT00159874|536838449|FG002|Overall Study|Withdrawal by Subject|8|||
148825382|NCT00159874|536838450|FG003|Overall Study|Withdrawal by Subject|4|||
148825383|NCT00159874|536838451|FG004|Overall Study|Withdrawal by Subject|3|||
148825384|NCT00159874|536838452|FG005|Overall Study|Withdrawal by Subject|2|||
148825385|NCT00159874|536838453|FG006|Overall Study|Withdrawal by Subject|1|||
148825386|NCT00159874|536838447|FG000|Overall Study|Pregnancy|1|||
148825387|NCT00159874|536838448|FG001|Overall Study|Pregnancy|1|||
148825388|NCT00159874|536838449|FG002|Overall Study|Pregnancy|0|||
148825389|NCT00159874|536838450|FG003|Overall Study|Pregnancy|0|||
148825390|NCT00159874|536838451|FG004|Overall Study|Pregnancy|0|||
148825391|NCT00159874|536838452|FG005|Overall Study|Pregnancy|0|||
148825392|NCT00159874|536838453|FG006|Overall Study|Pregnancy|0|||
148825393|NCT03596983|536838456|FG000|Overall Study|Withdrawal by Subject|3|||
148825394|NCT05287685|536838457|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
148825395|NCT05287685|536838458|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
148825396|NCT05287685|536838457|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
148825397|NCT05287685|536838458|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
148825398|NCT02571244|536838459|FG000|Overall Study|Lost to Follow-up|0|||
148825399|NCT02571244|536838460|FG001|Overall Study|Lost to Follow-up|1|||
148825400|NCT02571244|536838459|FG000|Overall Study|Unable to reach out post discharge|3|||
148825401|NCT02571244|536838460|FG001|Overall Study|Unable to reach out post discharge|0|||
148825402|NCT01570192|536838461|FG000|Overall Study|no qualifying organism|6|||
148825403|NCT01570192|536838462|FG001|Overall Study|no qualifying organism|12|||
148825404|NCT01570192|536838461|FG000|Overall Study|changed to palliative care|1|||
148825405|NCT01570192|536838462|FG001|Overall Study|changed to palliative care|0|||
148825406|NCT01570192|536838461|FG000|Overall Study|Physician Decision|0|||
148825407|NCT01570192|536838462|FG001|Overall Study|Physician Decision|1|||
148825408|NCT02134028|536838463|FG000|Overall Study|Lack of Efficacy|1|||
148825409|NCT02134028|536838464|FG001|Overall Study|Lack of Efficacy|0|||
148825410|NCT02134028|536838465|FG002|Overall Study|Lack of Efficacy|3|||
148825411|NCT02134028|536838466|FG003|Overall Study|Lack of Efficacy|2|||
148825412|NCT02134028|536838467|FG004|Overall Study|Lack of Efficacy|1|||
148825413|NCT02134028|536838468|FG005|Overall Study|Lack of Efficacy|2|||
148825414|NCT02134028|536838469|FG006|Overall Study|Lack of Efficacy|1|||
148825415|NCT02134028|536838470|FG007|Overall Study|Lack of Efficacy|0|||
148825416|NCT02134028|536838463|FG000|Overall Study|Poor compliance to protocol|1|||
148825417|NCT02134028|536838464|FG001|Overall Study|Poor compliance to protocol|1|||
148825418|NCT02134028|536838465|FG002|Overall Study|Poor compliance to protocol|3|||
148825419|NCT02134028|536838466|FG003|Overall Study|Poor compliance to protocol|7|||
148825420|NCT02134028|536838467|FG004|Overall Study|Poor compliance to protocol|1|||
148825421|NCT02134028|536838468|FG005|Overall Study|Poor compliance to protocol|1|||
148825422|NCT02134028|536838469|FG006|Overall Study|Poor compliance to protocol|0|||
148825423|NCT02134028|536838470|FG007|Overall Study|Poor compliance to protocol|0|||
148825424|NCT02134028|536838463|FG000|Overall Study|Other unspecified|4|||
148825425|NCT02134028|536838464|FG001|Overall Study|Other unspecified|22|||
148825426|NCT02134028|536838465|FG002|Overall Study|Other unspecified|33|||
148825427|NCT02134028|536838466|FG003|Overall Study|Other unspecified|64|||
148825428|NCT02134028|536838467|FG004|Overall Study|Other unspecified|8|||
148825429|NCT02134028|536838468|FG005|Overall Study|Other unspecified|6|||
148825430|NCT02134028|536838469|FG006|Overall Study|Other unspecified|2|||
148825431|NCT02134028|536838470|FG007|Overall Study|Other unspecified|1|||
148825432|NCT02134028|536838463|FG000|Overall Study|Adverse Event|3|||
148825433|NCT02134028|536838464|FG001|Overall Study|Adverse Event|19|||
148825434|NCT02134028|536838465|FG002|Overall Study|Adverse Event|13|||
148825435|NCT02134028|536838466|FG003|Overall Study|Adverse Event|32|||
148825436|NCT02134028|536838467|FG004|Overall Study|Adverse Event|4|||
148825437|NCT02134028|536838468|FG005|Overall Study|Adverse Event|5|||
148825438|NCT02134028|536838469|FG006|Overall Study|Adverse Event|1|||
148825439|NCT02134028|536838470|FG007|Overall Study|Adverse Event|2|||
148825440|NCT00806026|536838471|FG000|Overall Study|Death|0|||
148825441|NCT00806026|536838472|FG001|Overall Study|Death|0|||
148825442|NCT00806026|536838473|FG002|Overall Study|Death|0|||
148825443|NCT00806026|536838474|FG003|Overall Study|Death|1|||
148825444|NCT00806026|536838475|FG004|Overall Study|Death|0|||
148825445|NCT00806026|536838476|FG005|Overall Study|Death|0|||
148825446|NCT00806026|536838471|FG000|Overall Study|Did not meet entrance criteria|4|||
148825447|NCT00806026|536838472|FG001|Overall Study|Did not meet entrance criteria|1|||
148825448|NCT00806026|536838473|FG002|Overall Study|Did not meet entrance criteria|2|||
148825449|NCT00806026|536838474|FG003|Overall Study|Did not meet entrance criteria|1|||
148825450|NCT00806026|536838475|FG004|Overall Study|Did not meet entrance criteria|0|||
148825451|NCT00806026|536838476|FG005|Overall Study|Did not meet entrance criteria|0|||
148825452|NCT00806026|536838471|FG000|Overall Study|Lack of Efficacy|5|||
148825453|NCT00806026|536838472|FG001|Overall Study|Lack of Efficacy|18|||
148825454|NCT00806026|536838473|FG002|Overall Study|Lack of Efficacy|13|||
148825455|NCT00806026|536838474|FG003|Overall Study|Lack of Efficacy|4|||
148825456|NCT00806026|536838475|FG004|Overall Study|Lack of Efficacy|8|||
148825457|NCT00806026|536838476|FG005|Overall Study|Lack of Efficacy|7|||
148825458|NCT00806026|536838471|FG000|Overall Study|Lost to Follow-up|8|||
148825459|NCT00806026|536838472|FG001|Overall Study|Lost to Follow-up|15|||
148825460|NCT00806026|536838473|FG002|Overall Study|Lost to Follow-up|8|||
148825461|NCT00806026|536838474|FG003|Overall Study|Lost to Follow-up|2|||
148825462|NCT00806026|536838475|FG004|Overall Study|Lost to Follow-up|6|||
148825463|NCT00806026|536838476|FG005|Overall Study|Lost to Follow-up|6|||
148825464|NCT00806026|536838471|FG000|Overall Study|Withdrawal by Subject|14|||
148825465|NCT00806026|536838472|FG001|Overall Study|Withdrawal by Subject|17|||
148825466|NCT00806026|536838473|FG002|Overall Study|Withdrawal by Subject|9|||
148825467|NCT00806026|536838474|FG003|Overall Study|Withdrawal by Subject|2|||
148825468|NCT00806026|536838475|FG004|Overall Study|Withdrawal by Subject|5|||
148825469|NCT00806026|536838476|FG005|Overall Study|Withdrawal by Subject|3|||
148825470|NCT00806026|536838471|FG000|Overall Study|Other|3|||
148825471|NCT00806026|536838472|FG001|Overall Study|Other|6|||
148825472|NCT00806026|536838473|FG002|Overall Study|Other|8|||
148825473|NCT00806026|536838474|FG003|Overall Study|Other|2|||
148825474|NCT00806026|536838475|FG004|Overall Study|Other|0|||
148825475|NCT00806026|536838476|FG005|Overall Study|Other|4|||
148825476|NCT00806026|536838471|FG000|Overall Study|Protocol Violation|6|||
148825477|NCT00806026|536838472|FG001|Overall Study|Protocol Violation|9|||
148825478|NCT00806026|536838473|FG002|Overall Study|Protocol Violation|9|||
148825479|NCT00806026|536838474|FG003|Overall Study|Protocol Violation|0|||
148825480|NCT00806026|536838475|FG004|Overall Study|Protocol Violation|2|||
148825481|NCT00806026|536838476|FG005|Overall Study|Protocol Violation|3|||
148825482|NCT00806026|536838471|FG000|Overall Study|Adverse Event|52|||
148825483|NCT00806026|536838472|FG001|Overall Study|Adverse Event|35|||
148825484|NCT00806026|536838473|FG002|Overall Study|Adverse Event|44|||
148825485|NCT00806026|536838474|FG003|Overall Study|Adverse Event|17|||
148825486|NCT00806026|536838475|FG004|Overall Study|Adverse Event|9|||
148825487|NCT00806026|536838476|FG005|Overall Study|Adverse Event|9|||
148825488|NCT01903733|536838481|FG000|Overall Study|Death|23|||
148825489|NCT01903733|536838482|FG001|Overall Study|Death|54|||
148825490|NCT01903733|536838483|FG002|Overall Study|Death|30|||
148825491|NCT01903733|536838484|FG003|Overall Study|Death|98|||
148825492|NCT01903733|536838481|FG000|Overall Study|Participant refused further follow-up|35|||
148825493|NCT01903733|536838482|FG001|Overall Study|Participant refused further follow-up|38|||
148825494|NCT01903733|536838483|FG002|Overall Study|Participant refused further follow-up|13|||
148825495|NCT01903733|536838484|FG003|Overall Study|Participant refused further follow-up|9|||
148825496|NCT01903733|536838481|FG000|Overall Study|Lost to Follow-up|18|||
148825497|NCT01903733|536838482|FG001|Overall Study|Lost to Follow-up|19|||
148825498|NCT01903733|536838483|FG002|Overall Study|Lost to Follow-up|6|||
148825499|NCT01903733|536838484|FG003|Overall Study|Lost to Follow-up|9|||
149027468|NCT01237678|537578569|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
148825500|NCT01903733|536838481|FG000|Overall Study|Other|10|||
148825501|NCT01903733|536838482|FG001|Overall Study|Other|15|||
148825502|NCT01903733|536838483|FG002|Overall Study|Other|12|||
148825503|NCT01903733|536838484|FG003|Overall Study|Other|3|||
148825504|NCT01903733|536838481|FG000|Overall Study|Missing|2|||
148825505|NCT01903733|536838482|FG001|Overall Study|Missing|0|||
148825506|NCT01903733|536838483|FG002|Overall Study|Missing|0|||
148825507|NCT01903733|536838484|FG003|Overall Study|Missing|0|||
148825508|NCT01903733|536838481|FG000|Overall Study|Investigator request|18|||
148825509|NCT01903733|536838482|FG001|Overall Study|Investigator request|0|||
148825510|NCT01903733|536838483|FG002|Overall Study|Investigator request|0|||
148759565|NCT03525678|536591068|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
148759566|NCT03525678|536591069|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
148759567|NCT03525678|536591070|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
148759568|NCT03525678|536591066|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
148759569|NCT03525678|536591067|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
148759570|NCT03525678|536591068|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
148759571|NCT03525678|536591069|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
148759572|NCT03525678|536591070|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
148759573|NCT03525678|536591066|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
148759574|NCT03525678|536591067|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
148759575|NCT03525678|536591068|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
148759576|NCT03525678|536591069|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
148759577|NCT03525678|536591070|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
148759578|NCT03525678|536591066|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
148759579|NCT03525678|536591067|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
148759580|NCT03525678|536591068|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
148759581|NCT03525678|536591069|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
148759582|NCT03525678|536591070|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
148759583|NCT05086744|536592315|FG000|Part A|Adverse Event|0|||
148759584|NCT05086744|536592316|FG001|Part A|Adverse Event|1|||
148759585|NCT05086744|536592315|FG000|Part A|Lack of Efficacy|3|||
148759586|NCT05086744|536592316|FG001|Part A|Lack of Efficacy|0|||
148759587|NCT05086744|536592315|FG000|Part A|Protocol deviation|1|||
148759588|NCT05086744|536592316|FG001|Part A|Protocol deviation|0|||
148759589|NCT05086744|536592315|FG000|Part A|Subject decision|1|||
148759590|NCT05086744|536592316|FG001|Part A|Subject decision|0|||
148759591|NCT05086744|536592315|FG000|Part B|Adverse Event|0|||
148759592|NCT05086744|536592316|FG001|Part B|Adverse Event|1|||
148759593|NCT05086744|536592315|FG000|Part B|Lack of Efficacy|0|||
148759594|NCT05086744|536592316|FG001|Part B|Lack of Efficacy|1|||
148759595|NCT05086744|536592315|FG000|Part B|Study terminated by sponsor|1|||
148759596|NCT05086744|536592316|FG001|Part B|Study terminated by sponsor|6|||
148759597|NCT03055338|536592319|FG000|Overall Study|Lost to Follow-up|9|||
148759598|NCT03055338|536592320|FG001|Overall Study|Lost to Follow-up|2|||
148759599|NCT03055338|536592321|FG002|Overall Study|Lost to Follow-up|3|||
148759600|NCT03055338|536592319|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
148759601|NCT03055338|536592320|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
148759602|NCT03055338|536592321|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
148759603|NCT03055338|536592319|FG000|Overall Study|Physician Decision|0|||
148759604|NCT03055338|536592320|FG001|Overall Study|Physician Decision|0|||
148759605|NCT03055338|536592321|FG002|Overall Study|Physician Decision|2|||
148759606|NCT03055338|536592319|FG000|Overall Study|Withdrawal by Subject|9|||
148759607|NCT03055338|536592320|FG001|Overall Study|Withdrawal by Subject|8|||
148759608|NCT03055338|536592321|FG002|Overall Study|Withdrawal by Subject|7|||
148759609|NCT01894841|536592327|FG000|Overall Study|Withdrawal by Subject|9|||
148759610|NCT01894841|536592328|FG001|Overall Study|Withdrawal by Subject|4|||
148759611|NCT01894841|536592327|FG000|Overall Study|Withdrawn by investigator|2|||
148759612|NCT01894841|536592328|FG001|Overall Study|Withdrawn by investigator|2|||
148759613|NCT01894841|536592327|FG000|Overall Study|Lost to Follow-up|7|||
148759614|NCT01894841|536592328|FG001|Overall Study|Lost to Follow-up|3|||
148759615|NCT04227197|536592334|FG000|Randomization|Protocol Violation|1|||
148759616|NCT04227197|536592335|FG001|Randomization|Protocol Violation|0|||
148759617|NCT04227197|536592334|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
148759618|NCT04227197|536592335|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
148759619|NCT04227197|536592334|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
148759620|NCT04227197|536592335|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
148759621|NCT04227197|536592334|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
148759622|NCT04227197|536592335|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
148759623|NCT04227197|536592334|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
148759624|NCT04227197|536592335|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
148759625|NCT04227197|536592334|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
148759626|NCT04227197|536592335|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
148759627|NCT04227197|536592334|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
148759628|NCT04227197|536592335|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
148759629|NCT01379768|536592338|FG000|Overall Study|Adverse Event|1|||
148759630|NCT01379768|536592339|FG001|Overall Study|Adverse Event|1|||
148759631|NCT01379768|536592340|FG002|Overall Study|Adverse Event|0|||
148759632|NCT01379768|536592338|FG000|Overall Study|Lost to Follow-up|2|||
148759633|NCT01379768|536592339|FG001|Overall Study|Lost to Follow-up|0|||
148759634|NCT01379768|536592340|FG002|Overall Study|Lost to Follow-up|0|||
148759635|NCT01209949|536592343|FG000|Overall Study|Lost to Follow-up|3|||
148759636|NCT02075203|536592348|FG000|Overall Study|Withdrawal by Subject|1|||
148759637|NCT02075203|536592349|FG001|Overall Study|Withdrawal by Subject|0|||
148759638|NCT02075203|536592350|FG002|Overall Study|Withdrawal by Subject|1|||
148759639|NCT02075203|536592348|FG000|Overall Study|Adverse Event|1|||
148759640|NCT02075203|536592349|FG001|Overall Study|Adverse Event|0|||
148759641|NCT02075203|536592350|FG002|Overall Study|Adverse Event|0|||
148759642|NCT02075203|536592348|FG000|Overall Study|participant refused to use contraception|1|||
148759643|NCT02075203|536592349|FG001|Overall Study|participant refused to use contraception|0|||
148759644|NCT02075203|536592350|FG002|Overall Study|participant refused to use contraception|0|||
148759645|NCT00568451|536592359|FG000|Overall Study|Disease Progression|0|||
148759646|NCT00568451|536592360|FG001|Overall Study|Disease Progression|0|||
148759647|NCT00568451|536592361|FG002|Overall Study|Disease Progression|2|||
148759648|NCT00568451|536592362|FG003|Overall Study|Disease Progression|7|||
148759649|NCT05266053|536592363|FG000|Overall Study|Withdrawal by Subject|8|||
148759650|NCT05266053|536592364|FG001|Overall Study|Withdrawal by Subject|4|||
148759651|NCT05344560|536592365|FG000|Period 1|Subject out of visit window|1|||
148759652|NCT05344560|536592366|FG001|Period 1|Subject out of visit window|1|||
148759653|NCT05344560|536592365|FG000|Period 2|Covid-19 Related|1|||
148759654|NCT05344560|536592366|FG001|Period 2|Covid-19 Related|0|||
148759655|NCT05344560|536592365|FG000|Period 2|Adverse Event|1|||
148759656|NCT05344560|536592366|FG001|Period 2|Adverse Event|0|||
148759657|NCT05344560|536592365|FG000|Period 2|Subject out of visit window|1|||
148759658|NCT05344560|536592366|FG001|Period 2|Subject out of visit window|1|||
148759659|NCT05344560|536592365|FG000|Period 3|Subject out of visit window|1|||
148759660|NCT05344560|536592366|FG001|Period 3|Subject out of visit window|0|||
148759661|NCT02996968|536592367|FG000|Overall Study|Withdrawal by Subject|1|||
148759662|NCT02996968|536592368|FG001|Overall Study|Withdrawal by Subject|0|||
148759663|NCT00391768|536592369|FG000|Overall Study|Withdrawal by Subject|0|||
148759664|NCT00391768|536592370|FG001|Overall Study|Withdrawal by Subject|0|||
148759665|NCT00391768|536592371|FG002|Overall Study|Withdrawal by Subject|1|||
148759666|NCT00391768|536592372|FG003|Overall Study|Withdrawal by Subject|0|||
148759667|NCT00391768|536592373|FG004|Overall Study|Withdrawal by Subject|0|||
148759668|NCT00391768|536592374|FG005|Overall Study|Withdrawal by Subject|1|||
148759669|NCT00391768|536592375|FG006|Overall Study|Withdrawal by Subject|1|||
148759670|NCT00391768|536592369|FG000|Overall Study|Lost to Follow-up|0|||
148759671|NCT00391768|536592370|FG001|Overall Study|Lost to Follow-up|0|||
148759672|NCT00391768|536592371|FG002|Overall Study|Lost to Follow-up|0|||
148759673|NCT00391768|536592372|FG003|Overall Study|Lost to Follow-up|1|||
148759674|NCT00391768|536592373|FG004|Overall Study|Lost to Follow-up|2|||
148759675|NCT00391768|536592374|FG005|Overall Study|Lost to Follow-up|2|||
148759676|NCT00391768|536592375|FG006|Overall Study|Lost to Follow-up|3|||
148759677|NCT03313180|536592376|FG000|Overall Study|Adverse Event|120|||
148759678|NCT03313180|536592376|FG000|Overall Study|Lost to Follow-up|3|||
148759679|NCT03313180|536592376|FG000|Overall Study|Withdrawal by Subject|39|||
148759680|NCT03313180|536592376|FG000|Overall Study|Other than listed above|15|||
148759681|NCT03313180|536592376|FG000|Overall Study|Covid-19 related|2|||
148759682|NCT03376789|536592377|FG000|Overall Study|Withdrawal by Subject|3|||
148759683|NCT03376789|536592378|FG001|Overall Study|Withdrawal by Subject|5|||
148759684|NCT03376789|536592377|FG000|Overall Study|Protocol Violation|0|||
148759685|NCT03376789|536592378|FG001|Overall Study|Protocol Violation|1|||
148759686|NCT03376789|536592377|FG000|Overall Study|Adverse Event|0|||
148759687|NCT03376789|536592378|FG001|Overall Study|Adverse Event|1|||
148759688|NCT03376789|536592377|FG000|Overall Study|Lost to Follow-up|1|||
148759689|NCT03376789|536592378|FG001|Overall Study|Lost to Follow-up|1|||
148759690|NCT03376789|536592377|FG000|Overall Study|Per sponsor due to noncompliance|1|||
148759691|NCT03376789|536592378|FG001|Overall Study|Per sponsor due to noncompliance|0|||
148759692|NCT03376789|536592377|FG000|Overall Study|Subject off study medication|0|||
148759693|NCT03376789|536592378|FG001|Overall Study|Subject off study medication|1|||
148759694|NCT01703260|536592379|FG000|Overall Study|Adverse Event|1|||
148759695|NCT01703260|536592380|FG001|Overall Study|Adverse Event|2|||
148759696|NCT01703260|536592381|FG002|Overall Study|Adverse Event|2|||
148759697|NCT01703260|536592379|FG000|Overall Study|Lost to Follow-up|1|||
148759698|NCT01703260|536592380|FG001|Overall Study|Lost to Follow-up|0|||
148759699|NCT01703260|536592381|FG002|Overall Study|Lost to Follow-up|0|||
148759700|NCT01703260|536592379|FG000|Overall Study|Withdrawal by Subject|0|||
148759701|NCT01703260|536592380|FG001|Overall Study|Withdrawal by Subject|0|||
148759702|NCT01703260|536592381|FG002|Overall Study|Withdrawal by Subject|1|||
148759703|NCT01703260|536592379|FG000|Overall Study|Study Termination|1|||
148759704|NCT01703260|536592380|FG001|Overall Study|Study Termination|2|||
148759705|NCT01703260|536592381|FG002|Overall Study|Study Termination|0|||
148759706|NCT01346059|536592382|FG000|Overall Study|Withdrawal by Subject|1|||
148759707|NCT01346059|536592383|FG001|Overall Study|Withdrawal by Subject|0|||
148759708|NCT01464424|536592384|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
148759709|NCT01464424|536592385|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
148759710|NCT01808066|536592388|FG000|Overall Study|Withdrawal by Subject|15|||
148759711|NCT00745901|536592389|FG000|Overall Study|Adverse Event|3|||
148759712|NCT00745901|536592390|FG001|Overall Study|Adverse Event|4|||
148759713|NCT00745901|536592389|FG000|Overall Study|Protocol Violation|0|||
148759714|NCT00745901|536592390|FG001|Overall Study|Protocol Violation|1|||
148825511|NCT01903733|536838484|FG003|Overall Study|Investigator request|0|||
148825512|NCT01714063|536838485|FG000|Overall Study|Equipment malfunction|2|||
148825513|NCT03878602|536838486|FG000|Overall Study|cord blood donation|7|||
148825514|NCT03878602|536838487|FG001|Overall Study|cord blood donation|1|||
148825515|NCT03878602|536838486|FG000|Overall Study|incomplete data collection|2|||
148825516|NCT03878602|536838487|FG001|Overall Study|incomplete data collection|0|||
148825517|NCT02191397|536838489|FG000|Overall Study|Adverse Event|28|||
148825518|NCT02191397|536838490|FG001|Overall Study|Adverse Event|17|||
148825519|NCT02191397|536838489|FG000|Overall Study|Lack of Efficacy|10|||
148825520|NCT02191397|536838490|FG001|Overall Study|Lack of Efficacy|5|||
148825521|NCT02191397|536838489|FG000|Overall Study|Protocol Violation|0|||
148825522|NCT02191397|536838490|FG001|Overall Study|Protocol Violation|3|||
148825523|NCT02191397|536838489|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
148825524|NCT02191397|536838490|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
148825525|NCT02191397|536838489|FG000|Overall Study|Lost to Follow-up|10|||
148825526|NCT02191397|536838490|FG001|Overall Study|Lost to Follow-up|11|||
148825527|NCT02191397|536838489|FG000|Overall Study|Physician Decision|8|||
148825528|NCT02191397|536838490|FG001|Overall Study|Physician Decision|3|||
148825529|NCT02191397|536838489|FG000|Overall Study|Withdrawal by Subject|22|||
148825530|NCT02191397|536838490|FG001|Overall Study|Withdrawal by Subject|27|||
148825531|NCT02176525|536838492|FG000|Overall Study|Adverse Event|0|||
148825532|NCT02176525|536838493|FG001|Overall Study|Adverse Event|0|||
148825533|NCT02176525|536838494|FG002|Overall Study|Adverse Event|0|||
148825534|NCT02176525|536838495|FG003|Overall Study|Adverse Event|1|||
148825535|NCT02176525|536838496|FG004|Overall Study|Adverse Event|1|||
148825536|NCT02176525|536838497|FG005|Overall Study|Adverse Event|0|||
148825537|NCT02176525|536838498|FG006|Overall Study|Adverse Event|1|||
148825538|NCT02176525|536838499|FG007|Overall Study|Adverse Event|0|||
148825539|NCT02176525|536838492|FG000|Overall Study|not treated|1|||
148825540|NCT02176525|536838493|FG001|Overall Study|not treated|0|||
148825541|NCT02176525|536838494|FG002|Overall Study|not treated|0|||
148825542|NCT02176525|536838495|FG003|Overall Study|not treated|0|||
148825543|NCT02176525|536838496|FG004|Overall Study|not treated|0|||
148825544|NCT02176525|536838497|FG005|Overall Study|not treated|1|||
148825545|NCT02176525|536838498|FG006|Overall Study|not treated|0|||
148825546|NCT02176525|536838499|FG007|Overall Study|not treated|0|||
148825547|NCT00478140|536838500|FG000|Overall Study|Clinical Disease Progression|1|||
148825548|NCT02971137|536838501|FG000|Overall Study|Lost to Follow-up|44|||
148825549|NCT02971137|536838502|FG001|Overall Study|Lost to Follow-up|56|||
148825550|NCT02614066|536838506|FG000|Overall Study|Death|6|||
148825551|NCT02614066|536838507|FG001|Overall Study|Death|14|||
148825552|NCT02614066|536838508|FG002|Overall Study|Death|11|||
148825553|NCT02614066|536838509|FG003|Overall Study|Death|29|||
148825554|NCT02614066|536838506|FG000|Overall Study|Full consent withdrawn|0|||
148825555|NCT02614066|536838507|FG001|Overall Study|Full consent withdrawn|1|||
148825556|NCT02614066|536838508|FG002|Overall Study|Full consent withdrawn|0|||
148825557|NCT02614066|536838509|FG003|Overall Study|Full consent withdrawn|8|||
148825558|NCT02614066|536838506|FG000|Overall Study|Lost to Follow-up|0|||
148976907|NCT01513291|537396512|FG000|Treatment Period|Protocol Violation|1|||
148976908|NCT01513291|537396513|FG001|Treatment Period|Protocol Violation|2|||
148976909|NCT01513291|537396514|FG002|Treatment Period|Protocol Violation|0|||
148976910|NCT01513291|537396515|FG003|Treatment Period|Protocol Violation|0|||
148976911|NCT01513291|537396516|FG004|Treatment Period|Protocol Violation|0|||
148976912|NCT01513291|537396512|FG000|Treatment Period|Withdrawal by Subject|8|||
148976913|NCT01513291|537396513|FG001|Treatment Period|Withdrawal by Subject|5|||
148976914|NCT01513291|537396514|FG002|Treatment Period|Withdrawal by Subject|0|||
148976915|NCT01513291|537396515|FG003|Treatment Period|Withdrawal by Subject|0|||
148976916|NCT01513291|537396516|FG004|Treatment Period|Withdrawal by Subject|0|||
148976917|NCT01513291|537396512|FG000|Treatment Period|Randomized not treated|0|||
148976918|NCT01513291|537396513|FG001|Treatment Period|Randomized not treated|2|||
148976919|NCT01513291|537396514|FG002|Treatment Period|Randomized not treated|0|||
148976920|NCT01513291|537396515|FG003|Treatment Period|Randomized not treated|0|||
148976921|NCT01513291|537396516|FG004|Treatment Period|Randomized not treated|0|||
148976922|NCT01513291|537396512|FG000|Run-out Period|Lost to Follow-up|0|||
148976923|NCT01513291|537396513|FG001|Run-out Period|Lost to Follow-up|0|||
148976924|NCT01513291|537396514|FG002|Run-out Period|Lost to Follow-up|0|||
148976925|NCT01513291|537396515|FG003|Run-out Period|Lost to Follow-up|1|||
148976926|NCT01513291|537396516|FG004|Run-out Period|Lost to Follow-up|0|||
148825559|NCT02614066|536838507|FG001|Overall Study|Lost to Follow-up|2|||
148825560|NCT02614066|536838508|FG002|Overall Study|Lost to Follow-up|2|||
148976927|NCT01513291|537396512|FG000|Run-out Period|Withdrawal by Subject|0|||
148976928|NCT01513291|537396513|FG001|Run-out Period|Withdrawal by Subject|0|||
148825561|NCT02614066|536838509|FG003|Overall Study|Lost to Follow-up|2|||
148825562|NCT02614066|536838506|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
148825563|NCT02614066|536838507|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
148825564|NCT02614066|536838508|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
148825565|NCT02614066|536838509|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
148976929|NCT01513291|537396514|FG002|Run-out Period|Withdrawal by Subject|0|||
148759715|NCT00745901|536592389|FG000|Overall Study|Withdrawal by Subject|1|||
148759716|NCT00745901|536592390|FG001|Overall Study|Withdrawal by Subject|0|||
148759717|NCT00745901|536592389|FG000|Overall Study|Lost to Follow-up|7|||
148759718|NCT00745901|536592390|FG001|Overall Study|Lost to Follow-up|4|||
148759719|NCT00745901|536592389|FG000|Overall Study|Pregnancy|2|||
148759720|NCT00745901|536592390|FG001|Overall Study|Pregnancy|4|||
148759721|NCT00745901|536592389|FG000|Overall Study|Lack of compliance|2|||
148759722|NCT00745901|536592390|FG001|Overall Study|Lack of compliance|2|||
148759723|NCT00745901|536592389|FG000|Overall Study|Patient's next menses did not start with|1|||
148759724|NCT00745901|536592390|FG001|Overall Study|Patient's next menses did not start with|0|||
148759725|NCT00745901|536592389|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
148759726|NCT00745901|536592390|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
148759727|NCT00745901|536592389|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
148759728|NCT00745901|536592390|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
148759729|NCT00745901|536592389|FG000|Overall Study|Patient didn't take any study medication|7|||
148759730|NCT00745901|536592390|FG001|Overall Study|Patient didn't take any study medication|3|||
148759731|NCT00884117|536592393|FG000|Overall Study|Adverse Event|2|||
148759732|NCT00884117|536592393|FG000|Overall Study|Withdrawal by Subject|89|||
148759733|NCT00884117|536592393|FG000|Overall Study|Death|3|||
148759734|NCT00884117|536592393|FG000|Overall Study|Lost to Follow-up|143|||
148759735|NCT00884117|536592393|FG000|Overall Study|Other|12|||
148759736|NCT01383174|536592396|FG000|3 Month Assessment|Death|0|||
148759737|NCT01383174|536592397|FG001|3 Month Assessment|Death|1|||
148759738|NCT01383174|536592396|FG000|3 Month Assessment|Lost to Follow-up|2|||
148759739|NCT01383174|536592397|FG001|3 Month Assessment|Lost to Follow-up|0|||
148759740|NCT01383174|536592396|FG000|3 Month Assessment|Refused to complete|4|||
148759741|NCT01383174|536592397|FG001|3 Month Assessment|Refused to complete|0|||
148759742|NCT01383174|536592396|FG000|6 Month Assessment|Lost to Follow-up|1|||
148759743|NCT01383174|536592397|FG001|6 Month Assessment|Lost to Follow-up|1|||
148759744|NCT01383174|536592396|FG000|6 Month Assessment|Refused to complete|4|||
148759745|NCT01383174|536592397|FG001|6 Month Assessment|Refused to complete|0|||
148759746|NCT01153815|536592398|FG000|Overall Study|Adverse Event|3|||
148759747|NCT01153815|536592399|FG001|Overall Study|Adverse Event|1|||
148759748|NCT01153815|536592398|FG000|Overall Study|Withdrawal by Subject|6|||
148759749|NCT01153815|536592399|FG001|Overall Study|Withdrawal by Subject|4|||
148759750|NCT01786993|536592402|FG000|Overall Study|Death|6|||
148759751|NCT01786993|536592403|FG001|Overall Study|Death|7|||
148759752|NCT01786993|536592402|FG000|Overall Study|Withdrawal by Subject|3|||
148759753|NCT01786993|536592403|FG001|Overall Study|Withdrawal by Subject|2|||
148759754|NCT01786993|536592402|FG000|Overall Study|Lost to Follow-up|0|||
148759755|NCT01786993|536592403|FG001|Overall Study|Lost to Follow-up|1|||
148759756|NCT01786993|536592402|FG000|Overall Study|Subject Non-Compliance|1|||
148759757|NCT01786993|536592403|FG001|Overall Study|Subject Non-Compliance|0|||
148759758|NCT01786993|536592402|FG000|Overall Study|System Explant|1|||
148759759|NCT01786993|536592403|FG001|Overall Study|System Explant|0|||
148759760|NCT01786993|536592402|FG000|Overall Study|Hospice Admission|1|||
148759761|NCT01786993|536592403|FG001|Overall Study|Hospice Admission|0|||
148759762|NCT00450437|536592404|FG000|Overall Study|Withdrawal by Subject|10|||
148759763|NCT00450437|536592405|FG001|Overall Study|Withdrawal by Subject|2|||
148759764|NCT00450437|536592406|FG002|Overall Study|Withdrawal by Subject|0|||
148759765|NCT00450437|536592407|FG003|Overall Study|Withdrawal by Subject|1|||
148759766|NCT00450437|536592404|FG000|Overall Study|Lost to Follow-up|31|||
148759767|NCT00450437|536592405|FG001|Overall Study|Lost to Follow-up|12|||
148759768|NCT00450437|536592406|FG002|Overall Study|Lost to Follow-up|19|||
148759769|NCT00450437|536592407|FG003|Overall Study|Lost to Follow-up|9|||
148759770|NCT00450437|536592404|FG000|Overall Study|Protocol Violation|0|||
148759771|NCT00450437|536592405|FG001|Overall Study|Protocol Violation|1|||
148759772|NCT00450437|536592406|FG002|Overall Study|Protocol Violation|0|||
148759773|NCT00450437|536592407|FG003|Overall Study|Protocol Violation|1|||
148759774|NCT00450437|536592404|FG000|Overall Study|Inappropriate enrollment|4|||
148759775|NCT00450437|536592405|FG001|Overall Study|Inappropriate enrollment|1|||
148759776|NCT00450437|536592406|FG002|Overall Study|Inappropriate enrollment|3|||
148759777|NCT00450437|536592407|FG003|Overall Study|Inappropriate enrollment|0|||
148759778|NCT00450437|536592404|FG000|Overall Study|Administrative reason|0|||
148825566|NCT02614066|536838506|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
148825567|NCT02614066|536838507|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
148759779|NCT00450437|536592405|FG001|Overall Study|Administrative reason|0|||
148759780|NCT00450437|536592406|FG002|Overall Study|Administrative reason|1|||
148976930|NCT01513291|537396515|FG003|Run-out Period|Withdrawal by Subject|1|||
148759781|NCT00450437|536592407|FG003|Overall Study|Administrative reason|0|||
148759782|NCT00450437|536592404|FG000|Overall Study|Unable to Classify|1|||
148759783|NCT00450437|536592405|FG001|Overall Study|Unable to Classify|0|||
148759784|NCT00450437|536592406|FG002|Overall Study|Unable to Classify|1|||
148759785|NCT00450437|536592407|FG003|Overall Study|Unable to Classify|0|||
148759786|NCT01890122|536592408|FG000|Overall Study|Adverse Event|1|||
148759787|NCT01890122|536592409|FG001|Overall Study|Adverse Event|1|||
148976931|NCT01513291|537396516|FG004|Run-out Period|Withdrawal by Subject|0|||
148976932|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
148976933|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
148976934|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
148976935|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
148976936|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
148976937|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
148976938|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
148976939|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
148976940|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
148976941|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
148976942|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
148976943|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
148976944|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
148976945|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
148976946|NCT03732638|537396517|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
148976947|NCT03732638|537396518|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
148976948|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
148976949|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
148976950|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
148976951|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
148759788|NCT01890122|536592410|FG002|Overall Study|Adverse Event|1|||
148759789|NCT01890122|536592411|FG003|Overall Study|Adverse Event|2|||
148759790|NCT01890122|536592408|FG000|Overall Study|Major Protocol Deviation|3|||
148759791|NCT01890122|536592409|FG001|Overall Study|Major Protocol Deviation|1|||
148759792|NCT01890122|536592410|FG002|Overall Study|Major Protocol Deviation|0|||
148759793|NCT01890122|536592411|FG003|Overall Study|Major Protocol Deviation|1|||
148759794|NCT01890122|536592408|FG000|Overall Study|Lost to Follow-up|0|||
148759795|NCT01890122|536592409|FG001|Overall Study|Lost to Follow-up|1|||
148759796|NCT01890122|536592410|FG002|Overall Study|Lost to Follow-up|2|||
148759797|NCT01890122|536592411|FG003|Overall Study|Lost to Follow-up|2|||
148759798|NCT01890122|536592408|FG000|Overall Study|Voluntary Withdrawal|8|||
148759799|NCT01890122|536592409|FG001|Overall Study|Voluntary Withdrawal|8|||
148759800|NCT01890122|536592410|FG002|Overall Study|Voluntary Withdrawal|2|||
148759801|NCT01890122|536592411|FG003|Overall Study|Voluntary Withdrawal|11|||
148759802|NCT01890122|536592408|FG000|Overall Study|Lack of Efficacy|14|||
148759803|NCT01890122|536592409|FG001|Overall Study|Lack of Efficacy|24|||
148759804|NCT01890122|536592410|FG002|Overall Study|Lack of Efficacy|7|||
148759805|NCT01890122|536592411|FG003|Overall Study|Lack of Efficacy|41|||
148759806|NCT01890122|536592408|FG000|Overall Study|Reason not Specified|0|||
148759807|NCT01890122|536592409|FG001|Overall Study|Reason not Specified|1|||
148759808|NCT01890122|536592410|FG002|Overall Study|Reason not Specified|1|||
148759809|NCT01890122|536592411|FG003|Overall Study|Reason not Specified|2|||
148759810|NCT01890122|536592408|FG000|Overall Study|Randomized but not Treated|1|||
148759811|NCT01890122|536592409|FG001|Overall Study|Randomized but not Treated|1|||
148759812|NCT01890122|536592410|FG002|Overall Study|Randomized but not Treated|0|||
148759813|NCT01890122|536592411|FG003|Overall Study|Randomized but not Treated|0|||
148759814|NCT01565889|536592412|FG000|Part A|Withdrawal by Subject|1|||
148759815|NCT01565889|536592413|FG001|Part A|Withdrawal by Subject|0|||
148759816|NCT01565889|536592414|FG002|Part A|Withdrawal by Subject|0|||
148759817|NCT01565889|536592415|FG003|Part A|Withdrawal by Subject|0|||
148759818|NCT01565889|536592416|FG004|Part A|Withdrawal by Subject|0|||
148759819|NCT01565889|536592417|FG005|Part A|Withdrawal by Subject|0|||
148759820|NCT01565889|536592412|FG000|Part B|Withdrawal by Subject|0|||
148759821|NCT01565889|536592413|FG001|Part B|Withdrawal by Subject|0|||
148759822|NCT01565889|536592414|FG002|Part B|Withdrawal by Subject|0|||
148759823|NCT01565889|536592415|FG003|Part B|Withdrawal by Subject|0|||
148759824|NCT01565889|536592416|FG004|Part B|Withdrawal by Subject|0|||
148759825|NCT01565889|536592417|FG005|Part B|Withdrawal by Subject|1|||
148759826|NCT01565889|536592412|FG000|Part B|Lack of Efficacy|0|||
148759827|NCT01565889|536592413|FG001|Part B|Lack of Efficacy|0|||
148759828|NCT01565889|536592414|FG002|Part B|Lack of Efficacy|0|||
148759829|NCT01565889|536592415|FG003|Part B|Lack of Efficacy|0|||
148759830|NCT01565889|536592416|FG004|Part B|Lack of Efficacy|0|||
148759831|NCT01565889|536592417|FG005|Part B|Lack of Efficacy|2|||
148759832|NCT01565889|536592412|FG000|Part B|Lost to Follow-up|0|||
148759833|NCT01565889|536592413|FG001|Part B|Lost to Follow-up|0|||
148759834|NCT01565889|536592414|FG002|Part B|Lost to Follow-up|0|||
148759835|NCT01565889|536592415|FG003|Part B|Lost to Follow-up|0|||
148759836|NCT01565889|536592416|FG004|Part B|Lost to Follow-up|0|||
148976952|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
148759837|NCT01565889|536592417|FG005|Part B|Lost to Follow-up|1|||
148759838|NCT03591874|536592418|FG000|Overall Study|Adverse Event|4|||
148759839|NCT03591874|536592419|FG001|Overall Study|Adverse Event|0|||
148759840|NCT03591874|536592418|FG000|Overall Study|Withdrawal by Subject|2|||
148759841|NCT03591874|536592419|FG001|Overall Study|Withdrawal by Subject|1|||
148976953|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
148976954|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
148976955|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
148976956|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
148976957|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
148976958|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
148976959|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
148976960|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
148976961|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
148976962|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
148976963|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
148976964|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
148976965|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
148976966|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
148976967|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
148976968|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
148976969|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
148976970|NCT03732638|537396517|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
148976971|NCT03732638|537396518|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
148976972|NCT03732638|537396517|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
148976973|NCT03732638|537396518|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
148976974|NCT03732638|537396517|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
148976975|NCT03732638|537396518|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
148976976|NCT03732638|537396517|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
148976977|NCT03732638|537396518|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
148976978|NCT03732638|537396517|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
148976979|NCT03732638|537396518|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
148976980|NCT01358981|537396519|FG000|Period 1|Withdrawal by Subject|0|||
148976981|NCT01358981|537396520|FG001|Period 1|Withdrawal by Subject|0|||
148976982|NCT01358981|537396521|FG002|Period 1|Withdrawal by Subject|0|||
148976983|NCT01358981|537396522|FG003|Period 1|Withdrawal by Subject|1|||
148976984|NCT01358981|537396523|FG004|Period 1|Withdrawal by Subject|0|||
148976985|NCT01358981|537396524|FG005|Period 1|Withdrawal by Subject|0|||
148976986|NCT01358981|537396525|FG006|Period 1|Withdrawal by Subject|0|||
148976987|NCT03728582|537396526|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
148976988|NCT03728582|537396527|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
148976989|NCT03728582|537396526|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
148976990|NCT03728582|537396527|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
148976991|NCT02732847|537396528|FG000|Overall Study|some filled early|42|||
148976992|NCT02732847|537396529|FG001|Overall Study|some filled early|42|||
148976993|NCT02738775|537396530|FG000|Overall Study|Withdrawal by Subject|0|||
148976994|NCT02738775|537396531|FG001|Overall Study|Withdrawal by Subject|1|||
148976995|NCT02738775|537396532|FG002|Overall Study|Withdrawal by Subject|0|||
148976996|NCT02738775|537396533|FG003|Overall Study|Withdrawal by Subject|0|||
148976997|NCT02738775|537396534|FG004|Overall Study|Withdrawal by Subject|0|||
148976998|NCT02738775|537396535|FG005|Overall Study|Withdrawal by Subject|0|||
148976999|NCT02738775|537396530|FG000|Overall Study|Adverse Event|0|||
148977000|NCT02738775|537396531|FG001|Overall Study|Adverse Event|0|||
148759842|NCT03591874|536592418|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
148759843|NCT03591874|536592419|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
148759844|NCT03591874|536592418|FG000|Overall Study|On Study at Time of Study Termination|12|||
148759845|NCT03591874|536592419|FG001|Overall Study|On Study at Time of Study Termination|6|||
148759846|NCT00071110|536592422|FG000|Overall Study|Protocol Violation|0|||
148759847|NCT00071110|536592423|FG001|Overall Study|Protocol Violation|4|||
148759848|NCT02166333|536592425|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
148759849|NCT02166333|536592426|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
148759850|NCT02166333|536592427|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
148759851|NCT02166333|536592428|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
148759852|NCT02166333|536592429|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
148977001|NCT02738775|537396532|FG002|Overall Study|Adverse Event|0|||
148977002|NCT02738775|537396533|FG003|Overall Study|Adverse Event|1|||
148977003|NCT02738775|537396534|FG004|Overall Study|Adverse Event|0|||
148977004|NCT02738775|537396535|FG005|Overall Study|Adverse Event|0|||
148977005|NCT02738775|537396530|FG000|Overall Study|Pregnancy|0|||
148977006|NCT02738775|537396531|FG001|Overall Study|Pregnancy|1|||
148977007|NCT02738775|537396532|FG002|Overall Study|Pregnancy|0|||
148977008|NCT02738775|537396533|FG003|Overall Study|Pregnancy|0|||
148977009|NCT02738775|537396534|FG004|Overall Study|Pregnancy|0|||
148977010|NCT02738775|537396535|FG005|Overall Study|Pregnancy|0|||
148977011|NCT02738775|537396530|FG000|Overall Study|Missing|0|||
148977012|NCT02738775|537396531|FG001|Overall Study|Missing|0|||
148977013|NCT02738775|537396532|FG002|Overall Study|Missing|0|||
148977014|NCT02738775|537396533|FG003|Overall Study|Missing|0|||
148977015|NCT02738775|537396534|FG004|Overall Study|Missing|0|||
148977016|NCT02738775|537396535|FG005|Overall Study|Missing|1|||
148977017|NCT01018264|537396536|FG000|Overall Study|Withdrawal by Subject|1|||
148977018|NCT01018264|537396537|FG001|Overall Study|Withdrawal by Subject|0|||
148977019|NCT01018264|537396536|FG000|Overall Study|Lost to Follow-up|0|||
148759853|NCT02166333|536592430|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
148759854|NCT02166333|536592425|FG000|Stage 1|Death|4|||
148759855|NCT02166333|536592426|FG001|Stage 1|Death|0|||
148759856|NCT02166333|536592427|FG002|Stage 1|Death|2|||
148759857|NCT02166333|536592428|FG003|Stage 1|Death|0|||
148759858|NCT02166333|536592429|FG004|Stage 1|Death|3|||
148759859|NCT02166333|536592430|FG005|Stage 1|Death|2|||
148759860|NCT02166333|536592425|FG000|Stage 1|Lost to Follow-up|12|||
148759861|NCT02166333|536592426|FG001|Stage 1|Lost to Follow-up|0|||
148759862|NCT02166333|536592427|FG002|Stage 1|Lost to Follow-up|6|||
148759863|NCT02166333|536592428|FG003|Stage 1|Lost to Follow-up|0|||
148759864|NCT02166333|536592429|FG004|Stage 1|Lost to Follow-up|3|||
148759865|NCT02166333|536592430|FG005|Stage 1|Lost to Follow-up|3|||
148759866|NCT02166333|536592425|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
148759867|NCT02166333|536592426|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
148759868|NCT02166333|536592427|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
148759869|NCT02166333|536592428|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
148759870|NCT02166333|536592429|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
148759871|NCT02166333|536592430|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
148759872|NCT02166333|536592425|FG000|Stage 2|Death|4|||
148759873|NCT02166333|536592426|FG001|Stage 2|Death|2|||
148759874|NCT02166333|536592427|FG002|Stage 2|Death|1|||
148759875|NCT02166333|536592428|FG003|Stage 2|Death|0|||
148759876|NCT02166333|536592429|FG004|Stage 2|Death|0|||
148759877|NCT02166333|536592430|FG005|Stage 2|Death|1|||
148759878|NCT02166333|536592425|FG000|Stage 2|Lost to Follow-up|23|||
148759879|NCT02166333|536592426|FG001|Stage 2|Lost to Follow-up|4|||
148759880|NCT02166333|536592427|FG002|Stage 2|Lost to Follow-up|11|||
148759881|NCT02166333|536592428|FG003|Stage 2|Lost to Follow-up|9|||
148759882|NCT02166333|536592429|FG004|Stage 2|Lost to Follow-up|3|||
148759883|NCT02166333|536592430|FG005|Stage 2|Lost to Follow-up|6|||
148759884|NCT00503698|536592431|FG000|Overall Study|Protocol Violation|5|||
148759885|NCT00503698|536592432|FG001|Overall Study|Protocol Violation|6|||
148759886|NCT00503698|536592431|FG000|Overall Study|Adverse Event|52|||
148759887|NCT00503698|536592432|FG001|Overall Study|Adverse Event|41|||
148759888|NCT00503698|536592431|FG000|Overall Study|Death|1|||
148759889|NCT00503698|536592432|FG001|Overall Study|Death|0|||
148759890|NCT00503698|536592431|FG000|Overall Study|Lack of Efficacy|3|||
148759891|NCT00503698|536592432|FG001|Overall Study|Lack of Efficacy|4|||
148759892|NCT00503698|536592431|FG000|Overall Study|Trial terminated|216|||
148759893|NCT00503698|536592432|FG001|Overall Study|Trial terminated|253|||
148759894|NCT00503698|536592431|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
148759895|NCT00503698|536592432|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
148759896|NCT00503698|536592431|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
148759897|NCT00503698|536592432|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
148759898|NCT00503698|536592431|FG000|Overall Study|Any condition in exclusion criteria|4|||
148759899|NCT00503698|536592432|FG001|Overall Study|Any condition in exclusion criteria|6|||
148759900|NCT00503698|536592431|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
148759901|NCT00503698|536592432|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
148759902|NCT00503698|536592431|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
148759903|NCT00503698|536592432|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
148759904|NCT00503698|536592431|FG000|Overall Study|Critically ill|2|||
148759905|NCT00503698|536592432|FG001|Overall Study|Critically ill|0|||
148759906|NCT00503698|536592431|FG000|Overall Study|Unclassified|48|||
148759907|NCT00503698|536592432|FG001|Overall Study|Unclassified|32|||
148759908|NCT00503698|536592431|FG000|Overall Study|Not exposed to trial drug|11|||
148759909|NCT00503698|536592432|FG001|Overall Study|Not exposed to trial drug|6|||
148759910|NCT02269098|536592433|FG000|Overall Study|Lost to Follow-up|14|||
148759911|NCT02269098|536592434|FG001|Overall Study|Lost to Follow-up|9|||
148759912|NCT01445730|536592443|FG000|Overall Study|Adverse Event|1|||
148759913|NCT01445730|536592443|FG000|Overall Study|For the advice of a dentist|1|||
148759914|NCT01445730|536592443|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
148977020|NCT01018264|537396537|FG001|Overall Study|Lost to Follow-up|1|||
148977021|NCT01785524|537396538|FG000|Overall Study|Withdrawal by Subject|2|||
148977022|NCT01785524|537396539|FG001|Overall Study|Withdrawal by Subject|2|||
148977023|NCT01060384|537396540|FG000|Overall Study|Withdrawal by Subject|0|||
148759915|NCT01167140|536592446|FG000|Overall Study|Withdrawal by Subject|1|||
148759916|NCT03805412|536592447|FG000|Overall Study|Lost to Follow-up|0|||
148759917|NCT03805412|536592448|FG001|Overall Study|Lost to Follow-up|1|||
148759918|NCT00030901|536592449|FG000|Initial Registration|Ineligible|167|||
148759919|NCT00030901|536592450|FG001|Initial Registration|Ineligible|0|||
148825568|NCT02614066|536838508|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
148825569|NCT02614066|536838509|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
148825570|NCT02614066|536838506|FG000|Overall Study|Reason not specified|0|||
148825571|NCT02614066|536838507|FG001|Overall Study|Reason not specified|2|||
148825572|NCT02614066|536838508|FG002|Overall Study|Reason not specified|1|||
148825573|NCT02614066|536838509|FG003|Overall Study|Reason not specified|1|||
148825574|NCT00127933|536838518|FG000|Overall Study|Randomized but not dosed|1|||
148825575|NCT00127933|536838519|FG001|Overall Study|Randomized but not dosed|0|||
148825576|NCT01783938|536838525|FG000|Overall Study|Disease Progression|18|||
148825577|NCT01783938|536838526|FG001|Overall Study|Disease Progression|41|||
148825578|NCT01783938|536838525|FG000|Overall Study|Study Drug Toxicity|27|||
148825579|NCT01783938|536838526|FG001|Overall Study|Study Drug Toxicity|14|||
148759920|NCT00030901|536592451|FG002|Initial Registration|Ineligible|0|||
148759921|NCT00030901|536592449|FG000|Randomization|Adverse Event|0|||
148759922|NCT00030901|536592450|FG001|Randomization|Adverse Event|11|||
148759923|NCT00030901|536592451|FG002|Randomization|Adverse Event|7|||
148759924|NCT00030901|536592449|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
148759925|NCT00030901|536592450|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
148759926|NCT00030901|536592451|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
148759927|NCT00030901|536592449|FG000|Randomization|Progression/Relapse|0|||
148759928|NCT00030901|536592450|FG001|Randomization|Progression/Relapse|22|||
148759929|NCT00030901|536592451|FG002|Randomization|Progression/Relapse|21|||
148759930|NCT00030901|536592449|FG000|Randomization|Death|0|||
148759931|NCT00030901|536592450|FG001|Randomization|Death|1|||
148759932|NCT00030901|536592451|FG002|Randomization|Death|3|||
148759933|NCT00030901|536592449|FG000|Randomization|Other|0|||
148759934|NCT00030901|536592450|FG001|Randomization|Other|36|||
148759935|NCT00030901|536592451|FG002|Randomization|Other|33|||
148759936|NCT00030901|536592449|FG000|Randomization|Ineligible|0|||
148759937|NCT00030901|536592450|FG001|Randomization|Ineligible|15|||
148759938|NCT00030901|536592451|FG002|Randomization|Ineligible|14|||
148759939|NCT02576847|536592452|FG000|Overall Study|Adverse Event|27|||
148759940|NCT02576847|536592452|FG000|Overall Study|Lost to Follow-up|22|||
148759941|NCT02576847|536592452|FG000|Overall Study|Physician Decision|1|||
148759942|NCT02576847|536592452|FG000|Overall Study|Pregnancy|1|||
148759943|NCT02576847|536592452|FG000|Overall Study|Protocol Violation|3|||
148759944|NCT02576847|536592452|FG000|Overall Study|Withdrawal by Subject|78|||
148759945|NCT02576847|536592452|FG000|Overall Study|Other|5|||
148759946|NCT01806051|536592453|FG000|Overall Study|Withdrawal by Subject|6|||
148759947|NCT05966584|536592460|FG000|Overall Study|Lost to Follow-up|1|||
148759948|NCT04955691|536594266|FG000|Period 2|Discontinued intervention|1|||
148759949|NCT04955691|536594267|FG001|Period 2|Discontinued intervention|2|||
148759950|NCT05795153|536594268|FG000|Overall Study|Adverse Event|2|||
148759951|NCT05795153|536594268|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148759952|NCT05795153|536594268|FG000|Overall Study|Lost to Follow-up|1|||
148759953|NCT05795153|536594268|FG000|Overall Study|Subject decision|2|||
148759954|NCT03760744|536594269|FG000|Overall Study|Lost to Follow-up|3|||
148759955|NCT03760744|536594270|FG001|Overall Study|Lost to Follow-up|0|||
148759956|NCT03668119|536594271|FG000|Pre-treatment|Disease Progression|1|||
148759957|NCT03668119|536594272|FG001|Pre-treatment|Disease Progression|0|||
148759958|NCT03668119|536594271|FG000|Treatment|Disease Progression|76|||
148759959|NCT03668119|536594272|FG001|Treatment|Disease Progression|57|||
148759960|NCT03668119|536594271|FG000|Treatment|Study drug toxicity|19|||
148759961|NCT03668119|536594272|FG001|Treatment|Study drug toxicity|1|||
148759962|NCT03668119|536594271|FG000|Treatment|Death|3|||
148759963|NCT03668119|536594272|FG001|Treatment|Death|0|||
148759964|NCT03668119|536594271|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
148759965|NCT03668119|536594272|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
148759966|NCT03668119|536594271|FG000|Treatment|Withdrawal by Subject|1|||
148825580|NCT01783938|536838525|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
148759967|NCT03668119|536594272|FG001|Treatment|Withdrawal by Subject|1|||
148759968|NCT03668119|536594271|FG000|Treatment|Participant request to discontinue study treatment|3|||
148759969|NCT03668119|536594272|FG001|Treatment|Participant request to discontinue study treatment|1|||
148759970|NCT03668119|536594271|FG000|Treatment|Maximum Clinical Benefit|0|||
148759971|NCT03668119|536594272|FG001|Treatment|Maximum Clinical Benefit|1|||
148759972|NCT03668119|536594271|FG000|Treatment|Participants completed treatment|27|||
148759973|NCT03668119|536594272|FG001|Treatment|Participants completed treatment|11|||
148759974|NCT03668119|536594271|FG000|Treatment|Other reasons|2|||
148759975|NCT03668119|536594272|FG001|Treatment|Other reasons|1|||
148759976|NCT03769168|536594273|FG000|Overall Study|Adverse Event|0|||
148759977|NCT03769168|536594274|FG001|Overall Study|Adverse Event|1|||
148759978|NCT03769168|536594273|FG000|Overall Study|Lack of Efficacy|2|||
148759979|NCT03769168|536594274|FG001|Overall Study|Lack of Efficacy|4|||
148759980|NCT03769168|536594273|FG000|Overall Study|Post study access to treatment|3|||
148759981|NCT03769168|536594274|FG001|Overall Study|Post study access to treatment|11|||
148759982|NCT03769168|536594273|FG000|Overall Study|Physician Decision|1|||
148825581|NCT01783938|536838526|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
148825582|NCT01783938|536838525|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
148825583|NCT01783938|536838526|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
148825584|NCT01783938|536838525|FG000|Overall Study|Participant Withdrew Consent|2|||
148825585|NCT01783938|536838526|FG001|Overall Study|Participant Withdrew Consent|0|||
148825586|NCT01783938|536838525|FG000|Overall Study|Maximum Clinical Benefit|1|||
148825587|NCT01783938|536838526|FG001|Overall Study|Maximum Clinical Benefit|0|||
148825588|NCT01783938|536838525|FG000|Overall Study|Other Reasons|3|||
148825589|NCT01783938|536838526|FG001|Overall Study|Other Reasons|1|||
148825590|NCT00498485|536838527|FG000|Overall Study|Adverse Event|1|||
148825591|NCT00498485|536838528|FG001|Overall Study|Adverse Event|5|||
148825592|NCT03072875|536838529|FG000|Overall Study|Lost to Follow-up|1|||
148825593|NCT03111732|536838530|FG000|Overall Study|Enrolled in different study|1|||
148825594|NCT03111732|536838530|FG000|Overall Study|Progressive disease|3|||
148825595|NCT03111732|536838530|FG000|Overall Study|Withdrawal by Subject|1|||
148825596|NCT00401830|536838534|FG000|Overall Study|Adverse Event|10|||
148825597|NCT00401830|536838535|FG001|Overall Study|Adverse Event|18|||
148825598|NCT00401830|536838534|FG000|Overall Study|Lack of Efficacy|11|||
148825599|NCT00401830|536838535|FG001|Overall Study|Lack of Efficacy|5|||
148825600|NCT00401830|536838534|FG000|Overall Study|Withdrawal by Subject|4|||
148825601|NCT00401830|536838535|FG001|Overall Study|Withdrawal by Subject|3|||
148825602|NCT00401830|536838534|FG000|Overall Study|Protocol Violation|3|||
148825603|NCT00401830|536838535|FG001|Overall Study|Protocol Violation|3|||
148825604|NCT00401830|536838534|FG000|Overall Study|Non-compliance with drug study|1|||
148825605|NCT00401830|536838535|FG001|Overall Study|Non-compliance with drug study|0|||
148825606|NCT00401830|536838534|FG000|Overall Study|Lost to Follow-up|1|||
148825607|NCT00401830|536838535|FG001|Overall Study|Lost to Follow-up|3|||
148825608|NCT00401830|536838534|FG000|Overall Study|Other: Personal / Family problems|1|||
148825609|NCT00401830|536838535|FG001|Overall Study|Other: Personal / Family problems|0|||
148825610|NCT03726879|536838546|FG000|Overall Study|Death|11|||
148825611|NCT03726879|536838547|FG001|Overall Study|Death|13|||
148825612|NCT03726879|536838546|FG000|Overall Study|Physician Decision|0|||
148825613|NCT03726879|536838547|FG001|Overall Study|Physician Decision|2|||
148825614|NCT03726879|536838546|FG000|Overall Study|Protocol Violation|0|||
148825615|NCT03726879|536838547|FG001|Overall Study|Protocol Violation|1|||
148825616|NCT03726879|536838546|FG000|Overall Study|Withdrawal by Subject|5|||
148825617|NCT03726879|536838547|FG001|Overall Study|Withdrawal by Subject|6|||
148825618|NCT03726879|536838546|FG000|Overall Study|TSH result is unstable|0|||
148825619|NCT03726879|536838547|FG001|Overall Study|TSH result is unstable|1|||
148825620|NCT03726879|536838546|FG000|Overall Study|Disease relapse|1|||
148825621|NCT03726879|536838547|FG001|Overall Study|Disease relapse|0|||
148825622|NCT03726879|536838546|FG000|Overall Study|Lost to Follow-up|3|||
148825623|NCT03726879|536838547|FG001|Overall Study|Lost to Follow-up|0|||
148825624|NCT01093573|536838548|FG000|Overall Study|Physician Decision|0|||
148825625|NCT01093573|536838549|FG001|Overall Study|Physician Decision|0|||
148825626|NCT01093573|536838550|FG002|Overall Study|Physician Decision|1|||
148825627|NCT01093573|536838548|FG000|Overall Study|Insurance Denied|0|||
148825628|NCT01093573|536838549|FG001|Overall Study|Insurance Denied|0|||
148825629|NCT01093573|536838550|FG002|Overall Study|Insurance Denied|1|||
148825630|NCT00553475|536838551|FG000|Overall Study|Adverse Event|7|||
148825631|NCT00553475|536838552|FG001|Overall Study|Adverse Event|17|||
148825632|NCT00553475|536838553|FG002|Overall Study|Adverse Event|13|||
148825633|NCT00553475|536838551|FG000|Overall Study|Lack of Efficacy|7|||
148825634|NCT00553475|536838552|FG001|Overall Study|Lack of Efficacy|1|||
148825635|NCT00553475|536838553|FG002|Overall Study|Lack of Efficacy|0|||
148825636|NCT00553475|536838551|FG000|Overall Study|Withdrawal by Subject|1|||
148825637|NCT00553475|536838552|FG001|Overall Study|Withdrawal by Subject|1|||
148825638|NCT00553475|536838553|FG002|Overall Study|Withdrawal by Subject|0|||
148825639|NCT00553475|536838551|FG000|Overall Study|Physician Decision|1|||
148825640|NCT00553475|536838552|FG001|Overall Study|Physician Decision|0|||
148825641|NCT00553475|536838553|FG002|Overall Study|Physician Decision|0|||
148825642|NCT00553475|536838551|FG000|Overall Study|Due to moving|0|||
148825643|NCT00553475|536838552|FG001|Overall Study|Due to moving|1|||
148825644|NCT00553475|536838553|FG002|Overall Study|Due to moving|0|||
148825645|NCT01623154|536838554|FG000|Overall Study|Did not drink Pranactin Citric|4|||
148825646|NCT00954538|536838558|FG000|Part III|Withdrawal by Subject|0|||
148825647|NCT00954538|536838559|FG001|Part III|Withdrawal by Subject|0|||
148825648|NCT00954538|536838560|FG002|Part III|Withdrawal by Subject|0|||
148825649|NCT00954538|536838561|FG003|Part III|Withdrawal by Subject|0|||
148825650|NCT00954538|536838562|FG004|Part III|Withdrawal by Subject|1|||
148825651|NCT00954538|536838563|FG005|Part III|Withdrawal by Subject|0|||
148825652|NCT01905683|536838566|FG000|Overall Study|Protocol Violation|1|||
148825653|NCT01905683|536838566|FG000|Overall Study|Re-injection criteria not met; others|13|||
148825654|NCT01905683|536838566|FG000|Overall Study|Physician Decision|1|||
148825655|NCT01905683|536838566|FG000|Overall Study|Lack of Efficacy|8|||
148825656|NCT01905683|536838566|FG000|Overall Study|Withdrawal by Subject|20|||
148825657|NCT01905683|536838566|FG000|Overall Study|Adverse Event|4|||
148825658|NCT01905683|536838566|FG000|Overall Study|Lost to Follow-up|4|||
148825659|NCT02113878|536840242|FG000|Overall Study|Adverse Event|1|||
148825660|NCT02113878|536840243|FG001|Overall Study|Adverse Event|0|||
148825661|NCT02113878|536840242|FG000|Overall Study|Withdrawal by Subject|1|||
148825662|NCT02113878|536840243|FG001|Overall Study|Withdrawal by Subject|0|||
148825663|NCT02113878|536840242|FG000|Overall Study|patient non-compliance|1|||
148825664|NCT02113878|536840243|FG001|Overall Study|patient non-compliance|0|||
148825665|NCT01251965|536840244|FG000|Overall Study|Participant/physician decision|1|||
148825666|NCT01251965|536840245|FG001|Overall Study|Participant/physician decision|2|||
148825667|NCT01251965|536840246|FG002|Overall Study|Participant/physician decision|0|||
148825668|NCT01251965|536840244|FG000|Overall Study|Death|0|||
148825669|NCT01251965|536840245|FG001|Overall Study|Death|0|||
148825670|NCT01251965|536840246|FG002|Overall Study|Death|11|||
148825671|NCT00530257|536840247|FG000|Overall Study|Lost to Follow-up|1|||
148825672|NCT05130281|536840250|FG000|Overall Study|Withdrawal by Subject|0|||
148825673|NCT05130281|536840251|FG001|Overall Study|Withdrawal by Subject|0|||
148825674|NCT05130281|536840252|FG002|Overall Study|Withdrawal by Subject|1|||
148825675|NCT05333965|536840255|FG000|First Intervention|Adverse Event|0|||
148825676|NCT05333965|536840256|FG001|First Intervention|Adverse Event|1|||
148825677|NCT05333965|536840255|FG000|First Intervention|Withdrawal by Subject|0|||
148825678|NCT05333965|536840256|FG001|First Intervention|Withdrawal by Subject|1|||
148825679|NCT03701074|536840257|FG000|Overall Study|Physician Decision|1|||
148825680|NCT03701074|536840258|FG001|Overall Study|Physician Decision|0|||
148825681|NCT01517178|536840259|FG000|Period 1|Adverse Event|1|||
148825682|NCT01517178|536840260|FG001|Period 1|Adverse Event|2|||
148825683|NCT01517178|536840259|FG000|Period 1|Lack of Efficacy|0|||
148825684|NCT01517178|536840260|FG001|Period 1|Lack of Efficacy|1|||
148825685|NCT01517178|536840259|FG000|Period 1|E.g. study termination|3|||
148825686|NCT01517178|536840260|FG001|Period 1|E.g. study termination|1|||
148825687|NCT01517178|536840259|FG000|Period 1|Withdrawal by Subject|0|||
148825688|NCT01517178|536840260|FG001|Period 1|Withdrawal by Subject|1|||
148825689|NCT01517178|536840259|FG000|Period 2|Adverse Event|1|||
148825690|NCT01517178|536840260|FG001|Period 2|Adverse Event|0|||
148825691|NCT01517178|536840259|FG000|Period 2|Withdrawal by Subject|3|||
148825692|NCT01517178|536840260|FG001|Period 2|Withdrawal by Subject|0|||
148825693|NCT01517178|536840259|FG000|Period 2|E.g. study termination|2|||
148825694|NCT01517178|536840260|FG001|Period 2|E.g. study termination|2|||
148825695|NCT01959919|536840261|FG000|Overall Study|Did not meet the eligibility criteria|2|||
148825696|NCT01104870|536840263|FG000|Overall Study|Adverse Event|1|||
148825697|NCT01104870|536840264|FG001|Overall Study|Adverse Event|1|||
148825698|NCT01104870|536840265|FG002|Overall Study|Adverse Event|0|||
148825699|NCT01104870|536840263|FG000|Overall Study|Death|0|||
148825700|NCT01104870|536840264|FG001|Overall Study|Death|0|||
148825701|NCT01104870|536840265|FG002|Overall Study|Death|1|||
148825702|NCT01104870|536840263|FG000|Overall Study|Withdrawal by Subject|0|||
148825703|NCT01104870|536840264|FG001|Overall Study|Withdrawal by Subject|0|||
148825704|NCT01104870|536840265|FG002|Overall Study|Withdrawal by Subject|1|||
148825705|NCT02150863|536840273|FG000|Overall Study|Lost to Follow-up|0|||
148825706|NCT02150863|536840274|FG001|Overall Study|Lost to Follow-up|1|||
148825707|NCT02150863|536840275|FG002|Overall Study|Lost to Follow-up|0|||
148759983|NCT03769168|536594274|FG001|Overall Study|Physician Decision|4|||
148759984|NCT03769168|536594273|FG000|Overall Study|Subject Decision|2|||
148759985|NCT03769168|536594274|FG001|Overall Study|Subject Decision|4|||
148759986|NCT03769168|536594273|FG000|Overall Study|Guardian decision|1|||
148759987|NCT03769168|536594274|FG001|Overall Study|Guardian decision|0|||
148759988|NCT05336227|536594275|FG000|Overall Study|Adverse Event|1|||
148759989|NCT05336227|536594276|FG001|Overall Study|Adverse Event|0|||
148759990|NCT05336227|536594275|FG000|Overall Study|Lost to Follow-up|2|||
148759991|NCT05336227|536594276|FG001|Overall Study|Lost to Follow-up|0|||
148759992|NCT05336227|536594275|FG000|Overall Study|Withdrawal by Subject|1|||
148759993|NCT05336227|536594276|FG001|Overall Study|Withdrawal by Subject|0|||
148759994|NCT04050462|536594277|FG000|Overall Study|Withdrawal by Subject|1|||
148759995|NCT04050462|536594278|FG001|Overall Study|Withdrawal by Subject|0|||
148759996|NCT04050462|536594279|FG002|Overall Study|Withdrawal by Subject|0|||
148759997|NCT03058705|536594284|FG000|Overall Study|Withdrawal by Subject|2|||
148759998|NCT03058705|536594284|FG000|Overall Study|Physician Decision|2|||
148759999|NCT05468164|536594293|FG000|Treatment Period 4|Adverse Event|0|||
148760000|NCT05468164|536594294|FG001|Treatment Period 4|Adverse Event|0|||
148825708|NCT00835549|536840278|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
148825709|NCT00835549|536840279|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
148825710|NCT00835042|536840280|FG000|First Intervention|Withdrawal by Subject|3|||
148825711|NCT00835042|536840281|FG001|First Intervention|Withdrawal by Subject|0|||
148825712|NCT00835042|536840280|FG000|First Intervention|Adverse Event|1|||
148825713|NCT00835042|536840281|FG001|First Intervention|Adverse Event|2|||
148825714|NCT00835042|536840280|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
148760001|NCT05468164|536594295|FG002|Treatment Period 4|Adverse Event|0|||
148825715|NCT00835042|536840281|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
148825716|NCT04008069|536840282|FG000|Open-Label Period|Adverse Event|1|||
148825717|NCT04008069|536840283|FG001|Open-Label Period|Adverse Event|0|||
148825718|NCT04008069|536840284|FG002|Open-Label Period|Adverse Event|0|||
148825719|NCT04008069|536840282|FG000|Open-Label Period|Lack of Efficacy|4|||
148825720|NCT04008069|536840283|FG001|Open-Label Period|Lack of Efficacy|0|||
148825721|NCT04008069|536840284|FG002|Open-Label Period|Lack of Efficacy|0|||
148825722|NCT04008069|536840282|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
148825723|NCT04008069|536840283|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
148825724|NCT04008069|536840284|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
148825725|NCT04008069|536840282|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
148825726|NCT04008069|536840283|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
148825727|NCT04008069|536840284|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
148825728|NCT00511199|536840286|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
148825729|NCT00511199|536840287|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
148825730|NCT00511199|536840286|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
148825731|NCT00511199|536840287|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
148825732|NCT00511199|536840286|FG000|Overall Study|Withdrawal of Informed Consent|19|||
148977024|NCT01060384|537396541|FG001|Overall Study|Withdrawal by Subject|1|||
148977025|NCT01060384|537396542|FG002|Overall Study|Withdrawal by Subject|0|||
148977026|NCT01060384|537396543|FG003|Overall Study|Withdrawal by Subject|0|||
148760002|NCT05468164|536594296|FG003|Treatment Period 4|Adverse Event|1|||
148760003|NCT03827291|536594297|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
148760004|NCT03827291|536594298|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
148760005|NCT04795466|536594299|FG000|Overall Study|Adverse Event|3|||
148760006|NCT04795466|536594300|FG001|Overall Study|Adverse Event|1|||
148760007|NCT04795466|536594299|FG000|Overall Study|Physician Decision|1|||
148760008|NCT04795466|536594300|FG001|Overall Study|Physician Decision|0|||
148760009|NCT04795466|536594299|FG000|Overall Study|Withdrawal by Subject|2|||
148760010|NCT04795466|536594300|FG001|Overall Study|Withdrawal by Subject|1|||
148760011|NCT04652726|536594301|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
148760012|NCT04652726|536594302|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
148760013|NCT04652726|536594303|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
148760014|NCT04652726|536594301|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
148760015|NCT04652726|536594302|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
148760016|NCT04652726|536594303|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
148760017|NCT01102257|536594310|FG000|Overall Study|Adverse Event|1|||
148760018|NCT01102257|536594311|FG001|Overall Study|Adverse Event|0|||
148760019|NCT01102257|536594310|FG000|Overall Study|Adverse Event|1|||
148760020|NCT01102257|536594311|FG001|Overall Study|Adverse Event|0|||
148760021|NCT04066244|536594312|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
148760022|NCT04066244|536594313|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
148760023|NCT04066244|536594314|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
148760024|NCT04066244|536594315|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
148760025|NCT04066244|536594316|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
148760026|NCT04066244|536594317|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
148760027|NCT04066244|536594312|FG000|Part 2 (Cohort 5)|Death|0|||
148760028|NCT04066244|536594313|FG001|Part 2 (Cohort 5)|Death|0|||
148760029|NCT04066244|536594314|FG002|Part 2 (Cohort 5)|Death|0|||
148760030|NCT04066244|536594315|FG003|Part 2 (Cohort 5)|Death|0|||
148760031|NCT04066244|536594316|FG004|Part 2 (Cohort 5)|Death|0|||
148760032|NCT04066244|536594317|FG005|Part 2 (Cohort 5)|Death|2|||
148760033|NCT04066244|536594312|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
148760034|NCT04066244|536594313|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
148760035|NCT04066244|536594314|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
148760036|NCT04066244|536594315|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
148760037|NCT04066244|536594316|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
148760038|NCT04066244|536594317|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
148760039|NCT04066244|536594312|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
148760040|NCT04066244|536594313|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
148760041|NCT04066244|536594314|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
148760042|NCT04066244|536594315|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
148760043|NCT04066244|536594316|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
148760044|NCT04066244|536594317|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
148760045|NCT03752970|536594318|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
148760046|NCT03752970|536594319|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
148760047|NCT03752970|536594320|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
148825733|NCT00511199|536840287|FG001|Overall Study|Withdrawal of Informed Consent|4|||
148825734|NCT00511199|536840286|FG000|Overall Study|Pregnancy|6|||
148760048|NCT03752970|536594318|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
148760049|NCT03752970|536594319|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
148760050|NCT03752970|536594320|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
148760051|NCT03752970|536594318|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
148760052|NCT03752970|536594319|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
148760053|NCT03752970|536594320|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
148825735|NCT00511199|536840287|FG001|Overall Study|Pregnancy|3|||
148825736|NCT00511199|536840286|FG000|Overall Study|Pregnancy Wish|16|||
148825737|NCT00511199|536840287|FG001|Overall Study|Pregnancy Wish|8|||
148760054|NCT03752970|536594318|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
148760055|NCT03752970|536594319|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
148760056|NCT03752970|536594320|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
148760057|NCT03752970|536594318|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
148760058|NCT03752970|536594319|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
148760059|NCT03752970|536594320|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
148760060|NCT03976362|536594321|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
148760061|NCT03976362|536594322|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
148760062|NCT03976362|536594323|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
148760063|NCT03976362|536594321|FG000|Induction Phase|Death|62|||
148760064|NCT03976362|536594322|FG001|Induction Phase|Death|0|||
148760065|NCT03976362|536594323|FG002|Induction Phase|Death|0|||
148760066|NCT03976362|536594321|FG000|Maintenance Phase|Participants Ongoing|0|||
148760067|NCT03976362|536594322|FG001|Maintenance Phase|Participants Ongoing|106|||
148760068|NCT03976362|536594323|FG002|Maintenance Phase|Participants Ongoing|103|||
148760069|NCT03976362|536594321|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148760070|NCT03976362|536594322|FG001|Maintenance Phase|Withdrawal by Subject|4|||
148760071|NCT03976362|536594323|FG002|Maintenance Phase|Withdrawal by Subject|4|||
148760072|NCT03976362|536594321|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
148760073|NCT03976362|536594322|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
148760074|NCT03976362|536594323|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
148760075|NCT03976362|536594321|FG000|Maintenance Phase|Death|0|||
148760076|NCT03976362|536594322|FG001|Maintenance Phase|Death|186|||
148760077|NCT03976362|536594323|FG002|Maintenance Phase|Death|187|||
148760078|NCT04767282|536594324|FG000|Overall Study|Refused or did not begin surveys|6|||
148760079|NCT04767282|536594325|FG001|Overall Study|Refused or did not begin surveys|2|||
148760080|NCT04767282|536594326|FG002|Overall Study|Refused or did not begin surveys|2|||
148760081|NCT04767282|536594324|FG000|Overall Study|Duplicate household previously enrolled|2|||
148760082|NCT04767282|536594325|FG001|Overall Study|Duplicate household previously enrolled|0|||
148760083|NCT04767282|536594326|FG002|Overall Study|Duplicate household previously enrolled|8|||
148760084|NCT04767282|536594324|FG000|Overall Study|Unable to confirm legal guardian|0|||
148760085|NCT04767282|536594325|FG001|Overall Study|Unable to confirm legal guardian|2|||
148760086|NCT04767282|536594326|FG002|Overall Study|Unable to confirm legal guardian|8|||
148760087|NCT04767282|536594324|FG000|Overall Study|Withdrawal by Subject|0|||
148760088|NCT04767282|536594325|FG001|Overall Study|Withdrawal by Subject|0|||
148760089|NCT04767282|536594326|FG002|Overall Study|Withdrawal by Subject|6|||
148760090|NCT04767282|536594324|FG000|Overall Study|Survey comprehension challenges|4|||
148760091|NCT04767282|536594325|FG001|Overall Study|Survey comprehension challenges|0|||
148760092|NCT04767282|536594326|FG002|Overall Study|Survey comprehension challenges|0|||
148760093|NCT01467713|536594328|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
148760094|NCT01467713|536594329|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
148760095|NCT01467713|536594330|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
148760096|NCT01467713|536594331|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
148760097|NCT01467713|536594328|FG000|Overall Study|Major Protocol Deviation|2|||
148760098|NCT01467713|536594329|FG001|Overall Study|Major Protocol Deviation|4|||
148760099|NCT01467713|536594330|FG002|Overall Study|Major Protocol Deviation|4|||
148760100|NCT01467713|536594331|FG003|Overall Study|Major Protocol Deviation|1|||
148760101|NCT01467713|536594328|FG000|Overall Study|Lost to Follow-up|9|||
148760102|NCT01467713|536594329|FG001|Overall Study|Lost to Follow-up|12|||
148760103|NCT01467713|536594330|FG002|Overall Study|Lost to Follow-up|6|||
148760104|NCT01467713|536594331|FG003|Overall Study|Lost to Follow-up|9|||
148760105|NCT01467713|536594328|FG000|Overall Study|Voluntary Withdrawal|18|||
148760106|NCT01467713|536594329|FG001|Overall Study|Voluntary Withdrawal|14|||
148760107|NCT01467713|536594330|FG002|Overall Study|Voluntary Withdrawal|21|||
148760108|NCT01467713|536594331|FG003|Overall Study|Voluntary Withdrawal|20|||
148760109|NCT01467713|536594328|FG000|Overall Study|Study Termination|23|||
148760110|NCT01467713|536594329|FG001|Overall Study|Study Termination|33|||
148977027|NCT01060384|537396544|FG004|Overall Study|Withdrawal by Subject|0|||
148977028|NCT01060384|537396540|FG000|Overall Study|Death|0|||
148760111|NCT01467713|536594330|FG002|Overall Study|Study Termination|28|||
148760112|NCT01467713|536594331|FG003|Overall Study|Study Termination|29|||
148760113|NCT01467713|536594328|FG000|Overall Study|Pregnancy|0|||
148760114|NCT01467713|536594329|FG001|Overall Study|Pregnancy|1|||
148760115|NCT01467713|536594330|FG002|Overall Study|Pregnancy|1|||
148760116|NCT01467713|536594331|FG003|Overall Study|Pregnancy|3|||
148760117|NCT01467713|536594328|FG000|Overall Study|Relapse|35|||
148760118|NCT01467713|536594329|FG001|Overall Study|Relapse|25|||
148760119|NCT01467713|536594330|FG002|Overall Study|Relapse|28|||
148760120|NCT01467713|536594331|FG003|Overall Study|Relapse|35|||
148760121|NCT01467713|536594328|FG000|Overall Study|Reason not Specified|6|||
148760122|NCT01467713|536594329|FG001|Overall Study|Reason not Specified|11|||
148760123|NCT01467713|536594330|FG002|Overall Study|Reason not Specified|8|||
148977029|NCT01060384|537396541|FG001|Overall Study|Death|0|||
148977030|NCT01060384|537396542|FG002|Overall Study|Death|0|||
148760124|NCT01467713|536594331|FG003|Overall Study|Reason not Specified|7|||
148760125|NCT01120184|536594336|FG000|Overall Study|Adverse Event|0|||
148760126|NCT01120184|536594337|FG001|Overall Study|Adverse Event|1|||
148760127|NCT01120184|536594338|FG002|Overall Study|Adverse Event|0|||
148760128|NCT01120184|536594336|FG000|Overall Study|Lost to Follow-up|13|||
148760129|NCT01120184|536594337|FG001|Overall Study|Lost to Follow-up|13|||
148760130|NCT01120184|536594338|FG002|Overall Study|Lost to Follow-up|11|||
148760131|NCT01120184|536594336|FG000|Overall Study|Physician Decision|9|||
148760132|NCT01120184|536594337|FG001|Overall Study|Physician Decision|1|||
148760133|NCT01120184|536594338|FG002|Overall Study|Physician Decision|3|||
148760134|NCT01120184|536594336|FG000|Overall Study|Reason not Specified|8|||
148760135|NCT01120184|536594337|FG001|Overall Study|Reason not Specified|3|||
148760136|NCT01120184|536594338|FG002|Overall Study|Reason not Specified|12|||
148760137|NCT01120184|536594336|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
148760138|NCT01120184|536594337|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
148760139|NCT01120184|536594338|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
148760140|NCT01120184|536594336|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
148760141|NCT01120184|536594337|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
148760142|NCT01120184|536594338|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
148760143|NCT01120184|536594336|FG000|Overall Study|Death|170|||
148760144|NCT01120184|536594337|FG001|Overall Study|Death|176|||
148760145|NCT01120184|536594338|FG002|Overall Study|Death|169|||
148760146|NCT02525783|536594339|FG000|Overall Study|Lost to Follow-up|10|||
148760147|NCT00824772|536594340|FG000|Overall Study|Withdrawal by Subject|8|||
148760148|NCT00536939|536594341|FG000|Overall Study|Withdrawal by Subject|1|||
148760149|NCT00536939|536594342|FG001|Overall Study|Withdrawal by Subject|0|||
148760150|NCT00536939|536594341|FG000|Overall Study|Other Complicating Disease|1|||
148760151|NCT00536939|536594342|FG001|Overall Study|Other Complicating Disease|0|||
148760152|NCT01100086|536594347|FG000|Period 1|Withdrawal by Subject|1|||
148760153|NCT01100086|536594348|FG001|Period 1|Withdrawal by Subject|0|||
148760154|NCT02955355|536594355|FG000|Overall Study|Adverse Event|4|||
148760155|NCT02955355|536594355|FG000|Overall Study|Death|1|||
148760156|NCT02955355|536594355|FG000|Overall Study|Physician Decision|21|||
148760157|NCT02955355|536594355|FG000|Overall Study|Site Terminated by Sponsor|35|||
148760158|NCT02955355|536594355|FG000|Overall Study|Withdrawal by Subject|19|||
148760159|NCT02955355|536594355|FG000|Overall Study|Reason Not Specified|5|||
148760160|NCT03817853|536594363|FG000|Induction Phase|Adverse Event|5|||
148760161|NCT03817853|536594364|FG001|Induction Phase|Adverse Event|0|||
148760162|NCT03817853|536594365|FG002|Induction Phase|Adverse Event|0|||
148760163|NCT03817853|536594363|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
148760164|NCT03817853|536594364|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
148760165|NCT03817853|536594365|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
148760166|NCT03817853|536594363|FG000|Induction Phase|Physician Decision|2|||
148760167|NCT03817853|536594364|FG001|Induction Phase|Physician Decision|0|||
148760168|NCT03817853|536594365|FG002|Induction Phase|Physician Decision|0|||
148760169|NCT03817853|536594363|FG000|Induction Phase|Progressive Disease|6|||
148760170|NCT03817853|536594364|FG001|Induction Phase|Progressive Disease|0|||
148760171|NCT03817853|536594365|FG002|Induction Phase|Progressive Disease|0|||
148760172|NCT03817853|536594363|FG000|Induction Phase|Withdrawal by Subject|4|||
148760173|NCT03817853|536594364|FG001|Induction Phase|Withdrawal by Subject|0|||
148760174|NCT03817853|536594365|FG002|Induction Phase|Withdrawal by Subject|0|||
148760175|NCT03817853|536594363|FG000|Maintenance Phase|Adverse Event|0|||
148760176|NCT03817853|536594364|FG001|Maintenance Phase|Adverse Event|8|||
148760177|NCT03817853|536594365|FG002|Maintenance Phase|Adverse Event|0|||
148760178|NCT03817853|536594363|FG000|Maintenance Phase|Death|0|||
148760179|NCT03817853|536594364|FG001|Maintenance Phase|Death|5|||
148760180|NCT03817853|536594365|FG002|Maintenance Phase|Death|0|||
148760181|NCT03817853|536594363|FG000|Maintenance Phase|Progressive Disease|0|||
148760182|NCT03817853|536594364|FG001|Maintenance Phase|Progressive Disease|7|||
148760183|NCT03817853|536594365|FG002|Maintenance Phase|Progressive Disease|0|||
148760184|NCT03817853|536594363|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148760185|NCT03817853|536594364|FG001|Maintenance Phase|Withdrawal by Subject|2|||
148760186|NCT03817853|536594365|FG002|Maintenance Phase|Withdrawal by Subject|0|||
148760187|NCT03817853|536594363|FG000|Maintenance Phase|Physician Decision|0|||
148760188|NCT03817853|536594364|FG001|Maintenance Phase|Physician Decision|1|||
148760189|NCT03817853|536594365|FG002|Maintenance Phase|Physician Decision|0|||
148760190|NCT03817853|536594363|FG000|Maintenance Phase|Various reasons|0|||
148760191|NCT03817853|536594364|FG001|Maintenance Phase|Various reasons|4|||
148825738|NCT00511199|536840286|FG000|Overall Study|Lost to Follow-up|40|||
149027469|NCT01237678|537578567|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
148760192|NCT03817853|536594365|FG002|Maintenance Phase|Various reasons|0|||
148760193|NCT03817853|536594363|FG000|Maintenance Phase|Protocol Deviation|0|||
148760194|NCT03817853|536594364|FG001|Maintenance Phase|Protocol Deviation|1|||
148760195|NCT03817853|536594365|FG002|Maintenance Phase|Protocol Deviation|0|||
148760196|NCT03817853|536594363|FG000|Follow-up Phase|Adverse Event|0|||
148977031|NCT01060384|537396543|FG003|Overall Study|Death|0|||
148977032|NCT01060384|537396544|FG004|Overall Study|Death|1|||
148977033|NCT01060384|537396540|FG000|Overall Study|Intercurrent illness|0|||
148977034|NCT01060384|537396541|FG001|Overall Study|Intercurrent illness|0|||
148977035|NCT01060384|537396542|FG002|Overall Study|Intercurrent illness|0|||
148977036|NCT01060384|537396543|FG003|Overall Study|Intercurrent illness|0|||
148977037|NCT01060384|537396544|FG004|Overall Study|Intercurrent illness|1|||
148977038|NCT00812929|537396545|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
148760197|NCT03817853|536594364|FG001|Follow-up Phase|Adverse Event|0|||
148760198|NCT03817853|536594365|FG002|Follow-up Phase|Adverse Event|2|||
148760199|NCT03817853|536594363|FG000|Follow-up Phase|Death|0|||
148760200|NCT03817853|536594364|FG001|Follow-up Phase|Death|0|||
148760201|NCT03817853|536594365|FG002|Follow-up Phase|Death|1|||
148760202|NCT03817853|536594363|FG000|Follow-up Phase|Progressive Disease|0|||
148760203|NCT03817853|536594364|FG001|Follow-up Phase|Progressive Disease|0|||
148760204|NCT03817853|536594365|FG002|Follow-up Phase|Progressive Disease|3|||
148760205|NCT03817853|536594363|FG000|Follow-up Phase|Withdrawal by Subject|0|||
148760206|NCT03817853|536594364|FG001|Follow-up Phase|Withdrawal by Subject|0|||
148760207|NCT03817853|536594365|FG002|Follow-up Phase|Withdrawal by Subject|1|||
148760208|NCT00891020|536594367|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
148760209|NCT00891020|536594368|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
148760210|NCT00891020|536594369|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
148760211|NCT00891020|536594367|FG000|24 Week Treatment Period|Death|0|||
148760212|NCT00891020|536594368|FG001|24 Week Treatment Period|Death|2|||
148760213|NCT00891020|536594369|FG002|24 Week Treatment Period|Death|0|||
148760214|NCT00891020|536594367|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
148760215|NCT00891020|536594368|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
148760216|NCT00891020|536594369|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
148760217|NCT00891020|536594367|FG000|24 Week Treatment Period|Failure to return|4|||
148760218|NCT00891020|536594368|FG001|24 Week Treatment Period|Failure to return|5|||
148760219|NCT00891020|536594369|FG002|24 Week Treatment Period|Failure to return|5|||
148760220|NCT00891020|536594367|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
148760221|NCT00891020|536594368|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
148760222|NCT00891020|536594369|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
148760223|NCT00891020|536594367|FG000|24 Week Treatment Period|Other protocol violation|1|||
148760224|NCT00891020|536594368|FG001|24 Week Treatment Period|Other protocol violation|1|||
148760225|NCT00891020|536594369|FG002|24 Week Treatment Period|Other protocol violation|2|||
148760226|NCT00891020|536594367|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
148760227|NCT00891020|536594368|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
148760228|NCT00891020|536594369|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
148760229|NCT00891020|536594367|FG000|24 Week Treatment Period|Withdrew consent|6|||
148760230|NCT00891020|536594368|FG001|24 Week Treatment Period|Withdrew consent|3|||
148760231|NCT00891020|536594369|FG002|24 Week Treatment Period|Withdrew consent|15|||
148760232|NCT00891020|536594367|FG000|24 Week Treatment Period|Administrative/Other|5|||
148760233|NCT00891020|536594368|FG001|24 Week Treatment Period|Administrative/Other|6|||
148760234|NCT00891020|536594369|FG002|24 Week Treatment Period|Administrative/Other|1|||
148760235|NCT00891020|536594367|FG000|Long-term Extension Period|Adverse Event|1|||
148760236|NCT00891020|536594368|FG001|Long-term Extension Period|Adverse Event|11|||
148760237|NCT00891020|536594369|FG002|Long-term Extension Period|Adverse Event|10|||
148760238|NCT00891020|536594367|FG000|Long-term Extension Period|Death|0|||
148760239|NCT00891020|536594368|FG001|Long-term Extension Period|Death|0|||
148760240|NCT00891020|536594369|FG002|Long-term Extension Period|Death|1|||
148760241|NCT00891020|536594367|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
148760242|NCT00891020|536594368|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
148760243|NCT00891020|536594369|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
148760244|NCT00891020|536594367|FG000|Long-term Extension Period|Protocol Violation|0|||
148760245|NCT00891020|536594368|FG001|Long-term Extension Period|Protocol Violation|1|||
148760246|NCT00891020|536594369|FG002|Long-term Extension Period|Protocol Violation|1|||
148760247|NCT00891020|536594367|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
148760248|NCT00891020|536594368|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
148760249|NCT00891020|536594369|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
148760250|NCT00891020|536594367|FG000|Long-term Extension Period|Failure to return|0|||
148760251|NCT00891020|536594368|FG001|Long-term Extension Period|Failure to return|2|||
148760252|NCT00891020|536594369|FG002|Long-term Extension Period|Failure to return|3|||
148760253|NCT00891020|536594367|FG000|Long-term Extension Period|Administrative|1|||
148760254|NCT00891020|536594368|FG001|Long-term Extension Period|Administrative|2|||
148760255|NCT00891020|536594369|FG002|Long-term Extension Period|Administrative|2|||
148760256|NCT00320710|536594370|FG000|Overall Study|Disease progression|24|||
148760257|NCT00320710|536594371|FG001|Overall Study|Disease progression|19|||
148760258|NCT00320710|536594372|FG002|Overall Study|Disease progression|2|||
148977039|NCT00812929|537396546|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
148760259|NCT00320710|536594370|FG000|Overall Study|Death|10|||
148760260|NCT00320710|536594371|FG001|Overall Study|Death|7|||
148760261|NCT00320710|536594372|FG002|Overall Study|Death|1|||
148760262|NCT00320710|536594370|FG000|Overall Study|Administrative problems|1|||
148760263|NCT00320710|536594371|FG001|Overall Study|Administrative problems|2|||
148760264|NCT00320710|536594372|FG002|Overall Study|Administrative problems|0|||
148760265|NCT00320710|536594370|FG000|Overall Study|Withdrawal by Subject|20|||
148760266|NCT00320710|536594371|FG001|Overall Study|Withdrawal by Subject|26|||
148760267|NCT00320710|536594372|FG002|Overall Study|Withdrawal by Subject|1|||
148760268|NCT00320710|536594370|FG000|Overall Study|Protocol Violation|6|||
148760269|NCT00320710|536594371|FG001|Overall Study|Protocol Violation|5|||
148760270|NCT00320710|536594372|FG002|Overall Study|Protocol Violation|0|||
148760271|NCT00320710|536594370|FG000|Overall Study|Abnormal test procedure result(s)|2|||
148760272|NCT00320710|536594371|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148760273|NCT00320710|536594372|FG002|Overall Study|Abnormal test procedure result(s)|0|||
148760274|NCT00320710|536594370|FG000|Overall Study|Abnormal laboratory value(s)|12|||
148760275|NCT00320710|536594371|FG001|Overall Study|Abnormal laboratory value(s)|3|||
148760276|NCT00320710|536594372|FG002|Overall Study|Abnormal laboratory value(s)|0|||
148760277|NCT00320710|536594370|FG000|Overall Study|Adverse Event|18|||
148760278|NCT00320710|536594371|FG001|Overall Study|Adverse Event|14|||
148760279|NCT00320710|536594372|FG002|Overall Study|Adverse Event|1|||
148760280|NCT00320710|536594370|FG000|Overall Study|Lost to Follow-up|1|||
148760281|NCT00320710|536594371|FG001|Overall Study|Lost to Follow-up|0|||
148760282|NCT00320710|536594372|FG002|Overall Study|Lost to Follow-up|0|||
148760283|NCT03809663|536594379|FG000|Overall Study|Decision by sponsor|24|||
148760284|NCT03809663|536594380|FG001|Overall Study|Decision by sponsor|18|||
148760285|NCT03809663|536594381|FG002|Overall Study|Decision by sponsor|20|||
148760286|NCT03809663|536594382|FG003|Overall Study|Decision by sponsor|20|||
148760287|NCT03809663|536594383|FG004|Overall Study|Decision by sponsor|0|||
148760288|NCT03809663|536594384|FG005|Overall Study|Decision by sponsor|0|||
148760289|NCT03809663|536594379|FG000|Overall Study|Withdrawal by Subject|26|||
148760290|NCT03809663|536594380|FG001|Overall Study|Withdrawal by Subject|22|||
148760291|NCT03809663|536594381|FG002|Overall Study|Withdrawal by Subject|27|||
148760292|NCT03809663|536594382|FG003|Overall Study|Withdrawal by Subject|26|||
148760293|NCT03809663|536594383|FG004|Overall Study|Withdrawal by Subject|0|||
148760294|NCT03809663|536594384|FG005|Overall Study|Withdrawal by Subject|0|||
148760295|NCT03809663|536594379|FG000|Overall Study|Lost to Follow-up|1|||
148760296|NCT03809663|536594380|FG001|Overall Study|Lost to Follow-up|4|||
148760297|NCT03809663|536594381|FG002|Overall Study|Lost to Follow-up|1|||
148760298|NCT03809663|536594382|FG003|Overall Study|Lost to Follow-up|1|||
148760299|NCT03809663|536594383|FG004|Overall Study|Lost to Follow-up|0|||
148760300|NCT03809663|536594384|FG005|Overall Study|Lost to Follow-up|0|||
148760301|NCT02275819|536594387|FG000|Overall Study|Adverse Event|0|||
148760302|NCT02275819|536594388|FG001|Overall Study|Adverse Event|1|||
148760303|NCT02211209|536594389|FG000|Overall Study|Investigator judgment|0|||
148760304|NCT02211209|536594390|FG001|Overall Study|Investigator judgment|1|||
148760305|NCT02211209|536594389|FG000|Overall Study|Voluntary withdrawal|1|||
148760306|NCT02211209|536594390|FG001|Overall Study|Voluntary withdrawal|4|||
148760307|NCT02211209|536594389|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
148760308|NCT02211209|536594390|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
148760309|NCT02211209|536594389|FG000|Overall Study|Reason Not Specified|1|||
148760310|NCT02211209|536594390|FG001|Overall Study|Reason Not Specified|0|||
148760311|NCT00739661|536594392|FG000|Overall Study|Adverse Event|2|||
148760312|NCT00739661|536594393|FG001|Overall Study|Adverse Event|0|||
148760313|NCT00739661|536594392|FG000|Overall Study|Physician decision to withdraw patient|1|||
148760314|NCT00739661|536594393|FG001|Overall Study|Physician decision to withdraw patient|0|||
148760315|NCT00739661|536594392|FG000|Overall Study|Patient decision to withdraw|9|||
148760316|NCT00739661|536594393|FG001|Overall Study|Patient decision to withdraw|4|||
148760317|NCT00739661|536594392|FG000|Overall Study|Disease progression, radiographic|33|||
148760318|NCT00739661|536594393|FG001|Overall Study|Disease progression, radiographic|37|||
148760319|NCT00739661|536594392|FG000|Overall Study|Reason for discontinuation not available|1|||
148760320|NCT00739661|536594393|FG001|Overall Study|Reason for discontinuation not available|1|||
148760321|NCT02198664|536594394|FG000|Overall Study|Adverse Event|2|||
148760322|NCT02198664|536594395|FG001|Overall Study|Adverse Event|0|||
148760323|NCT02198664|536594394|FG000|Overall Study|Withdrawal by Subject|11|||
148760324|NCT02198664|536594395|FG001|Overall Study|Withdrawal by Subject|8|||
148760325|NCT02198664|536594394|FG000|Overall Study|Failure to tolerate|2|||
148760326|NCT02198664|536594395|FG001|Overall Study|Failure to tolerate|0|||
148760327|NCT02198664|536594394|FG000|Overall Study|Not stated|1|||
148760328|NCT02198664|536594395|FG001|Overall Study|Not stated|0|||
148760329|NCT02632409|536594396|FG000|Randomized|AE unrelated to study Drug|0|||
148760330|NCT02632409|536594397|FG001|Randomized|AE unrelated to study Drug|1|||
148760331|NCT02632409|536594396|FG000|Randomized|Participant withdrew consent|2|||
148760332|NCT02632409|536594397|FG001|Randomized|Participant withdrew consent|1|||
148760333|NCT02632409|536594396|FG000|Randomized|No Longer meets study criteria|5|||
148760334|NCT02632409|536594397|FG001|Randomized|No Longer meets study criteria|0|||
148760335|NCT02632409|536594396|FG000|Randomized|other reasons|1|||
148760336|NCT02632409|536594397|FG001|Randomized|other reasons|0|||
148760337|NCT02632409|536594396|FG000|Treatment Period|Ongoing Treatment|20|||
148760338|NCT02632409|536594397|FG001|Treatment Period|Ongoing Treatment|21|||
148760339|NCT02632409|536594396|FG000|Treatment Period|Disease Recurrence|147|||
148760340|NCT02632409|536594397|FG001|Treatment Period|Disease Recurrence|90|||
148760341|NCT02632409|536594396|FG000|Treatment Period|Study Drug Toxicity|8|||
148760342|NCT02632409|536594397|FG001|Treatment Period|Study Drug Toxicity|49|||
148760343|NCT02632409|536594396|FG000|Treatment Period|Death|1|||
148760344|NCT02632409|536594397|FG001|Treatment Period|Death|0|||
148760345|NCT02632409|536594396|FG000|Treatment Period|AE unrelated to study drug|15|||
148760346|NCT02632409|536594397|FG001|Treatment Period|AE unrelated to study drug|16|||
148760347|NCT02632409|536594396|FG000|Treatment Period|Request to discontinue treatment|4|||
148760348|NCT02632409|536594397|FG001|Treatment Period|Request to discontinue treatment|19|||
148760349|NCT02632409|536594396|FG000|Treatment Period|Participant withdrew consent|7|||
148760350|NCT02632409|536594397|FG001|Treatment Period|Participant withdrew consent|5|||
148760351|NCT02632409|536594396|FG000|Treatment Period|Lost to Follow-up|0|||
148760352|NCT02632409|536594397|FG001|Treatment Period|Lost to Follow-up|1|||
148760353|NCT02632409|536594396|FG000|Treatment Period|Maximum clinical benefit|1|||
148760354|NCT02632409|536594397|FG001|Treatment Period|Maximum clinical benefit|0|||
148760355|NCT02632409|536594396|FG000|Treatment Period|No longer meets study criteria|3|||
148760356|NCT02632409|536594397|FG001|Treatment Period|No longer meets study criteria|0|||
148760357|NCT02632409|536594396|FG000|Treatment Period|Administrative Reason by sponsor|0|||
148760358|NCT02632409|536594397|FG001|Treatment Period|Administrative Reason by sponsor|1|||
148760359|NCT02632409|536594396|FG000|Treatment Period|Other Reasons|10|||
148760360|NCT02632409|536594397|FG001|Treatment Period|Other Reasons|6|||
148760361|NCT05600283|536594398|FG000|Overall Study|Withdrawal by Subject|3|||
148760362|NCT05600283|536594399|FG001|Overall Study|Withdrawal by Subject|8|||
148760363|NCT05600283|536594398|FG000|Overall Study|invalid individual swab|1|||
148760364|NCT05600283|536594399|FG001|Overall Study|invalid individual swab|0|||
148760365|NCT05600283|536594398|FG000|Overall Study|missing clinician collection|3|||
148760366|NCT05600283|536594399|FG001|Overall Study|missing clinician collection|0|||
148760367|NCT05600283|536594398|FG000|Overall Study|screening failure|0|||
148760368|NCT05600283|536594399|FG001|Overall Study|screening failure|2|||
148760369|NCT02883062|536594400|FG000|Overall Study|Withdrawal by Subject|6|||
148760370|NCT02883062|536594401|FG001|Overall Study|Withdrawal by Subject|0|||
148760371|NCT04426006|536594402|FG000|Inclusion|Protocol Violation|1|||
148760372|NCT04426006|536594402|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
148760373|NCT04426006|536594402|FG000|Inclusion|Blood sample at inclusion not done|1|||
148760374|NCT04426006|536594402|FG000|3 Months|Lost to Follow-up|17|||
148760375|NCT04426006|536594402|FG000|12 Months|Lost to Follow-up|38|||
148760376|NCT00720213|536594405|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
148760377|NCT00720213|536594406|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
148760378|NCT00720213|536594407|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
148760379|NCT01252095|536594412|FG000|Overall Study|Disease progression|1|||
148760380|NCT01252095|536594413|FG001|Overall Study|Disease progression|0|||
148760381|NCT01420068|536594414|FG000|Overall Study|Administrative problems|1|||
148760382|NCT01420068|536594415|FG001|Overall Study|Administrative problems|3|||
148760383|NCT01420068|536594414|FG000|Overall Study|Withdrawal by Subject|1|||
148760384|NCT01420068|536594415|FG001|Overall Study|Withdrawal by Subject|2|||
148760385|NCT01753310|536594416|FG000|Overall Study|Entered into open label extension study|25|||
148760386|NCT01753310|536594417|FG001|Overall Study|Entered into open label extension study|22|||
148760387|NCT01753310|536594416|FG000|Overall Study|Adverse Event|1|||
148760388|NCT01753310|536594417|FG001|Overall Study|Adverse Event|0|||
148760389|NCT01753310|536594416|FG000|Overall Study|Lost to Follow-up|2|||
148760390|NCT01753310|536594417|FG001|Overall Study|Lost to Follow-up|0|||
148760391|NCT01753310|536594416|FG000|Overall Study|Subject decision|2|||
148760392|NCT01753310|536594417|FG001|Overall Study|Subject decision|2|||
148760393|NCT01753310|536594416|FG000|Overall Study|Sponsor decision|1|||
148760394|NCT01753310|536594417|FG001|Overall Study|Sponsor decision|0|||
148760395|NCT01753310|536594416|FG000|Overall Study|Withdrawal by Subject|1|||
148760396|NCT01753310|536594417|FG001|Overall Study|Withdrawal by Subject|0|||
148760397|NCT00952068|536594419|FG000|Overall Study|Adverse Event|3|||
148760398|NCT00952068|536594419|FG000|Overall Study|Withdrawal by Subject|4|||
148760399|NCT02022202|536594420|FG000|Overall Study|Withdrawal by Subject|2|||
148760400|NCT02022202|536594420|FG000|Overall Study|Disease Progression|3|||
148760401|NCT02022202|536594420|FG000|Overall Study|Desire go to immediately to surgery|3|||
148760402|NCT04390763|536594422|FG000|Safety run-in Part|Adverse Event|4|||
148760403|NCT04390763|536594423|FG001|Safety run-in Part|Adverse Event|0|||
148760404|NCT04390763|536594424|FG002|Safety run-in Part|Adverse Event|0|||
148760405|NCT04390763|536594425|FG003|Safety run-in Part|Adverse Event|0|||
148760406|NCT04390763|536594422|FG000|Safety run-in Part|Physician Decision|1|||
148825739|NCT00511199|536840287|FG001|Overall Study|Lost to Follow-up|17|||
148825740|NCT00511199|536840286|FG000|Overall Study|Other Reason|78|||
148760407|NCT04390763|536594423|FG001|Safety run-in Part|Physician Decision|0|||
148760408|NCT04390763|536594424|FG002|Safety run-in Part|Physician Decision|0|||
148760409|NCT04390763|536594425|FG003|Safety run-in Part|Physician Decision|0|||
148760410|NCT04390763|536594422|FG000|Safety run-in Part|Progressive Disease|6|||
148760411|NCT04390763|536594423|FG001|Safety run-in Part|Progressive Disease|0|||
148760412|NCT04390763|536594424|FG002|Safety run-in Part|Progressive Disease|0|||
148760413|NCT04390763|536594425|FG003|Safety run-in Part|Progressive Disease|0|||
148760414|NCT04390763|536594422|FG000|Randomized Part|Adverse Event|0|||
148760415|NCT04390763|536594423|FG001|Randomized Part|Adverse Event|11|||
148760416|NCT04390763|536594424|FG002|Randomized Part|Adverse Event|5|||
148760417|NCT04390763|536594425|FG003|Randomized Part|Adverse Event|5|||
148760418|NCT04390763|536594422|FG000|Randomized Part|Death|0|||
148760419|NCT04390763|536594423|FG001|Randomized Part|Death|3|||
148760420|NCT04390763|536594424|FG002|Randomized Part|Death|4|||
148760421|NCT04390763|536594425|FG003|Randomized Part|Death|2|||
148760422|NCT04390763|536594422|FG000|Randomized Part|Physician Decision|0|||
148760423|NCT04390763|536594423|FG001|Randomized Part|Physician Decision|2|||
148760424|NCT04390763|536594424|FG002|Randomized Part|Physician Decision|2|||
148760425|NCT04390763|536594425|FG003|Randomized Part|Physician Decision|9|||
148760426|NCT04390763|536594422|FG000|Randomized Part|Progressive Disease|0|||
148760427|NCT04390763|536594423|FG001|Randomized Part|Progressive Disease|24|||
148760428|NCT04390763|536594424|FG002|Randomized Part|Progressive Disease|31|||
148760429|NCT04390763|536594425|FG003|Randomized Part|Progressive Disease|23|||
148760430|NCT04390763|536594422|FG000|Randomized Part|Study terminated by sponsor|0|||
148760431|NCT04390763|536594423|FG001|Randomized Part|Study terminated by sponsor|1|||
148760432|NCT04390763|536594424|FG002|Randomized Part|Study terminated by sponsor|0|||
148760433|NCT04390763|536594425|FG003|Randomized Part|Study terminated by sponsor|0|||
148760434|NCT04390763|536594422|FG000|Randomized Part|Participant Decision|0|||
148760435|NCT04390763|536594423|FG001|Randomized Part|Participant Decision|5|||
148760436|NCT04390763|536594424|FG002|Randomized Part|Participant Decision|7|||
148760437|NCT04390763|536594425|FG003|Randomized Part|Participant Decision|6|||
148760438|NCT04390763|536594422|FG000|Randomized Part|Not treated|0|||
148760439|NCT04390763|536594423|FG001|Randomized Part|Not treated|4|||
148760440|NCT04390763|536594424|FG002|Randomized Part|Not treated|2|||
148760441|NCT04390763|536594425|FG003|Randomized Part|Not treated|7|||
148760442|NCT01956773|536594430|FG000|Overall Study|Lost to Follow-up|628|||
148760443|NCT01956773|536594431|FG001|Overall Study|Lost to Follow-up|1|||
148760444|NCT02040805|536594432|FG000|Overall Study|Lost to Follow-up|14|||
148760445|NCT02040805|536594433|FG001|Overall Study|Lost to Follow-up|9|||
148760446|NCT02040805|536594432|FG000|Overall Study|Withdrawal by Subject|28|||
148760447|NCT02040805|536594433|FG001|Overall Study|Withdrawal by Subject|41|||
148760448|NCT04495829|536594434|FG000|Overall Study|Lost to Follow-up|2|||
148760449|NCT04495829|536594434|FG000|Overall Study|Inclusion criterion not met|3|||
148760450|NCT02259010|536594437|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
148760451|NCT03194542|536594438|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
148760452|NCT03194542|536594439|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
148760453|NCT03194542|536594440|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
148760454|NCT03194542|536594441|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
148760455|NCT03194542|536594438|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
148760456|NCT03194542|536594439|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
148760457|NCT03194542|536594440|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
148760458|NCT03194542|536594441|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
148760459|NCT03194542|536594438|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
148760460|NCT03194542|536594439|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
148760461|NCT03194542|536594440|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
148760462|NCT03194542|536594441|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
148760463|NCT03194542|536594438|FG000|Overall Study|Loss of Response|4|||
148760464|NCT03194542|536594439|FG001|Overall Study|Loss of Response|2|||
148760465|NCT03194542|536594440|FG002|Overall Study|Loss of Response|3|||
148760466|NCT03194542|536594441|FG003|Overall Study|Loss of Response|4|||
148760467|NCT03194542|536594438|FG000|Overall Study|Physician Decision|0|||
148760468|NCT03194542|536594439|FG001|Overall Study|Physician Decision|1|||
148760469|NCT03194542|536594440|FG002|Overall Study|Physician Decision|0|||
148760470|NCT03194542|536594441|FG003|Overall Study|Physician Decision|0|||
148760471|NCT03194542|536594438|FG000|Overall Study|Lack of Efficacy|2|||
148760472|NCT03194542|536594439|FG001|Overall Study|Lack of Efficacy|2|||
148760473|NCT03194542|536594440|FG002|Overall Study|Lack of Efficacy|2|||
148760474|NCT03194542|536594441|FG003|Overall Study|Lack of Efficacy|6|||
148760475|NCT03194542|536594438|FG000|Overall Study|Withdrawal by Subject|2|||
148760476|NCT03194542|536594439|FG001|Overall Study|Withdrawal by Subject|1|||
148760477|NCT03194542|536594440|FG002|Overall Study|Withdrawal by Subject|5|||
148760478|NCT03194542|536594441|FG003|Overall Study|Withdrawal by Subject|4|||
148760479|NCT03194542|536594438|FG000|Overall Study|Progressive Disease|1|||
148760480|NCT03194542|536594439|FG001|Overall Study|Progressive Disease|0|||
148760481|NCT03194542|536594440|FG002|Overall Study|Progressive Disease|1|||
148760482|NCT03194542|536594441|FG003|Overall Study|Progressive Disease|1|||
148760483|NCT03194542|536594438|FG000|Overall Study|Adverse Event|1|||
148760484|NCT03194542|536594439|FG001|Overall Study|Adverse Event|2|||
148825741|NCT00511199|536840287|FG001|Overall Study|Other Reason|37|||
148825742|NCT02314247|536840292|FG000|Overall Study|Adverse Event|2|||
148825743|NCT02314247|536840293|FG001|Overall Study|Adverse Event|1|||
148825744|NCT02314247|536840294|FG002|Overall Study|Adverse Event|0|||
148825745|NCT02314247|536840292|FG000|Overall Study|Withdrawal by Subject|1|||
148825746|NCT02314247|536840293|FG001|Overall Study|Withdrawal by Subject|3|||
148825747|NCT02314247|536840294|FG002|Overall Study|Withdrawal by Subject|1|||
148825748|NCT02314247|536840292|FG000|Overall Study|Progression of Disease|6|||
148825749|NCT02314247|536840293|FG001|Overall Study|Progression of Disease|2|||
148825750|NCT02314247|536840294|FG002|Overall Study|Progression of Disease|0|||
148825751|NCT01953354|536840295|FG000|Overall Study|Withdrawal by Subject|0|||
148825752|NCT01953354|536840296|FG001|Overall Study|Withdrawal by Subject|1|||
148825753|NCT01953354|536840295|FG000|Overall Study|Decision of Sponsor|0|||
148825754|NCT01953354|536840296|FG001|Overall Study|Decision of Sponsor|1|||
148825755|NCT01953354|536840295|FG000|Overall Study|Disease Exacerbation|1|||
148825756|NCT01953354|536840296|FG001|Overall Study|Disease Exacerbation|0|||
148825757|NCT00489359|536840297|FG000|Overall Study|Death|0|||
148825758|NCT00489359|536840298|FG001|Overall Study|Death|2|||
148825759|NCT00489359|536840297|FG000|Overall Study|Progressive Disease|5|||
148825760|NCT00489359|536840298|FG001|Overall Study|Progressive Disease|6|||
148825761|NCT00489359|536840297|FG000|Overall Study|Lost to Follow-up|1|||
148825762|NCT00489359|536840298|FG001|Overall Study|Lost to Follow-up|0|||
148825763|NCT00489359|536840297|FG000|Overall Study|Withdrawal by Subject|1|||
148825764|NCT00489359|536840298|FG001|Overall Study|Withdrawal by Subject|5|||
148825765|NCT00489359|536840297|FG000|Overall Study|Adverse Event|0|||
148825766|NCT00489359|536840298|FG001|Overall Study|Adverse Event|16|||
148825767|NCT03180138|536840299|FG000|Overall Study|Mobile-phone could not be verified|2|||
148825768|NCT03180138|536840300|FG001|Overall Study|Mobile-phone could not be verified|13|||
148825769|NCT03180138|536840301|FG002|Overall Study|Mobile-phone could not be verified|15|||
148825770|NCT03180138|536840299|FG000|Overall Study|No prior immunization records|17|||
148825771|NCT03180138|536840300|FG001|Overall Study|No prior immunization records|0|||
148825772|NCT03180138|536840301|FG002|Overall Study|No prior immunization records|6|||
148825773|NCT03180138|536840299|FG000|Overall Study|Found to be >24 mon after randomization|3|||
148825774|NCT03180138|536840300|FG001|Overall Study|Found to be >24 mon after randomization|0|||
148825775|NCT03180138|536840301|FG002|Overall Study|Found to be >24 mon after randomization|3|||
148825776|NCT04191733|536840302|FG000|Overall Study|Withdrawn due to study closure|13|||
148825777|NCT04191733|536840303|FG001|Overall Study|Withdrawn due to study closure|14|||
148825778|NCT04191733|536840302|FG000|Overall Study|Withdrawal by Subject|2|||
148825779|NCT04191733|536840303|FG001|Overall Study|Withdrawal by Subject|4|||
148825780|NCT04191733|536840302|FG000|Overall Study|Physician Decision|1|||
148825781|NCT04191733|536840303|FG001|Overall Study|Physician Decision|1|||
148825782|NCT04191733|536840302|FG000|Overall Study|Lost to Follow-up|5|||
148825783|NCT04191733|536840303|FG001|Overall Study|Lost to Follow-up|6|||
148825784|NCT04191733|536840302|FG000|Overall Study|Death|0|||
148825785|NCT04191733|536840303|FG001|Overall Study|Death|1|||
148825786|NCT01260311|536840305|FG000|Overall Study|Adverse Event|11|||
148825787|NCT01260311|536840305|FG000|Overall Study|Lack of Efficacy|4|||
148825788|NCT01260311|536840305|FG000|Overall Study|Lost to Follow-up|25|||
148825789|NCT01260311|536840305|FG000|Overall Study|Withdrawal by Subject|6|||
148825790|NCT01260311|536840305|FG000|Overall Study|Financial Constraints|77|||
148825791|NCT01260311|536840305|FG000|Overall Study|Gone to Province|2|||
148825792|NCT01260311|536840305|FG000|Overall Study|Medication Stopped|1|||
148825793|NCT01260311|536840305|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
148825794|NCT05451329|536840306|FG000|Overall Study|Adverse Event|1|||
148825795|NCT05451329|536840307|FG001|Overall Study|Adverse Event|1|||
148825796|NCT05451329|536840308|FG002|Overall Study|Adverse Event|0|||
148825797|NCT05451329|536840306|FG000|Overall Study|Withdrawal by Subject|1|||
148825798|NCT05451329|536840307|FG001|Overall Study|Withdrawal by Subject|0|||
148825799|NCT05451329|536840308|FG002|Overall Study|Withdrawal by Subject|0|||
148825800|NCT05451329|536840306|FG000|Overall Study|Investigational Product Lot exchange|1|||
148825801|NCT05451329|536840307|FG001|Overall Study|Investigational Product Lot exchange|1|||
148825802|NCT05451329|536840308|FG002|Overall Study|Investigational Product Lot exchange|0|||
148825803|NCT02633527|536840311|FG000|Overall Study|Failed to meet eligibility|0|||
148825804|NCT02633527|536840312|FG001|Overall Study|Failed to meet eligibility|1|||
148825805|NCT02633527|536840313|FG002|Overall Study|Failed to meet eligibility|1|||
148825806|NCT02633527|536840314|FG003|Overall Study|Failed to meet eligibility|0|||
148825807|NCT02633527|536840315|FG004|Overall Study|Failed to meet eligibility|1|||
148825808|NCT02633527|536840311|FG000|Overall Study|Adverse Event|0|||
148825809|NCT02633527|536840312|FG001|Overall Study|Adverse Event|4|||
149027470|NCT01237678|537578568|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
149027471|NCT01237678|537578569|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
148825810|NCT02633527|536840313|FG002|Overall Study|Adverse Event|3|||
148825811|NCT02633527|536840314|FG003|Overall Study|Adverse Event|1|||
148825812|NCT02633527|536840315|FG004|Overall Study|Adverse Event|5|||
148825813|NCT02633527|536840311|FG000|Overall Study|Lost to Follow-up|1|||
148825814|NCT02633527|536840312|FG001|Overall Study|Lost to Follow-up|2|||
148825815|NCT02633527|536840313|FG002|Overall Study|Lost to Follow-up|5|||
148825816|NCT02633527|536840314|FG003|Overall Study|Lost to Follow-up|5|||
148825817|NCT02633527|536840315|FG004|Overall Study|Lost to Follow-up|4|||
148825818|NCT02633527|536840311|FG000|Overall Study|Withdrawal by Subject|0|||
148825819|NCT02633527|536840312|FG001|Overall Study|Withdrawal by Subject|3|||
148825820|NCT02633527|536840313|FG002|Overall Study|Withdrawal by Subject|5|||
148825821|NCT02633527|536840314|FG003|Overall Study|Withdrawal by Subject|4|||
148825822|NCT02633527|536840315|FG004|Overall Study|Withdrawal by Subject|4|||
148825823|NCT02633527|536840311|FG000|Overall Study|Protocol Violation|0|||
148825824|NCT02633527|536840312|FG001|Overall Study|Protocol Violation|1|||
149027472|NCT01237678|537578567|FG000|Phase II|Adverse Event|0|||
149027473|NCT01237678|537578568|FG001|Phase II|Adverse Event|39|||
149027474|NCT01237678|537578569|FG002|Phase II|Adverse Event|9|||
149027475|NCT01237678|537578567|FG000|Phase II|Death|0|||
149027476|NCT01237678|537578568|FG001|Phase II|Death|0|||
148760485|NCT03194542|536594440|FG002|Overall Study|Adverse Event|0|||
148760486|NCT03194542|536594441|FG003|Overall Study|Adverse Event|5|||
148825825|NCT02633527|536840313|FG002|Overall Study|Protocol Violation|1|||
148825826|NCT02633527|536840314|FG003|Overall Study|Protocol Violation|1|||
148825827|NCT02633527|536840315|FG004|Overall Study|Protocol Violation|1|||
148825828|NCT02633527|536840311|FG000|Overall Study|Physician Decision|0|||
148825829|NCT02633527|536840312|FG001|Overall Study|Physician Decision|0|||
148825830|NCT02633527|536840313|FG002|Overall Study|Physician Decision|0|||
148825831|NCT02633527|536840314|FG003|Overall Study|Physician Decision|0|||
148825832|NCT02633527|536840315|FG004|Overall Study|Physician Decision|1|||
148825833|NCT02633527|536840311|FG000|Overall Study|Administrative reason|1|||
148760487|NCT03194542|536594438|FG000|Overall Study|Death|1|||
148760488|NCT03194542|536594439|FG001|Overall Study|Death|2|||
148760489|NCT03194542|536594440|FG002|Overall Study|Death|0|||
148760490|NCT03194542|536594441|FG003|Overall Study|Death|5|||
148760491|NCT03194542|536594438|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
148760492|NCT03194542|536594439|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
148760493|NCT03194542|536594440|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
148760494|NCT03194542|536594441|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
148760495|NCT03655405|536594444|FG000|Overall Study|Death after initial data collection|4|||
148760496|NCT03655405|536594445|FG001|Overall Study|Death after initial data collection|2|||
148760497|NCT03655405|536594444|FG000|Overall Study|Died before initial data collection|1|||
148760498|NCT03655405|536594445|FG001|Overall Study|Died before initial data collection|2|||
148760499|NCT03655405|536594444|FG000|Overall Study|Protocol Violation|0|||
148760500|NCT03655405|536594445|FG001|Overall Study|Protocol Violation|1|||
148760501|NCT05151744|536596682|FG000|Overall Study|Adverse Event|6|||
148760502|NCT05151744|536596683|FG001|Overall Study|Adverse Event|2|||
148760503|NCT05151744|536596682|FG000|Overall Study|Death|1|||
148760504|NCT05151744|536596683|FG001|Overall Study|Death|2|||
148760505|NCT05151744|536596682|FG000|Overall Study|Lack of Efficacy|1|||
148760506|NCT05151744|536596683|FG001|Overall Study|Lack of Efficacy|1|||
148760507|NCT05151744|536596682|FG000|Overall Study|Lost to Follow-up|2|||
148760508|NCT05151744|536596683|FG001|Overall Study|Lost to Follow-up|2|||
148760509|NCT05151744|536596682|FG000|Overall Study|Need for Rescue Treatment|0|||
148760510|NCT05151744|536596683|FG001|Overall Study|Need for Rescue Treatment|1|||
148760511|NCT05151744|536596682|FG000|Overall Study|Non-compliance with Study Drug|0|||
148760512|NCT05151744|536596683|FG001|Overall Study|Non-compliance with Study Drug|1|||
148760513|NCT05151744|536596682|FG000|Overall Study|Reason not Specified|10|||
148760514|NCT05151744|536596683|FG001|Overall Study|Reason not Specified|0|||
148760515|NCT05151744|536596682|FG000|Overall Study|Physician Decision|2|||
148760516|NCT05151744|536596683|FG001|Overall Study|Physician Decision|1|||
148760517|NCT05151744|536596682|FG000|Overall Study|Protocol Violation|1|||
148760518|NCT05151744|536596683|FG001|Overall Study|Protocol Violation|0|||
148825834|NCT02633527|536840312|FG001|Overall Study|Administrative reason|0|||
148825835|NCT02633527|536840313|FG002|Overall Study|Administrative reason|0|||
148825836|NCT02633527|536840314|FG003|Overall Study|Administrative reason|1|||
148825837|NCT02633527|536840315|FG004|Overall Study|Administrative reason|0|||
148825838|NCT02633527|536840311|FG000|Overall Study|Multiple reasons|1|||
148825839|NCT02633527|536840312|FG001|Overall Study|Multiple reasons|0|||
148825840|NCT02633527|536840313|FG002|Overall Study|Multiple reasons|2|||
148825841|NCT02633527|536840314|FG003|Overall Study|Multiple reasons|2|||
148825842|NCT02633527|536840315|FG004|Overall Study|Multiple reasons|1|||
148825843|NCT00728182|536840318|FG000|Overall Study|Adverse Event|1|||
148825844|NCT00728182|536840319|FG001|Overall Study|Adverse Event|0|||
149027477|NCT01237678|537578569|FG002|Phase II|Death|2|||
148760519|NCT05151744|536596682|FG000|Overall Study|Withdrawal by Subject|6|||
148760520|NCT05151744|536596683|FG001|Overall Study|Withdrawal by Subject|3|||
148760521|NCT05228470|536596684|FG000|Overall Study|Death|6|||
148760522|NCT05228470|536596685|FG001|Overall Study|Death|11|||
148825845|NCT00728182|536840318|FG000|Overall Study|Lost to Follow-up|2|||
148825846|NCT00728182|536840319|FG001|Overall Study|Lost to Follow-up|0|||
148825847|NCT00728182|536840318|FG000|Overall Study|Death|0|||
149027478|NCT01237678|537578567|FG000|Phase II|Lack of Efficacy|0|||
148825848|NCT00728182|536840319|FG001|Overall Study|Death|2|||
148825849|NCT00728182|536840318|FG000|Overall Study|Protocol Noncompliance|0|||
148825850|NCT00728182|536840319|FG001|Overall Study|Protocol Noncompliance|1|||
148760523|NCT05228470|536596684|FG000|Overall Study|Withdrawal by Subject|1|||
148825851|NCT01898091|536840323|FG000|Overall Study|Lost to Follow-up|1|||
148825852|NCT01898091|536840324|FG001|Overall Study|Lost to Follow-up|1|||
148825853|NCT01898091|536840323|FG000|Overall Study|Withdrawal by Subject|1|||
148825854|NCT01898091|536840324|FG001|Overall Study|Withdrawal by Subject|5|||
148825855|NCT02913326|536840330|FG000|Overall Study|Reason not listed|0|||
148825856|NCT02913326|536840331|FG001|Overall Study|Reason not listed|1|||
148825857|NCT02913326|536840330|FG000|Overall Study|Lost to Follow-up|0|||
148825858|NCT02913326|536840331|FG001|Overall Study|Lost to Follow-up|1|||
148825859|NCT02913326|536840330|FG000|Overall Study|Adverse Event|1|||
148825860|NCT02913326|536840331|FG001|Overall Study|Adverse Event|0|||
148825861|NCT01725308|536840332|FG000|Treatment Period I|Did Not Receive Drug|1|||
148825862|NCT01725308|536840333|FG001|Treatment Period I|Did Not Receive Drug|0|||
148825863|NCT01725308|536840334|FG002|Treatment Period I|Did Not Receive Drug|0|||
148825864|NCT01725308|536840332|FG000|Treatment Period I|Adverse Event|5|||
148825865|NCT01725308|536840333|FG001|Treatment Period I|Adverse Event|4|||
148825866|NCT01725308|536840334|FG002|Treatment Period I|Adverse Event|21|||
148760524|NCT05228470|536596685|FG001|Overall Study|Withdrawal by Subject|8|||
148760525|NCT05228470|536596684|FG000|Overall Study|Ongoing|1|||
148760526|NCT05228470|536596685|FG001|Overall Study|Ongoing|11|||
148760527|NCT04053868|536596686|FG000|Overall Study|Withdrawal by Subject|1|||
148760528|NCT04053868|536596687|FG001|Overall Study|Withdrawal by Subject|0|||
148760529|NCT05731700|536596688|FG000|Overall Study|Death|1|||
148760530|NCT05400655|536596691|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
148760531|NCT05400655|536596692|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
148760532|NCT05400655|536596693|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
148760533|NCT05400655|536596694|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
148760534|NCT05400655|536596695|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
148760535|NCT05400655|536596696|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
148760536|NCT05400655|536596697|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
148760537|NCT05400655|536596698|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
148760538|NCT05400655|536596699|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
148760539|NCT05400655|536596700|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
148760540|NCT05400655|536596701|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
148760541|NCT05400655|536596702|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
148760542|NCT05400655|536596703|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
148760543|NCT05400655|536596704|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
148760544|NCT05400655|536596705|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
148760545|NCT05400655|536596706|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
148760546|NCT05400655|536596707|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
148760547|NCT05400655|536596708|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
148760548|NCT05400655|536596709|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
148760549|NCT05400655|536596710|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
148760550|NCT05400655|536596711|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
148760551|NCT05400655|536596712|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
148760552|NCT05400655|536596691|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760553|NCT05400655|536596692|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760554|NCT05400655|536596693|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760555|NCT05400655|536596694|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760556|NCT05400655|536596695|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760557|NCT05400655|536596696|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760558|NCT05400655|536596697|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760559|NCT05400655|536596698|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760560|NCT05400655|536596699|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760561|NCT05400655|536596700|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760562|NCT05400655|536596701|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760563|NCT05400655|536596702|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760564|NCT05400655|536596703|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
148825867|NCT01725308|536840332|FG000|Treatment Period I|Insufficient Response|7|||
148825868|NCT01725308|536840333|FG001|Treatment Period I|Insufficient Response|0|||
148825869|NCT01725308|536840334|FG002|Treatment Period I|Insufficient Response|5|||
148825870|NCT01725308|536840332|FG000|Treatment Period I|Worsening of the Target Disease|8|||
148825871|NCT01725308|536840333|FG001|Treatment Period I|Worsening of the Target Disease|0|||
148825872|NCT01725308|536840334|FG002|Treatment Period I|Worsening of the Target Disease|2|||
148825873|NCT01725308|536840332|FG000|Treatment Period I|Changes in the Episodes|3|||
148825874|NCT01725308|536840333|FG001|Treatment Period I|Changes in the Episodes|0|||
148825875|NCT01725308|536840334|FG002|Treatment Period I|Changes in the Episodes|2|||
148825876|NCT01725308|536840332|FG000|Treatment Period I|Withdrawal of Consent|12|||
148825877|NCT01725308|536840333|FG001|Treatment Period I|Withdrawal of Consent|7|||
148825878|NCT01725308|536840334|FG002|Treatment Period I|Withdrawal of Consent|5|||
148825879|NCT01725308|536840332|FG000|Treatment Period I|Lost to Follow-up|3|||
148825880|NCT01725308|536840333|FG001|Treatment Period I|Lost to Follow-up|2|||
148760565|NCT05400655|536596704|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760566|NCT05400655|536596705|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760567|NCT05400655|536596706|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760568|NCT05400655|536596707|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
148760569|NCT05400655|536596708|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760570|NCT05400655|536596709|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
148760571|NCT05400655|536596710|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
148760572|NCT05400655|536596711|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148760573|NCT05400655|536596712|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
148977040|NCT00812929|537396547|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
148977041|NCT00812929|537396548|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
148760574|NCT05400655|536596691|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760575|NCT05400655|536596692|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760576|NCT05400655|536596693|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760577|NCT05400655|536596694|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760578|NCT05400655|536596695|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760579|NCT05400655|536596696|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760580|NCT05400655|536596697|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760581|NCT05400655|536596698|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760582|NCT05400655|536596699|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760583|NCT05400655|536596700|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760584|NCT05400655|536596701|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760585|NCT05400655|536596702|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760586|NCT05400655|536596703|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760587|NCT05400655|536596704|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
148760588|NCT05400655|536596705|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760589|NCT05400655|536596706|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760590|NCT05400655|536596707|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
148760591|NCT05400655|536596708|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760592|NCT05400655|536596709|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
148760593|NCT05400655|536596710|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760594|NCT05400655|536596711|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760595|NCT05400655|536596712|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
148760596|NCT05400655|536596691|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760597|NCT05400655|536596692|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760598|NCT05400655|536596693|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760599|NCT05400655|536596694|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760600|NCT05400655|536596695|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760601|NCT05400655|536596696|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760602|NCT05400655|536596697|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760603|NCT05400655|536596698|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760604|NCT05400655|536596699|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760605|NCT05400655|536596700|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760606|NCT05400655|536596701|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760607|NCT05400655|536596702|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760608|NCT05400655|536596703|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760609|NCT05400655|536596704|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760610|NCT05400655|536596705|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760611|NCT05400655|536596706|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760612|NCT05400655|536596707|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
148760613|NCT05400655|536596708|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
148760614|NCT05400655|536596709|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
148760615|NCT05400655|536596710|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
148760616|NCT05400655|536596711|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
148760617|NCT05400655|536596712|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
148760618|NCT05400655|536596691|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760619|NCT05400655|536596692|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760620|NCT05400655|536596693|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760621|NCT05400655|536596694|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760622|NCT05400655|536596695|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760623|NCT05400655|536596696|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760624|NCT05400655|536596697|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760625|NCT05400655|536596698|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760626|NCT05400655|536596699|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760627|NCT05400655|536596700|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760628|NCT05400655|536596701|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760629|NCT05400655|536596702|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760630|NCT05400655|536596703|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760631|NCT05400655|536596704|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760632|NCT05400655|536596705|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148977042|NCT00812929|537396549|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
149027479|NCT01237678|537578568|FG001|Phase II|Lack of Efficacy|25|||
148977043|NCT00812929|537396550|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
148977044|NCT00812929|537396551|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
148977045|NCT00812929|537396552|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
148977046|NCT00812929|537396553|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
148977047|NCT00812929|537396554|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
148760633|NCT05400655|536596706|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760634|NCT05400655|536596707|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148977048|NCT00812929|537396545|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
148977049|NCT00812929|537396546|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
148760635|NCT05400655|536596708|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
148760636|NCT05400655|536596709|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
148760637|NCT05400655|536596710|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760638|NCT05400655|536596711|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760639|NCT05400655|536596712|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
148760640|NCT05400655|536596691|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760641|NCT05400655|536596692|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760642|NCT05400655|536596693|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760643|NCT05400655|536596694|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760644|NCT05400655|536596695|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760645|NCT05400655|536596696|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760646|NCT05400655|536596697|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760647|NCT05400655|536596698|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760648|NCT05400655|536596699|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760649|NCT05400655|536596700|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760650|NCT05400655|536596701|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760651|NCT05400655|536596702|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760652|NCT05400655|536596703|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760653|NCT05400655|536596704|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760654|NCT05400655|536596705|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760655|NCT05400655|536596706|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760656|NCT05400655|536596707|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
148760657|NCT05400655|536596708|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
148760658|NCT05400655|536596709|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
148760659|NCT05400655|536596710|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
148760660|NCT05400655|536596711|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
148760661|NCT05400655|536596712|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
148760662|NCT01068678|536596721|FG000|Overall Study|Lack of Efficacy|3|||
148760663|NCT01068678|536596722|FG001|Overall Study|Lack of Efficacy|2|||
148760664|NCT01068678|536596721|FG000|Overall Study|Protocol Violation|5|||
148760665|NCT01068678|536596722|FG001|Overall Study|Protocol Violation|1|||
148760666|NCT01068678|536596721|FG000|Overall Study|Withdrawal criteria|12|||
148760667|NCT01068678|536596722|FG001|Overall Study|Withdrawal criteria|6|||
148760668|NCT01068678|536596721|FG000|Overall Study|Unclassified|18|||
148760669|NCT01068678|536596722|FG001|Overall Study|Unclassified|15|||
148760670|NCT02088554|536596726|FG000|Overall Study|Exited before procedure|130|||
148760671|NCT02088554|536596726|FG000|Overall Study|Attempted but not implanted|31|||
148760672|NCT02088554|536596726|FG000|Overall Study|Implant not attempted|19|||
148760673|NCT02088554|536596726|FG000|Overall Study|Pending next visit|532|||
148760674|NCT02088554|536596726|FG000|Overall Study|Death|170|||
148760675|NCT02088554|536596726|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
148760676|NCT02088554|536596726|FG000|Overall Study|Lost to Follow-up|23|||
148760677|NCT02088554|536596726|FG000|Overall Study|Explanted|32|||
148760678|NCT02088554|536596726|FG000|Overall Study|Any other reason not covered by previous categories|11|||
148760679|NCT02275546|536596731|FG000|Treatment Period 2|Withdrawal by Subject|2|||
148760680|NCT02275546|536596732|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148760681|NCT02275546|536596731|FG000|Treatment Period 2|Protocol Violation|0|||
148760682|NCT02275546|536596732|FG001|Treatment Period 2|Protocol Violation|1|||
148760683|NCT02612623|536596738|FG000|Overall Study|Withdrawal by Subject|0|||
148760684|NCT02612623|536596739|FG001|Overall Study|Withdrawal by Subject|1|||
148760685|NCT02612623|536596740|FG002|Overall Study|Withdrawal by Subject|0|||
148760686|NCT02612623|536596741|FG003|Overall Study|Withdrawal by Subject|0|||
148760687|NCT02612623|536596738|FG000|Overall Study|Adverse Event|1|||
148977050|NCT00812929|537396547|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
148977051|NCT00812929|537396548|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
148760688|NCT02612623|536596739|FG001|Overall Study|Adverse Event|0|||
148977052|NCT00812929|537396549|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
148977053|NCT00812929|537396550|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
148977054|NCT00812929|537396551|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
148760689|NCT02612623|536596740|FG002|Overall Study|Adverse Event|1|||
148760690|NCT02612623|536596741|FG003|Overall Study|Adverse Event|0|||
148977055|NCT00812929|537396552|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
148825881|NCT01725308|536840334|FG002|Treatment Period I|Lost to Follow-up|2|||
148825882|NCT01725308|536840332|FG000|Treatment Period I|Protocol Deviations|3|||
148825883|NCT01725308|536840333|FG001|Treatment Period I|Protocol Deviations|1|||
148825884|NCT01725308|536840334|FG002|Treatment Period I|Protocol Deviations|1|||
148825885|NCT01725308|536840332|FG000|Treatment Period I|Miscellaneous|2|||
148825886|NCT01725308|536840333|FG001|Treatment Period I|Miscellaneous|0|||
148825887|NCT01725308|536840334|FG002|Treatment Period I|Miscellaneous|3|||
148825888|NCT01725308|536840332|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
148825889|NCT01725308|536840333|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
148825890|NCT01725308|536840334|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
148825891|NCT01725308|536840332|FG000|Treatment Period II|Did Not Receive Drug|4|||
148825892|NCT01725308|536840333|FG001|Treatment Period II|Did Not Receive Drug|0|||
148825893|NCT01725308|536840334|FG002|Treatment Period II|Did Not Receive Drug|0|||
148825894|NCT01725308|536840332|FG000|Treatment Period II|Adverse Event|13|||
148825895|NCT01725308|536840333|FG001|Treatment Period II|Adverse Event|8|||
148825896|NCT01725308|536840334|FG002|Treatment Period II|Adverse Event|20|||
148825897|NCT01725308|536840332|FG000|Treatment Period II|Insufficient Response|2|||
148825898|NCT01725308|536840333|FG001|Treatment Period II|Insufficient Response|4|||
148825899|NCT01725308|536840334|FG002|Treatment Period II|Insufficient Response|6|||
148825900|NCT01725308|536840332|FG000|Treatment Period II|Worsening of the Target Disease|1|||
148825901|NCT01725308|536840333|FG001|Treatment Period II|Worsening of the Target Disease|4|||
148825902|NCT01725308|536840334|FG002|Treatment Period II|Worsening of the Target Disease|2|||
148825903|NCT01725308|536840332|FG000|Treatment Period II|Changes in the Episodes|1|||
148825904|NCT01725308|536840333|FG001|Treatment Period II|Changes in the Episodes|0|||
148825905|NCT01725308|536840334|FG002|Treatment Period II|Changes in the Episodes|5|||
148825906|NCT01725308|536840332|FG000|Treatment Period II|Withdrawal of Consent|28|||
148825907|NCT01725308|536840333|FG001|Treatment Period II|Withdrawal of Consent|2|||
148825908|NCT01725308|536840334|FG002|Treatment Period II|Withdrawal of Consent|16|||
148825909|NCT01725308|536840332|FG000|Treatment Period II|Lost to Follow-up|1|||
148825910|NCT01725308|536840333|FG001|Treatment Period II|Lost to Follow-up|5|||
148825911|NCT01725308|536840334|FG002|Treatment Period II|Lost to Follow-up|3|||
148825912|NCT01725308|536840332|FG000|Treatment Period II|Protocol Deviations|0|||
148825913|NCT01725308|536840333|FG001|Treatment Period II|Protocol Deviations|0|||
148825914|NCT01725308|536840334|FG002|Treatment Period II|Protocol Deviations|1|||
148825915|NCT01725308|536840332|FG000|Treatment Period II|Miscellaneous|5|||
148825916|NCT01725308|536840333|FG001|Treatment Period II|Miscellaneous|3|||
148825917|NCT01725308|536840334|FG002|Treatment Period II|Miscellaneous|7|||
148825918|NCT01943825|536840341|FG000|Overall Study|Lost to Follow-up|9|||
148825919|NCT01943825|536840342|FG001|Overall Study|Lost to Follow-up|3|||
148825920|NCT01943825|536840343|FG002|Overall Study|Lost to Follow-up|12|||
149027480|NCT01237678|537578569|FG002|Phase II|Lack of Efficacy|3|||
149027481|NCT01237678|537578567|FG000|Phase II|Withdrawal by Subject|0|||
148760691|NCT00570141|536596746|FG000|Overall Study|Adverse Event|1|||
148760692|NCT00570141|536596746|FG000|Overall Study|Missed visits|1|||
148760693|NCT00570141|536596746|FG000|Overall Study|Lost to Follow-up|1|||
148760694|NCT02309411|536596749|FG000|Overall Study|Physician Decision|1|||
148760695|NCT02309411|536596750|FG001|Overall Study|Physician Decision|0|||
148760696|NCT02309411|536596751|FG002|Overall Study|Physician Decision|0|||
148760697|NCT02309411|536596749|FG000|Overall Study|Withdrawal by Subject|1|||
148760698|NCT02309411|536596750|FG001|Overall Study|Withdrawal by Subject|1|||
148760699|NCT02309411|536596751|FG002|Overall Study|Withdrawal by Subject|0|||
148760700|NCT00449865|536596757|FG000|Overall Study|Withdrawal by Subject|110|||
148760701|NCT00449865|536596758|FG001|Overall Study|Withdrawal by Subject|110|||
148760702|NCT00449865|536596757|FG000|Overall Study|Lost to Follow-up|36|||
148760703|NCT00449865|536596758|FG001|Overall Study|Lost to Follow-up|37|||
148760704|NCT00449865|536596757|FG000|Overall Study|Physician Decision|13|||
148760705|NCT00449865|536596758|FG001|Overall Study|Physician Decision|12|||
148760706|NCT00449865|536596757|FG000|Overall Study|Death|31|||
148760707|NCT00449865|536596758|FG001|Overall Study|Death|40|||
148760708|NCT00449865|536596757|FG000|Overall Study|Protocol Violation|8|||
148760709|NCT00449865|536596758|FG001|Overall Study|Protocol Violation|7|||
148760710|NCT00449865|536596757|FG000|Overall Study|Study was stopped|324|||
148760711|NCT00449865|536596758|FG001|Overall Study|Study was stopped|328|||
148760712|NCT00406367|536596759|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
148760713|NCT00406367|536596760|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
148760714|NCT00406367|536596759|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
148760715|NCT00406367|536596760|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
148760716|NCT00406367|536596759|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
148760717|NCT00406367|536596760|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
148760718|NCT00406367|536596759|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
148760719|NCT00406367|536596760|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
148760720|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
148760721|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
148760722|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
148977056|NCT00812929|537396553|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
148977057|NCT00812929|537396554|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
148977058|NCT00812929|537396545|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
148977059|NCT00812929|537396546|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
148977060|NCT00812929|537396547|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
148977061|NCT00812929|537396548|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
148977062|NCT00812929|537396549|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
148977063|NCT00812929|537396550|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
148977064|NCT00812929|537396551|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
148977065|NCT00812929|537396552|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
148977066|NCT00812929|537396553|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
148977067|NCT00812929|537396554|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
148977068|NCT04027686|537396555|FG000|Overall Study|Lost to Follow-up|2|||
148977069|NCT04027686|537396556|FG001|Overall Study|Lost to Follow-up|0|||
148977070|NCT04027686|537396555|FG000|Overall Study|Withdrawal by Subject|0|||
148977071|NCT04027686|537396556|FG001|Overall Study|Withdrawal by Subject|1|||
148977072|NCT03217136|537396562|FG000|Overall Study|Lost to Follow-up|2|||
148977073|NCT03217136|537396563|FG001|Overall Study|Lost to Follow-up|1|||
148977074|NCT03217136|537396562|FG000|Overall Study|Site Randomized Participant in Error|0|||
148977075|NCT03217136|537396563|FG001|Overall Study|Site Randomized Participant in Error|1|||
148977076|NCT03217136|537396562|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
148977077|NCT03217136|537396563|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
148977078|NCT03217136|537396562|FG000|Overall Study|Dispensing Error|1|||
148977079|NCT03217136|537396563|FG001|Overall Study|Dispensing Error|0|||
148977080|NCT03217136|537396562|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
148977081|NCT03217136|537396563|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148977082|NCT01401530|537396564|FG000|Overall Study|Disease Progression|1|||
148977083|NCT01401530|537396565|FG001|Overall Study|Disease Progression|2|||
148977084|NCT01401530|537396566|FG002|Overall Study|Disease Progression|1|||
148977085|NCT01401530|537396564|FG000|Overall Study|Adverse Event|1|||
148977086|NCT01401530|537396565|FG001|Overall Study|Adverse Event|1|||
148977087|NCT01401530|537396566|FG002|Overall Study|Adverse Event|1|||
148977088|NCT01401530|537396564|FG000|Overall Study|Participant Choice|1|||
148977089|NCT01401530|537396565|FG001|Overall Study|Participant Choice|2|||
148977090|NCT01401530|537396566|FG002|Overall Study|Participant Choice|1|||
148977091|NCT01401530|537396564|FG000|Overall Study|Physician Decision|0|||
148977092|NCT01401530|537396565|FG001|Overall Study|Physician Decision|1|||
148977093|NCT01401530|537396566|FG002|Overall Study|Physician Decision|0|||
148977094|NCT00678691|537396567|FG000|Overall Study|Adverse Event|6|||
148977095|NCT00678691|537396568|FG001|Overall Study|Adverse Event|4|||
148977096|NCT02203591|537396569|FG000|Overall Study|Did not meet treatment day baseline|147|||
148977097|NCT02203591|537396570|FG001|Overall Study|Did not meet treatment day baseline|141|||
148760723|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
148760724|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
148760725|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
148760726|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
148760727|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
148760728|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
148760729|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
148760730|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
148760731|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
148760732|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
148760733|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
148825921|NCT01943825|536840344|FG003|Overall Study|Lost to Follow-up|8|||
148825922|NCT01943825|536840341|FG000|Overall Study|Withdrawal by Subject|1|||
148977098|NCT02203591|537396571|FG002|Overall Study|Did not meet treatment day baseline|150|||
148977099|NCT02203591|537396572|FG003|Overall Study|Did not meet treatment day baseline|45|||
148977100|NCT02203591|537396573|FG004|Overall Study|Did not meet treatment day baseline|33|||
148977101|NCT02203591|537396574|FG005|Overall Study|Did not meet treatment day baseline|35|||
148977102|NCT02203591|537396575|FG006|Overall Study|Did not meet treatment day baseline|29|||
148977103|NCT02203591|537396576|FG007|Overall Study|Did not meet treatment day baseline|12|||
148977104|NCT02203591|537396569|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
148977105|NCT02203591|537396570|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
148977106|NCT02203591|537396571|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
148977107|NCT02203591|537396572|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
148977108|NCT02203591|537396573|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
148977109|NCT02203591|537396574|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
148977110|NCT02203591|537396575|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
148977111|NCT02203591|537396576|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
148977112|NCT03306264|537396579|FG000|Overall Study|Death|33|||
148977113|NCT03306264|537396580|FG001|Overall Study|Death|25|||
148825923|NCT01943825|536840342|FG001|Overall Study|Withdrawal by Subject|0|||
148825924|NCT01943825|536840343|FG002|Overall Study|Withdrawal by Subject|3|||
148825925|NCT01943825|536840344|FG003|Overall Study|Withdrawal by Subject|2|||
148825926|NCT01943825|536840341|FG000|Overall Study|Other than specified above|0|||
148825927|NCT01943825|536840342|FG001|Overall Study|Other than specified above|1|||
148825928|NCT01943825|536840343|FG002|Overall Study|Other than specified above|0|||
148825929|NCT01943825|536840344|FG003|Overall Study|Other than specified above|1|||
148825930|NCT00452400|536840345|FG000|Overall Study|Adverse Event|1|||
148825931|NCT00452400|536840346|FG001|Overall Study|Adverse Event|1|||
148825932|NCT00452400|536840347|FG002|Overall Study|Adverse Event|5|||
148825933|NCT00452400|536840348|FG003|Overall Study|Adverse Event|0|||
148825934|NCT00452400|536840349|FG004|Overall Study|Adverse Event|2|||
148825935|NCT00452400|536840345|FG000|Overall Study|Protocol Violation|0|||
148825936|NCT00452400|536840346|FG001|Overall Study|Protocol Violation|0|||
148825937|NCT00452400|536840347|FG002|Overall Study|Protocol Violation|1|||
148825938|NCT00452400|536840348|FG003|Overall Study|Protocol Violation|0|||
148825939|NCT00452400|536840349|FG004|Overall Study|Protocol Violation|0|||
148825940|NCT00452400|536840345|FG000|Overall Study|Lost to Follow-up|1|||
148825941|NCT00452400|536840346|FG001|Overall Study|Lost to Follow-up|0|||
148825942|NCT00452400|536840347|FG002|Overall Study|Lost to Follow-up|0|||
148825943|NCT00452400|536840348|FG003|Overall Study|Lost to Follow-up|0|||
148825944|NCT00452400|536840349|FG004|Overall Study|Lost to Follow-up|0|||
148825945|NCT00452400|536840345|FG000|Overall Study|Withdrawal by Subject|1|||
148825946|NCT00452400|536840346|FG001|Overall Study|Withdrawal by Subject|0|||
148825947|NCT00452400|536840347|FG002|Overall Study|Withdrawal by Subject|1|||
148825948|NCT00452400|536840348|FG003|Overall Study|Withdrawal by Subject|0|||
148825949|NCT00452400|536840349|FG004|Overall Study|Withdrawal by Subject|0|||
148825950|NCT00452400|536840345|FG000|Overall Study|Lack of Efficacy|2|||
148825951|NCT00452400|536840346|FG001|Overall Study|Lack of Efficacy|0|||
148825952|NCT00452400|536840347|FG002|Overall Study|Lack of Efficacy|0|||
148825953|NCT00452400|536840348|FG003|Overall Study|Lack of Efficacy|0|||
148825954|NCT00452400|536840349|FG004|Overall Study|Lack of Efficacy|0|||
148825955|NCT00452400|536840345|FG000|Overall Study|Other reasons not listed above|0|||
148825956|NCT00452400|536840346|FG001|Overall Study|Other reasons not listed above|0|||
148825957|NCT00452400|536840347|FG002|Overall Study|Other reasons not listed above|0|||
148825958|NCT00452400|536840348|FG003|Overall Study|Other reasons not listed above|1|||
148825959|NCT00452400|536840349|FG004|Overall Study|Other reasons not listed above|1|||
148977114|NCT03306264|537396581|FG002|Overall Study|Death|34|||
148977115|NCT03306264|537396582|FG003|Overall Study|Death|34|||
148977116|NCT03306264|537396579|FG000|Overall Study|Complete Consent Withdrawal|4|||
148977117|NCT03306264|537396580|FG001|Overall Study|Complete Consent Withdrawal|4|||
148977118|NCT03306264|537396581|FG002|Overall Study|Complete Consent Withdrawal|1|||
148977119|NCT03306264|537396582|FG003|Overall Study|Complete Consent Withdrawal|8|||
148977120|NCT03306264|537396579|FG000|Overall Study|Lost to Follow-up|1|||
148977121|NCT03306264|537396580|FG001|Overall Study|Lost to Follow-up|0|||
148977122|NCT03306264|537396581|FG002|Overall Study|Lost to Follow-up|1|||
148977123|NCT03306264|537396582|FG003|Overall Study|Lost to Follow-up|0|||
148977124|NCT03306264|537396579|FG000|Overall Study|Rollover to ASTX727-06|10|||
148977125|NCT03306264|537396580|FG001|Overall Study|Rollover to ASTX727-06|18|||
148977126|NCT03306264|537396581|FG002|Overall Study|Rollover to ASTX727-06|4|||
148977127|NCT03306264|537396582|FG003|Overall Study|Rollover to ASTX727-06|2|||
149027482|NCT01237678|537578568|FG001|Phase II|Withdrawal by Subject|1|||
149027483|NCT01237678|537578569|FG002|Phase II|Withdrawal by Subject|5|||
149027484|NCT01237678|537578567|FG000|Phase II|Completed Cycles 4-6|0|||
148825960|NCT01539525|536840350|FG000|Overall Study|Lost to Follow-up|19|||
148825961|NCT01539525|536840351|FG001|Overall Study|Lost to Follow-up|12|||
148825962|NCT01539525|536840352|FG002|Overall Study|Lost to Follow-up|11|||
149027485|NCT01237678|537578568|FG001|Phase II|Completed Cycles 4-6|11|||
148825963|NCT01539525|536840350|FG000|Overall Study|Withdrawal by Subject|0|||
148825964|NCT01539525|536840351|FG001|Overall Study|Withdrawal by Subject|3|||
148825965|NCT01539525|536840352|FG002|Overall Study|Withdrawal by Subject|2|||
149027486|NCT01237678|537578569|FG002|Phase II|Completed Cycles 4-6|21|||
148825966|NCT01539525|536840350|FG000|Overall Study|Protocol Violation|1|||
148825967|NCT01539525|536840351|FG001|Overall Study|Protocol Violation|1|||
149027487|NCT01237678|537578567|FG000|Phase II|Sponsor Decision/Study Closed|0|||
148825968|NCT01539525|536840352|FG002|Overall Study|Protocol Violation|4|||
148825969|NCT01712074|536840353|FG000|Placebo Run-in Period|Adverse Event|2|||
148825970|NCT01712074|536840354|FG001|Placebo Run-in Period|Adverse Event|0|||
149027488|NCT01237678|537578568|FG001|Phase II|Sponsor Decision/Study Closed|18|||
148825971|NCT01712074|536840355|FG002|Placebo Run-in Period|Adverse Event|0|||
148825972|NCT01712074|536840353|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
148825973|NCT01712074|536840354|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
148825974|NCT01712074|536840355|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
148825975|NCT01712074|536840353|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
148825976|NCT01712074|536840354|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
148977128|NCT03306264|537396579|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
149027489|NCT01237678|537578569|FG002|Phase II|Sponsor Decision/Study Closed|7|||
148825977|NCT01712074|536840355|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
148825978|NCT01712074|536840353|FG000|Placebo Run-in Period|Other|1|||
148825979|NCT01712074|536840354|FG001|Placebo Run-in Period|Other|0|||
148825980|NCT01712074|536840355|FG002|Placebo Run-in Period|Other|0|||
148825981|NCT01712074|536840353|FG000|Placebo Run-in Period|No longer willing to participate|1|||
148825982|NCT01712074|536840354|FG001|Placebo Run-in Period|No longer willing to participate|0|||
148825983|NCT01712074|536840355|FG002|Placebo Run-in Period|No longer willing to participate|0|||
148825984|NCT01712074|536840353|FG000|Double Blind Period|Adverse Event|0|||
148825985|NCT01712074|536840354|FG001|Double Blind Period|Adverse Event|2|||
148825986|NCT01712074|536840355|FG002|Double Blind Period|Adverse Event|1|||
148825987|NCT01712074|536840353|FG000|Double Blind Period|No longer willing to participate|0|||
148825988|NCT01712074|536840354|FG001|Double Blind Period|No longer willing to participate|2|||
148825989|NCT01712074|536840355|FG002|Double Blind Period|No longer willing to participate|4|||
148825990|NCT01712074|536840353|FG000|Double Blind Period|Death|0|||
148825991|NCT01712074|536840354|FG001|Double Blind Period|Death|1|||
148825992|NCT01712074|536840355|FG002|Double Blind Period|Death|0|||
148825993|NCT01712074|536840353|FG000|Double Blind Period|Lost to Follow-up|0|||
148825994|NCT01712074|536840354|FG001|Double Blind Period|Lost to Follow-up|2|||
148825995|NCT01712074|536840355|FG002|Double Blind Period|Lost to Follow-up|1|||
148825996|NCT01712074|536840353|FG000|Double Blind Period|Other|0|||
148825997|NCT01712074|536840354|FG001|Double Blind Period|Other|4|||
148825998|NCT01712074|536840355|FG002|Double Blind Period|Other|1|||
148825999|NCT01712074|536840353|FG000|Double Blind Period|Protocol Violation|0|||
148826000|NCT01712074|536840354|FG001|Double Blind Period|Protocol Violation|0|||
148826001|NCT01712074|536840355|FG002|Double Blind Period|Protocol Violation|1|||
148826002|NCT01712074|536840353|FG000|Double Blind Period|No longer met eligibility criteria|0|||
148826003|NCT01712074|536840354|FG001|Double Blind Period|No longer met eligibility criteria|3|||
148826004|NCT01712074|536840355|FG002|Double Blind Period|No longer met eligibility criteria|0|||
148826005|NCT02413346|536840356|FG000|Overall Study|Adverse Event|6|||
148826006|NCT02413346|536840357|FG001|Overall Study|Adverse Event|6|||
148826007|NCT02413346|536840356|FG000|Overall Study|Withdrawal by Subject|30|||
148826008|NCT02413346|536840357|FG001|Overall Study|Withdrawal by Subject|40|||
148826009|NCT02413346|536840356|FG000|Overall Study|Lost to Follow-up|17|||
148826010|NCT02413346|536840357|FG001|Overall Study|Lost to Follow-up|21|||
148826011|NCT02413346|536840356|FG000|Overall Study|Protocol Violation|2|||
148826012|NCT02413346|536840357|FG001|Overall Study|Protocol Violation|0|||
148826013|NCT02413346|536840356|FG000|Overall Study|Other Miscellaneous Reasons|4|||
148826014|NCT02413346|536840357|FG001|Overall Study|Other Miscellaneous Reasons|3|||
148826015|NCT01472835|536840358|FG000|Overall Study|Lost to Follow-up|2|||
148977129|NCT03306264|537396580|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
148977130|NCT03306264|537396581|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
148977131|NCT03306264|537396582|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
148977132|NCT02702401|537396591|FG000|Overall Study|Death|242|||
148977133|NCT02702401|537396592|FG001|Overall Study|Death|125|||
148977134|NCT02702401|537396591|FG000|Overall Study|Withdrawal by Subject|15|||
148977135|NCT02702401|537396592|FG001|Overall Study|Withdrawal by Subject|5|||
148977136|NCT02702401|537396591|FG000|Overall Study|Sponsor Decision|19|||
148977137|NCT02702401|537396592|FG001|Overall Study|Sponsor Decision|3|||
148977138|NCT02702401|537396591|FG000|Overall Study|Physician Decision|1|||
148977139|NCT02702401|537396592|FG001|Overall Study|Physician Decision|2|||
148977140|NCT02702401|537396591|FG000|Overall Study|Lost to Follow-up|1|||
148977141|NCT02702401|537396592|FG001|Overall Study|Lost to Follow-up|0|||
148977142|NCT01462357|537396597|FG000|Overall Study|Death|0|||
148977143|NCT01462357|537396598|FG001|Overall Study|Death|0|||
148977144|NCT01462357|537396599|FG002|Overall Study|Death|1|||
148977145|NCT01462357|537396597|FG000|Overall Study|Withdrawal by Subject|3|||
148977146|NCT01462357|537396598|FG001|Overall Study|Withdrawal by Subject|11|||
148977147|NCT01462357|537396599|FG002|Overall Study|Withdrawal by Subject|3|||
148977148|NCT01462357|537396597|FG000|Overall Study|Migrated/moved from study area|2|||
148977149|NCT01462357|537396598|FG001|Overall Study|Migrated/moved from study area|3|||
148977150|NCT01462357|537396599|FG002|Overall Study|Migrated/moved from study area|1|||
148977151|NCT01462357|537396597|FG000|Overall Study|Lost to Follow-up|3|||
148977152|NCT01462357|537396598|FG001|Overall Study|Lost to Follow-up|5|||
148977153|NCT01462357|537396599|FG002|Overall Study|Lost to Follow-up|7|||
148977154|NCT04292730|537396600|FG000|Overall Study|Lost to Follow-up|8|||
148977155|NCT04292730|537396601|FG001|Overall Study|Lost to Follow-up|12|||
148977156|NCT04292730|537396602|FG002|Overall Study|Lost to Follow-up|12|||
148977157|NCT04292730|537396603|FG003|Overall Study|Lost to Follow-up|48|||
148977158|NCT04292730|537396600|FG000|Overall Study|Death|2|||
148977159|NCT04292730|537396601|FG001|Overall Study|Death|2|||
148977160|NCT04292730|537396602|FG002|Overall Study|Death|4|||
148977161|NCT04292730|537396603|FG003|Overall Study|Death|12|||
148826016|NCT01472835|536840359|FG001|Overall Study|Lost to Follow-up|0|||
148826017|NCT03425188|536840361|FG000|Overall Study|Withdrawal by Subject|1|||
148826018|NCT01835431|536840362|FG000|Overall Study|Adverse Event|1|||
148977162|NCT04292730|537396600|FG000|Overall Study|Withdrew Consent|2|||
148826019|NCT01835431|536840363|FG001|Overall Study|Adverse Event|0|||
148977163|NCT04292730|537396601|FG001|Overall Study|Withdrew Consent|2|||
148826020|NCT01835431|536840362|FG000|Overall Study|other|0|||
148826021|NCT01835431|536840363|FG001|Overall Study|other|2|||
148826022|NCT01835431|536840362|FG000|Overall Study|Withdrawal by Subject|6|||
148826023|NCT01835431|536840363|FG001|Overall Study|Withdrawal by Subject|10|||
148826024|NCT01835431|536840362|FG000|Overall Study|Protocol Violation|1|||
148826025|NCT01835431|536840363|FG001|Overall Study|Protocol Violation|0|||
148826026|NCT02205359|536840368|FG000|Overall Study|Death|293|||
148826027|NCT02205359|536840369|FG001|Overall Study|Death|327|||
148826028|NCT02205359|536840368|FG000|Overall Study|Lost to Follow-up|182|||
148826029|NCT02205359|536840369|FG001|Overall Study|Lost to Follow-up|162|||
148826030|NCT02205359|536840368|FG000|Overall Study|Physician Decision|51|||
148826031|NCT02205359|536840369|FG001|Overall Study|Physician Decision|53|||
148826032|NCT02205359|536840368|FG000|Overall Study|Withdrawal by Subject|167|||
148826033|NCT02205359|536840369|FG001|Overall Study|Withdrawal by Subject|169|||
148826034|NCT01316900|536840370|FG000|Overall Study|Adverse Event|10|||
148826035|NCT01316900|536840371|FG001|Overall Study|Adverse Event|10|||
148826036|NCT01316900|536840372|FG002|Overall Study|Adverse Event|15|||
148826037|NCT01316900|536840373|FG003|Overall Study|Adverse Event|9|||
148826038|NCT01316900|536840370|FG000|Overall Study|Lack of Efficacy|17|||
148826039|NCT01316900|536840371|FG001|Overall Study|Lack of Efficacy|9|||
148826040|NCT01316900|536840372|FG002|Overall Study|Lack of Efficacy|5|||
148826041|NCT01316900|536840373|FG003|Overall Study|Lack of Efficacy|7|||
148826042|NCT01316900|536840370|FG000|Overall Study|Protocol Violation|7|||
148826043|NCT01316900|536840371|FG001|Overall Study|Protocol Violation|1|||
148826044|NCT01316900|536840372|FG002|Overall Study|Protocol Violation|4|||
148826045|NCT01316900|536840373|FG003|Overall Study|Protocol Violation|0|||
148826046|NCT01316900|536840370|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
148826047|NCT01316900|536840371|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
148826048|NCT01316900|536840372|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
148826049|NCT01316900|536840373|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
148826050|NCT01316900|536840370|FG000|Overall Study|Lost to Follow-up|1|||
148826051|NCT01316900|536840371|FG001|Overall Study|Lost to Follow-up|0|||
148826052|NCT01316900|536840372|FG002|Overall Study|Lost to Follow-up|1|||
148826053|NCT01316900|536840373|FG003|Overall Study|Lost to Follow-up|1|||
148826054|NCT01316900|536840370|FG000|Overall Study|Withdrawal by Subject|7|||
148826055|NCT01316900|536840371|FG001|Overall Study|Withdrawal by Subject|8|||
148826056|NCT01316900|536840372|FG002|Overall Study|Withdrawal by Subject|6|||
148826057|NCT01316900|536840373|FG003|Overall Study|Withdrawal by Subject|9|||
148826058|NCT00562861|536840374|FG000|Overall Study|Adverse Event|1|||
148826059|NCT00562861|536840375|FG001|Overall Study|Adverse Event|1|||
148826060|NCT00562861|536840374|FG000|Overall Study|Lack of Efficacy|5|||
148826061|NCT00562861|536840375|FG001|Overall Study|Lack of Efficacy|5|||
148826062|NCT00562861|536840374|FG000|Overall Study|noncompliance, moved|7|||
148826063|NCT00562861|536840375|FG001|Overall Study|noncompliance, moved|2|||
148826064|NCT00562861|536840374|FG000|Overall Study|Lost to Follow-up|7|||
148826065|NCT00562861|536840375|FG001|Overall Study|Lost to Follow-up|3|||
148826066|NCT01684033|536840376|FG000|Period 1, First 30 Days|Adverse Event|1|||
148826067|NCT01684033|536840377|FG001|Period 1, First 30 Days|Adverse Event|1|||
148826068|NCT01684033|536840376|FG000|Period 1, First 30 Days|Noncompliance|1|||
148826069|NCT01684033|536840377|FG001|Period 1, First 30 Days|Noncompliance|0|||
148826070|NCT01684033|536840376|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
148826071|NCT01684033|536840377|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
148826072|NCT01684033|536840376|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
148826073|NCT01684033|536840377|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
148826074|NCT01684033|536840376|FG000|Period 2, Second 30 Days|Adverse Event|1|||
148826075|NCT01684033|536840377|FG001|Period 2, Second 30 Days|Adverse Event|0|||
148826076|NCT00480025|536840378|FG000|Overall Study|Protocol Violation|12|||
148826077|NCT00480025|536840379|FG001|Overall Study|Protocol Violation|7|||
148826078|NCT00480025|536840378|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
148826079|NCT00480025|536840379|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
148826080|NCT00480025|536840378|FG000|Overall Study|Disease Progression / Recurrence|449|||
148826081|NCT00480025|536840379|FG001|Overall Study|Disease Progression / Recurrence|224|||
148826082|NCT00480025|536840378|FG000|Overall Study|Adverse Event|44|||
148826083|NCT00480025|536840379|FG001|Overall Study|Adverse Event|12|||
148826084|NCT00480025|536840378|FG000|Overall Study|Other|70|||
148826085|NCT00480025|536840379|FG001|Overall Study|Other|29|||
148826086|NCT00480025|536840378|FG000|Overall Study|SAE including intercurrent illness|76|||
148826087|NCT00480025|536840379|FG001|Overall Study|SAE including intercurrent illness|42|||
148826088|NCT02766478|536840381|FG000|Overall Study|Withdrawal by Subject|1|||
148826089|NCT02766478|536840382|FG001|Overall Study|Withdrawal by Subject|1|||
148826090|NCT02496156|536840383|FG000|Overall Study|Lost to Follow-up|5|||
148826091|NCT02496156|536840384|FG001|Overall Study|Lost to Follow-up|0|||
148826092|NCT02496156|536840383|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
148826093|NCT02496156|536840384|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
148826094|NCT00089583|536840385|FG000|Overall Study|Adverse Event|0|||
148826095|NCT00089583|536840386|FG001|Overall Study|Adverse Event|3|||
148826096|NCT00089583|536840385|FG000|Overall Study|Insufficient Viral Load Response|5|||
148760734|NCT00406367|536596759|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
148760735|NCT00406367|536596760|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
148760736|NCT03187301|536596761|FG000|Titration Period|Adverse Event|0|||
148760737|NCT03187301|536596762|FG001|Titration Period|Adverse Event|0|||
148760738|NCT03187301|536596763|FG002|Titration Period|Adverse Event|0|||
148760739|NCT03187301|536596764|FG003|Titration Period|Adverse Event|0|||
148760740|NCT03187301|536596765|FG004|Titration Period|Adverse Event|0|||
148760741|NCT03187301|536596766|FG005|Titration Period|Adverse Event|0|||
148760742|NCT03187301|536596767|FG006|Titration Period|Adverse Event|5|||
148760743|NCT03187301|536596761|FG000|Titration Period|Withdrawal by Subject|0|||
148760744|NCT03187301|536596762|FG001|Titration Period|Withdrawal by Subject|0|||
148760745|NCT03187301|536596763|FG002|Titration Period|Withdrawal by Subject|0|||
148760746|NCT03187301|536596764|FG003|Titration Period|Withdrawal by Subject|0|||
148760747|NCT03187301|536596765|FG004|Titration Period|Withdrawal by Subject|0|||
148760748|NCT03187301|536596766|FG005|Titration Period|Withdrawal by Subject|0|||
148760749|NCT03187301|536596767|FG006|Titration Period|Withdrawal by Subject|1|||
148760750|NCT03187301|536596761|FG000|Titration Period|Exclusion Criteria Met|0|||
148760751|NCT03187301|536596762|FG001|Titration Period|Exclusion Criteria Met|0|||
148760752|NCT03187301|536596763|FG002|Titration Period|Exclusion Criteria Met|0|||
148760753|NCT03187301|536596764|FG003|Titration Period|Exclusion Criteria Met|0|||
148760754|NCT03187301|536596765|FG004|Titration Period|Exclusion Criteria Met|0|||
148760755|NCT03187301|536596766|FG005|Titration Period|Exclusion Criteria Met|0|||
148760756|NCT03187301|536596767|FG006|Titration Period|Exclusion Criteria Met|1|||
148760757|NCT03187301|536596761|FG000|Pre-Intervention|Withdrawal by Subject|1|||
148760758|NCT03187301|536596762|FG001|Pre-Intervention|Withdrawal by Subject|0|||
148760759|NCT03187301|536596763|FG002|Pre-Intervention|Withdrawal by Subject|0|||
148760760|NCT03187301|536596764|FG003|Pre-Intervention|Withdrawal by Subject|0|||
148760761|NCT03187301|536596765|FG004|Pre-Intervention|Withdrawal by Subject|0|||
148760762|NCT03187301|536596766|FG005|Pre-Intervention|Withdrawal by Subject|0|||
148760763|NCT03187301|536596767|FG006|Pre-Intervention|Withdrawal by Subject|0|||
148760764|NCT00461630|536596773|FG000|Overall Study|Death|798|||
148760765|NCT00461630|536596774|FG001|Overall Study|Death|732|||
148760766|NCT00461630|536596773|FG000|Overall Study|Lost to Follow-up|108|||
148760767|NCT00461630|536596774|FG001|Overall Study|Lost to Follow-up|95|||
148760768|NCT00442897|536596778|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
148760769|NCT00442897|536596779|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
148760770|NCT00442897|536596778|FG000|Base Study (12 Week Follow-up)|Death|0|||
148760771|NCT00442897|536596779|FG001|Base Study (12 Week Follow-up)|Death|1|||
148760772|NCT00442897|536596778|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
148760773|NCT00442897|536596779|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
148760774|NCT00442897|536596778|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
148760775|NCT00442897|536596779|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
148760776|NCT00442897|536596778|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
148760777|NCT00442897|536596779|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
148760778|NCT00442897|536596778|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
148760779|NCT00442897|536596779|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
148760780|NCT00442897|536596778|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
148760781|NCT00442897|536596779|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
148760782|NCT00442897|536596778|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
148760783|NCT00442897|536596779|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
148760784|NCT04498182|536596780|FG000|Overall Study|Adverse Event|2|||
148760785|NCT04498182|536596781|FG001|Overall Study|Adverse Event|3|||
148760786|NCT04498182|536596782|FG002|Overall Study|Adverse Event|2|||
148760787|NCT04498182|536596780|FG000|Overall Study|Withdrawal of Consent|3|||
148760788|NCT04498182|536596781|FG001|Overall Study|Withdrawal of Consent|4|||
148760789|NCT04498182|536596782|FG002|Overall Study|Withdrawal of Consent|3|||
148760790|NCT04498182|536596780|FG000|Overall Study|Non-Compliant|1|||
148760791|NCT04498182|536596781|FG001|Overall Study|Non-Compliant|0|||
148760792|NCT04498182|536596782|FG002|Overall Study|Non-Compliant|1|||
148760793|NCT04498182|536596780|FG000|Overall Study|Lost to Follow-up|0|||
148760794|NCT04498182|536596781|FG001|Overall Study|Lost to Follow-up|0|||
148760795|NCT04498182|536596782|FG002|Overall Study|Lost to Follow-up|1|||
148760796|NCT04498182|536596780|FG000|Overall Study|Investigator Decision|0|||
148760797|NCT04498182|536596781|FG001|Overall Study|Investigator Decision|0|||
148760798|NCT04498182|536596782|FG002|Overall Study|Investigator Decision|1|||
148760799|NCT04498182|536596780|FG000|Overall Study|Protocol Violation|1|||
148760800|NCT04498182|536596781|FG001|Overall Study|Protocol Violation|0|||
148760801|NCT04498182|536596782|FG002|Overall Study|Protocol Violation|2|||
148760802|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
148760803|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
148760804|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
148760805|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
148760806|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
148760807|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
148977164|NCT04292730|537396602|FG002|Overall Study|Withdrew Consent|5|||
148977165|NCT04292730|537396603|FG003|Overall Study|Withdrew Consent|6|||
148977166|NCT04292730|537396600|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148977167|NCT04292730|537396601|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148977168|NCT04292730|537396602|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148977169|NCT04292730|537396603|FG003|Overall Study|Non-Compliance with Study Drug|0|||
148977170|NCT04292730|537396600|FG000|Overall Study|Protocol Violation|0|||
148977171|NCT04292730|537396601|FG001|Overall Study|Protocol Violation|0|||
148977172|NCT04292730|537396602|FG002|Overall Study|Protocol Violation|1|||
148977173|NCT04292730|537396603|FG003|Overall Study|Protocol Violation|0|||
148977174|NCT04292730|537396600|FG000|Overall Study|Randomized but not Treated|8|||
148760808|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
148760809|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
148760810|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
148760811|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
148760812|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
148760813|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
148760814|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
148760815|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
148760816|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
148977175|NCT04292730|537396601|FG001|Overall Study|Randomized but not Treated|4|||
148977176|NCT04292730|537396602|FG002|Overall Study|Randomized but not Treated|0|||
148760817|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
148760818|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
148760819|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
148760820|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
148760821|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
148760822|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
148760823|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
148760824|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
148760825|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
148760826|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
148760827|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
148760828|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
148760829|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
148760830|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
148760831|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
148760832|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
148760833|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
148760834|NCT00506415|536596795|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
148760835|NCT00506415|536596796|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
148760836|NCT00506415|536596797|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
148760837|NCT00506415|536596798|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
148760838|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
148760839|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
148760840|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
148760841|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
148760842|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
148760843|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
148760844|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
148760845|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
148760846|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
148760847|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
148760848|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
148760849|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
148760850|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
148760851|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
148760852|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
148760853|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
148760854|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
148760855|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
148760856|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
148977177|NCT04292730|537396603|FG003|Overall Study|Randomized but not Treated|14|||
148977178|NCT01247090|537396606|FG000|Overall Study|Physician Decision|1|||
148977179|NCT01247090|537396607|FG001|Overall Study|Physician Decision|0|||
148977180|NCT01247090|537396608|FG002|Overall Study|Physician Decision|0|||
148977181|NCT01247090|537396606|FG000|Overall Study|Withdrawal by Subject|0|||
148826097|NCT00089583|536840386|FG001|Overall Study|Insufficient Viral Load Response|5|||
148826098|NCT00089583|536840385|FG000|Overall Study|Withdrawal by Subject|0|||
148826099|NCT00089583|536840386|FG001|Overall Study|Withdrawal by Subject|4|||
148826100|NCT00089583|536840385|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
148826101|NCT00089583|536840386|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
148826102|NCT00089583|536840385|FG000|Overall Study|Participant Refused Study Medication|0|||
148826103|NCT00089583|536840386|FG001|Overall Study|Participant Refused Study Medication|2|||
148826104|NCT00089583|536840385|FG000|Overall Study|Non-Compliance|0|||
148826105|NCT00089583|536840386|FG001|Overall Study|Non-Compliance|4|||
149027490|NCT01237678|537578567|FG000|Phase II|Randomized but were not treated|0|||
149027491|NCT01237678|537578568|FG001|Phase II|Randomized but were not treated|4|||
149027492|NCT01237678|537578569|FG002|Phase II|Randomized but were not treated|3|||
149027493|NCT05124899|537578573|FG000|Overall Study|Lost to Follow-up|3|||
149027494|NCT00530777|537578583|FG000|Overall Study|Lost to Follow-up|0|||
149027495|NCT00530777|537578584|FG001|Overall Study|Lost to Follow-up|1|||
149027496|NCT00530777|537578583|FG000|Overall Study|Death|1|||
149027497|NCT00530777|537578584|FG001|Overall Study|Death|2|||
149027498|NCT00530777|537578583|FG000|Overall Study|Physician Decision|1|||
149027499|NCT00530777|537578584|FG001|Overall Study|Physician Decision|0|||
149027500|NCT00530777|537578583|FG000|Overall Study|Withdrawal by Subject|0|||
149027501|NCT00530777|537578584|FG001|Overall Study|Withdrawal by Subject|1|||
149027502|NCT00530777|537578583|FG000|Overall Study|Unable to adhere to visit schedule|5|||
149027503|NCT00530777|537578584|FG001|Overall Study|Unable to adhere to visit schedule|1|||
149027504|NCT01582243|537578586|FG000|Overall Study|Withdrawal by Subject|1|||
149027505|NCT01582243|537578586|FG000|Overall Study|Adverse Event|1|||
149027506|NCT01582243|537578586|FG000|Overall Study|Lost to Follow-up|1|||
149027507|NCT03382821|537578587|FG000|Overall Study|Did not receive allocated intervention.|0|||
149027508|NCT03382821|537578588|FG001|Overall Study|Did not receive allocated intervention.|3|||
149027509|NCT00797225|537578590|FG000|Weeks 1 to 12|Adverse Event|0|||
149027510|NCT00797225|537578591|FG001|Weeks 1 to 12|Adverse Event|0|||
149027511|NCT00797225|537578592|FG002|Weeks 1 to 12|Adverse Event|1|||
149027512|NCT00797225|537578593|FG003|Weeks 1 to 12|Adverse Event|0|||
149027513|NCT00797225|537578594|FG004|Weeks 1 to 12|Adverse Event|0|||
149027514|NCT00797225|537578595|FG005|Weeks 1 to 12|Adverse Event|0|||
149027515|NCT00797225|537578596|FG006|Weeks 1 to 12|Adverse Event|0|||
149027516|NCT00797225|537578597|FG007|Weeks 1 to 12|Adverse Event|0|||
149027517|NCT00797225|537578590|FG000|Weeks 1 to 12|Non-compliance|0|||
149027518|NCT00797225|537578591|FG001|Weeks 1 to 12|Non-compliance|1|||
149027519|NCT00797225|537578592|FG002|Weeks 1 to 12|Non-compliance|0|||
148760857|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
148760858|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
148760859|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
148760860|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
148760861|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
148760862|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
148760863|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
148760864|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
148760865|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
148760866|NCT00506415|536596795|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
148760867|NCT00506415|536596796|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
148760868|NCT00506415|536596797|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
148760869|NCT00506415|536596798|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
148760870|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
148760871|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
148760872|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
148760873|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
148760874|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
148760875|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
148760876|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
148760877|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
148760878|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
148760879|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
148826106|NCT00089583|536840385|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
149027520|NCT00797225|537578593|FG003|Weeks 1 to 12|Non-compliance|0|||
149027521|NCT00797225|537578594|FG004|Weeks 1 to 12|Non-compliance|0|||
149027522|NCT00797225|537578595|FG005|Weeks 1 to 12|Non-compliance|0|||
149027523|NCT00797225|537578596|FG006|Weeks 1 to 12|Non-compliance|0|||
148760880|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
148826107|NCT00089583|536840386|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
148826108|NCT00089583|536840385|FG000|Overall Study|Participant Management Criteria Met|0|||
149027524|NCT00797225|537578597|FG007|Weeks 1 to 12|Non-compliance|0|||
148977182|NCT01247090|537396607|FG001|Overall Study|Withdrawal by Subject|1|||
148977183|NCT01247090|537396608|FG002|Overall Study|Withdrawal by Subject|0|||
148977184|NCT01574703|537396609|FG000|Overall Study|Adverse Event|0|||
148977185|NCT01574703|537396610|FG001|Overall Study|Adverse Event|2|||
148977186|NCT01574703|537396611|FG002|Overall Study|Adverse Event|1|||
148977187|NCT01574703|537396612|FG003|Overall Study|Adverse Event|1|||
148977188|NCT01574703|537396609|FG000|Overall Study|Protocol Violation|0|||
148977189|NCT01574703|537396610|FG001|Overall Study|Protocol Violation|0|||
148977190|NCT01574703|537396611|FG002|Overall Study|Protocol Violation|0|||
148977191|NCT01574703|537396612|FG003|Overall Study|Protocol Violation|1|||
148977192|NCT01574703|537396609|FG000|Overall Study|Unspecified Reason|27|||
148977193|NCT01574703|537396610|FG001|Overall Study|Unspecified Reason|15|||
148977194|NCT01574703|537396611|FG002|Overall Study|Unspecified Reason|20|||
148977195|NCT01574703|537396612|FG003|Overall Study|Unspecified Reason|16|||
148977196|NCT01574703|537396609|FG000|Overall Study|Withdrawal by Subject|53|||
148977197|NCT01574703|537396610|FG001|Overall Study|Withdrawal by Subject|52|||
148977198|NCT01574703|537396611|FG002|Overall Study|Withdrawal by Subject|36|||
148977199|NCT01574703|537396612|FG003|Overall Study|Withdrawal by Subject|61|||
149027525|NCT00797225|537578590|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
148760881|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
148760882|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
148760883|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
148760884|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
148760885|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
148760886|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
148760887|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
148760888|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
148760889|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
148760890|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
148760891|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
148760892|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
148760893|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
148760894|NCT00506415|536596795|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
148760895|NCT00506415|536596796|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
148760896|NCT00506415|536596797|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
148760897|NCT00506415|536596798|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
148760898|NCT04578457|536596799|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
148760899|NCT04578457|536596799|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
148760900|NCT04578457|536596799|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
148760901|NCT04578457|536596799|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
148760902|NCT00997373|536596800|FG000|Overall Study|Withdrawal by Subject|5|||
148760903|NCT00997373|536596801|FG001|Overall Study|Withdrawal by Subject|0|||
148760904|NCT00997373|536596800|FG000|Overall Study|wrong tumor type|4|||
148760905|NCT00997373|536596801|FG001|Overall Study|wrong tumor type|0|||
148760906|NCT00997373|536596800|FG000|Overall Study|could not have hysterectomy|6|||
148760907|NCT00997373|536596801|FG001|Overall Study|could not have hysterectomy|0|||
148760908|NCT02841995|536596802|FG000|Overall Study|Disease progression|5|||
148760909|NCT02841995|536596803|FG001|Overall Study|Disease progression|11|||
148760910|NCT02841995|536596804|FG002|Overall Study|Disease progression|8|||
148760911|NCT02841995|536596802|FG000|Overall Study|Withdrawal by Subject|2|||
148760912|NCT02841995|536596803|FG001|Overall Study|Withdrawal by Subject|4|||
148760913|NCT02841995|536596804|FG002|Overall Study|Withdrawal by Subject|4|||
148760914|NCT02841995|536596802|FG000|Overall Study|Adverse Event|2|||
148760915|NCT02841995|536596803|FG001|Overall Study|Adverse Event|0|||
148760916|NCT02841995|536596804|FG002|Overall Study|Adverse Event|1|||
148760917|NCT02841995|536596802|FG000|Overall Study|Investigator decision|2|||
148760918|NCT02841995|536596803|FG001|Overall Study|Investigator decision|0|||
148760919|NCT02841995|536596804|FG002|Overall Study|Investigator decision|1|||
148760920|NCT02841995|536596802|FG000|Overall Study|Death|0|||
148760921|NCT02841995|536596803|FG001|Overall Study|Death|0|||
148760922|NCT02841995|536596804|FG002|Overall Study|Death|2|||
148760923|NCT02841995|536596802|FG000|Overall Study|Noncompliance to protocol|1|||
148760924|NCT02841995|536596803|FG001|Overall Study|Noncompliance to protocol|0|||
148760925|NCT02841995|536596804|FG002|Overall Study|Noncompliance to protocol|0|||
148760926|NCT02841995|536596802|FG000|Overall Study|Sponsor decision|1|||
148760927|NCT02841995|536596803|FG001|Overall Study|Sponsor decision|0|||
148760928|NCT02841995|536596804|FG002|Overall Study|Sponsor decision|0|||
148760929|NCT02841995|536596802|FG000|Overall Study|Other|4|||
148977200|NCT01574703|537396609|FG000|Overall Study|Met Withdrawal Criteria|0|||
148977201|NCT01574703|537396610|FG001|Overall Study|Met Withdrawal Criteria|1|||
148977202|NCT01574703|537396611|FG002|Overall Study|Met Withdrawal Criteria|1|||
148760930|NCT02841995|536596803|FG001|Overall Study|Other|1|||
148760931|NCT02841995|536596804|FG002|Overall Study|Other|5|||
148977203|NCT01574703|537396612|FG003|Overall Study|Met Withdrawal Criteria|0|||
148760932|NCT00630825|536596808|FG000|Overall Study|Adverse Event|4|||
148760933|NCT00630825|536596809|FG001|Overall Study|Adverse Event|4|||
148760934|NCT00630825|536596810|FG002|Overall Study|Adverse Event|3|||
148760935|NCT00630825|536596811|FG003|Overall Study|Adverse Event|1|||
148760936|NCT00630825|536596808|FG000|Overall Study|Entry Criteria Not Met|1|||
148760937|NCT00630825|536596809|FG001|Overall Study|Entry Criteria Not Met|0|||
148760938|NCT00630825|536596810|FG002|Overall Study|Entry Criteria Not Met|2|||
148760939|NCT00630825|536596811|FG003|Overall Study|Entry Criteria Not Met|1|||
148760940|NCT00630825|536596808|FG000|Overall Study|Lost to Follow-up|1|||
148760941|NCT00630825|536596809|FG001|Overall Study|Lost to Follow-up|1|||
148760942|NCT00630825|536596810|FG002|Overall Study|Lost to Follow-up|1|||
148760943|NCT00630825|536596811|FG003|Overall Study|Lost to Follow-up|1|||
148760944|NCT00630825|536596808|FG000|Overall Study|Physician Decision|1|||
148760945|NCT00630825|536596809|FG001|Overall Study|Physician Decision|0|||
148760946|NCT00630825|536596810|FG002|Overall Study|Physician Decision|0|||
148760947|NCT00630825|536596811|FG003|Overall Study|Physician Decision|0|||
148760948|NCT00630825|536596808|FG000|Overall Study|Withdrawal by Subject|2|||
148760949|NCT00630825|536596809|FG001|Overall Study|Withdrawal by Subject|2|||
148760950|NCT00630825|536596810|FG002|Overall Study|Withdrawal by Subject|2|||
148760951|NCT00630825|536596811|FG003|Overall Study|Withdrawal by Subject|3|||
148760952|NCT02042014|536596812|FG000|Overall Study|Adverse Event|1|||
148760953|NCT02042014|536596812|FG000|Overall Study|Physician Decision|7|||
148760954|NCT03123393|536596816|FG000|Overall Study|Study Terminated by Sponsor|6|||
148760955|NCT03123393|536596817|FG001|Overall Study|Study Terminated by Sponsor|9|||
148760956|NCT03123393|536596816|FG000|Overall Study|Withdrawal by Subject|2|||
148760957|NCT03123393|536596817|FG001|Overall Study|Withdrawal by Subject|1|||
148760958|NCT03123393|536596816|FG000|Overall Study|Reason not Specified|13|||
148760959|NCT03123393|536596817|FG001|Overall Study|Reason not Specified|13|||
148760960|NCT00558701|536596819|FG000|Overall Study|Protocol Deviations|1|||
148760961|NCT00558701|536596820|FG001|Overall Study|Protocol Deviations|4|||
148760962|NCT00427648|536596821|FG000|Overall Study|Protocol Violation|1|||
148760963|NCT00427648|536596822|FG001|Overall Study|Protocol Violation|2|||
148760964|NCT00427648|536596821|FG000|Overall Study|Adverse Event|0|||
148760965|NCT00427648|536596822|FG001|Overall Study|Adverse Event|1|||
148760966|NCT02230904|536596823|FG000|Overall Study|Safety follow up could not take place|0|||
148760967|NCT02230904|536596824|FG001|Overall Study|Safety follow up could not take place|1|||
148760968|NCT01464333|536596826|FG000|Overall Study|Adverse Event|34|||
148760969|NCT01464333|536596826|FG000|Overall Study|Lack of Efficacy|72|||
148760970|NCT01464333|536596826|FG000|Overall Study|Withdrawal by Subject|11|||
148760971|NCT01464333|536596826|FG000|Overall Study|Other|4|||
148760972|NCT01464333|536596826|FG000|Overall Study|No Hospital Visit|42|||
148760973|NCT00463047|536596830|FG000|Titration Period 1|Adverse Event|10|||
148760974|NCT00463047|536596831|FG001|Titration Period 1|Adverse Event|8|||
148760975|NCT00463047|536596830|FG000|Titration Period 1|Lack of Efficacy|10|||
148760976|NCT00463047|536596831|FG001|Titration Period 1|Lack of Efficacy|4|||
148760977|NCT00463047|536596830|FG000|Titration Period 1|Lost to Follow-up|2|||
148760978|NCT00463047|536596831|FG001|Titration Period 1|Lost to Follow-up|0|||
148760979|NCT00463047|536596830|FG000|Titration Period 1|Non-compliance with study medication|3|||
148760980|NCT00463047|536596831|FG001|Titration Period 1|Non-compliance with study medication|5|||
148760981|NCT00463047|536596830|FG000|Titration Period 1|Protocol Violation|5|||
148760982|NCT00463047|536596831|FG001|Titration Period 1|Protocol Violation|5|||
148760983|NCT00463047|536596830|FG000|Titration Period 1|Withdrawal by Subject|3|||
148760984|NCT00463047|536596831|FG001|Titration Period 1|Withdrawal by Subject|5|||
148760985|NCT00463047|536596830|FG000|Titration Period 1|Non-compliance procedures|4|||
148760986|NCT00463047|536596831|FG001|Titration Period 1|Non-compliance procedures|10|||
148760987|NCT00463047|536596830|FG000|Titration Period 1|Other|0|||
148760988|NCT00463047|536596831|FG001|Titration Period 1|Other|2|||
148760989|NCT00463047|536596830|FG000|Titration Period 2|Adverse Event|9|||
148760990|NCT00463047|536596831|FG001|Titration Period 2|Adverse Event|9|||
148760991|NCT00463047|536596830|FG000|Titration Period 2|Lack of Efficacy|6|||
148760992|NCT00463047|536596831|FG001|Titration Period 2|Lack of Efficacy|4|||
148760993|NCT00463047|536596830|FG000|Titration Period 2|Withdrawal by Subject|1|||
148826109|NCT00089583|536840386|FG001|Overall Study|Participant Management Criteria Met|1|||
148826110|NCT00089583|536840385|FG000|Overall Study|Reason Not Provided|0|||
148826111|NCT00089583|536840386|FG001|Overall Study|Reason Not Provided|1|||
148826112|NCT00089583|536840385|FG000|Overall Study|Protocol Violation|0|||
148977204|NCT01574703|537396609|FG000|Overall Study|Lost to Follow-up|43|||
148760994|NCT00463047|536596831|FG001|Titration Period 2|Withdrawal by Subject|0|||
148760995|NCT00463047|536596830|FG000|Titration Period 2|Protocol Violation|2|||
148760996|NCT00463047|536596831|FG001|Titration Period 2|Protocol Violation|3|||
148760997|NCT00463047|536596830|FG000|Titration Period 2|Lost to Follow-up|1|||
148760998|NCT00463047|536596831|FG001|Titration Period 2|Lost to Follow-up|2|||
148760999|NCT00463047|536596830|FG000|Titration Period 2|Non-compliance study medication|4|||
148761000|NCT00463047|536596831|FG001|Titration Period 2|Non-compliance study medication|2|||
148761001|NCT00463047|536596830|FG000|Titration Period 2|Non-compliance procedures|4|||
148826113|NCT00089583|536840386|FG001|Overall Study|Protocol Violation|3|||
148826114|NCT00089583|536840385|FG000|Overall Study|Principal Investigator Decision|0|||
148761002|NCT00463047|536596831|FG001|Titration Period 2|Non-compliance procedures|1|||
148761003|NCT00463047|536596830|FG000|Titration Period 2|Other|3|||
148761004|NCT00463047|536596831|FG001|Titration Period 2|Other|2|||
148761005|NCT00463047|536596830|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
148761006|NCT00463047|536596831|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
148761007|NCT00463047|536596830|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
148761008|NCT00463047|536596831|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
148761009|NCT00463047|536596830|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
148761010|NCT00463047|536596831|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
148761011|NCT00463047|536596830|FG000|Double-Blind Treatment Period 1|Other|1|||
148761012|NCT00463047|536596831|FG001|Double-Blind Treatment Period 1|Other|0|||
148761013|NCT00463047|536596830|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
148761014|NCT00463047|536596831|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
148761015|NCT00463047|536596830|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
148761016|NCT00463047|536596831|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
148761017|NCT00463047|536596830|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
148761018|NCT00463047|536596831|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
148761019|NCT01262872|536596837|FG000|Step 2|Death|0|||
148761020|NCT01262872|536596838|FG001|Step 2|Death|0|||
148761021|NCT01262872|536596839|FG002|Step 2|Death|0|||
148761022|NCT01262872|536596840|FG003|Step 2|Death|1|||
148761023|NCT01262872|536596841|FG004|Step 2|Death|0|||
148761024|NCT01262872|536596842|FG005|Step 2|Death|2|||
148761025|NCT01262872|536596843|FG006|Step 2|Death|2|||
148761026|NCT01262872|536596844|FG007|Step 2|Death|1|||
148761027|NCT01262872|536596837|FG000|Step 2|Protocol Violation|0|||
148761028|NCT01262872|536596838|FG001|Step 2|Protocol Violation|0|||
148761029|NCT01262872|536596839|FG002|Step 2|Protocol Violation|1|||
148761030|NCT01262872|536596840|FG003|Step 2|Protocol Violation|0|||
148761031|NCT01262872|536596841|FG004|Step 2|Protocol Violation|0|||
148761032|NCT01262872|536596842|FG005|Step 2|Protocol Violation|0|||
148761033|NCT01262872|536596843|FG006|Step 2|Protocol Violation|3|||
148761034|NCT01262872|536596844|FG007|Step 2|Protocol Violation|1|||
148761035|NCT01262872|536596837|FG000|Step 2|Withdrawal by Subject|0|||
148761036|NCT01262872|536596838|FG001|Step 2|Withdrawal by Subject|0|||
148761037|NCT01262872|536596839|FG002|Step 2|Withdrawal by Subject|4|||
148761038|NCT01262872|536596840|FG003|Step 2|Withdrawal by Subject|6|||
148761039|NCT01262872|536596841|FG004|Step 2|Withdrawal by Subject|3|||
148761040|NCT01262872|536596842|FG005|Step 2|Withdrawal by Subject|1|||
148761041|NCT01262872|536596843|FG006|Step 2|Withdrawal by Subject|2|||
148761042|NCT01262872|536596844|FG007|Step 2|Withdrawal by Subject|1|||
148761043|NCT01262872|536596837|FG000|Step 2|Migrated/moved from study area|0|||
148761044|NCT01262872|536596838|FG001|Step 2|Migrated/moved from study area|0|||
148761045|NCT01262872|536596839|FG002|Step 2|Migrated/moved from study area|4|||
148761046|NCT01262872|536596840|FG003|Step 2|Migrated/moved from study area|3|||
148761047|NCT01262872|536596841|FG004|Step 2|Migrated/moved from study area|2|||
148761048|NCT01262872|536596842|FG005|Step 2|Migrated/moved from study area|6|||
148761049|NCT01262872|536596843|FG006|Step 2|Migrated/moved from study area|2|||
148761050|NCT01262872|536596844|FG007|Step 2|Migrated/moved from study area|3|||
148761051|NCT01000155|536596845|FG000|Overall Study|Withdrawal by Subject|1|||
148761052|NCT01000155|536596845|FG000|Overall Study|Adverse Event|1|||
148761053|NCT00365794|536596847|FG000|Overall Study|Withdrawal by Subject|2|||
148761054|NCT02554682|536596848|FG000|Overall Study|Lost to Follow-up|11|||
148761055|NCT02554682|536596849|FG001|Overall Study|Lost to Follow-up|9|||
148761056|NCT02554682|536596850|FG002|Overall Study|Lost to Follow-up|4|||
148761057|NCT02554682|536596851|FG003|Overall Study|Lost to Follow-up|3|||
148761058|NCT02554682|536596852|FG004|Overall Study|Lost to Follow-up|2|||
148761059|NCT02554682|536596853|FG005|Overall Study|Lost to Follow-up|1|||
148761060|NCT02554682|536596854|FG006|Overall Study|Lost to Follow-up|6|||
148761061|NCT02554682|536596855|FG007|Overall Study|Lost to Follow-up|6|||
148761062|NCT02554682|536596856|FG008|Overall Study|Lost to Follow-up|2|||
148761063|NCT02554682|536596857|FG009|Overall Study|Lost to Follow-up|2|||
148761064|NCT02554682|536596848|FG000|Overall Study|Withdrawal by Subject|2|||
148761065|NCT02554682|536596849|FG001|Overall Study|Withdrawal by Subject|1|||
148826115|NCT00089583|536840386|FG001|Overall Study|Principal Investigator Decision|10|||
148761066|NCT02554682|536596850|FG002|Overall Study|Withdrawal by Subject|0|||
148761067|NCT02554682|536596851|FG003|Overall Study|Withdrawal by Subject|0|||
148761068|NCT02554682|536596852|FG004|Overall Study|Withdrawal by Subject|0|||
148761069|NCT02554682|536596853|FG005|Overall Study|Withdrawal by Subject|0|||
148761070|NCT02554682|536596854|FG006|Overall Study|Withdrawal by Subject|0|||
148761071|NCT02554682|536596855|FG007|Overall Study|Withdrawal by Subject|0|||
148761072|NCT02554682|536596856|FG008|Overall Study|Withdrawal by Subject|0|||
148761073|NCT02554682|536596857|FG009|Overall Study|Withdrawal by Subject|0|||
148761074|NCT02554682|536596848|FG000|Overall Study|Physician Decision|2|||
148761075|NCT02554682|536596849|FG001|Overall Study|Physician Decision|2|||
148761076|NCT02554682|536596850|FG002|Overall Study|Physician Decision|0|||
148761077|NCT02554682|536596851|FG003|Overall Study|Physician Decision|0|||
148761078|NCT02554682|536596852|FG004|Overall Study|Physician Decision|0|||
148761079|NCT02554682|536596853|FG005|Overall Study|Physician Decision|0|||
148761080|NCT02554682|536596854|FG006|Overall Study|Physician Decision|0|||
148761081|NCT02554682|536596855|FG007|Overall Study|Physician Decision|0|||
148761082|NCT02554682|536596856|FG008|Overall Study|Physician Decision|0|||
148761083|NCT02554682|536596857|FG009|Overall Study|Physician Decision|0|||
148761084|NCT02712554|536596859|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
148761085|NCT02712554|536596860|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
148761086|NCT02712554|536596859|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
148761087|NCT02712554|536596860|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
148761088|NCT02712554|536596859|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
148761089|NCT02712554|536596860|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
148761090|NCT02712554|536596859|FG000|Part B: Qualification Phase|Adverse Event|0|||
148761091|NCT02712554|536596860|FG001|Part B: Qualification Phase|Adverse Event|1|||
148761092|NCT02712554|536596859|FG000|Part B: Treatment Phase|Adverse Event|0|||
148761093|NCT02712554|536596860|FG001|Part B: Treatment Phase|Adverse Event|1|||
148761094|NCT02712554|536596859|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
148761095|NCT02712554|536596860|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
148761096|NCT02712554|536596859|FG000|Part B: Treatment Phase|Other|0|||
148761097|NCT02712554|536596860|FG001|Part B: Treatment Phase|Other|1|||
148761098|NCT02503540|536596862|FG000|Overall Study|Death|2|||
148761099|NCT02503540|536596862|FG000|Overall Study|Withdrawal by Subject|1|||
148761100|NCT01662492|536596863|FG000|Overall Study|Other miscellaneous reasons.|1|||
148761101|NCT01662492|536596864|FG001|Overall Study|Other miscellaneous reasons.|0|||
148761102|NCT01662492|536596865|FG002|Overall Study|Other miscellaneous reasons.|1|||
148761103|NCT01662492|536596863|FG000|Overall Study|Withdrawal by Subject|0|||
148761104|NCT01662492|536596864|FG001|Overall Study|Withdrawal by Subject|0|||
148826116|NCT00089583|536840385|FG000|Overall Study|Start of Disallowed Medication|0|||
148826117|NCT00089583|536840386|FG001|Overall Study|Start of Disallowed Medication|1|||
148826118|NCT00089583|536840385|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
149027526|NCT00797225|537578591|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
149027527|NCT00797225|537578592|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
148761105|NCT01662492|536596865|FG002|Overall Study|Withdrawal by Subject|1|||
148761106|NCT01662492|536596863|FG000|Overall Study|Protocol Violation|1|||
148761107|NCT01662492|536596864|FG001|Overall Study|Protocol Violation|0|||
148826119|NCT00089583|536840386|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
148826120|NCT00089583|536840385|FG000|Overall Study|Participant Incarcerated|0|||
148826121|NCT00089583|536840386|FG001|Overall Study|Participant Incarcerated|1|||
148826122|NCT01412983|536840387|FG000|1st Period|Ineligible|0|||
148826123|NCT01412983|536840388|FG001|1st Period|Ineligible|1|||
148826124|NCT01412983|536840387|FG000|1st Period|Positive slit lamp finding|0|||
148826125|NCT01412983|536840388|FG001|1st Period|Positive slit lamp finding|1|||
148826126|NCT01412983|536840387|FG000|1st Period|Unacceptable lens movement|0|||
148826127|NCT01412983|536840388|FG001|1st Period|Unacceptable lens movement|1|||
148826128|NCT01412983|536840387|FG000|1st Period|Inability to maintain wear|0|||
148826129|NCT01412983|536840388|FG001|1st Period|Inability to maintain wear|1|||
148826130|NCT00890097|536840389|FG000|Overall Study|Adverse Event|21|||
148826131|NCT00890097|536840390|FG001|Overall Study|Adverse Event|32|||
148826132|NCT00890097|536840391|FG002|Overall Study|Adverse Event|28|||
148826133|NCT00890097|536840389|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
148826134|NCT00890097|536840390|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
148826135|NCT00890097|536840391|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
148826136|NCT00890097|536840389|FG000|Overall Study|Withdrew Consent|9|||
148826137|NCT00890097|536840390|FG001|Overall Study|Withdrew Consent|6|||
148826138|NCT00890097|536840391|FG002|Overall Study|Withdrew Consent|9|||
148826139|NCT00890097|536840389|FG000|Overall Study|Lost to Follow-up|5|||
148826140|NCT00890097|536840390|FG001|Overall Study|Lost to Follow-up|5|||
148826141|NCT00890097|536840391|FG002|Overall Study|Lost to Follow-up|5|||
148826142|NCT00890097|536840389|FG000|Overall Study|Noncompliance|0|||
148826143|NCT00890097|536840390|FG001|Overall Study|Noncompliance|4|||
148826144|NCT00890097|536840391|FG002|Overall Study|Noncompliance|4|||
148826145|NCT00890097|536840389|FG000|Overall Study|Sponsor Decision|7|||
148826146|NCT00890097|536840390|FG001|Overall Study|Sponsor Decision|11|||
148826147|NCT00890097|536840391|FG002|Overall Study|Sponsor Decision|7|||
148826148|NCT00890097|536840389|FG000|Overall Study|Did not attend final visit|2|||
148826149|NCT00890097|536840390|FG001|Overall Study|Did not attend final visit|3|||
148826150|NCT00890097|536840391|FG002|Overall Study|Did not attend final visit|0|||
148826151|NCT00890097|536840389|FG000|Overall Study|Subject Decision|3|||
148826152|NCT00890097|536840390|FG001|Overall Study|Subject Decision|2|||
148826153|NCT00890097|536840391|FG002|Overall Study|Subject Decision|6|||
148826154|NCT00890097|536840389|FG000|Overall Study|Randomization Error|2|||
148826155|NCT00890097|536840390|FG001|Overall Study|Randomization Error|0|||
148826156|NCT00890097|536840391|FG002|Overall Study|Randomization Error|0|||
148826157|NCT00890097|536840389|FG000|Overall Study|Failed inclusion criteria|3|||
148826158|NCT00890097|536840390|FG001|Overall Study|Failed inclusion criteria|4|||
148826159|NCT00890097|536840391|FG002|Overall Study|Failed inclusion criteria|0|||
148826160|NCT00890097|536840389|FG000|Overall Study|Transportation|0|||
148977205|NCT01574703|537396610|FG001|Overall Study|Lost to Follow-up|41|||
148977206|NCT01574703|537396611|FG002|Overall Study|Lost to Follow-up|46|||
148977207|NCT01574703|537396612|FG003|Overall Study|Lost to Follow-up|35|||
148977208|NCT01574703|537396609|FG000|Overall Study|Death|2|||
148977209|NCT01574703|537396610|FG001|Overall Study|Death|1|||
148977210|NCT01574703|537396611|FG002|Overall Study|Death|1|||
148977211|NCT01574703|537396612|FG003|Overall Study|Death|0|||
149027528|NCT00797225|537578593|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
149027529|NCT00797225|537578594|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
148761108|NCT01662492|536596865|FG002|Overall Study|Protocol Violation|0|||
148761109|NCT01662492|536596863|FG000|Overall Study|Lost to Follow-up|0|||
148761110|NCT01662492|536596864|FG001|Overall Study|Lost to Follow-up|0|||
148761111|NCT01662492|536596865|FG002|Overall Study|Lost to Follow-up|2|||
148761112|NCT01662492|536596863|FG000|Overall Study|Lack of Efficacy|1|||
148761113|NCT01662492|536596864|FG001|Overall Study|Lack of Efficacy|1|||
148761114|NCT01662492|536596865|FG002|Overall Study|Lack of Efficacy|2|||
148761115|NCT02747108|536596866|FG000|Overall Study|Death|2|||
148761116|NCT02747108|536596867|FG001|Overall Study|Death|2|||
148761117|NCT02747108|536596866|FG000|Overall Study|Withdrawal by Subject|1|||
148761118|NCT02747108|536596867|FG001|Overall Study|Withdrawal by Subject|0|||
148761119|NCT02747108|536596866|FG000|Overall Study|Protocol Violation|2|||
148761120|NCT02747108|536596867|FG001|Overall Study|Protocol Violation|0|||
148761121|NCT00570687|536598655|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761122|NCT00570687|536598656|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761123|NCT00570687|536598657|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761124|NCT00570687|536598658|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761125|NCT00570687|536598659|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
148761126|NCT00570687|536598660|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
148761127|NCT00570687|536598661|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
148761128|NCT00570687|536598662|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
148761129|NCT00570687|536598663|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
148761130|NCT00570687|536598664|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
148761131|NCT00570687|536598655|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761132|NCT00570687|536598656|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761133|NCT00570687|536598657|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761134|NCT00570687|536598658|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761135|NCT00570687|536598659|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761136|NCT00570687|536598660|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761137|NCT00570687|536598661|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761138|NCT00570687|536598662|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761139|NCT00570687|536598663|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
148761140|NCT00570687|536598664|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761141|NCT00570687|536598655|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761142|NCT00570687|536598656|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761143|NCT00570687|536598657|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761144|NCT00570687|536598658|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761145|NCT00570687|536598659|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761146|NCT00570687|536598660|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761147|NCT00570687|536598661|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
148761148|NCT00570687|536598662|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761149|NCT00570687|536598663|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761150|NCT00570687|536598664|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
148761151|NCT00975611|536598665|FG000|Overall Study|Screen Fail|16|||
148761152|NCT00975611|536598665|FG000|Overall Study|Physician Decision|1|||
148761153|NCT05343000|536598666|FG000|Overall Study|Physician Decision|2|||
148761154|NCT03123120|536598667|FG000|Overall Study|Lost to Follow-up|0|||
148761155|NCT03123120|536598668|FG001|Overall Study|Lost to Follow-up|1|||
148761156|NCT03123120|536598667|FG000|Overall Study|Withdrawal by Subject|0|||
148761157|NCT03123120|536598668|FG001|Overall Study|Withdrawal by Subject|1|||
148761158|NCT03135548|536598669|FG000|Overall Study|Lost to Follow-up|3|||
148761159|NCT03135548|536598670|FG001|Overall Study|Lost to Follow-up|0|||
148977212|NCT04084769|537396615|FG000|Overall Study|Protocol Violation|1|||
148977213|NCT04084769|537396616|FG001|Overall Study|Protocol Violation|3|||
148977214|NCT04084769|537396617|FG002|Overall Study|Protocol Violation|0|||
149027530|NCT00797225|537578595|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
149027531|NCT00797225|537578596|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
149027532|NCT00797225|537578597|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
149027533|NCT00797225|537578590|FG000|Weeks 1 to 12|Sponsor Decision|1|||
149027534|NCT00797225|537578591|FG001|Weeks 1 to 12|Sponsor Decision|0|||
149027535|NCT00797225|537578592|FG002|Weeks 1 to 12|Sponsor Decision|0|||
148761160|NCT03135548|536598671|FG002|Overall Study|Lost to Follow-up|0|||
148761161|NCT03135548|536598669|FG000|Overall Study|Withdrawal by Subject|2|||
148761162|NCT03135548|536598670|FG001|Overall Study|Withdrawal by Subject|2|||
148977215|NCT04084769|537396618|FG003|Overall Study|Protocol Violation|1|||
148826161|NCT00890097|536840390|FG001|Overall Study|Transportation|2|||
148826162|NCT00890097|536840391|FG002|Overall Study|Transportation|0|||
148826163|NCT00890097|536840389|FG000|Overall Study|Subject Moved|0|||
148826164|NCT00890097|536840390|FG001|Overall Study|Subject Moved|4|||
148826165|NCT00890097|536840391|FG002|Overall Study|Subject Moved|0|||
148826166|NCT00890097|536840389|FG000|Overall Study|Protocol Deviation|1|||
148826167|NCT00890097|536840390|FG001|Overall Study|Protocol Deviation|1|||
148826168|NCT00890097|536840391|FG002|Overall Study|Protocol Deviation|1|||
148826169|NCT04349098|536840392|FG000|Overall Study|Death|16|||
148826170|NCT04349098|536840393|FG001|Overall Study|Death|8|||
148826171|NCT04349098|536840392|FG000|Overall Study|Lost to Follow-up|11|||
148826172|NCT04349098|536840393|FG001|Overall Study|Lost to Follow-up|8|||
148826173|NCT04349098|536840392|FG000|Overall Study|Withdrawal by Subject|8|||
148826174|NCT04349098|536840393|FG001|Overall Study|Withdrawal by Subject|5|||
148826175|NCT04349098|536840392|FG000|Overall Study|Other|3|||
148826176|NCT04349098|536840393|FG001|Overall Study|Other|5|||
148826177|NCT01703221|536840394|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
148826178|NCT01703221|536840395|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
148826179|NCT01703221|536840396|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
148826180|NCT01703221|536840394|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
148826181|NCT01703221|536840395|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
148826182|NCT01703221|536840396|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
148826183|NCT01703221|536840394|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
148826184|NCT01703221|536840395|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
148826185|NCT01703221|536840396|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
148826186|NCT01703221|536840394|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
148826187|NCT01703221|536840395|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
148826188|NCT01703221|536840396|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
148826189|NCT01703221|536840394|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
148826190|NCT01703221|536840395|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
148826191|NCT01703221|536840396|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
148826192|NCT01703221|536840394|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
148826193|NCT01703221|536840395|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
148826194|NCT01703221|536840396|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
148826195|NCT01703221|536840394|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
148826196|NCT01703221|536840395|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
148826197|NCT01703221|536840396|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
148826198|NCT01703221|536840394|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
148826199|NCT01703221|536840395|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
148826200|NCT01703221|536840396|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
148826201|NCT03810495|536840397|FG000|Overall Study|Lost to Follow-up|2|||
148826202|NCT03810495|536840397|FG000|Overall Study|Withdrawal by Subject|1|||
148826203|NCT02363283|536841982|FG000|Overall Study|Withdrawal by Subject|1|||
148826204|NCT02363283|536841982|FG000|Overall Study|Not eligible due to transaminitis|1|||
148826205|NCT02144337|536841992|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
148826206|NCT02144337|536841993|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
148826207|NCT02144337|536841992|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
148826208|NCT02144337|536841993|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
148826209|NCT02144337|536841992|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
148826210|NCT02144337|536841993|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
148826211|NCT02144337|536841992|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
148826212|NCT02144337|536841993|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
148826213|NCT02144337|536841992|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
148826214|NCT02144337|536841993|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
148826215|NCT00203242|536841994|FG000|Overall Study|Lost to Follow-up|1|||
148826216|NCT00866775|536841995|FG000|Overall Study|Adverse Event|5|||
148826217|NCT00866775|536841996|FG001|Overall Study|Adverse Event|19|||
148826218|NCT00866775|536841995|FG000|Overall Study|Death|1|||
148826219|NCT00866775|536841996|FG001|Overall Study|Death|0|||
148826220|NCT00866775|536841995|FG000|Overall Study|Lost to Follow-up|0|||
148826221|NCT00866775|536841996|FG001|Overall Study|Lost to Follow-up|4|||
148826222|NCT00866775|536841995|FG000|Overall Study|Physician Decision|0|||
149027536|NCT00797225|537578593|FG003|Weeks 1 to 12|Sponsor Decision|0|||
148826223|NCT00866775|536841996|FG001|Overall Study|Physician Decision|3|||
148826224|NCT00866775|536841995|FG000|Overall Study|Protocol Violation|3|||
148826225|NCT00866775|536841996|FG001|Overall Study|Protocol Violation|4|||
148826226|NCT00866775|536841995|FG000|Overall Study|Withdrawal by Subject|4|||
148826227|NCT00866775|536841996|FG001|Overall Study|Withdrawal by Subject|4|||
148826228|NCT00866775|536841995|FG000|Overall Study|met exit criteria|23|||
148826229|NCT00866775|536841996|FG001|Overall Study|met exit criteria|17|||
148826230|NCT00866775|536841995|FG000|Overall Study|discontinued due to communication error|0|||
148826231|NCT00866775|536841996|FG001|Overall Study|discontinued due to communication error|1|||
148826232|NCT01500135|536841997|FG000|Overall Study|Withdrawal of Consent|4|||
148826233|NCT01500135|536841998|FG001|Overall Study|Withdrawal of Consent|0|||
148826234|NCT01500135|536841997|FG000|Overall Study|Lost to Follow-up|6|||
148761163|NCT03135548|536598671|FG002|Overall Study|Withdrawal by Subject|1|||
148761164|NCT03135548|536598669|FG000|Overall Study|Other than listed|0|||
148761165|NCT03135548|536598670|FG001|Overall Study|Other than listed|2|||
148761166|NCT03135548|536598671|FG002|Overall Study|Other than listed|2|||
148761167|NCT02632175|536598672|FG000|Overall Study|Withdrawal by Subject|6|||
148761168|NCT02632175|536598672|FG000|Overall Study|Lost to Follow-up|1|||
148761169|NCT02632175|536598672|FG000|Overall Study|Lack of Efficacy|18|||
148761170|NCT02632175|536598672|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
148761171|NCT02632175|536598672|FG000|Overall Study|Subject noncompliance|3|||
148761172|NCT02632175|536598672|FG000|Overall Study|other|2|||
148761173|NCT04623216|536598673|FG000|Overall Study|Death|5|||
148761174|NCT04623216|536598674|FG001|Overall Study|Death|2|||
148761175|NCT04623216|536598675|FG002|Overall Study|Death|0|||
148761176|NCT04623216|536598676|FG003|Overall Study|Death|0|||
148761177|NCT04623216|536598673|FG000|Overall Study|Terminated by Sponsor|3|||
148761178|NCT04623216|536598674|FG001|Overall Study|Terminated by Sponsor|2|||
148761179|NCT04623216|536598675|FG002|Overall Study|Terminated by Sponsor|2|||
148761180|NCT04623216|536598676|FG003|Overall Study|Terminated by Sponsor|0|||
148761181|NCT04623216|536598673|FG000|Overall Study|Physician Decision|1|||
148761182|NCT04623216|536598674|FG001|Overall Study|Physician Decision|0|||
148761183|NCT04623216|536598675|FG002|Overall Study|Physician Decision|0|||
148761184|NCT04623216|536598676|FG003|Overall Study|Physician Decision|0|||
148761185|NCT03521154|536598679|FG000|Overall Study|Ongoing study at data cut-off|111|||
148761186|NCT03521154|536598680|FG001|Overall Study|Ongoing study at data cut-off|52|||
148761187|NCT05386680|536598681|FG000|Overall Study|Guardian decision|2|||
148761188|NCT00866281|536598686|FG000|Overall Study|Adverse Event|1|||
148761189|NCT00866281|536598687|FG001|Overall Study|Adverse Event|0|||
148761190|NCT00866281|536598686|FG000|Overall Study|Withdrawal by participants|3|||
148761191|NCT00866281|536598687|FG001|Overall Study|Withdrawal by participants|0|||
148761192|NCT00866281|536598686|FG000|Overall Study|Disease progression|3|||
148761193|NCT00866281|536598687|FG001|Overall Study|Disease progression|11|||
148761194|NCT00866281|536598686|FG000|Overall Study|New cancer therapy|0|||
148761195|NCT00866281|536598687|FG001|Overall Study|New cancer therapy|4|||
148761196|NCT02283268|536598691|FG000|Overall Study|Withdrawal by Subject|1|||
148761197|NCT00333983|536598692|FG000|Overall Study|Lost to Follow-up|2|||
148761198|NCT00333983|536598693|FG001|Overall Study|Lost to Follow-up|1|||
148761199|NCT00333983|536598694|FG002|Overall Study|Lost to Follow-up|0|||
148761200|NCT00333983|536598692|FG000|Overall Study|Adverse Event|1|||
148761201|NCT00333983|536598693|FG001|Overall Study|Adverse Event|1|||
148761202|NCT00333983|536598694|FG002|Overall Study|Adverse Event|1|||
148761203|NCT00333983|536598692|FG000|Overall Study|Withdrawal by Subject|0|||
148761204|NCT00333983|536598693|FG001|Overall Study|Withdrawal by Subject|3|||
148761205|NCT00333983|536598694|FG002|Overall Study|Withdrawal by Subject|1|||
148761206|NCT03270657|536598695|FG000|Overall Study|Withdrawal by Subject|1|||
148761207|NCT00455403|536598696|FG000|Overall Study|Lost to Follow-up|2|||
148761208|NCT00455403|536598697|FG001|Overall Study|Lost to Follow-up|1|||
148761209|NCT00455403|536598696|FG000|Overall Study|Withdrawal by Subject|1|||
148761210|NCT00455403|536598697|FG001|Overall Study|Withdrawal by Subject|3|||
148761211|NCT00455403|536598696|FG000|Overall Study|Protocol Violation|0|||
148761212|NCT00455403|536598697|FG001|Overall Study|Protocol Violation|2|||
148761213|NCT04509076|536598698|FG000|Overall Study|Withdrawal by Subject|1|||
148761214|NCT04509076|536598699|FG001|Overall Study|Withdrawal by Subject|2|||
148761215|NCT04509076|536598698|FG000|Overall Study|Lost to Follow-up|1|||
148761216|NCT04509076|536598699|FG001|Overall Study|Lost to Follow-up|2|||
148761217|NCT01343043|536598702|FG000|Overall Study|Disease progression before treatment|1|||
148761218|NCT01343043|536598703|FG001|Overall Study|Disease progression before treatment|0|||
148761219|NCT01343043|536598704|FG002|Overall Study|Disease progression before treatment|0|||
148761220|NCT01343043|536598705|FG003|Overall Study|Disease progression before treatment|0|||
148761221|NCT01343043|536598702|FG000|Overall Study|Withdrawal by Subject|1|||
148761222|NCT01343043|536598703|FG001|Overall Study|Withdrawal by Subject|0|||
148761223|NCT01343043|536598704|FG002|Overall Study|Withdrawal by Subject|0|||
148761224|NCT01343043|536598705|FG003|Overall Study|Withdrawal by Subject|0|||
148761225|NCT01343043|536598702|FG000|Overall Study|Death|1|||
148761226|NCT01343043|536598703|FG001|Overall Study|Death|1|||
148761227|NCT01343043|536598704|FG002|Overall Study|Death|0|||
148761228|NCT01343043|536598705|FG003|Overall Study|Death|1|||
148761229|NCT00925704|536598706|FG000|First Intervention|Withdrew consent|0|||
148761230|NCT00925704|536598707|FG001|First Intervention|Withdrew consent|0|||
148761231|NCT00925704|536598708|FG002|First Intervention|Withdrew consent|0|||
148761232|NCT00925704|536598709|FG003|First Intervention|Withdrew consent|1|||
148761233|NCT00925704|536598710|FG004|First Intervention|Withdrew consent|1|||
148761234|NCT00925704|536598711|FG005|First Intervention|Withdrew consent|0|||
148761235|NCT00925704|536598706|FG000|Second Intervention|Withdrawal by Subject|1|||
148761236|NCT00925704|536598707|FG001|Second Intervention|Withdrawal by Subject|0|||
148761237|NCT00925704|536598708|FG002|Second Intervention|Withdrawal by Subject|0|||
148761238|NCT00925704|536598709|FG003|Second Intervention|Withdrawal by Subject|0|||
148826235|NCT01500135|536841998|FG001|Overall Study|Lost to Follow-up|4|||
148761239|NCT00925704|536598710|FG004|Second Intervention|Withdrawal by Subject|1|||
148761240|NCT00925704|536598711|FG005|Second Intervention|Withdrawal by Subject|0|||
148761241|NCT00925704|536598706|FG000|Third Intervention|Withdrew consent|0|||
148761242|NCT00925704|536598707|FG001|Third Intervention|Withdrew consent|0|||
148761243|NCT00925704|536598708|FG002|Third Intervention|Withdrew consent|0|||
148761244|NCT00925704|536598709|FG003|Third Intervention|Withdrew consent|0|||
148761245|NCT00925704|536598710|FG004|Third Intervention|Withdrew consent|0|||
148761246|NCT00925704|536598711|FG005|Third Intervention|Withdrew consent|1|||
148761247|NCT00502242|536598717|FG000|Overall Study|Lack of Efficacy|1|||
148761248|NCT00502242|536598718|FG001|Overall Study|Lack of Efficacy|11|||
148761249|NCT00502242|536598717|FG000|Overall Study|Adverse Event|31|||
148761250|NCT00502242|536598718|FG001|Overall Study|Adverse Event|20|||
148761251|NCT00502242|536598717|FG000|Overall Study|Physician Decision|2|||
148761252|NCT00502242|536598718|FG001|Overall Study|Physician Decision|3|||
148761253|NCT00502242|536598717|FG000|Overall Study|Other - Unspecified|8|||
148761254|NCT00502242|536598718|FG001|Overall Study|Other - Unspecified|14|||
148761255|NCT00502242|536598717|FG000|Overall Study|Protocol Violation|3|||
148761256|NCT00502242|536598718|FG001|Overall Study|Protocol Violation|1|||
148761257|NCT00502242|536598717|FG000|Overall Study|Withdrawal by Subject|6|||
148761258|NCT00502242|536598718|FG001|Overall Study|Withdrawal by Subject|7|||
148761259|NCT03207815|536598719|FG000|Overall Study|Protocol Violation|3|||
148761260|NCT03207815|536598720|FG001|Overall Study|Protocol Violation|1|||
148761261|NCT03207815|536598719|FG000|Overall Study|Adverse Event|1|||
148761262|NCT03207815|536598720|FG001|Overall Study|Adverse Event|2|||
148761263|NCT03207815|536598719|FG000|Overall Study|Lost to Follow-up|1|||
148761264|NCT03207815|536598720|FG001|Overall Study|Lost to Follow-up|2|||
148761265|NCT03207815|536598719|FG000|Overall Study|Investigator's Discretion|1|||
148761266|NCT03207815|536598720|FG001|Overall Study|Investigator's Discretion|1|||
148761267|NCT03207815|536598719|FG000|Overall Study|Lack of Efficacy|0|||
148761268|NCT03207815|536598720|FG001|Overall Study|Lack of Efficacy|1|||
148761269|NCT03207815|536598719|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
148761270|NCT03207815|536598720|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
148761271|NCT03207815|536598719|FG000|Overall Study|Withdrew Consent|1|||
148761272|NCT03207815|536598720|FG001|Overall Study|Withdrew Consent|0|||
148761273|NCT01671007|536598721|FG000|Overall Study|Other reasons than listed|166|||
148761274|NCT01671007|536598722|FG001|Overall Study|Other reasons than listed|373|||
148761275|NCT01671007|536598723|FG002|Overall Study|Other reasons than listed|197|||
148761276|NCT01671007|536598724|FG003|Overall Study|Other reasons than listed|228|||
148761277|NCT01671007|536598725|FG004|Overall Study|Other reasons than listed|14|||
148761278|NCT01671007|536598726|FG005|Overall Study|Other reasons than listed|71|||
148761279|NCT01671007|536598727|FG006|Overall Study|Other reasons than listed|17|||
148761280|NCT01671007|536598728|FG007|Overall Study|Other reasons than listed|66|||
148761281|NCT01671007|536598729|FG008|Overall Study|Other reasons than listed|0|||
148761282|NCT01671007|536598721|FG000|Overall Study|Withdrawal by Subject|36|||
148761283|NCT01671007|536598722|FG001|Overall Study|Withdrawal by Subject|59|||
148761284|NCT01671007|536598723|FG002|Overall Study|Withdrawal by Subject|53|||
148761285|NCT01671007|536598724|FG003|Overall Study|Withdrawal by Subject|58|||
148761286|NCT01671007|536598725|FG004|Overall Study|Withdrawal by Subject|4|||
148761287|NCT01671007|536598726|FG005|Overall Study|Withdrawal by Subject|15|||
148761288|NCT01671007|536598727|FG006|Overall Study|Withdrawal by Subject|1|||
148761289|NCT01671007|536598728|FG007|Overall Study|Withdrawal by Subject|19|||
148761290|NCT01671007|536598729|FG008|Overall Study|Withdrawal by Subject|0|||
148761291|NCT01671007|536598721|FG000|Overall Study|Lost to Follow-up|93|||
148761292|NCT01671007|536598722|FG001|Overall Study|Lost to Follow-up|142|||
148761293|NCT01671007|536598723|FG002|Overall Study|Lost to Follow-up|91|||
148761294|NCT01671007|536598724|FG003|Overall Study|Lost to Follow-up|63|||
148761295|NCT01671007|536598725|FG004|Overall Study|Lost to Follow-up|7|||
148761296|NCT01671007|536598726|FG005|Overall Study|Lost to Follow-up|20|||
148761297|NCT01671007|536598727|FG006|Overall Study|Lost to Follow-up|2|||
148761298|NCT01671007|536598728|FG007|Overall Study|Lost to Follow-up|28|||
148761299|NCT01671007|536598729|FG008|Overall Study|Lost to Follow-up|0|||
148761300|NCT01671007|536598721|FG000|Overall Study|No end of study case report form|3|||
148761301|NCT01671007|536598722|FG001|Overall Study|No end of study case report form|1|||
148761302|NCT01671007|536598723|FG002|Overall Study|No end of study case report form|0|||
148761303|NCT01671007|536598724|FG003|Overall Study|No end of study case report form|2|||
148977216|NCT04084769|537396615|FG000|Overall Study|Withdrawal by Subject|0|||
148761304|NCT01671007|536598725|FG004|Overall Study|No end of study case report form|0|||
148761305|NCT01671007|536598726|FG005|Overall Study|No end of study case report form|0|||
148761306|NCT01671007|536598727|FG006|Overall Study|No end of study case report form|0|||
148761307|NCT01671007|536598728|FG007|Overall Study|No end of study case report form|0|||
148761308|NCT01671007|536598729|FG008|Overall Study|No end of study case report form|0|||
148761309|NCT01671007|536598721|FG000|Overall Study|Not eligible|23|||
148761310|NCT01671007|536598722|FG001|Overall Study|Not eligible|76|||
148761311|NCT01671007|536598723|FG002|Overall Study|Not eligible|25|||
148761312|NCT01671007|536598724|FG003|Overall Study|Not eligible|17|||
148761313|NCT01671007|536598725|FG004|Overall Study|Not eligible|0|||
148761314|NCT01671007|536598726|FG005|Overall Study|Not eligible|6|||
148761315|NCT01671007|536598727|FG006|Overall Study|Not eligible|1|||
148761316|NCT01671007|536598728|FG007|Overall Study|Not eligible|19|||
148761317|NCT01671007|536598729|FG008|Overall Study|Not eligible|0|||
148761318|NCT03877068|536598730|FG000|Overall Study|Physician Decision|9|||
148761319|NCT03877068|536598731|FG001|Overall Study|Physician Decision|3|||
148761320|NCT00171210|536598732|FG000|Overall Study|Adverse Event|16|||
148761321|NCT00171210|536598733|FG001|Overall Study|Adverse Event|27|||
148761322|NCT00171210|536598732|FG000|Overall Study|Abnormal laboratory value(s)|6|||
148761323|NCT00171210|536598733|FG001|Overall Study|Abnormal laboratory value(s)|3|||
148761324|NCT00171210|536598732|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148761325|NCT00171210|536598733|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148761326|NCT00171210|536598732|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
148761327|NCT00171210|536598733|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
148761328|NCT00171210|536598732|FG000|Overall Study|Protocol Violation|0|||
148761329|NCT00171210|536598733|FG001|Overall Study|Protocol Violation|2|||
148761330|NCT00171210|536598732|FG000|Overall Study|Withdrawal by Subject|32|||
148761331|NCT00171210|536598733|FG001|Overall Study|Withdrawal by Subject|30|||
148761332|NCT00171210|536598732|FG000|Overall Study|Lost to Follow-up|1|||
148761333|NCT00171210|536598733|FG001|Overall Study|Lost to Follow-up|0|||
148761334|NCT00171210|536598732|FG000|Overall Study|Administrative problems|1|||
148761335|NCT00171210|536598733|FG001|Overall Study|Administrative problems|1|||
148761336|NCT00171210|536598732|FG000|Overall Study|Death|2|||
148761337|NCT00171210|536598733|FG001|Overall Study|Death|3|||
148761338|NCT00171210|536598732|FG000|Overall Study|Stopped at end of core|0|||
148761339|NCT00171210|536598733|FG001|Overall Study|Stopped at end of core|32|||
148761340|NCT00171210|536598732|FG000|Overall Study|Stopped at end of extension 1|0|||
148761341|NCT00171210|536598733|FG001|Overall Study|Stopped at end of extension 1|1|||
148761342|NCT03252535|536598736|FG000|Overall Study|Withdrawal by Subject|1|||
148761343|NCT03252535|536598737|FG001|Overall Study|Withdrawal by Subject|0|||
148761344|NCT03252535|536598738|FG002|Overall Study|Withdrawal by Subject|0|||
148761345|NCT03252535|536598736|FG000|Overall Study|Physician Decision|0|||
148761346|NCT03252535|536598737|FG001|Overall Study|Physician Decision|1|||
148761347|NCT03252535|536598738|FG002|Overall Study|Physician Decision|0|||
148761348|NCT03252535|536598736|FG000|Overall Study|Met discontinuation criteria|0|||
148761349|NCT03252535|536598737|FG001|Overall Study|Met discontinuation criteria|1|||
148761350|NCT03252535|536598738|FG002|Overall Study|Met discontinuation criteria|0|||
148761351|NCT01812109|536598739|FG000|Overall Study|research personnel delay|16|||
148761352|NCT01812109|536598739|FG000|Overall Study|NIRS Unattainable|17|||
148761353|NCT01966120|536598740|FG000|Overall Study|Withdrawal by Subject|0|||
148761354|NCT01966120|536598741|FG001|Overall Study|Withdrawal by Subject|5|||
148761355|NCT01966120|536598740|FG000|Overall Study|Lost to Follow-up|1|||
148761356|NCT01966120|536598741|FG001|Overall Study|Lost to Follow-up|1|||
148761357|NCT02182843|536598743|FG000|Overall Study|Withdrawal by Subject|7|||
148761358|NCT02182843|536598743|FG000|Overall Study|Lost to Follow-up|2|||
148761359|NCT02182843|536598743|FG000|Overall Study|Adverse Event|1|||
148761360|NCT02588612|536598746|FG000|Overall Study|Physician Decision|1|||
148761361|NCT02588612|536598746|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
148761362|NCT02588612|536598746|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
148761363|NCT02588612|536598746|FG000|Overall Study|Death prior to T-cell infusion|1|||
148761364|NCT04548193|536598756|FG000|Overall Study|Lost to Follow-up|0|||
148761365|NCT04548193|536598757|FG001|Overall Study|Lost to Follow-up|1|||
148761366|NCT04548193|536598756|FG000|Overall Study|Death|0|||
148761367|NCT04548193|536598757|FG001|Overall Study|Death|1|||
148761368|NCT04548193|536598756|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
148761369|NCT04548193|536598757|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
148761370|NCT04548193|536598756|FG000|Overall Study|Withdrawal by Subject|2|||
148761371|NCT04548193|536598757|FG001|Overall Study|Withdrawal by Subject|2|||
148761372|NCT01681212|536598764|FG000|Overall Study|No longer met study criteria|5|||
148761373|NCT01681212|536598764|FG000|Overall Study|Administrative reason by sponsor|1|||
148761374|NCT05047211|536598768|FG000|Overall Study|Lost to Follow-up|8|||
148761375|NCT05047211|536598769|FG001|Overall Study|Lost to Follow-up|5|||
148761376|NCT02187198|536598770|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
148761377|NCT02187198|536598771|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
148761378|NCT02187198|536598770|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
148761379|NCT02187198|536598771|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
148761380|NCT00561392|536598772|FG000|Overall Study|Adverse Event|38|||
148761381|NCT00561392|536598772|FG000|Overall Study|Lack of Efficacy|2|||
148761382|NCT00561392|536598772|FG000|Overall Study|Protocol Violation|1|||
148761383|NCT00561392|536598772|FG000|Overall Study|Withdrawal by Subject|8|||
148761384|NCT00561392|536598772|FG000|Overall Study|Administrative problems|4|||
148977217|NCT04084769|537396616|FG001|Overall Study|Withdrawal by Subject|1|||
148761385|NCT03822468|536598773|FG000|Treatment Period|Progressive disease|98|||
148761386|NCT03822468|536598774|FG001|Treatment Period|Progressive disease|94|||
148761387|NCT03822468|536598773|FG000|Treatment Period|Adverse Event|21|||
148977218|NCT04084769|537396617|FG002|Overall Study|Withdrawal by Subject|0|||
148826236|NCT01500135|536841997|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
148826237|NCT01500135|536841998|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
148826238|NCT01500135|536841997|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
148826239|NCT01500135|536841998|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
148826240|NCT01500135|536841997|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
148826241|NCT01500135|536841998|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
148826242|NCT01500135|536841997|FG000|Overall Study|Participant was a Safety Concern|1|||
148826243|NCT01500135|536841998|FG001|Overall Study|Participant was a Safety Concern|0|||
148826244|NCT01500135|536841997|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
148826245|NCT01500135|536841998|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
148826246|NCT01661595|536841999|FG000|Phase 1: Week 0-4|Adverse Event|1|||
148826247|NCT01661595|536842000|FG001|Phase 1: Week 0-4|Adverse Event|0|||
148826248|NCT01661595|536842001|FG002|Phase 1: Week 0-4|Adverse Event|0|||
148826249|NCT01661595|536842002|FG003|Phase 1: Week 0-4|Adverse Event|0|||
148826250|NCT01661595|536841999|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
148826251|NCT01661595|536842000|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
148826252|NCT01661595|536842001|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
148826253|NCT01661595|536842002|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
148826254|NCT00912509|536842003|FG000|Overall Study|Lost to Follow-up|1|||
148826255|NCT00912509|536842004|FG001|Overall Study|Lost to Follow-up|0|||
148826256|NCT00912509|536842003|FG000|Overall Study|Lack of Efficacy|4|||
148826257|NCT00912509|536842004|FG001|Overall Study|Lack of Efficacy|3|||
148826258|NCT05538728|536842005|FG000|Overall Study|Withdrawal by Subject|1|||
148826259|NCT05538728|536842006|FG001|Overall Study|Withdrawal by Subject|1|||
148826260|NCT01034657|536842007|FG000|Core Phase|Withdrawal by Subject|1|||
148826261|NCT01034657|536842008|FG001|Core Phase|Withdrawal by Subject|0|||
148826262|NCT01034657|536842009|FG002|Core Phase|Withdrawal by Subject|0|||
148826263|NCT01034657|536842007|FG000|Core Phase|Lack of Efficacy|2|||
149027537|NCT00797225|537578594|FG004|Weeks 1 to 12|Sponsor Decision|0|||
149027538|NCT00797225|537578595|FG005|Weeks 1 to 12|Sponsor Decision|0|||
149027539|NCT00797225|537578596|FG006|Weeks 1 to 12|Sponsor Decision|0|||
149027540|NCT00797225|537578597|FG007|Weeks 1 to 12|Sponsor Decision|0|||
148761388|NCT03822468|536598774|FG001|Treatment Period|Adverse Event|24|||
148761389|NCT03822468|536598773|FG000|Treatment Period|Withdrawal by Subject|9|||
148761390|NCT03822468|536598774|FG001|Treatment Period|Withdrawal by Subject|5|||
148761391|NCT03822468|536598773|FG000|Treatment Period|Physician Decision|9|||
148761392|NCT03822468|536598774|FG001|Treatment Period|Physician Decision|7|||
148761393|NCT03822468|536598773|FG000|Treatment Period|Protocol Violation|2|||
148761394|NCT03822468|536598774|FG001|Treatment Period|Protocol Violation|1|||
148761395|NCT03822468|536598773|FG000|Treatment Period|Death|2|||
148761396|NCT03822468|536598774|FG001|Treatment Period|Death|3|||
148761397|NCT03822468|536598773|FG000|Treatment Period|Lost to Follow-up|1|||
148761398|NCT03822468|536598774|FG001|Treatment Period|Lost to Follow-up|1|||
148761399|NCT03822468|536598773|FG000|Treatment Period|Sponsor decision|46|||
148761400|NCT03822468|536598774|FG001|Treatment Period|Sponsor decision|53|||
148761401|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
148761402|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
148761403|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
148761404|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
148761405|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Death|1|||
148761406|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Death|0|||
148761407|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
148761408|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
148761409|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
148761410|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
148761411|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
148761412|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
148761413|NCT03822468|536598773|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
148761414|NCT03822468|536598774|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
148761415|NCT03321968|536598775|FG000|Overall Study|Withdrawal by Subject|1|||
148761416|NCT03321968|536598776|FG001|Overall Study|Withdrawal by Subject|2|||
148761417|NCT03321968|536598777|FG002|Overall Study|Withdrawal by Subject|1|||
148761418|NCT03321968|536598775|FG000|Overall Study|Lost to Follow-up|2|||
148761419|NCT03321968|536598776|FG001|Overall Study|Lost to Follow-up|0|||
148761420|NCT03321968|536598777|FG002|Overall Study|Lost to Follow-up|1|||
148761421|NCT03321968|536598775|FG000|Overall Study|Other than specified|0|||
148761422|NCT03321968|536598776|FG001|Overall Study|Other than specified|0|||
148761423|NCT03321968|536598777|FG002|Overall Study|Other than specified|1|||
148761424|NCT01532518|536598778|FG000|Overall Study|Withdrawal by Subject|0|||
148761425|NCT01532518|536598779|FG001|Overall Study|Withdrawal by Subject|0|||
148761426|NCT01532518|536598780|FG002|Overall Study|Withdrawal by Subject|1|||
148826264|NCT01034657|536842008|FG001|Core Phase|Lack of Efficacy|0|||
148826265|NCT01034657|536842009|FG002|Core Phase|Lack of Efficacy|0|||
148826266|NCT01034657|536842007|FG000|Core Phase|Abnormal laboratory value|1|||
149027541|NCT00797225|537578590|FG000|Weeks 13 to 24|Non-compliance|0|||
148761427|NCT01575834|536598781|FG000|Overall Study|Withdrawal by Subject|352|||
148761428|NCT01575834|536598782|FG001|Overall Study|Withdrawal by Subject|390|||
148761429|NCT01575834|536598781|FG000|Overall Study|Death|81|||
148761430|NCT01575834|536598782|FG001|Overall Study|Death|74|||
148761431|NCT01575834|536598781|FG000|Overall Study|Other|70|||
148761432|NCT01575834|536598782|FG001|Overall Study|Other|70|||
148761433|NCT01575834|536598781|FG000|Overall Study|Adverse Event|63|||
148761434|NCT01575834|536598782|FG001|Overall Study|Adverse Event|61|||
148761435|NCT01575834|536598781|FG000|Overall Study|Lost to Follow-up|55|||
148761436|NCT01575834|536598782|FG001|Overall Study|Lost to Follow-up|68|||
148761437|NCT01575834|536598781|FG000|Overall Study|Noncompliance|52|||
148761438|NCT01575834|536598782|FG001|Overall Study|Noncompliance|27|||
148761439|NCT01575834|536598781|FG000|Overall Study|Administrative decision|15|||
148761440|NCT01575834|536598782|FG001|Overall Study|Administrative decision|33|||
148761441|NCT01575834|536598781|FG000|Overall Study|Ineligibility Determined|5|||
148761442|NCT01575834|536598782|FG001|Overall Study|Ineligibility Determined|8|||
148761443|NCT01575834|536598781|FG000|Overall Study|Protocol Deviation|4|||
148761444|NCT01575834|536598782|FG001|Overall Study|Protocol Deviation|3|||
148761445|NCT01575834|536598781|FG000|Overall Study|Requirement for Alternative Therapy|2|||
148761446|NCT01575834|536598782|FG001|Overall Study|Requirement for Alternative Therapy|4|||
148761447|NCT02155283|536598783|FG000|Overall Study|Lost to Follow-up|3|||
148761448|NCT02155283|536598783|FG000|Overall Study|Withdrawal by Subject|1|||
148761449|NCT02155283|536598783|FG000|Overall Study|Protocol Violation|3|||
148761450|NCT01741688|536598786|FG000|Overall Study|Lack of insurance coverage|2|||
148761451|NCT01741688|536598786|FG000|Overall Study|Withdrawal by Subject|1|||
148761452|NCT02282813|536598787|FG000|Overall Study|Withdrawal by Subject|4|||
148761453|NCT02282813|536598788|FG001|Overall Study|Withdrawal by Subject|5|||
148761454|NCT02282813|536598789|FG002|Overall Study|Withdrawal by Subject|0|||
148761455|NCT02282813|536598787|FG000|Overall Study|Adverse Event|3|||
148761456|NCT02282813|536598788|FG001|Overall Study|Adverse Event|10|||
148761457|NCT02282813|536598789|FG002|Overall Study|Adverse Event|1|||
148761458|NCT02282813|536598787|FG000|Overall Study|Subject non-compliance|1|||
148761459|NCT02282813|536598788|FG001|Overall Study|Subject non-compliance|4|||
148761460|NCT02282813|536598789|FG002|Overall Study|Subject non-compliance|0|||
148761461|NCT02282813|536598787|FG000|Overall Study|Physician Decision|0|||
148761462|NCT02282813|536598788|FG001|Overall Study|Physician Decision|3|||
148761463|NCT02282813|536598789|FG002|Overall Study|Physician Decision|1|||
148761464|NCT02282813|536598787|FG000|Overall Study|Lost to Follow-up|2|||
148761465|NCT02282813|536598788|FG001|Overall Study|Lost to Follow-up|0|||
148761466|NCT02282813|536598789|FG002|Overall Study|Lost to Follow-up|1|||
148761467|NCT02282813|536598787|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
148761468|NCT02282813|536598788|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
148761469|NCT02282813|536598789|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
148761470|NCT02282813|536598787|FG000|Overall Study|Lack of Efficacy|1|||
148761471|NCT02282813|536598788|FG001|Overall Study|Lack of Efficacy|0|||
148761472|NCT02282813|536598789|FG002|Overall Study|Lack of Efficacy|0|||
148761473|NCT02282813|536598787|FG000|Overall Study|Administrative reasons|0|||
148761474|NCT02282813|536598788|FG001|Overall Study|Administrative reasons|1|||
148761475|NCT02282813|536598789|FG002|Overall Study|Administrative reasons|0|||
148761476|NCT00410813|536598790|FG000|Overall Study|Adverse Event|6|||
148761477|NCT00410813|536598791|FG001|Overall Study|Adverse Event|11|||
148761478|NCT00410813|536598790|FG000|Overall Study|Progression|32|||
148761479|NCT00410813|536598791|FG001|Overall Study|Progression|21|||
148761480|NCT00410813|536598790|FG000|Overall Study|Not protocol specified|3|||
148761481|NCT00410813|536598791|FG001|Overall Study|Not protocol specified|4|||
148761482|NCT00410813|536598790|FG000|Overall Study|Ineligible|2|||
148761483|NCT00410813|536598791|FG001|Overall Study|Ineligible|4|||
148761484|NCT00410813|536598790|FG000|Overall Study|Death|0|||
148761485|NCT00410813|536598791|FG001|Overall Study|Death|2|||
148761486|NCT04278417|536598792|FG000|Overall Study|Withdrawal by Subject|20|||
148761487|NCT04278417|536598793|FG001|Overall Study|Withdrawal by Subject|20|||
148761488|NCT04278417|536598792|FG000|Overall Study|Progressive disease|0|||
148761489|NCT04278417|536598793|FG001|Overall Study|Progressive disease|2|||
148761490|NCT04278417|536598792|FG000|Overall Study|Physician Decision|4|||
148761491|NCT04278417|536598793|FG001|Overall Study|Physician Decision|6|||
148761492|NCT04278417|536598792|FG000|Overall Study|Lost to Follow-up|11|||
148761493|NCT04278417|536598793|FG001|Overall Study|Lost to Follow-up|13|||
148761494|NCT04278417|536598792|FG000|Overall Study|Death|8|||
148761495|NCT04278417|536598793|FG001|Overall Study|Death|9|||
148761496|NCT04278417|536598792|FG000|Overall Study|Adverse Event|3|||
148761497|NCT04278417|536598793|FG001|Overall Study|Adverse Event|5|||
148761498|NCT06509438|536598794|FG000|Overall Study|Adverse Event|1|||
148761499|NCT06509438|536598794|FG000|Overall Study|Lost to Follow-up|3|||
148761500|NCT02169271|536598795|FG000|Overall Study|Protocol Violation|1|||
149027542|NCT00797225|537578591|FG001|Weeks 13 to 24|Non-compliance|2|||
148761501|NCT02169271|536598796|FG001|Overall Study|Protocol Violation|2|||
148761502|NCT04025879|536598797|FG000|Randomization|Participant withdrew consent|0|||
148761503|NCT04025879|536598798|FG001|Randomization|Participant withdrew consent|1|||
148761504|NCT04025879|536598797|FG000|Randomization|Participant no longer met study criteria|1|||
148761505|NCT04025879|536598798|FG001|Randomization|Participant no longer met study criteria|1|||
148761506|NCT04025879|536598797|FG000|Treatment|Ongoing treatment|10|||
148761507|NCT04025879|536598798|FG001|Treatment|Ongoing treatment|8|||
148761508|NCT04025879|536598797|FG000|Treatment|Disease progression/recurrence|36|||
148761509|NCT04025879|536598798|FG001|Treatment|Disease progression/recurrence|72|||
148761510|NCT04025879|536598797|FG000|Treatment|Study drug toxicity|36|||
148761511|NCT04025879|536598798|FG001|Treatment|Study drug toxicity|13|||
148761512|NCT04025879|536598797|FG000|Treatment|Death|2|||
148761513|NCT04025879|536598798|FG001|Treatment|Death|0|||
148761514|NCT04025879|536598797|FG000|Treatment|Adverse event unrelated to study drug|21|||
148761515|NCT04025879|536598798|FG001|Treatment|Adverse event unrelated to study drug|14|||
148761516|NCT04025879|536598797|FG000|Treatment|Participant request to discontinue study treatment|16|||
148826267|NCT01034657|536842008|FG001|Core Phase|Abnormal laboratory value|0|||
148826268|NCT01034657|536842009|FG002|Core Phase|Abnormal laboratory value|0|||
148826269|NCT01034657|536842007|FG000|Core Phase|Adverse Event|8|||
148826270|NCT01034657|536842008|FG001|Core Phase|Adverse Event|0|||
148826271|NCT01034657|536842009|FG002|Core Phase|Adverse Event|0|||
148826272|NCT01034657|536842007|FG000|Core Phase|Protocol Violation|2|||
148826273|NCT01034657|536842008|FG001|Core Phase|Protocol Violation|0|||
148826274|NCT01034657|536842009|FG002|Core Phase|Protocol Violation|0|||
148826275|NCT01034657|536842007|FG000|Randomized Phase|Withdrawal by Subject|0|||
148826276|NCT01034657|536842008|FG001|Randomized Phase|Withdrawal by Subject|2|||
148826277|NCT01034657|536842009|FG002|Randomized Phase|Withdrawal by Subject|0|||
148826278|NCT01034657|536842007|FG000|Randomized Phase|Lack of Efficacy|5|||
148826279|NCT01034657|536842008|FG001|Randomized Phase|Lack of Efficacy|1|||
148826280|NCT01034657|536842009|FG002|Randomized Phase|Lack of Efficacy|0|||
148826281|NCT01034657|536842007|FG000|Randomized Phase|Abnormal laboratory value|0|||
148826282|NCT01034657|536842008|FG001|Randomized Phase|Abnormal laboratory value|1|||
148826283|NCT01034657|536842009|FG002|Randomized Phase|Abnormal laboratory value|0|||
148826284|NCT01034657|536842007|FG000|Randomized Phase|Adverse Event|0|||
148826285|NCT01034657|536842008|FG001|Randomized Phase|Adverse Event|2|||
148826286|NCT01034657|536842009|FG002|Randomized Phase|Adverse Event|1|||
148826287|NCT02715856|536842010|FG000|Overall Study|Software Issues|12|||
148826288|NCT02715856|536842011|FG001|Overall Study|Software Issues|7|||
148826289|NCT02715856|536842010|FG000|Overall Study|Death|6|||
148826290|NCT02715856|536842011|FG001|Overall Study|Death|5|||
148826291|NCT02715856|536842010|FG000|Overall Study|Non- Compliant|0|||
148826292|NCT02715856|536842011|FG001|Overall Study|Non- Compliant|40|||
148826293|NCT01050218|536842012|FG000|Overall Study|Adverse Event|37|||
148826294|NCT01050218|536842012|FG000|Overall Study|Lack of Efficacy|8|||
148826295|NCT01050218|536842012|FG000|Overall Study|Protocol Violation|3|||
148826296|NCT01050218|536842012|FG000|Overall Study|Withdrawal by Subject|18|||
148826297|NCT01050218|536842012|FG000|Overall Study|Discontinued by sponsor|18|||
148826298|NCT01050218|536842012|FG000|Overall Study|Compliance|2|||
148826299|NCT01050218|536842012|FG000|Overall Study|Failed to return|7|||
148826300|NCT01050218|536842012|FG000|Overall Study|Serious Adverse Event|1|||
148826301|NCT01050218|536842012|FG000|Overall Study|Family emergency|1|||
148826302|NCT01772693|536842013|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
148826303|NCT01772693|536842014|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
148826304|NCT01772693|536842013|FG000|Overall Study|Withdrawal by Subject|2|||
148826305|NCT01772693|536842014|FG001|Overall Study|Withdrawal by Subject|0|||
148826306|NCT01772693|536842013|FG000|Overall Study|Alternative Treatment|2|||
148826307|NCT01772693|536842014|FG001|Overall Study|Alternative Treatment|0|||
148826308|NCT01633112|536842017|FG000|Overall Study|Lack of Efficacy|1|||
148826309|NCT01633112|536842018|FG001|Overall Study|Lack of Efficacy|6|||
148826310|NCT01633112|536842019|FG002|Overall Study|Lack of Efficacy|13|||
148826311|NCT01633112|536842017|FG000|Overall Study|Abnormal laboratory value(s)|3|||
148826312|NCT01633112|536842018|FG001|Overall Study|Abnormal laboratory value(s)|1|||
148826313|NCT01633112|536842019|FG002|Overall Study|Abnormal laboratory value(s)|0|||
148826314|NCT01633112|536842017|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148826315|NCT01633112|536842018|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148826316|NCT01633112|536842019|FG002|Overall Study|Abnormal test procedure result(s)|0|||
148977219|NCT04084769|537396618|FG003|Overall Study|Withdrawal by Subject|0|||
148761517|NCT04025879|536598798|FG001|Treatment|Participant request to discontinue study treatment|8|||
148826317|NCT01633112|536842017|FG000|Overall Study|Administrative problems|1|||
148826318|NCT01633112|536842018|FG001|Overall Study|Administrative problems|2|||
148826319|NCT01633112|536842019|FG002|Overall Study|Administrative problems|5|||
148826320|NCT01633112|536842017|FG000|Overall Study|Adverse Event|16|||
148826321|NCT01633112|536842018|FG001|Overall Study|Adverse Event|18|||
148826322|NCT01633112|536842019|FG002|Overall Study|Adverse Event|20|||
148826323|NCT01633112|536842017|FG000|Overall Study|Lost to Follow-up|7|||
148826324|NCT01633112|536842018|FG001|Overall Study|Lost to Follow-up|19|||
148826325|NCT01633112|536842019|FG002|Overall Study|Lost to Follow-up|6|||
148826326|NCT01633112|536842017|FG000|Overall Study|Protocol Violation|4|||
148826327|NCT01633112|536842018|FG001|Overall Study|Protocol Violation|0|||
148826328|NCT01633112|536842019|FG002|Overall Study|Protocol Violation|2|||
148826329|NCT01633112|536842017|FG000|Overall Study|Subject no longer requires study drug|0|||
148761518|NCT04025879|536598797|FG000|Treatment|Participant withdrew consent|1|||
148761519|NCT04025879|536598798|FG001|Treatment|Participant withdrew consent|3|||
148761520|NCT04025879|536598797|FG000|Treatment|Participant no longer meets study criteria|3|||
148761521|NCT04025879|536598798|FG001|Treatment|Participant no longer meets study criteria|2|||
148761522|NCT04025879|536598797|FG000|Treatment|Lost to Follow-up|1|||
148761523|NCT04025879|536598798|FG001|Treatment|Lost to Follow-up|0|||
148761524|NCT04025879|536598797|FG000|Treatment|Other reasons|15|||
148761525|NCT04025879|536598798|FG001|Treatment|Other reasons|17|||
148761526|NCT04025879|536598797|FG000|Treatment|Administrative reason by sponsor|0|||
148761527|NCT04025879|536598798|FG001|Treatment|Administrative reason by sponsor|1|||
148761528|NCT04025879|536598797|FG000|Treatment|Not reported|2|||
148761529|NCT04025879|536598798|FG001|Treatment|Not reported|0|||
148761530|NCT01991743|536598810|FG000|Overall Study|external cephalic version not performed|0|||
148761531|NCT01991743|536598811|FG001|Overall Study|external cephalic version not performed|0|||
148761532|NCT01991743|536598812|FG002|Overall Study|external cephalic version not performed|1|||
148761533|NCT01991743|536598813|FG003|Overall Study|external cephalic version not performed|0|||
148761534|NCT03830333|536598814|FG000|Overall Study|Death|0|||
148761535|NCT03830333|536598815|FG001|Overall Study|Death|1|||
148761536|NCT03830333|536598814|FG000|Overall Study|Withdrawal by Subject|5|||
148761537|NCT03830333|536598815|FG001|Overall Study|Withdrawal by Subject|1|||
148761538|NCT03830333|536598814|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
148761539|NCT03830333|536598815|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
148761540|NCT00722137|536598816|FG000|Overall Study|Overt Disease Progression|5|||
148761541|NCT00722137|536598817|FG001|Overall Study|Overt Disease Progression|4|||
148761542|NCT00722137|536598816|FG000|Overall Study|Adverse Event|17|||
148761543|NCT00722137|536598817|FG001|Overall Study|Adverse Event|21|||
148761544|NCT00722137|536598816|FG000|Overall Study|Death|12|||
148761545|NCT00722137|536598817|FG001|Overall Study|Death|7|||
148761546|NCT00722137|536598816|FG000|Overall Study|Withdrawal by Subject|6|||
148761547|NCT00722137|536598817|FG001|Overall Study|Withdrawal by Subject|9|||
148761548|NCT00722137|536598816|FG000|Overall Study|Other Reason Unknown|3|||
148761549|NCT00722137|536598817|FG001|Overall Study|Other Reason Unknown|4|||
148761550|NCT00722137|536598816|FG000|Overall Study|Randomized But Not Treated|2|||
148761551|NCT00722137|536598817|FG001|Overall Study|Randomized But Not Treated|3|||
148761552|NCT01367886|536598820|FG000|Overall Study|Lost to Follow-up|4|||
148761553|NCT01367886|536598820|FG000|Overall Study|Lack of Efficacy|2|||
148761554|NCT01367886|536598820|FG000|Overall Study|Death|1|||
148761555|NCT00985504|536598821|FG000|Acute Treatment Period|Adverse Event|3|||
148761556|NCT00985504|536598822|FG001|Acute Treatment Period|Adverse Event|4|||
148761557|NCT00985504|536598821|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
148761558|NCT00985504|536598822|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
148761559|NCT00985504|536598821|FG000|Acute Treatment Period|Protocol Violation|2|||
148761560|NCT00985504|536598822|FG001|Acute Treatment Period|Protocol Violation|0|||
148761561|NCT00985504|536598821|FG000|Acute Treatment Period|Sponsor Decision|0|||
148761562|NCT00985504|536598822|FG001|Acute Treatment Period|Sponsor Decision|1|||
148761563|NCT00985504|536598821|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
148761564|NCT00985504|536598822|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
148761565|NCT00985504|536598821|FG000|Optimization Period|Adverse Event|7|||
148761566|NCT00985504|536598822|FG001|Optimization Period|Adverse Event|9|||
148761567|NCT00985504|536598821|FG000|Optimization Period|Death|0|||
148761568|NCT00985504|536598822|FG001|Optimization Period|Death|1|||
148761569|NCT00985504|536598821|FG000|Optimization Period|Lack of Efficacy|5|||
148761570|NCT00985504|536598822|FG001|Optimization Period|Lack of Efficacy|3|||
148761571|NCT00985504|536598821|FG000|Optimization Period|Lost to Follow-up|0|||
148761572|NCT00985504|536598822|FG001|Optimization Period|Lost to Follow-up|1|||
148761573|NCT00985504|536598821|FG000|Optimization Period|Physician Decision|1|||
148761574|NCT00985504|536598822|FG001|Optimization Period|Physician Decision|0|||
148761575|NCT00985504|536598821|FG000|Optimization Period|Protocol Violation|3|||
148761576|NCT00985504|536598822|FG001|Optimization Period|Protocol Violation|1|||
148761577|NCT00985504|536598821|FG000|Optimization Period|Withdrawal by Subject|10|||
148761578|NCT00985504|536598822|FG001|Optimization Period|Withdrawal by Subject|8|||
148761579|NCT03711786|536598831|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
148761580|NCT03711786|536598832|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
149027543|NCT00797225|537578592|FG002|Weeks 13 to 24|Non-compliance|0|||
149027544|NCT00797225|537578593|FG003|Weeks 13 to 24|Non-compliance|0|||
148761581|NCT03711786|536598831|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
148761582|NCT03711786|536598832|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
148761583|NCT03711786|536598831|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
148761584|NCT03711786|536598832|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
148761585|NCT03711786|536598831|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
148761586|NCT03711786|536598832|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
148761587|NCT03711786|536598831|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
148761588|NCT03711786|536598832|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
148761589|NCT03711786|536598831|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
148761590|NCT03711786|536598832|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
148761591|NCT04390113|536598833|FG000|Overall Study|Not Treated|0|||
148761592|NCT04390113|536598834|FG001|Overall Study|Not Treated|1|||
148761593|NCT04390113|536598833|FG000|Overall Study|Adverse Event|1|||
148761594|NCT04390113|536598834|FG001|Overall Study|Adverse Event|0|||
148761595|NCT04390113|536598833|FG000|Overall Study|Death|2|||
148761596|NCT04390113|536598834|FG001|Overall Study|Death|1|||
148761597|NCT04390113|536598833|FG000|Overall Study|Physician Decision|1|||
148761598|NCT04390113|536598834|FG001|Overall Study|Physician Decision|3|||
148761599|NCT04390113|536598833|FG000|Overall Study|Study Terminated by Sponsor|5|||
148761600|NCT04390113|536598834|FG001|Overall Study|Study Terminated by Sponsor|3|||
148761601|NCT04390113|536598833|FG000|Overall Study|Withdrawal by Subject|10|||
148761602|NCT04390113|536598834|FG001|Overall Study|Withdrawal by Subject|5|||
148761603|NCT04390113|536598833|FG000|Overall Study|Other|1|||
148761604|NCT04390113|536598834|FG001|Overall Study|Other|0|||
148761605|NCT04390113|536598833|FG000|Overall Study|Missing|0|||
148761606|NCT04390113|536598834|FG001|Overall Study|Missing|1|||
148761607|NCT01611883|536598835|FG000|Overall Study|Adverse Event|1|||
148761608|NCT01611883|536598836|FG001|Overall Study|Adverse Event|1|||
148761609|NCT03379727|536598838|FG000|Overall Study|Lack of Efficacy|73|||
148761610|NCT03379727|536598838|FG000|Overall Study|Adverse Event|32|||
148761611|NCT03379727|536598838|FG000|Overall Study|Death|18|||
148761612|NCT03379727|536598838|FG000|Overall Study|Patient/guardian decision|17|||
148761613|NCT03379727|536598838|FG000|Overall Study|Physician Decision|104|||
148761614|NCT03379727|536598838|FG000|Overall Study|Protocol Violation|4|||
148761615|NCT03379727|536598838|FG000|Overall Study|Lost to Follow-up|1|||
148761616|NCT02418182|536598843|FG000|Overall Study|Unable to re-consent|18|||
148761617|NCT02418182|536598844|FG001|Overall Study|Unable to re-consent|15|||
148761618|NCT02418182|536598843|FG000|Overall Study|Lost to Follow-up|0|||
148761619|NCT02418182|536598844|FG001|Overall Study|Lost to Follow-up|2|||
148761620|NCT00734994|536598845|FG000|Overall Study|Withdrawal by Subject|1|||
148761621|NCT01622673|536598846|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148761622|NCT01622673|536598847|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148761623|NCT01622673|536598848|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148761624|NCT01622673|536598849|FG003|Treatment Period 1|Withdrawal by Subject|1|||
148761625|NCT01622673|536598850|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148761626|NCT01622673|536598851|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148761627|NCT01622673|536598846|FG000|Treatment Period 1|Protocol Violation|0|||
148761628|NCT01622673|536598847|FG001|Treatment Period 1|Protocol Violation|1|||
148761629|NCT01622673|536598848|FG002|Treatment Period 1|Protocol Violation|0|||
148761630|NCT01622673|536598849|FG003|Treatment Period 1|Protocol Violation|0|||
148761631|NCT01622673|536598850|FG004|Treatment Period 1|Protocol Violation|0|||
148761632|NCT01622673|536598851|FG005|Treatment Period 1|Protocol Violation|0|||
148761633|NCT01622673|536598846|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148761634|NCT01622673|536598847|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148761635|NCT01622673|536598848|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148761636|NCT01622673|536598849|FG003|Treatment Period 2|Withdrawal by Subject|1|||
148761637|NCT01622673|536598850|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148761638|NCT01622673|536598851|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148761639|NCT01622673|536598846|FG000|Treatment Period 3|Protocol Violation|0|||
148761640|NCT01622673|536598847|FG001|Treatment Period 3|Protocol Violation|1|||
148761641|NCT01622673|536598848|FG002|Treatment Period 3|Protocol Violation|0|||
148761642|NCT01622673|536598849|FG003|Treatment Period 3|Protocol Violation|0|||
148761643|NCT01622673|536598850|FG004|Treatment Period 3|Protocol Violation|0|||
148761644|NCT01622673|536598851|FG005|Treatment Period 3|Protocol Violation|0|||
148761645|NCT04010240|536600752|FG000|Overall Study|IHC not performed|2299|||
148761646|NCT01682226|536600753|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
148761647|NCT01682226|536600753|FG000|Overall Study|Participants did not receive treatment|2|||
148761648|NCT01682226|536600753|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
149027545|NCT00797225|537578594|FG004|Weeks 13 to 24|Non-compliance|0|||
148761649|NCT03771898|536600754|FG000|Overall Study|Adverse Event|1|||
148761650|NCT03771898|536600755|FG001|Overall Study|Adverse Event|0|||
148761651|NCT03771898|536600756|FG002|Overall Study|Adverse Event|0|||
148761652|NCT03771898|536600757|FG003|Overall Study|Adverse Event|0|||
148761653|NCT03771898|536600758|FG004|Overall Study|Adverse Event|0|||
148761654|NCT03771898|536600754|FG000|Overall Study|Lost to Follow-up|1|||
148761655|NCT03771898|536600755|FG001|Overall Study|Lost to Follow-up|1|||
148761656|NCT03771898|536600756|FG002|Overall Study|Lost to Follow-up|1|||
148761657|NCT03771898|536600757|FG003|Overall Study|Lost to Follow-up|0|||
148761658|NCT03771898|536600758|FG004|Overall Study|Lost to Follow-up|0|||
148761659|NCT03771898|536600754|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148761660|NCT03771898|536600755|FG001|Overall Study|Withdrawal by parent/guardian|1|||
148761661|NCT03771898|536600756|FG002|Overall Study|Withdrawal by parent/guardian|0|||
148761662|NCT03771898|536600757|FG003|Overall Study|Withdrawal by parent/guardian|0|||
148761663|NCT03771898|536600758|FG004|Overall Study|Withdrawal by parent/guardian|0|||
148761664|NCT03771898|536600754|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
148761665|NCT03771898|536600755|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
148761666|NCT03771898|536600756|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
148761667|NCT03771898|536600757|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
148761668|NCT03771898|536600758|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
148761669|NCT03263936|536600759|FG000|Overall Study|Adverse Event|0|||
148761670|NCT03263936|536600760|FG001|Overall Study|Adverse Event|1|||
148761671|NCT03263936|536600761|FG002|Overall Study|Adverse Event|0|||
148761672|NCT03263936|536600759|FG000|Overall Study|Death|0|||
148761673|NCT03263936|536600760|FG001|Overall Study|Death|1|||
148761674|NCT03263936|536600761|FG002|Overall Study|Death|0|||
148761675|NCT05271370|536600762|FG000|Overall Study|Study early termination|8|||
148761676|NCT05271370|536600763|FG001|Overall Study|Study early termination|16|||
148761677|NCT05271370|536600764|FG002|Overall Study|Study early termination|29|||
148761678|NCT00298272|536600777|FG000|Double-blind Phase|Adverse Event|2|||
148761679|NCT00298272|536600778|FG001|Double-blind Phase|Adverse Event|0|||
148826330|NCT01633112|536842018|FG001|Overall Study|Subject no longer requires study drug|0|||
148826331|NCT01633112|536842019|FG002|Overall Study|Subject no longer requires study drug|1|||
148826332|NCT01633112|536842017|FG000|Overall Study|Withdrawal by Subject|20|||
148826333|NCT01633112|536842018|FG001|Overall Study|Withdrawal by Subject|12|||
148826334|NCT01633112|536842019|FG002|Overall Study|Withdrawal by Subject|41|||
148826335|NCT01633112|536842017|FG000|Overall Study|missing Study Completion CRF|1|||
148826336|NCT01633112|536842018|FG001|Overall Study|missing Study Completion CRF|1|||
148826337|NCT01633112|536842019|FG002|Overall Study|missing Study Completion CRF|4|||
148826338|NCT03439072|536842022|FG000|Overall Study|Withdrawal by Subject|2|||
148826339|NCT03439072|536842023|FG001|Overall Study|Withdrawal by Subject|3|||
148761680|NCT00298272|536600777|FG000|Double-blind Phase|Failure to Return|2|||
148761681|NCT00298272|536600778|FG001|Double-blind Phase|Failure to Return|0|||
148761682|NCT00298272|536600777|FG000|Double-blind Phase|Protocol Violation|2|||
148761683|NCT00298272|536600778|FG001|Double-blind Phase|Protocol Violation|0|||
148761684|NCT00298272|536600777|FG000|Double-blind Phase|Withdrawal by Subject|2|||
148761685|NCT00298272|536600778|FG001|Double-blind Phase|Withdrawal by Subject|0|||
148761686|NCT00298272|536600777|FG000|Open Label Retreatment Phase|Adverse Event|1|||
148761687|NCT00298272|536600778|FG001|Open Label Retreatment Phase|Adverse Event|2|||
148761688|NCT00298272|536600777|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
148761689|NCT00298272|536600778|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
148761690|NCT00298272|536600777|FG000|Open Label Retreatment Phase|Failure to Return|1|||
148761691|NCT00298272|536600778|FG001|Open Label Retreatment Phase|Failure to Return|0|||
148761692|NCT00298272|536600777|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
148761693|NCT00298272|536600778|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
148761694|NCT00298272|536600777|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
148761695|NCT00298272|536600778|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
148761696|NCT00298272|536600777|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
148761697|NCT00298272|536600778|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
148761698|NCT00298272|536600777|FG000|Safety Follow-up Phase|Failure to Return|1|||
148761699|NCT00298272|536600778|FG001|Safety Follow-up Phase|Failure to Return|1|||
148761700|NCT00298272|536600777|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
148761701|NCT00298272|536600778|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
148761702|NCT00298272|536600777|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
148761703|NCT00298272|536600778|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
148761704|NCT04168112|536600779|FG000|Overall Study|Lost to Follow-up|1|||
148761705|NCT04168112|536600780|FG001|Overall Study|Lost to Follow-up|0|||
148761706|NCT04168112|536600779|FG000|Overall Study|Withdrawal by Subject|1|||
148761707|NCT04168112|536600780|FG001|Overall Study|Withdrawal by Subject|0|||
148761708|NCT00454246|536600783|FG000|Overall Study|Adverse Event|2|||
148761709|NCT00454246|536600784|FG001|Overall Study|Adverse Event|2|||
148761710|NCT00454246|536600785|FG002|Overall Study|Adverse Event|0|||
148761711|NCT00454246|536600783|FG000|Overall Study|Violation of selection criteria at entry|6|||
148761712|NCT00454246|536600784|FG001|Overall Study|Violation of selection criteria at entry|0|||
148826340|NCT03439072|536842022|FG000|Overall Study|Physician Decision|0|||
148826341|NCT03439072|536842023|FG001|Overall Study|Physician Decision|1|||
148826342|NCT00889005|536842030|FG000|Overall Study|Lost to Follow-up|4|||
148826343|NCT00889005|536842031|FG001|Overall Study|Lost to Follow-up|2|||
148826344|NCT00889005|536842030|FG000|Overall Study|Withdrawal by Subject|4|||
148826345|NCT00889005|536842031|FG001|Overall Study|Withdrawal by Subject|0|||
148761713|NCT00454246|536600785|FG002|Overall Study|Violation of selection criteria at entry|0|||
148761714|NCT00454246|536600783|FG000|Overall Study|Protocol Violation|1|||
148761715|NCT00454246|536600784|FG001|Overall Study|Protocol Violation|0|||
148761716|NCT00454246|536600785|FG002|Overall Study|Protocol Violation|0|||
148761717|NCT00454246|536600783|FG000|Overall Study|Refused Treatment|1|||
148826346|NCT00128492|536842032|FG000|Overall Study|AE unrelated to study|2|||
148826347|NCT00128492|536842033|FG001|Overall Study|AE unrelated to study|9|||
148826348|NCT00128492|536842032|FG000|Overall Study|Study drug intolerance (AE)|2|||
148826349|NCT00128492|536842033|FG001|Overall Study|Study drug intolerance (AE)|8|||
148761718|NCT00454246|536600784|FG001|Overall Study|Refused Treatment|1|||
148761719|NCT00454246|536600785|FG002|Overall Study|Refused Treatment|0|||
148761720|NCT00454246|536600783|FG000|Overall Study|Failure to return|1|||
148761721|NCT00454246|536600784|FG001|Overall Study|Failure to return|0|||
148761722|NCT00454246|536600785|FG002|Overall Study|Failure to return|0|||
148761723|NCT00454246|536600783|FG000|Overall Study|Early termination of study|62|||
148761724|NCT00454246|536600784|FG001|Overall Study|Early termination of study|26|||
148761725|NCT00454246|536600785|FG002|Overall Study|Early termination of study|9|||
148761726|NCT00833105|536600786|FG000|Overall Study|Withdrawal by Subject|1|||
148761727|NCT00833105|536600786|FG000|Overall Study|Adverse Event|2|||
148761728|NCT02898597|536600787|FG000|Overall Study|Protocol Violation|4|||
148761729|NCT02898597|536600788|FG001|Overall Study|Protocol Violation|2|||
148761730|NCT02898597|536600787|FG000|Overall Study|Lost to Follow-up|0|||
148761731|NCT02898597|536600788|FG001|Overall Study|Lost to Follow-up|9|||
148761732|NCT02898597|536600787|FG000|Overall Study|Death|0|||
148761733|NCT02898597|536600788|FG001|Overall Study|Death|1|||
148761734|NCT03656068|536600789|FG000|Overall Study|Withdrawal by Subject|4|||
148761735|NCT03656068|536600789|FG000|Overall Study|Adverse Event|1|||
148761736|NCT05326529|536600790|FG000|Overall Study|Lack of Efficacy|0|||
148761737|NCT05326529|536600791|FG001|Overall Study|Lack of Efficacy|1|||
148761738|NCT05326529|536600792|FG002|Overall Study|Lack of Efficacy|0|||
148761739|NCT05326529|536600790|FG000|Overall Study|Physician Decision|0|||
148761740|NCT05326529|536600791|FG001|Overall Study|Physician Decision|0|||
148761741|NCT05326529|536600792|FG002|Overall Study|Physician Decision|2|||
148761742|NCT00326716|536600793|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
148761743|NCT00326716|536600794|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
148761744|NCT00326716|536600795|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
148761745|NCT00326716|536600796|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
148761746|NCT00684411|536600797|FG000|Overall Study|New Primary Cancer|1|||
148761747|NCT00684411|536600797|FG000|Overall Study|Disease Progression|10|||
148761748|NCT00684411|536600797|FG000|Overall Study|Adverse Event|1|||
148761749|NCT03351608|536600800|FG000|Overall Study|Lost to Follow-up|0|||
148761750|NCT03351608|536600801|FG001|Overall Study|Lost to Follow-up|1|||
148761751|NCT03351608|536600802|FG002|Overall Study|Lost to Follow-up|1|||
148761752|NCT03351608|536600803|FG003|Overall Study|Lost to Follow-up|1|||
148761753|NCT03351608|536600804|FG004|Overall Study|Lost to Follow-up|1|||
148761754|NCT03351608|536600800|FG000|Overall Study|Physician Decision|1|||
148761755|NCT03351608|536600801|FG001|Overall Study|Physician Decision|0|||
148761756|NCT03351608|536600802|FG002|Overall Study|Physician Decision|0|||
148761757|NCT03351608|536600803|FG003|Overall Study|Physician Decision|2|||
148761758|NCT03351608|536600804|FG004|Overall Study|Physician Decision|1|||
148761759|NCT03351608|536600800|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
148761760|NCT03351608|536600801|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
148761761|NCT03351608|536600802|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
148761762|NCT03351608|536600803|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
148761763|NCT03351608|536600804|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
148761764|NCT03351608|536600800|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148761765|NCT03351608|536600801|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148761766|NCT03351608|536600802|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148761767|NCT03351608|536600803|FG003|Overall Study|Withdrawal by parent/guardian|1|||
148761768|NCT03351608|536600804|FG004|Overall Study|Withdrawal by parent/guardian|0|||
148761769|NCT03351608|536600800|FG000|Overall Study|Other|0|||
148761770|NCT03351608|536600801|FG001|Overall Study|Other|1|||
148761771|NCT03351608|536600802|FG002|Overall Study|Other|1|||
148761772|NCT03351608|536600803|FG003|Overall Study|Other|3|||
148761773|NCT03351608|536600804|FG004|Overall Study|Other|0|||
148761774|NCT01346696|536600809|FG000|Overall Study|Death|1|||
148761775|NCT04630002|536600810|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
148761776|NCT04630002|536600811|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
148761777|NCT04630002|536600812|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
148761778|NCT04630002|536600810|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
148761779|NCT04630002|536600811|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
148761780|NCT04630002|536600812|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
148761781|NCT04630002|536600810|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
148761782|NCT04630002|536600811|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
148761783|NCT04630002|536600812|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
148761784|NCT04630002|536600810|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
149027546|NCT00797225|537578595|FG005|Weeks 13 to 24|Non-compliance|0|||
149027547|NCT00797225|537578596|FG006|Weeks 13 to 24|Non-compliance|0|||
148761785|NCT04630002|536600811|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
148761786|NCT04630002|536600812|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
148761787|NCT04630002|536600810|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
148761788|NCT04630002|536600811|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
148761789|NCT04630002|536600812|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
148761790|NCT04630002|536600810|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
148761791|NCT04630002|536600811|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
148761792|NCT04630002|536600812|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
148761793|NCT04630002|536600810|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
148761794|NCT04630002|536600811|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
148761795|NCT04630002|536600812|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
148761796|NCT04630002|536600810|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
148761797|NCT04630002|536600811|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
148761798|NCT04630002|536600812|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
148761799|NCT03448419|536600813|FG000|Overall Study|Adverse Event|10|||
148761800|NCT03448419|536600814|FG001|Overall Study|Adverse Event|9|||
148761801|NCT03448419|536600813|FG000|Overall Study|Lost to Follow-up|0|||
148761802|NCT03448419|536600814|FG001|Overall Study|Lost to Follow-up|2|||
148761803|NCT03448419|536600813|FG000|Overall Study|Withdrawal by Subject|3|||
148761804|NCT03448419|536600814|FG001|Overall Study|Withdrawal by Subject|1|||
148761805|NCT03448419|536600813|FG000|Overall Study|Not treated|0|||
148761806|NCT03448419|536600814|FG001|Overall Study|Not treated|1|||
148761807|NCT03448419|536600813|FG000|Overall Study|Patient did not attend all visits|0|||
148761808|NCT03448419|536600814|FG001|Overall Study|Patient did not attend all visits|2|||
148761809|NCT03448419|536600813|FG000|Overall Study|Withdrawn by Sponsor|0|||
148761810|NCT03448419|536600814|FG001|Overall Study|Withdrawn by Sponsor|1|||
148761811|NCT02220764|536600821|FG000|Overall Study|Lost to Follow-up|3|||
148761812|NCT02220764|536600822|FG001|Overall Study|Lost to Follow-up|1|||
148761813|NCT02220764|536600821|FG000|Overall Study|Death|1|||
148761814|NCT02220764|536600822|FG001|Overall Study|Death|0|||
148761815|NCT02861807|536600823|FG000|Overall Study|Lost to Follow-up|7|||
148761816|NCT02861807|536600824|FG001|Overall Study|Lost to Follow-up|6|||
148761817|NCT02861807|536600823|FG000|Overall Study|Withdrawal by Subject|5|||
148761818|NCT02861807|536600824|FG001|Overall Study|Withdrawal by Subject|8|||
148761819|NCT05000164|536600825|FG000|Overall Study|Adverse Event|1|||
148761820|NCT05000164|536600825|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
148761821|NCT05000164|536600825|FG000|Overall Study|Lens Discomfort|3|||
148761822|NCT05000164|536600825|FG000|Overall Study|Withdrew Consent during Study|2|||
148761823|NCT05000164|536600825|FG000|Overall Study|Subject Withdrawn by PI|2|||
148761824|NCT05000164|536600825|FG000|Overall Study|Other Fractured Test Article|1|||
148761825|NCT03020992|536600826|FG000|Overall Study|Adverse Event|5|||
148761826|NCT03020992|536600826|FG000|Overall Study|Withdrawal by Subject|1|||
148761827|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
148761828|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
148761829|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
148761830|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
148761831|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Pregnancy|0|||
148761832|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Pregnancy|1|||
148761833|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
148761834|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
148761835|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
148761836|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
148761837|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
148761838|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
148761839|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Other|3|||
148761840|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Other|0|||
148761841|NCT01006122|536600827|FG000|First Double-blind Intervention Period|Adverse Event|0|||
148761842|NCT01006122|536600828|FG001|First Double-blind Intervention Period|Adverse Event|4|||
148761843|NCT01006122|536600827|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
148761844|NCT01006122|536600828|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
148761845|NCT01006122|536600827|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
148761846|NCT01006122|536600828|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
148761847|NCT01006122|536600827|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
148761848|NCT01006122|536600828|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
148761849|NCT01006122|536600827|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
148761850|NCT01006122|536600828|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
148761851|NCT01006122|536600827|FG000|Second Double-blind Intervention Period|Death|0|||
148761852|NCT01006122|536600828|FG001|Second Double-blind Intervention Period|Death|1|||
148761853|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
148761854|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
148761855|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
148761856|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
148761857|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
148761858|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
148826350|NCT00128492|536842032|FG000|Overall Study|AE related to study|1|||
148977220|NCT04084769|537396615|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148977221|NCT04084769|537396616|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148977222|NCT04084769|537396617|FG002|Overall Study|Withdrawal by parent/guardian|0|||
148977223|NCT04084769|537396618|FG003|Overall Study|Withdrawal by parent/guardian|1|||
148977224|NCT04084769|537396615|FG000|Overall Study|Lost to Follow-up|2|||
148761859|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
148761860|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
148761861|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
148761862|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
148761863|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
148761864|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
148761865|NCT03493854|536600829|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
148761866|NCT03493854|536600830|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
148761867|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
148761868|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
148761869|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
148761870|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
148761871|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
148761872|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
148761873|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
148761874|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
148761875|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
148761876|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
148761877|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
148761878|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
148761879|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
148761880|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
148761881|NCT03493854|536600829|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
148761882|NCT03493854|536600830|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
148761883|NCT03493854|536600829|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
148761884|NCT03493854|536600830|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
148761885|NCT03493854|536600829|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
148761886|NCT03493854|536600830|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
148761887|NCT03493854|536600829|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
148761888|NCT03493854|536600830|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
148761889|NCT00529308|536600833|FG000|Overall Study|Withdrawal by Subject|1|||
148761890|NCT00529308|536600834|FG001|Overall Study|Withdrawal by Subject|1|||
148761891|NCT03331796|536600845|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
148761892|NCT03331796|536600846|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
148761893|NCT03331796|536600847|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
148761894|NCT03331796|536600845|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
148761895|NCT03331796|536600846|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
148761896|NCT03331796|536600847|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
148761897|NCT03331796|536600845|FG000|Extended Follow-up|Adverse Event|1|||
148761898|NCT03331796|536600846|FG001|Extended Follow-up|Adverse Event|0|||
148761899|NCT03331796|536600847|FG002|Extended Follow-up|Adverse Event|1|||
148761900|NCT03331796|536600845|FG000|Extended Follow-up|Lost to Follow-up|0|||
148761901|NCT03331796|536600846|FG001|Extended Follow-up|Lost to Follow-up|0|||
148761902|NCT03331796|536600847|FG002|Extended Follow-up|Lost to Follow-up|1|||
148761903|NCT03331796|536600845|FG000|Extended Follow-up|Withdrawal by Subject|1|||
148761904|NCT03331796|536600846|FG001|Extended Follow-up|Withdrawal by Subject|0|||
148761905|NCT03331796|536600847|FG002|Extended Follow-up|Withdrawal by Subject|0|||
148761906|NCT03331796|536600845|FG000|Extended Follow-up|Termination of Funding|0|||
148761907|NCT03331796|536600846|FG001|Extended Follow-up|Termination of Funding|1|||
148761908|NCT03331796|536600847|FG002|Extended Follow-up|Termination of Funding|0|||
148761909|NCT04526288|536600861|FG000|Overall Study|Disease Progression|1|||
148761910|NCT04526288|536600862|FG001|Overall Study|Disease Progression|0|||
148761911|NCT04830969|536600863|FG000|Overall Study|Withdrawal by Subject|6|||
148761912|NCT04830969|536600864|FG001|Overall Study|Withdrawal by Subject|2|||
148761913|NCT04830969|536600863|FG000|Overall Study|Protocol Violation|3|||
148761914|NCT04830969|536600864|FG001|Overall Study|Protocol Violation|9|||
148761915|NCT04830969|536600863|FG000|Overall Study|Lost to Follow-up|4|||
148761916|NCT04830969|536600864|FG001|Overall Study|Lost to Follow-up|4|||
148761917|NCT01580670|536600865|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
148761918|NCT01580670|536600865|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
148761919|NCT00996125|536600866|FG000|Overall Study|Adverse Event|0|||
148761920|NCT00996125|536600867|FG001|Overall Study|Adverse Event|2|||
148761921|NCT00996125|536600866|FG000|Overall Study|Lost to Follow-up|1|||
148761922|NCT00996125|536600867|FG001|Overall Study|Lost to Follow-up|6|||
148761923|NCT00996125|536600866|FG000|Overall Study|Withdrawal by Subject|4|||
148977225|NCT04084769|537396616|FG001|Overall Study|Lost to Follow-up|0|||
148761924|NCT00996125|536600867|FG001|Overall Study|Withdrawal by Subject|3|||
148761925|NCT04926831|536600870|FG000|Overall Study|Withdrawal by Subject|2|||
148761926|NCT04926831|536600870|FG000|Overall Study|Adverse Event|2|||
148761927|NCT03482635|536600871|FG000|Overall Study|Lack of Efficacy|0|||
148761928|NCT03482635|536600872|FG001|Overall Study|Lack of Efficacy|0|||
148761929|NCT03482635|536600873|FG002|Overall Study|Lack of Efficacy|1|||
148761930|NCT03482635|536600874|FG003|Overall Study|Lack of Efficacy|3|||
148761931|NCT03482635|536600871|FG000|Overall Study|Adverse Event|2|||
148761932|NCT03482635|536600872|FG001|Overall Study|Adverse Event|2|||
148761933|NCT03482635|536600873|FG002|Overall Study|Adverse Event|0|||
148761934|NCT03482635|536600874|FG003|Overall Study|Adverse Event|3|||
148761935|NCT03482635|536600871|FG000|Overall Study|Withdrawal by Subject|2|||
148761936|NCT03482635|536600872|FG001|Overall Study|Withdrawal by Subject|1|||
148761937|NCT03482635|536600873|FG002|Overall Study|Withdrawal by Subject|0|||
148761938|NCT03482635|536600874|FG003|Overall Study|Withdrawal by Subject|1|||
148761939|NCT03482635|536600871|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
148761940|NCT03482635|536600872|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
148761941|NCT03482635|536600873|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
148761942|NCT03482635|536600874|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
148761943|NCT03482635|536600871|FG000|Overall Study|Not treated|0|||
148761944|NCT03482635|536600872|FG001|Overall Study|Not treated|0|||
148761945|NCT03482635|536600873|FG002|Overall Study|Not treated|0|||
148761946|NCT03482635|536600874|FG003|Overall Study|Not treated|1|||
148761947|NCT03859427|536600876|FG000|Overall Study|Withdrawal by Subject|4|||
148761948|NCT03859427|536600877|FG001|Overall Study|Withdrawal by Subject|7|||
148761949|NCT03859427|536600876|FG000|Overall Study|Decision by sponsor|0|||
148761950|NCT03859427|536600877|FG001|Overall Study|Decision by sponsor|3|||
148761951|NCT03859427|536600876|FG000|Overall Study|Lost to Follow-up|3|||
148761952|NCT03859427|536600877|FG001|Overall Study|Lost to Follow-up|2|||
148761953|NCT03859427|536600876|FG000|Overall Study|Death|22|||
148761954|NCT03859427|536600877|FG001|Overall Study|Death|25|||
148761955|NCT00979654|536600878|FG000|Overall Study|Lost to Follow-up|1|||
148761956|NCT00979654|536600878|FG000|Overall Study|Withdrawal by Subject|22|||
148761957|NCT00979654|536600878|FG000|Overall Study|Death|1|||
148761958|NCT00979654|536600878|FG000|Overall Study|Lack of Efficacy|6|||
148761959|NCT00979654|536600878|FG000|Overall Study|Adverse Event|1|||
148761960|NCT00979654|536600878|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
148761961|NCT00979654|536600878|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
148761962|NCT00979654|536600878|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
148761963|NCT00979654|536600878|FG000|Overall Study|Serious Adverse Event|1|||
148761964|NCT00979654|536600878|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
148761965|NCT01804946|536600881|FG000|Overall Study|Protocol Violation|1|||
148761966|NCT01804946|536600882|FG001|Overall Study|Protocol Violation|0|||
148761967|NCT01804946|536600881|FG000|Overall Study|Adverse Event|0|||
148761968|NCT01804946|536600882|FG001|Overall Study|Adverse Event|1|||
148761969|NCT01804946|536600881|FG000|Overall Study|Insufficient data available|0|||
148761970|NCT01804946|536600882|FG001|Overall Study|Insufficient data available|1|||
148761971|NCT01804946|536600881|FG000|Overall Study|Do not meet inclusion criteria|1|||
148761972|NCT01804946|536600882|FG001|Overall Study|Do not meet inclusion criteria|2|||
148761973|NCT01129557|536600883|FG000|Overall Study|Adverse Event|1|||
148761974|NCT01129557|536600884|FG001|Overall Study|Adverse Event|2|||
148761975|NCT01129557|536600885|FG002|Overall Study|Adverse Event|2|||
148761976|NCT01129557|536600883|FG000|Overall Study|Novartis terminated study early|3|||
148761977|NCT01129557|536600884|FG001|Overall Study|Novartis terminated study early|3|||
148761978|NCT01129557|536600885|FG002|Overall Study|Novartis terminated study early|2|||
148761979|NCT01486446|536600886|FG000|Overall Study|Adverse Event|1|||
148761980|NCT01486446|536600887|FG001|Overall Study|Adverse Event|0|||
148761981|NCT02431676|536600888|FG000|Overall Study|no lab obtained|0|||
148761982|NCT02431676|536600889|FG001|Overall Study|no lab obtained|1|||
148761983|NCT02431676|536600890|FG002|Overall Study|no lab obtained|2|||
148761984|NCT03048747|536602509|FG000|Overall Study|Adverse Event|2|||
148761985|NCT03048747|536602509|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
148761986|NCT03048747|536602509|FG000|Overall Study|Physician Decision|1|||
148761987|NCT00915018|536602510|FG000|Overall Study|Death|75|||
148977226|NCT04084769|537396617|FG002|Overall Study|Lost to Follow-up|0|||
148977227|NCT04084769|537396618|FG003|Overall Study|Lost to Follow-up|0|||
148977228|NCT03013491|537396619|FG000|Main Study|Death|2|||
148977229|NCT03013491|537396620|FG001|Main Study|Death|2|||
148761988|NCT00915018|536602511|FG001|Overall Study|Death|70|||
148761989|NCT00915018|536602510|FG000|Overall Study|Lost to Follow-up|10|||
148761990|NCT00915018|536602511|FG001|Overall Study|Lost to Follow-up|5|||
148761991|NCT00915018|536602510|FG000|Overall Study|Withdrawal by Subject|38|||
148761992|NCT00915018|536602511|FG001|Overall Study|Withdrawal by Subject|27|||
148761993|NCT00915018|536602510|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
148977230|NCT03013491|537396621|FG002|Main Study|Death|5|||
148761994|NCT00915018|536602511|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
148977231|NCT03013491|537396622|FG003|Main Study|Death|3|||
148977232|NCT03013491|537396623|FG004|Main Study|Death|9|||
148977233|NCT03013491|537396624|FG005|Main Study|Death|12|||
148977234|NCT03013491|537396625|FG006|Main Study|Death|3|||
148761995|NCT00457002|536602512|FG000|Overall Study|Death|40|||
148761996|NCT00457002|536602513|FG001|Overall Study|Death|47|||
148761997|NCT00457002|536602512|FG000|Overall Study|Adverse Event|284|||
148761998|NCT00457002|536602513|FG001|Overall Study|Adverse Event|260|||
148761999|NCT00457002|536602512|FG000|Overall Study|Withdrawal by Subject|299|||
148762000|NCT00457002|536602513|FG001|Overall Study|Withdrawal by Subject|271|||
148762001|NCT00457002|536602512|FG000|Overall Study|Lost to Follow-up|72|||
148762002|NCT00457002|536602513|FG001|Overall Study|Lost to Follow-up|71|||
148762003|NCT00457002|536602512|FG000|Overall Study|Poor/Non-compliance|46|||
148762004|NCT00457002|536602513|FG001|Overall Study|Poor/Non-compliance|33|||
148762005|NCT00457002|536602512|FG000|Overall Study|No longer met criteria|41|||
148762006|NCT00457002|536602513|FG001|Overall Study|No longer met criteria|37|||
148762007|NCT00457002|536602512|FG000|Overall Study|Administrative reason by Sponsor|1|||
148762008|NCT00457002|536602513|FG001|Overall Study|Administrative reason by Sponsor|0|||
148762009|NCT00457002|536602512|FG000|Overall Study|non-specified|29|||
148762010|NCT00457002|536602513|FG001|Overall Study|non-specified|38|||
148762011|NCT00457002|536602512|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
148762012|NCT00457002|536602513|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
148762013|NCT00154284|536602514|FG000|Overall Study|Adverse Event|6|||
148762014|NCT00154284|536602515|FG001|Overall Study|Adverse Event|9|||
148762015|NCT00154284|536602514|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148762016|NCT00154284|536602515|FG001|Overall Study|Abnormal laboratory value(s)|1|||
148762017|NCT00154284|536602514|FG000|Overall Study|Lack of Efficacy|1|||
148762018|NCT00154284|536602515|FG001|Overall Study|Lack of Efficacy|2|||
148762019|NCT00154284|536602514|FG000|Overall Study|Protocol Violation|0|||
148762020|NCT00154284|536602515|FG001|Overall Study|Protocol Violation|1|||
148762021|NCT05253573|536602516|FG000|Overall Study|Death|1|||
148762022|NCT05253573|536602517|FG001|Overall Study|Death|0|||
148762023|NCT01344824|536602518|FG000|Overall Study|Adverse Event|15|||
148762024|NCT01344824|536602518|FG000|Overall Study|Withdrawal by Subject|6|||
148762025|NCT01344824|536602518|FG000|Overall Study|Other complicating disease|1|||
148762026|NCT01344824|536602518|FG000|Overall Study|Progression|15|||
148762027|NCT02126579|536602525|FG000|Overall Study|disease progression|0|||
148762028|NCT02126579|536602526|FG001|Overall Study|disease progression|0|||
148762029|NCT02126579|536602527|FG002|Overall Study|disease progression|0|||
148762030|NCT02126579|536602528|FG003|Overall Study|disease progression|1|||
148762031|NCT02126579|536602529|FG004|Overall Study|disease progression|0|||
148762032|NCT02126579|536602530|FG005|Overall Study|disease progression|0|||
148762033|NCT02126579|536602531|FG006|Overall Study|disease progression|1|||
148762034|NCT01780038|536602534|FG000|Overall Study|Lost to Follow-up|4|||
148762035|NCT01780038|536602535|FG001|Overall Study|Lost to Follow-up|1|||
148762036|NCT01085630|536602536|FG000|Overall Study|Insufficient data|1|||
148762037|NCT01085630|536602537|FG001|Overall Study|Insufficient data|0|||
148762038|NCT01085630|536602536|FG000|Overall Study|Ineligible|3|||
148762039|NCT01085630|536602537|FG001|Overall Study|Ineligible|0|||
148762040|NCT02366637|536602543|FG000|First Intervention Period|Adverse Event|0|||
148762041|NCT02366637|536602544|FG001|First Intervention Period|Adverse Event|1|||
148762042|NCT02366637|536602543|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
148762043|NCT02366637|536602544|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
148762044|NCT02366637|536602543|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
148762045|NCT02366637|536602544|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
148762046|NCT02609607|536602545|FG000|Overall Study|Lost to Follow-up|0|||
148762047|NCT02609607|536602546|FG001|Overall Study|Lost to Follow-up|1|||
148762048|NCT03168711|536602549|FG000|Overall Study|Adverse Event|2|||
148762049|NCT03168711|536602550|FG001|Overall Study|Adverse Event|0|||
148762050|NCT03168711|536602549|FG000|Overall Study|Withdrawal by Subject|0|||
148762051|NCT03168711|536602550|FG001|Overall Study|Withdrawal by Subject|1|||
148826351|NCT00128492|536842033|FG001|Overall Study|AE related to study|4|||
148826352|NCT00128492|536842032|FG000|Overall Study|Death|1|||
148826353|NCT00128492|536842033|FG001|Overall Study|Death|0|||
148977235|NCT03013491|537396626|FG007|Main Study|Death|5|||
148762052|NCT03168711|536602549|FG000|Overall Study|Death|0|||
148762053|NCT03168711|536602550|FG001|Overall Study|Death|1|||
148762054|NCT01609010|536602551|FG000|Overall Study|Stable disease (SD)|22|||
148762055|NCT01609010|536602552|FG001|Overall Study|Stable disease (SD)|16|||
148762056|NCT01609010|536602551|FG000|Overall Study|Progressive disease (PD)|8|||
148762057|NCT01609010|536602552|FG001|Overall Study|Progressive disease (PD)|10|||
148762058|NCT01609010|536602551|FG000|Overall Study|Adverse Event|3|||
148762059|NCT01609010|536602552|FG001|Overall Study|Adverse Event|6|||
148762060|NCT01609010|536602551|FG000|Overall Study|Withdrawal by Subject|2|||
148762061|NCT01609010|536602552|FG001|Overall Study|Withdrawal by Subject|2|||
148762062|NCT01609010|536602551|FG000|Overall Study|Other|2|||
148762063|NCT01609010|536602552|FG001|Overall Study|Other|0|||
148762064|NCT01609010|536602551|FG000|Overall Study|Other malignancy|1|||
148826354|NCT00128492|536842032|FG000|Overall Study|Lost to Follow-up|1|||
148977236|NCT03013491|537396627|FG008|Main Study|Death|1|||
148977237|NCT03013491|537396628|FG009|Main Study|Death|2|||
148977238|NCT03013491|537396629|FG010|Main Study|Death|4|||
148762065|NCT01609010|536602552|FG001|Overall Study|Other malignancy|0|||
148762066|NCT01609010|536602551|FG000|Overall Study|Pathology review|2|||
148762067|NCT01609010|536602552|FG001|Overall Study|Pathology review|1|||
148762068|NCT01609010|536602551|FG000|Overall Study|Protocol Violation|1|||
148762069|NCT01609010|536602552|FG001|Overall Study|Protocol Violation|1|||
148977239|NCT03013491|537396630|FG011|Main Study|Death|1|||
148977240|NCT03013491|537396631|FG012|Main Study|Death|1|||
148977241|NCT03013491|537396632|FG013|Main Study|Death|4|||
148977242|NCT03013491|537396633|FG014|Main Study|Death|0|||
148977243|NCT03013491|537396634|FG015|Main Study|Death|3|||
148977244|NCT03013491|537396635|FG016|Main Study|Death|5|||
148977245|NCT03013491|537396636|FG017|Main Study|Death|1|||
148977246|NCT03013491|537396637|FG018|Main Study|Death|47|||
148977247|NCT03013491|537396619|FG000|Main Study|Lost to Follow-up|0|||
148977248|NCT03013491|537396620|FG001|Main Study|Lost to Follow-up|0|||
148977249|NCT03013491|537396621|FG002|Main Study|Lost to Follow-up|1|||
148977250|NCT03013491|537396622|FG003|Main Study|Lost to Follow-up|0|||
148977251|NCT03013491|537396623|FG004|Main Study|Lost to Follow-up|1|||
148977252|NCT03013491|537396624|FG005|Main Study|Lost to Follow-up|0|||
148977253|NCT03013491|537396625|FG006|Main Study|Lost to Follow-up|0|||
148977254|NCT03013491|537396626|FG007|Main Study|Lost to Follow-up|0|||
148977255|NCT03013491|537396627|FG008|Main Study|Lost to Follow-up|0|||
148977256|NCT03013491|537396628|FG009|Main Study|Lost to Follow-up|0|||
148977257|NCT03013491|537396629|FG010|Main Study|Lost to Follow-up|0|||
148977258|NCT03013491|537396630|FG011|Main Study|Lost to Follow-up|0|||
148977259|NCT03013491|537396631|FG012|Main Study|Lost to Follow-up|0|||
148977260|NCT03013491|537396632|FG013|Main Study|Lost to Follow-up|0|||
148977261|NCT03013491|537396633|FG014|Main Study|Lost to Follow-up|0|||
148977262|NCT03013491|537396634|FG015|Main Study|Lost to Follow-up|0|||
148977263|NCT03013491|537396635|FG016|Main Study|Lost to Follow-up|0|||
148977264|NCT03013491|537396636|FG017|Main Study|Lost to Follow-up|0|||
148977265|NCT03013491|537396637|FG018|Main Study|Lost to Follow-up|3|||
148977266|NCT03013491|537396619|FG000|Main Study|Termination of the study by Sponsor|0|||
148977267|NCT03013491|537396620|FG001|Main Study|Termination of the study by Sponsor|0|||
148977268|NCT03013491|537396621|FG002|Main Study|Termination of the study by Sponsor|2|||
148977269|NCT03013491|537396622|FG003|Main Study|Termination of the study by Sponsor|0|||
148977270|NCT03013491|537396623|FG004|Main Study|Termination of the study by Sponsor|1|||
148977271|NCT03013491|537396624|FG005|Main Study|Termination of the study by Sponsor|2|||
148977272|NCT03013491|537396625|FG006|Main Study|Termination of the study by Sponsor|0|||
148977273|NCT03013491|537396626|FG007|Main Study|Termination of the study by Sponsor|0|||
148977274|NCT03013491|537396627|FG008|Main Study|Termination of the study by Sponsor|1|||
148977275|NCT03013491|537396628|FG009|Main Study|Termination of the study by Sponsor|1|||
148977276|NCT03013491|537396629|FG010|Main Study|Termination of the study by Sponsor|1|||
148977277|NCT03013491|537396630|FG011|Main Study|Termination of the study by Sponsor|2|||
148977278|NCT03013491|537396631|FG012|Main Study|Termination of the study by Sponsor|0|||
148977279|NCT03013491|537396632|FG013|Main Study|Termination of the study by Sponsor|0|||
148977280|NCT03013491|537396633|FG014|Main Study|Termination of the study by Sponsor|0|||
148977281|NCT03013491|537396634|FG015|Main Study|Termination of the study by Sponsor|0|||
148977282|NCT03013491|537396635|FG016|Main Study|Termination of the study by Sponsor|0|||
148977283|NCT03013491|537396636|FG017|Main Study|Termination of the study by Sponsor|1|||
148977284|NCT03013491|537396637|FG018|Main Study|Termination of the study by Sponsor|13|||
148977285|NCT03013491|537396619|FG000|Main Study|Withdrawal by Subject|0|||
148977286|NCT03013491|537396620|FG001|Main Study|Withdrawal by Subject|0|||
148977287|NCT03013491|537396621|FG002|Main Study|Withdrawal by Subject|0|||
148977288|NCT03013491|537396622|FG003|Main Study|Withdrawal by Subject|4|||
148977289|NCT03013491|537396623|FG004|Main Study|Withdrawal by Subject|2|||
148977290|NCT03013491|537396624|FG005|Main Study|Withdrawal by Subject|1|||
148977291|NCT03013491|537396625|FG006|Main Study|Withdrawal by Subject|0|||
148977292|NCT03013491|537396626|FG007|Main Study|Withdrawal by Subject|0|||
148977293|NCT03013491|537396627|FG008|Main Study|Withdrawal by Subject|0|||
148977294|NCT03013491|537396628|FG009|Main Study|Withdrawal by Subject|0|||
148977295|NCT03013491|537396629|FG010|Main Study|Withdrawal by Subject|1|||
148977296|NCT03013491|537396630|FG011|Main Study|Withdrawal by Subject|2|||
148977297|NCT03013491|537396631|FG012|Main Study|Withdrawal by Subject|0|||
148977298|NCT03013491|537396632|FG013|Main Study|Withdrawal by Subject|2|||
148977299|NCT03013491|537396633|FG014|Main Study|Withdrawal by Subject|0|||
148977300|NCT03013491|537396634|FG015|Main Study|Withdrawal by Subject|0|||
148977301|NCT03013491|537396635|FG016|Main Study|Withdrawal by Subject|0|||
148977302|NCT03013491|537396636|FG017|Main Study|Withdrawal by Subject|0|||
148977303|NCT03013491|537396637|FG018|Main Study|Withdrawal by Subject|18|||
148977304|NCT03013491|537396619|FG000|Main Study|Disease progression|0|||
148762070|NCT01609010|536602551|FG000|Overall Study|New cancer|1|||
148762071|NCT01609010|536602552|FG001|Overall Study|New cancer|0|||
148977305|NCT03013491|537396620|FG001|Main Study|Disease progression|0|||
148762072|NCT01609010|536602551|FG000|Overall Study|Lost to Follow-up|1|||
148977306|NCT03013491|537396621|FG002|Main Study|Disease progression|0|||
148977307|NCT03013491|537396622|FG003|Main Study|Disease progression|1|||
148977308|NCT03013491|537396623|FG004|Main Study|Disease progression|0|||
148977309|NCT03013491|537396624|FG005|Main Study|Disease progression|0|||
148977310|NCT03013491|537396625|FG006|Main Study|Disease progression|0|||
148977311|NCT03013491|537396626|FG007|Main Study|Disease progression|0|||
149027548|NCT00797225|537578597|FG007|Weeks 13 to 24|Non-compliance|0|||
149027549|NCT00797225|537578590|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
149027550|NCT00797225|537578591|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
149027551|NCT00797225|537578592|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
149027552|NCT00797225|537578593|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
149027553|NCT00797225|537578594|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
149027554|NCT00797225|537578595|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
149027555|NCT00797225|537578596|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
149027556|NCT00797225|537578597|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
149027557|NCT00797225|537578590|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
149027558|NCT00797225|537578591|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
149027559|NCT00797225|537578592|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
149027560|NCT00797225|537578593|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
149027561|NCT00797225|537578594|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
149027562|NCT00797225|537578595|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
149027563|NCT00797225|537578596|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
149027564|NCT00797225|537578597|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
149027565|NCT00797225|537578590|FG000|Weeks 13 to 24|Adverse Event|0|||
149027566|NCT00797225|537578591|FG001|Weeks 13 to 24|Adverse Event|1|||
149027567|NCT00797225|537578592|FG002|Weeks 13 to 24|Adverse Event|0|||
149027568|NCT00797225|537578593|FG003|Weeks 13 to 24|Adverse Event|0|||
149027569|NCT00797225|537578594|FG004|Weeks 13 to 24|Adverse Event|0|||
149027570|NCT00797225|537578595|FG005|Weeks 13 to 24|Adverse Event|0|||
149027571|NCT00797225|537578596|FG006|Weeks 13 to 24|Adverse Event|1|||
149027572|NCT00797225|537578597|FG007|Weeks 13 to 24|Adverse Event|0|||
149027573|NCT00797225|537578590|FG000|Weeks 13 to 24|Sponsor Decision|0|||
149027574|NCT00797225|537578591|FG001|Weeks 13 to 24|Sponsor Decision|0|||
149027575|NCT00797225|537578592|FG002|Weeks 13 to 24|Sponsor Decision|0|||
149027576|NCT00797225|537578593|FG003|Weeks 13 to 24|Sponsor Decision|0|||
149027577|NCT00797225|537578594|FG004|Weeks 13 to 24|Sponsor Decision|0|||
149027578|NCT00797225|537578595|FG005|Weeks 13 to 24|Sponsor Decision|0|||
149027579|NCT00797225|537578596|FG006|Weeks 13 to 24|Sponsor Decision|1|||
149027580|NCT00797225|537578597|FG007|Weeks 13 to 24|Sponsor Decision|0|||
149027581|NCT02096003|537578600|FG000|Overall Study|Protocol Violation|0|||
149027582|NCT02096003|537578601|FG001|Overall Study|Protocol Violation|2|||
149027583|NCT02096003|537578600|FG000|Overall Study|additional surgery|2|||
149027584|NCT02096003|537578601|FG001|Overall Study|additional surgery|1|||
149027585|NCT01511250|537578602|FG000|Overall Study|Withdrawal of Consent|1|||
149027586|NCT01511250|537578603|FG001|Overall Study|Withdrawal of Consent|0|||
149027587|NCT01511250|537578604|FG002|Overall Study|Withdrawal of Consent|0|||
149027588|NCT01511250|537578605|FG003|Overall Study|Withdrawal of Consent|0|||
149027589|NCT01511250|537578606|FG004|Overall Study|Withdrawal of Consent|0|||
149027590|NCT01511250|537578607|FG005|Overall Study|Withdrawal of Consent|0|||
149027591|NCT01511250|537578608|FG006|Overall Study|Withdrawal of Consent|0|||
149027592|NCT01511250|537578609|FG007|Overall Study|Withdrawal of Consent|1|||
149027593|NCT01511250|537578610|FG008|Overall Study|Withdrawal of Consent|1|||
149027594|NCT01511250|537578611|FG009|Overall Study|Withdrawal of Consent|0|||
149027595|NCT01511250|537578602|FG000|Overall Study|Sponsor/Investigator Decision|1|||
149027596|NCT01511250|537578603|FG001|Overall Study|Sponsor/Investigator Decision|0|||
149027597|NCT01511250|537578604|FG002|Overall Study|Sponsor/Investigator Decision|0|||
149027598|NCT01511250|537578605|FG003|Overall Study|Sponsor/Investigator Decision|0|||
149027599|NCT01511250|537578606|FG004|Overall Study|Sponsor/Investigator Decision|0|||
149027600|NCT01511250|537578607|FG005|Overall Study|Sponsor/Investigator Decision|0|||
149027601|NCT01511250|537578608|FG006|Overall Study|Sponsor/Investigator Decision|0|||
148977312|NCT03013491|537396627|FG008|Main Study|Disease progression|1|||
148977313|NCT03013491|537396628|FG009|Main Study|Disease progression|0|||
148977314|NCT03013491|537396629|FG010|Main Study|Disease progression|1|||
148977315|NCT03013491|537396630|FG011|Main Study|Disease progression|0|||
148977316|NCT03013491|537396631|FG012|Main Study|Disease progression|0|||
148977317|NCT03013491|537396632|FG013|Main Study|Disease progression|0|||
148977318|NCT03013491|537396633|FG014|Main Study|Disease progression|0|||
149027602|NCT01511250|537578609|FG007|Overall Study|Sponsor/Investigator Decision|0|||
149027603|NCT01511250|537578610|FG008|Overall Study|Sponsor/Investigator Decision|0|||
149027604|NCT01511250|537578611|FG009|Overall Study|Sponsor/Investigator Decision|0|||
149027605|NCT01511250|537578602|FG000|Overall Study|Lost to Follow-up|7|||
149027606|NCT01511250|537578603|FG001|Overall Study|Lost to Follow-up|3|||
149027607|NCT01511250|537578604|FG002|Overall Study|Lost to Follow-up|3|||
148977319|NCT03013491|537396634|FG015|Main Study|Disease progression|0|||
149027608|NCT01511250|537578605|FG003|Overall Study|Lost to Follow-up|3|||
149027609|NCT01511250|537578606|FG004|Overall Study|Lost to Follow-up|0|||
149027610|NCT01511250|537578607|FG005|Overall Study|Lost to Follow-up|0|||
148762073|NCT01609010|536602552|FG001|Overall Study|Lost to Follow-up|1|||
148977320|NCT03013491|537396635|FG016|Main Study|Disease progression|0|||
149027611|NCT01511250|537578608|FG006|Overall Study|Lost to Follow-up|2|||
149027612|NCT01511250|537578609|FG007|Overall Study|Lost to Follow-up|3|||
149027613|NCT01511250|537578610|FG008|Overall Study|Lost to Follow-up|13|||
149027614|NCT01511250|537578611|FG009|Overall Study|Lost to Follow-up|5|||
148977321|NCT03013491|537396636|FG017|Main Study|Disease progression|0|||
148977322|NCT03013491|537396637|FG018|Main Study|Disease progression|4|||
148977323|NCT03013491|537396619|FG000|Main Study|Symptomatic deterioration|0|||
148977324|NCT03013491|537396620|FG001|Main Study|Symptomatic deterioration|0|||
148826355|NCT00128492|536842033|FG001|Overall Study|Lost to Follow-up|5|||
148977325|NCT03013491|537396621|FG002|Main Study|Symptomatic deterioration|0|||
148977326|NCT03013491|537396622|FG003|Main Study|Symptomatic deterioration|0|||
148977327|NCT03013491|537396623|FG004|Main Study|Symptomatic deterioration|0|||
148977328|NCT03013491|537396624|FG005|Main Study|Symptomatic deterioration|1|||
148977329|NCT03013491|537396625|FG006|Main Study|Symptomatic deterioration|0|||
148977330|NCT03013491|537396626|FG007|Main Study|Symptomatic deterioration|0|||
148977331|NCT03013491|537396627|FG008|Main Study|Symptomatic deterioration|0|||
148977332|NCT03013491|537396628|FG009|Main Study|Symptomatic deterioration|0|||
148977333|NCT03013491|537396629|FG010|Main Study|Symptomatic deterioration|0|||
148977334|NCT03013491|537396630|FG011|Main Study|Symptomatic deterioration|0|||
148977335|NCT03013491|537396631|FG012|Main Study|Symptomatic deterioration|0|||
148977336|NCT03013491|537396632|FG013|Main Study|Symptomatic deterioration|0|||
148977337|NCT03013491|537396633|FG014|Main Study|Symptomatic deterioration|0|||
148977338|NCT03013491|537396634|FG015|Main Study|Symptomatic deterioration|0|||
148977339|NCT03013491|537396635|FG016|Main Study|Symptomatic deterioration|0|||
148977340|NCT03013491|537396636|FG017|Main Study|Symptomatic deterioration|0|||
148977341|NCT03013491|537396637|FG018|Main Study|Symptomatic deterioration|0|||
148977342|NCT03013491|537396619|FG000|Main Study|Protocol version 8.0 approval|0|||
148977343|NCT03013491|537396620|FG001|Main Study|Protocol version 8.0 approval|0|||
148977344|NCT03013491|537396621|FG002|Main Study|Protocol version 8.0 approval|0|||
148977345|NCT03013491|537396622|FG003|Main Study|Protocol version 8.0 approval|0|||
148977346|NCT03013491|537396623|FG004|Main Study|Protocol version 8.0 approval|0|||
148977347|NCT03013491|537396624|FG005|Main Study|Protocol version 8.0 approval|0|||
148977348|NCT03013491|537396625|FG006|Main Study|Protocol version 8.0 approval|0|||
148977349|NCT03013491|537396626|FG007|Main Study|Protocol version 8.0 approval|0|||
148977350|NCT03013491|537396627|FG008|Main Study|Protocol version 8.0 approval|0|||
148977351|NCT03013491|537396628|FG009|Main Study|Protocol version 8.0 approval|0|||
148977352|NCT03013491|537396629|FG010|Main Study|Protocol version 8.0 approval|1|||
148977353|NCT03013491|537396630|FG011|Main Study|Protocol version 8.0 approval|0|||
148977354|NCT03013491|537396631|FG012|Main Study|Protocol version 8.0 approval|0|||
148977355|NCT03013491|537396632|FG013|Main Study|Protocol version 8.0 approval|0|||
148977356|NCT03013491|537396633|FG014|Main Study|Protocol version 8.0 approval|0|||
148977357|NCT03013491|537396634|FG015|Main Study|Protocol version 8.0 approval|0|||
148977358|NCT03013491|537396635|FG016|Main Study|Protocol version 8.0 approval|0|||
148977359|NCT03013491|537396636|FG017|Main Study|Protocol version 8.0 approval|0|||
148977360|NCT03013491|537396637|FG018|Main Study|Protocol version 8.0 approval|0|||
148977361|NCT03013491|537396619|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
148977362|NCT03013491|537396620|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
148977363|NCT03013491|537396621|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
148977364|NCT03013491|537396622|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
148977365|NCT03013491|537396623|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
148977366|NCT03013491|537396624|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
148977367|NCT03013491|537396625|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
148977368|NCT03013491|537396626|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
148977369|NCT03013491|537396627|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
148977370|NCT03013491|537396628|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
148977371|NCT03013491|537396629|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
148977372|NCT03013491|537396630|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
148977373|NCT03013491|537396631|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
148977374|NCT03013491|537396632|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
148977375|NCT03013491|537396633|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
148977376|NCT03013491|537396634|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
148977377|NCT03013491|537396635|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
148977378|NCT03013491|537396636|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
148826356|NCT00128492|536842032|FG000|Overall Study|Noncompliance|0|||
148826357|NCT00128492|536842033|FG001|Overall Study|Noncompliance|5|||
148977379|NCT03013491|537396637|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
148977380|NCT03013491|537396619|FG000|Main Study|Start of new anticancer therapy|0|||
148977381|NCT03013491|537396620|FG001|Main Study|Start of new anticancer therapy|0|||
148977382|NCT03013491|537396621|FG002|Main Study|Start of new anticancer therapy|0|||
148977383|NCT03013491|537396622|FG003|Main Study|Start of new anticancer therapy|0|||
148977384|NCT03013491|537396623|FG004|Main Study|Start of new anticancer therapy|0|||
148977385|NCT03013491|537396624|FG005|Main Study|Start of new anticancer therapy|0|||
148977386|NCT03013491|537396625|FG006|Main Study|Start of new anticancer therapy|0|||
148977387|NCT03013491|537396626|FG007|Main Study|Start of new anticancer therapy|0|||
148977388|NCT03013491|537396627|FG008|Main Study|Start of new anticancer therapy|0|||
148977389|NCT03013491|537396628|FG009|Main Study|Start of new anticancer therapy|0|||
148977390|NCT03013491|537396629|FG010|Main Study|Start of new anticancer therapy|0|||
148977391|NCT03013491|537396630|FG011|Main Study|Start of new anticancer therapy|0|||
148977392|NCT03013491|537396631|FG012|Main Study|Start of new anticancer therapy|0|||
148977393|NCT03013491|537396632|FG013|Main Study|Start of new anticancer therapy|0|||
148977394|NCT03013491|537396633|FG014|Main Study|Start of new anticancer therapy|0|||
148977395|NCT03013491|537396634|FG015|Main Study|Start of new anticancer therapy|0|||
148977396|NCT03013491|537396635|FG016|Main Study|Start of new anticancer therapy|0|||
148977397|NCT03013491|537396636|FG017|Main Study|Start of new anticancer therapy|0|||
148977398|NCT03013491|537396637|FG018|Main Study|Start of new anticancer therapy|2|||
148977399|NCT03013491|537396619|FG000|Long-term Extension|Disease progression|0|||
148977400|NCT03013491|537396620|FG001|Long-term Extension|Disease progression|0|||
148977401|NCT03013491|537396621|FG002|Long-term Extension|Disease progression|0|||
148977402|NCT03013491|537396622|FG003|Long-term Extension|Disease progression|1|||
148977403|NCT03013491|537396623|FG004|Long-term Extension|Disease progression|0|||
148977404|NCT03013491|537396624|FG005|Long-term Extension|Disease progression|0|||
148977405|NCT03013491|537396625|FG006|Long-term Extension|Disease progression|0|||
149027615|NCT01511250|537578602|FG000|Overall Study|Protocol Violation|0|||
149027616|NCT01511250|537578603|FG001|Overall Study|Protocol Violation|2|||
149027617|NCT01511250|537578604|FG002|Overall Study|Protocol Violation|1|||
149027618|NCT01511250|537578605|FG003|Overall Study|Protocol Violation|0|||
149027619|NCT01511250|537578606|FG004|Overall Study|Protocol Violation|0|||
149027620|NCT01511250|537578607|FG005|Overall Study|Protocol Violation|0|||
149027621|NCT01511250|537578608|FG006|Overall Study|Protocol Violation|0|||
149027622|NCT01511250|537578609|FG007|Overall Study|Protocol Violation|0|||
149027623|NCT01511250|537578610|FG008|Overall Study|Protocol Violation|0|||
149027624|NCT01511250|537578611|FG009|Overall Study|Protocol Violation|0|||
149027625|NCT03178201|537578612|FG000|Overall Study|Off study|5|||
149027626|NCT01763047|537578613|FG000|Period 1|Test Article Not Available|4|||
149027627|NCT01763047|537578614|FG001|Period 1|Test Article Not Available|1|||
149027628|NCT01763047|537578613|FG000|Period 1|Protocol Violation|4|||
149027629|NCT01763047|537578614|FG001|Period 1|Protocol Violation|4|||
149027630|NCT01763047|537578613|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
149027631|NCT01763047|537578614|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
149027632|NCT01763047|537578613|FG000|Period 1|Adverse Event|0|||
149027633|NCT01763047|537578614|FG001|Period 1|Adverse Event|1|||
149027634|NCT01763047|537578613|FG000|Period 1|Unsatisfactory Visual Response|0|||
149027635|NCT01763047|537578614|FG001|Period 1|Unsatisfactory Visual Response|3|||
149027636|NCT01763047|537578613|FG000|Period 1|Lens Power Not Available|0|||
149027637|NCT01763047|537578614|FG001|Period 1|Lens Power Not Available|1|||
149027638|NCT01763047|537578613|FG000|Period 1|Study Site office Closed|0|||
149027639|NCT01763047|537578614|FG001|Period 1|Study Site office Closed|1|||
149027640|NCT01763047|537578613|FG000|Period 2|Lens Discomfort|1|||
149027641|NCT01763047|537578614|FG001|Period 2|Lens Discomfort|0|||
149027642|NCT01763047|537578613|FG000|Period 2|No longer meets Eligibility Criteria|1|||
149027643|NCT01763047|537578614|FG001|Period 2|No longer meets Eligibility Criteria|0|||
149027644|NCT01763047|537578613|FG000|Period 2|Study Site office Closed|1|||
149027645|NCT01763047|537578614|FG001|Period 2|Study Site office Closed|1|||
149027646|NCT01763047|537578613|FG000|Period 2|Unsatisfactory Visual Response|1|||
149027647|NCT01763047|537578614|FG001|Period 2|Unsatisfactory Visual Response|1|||
149027648|NCT01763047|537578613|FG000|Period 2|Protocol Violation|0|||
149027649|NCT01763047|537578614|FG001|Period 2|Protocol Violation|2|||
149027650|NCT01763047|537578613|FG000|Period 2|Unsatisfactory lens Fitting|0|||
149027651|NCT01763047|537578614|FG001|Period 2|Unsatisfactory lens Fitting|1|||
149027652|NCT01767909|537578620|FG000|Overall Study|Withdrawal by Subject|4|||
149027653|NCT01767909|537578621|FG001|Overall Study|Withdrawal by Subject|7|||
149027654|NCT01767909|537578620|FG000|Overall Study|Adverse Event|3|||
149027655|NCT01767909|537578621|FG001|Overall Study|Adverse Event|1|||
149027656|NCT01767909|537578620|FG000|Overall Study|Withdrawal by Study Partner|3|||
149027657|NCT01767909|537578621|FG001|Overall Study|Withdrawal by Study Partner|1|||
149027658|NCT01767909|537578620|FG000|Overall Study|Non-Compliance|2|||
149027659|NCT01767909|537578621|FG001|Overall Study|Non-Compliance|0|||
149027660|NCT01767909|537578620|FG000|Overall Study|Perceived Lack of Efficacy|1|||
149027661|NCT01767909|537578621|FG001|Overall Study|Perceived Lack of Efficacy|0|||
149027662|NCT01767909|537578620|FG000|Overall Study|Investigator Recommendation|0|||
149027663|NCT01767909|537578621|FG001|Overall Study|Investigator Recommendation|1|||
149027664|NCT01767909|537578620|FG000|Overall Study|Lost to Follow-up|0|||
149027665|NCT01767909|537578621|FG001|Overall Study|Lost to Follow-up|1|||
149027666|NCT01767909|537578620|FG000|Overall Study|LP uncessessful|0|||
148977406|NCT03013491|537396626|FG007|Long-term Extension|Disease progression|0|||
148977407|NCT03013491|537396627|FG008|Long-term Extension|Disease progression|0|||
148977408|NCT03013491|537396628|FG009|Long-term Extension|Disease progression|0|||
148977409|NCT03013491|537396629|FG010|Long-term Extension|Disease progression|0|||
148977410|NCT03013491|537396630|FG011|Long-term Extension|Disease progression|0|||
148977411|NCT03013491|537396631|FG012|Long-term Extension|Disease progression|0|||
148977412|NCT03013491|537396632|FG013|Long-term Extension|Disease progression|0|||
148977413|NCT03013491|537396633|FG014|Long-term Extension|Disease progression|0|||
148826358|NCT00128492|536842032|FG000|Overall Study|Personal or administrative|10|||
148826359|NCT00128492|536842033|FG001|Overall Study|Personal or administrative|22|||
148826360|NCT00128492|536842032|FG000|Overall Study|Withdrawal by Subject|3|||
148826361|NCT00128492|536842033|FG001|Overall Study|Withdrawal by Subject|5|||
148826362|NCT00128492|536842032|FG000|Overall Study|Pregnancy|0|||
148826363|NCT00128492|536842033|FG001|Overall Study|Pregnancy|1|||
148826364|NCT00756314|536842037|FG000|Overall Study|Lost to Follow-up|2|||
148826365|NCT00756314|536842038|FG001|Overall Study|Lost to Follow-up|59|||
148977414|NCT03013491|537396634|FG015|Long-term Extension|Disease progression|0|||
148977415|NCT03013491|537396635|FG016|Long-term Extension|Disease progression|0|||
148977416|NCT03013491|537396636|FG017|Long-term Extension|Disease progression|0|||
148826366|NCT02872142|536842040|FG000|Overall Study|Adverse Event|2|||
148826367|NCT02872142|536842040|FG000|Overall Study|Death|1|||
148977417|NCT03013491|537396637|FG018|Long-term Extension|Disease progression|1|||
148977418|NCT03013491|537396619|FG000|Long-term Extension|Withdrawal by Subject|0|||
148977419|NCT03013491|537396620|FG001|Long-term Extension|Withdrawal by Subject|0|||
148977420|NCT03013491|537396621|FG002|Long-term Extension|Withdrawal by Subject|0|||
148977421|NCT03013491|537396622|FG003|Long-term Extension|Withdrawal by Subject|0|||
148977422|NCT03013491|537396623|FG004|Long-term Extension|Withdrawal by Subject|0|||
148977423|NCT03013491|537396624|FG005|Long-term Extension|Withdrawal by Subject|0|||
148977424|NCT03013491|537396625|FG006|Long-term Extension|Withdrawal by Subject|0|||
148977425|NCT03013491|537396626|FG007|Long-term Extension|Withdrawal by Subject|1|||
148977426|NCT03013491|537396627|FG008|Long-term Extension|Withdrawal by Subject|0|||
148977427|NCT03013491|537396628|FG009|Long-term Extension|Withdrawal by Subject|0|||
148977428|NCT03013491|537396629|FG010|Long-term Extension|Withdrawal by Subject|0|||
148977429|NCT03013491|537396630|FG011|Long-term Extension|Withdrawal by Subject|0|||
148977430|NCT03013491|537396631|FG012|Long-term Extension|Withdrawal by Subject|0|||
148977431|NCT03013491|537396632|FG013|Long-term Extension|Withdrawal by Subject|0|||
148977432|NCT03013491|537396633|FG014|Long-term Extension|Withdrawal by Subject|0|||
148977433|NCT03013491|537396634|FG015|Long-term Extension|Withdrawal by Subject|0|||
148977434|NCT03013491|537396635|FG016|Long-term Extension|Withdrawal by Subject|0|||
148977435|NCT03013491|537396636|FG017|Long-term Extension|Withdrawal by Subject|0|||
148977436|NCT03013491|537396637|FG018|Long-term Extension|Withdrawal by Subject|0|||
148977437|NCT03013491|537396619|FG000|Long-term Extension|Adverse Event|0|||
148977438|NCT03013491|537396620|FG001|Long-term Extension|Adverse Event|0|||
148977439|NCT03013491|537396621|FG002|Long-term Extension|Adverse Event|0|||
148977440|NCT03013491|537396622|FG003|Long-term Extension|Adverse Event|0|||
148977441|NCT03013491|537396623|FG004|Long-term Extension|Adverse Event|0|||
148977442|NCT03013491|537396624|FG005|Long-term Extension|Adverse Event|0|||
148977443|NCT03013491|537396625|FG006|Long-term Extension|Adverse Event|0|||
148977444|NCT03013491|537396626|FG007|Long-term Extension|Adverse Event|0|||
148977445|NCT03013491|537396627|FG008|Long-term Extension|Adverse Event|0|||
148977446|NCT03013491|537396628|FG009|Long-term Extension|Adverse Event|0|||
148977447|NCT03013491|537396629|FG010|Long-term Extension|Adverse Event|0|||
148977448|NCT03013491|537396630|FG011|Long-term Extension|Adverse Event|0|||
148977449|NCT03013491|537396631|FG012|Long-term Extension|Adverse Event|0|||
148977450|NCT03013491|537396632|FG013|Long-term Extension|Adverse Event|0|||
148977451|NCT03013491|537396633|FG014|Long-term Extension|Adverse Event|0|||
148977452|NCT03013491|537396634|FG015|Long-term Extension|Adverse Event|0|||
148977453|NCT03013491|537396635|FG016|Long-term Extension|Adverse Event|0|||
148977454|NCT03013491|537396636|FG017|Long-term Extension|Adverse Event|0|||
148977455|NCT03013491|537396637|FG018|Long-term Extension|Adverse Event|1|||
148977456|NCT03013491|537396619|FG000|Long-term Extension|Death|0|||
148977457|NCT03013491|537396620|FG001|Long-term Extension|Death|0|||
148977458|NCT03013491|537396621|FG002|Long-term Extension|Death|0|||
148977459|NCT03013491|537396622|FG003|Long-term Extension|Death|0|||
148826368|NCT02872142|536842040|FG000|Overall Study|Participant Decision|3|||
148826369|NCT00692237|536842044|FG000|Overall Study|Withdrawal by Subject|1|||
148826370|NCT00692237|536842045|FG001|Overall Study|Withdrawal by Subject|3|||
148977460|NCT03013491|537396623|FG004|Long-term Extension|Death|0|||
148977461|NCT03013491|537396624|FG005|Long-term Extension|Death|0|||
148977462|NCT03013491|537396625|FG006|Long-term Extension|Death|0|||
148977463|NCT03013491|537396626|FG007|Long-term Extension|Death|0|||
148977464|NCT03013491|537396627|FG008|Long-term Extension|Death|0|||
148977465|NCT03013491|537396628|FG009|Long-term Extension|Death|0|||
148977466|NCT03013491|537396629|FG010|Long-term Extension|Death|0|||
148977467|NCT03013491|537396630|FG011|Long-term Extension|Death|0|||
148977468|NCT03013491|537396631|FG012|Long-term Extension|Death|0|||
148977469|NCT03013491|537396632|FG013|Long-term Extension|Death|0|||
148977470|NCT03013491|537396633|FG014|Long-term Extension|Death|0|||
148977471|NCT03013491|537396634|FG015|Long-term Extension|Death|0|||
148977472|NCT03013491|537396635|FG016|Long-term Extension|Death|0|||
148977473|NCT03013491|537396636|FG017|Long-term Extension|Death|0|||
148977474|NCT03013491|537396637|FG018|Long-term Extension|Death|1|||
148977475|NCT00991302|537398317|FG000|Overall Study|Death|0|||
148977476|NCT00991302|537398318|FG001|Overall Study|Death|1|||
148977477|NCT00991302|537398317|FG000|Overall Study|Lost to Follow-up|14|||
148977478|NCT00991302|537398318|FG001|Overall Study|Lost to Follow-up|12|||
148977479|NCT03370341|537398319|FG000|Overall Study|Lost to Follow-up|0|||
148977480|NCT03370341|537398320|FG001|Overall Study|Lost to Follow-up|1|||
148977481|NCT02383758|537398321|FG000|Overall Study|Withdrawal by Subject|0|||
148826371|NCT00692237|536842044|FG000|Overall Study|Adverse Event|0|||
148826372|NCT00692237|536842045|FG001|Overall Study|Adverse Event|1|||
148826373|NCT01347086|536842046|FG000|Overall Study|failed screening visit|0|||
148826374|NCT01347086|536842047|FG001|Overall Study|failed screening visit|0|||
148826375|NCT01347086|536842048|FG002|Overall Study|failed screening visit|1|||
148826376|NCT01347086|536842049|FG003|Overall Study|failed screening visit|0|||
148826377|NCT01347086|536842050|FG004|Overall Study|failed screening visit|0|||
148826378|NCT01347086|536842051|FG005|Overall Study|failed screening visit|0|||
148826379|NCT01347086|536842052|FG006|Overall Study|failed screening visit|1|||
148826380|NCT01347086|536842053|FG007|Overall Study|failed screening visit|1|||
148826381|NCT01347086|536842054|FG008|Overall Study|failed screening visit|0|||
148826382|NCT01347086|536842055|FG009|Overall Study|failed screening visit|1|||
148826383|NCT02624687|536842056|FG000|Overall Study|Withdrawal by Subject|1|||
148826384|NCT02624687|536842057|FG001|Overall Study|Withdrawal by Subject|1|||
148826385|NCT02624687|536842056|FG000|Overall Study|medical leave from work|0|||
148826386|NCT02624687|536842057|FG001|Overall Study|medical leave from work|1|||
148826387|NCT00347269|536842058|FG000|Overall Study|Lost to Follow-up|74|||
148826388|NCT00347269|536842059|FG001|Overall Study|Lost to Follow-up|65|||
148826389|NCT00347269|536842058|FG000|Overall Study|Withdrawal by Subject|18|||
148826390|NCT00347269|536842059|FG001|Overall Study|Withdrawal by Subject|38|||
148826391|NCT00347269|536842058|FG000|Overall Study|Death|2|||
148826392|NCT00347269|536842059|FG001|Overall Study|Death|3|||
148826393|NCT03654326|536842060|FG000|Overall Study|Withdrawal by Subject|5|||
148826394|NCT03654326|536842061|FG001|Overall Study|Withdrawal by Subject|3|||
148826395|NCT03654326|536842060|FG000|Overall Study|Physician Decision|0|||
148826396|NCT03654326|536842061|FG001|Overall Study|Physician Decision|1|||
148826397|NCT03654326|536842060|FG000|Overall Study|Unable to adhere to study schedule|0|||
148826398|NCT03654326|536842061|FG001|Overall Study|Unable to adhere to study schedule|1|||
148826399|NCT03654326|536842060|FG000|Overall Study|Lost to Follow-up|1|||
148826400|NCT03654326|536842061|FG001|Overall Study|Lost to Follow-up|1|||
148826401|NCT04893811|536842062|FG000|Vaccination Phase|Death|1|||
148826402|NCT04893811|536842063|FG001|Vaccination Phase|Death|0|||
148826403|NCT04893811|536842062|FG000|Vaccination Phase|Lost to Follow-up|1|||
148826404|NCT04893811|536842063|FG001|Vaccination Phase|Lost to Follow-up|1|||
148826405|NCT04893811|536842062|FG000|Vaccination Phase|Protocol Violation|2|||
148826406|NCT04893811|536842063|FG001|Vaccination Phase|Protocol Violation|0|||
148826407|NCT04893811|536842062|FG000|Vaccination Phase|Withdrawal by Subject|2|||
148826408|NCT04893811|536842063|FG001|Vaccination Phase|Withdrawal by Subject|1|||
148826409|NCT04893811|536842062|FG000|Vaccination Phase|Other|0|||
148826410|NCT04893811|536842063|FG001|Vaccination Phase|Other|1|||
148826411|NCT04893811|536842062|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
148826412|NCT04893811|536842063|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
148826413|NCT04893811|536842062|FG000|Follow-up Phase|Lost to Follow-up|0|||
148826414|NCT04893811|536842063|FG001|Follow-up Phase|Lost to Follow-up|1|||
148977482|NCT02383758|537398322|FG001|Overall Study|Withdrawal by Subject|2|||
148977483|NCT01707004|537398325|FG000|Overall Study|Physician Decision|3|||
148977484|NCT03085927|537398329|FG000|Overall Study|Withdrawal by Subject|1|||
148977485|NCT03085927|537398330|FG001|Overall Study|Withdrawal by Subject|4|||
148977486|NCT03085927|537398329|FG000|Overall Study|Lost to Follow-up|3|||
148977487|NCT03085927|537398330|FG001|Overall Study|Lost to Follow-up|1|||
148977488|NCT03085927|537398329|FG000|Overall Study|Death|1|||
148977489|NCT03085927|537398330|FG001|Overall Study|Death|0|||
148977490|NCT03085927|537398329|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
148977491|NCT03085927|537398330|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
148977492|NCT03085927|537398329|FG000|Overall Study|Dyad Became Ineligible|0|||
148977493|NCT03085927|537398330|FG001|Overall Study|Dyad Became Ineligible|1|||
148977494|NCT02573324|537398331|FG000|Overall Study|Withdrawal by Subject|26|||
148977495|NCT02573324|537398332|FG001|Overall Study|Withdrawal by Subject|23|||
148977496|NCT02573324|537398333|FG002|Overall Study|Withdrawal by Subject|3|||
148826415|NCT02662582|536842064|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
148826416|NCT02662582|536842065|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
148826417|NCT02662582|536842064|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
148826418|NCT02662582|536842065|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
148826419|NCT02662582|536842064|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
148826420|NCT02662582|536842065|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
148826421|NCT02662582|536842064|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148826422|NCT02662582|536842065|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148826423|NCT01725282|536842066|FG000|Overall Study|Adverse Event|1|||
148977497|NCT02573324|537398331|FG000|Overall Study|Lost to Follow-up|4|||
148977498|NCT02573324|537398332|FG001|Overall Study|Lost to Follow-up|5|||
148977499|NCT02573324|537398333|FG002|Overall Study|Lost to Follow-up|0|||
148977500|NCT02573324|537398331|FG000|Overall Study|Study Terminated by Sponsor|107|||
148977501|NCT02573324|537398332|FG001|Overall Study|Study Terminated by Sponsor|89|||
148977502|NCT02573324|537398333|FG002|Overall Study|Study Terminated by Sponsor|2|||
148977503|NCT02573324|537398331|FG000|Overall Study|Death|182|||
148977504|NCT02573324|537398332|FG001|Overall Study|Death|200|||
149027667|NCT01767909|537578621|FG001|Overall Study|LP uncessessful|1|||
149027668|NCT04956692|537578629|FG000|Overall Study|Death|115|||
149027669|NCT04956692|537578630|FG001|Overall Study|Death|47|||
149027670|NCT04956692|537578629|FG000|Overall Study|Lost to Follow-up|0|||
149027671|NCT04956692|537578630|FG001|Overall Study|Lost to Follow-up|1|||
149027672|NCT04956692|537578629|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149027673|NCT04956692|537578630|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149027674|NCT04956692|537578629|FG000|Overall Study|Withdrawal by Subject|5|||
149027675|NCT04956692|537578630|FG001|Overall Study|Withdrawal by Subject|2|||
149027676|NCT04956692|537578629|FG000|Overall Study|Ongoing in Study|236|||
149027677|NCT04956692|537578630|FG001|Overall Study|Ongoing in Study|123|||
149027678|NCT02234310|537578633|FG000|Overall Study|Physician Decision|1|||
149027679|NCT02234310|537578633|FG000|Overall Study|Adverse Event|1|||
149027680|NCT02234310|537578633|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
149027681|NCT02234310|537578633|FG000|Overall Study|Withdrawal by Subject|2|||
149027682|NCT02487446|537578634|FG000|Period 1|Physician Decision|0|||
149027683|NCT02487446|537578635|FG001|Period 1|Physician Decision|1|||
149027684|NCT02487446|537578634|FG000|Period 1|Lack of Efficacy|1|||
149027685|NCT02487446|537578635|FG001|Period 1|Lack of Efficacy|0|||
149027686|NCT02487446|537578634|FG000|Period 1|Protocol deviation|3|||
149027687|NCT02487446|537578635|FG001|Period 1|Protocol deviation|2|||
149027688|NCT02487446|537578634|FG000|Period 1|Lost to Follow-up|2|||
149027689|NCT02487446|537578635|FG001|Period 1|Lost to Follow-up|0|||
148762074|NCT00651261|536602553|FG000|Overall Study|Adverse Event|32|||
148762075|NCT00651261|536602554|FG001|Overall Study|Adverse Event|22|||
148762076|NCT00651261|536602553|FG000|Overall Study|Death|18|||
148762077|NCT00651261|536602554|FG001|Overall Study|Death|18|||
148762078|NCT00651261|536602553|FG000|Overall Study|Withdrawal by Subject|22|||
148762079|NCT00651261|536602554|FG001|Overall Study|Withdrawal by Subject|40|||
148762080|NCT00651261|536602553|FG000|Overall Study|Induction failure|24|||
148762081|NCT00651261|536602554|FG001|Overall Study|Induction failure|35|||
148762082|NCT00651261|536602553|FG000|Overall Study|Disease progression|58|||
148762083|NCT00651261|536602554|FG001|Overall Study|Disease progression|58|||
148762084|NCT00651261|536602553|FG000|Overall Study|Alternative therapy|109|||
148762085|NCT00651261|536602554|FG001|Overall Study|Alternative therapy|107|||
148762086|NCT00651261|536602553|FG000|Overall Study|Other disease or participant decisions|23|||
148762087|NCT00651261|536602554|FG001|Overall Study|Other disease or participant decisions|23|||
148762088|NCT00651261|536602553|FG000|Overall Study|Never treated|5|||
148762089|NCT00651261|536602554|FG001|Overall Study|Never treated|3|||
148762090|NCT02770170|536602558|FG000|Overall Study|Withdrawal by Subject|0|||
148762091|NCT02770170|536602559|FG001|Overall Study|Withdrawal by Subject|0|||
148762092|NCT02770170|536602560|FG002|Overall Study|Withdrawal by Subject|0|||
148762093|NCT02770170|536602561|FG003|Overall Study|Withdrawal by Subject|2|||
148762094|NCT02770170|536602558|FG000|Overall Study|due to pregnancy|1|||
148762095|NCT02770170|536602559|FG001|Overall Study|due to pregnancy|0|||
148762096|NCT02770170|536602560|FG002|Overall Study|due to pregnancy|0|||
148762097|NCT02770170|536602561|FG003|Overall Study|due to pregnancy|0|||
148762098|NCT02770170|536602558|FG000|Overall Study|Lack of Efficacy|2|||
148762099|NCT02770170|536602559|FG001|Overall Study|Lack of Efficacy|0|||
148762100|NCT02770170|536602560|FG002|Overall Study|Lack of Efficacy|0|||
148762101|NCT02770170|536602561|FG003|Overall Study|Lack of Efficacy|1|||
148762102|NCT02770170|536602558|FG000|Overall Study|Adverse Event|4|||
148762103|NCT02770170|536602559|FG001|Overall Study|Adverse Event|3|||
148762104|NCT02770170|536602560|FG002|Overall Study|Adverse Event|5|||
148762105|NCT02770170|536602561|FG003|Overall Study|Adverse Event|3|||
148762106|NCT02770170|536602558|FG000|Overall Study|due to disease worsening|0|||
148762107|NCT02770170|536602559|FG001|Overall Study|due to disease worsening|0|||
148762108|NCT02770170|536602560|FG002|Overall Study|due to disease worsening|0|||
148762109|NCT02770170|536602561|FG003|Overall Study|due to disease worsening|1|||
148762110|NCT03581123|536602564|FG000|2-month Follow-up|Withdrawal by Subject|5|||
148762111|NCT03581123|536602565|FG001|2-month Follow-up|Withdrawal by Subject|4|||
148762112|NCT03581123|536602566|FG002|2-month Follow-up|Withdrawal by Subject|6|||
148762113|NCT03581123|536602567|FG003|2-month Follow-up|Withdrawal by Subject|4|||
148762114|NCT03581123|536602564|FG000|2-month Follow-up|Lost to Follow-up|8|||
148762115|NCT03581123|536602565|FG001|2-month Follow-up|Lost to Follow-up|1|||
148762116|NCT03581123|536602566|FG002|2-month Follow-up|Lost to Follow-up|2|||
148762117|NCT03581123|536602567|FG003|2-month Follow-up|Lost to Follow-up|2|||
148762118|NCT03581123|536602564|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
148762119|NCT03581123|536602565|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
148826424|NCT01725282|536842067|FG001|Overall Study|Adverse Event|3|||
148826425|NCT01725282|536842068|FG002|Overall Study|Adverse Event|6|||
149027690|NCT02487446|537578634|FG000|Period 1|Withdrawal by Subject|2|||
149027691|NCT02487446|537578635|FG001|Period 1|Withdrawal by Subject|0|||
149027692|NCT02487446|537578634|FG000|Period 1|Adverse Event|5|||
149027693|NCT02487446|537578635|FG001|Period 1|Adverse Event|5|||
149027694|NCT02487446|537578634|FG000|Washout|Lost to Follow-up|0|||
149027695|NCT02487446|537578635|FG001|Washout|Lost to Follow-up|2|||
148762120|NCT03581123|536602566|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
148762121|NCT03581123|536602567|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
148826426|NCT01725282|536842069|FG003|Overall Study|Adverse Event|4|||
148826427|NCT01725282|536842066|FG000|Overall Study|Exacerbation of Target Disease|1|||
148826428|NCT01725282|536842067|FG001|Overall Study|Exacerbation of Target Disease|0|||
148826429|NCT01725282|536842068|FG002|Overall Study|Exacerbation of Target Disease|0|||
148826430|NCT01725282|536842069|FG003|Overall Study|Exacerbation of Target Disease|1|||
148826431|NCT01725282|536842066|FG000|Overall Study|Met Exclusion Criteria|0|||
148826432|NCT01725282|536842067|FG001|Overall Study|Met Exclusion Criteria|0|||
148826433|NCT01725282|536842068|FG002|Overall Study|Met Exclusion Criteria|1|||
148826434|NCT01725282|536842069|FG003|Overall Study|Met Exclusion Criteria|0|||
148826435|NCT01725282|536842066|FG000|Overall Study|Study Site Withdrawal|0|||
148826436|NCT01725282|536842067|FG001|Overall Study|Study Site Withdrawal|1|||
148826437|NCT01725282|536842068|FG002|Overall Study|Study Site Withdrawal|0|||
148826438|NCT01725282|536842069|FG003|Overall Study|Study Site Withdrawal|0|||
148826439|NCT01725282|536842066|FG000|Overall Study|Withdrawal by Subject|0|||
148826440|NCT01725282|536842067|FG001|Overall Study|Withdrawal by Subject|0|||
148826441|NCT01725282|536842068|FG002|Overall Study|Withdrawal by Subject|1|||
148977505|NCT02573324|537398333|FG002|Overall Study|Death|1|||
148977506|NCT02573324|537398331|FG000|Overall Study|Other, Not Specified|20|||
148762122|NCT03581123|536602564|FG000|6-Month Follow-up|Lost to Follow-up|3|||
148762123|NCT03581123|536602565|FG001|6-Month Follow-up|Lost to Follow-up|3|||
148762124|NCT03581123|536602566|FG002|6-Month Follow-up|Lost to Follow-up|1|||
148762125|NCT03581123|536602567|FG003|6-Month Follow-up|Lost to Follow-up|1|||
148762126|NCT03581123|536602564|FG000|12-Month Follow-up|Lost to Follow-up|4|||
148762127|NCT03581123|536602565|FG001|12-Month Follow-up|Lost to Follow-up|3|||
148762128|NCT03581123|536602566|FG002|12-Month Follow-up|Lost to Follow-up|4|||
148762129|NCT03581123|536602567|FG003|12-Month Follow-up|Lost to Follow-up|5|||
148762130|NCT04195685|536602568|FG000|Overall Study|Withdrawal by Subject|6|||
148762131|NCT04195685|536602569|FG001|Overall Study|Withdrawal by Subject|2|||
148762132|NCT04195685|536602568|FG000|Overall Study|Lost to Follow-up|1|||
148762133|NCT04195685|536602569|FG001|Overall Study|Lost to Follow-up|4|||
148762134|NCT00162981|536602570|FG000|Overall Study|Adverse Event|2|||
148762135|NCT00162981|536602571|FG001|Overall Study|Adverse Event|5|||
148762136|NCT00162981|536602570|FG000|Overall Study|Withdrawal by Subject|1|||
148762137|NCT00162981|536602571|FG001|Overall Study|Withdrawal by Subject|1|||
148762138|NCT00162981|536602570|FG000|Overall Study|Physician Decision|1|||
148762139|NCT00162981|536602571|FG001|Overall Study|Physician Decision|0|||
148762140|NCT02877004|536602578|FG000|Overall Study|Pregnancy|0|||
148762141|NCT02877004|536602579|FG001|Overall Study|Pregnancy|0|||
148762142|NCT02877004|536602580|FG002|Overall Study|Pregnancy|1|||
148762143|NCT02044302|536602582|FG000|Overall Study|study terminated|2|||
148762144|NCT02044302|536602583|FG001|Overall Study|study terminated|0|||
148762145|NCT03309943|536602584|FG000|Overall Study|Withdrawal by Subject|0|||
148762146|NCT03309943|536602585|FG001|Overall Study|Withdrawal by Subject|1|||
148762147|NCT03309943|536602584|FG000|Overall Study|Inappropriate behavior towards staff|0|||
148762148|NCT03309943|536602585|FG001|Overall Study|Inappropriate behavior towards staff|1|||
148762149|NCT02019264|536602593|FG000|Overall Study|Not treated|6|||
148762150|NCT02019264|536602594|FG001|Overall Study|Not treated|4|||
148762151|NCT02019264|536602593|FG000|Overall Study|Lost to Follow-up|50|||
148762152|NCT02019264|536602594|FG001|Overall Study|Lost to Follow-up|47|||
148762153|NCT02019264|536602593|FG000|Overall Study|Withdrawal by Subject|142|||
148762154|NCT02019264|536602594|FG001|Overall Study|Withdrawal by Subject|117|||
148762155|NCT02019264|536602593|FG000|Overall Study|Administrative reason|36|||
148762156|NCT02019264|536602594|FG001|Overall Study|Administrative reason|28|||
148762157|NCT02019264|536602593|FG000|Overall Study|Missing|14|||
148762158|NCT02019264|536602594|FG001|Overall Study|Missing|11|||
148762159|NCT00628212|536602595|FG000|Overall Study|Adverse Event|2|||
148762160|NCT00628212|536602596|FG001|Overall Study|Adverse Event|0|||
148826442|NCT01725282|536842069|FG003|Overall Study|Withdrawal by Subject|1|||
148826443|NCT01725282|536842066|FG000|Overall Study|Lack of Efficacy|0|||
148826444|NCT01725282|536842067|FG001|Overall Study|Lack of Efficacy|1|||
148826445|NCT01725282|536842068|FG002|Overall Study|Lack of Efficacy|0|||
148826446|NCT01725282|536842069|FG003|Overall Study|Lack of Efficacy|1|||
148826447|NCT01687595|536842074|FG000|Overall Study|Withdrawal by Subject|8|||
148826448|NCT01687595|536842075|FG001|Overall Study|Withdrawal by Subject|0|||
148977507|NCT02573324|537398332|FG001|Overall Study|Other, Not Specified|27|||
148977508|NCT02573324|537398333|FG002|Overall Study|Other, Not Specified|0|||
148762161|NCT00628212|536602597|FG002|Overall Study|Adverse Event|1|||
148762162|NCT00628212|536602598|FG003|Overall Study|Adverse Event|2|||
148762163|NCT00628212|536602595|FG000|Overall Study|Physician Decision|1|||
148762164|NCT00628212|536602596|FG001|Overall Study|Physician Decision|1|||
148762165|NCT00628212|536602597|FG002|Overall Study|Physician Decision|2|||
148762166|NCT00628212|536602598|FG003|Overall Study|Physician Decision|3|||
148826449|NCT01687595|536842074|FG000|Overall Study|Lost to Follow-up|3|||
148826450|NCT01687595|536842075|FG001|Overall Study|Lost to Follow-up|1|||
148826451|NCT01687595|536842074|FG000|Overall Study|Investigator's decision|1|||
148977509|NCT02573324|537398331|FG000|Overall Study|Unknown Reason|2|||
148826452|NCT01687595|536842075|FG001|Overall Study|Investigator's decision|0|||
148826453|NCT01687595|536842074|FG000|Overall Study|Sponsor's decision|1|||
148762167|NCT02914613|536602599|FG000|Overall Study|Withdrawal by Subject|1|||
148762168|NCT02914613|536602600|FG001|Overall Study|Withdrawal by Subject|2|||
148762169|NCT02914613|536602599|FG000|Overall Study|Adverse Event|1|||
148762170|NCT02914613|536602600|FG001|Overall Study|Adverse Event|0|||
148762171|NCT00546377|536602601|FG000|Overall Study|Deemed ineligible|1|||
148762172|NCT00546377|536602601|FG000|Overall Study|Adverse Event|6|||
148762173|NCT01684423|536602605|FG000|Overall Study|Withdrawal by Subject|0|||
148762174|NCT01684423|536602606|FG001|Overall Study|Withdrawal by Subject|0|||
148762175|NCT01684423|536602607|FG002|Overall Study|Withdrawal by Subject|1|||
148762176|NCT01684423|536602608|FG003|Overall Study|Withdrawal by Subject|0|||
148762177|NCT01684423|536602609|FG004|Overall Study|Withdrawal by Subject|0|||
148762178|NCT03850496|536602613|FG000|Overall Study|Withdrawal by Subject|1|||
148762179|NCT03850496|536602614|FG001|Overall Study|Withdrawal by Subject|0|||
148762180|NCT03850496|536602615|FG002|Overall Study|Withdrawal by Subject|0|||
148762181|NCT03850496|536602613|FG000|Overall Study|Lost to Follow-up|0|||
148762182|NCT03850496|536602614|FG001|Overall Study|Lost to Follow-up|1|||
148762183|NCT03850496|536602615|FG002|Overall Study|Lost to Follow-up|4|||
148762184|NCT00869999|536602623|FG000|Overall Study|Withdrawal by Subject|1|||
148762185|NCT00869999|536602623|FG000|Overall Study|removed prior to starting therapy|1|||
148762186|NCT05343364|536602634|FG000|Overall Study|Miscellaneous|0|||
148762187|NCT05343364|536602635|FG001|Overall Study|Miscellaneous|1|||
148762188|NCT01753570|536602636|FG000|Overall Study|Adverse Event|1|||
148762189|NCT01753570|536602637|FG001|Overall Study|Adverse Event|0|||
148762190|NCT01753570|536602638|FG002|Overall Study|Adverse Event|1|||
148762191|NCT01753570|536602636|FG000|Overall Study|Physician Decision|0|||
148762192|NCT01753570|536602637|FG001|Overall Study|Physician Decision|1|||
148762193|NCT01753570|536602638|FG002|Overall Study|Physician Decision|0|||
148762194|NCT01753570|536602636|FG000|Overall Study|Withdrawal by Subject|1|||
148762195|NCT01753570|536602637|FG001|Overall Study|Withdrawal by Subject|4|||
148762196|NCT01753570|536602638|FG002|Overall Study|Withdrawal by Subject|0|||
148762197|NCT01422889|536602639|FG000|Overall Study|No Data Entered for Study Stent|9|||
148762198|NCT00488644|536602640|FG000|Overall Study|Not Eligible|1|||
148762199|NCT00488644|536602640|FG000|Overall Study|Not Evaluable|1|||
148762200|NCT04331067|536602641|FG000|Overall Study|Adverse Event|1|||
148762201|NCT04331067|536602642|FG001|Overall Study|Adverse Event|3|||
148762202|NCT04331067|536602643|FG002|Overall Study|Adverse Event|1|||
148762203|NCT04331067|536602641|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
148762204|NCT04331067|536602642|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
148762205|NCT04331067|536602643|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
148977510|NCT02573324|537398332|FG001|Overall Study|Unknown Reason|0|||
148977511|NCT02573324|537398333|FG002|Overall Study|Unknown Reason|0|||
148977512|NCT03892889|537398334|FG000|Overall Study|Adverse Event|17|||
148977513|NCT03892889|537398334|FG000|Overall Study|Lack of Efficacy|1|||
148977514|NCT03892889|537398334|FG000|Overall Study|Lost to Follow-up|46|||
148977515|NCT03892889|537398334|FG000|Overall Study|Non-compliance with study drug|22|||
148977516|NCT03892889|537398334|FG000|Overall Study|Pregnancy|1|||
148977517|NCT03892889|537398334|FG000|Overall Study|Protocol Deviation|3|||
148762214|NCT00314327|536602649|FG000|Overall Study|Withdrawal by Subject|1|||
148762215|NCT01205776|536602653|FG000|Overall Study|Lost to Follow-up|53|||
148762216|NCT01205776|536602654|FG001|Overall Study|Lost to Follow-up|61|||
148762217|NCT01205776|536602653|FG000|Overall Study|Withdrawal by Subject|11|||
148762218|NCT01205776|536602654|FG001|Overall Study|Withdrawal by Subject|34|||
148762219|NCT04031846|536602657|FG000|Overall Study|Lost to Follow-up|4|||
148762220|NCT04031846|536602658|FG001|Overall Study|Lost to Follow-up|4|||
148762221|NCT04031846|536602657|FG000|Overall Study|Physician Decision|0|||
148762222|NCT04031846|536602658|FG001|Overall Study|Physician Decision|1|||
148762223|NCT04031846|536602657|FG000|Overall Study|Protocol Violation|1|||
148762224|NCT04031846|536602658|FG001|Overall Study|Protocol Violation|1|||
148762225|NCT04031846|536602657|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
148762226|NCT04031846|536602658|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
148762227|NCT03103152|536602659|FG000|Overall Study|Physician Decision|5|||
148762228|NCT03103152|536602660|FG001|Overall Study|Physician Decision|2|||
148762229|NCT03103152|536602661|FG002|Overall Study|Physician Decision|6|||
148762230|NCT03103152|536602662|FG003|Overall Study|Physician Decision|3|||
148762231|NCT03103152|536602663|FG004|Overall Study|Physician Decision|3|||
148762232|NCT03103152|536602664|FG005|Overall Study|Physician Decision|1|||
148762233|NCT03103152|536602659|FG000|Overall Study|Protocol Violation|2|||
148762234|NCT03103152|536602660|FG001|Overall Study|Protocol Violation|2|||
148762235|NCT03103152|536602661|FG002|Overall Study|Protocol Violation|1|||
148762236|NCT03103152|536602662|FG003|Overall Study|Protocol Violation|2|||
148762237|NCT03103152|536602663|FG004|Overall Study|Protocol Violation|1|||
148762238|NCT03103152|536602664|FG005|Overall Study|Protocol Violation|1|||
148762239|NCT03103152|536602659|FG000|Overall Study|Inter-current illness|0|||
148762240|NCT03103152|536602660|FG001|Overall Study|Inter-current illness|0|||
148762241|NCT03103152|536602661|FG002|Overall Study|Inter-current illness|1|||
148762242|NCT03103152|536602662|FG003|Overall Study|Inter-current illness|0|||
148762243|NCT03103152|536602663|FG004|Overall Study|Inter-current illness|0|||
149027696|NCT02487446|537578634|FG000|Washout|Withdrawal by Subject|1|||
148826454|NCT01687595|536842075|FG001|Overall Study|Sponsor's decision|0|||
148826455|NCT01687595|536842074|FG000|Overall Study|Noncompliance|1|||
148826456|NCT01687595|536842075|FG001|Overall Study|Noncompliance|2|||
148826457|NCT01687595|536842074|FG000|Overall Study|Other than specified|56|||
148826458|NCT01687595|536842075|FG001|Overall Study|Other than specified|7|||
148826459|NCT03211832|536842080|FG000|Overall Study|No longer with agency|32|||
148762244|NCT03103152|536602664|FG005|Overall Study|Inter-current illness|0|||
148762245|NCT03103152|536602659|FG000|Overall Study|Death|0|||
148762246|NCT03103152|536602660|FG001|Overall Study|Death|1|||
148762247|NCT03103152|536602661|FG002|Overall Study|Death|0|||
148762248|NCT03103152|536602662|FG003|Overall Study|Death|0|||
148762249|NCT03103152|536602663|FG004|Overall Study|Death|0|||
148762250|NCT03103152|536602664|FG005|Overall Study|Death|0|||
148762251|NCT03103152|536602659|FG000|Overall Study|Adverse Event|0|||
148762252|NCT03103152|536602660|FG001|Overall Study|Adverse Event|0|||
148762253|NCT03103152|536602661|FG002|Overall Study|Adverse Event|1|||
148762254|NCT03103152|536602662|FG003|Overall Study|Adverse Event|0|||
148762255|NCT03103152|536602663|FG004|Overall Study|Adverse Event|0|||
148762256|NCT03103152|536602664|FG005|Overall Study|Adverse Event|1|||
148762257|NCT03103152|536602659|FG000|Overall Study|Withdrawal by Subject|1|||
148762258|NCT03103152|536602660|FG001|Overall Study|Withdrawal by Subject|0|||
148762259|NCT03103152|536602661|FG002|Overall Study|Withdrawal by Subject|1|||
148762260|NCT03103152|536602662|FG003|Overall Study|Withdrawal by Subject|1|||
148762261|NCT03103152|536602663|FG004|Overall Study|Withdrawal by Subject|1|||
148762262|NCT03103152|536602664|FG005|Overall Study|Withdrawal by Subject|1|||
148762263|NCT03103152|536602659|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
148762264|NCT03103152|536602660|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
148762265|NCT03103152|536602661|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
148762266|NCT03103152|536602662|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
148762267|NCT03103152|536602663|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
148762268|NCT03103152|536602664|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
148762269|NCT03103152|536602659|FG000|Overall Study|Unacceptable side effects|0|||
148762270|NCT03103152|536602660|FG001|Overall Study|Unacceptable side effects|0|||
148762271|NCT03103152|536602661|FG002|Overall Study|Unacceptable side effects|0|||
148762272|NCT03103152|536602662|FG003|Overall Study|Unacceptable side effects|0|||
148762273|NCT03103152|536602663|FG004|Overall Study|Unacceptable side effects|0|||
148762274|NCT03103152|536602664|FG005|Overall Study|Unacceptable side effects|1|||
148762275|NCT03103152|536602659|FG000|Overall Study|Lost to Follow-up|0|||
148762276|NCT03103152|536602660|FG001|Overall Study|Lost to Follow-up|1|||
148762277|NCT03103152|536602661|FG002|Overall Study|Lost to Follow-up|0|||
148762278|NCT03103152|536602662|FG003|Overall Study|Lost to Follow-up|1|||
148762279|NCT03103152|536602663|FG004|Overall Study|Lost to Follow-up|0|||
148762280|NCT03103152|536602664|FG005|Overall Study|Lost to Follow-up|1|||
148762281|NCT03103152|536602659|FG000|Overall Study|Testicular pain|0|||
148762282|NCT03103152|536602660|FG001|Overall Study|Testicular pain|0|||
148762283|NCT03103152|536602661|FG002|Overall Study|Testicular pain|0|||
148762284|NCT03103152|536602662|FG003|Overall Study|Testicular pain|1|||
148762285|NCT03103152|536602663|FG004|Overall Study|Testicular pain|0|||
148762286|NCT03103152|536602664|FG005|Overall Study|Testicular pain|0|||
148762287|NCT03474965|536602665|FG000|Overall Study|Pregnancy|1|||
148762288|NCT03474965|536602666|FG001|Overall Study|Pregnancy|0|||
148762289|NCT03474965|536602667|FG002|Overall Study|Pregnancy|0|||
148762290|NCT03474965|536602668|FG003|Overall Study|Pregnancy|0|||
148762291|NCT03474965|536602665|FG000|Overall Study|Lost to Follow-up|0|||
148762292|NCT03474965|536602666|FG001|Overall Study|Lost to Follow-up|0|||
148762293|NCT03474965|536602667|FG002|Overall Study|Lost to Follow-up|1|||
148762294|NCT03474965|536602668|FG003|Overall Study|Lost to Follow-up|0|||
148762295|NCT03474965|536602665|FG000|Overall Study|Death|1|||
148762296|NCT03474965|536602666|FG001|Overall Study|Death|0|||
148762297|NCT03474965|536602667|FG002|Overall Study|Death|0|||
148762298|NCT03474965|536602668|FG003|Overall Study|Death|0|||
148762299|NCT03474965|536602665|FG000|Overall Study|Adverse Event|1|||
148762300|NCT03474965|536602666|FG001|Overall Study|Adverse Event|0|||
148762301|NCT03474965|536602667|FG002|Overall Study|Adverse Event|0|||
148762302|NCT03474965|536602668|FG003|Overall Study|Adverse Event|1|||
148826460|NCT03211832|536842081|FG001|Overall Study|No longer with agency|49|||
148762303|NCT03474965|536602665|FG000|Overall Study|Physician Decision|3|||
148762304|NCT03474965|536602666|FG001|Overall Study|Physician Decision|1|||
148762305|NCT03474965|536602667|FG002|Overall Study|Physician Decision|2|||
148762306|NCT03474965|536602668|FG003|Overall Study|Physician Decision|0|||
148762307|NCT03474965|536602665|FG000|Overall Study|Participant Decision|7|||
148762308|NCT03474965|536602666|FG001|Overall Study|Participant Decision|0|||
148762309|NCT03474965|536602667|FG002|Overall Study|Participant Decision|1|||
148762310|NCT03474965|536602668|FG003|Overall Study|Participant Decision|0|||
148762311|NCT03474965|536602665|FG000|Overall Study|Guardian Decision|4|||
148762312|NCT03474965|536602666|FG001|Overall Study|Guardian Decision|2|||
148762313|NCT03474965|536602667|FG002|Overall Study|Guardian Decision|7|||
148826461|NCT03211832|536842082|FG002|Overall Study|No longer with agency|30|||
148826462|NCT03211832|536842080|FG000|Overall Study|Declined survey|3|||
148762314|NCT03474965|536602668|FG003|Overall Study|Guardian Decision|2|||
148762315|NCT04659993|536604388|FG000|Overall Study|Withdrawal by Subject|2|||
148762316|NCT04659993|536604388|FG000|Overall Study|Lost to Follow-up|2|||
148762317|NCT03782792|536604389|FG000|Overall Study|Patient left the country|0|||
148762318|NCT03782792|536604390|FG001|Overall Study|Patient left the country|1|||
148762319|NCT03782792|536604389|FG000|Overall Study|Withdrawal by Subject|1|||
148762320|NCT03782792|536604390|FG001|Overall Study|Withdrawal by Subject|2|||
148762321|NCT01295671|536604391|FG000|Overall Study|Lost to Follow-up|4|||
148762322|NCT01295671|536604392|FG001|Overall Study|Lost to Follow-up|6|||
148762323|NCT01295671|536604393|FG002|Overall Study|Lost to Follow-up|3|||
148762324|NCT01295671|536604391|FG000|Overall Study|Withdrawal by Subject|3|||
148762325|NCT01295671|536604392|FG001|Overall Study|Withdrawal by Subject|1|||
148762326|NCT01295671|536604393|FG002|Overall Study|Withdrawal by Subject|0|||
148762327|NCT01436370|536604396|FG000|Overall Study|Lost to Follow-up|0|||
148762328|NCT01436370|536604397|FG001|Overall Study|Lost to Follow-up|0|||
148762329|NCT01436370|536604398|FG002|Overall Study|Lost to Follow-up|0|||
148762330|NCT01436370|536604399|FG003|Overall Study|Lost to Follow-up|0|||
148762331|NCT01436370|536604400|FG004|Overall Study|Lost to Follow-up|1|||
148762332|NCT01436370|536604401|FG005|Overall Study|Lost to Follow-up|0|||
148762333|NCT01436370|536604402|FG006|Overall Study|Lost to Follow-up|0|||
148762334|NCT01436370|536604403|FG007|Overall Study|Lost to Follow-up|0|||
148762335|NCT02395848|536604404|FG000|Overall Study|Lost to Follow-up|2|||
148762336|NCT01754129|536604405|FG000|Overall Study|Death|13|||
148762337|NCT01754129|536604405|FG000|Overall Study|Duodopa discontinuation|9|||
148762338|NCT01754129|536604405|FG000|Overall Study|Lost to Follow-up|7|||
148762339|NCT01754129|536604405|FG000|Overall Study|Withdrew consent|1|||
148762340|NCT01754129|536604405|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
148762341|NCT02276560|536604406|FG000|Overall Study|Adverse Event|1|||
148762342|NCT02276560|536604407|FG001|Overall Study|Adverse Event|0|||
148762343|NCT02276560|536604408|FG002|Overall Study|Adverse Event|0|||
148762344|NCT02027545|536604416|FG000|Overall Study|Failed to sign HIPAA|0|||
148762345|NCT02027545|536604417|FG001|Overall Study|Failed to sign HIPAA|2|||
148762346|NCT02027545|536604416|FG000|Overall Study|Failed to attend study visit|2|||
148762347|NCT02027545|536604417|FG001|Overall Study|Failed to attend study visit|0|||
148762348|NCT02027545|536604416|FG000|Overall Study|Protocol Violation|1|||
148762349|NCT02027545|536604417|FG001|Overall Study|Protocol Violation|0|||
148762350|NCT02727478|536604420|FG000|Overall Study|Withdrawal by Subject|8|||
148762351|NCT02727478|536604421|FG001|Overall Study|Withdrawal by Subject|10|||
148762352|NCT02633293|536604422|FG000|Overall Study|Death|56|||
148762353|NCT02633293|536604422|FG000|Overall Study|Progressive Disease|12|||
148762354|NCT02633293|536604422|FG000|Overall Study|Adverse Event|29|||
148762355|NCT02633293|536604422|FG000|Overall Study|Withdrawal by Subject|41|||
148762356|NCT02633293|536604422|FG000|Overall Study|Protocol Violation|1|||
148762357|NCT02633293|536604422|FG000|Overall Study|Lost to Follow-up|1|||
148762358|NCT02633293|536604422|FG000|Overall Study|Study Terminated by Sponsor|24|||
148762359|NCT02633293|536604422|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
148762360|NCT02633293|536604422|FG000|Overall Study|Lung Transplant|5|||
148762361|NCT02633293|536604422|FG000|Overall Study|Lack of Efficacy|2|||
148762362|NCT02633293|536604422|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
148762363|NCT00778817|536604423|FG000|Overall Study|Adverse Event|2|||
148762364|NCT00778817|536604423|FG000|Overall Study|Withdrawal by Subject|2|||
148762365|NCT01418378|536604424|FG000|Overall Study|Death|1|||
148762366|NCT01418378|536604425|FG001|Overall Study|Death|2|||
148762367|NCT01418378|536604424|FG000|Overall Study|Physician Decision|0|||
148762368|NCT01418378|536604425|FG001|Overall Study|Physician Decision|1|||
148762369|NCT01418378|536604424|FG000|Overall Study|ligament imbalance|0|||
148762370|NCT01418378|536604425|FG001|Overall Study|ligament imbalance|1|||
148762371|NCT01418378|536604424|FG000|Overall Study|developed chronic myopathy|0|||
148762372|NCT01418378|536604425|FG001|Overall Study|developed chronic myopathy|1|||
148762373|NCT03150719|536604426|FG000|Overall Study|Adverse Event|0|||
148762374|NCT03150719|536604427|FG001|Overall Study|Adverse Event|1|||
148762375|NCT03150719|536604426|FG000|Overall Study|Death|0|||
148762376|NCT03150719|536604427|FG001|Overall Study|Death|1|||
148762377|NCT03150719|536604426|FG000|Overall Study|Other|1|||
148826463|NCT03211832|536842081|FG001|Overall Study|Declined survey|3|||
148762378|NCT03150719|536604427|FG001|Overall Study|Other|0|||
148762379|NCT01790984|536604428|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
148762380|NCT01790984|536604429|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
148762381|NCT01790984|536604430|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
148762382|NCT01790984|536604431|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
148826464|NCT03211832|536842082|FG002|Overall Study|Declined survey|2|||
148762383|NCT01051791|536604434|FG000|Overall Study|Failed screening|3|||
148762384|NCT01051791|536604434|FG000|Overall Study|Withdrawal by Subject|1|||
148762385|NCT00288626|536604439|FG000|Overall Study|Death|3|||
148762386|NCT00288626|536604439|FG000|Overall Study|Withdrawal by Subject|4|||
148762387|NCT01372618|536604442|FG000|Overall Study|PI Died. Study Terminated|9|||
148762388|NCT04610346|536604445|FG000|Overall Study|Withdrawal by Subject|1|||
148762389|NCT04610346|536604446|FG001|Overall Study|Withdrawal by Subject|1|||
148826465|NCT03211832|536842080|FG000|Overall Study|Not available during data collection|1|||
148762390|NCT04610346|536604445|FG000|Overall Study|did not complete shelter onboarding|2|||
148762391|NCT04610346|536604446|FG001|Overall Study|did not complete shelter onboarding|1|||
148762392|NCT01081769|536604450|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
148762393|NCT01081769|536604451|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
148762394|NCT01081769|536604450|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
148762395|NCT01081769|536604451|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
148762396|NCT01081769|536604450|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
148826466|NCT03211832|536842081|FG001|Overall Study|Not available during data collection|0|||
148826467|NCT03211832|536842082|FG002|Overall Study|Not available during data collection|2|||
148826468|NCT01514422|536842087|FG000|Overall Study|Lost to Follow-up|1|||
148826469|NCT03511209|536842088|FG000|Overall Study|Withdrawal by Subject|2|||
148762397|NCT01081769|536604451|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
148762398|NCT01081769|536604450|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
148762399|NCT01081769|536604451|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
148762400|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Adverse Event|14|||
148762401|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Adverse Event|11|||
148762402|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Death|1|||
148762403|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Death|1|||
148762404|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
148762405|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
148762406|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
148762407|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
148762408|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Pregnancy|1|||
148762409|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Pregnancy|0|||
148762410|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
148762411|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
148762412|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
148762413|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
148762414|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Other|0|||
148762415|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Other|1|||
148762416|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Ineligibility|3|||
148762417|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Ineligibility|4|||
148762418|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
148762419|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
148762420|NCT01081769|536604450|FG000|CORE Intent-To-Treat|Patient Moved|2|||
148762421|NCT01081769|536604451|FG001|CORE Intent-To-Treat|Patient Moved|2|||
148762422|NCT00558467|536604452|FG000|Overall Study|Adverse Event|1|||
148762423|NCT00558467|536604453|FG001|Overall Study|Adverse Event|2|||
148762424|NCT00558467|536604452|FG000|Overall Study|Lack of Efficacy|0|||
148762425|NCT00558467|536604453|FG001|Overall Study|Lack of Efficacy|1|||
148762426|NCT00558467|536604452|FG000|Overall Study|Patient moving out of state|0|||
148762427|NCT00558467|536604453|FG001|Overall Study|Patient moving out of state|1|||
148762428|NCT00507455|536604454|FG000|Overall Study|Adverse Event|3|||
148762429|NCT00507455|536604455|FG001|Overall Study|Adverse Event|3|||
148762430|NCT00507455|536604456|FG002|Overall Study|Adverse Event|6|||
148762431|NCT00507455|536604454|FG000|Overall Study|Withdrawal by Subject|2|||
148762432|NCT00507455|536604455|FG001|Overall Study|Withdrawal by Subject|1|||
148762433|NCT00507455|536604456|FG002|Overall Study|Withdrawal by Subject|2|||
148762434|NCT00507455|536604454|FG000|Overall Study|Protocol Violation|4|||
148762435|NCT00507455|536604455|FG001|Overall Study|Protocol Violation|1|||
148762436|NCT00507455|536604456|FG002|Overall Study|Protocol Violation|1|||
148762437|NCT00507455|536604454|FG000|Overall Study|Lost to Follow-up|2|||
148762438|NCT00507455|536604455|FG001|Overall Study|Lost to Follow-up|0|||
148826470|NCT03511209|536842089|FG001|Overall Study|Withdrawal by Subject|4|||
148826471|NCT03511209|536842088|FG000|Overall Study|Death|1|||
148826472|NCT03511209|536842089|FG001|Overall Study|Death|0|||
148826473|NCT03511209|536842088|FG000|Overall Study|Lost to Follow-up|0|||
148826474|NCT03511209|536842089|FG001|Overall Study|Lost to Follow-up|2|||
148826475|NCT00215657|536842095|FG000|Overall Study|Adverse Event|5|||
148762439|NCT00507455|536604456|FG002|Overall Study|Lost to Follow-up|2|||
148762440|NCT00507455|536604454|FG000|Overall Study|Lack of Efficacy|0|||
148762441|NCT00507455|536604455|FG001|Overall Study|Lack of Efficacy|1|||
148762442|NCT00507455|536604456|FG002|Overall Study|Lack of Efficacy|0|||
148762443|NCT00507455|536604454|FG000|Overall Study|Other - miscellaneous reason|1|||
148826476|NCT00215657|536842096|FG001|Overall Study|Adverse Event|1|||
148826477|NCT00215657|536842097|FG002|Overall Study|Adverse Event|3|||
148762444|NCT00507455|536604455|FG001|Overall Study|Other - miscellaneous reason|0|||
148826478|NCT00215657|536842098|FG003|Overall Study|Adverse Event|0|||
148762445|NCT00507455|536604456|FG002|Overall Study|Other - miscellaneous reason|1|||
148826479|NCT00215657|536842099|FG004|Overall Study|Adverse Event|3|||
148826480|NCT00215657|536842100|FG005|Overall Study|Adverse Event|1|||
148826481|NCT00215657|536842101|FG006|Overall Study|Adverse Event|0|||
148762446|NCT00931255|536604457|FG000|Overall Study|Follow up biopsy not done|2|||
148762447|NCT00931255|536604458|FG001|Overall Study|Follow up biopsy not done|3|||
148977518|NCT03892889|537398334|FG000|Overall Study|Withdrawal by Subject|50|||
148977519|NCT03892889|537398334|FG000|Overall Study|Withdrawal by Caregiver|1|||
148977520|NCT03892889|537398334|FG000|Overall Study|Study Terminated by Sponsor|50|||
148762448|NCT01372995|536604459|FG000|Overall Study|Spouse withdrew participant from study|0|||
148977521|NCT03892889|537398334|FG000|Overall Study|Physician Decision|8|||
148977522|NCT03892889|537398334|FG000|Overall Study|Reason not Specified|5|||
148977523|NCT02066298|537398335|FG000|Overall Study|Lost to Follow-up|3|||
148977524|NCT02066298|537398336|FG001|Overall Study|Lost to Follow-up|2|||
148977525|NCT02066298|537398337|FG002|Overall Study|Lost to Follow-up|3|||
148977526|NCT02066298|537398338|FG003|Overall Study|Lost to Follow-up|2|||
148977527|NCT02066298|537398339|FG004|Overall Study|Lost to Follow-up|3|||
148977528|NCT02066298|537398340|FG005|Overall Study|Lost to Follow-up|4|||
148977529|NCT02066298|537398335|FG000|Overall Study|Withdrawal by Subject|6|||
148977530|NCT02066298|537398336|FG001|Overall Study|Withdrawal by Subject|6|||
148977531|NCT02066298|537398337|FG002|Overall Study|Withdrawal by Subject|6|||
148977532|NCT02066298|537398338|FG003|Overall Study|Withdrawal by Subject|4|||
148977533|NCT02066298|537398339|FG004|Overall Study|Withdrawal by Subject|5|||
148977534|NCT02066298|537398340|FG005|Overall Study|Withdrawal by Subject|8|||
148977535|NCT02066298|537398335|FG000|Overall Study|Physician Decision|0|||
148977536|NCT02066298|537398336|FG001|Overall Study|Physician Decision|0|||
148977537|NCT02066298|537398337|FG002|Overall Study|Physician Decision|1|||
148977538|NCT02066298|537398338|FG003|Overall Study|Physician Decision|0|||
148977539|NCT02066298|537398339|FG004|Overall Study|Physician Decision|1|||
148977540|NCT02066298|537398340|FG005|Overall Study|Physician Decision|0|||
148977541|NCT00630877|537398343|FG000|Overall Study|Adverse Event|11|||
148977542|NCT00630877|537398344|FG001|Overall Study|Adverse Event|8|||
148977543|NCT00630877|537398345|FG002|Overall Study|Adverse Event|7|||
148977544|NCT00630877|537398343|FG000|Overall Study|Withdrawal by Subject|3|||
148977545|NCT00630877|537398344|FG001|Overall Study|Withdrawal by Subject|4|||
148977546|NCT00630877|537398345|FG002|Overall Study|Withdrawal by Subject|0|||
148977547|NCT00630877|537398343|FG000|Overall Study|Lost to Follow-up|2|||
148977548|NCT00630877|537398344|FG001|Overall Study|Lost to Follow-up|0|||
148977549|NCT00630877|537398345|FG002|Overall Study|Lost to Follow-up|0|||
148977550|NCT00630877|537398343|FG000|Overall Study|Noncompliance|2|||
148977551|NCT00630877|537398344|FG001|Overall Study|Noncompliance|3|||
148977552|NCT00630877|537398345|FG002|Overall Study|Noncompliance|1|||
148977553|NCT00630877|537398343|FG000|Overall Study|Protocol violation|1|||
148977554|NCT00630877|537398344|FG001|Overall Study|Protocol violation|0|||
148977555|NCT00630877|537398345|FG002|Overall Study|Protocol violation|1|||
148762449|NCT01372995|536604460|FG001|Overall Study|Spouse withdrew participant from study|1|||
148762450|NCT01372995|536604461|FG002|Overall Study|Spouse withdrew participant from study|0|||
148762451|NCT01372995|536604459|FG000|Overall Study|Physician Decision|0|||
148762452|NCT01372995|536604460|FG001|Overall Study|Physician Decision|0|||
148762453|NCT01372995|536604461|FG002|Overall Study|Physician Decision|1|||
148762454|NCT01297517|536604468|FG000|Overall Study|Adverse Event|21|||
148762455|NCT01297517|536604469|FG001|Overall Study|Adverse Event|7|||
148762456|NCT01297517|536604470|FG002|Overall Study|Adverse Event|16|||
148762457|NCT01297517|536604468|FG000|Overall Study|Lost to Follow-up|1|||
148762458|NCT01297517|536604469|FG001|Overall Study|Lost to Follow-up|0|||
148762459|NCT01297517|536604470|FG002|Overall Study|Lost to Follow-up|1|||
148762460|NCT01297517|536604468|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
148762461|NCT01297517|536604469|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
148762462|NCT01297517|536604470|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
148762463|NCT01297517|536604468|FG000|Overall Study|Noncompliance|1|||
148762464|NCT01297517|536604469|FG001|Overall Study|Noncompliance|0|||
148762465|NCT01297517|536604470|FG002|Overall Study|Noncompliance|0|||
148762466|NCT01297517|536604468|FG000|Overall Study|Protocol Violation|1|||
148762467|NCT01297517|536604469|FG001|Overall Study|Protocol Violation|1|||
148977556|NCT00630877|537398343|FG000|Overall Study|Personal reasons|0|||
148977557|NCT00630877|537398344|FG001|Overall Study|Personal reasons|0|||
148977558|NCT00630877|537398345|FG002|Overall Study|Personal reasons|1|||
148977559|NCT02343458|537398349|FG000|Overall Study|Adverse Event|15|||
148977560|NCT02343458|537398350|FG001|Overall Study|Adverse Event|14|||
148977561|NCT02343458|537398351|FG002|Overall Study|Adverse Event|15|||
148977562|NCT02343458|537398352|FG003|Overall Study|Adverse Event|3|||
148977563|NCT02343458|537398349|FG000|Overall Study|Lack of Efficacy|3|||
148977564|NCT02343458|537398350|FG001|Overall Study|Lack of Efficacy|8|||
148977565|NCT02343458|537398351|FG002|Overall Study|Lack of Efficacy|4|||
148977566|NCT02343458|537398352|FG003|Overall Study|Lack of Efficacy|8|||
148977567|NCT02343458|537398349|FG000|Overall Study|Withdrawal by Subject|18|||
149027697|NCT02487446|537578635|FG001|Washout|Withdrawal by Subject|4|||
148762468|NCT01297517|536604470|FG002|Overall Study|Protocol Violation|1|||
148762469|NCT01297517|536604468|FG000|Overall Study|Inadequate Control of IOP|1|||
148977568|NCT02343458|537398350|FG001|Overall Study|Withdrawal by Subject|17|||
148977569|NCT02343458|537398351|FG002|Overall Study|Withdrawal by Subject|23|||
148977570|NCT02343458|537398352|FG003|Overall Study|Withdrawal by Subject|14|||
148977571|NCT02343458|537398349|FG000|Overall Study|Physician Decision|1|||
148977572|NCT02343458|537398350|FG001|Overall Study|Physician Decision|4|||
148977573|NCT02343458|537398351|FG002|Overall Study|Physician Decision|2|||
148826482|NCT00215657|536842102|FG007|Overall Study|Adverse Event|3|||
148826483|NCT00215657|536842095|FG000|Overall Study|Withdrawal by Subject|6|||
148826484|NCT00215657|536842096|FG001|Overall Study|Withdrawal by Subject|3|||
148826485|NCT00215657|536842097|FG002|Overall Study|Withdrawal by Subject|3|||
148762470|NCT01297517|536604469|FG001|Overall Study|Inadequate Control of IOP|1|||
148762471|NCT01297517|536604470|FG002|Overall Study|Inadequate Control of IOP|2|||
148826486|NCT00215657|536842098|FG003|Overall Study|Withdrawal by Subject|1|||
148826487|NCT00215657|536842099|FG004|Overall Study|Withdrawal by Subject|6|||
148826488|NCT00215657|536842100|FG005|Overall Study|Withdrawal by Subject|1|||
148826489|NCT00215657|536842101|FG006|Overall Study|Withdrawal by Subject|10|||
148826490|NCT00215657|536842102|FG007|Overall Study|Withdrawal by Subject|3|||
148826491|NCT00215657|536842095|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
148826492|NCT00215657|536842096|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
148826493|NCT00215657|536842097|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
148826494|NCT00215657|536842098|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
148826495|NCT00215657|536842099|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
148826496|NCT00215657|536842100|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
148826497|NCT00215657|536842101|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
148826498|NCT00215657|536842102|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
148826499|NCT00215657|536842095|FG000|Overall Study|Insufficient testosterone response|5|||
148826500|NCT00215657|536842096|FG001|Overall Study|Insufficient testosterone response|4|||
148826501|NCT00215657|536842097|FG002|Overall Study|Insufficient testosterone response|1|||
148826502|NCT00215657|536842098|FG003|Overall Study|Insufficient testosterone response|12|||
148826503|NCT00215657|536842099|FG004|Overall Study|Insufficient testosterone response|8|||
148826504|NCT00215657|536842100|FG005|Overall Study|Insufficient testosterone response|12|||
148826505|NCT00215657|536842101|FG006|Overall Study|Insufficient testosterone response|4|||
148826506|NCT00215657|536842102|FG007|Overall Study|Insufficient testosterone response|7|||
148762472|NCT01609296|536604471|FG000|Overall Study|Death|253|||
148762473|NCT01609296|536604471|FG000|Overall Study|Withdrawal by Subject|151|||
148762474|NCT01609296|536604471|FG000|Overall Study|Lost to Follow-up|21|||
148762475|NCT01609296|536604471|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
148762476|NCT01609296|536604471|FG000|Overall Study|missed visit but known to be alive|28|||
148762477|NCT00386360|536604472|FG000|Overall Study|Adverse Event|4|||
148762478|NCT00386360|536604473|FG001|Overall Study|Adverse Event|2|||
148762479|NCT00386360|536604472|FG000|Overall Study|Physician Decision|2|||
148762480|NCT00386360|536604473|FG001|Overall Study|Physician Decision|2|||
148762481|NCT00386360|536604472|FG000|Overall Study|Lost to Follow-up|0|||
148762482|NCT00386360|536604473|FG001|Overall Study|Lost to Follow-up|2|||
148762483|NCT00386360|536604472|FG000|Overall Study|Protocol Violation|0|||
148762484|NCT00386360|536604473|FG001|Overall Study|Protocol Violation|3|||
148762485|NCT00386360|536604472|FG000|Overall Study|Withdrawal by Subject|3|||
148762486|NCT00386360|536604473|FG001|Overall Study|Withdrawal by Subject|6|||
148762487|NCT00386360|536604472|FG000|Overall Study|Did not take any study medication|0|||
148762488|NCT00386360|536604473|FG001|Overall Study|Did not take any study medication|2|||
148762489|NCT00789373|536604476|FG000|Induction|Adverse Event|64|||
148762490|NCT00789373|536604477|FG001|Induction|Adverse Event|0|||
148762491|NCT00789373|536604478|FG002|Induction|Adverse Event|0|||
148762492|NCT00789373|536604476|FG000|Induction|Death Due to study disease|24|||
148762493|NCT00789373|536604477|FG001|Induction|Death Due to study disease|0|||
148762494|NCT00789373|536604478|FG002|Induction|Death Due to study disease|0|||
148762495|NCT00789373|536604476|FG000|Induction|Death due to adverse event|19|||
148762496|NCT00789373|536604477|FG001|Induction|Death due to adverse event|0|||
148762497|NCT00789373|536604478|FG002|Induction|Death due to adverse event|0|||
148762498|NCT00789373|536604476|FG000|Induction|Death due to toxicity|11|||
148762499|NCT00789373|536604477|FG001|Induction|Death due to toxicity|0|||
148762500|NCT00789373|536604478|FG002|Induction|Death due to toxicity|0|||
148762501|NCT00789373|536604476|FG000|Induction|Death due to procedure|1|||
148762502|NCT00789373|536604477|FG001|Induction|Death due to procedure|0|||
148762503|NCT00789373|536604478|FG002|Induction|Death due to procedure|0|||
148762504|NCT00789373|536604476|FG000|Induction|Investigator decision|7|||
148762505|NCT00789373|536604477|FG001|Induction|Investigator decision|0|||
148762506|NCT00789373|536604478|FG002|Induction|Investigator decision|0|||
148826507|NCT00215657|536842095|FG000|Overall Study|Other|3|||
148826508|NCT00215657|536842096|FG001|Overall Study|Other|1|||
148826509|NCT00215657|536842097|FG002|Overall Study|Other|2|||
148826510|NCT00215657|536842098|FG003|Overall Study|Other|3|||
148762507|NCT00789373|536604476|FG000|Induction|Protocol entry criteria not met|9|||
148762508|NCT00789373|536604477|FG001|Induction|Protocol entry criteria not met|0|||
148826511|NCT00215657|536842099|FG004|Overall Study|Other|5|||
148826512|NCT00215657|536842100|FG005|Overall Study|Other|4|||
148762509|NCT00789373|536604478|FG002|Induction|Protocol entry criteria not met|0|||
148762510|NCT00789373|536604476|FG000|Induction|Lost to Follow-up|6|||
148762511|NCT00789373|536604477|FG001|Induction|Lost to Follow-up|0|||
148762512|NCT00789373|536604478|FG002|Induction|Lost to Follow-up|0|||
148762513|NCT00789373|536604476|FG000|Induction|Protocol Violation|1|||
148762514|NCT00789373|536604477|FG001|Induction|Protocol Violation|0|||
148762515|NCT00789373|536604478|FG002|Induction|Protocol Violation|0|||
148762516|NCT00789373|536604476|FG000|Induction|Progressive Disease|220|||
148762517|NCT00789373|536604477|FG001|Induction|Progressive Disease|0|||
148762518|NCT00789373|536604478|FG002|Induction|Progressive Disease|0|||
148762519|NCT00789373|536604476|FG000|Induction|Withdrawal by Subject|37|||
148762520|NCT00789373|536604477|FG001|Induction|Withdrawal by Subject|0|||
148762521|NCT00789373|536604478|FG002|Induction|Withdrawal by Subject|0|||
148762522|NCT00789373|536604476|FG000|Maintenance|Adverse Event|0|||
148762523|NCT00789373|536604477|FG001|Maintenance|Adverse Event|65|||
148762524|NCT00789373|536604478|FG002|Maintenance|Adverse Event|12|||
148762525|NCT00789373|536604476|FG000|Maintenance|Death due to study disease|0|||
148762526|NCT00789373|536604477|FG001|Maintenance|Death due to study disease|3|||
148762527|NCT00789373|536604478|FG002|Maintenance|Death due to study disease|1|||
148762528|NCT00789373|536604476|FG000|Maintenance|Death due to adverse event|0|||
148762529|NCT00789373|536604477|FG001|Maintenance|Death due to adverse event|4|||
148762530|NCT00789373|536604478|FG002|Maintenance|Death due to adverse event|1|||
148762531|NCT00789373|536604476|FG000|Maintenance|Death due to toxicity|0|||
148762532|NCT00789373|536604477|FG001|Maintenance|Death due to toxicity|1|||
148762533|NCT00789373|536604478|FG002|Maintenance|Death due to toxicity|2|||
148762534|NCT00789373|536604476|FG000|Maintenance|Investigator Decision|0|||
148762535|NCT00789373|536604477|FG001|Maintenance|Investigator Decision|4|||
148762536|NCT00789373|536604478|FG002|Maintenance|Investigator Decision|2|||
148762537|NCT00789373|536604476|FG000|Maintenance|Protocol entry criteria not met|0|||
148762538|NCT00789373|536604477|FG001|Maintenance|Protocol entry criteria not met|2|||
148762539|NCT00789373|536604478|FG002|Maintenance|Protocol entry criteria not met|0|||
148762540|NCT00789373|536604476|FG000|Maintenance|Lost to Follow-up|0|||
148762541|NCT00789373|536604477|FG001|Maintenance|Lost to Follow-up|2|||
148762542|NCT00789373|536604478|FG002|Maintenance|Lost to Follow-up|0|||
148762543|NCT00789373|536604476|FG000|Maintenance|Progressive Disease|0|||
148762544|NCT00789373|536604477|FG001|Maintenance|Progressive Disease|253|||
148762545|NCT00789373|536604478|FG002|Maintenance|Progressive Disease|152|||
148762546|NCT00789373|536604476|FG000|Maintenance|Withdrawal by Subject|0|||
148762547|NCT00789373|536604477|FG001|Maintenance|Withdrawal by Subject|21|||
148762548|NCT00789373|536604478|FG002|Maintenance|Withdrawal by Subject|8|||
148762549|NCT00789373|536604476|FG000|Maintenance|Sponsor Decision|0|||
148762550|NCT00789373|536604477|FG001|Maintenance|Sponsor Decision|0|||
148762551|NCT00789373|536604478|FG002|Maintenance|Sponsor Decision|2|||
148762552|NCT00789373|536604476|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
148762553|NCT00789373|536604477|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
148762554|NCT00789373|536604478|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
148762555|NCT03363776|536604484|FG000|Overall Study|Progressive disease|2|||
148762556|NCT03363776|536604485|FG001|Overall Study|Progressive disease|3|||
148762557|NCT03363776|536604486|FG002|Overall Study|Progressive disease|1|||
148762558|NCT03363776|536604484|FG000|Overall Study|Study drug toxicity|0|||
148762559|NCT03363776|536604485|FG001|Overall Study|Study drug toxicity|0|||
148762560|NCT03363776|536604486|FG002|Overall Study|Study drug toxicity|1|||
148762561|NCT03363776|536604484|FG000|Overall Study|Death|1|||
148762562|NCT03363776|536604485|FG001|Overall Study|Death|0|||
148762563|NCT03363776|536604486|FG002|Overall Study|Death|0|||
148762564|NCT04157348|536604487|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
148762565|NCT04157348|536604488|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
148762566|NCT04157348|536604487|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
148762567|NCT04157348|536604488|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
148762568|NCT04157348|536604487|FG000|Double-blind Treatment Period|Adverse Event|0|||
148762569|NCT04157348|536604488|FG001|Double-blind Treatment Period|Adverse Event|1|||
148762570|NCT04157348|536604487|FG000|Open-label Extension Period|Adverse Event|1|||
148762571|NCT04157348|536604488|FG001|Open-label Extension Period|Adverse Event|1|||
148762572|NCT04157348|536604487|FG000|Open-label Extension Period|Death|0|||
148762573|NCT04157348|536604488|FG001|Open-label Extension Period|Death|1|||
148762574|NCT04157348|536604487|FG000|Open-label Extension Period|Lack of Efficacy|2|||
148762575|NCT04157348|536604488|FG001|Open-label Extension Period|Lack of Efficacy|2|||
148762576|NCT04157348|536604487|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
148762577|NCT04157348|536604488|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
148762578|NCT04157348|536604487|FG000|Open-label Extension Period|Ongoing|60|||
148977574|NCT02343458|537398352|FG003|Overall Study|Physician Decision|2|||
148977575|NCT02343458|537398349|FG000|Overall Study|Lost to Follow-up|5|||
148977576|NCT02343458|537398350|FG001|Overall Study|Lost to Follow-up|5|||
148762579|NCT04157348|536604488|FG001|Open-label Extension Period|Ongoing|57|||
148762580|NCT04157348|536604487|FG000|Open-label Extension Period|other reasons|1|||
148762581|NCT04157348|536604488|FG001|Open-label Extension Period|other reasons|1|||
148762582|NCT02527434|536604489|FG000|Overall Study|Lost to Follow-up|2|||
148762583|NCT02527434|536604490|FG001|Overall Study|Lost to Follow-up|2|||
148762584|NCT02527434|536604491|FG002|Overall Study|Lost to Follow-up|0|||
148762585|NCT02527434|536604489|FG000|Overall Study|Death|19|||
148762586|NCT02527434|536604490|FG001|Overall Study|Death|6|||
148762587|NCT02527434|536604491|FG002|Overall Study|Death|17|||
148762588|NCT02527434|536604489|FG000|Overall Study|Withdrawal by Subject|5|||
148977577|NCT02343458|537398351|FG002|Overall Study|Lost to Follow-up|3|||
148762589|NCT02527434|536604490|FG001|Overall Study|Withdrawal by Subject|3|||
148762590|NCT02527434|536604491|FG002|Overall Study|Withdrawal by Subject|3|||
148762591|NCT02527434|536604489|FG000|Overall Study|Reason Not Specified|1|||
148762592|NCT02527434|536604490|FG001|Overall Study|Reason Not Specified|0|||
148762593|NCT02527434|536604491|FG002|Overall Study|Reason Not Specified|0|||
148762594|NCT02527434|536604489|FG000|Overall Study|Site closure|1|||
148762595|NCT02527434|536604490|FG001|Overall Study|Site closure|0|||
148762596|NCT02527434|536604491|FG002|Overall Study|Site closure|0|||
148762597|NCT00568061|536604492|FG000|Overall Study|Inclusion / exclusion criteria|5|||
148762598|NCT00568061|536604493|FG001|Overall Study|Inclusion / exclusion criteria|1|||
148762599|NCT00568061|536604492|FG000|Overall Study|Adverse Event|0|||
148762600|NCT00568061|536604493|FG001|Overall Study|Adverse Event|1|||
148762601|NCT05027451|536604494|FG000|Overall Study|Lost to Follow-up|1|||
148762602|NCT05027451|536604495|FG001|Overall Study|Lost to Follow-up|1|||
148762603|NCT02693002|536604497|FG000|Overall Study|Withdrawal by Subject|1|||
148762604|NCT02693002|536604498|FG001|Overall Study|Withdrawal by Subject|0|||
148762605|NCT01791894|536604501|FG000|Overall Study|Adverse Event|1|||
148762606|NCT02268916|536604502|FG000|Overall Study|Lost to Follow-up|1|||
148762607|NCT02268916|536604503|FG001|Overall Study|Lost to Follow-up|1|||
148762608|NCT02268916|536604502|FG000|Overall Study|Withdrawal by Subject|6|||
148762609|NCT02268916|536604503|FG001|Overall Study|Withdrawal by Subject|5|||
148762610|NCT02268916|536604502|FG000|Overall Study|Participant did not have diabetes|1|||
148762611|NCT02268916|536604503|FG001|Overall Study|Participant did not have diabetes|0|||
148762612|NCT02268916|536604502|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
148762613|NCT02268916|536604503|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
148762614|NCT00594165|536604504|FG000|Overall Study|Major protocol violation|1|||
148762615|NCT00594165|536604504|FG000|Overall Study|Lack of Efficacy|12|||
148762616|NCT00594165|536604504|FG000|Overall Study|Adverse Event|52|||
148762617|NCT00594165|536604504|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
148762618|NCT00594165|536604504|FG000|Overall Study|Subject withdrew consent|27|||
148762619|NCT00594165|536604504|FG000|Overall Study|Study ended per sponsor|102|||
148762620|NCT00594165|536604504|FG000|Overall Study|Lost to Follow-up|4|||
148762621|NCT00594165|536604504|FG000|Overall Study|Other: PI discretion|5|||
148762622|NCT00594165|536604504|FG000|Overall Study|Other: Subject moving|3|||
148762623|NCT00594165|536604504|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
148762624|NCT00594165|536604504|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
148762625|NCT00594165|536604504|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
148762626|NCT00594165|536604504|FG000|Overall Study|Other: Site terminated participation|2|||
148762627|NCT02062450|536604506|FG000|Overall Study|No follow-up visit|124|||
148762628|NCT02203721|536604507|FG000|Overall Study|Lost to Follow-up|1|||
148762629|NCT02203721|536604508|FG001|Overall Study|Lost to Follow-up|0|||
148762630|NCT02203721|536604507|FG000|Overall Study|Death|0|||
148762631|NCT02203721|536604508|FG001|Overall Study|Death|2|||
148762632|NCT02203721|536604507|FG000|Overall Study|Illness|0|||
148762633|NCT02203721|536604508|FG001|Overall Study|Illness|1|||
148762634|NCT00153179|536604509|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
148762635|NCT00153179|536604510|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
148762636|NCT00153179|536604511|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
148762637|NCT00153179|536604512|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
148762638|NCT02640664|536604517|FG000|Epoch 1|Withdrawal of informed consent|1|||
148762639|NCT02640664|536604518|FG001|Epoch 1|Withdrawal of informed consent|0|||
148762640|NCT02640664|536604519|FG002|Epoch 1|Withdrawal of informed consent|0|||
148762641|NCT02640664|536604517|FG000|Epoch 1|Death|0|||
148762642|NCT02640664|536604518|FG001|Epoch 1|Death|0|||
148762643|NCT02640664|536604519|FG002|Epoch 1|Death|1|||
148762644|NCT02640664|536604517|FG000|Epoch 2|Withdrawal of informed consent|3|||
148762645|NCT02640664|536604518|FG001|Epoch 2|Withdrawal of informed consent|4|||
148762646|NCT02640664|536604519|FG002|Epoch 2|Withdrawal of informed consent|2|||
148762647|NCT02640664|536604517|FG000|Epoch 2|Subject/guardian decision|0|||
148762648|NCT02640664|536604518|FG001|Epoch 2|Subject/guardian decision|2|||
148762649|NCT02640664|536604519|FG002|Epoch 2|Subject/guardian decision|2|||
148762650|NCT02640664|536604517|FG000|Epoch 2|Lost to Follow-up|3|||
148762651|NCT02640664|536604518|FG001|Epoch 2|Lost to Follow-up|4|||
148762652|NCT02640664|536604519|FG002|Epoch 2|Lost to Follow-up|1|||
148826513|NCT00215657|536842101|FG006|Overall Study|Other|6|||
148762653|NCT02640664|536604517|FG000|Epoch 2|Death|0|||
148762654|NCT02640664|536604518|FG001|Epoch 2|Death|0|||
148762655|NCT02640664|536604519|FG002|Epoch 2|Death|1|||
148762656|NCT01408303|536604520|FG000|Overall Study|Adverse Event|3|||
148762657|NCT01408303|536604521|FG001|Overall Study|Adverse Event|7|||
148762658|NCT01408303|536604522|FG002|Overall Study|Adverse Event|2|||
148762659|NCT01408303|536604520|FG000|Overall Study|Lost to Follow-up|0|||
148762660|NCT01408303|536604521|FG001|Overall Study|Lost to Follow-up|1|||
148762661|NCT01408303|536604522|FG002|Overall Study|Lost to Follow-up|2|||
148762662|NCT01408303|536604520|FG000|Overall Study|Withdrawal by Subject|2|||
148762663|NCT01408303|536604521|FG001|Overall Study|Withdrawal by Subject|3|||
148762664|NCT01408303|536604522|FG002|Overall Study|Withdrawal by Subject|1|||
148762665|NCT01408303|536604520|FG000|Overall Study|Protocol Violation|0|||
148977578|NCT02343458|537398352|FG003|Overall Study|Lost to Follow-up|1|||
148977579|NCT02343458|537398349|FG000|Overall Study|Protocol Violation|2|||
148977580|NCT02343458|537398350|FG001|Overall Study|Protocol Violation|5|||
148977581|NCT02343458|537398351|FG002|Overall Study|Protocol Violation|2|||
148762666|NCT01408303|536604521|FG001|Overall Study|Protocol Violation|1|||
148762667|NCT01408303|536604522|FG002|Overall Study|Protocol Violation|0|||
148762668|NCT01408303|536604520|FG000|Overall Study|Noncompliance|1|||
148762669|NCT01408303|536604521|FG001|Overall Study|Noncompliance|0|||
148762670|NCT01408303|536604522|FG002|Overall Study|Noncompliance|1|||
148762671|NCT00669669|536604524|FG000|Overall Study|To late to start treatment|1|||
148762672|NCT03100903|536606163|FG000|Overall Study|Withdrawal by Subject|0|||
148762673|NCT03100903|536606164|FG001|Overall Study|Withdrawal by Subject|0|||
148762674|NCT03100903|536606165|FG002|Overall Study|Withdrawal by Subject|1|||
148762675|NCT03691207|536606166|FG000|Overall Study|Death|41|||
148762676|NCT03691207|536606167|FG001|Overall Study|Death|26|||
148762677|NCT03691207|536606166|FG000|Overall Study|Lost to Follow-up|1|||
148762678|NCT03691207|536606167|FG001|Overall Study|Lost to Follow-up|1|||
148762679|NCT03691207|536606166|FG000|Overall Study|Withdrawal by Subject|2|||
148762680|NCT03691207|536606167|FG001|Overall Study|Withdrawal by Subject|8|||
148762681|NCT03691207|536606166|FG000|Overall Study|Sponsor decision|1|||
148762682|NCT03691207|536606167|FG001|Overall Study|Sponsor decision|7|||
148762683|NCT01134107|536606168|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
148762684|NCT01134107|536606169|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
148762685|NCT01134107|536606168|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
148762686|NCT01134107|536606169|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
148762687|NCT01134107|536606168|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
148762688|NCT01134107|536606169|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
148762689|NCT01134107|536606168|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
148762690|NCT01134107|536606169|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
148762691|NCT01134107|536606168|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
148762692|NCT01134107|536606169|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
148762693|NCT01134107|536606168|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
148762694|NCT01134107|536606169|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
148762695|NCT01134107|536606168|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
148762696|NCT01134107|536606169|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
148762697|NCT00687271|536606171|FG000|Overall Study|Adverse Event|1|||
148762698|NCT00687271|536606172|FG001|Overall Study|Adverse Event|3|||
148762699|NCT00687271|536606173|FG002|Overall Study|Adverse Event|1|||
148762700|NCT00687271|536606174|FG003|Overall Study|Adverse Event|0|||
148762701|NCT00687271|536606171|FG000|Overall Study|Lost to Follow-up|0|||
148762702|NCT00687271|536606172|FG001|Overall Study|Lost to Follow-up|1|||
148762703|NCT00687271|536606173|FG002|Overall Study|Lost to Follow-up|0|||
148762704|NCT00687271|536606174|FG003|Overall Study|Lost to Follow-up|0|||
148762705|NCT00687271|536606171|FG000|Overall Study|Protocol Violation|2|||
148762706|NCT00687271|536606172|FG001|Overall Study|Protocol Violation|1|||
148762707|NCT00687271|536606173|FG002|Overall Study|Protocol Violation|1|||
148762708|NCT00687271|536606174|FG003|Overall Study|Protocol Violation|0|||
148762709|NCT00687271|536606171|FG000|Overall Study|Withdrawal by Subject|0|||
148762710|NCT00687271|536606172|FG001|Overall Study|Withdrawal by Subject|1|||
148762711|NCT00687271|536606173|FG002|Overall Study|Withdrawal by Subject|3|||
148762712|NCT00687271|536606174|FG003|Overall Study|Withdrawal by Subject|0|||
148977582|NCT02343458|537398352|FG003|Overall Study|Protocol Violation|2|||
148977583|NCT02343458|537398349|FG000|Overall Study|Protocol Specified Criteria|17|||
148977584|NCT02343458|537398350|FG001|Overall Study|Protocol Specified Criteria|13|||
148977585|NCT02343458|537398351|FG002|Overall Study|Protocol Specified Criteria|14|||
148977586|NCT02343458|537398352|FG003|Overall Study|Protocol Specified Criteria|8|||
148977587|NCT01913041|537398353|FG000|Overall Study|Protocol Violation|35|||
148977588|NCT01913041|537398353|FG000|Overall Study|Withdrawal by Subject|3|||
148977589|NCT01913041|537398353|FG000|Overall Study|Physician Decision|1|||
148977590|NCT01513317|537398354|FG000|Overall Study|Withdrawal by Subject|15|||
148977591|NCT01513317|537398355|FG001|Overall Study|Withdrawal by Subject|4|||
148977592|NCT01513317|537398354|FG000|Overall Study|Death|1|||
148977593|NCT01513317|537398355|FG001|Overall Study|Death|1|||
148977594|NCT01513317|537398354|FG000|Overall Study|Study terminated by sponsor|18|||
148977595|NCT01513317|537398355|FG001|Overall Study|Study terminated by sponsor|18|||
148762713|NCT04541589|536606177|FG000|Treatment Period|Adverse Event|8|||
148762714|NCT04541589|536606178|FG001|Treatment Period|Adverse Event|2|||
148762715|NCT04541589|536606177|FG000|Treatment Period|Physician Decision|3|||
148762716|NCT04541589|536606178|FG001|Treatment Period|Physician Decision|1|||
148762717|NCT04541589|536606177|FG000|Treatment Period|Subject decision|7|||
148762718|NCT04541589|536606178|FG001|Treatment Period|Subject decision|4|||
148762719|NCT04541589|536606177|FG000|Treatment Period|Withdrawal by Subject|1|||
148977596|NCT01513317|537398354|FG000|Overall Study|Other|0|||
148977597|NCT01513317|537398355|FG001|Overall Study|Other|1|||
148977598|NCT02564198|537398357|FG000|Overall Study|Withdrawal by Subject|2|||
148977599|NCT02564198|537398358|FG001|Overall Study|Withdrawal by Subject|4|||
148977600|NCT02564198|537398359|FG002|Overall Study|Withdrawal by Subject|0|||
148977601|NCT02564198|537398357|FG000|Overall Study|Adverse Event|0|||
148977602|NCT02564198|537398358|FG001|Overall Study|Adverse Event|1|||
148977603|NCT02564198|537398359|FG002|Overall Study|Adverse Event|0|||
148977604|NCT02660359|537398362|FG000|Overall Study|Protocol Deviation|0|||
148977605|NCT02660359|537398363|FG001|Overall Study|Protocol Deviation|0|||
148977606|NCT02660359|537398364|FG002|Overall Study|Protocol Deviation|1|||
148977607|NCT02660359|537398362|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
148762720|NCT04541589|536606178|FG001|Treatment Period|Withdrawal by Subject|0|||
148762721|NCT04541589|536606177|FG000|Safety Follow-up Period|Adverse Event|2|||
148762722|NCT04541589|536606178|FG001|Safety Follow-up Period|Adverse Event|1|||
148762723|NCT04541589|536606177|FG000|Safety Follow-up Period|Physician Decision|1|||
148762724|NCT04541589|536606178|FG001|Safety Follow-up Period|Physician Decision|0|||
148762725|NCT04541589|536606177|FG000|Safety Follow-up Period|Subject decision|5|||
148762726|NCT04541589|536606178|FG001|Safety Follow-up Period|Subject decision|3|||
148762727|NCT04541589|536606177|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
148762728|NCT04541589|536606178|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
148762729|NCT01017874|536606179|FG000|Overall Study|Withdrawal by Subject|23|||
148762730|NCT01017874|536606180|FG001|Overall Study|Withdrawal by Subject|20|||
148762731|NCT01017874|536606179|FG000|Overall Study|Sponsor decision|3|||
148762732|NCT01017874|536606180|FG001|Overall Study|Sponsor decision|1|||
148762733|NCT01017874|536606179|FG000|Overall Study|Lost to Follow-up|3|||
148762734|NCT01017874|536606180|FG001|Overall Study|Lost to Follow-up|2|||
148762735|NCT01017874|536606179|FG000|Overall Study|Physician Decision|1|||
148762736|NCT01017874|536606180|FG001|Overall Study|Physician Decision|3|||
148762737|NCT00808210|536606184|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
148762738|NCT00808210|536606185|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
148762739|NCT00808210|536606184|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
148762740|NCT00808210|536606185|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
148762741|NCT00808210|536606184|FG000|Double-Blind TX Period|Adverse Event|0|||
148762742|NCT00808210|536606185|FG001|Double-Blind TX Period|Adverse Event|1|||
148762743|NCT00808210|536606184|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
148762744|NCT00808210|536606185|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
148762745|NCT00808210|536606184|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
148762746|NCT00808210|536606185|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
148762747|NCT00808210|536606184|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
148762748|NCT00808210|536606185|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
148762749|NCT02356588|536606187|FG000|Overall Study|Lack of Efficacy|4|||
148762750|NCT02356588|536606188|FG001|Overall Study|Lack of Efficacy|10|||
148762751|NCT02356588|536606187|FG000|Overall Study|Adverse Event|0|||
148762752|NCT02356588|536606188|FG001|Overall Study|Adverse Event|2|||
148762753|NCT02356588|536606187|FG000|Overall Study|Withdrawal by Subject|1|||
148762754|NCT02356588|536606188|FG001|Overall Study|Withdrawal by Subject|0|||
148762755|NCT02356588|536606187|FG000|Overall Study|Protocol Violation|0|||
148762756|NCT02356588|536606188|FG001|Overall Study|Protocol Violation|1|||
148762757|NCT01964222|536606194|FG000|Overall Study|Lost to Follow-up|7|||
148762758|NCT01964222|536606195|FG001|Overall Study|Lost to Follow-up|5|||
148762759|NCT01964222|536606194|FG000|Overall Study|Withdrawal by Subject|6|||
148762760|NCT01964222|536606195|FG001|Overall Study|Withdrawal by Subject|6|||
148762761|NCT01964222|536606194|FG000|Overall Study|Screening Failure|2|||
148762762|NCT01964222|536606195|FG001|Overall Study|Screening Failure|0|||
148762763|NCT01019694|536606200|FG000|Overall Study|Adverse Event|12|||
148762764|NCT01019694|536606201|FG001|Overall Study|Adverse Event|16|||
148762765|NCT01019694|536606202|FG002|Overall Study|Adverse Event|19|||
148762766|NCT01019694|536606200|FG000|Overall Study|Protocol Violation|2|||
148762767|NCT01019694|536606201|FG001|Overall Study|Protocol Violation|6|||
148762768|NCT01019694|536606202|FG002|Overall Study|Protocol Violation|4|||
148762769|NCT01019694|536606200|FG000|Overall Study|Lost to Follow-up|5|||
148762770|NCT01019694|536606201|FG001|Overall Study|Lost to Follow-up|3|||
148762771|NCT01019694|536606202|FG002|Overall Study|Lost to Follow-up|3|||
148762772|NCT01019694|536606200|FG000|Overall Study|Withdrawal by Subject|4|||
148762773|NCT01019694|536606201|FG001|Overall Study|Withdrawal by Subject|6|||
148762774|NCT01019694|536606202|FG002|Overall Study|Withdrawal by Subject|12|||
148977608|NCT02660359|537398363|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
148977609|NCT02660359|537398364|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
148977610|NCT02660359|537398362|FG000|Overall Study|Lack of Efficacy|1|||
148762775|NCT01019694|536606200|FG000|Overall Study|Not treated|0|||
148762776|NCT01019694|536606201|FG001|Overall Study|Not treated|2|||
148762777|NCT01019694|536606202|FG002|Overall Study|Not treated|3|||
148762778|NCT01019694|536606200|FG000|Overall Study|Other reason (not specified)|1|||
148762779|NCT01019694|536606201|FG001|Overall Study|Other reason (not specified)|5|||
148977611|NCT02660359|537398363|FG001|Overall Study|Lack of Efficacy|1|||
148977612|NCT02660359|537398364|FG002|Overall Study|Lack of Efficacy|1|||
148977613|NCT02660359|537398362|FG000|Overall Study|Adverse Event|0|||
148977614|NCT02660359|537398363|FG001|Overall Study|Adverse Event|1|||
148826514|NCT00215657|536842102|FG007|Overall Study|Other|1|||
148762780|NCT01019694|536606202|FG002|Overall Study|Other reason (not specified)|6|||
148762781|NCT00026494|536606207|FG000|Overall Study|Withdrawal by Subject|1|||
148762782|NCT00026494|536606208|FG001|Overall Study|Withdrawal by Subject|0|||
148762783|NCT00026494|536606209|FG002|Overall Study|Withdrawal by Subject|1|||
148762784|NCT00026494|536606210|FG003|Overall Study|Withdrawal by Subject|0|||
148762785|NCT00026494|536606207|FG000|Overall Study|Patient non-compliance|1|||
148762786|NCT00026494|536606208|FG001|Overall Study|Patient non-compliance|0|||
148762787|NCT00026494|536606209|FG002|Overall Study|Patient non-compliance|0|||
148762788|NCT00026494|536606210|FG003|Overall Study|Patient non-compliance|0|||
148762789|NCT00026494|536606207|FG000|Overall Study|Patient not treated|0|||
148762790|NCT00026494|536606208|FG001|Overall Study|Patient not treated|0|||
148762791|NCT00026494|536606209|FG002|Overall Study|Patient not treated|2|||
148762792|NCT00026494|536606210|FG003|Overall Study|Patient not treated|0|||
148762793|NCT00026494|536606207|FG000|Overall Study|Clinical progression|0|||
148762794|NCT00026494|536606208|FG001|Overall Study|Clinical progression|0|||
148762795|NCT00026494|536606209|FG002|Overall Study|Clinical progression|3|||
148762796|NCT00026494|536606210|FG003|Overall Study|Clinical progression|0|||
148762797|NCT01455597|536606211|FG000|Overall Study|Adverse Event|7|||
148762798|NCT01455597|536606212|FG001|Overall Study|Adverse Event|0|||
148762799|NCT01455597|536606213|FG002|Overall Study|Adverse Event|5|||
148762800|NCT01455597|536606214|FG003|Overall Study|Adverse Event|1|||
148762801|NCT01455597|536606211|FG000|Overall Study|Lack of Efficacy|0|||
148762802|NCT01455597|536606212|FG001|Overall Study|Lack of Efficacy|1|||
148762803|NCT01455597|536606213|FG002|Overall Study|Lack of Efficacy|2|||
148762804|NCT01455597|536606214|FG003|Overall Study|Lack of Efficacy|0|||
148762805|NCT01455597|536606211|FG000|Overall Study|Lost to Follow-up|3|||
148762806|NCT01455597|536606212|FG001|Overall Study|Lost to Follow-up|0|||
148762807|NCT01455597|536606213|FG002|Overall Study|Lost to Follow-up|2|||
148762808|NCT01455597|536606214|FG003|Overall Study|Lost to Follow-up|1|||
148762809|NCT01455597|536606211|FG000|Overall Study|Withdrew Consent|6|||
148762810|NCT01455597|536606212|FG001|Overall Study|Withdrew Consent|5|||
148762811|NCT01455597|536606213|FG002|Overall Study|Withdrew Consent|8|||
148762812|NCT01455597|536606214|FG003|Overall Study|Withdrew Consent|5|||
148762813|NCT01455597|536606211|FG000|Overall Study|Reason not Specified|1|||
148762814|NCT01455597|536606212|FG001|Overall Study|Reason not Specified|2|||
148762815|NCT01455597|536606213|FG002|Overall Study|Reason not Specified|3|||
148762816|NCT01455597|536606214|FG003|Overall Study|Reason not Specified|3|||
148762817|NCT00441129|536606215|FG000|Overall Study|Withdrawal by Subject|6|||
148762818|NCT00441129|536606216|FG001|Overall Study|Withdrawal by Subject|14|||
148762819|NCT01737710|536606217|FG000|Overall Study|Lost to Follow-up|0|||
148762820|NCT01737710|536606218|FG001|Overall Study|Lost to Follow-up|2|||
148762821|NCT01737710|536606219|FG002|Overall Study|Lost to Follow-up|2|||
148762822|NCT01737710|536606220|FG003|Overall Study|Lost to Follow-up|0|||
148762823|NCT01737710|536606221|FG004|Overall Study|Lost to Follow-up|0|||
148762824|NCT01737710|536606217|FG000|Overall Study|Withdrawal by Subject|1|||
148762825|NCT01737710|536606218|FG001|Overall Study|Withdrawal by Subject|1|||
148762826|NCT01737710|536606219|FG002|Overall Study|Withdrawal by Subject|1|||
148762827|NCT01737710|536606220|FG003|Overall Study|Withdrawal by Subject|0|||
148762828|NCT01737710|536606221|FG004|Overall Study|Withdrawal by Subject|0|||
148762829|NCT01737710|536606217|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
148762830|NCT01737710|536606218|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
148762831|NCT01737710|536606219|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
148762832|NCT01737710|536606220|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
148762833|NCT01737710|536606221|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
148762834|NCT00656292|536606222|FG000|Overall Study|Withdrawal by Subject|2|||
148762835|NCT00656292|536606223|FG001|Overall Study|Withdrawal by Subject|3|||
148826515|NCT00911157|536842103|FG000|Overall Study|Adverse Event|4|||
148977615|NCT02660359|537398364|FG002|Overall Study|Adverse Event|0|||
148977616|NCT02660359|537398362|FG000|Overall Study|Other|2|||
148977617|NCT02660359|537398363|FG001|Overall Study|Other|1|||
148977618|NCT02660359|537398364|FG002|Overall Study|Other|3|||
148762836|NCT00656292|536606222|FG000|Overall Study|Screen failure|1|||
148762837|NCT00656292|536606223|FG001|Overall Study|Screen failure|2|||
148762838|NCT03674112|536606224|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
148762839|NCT03674112|536606225|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
148762840|NCT03674112|536606224|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
148762841|NCT03674112|536606225|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
148762842|NCT03674112|536606224|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
148762843|NCT03674112|536606225|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
148762844|NCT03674112|536606224|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
148762845|NCT03674112|536606225|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
148977619|NCT02660359|537398362|FG000|Overall Study|Withdrawal by Subject|7|||
148977620|NCT02660359|537398363|FG001|Overall Study|Withdrawal by Subject|5|||
148977621|NCT02660359|537398364|FG002|Overall Study|Withdrawal by Subject|8|||
148977622|NCT02660359|537398362|FG000|Overall Study|Lost to Follow-up|3|||
148762846|NCT03674112|536606224|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
148762847|NCT03674112|536606225|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
148762848|NCT03674112|536606224|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
148762849|NCT03674112|536606225|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
148762850|NCT03674112|536606224|FG000|Follow-Up Period (≥3 Years)|Death|2|||
148762851|NCT03674112|536606225|FG001|Follow-Up Period (≥3 Years)|Death|0|||
148762852|NCT03674112|536606224|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
148762853|NCT03674112|536606225|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
148762854|NCT00812981|536606231|FG000|Overall Study|Other|0|||
148762855|NCT00812981|536606232|FG001|Overall Study|Other|1|||
148762856|NCT04666259|536606237|FG000|Treatment Phase|Physician Decision|9|||
148762857|NCT04666259|536606238|FG001|Treatment Phase|Physician Decision|3|||
148762858|NCT04666259|536606239|FG002|Treatment Phase|Physician Decision|3|||
148762859|NCT04666259|536606237|FG000|Treatment Phase|Adverse Event|3|||
148762860|NCT04666259|536606238|FG001|Treatment Phase|Adverse Event|1|||
148762861|NCT04666259|536606239|FG002|Treatment Phase|Adverse Event|0|||
148762862|NCT04666259|536606237|FG000|Treatment Phase|Subject decision|1|||
148762863|NCT04666259|536606238|FG001|Treatment Phase|Subject decision|2|||
148762864|NCT04666259|536606239|FG002|Treatment Phase|Subject decision|0|||
148762865|NCT04666259|536606237|FG000|Treatment Phase|Progressive disease|0|||
148762866|NCT04666259|536606238|FG001|Treatment Phase|Progressive disease|1|||
148762867|NCT04666259|536606239|FG002|Treatment Phase|Progressive disease|0|||
148762868|NCT04666259|536606237|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
148762869|NCT04666259|536606238|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
148762870|NCT04666259|536606239|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
148762871|NCT04666259|536606237|FG000|Safety Follow-up Phase|Physician Decision|2|||
148762872|NCT04666259|536606238|FG001|Safety Follow-up Phase|Physician Decision|0|||
148762873|NCT04666259|536606239|FG002|Safety Follow-up Phase|Physician Decision|0|||
148762874|NCT04666259|536606237|FG000|Safety Follow-up Phase|Subject decision|1|||
148762875|NCT04666259|536606238|FG001|Safety Follow-up Phase|Subject decision|0|||
148762876|NCT04666259|536606239|FG002|Safety Follow-up Phase|Subject decision|0|||
148762877|NCT04666259|536606237|FG000|Safety Follow-up Phase|Death|0|||
148762878|NCT04666259|536606238|FG001|Safety Follow-up Phase|Death|1|||
148762879|NCT04666259|536606239|FG002|Safety Follow-up Phase|Death|0|||
148762880|NCT04178122|536606240|FG000|Overall Study|Withdrawal by Subject|1|||
148762881|NCT04178122|536606241|FG001|Overall Study|Withdrawal by Subject|1|||
148762882|NCT04178122|536606240|FG000|Overall Study|Death|2|||
148762883|NCT04178122|536606241|FG001|Overall Study|Death|0|||
148762884|NCT04178122|536606240|FG000|Overall Study|Did not complete testing|3|||
148762885|NCT04178122|536606241|FG001|Overall Study|Did not complete testing|13|||
148762886|NCT02677922|536606242|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
148762887|NCT02677922|536606243|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
148826516|NCT00911157|536842104|FG001|Overall Study|Adverse Event|1|||
148826517|NCT00911157|536842103|FG000|Overall Study|Withdrawal by Subject|1|||
148826518|NCT00911157|536842104|FG001|Overall Study|Withdrawal by Subject|1|||
148826519|NCT00911157|536842103|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
148826520|NCT00911157|536842104|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
148826521|NCT00911157|536842103|FG000|Overall Study|Need to treat for lung cancer|1|||
148826522|NCT00911157|536842104|FG001|Overall Study|Need to treat for lung cancer|0|||
148826523|NCT04565756|536842105|FG000|Overall Study|Withdrawal by Subject|0|||
148826524|NCT04565756|536842106|FG001|Overall Study|Withdrawal by Subject|0|||
148826525|NCT04565756|536842107|FG002|Overall Study|Withdrawal by Subject|0|||
148826526|NCT04565756|536842108|FG003|Overall Study|Withdrawal by Subject|0|||
148826527|NCT04565756|536842109|FG004|Overall Study|Withdrawal by Subject|1|||
148826528|NCT04565756|536842110|FG005|Overall Study|Withdrawal by Subject|0|||
148826529|NCT04565756|536842105|FG000|Overall Study|Protocol Violation|0|||
148826530|NCT04565756|536842106|FG001|Overall Study|Protocol Violation|0|||
148762888|NCT02677922|536606244|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
148826531|NCT04565756|536842107|FG002|Overall Study|Protocol Violation|0|||
148826532|NCT04565756|536842108|FG003|Overall Study|Protocol Violation|0|||
148826533|NCT04565756|536842109|FG004|Overall Study|Protocol Violation|0|||
148826534|NCT04565756|536842110|FG005|Overall Study|Protocol Violation|1|||
148762889|NCT02677922|536606245|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
148762890|NCT02677922|536606246|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
148762891|NCT02677922|536606247|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
148762892|NCT02677922|536606242|FG000|Treatment Period|Adverse Event|0|||
148762893|NCT02677922|536606243|FG001|Treatment Period|Adverse Event|0|||
148826535|NCT03688139|536842111|FG000|Overall Study|Lost to Follow-up|2|||
148826536|NCT03688139|536842112|FG001|Overall Study|Lost to Follow-up|0|||
148826537|NCT03688139|536842111|FG000|Overall Study|Physician Decision|0|||
148826538|NCT03688139|536842112|FG001|Overall Study|Physician Decision|1|||
148762894|NCT02677922|536606244|FG002|Treatment Period|Adverse Event|1|||
148762895|NCT02677922|536606245|FG003|Treatment Period|Adverse Event|3|||
148762896|NCT02677922|536606246|FG004|Treatment Period|Adverse Event|5|||
148762897|NCT02677922|536606247|FG005|Treatment Period|Adverse Event|2|||
148762898|NCT02677922|536606242|FG000|Treatment Period|Progressive Disease|1|||
148826539|NCT03688139|536842111|FG000|Overall Study|Withdrawal by Subject|2|||
148826540|NCT03688139|536842112|FG001|Overall Study|Withdrawal by Subject|3|||
148826541|NCT00420056|536842113|FG000|Overall Study|Objective progression or relapse|17|||
148826542|NCT01390584|536842115|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
148826543|NCT01390584|536842116|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
148826544|NCT01390584|536842117|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
148826545|NCT02268851|536842118|FG000|Overall Study|Death|0|||
148826546|NCT02268851|536842119|FG001|Overall Study|Death|0|||
148826547|NCT02268851|536842120|FG002|Overall Study|Death|0|||
148826548|NCT02268851|536842121|FG003|Overall Study|Death|1|||
148826549|NCT02268851|536842122|FG004|Overall Study|Death|2|||
148826550|NCT02268851|536842123|FG005|Overall Study|Death|1|||
148826551|NCT02268851|536842118|FG000|Overall Study|Adverse Event|0|||
148826552|NCT02268851|536842119|FG001|Overall Study|Adverse Event|0|||
148826553|NCT02268851|536842120|FG002|Overall Study|Adverse Event|0|||
148826554|NCT02268851|536842121|FG003|Overall Study|Adverse Event|0|||
148826555|NCT02268851|536842122|FG004|Overall Study|Adverse Event|2|||
148826556|NCT02268851|536842123|FG005|Overall Study|Adverse Event|2|||
148826557|NCT02268851|536842118|FG000|Overall Study|Withdrawal by Subject|0|||
148826558|NCT02268851|536842119|FG001|Overall Study|Withdrawal by Subject|0|||
148826559|NCT02268851|536842120|FG002|Overall Study|Withdrawal by Subject|0|||
148826560|NCT02268851|536842121|FG003|Overall Study|Withdrawal by Subject|2|||
148826561|NCT02268851|536842122|FG004|Overall Study|Withdrawal by Subject|0|||
148826562|NCT02268851|536842123|FG005|Overall Study|Withdrawal by Subject|1|||
148826563|NCT02268851|536842118|FG000|Overall Study|Progressive Disease|1|||
148826564|NCT02268851|536842119|FG001|Overall Study|Progressive Disease|3|||
148826565|NCT02268851|536842120|FG002|Overall Study|Progressive Disease|0|||
148826566|NCT02268851|536842121|FG003|Overall Study|Progressive Disease|0|||
148826567|NCT02268851|536842122|FG004|Overall Study|Progressive Disease|1|||
148826568|NCT02268851|536842123|FG005|Overall Study|Progressive Disease|4|||
148826569|NCT02268851|536842118|FG000|Overall Study|Physician Decision|0|||
148826570|NCT02268851|536842119|FG001|Overall Study|Physician Decision|0|||
148826571|NCT02268851|536842120|FG002|Overall Study|Physician Decision|1|||
148826572|NCT02268851|536842121|FG003|Overall Study|Physician Decision|0|||
148826573|NCT02268851|536842122|FG004|Overall Study|Physician Decision|0|||
148826574|NCT02268851|536842123|FG005|Overall Study|Physician Decision|1|||
148826575|NCT02268851|536842118|FG000|Overall Study|Patient Compliance|0|||
148826576|NCT02268851|536842119|FG001|Overall Study|Patient Compliance|0|||
148826577|NCT02268851|536842120|FG002|Overall Study|Patient Compliance|0|||
148826578|NCT02268851|536842121|FG003|Overall Study|Patient Compliance|0|||
148826579|NCT02268851|536842122|FG004|Overall Study|Patient Compliance|1|||
148826580|NCT02268851|536842123|FG005|Overall Study|Patient Compliance|1|||
148826581|NCT02268851|536842118|FG000|Overall Study|Co-Morbid Condition|0|||
148826582|NCT02268851|536842119|FG001|Overall Study|Co-Morbid Condition|0|||
148826583|NCT02268851|536842120|FG002|Overall Study|Co-Morbid Condition|0|||
148826584|NCT02268851|536842121|FG003|Overall Study|Co-Morbid Condition|0|||
148826585|NCT02268851|536842122|FG004|Overall Study|Co-Morbid Condition|1|||
148826586|NCT02268851|536842123|FG005|Overall Study|Co-Morbid Condition|1|||
148826587|NCT03378635|536842124|FG000|Overall Study|Adverse Event|1|||
148826588|NCT03378635|536842125|FG001|Overall Study|Adverse Event|0|||
148826589|NCT03378635|536842126|FG002|Overall Study|Adverse Event|0|||
148826590|NCT03378635|536842124|FG000|Overall Study|Withdrawal by Subject|1|||
148762899|NCT02677922|536606243|FG001|Treatment Period|Progressive Disease|1|||
148762900|NCT02677922|536606244|FG002|Treatment Period|Progressive Disease|0|||
148762901|NCT02677922|536606245|FG003|Treatment Period|Progressive Disease|0|||
148762902|NCT02677922|536606246|FG004|Treatment Period|Progressive Disease|8|||
148762903|NCT02677922|536606247|FG005|Treatment Period|Progressive Disease|7|||
148762904|NCT02677922|536606242|FG000|Treatment Period|Lack of Efficacy|0|||
148762905|NCT02677922|536606243|FG001|Treatment Period|Lack of Efficacy|0|||
148762906|NCT02677922|536606244|FG002|Treatment Period|Lack of Efficacy|0|||
148762907|NCT02677922|536606245|FG003|Treatment Period|Lack of Efficacy|1|||
148762908|NCT02677922|536606246|FG004|Treatment Period|Lack of Efficacy|1|||
148762909|NCT02677922|536606247|FG005|Treatment Period|Lack of Efficacy|6|||
148762910|NCT02677922|536606242|FG000|Treatment Period|Withdrawal by Subject|0|||
148762911|NCT02677922|536606243|FG001|Treatment Period|Withdrawal by Subject|0|||
148826591|NCT03378635|536842125|FG001|Overall Study|Withdrawal by Subject|0|||
148826592|NCT03378635|536842126|FG002|Overall Study|Withdrawal by Subject|0|||
148826593|NCT02539394|536842129|FG000|Overall Study|Protocol Violation|1|||
148826594|NCT02539394|536842130|FG001|Overall Study|Protocol Violation|3|||
148826595|NCT02539394|536842129|FG000|Overall Study|Lost to Follow-up|1|||
148826596|NCT02539394|536842130|FG001|Overall Study|Lost to Follow-up|2|||
148762912|NCT02677922|536606244|FG002|Treatment Period|Withdrawal by Subject|1|||
148762913|NCT02677922|536606245|FG003|Treatment Period|Withdrawal by Subject|3|||
148762914|NCT02677922|536606246|FG004|Treatment Period|Withdrawal by Subject|5|||
148826597|NCT02539394|536842129|FG000|Overall Study|Incomplete dataset|6|||
148826598|NCT02539394|536842130|FG001|Overall Study|Incomplete dataset|6|||
148826599|NCT01197300|536844249|FG000|Overall Study|Lost to Follow-up|0|||
148826600|NCT01197300|536844250|FG001|Overall Study|Lost to Follow-up|1|||
148826601|NCT01197300|536844249|FG000|Overall Study|Protocol Violation|0|||
148826602|NCT01197300|536844250|FG001|Overall Study|Protocol Violation|1|||
148826603|NCT04744831|536844251|FG000|Overall Study|Progressive Disease|31|||
148826604|NCT04744831|536844252|FG001|Overall Study|Progressive Disease|27|||
148826605|NCT04744831|536844253|FG002|Overall Study|Progressive Disease|25|||
148977623|NCT02660359|537398363|FG001|Overall Study|Lost to Follow-up|3|||
148977624|NCT02660359|537398364|FG002|Overall Study|Lost to Follow-up|0|||
148762915|NCT02677922|536606247|FG005|Treatment Period|Withdrawal by Subject|5|||
148762916|NCT02677922|536606242|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
148762917|NCT02677922|536606243|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
148762918|NCT02677922|536606244|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
148762919|NCT02677922|536606245|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
148762920|NCT02677922|536606246|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
148762921|NCT02677922|536606247|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
148762922|NCT02677922|536606242|FG000|Treatment Period|Disease Relapse|0|||
148762923|NCT02677922|536606243|FG001|Treatment Period|Disease Relapse|0|||
148762924|NCT02677922|536606244|FG002|Treatment Period|Disease Relapse|0|||
148762925|NCT02677922|536606245|FG003|Treatment Period|Disease Relapse|3|||
148762926|NCT02677922|536606246|FG004|Treatment Period|Disease Relapse|6|||
148762927|NCT02677922|536606247|FG005|Treatment Period|Disease Relapse|1|||
148762928|NCT02677922|536606242|FG000|Treatment Period|Allogeneic HSCT|1|||
148762929|NCT02677922|536606243|FG001|Treatment Period|Allogeneic HSCT|0|||
148762930|NCT02677922|536606244|FG002|Treatment Period|Allogeneic HSCT|0|||
148762931|NCT02677922|536606245|FG003|Treatment Period|Allogeneic HSCT|1|||
148762932|NCT02677922|536606246|FG004|Treatment Period|Allogeneic HSCT|4|||
148762933|NCT02677922|536606247|FG005|Treatment Period|Allogeneic HSCT|1|||
148762934|NCT02677922|536606242|FG000|Treatment Period|Other Reasons|0|||
148762935|NCT02677922|536606243|FG001|Treatment Period|Other Reasons|0|||
148762936|NCT02677922|536606244|FG002|Treatment Period|Other Reasons|0|||
148762937|NCT02677922|536606245|FG003|Treatment Period|Other Reasons|1|||
148762938|NCT02677922|536606246|FG004|Treatment Period|Other Reasons|3|||
148762939|NCT02677922|536606247|FG005|Treatment Period|Other Reasons|5|||
148762940|NCT02677922|536606242|FG000|Treatment Period|Death|0|||
148762941|NCT02677922|536606243|FG001|Treatment Period|Death|0|||
148762942|NCT02677922|536606244|FG002|Treatment Period|Death|0|||
148762943|NCT02677922|536606245|FG003|Treatment Period|Death|0|||
148762944|NCT02677922|536606246|FG004|Treatment Period|Death|12|||
148762945|NCT02677922|536606247|FG005|Treatment Period|Death|1|||
148762946|NCT02677922|536606242|FG000|Treatment Period|Non-compliance with Study Drug|0|||
148762947|NCT02677922|536606243|FG001|Treatment Period|Non-compliance with Study Drug|0|||
148762948|NCT02677922|536606244|FG002|Treatment Period|Non-compliance with Study Drug|0|||
148762949|NCT02677922|536606245|FG003|Treatment Period|Non-compliance with Study Drug|0|||
148762950|NCT02677922|536606246|FG004|Treatment Period|Non-compliance with Study Drug|1|||
148762951|NCT02677922|536606247|FG005|Treatment Period|Non-compliance with Study Drug|0|||
148762952|NCT02677922|536606242|FG000|Treatment Period|Physician Decision|0|||
148762953|NCT02677922|536606243|FG001|Treatment Period|Physician Decision|0|||
148762954|NCT02677922|536606244|FG002|Treatment Period|Physician Decision|0|||
148762955|NCT02677922|536606245|FG003|Treatment Period|Physician Decision|0|||
148762956|NCT02677922|536606246|FG004|Treatment Period|Physician Decision|0|||
148762957|NCT02677922|536606247|FG005|Treatment Period|Physician Decision|1|||
148762958|NCT02677922|536606242|FG000|Treatment Period|Symptomatic Deterioration|0|||
148762959|NCT02677922|536606243|FG001|Treatment Period|Symptomatic Deterioration|0|||
148762960|NCT02677922|536606244|FG002|Treatment Period|Symptomatic Deterioration|0|||
148762961|NCT02677922|536606245|FG003|Treatment Period|Symptomatic Deterioration|0|||
148762962|NCT02677922|536606246|FG004|Treatment Period|Symptomatic Deterioration|1|||
148762963|NCT02677922|536606247|FG005|Treatment Period|Symptomatic Deterioration|0|||
148762964|NCT02105987|536606249|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
148762965|NCT02105987|536606250|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
148762966|NCT02105987|536606251|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
148762967|NCT02105987|536606252|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
148762968|NCT02105987|536606253|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
148762969|NCT02105987|536606254|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
148762970|NCT02105987|536606249|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
148762971|NCT02105987|536606250|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
148762972|NCT02105987|536606251|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
148762973|NCT02105987|536606252|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
148762974|NCT02105987|536606253|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
148826606|NCT04744831|536844251|FG000|Overall Study|Adverse Event|3|||
148977625|NCT01263873|537398368|FG000|Overall Study|One provider unable to complete numbers|1|||
148762975|NCT02105987|536606254|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
148762976|NCT02105987|536606249|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
148762977|NCT02105987|536606250|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
148762978|NCT02105987|536606251|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148826607|NCT04744831|536844252|FG001|Overall Study|Adverse Event|3|||
148977626|NCT01263873|537398369|FG001|Overall Study|One provider unable to complete numbers|1|||
148762979|NCT02105987|536606252|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148762980|NCT02105987|536606253|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148762981|NCT02105987|536606254|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148762982|NCT02105987|536606249|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
148762983|NCT02105987|536606250|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
148762984|NCT02105987|536606251|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148762985|NCT02105987|536606252|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148762986|NCT02105987|536606253|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148762987|NCT02105987|536606254|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148762988|NCT02105987|536606249|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
148762989|NCT02105987|536606250|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
148762990|NCT02105987|536606251|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
148762991|NCT02105987|536606252|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
148762992|NCT02105987|536606253|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
148762993|NCT02105987|536606254|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
148762994|NCT02105987|536606249|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
148762995|NCT02105987|536606250|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
148762996|NCT02105987|536606251|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
148762997|NCT02105987|536606252|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
148762998|NCT02105987|536606253|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
148762999|NCT02105987|536606254|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
148763000|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
148763001|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
148763002|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
148763003|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
148763004|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
148763005|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
148763006|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
148763007|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
148763008|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
148763009|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
148763010|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
148763011|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
148763012|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148763013|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148763014|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
148763015|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
148763016|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148763017|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
148763018|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148763019|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148763020|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
148763021|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
148763022|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148763023|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
148763024|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
148763025|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
148763026|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
148763027|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
148763028|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
148763029|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
148763030|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
148763031|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
148763032|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
148763033|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
148763034|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
148763035|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
148763036|NCT02105987|536606249|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
148763037|NCT02105987|536606250|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
148763038|NCT02105987|536606251|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
148763039|NCT02105987|536606252|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
148763040|NCT02105987|536606253|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
148763041|NCT02105987|536606254|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
148763042|NCT02105987|536606249|FG000|Continuation Phase|Protocol Violation|0|||
148763043|NCT02105987|536606250|FG001|Continuation Phase|Protocol Violation|0|||
148763044|NCT02105987|536606251|FG002|Continuation Phase|Protocol Violation|0|||
148763045|NCT02105987|536606252|FG003|Continuation Phase|Protocol Violation|0|||
148763046|NCT02105987|536606253|FG004|Continuation Phase|Protocol Violation|1|||
148763047|NCT02105987|536606254|FG005|Continuation Phase|Protocol Violation|0|||
148763048|NCT03926117|536606261|FG000|Overall Study|Unclassified|1|||
148763049|NCT03926117|536606262|FG001|Overall Study|Unclassified|4|||
148763050|NCT03926117|536606263|FG002|Overall Study|Unclassified|1|||
148763051|NCT03926117|536606264|FG003|Overall Study|Unclassified|4|||
148763052|NCT03926117|536606261|FG000|Overall Study|Withdrawal by Subject|3|||
148763053|NCT03926117|536606262|FG001|Overall Study|Withdrawal by Subject|0|||
148763054|NCT03926117|536606263|FG002|Overall Study|Withdrawal by Subject|1|||
148763055|NCT03926117|536606264|FG003|Overall Study|Withdrawal by Subject|1|||
148763056|NCT03926117|536606261|FG000|Overall Study|Lost to Follow-up|0|||
148763057|NCT03926117|536606262|FG001|Overall Study|Lost to Follow-up|2|||
148763058|NCT03926117|536606263|FG002|Overall Study|Lost to Follow-up|1|||
148763059|NCT03926117|536606264|FG003|Overall Study|Lost to Follow-up|0|||
148763060|NCT03926117|536606261|FG000|Overall Study|Adverse Event|1|||
148763061|NCT03926117|536606262|FG001|Overall Study|Adverse Event|2|||
148763062|NCT03926117|536606263|FG002|Overall Study|Adverse Event|3|||
148763063|NCT03926117|536606264|FG003|Overall Study|Adverse Event|1|||
148763064|NCT03926117|536606261|FG000|Overall Study|Randomized but not treated|1|||
148763065|NCT03926117|536606262|FG001|Overall Study|Randomized but not treated|1|||
148763066|NCT03926117|536606263|FG002|Overall Study|Randomized but not treated|0|||
148763067|NCT03926117|536606264|FG003|Overall Study|Randomized but not treated|1|||
148763068|NCT02748356|536606271|FG000|Overall Study|Withdrawal by Subject|1|||
148763069|NCT05236764|536606272|FG000|Overall Study|In follow up (ongoing)|1|||
148763070|NCT05236764|536606272|FG000|Overall Study|Taken off study - secondary graft failure|1|||
148763071|NCT05236764|536606272|FG000|Overall Study|Death|1|||
148763072|NCT05870371|536606273|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
148763073|NCT05870371|536606274|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
148763074|NCT00347009|536606276|FG000|Overall Study|Death|1|||
148763075|NCT00347009|536606276|FG000|Overall Study|Adverse Event|6|||
148763076|NCT00347009|536606276|FG000|Overall Study|Withdrawal by Subject|3|||
148763077|NCT00347009|536606276|FG000|Overall Study|Physician Decision|5|||
148763078|NCT00347009|536606276|FG000|Overall Study|Lost to Follow-up|4|||
148763079|NCT00347009|536606276|FG000|Overall Study|Protocol Violation|2|||
148763080|NCT00347009|536606276|FG000|Overall Study|Adverse Laboratory Experience|1|||
148763081|NCT00347009|536606276|FG000|Overall Study|Insufficient Viral Suppression|3|||
148763082|NCT00347009|536606276|FG000|Overall Study|Increased ALT/HBV DNA|1|||
148763083|NCT00347009|536606276|FG000|Overall Study|Serious Adverse Event|1|||
148763084|NCT02522884|536606279|FG000|Overall Study|Withdrawal by Subject|6|||
148763085|NCT02522884|536606279|FG000|Overall Study|Death|3|||
148763086|NCT02522884|536606279|FG000|Overall Study|Missed 12-month Follow-up|9|||
148763087|NCT04495751|536606280|FG000|Overall Study|Withdrawal by Subject|1|||
148763088|NCT04495751|536606281|FG001|Overall Study|Withdrawal by Subject|0|||
148763089|NCT04495751|536606280|FG000|Overall Study|Lost to Follow-up|1|||
148763090|NCT04495751|536606281|FG001|Overall Study|Lost to Follow-up|0|||
148763091|NCT03289754|536606282|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
148763092|NCT04873934|536606283|FG000|Overall Study|Adverse Event|0|||
148763093|NCT04873934|536606284|FG001|Overall Study|Adverse Event|1|||
148763094|NCT04873934|536606283|FG000|Overall Study|Death|0|||
148763095|NCT04873934|536606284|FG001|Overall Study|Death|2|||
148763096|NCT04873934|536606283|FG000|Overall Study|Lost to Follow-up|13|||
148763097|NCT04873934|536606284|FG001|Overall Study|Lost to Follow-up|9|||
148763098|NCT04873934|536606283|FG000|Overall Study|Physician Decision|1|||
148763099|NCT04873934|536606284|FG001|Overall Study|Physician Decision|1|||
148763100|NCT04873934|536606283|FG000|Overall Study|Protocol deviation|2|||
148763101|NCT04873934|536606284|FG001|Overall Study|Protocol deviation|1|||
148763102|NCT04873934|536606283|FG000|Overall Study|Subject decision|1|||
148763103|NCT04873934|536606284|FG001|Overall Study|Subject decision|8|||
148763104|NCT04873934|536606283|FG000|Overall Study|Withdrew consent|0|||
148763105|NCT04873934|536606284|FG001|Overall Study|Withdrew consent|4|||
148763106|NCT04873934|536606283|FG000|Overall Study|Missing|1|||
148763107|NCT04873934|536606284|FG001|Overall Study|Missing|0|||
148763108|NCT00708461|536606285|FG000|Overall Study|Lost to Follow-up|18|||
148763109|NCT00708461|536606286|FG001|Overall Study|Lost to Follow-up|11|||
148763110|NCT00708461|536606285|FG000|Overall Study|Withdrawal by Subject|8|||
148763111|NCT00708461|536606286|FG001|Overall Study|Withdrawal by Subject|9|||
148763112|NCT00708461|536606285|FG000|Overall Study|left workforce|115|||
148763113|NCT00708461|536606286|FG001|Overall Study|left workforce|180|||
148763114|NCT03584854|536606292|FG000|Overall Study|Primary outcome not measured|1|||
148763115|NCT03584854|536606293|FG001|Overall Study|Primary outcome not measured|2|||
148763116|NCT02505217|536606294|FG000|Overall Study|Withdrawal by Subject|1|||
148763117|NCT02505217|536606295|FG001|Overall Study|Withdrawal by Subject|2|||
148763118|NCT04639219|536606296|FG000|Overall Study|Withdrawal by Subject|8|||
148763119|NCT04639219|536606296|FG000|Overall Study|Lost to Follow-up|6|||
148763120|NCT04639219|536606296|FG000|Overall Study|Death|55|||
148763121|NCT00564850|536606300|FG000|Overall Study|Protocol Violation|2|||
148763122|NCT02134015|536606303|FG000|Overall Study|Protocol Violation|0|||
148763123|NCT02134015|536606304|FG001|Overall Study|Protocol Violation|1|||
148763124|NCT02134015|536606303|FG000|Overall Study|Death|2|||
148763125|NCT02134015|536606304|FG001|Overall Study|Death|1|||
148763126|NCT02134015|536606303|FG000|Overall Study|Reason not provided|1|||
148763127|NCT02134015|536606304|FG001|Overall Study|Reason not provided|2|||
148763128|NCT02134015|536606303|FG000|Overall Study|Clinical progression|14|||
148763129|NCT02134015|536606304|FG001|Overall Study|Clinical progression|7|||
148763130|NCT02134015|536606303|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
148763131|NCT02134015|536606304|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
148763132|NCT02134015|536606303|FG000|Overall Study|Study terminated by sponsor|2|||
148763133|NCT02134015|536606304|FG001|Overall Study|Study terminated by sponsor|3|||
148763134|NCT02134015|536606303|FG000|Overall Study|Adverse Event|9|||
148763135|NCT02134015|536606304|FG001|Overall Study|Adverse Event|10|||
148763136|NCT02134015|536606303|FG000|Overall Study|Withdrawal by Subject|3|||
148763137|NCT02134015|536606304|FG001|Overall Study|Withdrawal by Subject|7|||
148763138|NCT02186873|536607964|FG000|Overall Study|Adverse Event|1|||
148763139|NCT02186873|536607965|FG001|Overall Study|Adverse Event|3|||
148763140|NCT02186873|536607964|FG000|Overall Study|Lack of Efficacy|0|||
148763141|NCT02186873|536607965|FG001|Overall Study|Lack of Efficacy|1|||
148763142|NCT02186873|536607964|FG000|Overall Study|Lost to Follow-up|1|||
148763143|NCT02186873|536607965|FG001|Overall Study|Lost to Follow-up|2|||
148763144|NCT02186873|536607964|FG000|Overall Study|Withdrawal by Subject|7|||
148763145|NCT02186873|536607965|FG001|Overall Study|Withdrawal by Subject|2|||
148763146|NCT03694002|536607966|FG000|Overall Study|Progression|4|||
148763147|NCT03694002|536607967|FG001|Overall Study|Progression|2|||
148763148|NCT03694002|536607966|FG000|Overall Study|Adverse Event|2|||
148763149|NCT03694002|536607967|FG001|Overall Study|Adverse Event|0|||
148763150|NCT03694002|536607966|FG000|Overall Study|Other not protocol specified|1|||
148763151|NCT03694002|536607967|FG001|Overall Study|Other not protocol specified|0|||
148763152|NCT03694002|536607966|FG000|Overall Study|Ineligible|0|||
148763153|NCT03694002|536607967|FG001|Overall Study|Ineligible|1|||
148763154|NCT03694002|536607966|FG000|Overall Study|Withdrew consent before starting treatment|0|||
148763155|NCT03694002|536607967|FG001|Overall Study|Withdrew consent before starting treatment|3|||
148763156|NCT05678959|536607968|FG000|Overall Study|Study Terminated by Sponsor|76|||
148763157|NCT05678959|536607969|FG001|Overall Study|Study Terminated by Sponsor|76|||
148763158|NCT05678959|536607968|FG000|Overall Study|Physician Decision|2|||
148763159|NCT05678959|536607969|FG001|Overall Study|Physician Decision|3|||
148763160|NCT05678959|536607968|FG000|Overall Study|Adverse Event|1|||
148763161|NCT05678959|536607969|FG001|Overall Study|Adverse Event|1|||
148763162|NCT05678959|536607968|FG000|Overall Study|Guardian Decision|1|||
148763163|NCT05678959|536607969|FG001|Overall Study|Guardian Decision|0|||
148763164|NCT05678959|536607968|FG000|Overall Study|Protocol Deviation|0|||
148763165|NCT05678959|536607969|FG001|Overall Study|Protocol Deviation|1|||
148763166|NCT05678959|536607968|FG000|Overall Study|Subject Decision|1|||
148763167|NCT05678959|536607969|FG001|Overall Study|Subject Decision|0|||
148763168|NCT05678959|536607968|FG000|Overall Study|Technical Problem|0|||
148763169|NCT05678959|536607969|FG001|Overall Study|Technical Problem|1|||
148763170|NCT03868930|536607973|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
148763171|NCT03868930|536607974|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
148763172|NCT03868930|536607973|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
148763173|NCT03868930|536607974|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
148763174|NCT03868930|536607973|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
148763175|NCT03868930|536607974|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
148763176|NCT03868930|536607973|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
148763177|NCT03868930|536607974|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
148763178|NCT03868930|536607973|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
148763179|NCT03868930|536607974|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
148763180|NCT01540487|536607979|FG000|Overall Study|Protocol Violation|1|||
148763181|NCT01540487|536607980|FG001|Overall Study|Protocol Violation|0|||
148763182|NCT00617890|536607981|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
148763183|NCT00617890|536607982|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
148763184|NCT00617890|536607983|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
148763185|NCT00617890|536607984|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
148763186|NCT00617890|536607981|FG000|Overall Study|Lack of Efficacy|23|||
148763187|NCT00617890|536607982|FG001|Overall Study|Lack of Efficacy|26|||
148763188|NCT00617890|536607983|FG002|Overall Study|Lack of Efficacy|30|||
148763189|NCT00617890|536607984|FG003|Overall Study|Lack of Efficacy|97|||
148763190|NCT00617890|536607981|FG000|Overall Study|Lost to Follow-up|0|||
148763191|NCT00617890|536607982|FG001|Overall Study|Lost to Follow-up|0|||
148763192|NCT00617890|536607983|FG002|Overall Study|Lost to Follow-up|1|||
148763193|NCT00617890|536607984|FG003|Overall Study|Lost to Follow-up|2|||
148763194|NCT00617890|536607981|FG000|Overall Study|Withdrawal by Subject|4|||
148763195|NCT00617890|536607982|FG001|Overall Study|Withdrawal by Subject|1|||
148763196|NCT00617890|536607983|FG002|Overall Study|Withdrawal by Subject|0|||
148763197|NCT00617890|536607984|FG003|Overall Study|Withdrawal by Subject|2|||
148763198|NCT00617890|536607981|FG000|Overall Study|Protocol Violation|2|||
148763199|NCT00617890|536607982|FG001|Overall Study|Protocol Violation|1|||
148763200|NCT00617890|536607983|FG002|Overall Study|Protocol Violation|0|||
148763201|NCT00617890|536607984|FG003|Overall Study|Protocol Violation|0|||
148763202|NCT00617890|536607981|FG000|Overall Study|Adverse Event|1|||
148763203|NCT00617890|536607982|FG001|Overall Study|Adverse Event|0|||
148763204|NCT00617890|536607983|FG002|Overall Study|Adverse Event|3|||
148763205|NCT00617890|536607984|FG003|Overall Study|Adverse Event|8|||
148763206|NCT00617890|536607981|FG000|Overall Study|Not treated|1|||
148763207|NCT00617890|536607982|FG001|Overall Study|Not treated|0|||
148763208|NCT00617890|536607983|FG002|Overall Study|Not treated|1|||
148763209|NCT00617890|536607984|FG003|Overall Study|Not treated|1|||
148763210|NCT03503370|536607985|FG000|Overall Study|Death|3|||
148763211|NCT03503370|536607986|FG001|Overall Study|Death|1|||
148763212|NCT03483961|536607987|FG000|Overall Study|Lost to Follow-up|7|||
148763213|NCT03483961|536607988|FG001|Overall Study|Lost to Follow-up|6|||
148763214|NCT03483961|536607989|FG002|Overall Study|Lost to Follow-up|6|||
148763215|NCT03483961|536607990|FG003|Overall Study|Lost to Follow-up|6|||
148763216|NCT03483961|536607991|FG004|Overall Study|Lost to Follow-up|6|||
148763217|NCT03483961|536607992|FG005|Overall Study|Lost to Follow-up|4|||
148763218|NCT03483961|536607993|FG006|Overall Study|Lost to Follow-up|4|||
148763219|NCT03483961|536607994|FG007|Overall Study|Lost to Follow-up|11|||
148763220|NCT03483961|536607995|FG008|Overall Study|Lost to Follow-up|1|||
148763221|NCT03483961|536607996|FG009|Overall Study|Lost to Follow-up|0|||
148763222|NCT03483961|536607987|FG000|Overall Study|Withdrawal by Subject|3|||
148763223|NCT03483961|536607988|FG001|Overall Study|Withdrawal by Subject|4|||
148763224|NCT03483961|536607989|FG002|Overall Study|Withdrawal by Subject|5|||
148763225|NCT03483961|536607990|FG003|Overall Study|Withdrawal by Subject|3|||
148763226|NCT03483961|536607991|FG004|Overall Study|Withdrawal by Subject|4|||
148763227|NCT03483961|536607992|FG005|Overall Study|Withdrawal by Subject|2|||
148763228|NCT03483961|536607993|FG006|Overall Study|Withdrawal by Subject|1|||
148763229|NCT03483961|536607994|FG007|Overall Study|Withdrawal by Subject|2|||
148763230|NCT03483961|536607995|FG008|Overall Study|Withdrawal by Subject|1|||
148763231|NCT03483961|536607996|FG009|Overall Study|Withdrawal by Subject|0|||
148763232|NCT03483961|536607987|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
148763233|NCT03483961|536607988|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763234|NCT03483961|536607989|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763235|NCT03483961|536607990|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763236|NCT03483961|536607991|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763237|NCT03483961|536607992|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763238|NCT03483961|536607993|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763239|NCT03483961|536607994|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763240|NCT03483961|536607995|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763241|NCT03483961|536607996|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
148763242|NCT03483961|536607987|FG000|Overall Study|Adverse Event|0|||
148763243|NCT03483961|536607988|FG001|Overall Study|Adverse Event|0|||
148763244|NCT03483961|536607989|FG002|Overall Study|Adverse Event|1|||
148763245|NCT03483961|536607990|FG003|Overall Study|Adverse Event|0|||
148763246|NCT03483961|536607991|FG004|Overall Study|Adverse Event|0|||
148763247|NCT03483961|536607992|FG005|Overall Study|Adverse Event|0|||
148763248|NCT03483961|536607993|FG006|Overall Study|Adverse Event|0|||
148763249|NCT03483961|536607994|FG007|Overall Study|Adverse Event|0|||
148763250|NCT03483961|536607995|FG008|Overall Study|Adverse Event|0|||
148763251|NCT03483961|536607996|FG009|Overall Study|Adverse Event|0|||
148763252|NCT02640950|536607997|FG000|Overall Study|Adverse Event|1|||
148763253|NCT02640950|536607997|FG000|Overall Study|Withdrawal by Subject|1|||
148763254|NCT04545489|536607998|FG000|Overall Study|Withdrawal by Subject|12|||
148763255|NCT04545489|536607999|FG001|Overall Study|Withdrawal by Subject|4|||
148763256|NCT04545489|536607998|FG000|Overall Study|Lost to Follow-up|17|||
148763257|NCT04545489|536607999|FG001|Overall Study|Lost to Follow-up|18|||
148763258|NCT04545489|536607998|FG000|Overall Study|12month BP not collected|4|||
148763259|NCT04545489|536607999|FG001|Overall Study|12month BP not collected|4|||
148763260|NCT00652626|536608000|FG000|Initial Treatment Phase|Adverse Event|0|||
148763261|NCT00652626|536608001|FG001|Initial Treatment Phase|Adverse Event|0|||
148763262|NCT00652626|536608002|FG002|Initial Treatment Phase|Adverse Event|0|||
148763263|NCT00652626|536608003|FG003|Initial Treatment Phase|Adverse Event|0|||
148763264|NCT00652626|536608004|FG004|Initial Treatment Phase|Adverse Event|1|||
148763265|NCT00652626|536608005|FG005|Initial Treatment Phase|Adverse Event|0|||
148763266|NCT00652626|536608006|FG006|Initial Treatment Phase|Adverse Event|0|||
148763267|NCT00652626|536608000|FG000|Initial Treatment Phase|Protocol Violation|0|||
148977627|NCT02664038|537398382|FG000|13 Week|Lost to Follow-up|7|||
148977628|NCT02664038|537398383|FG001|13 Week|Lost to Follow-up|14|||
148763268|NCT00652626|536608001|FG001|Initial Treatment Phase|Protocol Violation|0|||
148977629|NCT02664038|537398382|FG000|13 Week|Withdrawal by Subject|1|||
148977630|NCT02664038|537398383|FG001|13 Week|Withdrawal by Subject|0|||
148977631|NCT02664038|537398382|FG000|26 Week|Lost to Follow-up|5|||
148763269|NCT00652626|536608002|FG002|Initial Treatment Phase|Protocol Violation|0|||
148763270|NCT00652626|536608003|FG003|Initial Treatment Phase|Protocol Violation|1|||
148763271|NCT00652626|536608004|FG004|Initial Treatment Phase|Protocol Violation|0|||
148763272|NCT00652626|536608005|FG005|Initial Treatment Phase|Protocol Violation|0|||
148763273|NCT00652626|536608006|FG006|Initial Treatment Phase|Protocol Violation|0|||
148763274|NCT00652626|536608000|FG000|Initial Treatment Phase|Physician Decision|0|||
148763275|NCT00652626|536608001|FG001|Initial Treatment Phase|Physician Decision|0|||
148763276|NCT00652626|536608002|FG002|Initial Treatment Phase|Physician Decision|0|||
148763277|NCT00652626|536608003|FG003|Initial Treatment Phase|Physician Decision|0|||
148763278|NCT00652626|536608004|FG004|Initial Treatment Phase|Physician Decision|1|||
148763279|NCT00652626|536608005|FG005|Initial Treatment Phase|Physician Decision|0|||
148763280|NCT00652626|536608006|FG006|Initial Treatment Phase|Physician Decision|0|||
148763281|NCT00652626|536608000|FG000|Initial Treatment Phase|Sponsor Request|0|||
148763282|NCT00652626|536608001|FG001|Initial Treatment Phase|Sponsor Request|0|||
148763283|NCT00652626|536608002|FG002|Initial Treatment Phase|Sponsor Request|1|||
148763284|NCT00652626|536608003|FG003|Initial Treatment Phase|Sponsor Request|0|||
148763285|NCT00652626|536608004|FG004|Initial Treatment Phase|Sponsor Request|0|||
148763286|NCT00652626|536608005|FG005|Initial Treatment Phase|Sponsor Request|0|||
148763287|NCT00652626|536608006|FG006|Initial Treatment Phase|Sponsor Request|0|||
148763288|NCT00652626|536608000|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
148763289|NCT00652626|536608001|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
148763290|NCT00652626|536608002|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
148763291|NCT00652626|536608003|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
148763292|NCT00652626|536608004|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
148763293|NCT00652626|536608005|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
148763294|NCT00652626|536608006|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
148763295|NCT00652626|536608000|FG000|Extension Phase|Withdrawal by Subject|0|||
148763296|NCT00652626|536608001|FG001|Extension Phase|Withdrawal by Subject|0|||
148763297|NCT00652626|536608002|FG002|Extension Phase|Withdrawal by Subject|0|||
148763298|NCT00652626|536608003|FG003|Extension Phase|Withdrawal by Subject|0|||
148763299|NCT00652626|536608004|FG004|Extension Phase|Withdrawal by Subject|0|||
148763300|NCT00652626|536608005|FG005|Extension Phase|Withdrawal by Subject|2|||
148763301|NCT00652626|536608006|FG006|Extension Phase|Withdrawal by Subject|0|||
148763302|NCT00652626|536608000|FG000|Extension Phase|Adverse Event|0|||
148763303|NCT00652626|536608001|FG001|Extension Phase|Adverse Event|0|||
148763304|NCT00652626|536608002|FG002|Extension Phase|Adverse Event|0|||
148763305|NCT00652626|536608003|FG003|Extension Phase|Adverse Event|0|||
148763306|NCT00652626|536608004|FG004|Extension Phase|Adverse Event|0|||
148763307|NCT00652626|536608005|FG005|Extension Phase|Adverse Event|2|||
148763308|NCT00652626|536608006|FG006|Extension Phase|Adverse Event|1|||
148763309|NCT00652626|536608000|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
148763310|NCT00652626|536608001|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
148763311|NCT00652626|536608002|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
148763312|NCT00652626|536608003|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
148763313|NCT00652626|536608004|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
148763314|NCT00652626|536608005|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
148763315|NCT00652626|536608006|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
148763316|NCT00652626|536608000|FG000|Extension Phase|Physician Decision|0|||
148763317|NCT00652626|536608001|FG001|Extension Phase|Physician Decision|0|||
148763318|NCT00652626|536608002|FG002|Extension Phase|Physician Decision|0|||
148763319|NCT00652626|536608003|FG003|Extension Phase|Physician Decision|0|||
148763320|NCT00652626|536608004|FG004|Extension Phase|Physician Decision|0|||
148763321|NCT00652626|536608005|FG005|Extension Phase|Physician Decision|1|||
148763322|NCT00652626|536608006|FG006|Extension Phase|Physician Decision|1|||
148763323|NCT00652626|536608000|FG000|Extension Phase|Death|0|||
148763324|NCT00652626|536608001|FG001|Extension Phase|Death|0|||
148763325|NCT00652626|536608002|FG002|Extension Phase|Death|0|||
148763326|NCT00652626|536608003|FG003|Extension Phase|Death|0|||
148763327|NCT00652626|536608004|FG004|Extension Phase|Death|0|||
148763328|NCT00652626|536608005|FG005|Extension Phase|Death|1|||
148763329|NCT00652626|536608006|FG006|Extension Phase|Death|1|||
148763330|NCT04003636|536608007|FG000|Overall Study|Death|409|||
148763331|NCT04003636|536608008|FG001|Overall Study|Death|443|||
148763332|NCT04003636|536608007|FG000|Overall Study|Lost to Follow-up|0|||
148763333|NCT04003636|536608008|FG001|Overall Study|Lost to Follow-up|1|||
148763334|NCT04003636|536608007|FG000|Overall Study|Withdrawal by Subject|5|||
148763335|NCT04003636|536608008|FG001|Overall Study|Withdrawal by Subject|2|||
148763336|NCT04003636|536608007|FG000|Overall Study|Participant On-going|119|||
148763337|NCT04003636|536608008|FG001|Overall Study|Participant On-going|90|||
148763338|NCT04134767|536608009|FG000|Overall Study|Death|0|||
148763339|NCT04134767|536608010|FG001|Overall Study|Death|1|||
148763340|NCT04134767|536608009|FG000|Overall Study|Removed for harassing staff|0|||
148763341|NCT04134767|536608010|FG001|Overall Study|Removed for harassing staff|1|||
148763342|NCT04134767|536608009|FG000|Overall Study|Lost to Follow-up|44|||
148763343|NCT04134767|536608010|FG001|Overall Study|Lost to Follow-up|40|||
148763344|NCT00300885|536608011|FG000|Treatment|Adverse Event|134|||
148763345|NCT00300885|536608012|FG001|Treatment|Adverse Event|82|||
148763346|NCT00300885|536608011|FG000|Treatment|Death|20|||
148763347|NCT00300885|536608012|FG001|Treatment|Death|7|||
148763348|NCT00300885|536608011|FG000|Treatment|Lack of Efficacy|1|||
148763349|NCT00300885|536608012|FG001|Treatment|Lack of Efficacy|1|||
148763350|NCT00300885|536608011|FG000|Treatment|Lost to Follow-up|3|||
148763351|NCT00300885|536608012|FG001|Treatment|Lost to Follow-up|2|||
148763352|NCT00300885|536608011|FG000|Treatment|Physician Decision|4|||
148763353|NCT00300885|536608012|FG001|Treatment|Physician Decision|5|||
148763354|NCT00300885|536608011|FG000|Treatment|Protocol Violation|11|||
148763355|NCT00300885|536608012|FG001|Treatment|Protocol Violation|11|||
148763356|NCT00300885|536608011|FG000|Treatment|Withdrawal by Subject|26|||
148763357|NCT00300885|536608012|FG001|Treatment|Withdrawal by Subject|23|||
148763358|NCT00300885|536608011|FG000|Treatment|Disease progression|171|||
148763359|NCT00300885|536608012|FG001|Treatment|Disease progression|238|||
148763360|NCT00300885|536608011|FG000|Treatment|Random code broken (subject died)|0|||
148763361|NCT00300885|536608012|FG001|Treatment|Random code broken (subject died)|1|||
148763362|NCT00300885|536608011|FG000|Treatment|Non-compliant with study medication|3|||
148763363|NCT00300885|536608012|FG001|Treatment|Non-compliant with study medication|4|||
148763364|NCT00300885|536608011|FG000|Follow-up|Death|141|||
148763365|NCT00300885|536608012|FG001|Follow-up|Death|163|||
148763366|NCT00300885|536608011|FG000|Follow-up|Lost to Follow-up|11|||
148763367|NCT00300885|536608012|FG001|Follow-up|Lost to Follow-up|7|||
148763368|NCT00300885|536608011|FG000|Follow-up|Withdrawal by Subject|26|||
148763369|NCT00300885|536608012|FG001|Follow-up|Withdrawal by Subject|25|||
148763370|NCT02058537|536608013|FG000|Overall Study|Withdrawal by Subject|1|||
148763371|NCT00638404|536608014|FG000|Overall Study|Physician Decision|8|||
148763372|NCT00638404|536608015|FG001|Overall Study|Physician Decision|0|||
148763373|NCT02101736|536608019|FG000|Overall Study|Protocol Violation|3|||
148763374|NCT02101736|536608020|FG001|Overall Study|Protocol Violation|0|||
148763375|NCT02101736|536608019|FG000|Overall Study|Withdrawal by Subject|1|||
148763376|NCT02101736|536608020|FG001|Overall Study|Withdrawal by Subject|1|||
148763377|NCT00459290|536608021|FG000|Overall Study|Adverse Event|3|||
148763378|NCT00459290|536608021|FG000|Overall Study|Ineligible|2|||
148763379|NCT02453334|536608022|FG000|Overall Study|Death|15|||
148763380|NCT02453334|536608023|FG001|Overall Study|Death|13|||
148763381|NCT02453334|536608022|FG000|Overall Study|Adverse Event|2|||
148763382|NCT02453334|536608023|FG001|Overall Study|Adverse Event|1|||
148763383|NCT02453334|536608022|FG000|Overall Study|Lost to Follow-up|5|||
148763384|NCT02453334|536608023|FG001|Overall Study|Lost to Follow-up|9|||
148763385|NCT02453334|536608022|FG000|Overall Study|Physician Decision|1|||
148763386|NCT02453334|536608023|FG001|Overall Study|Physician Decision|0|||
148763387|NCT02453334|536608022|FG000|Overall Study|Withdrawal by Subject|17|||
148763388|NCT02453334|536608023|FG001|Overall Study|Withdrawal by Subject|13|||
148763389|NCT02453334|536608022|FG000|Overall Study|Other reason|1|||
148763390|NCT02453334|536608023|FG001|Overall Study|Other reason|4|||
148763391|NCT05483686|536608027|FG000|Overall Study|Lost to Follow-up|5|||
148763392|NCT05483686|536608028|FG001|Overall Study|Lost to Follow-up|7|||
148763393|NCT05780983|536608029|FG000|Overall Study|Withdrawal by Subject|1|||
148763394|NCT01954056|536608035|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
148763395|NCT01954056|536608036|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
148763396|NCT00105079|536608039|FG000|Overall Study|Adverse Event|5|||
148763397|NCT00105079|536608040|FG001|Overall Study|Adverse Event|12|||
148763398|NCT00105079|536608039|FG000|Overall Study|Death|3|||
148763399|NCT00105079|536608040|FG001|Overall Study|Death|1|||
148763400|NCT00105079|536608039|FG000|Overall Study|Lost to Follow-up|12|||
148763401|NCT00105079|536608040|FG001|Overall Study|Lost to Follow-up|12|||
148763402|NCT00105079|536608039|FG000|Overall Study|Lack of Efficacy|9|||
148763403|NCT00105079|536608040|FG001|Overall Study|Lack of Efficacy|3|||
148763404|NCT00105079|536608039|FG000|Overall Study|Refused treatment|6|||
148763405|NCT00105079|536608040|FG001|Overall Study|Refused treatment|4|||
148763406|NCT00105079|536608039|FG000|Overall Study|Violation of selection criteria at entry|0|||
148826608|NCT04744831|536844253|FG002|Overall Study|Adverse Event|3|||
148826609|NCT04744831|536844251|FG000|Overall Study|Clinical Progression|3|||
148826610|NCT04744831|536844252|FG001|Overall Study|Clinical Progression|2|||
148826611|NCT04744831|536844253|FG002|Overall Study|Clinical Progression|5|||
148977632|NCT02664038|537398383|FG001|26 Week|Lost to Follow-up|4|||
148763407|NCT00105079|536608040|FG001|Overall Study|Violation of selection criteria at entry|2|||
148763408|NCT00105079|536608039|FG000|Overall Study|Protocol Violation|1|||
148763409|NCT00105079|536608040|FG001|Overall Study|Protocol Violation|0|||
148763410|NCT00105079|536608039|FG000|Overall Study|Other|3|||
148763411|NCT00105079|536608040|FG001|Overall Study|Other|1|||
148763412|NCT01464593|536608043|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
148763413|NCT04747886|536608046|FG000|Overall Study|Withdrawal by Subject|1|||
148763414|NCT04747886|536608047|FG001|Overall Study|Withdrawal by Subject|4|||
148763415|NCT03777436|536608048|FG000|Placebo-controlled Phase|Adverse Event|8|||
148763416|NCT03777436|536608049|FG001|Placebo-controlled Phase|Adverse Event|10|||
148763417|NCT03777436|536608050|FG002|Placebo-controlled Phase|Adverse Event|0|||
148826612|NCT04744831|536844251|FG000|Overall Study|Other|0|||
148977633|NCT04456699|537398389|FG000|Overall Study|Death|48|||
148763418|NCT03777436|536608048|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
148763419|NCT03777436|536608049|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
148763420|NCT03777436|536608050|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
148763421|NCT03777436|536608048|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
148763422|NCT03777436|536608049|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
148763423|NCT03777436|536608050|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
148763424|NCT03777436|536608048|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
148763425|NCT03777436|536608049|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
148763426|NCT03777436|536608050|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
148763427|NCT03777436|536608048|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
148763428|NCT03777436|536608049|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
148763429|NCT03777436|536608050|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
148763430|NCT03777436|536608048|FG000|Placebo-controlled Phase|Physician Decision|0|||
148763431|NCT03777436|536608049|FG001|Placebo-controlled Phase|Physician Decision|1|||
148763432|NCT03777436|536608050|FG002|Placebo-controlled Phase|Physician Decision|0|||
148763433|NCT03777436|536608048|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
148763434|NCT03777436|536608049|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
148763435|NCT03777436|536608050|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
148763436|NCT03777436|536608048|FG000|Apremilast Extension Phase|Adverse Event|0|||
148763437|NCT03777436|536608049|FG001|Apremilast Extension Phase|Adverse Event|0|||
148763438|NCT03777436|536608050|FG002|Apremilast Extension Phase|Adverse Event|6|||
148763439|NCT03777436|536608048|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
148763440|NCT03777436|536608049|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
148763441|NCT03777436|536608050|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
148763442|NCT03777436|536608048|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
148763443|NCT03777436|536608049|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
148763444|NCT03777436|536608050|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
148763445|NCT03777436|536608048|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
148763446|NCT03777436|536608049|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
148763447|NCT03777436|536608050|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
148763448|NCT03777436|536608048|FG000|Apremilast Extension Phase|Miscellaneous|0|||
148763449|NCT03777436|536608049|FG001|Apremilast Extension Phase|Miscellaneous|0|||
148763450|NCT03777436|536608050|FG002|Apremilast Extension Phase|Miscellaneous|1|||
148763451|NCT00685399|536608051|FG000|Treatment Period 1|Withdrawal by Subject|2|||
148763452|NCT00685399|536608052|FG001|Treatment Period 1|Withdrawal by Subject|0|||
148763453|NCT00685399|536608053|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148763454|NCT00685399|536608054|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148763455|NCT00685399|536608055|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148763456|NCT00685399|536608056|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148763457|NCT00685399|536608057|FG006|Treatment Period 1|Withdrawal by Subject|0|||
148763458|NCT00685399|536608058|FG007|Treatment Period 1|Withdrawal by Subject|0|||
148763459|NCT00685399|536608051|FG000|Treatment Period 1|Protocol Violation|1|||
148763460|NCT00685399|536608052|FG001|Treatment Period 1|Protocol Violation|0|||
148763461|NCT00685399|536608053|FG002|Treatment Period 1|Protocol Violation|0|||
148763462|NCT00685399|536608054|FG003|Treatment Period 1|Protocol Violation|0|||
148763463|NCT00685399|536608055|FG004|Treatment Period 1|Protocol Violation|0|||
148763464|NCT00685399|536608056|FG005|Treatment Period 1|Protocol Violation|0|||
148763465|NCT00685399|536608057|FG006|Treatment Period 1|Protocol Violation|0|||
148763466|NCT00685399|536608058|FG007|Treatment Period 1|Protocol Violation|0|||
148763467|NCT00685399|536608051|FG000|Treatment Period 1|Administrative|2|||
148763468|NCT00685399|536608052|FG001|Treatment Period 1|Administrative|0|||
148763469|NCT00685399|536608053|FG002|Treatment Period 1|Administrative|0|||
148763470|NCT00685399|536608054|FG003|Treatment Period 1|Administrative|0|||
148763471|NCT00685399|536608055|FG004|Treatment Period 1|Administrative|0|||
148763472|NCT00685399|536608056|FG005|Treatment Period 1|Administrative|0|||
148763473|NCT00685399|536608057|FG006|Treatment Period 1|Administrative|0|||
148763474|NCT00685399|536608058|FG007|Treatment Period 1|Administrative|0|||
148763475|NCT00685399|536608051|FG000|Treatment Period 1|Lack of Efficacy|1|||
148763476|NCT00685399|536608052|FG001|Treatment Period 1|Lack of Efficacy|0|||
148763477|NCT00685399|536608053|FG002|Treatment Period 1|Lack of Efficacy|0|||
148763478|NCT00685399|536608054|FG003|Treatment Period 1|Lack of Efficacy|0|||
148763479|NCT00685399|536608055|FG004|Treatment Period 1|Lack of Efficacy|0|||
148763480|NCT00685399|536608056|FG005|Treatment Period 1|Lack of Efficacy|0|||
148763481|NCT00685399|536608057|FG006|Treatment Period 1|Lack of Efficacy|0|||
148763482|NCT00685399|536608058|FG007|Treatment Period 1|Lack of Efficacy|0|||
148763483|NCT00685399|536608051|FG000|Treatment Period 2|Administrative Problems|0|||
148763484|NCT00685399|536608052|FG001|Treatment Period 2|Administrative Problems|2|||
148763485|NCT00685399|536608053|FG002|Treatment Period 2|Administrative Problems|1|||
148763486|NCT00685399|536608054|FG003|Treatment Period 2|Administrative Problems|0|||
148763487|NCT00685399|536608055|FG004|Treatment Period 2|Administrative Problems|0|||
148826613|NCT04744831|536844252|FG001|Overall Study|Other|2|||
148763488|NCT00685399|536608056|FG005|Treatment Period 2|Administrative Problems|0|||
148763489|NCT00685399|536608057|FG006|Treatment Period 2|Administrative Problems|0|||
148763490|NCT00685399|536608058|FG007|Treatment Period 2|Administrative Problems|0|||
148763491|NCT00685399|536608051|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148763492|NCT00685399|536608052|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148763493|NCT00685399|536608053|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148763494|NCT00685399|536608054|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148763495|NCT00685399|536608055|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148763496|NCT00685399|536608056|FG005|Treatment Period 2|Withdrawal by Subject|0|||
148763497|NCT00685399|536608057|FG006|Treatment Period 2|Withdrawal by Subject|0|||
148763498|NCT00685399|536608058|FG007|Treatment Period 2|Withdrawal by Subject|2|||
148763499|NCT00685399|536608051|FG000|Treatment Period 2|Adverse Event|0|||
148763500|NCT00685399|536608052|FG001|Treatment Period 2|Adverse Event|0|||
148763501|NCT00685399|536608053|FG002|Treatment Period 2|Adverse Event|0|||
148763502|NCT00685399|536608054|FG003|Treatment Period 2|Adverse Event|0|||
148763503|NCT00685399|536608055|FG004|Treatment Period 2|Adverse Event|0|||
148763504|NCT00685399|536608056|FG005|Treatment Period 2|Adverse Event|1|||
148763505|NCT00685399|536608057|FG006|Treatment Period 2|Adverse Event|0|||
148763506|NCT00685399|536608058|FG007|Treatment Period 2|Adverse Event|0|||
148763507|NCT00685399|536608051|FG000|Treatment Period 2|Lack of Efficacy|0|||
148763508|NCT00685399|536608052|FG001|Treatment Period 2|Lack of Efficacy|10|||
148763509|NCT00685399|536608053|FG002|Treatment Period 2|Lack of Efficacy|2|||
148763510|NCT00685399|536608054|FG003|Treatment Period 2|Lack of Efficacy|0|||
148763511|NCT00685399|536608055|FG004|Treatment Period 2|Lack of Efficacy|0|||
148763512|NCT00685399|536608056|FG005|Treatment Period 2|Lack of Efficacy|1|||
148763513|NCT00685399|536608057|FG006|Treatment Period 2|Lack of Efficacy|0|||
148763514|NCT00685399|536608058|FG007|Treatment Period 2|Lack of Efficacy|0|||
148763515|NCT00685399|536608051|FG000|Extension|Administrative Issues|0|||
148763516|NCT00685399|536608052|FG001|Extension|Administrative Issues|0|||
148763517|NCT00685399|536608053|FG002|Extension|Administrative Issues|0|||
148763518|NCT00685399|536608054|FG003|Extension|Administrative Issues|1|||
148763519|NCT00685399|536608055|FG004|Extension|Administrative Issues|0|||
148763520|NCT00685399|536608056|FG005|Extension|Administrative Issues|0|||
148763521|NCT00685399|536608057|FG006|Extension|Administrative Issues|0|||
148763522|NCT00685399|536608058|FG007|Extension|Administrative Issues|0|||
148763523|NCT00685399|536608051|FG000|Extension|Withdrawal by Subject|0|||
148763524|NCT00685399|536608052|FG001|Extension|Withdrawal by Subject|0|||
148763525|NCT00685399|536608053|FG002|Extension|Withdrawal by Subject|0|||
148763526|NCT00685399|536608054|FG003|Extension|Withdrawal by Subject|1|||
148763527|NCT00685399|536608055|FG004|Extension|Withdrawal by Subject|0|||
148763528|NCT00685399|536608056|FG005|Extension|Withdrawal by Subject|0|||
148763529|NCT00685399|536608057|FG006|Extension|Withdrawal by Subject|0|||
148763530|NCT00685399|536608058|FG007|Extension|Withdrawal by Subject|0|||
148763531|NCT00685399|536608051|FG000|Extension|Protocol Violation|0|||
148763532|NCT00685399|536608052|FG001|Extension|Protocol Violation|0|||
148763533|NCT00685399|536608053|FG002|Extension|Protocol Violation|0|||
148763534|NCT00685399|536608054|FG003|Extension|Protocol Violation|1|||
148763535|NCT00685399|536608055|FG004|Extension|Protocol Violation|0|||
148763536|NCT00685399|536608056|FG005|Extension|Protocol Violation|0|||
148763537|NCT00685399|536608057|FG006|Extension|Protocol Violation|0|||
148763538|NCT00685399|536608058|FG007|Extension|Protocol Violation|0|||
148763539|NCT00685399|536608051|FG000|Extension|Lack of Efficacy|0|||
148763540|NCT00685399|536608052|FG001|Extension|Lack of Efficacy|0|||
148763541|NCT00685399|536608053|FG002|Extension|Lack of Efficacy|0|||
148763542|NCT00685399|536608054|FG003|Extension|Lack of Efficacy|2|||
148763543|NCT00685399|536608055|FG004|Extension|Lack of Efficacy|0|||
148763544|NCT00685399|536608056|FG005|Extension|Lack of Efficacy|0|||
148763545|NCT00685399|536608057|FG006|Extension|Lack of Efficacy|0|||
148763546|NCT00685399|536608058|FG007|Extension|Lack of Efficacy|0|||
148763547|NCT00685399|536608051|FG000|Extension|Adverse Event|0|||
148763548|NCT00685399|536608052|FG001|Extension|Adverse Event|0|||
148763549|NCT00685399|536608053|FG002|Extension|Adverse Event|0|||
148763550|NCT00685399|536608054|FG003|Extension|Adverse Event|2|||
148763551|NCT00685399|536608055|FG004|Extension|Adverse Event|0|||
148763552|NCT00685399|536608056|FG005|Extension|Adverse Event|0|||
148763553|NCT00685399|536608057|FG006|Extension|Adverse Event|0|||
148763554|NCT00685399|536608058|FG007|Extension|Adverse Event|0|||
148763555|NCT02684097|536608064|FG000|Overall Study|Lack of Efficacy|13|||
148763556|NCT02684097|536608065|FG001|Overall Study|Lack of Efficacy|6|||
148763557|NCT00462709|536608066|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
148763558|NCT00462709|536608066|FG000|Overall Study|Lost to Follow-up|10|||
148763559|NCT00462709|536608066|FG000|Overall Study|Withdrawal by Subject|8|||
148763560|NCT00462709|536608066|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
148763561|NCT00462709|536608066|FG000|Overall Study|Death|2|||
148763562|NCT00462709|536608066|FG000|Overall Study|Logistical reasons|2|||
148763563|NCT00462709|536608066|FG000|Overall Study|Physician Decision|1|||
148763564|NCT00462709|536608066|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
148763565|NCT02064816|536608067|FG000|Overall Study|Adverse Event|3|||
148763566|NCT02064816|536608068|FG001|Overall Study|Adverse Event|2|||
148763567|NCT02064816|536608067|FG000|Overall Study|Withdrawal by Subject|2|||
148763568|NCT02064816|536608068|FG001|Overall Study|Withdrawal by Subject|1|||
148763569|NCT02064816|536608067|FG000|Overall Study|Lost to Follow-up|2|||
148763570|NCT02064816|536608068|FG001|Overall Study|Lost to Follow-up|1|||
148763571|NCT02064816|536608067|FG000|Overall Study|Therapeutic failure|0|||
148763572|NCT02064816|536608068|FG001|Overall Study|Therapeutic failure|1|||
148763573|NCT02064816|536608067|FG000|Overall Study|Other|1|||
148763574|NCT02064816|536608068|FG001|Overall Study|Other|3|||
148763575|NCT04468347|536608069|FG000|Overall Study|Withdrawal by Subject|0|||
148763576|NCT04468347|536608070|FG001|Overall Study|Withdrawal by Subject|1|||
148763577|NCT04468347|536608071|FG002|Overall Study|Withdrawal by Subject|3|||
148763578|NCT04468347|536608072|FG003|Overall Study|Withdrawal by Subject|3|||
148763579|NCT04468347|536608069|FG000|Overall Study|Lost to Follow-up|0|||
148763580|NCT04468347|536608070|FG001|Overall Study|Lost to Follow-up|0|||
148763581|NCT04468347|536608071|FG002|Overall Study|Lost to Follow-up|1|||
148763582|NCT04468347|536608072|FG003|Overall Study|Lost to Follow-up|1|||
148763583|NCT04468347|536608069|FG000|Overall Study|Physician Decision|1|||
148763584|NCT04468347|536608070|FG001|Overall Study|Physician Decision|0|||
148763585|NCT04468347|536608071|FG002|Overall Study|Physician Decision|2|||
148763586|NCT04468347|536608072|FG003|Overall Study|Physician Decision|0|||
148763587|NCT04468347|536608069|FG000|Overall Study|Protocol Violation|1|||
148763588|NCT04468347|536608070|FG001|Overall Study|Protocol Violation|0|||
148763589|NCT04468347|536608071|FG002|Overall Study|Protocol Violation|0|||
148763590|NCT04468347|536608072|FG003|Overall Study|Protocol Violation|0|||
148763591|NCT01732458|536608073|FG000|Overall Study|Lost to Follow-up|0|||
148763592|NCT01732458|536608074|FG001|Overall Study|Lost to Follow-up|2|||
148763593|NCT01732458|536608075|FG002|Overall Study|Lost to Follow-up|0|||
148763594|NCT01732458|536608076|FG003|Overall Study|Lost to Follow-up|0|||
148763595|NCT01732458|536608073|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148763596|NCT01732458|536608074|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148763597|NCT01732458|536608075|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148763598|NCT01732458|536608076|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148763599|NCT01732458|536608073|FG000|Overall Study|Physician Decision|1|||
148763600|NCT01732458|536608074|FG001|Overall Study|Physician Decision|2|||
148763601|NCT01732458|536608075|FG002|Overall Study|Physician Decision|2|||
148763602|NCT01732458|536608076|FG003|Overall Study|Physician Decision|0|||
148763603|NCT01732458|536608073|FG000|Overall Study|Protocol Violation|2|||
148763604|NCT01732458|536608074|FG001|Overall Study|Protocol Violation|0|||
148763605|NCT01732458|536608075|FG002|Overall Study|Protocol Violation|0|||
148763606|NCT01732458|536608076|FG003|Overall Study|Protocol Violation|2|||
148763607|NCT01732458|536608073|FG000|Overall Study|Screen Failure|0|||
148763608|NCT01732458|536608074|FG001|Overall Study|Screen Failure|1|||
148763609|NCT01732458|536608075|FG002|Overall Study|Screen Failure|0|||
148763610|NCT01732458|536608076|FG003|Overall Study|Screen Failure|0|||
148763611|NCT05107492|536608077|FG000|Overall Study|Lost to Follow-up|1|||
148763612|NCT05107492|536608078|FG001|Overall Study|Lost to Follow-up|0|||
148763613|NCT04339062|536608079|FG000|Overall Study|Death|0|||
148763614|NCT04339062|536608080|FG001|Overall Study|Death|1|||
148763615|NCT03218826|536608081|FG000|Overall Study|Non-compliance with protocol|1|||
148763616|NCT03218826|536608082|FG001|Overall Study|Non-compliance with protocol|0|||
148763617|NCT03218826|536608083|FG002|Overall Study|Non-compliance with protocol|2|||
148763618|NCT03218826|536608084|FG003|Overall Study|Non-compliance with protocol|1|||
148763619|NCT03218826|536608085|FG004|Overall Study|Non-compliance with protocol|1|||
148763620|NCT01197534|536608086|FG000|Overall Study|Not reported|16|||
148763621|NCT01197534|536608087|FG001|Overall Study|Not reported|10|||
148763622|NCT01197534|536608088|FG002|Overall Study|Not reported|16|||
148763623|NCT01197534|536608086|FG000|Overall Study|Enrolment in long term extension|57|||
148763624|NCT01197534|536608087|FG001|Overall Study|Enrolment in long term extension|66|||
148763625|NCT01197534|536608088|FG002|Overall Study|Enrolment in long term extension|119|||
148763626|NCT01197534|536608086|FG000|Overall Study|Severe non-compliance to protocol|3|||
148763627|NCT01197534|536608087|FG001|Overall Study|Severe non-compliance to protocol|4|||
148763628|NCT01197534|536608088|FG002|Overall Study|Severe non-compliance to protocol|1|||
148763629|NCT01197534|536608086|FG000|Overall Study|Lack of therapeutic response|9|||
148763630|NCT01197534|536608087|FG001|Overall Study|Lack of therapeutic response|4|||
148763631|NCT01197534|536608088|FG002|Overall Study|Lack of therapeutic response|9|||
148763632|NCT01197534|536608086|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
148763633|NCT01197534|536608087|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
148763634|NCT01197534|536608088|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
148763635|NCT01197534|536608086|FG000|Overall Study|Lost to Follow-up|1|||
148763636|NCT01197534|536608087|FG001|Overall Study|Lost to Follow-up|4|||
148763637|NCT01197534|536608088|FG002|Overall Study|Lost to Follow-up|2|||
148763638|NCT01197534|536608086|FG000|Overall Study|Adverse Event|35|||
148763639|NCT01197534|536608087|FG001|Overall Study|Adverse Event|36|||
148763640|NCT01197534|536608088|FG002|Overall Study|Adverse Event|24|||
148763641|NCT02589639|536608093|FG000|Overall Study|Lost to Follow-up|1|||
148763642|NCT02589639|536608094|FG001|Overall Study|Lost to Follow-up|0|||
148763643|NCT02589639|536608095|FG002|Overall Study|Lost to Follow-up|0|||
148763644|NCT02589639|536608093|FG000|Overall Study|Protocol Violation|1|||
148763645|NCT02589639|536608094|FG001|Overall Study|Protocol Violation|0|||
148763646|NCT02589639|536608095|FG002|Overall Study|Protocol Violation|0|||
148826614|NCT04744831|536844253|FG002|Overall Study|Other|1|||
148763647|NCT02589639|536608093|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
148763648|NCT02589639|536608094|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
148763649|NCT02589639|536608095|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
148763650|NCT02589639|536608093|FG000|Overall Study|Adverse Event|4|||
148763651|NCT02589639|536608094|FG001|Overall Study|Adverse Event|5|||
148763652|NCT02589639|536608095|FG002|Overall Study|Adverse Event|3|||
148763653|NCT02589639|536608093|FG000|Overall Study|Other reason than specified above|1|||
148763654|NCT02589639|536608094|FG001|Overall Study|Other reason than specified above|2|||
148763655|NCT02589639|536608095|FG002|Overall Study|Other reason than specified above|1|||
148763656|NCT02589639|536608093|FG000|Overall Study|Not Treated|0|||
148763657|NCT02589639|536608094|FG001|Overall Study|Not Treated|3|||
148763658|NCT02589639|536608095|FG002|Overall Study|Not Treated|0|||
148763659|NCT00703157|536608096|FG000|Overall Study|Lost to Follow-up|0|||
148763660|NCT00703157|536608097|FG001|Overall Study|Lost to Follow-up|1|||
148763661|NCT00703157|536608096|FG000|Overall Study|source data permanently lost/ other|4|||
148763662|NCT00703157|536608097|FG001|Overall Study|source data permanently lost/ other|1|||
148763663|NCT02907177|536608098|FG000|Overall Study|Death|0|||
148763664|NCT02907177|536608099|FG001|Overall Study|Death|1|||
148763665|NCT02907177|536608098|FG000|Overall Study|Physician Decision|3|||
148763666|NCT02907177|536608099|FG001|Overall Study|Physician Decision|3|||
148763667|NCT02907177|536608098|FG000|Overall Study|Withdrawal by Subject|15|||
148763668|NCT02907177|536608099|FG001|Overall Study|Withdrawal by Subject|7|||
148763669|NCT02907177|536608098|FG000|Overall Study|Sponsor's Decision|50|||
148763670|NCT02907177|536608099|FG001|Overall Study|Sponsor's Decision|57|||
148763671|NCT02968173|536608102|FG000|Overall Study|Withdrawal by Subject|1|||
148763672|NCT02670525|536608103|FG000|Overall Study|Death|94|||
148763673|NCT02670525|536608104|FG001|Overall Study|Death|14|||
148763674|NCT02670525|536608103|FG000|Overall Study|Lost to Follow-up|4|||
148763675|NCT02670525|536608104|FG001|Overall Study|Lost to Follow-up|1|||
148763676|NCT02670525|536608103|FG000|Overall Study|Subject withdrew consent|1|||
148763677|NCT02670525|536608104|FG001|Overall Study|Subject withdrew consent|0|||
148763678|NCT02670525|536608103|FG000|Overall Study|Unknown, data entry delayed|123|||
148763679|NCT02670525|536608104|FG001|Overall Study|Unknown, data entry delayed|78|||
148763680|NCT01796392|536608105|FG000|Overall Study|Withdrawal by Subject|2|||
148763681|NCT01796392|536608106|FG001|Overall Study|Withdrawal by Subject|0|||
148763682|NCT01796392|536608105|FG000|Overall Study|Death|5|||
148763683|NCT01796392|536608106|FG001|Overall Study|Death|1|||
148763684|NCT01796392|536608105|FG000|Overall Study|Excluded for medical reasons|1|||
148763685|NCT01796392|536608106|FG001|Overall Study|Excluded for medical reasons|2|||
148763686|NCT01796392|536608105|FG000|Overall Study|Lost to Follow-up|1|||
148763687|NCT01796392|536608106|FG001|Overall Study|Lost to Follow-up|0|||
148763688|NCT04681066|536608107|FG000|Overall Study|Lost to Follow-up|3|||
148763689|NCT04681066|536608108|FG001|Overall Study|Lost to Follow-up|1|||
148763690|NCT04681066|536608109|FG002|Overall Study|Lost to Follow-up|2|||
148763691|NCT04681066|536608110|FG003|Overall Study|Lost to Follow-up|1|||
148763692|NCT04681066|536608107|FG000|Overall Study|Withdrawal by Subject|2|||
148763693|NCT04681066|536608108|FG001|Overall Study|Withdrawal by Subject|1|||
148763694|NCT04681066|536608109|FG002|Overall Study|Withdrawal by Subject|0|||
148763695|NCT04681066|536608110|FG003|Overall Study|Withdrawal by Subject|3|||
148763696|NCT04681066|536608107|FG000|Overall Study|Death|0|||
148763697|NCT04681066|536608108|FG001|Overall Study|Death|1|||
148763698|NCT04681066|536608109|FG002|Overall Study|Death|0|||
148763699|NCT04681066|536608110|FG003|Overall Study|Death|0|||
148763700|NCT03517540|536608116|FG000|Overall Study|Protocol Violation|2|||
148763701|NCT03517540|536608117|FG001|Overall Study|Protocol Violation|0|||
148763702|NCT03517540|536608118|FG002|Overall Study|Protocol Violation|0|||
148763703|NCT03517540|536608119|FG003|Overall Study|Protocol Violation|1|||
148763704|NCT03517540|536608116|FG000|Overall Study|Adverse Event|9|||
148763705|NCT03517540|536608117|FG001|Overall Study|Adverse Event|3|||
148763706|NCT03517540|536608118|FG002|Overall Study|Adverse Event|8|||
148763707|NCT03517540|536608119|FG003|Overall Study|Adverse Event|1|||
148763708|NCT03517540|536608116|FG000|Overall Study|Withdrawal by Subject|3|||
148763709|NCT03517540|536608117|FG001|Overall Study|Withdrawal by Subject|4|||
148763710|NCT03517540|536608118|FG002|Overall Study|Withdrawal by Subject|1|||
149027698|NCT02487446|537578634|FG000|Washout|Adverse Event|2|||
148763711|NCT03517540|536608119|FG003|Overall Study|Withdrawal by Subject|3|||
148763712|NCT01205269|536608120|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
148763713|NCT01205269|536608121|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
148763714|NCT01205269|536608122|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
148763715|NCT01205269|536608123|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
148763716|NCT01205269|536608124|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
148763717|NCT01205269|536608125|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
148763718|NCT01207687|536608126|FG000|Overall Study|Adverse Event|1|||
148763719|NCT01207687|536608126|FG000|Overall Study|Withdrawal by Subject|1|||
148763720|NCT00987337|536608127|FG000|Overall Study|Adverse Event|10|||
148763721|NCT00987337|536608128|FG001|Overall Study|Adverse Event|9|||
148763722|NCT00987337|536608129|FG002|Overall Study|Adverse Event|8|||
148763723|NCT00987337|536608127|FG000|Overall Study|Insufficient Virologic Response|10|||
148826615|NCT04744831|536844251|FG000|Overall Study|Death|0|||
148826616|NCT04744831|536844252|FG001|Overall Study|Death|2|||
148826617|NCT04744831|536844253|FG002|Overall Study|Death|1|||
148826618|NCT00590317|536844256|FG000|Overall Study|Lack of Efficacy|1|||
148826619|NCT00590317|536844257|FG001|Overall Study|Lack of Efficacy|5|||
148826620|NCT03443401|536844260|FG000|Overall Study|Lost to Follow-up|13|||
148826621|NCT03443401|536844260|FG000|Overall Study|Influential outlier|1|||
148826622|NCT01394185|536844261|FG000|Overall Study|Withdrawal by Subject|2|||
148826623|NCT01394185|536844262|FG001|Overall Study|Withdrawal by Subject|0|||
148826624|NCT01394185|536844263|FG002|Overall Study|Withdrawal by Subject|0|||
148826625|NCT01394185|536844264|FG003|Overall Study|Withdrawal by Subject|0|||
148826626|NCT01394185|536844265|FG004|Overall Study|Withdrawal by Subject|1|||
148826627|NCT01394185|536844266|FG005|Overall Study|Withdrawal by Subject|0|||
148826628|NCT01394185|536844261|FG000|Overall Study|Change in protocol|3|||
148826629|NCT01394185|536844262|FG001|Overall Study|Change in protocol|0|||
148826630|NCT01394185|536844263|FG002|Overall Study|Change in protocol|0|||
148826631|NCT01394185|536844264|FG003|Overall Study|Change in protocol|0|||
148826632|NCT01394185|536844265|FG004|Overall Study|Change in protocol|3|||
148826633|NCT01394185|536844266|FG005|Overall Study|Change in protocol|0|||
148977634|NCT04456699|537398390|FG001|Overall Study|Death|50|||
148977635|NCT04456699|537398391|FG002|Overall Study|Death|52|||
148977636|NCT04456699|537398389|FG000|Overall Study|Physician Decision|0|||
148977637|NCT04456699|537398390|FG001|Overall Study|Physician Decision|0|||
148977638|NCT04456699|537398391|FG002|Overall Study|Physician Decision|2|||
148977639|NCT04456699|537398389|FG000|Overall Study|Sponsor Decision|55|||
148977640|NCT04456699|537398390|FG001|Overall Study|Sponsor Decision|61|||
148977641|NCT04456699|537398391|FG002|Overall Study|Sponsor Decision|50|||
148977642|NCT04456699|537398389|FG000|Overall Study|Withdrawal by Subject|8|||
148977643|NCT04456699|537398390|FG001|Overall Study|Withdrawal by Subject|4|||
148977644|NCT04456699|537398391|FG002|Overall Study|Withdrawal by Subject|5|||
148977645|NCT02247349|537398399|FG000|Overall Study|Disease Progression|7|||
148977646|NCT02247349|537398400|FG001|Overall Study|Disease Progression|4|||
148977647|NCT02247349|537398401|FG002|Overall Study|Disease Progression|26|||
148977648|NCT02247349|537398402|FG003|Overall Study|Disease Progression|31|||
148977649|NCT02247349|537398403|FG004|Overall Study|Disease Progression|16|||
148977650|NCT02247349|537398404|FG005|Overall Study|Disease Progression|6|||
148977651|NCT02247349|537398399|FG000|Overall Study|Study drug toxicity|0|||
148977652|NCT02247349|537398400|FG001|Overall Study|Study drug toxicity|1|||
148977653|NCT02247349|537398401|FG002|Overall Study|Study drug toxicity|1|||
148977654|NCT02247349|537398402|FG003|Overall Study|Study drug toxicity|1|||
148977655|NCT02247349|537398403|FG004|Overall Study|Study drug toxicity|2|||
148977656|NCT02247349|537398404|FG005|Overall Study|Study drug toxicity|2|||
148977657|NCT02247349|537398399|FG000|Overall Study|Death|0|||
148977658|NCT02247349|537398400|FG001|Overall Study|Death|0|||
148977659|NCT02247349|537398401|FG002|Overall Study|Death|0|||
148977660|NCT02247349|537398402|FG003|Overall Study|Death|1|||
148977661|NCT02247349|537398403|FG004|Overall Study|Death|0|||
148977662|NCT02247349|537398404|FG005|Overall Study|Death|0|||
148977663|NCT02247349|537398399|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
148977664|NCT02247349|537398400|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
148977665|NCT02247349|537398401|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
148977666|NCT02247349|537398402|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
148977667|NCT02247349|537398403|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
148977668|NCT02247349|537398404|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
148977669|NCT02247349|537398399|FG000|Overall Study|Participant request to discontinue study treatment|0|||
148826634|NCT01394185|536844261|FG000|Overall Study|Protocol Violation|1|||
148826635|NCT01394185|536844262|FG001|Overall Study|Protocol Violation|0|||
148826636|NCT01394185|536844263|FG002|Overall Study|Protocol Violation|0|||
148826637|NCT01394185|536844264|FG003|Overall Study|Protocol Violation|1|||
148826638|NCT01394185|536844265|FG004|Overall Study|Protocol Violation|0|||
148826639|NCT01394185|536844266|FG005|Overall Study|Protocol Violation|1|||
148826640|NCT05401409|536844267|FG000|Overall Study|Lost to Follow-up|1|||
148826641|NCT05401409|536844268|FG001|Overall Study|Lost to Follow-up|0|||
148977670|NCT02247349|537398400|FG001|Overall Study|Participant request to discontinue study treatment|0|||
148977671|NCT02247349|537398401|FG002|Overall Study|Participant request to discontinue study treatment|1|||
148977672|NCT02247349|537398402|FG003|Overall Study|Participant request to discontinue study treatment|2|||
148977673|NCT02247349|537398403|FG004|Overall Study|Participant request to discontinue study treatment|1|||
148977674|NCT02247349|537398404|FG005|Overall Study|Participant request to discontinue study treatment|0|||
148977675|NCT02247349|537398399|FG000|Overall Study|Withdrawal by Subject|0|||
148977676|NCT02247349|537398400|FG001|Overall Study|Withdrawal by Subject|1|||
148977677|NCT02247349|537398401|FG002|Overall Study|Withdrawal by Subject|0|||
148977678|NCT02247349|537398402|FG003|Overall Study|Withdrawal by Subject|0|||
148977679|NCT02247349|537398403|FG004|Overall Study|Withdrawal by Subject|0|||
148977680|NCT02247349|537398404|FG005|Overall Study|Withdrawal by Subject|0|||
148977681|NCT02247349|537398399|FG000|Overall Study|Administrative reason by sponsor|0|||
148977682|NCT02247349|537398400|FG001|Overall Study|Administrative reason by sponsor|0|||
148977683|NCT02247349|537398401|FG002|Overall Study|Administrative reason by sponsor|0|||
148763724|NCT00987337|536608128|FG001|Overall Study|Insufficient Virologic Response|7|||
148763725|NCT00987337|536608129|FG002|Overall Study|Insufficient Virologic Response|12|||
148763726|NCT00987337|536608127|FG000|Overall Study|Virologic Breakthrough|2|||
148763727|NCT00987337|536608128|FG001|Overall Study|Virologic Breakthrough|2|||
148763728|NCT00987337|536608129|FG002|Overall Study|Virologic Breakthrough|8|||
148763729|NCT00987337|536608127|FG000|Overall Study|Lost to Follow-up|10|||
148763730|NCT00987337|536608128|FG001|Overall Study|Lost to Follow-up|6|||
148763731|NCT00987337|536608129|FG002|Overall Study|Lost to Follow-up|2|||
148763732|NCT00987337|536608127|FG000|Overall Study|Withdrawal by Subject|6|||
148763733|NCT00987337|536608128|FG001|Overall Study|Withdrawal by Subject|9|||
148763734|NCT00987337|536608129|FG002|Overall Study|Withdrawal by Subject|9|||
148763735|NCT00987337|536608127|FG000|Overall Study|Other|0|||
148763736|NCT00987337|536608128|FG001|Overall Study|Other|2|||
148763737|NCT00987337|536608129|FG002|Overall Study|Other|5|||
148763738|NCT00987337|536608127|FG000|Overall Study|Protocol Violation|1|||
148763739|NCT00987337|536608128|FG001|Overall Study|Protocol Violation|0|||
148763740|NCT00987337|536608129|FG002|Overall Study|Protocol Violation|2|||
148763741|NCT00987337|536608127|FG000|Overall Study|Participant Relapsed|18|||
148763742|NCT00987337|536608128|FG001|Overall Study|Participant Relapsed|20|||
148763743|NCT00987337|536608129|FG002|Overall Study|Participant Relapsed|5|||
148763744|NCT01801865|536608130|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
148763745|NCT01801865|536608130|FG000|Overall Study|Physician Decision|7|||
148763746|NCT03867201|536608131|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
148763747|NCT03867201|536608132|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
148763748|NCT03867201|536608131|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
148763749|NCT03867201|536608132|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
148763750|NCT03867201|536608131|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
148763751|NCT03867201|536608132|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
148763752|NCT03867201|536608131|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
148763753|NCT03867201|536608132|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
148763754|NCT03867201|536608131|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
148763755|NCT03867201|536608132|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
148763756|NCT03867201|536608131|FG000|Open-Label Period From Week 12|Adverse Event|5|||
148763757|NCT03867201|536608132|FG001|Open-Label Period From Week 12|Adverse Event|11|||
148763758|NCT03867201|536608131|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
148763759|NCT03867201|536608132|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
148763760|NCT03867201|536608131|FG000|Open-Label Period From Week 12|Physician Decision|6|||
148763761|NCT03867201|536608132|FG001|Open-Label Period From Week 12|Physician Decision|3|||
148763762|NCT03867201|536608131|FG000|Open-Label Period From Week 12|Pregnancy|2|||
148763763|NCT03867201|536608132|FG001|Open-Label Period From Week 12|Pregnancy|2|||
148763764|NCT03867201|536608131|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
148763765|NCT03867201|536608132|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
148763766|NCT03867201|536608131|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
148763767|NCT03867201|536608132|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
148763768|NCT03867201|536608131|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
148763769|NCT03867201|536608132|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
148763770|NCT03867201|536608131|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
148763771|NCT03867201|536608132|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
148763772|NCT05763875|536608137|FG000|Overall Study|Subject decision|5|||
148763773|NCT05763875|536608138|FG001|Overall Study|Subject decision|2|||
148763774|NCT05763875|536608139|FG002|Overall Study|Subject decision|1|||
148763775|NCT05763875|536608137|FG000|Overall Study|Lost to Follow-up|4|||
148763776|NCT05763875|536608138|FG001|Overall Study|Lost to Follow-up|1|||
148763777|NCT05763875|536608139|FG002|Overall Study|Lost to Follow-up|2|||
148977684|NCT02247349|537398402|FG003|Overall Study|Administrative reason by sponsor|0|||
148763778|NCT05763875|536608137|FG000|Overall Study|Adverse Event|1|||
148763779|NCT05763875|536608138|FG001|Overall Study|Adverse Event|0|||
148763780|NCT05763875|536608139|FG002|Overall Study|Adverse Event|0|||
148763781|NCT01777282|536608140|FG000|Overall Study|Persistent Hyperglycemia|0|||
148763782|NCT01777282|536608141|FG001|Overall Study|Persistent Hyperglycemia|0|||
148763783|NCT01777282|536608142|FG002|Overall Study|Persistent Hyperglycemia|1|||
148763784|NCT01777282|536608143|FG003|Overall Study|Persistent Hyperglycemia|0|||
148763785|NCT01777282|536608144|FG004|Overall Study|Persistent Hyperglycemia|0|||
148763786|NCT01777282|536608140|FG000|Overall Study|New Antidiabetic Medication|0|||
148763787|NCT01777282|536608141|FG001|Overall Study|New Antidiabetic Medication|0|||
148977685|NCT02247349|537398403|FG004|Overall Study|Administrative reason by sponsor|1|||
148977686|NCT02247349|537398404|FG005|Overall Study|Administrative reason by sponsor|0|||
148763788|NCT01777282|536608142|FG002|Overall Study|New Antidiabetic Medication|1|||
148763789|NCT01777282|536608143|FG003|Overall Study|New Antidiabetic Medication|0|||
148763790|NCT01777282|536608144|FG004|Overall Study|New Antidiabetic Medication|0|||
148763791|NCT01777282|536608140|FG000|Overall Study|Adverse Event|4|||
148763792|NCT01777282|536608141|FG001|Overall Study|Adverse Event|4|||
148977687|NCT02247349|537398399|FG000|Overall Study|Other reasons|0|||
148977688|NCT02247349|537398400|FG001|Overall Study|Other reasons|0|||
148826642|NCT02371889|536844269|FG000|Overall Study|Adverse medication effect|11|||
148826643|NCT02371889|536844270|FG001|Overall Study|Adverse medication effect|2|||
148826644|NCT02371889|536844269|FG000|Overall Study|Lost to Follow-up|6|||
148826645|NCT02371889|536844270|FG001|Overall Study|Lost to Follow-up|5|||
148826646|NCT02371889|536844269|FG000|Overall Study|Personal time constraints|2|||
148826647|NCT02371889|536844270|FG001|Overall Study|Personal time constraints|4|||
148826648|NCT02371889|536844269|FG000|Overall Study|Lack of Efficacy|0|||
148826649|NCT02371889|536844270|FG001|Overall Study|Lack of Efficacy|2|||
148826650|NCT02371889|536844269|FG000|Overall Study|Relapse|0|||
148826651|NCT02371889|536844270|FG001|Overall Study|Relapse|1|||
148826652|NCT06844812|536844271|FG000|Overall Study|Lost to Follow-up|5|||
148826653|NCT06844812|536844271|FG000|Overall Study|stigmatization concerns|2|||
148826654|NCT06844812|536844271|FG000|Overall Study|medication refusal|2|||
148826655|NCT06844812|536844271|FG000|Overall Study|concerns about possible side effects|2|||
148826656|NCT06844812|536844271|FG000|Overall Study|wanting to seek another specialist opinion|2|||
148826657|NCT06844812|536844271|FG000|Overall Study|side effects (dizziness)|1|||
148826658|NCT05520333|536844272|FG000|Overall Study|Lost to Follow-up|3|||
148826659|NCT05520333|536844273|FG001|Overall Study|Lost to Follow-up|6|||
148826660|NCT02410200|536844274|FG000|Overall Study|Adverse Event|2|||
148826661|NCT02336555|536844276|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
148826662|NCT02336555|536844277|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
148826663|NCT02336555|536844276|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
148826664|NCT02336555|536844277|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
148826665|NCT02336555|536844276|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
148826666|NCT02336555|536844277|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
148826667|NCT03682367|536844280|FG000|Overall Study|Protocol Violation|2|||
148826668|NCT03682367|536844281|FG001|Overall Study|Protocol Violation|1|||
148826669|NCT03682367|536844280|FG000|Overall Study|Closed Study Early|0|||
148826670|NCT03682367|536844281|FG001|Overall Study|Closed Study Early|3|||
148826671|NCT02605967|536844284|FG000|Overall Study|subject / guardian decision|1|||
148826672|NCT02605967|536844285|FG001|Overall Study|subject / guardian decision|2|||
148826673|NCT02605967|536844284|FG000|Overall Study|Physician Decision|10|||
148826674|NCT02605967|536844285|FG001|Overall Study|Physician Decision|1|||
148826675|NCT02605967|536844284|FG000|Overall Study|Death|4|||
148826676|NCT02605967|536844285|FG001|Overall Study|Death|2|||
148826677|NCT02605967|536844284|FG000|Overall Study|Adverse Event|1|||
148826678|NCT02605967|536844285|FG001|Overall Study|Adverse Event|0|||
148826679|NCT02605967|536844284|FG000|Overall Study|progressive disease|66|||
148826680|NCT02605967|536844285|FG001|Overall Study|progressive disease|35|||
148826681|NCT01903720|536844287|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
148826682|NCT01903720|536844287|FG000|Overall Study|Adverse Event|1|||
148826683|NCT01903720|536844287|FG000|Overall Study|Rescinding of informed consent|2|||
148826684|NCT01903720|536844287|FG000|Overall Study|Lost to Follow-up|2|||
148826685|NCT01903720|536844287|FG000|Overall Study|Treatment with alternative drug|1|||
148826686|NCT03627468|536844290|FG000|Overall Study|Adverse Event|5|||
148826687|NCT03627468|536844291|FG001|Overall Study|Adverse Event|33|||
148826688|NCT03627468|536844290|FG000|Overall Study|Withdrawal by Subject|13|||
148826689|NCT03627468|536844291|FG001|Overall Study|Withdrawal by Subject|23|||
148826690|NCT03627468|536844290|FG000|Overall Study|Physician Decision|1|||
148826691|NCT03627468|536844291|FG001|Overall Study|Physician Decision|0|||
148826692|NCT03627468|536844290|FG000|Overall Study|Protocol Violation|0|||
148826693|NCT03627468|536844291|FG001|Overall Study|Protocol Violation|2|||
148826694|NCT03627468|536844290|FG000|Overall Study|Lost to Follow-up|10|||
148826695|NCT03627468|536844291|FG001|Overall Study|Lost to Follow-up|16|||
148826696|NCT03627468|536844290|FG000|Overall Study|Death|1|||
148826697|NCT03627468|536844291|FG001|Overall Study|Death|0|||
148826698|NCT03627468|536844290|FG000|Overall Study|Pregnancy|1|||
148826699|NCT03627468|536844291|FG001|Overall Study|Pregnancy|1|||
148826700|NCT03627468|536844290|FG000|Overall Study|Lack of Efficacy|0|||
148826701|NCT03627468|536844291|FG001|Overall Study|Lack of Efficacy|2|||
148826702|NCT03627468|536844290|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
148826703|NCT03627468|536844291|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
148826704|NCT05122143|536844292|FG000|Overall Study|Adverse Event|1|||
148826705|NCT05122143|536844293|FG001|Overall Study|Adverse Event|0|||
148826706|NCT05122143|536844294|FG002|Overall Study|Adverse Event|0|||
148826707|NCT05122143|536844295|FG003|Overall Study|Adverse Event|0|||
148826708|NCT05122143|536844296|FG004|Overall Study|Adverse Event|1|||
148826709|NCT05122143|536844297|FG005|Overall Study|Adverse Event|0|||
148826710|NCT05122143|536844292|FG000|Overall Study|Protocol non-compliance|0|||
148826711|NCT05122143|536844293|FG001|Overall Study|Protocol non-compliance|0|||
148826712|NCT05122143|536844294|FG002|Overall Study|Protocol non-compliance|1|||
148826713|NCT05122143|536844295|FG003|Overall Study|Protocol non-compliance|0|||
148826714|NCT05122143|536844296|FG004|Overall Study|Protocol non-compliance|0|||
148826715|NCT05122143|536844297|FG005|Overall Study|Protocol non-compliance|0|||
148826716|NCT05122143|536844292|FG000|Overall Study|Covid contact|0|||
148826717|NCT05122143|536844293|FG001|Overall Study|Covid contact|0|||
148826718|NCT05122143|536844294|FG002|Overall Study|Covid contact|0|||
148826719|NCT05122143|536844295|FG003|Overall Study|Covid contact|0|||
148763793|NCT01777282|536608142|FG002|Overall Study|Adverse Event|2|||
148763794|NCT01777282|536608143|FG003|Overall Study|Adverse Event|1|||
148763795|NCT01777282|536608144|FG004|Overall Study|Adverse Event|3|||
148763796|NCT01777282|536608140|FG000|Overall Study|Withdrawal by Subject|4|||
148763797|NCT01777282|536608141|FG001|Overall Study|Withdrawal by Subject|0|||
148763798|NCT01777282|536608142|FG002|Overall Study|Withdrawal by Subject|0|||
148763799|NCT01777282|536608143|FG003|Overall Study|Withdrawal by Subject|1|||
148763800|NCT01777282|536608144|FG004|Overall Study|Withdrawal by Subject|2|||
148763801|NCT01777282|536608140|FG000|Overall Study|Protocol Violation|2|||
148763802|NCT01777282|536608141|FG001|Overall Study|Protocol Violation|0|||
148763803|NCT01777282|536608142|FG002|Overall Study|Protocol Violation|1|||
148763804|NCT01777282|536608143|FG003|Overall Study|Protocol Violation|0|||
148763805|NCT01777282|536608144|FG004|Overall Study|Protocol Violation|2|||
148763806|NCT01777282|536608140|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
148763807|NCT01777282|536608141|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
148763808|NCT01777282|536608142|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
148763809|NCT01777282|536608143|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
148763810|NCT01777282|536608144|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
148763811|NCT06360588|536610424|FG000|Overall Study|Adverse Event|3|||
148763812|NCT06360588|536610424|FG000|Overall Study|Death|2|||
148763813|NCT06360588|536610424|FG000|Overall Study|Disease Progression|14|||
148763814|NCT06360588|536610424|FG000|Overall Study|Withdrawal by Subject|1|||
148763815|NCT06360588|536610424|FG000|Overall Study|Lack of Efficacy|1|||
148763816|NCT06360588|536610424|FG000|Overall Study|Ineligible|1|||
148763817|NCT01481766|536610425|FG000|4 months|Lost to Follow-up|3|||
148763818|NCT01481766|536610426|FG001|4 months|Lost to Follow-up|2|||
148763819|NCT01481766|536610427|FG002|4 months|Lost to Follow-up|1|||
148763820|NCT01481766|536610428|FG003|4 months|Lost to Follow-up|5|||
148763821|NCT01481766|536610425|FG000|12 months|Lost to Follow-up|7|||
148763822|NCT01481766|536610426|FG001|12 months|Lost to Follow-up|8|||
148763823|NCT01481766|536610427|FG002|12 months|Lost to Follow-up|5|||
148763824|NCT01481766|536610428|FG003|12 months|Lost to Follow-up|3|||
148763825|NCT00347958|536610429|FG000|Overall Study|Adverse Event|1|||
148763826|NCT00347958|536610429|FG000|Overall Study|Protocol Violation|2|||
148763827|NCT00347958|536610429|FG000|Overall Study|Withdrawal by Subject|1|||
148763828|NCT00754234|536610430|FG000|Overall Study|Withdrawal by Subject|3|||
148763829|NCT04432831|536610431|FG000|Overall Study|Withdrawal by Subject|24|||
148763830|NCT04432831|536610432|FG001|Overall Study|Withdrawal by Subject|28|||
148763831|NCT04432831|536610433|FG002|Overall Study|Withdrawal by Subject|21|||
148763832|NCT04432831|536610431|FG000|Overall Study|Death|23|||
148763833|NCT04432831|536610432|FG001|Overall Study|Death|23|||
148763834|NCT04432831|536610433|FG002|Overall Study|Death|17|||
148763835|NCT04432831|536610431|FG000|Overall Study|Lost to Follow-up|15|||
148763836|NCT04432831|536610432|FG001|Overall Study|Lost to Follow-up|15|||
148763837|NCT04432831|536610433|FG002|Overall Study|Lost to Follow-up|12|||
148763838|NCT04432831|536610431|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
148763839|NCT04432831|536610432|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
148763840|NCT04432831|536610433|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
148763841|NCT04432831|536610431|FG000|Overall Study|Reason Not Specified|7|||
148763842|NCT04432831|536610432|FG001|Overall Study|Reason Not Specified|11|||
148763843|NCT04432831|536610433|FG002|Overall Study|Reason Not Specified|9|||
148763844|NCT04432831|536610431|FG000|Overall Study|Adverse Event|7|||
148763845|NCT04432831|536610432|FG001|Overall Study|Adverse Event|7|||
148763846|NCT04432831|536610433|FG002|Overall Study|Adverse Event|7|||
148763847|NCT04432831|536610431|FG000|Overall Study|Physician Decision|1|||
148763848|NCT04432831|536610432|FG001|Overall Study|Physician Decision|3|||
148763849|NCT04432831|536610433|FG002|Overall Study|Physician Decision|6|||
148763850|NCT04432831|536610431|FG000|Overall Study|Protocol Violation|1|||
148763851|NCT04432831|536610432|FG001|Overall Study|Protocol Violation|0|||
148763852|NCT04432831|536610433|FG002|Overall Study|Protocol Violation|2|||
148763853|NCT04432831|536610431|FG000|Overall Study|Pregnancy|0|||
148763854|NCT04432831|536610432|FG001|Overall Study|Pregnancy|1|||
148826720|NCT05122143|536844296|FG004|Overall Study|Covid contact|1|||
148763855|NCT04432831|536610433|FG002|Overall Study|Pregnancy|0|||
148763856|NCT04432831|536610431|FG000|Overall Study|Lack of Efficacy|0|||
148763857|NCT04432831|536610432|FG001|Overall Study|Lack of Efficacy|0|||
148763858|NCT04432831|536610433|FG002|Overall Study|Lack of Efficacy|2|||
148763859|NCT02151851|536610436|FG000|Overall Study|Lack of Efficacy|67|||
148826721|NCT05122143|536844297|FG005|Overall Study|Covid contact|0|||
148763860|NCT02151851|536610437|FG001|Overall Study|Lack of Efficacy|94|||
148763861|NCT02151851|536610436|FG000|Overall Study|Protocol Violation|0|||
148763862|NCT02151851|536610437|FG001|Overall Study|Protocol Violation|1|||
148763863|NCT02151851|536610436|FG000|Overall Study|Withdrawal by Subject|2|||
148763864|NCT02151851|536610437|FG001|Overall Study|Withdrawal by Subject|5|||
148763865|NCT02151851|536610436|FG000|Overall Study|Medical impairment|1|||
148826722|NCT00309946|536844298|FG000|Overall Study|Withdrawal by Subject|1|||
148826723|NCT02244957|536844299|FG000|Overall Study|Lack of Efficacy|1|||
148826724|NCT02244957|536844300|FG001|Overall Study|Lack of Efficacy|0|||
148826725|NCT00395447|536844303|FG000|Overall Study|Death|37|||
148763866|NCT02151851|536610437|FG001|Overall Study|Medical impairment|0|||
148763867|NCT02151851|536610436|FG000|Overall Study|Low compliance to study visits|0|||
148763868|NCT02151851|536610437|FG001|Overall Study|Low compliance to study visits|1|||
148763869|NCT02151851|536610436|FG000|Overall Study|Subject entered into study in error|0|||
148763870|NCT02151851|536610437|FG001|Overall Study|Subject entered into study in error|1|||
148763871|NCT02151851|536610436|FG000|Overall Study|Adverse Event|6|||
148763872|NCT02151851|536610437|FG001|Overall Study|Adverse Event|28|||
148763873|NCT02159053|536610438|FG000|Overall Study|Death|2|||
148763874|NCT02159053|536610439|FG001|Overall Study|Death|0|||
148763875|NCT02159053|536610440|FG002|Overall Study|Death|1|||
148763876|NCT02159053|536610438|FG000|Overall Study|Physician Decision|0|||
148763877|NCT02159053|536610439|FG001|Overall Study|Physician Decision|1|||
148763878|NCT02159053|536610440|FG002|Overall Study|Physician Decision|1|||
148763879|NCT02159053|536610438|FG000|Overall Study|Lack of Efficacy|3|||
148763880|NCT02159053|536610439|FG001|Overall Study|Lack of Efficacy|4|||
148763881|NCT02159053|536610440|FG002|Overall Study|Lack of Efficacy|7|||
148763882|NCT02159053|536610438|FG000|Overall Study|Adverse Event|7|||
148763883|NCT02159053|536610439|FG001|Overall Study|Adverse Event|6|||
148763884|NCT02159053|536610440|FG002|Overall Study|Adverse Event|5|||
148763885|NCT02159053|536610438|FG000|Overall Study|Participants/guardian decision|8|||
148763886|NCT02159053|536610439|FG001|Overall Study|Participants/guardian decision|10|||
148763887|NCT02159053|536610440|FG002|Overall Study|Participants/guardian decision|6|||
148763888|NCT01623310|536610443|FG000|Overall Study|Adverse Event|21|||
148763889|NCT01623310|536610443|FG000|Overall Study|Lost to Follow-up|18|||
148763890|NCT01623310|536610443|FG000|Overall Study|Lack of Efficacy|6|||
148763891|NCT01623310|536610443|FG000|Overall Study|Protocol Violation|6|||
148763892|NCT01623310|536610443|FG000|Overall Study|Withdrawal by Subject|25|||
148763893|NCT01623310|536610443|FG000|Overall Study|Became potentially child-bearing|1|||
148763894|NCT01623310|536610443|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
148763895|NCT01623310|536610443|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
148763896|NCT00356603|536610444|FG000|Overall Study|Other|6|||
148763897|NCT00356603|536610445|FG001|Overall Study|Other|3|||
148763898|NCT00734162|536610447|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
148763899|NCT00734162|536610448|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
148763900|NCT00734162|536610449|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
148763901|NCT00734162|536610450|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
148763902|NCT00734162|536610447|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
148763903|NCT00734162|536610448|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
148763904|NCT00734162|536610449|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
148763905|NCT00734162|536610450|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
148763906|NCT00734162|536610447|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
148763907|NCT00734162|536610448|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
148763908|NCT00734162|536610449|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
148763909|NCT00734162|536610450|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
148763910|NCT00734162|536610447|FG000|Open-Label Phase|Withdrew Consent|1|||
148763911|NCT00734162|536610448|FG001|Open-Label Phase|Withdrew Consent|0|||
148763912|NCT00734162|536610449|FG002|Open-Label Phase|Withdrew Consent|1|||
148763913|NCT00734162|536610450|FG003|Open-Label Phase|Withdrew Consent|1|||
148763914|NCT00734162|536610447|FG000|Open-Label Phase|Lost to Follow-up|1|||
148763915|NCT00734162|536610448|FG001|Open-Label Phase|Lost to Follow-up|2|||
148763916|NCT00734162|536610449|FG002|Open-Label Phase|Lost to Follow-up|0|||
148763917|NCT00734162|536610450|FG003|Open-Label Phase|Lost to Follow-up|1|||
148763918|NCT00734162|536610447|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
148763919|NCT00734162|536610448|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
148763920|NCT00734162|536610449|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
148763921|NCT00734162|536610450|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
148763922|NCT00566020|536610451|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
148763923|NCT00566020|536610452|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
148763924|NCT00566020|536610451|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
148763925|NCT00566020|536610452|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
148763926|NCT00566020|536610451|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
148763927|NCT00566020|536610452|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
148763928|NCT00566020|536610451|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
148763929|NCT00566020|536610452|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
148763930|NCT00566020|536610451|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
148763931|NCT00566020|536610452|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
148763932|NCT00566020|536610451|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
148763933|NCT00566020|536610452|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
148763934|NCT00596687|536610453|FG000|Overall Study|< 24 hours of insulin treatment|8|||
148763935|NCT00596687|536610454|FG001|Overall Study|< 24 hours of insulin treatment|6|||
148763936|NCT00596687|536610453|FG000|Overall Study|continuous insulin infusion during TPN|2|||
148763937|NCT00596687|536610454|FG001|Overall Study|continuous insulin infusion during TPN|1|||
148763938|NCT00596687|536610453|FG000|Overall Study|Withdrawal by Subject|3|||
148763939|NCT00596687|536610454|FG001|Overall Study|Withdrawal by Subject|1|||
148763940|NCT00596687|536610453|FG000|Overall Study|cancelled surgery|1|||
148763941|NCT00596687|536610454|FG001|Overall Study|cancelled surgery|1|||
148763942|NCT01262287|536610455|FG000|Overall Study|Lost to Follow-up|2|||
148763943|NCT01262287|536610456|FG001|Overall Study|Lost to Follow-up|1|||
148763944|NCT00932373|536610457|FG000|Overall Study|Progressive disease|3|||
148763945|NCT00932373|536610458|FG001|Overall Study|Progressive disease|1|||
148763946|NCT00932373|536610459|FG002|Overall Study|Progressive disease|0|||
148763947|NCT00932373|536610460|FG003|Overall Study|Progressive disease|0|||
148763948|NCT00932373|536610461|FG004|Overall Study|Progressive disease|10|||
148763949|NCT00932373|536610462|FG005|Overall Study|Progressive disease|1|||
148763950|NCT00932373|536610463|FG006|Overall Study|Progressive disease|0|||
148763951|NCT00932373|536610464|FG007|Overall Study|Progressive disease|2|||
148763952|NCT00932373|536610465|FG008|Overall Study|Progressive disease|1|||
148763953|NCT00932373|536610466|FG009|Overall Study|Progressive disease|9|||
148763954|NCT00932373|536610467|FG010|Overall Study|Progressive disease|2|||
148763955|NCT00932373|536610457|FG000|Overall Study|Adverse Event|0|||
148763956|NCT00932373|536610458|FG001|Overall Study|Adverse Event|0|||
148763957|NCT00932373|536610459|FG002|Overall Study|Adverse Event|0|||
148763958|NCT00932373|536610460|FG003|Overall Study|Adverse Event|0|||
148763959|NCT00932373|536610461|FG004|Overall Study|Adverse Event|2|||
148763960|NCT00932373|536610462|FG005|Overall Study|Adverse Event|1|||
148763961|NCT00932373|536610463|FG006|Overall Study|Adverse Event|0|||
148763962|NCT00932373|536610464|FG007|Overall Study|Adverse Event|1|||
148763963|NCT00932373|536610465|FG008|Overall Study|Adverse Event|0|||
148763964|NCT00932373|536610466|FG009|Overall Study|Adverse Event|2|||
148763965|NCT00932373|536610467|FG010|Overall Study|Adverse Event|1|||
148763966|NCT00932373|536610457|FG000|Overall Study|Physician Decision|0|||
148763967|NCT00932373|536610458|FG001|Overall Study|Physician Decision|0|||
148763968|NCT00932373|536610459|FG002|Overall Study|Physician Decision|1|||
148763969|NCT00932373|536610460|FG003|Overall Study|Physician Decision|0|||
148763970|NCT00932373|536610461|FG004|Overall Study|Physician Decision|2|||
148763971|NCT00932373|536610462|FG005|Overall Study|Physician Decision|0|||
148763972|NCT00932373|536610463|FG006|Overall Study|Physician Decision|0|||
148763973|NCT00932373|536610464|FG007|Overall Study|Physician Decision|0|||
148763974|NCT00932373|536610465|FG008|Overall Study|Physician Decision|0|||
148763975|NCT00932373|536610466|FG009|Overall Study|Physician Decision|1|||
148763976|NCT00932373|536610467|FG010|Overall Study|Physician Decision|0|||
148763977|NCT00932373|536610457|FG000|Overall Study|Dose limiting toxicity|0|||
148763978|NCT00932373|536610458|FG001|Overall Study|Dose limiting toxicity|0|||
148763979|NCT00932373|536610459|FG002|Overall Study|Dose limiting toxicity|0|||
148763980|NCT00932373|536610460|FG003|Overall Study|Dose limiting toxicity|0|||
148763981|NCT00932373|536610461|FG004|Overall Study|Dose limiting toxicity|0|||
148763982|NCT00932373|536610462|FG005|Overall Study|Dose limiting toxicity|1|||
148763983|NCT00932373|536610463|FG006|Overall Study|Dose limiting toxicity|0|||
148763984|NCT00932373|536610464|FG007|Overall Study|Dose limiting toxicity|0|||
148763985|NCT00932373|536610465|FG008|Overall Study|Dose limiting toxicity|0|||
148763986|NCT00932373|536610466|FG009|Overall Study|Dose limiting toxicity|0|||
148763987|NCT00932373|536610467|FG010|Overall Study|Dose limiting toxicity|0|||
148763988|NCT00932373|536610457|FG000|Overall Study|Withdrawal by Subject|0|||
148763989|NCT00932373|536610458|FG001|Overall Study|Withdrawal by Subject|0|||
148763990|NCT00932373|536610459|FG002|Overall Study|Withdrawal by Subject|0|||
148763991|NCT00932373|536610460|FG003|Overall Study|Withdrawal by Subject|0|||
148763992|NCT00932373|536610461|FG004|Overall Study|Withdrawal by Subject|0|||
148763993|NCT00932373|536610462|FG005|Overall Study|Withdrawal by Subject|0|||
148763994|NCT00932373|536610463|FG006|Overall Study|Withdrawal by Subject|0|||
148763995|NCT00932373|536610464|FG007|Overall Study|Withdrawal by Subject|0|||
148763996|NCT00932373|536610465|FG008|Overall Study|Withdrawal by Subject|1|||
148763997|NCT00932373|536610466|FG009|Overall Study|Withdrawal by Subject|0|||
148763998|NCT00932373|536610467|FG010|Overall Study|Withdrawal by Subject|0|||
148763999|NCT00932373|536610457|FG000|Overall Study|Clinical progression|0|||
148764000|NCT00932373|536610458|FG001|Overall Study|Clinical progression|0|||
148764001|NCT00932373|536610459|FG002|Overall Study|Clinical progression|0|||
148764002|NCT00932373|536610460|FG003|Overall Study|Clinical progression|0|||
148764003|NCT00932373|536610461|FG004|Overall Study|Clinical progression|0|||
148764004|NCT00932373|536610462|FG005|Overall Study|Clinical progression|0|||
148764005|NCT00932373|536610463|FG006|Overall Study|Clinical progression|1|||
148764006|NCT00932373|536610464|FG007|Overall Study|Clinical progression|0|||
148764007|NCT00932373|536610465|FG008|Overall Study|Clinical progression|0|||
148764008|NCT00932373|536610466|FG009|Overall Study|Clinical progression|0|||
148764009|NCT00932373|536610467|FG010|Overall Study|Clinical progression|0|||
148764010|NCT00932373|536610457|FG000|Overall Study|Lack of Efficacy|0|||
148764011|NCT00932373|536610458|FG001|Overall Study|Lack of Efficacy|0|||
148764012|NCT00932373|536610459|FG002|Overall Study|Lack of Efficacy|0|||
148764013|NCT00932373|536610460|FG003|Overall Study|Lack of Efficacy|0|||
148764014|NCT00932373|536610461|FG004|Overall Study|Lack of Efficacy|0|||
148764015|NCT00932373|536610462|FG005|Overall Study|Lack of Efficacy|0|||
148764016|NCT00932373|536610463|FG006|Overall Study|Lack of Efficacy|0|||
148764017|NCT00932373|536610464|FG007|Overall Study|Lack of Efficacy|0|||
148764018|NCT00932373|536610465|FG008|Overall Study|Lack of Efficacy|0|||
148764019|NCT00932373|536610466|FG009|Overall Study|Lack of Efficacy|1|||
148764020|NCT00932373|536610467|FG010|Overall Study|Lack of Efficacy|0|||
148764021|NCT06098339|536610468|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
148764022|NCT06098339|536610469|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
148764023|NCT06098339|536610468|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
148764024|NCT06098339|536610469|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
148764025|NCT02582242|536610472|FG000|Overall Study|Adverse Event|4|||
148764026|NCT02582242|536610473|FG001|Overall Study|Adverse Event|3|||
148764027|NCT02582242|536610472|FG000|Overall Study|Protocol Violation|3|||
148764028|NCT02582242|536610473|FG001|Overall Study|Protocol Violation|1|||
148764029|NCT02582242|536610472|FG000|Overall Study|Lost to Follow-up|0|||
148764030|NCT02582242|536610473|FG001|Overall Study|Lost to Follow-up|1|||
148764031|NCT02582242|536610472|FG000|Overall Study|Withdrawal by Subject|11|||
148764032|NCT02582242|536610473|FG001|Overall Study|Withdrawal by Subject|11|||
148764033|NCT02582242|536610472|FG000|Overall Study|Unclassified|2|||
148764034|NCT02582242|536610473|FG001|Overall Study|Unclassified|1|||
148764035|NCT02492984|536610474|FG000|Overall Study|Adverse Event|1|||
148764036|NCT02492984|536610475|FG001|Overall Study|Adverse Event|0|||
148764037|NCT02492984|536610474|FG000|Overall Study|Protocol Violation|1|||
148764038|NCT02492984|536610475|FG001|Overall Study|Protocol Violation|0|||
148764039|NCT02492984|536610474|FG000|Overall Study|Withdrawal by Subject|1|||
148764040|NCT02492984|536610475|FG001|Overall Study|Withdrawal by Subject|0|||
148764041|NCT02282631|536610476|FG000|Overall Study|Lost to Follow-up|2|||
148764042|NCT02282631|536610477|FG001|Overall Study|Lost to Follow-up|0|||
148764043|NCT06152224|536610486|FG000|Overall Study|Withdrawal by Subject|1|||
148764044|NCT06152224|536610487|FG001|Overall Study|Withdrawal by Subject|0|||
148764045|NCT06152224|536610486|FG000|Overall Study|Lost to Follow-up|0|||
148764046|NCT06152224|536610487|FG001|Overall Study|Lost to Follow-up|1|||
148764047|NCT06152224|536610486|FG000|Overall Study|On Follow Up|18|||
148764048|NCT06152224|536610487|FG001|Overall Study|On Follow Up|18|||
148764049|NCT06028438|536610490|FG000|Overall Study|Adverse Event|3|||
148764050|NCT06028438|536610491|FG001|Overall Study|Adverse Event|9|||
148764051|NCT06028438|536610490|FG000|Overall Study|Lack of Efficacy|1|||
148764052|NCT06028438|536610491|FG001|Overall Study|Lack of Efficacy|1|||
148764053|NCT06028438|536610490|FG000|Overall Study|Lost to Follow-up|1|||
148764054|NCT06028438|536610491|FG001|Overall Study|Lost to Follow-up|0|||
148764055|NCT06028438|536610490|FG000|Overall Study|Withdrawal by Subject|1|||
148764056|NCT06028438|536610491|FG001|Overall Study|Withdrawal by Subject|0|||
148764057|NCT06028438|536610490|FG000|Overall Study|Other|3|||
148764058|NCT06028438|536610491|FG001|Overall Study|Other|3|||
148764059|NCT05625802|536610492|FG000|Overall Study|Lost to Follow-up|1|||
148764060|NCT05625802|536610493|FG001|Overall Study|Lost to Follow-up|0|||
148764061|NCT02509507|536610494|FG000|Overall Study|Death|21|||
148764062|NCT02509507|536610495|FG001|Overall Study|Death|3|||
148764063|NCT02509507|536610496|FG002|Overall Study|Death|22|||
148764064|NCT02509507|536610497|FG003|Overall Study|Death|14|||
148764065|NCT02509507|536610498|FG004|Overall Study|Death|8|||
148764066|NCT02509507|536610499|FG005|Overall Study|Death|12|||
148764067|NCT02509507|536610500|FG006|Overall Study|Death|5|||
148764068|NCT02509507|536610501|FG007|Overall Study|Death|4|||
148764069|NCT02509507|536610502|FG008|Overall Study|Death|8|||
148764070|NCT02509507|536610494|FG000|Overall Study|Lost to Follow-up|0|||
148764071|NCT02509507|536610495|FG001|Overall Study|Lost to Follow-up|1|||
148764072|NCT02509507|536610496|FG002|Overall Study|Lost to Follow-up|0|||
148764073|NCT02509507|536610497|FG003|Overall Study|Lost to Follow-up|0|||
148764074|NCT02509507|536610498|FG004|Overall Study|Lost to Follow-up|0|||
148764075|NCT02509507|536610499|FG005|Overall Study|Lost to Follow-up|2|||
148764076|NCT02509507|536610500|FG006|Overall Study|Lost to Follow-up|0|||
148764077|NCT02509507|536610501|FG007|Overall Study|Lost to Follow-up|0|||
148764078|NCT02509507|536610502|FG008|Overall Study|Lost to Follow-up|0|||
148764079|NCT02509507|536610494|FG000|Overall Study|Withdrawal by Subject|2|||
148764080|NCT02509507|536610495|FG001|Overall Study|Withdrawal by Subject|0|||
148764081|NCT02509507|536610496|FG002|Overall Study|Withdrawal by Subject|1|||
148764082|NCT02509507|536610497|FG003|Overall Study|Withdrawal by Subject|4|||
148764083|NCT02509507|536610498|FG004|Overall Study|Withdrawal by Subject|1|||
148764084|NCT02509507|536610499|FG005|Overall Study|Withdrawal by Subject|3|||
148764085|NCT02509507|536610500|FG006|Overall Study|Withdrawal by Subject|4|||
148764086|NCT02509507|536610501|FG007|Overall Study|Withdrawal by Subject|0|||
148764087|NCT02509507|536610502|FG008|Overall Study|Withdrawal by Subject|1|||
148764088|NCT03337113|536610512|FG000|Overall Study|Adverse Event|1|||
148764089|NCT03337113|536610513|FG001|Overall Study|Adverse Event|1|||
148764090|NCT03337113|536610514|FG002|Overall Study|Adverse Event|0|||
148764091|NCT03337113|536610515|FG003|Overall Study|Adverse Event|1|||
148764092|NCT03337113|536610512|FG000|Overall Study|Physician Decision|0|||
148764093|NCT03337113|536610513|FG001|Overall Study|Physician Decision|2|||
148764094|NCT03337113|536610514|FG002|Overall Study|Physician Decision|0|||
148764095|NCT03337113|536610515|FG003|Overall Study|Physician Decision|1|||
148764096|NCT03337113|536610512|FG000|Overall Study|Withdrawal by Subject|0|||
148764097|NCT03337113|536610513|FG001|Overall Study|Withdrawal by Subject|0|||
148764098|NCT03337113|536610514|FG002|Overall Study|Withdrawal by Subject|1|||
148764099|NCT03337113|536610515|FG003|Overall Study|Withdrawal by Subject|0|||
148764100|NCT02476578|536610527|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
148764101|NCT02476578|536610528|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
148764102|NCT02476578|536610527|FG000|Overall Study|Lost to Follow-up|6|||
148764103|NCT02476578|536610528|FG001|Overall Study|Lost to Follow-up|13|||
148764104|NCT03491462|536610529|FG000|Overall Study|Lost to Follow-up|2|||
148764105|NCT03491462|536610530|FG001|Overall Study|Lost to Follow-up|0|||
148764106|NCT03491462|536610529|FG000|Overall Study|Adverse Event|11|||
148764107|NCT03491462|536610530|FG001|Overall Study|Adverse Event|1|||
148764108|NCT03491462|536610529|FG000|Overall Study|Physician Decision|3|||
148764109|NCT03491462|536610530|FG001|Overall Study|Physician Decision|0|||
148764110|NCT03491462|536610529|FG000|Overall Study|Withdrawal by Subject|22|||
148764111|NCT03491462|536610530|FG001|Overall Study|Withdrawal by Subject|15|||
148764112|NCT04938180|536610531|FG000|Overall Study|Adverse Event|1|||
148764113|NCT00423332|536610532|FG000|Overall Study|Adverse Event|6|||
148764114|NCT00423332|536610533|FG001|Overall Study|Adverse Event|2|||
148764115|NCT00423332|536610532|FG000|Overall Study|Withdrawal by Subject|1|||
148764116|NCT00423332|536610533|FG001|Overall Study|Withdrawal by Subject|0|||
148764117|NCT00423332|536610532|FG000|Overall Study|Condition under investigation worsened|1|||
148764118|NCT00423332|536610533|FG001|Overall Study|Condition under investigation worsened|1|||
148764119|NCT00423332|536610532|FG000|Overall Study|Progressive at Week 6|0|||
148764120|NCT00423332|536610533|FG001|Overall Study|Progressive at Week 6|1|||
148764121|NCT00423332|536610532|FG000|Overall Study|Unblinded before 12 weeks|1|||
148764122|NCT00423332|536610533|FG001|Overall Study|Unblinded before 12 weeks|3|||
148764123|NCT02035202|536610534|FG000|Overall Study|Lost to Follow-up|8|||
148764124|NCT02035202|536610535|FG001|Overall Study|Lost to Follow-up|16|||
148764125|NCT02035202|536610536|FG002|Overall Study|Lost to Follow-up|2|||
148764126|NCT00644917|536610538|FG000|Overall Study|Withdrawal by Subject|2|||
148764127|NCT00758485|536610539|FG000|Overall Study|Lost to Follow-up|0|||
148764128|NCT00758485|536610540|FG001|Overall Study|Lost to Follow-up|1|||
148764129|NCT00758485|536610539|FG000|Overall Study|Not Treated|1|||
148764130|NCT00758485|536610540|FG001|Overall Study|Not Treated|2|||
148764131|NCT00921557|536610541|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
148764132|NCT00921557|536610542|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
148764133|NCT00921557|536610543|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
148764134|NCT00921557|536610541|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
148764135|NCT00921557|536610542|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
148764136|NCT00921557|536610543|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
148764137|NCT00921557|536610541|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
148764138|NCT00921557|536610542|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
148764139|NCT00921557|536610543|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
148764140|NCT00921557|536610541|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
148764141|NCT00921557|536610542|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
148764142|NCT00921557|536610543|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
148764143|NCT00921557|536610541|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
148764144|NCT00921557|536610542|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
148764145|NCT00921557|536610543|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
148764146|NCT03259425|536610553|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
148826726|NCT00395447|536844304|FG001|Overall Study|Death|32|||
148826727|NCT00395447|536844303|FG000|Overall Study|Lost to Follow-up|52|||
148826728|NCT00395447|536844304|FG001|Overall Study|Lost to Follow-up|43|||
148826729|NCT00395447|536844303|FG000|Overall Study|Withdrawal by Subject|24|||
148826730|NCT00395447|536844304|FG001|Overall Study|Withdrawal by Subject|19|||
148826731|NCT00395447|536844303|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
148826732|NCT00395447|536844304|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
148826733|NCT03111108|536844306|FG000|Overall Study|Death|0|||
148826734|NCT03111108|536844307|FG001|Overall Study|Death|1|||
148826735|NCT03111108|536844306|FG000|Overall Study|Withdrawal by Subject|1|||
148826736|NCT03111108|536844307|FG001|Overall Study|Withdrawal by Subject|0|||
148826737|NCT01514357|536844308|FG000|Overall Study|Screen failure|2|||
148826738|NCT01514357|536844309|FG001|Overall Study|Screen failure|0|||
148826739|NCT01514357|536844308|FG000|Overall Study|Withdrawal by Subject|2|||
148826740|NCT01514357|536844309|FG001|Overall Study|Withdrawal by Subject|0|||
148826741|NCT01853280|536844310|FG000|Overall Study|Lack of Efficacy|2|||
148826742|NCT01853280|536844311|FG001|Overall Study|Lack of Efficacy|2|||
148826743|NCT01853280|536844310|FG000|Overall Study|Lost to Follow-up|0|||
148826744|NCT01853280|536844311|FG001|Overall Study|Lost to Follow-up|1|||
148826745|NCT01853280|536844310|FG000|Overall Study|Physician Decision|0|||
148826746|NCT01853280|536844311|FG001|Overall Study|Physician Decision|1|||
148977689|NCT02247349|537398401|FG002|Overall Study|Other reasons|1|||
148764147|NCT01106911|536610561|FG000|Overall Study|Physician Decision|2|||
148764148|NCT01106911|536610561|FG000|Overall Study|deemed ineligible after screening|3|||
148764149|NCT00984542|536610563|FG000|Overall Study|disease progression|19|||
148764150|NCT00984542|536610563|FG000|Overall Study|toxicity|7|||
148764151|NCT00984542|536610563|FG000|Overall Study|Death|7|||
148764152|NCT00984542|536610563|FG000|Overall Study|complicating disease|3|||
148764153|NCT00984542|536610563|FG000|Overall Study|Withdrawal by Subject|3|||
148764154|NCT00984542|536610563|FG000|Overall Study|clinical deterioration|2|||
148764155|NCT00425750|536610564|FG000|Overall Study|Death|1|||
148764156|NCT00425750|536610564|FG000|Overall Study|Withdrawal by Subject|3|||
148764157|NCT00425750|536610564|FG000|Overall Study|Adverse Event|3|||
148764158|NCT00425750|536610564|FG000|Overall Study|Progression of disease|18|||
148764159|NCT03515811|536610567|FG000|Overall Study|Lost to Follow-up|2|||
148764160|NCT03515811|536610568|FG001|Overall Study|Lost to Follow-up|1|||
148764161|NCT03515811|536610567|FG000|Overall Study|Protocol Violation|1|||
148764162|NCT03515811|536610568|FG001|Overall Study|Protocol Violation|1|||
148764163|NCT03515811|536610567|FG000|Overall Study|Death|1|||
148764164|NCT03515811|536610568|FG001|Overall Study|Death|1|||
148764165|NCT03515811|536610567|FG000|Overall Study|Withdrawal by Subject|0|||
148764166|NCT03515811|536610568|FG001|Overall Study|Withdrawal by Subject|2|||
148764167|NCT03515811|536610567|FG000|Overall Study|Technical Problems|1|||
148764168|NCT03515811|536610568|FG001|Overall Study|Technical Problems|0|||
148764169|NCT03515811|536610567|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
148977690|NCT02247349|537398402|FG003|Overall Study|Other reasons|0|||
148977691|NCT02247349|537398403|FG004|Overall Study|Other reasons|0|||
148977692|NCT02247349|537398404|FG005|Overall Study|Other reasons|0|||
148977693|NCT02410811|537398409|FG000|Overall Study|Withdrawal by Subject|0|||
148977694|NCT02410811|537398410|FG001|Overall Study|Withdrawal by Subject|0|||
148977695|NCT02410811|537398411|FG002|Overall Study|Withdrawal by Subject|1|||
148977696|NCT02410811|537398412|FG003|Overall Study|Withdrawal by Subject|0|||
148977697|NCT03049813|537398413|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
148977698|NCT03049813|537398414|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
148977699|NCT03049813|537398415|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
148977700|NCT03049813|537398416|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
148977701|NCT03049813|537398413|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
148977702|NCT03049813|537398414|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
148977703|NCT03049813|537398415|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
148977704|NCT03049813|537398416|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
148977705|NCT03049813|537398413|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
148977706|NCT03049813|537398414|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
148977707|NCT03049813|537398415|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
148977708|NCT03049813|537398416|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
149027699|NCT02487446|537578635|FG001|Washout|Adverse Event|2|||
149027700|NCT02487446|537578634|FG000|Period 2|Protocol deviation|0|||
148764170|NCT03515811|536610568|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
148764171|NCT03515811|536610567|FG000|Overall Study|COVID-19|0|||
148764172|NCT03515811|536610568|FG001|Overall Study|COVID-19|1|||
148764173|NCT00237458|536610569|FG000|Overall Study|Lack of Efficacy|1|||
148764174|NCT00237458|536610569|FG000|Overall Study|Adverse Event|1|||
148764175|NCT00237458|536610569|FG000|Overall Study|Withdrawal by Subject|1|||
148764176|NCT01276756|536610570|FG000|Overall Study|Lost to Follow-up|2|||
148764177|NCT01276756|536610571|FG001|Overall Study|Lost to Follow-up|0|||
148764178|NCT01276756|536610570|FG000|Overall Study|Adverse Event|3|||
148826747|NCT01853280|536844310|FG000|Overall Study|Withdrawal by Subject|0|||
149027701|NCT02487446|537578635|FG001|Period 2|Protocol deviation|1|||
149027702|NCT02487446|537578634|FG000|Period 2|Lost to Follow-up|1|||
149027703|NCT02487446|537578635|FG001|Period 2|Lost to Follow-up|1|||
149027704|NCT02487446|537578634|FG000|Period 2|Withdrawal by Subject|1|||
149027705|NCT02487446|537578635|FG001|Period 2|Withdrawal by Subject|1|||
149027706|NCT02487446|537578634|FG000|Period 2|Adverse Event|6|||
148764179|NCT01276756|536610571|FG001|Overall Study|Adverse Event|2|||
148764180|NCT05868577|536610572|FG000|Overall Study|Lost to Follow-up|5|||
148764181|NCT05868577|536610573|FG001|Overall Study|Lost to Follow-up|5|||
148764182|NCT02630251|536610574|FG000|Overall Study|Physician Decision|0|||
148764183|NCT02630251|536610575|FG001|Overall Study|Physician Decision|0|||
148764184|NCT02630251|536610576|FG002|Overall Study|Physician Decision|1|||
148764185|NCT02630251|536610577|FG003|Overall Study|Physician Decision|0|||
148764186|NCT04586244|536610578|FG000|Overall Study|Lost to Follow-up|1|||
148764187|NCT04586244|536610579|FG001|Overall Study|Lost to Follow-up|0|||
148977709|NCT03049813|537398413|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
148977710|NCT03049813|537398414|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
148977711|NCT03049813|537398415|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
148977712|NCT03049813|537398416|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
148977713|NCT01193556|537398422|FG000|Overall Study|Study termination|26|||
148977714|NCT01193556|537398423|FG001|Overall Study|Study termination|25|||
148977715|NCT03025828|537398425|FG000|Overall Study|Lost to Follow-up|1|||
149027707|NCT02487446|537578635|FG001|Period 2|Adverse Event|2|||
149027708|NCT01822821|537578636|FG000|Overall Study|Eligible surgery cancelled|1|||
149027709|NCT01822821|537578637|FG001|Overall Study|Eligible surgery cancelled|1|||
149027710|NCT01822821|537578636|FG000|Overall Study|Other reasons|1|||
149027711|NCT01822821|537578637|FG001|Overall Study|Other reasons|0|||
149027712|NCT03251378|537578638|FG000|Overall Study|Death|3|||
149027713|NCT03251378|537578639|FG001|Overall Study|Death|2|||
149027714|NCT03251378|537578640|FG002|Overall Study|Death|3|||
149027715|NCT03251378|537578641|FG003|Overall Study|Death|30|||
149027716|NCT03251378|537578642|FG004|Overall Study|Death|24|||
149027717|NCT03251378|537578643|FG005|Overall Study|Death|12|||
149027718|NCT03251378|537578644|FG006|Overall Study|Death|12|||
149027719|NCT03251378|537578638|FG000|Overall Study|Lost to Follow-up|0|||
149027720|NCT03251378|537578639|FG001|Overall Study|Lost to Follow-up|0|||
149027721|NCT03251378|537578640|FG002|Overall Study|Lost to Follow-up|1|||
149027722|NCT03251378|537578641|FG003|Overall Study|Lost to Follow-up|3|||
149027723|NCT03251378|537578642|FG004|Overall Study|Lost to Follow-up|0|||
149027724|NCT03251378|537578643|FG005|Overall Study|Lost to Follow-up|0|||
149027725|NCT03251378|537578644|FG006|Overall Study|Lost to Follow-up|0|||
149027726|NCT03251378|537578638|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
149027727|NCT03251378|537578639|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
149027728|NCT03251378|537578640|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
149027729|NCT03251378|537578641|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
149027730|NCT03251378|537578642|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
149027731|NCT03251378|537578643|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
149027732|NCT03251378|537578644|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
149027733|NCT03251378|537578638|FG000|Overall Study|Progressive disease|2|||
149027734|NCT03251378|537578639|FG001|Overall Study|Progressive disease|0|||
149027735|NCT03251378|537578640|FG002|Overall Study|Progressive disease|0|||
149027736|NCT03251378|537578641|FG003|Overall Study|Progressive disease|1|||
149027737|NCT03251378|537578642|FG004|Overall Study|Progressive disease|0|||
149027738|NCT03251378|537578643|FG005|Overall Study|Progressive disease|0|||
149027739|NCT03251378|537578644|FG006|Overall Study|Progressive disease|0|||
149027740|NCT03251378|537578638|FG000|Overall Study|Physician Decision|0|||
149027741|NCT03251378|537578639|FG001|Overall Study|Physician Decision|2|||
149027742|NCT03251378|537578640|FG002|Overall Study|Physician Decision|0|||
149027743|NCT03251378|537578641|FG003|Overall Study|Physician Decision|0|||
148764188|NCT04586244|536610580|FG002|Overall Study|Lost to Follow-up|0|||
148764189|NCT04586244|536610581|FG003|Overall Study|Lost to Follow-up|1|||
148764190|NCT04586244|536610582|FG004|Overall Study|Lost to Follow-up|0|||
148764191|NCT04586244|536610578|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
148764192|NCT04586244|536610579|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
148764193|NCT04586244|536610580|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
148764194|NCT04586244|536610581|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
148764195|NCT04586244|536610582|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
148764196|NCT03564119|536610585|FG000|Overall Study|Adverse Event|4|||
148764197|NCT03564119|536610586|FG001|Overall Study|Adverse Event|0|||
148764198|NCT03564119|536610585|FG000|Overall Study|Lost to Follow-up|1|||
148764199|NCT03564119|536610586|FG001|Overall Study|Lost to Follow-up|4|||
148764200|NCT03564119|536610585|FG000|Overall Study|Protocol Violation|1|||
148764201|NCT03564119|536610586|FG001|Overall Study|Protocol Violation|0|||
148764202|NCT03564119|536610585|FG000|Overall Study|Withdrawal by Subject|9|||
148764203|NCT03564119|536610586|FG001|Overall Study|Withdrawal by Subject|4|||
148764204|NCT03564119|536610585|FG000|Overall Study|Other Than Specified|0|||
148764205|NCT03564119|536610586|FG001|Overall Study|Other Than Specified|1|||
148764206|NCT00634036|536610587|FG000|Overall Study|Lost to Follow-up|1|||
148764207|NCT00634036|536610588|FG001|Overall Study|Lost to Follow-up|1|||
148764208|NCT00634036|536610587|FG000|Overall Study|Withdrawal by Subject|1|||
148764209|NCT00634036|536610588|FG001|Overall Study|Withdrawal by Subject|1|||
148764210|NCT03896022|536610589|FG000|Overall Study|Withdrawal by Subject|1|||
149027744|NCT03251378|537578642|FG004|Overall Study|Physician Decision|0|||
149027745|NCT03251378|537578643|FG005|Overall Study|Physician Decision|0|||
149027746|NCT03251378|537578644|FG006|Overall Study|Physician Decision|0|||
148764211|NCT03896022|536610590|FG001|Overall Study|Withdrawal by Subject|0|||
148826748|NCT01853280|536844311|FG001|Overall Study|Withdrawal by Subject|1|||
148826749|NCT01853280|536844310|FG000|Overall Study|Ineligible|0|||
148826750|NCT01853280|536844311|FG001|Overall Study|Ineligible|1|||
148826751|NCT00104884|536844312|FG000|Overall Study|Disease progression|4|||
148826752|NCT03032484|536844313|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
148826753|NCT03032484|536844314|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
148826754|NCT03032484|536844313|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
148826755|NCT03032484|536844314|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
148826756|NCT01689649|536844315|FG000|Overall Study|Lack of Efficacy|3|||
148764212|NCT03896022|536610591|FG002|Overall Study|Withdrawal by Subject|0|||
148764213|NCT03896022|536610589|FG000|Overall Study|Did not have procedure|3|||
148764214|NCT03896022|536610590|FG001|Overall Study|Did not have procedure|0|||
148764215|NCT03896022|536610591|FG002|Overall Study|Did not have procedure|0|||
148764216|NCT01500382|536610598|FG000|Washout Period|Study site went out of business|0|||
148764217|NCT01500382|536610599|FG001|Washout Period|Study site went out of business|0|||
148764218|NCT01500382|536610600|FG002|Washout Period|Study site went out of business|1|||
148764219|NCT01500382|536610601|FG003|Washout Period|Study site went out of business|0|||
148764220|NCT04015518|536610602|FG000|Overall Study|Adverse Event|6|||
148764221|NCT04015518|536610603|FG001|Overall Study|Adverse Event|1|||
148764222|NCT04015518|536610604|FG002|Overall Study|Adverse Event|1|||
148764223|NCT04015518|536610605|FG003|Overall Study|Adverse Event|3|||
148764224|NCT04015518|536610606|FG004|Overall Study|Adverse Event|3|||
148764225|NCT04015518|536610602|FG000|Overall Study|Lack of Efficacy|1|||
148764226|NCT04015518|536610603|FG001|Overall Study|Lack of Efficacy|0|||
148764227|NCT04015518|536610604|FG002|Overall Study|Lack of Efficacy|1|||
148764228|NCT04015518|536610605|FG003|Overall Study|Lack of Efficacy|0|||
148764229|NCT04015518|536610606|FG004|Overall Study|Lack of Efficacy|4|||
148764230|NCT04015518|536610602|FG000|Overall Study|Lost to Follow-up|0|||
148764231|NCT04015518|536610603|FG001|Overall Study|Lost to Follow-up|0|||
148764232|NCT04015518|536610604|FG002|Overall Study|Lost to Follow-up|0|||
148764233|NCT04015518|536610605|FG003|Overall Study|Lost to Follow-up|0|||
148764234|NCT04015518|536610606|FG004|Overall Study|Lost to Follow-up|1|||
148764235|NCT04015518|536610602|FG000|Overall Study|Withdrawal by Subject|0|||
148764236|NCT04015518|536610603|FG001|Overall Study|Withdrawal by Subject|1|||
148764237|NCT04015518|536610604|FG002|Overall Study|Withdrawal by Subject|0|||
148764238|NCT04015518|536610605|FG003|Overall Study|Withdrawal by Subject|1|||
148764239|NCT04015518|536610606|FG004|Overall Study|Withdrawal by Subject|1|||
148764240|NCT04015518|536610602|FG000|Overall Study|Patient did not come for consecutive visits|0|||
148764241|NCT04015518|536610603|FG001|Overall Study|Patient did not come for consecutive visits|1|||
148764242|NCT04015518|536610604|FG002|Overall Study|Patient did not come for consecutive visits|0|||
148764243|NCT04015518|536610605|FG003|Overall Study|Patient did not come for consecutive visits|0|||
148764244|NCT04015518|536610606|FG004|Overall Study|Patient did not come for consecutive visits|0|||
148764245|NCT04015518|536610602|FG000|Overall Study|not willing to travel due to Covid-19|0|||
148764246|NCT04015518|536610603|FG001|Overall Study|not willing to travel due to Covid-19|0|||
148764247|NCT04015518|536610604|FG002|Overall Study|not willing to travel due to Covid-19|1|||
148764248|NCT04015518|536610605|FG003|Overall Study|not willing to travel due to Covid-19|0|||
148764249|NCT04015518|536610606|FG004|Overall Study|not willing to travel due to Covid-19|0|||
148764250|NCT04015518|536610602|FG000|Overall Study|Patient wants to discontinue treatment|0|||
148764251|NCT04015518|536610603|FG001|Overall Study|Patient wants to discontinue treatment|0|||
148764252|NCT04015518|536610604|FG002|Overall Study|Patient wants to discontinue treatment|0|||
148764253|NCT04015518|536610605|FG003|Overall Study|Patient wants to discontinue treatment|1|||
148764254|NCT04015518|536610606|FG004|Overall Study|Patient wants to discontinue treatment|0|||
148764255|NCT04015518|536610602|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
148764256|NCT04015518|536610603|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
148764257|NCT04015518|536610604|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
148764258|NCT04015518|536610605|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
148764259|NCT04015518|536610606|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
148764260|NCT04015518|536610602|FG000|Overall Study|Pregnancy|0|||
148764261|NCT04015518|536610603|FG001|Overall Study|Pregnancy|0|||
148764262|NCT04015518|536610604|FG002|Overall Study|Pregnancy|0|||
148764263|NCT04015518|536610605|FG003|Overall Study|Pregnancy|0|||
148764264|NCT04015518|536610606|FG004|Overall Study|Pregnancy|1|||
148764265|NCT04015518|536610602|FG000|Overall Study|Personal reasons|1|||
148764266|NCT04015518|536610603|FG001|Overall Study|Personal reasons|0|||
148764267|NCT04015518|536610604|FG002|Overall Study|Personal reasons|0|||
148764268|NCT04015518|536610605|FG003|Overall Study|Personal reasons|0|||
148764269|NCT04015518|536610606|FG004|Overall Study|Personal reasons|1|||
148764270|NCT04015518|536610602|FG000|Overall Study|Withdrew consent|1|||
148764271|NCT04015518|536610603|FG001|Overall Study|Withdrew consent|0|||
148764272|NCT04015518|536610604|FG002|Overall Study|Withdrew consent|0|||
148764273|NCT04015518|536610605|FG003|Overall Study|Withdrew consent|0|||
148764274|NCT04015518|536610606|FG004|Overall Study|Withdrew consent|0|||
148764275|NCT04015518|536610602|FG000|Overall Study|Prostate carcinoma|1|||
148764276|NCT04015518|536610603|FG001|Overall Study|Prostate carcinoma|0|||
148764277|NCT04015518|536610604|FG002|Overall Study|Prostate carcinoma|0|||
148764278|NCT04015518|536610605|FG003|Overall Study|Prostate carcinoma|0|||
148764279|NCT04015518|536610606|FG004|Overall Study|Prostate carcinoma|0|||
148764280|NCT04015518|536610602|FG000|Overall Study|Could not keep appointments due to work|1|||
148826757|NCT01689649|536844315|FG000|Overall Study|Non-compliance|11|||
148764281|NCT04015518|536610603|FG001|Overall Study|Could not keep appointments due to work|0|||
149027747|NCT03251378|537578638|FG000|Overall Study|Other|2|||
148764282|NCT04015518|536610604|FG002|Overall Study|Could not keep appointments due to work|0|||
148764283|NCT04015518|536610605|FG003|Overall Study|Could not keep appointments due to work|0|||
148977716|NCT00094653|537398426|FG000|Overall Study|Death|306|||
148977717|NCT00094653|537398427|FG001|Overall Study|Death|100|||
148977718|NCT00094653|537398428|FG002|Overall Study|Death|119|||
148977719|NCT00094653|537398426|FG000|Overall Study|Subject Withdrew Consent|10|||
148977720|NCT00094653|537398427|FG001|Overall Study|Subject Withdrew Consent|2|||
148764284|NCT04015518|536610606|FG004|Overall Study|Could not keep appointments due to work|0|||
148764285|NCT00550745|536610607|FG000|Overall Study|Death|20|||
148764286|NCT00550745|536610608|FG001|Overall Study|Death|16|||
148764287|NCT00550745|536610607|FG000|Overall Study|Lost to Follow-up|45|||
148764288|NCT00550745|536610608|FG001|Overall Study|Lost to Follow-up|30|||
148764289|NCT00550745|536610607|FG000|Overall Study|Physician Decision|0|||
148764290|NCT00550745|536610608|FG001|Overall Study|Physician Decision|2|||
148764291|NCT00550745|536610607|FG000|Overall Study|Protocol Violation|4|||
148764292|NCT00550745|536610608|FG001|Overall Study|Protocol Violation|2|||
148764293|NCT00550745|536610607|FG000|Overall Study|Withdrawal by Subject|17|||
148764294|NCT00550745|536610608|FG001|Overall Study|Withdrawal by Subject|10|||
148764295|NCT00550745|536610607|FG000|Overall Study|Screen failure|1|||
148764296|NCT00550745|536610608|FG001|Overall Study|Screen failure|0|||
148764297|NCT00764660|536610609|FG000|Overall Study|Adverse Event|6|||
148764298|NCT00764660|536610610|FG001|Overall Study|Adverse Event|3|||
148764299|NCT00764660|536610609|FG000|Overall Study|Lost to Follow-up|3|||
148764300|NCT00764660|536610610|FG001|Overall Study|Lost to Follow-up|4|||
148764301|NCT00764660|536610609|FG000|Overall Study|Withdrawal by Subject|7|||
148764302|NCT00764660|536610610|FG001|Overall Study|Withdrawal by Subject|3|||
148764303|NCT00764660|536610609|FG000|Overall Study|Noncompliance With Protocol|5|||
148764304|NCT00764660|536610610|FG001|Overall Study|Noncompliance With Protocol|1|||
148764305|NCT00764660|536610609|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
148764306|NCT00764660|536610610|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
148764307|NCT01131455|536610611|FG000|Overall Study|Death of PI|6|||
148764308|NCT01131455|536610612|FG001|Overall Study|Death of PI|4|||
148764309|NCT01131455|536610613|FG002|Overall Study|Death of PI|0|||
148764310|NCT03831113|536611928|FG000|Overall Study|Withdrawal by Subject|0|||
148764311|NCT03831113|536611929|FG001|Overall Study|Withdrawal by Subject|2|||
148764312|NCT03831113|536611928|FG000|Overall Study|Protocol Violation|0|||
148764313|NCT03831113|536611929|FG001|Overall Study|Protocol Violation|9|||
148764314|NCT02693106|536611932|FG000|Overall Study|No time|3|||
148764315|NCT03981900|536611933|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
148764316|NCT03981900|536611933|FG000|Overall Study|Adverse Event|5|||
148764317|NCT03981900|536611933|FG000|Overall Study|Protocol Violation|1|||
148764318|NCT03981900|536611933|FG000|Overall Study|Withdrawal by Subject|7|||
148764319|NCT03981900|536611933|FG000|Overall Study|Lost to Follow-up|46|||
148764320|NCT03981900|536611933|FG000|Overall Study|Decision of the researcher|3|||
148764321|NCT03981900|536611933|FG000|Overall Study|Death|3|||
148764322|NCT03981900|536611933|FG000|Overall Study|Other|5|||
148764323|NCT01163851|536611936|FG000|Overall Study|Site Closure|0|||
148764324|NCT01163851|536611937|FG001|Overall Study|Site Closure|1|||
148764325|NCT01163851|536611936|FG000|Overall Study|Enrolled but not treated|1|||
148764326|NCT01163851|536611937|FG001|Overall Study|Enrolled but not treated|0|||
148764327|NCT01073605|536611941|FG000|Overall Study|Ongoing at Cutoff Date|1|||
148764328|NCT01073605|536611942|FG001|Overall Study|Ongoing at Cutoff Date|1|||
148764329|NCT01073605|536611943|FG002|Overall Study|Ongoing at Cutoff Date|0|||
148764330|NCT01073605|536611941|FG000|Overall Study|Adverse Event|2|||
148764331|NCT01073605|536611942|FG001|Overall Study|Adverse Event|1|||
148764332|NCT01073605|536611943|FG002|Overall Study|Adverse Event|0|||
148764333|NCT01073605|536611941|FG000|Overall Study|Lost to Follow-up|3|||
148764334|NCT01073605|536611942|FG001|Overall Study|Lost to Follow-up|4|||
148764335|NCT01073605|536611943|FG002|Overall Study|Lost to Follow-up|9|||
148764336|NCT01073605|536611941|FG000|Overall Study|Other|25|||
148764337|NCT01073605|536611942|FG001|Overall Study|Other|21|||
148764338|NCT01073605|536611943|FG002|Overall Study|Other|29|||
148764339|NCT01073605|536611941|FG000|Overall Study|Withdrawal by Subject|31|||
148764340|NCT01073605|536611942|FG001|Overall Study|Withdrawal by Subject|39|||
148977721|NCT00094653|537398428|FG002|Overall Study|Subject Withdrew Consent|3|||
148977722|NCT00094653|537398426|FG000|Overall Study|Other|2|||
148764341|NCT01073605|536611943|FG002|Overall Study|Withdrawal by Subject|22|||
148764342|NCT01073605|536611941|FG000|Overall Study|Randomized But Not Treated|0|||
148764343|NCT01073605|536611942|FG001|Overall Study|Randomized But Not Treated|1|||
148764344|NCT01073605|536611943|FG002|Overall Study|Randomized But Not Treated|1|||
148764345|NCT03018080|536611944|FG000|Overall Study|Death|12|||
148764346|NCT03018080|536611945|FG001|Overall Study|Death|19|||
148764347|NCT00740792|536611946|FG000|Overall Study|Adverse Event|3|||
148764348|NCT00740792|536611947|FG001|Overall Study|Adverse Event|1|||
148764349|NCT00740792|536611948|FG002|Overall Study|Adverse Event|1|||
148764350|NCT00740792|536611949|FG003|Overall Study|Adverse Event|3|||
148764351|NCT00740792|536611946|FG000|Overall Study|Lack of Efficacy|1|||
148764352|NCT00740792|536611947|FG001|Overall Study|Lack of Efficacy|1|||
148764353|NCT00740792|536611948|FG002|Overall Study|Lack of Efficacy|0|||
148764354|NCT00740792|536611949|FG003|Overall Study|Lack of Efficacy|3|||
148977723|NCT00094653|537398427|FG001|Overall Study|Other|2|||
148977724|NCT00094653|537398428|FG002|Overall Study|Other|2|||
148764355|NCT00740792|536611946|FG000|Overall Study|Lost to Follow-up|2|||
148764356|NCT00740792|536611947|FG001|Overall Study|Lost to Follow-up|1|||
148764357|NCT00740792|536611948|FG002|Overall Study|Lost to Follow-up|0|||
148764358|NCT00740792|536611949|FG003|Overall Study|Lost to Follow-up|0|||
148764359|NCT00740792|536611946|FG000|Overall Study|Protocol Violation|0|||
148764360|NCT00740792|536611947|FG001|Overall Study|Protocol Violation|1|||
148764361|NCT00740792|536611948|FG002|Overall Study|Protocol Violation|0|||
148764362|NCT00740792|536611949|FG003|Overall Study|Protocol Violation|2|||
148764363|NCT00740792|536611946|FG000|Overall Study|Withdrawal by Subject|1|||
148764364|NCT00740792|536611947|FG001|Overall Study|Withdrawal by Subject|1|||
148764365|NCT00740792|536611948|FG002|Overall Study|Withdrawal by Subject|0|||
148764366|NCT00740792|536611949|FG003|Overall Study|Withdrawal by Subject|0|||
148764367|NCT00740792|536611946|FG000|Overall Study|administrative|3|||
148764368|NCT00740792|536611947|FG001|Overall Study|administrative|3|||
148764369|NCT00740792|536611948|FG002|Overall Study|administrative|8|||
148764370|NCT00740792|536611949|FG003|Overall Study|administrative|2|||
148764371|NCT03412734|536611958|FG000|Overall Study|Incorrect labeling of samples|2|||
148764372|NCT03412734|536611959|FG001|Overall Study|Incorrect labeling of samples|0|||
148764373|NCT03412734|536611958|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
148764374|NCT03412734|536611959|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
148764375|NCT02097238|536611970|FG000|Overall Study|Death|1|||
148764376|NCT02097238|536611970|FG000|Overall Study|Physician Decision|1|||
148764377|NCT02097238|536611970|FG000|Overall Study|Progressive Disease|17|||
148764378|NCT01282372|536611971|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
148764379|NCT01282372|536611971|FG000|Overall Study|Lost to Follow-up|23|||
148764380|NCT01282372|536611971|FG000|Overall Study|Withdrawal by Subject|11|||
148764381|NCT01282372|536611971|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
148764382|NCT01282372|536611971|FG000|Overall Study|Death|1|||
148764383|NCT01282372|536611971|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
148764384|NCT01282372|536611971|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
148764385|NCT01282372|536611971|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
148764386|NCT01282372|536611971|FG000|Overall Study|Adverse Event|12|||
148764387|NCT01814696|536611972|FG000|Overall Study|Withdrawal by Subject|1|||
148764388|NCT01814696|536611973|FG001|Overall Study|Withdrawal by Subject|0|||
148764389|NCT01814696|536611972|FG000|Overall Study|Randomized to wrong group|1|||
148764390|NCT01814696|536611973|FG001|Overall Study|Randomized to wrong group|0|||
148764391|NCT00713258|536611974|FG000|Overall Study|Adverse Event|2|||
148764392|NCT00713258|536611975|FG001|Overall Study|Adverse Event|4|||
148764393|NCT00713258|536611974|FG000|Overall Study|Non-Compliance|2|||
148764394|NCT00713258|536611975|FG001|Overall Study|Non-Compliance|1|||
148764395|NCT00713258|536611974|FG000|Overall Study|Other|1|||
148764396|NCT00713258|536611975|FG001|Overall Study|Other|1|||
148764397|NCT01322490|536611976|FG000|Treatment Period|Adverse Event|12|||
148764398|NCT01322490|536611977|FG001|Treatment Period|Adverse Event|18|||
148764399|NCT01322490|536611978|FG002|Treatment Period|Adverse Event|15|||
148764400|NCT01322490|536611976|FG000|Treatment Period|Death|5|||
148764401|NCT01322490|536611977|FG001|Treatment Period|Death|7|||
148764402|NCT01322490|536611978|FG002|Treatment Period|Death|3|||
148764403|NCT01322490|536611976|FG000|Treatment Period|Lack of Efficacy|89|||
148764404|NCT01322490|536611977|FG001|Treatment Period|Lack of Efficacy|100|||
148764405|NCT01322490|536611978|FG002|Treatment Period|Lack of Efficacy|112|||
148764406|NCT01322490|536611976|FG000|Treatment Period|Physician Decision|0|||
148764407|NCT01322490|536611977|FG001|Treatment Period|Physician Decision|2|||
148764408|NCT01322490|536611978|FG002|Treatment Period|Physician Decision|1|||
148764409|NCT01322490|536611976|FG000|Treatment Period|Protocol Violation|7|||
148764410|NCT01322490|536611977|FG001|Treatment Period|Protocol Violation|5|||
148764411|NCT01322490|536611978|FG002|Treatment Period|Protocol Violation|4|||
148764412|NCT01322490|536611976|FG000|Treatment Period|Withdrawal by Subject|14|||
148764413|NCT01322490|536611977|FG001|Treatment Period|Withdrawal by Subject|16|||
148764414|NCT01322490|536611978|FG002|Treatment Period|Withdrawal by Subject|11|||
148764415|NCT01322490|536611976|FG000|Treatment Period|Non-compliance with study drug|0|||
148764416|NCT01322490|536611977|FG001|Treatment Period|Non-compliance with study drug|0|||
148764417|NCT01322490|536611978|FG002|Treatment Period|Non-compliance with study drug|1|||
148764418|NCT01322490|536611976|FG000|Treatment Period|Other per report|2|||
148977725|NCT00094653|537398426|FG000|Overall Study|Lost to Follow-up|3|||
148977726|NCT00094653|537398427|FG001|Overall Study|Lost to Follow-up|2|||
148977727|NCT00094653|537398428|FG002|Overall Study|Lost to Follow-up|1|||
148764419|NCT01322490|536611977|FG001|Treatment Period|Other per report|2|||
148764420|NCT01322490|536611978|FG002|Treatment Period|Other per report|1|||
148764421|NCT01322490|536611976|FG000|Treatment Period|Randomized but Not Treated|3|||
148764422|NCT01322490|536611977|FG001|Treatment Period|Randomized but Not Treated|3|||
148764423|NCT01322490|536611978|FG002|Treatment Period|Randomized but Not Treated|5|||
148764424|NCT01322490|536611976|FG000|Long Term Follow-up Period|Death|235|||
148764425|NCT01322490|536611977|FG001|Long Term Follow-up Period|Death|239|||
148764426|NCT01322490|536611978|FG002|Long Term Follow-up Period|Death|236|||
148764427|NCT01322490|536611976|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
148977728|NCT00094653|537398426|FG000|Overall Study|Protocol Violation|0|||
148764428|NCT01322490|536611977|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
148764429|NCT01322490|536611978|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
148764430|NCT01322490|536611976|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
148764431|NCT01322490|536611977|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
148764432|NCT01322490|536611978|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
148764433|NCT01322490|536611976|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
148764434|NCT01322490|536611977|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
148764435|NCT01322490|536611978|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
148764436|NCT01322490|536611976|FG000|Long Term Follow-up Period|Other per report|3|||
148764437|NCT01322490|536611977|FG001|Long Term Follow-up Period|Other per report|2|||
148764438|NCT01322490|536611978|FG002|Long Term Follow-up Period|Other per report|2|||
148764439|NCT01322490|536611976|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
148764440|NCT01322490|536611977|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
148764441|NCT01322490|536611978|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
148764442|NCT01431716|536611979|FG000|Overall Study|Withdrawal of consent|1|||
148764443|NCT02199795|536611980|FG000|Overall Study|no longer met inclusion criteria|1|||
148764444|NCT02199795|536611981|FG001|Overall Study|no longer met inclusion criteria|0|||
148764445|NCT02199795|536611980|FG000|Overall Study|withdrew due to shoulder pain|1|||
148764446|NCT02199795|536611981|FG001|Overall Study|withdrew due to shoulder pain|0|||
148764447|NCT05310071|536611995|FG000|Overall Study|Death|0|||
148764448|NCT05310071|536611996|FG001|Overall Study|Death|3|||
148764449|NCT05310071|536611995|FG000|Overall Study|Adverse Event|4|||
148764450|NCT05310071|536611996|FG001|Overall Study|Adverse Event|31|||
148764451|NCT05310071|536611995|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
148764452|NCT05310071|536611996|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
148764453|NCT05310071|536611995|FG000|Overall Study|Protocol Deviation|2|||
148764454|NCT05310071|536611996|FG001|Overall Study|Protocol Deviation|0|||
148764455|NCT05310071|536611995|FG000|Overall Study|Randomized by Mistake|0|||
148764456|NCT05310071|536611996|FG001|Overall Study|Randomized by Mistake|1|||
148764457|NCT05310071|536611995|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
148764458|NCT05310071|536611996|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
148764459|NCT05310071|536611995|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
148764460|NCT05310071|536611996|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
148764461|NCT05310071|536611995|FG000|Overall Study|Site Terminated by Sponsor|0|||
148764462|NCT05310071|536611996|FG001|Overall Study|Site Terminated by Sponsor|2|||
148764463|NCT05310071|536611995|FG000|Overall Study|Study Terminated by Sponsor|282|||
148764464|NCT05310071|536611996|FG001|Overall Study|Study Terminated by Sponsor|559|||
148764465|NCT05310071|536611995|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
148764466|NCT05310071|536611996|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
148764467|NCT05310071|536611995|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
148764468|NCT05310071|536611996|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
148764469|NCT05310071|536611995|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
148764470|NCT05310071|536611996|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
148764471|NCT05310071|536611995|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
148764472|NCT05310071|536611996|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
148764473|NCT05310071|536611995|FG000|Overall Study|Withdrawal by Participant - Other|25|||
148764474|NCT05310071|536611996|FG001|Overall Study|Withdrawal by Participant - Other|30|||
148764475|NCT05310071|536611995|FG000|Overall Study|Lost to Follow-up|2|||
148764476|NCT05310071|536611996|FG001|Overall Study|Lost to Follow-up|4|||
148764477|NCT05310071|536611995|FG000|Overall Study|Reason Not Specified|1|||
148764478|NCT05310071|536611996|FG001|Overall Study|Reason Not Specified|3|||
148764479|NCT02418949|536611997|FG000|Overall Study|Withdrawal by Subject|1|||
148764480|NCT02418949|536611998|FG001|Overall Study|Withdrawal by Subject|0|||
148764481|NCT02418949|536611999|FG002|Overall Study|Withdrawal by Subject|1|||
148764482|NCT02418949|536612000|FG003|Overall Study|Withdrawal by Subject|1|||
148764483|NCT02418949|536611997|FG000|Overall Study|Lost to Follow-up|1|||
148764484|NCT02418949|536611998|FG001|Overall Study|Lost to Follow-up|0|||
148764485|NCT02418949|536611999|FG002|Overall Study|Lost to Follow-up|1|||
148764486|NCT02418949|536612000|FG003|Overall Study|Lost to Follow-up|0|||
148764487|NCT02418949|536611997|FG000|Overall Study|Physician Decision|1|||
148764488|NCT02418949|536611998|FG001|Overall Study|Physician Decision|1|||
148764489|NCT02418949|536611999|FG002|Overall Study|Physician Decision|1|||
148764490|NCT02418949|536612000|FG003|Overall Study|Physician Decision|0|||
148764491|NCT02343939|536612005|FG000|Overall Study|Death|0|||
148764492|NCT02343939|536612006|FG001|Overall Study|Death|15|||
148764493|NCT02343939|536612007|FG002|Overall Study|Death|4|||
148764494|NCT02343939|536612008|FG003|Overall Study|Death|2|||
148764495|NCT02343939|536612009|FG004|Overall Study|Death|5|||
148764496|NCT02343939|536612010|FG005|Overall Study|Death|11|||
148764497|NCT02343939|536612011|FG006|Overall Study|Death|8|||
148764498|NCT02343939|536612012|FG007|Overall Study|Death|22|||
148764499|NCT02343939|536612013|FG008|Overall Study|Death|1|||
148977729|NCT00094653|537398427|FG001|Overall Study|Protocol Violation|0|||
148977730|NCT00094653|537398428|FG002|Overall Study|Protocol Violation|1|||
148977731|NCT02143843|537398429|FG000|Overall Study|Adverse Event|8|||
148977732|NCT02143843|537398429|FG000|Overall Study|Lack of Efficacy|2|||
148977733|NCT02143843|537398429|FG000|Overall Study|Withdrawal by Subject|2|||
148977734|NCT00480779|537398430|FG000|Overall Study|Other|2|||
148977735|NCT00480779|537398431|FG001|Overall Study|Other|0|||
148977736|NCT00480779|537398430|FG000|Overall Study|Job and Health-related|0|||
148977737|NCT00480779|537398431|FG001|Overall Study|Job and Health-related|3|||
148977738|NCT01482767|537398442|FG000|Overall Study|Death|1|||
148977739|NCT01482767|537398443|FG001|Overall Study|Death|1|||
148977740|NCT01482767|537398442|FG000|Overall Study|Withdrawal by Subject|7|||
148977741|NCT01482767|537398443|FG001|Overall Study|Withdrawal by Subject|5|||
148977742|NCT01482767|537398442|FG000|Overall Study|Lost to Follow-up|12|||
148977743|NCT01482767|537398443|FG001|Overall Study|Lost to Follow-up|6|||
148977744|NCT01482767|537398442|FG000|Overall Study|Adverse Event|0|||
148977745|NCT01482767|537398443|FG001|Overall Study|Adverse Event|3|||
148977746|NCT01482767|537398442|FG000|Overall Study|Site closure|22|||
148977747|NCT01482767|537398443|FG001|Overall Study|Site closure|14|||
148977748|NCT01482767|537398442|FG000|Overall Study|Non-adherence to study requirements|4|||
148977749|NCT01482767|537398443|FG001|Overall Study|Non-adherence to study requirements|7|||
148977750|NCT01482767|537398442|FG000|Overall Study|Alternate HCV treatment|7|||
148977751|NCT01482767|537398443|FG001|Overall Study|Alternate HCV treatment|8|||
148977752|NCT01482767|537398442|FG000|Overall Study|Ineligible|0|||
148977753|NCT01482767|537398443|FG001|Overall Study|Ineligible|5|||
148977754|NCT01482767|537398442|FG000|Overall Study|Nurse error|1|||
148764500|NCT02343939|536612005|FG000|Overall Study|Study terminated by sponsor|0|||
148764501|NCT02343939|536612006|FG001|Overall Study|Study terminated by sponsor|27|||
148764502|NCT02343939|536612007|FG002|Overall Study|Study terminated by sponsor|0|||
148764503|NCT02343939|536612008|FG003|Overall Study|Study terminated by sponsor|1|||
148764504|NCT02343939|536612009|FG004|Overall Study|Study terminated by sponsor|1|||
148764505|NCT02343939|536612010|FG005|Overall Study|Study terminated by sponsor|5|||
148764506|NCT02343939|536612011|FG006|Overall Study|Study terminated by sponsor|3|||
148764507|NCT02343939|536612012|FG007|Overall Study|Study terminated by sponsor|4|||
148764508|NCT02343939|536612013|FG008|Overall Study|Study terminated by sponsor|0|||
148764509|NCT02343939|536612005|FG000|Overall Study|Withdrew consent|3|||
148764510|NCT02343939|536612006|FG001|Overall Study|Withdrew consent|6|||
148764511|NCT02343939|536612007|FG002|Overall Study|Withdrew consent|1|||
148764512|NCT02343939|536612008|FG003|Overall Study|Withdrew consent|2|||
148764513|NCT02343939|536612009|FG004|Overall Study|Withdrew consent|2|||
148764514|NCT02343939|536612010|FG005|Overall Study|Withdrew consent|0|||
148764515|NCT02343939|536612011|FG006|Overall Study|Withdrew consent|0|||
148764516|NCT02343939|536612012|FG007|Overall Study|Withdrew consent|8|||
148764517|NCT02343939|536612013|FG008|Overall Study|Withdrew consent|6|||
148764518|NCT02343939|536612005|FG000|Overall Study|Treatment failure|0|||
148764519|NCT02343939|536612006|FG001|Overall Study|Treatment failure|0|||
148764520|NCT02343939|536612007|FG002|Overall Study|Treatment failure|0|||
148764521|NCT02343939|536612008|FG003|Overall Study|Treatment failure|0|||
148764522|NCT02343939|536612009|FG004|Overall Study|Treatment failure|0|||
148764523|NCT02343939|536612010|FG005|Overall Study|Treatment failure|0|||
148764524|NCT02343939|536612011|FG006|Overall Study|Treatment failure|2|||
148764525|NCT02343939|536612012|FG007|Overall Study|Treatment failure|1|||
148764526|NCT02343939|536612013|FG008|Overall Study|Treatment failure|0|||
148764527|NCT02343939|536612005|FG000|Overall Study|Investigator's discretion|0|||
148977755|NCT01482767|537398443|FG001|Overall Study|Nurse error|0|||
148977756|NCT00806546|537398455|FG000|Overall Study|Enrolled, not treated|35|||
148977757|NCT00806546|537398455|FG000|Overall Study|Lost to Follow-up|32|||
148977758|NCT00806546|537398455|FG000|Overall Study|Adverse Event|74|||
148764528|NCT02343939|536612006|FG001|Overall Study|Investigator's discretion|0|||
148764529|NCT02343939|536612007|FG002|Overall Study|Investigator's discretion|0|||
148764530|NCT02343939|536612008|FG003|Overall Study|Investigator's discretion|1|||
148764531|NCT02343939|536612009|FG004|Overall Study|Investigator's discretion|0|||
148764532|NCT02343939|536612010|FG005|Overall Study|Investigator's discretion|0|||
148764533|NCT02343939|536612011|FG006|Overall Study|Investigator's discretion|1|||
148764534|NCT02343939|536612012|FG007|Overall Study|Investigator's discretion|0|||
148764535|NCT02343939|536612013|FG008|Overall Study|Investigator's discretion|0|||
148764536|NCT02343939|536612005|FG000|Overall Study|Adverse Event|0|||
148764537|NCT02343939|536612006|FG001|Overall Study|Adverse Event|0|||
148764538|NCT02343939|536612007|FG002|Overall Study|Adverse Event|0|||
148764539|NCT02343939|536612008|FG003|Overall Study|Adverse Event|0|||
148764540|NCT02343939|536612009|FG004|Overall Study|Adverse Event|0|||
148764541|NCT02343939|536612010|FG005|Overall Study|Adverse Event|1|||
148764542|NCT02343939|536612011|FG006|Overall Study|Adverse Event|0|||
148977759|NCT00806546|537398455|FG000|Overall Study|Withdrawal by Subject|75|||
148977760|NCT00806546|537398455|FG000|Overall Study|Protocol Violation|49|||
148977761|NCT00806546|537398455|FG000|Overall Study|Various|42|||
148977762|NCT02457325|537398463|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
148977763|NCT02457325|537398464|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
148977764|NCT01541930|537398467|FG000|Overall Study|Withdrawal by Subject|1|||
148826758|NCT01689649|536844315|FG000|Overall Study|Protocol Violation|3|||
148826759|NCT01689649|536844315|FG000|Overall Study|Lost to Follow-up|5|||
148826760|NCT03760081|536844329|FG000|Overall Study|Miscellaneous|0|||
148826761|NCT03760081|536844330|FG001|Overall Study|Miscellaneous|1|||
148826762|NCT03760081|536844329|FG000|Overall Study|Progressive Disease|5|||
148826763|NCT03760081|536844330|FG001|Overall Study|Progressive Disease|10|||
148826764|NCT03760081|536844329|FG000|Overall Study|Death|1|||
148826765|NCT03760081|536844330|FG001|Overall Study|Death|1|||
148826766|NCT04064567|536844331|FG000|Overall Study|Lost to Follow-up|23|||
148826767|NCT04064567|536844332|FG001|Overall Study|Lost to Follow-up|22|||
148826768|NCT04064567|536844331|FG000|Overall Study|Withdrawal by Subject|0|||
148826769|NCT04064567|536844332|FG001|Overall Study|Withdrawal by Subject|1|||
148826770|NCT04064567|536844331|FG000|Overall Study|Reincarcerated|7|||
148826771|NCT04064567|536844332|FG001|Overall Study|Reincarcerated|10|||
148826772|NCT04064567|536844331|FG000|Overall Study|Moved out of U.S.|0|||
148826773|NCT04064567|536844332|FG001|Overall Study|Moved out of U.S.|1|||
148826774|NCT05524948|536844335|FG000|Overall Study|Withdrawal by Subject|1|||
148826775|NCT05524948|536844336|FG001|Overall Study|Withdrawal by Subject|0|||
148826776|NCT05524948|536844335|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
148826777|NCT05524948|536844336|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
148826778|NCT02758626|536844339|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
148826779|NCT02758626|536844340|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
148826780|NCT02758626|536844339|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
148826781|NCT02758626|536844340|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
148826782|NCT02758626|536844339|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
148826783|NCT02758626|536844340|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
148826784|NCT02758626|536844339|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
148826785|NCT02758626|536844340|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
148826786|NCT02739828|536844341|FG000|Overall Study|Adverse Event|1|||
148826787|NCT02739828|536844341|FG000|Overall Study|Lost to Follow-up|4|||
148826788|NCT02202577|536844342|FG000|Overall Study|Lost to Follow-up|6|||
148826789|NCT02202577|536844343|FG001|Overall Study|Lost to Follow-up|16|||
148826790|NCT02202577|536844342|FG000|Overall Study|Protocol Violation|7|||
148826791|NCT02202577|536844343|FG001|Overall Study|Protocol Violation|3|||
148826792|NCT02100644|536844344|FG000|LTG Escalation Phase|Adverse Event|9|||
148826793|NCT02100644|536844345|FG001|LTG Escalation Phase|Adverse Event|0|||
148826794|NCT02100644|536844346|FG002|LTG Escalation Phase|Adverse Event|0|||
148826795|NCT02100644|536844344|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
148826796|NCT02100644|536844345|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
148826797|NCT02100644|536844346|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
148826798|NCT02100644|536844344|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
148826799|NCT02100644|536844345|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
148826800|NCT02100644|536844346|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
148826801|NCT02852005|536844347|FG000|Overall Study|Lost to Follow-up|0|||
148826802|NCT02852005|536844348|FG001|Overall Study|Lost to Follow-up|0|||
148826803|NCT02852005|536844349|FG002|Overall Study|Lost to Follow-up|0|||
148826804|NCT02852005|536844350|FG003|Overall Study|Lost to Follow-up|0|||
148826805|NCT02852005|536844351|FG004|Overall Study|Lost to Follow-up|1|||
148826806|NCT02852005|536844347|FG000|Overall Study|Withdrawal by Subject|1|||
148826807|NCT02852005|536844348|FG001|Overall Study|Withdrawal by Subject|0|||
148826808|NCT02852005|536844349|FG002|Overall Study|Withdrawal by Subject|0|||
148826809|NCT02852005|536844350|FG003|Overall Study|Withdrawal by Subject|0|||
148826810|NCT02852005|536844351|FG004|Overall Study|Withdrawal by Subject|0|||
148826811|NCT04629521|536844352|FG000|Overall Study|Death|1|||
148826812|NCT04629521|536844352|FG000|Overall Study|Lost to Follow-up|3|||
148826813|NCT04629521|536844352|FG000|Overall Study|Subject withdrew consent|3|||
148826814|NCT04629521|536844352|FG000|Overall Study|Enrolled in error|1|||
148826815|NCT02369159|536844355|FG000|Overall Study|Adverse Event|0|||
148826816|NCT02369159|536844356|FG001|Overall Study|Adverse Event|1|||
148826817|NCT02369159|536844355|FG000|Overall Study|Lost to Follow-up|1|||
148826818|NCT02369159|536844356|FG001|Overall Study|Lost to Follow-up|1|||
148826819|NCT02369159|536844355|FG000|Overall Study|Withdrawal by Subject|7|||
148826820|NCT02369159|536844356|FG001|Overall Study|Withdrawal by Subject|0|||
148826821|NCT02554474|536844357|FG000|Overall Study|Protocol Violation|1|||
148826822|NCT02554474|536844358|FG001|Overall Study|Protocol Violation|1|||
148826823|NCT02554474|536844357|FG000|Overall Study|Health issue not related to the study|1|||
148826824|NCT02554474|536844358|FG001|Overall Study|Health issue not related to the study|0|||
148826825|NCT02554474|536844357|FG000|Overall Study|Withdrawal by Subject|1|||
148826826|NCT02554474|536844358|FG001|Overall Study|Withdrawal by Subject|1|||
148826827|NCT00489476|536844364|FG000|Overall Study|Lost to Follow-up|0|||
148826828|NCT00489476|536844365|FG001|Overall Study|Lost to Follow-up|1|||
148977765|NCT01957475|537398468|FG000|Test Period 1|Withdrawal by Subject|1|||
148977766|NCT01957475|537398469|FG001|Test Period 1|Withdrawal by Subject|0|||
148977767|NCT01957475|537398468|FG000|Test Period 1|Other|1|||
148977768|NCT01957475|537398469|FG001|Test Period 1|Other|0|||
148977769|NCT01957475|537398468|FG000|Test Period 1|Lack of Efficacy|0|||
148764543|NCT02343939|536612012|FG007|Overall Study|Adverse Event|0|||
148764544|NCT02343939|536612013|FG008|Overall Study|Adverse Event|0|||
148764545|NCT02343939|536612005|FG000|Overall Study|Never Treated With ENTO|0|||
148764546|NCT02343939|536612006|FG001|Overall Study|Never Treated With ENTO|0|||
148764547|NCT02343939|536612007|FG002|Overall Study|Never Treated With ENTO|0|||
148764548|NCT02343939|536612008|FG003|Overall Study|Never Treated With ENTO|0|||
148764549|NCT02343939|536612009|FG004|Overall Study|Never Treated With ENTO|0|||
148764550|NCT02343939|536612010|FG005|Overall Study|Never Treated With ENTO|0|||
148764551|NCT02343939|536612011|FG006|Overall Study|Never Treated With ENTO|1|||
148764552|NCT02343939|536612012|FG007|Overall Study|Never Treated With ENTO|2|||
148764553|NCT02343939|536612013|FG008|Overall Study|Never Treated With ENTO|0|||
148764554|NCT00460811|536612014|FG000|Overall Study|Adverse Event|4|||
148764555|NCT00460811|536612015|FG001|Overall Study|Adverse Event|6|||
148764556|NCT00460811|536612016|FG002|Overall Study|Adverse Event|3|||
148764557|NCT00460811|536612017|FG003|Overall Study|Adverse Event|10|||
148764558|NCT00460811|536612018|FG004|Overall Study|Adverse Event|2|||
148764559|NCT00460811|536612014|FG000|Overall Study|Noncompliance|1|||
148764560|NCT00460811|536612015|FG001|Overall Study|Noncompliance|0|||
148764561|NCT00460811|536612016|FG002|Overall Study|Noncompliance|0|||
148764562|NCT00460811|536612017|FG003|Overall Study|Noncompliance|2|||
148764563|NCT00460811|536612018|FG004|Overall Study|Noncompliance|1|||
148764564|NCT00460811|536612014|FG000|Overall Study|Withdrawal by Subject|7|||
148764565|NCT00460811|536612015|FG001|Overall Study|Withdrawal by Subject|7|||
148764566|NCT00460811|536612016|FG002|Overall Study|Withdrawal by Subject|6|||
148764567|NCT00460811|536612017|FG003|Overall Study|Withdrawal by Subject|3|||
148764568|NCT00460811|536612018|FG004|Overall Study|Withdrawal by Subject|11|||
148764569|NCT00460811|536612014|FG000|Overall Study|Physician Decision|1|||
148764570|NCT00460811|536612015|FG001|Overall Study|Physician Decision|0|||
148764571|NCT00460811|536612016|FG002|Overall Study|Physician Decision|0|||
148764572|NCT00460811|536612017|FG003|Overall Study|Physician Decision|0|||
148764573|NCT00460811|536612018|FG004|Overall Study|Physician Decision|0|||
148764574|NCT00460811|536612014|FG000|Overall Study|Lost to Follow-up|3|||
148764575|NCT00460811|536612015|FG001|Overall Study|Lost to Follow-up|2|||
148764576|NCT00460811|536612016|FG002|Overall Study|Lost to Follow-up|5|||
148764577|NCT00460811|536612017|FG003|Overall Study|Lost to Follow-up|3|||
148764578|NCT00460811|536612018|FG004|Overall Study|Lost to Follow-up|6|||
148764579|NCT02097745|536612019|FG000|Overall Study|Adverse Event|25|||
148764580|NCT02097745|536612019|FG000|Overall Study|Death|16|||
148764581|NCT02097745|536612019|FG000|Overall Study|Failure to Return|14|||
148764582|NCT02097745|536612019|FG000|Overall Study|Administrative/Other|27|||
148764583|NCT02097745|536612019|FG000|Overall Study|Reason Not Specified|96|||
148764584|NCT02099110|536612025|FG000|Overall Study|Protocol Violation|2|||
148764585|NCT02099110|536612026|FG001|Overall Study|Protocol Violation|1|||
148764586|NCT02099110|536612027|FG002|Overall Study|Protocol Violation|0|||
148764587|NCT02099110|536612028|FG003|Overall Study|Protocol Violation|3|||
148764588|NCT02099110|536612029|FG004|Overall Study|Protocol Violation|1|||
148764589|NCT02099110|536612025|FG000|Overall Study|Participant moved|1|||
148764590|NCT02099110|536612026|FG001|Overall Study|Participant moved|1|||
148764591|NCT02099110|536612027|FG002|Overall Study|Participant moved|1|||
148764592|NCT02099110|536612028|FG003|Overall Study|Participant moved|0|||
148764593|NCT02099110|536612029|FG004|Overall Study|Participant moved|2|||
148764594|NCT02099110|536612025|FG000|Overall Study|Withdrawal by Subject|7|||
148764595|NCT02099110|536612026|FG001|Overall Study|Withdrawal by Subject|11|||
148764596|NCT02099110|536612027|FG002|Overall Study|Withdrawal by Subject|13|||
148764597|NCT02099110|536612028|FG003|Overall Study|Withdrawal by Subject|9|||
148764598|NCT02099110|536612029|FG004|Overall Study|Withdrawal by Subject|13|||
148764599|NCT02099110|536612025|FG000|Overall Study|Adverse Event|3|||
148764600|NCT02099110|536612026|FG001|Overall Study|Adverse Event|5|||
148764601|NCT02099110|536612027|FG002|Overall Study|Adverse Event|2|||
148764602|NCT02099110|536612028|FG003|Overall Study|Adverse Event|3|||
148764603|NCT02099110|536612029|FG004|Overall Study|Adverse Event|2|||
148977770|NCT01957475|537398469|FG001|Test Period 1|Lack of Efficacy|1|||
148764604|NCT02099110|536612025|FG000|Overall Study|Lost to Follow-up|6|||
148764605|NCT02099110|536612026|FG001|Overall Study|Lost to Follow-up|12|||
148764606|NCT02099110|536612027|FG002|Overall Study|Lost to Follow-up|11|||
148764607|NCT02099110|536612028|FG003|Overall Study|Lost to Follow-up|5|||
148764608|NCT02099110|536612029|FG004|Overall Study|Lost to Follow-up|6|||
148764609|NCT02099110|536612025|FG000|Overall Study|Death|0|||
148764610|NCT02099110|536612026|FG001|Overall Study|Death|1|||
148764611|NCT02099110|536612027|FG002|Overall Study|Death|0|||
148764612|NCT02099110|536612028|FG003|Overall Study|Death|0|||
148764613|NCT02099110|536612029|FG004|Overall Study|Death|0|||
148977771|NCT01957475|537398468|FG000|Test Period 2|Adverse Event|1|||
148764614|NCT02099110|536612025|FG000|Overall Study|Screen failure|0|||
148764615|NCT02099110|536612026|FG001|Overall Study|Screen failure|0|||
148977772|NCT01957475|537398469|FG001|Test Period 2|Adverse Event|0|||
148764616|NCT02099110|536612027|FG002|Overall Study|Screen failure|0|||
148764617|NCT02099110|536612028|FG003|Overall Study|Screen failure|0|||
148764618|NCT02099110|536612029|FG004|Overall Study|Screen failure|1|||
148764619|NCT02099110|536612025|FG000|Overall Study|Non-compliance with study drug|2|||
148764620|NCT02099110|536612026|FG001|Overall Study|Non-compliance with study drug|0|||
148764621|NCT02099110|536612027|FG002|Overall Study|Non-compliance with study drug|0|||
148764622|NCT02099110|536612028|FG003|Overall Study|Non-compliance with study drug|0|||
148764623|NCT02099110|536612029|FG004|Overall Study|Non-compliance with study drug|1|||
148764624|NCT02099110|536612025|FG000|Overall Study|Physician Decision|3|||
148764625|NCT02099110|536612026|FG001|Overall Study|Physician Decision|0|||
148764626|NCT02099110|536612027|FG002|Overall Study|Physician Decision|1|||
148764627|NCT02099110|536612028|FG003|Overall Study|Physician Decision|2|||
148764628|NCT02099110|536612029|FG004|Overall Study|Physician Decision|1|||
148764629|NCT01757184|536612036|FG000|Double-blind Period|Adverse Event|1|||
148764630|NCT01757184|536612037|FG001|Double-blind Period|Adverse Event|0|||
148764631|NCT01757184|536612038|FG002|Double-blind Period|Adverse Event|0|||
148764632|NCT01757184|536612039|FG003|Double-blind Period|Adverse Event|0|||
148764633|NCT01757184|536612036|FG000|Open-label Period|Lost to Follow-up|0|||
148764634|NCT01757184|536612037|FG001|Open-label Period|Lost to Follow-up|0|||
148764635|NCT01757184|536612038|FG002|Open-label Period|Lost to Follow-up|2|||
148764636|NCT01757184|536612039|FG003|Open-label Period|Lost to Follow-up|0|||
148764637|NCT01757184|536612036|FG000|Open-label Period|Withdrawal by Subject|0|||
148764638|NCT01757184|536612037|FG001|Open-label Period|Withdrawal by Subject|0|||
148764639|NCT01757184|536612038|FG002|Open-label Period|Withdrawal by Subject|1|||
148764640|NCT01757184|536612039|FG003|Open-label Period|Withdrawal by Subject|1|||
148764641|NCT01757184|536612036|FG000|Open-label Period|Discontinued by Sponsor|0|||
148764642|NCT01757184|536612037|FG001|Open-label Period|Discontinued by Sponsor|0|||
148764643|NCT01757184|536612038|FG002|Open-label Period|Discontinued by Sponsor|1|||
148764644|NCT01757184|536612039|FG003|Open-label Period|Discontinued by Sponsor|2|||
148764645|NCT02977572|536612040|FG000|Overall Study|Exclusion criterion|2|||
148764646|NCT02977572|536612041|FG001|Overall Study|Exclusion criterion|2|||
148764647|NCT00615550|536612047|FG000|Overall Study|Lost to Follow-up|6|||
148764648|NCT00615550|536612048|FG001|Overall Study|Lost to Follow-up|1|||
148764649|NCT01537042|536612049|FG000|Overall Study|Adverse Event|0|||
148764650|NCT01537042|536612050|FG001|Overall Study|Adverse Event|2|||
148764651|NCT01537042|536612049|FG000|Overall Study|Lack of Efficacy|0|||
148764652|NCT01537042|536612050|FG001|Overall Study|Lack of Efficacy|1|||
148764653|NCT01537042|536612049|FG000|Overall Study|Protocol Violation|0|||
148764654|NCT01537042|536612050|FG001|Overall Study|Protocol Violation|1|||
148764655|NCT01537042|536612049|FG000|Overall Study|Other|0|||
148764656|NCT01537042|536612050|FG001|Overall Study|Other|1|||
148764657|NCT02741076|536612051|FG000|Overall Study|Adverse Event|0|||
148764658|NCT02741076|536612052|FG001|Overall Study|Adverse Event|1|||
148764659|NCT02741076|536612053|FG002|Overall Study|Adverse Event|1|||
148764660|NCT02741076|536612054|FG003|Overall Study|Adverse Event|0|||
148764661|NCT02741076|536612051|FG000|Overall Study|Lack of Efficacy|1|||
148764662|NCT02741076|536612052|FG001|Overall Study|Lack of Efficacy|0|||
148764663|NCT02741076|536612053|FG002|Overall Study|Lack of Efficacy|0|||
148764664|NCT02741076|536612054|FG003|Overall Study|Lack of Efficacy|0|||
148764665|NCT02741076|536612051|FG000|Overall Study|Withdrawal by Subject|0|||
148764666|NCT02741076|536612052|FG001|Overall Study|Withdrawal by Subject|1|||
148764667|NCT02741076|536612053|FG002|Overall Study|Withdrawal by Subject|0|||
148977773|NCT01466192|537398470|FG000|Overall Study|Physician Decision|1|||
148764668|NCT02741076|536612054|FG003|Overall Study|Withdrawal by Subject|0|||
148764669|NCT02741076|536612051|FG000|Overall Study|Sponsor Request|2|||
148764670|NCT02741076|536612052|FG001|Overall Study|Sponsor Request|3|||
148764671|NCT02741076|536612053|FG002|Overall Study|Sponsor Request|0|||
148764672|NCT02741076|536612054|FG003|Overall Study|Sponsor Request|1|||
148764673|NCT02741076|536612051|FG000|Overall Study|No additional information available|0|||
148764674|NCT02741076|536612052|FG001|Overall Study|No additional information available|0|||
148764675|NCT02741076|536612053|FG002|Overall Study|No additional information available|1|||
148826829|NCT00489476|536844366|FG002|Overall Study|Lost to Follow-up|0|||
148826830|NCT00489476|536844367|FG003|Overall Study|Lost to Follow-up|0|||
148826831|NCT03769116|536844368|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
148826832|NCT03769116|536844369|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
148826833|NCT03769116|536844368|FG000|Part 3 - Open Label|Physician Decision|1|||
148826834|NCT03769116|536844369|FG001|Part 3 - Open Label|Physician Decision|0|||
148826835|NCT03769116|536844368|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
148826836|NCT03769116|536844369|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
148826837|NCT02181413|536844370|FG000|Overall Study|Withdrawal by Subject|45|||
148826838|NCT02181413|536844371|FG001|Overall Study|Withdrawal by Subject|61|||
148826839|NCT02181413|536844370|FG000|Overall Study|Reason Not Specified|2|||
148826840|NCT02181413|536844371|FG001|Overall Study|Reason Not Specified|5|||
148826841|NCT02181413|536844370|FG000|Overall Study|Lost to Follow-up|8|||
148826842|NCT02181413|536844371|FG001|Overall Study|Lost to Follow-up|7|||
148826843|NCT02757963|536844380|FG000|Overall Study|Adverse Event|3|||
148826844|NCT02757963|536844380|FG000|Overall Study|Reached Stopping Criteria|1054|||
148764676|NCT02741076|536612054|FG003|Overall Study|No additional information available|1|||
148764677|NCT01779440|536612055|FG000|Overall Study|Withdrawal by Subject|3|||
148764678|NCT01779440|536612056|FG001|Overall Study|Withdrawal by Subject|5|||
148977774|NCT01466192|537398470|FG000|Overall Study|Withdrawal by Subject|3|||
148977775|NCT03591575|537398471|FG000|Overall Study|Adverse Event|2|||
148977776|NCT03591575|537398472|FG001|Overall Study|Adverse Event|0|||
148977777|NCT03591575|537398471|FG000|Overall Study|Withdrawal by Subject|4|||
148977778|NCT03591575|537398472|FG001|Overall Study|Withdrawal by Subject|1|||
148977779|NCT00813358|537398475|FG000|Overall Study|Death|32|||
148977780|NCT00813358|537398475|FG000|Overall Study|Lost to Follow-up|12|||
148977781|NCT00813358|537398475|FG000|Overall Study|other endpoints|5|||
148977782|NCT00813358|537398475|FG000|Overall Study|Withdrawal by Subject|20|||
148977783|NCT04497987|537398477|FG000|Overall Study|Adverse Event|1|||
148977784|NCT04497987|537398478|FG001|Overall Study|Adverse Event|0|||
148977785|NCT04497987|537398477|FG000|Overall Study|Death|21|||
148977786|NCT04497987|537398478|FG001|Overall Study|Death|13|||
148977787|NCT04497987|537398477|FG000|Overall Study|Lost to Follow-up|19|||
148977788|NCT04497987|537398478|FG001|Overall Study|Lost to Follow-up|17|||
148977789|NCT04497987|537398477|FG000|Overall Study|Other - as reported by the investigator|22|||
148977790|NCT04497987|537398478|FG001|Overall Study|Other - as reported by the investigator|16|||
148977791|NCT04497987|537398477|FG000|Overall Study|Physician Decision|1|||
148977792|NCT04497987|537398478|FG001|Overall Study|Physician Decision|0|||
148977793|NCT04497987|537398477|FG000|Overall Study|Withdrawal by Subject|35|||
148977794|NCT04497987|537398478|FG001|Overall Study|Withdrawal by Subject|21|||
148977795|NCT03665038|537398479|FG000|Overall Study|Lost to Follow-up|0|||
148977796|NCT03665038|537398480|FG001|Overall Study|Lost to Follow-up|0|||
148977797|NCT03665038|537398481|FG002|Overall Study|Lost to Follow-up|1|||
148977798|NCT01660412|537398482|FG000|Overall Study|Protocol Violation|0|||
148977799|NCT01660412|537398483|FG001|Overall Study|Protocol Violation|3|||
148977800|NCT03551210|537398484|FG000|Overall Study|Adverse Event|5|||
148977801|NCT03551210|537398485|FG001|Overall Study|Adverse Event|6|||
148977802|NCT03551210|537398484|FG000|Overall Study|Withdrawal by Subject|1|||
148977803|NCT03551210|537398485|FG001|Overall Study|Withdrawal by Subject|7|||
148977804|NCT03551210|537398484|FG000|Overall Study|Needed in other antibiotic treatment|2|||
148977805|NCT03551210|537398485|FG001|Overall Study|Needed in other antibiotic treatment|5|||
148977806|NCT03551210|537398484|FG000|Overall Study|Lost to Follow-up|1|||
148977807|NCT03551210|537398485|FG001|Overall Study|Lost to Follow-up|1|||
148977808|NCT03551210|537398484|FG000|Overall Study|Absence of visit 4 and 5|1|||
148977809|NCT03551210|537398485|FG001|Overall Study|Absence of visit 4 and 5|0|||
148977810|NCT03551210|537398484|FG000|Overall Study|No drug for dispensing|0|||
148977811|NCT03551210|537398485|FG001|Overall Study|No drug for dispensing|1|||
148977812|NCT03265119|537398486|FG000|Overall Study|Adverse Event|2|||
148977813|NCT03265119|537398487|FG001|Overall Study|Adverse Event|1|||
148977814|NCT03265119|537398486|FG000|Overall Study|Lack of Efficacy|3|||
148977815|NCT03265119|537398487|FG001|Overall Study|Lack of Efficacy|0|||
148977816|NCT03265119|537398486|FG000|Overall Study|Protocol Violation|1|||
148977817|NCT03265119|537398487|FG001|Overall Study|Protocol Violation|2|||
148977818|NCT03265119|537398486|FG000|Overall Study|Withdrawal by Subject|2|||
148764679|NCT00315458|536612060|FG000|Overall Study|Administrative|0|||
148764680|NCT00315458|536612061|FG001|Overall Study|Administrative|3|||
148764681|NCT00315458|536612062|FG002|Overall Study|Administrative|8|||
148764682|NCT00315458|536612063|FG003|Overall Study|Administrative|21|||
148764683|NCT00315458|536612060|FG000|Overall Study|Adverse Event|2|||
148764684|NCT00315458|536612061|FG001|Overall Study|Adverse Event|4|||
148764685|NCT00315458|536612062|FG002|Overall Study|Adverse Event|23|||
148764686|NCT00315458|536612063|FG003|Overall Study|Adverse Event|3|||
148764687|NCT00315458|536612060|FG000|Overall Study|Lost to Follow-up|1|||
148764688|NCT00315458|536612061|FG001|Overall Study|Lost to Follow-up|2|||
148764689|NCT00315458|536612062|FG002|Overall Study|Lost to Follow-up|0|||
148764690|NCT00315458|536612063|FG003|Overall Study|Lost to Follow-up|2|||
148764691|NCT00315458|536612060|FG000|Overall Study|Withdrawal by Subject|0|||
148764692|NCT00315458|536612061|FG001|Overall Study|Withdrawal by Subject|3|||
148764693|NCT00315458|536612062|FG002|Overall Study|Withdrawal by Subject|0|||
148764694|NCT00315458|536612063|FG003|Overall Study|Withdrawal by Subject|2|||
148977819|NCT03265119|537398487|FG001|Overall Study|Withdrawal by Subject|4|||
148977820|NCT03265119|537398486|FG000|Overall Study|Lost to Follow-up|1|||
148977821|NCT03265119|537398487|FG001|Overall Study|Lost to Follow-up|0|||
148977822|NCT03265119|537398486|FG000|Overall Study|Lack of Compliance|1|||
148764695|NCT00315458|536612060|FG000|Overall Study|Lack of Efficacy|0|||
148977823|NCT03265119|537398487|FG001|Overall Study|Lack of Compliance|0|||
148977824|NCT04579679|537398488|FG000|Overall Study|New Antitumor Therapy|6|||
148977825|NCT04579679|537398489|FG001|Overall Study|New Antitumor Therapy|4|||
148764696|NCT00315458|536612061|FG001|Overall Study|Lack of Efficacy|0|||
148764697|NCT00315458|536612062|FG002|Overall Study|Lack of Efficacy|20|||
148764698|NCT00315458|536612063|FG003|Overall Study|Lack of Efficacy|1|||
148764699|NCT00315458|536612060|FG000|Overall Study|Did not qualify|0|||
148826845|NCT02757963|536844380|FG000|Overall Study|Lost to Follow-up|5|||
148826846|NCT02757963|536844380|FG000|Overall Study|Physician Decision|1|||
148977826|NCT04579679|537398490|FG002|Overall Study|New Antitumor Therapy|7|||
148977827|NCT04579679|537398491|FG003|Overall Study|New Antitumor Therapy|0|||
148977828|NCT04579679|537398488|FG000|Overall Study|Withdrawal of Consent|1|||
148977829|NCT04579679|537398489|FG001|Overall Study|Withdrawal of Consent|1|||
148764700|NCT00315458|536612061|FG001|Overall Study|Did not qualify|0|||
148977830|NCT04579679|537398490|FG002|Overall Study|Withdrawal of Consent|2|||
148977831|NCT04579679|537398491|FG003|Overall Study|Withdrawal of Consent|4|||
148977832|NCT04579679|537398488|FG000|Overall Study|Death|2|||
148977833|NCT04579679|537398489|FG001|Overall Study|Death|2|||
148764701|NCT00315458|536612062|FG002|Overall Study|Did not qualify|1|||
148764702|NCT00315458|536612063|FG003|Overall Study|Did not qualify|0|||
148764703|NCT00523848|536612064|FG000|Overall Study|Adverse Event|11|||
148764704|NCT00523848|536612064|FG000|Overall Study|Withdrawal by Subject|2|||
148764705|NCT00523848|536612064|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
148764706|NCT00523848|536612064|FG000|Overall Study|Disease Progression|5|||
148764707|NCT00523848|536612064|FG000|Overall Study|Other, unspecified|4|||
148764708|NCT00086619|536612065|FG000|Overall Study|Withdrawal by Subject|6|||
148764709|NCT00086619|536612066|FG001|Overall Study|Withdrawal by Subject|6|||
148764710|NCT00086619|536612065|FG000|Overall Study|Adverse Event|8|||
148764711|NCT00086619|536612066|FG001|Overall Study|Adverse Event|10|||
148764712|NCT00086619|536612065|FG000|Overall Study|Protocol Violation|1|||
148764713|NCT00086619|536612066|FG001|Overall Study|Protocol Violation|1|||
148764714|NCT00489918|536612067|FG000|Overall Study|Withdrawal by Subject|2|||
148764715|NCT00489918|536612068|FG001|Overall Study|Withdrawal by Subject|1|||
148764716|NCT00489918|536612069|FG002|Overall Study|Withdrawal by Subject|1|||
148764717|NCT00489918|536612070|FG003|Overall Study|Withdrawal by Subject|0|||
148764718|NCT00489918|536612071|FG004|Overall Study|Withdrawal by Subject|1|||
148764719|NCT00489918|536612067|FG000|Overall Study|Adverse Event|0|||
148764720|NCT00489918|536612068|FG001|Overall Study|Adverse Event|1|||
148764721|NCT00489918|536612069|FG002|Overall Study|Adverse Event|1|||
148764722|NCT00489918|536612070|FG003|Overall Study|Adverse Event|0|||
148764723|NCT00489918|536612071|FG004|Overall Study|Adverse Event|0|||
148764724|NCT00489918|536612067|FG000|Overall Study|Lost to Follow-up|0|||
148764725|NCT00489918|536612068|FG001|Overall Study|Lost to Follow-up|0|||
148764726|NCT00489918|536612069|FG002|Overall Study|Lost to Follow-up|1|||
148764727|NCT00489918|536612070|FG003|Overall Study|Lost to Follow-up|1|||
148764728|NCT00489918|536612071|FG004|Overall Study|Lost to Follow-up|0|||
148764729|NCT00489918|536612067|FG000|Overall Study|Physician Decision|0|||
148764730|NCT00489918|536612068|FG001|Overall Study|Physician Decision|0|||
148764731|NCT00489918|536612069|FG002|Overall Study|Physician Decision|1|||
148764732|NCT00489918|536612070|FG003|Overall Study|Physician Decision|0|||
148764733|NCT00489918|536612071|FG004|Overall Study|Physician Decision|0|||
148764734|NCT02748213|536612072|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
148764735|NCT02748213|536612073|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
148764736|NCT02748213|536612072|FG000|Overall Study|Abnormal Laboratory Test|1|||
148764737|NCT02748213|536612073|FG001|Overall Study|Abnormal Laboratory Test|0|||
148764738|NCT02748213|536612072|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
148764739|NCT02748213|536612073|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
148764740|NCT02748213|536612072|FG000|Overall Study|Death|5|||
148764741|NCT02748213|536612073|FG001|Overall Study|Death|3|||
148764742|NCT02748213|536612072|FG000|Overall Study|Insufficient Therapeutic Response|56|||
148764743|NCT02748213|536612073|FG001|Overall Study|Insufficient Therapeutic Response|57|||
148764744|NCT02748213|536612072|FG000|Overall Study|Violation of Selection Criteria|2|||
148764745|NCT02748213|536612073|FG001|Overall Study|Violation of Selection Criteria|0|||
148764746|NCT02748213|536612072|FG000|Overall Study|Protocol Violation|6|||
148764747|NCT02748213|536612073|FG001|Overall Study|Protocol Violation|4|||
148764748|NCT02748213|536612072|FG000|Overall Study|Refused Treatment*|6|||
148764749|NCT02748213|536612073|FG001|Overall Study|Refused Treatment*|6|||
148764750|NCT02748213|536612072|FG000|Overall Study|Failure to Return|1|||
148764751|NCT02748213|536612073|FG001|Overall Study|Failure to Return|0|||
148764752|NCT02748213|536612072|FG000|Overall Study|Other|30|||
148764753|NCT02748213|536612073|FG001|Overall Study|Other|29|||
148764754|NCT01209520|536612075|FG000|Overall Study|Withdrawal by Subject|3|||
148764755|NCT00961350|536612076|FG000|Overall Study|Adverse Event|18|||
148764756|NCT00961350|536612077|FG001|Overall Study|Adverse Event|33|||
148764757|NCT00961350|536612076|FG000|Overall Study|Withdrawal by Subject|10|||
148764758|NCT00961350|536612077|FG001|Overall Study|Withdrawal by Subject|10|||
148764759|NCT00961350|536612076|FG000|Overall Study|Lost to Follow-up|3|||
148764760|NCT00961350|536612077|FG001|Overall Study|Lost to Follow-up|3|||
148764761|NCT00961350|536612076|FG000|Overall Study|Misc|16|||
148764762|NCT00961350|536612077|FG001|Overall Study|Misc|21|||
148764763|NCT06868654|536612079|FG000|Overall Study|Death|4|||
148764764|NCT06868654|536612080|FG001|Overall Study|Death|14|||
148764765|NCT06868654|536612079|FG000|Overall Study|Lost to Follow-up|0|||
148977834|NCT04579679|537398490|FG002|Overall Study|Death|2|||
148764766|NCT06868654|536612080|FG001|Overall Study|Lost to Follow-up|1|||
148764767|NCT06868654|536612079|FG000|Overall Study|Withdrawal by Subject|5|||
148764768|NCT06868654|536612080|FG001|Overall Study|Withdrawal by Subject|3|||
148764769|NCT06868654|536612079|FG000|Overall Study|Physician Decision|0|||
148764770|NCT06868654|536612080|FG001|Overall Study|Physician Decision|1|||
148764771|NCT06868654|536612079|FG000|Overall Study|Ongoing|23|||
148764772|NCT06868654|536612080|FG001|Overall Study|Ongoing|21|||
148977835|NCT04579679|537398491|FG003|Overall Study|Death|0|||
148764773|NCT01760655|536613193|FG000|Overall Study|Death|18|||
148764774|NCT01760655|536613193|FG000|Overall Study|Physician Decision|1|||
148764775|NCT03056638|536613206|FG000|Overall Study|Death|1|||
148764776|NCT03056638|536613207|FG001|Overall Study|Death|0|||
148764777|NCT02530125|536613208|FG000|Completed Treatment|Early termination of study|1|||
148764778|NCT02530125|536613208|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
148764779|NCT00468481|536613209|FG000|Overall Study|Adverse Event|13|||
148764780|NCT00468481|536613210|FG001|Overall Study|Adverse Event|3|||
148764781|NCT00468481|536613209|FG000|Overall Study|Lost to Follow-up|25|||
148764782|NCT00468481|536613210|FG001|Overall Study|Lost to Follow-up|8|||
148764783|NCT00468481|536613209|FG000|Overall Study|Pregnancy|2|||
148764784|NCT00468481|536613210|FG001|Overall Study|Pregnancy|0|||
148764785|NCT00468481|536613209|FG000|Overall Study|Protocol Violation|18|||
148764786|NCT00468481|536613210|FG001|Overall Study|Protocol Violation|8|||
148764787|NCT00468481|536613209|FG000|Overall Study|Withdrawal by Subject|12|||
148764788|NCT00468481|536613210|FG001|Overall Study|Withdrawal by Subject|3|||
148764789|NCT00468481|536613209|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
148764790|NCT00468481|536613210|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
148764791|NCT00468481|536613209|FG000|Overall Study|Prohibited Medication|1|||
148764792|NCT00468481|536613210|FG001|Overall Study|Prohibited Medication|1|||
148764793|NCT00468481|536613209|FG000|Overall Study|Egg Donor|1|||
148764794|NCT00468481|536613210|FG001|Overall Study|Egg Donor|0|||
148764795|NCT00468481|536613209|FG000|Overall Study|Moved out of area|4|||
148764796|NCT00468481|536613210|FG001|Overall Study|Moved out of area|1|||
148764797|NCT00468481|536613209|FG000|Overall Study|Non-Compliance|5|||
148764798|NCT00468481|536613210|FG001|Overall Study|Non-Compliance|0|||
148764799|NCT00468481|536613209|FG000|Overall Study|Other|6|||
148764800|NCT00468481|536613210|FG001|Overall Study|Other|0|||
148764801|NCT00728468|536613212|FG000|Overall Study|Enrolled but not treated|1|||
148764802|NCT00728468|536613212|FG000|Overall Study|Death|1|||
148764803|NCT00728468|536613212|FG000|Overall Study|Protocol Violation|4|||
148764804|NCT00728468|536613212|FG000|Overall Study|Objective progression or relapse|9|||
148764805|NCT00728468|536613212|FG000|Overall Study|Study terminated by sponsor|1|||
148764806|NCT01568034|536613213|FG000|Overall Study|Withdrawal by Subject|1|||
148764807|NCT01568034|536613214|FG001|Overall Study|Withdrawal by Subject|0|||
148764808|NCT01568034|536613215|FG002|Overall Study|Withdrawal by Subject|0|||
148764809|NCT01568034|536613216|FG003|Overall Study|Withdrawal by Subject|0|||
148764810|NCT01637922|536613217|FG000|Overall Study|Adverse Event|0|||
148764811|NCT01637922|536613218|FG001|Overall Study|Adverse Event|1|||
148764812|NCT01637922|536613217|FG000|Overall Study|Protocol Violation|0|||
148764813|NCT01637922|536613218|FG001|Overall Study|Protocol Violation|1|||
148764814|NCT01637922|536613217|FG000|Overall Study|Withdrawal by Subject|0|||
148764815|NCT01637922|536613218|FG001|Overall Study|Withdrawal by Subject|3|||
148764816|NCT01637922|536613217|FG000|Overall Study|Lost to Follow-up|2|||
148764817|NCT01637922|536613218|FG001|Overall Study|Lost to Follow-up|0|||
148764818|NCT01515865|536613219|FG000|Part A (Open-label)|Other|3|||
148764819|NCT01515865|536613220|FG001|Part A (Open-label)|Other|0|||
148764820|NCT01515865|536613221|FG002|Part A (Open-label)|Other|0|||
148764821|NCT01515865|536613219|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
148764822|NCT01515865|536613220|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
148764823|NCT01515865|536613221|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
148764824|NCT01515865|536613219|FG000|Part B (Open-label)|Other|1|||
148764825|NCT01515865|536613220|FG001|Part B (Open-label)|Other|0|||
148764826|NCT01515865|536613221|FG002|Part B (Open-label)|Other|0|||
148764827|NCT02498444|536613224|FG000|Overall Study|Withdrawal by Subject|3|||
148764828|NCT02498444|536613225|FG001|Overall Study|Withdrawal by Subject|0|||
148764829|NCT02498444|536613224|FG000|Overall Study|Physician Decision|1|||
148764830|NCT02498444|536613225|FG001|Overall Study|Physician Decision|0|||
148764831|NCT03656692|536613226|FG000|Overall Study|Worsening of disease activity|2|||
148764832|NCT03656692|536613226|FG000|Overall Study|Physician Decision|1|||
148764833|NCT01841762|536613227|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
148764834|NCT01841762|536613227|FG000|Treatment Period|Adverse Event|16|||
148764835|NCT01841762|536613227|FG000|Treatment Period|Death|1|||
148764836|NCT01841762|536613227|FG000|Treatment Period|Withdrawal by Subject|7|||
148764837|NCT01841762|536613227|FG000|Treatment Period|Lost to Follow-up|1|||
148764838|NCT01841762|536613227|FG000|Treatment Period|Physician Decision|2|||
148764839|NCT01841762|536613227|FG000|Treatment Period|Other, including non-compliance|5|||
148764840|NCT01841762|536613227|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
148764841|NCT01841762|536613227|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
148764842|NCT01841762|536613227|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
148764843|NCT01841762|536613227|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
148764844|NCT02510664|536613232|FG000|Overall Study|Transferred Care|9|||
148764845|NCT02510664|536613233|FG001|Overall Study|Transferred Care|9|||
148764846|NCT02510664|536613234|FG002|Overall Study|Transferred Care|0|||
148764847|NCT02510664|536613232|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
148764848|NCT02510664|536613233|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
148764849|NCT02510664|536613234|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
148977836|NCT04579679|537398488|FG000|Overall Study|Adverse Event|0|||
148764850|NCT02510664|536613232|FG000|Overall Study|Time Constraints|1|||
148764851|NCT02510664|536613233|FG001|Overall Study|Time Constraints|1|||
148764852|NCT02510664|536613234|FG002|Overall Study|Time Constraints|0|||
148764853|NCT02801617|536613236|FG000|Overall Study|Protocol Violation|2|||
148764854|NCT02801617|536613237|FG001|Overall Study|Protocol Violation|6|||
148764855|NCT04090060|536613243|FG000|Overall Study|Lost to Follow-up|76|||
148764856|NCT04090060|536613244|FG001|Overall Study|Lost to Follow-up|77|||
148764857|NCT02176655|536613245|FG000|Overall Study|Subjects did not treat|6|||
148764858|NCT06110494|536613246|FG000|Overall Study|Protocol Violation|2|||
148764859|NCT06110494|536613247|FG001|Overall Study|Protocol Violation|0|||
148764860|NCT06110494|536613248|FG002|Overall Study|Protocol Violation|1|||
148764861|NCT06110494|536613246|FG000|Overall Study|Dixon's test for outlier analysis|1|||
148764862|NCT06110494|536613247|FG001|Overall Study|Dixon's test for outlier analysis|1|||
148764863|NCT06110494|536613248|FG002|Overall Study|Dixon's test for outlier analysis|0|||
148764864|NCT02490371|536613251|FG000|Overall Study|Lost to Follow-up|1|||
148764865|NCT02490371|536613252|FG001|Overall Study|Lost to Follow-up|1|||
148764866|NCT01718535|536613255|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
148764867|NCT01718535|536613256|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
148764868|NCT01718535|536613257|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
148764869|NCT01718535|536613258|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
148764870|NCT01718535|536613259|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
148764871|NCT01718535|536613260|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
148764872|NCT01718535|536613261|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
148764873|NCT01718535|536613262|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
148764874|NCT01718535|536613263|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
148764875|NCT01718535|536613264|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
148764876|NCT00179660|536613265|FG000|Overall Study|Adverse Event|7|||
148764877|NCT00179660|536613265|FG000|Overall Study|Lack of therapeutic effect|28|||
148764878|NCT00179660|536613265|FG000|Overall Study|Withdrawal by Subject|2|||
148764879|NCT00179660|536613265|FG000|Overall Study|Lost to Follow-up|1|||
148764880|NCT00179660|536613265|FG000|Overall Study|Death|3|||
148764881|NCT00179660|536613265|FG000|Overall Study|Other - Unspecified|9|||
148764882|NCT00402688|536613269|FG000|Overall Study|Adverse Event|12|||
148764883|NCT00402688|536613270|FG001|Overall Study|Adverse Event|9|||
148764884|NCT00402688|536613271|FG002|Overall Study|Adverse Event|3|||
148764885|NCT00402688|536613269|FG000|Overall Study|Withdrawal by Subject|3|||
148764886|NCT00402688|536613270|FG001|Overall Study|Withdrawal by Subject|1|||
148764887|NCT00402688|536613271|FG002|Overall Study|Withdrawal by Subject|1|||
148764888|NCT00402688|536613269|FG000|Overall Study|Physician Decision|0|||
148764889|NCT00402688|536613270|FG001|Overall Study|Physician Decision|0|||
148764890|NCT00402688|536613271|FG002|Overall Study|Physician Decision|1|||
148764891|NCT00402688|536613269|FG000|Overall Study|Lack of Efficacy|4|||
148764892|NCT00402688|536613270|FG001|Overall Study|Lack of Efficacy|4|||
148764893|NCT00402688|536613271|FG002|Overall Study|Lack of Efficacy|5|||
148764894|NCT00402688|536613269|FG000|Overall Study|Protocol Violation|1|||
148764895|NCT00402688|536613270|FG001|Overall Study|Protocol Violation|1|||
148764896|NCT00402688|536613271|FG002|Overall Study|Protocol Violation|1|||
148764897|NCT00402688|536613269|FG000|Overall Study|Lost to Follow-up|1|||
148764898|NCT00402688|536613270|FG001|Overall Study|Lost to Follow-up|0|||
148764899|NCT00402688|536613271|FG002|Overall Study|Lost to Follow-up|2|||
148764900|NCT00402688|536613269|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
148764901|NCT00402688|536613270|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
148764902|NCT00402688|536613271|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
148764903|NCT00402688|536613269|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
148764904|NCT00402688|536613270|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
148764905|NCT00402688|536613271|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
148764906|NCT00402688|536613269|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
148764907|NCT00402688|536613270|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
148764908|NCT00402688|536613271|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
148764909|NCT02929589|536613311|FG000|Overall Study|Withdrawal by Subject|1|||
148977837|NCT04579679|537398489|FG001|Overall Study|Adverse Event|4|||
148977838|NCT04579679|537398490|FG002|Overall Study|Adverse Event|0|||
148764910|NCT02929589|536613312|FG001|Overall Study|Withdrawal by Subject|0|||
148764911|NCT02929589|536613313|FG002|Overall Study|Withdrawal by Subject|0|||
148764912|NCT02929589|536613314|FG003|Overall Study|Withdrawal by Subject|0|||
148764913|NCT02929589|536613311|FG000|Overall Study|Physician Decision|2|||
148764914|NCT02929589|536613312|FG001|Overall Study|Physician Decision|0|||
148764915|NCT02929589|536613313|FG002|Overall Study|Physician Decision|0|||
148764916|NCT02929589|536613314|FG003|Overall Study|Physician Decision|0|||
148764917|NCT02091089|536613316|FG000|Overall Study|Lost to Follow-up|2|||
148977839|NCT04579679|537398491|FG003|Overall Study|Adverse Event|0|||
148764918|NCT01303172|536613323|FG000|Overall Study|Physician Decision|9|||
148764919|NCT01303172|536613324|FG001|Overall Study|Physician Decision|6|||
148764920|NCT01303172|536613323|FG000|Overall Study|Adverse Event|5|||
148826847|NCT02757963|536844380|FG000|Overall Study|Withdrawal by Subject|34|||
148826848|NCT03769467|536844381|FG000|Overall Study|Adverse Event|1|||
148826849|NCT03769467|536844382|FG001|Overall Study|Adverse Event|1|||
148826850|NCT03769467|536844383|FG002|Overall Study|Adverse Event|0|||
148826851|NCT03769467|536844381|FG000|Overall Study|Death|3|||
148826852|NCT03769467|536844382|FG001|Overall Study|Death|3|||
148826853|NCT03769467|536844383|FG002|Overall Study|Death|0|||
148826854|NCT03769467|536844381|FG000|Overall Study|Study Terminated By Sponsor|2|||
148826855|NCT03769467|536844382|FG001|Overall Study|Study Terminated By Sponsor|1|||
148826856|NCT03769467|536844383|FG002|Overall Study|Study Terminated By Sponsor|0|||
148826857|NCT03769467|536844381|FG000|Overall Study|Withdrawal by Subject|0|||
148826858|NCT03769467|536844382|FG001|Overall Study|Withdrawal by Subject|1|||
148826859|NCT03769467|536844383|FG002|Overall Study|Withdrawal by Subject|0|||
148826860|NCT05259722|536844384|FG000|Overall Study|Adverse Event|2|||
148826861|NCT05259722|536844385|FG001|Overall Study|Adverse Event|24|||
148826862|NCT05259722|536844384|FG000|Overall Study|Lost to Follow-up|5|||
148826863|NCT05259722|536844385|FG001|Overall Study|Lost to Follow-up|1|||
148826864|NCT05259722|536844384|FG000|Overall Study|Lack of Efficacy|8|||
148826865|NCT05259722|536844385|FG001|Overall Study|Lack of Efficacy|26|||
148826866|NCT05259722|536844384|FG000|Overall Study|Withdrawal by Subject|15|||
148826867|NCT05259722|536844385|FG001|Overall Study|Withdrawal by Subject|33|||
148826868|NCT05259722|536844384|FG000|Overall Study|Various reasons|3|||
148826869|NCT05259722|536844385|FG001|Overall Study|Various reasons|9|||
148826870|NCT05259722|536844384|FG000|Overall Study|Not exposed to IMP|1|||
148826871|NCT05259722|536844385|FG001|Overall Study|Not exposed to IMP|12|||
148826872|NCT05259722|536844384|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
148826873|NCT05259722|536844385|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
148826874|NCT01887600|536844386|FG000|Overall Study|Death|39|||
148826875|NCT01887600|536844387|FG001|Overall Study|Death|16|||
148826876|NCT01887600|536844386|FG000|Overall Study|Lack of Efficacy|3|||
148826877|NCT01887600|536844387|FG001|Overall Study|Lack of Efficacy|26|||
148826878|NCT01887600|536844386|FG000|Overall Study|Lost to Follow-up|5|||
148826879|NCT01887600|536844387|FG001|Overall Study|Lost to Follow-up|1|||
148826880|NCT01887600|536844386|FG000|Overall Study|Physician Decision|7|||
148764921|NCT01303172|536613324|FG001|Overall Study|Adverse Event|2|||
148764922|NCT01303172|536613323|FG000|Overall Study|Withdrawal by Subject|4|||
148764923|NCT01303172|536613324|FG001|Overall Study|Withdrawal by Subject|2|||
148764924|NCT01303172|536613323|FG000|Overall Study|Death|20|||
148764925|NCT01303172|536613324|FG001|Overall Study|Death|7|||
148764926|NCT01303172|536613323|FG000|Overall Study|Lack of Efficacy|25|||
148764927|NCT01303172|536613324|FG001|Overall Study|Lack of Efficacy|17|||
148764928|NCT02821754|536613325|FG000|Overall Study|Procedure not required prior to amendment change|13|||
148764929|NCT02821754|536613326|FG001|Overall Study|Procedure not required prior to amendment change|11|||
148977840|NCT04579679|537398488|FG000|Overall Study|Disease Progression|9|||
148977841|NCT04579679|537398489|FG001|Overall Study|Disease Progression|13|||
148764930|NCT02821754|536613327|FG002|Overall Study|Procedure not required prior to amendment change|0|||
148764931|NCT02821754|536613325|FG000|Overall Study|Participant's Clinical status|2|||
148764932|NCT02821754|536613326|FG001|Overall Study|Participant's Clinical status|0|||
148764933|NCT02821754|536613327|FG002|Overall Study|Participant's Clinical status|0|||
148764934|NCT02821754|536613325|FG000|Overall Study|Participant removed for noncompliance|1|||
148764935|NCT02821754|536613326|FG001|Overall Study|Participant removed for noncompliance|0|||
148764936|NCT02821754|536613327|FG002|Overall Study|Participant removed for noncompliance|0|||
148764937|NCT02821754|536613325|FG000|Overall Study|Drug not available.|0|||
148764938|NCT02821754|536613326|FG001|Overall Study|Drug not available.|0|||
148764939|NCT02821754|536613327|FG002|Overall Study|Drug not available.|1|||
148826881|NCT01887600|536844387|FG001|Overall Study|Physician Decision|8|||
148826882|NCT01887600|536844386|FG000|Overall Study|Protocol Deviation|3|||
148826883|NCT01887600|536844387|FG001|Overall Study|Protocol Deviation|0|||
148826884|NCT01887600|536844386|FG000|Overall Study|Withdrawal by Subject|58|||
148826885|NCT01887600|536844387|FG001|Overall Study|Withdrawal by Subject|52|||
148977842|NCT04579679|537398490|FG002|Overall Study|Disease Progression|7|||
148977843|NCT04579679|537398491|FG003|Overall Study|Disease Progression|0|||
148764940|NCT02821754|536613325|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
148764941|NCT02821754|536613326|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
148764942|NCT02821754|536613327|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
148764943|NCT00994461|536613331|FG000|Overall Study|Adverse Event|2|||
148826886|NCT01887600|536844386|FG000|Overall Study|Adverse Event|21|||
148764944|NCT00994461|536613332|FG001|Overall Study|Adverse Event|1|||
148764945|NCT00994461|536613333|FG002|Overall Study|Adverse Event|0|||
148764946|NCT00766636|536613334|FG000|Overall Study|Withdrawal by Subject|1|||
148826887|NCT01887600|536844387|FG001|Overall Study|Adverse Event|9|||
148826888|NCT01887600|536844386|FG000|Overall Study|Non-compliance with study drug|3|||
148826889|NCT01887600|536844387|FG001|Overall Study|Non-compliance with study drug|0|||
148826890|NCT01887600|536844386|FG000|Overall Study|Miscellaneous|6|||
148826891|NCT01887600|536844387|FG001|Overall Study|Miscellaneous|2|||
148977844|NCT04579679|537398488|FG000|Overall Study|Physician Decision|0|||
148764947|NCT00766636|536613335|FG001|Overall Study|Withdrawal by Subject|1|||
148764948|NCT00766636|536613334|FG000|Overall Study|Incomplete Treatment|0|||
148764949|NCT00766636|536613335|FG001|Overall Study|Incomplete Treatment|1|||
148764950|NCT00766636|536613334|FG000|Overall Study|Adverse Event|1|||
148764951|NCT00766636|536613335|FG001|Overall Study|Adverse Event|0|||
148764952|NCT00766636|536613334|FG000|Overall Study|Disease Progression|1|||
148764953|NCT00766636|536613335|FG001|Overall Study|Disease Progression|0|||
148764954|NCT00591565|536613348|FG000|Overall Study|lost follow up, withdrawn|5|||
148764955|NCT01863667|536613350|FG000|Overall Study|Adverse Event|1|||
148764956|NCT01863667|536613351|FG001|Overall Study|Adverse Event|0|||
148764957|NCT01863667|536613350|FG000|Overall Study|Study terminated by Sponsor|30|||
148764958|NCT01863667|536613351|FG001|Overall Study|Study terminated by Sponsor|30|||
148764959|NCT01863667|536613350|FG000|Overall Study|Withdrawal by Subject|2|||
148764960|NCT01863667|536613351|FG001|Overall Study|Withdrawal by Subject|2|||
148764961|NCT03627546|536613352|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
148764962|NCT03627546|536613353|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
148764963|NCT03627546|536613354|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
148764964|NCT03627546|536613352|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
148764965|NCT03627546|536613353|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
148764966|NCT03627546|536613354|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
148764967|NCT02965573|536613357|FG000|Overall Study|Lack of Efficacy|1|||
148764968|NCT02965573|536613358|FG001|Overall Study|Lack of Efficacy|0|||
148764969|NCT02448537|536615351|FG000|Overall Study|Withdrawal by Subject|1|||
148764970|NCT02448537|536615352|FG001|Overall Study|Withdrawal by Subject|1|||
148764971|NCT02448537|536615353|FG002|Overall Study|Withdrawal by Subject|1|||
148764972|NCT01270464|536615354|FG000|Overall Study|Protocol Violation|4|||
148764973|NCT01270464|536615355|FG001|Overall Study|Protocol Violation|3|||
148764974|NCT01270464|536615356|FG002|Overall Study|Protocol Violation|2|||
148764975|NCT01270464|536615354|FG000|Overall Study|Lack of Efficacy|2|||
148764976|NCT01270464|536615355|FG001|Overall Study|Lack of Efficacy|3|||
148764977|NCT01270464|536615356|FG002|Overall Study|Lack of Efficacy|1|||
148764978|NCT01270464|536615354|FG000|Overall Study|Adverse Event|9|||
148764979|NCT01270464|536615355|FG001|Overall Study|Adverse Event|1|||
148764980|NCT01270464|536615356|FG002|Overall Study|Adverse Event|7|||
148764981|NCT01270464|536615354|FG000|Overall Study|Withdrawal by Subject|2|||
148764982|NCT01270464|536615355|FG001|Overall Study|Withdrawal by Subject|1|||
148764983|NCT01270464|536615356|FG002|Overall Study|Withdrawal by Subject|4|||
148764984|NCT01270464|536615354|FG000|Overall Study|Lost to Follow-up|2|||
148764985|NCT01270464|536615355|FG001|Overall Study|Lost to Follow-up|3|||
148764986|NCT01270464|536615356|FG002|Overall Study|Lost to Follow-up|1|||
148764987|NCT01270464|536615354|FG000|Overall Study|Other|1|||
148764988|NCT01270464|536615355|FG001|Overall Study|Other|1|||
148764989|NCT01270464|536615356|FG002|Overall Study|Other|3|||
148764990|NCT04725812|536615357|FG000|Overall Study|Withdrawal by Subject|1|||
148764991|NCT05656534|536615359|FG000|Overall Study|Withdrawal by Subject|1|||
148764992|NCT05656534|536615360|FG001|Overall Study|Withdrawal by Subject|1|||
148764993|NCT05656534|536615361|FG002|Overall Study|Withdrawal by Subject|0|||
148764994|NCT05656534|536615362|FG003|Overall Study|Withdrawal by Subject|0|||
148764995|NCT05656534|536615359|FG000|Overall Study|Physician Decision|1|||
148764996|NCT05656534|536615360|FG001|Overall Study|Physician Decision|1|||
148764997|NCT05656534|536615361|FG002|Overall Study|Physician Decision|0|||
148764998|NCT05656534|536615362|FG003|Overall Study|Physician Decision|0|||
148764999|NCT00839800|536615364|FG000|Overall Study|Adverse Event|8|||
148765000|NCT00839800|536615365|FG001|Overall Study|Adverse Event|12|||
148765001|NCT00839800|536615364|FG000|Overall Study|Lost to Follow-up|31|||
148765002|NCT00839800|536615365|FG001|Overall Study|Lost to Follow-up|26|||
148765003|NCT00839800|536615364|FG000|Overall Study|Withdrawal by Subject|28|||
148765004|NCT00839800|536615365|FG001|Overall Study|Withdrawal by Subject|34|||
148765005|NCT00839800|536615364|FG000|Overall Study|Incorrect Enrolment|3|||
148765006|NCT00839800|536615365|FG001|Overall Study|Incorrect Enrolment|3|||
148765007|NCT00839800|536615364|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
148765008|NCT00839800|536615365|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
148765009|NCT00839800|536615364|FG000|Overall Study|Safety Reasons|2|||
148765010|NCT00839800|536615365|FG001|Overall Study|Safety Reasons|1|||
148765011|NCT00839800|536615364|FG000|Overall Study|Other|8|||
148765012|NCT00839800|536615365|FG001|Overall Study|Other|14|||
148826892|NCT01887600|536844386|FG000|Overall Study|Progressive Disease|1|||
148765013|NCT00839800|536615364|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
148765014|NCT00839800|536615365|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
148765015|NCT01164579|536615366|FG000|Overall Study|Lack of Efficacy|0|||
148765016|NCT01164579|536615367|FG001|Overall Study|Lack of Efficacy|0|||
148765017|NCT01164579|536615368|FG002|Overall Study|Lack of Efficacy|6|||
148765018|NCT01164579|536615366|FG000|Overall Study|Lost to Follow-up|1|||
148765019|NCT01164579|536615367|FG001|Overall Study|Lost to Follow-up|1|||
148765020|NCT01164579|536615368|FG002|Overall Study|Lost to Follow-up|0|||
148765021|NCT01164579|536615366|FG000|Overall Study|Withdrawal by Subject|2|||
148765022|NCT01164579|536615367|FG001|Overall Study|Withdrawal by Subject|5|||
148826893|NCT01887600|536844387|FG001|Overall Study|Progressive Disease|0|||
148977845|NCT04579679|537398489|FG001|Overall Study|Physician Decision|0|||
148977846|NCT04579679|537398490|FG002|Overall Study|Physician Decision|1|||
148977847|NCT04579679|537398491|FG003|Overall Study|Physician Decision|0|||
148977848|NCT04579679|537398488|FG000|Overall Study|Study Terminated by Sponsor|2|||
148977849|NCT04579679|537398489|FG001|Overall Study|Study Terminated by Sponsor|7|||
148977850|NCT04579679|537398490|FG002|Overall Study|Study Terminated by Sponsor|1|||
148977851|NCT04579679|537398491|FG003|Overall Study|Study Terminated by Sponsor|0|||
148977852|NCT04524403|537400754|FG000|Overall Study|Withdrawal by Subject|10|||
148977853|NCT04524403|537400755|FG001|Overall Study|Withdrawal by Subject|3|||
148765023|NCT01164579|536615368|FG002|Overall Study|Withdrawal by Subject|3|||
148765024|NCT01164579|536615366|FG000|Overall Study|Protocol Violation|0|||
148765025|NCT01164579|536615367|FG001|Overall Study|Protocol Violation|1|||
148765026|NCT01164579|536615368|FG002|Overall Study|Protocol Violation|2|||
148765027|NCT01164579|536615366|FG000|Overall Study|Adverse Event|4|||
148765028|NCT01164579|536615367|FG001|Overall Study|Adverse Event|2|||
148765029|NCT01164579|536615368|FG002|Overall Study|Adverse Event|5|||
148765030|NCT01164579|536615366|FG000|Overall Study|Reason not specified|1|||
148765031|NCT01164579|536615367|FG001|Overall Study|Reason not specified|0|||
148765032|NCT01164579|536615368|FG002|Overall Study|Reason not specified|0|||
148765033|NCT04478695|536615370|FG000|Overall Study|Death|1|||
148765034|NCT04478695|536615371|FG001|Overall Study|Death|0|||
148765035|NCT02875613|536615372|FG000|Overall Study|Withdrawal by Subject|1|||
148765036|NCT02875613|536615372|FG000|Overall Study|Screen Failure|1|||
148765037|NCT01136356|536615373|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
148765038|NCT01136356|536615374|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
148765039|NCT01136356|536615373|FG000|First 18-day Withdrawal|Physician Decision|1|||
148765040|NCT01136356|536615374|FG001|First 18-day Withdrawal|Physician Decision|0|||
148765041|NCT01136356|536615373|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
148765042|NCT01136356|536615374|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
148765043|NCT02347774|536615375|FG000|Study Participation|Lost to Follow-up|3|||
148765044|NCT02347774|536615376|FG001|Study Participation|Lost to Follow-up|6|||
148765045|NCT02347774|536615377|FG002|Study Participation|Lost to Follow-up|2|||
148765046|NCT02347774|536615375|FG000|Study Participation|Withdrawal by Subject|8|||
148765047|NCT02347774|536615376|FG001|Study Participation|Withdrawal by Subject|9|||
148765048|NCT02347774|536615377|FG002|Study Participation|Withdrawal by Subject|15|||
148765049|NCT02347774|536615375|FG000|Study Participation|Adverse Event|1|||
148765050|NCT02347774|536615376|FG001|Study Participation|Adverse Event|4|||
148765051|NCT02347774|536615377|FG002|Study Participation|Adverse Event|6|||
148765052|NCT02347774|536615375|FG000|Study Participation|withdrew consent|1|||
148765053|NCT02347774|536615376|FG001|Study Participation|withdrew consent|1|||
148765054|NCT02347774|536615377|FG002|Study Participation|withdrew consent|1|||
148765055|NCT02347774|536615375|FG000|Study Participation|Met Prolonged QT criteria|1|||
148765056|NCT02347774|536615376|FG001|Study Participation|Met Prolonged QT criteria|0|||
148765057|NCT02347774|536615377|FG002|Study Participation|Met Prolonged QT criteria|0|||
148765058|NCT02347774|536615375|FG000|Study Participation|non-compliance with study drug|0|||
148765059|NCT02347774|536615376|FG001|Study Participation|non-compliance with study drug|1|||
148765060|NCT02347774|536615377|FG002|Study Participation|non-compliance with study drug|0|||
148765061|NCT02347774|536615375|FG000|Study Participation|incarceration|1|||
148765062|NCT02347774|536615376|FG001|Study Participation|incarceration|0|||
148765063|NCT02347774|536615377|FG002|Study Participation|incarceration|0|||
148765064|NCT02347774|536615375|FG000|Study Participation|randomized in error|0|||
148765065|NCT02347774|536615376|FG001|Study Participation|randomized in error|0|||
148765066|NCT02347774|536615377|FG002|Study Participation|randomized in error|1|||
148765067|NCT02347774|536615375|FG000|On Study Treatment|Adverse Event|9|||
148765068|NCT02347774|536615376|FG001|On Study Treatment|Adverse Event|15|||
148765069|NCT02347774|536615377|FG002|On Study Treatment|Adverse Event|19|||
148765070|NCT02347774|536615375|FG000|On Study Treatment|Lack of Efficacy|3|||
148765071|NCT02347774|536615376|FG001|On Study Treatment|Lack of Efficacy|0|||
148765072|NCT02347774|536615377|FG002|On Study Treatment|Lack of Efficacy|2|||
148765073|NCT02347774|536615375|FG000|On Study Treatment|non-complicance with study medication|0|||
148765074|NCT02347774|536615376|FG001|On Study Treatment|non-complicance with study medication|2|||
148765075|NCT02347774|536615377|FG002|On Study Treatment|non-complicance with study medication|0|||
148765076|NCT02347774|536615375|FG000|On Study Treatment|Protocol Violation|0|||
148765077|NCT02347774|536615376|FG001|On Study Treatment|Protocol Violation|0|||
148765078|NCT02347774|536615377|FG002|On Study Treatment|Protocol Violation|1|||
148765079|NCT02347774|536615375|FG000|On Study Treatment|withdrew consent|9|||
148765080|NCT02347774|536615376|FG001|On Study Treatment|withdrew consent|8|||
148765081|NCT02347774|536615377|FG002|On Study Treatment|withdrew consent|12|||
148765082|NCT02347774|536615375|FG000|On Study Treatment|Lost to Follow-up|2|||
148765083|NCT02347774|536615376|FG001|On Study Treatment|Lost to Follow-up|6|||
148765084|NCT02347774|536615377|FG002|On Study Treatment|Lost to Follow-up|1|||
148765085|NCT02347774|536615375|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
148765086|NCT02347774|536615376|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
148977854|NCT04524403|537400756|FG002|Overall Study|Withdrawal by Subject|8|||
148977855|NCT04524403|537400754|FG000|Overall Study|Lost to Follow-up|3|||
148765087|NCT02347774|536615377|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
148765088|NCT02347774|536615375|FG000|On Study Treatment|ranomized in error|0|||
148765089|NCT02347774|536615376|FG001|On Study Treatment|ranomized in error|0|||
148765090|NCT02347774|536615377|FG002|On Study Treatment|ranomized in error|1|||
148765091|NCT00927862|536615378|FG000|Overall Study|Missing data needed for endpt analyses|27|||
148765092|NCT00927862|536615379|FG001|Overall Study|Missing data needed for endpt analyses|45|||
148765093|NCT00820248|536615380|FG000|Overall Study|No treated|4|||
148765094|NCT00820248|536615381|FG001|Overall Study|No treated|1|||
148765095|NCT01562782|536615390|FG000|Overall Study|Withdrawal by Subject|3|||
148765096|NCT01562782|536615391|FG001|Overall Study|Withdrawal by Subject|3|||
148765097|NCT01562782|536615390|FG000|Overall Study|screen failure|1|||
148765098|NCT01562782|536615391|FG001|Overall Study|screen failure|2|||
148765099|NCT02308540|536615392|FG000|Overall Study|Lost to Follow-up|0|||
148765100|NCT02308540|536615393|FG001|Overall Study|Lost to Follow-up|0|||
148765101|NCT02308540|536615394|FG002|Overall Study|Lost to Follow-up|0|||
148765102|NCT02308540|536615395|FG003|Overall Study|Lost to Follow-up|0|||
148765103|NCT02308540|536615396|FG004|Overall Study|Lost to Follow-up|0|||
148765104|NCT02308540|536615397|FG005|Overall Study|Lost to Follow-up|1|||
148765105|NCT01091662|536615398|FG000|Overall Study|Adverse Event|1|||
148765106|NCT01091662|536615399|FG001|Overall Study|Adverse Event|9|||
148765107|NCT01091662|536615398|FG000|Overall Study|Physician Decision|1|||
148765108|NCT01091662|536615399|FG001|Overall Study|Physician Decision|1|||
148765109|NCT01091662|536615398|FG000|Overall Study|Withdrawal by Subject|7|||
148765110|NCT01091662|536615399|FG001|Overall Study|Withdrawal by Subject|6|||
148765111|NCT01091662|536615398|FG000|Overall Study|met exit criteria|7|||
148765112|NCT01091662|536615399|FG001|Overall Study|met exit criteria|13|||
148765113|NCT01091662|536615398|FG000|Overall Study|met exclusion criteria|1|||
148765114|NCT01091662|536615399|FG001|Overall Study|met exclusion criteria|0|||
148765115|NCT01091662|536615398|FG000|Overall Study|Lost to Follow-up|0|||
148765116|NCT01091662|536615399|FG001|Overall Study|Lost to Follow-up|1|||
148765117|NCT01091662|536615398|FG000|Overall Study|Pregnancy|0|||
148765118|NCT01091662|536615399|FG001|Overall Study|Pregnancy|1|||
148765119|NCT01091662|536615398|FG000|Overall Study|Protocol Violation|0|||
148765120|NCT01091662|536615399|FG001|Overall Study|Protocol Violation|2|||
148765121|NCT01091662|536615398|FG000|Overall Study|unable to swallow capsule|0|||
148765122|NCT01091662|536615399|FG001|Overall Study|unable to swallow capsule|1|||
148765123|NCT04109391|536615400|FG000|Overall Study|Adverse Event|2|||
148765124|NCT04109391|536615401|FG001|Overall Study|Adverse Event|2|||
148765125|NCT04109391|536615402|FG002|Overall Study|Adverse Event|0|||
148765126|NCT04109391|536615400|FG000|Overall Study|Withdrawal by Subject|2|||
148765127|NCT04109391|536615401|FG001|Overall Study|Withdrawal by Subject|0|||
148765128|NCT04109391|536615402|FG002|Overall Study|Withdrawal by Subject|0|||
148765129|NCT04109391|536615400|FG000|Overall Study|Pregnancy|1|||
148765130|NCT04109391|536615401|FG001|Overall Study|Pregnancy|0|||
148765131|NCT04109391|536615402|FG002|Overall Study|Pregnancy|0|||
148765132|NCT04109391|536615400|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
148765133|NCT04109391|536615401|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
148765134|NCT04109391|536615402|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
148765135|NCT04109391|536615400|FG000|Overall Study|Lost to Follow-up|0|||
148765136|NCT04109391|536615401|FG001|Overall Study|Lost to Follow-up|0|||
148765137|NCT04109391|536615402|FG002|Overall Study|Lost to Follow-up|1|||
148765138|NCT04109391|536615400|FG000|Overall Study|Lack of Efficacy|2|||
148765139|NCT04109391|536615401|FG001|Overall Study|Lack of Efficacy|2|||
148765140|NCT04109391|536615402|FG002|Overall Study|Lack of Efficacy|3|||
148765141|NCT02049814|536615407|FG000|Overall Study|Reason not Specified|4|||
148765142|NCT02049814|536615408|FG001|Overall Study|Reason not Specified|3|||
148765143|NCT02049814|536615407|FG000|Overall Study|Pregnancy|1|||
148765144|NCT02049814|536615408|FG001|Overall Study|Pregnancy|0|||
148765145|NCT02049814|536615407|FG000|Overall Study|Lost to Follow-up|2|||
148765146|NCT02049814|536615408|FG001|Overall Study|Lost to Follow-up|3|||
148765147|NCT02049814|536615407|FG000|Overall Study|Serious Protocol Violation|5|||
148765148|NCT02049814|536615408|FG001|Overall Study|Serious Protocol Violation|7|||
148765149|NCT02049814|536615407|FG000|Overall Study|Study Termination|0|||
148765150|NCT02049814|536615408|FG001|Overall Study|Study Termination|1|||
148765151|NCT02049814|536615407|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
148765152|NCT02049814|536615408|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
148765153|NCT02049814|536615407|FG000|Overall Study|Voluntary withdrawal|9|||
148765154|NCT02049814|536615408|FG001|Overall Study|Voluntary withdrawal|8|||
148826894|NCT00962650|536844388|FG000|Overall Study|Transgastric DP was not completed|2|||
148765155|NCT02993250|536615418|FG000|Overall Study|Lost to Follow-up|0|||
148765156|NCT02993250|536615419|FG001|Overall Study|Lost to Follow-up|1|||
148765157|NCT00356148|536615423|FG000|Overall Study|Reoperation within 30 days|2|||
148765158|NCT00356148|536615424|FG001|Overall Study|Reoperation within 30 days|1|||
148977856|NCT04524403|537400755|FG001|Overall Study|Lost to Follow-up|4|||
148765159|NCT02484456|536615425|FG000|Washout Period|Withdrawal by Subject|0|||
148765160|NCT02484456|536615426|FG001|Washout Period|Withdrawal by Subject|1|||
148977857|NCT04524403|537400756|FG002|Overall Study|Lost to Follow-up|3|||
148826895|NCT00231465|536844389|FG000|Overall Study|Completed only one cycle|1|||
148826896|NCT00231465|536844389|FG000|Overall Study|Did not have follow up CT scans|1|||
148826897|NCT03624036|536844390|FG000|Overall Study|Death|2|||
148826898|NCT03624036|536844391|FG001|Overall Study|Death|3|||
148826899|NCT03624036|536844392|FG002|Overall Study|Death|0|||
148826900|NCT03624036|536844393|FG003|Overall Study|Death|1|||
148826901|NCT03624036|536844390|FG000|Overall Study|Withdrawal by Subject|1|||
148826902|NCT03624036|536844391|FG001|Overall Study|Withdrawal by Subject|0|||
148826903|NCT03624036|536844392|FG002|Overall Study|Withdrawal by Subject|1|||
148826904|NCT03624036|536844393|FG003|Overall Study|Withdrawal by Subject|0|||
148826905|NCT03624036|536844390|FG000|Overall Study|Enrolled but Never Treated|1|||
148826906|NCT03624036|536844391|FG001|Overall Study|Enrolled but Never Treated|0|||
148826907|NCT03624036|536844392|FG002|Overall Study|Enrolled but Never Treated|0|||
148826908|NCT03624036|536844393|FG003|Overall Study|Enrolled but Never Treated|0|||
148826909|NCT03624036|536844390|FG000|Overall Study|Reason not Specified|3|||
148826910|NCT03624036|536844391|FG001|Overall Study|Reason not Specified|0|||
148826911|NCT03624036|536844392|FG002|Overall Study|Reason not Specified|2|||
148826912|NCT03624036|536844393|FG003|Overall Study|Reason not Specified|2|||
148826913|NCT03478787|536844402|FG000|Overall Study|Adverse Event|5|||
148826914|NCT03478787|536844403|FG001|Overall Study|Adverse Event|1|||
148977858|NCT04524403|537400754|FG000|Overall Study|Adverse Event|3|||
148977859|NCT04524403|537400755|FG001|Overall Study|Adverse Event|1|||
148977860|NCT04524403|537400756|FG002|Overall Study|Adverse Event|4|||
148977861|NCT04524403|537400754|FG000|Overall Study|Non-compliant with study drug|1|||
148977862|NCT04524403|537400755|FG001|Overall Study|Non-compliant with study drug|2|||
148977863|NCT04524403|537400756|FG002|Overall Study|Non-compliant with study drug|3|||
148977864|NCT04524403|537400754|FG000|Overall Study|Moved|0|||
148826915|NCT03478787|536844402|FG000|Overall Study|Protocol Violation|3|||
148826916|NCT03478787|536844403|FG001|Overall Study|Protocol Violation|0|||
148826917|NCT03478787|536844402|FG000|Overall Study|Lack of Efficacy|7|||
148826918|NCT03478787|536844403|FG001|Overall Study|Lack of Efficacy|1|||
148826919|NCT03478787|536844402|FG000|Overall Study|Lost to Follow-up|9|||
148826920|NCT03478787|536844403|FG001|Overall Study|Lost to Follow-up|5|||
148826921|NCT03478787|536844402|FG000|Overall Study|Withdrawal by Subject|2|||
148977865|NCT04524403|537400755|FG001|Overall Study|Moved|1|||
148977866|NCT04524403|537400756|FG002|Overall Study|Moved|0|||
148977867|NCT01709318|537400757|FG000|Overall Study|Adverse Event|3|||
148977868|NCT01709318|537400758|FG001|Overall Study|Adverse Event|4|||
148977869|NCT01709318|537400759|FG002|Overall Study|Adverse Event|2|||
148977870|NCT01709318|537400760|FG003|Overall Study|Adverse Event|2|||
148977871|NCT01709318|537400761|FG004|Overall Study|Adverse Event|0|||
148977872|NCT01709318|537400762|FG005|Overall Study|Adverse Event|1|||
148977873|NCT01709318|537400763|FG006|Overall Study|Adverse Event|2|||
148977874|NCT01709318|537400757|FG000|Overall Study|Lost to Follow-up|2|||
148977875|NCT01709318|537400758|FG001|Overall Study|Lost to Follow-up|0|||
148977876|NCT01709318|537400759|FG002|Overall Study|Lost to Follow-up|0|||
148977877|NCT01709318|537400760|FG003|Overall Study|Lost to Follow-up|0|||
148977878|NCT01709318|537400761|FG004|Overall Study|Lost to Follow-up|1|||
148977879|NCT01709318|537400762|FG005|Overall Study|Lost to Follow-up|1|||
148977880|NCT01709318|537400763|FG006|Overall Study|Lost to Follow-up|1|||
148977881|NCT01709318|537400757|FG000|Overall Study|Non-compliance with Study Drug|0|||
148977882|NCT01709318|537400758|FG001|Overall Study|Non-compliance with Study Drug|2|||
148977883|NCT01709318|537400759|FG002|Overall Study|Non-compliance with Study Drug|1|||
148977884|NCT01709318|537400760|FG003|Overall Study|Non-compliance with Study Drug|1|||
148977885|NCT01709318|537400761|FG004|Overall Study|Non-compliance with Study Drug|0|||
148977886|NCT01709318|537400762|FG005|Overall Study|Non-compliance with Study Drug|0|||
148977887|NCT01709318|537400763|FG006|Overall Study|Non-compliance with Study Drug|2|||
148826922|NCT03478787|536844403|FG001|Overall Study|Withdrawal by Subject|6|||
148826923|NCT03478787|536844402|FG000|Overall Study|Other, Not Specified|3|||
148826924|NCT03478787|536844403|FG001|Overall Study|Other, Not Specified|0|||
148826925|NCT00655356|536844406|FG000|Overall Study|Withdrawal by Subject|3|||
148826926|NCT00655356|536844407|FG001|Overall Study|Withdrawal by Subject|4|||
148826927|NCT00655356|536844406|FG000|Overall Study|Sponsor Request|10|||
148826928|NCT00655356|536844407|FG001|Overall Study|Sponsor Request|4|||
148826929|NCT00655356|536844406|FG000|Overall Study|Adverse Event|1|||
148826930|NCT00655356|536844407|FG001|Overall Study|Adverse Event|1|||
148977888|NCT01709318|537400757|FG000|Overall Study|Physician Decision|0|||
148826931|NCT00655356|536844406|FG000|Overall Study|Protocol Violation|2|||
148826932|NCT00655356|536844407|FG001|Overall Study|Protocol Violation|1|||
148826933|NCT00655356|536844406|FG000|Overall Study|Other Reason|1|||
148826934|NCT00655356|536844407|FG001|Overall Study|Other Reason|0|||
148826935|NCT01044459|536844408|FG000|Overall Study|Withdrawal by Subject|21|||
148977889|NCT01709318|537400758|FG001|Overall Study|Physician Decision|0|||
148977890|NCT01709318|537400759|FG002|Overall Study|Physician Decision|0|||
148977891|NCT01709318|537400760|FG003|Overall Study|Physician Decision|0|||
148977892|NCT01709318|537400761|FG004|Overall Study|Physician Decision|0|||
148977893|NCT01709318|537400762|FG005|Overall Study|Physician Decision|0|||
148977894|NCT01709318|537400763|FG006|Overall Study|Physician Decision|1|||
148765161|NCT02484456|536615425|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
148765162|NCT02484456|536615426|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
148765163|NCT02484456|536615425|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
148765164|NCT02484456|536615426|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
148765165|NCT02484456|536615425|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
148765166|NCT02484456|536615426|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
148765167|NCT02737930|536615429|FG000|Overall Study|Withdrawal by Subject|0|||
148765168|NCT02737930|536615430|FG001|Overall Study|Withdrawal by Subject|1|||
148765169|NCT00708214|536615431|FG000|Overall Study|Other Adverse Event|3|||
148765170|NCT00708214|536615432|FG001|Overall Study|Other Adverse Event|6|||
148765171|NCT00708214|536615433|FG002|Overall Study|Other Adverse Event|2|||
148765172|NCT00708214|536615431|FG000|Overall Study|Other|0|||
148765173|NCT00708214|536615432|FG001|Overall Study|Other|1|||
148765174|NCT00708214|536615433|FG002|Overall Study|Other|1|||
148765175|NCT00708214|536615431|FG000|Overall Study|Progressive Disease|4|||
148765176|NCT00708214|536615432|FG001|Overall Study|Progressive Disease|6|||
148765177|NCT00708214|536615433|FG002|Overall Study|Progressive Disease|5|||
148765178|NCT03852264|536615434|FG000|Third Research Visit|Lost to Follow-up|1|||
148765179|NCT03852264|536615435|FG001|Third Research Visit|Lost to Follow-up|0|||
148765180|NCT01430403|536615442|FG000|Overall Study|Lost to Follow-up|5|||
148765181|NCT01430403|536615443|FG001|Overall Study|Lost to Follow-up|5|||
148765182|NCT01430403|536615444|FG002|Overall Study|Lost to Follow-up|3|||
148765183|NCT01430403|536615442|FG000|Overall Study|Physician Decision|1|||
148765184|NCT01430403|536615443|FG001|Overall Study|Physician Decision|0|||
148765185|NCT01430403|536615444|FG002|Overall Study|Physician Decision|0|||
148765186|NCT01430403|536615442|FG000|Overall Study|Protocol Violation|2|||
148765187|NCT01430403|536615443|FG001|Overall Study|Protocol Violation|3|||
148765188|NCT01430403|536615444|FG002|Overall Study|Protocol Violation|2|||
148765189|NCT01430403|536615442|FG000|Overall Study|Withdrawal by Subject|9|||
148765190|NCT01430403|536615443|FG001|Overall Study|Withdrawal by Subject|1|||
148765191|NCT01430403|536615444|FG002|Overall Study|Withdrawal by Subject|3|||
148765192|NCT04481789|536615447|FG000|Period 1|Withdrawal by Subject|1|||
148765193|NCT04481789|536615448|FG001|Period 1|Withdrawal by Subject|0|||
148765194|NCT04481789|536615449|FG002|Period 1|Withdrawal by Subject|0|||
148765195|NCT04481789|536615450|FG003|Period 1|Withdrawal by Subject|0|||
148765196|NCT04481789|536615451|FG004|Period 1|Withdrawal by Subject|0|||
148765197|NCT04481789|536615452|FG005|Period 1|Withdrawal by Subject|0|||
148765198|NCT03124407|536615457|FG000|Overall Study|Lost to Follow-up|1|||
148765199|NCT03124407|536615458|FG001|Overall Study|Lost to Follow-up|0|||
148765200|NCT03124407|536615459|FG002|Overall Study|Lost to Follow-up|0|||
148826936|NCT01044459|536844409|FG001|Overall Study|Withdrawal by Subject|28|||
148826937|NCT01044459|536844408|FG000|Overall Study|Terminated by Sponsor|22|||
148826938|NCT01044459|536844409|FG001|Overall Study|Terminated by Sponsor|21|||
148826939|NCT01044459|536844408|FG000|Overall Study|Adverse Event|22|||
148826940|NCT01044459|536844409|FG001|Overall Study|Adverse Event|20|||
148826941|NCT01044459|536844408|FG000|Overall Study|Lack of Efficacy|23|||
148826942|NCT01044459|536844409|FG001|Overall Study|Lack of Efficacy|12|||
148826943|NCT01044459|536844408|FG000|Overall Study|Protocol Violation|11|||
148826944|NCT01044459|536844409|FG001|Overall Study|Protocol Violation|16|||
148826945|NCT01044459|536844408|FG000|Overall Study|Other Reason|7|||
148826946|NCT01044459|536844409|FG001|Overall Study|Other Reason|14|||
148826947|NCT01044459|536844408|FG000|Overall Study|COPD exacerbation|9|||
148826948|NCT01044459|536844409|FG001|Overall Study|COPD exacerbation|8|||
148826949|NCT01044459|536844408|FG000|Overall Study|Lost to Follow-up|18|||
148826950|NCT01044459|536844409|FG001|Overall Study|Lost to Follow-up|12|||
148826951|NCT04105725|536844410|FG000|Primary Intervention|Lost to Follow-up|0|||
148826952|NCT04105725|536844411|FG001|Primary Intervention|Lost to Follow-up|2|||
148826953|NCT04105725|536844410|FG000|Primary Intervention|Withdrawal by Subject|0|||
148826954|NCT04105725|536844411|FG001|Primary Intervention|Withdrawal by Subject|1|||
148826955|NCT05346640|536844412|FG000|Overall Study|Lack of Efficacy|2|||
148826956|NCT05346640|536844412|FG000|Overall Study|Lost to Follow-up|14|||
148826957|NCT05346640|536844412|FG000|Overall Study|Protocol Violation|4|||
148826958|NCT05346640|536844412|FG000|Overall Study|Withdrawal by Subject|2|||
148826959|NCT05346640|536844412|FG000|Overall Study|Physiological Complications|3|||
148826960|NCT05346640|536844412|FG000|Overall Study|Other Reason|3|||
148826961|NCT04634331|536844413|FG000|Overall Study|Withdrawal by Subject|2|||
148826962|NCT04634331|536844414|FG001|Overall Study|Withdrawal by Subject|2|||
148826963|NCT05626686|536844415|FG000|Overall Study|Protocol Violation|3|||
148826964|NCT05626686|536844415|FG000|Overall Study|Withdrawal by Subject|3|||
148826965|NCT00289900|536844416|FG000|Overall Study|Adverse Event|28|||
148826966|NCT00289900|536844417|FG001|Overall Study|Adverse Event|40|||
148826967|NCT00289900|536844418|FG002|Overall Study|Adverse Event|13|||
148826968|NCT00289900|536844419|FG003|Overall Study|Adverse Event|19|||
148765201|NCT03124407|536615460|FG003|Overall Study|Lost to Follow-up|0|||
148765202|NCT03124407|536615457|FG000|Overall Study|Adverse Event|0|||
148765203|NCT03124407|536615458|FG001|Overall Study|Adverse Event|0|||
148765204|NCT03124407|536615459|FG002|Overall Study|Adverse Event|1|||
148765205|NCT03124407|536615460|FG003|Overall Study|Adverse Event|0|||
148826969|NCT00289900|536844420|FG004|Overall Study|Adverse Event|20|||
148765206|NCT05708976|536615465|FG000|Overall Study|Withdrawal by Subject|0|||
148977895|NCT01709318|537400757|FG000|Overall Study|Pregnancy|0|||
148977896|NCT01709318|537400758|FG001|Overall Study|Pregnancy|0|||
148977897|NCT01709318|537400759|FG002|Overall Study|Pregnancy|0|||
148977898|NCT01709318|537400760|FG003|Overall Study|Pregnancy|0|||
148977899|NCT01709318|537400761|FG004|Overall Study|Pregnancy|1|||
148977900|NCT01709318|537400762|FG005|Overall Study|Pregnancy|0|||
148977901|NCT01709318|537400763|FG006|Overall Study|Pregnancy|0|||
148977902|NCT01709318|537400757|FG000|Overall Study|Protocol Violation|0|||
148977903|NCT01709318|537400758|FG001|Overall Study|Protocol Violation|0|||
148977904|NCT01709318|537400759|FG002|Overall Study|Protocol Violation|0|||
148977905|NCT01709318|537400760|FG003|Overall Study|Protocol Violation|0|||
148977906|NCT01709318|537400761|FG004|Overall Study|Protocol Violation|2|||
148977907|NCT01709318|537400762|FG005|Overall Study|Protocol Violation|0|||
148977908|NCT01709318|537400763|FG006|Overall Study|Protocol Violation|1|||
148765207|NCT05708976|536615466|FG001|Overall Study|Withdrawal by Subject|1|||
148765208|NCT00183885|536615469|FG000|Overall Study|Adverse Event|11|||
148765209|NCT00183885|536615469|FG000|Overall Study|Death|1|||
148765210|NCT00183885|536615469|FG000|Overall Study|Lost to Follow-up|3|||
148765211|NCT00183885|536615469|FG000|Overall Study|Physician Decision|6|||
148765212|NCT00183885|536615469|FG000|Overall Study|Withdrawal by Subject|5|||
148765213|NCT00183885|536615469|FG000|Overall Study|Switched to alternative treatment|8|||
148765214|NCT00183885|536615469|FG000|Overall Study|Treatment delayed too long|4|||
148765215|NCT00183885|536615469|FG000|Overall Study|Developed second malignancy|1|||
148765216|NCT00014495|536615470|FG000|Overall Study|Death|0|||
148765217|NCT00014495|536615471|FG001|Overall Study|Death|0|||
148765218|NCT00014495|536615472|FG002|Overall Study|Death|1|||
148765219|NCT00014495|536615473|FG003|Overall Study|Death|0|||
148765220|NCT00014495|536615470|FG000|Overall Study|Clinical deterioration|0|||
148765221|NCT00014495|536615471|FG001|Overall Study|Clinical deterioration|0|||
148765222|NCT00014495|536615472|FG002|Overall Study|Clinical deterioration|0|||
148765223|NCT00014495|536615473|FG003|Overall Study|Clinical deterioration|1|||
148765224|NCT00396656|536615476|FG000|First Treatment Period|Withdrawal by Subject|0|||
148765225|NCT00396656|536615477|FG001|First Treatment Period|Withdrawal by Subject|2|||
148765226|NCT00396656|536615476|FG000|Second Treatment Period|Adverse Event|0|||
148765227|NCT00396656|536615477|FG001|Second Treatment Period|Adverse Event|1|||
148765228|NCT00554515|536615480|FG000|Overall Study|Withdrawal by Subject|3|||
148765229|NCT00554515|536615480|FG000|Overall Study|Disease progression|52|||
148765230|NCT00554515|536615480|FG000|Overall Study|Physician Decision|18|||
148765231|NCT00554515|536615480|FG000|Overall Study|Withdrawal by Subject|11|||
148765232|NCT00554515|536615480|FG000|Overall Study|Adverse Event|9|||
148765233|NCT00554515|536615480|FG000|Overall Study|Death|2|||
148765234|NCT00554515|536615480|FG000|Overall Study|Achieved Stable Disease|7|||
148765235|NCT00554515|536615480|FG000|Overall Study|Other|1|||
148765236|NCT00554515|536615480|FG000|Overall Study|Misc|15|||
148765237|NCT02477332|536615481|FG000|Overall Study|Adverse Event|0|||
148765238|NCT02477332|536615482|FG001|Overall Study|Adverse Event|1|||
148765239|NCT02477332|536615483|FG002|Overall Study|Adverse Event|1|||
148765240|NCT02477332|536615484|FG003|Overall Study|Adverse Event|2|||
148765241|NCT02477332|536615485|FG004|Overall Study|Adverse Event|1|||
148765242|NCT02477332|536615486|FG005|Overall Study|Adverse Event|2|||
148765243|NCT02477332|536615481|FG000|Overall Study|Lack of Efficacy|1|||
148765244|NCT02477332|536615482|FG001|Overall Study|Lack of Efficacy|2|||
148765245|NCT02477332|536615483|FG002|Overall Study|Lack of Efficacy|1|||
148765246|NCT02477332|536615484|FG003|Overall Study|Lack of Efficacy|2|||
148765247|NCT02477332|536615485|FG004|Overall Study|Lack of Efficacy|1|||
148765248|NCT02477332|536615486|FG005|Overall Study|Lack of Efficacy|1|||
148765249|NCT02477332|536615481|FG000|Overall Study|Non-compliance with study treatment|0|||
148765250|NCT02477332|536615482|FG001|Overall Study|Non-compliance with study treatment|1|||
148765251|NCT02477332|536615483|FG002|Overall Study|Non-compliance with study treatment|2|||
148765252|NCT02477332|536615484|FG003|Overall Study|Non-compliance with study treatment|0|||
148765253|NCT02477332|536615485|FG004|Overall Study|Non-compliance with study treatment|0|||
148765254|NCT02477332|536615486|FG005|Overall Study|Non-compliance with study treatment|0|||
148765255|NCT02477332|536615481|FG000|Overall Study|Pregnancy|0|||
148765256|NCT02477332|536615482|FG001|Overall Study|Pregnancy|0|||
148765257|NCT02477332|536615483|FG002|Overall Study|Pregnancy|0|||
148765258|NCT02477332|536615484|FG003|Overall Study|Pregnancy|1|||
148765259|NCT02477332|536615485|FG004|Overall Study|Pregnancy|0|||
148765260|NCT02477332|536615486|FG005|Overall Study|Pregnancy|0|||
148765261|NCT02477332|536615481|FG000|Overall Study|Protocol Violation|2|||
148765262|NCT02477332|536615482|FG001|Overall Study|Protocol Violation|0|||
148765263|NCT02477332|536615483|FG002|Overall Study|Protocol Violation|3|||
148765264|NCT02477332|536615484|FG003|Overall Study|Protocol Violation|3|||
148826970|NCT00289900|536844421|FG005|Overall Study|Adverse Event|33|||
148977909|NCT01709318|537400757|FG000|Overall Study|Technical Problems|1|||
148977910|NCT01709318|537400758|FG001|Overall Study|Technical Problems|0|||
148977911|NCT01709318|537400759|FG002|Overall Study|Technical Problems|0|||
148765265|NCT02477332|536615485|FG004|Overall Study|Protocol Violation|1|||
148765266|NCT02477332|536615486|FG005|Overall Study|Protocol Violation|1|||
148977912|NCT01709318|537400760|FG003|Overall Study|Technical Problems|0|||
148826971|NCT00289900|536844416|FG000|Overall Study|Lost to Follow-up|7|||
148826972|NCT00289900|536844417|FG001|Overall Study|Lost to Follow-up|7|||
148826973|NCT00289900|536844418|FG002|Overall Study|Lost to Follow-up|8|||
148826974|NCT00289900|536844419|FG003|Overall Study|Lost to Follow-up|8|||
148826975|NCT00289900|536844420|FG004|Overall Study|Lost to Follow-up|4|||
148826976|NCT00289900|536844421|FG005|Overall Study|Lost to Follow-up|8|||
148826977|NCT00289900|536844416|FG000|Overall Study|Participant had flushing|18|||
148826978|NCT00289900|536844417|FG001|Overall Study|Participant had flushing|42|||
148826979|NCT00289900|536844418|FG002|Overall Study|Participant had flushing|1|||
148826980|NCT00289900|536844419|FG003|Overall Study|Participant had flushing|2|||
148826981|NCT00289900|536844420|FG004|Overall Study|Participant had flushing|0|||
148826982|NCT00289900|536844421|FG005|Overall Study|Participant had flushing|4|||
148826983|NCT00289900|536844416|FG000|Overall Study|Other|0|||
148826984|NCT00289900|536844417|FG001|Overall Study|Other|0|||
148826985|NCT00289900|536844418|FG002|Overall Study|Other|0|||
148826986|NCT00289900|536844419|FG003|Overall Study|Other|5|||
148826987|NCT00289900|536844420|FG004|Overall Study|Other|1|||
148826988|NCT00289900|536844421|FG005|Overall Study|Other|0|||
148826989|NCT00289900|536844416|FG000|Overall Study|Participant moved|1|||
148826990|NCT00289900|536844417|FG001|Overall Study|Participant moved|0|||
148826991|NCT00289900|536844418|FG002|Overall Study|Participant moved|0|||
148826992|NCT00289900|536844419|FG003|Overall Study|Participant moved|1|||
148826993|NCT00289900|536844420|FG004|Overall Study|Participant moved|1|||
148826994|NCT00289900|536844421|FG005|Overall Study|Participant moved|1|||
148826995|NCT00289900|536844416|FG000|Overall Study|Withdrawal by Subject|10|||
148826996|NCT00289900|536844417|FG001|Overall Study|Withdrawal by Subject|21|||
148826997|NCT00289900|536844418|FG002|Overall Study|Withdrawal by Subject|8|||
148826998|NCT00289900|536844419|FG003|Overall Study|Withdrawal by Subject|18|||
148826999|NCT00289900|536844420|FG004|Overall Study|Withdrawal by Subject|12|||
148827000|NCT00289900|536844421|FG005|Overall Study|Withdrawal by Subject|11|||
148827001|NCT00289900|536844416|FG000|Overall Study|Protocol Violation|3|||
148827002|NCT00289900|536844417|FG001|Overall Study|Protocol Violation|9|||
148827003|NCT00289900|536844418|FG002|Overall Study|Protocol Violation|2|||
148827004|NCT00289900|536844419|FG003|Overall Study|Protocol Violation|6|||
148827005|NCT00289900|536844420|FG004|Overall Study|Protocol Violation|7|||
148827006|NCT00289900|536844421|FG005|Overall Study|Protocol Violation|4|||
148827007|NCT00289900|536844416|FG000|Overall Study|site terminated|1|||
148827008|NCT00289900|536844417|FG001|Overall Study|site terminated|0|||
148827009|NCT00289900|536844418|FG002|Overall Study|site terminated|1|||
148827010|NCT00289900|536844419|FG003|Overall Study|site terminated|0|||
148827011|NCT00289900|536844420|FG004|Overall Study|site terminated|0|||
148827012|NCT00289900|536844421|FG005|Overall Study|site terminated|0|||
148827013|NCT00289900|536844416|FG000|Overall Study|Not treated|0|||
148827014|NCT00289900|536844417|FG001|Overall Study|Not treated|1|||
148827015|NCT00289900|536844418|FG002|Overall Study|Not treated|0|||
148827016|NCT00289900|536844419|FG003|Overall Study|Not treated|0|||
148827017|NCT00289900|536844420|FG004|Overall Study|Not treated|0|||
148977913|NCT01709318|537400761|FG004|Overall Study|Technical Problems|0|||
148977914|NCT01709318|537400762|FG005|Overall Study|Technical Problems|0|||
148977915|NCT01709318|537400763|FG006|Overall Study|Technical Problems|0|||
148827018|NCT00289900|536844421|FG005|Overall Study|Not treated|0|||
148827019|NCT01152385|536844422|FG000|Overall Study|Withdrawal by Subject|3|||
148827020|NCT01152385|536844423|FG001|Overall Study|Withdrawal by Subject|1|||
148827021|NCT01152385|536844424|FG002|Overall Study|Withdrawal by Subject|1|||
148827022|NCT01152385|536844425|FG003|Overall Study|Withdrawal by Subject|1|||
148827023|NCT01152385|536844422|FG000|Overall Study|Protocol Violation|0|||
148827024|NCT01152385|536844423|FG001|Overall Study|Protocol Violation|0|||
148827025|NCT01152385|536844424|FG002|Overall Study|Protocol Violation|0|||
148827026|NCT01152385|536844425|FG003|Overall Study|Protocol Violation|1|||
148827027|NCT01152385|536844422|FG000|Overall Study|Adverse Event|1|||
148977916|NCT01709318|537400757|FG000|Overall Study|Withdrawal by Subject|3|||
148977917|NCT01709318|537400758|FG001|Overall Study|Withdrawal by Subject|0|||
148977918|NCT01709318|537400759|FG002|Overall Study|Withdrawal by Subject|3|||
148977919|NCT01709318|537400760|FG003|Overall Study|Withdrawal by Subject|3|||
148977920|NCT01709318|537400761|FG004|Overall Study|Withdrawal by Subject|0|||
148977921|NCT01709318|537400762|FG005|Overall Study|Withdrawal by Subject|2|||
148977922|NCT01709318|537400763|FG006|Overall Study|Withdrawal by Subject|4|||
148977923|NCT01709318|537400757|FG000|Overall Study|Other Protocol Specified Criteria|0|||
148977924|NCT01709318|537400758|FG001|Overall Study|Other Protocol Specified Criteria|1|||
148977925|NCT01709318|537400759|FG002|Overall Study|Other Protocol Specified Criteria|0|||
148977926|NCT01709318|537400760|FG003|Overall Study|Other Protocol Specified Criteria|0|||
148977927|NCT01709318|537400761|FG004|Overall Study|Other Protocol Specified Criteria|0|||
148977928|NCT01709318|537400762|FG005|Overall Study|Other Protocol Specified Criteria|0|||
148977929|NCT01709318|537400763|FG006|Overall Study|Other Protocol Specified Criteria|0|||
148977930|NCT00646958|537400764|FG000|Overall Study|Lack of Efficacy|1|||
148977931|NCT00646958|537400765|FG001|Overall Study|Lack of Efficacy|0|||
148827028|NCT01152385|536844423|FG001|Overall Study|Adverse Event|1|||
148827029|NCT01152385|536844424|FG002|Overall Study|Adverse Event|0|||
148827030|NCT01152385|536844425|FG003|Overall Study|Adverse Event|0|||
148765267|NCT02477332|536615481|FG000|Overall Study|Technical problems|0|||
148765268|NCT02477332|536615482|FG001|Overall Study|Technical problems|0|||
148765269|NCT02477332|536615483|FG002|Overall Study|Technical problems|1|||
148765270|NCT02477332|536615484|FG003|Overall Study|Technical problems|0|||
148765271|NCT02477332|536615485|FG004|Overall Study|Technical problems|0|||
148765272|NCT02477332|536615486|FG005|Overall Study|Technical problems|0|||
148765273|NCT02477332|536615481|FG000|Overall Study|Lost to Follow-up|0|||
148765274|NCT02477332|536615482|FG001|Overall Study|Lost to Follow-up|0|||
148765275|NCT02477332|536615483|FG002|Overall Study|Lost to Follow-up|2|||
148765276|NCT02477332|536615484|FG003|Overall Study|Lost to Follow-up|0|||
148765277|NCT02477332|536615485|FG004|Overall Study|Lost to Follow-up|0|||
148765278|NCT02477332|536615486|FG005|Overall Study|Lost to Follow-up|0|||
148765279|NCT02477332|536615481|FG000|Overall Study|Physician Decision|0|||
148765280|NCT02477332|536615482|FG001|Overall Study|Physician Decision|0|||
148977932|NCT00646958|537400766|FG002|Overall Study|Lack of Efficacy|0|||
148977933|NCT00646958|537400764|FG000|Overall Study|Adverse Event|4|||
148977934|NCT00646958|537400765|FG001|Overall Study|Adverse Event|0|||
148977935|NCT00646958|537400766|FG002|Overall Study|Adverse Event|0|||
148977936|NCT00646958|537400764|FG000|Overall Study|Lost to Follow-up|1|||
148977937|NCT00646958|537400765|FG001|Overall Study|Lost to Follow-up|5|||
148977938|NCT00646958|537400766|FG002|Overall Study|Lost to Follow-up|7|||
148977939|NCT00646958|537400764|FG000|Overall Study|Protocol Violation|1|||
148977940|NCT00646958|537400765|FG001|Overall Study|Protocol Violation|1|||
148977941|NCT00646958|537400766|FG002|Overall Study|Protocol Violation|0|||
148977942|NCT00646958|537400764|FG000|Overall Study|Abnormal screening lab tests|1|||
148977943|NCT00646958|537400765|FG001|Overall Study|Abnormal screening lab tests|1|||
148977944|NCT00646958|537400766|FG002|Overall Study|Abnormal screening lab tests|0|||
148977945|NCT00646958|537400764|FG000|Overall Study|Withdrawal by Subject|1|||
148977946|NCT00646958|537400765|FG001|Overall Study|Withdrawal by Subject|2|||
148977947|NCT00646958|537400766|FG002|Overall Study|Withdrawal by Subject|0|||
148977948|NCT00646958|537400764|FG000|Overall Study|Did not receive study drug|2|||
148977949|NCT00646958|537400765|FG001|Overall Study|Did not receive study drug|0|||
148977950|NCT00646958|537400766|FG002|Overall Study|Did not receive study drug|2|||
148977951|NCT00600821|537400767|FG000|Overall Study|Death|45|||
148977952|NCT00600821|537400768|FG001|Overall Study|Death|46|||
148977953|NCT00600821|537400767|FG000|Overall Study|Lost to Follow-up|2|||
148977954|NCT00600821|537400768|FG001|Overall Study|Lost to Follow-up|2|||
148977955|NCT00600821|537400767|FG000|Overall Study|Withdrawal by Subject|1|||
148977956|NCT00600821|537400768|FG001|Overall Study|Withdrawal by Subject|1|||
148977957|NCT00600821|537400767|FG000|Overall Study|Terminated by sponsor|8|||
148977958|NCT00600821|537400768|FG001|Overall Study|Terminated by sponsor|6|||
148977959|NCT00600821|537400767|FG000|Overall Study|Objective progression or relapse|0|||
148977960|NCT00600821|537400768|FG001|Overall Study|Objective progression or relapse|1|||
148977961|NCT00600821|537400767|FG000|Overall Study|Randomized but not treated|0|||
148977962|NCT00600821|537400768|FG001|Overall Study|Randomized but not treated|1|||
148977963|NCT00600821|537400767|FG000|Overall Study|Other|2|||
148977964|NCT00600821|537400768|FG001|Overall Study|Other|3|||
148977965|NCT01607905|537400769|FG000|Overall Study|Withdrawal by participant|7|||
148977966|NCT01607905|537400770|FG001|Overall Study|Withdrawal by participant|2|||
148765281|NCT02477332|536615483|FG002|Overall Study|Physician Decision|1|||
148765282|NCT02477332|536615484|FG003|Overall Study|Physician Decision|3|||
148765283|NCT02477332|536615485|FG004|Overall Study|Physician Decision|0|||
148765284|NCT02477332|536615486|FG005|Overall Study|Physician Decision|1|||
148765285|NCT02477332|536615481|FG000|Overall Study|Withdrawal by Subject|0|||
148765286|NCT02477332|536615482|FG001|Overall Study|Withdrawal by Subject|3|||
148765287|NCT02477332|536615483|FG002|Overall Study|Withdrawal by Subject|1|||
148765288|NCT02477332|536615484|FG003|Overall Study|Withdrawal by Subject|2|||
148765289|NCT02477332|536615485|FG004|Overall Study|Withdrawal by Subject|1|||
148765290|NCT02477332|536615486|FG005|Overall Study|Withdrawal by Subject|0|||
148765291|NCT02593097|536615491|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
148765292|NCT02593097|536615492|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
148765293|NCT02593097|536615491|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
148977967|NCT01607905|537400771|FG002|Overall Study|Withdrawal by participant|4|||
148977968|NCT01607905|537400772|FG003|Overall Study|Withdrawal by participant|6|||
148977969|NCT01607905|537400773|FG004|Overall Study|Withdrawal by participant|0|||
148977970|NCT01607905|537400774|FG005|Overall Study|Withdrawal by participant|4|||
148977971|NCT01607905|537400775|FG006|Overall Study|Withdrawal by participant|12|||
148977972|NCT01607905|537400769|FG000|Overall Study|Incidence or severity of AEs|5|||
148765294|NCT02593097|536615492|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
148765295|NCT02593097|536615491|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
148765296|NCT02593097|536615492|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
148765297|NCT02593097|536615491|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
148765298|NCT02593097|536615492|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
148977973|NCT01607905|537400770|FG001|Overall Study|Incidence or severity of AEs|1|||
148977974|NCT01607905|537400771|FG002|Overall Study|Incidence or severity of AEs|1|||
148977975|NCT01607905|537400772|FG003|Overall Study|Incidence or severity of AEs|3|||
149027748|NCT03251378|537578639|FG001|Overall Study|Other|3|||
148977976|NCT01607905|537400773|FG004|Overall Study|Incidence or severity of AEs|0|||
148977977|NCT01607905|537400774|FG005|Overall Study|Incidence or severity of AEs|2|||
148765299|NCT02593097|536615491|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
148765300|NCT02593097|536615492|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
148765301|NCT03759587|536615493|FG000|Overall Study|Adverse Event|5|||
148765302|NCT03759587|536615493|FG000|Overall Study|Progressive Disease|10|||
148765303|NCT03759587|536615493|FG000|Overall Study|Site Terminated by Sponsor|3|||
148765304|NCT03759587|536615493|FG000|Overall Study|Withdrawal by Subject|1|||
148765305|NCT00665431|536615495|FG000|Overall Study|Adverse Event|16|||
148765306|NCT00665431|536615496|FG001|Overall Study|Adverse Event|22|||
148765307|NCT00665431|536615497|FG002|Overall Study|Adverse Event|6|||
148765308|NCT00665431|536615495|FG000|Overall Study|Withdrawal by Subject|17|||
148765309|NCT00665431|536615496|FG001|Overall Study|Withdrawal by Subject|25|||
148765310|NCT00665431|536615497|FG002|Overall Study|Withdrawal by Subject|15|||
148765311|NCT00665431|536615495|FG000|Overall Study|Lost to Follow-up|3|||
148765312|NCT00665431|536615496|FG001|Overall Study|Lost to Follow-up|3|||
148765313|NCT00665431|536615497|FG002|Overall Study|Lost to Follow-up|1|||
148765314|NCT00665431|536615495|FG000|Overall Study|Other|4|||
148765315|NCT00665431|536615496|FG001|Overall Study|Other|7|||
148765316|NCT00665431|536615497|FG002|Overall Study|Other|2|||
148765317|NCT00454363|536615498|FG000|Overall Study|Adverse Event|1|||
148765318|NCT00454363|536615499|FG001|Overall Study|Adverse Event|2|||
148765319|NCT00454363|536615498|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
148765320|NCT00454363|536615499|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
148765321|NCT01578239|536615500|FG000|Treatment Period|Progressive Disease|19|||
148765322|NCT01578239|536615501|FG001|Treatment Period|Progressive Disease|64|||
148765323|NCT01578239|536615500|FG000|Treatment Period|Physician Decision|17|||
148977978|NCT01607905|537400775|FG006|Overall Study|Incidence or severity of AEs|8|||
148977979|NCT01607905|537400769|FG000|Overall Study|Disease progression|44|||
148765324|NCT01578239|536615501|FG001|Treatment Period|Physician Decision|17|||
148765325|NCT01578239|536615500|FG000|Treatment Period|Adverse Event|13|||
148765326|NCT01578239|536615501|FG001|Treatment Period|Adverse Event|10|||
148765327|NCT01578239|536615500|FG000|Treatment Period|Non-compliance|2|||
148765328|NCT01578239|536615501|FG001|Treatment Period|Non-compliance|0|||
148765329|NCT01578239|536615500|FG000|Treatment Period|Withdrawal by Subject|10|||
148765330|NCT01578239|536615501|FG001|Treatment Period|Withdrawal by Subject|9|||
148765331|NCT01578239|536615500|FG000|Treatment Period|Other|6|||
148765332|NCT01578239|536615501|FG001|Treatment Period|Other|1|||
148765333|NCT01578239|536615500|FG000|Long-term Follow-Up Period|Death|69|||
148765334|NCT01578239|536615501|FG001|Long-term Follow-Up Period|Death|64|||
148765335|NCT01578239|536615500|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
148765336|NCT01578239|536615501|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
148765337|NCT01578239|536615500|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
148765338|NCT01578239|536615501|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
148765339|NCT01578239|536615500|FG000|Long-term Follow-Up Period|Other|2|||
148765340|NCT01578239|536615501|FG001|Long-term Follow-Up Period|Other|2|||
148765341|NCT02837731|536615507|FG000|Allocation|Admitted to General Floor|3|||
148765342|NCT02837731|536615508|FG001|Allocation|Admitted to General Floor|4|||
148765343|NCT02837731|536615507|FG000|Allocation|Immediate surgery/withdrew|2|||
148765344|NCT02837731|536615508|FG001|Allocation|Immediate surgery/withdrew|0|||
148765345|NCT02837731|536615507|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
148765346|NCT02837731|536615508|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
148765347|NCT02837731|536615507|FG000|Allocation|Withdrawal by Subject|2|||
148765348|NCT02837731|536615508|FG001|Allocation|Withdrawal by Subject|0|||
148765349|NCT02837731|536615507|FG000|Allocation|Device not available|1|||
148765350|NCT02837731|536615508|FG001|Allocation|Device not available|0|||
148765351|NCT02837731|536615507|FG000|Allocation|Protocol not implemented|7|||
148765352|NCT02837731|536615508|FG001|Allocation|Protocol not implemented|0|||
148765353|NCT02837731|536615507|FG000|Allocation|Moribund/Do not resuscitate|2|||
148765354|NCT02837731|536615508|FG001|Allocation|Moribund/Do not resuscitate|0|||
148765355|NCT02837731|536615507|FG000|Allocation|Did not meet sepsis criteria|1|||
148765356|NCT02837731|536615508|FG001|Allocation|Did not meet sepsis criteria|2|||
148765357|NCT02837731|536615507|FG000|Allocation|Known aortic abnormalities|0|||
148765358|NCT02837731|536615508|FG001|Allocation|Known aortic abnormalities|1|||
148765359|NCT01119859|536615509|FG000|Overall Study|Adverse Event|9|||
148765360|NCT01119859|536615510|FG001|Overall Study|Adverse Event|10|||
148765361|NCT01119859|536615509|FG000|Overall Study|Death|2|||
148765362|NCT01119859|536615510|FG001|Overall Study|Death|0|||
148765363|NCT01119859|536615509|FG000|Overall Study|Insufficient therapeutic response|7|||
148765364|NCT01119859|536615510|FG001|Overall Study|Insufficient therapeutic response|14|||
148765365|NCT01119859|536615509|FG000|Overall Study|Refused treatment|3|||
148765366|NCT01119859|536615510|FG001|Overall Study|Refused treatment|6|||
148765367|NCT01119859|536615509|FG000|Overall Study|Failure to return|3|||
148765368|NCT01119859|536615510|FG001|Overall Study|Failure to return|0|||
148765369|NCT02644668|536615512|FG000|Overall Study|Adverse Event|2|||
148765370|NCT02644668|536615513|FG001|Overall Study|Adverse Event|0|||
148765371|NCT02644668|536615514|FG002|Overall Study|Adverse Event|1|||
148827031|NCT01152385|536844422|FG000|Overall Study|Study-specific withdrawal criteria|1|||
148977980|NCT01607905|537400770|FG001|Overall Study|Disease progression|16|||
148977981|NCT01607905|537400771|FG002|Overall Study|Disease progression|15|||
148765372|NCT02644668|536615512|FG000|Overall Study|Protocol Violation|0|||
148765373|NCT02644668|536615513|FG001|Overall Study|Protocol Violation|0|||
148765374|NCT02644668|536615514|FG002|Overall Study|Protocol Violation|1|||
148765375|NCT02644668|536615512|FG000|Overall Study|Withdrawal by Subject|0|||
148765376|NCT02644668|536615513|FG001|Overall Study|Withdrawal by Subject|0|||
148765377|NCT02644668|536615514|FG002|Overall Study|Withdrawal by Subject|1|||
148765378|NCT03291431|536615517|FG000|Overall Study|Protocol Violation|2|||
148765379|NCT03291431|536615518|FG001|Overall Study|Protocol Violation|1|||
148765380|NCT03291431|536615517|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
148765381|NCT03291431|536615518|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
148765382|NCT03291431|536615517|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
148765383|NCT03291431|536615518|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
148765384|NCT03850483|536615519|FG000|Treatment for Stage 1|Adverse Event|1|||
148765385|NCT03850483|536615520|FG001|Treatment for Stage 1|Adverse Event|1|||
148765386|NCT03850483|536615521|FG002|Treatment for Stage 1|Adverse Event|3|||
148765387|NCT03850483|536615522|FG003|Treatment for Stage 1|Adverse Event|0|||
148765388|NCT03850483|536615523|FG004|Treatment for Stage 1|Adverse Event|2|||
148765389|NCT03850483|536615524|FG005|Treatment for Stage 1|Adverse Event|0|||
148765390|NCT03850483|536615525|FG006|Treatment for Stage 1|Adverse Event|2|||
148765391|NCT03850483|536615526|FG007|Treatment for Stage 1|Adverse Event|2|||
148765392|NCT03850483|536615527|FG008|Treatment for Stage 1|Adverse Event|0|||
148765393|NCT03850483|536615528|FG009|Treatment for Stage 1|Adverse Event|0|||
148765394|NCT03850483|536615519|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
148765395|NCT03850483|536615520|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
148765396|NCT03850483|536615521|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
148765397|NCT03850483|536615522|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
148765398|NCT03850483|536615523|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
148765399|NCT03850483|536615524|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
148765400|NCT03850483|536615525|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
148765401|NCT03850483|536615526|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
148765402|NCT03850483|536615527|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
148765403|NCT03850483|536615528|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
148765404|NCT03850483|536615519|FG000|Treatment for Stage 1|Protocol Violation|1|||
148765405|NCT03850483|536615520|FG001|Treatment for Stage 1|Protocol Violation|0|||
148765406|NCT03850483|536615521|FG002|Treatment for Stage 1|Protocol Violation|0|||
148765407|NCT03850483|536615522|FG003|Treatment for Stage 1|Protocol Violation|0|||
148765408|NCT03850483|536615523|FG004|Treatment for Stage 1|Protocol Violation|0|||
148765409|NCT03850483|536615524|FG005|Treatment for Stage 1|Protocol Violation|0|||
148765410|NCT03850483|536615525|FG006|Treatment for Stage 1|Protocol Violation|1|||
148765411|NCT03850483|536615526|FG007|Treatment for Stage 1|Protocol Violation|0|||
148765412|NCT03850483|536615527|FG008|Treatment for Stage 1|Protocol Violation|0|||
148765413|NCT03850483|536615528|FG009|Treatment for Stage 1|Protocol Violation|0|||
148765414|NCT03850483|536615519|FG000|Treatment for Stage 1|Physician Decision|0|||
148765415|NCT03850483|536615520|FG001|Treatment for Stage 1|Physician Decision|0|||
148765416|NCT03850483|536615521|FG002|Treatment for Stage 1|Physician Decision|0|||
148765417|NCT03850483|536615522|FG003|Treatment for Stage 1|Physician Decision|0|||
148765418|NCT03850483|536615523|FG004|Treatment for Stage 1|Physician Decision|0|||
148765419|NCT03850483|536615524|FG005|Treatment for Stage 1|Physician Decision|1|||
148765420|NCT03850483|536615525|FG006|Treatment for Stage 1|Physician Decision|0|||
148765421|NCT03850483|536615526|FG007|Treatment for Stage 1|Physician Decision|0|||
148765422|NCT03850483|536615527|FG008|Treatment for Stage 1|Physician Decision|0|||
148765423|NCT03850483|536615528|FG009|Treatment for Stage 1|Physician Decision|0|||
148765424|NCT03850483|536615519|FG000|Treatment for Stage 1|Other|0|||
148765425|NCT03850483|536615520|FG001|Treatment for Stage 1|Other|0|||
148765426|NCT03850483|536615521|FG002|Treatment for Stage 1|Other|0|||
148765427|NCT03850483|536615522|FG003|Treatment for Stage 1|Other|0|||
148765428|NCT03850483|536615523|FG004|Treatment for Stage 1|Other|2|||
148765429|NCT03850483|536615524|FG005|Treatment for Stage 1|Other|1|||
148765430|NCT03850483|536615525|FG006|Treatment for Stage 1|Other|0|||
148765431|NCT03850483|536615526|FG007|Treatment for Stage 1|Other|0|||
148765432|NCT03850483|536615527|FG008|Treatment for Stage 1|Other|0|||
148765433|NCT03850483|536615528|FG009|Treatment for Stage 1|Other|0|||
148765434|NCT03850483|536615519|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765435|NCT03850483|536615520|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765436|NCT03850483|536615521|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
148827032|NCT01152385|536844423|FG001|Overall Study|Study-specific withdrawal criteria|1|||
148827033|NCT01152385|536844424|FG002|Overall Study|Study-specific withdrawal criteria|2|||
148977982|NCT01607905|537400772|FG003|Overall Study|Disease progression|11|||
148977983|NCT01607905|537400773|FG004|Overall Study|Disease progression|6|||
148977984|NCT01607905|537400774|FG005|Overall Study|Disease progression|7|||
148765437|NCT03850483|536615522|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765438|NCT03850483|536615523|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765439|NCT03850483|536615524|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148977985|NCT01607905|537400775|FG006|Overall Study|Disease progression|21|||
148977986|NCT01607905|537400769|FG000|Overall Study|Non-compliance with study procedures|0|||
148977987|NCT01607905|537400770|FG001|Overall Study|Non-compliance with study procedures|0|||
148977988|NCT01607905|537400771|FG002|Overall Study|Non-compliance with study procedures|0|||
148977989|NCT01607905|537400772|FG003|Overall Study|Non-compliance with study procedures|0|||
148765440|NCT03850483|536615525|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765441|NCT03850483|536615526|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765442|NCT03850483|536615527|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765443|NCT03850483|536615528|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
148765444|NCT03850483|536615519|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765445|NCT03850483|536615520|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765446|NCT03850483|536615521|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765447|NCT03850483|536615522|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765448|NCT03850483|536615523|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765449|NCT03850483|536615524|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
148765450|NCT03850483|536615525|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765451|NCT03850483|536615526|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765452|NCT03850483|536615527|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765453|NCT03850483|536615528|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
148765454|NCT03850483|536615519|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
148765455|NCT03850483|536615520|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
148765456|NCT03850483|536615521|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
148765457|NCT03850483|536615522|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
148765458|NCT03850483|536615523|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
148765459|NCT03850483|536615524|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
148765460|NCT03850483|536615525|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
148765461|NCT03850483|536615526|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
148765462|NCT03850483|536615527|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
148765463|NCT03850483|536615528|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
148765464|NCT03850483|536615519|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
148765465|NCT03850483|536615520|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
148765466|NCT03850483|536615521|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
148765467|NCT03850483|536615522|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
148765468|NCT03850483|536615523|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
148765469|NCT03850483|536615524|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
148765470|NCT03850483|536615525|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
148765471|NCT03850483|536615526|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
148765472|NCT03850483|536615527|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
148765473|NCT03850483|536615528|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
148765474|NCT03850483|536615519|FG000|Treatment for Stage 1|Death|0|||
148765475|NCT03850483|536615520|FG001|Treatment for Stage 1|Death|0|||
148765476|NCT03850483|536615521|FG002|Treatment for Stage 1|Death|0|||
148765477|NCT03850483|536615522|FG003|Treatment for Stage 1|Death|0|||
148765478|NCT03850483|536615523|FG004|Treatment for Stage 1|Death|0|||
148765479|NCT03850483|536615524|FG005|Treatment for Stage 1|Death|1|||
148765480|NCT03850483|536615525|FG006|Treatment for Stage 1|Death|0|||
148765481|NCT03850483|536615526|FG007|Treatment for Stage 1|Death|0|||
148765482|NCT03850483|536615527|FG008|Treatment for Stage 1|Death|0|||
148765483|NCT03850483|536615528|FG009|Treatment for Stage 1|Death|0|||
148765484|NCT03850483|536615519|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
148765485|NCT03850483|536615520|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
148765486|NCT03850483|536615521|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
148765487|NCT03850483|536615522|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
148765488|NCT03850483|536615523|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
148765489|NCT03850483|536615524|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
148765490|NCT03850483|536615525|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
148765491|NCT03850483|536615526|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
148765492|NCT03850483|536615527|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
148765493|NCT03850483|536615528|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
148765494|NCT03850483|536615519|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
148765495|NCT03850483|536615520|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
148765496|NCT03850483|536615521|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
148765497|NCT03850483|536615522|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
148765498|NCT03850483|536615523|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
148977990|NCT01607905|537400773|FG004|Overall Study|Non-compliance with study procedures|0|||
148765499|NCT03850483|536615524|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
148765500|NCT03850483|536615525|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
148765501|NCT03850483|536615526|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
148827034|NCT01152385|536844425|FG003|Overall Study|Study-specific withdrawal criteria|0|||
148827035|NCT01152385|536844422|FG000|Overall Study|Other|4|||
148827036|NCT01152385|536844423|FG001|Overall Study|Other|3|||
148827037|NCT01152385|536844424|FG002|Overall Study|Other|2|||
148827038|NCT01152385|536844425|FG003|Overall Study|Other|3|||
148827039|NCT02656173|536844426|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
148827040|NCT02656173|536844427|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
148827041|NCT02656173|536844426|FG000|Overall Study|Adverse Event|7|||
148827042|NCT02656173|536844427|FG001|Overall Study|Adverse Event|5|||
148827043|NCT02656173|536844426|FG000|Overall Study|Withdrawal by Subject|1|||
148827044|NCT02656173|536844427|FG001|Overall Study|Withdrawal by Subject|3|||
148827045|NCT02656173|536844426|FG000|Overall Study|Protocol Violation|0|||
148827046|NCT02656173|536844427|FG001|Overall Study|Protocol Violation|1|||
148827047|NCT02656173|536844426|FG000|Overall Study|Miscellaneous|2|||
148827048|NCT02656173|536844427|FG001|Overall Study|Miscellaneous|0|||
148827049|NCT03449147|536844428|FG000|52-week Treatment Period|Death|0|||
148827050|NCT03449147|536844429|FG001|52-week Treatment Period|Death|1|||
148827051|NCT03449147|536844430|FG002|52-week Treatment Period|Death|0|||
148827052|NCT03449147|536844428|FG000|52-week Treatment Period|Lost to Follow-up|6|||
148827053|NCT03449147|536844429|FG001|52-week Treatment Period|Lost to Follow-up|2|||
148827054|NCT03449147|536844430|FG002|52-week Treatment Period|Lost to Follow-up|5|||
148827055|NCT03449147|536844428|FG000|52-week Treatment Period|Other|0|||
148827056|NCT03449147|536844429|FG001|52-week Treatment Period|Other|1|||
148827057|NCT03449147|536844430|FG002|52-week Treatment Period|Other|2|||
148827058|NCT03449147|536844428|FG000|52-week Treatment Period|Physician Decision|1|||
148827059|NCT03449147|536844429|FG001|52-week Treatment Period|Physician Decision|0|||
148827060|NCT03449147|536844430|FG002|52-week Treatment Period|Physician Decision|3|||
148827061|NCT03449147|536844428|FG000|52-week Treatment Period|Screen Failure|1|||
148827062|NCT03449147|536844429|FG001|52-week Treatment Period|Screen Failure|2|||
148827063|NCT03449147|536844430|FG002|52-week Treatment Period|Screen Failure|0|||
148827064|NCT03449147|536844428|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
148827065|NCT03449147|536844429|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
148827066|NCT03449147|536844430|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
148827067|NCT03449147|536844428|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
148827068|NCT03449147|536844429|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
148827069|NCT03449147|536844430|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
148827070|NCT03449147|536844428|FG000|12-Week Off-Treatment Durability Period|Other|0|||
148827071|NCT03449147|536844429|FG001|12-Week Off-Treatment Durability Period|Other|1|||
148827072|NCT03449147|536844430|FG002|12-Week Off-Treatment Durability Period|Other|0|||
148827073|NCT00992394|536844432|FG000|Overall Study|Lack of Efficacy|6|||
148827074|NCT00992394|536844433|FG001|Overall Study|Lack of Efficacy|3|||
148827075|NCT00992394|536844432|FG000|Overall Study|Adverse Event|4|||
148827076|NCT00992394|536844433|FG001|Overall Study|Adverse Event|5|||
148827077|NCT00992394|536844432|FG000|Overall Study|Withdrawal by Subject|8|||
148827078|NCT00992394|536844433|FG001|Overall Study|Withdrawal by Subject|2|||
148827079|NCT00992394|536844432|FG000|Overall Study|Physician Decision|1|||
148827080|NCT00992394|536844433|FG001|Overall Study|Physician Decision|0|||
148827081|NCT00992394|536844432|FG000|Overall Study|Protocol Violation|2|||
148827082|NCT00992394|536844433|FG001|Overall Study|Protocol Violation|4|||
148827083|NCT00992394|536844432|FG000|Overall Study|Lost to Follow-up|2|||
148827084|NCT00992394|536844433|FG001|Overall Study|Lost to Follow-up|0|||
148827085|NCT00992394|536844432|FG000|Overall Study|Other event|1|||
148827086|NCT00992394|536844433|FG001|Overall Study|Other event|0|||
148765502|NCT03850483|536615527|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
148765503|NCT03850483|536615528|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
148765504|NCT03850483|536615519|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765505|NCT03850483|536615520|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765506|NCT03850483|536615521|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765507|NCT03850483|536615522|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765508|NCT03850483|536615523|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765509|NCT03850483|536615524|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765510|NCT03850483|536615525|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
148765511|NCT03850483|536615526|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
148765512|NCT03850483|536615527|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765513|NCT03850483|536615528|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
148765514|NCT03850483|536615519|FG000|Follow-up for Stage 1|Physician Decision|0|||
148765515|NCT03850483|536615520|FG001|Follow-up for Stage 1|Physician Decision|0|||
148765516|NCT03850483|536615521|FG002|Follow-up for Stage 1|Physician Decision|0|||
148765517|NCT03850483|536615522|FG003|Follow-up for Stage 1|Physician Decision|0|||
148827087|NCT02037984|536844434|FG000|Overall Study|Lack of Efficacy|0|||
148827088|NCT02037984|536844435|FG001|Overall Study|Lack of Efficacy|0|||
148827089|NCT02037984|536844436|FG002|Overall Study|Lack of Efficacy|3|||
148827090|NCT02037984|536844437|FG003|Overall Study|Lack of Efficacy|10|||
148827091|NCT02037984|536844438|FG004|Overall Study|Lack of Efficacy|2|||
149027749|NCT03251378|537578640|FG002|Overall Study|Other|2|||
149027750|NCT03251378|537578641|FG003|Overall Study|Other|0|||
148827092|NCT02037984|536844439|FG005|Overall Study|Lack of Efficacy|2|||
148827093|NCT02037984|536844440|FG006|Overall Study|Lack of Efficacy|4|||
148827094|NCT02037984|536844441|FG007|Overall Study|Lack of Efficacy|3|||
148827095|NCT02037984|536844434|FG000|Overall Study|Lost to Follow-up|1|||
148827096|NCT02037984|536844435|FG001|Overall Study|Lost to Follow-up|0|||
148827097|NCT02037984|536844436|FG002|Overall Study|Lost to Follow-up|3|||
148827098|NCT02037984|536844437|FG003|Overall Study|Lost to Follow-up|5|||
148827099|NCT02037984|536844438|FG004|Overall Study|Lost to Follow-up|2|||
148827100|NCT02037984|536844439|FG005|Overall Study|Lost to Follow-up|2|||
148827101|NCT02037984|536844440|FG006|Overall Study|Lost to Follow-up|2|||
148827102|NCT02037984|536844441|FG007|Overall Study|Lost to Follow-up|4|||
148827103|NCT02037984|536844434|FG000|Overall Study|Physician Decision|0|||
148827104|NCT02037984|536844435|FG001|Overall Study|Physician Decision|0|||
148827105|NCT02037984|536844436|FG002|Overall Study|Physician Decision|0|||
148827106|NCT02037984|536844437|FG003|Overall Study|Physician Decision|0|||
148827107|NCT02037984|536844438|FG004|Overall Study|Physician Decision|0|||
148827108|NCT02037984|536844439|FG005|Overall Study|Physician Decision|0|||
148827109|NCT02037984|536844440|FG006|Overall Study|Physician Decision|1|||
148827110|NCT02037984|536844441|FG007|Overall Study|Physician Decision|0|||
148827111|NCT02037984|536844434|FG000|Overall Study|Protocol Violation|0|||
148827112|NCT02037984|536844435|FG001|Overall Study|Protocol Violation|0|||
148827113|NCT02037984|536844436|FG002|Overall Study|Protocol Violation|0|||
148827114|NCT02037984|536844437|FG003|Overall Study|Protocol Violation|0|||
148827115|NCT02037984|536844438|FG004|Overall Study|Protocol Violation|0|||
148827116|NCT02037984|536844439|FG005|Overall Study|Protocol Violation|1|||
148827117|NCT02037984|536844440|FG006|Overall Study|Protocol Violation|2|||
148827118|NCT02037984|536844441|FG007|Overall Study|Protocol Violation|0|||
148827119|NCT02037984|536844434|FG000|Overall Study|Technical Problems|0|||
148827120|NCT02037984|536844435|FG001|Overall Study|Technical Problems|0|||
148827121|NCT02037984|536844436|FG002|Overall Study|Technical Problems|3|||
148827122|NCT02037984|536844437|FG003|Overall Study|Technical Problems|3|||
148827123|NCT02037984|536844438|FG004|Overall Study|Technical Problems|2|||
148827124|NCT02037984|536844439|FG005|Overall Study|Technical Problems|3|||
148827125|NCT02037984|536844440|FG006|Overall Study|Technical Problems|4|||
148827126|NCT02037984|536844441|FG007|Overall Study|Technical Problems|2|||
148827127|NCT02037984|536844434|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148827128|NCT02037984|536844435|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148827129|NCT02037984|536844436|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
148827130|NCT02037984|536844437|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
148827131|NCT02037984|536844438|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
148827132|NCT02037984|536844439|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
148827133|NCT02037984|536844440|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
148827134|NCT02037984|536844441|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
148827135|NCT02037984|536844434|FG000|Overall Study|Withdrawal by Subject|0|||
148827136|NCT02037984|536844435|FG001|Overall Study|Withdrawal by Subject|0|||
148827137|NCT02037984|536844436|FG002|Overall Study|Withdrawal by Subject|0|||
148827138|NCT02037984|536844437|FG003|Overall Study|Withdrawal by Subject|1|||
148827139|NCT02037984|536844438|FG004|Overall Study|Withdrawal by Subject|1|||
148827140|NCT02037984|536844439|FG005|Overall Study|Withdrawal by Subject|3|||
148827141|NCT02037984|536844440|FG006|Overall Study|Withdrawal by Subject|0|||
148827142|NCT02037984|536844441|FG007|Overall Study|Withdrawal by Subject|1|||
148827143|NCT00974233|536844445|FG000|Induction Chemoimmunotherapy|Death|2|||
148827144|NCT00974233|536844445|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
148977991|NCT01607905|537400774|FG005|Overall Study|Non-compliance with study procedures|0|||
148977992|NCT01607905|537400775|FG006|Overall Study|Non-compliance with study procedures|1|||
148977993|NCT01607905|537400769|FG000|Overall Study|Death|1|||
148977994|NCT01607905|537400770|FG001|Overall Study|Death|1|||
148977995|NCT01607905|537400771|FG002|Overall Study|Death|1|||
148977996|NCT01607905|537400772|FG003|Overall Study|Death|1|||
148977997|NCT01607905|537400773|FG004|Overall Study|Death|0|||
148977998|NCT01607905|537400774|FG005|Overall Study|Death|0|||
148977999|NCT01607905|537400775|FG006|Overall Study|Death|3|||
148827145|NCT00974233|536844445|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
148827146|NCT00974233|536844445|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
148827147|NCT00974233|536844445|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
148827148|NCT00974233|536844445|FG000|Maintenance Lenalidomide|Adverse Event|8|||
148827149|NCT01691092|536844446|FG000|Overall Study|Lost to Follow-up|10|||
148978000|NCT01607905|537400769|FG000|Overall Study|Other treatments become available|1|||
148978001|NCT01607905|537400770|FG001|Overall Study|Other treatments become available|0|||
148827150|NCT01691092|536844446|FG000|Overall Study|Physician Decision|4|||
148827151|NCT01691092|536844446|FG000|Overall Study|Withdrawal by Subject|3|||
148827152|NCT01691092|536844446|FG000|Overall Study|non-compliance|3|||
148827153|NCT01691092|536844446|FG000|Overall Study|used for different study|2|||
148827154|NCT01691092|536844446|FG000|Overall Study|screen fail|19|||
148827155|NCT00561821|536844447|FG000|Overall Study|Not treated|0|||
148827156|NCT00561821|536844448|FG001|Overall Study|Not treated|0|||
148978002|NCT01607905|537400771|FG002|Overall Study|Other treatments become available|0|||
148827157|NCT00561821|536844449|FG002|Overall Study|Not treated|1|||
148978003|NCT01607905|537400772|FG003|Overall Study|Other treatments become available|0|||
148978004|NCT01607905|537400773|FG004|Overall Study|Other treatments become available|0|||
148978005|NCT01607905|537400774|FG005|Overall Study|Other treatments become available|0|||
148978006|NCT01607905|537400775|FG006|Overall Study|Other treatments become available|1|||
148978007|NCT01607905|537400769|FG000|Overall Study|Investigator discretion|0|||
148978008|NCT01607905|537400770|FG001|Overall Study|Investigator discretion|0|||
148978009|NCT01607905|537400771|FG002|Overall Study|Investigator discretion|0|||
148978010|NCT01607905|537400772|FG003|Overall Study|Investigator discretion|0|||
148978011|NCT01607905|537400773|FG004|Overall Study|Investigator discretion|0|||
148978012|NCT01607905|537400774|FG005|Overall Study|Investigator discretion|1|||
148978013|NCT01607905|537400775|FG006|Overall Study|Investigator discretion|0|||
148765518|NCT03850483|536615523|FG004|Follow-up for Stage 1|Physician Decision|1|||
148765519|NCT03850483|536615524|FG005|Follow-up for Stage 1|Physician Decision|0|||
148765520|NCT03850483|536615525|FG006|Follow-up for Stage 1|Physician Decision|1|||
148765521|NCT03850483|536615526|FG007|Follow-up for Stage 1|Physician Decision|0|||
148765522|NCT03850483|536615527|FG008|Follow-up for Stage 1|Physician Decision|0|||
148765523|NCT03850483|536615528|FG009|Follow-up for Stage 1|Physician Decision|0|||
148765524|NCT03850483|536615519|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
148765525|NCT03850483|536615520|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
148765526|NCT03850483|536615521|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
148765527|NCT03850483|536615522|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
148765528|NCT03850483|536615523|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
148765529|NCT03850483|536615524|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
148765530|NCT03850483|536615525|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
148765531|NCT03850483|536615526|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
148765532|NCT03850483|536615527|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
148765533|NCT03850483|536615528|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
148765534|NCT03850483|536615519|FG000|Follow-up for Stage 1|Adverse Event|0|||
148765535|NCT03850483|536615520|FG001|Follow-up for Stage 1|Adverse Event|0|||
148765536|NCT03850483|536615521|FG002|Follow-up for Stage 1|Adverse Event|1|||
148765537|NCT03850483|536615522|FG003|Follow-up for Stage 1|Adverse Event|0|||
148765538|NCT03850483|536615523|FG004|Follow-up for Stage 1|Adverse Event|0|||
148765539|NCT03850483|536615524|FG005|Follow-up for Stage 1|Adverse Event|1|||
148765540|NCT03850483|536615525|FG006|Follow-up for Stage 1|Adverse Event|0|||
148765541|NCT03850483|536615526|FG007|Follow-up for Stage 1|Adverse Event|0|||
148765542|NCT03850483|536615527|FG008|Follow-up for Stage 1|Adverse Event|0|||
148765543|NCT03850483|536615528|FG009|Follow-up for Stage 1|Adverse Event|0|||
148765544|NCT03850483|536615519|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765545|NCT03850483|536615520|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
148765546|NCT03850483|536615521|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765547|NCT03850483|536615522|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765548|NCT03850483|536615523|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
148765549|NCT03850483|536615524|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
148765550|NCT03850483|536615525|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765551|NCT03850483|536615526|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765552|NCT03850483|536615527|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765553|NCT03850483|536615528|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
148765554|NCT03850483|536615519|FG000|Follow-up for Stage 1|Other|0|||
148765555|NCT03850483|536615520|FG001|Follow-up for Stage 1|Other|2|||
148765556|NCT03850483|536615521|FG002|Follow-up for Stage 1|Other|0|||
148765557|NCT03850483|536615522|FG003|Follow-up for Stage 1|Other|2|||
148765558|NCT03850483|536615523|FG004|Follow-up for Stage 1|Other|0|||
148765559|NCT03850483|536615524|FG005|Follow-up for Stage 1|Other|1|||
148765560|NCT03850483|536615525|FG006|Follow-up for Stage 1|Other|0|||
148765561|NCT03850483|536615526|FG007|Follow-up for Stage 1|Other|0|||
148765562|NCT03850483|536615527|FG008|Follow-up for Stage 1|Other|0|||
148765563|NCT03850483|536615528|FG009|Follow-up for Stage 1|Other|0|||
148765564|NCT03850483|536615519|FG000|Treatment for Stage 2|Adverse Event|0|||
148765565|NCT03850483|536615520|FG001|Treatment for Stage 2|Adverse Event|0|||
148765566|NCT03850483|536615521|FG002|Treatment for Stage 2|Adverse Event|0|||
148765567|NCT03850483|536615522|FG003|Treatment for Stage 2|Adverse Event|0|||
148765568|NCT03850483|536615523|FG004|Treatment for Stage 2|Adverse Event|0|||
148765569|NCT03850483|536615524|FG005|Treatment for Stage 2|Adverse Event|0|||
148765570|NCT03850483|536615525|FG006|Treatment for Stage 2|Adverse Event|0|||
148765571|NCT03850483|536615526|FG007|Treatment for Stage 2|Adverse Event|0|||
148765572|NCT03850483|536615527|FG008|Treatment for Stage 2|Adverse Event|0|||
148765573|NCT03850483|536615528|FG009|Treatment for Stage 2|Adverse Event|1|||
148765574|NCT03850483|536615519|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
148765575|NCT03850483|536615520|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
148765576|NCT03850483|536615521|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
148765577|NCT03850483|536615522|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
148765578|NCT03850483|536615523|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
148765579|NCT03850483|536615524|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
149027751|NCT03251378|537578642|FG004|Overall Study|Other|1|||
148765580|NCT03850483|536615525|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
148765581|NCT03850483|536615526|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
148765582|NCT03850483|536615527|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
148765583|NCT03850483|536615528|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
148765584|NCT03850483|536615519|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
148765585|NCT03850483|536615520|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
148765586|NCT03850483|536615521|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
148765587|NCT03850483|536615522|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
148765588|NCT03850483|536615523|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
148765589|NCT03850483|536615524|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
148765590|NCT03850483|536615525|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
148765591|NCT03850483|536615526|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
148765592|NCT03850483|536615527|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
148765593|NCT03850483|536615528|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
148765594|NCT03850483|536615519|FG000|Treatment for Stage 2|Physician Decision|0|||
148765595|NCT03850483|536615520|FG001|Treatment for Stage 2|Physician Decision|0|||
148765596|NCT03850483|536615521|FG002|Treatment for Stage 2|Physician Decision|0|||
148765597|NCT03850483|536615522|FG003|Treatment for Stage 2|Physician Decision|0|||
148765598|NCT03850483|536615523|FG004|Treatment for Stage 2|Physician Decision|0|||
148765599|NCT03850483|536615524|FG005|Treatment for Stage 2|Physician Decision|0|||
148765600|NCT03850483|536615525|FG006|Treatment for Stage 2|Physician Decision|0|||
148765601|NCT03850483|536615526|FG007|Treatment for Stage 2|Physician Decision|0|||
148765602|NCT03850483|536615527|FG008|Treatment for Stage 2|Physician Decision|0|||
148765603|NCT03850483|536615528|FG009|Treatment for Stage 2|Physician Decision|1|||
148765604|NCT03850483|536615519|FG000|Treatment for Stage 2|Protocol Violation|0|||
148765605|NCT03850483|536615520|FG001|Treatment for Stage 2|Protocol Violation|0|||
148765606|NCT03850483|536615521|FG002|Treatment for Stage 2|Protocol Violation|0|||
148765607|NCT03850483|536615522|FG003|Treatment for Stage 2|Protocol Violation|0|||
148765608|NCT03850483|536615523|FG004|Treatment for Stage 2|Protocol Violation|0|||
148765609|NCT03850483|536615524|FG005|Treatment for Stage 2|Protocol Violation|0|||
148765610|NCT03850483|536615525|FG006|Treatment for Stage 2|Protocol Violation|0|||
148765611|NCT03850483|536615526|FG007|Treatment for Stage 2|Protocol Violation|0|||
148765612|NCT03850483|536615527|FG008|Treatment for Stage 2|Protocol Violation|1|||
148765613|NCT03850483|536615528|FG009|Treatment for Stage 2|Protocol Violation|0|||
148765614|NCT03850483|536615519|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
148765615|NCT03850483|536615520|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
148765616|NCT03850483|536615521|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
148765617|NCT03850483|536615522|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
148765618|NCT03850483|536615523|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
148765619|NCT03850483|536615524|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
148765620|NCT03850483|536615525|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
148765621|NCT03850483|536615526|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
148765622|NCT03850483|536615527|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
148765623|NCT03850483|536615528|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
148765624|NCT03850483|536615519|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765625|NCT03850483|536615520|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765626|NCT03850483|536615521|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765627|NCT03850483|536615522|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765628|NCT03850483|536615523|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765629|NCT03850483|536615524|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765630|NCT03850483|536615525|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765631|NCT03850483|536615526|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765632|NCT03850483|536615527|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
148765633|NCT03850483|536615528|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
148765634|NCT03850483|536615519|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
148765635|NCT03850483|536615520|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
148765636|NCT03850483|536615521|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
148765637|NCT03850483|536615522|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
148765638|NCT03850483|536615523|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
148765639|NCT03850483|536615524|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
148765640|NCT03850483|536615525|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
148765641|NCT03850483|536615526|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
148765642|NCT03850483|536615527|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
148765643|NCT03850483|536615528|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
148765644|NCT03850483|536615519|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
148765645|NCT03850483|536615520|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
148765646|NCT03850483|536615521|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
148765647|NCT03850483|536615522|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
148765648|NCT03850483|536615523|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
148765649|NCT03850483|536615524|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
148765650|NCT03850483|536615525|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
148827158|NCT00561821|536844450|FG003|Overall Study|Not treated|0|||
148827159|NCT00561821|536844447|FG000|Overall Study|Withdrawal by Subject|0|||
148827160|NCT00561821|536844448|FG001|Overall Study|Withdrawal by Subject|1|||
148827161|NCT00561821|536844449|FG002|Overall Study|Withdrawal by Subject|0|||
148827162|NCT00561821|536844450|FG003|Overall Study|Withdrawal by Subject|2|||
148827163|NCT00561821|536844447|FG000|Overall Study|Reasons not related to trial|2|||
148827164|NCT00561821|536844448|FG001|Overall Study|Reasons not related to trial|1|||
148827165|NCT00561821|536844449|FG002|Overall Study|Reasons not related to trial|0|||
148827166|NCT00561821|536844450|FG003|Overall Study|Reasons not related to trial|0|||
148827167|NCT00561821|536844447|FG000|Overall Study|Other (reason not specified)|1|||
148827168|NCT00561821|536844448|FG001|Overall Study|Other (reason not specified)|1|||
148827169|NCT00561821|536844449|FG002|Overall Study|Other (reason not specified)|0|||
148827170|NCT00561821|536844450|FG003|Overall Study|Other (reason not specified)|0|||
148827171|NCT00561821|536844447|FG000|Overall Study|Adverse Event|2|||
148827172|NCT00561821|536844448|FG001|Overall Study|Adverse Event|3|||
148827173|NCT00561821|536844449|FG002|Overall Study|Adverse Event|1|||
148827174|NCT00561821|536844450|FG003|Overall Study|Adverse Event|1|||
148827175|NCT01657942|536844451|FG000|Overall Study|Alternative Treatment|7|||
148827176|NCT01657942|536844451|FG000|Overall Study|Lost to Follow-up|1|||
148827177|NCT04616196|536845546|FG000|Overall Study|Progressive Disease|3|||
148827178|NCT04616196|536845547|FG001|Overall Study|Progressive Disease|0|||
148827179|NCT04616196|536845548|FG002|Overall Study|Progressive Disease|4|||
148827180|NCT04616196|536845549|FG003|Overall Study|Progressive Disease|1|||
148827181|NCT04616196|536845546|FG000|Overall Study|Death|2|||
148827182|NCT04616196|536845547|FG001|Overall Study|Death|4|||
148827183|NCT04616196|536845548|FG002|Overall Study|Death|1|||
148827184|NCT04616196|536845549|FG003|Overall Study|Death|0|||
148827185|NCT04616196|536845546|FG000|Overall Study|Withdrawal by Subject|0|||
148827186|NCT04616196|536845547|FG001|Overall Study|Withdrawal by Subject|2|||
148827187|NCT04616196|536845548|FG002|Overall Study|Withdrawal by Subject|0|||
148827188|NCT04616196|536845549|FG003|Overall Study|Withdrawal by Subject|0|||
148827189|NCT04616196|536845546|FG000|Overall Study|Lost to Follow-up|1|||
148827190|NCT04616196|536845547|FG001|Overall Study|Lost to Follow-up|0|||
148827191|NCT04616196|536845548|FG002|Overall Study|Lost to Follow-up|0|||
148827192|NCT04616196|536845549|FG003|Overall Study|Lost to Follow-up|0|||
148827193|NCT04616196|536845546|FG000|Overall Study|Sponsor request|2|||
148827194|NCT04616196|536845547|FG001|Overall Study|Sponsor request|1|||
148827195|NCT04616196|536845548|FG002|Overall Study|Sponsor request|1|||
148827196|NCT04616196|536845549|FG003|Overall Study|Sponsor request|2|||
148827197|NCT00129974|536845571|FG000|Overall Study|Other|1|||
148827198|NCT03766906|536845576|FG000|Overall Study|Withdrawal by Subject|6|||
148827199|NCT01437189|536845584|FG000|Overall Study|Adverse Event|3|||
148827200|NCT01437189|536845584|FG000|Overall Study|Lack of Efficacy|4|||
148827201|NCT01437189|536845584|FG000|Overall Study|Withdrawal by Subject|8|||
148827202|NCT04576481|536845592|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
148827203|NCT04576481|536845593|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
148827204|NCT04576481|536845594|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
148827205|NCT04576481|536845595|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
148827206|NCT03464461|536845596|FG000|Overall Study|exclusionary medication given ,|1|||
148827207|NCT03464461|536845597|FG001|Overall Study|exclusionary medication given ,|2|||
148827208|NCT03464461|536845598|FG002|Overall Study|exclusionary medication given ,|0|||
148827209|NCT03464461|536845596|FG000|Overall Study|Physician Decision|0|||
148827210|NCT03464461|536845597|FG001|Overall Study|Physician Decision|1|||
148827211|NCT03464461|536845598|FG002|Overall Study|Physician Decision|0|||
148827212|NCT05261490|536845600|FG000|Overall Study|Other|1|||
148827213|NCT05261490|536845601|FG001|Overall Study|Other|0|||
148827214|NCT05261490|536845602|FG002|Overall Study|Other|0|||
148827215|NCT05261490|536845600|FG000|Overall Study|Study Terminated by Sponsor|1|||
148827216|NCT05261490|536845601|FG001|Overall Study|Study Terminated by Sponsor|1|||
148827217|NCT05261490|536845602|FG002|Overall Study|Study Terminated by Sponsor|4|||
148827218|NCT05261490|536845600|FG000|Overall Study|Death|1|||
148978014|NCT01607905|537400769|FG000|Overall Study|Other|1|||
148827219|NCT05261490|536845601|FG001|Overall Study|Death|2|||
148827220|NCT05261490|536845602|FG002|Overall Study|Death|0|||
148827221|NCT01682720|536845610|FG000|Overall Study|Randomized but Not Treated|0|||
148827222|NCT01682720|536845611|FG001|Overall Study|Randomized but Not Treated|1|||
148827223|NCT01682720|536845612|FG002|Overall Study|Randomized but Not Treated|1|||
148827224|NCT01682720|536845613|FG003|Overall Study|Randomized but Not Treated|0|||
148827225|NCT01682720|536845610|FG000|Overall Study|Terminated by Sponsor|83|||
148827226|NCT01682720|536845611|FG001|Overall Study|Terminated by Sponsor|0|||
148827227|NCT01682720|536845612|FG002|Overall Study|Terminated by Sponsor|0|||
148827228|NCT01682720|536845613|FG003|Overall Study|Terminated by Sponsor|0|||
148827229|NCT01682720|536845610|FG000|Overall Study|Efficacy Failure|0|||
148978015|NCT01607905|537400770|FG001|Overall Study|Other|0|||
148978016|NCT01607905|537400771|FG002|Overall Study|Other|0|||
148827230|NCT01682720|536845611|FG001|Overall Study|Efficacy Failure|3|||
148827231|NCT01682720|536845612|FG002|Overall Study|Efficacy Failure|3|||
148827232|NCT01682720|536845613|FG003|Overall Study|Efficacy Failure|30|||
148978017|NCT01607905|537400772|FG003|Overall Study|Other|0|||
148827233|NCT01682720|536845610|FG000|Overall Study|Lost to Follow-up|1|||
148827234|NCT01682720|536845611|FG001|Overall Study|Lost to Follow-up|1|||
148827235|NCT01682720|536845612|FG002|Overall Study|Lost to Follow-up|0|||
148827236|NCT01682720|536845613|FG003|Overall Study|Lost to Follow-up|6|||
148827237|NCT01682720|536845610|FG000|Overall Study|Subject Withdrew Consent|0|||
148827238|NCT01682720|536845611|FG001|Overall Study|Subject Withdrew Consent|0|||
148827239|NCT01682720|536845612|FG002|Overall Study|Subject Withdrew Consent|2|||
148827240|NCT01682720|536845613|FG003|Overall Study|Subject Withdrew Consent|2|||
148827241|NCT01682720|536845610|FG000|Overall Study|Adverse Event|1|||
148827242|NCT01682720|536845611|FG001|Overall Study|Adverse Event|0|||
148827243|NCT01682720|536845612|FG002|Overall Study|Adverse Event|1|||
148827244|NCT01682720|536845613|FG003|Overall Study|Adverse Event|1|||
148827245|NCT04204902|536845614|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
148827246|NCT04204902|536845615|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
148827247|NCT06091956|536845618|FG000|Overall Study|Withdrawal by Subject|1|||
148827248|NCT06091956|536845618|FG000|Overall Study|Complicating Disease|1|||
148827249|NCT01618708|536845622|FG000|Overall Study|Adverse Event|10|||
148827250|NCT01618708|536845623|FG001|Overall Study|Adverse Event|10|||
148827251|NCT01618708|536845622|FG000|Overall Study|Lost to Follow-up|3|||
148827252|NCT01618708|536845623|FG001|Overall Study|Lost to Follow-up|3|||
148827253|NCT01618708|536845622|FG000|Overall Study|Withdrawal by Subject|17|||
148827254|NCT01618708|536845623|FG001|Overall Study|Withdrawal by Subject|22|||
148827255|NCT01618708|536845622|FG000|Overall Study|Lack of Efficacy|8|||
148827256|NCT01618708|536845623|FG001|Overall Study|Lack of Efficacy|8|||
148827257|NCT01618708|536845622|FG000|Overall Study|Technical problems|2|||
148827258|NCT01618708|536845623|FG001|Overall Study|Technical problems|0|||
148827259|NCT01618708|536845622|FG000|Overall Study|Other than specified above|1|||
148827260|NCT01618708|536845623|FG001|Overall Study|Other than specified above|1|||
148827261|NCT01618708|536845622|FG000|Overall Study|Randomized but not treated|3|||
148827262|NCT01618708|536845623|FG001|Overall Study|Randomized but not treated|2|||
148827263|NCT04003142|536845626|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
148827264|NCT04003142|536845627|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
148827265|NCT04003142|536845628|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
148827266|NCT04003142|536845629|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
148827267|NCT04003142|536845630|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
148827268|NCT04003142|536845626|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
148827269|NCT04003142|536845627|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
148827270|NCT04003142|536845628|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
148827271|NCT04003142|536845629|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
148827272|NCT04003142|536845630|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
148827273|NCT04003142|536845626|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
148827274|NCT04003142|536845627|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
148827275|NCT04003142|536845628|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
148827276|NCT04003142|536845629|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
148827277|NCT04003142|536845630|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
148827278|NCT04003142|536845626|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
148827279|NCT04003142|536845627|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
148827280|NCT04003142|536845628|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
148827281|NCT04003142|536845629|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
148827282|NCT04003142|536845630|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
148827283|NCT04003142|536845626|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
148827284|NCT04003142|536845627|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
148827285|NCT04003142|536845628|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
148827286|NCT04003142|536845629|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
148827287|NCT04003142|536845630|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
148827288|NCT04003142|536845626|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
148827289|NCT04003142|536845627|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
148827290|NCT04003142|536845628|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
148827291|NCT04003142|536845629|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
148827292|NCT04003142|536845630|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
148827293|NCT04003142|536845626|FG000|Extension Period (40 Weeks)|Death|0|||
148827294|NCT04003142|536845627|FG001|Extension Period (40 Weeks)|Death|0|||
148827295|NCT04003142|536845628|FG002|Extension Period (40 Weeks)|Death|0|||
148827296|NCT04003142|536845629|FG003|Extension Period (40 Weeks)|Death|0|||
148827297|NCT04003142|536845630|FG004|Extension Period (40 Weeks)|Death|1|||
148827298|NCT04003142|536845626|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
148827299|NCT04003142|536845627|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
148827300|NCT04003142|536845628|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
148827301|NCT04003142|536845629|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
148827302|NCT04003142|536845630|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
148827303|NCT04003142|536845626|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
148827304|NCT04003142|536845627|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
148827305|NCT04003142|536845628|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
148978018|NCT01607905|537400773|FG004|Overall Study|Other|0|||
148978019|NCT01607905|537400774|FG005|Overall Study|Other|0|||
148978020|NCT01607905|537400775|FG006|Overall Study|Other|1|||
148765651|NCT03850483|536615526|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
148765652|NCT03850483|536615527|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
148765653|NCT03850483|536615528|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
148765654|NCT03850483|536615519|FG000|Follow-up For Stage 2|Other|0|||
148765655|NCT03850483|536615520|FG001|Follow-up For Stage 2|Other|0|||
148765656|NCT03850483|536615521|FG002|Follow-up For Stage 2|Other|0|||
148765657|NCT03850483|536615522|FG003|Follow-up For Stage 2|Other|0|||
148765658|NCT03850483|536615523|FG004|Follow-up For Stage 2|Other|0|||
148765659|NCT03850483|536615524|FG005|Follow-up For Stage 2|Other|0|||
148765660|NCT03850483|536615525|FG006|Follow-up For Stage 2|Other|0|||
148765661|NCT03850483|536615526|FG007|Follow-up For Stage 2|Other|0|||
148765662|NCT03850483|536615527|FG008|Follow-up For Stage 2|Other|0|||
148765663|NCT03850483|536615528|FG009|Follow-up For Stage 2|Other|1|||
148765664|NCT00302328|536617385|FG000|Overall Study|Physician Decision|0|||
148765665|NCT00302328|536617386|FG001|Overall Study|Physician Decision|1|||
148765666|NCT00302328|536617387|FG002|Overall Study|Physician Decision|0|||
148765667|NCT01288937|536617388|FG000|Overall Study|Adverse Event|1|||
148765668|NCT01288937|536617389|FG001|Overall Study|Adverse Event|0|||
148765669|NCT00912743|536617394|FG000|Overall Study|Adverse Event|3|||
148765670|NCT00912743|536617395|FG001|Overall Study|Adverse Event|1|||
148765671|NCT00912743|536617394|FG000|Overall Study|Lack of Efficacy|9|||
148765672|NCT00912743|536617395|FG001|Overall Study|Lack of Efficacy|18|||
148765673|NCT00912743|536617394|FG000|Overall Study|Toxicity|0|||
148765674|NCT00912743|536617395|FG001|Overall Study|Toxicity|1|||
148765675|NCT00912743|536617394|FG000|Overall Study|End of treatment form was not collected|1|||
148765676|NCT00912743|536617395|FG001|Overall Study|End of treatment form was not collected|0|||
148765677|NCT04157296|536617396|FG000|Overall Study|Withdrawal by Subject|0|||
148765678|NCT04157296|536617397|FG001|Overall Study|Withdrawal by Subject|1|||
148765679|NCT04157296|536617396|FG000|Overall Study|Did not obtain second fMRI.|0|||
148765680|NCT04157296|536617397|FG001|Overall Study|Did not obtain second fMRI.|1|||
148765681|NCT04157296|536617396|FG000|Overall Study|MRI failed/no second fMRI|0|||
148765682|NCT04157296|536617397|FG001|Overall Study|MRI failed/no second fMRI|1|||
148765683|NCT02237196|536617398|FG000|Overall Study|Adverse Event|0|||
148765684|NCT02237196|536617399|FG001|Overall Study|Adverse Event|1|||
148765685|NCT02237196|536617400|FG002|Overall Study|Adverse Event|1|||
148765686|NCT02237196|536617401|FG003|Overall Study|Adverse Event|0|||
148765687|NCT02237196|536617398|FG000|Overall Study|Lost to Follow-up|4|||
148765688|NCT02237196|536617399|FG001|Overall Study|Lost to Follow-up|2|||
148765689|NCT02237196|536617400|FG002|Overall Study|Lost to Follow-up|4|||
148765690|NCT02237196|536617401|FG003|Overall Study|Lost to Follow-up|6|||
148765691|NCT02237196|536617398|FG000|Overall Study|Physician Decision|2|||
148765692|NCT02237196|536617399|FG001|Overall Study|Physician Decision|0|||
148765693|NCT02237196|536617400|FG002|Overall Study|Physician Decision|0|||
148765694|NCT02237196|536617401|FG003|Overall Study|Physician Decision|1|||
148765695|NCT02237196|536617398|FG000|Overall Study|Pregnancy|0|||
148765696|NCT02237196|536617399|FG001|Overall Study|Pregnancy|0|||
148765697|NCT02237196|536617400|FG002|Overall Study|Pregnancy|1|||
148765698|NCT02237196|536617401|FG003|Overall Study|Pregnancy|1|||
148765699|NCT02237196|536617398|FG000|Overall Study|Withdrawal by Subject|1|||
148765700|NCT02237196|536617399|FG001|Overall Study|Withdrawal by Subject|1|||
148765701|NCT02237196|536617400|FG002|Overall Study|Withdrawal by Subject|4|||
148765702|NCT02237196|536617401|FG003|Overall Study|Withdrawal by Subject|1|||
148765703|NCT02237196|536617398|FG000|Overall Study|Site Error|1|||
148765704|NCT02237196|536617399|FG001|Overall Study|Site Error|2|||
148765705|NCT02237196|536617400|FG002|Overall Study|Site Error|0|||
148765706|NCT02237196|536617401|FG003|Overall Study|Site Error|2|||
148765707|NCT00862823|536617402|FG000|First Intervention|Withdrawal by Subject|1|||
148765708|NCT00862823|536617403|FG001|First Intervention|Withdrawal by Subject|1|||
148765709|NCT00619892|536617404|FG000|Overall Study|Adverse Event|3|||
148765710|NCT00619892|536617405|FG001|Overall Study|Adverse Event|0|||
148765711|NCT00619892|536617404|FG000|Overall Study|Lost to Follow-up|0|||
148765712|NCT00619892|536617405|FG001|Overall Study|Lost to Follow-up|1|||
148765713|NCT00619892|536617404|FG000|Overall Study|Intercurrent illness|0|||
148765714|NCT00619892|536617405|FG001|Overall Study|Intercurrent illness|1|||
148765715|NCT00857896|536617409|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
148765716|NCT02714595|536617410|FG000|Overall Study|Lost to Follow-up|1|||
148765717|NCT02714595|536617411|FG001|Overall Study|Lost to Follow-up|0|||
148765718|NCT02714595|536617410|FG000|Overall Study|Withdrawal by Subject|1|||
148765719|NCT02714595|536617411|FG001|Overall Study|Withdrawal by Subject|2|||
148765720|NCT02714595|536617410|FG000|Overall Study|Lack of Efficacy|0|||
148765721|NCT02714595|536617411|FG001|Overall Study|Lack of Efficacy|1|||
148765722|NCT02714595|536617410|FG000|Overall Study|Death|30|||
148765723|NCT02714595|536617411|FG001|Overall Study|Death|9|||
148765724|NCT02714595|536617410|FG000|Overall Study|Other-Miscellaneous|0|||
148765725|NCT02714595|536617411|FG001|Overall Study|Other-Miscellaneous|1|||
148765726|NCT02257489|536617412|FG000|Overall Study|Withdrawal by Subject|0|||
148765727|NCT02257489|536617413|FG001|Overall Study|Withdrawal by Subject|0|||
148765728|NCT02257489|536617414|FG002|Overall Study|Withdrawal by Subject|0|||
148827306|NCT04003142|536845629|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
148827307|NCT04003142|536845630|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
148827308|NCT04003142|536845626|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
148827309|NCT04003142|536845627|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
148827310|NCT04003142|536845628|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
148827311|NCT04003142|536845629|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
148827312|NCT04003142|536845630|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
148827313|NCT04003142|536845626|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
148827314|NCT04003142|536845627|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
148827315|NCT04003142|536845628|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
148827316|NCT04003142|536845629|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
148827317|NCT04003142|536845630|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
148827318|NCT04755231|536845638|FG000|Overall Study|Lost to Follow-up|5|||
148827319|NCT04755231|536845638|FG000|Overall Study|Withdrawal by Subject|5|||
148827320|NCT04754399|536845639|FG000|Overall Study|Adverse Event|5|||
148827321|NCT04754399|536845639|FG000|Overall Study|Withdrawal by Subject|6|||
148827322|NCT00025233|536845642|FG000|Overall Study|Ineligible: wrong cell type|1|||
148827323|NCT00025233|536845642|FG000|Overall Study|Ineligible: wrong primary|1|||
148827324|NCT00025233|536845642|FG000|Overall Study|Ineligible: improper prior treatment|1|||
148827325|NCT00025233|536845642|FG000|Overall Study|Never treated|1|||
148827326|NCT01720602|536845643|FG000|Overall Study|Adverse Event|3|||
148827327|NCT01720602|536845643|FG000|Overall Study|Progressive disease on therapy|2|||
148827328|NCT00507507|536845646|FG000|Treatment Period|Lost to Follow-up|0|||
148827329|NCT00507507|536845647|FG001|Treatment Period|Lost to Follow-up|2|||
148827330|NCT00507507|536845646|FG000|Treatment Period|Physician Decision|4|||
148827331|NCT00507507|536845647|FG001|Treatment Period|Physician Decision|1|||
148827332|NCT00507507|536845646|FG000|Treatment Period|Protocol Violation|1|||
148827333|NCT00507507|536845647|FG001|Treatment Period|Protocol Violation|2|||
148827334|NCT00507507|536845646|FG000|Treatment Period|Adverse Event|1|||
148827335|NCT00507507|536845647|FG001|Treatment Period|Adverse Event|1|||
148827336|NCT00507507|536845646|FG000|Treatment Period|Withdrawal by Subject|46|||
148827337|NCT00507507|536845647|FG001|Treatment Period|Withdrawal by Subject|47|||
148827338|NCT00507507|536845646|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
148827339|NCT00507507|536845647|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
148827340|NCT00507507|536845646|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
148827341|NCT00507507|536845647|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
148827342|NCT00507507|536845646|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
148827343|NCT00507507|536845647|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
148827344|NCT02916433|536845648|FG000|Overall Study|Withdrawal by Subject|1|||
148827345|NCT02916433|536845649|FG001|Overall Study|Withdrawal by Subject|0|||
148827346|NCT02916433|536845648|FG000|Overall Study|Physician Decision|1|||
148827347|NCT02916433|536845649|FG001|Overall Study|Physician Decision|0|||
148827348|NCT01694771|536845651|FG000|Overall Study|Adverse Event|18|||
148827349|NCT01694771|536845652|FG001|Overall Study|Adverse Event|16|||
148827350|NCT01694771|536845651|FG000|Overall Study|Lack of Efficacy|1|||
148827351|NCT01694771|536845652|FG001|Overall Study|Lack of Efficacy|0|||
148827352|NCT01694771|536845651|FG000|Overall Study|Non compliance protocol|7|||
148827353|NCT01694771|536845652|FG001|Overall Study|Non compliance protocol|6|||
148827354|NCT01694771|536845651|FG000|Overall Study|Lost to Follow-up|2|||
148827355|NCT01694771|536845652|FG001|Overall Study|Lost to Follow-up|3|||
148827356|NCT01694771|536845651|FG000|Overall Study|Consent withdrawn|7|||
148827357|NCT01694771|536845652|FG001|Overall Study|Consent withdrawn|9|||
148827358|NCT01694771|536845651|FG000|Overall Study|Other reasons|5|||
148827359|NCT01694771|536845652|FG001|Overall Study|Other reasons|6|||
148827360|NCT03927846|536845658|FG000|Overall Study|Lost to Follow-up|10|||
148827361|NCT03927846|536845659|FG001|Overall Study|Lost to Follow-up|11|||
148827362|NCT03878069|536845660|FG000|Overall Study|Death|0|||
148827363|NCT03878069|536845661|FG001|Overall Study|Death|1|||
148827364|NCT03878069|536845662|FG002|Overall Study|Death|0|||
148827365|NCT00834587|536845663|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
148827366|NCT00834587|536845664|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
148827367|NCT00176254|536845665|FG000|Overall Study|Lost to Follow-up|1|||
148827368|NCT03289741|536845666|FG000|Overall Study|Adverse Event|1|||
148827369|NCT03289741|536845667|FG001|Overall Study|Adverse Event|1|||
148827370|NCT03289741|536845666|FG000|Overall Study|Physician Decision|2|||
148827371|NCT03289741|536845667|FG001|Overall Study|Physician Decision|2|||
148827372|NCT03289741|536845666|FG000|Overall Study|Withdrawal by Subject|1|||
148827373|NCT03289741|536845667|FG001|Overall Study|Withdrawal by Subject|0|||
148827374|NCT02536339|536845669|FG000|Overall Study|Death|20|||
148827375|NCT02536339|536845669|FG000|Overall Study|Withdrawal by Subject|3|||
148827376|NCT02536339|536845669|FG000|Overall Study|Lost to Follow-up|2|||
148827377|NCT02536339|536845669|FG000|Overall Study|Treatment discontinued|2|||
148827378|NCT02536339|536845669|FG000|Overall Study|Physician Decision|1|||
148827379|NCT04280783|536847047|FG000|Overall Study|Family issues unrelated to the study.|1|||
148827380|NCT04280783|536847048|FG001|Overall Study|Family issues unrelated to the study.|0|||
148827381|NCT04280783|536847047|FG000|Overall Study|Withdrawal by Subject|0|||
148978021|NCT01607905|537400769|FG000|Overall Study|Randomized but not treated|1|||
148978022|NCT01607905|537400770|FG001|Overall Study|Randomized but not treated|0|||
148978023|NCT01607905|537400771|FG002|Overall Study|Randomized but not treated|0|||
148978024|NCT01607905|537400772|FG003|Overall Study|Randomized but not treated|0|||
148978025|NCT01607905|537400773|FG004|Overall Study|Randomized but not treated|1|||
148765729|NCT02257489|536617415|FG003|Overall Study|Withdrawal by Subject|1|||
148765730|NCT02257489|536617416|FG004|Overall Study|Withdrawal by Subject|0|||
148765731|NCT02257489|536617417|FG005|Overall Study|Withdrawal by Subject|0|||
148765732|NCT02257489|536617418|FG006|Overall Study|Withdrawal by Subject|0|||
148765733|NCT02257489|536617419|FG007|Overall Study|Withdrawal by Subject|0|||
148765734|NCT02257489|536617420|FG008|Overall Study|Withdrawal by Subject|0|||
148765735|NCT04606394|536617421|FG000|Overall Study|Withdrawal by Subject|3|||
148765736|NCT04606394|536617421|FG000|Overall Study|Exclusion criteria screen failure|12|||
148765737|NCT00954941|536617422|FG000|Overall Study|Received treatment at home|1|||
148765738|NCT00954941|536617423|FG001|Overall Study|Received treatment at home|0|||
148765739|NCT00954941|536617422|FG000|Overall Study|Withdrawal by Subject|1|||
148765740|NCT00954941|536617423|FG001|Overall Study|Withdrawal by Subject|0|||
148765741|NCT00954941|536617422|FG000|Overall Study|Insurance Denial|2|||
148765742|NCT00954941|536617423|FG001|Overall Study|Insurance Denial|2|||
148765743|NCT00954941|536617422|FG000|Overall Study|Physician Decision|2|||
148765744|NCT00954941|536617423|FG001|Overall Study|Physician Decision|2|||
148765745|NCT00954941|536617422|FG000|Overall Study|Ineligible|2|||
148765746|NCT00954941|536617423|FG001|Overall Study|Ineligible|2|||
148765747|NCT00954941|536617422|FG000|Overall Study|Adverse Event|0|||
148765748|NCT00954941|536617423|FG001|Overall Study|Adverse Event|1|||
148765749|NCT01996254|536617425|FG000|Overall Study|Change in Eligibility|0|||
148765750|NCT01996254|536617426|FG001|Overall Study|Change in Eligibility|2|||
148765751|NCT01996254|536617427|FG002|Overall Study|Change in Eligibility|0|||
148765752|NCT01996254|536617425|FG000|Overall Study|Withdrawal by Subject|0|||
148765753|NCT01996254|536617426|FG001|Overall Study|Withdrawal by Subject|3|||
148765754|NCT01996254|536617427|FG002|Overall Study|Withdrawal by Subject|4|||
148765755|NCT01996254|536617425|FG000|Overall Study|Lost to Follow-up|1|||
148765756|NCT01996254|536617426|FG001|Overall Study|Lost to Follow-up|0|||
148765757|NCT01996254|536617427|FG002|Overall Study|Lost to Follow-up|4|||
148765758|NCT01053663|536617430|FG000|Overall Study|Death|2|||
148765759|NCT01053663|536617430|FG000|Overall Study|Lost to Follow-up|1|||
148765760|NCT01053663|536617430|FG000|Overall Study|Poor IV Access|1|||
148765761|NCT01053663|536617430|FG000|Overall Study|Transferred to Another Hospital|1|||
148765762|NCT01053663|536617430|FG000|Overall Study|Negative Influenza Diagnosis|1|||
148765763|NCT03533114|536617431|FG000|Overall|Adverse Event|16|||
148765764|NCT03533114|536617432|FG001|Overall|Adverse Event|11|||
148765765|NCT03533114|536617431|FG000|Overall|Consent Withdrawal by Participant|7|||
148765766|NCT03533114|536617432|FG001|Overall|Consent Withdrawal by Participant|6|||
148765767|NCT03533114|536617431|FG000|Overall|Lack of Efficacy|5|||
148765768|NCT03533114|536617432|FG001|Overall|Lack of Efficacy|3|||
148765769|NCT03533114|536617431|FG000|Overall|Lost to Follow-up|1|||
148765770|NCT03533114|536617432|FG001|Overall|Lost to Follow-up|1|||
148765771|NCT03533114|536617431|FG000|Overall|Physician Decision|0|||
148765772|NCT03533114|536617432|FG001|Overall|Physician Decision|2|||
148765773|NCT03533114|536617431|FG000|Overall|Protocol deviation|1|||
148765774|NCT03533114|536617432|FG001|Overall|Protocol deviation|1|||
148765775|NCT03533114|536617431|FG000|Overall|Failure to meet randomization criteria|1|||
148765776|NCT03533114|536617432|FG001|Overall|Failure to meet randomization criteria|2|||
148765777|NCT03533114|536617431|FG000|Overall|Non-Compliance with study drug|0|||
148765778|NCT03533114|536617432|FG001|Overall|Non-Compliance with study drug|1|||
148765779|NCT03533114|536617431|FG000|Overall|Other|0|||
148765780|NCT03533114|536617432|FG001|Overall|Other|1|||
148765781|NCT03533114|536617431|FG000|Open Label Titration and Optimization|Adverse Event|11|||
148765782|NCT03533114|536617432|FG001|Open Label Titration and Optimization|Adverse Event|8|||
148765783|NCT03533114|536617431|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
148765784|NCT03533114|536617432|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
148765785|NCT03533114|536617431|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
148765786|NCT03533114|536617432|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
148765787|NCT03533114|536617431|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
148765788|NCT03533114|536617432|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
148765789|NCT03533114|536617431|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
148765790|NCT03533114|536617432|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
148765791|NCT03533114|536617431|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
148765792|NCT03533114|536617432|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
148765793|NCT03533114|536617431|FG000|Stable Dose|Adverse Event|0|||
148765794|NCT03533114|536617432|FG001|Stable Dose|Adverse Event|2|||
148765795|NCT03533114|536617431|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
148978026|NCT01607905|537400774|FG005|Overall Study|Randomized but not treated|1|||
149027752|NCT03251378|537578643|FG005|Overall Study|Other|1|||
148765796|NCT03533114|536617432|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
148765797|NCT03533114|536617431|FG000|Stable Dose|Lack of Efficacy|1|||
148978027|NCT01607905|537400775|FG006|Overall Study|Randomized but not treated|0|||
148978028|NCT02602288|537400776|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
148978029|NCT02602288|537400777|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
148978030|NCT02602288|537400776|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
148978031|NCT02602288|537400777|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
148978032|NCT02602288|537400776|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
148978033|NCT02602288|537400777|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
148978034|NCT02602288|537400776|FG000|12 Month Follow-up|Lost to Follow-up|0|||
148978035|NCT02602288|537400777|FG001|12 Month Follow-up|Lost to Follow-up|4|||
149027753|NCT03251378|537578644|FG006|Overall Study|Other|1|||
149027754|NCT03251378|537578638|FG000|Overall Study|Other|0|||
148765798|NCT03533114|536617432|FG001|Stable Dose|Lack of Efficacy|0|||
148765799|NCT03533114|536617431|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
148765800|NCT03533114|536617432|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
148765801|NCT03533114|536617431|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
148765802|NCT03533114|536617432|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
148765803|NCT03533114|536617431|FG000|Open-Label Safety Extension|Adverse Event|3|||
148765804|NCT03533114|536617432|FG001|Open-Label Safety Extension|Adverse Event|0|||
148765805|NCT03533114|536617431|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
148765806|NCT03533114|536617432|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
148765807|NCT03533114|536617431|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
148765808|NCT03533114|536617432|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
148765809|NCT03533114|536617431|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
148765810|NCT03533114|536617432|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
148765811|NCT03533114|536617431|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
148765812|NCT03533114|536617432|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
148765813|NCT02411396|536617436|FG000|Overall Study|Lost to Follow-up|31|||
148765814|NCT02411396|536617436|FG000|Overall Study|Death|10|||
148765815|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
148765816|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
148765817|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
148765818|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
148765819|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
148765820|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
148765821|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
148765822|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
148765823|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
148765824|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
148765825|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
148765826|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
148765827|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
148765828|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
148765829|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
148765830|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
148765831|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
148765832|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
148765833|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
148765834|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
148765835|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
148765836|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
148765837|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
148765838|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
148765839|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
148765840|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
148765841|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
148765842|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
148765843|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
148765844|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
148765845|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
148765846|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
148765847|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
148765848|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
148765849|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
148765850|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
148765851|NCT02016105|536617443|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
148765852|NCT02016105|536617444|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
148765853|NCT02016105|536617445|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
148765854|NCT02016105|536617446|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
148765855|NCT02016105|536617447|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
148765856|NCT02016105|536617448|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
148765857|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
148765858|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
148765859|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
149027755|NCT03251378|537578639|FG001|Overall Study|Other|0|||
148827382|NCT04280783|536847048|FG001|Overall Study|Withdrawal by Subject|1|||
148827383|NCT02904265|536847049|FG000|Overall Study|Physician Decision|1|||
148827384|NCT02904265|536847050|FG001|Overall Study|Physician Decision|2|||
148827385|NCT00185614|536847051|FG000|Inter-treatment Period|Physician Decision|1|||
148827386|NCT00185614|536847051|FG000|Inter-treatment Period|Relapse|2|||
148827387|NCT00185614|536847051|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
148827388|NCT00003907|536847058|FG000|Overall Study|Adverse Event|2|||
148827389|NCT00003907|536847059|FG001|Overall Study|Adverse Event|11|||
148827390|NCT00003907|536847058|FG000|Overall Study|Death|2|||
148827391|NCT00003907|536847059|FG001|Overall Study|Death|0|||
148827392|NCT00003907|536847058|FG000|Overall Study|Withdrawal by Subject|1|||
148827393|NCT00003907|536847059|FG001|Overall Study|Withdrawal by Subject|3|||
148827394|NCT00003907|536847058|FG000|Overall Study|Progressive disease|4|||
148978036|NCT02602288|537400776|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
148978037|NCT02602288|537400777|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
148978038|NCT00941733|537400778|FG000|Overall Study|Death|24|||
148978039|NCT00941733|537400779|FG001|Overall Study|Death|10|||
148978040|NCT00941733|537400778|FG000|Overall Study|Withdrawal by Subject|14|||
148978041|NCT00941733|537400779|FG001|Overall Study|Withdrawal by Subject|6|||
148827395|NCT00003907|536847059|FG001|Overall Study|Progressive disease|4|||
148827396|NCT00003907|536847058|FG000|Overall Study|Complicating disease|1|||
148827397|NCT00003907|536847059|FG001|Overall Study|Complicating disease|0|||
148827398|NCT00003907|536847058|FG000|Overall Study|Other|1|||
148827399|NCT00003907|536847059|FG001|Overall Study|Other|3|||
148827400|NCT00003907|536847058|FG000|Overall Study|ineligible or not treated|2|||
148827401|NCT00003907|536847059|FG001|Overall Study|ineligible or not treated|2|||
148827402|NCT01557569|536847060|FG000|Overall Study|Adverse Event|2|||
148827403|NCT01557569|536847061|FG001|Overall Study|Adverse Event|0|||
148827404|NCT01557569|536847060|FG000|Overall Study|high blood pressure|0|||
148827405|NCT01557569|536847061|FG001|Overall Study|high blood pressure|1|||
148827406|NCT01557569|536847060|FG000|Overall Study|Withdrawal by Subject|3|||
148827407|NCT01557569|536847061|FG001|Overall Study|Withdrawal by Subject|5|||
148827408|NCT01557569|536847060|FG000|Overall Study|noncompliance with rules of residential|0|||
148827409|NCT01557569|536847061|FG001|Overall Study|noncompliance with rules of residential|1|||
148827410|NCT02254460|536847062|FG000|Overall Study|Adverse Event|1|||
148827411|NCT02254460|536847063|FG001|Overall Study|Adverse Event|0|||
148827412|NCT00993473|536847064|FG000|Overall Study|Adverse Event|0|||
148827413|NCT00993473|536847065|FG001|Overall Study|Adverse Event|2|||
148827414|NCT00993473|536847064|FG000|Overall Study|Protocol Violation|1|||
148827415|NCT00993473|536847065|FG001|Overall Study|Protocol Violation|2|||
148827416|NCT00993473|536847064|FG000|Overall Study|Lost to Follow-up|1|||
148827417|NCT00993473|536847065|FG001|Overall Study|Lost to Follow-up|0|||
148827418|NCT00993473|536847064|FG000|Overall Study|Withdrawal by Subject|1|||
148827419|NCT00993473|536847065|FG001|Overall Study|Withdrawal by Subject|5|||
148827420|NCT00993473|536847064|FG000|Overall Study|Technical problem with CGM device|0|||
148827421|NCT00993473|536847065|FG001|Overall Study|Technical problem with CGM device|1|||
148827422|NCT00993473|536847064|FG000|Overall Study|Family event|1|||
148827423|NCT00993473|536847065|FG001|Overall Study|Family event|0|||
148827424|NCT00770679|536847074|FG000|Overall Study|Lost to Follow-up|3|||
148827425|NCT00770679|536847074|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
148827426|NCT01475825|536847080|FG000|Overall Study|Adverse Event|41|||
148827427|NCT01475825|536847081|FG001|Overall Study|Adverse Event|15|||
148827428|NCT01475825|536847082|FG002|Overall Study|Adverse Event|27|||
148827429|NCT01475825|536847083|FG003|Overall Study|Adverse Event|11|||
148827430|NCT01475825|536847080|FG000|Overall Study|Death|1|||
148827431|NCT01475825|536847081|FG001|Overall Study|Death|0|||
148827432|NCT01475825|536847082|FG002|Overall Study|Death|1|||
148827433|NCT01475825|536847083|FG003|Overall Study|Death|0|||
148827434|NCT01475825|536847080|FG000|Overall Study|Lack of Efficacy|0|||
148827435|NCT01475825|536847081|FG001|Overall Study|Lack of Efficacy|0|||
148827436|NCT01475825|536847082|FG002|Overall Study|Lack of Efficacy|1|||
148827437|NCT01475825|536847083|FG003|Overall Study|Lack of Efficacy|0|||
148827438|NCT01475825|536847080|FG000|Overall Study|Lost to Follow-up|0|||
148827439|NCT01475825|536847081|FG001|Overall Study|Lost to Follow-up|0|||
148827440|NCT01475825|536847082|FG002|Overall Study|Lost to Follow-up|3|||
148827441|NCT01475825|536847083|FG003|Overall Study|Lost to Follow-up|1|||
148827442|NCT01475825|536847080|FG000|Overall Study|Non-compliance with Study Drug|1|||
148827443|NCT01475825|536847081|FG001|Overall Study|Non-compliance with Study Drug|2|||
148978042|NCT00941733|537400778|FG000|Overall Study|Adverse Event|20|||
148827444|NCT01475825|536847082|FG002|Overall Study|Non-compliance with Study Drug|4|||
148827445|NCT01475825|536847083|FG003|Overall Study|Non-compliance with Study Drug|0|||
148827446|NCT01475825|536847080|FG000|Overall Study|Other: Not available|0|||
148827447|NCT01475825|536847081|FG001|Overall Study|Other: Not available|0|||
148827448|NCT01475825|536847082|FG002|Overall Study|Other: Not available|2|||
148827449|NCT01475825|536847083|FG003|Overall Study|Other: Not available|0|||
148978043|NCT00941733|537400779|FG001|Overall Study|Adverse Event|4|||
148978044|NCT00941733|537400778|FG000|Overall Study|Lost to Follow-up|1|||
148978045|NCT00941733|537400779|FG001|Overall Study|Lost to Follow-up|2|||
148827450|NCT01475825|536847080|FG000|Overall Study|Protocol Violation|1|||
148827451|NCT01475825|536847081|FG001|Overall Study|Protocol Violation|0|||
148827452|NCT01475825|536847082|FG002|Overall Study|Protocol Violation|0|||
148827453|NCT01475825|536847083|FG003|Overall Study|Protocol Violation|0|||
148827454|NCT01475825|536847080|FG000|Overall Study|Physician Decision|0|||
148827455|NCT01475825|536847081|FG001|Overall Study|Physician Decision|1|||
148827456|NCT01475825|536847082|FG002|Overall Study|Physician Decision|0|||
148827457|NCT01475825|536847083|FG003|Overall Study|Physician Decision|0|||
148827458|NCT01475825|536847080|FG000|Overall Study|Withdrawal by Subject|8|||
148827459|NCT01475825|536847081|FG001|Overall Study|Withdrawal by Subject|3|||
148827460|NCT01475825|536847082|FG002|Overall Study|Withdrawal by Subject|11|||
148827461|NCT01475825|536847083|FG003|Overall Study|Withdrawal by Subject|7|||
148827462|NCT01475825|536847080|FG000|Overall Study|Did not enter OLC|15|||
148827463|NCT01475825|536847081|FG001|Overall Study|Did not enter OLC|11|||
148978046|NCT00941733|537400778|FG000|Overall Study|Protocol Violation|15|||
148978047|NCT00941733|537400779|FG001|Overall Study|Protocol Violation|6|||
148978048|NCT00194012|537400780|FG000|Randomized Phase|Lack of Efficacy|8|||
148978049|NCT00194012|537400781|FG001|Randomized Phase|Lack of Efficacy|18|||
148978050|NCT00194012|537400780|FG000|Randomized Phase|Study nonadherence|2|||
148978051|NCT00194012|537400781|FG001|Randomized Phase|Study nonadherence|1|||
148978052|NCT00194012|537400780|FG000|Randomized Phase|Withdrawal by Subject|3|||
148827464|NCT01475825|536847082|FG002|Overall Study|Did not enter OLC|15|||
148827465|NCT01475825|536847083|FG003|Overall Study|Did not enter OLC|11|||
148827466|NCT04157738|536847084|FG000|Overall Study|Moved out of state|0|||
148827467|NCT04157738|536847085|FG001|Overall Study|Moved out of state|2|||
148827468|NCT04157738|536847084|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
148827469|NCT04157738|536847085|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
148827470|NCT00160563|536847086|FG000|Overall Study|Adverse Event|1|||
148827471|NCT00160563|536847087|FG001|Overall Study|Adverse Event|1|||
148827472|NCT00160563|536847088|FG002|Overall Study|Adverse Event|1|||
148827473|NCT00160563|536847086|FG000|Overall Study|Lost to Follow-up|1|||
148827474|NCT00160563|536847087|FG001|Overall Study|Lost to Follow-up|1|||
148827475|NCT00160563|536847088|FG002|Overall Study|Lost to Follow-up|2|||
148827476|NCT00160563|536847086|FG000|Overall Study|Protocol Violation|0|||
148827477|NCT00160563|536847087|FG001|Overall Study|Protocol Violation|0|||
148827478|NCT00160563|536847088|FG002|Overall Study|Protocol Violation|3|||
148827479|NCT00160563|536847086|FG000|Overall Study|Withdrawal by Subject|1|||
148827480|NCT00160563|536847087|FG001|Overall Study|Withdrawal by Subject|2|||
148827481|NCT00160563|536847088|FG002|Overall Study|Withdrawal by Subject|3|||
148827482|NCT00160563|536847086|FG000|Overall Study|Other (listed in the study report)|48|||
148827483|NCT00160563|536847087|FG001|Overall Study|Other (listed in the study report)|40|||
148827484|NCT00160563|536847088|FG002|Overall Study|Other (listed in the study report)|81|||
148827485|NCT00160563|536847086|FG000|Overall Study|Missing reason|0|||
148827486|NCT00160563|536847087|FG001|Overall Study|Missing reason|1|||
148827487|NCT00160563|536847088|FG002|Overall Study|Missing reason|0|||
148827488|NCT00752219|536847089|FG000|Overall Study|Clinical failure|0|||
148827489|NCT00752219|536847090|FG001|Overall Study|Clinical failure|1|||
148827490|NCT00752219|536847089|FG000|Overall Study|Adverse Event|5|||
148827491|NCT00752219|536847090|FG001|Overall Study|Adverse Event|3|||
148827492|NCT00752219|536847089|FG000|Overall Study|Protocol deviation|1|||
148827493|NCT00752219|536847090|FG001|Overall Study|Protocol deviation|0|||
148827494|NCT00752219|536847089|FG000|Overall Study|Lost to Follow-up|1|||
148827495|NCT00752219|536847090|FG001|Overall Study|Lost to Follow-up|2|||
148827496|NCT00752219|536847089|FG000|Overall Study|Randomized but not treated|1|||
148827497|NCT00752219|536847090|FG001|Overall Study|Randomized but not treated|0|||
148827498|NCT00752219|536847089|FG000|Overall Study|Other|3|||
148827499|NCT00752219|536847090|FG001|Overall Study|Other|0|||
148827500|NCT04691115|536847093|FG000|Overall Study|Withdrawal by Subject|0|||
148827501|NCT04691115|536847094|FG001|Overall Study|Withdrawal by Subject|0|||
148827502|NCT04691115|536847095|FG002|Overall Study|Withdrawal by Subject|0|||
148827503|NCT04691115|536847096|FG003|Overall Study|Withdrawal by Subject|0|||
148827504|NCT04691115|536847097|FG004|Overall Study|Withdrawal by Subject|0|||
148827505|NCT04691115|536847098|FG005|Overall Study|Withdrawal by Subject|1|||
148978053|NCT00194012|537400781|FG001|Randomized Phase|Withdrawal by Subject|3|||
148978054|NCT00194012|537400780|FG000|Randomized Phase|Adverse Event|2|||
148978055|NCT00194012|537400781|FG001|Randomized Phase|Adverse Event|1|||
148978056|NCT00194012|537400780|FG000|Randomized Phase|Participant reported having a rash|1|||
148827506|NCT04691115|536847099|FG006|Overall Study|Withdrawal by Subject|0|||
148827507|NCT04691115|536847100|FG007|Overall Study|Withdrawal by Subject|0|||
148827508|NCT04691115|536847101|FG008|Overall Study|Withdrawal by Subject|0|||
148827509|NCT04691115|536847102|FG009|Overall Study|Withdrawal by Subject|0|||
148827510|NCT04691115|536847103|FG010|Overall Study|Withdrawal by Subject|0|||
148827511|NCT04691115|536847104|FG011|Overall Study|Withdrawal by Subject|0|||
148827512|NCT04691115|536847105|FG012|Overall Study|Withdrawal by Subject|0|||
148827513|NCT04691115|536847106|FG013|Overall Study|Withdrawal by Subject|0|||
148827514|NCT00867334|536847112|FG000|Overall Study|Withdrawal by Subject|0|||
148978057|NCT00194012|537400781|FG001|Randomized Phase|Participant reported having a rash|0|||
149027756|NCT03251378|537578640|FG002|Overall Study|Other|0|||
148765860|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
148765861|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
148765862|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
148765863|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
148765864|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
148765865|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
148765866|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
148765867|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
148765868|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
148765869|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
148765870|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
148765871|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
148765872|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
148765873|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
148765874|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
148765875|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Death|0|||
148765876|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Death|0|||
148765877|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Death|0|||
148765878|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Death|0|||
148765879|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Death|0|||
148765880|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Death|1|||
148765881|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
148765882|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
148765883|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
148765884|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
148765885|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
148765886|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
148765887|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
148765888|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
148765889|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
148765890|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
148765891|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
148765892|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
148765893|NCT02016105|536617443|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
148765894|NCT02016105|536617444|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
148765895|NCT02016105|536617445|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
148765896|NCT02016105|536617446|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
148765897|NCT02016105|536617447|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
148765898|NCT02016105|536617448|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
148765899|NCT02016105|536617443|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
148765900|NCT02016105|536617444|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
148765901|NCT02016105|536617445|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
148765902|NCT02016105|536617446|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
148765903|NCT02016105|536617447|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
148765904|NCT02016105|536617448|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
148765905|NCT02016105|536617443|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
148765906|NCT02016105|536617444|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
148765907|NCT02016105|536617445|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
148765908|NCT02016105|536617446|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
148765909|NCT02016105|536617447|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
148765910|NCT02016105|536617448|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
148765911|NCT02016105|536617443|FG000|EXTENSION PERIOD|Adverse Event|0|||
148765912|NCT02016105|536617444|FG001|EXTENSION PERIOD|Adverse Event|0|||
148765913|NCT02016105|536617445|FG002|EXTENSION PERIOD|Adverse Event|2|||
148765914|NCT02016105|536617446|FG003|EXTENSION PERIOD|Adverse Event|0|||
148765915|NCT02016105|536617447|FG004|EXTENSION PERIOD|Adverse Event|1|||
148765916|NCT02016105|536617448|FG005|EXTENSION PERIOD|Adverse Event|0|||
148765917|NCT02016105|536617443|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
148765918|NCT02016105|536617444|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
148765919|NCT02016105|536617445|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
148765920|NCT02016105|536617446|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
148765921|NCT02016105|536617447|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
148765922|NCT02016105|536617448|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
148765923|NCT02016105|536617443|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
148765924|NCT02016105|536617444|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
148765925|NCT02016105|536617445|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
148765926|NCT02016105|536617446|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
148765927|NCT02016105|536617447|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
148765928|NCT02016105|536617448|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
148765929|NCT02016105|536617443|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
148765930|NCT02016105|536617444|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
148765931|NCT02016105|536617445|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
148765932|NCT02016105|536617446|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
148765933|NCT02016105|536617447|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
148765934|NCT02016105|536617448|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
148765935|NCT00090493|536617449|FG000|Overall Study|Physician Decision|2|||
148827515|NCT00867334|536847113|FG001|Overall Study|Withdrawal by Subject|1|||
148827516|NCT00867334|536847112|FG000|Overall Study|Withdrawal by Subject|1|||
148827517|NCT00867334|536847113|FG001|Overall Study|Withdrawal by Subject|0|||
148827518|NCT00867334|536847112|FG000|Overall Study|Withdrawal by Subject|1|||
148827519|NCT00867334|536847113|FG001|Overall Study|Withdrawal by Subject|0|||
148827520|NCT01047540|536847116|FG000|Overall Study|Protocol Violation|1|||
148827521|NCT01047540|536847117|FG001|Overall Study|Protocol Violation|0|||
148827522|NCT01047540|536847118|FG002|Overall Study|Protocol Violation|0|||
148827523|NCT01047540|536847119|FG003|Overall Study|Protocol Violation|0|||
148827524|NCT01047540|536847120|FG004|Overall Study|Protocol Violation|0|||
148827525|NCT01047540|536847116|FG000|Overall Study|Lost to Follow-up|1|||
148827526|NCT01047540|536847117|FG001|Overall Study|Lost to Follow-up|0|||
148827527|NCT01047540|536847118|FG002|Overall Study|Lost to Follow-up|0|||
148827528|NCT01047540|536847119|FG003|Overall Study|Lost to Follow-up|0|||
148827529|NCT01047540|536847120|FG004|Overall Study|Lost to Follow-up|0|||
148827530|NCT01047540|536847116|FG000|Overall Study|Withdrawal by Subject|1|||
148827531|NCT01047540|536847117|FG001|Overall Study|Withdrawal by Subject|0|||
148827532|NCT01047540|536847118|FG002|Overall Study|Withdrawal by Subject|3|||
148827533|NCT01047540|536847119|FG003|Overall Study|Withdrawal by Subject|0|||
148827534|NCT01047540|536847120|FG004|Overall Study|Withdrawal by Subject|1|||
148827535|NCT01047540|536847116|FG000|Overall Study|Pregnancy|1|||
148827536|NCT01047540|536847117|FG001|Overall Study|Pregnancy|0|||
148827537|NCT01047540|536847118|FG002|Overall Study|Pregnancy|0|||
148827538|NCT01047540|536847119|FG003|Overall Study|Pregnancy|0|||
148827539|NCT01047540|536847120|FG004|Overall Study|Pregnancy|0|||
148827540|NCT01047540|536847116|FG000|Overall Study|Adverse Event|1|||
148827541|NCT01047540|536847117|FG001|Overall Study|Adverse Event|0|||
148827542|NCT01047540|536847118|FG002|Overall Study|Adverse Event|0|||
148827543|NCT01047540|536847119|FG003|Overall Study|Adverse Event|0|||
148827544|NCT01047540|536847120|FG004|Overall Study|Adverse Event|0|||
148827545|NCT00595075|536847122|FG000|Overall Study|Withdrawal by Subject|1|||
148827546|NCT00595075|536847123|FG001|Overall Study|Withdrawal by Subject|0|||
148827547|NCT00456365|536847134|FG000|Overall Study|Lost to Follow-up|1|||
148827548|NCT00456365|536847135|FG001|Overall Study|Lost to Follow-up|3|||
148827549|NCT00456365|536847134|FG000|Overall Study|Withdrawal by Subject|4|||
148827550|NCT00456365|536847135|FG001|Overall Study|Withdrawal by Subject|7|||
148827551|NCT00456365|536847134|FG000|Overall Study|Pregnancy|1|||
148827552|NCT00456365|536847135|FG001|Overall Study|Pregnancy|1|||
148827553|NCT00456365|536847134|FG000|Overall Study|oncologic diagnosis|1|||
148827554|NCT00456365|536847135|FG001|Overall Study|oncologic diagnosis|1|||
148827555|NCT03579719|536847137|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
148827556|NCT00069953|536847138|FG000|Overall Study|Protocol Violation|2|||
148827557|NCT01646216|536847139|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
148827558|NCT01646216|536847140|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
148827559|NCT01646216|536847139|FG000|Overall Study|Did not complete training|0|||
148827560|NCT01646216|536847140|FG001|Overall Study|Did not complete training|2|||
148827561|NCT01646216|536847139|FG000|Overall Study|Investigator decision|1|||
148827562|NCT01646216|536847140|FG001|Overall Study|Investigator decision|1|||
148827563|NCT00113373|536847141|FG000|Overall Study|Ineligible: wrong primary|1|||
148827564|NCT00113373|536847141|FG000|Overall Study|Ineligible: second primary|1|||
148827565|NCT00113373|536847141|FG000|Overall Study|Never Treated|1|||
148827566|NCT02395627|536847142|FG000|Overall Study|Withdrawal by Subject|0|||
148827567|NCT02395627|536847143|FG001|Overall Study|Withdrawal by Subject|2|||
148827568|NCT02395627|536847144|FG002|Overall Study|Withdrawal by Subject|0|||
148827569|NCT02395627|536847142|FG000|Overall Study|Did not receive pembrolizumab|3|||
148827570|NCT02395627|536847143|FG001|Overall Study|Did not receive pembrolizumab|1|||
148827571|NCT02395627|536847144|FG002|Overall Study|Did not receive pembrolizumab|0|||
148827572|NCT01681849|536847151|FG000|Overall Study|Protocol Violation|2|||
148827573|NCT01681849|536847152|FG001|Overall Study|Protocol Violation|0|||
148827574|NCT01681849|536847153|FG002|Overall Study|Protocol Violation|0|||
148827575|NCT01681849|536847151|FG000|Overall Study|Withdrawal by Subject|3|||
148827576|NCT01681849|536847152|FG001|Overall Study|Withdrawal by Subject|5|||
149027757|NCT03251378|537578641|FG003|Overall Study|Other|4|||
148827577|NCT01681849|536847153|FG002|Overall Study|Withdrawal by Subject|33|||
148827578|NCT01681849|536847151|FG000|Overall Study|Lost to Follow-up|3|||
148827579|NCT01681849|536847152|FG001|Overall Study|Lost to Follow-up|2|||
148827580|NCT01681849|536847153|FG002|Overall Study|Lost to Follow-up|6|||
148827581|NCT04525183|536847156|FG000|Overall Study|Withdrawal by Subject|0|||
148827582|NCT04525183|536847157|FG001|Overall Study|Withdrawal by Subject|0|||
148827583|NCT04525183|536847158|FG002|Overall Study|Withdrawal by Subject|3|||
148827584|NCT04525183|536847156|FG000|Overall Study|Study non-compliance|0|||
148827585|NCT04525183|536847157|FG001|Overall Study|Study non-compliance|0|||
148827586|NCT04525183|536847158|FG002|Overall Study|Study non-compliance|1|||
148827587|NCT04525183|536847156|FG000|Overall Study|Recurrent disease before starting on study|0|||
148827588|NCT04525183|536847157|FG001|Overall Study|Recurrent disease before starting on study|0|||
148827589|NCT04525183|536847158|FG002|Overall Study|Recurrent disease before starting on study|1|||
148827590|NCT00979407|536847159|FG000|Overall Study|Withdrawal by Subject|3|||
148827591|NCT00979407|536847160|FG001|Overall Study|Withdrawal by Subject|4|||
148827592|NCT00979407|536847159|FG000|Overall Study|Lost to Follow-up|3|||
148827593|NCT00979407|536847160|FG001|Overall Study|Lost to Follow-up|3|||
148827594|NCT01166646|536847161|FG000|Overall Study|Protocol Violation|0|||
148827595|NCT01166646|536847162|FG001|Overall Study|Protocol Violation|1|||
148827596|NCT01166646|536847161|FG000|Overall Study|Adverse Event|1|||
148827597|NCT01166646|536847162|FG001|Overall Study|Adverse Event|0|||
148827598|NCT01335685|536847165|FG000|Overall Study|Study Terminated by Sponsor|2|||
148827599|NCT01335685|536847166|FG001|Overall Study|Study Terminated by Sponsor|1|||
148827600|NCT01335685|536847167|FG002|Overall Study|Study Terminated by Sponsor|1|||
148827601|NCT01335685|536847168|FG003|Overall Study|Study Terminated by Sponsor|10|||
148827602|NCT01335685|536847169|FG004|Overall Study|Study Terminated by Sponsor|0|||
148827603|NCT01335685|536847170|FG005|Overall Study|Study Terminated by Sponsor|4|||
148827604|NCT01335685|536847171|FG006|Overall Study|Study Terminated by Sponsor|2|||
148827605|NCT01335685|536847172|FG007|Overall Study|Study Terminated by Sponsor|3|||
148827606|NCT01335685|536847165|FG000|Overall Study|Withdrawal by Subject|1|||
148827607|NCT01335685|536847166|FG001|Overall Study|Withdrawal by Subject|0|||
148827608|NCT01335685|536847167|FG002|Overall Study|Withdrawal by Subject|0|||
148827609|NCT01335685|536847168|FG003|Overall Study|Withdrawal by Subject|1|||
148827610|NCT01335685|536847169|FG004|Overall Study|Withdrawal by Subject|0|||
148827611|NCT01335685|536847170|FG005|Overall Study|Withdrawal by Subject|0|||
148827612|NCT01335685|536847171|FG006|Overall Study|Withdrawal by Subject|0|||
148827613|NCT01335685|536847172|FG007|Overall Study|Withdrawal by Subject|0|||
148827614|NCT01335685|536847165|FG000|Overall Study|Reason not Specified|0|||
148827615|NCT01335685|536847166|FG001|Overall Study|Reason not Specified|0|||
148827616|NCT01335685|536847167|FG002|Overall Study|Reason not Specified|1|||
148827617|NCT01335685|536847168|FG003|Overall Study|Reason not Specified|0|||
148827618|NCT01335685|536847169|FG004|Overall Study|Reason not Specified|0|||
148827619|NCT01335685|536847170|FG005|Overall Study|Reason not Specified|1|||
148827620|NCT01335685|536847171|FG006|Overall Study|Reason not Specified|0|||
148827621|NCT01335685|536847172|FG007|Overall Study|Reason not Specified|0|||
148827622|NCT03777020|536847175|FG000|Overall Study|Withdrawal by Subject|4|||
148827623|NCT03777020|536847176|FG001|Overall Study|Withdrawal by Subject|4|||
148827624|NCT03777020|536847175|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
148827625|NCT03777020|536847176|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
148827626|NCT03460704|536847177|FG000|Overall Study|Withdrawal by Subject|11|||
148827627|NCT03460704|536847178|FG001|Overall Study|Withdrawal by Subject|14|||
148827628|NCT03460704|536847177|FG000|Overall Study|Study terminated by the Sponsor|29|||
148827629|NCT03460704|536847178|FG001|Overall Study|Study terminated by the Sponsor|19|||
148827630|NCT03460704|536847177|FG000|Overall Study|Adverse Event|10|||
148827631|NCT03460704|536847178|FG001|Overall Study|Adverse Event|5|||
148827632|NCT03460704|536847177|FG000|Overall Study|Death|3|||
148827633|NCT03460704|536847178|FG001|Overall Study|Death|2|||
148827634|NCT03460704|536847177|FG000|Overall Study|Non-Compliance with Study Drug|3|||
148827635|NCT03460704|536847178|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148827636|NCT03460704|536847177|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148827637|NCT03460704|536847178|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
148827638|NCT03460704|536847177|FG000|Overall Study|Other|2|||
148827639|NCT03460704|536847178|FG001|Overall Study|Other|1|||
148827640|NCT01767857|536847179|FG000|Overall Study|Adverse Event|27|||
148827641|NCT01767857|536847180|FG001|Overall Study|Adverse Event|7|||
148827642|NCT01767857|536847179|FG000|Overall Study|Death|28|||
148827643|NCT01767857|536847180|FG001|Overall Study|Death|13|||
148827644|NCT01767857|536847179|FG000|Overall Study|Lack of Efficacy|299|||
148827645|NCT01767857|536847180|FG001|Overall Study|Lack of Efficacy|151|||
148827646|NCT01767857|536847179|FG000|Overall Study|Lost to Follow-up|1|||
148827647|NCT01767857|536847180|FG001|Overall Study|Lost to Follow-up|1|||
148827648|NCT01767857|536847179|FG000|Overall Study|Withdrawal by Subject|38|||
148827649|NCT01767857|536847180|FG001|Overall Study|Withdrawal by Subject|18|||
148827650|NCT01767857|536847179|FG000|Overall Study|Physician Decision|17|||
148827651|NCT01767857|536847180|FG001|Overall Study|Physician Decision|10|||
148827652|NCT01767857|536847179|FG000|Overall Study|Protocol Terminated|1|||
148827653|NCT01767857|536847180|FG001|Overall Study|Protocol Terminated|0|||
148827654|NCT01767857|536847179|FG000|Overall Study|Randomized But Never Treated|19|||
148827655|NCT01767857|536847180|FG001|Overall Study|Randomized But Never Treated|13|||
148827656|NCT01421459|536847181|FG000|Overall Study|Adverse Event|6|||
148827657|NCT01421459|536847182|FG001|Overall Study|Adverse Event|10|||
148827658|NCT01421459|536847181|FG000|Overall Study|Death|1|||
148827659|NCT01421459|536847182|FG001|Overall Study|Death|1|||
148827660|NCT01421459|536847181|FG000|Overall Study|Lack of Efficacy|1|||
148827661|NCT01421459|536847182|FG001|Overall Study|Lack of Efficacy|2|||
148827662|NCT01421459|536847181|FG000|Overall Study|Lost to Follow-up|8|||
148827663|NCT01421459|536847182|FG001|Overall Study|Lost to Follow-up|9|||
148827664|NCT01421459|536847181|FG000|Overall Study|Physician Decision|9|||
148827665|NCT01421459|536847182|FG001|Overall Study|Physician Decision|9|||
148827666|NCT01421459|536847181|FG000|Overall Study|Protocol Violation|8|||
148827667|NCT01421459|536847182|FG001|Overall Study|Protocol Violation|5|||
148827668|NCT01421459|536847181|FG000|Overall Study|Withdrawal by Subject|12|||
148827669|NCT01421459|536847182|FG001|Overall Study|Withdrawal by Subject|16|||
148827670|NCT01422382|536847185|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
148827671|NCT04126174|536847186|FG000|Overall Study|Lost to Follow-up|3|||
148827672|NCT04126174|536847187|FG001|Overall Study|Lost to Follow-up|3|||
148827673|NCT04439903|536847198|FG000|Overall Study|Withdrawal by Subject|2|||
148827674|NCT04439903|536847198|FG000|Overall Study|Screen Failure|1|||
148827675|NCT02899754|536847199|FG000|Overall Study|Lost to Follow-up|7|||
148827676|NCT02899754|536847200|FG001|Overall Study|Lost to Follow-up|9|||
148827677|NCT04818229|536847201|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
148827678|NCT04818229|536847202|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
148827679|NCT04818229|536847203|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
148827680|NCT04818229|536847201|FG000|Overall Study|Adverse Event|3|||
148827681|NCT04818229|536847202|FG001|Overall Study|Adverse Event|1|||
148827682|NCT04818229|536847203|FG002|Overall Study|Adverse Event|1|||
148827683|NCT04818229|536847201|FG000|Overall Study|Withdrawal by Subject|0|||
148827684|NCT04818229|536847202|FG001|Overall Study|Withdrawal by Subject|0|||
148827685|NCT04818229|536847203|FG002|Overall Study|Withdrawal by Subject|2|||
148827686|NCT04818229|536847201|FG000|Overall Study|Lost to Follow-up|0|||
148827687|NCT04818229|536847202|FG001|Overall Study|Lost to Follow-up|0|||
148827688|NCT04818229|536847203|FG002|Overall Study|Lost to Follow-up|1|||
148827689|NCT00581100|536848833|FG000|Overall Study|Death|1|||
148827690|NCT00581100|536848834|FG001|Overall Study|Death|0|||
148827691|NCT00581100|536848833|FG000|Overall Study|Adverse Event|2|||
148827692|NCT00581100|536848834|FG001|Overall Study|Adverse Event|1|||
148827693|NCT00581100|536848833|FG000|Overall Study|Withdrawal by Subject|1|||
148827694|NCT00581100|536848834|FG001|Overall Study|Withdrawal by Subject|4|||
148827695|NCT00581100|536848833|FG000|Overall Study|Other|3|||
148827696|NCT00581100|536848834|FG001|Overall Study|Other|0|||
148827697|NCT04129398|536848835|FG000|Overall Study|Physician Decision|2|||
148827698|NCT04110145|536848836|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
148827699|NCT04110145|536848837|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
148827700|NCT04110145|536848838|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
148827701|NCT04110145|536848839|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
148827702|NCT04110145|536848840|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
148827703|NCT02579759|536848841|FG000|Overall Study|Protocol Violation|2|||
148827704|NCT02579759|536848842|FG001|Overall Study|Protocol Violation|0|||
148827705|NCT02579759|536848843|FG002|Overall Study|Protocol Violation|0|||
148827706|NCT02579759|536848841|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
148827707|NCT02579759|536848842|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
148827708|NCT02579759|536848843|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
148827709|NCT02579759|536848841|FG000|Overall Study|BfArM hold|13|||
148827710|NCT02579759|536848842|FG001|Overall Study|BfArM hold|12|||
148827711|NCT02579759|536848843|FG002|Overall Study|BfArM hold|12|||
148827712|NCT02579759|536848841|FG000|Overall Study|Sponsor stopped Dose 2|0|||
148827713|NCT02579759|536848842|FG001|Overall Study|Sponsor stopped Dose 2|41|||
148827714|NCT02579759|536848843|FG002|Overall Study|Sponsor stopped Dose 2|0|||
148827715|NCT02579759|536848841|FG000|Overall Study|Non compliance|0|||
148827716|NCT02579759|536848842|FG001|Overall Study|Non compliance|1|||
148827717|NCT02579759|536848843|FG002|Overall Study|Non compliance|0|||
148827718|NCT02579759|536848841|FG000|Overall Study|Pregnancy|0|||
148827719|NCT02579759|536848842|FG001|Overall Study|Pregnancy|1|||
148827720|NCT02579759|536848843|FG002|Overall Study|Pregnancy|0|||
148827721|NCT02579759|536848841|FG000|Overall Study|Inclusion/exclusion criteria|0|||
148827722|NCT02579759|536848842|FG001|Overall Study|Inclusion/exclusion criteria|0|||
148827723|NCT02579759|536848843|FG002|Overall Study|Inclusion/exclusion criteria|1|||
148827724|NCT02579759|536848841|FG000|Overall Study|Adverse Event|4|||
148827725|NCT02579759|536848842|FG001|Overall Study|Adverse Event|3|||
148827726|NCT02579759|536848843|FG002|Overall Study|Adverse Event|1|||
148827727|NCT02579759|536848841|FG000|Overall Study|Withdrawal by Subject|3|||
148827728|NCT02579759|536848842|FG001|Overall Study|Withdrawal by Subject|3|||
148827729|NCT02579759|536848843|FG002|Overall Study|Withdrawal by Subject|5|||
148827730|NCT02579759|536848841|FG000|Overall Study|Lost to Follow-up|2|||
148827731|NCT02579759|536848842|FG001|Overall Study|Lost to Follow-up|2|||
148827732|NCT02579759|536848843|FG002|Overall Study|Lost to Follow-up|2|||
148827733|NCT00814983|536848856|FG000|Overall Study|Screen failure|1|||
148827734|NCT00814983|536848857|FG001|Overall Study|Screen failure|0|||
148827735|NCT00814983|536848856|FG000|Overall Study|Withdrawal by Subject|1|||
148827736|NCT00814983|536848857|FG001|Overall Study|Withdrawal by Subject|0|||
148827737|NCT00814983|536848856|FG000|Overall Study|Graft failure|1|||
148978058|NCT00194012|537400780|FG000|Randomized Phase|Emesis and enuresis|0|||
148827738|NCT00814983|536848857|FG001|Overall Study|Graft failure|0|||
148827739|NCT01935947|536848858|FG000|Overall Study|Adverse Event|0|||
148827740|NCT01935947|536848859|FG001|Overall Study|Adverse Event|2|||
148978059|NCT00194012|537400781|FG001|Randomized Phase|Emesis and enuresis|1|||
148978060|NCT00194012|537400780|FG000|Randomized Phase|Oral/nasal twitching|0|||
148827741|NCT01935947|536848860|FG002|Overall Study|Adverse Event|0|||
148827742|NCT01935947|536848858|FG000|Overall Study|Diease Progression|2|||
148827743|NCT01935947|536848859|FG001|Overall Study|Diease Progression|2|||
148827744|NCT01935947|536848860|FG002|Overall Study|Diease Progression|2|||
148827745|NCT01935947|536848858|FG000|Overall Study|Death|1|||
148827746|NCT01935947|536848859|FG001|Overall Study|Death|0|||
148827747|NCT01935947|536848860|FG002|Overall Study|Death|0|||
148827748|NCT00836901|536848861|FG000|First Intervention|Withdrawal by Subject|1|||
148827749|NCT00836901|536848862|FG001|First Intervention|Withdrawal by Subject|0|||
148827750|NCT00830336|536848863|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
148827751|NCT00830336|536848864|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
148827752|NCT01148771|536848865|FG000|Washout Period|Withdrawal by Subject|0|||
148827753|NCT01148771|536848866|FG001|Washout Period|Withdrawal by Subject|1|||
148827754|NCT05071027|536848870|FG000|Overall Study|Lost to Follow-up|1|||
148827755|NCT05071027|536848871|FG001|Overall Study|Lost to Follow-up|4|||
148827756|NCT05463952|536848877|FG000|Treatment|Progressive disease|4|||
148827757|NCT05463952|536848877|FG000|Treatment|Ongoing|2|||
148827758|NCT02096354|536848882|FG000|Overall Study|Physician Decision|4|||
148827759|NCT02096354|536848883|FG001|Overall Study|Physician Decision|5|||
148827760|NCT02096354|536848884|FG002|Overall Study|Physician Decision|0|||
148827761|NCT02096354|536848882|FG000|Overall Study|Withdrawal by Subject|3|||
148827762|NCT02096354|536848883|FG001|Overall Study|Withdrawal by Subject|1|||
148827763|NCT02096354|536848884|FG002|Overall Study|Withdrawal by Subject|0|||
148827764|NCT02096354|536848882|FG000|Overall Study|Adverse Event|7|||
148827765|NCT02096354|536848883|FG001|Overall Study|Adverse Event|4|||
148827766|NCT02096354|536848884|FG002|Overall Study|Adverse Event|0|||
148827767|NCT02096354|536848882|FG000|Overall Study|Ineligible|0|||
148827768|NCT02096354|536848883|FG001|Overall Study|Ineligible|0|||
148827769|NCT02096354|536848884|FG002|Overall Study|Ineligible|11|||
148827770|NCT03253627|536848888|FG000|Overall Study|Lost to Follow-up|1|||
148827771|NCT03253627|536848889|FG001|Overall Study|Lost to Follow-up|2|||
148827772|NCT03253627|536848888|FG000|Overall Study|Withdrawal by Subject|0|||
148827773|NCT03253627|536848889|FG001|Overall Study|Withdrawal by Subject|2|||
148827774|NCT03253627|536848888|FG000|Overall Study|Inability to complete MRI|1|||
148827775|NCT03253627|536848889|FG001|Overall Study|Inability to complete MRI|0|||
148827776|NCT03829683|536848890|FG000|Overall Study|Lost to Follow-up|1|||
148827777|NCT03829683|536848891|FG001|Overall Study|Lost to Follow-up|0|||
148827778|NCT03829683|536848890|FG000|Overall Study|Physician Decision|3|||
148827779|NCT03829683|536848891|FG001|Overall Study|Physician Decision|1|||
148827780|NCT03829683|536848890|FG000|Overall Study|Withdrawal by Subject|0|||
148827781|NCT03829683|536848891|FG001|Overall Study|Withdrawal by Subject|1|||
148827782|NCT03829683|536848890|FG000|Overall Study|Discharge from hospital|1|||
148827783|NCT03829683|536848891|FG001|Overall Study|Discharge from hospital|0|||
148827784|NCT03163667|536848892|FG000|Overall Study|Death|15|||
148827785|NCT03163667|536848893|FG001|Overall Study|Death|27|||
148827786|NCT03163667|536848892|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
148827787|NCT03163667|536848893|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
148827788|NCT02420314|536848894|FG000|Overall Study|Withdrawal by Subject|1|||
148827789|NCT02420314|536848894|FG000|Overall Study|Protocol Violation|1|||
148827790|NCT03760068|536848895|FG000|Overall Study|Withdrawal by Subject|7|||
148827791|NCT03760068|536848896|FG001|Overall Study|Withdrawal by Subject|8|||
148827792|NCT03760068|536848895|FG000|Overall Study|Adverse Event|1|||
148827793|NCT03760068|536848896|FG001|Overall Study|Adverse Event|2|||
148827794|NCT03760068|536848895|FG000|Overall Study|Administrative Decision by Sponsor|0|||
148827795|NCT03760068|536848896|FG001|Overall Study|Administrative Decision by Sponsor|2|||
148827796|NCT03760068|536848895|FG000|Overall Study|Physician Decision|1|||
148827797|NCT03760068|536848896|FG001|Overall Study|Physician Decision|2|||
148827798|NCT03760068|536848895|FG000|Overall Study|Lost to Follow-up|4|||
148827799|NCT03760068|536848896|FG001|Overall Study|Lost to Follow-up|9|||
148827800|NCT03760068|536848895|FG000|Overall Study|Subject Moved Out of State|1|||
148827801|NCT03760068|536848896|FG001|Overall Study|Subject Moved Out of State|0|||
148827802|NCT05430919|536848897|FG000|Overall Study|Protocol Violation|0|||
148827803|NCT05430919|536848898|FG001|Overall Study|Protocol Violation|0|||
148827804|NCT05430919|536848899|FG002|Overall Study|Protocol Violation|1|||
148827805|NCT05430919|536848900|FG003|Overall Study|Protocol Violation|0|||
148827806|NCT05430919|536848897|FG000|Overall Study|Lost to Follow-up|0|||
148827807|NCT05430919|536848898|FG001|Overall Study|Lost to Follow-up|1|||
148827808|NCT05430919|536848899|FG002|Overall Study|Lost to Follow-up|0|||
148827809|NCT05430919|536848900|FG003|Overall Study|Lost to Follow-up|0|||
148827810|NCT05430919|536848897|FG000|Overall Study|Withdrawal by Subject|3|||
148827811|NCT05430919|536848898|FG001|Overall Study|Withdrawal by Subject|0|||
148827812|NCT05430919|536848899|FG002|Overall Study|Withdrawal by Subject|0|||
148827813|NCT05430919|536848900|FG003|Overall Study|Withdrawal by Subject|1|||
148827814|NCT00855166|536848903|FG000|Overall Study|Adverse Event|0|||
148827815|NCT00855166|536848904|FG001|Overall Study|Adverse Event|2|||
148827816|NCT00855166|536848903|FG000|Overall Study|Death|0|||
148827817|NCT00855166|536848904|FG001|Overall Study|Death|1|||
148827818|NCT00855166|536848903|FG000|Overall Study|Withdrawal by Subject|1|||
148827819|NCT00855166|536848904|FG001|Overall Study|Withdrawal by Subject|4|||
148827820|NCT00855166|536848903|FG000|Overall Study|Poor/non-compliance|2|||
148827821|NCT00855166|536848904|FG001|Overall Study|Poor/non-compliance|0|||
148827822|NCT00855166|536848903|FG000|Overall Study|Administrative reasons by sponsor|1|||
148827823|NCT00855166|536848904|FG001|Overall Study|Administrative reasons by sponsor|0|||
148827824|NCT00855166|536848903|FG000|Overall Study|Subject no longer meets study criteria|1|||
148827825|NCT00855166|536848904|FG001|Overall Study|Subject no longer meets study criteria|1|||
148827826|NCT00803049|536848905|FG000|Overall Study|Adverse Event|21|||
148827827|NCT00803049|536848906|FG001|Overall Study|Adverse Event|33|||
148827828|NCT00803049|536848907|FG002|Overall Study|Adverse Event|13|||
148827829|NCT00803049|536848908|FG003|Overall Study|Adverse Event|27|||
148827830|NCT00803049|536848905|FG000|Overall Study|Lack of Efficacy|10|||
148827831|NCT00803049|536848906|FG001|Overall Study|Lack of Efficacy|19|||
148827832|NCT00803049|536848907|FG002|Overall Study|Lack of Efficacy|6|||
148827833|NCT00803049|536848908|FG003|Overall Study|Lack of Efficacy|13|||
148827834|NCT00803049|536848905|FG000|Overall Study|Lost to Follow-up|0|||
148827835|NCT00803049|536848906|FG001|Overall Study|Lost to Follow-up|2|||
148827836|NCT00803049|536848907|FG002|Overall Study|Lost to Follow-up|0|||
148827837|NCT00803049|536848908|FG003|Overall Study|Lost to Follow-up|3|||
148827838|NCT00803049|536848905|FG000|Overall Study|Death|2|||
148827839|NCT00803049|536848906|FG001|Overall Study|Death|1|||
148827840|NCT00803049|536848907|FG002|Overall Study|Death|0|||
148827841|NCT00803049|536848908|FG003|Overall Study|Death|2|||
148827842|NCT00803049|536848905|FG000|Overall Study|Progressive Disease|6|||
148827843|NCT00803049|536848906|FG001|Overall Study|Progressive Disease|10|||
148827844|NCT00803049|536848907|FG002|Overall Study|Progressive Disease|6|||
148827845|NCT00803049|536848908|FG003|Overall Study|Progressive Disease|6|||
148827846|NCT00803049|536848905|FG000|Overall Study|Withdrawal by Subject|19|||
148827847|NCT00803049|536848906|FG001|Overall Study|Withdrawal by Subject|43|||
148827848|NCT00803049|536848907|FG002|Overall Study|Withdrawal by Subject|16|||
148827849|NCT00803049|536848908|FG003|Overall Study|Withdrawal by Subject|44|||
148827850|NCT00803049|536848905|FG000|Overall Study|Protocol Violation|0|||
148827851|NCT00803049|536848906|FG001|Overall Study|Protocol Violation|1|||
148827852|NCT00803049|536848907|FG002|Overall Study|Protocol Violation|1|||
148827853|NCT00803049|536848908|FG003|Overall Study|Protocol Violation|0|||
148827854|NCT00803049|536848905|FG000|Overall Study|Randomized and Not Treated|0|||
148827855|NCT00803049|536848906|FG001|Overall Study|Randomized and Not Treated|0|||
148978061|NCT00194012|537400781|FG001|Randomized Phase|Oral/nasal twitching|1|||
148827856|NCT00803049|536848907|FG002|Overall Study|Randomized and Not Treated|0|||
148827857|NCT00803049|536848908|FG003|Overall Study|Randomized and Not Treated|2|||
148827858|NCT00803049|536848905|FG000|Overall Study|Other than Specified Above|3|||
148827859|NCT00803049|536848906|FG001|Overall Study|Other than Specified Above|9|||
148827860|NCT00803049|536848907|FG002|Overall Study|Other than Specified Above|2|||
148827861|NCT00803049|536848908|FG003|Overall Study|Other than Specified Above|5|||
148827862|NCT01272219|536848909|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
148827863|NCT01272219|536848910|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
148827864|NCT01272219|536848911|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
148827865|NCT01272219|536848912|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
148827866|NCT01272219|536848913|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
148827867|NCT01272219|536848914|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
148827868|NCT01272219|536848909|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
148827869|NCT01272219|536848910|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
148827870|NCT01272219|536848911|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
148827871|NCT01272219|536848912|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
148827872|NCT01272219|536848913|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
148827873|NCT01272219|536848914|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
148827874|NCT01272219|536848909|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
148827875|NCT01272219|536848910|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
148827876|NCT01272219|536848911|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
148827877|NCT01272219|536848912|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
148827878|NCT01272219|536848913|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
148827879|NCT01272219|536848914|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
148827880|NCT01272219|536848909|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
148827881|NCT01272219|536848910|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
148827882|NCT01272219|536848911|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
148978062|NCT00194012|537400780|FG000|Open Label Extension (OLE)|Weight Gain|1|||
148827883|NCT01272219|536848912|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
148827884|NCT01272219|536848913|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
148827885|NCT01272219|536848914|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
148978063|NCT00194012|537400781|FG001|Open Label Extension (OLE)|Weight Gain|0|||
148827886|NCT01272219|536848909|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
148827887|NCT01272219|536848910|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
148827888|NCT01272219|536848911|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
148827889|NCT01272219|536848912|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
148827890|NCT01272219|536848913|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
148827891|NCT01272219|536848914|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
148827892|NCT01272219|536848909|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
148827893|NCT01272219|536848910|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
148827894|NCT01272219|536848911|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
148827895|NCT01272219|536848912|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
148827896|NCT01272219|536848913|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
148827897|NCT01272219|536848914|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
148827898|NCT01272219|536848909|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
148827899|NCT01272219|536848910|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
148827900|NCT01272219|536848911|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
148827901|NCT01272219|536848912|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
148827902|NCT01272219|536848913|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
148827903|NCT01272219|536848914|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
148827904|NCT01272219|536848909|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
148827905|NCT01272219|536848910|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
148827906|NCT01272219|536848911|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
148827907|NCT01272219|536848912|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
148827908|NCT01272219|536848913|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
148827909|NCT01272219|536848914|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
148827910|NCT01272219|536848909|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
148827911|NCT01272219|536848910|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
148827912|NCT01272219|536848911|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
148827913|NCT01272219|536848912|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
148827914|NCT01272219|536848913|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
148827915|NCT01272219|536848914|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
148827916|NCT01272219|536848909|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
148827917|NCT01272219|536848910|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
148827918|NCT01272219|536848911|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
148827919|NCT01272219|536848912|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
148827920|NCT01272219|536848913|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
148827921|NCT01272219|536848914|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
148827922|NCT01272219|536848909|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
148827923|NCT01272219|536848910|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
148827924|NCT01272219|536848911|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
148827925|NCT01272219|536848912|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
148827926|NCT01272219|536848913|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
148827927|NCT01272219|536848914|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
148827928|NCT01272219|536848909|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
148827929|NCT01272219|536848910|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
148827930|NCT01272219|536848911|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
148827931|NCT01272219|536848912|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
148827932|NCT01272219|536848913|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
148827933|NCT01272219|536848914|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
148827934|NCT01272219|536848909|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
148827935|NCT01272219|536848910|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
148827936|NCT01272219|536848911|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
148827937|NCT01272219|536848912|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
148827938|NCT01272219|536848913|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
148827939|NCT01272219|536848914|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
148827940|NCT01272219|536848909|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
148827941|NCT01272219|536848910|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
148827942|NCT01272219|536848911|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
148827943|NCT01272219|536848912|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
148827944|NCT01272219|536848913|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
148827945|NCT01272219|536848914|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
148827946|NCT01272219|536848909|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
148827947|NCT01272219|536848910|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
148827948|NCT01272219|536848911|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
148827949|NCT01272219|536848912|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
148827950|NCT01272219|536848913|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
148827951|NCT01272219|536848914|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
148827952|NCT01272219|536848909|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
148827953|NCT01272219|536848910|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
148827954|NCT01272219|536848911|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
148827955|NCT01272219|536848912|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
148827956|NCT01272219|536848913|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
148827957|NCT01272219|536848914|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
148827958|NCT01491919|536848915|FG000|Overall Study|Insufficient PK sampling|1|||
148827959|NCT01491919|536848916|FG001|Overall Study|Insufficient PK sampling|2|||
148827960|NCT01491919|536848917|FG002|Overall Study|Insufficient PK sampling|1|||
148827961|NCT04003389|536848918|FG000|Overall Study|Adverse Event|27|||
148827962|NCT04003389|536848919|FG001|Overall Study|Adverse Event|34|||
148827963|NCT04003389|536848920|FG002|Overall Study|Adverse Event|28|||
148827964|NCT04003389|536848918|FG000|Overall Study|Lost to Follow-up|39|||
148827965|NCT04003389|536848919|FG001|Overall Study|Lost to Follow-up|30|||
148827966|NCT04003389|536848920|FG002|Overall Study|Lost to Follow-up|33|||
148827967|NCT04003389|536848918|FG000|Overall Study|Protocol Violation|1|||
148827968|NCT04003389|536848919|FG001|Overall Study|Protocol Violation|6|||
148827969|NCT04003389|536848920|FG002|Overall Study|Protocol Violation|5|||
148827970|NCT04003389|536848918|FG000|Overall Study|Withdrawal by Subject|119|||
148827971|NCT04003389|536848919|FG001|Overall Study|Withdrawal by Subject|79|||
148827972|NCT04003389|536848920|FG002|Overall Study|Withdrawal by Subject|85|||
148827973|NCT04003389|536848918|FG000|Overall Study|Miscellaneous|14|||
148827974|NCT04003389|536848919|FG001|Overall Study|Miscellaneous|11|||
148827975|NCT04003389|536848920|FG002|Overall Study|Miscellaneous|14|||
148827976|NCT04003389|536848918|FG000|Overall Study|Participant did not receive study drug|1|||
148827977|NCT04003389|536848919|FG001|Overall Study|Participant did not receive study drug|0|||
148827978|NCT04003389|536848920|FG002|Overall Study|Participant did not receive study drug|0|||
148827979|NCT04082364|536848925|FG000|Overall Study|Death|23|||
148827980|NCT04082364|536848926|FG001|Overall Study|Death|1|||
148827981|NCT04082364|536848927|FG002|Overall Study|Death|1|||
148827982|NCT04082364|536848928|FG003|Overall Study|Death|2|||
148827983|NCT04082364|536848929|FG004|Overall Study|Death|1|||
148827984|NCT04082364|536848925|FG000|Overall Study|Lost to Follow-up|1|||
148827985|NCT04082364|536848926|FG001|Overall Study|Lost to Follow-up|0|||
148827986|NCT04082364|536848927|FG002|Overall Study|Lost to Follow-up|0|||
148827987|NCT04082364|536848928|FG003|Overall Study|Lost to Follow-up|0|||
148827988|NCT04082364|536848929|FG004|Overall Study|Lost to Follow-up|1|||
148827989|NCT04082364|536848925|FG000|Overall Study|Physician Decision|1|||
148827990|NCT04082364|536848926|FG001|Overall Study|Physician Decision|1|||
148827991|NCT04082364|536848927|FG002|Overall Study|Physician Decision|0|||
148827992|NCT04082364|536848928|FG003|Overall Study|Physician Decision|2|||
148827993|NCT04082364|536848929|FG004|Overall Study|Physician Decision|1|||
148827994|NCT04082364|536848925|FG000|Overall Study|Withdrawal by Subject|1|||
148827995|NCT04082364|536848926|FG001|Overall Study|Withdrawal by Subject|1|||
148827996|NCT04082364|536848927|FG002|Overall Study|Withdrawal by Subject|0|||
148827997|NCT04082364|536848928|FG003|Overall Study|Withdrawal by Subject|0|||
148827998|NCT04082364|536848929|FG004|Overall Study|Withdrawal by Subject|1|||
148827999|NCT04082364|536848925|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
148828000|NCT04082364|536848926|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
148828001|NCT04082364|536848927|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
148828002|NCT04082364|536848928|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
148828003|NCT04082364|536848929|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
148828004|NCT04082364|536848925|FG000|Overall Study|Disease progression|0|||
148828005|NCT04082364|536848926|FG001|Overall Study|Disease progression|0|||
148828006|NCT04082364|536848927|FG002|Overall Study|Disease progression|0|||
148828007|NCT04082364|536848928|FG003|Overall Study|Disease progression|1|||
148828008|NCT04082364|536848929|FG004|Overall Study|Disease progression|0|||
148828009|NCT03186378|536848930|FG000|Overall Study|Lost to Follow-up|1|||
148828010|NCT03186378|536848931|FG001|Overall Study|Lost to Follow-up|0|||
148828011|NCT02514746|536848938|FG000|Overall Study|Chronically Ill|1|||
148828012|NCT02514746|536848939|FG001|Overall Study|Chronically Ill|2|||
148828013|NCT02514746|536848938|FG000|Overall Study|Physician Decision|4|||
148828014|NCT02514746|536848939|FG001|Overall Study|Physician Decision|2|||
148828015|NCT02514746|536848938|FG000|Overall Study|Withdrawal by Subject|12|||
148828016|NCT02514746|536848939|FG001|Overall Study|Withdrawal by Subject|10|||
148828017|NCT02514746|536848938|FG000|Overall Study|Other|5|||
148828018|NCT02514746|536848939|FG001|Overall Study|Other|1|||
148828019|NCT04042311|536848941|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
148828020|NCT04042311|536848941|FG000|Overall Study|Unable to tolerate|4|||
148828021|NCT04042311|536848941|FG000|Overall Study|Concurrent illness|2|||
148828022|NCT04042311|536848941|FG000|Overall Study|Adverse Event|2|||
148828023|NCT04042311|536848941|FG000|Overall Study|No longer meeting inclusion criteria|2|||
148828024|NCT04042311|536848941|FG000|Overall Study|No reason given|1|||
148828025|NCT04042311|536848941|FG000|Overall Study|Withdrawal by Subject|4|||
148828026|NCT03382873|536848942|FG000|Overall Study|Lost to Follow-up|9|||
148828027|NCT03382873|536848943|FG001|Overall Study|Lost to Follow-up|10|||
148828028|NCT03382873|536848942|FG000|Overall Study|Withdrawal by Subject|6|||
148828029|NCT03382873|536848943|FG001|Overall Study|Withdrawal by Subject|11|||
148828030|NCT03382873|536848942|FG000|Overall Study|Visit not completed due to pandemic|16|||
148828031|NCT03382873|536848943|FG001|Overall Study|Visit not completed due to pandemic|41|||
148828032|NCT05021224|536848944|FG000|Overall Study|Did not complete all survey items|4|||
148828033|NCT05021224|536848945|FG001|Overall Study|Did not complete all survey items|1|||
148828034|NCT05021224|536848946|FG002|Overall Study|Did not complete all survey items|0|||
148828035|NCT05021224|536848947|FG003|Overall Study|Did not complete all survey items|2|||
148828036|NCT03996395|536848948|FG000|Overall Study|Lost to Follow-up|4|||
148828037|NCT03996395|536848948|FG000|Overall Study|Withdrawal by Subject|1|||
148828038|NCT03996395|536848948|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
148828039|NCT05375929|536848949|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
148828040|NCT05375929|536848950|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
148828041|NCT05375929|536848951|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
148828042|NCT05375929|536848952|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
148828043|NCT05375929|536848949|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
148828044|NCT05375929|536848950|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
148828045|NCT05375929|536848951|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
148828046|NCT05375929|536848952|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
148828047|NCT05375929|536848949|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
148828048|NCT05375929|536848950|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
148828049|NCT05375929|536848951|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
148828050|NCT05375929|536848952|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
148828051|NCT05375929|536848949|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
148828052|NCT05375929|536848950|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
148828053|NCT05375929|536848951|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
148828054|NCT05375929|536848952|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
148828055|NCT05375929|536848949|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
148828056|NCT05375929|536848950|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
148828057|NCT05375929|536848951|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
148828058|NCT05375929|536848952|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
148828059|NCT05375929|536848949|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
148828060|NCT05375929|536848950|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
148828061|NCT05375929|536848951|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
148828062|NCT05375929|536848952|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
148828063|NCT05375929|536848949|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
148828064|NCT05375929|536848950|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
148828065|NCT05375929|536848951|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
148828066|NCT05375929|536848952|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
148828067|NCT05375929|536848949|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
148828068|NCT05375929|536848950|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
148828069|NCT05375929|536848951|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
148828070|NCT05375929|536848952|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
148828071|NCT05375929|536848949|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
148828072|NCT05375929|536848950|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
148828073|NCT05375929|536848951|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
148828074|NCT05375929|536848952|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
148828075|NCT05375929|536848949|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
148828076|NCT05375929|536848950|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
148828077|NCT05375929|536848951|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
148828078|NCT05375929|536848952|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
148828079|NCT03973489|536848953|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
148828080|NCT03973489|536848954|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
148828081|NCT03973489|536848955|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
148828082|NCT03973489|536848956|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
148828083|NCT03973489|536848957|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
148828084|NCT03973489|536848958|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
148828085|NCT03973489|536848959|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
148828086|NCT03973489|536848960|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
148828087|NCT03973489|536848953|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
148828088|NCT03973489|536848954|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
148828089|NCT03973489|536848955|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
148828090|NCT03973489|536848956|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
148978064|NCT00194012|537400780|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
148978065|NCT00194012|537400781|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
148828091|NCT03973489|536848957|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
148828092|NCT03973489|536848958|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
148828093|NCT03973489|536848959|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
148828094|NCT03973489|536848960|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
148978066|NCT00194012|537400780|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
148978067|NCT00194012|537400781|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
149027758|NCT03251378|537578642|FG004|Overall Study|Other|13|||
148828095|NCT03973489|536848953|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
148828096|NCT03973489|536848954|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
148828097|NCT03973489|536848955|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
148828098|NCT03973489|536848956|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
148828099|NCT03973489|536848957|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
148828100|NCT03973489|536848958|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
148828101|NCT03973489|536848959|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
148828102|NCT03973489|536848960|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
148828103|NCT03973489|536848953|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
148828104|NCT03973489|536848954|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
148828105|NCT03973489|536848955|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
148828106|NCT03973489|536848956|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
148828107|NCT03973489|536848957|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
148828108|NCT03973489|536848958|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
148828109|NCT03973489|536848959|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
148828110|NCT03973489|536848960|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
148828111|NCT03973489|536848953|FG000|Second Intervention (1 Day)|Adverse Event|0|||
148828112|NCT03973489|536848954|FG001|Second Intervention (1 Day)|Adverse Event|0|||
148828113|NCT03973489|536848955|FG002|Second Intervention (1 Day)|Adverse Event|0|||
148828114|NCT03973489|536848956|FG003|Second Intervention (1 Day)|Adverse Event|1|||
148828115|NCT03973489|536848957|FG004|Second Intervention (1 Day)|Adverse Event|0|||
148828116|NCT03973489|536848958|FG005|Second Intervention (1 Day)|Adverse Event|0|||
148828117|NCT03973489|536848959|FG006|Second Intervention (1 Day)|Adverse Event|0|||
148828118|NCT03973489|536848960|FG007|Second Intervention (1 Day)|Adverse Event|0|||
148828119|NCT03301415|536848961|FG000|Overall Study|Lost to Follow-up|2|||
148828120|NCT03301415|536848961|FG000|Overall Study|Unable to comply with visit schedule|2|||
148828121|NCT03247673|536848962|FG000|Overall Study|Withdrawal by Subject|1|||
148828122|NCT03247673|536848963|FG001|Overall Study|Withdrawal by Subject|0|||
148828123|NCT03247673|536848964|FG002|Overall Study|Withdrawal by Subject|3|||
148828124|NCT03247673|536848962|FG000|Overall Study|Lost to Follow-up|0|||
148828125|NCT03247673|536848963|FG001|Overall Study|Lost to Follow-up|0|||
148828126|NCT03247673|536848964|FG002|Overall Study|Lost to Follow-up|1|||
148828127|NCT00392288|536848965|FG000|Overall Study|Adverse Event|17|||
148828128|NCT00392288|536848966|FG001|Overall Study|Adverse Event|7|||
148828129|NCT00392288|536848967|FG002|Overall Study|Adverse Event|8|||
148828130|NCT00392288|536848965|FG000|Overall Study|Lack of Efficacy|8|||
148828131|NCT00392288|536848966|FG001|Overall Study|Lack of Efficacy|5|||
148828132|NCT00392288|536848967|FG002|Overall Study|Lack of Efficacy|3|||
148828133|NCT00392288|536848965|FG000|Overall Study|Protocol Violation|1|||
148828134|NCT00392288|536848966|FG001|Overall Study|Protocol Violation|3|||
148828135|NCT00392288|536848967|FG002|Overall Study|Protocol Violation|1|||
148828136|NCT00392288|536848965|FG000|Overall Study|Lost to Follow-up|1|||
148828137|NCT00392288|536848966|FG001|Overall Study|Lost to Follow-up|1|||
148828138|NCT00392288|536848967|FG002|Overall Study|Lost to Follow-up|1|||
148828139|NCT00392288|536848965|FG000|Overall Study|Withdrawal by Subject|1|||
148828140|NCT00392288|536848966|FG001|Overall Study|Withdrawal by Subject|0|||
148828141|NCT00392288|536848967|FG002|Overall Study|Withdrawal by Subject|2|||
148828142|NCT00392288|536848965|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
148828143|NCT00392288|536848966|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
148828144|NCT00392288|536848967|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
148828145|NCT00392288|536848965|FG000|Overall Study|Other|3|||
148828146|NCT00392288|536848966|FG001|Overall Study|Other|4|||
148828147|NCT00392288|536848967|FG002|Overall Study|Other|1|||
148828148|NCT02184442|536848971|FG000|Overall Study|Death|61|||
148828149|NCT02184442|536848972|FG001|Overall Study|Death|65|||
148828150|NCT02184442|536848971|FG000|Overall Study|Withdrawal by Subject|3|||
148828151|NCT02184442|536848972|FG001|Overall Study|Withdrawal by Subject|11|||
148828152|NCT02691494|536848975|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
148828153|NCT02691494|536848976|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
148828154|NCT02691494|536848977|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
148828155|NCT02691494|536848975|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
148828156|NCT02691494|536848976|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
148828157|NCT02691494|536848977|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
148828158|NCT02691494|536848975|FG000|Post-Treatment Follow-Up Period|Other|2|||
148828159|NCT02691494|536848976|FG001|Post-Treatment Follow-Up Period|Other|1|||
148828160|NCT02691494|536848977|FG002|Post-Treatment Follow-Up Period|Other|1|||
148828161|NCT02691494|536848975|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
148828162|NCT02691494|536848976|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
148828163|NCT02691494|536848977|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
148828164|NCT02691494|536848975|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
148828165|NCT02691494|536848976|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
148828166|NCT02691494|536848977|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
148828167|NCT03249558|536848981|FG000|Overall Study|Lost to Follow-up|2|||
148828168|NCT03249558|536848982|FG001|Overall Study|Lost to Follow-up|1|||
148828169|NCT03249558|536848983|FG002|Overall Study|Lost to Follow-up|4|||
148828170|NCT03249558|536848981|FG000|Overall Study|Physician Decision|1|||
148828171|NCT03249558|536848982|FG001|Overall Study|Physician Decision|0|||
148828172|NCT03249558|536848983|FG002|Overall Study|Physician Decision|0|||
148828173|NCT03249558|536848981|FG000|Overall Study|Withdrawal by Subject|6|||
148828174|NCT03249558|536848982|FG001|Overall Study|Withdrawal by Subject|5|||
148828175|NCT03249558|536848983|FG002|Overall Study|Withdrawal by Subject|7|||
148828176|NCT03249558|536848981|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
148828177|NCT03249558|536848982|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
148828178|NCT03249558|536848983|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
148828179|NCT03249558|536848981|FG000|Overall Study|Protocol Violation|1|||
148828180|NCT03249558|536848982|FG001|Overall Study|Protocol Violation|1|||
148828181|NCT03249558|536848983|FG002|Overall Study|Protocol Violation|2|||
148828182|NCT00908141|536848986|FG000|Overall Study|Withdrawal by Subject|0|||
148828183|NCT00908141|536848987|FG001|Overall Study|Withdrawal by Subject|1|||
148828184|NCT00980044|536850541|FG000|Overall Study|Withdrawal by Subject|5|||
148828185|NCT00980044|536850542|FG001|Overall Study|Withdrawal by Subject|7|||
148828186|NCT00980044|536850543|FG002|Overall Study|Withdrawal by Subject|3|||
148828187|NCT00980044|536850541|FG000|Overall Study|Protocol Violation|0|||
148828188|NCT00980044|536850542|FG001|Overall Study|Protocol Violation|0|||
148828189|NCT00980044|536850543|FG002|Overall Study|Protocol Violation|2|||
148828190|NCT02254291|536850544|FG000|Overall Study|Withdrawal by Subject|0|||
148828191|NCT02254291|536850545|FG001|Overall Study|Withdrawal by Subject|3|||
148828192|NCT02254291|536850546|FG002|Overall Study|Withdrawal by Subject|1|||
148828193|NCT02254291|536850544|FG000|Overall Study|Missing follow-up information|0|||
148828194|NCT02254291|536850545|FG001|Overall Study|Missing follow-up information|0|||
148828195|NCT02254291|536850546|FG002|Overall Study|Missing follow-up information|1|||
148828196|NCT00500331|536850554|FG000|Overall Study|Adverse Event|0|||
148828197|NCT00500331|536850555|FG001|Overall Study|Adverse Event|2|||
148828198|NCT00500331|536850556|FG002|Overall Study|Adverse Event|0|||
148828199|NCT00500331|536850557|FG003|Overall Study|Adverse Event|1|||
148828200|NCT00500331|536850558|FG004|Overall Study|Adverse Event|2|||
148828201|NCT00500331|536850559|FG005|Overall Study|Adverse Event|2|||
148828202|NCT00500331|536850560|FG006|Overall Study|Adverse Event|0|||
148828203|NCT00500331|536850554|FG000|Overall Study|Lost to Follow-up|1|||
148828204|NCT00500331|536850555|FG001|Overall Study|Lost to Follow-up|1|||
148828205|NCT00500331|536850556|FG002|Overall Study|Lost to Follow-up|1|||
148828206|NCT00500331|536850557|FG003|Overall Study|Lost to Follow-up|2|||
148828207|NCT00500331|536850558|FG004|Overall Study|Lost to Follow-up|1|||
148828208|NCT00500331|536850559|FG005|Overall Study|Lost to Follow-up|0|||
148828209|NCT00500331|536850560|FG006|Overall Study|Lost to Follow-up|0|||
148828210|NCT00500331|536850554|FG000|Overall Study|Protocol Violation|3|||
148828211|NCT00500331|536850555|FG001|Overall Study|Protocol Violation|1|||
148828212|NCT00500331|536850556|FG002|Overall Study|Protocol Violation|1|||
148828213|NCT00500331|536850557|FG003|Overall Study|Protocol Violation|0|||
148828214|NCT00500331|536850558|FG004|Overall Study|Protocol Violation|1|||
148828215|NCT00500331|536850559|FG005|Overall Study|Protocol Violation|1|||
148828216|NCT00500331|536850560|FG006|Overall Study|Protocol Violation|1|||
148828217|NCT00500331|536850554|FG000|Overall Study|Withdrawal by Subject|4|||
148828218|NCT00500331|536850555|FG001|Overall Study|Withdrawal by Subject|0|||
148828219|NCT00500331|536850556|FG002|Overall Study|Withdrawal by Subject|1|||
148828220|NCT00500331|536850557|FG003|Overall Study|Withdrawal by Subject|5|||
148828221|NCT00500331|536850558|FG004|Overall Study|Withdrawal by Subject|0|||
148828222|NCT00500331|536850559|FG005|Overall Study|Withdrawal by Subject|1|||
148828223|NCT00500331|536850560|FG006|Overall Study|Withdrawal by Subject|1|||
148828224|NCT00500331|536850554|FG000|Overall Study|Lack of Efficacy|3|||
148828225|NCT00500331|536850555|FG001|Overall Study|Lack of Efficacy|1|||
148828226|NCT00500331|536850556|FG002|Overall Study|Lack of Efficacy|0|||
148828227|NCT00500331|536850557|FG003|Overall Study|Lack of Efficacy|0|||
148828228|NCT00500331|536850558|FG004|Overall Study|Lack of Efficacy|0|||
148978068|NCT00194012|537400780|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
148828229|NCT00500331|536850559|FG005|Overall Study|Lack of Efficacy|0|||
148828230|NCT00500331|536850560|FG006|Overall Study|Lack of Efficacy|0|||
148828231|NCT00500331|536850554|FG000|Overall Study|Liver function test abnormality|0|||
148828232|NCT00500331|536850555|FG001|Overall Study|Liver function test abnormality|0|||
148828233|NCT00500331|536850556|FG002|Overall Study|Liver function test abnormality|1|||
148828234|NCT00500331|536850557|FG003|Overall Study|Liver function test abnormality|0|||
148828235|NCT00500331|536850558|FG004|Overall Study|Liver function test abnormality|0|||
148828236|NCT00500331|536850559|FG005|Overall Study|Liver function test abnormality|0|||
148828237|NCT00500331|536850560|FG006|Overall Study|Liver function test abnormality|0|||
148828238|NCT00500331|536850554|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
148828239|NCT00500331|536850555|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
148828240|NCT00500331|536850556|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
148828241|NCT00500331|536850557|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
148978069|NCT00194012|537400781|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
148978070|NCT04260191|537400787|FG000|Overall Study|Decision by Sponsor|0|||
148978071|NCT04260191|537400788|FG001|Overall Study|Decision by Sponsor|1|||
148978072|NCT04260191|537400789|FG002|Overall Study|Decision by Sponsor|0|||
148978073|NCT04260191|537400787|FG000|Overall Study|Withdrawal by Subject|1|||
148978074|NCT04260191|537400788|FG001|Overall Study|Withdrawal by Subject|0|||
148978075|NCT04260191|537400789|FG002|Overall Study|Withdrawal by Subject|3|||
148978076|NCT04260191|537400787|FG000|Overall Study|Death|4|||
148978077|NCT04260191|537400788|FG001|Overall Study|Death|3|||
148978078|NCT04260191|537400789|FG002|Overall Study|Death|2|||
148978079|NCT01643473|537400790|FG000|Overall Study|Lost to Follow-up|1|||
148978080|NCT01643473|537400791|FG001|Overall Study|Lost to Follow-up|0|||
148978081|NCT01519518|537400793|FG000|Overall Study|Consent not available|7|||
148765936|NCT02071706|536617450|FG000|Overall Study|Adverse Event|1|||
148765937|NCT02071706|536617450|FG000|Overall Study|Withdrawal by Subject|2|||
148828242|NCT00500331|536850558|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
148828243|NCT00500331|536850559|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
148828244|NCT00500331|536850560|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
148828245|NCT00500331|536850554|FG000|Overall Study|Didn't return for continuation of study|1|||
148828246|NCT00500331|536850555|FG001|Overall Study|Didn't return for continuation of study|0|||
148828247|NCT00500331|536850556|FG002|Overall Study|Didn't return for continuation of study|0|||
148828248|NCT00500331|536850557|FG003|Overall Study|Didn't return for continuation of study|0|||
148828249|NCT00500331|536850558|FG004|Overall Study|Didn't return for continuation of study|0|||
148828250|NCT00500331|536850559|FG005|Overall Study|Didn't return for continuation of study|0|||
148828251|NCT00500331|536850560|FG006|Overall Study|Didn't return for continuation of study|0|||
148828252|NCT00500331|536850554|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
148828253|NCT00500331|536850555|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
148828254|NCT00500331|536850556|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
148828255|NCT00500331|536850557|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
148828256|NCT00500331|536850558|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
148978082|NCT01519518|537400794|FG001|Overall Study|Consent not available|10|||
148765938|NCT01908829|536617454|FG000|Overall Study|Adverse Event|13|||
148765939|NCT01908829|536617455|FG001|Overall Study|Adverse Event|11|||
148765940|NCT01908829|536617456|FG002|Overall Study|Adverse Event|13|||
148765941|NCT01908829|536617454|FG000|Overall Study|Lost to Follow-up|4|||
148765942|NCT01908829|536617455|FG001|Overall Study|Lost to Follow-up|2|||
148765943|NCT01908829|536617456|FG002|Overall Study|Lost to Follow-up|1|||
148765944|NCT01908829|536617454|FG000|Overall Study|Randomized no double-blind drug received|1|||
148765945|NCT01908829|536617455|FG001|Overall Study|Randomized no double-blind drug received|0|||
148765946|NCT01908829|536617456|FG002|Overall Study|Randomized no double-blind drug received|1|||
148765947|NCT01908829|536617454|FG000|Overall Study|Discontinued (no EoT page)|2|||
148765948|NCT01908829|536617455|FG001|Overall Study|Discontinued (no EoT page)|0|||
148765949|NCT01908829|536617456|FG002|Overall Study|Discontinued (no EoT page)|0|||
148765950|NCT01908829|536617454|FG000|Overall Study|Miscellaneous|0|||
148765951|NCT01908829|536617455|FG001|Overall Study|Miscellaneous|2|||
148765952|NCT01908829|536617456|FG002|Overall Study|Miscellaneous|0|||
148765953|NCT01908829|536617454|FG000|Overall Study|Protocol Violation|2|||
148765954|NCT01908829|536617455|FG001|Overall Study|Protocol Violation|2|||
148765955|NCT01908829|536617456|FG002|Overall Study|Protocol Violation|0|||
148765956|NCT01908829|536617454|FG000|Overall Study|Lack of Efficacy|1|||
148765957|NCT01908829|536617455|FG001|Overall Study|Lack of Efficacy|3|||
148765958|NCT01908829|536617456|FG002|Overall Study|Lack of Efficacy|2|||
148765959|NCT01908829|536617454|FG000|Overall Study|Withdrawal by Subject|26|||
148765960|NCT01908829|536617455|FG001|Overall Study|Withdrawal by Subject|29|||
148765961|NCT01908829|536617456|FG002|Overall Study|Withdrawal by Subject|22|||
148765962|NCT02865499|536617457|FG000|Baseline|Adverse Event|1|||
148765963|NCT02865499|536617457|FG000|Baseline|Withdrawal by Subject|1|||
148765964|NCT02247440|536617458|FG000|Overall Study|Withdrawal by Subject|1|||
148765965|NCT02247440|536617458|FG000|Overall Study|Lack of Efficacy|3|||
148765966|NCT02792192|536617459|FG000|Overall Study|Death|1|||
148765967|NCT02792192|536617460|FG001|Overall Study|Death|0|||
148765968|NCT02792192|536617461|FG002|Overall Study|Death|0|||
148765969|NCT02792192|536617462|FG003|Overall Study|Death|0|||
148765970|NCT02792192|536617459|FG000|Overall Study|Informed Consent Withdrawn|4|||
148765971|NCT02792192|536617460|FG001|Overall Study|Informed Consent Withdrawn|0|||
148765972|NCT02792192|536617461|FG002|Overall Study|Informed Consent Withdrawn|0|||
148765973|NCT02792192|536617462|FG003|Overall Study|Informed Consent Withdrawn|0|||
148828257|NCT00500331|536850559|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
148978083|NCT02033889|537400795|FG000|Overall Study|Adverse Event|3|||
148978084|NCT02033889|537400796|FG001|Overall Study|Adverse Event|1|||
148765974|NCT02792192|536617459|FG000|Overall Study|Physician Decision|1|||
148765975|NCT02792192|536617460|FG001|Overall Study|Physician Decision|0|||
148765976|NCT02792192|536617461|FG002|Overall Study|Physician Decision|0|||
148765977|NCT02792192|536617462|FG003|Overall Study|Physician Decision|0|||
148765978|NCT02792192|536617459|FG000|Overall Study|Progressive Disease|0|||
148765979|NCT02792192|536617460|FG001|Overall Study|Progressive Disease|1|||
148978085|NCT02033889|537400797|FG002|Overall Study|Adverse Event|3|||
148828258|NCT00500331|536850560|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
148828259|NCT00500331|536850554|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
148828260|NCT00500331|536850555|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
148828261|NCT00500331|536850556|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
148828262|NCT00500331|536850557|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
148828263|NCT00500331|536850558|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
148828264|NCT00500331|536850559|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
148828265|NCT00500331|536850560|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
148828266|NCT00500331|536850554|FG000|Overall Study|Participant was randomized by mistake|1|||
148828267|NCT00500331|536850555|FG001|Overall Study|Participant was randomized by mistake|0|||
148828268|NCT00500331|536850556|FG002|Overall Study|Participant was randomized by mistake|0|||
148828269|NCT00500331|536850557|FG003|Overall Study|Participant was randomized by mistake|0|||
148828270|NCT00500331|536850558|FG004|Overall Study|Participant was randomized by mistake|0|||
148828271|NCT00500331|536850559|FG005|Overall Study|Participant was randomized by mistake|0|||
148978086|NCT02033889|537400795|FG000|Overall Study|Death|3|||
148978087|NCT02033889|537400796|FG001|Overall Study|Death|1|||
148978088|NCT02033889|537400797|FG002|Overall Study|Death|2|||
148978089|NCT02033889|537400795|FG000|Overall Study|Excluded Medication|1|||
148978090|NCT02033889|537400796|FG001|Overall Study|Excluded Medication|1|||
148978091|NCT02033889|537400797|FG002|Overall Study|Excluded Medication|0|||
148978092|NCT02033889|537400795|FG000|Overall Study|Lost to Follow-up|8|||
148978093|NCT02033889|537400796|FG001|Overall Study|Lost to Follow-up|5|||
148978094|NCT02033889|537400797|FG002|Overall Study|Lost to Follow-up|6|||
148978095|NCT02033889|537400795|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148978096|NCT02033889|537400796|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148978097|NCT02033889|537400797|FG002|Overall Study|Non-Compliance With Study Drug|0|||
148978098|NCT02033889|537400795|FG000|Overall Study|Physician Decision|0|||
148978099|NCT02033889|537400796|FG001|Overall Study|Physician Decision|1|||
148978100|NCT02033889|537400797|FG002|Overall Study|Physician Decision|1|||
148978101|NCT02033889|537400795|FG000|Overall Study|Participant moved|0|||
148978102|NCT02033889|537400796|FG001|Overall Study|Participant moved|1|||
148978103|NCT02033889|537400797|FG002|Overall Study|Participant moved|0|||
148978104|NCT02033889|537400795|FG000|Overall Study|Withdrawal by Subject|18|||
148978105|NCT02033889|537400796|FG001|Overall Study|Withdrawal by Subject|10|||
148978106|NCT02033889|537400797|FG002|Overall Study|Withdrawal by Subject|13|||
148978107|NCT03019536|537400798|FG000|Overall Study|Withdrawal by Subject|1|||
148978108|NCT03019536|537400799|FG001|Overall Study|Withdrawal by Subject|1|||
148978109|NCT03019536|537400800|FG002|Overall Study|Withdrawal by Subject|0|||
148978110|NCT03019536|537400798|FG000|Overall Study|Adverse Event|0|||
148978111|NCT03019536|537400799|FG001|Overall Study|Adverse Event|0|||
148978112|NCT03019536|537400800|FG002|Overall Study|Adverse Event|2|||
148978113|NCT01312909|537400801|FG000|Overall Study|Randomized but not treated|1|||
148828272|NCT00500331|536850560|FG006|Overall Study|Participant was randomized by mistake|0|||
148828273|NCT00500331|536850554|FG000|Overall Study|Diabetologist nurse in the study|0|||
148978114|NCT01312909|537400802|FG001|Overall Study|Randomized but not treated|3|||
148978115|NCT01312909|537400803|FG002|Overall Study|Randomized but not treated|1|||
148978116|NCT01312909|537400801|FG000|Overall Study|Adverse Event|1|||
148978117|NCT01312909|537400802|FG001|Overall Study|Adverse Event|0|||
148978118|NCT01312909|537400803|FG002|Overall Study|Adverse Event|3|||
148978119|NCT01312909|537400801|FG000|Overall Study|Protocol Violation|2|||
148978120|NCT01312909|537400802|FG001|Overall Study|Protocol Violation|0|||
148978121|NCT01312909|537400803|FG002|Overall Study|Protocol Violation|2|||
148765980|NCT02792192|536617461|FG002|Overall Study|Progressive Disease|0|||
148765981|NCT02792192|536617462|FG003|Overall Study|Progressive Disease|0|||
148765982|NCT02792192|536617459|FG000|Overall Study|Study Terminated By Sponsor|6|||
148765983|NCT02792192|536617460|FG001|Overall Study|Study Terminated By Sponsor|10|||
148765984|NCT02792192|536617461|FG002|Overall Study|Study Terminated By Sponsor|0|||
148765985|NCT02792192|536617462|FG003|Overall Study|Study Terminated By Sponsor|0|||
148765986|NCT02320058|536617463|FG000|Overall Study|Death|25|||
148765987|NCT02320058|536617464|FG001|Overall Study|Death|10|||
148765988|NCT02320058|536617463|FG000|Overall Study|Lost to Follow-up|4|||
148765989|NCT02320058|536617464|FG001|Overall Study|Lost to Follow-up|0|||
148765990|NCT02320058|536617463|FG000|Overall Study|Other reasons|4|||
148765991|NCT02320058|536617464|FG001|Overall Study|Other reasons|1|||
148765992|NCT02320058|536617463|FG000|Overall Study|Withdrawal by Subject|8|||
148765993|NCT02320058|536617464|FG001|Overall Study|Withdrawal by Subject|2|||
148765994|NCT02320058|536617463|FG000|Overall Study|Not reported|1|||
148765995|NCT02320058|536617464|FG001|Overall Study|Not reported|0|||
148765996|NCT01339923|536617465|FG000|Overall Study|Adverse Event|1|||
148765997|NCT01339923|536617466|FG001|Overall Study|Adverse Event|1|||
148765998|NCT01339923|536617467|FG002|Overall Study|Adverse Event|1|||
148765999|NCT01339923|536617468|FG003|Overall Study|Adverse Event|0|||
148766000|NCT01339923|536617469|FG004|Overall Study|Adverse Event|0|||
148766001|NCT01339923|536617470|FG005|Overall Study|Adverse Event|0|||
148766002|NCT01339923|536617471|FG006|Overall Study|Adverse Event|1|||
148766003|NCT01339923|536617465|FG000|Overall Study|Inappropriate Enrollment|1|||
148978122|NCT01312909|537400801|FG000|Overall Study|Other|9|||
148978123|NCT01312909|537400802|FG001|Overall Study|Other|6|||
148978124|NCT01312909|537400803|FG002|Overall Study|Other|11|||
148978125|NCT01312909|537400801|FG000|Overall Study|Withdrawal by Subject|8|||
148978126|NCT01312909|537400802|FG001|Overall Study|Withdrawal by Subject|10|||
148978127|NCT01312909|537400803|FG002|Overall Study|Withdrawal by Subject|7|||
148978128|NCT01312909|537400801|FG000|Overall Study|Lost to Follow-up|21|||
148978129|NCT01312909|537400802|FG001|Overall Study|Lost to Follow-up|17|||
148978130|NCT01312909|537400803|FG002|Overall Study|Lost to Follow-up|20|||
148978131|NCT01312909|537400801|FG000|Overall Study|Insufficient clinical response|0|||
148978132|NCT01312909|537400802|FG001|Overall Study|Insufficient clinical response|0|||
148978133|NCT01312909|537400803|FG002|Overall Study|Insufficient clinical response|1|||
148978134|NCT01312909|537400801|FG000|Overall Study|Entrance criteria not met|0|||
148978135|NCT01312909|537400802|FG001|Overall Study|Entrance criteria not met|0|||
148978136|NCT01312909|537400803|FG002|Overall Study|Entrance criteria not met|2|||
148766004|NCT01339923|536617466|FG001|Overall Study|Inappropriate Enrollment|0|||
148766005|NCT01339923|536617467|FG002|Overall Study|Inappropriate Enrollment|0|||
148766006|NCT01339923|536617468|FG003|Overall Study|Inappropriate Enrollment|0|||
148766007|NCT01339923|536617469|FG004|Overall Study|Inappropriate Enrollment|0|||
148766008|NCT01339923|536617470|FG005|Overall Study|Inappropriate Enrollment|1|||
148766009|NCT01339923|536617471|FG006|Overall Study|Inappropriate Enrollment|0|||
148978137|NCT00182689|537400809|FG000|Overall Study|Adverse Event|8|||
148978138|NCT00182689|537400810|FG001|Overall Study|Adverse Event|11|||
149027759|NCT03251378|537578643|FG005|Overall Study|Other|0|||
149027760|NCT03251378|537578644|FG006|Overall Study|Other|0|||
148766010|NCT01339923|536617465|FG000|Overall Study|Lost to Follow-up|4|||
148766011|NCT01339923|536617466|FG001|Overall Study|Lost to Follow-up|4|||
148766012|NCT01339923|536617467|FG002|Overall Study|Lost to Follow-up|0|||
148766013|NCT01339923|536617468|FG003|Overall Study|Lost to Follow-up|3|||
148766014|NCT01339923|536617469|FG004|Overall Study|Lost to Follow-up|1|||
148766015|NCT01339923|536617470|FG005|Overall Study|Lost to Follow-up|1|||
148766016|NCT01339923|536617471|FG006|Overall Study|Lost to Follow-up|5|||
148766017|NCT01339923|536617465|FG000|Overall Study|Protocol Violation|0|||
148766018|NCT01339923|536617466|FG001|Overall Study|Protocol Violation|0|||
148766019|NCT01339923|536617467|FG002|Overall Study|Protocol Violation|0|||
148766020|NCT01339923|536617468|FG003|Overall Study|Protocol Violation|0|||
148766021|NCT01339923|536617469|FG004|Overall Study|Protocol Violation|0|||
148766022|NCT01339923|536617470|FG005|Overall Study|Protocol Violation|3|||
148766023|NCT01339923|536617471|FG006|Overall Study|Protocol Violation|1|||
148766024|NCT01339923|536617465|FG000|Overall Study|Unable to Classify|1|||
148766025|NCT01339923|536617466|FG001|Overall Study|Unable to Classify|0|||
148766026|NCT01339923|536617467|FG002|Overall Study|Unable to Classify|1|||
148766027|NCT01339923|536617468|FG003|Overall Study|Unable to Classify|0|||
148766028|NCT01339923|536617469|FG004|Overall Study|Unable to Classify|0|||
148766029|NCT01339923|536617470|FG005|Overall Study|Unable to Classify|1|||
148766030|NCT01339923|536617471|FG006|Overall Study|Unable to Classify|5|||
148766031|NCT01339923|536617465|FG000|Overall Study|Withdrawal by Subject|7|||
148766032|NCT01339923|536617466|FG001|Overall Study|Withdrawal by Subject|11|||
148766033|NCT01339923|536617467|FG002|Overall Study|Withdrawal by Subject|6|||
148766034|NCT01339923|536617468|FG003|Overall Study|Withdrawal by Subject|1|||
148766035|NCT01339923|536617469|FG004|Overall Study|Withdrawal by Subject|4|||
148766036|NCT01339923|536617470|FG005|Overall Study|Withdrawal by Subject|3|||
148766037|NCT01339923|536617471|FG006|Overall Study|Withdrawal by Subject|2|||
148766038|NCT00661609|536617472|FG000|Overall Study|Adverse Event|4|||
148766039|NCT00661609|536617472|FG000|Overall Study|Death|20|||
148766040|NCT00661609|536617472|FG000|Overall Study|Withdrawal by Subject|2|||
148766041|NCT00661609|536617472|FG000|Overall Study|PI Decision|1|||
148766042|NCT00661609|536617472|FG000|Overall Study|Survival follow up stage discontinued|11|||
148766043|NCT00661609|536617472|FG000|Overall Study|Disease progression|3|||
148766044|NCT00637000|536617473|FG000|Overall Study|Withdrawal by Subject|4|||
148766045|NCT00637000|536617474|FG001|Overall Study|Withdrawal by Subject|3|||
148766046|NCT01855243|536617475|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
148766047|NCT01855243|536617476|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
148766048|NCT01855243|536617477|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
148766049|NCT01860040|536617480|FG000|Overall Study|Withdrawal by Subject|1|||
148828274|NCT00500331|536850555|FG001|Overall Study|Diabetologist nurse in the study|0|||
148766050|NCT01860040|536617481|FG001|Overall Study|Withdrawal by Subject|0|||
148766051|NCT01931995|536617482|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
148766052|NCT01931995|536617483|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
148978139|NCT00182689|537400809|FG000|Overall Study|Withdrawal by Subject|2|||
148978140|NCT00182689|537400810|FG001|Overall Study|Withdrawal by Subject|2|||
148978141|NCT00182689|537400809|FG000|Overall Study|Progression|27|||
148978142|NCT00182689|537400810|FG001|Overall Study|Progression|29|||
148978143|NCT00182689|537400809|FG000|Overall Study|Death|1|||
149027761|NCT04739423|537578650|FG000|Overall Study|Protocol Violation|0|||
148766053|NCT01931995|536617482|FG000|First Intervention (1 Day)|Physician Decision|1|||
148766054|NCT01931995|536617483|FG001|First Intervention (1 Day)|Physician Decision|1|||
148978144|NCT00182689|537400810|FG001|Overall Study|Death|0|||
148978145|NCT00182689|537400809|FG000|Overall Study|not protocol specified|0|||
148978146|NCT00182689|537400810|FG001|Overall Study|not protocol specified|3|||
148978147|NCT00182689|537400809|FG000|Overall Study|Ineligible|1|||
148978148|NCT00182689|537400810|FG001|Overall Study|Ineligible|4|||
148978149|NCT00182689|537400809|FG000|Overall Study|Never received treatment|1|||
148978150|NCT00182689|537400810|FG001|Overall Study|Never received treatment|0|||
148978151|NCT00659646|537400811|FG000|Overall Study|Protocol Violation|12|||
148978152|NCT00659646|537400812|FG001|Overall Study|Protocol Violation|8|||
148978153|NCT00659646|537400811|FG000|Overall Study|Adverse Event|1|||
148978154|NCT00659646|537400812|FG001|Overall Study|Adverse Event|0|||
148978155|NCT00659646|537400811|FG000|Overall Study|Lost to Follow-up|1|||
148978156|NCT00659646|537400812|FG001|Overall Study|Lost to Follow-up|0|||
148978157|NCT00659646|537400811|FG000|Overall Study|protocol noncompliance after randomized|1|||
148978158|NCT00659646|537400812|FG001|Overall Study|protocol noncompliance after randomized|0|||
148978159|NCT01640301|537400813|FG000|Overall Study|Death|0|||
148978160|NCT01640301|537400814|FG001|Overall Study|Death|8|||
148978161|NCT02200042|537400817|FG000|Overall Study|Withdrawal by Subject|0|||
148978162|NCT02200042|537400818|FG001|Overall Study|Withdrawal by Subject|1|||
148978163|NCT01969838|537400819|FG000|Double-blind Phase|Adverse Event|10|||
148978164|NCT01969838|537400820|FG001|Double-blind Phase|Adverse Event|4|||
148978165|NCT01969838|537400821|FG002|Double-blind Phase|Adverse Event|0|||
148978166|NCT01969838|537400822|FG003|Double-blind Phase|Adverse Event|0|||
148978167|NCT01969838|537400819|FG000|Double-blind Phase|Death|5|||
148978168|NCT01969838|537400820|FG001|Double-blind Phase|Death|2|||
148978169|NCT01969838|537400821|FG002|Double-blind Phase|Death|0|||
148978170|NCT01969838|537400822|FG003|Double-blind Phase|Death|0|||
148978171|NCT01969838|537400819|FG000|Double-blind Phase|Physician Decision|5|||
148978172|NCT01969838|537400820|FG001|Double-blind Phase|Physician Decision|1|||
148978173|NCT01969838|537400821|FG002|Double-blind Phase|Physician Decision|0|||
148978174|NCT01969838|537400822|FG003|Double-blind Phase|Physician Decision|0|||
148978175|NCT01969838|537400819|FG000|Double-blind Phase|Subject Decision|4|||
148978176|NCT01969838|537400820|FG001|Double-blind Phase|Subject Decision|2|||
148978177|NCT01969838|537400821|FG002|Double-blind Phase|Subject Decision|0|||
148978178|NCT01969838|537400822|FG003|Double-blind Phase|Subject Decision|0|||
148978179|NCT01969838|537400819|FG000|Double-blind Phase|Disease Progression|2|||
148978180|NCT01969838|537400820|FG001|Double-blind Phase|Disease Progression|0|||
148978181|NCT01969838|537400821|FG002|Double-blind Phase|Disease Progression|0|||
148978182|NCT01969838|537400822|FG003|Double-blind Phase|Disease Progression|0|||
148978183|NCT01969838|537400819|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
148978184|NCT01969838|537400820|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
148978185|NCT01969838|537400821|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
148978186|NCT01969838|537400822|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
148978187|NCT01969838|537400819|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
148978188|NCT01969838|537400820|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
148978189|NCT01969838|537400821|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
148978190|NCT01969838|537400822|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
148978191|NCT01969838|537400819|FG000|Open-label Phase|Adverse Event|0|||
148978192|NCT01969838|537400820|FG001|Open-label Phase|Adverse Event|0|||
148828275|NCT00500331|536850556|FG002|Overall Study|Diabetologist nurse in the study|1|||
148828276|NCT00500331|536850557|FG003|Overall Study|Diabetologist nurse in the study|0|||
148828277|NCT00500331|536850558|FG004|Overall Study|Diabetologist nurse in the study|0|||
148828278|NCT00500331|536850559|FG005|Overall Study|Diabetologist nurse in the study|0|||
148828279|NCT00500331|536850560|FG006|Overall Study|Diabetologist nurse in the study|0|||
148828280|NCT00500331|536850554|FG000|Overall Study|State ban of biological samples export|0|||
148828281|NCT00500331|536850555|FG001|Overall Study|State ban of biological samples export|0|||
148828282|NCT00500331|536850556|FG002|Overall Study|State ban of biological samples export|0|||
148828283|NCT00500331|536850557|FG003|Overall Study|State ban of biological samples export|1|||
148828284|NCT00500331|536850558|FG004|Overall Study|State ban of biological samples export|0|||
148828285|NCT00500331|536850559|FG005|Overall Study|State ban of biological samples export|0|||
148978193|NCT01969838|537400821|FG002|Open-label Phase|Adverse Event|37|||
148978194|NCT01969838|537400822|FG003|Open-label Phase|Adverse Event|49|||
148978195|NCT01969838|537400819|FG000|Open-label Phase|Disease Progression|0|||
148978196|NCT01969838|537400820|FG001|Open-label Phase|Disease Progression|0|||
148978197|NCT01969838|537400821|FG002|Open-label Phase|Disease Progression|26|||
148978198|NCT01969838|537400822|FG003|Open-label Phase|Disease Progression|27|||
148828286|NCT00500331|536850560|FG006|Overall Study|State ban of biological samples export|0|||
148978199|NCT01969838|537400819|FG000|Open-label Phase|Lack of Efficacy|0|||
148978200|NCT01969838|537400820|FG001|Open-label Phase|Lack of Efficacy|0|||
148978201|NCT01969838|537400821|FG002|Open-label Phase|Lack of Efficacy|17|||
148978202|NCT01969838|537400822|FG003|Open-label Phase|Lack of Efficacy|19|||
148978203|NCT01969838|537400819|FG000|Open-label Phase|Subject Decision|0|||
148978204|NCT01969838|537400820|FG001|Open-label Phase|Subject Decision|0|||
148978205|NCT01969838|537400821|FG002|Open-label Phase|Subject Decision|14|||
148978206|NCT01969838|537400822|FG003|Open-label Phase|Subject Decision|15|||
148978207|NCT01969838|537400819|FG000|Open-label Phase|Death|0|||
148978208|NCT01969838|537400820|FG001|Open-label Phase|Death|0|||
148828287|NCT00500331|536850554|FG000|Overall Study|Protocol violated|0|||
148828288|NCT00500331|536850555|FG001|Overall Study|Protocol violated|0|||
148828289|NCT00500331|536850556|FG002|Overall Study|Protocol violated|0|||
148828290|NCT00500331|536850557|FG003|Overall Study|Protocol violated|1|||
148828291|NCT00500331|536850558|FG004|Overall Study|Protocol violated|0|||
148828292|NCT00500331|536850559|FG005|Overall Study|Protocol violated|0|||
148828293|NCT00500331|536850560|FG006|Overall Study|Protocol violated|0|||
148828294|NCT00833703|536850566|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
148828295|NCT00833703|536850567|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
148828296|NCT03033784|536850568|FG000|Overall Study|Anxiety related to MRI scanner|0|||
148828297|NCT03033784|536850569|FG001|Overall Study|Anxiety related to MRI scanner|1|||
148828298|NCT03033784|536850570|FG002|Overall Study|Anxiety related to MRI scanner|0|||
148828299|NCT03033784|536850571|FG003|Overall Study|Anxiety related to MRI scanner|0|||
148828300|NCT03033784|536850572|FG004|Overall Study|Anxiety related to MRI scanner|0|||
148828301|NCT03033784|536850573|FG005|Overall Study|Anxiety related to MRI scanner|0|||
148828302|NCT03033784|536850574|FG006|Overall Study|Anxiety related to MRI scanner|0|||
148828303|NCT03033784|536850575|FG007|Overall Study|Anxiety related to MRI scanner|0|||
148828304|NCT03033784|536850576|FG008|Overall Study|Anxiety related to MRI scanner|0|||
148828305|NCT03033784|536850577|FG009|Overall Study|Anxiety related to MRI scanner|0|||
148828306|NCT03033784|536850578|FG010|Overall Study|Anxiety related to MRI scanner|0|||
148828307|NCT03033784|536850579|FG011|Overall Study|Anxiety related to MRI scanner|0|||
148828308|NCT03033784|536850580|FG012|Overall Study|Anxiety related to MRI scanner|0|||
148828309|NCT03033784|536850568|FG000|Overall Study|Withdrawal by Subject|0|||
148828310|NCT03033784|536850569|FG001|Overall Study|Withdrawal by Subject|0|||
148828311|NCT03033784|536850570|FG002|Overall Study|Withdrawal by Subject|0|||
148828312|NCT03033784|536850571|FG003|Overall Study|Withdrawal by Subject|0|||
148828313|NCT03033784|536850572|FG004|Overall Study|Withdrawal by Subject|0|||
148828314|NCT03033784|536850573|FG005|Overall Study|Withdrawal by Subject|0|||
148828315|NCT03033784|536850574|FG006|Overall Study|Withdrawal by Subject|0|||
148828316|NCT03033784|536850575|FG007|Overall Study|Withdrawal by Subject|0|||
148828317|NCT03033784|536850576|FG008|Overall Study|Withdrawal by Subject|0|||
148828318|NCT03033784|536850577|FG009|Overall Study|Withdrawal by Subject|0|||
148828319|NCT03033784|536850578|FG010|Overall Study|Withdrawal by Subject|0|||
148828320|NCT03033784|536850579|FG011|Overall Study|Withdrawal by Subject|0|||
148828321|NCT03033784|536850580|FG012|Overall Study|Withdrawal by Subject|2|||
148828322|NCT00267488|536850581|FG000|Overall Study|Sponsor Terminated Study|9|||
148828323|NCT00267488|536850581|FG000|Overall Study|Protocol Violation|1|||
148828324|NCT00267488|536850581|FG000|Overall Study|Other (Disease Progression)|1|||
148828325|NCT01149460|536850582|FG000|Overall Study|Withdrawal by Subject|0|||
148828326|NCT01149460|536850583|FG001|Overall Study|Withdrawal by Subject|2|||
148828327|NCT01904279|536850589|FG000|Overall Study|Lack of Efficacy|2|||
148828328|NCT01904279|536850590|FG001|Overall Study|Lack of Efficacy|3|||
148828329|NCT01904279|536850589|FG000|Overall Study|Withdrawal by Subject|1|||
148828330|NCT01904279|536850590|FG001|Overall Study|Withdrawal by Subject|0|||
148828331|NCT03257657|536850600|FG000|Overall Study|Lost to Follow-up|0|||
148828332|NCT03257657|536850601|FG001|Overall Study|Lost to Follow-up|3|||
148828333|NCT03257657|536850600|FG000|Overall Study|Withdrawn|0|||
148828334|NCT03257657|536850601|FG001|Overall Study|Withdrawn|1|||
148828335|NCT03257657|536850600|FG000|Overall Study|Noted not eligible right after enrolled|0|||
148828336|NCT03257657|536850601|FG001|Overall Study|Noted not eligible right after enrolled|1|||
148828337|NCT02801578|536850602|FG000|Overall Study|Adverse Event|2|||
148828338|NCT00137449|536850603|FG000|Overall Study|Disease Progression|8|||
148828339|NCT00137449|536850604|FG001|Overall Study|Disease Progression|13|||
148828340|NCT00137449|536850603|FG000|Overall Study|Death|4|||
148828341|NCT00137449|536850604|FG001|Overall Study|Death|3|||
148828342|NCT00137449|536850603|FG000|Overall Study|Adverse Event|3|||
148828343|NCT00137449|536850604|FG001|Overall Study|Adverse Event|1|||
148828344|NCT00137449|536850603|FG000|Overall Study|Withdrawal by Subject|1|||
148978209|NCT01969838|537400821|FG002|Open-label Phase|Death|13|||
148978210|NCT01969838|537400822|FG003|Open-label Phase|Death|11|||
148828345|NCT00137449|536850604|FG001|Overall Study|Withdrawal by Subject|1|||
148978211|NCT01969838|537400819|FG000|Open-label Phase|Physician Decision|0|||
148828346|NCT01356940|536850612|FG000|First Intervention (28 Days)|Adverse Event|1|||
148978212|NCT01969838|537400820|FG001|Open-label Phase|Physician Decision|0|||
148828347|NCT01356940|536850613|FG001|First Intervention (28 Days)|Adverse Event|0|||
148828348|NCT01356940|536850612|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
148828349|NCT01356940|536850613|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
148828350|NCT00668642|536850614|FG000|First Off-cycle|Cancer progression|1|||
148828351|NCT00668642|536850615|FG001|First Off-cycle|Cancer progression|0|||
148828352|NCT00668642|536850614|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
148978213|NCT01969838|537400821|FG002|Open-label Phase|Physician Decision|9|||
148978214|NCT01969838|537400822|FG003|Open-label Phase|Physician Decision|14|||
148978215|NCT01969838|537400819|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
148828353|NCT00668642|536850615|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
148828354|NCT03412591|536850616|FG000|Overall Study|Withdrawal by Subject|1|||
148978216|NCT01969838|537400820|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
148978217|NCT01969838|537400821|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
148978218|NCT01969838|537400822|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
148978219|NCT00408993|537400823|FG000|Overall Study|Adverse Event|15|||
148978220|NCT00408993|537400824|FG001|Overall Study|Adverse Event|4|||
148978221|NCT00408993|537400823|FG000|Overall Study|Protocol Violation|1|||
148978222|NCT00408993|537400824|FG001|Overall Study|Protocol Violation|6|||
148978223|NCT00408993|537400823|FG000|Overall Study|Lack of Efficacy|1|||
148978224|NCT00408993|537400824|FG001|Overall Study|Lack of Efficacy|4|||
149027762|NCT04739423|537578651|FG001|Overall Study|Protocol Violation|1|||
148766055|NCT01931995|536617482|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
148766056|NCT01931995|536617483|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
148766057|NCT02477826|536617502|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
148766058|NCT02477826|536617503|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
148766059|NCT02477826|536617504|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
148766060|NCT02477826|536617505|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
148766061|NCT02477826|536617506|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
148766062|NCT02477826|536617507|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
148766063|NCT02477826|536617508|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
148766064|NCT02477826|536617509|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
148766065|NCT02477826|536617510|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
148766066|NCT02477826|536617511|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
148766067|NCT02477826|536617502|FG000|Pre-Treatment|Other reasons|4|||
148766068|NCT02477826|536617503|FG001|Pre-Treatment|Other reasons|1|||
148766069|NCT02477826|536617504|FG002|Pre-Treatment|Other reasons|4|||
148766070|NCT02477826|536617505|FG003|Pre-Treatment|Other reasons|1|||
148766071|NCT02477826|536617506|FG004|Pre-Treatment|Other reasons|4|||
148766072|NCT02477826|536617507|FG005|Pre-Treatment|Other reasons|2|||
148766073|NCT02477826|536617508|FG006|Pre-Treatment|Other reasons|0|||
148766074|NCT02477826|536617509|FG007|Pre-Treatment|Other reasons|0|||
148766075|NCT02477826|536617510|FG008|Pre-Treatment|Other reasons|0|||
148766076|NCT02477826|536617511|FG009|Pre-Treatment|Other reasons|0|||
148766077|NCT02477826|536617502|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
148766078|NCT02477826|536617503|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
148766079|NCT02477826|536617504|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
148766080|NCT02477826|536617505|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
148766081|NCT02477826|536617506|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
148766082|NCT02477826|536617507|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
148766083|NCT02477826|536617508|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
148766084|NCT02477826|536617509|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
148766085|NCT02477826|536617510|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
148766086|NCT02477826|536617511|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
148766087|NCT02477826|536617502|FG000|Pre-Treatment|Subject withdrew consent|0|||
148766088|NCT02477826|536617503|FG001|Pre-Treatment|Subject withdrew consent|0|||
148766089|NCT02477826|536617504|FG002|Pre-Treatment|Subject withdrew consent|3|||
148766090|NCT02477826|536617505|FG003|Pre-Treatment|Subject withdrew consent|0|||
148766091|NCT02477826|536617506|FG004|Pre-Treatment|Subject withdrew consent|0|||
148766092|NCT02477826|536617507|FG005|Pre-Treatment|Subject withdrew consent|1|||
148766093|NCT02477826|536617508|FG006|Pre-Treatment|Subject withdrew consent|0|||
148766094|NCT02477826|536617509|FG007|Pre-Treatment|Subject withdrew consent|1|||
148766095|NCT02477826|536617510|FG008|Pre-Treatment|Subject withdrew consent|0|||
148766096|NCT02477826|536617511|FG009|Pre-Treatment|Subject withdrew consent|3|||
148766097|NCT02477826|536617502|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766098|NCT02477826|536617503|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
148766099|NCT02477826|536617504|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766100|NCT02477826|536617505|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766101|NCT02477826|536617506|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766102|NCT02477826|536617507|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766103|NCT02477826|536617508|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766104|NCT02477826|536617509|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766105|NCT02477826|536617510|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
148766106|NCT02477826|536617511|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
148766107|NCT02477826|536617502|FG000|Pre-Treatment|Death|0|||
148766108|NCT02477826|536617503|FG001|Pre-Treatment|Death|0|||
148766109|NCT02477826|536617504|FG002|Pre-Treatment|Death|0|||
148766110|NCT02477826|536617505|FG003|Pre-Treatment|Death|0|||
148766111|NCT02477826|536617506|FG004|Pre-Treatment|Death|0|||
148766112|NCT02477826|536617507|FG005|Pre-Treatment|Death|0|||
148766113|NCT02477826|536617508|FG006|Pre-Treatment|Death|1|||
148766114|NCT02477826|536617509|FG007|Pre-Treatment|Death|0|||
148766115|NCT02477826|536617510|FG008|Pre-Treatment|Death|0|||
149027763|NCT04739423|537578652|FG002|Overall Study|Protocol Violation|0|||
148978225|NCT00408993|537400823|FG000|Overall Study|Withdrawal by Subject|2|||
148978226|NCT00408993|537400824|FG001|Overall Study|Withdrawal by Subject|3|||
148978227|NCT00298896|537400825|FG000|Overall Study|Death|3|||
148978228|NCT00298896|537400825|FG000|Overall Study|Physician Decision|2|||
148978229|NCT00298896|537400825|FG000|Overall Study|Intercurrent Illness|1|||
148978230|NCT00298896|537400825|FG000|Overall Study|Disease Progression|41|||
148978231|NCT00298896|537400825|FG000|Overall Study|Withdrawal by Subject|2|||
148978232|NCT00298896|537400825|FG000|Overall Study|Assigned to treatment in error|1|||
148978233|NCT02880371|537400826|FG000|Phase 1b|Lost to Follow-up|1|||
148978234|NCT02880371|537400827|FG001|Phase 1b|Lost to Follow-up|0|||
148978235|NCT02880371|537400828|FG002|Phase 1b|Lost to Follow-up|0|||
148978236|NCT02880371|537400829|FG003|Phase 1b|Lost to Follow-up|0|||
149027764|NCT04739423|537578653|FG003|Overall Study|Protocol Violation|0|||
148828355|NCT03412591|536850617|FG001|Overall Study|Withdrawal by Subject|8|||
148828356|NCT03412591|536850616|FG000|Overall Study|Adverse Event|0|||
148828357|NCT03412591|536850617|FG001|Overall Study|Adverse Event|1|||
148828358|NCT02272985|536850618|FG000|Overall Study|Withdrawal by Subject|1|||
148828359|NCT02272985|536850618|FG000|Overall Study|hip fracture|1|||
148828360|NCT02272985|536850618|FG000|Overall Study|kidney transplantation|1|||
148828361|NCT02489279|536850623|FG000|Overall Study|Lost to Follow-up|12|||
148828362|NCT02489279|536850624|FG001|Overall Study|Lost to Follow-up|10|||
149027765|NCT04739423|537578654|FG004|Overall Study|Protocol Violation|0|||
148766116|NCT02477826|536617511|FG009|Pre-Treatment|Death|0|||
148766117|NCT02477826|536617502|FG000|Treatment Period|Not reported|8|||
148766118|NCT02477826|536617503|FG001|Treatment Period|Not reported|6|||
148766119|NCT02477826|536617504|FG002|Treatment Period|Not reported|4|||
148766120|NCT02477826|536617505|FG003|Treatment Period|Not reported|4|||
148766121|NCT02477826|536617506|FG004|Treatment Period|Not reported|2|||
148766122|NCT02477826|536617507|FG005|Treatment Period|Not reported|1|||
148766123|NCT02477826|536617508|FG006|Treatment Period|Not reported|14|||
148766124|NCT02477826|536617509|FG007|Treatment Period|Not reported|8|||
148766125|NCT02477826|536617510|FG008|Treatment Period|Not reported|5|||
148766126|NCT02477826|536617511|FG009|Treatment Period|Not reported|2|||
148766127|NCT02477826|536617502|FG000|Treatment Period|Other reasons|5|||
148766128|NCT02477826|536617503|FG001|Treatment Period|Other reasons|6|||
148766129|NCT02477826|536617504|FG002|Treatment Period|Other reasons|12|||
148766130|NCT02477826|536617505|FG003|Treatment Period|Other reasons|7|||
148766131|NCT02477826|536617506|FG004|Treatment Period|Other reasons|5|||
148766132|NCT02477826|536617507|FG005|Treatment Period|Other reasons|1|||
148766133|NCT02477826|536617508|FG006|Treatment Period|Other reasons|8|||
148766134|NCT02477826|536617509|FG007|Treatment Period|Other reasons|8|||
148766135|NCT02477826|536617510|FG008|Treatment Period|Other reasons|21|||
148766136|NCT02477826|536617511|FG009|Treatment Period|Other reasons|1|||
148766137|NCT02477826|536617502|FG000|Treatment Period|Administrative reason by sponsor|0|||
148766138|NCT02477826|536617503|FG001|Treatment Period|Administrative reason by sponsor|3|||
148766139|NCT02477826|536617504|FG002|Treatment Period|Administrative reason by sponsor|0|||
148766140|NCT02477826|536617505|FG003|Treatment Period|Administrative reason by sponsor|0|||
148766141|NCT02477826|536617506|FG004|Treatment Period|Administrative reason by sponsor|0|||
148766142|NCT02477826|536617507|FG005|Treatment Period|Administrative reason by sponsor|0|||
148766143|NCT02477826|536617508|FG006|Treatment Period|Administrative reason by sponsor|0|||
148766144|NCT02477826|536617509|FG007|Treatment Period|Administrative reason by sponsor|0|||
148766145|NCT02477826|536617510|FG008|Treatment Period|Administrative reason by sponsor|0|||
148766146|NCT02477826|536617511|FG009|Treatment Period|Administrative reason by sponsor|0|||
148766147|NCT02477826|536617502|FG000|Treatment Period|Participant meet no longer study criteria|1|||
148766148|NCT02477826|536617503|FG001|Treatment Period|Participant meet no longer study criteria|1|||
148766149|NCT02477826|536617504|FG002|Treatment Period|Participant meet no longer study criteria|0|||
148766150|NCT02477826|536617505|FG003|Treatment Period|Participant meet no longer study criteria|0|||
148766151|NCT02477826|536617506|FG004|Treatment Period|Participant meet no longer study criteria|1|||
148766152|NCT02477826|536617507|FG005|Treatment Period|Participant meet no longer study criteria|1|||
148766153|NCT02477826|536617508|FG006|Treatment Period|Participant meet no longer study criteria|0|||
148766154|NCT02477826|536617509|FG007|Treatment Period|Participant meet no longer study criteria|1|||
148766155|NCT02477826|536617510|FG008|Treatment Period|Participant meet no longer study criteria|0|||
148766156|NCT02477826|536617511|FG009|Treatment Period|Participant meet no longer study criteria|0|||
148766157|NCT02477826|536617502|FG000|Treatment Period|Poor/Non Compliance|1|||
148766158|NCT02477826|536617503|FG001|Treatment Period|Poor/Non Compliance|0|||
148828363|NCT02263547|536850625|FG000|Overall Study|Adverse Event|1|||
148828364|NCT02263547|536850625|FG000|Overall Study|Lost to Follow-up|2|||
148828365|NCT00505687|536850628|FG000|Overall Study|Important protocol violation|2|||
148978237|NCT02880371|537400830|FG004|Phase 1b|Lost to Follow-up|0|||
148766159|NCT02477826|536617504|FG002|Treatment Period|Poor/Non Compliance|2|||
148766160|NCT02477826|536617505|FG003|Treatment Period|Poor/Non Compliance|0|||
148766161|NCT02477826|536617506|FG004|Treatment Period|Poor/Non Compliance|0|||
148766162|NCT02477826|536617507|FG005|Treatment Period|Poor/Non Compliance|1|||
148828366|NCT00505687|536850628|FG000|Overall Study|Lack of Efficacy|15|||
148828367|NCT00505687|536850628|FG000|Overall Study|Adverse Event|48|||
148978238|NCT02880371|537400831|FG005|Phase 1b|Lost to Follow-up|0|||
148978239|NCT02880371|537400832|FG006|Phase 1b|Lost to Follow-up|0|||
148978240|NCT02880371|537400833|FG007|Phase 1b|Lost to Follow-up|0|||
148978241|NCT02880371|537400826|FG000|Phase 1b|Participants terminated by Sponsor|1|||
148828368|NCT00505687|536850628|FG000|Overall Study|Subject withdrew consent|15|||
148828369|NCT00505687|536850628|FG000|Overall Study|Lost to Follow-up|1|||
148828370|NCT00505687|536850628|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
148828371|NCT00505687|536850628|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
148828372|NCT00505687|536850628|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
148828373|NCT00505687|536850628|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
148828374|NCT00505687|536850628|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
148828375|NCT00505687|536850628|FG000|Overall Study|Other: Disease Progression|1|||
148828376|NCT00505687|536850628|FG000|Overall Study|Other: As Per Sponsor|8|||
148828377|NCT03707821|536850629|FG000|Overall Study|Protocol Violation|0|||
148828378|NCT03707821|536850630|FG001|Overall Study|Protocol Violation|1|||
148828379|NCT03707821|536850629|FG000|Overall Study|Unsatisfactory Visual Response|1|||
148828380|NCT03707821|536850630|FG001|Overall Study|Unsatisfactory Visual Response|0|||
148828381|NCT03707821|536850629|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
148828382|NCT03707821|536850630|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
148828383|NCT03283241|536850631|FG000|Overall Study|Adverse Event|4|||
148828384|NCT03283241|536850632|FG001|Overall Study|Adverse Event|1|||
148828385|NCT03283241|536850631|FG000|Overall Study|Withdrawal by Subject|0|||
148828386|NCT03283241|536850632|FG001|Overall Study|Withdrawal by Subject|1|||
148828387|NCT03283241|536850631|FG000|Overall Study|Subject relocated to Finland|0|||
148828388|NCT03283241|536850632|FG001|Overall Study|Subject relocated to Finland|1|||
148828389|NCT02439957|536850635|FG000|Overall Study|Study Terminated|3|||
148828390|NCT02439957|536850636|FG001|Overall Study|Study Terminated|3|||
148828391|NCT00666263|536850637|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
148828392|NCT00666263|536850638|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
148828393|NCT00666263|536850637|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
148828394|NCT00666263|536850638|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
148828395|NCT00666263|536850637|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
148828396|NCT00666263|536850638|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
148828397|NCT00586157|536850639|FG000|First Intervention|Worsening behavior|1|||
148828398|NCT00586157|536850640|FG001|First Intervention|Worsening behavior|0|||
148828399|NCT00586157|536850639|FG000|Second Intervention|Withdrawal by Subject|1|||
148828400|NCT00586157|536850640|FG001|Second Intervention|Withdrawal by Subject|0|||
148828401|NCT00586157|536850639|FG000|Second Intervention|Worsening behavior|1|||
148828402|NCT00586157|536850640|FG001|Second Intervention|Worsening behavior|0|||
148828403|NCT00586157|536850639|FG000|Second Intervention|Adverse Event|0|||
148828404|NCT00586157|536850640|FG001|Second Intervention|Adverse Event|1|||
148828405|NCT02014467|536850642|FG000|Overall Study|Adverse Event|4|||
148828406|NCT02014467|536850643|FG001|Overall Study|Adverse Event|0|||
148828407|NCT02014467|536850642|FG000|Overall Study|Protocol Violation|3|||
148828408|NCT02014467|536850643|FG001|Overall Study|Protocol Violation|0|||
148828409|NCT02014467|536850642|FG000|Overall Study|Physician Decision|2|||
148828410|NCT02014467|536850643|FG001|Overall Study|Physician Decision|3|||
148828411|NCT02014467|536850642|FG000|Overall Study|Withdrawal by Subject|16|||
148828412|NCT02014467|536850643|FG001|Overall Study|Withdrawal by Subject|4|||
148828413|NCT00831389|536850646|FG000|Overall Study|Withdrawal by Subject|0|||
148828414|NCT00831389|536850647|FG001|Overall Study|Withdrawal by Subject|1|||
148828415|NCT00278161|536850649|FG000|Overall Study|Death|11|||
148828416|NCT01817777|536850650|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
148828417|NCT01817777|536850651|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
148828418|NCT01817777|536850652|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
148828419|NCT01817777|536850650|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
148828420|NCT01817777|536850651|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
148828421|NCT01817777|536850652|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
148828422|NCT01817777|536850650|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
148978242|NCT02880371|537400827|FG001|Phase 1b|Participants terminated by Sponsor|0|||
148978243|NCT02880371|537400828|FG002|Phase 1b|Participants terminated by Sponsor|0|||
148978244|NCT02880371|537400829|FG003|Phase 1b|Participants terminated by Sponsor|0|||
148828423|NCT01817777|536850651|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
148978245|NCT02880371|537400830|FG004|Phase 1b|Participants terminated by Sponsor|0|||
148828424|NCT01817777|536850652|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
148828425|NCT01817777|536850650|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
148828426|NCT01817777|536850651|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
148828427|NCT01817777|536850652|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
148828428|NCT01817777|536850650|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
148828429|NCT01817777|536850651|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
148828430|NCT01817777|536850652|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
148978246|NCT02880371|537400831|FG005|Phase 1b|Participants terminated by Sponsor|0|||
148828431|NCT00443456|536850653|FG000|Overall Study|Adverse Event|16|||
148978247|NCT02880371|537400832|FG006|Phase 1b|Participants terminated by Sponsor|0|||
148978248|NCT02880371|537400833|FG007|Phase 1b|Participants terminated by Sponsor|0|||
148978249|NCT02880371|537400826|FG000|Phase 1b|Withdrawal by Subject|0|||
148978250|NCT02880371|537400827|FG001|Phase 1b|Withdrawal by Subject|0|||
148978251|NCT02880371|537400828|FG002|Phase 1b|Withdrawal by Subject|1|||
148978252|NCT02880371|537400829|FG003|Phase 1b|Withdrawal by Subject|0|||
148978253|NCT02880371|537400830|FG004|Phase 1b|Withdrawal by Subject|0|||
148978254|NCT02880371|537400831|FG005|Phase 1b|Withdrawal by Subject|0|||
148978255|NCT02880371|537400832|FG006|Phase 1b|Withdrawal by Subject|0|||
148978256|NCT02880371|537400833|FG007|Phase 1b|Withdrawal by Subject|0|||
148978257|NCT02880371|537400826|FG000|Phase 1b|Death|4|||
148978258|NCT02880371|537400827|FG001|Phase 1b|Death|6|||
148978259|NCT02880371|537400828|FG002|Phase 1b|Death|5|||
148978260|NCT02880371|537400829|FG003|Phase 1b|Death|1|||
148978261|NCT02880371|537400830|FG004|Phase 1b|Death|0|||
148978262|NCT02880371|537400831|FG005|Phase 1b|Death|0|||
148978263|NCT02880371|537400832|FG006|Phase 1b|Death|0|||
148978264|NCT02880371|537400833|FG007|Phase 1b|Death|0|||
148978265|NCT02880371|537400826|FG000|Phase 1b|Enrolled but not Treated|0|||
148978266|NCT02880371|537400827|FG001|Phase 1b|Enrolled but not Treated|1|||
148978267|NCT02880371|537400828|FG002|Phase 1b|Enrolled but not Treated|0|||
148978268|NCT02880371|537400829|FG003|Phase 1b|Enrolled but not Treated|0|||
148978269|NCT02880371|537400830|FG004|Phase 1b|Enrolled but not Treated|0|||
148978270|NCT02880371|537400831|FG005|Phase 1b|Enrolled but not Treated|0|||
148978271|NCT02880371|537400832|FG006|Phase 1b|Enrolled but not Treated|0|||
148978272|NCT02880371|537400833|FG007|Phase 1b|Enrolled but not Treated|0|||
148978273|NCT02880371|537400826|FG000|Phase 2|Enrolled but not Treated|0|||
148978274|NCT02880371|537400827|FG001|Phase 2|Enrolled but not Treated|0|||
148978275|NCT02880371|537400828|FG002|Phase 2|Enrolled but not Treated|0|||
148978276|NCT02880371|537400829|FG003|Phase 2|Enrolled but not Treated|0|||
148978277|NCT02880371|537400830|FG004|Phase 2|Enrolled but not Treated|0|||
148978278|NCT02880371|537400831|FG005|Phase 2|Enrolled but not Treated|1|||
148978279|NCT02880371|537400832|FG006|Phase 2|Enrolled but not Treated|1|||
148978280|NCT02880371|537400833|FG007|Phase 2|Enrolled but not Treated|0|||
148828432|NCT00443456|536850653|FG000|Overall Study|Move|1|||
148828433|NCT00443456|536850653|FG000|Overall Study|Withdrawal by Subject|1|||
148828434|NCT03242434|536850654|FG000|Overall Study|Death|0|||
148828435|NCT03242434|536850655|FG001|Overall Study|Death|2|||
148828436|NCT00414609|536850656|FG000|Core Study|Adverse Event|9|||
148828437|NCT00414609|536850657|FG001|Core Study|Adverse Event|11|||
148828438|NCT00414609|536850658|FG002|Core Study|Adverse Event|0|||
148828439|NCT00414609|536850656|FG000|Core Study|Abnormal laboratory values|0|||
148828440|NCT00414609|536850657|FG001|Core Study|Abnormal laboratory values|1|||
148828441|NCT00414609|536850658|FG002|Core Study|Abnormal laboratory values|0|||
148828442|NCT00414609|536850656|FG000|Core Study|Abnormal test procedure results|1|||
148828443|NCT00414609|536850657|FG001|Core Study|Abnormal test procedure results|1|||
148828444|NCT00414609|536850658|FG002|Core Study|Abnormal test procedure results|0|||
148828445|NCT00414609|536850656|FG000|Core Study|Protocol deviation|0|||
148828446|NCT00414609|536850657|FG001|Core Study|Protocol deviation|1|||
148828447|NCT00414609|536850658|FG002|Core Study|Protocol deviation|0|||
148828448|NCT00414609|536850656|FG000|Core Study|Patient withdrew consent|10|||
148828449|NCT00414609|536850657|FG001|Core Study|Patient withdrew consent|11|||
148828450|NCT00414609|536850658|FG002|Core Study|Patient withdrew consent|0|||
148828451|NCT00414609|536850656|FG000|Core Study|Lost to Follow-up|7|||
148828452|NCT00414609|536850657|FG001|Core Study|Lost to Follow-up|4|||
148828453|NCT00414609|536850658|FG002|Core Study|Lost to Follow-up|0|||
148828454|NCT00414609|536850656|FG000|Core Study|Administrative problems|0|||
148828455|NCT00414609|536850657|FG001|Core Study|Administrative problems|2|||
148828456|NCT00414609|536850658|FG002|Core Study|Administrative problems|0|||
148828457|NCT00414609|536850656|FG000|Core Study|Death|7|||
148828458|NCT00414609|536850657|FG001|Core Study|Death|14|||
148828459|NCT00414609|536850658|FG002|Core Study|Death|0|||
148828460|NCT00414609|536850656|FG000|Extension Study|Adverse Event|0|||
148978281|NCT02880371|537400826|FG000|Phase 2|Other|0|||
148978282|NCT02880371|537400827|FG001|Phase 2|Other|0|||
148978283|NCT02880371|537400828|FG002|Phase 2|Other|0|||
148978284|NCT02880371|537400829|FG003|Phase 2|Other|0|||
148828461|NCT00414609|536850657|FG001|Extension Study|Adverse Event|0|||
148828462|NCT00414609|536850658|FG002|Extension Study|Adverse Event|14|||
148828463|NCT00414609|536850656|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
148828464|NCT00414609|536850657|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
148828465|NCT00414609|536850658|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
148828466|NCT00414609|536850656|FG000|Extension Study|Withdrawal by Subject|0|||
148828467|NCT00414609|536850657|FG001|Extension Study|Withdrawal by Subject|0|||
148828468|NCT00414609|536850658|FG002|Extension Study|Withdrawal by Subject|13|||
148828469|NCT00414609|536850656|FG000|Extension Study|Lost to Follow-up|0|||
148828470|NCT00414609|536850657|FG001|Extension Study|Lost to Follow-up|0|||
148978285|NCT02880371|537400830|FG004|Phase 2|Other|0|||
148978286|NCT02880371|537400831|FG005|Phase 2|Other|1|||
148978287|NCT02880371|537400832|FG006|Phase 2|Other|2|||
148978288|NCT02880371|537400833|FG007|Phase 2|Other|1|||
148978289|NCT02880371|537400826|FG000|Phase 2|Participants terminated by Sponsor|0|||
148828471|NCT00414609|536850658|FG002|Extension Study|Lost to Follow-up|10|||
148828472|NCT00414609|536850656|FG000|Extension Study|Administrative problems|0|||
148828473|NCT00414609|536850657|FG001|Extension Study|Administrative problems|0|||
148828474|NCT00414609|536850658|FG002|Extension Study|Administrative problems|1|||
148828475|NCT00414609|536850656|FG000|Extension Study|Death|0|||
148828476|NCT00414609|536850657|FG001|Extension Study|Death|0|||
148828477|NCT00414609|536850658|FG002|Extension Study|Death|17|||
148828478|NCT00266032|536850659|FG000|Treatment|Adverse Event|42|||
148828479|NCT00266032|536850660|FG001|Treatment|Adverse Event|26|||
148828480|NCT00266032|536850661|FG002|Treatment|Adverse Event|10|||
148828481|NCT00266032|536850659|FG000|Treatment|Lost to Follow-up|19|||
148828482|NCT00266032|536850660|FG001|Treatment|Lost to Follow-up|4|||
148828483|NCT00266032|536850661|FG002|Treatment|Lost to Follow-up|2|||
148828484|NCT00266032|536850659|FG000|Treatment|Pregnancy|3|||
148828485|NCT00266032|536850660|FG001|Treatment|Pregnancy|2|||
148828486|NCT00266032|536850661|FG002|Treatment|Pregnancy|2|||
148828487|NCT00266032|536850659|FG000|Treatment|Protocol Violation|6|||
148828488|NCT00266032|536850660|FG001|Treatment|Protocol Violation|14|||
148828489|NCT00266032|536850661|FG002|Treatment|Protocol Violation|13|||
148828490|NCT00266032|536850659|FG000|Treatment|Withdrawal by Subject|28|||
148828491|NCT00266032|536850660|FG001|Treatment|Withdrawal by Subject|13|||
148828492|NCT00266032|536850661|FG002|Treatment|Withdrawal by Subject|12|||
148828493|NCT00266032|536850659|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
148828494|NCT00266032|536850660|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
148828495|NCT00266032|536850661|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
148828496|NCT00266032|536850659|FG000|Open-label Safety Extension|Adverse Event|5|||
148828497|NCT00266032|536850660|FG001|Open-label Safety Extension|Adverse Event|0|||
148828498|NCT00266032|536850661|FG002|Open-label Safety Extension|Adverse Event|4|||
148828499|NCT00266032|536850659|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
148828500|NCT00266032|536850660|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
148828501|NCT00266032|536850661|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
148828502|NCT00266032|536850659|FG000|Open-label Safety Extension|Pregnancy|4|||
148828503|NCT00266032|536850660|FG001|Open-label Safety Extension|Pregnancy|1|||
148828504|NCT00266032|536850661|FG002|Open-label Safety Extension|Pregnancy|2|||
148828505|NCT00266032|536850659|FG000|Open-label Safety Extension|Protocol Violation|1|||
148828506|NCT00266032|536850660|FG001|Open-label Safety Extension|Protocol Violation|3|||
148828507|NCT00266032|536850661|FG002|Open-label Safety Extension|Protocol Violation|2|||
148828508|NCT00266032|536850659|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
148828509|NCT00266032|536850660|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
148828510|NCT00266032|536850661|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
148828511|NCT00266032|536850659|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
148828512|NCT00266032|536850660|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
148828513|NCT00266032|536850661|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
148828514|NCT00124657|536850662|FG000|Overall Study|Toxicity|0|||
148828515|NCT00124657|536850663|FG001|Overall Study|Toxicity|0|||
148828516|NCT00124657|536850664|FG002|Overall Study|Toxicity|1|||
148828517|NCT00124657|536850662|FG000|Overall Study|Non-compliance|1|||
148828518|NCT00124657|536850663|FG001|Overall Study|Non-compliance|0|||
148828519|NCT00124657|536850664|FG002|Overall Study|Non-compliance|4|||
148828520|NCT00124657|536850662|FG000|Overall Study|Progressive disease|14|||
148828521|NCT00124657|536850663|FG001|Overall Study|Progressive disease|5|||
148828522|NCT00124657|536850664|FG002|Overall Study|Progressive disease|27|||
148828523|NCT00124657|536850662|FG000|Overall Study|Intercurrent illness|1|||
148828524|NCT00124657|536850663|FG001|Overall Study|Intercurrent illness|0|||
148828525|NCT00124657|536850664|FG002|Overall Study|Intercurrent illness|0|||
148828526|NCT01229111|536850669|FG000|Overall Study|Death|1|||
148828527|NCT04102514|536850670|FG000|Overall Study|Death|3|||
148828528|NCT04102514|536850671|FG001|Overall Study|Death|0|||
148828529|NCT04102514|536850672|FG002|Overall Study|Death|0|||
148828530|NCT04102514|536850673|FG003|Overall Study|Death|0|||
148828531|NCT04102514|536850670|FG000|Overall Study|Lost to Follow-up|0|||
148828532|NCT04102514|536850671|FG001|Overall Study|Lost to Follow-up|0|||
148828533|NCT04102514|536850672|FG002|Overall Study|Lost to Follow-up|3|||
148828534|NCT04102514|536850673|FG003|Overall Study|Lost to Follow-up|0|||
148828535|NCT04102514|536850670|FG000|Overall Study|Physician Decision|0|||
148828536|NCT04102514|536850671|FG001|Overall Study|Physician Decision|0|||
148828537|NCT04102514|536850672|FG002|Overall Study|Physician Decision|1|||
148978290|NCT02880371|537400827|FG001|Phase 2|Participants terminated by Sponsor|0|||
148828538|NCT04102514|536850673|FG003|Overall Study|Physician Decision|0|||
148828539|NCT04102514|536850670|FG000|Overall Study|Withdrawal by Subject|7|||
148978291|NCT02880371|537400828|FG002|Phase 2|Participants terminated by Sponsor|0|||
148828540|NCT04102514|536850671|FG001|Overall Study|Withdrawal by Subject|13|||
148828541|NCT04102514|536850672|FG002|Overall Study|Withdrawal by Subject|7|||
148828542|NCT04102514|536850673|FG003|Overall Study|Withdrawal by Subject|14|||
148828543|NCT04102514|536850670|FG000|Overall Study|Moved to longterm care facility|6|||
148828544|NCT04102514|536850671|FG001|Overall Study|Moved to longterm care facility|0|||
148828545|NCT04102514|536850672|FG002|Overall Study|Moved to longterm care facility|4|||
148828546|NCT04102514|536850673|FG003|Overall Study|Moved to longterm care facility|0|||
148828547|NCT03268499|536850674|FG000|Overall Study|Withdrawal by Subject|2|||
148828548|NCT03268499|536850675|FG001|Overall Study|Withdrawal by Subject|1|||
148828549|NCT00619918|536850676|FG000|Overall Study|Withdrawal by Subject|4|||
148828550|NCT00619918|536850677|FG001|Overall Study|Withdrawal by Subject|3|||
148828551|NCT00619918|536850676|FG000|Overall Study|Physician Decision|2|||
148828552|NCT00619918|536850677|FG001|Overall Study|Physician Decision|4|||
148828553|NCT00619918|536850676|FG000|Overall Study|Transfer to outside facility|3|||
148828554|NCT00619918|536850677|FG001|Overall Study|Transfer to outside facility|3|||
148828555|NCT00619918|536850676|FG000|Overall Study|Left before receiving first dose|7|||
148828556|NCT00619918|536850677|FG001|Overall Study|Left before receiving first dose|6|||
148828557|NCT00619918|536850676|FG000|Overall Study|ICU admission|4|||
148828558|NCT00619918|536850677|FG001|Overall Study|ICU admission|6|||
148828559|NCT03533491|536850682|FG000|Overall Study|Lost to Follow-up|2|||
148828560|NCT02951819|536850687|FG000|Overall Study|Death|9|||
148828561|NCT02951819|536850688|FG001|Overall Study|Death|7|||
148828562|NCT02951819|536850687|FG000|Overall Study|Withdrawal by Subject|3|||
148828563|NCT02951819|536850688|FG001|Overall Study|Withdrawal by Subject|0|||
148828564|NCT02951819|536850687|FG000|Overall Study|Adverse Event|1|||
148828565|NCT02951819|536850688|FG001|Overall Study|Adverse Event|0|||
148828566|NCT02951819|536850687|FG000|Overall Study|Lack of Efficacy|4|||
148828567|NCT02951819|536850688|FG001|Overall Study|Lack of Efficacy|0|||
148828568|NCT02951819|536850687|FG000|Overall Study|Lost to Follow-up|1|||
148828569|NCT02951819|536850688|FG001|Overall Study|Lost to Follow-up|0|||
148828570|NCT02951819|536850687|FG000|Overall Study|Progressive Disease|1|||
148828571|NCT02951819|536850688|FG001|Overall Study|Progressive Disease|0|||
148828572|NCT02951819|536850687|FG000|Overall Study|Other|9|||
148828573|NCT02951819|536850688|FG001|Overall Study|Other|0|||
148828574|NCT03715829|536850689|FG000|Dose Ranging Period|Adverse Event|2|||
148828575|NCT03715829|536850690|FG001|Dose Ranging Period|Adverse Event|4|||
148828576|NCT03715829|536850691|FG002|Dose Ranging Period|Adverse Event|5|||
148828577|NCT03715829|536850692|FG003|Dose Ranging Period|Adverse Event|2|||
148828578|NCT03715829|536850693|FG004|Dose Ranging Period|Adverse Event|3|||
148828579|NCT03715829|536850694|FG005|Dose Ranging Period|Adverse Event|3|||
148828580|NCT03715829|536850695|FG006|Dose Ranging Period|Adverse Event|0|||
148828581|NCT03715829|536850696|FG007|Dose Ranging Period|Adverse Event|0|||
148828582|NCT03715829|536850697|FG008|Dose Ranging Period|Adverse Event|0|||
148828583|NCT03715829|536850698|FG009|Dose Ranging Period|Adverse Event|0|||
148828584|NCT03715829|536850699|FG010|Dose Ranging Period|Adverse Event|0|||
148828585|NCT03715829|536850689|FG000|Dose Ranging Period|Lack of Efficacy|0|||
148828586|NCT03715829|536850690|FG001|Dose Ranging Period|Lack of Efficacy|1|||
148828587|NCT03715829|536850691|FG002|Dose Ranging Period|Lack of Efficacy|0|||
148828588|NCT03715829|536850692|FG003|Dose Ranging Period|Lack of Efficacy|1|||
148978292|NCT02880371|537400829|FG003|Phase 2|Participants terminated by Sponsor|0|||
148766163|NCT02477826|536617508|FG006|Treatment Period|Poor/Non Compliance|1|||
148766164|NCT02477826|536617509|FG007|Treatment Period|Poor/Non Compliance|0|||
148766165|NCT02477826|536617510|FG008|Treatment Period|Poor/Non Compliance|0|||
148766166|NCT02477826|536617511|FG009|Treatment Period|Poor/Non Compliance|1|||
148766167|NCT02477826|536617502|FG000|Treatment Period|Maximum Clinical Benefit|3|||
148766168|NCT02477826|536617503|FG001|Treatment Period|Maximum Clinical Benefit|3|||
148766169|NCT02477826|536617504|FG002|Treatment Period|Maximum Clinical Benefit|1|||
148766170|NCT02477826|536617505|FG003|Treatment Period|Maximum Clinical Benefit|1|||
148766171|NCT02477826|536617506|FG004|Treatment Period|Maximum Clinical Benefit|3|||
148766172|NCT02477826|536617507|FG005|Treatment Period|Maximum Clinical Benefit|0|||
148766173|NCT02477826|536617508|FG006|Treatment Period|Maximum Clinical Benefit|3|||
148766174|NCT02477826|536617509|FG007|Treatment Period|Maximum Clinical Benefit|2|||
148766175|NCT02477826|536617510|FG008|Treatment Period|Maximum Clinical Benefit|2|||
148766176|NCT02477826|536617511|FG009|Treatment Period|Maximum Clinical Benefit|2|||
148766177|NCT02477826|536617502|FG000|Treatment Period|Lost to Follow-up|0|||
148766178|NCT02477826|536617503|FG001|Treatment Period|Lost to Follow-up|0|||
148766179|NCT02477826|536617504|FG002|Treatment Period|Lost to Follow-up|1|||
148766180|NCT02477826|536617505|FG003|Treatment Period|Lost to Follow-up|1|||
148766181|NCT02477826|536617506|FG004|Treatment Period|Lost to Follow-up|0|||
148766182|NCT02477826|536617507|FG005|Treatment Period|Lost to Follow-up|0|||
148766183|NCT02477826|536617508|FG006|Treatment Period|Lost to Follow-up|2|||
148766184|NCT02477826|536617509|FG007|Treatment Period|Lost to Follow-up|2|||
148766185|NCT02477826|536617510|FG008|Treatment Period|Lost to Follow-up|0|||
148766186|NCT02477826|536617511|FG009|Treatment Period|Lost to Follow-up|0|||
148766187|NCT02477826|536617502|FG000|Treatment Period|Participant withdrew Consent|5|||
148766188|NCT02477826|536617503|FG001|Treatment Period|Participant withdrew Consent|5|||
148766189|NCT02477826|536617504|FG002|Treatment Period|Participant withdrew Consent|3|||
148766190|NCT02477826|536617505|FG003|Treatment Period|Participant withdrew Consent|3|||
148766191|NCT02477826|536617506|FG004|Treatment Period|Participant withdrew Consent|1|||
148828589|NCT03715829|536850693|FG004|Dose Ranging Period|Lack of Efficacy|0|||
148828590|NCT03715829|536850694|FG005|Dose Ranging Period|Lack of Efficacy|0|||
148828591|NCT03715829|536850695|FG006|Dose Ranging Period|Lack of Efficacy|0|||
148828592|NCT03715829|536850696|FG007|Dose Ranging Period|Lack of Efficacy|0|||
148828593|NCT03715829|536850697|FG008|Dose Ranging Period|Lack of Efficacy|0|||
148828594|NCT03715829|536850698|FG009|Dose Ranging Period|Lack of Efficacy|0|||
148828595|NCT03715829|536850699|FG010|Dose Ranging Period|Lack of Efficacy|0|||
148828596|NCT03715829|536850689|FG000|Dose Ranging Period|Lost to Follow-up|2|||
148828597|NCT03715829|536850690|FG001|Dose Ranging Period|Lost to Follow-up|0|||
148828598|NCT03715829|536850691|FG002|Dose Ranging Period|Lost to Follow-up|1|||
148828599|NCT03715829|536850692|FG003|Dose Ranging Period|Lost to Follow-up|1|||
148828600|NCT03715829|536850693|FG004|Dose Ranging Period|Lost to Follow-up|1|||
148828601|NCT03715829|536850694|FG005|Dose Ranging Period|Lost to Follow-up|2|||
148828602|NCT03715829|536850695|FG006|Dose Ranging Period|Lost to Follow-up|0|||
148828603|NCT03715829|536850696|FG007|Dose Ranging Period|Lost to Follow-up|0|||
148828604|NCT03715829|536850697|FG008|Dose Ranging Period|Lost to Follow-up|0|||
148828605|NCT03715829|536850698|FG009|Dose Ranging Period|Lost to Follow-up|0|||
148828606|NCT03715829|536850699|FG010|Dose Ranging Period|Lost to Follow-up|0|||
148828607|NCT03715829|536850689|FG000|Dose Ranging Period|Protocol Violation|0|||
148828608|NCT03715829|536850690|FG001|Dose Ranging Period|Protocol Violation|0|||
148828609|NCT03715829|536850691|FG002|Dose Ranging Period|Protocol Violation|0|||
148828610|NCT03715829|536850692|FG003|Dose Ranging Period|Protocol Violation|1|||
148828611|NCT03715829|536850693|FG004|Dose Ranging Period|Protocol Violation|0|||
148828612|NCT03715829|536850694|FG005|Dose Ranging Period|Protocol Violation|0|||
148828613|NCT03715829|536850695|FG006|Dose Ranging Period|Protocol Violation|0|||
148828614|NCT03715829|536850696|FG007|Dose Ranging Period|Protocol Violation|0|||
148828615|NCT03715829|536850697|FG008|Dose Ranging Period|Protocol Violation|0|||
148828616|NCT03715829|536850698|FG009|Dose Ranging Period|Protocol Violation|0|||
148828617|NCT03715829|536850699|FG010|Dose Ranging Period|Protocol Violation|0|||
148828618|NCT03715829|536850689|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
148828619|NCT03715829|536850690|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
148828620|NCT03715829|536850691|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
148828621|NCT03715829|536850692|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
148828622|NCT03715829|536850693|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
148828623|NCT03715829|536850694|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
148828624|NCT03715829|536850695|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
148828625|NCT03715829|536850696|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
148828626|NCT03715829|536850697|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
148828627|NCT03715829|536850698|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
148828628|NCT03715829|536850699|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
148828629|NCT03715829|536850689|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828630|NCT03715829|536850690|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828631|NCT03715829|536850691|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
148828632|NCT03715829|536850692|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828633|NCT03715829|536850693|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828634|NCT03715829|536850694|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828635|NCT03715829|536850695|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828636|NCT03715829|536850696|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828637|NCT03715829|536850697|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828638|NCT03715829|536850698|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828639|NCT03715829|536850699|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
148828640|NCT03715829|536850689|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828641|NCT03715829|536850690|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828642|NCT03715829|536850691|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
148828643|NCT03715829|536850692|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828644|NCT03715829|536850693|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
148828645|NCT03715829|536850694|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828646|NCT03715829|536850695|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828647|NCT03715829|536850696|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828648|NCT03715829|536850697|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828649|NCT03715829|536850698|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828650|NCT03715829|536850699|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
148828651|NCT03715829|536850689|FG000|Dose Ranging Period|Other|0|||
148828652|NCT03715829|536850690|FG001|Dose Ranging Period|Other|0|||
148828653|NCT03715829|536850691|FG002|Dose Ranging Period|Other|2|||
148828654|NCT03715829|536850692|FG003|Dose Ranging Period|Other|0|||
148828655|NCT03715829|536850693|FG004|Dose Ranging Period|Other|0|||
148828656|NCT03715829|536850694|FG005|Dose Ranging Period|Other|3|||
148828657|NCT03715829|536850695|FG006|Dose Ranging Period|Other|0|||
148828658|NCT03715829|536850696|FG007|Dose Ranging Period|Other|0|||
148828659|NCT03715829|536850697|FG008|Dose Ranging Period|Other|0|||
148828660|NCT03715829|536850698|FG009|Dose Ranging Period|Other|0|||
148978293|NCT02880371|537400830|FG004|Phase 2|Participants terminated by Sponsor|1|||
148828661|NCT03715829|536850699|FG010|Dose Ranging Period|Other|0|||
148828662|NCT03715829|536850689|FG000|Extension Period|Adverse Event|0|||
148828663|NCT03715829|536850690|FG001|Extension Period|Adverse Event|0|||
148828664|NCT03715829|536850691|FG002|Extension Period|Adverse Event|0|||
148828665|NCT03715829|536850692|FG003|Extension Period|Adverse Event|0|||
148828666|NCT03715829|536850693|FG004|Extension Period|Adverse Event|0|||
148828667|NCT03715829|536850694|FG005|Extension Period|Adverse Event|0|||
148828668|NCT03715829|536850695|FG006|Extension Period|Adverse Event|3|||
148828669|NCT03715829|536850696|FG007|Extension Period|Adverse Event|1|||
148828670|NCT03715829|536850697|FG008|Extension Period|Adverse Event|6|||
148828671|NCT03715829|536850698|FG009|Extension Period|Adverse Event|0|||
148828672|NCT03715829|536850699|FG010|Extension Period|Adverse Event|0|||
148828673|NCT03715829|536850689|FG000|Extension Period|Lack of Efficacy|0|||
148828674|NCT03715829|536850690|FG001|Extension Period|Lack of Efficacy|0|||
148828675|NCT03715829|536850691|FG002|Extension Period|Lack of Efficacy|0|||
148828676|NCT03715829|536850692|FG003|Extension Period|Lack of Efficacy|0|||
148828677|NCT03715829|536850693|FG004|Extension Period|Lack of Efficacy|0|||
148828678|NCT03715829|536850694|FG005|Extension Period|Lack of Efficacy|0|||
148828679|NCT03715829|536850695|FG006|Extension Period|Lack of Efficacy|1|||
148828680|NCT03715829|536850696|FG007|Extension Period|Lack of Efficacy|9|||
148828681|NCT03715829|536850697|FG008|Extension Period|Lack of Efficacy|2|||
148828682|NCT03715829|536850698|FG009|Extension Period|Lack of Efficacy|0|||
148828683|NCT03715829|536850699|FG010|Extension Period|Lack of Efficacy|0|||
148828684|NCT03715829|536850689|FG000|Extension Period|Lost to Follow-up|0|||
148828685|NCT03715829|536850690|FG001|Extension Period|Lost to Follow-up|0|||
148828686|NCT03715829|536850691|FG002|Extension Period|Lost to Follow-up|0|||
148828687|NCT03715829|536850692|FG003|Extension Period|Lost to Follow-up|0|||
148828688|NCT03715829|536850693|FG004|Extension Period|Lost to Follow-up|0|||
148828689|NCT03715829|536850694|FG005|Extension Period|Lost to Follow-up|0|||
148828690|NCT03715829|536850695|FG006|Extension Period|Lost to Follow-up|0|||
148828691|NCT03715829|536850696|FG007|Extension Period|Lost to Follow-up|0|||
148828692|NCT03715829|536850697|FG008|Extension Period|Lost to Follow-up|2|||
148828693|NCT03715829|536850698|FG009|Extension Period|Lost to Follow-up|0|||
148828694|NCT03715829|536850699|FG010|Extension Period|Lost to Follow-up|0|||
148828695|NCT03715829|536850689|FG000|Extension Period|Protocol Violation|0|||
148828696|NCT03715829|536850690|FG001|Extension Period|Protocol Violation|0|||
148828697|NCT03715829|536850691|FG002|Extension Period|Protocol Violation|0|||
148828698|NCT03715829|536850692|FG003|Extension Period|Protocol Violation|0|||
148828699|NCT03715829|536850693|FG004|Extension Period|Protocol Violation|0|||
148828700|NCT03715829|536850694|FG005|Extension Period|Protocol Violation|0|||
148828701|NCT03715829|536850695|FG006|Extension Period|Protocol Violation|0|||
148828702|NCT03715829|536850696|FG007|Extension Period|Protocol Violation|0|||
148828703|NCT03715829|536850697|FG008|Extension Period|Protocol Violation|1|||
148828704|NCT03715829|536850698|FG009|Extension Period|Protocol Violation|0|||
148828705|NCT03715829|536850699|FG010|Extension Period|Protocol Violation|0|||
148828706|NCT03715829|536850689|FG000|Extension Period|Withdrawal by Subject|0|||
148828707|NCT03715829|536850690|FG001|Extension Period|Withdrawal by Subject|0|||
148828708|NCT03715829|536850691|FG002|Extension Period|Withdrawal by Subject|0|||
148828709|NCT03715829|536850692|FG003|Extension Period|Withdrawal by Subject|0|||
148828710|NCT03715829|536850693|FG004|Extension Period|Withdrawal by Subject|0|||
148828711|NCT03715829|536850694|FG005|Extension Period|Withdrawal by Subject|0|||
148828712|NCT03715829|536850695|FG006|Extension Period|Withdrawal by Subject|3|||
148828713|NCT03715829|536850696|FG007|Extension Period|Withdrawal by Subject|3|||
148828714|NCT03715829|536850697|FG008|Extension Period|Withdrawal by Subject|12|||
148828715|NCT03715829|536850698|FG009|Extension Period|Withdrawal by Subject|3|||
148828716|NCT03715829|536850699|FG010|Extension Period|Withdrawal by Subject|0|||
148828717|NCT03715829|536850689|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828718|NCT03715829|536850690|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828719|NCT03715829|536850691|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828720|NCT03715829|536850692|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828721|NCT03715829|536850693|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828722|NCT03715829|536850694|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828723|NCT03715829|536850695|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828724|NCT03715829|536850696|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
148828725|NCT03715829|536850697|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
148828726|NCT03715829|536850698|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828727|NCT03715829|536850699|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
148828728|NCT03715829|536850689|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828729|NCT03715829|536850690|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828730|NCT03715829|536850691|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828731|NCT03715829|536850692|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828732|NCT03715829|536850693|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828733|NCT03715829|536850694|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828734|NCT03715829|536850695|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828735|NCT03715829|536850696|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828736|NCT03715829|536850697|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
148828737|NCT03715829|536850698|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828738|NCT03715829|536850699|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
148828739|NCT03715829|536850689|FG000|Extension Period|Other|0|||
148828740|NCT03715829|536850690|FG001|Extension Period|Other|0|||
148828741|NCT03715829|536850691|FG002|Extension Period|Other|0|||
148828742|NCT03715829|536850692|FG003|Extension Period|Other|0|||
148828743|NCT03715829|536850693|FG004|Extension Period|Other|0|||
148828744|NCT03715829|536850694|FG005|Extension Period|Other|0|||
148828745|NCT03715829|536850695|FG006|Extension Period|Other|1|||
148828746|NCT03715829|536850696|FG007|Extension Period|Other|2|||
148828747|NCT03715829|536850697|FG008|Extension Period|Other|4|||
148828748|NCT03715829|536850698|FG009|Extension Period|Other|0|||
148828749|NCT03715829|536850699|FG010|Extension Period|Other|0|||
148828750|NCT02657356|536851713|FG000|Overall Study|Death|1|||
148828751|NCT02657356|536851714|FG001|Overall Study|Death|0|||
148828752|NCT02657356|536851713|FG000|Overall Study|Withdrawal by Subject|5|||
148828753|NCT02657356|536851714|FG001|Overall Study|Withdrawal by Subject|6|||
148828754|NCT02657356|536851713|FG000|Overall Study|Terminated by Sponsor|8|||
148828755|NCT02657356|536851714|FG001|Overall Study|Terminated by Sponsor|5|||
148828756|NCT02657356|536851713|FG000|Overall Study|Rolled over to EAP study|6|||
148828757|NCT02657356|536851714|FG001|Overall Study|Rolled over to EAP study|4|||
148828758|NCT03379870|536851715|FG000|Overall Study|Lost to Follow-up|1|||
148828759|NCT03379870|536851716|FG001|Overall Study|Lost to Follow-up|0|||
148828760|NCT03379870|536851715|FG000|Overall Study|Protocol Violation|1|||
148828761|NCT03379870|536851716|FG001|Overall Study|Protocol Violation|1|||
148828762|NCT03768336|536851717|FG000|Overall Study|Lost to Follow-up|3|||
148828763|NCT03768336|536851718|FG001|Overall Study|Lost to Follow-up|2|||
148828764|NCT03768336|536851717|FG000|Overall Study|Became Ineligible|2|||
148828765|NCT03768336|536851718|FG001|Overall Study|Became Ineligible|0|||
148828766|NCT03768336|536851717|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
148828767|NCT03768336|536851718|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
148828768|NCT03768336|536851717|FG000|Overall Study|Missed final survey (post-treatment|0|||
148828769|NCT03768336|536851718|FG001|Overall Study|Missed final survey (post-treatment|1|||
148828770|NCT01444781|536851719|FG000|Overall Study|Lost to Follow-up|0|||
148828771|NCT01444781|536851720|FG001|Overall Study|Lost to Follow-up|3|||
148828772|NCT01444781|536851721|FG002|Overall Study|Lost to Follow-up|1|||
148828773|NCT01444781|536851719|FG000|Overall Study|Withdrawal by Subject|3|||
148828774|NCT01444781|536851720|FG001|Overall Study|Withdrawal by Subject|1|||
148828775|NCT01444781|536851721|FG002|Overall Study|Withdrawal by Subject|2|||
148828776|NCT06790303|536851722|FG000|Overall Study|Study Terminated by sponsor|4|||
148828777|NCT06790303|536851722|FG000|Overall Study|Death|4|||
148828778|NCT03345550|536851724|FG000|Overall Study|Withdrawal by Subject|1|||
148828779|NCT03345550|536851725|FG001|Overall Study|Withdrawal by Subject|0|||
148828780|NCT03345550|536851724|FG000|Overall Study|Lost to Follow-up|4|||
148828781|NCT03345550|536851725|FG001|Overall Study|Lost to Follow-up|5|||
148828782|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
148828783|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
148828784|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
148828785|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
148828786|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
148828787|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
148828788|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
148828789|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
148828790|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
148828791|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
148828792|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
148828793|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
148828794|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
148978294|NCT02880371|537400831|FG005|Phase 2|Participants terminated by Sponsor|6|||
148978295|NCT02880371|537400832|FG006|Phase 2|Participants terminated by Sponsor|1|||
148828795|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
148828796|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
148828797|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
148828798|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
148828799|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
148828800|NCT01432444|536851726|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
148828801|NCT01432444|536851727|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
148828802|NCT01432444|536851728|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
148828803|NCT01432444|536851726|FG000|Treatment Phase|Lost to Follow-up|0|||
148828804|NCT01432444|536851727|FG001|Treatment Phase|Lost to Follow-up|33|||
148978296|NCT02880371|537400833|FG007|Phase 2|Participants terminated by Sponsor|5|||
148978297|NCT02880371|537400826|FG000|Phase 2|Death|0|||
148978298|NCT02880371|537400827|FG001|Phase 2|Death|0|||
148978299|NCT02880371|537400828|FG002|Phase 2|Death|0|||
148978300|NCT02880371|537400829|FG003|Phase 2|Death|0|||
148766192|NCT02477826|536617507|FG005|Treatment Period|Participant withdrew Consent|3|||
148766193|NCT02477826|536617508|FG006|Treatment Period|Participant withdrew Consent|3|||
148766194|NCT02477826|536617509|FG007|Treatment Period|Participant withdrew Consent|3|||
148766195|NCT02477826|536617510|FG008|Treatment Period|Participant withdrew Consent|2|||
148766196|NCT02477826|536617511|FG009|Treatment Period|Participant withdrew Consent|3|||
148766197|NCT02477826|536617502|FG000|Treatment Period|Participant request to discontinue treatment|5|||
148766198|NCT02477826|536617503|FG001|Treatment Period|Participant request to discontinue treatment|3|||
148766199|NCT02477826|536617504|FG002|Treatment Period|Participant request to discontinue treatment|15|||
148766200|NCT02477826|536617505|FG003|Treatment Period|Participant request to discontinue treatment|5|||
148766201|NCT02477826|536617506|FG004|Treatment Period|Participant request to discontinue treatment|3|||
148766202|NCT02477826|536617507|FG005|Treatment Period|Participant request to discontinue treatment|6|||
148766203|NCT02477826|536617508|FG006|Treatment Period|Participant request to discontinue treatment|13|||
148766204|NCT02477826|536617509|FG007|Treatment Period|Participant request to discontinue treatment|15|||
148766205|NCT02477826|536617510|FG008|Treatment Period|Participant request to discontinue treatment|4|||
148766206|NCT02477826|536617511|FG009|Treatment Period|Participant request to discontinue treatment|18|||
148766207|NCT02477826|536617502|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
148766208|NCT02477826|536617503|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
148766209|NCT02477826|536617504|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
148766210|NCT02477826|536617505|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
148766211|NCT02477826|536617506|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
148766212|NCT02477826|536617507|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
148766213|NCT02477826|536617508|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
148766214|NCT02477826|536617509|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
148766215|NCT02477826|536617510|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
148766216|NCT02477826|536617511|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
148766217|NCT02477826|536617502|FG000|Treatment Period|Death|4|||
148766218|NCT02477826|536617503|FG001|Treatment Period|Death|7|||
148766219|NCT02477826|536617504|FG002|Treatment Period|Death|0|||
148766220|NCT02477826|536617505|FG003|Treatment Period|Death|0|||
148766221|NCT02477826|536617506|FG004|Treatment Period|Death|1|||
148766222|NCT02477826|536617507|FG005|Treatment Period|Death|2|||
148766223|NCT02477826|536617508|FG006|Treatment Period|Death|6|||
148766224|NCT02477826|536617509|FG007|Treatment Period|Death|5|||
148766225|NCT02477826|536617510|FG008|Treatment Period|Death|9|||
148766226|NCT02477826|536617511|FG009|Treatment Period|Death|0|||
148766227|NCT02477826|536617502|FG000|Treatment Period|Study Drug Toxicity|79|||
148766228|NCT02477826|536617503|FG001|Treatment Period|Study Drug Toxicity|51|||
148766229|NCT02477826|536617504|FG002|Treatment Period|Study Drug Toxicity|31|||
148766230|NCT02477826|536617505|FG003|Treatment Period|Study Drug Toxicity|39|||
148766231|NCT02477826|536617506|FG004|Treatment Period|Study Drug Toxicity|12|||
148766232|NCT02477826|536617507|FG005|Treatment Period|Study Drug Toxicity|25|||
148766233|NCT02477826|536617508|FG006|Treatment Period|Study Drug Toxicity|52|||
148766234|NCT02477826|536617509|FG007|Treatment Period|Study Drug Toxicity|30|||
148766235|NCT02477826|536617510|FG008|Treatment Period|Study Drug Toxicity|20|||
148766236|NCT02477826|536617511|FG009|Treatment Period|Study Drug Toxicity|9|||
148766237|NCT02477826|536617502|FG000|Treatment Period|Disease progression|212|||
148766238|NCT02477826|536617503|FG001|Treatment Period|Disease progression|240|||
148766239|NCT02477826|536617504|FG002|Treatment Period|Disease progression|202|||
148766240|NCT02477826|536617505|FG003|Treatment Period|Disease progression|93|||
148766241|NCT02477826|536617506|FG004|Treatment Period|Disease progression|113|||
148766242|NCT02477826|536617507|FG005|Treatment Period|Disease progression|96|||
148766243|NCT02477826|536617508|FG006|Treatment Period|Disease progression|208|||
148766244|NCT02477826|536617509|FG007|Treatment Period|Disease progression|195|||
148766245|NCT02477826|536617510|FG008|Treatment Period|Disease progression|59|||
148766246|NCT02477826|536617511|FG009|Treatment Period|Disease progression|46|||
148766247|NCT02477826|536617502|FG000|Treatment Period|Pregnancy|0|||
148766248|NCT02477826|536617503|FG001|Treatment Period|Pregnancy|0|||
148766249|NCT02477826|536617504|FG002|Treatment Period|Pregnancy|0|||
148766250|NCT02477826|536617505|FG003|Treatment Period|Pregnancy|0|||
148766251|NCT02477826|536617506|FG004|Treatment Period|Pregnancy|0|||
148828805|NCT01432444|536851728|FG002|Treatment Phase|Lost to Follow-up|0|||
148978301|NCT02880371|537400830|FG004|Phase 2|Death|1|||
148766252|NCT02477826|536617507|FG005|Treatment Period|Pregnancy|0|||
148766253|NCT02477826|536617508|FG006|Treatment Period|Pregnancy|0|||
148766254|NCT02477826|536617509|FG007|Treatment Period|Pregnancy|0|||
148766255|NCT02477826|536617510|FG008|Treatment Period|Pregnancy|0|||
148766256|NCT02477826|536617511|FG009|Treatment Period|Pregnancy|1|||
148766257|NCT02477826|536617502|FG000|Treatment Period|Other|0|||
148766258|NCT02477826|536617503|FG001|Treatment Period|Other|0|||
148766259|NCT02477826|536617504|FG002|Treatment Period|Other|0|||
148766260|NCT02477826|536617505|FG003|Treatment Period|Other|0|||
148766261|NCT02477826|536617506|FG004|Treatment Period|Other|0|||
148828806|NCT01432444|536851726|FG000|Treatment Phase|Adverse Event|0|||
148978302|NCT02880371|537400831|FG005|Phase 2|Death|10|||
148828807|NCT01432444|536851727|FG001|Treatment Phase|Adverse Event|37|||
148828808|NCT01432444|536851728|FG002|Treatment Phase|Adverse Event|0|||
148828809|NCT01432444|536851726|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
148828810|NCT01432444|536851727|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
148828811|NCT01432444|536851728|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
148828812|NCT01432444|536851726|FG000|Treatment Phase|Physician Decision|0|||
148828813|NCT01432444|536851727|FG001|Treatment Phase|Physician Decision|5|||
148828814|NCT01432444|536851728|FG002|Treatment Phase|Physician Decision|0|||
148828815|NCT01432444|536851726|FG000|Treatment Phase|Withdrawal by Subject|0|||
148828816|NCT01432444|536851727|FG001|Treatment Phase|Withdrawal by Subject|41|||
148828817|NCT01432444|536851728|FG002|Treatment Phase|Withdrawal by Subject|0|||
148828818|NCT01432444|536851726|FG000|Treatment Phase|Protocol Deviation|0|||
148828819|NCT01432444|536851727|FG001|Treatment Phase|Protocol Deviation|3|||
148828820|NCT01432444|536851728|FG002|Treatment Phase|Protocol Deviation|0|||
148828821|NCT01432444|536851726|FG000|Treatment Phase|Lack of Efficacy|0|||
148828822|NCT01432444|536851727|FG001|Treatment Phase|Lack of Efficacy|10|||
148828823|NCT01432444|536851728|FG002|Treatment Phase|Lack of Efficacy|0|||
148828824|NCT01432444|536851726|FG000|Extension Phase|Lost to Follow-up|0|||
148828825|NCT01432444|536851727|FG001|Extension Phase|Lost to Follow-up|0|||
148828826|NCT01432444|536851728|FG002|Extension Phase|Lost to Follow-up|17|||
148828827|NCT01432444|536851726|FG000|Extension Phase|Adverse Event|0|||
148828828|NCT01432444|536851727|FG001|Extension Phase|Adverse Event|0|||
148766262|NCT02477826|536617507|FG005|Treatment Period|Other|0|||
148766263|NCT02477826|536617508|FG006|Treatment Period|Other|0|||
148766264|NCT02477826|536617509|FG007|Treatment Period|Other|0|||
148766265|NCT02477826|536617510|FG008|Treatment Period|Other|0|||
148766266|NCT02477826|536617511|FG009|Treatment Period|Other|1|||
148766267|NCT00828568|536617512|FG000|Randomized|Withdrawal by Subject|1|||
148766268|NCT00828568|536617513|FG001|Randomized|Withdrawal by Subject|0|||
148766269|NCT00828568|536617514|FG002|Randomized|Withdrawal by Subject|2|||
148828829|NCT01432444|536851728|FG002|Extension Phase|Adverse Event|10|||
148828830|NCT01432444|536851726|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
148828831|NCT01432444|536851727|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
148828832|NCT01432444|536851728|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
148828833|NCT01432444|536851726|FG000|Extension Phase|Met Withdrawal Criteria|0|||
148828834|NCT01432444|536851727|FG001|Extension Phase|Met Withdrawal Criteria|0|||
148828835|NCT01432444|536851728|FG002|Extension Phase|Met Withdrawal Criteria|144|||
148828836|NCT01432444|536851726|FG000|Extension Phase|Physician Decision|0|||
148828837|NCT01432444|536851727|FG001|Extension Phase|Physician Decision|0|||
148828838|NCT01432444|536851728|FG002|Extension Phase|Physician Decision|1|||
148828839|NCT01432444|536851726|FG000|Extension Phase|Withdrawal by Subject|0|||
148828840|NCT01432444|536851727|FG001|Extension Phase|Withdrawal by Subject|0|||
148828841|NCT01432444|536851728|FG002|Extension Phase|Withdrawal by Subject|13|||
148828842|NCT01225952|536851729|FG000|Overall Study|Lost to Follow-up|1|||
148828843|NCT01225952|536851730|FG001|Overall Study|Lost to Follow-up|0|||
148828844|NCT01225952|536851731|FG002|Overall Study|Lost to Follow-up|0|||
148828845|NCT01225952|536851729|FG000|Overall Study|Study Eye Explanted|0|||
148828846|NCT01225952|536851730|FG001|Overall Study|Study Eye Explanted|0|||
148828847|NCT01225952|536851731|FG002|Overall Study|Study Eye Explanted|1|||
148828848|NCT01225952|536851729|FG000|Overall Study|Withdrawal by Subject|4|||
148828849|NCT01225952|536851730|FG001|Overall Study|Withdrawal by Subject|4|||
148828850|NCT01225952|536851731|FG002|Overall Study|Withdrawal by Subject|5|||
148828851|NCT01225952|536851729|FG000|Overall Study|Surgical complications|1|||
148828852|NCT01225952|536851730|FG001|Overall Study|Surgical complications|0|||
148828853|NCT01225952|536851731|FG002|Overall Study|Surgical complications|0|||
148828854|NCT01230060|536851732|FG000|Overall Study|Withdrawal by Subject|1|||
148828855|NCT03802916|536851733|FG000|Overall Study|Adverse Event|0|||
148766270|NCT00828568|536617512|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
148766271|NCT00828568|536617513|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
148766272|NCT00828568|536617514|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
148766273|NCT00828568|536617512|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
148828856|NCT03802916|536851734|FG001|Overall Study|Adverse Event|1|||
148828857|NCT03802916|536851733|FG000|Overall Study|Withdrawal by Subject|0|||
148828858|NCT03802916|536851734|FG001|Overall Study|Withdrawal by Subject|1|||
148828859|NCT00480532|536851735|FG000|Overall Study|Withdrawal by Subject|2|||
148828860|NCT00480532|536851736|FG001|Overall Study|Withdrawal by Subject|4|||
148828861|NCT00480532|536851737|FG002|Overall Study|Withdrawal by Subject|3|||
148828862|NCT00480532|536851738|FG003|Overall Study|Withdrawal by Subject|1|||
148828863|NCT00480532|536851735|FG000|Overall Study|Protocol Violation|0|||
148828864|NCT00480532|536851736|FG001|Overall Study|Protocol Violation|0|||
148828865|NCT00480532|536851737|FG002|Overall Study|Protocol Violation|1|||
148828866|NCT00480532|536851738|FG003|Overall Study|Protocol Violation|0|||
148828867|NCT02157610|536851739|FG000|Overall Study|Death|4|||
148828868|NCT02157610|536851740|FG001|Overall Study|Death|4|||
148828869|NCT01592747|536851741|FG000|Overall Study|Loss of Therapeutic Response|107|||
148828870|NCT01592747|536851742|FG001|Overall Study|Loss of Therapeutic Response|108|||
148828871|NCT01592747|536851743|FG002|Overall Study|Loss of Therapeutic Response|100|||
148828872|NCT01592747|536851741|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
148828873|NCT01592747|536851742|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
148828874|NCT01592747|536851743|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
148828875|NCT01592747|536851741|FG000|Overall Study|Adverse Event|1|||
148828876|NCT01592747|536851742|FG001|Overall Study|Adverse Event|0|||
148828877|NCT01592747|536851743|FG002|Overall Study|Adverse Event|0|||
148828878|NCT01592747|536851741|FG000|Overall Study|Protocol Violation|4|||
148828879|NCT01592747|536851742|FG001|Overall Study|Protocol Violation|0|||
148828880|NCT01592747|536851743|FG002|Overall Study|Protocol Violation|4|||
148828881|NCT01592747|536851741|FG000|Overall Study|Lack of Efficacy|0|||
148828882|NCT01592747|536851742|FG001|Overall Study|Lack of Efficacy|1|||
148828883|NCT01592747|536851743|FG002|Overall Study|Lack of Efficacy|0|||
148828884|NCT01592747|536851741|FG000|Overall Study|Withdrawal by Subject|2|||
148828885|NCT01592747|536851742|FG001|Overall Study|Withdrawal by Subject|0|||
148828886|NCT01592747|536851743|FG002|Overall Study|Withdrawal by Subject|2|||
148828887|NCT01592747|536851741|FG000|Overall Study|Lost to Follow-up|1|||
148828888|NCT01592747|536851742|FG001|Overall Study|Lost to Follow-up|0|||
148828889|NCT01592747|536851743|FG002|Overall Study|Lost to Follow-up|1|||
148828890|NCT01592747|536851741|FG000|Overall Study|Other Reasons|1|||
148828891|NCT01592747|536851742|FG001|Overall Study|Other Reasons|1|||
148828892|NCT01592747|536851743|FG002|Overall Study|Other Reasons|0|||
148828893|NCT01602484|536851744|FG000|Overall Study|Airway issues unrelated to study|0|||
148828894|NCT01602484|536851745|FG001|Overall Study|Airway issues unrelated to study|1|||
148828895|NCT00425555|536851749|FG000|Overall Study|Withdrawal by Subject|11|||
148828896|NCT00425555|536851750|FG001|Overall Study|Withdrawal by Subject|8|||
148828897|NCT00425555|536851749|FG000|Overall Study|Lost to Follow-up|0|||
148828898|NCT00425555|536851750|FG001|Overall Study|Lost to Follow-up|1|||
148828899|NCT00425555|536851749|FG000|Overall Study|Administrative problems|3|||
148828900|NCT00425555|536851750|FG001|Overall Study|Administrative problems|0|||
148828901|NCT00425555|536851749|FG000|Overall Study|Death|1|||
148828902|NCT00425555|536851750|FG001|Overall Study|Death|2|||
148828903|NCT00425555|536851749|FG000|Overall Study|New cancer therapy|2|||
148828904|NCT00425555|536851750|FG001|Overall Study|New cancer therapy|1|||
148828905|NCT00425555|536851749|FG000|Overall Study|Disease progression|36|||
148828906|NCT00425555|536851750|FG001|Overall Study|Disease progression|33|||
148828907|NCT00425555|536851749|FG000|Overall Study|Adverse Event|25|||
148828908|NCT00425555|536851750|FG001|Overall Study|Adverse Event|15|||
148828909|NCT00425555|536851749|FG000|Overall Study|Protocol Violation|1|||
149027766|NCT04739423|537578655|FG005|Overall Study|Protocol Violation|0|||
149027767|NCT04739423|537578650|FG000|Overall Study|Adverse Event|0|||
149027768|NCT04739423|537578651|FG001|Overall Study|Adverse Event|0|||
149027769|NCT04739423|537578652|FG002|Overall Study|Adverse Event|1|||
149027770|NCT04739423|537578653|FG003|Overall Study|Adverse Event|0|||
149027771|NCT04739423|537578654|FG004|Overall Study|Adverse Event|1|||
149027772|NCT04739423|537578655|FG005|Overall Study|Adverse Event|0|||
149027773|NCT04739423|537578650|FG000|Overall Study|Withdrawal by Subject|0|||
149027774|NCT04739423|537578651|FG001|Overall Study|Withdrawal by Subject|0|||
149027775|NCT04739423|537578652|FG002|Overall Study|Withdrawal by Subject|0|||
149027776|NCT04739423|537578653|FG003|Overall Study|Withdrawal by Subject|0|||
149027777|NCT04739423|537578654|FG004|Overall Study|Withdrawal by Subject|0|||
149027778|NCT04739423|537578655|FG005|Overall Study|Withdrawal by Subject|1|||
149027779|NCT01737268|537578657|FG000|Overall Study|Adverse Event|6|||
149027780|NCT01737268|537578657|FG000|Overall Study|Worsening of Target Disease|2|||
149027781|NCT01737268|537578657|FG000|Overall Study|In consideration of the patient's safety|1|||
149027782|NCT02696226|537578662|FG000|Overall Study|Study terminated - lack of enrollment|1|||
149027783|NCT02696226|537578663|FG001|Overall Study|Study terminated - lack of enrollment|0|||
149027784|NCT02696226|537578664|FG002|Overall Study|Study terminated - lack of enrollment|2|||
149027785|NCT02696226|537578665|FG003|Overall Study|Study terminated - lack of enrollment|0|||
149027786|NCT02698436|537578670|FG000|Overall Study|Adverse Event|1|||
149027787|NCT02698436|537578671|FG001|Overall Study|Adverse Event|0|||
149027788|NCT02698436|537578670|FG000|Overall Study|Withdrawal by Subject|3|||
149027789|NCT02698436|537578671|FG001|Overall Study|Withdrawal by Subject|3|||
149027790|NCT02698436|537578670|FG000|Overall Study|Lost to Follow-up|2|||
149027791|NCT02698436|537578671|FG001|Overall Study|Lost to Follow-up|4|||
149027792|NCT02698436|537578670|FG000|Overall Study|Non-compliance with study regimen|1|||
148828910|NCT00425555|536851750|FG001|Overall Study|Protocol Violation|0|||
148828911|NCT03729609|536851751|FG000|Overall Study|Protocol Violation|1|||
148828912|NCT05418426|536851753|FG000|Overall Study|Adverse Event|0|||
148828913|NCT05418426|536851754|FG001|Overall Study|Adverse Event|1|||
148828914|NCT05418426|536851755|FG002|Overall Study|Adverse Event|0|||
148828915|NCT05418426|536851753|FG000|Overall Study|Withdrawal by Subject|0|||
148828916|NCT05418426|536851754|FG001|Overall Study|Withdrawal by Subject|1|||
148828917|NCT05418426|536851755|FG002|Overall Study|Withdrawal by Subject|0|||
148828918|NCT05418426|536851753|FG000|Overall Study|Protocol Violation|0|||
148828919|NCT05418426|536851754|FG001|Overall Study|Protocol Violation|0|||
148828920|NCT05418426|536851755|FG002|Overall Study|Protocol Violation|1|||
148828921|NCT04661839|536851758|FG000|Overall Study|Not Treated|0|||
148828922|NCT04661839|536851759|FG001|Overall Study|Not Treated|0|||
148828923|NCT04661839|536851760|FG002|Overall Study|Not Treated|1|||
148828924|NCT04661839|536851761|FG003|Overall Study|Not Treated|0|||
148828925|NCT04661839|536851758|FG000|Overall Study|Lost to Follow-up|1|||
148828926|NCT04661839|536851759|FG001|Overall Study|Lost to Follow-up|0|||
148828927|NCT04661839|536851760|FG002|Overall Study|Lost to Follow-up|0|||
148828928|NCT04661839|536851761|FG003|Overall Study|Lost to Follow-up|1|||
148828929|NCT03647137|536851762|FG000|Overall Study|Scan Limitation|2|||
148828930|NCT03647137|536851763|FG001|Overall Study|Scan Limitation|1|||
148828931|NCT03647137|536851764|FG002|Overall Study|Scan Limitation|1|||
148828932|NCT03647137|536851765|FG003|Overall Study|Scan Limitation|2|||
148828933|NCT01443026|536851766|FG000|Overall Study|Physician Decision|1|||
148828934|NCT01443026|536851767|FG001|Overall Study|Physician Decision|0|||
148828935|NCT01443026|536851766|FG000|Overall Study|Death|0|||
148828936|NCT01443026|536851767|FG001|Overall Study|Death|1|||
148828937|NCT01443026|536851766|FG000|Overall Study|Withdrawal by Subject|0|||
148828938|NCT01443026|536851767|FG001|Overall Study|Withdrawal by Subject|3|||
148828939|NCT01443026|536851766|FG000|Overall Study|Lost to Follow-up|2|||
148828940|NCT01443026|536851767|FG001|Overall Study|Lost to Follow-up|1|||
148828941|NCT00829868|536851768|FG000|Washout|Physician Decision|1|||
148828942|NCT00829868|536851769|FG001|Washout|Physician Decision|0|||
148828943|NCT03773562|536851772|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
148828944|NCT03773562|536851772|FG000|Overall Study|Lost to Follow-up|10|||
148828945|NCT03773562|536851772|FG000|Overall Study|Withdrawal by Subject|1|||
148828946|NCT03131479|536851773|FG000|Overall Study|Adverse Event|0|||
148828947|NCT03131479|536851774|FG001|Overall Study|Adverse Event|0|||
148828948|NCT03131479|536851775|FG002|Overall Study|Adverse Event|1|||
148828949|NCT03131479|536851776|FG003|Overall Study|Adverse Event|1|||
148828950|NCT03131479|536851777|FG004|Overall Study|Adverse Event|0|||
148828951|NCT03131479|536851773|FG000|Overall Study|Subject/Guardian Decision|0|||
148828952|NCT03131479|536851774|FG001|Overall Study|Subject/Guardian Decision|0|||
148828953|NCT03131479|536851775|FG002|Overall Study|Subject/Guardian Decision|0|||
148828954|NCT03131479|536851776|FG003|Overall Study|Subject/Guardian Decision|1|||
148828955|NCT03131479|536851777|FG004|Overall Study|Subject/Guardian Decision|0|||
148828956|NCT04806373|536851783|FG000|Overall Study|Withdrawal by Subject|1|||
148828957|NCT04806373|536851784|FG001|Overall Study|Withdrawal by Subject|1|||
148828958|NCT02061085|536851789|FG000|Overall Study|Adverse Event|8|||
148828959|NCT03204812|536851794|FG000|Overall Study|Adverse Event|3|||
148828960|NCT04091438|536851796|FG000|Treatment Period 1 (1 Day)|Other|1|||
148828961|NCT04091438|536851797|FG001|Treatment Period 1 (1 Day)|Other|0|||
148828962|NCT04091438|536851796|FG000|Washout Period (1 Day)|Protocol deviation|0|||
148828963|NCT04091438|536851797|FG001|Washout Period (1 Day)|Protocol deviation|1|||
148828964|NCT04091438|536851796|FG000|Washout Period (1 Day)|Other|0|||
148828965|NCT04091438|536851797|FG001|Washout Period (1 Day)|Other|1|||
148828966|NCT00787800|536851801|FG000|Overall Study|Withdrawal by Subject|3|||
148828967|NCT00787800|536851802|FG001|Overall Study|Withdrawal by Subject|5|||
148828968|NCT00787800|536851801|FG000|Overall Study|Death|0|||
148828969|NCT00787800|536851802|FG001|Overall Study|Death|2|||
148828970|NCT04309500|536851803|FG000|Overall Study|Lost to Follow-up|1|||
148828971|NCT04309500|536851804|FG001|Overall Study|Lost to Follow-up|0|||
148828972|NCT04309500|536851805|FG002|Overall Study|Lost to Follow-up|0|||
148828973|NCT04309500|536851806|FG003|Overall Study|Lost to Follow-up|0|||
148828974|NCT00913835|536851808|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
148828975|NCT00913835|536851809|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
148828976|NCT00913835|536851808|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
148828977|NCT00913835|536851809|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
148828978|NCT00913835|536851808|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
148828979|NCT00913835|536851809|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
148828980|NCT00913835|536851808|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
148828981|NCT00913835|536851809|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
148828982|NCT00913835|536851808|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
148828983|NCT00913835|536851809|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
148828984|NCT00773461|536851810|FG000|Overall Study|Adverse Event|1|||
148828985|NCT00773461|536851811|FG001|Overall Study|Adverse Event|3|||
148828986|NCT00773461|536851810|FG000|Overall Study|Withdrawal by Subject|4|||
148828987|NCT00773461|536851811|FG001|Overall Study|Withdrawal by Subject|1|||
148828988|NCT00637156|536851814|FG000|Overall Study|Withdrawal by Subject|0|||
148828989|NCT00637156|536851815|FG001|Overall Study|Withdrawal by Subject|7|||
148828990|NCT00637156|536851814|FG000|Overall Study|Death|0|||
148828991|NCT00637156|536851815|FG001|Overall Study|Death|1|||
148828992|NCT00637156|536851814|FG000|Overall Study|Lost to Follow-up|10|||
148828993|NCT00637156|536851815|FG001|Overall Study|Lost to Follow-up|16|||
148828994|NCT02471144|536853664|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
148828995|NCT02471144|536853665|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
148828996|NCT02471144|536853666|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
148828997|NCT02471144|536853667|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
148828998|NCT02471144|536853668|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
148828999|NCT02471144|536853669|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
148978303|NCT02880371|537400832|FG006|Phase 2|Death|20|||
148978304|NCT02880371|537400833|FG007|Phase 2|Death|5|||
148978305|NCT02880371|537400826|FG000|Phase 2|Lost to Follow-up|0|||
148978306|NCT02880371|537400827|FG001|Phase 2|Lost to Follow-up|0|||
148978307|NCT02880371|537400828|FG002|Phase 2|Lost to Follow-up|0|||
148978308|NCT02880371|537400829|FG003|Phase 2|Lost to Follow-up|0|||
148766274|NCT00828568|536617513|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
148766275|NCT00828568|536617514|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
148766276|NCT00828568|536617512|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
148766277|NCT00828568|536617513|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
148766278|NCT00828568|536617514|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
148766279|NCT00828568|536617512|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
148766280|NCT00828568|536617513|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
148766281|NCT00828568|536617514|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
148766282|NCT00403481|536617515|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
148766283|NCT00403481|536617515|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
148766284|NCT00403481|536617515|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
148766285|NCT00403481|536617515|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
148766286|NCT00403481|536617515|FG000|Olm 40 mg|Adverse Event|2|||
148766287|NCT00403481|536617515|FG000|Olm 40 mg|Protocol Violation|1|||
148766288|NCT00403481|536617515|FG000|Olm 40 mg|Withdrawal by Subject|1|||
148766289|NCT00403481|536617515|FG000|Olm 40 mg|Other|1|||
148766290|NCT00403481|536617515|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
148766291|NCT00403481|536617515|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
148766292|NCT00403481|536617515|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
148766293|NCT00403481|536617515|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
148766294|NCT00403481|536617515|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
148766295|NCT00403481|536617515|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
148978309|NCT02880371|537400830|FG004|Phase 2|Lost to Follow-up|0|||
148978310|NCT02880371|537400831|FG005|Phase 2|Lost to Follow-up|0|||
148978311|NCT02880371|537400832|FG006|Phase 2|Lost to Follow-up|3|||
148978312|NCT02880371|537400833|FG007|Phase 2|Lost to Follow-up|0|||
148978313|NCT02880371|537400826|FG000|Phase 2|Withdrawal by Subject|0|||
148978314|NCT02880371|537400827|FG001|Phase 2|Withdrawal by Subject|0|||
148978315|NCT02880371|537400828|FG002|Phase 2|Withdrawal by Subject|0|||
148978316|NCT02880371|537400829|FG003|Phase 2|Withdrawal by Subject|0|||
148978317|NCT02880371|537400830|FG004|Phase 2|Withdrawal by Subject|0|||
148978318|NCT02880371|537400831|FG005|Phase 2|Withdrawal by Subject|1|||
148978319|NCT02880371|537400832|FG006|Phase 2|Withdrawal by Subject|1|||
148978320|NCT02880371|537400833|FG007|Phase 2|Withdrawal by Subject|0|||
148978321|NCT02880371|537400826|FG000|Phase 2|End of Study page not completed by error|0|||
148978322|NCT02880371|537400827|FG001|Phase 2|End of Study page not completed by error|0|||
148978323|NCT02880371|537400828|FG002|Phase 2|End of Study page not completed by error|0|||
148978324|NCT02880371|537400829|FG003|Phase 2|End of Study page not completed by error|0|||
148978325|NCT02880371|537400830|FG004|Phase 2|End of Study page not completed by error|0|||
148978326|NCT02880371|537400831|FG005|Phase 2|End of Study page not completed by error|1|||
148978327|NCT02880371|537400832|FG006|Phase 2|End of Study page not completed by error|0|||
148978328|NCT02880371|537400833|FG007|Phase 2|End of Study page not completed by error|0|||
148978329|NCT03394391|537400834|FG000|Overall Study|Lost to Follow-up|1|||
148978330|NCT03394391|537400835|FG001|Overall Study|Lost to Follow-up|2|||
148978331|NCT04622254|537400836|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
148978332|NCT04622254|537400837|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
148978333|NCT04622254|537400838|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
148978334|NCT04622254|537400839|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
148978335|NCT04622254|537400840|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
148978336|NCT04622254|537400841|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
148978337|NCT04622254|537400836|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
148978338|NCT04622254|537400837|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
148978339|NCT04622254|537400838|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
148978340|NCT04622254|537400839|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
148978341|NCT04622254|537400840|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
148978342|NCT04622254|537400841|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
148978343|NCT04622254|537400836|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
148978344|NCT04622254|537400837|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
148978345|NCT04622254|537400838|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
148978346|NCT04622254|537400839|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
148978347|NCT04622254|537400840|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
148978348|NCT04622254|537400841|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
148978349|NCT04622254|537400836|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
148978350|NCT04622254|537400837|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
148978351|NCT04622254|537400838|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
148978352|NCT04622254|537400839|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
148978353|NCT04622254|537400840|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
148978354|NCT04622254|537400841|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
148978355|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
148978356|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
148978357|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
148978358|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
148978359|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
148978360|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
148978361|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
148978362|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
148978363|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
148978364|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
148978365|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
148978366|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
148978367|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
148978368|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
148978369|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
148978370|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
148978371|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
148978372|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
148978373|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
148978374|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
148978375|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
148978376|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
148978377|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
148978378|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
148978379|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
148978380|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
148978381|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
148978382|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
148978383|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
148978384|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
148978385|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
148978386|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
148978387|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
148978388|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
148978389|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
148978390|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
148978391|NCT04622254|537400836|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
148978392|NCT04622254|537400837|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
148978393|NCT04622254|537400838|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
148978394|NCT04622254|537400839|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
148978395|NCT04622254|537400840|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
148978396|NCT04622254|537400841|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
148978397|NCT00451282|537400844|FG000|Overall Study|Lost to Follow-up|6|||
148978398|NCT00451282|537400845|FG001|Overall Study|Lost to Follow-up|5|||
148978399|NCT00098839|537400846|FG000|Overall Study|Adverse Event|5|||
148766296|NCT04657198|536617521|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
148978400|NCT00098839|537400847|FG001|Overall Study|Adverse Event|2|||
148978401|NCT00098839|537400846|FG000|Overall Study|Death|1|||
148978402|NCT00098839|537400847|FG001|Overall Study|Death|2|||
148978403|NCT00098839|537400846|FG000|Overall Study|Physician Decision|4|||
148766297|NCT04657198|536617522|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
148766298|NCT04657198|536617523|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
148766299|NCT03793842|536617524|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
148766300|NCT03793842|536617525|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
148766301|NCT03793842|536617524|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
148766302|NCT03793842|536617525|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
148978404|NCT00098839|537400847|FG001|Overall Study|Physician Decision|14|||
148978405|NCT00098839|537400846|FG000|Overall Study|Withdrawal by Subject|1|||
148766305|NCT00900159|536617527|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
148766306|NCT00900159|536617528|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
148766307|NCT01075256|536617529|FG000|Overall Study|Withdrawal by Subject|1|||
148766308|NCT01075256|536617530|FG001|Overall Study|Withdrawal by Subject|0|||
148766309|NCT01075256|536617531|FG002|Overall Study|Withdrawal by Subject|0|||
148766310|NCT01134939|536617545|FG000|Overall Study|Adverse Event|9|||
148766311|NCT01134939|536617546|FG001|Overall Study|Adverse Event|3|||
148766312|NCT01134939|536617547|FG002|Overall Study|Adverse Event|4|||
148766313|NCT01134939|536617548|FG003|Overall Study|Adverse Event|5|||
148978406|NCT00098839|537400847|FG001|Overall Study|Withdrawal by Subject|0|||
148766314|NCT01134939|536617549|FG004|Overall Study|Adverse Event|5|||
148766315|NCT01134939|536617550|FG005|Overall Study|Adverse Event|5|||
148978407|NCT00098839|537400846|FG000|Overall Study|Refusal of further protocol therapy|3|||
148766316|NCT01134939|536617551|FG006|Overall Study|Adverse Event|1|||
148766317|NCT01134939|536617552|FG007|Overall Study|Adverse Event|0|||
148766318|NCT01134939|536617545|FG000|Overall Study|Lack of Efficacy|2|||
148766319|NCT01134939|536617546|FG001|Overall Study|Lack of Efficacy|5|||
148766320|NCT01134939|536617547|FG002|Overall Study|Lack of Efficacy|1|||
148766321|NCT01134939|536617548|FG003|Overall Study|Lack of Efficacy|0|||
148766322|NCT01134939|536617549|FG004|Overall Study|Lack of Efficacy|3|||
148766323|NCT01134939|536617550|FG005|Overall Study|Lack of Efficacy|0|||
148766324|NCT01134939|536617551|FG006|Overall Study|Lack of Efficacy|1|||
148766325|NCT01134939|536617552|FG007|Overall Study|Lack of Efficacy|0|||
148766326|NCT01134939|536617545|FG000|Overall Study|Lost to Follow-up|2|||
148766327|NCT01134939|536617546|FG001|Overall Study|Lost to Follow-up|3|||
148766328|NCT01134939|536617547|FG002|Overall Study|Lost to Follow-up|0|||
148766329|NCT01134939|536617548|FG003|Overall Study|Lost to Follow-up|1|||
148766330|NCT01134939|536617549|FG004|Overall Study|Lost to Follow-up|2|||
148766331|NCT01134939|536617550|FG005|Overall Study|Lost to Follow-up|1|||
148766332|NCT01134939|536617551|FG006|Overall Study|Lost to Follow-up|0|||
148766333|NCT01134939|536617552|FG007|Overall Study|Lost to Follow-up|0|||
148766334|NCT01134939|536617545|FG000|Overall Study|Death|0|||
148766335|NCT01134939|536617546|FG001|Overall Study|Death|1|||
148766336|NCT01134939|536617547|FG002|Overall Study|Death|0|||
148766337|NCT01134939|536617548|FG003|Overall Study|Death|0|||
148766338|NCT01134939|536617549|FG004|Overall Study|Death|0|||
148766339|NCT01134939|536617550|FG005|Overall Study|Death|0|||
148766340|NCT01134939|536617551|FG006|Overall Study|Death|0|||
148766341|NCT01134939|536617552|FG007|Overall Study|Death|0|||
148766342|NCT01134939|536617545|FG000|Overall Study|Termination page not available|4|||
148766343|NCT01134939|536617546|FG001|Overall Study|Termination page not available|6|||
148766344|NCT01134939|536617547|FG002|Overall Study|Termination page not available|5|||
148766345|NCT01134939|536617548|FG003|Overall Study|Termination page not available|8|||
148766346|NCT01134939|536617549|FG004|Overall Study|Termination page not available|0|||
148766347|NCT01134939|536617550|FG005|Overall Study|Termination page not available|3|||
148766348|NCT01134939|536617551|FG006|Overall Study|Termination page not available|7|||
148766349|NCT01134939|536617552|FG007|Overall Study|Termination page not available|0|||
148766350|NCT00757042|536617561|FG000|Overall Study|Lost to Follow-up|0|||
148766351|NCT00757042|536617562|FG001|Overall Study|Lost to Follow-up|0|||
148766352|NCT00757042|536617563|FG002|Overall Study|Lost to Follow-up|0|||
148766353|NCT00757042|536617564|FG003|Overall Study|Lost to Follow-up|0|||
148766354|NCT00757042|536617565|FG004|Overall Study|Lost to Follow-up|0|||
148766355|NCT00757042|536617566|FG005|Overall Study|Lost to Follow-up|0|||
148766356|NCT00757042|536617567|FG006|Overall Study|Lost to Follow-up|0|||
148766357|NCT00757042|536617568|FG007|Overall Study|Lost to Follow-up|0|||
148766358|NCT00757042|536617569|FG008|Overall Study|Lost to Follow-up|1|||
148766359|NCT00757042|536617570|FG009|Overall Study|Lost to Follow-up|0|||
148766360|NCT00757042|536617571|FG010|Overall Study|Lost to Follow-up|0|||
148766361|NCT00757042|536617561|FG000|Overall Study|Ineligibility Determined|0|||
148766362|NCT00757042|536617562|FG001|Overall Study|Ineligibility Determined|0|||
148766363|NCT00757042|536617563|FG002|Overall Study|Ineligibility Determined|0|||
148766364|NCT00757042|536617564|FG003|Overall Study|Ineligibility Determined|0|||
148766365|NCT00757042|536617565|FG004|Overall Study|Ineligibility Determined|0|||
148766366|NCT00757042|536617566|FG005|Overall Study|Ineligibility Determined|0|||
148766367|NCT00757042|536617567|FG006|Overall Study|Ineligibility Determined|0|||
148766368|NCT00757042|536617568|FG007|Overall Study|Ineligibility Determined|0|||
148766369|NCT00757042|536617569|FG008|Overall Study|Ineligibility Determined|0|||
148766370|NCT00757042|536617570|FG009|Overall Study|Ineligibility Determined|0|||
148766371|NCT00757042|536617571|FG010|Overall Study|Ineligibility Determined|1|||
148766372|NCT00757042|536617561|FG000|Overall Study|Withdrawal by Subject|0|||
148766373|NCT00757042|536617562|FG001|Overall Study|Withdrawal by Subject|0|||
148766374|NCT00757042|536617563|FG002|Overall Study|Withdrawal by Subject|0|||
148766375|NCT00757042|536617564|FG003|Overall Study|Withdrawal by Subject|0|||
148766376|NCT00757042|536617565|FG004|Overall Study|Withdrawal by Subject|0|||
148766377|NCT00757042|536617566|FG005|Overall Study|Withdrawal by Subject|0|||
148766378|NCT00757042|536617567|FG006|Overall Study|Withdrawal by Subject|0|||
148766379|NCT00757042|536617568|FG007|Overall Study|Withdrawal by Subject|0|||
148766380|NCT00757042|536617569|FG008|Overall Study|Withdrawal by Subject|0|||
148766381|NCT00757042|536617570|FG009|Overall Study|Withdrawal by Subject|1|||
148766382|NCT00757042|536617571|FG010|Overall Study|Withdrawal by Subject|0|||
148766383|NCT02654977|536617572|FG000|Overall Study|Death|1|||
148766384|NCT02654977|536617572|FG000|Overall Study|Lost to Follow-up|1|||
148766385|NCT02654977|536617572|FG000|Overall Study|Adverse Event|1|||
148766386|NCT02654977|536617572|FG000|Overall Study|Withdrawal by Subject|1|||
148766387|NCT02654977|536617572|FG000|Overall Study|Lack of Efficacy|3|||
148766388|NCT01266291|536617573|FG000|Overall Study|Adverse Event|1|||
148766389|NCT01190410|536618745|FG000|Overall Study|Adverse Event|0|||
148766390|NCT01190410|536618746|FG001|Overall Study|Adverse Event|3|||
148766391|NCT01190410|536618745|FG000|Overall Study|Lack of Efficacy|0|||
148766392|NCT01190410|536618746|FG001|Overall Study|Lack of Efficacy|2|||
148766393|NCT01190410|536618745|FG000|Overall Study|Withdrawal by Subject|0|||
148978408|NCT00098839|537400847|FG001|Overall Study|Refusal of further protocol therapy|1|||
148978409|NCT00098839|537400846|FG000|Overall Study|Relapse|6|||
148978410|NCT00098839|537400847|FG001|Overall Study|Relapse|3|||
148978411|NCT00098839|537400846|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
148978412|NCT00098839|537400847|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
148978413|NCT00098839|537400846|FG000|Overall Study|Ineligible|2|||
148978414|NCT00098839|537400847|FG001|Overall Study|Ineligible|0|||
148978415|NCT03228680|537400849|FG000|Overall Study|Adverse Event|13|||
148766394|NCT01190410|536618746|FG001|Overall Study|Withdrawal by Subject|2|||
148978416|NCT03228680|537400850|FG001|Overall Study|Adverse Event|18|||
148978417|NCT03228680|537400849|FG000|Overall Study|Randomization failure|0|||
149027793|NCT02698436|537578671|FG001|Overall Study|Non-compliance with study regimen|0|||
148978418|NCT03228680|537400850|FG001|Overall Study|Randomization failure|1|||
148978419|NCT03228680|537400849|FG000|Overall Study|Withdrawal by Subject|1|||
148978420|NCT03228680|537400850|FG001|Overall Study|Withdrawal by Subject|0|||
148978421|NCT03228680|537400849|FG000|Overall Study|Other|9|||
148978422|NCT03228680|537400850|FG001|Overall Study|Other|16|||
148978423|NCT02167035|537400851|FG000|Overall Study|Adverse Event|2|||
148978424|NCT02167035|537400852|FG001|Overall Study|Adverse Event|2|||
148978425|NCT02167035|537400851|FG000|Overall Study|Lost to Follow-up|3|||
148978426|NCT02167035|537400852|FG001|Overall Study|Lost to Follow-up|3|||
148978427|NCT02167035|537400851|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
148978428|NCT02167035|537400852|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
148978429|NCT02148003|537400853|FG000|Overall Study|Failed inclusion criteria|1|||
148978430|NCT02148003|537400854|FG001|Overall Study|Failed inclusion criteria|0|||
148978431|NCT02148003|537400853|FG000|Overall Study|Met exclusion criteria|0|||
148978432|NCT02148003|537400854|FG001|Overall Study|Met exclusion criteria|1|||
148978433|NCT02148003|537400853|FG000|Overall Study|Withdrawal by Subject|0|||
148978434|NCT02148003|537400854|FG001|Overall Study|Withdrawal by Subject|1|||
148978435|NCT02489981|537400855|FG000|Overall Study|Adverse Event|21|||
148978436|NCT02489981|537400855|FG000|Overall Study|Insufficient effectiveness|16|||
148978437|NCT02489981|537400855|FG000|Overall Study|Improved|31|||
148978438|NCT02489981|537400855|FG000|Overall Study|Lost to Follow-up|31|||
148978439|NCT02489981|537400855|FG000|Overall Study|Other than listed|28|||
148978440|NCT03348904|537400858|FG000|Overall Study|Administrative reason by the sponsor|0|||
148978441|NCT03348904|537400859|FG001|Overall Study|Administrative reason by the sponsor|1|||
148978442|NCT03348904|537400860|FG002|Overall Study|Administrative reason by the sponsor|0|||
148978443|NCT00436280|537400861|FG000|Period 1: Induction|Adverse Event|8|||
148978444|NCT00436280|537400861|FG000|Period 1: Induction|Progressive Disease|12|||
148978445|NCT00436280|537400861|FG000|Period 1: Induction|Stable Disease|6|||
148978446|NCT00436280|537400861|FG000|Period 1: Induction|Withdrawal by Subject|1|||
148978447|NCT00436280|537400861|FG000|Period 1: Induction|Death|1|||
148978448|NCT00436280|537400861|FG000|Period 2: Consolidation|Adverse Event|1|||
148978449|NCT00436280|537400861|FG000|Period 2: Consolidation|Progressive Disease|10|||
148978450|NCT00436280|537400861|FG000|Period 2: Consolidation|Stable Disease|1|||
148978451|NCT00436280|537400861|FG000|Period 2: Consolidation|Physician Decision|2|||
148978452|NCT00436280|537400861|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
148978453|NCT00436280|537400861|FG000|Period 2: Consolidation|Death|1|||
148978454|NCT00436280|537400861|FG000|Period 3: Maintenance|Adverse Event|6|||
148978455|NCT00436280|537400861|FG000|Period 3: Maintenance|Progressive Disease|12|||
148978456|NCT00087568|537400863|FG000|Overall Study|Adverse Event|4|||
148978457|NCT00087568|537400864|FG001|Overall Study|Adverse Event|0|||
148978458|NCT00087568|537400863|FG000|Overall Study|Withdrawal by Subject|1|||
148978459|NCT00087568|537400864|FG001|Overall Study|Withdrawal by Subject|1|||
148978460|NCT00087568|537400863|FG000|Overall Study|Lost to Follow-up|1|||
148978461|NCT00087568|537400864|FG001|Overall Study|Lost to Follow-up|0|||
148978462|NCT00087568|537400863|FG000|Overall Study|Lack of Efficacy|24|||
148978463|NCT00087568|537400864|FG001|Overall Study|Lack of Efficacy|1|||
148978464|NCT01034397|537400865|FG000|Overall Study|Lack of compliance|0|||
148978465|NCT01034397|537400866|FG001|Overall Study|Lack of compliance|1|||
148978466|NCT01034397|537400865|FG000|Overall Study|Lack of Efficacy|3|||
148978467|NCT01034397|537400866|FG001|Overall Study|Lack of Efficacy|0|||
148978468|NCT01034397|537400865|FG000|Overall Study|Adverse Event|4|||
148978469|NCT01034397|537400866|FG001|Overall Study|Adverse Event|0|||
148978470|NCT01034397|537400865|FG000|Overall Study|Other|0|||
148978471|NCT01034397|537400866|FG001|Overall Study|Other|1|||
148978472|NCT02606136|537400871|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
148978473|NCT02606136|537400871|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
148978474|NCT02606136|537400871|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
148978475|NCT02606136|537400871|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
148978476|NCT03296696|537400872|FG000|Overall Study|Started Other Antitumor Therapy|1|||
148978477|NCT03296696|537400873|FG001|Overall Study|Started Other Antitumor Therapy|2|||
148978478|NCT03296696|537400874|FG002|Overall Study|Started Other Antitumor Therapy|1|||
148978479|NCT03296696|537400875|FG003|Overall Study|Started Other Antitumor Therapy|2|||
148978480|NCT03296696|537400876|FG004|Overall Study|Started Other Antitumor Therapy|1|||
148978481|NCT03296696|537400877|FG005|Overall Study|Started Other Antitumor Therapy|1|||
148978482|NCT03296696|537400878|FG006|Overall Study|Started Other Antitumor Therapy|2|||
148978483|NCT03296696|537400879|FG007|Overall Study|Started Other Antitumor Therapy|3|||
148978484|NCT03296696|537400880|FG008|Overall Study|Started Other Antitumor Therapy|1|||
148978485|NCT03296696|537400881|FG009|Overall Study|Started Other Antitumor Therapy|0|||
148978486|NCT03296696|537400872|FG000|Overall Study|Death|0|||
148978487|NCT03296696|537400873|FG001|Overall Study|Death|1|||
148978488|NCT03296696|537400874|FG002|Overall Study|Death|1|||
148978489|NCT03296696|537400875|FG003|Overall Study|Death|2|||
148978490|NCT03296696|537400876|FG004|Overall Study|Death|2|||
148978491|NCT03296696|537400877|FG005|Overall Study|Death|3|||
148978492|NCT03296696|537400878|FG006|Overall Study|Death|1|||
148978493|NCT03296696|537400879|FG007|Overall Study|Death|2|||
148978494|NCT03296696|537400880|FG008|Overall Study|Death|0|||
148978495|NCT03296696|537400881|FG009|Overall Study|Death|0|||
148978496|NCT03296696|537400872|FG000|Overall Study|Withdrawal by Subject|0|||
148978497|NCT03296696|537400873|FG001|Overall Study|Withdrawal by Subject|0|||
148978498|NCT03296696|537400874|FG002|Overall Study|Withdrawal by Subject|1|||
148978499|NCT03296696|537400875|FG003|Overall Study|Withdrawal by Subject|0|||
148978500|NCT03296696|537400876|FG004|Overall Study|Withdrawal by Subject|1|||
148978501|NCT03296696|537400877|FG005|Overall Study|Withdrawal by Subject|0|||
148978502|NCT03296696|537400878|FG006|Overall Study|Withdrawal by Subject|0|||
148978503|NCT03296696|537400879|FG007|Overall Study|Withdrawal by Subject|0|||
148978504|NCT03296696|537400880|FG008|Overall Study|Withdrawal by Subject|0|||
148978505|NCT03296696|537400881|FG009|Overall Study|Withdrawal by Subject|1|||
148978506|NCT04694131|537400882|FG000|Overall Study|Withdrawal by Subject|7|||
148978507|NCT04694131|537400882|FG000|Overall Study|Screen Failure|1|||
148978508|NCT04694131|537400882|FG000|Overall Study|High stimulation threshold|3|||
148978509|NCT00086580|537400886|FG000|Treatment Period|Disease progression|9|||
148978510|NCT00086580|537400887|FG001|Treatment Period|Disease progression|8|||
148978511|NCT00086580|537400886|FG000|Treatment Period|Unable to comply with protocol|3|||
148978512|NCT00086580|537400887|FG001|Treatment Period|Unable to comply with protocol|1|||
148978513|NCT00086580|537400886|FG000|Treatment Period|Withdrawal by Subject|7|||
148978514|NCT00086580|537400887|FG001|Treatment Period|Withdrawal by Subject|8|||
148978515|NCT00086580|537400886|FG000|Treatment Period|Physician Decision|13|||
148978516|NCT00086580|537400887|FG001|Treatment Period|Physician Decision|7|||
148978517|NCT00086580|537400886|FG000|Treatment Period|AE - not treatment related|7|||
148978518|NCT00086580|537400887|FG001|Treatment Period|AE - not treatment related|7|||
148978519|NCT00086580|537400886|FG000|Treatment Period|Toxicity - treatment related|15|||
148978520|NCT00086580|537400887|FG001|Treatment Period|Toxicity - treatment related|15|||
148978521|NCT00086580|537400886|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
148978522|NCT00086580|537400887|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
148978523|NCT00086580|537400886|FG000|Treatment Period|Death|5|||
148978524|NCT00086580|537400887|FG001|Treatment Period|Death|7|||
148978525|NCT00086580|537400886|FG000|Treatment Period|Other|5|||
148978526|NCT00086580|537400887|FG001|Treatment Period|Other|3|||
149027794|NCT03369951|537578672|FG000|Overall Study|Withdrawal by Subject|3|||
149027795|NCT03369951|537578672|FG000|Overall Study|Death|1|||
148766395|NCT01190410|536618745|FG000|Overall Study|Administrative decision|1|||
148766396|NCT01190410|536618746|FG001|Overall Study|Administrative decision|0|||
148766397|NCT01190410|536618745|FG000|Overall Study|PI discretion|0|||
148766398|NCT01190410|536618746|FG001|Overall Study|PI discretion|2|||
148766399|NCT03300505|536618754|FG000|Overall Study|Death|0|||
148766400|NCT03300505|536618755|FG001|Overall Study|Death|1|||
148766401|NCT03300505|536618756|FG002|Overall Study|Death|0|||
148766402|NCT03300505|536618754|FG000|Overall Study|Withdrawal by Subject|0|||
148766403|NCT03300505|536618755|FG001|Overall Study|Withdrawal by Subject|1|||
148766404|NCT03300505|536618756|FG002|Overall Study|Withdrawal by Subject|1|||
148766405|NCT03300505|536618754|FG000|Overall Study|Sponsor Termination|0|||
148766406|NCT03300505|536618755|FG001|Overall Study|Sponsor Termination|1|||
148766407|NCT03300505|536618756|FG002|Overall Study|Sponsor Termination|0|||
148766408|NCT03300505|536618754|FG000|Overall Study|Adverse Event|0|||
148766409|NCT03300505|536618755|FG001|Overall Study|Adverse Event|0|||
148766410|NCT03300505|536618756|FG002|Overall Study|Adverse Event|2|||
148766411|NCT05119595|536618757|FG000|Overall Study|Death|1|||
148766412|NCT05119595|536618757|FG000|Overall Study|Lost to Follow-up|7|||
148766413|NCT01108341|536618758|FG000|Overall Study|Death|2|||
148766414|NCT01108341|536618758|FG000|Overall Study|Withdrawal by Subject|1|||
148766415|NCT01108341|536618758|FG000|Overall Study|Lost to Follow-up|1|||
148766416|NCT01108341|536618758|FG000|Overall Study|Other|1|||
148766417|NCT03508726|536618759|FG000|Overall Study|Withdrawal by Subject|0|||
148766418|NCT03508726|536618760|FG001|Overall Study|Withdrawal by Subject|1|||
148766419|NCT00178685|536618765|FG000|Overall Study|Death|3|||
148766420|NCT00178685|536618766|FG001|Overall Study|Death|3|||
148766421|NCT00178685|536618767|FG002|Overall Study|Death|6|||
148766422|NCT00178685|536618765|FG000|Overall Study|Lost to Follow-up|100|||
148766423|NCT00178685|536618766|FG001|Overall Study|Lost to Follow-up|187|||
148766424|NCT00178685|536618767|FG002|Overall Study|Lost to Follow-up|183|||
148766425|NCT00178685|536618765|FG000|Overall Study|Withdrawal by Subject|8|||
148766426|NCT00178685|536618766|FG001|Overall Study|Withdrawal by Subject|14|||
148766427|NCT00178685|536618767|FG002|Overall Study|Withdrawal by Subject|7|||
148766428|NCT04112043|536618768|FG000|Overall Study|Withdrawal by Subject|1|||
148766429|NCT04112043|536618769|FG001|Overall Study|Withdrawal by Subject|1|||
148766430|NCT04112043|536618770|FG002|Overall Study|Withdrawal by Subject|1|||
148766431|NCT04112043|536618768|FG000|Overall Study|Taking NR supplement|1|||
148766432|NCT04112043|536618769|FG001|Overall Study|Taking NR supplement|0|||
148766433|NCT04112043|536618770|FG002|Overall Study|Taking NR supplement|0|||
148766434|NCT04112043|536618768|FG000|Overall Study|Adverse Event|0|||
148766435|NCT04112043|536618769|FG001|Overall Study|Adverse Event|1|||
148766436|NCT04112043|536618770|FG002|Overall Study|Adverse Event|0|||
148766437|NCT01750697|536618773|FG000|Overall Study|Transferred Back to Local Hospital|1|||
148766438|NCT01750697|536618773|FG000|Overall Study|Physician and Family Decision|1|||
148766439|NCT01750697|536618773|FG000|Overall Study|Transferred to Adult Services|5|||
148766440|NCT01750697|536618773|FG000|Overall Study|Physician Decision|1|||
148766441|NCT01750697|536618773|FG000|Overall Study|Withdrawal by Subject|1|||
148766442|NCT01057810|536618774|FG000|Overall Study|Disease progression|156|||
148766443|NCT01057810|536618775|FG001|Overall Study|Disease progression|197|||
148766444|NCT01057810|536618774|FG000|Overall Study|Study drug toxicity|5|||
148766445|NCT01057810|536618775|FG001|Overall Study|Study drug toxicity|114|||
148766446|NCT01057810|536618774|FG000|Overall Study|Adverse event unrelated to study drug|13|||
148766447|NCT01057810|536618775|FG001|Overall Study|Adverse event unrelated to study drug|29|||
148766448|NCT01057810|536618774|FG000|Overall Study|Withdrawal by Subject|10|||
148766449|NCT01057810|536618775|FG001|Overall Study|Withdrawal by Subject|25|||
148766450|NCT01057810|536618774|FG000|Overall Study|Death|2|||
148766451|NCT01057810|536618775|FG001|Overall Study|Death|12|||
148766452|NCT01057810|536618774|FG000|Overall Study|Maximum clinical benefit|5|||
148766453|NCT01057810|536618775|FG001|Overall Study|Maximum clinical benefit|5|||
148766454|NCT01057810|536618774|FG000|Overall Study|Poor/non-compliance|0|||
148766455|NCT01057810|536618775|FG001|Overall Study|Poor/non-compliance|1|||
148766456|NCT01057810|536618774|FG000|Overall Study|No longer met study criteria|0|||
148766457|NCT01057810|536618775|FG001|Overall Study|No longer met study criteria|1|||
148766458|NCT01057810|536618774|FG000|Overall Study|Other|7|||
148766459|NCT01057810|536618775|FG001|Overall Study|Other|14|||
148766460|NCT02088905|536618776|FG000|Overall Study|Withdrawal by Subject|5|||
148766461|NCT02088905|536618777|FG001|Overall Study|Withdrawal by Subject|1|||
148766462|NCT00267969|536618778|FG000|Controlled Period|Adverse Event|6|||
148766463|NCT00267969|536618779|FG001|Controlled Period|Adverse Event|0|||
148766464|NCT00267969|536618780|FG002|Controlled Period|Adverse Event|2|||
148766465|NCT00267969|536618781|FG003|Controlled Period|Adverse Event|0|||
148766466|NCT00267969|536618782|FG004|Controlled Period|Adverse Event|0|||
148766467|NCT00267969|536618783|FG005|Controlled Period|Adverse Event|0|||
148766468|NCT00267969|536618784|FG006|Controlled Period|Adverse Event|0|||
148766469|NCT00267969|536618778|FG000|Controlled Period|Lack of Efficacy|3|||
148766470|NCT00267969|536618779|FG001|Controlled Period|Lack of Efficacy|0|||
148766471|NCT00267969|536618780|FG002|Controlled Period|Lack of Efficacy|1|||
148978527|NCT00086580|537400886|FG000|Follow-up Period|Disease progression|72|||
148978528|NCT00086580|537400887|FG001|Follow-up Period|Disease progression|99|||
148978529|NCT00086580|537400886|FG000|Follow-up Period|Unable to comply with protocol|5|||
148978530|NCT00086580|537400887|FG001|Follow-up Period|Unable to comply with protocol|0|||
148978531|NCT00086580|537400886|FG000|Follow-up Period|Withdrawal by Subject|6|||
148978532|NCT00086580|537400887|FG001|Follow-up Period|Withdrawal by Subject|6|||
148978533|NCT00086580|537400886|FG000|Follow-up Period|Physician Decision|0|||
148978534|NCT00086580|537400887|FG001|Follow-up Period|Physician Decision|1|||
148978535|NCT00086580|537400886|FG000|Follow-up Period|AE - not related|1|||
148978536|NCT00086580|537400887|FG001|Follow-up Period|AE - not related|0|||
148978537|NCT00086580|537400886|FG000|Follow-up Period|Death|13|||
148978538|NCT00086580|537400887|FG001|Follow-up Period|Death|7|||
148978539|NCT00086580|537400886|FG000|Follow-up Period|Other|7|||
148978540|NCT00086580|537400887|FG001|Follow-up Period|Other|6|||
148978541|NCT00086580|537400886|FG000|Observation Period|Unable to comply with protocol|1|||
148978542|NCT00086580|537400887|FG001|Observation Period|Unable to comply with protocol|1|||
148766472|NCT00267969|536618781|FG003|Controlled Period|Lack of Efficacy|0|||
148978543|NCT00086580|537400886|FG000|Observation Period|Withdrawal by Subject|4|||
148978544|NCT00086580|537400887|FG001|Observation Period|Withdrawal by Subject|2|||
148978545|NCT00086580|537400886|FG000|Observation Period|Death|33|||
148978546|NCT00086580|537400887|FG001|Observation Period|Death|55|||
148978547|NCT00086580|537400886|FG000|Observation Period|Other|8|||
148978548|NCT00086580|537400887|FG001|Observation Period|Other|7|||
148978549|NCT03235024|537400888|FG000|Overall Study|Adverse Event|2|||
148978550|NCT03235024|537400889|FG001|Overall Study|Adverse Event|2|||
148978551|NCT03235024|537400888|FG000|Overall Study|Death|1|||
148766473|NCT00267969|536618782|FG004|Controlled Period|Lack of Efficacy|0|||
148766474|NCT00267969|536618783|FG005|Controlled Period|Lack of Efficacy|0|||
148766475|NCT00267969|536618784|FG006|Controlled Period|Lack of Efficacy|0|||
148766476|NCT00267969|536618778|FG000|Controlled Period|Lost to Follow-up|1|||
148766477|NCT00267969|536618779|FG001|Controlled Period|Lost to Follow-up|0|||
148766478|NCT00267969|536618780|FG002|Controlled Period|Lost to Follow-up|1|||
148766479|NCT00267969|536618781|FG003|Controlled Period|Lost to Follow-up|0|||
148766480|NCT00267969|536618782|FG004|Controlled Period|Lost to Follow-up|0|||
148766481|NCT00267969|536618783|FG005|Controlled Period|Lost to Follow-up|0|||
148766482|NCT00267969|536618784|FG006|Controlled Period|Lost to Follow-up|0|||
148766483|NCT00267969|536618778|FG000|Controlled Period|Randomized but not treated|0|||
148766484|NCT00267969|536618779|FG001|Controlled Period|Randomized but not treated|0|||
148766485|NCT00267969|536618780|FG002|Controlled Period|Randomized but not treated|1|||
148766486|NCT00267969|536618781|FG003|Controlled Period|Randomized but not treated|0|||
148766487|NCT00267969|536618782|FG004|Controlled Period|Randomized but not treated|0|||
148766488|NCT00267969|536618783|FG005|Controlled Period|Randomized but not treated|0|||
148766489|NCT00267969|536618784|FG006|Controlled Period|Randomized but not treated|0|||
148766490|NCT00267969|536618778|FG000|Controlled Period|Other|2|||
148766491|NCT00267969|536618779|FG001|Controlled Period|Other|1|||
148766492|NCT00267969|536618780|FG002|Controlled Period|Other|6|||
148766493|NCT00267969|536618781|FG003|Controlled Period|Other|0|||
148766494|NCT00267969|536618782|FG004|Controlled Period|Other|0|||
148766495|NCT00267969|536618783|FG005|Controlled Period|Other|0|||
148766496|NCT00267969|536618784|FG006|Controlled Period|Other|0|||
148766497|NCT00267969|536618778|FG000|After Controlled Period|Adverse Event|0|||
148766498|NCT00267969|536618779|FG001|After Controlled Period|Adverse Event|0|||
148766499|NCT00267969|536618780|FG002|After Controlled Period|Adverse Event|0|||
148766500|NCT00267969|536618781|FG003|After Controlled Period|Adverse Event|7|||
148766501|NCT00267969|536618782|FG004|After Controlled Period|Adverse Event|8|||
148766502|NCT00267969|536618783|FG005|After Controlled Period|Adverse Event|23|||
148766503|NCT00267969|536618784|FG006|After Controlled Period|Adverse Event|21|||
148766504|NCT00267969|536618778|FG000|After Controlled Period|Death|0|||
148766505|NCT00267969|536618779|FG001|After Controlled Period|Death|0|||
148766506|NCT00267969|536618780|FG002|After Controlled Period|Death|0|||
148766507|NCT00267969|536618781|FG003|After Controlled Period|Death|1|||
148766508|NCT00267969|536618782|FG004|After Controlled Period|Death|2|||
148766509|NCT00267969|536618783|FG005|After Controlled Period|Death|0|||
148766510|NCT00267969|536618784|FG006|After Controlled Period|Death|1|||
148766511|NCT00267969|536618778|FG000|After Controlled Period|Lack of Efficacy|0|||
148766512|NCT00267969|536618779|FG001|After Controlled Period|Lack of Efficacy|0|||
148766513|NCT00267969|536618780|FG002|After Controlled Period|Lack of Efficacy|0|||
148766514|NCT00267969|536618781|FG003|After Controlled Period|Lack of Efficacy|10|||
148766515|NCT00267969|536618782|FG004|After Controlled Period|Lack of Efficacy|6|||
148766516|NCT00267969|536618783|FG005|After Controlled Period|Lack of Efficacy|28|||
148766517|NCT00267969|536618784|FG006|After Controlled Period|Lack of Efficacy|15|||
148766518|NCT00267969|536618778|FG000|After Controlled Period|Lost to Follow-up|0|||
148766519|NCT00267969|536618779|FG001|After Controlled Period|Lost to Follow-up|0|||
148766520|NCT00267969|536618780|FG002|After Controlled Period|Lost to Follow-up|0|||
148766521|NCT00267969|536618781|FG003|After Controlled Period|Lost to Follow-up|5|||
148766522|NCT00267969|536618782|FG004|After Controlled Period|Lost to Follow-up|8|||
148766523|NCT00267969|536618783|FG005|After Controlled Period|Lost to Follow-up|9|||
148766524|NCT00267969|536618784|FG006|After Controlled Period|Lost to Follow-up|10|||
148766525|NCT00267969|536618778|FG000|After Controlled Period|Other|0|||
148766526|NCT00267969|536618779|FG001|After Controlled Period|Other|0|||
148978552|NCT03235024|537400889|FG001|Overall Study|Death|0|||
148766527|NCT00267969|536618780|FG002|After Controlled Period|Other|0|||
148766528|NCT00267969|536618781|FG003|After Controlled Period|Other|13|||
148766529|NCT00267969|536618782|FG004|After Controlled Period|Other|11|||
148766530|NCT00267969|536618783|FG005|After Controlled Period|Other|22|||
148766531|NCT00267969|536618784|FG006|After Controlled Period|Other|25|||
148766532|NCT04075682|536618785|FG000|Overall Study|Lost to Follow-up|5|||
148766533|NCT04075682|536618786|FG001|Overall Study|Lost to Follow-up|5|||
148978553|NCT03235024|537400888|FG000|Overall Study|Lost to Follow-up|2|||
148978554|NCT03235024|537400889|FG001|Overall Study|Lost to Follow-up|5|||
148978555|NCT03235024|537400888|FG000|Overall Study|Protocol Violation|1|||
148766534|NCT04075682|536618787|FG002|Overall Study|Lost to Follow-up|2|||
148766535|NCT04075682|536618788|FG003|Overall Study|Lost to Follow-up|2|||
148766536|NCT04075682|536618785|FG000|Overall Study|Withdrawal by Subject|1|||
148978556|NCT03235024|537400889|FG001|Overall Study|Protocol Violation|0|||
148978557|NCT03235024|537400888|FG000|Overall Study|Withdrawal by Subject|0|||
148978558|NCT03235024|537400889|FG001|Overall Study|Withdrawal by Subject|3|||
148978559|NCT02357576|537400890|FG000|Treatment Period|Withdrawal by Subject|0|||
148978560|NCT02357576|537400891|FG001|Treatment Period|Withdrawal by Subject|1|||
148978561|NCT02357576|537400890|FG000|Treatment Period|Physician Decision|0|||
148978562|NCT02357576|537400891|FG001|Treatment Period|Physician Decision|1|||
148978563|NCT02357576|537400890|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
148978564|NCT02357576|537400891|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
148978565|NCT02357576|537400890|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
148978566|NCT02357576|537400891|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
148978567|NCT02357576|537400890|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
148978568|NCT02357576|537400891|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
149027796|NCT03369951|537578672|FG000|Overall Study|Lost to Follow-up|1|||
149027797|NCT03369951|537578672|FG000|Overall Study|Protocol Violation|1|||
149027798|NCT00097370|537578673|FG000|Stage 1|Adverse Event|3|||
149027799|NCT00097370|537578673|FG000|Stage 1|Withdrawal by Subject|1|||
149027800|NCT00097370|537578673|FG000|Stage 1|Lack of Efficacy|2|||
149027801|NCT00097370|537578673|FG000|Stage 2|Adverse Event|5|||
149027802|NCT00097370|537578673|FG000|Stage 2|Withdrawal by Subject|1|||
149027803|NCT00097370|537578673|FG000|Stage 2|Lack of Efficacy|3|||
149027804|NCT00097370|537578673|FG000|Stage 2|Pregnancy|1|||
149027805|NCT00097370|537578673|FG000|Stage 2|Sponsor Terminated Study|2|||
149027806|NCT00097370|537578673|FG000|Stage 2|Lost to Follow-up|1|||
149027807|NCT00097370|537578673|FG000|Stage 3|Adverse Event|2|||
149027808|NCT00097370|537578673|FG000|Stage 3|Withdrawal by Subject|3|||
149027809|NCT00097370|537578673|FG000|Stage 3|Lack of Efficacy|1|||
149027810|NCT00097370|537578673|FG000|Stage 3|Sponsor Terminated Study|52|||
149027811|NCT00097370|537578673|FG000|Stage 3|Lost to Follow-up|1|||
149027812|NCT00062868|537578683|FG000|Dose Level 1|Death|2|||
149027813|NCT00062868|537578684|FG001|Dose Level 1|Death|0|||
149027814|NCT00062868|537578685|FG002|Dose Level 1|Death|0|||
149027815|NCT00062868|537578686|FG003|Dose Level 1|Death|2|||
149027816|NCT00062868|537578687|FG004|Dose Level 1|Death|0|||
149027817|NCT00062868|537578688|FG005|Dose Level 1|Death|0|||
149027818|NCT00062868|537578689|FG006|Dose Level 1|Death|3|||
149027819|NCT00062868|537578690|FG007|Dose Level 1|Death|0|||
149027820|NCT00062868|537578691|FG008|Dose Level 1|Death|0|||
149027821|NCT00062868|537578692|FG009|Dose Level 1|Death|0|||
149027822|NCT00062868|537578693|FG010|Dose Level 1|Death|0|||
149027823|NCT00062868|537578694|FG011|Dose Level 1|Death|0|||
149027824|NCT00062868|537578695|FG012|Dose Level 1|Death|0|||
149027825|NCT00062868|537578696|FG013|Dose Level 1|Death|0|||
149027826|NCT00062868|537578697|FG014|Dose Level 1|Death|0|||
149027827|NCT00062868|537578698|FG015|Dose Level 1|Death|0|||
149027828|NCT00062868|537578699|FG016|Dose Level 1|Death|0|||
149027829|NCT00062868|537578700|FG017|Dose Level 1|Death|0|||
149027830|NCT00062868|537578701|FG018|Dose Level 1|Death|7|||
149027831|NCT00062868|537578702|FG019|Dose Level 1|Death|0|||
149027832|NCT00062868|537578703|FG020|Dose Level 1|Death|1|||
149027833|NCT00062868|537578683|FG000|Dose Level 1|Lost to Follow-up|0|||
149027834|NCT00062868|537578684|FG001|Dose Level 1|Lost to Follow-up|0|||
149027835|NCT00062868|537578685|FG002|Dose Level 1|Lost to Follow-up|0|||
149027836|NCT00062868|537578686|FG003|Dose Level 1|Lost to Follow-up|0|||
149027837|NCT00062868|537578687|FG004|Dose Level 1|Lost to Follow-up|0|||
149027838|NCT00062868|537578688|FG005|Dose Level 1|Lost to Follow-up|0|||
149027839|NCT00062868|537578689|FG006|Dose Level 1|Lost to Follow-up|0|||
149027840|NCT00062868|537578690|FG007|Dose Level 1|Lost to Follow-up|0|||
149027841|NCT00062868|537578691|FG008|Dose Level 1|Lost to Follow-up|0|||
149027842|NCT00062868|537578692|FG009|Dose Level 1|Lost to Follow-up|0|||
149027843|NCT00062868|537578693|FG010|Dose Level 1|Lost to Follow-up|0|||
149027844|NCT00062868|537578694|FG011|Dose Level 1|Lost to Follow-up|0|||
149027845|NCT00062868|537578695|FG012|Dose Level 1|Lost to Follow-up|1|||
149027846|NCT00062868|537578696|FG013|Dose Level 1|Lost to Follow-up|0|||
149027847|NCT00062868|537578697|FG014|Dose Level 1|Lost to Follow-up|0|||
149027848|NCT00062868|537578698|FG015|Dose Level 1|Lost to Follow-up|0|||
149027849|NCT00062868|537578699|FG016|Dose Level 1|Lost to Follow-up|0|||
149027850|NCT00062868|537578700|FG017|Dose Level 1|Lost to Follow-up|0|||
149027851|NCT00062868|537578701|FG018|Dose Level 1|Lost to Follow-up|2|||
149027852|NCT00062868|537578702|FG019|Dose Level 1|Lost to Follow-up|0|||
149027853|NCT00062868|537578703|FG020|Dose Level 1|Lost to Follow-up|1|||
149027854|NCT00062868|537578683|FG000|Dose Level 2|Death|0|||
149027855|NCT00062868|537578684|FG001|Dose Level 2|Death|3|||
149027856|NCT00062868|537578685|FG002|Dose Level 2|Death|0|||
149027857|NCT00062868|537578686|FG003|Dose Level 2|Death|0|||
149027858|NCT00062868|537578687|FG004|Dose Level 2|Death|2|||
149027859|NCT00062868|537578688|FG005|Dose Level 2|Death|0|||
149027860|NCT00062868|537578689|FG006|Dose Level 2|Death|0|||
149027861|NCT00062868|537578690|FG007|Dose Level 2|Death|0|||
149027862|NCT00062868|537578691|FG008|Dose Level 2|Death|0|||
149027863|NCT00062868|537578692|FG009|Dose Level 2|Death|0|||
149027864|NCT00062868|537578693|FG010|Dose Level 2|Death|1|||
149027865|NCT00062868|537578694|FG011|Dose Level 2|Death|0|||
149027866|NCT00062868|537578695|FG012|Dose Level 2|Death|0|||
149027867|NCT00062868|537578696|FG013|Dose Level 2|Death|0|||
148978569|NCT02357576|537400890|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
148978570|NCT02357576|537400891|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
148978571|NCT00261716|537400892|FG000|Overall Study|Withdrawal by Subject|6|||
148978572|NCT00261716|537400893|FG001|Overall Study|Withdrawal by Subject|8|||
148978573|NCT00261716|537400892|FG000|Overall Study|Lost to Follow-up|0|||
148978574|NCT00261716|537400893|FG001|Overall Study|Lost to Follow-up|2|||
148978575|NCT01632800|537400898|FG000|Overall Study|Subject did not fit in apparatus|1|||
148978576|NCT01000051|537400899|FG000|Overall Study|Withdrawal by Subject|1|||
148978577|NCT01000051|537400900|FG001|Overall Study|Withdrawal by Subject|1|||
148978578|NCT01000051|537400899|FG000|Overall Study|Disease Progression|1|||
148978579|NCT01000051|537400900|FG001|Overall Study|Disease Progression|0|||
148978580|NCT01000051|537400899|FG000|Overall Study|Serious noncompliance|1|||
148978581|NCT01000051|537400900|FG001|Overall Study|Serious noncompliance|0|||
148978582|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Adverse Event|41|||
148978583|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Adverse Event|24|||
148978584|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
148978585|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
148978586|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
148978587|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
148978588|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Physician Decision|0|||
148978589|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Physician Decision|6|||
148978590|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
148978591|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
148978592|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
148978593|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
148978594|NCT00673452|537400901|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
148978595|NCT00673452|537400902|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
148978596|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
148978597|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
148978598|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
148978599|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
148978600|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
148978601|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
148978602|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
148978603|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
148978604|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
148978605|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
148978606|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
148978607|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
148978608|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
148978609|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
148978610|NCT00673452|537400901|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
148978611|NCT00673452|537400902|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
148978612|NCT03495908|537400905|FG000|Overall Study|Withdrawal by Subject|3|||
148978613|NCT03495908|537400906|FG001|Overall Study|Withdrawal by Subject|1|||
148978614|NCT03495908|537400905|FG000|Overall Study|Lost to Follow-up|1|||
148978615|NCT03495908|537400906|FG001|Overall Study|Lost to Follow-up|4|||
148978616|NCT03495908|537400905|FG000|Overall Study|Adverse Event|0|||
148978617|NCT03495908|537400906|FG001|Overall Study|Adverse Event|2|||
148978618|NCT03495908|537400905|FG000|Overall Study|Death|1|||
148978619|NCT03495908|537400906|FG001|Overall Study|Death|0|||
148978620|NCT03495908|537400905|FG000|Overall Study|Physician Decision|5|||
148978621|NCT03495908|537400906|FG001|Overall Study|Physician Decision|4|||
148978622|NCT03495908|537400905|FG000|Overall Study|No documented reason|0|||
148978623|NCT03495908|537400906|FG001|Overall Study|No documented reason|2|||
148978624|NCT00378703|537400909|FG000|Overall Study|Disease progression|59|||
148978625|NCT00378703|537400910|FG001|Overall Study|Disease progression|43|||
148978626|NCT00378703|537400911|FG002|Overall Study|Disease progression|48|||
148978627|NCT00378703|537400912|FG003|Overall Study|Disease progression|49|||
148978628|NCT00378703|537400909|FG000|Overall Study|Adverse Event|11|||
148978629|NCT00378703|537400910|FG001|Overall Study|Adverse Event|17|||
148978630|NCT00378703|537400911|FG002|Overall Study|Adverse Event|20|||
148978631|NCT00378703|537400912|FG003|Overall Study|Adverse Event|18|||
148978632|NCT00378703|537400909|FG000|Overall Study|Death|2|||
148766537|NCT04075682|536618786|FG001|Overall Study|Withdrawal by Subject|0|||
148766538|NCT04075682|536618787|FG002|Overall Study|Withdrawal by Subject|1|||
148978633|NCT00378703|537400910|FG001|Overall Study|Death|2|||
148978634|NCT00378703|537400911|FG002|Overall Study|Death|4|||
148978635|NCT00378703|537400912|FG003|Overall Study|Death|3|||
148978636|NCT00378703|537400909|FG000|Overall Study|Withdrawal by Subject|4|||
148978637|NCT00378703|537400910|FG001|Overall Study|Withdrawal by Subject|8|||
148978638|NCT00378703|537400911|FG002|Overall Study|Withdrawal by Subject|5|||
148978639|NCT00378703|537400912|FG003|Overall Study|Withdrawal by Subject|7|||
148978640|NCT00378703|537400909|FG000|Overall Study|Physician Decision|1|||
148978641|NCT00378703|537400910|FG001|Overall Study|Physician Decision|4|||
148978642|NCT00378703|537400911|FG002|Overall Study|Physician Decision|1|||
148978643|NCT00378703|537400912|FG003|Overall Study|Physician Decision|0|||
148978644|NCT00378703|537400909|FG000|Overall Study|Alternative therapy|4|||
148978645|NCT00378703|537400910|FG001|Overall Study|Alternative therapy|2|||
148978646|NCT00378703|537400911|FG002|Overall Study|Alternative therapy|0|||
148978647|NCT00378703|537400912|FG003|Overall Study|Alternative therapy|0|||
148978648|NCT00378703|537400909|FG000|Overall Study|Other complicated disease|0|||
148978649|NCT00378703|537400910|FG001|Overall Study|Other complicated disease|2|||
148978650|NCT00378703|537400911|FG002|Overall Study|Other complicated disease|2|||
148978651|NCT00378703|537400912|FG003|Overall Study|Other complicated disease|0|||
148978652|NCT00378703|537400909|FG000|Overall Study|Symptomatic deterioration|0|||
148978653|NCT00378703|537400910|FG001|Overall Study|Symptomatic deterioration|1|||
148978654|NCT00378703|537400911|FG002|Overall Study|Symptomatic deterioration|0|||
148978655|NCT00378703|537400912|FG003|Overall Study|Symptomatic deterioration|2|||
148978656|NCT00378703|537400909|FG000|Overall Study|Surgery|1|||
148978657|NCT00378703|537400910|FG001|Overall Study|Surgery|0|||
148978658|NCT00378703|537400911|FG002|Overall Study|Surgery|0|||
148978659|NCT00378703|537400912|FG003|Overall Study|Surgery|1|||
148978660|NCT00378703|537400909|FG000|Overall Study|Joint decision of physician and patient|1|||
148978661|NCT00378703|537400910|FG001|Overall Study|Joint decision of physician and patient|0|||
148978662|NCT00378703|537400911|FG002|Overall Study|Joint decision of physician and patient|0|||
148978663|NCT00378703|537400912|FG003|Overall Study|Joint decision of physician and patient|0|||
148978664|NCT00378703|537400909|FG000|Overall Study|Adverse events and progressive disease|0|||
148978665|NCT00378703|537400910|FG001|Overall Study|Adverse events and progressive disease|0|||
148978666|NCT00378703|537400911|FG002|Overall Study|Adverse events and progressive disease|0|||
148978667|NCT00378703|537400912|FG003|Overall Study|Adverse events and progressive disease|1|||
148978668|NCT00378703|537400909|FG000|Overall Study|Relocation|0|||
148978669|NCT00378703|537400910|FG001|Overall Study|Relocation|0|||
148978670|NCT00378703|537400911|FG002|Overall Study|Relocation|1|||
148978671|NCT00378703|537400912|FG003|Overall Study|Relocation|0|||
148978672|NCT00378703|537400909|FG000|Overall Study|Ineligible|4|||
148978673|NCT00378703|537400910|FG001|Overall Study|Ineligible|7|||
148978674|NCT00378703|537400911|FG002|Overall Study|Ineligible|7|||
148978675|NCT00378703|537400912|FG003|Overall Study|Ineligible|7|||
148978676|NCT00378703|537400909|FG000|Overall Study|Never started treatment|1|||
148978677|NCT00378703|537400910|FG001|Overall Study|Never started treatment|4|||
148978678|NCT00378703|537400911|FG002|Overall Study|Never started treatment|0|||
148766539|NCT04075682|536618788|FG003|Overall Study|Withdrawal by Subject|0|||
148766540|NCT04075682|536618785|FG000|Overall Study|Protocol Violation|0|||
148766541|NCT04075682|536618786|FG001|Overall Study|Protocol Violation|1|||
148766542|NCT04075682|536618787|FG002|Overall Study|Protocol Violation|1|||
148766543|NCT04075682|536618788|FG003|Overall Study|Protocol Violation|0|||
148766544|NCT04075682|536618785|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
148766545|NCT04075682|536618786|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
148766546|NCT04075682|536618787|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
148766547|NCT04075682|536618788|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
148766548|NCT04075682|536618785|FG000|Overall Study|Lost study phone the first day of study participation|0|||
148766549|NCT04075682|536618786|FG001|Overall Study|Lost study phone the first day of study participation|1|||
148766550|NCT04075682|536618787|FG002|Overall Study|Lost study phone the first day of study participation|0|||
148766551|NCT04075682|536618788|FG003|Overall Study|Lost study phone the first day of study participation|0|||
148766552|NCT00887315|536618791|FG000|Overall Study|Study termination|7|||
148766553|NCT00887315|536618792|FG001|Overall Study|Study termination|4|||
148766554|NCT02285166|536618795|FG000|Overall Study|Case Report Forms Uncollected|564|||
148766555|NCT02285166|536618795|FG000|Overall Study|Protocol Deviation|402|||
148766556|NCT00384839|536618800|FG000|Overall Study|Adverse Event|4|||
148766557|NCT00384839|536618800|FG000|Overall Study|Investigator Request|1|||
148766558|NCT00384839|536618800|FG000|Overall Study|Patient Request|1|||
148766559|NCT00384839|536618800|FG000|Overall Study|Ineligible|2|||
148766560|NCT00443079|536618801|FG000|Overall Study|Lost to Follow-up|0|||
148766561|NCT00443079|536618802|FG001|Overall Study|Lost to Follow-up|1|||
148766562|NCT01421225|536618805|FG000|Overall Study|Withdrawal by Subject|0|||
148766563|NCT01421225|536618806|FG001|Overall Study|Withdrawal by Subject|1|||
148766564|NCT02649439|536618807|FG000|Overall Study|Switched to alternative treatment|6|||
148766565|NCT02649439|536618808|FG001|Overall Study|Switched to alternative treatment|4|||
148766566|NCT02649439|536618807|FG000|Overall Study|Patient decision|1|||
148766567|NCT02649439|536618808|FG001|Overall Study|Patient decision|0|||
148766568|NCT02649439|536618807|FG000|Overall Study|Patient going out of country|1|||
148766569|NCT02649439|536618808|FG001|Overall Study|Patient going out of country|0|||
148766570|NCT02649439|536618807|FG000|Overall Study|To start finasteride|1|||
148766571|NCT02649439|536618808|FG001|Overall Study|To start finasteride|0|||
148766572|NCT02649439|536618807|FG000|Overall Study|Physician Decision|1|||
148766573|NCT02649439|536618808|FG001|Overall Study|Physician Decision|0|||
148766574|NCT02649439|536618807|FG000|Overall Study|Disease progression on study|12|||
148766575|NCT02649439|536618808|FG001|Overall Study|Disease progression on study|13|||
148766576|NCT02649439|536618807|FG000|Overall Study|Refused further treatment|1|||
148766577|NCT02649439|536618808|FG001|Overall Study|Refused further treatment|0|||
148766578|NCT02649439|536618807|FG000|Overall Study|Refused further follow up|2|||
148766579|NCT02649439|536618808|FG001|Overall Study|Refused further follow up|7|||
148766580|NCT02649439|536618807|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
148766581|NCT02649439|536618808|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
148766582|NCT02649439|536618807|FG000|Overall Study|No treatment, per protocol|1|||
148766583|NCT02649439|536618808|FG001|Overall Study|No treatment, per protocol|0|||
148766584|NCT02649439|536618807|FG000|Overall Study|PSA DT makes ineligible|0|||
148766585|NCT02649439|536618808|FG001|Overall Study|PSA DT makes ineligible|1|||
148766586|NCT02649439|536618807|FG000|Overall Study|Rising PSA No Mets|0|||
148766587|NCT02649439|536618808|FG001|Overall Study|Rising PSA No Mets|1|||
148766588|NCT02649439|536618807|FG000|Overall Study|Rising PSA|0|||
148766589|NCT02649439|536618808|FG001|Overall Study|Rising PSA|1|||
148766590|NCT02649439|536618807|FG000|Overall Study|Signed follow up protocol|0|||
148766591|NCT02649439|536618808|FG001|Overall Study|Signed follow up protocol|1|||
148766592|NCT01896128|536618811|FG000|Overall Study|Withdrawal by Subject|3|||
148978679|NCT00378703|537400912|FG003|Overall Study|Never started treatment|0|||
148978680|NCT00378703|537400909|FG000|Overall Study|Other|1|||
148978681|NCT00378703|537400910|FG001|Overall Study|Other|1|||
148978682|NCT00378703|537400911|FG002|Overall Study|Other|2|||
148978683|NCT00378703|537400912|FG003|Overall Study|Other|3|||
148978684|NCT03890367|537400918|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148978685|NCT03890367|537400919|FG001|Overall Study|Withdrawal by parent/guardian|3|||
148978686|NCT03890367|537400920|FG002|Overall Study|Withdrawal by parent/guardian|0|||
148978687|NCT03890367|537400918|FG000|Overall Study|Protocol deviation|2|||
148978688|NCT03890367|537400919|FG001|Overall Study|Protocol deviation|2|||
148978689|NCT03890367|537400920|FG002|Overall Study|Protocol deviation|1|||
148978690|NCT03890367|537400918|FG000|Overall Study|Lost to Follow-up|1|||
148978691|NCT03890367|537400919|FG001|Overall Study|Lost to Follow-up|1|||
148978692|NCT03890367|537400920|FG002|Overall Study|Lost to Follow-up|0|||
148978693|NCT01743092|537402465|FG000|Overall Study|Lost to Follow-up|14|||
148978694|NCT01743092|537402466|FG001|Overall Study|Lost to Follow-up|15|||
148978695|NCT03586869|537402467|FG000|Overall Study|Progressive Disease|3|||
148978696|NCT04116229|537402468|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
148978697|NCT04116229|537402469|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
148978698|NCT04116229|537402468|FG000|Overall Study|Scheduling not possible.|0|||
148978699|NCT04116229|537402469|FG001|Overall Study|Scheduling not possible.|1|||
148978700|NCT02992899|537402476|FG000|Overall Study|Withdrawal by Subject|1|||
148978701|NCT02992899|537402477|FG001|Overall Study|Withdrawal by Subject|0|||
148978702|NCT02992899|537402476|FG000|Overall Study|Lost to Follow-up|1|||
148978703|NCT02992899|537402477|FG001|Overall Study|Lost to Follow-up|3|||
148978704|NCT02370888|537402478|FG000|Overall Study|disease progression|2|||
148978705|NCT02370888|537402478|FG000|Overall Study|did not meet chimerism criteria|6|||
148978706|NCT01332305|537402479|FG000|Overall Study|Adverse Event|1|||
148978707|NCT01332305|537402480|FG001|Overall Study|Adverse Event|4|||
148978708|NCT01332305|537402481|FG002|Overall Study|Adverse Event|6|||
148978709|NCT01332305|537402482|FG003|Overall Study|Adverse Event|3|||
148978710|NCT01332305|537402483|FG004|Overall Study|Adverse Event|5|||
148978711|NCT01332305|537402479|FG000|Overall Study|Withdrawal by Subject|6|||
148978712|NCT01332305|537402480|FG001|Overall Study|Withdrawal by Subject|5|||
148978713|NCT01332305|537402481|FG002|Overall Study|Withdrawal by Subject|4|||
148978714|NCT01332305|537402482|FG003|Overall Study|Withdrawal by Subject|1|||
148978715|NCT01332305|537402483|FG004|Overall Study|Withdrawal by Subject|0|||
148978716|NCT01332305|537402479|FG000|Overall Study|Lost to Follow-up|0|||
148978717|NCT01332305|537402480|FG001|Overall Study|Lost to Follow-up|2|||
148978718|NCT01332305|537402481|FG002|Overall Study|Lost to Follow-up|3|||
148978719|NCT01332305|537402482|FG003|Overall Study|Lost to Follow-up|2|||
148978720|NCT01332305|537402483|FG004|Overall Study|Lost to Follow-up|3|||
148978721|NCT01332305|537402479|FG000|Overall Study|Protocol Violation|1|||
148978722|NCT01332305|537402480|FG001|Overall Study|Protocol Violation|2|||
148978723|NCT01332305|537402481|FG002|Overall Study|Protocol Violation|1|||
148978724|NCT01332305|537402482|FG003|Overall Study|Protocol Violation|0|||
148978725|NCT01332305|537402483|FG004|Overall Study|Protocol Violation|3|||
148978726|NCT01332305|537402479|FG000|Overall Study|Withdrawal by Sponsor|1|||
148978727|NCT01332305|537402480|FG001|Overall Study|Withdrawal by Sponsor|0|||
148978728|NCT01332305|537402481|FG002|Overall Study|Withdrawal by Sponsor|0|||
148978729|NCT01332305|537402482|FG003|Overall Study|Withdrawal by Sponsor|1|||
148978730|NCT01332305|537402483|FG004|Overall Study|Withdrawal by Sponsor|1|||
148978731|NCT01332305|537402479|FG000|Overall Study|Treatment Failure|1|||
148978732|NCT01332305|537402480|FG001|Overall Study|Treatment Failure|1|||
148978733|NCT01332305|537402481|FG002|Overall Study|Treatment Failure|0|||
148978734|NCT01332305|537402482|FG003|Overall Study|Treatment Failure|0|||
148978735|NCT01332305|537402483|FG004|Overall Study|Treatment Failure|0|||
148978736|NCT01332305|537402479|FG000|Overall Study|Physician Decision|0|||
148978737|NCT01332305|537402480|FG001|Overall Study|Physician Decision|0|||
148978738|NCT01332305|537402481|FG002|Overall Study|Physician Decision|0|||
148978739|NCT01332305|537402482|FG003|Overall Study|Physician Decision|1|||
148978740|NCT01332305|537402483|FG004|Overall Study|Physician Decision|0|||
148978741|NCT03192150|537402486|FG000|Overall Study|Adverse Event|14|||
148978742|NCT03192150|537402487|FG001|Overall Study|Adverse Event|12|||
148978743|NCT03192150|537402486|FG000|Overall Study|Lack of Efficacy|23|||
148978744|NCT03192150|537402487|FG001|Overall Study|Lack of Efficacy|30|||
148978745|NCT03192150|537402486|FG000|Overall Study|Lost to Follow-up|1|||
148978746|NCT03192150|537402487|FG001|Overall Study|Lost to Follow-up|1|||
148978747|NCT03192150|537402486|FG000|Overall Study|Withdrawal by Subject|4|||
148978748|NCT03192150|537402487|FG001|Overall Study|Withdrawal by Subject|2|||
148978749|NCT03192150|537402486|FG000|Overall Study|Protocol Violation|5|||
148978750|NCT03192150|537402487|FG001|Overall Study|Protocol Violation|2|||
148978751|NCT03192150|537402486|FG000|Overall Study|Surgery Canceled|6|||
148978752|NCT03192150|537402487|FG001|Overall Study|Surgery Canceled|2|||
148978753|NCT03192150|537402486|FG000|Overall Study|Other-Various Administrative Reasons|2|||
148978754|NCT03192150|537402487|FG001|Overall Study|Other-Various Administrative Reasons|5|||
148978755|NCT02579616|537402488|FG000|Overall Study|Participants did not receive treatment|3|||
148978756|NCT02178475|537402489|FG000|Overall Study|Withdrawal by Subject|7|||
148978757|NCT02178475|537402489|FG000|Overall Study|Lost to Follow-up|10|||
148978758|NCT02178475|537402489|FG000|Overall Study|Death|13|||
148978759|NCT02178475|537402489|FG000|Overall Study|Protocol-specified Criteria|99|||
148766593|NCT01896128|536618812|FG001|Overall Study|Withdrawal by Subject|3|||
148766594|NCT03423173|536618813|FG000|Overall Study|Randomized but not vaccinated|1|||
148766595|NCT03423173|536618814|FG001|Overall Study|Randomized but not vaccinated|0|||
148766596|NCT03423173|536618815|FG002|Overall Study|Randomized but not vaccinated|2|||
148766597|NCT03423173|536618816|FG003|Overall Study|Randomized but not vaccinated|1|||
148766598|NCT03423173|536618813|FG000|Overall Study|Adverse Event|1|||
148766599|NCT03423173|536618814|FG001|Overall Study|Adverse Event|1|||
148766600|NCT03423173|536618815|FG002|Overall Study|Adverse Event|1|||
148766601|NCT03423173|536618816|FG003|Overall Study|Adverse Event|1|||
148766602|NCT03423173|536618813|FG000|Overall Study|Lost to Follow-up|10|||
148766603|NCT03423173|536618814|FG001|Overall Study|Lost to Follow-up|19|||
148766604|NCT03423173|536618815|FG002|Overall Study|Lost to Follow-up|17|||
148766605|NCT03423173|536618816|FG003|Overall Study|Lost to Follow-up|22|||
148766606|NCT03423173|536618813|FG000|Overall Study|Withdrawal of consent|4|||
148766607|NCT03423173|536618814|FG001|Overall Study|Withdrawal of consent|10|||
148766608|NCT03423173|536618815|FG002|Overall Study|Withdrawal of consent|4|||
148766609|NCT03423173|536618816|FG003|Overall Study|Withdrawal of consent|5|||
148766610|NCT03423173|536618813|FG000|Overall Study|Death|1|||
148766611|NCT03423173|536618814|FG001|Overall Study|Death|0|||
148766612|NCT03423173|536618815|FG002|Overall Study|Death|0|||
148766613|NCT03423173|536618816|FG003|Overall Study|Death|0|||
148766614|NCT03423173|536618813|FG000|Overall Study|Reason not Specified|2|||
148766615|NCT03423173|536618814|FG001|Overall Study|Reason not Specified|5|||
148766616|NCT03423173|536618815|FG002|Overall Study|Reason not Specified|3|||
148766617|NCT03423173|536618816|FG003|Overall Study|Reason not Specified|1|||
148766618|NCT01862250|536618817|FG000|Overall Study|Adverse Event|4|||
148766619|NCT01028014|536618818|FG000|Overall Study|Lost to Follow-up|1|||
148766620|NCT01028014|536618819|FG001|Overall Study|Lost to Follow-up|2|||
148766621|NCT01028014|536618820|FG002|Overall Study|Lost to Follow-up|0|||
148766622|NCT01028014|536618821|FG003|Overall Study|Lost to Follow-up|1|||
148766623|NCT01028014|536618822|FG004|Overall Study|Lost to Follow-up|1|||
148766624|NCT01028014|536618823|FG005|Overall Study|Lost to Follow-up|2|||
148766625|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
148766626|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
148766627|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
148766628|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
148766629|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
148766630|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
148766631|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
148766632|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
148766633|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
148766634|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
148766635|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
148766636|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
148766637|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
148766638|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
148766639|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
148766640|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
148766641|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
148766642|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
148766643|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
148766644|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
148766645|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
148766646|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
148766647|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
148766648|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
148766649|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
148766650|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
148766651|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
148766652|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
148978760|NCT01430585|537402490|FG000|Overall Study|Death|1|||
148978761|NCT01430585|537402490|FG000|Overall Study|Objective Progression or Relapse|3|||
148978762|NCT01430585|537402490|FG000|Overall Study|Study Terminated by Sponsor|3|||
148978763|NCT01430585|537402490|FG000|Overall Study|Other|7|||
148978764|NCT00482391|537402491|FG000|Overall Study|Withdrawal by Subject|1|||
148978765|NCT00482391|537402491|FG000|Overall Study|Adverse Event|1|||
148978766|NCT00482391|537402491|FG000|Overall Study|Death|1|||
148978767|NCT01448850|537402492|FG000|Overall Study|Death|3|||
148978768|NCT01448850|537402493|FG001|Overall Study|Death|6|||
148978769|NCT01448850|537402492|FG000|Overall Study|Withdrawal by Subject|13|||
148978770|NCT01448850|537402493|FG001|Overall Study|Withdrawal by Subject|21|||
148978771|NCT01448850|537402492|FG000|Overall Study|Lost to Follow-up|3|||
148978772|NCT01448850|537402493|FG001|Overall Study|Lost to Follow-up|1|||
148978773|NCT01448850|537402492|FG000|Overall Study|Other|15|||
148978774|NCT01448850|537402493|FG001|Overall Study|Other|12|||
148978775|NCT00779766|537402494|FG000|Month 24|Serious Adverse Event|2|||
148978776|NCT00779766|537402495|FG001|Month 24|Serious Adverse Event|3|||
148978777|NCT00779766|537402494|FG000|Month 24|Adverse Event|3|||
148978778|NCT00779766|537402495|FG001|Month 24|Adverse Event|3|||
148766653|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
148766654|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
148766655|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
148766656|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
148766657|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
148766658|NCT00839527|536618826|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
148766659|NCT00839527|536618827|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
148766660|NCT00839527|536618828|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
148766661|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
148766662|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
148766663|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
148766664|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
148766665|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
148766666|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
148766667|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
148766668|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
148766669|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
148766670|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
148766671|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
148766672|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
148766673|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
148766674|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
148766675|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
148766676|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
148766677|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
148766678|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
148766679|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
148766680|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
148766681|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
148766682|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
148766683|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
148766684|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
148766685|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
148766686|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
148766687|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
148766688|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
148766689|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
148766690|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
148766691|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
148766692|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
148766693|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
148766694|NCT00839527|536618826|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
148766695|NCT00839527|536618827|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
148766696|NCT00839527|536618828|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
148766697|NCT02549287|536618829|FG000|Overall Study|Lost to Follow-up|65|||
148766698|NCT02549287|536618830|FG001|Overall Study|Lost to Follow-up|26|||
148978779|NCT00779766|537402494|FG000|Month 24|Protocol Violation|3|||
148978780|NCT00779766|537402495|FG001|Month 24|Protocol Violation|1|||
148978781|NCT00779766|537402494|FG000|Month 24|Withdrawal by Subject|159|||
148978782|NCT00779766|537402495|FG001|Month 24|Withdrawal by Subject|127|||
148978783|NCT00779766|537402494|FG000|Month 24|Migrated/moved from study area|138|||
148978784|NCT00779766|537402495|FG001|Month 24|Migrated/moved from study area|162|||
148978785|NCT00779766|537402494|FG000|Month 24|Lost to Follow-up|9|||
148766699|NCT02549287|536618829|FG000|Overall Study|Withdrawal by Subject|15|||
148766700|NCT02549287|536618830|FG001|Overall Study|Withdrawal by Subject|6|||
148766701|NCT04087720|536618831|FG000|Overall Study|Withdrawal by Subject|2|||
148766702|NCT04087720|536618831|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
148766703|NCT00427921|536618835|FG000|Overall Study|Adverse Event|26|||
148766704|NCT00427921|536618835|FG000|Overall Study|Withdrawal by Subject|4|||
148766705|NCT00427921|536618835|FG000|Overall Study|Lost to Follow-up|2|||
148766706|NCT00427921|536618835|FG000|Overall Study|Other reason not specified|10|||
148766707|NCT00427921|536618835|FG000|Overall Study|Adverse Event + Hospitalization|1|||
148766708|NCT00427921|536618835|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
148766709|NCT00427921|536618835|FG000|Overall Study|Adverse Event + No Response|1|||
148766710|NCT00427921|536618835|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
148766711|NCT00427921|536618835|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
148766712|NCT00427921|536618835|FG000|Overall Study|Adverse Event + Lost Response|1|||
148766713|NCT00427921|536618835|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
148766714|NCT00427921|536618835|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
148766715|NCT00520533|536618836|FG000|Overall Study|Death|1|||
148766716|NCT00520533|536618836|FG000|Overall Study|Suspension of the study for safety reasons|1|||
148766717|NCT00520533|536618836|FG000|Overall Study|Withdrawal by Subject|1|||
148766718|NCT00520533|536618836|FG000|Overall Study|Physician Decision|1|||
148766719|NCT01166438|536618837|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
148766720|NCT01166438|536618838|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
148766721|NCT01166438|536618837|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
148766722|NCT01166438|536618838|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
148766723|NCT01166438|536618837|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
148766724|NCT01166438|536618838|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
148766725|NCT01166438|536618837|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
148766726|NCT01166438|536618838|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
148978786|NCT00779766|537402495|FG001|Month 24|Lost to Follow-up|9|||
148978787|NCT00779766|537402494|FG000|Month 24|Other|18|||
148978788|NCT00779766|537402495|FG001|Month 24|Other|27|||
148978789|NCT00779766|537402494|FG000|Month 48|Withdrawal by Subject|68|||
148978790|NCT00779766|537402495|FG001|Month 48|Withdrawal by Subject|63|||
148978791|NCT00779766|537402494|FG000|Month 48|Migrated/moved from study area|76|||
148978792|NCT00779766|537402495|FG001|Month 48|Migrated/moved from study area|75|||
148978793|NCT00779766|537402494|FG000|Month 48|Lost to Follow-up|29|||
148978794|NCT00779766|537402495|FG001|Month 48|Lost to Follow-up|30|||
148978795|NCT00779766|537402494|FG000|Month 48|Other|1|||
148978796|NCT00779766|537402495|FG001|Month 48|Other|0|||
148978797|NCT00779766|537402494|FG000|Month 72|Withdrawal by Subject|55|||
148978798|NCT00779766|537402495|FG001|Month 72|Withdrawal by Subject|71|||
148978799|NCT00779766|537402494|FG000|Month 72|Migrated/moved from study area|124|||
148978800|NCT00779766|537402495|FG001|Month 72|Migrated/moved from study area|109|||
148978801|NCT00779766|537402494|FG000|Month 72|Lost to Follow-up|6|||
149027868|NCT00062868|537578697|FG014|Dose Level 2|Death|0|||
148766727|NCT01166438|536618837|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
148766728|NCT01166438|536618838|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
148766729|NCT01166438|536618837|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
148766730|NCT01166438|536618838|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
148766731|NCT03502070|536618839|FG000|Overall Study|Withdrawal by Subject|1|||
148766732|NCT03502070|536618839|FG000|Overall Study|Screen Failure|1|||
148766733|NCT01218087|536618840|FG000|Overall Study|Death|2|||
148766734|NCT01218087|536618841|FG001|Overall Study|Death|1|||
148766735|NCT01218087|536618840|FG000|Overall Study|Withdrawal by Subject|5|||
148766736|NCT01218087|536618841|FG001|Overall Study|Withdrawal by Subject|0|||
148766737|NCT01218087|536618840|FG000|Overall Study|Transferred|8|||
148766738|NCT01218087|536618841|FG001|Overall Study|Transferred|5|||
148766739|NCT03340454|536618842|FG000|Overall Study|Lost to Follow-up|0|||
148766740|NCT03340454|536618843|FG001|Overall Study|Lost to Follow-up|4|||
148766741|NCT01464164|536618844|FG000|Overall Study|Screen failure|0|||
148766742|NCT01464164|536618845|FG001|Overall Study|Screen failure|1|||
148766743|NCT01464164|536618846|FG002|Overall Study|Screen failure|2|||
148766744|NCT01464164|536618847|FG003|Overall Study|Screen failure|0|||
148766745|NCT01464164|536618848|FG004|Overall Study|Screen failure|0|||
148766746|NCT01464164|536618849|FG005|Overall Study|Screen failure|0|||
148766747|NCT01464164|536618850|FG006|Overall Study|Screen failure|0|||
148766748|NCT01464164|536618844|FG000|Overall Study|Physician Decision|0|||
148766749|NCT01464164|536618845|FG001|Overall Study|Physician Decision|1|||
148766750|NCT01464164|536618846|FG002|Overall Study|Physician Decision|0|||
148766751|NCT01464164|536618847|FG003|Overall Study|Physician Decision|0|||
148766752|NCT01464164|536618848|FG004|Overall Study|Physician Decision|0|||
148766753|NCT01464164|536618849|FG005|Overall Study|Physician Decision|0|||
148766754|NCT01464164|536618850|FG006|Overall Study|Physician Decision|2|||
148766755|NCT02568189|536618851|FG000|Overall Study|Protocol Violation|0|||
148766756|NCT02568189|536618852|FG001|Overall Study|Protocol Violation|0|||
148766757|NCT02568189|536618853|FG002|Overall Study|Protocol Violation|19|||
148766758|NCT02568189|536618854|FG003|Overall Study|Protocol Violation|18|||
148766759|NCT02347813|536618857|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
148766760|NCT02347813|536618858|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
148766761|NCT02347813|536618857|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
148766762|NCT02347813|536618858|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
148766763|NCT03817229|536618859|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
148766764|NCT03817229|536618860|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
148766765|NCT03817229|536618861|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
148766766|NCT03817229|536618862|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
148766767|NCT03817229|536618859|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
148766768|NCT03817229|536618860|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
148766769|NCT03817229|536618861|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
148766770|NCT03817229|536618862|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
148766771|NCT03817229|536618859|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
148766772|NCT03817229|536618860|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
148978802|NCT00779766|537402495|FG001|Month 72|Lost to Follow-up|8|||
148978803|NCT00779766|537402494|FG000|Month 72|Other|0|||
148978804|NCT00779766|537402495|FG001|Month 72|Other|1|||
148978805|NCT01412424|537402500|FG000|Core Treatment Period|Treatment Failure|24|||
148978806|NCT01412424|537402500|FG000|Core Treatment Period|Adverse Event|21|||
148978807|NCT01412424|537402500|FG000|Core Treatment Period|Patient Request|5|||
148978808|NCT01412424|537402500|FG000|Core Treatment Period|Lost to Follow-up|2|||
148978809|NCT01412424|537402500|FG000|Core Treatment Period|Sponsor Request|1|||
148978810|NCT01412424|537402500|FG000|Extension Treatment Period|Adverse Event|2|||
148978811|NCT01412424|537402500|FG000|Extension Treatment Period|Treatment Failure|2|||
148978812|NCT01412424|537402500|FG000|Extension Treatment Period|Patient Request|2|||
148978813|NCT01274637|537402503|FG000|Overall Study|Withdrawal by Subject|0|||
148978814|NCT01274637|537402504|FG001|Overall Study|Withdrawal by Subject|1|||
148978815|NCT01274637|537402503|FG000|Overall Study|Lost to Follow-up|0|||
148978816|NCT01274637|537402504|FG001|Overall Study|Lost to Follow-up|1|||
148978817|NCT01824303|537402509|FG000|Randomized Study|Withdrawal by Subject|1|||
148978818|NCT01824303|537402510|FG001|Randomized Study|Withdrawal by Subject|1|||
148978819|NCT01824303|537402509|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
148978820|NCT01824303|537402510|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
148978821|NCT02047110|537402516|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
148978822|NCT02047110|537402517|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
148978823|NCT02047110|537402518|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
148978824|NCT02047110|537402519|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
148978825|NCT02047110|537402516|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
149027869|NCT00062868|537578698|FG015|Dose Level 2|Death|0|||
149027870|NCT00062868|537578699|FG016|Dose Level 2|Death|2|||
149027871|NCT00062868|537578700|FG017|Dose Level 2|Death|0|||
149027872|NCT00062868|537578701|FG018|Dose Level 2|Death|0|||
149027873|NCT00062868|537578702|FG019|Dose Level 2|Death|0|||
149027874|NCT00062868|537578703|FG020|Dose Level 2|Death|0|||
149027875|NCT00062868|537578683|FG000|Dose Level 2|Lost to Follow-up|0|||
149027876|NCT00062868|537578684|FG001|Dose Level 2|Lost to Follow-up|0|||
149027877|NCT00062868|537578685|FG002|Dose Level 2|Lost to Follow-up|0|||
149027878|NCT00062868|537578686|FG003|Dose Level 2|Lost to Follow-up|0|||
149027879|NCT00062868|537578687|FG004|Dose Level 2|Lost to Follow-up|0|||
149027880|NCT00062868|537578688|FG005|Dose Level 2|Lost to Follow-up|0|||
149027881|NCT00062868|537578689|FG006|Dose Level 2|Lost to Follow-up|0|||
149027882|NCT00062868|537578690|FG007|Dose Level 2|Lost to Follow-up|0|||
149027883|NCT00062868|537578691|FG008|Dose Level 2|Lost to Follow-up|0|||
149027884|NCT00062868|537578692|FG009|Dose Level 2|Lost to Follow-up|0|||
149027885|NCT00062868|537578693|FG010|Dose Level 2|Lost to Follow-up|0|||
149027886|NCT00062868|537578694|FG011|Dose Level 2|Lost to Follow-up|0|||
149027887|NCT00062868|537578695|FG012|Dose Level 2|Lost to Follow-up|0|||
149027888|NCT00062868|537578696|FG013|Dose Level 2|Lost to Follow-up|1|||
148978826|NCT02047110|537402517|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
148978827|NCT02047110|537402518|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
148978828|NCT02047110|537402519|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
148978829|NCT02047110|537402516|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
149027889|NCT00062868|537578697|FG014|Dose Level 2|Lost to Follow-up|0|||
149027890|NCT00062868|537578698|FG015|Dose Level 2|Lost to Follow-up|0|||
149027891|NCT00062868|537578699|FG016|Dose Level 2|Lost to Follow-up|1|||
149027892|NCT00062868|537578700|FG017|Dose Level 2|Lost to Follow-up|0|||
148978830|NCT02047110|537402517|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
148978831|NCT02047110|537402518|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
149027893|NCT00062868|537578701|FG018|Dose Level 2|Lost to Follow-up|0|||
149027894|NCT00062868|537578702|FG019|Dose Level 2|Lost to Follow-up|0|||
148978832|NCT02047110|537402519|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
148978833|NCT02047110|537402516|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
148978834|NCT02047110|537402517|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
148978835|NCT02047110|537402518|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
148978836|NCT02047110|537402519|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
148978837|NCT02047110|537402516|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
148978838|NCT02047110|537402517|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
148978839|NCT02047110|537402518|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
148978840|NCT02047110|537402519|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
148978841|NCT02047110|537402516|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
148978842|NCT02047110|537402517|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
148978843|NCT02047110|537402518|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
148978844|NCT02047110|537402519|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
148978845|NCT02047110|537402516|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
148978846|NCT02047110|537402517|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
148978847|NCT02047110|537402518|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
148978848|NCT02047110|537402519|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
148978849|NCT02047110|537402516|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
148978850|NCT02047110|537402517|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
148766773|NCT03817229|536618861|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
148766774|NCT03817229|536618862|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
148766775|NCT03817229|536618859|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
148766776|NCT03817229|536618860|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
148766777|NCT03817229|536618861|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
148766778|NCT03817229|536618862|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
148766779|NCT03817229|536618859|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
148766780|NCT03817229|536618860|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
148766781|NCT03817229|536618861|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
148766782|NCT03817229|536618862|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
148766783|NCT03817229|536618859|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
148766784|NCT03817229|536618860|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
148766785|NCT03817229|536618861|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
148766786|NCT03817229|536618862|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
148766787|NCT03817229|536618859|FG000|Post-Intervention|Withdrawal by Subject|6|||
148766788|NCT03817229|536618860|FG001|Post-Intervention|Withdrawal by Subject|0|||
148978851|NCT02047110|537402518|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
148978852|NCT02047110|537402519|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
148978853|NCT02047110|537402516|FG000|Escape Treatment Period|Adverse Event|1|||
148766789|NCT03817229|536618861|FG002|Post-Intervention|Withdrawal by Subject|2|||
148766790|NCT03817229|536618862|FG003|Post-Intervention|Withdrawal by Subject|2|||
148766791|NCT03817229|536618859|FG000|Post-Intervention|Withdrawal by Study Team|3|||
148766792|NCT03817229|536618860|FG001|Post-Intervention|Withdrawal by Study Team|1|||
148766793|NCT03817229|536618861|FG002|Post-Intervention|Withdrawal by Study Team|1|||
148766794|NCT03817229|536618862|FG003|Post-Intervention|Withdrawal by Study Team|4|||
148766795|NCT03817229|536618859|FG000|Post-Intervention|Weaned from medication|3|||
148766796|NCT03817229|536618860|FG001|Post-Intervention|Weaned from medication|0|||
148766797|NCT03817229|536618861|FG002|Post-Intervention|Weaned from medication|2|||
148766798|NCT03817229|536618862|FG003|Post-Intervention|Weaned from medication|1|||
148766799|NCT03817229|536618859|FG000|Post-Intervention|Transferred care to another institution|1|||
148766800|NCT03817229|536618860|FG001|Post-Intervention|Transferred care to another institution|0|||
148766801|NCT03817229|536618861|FG002|Post-Intervention|Transferred care to another institution|0|||
148766802|NCT03817229|536618862|FG003|Post-Intervention|Transferred care to another institution|0|||
148766803|NCT03817229|536618859|FG000|Post-Intervention|Change in parental guardianship|0|||
148766804|NCT03817229|536618860|FG001|Post-Intervention|Change in parental guardianship|0|||
148766805|NCT03817229|536618861|FG002|Post-Intervention|Change in parental guardianship|1|||
148766806|NCT03817229|536618862|FG003|Post-Intervention|Change in parental guardianship|0|||
148766807|NCT03817229|536618859|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
148766808|NCT03817229|536618860|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
148766809|NCT03817229|536618861|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
148766810|NCT03817229|536618862|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
148766811|NCT03817229|536618859|FG000|Follow-up 1|Withdrawal by Subject|1|||
148766812|NCT03817229|536618860|FG001|Follow-up 1|Withdrawal by Subject|2|||
148766813|NCT03817229|536618861|FG002|Follow-up 1|Withdrawal by Subject|0|||
148766814|NCT03817229|536618862|FG003|Follow-up 1|Withdrawal by Subject|0|||
148766815|NCT03817229|536618859|FG000|Follow-up 1|Withdrawal by Study Team|3|||
148766816|NCT03817229|536618860|FG001|Follow-up 1|Withdrawal by Study Team|1|||
148766817|NCT03817229|536618861|FG002|Follow-up 1|Withdrawal by Study Team|0|||
148766818|NCT03817229|536618862|FG003|Follow-up 1|Withdrawal by Study Team|0|||
148766819|NCT03817229|536618859|FG000|Follow-up 1|Wean from medication|3|||
148766820|NCT03817229|536618860|FG001|Follow-up 1|Wean from medication|4|||
148766821|NCT03817229|536618861|FG002|Follow-up 1|Wean from medication|0|||
148766822|NCT03817229|536618862|FG003|Follow-up 1|Wean from medication|1|||
148766823|NCT03817229|536618859|FG000|Follow-up 1|Transferred care to another hospital|1|||
148766824|NCT03817229|536618860|FG001|Follow-up 1|Transferred care to another hospital|0|||
148766825|NCT03817229|536618861|FG002|Follow-up 1|Transferred care to another hospital|0|||
148766826|NCT03817229|536618862|FG003|Follow-up 1|Transferred care to another hospital|0|||
148766827|NCT03817229|536618859|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
148766828|NCT03817229|536618860|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
148766829|NCT03817229|536618861|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
148766830|NCT03817229|536618862|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
148766831|NCT03817229|536618859|FG000|Follow-up 2|Withdrawal by Subject|2|||
148766832|NCT03817229|536618860|FG001|Follow-up 2|Withdrawal by Subject|0|||
148766833|NCT03817229|536618861|FG002|Follow-up 2|Withdrawal by Subject|1|||
148766834|NCT03817229|536618862|FG003|Follow-up 2|Withdrawal by Subject|1|||
148766835|NCT03817229|536618859|FG000|Follow-up 2|Withdrawal by Study Team|2|||
148766836|NCT03817229|536618860|FG001|Follow-up 2|Withdrawal by Study Team|0|||
148766837|NCT03817229|536618861|FG002|Follow-up 2|Withdrawal by Study Team|1|||
148766838|NCT03817229|536618862|FG003|Follow-up 2|Withdrawal by Study Team|0|||
148766839|NCT03817229|536618859|FG000|Follow-up 2|Wean from medication|1|||
148766840|NCT03817229|536618860|FG001|Follow-up 2|Wean from medication|0|||
148766841|NCT03817229|536618861|FG002|Follow-up 2|Wean from medication|0|||
148766842|NCT03817229|536618862|FG003|Follow-up 2|Wean from medication|0|||
148766843|NCT03817229|536618859|FG000|Follow-up 2|Transferred care|0|||
148766844|NCT03817229|536618860|FG001|Follow-up 2|Transferred care|0|||
148766845|NCT03817229|536618861|FG002|Follow-up 2|Transferred care|1|||
148766846|NCT03817229|536618862|FG003|Follow-up 2|Transferred care|0|||
148766847|NCT01186692|536618863|FG000|Overall Study|Not Catheterized|11|||
148766848|NCT01186692|536618863|FG000|Overall Study|Futher testing contraindicated implant|19|||
148766849|NCT01186692|536618863|FG000|Overall Study|Adverse Event|2|||
148766850|NCT03319732|536618864|FG000|Overall Study|Adverse Event|40|||
148978854|NCT02047110|537402517|FG001|Escape Treatment Period|Adverse Event|2|||
148978855|NCT02047110|537402518|FG002|Escape Treatment Period|Adverse Event|2|||
148978856|NCT02047110|537402519|FG003|Escape Treatment Period|Adverse Event|0|||
148978857|NCT02047110|537402516|FG000|Escape Treatment Period|Other than specified|1|||
148766851|NCT03319732|536618864|FG000|Overall Study|Withdrawal by Subject|50|||
148766852|NCT03319732|536618864|FG000|Overall Study|MS relapse|10|||
148766853|NCT03319732|536618864|FG000|Overall Study|reason not specified|5|||
148978858|NCT02047110|537402517|FG001|Escape Treatment Period|Other than specified|2|||
148978859|NCT02047110|537402518|FG002|Escape Treatment Period|Other than specified|0|||
148978860|NCT02047110|537402519|FG003|Escape Treatment Period|Other than specified|1|||
148978861|NCT02047110|537402516|FG000|OLE Treatment Period|Other than specified|0|||
148978862|NCT02047110|537402517|FG001|OLE Treatment Period|Other than specified|0|||
148978863|NCT02047110|537402518|FG002|OLE Treatment Period|Other than specified|1|||
148978864|NCT02047110|537402519|FG003|OLE Treatment Period|Other than specified|0|||
148978865|NCT00699699|537402520|FG000|Overall Study|Adverse Event|36|||
148978866|NCT00699699|537402520|FG000|Overall Study|Individual different reasons|21|||
148978867|NCT00705575|537402521|FG000|Overall Study|Abnormal laboratory value(s)|0|||
148766854|NCT03232931|536620096|FG000|Overall Study|Physician Decision|1|||
148766855|NCT03232931|536620097|FG001|Overall Study|Physician Decision|1|||
148766856|NCT03232931|536620096|FG000|Overall Study|Withdrawal by Subject|6|||
148766857|NCT03232931|536620097|FG001|Overall Study|Withdrawal by Subject|0|||
148766858|NCT03232931|536620096|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
148766859|NCT03232931|536620097|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
148766860|NCT03232931|536620096|FG000|Overall Study|Parent did not record voice|1|||
148766861|NCT03232931|536620097|FG001|Overall Study|Parent did not record voice|2|||
148766862|NCT03232931|536620096|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
148766863|NCT03232931|536620097|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
148766864|NCT04925557|536620098|FG000|Overall Study|Study closed|5|||
148766865|NCT04925557|536620099|FG001|Overall Study|Study closed|3|||
148766866|NCT05488470|536620100|FG000|Overall Study|Physician Decision|2|||
148766867|NCT05488470|536620100|FG000|Overall Study|Withdrawal by Subject|1|||
148766868|NCT05488470|536620100|FG000|Overall Study|Death|1|||
148766869|NCT00068393|536620101|FG000|Overall Study|Adverse Event|2|||
148766870|NCT00068393|536620101|FG000|Overall Study|Death|3|||
148766871|NCT00068393|536620101|FG000|Overall Study|Withdrawal by Subject|3|||
148766872|NCT00068393|536620101|FG000|Overall Study|Alternative treatment|1|||
148766873|NCT00068393|536620101|FG000|Overall Study|Quality of life worsening|1|||
148766874|NCT01399047|536620106|FG000|Overall Study|Withdrawal by Subject|0|||
148766875|NCT01399047|536620107|FG001|Overall Study|Withdrawal by Subject|1|||
148766876|NCT03652636|536620115|FG000|Overall Study|Withdrawal by Subject|7|||
148766877|NCT01283334|536620121|FG000|Overall Study|Withdrawal by Subject|1|||
148766878|NCT01283334|536620121|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
148766879|NCT01283334|536620121|FG000|Overall Study|Adverse Event|4|||
148766880|NCT01283334|536620121|FG000|Overall Study|Physician Decision|1|||
148766881|NCT03467217|536620122|FG000|Overall Study|Trial stopped early|5|||
148766882|NCT03467217|536620123|FG001|Overall Study|Trial stopped early|2|||
148766883|NCT03467217|536620122|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
148766884|NCT03467217|536620123|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
148766885|NCT03467217|536620122|FG000|Overall Study|Lost to Follow-up|0|||
148766886|NCT03467217|536620123|FG001|Overall Study|Lost to Follow-up|2|||
148766887|NCT04402138|536620124|FG000|Overall Study|Progressive Disease|2|||
148766888|NCT04402138|536620124|FG000|Overall Study|Adverse Event|1|||
148766889|NCT00784238|536620125|FG000|Overall Study|Adverse Event|14|||
148766890|NCT00784238|536620125|FG000|Overall Study|Death|2|||
148766891|NCT00784238|536620125|FG000|Overall Study|Lack of Efficacy|33|||
148766892|NCT00784238|536620125|FG000|Overall Study|Lost to Follow-up|29|||
148766893|NCT00784238|536620125|FG000|Overall Study|Pregnancy|1|||
148766894|NCT00784238|536620125|FG000|Overall Study|Withdrawal by Subject|26|||
148766895|NCT00784238|536620125|FG000|Overall Study|Other|14|||
148766896|NCT04390503|536620126|FG000|Overall Study|Physician Decision|2|||
148766897|NCT04390503|536620127|FG001|Overall Study|Physician Decision|1|||
148766898|NCT04390503|536620126|FG000|Overall Study|Adverse Event|1|||
148766899|NCT04390503|536620127|FG001|Overall Study|Adverse Event|0|||
148766900|NCT03806933|536620128|FG000|Main Period|Physician Decision|0|||
148766901|NCT03806933|536620129|FG001|Main Period|Physician Decision|0|||
148766902|NCT03806933|536620130|FG002|Main Period|Physician Decision|0|||
148766903|NCT03806933|536620131|FG003|Main Period|Physician Decision|1|||
148766904|NCT03806933|536620128|FG000|Main Period|Pregnancy|0|||
148766905|NCT03806933|536620129|FG001|Main Period|Pregnancy|0|||
148766906|NCT03806933|536620130|FG002|Main Period|Pregnancy|1|||
148766907|NCT03806933|536620131|FG003|Main Period|Pregnancy|0|||
148766908|NCT03806933|536620128|FG000|Main Period|Withdrawal by Subject|2|||
148766909|NCT03806933|536620129|FG001|Main Period|Withdrawal by Subject|1|||
148766910|NCT03806933|536620130|FG002|Main Period|Withdrawal by Subject|1|||
148766911|NCT03806933|536620131|FG003|Main Period|Withdrawal by Subject|2|||
148766912|NCT03806933|536620128|FG000|Main Period|Lost to Follow-up|2|||
148766913|NCT03806933|536620129|FG001|Main Period|Lost to Follow-up|2|||
148766914|NCT03806933|536620130|FG002|Main Period|Lost to Follow-up|0|||
148978868|NCT00705575|537402522|FG001|Overall Study|Abnormal laboratory value(s)|3|||
148766915|NCT03806933|536620131|FG003|Main Period|Lost to Follow-up|0|||
148766916|NCT03806933|536620128|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
148766917|NCT03806933|536620129|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
148766918|NCT03806933|536620130|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
148766919|NCT03806933|536620131|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
148766920|NCT01068730|536620132|FG000|Period 3|Personal reason|1|||
148766921|NCT01068730|536620133|FG001|Period 3|Personal reason|0|||
148978869|NCT00705575|537402521|FG000|Overall Study|Abnormal test procedure result(s)|2|||
148978870|NCT00705575|537402522|FG001|Overall Study|Abnormal test procedure result(s)|12|||
148978871|NCT00705575|537402521|FG000|Overall Study|Adverse Event|11|||
148978872|NCT00705575|537402522|FG001|Overall Study|Adverse Event|15|||
148978873|NCT00705575|537402521|FG000|Overall Study|Lost to Follow-up|3|||
148978874|NCT00705575|537402522|FG001|Overall Study|Lost to Follow-up|4|||
148978875|NCT00705575|537402521|FG000|Overall Study|Protocol Violation|2|||
148978876|NCT00705575|537402522|FG001|Overall Study|Protocol Violation|2|||
148978877|NCT00705575|537402521|FG000|Overall Study|Withdrawal by Subject|5|||
148978878|NCT00705575|537402522|FG001|Overall Study|Withdrawal by Subject|10|||
148978879|NCT02170727|537402524|FG000|Overall Study|Lost to Follow-up|1|||
148978880|NCT02170727|537402525|FG001|Overall Study|Lost to Follow-up|0|||
148978881|NCT02170727|537402524|FG000|Overall Study|Withdrawal by Subject|2|||
148978882|NCT02170727|537402525|FG001|Overall Study|Withdrawal by Subject|0|||
148978883|NCT00414050|537402528|FG000|Overall Study|Adverse Event|1|||
148978884|NCT00414050|537402529|FG001|Overall Study|Adverse Event|1|||
148978885|NCT00414050|537402530|FG002|Overall Study|Adverse Event|1|||
148978886|NCT00414050|537402531|FG003|Overall Study|Adverse Event|1|||
148978887|NCT00414050|537402528|FG000|Overall Study|Lost to Follow-up|2|||
148978888|NCT00414050|537402529|FG001|Overall Study|Lost to Follow-up|2|||
148978889|NCT00414050|537402530|FG002|Overall Study|Lost to Follow-up|1|||
148978890|NCT00414050|537402531|FG003|Overall Study|Lost to Follow-up|1|||
148978891|NCT00414050|537402528|FG000|Overall Study|Withdrawal by Subject|5|||
148978892|NCT00414050|537402529|FG001|Overall Study|Withdrawal by Subject|3|||
148978893|NCT00414050|537402530|FG002|Overall Study|Withdrawal by Subject|2|||
148978894|NCT00414050|537402531|FG003|Overall Study|Withdrawal by Subject|4|||
148978895|NCT00414050|537402528|FG000|Overall Study|Subject discontinued for other reason|1|||
148978896|NCT00414050|537402529|FG001|Overall Study|Subject discontinued for other reason|2|||
148978897|NCT00414050|537402530|FG002|Overall Study|Subject discontinued for other reason|2|||
148978898|NCT00414050|537402531|FG003|Overall Study|Subject discontinued for other reason|1|||
148978899|NCT00414050|537402528|FG000|Overall Study|Subject Moved|0|||
149027895|NCT00062868|537578703|FG020|Dose Level 2|Lost to Follow-up|0|||
149027896|NCT00062868|537578683|FG000|Dose Level 3|Death|0|||
149027897|NCT00062868|537578684|FG001|Dose Level 3|Death|0|||
149027898|NCT00062868|537578685|FG002|Dose Level 3|Death|0|||
148978900|NCT00414050|537402529|FG001|Overall Study|Subject Moved|0|||
148978901|NCT00414050|537402530|FG002|Overall Study|Subject Moved|0|||
148978902|NCT00414050|537402531|FG003|Overall Study|Subject Moved|1|||
149027899|NCT00062868|537578686|FG003|Dose Level 3|Death|0|||
148978903|NCT01959581|537402532|FG000|Overall Study|Lost to Follow-up|5|||
148978904|NCT02075320|537402539|FG000|Overall Study|Withdrawal by Subject|2|||
148978905|NCT03773757|537402540|FG000|Overall Study|Withdrawal by Subject|2|||
148978906|NCT03773757|537402541|FG001|Overall Study|Withdrawal by Subject|4|||
148978907|NCT00057746|537402542|FG000|Overall Study|Withdrawal by Subject|0|||
148978908|NCT00057746|537402543|FG001|Overall Study|Withdrawal by Subject|0|||
148978909|NCT00057746|537402544|FG002|Overall Study|Withdrawal by Subject|1|||
148978910|NCT01109316|537402545|FG000|Study Period 1|Adverse Event|0|||
148978911|NCT01109316|537402546|FG001|Study Period 1|Adverse Event|0|||
148978912|NCT01109316|537402547|FG002|Study Period 1|Adverse Event|1|||
148978913|NCT01109316|537402548|FG003|Study Period 1|Adverse Event|0|||
148978914|NCT01109316|537402549|FG004|Study Period 1|Adverse Event|0|||
148978915|NCT01109316|537402550|FG005|Study Period 1|Adverse Event|0|||
148978916|NCT01109316|537402545|FG000|Study Period 1|Lost to Follow-up|0|||
148978917|NCT01109316|537402546|FG001|Study Period 1|Lost to Follow-up|0|||
148978918|NCT01109316|537402547|FG002|Study Period 1|Lost to Follow-up|1|||
148978919|NCT01109316|537402548|FG003|Study Period 1|Lost to Follow-up|1|||
148978920|NCT01109316|537402549|FG004|Study Period 1|Lost to Follow-up|0|||
148978921|NCT01109316|537402550|FG005|Study Period 1|Lost to Follow-up|0|||
148978922|NCT01109316|537402545|FG000|Study Period 1|Withdrawal by Subject|0|||
148978923|NCT01109316|537402546|FG001|Study Period 1|Withdrawal by Subject|0|||
148978924|NCT01109316|537402547|FG002|Study Period 1|Withdrawal by Subject|1|||
148978925|NCT01109316|537402548|FG003|Study Period 1|Withdrawal by Subject|0|||
148978926|NCT01109316|537402549|FG004|Study Period 1|Withdrawal by Subject|2|||
148978927|NCT01109316|537402550|FG005|Study Period 1|Withdrawal by Subject|0|||
148978928|NCT01109316|537402545|FG000|Study Period 1|Sponsor Decision|0|||
148978929|NCT01109316|537402546|FG001|Study Period 1|Sponsor Decision|0|||
148978930|NCT01109316|537402547|FG002|Study Period 1|Sponsor Decision|0|||
148978931|NCT01109316|537402548|FG003|Study Period 1|Sponsor Decision|0|||
148978932|NCT01109316|537402549|FG004|Study Period 1|Sponsor Decision|0|||
148978933|NCT01109316|537402550|FG005|Study Period 1|Sponsor Decision|2|||
148978934|NCT01109316|537402545|FG000|Study Period 2|Entry Criteria Not Met|0|||
148978935|NCT01109316|537402546|FG001|Study Period 2|Entry Criteria Not Met|1|||
148978936|NCT01109316|537402547|FG002|Study Period 2|Entry Criteria Not Met|0|||
148978937|NCT01109316|537402548|FG003|Study Period 2|Entry Criteria Not Met|0|||
148978938|NCT01109316|537402549|FG004|Study Period 2|Entry Criteria Not Met|0|||
148978939|NCT01109316|537402550|FG005|Study Period 2|Entry Criteria Not Met|0|||
148978940|NCT01109316|537402545|FG000|Study Period 2|Physician Decision|0|||
148978941|NCT01109316|537402546|FG001|Study Period 2|Physician Decision|0|||
148978942|NCT01109316|537402547|FG002|Study Period 2|Physician Decision|0|||
148978943|NCT01109316|537402548|FG003|Study Period 2|Physician Decision|1|||
148978944|NCT01109316|537402549|FG004|Study Period 2|Physician Decision|0|||
148978945|NCT01109316|537402550|FG005|Study Period 2|Physician Decision|0|||
148978946|NCT01109316|537402545|FG000|Study Period 2|Protocol Violation|1|||
148978947|NCT01109316|537402546|FG001|Study Period 2|Protocol Violation|0|||
148978948|NCT01109316|537402547|FG002|Study Period 2|Protocol Violation|0|||
148978949|NCT01109316|537402548|FG003|Study Period 2|Protocol Violation|0|||
148978950|NCT01109316|537402549|FG004|Study Period 2|Protocol Violation|0|||
148978951|NCT01109316|537402550|FG005|Study Period 2|Protocol Violation|0|||
148978952|NCT01109316|537402545|FG000|Study Period 2|Withdrawal by Subject|0|||
148978953|NCT01109316|537402546|FG001|Study Period 2|Withdrawal by Subject|0|||
148978954|NCT01109316|537402547|FG002|Study Period 2|Withdrawal by Subject|1|||
148978955|NCT01109316|537402548|FG003|Study Period 2|Withdrawal by Subject|0|||
148978956|NCT01109316|537402549|FG004|Study Period 2|Withdrawal by Subject|0|||
148978957|NCT01109316|537402550|FG005|Study Period 2|Withdrawal by Subject|1|||
148978958|NCT01109316|537402545|FG000|Study Period 3|Lost to Follow-up|0|||
148978959|NCT01109316|537402546|FG001|Study Period 3|Lost to Follow-up|0|||
148978960|NCT01109316|537402547|FG002|Study Period 3|Lost to Follow-up|0|||
148978961|NCT01109316|537402548|FG003|Study Period 3|Lost to Follow-up|0|||
148978962|NCT01109316|537402549|FG004|Study Period 3|Lost to Follow-up|1|||
148978963|NCT01109316|537402550|FG005|Study Period 3|Lost to Follow-up|0|||
148978964|NCT01109316|537402545|FG000|Study Period 3|Withdrawal by Subject|1|||
148978965|NCT01109316|537402546|FG001|Study Period 3|Withdrawal by Subject|0|||
148978966|NCT01109316|537402547|FG002|Study Period 3|Withdrawal by Subject|0|||
148978967|NCT01109316|537402548|FG003|Study Period 3|Withdrawal by Subject|0|||
148978968|NCT01109316|537402549|FG004|Study Period 3|Withdrawal by Subject|1|||
148978969|NCT01109316|537402550|FG005|Study Period 3|Withdrawal by Subject|0|||
148978970|NCT03511560|537402560|FG000|Overall Study|Death|0|||
148978971|NCT03511560|537402561|FG001|Overall Study|Death|1|||
148978972|NCT03511560|537402560|FG000|Overall Study|Adverse Event|0|||
148978973|NCT03511560|537402561|FG001|Overall Study|Adverse Event|2|||
148978974|NCT03511560|537402560|FG000|Overall Study|Transplant cancelled|0|||
148978975|NCT03511560|537402561|FG001|Overall Study|Transplant cancelled|1|||
148978976|NCT03511560|537402560|FG000|Overall Study|Patient switched to another drug|1|||
148978977|NCT03511560|537402561|FG001|Overall Study|Patient switched to another drug|0|||
148978978|NCT02985736|537402566|FG000|Overall Study|Lost to Follow-up|3|||
148978979|NCT00382733|537402567|FG000|Overall Study|Withdrawal by Subject|0|||
148978980|NCT00382733|537402568|FG001|Overall Study|Withdrawal by Subject|1|||
148978981|NCT00382733|537402569|FG002|Overall Study|Withdrawal by Subject|0|||
148978982|NCT00382733|537402570|FG003|Overall Study|Withdrawal by Subject|0|||
148978983|NCT00382733|537402571|FG004|Overall Study|Withdrawal by Subject|0|||
148978984|NCT00550836|537402572|FG000|Overall Study|Withdrawal by Subject|3|||
148978985|NCT00550836|537402573|FG001|Overall Study|Withdrawal by Subject|9|||
148978986|NCT00179413|537402574|FG000|Overall Study|Adverse Event|38|||
148978987|NCT00179413|537402575|FG001|Overall Study|Adverse Event|20|||
148978988|NCT00179413|537402574|FG000|Overall Study|Withdrawal by Subject|87|||
148978989|NCT00179413|537402575|FG001|Overall Study|Withdrawal by Subject|95|||
148978990|NCT03075644|537402578|FG000|Overall Study|Withdrawal by Subject|1|||
148978991|NCT03075644|537402579|FG001|Overall Study|Withdrawal by Subject|1|||
148978992|NCT00439140|537402580|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
148978993|NCT00439140|537402581|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
148978994|NCT00439140|537402582|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
148978995|NCT00439140|537402580|FG000|Treatment Cycle 1|Personal reasons|0|||
148978996|NCT00439140|537402581|FG001|Treatment Cycle 1|Personal reasons|2|||
148978997|NCT00439140|537402582|FG002|Treatment Cycle 1|Personal reasons|0|||
148978998|NCT00439140|537402580|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
148978999|NCT00439140|537402581|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
148979000|NCT00439140|537402582|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
148979001|NCT00439140|537402580|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
148979002|NCT00439140|537402581|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
148979003|NCT00439140|537402582|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
148979004|NCT00439140|537402580|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
148979005|NCT00439140|537402581|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
148979006|NCT00439140|537402582|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
148979007|NCT01458171|537402583|FG000|Overall Study|Adverse Event|1|||
148979008|NCT00578565|537402587|FG000|Overall Study|Adverse Event|3|||
148979009|NCT01192152|537402588|FG000|Period 1|left prematurely (while on treatment B)|0|||
148979010|NCT01192152|537402589|FG001|Period 1|left prematurely (while on treatment B)|1|||
148979011|NCT01192152|537402588|FG000|Period 3|family emergency|1|||
148979012|NCT01192152|537402589|FG001|Period 3|family emergency|0|||
148979013|NCT00854581|537402593|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
148979014|NCT00854581|537402593|FG000|Induction (Up to Day 21)|Death|1|||
148979015|NCT00854581|537402593|FG000|Induction (Up to Day 21)|Physician Decision|1|||
148979016|NCT00854581|537402593|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
148979017|NCT01339390|537402594|FG000|Overall Study|Death|32|||
148979018|NCT01339390|537402595|FG001|Overall Study|Death|29|||
148979019|NCT01339390|537402594|FG000|Overall Study|Lost to Follow-up|125|||
148979020|NCT01339390|537402595|FG001|Overall Study|Lost to Follow-up|127|||
148979021|NCT03181542|537402596|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
148979022|NCT03181542|537402597|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
148979023|NCT00298038|537402598|FG000|Overall Study|Lost to Follow-up|0|||
148979024|NCT00298038|537402599|FG001|Overall Study|Lost to Follow-up|1|||
148979025|NCT00298038|537402598|FG000|Overall Study|Liver Transplant|0|||
148979026|NCT00298038|537402599|FG001|Overall Study|Liver Transplant|1|||
148979027|NCT00298038|537402598|FG000|Overall Study|Protocol Violation|1|||
148979028|NCT00298038|537402599|FG001|Overall Study|Protocol Violation|3|||
148979029|NCT00298038|537402598|FG000|Overall Study|Death|6|||
148979030|NCT00298038|537402599|FG001|Overall Study|Death|3|||
148979031|NCT00298038|537402598|FG000|Overall Study|Withdrawal by Subject|6|||
148979032|NCT00298038|537402599|FG001|Overall Study|Withdrawal by Subject|9|||
148979033|NCT00298038|537402598|FG000|Overall Study|Adverse Event|8|||
148979034|NCT00298038|537402599|FG001|Overall Study|Adverse Event|7|||
148979035|NCT00298038|537402598|FG000|Overall Study|Breakthrough overt HE episode|28|||
148979036|NCT00298038|537402599|FG001|Overall Study|Breakthrough overt HE episode|69|||
148979037|NCT00298038|537402598|FG000|Overall Study|Noncompliance|1|||
148979038|NCT00298038|537402599|FG001|Overall Study|Noncompliance|0|||
148979039|NCT00298038|537402598|FG000|Overall Study|Cocaine Abuse|1|||
148979040|NCT00298038|537402599|FG001|Overall Study|Cocaine Abuse|0|||
148979041|NCT00298038|537402598|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
148979042|NCT00298038|537402599|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
148979043|NCT02696096|537402600|FG000|Overall Study|ruled out at screening|1|||
148979044|NCT02696096|537402600|FG000|Overall Study|did not attend second fMRI|1|||
148979045|NCT01310413|537404312|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
148979046|NCT01310413|537404313|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
148979047|NCT01310413|537404314|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
148979048|NCT01310413|537404315|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
148979049|NCT01310413|537404316|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
148979050|NCT01310413|537404317|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
148979051|NCT01310413|537404318|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
148979052|NCT01310413|537404312|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
148979053|NCT01310413|537404313|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
148979054|NCT01310413|537404314|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
148979055|NCT01310413|537404315|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
148979056|NCT01310413|537404316|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
148979057|NCT01310413|537404317|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
148979058|NCT01310413|537404318|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
148979059|NCT01310413|537404312|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
148979060|NCT01310413|537404313|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
148979061|NCT01310413|537404314|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
148979062|NCT01310413|537404315|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
148979063|NCT01310413|537404316|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
148979064|NCT01310413|537404317|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
148979065|NCT01310413|537404318|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
148979066|NCT01310413|537404312|FG000|Day 0 to Day 385|Other|1|||
148979067|NCT01310413|537404313|FG001|Day 0 to Day 385|Other|0|||
148979068|NCT01310413|537404314|FG002|Day 0 to Day 385|Other|3|||
148979069|NCT01310413|537404315|FG003|Day 0 to Day 385|Other|0|||
148979070|NCT01310413|537404316|FG004|Day 0 to Day 385|Other|0|||
148979071|NCT01310413|537404317|FG005|Day 0 to Day 385|Other|0|||
148979072|NCT01310413|537404318|FG006|Day 0 to Day 385|Other|0|||
148979073|NCT01310413|537404312|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
148979074|NCT01310413|537404313|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
148979075|NCT01310413|537404314|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
148979076|NCT01310413|537404315|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
148979077|NCT01310413|537404316|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
148979078|NCT01310413|537404317|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
148979079|NCT01310413|537404318|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
148979080|NCT01310413|537404312|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
148979081|NCT01310413|537404313|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
148979082|NCT01310413|537404314|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
148979083|NCT01310413|537404315|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
148979084|NCT01310413|537404316|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
148979085|NCT01310413|537404317|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
148979086|NCT01310413|537404318|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
148979087|NCT02564471|537404319|FG000|Overall Study|Adverse Event|1|||
148979088|NCT02564471|537404320|FG001|Overall Study|Adverse Event|0|||
148979089|NCT02564471|537404321|FG002|Overall Study|Adverse Event|0|||
148979090|NCT02564471|537404322|FG003|Overall Study|Adverse Event|0|||
148979091|NCT02564471|537404319|FG000|Overall Study|Withdrawal by Subject|2|||
148979092|NCT02564471|537404320|FG001|Overall Study|Withdrawal by Subject|1|||
148979093|NCT02564471|537404321|FG002|Overall Study|Withdrawal by Subject|3|||
148979094|NCT02564471|537404322|FG003|Overall Study|Withdrawal by Subject|0|||
148979095|NCT02564471|537404319|FG000|Overall Study|Lost to Follow-up|0|||
148979096|NCT02564471|537404320|FG001|Overall Study|Lost to Follow-up|2|||
148979097|NCT02564471|537404321|FG002|Overall Study|Lost to Follow-up|0|||
148979098|NCT02564471|537404322|FG003|Overall Study|Lost to Follow-up|0|||
148979099|NCT02348489|537404330|FG000|Overall Study|Death|336|||
148979100|NCT02348489|537404331|FG001|Overall Study|Death|335|||
148979101|NCT02348489|537404330|FG000|Overall Study|Withdrawal by Subject|14|||
148979102|NCT02348489|537404331|FG001|Overall Study|Withdrawal by Subject|27|||
148979103|NCT02348489|537404330|FG000|Overall Study|Lost to Follow-up|3|||
148979104|NCT02348489|537404331|FG001|Overall Study|Lost to Follow-up|5|||
148766922|NCT01068730|536620134|FG002|Period 3|Personal reason|0|||
148766923|NCT01068730|536620135|FG003|Period 3|Personal reason|0|||
148766924|NCT01068730|536620132|FG000|Period 4|Family emergency|0|||
148766925|NCT01068730|536620133|FG001|Period 4|Family emergency|1|||
148766926|NCT01068730|536620134|FG002|Period 4|Family emergency|0|||
148766927|NCT01068730|536620135|FG003|Period 4|Family emergency|0|||
148979105|NCT02866682|537404332|FG000|Overall Study|Death|0|||
148979106|NCT02866682|537404333|FG001|Overall Study|Death|1|||
148979107|NCT02866682|537404332|FG000|Overall Study|Lost to Follow-up|0|||
148979108|NCT02866682|537404333|FG001|Overall Study|Lost to Follow-up|4|||
148979109|NCT02866682|537404332|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
148979110|NCT02866682|537404333|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
148979111|NCT02866682|537404332|FG000|Overall Study|Other|0|||
148979112|NCT02866682|537404333|FG001|Overall Study|Other|1|||
148979113|NCT00201006|537404334|FG000|Overall Study|Withdrawal by Subject|7|||
148979114|NCT00201006|537404335|FG001|Overall Study|Withdrawal by Subject|2|||
148979115|NCT00201006|537404336|FG002|Overall Study|Withdrawal by Subject|3|||
148979116|NCT00201006|537404334|FG000|Overall Study|Adverse Event|1|||
148979117|NCT00201006|537404335|FG001|Overall Study|Adverse Event|0|||
148979118|NCT00201006|537404336|FG002|Overall Study|Adverse Event|1|||
148979119|NCT01750268|537404338|FG000|Overall Study|Lost to Follow-up|0|||
148979120|NCT01750268|537404339|FG001|Overall Study|Lost to Follow-up|2|||
148979121|NCT01750268|537404338|FG000|Overall Study|Physician Decision|0|||
148979122|NCT01750268|537404339|FG001|Overall Study|Physician Decision|3|||
148979123|NCT01750268|537404338|FG000|Overall Study|Withdrawal by Subject|2|||
148979124|NCT01750268|537404339|FG001|Overall Study|Withdrawal by Subject|0|||
148979125|NCT01694706|537404342|FG000|Overall Study|Adverse Event|0|||
148979126|NCT01694706|537404343|FG001|Overall Study|Adverse Event|1|||
148979127|NCT01694706|537404344|FG002|Overall Study|Adverse Event|0|||
148979128|NCT01694706|537404342|FG000|Overall Study|other reason not defined above|1|||
148979129|NCT01694706|537404343|FG001|Overall Study|other reason not defined above|0|||
148979130|NCT01694706|537404344|FG002|Overall Study|other reason not defined above|0|||
148979131|NCT01923181|537404345|FG000|Overall Study|Protocol Violation|2|||
148979132|NCT01923181|537404346|FG001|Overall Study|Protocol Violation|2|||
148979133|NCT01923181|537404347|FG002|Overall Study|Protocol Violation|0|||
148979134|NCT01923181|537404348|FG003|Overall Study|Protocol Violation|2|||
148979135|NCT01923181|537404349|FG004|Overall Study|Protocol Violation|2|||
148979136|NCT01923181|537404350|FG005|Overall Study|Protocol Violation|1|||
148979137|NCT01923181|537404351|FG006|Overall Study|Protocol Violation|1|||
148979138|NCT01923181|537404352|FG007|Overall Study|Protocol Violation|2|||
148979139|NCT01923181|537404353|FG008|Overall Study|Protocol Violation|1|||
148979140|NCT01923181|537404345|FG000|Overall Study|Withdrawal by Subject|0|||
148979141|NCT01923181|537404346|FG001|Overall Study|Withdrawal by Subject|1|||
148979142|NCT01923181|537404347|FG002|Overall Study|Withdrawal by Subject|0|||
148979143|NCT01923181|537404348|FG003|Overall Study|Withdrawal by Subject|1|||
148979144|NCT01923181|537404349|FG004|Overall Study|Withdrawal by Subject|4|||
148979145|NCT01923181|537404350|FG005|Overall Study|Withdrawal by Subject|2|||
148979146|NCT01923181|537404351|FG006|Overall Study|Withdrawal by Subject|4|||
148979147|NCT01923181|537404352|FG007|Overall Study|Withdrawal by Subject|3|||
148979148|NCT01923181|537404353|FG008|Overall Study|Withdrawal by Subject|1|||
148979149|NCT01923181|537404345|FG000|Overall Study|Other|1|||
148979150|NCT01923181|537404346|FG001|Overall Study|Other|0|||
148979151|NCT01923181|537404347|FG002|Overall Study|Other|0|||
148979152|NCT01923181|537404348|FG003|Overall Study|Other|1|||
148979153|NCT01923181|537404349|FG004|Overall Study|Other|0|||
148979154|NCT01923181|537404350|FG005|Overall Study|Other|0|||
148979155|NCT01923181|537404351|FG006|Overall Study|Other|0|||
148979156|NCT01923181|537404352|FG007|Overall Study|Other|0|||
148979157|NCT01923181|537404353|FG008|Overall Study|Other|0|||
148979158|NCT01923181|537404345|FG000|Overall Study|Lost to Follow-up|0|||
148979159|NCT01923181|537404346|FG001|Overall Study|Lost to Follow-up|3|||
148979160|NCT01923181|537404347|FG002|Overall Study|Lost to Follow-up|2|||
148979161|NCT01923181|537404348|FG003|Overall Study|Lost to Follow-up|1|||
148979162|NCT01923181|537404349|FG004|Overall Study|Lost to Follow-up|2|||
148979163|NCT01923181|537404350|FG005|Overall Study|Lost to Follow-up|1|||
148979164|NCT01923181|537404351|FG006|Overall Study|Lost to Follow-up|3|||
148979165|NCT01923181|537404352|FG007|Overall Study|Lost to Follow-up|3|||
148979166|NCT01923181|537404353|FG008|Overall Study|Lost to Follow-up|1|||
148979167|NCT02944578|537404354|FG000|Overall Study|Physician Decision|1|||
148979168|NCT02944578|537404355|FG001|Overall Study|Physician Decision|0|||
148979169|NCT02932891|537404357|FG000|Overall Study|Lost to Follow-up|2|||
148979170|NCT02932891|537404357|FG000|Overall Study|HPA Suppress|2|||
148979171|NCT00577122|537404360|FG000|Overall Study|Adverse Event|0|||
148979172|NCT00577122|537404361|FG001|Overall Study|Adverse Event|2|||
148979173|NCT00577122|537404360|FG000|Overall Study|Progression, relapse during active trt|6|||
148979174|NCT00577122|537404361|FG001|Overall Study|Progression, relapse during active trt|8|||
148979175|NCT00577122|537404360|FG000|Overall Study|Prog, refract disease during active trt|8|||
148979176|NCT00577122|537404361|FG001|Overall Study|Prog, refract disease during active trt|5|||
148979177|NCT00577122|537404360|FG000|Overall Study|Alternative Therapy|0|||
148979178|NCT00577122|537404361|FG001|Overall Study|Alternative Therapy|1|||
148979179|NCT00440271|537404363|FG000|Overall Study|Protocol Violation|1|||
148979180|NCT00440271|537404364|FG001|Overall Study|Protocol Violation|1|||
148979181|NCT00440271|537404363|FG000|Overall Study|Adverse Event|0|||
148979182|NCT00440271|537404364|FG001|Overall Study|Adverse Event|1|||
148979183|NCT00440271|537404363|FG000|Overall Study|Lost to Follow-up|1|||
148979184|NCT00440271|537404364|FG001|Overall Study|Lost to Follow-up|0|||
148979185|NCT00440271|537404363|FG000|Overall Study|Withdrawal by Subject|0|||
148979186|NCT00440271|537404364|FG001|Overall Study|Withdrawal by Subject|2|||
148979187|NCT00440271|537404363|FG000|Overall Study|Lack of Efficacy|0|||
148979188|NCT00440271|537404364|FG001|Overall Study|Lack of Efficacy|1|||
148979189|NCT00440271|537404363|FG000|Overall Study|Due to closure of trial|8|||
148979190|NCT00440271|537404364|FG001|Overall Study|Due to closure of trial|10|||
148979191|NCT00440271|537404363|FG000|Overall Study|Other|2|||
148979192|NCT00440271|537404364|FG001|Overall Study|Other|0|||
148979193|NCT00456092|537404365|FG000|Extension Phase|Grade 2 or Greater AE|2|||
148979194|NCT00456092|537404366|FG001|Extension Phase|Grade 2 or Greater AE|2|||
148979195|NCT00456092|537404367|FG002|Extension Phase|Grade 2 or Greater AE|0|||
148979196|NCT00456092|537404368|FG003|Extension Phase|Grade 2 or Greater AE|0|||
148979197|NCT00456092|537404369|FG004|Extension Phase|Grade 2 or Greater AE|2|||
148979198|NCT00456092|537404365|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
148979199|NCT00456092|537404366|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
148979200|NCT00456092|537404367|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
148766928|NCT01736397|536620138|FG000|Overall Study|Lack of Efficacy|1|||
148979201|NCT00456092|537404368|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
148979202|NCT00456092|537404369|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
148979203|NCT00456092|537404365|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
148979204|NCT00456092|537404366|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
148979205|NCT00456092|537404367|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
148979206|NCT00456092|537404368|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
148979207|NCT00456092|537404369|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
148979208|NCT00456092|537404365|FG000|Extension Phase|Withdrew Consent|2|||
148979209|NCT00456092|537404366|FG001|Extension Phase|Withdrew Consent|0|||
148979210|NCT00456092|537404367|FG002|Extension Phase|Withdrew Consent|0|||
148979211|NCT00456092|537404368|FG003|Extension Phase|Withdrew Consent|0|||
148979212|NCT00456092|537404369|FG004|Extension Phase|Withdrew Consent|0|||
148766929|NCT01736397|536620139|FG001|Overall Study|Lack of Efficacy|11|||
148766930|NCT01736397|536620138|FG000|Overall Study|Withdrawal by Subject|6|||
148979213|NCT00456092|537404365|FG000|Extension Phase|Lost to Follow-up|1|||
148979214|NCT00456092|537404366|FG001|Extension Phase|Lost to Follow-up|1|||
148979215|NCT00456092|537404367|FG002|Extension Phase|Lost to Follow-up|0|||
148979216|NCT00456092|537404368|FG003|Extension Phase|Lost to Follow-up|0|||
148979217|NCT00456092|537404369|FG004|Extension Phase|Lost to Follow-up|1|||
148979218|NCT00456092|537404365|FG000|Extension Phase|Other|2|||
148979219|NCT00456092|537404366|FG001|Extension Phase|Other|0|||
148979220|NCT00456092|537404367|FG002|Extension Phase|Other|0|||
148979221|NCT00456092|537404368|FG003|Extension Phase|Other|1|||
148979222|NCT00456092|537404369|FG004|Extension Phase|Other|1|||
148979223|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
148979224|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
148979225|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
148979226|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
148979227|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
148979228|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
148979229|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
148979230|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
148979231|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
148979232|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
148979233|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
148979234|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
148979235|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
148979236|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
148979237|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
148979238|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
148979239|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
148979240|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
148766931|NCT01736397|536620139|FG001|Overall Study|Withdrawal by Subject|5|||
148766932|NCT01736397|536620138|FG000|Overall Study|Lost to Follow-up|0|||
148766933|NCT01736397|536620139|FG001|Overall Study|Lost to Follow-up|1|||
148766934|NCT01736397|536620138|FG000|Overall Study|Adverse Event|6|||
148766935|NCT01736397|536620139|FG001|Overall Study|Adverse Event|3|||
148766936|NCT01736397|536620138|FG000|Overall Study|Not stated|1|||
148766937|NCT01736397|536620139|FG001|Overall Study|Not stated|4|||
148766938|NCT05088603|536620140|FG000|Overall Study|Protocol Violation|6|||
148766939|NCT05088603|536620141|FG001|Overall Study|Protocol Violation|1|||
148766940|NCT00956592|536620144|FG000|Overall Study|Protocol Violation|1|||
148766941|NCT00956592|536620145|FG001|Overall Study|Protocol Violation|3|||
148766942|NCT00379080|536620149|FG000|Overall Study|Withdrawal by Subject|0|||
148766943|NCT00379080|536620150|FG001|Overall Study|Withdrawal by Subject|4|||
148766944|NCT00379080|536620151|FG002|Overall Study|Withdrawal by Subject|0|||
148766945|NCT01222520|536620152|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
148766946|NCT01222520|536620153|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
148766947|NCT01222520|536620152|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
148766948|NCT01222520|536620153|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
148766949|NCT01222520|536620152|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
148766950|NCT01222520|536620153|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
148766951|NCT01222520|536620152|FG000|Double-blind Period|Adverse Event|0|||
148766952|NCT01222520|536620153|FG001|Double-blind Period|Adverse Event|1|||
148766953|NCT01222520|536620152|FG000|Double-blind Period|Lack of Efficacy|0|||
148766954|NCT01222520|536620153|FG001|Double-blind Period|Lack of Efficacy|1|||
148766955|NCT01222520|536620152|FG000|Double-blind Period|Study medication stolen|1|||
148766956|NCT01222520|536620153|FG001|Double-blind Period|Study medication stolen|0|||
148766957|NCT00955955|536620156|FG000|Overall Study|Lost to Follow-up|2|||
148766958|NCT00955955|536620157|FG001|Overall Study|Lost to Follow-up|0|||
148766959|NCT00955955|536620158|FG002|Overall Study|Lost to Follow-up|0|||
148766960|NCT03348930|536620159|FG000|Washout (1 Week)|Lost to Follow-up|1|||
148766961|NCT03348930|536620160|FG001|Washout (1 Week)|Lost to Follow-up|1|||
148766962|NCT02920008|536620161|FG000|Overall Study|Death|117|||
148766963|NCT02920008|536620162|FG001|Overall Study|Death|127|||
148766964|NCT02920008|536620161|FG000|Overall Study|Withdrawal by Subject|3|||
148766965|NCT02920008|536620162|FG001|Overall Study|Withdrawal by Subject|6|||
148766966|NCT02920008|536620161|FG000|Overall Study|Lost to Follow-up|0|||
148766967|NCT02920008|536620162|FG001|Overall Study|Lost to Follow-up|1|||
148766968|NCT02858583|536620165|FG000|Overall Study|Declined consent|1|||
148766969|NCT02858583|536620166|FG001|Overall Study|Declined consent|1|||
148766970|NCT03170362|536620167|FG000|Overall Study|Death|2|||
148766971|NCT03170362|536620168|FG001|Overall Study|Death|2|||
148766972|NCT03170362|536620167|FG000|Overall Study|Withdrawal by Subject|23|||
148766973|NCT03170362|536620168|FG001|Overall Study|Withdrawal by Subject|22|||
148766974|NCT03170362|536620167|FG000|Overall Study|Lost to Follow-up|187|||
148766975|NCT03170362|536620168|FG001|Overall Study|Lost to Follow-up|167|||
148766976|NCT01972438|536620169|FG000|Baseline-Month 3 Crossover Period|Death|1|||
148766977|NCT01972438|536620170|FG001|Baseline-Month 3 Crossover Period|Death|0|||
148766978|NCT01972438|536620169|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
148766979|NCT01972438|536620170|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
148766980|NCT01972438|536620169|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
148766981|NCT01972438|536620170|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
148766982|NCT01972438|536620169|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
148766983|NCT01972438|536620170|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
148766984|NCT01972438|536620169|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
148766985|NCT01972438|536620170|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
148766986|NCT01972438|536620169|FG000|Months 6-12 Study Period|Death|1|||
148766987|NCT01972438|536620170|FG001|Months 6-12 Study Period|Death|0|||
149027900|NCT00062868|537578687|FG004|Dose Level 3|Death|0|||
148766988|NCT01972438|536620169|FG000|Months 6-12 Study Period|Early Study Closure|2|||
148766989|NCT01972438|536620170|FG001|Months 6-12 Study Period|Early Study Closure|2|||
148979241|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
148979242|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
148979243|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
148979244|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
148979245|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
148979246|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
148979247|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
148979248|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
148979249|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
148979250|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
148979251|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
148979252|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
148979253|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
148979254|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
148979255|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
148979256|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
148979257|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
148979258|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
148979259|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
148979260|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
149027901|NCT00062868|537578688|FG005|Dose Level 3|Death|0|||
149027902|NCT00062868|537578689|FG006|Dose Level 3|Death|0|||
148766990|NCT01972438|536620169|FG000|Post Month 12 Study Period|Early Study Closure|3|||
148766991|NCT01972438|536620170|FG001|Post Month 12 Study Period|Early Study Closure|4|||
148766992|NCT01052480|536620176|FG000|Overall Study|Lost to Follow-up|3|||
148766993|NCT01052480|536620177|FG001|Overall Study|Lost to Follow-up|3|||
148766994|NCT01052480|536620176|FG000|Overall Study|Protocol Violation|1|||
148766995|NCT01052480|536620177|FG001|Overall Study|Protocol Violation|0|||
148766996|NCT01052480|536620176|FG000|Overall Study|Withdrawal by Subject|3|||
148766997|NCT01052480|536620177|FG001|Overall Study|Withdrawal by Subject|7|||
148766998|NCT01052480|536620176|FG000|Overall Study|Physician Decision|0|||
148766999|NCT01052480|536620177|FG001|Overall Study|Physician Decision|2|||
148767000|NCT01052480|536620176|FG000|Overall Study|Death|1|||
148767001|NCT01052480|536620177|FG001|Overall Study|Death|5|||
148767002|NCT02157376|536620178|FG000|Overall Study|Death|10|||
148767003|NCT02157376|536620179|FG001|Overall Study|Death|4|||
148767004|NCT02157376|536620178|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148767005|NCT02157376|536620179|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
148767006|NCT02157376|536620178|FG000|Overall Study|Withdrawal by Subject|3|||
148767007|NCT02157376|536620179|FG001|Overall Study|Withdrawal by Subject|8|||
148767008|NCT02157376|536620178|FG000|Overall Study|Not treated|8|||
148767009|NCT02157376|536620179|FG001|Overall Study|Not treated|3|||
148767010|NCT02157376|536620178|FG000|Overall Study|Investigator's misjudgement|1|||
148767011|NCT02157376|536620179|FG001|Overall Study|Investigator's misjudgement|2|||
148767012|NCT00529373|536620180|FG000|Base Study|Adverse Event|525|||
148767013|NCT00529373|536620181|FG001|Base Study|Adverse Event|470|||
148767014|NCT00529373|536620180|FG000|Base Study|Lack of Efficacy|16|||
148767015|NCT00529373|536620181|FG001|Base Study|Lack of Efficacy|75|||
148767016|NCT00529373|536620180|FG000|Base Study|Lost to Follow-up|221|||
148767017|NCT00529373|536620181|FG001|Base Study|Lost to Follow-up|208|||
148767018|NCT00529373|536620180|FG000|Base Study|Other Protocol Specified Criteria|19|||
148767019|NCT00529373|536620181|FG001|Base Study|Other Protocol Specified Criteria|20|||
148767020|NCT00529373|536620180|FG000|Base Study|Physician Decision|60|||
148767021|NCT00529373|536620181|FG001|Base Study|Physician Decision|52|||
148767022|NCT00529373|536620180|FG000|Base Study|Protocol Violation|48|||
148767023|NCT00529373|536620181|FG001|Base Study|Protocol Violation|38|||
148767024|NCT00529373|536620180|FG000|Base Study|Withdrawal by Subject|1062|||
148767025|NCT00529373|536620181|FG001|Base Study|Withdrawal by Subject|967|||
148767026|NCT00529373|536620180|FG000|Base Study|Did not continue into Extension|1795|||
148767027|NCT00529373|536620181|FG001|Base Study|Did not continue into Extension|2238|||
148767028|NCT00529373|536620180|FG000|First Extension Study|Adverse Event|162|||
148767029|NCT00529373|536620181|FG001|First Extension Study|Adverse Event|142|||
148767030|NCT00529373|536620180|FG000|First Extension Study|Lack of Efficacy|65|||
148767031|NCT00529373|536620181|FG001|First Extension Study|Lack of Efficacy|427|||
148767032|NCT00529373|536620180|FG000|First Extension Study|Lost to Follow-up|41|||
148767033|NCT00529373|536620181|FG001|First Extension Study|Lost to Follow-up|37|||
148767034|NCT00529373|536620180|FG000|First Extension Study|Other|27|||
148767035|NCT00529373|536620181|FG001|First Extension Study|Other|47|||
148767036|NCT00529373|536620180|FG000|First Extension Study|Physician Decision|50|||
148767037|NCT00529373|536620181|FG001|First Extension Study|Physician Decision|45|||
148767038|NCT00529373|536620180|FG000|First Extension Study|Protocol Violation|16|||
148767039|NCT00529373|536620181|FG001|First Extension Study|Protocol Violation|13|||
148767040|NCT00529373|536620180|FG000|First Extension Study|Withdrawal by Subject|296|||
148767041|NCT00529373|536620181|FG001|First Extension Study|Withdrawal by Subject|287|||
148767042|NCT00529373|536620180|FG000|First Extension Study|Disposition record non-existing|0|||
148767043|NCT00529373|536620181|FG001|First Extension Study|Disposition record non-existing|1|||
148767044|NCT00529373|536620180|FG000|First Extension Study|Discontinued after 5 years completion|208|||
148767045|NCT00529373|536620181|FG001|First Extension Study|Discontinued after 5 years completion|346|||
148767046|NCT00529373|536620180|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
148767047|NCT00529373|536620181|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
148767048|NCT00529373|536620180|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
148979261|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
148767049|NCT00529373|536620181|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
148767050|NCT00529373|536620180|FG000|Second Extension Study|Adverse Event|101|||
148979262|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
148979263|NCT00456092|537404365|FG000|Treatment Phase (12 Weeks)|Other|1|||
148979264|NCT00456092|537404366|FG001|Treatment Phase (12 Weeks)|Other|0|||
148767051|NCT00529373|536620181|FG001|Second Extension Study|Adverse Event|51|||
148767052|NCT00529373|536620180|FG000|Second Extension Study|Lack of Efficacy|7|||
148767053|NCT00529373|536620181|FG001|Second Extension Study|Lack of Efficacy|15|||
148767054|NCT00529373|536620180|FG000|Second Extension Study|Lost to Follow-up|18|||
148767055|NCT00529373|536620181|FG001|Second Extension Study|Lost to Follow-up|12|||
148767056|NCT00529373|536620180|FG000|Second Extension Study|Other|7|||
148767057|NCT00529373|536620181|FG001|Second Extension Study|Other|12|||
148767058|NCT00529373|536620180|FG000|Second Extension Study|Physician Decision|63|||
148767059|NCT00529373|536620181|FG001|Second Extension Study|Physician Decision|26|||
148767060|NCT00529373|536620180|FG000|Second Extension Study|Protocol Violation|2|||
148979265|NCT00456092|537404367|FG002|Treatment Phase (12 Weeks)|Other|1|||
148767061|NCT00529373|536620181|FG001|Second Extension Study|Protocol Violation|1|||
148767062|NCT00529373|536620180|FG000|Second Extension Study|Withdrawal by Subject|97|||
148767063|NCT00529373|536620181|FG001|Second Extension Study|Withdrawal by Subject|75|||
148767064|NCT00529373|536620180|FG000|Second Extension Study|Status Missing|5|||
148767065|NCT00529373|536620181|FG001|Second Extension Study|Status Missing|5|||
148767066|NCT00603473|536620182|FG000|Overall Study|Adverse Event|4|||
148767067|NCT00603473|536620182|FG000|Overall Study|Lack of Efficacy|4|||
148767068|NCT00603473|536620182|FG000|Overall Study|Protocol Violation|1|||
148767069|NCT04200651|536620183|FG000|Overall Study|Moved to another country during follow-up|2|||
148767070|NCT04200651|536620184|FG001|Overall Study|Moved to another country during follow-up|2|||
148767071|NCT04200651|536620183|FG000|Overall Study|Lost to Follow-up|1|||
148767072|NCT04200651|536620184|FG001|Overall Study|Lost to Follow-up|3|||
148767073|NCT02547220|536620188|FG000|Overall Study|Withdrawal by Subject|1|||
148767074|NCT02547220|536620189|FG001|Overall Study|Withdrawal by Subject|0|||
148767075|NCT02547220|536620188|FG000|Overall Study|Study terminated by sponsor|18|||
148767076|NCT02547220|536620189|FG001|Overall Study|Study terminated by sponsor|20|||
148767077|NCT04185220|536620190|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
148767078|NCT04185220|536620191|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
148767079|NCT04185220|536620190|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
148767080|NCT04185220|536620191|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
148767081|NCT02887183|536620196|FG000|Overall Study|Adverse Event|44|||
148767082|NCT02887183|536620196|FG000|Overall Study|Death|30|||
148767083|NCT02887183|536620196|FG000|Overall Study|Pregnancy|1|||
148767084|NCT02887183|536620196|FG000|Overall Study|Protocol Violation|6|||
148767085|NCT02887183|536620196|FG000|Overall Study|Technical Problems|2|||
148767086|NCT02887183|536620196|FG000|Overall Study|Lost to Follow-up|13|||
148767087|NCT02887183|536620196|FG000|Overall Study|Physician Decision|10|||
148767088|NCT02887183|536620196|FG000|Overall Study|Withdrawal by Subject|35|||
148767089|NCT01031680|536620197|FG000|Overall Study|Adverse Event|8|||
148767090|NCT01031680|536620198|FG001|Overall Study|Adverse Event|3|||
148767091|NCT01031680|536620197|FG000|Overall Study|Lost to Follow-up|2|||
148767092|NCT01031680|536620198|FG001|Overall Study|Lost to Follow-up|10|||
148767093|NCT01031680|536620197|FG000|Overall Study|Withdrawal by Subject|12|||
148767094|NCT01031680|536620198|FG001|Overall Study|Withdrawal by Subject|16|||
148767095|NCT01031680|536620197|FG000|Overall Study|Death|2|||
148767096|NCT01031680|536620198|FG001|Overall Study|Death|1|||
148767097|NCT01031680|536620197|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
148767098|NCT01031680|536620198|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
148767099|NCT01031680|536620197|FG000|Overall Study|Poor/Non-compliance|5|||
148767100|NCT01031680|536620198|FG001|Overall Study|Poor/Non-compliance|6|||
148767101|NCT01031680|536620197|FG000|Overall Study|Safety|1|||
148767102|NCT01031680|536620198|FG001|Overall Study|Safety|0|||
148767103|NCT01031680|536620197|FG000|Overall Study|Incorrect Enrolment|1|||
148767104|NCT01031680|536620198|FG001|Overall Study|Incorrect Enrolment|2|||
148767105|NCT01031680|536620197|FG000|Overall Study|Administrative Reason by Sponsor|0|||
148767106|NCT01031680|536620198|FG001|Overall Study|Administrative Reason by Sponsor|1|||
148767107|NCT01031680|536620197|FG000|Overall Study|Various|0|||
148767108|NCT01031680|536620198|FG001|Overall Study|Various|2|||
148767109|NCT01029782|536620201|FG000|Overall Study|Lost to Follow-up|2|||
148767110|NCT01029782|536620202|FG001|Overall Study|Lost to Follow-up|2|||
148767111|NCT01029782|536620201|FG000|Overall Study|Diagnosis changed|1|||
148767112|NCT01029782|536620202|FG001|Overall Study|Diagnosis changed|1|||
148767113|NCT01029782|536620201|FG000|Overall Study|Adverse Event|0|||
148767114|NCT01029782|536620202|FG001|Overall Study|Adverse Event|1|||
148767115|NCT01029782|536620201|FG000|Overall Study|Physician Decision|0|||
148767116|NCT01029782|536620202|FG001|Overall Study|Physician Decision|1|||
148767117|NCT01029782|536620201|FG000|Overall Study|Protocol Violation|0|||
148767118|NCT01029782|536620202|FG001|Overall Study|Protocol Violation|2|||
148767119|NCT01029782|536620201|FG000|Overall Study|Withdrawal by Subject|0|||
148767120|NCT01029782|536620202|FG001|Overall Study|Withdrawal by Subject|1|||
148767121|NCT02195869|536620206|FG000|Overall Study|cGVHD Progression|5|||
148767122|NCT02195869|536620206|FG000|Overall Study|Malignancy Progression/relapse|2|||
148767123|NCT02195869|536620206|FG000|Overall Study|Adverse Event|15|||
148767124|NCT02195869|536620206|FG000|Overall Study|Withdrawal by Subject|7|||
148767125|NCT02195869|536620206|FG000|Overall Study|Physician Decision|4|||
148767126|NCT02195869|536620206|FG000|Overall Study|Study Terminated by Sponsor|7|||
148767127|NCT02195869|536620206|FG000|Overall Study|Noncompliance with study drug|2|||
148767128|NCT00767455|536620207|FG000|Overall Study|Investigator error|19|||
148767129|NCT01921101|536620208|FG000|Overall Study|Death|16|||
148767130|NCT01921101|536620209|FG001|Overall Study|Death|6|||
148767131|NCT02729051|536620211|FG000|Overall Study|Adverse Event|21|||
148767132|NCT02729051|536620212|FG001|Overall Study|Adverse Event|11|||
148767133|NCT02729051|536620211|FG000|Overall Study|Lack of Efficacy|1|||
148767134|NCT02729051|536620212|FG001|Overall Study|Lack of Efficacy|1|||
148767135|NCT02729051|536620211|FG000|Overall Study|Lost to Follow-up|1|||
148767136|NCT02729051|536620212|FG001|Overall Study|Lost to Follow-up|2|||
148767137|NCT02729051|536620211|FG000|Overall Study|Physician Decision|1|||
148767138|NCT02729051|536620212|FG001|Overall Study|Physician Decision|1|||
148767139|NCT02729051|536620211|FG000|Overall Study|Withdrawal by Subject|6|||
148767140|NCT02729051|536620212|FG001|Overall Study|Withdrawal by Subject|17|||
148767141|NCT01806961|536621581|FG000|Overall Study|sponsor decision|16|||
148767142|NCT00679029|536621584|FG000|Overall Study|Adverse Event|3|||
148767143|NCT00679029|536621584|FG000|Overall Study|Withdrawal by Subject|1|||
148767144|NCT00679029|536621584|FG000|Overall Study|Lost to Follow-up|1|||
148767145|NCT00769067|536621588|FG000|Overall Study|Death|89|||
148767146|NCT00769067|536621589|FG001|Overall Study|Death|86|||
148767147|NCT00769067|536621588|FG000|Overall Study|Lost to Follow-up|3|||
148767148|NCT00769067|536621589|FG001|Overall Study|Lost to Follow-up|1|||
148767149|NCT00769067|536621588|FG000|Overall Study|Study terminated by sponsor|1|||
148767150|NCT00769067|536621589|FG001|Overall Study|Study terminated by sponsor|3|||
148767151|NCT00769067|536621588|FG000|Overall Study|Other|1|||
148767152|NCT00769067|536621589|FG001|Overall Study|Other|3|||
148767153|NCT00769067|536621588|FG000|Overall Study|Withdrawal by Subject|0|||
148767154|NCT00769067|536621589|FG001|Overall Study|Withdrawal by Subject|1|||
148767155|NCT04981470|536621592|FG000|Overall Study|Device failure in all 4 patients|4|||
148767156|NCT00078767|536621593|FG000|Overall Study|Withdrawal by Subject|1|||
148767157|NCT00078767|536621594|FG001|Overall Study|Withdrawal by Subject|1|||
148767158|NCT01868438|536621595|FG000|First Intervention|Withdrawal by Subject|5|||
148767159|NCT01868438|536621596|FG001|First Intervention|Withdrawal by Subject|1|||
148767160|NCT01868438|536621595|FG000|First Intervention|Lost to Follow-up|2|||
148767161|NCT01868438|536621596|FG001|First Intervention|Lost to Follow-up|3|||
148767162|NCT01868438|536621595|FG000|First Intervention|Meeting the non-redosing criteria|0|||
148767163|NCT01868438|536621596|FG001|First Intervention|Meeting the non-redosing criteria|1|||
148767164|NCT01868438|536621595|FG000|Second Intervention|Adverse Event|3|||
148767165|NCT01868438|536621596|FG001|Second Intervention|Adverse Event|3|||
148767166|NCT03233529|536621597|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
148767167|NCT03233529|536621597|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
148767168|NCT03260244|536621598|FG000|Overall Study|Death|19|||
148767169|NCT03260244|536621598|FG000|Overall Study|Lost to Follow-up|60|||
148767170|NCT03260244|536621598|FG000|Overall Study|Withdrawal by Subject|48|||
148767171|NCT03260244|536621598|FG000|Overall Study|Procedure Not Performed|21|||
148767172|NCT03260244|536621598|FG000|Overall Study|Enrollment Criteria Not Met|31|||
148767173|NCT03260244|536621598|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
148767174|NCT03260244|536621598|FG000|Overall Study|Subject Noncompliance|6|||
148767175|NCT03260244|536621598|FG000|Overall Study|No inducible Arrhythmia|2|||
148767176|NCT03260244|536621598|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
148767177|NCT03260244|536621598|FG000|Overall Study|Screen Failure|2|||
148767178|NCT03260244|536621598|FG000|Overall Study|Treated Off Label|69|||
148767179|NCT03260244|536621598|FG000|Overall Study|No Radiofrequency Ablation|14|||
148767180|NCT01177293|536621604|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
148767181|NCT01177293|536621605|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
148767182|NCT00594100|536621610|FG000|Procedure|Technical Failure|9|||
148767183|NCT00594100|536621610|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
148767184|NCT00594100|536621610|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
148767185|NCT00594100|536621610|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
148767186|NCT03528369|536621613|FG000|Overall Study|Withdrawal by Subject|2|||
148767187|NCT03528369|536621614|FG001|Overall Study|Withdrawal by Subject|0|||
148767188|NCT03528369|536621615|FG002|Overall Study|Withdrawal by Subject|0|||
148767189|NCT03528369|536621613|FG000|Overall Study|Lost to Follow-up|1|||
148767190|NCT03528369|536621614|FG001|Overall Study|Lost to Follow-up|0|||
148767191|NCT03528369|536621615|FG002|Overall Study|Lost to Follow-up|0|||
148767192|NCT03528369|536621613|FG000|Overall Study|Adverse Event|0|||
148767193|NCT03528369|536621614|FG001|Overall Study|Adverse Event|1|||
148767194|NCT03528369|536621615|FG002|Overall Study|Adverse Event|0|||
148767195|NCT00160706|536621616|FG000|Overall Study|Adverse Event|53|||
148767196|NCT00160706|536621616|FG000|Overall Study|Adverse Event and Other Reason|105|||
148767197|NCT00160706|536621616|FG000|Overall Study|Protocol Violation|3|||
148767198|NCT00160706|536621616|FG000|Overall Study|Withdrawal by Subject|41|||
148767199|NCT00160706|536621616|FG000|Overall Study|Withdrawal by Subject and Other|12|||
148767200|NCT00160706|536621616|FG000|Overall Study|Physician Decision|10|||
148767201|NCT00160706|536621616|FG000|Overall Study|Physician Decision and Other|3|||
148767202|NCT00160706|536621616|FG000|Overall Study|Lost to Follow-up|4|||
148767203|NCT00160706|536621616|FG000|Overall Study|Lost to Follow-up and Other|1|||
148767204|NCT00160706|536621616|FG000|Overall Study|Lack of Efficacy|42|||
148767205|NCT00160706|536621616|FG000|Overall Study|Lack of Efficacy and Other|1|||
148767206|NCT00160706|536621616|FG000|Overall Study|Other Reason|11|||
148767207|NCT02162719|536621617|FG000|Overall Study|Death|41|||
148767208|NCT02162719|536621618|FG001|Overall Study|Death|46|||
148767209|NCT02162719|536621617|FG000|Overall Study|Lost to Follow-up|1|||
148767210|NCT02162719|536621618|FG001|Overall Study|Lost to Follow-up|3|||
148767211|NCT02162719|536621617|FG000|Overall Study|Disease Progression|2|||
148767212|NCT02162719|536621618|FG001|Overall Study|Disease Progression|1|||
148767213|NCT02162719|536621617|FG000|Overall Study|Withdrawal by Subject|8|||
148767214|NCT02162719|536621618|FG001|Overall Study|Withdrawal by Subject|2|||
148767215|NCT02162719|536621617|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
148767216|NCT02162719|536621618|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
148767217|NCT03555565|536621619|FG000|Overall Study|Case Report Forms Uncollected|2|||
148767218|NCT03555565|536621619|FG000|Overall Study|Protocol Deviation|13|||
148767219|NCT00076752|536621625|FG000|Overall Study|Death|2|||
148767220|NCT00076752|536621625|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
148767221|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
148767222|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
148767223|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
148767224|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
148767225|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
148767226|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
148767227|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
148767228|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
148767229|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Death|0|||
148767230|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Death|1|||
148767231|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
148767232|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
148767233|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
148767234|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
148767235|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
148767236|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
148767237|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
148767238|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
148767239|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
148767240|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
148767241|NCT00394836|536621626|FG000|Teatment or Follow-up Phase|Non compliance|0|||
148767242|NCT00394836|536621627|FG001|Teatment or Follow-up Phase|Non compliance|1|||
148767243|NCT00394836|536621626|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
148767244|NCT00394836|536621627|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
148767245|NCT00394836|536621626|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
148767246|NCT00394836|536621627|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
148767247|NCT00394836|536621626|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
148767248|NCT00394836|536621627|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
148767249|NCT00394836|536621626|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
148767250|NCT00394836|536621627|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
148767251|NCT00748189|536621628|FG000|Overall Study|Death|99|||
148767252|NCT00748189|536621629|FG001|Overall Study|Death|84|||
148767253|NCT00748189|536621628|FG000|Overall Study|Withdrawal by Subject|23|||
148767254|NCT00748189|536621629|FG001|Overall Study|Withdrawal by Subject|29|||
148979266|NCT00456092|537404368|FG003|Treatment Phase (12 Weeks)|Other|0|||
148979267|NCT00456092|537404369|FG004|Treatment Phase (12 Weeks)|Other|0|||
148979268|NCT01565993|537404384|FG000|Overall Study|Physician Decision|0|||
148767255|NCT00748189|536621628|FG000|Overall Study|Physician Decision|16|||
148767256|NCT00748189|536621629|FG001|Overall Study|Physician Decision|5|||
148767257|NCT00748189|536621628|FG000|Overall Study|Lost to Follow-up|8|||
148767258|NCT00748189|536621629|FG001|Overall Study|Lost to Follow-up|15|||
148767259|NCT00748189|536621628|FG000|Overall Study|Study terminated by Sponsor|70|||
148767260|NCT00748189|536621629|FG001|Overall Study|Study terminated by Sponsor|79|||
148767261|NCT04696055|536621635|FG000|Overall Study|Adverse Event|10|||
148767262|NCT04696055|536621636|FG001|Overall Study|Adverse Event|2|||
148767263|NCT04696055|536621635|FG000|Overall Study|Death|4|||
148767264|NCT04696055|536621636|FG001|Overall Study|Death|0|||
148767265|NCT04696055|536621635|FG000|Overall Study|Other|7|||
148767266|NCT04696055|536621636|FG001|Overall Study|Other|2|||
148767267|NCT04696055|536621635|FG000|Overall Study|Physician Decision|3|||
148767268|NCT04696055|536621636|FG001|Overall Study|Physician Decision|0|||
148767269|NCT04696055|536621635|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
148979269|NCT01565993|537404385|FG001|Overall Study|Physician Decision|3|||
148979270|NCT04086472|537404386|FG000|Overall Study|Lost to Follow-up|1|||
148979271|NCT04086472|537404387|FG001|Overall Study|Lost to Follow-up|0|||
148767270|NCT04696055|536621636|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
148767271|NCT04696055|536621635|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
148767272|NCT04696055|536621636|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
148767273|NCT04696055|536621635|FG000|Overall Study|Subject Decision|1|||
148767274|NCT04696055|536621636|FG001|Overall Study|Subject Decision|2|||
148767275|NCT03969901|536621637|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148767276|NCT03969901|536621638|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148979272|NCT04086472|537404388|FG002|Overall Study|Lost to Follow-up|0|||
149027903|NCT00062868|537578690|FG007|Dose Level 3|Death|0|||
149027904|NCT00062868|537578691|FG008|Dose Level 3|Death|0|||
149027905|NCT00062868|537578692|FG009|Dose Level 3|Death|0|||
149027906|NCT00062868|537578693|FG010|Dose Level 3|Death|0|||
149027907|NCT00062868|537578694|FG011|Dose Level 3|Death|1|||
149027908|NCT00062868|537578695|FG012|Dose Level 3|Death|0|||
149027909|NCT00062868|537578696|FG013|Dose Level 3|Death|0|||
149027910|NCT00062868|537578697|FG014|Dose Level 3|Death|0|||
149027911|NCT00062868|537578698|FG015|Dose Level 3|Death|0|||
149027912|NCT00062868|537578699|FG016|Dose Level 3|Death|0|||
149027913|NCT00062868|537578700|FG017|Dose Level 3|Death|1|||
149027914|NCT00062868|537578701|FG018|Dose Level 3|Death|0|||
149027915|NCT00062868|537578702|FG019|Dose Level 3|Death|0|||
149027916|NCT00062868|537578703|FG020|Dose Level 3|Death|0|||
149027917|NCT00062868|537578683|FG000|Dose Level 3|Lost to Follow-up|0|||
149027918|NCT00062868|537578684|FG001|Dose Level 3|Lost to Follow-up|0|||
149027919|NCT00062868|537578685|FG002|Dose Level 3|Lost to Follow-up|0|||
148979273|NCT04086472|537404389|FG003|Overall Study|Lost to Follow-up|0|||
148979274|NCT04086472|537404390|FG004|Overall Study|Lost to Follow-up|1|||
148979275|NCT04086472|537404386|FG000|Overall Study|Physician Decision|0|||
148979276|NCT04086472|537404387|FG001|Overall Study|Physician Decision|1|||
148979277|NCT04086472|537404388|FG002|Overall Study|Physician Decision|1|||
148979278|NCT04086472|537404389|FG003|Overall Study|Physician Decision|0|||
148979279|NCT04086472|537404390|FG004|Overall Study|Physician Decision|0|||
148979280|NCT04086472|537404386|FG000|Overall Study|Withdrawal by Subject|1|||
148979281|NCT04086472|537404387|FG001|Overall Study|Withdrawal by Subject|1|||
148979282|NCT04086472|537404388|FG002|Overall Study|Withdrawal by Subject|1|||
148979283|NCT04086472|537404389|FG003|Overall Study|Withdrawal by Subject|0|||
148979284|NCT04086472|537404390|FG004|Overall Study|Withdrawal by Subject|0|||
148979285|NCT04086472|537404386|FG000|Overall Study|Various reasons|2|||
148979286|NCT04086472|537404387|FG001|Overall Study|Various reasons|0|||
148979287|NCT04086472|537404388|FG002|Overall Study|Various reasons|0|||
148979288|NCT04086472|537404389|FG003|Overall Study|Various reasons|3|||
148979289|NCT04086472|537404390|FG004|Overall Study|Various reasons|1|||
148979290|NCT02252081|537404391|FG000|Overall Study|Withdrawal by Subject|2|||
148979291|NCT02252081|537404392|FG001|Overall Study|Withdrawal by Subject|1|||
148979292|NCT02252081|537404391|FG000|Overall Study|Adverse Event|4|||
148767277|NCT03969901|536621639|FG002|Overall Study|Withdrawal by parent/guardian|0|||
148767278|NCT03969901|536621640|FG003|Overall Study|Withdrawal by parent/guardian|0|||
148767279|NCT03969901|536621641|FG004|Overall Study|Withdrawal by parent/guardian|1|||
148767280|NCT03969901|536621642|FG005|Overall Study|Withdrawal by parent/guardian|0|||
148767281|NCT03969901|536621643|FG006|Overall Study|Withdrawal by parent/guardian|0|||
148767282|NCT03969901|536621644|FG007|Overall Study|Withdrawal by parent/guardian|1|||
148767283|NCT03969901|536621645|FG008|Overall Study|Withdrawal by parent/guardian|1|||
148767284|NCT03969901|536621646|FG009|Overall Study|Withdrawal by parent/guardian|0|||
148767285|NCT04411810|536621647|FG000|Overall Study|Screen failure|1|||
148767286|NCT04411810|536621647|FG000|Overall Study|Withdrawal by Subject|1|||
148767287|NCT01920958|536621648|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
148767288|NCT00610155|536621649|FG000|Period 1|Withdrawal by Subject|0|||
148767289|NCT00610155|536621650|FG001|Period 1|Withdrawal by Subject|0|||
148979293|NCT02252081|537404392|FG001|Overall Study|Adverse Event|1|||
148979294|NCT02252081|537404391|FG000|Overall Study|non compliance & others|0|||
148979295|NCT02252081|537404392|FG001|Overall Study|non compliance & others|2|||
148979296|NCT00048724|537404398|FG000|Overall Study|Adverse Event|53|||
148979297|NCT00048724|537404399|FG001|Overall Study|Adverse Event|12|||
148979298|NCT00048724|537404398|FG000|Overall Study|Withdrawal by Subject|34|||
148979299|NCT00048724|537404399|FG001|Overall Study|Withdrawal by Subject|54|||
148979300|NCT00048724|537404398|FG000|Overall Study|Lost to Follow-up|5|||
148979301|NCT00048724|537404399|FG001|Overall Study|Lost to Follow-up|5|||
149027920|NCT00062868|537578686|FG003|Dose Level 3|Lost to Follow-up|0|||
149027921|NCT00062868|537578687|FG004|Dose Level 3|Lost to Follow-up|0|||
149027922|NCT00062868|537578688|FG005|Dose Level 3|Lost to Follow-up|0|||
148979302|NCT00048724|537404398|FG000|Overall Study|Protocol-defined Clinical Event|17|||
148767290|NCT00610155|536621651|FG002|Period 1|Withdrawal by Subject|1|||
148767291|NCT00610155|536621652|FG003|Period 1|Withdrawal by Subject|0|||
148767292|NCT00610155|536621653|FG004|Period 1|Withdrawal by Subject|0|||
148767293|NCT00610155|536621654|FG005|Period 1|Withdrawal by Subject|0|||
148979303|NCT00048724|537404399|FG001|Overall Study|Protocol-defined Clinical Event|32|||
148979304|NCT00048724|537404398|FG000|Overall Study|Noncompliance With Protocol|4|||
148979305|NCT00048724|537404399|FG001|Overall Study|Noncompliance With Protocol|12|||
148979306|NCT00048724|537404398|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
148979307|NCT00048724|537404399|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
148979308|NCT00048724|537404398|FG000|Overall Study|Administrative|1|||
149027923|NCT00062868|537578689|FG006|Dose Level 3|Lost to Follow-up|0|||
149027924|NCT00062868|537578690|FG007|Dose Level 3|Lost to Follow-up|0|||
149027925|NCT00062868|537578691|FG008|Dose Level 3|Lost to Follow-up|0|||
149027926|NCT00062868|537578692|FG009|Dose Level 3|Lost to Follow-up|0|||
149027927|NCT00062868|537578693|FG010|Dose Level 3|Lost to Follow-up|0|||
149027928|NCT00062868|537578694|FG011|Dose Level 3|Lost to Follow-up|0|||
148979309|NCT00048724|537404399|FG001|Overall Study|Administrative|1|||
148979310|NCT04574362|537404400|FG000|Overall Study|Other|0|||
148979311|NCT04574362|537404401|FG001|Overall Study|Other|5|||
148979312|NCT04574362|537404400|FG000|Overall Study|COVID-19|0|||
148979313|NCT04574362|537404401|FG001|Overall Study|COVID-19|1|||
148979314|NCT04574362|537404400|FG000|Overall Study|Adverse Event|1|||
148767294|NCT00610155|536621649|FG000|Period 3|Adverse Event|1|||
148767295|NCT00610155|536621650|FG001|Period 3|Adverse Event|0|||
148767296|NCT00610155|536621651|FG002|Period 3|Adverse Event|0|||
148767297|NCT00610155|536621652|FG003|Period 3|Adverse Event|0|||
148767298|NCT00610155|536621653|FG004|Period 3|Adverse Event|0|||
148767299|NCT00610155|536621654|FG005|Period 3|Adverse Event|0|||
148767300|NCT02028767|536621657|FG000|Treatment Period 2|Non compliant with protocol|1|||
148767301|NCT02028767|536621658|FG001|Treatment Period 2|Non compliant with protocol|0|||
148767302|NCT02028767|536621657|FG000|Treatment Period 2|Reason other than those specified above|1|||
148767303|NCT02028767|536621658|FG001|Treatment Period 2|Reason other than those specified above|0|||
148767304|NCT01284348|536621659|FG000|Overall Study|Death|1|||
148767305|NCT01284348|536621660|FG001|Overall Study|Death|1|||
148767306|NCT01284348|536621659|FG000|Overall Study|Withdrew consent|0|||
148767307|NCT01284348|536621660|FG001|Overall Study|Withdrew consent|1|||
148767308|NCT01284348|536621659|FG000|Overall Study|Status not recorded|9|||
148767309|NCT01284348|536621660|FG001|Overall Study|Status not recorded|10|||
148767310|NCT03192306|536621665|FG000|Overall Study|Did not treat cold sore during study|149|||
148767311|NCT03192306|536621666|FG001|Overall Study|Did not treat cold sore during study|143|||
148767312|NCT03192306|536621665|FG000|Overall Study|Withdrawal by Subject|1|||
148767313|NCT03192306|536621666|FG001|Overall Study|Withdrawal by Subject|1|||
148767314|NCT03192306|536621665|FG000|Overall Study|Lost to Follow-up|1|||
148767315|NCT03192306|536621666|FG001|Overall Study|Lost to Follow-up|0|||
148767316|NCT03192306|536621665|FG000|Overall Study|Protocol Violation|1|||
148767317|NCT03192306|536621666|FG001|Overall Study|Protocol Violation|1|||
148767318|NCT02429778|536621671|FG000|Overall Study|Lost to Follow-up|2|||
148767319|NCT02429778|536621672|FG001|Overall Study|Lost to Follow-up|0|||
148767320|NCT02429778|536621671|FG000|Overall Study|Withdrawal by Subject|5|||
148767321|NCT02429778|536621672|FG001|Overall Study|Withdrawal by Subject|0|||
148767322|NCT02751450|536621673|FG000|Overall Study|Adverse Event|1|||
148767323|NCT02751450|536621674|FG001|Overall Study|Adverse Event|0|||
148767324|NCT01598090|536621675|FG000|Treatment Period|Poor/non-compliance|0|||
148767325|NCT01598090|536621676|FG001|Treatment Period|Poor/non-compliance|2|||
148767326|NCT01598090|536621677|FG002|Treatment Period|Poor/non-compliance|0|||
148767327|NCT01598090|536621675|FG000|Treatment Period|No longer meet study criteria|0|||
148767328|NCT01598090|536621676|FG001|Treatment Period|No longer meet study criteria|1|||
148767329|NCT01598090|536621677|FG002|Treatment Period|No longer meet study criteria|0|||
148767330|NCT01598090|536621675|FG000|Treatment Period|Lack of Efficacy|5|||
148767331|NCT01598090|536621676|FG001|Treatment Period|Lack of Efficacy|14|||
148767332|NCT01598090|536621677|FG002|Treatment Period|Lack of Efficacy|6|||
148767333|NCT01598090|536621675|FG000|Treatment Period|Adverse Event|2|||
148767334|NCT01598090|536621676|FG001|Treatment Period|Adverse Event|33|||
148767335|NCT01598090|536621677|FG002|Treatment Period|Adverse Event|17|||
148767336|NCT01598090|536621675|FG000|Treatment Period|Other reasons|0|||
148767337|NCT01598090|536621676|FG001|Treatment Period|Other reasons|4|||
148767338|NCT01598090|536621677|FG002|Treatment Period|Other reasons|1|||
148767339|NCT01598090|536621675|FG000|Treatment Period|Withdrawal by Subject|3|||
148767340|NCT01598090|536621676|FG001|Treatment Period|Withdrawal by Subject|13|||
148767341|NCT01598090|536621677|FG002|Treatment Period|Withdrawal by Subject|10|||
148767342|NCT01598090|536621675|FG000|Treatment Period|Lost to Follow-up|1|||
148767343|NCT01598090|536621676|FG001|Treatment Period|Lost to Follow-up|5|||
148767344|NCT01598090|536621677|FG002|Treatment Period|Lost to Follow-up|1|||
148767345|NCT01598090|536621675|FG000|Follow-up Period|Death|0|||
148979315|NCT04574362|537404401|FG001|Overall Study|Adverse Event|1|||
148979316|NCT04574362|537404400|FG000|Overall Study|Withdrawal by Subject|2|||
148767346|NCT01598090|536621676|FG001|Follow-up Period|Death|1|||
148767347|NCT01598090|536621677|FG002|Follow-up Period|Death|0|||
148767348|NCT01598090|536621675|FG000|Follow-up Period|No longer required per protocol|1|||
148767349|NCT01598090|536621676|FG001|Follow-up Period|No longer required per protocol|3|||
148767350|NCT01598090|536621677|FG002|Follow-up Period|No longer required per protocol|2|||
148767351|NCT01598090|536621675|FG000|Follow-up Period|Not reported|0|||
148767352|NCT01598090|536621676|FG001|Follow-up Period|Not reported|10|||
148767353|NCT01598090|536621677|FG002|Follow-up Period|Not reported|4|||
148767354|NCT01598090|536621675|FG000|Follow-up Period|Withdrawal by Subject|0|||
148767355|NCT01598090|536621676|FG001|Follow-up Period|Withdrawal by Subject|3|||
148767356|NCT01598090|536621677|FG002|Follow-up Period|Withdrawal by Subject|2|||
148767357|NCT01598090|536621675|FG000|Follow-up Period|Other reasons|2|||
148979317|NCT04574362|537404401|FG001|Overall Study|Withdrawal by Subject|4|||
148979318|NCT04574362|537404400|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
148767358|NCT01598090|536621676|FG001|Follow-up Period|Other reasons|8|||
148767359|NCT01598090|536621677|FG002|Follow-up Period|Other reasons|8|||
148767360|NCT01598090|536621675|FG000|Follow-up Period|Lost to Follow-up|2|||
148767361|NCT01598090|536621676|FG001|Follow-up Period|Lost to Follow-up|10|||
148979319|NCT04574362|537404401|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
148979320|NCT04574362|537404400|FG000|Overall Study|Participant refused to come to the hospital|1|||
148979321|NCT04574362|537404401|FG001|Overall Study|Participant refused to come to the hospital|0|||
148979322|NCT04574362|537404400|FG000|Overall Study|Participant refused the visit|1|||
148979323|NCT04574362|537404401|FG001|Overall Study|Participant refused the visit|0|||
148979324|NCT04574362|537404400|FG000|Overall Study|Participant quit early because of business trip|1|||
148979325|NCT04574362|537404401|FG001|Overall Study|Participant quit early because of business trip|0|||
148979326|NCT01600040|537404403|FG000|Overall Study|Withdrawal by Subject|1|||
148979327|NCT00642304|537404404|FG000|Overall Study|Adverse Event|1|||
148979328|NCT00642304|537404404|FG000|Overall Study|Death|1|||
148979329|NCT00642304|537404404|FG000|Overall Study|Blood transfusion|2|||
148979330|NCT00642304|537404404|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
148979331|NCT00642304|537404404|FG000|Overall Study|Transplantation|1|||
148979332|NCT01490060|537404408|FG000|Cycle 1|Change of Treatment|0|||
148979333|NCT01490060|537404409|FG001|Cycle 1|Change of Treatment|1|||
148979334|NCT01490060|537404410|FG002|Cycle 1|Change of Treatment|1|||
148979335|NCT01490060|537404411|FG003|Cycle 1|Change of Treatment|1|||
148979336|NCT01490060|537404408|FG000|Cycle 1|Insurance Denied|0|||
148979337|NCT01490060|537404409|FG001|Cycle 1|Insurance Denied|0|||
148979338|NCT01490060|537404410|FG002|Cycle 1|Insurance Denied|2|||
148979339|NCT01490060|537404411|FG003|Cycle 1|Insurance Denied|0|||
148767362|NCT01598090|536621677|FG002|Follow-up Period|Lost to Follow-up|12|||
148767363|NCT01377922|536621680|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
148767364|NCT01377922|536621681|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
148979340|NCT01490060|537404408|FG000|Cycle 1|Withdrawal by Subject|0|||
148767365|NCT04615403|536621683|FG000|Overall Study|Death|1|||
148767366|NCT01074268|536621694|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
148767367|NCT01074268|536621695|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
148767368|NCT01074268|536621694|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
148767369|NCT01074268|536621695|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
148767370|NCT01074268|536621694|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
148767371|NCT01074268|536621695|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
148767372|NCT01074268|536621694|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
148767373|NCT01074268|536621695|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
148767374|NCT01074268|536621694|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
148767375|NCT01074268|536621695|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
148767376|NCT01074268|536621694|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
148767377|NCT01074268|536621695|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
148767378|NCT01074268|536621694|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
148767379|NCT01074268|536621695|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
148767380|NCT01074268|536621694|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
148767381|NCT01074268|536621695|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
148767382|NCT01074268|536621694|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
148767383|NCT01074268|536621695|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
148767384|NCT00733421|536621696|FG000|Overall Study|Withdrawal by Subject|1|||
148767385|NCT00733421|536621697|FG001|Overall Study|Withdrawal by Subject|1|||
148767386|NCT00789698|536621702|FG000|Overall Study|Lack of Efficacy|10|||
148767387|NCT00789698|536621703|FG001|Overall Study|Lack of Efficacy|4|||
148767388|NCT00789698|536621704|FG002|Overall Study|Lack of Efficacy|5|||
148767389|NCT00789698|536621705|FG003|Overall Study|Lack of Efficacy|18|||
148767390|NCT00789698|536621702|FG000|Overall Study|Adverse Event|5|||
148767391|NCT00789698|536621703|FG001|Overall Study|Adverse Event|5|||
148767392|NCT00789698|536621704|FG002|Overall Study|Adverse Event|3|||
148767393|NCT00789698|536621705|FG003|Overall Study|Adverse Event|4|||
148767394|NCT00789698|536621702|FG000|Overall Study|Lost to Follow-up|5|||
148767395|NCT00789698|536621703|FG001|Overall Study|Lost to Follow-up|5|||
148767396|NCT00789698|536621704|FG002|Overall Study|Lost to Follow-up|2|||
148767397|NCT00789698|536621705|FG003|Overall Study|Lost to Follow-up|9|||
148767398|NCT00789698|536621702|FG000|Overall Study|Protocol Violation|6|||
148767399|NCT00789698|536621703|FG001|Overall Study|Protocol Violation|1|||
148767400|NCT00789698|536621704|FG002|Overall Study|Protocol Violation|2|||
148767401|NCT00789698|536621705|FG003|Overall Study|Protocol Violation|1|||
148767402|NCT00789698|536621702|FG000|Overall Study|Withdrawal by Subject|14|||
148767403|NCT00789698|536621703|FG001|Overall Study|Withdrawal by Subject|15|||
148767404|NCT00789698|536621704|FG002|Overall Study|Withdrawal by Subject|12|||
148767405|NCT00789698|536621705|FG003|Overall Study|Withdrawal by Subject|19|||
148767406|NCT00789698|536621702|FG000|Overall Study|Administrative|0|||
148767407|NCT00789698|536621703|FG001|Overall Study|Administrative|3|||
148767408|NCT00789698|536621704|FG002|Overall Study|Administrative|3|||
148767409|NCT00789698|536621705|FG003|Overall Study|Administrative|1|||
148767410|NCT01870973|536621706|FG000|Overall Study|Lost to Follow-up|10|||
148767411|NCT01870973|536621707|FG001|Overall Study|Lost to Follow-up|3|||
148767412|NCT02702388|536621710|FG000|Overall Study|Disease Progression|18|||
148767413|NCT02702388|536621711|FG001|Overall Study|Disease Progression|25|||
148767414|NCT02702388|536621710|FG000|Overall Study|Withdrawal by Subject|9|||
148767415|NCT02702388|536621711|FG001|Overall Study|Withdrawal by Subject|7|||
148767416|NCT02702388|536621710|FG000|Overall Study|Adverse Event|11|||
148767417|NCT02702388|536621711|FG001|Overall Study|Adverse Event|15|||
148767418|NCT02702388|536621710|FG000|Overall Study|Other|2|||
148767419|NCT02702388|536621711|FG001|Overall Study|Other|4|||
148767420|NCT00596817|536621712|FG000|Open-label Period|Adverse Event|0|||
148767421|NCT00596817|536621713|FG001|Open-label Period|Adverse Event|49|||
148767422|NCT00596817|536621712|FG000|Open-label Period|Lack of Efficacy|0|||
148767423|NCT00596817|536621713|FG001|Open-label Period|Lack of Efficacy|33|||
148767424|NCT00596817|536621712|FG000|Open-label Period|Other Reasons|0|||
148767425|NCT00596817|536621713|FG001|Open-label Period|Other Reasons|65|||
148767426|NCT00596817|536621712|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
148767427|NCT00596817|536621713|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
148767428|NCT00596817|536621712|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
148767429|NCT00596817|536621713|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
148767430|NCT00596817|536621712|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
148767431|NCT00596817|536621713|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
148767432|NCT00596817|536621712|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
148767433|NCT00596817|536621713|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
148767434|NCT00596817|536621712|FG000|Double-blind Period|Adverse Event|5|||
148767435|NCT00596817|536621713|FG001|Double-blind Period|Adverse Event|16|||
148767436|NCT00596817|536621712|FG000|Double-blind Period|Lack of Efficacy|52|||
148767437|NCT00596817|536621713|FG001|Double-blind Period|Lack of Efficacy|28|||
148767438|NCT00596817|536621712|FG000|Double-blind Period|Non-compliance With Study Product|3|||
148767439|NCT00596817|536621713|FG001|Double-blind Period|Non-compliance With Study Product|4|||
148767440|NCT00596817|536621712|FG000|Double-blind Period|Protocol Violation|11|||
148767441|NCT00596817|536621713|FG001|Double-blind Period|Protocol Violation|8|||
148767442|NCT00596817|536621712|FG000|Double-blind Period|Withdrawal of Consent|7|||
148767443|NCT00596817|536621713|FG001|Double-blind Period|Withdrawal of Consent|3|||
148767444|NCT00596817|536621712|FG000|Double-blind Period|Lost to Follow-up|0|||
148767445|NCT00596817|536621713|FG001|Double-blind Period|Lost to Follow-up|2|||
148767446|NCT00596817|536621712|FG000|Double-blind Period|Other Reasons|10|||
148767447|NCT00596817|536621713|FG001|Double-blind Period|Other Reasons|18|||
148767448|NCT03225105|536621720|FG000|Overall Study|Withdrawal by Subject|1|||
148767449|NCT03225105|536621721|FG001|Overall Study|Withdrawal by Subject|0|||
148767450|NCT03225105|536621722|FG002|Overall Study|Withdrawal by Subject|0|||
148767451|NCT03225105|536621723|FG003|Overall Study|Withdrawal by Subject|0|||
148767452|NCT03225105|536621720|FG000|Overall Study|Death|0|||
148767453|NCT03225105|536621721|FG001|Overall Study|Death|4|||
148767454|NCT03225105|536621722|FG002|Overall Study|Death|2|||
148767455|NCT03225105|536621723|FG003|Overall Study|Death|0|||
148767456|NCT03225105|536621720|FG000|Overall Study|Study termination per Sponsor Decision|2|||
148767457|NCT03225105|536621721|FG001|Overall Study|Study termination per Sponsor Decision|0|||
148767458|NCT03225105|536621722|FG002|Overall Study|Study termination per Sponsor Decision|3|||
148767459|NCT03225105|536621723|FG003|Overall Study|Study termination per Sponsor Decision|3|||
148767460|NCT00083759|536623437|FG000|Overall Study|Adverse Event|5|||
148767461|NCT00083759|536623438|FG001|Overall Study|Adverse Event|3|||
148767462|NCT00083759|536623437|FG000|Overall Study|Lost to Follow-up|1|||
148767463|NCT00083759|536623438|FG001|Overall Study|Lost to Follow-up|0|||
148767464|NCT00083759|536623437|FG000|Overall Study|Death|1|||
148767465|NCT00083759|536623438|FG001|Overall Study|Death|1|||
148767466|NCT00083759|536623437|FG000|Overall Study|Inadequate Therapeutic Response|32|||
148767467|NCT00083759|536623438|FG001|Overall Study|Inadequate Therapeutic Response|35|||
148767468|NCT00083759|536623437|FG000|Overall Study|Subject Withdrew Consent|2|||
148767469|NCT00083759|536623438|FG001|Overall Study|Subject Withdrew Consent|2|||
148767470|NCT00083759|536623437|FG000|Overall Study|Non-Compliance|1|||
148767471|NCT00083759|536623438|FG001|Overall Study|Non-Compliance|0|||
148767472|NCT00083759|536623437|FG000|Overall Study|Sponsor's Discretion|28|||
148767473|NCT00083759|536623438|FG001|Overall Study|Sponsor's Discretion|29|||
148767474|NCT00083759|536623437|FG000|Overall Study|Other|14|||
148767475|NCT00083759|536623438|FG001|Overall Study|Other|13|||
148979341|NCT01490060|537404409|FG001|Cycle 1|Withdrawal by Subject|0|||
148979342|NCT01490060|537404410|FG002|Cycle 1|Withdrawal by Subject|0|||
148979343|NCT01490060|537404411|FG003|Cycle 1|Withdrawal by Subject|1|||
148979344|NCT01490060|537404408|FG000|Cycle 1|Treatment at Another Facility|0|||
148767476|NCT02589626|536623441|FG000|Overall Study|Other than the reason specified|1|||
148767477|NCT02589626|536623442|FG001|Overall Study|Other than the reason specified|0|||
148767478|NCT02589626|536623441|FG000|Overall Study|Withdrawal by Subject|1|||
148767479|NCT02589626|536623442|FG001|Overall Study|Withdrawal by Subject|1|||
148767480|NCT02589626|536623441|FG000|Overall Study|Adverse Event|1|||
148767481|NCT02589626|536623442|FG001|Overall Study|Adverse Event|1|||
148767482|NCT03645395|536623443|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
148767483|NCT03645395|536623444|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
148767484|NCT03645395|536623445|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
148979345|NCT01490060|537404409|FG001|Cycle 1|Treatment at Another Facility|0|||
148979346|NCT01490060|537404410|FG002|Cycle 1|Treatment at Another Facility|0|||
148979347|NCT01490060|537404411|FG003|Cycle 1|Treatment at Another Facility|1|||
148979348|NCT01490060|537404408|FG000|Cycle 2|Change of Treatment|1|||
148767485|NCT03645395|536623446|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
148767486|NCT03645395|536623443|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
148767487|NCT03645395|536623444|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
148767488|NCT03645395|536623445|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
148767489|NCT03645395|536623446|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
148767490|NCT03645395|536623443|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
148767491|NCT03645395|536623444|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
148767492|NCT03645395|536623445|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
148767493|NCT03645395|536623446|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
148767494|NCT03645395|536623443|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
148767495|NCT03645395|536623444|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
148767496|NCT03645395|536623445|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
148767497|NCT03645395|536623446|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
148767498|NCT02564900|536623447|FG000|Dose Escalation|Progressive disease per RECIST|2|||
148767499|NCT02564900|536623448|FG001|Dose Escalation|Progressive disease per RECIST|3|||
148767500|NCT02564900|536623449|FG002|Dose Escalation|Progressive disease per RECIST|3|||
148767501|NCT02564900|536623450|FG003|Dose Escalation|Progressive disease per RECIST|3|||
148767502|NCT02564900|536623451|FG004|Dose Escalation|Progressive disease per RECIST|3|||
148767503|NCT02564900|536623452|FG005|Dose Escalation|Progressive disease per RECIST|1|||
148767504|NCT02564900|536623453|FG006|Dose Escalation|Progressive disease per RECIST|0|||
148767505|NCT02564900|536623454|FG007|Dose Escalation|Progressive disease per RECIST|0|||
148767506|NCT02564900|536623455|FG008|Dose Escalation|Progressive disease per RECIST|0|||
148767507|NCT02564900|536623456|FG009|Dose Escalation|Progressive disease per RECIST|0|||
148767508|NCT02564900|536623457|FG010|Dose Escalation|Progressive disease per RECIST|0|||
148767509|NCT02564900|536623458|FG011|Dose Escalation|Progressive disease per RECIST|0|||
148767510|NCT02564900|536623459|FG012|Dose Escalation|Progressive disease per RECIST|0|||
148767511|NCT02564900|536623460|FG013|Dose Escalation|Progressive disease per RECIST|0|||
148767512|NCT02564900|536623461|FG014|Dose Escalation|Progressive disease per RECIST|0|||
148767513|NCT02564900|536623447|FG000|Dose Escalation|Ongoing|1|||
148767514|NCT02564900|536623448|FG001|Dose Escalation|Ongoing|0|||
148767515|NCT02564900|536623449|FG002|Dose Escalation|Ongoing|0|||
148767516|NCT02564900|536623450|FG003|Dose Escalation|Ongoing|2|||
148767517|NCT02564900|536623451|FG004|Dose Escalation|Ongoing|2|||
148767518|NCT02564900|536623452|FG005|Dose Escalation|Ongoing|2|||
148767519|NCT02564900|536623453|FG006|Dose Escalation|Ongoing|0|||
148767520|NCT02564900|536623454|FG007|Dose Escalation|Ongoing|0|||
148767521|NCT02564900|536623455|FG008|Dose Escalation|Ongoing|0|||
148767522|NCT02564900|536623456|FG009|Dose Escalation|Ongoing|0|||
148767523|NCT02564900|536623457|FG010|Dose Escalation|Ongoing|0|||
148767524|NCT02564900|536623458|FG011|Dose Escalation|Ongoing|0|||
148767525|NCT02564900|536623459|FG012|Dose Escalation|Ongoing|0|||
148767526|NCT02564900|536623460|FG013|Dose Escalation|Ongoing|0|||
148767527|NCT02564900|536623461|FG014|Dose Escalation|Ongoing|0|||
148767528|NCT02564900|536623447|FG000|Dose Escalation|Adverse Event|0|||
148767529|NCT02564900|536623448|FG001|Dose Escalation|Adverse Event|0|||
148767530|NCT02564900|536623449|FG002|Dose Escalation|Adverse Event|0|||
148767531|NCT02564900|536623450|FG003|Dose Escalation|Adverse Event|1|||
148767532|NCT02564900|536623451|FG004|Dose Escalation|Adverse Event|1|||
148767533|NCT02564900|536623452|FG005|Dose Escalation|Adverse Event|3|||
148767534|NCT02564900|536623453|FG006|Dose Escalation|Adverse Event|0|||
148767535|NCT02564900|536623454|FG007|Dose Escalation|Adverse Event|0|||
148767536|NCT02564900|536623455|FG008|Dose Escalation|Adverse Event|0|||
148767537|NCT02564900|536623456|FG009|Dose Escalation|Adverse Event|0|||
148767538|NCT02564900|536623457|FG010|Dose Escalation|Adverse Event|0|||
148767539|NCT02564900|536623458|FG011|Dose Escalation|Adverse Event|0|||
148767540|NCT02564900|536623459|FG012|Dose Escalation|Adverse Event|0|||
148767541|NCT02564900|536623460|FG013|Dose Escalation|Adverse Event|0|||
148767542|NCT02564900|536623461|FG014|Dose Escalation|Adverse Event|0|||
148767543|NCT02564900|536623447|FG000|Dose Expansion|Progressive disease per RECIST|0|||
148767544|NCT02564900|536623448|FG001|Dose Expansion|Progressive disease per RECIST|0|||
148767545|NCT02564900|536623449|FG002|Dose Expansion|Progressive disease per RECIST|0|||
148767546|NCT02564900|536623450|FG003|Dose Expansion|Progressive disease per RECIST|0|||
148767547|NCT02564900|536623451|FG004|Dose Expansion|Progressive disease per RECIST|0|||
148767548|NCT02564900|536623452|FG005|Dose Expansion|Progressive disease per RECIST|0|||
148767549|NCT02564900|536623453|FG006|Dose Expansion|Progressive disease per RECIST|19|||
148979349|NCT01490060|537404409|FG001|Cycle 2|Change of Treatment|1|||
148767550|NCT02564900|536623454|FG007|Dose Expansion|Progressive disease per RECIST|17|||
148767551|NCT02564900|536623455|FG008|Dose Expansion|Progressive disease per RECIST|8|||
148767552|NCT02564900|536623456|FG009|Dose Expansion|Progressive disease per RECIST|16|||
148767553|NCT02564900|536623457|FG010|Dose Expansion|Progressive disease per RECIST|13|||
148767554|NCT02564900|536623458|FG011|Dose Expansion|Progressive disease per RECIST|19|||
148767555|NCT02564900|536623459|FG012|Dose Expansion|Progressive disease per RECIST|10|||
148767556|NCT02564900|536623460|FG013|Dose Expansion|Progressive disease per RECIST|13|||
148767557|NCT02564900|536623461|FG014|Dose Expansion|Progressive disease per RECIST|11|||
148767558|NCT02564900|536623447|FG000|Dose Expansion|Clinical progression|0|||
148767559|NCT02564900|536623448|FG001|Dose Expansion|Clinical progression|0|||
148767560|NCT02564900|536623449|FG002|Dose Expansion|Clinical progression|0|||
148767561|NCT02564900|536623450|FG003|Dose Expansion|Clinical progression|0|||
148767562|NCT02564900|536623451|FG004|Dose Expansion|Clinical progression|0|||
148767563|NCT02564900|536623452|FG005|Dose Expansion|Clinical progression|0|||
148767564|NCT02564900|536623453|FG006|Dose Expansion|Clinical progression|5|||
148767565|NCT02564900|536623454|FG007|Dose Expansion|Clinical progression|12|||
148767566|NCT02564900|536623455|FG008|Dose Expansion|Clinical progression|0|||
148767567|NCT02564900|536623456|FG009|Dose Expansion|Clinical progression|3|||
148767568|NCT02564900|536623457|FG010|Dose Expansion|Clinical progression|2|||
148767569|NCT02564900|536623458|FG011|Dose Expansion|Clinical progression|0|||
148767570|NCT02564900|536623459|FG012|Dose Expansion|Clinical progression|1|||
148767571|NCT02564900|536623460|FG013|Dose Expansion|Clinical progression|3|||
148767572|NCT02564900|536623461|FG014|Dose Expansion|Clinical progression|1|||
148767573|NCT02564900|536623447|FG000|Dose Expansion|Adverse Event|0|||
148767574|NCT02564900|536623448|FG001|Dose Expansion|Adverse Event|0|||
148767575|NCT02564900|536623449|FG002|Dose Expansion|Adverse Event|0|||
148767576|NCT02564900|536623450|FG003|Dose Expansion|Adverse Event|0|||
148767577|NCT02564900|536623451|FG004|Dose Expansion|Adverse Event|0|||
148767578|NCT02564900|536623452|FG005|Dose Expansion|Adverse Event|0|||
148767579|NCT02564900|536623453|FG006|Dose Expansion|Adverse Event|9|||
148767580|NCT02564900|536623454|FG007|Dose Expansion|Adverse Event|22|||
148767581|NCT02564900|536623455|FG008|Dose Expansion|Adverse Event|0|||
148767582|NCT02564900|536623456|FG009|Dose Expansion|Adverse Event|11|||
148767583|NCT02564900|536623457|FG010|Dose Expansion|Adverse Event|0|||
148767584|NCT02564900|536623458|FG011|Dose Expansion|Adverse Event|5|||
148767585|NCT02564900|536623459|FG012|Dose Expansion|Adverse Event|2|||
148767586|NCT02564900|536623460|FG013|Dose Expansion|Adverse Event|2|||
148767587|NCT02564900|536623461|FG014|Dose Expansion|Adverse Event|1|||
148767588|NCT02564900|536623447|FG000|Dose Expansion|Ongoing|0|||
148767589|NCT02564900|536623448|FG001|Dose Expansion|Ongoing|0|||
148767590|NCT02564900|536623449|FG002|Dose Expansion|Ongoing|0|||
148767591|NCT02564900|536623450|FG003|Dose Expansion|Ongoing|0|||
148767592|NCT02564900|536623451|FG004|Dose Expansion|Ongoing|0|||
148767593|NCT02564900|536623452|FG005|Dose Expansion|Ongoing|0|||
148767594|NCT02564900|536623453|FG006|Dose Expansion|Ongoing|9|||
148767595|NCT02564900|536623454|FG007|Dose Expansion|Ongoing|10|||
148767596|NCT02564900|536623455|FG008|Dose Expansion|Ongoing|11|||
148767597|NCT02564900|536623456|FG009|Dose Expansion|Ongoing|3|||
148767598|NCT02564900|536623457|FG010|Dose Expansion|Ongoing|0|||
148767599|NCT02564900|536623458|FG011|Dose Expansion|Ongoing|0|||
148767600|NCT02564900|536623459|FG012|Dose Expansion|Ongoing|4|||
148767601|NCT02564900|536623460|FG013|Dose Expansion|Ongoing|0|||
148767602|NCT02564900|536623461|FG014|Dose Expansion|Ongoing|6|||
148767603|NCT02564900|536623447|FG000|Dose Expansion|Death|0|||
148767604|NCT02564900|536623448|FG001|Dose Expansion|Death|0|||
148767605|NCT02564900|536623449|FG002|Dose Expansion|Death|0|||
148767606|NCT02564900|536623450|FG003|Dose Expansion|Death|0|||
148767607|NCT02564900|536623451|FG004|Dose Expansion|Death|0|||
148767608|NCT02564900|536623452|FG005|Dose Expansion|Death|0|||
148767609|NCT02564900|536623453|FG006|Dose Expansion|Death|1|||
148767610|NCT02564900|536623454|FG007|Dose Expansion|Death|0|||
148767611|NCT02564900|536623455|FG008|Dose Expansion|Death|0|||
148767612|NCT02564900|536623456|FG009|Dose Expansion|Death|0|||
148767613|NCT02564900|536623457|FG010|Dose Expansion|Death|1|||
148767614|NCT02564900|536623458|FG011|Dose Expansion|Death|0|||
148767615|NCT02564900|536623459|FG012|Dose Expansion|Death|1|||
148767616|NCT02564900|536623460|FG013|Dose Expansion|Death|1|||
148767617|NCT02564900|536623461|FG014|Dose Expansion|Death|0|||
148767618|NCT02564900|536623447|FG000|Dose Expansion|Withdrawal by Subject|0|||
148767619|NCT02564900|536623448|FG001|Dose Expansion|Withdrawal by Subject|0|||
148767620|NCT02564900|536623449|FG002|Dose Expansion|Withdrawal by Subject|0|||
148767621|NCT02564900|536623450|FG003|Dose Expansion|Withdrawal by Subject|0|||
148767622|NCT02564900|536623451|FG004|Dose Expansion|Withdrawal by Subject|0|||
148767623|NCT02564900|536623452|FG005|Dose Expansion|Withdrawal by Subject|0|||
148767624|NCT02564900|536623453|FG006|Dose Expansion|Withdrawal by Subject|4|||
148767625|NCT02564900|536623454|FG007|Dose Expansion|Withdrawal by Subject|0|||
148767626|NCT02564900|536623455|FG008|Dose Expansion|Withdrawal by Subject|0|||
148767627|NCT02564900|536623456|FG009|Dose Expansion|Withdrawal by Subject|0|||
148767628|NCT02564900|536623457|FG010|Dose Expansion|Withdrawal by Subject|1|||
148767629|NCT02564900|536623458|FG011|Dose Expansion|Withdrawal by Subject|0|||
148767630|NCT02564900|536623459|FG012|Dose Expansion|Withdrawal by Subject|0|||
148767631|NCT02564900|536623460|FG013|Dose Expansion|Withdrawal by Subject|1|||
148767632|NCT02564900|536623461|FG014|Dose Expansion|Withdrawal by Subject|1|||
148767633|NCT02564900|536623447|FG000|Dose Expansion|Other|0|||
148767634|NCT02564900|536623448|FG001|Dose Expansion|Other|0|||
148767635|NCT02564900|536623449|FG002|Dose Expansion|Other|0|||
148767636|NCT02564900|536623450|FG003|Dose Expansion|Other|0|||
148767637|NCT02564900|536623451|FG004|Dose Expansion|Other|0|||
148767638|NCT02564900|536623452|FG005|Dose Expansion|Other|0|||
148767639|NCT02564900|536623453|FG006|Dose Expansion|Other|1|||
148767640|NCT02564900|536623454|FG007|Dose Expansion|Other|0|||
148767641|NCT02564900|536623455|FG008|Dose Expansion|Other|1|||
148979350|NCT01490060|537404410|FG002|Cycle 2|Change of Treatment|0|||
148979351|NCT01490060|537404411|FG003|Cycle 2|Change of Treatment|0|||
148979352|NCT01490060|537404408|FG000|Cycle 2|Non-Compliance|0|||
148979353|NCT01490060|537404409|FG001|Cycle 2|Non-Compliance|0|||
148979354|NCT01490060|537404410|FG002|Cycle 2|Non-Compliance|1|||
148979355|NCT01490060|537404411|FG003|Cycle 2|Non-Compliance|0|||
148979356|NCT01490060|537404408|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
148979357|NCT01490060|537404409|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
148979358|NCT01490060|537404410|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
148979359|NCT01490060|537404411|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
148979360|NCT03698773|537404419|FG000|Overall Study|Lost to Follow-up|2|||
148979361|NCT03698773|537404420|FG001|Overall Study|Lost to Follow-up|1|||
148979362|NCT02399085|537404421|FG000|Overall Study|Adverse Event|16|||
148979363|NCT02399085|537404421|FG000|Overall Study|Death|2|||
148979364|NCT02399085|537404421|FG000|Overall Study|Withdrawal by Subject|8|||
148979365|NCT02399085|537404421|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
148979366|NCT02399085|537404421|FG000|Overall Study|Physician Decision|5|||
148979367|NCT02802345|537404423|FG000|Overall Study|Not Treated|0|||
148979368|NCT02802345|537404424|FG001|Overall Study|Not Treated|1|||
148979369|NCT02802345|537404423|FG000|Overall Study|Adverse Event|28|||
148979370|NCT02802345|537404424|FG001|Overall Study|Adverse Event|20|||
148979371|NCT02802345|537404423|FG000|Overall Study|Withdrawal by Subject|3|||
148979372|NCT02802345|537404424|FG001|Overall Study|Withdrawal by Subject|3|||
148979373|NCT02802345|537404423|FG000|Overall Study|Protocol Violation|0|||
148979374|NCT02802345|537404424|FG001|Overall Study|Protocol Violation|1|||
148979375|NCT02802345|537404423|FG000|Overall Study|Other than listed|1|||
148767642|NCT02564900|536623456|FG009|Dose Expansion|Other|0|||
148767643|NCT02564900|536623457|FG010|Dose Expansion|Other|0|||
148767644|NCT02564900|536623458|FG011|Dose Expansion|Other|0|||
148767645|NCT02564900|536623459|FG012|Dose Expansion|Other|0|||
148767646|NCT02564900|536623460|FG013|Dose Expansion|Other|0|||
148767647|NCT02564900|536623461|FG014|Dose Expansion|Other|1|||
148767648|NCT02564900|536623447|FG000|Dose Expansion|Did not receive treatment|0|||
148767649|NCT02564900|536623448|FG001|Dose Expansion|Did not receive treatment|0|||
148767650|NCT02564900|536623449|FG002|Dose Expansion|Did not receive treatment|0|||
148767651|NCT02564900|536623450|FG003|Dose Expansion|Did not receive treatment|0|||
148767652|NCT02564900|536623451|FG004|Dose Expansion|Did not receive treatment|0|||
148767653|NCT02564900|536623452|FG005|Dose Expansion|Did not receive treatment|0|||
148767654|NCT02564900|536623453|FG006|Dose Expansion|Did not receive treatment|1|||
148767655|NCT02564900|536623454|FG007|Dose Expansion|Did not receive treatment|1|||
148767656|NCT02564900|536623455|FG008|Dose Expansion|Did not receive treatment|0|||
148767657|NCT02564900|536623456|FG009|Dose Expansion|Did not receive treatment|0|||
148767658|NCT02564900|536623457|FG010|Dose Expansion|Did not receive treatment|0|||
148767659|NCT02564900|536623458|FG011|Dose Expansion|Did not receive treatment|0|||
148767660|NCT02564900|536623459|FG012|Dose Expansion|Did not receive treatment|0|||
148767661|NCT02564900|536623460|FG013|Dose Expansion|Did not receive treatment|0|||
148767662|NCT02564900|536623461|FG014|Dose Expansion|Did not receive treatment|1|||
148767663|NCT00892151|536623462|FG000|Overall Study|Protocol Violation|1|||
148767664|NCT01089608|536623463|FG000|Overall Study|Adverse Event|0|||
148767665|NCT01089608|536623464|FG001|Overall Study|Adverse Event|4|||
148767666|NCT01089608|536623463|FG000|Overall Study|Lost to Follow-up|0|||
148767667|NCT01089608|536623464|FG001|Overall Study|Lost to Follow-up|2|||
148767668|NCT04292912|536623465|FG000|Overall Study|Physician Decision|1|||
148767669|NCT04292912|536623465|FG000|Overall Study|Protocol Violation|6|||
148767670|NCT05338502|536623473|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
148767671|NCT05338502|536623474|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
148767672|NCT05338502|536623475|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
148767673|NCT05338502|536623473|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
148979376|NCT02802345|537404424|FG001|Overall Study|Other than listed|5|||
148979377|NCT01559311|537404426|FG000|Overall Study|Protocol Violation|0|||
148979378|NCT01559311|537404427|FG001|Overall Study|Protocol Violation|0|||
148767674|NCT05338502|536623474|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
148979379|NCT01559311|537404428|FG002|Overall Study|Protocol Violation|2|||
148979380|NCT01559311|537404426|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
148979381|NCT01559311|537404427|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
148767675|NCT05338502|536623475|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
148767676|NCT03575793|536623478|FG000|Overall Study|Withdrawal by Subject|0|||
148767677|NCT03575793|536623479|FG001|Overall Study|Withdrawal by Subject|1|||
148767678|NCT03575793|536623478|FG000|Overall Study|Never Treated|0|||
148767679|NCT03575793|536623479|FG001|Overall Study|Never Treated|2|||
148979382|NCT01559311|537404428|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
148979383|NCT01559311|537404426|FG000|Overall Study|Withdrawal by Subject|2|||
148979384|NCT01559311|537404427|FG001|Overall Study|Withdrawal by Subject|1|||
149027929|NCT00062868|537578695|FG012|Dose Level 3|Lost to Follow-up|0|||
148979385|NCT01559311|537404428|FG002|Overall Study|Withdrawal by Subject|0|||
148979386|NCT01559311|537404426|FG000|Overall Study|Death|0|||
148979387|NCT01559311|537404427|FG001|Overall Study|Death|2|||
148979388|NCT01559311|537404428|FG002|Overall Study|Death|3|||
148979389|NCT01559311|537404426|FG000|Overall Study|Lost to Follow-up|0|||
148979390|NCT01559311|537404427|FG001|Overall Study|Lost to Follow-up|3|||
148979391|NCT01559311|537404428|FG002|Overall Study|Lost to Follow-up|2|||
148979392|NCT01559311|537404426|FG000|Overall Study|Adverse Event|0|||
148979393|NCT01559311|537404427|FG001|Overall Study|Adverse Event|0|||
148979394|NCT01559311|537404428|FG002|Overall Study|Adverse Event|1|||
148979395|NCT05013905|537404429|FG000|Overall Study|Adverse Event|1|||
148979396|NCT05013905|537404429|FG000|Overall Study|Lack of Efficacy|1|||
148979397|NCT01849588|537404431|FG000|Overall Study|Lack of Efficacy|3|||
148979398|NCT01706250|537404435|FG000|Overall Study|Lost to Follow-up|2|||
148979399|NCT03286140|537404436|FG000|Overall Study|Withdrawal by Subject|10|||
148979400|NCT03286140|537404437|FG001|Overall Study|Withdrawal by Subject|5|||
148979401|NCT03286140|537404436|FG000|Overall Study|Lost to Follow-up|5|||
148979402|NCT03286140|537404437|FG001|Overall Study|Lost to Follow-up|10|||
148979403|NCT03286140|537404436|FG000|Overall Study|Failure to comply|0|||
148979404|NCT03286140|537404437|FG001|Overall Study|Failure to comply|1|||
148979405|NCT01826825|537404438|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
148979406|NCT01826825|537404439|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
148979407|NCT00515827|537404440|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
148979408|NCT00515827|537404441|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
148979409|NCT00515827|537404440|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
148979410|NCT00515827|537404441|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
148979411|NCT03254134|537404442|FG000|Overall Study|Not eligible patients|599|||
148979412|NCT03254134|537404443|FG001|Overall Study|Not eligible patients|3630|||
148979413|NCT02563028|537404444|FG000|Overall Study|Lack of equipment|1|||
148979414|NCT02563028|537404444|FG000|Overall Study|Unable to elicit VEP post induction|1|||
148979415|NCT01009099|537404445|FG000|Overall Study|Lost to Follow-up|1|||
148979416|NCT01009099|537404446|FG001|Overall Study|Lost to Follow-up|0|||
148979417|NCT01009099|537404445|FG000|Overall Study|Physician Decision|3|||
148979418|NCT01009099|537404446|FG001|Overall Study|Physician Decision|2|||
148979419|NCT01009099|537404445|FG000|Overall Study|Withdrawal by Subject|1|||
148979420|NCT01009099|537404446|FG001|Overall Study|Withdrawal by Subject|1|||
148979421|NCT01009099|537404445|FG000|Overall Study|Death|0|||
148979422|NCT01009099|537404446|FG001|Overall Study|Death|1|||
148979423|NCT01856543|537404447|FG000|Overall Study|Treatment discontinued|6|||
148979424|NCT01856543|537404448|FG001|Overall Study|Treatment discontinued|3|||
148979425|NCT01856543|537404447|FG000|Overall Study|Withdrawn before start|7|||
148979426|NCT01856543|537404448|FG001|Overall Study|Withdrawn before start|3|||
148979427|NCT00799617|537404453|FG000|Main Testosterone Trial|Randomized in error|1|||
148979428|NCT00799617|537404454|FG001|Main Testosterone Trial|Randomized in error|1|||
148979429|NCT00799617|537404453|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
148979430|NCT00799617|537404454|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
148979431|NCT00799617|537404453|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
148979432|NCT00799617|537404454|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
148979433|NCT00799617|537404453|FG000|Sexual Funtion Trial|No Baseline Data|4|||
148979434|NCT00799617|537404454|FG001|Sexual Funtion Trial|No Baseline Data|7|||
149027930|NCT00062868|537578696|FG013|Dose Level 3|Lost to Follow-up|0|||
149027931|NCT00062868|537578697|FG014|Dose Level 3|Lost to Follow-up|1|||
148767680|NCT02278939|536623480|FG000|Overall Study|lack of time|1|||
148767681|NCT02278939|536623481|FG001|Overall Study|lack of time|0|||
148767682|NCT02278939|536623480|FG000|Overall Study|Lost to Follow-up|1|||
148767683|NCT02278939|536623481|FG001|Overall Study|Lost to Follow-up|1|||
148767684|NCT02278939|536623480|FG000|Overall Study|death in family|1|||
148767685|NCT02278939|536623481|FG001|Overall Study|death in family|0|||
148767686|NCT02278939|536623480|FG000|Overall Study|family emergency unable to commit|2|||
148767687|NCT02278939|536623481|FG001|Overall Study|family emergency unable to commit|0|||
148767688|NCT02423343|536623487|FG000|Overall Study|Withdrawal by Subject|0|||
148767689|NCT02423343|536623488|FG001|Overall Study|Withdrawal by Subject|1|||
148767690|NCT02423343|536623489|FG002|Overall Study|Withdrawal by Subject|0|||
148979435|NCT00799617|537404453|FG000|Physical Function Trial|Lost to Follow-up|6|||
148979436|NCT00799617|537404454|FG001|Physical Function Trial|Lost to Follow-up|11|||
149027932|NCT00062868|537578698|FG015|Dose Level 3|Lost to Follow-up|0|||
149027933|NCT00062868|537578699|FG016|Dose Level 3|Lost to Follow-up|0|||
148979437|NCT00799617|537404453|FG000|Vitality Trial|Lost to Follow-up|7|||
148979438|NCT00799617|537404454|FG001|Vitality Trial|Lost to Follow-up|22|||
148979439|NCT00799617|537404453|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
148767691|NCT02423343|536623490|FG003|Overall Study|Withdrawal by Subject|0|||
148767692|NCT02423343|536623491|FG004|Overall Study|Withdrawal by Subject|0|||
148979440|NCT00799617|537404454|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
148979441|NCT00799617|537404453|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
148979442|NCT00799617|537404454|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
149027934|NCT00062868|537578700|FG017|Dose Level 3|Lost to Follow-up|0|||
148767693|NCT02423343|536623492|FG005|Overall Study|Withdrawal by Subject|0|||
148767694|NCT02423343|536623487|FG000|Overall Study|Progressive Disease|0|||
148767695|NCT02423343|536623488|FG001|Overall Study|Progressive Disease|0|||
148767696|NCT02423343|536623489|FG002|Overall Study|Progressive Disease|0|||
148767697|NCT02423343|536623490|FG003|Overall Study|Progressive Disease|0|||
148767698|NCT02423343|536623491|FG004|Overall Study|Progressive Disease|2|||
148767699|NCT02423343|536623492|FG005|Overall Study|Progressive Disease|0|||
148767700|NCT02423343|536623487|FG000|Overall Study|Adverse Event|0|||
148767701|NCT02423343|536623488|FG001|Overall Study|Adverse Event|0|||
148767702|NCT02423343|536623489|FG002|Overall Study|Adverse Event|0|||
148767703|NCT02423343|536623490|FG003|Overall Study|Adverse Event|0|||
148767704|NCT02423343|536623491|FG004|Overall Study|Adverse Event|2|||
148767705|NCT02423343|536623492|FG005|Overall Study|Adverse Event|0|||
148767706|NCT02423343|536623487|FG000|Overall Study|Death|0|||
148767707|NCT02423343|536623488|FG001|Overall Study|Death|0|||
148767708|NCT02423343|536623489|FG002|Overall Study|Death|0|||
148767709|NCT02423343|536623490|FG003|Overall Study|Death|0|||
148767710|NCT02423343|536623491|FG004|Overall Study|Death|1|||
148767711|NCT02423343|536623492|FG005|Overall Study|Death|0|||
148767712|NCT01127451|536623495|FG000|Overall Study|Other|2|||
148767713|NCT01127451|536623496|FG001|Overall Study|Other|1|||
148767714|NCT01127451|536623495|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
148767715|NCT01127451|536623496|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
148767716|NCT01127451|536623495|FG000|Overall Study|Death|22|||
148767717|NCT01127451|536623496|FG001|Overall Study|Death|17|||
148767718|NCT01127451|536623495|FG000|Overall Study|Lost to Follow-up|3|||
148767719|NCT01127451|536623496|FG001|Overall Study|Lost to Follow-up|0|||
148767720|NCT01127451|536623495|FG000|Overall Study|Administrative Reason by Sponsor|2|||
148767721|NCT01127451|536623496|FG001|Overall Study|Administrative Reason by Sponsor|2|||
148767722|NCT02111577|536623497|FG000|Overall Study|Protocol Violation|2|||
148767723|NCT02111577|536623498|FG001|Overall Study|Protocol Violation|0|||
148767724|NCT02111577|536623497|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
148767725|NCT02111577|536623498|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
148767726|NCT02111577|536623497|FG000|Overall Study|Failure to produce study treatment|6|||
148767727|NCT02111577|536623498|FG001|Overall Study|Failure to produce study treatment|0|||
148767728|NCT02111577|536623497|FG000|Overall Study|Death|518|||
148767729|NCT02111577|536623498|FG001|Overall Study|Death|254|||
148767730|NCT02111577|536623497|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
148767731|NCT02111577|536623498|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
148767732|NCT02111577|536623497|FG000|Overall Study|Adverse Event|1|||
148767733|NCT02111577|536623498|FG001|Overall Study|Adverse Event|1|||
148767734|NCT02111577|536623497|FG000|Overall Study|Withdrawal by Subject|51|||
148767735|NCT02111577|536623498|FG001|Overall Study|Withdrawal by Subject|23|||
148767736|NCT02111577|536623497|FG000|Overall Study|Disease progression|0|||
148767737|NCT02111577|536623498|FG001|Overall Study|Disease progression|1|||
148767738|NCT02111577|536623497|FG000|Overall Study|Lost to Follow-up|19|||
148767739|NCT02111577|536623498|FG001|Overall Study|Lost to Follow-up|10|||
148767740|NCT01014988|536623499|FG000|Overall Study|Adverse Event|20|||
148767741|NCT01014988|536623500|FG001|Overall Study|Adverse Event|0|||
148767742|NCT01014988|536623501|FG002|Overall Study|Adverse Event|1|||
148767743|NCT01014988|536623502|FG003|Overall Study|Adverse Event|0|||
148767744|NCT01014988|536623503|FG004|Overall Study|Adverse Event|1|||
148767745|NCT01014988|536623504|FG005|Overall Study|Adverse Event|3|||
148767746|NCT01014988|536623499|FG000|Overall Study|Lost to Follow-up|1|||
148767747|NCT01014988|536623500|FG001|Overall Study|Lost to Follow-up|0|||
148767748|NCT01014988|536623501|FG002|Overall Study|Lost to Follow-up|1|||
148767749|NCT01014988|536623502|FG003|Overall Study|Lost to Follow-up|0|||
148767750|NCT01014988|536623503|FG004|Overall Study|Lost to Follow-up|0|||
148767751|NCT01014988|536623504|FG005|Overall Study|Lost to Follow-up|0|||
148767752|NCT01014988|536623499|FG000|Overall Study|Physician Decision|1|||
148979443|NCT00799617|537404453|FG000|Bone Trial|Month 12 scan not available|6|||
148979444|NCT00799617|537404454|FG001|Bone Trial|Month 12 scan not available|16|||
148979445|NCT00799617|537404453|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
148767753|NCT01014988|536623500|FG001|Overall Study|Physician Decision|0|||
148767754|NCT01014988|536623501|FG002|Overall Study|Physician Decision|0|||
148767755|NCT01014988|536623502|FG003|Overall Study|Physician Decision|0|||
148767756|NCT01014988|536623503|FG004|Overall Study|Physician Decision|0|||
148767757|NCT01014988|536623504|FG005|Overall Study|Physician Decision|0|||
148767758|NCT01014988|536623499|FG000|Overall Study|Withdrawal by Subject|1|||
148767759|NCT01014988|536623500|FG001|Overall Study|Withdrawal by Subject|0|||
148767760|NCT01014988|536623501|FG002|Overall Study|Withdrawal by Subject|0|||
148767761|NCT01014988|536623502|FG003|Overall Study|Withdrawal by Subject|0|||
148767762|NCT01014988|536623503|FG004|Overall Study|Withdrawal by Subject|0|||
148767763|NCT01014988|536623504|FG005|Overall Study|Withdrawal by Subject|0|||
148767764|NCT00729157|536623505|FG000|Overall Study|Withdrawal by Subject|1|||
148767765|NCT00886743|536623506|FG000|Overall Study|Adverse Event|3|||
148767766|NCT00886743|536623506|FG000|Overall Study|Other|1|||
148767767|NCT00626821|536623510|FG000|Overall Study|Adverse Event|44|||
148767768|NCT00626821|536623510|FG000|Overall Study|Protocol Violation|33|||
148767769|NCT00626821|536623510|FG000|Overall Study|Withdrawal by Subject|10|||
148767770|NCT00626821|536623510|FG000|Overall Study|Physician Decision|9|||
148767771|NCT00626821|536623510|FG000|Overall Study|Product dysfunction|21|||
148767772|NCT00626821|536623510|FG000|Overall Study|other/unknown reason|104|||
148767773|NCT01940887|536623515|FG000|Year 1|Protocol Violation|0|||
148767774|NCT01940887|536623516|FG001|Year 1|Protocol Violation|1|||
148767775|NCT01940887|536623515|FG000|Year 1|Physician Decision|7|||
148767776|NCT01940887|536623516|FG001|Year 1|Physician Decision|3|||
148767777|NCT01940887|536623515|FG000|Year 1|Death|5|||
148767778|NCT01940887|536623516|FG001|Year 1|Death|3|||
148767779|NCT01940887|536623515|FG000|Year 1|Adverse Event|7|||
148767780|NCT01940887|536623516|FG001|Year 1|Adverse Event|6|||
148767781|NCT01940887|536623515|FG000|Year 1|Withdrawal by Subject|18|||
148767782|NCT01940887|536623516|FG001|Year 1|Withdrawal by Subject|9|||
148767783|NCT01940887|536623515|FG000|Year 1|Lost to Follow-up|2|||
148767784|NCT01940887|536623516|FG001|Year 1|Lost to Follow-up|1|||
148767785|NCT01940887|536623515|FG000|Year 2|Physician Decision|8|||
148767786|NCT01940887|536623516|FG001|Year 2|Physician Decision|1|||
148767787|NCT01940887|536623515|FG000|Year 2|Death|0|||
148767788|NCT01940887|536623516|FG001|Year 2|Death|2|||
148767789|NCT01940887|536623515|FG000|Year 2|Sponsor Decision, early termination|192|||
148767790|NCT01940887|536623516|FG001|Year 2|Sponsor Decision, early termination|203|||
148767791|NCT01940887|536623515|FG000|Year 2|Adverse Event|8|||
148767792|NCT01940887|536623516|FG001|Year 2|Adverse Event|2|||
148767793|NCT01940887|536623515|FG000|Year 2|Withdrawal by Subject|8|||
148829000|NCT02471144|536853670|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
148829001|NCT02471144|536853671|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
148829002|NCT02471144|536853672|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
148829003|NCT02471144|536853673|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
148829004|NCT02471144|536853674|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
148829005|NCT02471144|536853664|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829006|NCT02471144|536853665|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829007|NCT02471144|536853666|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829008|NCT02471144|536853667|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
148829009|NCT02471144|536853668|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829010|NCT02471144|536853669|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829011|NCT02471144|536853670|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829012|NCT02471144|536853671|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829013|NCT02471144|536853672|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829014|NCT02471144|536853673|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829015|NCT02471144|536853674|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
148829016|NCT02471144|536853664|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829017|NCT02471144|536853665|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829018|NCT02471144|536853666|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
148829019|NCT02471144|536853667|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829020|NCT02471144|536853668|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829021|NCT02471144|536853669|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829022|NCT02471144|536853670|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829023|NCT02471144|536853671|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829024|NCT02471144|536853672|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829025|NCT02471144|536853673|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829026|NCT02471144|536853674|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
148829027|NCT02471144|536853664|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
148829028|NCT02471144|536853665|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
148829029|NCT02471144|536853666|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829030|NCT02471144|536853667|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829031|NCT02471144|536853668|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829032|NCT02471144|536853669|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829033|NCT02471144|536853670|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829034|NCT02471144|536853671|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829035|NCT02471144|536853672|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148979446|NCT00799617|537404454|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
148979447|NCT00799617|537404453|FG000|Anemia Trial|Withdrawal by Subject|3|||
148979448|NCT00799617|537404454|FG001|Anemia Trial|Withdrawal by Subject|3|||
148829036|NCT02471144|536853673|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148767794|NCT01940887|536623516|FG001|Year 2|Withdrawal by Subject|8|||
148767795|NCT01940887|536623515|FG000|Year 2|Lost to Follow-up|1|||
148767796|NCT01940887|536623516|FG001|Year 2|Lost to Follow-up|6|||
148767797|NCT03521115|536623518|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
148829037|NCT02471144|536853674|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
148829038|NCT02471144|536853664|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829039|NCT02471144|536853665|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148979449|NCT04545515|537404455|FG000|Overall Study|Adverse Event|1|||
148979450|NCT04545515|537404455|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
148979451|NCT04545515|537404455|FG000|Overall Study|Commercial drug is available for participant|7|||
148979452|NCT01848990|537404456|FG000|Overall Study|Adverse Event|6|||
148979453|NCT01848990|537404457|FG001|Overall Study|Adverse Event|2|||
148979454|NCT01848990|537404458|FG002|Overall Study|Adverse Event|0|||
148979455|NCT01848990|537404456|FG000|Overall Study|Lost to Follow-up|6|||
148979456|NCT01848990|537404457|FG001|Overall Study|Lost to Follow-up|2|||
148979457|NCT01848990|537404458|FG002|Overall Study|Lost to Follow-up|2|||
148979458|NCT01848990|537404456|FG000|Overall Study|Protocol Violation|1|||
148979459|NCT01848990|537404457|FG001|Overall Study|Protocol Violation|1|||
148979460|NCT01848990|537404458|FG002|Overall Study|Protocol Violation|0|||
148979461|NCT01848990|537404456|FG000|Overall Study|Withdrawal by Subject|29|||
148979462|NCT01848990|537404457|FG001|Overall Study|Withdrawal by Subject|10|||
148979463|NCT01848990|537404458|FG002|Overall Study|Withdrawal by Subject|11|||
148979464|NCT01848990|537404456|FG000|Overall Study|Physician Decision|1|||
148979465|NCT01848990|537404457|FG001|Overall Study|Physician Decision|1|||
148979466|NCT01848990|537404458|FG002|Overall Study|Physician Decision|0|||
148829040|NCT02471144|536853666|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829041|NCT02471144|536853667|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829042|NCT02471144|536853668|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
148829043|NCT02471144|536853669|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829044|NCT02471144|536853670|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
148829045|NCT02471144|536853671|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829046|NCT02471144|536853672|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
148829047|NCT02471144|536853673|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829048|NCT02471144|536853674|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
148829049|NCT02471144|536853664|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829050|NCT02471144|536853665|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829051|NCT02471144|536853666|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829052|NCT02471144|536853667|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829053|NCT02471144|536853668|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829054|NCT02471144|536853669|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
148829055|NCT02471144|536853670|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829056|NCT02471144|536853671|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829057|NCT02471144|536853672|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
148829058|NCT02471144|536853673|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829059|NCT02471144|536853674|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
148829060|NCT02471144|536853664|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829061|NCT02471144|536853665|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829062|NCT02471144|536853666|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829063|NCT02471144|536853667|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829064|NCT02471144|536853668|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829065|NCT02471144|536853669|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829066|NCT02471144|536853670|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829067|NCT02471144|536853671|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829068|NCT02471144|536853672|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
148829069|NCT02471144|536853673|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829070|NCT02471144|536853674|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
148829071|NCT02471144|536853664|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829072|NCT02471144|536853665|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829073|NCT02471144|536853666|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829074|NCT02471144|536853667|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829075|NCT02471144|536853668|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829076|NCT02471144|536853669|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829077|NCT02471144|536853670|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829078|NCT02471144|536853671|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
148829079|NCT02471144|536853672|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
148829080|NCT02471144|536853673|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829081|NCT02471144|536853674|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
148829082|NCT02471144|536853664|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829083|NCT02471144|536853665|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829084|NCT02471144|536853666|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148979467|NCT01848990|537404456|FG000|Overall Study|Non Compliance|1|||
148979468|NCT01848990|537404457|FG001|Overall Study|Non Compliance|0|||
148979469|NCT01848990|537404458|FG002|Overall Study|Non Compliance|0|||
148979470|NCT01848990|537404456|FG000|Overall Study|Death|1|||
148979471|NCT01848990|537404457|FG001|Overall Study|Death|0|||
148979472|NCT01848990|537404458|FG002|Overall Study|Death|1|||
148979473|NCT01848990|537404456|FG000|Overall Study|Other|1|||
148979474|NCT01848990|537404457|FG001|Overall Study|Other|4|||
148829085|NCT02471144|536853667|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829086|NCT02471144|536853668|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829087|NCT02471144|536853669|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829088|NCT02471144|536853670|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829089|NCT02471144|536853671|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829090|NCT02471144|536853672|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
148829091|NCT02471144|536853673|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
148829092|NCT02471144|536853674|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
148829093|NCT02471144|536853664|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829094|NCT02471144|536853665|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829095|NCT02471144|536853666|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829096|NCT02471144|536853667|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829097|NCT02471144|536853668|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829098|NCT02471144|536853669|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829099|NCT02471144|536853670|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829100|NCT02471144|536853671|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829101|NCT02471144|536853672|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829102|NCT02471144|536853673|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
148829103|NCT02471144|536853674|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
148829104|NCT02471144|536853664|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829105|NCT02471144|536853665|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829106|NCT02471144|536853666|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829107|NCT02471144|536853667|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829108|NCT02471144|536853668|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829109|NCT02471144|536853669|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829110|NCT02471144|536853670|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829111|NCT02471144|536853671|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829112|NCT02471144|536853672|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829113|NCT02471144|536853673|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
148829114|NCT02471144|536853674|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
148829115|NCT02471144|536853664|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829116|NCT02471144|536853665|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829117|NCT02471144|536853666|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829118|NCT02471144|536853667|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829119|NCT02471144|536853668|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829120|NCT02471144|536853669|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829121|NCT02471144|536853670|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829122|NCT02471144|536853671|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829123|NCT02471144|536853672|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
148829124|NCT02471144|536853673|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
148829125|NCT02471144|536853674|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
148829126|NCT02471144|536853664|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829127|NCT02471144|536853665|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829128|NCT02471144|536853666|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829129|NCT02471144|536853667|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829130|NCT02471144|536853668|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829131|NCT02471144|536853669|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829132|NCT02471144|536853670|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829133|NCT02471144|536853671|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829134|NCT02471144|536853672|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829135|NCT02471144|536853673|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
148829136|NCT02471144|536853674|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
148829137|NCT02471144|536853664|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829138|NCT02471144|536853665|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829139|NCT02471144|536853666|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829140|NCT02471144|536853667|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829141|NCT02471144|536853668|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829142|NCT02471144|536853669|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829143|NCT02471144|536853670|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829144|NCT02471144|536853671|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829145|NCT02471144|536853672|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
148829146|NCT02471144|536853673|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
148829147|NCT02471144|536853674|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
148829148|NCT03058952|536853677|FG000|Overall Study|Adverse Event|1|||
148829149|NCT03058952|536853678|FG001|Overall Study|Adverse Event|0|||
148979475|NCT01848990|537404458|FG002|Overall Study|Other|2|||
148979476|NCT02501096|537404459|FG000|Overall Study|Lost to Follow-up|0|||
148979477|NCT02501096|537404460|FG001|Overall Study|Lost to Follow-up|0|||
148979478|NCT02501096|537404461|FG002|Overall Study|Lost to Follow-up|0|||
148979479|NCT02501096|537404462|FG003|Overall Study|Lost to Follow-up|0|||
148979480|NCT02501096|537404463|FG004|Overall Study|Lost to Follow-up|1|||
148979481|NCT02501096|537404464|FG005|Overall Study|Lost to Follow-up|1|||
148979482|NCT02501096|537404465|FG006|Overall Study|Lost to Follow-up|3|||
148979483|NCT02501096|537404466|FG007|Overall Study|Lost to Follow-up|0|||
148979484|NCT02501096|537404467|FG008|Overall Study|Lost to Follow-up|0|||
149027935|NCT00062868|537578701|FG018|Dose Level 3|Lost to Follow-up|0|||
149027936|NCT00062868|537578702|FG019|Dose Level 3|Lost to Follow-up|0|||
149027937|NCT00062868|537578703|FG020|Dose Level 3|Lost to Follow-up|0|||
149027938|NCT00062868|537578683|FG000|Dose Level 3|Withdrew|0|||
149027939|NCT00062868|537578684|FG001|Dose Level 3|Withdrew|0|||
149027940|NCT00062868|537578685|FG002|Dose Level 3|Withdrew|2|||
149027941|NCT00062868|537578686|FG003|Dose Level 3|Withdrew|0|||
149027942|NCT00062868|537578687|FG004|Dose Level 3|Withdrew|0|||
149027943|NCT00062868|537578688|FG005|Dose Level 3|Withdrew|0|||
149027944|NCT00062868|537578689|FG006|Dose Level 3|Withdrew|0|||
149027945|NCT00062868|537578690|FG007|Dose Level 3|Withdrew|0|||
149027946|NCT00062868|537578691|FG008|Dose Level 3|Withdrew|0|||
149027947|NCT00062868|537578692|FG009|Dose Level 3|Withdrew|0|||
149027948|NCT00062868|537578693|FG010|Dose Level 3|Withdrew|0|||
149027949|NCT00062868|537578694|FG011|Dose Level 3|Withdrew|0|||
149027950|NCT00062868|537578695|FG012|Dose Level 3|Withdrew|0|||
149027951|NCT00062868|537578696|FG013|Dose Level 3|Withdrew|0|||
149027952|NCT00062868|537578697|FG014|Dose Level 3|Withdrew|0|||
149027953|NCT00062868|537578698|FG015|Dose Level 3|Withdrew|0|||
149027954|NCT00062868|537578699|FG016|Dose Level 3|Withdrew|0|||
149027955|NCT00062868|537578700|FG017|Dose Level 3|Withdrew|0|||
149027956|NCT00062868|537578701|FG018|Dose Level 3|Withdrew|0|||
149027957|NCT00062868|537578702|FG019|Dose Level 3|Withdrew|0|||
149027958|NCT00062868|537578703|FG020|Dose Level 3|Withdrew|0|||
149027959|NCT04949399|537578706|FG000|Overall Study|Lost to Follow-up|11|||
149027960|NCT04949399|537578707|FG001|Overall Study|Lost to Follow-up|6|||
149027961|NCT04949399|537578706|FG000|Overall Study|Withdrawal by Subject|2|||
149027962|NCT04949399|537578707|FG001|Overall Study|Withdrawal by Subject|3|||
149027963|NCT00670540|537578708|FG000|Overall Study|ineligible|17|||
149027964|NCT00670540|537578708|FG000|Overall Study|not living in France|348|||
149027965|NCT00670540|537578708|FG000|Overall Study|refused to participate|189|||
149027966|NCT00670540|537578708|FG000|Overall Study|controls randomised for no follow up|2770|||
149027967|NCT00670540|537578708|FG000|Overall Study|missing information inclusion criteria|1|||
149027968|NCT01866917|537578712|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
149027969|NCT01866917|537578713|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
149027970|NCT01140347|537578717|FG000|Overall Study|Lost to Follow-up|5|||
149027971|NCT01140347|537578718|FG001|Overall Study|Lost to Follow-up|6|||
149027972|NCT01140347|537578717|FG000|Overall Study|Withdrawal by Subject|13|||
149027973|NCT01140347|537578718|FG001|Overall Study|Withdrawal by Subject|8|||
149027974|NCT00901485|537578719|FG000|Overall Study|Lack of Efficacy|0|||
149027975|NCT00901485|537578720|FG001|Overall Study|Lack of Efficacy|2|||
149027976|NCT00901485|537578719|FG000|Overall Study|Withdrawal by Subject|1|||
149027977|NCT00901485|537578720|FG001|Overall Study|Withdrawal by Subject|2|||
149027978|NCT01919619|537578721|FG000|Overall Study|Physician Decision|1|||
149027979|NCT01919619|537578722|FG001|Overall Study|Physician Decision|1|||
149027980|NCT00172185|537580045|FG000|Overall Study|Adverse Event|0|||
149027981|NCT00172185|537580046|FG001|Overall Study|Adverse Event|1|||
149027982|NCT00172185|537580047|FG002|Overall Study|Adverse Event|3|||
149027983|NCT00172185|537580048|FG003|Overall Study|Adverse Event|4|||
149027984|NCT00172185|537580045|FG000|Overall Study|Physician Decision|0|||
148767798|NCT03521115|536623519|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
149027985|NCT00172185|537580046|FG001|Overall Study|Physician Decision|0|||
149027986|NCT00172185|537580047|FG002|Overall Study|Physician Decision|1|||
149027987|NCT00172185|537580048|FG003|Overall Study|Physician Decision|0|||
149027988|NCT00172185|537580045|FG000|Overall Study|SPONSOR Decision|0|||
149027989|NCT00172185|537580046|FG001|Overall Study|SPONSOR Decision|1|||
149027990|NCT00172185|537580047|FG002|Overall Study|SPONSOR Decision|0|||
149027991|NCT00172185|537580048|FG003|Overall Study|SPONSOR Decision|0|||
148767799|NCT03521115|536623518|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
148767800|NCT03521115|536623519|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
148979485|NCT02501096|537404459|FG000|Overall Study|Withdrawal by Subject|1|||
148979486|NCT02501096|537404460|FG001|Overall Study|Withdrawal by Subject|0|||
148979487|NCT02501096|537404461|FG002|Overall Study|Withdrawal by Subject|7|||
149027992|NCT00172185|537580045|FG000|Overall Study|Withdrawal by Subject|0|||
149027993|NCT00172185|537580046|FG001|Overall Study|Withdrawal by Subject|0|||
149027994|NCT00172185|537580047|FG002|Overall Study|Withdrawal by Subject|1|||
149027995|NCT00172185|537580048|FG003|Overall Study|Withdrawal by Subject|0|||
149027996|NCT00946114|537580053|FG000|Overall Study|Death|5|||
149027997|NCT00946114|537580054|FG001|Overall Study|Death|2|||
149027998|NCT00946114|537580053|FG000|Overall Study|Other|1|||
149027999|NCT00946114|537580054|FG001|Overall Study|Other|0|||
148979488|NCT02501096|537404462|FG003|Overall Study|Withdrawal by Subject|13|||
148979489|NCT02501096|537404463|FG004|Overall Study|Withdrawal by Subject|2|||
148979490|NCT02501096|537404464|FG005|Overall Study|Withdrawal by Subject|2|||
148979491|NCT02501096|537404465|FG006|Overall Study|Withdrawal by Subject|2|||
148979492|NCT02501096|537404466|FG007|Overall Study|Withdrawal by Subject|3|||
148979493|NCT02501096|537404467|FG008|Overall Study|Withdrawal by Subject|0|||
148979494|NCT02501096|537404459|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
148979495|NCT02501096|537404460|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
148979496|NCT02501096|537404461|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
148979497|NCT02501096|537404462|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
148979498|NCT02501096|537404463|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
148979499|NCT02501096|537404464|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
148829150|NCT03058952|536853677|FG000|Overall Study|Lost to Follow-up|15|||
148829151|NCT03058952|536853678|FG001|Overall Study|Lost to Follow-up|15|||
148829152|NCT03058952|536853677|FG000|Overall Study|Withdrawal by Subject|7|||
148829153|NCT03058952|536853678|FG001|Overall Study|Withdrawal by Subject|11|||
148829154|NCT05654181|536853681|FG000|Overall Study|Adverse Event|1|||
148829155|NCT05654181|536853682|FG001|Overall Study|Adverse Event|0|||
148829156|NCT05654181|536853683|FG002|Overall Study|Adverse Event|0|||
148829157|NCT05654181|536853684|FG003|Overall Study|Adverse Event|0|||
148829158|NCT05654181|536853685|FG004|Overall Study|Adverse Event|0|||
148829159|NCT05654181|536853686|FG005|Overall Study|Adverse Event|0|||
148829160|NCT05654181|536853687|FG006|Overall Study|Adverse Event|0|||
148829161|NCT05654181|536853688|FG007|Overall Study|Adverse Event|1|||
148829162|NCT05654181|536853689|FG008|Overall Study|Adverse Event|0|||
148829163|NCT05654181|536853690|FG009|Overall Study|Adverse Event|0|||
148829164|NCT05654181|536853681|FG000|Overall Study|Withdrawal by Subject|0|||
148829165|NCT05654181|536853682|FG001|Overall Study|Withdrawal by Subject|0|||
148829166|NCT05654181|536853683|FG002|Overall Study|Withdrawal by Subject|0|||
148829167|NCT05654181|536853684|FG003|Overall Study|Withdrawal by Subject|0|||
148829168|NCT05654181|536853685|FG004|Overall Study|Withdrawal by Subject|0|||
148829169|NCT05654181|536853686|FG005|Overall Study|Withdrawal by Subject|0|||
148829170|NCT05654181|536853687|FG006|Overall Study|Withdrawal by Subject|0|||
148829171|NCT05654181|536853688|FG007|Overall Study|Withdrawal by Subject|1|||
148829172|NCT05654181|536853689|FG008|Overall Study|Withdrawal by Subject|0|||
148829173|NCT05654181|536853690|FG009|Overall Study|Withdrawal by Subject|0|||
148829174|NCT05654181|536853681|FG000|Overall Study|Other|0|||
148829175|NCT05654181|536853682|FG001|Overall Study|Other|0|||
148829176|NCT05654181|536853683|FG002|Overall Study|Other|0|||
148829177|NCT05654181|536853684|FG003|Overall Study|Other|0|||
148829178|NCT05654181|536853685|FG004|Overall Study|Other|1|||
148829179|NCT05654181|536853686|FG005|Overall Study|Other|1|||
148829180|NCT05654181|536853687|FG006|Overall Study|Other|0|||
148829181|NCT05654181|536853688|FG007|Overall Study|Other|0|||
148829182|NCT05654181|536853689|FG008|Overall Study|Other|0|||
148829183|NCT05654181|536853690|FG009|Overall Study|Other|0|||
148829184|NCT04101331|536853691|FG000|Overall Study|Adverse Event|9|||
148829185|NCT04101331|536853691|FG000|Overall Study|Disease progression|82|||
148829186|NCT04101331|536853691|FG000|Overall Study|Withdrawal by Subject|1|||
148829187|NCT04101331|536853691|FG000|Overall Study|Investigator decision|6|||
148829188|NCT04101331|536853691|FG000|Overall Study|Death|6|||
148829189|NCT04101331|536853691|FG000|Overall Study|Allogenic transplant|1|||
148829190|NCT00851084|536853692|FG000|Overall Study|Randomized but not treated|1|||
148829191|NCT00851084|536853693|FG001|Overall Study|Randomized but not treated|0|||
148829192|NCT00851084|536853692|FG000|Overall Study|Adverse Event|26|||
148829193|NCT00851084|536853693|FG001|Overall Study|Adverse Event|36|||
148829194|NCT00851084|536853692|FG000|Overall Study|Disease progression|52|||
148767801|NCT02475265|536623523|FG000|Overall Study|Physician Decision|1|||
148767802|NCT02475265|536623523|FG000|Overall Study|Withdrawal by Subject|2|||
148767803|NCT03655470|536623529|FG000|Overall Study|Lost to Follow-up|6|||
148767804|NCT03655470|536623530|FG001|Overall Study|Lost to Follow-up|7|||
148767805|NCT03063086|536623531|FG000|Overall Study|technical problems|1|||
148767806|NCT03063086|536623532|FG001|Overall Study|technical problems|0|||
148767807|NCT03063086|536623533|FG002|Overall Study|technical problems|0|||
148767808|NCT03063086|536623534|FG003|Overall Study|technical problems|0|||
148767809|NCT03063086|536623535|FG004|Overall Study|technical problems|0|||
148767810|NCT03063086|536623536|FG005|Overall Study|technical problems|0|||
148767811|NCT03063086|536623531|FG000|Overall Study|Adverse Event|1|||
148767812|NCT03063086|536623532|FG001|Overall Study|Adverse Event|1|||
148767813|NCT03063086|536623533|FG002|Overall Study|Adverse Event|1|||
148767814|NCT03063086|536623534|FG003|Overall Study|Adverse Event|1|||
148767815|NCT03063086|536623535|FG004|Overall Study|Adverse Event|0|||
148767816|NCT03063086|536623536|FG005|Overall Study|Adverse Event|0|||
148829195|NCT00851084|536853693|FG001|Overall Study|Disease progression|47|||
148829196|NCT00851084|536853692|FG000|Overall Study|Poor compliance to protocol|1|||
148829197|NCT00851084|536853693|FG001|Overall Study|Poor compliance to protocol|1|||
148829198|NCT00851084|536853692|FG000|Overall Study|Physician Decision|13|||
148829199|NCT00851084|536853693|FG001|Overall Study|Physician Decision|14|||
148829200|NCT00851084|536853692|FG000|Overall Study|Consent withdrawn|0|||
148829201|NCT00851084|536853693|FG001|Overall Study|Consent withdrawn|2|||
148829202|NCT00851084|536853692|FG000|Overall Study|Withdrawal by Subject|11|||
148829203|NCT00851084|536853693|FG001|Overall Study|Withdrawal by Subject|12|||
148829204|NCT00851084|536853692|FG000|Overall Study|Metastatic surgery|6|||
148829205|NCT00851084|536853693|FG001|Overall Study|Metastatic surgery|6|||
148829206|NCT00851084|536853692|FG000|Overall Study|Other|7|||
148829207|NCT00851084|536853693|FG001|Overall Study|Other|1|||
148829208|NCT00734032|536853694|FG000|Overall Study|Adverse Event|0|||
148829209|NCT00734032|536853695|FG001|Overall Study|Adverse Event|1|||
148829210|NCT00734032|536853696|FG002|Overall Study|Adverse Event|0|||
148829211|NCT00734032|536853697|FG003|Overall Study|Adverse Event|0|||
148829212|NCT03787615|536853701|FG000|Overall Study|Withdrawal by Subject|2|||
148829213|NCT03787615|536853701|FG000|Overall Study|Lost to Follow-up|2|||
148829214|NCT03412929|536853703|FG000|Overall Study|Protocol Violation|3|||
148829215|NCT01946880|536853705|FG000|Overall Study|Lost to Follow-up|1|||
148829216|NCT01946880|536853706|FG001|Overall Study|Lost to Follow-up|0|||
148829217|NCT01946880|536853705|FG000|Overall Study|Physician Decision|1|||
148829218|NCT01946880|536853706|FG001|Overall Study|Physician Decision|1|||
148829219|NCT01946880|536853705|FG000|Overall Study|Withdrawal by Subject|3|||
148829220|NCT01946880|536853706|FG001|Overall Study|Withdrawal by Subject|2|||
148829221|NCT01946880|536853705|FG000|Overall Study|Met Primary Endpoint|1|||
148829222|NCT01946880|536853706|FG001|Overall Study|Met Primary Endpoint|0|||
148829223|NCT01946880|536853705|FG000|Overall Study|Personal and Family Issues|1|||
148829224|NCT01946880|536853706|FG001|Overall Study|Personal and Family Issues|0|||
148829225|NCT02034565|536853707|FG000|Overall Study|Adverse Event|1|||
148829226|NCT02034565|536853708|FG001|Overall Study|Adverse Event|0|||
148829227|NCT00581919|536853709|FG000|Overall Study|Adverse Event|8|||
148829228|NCT00581919|536853709|FG000|Overall Study|Death|1|||
148829229|NCT00581919|536853709|FG000|Overall Study|Disease Progression|10|||
148829230|NCT00581919|536853709|FG000|Overall Study|Physician Decision|1|||
148829231|NCT00581919|536853709|FG000|Overall Study|Other Complicating Disease|1|||
148829232|NCT00581919|536853709|FG000|Overall Study|Started Non-Protocol Therapy|2|||
148829233|NCT00581919|536853709|FG000|Overall Study|Withdrawal by Subject|1|||
148829234|NCT02655601|536853710|FG000|Overall Study|Adverse Event|0|||
148829235|NCT02655601|536853711|FG001|Overall Study|Adverse Event|0|||
148829236|NCT02655601|536853712|FG002|Overall Study|Adverse Event|0|||
148829237|NCT02655601|536853713|FG003|Overall Study|Adverse Event|1|||
148829238|NCT02655601|536853714|FG004|Overall Study|Adverse Event|1|||
148829239|NCT02655601|536853715|FG005|Overall Study|Adverse Event|0|||
148829240|NCT02655601|536853710|FG000|Overall Study|Physician Decision|0|||
148829241|NCT02655601|536853711|FG001|Overall Study|Physician Decision|0|||
148829242|NCT02655601|536853712|FG002|Overall Study|Physician Decision|0|||
148829243|NCT02655601|536853713|FG003|Overall Study|Physician Decision|0|||
148829244|NCT02655601|536853714|FG004|Overall Study|Physician Decision|1|||
148829245|NCT02655601|536853715|FG005|Overall Study|Physician Decision|1|||
148829246|NCT02655601|536853710|FG000|Overall Study|Withdrawal by Subject|0|||
148829247|NCT02655601|536853711|FG001|Overall Study|Withdrawal by Subject|0|||
148829248|NCT02655601|536853712|FG002|Overall Study|Withdrawal by Subject|0|||
148829249|NCT02655601|536853713|FG003|Overall Study|Withdrawal by Subject|0|||
148829250|NCT02655601|536853714|FG004|Overall Study|Withdrawal by Subject|4|||
148829251|NCT02655601|536853715|FG005|Overall Study|Withdrawal by Subject|8|||
148829252|NCT02655601|536853710|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
148829253|NCT02655601|536853711|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
148829254|NCT02655601|536853712|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
148829255|NCT02655601|536853713|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
148829256|NCT02655601|536853714|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
148829257|NCT02655601|536853715|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
148829258|NCT01969409|536853716|FG000|Overall Study|Death|2|||
148829259|NCT01969409|536853717|FG001|Overall Study|Death|2|||
148829260|NCT01969409|536853716|FG000|Overall Study|Transplant|1|||
148829261|NCT01969409|536853717|FG001|Overall Study|Transplant|1|||
148979500|NCT02501096|537404465|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
148979501|NCT02501096|537404466|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
148829262|NCT01969409|536853716|FG000|Overall Study|Withdrawal by Subject|0|||
148829263|NCT01969409|536853717|FG001|Overall Study|Withdrawal by Subject|1|||
148829264|NCT02799043|536853720|FG000|Overall Study|Adverse Event|0|||
148829265|NCT02799043|536853721|FG001|Overall Study|Adverse Event|1|||
148829266|NCT02799043|536853720|FG000|Overall Study|Death|1|||
148829267|NCT02799043|536853721|FG001|Overall Study|Death|1|||
148829268|NCT02799043|536853720|FG000|Overall Study|Lost to Follow-up|3|||
148829269|NCT02799043|536853721|FG001|Overall Study|Lost to Follow-up|6|||
148829270|NCT02799043|536853720|FG000|Overall Study|Withdrawal by Subject|4|||
148829271|NCT02799043|536853721|FG001|Overall Study|Withdrawal by Subject|4|||
148829272|NCT02799043|536853720|FG000|Overall Study|Moved to different country|0|||
148829273|NCT02799043|536853721|FG001|Overall Study|Moved to different country|1|||
148767817|NCT03063086|536623531|FG000|Overall Study|subject/guardian decision|1|||
148767818|NCT03063086|536623532|FG001|Overall Study|subject/guardian decision|0|||
148767819|NCT03063086|536623533|FG002|Overall Study|subject/guardian decision|0|||
148767820|NCT03063086|536623534|FG003|Overall Study|subject/guardian decision|0|||
148767821|NCT03063086|536623535|FG004|Overall Study|subject/guardian decision|0|||
148767822|NCT03063086|536623536|FG005|Overall Study|subject/guardian decision|0|||
148767823|NCT03063086|536623531|FG000|Overall Study|Non-compliance with study treatment|0|||
148767824|NCT03063086|536623532|FG001|Overall Study|Non-compliance with study treatment|0|||
148767825|NCT03063086|536623533|FG002|Overall Study|Non-compliance with study treatment|0|||
148767826|NCT03063086|536623534|FG003|Overall Study|Non-compliance with study treatment|1|||
148767827|NCT03063086|536623535|FG004|Overall Study|Non-compliance with study treatment|0|||
148767828|NCT03063086|536623536|FG005|Overall Study|Non-compliance with study treatment|1|||
148767829|NCT03063086|536623531|FG000|Overall Study|Physician Decision|0|||
148767830|NCT03063086|536623532|FG001|Overall Study|Physician Decision|0|||
148767831|NCT03063086|536623533|FG002|Overall Study|Physician Decision|0|||
148767832|NCT03063086|536623534|FG003|Overall Study|Physician Decision|1|||
148767833|NCT03063086|536623535|FG004|Overall Study|Physician Decision|0|||
148767834|NCT03063086|536623536|FG005|Overall Study|Physician Decision|0|||
148767835|NCT04590586|536623537|FG000|Overall Study|Death|7|||
148767836|NCT04590586|536623538|FG001|Overall Study|Death|1|||
148767837|NCT04590586|536623539|FG002|Overall Study|Death|37|||
148767838|NCT04590586|536623540|FG003|Overall Study|Death|34|||
148767839|NCT04590586|536623541|FG004|Overall Study|Death|19|||
148767840|NCT04590586|536623542|FG005|Overall Study|Death|3|||
148767841|NCT04590586|536623537|FG000|Overall Study|Lost to Follow-up|3|||
148767842|NCT04590586|536623538|FG001|Overall Study|Lost to Follow-up|0|||
148767843|NCT04590586|536623539|FG002|Overall Study|Lost to Follow-up|11|||
148767844|NCT04590586|536623540|FG003|Overall Study|Lost to Follow-up|11|||
148767845|NCT04590586|536623541|FG004|Overall Study|Lost to Follow-up|6|||
148767846|NCT04590586|536623542|FG005|Overall Study|Lost to Follow-up|0|||
148767847|NCT04590586|536623537|FG000|Overall Study|Withdrawal by Subject|0|||
148767848|NCT04590586|536623538|FG001|Overall Study|Withdrawal by Subject|0|||
148767849|NCT04590586|536623539|FG002|Overall Study|Withdrawal by Subject|6|||
148767850|NCT04590586|536623540|FG003|Overall Study|Withdrawal by Subject|0|||
148767851|NCT04590586|536623541|FG004|Overall Study|Withdrawal by Subject|3|||
148767852|NCT04590586|536623542|FG005|Overall Study|Withdrawal by Subject|0|||
148767853|NCT04590586|536623537|FG000|Overall Study|Other|3|||
148767854|NCT04590586|536623538|FG001|Overall Study|Other|0|||
148767855|NCT04590586|536623539|FG002|Overall Study|Other|1|||
148767856|NCT04590586|536623540|FG003|Overall Study|Other|1|||
148767857|NCT04590586|536623541|FG004|Overall Study|Other|2|||
148767858|NCT04590586|536623542|FG005|Overall Study|Other|1|||
148767859|NCT01893281|536623543|FG000|Overall Study|Adverse Event|1|||
148767860|NCT01893281|536623543|FG000|Overall Study|Protocol Violation|1|||
148767861|NCT01893281|536623543|FG000|Overall Study|Withdrawal by Subject|1|||
148767862|NCT02244463|536623546|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
148767863|NCT02244463|536623547|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
148767864|NCT02244463|536623548|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
148767865|NCT02244463|536623549|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
148767866|NCT02244463|536623550|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
148767867|NCT02244463|536623551|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
148767868|NCT02244463|536623546|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
148767869|NCT02244463|536623547|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
148767870|NCT02244463|536623548|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
148767871|NCT02244463|536623549|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
148767872|NCT02244463|536623550|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
148767873|NCT02244463|536623551|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
148767874|NCT02244463|536623546|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
148767875|NCT02244463|536623547|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
148767876|NCT02244463|536623548|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
148767877|NCT02244463|536623549|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
148767878|NCT02244463|536623550|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
148767879|NCT02244463|536623551|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
148767880|NCT02244463|536623546|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
148767881|NCT02244463|536623547|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
148767882|NCT02244463|536623548|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
148767883|NCT02244463|536623549|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
148767884|NCT02244463|536623550|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
148767885|NCT02244463|536623551|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
148767886|NCT02244463|536623546|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
148767887|NCT02244463|536623547|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
148767888|NCT02244463|536623548|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
148767889|NCT02244463|536623549|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
148767890|NCT02244463|536623550|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
148767891|NCT02244463|536623551|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
148767892|NCT02244463|536623546|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
148767893|NCT02244463|536623547|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
148767894|NCT02244463|536623548|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
148767895|NCT02244463|536623549|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
148767896|NCT02244463|536623550|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
148767897|NCT02244463|536623551|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
148767898|NCT02244463|536623546|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
148767899|NCT02244463|536623547|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
148767900|NCT02244463|536623548|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
148767901|NCT02244463|536623549|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
148767902|NCT02244463|536623550|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
148767903|NCT02244463|536623551|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
148767904|NCT02244463|536623546|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
148767905|NCT02244463|536623547|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
148767906|NCT02244463|536623548|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
148767907|NCT02244463|536623549|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
148767908|NCT02244463|536623550|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
148767909|NCT02244463|536623551|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
148767910|NCT02244463|536623546|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
148767911|NCT02244463|536623547|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
148767912|NCT02244463|536623548|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
148767913|NCT02244463|536623549|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
148767914|NCT02244463|536623550|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
148767915|NCT02244463|536623551|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
148767916|NCT02244463|536623546|FG000|Period 5: Phase II|Disease Progression|0|||
148767917|NCT02244463|536623547|FG001|Period 5: Phase II|Disease Progression|0|||
148767918|NCT02244463|536623548|FG002|Period 5: Phase II|Disease Progression|0|||
148767919|NCT02244463|536623549|FG003|Period 5: Phase II|Disease Progression|0|||
148767920|NCT02244463|536623550|FG004|Period 5: Phase II|Disease Progression|10|||
148767921|NCT02244463|536623551|FG005|Period 5: Phase II|Disease Progression|11|||
148767922|NCT02244463|536623546|FG000|Period 5: Phase II|Physician Decision|0|||
148767923|NCT02244463|536623547|FG001|Period 5: Phase II|Physician Decision|0|||
148767924|NCT02244463|536623548|FG002|Period 5: Phase II|Physician Decision|0|||
148767925|NCT02244463|536623549|FG003|Period 5: Phase II|Physician Decision|0|||
148767926|NCT02244463|536623550|FG004|Period 5: Phase II|Physician Decision|3|||
148767927|NCT02244463|536623551|FG005|Period 5: Phase II|Physician Decision|2|||
148767928|NCT02244463|536623546|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
148767929|NCT02244463|536623547|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
148767930|NCT02244463|536623548|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
148767931|NCT02244463|536623549|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
148767932|NCT02244463|536623550|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
148767933|NCT02244463|536623551|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
148767934|NCT02244463|536623546|FG000|Period 5: Phase II|Intercurrent Illness|0|||
148767935|NCT02244463|536623547|FG001|Period 5: Phase II|Intercurrent Illness|0|||
148767936|NCT02244463|536623548|FG002|Period 5: Phase II|Intercurrent Illness|0|||
148767937|NCT02244463|536623549|FG003|Period 5: Phase II|Intercurrent Illness|0|||
148767938|NCT02244463|536623550|FG004|Period 5: Phase II|Intercurrent Illness|2|||
148767939|NCT02244463|536623551|FG005|Period 5: Phase II|Intercurrent Illness|0|||
148767940|NCT02244463|536623546|FG000|Period 5: Phase II|Adverse Event|0|||
148767941|NCT02244463|536623547|FG001|Period 5: Phase II|Adverse Event|0|||
148767942|NCT02244463|536623548|FG002|Period 5: Phase II|Adverse Event|0|||
148767943|NCT02244463|536623549|FG003|Period 5: Phase II|Adverse Event|0|||
148767944|NCT02244463|536623550|FG004|Period 5: Phase II|Adverse Event|0|||
148767945|NCT02244463|536623551|FG005|Period 5: Phase II|Adverse Event|2|||
148767946|NCT02244463|536623546|FG000|Period 5: Phase II|Still On treatment|0|||
148767947|NCT02244463|536623547|FG001|Period 5: Phase II|Still On treatment|0|||
148767948|NCT02244463|536623548|FG002|Period 5: Phase II|Still On treatment|0|||
148767949|NCT02244463|536623549|FG003|Period 5: Phase II|Still On treatment|0|||
148767950|NCT02244463|536623550|FG004|Period 5: Phase II|Still On treatment|0|||
148767951|NCT02244463|536623551|FG005|Period 5: Phase II|Still On treatment|3|||
148767952|NCT05481125|536623552|FG000|Overall Study|Adverse Event|1|||
148767953|NCT05481125|536623553|FG001|Overall Study|Adverse Event|0|||
148767954|NCT05481125|536623552|FG000|Overall Study|Lost to Follow-up|0|||
148767955|NCT05481125|536623553|FG001|Overall Study|Lost to Follow-up|1|||
148767956|NCT05481125|536623552|FG000|Overall Study|Withdrawal by Subject|0|||
148767957|NCT05481125|536623553|FG001|Overall Study|Withdrawal by Subject|1|||
148767958|NCT01769508|536623554|FG000|Overall Study|Death|3|||
148767959|NCT01769508|536623554|FG000|Overall Study|Withdrawal by Subject|1|||
148767960|NCT01769508|536623554|FG000|Overall Study|Adverse Event|1|||
148767961|NCT01769508|536623554|FG000|Overall Study|Lost to Follow-up|1|||
148767962|NCT00562302|536623558|FG000|Overall Study|Lost to Follow-up|3|||
148767963|NCT00562302|536623559|FG001|Overall Study|Lost to Follow-up|3|||
148829274|NCT02799043|536853720|FG000|Overall Study|Trial Screen Failure|1|||
148829275|NCT02799043|536853721|FG001|Overall Study|Trial Screen Failure|0|||
148829276|NCT02799043|536853720|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
148829277|NCT02799043|536853721|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
148829278|NCT01554904|536853722|FG000|Overall Study|Withdrawal by Subject|3|||
148829279|NCT01554904|536853722|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
148829280|NCT01051661|536853725|FG000|Overall Study|Adverse Event|1|||
148829281|NCT01051661|536853726|FG001|Overall Study|Adverse Event|1|||
148829282|NCT01051661|536853727|FG002|Overall Study|Adverse Event|1|||
148829283|NCT01051661|536853728|FG003|Overall Study|Adverse Event|1|||
148829284|NCT01051661|536853729|FG004|Overall Study|Adverse Event|0|||
148829285|NCT01051661|536853730|FG005|Overall Study|Adverse Event|0|||
148829286|NCT01051661|536853725|FG000|Overall Study|Lost to Follow-up|13|||
148829287|NCT01051661|536853726|FG001|Overall Study|Lost to Follow-up|22|||
148829288|NCT01051661|536853727|FG002|Overall Study|Lost to Follow-up|15|||
148829289|NCT01051661|536853728|FG003|Overall Study|Lost to Follow-up|17|||
148829290|NCT01051661|536853729|FG004|Overall Study|Lost to Follow-up|10|||
148829291|NCT01051661|536853730|FG005|Overall Study|Lost to Follow-up|24|||
148829292|NCT01051661|536853725|FG000|Overall Study|Migrated/moved from study area|1|||
148829293|NCT01051661|536853726|FG001|Overall Study|Migrated/moved from study area|6|||
148829294|NCT01051661|536853727|FG002|Overall Study|Migrated/moved from study area|6|||
148829295|NCT01051661|536853728|FG003|Overall Study|Migrated/moved from study area|8|||
148829296|NCT01051661|536853729|FG004|Overall Study|Migrated/moved from study area|7|||
148829297|NCT01051661|536853730|FG005|Overall Study|Migrated/moved from study area|3|||
148829298|NCT01051661|536853725|FG000|Overall Study|Refused blood sampling|0|||
148829299|NCT01051661|536853726|FG001|Overall Study|Refused blood sampling|0|||
148829300|NCT01051661|536853727|FG002|Overall Study|Refused blood sampling|0|||
148829301|NCT01051661|536853728|FG003|Overall Study|Refused blood sampling|0|||
148829302|NCT01051661|536853729|FG004|Overall Study|Refused blood sampling|0|||
148829303|NCT01051661|536853730|FG005|Overall Study|Refused blood sampling|1|||
148829304|NCT01051661|536853725|FG000|Overall Study|Data not reliable|1|||
148829305|NCT01051661|536853726|FG001|Overall Study|Data not reliable|0|||
148829306|NCT01051661|536853727|FG002|Overall Study|Data not reliable|0|||
148829307|NCT01051661|536853728|FG003|Overall Study|Data not reliable|0|||
148829308|NCT01051661|536853729|FG004|Overall Study|Data not reliable|0|||
148829309|NCT01051661|536853730|FG005|Overall Study|Data not reliable|1|||
148829310|NCT01051661|536853725|FG000|Overall Study|Unable to attend visit(s)|2|||
148829311|NCT01051661|536853726|FG001|Overall Study|Unable to attend visit(s)|4|||
148829312|NCT01051661|536853727|FG002|Overall Study|Unable to attend visit(s)|2|||
148829313|NCT01051661|536853728|FG003|Overall Study|Unable to attend visit(s)|1|||
148829314|NCT01051661|536853729|FG004|Overall Study|Unable to attend visit(s)|3|||
148829315|NCT01051661|536853730|FG005|Overall Study|Unable to attend visit(s)|2|||
148829316|NCT01051661|536853725|FG000|Overall Study|Consent not received from both parents|0|||
148829317|NCT01051661|536853726|FG001|Overall Study|Consent not received from both parents|0|||
148829318|NCT01051661|536853727|FG002|Overall Study|Consent not received from both parents|0|||
148829319|NCT01051661|536853728|FG003|Overall Study|Consent not received from both parents|0|||
148829320|NCT01051661|536853729|FG004|Overall Study|Consent not received from both parents|0|||
148829321|NCT01051661|536853730|FG005|Overall Study|Consent not received from both parents|1|||
148829322|NCT01051661|536853725|FG000|Overall Study|Failure to comply with protocol|0|||
148829323|NCT01051661|536853726|FG001|Overall Study|Failure to comply with protocol|0|||
148829324|NCT01051661|536853727|FG002|Overall Study|Failure to comply with protocol|2|||
148829325|NCT01051661|536853728|FG003|Overall Study|Failure to comply with protocol|0|||
148829326|NCT01051661|536853729|FG004|Overall Study|Failure to comply with protocol|0|||
148829327|NCT01051661|536853730|FG005|Overall Study|Failure to comply with protocol|0|||
148829328|NCT01051661|536853725|FG000|Overall Study|Subject lost legal representation|0|||
148829329|NCT01051661|536853726|FG001|Overall Study|Subject lost legal representation|0|||
148829330|NCT01051661|536853727|FG002|Overall Study|Subject lost legal representation|0|||
148829331|NCT01051661|536853728|FG003|Overall Study|Subject lost legal representation|0|||
148829332|NCT01051661|536853729|FG004|Overall Study|Subject lost legal representation|1|||
148829333|NCT01051661|536853730|FG005|Overall Study|Subject lost legal representation|0|||
148829334|NCT01051661|536853725|FG000|Overall Study|Protocol Violation|0|||
148829335|NCT01051661|536853726|FG001|Overall Study|Protocol Violation|0|||
148829336|NCT01051661|536853727|FG002|Overall Study|Protocol Violation|0|||
148829337|NCT01051661|536853728|FG003|Overall Study|Protocol Violation|1|||
148829338|NCT01051661|536853729|FG004|Overall Study|Protocol Violation|2|||
148829339|NCT01051661|536853730|FG005|Overall Study|Protocol Violation|1|||
148829340|NCT01051661|536853725|FG000|Overall Study|Withdrawal by Subject|16|||
148829341|NCT01051661|536853726|FG001|Overall Study|Withdrawal by Subject|30|||
148829342|NCT01051661|536853727|FG002|Overall Study|Withdrawal by Subject|13|||
148829343|NCT01051661|536853728|FG003|Overall Study|Withdrawal by Subject|28|||
148829344|NCT01051661|536853729|FG004|Overall Study|Withdrawal by Subject|12|||
148829345|NCT01051661|536853730|FG005|Overall Study|Withdrawal by Subject|34|||
148829346|NCT01922895|536853731|FG000|Overall Study|Death|0|||
148829347|NCT01922895|536853732|FG001|Overall Study|Death|1|||
148829348|NCT01922895|536853731|FG000|Overall Study|Withdrawal by Subject|1|||
148767964|NCT00562302|536623558|FG000|Overall Study|Adverse Event|0|||
148767965|NCT00562302|536623559|FG001|Overall Study|Adverse Event|6|||
148767966|NCT00562302|536623558|FG000|Overall Study|Non-compliance|1|||
148767967|NCT00562302|536623559|FG001|Overall Study|Non-compliance|2|||
148767968|NCT00562302|536623558|FG000|Overall Study|Withdrawal by Subject|7|||
148767969|NCT00562302|536623559|FG001|Overall Study|Withdrawal by Subject|8|||
148767970|NCT00562302|536623558|FG000|Overall Study|Death|1|||
148767971|NCT00562302|536623559|FG001|Overall Study|Death|2|||
148767972|NCT00562302|536623558|FG000|Overall Study|Lung resection prior to study completion|7|||
148767973|NCT00562302|536623559|FG001|Overall Study|Lung resection prior to study completion|7|||
148767974|NCT00562302|536623558|FG000|Overall Study|Not stated|1|||
148767975|NCT00562302|536623559|FG001|Overall Study|Not stated|4|||
148767976|NCT01290679|536623560|FG000|Overall Study|Adverse Event|2|||
148767977|NCT01290679|536623561|FG001|Overall Study|Adverse Event|0|||
148767978|NCT01290679|536623560|FG000|Overall Study|Lost to Follow-up|8|||
148767979|NCT01290679|536623561|FG001|Overall Study|Lost to Follow-up|10|||
148767980|NCT01290679|536623560|FG000|Overall Study|Protocol Violation|0|||
148767981|NCT01290679|536623561|FG001|Overall Study|Protocol Violation|1|||
148767982|NCT01290679|536623560|FG000|Overall Study|Withdrawal by Subject|6|||
148767983|NCT01290679|536623561|FG001|Overall Study|Withdrawal by Subject|5|||
148767984|NCT01290679|536623560|FG000|Overall Study|Subject Entered Another Trial|0|||
148767985|NCT01290679|536623561|FG001|Overall Study|Subject Entered Another Trial|5|||
148767986|NCT03615144|536623562|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
148767987|NCT03615144|536623563|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
148767988|NCT02587598|536623564|FG000|Overall Study|Death|4|||
148767989|NCT02587598|536623565|FG001|Overall Study|Death|8|||
148767990|NCT02587598|536623566|FG002|Overall Study|Death|4|||
148767991|NCT02587598|536623567|FG003|Overall Study|Death|16|||
148767992|NCT02587598|536623568|FG004|Overall Study|Death|9|||
148767993|NCT02587598|536623569|FG005|Overall Study|Death|4|||
148767994|NCT02587598|536623570|FG006|Overall Study|Death|6|||
148767995|NCT02587598|536623571|FG007|Overall Study|Death|7|||
148767996|NCT02587598|536623572|FG008|Overall Study|Death|9|||
148767997|NCT02587598|536623573|FG009|Overall Study|Death|1|||
148767998|NCT02587598|536623574|FG010|Overall Study|Death|3|||
148767999|NCT02587598|536623564|FG000|Overall Study|Study Terminated by the Sponsor|0|||
148768000|NCT02587598|536623565|FG001|Overall Study|Study Terminated by the Sponsor|1|||
148768001|NCT02587598|536623566|FG002|Overall Study|Study Terminated by the Sponsor|0|||
148768002|NCT02587598|536623567|FG003|Overall Study|Study Terminated by the Sponsor|3|||
148768003|NCT02587598|536623568|FG004|Overall Study|Study Terminated by the Sponsor|0|||
148768004|NCT02587598|536623569|FG005|Overall Study|Study Terminated by the Sponsor|1|||
148768005|NCT02587598|536623570|FG006|Overall Study|Study Terminated by the Sponsor|0|||
148768006|NCT02587598|536623571|FG007|Overall Study|Study Terminated by the Sponsor|0|||
148768007|NCT02587598|536623572|FG008|Overall Study|Study Terminated by the Sponsor|0|||
148768008|NCT02587598|536623573|FG009|Overall Study|Study Terminated by the Sponsor|1|||
148768009|NCT02587598|536623574|FG010|Overall Study|Study Terminated by the Sponsor|6|||
148768010|NCT02587598|536623564|FG000|Overall Study|Reason for study withdrawal not specified|0|||
148768011|NCT02587598|536623565|FG001|Overall Study|Reason for study withdrawal not specified|1|||
148768012|NCT02587598|536623566|FG002|Overall Study|Reason for study withdrawal not specified|0|||
148768013|NCT02587598|536623567|FG003|Overall Study|Reason for study withdrawal not specified|0|||
148768014|NCT02587598|536623568|FG004|Overall Study|Reason for study withdrawal not specified|0|||
148768015|NCT02587598|536623569|FG005|Overall Study|Reason for study withdrawal not specified|0|||
148768016|NCT02587598|536623570|FG006|Overall Study|Reason for study withdrawal not specified|0|||
148768017|NCT02587598|536623571|FG007|Overall Study|Reason for study withdrawal not specified|0|||
148768018|NCT02587598|536623572|FG008|Overall Study|Reason for study withdrawal not specified|0|||
148768019|NCT02587598|536623573|FG009|Overall Study|Reason for study withdrawal not specified|0|||
148768020|NCT02587598|536623574|FG010|Overall Study|Reason for study withdrawal not specified|0|||
148768021|NCT02587598|536623564|FG000|Overall Study|Withdrawal by Subject|0|||
148768022|NCT02587598|536623565|FG001|Overall Study|Withdrawal by Subject|1|||
148768023|NCT02587598|536623566|FG002|Overall Study|Withdrawal by Subject|0|||
148768024|NCT02587598|536623567|FG003|Overall Study|Withdrawal by Subject|2|||
148768025|NCT02587598|536623568|FG004|Overall Study|Withdrawal by Subject|3|||
148768026|NCT02587598|536623569|FG005|Overall Study|Withdrawal by Subject|1|||
148768027|NCT02587598|536623570|FG006|Overall Study|Withdrawal by Subject|0|||
148768028|NCT02587598|536623571|FG007|Overall Study|Withdrawal by Subject|0|||
148768029|NCT02587598|536623572|FG008|Overall Study|Withdrawal by Subject|0|||
148768030|NCT02587598|536623573|FG009|Overall Study|Withdrawal by Subject|1|||
148768031|NCT02587598|536623574|FG010|Overall Study|Withdrawal by Subject|2|||
148768032|NCT02587598|536623564|FG000|Overall Study|Physician Decision|0|||
148768033|NCT02587598|536623565|FG001|Overall Study|Physician Decision|0|||
148768034|NCT02587598|536623566|FG002|Overall Study|Physician Decision|0|||
148768035|NCT02587598|536623567|FG003|Overall Study|Physician Decision|0|||
148829349|NCT01922895|536853732|FG001|Overall Study|Withdrawal by Subject|2|||
148829350|NCT01922895|536853731|FG000|Overall Study|Lost to Follow-up|5|||
148829351|NCT01922895|536853732|FG001|Overall Study|Lost to Follow-up|11|||
148829352|NCT01916226|536853733|FG000|Overall Study|Adverse Event|1|||
148829353|NCT01916226|536853734|FG001|Overall Study|Adverse Event|0|||
148829354|NCT01916226|536853735|FG002|Overall Study|Adverse Event|1|||
148829355|NCT01916226|536853736|FG003|Overall Study|Adverse Event|1|||
148829356|NCT01916226|536853733|FG000|Overall Study|Lack of Efficacy|0|||
148829357|NCT01916226|536853734|FG001|Overall Study|Lack of Efficacy|0|||
148829358|NCT01916226|536853735|FG002|Overall Study|Lack of Efficacy|2|||
148829359|NCT01916226|536853736|FG003|Overall Study|Lack of Efficacy|1|||
148829360|NCT01916226|536853733|FG000|Overall Study|Protocol Violation|0|||
148829361|NCT01916226|536853734|FG001|Overall Study|Protocol Violation|1|||
148829362|NCT01916226|536853735|FG002|Overall Study|Protocol Violation|0|||
148829363|NCT01916226|536853736|FG003|Overall Study|Protocol Violation|1|||
148829364|NCT01916226|536853733|FG000|Overall Study|Physician Decision|0|||
148829365|NCT01916226|536853734|FG001|Overall Study|Physician Decision|0|||
148829366|NCT01916226|536853735|FG002|Overall Study|Physician Decision|0|||
148829367|NCT01916226|536853736|FG003|Overall Study|Physician Decision|1|||
148829368|NCT05142306|536853738|FG000|Overall Study|Withdrawal by Subject|0|||
148829369|NCT05142306|536853739|FG001|Overall Study|Withdrawal by Subject|0|||
148829370|NCT05142306|536853740|FG002|Overall Study|Withdrawal by Subject|1|||
148829371|NCT05305651|536853746|FG000|Overall Study|Death|1|||
148829372|NCT05305651|536853746|FG000|Overall Study|Withdrawal by Subject|4|||
148829373|NCT05305651|536853746|FG000|Overall Study|Lost to Follow-up|4|||
148829374|NCT00967499|536853751|FG000|Overall Study|Adverse Event|0|||
148829375|NCT00967499|536853752|FG001|Overall Study|Adverse Event|1|||
148829376|NCT00967499|536853751|FG000|Overall Study|Protocol Violation|1|||
148829377|NCT00967499|536853752|FG001|Overall Study|Protocol Violation|0|||
148829378|NCT00967499|536853751|FG000|Overall Study|Sponsor Decision|1|||
148829379|NCT00967499|536853752|FG001|Overall Study|Sponsor Decision|0|||
148829380|NCT00967499|536853751|FG000|Overall Study|Randomized but not treated|63|||
148829381|NCT00967499|536853752|FG001|Overall Study|Randomized but not treated|59|||
148829382|NCT00050011|536853755|FG000|Overall Study|Adverse Event|41|||
148829383|NCT00050011|536853756|FG001|Overall Study|Adverse Event|46|||
148829384|NCT00050011|536853755|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148829385|NCT00050011|536853756|FG001|Overall Study|Abnormal laboratory value(s)|1|||
148829386|NCT00050011|536853755|FG000|Overall Study|Abnormal test procedure results|0|||
148829387|NCT00050011|536853756|FG001|Overall Study|Abnormal test procedure results|1|||
148829388|NCT00050011|536853755|FG000|Overall Study|Lack of Efficacy|16|||
148829389|NCT00050011|536853756|FG001|Overall Study|Lack of Efficacy|21|||
148829390|NCT00050011|536853755|FG000|Overall Study|Participant condition no longer required|1|||
148829391|NCT00050011|536853756|FG001|Overall Study|Participant condition no longer required|0|||
148829392|NCT00050011|536853755|FG000|Overall Study|Protocol Violation|4|||
148829393|NCT00050011|536853756|FG001|Overall Study|Protocol Violation|10|||
148829394|NCT00050011|536853755|FG000|Overall Study|Withdrawal by Subject|34|||
148829395|NCT00050011|536853756|FG001|Overall Study|Withdrawal by Subject|26|||
148829396|NCT00050011|536853755|FG000|Overall Study|Lost to Follow-up|7|||
148829397|NCT00050011|536853756|FG001|Overall Study|Lost to Follow-up|9|||
148829398|NCT00050011|536853755|FG000|Overall Study|Administrative problems|10|||
148829399|NCT00050011|536853756|FG001|Overall Study|Administrative problems|6|||
148829400|NCT00050011|536853755|FG000|Overall Study|Death|7|||
148829401|NCT00050011|536853756|FG001|Overall Study|Death|4|||
148829402|NCT00050011|536853755|FG000|Overall Study|Unknown - Reason is missing|0|||
148829403|NCT00050011|536853756|FG001|Overall Study|Unknown - Reason is missing|2|||
148829408|NCT04197583|536853760|FG000|Overall Study|Study Stent Replacement|34|||
148829409|NCT04197583|536853761|FG001|Overall Study|Study Stent Replacement|8|||
148829410|NCT04197583|536853760|FG000|Overall Study|Lost to Follow-up|14|||
148829411|NCT04197583|536853761|FG001|Overall Study|Lost to Follow-up|3|||
148829412|NCT04197583|536853760|FG000|Overall Study|Death|3|||
148829413|NCT04197583|536853761|FG001|Overall Study|Death|0|||
148829414|NCT04197583|536853760|FG000|Overall Study|Physician Decision|1|||
148829415|NCT04197583|536853761|FG001|Overall Study|Physician Decision|0|||
148829416|NCT04197583|536853760|FG000|Overall Study|Withdrawal by Subject|1|||
148829417|NCT04197583|536853761|FG001|Overall Study|Withdrawal by Subject|1|||
148829418|NCT04197583|536853760|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
148829419|NCT04197583|536853761|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
148829420|NCT04197583|536853760|FG000|Overall Study|Screen Failure|0|||
148829421|NCT04197583|536853761|FG001|Overall Study|Screen Failure|20|||
148829422|NCT04134936|536853762|FG000|Overall Study|Adverse Event|3|||
148829423|NCT04134936|536853763|FG001|Overall Study|Adverse Event|2|||
148829424|NCT04134936|536853762|FG000|Overall Study|Withdrawal by Subject|2|||
148829425|NCT04134936|536853763|FG001|Overall Study|Withdrawal by Subject|3|||
148829426|NCT04134936|536853762|FG000|Overall Study|Physician Decision|0|||
148829427|NCT04134936|536853763|FG001|Overall Study|Physician Decision|1|||
148829428|NCT04134936|536853762|FG000|Overall Study|Progressive disease, joined another trial|1|||
148829429|NCT04134936|536853763|FG001|Overall Study|Progressive disease, joined another trial|0|||
148829430|NCT04134936|536853762|FG000|Overall Study|Progressive disease|1|||
148829431|NCT04134936|536853763|FG001|Overall Study|Progressive disease|0|||
148829432|NCT03518060|536853764|FG000|Overall Study|Death|1|||
148829433|NCT03518060|536853764|FG000|Overall Study|Poor adherence|1|||
148829434|NCT03518060|536853764|FG000|Overall Study|Withdrawal of informed consent|2|||
148829435|NCT03518060|536853764|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
148829436|NCT03518060|536853764|FG000|Overall Study|Physician Decision|7|||
148829437|NCT03518060|536853764|FG000|Overall Study|Adverse drug reactions|23|||
148829438|NCT03518060|536853764|FG000|Overall Study|Withdrawal by Subject|25|||
148829439|NCT03518060|536853764|FG000|Overall Study|Lost to Follow-up|13|||
148829440|NCT04629196|536853766|FG000|Overall Study|Subject discontinued study drug|1|||
148829441|NCT04629196|536853767|FG001|Overall Study|Subject discontinued study drug|0|||
148829442|NCT04629196|536853766|FG000|Overall Study|Subject study drug dosing increased|1|||
148829443|NCT04629196|536853767|FG001|Overall Study|Subject study drug dosing increased|1|||
148829444|NCT04629196|536853766|FG000|Overall Study|Withdrawal by Subject|1|||
148829445|NCT04629196|536853767|FG001|Overall Study|Withdrawal by Subject|2|||
148829446|NCT05810597|536853771|FG000|Period 1|Adverse Event|2|||
148829447|NCT05810597|536853772|FG001|Period 1|Adverse Event|0|||
148829448|NCT05810597|536853771|FG000|Period 1|Physician Decision|1|||
148829449|NCT05810597|536853772|FG001|Period 1|Physician Decision|0|||
148829450|NCT01450631|536853773|FG000|Overall Study|Lost to Follow-up|2|||
148829451|NCT01450631|536853774|FG001|Overall Study|Lost to Follow-up|4|||
148829452|NCT01450631|536853773|FG000|Overall Study|Withdrawal by Subject|1|||
148829453|NCT01450631|536853774|FG001|Overall Study|Withdrawal by Subject|0|||
148829454|NCT04903093|536853777|FG000|Overall Study|Withdrawal by Subject|0|||
148829455|NCT04903093|536853778|FG001|Overall Study|Withdrawal by Subject|0|||
148829456|NCT04903093|536853779|FG002|Overall Study|Withdrawal by Subject|0|||
148829457|NCT04903093|536853780|FG003|Overall Study|Withdrawal by Subject|1|||
148829458|NCT04903093|536853781|FG004|Overall Study|Withdrawal by Subject|0|||
148829459|NCT04903093|536853782|FG005|Overall Study|Withdrawal by Subject|0|||
148829460|NCT02412436|536853788|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
148829461|NCT02412436|536853788|FG000|Overall Study|Lost to Follow-up|6|||
148829462|NCT02412436|536853788|FG000|Overall Study|Unable to get to clinic|3|||
148829463|NCT02412436|536853788|FG000|Overall Study|Death|1|||
148829464|NCT02412436|536853788|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
148829465|NCT02544763|536853789|FG000|Overall Study|Adverse Event|8|||
148829466|NCT02544763|536853790|FG001|Overall Study|Adverse Event|8|||
148829467|NCT02544763|536853791|FG002|Overall Study|Adverse Event|0|||
148829468|NCT02544763|536853789|FG000|Overall Study|Withdrawn by parent/guardian|1|||
148829469|NCT02544763|536853790|FG001|Overall Study|Withdrawn by parent/guardian|1|||
148829470|NCT02544763|536853791|FG002|Overall Study|Withdrawn by parent/guardian|1|||
148829471|NCT02544763|536853789|FG000|Overall Study|Met withdrawal criteria|0|||
148829472|NCT02544763|536853790|FG001|Overall Study|Met withdrawal criteria|2|||
148829473|NCT02544763|536853791|FG002|Overall Study|Met withdrawal criteria|0|||
148829474|NCT02544763|536853789|FG000|Overall Study|Physician Decision|0|||
148829475|NCT02544763|536853790|FG001|Overall Study|Physician Decision|1|||
148829476|NCT02544763|536853791|FG002|Overall Study|Physician Decision|0|||
148829477|NCT02544763|536853789|FG000|Overall Study|Difficulties taking IMP|1|||
148829478|NCT02544763|536853790|FG001|Overall Study|Difficulties taking IMP|0|||
148829479|NCT02544763|536853791|FG002|Overall Study|Difficulties taking IMP|0|||
148829480|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
148829481|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
148829482|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
148829483|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
148829484|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
148829485|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
148829486|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
148829487|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
148829488|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
148829489|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
148829490|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
148829491|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
148829492|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
148829493|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
148829494|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
148829495|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
148829496|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
148829497|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
148829498|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
148829499|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
148829500|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
148829501|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
148829502|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
148829503|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
148829504|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
148829505|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
148829506|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
148829507|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
148829508|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
148829509|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
148829510|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
148829511|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
148829512|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
148829513|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
148829514|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
148829515|NCT01111552|536853792|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
148829516|NCT01111552|536853793|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
148829517|NCT01111552|536853794|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
148829518|NCT01111552|536853795|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
148829519|NCT01111552|536853796|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
148829520|NCT01111552|536853792|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148829521|NCT01111552|536853793|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148829522|NCT01111552|536853794|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148829523|NCT01111552|536853795|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
148829524|NCT01111552|536853796|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
148829525|NCT01111552|536853792|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
148829526|NCT01111552|536853793|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
148829527|NCT01111552|536853794|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
148829528|NCT01111552|536853795|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
148829529|NCT01111552|536853796|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
148829530|NCT01111552|536853792|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
148829531|NCT01111552|536853793|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
148829532|NCT01111552|536853794|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
148829533|NCT01111552|536853795|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
148829534|NCT01111552|536853796|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
148829535|NCT01111552|536853792|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
148829536|NCT01111552|536853793|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
148979502|NCT02501096|537404467|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
148979503|NCT02501096|537404459|FG000|Overall Study|Death|1|||
148979504|NCT02501096|537404460|FG001|Overall Study|Death|1|||
148979505|NCT02501096|537404461|FG002|Overall Study|Death|88|||
148829537|NCT01111552|536853794|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
148829538|NCT01111552|536853795|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
148829539|NCT01111552|536853796|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
148829540|NCT01111552|536853792|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
148979506|NCT02501096|537404462|FG003|Overall Study|Death|74|||
148979507|NCT02501096|537404463|FG004|Overall Study|Death|15|||
148979508|NCT02501096|537404464|FG005|Overall Study|Death|16|||
148979509|NCT02501096|537404465|FG006|Overall Study|Death|15|||
148979510|NCT02501096|537404466|FG007|Overall Study|Death|16|||
148979511|NCT02501096|537404467|FG008|Overall Study|Death|1|||
148979512|NCT01712984|537404468|FG000|Overall Study|Adverse Event|0|||
148979513|NCT01712984|537404469|FG001|Overall Study|Adverse Event|0|||
148979514|NCT01712984|537404470|FG002|Overall Study|Adverse Event|1|||
148979515|NCT01712984|537404468|FG000|Overall Study|Protocol Violation|2|||
148979516|NCT01712984|537404469|FG001|Overall Study|Protocol Violation|0|||
148979517|NCT01712984|537404470|FG002|Overall Study|Protocol Violation|1|||
148979518|NCT01712984|537404468|FG000|Overall Study|Lost to Follow-up|8|||
148979519|NCT01712984|537404469|FG001|Overall Study|Lost to Follow-up|10|||
148979520|NCT01712984|537404470|FG002|Overall Study|Lost to Follow-up|1|||
148979521|NCT01712984|537404468|FG000|Overall Study|Withdrawal by Subject|6|||
148979522|NCT01712984|537404469|FG001|Overall Study|Withdrawal by Subject|6|||
148979523|NCT01712984|537404470|FG002|Overall Study|Withdrawal by Subject|7|||
148979524|NCT00512096|537404474|FG000|Overall Study|Adverse Event|2|||
148979525|NCT00512096|537404474|FG000|Overall Study|Withdrawal by Subject|2|||
148979526|NCT00512096|537404474|FG000|Overall Study|Lack of Efficacy|3|||
148979527|NCT01069289|537404478|FG000|Overall Study|Withdrawal by Subject|15|||
148979528|NCT01069289|537404479|FG001|Overall Study|Withdrawal by Subject|26|||
148829541|NCT01111552|536853793|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
148829542|NCT01111552|536853794|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
148829543|NCT01111552|536853795|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
148829544|NCT01111552|536853796|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
148829545|NCT01111552|536853792|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
148829546|NCT01111552|536853793|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
148829547|NCT01111552|536853794|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
148829548|NCT01111552|536853795|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
148829549|NCT01111552|536853796|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
148829550|NCT01027351|536853797|FG000|Overall Study|Withdrawal by Subject|1|||
148829551|NCT01027351|536853798|FG001|Overall Study|Withdrawal by Subject|0|||
148829552|NCT01027351|536853799|FG002|Overall Study|Withdrawal by Subject|1|||
148829553|NCT01027351|536853800|FG003|Overall Study|Withdrawal by Subject|0|||
148829554|NCT01027351|536853801|FG004|Overall Study|Withdrawal by Subject|3|||
148829555|NCT01027351|536853802|FG005|Overall Study|Withdrawal by Subject|5|||
148829556|NCT01027351|536853797|FG000|Overall Study|Lost to Follow-up|1|||
148829557|NCT01027351|536853798|FG001|Overall Study|Lost to Follow-up|1|||
148829558|NCT01027351|536853799|FG002|Overall Study|Lost to Follow-up|0|||
148829559|NCT01027351|536853800|FG003|Overall Study|Lost to Follow-up|1|||
148829560|NCT01027351|536853801|FG004|Overall Study|Lost to Follow-up|6|||
148829561|NCT01027351|536853802|FG005|Overall Study|Lost to Follow-up|0|||
148829562|NCT01027351|536853797|FG000|Overall Study|Inappropriate enrollment|0|||
148829563|NCT01027351|536853798|FG001|Overall Study|Inappropriate enrollment|0|||
148829564|NCT01027351|536853799|FG002|Overall Study|Inappropriate enrollment|0|||
148829565|NCT01027351|536853800|FG003|Overall Study|Inappropriate enrollment|0|||
148829566|NCT01027351|536853801|FG004|Overall Study|Inappropriate enrollment|1|||
148829567|NCT01027351|536853802|FG005|Overall Study|Inappropriate enrollment|0|||
148829568|NCT01027351|536853797|FG000|Overall Study|Protocol Violation|1|||
148829569|NCT01027351|536853798|FG001|Overall Study|Protocol Violation|0|||
148829570|NCT01027351|536853799|FG002|Overall Study|Protocol Violation|0|||
148829571|NCT01027351|536853800|FG003|Overall Study|Protocol Violation|1|||
148829572|NCT01027351|536853801|FG004|Overall Study|Protocol Violation|1|||
148829573|NCT01027351|536853802|FG005|Overall Study|Protocol Violation|0|||
148829574|NCT04650893|536853803|FG000|Overall Study|Lost to Follow-up|11|||
148829575|NCT04650893|536853804|FG001|Overall Study|Lost to Follow-up|10|||
148829576|NCT04650893|536853805|FG002|Overall Study|Lost to Follow-up|11|||
148829577|NCT04090749|536853808|FG000|Open Label Pilot|Lost to Follow-up|1|||
148829578|NCT04090749|536853809|FG001|Open Label Pilot|Lost to Follow-up|0|||
148829579|NCT04090749|536853810|FG002|Open Label Pilot|Lost to Follow-up|0|||
148829580|NCT04090749|536853808|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
148829581|NCT04090749|536853809|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
148829582|NCT04090749|536853810|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
148829583|NCT04090749|536853808|FG000|Pilot Trial|Lost to Follow-up|0|||
148829584|NCT04090749|536853809|FG001|Pilot Trial|Lost to Follow-up|1|||
148829585|NCT04090749|536853810|FG002|Pilot Trial|Lost to Follow-up|1|||
148829586|NCT02528305|536853811|FG000|Overall Study|Withdrawal by Subject|1|||
148829587|NCT02528305|536853811|FG000|Overall Study|Adverse Event|1|||
148829588|NCT02528305|536853811|FG000|Overall Study|Physician Decision|1|||
148829589|NCT00421408|536853812|FG000|Overall Study|Lost to Follow-up|30|||
148829590|NCT00421408|536853813|FG001|Overall Study|Lost to Follow-up|20|||
148829591|NCT00421408|536853812|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
148829592|NCT00421408|536853813|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
148829593|NCT00461812|536853818|FG000|Overall Study|study terminated|10|||
148829594|NCT01308788|536853819|FG000|2-year Treatment|medication change by treating physician|4|||
148829595|NCT01308788|536853820|FG001|2-year Treatment|medication change by treating physician|11|||
148829596|NCT00322218|536853821|FG000|Overall Study|Death|3|||
148829597|NCT00322218|536853822|FG001|Overall Study|Death|6|||
148829598|NCT03193437|536853829|FG000|Overall Study|Adverse Event|4|||
148829599|NCT03193437|536853829|FG000|Overall Study|Withdrawal by Subject|2|||
148829600|NCT03193437|536853829|FG000|Overall Study|Disease Progression|2|||
148829601|NCT02414841|536853832|FG000|Overall Study|Withdrawal by Subject|7|||
148829602|NCT02414841|536853833|FG001|Overall Study|Withdrawal by Subject|5|||
148829603|NCT02414841|536853832|FG000|Overall Study|Lost to Follow-up|13|||
148979529|NCT01069289|537404478|FG000|Overall Study|Adverse Event|21|||
148979530|NCT01069289|537404479|FG001|Overall Study|Adverse Event|28|||
148829604|NCT02414841|536853833|FG001|Overall Study|Lost to Follow-up|6|||
148829605|NCT02414841|536853832|FG000|Overall Study|Death|17|||
148829606|NCT02414841|536853833|FG001|Overall Study|Death|14|||
148829607|NCT02414841|536853832|FG000|Overall Study|Received a Kidney Transplant|13|||
148829608|NCT02414841|536853833|FG001|Overall Study|Received a Kidney Transplant|4|||
148829609|NCT02414841|536853832|FG000|Overall Study|Randomized But Not Treated|6|||
148829610|NCT02414841|536853833|FG001|Overall Study|Randomized But Not Treated|4|||
148829611|NCT03941093|536853842|FG000|Overall Study|Protocol Violation|0|||
148829612|NCT03941093|536853843|FG001|Overall Study|Protocol Violation|1|||
148829613|NCT03941093|536853842|FG000|Overall Study|Withdrawal by Subject|9|||
148829614|NCT03941093|536853843|FG001|Overall Study|Withdrawal by Subject|6|||
148829615|NCT02374255|536855647|FG000|Overall Study|Withdrawal by Subject|2|||
148829616|NCT02374255|536855648|FG001|Overall Study|Withdrawal by Subject|0|||
148829617|NCT02374255|536855649|FG002|Overall Study|Withdrawal by Subject|0|||
148829618|NCT02374255|536855650|FG003|Overall Study|Withdrawal by Subject|0|||
148829619|NCT02093520|536855651|FG000|Overall Study|Not treated|6|||
148829620|NCT02093520|536855652|FG001|Overall Study|Not treated|22|||
148829621|NCT03014089|536855653|FG000|Overall Study|Withdrawal by Subject|0|||
148829622|NCT03014089|536855654|FG001|Overall Study|Withdrawal by Subject|1|||
148829623|NCT03014089|536855655|FG002|Overall Study|Withdrawal by Subject|1|||
148829624|NCT03014089|536855656|FG003|Overall Study|Withdrawal by Subject|1|||
148829625|NCT03014089|536855653|FG000|Overall Study|Lost to Follow-up|1|||
148829626|NCT03014089|536855654|FG001|Overall Study|Lost to Follow-up|0|||
148829627|NCT03014089|536855655|FG002|Overall Study|Lost to Follow-up|0|||
148829628|NCT03014089|536855656|FG003|Overall Study|Lost to Follow-up|0|||
148829629|NCT03014089|536855653|FG000|Overall Study|Adverse Event|1|||
148829630|NCT03014089|536855654|FG001|Overall Study|Adverse Event|0|||
148829631|NCT03014089|536855655|FG002|Overall Study|Adverse Event|1|||
148829632|NCT03014089|536855656|FG003|Overall Study|Adverse Event|0|||
148829633|NCT03360344|536855657|FG000|Overall Study|Withdrawal by Subject|0|||
148829634|NCT03360344|536855658|FG001|Overall Study|Withdrawal by Subject|1|||
148829635|NCT03360344|536855659|FG002|Overall Study|Withdrawal by Subject|1|||
148829636|NCT00133705|536855664|FG000|Overall Study|Withdrawal by Subject|2|||
148829637|NCT00133705|536855665|FG001|Overall Study|Withdrawal by Subject|3|||
148829638|NCT00337168|536855667|FG000|Overall Study|Death|5|||
148829639|NCT00337168|536855667|FG000|Overall Study|Not protocol specified|2|||
148829640|NCT00337168|536855667|FG000|Overall Study|Did not start therapy|1|||
148829641|NCT01217892|536855669|FG000|Overall Study|Adverse Event|1|||
148829642|NCT01217892|536855670|FG001|Overall Study|Adverse Event|1|||
148829643|NCT01217892|536855671|FG002|Overall Study|Adverse Event|1|||
148829644|NCT01217892|536855672|FG003|Overall Study|Adverse Event|0|||
148829645|NCT01217892|536855669|FG000|Overall Study|Withdrawal by Subject|0|||
148829646|NCT01217892|536855670|FG001|Overall Study|Withdrawal by Subject|2|||
148829647|NCT01217892|536855671|FG002|Overall Study|Withdrawal by Subject|1|||
148829648|NCT01217892|536855672|FG003|Overall Study|Withdrawal by Subject|0|||
148829649|NCT01217892|536855669|FG000|Overall Study|Lab value|1|||
148829650|NCT01217892|536855670|FG001|Overall Study|Lab value|0|||
148829651|NCT01217892|536855671|FG002|Overall Study|Lab value|1|||
148829652|NCT01217892|536855672|FG003|Overall Study|Lab value|0|||
148829653|NCT01217892|536855669|FG000|Overall Study|Subject no longer meets study criteria|5|||
148829654|NCT01217892|536855670|FG001|Overall Study|Subject no longer meets study criteria|2|||
148829655|NCT01217892|536855671|FG002|Overall Study|Subject no longer meets study criteria|4|||
148829656|NCT01217892|536855672|FG003|Overall Study|Subject no longer meets study criteria|8|||
148829657|NCT01217892|536855669|FG000|Overall Study|Incorrect enrollment|0|||
148829658|NCT01217892|536855670|FG001|Overall Study|Incorrect enrollment|1|||
148829659|NCT01217892|536855671|FG002|Overall Study|Incorrect enrollment|1|||
148829660|NCT01217892|536855672|FG003|Overall Study|Incorrect enrollment|0|||
148829661|NCT01217892|536855669|FG000|Overall Study|Poor/Non-Compliance|0|||
148829662|NCT01217892|536855670|FG001|Overall Study|Poor/Non-Compliance|0|||
148829663|NCT01217892|536855671|FG002|Overall Study|Poor/Non-Compliance|1|||
148829664|NCT01217892|536855672|FG003|Overall Study|Poor/Non-Compliance|0|||
148829665|NCT01052779|536855673|FG000|Overall Study|Adverse Event|1|||
148829666|NCT01052779|536855674|FG001|Overall Study|Adverse Event|4|||
148829667|NCT01052779|536855673|FG000|Overall Study|Withdrawal by Subject|1|||
148829668|NCT01052779|536855674|FG001|Overall Study|Withdrawal by Subject|2|||
148829669|NCT01052779|536855673|FG000|Overall Study|Other-Protocol Violation|1|||
148829670|NCT01052779|536855674|FG001|Overall Study|Other-Protocol Violation|1|||
148829671|NCT01052779|536855673|FG000|Overall Study|Other-Surgery|0|||
148829672|NCT01052779|536855674|FG001|Overall Study|Other-Surgery|2|||
148829673|NCT01052779|536855673|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
148829674|NCT01052779|536855674|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
148829675|NCT03663582|536855675|FG000|Overall Study|Physician Decision|1|||
148829676|NCT02367885|536855676|FG000|Overall Study|Lost to Follow-up|1|||
148829677|NCT02367885|536855677|FG001|Overall Study|Lost to Follow-up|0|||
148829678|NCT02367885|536855678|FG002|Overall Study|Lost to Follow-up|0|||
148829679|NCT02367885|536855676|FG000|Overall Study|Withdrawal by Subject|1|||
148829680|NCT02367885|536855677|FG001|Overall Study|Withdrawal by Subject|0|||
148829681|NCT02367885|536855678|FG002|Overall Study|Withdrawal by Subject|0|||
148829682|NCT01378195|536855679|FG000|Overall Study|Lost to Follow-up|29|||
148829683|NCT01378195|536855680|FG001|Overall Study|Lost to Follow-up|18|||
148829684|NCT03427619|536855681|FG000|Overall Study|Physician Decision|3|||
148829685|NCT03427619|536855681|FG000|Overall Study|Withdrawal by Subject|4|||
148829686|NCT03427619|536855681|FG000|Overall Study|Lost to Follow-up|5|||
148829687|NCT03427619|536855681|FG000|Overall Study|Administrative|4|||
148829688|NCT03427619|536855681|FG000|Overall Study|Other|2|||
148829689|NCT03427619|536855681|FG000|Overall Study|Unknown or Missing Completion Status|48|||
148829690|NCT05763381|536855684|FG000|Overall Study|Lost to Follow-up|2|||
148829691|NCT05763381|536855685|FG001|Overall Study|Lost to Follow-up|3|||
148829692|NCT05763381|536855684|FG000|Overall Study|Withdrawal by Subject|1|||
148829693|NCT05763381|536855685|FG001|Overall Study|Withdrawal by Subject|2|||
148829694|NCT02853136|536855686|FG000|Wash-out|Adverse Event|0|||
149028000|NCT00946114|537580053|FG000|Overall Study|Withdrawal by Subject|2|||
149028001|NCT00946114|537580054|FG001|Overall Study|Withdrawal by Subject|0|||
149028002|NCT00723294|537580055|FG000|Overall Study|Lobular histology|2|||
148829695|NCT02853136|536855687|FG001|Wash-out|Adverse Event|0|||
148829696|NCT02853136|536855688|FG002|Wash-out|Adverse Event|0|||
148829697|NCT02853136|536855689|FG003|Wash-out|Adverse Event|1|||
148829698|NCT00841815|536855690|FG000|Washout|Withdrawal by Subject|0|||
148829699|NCT00841815|536855691|FG001|Washout|Withdrawal by Subject|1|||
148829700|NCT02697448|536855695|FG000|Overall Study|Protocol Violation|2|||
148829701|NCT02697448|536855696|FG001|Overall Study|Protocol Violation|4|||
148829702|NCT02697448|536855695|FG000|Overall Study|Clinical concerns during ablation|1|||
148829703|NCT02697448|536855696|FG001|Overall Study|Clinical concerns during ablation|1|||
148829704|NCT02697448|536855695|FG000|Overall Study|No data collected|2|||
148829705|NCT02697448|536855696|FG001|Overall Study|No data collected|0|||
148829706|NCT01674062|536855697|FG000|Overall Study|Insufficient Therapeutic Response|56|||
148829707|NCT01674062|536855698|FG001|Overall Study|Insufficient Therapeutic Response|26|||
148829708|NCT01674062|536855697|FG000|Overall Study|Other|8|||
148829709|NCT01674062|536855698|FG001|Overall Study|Other|1|||
148829710|NCT01674062|536855697|FG000|Overall Study|Adverse Event|1|||
148829711|NCT01674062|536855698|FG001|Overall Study|Adverse Event|1|||
148829712|NCT01674062|536855697|FG000|Overall Study|Death|0|||
148829713|NCT01674062|536855698|FG001|Overall Study|Death|1|||
148829714|NCT01674062|536855697|FG000|Overall Study|Programming Error|1|||
148829715|NCT01674062|536855698|FG001|Overall Study|Programming Error|0|||
148829716|NCT02796651|536855704|FG000|Overall Study|Adverse Event|6|||
148829717|NCT02796651|536855704|FG000|Overall Study|Lost to Follow-up|1|||
148829718|NCT02796651|536855704|FG000|Overall Study|Withdrawal by Subject|4|||
148829719|NCT02796651|536855704|FG000|Overall Study|Protocol Violation|4|||
148829720|NCT02796651|536855704|FG000|Overall Study|Lack of Efficacy|1|||
148829721|NCT02796651|536855704|FG000|Overall Study|Other|10|||
148829722|NCT04079920|536855708|FG000|Overall Study|Adverse event, not related to study drug|2|||
148829723|NCT04079920|536855708|FG000|Overall Study|Adverse event related to study drug|10|||
148829724|NCT04079920|536855708|FG000|Overall Study|Death|2|||
148829725|NCT04079920|536855708|FG000|Overall Study|Lost to Follow-up|22|||
148829726|NCT04079920|536855708|FG000|Overall Study|Physician Decision|1|||
148829727|NCT04079920|536855708|FG000|Overall Study|Withdrawal by Subject|11|||
148829728|NCT05014919|536855709|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
148829729|NCT05014919|536855710|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
148829730|NCT05014919|536855711|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
148829731|NCT05014919|536855709|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
148829732|NCT05014919|536855710|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
148829733|NCT05014919|536855711|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
148829734|NCT05014919|536855709|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
148829735|NCT05014919|536855710|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
148829736|NCT05014919|536855711|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
148829737|NCT05014919|536855709|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
148829738|NCT05014919|536855710|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
148829739|NCT05014919|536855711|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
148829740|NCT05014919|536855709|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
148829741|NCT05014919|536855710|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
148829742|NCT05014919|536855711|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
148829743|NCT05014919|536855709|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
148829744|NCT05014919|536855710|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
148829745|NCT05014919|536855711|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
148829746|NCT05014919|536855709|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
148829747|NCT05014919|536855710|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
148829748|NCT05014919|536855711|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
148829749|NCT05014919|536855709|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
148829750|NCT05014919|536855710|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
148829751|NCT05014919|536855711|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
148829752|NCT00680914|536855712|FG000|Overall Study|Consent withdrawal|6|||
148829753|NCT00680914|536855713|FG001|Overall Study|Consent withdrawal|3|||
148829754|NCT00680914|536855712|FG000|Overall Study|Lost to Follow-up|4|||
149028003|NCT00723294|537580055|FG000|Overall Study|>25% intraductal component|1|||
148829755|NCT00680914|536855713|FG001|Overall Study|Lost to Follow-up|0|||
148829756|NCT00680914|536855712|FG000|Overall Study|serious adverse event (SAE)|0|||
148829757|NCT00680914|536855713|FG001|Overall Study|serious adverse event (SAE)|1|||
148829758|NCT02971163|536855714|FG000|Overall Study|Lost to Follow-up|4|||
148829759|NCT02971163|536855715|FG001|Overall Study|Lost to Follow-up|2|||
148829760|NCT01848457|536855716|FG000|Overall Study|Death|1|||
148829761|NCT01848457|536855717|FG001|Overall Study|Death|0|||
149028004|NCT00723294|537580055|FG000|Overall Study|No MRI tumor enhancement|1|||
148829762|NCT01848457|536855718|FG002|Overall Study|Death|0|||
148829763|NCT01848457|536855719|FG003|Overall Study|Death|0|||
148829764|NCT02940223|536855724|FG000|Overall Study|Failed Requirement|2|||
148829765|NCT02940223|536855725|FG001|Overall Study|Failed Requirement|0|||
148829766|NCT00526799|536855726|FG000|Overall Study|Withdrawal by Subject|1|||
148829767|NCT00526799|536855727|FG001|Overall Study|Withdrawal by Subject|0|||
148829768|NCT00526799|536855726|FG000|Overall Study|Intercurrent Complicating Disease|0|||
148829769|NCT00526799|536855727|FG001|Overall Study|Intercurrent Complicating Disease|1|||
148829770|NCT00522379|536855728|FG000|Overall Study|Adverse Event|12|||
148829771|NCT00522379|536855729|FG001|Overall Study|Adverse Event|15|||
148829772|NCT00522379|536855730|FG002|Overall Study|Adverse Event|12|||
148829773|NCT00522379|536855731|FG003|Overall Study|Adverse Event|5|||
148829774|NCT00522379|536855732|FG004|Overall Study|Adverse Event|17|||
148829775|NCT00522379|536855728|FG000|Overall Study|Lack of Efficacy|3|||
148829776|NCT00522379|536855729|FG001|Overall Study|Lack of Efficacy|0|||
148829777|NCT00522379|536855730|FG002|Overall Study|Lack of Efficacy|2|||
148829778|NCT00522379|536855731|FG003|Overall Study|Lack of Efficacy|2|||
148829779|NCT00522379|536855732|FG004|Overall Study|Lack of Efficacy|7|||
148829780|NCT00522379|536855728|FG000|Overall Study|Withdrawal by Subject|2|||
148829781|NCT00522379|536855729|FG001|Overall Study|Withdrawal by Subject|3|||
148829782|NCT00522379|536855730|FG002|Overall Study|Withdrawal by Subject|1|||
148829783|NCT00522379|536855731|FG003|Overall Study|Withdrawal by Subject|2|||
148829784|NCT00522379|536855732|FG004|Overall Study|Withdrawal by Subject|0|||
148829785|NCT00522379|536855728|FG000|Overall Study|Protocol Violation|1|||
148829786|NCT00522379|536855729|FG001|Overall Study|Protocol Violation|1|||
148829787|NCT00522379|536855730|FG002|Overall Study|Protocol Violation|2|||
148829788|NCT00522379|536855731|FG003|Overall Study|Protocol Violation|0|||
148829789|NCT00522379|536855732|FG004|Overall Study|Protocol Violation|0|||
148829790|NCT00522379|536855728|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
148829791|NCT00522379|536855729|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
148829792|NCT00522379|536855730|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
148829793|NCT00522379|536855731|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
148829794|NCT00522379|536855732|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
148829795|NCT00522379|536855728|FG000|Overall Study|Lost to Follow-up|1|||
148829796|NCT00522379|536855729|FG001|Overall Study|Lost to Follow-up|0|||
148829797|NCT00522379|536855730|FG002|Overall Study|Lost to Follow-up|4|||
148829798|NCT00522379|536855731|FG003|Overall Study|Lost to Follow-up|2|||
148829799|NCT00522379|536855732|FG004|Overall Study|Lost to Follow-up|2|||
148829800|NCT00522379|536855728|FG000|Overall Study|Randomization error|0|||
148829801|NCT00522379|536855729|FG001|Overall Study|Randomization error|0|||
148829802|NCT00522379|536855730|FG002|Overall Study|Randomization error|0|||
148829803|NCT00522379|536855731|FG003|Overall Study|Randomization error|0|||
148829804|NCT00522379|536855732|FG004|Overall Study|Randomization error|1|||
148829805|NCT00522379|536855728|FG000|Overall Study|Dispensing error|1|||
148829806|NCT00522379|536855729|FG001|Overall Study|Dispensing error|0|||
148829807|NCT00522379|536855730|FG002|Overall Study|Dispensing error|0|||
148829808|NCT00522379|536855731|FG003|Overall Study|Dispensing error|1|||
148829809|NCT00522379|536855732|FG004|Overall Study|Dispensing error|0|||
148829810|NCT00522379|536855728|FG000|Overall Study|Subject Moved|1|||
148829811|NCT00522379|536855729|FG001|Overall Study|Subject Moved|1|||
148829812|NCT00522379|536855730|FG002|Overall Study|Subject Moved|0|||
148829813|NCT00522379|536855731|FG003|Overall Study|Subject Moved|0|||
148829814|NCT00522379|536855732|FG004|Overall Study|Subject Moved|0|||
148829815|NCT00522379|536855728|FG000|Overall Study|Sponsor Request|0|||
148829816|NCT00522379|536855729|FG001|Overall Study|Sponsor Request|1|||
148829817|NCT00522379|536855730|FG002|Overall Study|Sponsor Request|0|||
148829818|NCT00522379|536855731|FG003|Overall Study|Sponsor Request|0|||
148829819|NCT00522379|536855732|FG004|Overall Study|Sponsor Request|0|||
148829820|NCT00522379|536855728|FG000|Overall Study|Family Problem|0|||
148829821|NCT00522379|536855729|FG001|Overall Study|Family Problem|0|||
148829822|NCT00522379|536855730|FG002|Overall Study|Family Problem|1|||
148829823|NCT00522379|536855731|FG003|Overall Study|Family Problem|0|||
148829824|NCT00522379|536855732|FG004|Overall Study|Family Problem|0|||
148829825|NCT00522379|536855728|FG000|Overall Study|Site Closed|0|||
148829826|NCT00522379|536855729|FG001|Overall Study|Site Closed|0|||
148979531|NCT01069289|537404478|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
148829827|NCT00522379|536855730|FG002|Overall Study|Site Closed|0|||
148829828|NCT00522379|536855731|FG003|Overall Study|Site Closed|1|||
148829829|NCT00522379|536855732|FG004|Overall Study|Site Closed|0|||
148829830|NCT00522379|536855728|FG000|Overall Study|Subject Withdrawal|0|||
148829831|NCT00522379|536855729|FG001|Overall Study|Subject Withdrawal|0|||
148829832|NCT00522379|536855730|FG002|Overall Study|Subject Withdrawal|0|||
148829833|NCT00522379|536855731|FG003|Overall Study|Subject Withdrawal|1|||
148829834|NCT00522379|536855732|FG004|Overall Study|Subject Withdrawal|0|||
148829835|NCT02298946|536855736|FG000|Overall Study|Did not receive treatment|2|||
148829836|NCT02298946|536855737|FG001|Overall Study|Did not receive treatment|0|||
148829837|NCT02298946|536855736|FG000|Overall Study|Unevaluable|2|||
148829838|NCT02298946|536855737|FG001|Overall Study|Unevaluable|1|||
148829839|NCT00323622|536855738|FG000|Overall Study|Other|30|||
148829840|NCT00323622|536855739|FG001|Overall Study|Other|91|||
148829841|NCT00323622|536855740|FG002|Overall Study|Other|4|||
148829842|NCT00323622|536855741|FG003|Overall Study|Other|12|||
148829843|NCT00323622|536855742|FG004|Overall Study|Other|32|||
148829844|NCT00323622|536855743|FG005|Overall Study|Other|74|||
148829845|NCT00323622|536855744|FG006|Overall Study|Other|5|||
148829846|NCT00323622|536855745|FG007|Overall Study|Other|13|||
148829847|NCT00323622|536855738|FG000|Overall Study|Death|1|||
148829848|NCT00323622|536855739|FG001|Overall Study|Death|1|||
148829849|NCT00323622|536855740|FG002|Overall Study|Death|0|||
148829850|NCT00323622|536855741|FG003|Overall Study|Death|0|||
148829851|NCT00323622|536855742|FG004|Overall Study|Death|7|||
148829852|NCT00323622|536855743|FG005|Overall Study|Death|0|||
148829853|NCT00323622|536855744|FG006|Overall Study|Death|0|||
148829854|NCT00323622|536855745|FG007|Overall Study|Death|2|||
148829855|NCT00835354|536855746|FG000|First Intervention|Adverse Event|0|||
148829856|NCT00835354|536855747|FG001|First Intervention|Adverse Event|1|||
148829857|NCT02097225|536855752|FG000|Dose Level 4|Adverse Event|0|||
148829858|NCT02097225|536855753|FG001|Dose Level 4|Adverse Event|0|||
148829859|NCT02097225|536855754|FG002|Dose Level 4|Adverse Event|0|||
148829860|NCT02097225|536855755|FG003|Dose Level 4|Adverse Event|0|||
148829861|NCT02097225|536855756|FG004|Dose Level 4|Adverse Event|1|||
148829862|NCT01852214|536855758|FG000|Period 1|Adverse Event|1|||
148829863|NCT01852214|536855759|FG001|Period 1|Adverse Event|2|||
148829864|NCT01852214|536855758|FG000|Period 1|Withdrawal by Subject|0|||
148829865|NCT01852214|536855759|FG001|Period 1|Withdrawal by Subject|1|||
148829866|NCT01852214|536855758|FG000|Washout Period|Withdrawal by Subject|0|||
148829867|NCT01852214|536855759|FG001|Washout Period|Withdrawal by Subject|1|||
148829868|NCT02679274|536855760|FG000|Overall Study|Withdrawal by Subject|1|||
148829869|NCT02679274|536855761|FG001|Overall Study|Withdrawal by Subject|0|||
148829870|NCT04976855|536855762|FG000|Part I|Withdrawal by Subject|0|||
148829871|NCT04976855|536855763|FG001|Part I|Withdrawal by Subject|1|||
148829872|NCT04976855|536855764|FG002|Part I|Withdrawal by Subject|0|||
148829873|NCT04976855|536855765|FG003|Part I|Withdrawal by Subject|0|||
148829874|NCT04976855|536855766|FG004|Part I|Withdrawal by Subject|0|||
148829875|NCT04976855|536855767|FG005|Part I|Withdrawal by Subject|0|||
148829876|NCT04976855|536855768|FG006|Part I|Withdrawal by Subject|0|||
148829877|NCT04976855|536855762|FG000|Part II|Adverse Event|0|||
148829878|NCT04976855|536855763|FG001|Part II|Adverse Event|0|||
148829879|NCT04976855|536855764|FG002|Part II|Adverse Event|0|||
148829880|NCT04976855|536855765|FG003|Part II|Adverse Event|1|||
148829881|NCT04976855|536855766|FG004|Part II|Adverse Event|0|||
148829882|NCT04976855|536855767|FG005|Part II|Adverse Event|0|||
148829883|NCT04976855|536855768|FG006|Part II|Adverse Event|0|||
148829884|NCT04976855|536855762|FG000|Part II|Withdrawal by Subject|0|||
148829885|NCT04976855|536855763|FG001|Part II|Withdrawal by Subject|0|||
148829886|NCT04976855|536855764|FG002|Part II|Withdrawal by Subject|0|||
148829887|NCT04976855|536855765|FG003|Part II|Withdrawal by Subject|0|||
148829888|NCT04976855|536855766|FG004|Part II|Withdrawal by Subject|1|||
148829889|NCT04976855|536855767|FG005|Part II|Withdrawal by Subject|0|||
148829890|NCT04976855|536855768|FG006|Part II|Withdrawal by Subject|0|||
148829891|NCT04976855|536855762|FG000|Part II|Lost to Follow-up|0|||
148829892|NCT04976855|536855763|FG001|Part II|Lost to Follow-up|0|||
148829893|NCT04976855|536855764|FG002|Part II|Lost to Follow-up|0|||
148829894|NCT04976855|536855765|FG003|Part II|Lost to Follow-up|0|||
148829895|NCT04976855|536855766|FG004|Part II|Lost to Follow-up|0|||
148829896|NCT04976855|536855767|FG005|Part II|Lost to Follow-up|1|||
148829897|NCT04976855|536855768|FG006|Part II|Lost to Follow-up|0|||
148829898|NCT05487378|536855769|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
148829899|NCT05487378|536855770|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
148829900|NCT05487378|536855769|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
148829901|NCT05487378|536855770|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
148829902|NCT01385995|536855778|FG000|Period 1, 2 Months|Physician Decision|1|||
148829903|NCT01385995|536855779|FG001|Period 1, 2 Months|Physician Decision|0|||
148829904|NCT00112385|536855780|FG000|Overall Study|Lost to Follow-up|1|||
148829905|NCT00112385|536855781|FG001|Overall Study|Lost to Follow-up|0|||
148829906|NCT00112385|536855780|FG000|Overall Study|Withdrawal by Subject|0|||
148829907|NCT00112385|536855781|FG001|Overall Study|Withdrawal by Subject|1|||
148829908|NCT00835172|536855789|FG000|Washout|Protocol Violation|0|||
148829909|NCT00835172|536855790|FG001|Washout|Protocol Violation|1|||
148829910|NCT02613507|536855798|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
148829911|NCT02613507|536855799|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
148829912|NCT02613507|536855798|FG000|Pre-Treamtent|Participant withdrew consent|0|||
148829913|NCT02613507|536855799|FG001|Pre-Treamtent|Participant withdrew consent|4|||
148829914|NCT02613507|536855798|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
148829915|NCT02613507|536855799|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
148829916|NCT02613507|536855798|FG000|Treatment|Not reported|3|||
148829917|NCT02613507|536855799|FG001|Treatment|Not reported|0|||
148829918|NCT02613507|536855798|FG000|Treatment|Other reasons|8|||
148829919|NCT02613507|536855799|FG001|Treatment|Other reasons|0|||
148829920|NCT02613507|536855798|FG000|Treatment|Participant no longer meets criteria|3|||
148829921|NCT02613507|536855799|FG001|Treatment|Participant no longer meets criteria|0|||
148979532|NCT01069289|537404479|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148979533|NCT01069289|537404478|FG000|Overall Study|Severe non-compliance to protocol|3|||
148979534|NCT01069289|537404479|FG001|Overall Study|Severe non-compliance to protocol|2|||
148979535|NCT01069289|537404478|FG000|Overall Study|Due to deteriorating health condition|1|||
148979536|NCT01069289|537404479|FG001|Overall Study|Due to deteriorating health condition|0|||
149005475|NCT03217747|537497894|FG002|Overall Study|Toxicity and progression|0|||
148829922|NCT02613507|536855798|FG000|Treatment|Maximum clinical benefit|5|||
148829923|NCT02613507|536855799|FG001|Treatment|Maximum clinical benefit|10|||
148829924|NCT02613507|536855798|FG000|Treatment|Lost to Follow-up|1|||
148829925|NCT02613507|536855799|FG001|Treatment|Lost to Follow-up|0|||
148829926|NCT02613507|536855798|FG000|Treatment|Participant withdrew consent|0|||
148829927|NCT02613507|536855799|FG001|Treatment|Participant withdrew consent|2|||
148829928|NCT02613507|536855798|FG000|Treatment|Participant request to discontinue study treatment|13|||
148829929|NCT02613507|536855799|FG001|Treatment|Participant request to discontinue study treatment|17|||
148829930|NCT02613507|536855798|FG000|Treatment|Adverse event unrelated to study drug|20|||
148829931|NCT02613507|536855799|FG001|Treatment|Adverse event unrelated to study drug|3|||
148829932|NCT02613507|536855798|FG000|Treatment|Death|2|||
148829933|NCT02613507|536855799|FG001|Treatment|Death|0|||
148829934|NCT02613507|536855798|FG000|Treatment|Study drug toxicity|19|||
148829935|NCT02613507|536855799|FG001|Treatment|Study drug toxicity|14|||
148829936|NCT02613507|536855798|FG000|Treatment|Disease progression|263|||
148829937|NCT02613507|536855799|FG001|Treatment|Disease progression|110|||
148829938|NCT03648372|536855805|FG000|Overall Study|Withdrawal by Subject|2|||
148829939|NCT03648372|536855806|FG001|Overall Study|Withdrawal by Subject|0|||
148829940|NCT03648372|536855807|FG002|Overall Study|Withdrawal by Subject|0|||
148829941|NCT03648372|536855808|FG003|Overall Study|Withdrawal by Subject|0|||
148829942|NCT03648372|536855809|FG004|Overall Study|Withdrawal by Subject|0|||
148829943|NCT03648372|536855810|FG005|Overall Study|Withdrawal by Subject|1|||
148829944|NCT03648372|536855811|FG006|Overall Study|Withdrawal by Subject|2|||
148829945|NCT03648372|536855812|FG007|Overall Study|Withdrawal by Subject|0|||
148829946|NCT03648372|536855813|FG008|Overall Study|Withdrawal by Subject|0|||
148829947|NCT03648372|536855814|FG009|Overall Study|Withdrawal by Subject|0|||
148829948|NCT03648372|536855815|FG010|Overall Study|Withdrawal by Subject|2|||
148829949|NCT03648372|536855816|FG011|Overall Study|Withdrawal by Subject|0|||
148829950|NCT03648372|536855817|FG012|Overall Study|Withdrawal by Subject|2|||
148829951|NCT03648372|536855818|FG013|Overall Study|Withdrawal by Subject|0|||
148829952|NCT03648372|536855819|FG014|Overall Study|Withdrawal by Subject|0|||
148829953|NCT03648372|536855820|FG015|Overall Study|Withdrawal by Subject|0|||
148829954|NCT03648372|536855821|FG016|Overall Study|Withdrawal by Subject|1|||
148829955|NCT03648372|536855822|FG017|Overall Study|Withdrawal by Subject|0|||
148829956|NCT03648372|536855823|FG018|Overall Study|Withdrawal by Subject|0|||
148829957|NCT03648372|536855824|FG019|Overall Study|Withdrawal by Subject|0|||
148829958|NCT03648372|536855825|FG020|Overall Study|Withdrawal by Subject|0|||
148829959|NCT03648372|536855805|FG000|Overall Study|Progressive Disease|2|||
148829960|NCT03648372|536855806|FG001|Overall Study|Progressive Disease|3|||
148829961|NCT03648372|536855807|FG002|Overall Study|Progressive Disease|4|||
148829962|NCT03648372|536855808|FG003|Overall Study|Progressive Disease|3|||
148829963|NCT03648372|536855809|FG004|Overall Study|Progressive Disease|2|||
148829964|NCT03648372|536855810|FG005|Overall Study|Progressive Disease|2|||
148829965|NCT03648372|536855811|FG006|Overall Study|Progressive Disease|3|||
148829966|NCT03648372|536855812|FG007|Overall Study|Progressive Disease|3|||
148829967|NCT03648372|536855813|FG008|Overall Study|Progressive Disease|5|||
148829968|NCT03648372|536855814|FG009|Overall Study|Progressive Disease|5|||
148829969|NCT03648372|536855815|FG010|Overall Study|Progressive Disease|2|||
148829970|NCT03648372|536855816|FG011|Overall Study|Progressive Disease|3|||
148829971|NCT03648372|536855817|FG012|Overall Study|Progressive Disease|3|||
148829972|NCT03648372|536855818|FG013|Overall Study|Progressive Disease|3|||
149005476|NCT03217747|537497895|FG003|Overall Study|Toxicity and progression|0|||
149005477|NCT03217747|537497896|FG004|Overall Study|Toxicity and progression|0|||
149005478|NCT03217747|537497897|FG005|Overall Study|Toxicity and progression|0|||
149005479|NCT03217747|537497898|FG006|Overall Study|Toxicity and progression|0|||
149005480|NCT03217747|537497899|FG007|Overall Study|Toxicity and progression|0|||
149005481|NCT03217747|537497900|FG008|Overall Study|Toxicity and progression|0|||
149005482|NCT03217747|537497901|FG009|Overall Study|Toxicity and progression|0|||
149005483|NCT03217747|537497902|FG010|Overall Study|Toxicity and progression|0|||
149005484|NCT03217747|537497903|FG011|Overall Study|Toxicity and progression|0|||
149005485|NCT03217747|537497904|FG012|Overall Study|Toxicity and progression|0|||
149005486|NCT03217747|537497905|FG013|Overall Study|Toxicity and progression|0|||
149005487|NCT03217747|537497892|FG000|Overall Study|Removal of sole target lesion|1|||
148829973|NCT03648372|536855819|FG014|Overall Study|Progressive Disease|6|||
148829974|NCT03648372|536855820|FG015|Overall Study|Progressive Disease|0|||
148829975|NCT03648372|536855821|FG016|Overall Study|Progressive Disease|0|||
148829976|NCT03648372|536855822|FG017|Overall Study|Progressive Disease|0|||
148829977|NCT03648372|536855823|FG018|Overall Study|Progressive Disease|0|||
148829978|NCT03648372|536855824|FG019|Overall Study|Progressive Disease|0|||
148829979|NCT03648372|536855825|FG020|Overall Study|Progressive Disease|0|||
148768036|NCT02587598|536623568|FG004|Overall Study|Physician Decision|0|||
148768037|NCT02587598|536623569|FG005|Overall Study|Physician Decision|0|||
148768038|NCT02587598|536623570|FG006|Overall Study|Physician Decision|0|||
148768039|NCT02587598|536623571|FG007|Overall Study|Physician Decision|0|||
148768040|NCT02587598|536623572|FG008|Overall Study|Physician Decision|0|||
148768041|NCT02587598|536623573|FG009|Overall Study|Physician Decision|0|||
148768042|NCT02587598|536623574|FG010|Overall Study|Physician Decision|3|||
148768043|NCT01704651|536623581|FG000|Overall Study|Pre-op withdrawal by subject|1|||
148768044|NCT01704651|536623582|FG001|Overall Study|Pre-op withdrawal by subject|1|||
148768045|NCT01704651|536623581|FG000|Overall Study|Pre-op change in treatment plan|1|||
148768046|NCT01704651|536623582|FG001|Overall Study|Pre-op change in treatment plan|4|||
148768047|NCT01704651|536623581|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
148768048|NCT01704651|536623582|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
148768049|NCT01704651|536623581|FG000|Overall Study|Post-op did not have laparotomy|2|||
148768050|NCT01704651|536623582|FG001|Overall Study|Post-op did not have laparotomy|1|||
148768051|NCT00791661|536623583|FG000|7 Day Wash-out|Adverse Event|0|||
148768052|NCT00791661|536623584|FG001|7 Day Wash-out|Adverse Event|0|||
148768053|NCT00791661|536623585|FG002|7 Day Wash-out|Adverse Event|1|||
148768054|NCT00791661|536623583|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
148768055|NCT00791661|536623584|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
148768056|NCT00791661|536623585|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
148768057|NCT03605862|536623586|FG000|Overall Study|Withdrawal by Subject|12|||
148768058|NCT03605862|536623587|FG001|Overall Study|Withdrawal by Subject|9|||
148768059|NCT03605862|536623586|FG000|Overall Study|Adverse Event|2|||
148768060|NCT03605862|536623587|FG001|Overall Study|Adverse Event|1|||
148768061|NCT03605862|536623586|FG000|Overall Study|Physician Decision|3|||
148768062|NCT03605862|536623587|FG001|Overall Study|Physician Decision|1|||
148768063|NCT03605862|536623586|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
148768064|NCT03605862|536623587|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
148768065|NCT00679289|536623588|FG000|Overall Study|Progressive disease|4|||
148768066|NCT00679289|536623589|FG001|Overall Study|Progressive disease|5|||
148768067|NCT00679289|536623590|FG002|Overall Study|Progressive disease|18|||
148768068|NCT00679289|536623588|FG000|Overall Study|Withdrawal by Subject|0|||
148768069|NCT00679289|536623589|FG001|Overall Study|Withdrawal by Subject|1|||
148768070|NCT00679289|536623590|FG002|Overall Study|Withdrawal by Subject|1|||
148768071|NCT00679289|536623588|FG000|Overall Study|Adverse Event|0|||
148768072|NCT00679289|536623589|FG001|Overall Study|Adverse Event|0|||
148768073|NCT00679289|536623590|FG002|Overall Study|Adverse Event|3|||
148768074|NCT00679289|536623588|FG000|Overall Study|Physician Decision|1|||
148768075|NCT00679289|536623589|FG001|Overall Study|Physician Decision|0|||
148768076|NCT00679289|536623590|FG002|Overall Study|Physician Decision|1|||
148768077|NCT00937040|536623591|FG000|Overall Study|Adverse Event|5|||
148768078|NCT00937040|536623592|FG001|Overall Study|Adverse Event|8|||
148768079|NCT00937040|536623591|FG000|Overall Study|Lost to Follow-up|12|||
148768080|NCT00937040|536623592|FG001|Overall Study|Lost to Follow-up|12|||
148768081|NCT00937040|536623591|FG000|Overall Study|Protocol Violation|3|||
148768082|NCT00937040|536623592|FG001|Overall Study|Protocol Violation|0|||
148768083|NCT00937040|536623591|FG000|Overall Study|Withdrawal by Subject|13|||
148768084|NCT00937040|536623592|FG001|Overall Study|Withdrawal by Subject|7|||
148768085|NCT00937040|536623591|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
148768086|NCT00937040|536623592|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
148768087|NCT00937040|536623591|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
148768088|NCT00937040|536623592|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
148768089|NCT00634803|536623595|FG000|Overall Study|Lost to Follow-up|6|||
148768090|NCT00634803|536623596|FG001|Overall Study|Lost to Follow-up|7|||
148768091|NCT00634803|536623597|FG002|Overall Study|Lost to Follow-up|7|||
148768092|NCT00972816|536625225|FG000|Overall Study|Adverse Event|0|||
148768093|NCT00972816|536625226|FG001|Overall Study|Adverse Event|0|||
148768094|NCT00972816|536625227|FG002|Overall Study|Adverse Event|1|||
148768095|NCT00972816|536625228|FG003|Overall Study|Adverse Event|0|||
148768096|NCT00972816|536625229|FG004|Overall Study|Adverse Event|0|||
148768097|NCT00972816|536625230|FG005|Overall Study|Adverse Event|0|||
148768098|NCT00972816|536625231|FG006|Overall Study|Adverse Event|0|||
148768099|NCT00972816|536625232|FG007|Overall Study|Adverse Event|0|||
148768100|NCT00972816|536625225|FG000|Overall Study|Withdrawal by Subject|4|||
148768101|NCT00972816|536625226|FG001|Overall Study|Withdrawal by Subject|2|||
148768102|NCT00972816|536625227|FG002|Overall Study|Withdrawal by Subject|1|||
148768103|NCT00972816|536625228|FG003|Overall Study|Withdrawal by Subject|3|||
148768104|NCT00972816|536625229|FG004|Overall Study|Withdrawal by Subject|0|||
148768105|NCT00972816|536625230|FG005|Overall Study|Withdrawal by Subject|1|||
148768106|NCT00972816|536625231|FG006|Overall Study|Withdrawal by Subject|1|||
148768107|NCT00972816|536625232|FG007|Overall Study|Withdrawal by Subject|2|||
148768108|NCT00972816|536625225|FG000|Overall Study|Lost to Follow-up|11|||
148768109|NCT00972816|536625226|FG001|Overall Study|Lost to Follow-up|9|||
148768110|NCT00972816|536625227|FG002|Overall Study|Lost to Follow-up|7|||
148768111|NCT00972816|536625228|FG003|Overall Study|Lost to Follow-up|5|||
148979537|NCT00827372|537405707|FG000|Overall Study|Adverse Event|5|||
148979538|NCT00827372|537405707|FG000|Overall Study|Lack of Efficacy|3|||
148979539|NCT01076400|537405709|FG000|Overall Study|Adverse Event|2|||
148979540|NCT01076400|537405710|FG001|Overall Study|Adverse Event|0|||
148979541|NCT01076400|537405711|FG002|Overall Study|Adverse Event|0|||
148979542|NCT01076400|537405709|FG000|Overall Study|Progressive Disease|5|||
148979543|NCT01076400|537405710|FG001|Overall Study|Progressive Disease|0|||
148979544|NCT01076400|537405711|FG002|Overall Study|Progressive Disease|0|||
148979545|NCT02766608|537405714|FG000|Overall Study|Adverse Event|27|||
148979546|NCT02766608|537405715|FG001|Overall Study|Adverse Event|22|||
148979547|NCT02766608|537405716|FG002|Overall Study|Adverse Event|17|||
148979548|NCT02766608|537405717|FG003|Overall Study|Adverse Event|13|||
148979549|NCT02766608|537405718|FG004|Overall Study|Adverse Event|12|||
148979550|NCT02766608|537405714|FG000|Overall Study|Withdrawal by Subject|21|||
148979551|NCT02766608|537405715|FG001|Overall Study|Withdrawal by Subject|20|||
148979552|NCT02766608|537405716|FG002|Overall Study|Withdrawal by Subject|24|||
148979553|NCT02766608|537405717|FG003|Overall Study|Withdrawal by Subject|13|||
148979554|NCT02766608|537405718|FG004|Overall Study|Withdrawal by Subject|10|||
148979555|NCT02766608|537405714|FG000|Overall Study|Lack of Efficacy|16|||
148979556|NCT02766608|537405715|FG001|Overall Study|Lack of Efficacy|15|||
148979557|NCT02766608|537405716|FG002|Overall Study|Lack of Efficacy|32|||
148979558|NCT02766608|537405717|FG003|Overall Study|Lack of Efficacy|8|||
148979559|NCT02766608|537405718|FG004|Overall Study|Lack of Efficacy|2|||
148979560|NCT02766608|537405714|FG000|Overall Study|Lost to Follow-up|6|||
148979561|NCT02766608|537405715|FG001|Overall Study|Lost to Follow-up|3|||
148979562|NCT02766608|537405716|FG002|Overall Study|Lost to Follow-up|5|||
148979563|NCT02766608|537405717|FG003|Overall Study|Lost to Follow-up|2|||
148979564|NCT02766608|537405718|FG004|Overall Study|Lost to Follow-up|2|||
148979565|NCT02766608|537405714|FG000|Overall Study|Physician Decision|3|||
148979566|NCT02766608|537405715|FG001|Overall Study|Physician Decision|2|||
148979567|NCT02766608|537405716|FG002|Overall Study|Physician Decision|3|||
148979568|NCT02766608|537405717|FG003|Overall Study|Physician Decision|1|||
148979569|NCT02766608|537405718|FG004|Overall Study|Physician Decision|2|||
148979570|NCT02766608|537405714|FG000|Overall Study|Protocol disc criteria|3|||
148979571|NCT02766608|537405715|FG001|Overall Study|Protocol disc criteria|3|||
148979572|NCT02766608|537405716|FG002|Overall Study|Protocol disc criteria|4|||
148979573|NCT02766608|537405717|FG003|Overall Study|Protocol disc criteria|0|||
148979574|NCT02766608|537405718|FG004|Overall Study|Protocol disc criteria|0|||
148979575|NCT02766608|537405714|FG000|Overall Study|Protocol Violation|0|||
148979576|NCT02766608|537405715|FG001|Overall Study|Protocol Violation|4|||
148979577|NCT02766608|537405716|FG002|Overall Study|Protocol Violation|4|||
148979578|NCT02766608|537405717|FG003|Overall Study|Protocol Violation|0|||
148979579|NCT02766608|537405718|FG004|Overall Study|Protocol Violation|1|||
148979580|NCT02766608|537405714|FG000|Overall Study|Administrative Reasons|3|||
148979581|NCT02766608|537405715|FG001|Overall Study|Administrative Reasons|1|||
148979582|NCT02766608|537405716|FG002|Overall Study|Administrative Reasons|1|||
148979583|NCT02766608|537405717|FG003|Overall Study|Administrative Reasons|0|||
148979584|NCT02766608|537405718|FG004|Overall Study|Administrative Reasons|0|||
148979585|NCT02080091|537405719|FG000|Overall Study|Study Terminated|22|||
148979586|NCT02080091|537405719|FG000|Overall Study|Death|1|||
148979587|NCT02080091|537405719|FG000|Overall Study|Withdrawal by Subject|1|||
148979588|NCT02080091|537405719|FG000|Overall Study|Other|1|||
148979589|NCT01265953|537405722|FG000|Overall Study|Non compliance|5|||
148979590|NCT01265953|537405723|FG001|Overall Study|Non compliance|3|||
148979591|NCT02391948|537405725|FG000|6-month Assessment|Death|0|||
148979592|NCT02391948|537405726|FG001|6-month Assessment|Death|0|||
148979593|NCT02391948|537405727|FG002|6-month Assessment|Death|0|||
148979594|NCT02391948|537405728|FG003|6-month Assessment|Death|0|||
148979595|NCT02391948|537405729|FG004|6-month Assessment|Death|1|||
148979596|NCT02391948|537405725|FG000|6-month Assessment|Withdrawal by Subject|0|||
148979597|NCT02391948|537405726|FG001|6-month Assessment|Withdrawal by Subject|0|||
148979598|NCT02391948|537405727|FG002|6-month Assessment|Withdrawal by Subject|1|||
148979599|NCT02391948|537405728|FG003|6-month Assessment|Withdrawal by Subject|2|||
148979600|NCT02391948|537405729|FG004|6-month Assessment|Withdrawal by Subject|0|||
149028005|NCT00723294|537580055|FG000|Overall Study|1.0-Tesla MRI|1|||
148768112|NCT00972816|536625229|FG004|Overall Study|Lost to Follow-up|11|||
148768113|NCT00972816|536625230|FG005|Overall Study|Lost to Follow-up|10|||
148768114|NCT00972816|536625231|FG006|Overall Study|Lost to Follow-up|7|||
148768115|NCT00972816|536625232|FG007|Overall Study|Lost to Follow-up|7|||
148979601|NCT02391948|537405725|FG000|6-month Assessment|Lost to Follow-up|4|||
148979602|NCT02391948|537405726|FG001|6-month Assessment|Lost to Follow-up|5|||
148979603|NCT02391948|537405727|FG002|6-month Assessment|Lost to Follow-up|2|||
148768116|NCT00972816|536625225|FG000|Overall Study|Inappropriate enrolment|0|||
148979604|NCT02391948|537405728|FG003|6-month Assessment|Lost to Follow-up|3|||
148979605|NCT02391948|537405729|FG004|6-month Assessment|Lost to Follow-up|1|||
148979606|NCT02391948|537405725|FG000|6-month Assessment|Medical issue/illness|1|||
148768117|NCT00972816|536625226|FG001|Overall Study|Inappropriate enrolment|0|||
148979607|NCT02391948|537405726|FG001|6-month Assessment|Medical issue/illness|1|||
148979608|NCT02391948|537405727|FG002|6-month Assessment|Medical issue/illness|0|||
148829980|NCT03648372|536855805|FG000|Overall Study|Other|0|||
148829981|NCT03648372|536855806|FG001|Overall Study|Other|0|||
148829982|NCT03648372|536855807|FG002|Overall Study|Other|0|||
148829983|NCT03648372|536855808|FG003|Overall Study|Other|0|||
148829984|NCT03648372|536855809|FG004|Overall Study|Other|1|||
148829985|NCT03648372|536855810|FG005|Overall Study|Other|0|||
148829986|NCT03648372|536855811|FG006|Overall Study|Other|0|||
148829987|NCT03648372|536855812|FG007|Overall Study|Other|0|||
148829988|NCT03648372|536855813|FG008|Overall Study|Other|0|||
148829989|NCT03648372|536855814|FG009|Overall Study|Other|0|||
148829990|NCT03648372|536855815|FG010|Overall Study|Other|1|||
148829991|NCT03648372|536855816|FG011|Overall Study|Other|2|||
148829992|NCT03648372|536855817|FG012|Overall Study|Other|1|||
148829993|NCT03648372|536855818|FG013|Overall Study|Other|3|||
148829994|NCT03648372|536855819|FG014|Overall Study|Other|0|||
148829995|NCT03648372|536855820|FG015|Overall Study|Other|5|||
148979609|NCT02391948|537405728|FG003|6-month Assessment|Medical issue/illness|0|||
148979610|NCT02391948|537405729|FG004|6-month Assessment|Medical issue/illness|0|||
148979611|NCT02391948|537405725|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
148829996|NCT03648372|536855821|FG016|Overall Study|Other|1|||
148829997|NCT03648372|536855822|FG017|Overall Study|Other|5|||
148829998|NCT03648372|536855823|FG018|Overall Study|Other|0|||
148829999|NCT03648372|536855824|FG019|Overall Study|Other|1|||
148830000|NCT03648372|536855825|FG020|Overall Study|Other|0|||
148830001|NCT03648372|536855805|FG000|Overall Study|Lost to Follow-up|0|||
148830002|NCT03648372|536855806|FG001|Overall Study|Lost to Follow-up|0|||
148830003|NCT03648372|536855807|FG002|Overall Study|Lost to Follow-up|0|||
148830004|NCT03648372|536855808|FG003|Overall Study|Lost to Follow-up|0|||
148830005|NCT03648372|536855809|FG004|Overall Study|Lost to Follow-up|0|||
148830006|NCT03648372|536855810|FG005|Overall Study|Lost to Follow-up|0|||
148830007|NCT03648372|536855811|FG006|Overall Study|Lost to Follow-up|0|||
148830008|NCT03648372|536855812|FG007|Overall Study|Lost to Follow-up|0|||
148830009|NCT03648372|536855813|FG008|Overall Study|Lost to Follow-up|0|||
148830010|NCT03648372|536855814|FG009|Overall Study|Lost to Follow-up|0|||
148830011|NCT03648372|536855815|FG010|Overall Study|Lost to Follow-up|0|||
148830012|NCT03648372|536855816|FG011|Overall Study|Lost to Follow-up|0|||
148830013|NCT03648372|536855817|FG012|Overall Study|Lost to Follow-up|0|||
148830014|NCT03648372|536855818|FG013|Overall Study|Lost to Follow-up|1|||
148830015|NCT03648372|536855819|FG014|Overall Study|Lost to Follow-up|0|||
148830016|NCT03648372|536855820|FG015|Overall Study|Lost to Follow-up|1|||
148830017|NCT03648372|536855821|FG016|Overall Study|Lost to Follow-up|0|||
148830018|NCT03648372|536855822|FG017|Overall Study|Lost to Follow-up|1|||
148830019|NCT03648372|536855823|FG018|Overall Study|Lost to Follow-up|0|||
148830020|NCT03648372|536855824|FG019|Overall Study|Lost to Follow-up|0|||
148830021|NCT03648372|536855825|FG020|Overall Study|Lost to Follow-up|0|||
148830022|NCT03648372|536855805|FG000|Overall Study|Start of a New Systemic Treatment|0|||
148830023|NCT03648372|536855806|FG001|Overall Study|Start of a New Systemic Treatment|0|||
148830024|NCT03648372|536855807|FG002|Overall Study|Start of a New Systemic Treatment|0|||
148830025|NCT03648372|536855808|FG003|Overall Study|Start of a New Systemic Treatment|0|||
148830026|NCT03648372|536855809|FG004|Overall Study|Start of a New Systemic Treatment|0|||
148830027|NCT03648372|536855810|FG005|Overall Study|Start of a New Systemic Treatment|0|||
148830028|NCT03648372|536855811|FG006|Overall Study|Start of a New Systemic Treatment|0|||
148830029|NCT03648372|536855812|FG007|Overall Study|Start of a New Systemic Treatment|2|||
148830030|NCT03648372|536855813|FG008|Overall Study|Start of a New Systemic Treatment|0|||
148830031|NCT03648372|536855814|FG009|Overall Study|Start of a New Systemic Treatment|0|||
148830032|NCT03648372|536855815|FG010|Overall Study|Start of a New Systemic Treatment|1|||
148830033|NCT03648372|536855816|FG011|Overall Study|Start of a New Systemic Treatment|0|||
148830034|NCT03648372|536855817|FG012|Overall Study|Start of a New Systemic Treatment|0|||
148830035|NCT03648372|536855818|FG013|Overall Study|Start of a New Systemic Treatment|0|||
148979612|NCT02391948|537405726|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
148979613|NCT02391948|537405727|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
148979614|NCT02391948|537405728|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
148830036|NCT03648372|536855819|FG014|Overall Study|Start of a New Systemic Treatment|0|||
148830037|NCT03648372|536855820|FG015|Overall Study|Start of a New Systemic Treatment|0|||
148830038|NCT03648372|536855821|FG016|Overall Study|Start of a New Systemic Treatment|0|||
148830039|NCT03648372|536855822|FG017|Overall Study|Start of a New Systemic Treatment|0|||
148979615|NCT02391948|537405729|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
148979616|NCT02391948|537405725|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
148830040|NCT03648372|536855823|FG018|Overall Study|Start of a New Systemic Treatment|0|||
148830041|NCT03648372|536855824|FG019|Overall Study|Start of a New Systemic Treatment|0|||
148830042|NCT03648372|536855825|FG020|Overall Study|Start of a New Systemic Treatment|0|||
148830043|NCT03514134|536857036|FG000|Overall Study|Lost to Follow-up|0|||
148830044|NCT03514134|536857037|FG001|Overall Study|Lost to Follow-up|1|||
148830045|NCT00003645|536857038|FG000|Overall Study|Death|4|||
148830046|NCT00003645|536857039|FG001|Overall Study|Death|1|||
148830047|NCT00003645|536857038|FG000|Overall Study|Lost to Follow-up|7|||
148830048|NCT00003645|536857039|FG001|Overall Study|Lost to Follow-up|8|||
148830049|NCT00003645|536857038|FG000|Overall Study|Withdrawal by Subject|1|||
148830050|NCT00003645|536857039|FG001|Overall Study|Withdrawal by Subject|3|||
148830051|NCT00363298|536857050|FG000|First Study Week|Lack of Efficacy|6|||
148830052|NCT00363298|536857051|FG001|First Study Week|Lack of Efficacy|5|||
148830053|NCT00363298|536857050|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
148830054|NCT00363298|536857051|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
148830055|NCT03332056|536857054|FG000|Overall Study|Incomplete questionnaires|8|||
148830056|NCT03332056|536857055|FG001|Overall Study|Incomplete questionnaires|9|||
148830057|NCT03332056|536857054|FG000|Overall Study|Passed stone prior to surgery date|1|||
148830058|NCT03332056|536857055|FG001|Overall Study|Passed stone prior to surgery date|0|||
148830059|NCT03332056|536857054|FG000|Overall Study|Did not require a ureteral stent|0|||
148830060|NCT03332056|536857055|FG001|Overall Study|Did not require a ureteral stent|1|||
148830061|NCT00321932|536857056|FG000|Overall Study|Death|3|||
148830062|NCT00321932|536857057|FG001|Overall Study|Death|6|||
148830063|NCT00321932|536857056|FG000|Overall Study|Withdrawal by Subject|3|||
148830064|NCT00321932|536857057|FG001|Overall Study|Withdrawal by Subject|6|||
148830065|NCT00321932|536857056|FG000|Overall Study|Early relapse|2|||
148830066|NCT00321932|536857057|FG001|Overall Study|Early relapse|8|||
148830067|NCT00321932|536857056|FG000|Overall Study|Missing data|2|||
148830068|NCT00321932|536857057|FG001|Overall Study|Missing data|1|||
148830069|NCT01892189|536857067|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
148830070|NCT01892189|536857068|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
148830071|NCT01892189|536857069|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
148830072|NCT01892189|536857070|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
148830073|NCT01892189|536857071|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
148830074|NCT01892189|536857072|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
148830075|NCT01892189|536857073|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
148979617|NCT02391948|537405726|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
148979618|NCT02391948|537405727|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
148979619|NCT02391948|537405728|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
148979620|NCT02391948|537405729|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
148979621|NCT02391948|537405725|FG000|12-month Assessment|Death|0|||
148979622|NCT02391948|537405726|FG001|12-month Assessment|Death|0|||
148979623|NCT02391948|537405727|FG002|12-month Assessment|Death|0|||
148979624|NCT02391948|537405728|FG003|12-month Assessment|Death|1|||
148979625|NCT02391948|537405729|FG004|12-month Assessment|Death|0|||
148979626|NCT02391948|537405725|FG000|12-month Assessment|Withdrawal by Subject|1|||
148979627|NCT02391948|537405726|FG001|12-month Assessment|Withdrawal by Subject|0|||
148979628|NCT02391948|537405727|FG002|12-month Assessment|Withdrawal by Subject|0|||
148979629|NCT02391948|537405728|FG003|12-month Assessment|Withdrawal by Subject|1|||
148979630|NCT02391948|537405729|FG004|12-month Assessment|Withdrawal by Subject|0|||
148979631|NCT02391948|537405725|FG000|12-month Assessment|Lost to Follow-up|5|||
148979632|NCT02391948|537405726|FG001|12-month Assessment|Lost to Follow-up|4|||
148979633|NCT02391948|537405727|FG002|12-month Assessment|Lost to Follow-up|4|||
148979634|NCT02391948|537405728|FG003|12-month Assessment|Lost to Follow-up|4|||
148979635|NCT02391948|537405729|FG004|12-month Assessment|Lost to Follow-up|5|||
148979636|NCT02391948|537405725|FG000|12-month Assessment|Medical issue/illness|0|||
148979637|NCT02391948|537405726|FG001|12-month Assessment|Medical issue/illness|1|||
148979638|NCT02391948|537405727|FG002|12-month Assessment|Medical issue/illness|0|||
148979639|NCT02391948|537405728|FG003|12-month Assessment|Medical issue/illness|1|||
148979640|NCT02391948|537405729|FG004|12-month Assessment|Medical issue/illness|0|||
148979641|NCT02391948|537405725|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
148979642|NCT02391948|537405726|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
148979643|NCT02391948|537405727|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
148979644|NCT02391948|537405728|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
148979645|NCT02391948|537405729|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
148979646|NCT02391948|537405725|FG000|18-month Assessment|Death|0|||
148979647|NCT02391948|537405726|FG001|18-month Assessment|Death|0|||
148979648|NCT02391948|537405727|FG002|18-month Assessment|Death|0|||
148979649|NCT02391948|537405728|FG003|18-month Assessment|Death|1|||
148979650|NCT02391948|537405729|FG004|18-month Assessment|Death|1|||
148979651|NCT02391948|537405725|FG000|18-month Assessment|Withdrawal by Subject|1|||
148979652|NCT02391948|537405726|FG001|18-month Assessment|Withdrawal by Subject|0|||
148979653|NCT02391948|537405727|FG002|18-month Assessment|Withdrawal by Subject|0|||
148979654|NCT02391948|537405728|FG003|18-month Assessment|Withdrawal by Subject|1|||
148979655|NCT02391948|537405729|FG004|18-month Assessment|Withdrawal by Subject|0|||
148979656|NCT02391948|537405725|FG000|18-month Assessment|Lost to Follow-up|2|||
148979657|NCT02391948|537405726|FG001|18-month Assessment|Lost to Follow-up|6|||
148979658|NCT02391948|537405727|FG002|18-month Assessment|Lost to Follow-up|2|||
148979659|NCT02391948|537405728|FG003|18-month Assessment|Lost to Follow-up|2|||
148830076|NCT01892189|536857074|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
148830077|NCT01892189|536857075|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
148830078|NCT01892189|536857067|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148830079|NCT01892189|536857068|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148830080|NCT01892189|536857069|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
148979660|NCT02391948|537405729|FG004|18-month Assessment|Lost to Follow-up|3|||
148979661|NCT02391948|537405725|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
148979662|NCT02391948|537405726|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
148979663|NCT02391948|537405727|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
148979664|NCT02391948|537405728|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
148979665|NCT02391948|537405729|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
148979666|NCT02391948|537405725|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
148768118|NCT00972816|536625227|FG002|Overall Study|Inappropriate enrolment|0|||
148768119|NCT00972816|536625228|FG003|Overall Study|Inappropriate enrolment|0|||
148768120|NCT00972816|536625229|FG004|Overall Study|Inappropriate enrolment|0|||
148768121|NCT00972816|536625230|FG005|Overall Study|Inappropriate enrolment|0|||
148768122|NCT00972816|536625231|FG006|Overall Study|Inappropriate enrolment|2|||
148768123|NCT00972816|536625232|FG007|Overall Study|Inappropriate enrolment|0|||
148768124|NCT00972816|536625225|FG000|Overall Study|Unable to classify|2|||
148768125|NCT00972816|536625226|FG001|Overall Study|Unable to classify|0|||
148768126|NCT00972816|536625227|FG002|Overall Study|Unable to classify|0|||
148768127|NCT00972816|536625228|FG003|Overall Study|Unable to classify|0|||
148768128|NCT00972816|536625229|FG004|Overall Study|Unable to classify|1|||
148768129|NCT00972816|536625230|FG005|Overall Study|Unable to classify|0|||
148768130|NCT00972816|536625231|FG006|Overall Study|Unable to classify|0|||
148768131|NCT00972816|536625232|FG007|Overall Study|Unable to classify|0|||
148768132|NCT00593684|536625235|FG000|Overall Study|Death|2|||
148768133|NCT00593684|536625236|FG001|Overall Study|Death|1|||
148768134|NCT03625466|536625237|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
148768135|NCT03625466|536625238|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
148768136|NCT03625466|536625239|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
148768137|NCT03625466|536625237|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
148768138|NCT03625466|536625238|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
148768139|NCT03625466|536625239|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
148768140|NCT03625466|536625237|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
148768141|NCT03625466|536625238|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
148768142|NCT03625466|536625239|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
148768143|NCT00809471|536625242|FG000|Overall Study|Protocol non-compliance|15|||
148768144|NCT00809471|536625243|FG001|Overall Study|Protocol non-compliance|15|||
148768145|NCT00809471|536625244|FG002|Overall Study|Protocol non-compliance|6|||
148768146|NCT00809471|536625242|FG000|Overall Study|Lost to Follow-up|4|||
148768147|NCT00809471|536625243|FG001|Overall Study|Lost to Follow-up|2|||
148768148|NCT00809471|536625244|FG002|Overall Study|Lost to Follow-up|9|||
148768149|NCT00809471|536625242|FG000|Overall Study|Adverse Event|0|||
148768150|NCT00809471|536625243|FG001|Overall Study|Adverse Event|2|||
148768151|NCT00809471|536625244|FG002|Overall Study|Adverse Event|2|||
148768152|NCT00809471|536625242|FG000|Overall Study|Requirement for restricted medication|1|||
148768153|NCT00809471|536625243|FG001|Overall Study|Requirement for restricted medication|1|||
148768154|NCT00809471|536625244|FG002|Overall Study|Requirement for restricted medication|0|||
148768155|NCT00831311|536625245|FG000|Overall Study|Definitive Contraindication|3|||
148768156|NCT00831311|536625246|FG001|Overall Study|Definitive Contraindication|3|||
148768157|NCT00831311|536625245|FG000|Overall Study|Lost to Follow-up|3|||
148768158|NCT00831311|536625246|FG001|Overall Study|Lost to Follow-up|0|||
148768159|NCT00831311|536625245|FG000|Overall Study|Physician Decision|0|||
148768160|NCT00831311|536625246|FG001|Overall Study|Physician Decision|1|||
148768161|NCT00831311|536625245|FG000|Overall Study|Withdrawal by Subject|6|||
148768162|NCT00831311|536625246|FG001|Overall Study|Withdrawal by Subject|4|||
148768163|NCT03214380|536625249|FG000|Lead-in|Adverse Event|3|||
148768164|NCT03214380|536625250|FG001|Lead-in|Adverse Event|0|||
148768165|NCT03214380|536625251|FG002|Lead-in|Adverse Event|0|||
148768166|NCT03214380|536625252|FG003|Lead-in|Adverse Event|1|||
148768167|NCT03214380|536625253|FG004|Lead-in|Adverse Event|0|||
148768168|NCT03214380|536625254|FG005|Lead-in|Adverse Event|0|||
148768169|NCT03214380|536625249|FG000|Lead-in|Lost to Follow-up|4|||
148768170|NCT03214380|536625250|FG001|Lead-in|Lost to Follow-up|0|||
148768171|NCT03214380|536625251|FG002|Lead-in|Lost to Follow-up|0|||
148768172|NCT03214380|536625252|FG003|Lead-in|Lost to Follow-up|1|||
148768173|NCT03214380|536625253|FG004|Lead-in|Lost to Follow-up|0|||
148768174|NCT03214380|536625254|FG005|Lead-in|Lost to Follow-up|0|||
148768175|NCT03214380|536625249|FG000|Lead-in|Eligibility Criteria|3|||
148768176|NCT03214380|536625250|FG001|Lead-in|Eligibility Criteria|0|||
148768177|NCT03214380|536625251|FG002|Lead-in|Eligibility Criteria|0|||
148768178|NCT03214380|536625252|FG003|Lead-in|Eligibility Criteria|0|||
148768179|NCT03214380|536625253|FG004|Lead-in|Eligibility Criteria|0|||
148768180|NCT03214380|536625254|FG005|Lead-in|Eligibility Criteria|0|||
148768181|NCT03214380|536625249|FG000|Lead-in|Physician Decision|6|||
148768182|NCT03214380|536625250|FG001|Lead-in|Physician Decision|0|||
148768183|NCT03214380|536625251|FG002|Lead-in|Physician Decision|0|||
148768184|NCT03214380|536625252|FG003|Lead-in|Physician Decision|0|||
148768185|NCT03214380|536625253|FG004|Lead-in|Physician Decision|0|||
148768186|NCT03214380|536625254|FG005|Lead-in|Physician Decision|0|||
148979667|NCT02391948|537405726|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
148979668|NCT02391948|537405727|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
148979669|NCT02391948|537405728|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
148979670|NCT02391948|537405729|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
148979671|NCT02391948|537405725|FG000|24-month Assessment|Death|0|||
148979672|NCT02391948|537405726|FG001|24-month Assessment|Death|0|||
148979673|NCT02391948|537405727|FG002|24-month Assessment|Death|0|||
148979674|NCT02391948|537405728|FG003|24-month Assessment|Death|0|||
148979675|NCT02391948|537405729|FG004|24-month Assessment|Death|1|||
148979676|NCT02391948|537405725|FG000|24-month Assessment|Withdrawal by Subject|1|||
148979677|NCT02391948|537405726|FG001|24-month Assessment|Withdrawal by Subject|1|||
148979678|NCT02391948|537405727|FG002|24-month Assessment|Withdrawal by Subject|0|||
148979679|NCT02391948|537405728|FG003|24-month Assessment|Withdrawal by Subject|0|||
148979680|NCT02391948|537405729|FG004|24-month Assessment|Withdrawal by Subject|1|||
148979681|NCT02391948|537405725|FG000|24-month Assessment|Lost to Follow-up|5|||
148979682|NCT02391948|537405726|FG001|24-month Assessment|Lost to Follow-up|4|||
148979683|NCT02391948|537405727|FG002|24-month Assessment|Lost to Follow-up|0|||
148979684|NCT02391948|537405728|FG003|24-month Assessment|Lost to Follow-up|0|||
148979685|NCT02391948|537405729|FG004|24-month Assessment|Lost to Follow-up|0|||
148979686|NCT02391948|537405725|FG000|24-month Assessment|Medical issue/illness|0|||
148979687|NCT02391948|537405726|FG001|24-month Assessment|Medical issue/illness|0|||
148979688|NCT02391948|537405727|FG002|24-month Assessment|Medical issue/illness|1|||
148979689|NCT02391948|537405728|FG003|24-month Assessment|Medical issue/illness|0|||
148979690|NCT02391948|537405729|FG004|24-month Assessment|Medical issue/illness|0|||
148979691|NCT02391948|537405725|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
148979692|NCT02391948|537405726|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
148979693|NCT02391948|537405727|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
148979694|NCT02391948|537405728|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
148979695|NCT02391948|537405729|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
148979696|NCT00938431|537405733|FG000|Overall Study|Adverse Event|5|||
148979697|NCT00938431|537405734|FG001|Overall Study|Adverse Event|8|||
148979698|NCT00938431|537405735|FG002|Overall Study|Adverse Event|6|||
148979699|NCT00938431|537405733|FG000|Overall Study|Lack of Efficacy|0|||
148979700|NCT00938431|537405734|FG001|Overall Study|Lack of Efficacy|1|||
148979701|NCT00938431|537405735|FG002|Overall Study|Lack of Efficacy|0|||
148979702|NCT00938431|537405733|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
148979703|NCT00938431|537405734|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
148979704|NCT00938431|537405735|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
148979705|NCT00938431|537405733|FG000|Overall Study|Dosing compliance issue|0|||
148979706|NCT00938431|537405734|FG001|Overall Study|Dosing compliance issue|0|||
148979707|NCT00938431|537405735|FG002|Overall Study|Dosing compliance issue|1|||
148979708|NCT00938431|537405733|FG000|Overall Study|Reached maximum dose early|0|||
148979709|NCT00938431|537405734|FG001|Overall Study|Reached maximum dose early|0|||
148979710|NCT00938431|537405735|FG002|Overall Study|Reached maximum dose early|1|||
148979711|NCT02086591|537405736|FG000|Overall Study|Adverse Event|1|||
148979712|NCT02086591|537405736|FG000|Overall Study|Withdrawal by Subject|1|||
148979713|NCT02086591|537405736|FG000|Overall Study|protocol terminated|3|||
148979714|NCT03738865|537405739|FG000|Overall Study|Withdrawal by Subject|3|||
148979715|NCT03738865|537405740|FG001|Overall Study|Withdrawal by Subject|3|||
148979716|NCT03738865|537405739|FG000|Overall Study|Adverse Event|2|||
148979717|NCT03738865|537405740|FG001|Overall Study|Adverse Event|0|||
148979718|NCT03738865|537405739|FG000|Overall Study|Physician Decision|0|||
148979719|NCT03738865|537405740|FG001|Overall Study|Physician Decision|1|||
148979720|NCT00274716|537405741|FG000|Phase A|Other non-reported reason|4|||
148979721|NCT00274716|537405742|FG001|Phase A|Other non-reported reason|2|||
148979722|NCT00274716|537405743|FG002|Phase A|Other non-reported reason|1|||
148979723|NCT00274716|537405744|FG003|Phase A|Other non-reported reason|2|||
148979724|NCT00274716|537405745|FG004|Phase A|Other non-reported reason|0|||
148979725|NCT00274716|537405746|FG005|Phase A|Other non-reported reason|1|||
148979726|NCT00274716|537405741|FG000|Phase A|Participant moved|0|||
149028006|NCT00723294|537580055|FG000|Overall Study|No cryoabalation|2|||
148768187|NCT03214380|536625249|FG000|Lead-in|Protocol Deviation|7|||
148768188|NCT03214380|536625250|FG001|Lead-in|Protocol Deviation|0|||
148979727|NCT00274716|537405742|FG001|Phase A|Participant moved|0|||
148979728|NCT00274716|537405743|FG002|Phase A|Participant moved|1|||
148979729|NCT00274716|537405744|FG003|Phase A|Participant moved|0|||
148979730|NCT00274716|537405745|FG004|Phase A|Participant moved|0|||
148979731|NCT00274716|537405746|FG005|Phase A|Participant moved|1|||
148979732|NCT00274716|537405741|FG000|Phase A|Site Terminated|0|||
148979733|NCT00274716|537405742|FG001|Phase A|Site Terminated|0|||
148979734|NCT00274716|537405743|FG002|Phase A|Site Terminated|0|||
148979735|NCT00274716|537405744|FG003|Phase A|Site Terminated|1|||
148979736|NCT00274716|537405745|FG004|Phase A|Site Terminated|0|||
148979737|NCT00274716|537405746|FG005|Phase A|Site Terminated|0|||
148979738|NCT00274716|537405741|FG000|Phase A|Protocol Violation|1|||
148979739|NCT00274716|537405742|FG001|Phase A|Protocol Violation|0|||
148979740|NCT00274716|537405743|FG002|Phase A|Protocol Violation|0|||
148768189|NCT03214380|536625251|FG002|Lead-in|Protocol Deviation|0|||
148768190|NCT03214380|536625252|FG003|Lead-in|Protocol Deviation|3|||
148768191|NCT03214380|536625253|FG004|Lead-in|Protocol Deviation|0|||
148768192|NCT03214380|536625254|FG005|Lead-in|Protocol Deviation|0|||
148768193|NCT03214380|536625249|FG000|Lead-in|Withdrawal by Subject|41|||
148768194|NCT03214380|536625250|FG001|Lead-in|Withdrawal by Subject|0|||
148768195|NCT03214380|536625251|FG002|Lead-in|Withdrawal by Subject|0|||
148768196|NCT03214380|536625252|FG003|Lead-in|Withdrawal by Subject|14|||
148768197|NCT03214380|536625253|FG004|Lead-in|Withdrawal by Subject|0|||
148768198|NCT03214380|536625254|FG005|Lead-in|Withdrawal by Subject|0|||
148768199|NCT03214380|536625249|FG000|Lead-in|Family Emergency|1|||
148830081|NCT01892189|536857070|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
148830082|NCT01892189|536857071|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148830083|NCT01892189|536857072|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148830084|NCT01892189|536857073|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
148830085|NCT01892189|536857074|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148830086|NCT01892189|536857075|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
148830087|NCT01892189|536857067|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830088|NCT01892189|536857068|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830089|NCT01892189|536857069|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830090|NCT01892189|536857070|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830091|NCT01892189|536857071|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830092|NCT01892189|536857072|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
148830093|NCT01892189|536857073|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830094|NCT01892189|536857074|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830095|NCT01892189|536857075|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
148830096|NCT01992757|536857078|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
148830097|NCT03440411|536857079|FG000|Overall Study|Adverse Event|0|||
148830098|NCT03440411|536857080|FG001|Overall Study|Adverse Event|0|||
148830099|NCT03440411|536857081|FG002|Overall Study|Adverse Event|1|||
148830100|NCT03440411|536857082|FG003|Overall Study|Adverse Event|0|||
148830101|NCT03440411|536857079|FG000|Overall Study|PD|2|||
148830102|NCT03440411|536857080|FG001|Overall Study|PD|1|||
148830103|NCT03440411|536857081|FG002|Overall Study|PD|1|||
148830104|NCT03440411|536857082|FG003|Overall Study|PD|1|||
148830105|NCT03440411|536857079|FG000|Overall Study|Withdrawal by Subject|1|||
148830106|NCT03440411|536857080|FG001|Overall Study|Withdrawal by Subject|0|||
148830107|NCT03440411|536857081|FG002|Overall Study|Withdrawal by Subject|0|||
148830108|NCT03440411|536857082|FG003|Overall Study|Withdrawal by Subject|0|||
148830109|NCT03440411|536857079|FG000|Overall Study|Closed study by sponsor|0|||
148830110|NCT03440411|536857080|FG001|Overall Study|Closed study by sponsor|0|||
148830111|NCT03440411|536857081|FG002|Overall Study|Closed study by sponsor|0|||
148830112|NCT03440411|536857082|FG003|Overall Study|Closed study by sponsor|1|||
148830113|NCT00688740|536857083|FG000|Overall Study|Adverse Event|45|||
148830114|NCT00688740|536857084|FG001|Overall Study|Adverse Event|8|||
148830115|NCT00688740|536857083|FG000|Overall Study|Death|2|||
148830116|NCT00688740|536857084|FG001|Overall Study|Death|2|||
148830117|NCT00688740|536857083|FG000|Overall Study|Lost to Follow-up|0|||
148979741|NCT00274716|537405744|FG003|Phase A|Protocol Violation|1|||
148979742|NCT00274716|537405745|FG004|Phase A|Protocol Violation|0|||
148979743|NCT00274716|537405746|FG005|Phase A|Protocol Violation|0|||
148979744|NCT00274716|537405741|FG000|Phase A|Met criteria for discontinuation|1|||
148979745|NCT00274716|537405742|FG001|Phase A|Met criteria for discontinuation|1|||
148979746|NCT00274716|537405743|FG002|Phase A|Met criteria for discontinuation|0|||
148979747|NCT00274716|537405744|FG003|Phase A|Met criteria for discontinuation|0|||
148979748|NCT00274716|537405745|FG004|Phase A|Met criteria for discontinuation|0|||
148979749|NCT00274716|537405746|FG005|Phase A|Met criteria for discontinuation|0|||
148979750|NCT00274716|537405741|FG000|Phase A|Withdrawal by Subject|2|||
148979751|NCT00274716|537405742|FG001|Phase A|Withdrawal by Subject|2|||
148979752|NCT00274716|537405743|FG002|Phase A|Withdrawal by Subject|1|||
148979753|NCT00274716|537405744|FG003|Phase A|Withdrawal by Subject|3|||
148979754|NCT00274716|537405745|FG004|Phase A|Withdrawal by Subject|0|||
148979755|NCT00274716|537405746|FG005|Phase A|Withdrawal by Subject|1|||
148768200|NCT03214380|536625250|FG001|Lead-in|Family Emergency|0|||
148768201|NCT03214380|536625251|FG002|Lead-in|Family Emergency|0|||
148768202|NCT03214380|536625252|FG003|Lead-in|Family Emergency|0|||
148830118|NCT00688740|536857084|FG001|Overall Study|Lost to Follow-up|1|||
148979756|NCT00274716|537405741|FG000|Phase A|Adverse Event|2|||
148979757|NCT00274716|537405742|FG001|Phase A|Adverse Event|3|||
148979758|NCT00274716|537405743|FG002|Phase A|Adverse Event|3|||
148830119|NCT00688740|536857083|FG000|Overall Study|Consent Withdrawn|17|||
148830120|NCT00688740|536857084|FG001|Overall Study|Consent Withdrawn|17|||
148830121|NCT00688740|536857083|FG000|Overall Study|Breast Cancer Relapse|1|||
148830122|NCT00688740|536857084|FG001|Overall Study|Breast Cancer Relapse|4|||
148830123|NCT00688740|536857083|FG000|Overall Study|Violation of Inclusion Criteria|1|||
148979759|NCT00274716|537405744|FG003|Phase A|Adverse Event|0|||
148979760|NCT00274716|537405745|FG004|Phase A|Adverse Event|2|||
148768203|NCT03214380|536625253|FG004|Lead-in|Family Emergency|0|||
148830124|NCT00688740|536857084|FG001|Overall Study|Violation of Inclusion Criteria|3|||
148830125|NCT01344356|536857085|FG000|Overall Study|Physician Decision|0|||
148830126|NCT01344356|536857086|FG001|Overall Study|Physician Decision|3|||
148830127|NCT01344356|536857085|FG000|Overall Study|Lost to Follow-up|0|||
148830128|NCT01344356|536857086|FG001|Overall Study|Lost to Follow-up|6|||
148830129|NCT00095576|536857087|FG000|Overall Study|Adverse Event|5|||
148830130|NCT00095576|536857088|FG001|Overall Study|Adverse Event|3|||
148830131|NCT00095576|536857087|FG000|Overall Study|Lost to Follow-up|233|||
148830132|NCT00095576|536857088|FG001|Overall Study|Lost to Follow-up|229|||
148830133|NCT00095576|536857087|FG000|Overall Study|Protocol Violation|1|||
148830134|NCT00095576|536857088|FG001|Overall Study|Protocol Violation|0|||
148830135|NCT00095576|536857087|FG000|Overall Study|Withdrawal by Subject|34|||
148830136|NCT00095576|536857088|FG001|Overall Study|Withdrawal by Subject|47|||
148830137|NCT00095576|536857087|FG000|Overall Study|Option to switch to a rollover study|1097|||
148830138|NCT00095576|536857088|FG001|Overall Study|Option to switch to a rollover study|1099|||
148830139|NCT00095576|536857087|FG000|Overall Study|Site terminated|75|||
148830140|NCT00095576|536857088|FG001|Overall Study|Site terminated|67|||
148830141|NCT00095576|536857087|FG000|Overall Study|Subject moved|30|||
148830142|NCT00095576|536857088|FG001|Overall Study|Subject moved|36|||
148830143|NCT00856557|536857091|FG000|Overall Study|No patients with contextual flags|12|||
148830144|NCT00856557|536857092|FG001|Overall Study|No patients with contextual flags|16|||
148830145|NCT03673176|536857093|FG000|Overall Study|Death prior to intervention|1|||
148830146|NCT03673176|536857093|FG000|Overall Study|Death following intervention|3|||
148830147|NCT03673176|536857093|FG000|Overall Study|Withdrawal by Subject|1|||
148830148|NCT02301897|536857094|FG000|Treatment Course 1|Non-Compliance|0|||
148830149|NCT02301897|536857095|FG001|Treatment Course 1|Non-Compliance|0|||
148830150|NCT02301897|536857096|FG002|Treatment Course 1|Non-Compliance|1|||
148830151|NCT02301897|536857094|FG000|Treatment Course 1|Adverse Event|1|||
148830152|NCT02301897|536857095|FG001|Treatment Course 1|Adverse Event|1|||
148830153|NCT02301897|536857096|FG002|Treatment Course 1|Adverse Event|0|||
148830154|NCT02301897|536857094|FG000|Treatment Course 1|Lost to Follow-up|1|||
148830155|NCT02301897|536857095|FG001|Treatment Course 1|Lost to Follow-up|2|||
148830156|NCT02301897|536857096|FG002|Treatment Course 1|Lost to Follow-up|1|||
148830157|NCT02301897|536857094|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
148830158|NCT02301897|536857095|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
148830159|NCT02301897|536857096|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
148830160|NCT02301897|536857094|FG000|Treatment Course 1|Withdrawal by Subject|0|||
148830161|NCT02301897|536857095|FG001|Treatment Course 1|Withdrawal by Subject|0|||
148830162|NCT02301897|536857096|FG002|Treatment Course 1|Withdrawal by Subject|2|||
148830163|NCT02301897|536857094|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
148830164|NCT02301897|536857095|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
148830165|NCT02301897|536857096|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
148830166|NCT02301897|536857094|FG000|Treatment Course 2|Lost to Follow-up|0|||
148830167|NCT02301897|536857095|FG001|Treatment Course 2|Lost to Follow-up|2|||
148830168|NCT02301897|536857096|FG002|Treatment Course 2|Lost to Follow-up|0|||
148830169|NCT02301897|536857094|FG000|Treatment Course 2|Pregnancy|0|||
148830170|NCT02301897|536857095|FG001|Treatment Course 2|Pregnancy|1|||
148830171|NCT02301897|536857096|FG002|Treatment Course 2|Pregnancy|1|||
148830172|NCT02301897|536857094|FG000|Treatment Course 2|Withdrawal by Subject|0|||
148830173|NCT02301897|536857095|FG001|Treatment Course 2|Withdrawal by Subject|2|||
148830174|NCT02301897|536857096|FG002|Treatment Course 2|Withdrawal by Subject|0|||
148830175|NCT02301897|536857094|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
148830176|NCT02301897|536857095|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
148830177|NCT02301897|536857096|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
148830178|NCT02378480|536857097|FG000|Overall Study|Physician Decision|1|||
148830179|NCT02378480|536857098|FG001|Overall Study|Physician Decision|1|||
148830180|NCT02378480|536857097|FG000|Overall Study|Death|1|||
148830181|NCT02378480|536857098|FG001|Overall Study|Death|2|||
148830182|NCT02378480|536857097|FG000|Overall Study|Randomized, but Not Treated|6|||
148830183|NCT02378480|536857098|FG001|Overall Study|Randomized, but Not Treated|4|||
148830184|NCT02378480|536857097|FG000|Overall Study|Adverse Event|0|||
148830185|NCT02378480|536857098|FG001|Overall Study|Adverse Event|1|||
148830186|NCT02378480|536857097|FG000|Overall Study|Missed EOT/PTE Visit|1|||
148830187|NCT02378480|536857098|FG001|Overall Study|Missed EOT/PTE Visit|2|||
148830188|NCT02378480|536857097|FG000|Overall Study|Withdrawal by Subject|9|||
148830189|NCT02378480|536857098|FG001|Overall Study|Withdrawal by Subject|4|||
148830190|NCT02378480|536857097|FG000|Overall Study|Lost to Follow-up|10|||
148830191|NCT02378480|536857098|FG001|Overall Study|Lost to Follow-up|18|||
148830192|NCT01285102|536857103|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
148830193|NCT00557440|536857113|FG000|Treatment Period 1|Adverse Event|0|||
148830194|NCT00557440|536857114|FG001|Treatment Period 1|Adverse Event|0|||
148830195|NCT00557440|536857115|FG002|Treatment Period 1|Adverse Event|1|||
148830196|NCT03524157|536857116|FG000|Overall Study|cytology not readable|0|||
148830197|NCT03524157|536857117|FG001|Overall Study|cytology not readable|0|||
148830198|NCT03524157|536857118|FG002|Overall Study|cytology not readable|1|||
148830199|NCT04507763|536857119|FG000|Overall Study|Participants did not meet entrance criteria|201|||
148768204|NCT03214380|536625254|FG005|Lead-in|Family Emergency|0|||
148768205|NCT03214380|536625249|FG000|Lead-in|Natural Disaster|9|||
148768206|NCT03214380|536625250|FG001|Lead-in|Natural Disaster|0|||
148768207|NCT03214380|536625251|FG002|Lead-in|Natural Disaster|0|||
148768208|NCT03214380|536625252|FG003|Lead-in|Natural Disaster|0|||
148768209|NCT03214380|536625253|FG004|Lead-in|Natural Disaster|0|||
148768210|NCT03214380|536625254|FG005|Lead-in|Natural Disaster|0|||
148768211|NCT03214380|536625249|FG000|Lead-in|Non Compliance|1|||
148768212|NCT03214380|536625250|FG001|Lead-in|Non Compliance|0|||
148768213|NCT03214380|536625251|FG002|Lead-in|Non Compliance|0|||
148768214|NCT03214380|536625252|FG003|Lead-in|Non Compliance|0|||
148768215|NCT03214380|536625253|FG004|Lead-in|Non Compliance|0|||
148768216|NCT03214380|536625254|FG005|Lead-in|Non Compliance|0|||
148768217|NCT03214380|536625249|FG000|Lead-in|Participant Schedule|2|||
148768218|NCT03214380|536625250|FG001|Lead-in|Participant Schedule|0|||
148768219|NCT03214380|536625251|FG002|Lead-in|Participant Schedule|0|||
148768220|NCT03214380|536625252|FG003|Lead-in|Participant Schedule|0|||
148768221|NCT03214380|536625253|FG004|Lead-in|Participant Schedule|0|||
148768222|NCT03214380|536625254|FG005|Lead-in|Participant Schedule|0|||
148768223|NCT03214380|536625249|FG000|Treatment Period|Adverse Event|0|||
148768224|NCT03214380|536625250|FG001|Treatment Period|Adverse Event|1|||
148768225|NCT03214380|536625251|FG002|Treatment Period|Adverse Event|1|||
148768226|NCT03214380|536625252|FG003|Treatment Period|Adverse Event|0|||
148768227|NCT03214380|536625253|FG004|Treatment Period|Adverse Event|1|||
148768228|NCT03214380|536625254|FG005|Treatment Period|Adverse Event|0|||
148768229|NCT03214380|536625249|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
148768230|NCT03214380|536625250|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
148768231|NCT03214380|536625251|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
148768232|NCT03214380|536625252|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
148768233|NCT03214380|536625253|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
148768234|NCT03214380|536625254|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
148768235|NCT03214380|536625249|FG000|Treatment Period|Withdrawal by Subject|0|||
148768236|NCT03214380|536625250|FG001|Treatment Period|Withdrawal by Subject|10|||
148768237|NCT03214380|536625251|FG002|Treatment Period|Withdrawal by Subject|8|||
148768238|NCT03214380|536625252|FG003|Treatment Period|Withdrawal by Subject|0|||
148768239|NCT03214380|536625253|FG004|Treatment Period|Withdrawal by Subject|7|||
148768240|NCT03214380|536625254|FG005|Treatment Period|Withdrawal by Subject|11|||
148768241|NCT03214380|536625249|FG000|Treatment Period|Death|0|||
148768242|NCT03214380|536625250|FG001|Treatment Period|Death|1|||
148768243|NCT03214380|536625251|FG002|Treatment Period|Death|2|||
148768244|NCT03214380|536625252|FG003|Treatment Period|Death|0|||
148768245|NCT03214380|536625253|FG004|Treatment Period|Death|0|||
148768246|NCT03214380|536625254|FG005|Treatment Period|Death|0|||
148768247|NCT03214380|536625249|FG000|Treatment Period|Lost to Follow-up|0|||
148768248|NCT03214380|536625250|FG001|Treatment Period|Lost to Follow-up|6|||
148768249|NCT03214380|536625251|FG002|Treatment Period|Lost to Follow-up|3|||
148768250|NCT03214380|536625252|FG003|Treatment Period|Lost to Follow-up|0|||
148768251|NCT03214380|536625253|FG004|Treatment Period|Lost to Follow-up|0|||
148768252|NCT03214380|536625254|FG005|Treatment Period|Lost to Follow-up|0|||
148768253|NCT03214380|536625249|FG000|Treatment Period|Participant schedule|0|||
148768254|NCT03214380|536625250|FG001|Treatment Period|Participant schedule|0|||
148768255|NCT03214380|536625251|FG002|Treatment Period|Participant schedule|1|||
148768256|NCT03214380|536625252|FG003|Treatment Period|Participant schedule|0|||
148768257|NCT03214380|536625253|FG004|Treatment Period|Participant schedule|0|||
148768258|NCT03214380|536625254|FG005|Treatment Period|Participant schedule|0|||
148768259|NCT03214380|536625249|FG000|Treatment Period|Treatment Interruption|0|||
148768260|NCT03214380|536625250|FG001|Treatment Period|Treatment Interruption|0|||
148768261|NCT03214380|536625251|FG002|Treatment Period|Treatment Interruption|1|||
148768262|NCT03214380|536625252|FG003|Treatment Period|Treatment Interruption|0|||
148768263|NCT03214380|536625253|FG004|Treatment Period|Treatment Interruption|0|||
148768264|NCT03214380|536625254|FG005|Treatment Period|Treatment Interruption|0|||
148768265|NCT01905553|536625258|FG000|Period 2|Adverse Event|1|||
148768266|NCT01905553|536625259|FG001|Period 2|Adverse Event|0|||
148768267|NCT03692325|536625263|FG000|Overall Study|Adverse Event|2|||
148768268|NCT03692325|536625263|FG000|Overall Study|Progression/Recurrence|2|||
148768269|NCT02817516|536625264|FG000|Overall Study|Other|0|||
148768270|NCT02817516|536625265|FG001|Overall Study|Other|0|||
148768271|NCT02817516|536625266|FG002|Overall Study|Other|1|||
148768272|NCT02817516|536625267|FG003|Overall Study|Other|0|||
148768273|NCT00664859|536625268|FG000|Overall Study|Adverse Event|2|||
148768274|NCT00664859|536625269|FG001|Overall Study|Adverse Event|1|||
148768275|NCT00664859|536625270|FG002|Overall Study|Adverse Event|3|||
148768276|NCT00664859|536625268|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
148768277|NCT00664859|536625269|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
148768278|NCT00664859|536625270|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
148768279|NCT00664859|536625268|FG000|Overall Study|Noncompliance with protocol|1|||
148768280|NCT00664859|536625269|FG001|Overall Study|Noncompliance with protocol|0|||
148768281|NCT00664859|536625270|FG002|Overall Study|Noncompliance with protocol|4|||
148768282|NCT00664859|536625268|FG000|Overall Study|Laboratory abnormality|2|||
148768283|NCT00664859|536625269|FG001|Overall Study|Laboratory abnormality|1|||
148768284|NCT00664859|536625270|FG002|Overall Study|Laboratory abnormality|4|||
148768285|NCT00664859|536625268|FG000|Overall Study|Withdrawal by Subject|4|||
148768286|NCT00664859|536625269|FG001|Overall Study|Withdrawal by Subject|1|||
148768287|NCT00664859|536625270|FG002|Overall Study|Withdrawal by Subject|3|||
148768288|NCT00664859|536625268|FG000|Overall Study|Lost to Follow-up|2|||
148768289|NCT00664859|536625269|FG001|Overall Study|Lost to Follow-up|2|||
148768290|NCT00664859|536625270|FG002|Overall Study|Lost to Follow-up|1|||
148768291|NCT00664859|536625268|FG000|Overall Study|Other|0|||
148768292|NCT00664859|536625269|FG001|Overall Study|Other|1|||
148768293|NCT00664859|536625270|FG002|Overall Study|Other|2|||
148768294|NCT04481191|536625271|FG000|Overall Study|Withdrawn by parent/guardian|15|||
148768295|NCT04481191|536625272|FG001|Overall Study|Withdrawn by parent/guardian|10|||
148768296|NCT00546117|536625273|FG000|Overall Study|Withdrawal by Subject|3|||
148768297|NCT00546117|536625274|FG001|Overall Study|Withdrawal by Subject|0|||
148768298|NCT00546117|536625273|FG000|Overall Study|Inability to schedule follow-up visit|1|||
148768299|NCT00546117|536625274|FG001|Overall Study|Inability to schedule follow-up visit|0|||
148768300|NCT00348595|536625277|FG000|Overall Study|Adverse Event|5|||
148768301|NCT00348595|536625278|FG001|Overall Study|Adverse Event|8|||
148768302|NCT01560234|536625279|FG000|Overall Study|Lost to Follow-up|3|||
148768303|NCT01560234|536625280|FG001|Overall Study|Lost to Follow-up|0|||
148768304|NCT01560234|536625281|FG002|Overall Study|Lost to Follow-up|1|||
148768305|NCT01560234|536625282|FG003|Overall Study|Lost to Follow-up|0|||
148768306|NCT01560234|536625283|FG004|Overall Study|Lost to Follow-up|0|||
148768307|NCT01560234|536625284|FG005|Overall Study|Lost to Follow-up|2|||
148768308|NCT01560234|536625285|FG006|Overall Study|Lost to Follow-up|0|||
148768309|NCT01560234|536625286|FG007|Overall Study|Lost to Follow-up|2|||
148768310|NCT00280397|536625291|FG000|Overall Study|Adverse Event|1|||
148768311|NCT01250873|536625292|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
148768312|NCT01250873|536625292|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
148768313|NCT01062113|536625293|FG000|Overall Study|Adverse Event|1|||
148768314|NCT01062113|536625294|FG001|Overall Study|Adverse Event|0|||
148768315|NCT01062113|536625295|FG002|Overall Study|Adverse Event|0|||
148768316|NCT01062113|536625293|FG000|Overall Study|Lack of Efficacy|38|||
148768317|NCT01062113|536625294|FG001|Overall Study|Lack of Efficacy|22|||
148768318|NCT01062113|536625295|FG002|Overall Study|Lack of Efficacy|31|||
148768319|NCT01062113|536625293|FG000|Overall Study|Withdrawal by Subject|1|||
148768320|NCT01062113|536625294|FG001|Overall Study|Withdrawal by Subject|0|||
148768321|NCT01062113|536625295|FG002|Overall Study|Withdrawal by Subject|0|||
148768322|NCT04791319|536625296|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
148768323|NCT04791319|536625297|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
148768324|NCT04791319|536625298|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
148768325|NCT04791319|536625299|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
148768326|NCT04791319|536625300|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768327|NCT04791319|536625301|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768328|NCT04791319|536625302|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768329|NCT04791319|536625303|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768330|NCT04791319|536625304|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768331|NCT04791319|536625305|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768332|NCT04791319|536625306|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
148768333|NCT04791319|536625296|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
148768334|NCT04791319|536625297|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768335|NCT04791319|536625298|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
148768336|NCT04791319|536625299|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
148768337|NCT04791319|536625300|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768338|NCT04791319|536625301|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768339|NCT04791319|536625302|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768340|NCT04791319|536625303|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768341|NCT04791319|536625304|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768342|NCT04791319|536625305|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768343|NCT04791319|536625306|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
148768344|NCT04791319|536625296|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
148768345|NCT04791319|536625297|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
149028007|NCT00723294|537580055|FG000|Overall Study|Did not undergo surgery|1|||
148768346|NCT04791319|536625298|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
148768347|NCT04791319|536625299|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
148768348|NCT04791319|536625300|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148768349|NCT04791319|536625301|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148768350|NCT04791319|536625302|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148768351|NCT04791319|536625303|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148768352|NCT04791319|536625304|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148830200|NCT03322566|536857120|FG000|Overall Study|Death|34|||
148830201|NCT03322566|536857121|FG001|Overall Study|Death|35|||
148830202|NCT03322566|536857122|FG002|Overall Study|Death|23|||
148830203|NCT03322566|536857120|FG000|Overall Study|Physician Decision|6|||
148830204|NCT03322566|536857121|FG001|Overall Study|Physician Decision|7|||
148830205|NCT03322566|536857122|FG002|Overall Study|Physician Decision|2|||
148830206|NCT03322566|536857120|FG000|Overall Study|Withdrawal by Subject|4|||
148830207|NCT03322566|536857121|FG001|Overall Study|Withdrawal by Subject|3|||
148830208|NCT03322566|536857122|FG002|Overall Study|Withdrawal by Subject|6|||
148830209|NCT03322566|536857120|FG000|Overall Study|Lost to Follow-up|0|||
148830210|NCT03322566|536857121|FG001|Overall Study|Lost to Follow-up|0|||
148830211|NCT03322566|536857122|FG002|Overall Study|Lost to Follow-up|1|||
148830212|NCT03322566|536857120|FG000|Overall Study|Study terminated by sponsor|1|||
148830213|NCT03322566|536857121|FG001|Overall Study|Study terminated by sponsor|0|||
148830214|NCT03322566|536857122|FG002|Overall Study|Study terminated by sponsor|1|||
148830215|NCT00605189|536857123|FG000|Overall Study|Adverse Event|1|||
148830216|NCT00605189|536857124|FG001|Overall Study|Adverse Event|0|||
148830217|NCT00605189|536857125|FG002|Overall Study|Adverse Event|0|||
148830218|NCT00605189|536857123|FG000|Overall Study|Other|2|||
148830219|NCT00605189|536857124|FG001|Overall Study|Other|2|||
148830220|NCT00605189|536857125|FG002|Overall Study|Other|0|||
148830221|NCT03411044|536857129|FG000|Overall Study|Death|30|||
148830222|NCT03411044|536857129|FG000|Overall Study|Withdrawal by Subject|48|||
148830223|NCT03411044|536857129|FG000|Overall Study|Lost to Follow-up|78|||
148830224|NCT03411044|536857129|FG000|Overall Study|Adverse Event|30|||
148830225|NCT03411044|536857129|FG000|Overall Study|Missing status|4|||
148830226|NCT04620668|536857136|FG000|Overall Study|Withdrawal by Subject|2|||
148830227|NCT04620668|536857137|FG001|Overall Study|Withdrawal by Subject|0|||
148830228|NCT04620668|536857136|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
148830229|NCT04620668|536857137|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
148830230|NCT04620668|536857136|FG000|Overall Study|Removed before analysis: missing data|2|||
148830231|NCT04620668|536857137|FG001|Overall Study|Removed before analysis: missing data|0|||
148830232|NCT04620668|536857136|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
148830233|NCT04620668|536857137|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
148830234|NCT04620668|536857136|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
148830235|NCT04620668|536857137|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
148830236|NCT03685149|536857138|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
148830237|NCT03685149|536857139|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
148830238|NCT03685149|536857138|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148830239|NCT03685149|536857139|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
148830240|NCT03685149|536857138|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
148830241|NCT03685149|536857139|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
148830242|NCT02609503|536857140|FG000|Overall Study|Adverse Event|1|||
148830243|NCT02609503|536857140|FG000|Overall Study|Death|1|||
148830244|NCT02609503|536857140|FG000|Overall Study|Withdrawal by Subject|1|||
148830245|NCT02609503|536857140|FG000|Overall Study|Disease progression|1|||
148830246|NCT02014376|536857145|FG000|Overall Study|Adverse Event|1|||
148830247|NCT02014376|536857146|FG001|Overall Study|Adverse Event|1|||
148830248|NCT02014376|536857147|FG002|Overall Study|Adverse Event|0|||
148830249|NCT02014376|536857145|FG000|Overall Study|Lost to Follow-up|2|||
148830250|NCT02014376|536857146|FG001|Overall Study|Lost to Follow-up|0|||
148830251|NCT02014376|536857147|FG002|Overall Study|Lost to Follow-up|0|||
148830252|NCT00721110|536857150|FG000|Overall Study|Ultram use|1|||
148830253|NCT00721110|536857151|FG001|Overall Study|Ultram use|0|||
148830254|NCT00721110|536857152|FG002|Overall Study|Ultram use|0|||
148830255|NCT00721110|536857153|FG003|Overall Study|Ultram use|0|||
148830256|NCT00721110|536857150|FG000|Overall Study|vertical incision|0|||
148830257|NCT00721110|536857151|FG001|Overall Study|vertical incision|0|||
148979761|NCT00274716|537405746|FG005|Phase A|Adverse Event|0|||
148979762|NCT00274716|537405741|FG000|Phase A|Completed but did not enter Phase B|1|||
148979763|NCT00274716|537405742|FG001|Phase A|Completed but did not enter Phase B|2|||
148979764|NCT00274716|537405743|FG002|Phase A|Completed but did not enter Phase B|2|||
148979765|NCT00274716|537405744|FG003|Phase A|Completed but did not enter Phase B|2|||
148979766|NCT00274716|537405745|FG004|Phase A|Completed but did not enter Phase B|1|||
148979767|NCT00274716|537405746|FG005|Phase A|Completed but did not enter Phase B|1|||
148979768|NCT00274716|537405741|FG000|Phase B|Adverse Event|0|||
148979769|NCT00274716|537405742|FG001|Phase B|Adverse Event|0|||
148830258|NCT00721110|536857152|FG002|Overall Study|vertical incision|1|||
148830259|NCT00721110|536857153|FG003|Overall Study|vertical incision|0|||
148830260|NCT02457065|536857155|FG000|Overall Study|Lost to Follow-up|9|||
148830261|NCT02457065|536857156|FG001|Overall Study|Lost to Follow-up|11|||
148830262|NCT04642079|536857161|FG000|Overall Study|Lost to Follow-up|2|||
148830263|NCT04642079|536857162|FG001|Overall Study|Lost to Follow-up|5|||
148830264|NCT04642079|536857163|FG002|Overall Study|Lost to Follow-up|2|||
148830265|NCT04642079|536857164|FG003|Overall Study|Lost to Follow-up|0|||
148830266|NCT04642079|536857161|FG000|Overall Study|Withdrawal by Subject|0|||
148979770|NCT00274716|537405743|FG002|Phase B|Adverse Event|2|||
148830267|NCT04642079|536857162|FG001|Overall Study|Withdrawal by Subject|4|||
148830268|NCT04642079|536857163|FG002|Overall Study|Withdrawal by Subject|1|||
148830269|NCT04642079|536857164|FG003|Overall Study|Withdrawal by Subject|2|||
148830270|NCT04642079|536857161|FG000|Overall Study|Other|0|||
148830271|NCT04642079|536857162|FG001|Overall Study|Other|0|||
148830272|NCT04642079|536857163|FG002|Overall Study|Other|0|||
148830273|NCT04642079|536857164|FG003|Overall Study|Other|1|||
148830274|NCT04642079|536857161|FG000|Overall Study|No longer met eligibility criteria|1|||
148830275|NCT04642079|536857162|FG001|Overall Study|No longer met eligibility criteria|0|||
148830276|NCT04642079|536857163|FG002|Overall Study|No longer met eligibility criteria|1|||
148830277|NCT04642079|536857164|FG003|Overall Study|No longer met eligibility criteria|1|||
148830278|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
148830279|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
148830280|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
148830281|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
148830282|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
148830283|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
148830284|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
148830285|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
148830286|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
148830287|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
148830288|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
148830289|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
148830290|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
148830291|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
148830292|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
148830293|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
148830294|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
148830295|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
148830296|NCT00086515|536857170|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
148830297|NCT00086515|536857171|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
148979771|NCT00274716|537405744|FG003|Phase B|Adverse Event|0|||
148979772|NCT00274716|537405745|FG004|Phase B|Adverse Event|0|||
148830298|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
148830299|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
148830300|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
148830301|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
148830302|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
148830303|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
148830304|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
148830305|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
148830306|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
148768353|NCT04791319|536625305|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148768354|NCT04791319|536625306|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
148768355|NCT04791319|536625296|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
148768356|NCT04791319|536625297|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
148768357|NCT04791319|536625298|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
148768358|NCT04791319|536625299|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
148768359|NCT04791319|536625300|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768360|NCT04791319|536625301|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768361|NCT04791319|536625302|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768362|NCT04791319|536625303|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768363|NCT04791319|536625304|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768364|NCT04791319|536625305|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768365|NCT04791319|536625306|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
148768366|NCT04791319|536625296|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768367|NCT04791319|536625297|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768368|NCT04791319|536625298|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768369|NCT04791319|536625299|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
148768370|NCT04791319|536625300|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768371|NCT04791319|536625301|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768372|NCT04791319|536625302|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768373|NCT04791319|536625303|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148830307|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
148979773|NCT00274716|537405746|FG005|Phase B|Adverse Event|1|||
148979774|NCT00274716|537405741|FG000|Phase B|Protocol Violation|0|||
148979775|NCT00274716|537405742|FG001|Phase B|Protocol Violation|2|||
148768374|NCT04791319|536625304|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768375|NCT04791319|536625305|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768376|NCT04791319|536625306|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
148768377|NCT04791319|536625296|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768378|NCT04791319|536625297|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768379|NCT04791319|536625298|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768380|NCT04791319|536625299|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768381|NCT04791319|536625300|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
148768382|NCT04791319|536625301|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
148768383|NCT04791319|536625302|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
148768384|NCT04791319|536625303|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768385|NCT04791319|536625304|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768386|NCT04791319|536625305|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
148768387|NCT04791319|536625306|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
148768388|NCT04791319|536625296|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768389|NCT04791319|536625297|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768390|NCT04791319|536625298|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768391|NCT04791319|536625299|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768392|NCT04791319|536625300|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768393|NCT04791319|536625301|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768394|NCT04791319|536625302|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768395|NCT04791319|536625303|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768396|NCT04791319|536625304|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768397|NCT04791319|536625305|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
148768398|NCT04791319|536625306|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
148768399|NCT04791319|536625296|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
148768400|NCT04791319|536625297|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
148768401|NCT04791319|536625298|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
148768402|NCT04791319|536625299|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
148768403|NCT04791319|536625300|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
148768404|NCT04791319|536625301|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
148768405|NCT04791319|536625302|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
148768406|NCT04791319|536625303|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
148768407|NCT04791319|536625304|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
148768408|NCT04791319|536625305|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
148768409|NCT04791319|536625306|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
148768410|NCT04791319|536625296|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
148768411|NCT04791319|536625297|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
148768412|NCT04791319|536625298|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
148768413|NCT04791319|536625299|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
148768414|NCT04791319|536625300|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
148768415|NCT04791319|536625301|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
148768416|NCT04791319|536625302|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
148768417|NCT04791319|536625303|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
148768418|NCT04791319|536625304|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
148768419|NCT04791319|536625305|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
148768420|NCT04791319|536625306|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
148768421|NCT00364923|536625308|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
148768422|NCT00364923|536625308|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
148768423|NCT03474731|536625317|FG000|Overall Study|Withdrawal by Subject|36|||
148768424|NCT03474731|536625318|FG001|Overall Study|Withdrawal by Subject|29|||
148768425|NCT03474731|536625319|FG002|Overall Study|Withdrawal by Subject|11|||
148768426|NCT03474731|536625320|FG003|Overall Study|Withdrawal by Subject|27|||
148768427|NCT03474731|536625317|FG000|Overall Study|COVID|0|||
148768428|NCT03474731|536625318|FG001|Overall Study|COVID|23|||
148768429|NCT03474731|536625319|FG002|Overall Study|COVID|0|||
148768430|NCT03474731|536625320|FG003|Overall Study|COVID|0|||
148768431|NCT03474731|536625317|FG000|Overall Study|Participant moved from area|1|||
148768432|NCT03474731|536625318|FG001|Overall Study|Participant moved from area|0|||
148768433|NCT03474731|536625319|FG002|Overall Study|Participant moved from area|0|||
148768434|NCT03474731|536625320|FG003|Overall Study|Participant moved from area|0|||
148768435|NCT03474731|536625317|FG000|Overall Study|Lost to Follow-up|11|||
148889338|NCT00101686|537074379|FG008|Overall Study|Randomized but did not receive treament|0|||
148768436|NCT03474731|536625318|FG001|Overall Study|Lost to Follow-up|3|||
148768437|NCT03474731|536625319|FG002|Overall Study|Lost to Follow-up|18|||
148768438|NCT03474731|536625320|FG003|Overall Study|Lost to Follow-up|17|||
148768439|NCT03474731|536625317|FG000|Overall Study|Death|0|||
148768440|NCT03474731|536625318|FG001|Overall Study|Death|1|||
148768441|NCT03474731|536625319|FG002|Overall Study|Death|0|||
148768442|NCT03474731|536625320|FG003|Overall Study|Death|0|||
148768443|NCT03474731|536625317|FG000|Overall Study|Participant Removed|0|||
148768444|NCT03474731|536625318|FG001|Overall Study|Participant Removed|0|||
148768445|NCT03474731|536625319|FG002|Overall Study|Participant Removed|0|||
148768446|NCT03474731|536625320|FG003|Overall Study|Participant Removed|1|||
148768447|NCT01355575|536625324|FG000|Overall Study|Withdrawal by Subject|2|||
148768448|NCT02887248|536625325|FG000|Overall Study|Withdrawal by Subject|1|||
148768449|NCT02887248|536625325|FG000|Overall Study|Adverse Event|1|||
148768450|NCT02887248|536625325|FG000|Overall Study|Progressive Disease|1|||
148768451|NCT00675428|536625330|FG000|Overall Study|Disease Progression|2|||
148768452|NCT00675428|536625331|FG001|Overall Study|Disease Progression|2|||
148768453|NCT00675428|536625330|FG000|Overall Study|No Disease Response After Cycle 6|0|||
148768454|NCT00675428|536625331|FG001|Overall Study|No Disease Response After Cycle 6|1|||
148768455|NCT00675428|536625330|FG000|Overall Study|Physician Decision|1|||
148768456|NCT00675428|536625331|FG001|Overall Study|Physician Decision|0|||
148768457|NCT00765336|536625333|FG000|Overall Study|Protocol Violation|4|||
148768458|NCT00765336|536625334|FG001|Overall Study|Protocol Violation|2|||
148768459|NCT00765336|536625333|FG000|Overall Study|Withdrawal by Subject|6|||
148768460|NCT00765336|536625334|FG001|Overall Study|Withdrawal by Subject|4|||
148768461|NCT00765336|536625333|FG000|Overall Study|Lost to Follow-up|7|||
148768462|NCT00765336|536625334|FG001|Overall Study|Lost to Follow-up|9|||
148768463|NCT00765336|536625333|FG000|Overall Study|Adverse Event|2|||
148768464|NCT00765336|536625334|FG001|Overall Study|Adverse Event|1|||
148768465|NCT00478777|536625335|FG000|Overall Study|Adverse Event|29|||
148768466|NCT00478777|536625335|FG000|Overall Study|Lack of Efficacy|23|||
148768467|NCT00478777|536625335|FG000|Overall Study|Withdrawal by Subject|4|||
148768468|NCT00478777|536625335|FG000|Overall Study|Death|3|||
148768469|NCT00478777|536625335|FG000|Overall Study|Protocol Violation|3|||
148768470|NCT00478777|536625335|FG000|Overall Study|Lost to Follow-up|3|||
148768471|NCT00478777|536625335|FG000|Overall Study|Physician Decision|1|||
148768472|NCT00478777|536625335|FG000|Overall Study|Intolerance of therapy|1|||
148768473|NCT00478777|536625335|FG000|Overall Study|Lack of compliance|1|||
148768474|NCT00478777|536625335|FG000|Overall Study|Lymphocytes infusion|1|||
148768475|NCT00478777|536625335|FG000|Overall Study|End of therapy|2|||
148768476|NCT00478777|536625335|FG000|Overall Study|Not treated with lenalidomide|6|||
148768477|NCT04105218|536625341|FG000|Overall Study|Withdrawal by Subject|3|||
148768478|NCT04105218|536625342|FG001|Overall Study|Withdrawal by Subject|2|||
148768479|NCT04105218|536625341|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
148768480|NCT04105218|536625342|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
148768481|NCT04105218|536625341|FG000|Overall Study|Failed screening tests|2|||
148768482|NCT04105218|536625342|FG001|Overall Study|Failed screening tests|1|||
148768483|NCT00552396|536625351|FG000|Overall Study|protocol withdrawal criteria|3|||
148768484|NCT00552396|536625352|FG001|Overall Study|protocol withdrawal criteria|3|||
148768485|NCT00552396|536625353|FG002|Overall Study|protocol withdrawal criteria|3|||
148768486|NCT00552396|536625354|FG003|Overall Study|protocol withdrawal criteria|6|||
148768487|NCT00552396|536625355|FG004|Overall Study|protocol withdrawal criteria|3|||
148768488|NCT00552396|536625356|FG005|Overall Study|protocol withdrawal criteria|3|||
148768489|NCT00552396|536625357|FG006|Overall Study|protocol withdrawal criteria|9|||
148768490|NCT01323387|536625362|FG000|Overall Study|Withdrawal by Subject|41|||
148768491|NCT01323387|536625362|FG000|Overall Study|Radiographic Data Unavailable|1|||
148768492|NCT01323387|536625362|FG000|Overall Study|Revision|14|||
148768493|NCT01323387|536625362|FG000|Overall Study|Protocol Violation|12|||
148768494|NCT01323387|536625362|FG000|Overall Study|Randomized but Never Treated|16|||
148768495|NCT00697463|536625365|FG000|Overall Study|Withdrawal by Subject|1|||
148768496|NCT03307252|536625366|FG000|Part 2, Period 1|Treatment not received|0|||
148768497|NCT03307252|536625367|FG001|Part 2, Period 1|Treatment not received|0|||
148768498|NCT03307252|536625368|FG002|Part 2, Period 1|Treatment not received|0|||
148768499|NCT03307252|536625369|FG003|Part 2, Period 1|Treatment not received|0|||
148768500|NCT03307252|536625370|FG004|Part 2, Period 1|Treatment not received|0|||
148768501|NCT03307252|536625371|FG005|Part 2, Period 1|Treatment not received|1|||
148768502|NCT03307252|536625372|FG006|Part 2, Period 1|Treatment not received|0|||
148768503|NCT03307252|536625373|FG007|Part 2, Period 1|Treatment not received|0|||
148768504|NCT03307252|536625374|FG008|Part 2, Period 1|Treatment not received|0|||
148768505|NCT03307252|536625375|FG009|Part 2, Period 1|Treatment not received|0|||
148768506|NCT03307252|536625376|FG010|Part 2, Period 1|Treatment not received|0|||
148768507|NCT03307252|536625366|FG000|Part 2, Period 3|Other than listed|0|||
148768508|NCT03307252|536625367|FG001|Part 2, Period 3|Other than listed|0|||
148768509|NCT03307252|536625368|FG002|Part 2, Period 3|Other than listed|0|||
148768510|NCT03307252|536625369|FG003|Part 2, Period 3|Other than listed|0|||
148768511|NCT03307252|536625370|FG004|Part 2, Period 3|Other than listed|1|||
148768512|NCT03307252|536625371|FG005|Part 2, Period 3|Other than listed|0|||
148768513|NCT03307252|536625372|FG006|Part 2, Period 3|Other than listed|0|||
148768514|NCT03307252|536625373|FG007|Part 2, Period 3|Other than listed|0|||
148768515|NCT03307252|536625374|FG008|Part 2, Period 3|Other than listed|0|||
148768516|NCT03307252|536625375|FG009|Part 2, Period 3|Other than listed|0|||
148768517|NCT03307252|536625376|FG010|Part 2, Period 3|Other than listed|0|||
148768518|NCT03307252|536625366|FG000|Part 2, Period 4|Other than listed|0|||
148768519|NCT03307252|536625367|FG001|Part 2, Period 4|Other than listed|0|||
148768520|NCT03307252|536625368|FG002|Part 2, Period 4|Other than listed|0|||
148768521|NCT03307252|536625369|FG003|Part 2, Period 4|Other than listed|0|||
148768522|NCT03307252|536625370|FG004|Part 2, Period 4|Other than listed|0|||
148768523|NCT03307252|536625371|FG005|Part 2, Period 4|Other than listed|0|||
148768524|NCT03307252|536625372|FG006|Part 2, Period 4|Other than listed|1|||
148768525|NCT03307252|536625373|FG007|Part 2, Period 4|Other than listed|0|||
148768526|NCT03307252|536625374|FG008|Part 2, Period 4|Other than listed|0|||
148768527|NCT03307252|536625375|FG009|Part 2, Period 4|Other than listed|0|||
148768528|NCT03307252|536625376|FG010|Part 2, Period 4|Other than listed|0|||
148768529|NCT03307252|536625366|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768530|NCT03307252|536625367|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768531|NCT03307252|536625368|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768532|NCT03307252|536625369|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768533|NCT03307252|536625370|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768534|NCT03307252|536625371|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768535|NCT03307252|536625372|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768536|NCT03307252|536625373|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768537|NCT03307252|536625374|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768538|NCT03307252|536625375|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
148768539|NCT03307252|536625376|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
148768540|NCT03482453|536625377|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768541|NCT03482453|536625378|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768542|NCT03482453|536625379|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768543|NCT03482453|536625380|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768544|NCT03482453|536625381|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768545|NCT03482453|536625382|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768546|NCT03482453|536625383|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768547|NCT03482453|536625384|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768548|NCT03482453|536625385|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768549|NCT03482453|536625386|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768550|NCT03482453|536625387|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
148768551|NCT03482453|536625388|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
148768552|NCT01554527|536625389|FG000|Overall Study|Withdrawal by Subject|1|||
148768553|NCT01554527|536625390|FG001|Overall Study|Withdrawal by Subject|0|||
148768554|NCT01554527|536625391|FG002|Overall Study|Withdrawal by Subject|3|||
148768555|NCT01554527|536625389|FG000|Overall Study|Lost to Follow-up|0|||
148768556|NCT01554527|536625390|FG001|Overall Study|Lost to Follow-up|0|||
148768557|NCT01554527|536625391|FG002|Overall Study|Lost to Follow-up|4|||
148768558|NCT01554527|536625389|FG000|Overall Study|Physician Decision|0|||
148768559|NCT01554527|536625390|FG001|Overall Study|Physician Decision|0|||
148768560|NCT01554527|536625391|FG002|Overall Study|Physician Decision|1|||
148768561|NCT00550043|536625394|FG000|Overall Study|Adverse Event|0|||
148768562|NCT00550043|536625395|FG001|Overall Study|Adverse Event|0|||
148768563|NCT00550043|536625396|FG002|Overall Study|Adverse Event|0|||
148768564|NCT00550043|536625397|FG003|Overall Study|Adverse Event|1|||
148768565|NCT00550043|536625398|FG004|Overall Study|Adverse Event|1|||
148768566|NCT00550043|536625394|FG000|Overall Study|Subject Withdrew Consent|0|||
148768567|NCT00550043|536625395|FG001|Overall Study|Subject Withdrew Consent|2|||
148768568|NCT00550043|536625396|FG002|Overall Study|Subject Withdrew Consent|1|||
148768569|NCT00550043|536625397|FG003|Overall Study|Subject Withdrew Consent|0|||
148768570|NCT00550043|536625398|FG004|Overall Study|Subject Withdrew Consent|0|||
148768571|NCT00550043|536625394|FG000|Overall Study|Other Reasons- Unspecified|0|||
148768572|NCT00550043|536625395|FG001|Overall Study|Other Reasons- Unspecified|1|||
148768573|NCT00550043|536625396|FG002|Overall Study|Other Reasons- Unspecified|0|||
148768574|NCT00550043|536625397|FG003|Overall Study|Other Reasons- Unspecified|1|||
148768575|NCT00550043|536625398|FG004|Overall Study|Other Reasons- Unspecified|0|||
148768576|NCT01483027|536625401|FG000|Overall Study|Administrative Reasons|2|||
148768577|NCT01483027|536625402|FG001|Overall Study|Administrative Reasons|1|||
148768578|NCT01483027|536625401|FG000|Overall Study|Withdrawal by Subject|21|||
148768579|NCT01483027|536625402|FG001|Overall Study|Withdrawal by Subject|32|||
148768580|NCT01483027|536625401|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
148768581|NCT01483027|536625402|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
148768582|NCT01483027|536625401|FG000|Overall Study|Lost to Follow-up|1|||
148979776|NCT00274716|537405743|FG002|Phase B|Protocol Violation|0|||
148979777|NCT00274716|537405744|FG003|Phase B|Protocol Violation|0|||
148979778|NCT00274716|537405745|FG004|Phase B|Protocol Violation|0|||
148979779|NCT00274716|537405746|FG005|Phase B|Protocol Violation|0|||
148979780|NCT00274716|537405741|FG000|Phase B|Withdrawal by Subject|0|||
148979781|NCT00274716|537405742|FG001|Phase B|Withdrawal by Subject|1|||
148979782|NCT00274716|537405743|FG002|Phase B|Withdrawal by Subject|0|||
148979783|NCT00274716|537405744|FG003|Phase B|Withdrawal by Subject|0|||
148768583|NCT01483027|536625402|FG001|Overall Study|Lost to Follow-up|1|||
148768584|NCT01483027|536625401|FG000|Overall Study|Adverse Event|0|||
148768585|NCT01483027|536625402|FG001|Overall Study|Adverse Event|1|||
148768586|NCT01483027|536625401|FG000|Overall Study|Withdrawal by Subject|0|||
148768587|NCT01483027|536625402|FG001|Overall Study|Withdrawal by Subject|1|||
148768588|NCT01314872|536625405|FG000|Treatment Period 1|Protocol Violation|2|||
148768589|NCT01314872|536625406|FG001|Treatment Period 1|Protocol Violation|1|||
148768590|NCT01314872|536625407|FG002|Treatment Period 1|Protocol Violation|1|||
148768591|NCT01314872|536625408|FG003|Treatment Period 1|Protocol Violation|0|||
148768592|NCT01314872|536625409|FG004|Treatment Period 1|Protocol Violation|1|||
148768593|NCT01314872|536625410|FG005|Treatment Period 1|Protocol Violation|0|||
148768594|NCT01314872|536625411|FG006|Treatment Period 1|Protocol Violation|0|||
148768595|NCT01314872|536625412|FG007|Treatment Period 1|Protocol Violation|0|||
148768596|NCT01314872|536625413|FG008|Treatment Period 1|Protocol Violation|0|||
148768597|NCT01314872|536625414|FG009|Treatment Period 1|Protocol Violation|1|||
148768598|NCT01314872|536625415|FG010|Treatment Period 1|Protocol Violation|1|||
148768599|NCT01314872|536625416|FG011|Treatment Period 1|Protocol Violation|0|||
148768600|NCT01314872|536625417|FG012|Treatment Period 1|Protocol Violation|0|||
148768601|NCT01314872|536625418|FG013|Treatment Period 1|Protocol Violation|0|||
148768602|NCT01314872|536625419|FG014|Treatment Period 1|Protocol Violation|0|||
148768603|NCT01314872|536625405|FG000|Treatment Period 1|Physician Decision|0|||
148768604|NCT01314872|536625406|FG001|Treatment Period 1|Physician Decision|1|||
148768605|NCT01314872|536625407|FG002|Treatment Period 1|Physician Decision|0|||
148768606|NCT01314872|536625408|FG003|Treatment Period 1|Physician Decision|1|||
148768607|NCT01314872|536625409|FG004|Treatment Period 1|Physician Decision|0|||
148768608|NCT01314872|536625410|FG005|Treatment Period 1|Physician Decision|0|||
148768609|NCT01314872|536625411|FG006|Treatment Period 1|Physician Decision|0|||
148768610|NCT01314872|536625412|FG007|Treatment Period 1|Physician Decision|0|||
148768611|NCT01314872|536625413|FG008|Treatment Period 1|Physician Decision|0|||
148768612|NCT01314872|536625414|FG009|Treatment Period 1|Physician Decision|1|||
148768613|NCT01314872|536625415|FG010|Treatment Period 1|Physician Decision|0|||
148768614|NCT01314872|536625416|FG011|Treatment Period 1|Physician Decision|0|||
148768615|NCT01314872|536625417|FG012|Treatment Period 1|Physician Decision|0|||
148768616|NCT01314872|536625418|FG013|Treatment Period 1|Physician Decision|0|||
148768617|NCT01314872|536625419|FG014|Treatment Period 1|Physician Decision|0|||
148768618|NCT01314872|536625405|FG000|Treatment Period 1|Lack of Efficacy|1|||
148768619|NCT01314872|536625406|FG001|Treatment Period 1|Lack of Efficacy|0|||
148768620|NCT01314872|536625407|FG002|Treatment Period 1|Lack of Efficacy|0|||
148768621|NCT01314872|536625408|FG003|Treatment Period 1|Lack of Efficacy|0|||
148768622|NCT01314872|536625409|FG004|Treatment Period 1|Lack of Efficacy|0|||
148768623|NCT01314872|536625410|FG005|Treatment Period 1|Lack of Efficacy|1|||
148768624|NCT01314872|536625411|FG006|Treatment Period 1|Lack of Efficacy|0|||
148768625|NCT01314872|536625412|FG007|Treatment Period 1|Lack of Efficacy|2|||
148768626|NCT01314872|536625413|FG008|Treatment Period 1|Lack of Efficacy|0|||
148768627|NCT01314872|536625414|FG009|Treatment Period 1|Lack of Efficacy|0|||
148768628|NCT01314872|536625415|FG010|Treatment Period 1|Lack of Efficacy|0|||
148768629|NCT01314872|536625416|FG011|Treatment Period 1|Lack of Efficacy|0|||
148768630|NCT01314872|536625417|FG012|Treatment Period 1|Lack of Efficacy|0|||
148768631|NCT01314872|536625418|FG013|Treatment Period 1|Lack of Efficacy|0|||
148768632|NCT01314872|536625419|FG014|Treatment Period 1|Lack of Efficacy|0|||
148768633|NCT01314872|536625405|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
148768634|NCT01314872|536625406|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
148768635|NCT01314872|536625407|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
148768636|NCT01314872|536625408|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
148768637|NCT01314872|536625409|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
148768638|NCT01314872|536625410|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
148979784|NCT00274716|537405745|FG004|Phase B|Withdrawal by Subject|0|||
148768639|NCT01314872|536625411|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
148768640|NCT01314872|536625412|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
148768641|NCT01314872|536625413|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
148768642|NCT01314872|536625414|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
148768643|NCT01314872|536625415|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
148768644|NCT01314872|536625416|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
148768645|NCT01314872|536625417|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
148979785|NCT00274716|537405746|FG005|Phase B|Withdrawal by Subject|0|||
148979786|NCT00274716|537405741|FG000|Phase B|Participant moved|1|||
148979787|NCT00274716|537405742|FG001|Phase B|Participant moved|0|||
148979788|NCT00274716|537405743|FG002|Phase B|Participant moved|0|||
148979789|NCT00274716|537405744|FG003|Phase B|Participant moved|0|||
148979790|NCT00274716|537405745|FG004|Phase B|Participant moved|0|||
148979791|NCT00274716|537405746|FG005|Phase B|Participant moved|0|||
148979792|NCT00274716|537405741|FG000|Phase B|Other non-reported reason|0|||
148979793|NCT00274716|537405742|FG001|Phase B|Other non-reported reason|0|||
148979794|NCT00274716|537405743|FG002|Phase B|Other non-reported reason|1|||
148979795|NCT00274716|537405744|FG003|Phase B|Other non-reported reason|1|||
148979796|NCT00274716|537405745|FG004|Phase B|Other non-reported reason|0|||
148979797|NCT00274716|537405746|FG005|Phase B|Other non-reported reason|0|||
148979798|NCT00274716|537405741|FG000|Phase B|Lost to Follow-up|0|||
148979799|NCT00274716|537405742|FG001|Phase B|Lost to Follow-up|1|||
148979800|NCT00274716|537405743|FG002|Phase B|Lost to Follow-up|0|||
148979801|NCT00274716|537405744|FG003|Phase B|Lost to Follow-up|0|||
148979802|NCT00274716|537405745|FG004|Phase B|Lost to Follow-up|0|||
148979803|NCT00274716|537405746|FG005|Phase B|Lost to Follow-up|0|||
148979804|NCT02212730|537405747|FG000|Overall Study|Tumor not of the required cell histology|1|||
148979805|NCT02212730|537405748|FG001|Overall Study|Tumor not of the required cell histology|0|||
148979806|NCT02212730|537405747|FG000|Overall Study|Withdrawal by Subject|1|||
148979807|NCT02212730|537405748|FG001|Overall Study|Withdrawal by Subject|0|||
148979808|NCT02212730|537405747|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
148979809|NCT02212730|537405748|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
148979810|NCT01777997|537405751|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
148979811|NCT01777997|537405751|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
148979812|NCT01777997|537405751|FG000|Weeks 48 to 72/96 on ART|Death|1|||
148979813|NCT01777997|537405751|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
148979814|NCT00975975|537405752|FG000|Overall Study|Death|6|||
148979815|NCT01257204|537405755|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
148979816|NCT01257204|537405756|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
148979817|NCT01257204|537405757|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
148979818|NCT01257204|537405755|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
148979819|NCT01257204|537405756|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
148979820|NCT01257204|537405757|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
148979821|NCT01257204|537405755|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
148979822|NCT01257204|537405756|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
148979823|NCT01257204|537405757|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
148979824|NCT01257204|537405755|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
148979825|NCT01257204|537405756|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
148979826|NCT01257204|537405757|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
148979827|NCT01257204|537405755|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
148979828|NCT01257204|537405756|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
148979829|NCT01257204|537405757|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
148979830|NCT01257204|537405755|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
148979831|NCT01257204|537405756|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
148979832|NCT01257204|537405757|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
148979833|NCT01257204|537405755|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
148979834|NCT01257204|537405756|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
148979835|NCT01257204|537405757|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
148979836|NCT01257204|537405755|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
148979837|NCT01257204|537405756|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
148979838|NCT01257204|537405757|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
148979839|NCT01257204|537405755|FG000|Follow-up Period (up to Week 48)|Other|0|||
148979840|NCT01257204|537405756|FG001|Follow-up Period (up to Week 48)|Other|0|||
148979841|NCT01257204|537405757|FG002|Follow-up Period (up to Week 48)|Other|5|||
148979842|NCT02057757|537405758|FG000|Overall Study|Withdrawal by Subject|3|||
148979843|NCT02057757|537405759|FG001|Overall Study|Withdrawal by Subject|5|||
148979844|NCT02057757|537405758|FG000|Overall Study|Death|2|||
148979845|NCT02057757|537405759|FG001|Overall Study|Death|0|||
148979846|NCT02057757|537405758|FG000|Overall Study|Lost to Follow-up|8|||
148979847|NCT02057757|537405759|FG001|Overall Study|Lost to Follow-up|3|||
148979848|NCT02057757|537405758|FG000|Overall Study|Non-compliance|1|||
148979849|NCT02057757|537405759|FG001|Overall Study|Non-compliance|0|||
148979850|NCT00723801|537405761|FG000|Overall Study|Lost to Follow-up|1|||
148979851|NCT00723801|537405762|FG001|Overall Study|Lost to Follow-up|2|||
148979852|NCT00723801|537405761|FG000|Overall Study|Protocol Violation|2|||
148979853|NCT00723801|537405762|FG001|Overall Study|Protocol Violation|1|||
148768646|NCT01314872|536625418|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
148979854|NCT00113516|537405763|FG000|Part 1|Adverse Event|6|||
148979855|NCT00113516|537405764|FG001|Part 1|Adverse Event|0|||
148979856|NCT00113516|537405763|FG000|Part 1|Death|3|||
148979857|NCT00113516|537405764|FG001|Part 1|Death|0|||
148979858|NCT00113516|537405763|FG000|Part 1|Other|3|||
148979859|NCT00113516|537405764|FG001|Part 1|Other|0|||
148979860|NCT00113516|537405763|FG000|Part 1|Withdrawal by Subject|2|||
148979861|NCT00113516|537405764|FG001|Part 1|Withdrawal by Subject|0|||
148979862|NCT00113516|537405763|FG000|Part 1|Lack of Efficacy|2|||
148768647|NCT01314872|536625419|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
148768648|NCT01314872|536625405|FG000|Treatment Period 1|Withdrawal by Subject|3|||
148768649|NCT01314872|536625406|FG001|Treatment Period 1|Withdrawal by Subject|1|||
148768650|NCT01314872|536625407|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148768651|NCT01314872|536625408|FG003|Treatment Period 1|Withdrawal by Subject|2|||
148768652|NCT01314872|536625409|FG004|Treatment Period 1|Withdrawal by Subject|3|||
148768653|NCT01314872|536625410|FG005|Treatment Period 1|Withdrawal by Subject|1|||
148768654|NCT01314872|536625411|FG006|Treatment Period 1|Withdrawal by Subject|3|||
148768655|NCT01314872|536625412|FG007|Treatment Period 1|Withdrawal by Subject|2|||
148768656|NCT01314872|536625413|FG008|Treatment Period 1|Withdrawal by Subject|2|||
148768657|NCT01314872|536625414|FG009|Treatment Period 1|Withdrawal by Subject|2|||
148768658|NCT01314872|536625415|FG010|Treatment Period 1|Withdrawal by Subject|1|||
148768659|NCT01314872|536625416|FG011|Treatment Period 1|Withdrawal by Subject|0|||
148768660|NCT01314872|536625417|FG012|Treatment Period 1|Withdrawal by Subject|0|||
148768661|NCT01314872|536625418|FG013|Treatment Period 1|Withdrawal by Subject|0|||
148768662|NCT01314872|536625419|FG014|Treatment Period 1|Withdrawal by Subject|0|||
148768663|NCT01314872|536625405|FG000|Treatment Period 1|Lost to Follow-up|0|||
148768664|NCT01314872|536625406|FG001|Treatment Period 1|Lost to Follow-up|1|||
148768665|NCT01314872|536625407|FG002|Treatment Period 1|Lost to Follow-up|2|||
148768666|NCT01314872|536625408|FG003|Treatment Period 1|Lost to Follow-up|2|||
148768667|NCT01314872|536625409|FG004|Treatment Period 1|Lost to Follow-up|1|||
148768668|NCT01314872|536625410|FG005|Treatment Period 1|Lost to Follow-up|1|||
148768669|NCT01314872|536625411|FG006|Treatment Period 1|Lost to Follow-up|1|||
148768670|NCT01314872|536625412|FG007|Treatment Period 1|Lost to Follow-up|1|||
148768671|NCT01314872|536625413|FG008|Treatment Period 1|Lost to Follow-up|1|||
148768672|NCT01314872|536625414|FG009|Treatment Period 1|Lost to Follow-up|0|||
148768673|NCT01314872|536625415|FG010|Treatment Period 1|Lost to Follow-up|0|||
148768674|NCT01314872|536625416|FG011|Treatment Period 1|Lost to Follow-up|0|||
148768675|NCT01314872|536625417|FG012|Treatment Period 1|Lost to Follow-up|0|||
148768676|NCT01314872|536625418|FG013|Treatment Period 1|Lost to Follow-up|0|||
148768677|NCT01314872|536625419|FG014|Treatment Period 1|Lost to Follow-up|0|||
148768678|NCT01314872|536625405|FG000|Period 2|Protocol Violation|0|||
148768679|NCT01314872|536625406|FG001|Period 2|Protocol Violation|0|||
148768680|NCT01314872|536625407|FG002|Period 2|Protocol Violation|0|||
148768681|NCT01314872|536625408|FG003|Period 2|Protocol Violation|0|||
148768682|NCT01314872|536625409|FG004|Period 2|Protocol Violation|0|||
148768683|NCT01314872|536625410|FG005|Period 2|Protocol Violation|0|||
148768684|NCT01314872|536625411|FG006|Period 2|Protocol Violation|0|||
148768685|NCT01314872|536625412|FG007|Period 2|Protocol Violation|0|||
148768686|NCT01314872|536625413|FG008|Period 2|Protocol Violation|0|||
148768687|NCT01314872|536625414|FG009|Period 2|Protocol Violation|0|||
148768688|NCT01314872|536625415|FG010|Period 2|Protocol Violation|0|||
148768689|NCT01314872|536625416|FG011|Period 2|Protocol Violation|3|||
148768690|NCT01314872|536625417|FG012|Period 2|Protocol Violation|3|||
148768691|NCT01314872|536625418|FG013|Period 2|Protocol Violation|2|||
148768692|NCT01314872|536625419|FG014|Period 2|Protocol Violation|0|||
148768693|NCT01314872|536625405|FG000|Period 2|Non-compliance with study drug|0|||
148768694|NCT01314872|536625406|FG001|Period 2|Non-compliance with study drug|0|||
148768695|NCT01314872|536625407|FG002|Period 2|Non-compliance with study drug|0|||
148768696|NCT01314872|536625408|FG003|Period 2|Non-compliance with study drug|0|||
148768697|NCT01314872|536625409|FG004|Period 2|Non-compliance with study drug|0|||
148768698|NCT01314872|536625410|FG005|Period 2|Non-compliance with study drug|0|||
148768699|NCT01314872|536625411|FG006|Period 2|Non-compliance with study drug|0|||
148768700|NCT01314872|536625412|FG007|Period 2|Non-compliance with study drug|0|||
148768701|NCT01314872|536625413|FG008|Period 2|Non-compliance with study drug|0|||
148768702|NCT01314872|536625414|FG009|Period 2|Non-compliance with study drug|0|||
148768703|NCT01314872|536625415|FG010|Period 2|Non-compliance with study drug|0|||
148768704|NCT01314872|536625416|FG011|Period 2|Non-compliance with study drug|3|||
148768705|NCT01314872|536625417|FG012|Period 2|Non-compliance with study drug|3|||
148768706|NCT01314872|536625418|FG013|Period 2|Non-compliance with study drug|1|||
148768707|NCT01314872|536625419|FG014|Period 2|Non-compliance with study drug|2|||
148768708|NCT01314872|536625405|FG000|Period 2|Lack of Efficacy|0|||
148768709|NCT01314872|536625406|FG001|Period 2|Lack of Efficacy|0|||
148768710|NCT01314872|536625407|FG002|Period 2|Lack of Efficacy|0|||
148768711|NCT01314872|536625408|FG003|Period 2|Lack of Efficacy|0|||
148768712|NCT01314872|536625409|FG004|Period 2|Lack of Efficacy|0|||
148979863|NCT00113516|537405764|FG001|Part 1|Lack of Efficacy|0|||
148979864|NCT00113516|537405763|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
148979865|NCT00113516|537405764|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
148979866|NCT00113516|537405763|FG000|Part 1|Laboratory Abnormality|1|||
148768713|NCT01314872|536625410|FG005|Period 2|Lack of Efficacy|0|||
148768714|NCT01314872|536625411|FG006|Period 2|Lack of Efficacy|0|||
148768715|NCT01314872|536625412|FG007|Period 2|Lack of Efficacy|0|||
148768716|NCT01314872|536625413|FG008|Period 2|Lack of Efficacy|0|||
148768717|NCT01314872|536625414|FG009|Period 2|Lack of Efficacy|0|||
148768718|NCT01314872|536625415|FG010|Period 2|Lack of Efficacy|0|||
148768719|NCT01314872|536625416|FG011|Period 2|Lack of Efficacy|7|||
148768720|NCT01314872|536625417|FG012|Period 2|Lack of Efficacy|12|||
148768721|NCT01314872|536625418|FG013|Period 2|Lack of Efficacy|9|||
148768722|NCT01314872|536625419|FG014|Period 2|Lack of Efficacy|2|||
148768723|NCT01314872|536625405|FG000|Period 2|Pregnancy|0|||
148768724|NCT01314872|536625406|FG001|Period 2|Pregnancy|0|||
148768725|NCT01314872|536625407|FG002|Period 2|Pregnancy|0|||
148768726|NCT01314872|536625408|FG003|Period 2|Pregnancy|0|||
148768727|NCT01314872|536625409|FG004|Period 2|Pregnancy|0|||
148768728|NCT01314872|536625410|FG005|Period 2|Pregnancy|0|||
148768729|NCT01314872|536625411|FG006|Period 2|Pregnancy|0|||
148768730|NCT01314872|536625412|FG007|Period 2|Pregnancy|0|||
148768731|NCT01314872|536625413|FG008|Period 2|Pregnancy|0|||
148768732|NCT01314872|536625414|FG009|Period 2|Pregnancy|0|||
148768733|NCT01314872|536625415|FG010|Period 2|Pregnancy|0|||
148768734|NCT01314872|536625416|FG011|Period 2|Pregnancy|0|||
148768735|NCT01314872|536625417|FG012|Period 2|Pregnancy|0|||
148768736|NCT01314872|536625418|FG013|Period 2|Pregnancy|0|||
148768737|NCT01314872|536625419|FG014|Period 2|Pregnancy|1|||
148768738|NCT01314872|536625405|FG000|Period 2|Study terminated by Sponsor|0|||
148768739|NCT01314872|536625406|FG001|Period 2|Study terminated by Sponsor|0|||
148768740|NCT01314872|536625407|FG002|Period 2|Study terminated by Sponsor|0|||
148768741|NCT01314872|536625408|FG003|Period 2|Study terminated by Sponsor|0|||
148768742|NCT01314872|536625409|FG004|Period 2|Study terminated by Sponsor|0|||
148768743|NCT01314872|536625410|FG005|Period 2|Study terminated by Sponsor|0|||
148768744|NCT01314872|536625411|FG006|Period 2|Study terminated by Sponsor|0|||
148768745|NCT01314872|536625412|FG007|Period 2|Study terminated by Sponsor|0|||
148768746|NCT01314872|536625413|FG008|Period 2|Study terminated by Sponsor|0|||
148768747|NCT01314872|536625414|FG009|Period 2|Study terminated by Sponsor|0|||
148768748|NCT01314872|536625415|FG010|Period 2|Study terminated by Sponsor|0|||
148768749|NCT01314872|536625416|FG011|Period 2|Study terminated by Sponsor|2|||
148768750|NCT01314872|536625417|FG012|Period 2|Study terminated by Sponsor|2|||
148768751|NCT01314872|536625418|FG013|Period 2|Study terminated by Sponsor|3|||
148768752|NCT01314872|536625419|FG014|Period 2|Study terminated by Sponsor|0|||
148768753|NCT01314872|536625405|FG000|Period 2|Adverse event, non-fatal|0|||
148768754|NCT01314872|536625406|FG001|Period 2|Adverse event, non-fatal|0|||
148768755|NCT01314872|536625407|FG002|Period 2|Adverse event, non-fatal|0|||
148768756|NCT01314872|536625408|FG003|Period 2|Adverse event, non-fatal|0|||
148768757|NCT01314872|536625409|FG004|Period 2|Adverse event, non-fatal|0|||
148768758|NCT01314872|536625410|FG005|Period 2|Adverse event, non-fatal|0|||
148768759|NCT01314872|536625411|FG006|Period 2|Adverse event, non-fatal|0|||
148768760|NCT01314872|536625412|FG007|Period 2|Adverse event, non-fatal|0|||
148768761|NCT01314872|536625413|FG008|Period 2|Adverse event, non-fatal|0|||
148768762|NCT01314872|536625414|FG009|Period 2|Adverse event, non-fatal|0|||
148768763|NCT01314872|536625415|FG010|Period 2|Adverse event, non-fatal|0|||
148768764|NCT01314872|536625416|FG011|Period 2|Adverse event, non-fatal|13|||
148768765|NCT01314872|536625417|FG012|Period 2|Adverse event, non-fatal|16|||
148768766|NCT01314872|536625418|FG013|Period 2|Adverse event, non-fatal|24|||
148768767|NCT01314872|536625419|FG014|Period 2|Adverse event, non-fatal|9|||
148768768|NCT01314872|536625405|FG000|Period 2|Withdrawal by Subject|0|||
148768769|NCT01314872|536625406|FG001|Period 2|Withdrawal by Subject|0|||
148768770|NCT01314872|536625407|FG002|Period 2|Withdrawal by Subject|0|||
148768771|NCT01314872|536625408|FG003|Period 2|Withdrawal by Subject|0|||
148768772|NCT01314872|536625409|FG004|Period 2|Withdrawal by Subject|0|||
148768773|NCT01314872|536625410|FG005|Period 2|Withdrawal by Subject|0|||
148768774|NCT01314872|536625411|FG006|Period 2|Withdrawal by Subject|0|||
148768775|NCT01314872|536625412|FG007|Period 2|Withdrawal by Subject|0|||
148768776|NCT01314872|536625413|FG008|Period 2|Withdrawal by Subject|0|||
148768777|NCT01314872|536625414|FG009|Period 2|Withdrawal by Subject|0|||
148768778|NCT01314872|536625415|FG010|Period 2|Withdrawal by Subject|0|||
148768779|NCT01314872|536625416|FG011|Period 2|Withdrawal by Subject|14|||
148768780|NCT01314872|536625417|FG012|Period 2|Withdrawal by Subject|17|||
149028008|NCT00723294|537580055|FG000|Overall Study|Treated prior to registration|1|||
149028009|NCT00723294|537580055|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
149028010|NCT00723294|537580055|FG000|Overall Study|Benign lesion|1|||
149028011|NCT00723294|537580055|FG000|Overall Study|Withdrawal by Subject|1|||
148768781|NCT01314872|536625418|FG013|Period 2|Withdrawal by Subject|12|||
149028012|NCT00723294|537580055|FG000|Overall Study|No treatment due to probe failure|1|||
148768782|NCT01314872|536625419|FG014|Period 2|Withdrawal by Subject|4|||
148768783|NCT01314872|536625405|FG000|Period 2|Lost to Follow-up|0|||
148768784|NCT01314872|536625406|FG001|Period 2|Lost to Follow-up|0|||
148768785|NCT01314872|536625407|FG002|Period 2|Lost to Follow-up|0|||
148768786|NCT01314872|536625408|FG003|Period 2|Lost to Follow-up|0|||
148768787|NCT01314872|536625409|FG004|Period 2|Lost to Follow-up|0|||
148768788|NCT01314872|536625410|FG005|Period 2|Lost to Follow-up|0|||
148768789|NCT01314872|536625411|FG006|Period 2|Lost to Follow-up|0|||
148768790|NCT01314872|536625412|FG007|Period 2|Lost to Follow-up|0|||
148768791|NCT01314872|536625413|FG008|Period 2|Lost to Follow-up|0|||
148768792|NCT01314872|536625414|FG009|Period 2|Lost to Follow-up|0|||
148768793|NCT01314872|536625415|FG010|Period 2|Lost to Follow-up|0|||
148768794|NCT01314872|536625416|FG011|Period 2|Lost to Follow-up|6|||
148768795|NCT01314872|536625417|FG012|Period 2|Lost to Follow-up|7|||
148768796|NCT01314872|536625418|FG013|Period 2|Lost to Follow-up|2|||
148979867|NCT00113516|537405764|FG001|Part 1|Laboratory Abnormality|0|||
148979868|NCT00113516|537405763|FG000|Part 1|Ongoing|1|||
148979869|NCT00113516|537405764|FG001|Part 1|Ongoing|0|||
148979870|NCT00113516|537405763|FG000|Part 1|Missing|65|||
148979871|NCT00113516|537405764|FG001|Part 1|Missing|0|||
148979872|NCT00113516|537405763|FG000|Part 2|Adverse Event|0|||
148979873|NCT00113516|537405764|FG001|Part 2|Adverse Event|16|||
148979874|NCT00113516|537405763|FG000|Part 2|Death|0|||
148979875|NCT00113516|537405764|FG001|Part 2|Death|5|||
148979876|NCT00113516|537405763|FG000|Part 2|Lack of Efficacy|0|||
148979877|NCT00113516|537405764|FG001|Part 2|Lack of Efficacy|37|||
148979878|NCT00113516|537405763|FG000|Part 2|Withdrawal by Subject|0|||
148979879|NCT00113516|537405764|FG001|Part 2|Withdrawal by Subject|3|||
148979880|NCT00113516|537405763|FG000|Part 2|Other|0|||
148979881|NCT00113516|537405764|FG001|Part 2|Other|3|||
148979882|NCT00113516|537405763|FG000|Part 2|Laboratory Abnormality|0|||
148979883|NCT00113516|537405764|FG001|Part 2|Laboratory Abnormality|1|||
148979884|NCT00113516|537405763|FG000|Part 2|Ongoing|0|||
148979885|NCT00113516|537405764|FG001|Part 2|Ongoing|1|||
148979886|NCT00047463|537405765|FG000|Overall Study|Withdrawal by Subject|0|||
148979887|NCT00047463|537405766|FG001|Overall Study|Withdrawal by Subject|3|||
148979888|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
148979889|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
148979890|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
148979891|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
148979892|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
148979893|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
149028013|NCT01257503|537580056|FG000|Overall Study|Lost to Follow-up|7|||
149028014|NCT01257503|537580057|FG001|Overall Study|Lost to Follow-up|10|||
148979894|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
148979895|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
148979896|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
148979897|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
148979898|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
148979899|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
148979900|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
148979901|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
148979902|NCT02464969|537405769|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
148979903|NCT02464969|537405770|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
148979904|NCT02464969|537405769|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
148979905|NCT02464969|537405770|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
148979906|NCT02464969|537405769|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
148979907|NCT02464969|537405770|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
148979908|NCT02464969|537405769|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
148979909|NCT02464969|537405770|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
148979910|NCT03509948|537405777|FG000|Overall Study|Protocol Violation|0|||
148979911|NCT03509948|537405778|FG001|Overall Study|Protocol Violation|1|||
148979912|NCT03221257|537405779|FG000|Overall Study|Lost to Follow-up|0|||
148979913|NCT03221257|537405780|FG001|Overall Study|Lost to Follow-up|1|||
148979914|NCT03221257|537405779|FG000|Overall Study|Withdrawal by Subject|1|||
148979915|NCT03221257|537405780|FG001|Overall Study|Withdrawal by Subject|1|||
148979916|NCT05402995|537405783|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
148979917|NCT05402995|537405784|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
148979918|NCT05402995|537405785|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
148979919|NCT05402995|537405786|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
148979920|NCT00205712|537405787|FG000|Overall Study|Lost to Follow-up|0|||
148979921|NCT00205712|537405788|FG001|Overall Study|Lost to Follow-up|1|||
148979922|NCT02188485|537405789|FG000|Overall Study|Withdrawal by Subject|2|||
148979923|NCT02188485|537405790|FG001|Overall Study|Withdrawal by Subject|1|||
148979924|NCT02188485|537405789|FG000|Overall Study|PI withdrew, lack of capacity|0|||
149028015|NCT01257503|537580056|FG000|Overall Study|Over 5 years old at enrollment|0|||
148768797|NCT01314872|536625419|FG014|Period 2|Lost to Follow-up|6|||
148768798|NCT00199797|536627088|FG000|Overall Study|Progressive Disease|1|||
148768799|NCT00199797|536627088|FG000|Overall Study|Adverse Event|1|||
148979925|NCT02188485|537405790|FG001|Overall Study|PI withdrew, lack of capacity|2|||
148979926|NCT00096044|537405793|FG000|Overall Study|Withdrawal by Subject|9|||
148979927|NCT00096044|537405793|FG000|Overall Study|Adverse Event|21|||
148979928|NCT00096044|537405793|FG000|Overall Study|Disease Progression|4|||
148979929|NCT03149237|537405794|FG000|Overall Study|Withdrawal by Subject|4|||
148979930|NCT03149237|537405795|FG001|Overall Study|Withdrawal by Subject|5|||
148979931|NCT02442830|537405796|FG000|Overall Study|Technical Failure|0|||
148979932|NCT02442830|537405797|FG001|Overall Study|Technical Failure|1|||
148979933|NCT04587193|537405798|FG000|Overall Study|Screen failure after consent|3|||
148979934|NCT04587193|537405799|FG001|Overall Study|Screen failure after consent|0|||
148979935|NCT04587193|537405798|FG000|Overall Study|Device broke during study|3|||
148768800|NCT00199797|536627088|FG000|Overall Study|Physician Decision|1|||
148768801|NCT00504725|536627093|FG000|Overall Study|Protocol Violation|1|||
148768802|NCT00504725|536627094|FG001|Overall Study|Protocol Violation|0|||
148768803|NCT01435018|536627095|FG000|Overall Study|Death|37|||
148768804|NCT01435018|536627096|FG001|Overall Study|Death|18|||
148768805|NCT01435018|536627097|FG002|Overall Study|Death|25|||
148768806|NCT01435018|536627095|FG000|Overall Study|Site is closing|4|||
148768807|NCT01435018|536627096|FG001|Overall Study|Site is closing|9|||
148768808|NCT01435018|536627097|FG002|Overall Study|Site is closing|7|||
148768809|NCT01435018|536627095|FG000|Overall Study|Withdrew consent|0|||
148768810|NCT01435018|536627096|FG001|Overall Study|Withdrew consent|3|||
148768811|NCT01435018|536627097|FG002|Overall Study|Withdrew consent|1|||
148768812|NCT01435018|536627095|FG000|Overall Study|Not willing to adhere to requirements|0|||
148768813|NCT01435018|536627096|FG001|Overall Study|Not willing to adhere to requirements|2|||
148768814|NCT01435018|536627097|FG002|Overall Study|Not willing to adhere to requirements|3|||
148768815|NCT01435018|536627095|FG000|Overall Study|Not able to get to clinic|2|||
148768816|NCT01435018|536627096|FG001|Overall Study|Not able to get to clinic|0|||
148768817|NCT01435018|536627097|FG002|Overall Study|Not able to get to clinic|2|||
148768818|NCT01435018|536627095|FG000|Overall Study|Severe debilitation, unable to continue|0|||
148768819|NCT01435018|536627096|FG001|Overall Study|Severe debilitation, unable to continue|0|||
148768820|NCT01435018|536627097|FG002|Overall Study|Severe debilitation, unable to continue|1|||
148768821|NCT01435018|536627095|FG000|Overall Study|Unable to contact participant/parent|1|||
148768822|NCT01435018|536627096|FG001|Overall Study|Unable to contact participant/parent|1|||
148768823|NCT01435018|536627097|FG002|Overall Study|Unable to contact participant/parent|1|||
148768824|NCT01435018|536627095|FG000|Overall Study|Enrollment Violation|0|||
148768825|NCT01435018|536627096|FG001|Overall Study|Enrollment Violation|1|||
148768826|NCT01435018|536627097|FG002|Overall Study|Enrollment Violation|0|||
148768827|NCT01435018|536627095|FG000|Overall Study|Never started chemotherapy|3|||
148979936|NCT04587193|537405799|FG001|Overall Study|Device broke during study|2|||
148979937|NCT01552772|537405800|FG000|Overall Study|Lost to Follow-up|2|||
148979938|NCT01552772|537405800|FG000|Overall Study|Adverse Event|1|||
148979939|NCT01552772|537405800|FG000|Overall Study|Protocol Deviation|1|||
148979940|NCT03851016|537405803|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
148979941|NCT03851016|537405804|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
148979942|NCT03878134|537405805|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
148979943|NCT00853658|537405806|FG000|Overall Study|Death|713|||
148979944|NCT00853658|537405807|FG001|Overall Study|Death|768|||
148979945|NCT00853658|537405808|FG002|Overall Study|Death|753|||
148979946|NCT00853658|537405806|FG000|Overall Study|Lost to Follow-up|11|||
148979947|NCT00853658|537405807|FG001|Overall Study|Lost to Follow-up|6|||
148979948|NCT00853658|537405808|FG002|Overall Study|Lost to Follow-up|11|||
148979949|NCT00853658|537405806|FG000|Overall Study|H.A. Request|26|||
148979950|NCT00853658|537405807|FG001|Overall Study|H.A. Request|23|||
148979951|NCT00853658|537405808|FG002|Overall Study|H.A. Request|19|||
148768828|NCT01435018|536627096|FG001|Overall Study|Never started chemotherapy|0|||
148768829|NCT01435018|536627097|FG002|Overall Study|Never started chemotherapy|1|||
148768830|NCT00378508|536627098|FG000|Overall Study|Withdrawal by Subject|1|||
148768831|NCT00378508|536627099|FG001|Overall Study|Withdrawal by Subject|3|||
148768832|NCT00378508|536627098|FG000|Overall Study|Lost to Follow-up|1|||
148768833|NCT00378508|536627099|FG001|Overall Study|Lost to Follow-up|0|||
148768834|NCT02780713|536627104|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
148768835|NCT02780713|536627105|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
148768836|NCT02780713|536627106|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
148768837|NCT02780713|536627107|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
148768838|NCT02780713|536627108|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
148768839|NCT01931475|536627111|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
148768840|NCT01931475|536627112|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
148768841|NCT01931475|536627111|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
148768842|NCT01931475|536627112|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
148768843|NCT01931475|536627111|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
148768844|NCT01931475|536627112|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
148768845|NCT01931475|536627111|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
148768846|NCT01931475|536627112|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
148768847|NCT01931475|536627111|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
148768848|NCT01931475|536627112|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
148768849|NCT01931475|536627111|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
148979952|NCT00853658|537405806|FG000|Overall Study|IRB request|0|||
148979953|NCT00853658|537405807|FG001|Overall Study|IRB request|0|||
148979954|NCT00853658|537405808|FG002|Overall Study|IRB request|2|||
148979955|NCT00853658|537405806|FG000|Overall Study|Vital Status known (alive) at study end|2|||
148768850|NCT01931475|536627112|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
148768851|NCT01931475|536627111|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
148768852|NCT01931475|536627112|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
148768853|NCT01931475|536627111|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
148768854|NCT01931475|536627112|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
148768855|NCT01931475|536627111|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
148768856|NCT01931475|536627112|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
148768857|NCT01931475|536627111|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
148768858|NCT01931475|536627112|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
148768859|NCT01931475|536627111|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
148768860|NCT01931475|536627112|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
148768861|NCT00930774|536627114|FG000|Overall Study|Withdrawal by Subject|1|||
148768862|NCT00930774|536627115|FG001|Overall Study|Withdrawal by Subject|9|||
148768863|NCT00930774|536627116|FG002|Overall Study|Withdrawal by Subject|2|||
148768864|NCT00930774|536627117|FG003|Overall Study|Withdrawal by Subject|0|||
148768865|NCT03200704|536627118|FG000|Overall Study|Withdrawal by Subject|1|||
148768866|NCT01680861|536627119|FG000|Early Post-transplant Period|Protocol Violation|1|||
148768867|NCT01680861|536627120|FG001|Early Post-transplant Period|Protocol Violation|1|||
148768868|NCT00654875|536627121|FG000|Overall Study|Adverse Event|5|||
148768869|NCT00654875|536627122|FG001|Overall Study|Adverse Event|5|||
148768870|NCT00654875|536627121|FG000|Overall Study|Withdrawal by Subject|4|||
148768871|NCT00654875|536627122|FG001|Overall Study|Withdrawal by Subject|4|||
148768872|NCT00654875|536627121|FG000|Overall Study|Protocol Violation|3|||
148768873|NCT00654875|536627122|FG001|Overall Study|Protocol Violation|3|||
148768874|NCT00654875|536627121|FG000|Overall Study|Lack of Efficacy|2|||
148768875|NCT00654875|536627122|FG001|Overall Study|Lack of Efficacy|2|||
148768876|NCT00654875|536627121|FG000|Overall Study|Lost to Follow-up|1|||
148768877|NCT00654875|536627122|FG001|Overall Study|Lost to Follow-up|3|||
148768878|NCT00654875|536627121|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
148768879|NCT00654875|536627122|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
148768880|NCT00654875|536627121|FG000|Overall Study|Administrative Problems|1|||
148768881|NCT00654875|536627122|FG001|Overall Study|Administrative Problems|0|||
148768882|NCT01011465|536627123|FG000|Overall Study|Withdrawal by Subject|2|||
148830308|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
148830309|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
148830310|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
148830311|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
148830312|NCT00086515|536857170|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
148830313|NCT00086515|536857171|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
148830314|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
148830315|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
148830316|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
148830317|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
148830318|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
148830319|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
148830320|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
148830321|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
148830322|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
148830323|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
148830324|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
148830325|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
148830326|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
148830327|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
148830328|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
148830329|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
148830330|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
148830331|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
148830332|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
148830333|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
148830334|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
148830335|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
148830336|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
148830337|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
148830338|NCT00086515|536857170|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
148830339|NCT00086515|536857171|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
148979956|NCT00853658|537405807|FG001|Overall Study|Vital Status known (alive) at study end|3|||
148979957|NCT00853658|537405808|FG002|Overall Study|Vital Status known (alive) at study end|3|||
148830340|NCT05360784|536857172|FG000|Overall Study|Discontinued|25|||
148830341|NCT05360784|536857173|FG001|Overall Study|Discontinued|11|||
148830342|NCT02251041|536857174|FG000|Overall Study|Did not receive intervention|15|||
148830343|NCT02251041|536857175|FG001|Overall Study|Did not receive intervention|4|||
148979958|NCT00853658|537405806|FG000|Overall Study|Vital Status unknown at study end|1|||
148768883|NCT01011465|536627124|FG001|Overall Study|Withdrawal by Subject|1|||
148979959|NCT00853658|537405807|FG001|Overall Study|Vital Status unknown at study end|1|||
148979960|NCT00853658|537405808|FG002|Overall Study|Vital Status unknown at study end|0|||
148979961|NCT00853658|537405806|FG000|Overall Study|Vital Status at study end N/A|8|||
148979962|NCT00853658|537405807|FG001|Overall Study|Vital Status at study end N/A|10|||
148979963|NCT00853658|537405808|FG002|Overall Study|Vital Status at study end N/A|10|||
148979964|NCT00853658|537405806|FG000|Overall Study|Patient's request|21|||
148979965|NCT00853658|537405807|FG001|Overall Study|Patient's request|17|||
148979966|NCT00853658|537405808|FG002|Overall Study|Patient's request|11|||
148979967|NCT00853658|537405806|FG000|Overall Study|Missing study completion information|5|||
148979968|NCT00853658|537405807|FG001|Overall Study|Missing study completion information|4|||
148979969|NCT00853658|537405808|FG002|Overall Study|Missing study completion information|6|||
148979970|NCT00586469|537405810|FG000|Overall Study|Adverse Event|0|||
148979971|NCT00586469|537405811|FG001|Overall Study|Adverse Event|1|||
148979972|NCT01227512|537405814|FG000|Overall Study|Physician Decision|6|||
148979973|NCT01227512|537405815|FG001|Overall Study|Physician Decision|6|||
148979974|NCT01227512|537405814|FG000|Overall Study|Adverse Event|4|||
148979975|NCT01227512|537405815|FG001|Overall Study|Adverse Event|3|||
148979976|NCT01227512|537405814|FG000|Overall Study|Withdrawal by Subject|3|||
148979977|NCT01227512|537405815|FG001|Overall Study|Withdrawal by Subject|0|||
148979978|NCT01227512|537405814|FG000|Overall Study|Participant met withdrawal criteria|0|||
148979979|NCT01227512|537405815|FG001|Overall Study|Participant met withdrawal criteria|1|||
148979980|NCT04055116|537405822|FG000|First Intervention|Physician Decision|2|||
148979981|NCT04055116|537405823|FG001|First Intervention|Physician Decision|7|||
148979982|NCT02774681|537405824|FG000|Treatment on Study|Progressive Disease|7|||
148979983|NCT02774681|537405824|FG000|Follow-Up for 3 Years|Death|11|||
148979984|NCT02774681|537405824|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
148979985|NCT02556710|537407838|FG000|Overall Study|Surgical treatment|3|||
148979986|NCT02556710|537407839|FG001|Overall Study|Surgical treatment|0|||
148979987|NCT02556710|537407838|FG000|Overall Study|Required proscribed pain medication|2|||
148979988|NCT02556710|537407839|FG001|Overall Study|Required proscribed pain medication|1|||
148979989|NCT02556710|537407838|FG000|Overall Study|Lack of Efficacy|1|||
148979990|NCT02556710|537407839|FG001|Overall Study|Lack of Efficacy|0|||
148979991|NCT02556710|537407838|FG000|Overall Study|Worsening osteoarthritis|1|||
148979992|NCT02556710|537407839|FG001|Overall Study|Worsening osteoarthritis|0|||
148979993|NCT02556710|537407838|FG000|Overall Study|Moved out of state|1|||
148979994|NCT02556710|537407839|FG001|Overall Study|Moved out of state|0|||
148979995|NCT02556710|537407838|FG000|Overall Study|Missing reason|3|||
148979996|NCT02556710|537407839|FG001|Overall Study|Missing reason|1|||
148979997|NCT02556710|537407838|FG000|Overall Study|Pain as lack of efficacy|0|||
148979998|NCT02556710|537407839|FG001|Overall Study|Pain as lack of efficacy|4|||
148979999|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
148980000|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
148980001|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
148980002|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
148980003|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
148980004|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
148980005|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
148980006|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
148980007|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
148980008|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
148980009|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
148980010|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
148980011|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
148980012|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148980013|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148980014|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148980015|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148980016|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
148980017|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
148980018|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
148980019|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
148980020|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
148980021|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
148980022|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
148980023|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
148980024|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
148980025|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
148980026|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
148980027|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
148980028|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
148980029|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
148980030|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
148980031|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
148980032|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
148980033|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
148980034|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
148980035|NCT02139644|537407840|FG000|Run-In Period (Pre-assignment)|Other|6|||
148980036|NCT02139644|537407841|FG001|Run-In Period (Pre-assignment)|Other|0|||
148980037|NCT02139644|537407842|FG002|Run-In Period (Pre-assignment)|Other|0|||
148980038|NCT02139644|537407843|FG003|Run-In Period (Pre-assignment)|Other|0|||
148980039|NCT02139644|537407844|FG004|Run-In Period (Pre-assignment)|Other|0|||
148980040|NCT02139644|537407845|FG005|Run-In Period (Pre-assignment)|Other|0|||
148980041|NCT02139644|537407840|FG000|Treatment Period|Adverse Event|0|||
148980042|NCT02139644|537407841|FG001|Treatment Period|Adverse Event|0|||
148980043|NCT02139644|537407842|FG002|Treatment Period|Adverse Event|3|||
149028016|NCT01257503|537580057|FG001|Overall Study|Over 5 years old at enrollment|1|||
148768884|NCT01011465|536627125|FG002|Overall Study|Withdrawal by Subject|0|||
148768885|NCT01011465|536627126|FG003|Overall Study|Withdrawal by Subject|0|||
148768886|NCT01011465|536627127|FG004|Overall Study|Withdrawal by Subject|1|||
148768887|NCT01011465|536627128|FG005|Overall Study|Withdrawal by Subject|0|||
148768888|NCT01011465|536627129|FG006|Overall Study|Withdrawal by Subject|1|||
148768889|NCT01011465|536627130|FG007|Overall Study|Withdrawal by Subject|0|||
148768890|NCT02042950|536627133|FG000|Overall Study|Progressive Disease|4|||
148768891|NCT01683266|536627140|FG000|Overall Study|Adverse Event|5|||
148768892|NCT01683266|536627141|FG001|Overall Study|Adverse Event|4|||
148768893|NCT01683266|536627140|FG000|Overall Study|Lack of Efficacy|5|||
148768894|NCT01683266|536627141|FG001|Overall Study|Lack of Efficacy|2|||
148768895|NCT01683266|536627140|FG000|Overall Study|Protocol Violation|13|||
148768896|NCT01683266|536627141|FG001|Overall Study|Protocol Violation|6|||
148768897|NCT01683266|536627140|FG000|Overall Study|Personal Reason|17|||
148768898|NCT01683266|536627141|FG001|Overall Study|Personal Reason|25|||
148768899|NCT01683266|536627140|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
148768900|NCT01683266|536627141|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
148768901|NCT01683266|536627140|FG000|Overall Study|Lost to Follow-up|5|||
148768902|NCT01683266|536627141|FG001|Overall Study|Lost to Follow-up|0|||
148768903|NCT01683266|536627140|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
148768904|NCT01683266|536627141|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
148768905|NCT01683266|536627140|FG000|Overall Study|Nonserious Hypoglycemia|0|||
148768906|NCT01683266|536627141|FG001|Overall Study|Nonserious Hypoglycemia|3|||
148768907|NCT01683266|536627140|FG000|Overall Study|Perceived Lack of Efficacy|1|||
148768908|NCT01683266|536627141|FG001|Overall Study|Perceived Lack of Efficacy|1|||
148768909|NCT01683266|536627140|FG000|Overall Study|Possibly Hypoglycemia|1|||
148768910|NCT01683266|536627141|FG001|Overall Study|Possibly Hypoglycemia|0|||
148768911|NCT01683266|536627140|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
148768912|NCT01683266|536627141|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
148768913|NCT02217410|536627142|FG000|Overall Study|Graft Loss|0|||
148768914|NCT02217410|536627143|FG001|Overall Study|Graft Loss|0|||
148768915|NCT02217410|536627144|FG002|Overall Study|Graft Loss|2|||
148768916|NCT02217410|536627142|FG000|Overall Study|Withdrawal by Subject|0|||
148768917|NCT02217410|536627143|FG001|Overall Study|Withdrawal by Subject|0|||
148768918|NCT02217410|536627144|FG002|Overall Study|Withdrawal by Subject|2|||
148768919|NCT02217410|536627142|FG000|Overall Study|Lost to Follow-up|0|||
148768920|NCT02217410|536627143|FG001|Overall Study|Lost to Follow-up|0|||
148768921|NCT02217410|536627144|FG002|Overall Study|Lost to Follow-up|1|||
148768922|NCT02217410|536627142|FG000|Overall Study|Lack of Efficacy|0|||
148768923|NCT02217410|536627143|FG001|Overall Study|Lack of Efficacy|1|||
148768924|NCT02217410|536627144|FG002|Overall Study|Lack of Efficacy|0|||
148768925|NCT02217410|536627142|FG000|Overall Study|Physician Decision|1|||
148768926|NCT02217410|536627143|FG001|Overall Study|Physician Decision|3|||
148768927|NCT02217410|536627144|FG002|Overall Study|Physician Decision|0|||
148768928|NCT03702010|536627151|FG000|Follow-up (30days)|Lack of Efficacy|2|||
148768929|NCT03702010|536627152|FG001|Follow-up (30days)|Lack of Efficacy|2|||
148768930|NCT01254318|536627153|FG000|Overall Study|Lost to Follow-up|5|||
148768931|NCT01254318|536627153|FG000|Overall Study|Death|47|||
148768932|NCT02295020|536627166|FG000|Overall Study|Adverse Event|0|||
148768933|NCT02295020|536627167|FG001|Overall Study|Adverse Event|1|||
148768934|NCT02295020|536627166|FG000|Overall Study|Withdrawal by Subject|3|||
148768935|NCT02295020|536627167|FG001|Overall Study|Withdrawal by Subject|2|||
148768936|NCT01137110|536627168|FG000|Overall Study|Protocol Violation|1|||
148768937|NCT01137110|536627169|FG001|Overall Study|Protocol Violation|0|||
148830344|NCT04918771|536857176|FG000|Overall Study|Withdrawal by Subject|4|||
148768938|NCT00355147|536627174|FG000|Overall Study|Lost to Follow-up|10|||
148768939|NCT00355147|536627175|FG001|Overall Study|Lost to Follow-up|8|||
148768940|NCT00355147|536627174|FG000|Overall Study|Withdrawal by Subject|8|||
148830345|NCT04918771|536857177|FG001|Overall Study|Withdrawal by Subject|5|||
148980044|NCT02139644|537407843|FG003|Treatment Period|Adverse Event|2|||
148980045|NCT02139644|537407844|FG004|Treatment Period|Adverse Event|1|||
148980046|NCT02139644|537407845|FG005|Treatment Period|Adverse Event|6|||
148830346|NCT04918771|536857176|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
148830347|NCT04918771|536857177|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
148830348|NCT01813357|536857184|FG000|Overall Study|Lost to Follow-up|5|||
148830349|NCT01813357|536857185|FG001|Overall Study|Lost to Follow-up|6|||
148830350|NCT00462826|536858527|FG000|Overall Study|Ineligible - second primary|1|||
148830351|NCT00462826|536858527|FG000|Overall Study|Ineligible - wrong cell type|1|||
148830352|NCT00462826|536858527|FG000|Overall Study|Ineligible - wrong primary|2|||
148830353|NCT00462826|536858527|FG000|Overall Study|Never treated|1|||
148830354|NCT00488293|536858529|FG000|Overall Study|Lost to Follow-up|28|||
148830355|NCT00488293|536858530|FG001|Overall Study|Lost to Follow-up|25|||
148830356|NCT00488293|536858529|FG000|Overall Study|Withdrawal by Subject|5|||
148830357|NCT00488293|536858530|FG001|Overall Study|Withdrawal by Subject|3|||
148830358|NCT00488293|536858529|FG000|Overall Study|Death|2|||
148830359|NCT00488293|536858530|FG001|Overall Study|Death|1|||
148830360|NCT00488293|536858529|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
148830361|NCT00488293|536858530|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
148830362|NCT03436732|536858531|FG000|Overall Study|Not treated-enrolled in different study|1|||
148830363|NCT03436732|536858532|FG001|Overall Study|Not treated-enrolled in different study|0|||
148830364|NCT03436732|536858531|FG000|Overall Study|Off study after cycle 1|1|||
148830365|NCT03436732|536858532|FG001|Overall Study|Off study after cycle 1|0|||
148830366|NCT03436732|536858531|FG000|Overall Study|Adverse Event|2|||
148830367|NCT03436732|536858532|FG001|Overall Study|Adverse Event|0|||
148830368|NCT03436732|536858531|FG000|Overall Study|Death|0|||
148830369|NCT03436732|536858532|FG001|Overall Study|Death|1|||
148830370|NCT00939185|536858533|FG000|Overall Study|Adverse Event|3|||
148830371|NCT00939185|536858533|FG000|Overall Study|Lack of Efficacy|1|||
148830372|NCT00939185|536858533|FG000|Overall Study|Lost to Follow-up|6|||
148830373|NCT00939185|536858533|FG000|Overall Study|Other|3|||
148830374|NCT00939185|536858533|FG000|Overall Study|Withdrawal by Subject|2|||
148830375|NCT00939185|536858533|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
148830376|NCT03468998|536858535|FG000|Overall Study|Withdrawal by Subject|1|||
148830377|NCT03468998|536858536|FG001|Overall Study|Withdrawal by Subject|1|||
148830378|NCT03468998|536858537|FG002|Overall Study|Withdrawal by Subject|0|||
148830379|NCT03468998|536858538|FG003|Overall Study|Withdrawal by Subject|4|||
148830380|NCT03468998|536858539|FG004|Overall Study|Withdrawal by Subject|1|||
148830381|NCT03468998|536858540|FG005|Overall Study|Withdrawal by Subject|0|||
148830382|NCT00959049|536858541|FG000|Overall Study|Adverse Event|1|||
148830383|NCT00959049|536858542|FG001|Overall Study|Adverse Event|0|||
148830384|NCT00959049|536858543|FG002|Overall Study|Adverse Event|0|||
148830385|NCT00959049|536858544|FG003|Overall Study|Adverse Event|0|||
148830386|NCT00959049|536858545|FG004|Overall Study|Adverse Event|0|||
148830387|NCT00959049|536858546|FG005|Overall Study|Adverse Event|0|||
148830388|NCT00959049|536858541|FG000|Overall Study|Lost to Follow-up|17|||
148830389|NCT00959049|536858542|FG001|Overall Study|Lost to Follow-up|5|||
148830390|NCT00959049|536858543|FG002|Overall Study|Lost to Follow-up|1|||
148830391|NCT00959049|536858544|FG003|Overall Study|Lost to Follow-up|10|||
148830392|NCT00959049|536858545|FG004|Overall Study|Lost to Follow-up|9|||
148830393|NCT00959049|536858546|FG005|Overall Study|Lost to Follow-up|1|||
148830394|NCT00959049|536858541|FG000|Overall Study|Contraindicated medication|0|||
148830395|NCT00959049|536858542|FG001|Overall Study|Contraindicated medication|0|||
148830396|NCT00959049|536858543|FG002|Overall Study|Contraindicated medication|0|||
148830397|NCT00959049|536858544|FG003|Overall Study|Contraindicated medication|1|||
148830398|NCT00959049|536858545|FG004|Overall Study|Contraindicated medication|0|||
148830399|NCT00959049|536858546|FG005|Overall Study|Contraindicated medication|0|||
148830400|NCT00959049|536858541|FG000|Overall Study|Withdrawal by Subject|0|||
148830401|NCT00959049|536858542|FG001|Overall Study|Withdrawal by Subject|2|||
148830402|NCT00959049|536858543|FG002|Overall Study|Withdrawal by Subject|0|||
148830403|NCT00959049|536858544|FG003|Overall Study|Withdrawal by Subject|0|||
148830404|NCT00959049|536858545|FG004|Overall Study|Withdrawal by Subject|0|||
148980047|NCT02139644|537407840|FG000|Treatment Period|Withdrawal by Subject|0|||
148980048|NCT02139644|537407841|FG001|Treatment Period|Withdrawal by Subject|0|||
148980049|NCT02139644|537407842|FG002|Treatment Period|Withdrawal by Subject|2|||
148830405|NCT00959049|536858546|FG005|Overall Study|Withdrawal by Subject|0|||
148830406|NCT03847519|536858549|FG000|Overall Study|Death|5|||
148830407|NCT03847519|536858550|FG001|Overall Study|Death|8|||
148830408|NCT03847519|536858551|FG002|Overall Study|Death|1|||
148830409|NCT03847519|536858549|FG000|Overall Study|Lost to Follow-up|1|||
148830410|NCT03847519|536858550|FG001|Overall Study|Lost to Follow-up|2|||
148980050|NCT02139644|537407843|FG003|Treatment Period|Withdrawal by Subject|2|||
148830411|NCT03847519|536858551|FG002|Overall Study|Lost to Follow-up|0|||
148830412|NCT03847519|536858549|FG000|Overall Study|Study Terminated by Sponsor|0|||
148830413|NCT03847519|536858550|FG001|Overall Study|Study Terminated by Sponsor|3|||
148830414|NCT03847519|536858551|FG002|Overall Study|Study Terminated by Sponsor|2|||
148830415|NCT00863304|536858555|FG000|Overall Study|Adverse Event|10|||
148830416|NCT00863304|536858556|FG001|Overall Study|Adverse Event|4|||
148830417|NCT00863304|536858557|FG002|Overall Study|Adverse Event|14|||
148830418|NCT00863304|536858558|FG003|Overall Study|Adverse Event|16|||
148830419|NCT00863304|536858555|FG000|Overall Study|Lost to Follow-up|1|||
148768941|NCT00355147|536627175|FG001|Overall Study|Withdrawal by Subject|12|||
148768942|NCT03557931|536627182|FG000|Overall Study|Adverse Event|4|||
148768943|NCT03557931|536627183|FG001|Overall Study|Adverse Event|6|||
148768944|NCT03557931|536627184|FG002|Overall Study|Adverse Event|1|||
148768945|NCT03557931|536627182|FG000|Overall Study|Lost to Follow-up|4|||
148768946|NCT03557931|536627183|FG001|Overall Study|Lost to Follow-up|4|||
148768947|NCT03557931|536627184|FG002|Overall Study|Lost to Follow-up|1|||
148768948|NCT03557931|536627182|FG000|Overall Study|Protocol Violation|1|||
148768949|NCT03557931|536627183|FG001|Overall Study|Protocol Violation|4|||
148768950|NCT03557931|536627184|FG002|Overall Study|Protocol Violation|1|||
148768951|NCT03557931|536627182|FG000|Overall Study|Withdrawal by Subject|14|||
148768952|NCT03557931|536627183|FG001|Overall Study|Withdrawal by Subject|0|||
148768953|NCT03557931|536627184|FG002|Overall Study|Withdrawal by Subject|7|||
148768954|NCT03557931|536627182|FG000|Overall Study|Miscellaneous|8|||
148768955|NCT03557931|536627183|FG001|Overall Study|Miscellaneous|5|||
148768956|NCT03557931|536627184|FG002|Overall Study|Miscellaneous|3|||
148768957|NCT02438826|536627185|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
148768958|NCT02438826|536627186|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
148768959|NCT02438826|536627187|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
148768960|NCT02438826|536627188|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
148768961|NCT02438826|536627185|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
148768962|NCT02438826|536627186|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
148768963|NCT02438826|536627187|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
148768964|NCT02438826|536627188|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
148768965|NCT02438826|536627185|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
148768966|NCT02438826|536627186|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
148768967|NCT02438826|536627187|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
148768968|NCT02438826|536627188|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
148768969|NCT02438826|536627185|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
148768970|NCT02438826|536627186|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
148768971|NCT02438826|536627187|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
148768972|NCT02438826|536627188|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
148768973|NCT02438826|536627185|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
148768974|NCT02438826|536627186|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
148768975|NCT02438826|536627187|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
148768976|NCT02438826|536627188|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
148768977|NCT02438826|536627185|FG000|Open-Label Treatment Phase|Adverse Event|11|||
148768978|NCT02438826|536627186|FG001|Open-Label Treatment Phase|Adverse Event|6|||
148768979|NCT02438826|536627187|FG002|Open-Label Treatment Phase|Adverse Event|0|||
148768980|NCT02438826|536627188|FG003|Open-Label Treatment Phase|Adverse Event|0|||
148768981|NCT02438826|536627185|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
148768982|NCT02438826|536627186|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
148768983|NCT02438826|536627187|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
148768984|NCT02438826|536627188|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
148768985|NCT02438826|536627185|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
148768986|NCT02438826|536627186|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
148768987|NCT02438826|536627187|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
148768988|NCT02438826|536627188|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
148768989|NCT02438826|536627185|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
148768990|NCT02438826|536627186|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
148768991|NCT02438826|536627187|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
148768992|NCT02438826|536627188|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
148768993|NCT02438826|536627185|FG000|Post-Treatment Phase|Adverse Event|3|||
148768994|NCT02438826|536627186|FG001|Post-Treatment Phase|Adverse Event|0|||
148768995|NCT02438826|536627187|FG002|Post-Treatment Phase|Adverse Event|0|||
148768996|NCT02438826|536627188|FG003|Post-Treatment Phase|Adverse Event|0|||
148768997|NCT02438826|536627185|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
148768998|NCT02438826|536627186|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
148768999|NCT02438826|536627187|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
148769000|NCT02438826|536627188|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
148769001|NCT02438826|536627185|FG000|Post-Treatment Phase|Physician Decision|1|||
148769002|NCT02438826|536627186|FG001|Post-Treatment Phase|Physician Decision|0|||
148769003|NCT02438826|536627187|FG002|Post-Treatment Phase|Physician Decision|0|||
148769004|NCT02438826|536627188|FG003|Post-Treatment Phase|Physician Decision|0|||
148769005|NCT02438826|536627185|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
148769006|NCT02438826|536627186|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
148769007|NCT02438826|536627187|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
148769008|NCT02438826|536627188|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
148769009|NCT02553499|536627196|FG000|Overall Study|Adverse Event|0|||
148769010|NCT02553499|536627197|FG001|Overall Study|Adverse Event|0|||
148769011|NCT02553499|536627198|FG002|Overall Study|Adverse Event|0|||
148769012|NCT02553499|536627199|FG003|Overall Study|Adverse Event|0|||
148769013|NCT02553499|536627200|FG004|Overall Study|Adverse Event|0|||
148769014|NCT02553499|536627201|FG005|Overall Study|Adverse Event|0|||
148980051|NCT02139644|537407844|FG004|Treatment Period|Withdrawal by Subject|3|||
148980052|NCT02139644|537407845|FG005|Treatment Period|Withdrawal by Subject|2|||
148980053|NCT02139644|537407840|FG000|Treatment Period|Non-compliance|0|||
148980054|NCT02139644|537407841|FG001|Treatment Period|Non-compliance|0|||
148980055|NCT02139644|537407842|FG002|Treatment Period|Non-compliance|0|||
148980056|NCT02139644|537407843|FG003|Treatment Period|Non-compliance|1|||
148980057|NCT02139644|537407844|FG004|Treatment Period|Non-compliance|0|||
148769015|NCT02553499|536627202|FG006|Overall Study|Adverse Event|1|||
148769016|NCT02553499|536627203|FG007|Overall Study|Adverse Event|1|||
148769017|NCT02553499|536627204|FG008|Overall Study|Adverse Event|0|||
148769018|NCT02553499|536627205|FG009|Overall Study|Adverse Event|0|||
148769019|NCT02553499|536627206|FG010|Overall Study|Adverse Event|0|||
148769020|NCT02553499|536627207|FG011|Overall Study|Adverse Event|0|||
148769021|NCT02553499|536627208|FG012|Overall Study|Adverse Event|0|||
148769022|NCT02553499|536627209|FG013|Overall Study|Adverse Event|1|||
148769023|NCT02553499|536627196|FG000|Overall Study|Death|0|||
148769024|NCT02553499|536627197|FG001|Overall Study|Death|1|||
148769025|NCT02553499|536627198|FG002|Overall Study|Death|1|||
148769026|NCT02553499|536627199|FG003|Overall Study|Death|0|||
148769027|NCT02553499|536627200|FG004|Overall Study|Death|1|||
148769028|NCT02553499|536627201|FG005|Overall Study|Death|2|||
148769029|NCT02553499|536627202|FG006|Overall Study|Death|0|||
148769030|NCT02553499|536627203|FG007|Overall Study|Death|0|||
148769031|NCT02553499|536627204|FG008|Overall Study|Death|0|||
148769032|NCT02553499|536627205|FG009|Overall Study|Death|0|||
148769033|NCT02553499|536627206|FG010|Overall Study|Death|1|||
148769034|NCT02553499|536627207|FG011|Overall Study|Death|0|||
148769035|NCT02553499|536627208|FG012|Overall Study|Death|0|||
148769036|NCT02553499|536627209|FG013|Overall Study|Death|0|||
148769037|NCT02553499|536627196|FG000|Overall Study|Lost to Follow-up|0|||
148769038|NCT02553499|536627197|FG001|Overall Study|Lost to Follow-up|0|||
148769039|NCT02553499|536627198|FG002|Overall Study|Lost to Follow-up|0|||
148769040|NCT02553499|536627199|FG003|Overall Study|Lost to Follow-up|0|||
148769041|NCT02553499|536627200|FG004|Overall Study|Lost to Follow-up|0|||
148769042|NCT02553499|536627201|FG005|Overall Study|Lost to Follow-up|0|||
148769043|NCT02553499|536627202|FG006|Overall Study|Lost to Follow-up|1|||
148769044|NCT02553499|536627203|FG007|Overall Study|Lost to Follow-up|0|||
148769045|NCT02553499|536627204|FG008|Overall Study|Lost to Follow-up|0|||
148769046|NCT02553499|536627205|FG009|Overall Study|Lost to Follow-up|0|||
148769047|NCT02553499|536627206|FG010|Overall Study|Lost to Follow-up|0|||
148769048|NCT02553499|536627207|FG011|Overall Study|Lost to Follow-up|0|||
148769049|NCT02553499|536627208|FG012|Overall Study|Lost to Follow-up|0|||
148769050|NCT02553499|536627209|FG013|Overall Study|Lost to Follow-up|0|||
148769051|NCT02553499|536627196|FG000|Overall Study|Physician Decision|0|||
148769052|NCT02553499|536627197|FG001|Overall Study|Physician Decision|1|||
148769053|NCT02553499|536627198|FG002|Overall Study|Physician Decision|1|||
148769054|NCT02553499|536627199|FG003|Overall Study|Physician Decision|0|||
148769055|NCT02553499|536627200|FG004|Overall Study|Physician Decision|1|||
148769056|NCT02553499|536627201|FG005|Overall Study|Physician Decision|0|||
148769057|NCT02553499|536627202|FG006|Overall Study|Physician Decision|0|||
148769058|NCT02553499|536627203|FG007|Overall Study|Physician Decision|1|||
148769059|NCT02553499|536627204|FG008|Overall Study|Physician Decision|1|||
148769060|NCT02553499|536627205|FG009|Overall Study|Physician Decision|2|||
148769061|NCT02553499|536627206|FG010|Overall Study|Physician Decision|1|||
148769062|NCT02553499|536627207|FG011|Overall Study|Physician Decision|3|||
148769063|NCT02553499|536627208|FG012|Overall Study|Physician Decision|1|||
148769064|NCT02553499|536627209|FG013|Overall Study|Physician Decision|0|||
148769065|NCT02553499|536627196|FG000|Overall Study|Progressive Disease|0|||
148769066|NCT02553499|536627197|FG001|Overall Study|Progressive Disease|0|||
148769067|NCT02553499|536627198|FG002|Overall Study|Progressive Disease|0|||
148769068|NCT02553499|536627199|FG003|Overall Study|Progressive Disease|2|||
148769069|NCT02553499|536627200|FG004|Overall Study|Progressive Disease|1|||
148769070|NCT02553499|536627201|FG005|Overall Study|Progressive Disease|1|||
148769071|NCT02553499|536627202|FG006|Overall Study|Progressive Disease|1|||
148769072|NCT02553499|536627203|FG007|Overall Study|Progressive Disease|0|||
148980058|NCT02139644|537407845|FG005|Treatment Period|Non-compliance|0|||
148769073|NCT02553499|536627204|FG008|Overall Study|Progressive Disease|0|||
148769074|NCT02553499|536627205|FG009|Overall Study|Progressive Disease|1|||
148769075|NCT02553499|536627206|FG010|Overall Study|Progressive Disease|0|||
148769076|NCT02553499|536627207|FG011|Overall Study|Progressive Disease|0|||
148980059|NCT02139644|537407840|FG000|Treatment Period|Protocol Violation|0|||
148769077|NCT02553499|536627208|FG012|Overall Study|Progressive Disease|2|||
148769078|NCT02553499|536627209|FG013|Overall Study|Progressive Disease|1|||
148769079|NCT02553499|536627196|FG000|Overall Study|Study Terminated by Sponsor|0|||
148769080|NCT02553499|536627197|FG001|Overall Study|Study Terminated by Sponsor|0|||
148769081|NCT02553499|536627198|FG002|Overall Study|Study Terminated by Sponsor|0|||
148769082|NCT02553499|536627199|FG003|Overall Study|Study Terminated by Sponsor|0|||
148769083|NCT02553499|536627200|FG004|Overall Study|Study Terminated by Sponsor|0|||
148769084|NCT02553499|536627201|FG005|Overall Study|Study Terminated by Sponsor|0|||
148769085|NCT02553499|536627202|FG006|Overall Study|Study Terminated by Sponsor|0|||
148769086|NCT02553499|536627203|FG007|Overall Study|Study Terminated by Sponsor|0|||
148769087|NCT02553499|536627204|FG008|Overall Study|Study Terminated by Sponsor|1|||
148769088|NCT02553499|536627205|FG009|Overall Study|Study Terminated by Sponsor|0|||
148769089|NCT02553499|536627206|FG010|Overall Study|Study Terminated by Sponsor|0|||
148769090|NCT02553499|536627207|FG011|Overall Study|Study Terminated by Sponsor|0|||
148769091|NCT02553499|536627208|FG012|Overall Study|Study Terminated by Sponsor|0|||
148769092|NCT02553499|536627209|FG013|Overall Study|Study Terminated by Sponsor|0|||
148769093|NCT02553499|536627196|FG000|Overall Study|Withdrawal by Subject|2|||
148769094|NCT02553499|536627197|FG001|Overall Study|Withdrawal by Subject|0|||
148769095|NCT02553499|536627198|FG002|Overall Study|Withdrawal by Subject|0|||
148769096|NCT02553499|536627199|FG003|Overall Study|Withdrawal by Subject|0|||
148769097|NCT02553499|536627200|FG004|Overall Study|Withdrawal by Subject|0|||
148769098|NCT02553499|536627201|FG005|Overall Study|Withdrawal by Subject|0|||
148769099|NCT02553499|536627202|FG006|Overall Study|Withdrawal by Subject|0|||
148769100|NCT02553499|536627203|FG007|Overall Study|Withdrawal by Subject|1|||
148769101|NCT02553499|536627204|FG008|Overall Study|Withdrawal by Subject|1|||
148769102|NCT02553499|536627205|FG009|Overall Study|Withdrawal by Subject|0|||
148769103|NCT02553499|536627206|FG010|Overall Study|Withdrawal by Subject|1|||
148769104|NCT02553499|536627207|FG011|Overall Study|Withdrawal by Subject|0|||
148769105|NCT02553499|536627208|FG012|Overall Study|Withdrawal by Subject|0|||
148769106|NCT02553499|536627209|FG013|Overall Study|Withdrawal by Subject|0|||
148769107|NCT01582178|536627210|FG000|Overall Study|Physician Decision|6|||
148769108|NCT01582178|536627211|FG001|Overall Study|Physician Decision|5|||
148769109|NCT01726270|536627212|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
148769110|NCT01726270|536627212|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
148769111|NCT01726270|536627212|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
148769112|NCT01726270|536627212|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
148769113|NCT01726270|536627212|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
148769114|NCT01726270|536627212|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
148769115|NCT00582608|536627214|FG000|Overall Study|Not Treated|7|||
148769116|NCT00582608|536627214|FG000|Overall Study|Patient Ineligible|1|||
148769117|NCT00582608|536627214|FG000|Overall Study|Lack of accrual|4|||
148769118|NCT00570063|536627215|FG000|Overall Study|Adverse Event|4|||
148769119|NCT00570063|536627216|FG001|Overall Study|Adverse Event|1|||
148769120|NCT00570063|536627215|FG000|Overall Study|Lack of Efficacy|0|||
148769121|NCT00570063|536627216|FG001|Overall Study|Lack of Efficacy|1|||
148769122|NCT00570063|536627215|FG000|Overall Study|Withdrawal by Subject|4|||
148769123|NCT00570063|536627216|FG001|Overall Study|Withdrawal by Subject|3|||
148769124|NCT00570063|536627215|FG000|Overall Study|Sponsor's Decision|7|||
148769125|NCT00570063|536627216|FG001|Overall Study|Sponsor's Decision|3|||
148769126|NCT03478644|536627220|FG000|Phase 2|Withdrawal by Subject|2|||
148769127|NCT03478644|536627221|FG001|Phase 2|Withdrawal by Subject|1|||
148769128|NCT03478644|536627220|FG000|Phase 2|Lost to Follow-up|1|||
148769129|NCT03478644|536627221|FG001|Phase 2|Lost to Follow-up|0|||
148769130|NCT04152837|536627224|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
148769131|NCT04152837|536627224|FG000|Maintenance Period|Adverse Event|1|||
148769132|NCT04152837|536627224|FG000|Maintenance Period|Withdrawal by Subject|1|||
148769133|NCT04152837|536627224|FG000|Maintenance Period|Sponsor Termination of Study|2|||
148769134|NCT00586820|536627225|FG000|Overall Study|Unsuccessful PCI|1|||
148769135|NCT00586820|536627226|FG001|Overall Study|Unsuccessful PCI|0|||
148769136|NCT02073929|536627227|FG000|Overall Study|Lost to Follow-up|2|||
148769137|NCT02073929|536627228|FG001|Overall Study|Lost to Follow-up|1|||
148769138|NCT02073929|536627227|FG000|Overall Study|Adverse Event|2|||
148769139|NCT02073929|536627228|FG001|Overall Study|Adverse Event|1|||
148769140|NCT02073929|536627227|FG000|Overall Study|Withdrawal by Subject|0|||
148769141|NCT02073929|536627228|FG001|Overall Study|Withdrawal by Subject|1|||
148769142|NCT00101166|536627229|FG000|Overall Study|progressive disease|10|||
148769143|NCT00686829|536627230|FG000|Overall Study|Adverse Event|5|||
148769144|NCT00686829|536627230|FG000|Overall Study|Lack of Efficacy|6|||
148769145|NCT00686829|536627230|FG000|Overall Study|Lost to Follow-up|4|||
148769146|NCT00686829|536627230|FG000|Overall Study|Withdrawal by Subject|14|||
148769147|NCT00686829|536627230|FG000|Overall Study|Protocol Violation|3|||
148769148|NCT00686829|536627230|FG000|Overall Study|Sponsor discontinued VCV|47|||
148769149|NCT01732640|536627231|FG000|Overall Study|Adverse Event|0|||
148769150|NCT01732640|536627232|FG001|Overall Study|Adverse Event|1|||
148769151|NCT01732640|536627231|FG000|Overall Study|Death|0|||
148769152|NCT01732640|536627232|FG001|Overall Study|Death|1|||
148769153|NCT00712543|536627235|FG000|Day 8-14|Lost to Follow-up|0|||
148769154|NCT00712543|536627236|FG001|Day 8-14|Lost to Follow-up|2|||
148769155|NCT02981082|536627247|FG000|Overall Study|Withdrawal by Subject|2|||
148769156|NCT02981082|536627248|FG001|Overall Study|Withdrawal by Subject|0|||
148769157|NCT02981082|536627247|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
148769158|NCT02981082|536627248|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
148769159|NCT02981082|536627247|FG000|Overall Study|Adverse Event|0|||
148769160|NCT02981082|536627248|FG001|Overall Study|Adverse Event|1|||
148769161|NCT04250350|536629324|FG000|Overall Study|Withdrawal by Subject|13|||
148769162|NCT04250350|536629324|FG000|Overall Study|Lost to Follow-up|8|||
148769163|NCT04250350|536629324|FG000|Overall Study|Adverse Event|5|||
148769164|NCT04250350|536629324|FG000|Overall Study|Lack of Efficacy|4|||
148769165|NCT04250350|536629324|FG000|Overall Study|Physician Decision|1|||
148769166|NCT04250350|536629324|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
148769167|NCT03937908|536629325|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
148769168|NCT03937908|536629326|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
148769169|NCT03205761|536629327|FG000|Overall Study|Withdrawal by Subject|1|||
148769170|NCT03205761|536629327|FG000|Overall Study|Progressive Disease|10|||
148769171|NCT00636194|536629328|FG000|Overall Study|Study related symptoms and complaints|1|||
148769172|NCT00636194|536629329|FG001|Overall Study|Study related symptoms and complaints|0|||
148769173|NCT00636194|536629328|FG000|Overall Study|Protocol Violation|2|||
148769174|NCT00636194|536629329|FG001|Overall Study|Protocol Violation|0|||
148769175|NCT02163226|536629331|FG000|Overall Study|Death|2|||
148769176|NCT02163226|536629332|FG001|Overall Study|Death|1|||
148769177|NCT02163226|536629331|FG000|Overall Study|Withdrawal by Subject|5|||
148769178|NCT02163226|536629332|FG001|Overall Study|Withdrawal by Subject|2|||
148769179|NCT02163226|536629331|FG000|Overall Study|Returned home, local radiotherapy|3|||
148769180|NCT02163226|536629332|FG001|Overall Study|Returned home, local radiotherapy|0|||
148769181|NCT02163226|536629331|FG000|Overall Study|Repeat imaging showed no disease|2|||
148769182|NCT02163226|536629332|FG001|Overall Study|Repeat imaging showed no disease|0|||
148769183|NCT02163226|536629331|FG000|Overall Study|Incomplete radiotherapy|3|||
148769184|NCT02163226|536629332|FG001|Overall Study|Incomplete radiotherapy|0|||
148769185|NCT02163226|536629331|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
148769186|NCT02163226|536629332|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
148830420|NCT00863304|536858556|FG001|Overall Study|Lost to Follow-up|5|||
148830421|NCT00863304|536858557|FG002|Overall Study|Lost to Follow-up|4|||
148830422|NCT00863304|536858558|FG003|Overall Study|Lost to Follow-up|2|||
148830423|NCT00863304|536858555|FG000|Overall Study|Lack of Efficacy|57|||
148830424|NCT00863304|536858556|FG001|Overall Study|Lack of Efficacy|26|||
148980060|NCT02139644|537407841|FG001|Treatment Period|Protocol Violation|0|||
148980061|NCT02139644|537407842|FG002|Treatment Period|Protocol Violation|0|||
148980062|NCT02139644|537407843|FG003|Treatment Period|Protocol Violation|1|||
148980063|NCT02139644|537407844|FG004|Treatment Period|Protocol Violation|1|||
148980064|NCT02139644|537407845|FG005|Treatment Period|Protocol Violation|1|||
148980065|NCT02139644|537407840|FG000|Treatment Period|Disease progression|0|||
148980066|NCT02139644|537407841|FG001|Treatment Period|Disease progression|0|||
148980067|NCT02139644|537407842|FG002|Treatment Period|Disease progression|0|||
148980068|NCT02139644|537407843|FG003|Treatment Period|Disease progression|1|||
148980069|NCT02139644|537407844|FG004|Treatment Period|Disease progression|1|||
148980070|NCT02139644|537407845|FG005|Treatment Period|Disease progression|2|||
148980071|NCT02139644|537407840|FG000|Treatment Period|Lost to Follow-up|0|||
148980072|NCT02139644|537407841|FG001|Treatment Period|Lost to Follow-up|0|||
148980073|NCT02139644|537407842|FG002|Treatment Period|Lost to Follow-up|1|||
148980074|NCT02139644|537407843|FG003|Treatment Period|Lost to Follow-up|1|||
148980075|NCT02139644|537407844|FG004|Treatment Period|Lost to Follow-up|1|||
148980076|NCT02139644|537407845|FG005|Treatment Period|Lost to Follow-up|1|||
148980077|NCT02139644|537407840|FG000|Treatment Period|Lack of Efficacy|0|||
148980078|NCT02139644|537407841|FG001|Treatment Period|Lack of Efficacy|0|||
148980079|NCT02139644|537407842|FG002|Treatment Period|Lack of Efficacy|1|||
148980080|NCT02139644|537407843|FG003|Treatment Period|Lack of Efficacy|0|||
148980081|NCT02139644|537407844|FG004|Treatment Period|Lack of Efficacy|1|||
148980082|NCT02139644|537407845|FG005|Treatment Period|Lack of Efficacy|4|||
148980083|NCT02139644|537407840|FG000|Treatment Period|Other|0|||
148980084|NCT02139644|537407841|FG001|Treatment Period|Other|3|||
148980085|NCT02139644|537407842|FG002|Treatment Period|Other|1|||
148980086|NCT02139644|537407843|FG003|Treatment Period|Other|1|||
148980087|NCT02139644|537407844|FG004|Treatment Period|Other|0|||
148980088|NCT02139644|537407845|FG005|Treatment Period|Other|1|||
148980089|NCT03143829|537407850|FG000|Overall Study|Withdrawal by Subject|2|||
148980090|NCT03143829|537407851|FG001|Overall Study|Withdrawal by Subject|5|||
148980091|NCT03143829|537407850|FG000|Overall Study|Lost to Follow-up|0|||
148980092|NCT03143829|537407851|FG001|Overall Study|Lost to Follow-up|2|||
148980093|NCT03143829|537407850|FG000|Overall Study|Death|1|||
148980094|NCT03143829|537407851|FG001|Overall Study|Death|1|||
148980095|NCT03143829|537407850|FG000|Overall Study|changed treatment, no longer eligible|2|||
148980096|NCT03143829|537407851|FG001|Overall Study|changed treatment, no longer eligible|2|||
148980097|NCT01529645|537407855|FG000|Overall Study|Lost to Follow-up|0|||
148980098|NCT01529645|537407856|FG001|Overall Study|Lost to Follow-up|1|||
148980099|NCT01529645|537407857|FG002|Overall Study|Lost to Follow-up|1|||
148980100|NCT01529645|537407858|FG003|Overall Study|Lost to Follow-up|1|||
148980101|NCT01529645|537407859|FG004|Overall Study|Lost to Follow-up|1|||
148980102|NCT01529645|537407860|FG005|Overall Study|Lost to Follow-up|0|||
148980103|NCT01529645|537407861|FG006|Overall Study|Lost to Follow-up|2|||
148980104|NCT01529645|537407862|FG007|Overall Study|Lost to Follow-up|0|||
148980105|NCT01529645|537407863|FG008|Overall Study|Lost to Follow-up|1|||
148980106|NCT01529645|537407864|FG009|Overall Study|Lost to Follow-up|0|||
148980107|NCT01529645|537407855|FG000|Overall Study|SAE - Premature contractions|0|||
148980108|NCT01529645|537407856|FG001|Overall Study|SAE - Premature contractions|0|||
148980109|NCT01529645|537407857|FG002|Overall Study|SAE - Premature contractions|1|||
148980110|NCT01529645|537407858|FG003|Overall Study|SAE - Premature contractions|0|||
148980111|NCT01529645|537407859|FG004|Overall Study|SAE - Premature contractions|0|||
148980112|NCT01529645|537407860|FG005|Overall Study|SAE - Premature contractions|0|||
148980113|NCT01529645|537407861|FG006|Overall Study|SAE - Premature contractions|0|||
148980114|NCT01529645|537407862|FG007|Overall Study|SAE - Premature contractions|0|||
148980115|NCT01529645|537407863|FG008|Overall Study|SAE - Premature contractions|0|||
148980116|NCT01529645|537407864|FG009|Overall Study|SAE - Premature contractions|0|||
148980117|NCT01529645|537407855|FG000|Overall Study|Withdrawal by Subject|2|||
148980118|NCT01529645|537407856|FG001|Overall Study|Withdrawal by Subject|0|||
148980119|NCT01529645|537407857|FG002|Overall Study|Withdrawal by Subject|0|||
148980120|NCT01529645|537407858|FG003|Overall Study|Withdrawal by Subject|1|||
148980121|NCT01529645|537407859|FG004|Overall Study|Withdrawal by Subject|1|||
148980122|NCT01529645|537407860|FG005|Overall Study|Withdrawal by Subject|1|||
148980123|NCT01529645|537407861|FG006|Overall Study|Withdrawal by Subject|0|||
148980124|NCT01529645|537407862|FG007|Overall Study|Withdrawal by Subject|0|||
148980125|NCT01529645|537407863|FG008|Overall Study|Withdrawal by Subject|0|||
148980126|NCT01529645|537407864|FG009|Overall Study|Withdrawal by Subject|0|||
148980127|NCT01602315|537407869|FG000|Overall Study|Protocol Violation|0|||
148980128|NCT01602315|537407870|FG001|Overall Study|Protocol Violation|0|||
148980129|NCT01602315|537407871|FG002|Overall Study|Protocol Violation|0|||
148980130|NCT01602315|537407872|FG003|Overall Study|Protocol Violation|0|||
148980131|NCT01602315|537407873|FG004|Overall Study|Protocol Violation|0|||
148980132|NCT01602315|537407874|FG005|Overall Study|Protocol Violation|1|||
148980133|NCT01602315|537407875|FG006|Overall Study|Protocol Violation|0|||
148980134|NCT01602315|537407869|FG000|Overall Study|Physician Decision|2|||
148980135|NCT01602315|537407870|FG001|Overall Study|Physician Decision|0|||
148980136|NCT01602315|537407871|FG002|Overall Study|Physician Decision|0|||
148980137|NCT01602315|537407872|FG003|Overall Study|Physician Decision|0|||
148980138|NCT01602315|537407873|FG004|Overall Study|Physician Decision|2|||
148980139|NCT01602315|537407874|FG005|Overall Study|Physician Decision|1|||
148830425|NCT00863304|536858557|FG002|Overall Study|Lack of Efficacy|30|||
148830426|NCT00863304|536858558|FG003|Overall Study|Lack of Efficacy|28|||
148830427|NCT00863304|536858555|FG000|Overall Study|Withdrawal by Subject|19|||
148830428|NCT00863304|536858556|FG001|Overall Study|Withdrawal by Subject|14|||
148830429|NCT00863304|536858557|FG002|Overall Study|Withdrawal by Subject|20|||
148830430|NCT00863304|536858558|FG003|Overall Study|Withdrawal by Subject|18|||
148830431|NCT00863304|536858555|FG000|Overall Study|Other|1|||
148830432|NCT00863304|536858556|FG001|Overall Study|Other|0|||
148830433|NCT00863304|536858557|FG002|Overall Study|Other|0|||
148830434|NCT00863304|536858558|FG003|Overall Study|Other|1|||
148830435|NCT00863304|536858555|FG000|Overall Study|Protocol Violation|2|||
148830436|NCT00863304|536858556|FG001|Overall Study|Protocol Violation|6|||
148830437|NCT00863304|536858557|FG002|Overall Study|Protocol Violation|2|||
148830438|NCT00863304|536858558|FG003|Overall Study|Protocol Violation|0|||
148830439|NCT00863304|536858555|FG000|Overall Study|Randomized, but not Treated|3|||
148830440|NCT00863304|536858556|FG001|Overall Study|Randomized, but not Treated|1|||
148830441|NCT00863304|536858557|FG002|Overall Study|Randomized, but not Treated|4|||
148830442|NCT00863304|536858558|FG003|Overall Study|Randomized, but not Treated|1|||
148830443|NCT00863304|536858555|FG000|Overall Study|Entered extension study|101|||
148830444|NCT00863304|536858556|FG001|Overall Study|Entered extension study|129|||
148830445|NCT00863304|536858557|FG002|Overall Study|Entered extension study|113|||
148830446|NCT00863304|536858558|FG003|Overall Study|Entered extension study|125|||
148830447|NCT02327169|536858559|FG000|Overall Study|Progressive Disease|1|||
148830448|NCT02327169|536858560|FG001|Overall Study|Progressive Disease|3|||
148830449|NCT02327169|536858561|FG002|Overall Study|Progressive Disease|4|||
148830450|NCT02327169|536858562|FG003|Overall Study|Progressive Disease|3|||
148830451|NCT02327169|536858563|FG004|Overall Study|Progressive Disease|4|||
148830452|NCT02327169|536858564|FG005|Overall Study|Progressive Disease|3|||
148830453|NCT02327169|536858565|FG006|Overall Study|Progressive Disease|3|||
148830454|NCT02327169|536858566|FG007|Overall Study|Progressive Disease|3|||
148830455|NCT02327169|536858567|FG008|Overall Study|Progressive Disease|4|||
148830456|NCT02327169|536858568|FG009|Overall Study|Progressive Disease|4|||
148830457|NCT02327169|536858569|FG010|Overall Study|Progressive Disease|4|||
148830458|NCT02327169|536858570|FG011|Overall Study|Progressive Disease|3|||
148830459|NCT02327169|536858571|FG012|Overall Study|Progressive Disease|1|||
148830460|NCT02327169|536858572|FG013|Overall Study|Progressive Disease|3|||
148830461|NCT02327169|536858573|FG014|Overall Study|Progressive Disease|3|||
148830462|NCT02327169|536858559|FG000|Overall Study|Adverse Event|2|||
148830463|NCT02327169|536858560|FG001|Overall Study|Adverse Event|0|||
148830464|NCT02327169|536858561|FG002|Overall Study|Adverse Event|1|||
148980140|NCT01602315|537407875|FG006|Overall Study|Physician Decision|1|||
148980141|NCT01602315|537407869|FG000|Overall Study|Disease progression|6|||
148980142|NCT01602315|537407870|FG001|Overall Study|Disease progression|3|||
148980143|NCT01602315|537407871|FG002|Overall Study|Disease progression|10|||
148980144|NCT01602315|537407872|FG003|Overall Study|Disease progression|1|||
148980145|NCT01602315|537407873|FG004|Overall Study|Disease progression|41|||
148980146|NCT01602315|537407874|FG005|Overall Study|Disease progression|12|||
148980147|NCT01602315|537407875|FG006|Overall Study|Disease progression|15|||
148980148|NCT01602315|537407869|FG000|Overall Study|Death|1|||
148980149|NCT01602315|537407870|FG001|Overall Study|Death|1|||
148980150|NCT01602315|537407871|FG002|Overall Study|Death|1|||
148980151|NCT01602315|537407872|FG003|Overall Study|Death|1|||
148980152|NCT01602315|537407873|FG004|Overall Study|Death|7|||
148980153|NCT01602315|537407874|FG005|Overall Study|Death|2|||
148980154|NCT01602315|537407875|FG006|Overall Study|Death|2|||
148980155|NCT01602315|537407869|FG000|Overall Study|Withdrawal by Subject|2|||
148769187|NCT02163226|536629331|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
148769188|NCT02163226|536629332|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
148769189|NCT02163226|536629331|FG000|Overall Study|ineligible|0|||
148769190|NCT02163226|536629332|FG001|Overall Study|ineligible|3|||
148769191|NCT05318092|536629336|FG000|Overall Study|Lost to Follow-up|3|||
148769192|NCT05318092|536629336|FG000|Overall Study|Withdrawal by Subject|1|||
148769193|NCT03854370|536629344|FG000|Overall Study|samples not collected|1|||
148769194|NCT03854370|536629345|FG001|Overall Study|samples not collected|1|||
148769195|NCT03854370|536629346|FG002|Overall Study|samples not collected|1|||
148769196|NCT03854370|536629347|FG003|Overall Study|samples not collected|1|||
148769197|NCT02656290|536629349|FG000|Overall Study|Lost to Follow-up|1|||
148769198|NCT02656290|536629349|FG000|Overall Study|Reintervention|3|||
148769199|NCT01608087|536629350|FG000|Overall Study|Lost to Follow-up|0|||
148769200|NCT01608087|536629351|FG001|Overall Study|Lost to Follow-up|1|||
148769201|NCT01608087|536629352|FG002|Overall Study|Lost to Follow-up|0|||
148769202|NCT01608087|536629350|FG000|Overall Study|Other Reason|0|||
148769203|NCT01608087|536629351|FG001|Overall Study|Other Reason|1|||
148769204|NCT01608087|536629352|FG002|Overall Study|Other Reason|0|||
148769205|NCT01300338|536629353|FG000|Overall Study|Lost to Follow-up|5|||
148769206|NCT01300338|536629354|FG001|Overall Study|Lost to Follow-up|0|||
148769207|NCT02461524|536629356|FG000|Overall Study|Death|16|||
148769208|NCT02461524|536629356|FG000|Overall Study|Withdrawal by Subject|4|||
148769209|NCT02461524|536629356|FG000|Overall Study|Device Explanted|5|||
148769210|NCT02461524|536629356|FG000|Overall Study|Missed Visit|6|||
148769211|NCT01943851|536629358|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769212|NCT01943851|536629359|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769213|NCT01943851|536629360|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769214|NCT01943851|536629361|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
148769215|NCT01943851|536629362|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769216|NCT01943851|536629363|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769217|NCT01943851|536629364|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
148769218|NCT01943851|536629365|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
148769219|NCT01943851|536629366|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
148769220|NCT01943851|536629367|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769221|NCT01943851|536629368|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769222|NCT01943851|536629369|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769223|NCT01943851|536629370|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769224|NCT01943851|536629371|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769225|NCT01943851|536629372|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769226|NCT01943851|536629373|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769227|NCT01943851|536629374|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769228|NCT01943851|536629375|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
148769229|NCT01943851|536629358|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769230|NCT01943851|536629359|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769231|NCT01943851|536629360|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769232|NCT01943851|536629361|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769233|NCT01943851|536629362|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
148769234|NCT01943851|536629363|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769235|NCT01943851|536629364|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769236|NCT01943851|536629365|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
148769237|NCT01943851|536629366|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769238|NCT01943851|536629367|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769239|NCT01943851|536629368|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769240|NCT01943851|536629369|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769241|NCT01943851|536629370|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769242|NCT01943851|536629371|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769243|NCT01943851|536629372|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769244|NCT01943851|536629373|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769245|NCT01943851|536629374|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769246|NCT01943851|536629375|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
148769247|NCT01943851|536629358|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769248|NCT01943851|536629359|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769249|NCT01943851|536629360|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148980156|NCT01602315|537407870|FG001|Overall Study|Withdrawal by Subject|0|||
148980157|NCT01602315|537407871|FG002|Overall Study|Withdrawal by Subject|2|||
148830465|NCT02327169|536858562|FG003|Overall Study|Adverse Event|0|||
148830466|NCT02327169|536858563|FG004|Overall Study|Adverse Event|1|||
148830467|NCT02327169|536858564|FG005|Overall Study|Adverse Event|0|||
148830468|NCT02327169|536858565|FG006|Overall Study|Adverse Event|0|||
148830469|NCT02327169|536858566|FG007|Overall Study|Adverse Event|0|||
148830470|NCT02327169|536858567|FG008|Overall Study|Adverse Event|0|||
148830471|NCT02327169|536858568|FG009|Overall Study|Adverse Event|2|||
148830472|NCT02327169|536858569|FG010|Overall Study|Adverse Event|0|||
148830473|NCT02327169|536858570|FG011|Overall Study|Adverse Event|3|||
148830474|NCT02327169|536858571|FG012|Overall Study|Adverse Event|0|||
148830475|NCT02327169|536858572|FG013|Overall Study|Adverse Event|2|||
148830476|NCT02327169|536858573|FG014|Overall Study|Adverse Event|1|||
148830477|NCT02327169|536858559|FG000|Overall Study|Symptomatic Deterioration|0|||
148830478|NCT02327169|536858560|FG001|Overall Study|Symptomatic Deterioration|0|||
148830479|NCT02327169|536858561|FG002|Overall Study|Symptomatic Deterioration|1|||
148830480|NCT02327169|536858562|FG003|Overall Study|Symptomatic Deterioration|0|||
148830481|NCT02327169|536858563|FG004|Overall Study|Symptomatic Deterioration|1|||
148830482|NCT02327169|536858564|FG005|Overall Study|Symptomatic Deterioration|1|||
148830483|NCT02327169|536858565|FG006|Overall Study|Symptomatic Deterioration|0|||
148830484|NCT02327169|536858566|FG007|Overall Study|Symptomatic Deterioration|0|||
148830485|NCT02327169|536858567|FG008|Overall Study|Symptomatic Deterioration|2|||
148830486|NCT02327169|536858568|FG009|Overall Study|Symptomatic Deterioration|1|||
148830487|NCT02327169|536858569|FG010|Overall Study|Symptomatic Deterioration|0|||
148830488|NCT02327169|536858570|FG011|Overall Study|Symptomatic Deterioration|0|||
148830489|NCT02327169|536858571|FG012|Overall Study|Symptomatic Deterioration|0|||
148830490|NCT02327169|536858572|FG013|Overall Study|Symptomatic Deterioration|2|||
148830491|NCT02327169|536858573|FG014|Overall Study|Symptomatic Deterioration|1|||
148830492|NCT02327169|536858559|FG000|Overall Study|Reason Not Specified|0|||
148830493|NCT02327169|536858560|FG001|Overall Study|Reason Not Specified|0|||
148830494|NCT02327169|536858561|FG002|Overall Study|Reason Not Specified|1|||
148830495|NCT02327169|536858562|FG003|Overall Study|Reason Not Specified|0|||
148830496|NCT02327169|536858563|FG004|Overall Study|Reason Not Specified|0|||
148830497|NCT02327169|536858564|FG005|Overall Study|Reason Not Specified|0|||
148830498|NCT02327169|536858565|FG006|Overall Study|Reason Not Specified|0|||
148830499|NCT02327169|536858566|FG007|Overall Study|Reason Not Specified|0|||
148830500|NCT02327169|536858567|FG008|Overall Study|Reason Not Specified|0|||
148830501|NCT02327169|536858568|FG009|Overall Study|Reason Not Specified|1|||
148830502|NCT02327169|536858569|FG010|Overall Study|Reason Not Specified|2|||
148830503|NCT02327169|536858570|FG011|Overall Study|Reason Not Specified|1|||
148830504|NCT02327169|536858571|FG012|Overall Study|Reason Not Specified|0|||
148830505|NCT02327169|536858572|FG013|Overall Study|Reason Not Specified|0|||
148830506|NCT02327169|536858573|FG014|Overall Study|Reason Not Specified|2|||
148830507|NCT02327169|536858559|FG000|Overall Study|Withdrawal by Subject|1|||
148830508|NCT02327169|536858560|FG001|Overall Study|Withdrawal by Subject|0|||
148830509|NCT02327169|536858561|FG002|Overall Study|Withdrawal by Subject|0|||
148830510|NCT02327169|536858562|FG003|Overall Study|Withdrawal by Subject|0|||
148830511|NCT02327169|536858563|FG004|Overall Study|Withdrawal by Subject|1|||
148830512|NCT02327169|536858564|FG005|Overall Study|Withdrawal by Subject|0|||
148830513|NCT02327169|536858565|FG006|Overall Study|Withdrawal by Subject|0|||
148830514|NCT02327169|536858566|FG007|Overall Study|Withdrawal by Subject|1|||
148980158|NCT01602315|537407872|FG003|Overall Study|Withdrawal by Subject|0|||
148830515|NCT02327169|536858567|FG008|Overall Study|Withdrawal by Subject|0|||
148830516|NCT02327169|536858568|FG009|Overall Study|Withdrawal by Subject|0|||
148830517|NCT02327169|536858569|FG010|Overall Study|Withdrawal by Subject|0|||
148830518|NCT02327169|536858570|FG011|Overall Study|Withdrawal by Subject|0|||
148830519|NCT02327169|536858571|FG012|Overall Study|Withdrawal by Subject|0|||
148830520|NCT02327169|536858572|FG013|Overall Study|Withdrawal by Subject|0|||
148830521|NCT02327169|536858573|FG014|Overall Study|Withdrawal by Subject|3|||
148980159|NCT01602315|537407873|FG004|Overall Study|Withdrawal by Subject|6|||
148980160|NCT01602315|537407874|FG005|Overall Study|Withdrawal by Subject|0|||
148980161|NCT01602315|537407875|FG006|Overall Study|Withdrawal by Subject|1|||
148980162|NCT01602315|537407869|FG000|Overall Study|Adverse Event|5|||
148980163|NCT01602315|537407870|FG001|Overall Study|Adverse Event|1|||
148980164|NCT01602315|537407871|FG002|Overall Study|Adverse Event|5|||
148980165|NCT01602315|537407872|FG003|Overall Study|Adverse Event|4|||
148980166|NCT01602315|537407873|FG004|Overall Study|Adverse Event|15|||
148830522|NCT02327169|536858559|FG000|Overall Study|Lost to Follow-up|0|||
148830523|NCT02327169|536858560|FG001|Overall Study|Lost to Follow-up|0|||
148830524|NCT02327169|536858561|FG002|Overall Study|Lost to Follow-up|0|||
148830525|NCT02327169|536858562|FG003|Overall Study|Lost to Follow-up|0|||
148830526|NCT02327169|536858563|FG004|Overall Study|Lost to Follow-up|1|||
148830527|NCT02327169|536858564|FG005|Overall Study|Lost to Follow-up|0|||
148830528|NCT02327169|536858565|FG006|Overall Study|Lost to Follow-up|0|||
148830529|NCT02327169|536858566|FG007|Overall Study|Lost to Follow-up|0|||
148830530|NCT02327169|536858567|FG008|Overall Study|Lost to Follow-up|0|||
148830531|NCT02327169|536858568|FG009|Overall Study|Lost to Follow-up|0|||
148980167|NCT01602315|537407874|FG005|Overall Study|Adverse Event|3|||
148830532|NCT02327169|536858569|FG010|Overall Study|Lost to Follow-up|0|||
148830533|NCT02327169|536858570|FG011|Overall Study|Lost to Follow-up|0|||
148830534|NCT02327169|536858571|FG012|Overall Study|Lost to Follow-up|0|||
148830535|NCT02327169|536858572|FG013|Overall Study|Lost to Follow-up|0|||
148830536|NCT02327169|536858573|FG014|Overall Study|Lost to Follow-up|0|||
148830537|NCT05473715|536858579|FG000|Overall Study|Trial terminate|2|||
148830538|NCT05473715|536858580|FG001|Overall Study|Trial terminate|1|||
148830539|NCT02592863|536858581|FG000|Overall Study|Withdrawal by Subject|2|||
148830540|NCT02592863|536858582|FG001|Overall Study|Withdrawal by Subject|2|||
148830541|NCT02592863|536858581|FG000|Overall Study|Lost to Follow-up|1|||
148830542|NCT02592863|536858582|FG001|Overall Study|Lost to Follow-up|1|||
148830543|NCT02743221|536858583|FG000|Overall Study|Progressive disease|29|||
148830544|NCT02743221|536858584|FG001|Overall Study|Progressive disease|38|||
148830545|NCT02743221|536858583|FG000|Overall Study|Adverse Event|17|||
148830546|NCT02743221|536858584|FG001|Overall Study|Adverse Event|14|||
148830547|NCT02743221|536858583|FG000|Overall Study|non medical reason|8|||
148830548|NCT02743221|536858584|FG001|Overall Study|non medical reason|2|||
148830549|NCT02743221|536858583|FG000|Overall Study|Physician Decision|2|||
148830550|NCT02743221|536858584|FG001|Overall Study|Physician Decision|5|||
148830551|NCT02743221|536858583|FG000|Overall Study|Patient not eligible, not treated|0|||
148830552|NCT02743221|536858584|FG001|Overall Study|Patient not eligible, not treated|1|||
148830553|NCT03528902|536858585|FG000|Overall Study|Adverse Event|1|||
148830554|NCT03528902|536858586|FG001|Overall Study|Adverse Event|0|||
148830555|NCT05889468|536858588|FG000|Overall Study|Lost to Follow-up|9|||
148830556|NCT05889468|536858589|FG001|Overall Study|Lost to Follow-up|2|||
148830557|NCT05889468|536858588|FG000|Overall Study|Withdrawal by Subject|2|||
148830558|NCT05889468|536858589|FG001|Overall Study|Withdrawal by Subject|2|||
148830559|NCT03900650|536858592|FG000|Overall Study|Withdrawal by Subject|1|||
148830560|NCT03900650|536858593|FG001|Overall Study|Withdrawal by Subject|1|||
148830561|NCT03900650|536858594|FG002|Overall Study|Withdrawal by Subject|0|||
148830562|NCT03900650|536858595|FG003|Overall Study|Withdrawal by Subject|0|||
148830563|NCT03900650|536858592|FG000|Overall Study|Withdrawn by staff|1|||
148830564|NCT03900650|536858593|FG001|Overall Study|Withdrawn by staff|0|||
148830565|NCT03900650|536858594|FG002|Overall Study|Withdrawn by staff|0|||
148830566|NCT03900650|536858595|FG003|Overall Study|Withdrawn by staff|0|||
148830567|NCT00427700|536858598|FG000|Overall Study|Lost to Follow-up|2|||
148830568|NCT00427700|536858599|FG001|Overall Study|Lost to Follow-up|5|||
148830569|NCT00427700|536858598|FG000|Overall Study|no induction of menses|1|||
148830570|NCT00427700|536858599|FG001|Overall Study|no induction of menses|4|||
148830571|NCT00427700|536858598|FG000|Overall Study|Pregnancy|0|||
148830572|NCT00427700|536858599|FG001|Overall Study|Pregnancy|2|||
148830573|NCT03038087|536858606|FG000|Overall Study|lost data|1|||
148830574|NCT02226653|536858613|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
148830575|NCT02226653|536858614|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
148830576|NCT02226653|536858613|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
148830577|NCT02226653|536858614|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
148830578|NCT00635050|536858615|FG000|Overall Study|Withdrawal by Subject|1|||
148830579|NCT00759395|536858616|FG000|Overall Study|Adverse Event|1|||
148830580|NCT00759395|536858617|FG001|Overall Study|Adverse Event|0|||
148830581|NCT00759395|536858616|FG000|Overall Study|Withdrawal by Subject|1|||
148830582|NCT00759395|536858617|FG001|Overall Study|Withdrawal by Subject|0|||
148830583|NCT00759395|536858616|FG000|Overall Study|Lack of Efficacy|0|||
148830584|NCT00759395|536858617|FG001|Overall Study|Lack of Efficacy|2|||
148830585|NCT01435356|536858618|FG000|Overall Study|Adverse Event|2|||
148830586|NCT01435356|536858619|FG001|Overall Study|Adverse Event|0|||
148830587|NCT01435356|536858618|FG000|Overall Study|Disease progression/recurrence|17|||
148830588|NCT01435356|536858619|FG001|Overall Study|Disease progression/recurrence|10|||
148830589|NCT01435356|536858618|FG000|Overall Study|Protocol Violation|0|||
148830590|NCT01435356|536858619|FG001|Overall Study|Protocol Violation|1|||
148830591|NCT01435356|536858618|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
148830592|NCT01435356|536858619|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
148830593|NCT01435356|536858618|FG000|Overall Study|Withdrawal by Subject|1|||
148830594|NCT01435356|536858619|FG001|Overall Study|Withdrawal by Subject|1|||
148830595|NCT01435356|536858618|FG000|Overall Study|Facial palsy|1|||
148830596|NCT01435356|536858619|FG001|Overall Study|Facial palsy|0|||
148830597|NCT01435356|536858618|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
148980168|NCT01602315|537407875|FG006|Overall Study|Adverse Event|9|||
148830598|NCT01435356|536858619|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
148830599|NCT01435356|536858618|FG000|Overall Study|Physician Decision|1|||
148830600|NCT01435356|536858619|FG001|Overall Study|Physician Decision|0|||
148830601|NCT01435356|536858618|FG000|Overall Study|Patient decision|3|||
148830602|NCT01435356|536858619|FG001|Overall Study|Patient decision|0|||
148830603|NCT01435356|536858618|FG000|Overall Study|Patient moved to another city|1|||
148830604|NCT01435356|536858619|FG001|Overall Study|Patient moved to another city|1|||
148830605|NCT00209131|536858623|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
148830606|NCT00209131|536858624|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
148830607|NCT01299961|536858626|FG000|Overall Study|Adverse Event|3|||
148830608|NCT01299961|536858626|FG000|Overall Study|Lack of Efficacy|2|||
148830609|NCT01299961|536858626|FG000|Overall Study|Lost to Follow-up|1|||
148830610|NCT02871219|536858629|FG000|Overall Study|Adverse Event|15|||
148830611|NCT02871219|536858629|FG000|Overall Study|Death|3|||
148830612|NCT02871219|536858629|FG000|Overall Study|Progression|3|||
148830613|NCT02871219|536858629|FG000|Overall Study|Infections|7|||
148830614|NCT02871219|536858629|FG000|Overall Study|Infusion Related|4|||
148830615|NCT05081843|536858630|FG000|Overall Study|Lost to Follow-up|135|||
148830616|NCT05081843|536858631|FG001|Overall Study|Lost to Follow-up|145|||
148830617|NCT03034044|536858632|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
148830618|NCT03709472|536858638|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
148830619|NCT03709472|536858639|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
148980169|NCT01602315|537407869|FG000|Overall Study|Subject/guardian decision|0|||
148830620|NCT03709472|536858638|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
148830621|NCT03709472|536858639|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
148830622|NCT03559556|536858640|FG000|Overall Study|Withdrawal by Subject|1|||
148830623|NCT01969058|536858642|FG000|Overall Study|Withdrawal by Subject|2|||
148830624|NCT01969058|536858643|FG001|Overall Study|Withdrawal by Subject|0|||
148830625|NCT01969058|536858642|FG000|Overall Study|Adverse Event|1|||
148830626|NCT01969058|536858643|FG001|Overall Study|Adverse Event|0|||
148830627|NCT02038036|536858649|FG000|Core Study|Adverse Event|7|||
148830628|NCT02038036|536858650|FG001|Core Study|Adverse Event|7|||
148830629|NCT02038036|536858649|FG000|Core Study|Death|1|||
148830630|NCT02038036|536858650|FG001|Core Study|Death|1|||
148830631|NCT02038036|536858649|FG000|Core Study|Disease progression|2|||
148830632|NCT02038036|536858650|FG001|Core Study|Disease progression|2|||
148830633|NCT02038036|536858649|FG000|Core Study|Lost to Follow-up|0|||
148830634|NCT02038036|536858650|FG001|Core Study|Lost to Follow-up|1|||
148830635|NCT02038036|536858649|FG000|Core Study|Physician Decision|2|||
148830636|NCT02038036|536858650|FG001|Core Study|Physician Decision|1|||
148830637|NCT02038036|536858649|FG000|Core Study|Subject/guardian decision|0|||
148830638|NCT02038036|536858650|FG001|Core Study|Subject/guardian decision|1|||
148830639|NCT02038036|536858649|FG000|Core Study|Withdrawal by Subject|3|||
148830640|NCT02038036|536858650|FG001|Core Study|Withdrawal by Subject|1|||
148830641|NCT02038036|536858649|FG000|Crossover Period|Withdrawal by Subject|0|||
148830642|NCT02038036|536858650|FG001|Crossover Period|Withdrawal by Subject|3|||
148830643|NCT02038036|536858649|FG000|Crossover Period|Adverse Event|0|||
148830644|NCT02038036|536858650|FG001|Crossover Period|Adverse Event|9|||
148830645|NCT02038036|536858649|FG000|Crossover Period|Death|0|||
148830646|NCT02038036|536858650|FG001|Crossover Period|Death|2|||
148830647|NCT02038036|536858649|FG000|Crossover Period|Disease progression|0|||
148830648|NCT02038036|536858650|FG001|Crossover Period|Disease progression|3|||
148830649|NCT02038036|536858649|FG000|Crossover Period|Lost to Follow-up|0|||
148830650|NCT02038036|536858650|FG001|Crossover Period|Lost to Follow-up|1|||
148830651|NCT02038036|536858649|FG000|Crossover Period|Physician Decision|0|||
148830652|NCT02038036|536858650|FG001|Crossover Period|Physician Decision|2|||
148830653|NCT00791648|536860216|FG000|Overall Study|Physician Decision|0|||
148830654|NCT00791648|536860217|FG001|Overall Study|Physician Decision|1|||
148830655|NCT00791648|536860216|FG000|Overall Study|Withdrawal by Subject|0|||
148830656|NCT00791648|536860217|FG001|Overall Study|Withdrawal by Subject|1|||
148830657|NCT03977155|536860218|FG000|Overall Study|Adverse Event|3|||
148830658|NCT03977155|536860219|FG001|Overall Study|Adverse Event|0|||
148830659|NCT03977155|536860220|FG002|Overall Study|Adverse Event|0|||
148830660|NCT03977155|536860218|FG000|Overall Study|Lost to Follow-up|0|||
148830661|NCT03977155|536860219|FG001|Overall Study|Lost to Follow-up|1|||
148830662|NCT03977155|536860220|FG002|Overall Study|Lost to Follow-up|0|||
148830663|NCT03977155|536860218|FG000|Overall Study|Withdrawal by Subject|1|||
148830664|NCT03977155|536860219|FG001|Overall Study|Withdrawal by Subject|1|||
148830665|NCT03977155|536860220|FG002|Overall Study|Withdrawal by Subject|2|||
148830666|NCT03977155|536860218|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
148980170|NCT01602315|537407870|FG001|Overall Study|Subject/guardian decision|0|||
148980171|NCT01602315|537407871|FG002|Overall Study|Subject/guardian decision|0|||
148980172|NCT01602315|537407872|FG003|Overall Study|Subject/guardian decision|0|||
148980173|NCT01602315|537407873|FG004|Overall Study|Subject/guardian decision|0|||
148980174|NCT01602315|537407874|FG005|Overall Study|Subject/guardian decision|0|||
148830667|NCT03977155|536860219|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
148830668|NCT03977155|536860220|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
148830669|NCT01373281|536860221|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
148830670|NCT01373281|536860222|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
148830671|NCT01373281|536860221|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
148830672|NCT01373281|536860222|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
148830673|NCT01373281|536860221|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
148830674|NCT01373281|536860222|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
148830675|NCT01373281|536860221|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
148830676|NCT01373281|536860222|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
148830677|NCT01373281|536860221|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
148830678|NCT01373281|536860222|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
148830679|NCT01373281|536860221|FG000|Surveillance Expansion Period|Protocol Violation|9|||
148830680|NCT01373281|536860222|FG001|Surveillance Expansion Period|Protocol Violation|1|||
148830681|NCT01373281|536860221|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
148830682|NCT01373281|536860222|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
148830683|NCT01373281|536860221|FG000|Surveillance Expansion Period|Serious adverse event|3|||
148830684|NCT01373281|536860222|FG001|Surveillance Expansion Period|Serious adverse event|4|||
148830685|NCT01397253|536860223|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
148830686|NCT01397253|536860224|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
148830687|NCT02296476|536860225|FG000|Overall Study|Disease Progression|6|||
148830688|NCT02296476|536860226|FG001|Overall Study|Disease Progression|4|||
148830689|NCT02296476|536860227|FG002|Overall Study|Disease Progression|2|||
148830690|NCT03502681|536860230|FG000|Overall Study|Adverse Event|1|||
148830691|NCT03502681|536860231|FG001|Overall Study|Adverse Event|1|||
148830692|NCT03502681|536860230|FG000|Overall Study|Disease Progression|2|||
148830693|NCT03502681|536860231|FG001|Overall Study|Disease Progression|1|||
148830694|NCT03552029|536860236|FG000|Overall Study|Death|3|||
148830695|NCT03552029|536860237|FG001|Overall Study|Death|0|||
148830696|NCT03552029|536860236|FG000|Overall Study|Adverse Event|1|||
148830697|NCT03552029|536860237|FG001|Overall Study|Adverse Event|0|||
148830698|NCT03552029|536860236|FG000|Overall Study|Lack of Efficacy|0|||
148830699|NCT03552029|536860237|FG001|Overall Study|Lack of Efficacy|2|||
148830700|NCT03552029|536860236|FG000|Overall Study|Physician Decision|0|||
148830701|NCT03552029|536860237|FG001|Overall Study|Physician Decision|1|||
148830702|NCT03552029|536860236|FG000|Overall Study|Study terminated by Sponsor|0|||
148830703|NCT03552029|536860237|FG001|Overall Study|Study terminated by Sponsor|1|||
148830704|NCT03552029|536860236|FG000|Overall Study|Other|0|||
148830705|NCT03552029|536860237|FG001|Overall Study|Other|2|||
148830706|NCT00836706|536860238|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
148830707|NCT00836706|536860239|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
148830708|NCT02989857|536860240|FG000|Randomization Phase|Not Treated|3|||
148830709|NCT02989857|536860241|FG001|Randomization Phase|Not Treated|2|||
148830710|NCT02989857|536860242|FG002|Randomization Phase|Not Treated|0|||
148830711|NCT00633126|536860243|FG000|Overall Study|Did not receive full dose|1|||
148830712|NCT00567502|536860252|FG000|Overall Study|Lost to Follow-up|91|||
148830713|NCT00567502|536860253|FG001|Overall Study|Lost to Follow-up|14|||
148830714|NCT00567502|536860254|FG002|Overall Study|Lost to Follow-up|351|||
148830715|NCT00567502|536860255|FG003|Overall Study|Lost to Follow-up|2|||
148830716|NCT00567502|536860252|FG000|Overall Study|Death|65|||
148830717|NCT00567502|536860253|FG001|Overall Study|Death|16|||
148830718|NCT00567502|536860254|FG002|Overall Study|Death|360|||
148830719|NCT00567502|536860255|FG003|Overall Study|Death|5|||
148830720|NCT00567502|536860252|FG000|Overall Study|Other|64|||
148830721|NCT00567502|536860253|FG001|Overall Study|Other|2|||
148830722|NCT00567502|536860254|FG002|Overall Study|Other|134|||
148830723|NCT00567502|536860255|FG003|Overall Study|Other|6|||
148830724|NCT00567502|536860252|FG000|Overall Study|Participant request|12|||
148830725|NCT00567502|536860253|FG001|Overall Study|Participant request|1|||
148830726|NCT00567502|536860254|FG002|Overall Study|Participant request|33|||
148830727|NCT00567502|536860255|FG003|Overall Study|Participant request|1|||
148830728|NCT00567502|536860252|FG000|Overall Study|Sponsor request|9|||
148830729|NCT00567502|536860253|FG001|Overall Study|Sponsor request|0|||
148830730|NCT00567502|536860254|FG002|Overall Study|Sponsor request|30|||
148830731|NCT00567502|536860255|FG003|Overall Study|Sponsor request|1|||
148830732|NCT00567502|536860252|FG000|Overall Study|Never Initiated Treatment|0|||
148830733|NCT00567502|536860253|FG001|Overall Study|Never Initiated Treatment|0|||
148830734|NCT00567502|536860254|FG002|Overall Study|Never Initiated Treatment|0|||
148830735|NCT00567502|536860255|FG003|Overall Study|Never Initiated Treatment|72|||
148830736|NCT02332928|536860257|FG000|Overall Study|Withdrawal by Subject|0|||
148830737|NCT02332928|536860258|FG001|Overall Study|Withdrawal by Subject|2|||
148830738|NCT02332928|536860257|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
148830739|NCT02332928|536860258|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
148830740|NCT04484857|536860259|FG000|Overall Study|Adverse Event|2|||
148830741|NCT04484857|536860259|FG000|Overall Study|Death|10|||
148830742|NCT04484857|536860259|FG000|Overall Study|Withdrawal by Subject|3|||
148830743|NCT04484857|536860259|FG000|Overall Study|Transferred/Relocation|5|||
148830744|NCT04484857|536860259|FG000|Overall Study|Kidney Transplant|7|||
148830745|NCT04484857|536860259|FG000|Overall Study|Other than specified|4|||
148830746|NCT04484857|536860259|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
148830747|NCT01425814|536860260|FG000|Period 1|Stability criteria not fulfilled|0|||
148830748|NCT01425814|536860261|FG001|Period 1|Stability criteria not fulfilled|1|||
148830749|NCT01425814|536860262|FG002|Period 1|Stability criteria not fulfilled|0|||
148830750|NCT01425814|536860263|FG003|Period 1|Stability criteria not fulfilled|0|||
148830751|NCT01425814|536860264|FG004|Period 1|Stability criteria not fulfilled|0|||
148830752|NCT01425814|536860265|FG005|Period 1|Stability criteria not fulfilled|0|||
148830753|NCT01425814|536860260|FG000|Period 2|Stability criteria not fulfilled|0|||
148830754|NCT01425814|536860261|FG001|Period 2|Stability criteria not fulfilled|1|||
148830755|NCT01425814|536860262|FG002|Period 2|Stability criteria not fulfilled|0|||
148830756|NCT01425814|536860263|FG003|Period 2|Stability criteria not fulfilled|0|||
148830757|NCT01425814|536860264|FG004|Period 2|Stability criteria not fulfilled|0|||
148830758|NCT01425814|536860265|FG005|Period 2|Stability criteria not fulfilled|0|||
148830759|NCT01425814|536860260|FG000|Period 3|Adverse Event|0|||
148830760|NCT01425814|536860261|FG001|Period 3|Adverse Event|0|||
148830761|NCT01425814|536860262|FG002|Period 3|Adverse Event|0|||
148830762|NCT01425814|536860263|FG003|Period 3|Adverse Event|0|||
148830763|NCT01425814|536860264|FG004|Period 3|Adverse Event|0|||
148830764|NCT01425814|536860265|FG005|Period 3|Adverse Event|1|||
148830765|NCT01425814|536860260|FG000|Period 4|Adverse Event|1|||
148830766|NCT01425814|536860261|FG001|Period 4|Adverse Event|0|||
148830767|NCT01425814|536860262|FG002|Period 4|Adverse Event|1|||
148830768|NCT01425814|536860263|FG003|Period 4|Adverse Event|0|||
148830769|NCT01425814|536860264|FG004|Period 4|Adverse Event|0|||
148830770|NCT01425814|536860265|FG005|Period 4|Adverse Event|0|||
148830771|NCT01425814|536860260|FG000|Period 5|Stability criteria not fulfilled|0|||
148830772|NCT01425814|536860261|FG001|Period 5|Stability criteria not fulfilled|0|||
148830773|NCT01425814|536860262|FG002|Period 5|Stability criteria not fulfilled|1|||
148830774|NCT01425814|536860263|FG003|Period 5|Stability criteria not fulfilled|0|||
148830775|NCT01425814|536860264|FG004|Period 5|Stability criteria not fulfilled|0|||
148830776|NCT01425814|536860265|FG005|Period 5|Stability criteria not fulfilled|1|||
148830777|NCT01905540|536860266|FG000|Period 3|Other|1|||
148830778|NCT01905540|536860267|FG001|Period 3|Other|0|||
148830779|NCT01905540|536860268|FG002|Period 3|Other|1|||
148830780|NCT01905540|536860269|FG003|Period 3|Other|1|||
148830781|NCT02743962|536860270|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
148830782|NCT02743962|536860271|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
148830783|NCT00725985|536860272|FG000|ITP- Treatment Disposition|Adverse Event|20|||
148830784|NCT00725985|536860273|FG001|ITP- Treatment Disposition|Adverse Event|10|||
148830785|NCT00725985|536860274|FG002|ITP- Treatment Disposition|Adverse Event|5|||
148830786|NCT00725985|536860275|FG003|ITP- Treatment Disposition|Adverse Event|0|||
148830787|NCT00725985|536860276|FG004|ITP- Treatment Disposition|Adverse Event|0|||
148830788|NCT00725985|536860277|FG005|ITP- Treatment Disposition|Adverse Event|0|||
148830789|NCT00725985|536860278|FG006|ITP- Treatment Disposition|Adverse Event|0|||
148830790|NCT00725985|536860279|FG007|ITP- Treatment Disposition|Adverse Event|0|||
148830791|NCT00725985|536860280|FG008|ITP- Treatment Disposition|Adverse Event|0|||
148830792|NCT00725985|536860281|FG009|ITP- Treatment Disposition|Adverse Event|0|||
148830793|NCT00725985|536860282|FG010|ITP- Treatment Disposition|Adverse Event|0|||
148830794|NCT00725985|536860283|FG011|ITP- Treatment Disposition|Adverse Event|0|||
148830795|NCT00725985|536860272|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830796|NCT00725985|536860273|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830797|NCT00725985|536860274|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
148830798|NCT00725985|536860275|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830799|NCT00725985|536860276|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830800|NCT00725985|536860277|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830801|NCT00725985|536860278|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830802|NCT00725985|536860279|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830803|NCT00725985|536860280|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830804|NCT00725985|536860281|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830805|NCT00725985|536860282|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830806|NCT00725985|536860283|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
148830807|NCT00725985|536860272|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
148830808|NCT00725985|536860273|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
148830809|NCT00725985|536860274|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
148830810|NCT00725985|536860275|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
148830811|NCT00725985|536860276|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
148830812|NCT00725985|536860277|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
148830813|NCT00725985|536860278|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
148830814|NCT00725985|536860279|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
148830815|NCT00725985|536860280|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
148830816|NCT00725985|536860281|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
148830817|NCT00725985|536860282|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
148830818|NCT00725985|536860283|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
148830819|NCT00725985|536860272|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
148830820|NCT00725985|536860273|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
148830821|NCT00725985|536860274|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
148830822|NCT00725985|536860275|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
148830823|NCT00725985|536860276|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
148830824|NCT00725985|536860277|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
148830825|NCT00725985|536860278|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
148830826|NCT00725985|536860279|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
148830827|NCT00725985|536860280|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
148830828|NCT00725985|536860281|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
148830829|NCT00725985|536860282|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
148980175|NCT01602315|537407875|FG006|Overall Study|Subject/guardian decision|1|||
148980176|NCT01602315|537407869|FG000|Overall Study|Cross-over patients to combo treatment|0|||
148980177|NCT01602315|537407870|FG001|Overall Study|Cross-over patients to combo treatment|0|||
148769250|NCT01943851|536629361|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769251|NCT01943851|536629362|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769252|NCT01943851|536629363|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769253|NCT01943851|536629364|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769254|NCT01943851|536629365|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769255|NCT01943851|536629366|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769256|NCT01943851|536629367|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769257|NCT01943851|536629368|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769258|NCT01943851|536629369|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769259|NCT01943851|536629370|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769260|NCT01943851|536629371|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
148769261|NCT01943851|536629372|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769262|NCT01943851|536629373|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769263|NCT01943851|536629374|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769264|NCT01943851|536629375|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
148769265|NCT01943851|536629358|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769266|NCT01943851|536629359|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769267|NCT01943851|536629360|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769268|NCT01943851|536629361|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769269|NCT01943851|536629362|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769270|NCT01943851|536629363|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769271|NCT01943851|536629364|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769272|NCT01943851|536629365|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769273|NCT01943851|536629366|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769274|NCT01943851|536629367|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769275|NCT01943851|536629368|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769276|NCT01943851|536629369|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769277|NCT01943851|536629370|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769278|NCT01943851|536629371|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769279|NCT01943851|536629372|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769280|NCT01943851|536629373|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
148769281|NCT01943851|536629374|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769282|NCT01943851|536629375|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
148769283|NCT01943851|536629358|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769284|NCT01943851|536629359|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769285|NCT01943851|536629360|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769286|NCT01943851|536629361|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769287|NCT01943851|536629362|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769288|NCT01943851|536629363|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769289|NCT01943851|536629364|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769290|NCT01943851|536629365|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769291|NCT01943851|536629366|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769292|NCT01943851|536629367|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769293|NCT01943851|536629368|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769294|NCT01943851|536629369|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769295|NCT01943851|536629370|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769296|NCT01943851|536629371|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769297|NCT01943851|536629372|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
148769298|NCT01943851|536629373|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
148769299|NCT01943851|536629374|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
148769300|NCT01943851|536629375|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
148769301|NCT00381238|536629386|FG000|Overall Study|Adverse Event|3|||
148769302|NCT00381238|536629386|FG000|Overall Study|Protocol Violation|1|||
148769303|NCT00381238|536629386|FG000|Overall Study|Withdrawal by Subject|4|||
148769304|NCT00381238|536629386|FG000|Overall Study|Lack of Efficacy|2|||
148769305|NCT00381238|536629386|FG000|Overall Study|Withdrew by physician|1|||
148769306|NCT00381238|536629386|FG000|Overall Study|Disease progression|1|||
148769307|NCT00843037|536629390|FG000|Overall Study|Lost to Follow-up|1|||
148769308|NCT00401544|536629393|FG000|Overall Study|Adverse Event|5|||
148769309|NCT00401544|536629394|FG001|Overall Study|Adverse Event|1|||
148769310|NCT00401544|536629395|FG002|Overall Study|Adverse Event|1|||
148769311|NCT00401544|536629396|FG003|Overall Study|Adverse Event|1|||
148769312|NCT00401544|536629393|FG000|Overall Study|Death|3|||
148769313|NCT00401544|536629394|FG001|Overall Study|Death|6|||
148769314|NCT00401544|536629395|FG002|Overall Study|Death|2|||
148769315|NCT00401544|536629396|FG003|Overall Study|Death|5|||
148769316|NCT00401544|536629393|FG000|Overall Study|Lost to Follow-up|2|||
148769317|NCT00401544|536629394|FG001|Overall Study|Lost to Follow-up|0|||
148769318|NCT00401544|536629395|FG002|Overall Study|Lost to Follow-up|1|||
148830830|NCT00725985|536860283|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
148830831|NCT00725985|536860272|FG000|ITP- Treatment Disposition|Other|50|||
148830832|NCT00725985|536860273|FG001|ITP- Treatment Disposition|Other|38|||
148830833|NCT00725985|536860274|FG002|ITP- Treatment Disposition|Other|24|||
148830834|NCT00725985|536860275|FG003|ITP- Treatment Disposition|Other|0|||
148830835|NCT00725985|536860276|FG004|ITP- Treatment Disposition|Other|0|||
148830836|NCT00725985|536860277|FG005|ITP- Treatment Disposition|Other|0|||
148830837|NCT00725985|536860278|FG006|ITP- Treatment Disposition|Other|0|||
148830838|NCT00725985|536860279|FG007|ITP- Treatment Disposition|Other|0|||
148830839|NCT00725985|536860280|FG008|ITP- Treatment Disposition|Other|0|||
148830840|NCT00725985|536860281|FG009|ITP- Treatment Disposition|Other|0|||
148830841|NCT00725985|536860282|FG010|ITP- Treatment Disposition|Other|0|||
148830842|NCT00725985|536860283|FG011|ITP- Treatment Disposition|Other|0|||
148830843|NCT00725985|536860272|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830844|NCT00725985|536860273|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830845|NCT00725985|536860274|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830846|NCT00725985|536860275|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
148830847|NCT00725985|536860276|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
148830848|NCT00725985|536860277|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
148830849|NCT00725985|536860278|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830850|NCT00725985|536860279|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830851|NCT00725985|536860280|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830852|NCT00725985|536860281|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830853|NCT00725985|536860282|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830854|NCT00725985|536860283|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
148830855|NCT00725985|536860272|FG000|OLMP (Up to 96 Weeks)|Death|0|||
148830856|NCT00725985|536860273|FG001|OLMP (Up to 96 Weeks)|Death|0|||
148830857|NCT00725985|536860274|FG002|OLMP (Up to 96 Weeks)|Death|0|||
148830858|NCT00725985|536860275|FG003|OLMP (Up to 96 Weeks)|Death|0|||
148830859|NCT00725985|536860276|FG004|OLMP (Up to 96 Weeks)|Death|1|||
148830860|NCT00725985|536860277|FG005|OLMP (Up to 96 Weeks)|Death|0|||
148830861|NCT00725985|536860278|FG006|OLMP (Up to 96 Weeks)|Death|0|||
148830862|NCT00725985|536860279|FG007|OLMP (Up to 96 Weeks)|Death|0|||
148830863|NCT00725985|536860280|FG008|OLMP (Up to 96 Weeks)|Death|0|||
148830864|NCT00725985|536860281|FG009|OLMP (Up to 96 Weeks)|Death|0|||
148830865|NCT00725985|536860282|FG010|OLMP (Up to 96 Weeks)|Death|0|||
148830866|NCT00725985|536860283|FG011|OLMP (Up to 96 Weeks)|Death|0|||
148830867|NCT00725985|536860272|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830868|NCT00725985|536860273|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830869|NCT00725985|536860274|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830870|NCT00725985|536860275|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
148830871|NCT00725985|536860276|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830872|NCT00725985|536860277|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830873|NCT00725985|536860278|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830874|NCT00725985|536860279|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830875|NCT00725985|536860280|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830876|NCT00725985|536860281|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830877|NCT00725985|536860282|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830878|NCT00725985|536860283|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
148830879|NCT00725985|536860272|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830880|NCT00725985|536860273|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830881|NCT00725985|536860274|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830882|NCT00725985|536860275|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830883|NCT00725985|536860276|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830884|NCT00725985|536860277|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
148830885|NCT00725985|536860278|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830886|NCT00725985|536860279|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830887|NCT00725985|536860280|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830888|NCT00725985|536860281|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830889|NCT00725985|536860282|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
148830890|NCT00725985|536860283|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
148980178|NCT01602315|537407871|FG002|Overall Study|Cross-over patients to combo treatment|0|||
148830891|NCT00725985|536860272|FG000|OLMP (Up to 96 Weeks)|Other|0|||
148830892|NCT00725985|536860273|FG001|OLMP (Up to 96 Weeks)|Other|0|||
148830893|NCT00725985|536860274|FG002|OLMP (Up to 96 Weeks)|Other|0|||
148980179|NCT01602315|537407872|FG003|Overall Study|Cross-over patients to combo treatment|0|||
148830894|NCT00725985|536860275|FG003|OLMP (Up to 96 Weeks)|Other|15|||
148980180|NCT01602315|537407873|FG004|Overall Study|Cross-over patients to combo treatment|0|||
148980181|NCT01602315|537407874|FG005|Overall Study|Cross-over patients to combo treatment|16|||
148980182|NCT01602315|537407875|FG006|Overall Study|Cross-over patients to combo treatment|0|||
148830895|NCT00725985|536860276|FG004|OLMP (Up to 96 Weeks)|Other|20|||
148830896|NCT00725985|536860277|FG005|OLMP (Up to 96 Weeks)|Other|44|||
148980183|NCT04193202|537407876|FG000|Overall Study|Adverse Event|2|||
148830897|NCT00725985|536860278|FG006|OLMP (Up to 96 Weeks)|Other|0|||
148830898|NCT00725985|536860279|FG007|OLMP (Up to 96 Weeks)|Other|0|||
148980184|NCT04193202|537407877|FG001|Overall Study|Adverse Event|1|||
148980185|NCT04193202|537407876|FG000|Overall Study|Death|0|||
148980186|NCT04193202|537407877|FG001|Overall Study|Death|1|||
148980187|NCT04193202|537407876|FG000|Overall Study|Physician Decision|1|||
148980188|NCT04193202|537407877|FG001|Overall Study|Physician Decision|1|||
148980189|NCT04193202|537407876|FG000|Overall Study|Protocol Violation|2|||
148980190|NCT04193202|537407877|FG001|Overall Study|Protocol Violation|2|||
148980191|NCT04193202|537407876|FG000|Overall Study|Withdrawal by Subject|11|||
148980192|NCT04193202|537407877|FG001|Overall Study|Withdrawal by Subject|5|||
148980193|NCT00961259|537407884|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
148980194|NCT00961259|537407885|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
148980195|NCT00961259|537407886|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
148980196|NCT01252251|537407889|FG000|Overall Study|Withdrawal by Subject|1|||
148980197|NCT01324024|537407890|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
148980198|NCT01324024|537407891|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148769319|NCT00401544|536629396|FG003|Overall Study|Lost to Follow-up|1|||
148769320|NCT00401544|536629393|FG000|Overall Study|Withdrawal by Subject|7|||
148769321|NCT00401544|536629394|FG001|Overall Study|Withdrawal by Subject|6|||
148769322|NCT00401544|536629395|FG002|Overall Study|Withdrawal by Subject|6|||
148769323|NCT00401544|536629396|FG003|Overall Study|Withdrawal by Subject|5|||
148769324|NCT00401544|536629393|FG000|Overall Study|Physician Decision|1|||
148769325|NCT00401544|536629394|FG001|Overall Study|Physician Decision|3|||
148769326|NCT00401544|536629395|FG002|Overall Study|Physician Decision|0|||
148769327|NCT00401544|536629396|FG003|Overall Study|Physician Decision|0|||
148769328|NCT00401544|536629393|FG000|Overall Study|Ineligibility determined|0|||
148769329|NCT00401544|536629394|FG001|Overall Study|Ineligibility determined|1|||
148769330|NCT00401544|536629395|FG002|Overall Study|Ineligibility determined|0|||
148769331|NCT00401544|536629396|FG003|Overall Study|Ineligibility determined|2|||
148769332|NCT00401544|536629393|FG000|Overall Study|Disease progression|0|||
148769333|NCT00401544|536629394|FG001|Overall Study|Disease progression|1|||
148769334|NCT00401544|536629395|FG002|Overall Study|Disease progression|0|||
148769335|NCT00401544|536629396|FG003|Overall Study|Disease progression|0|||
148769336|NCT00401544|536629393|FG000|Overall Study|Other|0|||
148769337|NCT00401544|536629394|FG001|Overall Study|Other|0|||
148769338|NCT00401544|536629395|FG002|Overall Study|Other|2|||
148769339|NCT00401544|536629396|FG003|Overall Study|Other|2|||
148769340|NCT04984278|536629397|FG000|Period 1|Withdrawal by Subject|1|||
148769341|NCT04984278|536629398|FG001|Period 1|Withdrawal by Subject|0|||
148769342|NCT04984278|536629397|FG000|Period 1|Other|0|||
148769343|NCT04984278|536629398|FG001|Period 1|Other|1|||
148769344|NCT04984278|536629397|FG000|Period 2|Adverse Event|1|||
148769345|NCT04984278|536629398|FG001|Period 2|Adverse Event|0|||
148769346|NCT04984278|536629397|FG000|Period 2|Other|0|||
148769347|NCT04984278|536629398|FG001|Period 2|Other|1|||
148769348|NCT03535194|536629399|FG000|Induction Period|Adverse Event|2|||
148769349|NCT03535194|536629400|FG001|Induction Period|Adverse Event|2|||
148769350|NCT03535194|536629401|FG002|Induction Period|Adverse Event|1|||
148769351|NCT03535194|536629402|FG003|Induction Period|Adverse Event|3|||
148769352|NCT03535194|536629403|FG004|Induction Period|Adverse Event|0|||
148769353|NCT03535194|536629399|FG000|Induction Period|Death|0|||
148769354|NCT03535194|536629400|FG001|Induction Period|Death|1|||
148769355|NCT03535194|536629401|FG002|Induction Period|Death|0|||
148769356|NCT03535194|536629402|FG003|Induction Period|Death|0|||
148769357|NCT03535194|536629403|FG004|Induction Period|Death|0|||
148769358|NCT03535194|536629399|FG000|Induction Period|Lack of Efficacy|1|||
148769359|NCT03535194|536629400|FG001|Induction Period|Lack of Efficacy|3|||
148769360|NCT03535194|536629401|FG002|Induction Period|Lack of Efficacy|2|||
148769361|NCT03535194|536629402|FG003|Induction Period|Lack of Efficacy|2|||
148769362|NCT03535194|536629403|FG004|Induction Period|Lack of Efficacy|0|||
148769363|NCT03535194|536629399|FG000|Induction Period|Lost to Follow-up|3|||
148769364|NCT03535194|536629400|FG001|Induction Period|Lost to Follow-up|5|||
148769365|NCT03535194|536629401|FG002|Induction Period|Lost to Follow-up|2|||
148769366|NCT03535194|536629402|FG003|Induction Period|Lost to Follow-up|3|||
148769367|NCT03535194|536629403|FG004|Induction Period|Lost to Follow-up|0|||
148769368|NCT03535194|536629399|FG000|Induction Period|Physician Decision|1|||
148769369|NCT03535194|536629400|FG001|Induction Period|Physician Decision|1|||
148769370|NCT03535194|536629401|FG002|Induction Period|Physician Decision|0|||
148769371|NCT03535194|536629402|FG003|Induction Period|Physician Decision|0|||
148769372|NCT03535194|536629403|FG004|Induction Period|Physician Decision|0|||
148769373|NCT03535194|536629399|FG000|Induction Period|Protocol Violation|1|||
148769374|NCT03535194|536629400|FG001|Induction Period|Protocol Violation|0|||
148769375|NCT03535194|536629401|FG002|Induction Period|Protocol Violation|0|||
148769376|NCT03535194|536629402|FG003|Induction Period|Protocol Violation|1|||
148769377|NCT03535194|536629403|FG004|Induction Period|Protocol Violation|0|||
148980199|NCT02691455|537407892|FG000|Overall Study|Withdrawal by Subject|1|||
149028017|NCT01257503|537580056|FG000|Overall Study|strep culture positive at enrollment|1|||
148769378|NCT03535194|536629399|FG000|Induction Period|Screen Failure|0|||
148769379|NCT03535194|536629400|FG001|Induction Period|Screen Failure|1|||
148769380|NCT03535194|536629401|FG002|Induction Period|Screen Failure|0|||
148769381|NCT03535194|536629402|FG003|Induction Period|Screen Failure|0|||
148980200|NCT02691455|537407893|FG001|Overall Study|Withdrawal by Subject|2|||
148830899|NCT00725985|536860280|FG008|OLMP (Up to 96 Weeks)|Other|0|||
148830900|NCT00725985|536860281|FG009|OLMP (Up to 96 Weeks)|Other|0|||
148830901|NCT00725985|536860282|FG010|OLMP (Up to 96 Weeks)|Other|0|||
148830902|NCT00725985|536860283|FG011|OLMP (Up to 96 Weeks)|Other|0|||
148830903|NCT00725985|536860272|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830904|NCT00725985|536860273|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830905|NCT00725985|536860274|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830906|NCT00725985|536860275|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830907|NCT00725985|536860276|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830908|NCT00725985|536860277|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830909|NCT00725985|536860278|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830910|NCT00725985|536860279|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
148830911|NCT00725985|536860280|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830912|NCT00725985|536860281|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830913|NCT00725985|536860282|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830914|NCT00725985|536860283|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
148830915|NCT00725985|536860272|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830916|NCT00725985|536860273|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830917|NCT00725985|536860274|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830918|NCT00725985|536860275|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830919|NCT00725985|536860276|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830920|NCT00725985|536860277|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830921|NCT00725985|536860278|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830922|NCT00725985|536860279|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830923|NCT00725985|536860280|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
148830924|NCT00725985|536860281|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830925|NCT00725985|536860282|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830926|NCT00725985|536860283|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
148830927|NCT00725985|536860272|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830928|NCT00725985|536860273|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830929|NCT00725985|536860274|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830930|NCT00725985|536860275|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830931|NCT00725985|536860276|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830932|NCT00725985|536860277|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830933|NCT00725985|536860278|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
148830934|NCT00725985|536860279|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
148830935|NCT00725985|536860280|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
148830936|NCT00725985|536860281|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830937|NCT00725985|536860282|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830938|NCT00725985|536860283|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
148830939|NCT00725985|536860272|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830940|NCT00725985|536860273|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830941|NCT00725985|536860274|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830942|NCT00725985|536860275|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830943|NCT00725985|536860276|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830944|NCT00725985|536860277|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830945|NCT00725985|536860278|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830946|NCT00725985|536860279|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830947|NCT00725985|536860280|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
148830948|NCT00725985|536860281|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
148830949|NCT00725985|536860282|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
148830950|NCT00725985|536860283|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
148830951|NCT02546323|536860284|FG000|Overall Study|Withdrawal by Subject|36|||
148830952|NCT02546323|536860285|FG001|Overall Study|Withdrawal by Subject|33|||
148830953|NCT02546323|536860284|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
148830954|NCT02546323|536860285|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
148830955|NCT02546323|536860284|FG000|Overall Study|Adverse Event|17|||
148830956|NCT02546323|536860285|FG001|Overall Study|Adverse Event|11|||
148830957|NCT02546323|536860284|FG000|Overall Study|Patient Specific Reasons|1|||
148769382|NCT03535194|536629403|FG004|Induction Period|Screen Failure|0|||
148769383|NCT03535194|536629399|FG000|Induction Period|Withdrawal by Subject|3|||
148769384|NCT03535194|536629400|FG001|Induction Period|Withdrawal by Subject|4|||
148769385|NCT03535194|536629401|FG002|Induction Period|Withdrawal by Subject|3|||
148769386|NCT03535194|536629402|FG003|Induction Period|Withdrawal by Subject|2|||
148769387|NCT03535194|536629403|FG004|Induction Period|Withdrawal by Subject|0|||
148769388|NCT03535194|536629399|FG000|Maintenance Period|Adverse Event|6|||
148769389|NCT03535194|536629400|FG001|Maintenance Period|Adverse Event|5|||
148769390|NCT03535194|536629401|FG002|Maintenance Period|Adverse Event|1|||
148769391|NCT03535194|536629402|FG003|Maintenance Period|Adverse Event|11|||
148769392|NCT03535194|536629403|FG004|Maintenance Period|Adverse Event|4|||
148769393|NCT03535194|536629399|FG000|Maintenance Period|Lack of Efficacy|3|||
148830958|NCT02546323|536860285|FG001|Overall Study|Patient Specific Reasons|2|||
148830959|NCT02546323|536860284|FG000|Overall Study|Lost to Follow-up|2|||
148830960|NCT02546323|536860285|FG001|Overall Study|Lost to Follow-up|3|||
148830961|NCT02546323|536860284|FG000|Overall Study|Non-compliance with Study Drug|2|||
148830962|NCT02546323|536860285|FG001|Overall Study|Non-compliance with Study Drug|2|||
148830963|NCT02546323|536860284|FG000|Overall Study|Met Withdrawal Criteria|2|||
148830964|NCT02546323|536860285|FG001|Overall Study|Met Withdrawal Criteria|14|||
148830965|NCT04476784|536860286|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
148830966|NCT04476784|536860287|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
148830967|NCT00478257|536860288|FG000|Overall Study|Withdrawal by Subject|8|||
148830968|NCT00478257|536860289|FG001|Overall Study|Withdrawal by Subject|3|||
148830969|NCT06582732|536860290|FG000|Initial Study Period|Adverse Event|0|||
148830970|NCT06582732|536860291|FG001|Initial Study Period|Adverse Event|0|||
148830971|NCT06582732|536860292|FG002|Initial Study Period|Adverse Event|0|||
148830972|NCT06582732|536860293|FG003|Initial Study Period|Adverse Event|2|||
148830973|NCT06582732|536860294|FG004|Initial Study Period|Adverse Event|0|||
148830974|NCT06582732|536860295|FG005|Initial Study Period|Adverse Event|0|||
148830975|NCT06582732|536860296|FG006|Initial Study Period|Adverse Event|0|||
148830976|NCT06582732|536860290|FG000|Initial Study Period|Death|1|||
148830977|NCT06582732|536860291|FG001|Initial Study Period|Death|0|||
148830978|NCT06582732|536860292|FG002|Initial Study Period|Death|0|||
148830979|NCT06582732|536860293|FG003|Initial Study Period|Death|0|||
148830980|NCT06582732|536860294|FG004|Initial Study Period|Death|1|||
148830981|NCT06582732|536860295|FG005|Initial Study Period|Death|0|||
148830982|NCT06582732|536860296|FG006|Initial Study Period|Death|0|||
148830983|NCT06582732|536860290|FG000|Initial Study Period|Lost to Follow-up|0|||
148830984|NCT06582732|536860291|FG001|Initial Study Period|Lost to Follow-up|0|||
148830985|NCT06582732|536860292|FG002|Initial Study Period|Lost to Follow-up|2|||
148830986|NCT06582732|536860293|FG003|Initial Study Period|Lost to Follow-up|0|||
148830987|NCT06582732|536860294|FG004|Initial Study Period|Lost to Follow-up|0|||
148830988|NCT06582732|536860295|FG005|Initial Study Period|Lost to Follow-up|0|||
148830989|NCT06582732|536860296|FG006|Initial Study Period|Lost to Follow-up|0|||
148830990|NCT06582732|536860290|FG000|Initial Study Period|Withdrawal by Subject|0|||
148830991|NCT06582732|536860291|FG001|Initial Study Period|Withdrawal by Subject|1|||
148830992|NCT06582732|536860292|FG002|Initial Study Period|Withdrawal by Subject|0|||
148830993|NCT06582732|536860293|FG003|Initial Study Period|Withdrawal by Subject|1|||
148830994|NCT06582732|536860294|FG004|Initial Study Period|Withdrawal by Subject|3|||
148830995|NCT06582732|536860295|FG005|Initial Study Period|Withdrawal by Subject|1|||
148830996|NCT06582732|536860296|FG006|Initial Study Period|Withdrawal by Subject|2|||
148830997|NCT06582732|536860290|FG000|Initial Study Period|Moved Away|0|||
148830998|NCT06582732|536860291|FG001|Initial Study Period|Moved Away|0|||
148830999|NCT06582732|536860292|FG002|Initial Study Period|Moved Away|0|||
148831000|NCT06582732|536860293|FG003|Initial Study Period|Moved Away|0|||
148831001|NCT06582732|536860294|FG004|Initial Study Period|Moved Away|1|||
148831002|NCT06582732|536860295|FG005|Initial Study Period|Moved Away|0|||
148831003|NCT06582732|536860296|FG006|Initial Study Period|Moved Away|0|||
148831004|NCT03931330|536860297|FG000|Overall Study|Physician Decision|1|||
148831005|NCT01182350|536860298|FG000|Overall Study|Adverse Event|5|||
148831006|NCT01182350|536860299|FG001|Overall Study|Adverse Event|0|||
148831007|NCT01182350|536860300|FG002|Overall Study|Adverse Event|0|||
148831008|NCT01182350|536860301|FG003|Overall Study|Adverse Event|0|||
148831009|NCT01182350|536860302|FG004|Overall Study|Adverse Event|0|||
148831010|NCT01182350|536860298|FG000|Overall Study|Disease Progression|15|||
148831011|NCT01182350|536860299|FG001|Overall Study|Disease Progression|12|||
148831012|NCT01182350|536860300|FG002|Overall Study|Disease Progression|0|||
148831013|NCT01182350|536860301|FG003|Overall Study|Disease Progression|1|||
148831014|NCT01182350|536860302|FG004|Overall Study|Disease Progression|0|||
148831015|NCT01182350|536860298|FG000|Overall Study|Death|0|||
148831016|NCT01182350|536860299|FG001|Overall Study|Death|1|||
148831017|NCT01182350|536860300|FG002|Overall Study|Death|1|||
148831018|NCT01182350|536860301|FG003|Overall Study|Death|0|||
148831019|NCT01182350|536860302|FG004|Overall Study|Death|0|||
148831020|NCT01182350|536860298|FG000|Overall Study|Withdrawal by Subject|3|||
148831021|NCT01182350|536860299|FG001|Overall Study|Withdrawal by Subject|1|||
148831022|NCT01182350|536860300|FG002|Overall Study|Withdrawal by Subject|0|||
148831023|NCT01182350|536860301|FG003|Overall Study|Withdrawal by Subject|1|||
148831024|NCT01182350|536860302|FG004|Overall Study|Withdrawal by Subject|0|||
148831025|NCT01182350|536860298|FG000|Overall Study|Alternative Therapy|2|||
148831026|NCT01182350|536860299|FG001|Overall Study|Alternative Therapy|0|||
148831027|NCT01182350|536860300|FG002|Overall Study|Alternative Therapy|1|||
148831028|NCT01182350|536860301|FG003|Overall Study|Alternative Therapy|0|||
148831029|NCT01182350|536860302|FG004|Overall Study|Alternative Therapy|0|||
148831030|NCT01182350|536860298|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
148831031|NCT01182350|536860299|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
148831032|NCT01182350|536860300|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
148980201|NCT02691455|537407892|FG000|Overall Study|Lost to Follow-up|15|||
148980202|NCT02691455|537407893|FG001|Overall Study|Lost to Follow-up|15|||
148980203|NCT02809976|537407894|FG000|Overall Study|Lost to Follow-up|1|||
148980204|NCT02809976|537407894|FG000|Overall Study|Withdrawal by Subject|1|||
148980205|NCT00211081|537407895|FG000|Overall Study|Withdrawal by Subject|2|||
148980206|NCT03755765|537407896|FG000|Overall Study|Withdrawal by Subject|2|||
148980207|NCT03755765|537407897|FG001|Overall Study|Withdrawal by Subject|4|||
148980208|NCT03755765|537407898|FG002|Overall Study|Withdrawal by Subject|4|||
148980209|NCT02104557|537407899|FG000|Overall Study|Adverse Event|24|||
148980210|NCT02104557|537407899|FG000|Overall Study|Lost to Follow-up|34|||
148980211|NCT02104557|537407899|FG000|Overall Study|Violated the usage and dosage|14|||
148980212|NCT02104557|537407899|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
148769394|NCT03535194|536629400|FG001|Maintenance Period|Lack of Efficacy|2|||
148769395|NCT03535194|536629401|FG002|Maintenance Period|Lack of Efficacy|5|||
148769396|NCT03535194|536629402|FG003|Maintenance Period|Lack of Efficacy|9|||
148769397|NCT03535194|536629403|FG004|Maintenance Period|Lack of Efficacy|0|||
148769398|NCT03535194|536629399|FG000|Maintenance Period|Lost to Follow-up|4|||
148769399|NCT03535194|536629400|FG001|Maintenance Period|Lost to Follow-up|2|||
148769400|NCT03535194|536629401|FG002|Maintenance Period|Lost to Follow-up|1|||
148769401|NCT03535194|536629402|FG003|Maintenance Period|Lost to Follow-up|5|||
148769402|NCT03535194|536629403|FG004|Maintenance Period|Lost to Follow-up|2|||
148769403|NCT03535194|536629399|FG000|Maintenance Period|Other|1|||
148769404|NCT03535194|536629400|FG001|Maintenance Period|Other|2|||
148769405|NCT03535194|536629401|FG002|Maintenance Period|Other|0|||
148769406|NCT03535194|536629402|FG003|Maintenance Period|Other|0|||
148769407|NCT03535194|536629403|FG004|Maintenance Period|Other|0|||
148769408|NCT03535194|536629399|FG000|Maintenance Period|Physician Decision|1|||
148769409|NCT03535194|536629400|FG001|Maintenance Period|Physician Decision|2|||
148769410|NCT03535194|536629401|FG002|Maintenance Period|Physician Decision|0|||
148769411|NCT03535194|536629402|FG003|Maintenance Period|Physician Decision|2|||
148769412|NCT03535194|536629403|FG004|Maintenance Period|Physician Decision|0|||
148769413|NCT03535194|536629399|FG000|Maintenance Period|Pregnancy|0|||
148769414|NCT03535194|536629400|FG001|Maintenance Period|Pregnancy|0|||
148769415|NCT03535194|536629401|FG002|Maintenance Period|Pregnancy|0|||
148769416|NCT03535194|536629402|FG003|Maintenance Period|Pregnancy|2|||
148769417|NCT03535194|536629403|FG004|Maintenance Period|Pregnancy|0|||
148769418|NCT03535194|536629399|FG000|Maintenance Period|Protocol Violation|0|||
148769419|NCT03535194|536629400|FG001|Maintenance Period|Protocol Violation|1|||
148769420|NCT03535194|536629401|FG002|Maintenance Period|Protocol Violation|0|||
148769421|NCT03535194|536629402|FG003|Maintenance Period|Protocol Violation|0|||
148769422|NCT03535194|536629403|FG004|Maintenance Period|Protocol Violation|0|||
148769423|NCT03535194|536629399|FG000|Maintenance Period|Withdrawal by Subject|7|||
148769424|NCT03535194|536629400|FG001|Maintenance Period|Withdrawal by Subject|2|||
148769425|NCT03535194|536629401|FG002|Maintenance Period|Withdrawal by Subject|1|||
148769426|NCT03535194|536629402|FG003|Maintenance Period|Withdrawal by Subject|8|||
148769427|NCT03535194|536629403|FG004|Maintenance Period|Withdrawal by Subject|0|||
148769428|NCT03535194|536629399|FG000|Post-Treatment Followup Period|Adverse Event|4|||
148769429|NCT03535194|536629400|FG001|Post-Treatment Followup Period|Adverse Event|5|||
148769430|NCT03535194|536629401|FG002|Post-Treatment Followup Period|Adverse Event|1|||
148769431|NCT03535194|536629402|FG003|Post-Treatment Followup Period|Adverse Event|8|||
148769432|NCT03535194|536629403|FG004|Post-Treatment Followup Period|Adverse Event|0|||
148769433|NCT03535194|536629399|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
148769434|NCT03535194|536629400|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
148769435|NCT03535194|536629401|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
148769436|NCT03535194|536629402|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
148769437|NCT03535194|536629403|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
148769438|NCT03535194|536629399|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
148769439|NCT03535194|536629400|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
148769440|NCT03535194|536629401|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
148769441|NCT03535194|536629402|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
148769442|NCT03535194|536629403|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
148769443|NCT03535194|536629399|FG000|Post-Treatment Followup Period|Other|1|||
148769444|NCT03535194|536629400|FG001|Post-Treatment Followup Period|Other|0|||
148769445|NCT03535194|536629401|FG002|Post-Treatment Followup Period|Other|0|||
148769446|NCT03535194|536629402|FG003|Post-Treatment Followup Period|Other|5|||
148769447|NCT03535194|536629403|FG004|Post-Treatment Followup Period|Other|0|||
148769448|NCT03535194|536629399|FG000|Post-Treatment Followup Period|Physician Decision|0|||
148769449|NCT03535194|536629400|FG001|Post-Treatment Followup Period|Physician Decision|2|||
148769450|NCT03535194|536629401|FG002|Post-Treatment Followup Period|Physician Decision|1|||
148980213|NCT02104557|537407899|FG000|Overall Study|Administered Sayana prior to the contract|1|||
148980214|NCT02104557|537407899|FG000|Overall Study|Other|17|||
148769451|NCT03535194|536629402|FG003|Post-Treatment Followup Period|Physician Decision|1|||
148769452|NCT03535194|536629403|FG004|Post-Treatment Followup Period|Physician Decision|0|||
148769453|NCT03535194|536629399|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
148769454|NCT03535194|536629400|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
148769455|NCT03535194|536629401|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
148980215|NCT02104557|537407899|FG000|Overall Study|Change to other contraception methods|5|||
148980216|NCT02104557|537407899|FG000|Overall Study|Discontinuation due to no pain|1|||
148980217|NCT02104557|537407899|FG000|Overall Study|Withdrawal consent|2|||
148980218|NCT02104557|537407899|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
148980219|NCT02104557|537407899|FG000|Overall Study|Discontinuation of contraception|9|||
148980220|NCT01158222|537407903|FG000|Overall Study|Not eligible for intermediate phase|17|||
148980221|NCT00111228|537407906|FG000|Overall Study|Withdrawal by Subject|5|||
148980222|NCT00111228|537407907|FG001|Overall Study|Withdrawal by Subject|1|||
148980223|NCT00111228|537407908|FG002|Overall Study|Withdrawal by Subject|0|||
148980224|NCT02863354|537407911|FG000|Year 1|Lost to Follow-up|1|||
148980225|NCT02863354|537407912|FG001|Year 1|Lost to Follow-up|1|||
148980226|NCT02863354|537407911|FG000|Year 1|Withdrawal by Subject|3|||
148980227|NCT02863354|537407912|FG001|Year 1|Withdrawal by Subject|0|||
148980228|NCT02863354|537407911|FG000|Year 1|Death|0|||
148980229|NCT02863354|537407912|FG001|Year 1|Death|1|||
148980230|NCT02863354|537407911|FG000|Year 2|Lost to Follow-up|2|||
148980231|NCT02863354|537407912|FG001|Year 2|Lost to Follow-up|2|||
148980232|NCT00724451|537407916|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
148980233|NCT00724451|537407916|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
148980234|NCT00724451|537407916|FG000|Overall Study|Not Eligible for Treatment|431|||
148980235|NCT00724451|537407916|FG000|Overall Study|Participant Refused Treatment|89|||
148980236|NCT00724451|537407916|FG000|Overall Study|Never Started Treatment|89|||
148980237|NCT00724451|537407916|FG000|Overall Study|Unknown; No Data Sources Available|9|||
148980238|NCT00724451|537407916|FG000|Overall Study|Physician Decision|116|||
148980239|NCT00724451|537407916|FG000|Overall Study|Withdrawal by Subject|45|||
148980240|NCT00724451|537407916|FG000|Overall Study|Investigator + Participant Decision|13|||
148980241|NCT01599650|537407917|FG000|Overall Study|Administrative issue|1|||
148980242|NCT01599650|537407918|FG001|Overall Study|Administrative issue|0|||
148980243|NCT01599650|537407919|FG002|Overall Study|Administrative issue|1|||
148980244|NCT01599650|537407917|FG000|Overall Study|Physician Decision|2|||
148980245|NCT01599650|537407918|FG001|Overall Study|Physician Decision|0|||
148980246|NCT01599650|537407919|FG002|Overall Study|Physician Decision|7|||
148980247|NCT01599650|537407917|FG000|Overall Study|Protocol Violation|0|||
148980248|NCT01599650|537407918|FG001|Overall Study|Protocol Violation|3|||
148980249|NCT01599650|537407919|FG002|Overall Study|Protocol Violation|0|||
148980250|NCT01599650|537407917|FG000|Overall Study|Death|2|||
148980251|NCT01599650|537407918|FG001|Overall Study|Death|1|||
148980252|NCT01599650|537407919|FG002|Overall Study|Death|2|||
148980253|NCT01599650|537407917|FG000|Overall Study|Lost to Follow-up|3|||
148980254|NCT01599650|537407918|FG001|Overall Study|Lost to Follow-up|3|||
148980255|NCT01599650|537407919|FG002|Overall Study|Lost to Follow-up|3|||
148980256|NCT01599650|537407917|FG000|Overall Study|Withdrawal by Subject|11|||
148980257|NCT01599650|537407918|FG001|Overall Study|Withdrawal by Subject|11|||
148980258|NCT01599650|537407919|FG002|Overall Study|Withdrawal by Subject|10|||
148769456|NCT03535194|536629402|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
148769457|NCT03535194|536629403|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148769458|NCT01289639|536629406|FG000|Overall Study|Lost to Follow-up|1|||
148769459|NCT01289639|536629407|FG001|Overall Study|Lost to Follow-up|0|||
148769460|NCT01289639|536629408|FG002|Overall Study|Lost to Follow-up|0|||
148769461|NCT03991299|536629409|FG000|Overall Study|Study closed, sponsor decision|3|||
148769462|NCT03991299|536629409|FG000|Overall Study|Withdrawal by Subject|1|||
148769463|NCT04304235|536629410|FG000|Overall Study|incomplete triage data|0|||
148769464|NCT04304235|536629411|FG001|Overall Study|incomplete triage data|69|||
148769465|NCT04304235|536629412|FG002|Overall Study|incomplete triage data|0|||
148769466|NCT04304235|536629413|FG003|Overall Study|incomplete triage data|0|||
148769467|NCT04304235|536629414|FG004|Overall Study|incomplete triage data|289|||
148769468|NCT04304235|536629415|FG005|Overall Study|incomplete triage data|123|||
148769469|NCT04304235|536629416|FG006|Overall Study|incomplete triage data|65|||
148769470|NCT00425061|536629417|FG000|Overall Study|Adverse Event|1|||
148769471|NCT00425061|536629418|FG001|Overall Study|Adverse Event|0|||
148769472|NCT00425061|536629419|FG002|Overall Study|Adverse Event|0|||
148769473|NCT00425061|536629420|FG003|Overall Study|Adverse Event|2|||
148769474|NCT00425061|536629421|FG004|Overall Study|Adverse Event|2|||
148769475|NCT00425061|536629422|FG005|Overall Study|Adverse Event|0|||
148769476|NCT00425061|536629423|FG006|Overall Study|Adverse Event|0|||
148769477|NCT00425061|536629417|FG000|Overall Study|Lost to Follow-up|0|||
148769478|NCT00425061|536629418|FG001|Overall Study|Lost to Follow-up|1|||
148980259|NCT01599650|537407917|FG000|Overall Study|Adverse Event|3|||
148980260|NCT01599650|537407918|FG001|Overall Study|Adverse Event|8|||
148980261|NCT01599650|537407919|FG002|Overall Study|Adverse Event|4|||
148769479|NCT00425061|536629419|FG002|Overall Study|Lost to Follow-up|0|||
148769480|NCT00425061|536629420|FG003|Overall Study|Lost to Follow-up|0|||
148769481|NCT00425061|536629421|FG004|Overall Study|Lost to Follow-up|0|||
148769482|NCT00425061|536629422|FG005|Overall Study|Lost to Follow-up|0|||
148769483|NCT00425061|536629423|FG006|Overall Study|Lost to Follow-up|0|||
148980262|NCT00720876|537407920|FG000|Overall Study|found to be ineligible after starting tx|2|||
148980263|NCT03304379|537407922|FG000|Overall Study|Protocol Violation|8|||
148980264|NCT03304379|537407923|FG001|Overall Study|Protocol Violation|10|||
148831033|NCT01182350|536860301|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
148831034|NCT01182350|536860302|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
148980265|NCT03304379|537407924|FG002|Overall Study|Protocol Violation|5|||
148980266|NCT03304379|537407925|FG003|Overall Study|Protocol Violation|0|||
148980267|NCT03304379|537407926|FG004|Overall Study|Protocol Violation|2|||
148980268|NCT03304379|537407922|FG000|Overall Study|Adverse Event|4|||
148980269|NCT03304379|537407923|FG001|Overall Study|Adverse Event|20|||
148980270|NCT03304379|537407924|FG002|Overall Study|Adverse Event|17|||
148980271|NCT03304379|537407925|FG003|Overall Study|Adverse Event|1|||
148980272|NCT03304379|537407926|FG004|Overall Study|Adverse Event|0|||
148980273|NCT03304379|537407922|FG000|Overall Study|Lack of Efficacy|17|||
148980274|NCT03304379|537407923|FG001|Overall Study|Lack of Efficacy|16|||
148980275|NCT03304379|537407924|FG002|Overall Study|Lack of Efficacy|20|||
148980276|NCT03304379|537407925|FG003|Overall Study|Lack of Efficacy|0|||
148980277|NCT03304379|537407926|FG004|Overall Study|Lack of Efficacy|0|||
148980278|NCT03304379|537407922|FG000|Overall Study|Physician Decision|6|||
148980279|NCT03304379|537407923|FG001|Overall Study|Physician Decision|10|||
148980280|NCT03304379|537407924|FG002|Overall Study|Physician Decision|6|||
148980281|NCT03304379|537407925|FG003|Overall Study|Physician Decision|9|||
148980282|NCT03304379|537407926|FG004|Overall Study|Physician Decision|10|||
148980283|NCT03304379|537407922|FG000|Overall Study|Withdrawal by Subject|26|||
148980284|NCT03304379|537407923|FG001|Overall Study|Withdrawal by Subject|58|||
148980285|NCT03304379|537407924|FG002|Overall Study|Withdrawal by Subject|66|||
148980286|NCT03304379|537407925|FG003|Overall Study|Withdrawal by Subject|3|||
148980287|NCT03304379|537407926|FG004|Overall Study|Withdrawal by Subject|5|||
148980288|NCT03304379|537407922|FG000|Overall Study|Lost to Follow-up|8|||
148980289|NCT03304379|537407923|FG001|Overall Study|Lost to Follow-up|24|||
148980290|NCT03304379|537407924|FG002|Overall Study|Lost to Follow-up|35|||
148980291|NCT03304379|537407925|FG003|Overall Study|Lost to Follow-up|4|||
148980292|NCT03304379|537407926|FG004|Overall Study|Lost to Follow-up|0|||
148980293|NCT03304379|537407922|FG000|Overall Study|Death|1|||
148980294|NCT03304379|537407923|FG001|Overall Study|Death|2|||
148980295|NCT03304379|537407924|FG002|Overall Study|Death|0|||
148980296|NCT03304379|537407925|FG003|Overall Study|Death|0|||
148980297|NCT03304379|537407926|FG004|Overall Study|Death|0|||
148980298|NCT03304379|537407922|FG000|Overall Study|Other|0|||
148980299|NCT03304379|537407923|FG001|Overall Study|Other|1|||
148980300|NCT03304379|537407924|FG002|Overall Study|Other|0|||
148980301|NCT03304379|537407925|FG003|Overall Study|Other|0|||
148980302|NCT03304379|537407926|FG004|Overall Study|Other|0|||
148980303|NCT02520531|537407943|FG000|Overall Study|Revision of study device components|2|||
148980304|NCT02520531|537407944|FG001|Overall Study|Revision of study device components|2|||
148980305|NCT02520531|537407943|FG000|Overall Study|Death|1|||
148831035|NCT01182350|536860298|FG000|Overall Study|Unevaluable for Biopsy|0|||
148831036|NCT01182350|536860299|FG001|Overall Study|Unevaluable for Biopsy|0|||
148831037|NCT01182350|536860300|FG002|Overall Study|Unevaluable for Biopsy|0|||
148831038|NCT01182350|536860301|FG003|Overall Study|Unevaluable for Biopsy|0|||
148831039|NCT01182350|536860302|FG004|Overall Study|Unevaluable for Biopsy|3|||
148831040|NCT02919618|536860307|FG000|Overall Study|Death|1|||
148831041|NCT03559530|536860308|FG000|Overall Study|non-location of medical records|44|||
148831042|NCT03559530|536860309|FG001|Overall Study|non-location of medical records|0|||
148831043|NCT03559530|536860308|FG000|Overall Study|culture results not considered for treat|29|||
148831044|NCT03559530|536860309|FG001|Overall Study|culture results not considered for treat|0|||
148831045|NCT03559530|536860308|FG000|Overall Study|duplicate cases|8|||
148831046|NCT03559530|536860309|FG001|Overall Study|duplicate cases|0|||
148831047|NCT03559530|536860308|FG000|Overall Study|other species of Acinetobacte|7|||
148831048|NCT03559530|536860309|FG001|Overall Study|other species of Acinetobacte|0|||
148980306|NCT02520531|537407944|FG001|Overall Study|Death|2|||
148980307|NCT02520531|537407943|FG000|Overall Study|Lost to Follow-up|1|||
148980308|NCT02520531|537407944|FG001|Overall Study|Lost to Follow-up|1|||
148831049|NCT03559530|536860308|FG000|Overall Study|contamination / colonization|3|||
148831050|NCT03559530|536860309|FG001|Overall Study|contamination / colonization|0|||
148831051|NCT00023595|536860312|FG000|5 Year Follow up|Lost to Follow-up|2|||
148831052|NCT00023595|536860313|FG001|5 Year Follow up|Lost to Follow-up|2|||
148831053|NCT00023595|536860314|FG002|5 Year Follow up|Lost to Follow-up|1|||
148980309|NCT02520531|537407943|FG000|Overall Study|Meet exclusion criterion|0|||
148980310|NCT02520531|537407944|FG001|Overall Study|Meet exclusion criterion|1|||
148980311|NCT02520531|537407943|FG000|Overall Study|Withdrawal by Subject|1|||
148831054|NCT00023595|536860315|FG003|5 Year Follow up|Lost to Follow-up|7|||
148980312|NCT02520531|537407944|FG001|Overall Study|Withdrawal by Subject|0|||
148831055|NCT00023595|536860316|FG004|5 Year Follow up|Lost to Follow-up|3|||
148831056|NCT00023595|536860312|FG000|10 Year Follow up|Lost to Follow-up|12|||
148980313|NCT02520531|537407943|FG000|Overall Study|Not study device|1|||
148831057|NCT00023595|536860313|FG001|10 Year Follow up|Lost to Follow-up|10|||
148980314|NCT02520531|537407944|FG001|Overall Study|Not study device|0|||
148980315|NCT01723904|537407945|FG000|Overall Study|Noncompliant|3|||
148980316|NCT01723904|537407945|FG000|Overall Study|Adverse Event|5|||
148980317|NCT01723904|537407945|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
148769484|NCT00425061|536629417|FG000|Overall Study|Protocol Violation|1|||
148769485|NCT00425061|536629418|FG001|Overall Study|Protocol Violation|0|||
148769486|NCT00425061|536629419|FG002|Overall Study|Protocol Violation|0|||
148769487|NCT00425061|536629420|FG003|Overall Study|Protocol Violation|0|||
148769488|NCT00425061|536629421|FG004|Overall Study|Protocol Violation|0|||
148769489|NCT00425061|536629422|FG005|Overall Study|Protocol Violation|0|||
148769490|NCT00425061|536629423|FG006|Overall Study|Protocol Violation|0|||
148769491|NCT00425061|536629417|FG000|Overall Study|Withdrawal by Subject|0|||
148769492|NCT00425061|536629418|FG001|Overall Study|Withdrawal by Subject|1|||
148769493|NCT00425061|536629419|FG002|Overall Study|Withdrawal by Subject|0|||
148769494|NCT00425061|536629420|FG003|Overall Study|Withdrawal by Subject|0|||
148769495|NCT00425061|536629421|FG004|Overall Study|Withdrawal by Subject|1|||
148769496|NCT00425061|536629422|FG005|Overall Study|Withdrawal by Subject|0|||
148769497|NCT00425061|536629423|FG006|Overall Study|Withdrawal by Subject|3|||
148769498|NCT00425061|536629417|FG000|Overall Study|Sponsor's request|0|||
148769499|NCT00425061|536629418|FG001|Overall Study|Sponsor's request|0|||
148769500|NCT00425061|536629419|FG002|Overall Study|Sponsor's request|0|||
148769501|NCT00425061|536629420|FG003|Overall Study|Sponsor's request|0|||
148769502|NCT00425061|536629421|FG004|Overall Study|Sponsor's request|19|||
148769503|NCT00425061|536629422|FG005|Overall Study|Sponsor's request|4|||
148769504|NCT00425061|536629423|FG006|Overall Study|Sponsor's request|15|||
148769505|NCT00425061|536629417|FG000|Overall Study|Physician Decision|0|||
148769506|NCT00425061|536629418|FG001|Overall Study|Physician Decision|0|||
148769507|NCT00425061|536629419|FG002|Overall Study|Physician Decision|0|||
148769508|NCT00425061|536629420|FG003|Overall Study|Physician Decision|0|||
148769509|NCT00425061|536629421|FG004|Overall Study|Physician Decision|1|||
148769510|NCT00425061|536629422|FG005|Overall Study|Physician Decision|0|||
148769511|NCT00425061|536629423|FG006|Overall Study|Physician Decision|0|||
148769512|NCT00425061|536629417|FG000|Overall Study|Other|0|||
148769513|NCT00425061|536629418|FG001|Overall Study|Other|0|||
148769514|NCT00425061|536629419|FG002|Overall Study|Other|0|||
148769515|NCT00425061|536629420|FG003|Overall Study|Other|0|||
148769516|NCT00425061|536629421|FG004|Overall Study|Other|3|||
148769517|NCT00425061|536629422|FG005|Overall Study|Other|0|||
148769518|NCT00425061|536629423|FG006|Overall Study|Other|1|||
148769519|NCT03436693|536629424|FG000|Overall Study|Adverse Event|22|||
148769520|NCT03436693|536629425|FG001|Overall Study|Adverse Event|10|||
148769521|NCT03436693|536629424|FG000|Overall Study|Physician Decision|3|||
148769522|NCT03436693|536629425|FG001|Overall Study|Physician Decision|3|||
148769523|NCT03436693|536629424|FG000|Overall Study|Withdrawal by Subject|4|||
148769524|NCT03436693|536629425|FG001|Overall Study|Withdrawal by Subject|13|||
148769525|NCT03436693|536629424|FG000|Overall Study|Progressive Disease|1|||
148769526|NCT03436693|536629425|FG001|Overall Study|Progressive Disease|1|||
148769527|NCT04967885|536629426|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
148769528|NCT04967885|536629427|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
148769529|NCT04967885|536629426|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
148769530|NCT04967885|536629427|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
148769531|NCT04967885|536629426|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
148769532|NCT04967885|536629427|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
148769533|NCT04967885|536629426|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
148769534|NCT04967885|536629427|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
148769535|NCT04967885|536629426|FG000|EMI-II Intervention|Lost to Follow-up|14|||
148769536|NCT04967885|536629427|FG001|EMI-II Intervention|Lost to Follow-up|10|||
148769537|NCT00723008|536629428|FG000|Enrollment|Lost to Follow-up|1|||
148769538|NCT00723008|536629429|FG001|Enrollment|Lost to Follow-up|0|||
148769539|NCT00723008|536629428|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
148769540|NCT00723008|536629429|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
148769541|NCT00723008|536629428|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
148769542|NCT00723008|536629429|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
148769543|NCT00723008|536629428|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
148769544|NCT00723008|536629429|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
148769545|NCT00723008|536629428|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
148769546|NCT00723008|536629429|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
148769547|NCT00723008|536629428|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
148769548|NCT00723008|536629429|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
148769549|NCT05835011|536629430|FG000|Overall Study|Study Terminated by the Sponsor|1|||
148769550|NCT05835011|536629430|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
148769551|NCT01867710|536629435|FG000|Overall Study|Death|25|||
148769552|NCT01867710|536629436|FG001|Overall Study|Death|15|||
148769553|NCT01867710|536629437|FG002|Overall Study|Death|27|||
148769554|NCT01867710|536629438|FG003|Overall Study|Death|20|||
148769555|NCT01867710|536629435|FG000|Overall Study|Lost to Follow-up|3|||
148769556|NCT01867710|536629436|FG001|Overall Study|Lost to Follow-up|4|||
148769557|NCT01867710|536629437|FG002|Overall Study|Lost to Follow-up|3|||
148769558|NCT01867710|536629438|FG003|Overall Study|Lost to Follow-up|2|||
148769559|NCT01867710|536629435|FG000|Overall Study|Withdrawal of consent|2|||
148769560|NCT01867710|536629436|FG001|Overall Study|Withdrawal of consent|5|||
148769561|NCT01867710|536629437|FG002|Overall Study|Withdrawal of consent|1|||
148769562|NCT01867710|536629438|FG003|Overall Study|Withdrawal of consent|2|||
149028018|NCT01257503|537580057|FG001|Overall Study|strep culture positive at enrollment|0|||
149028019|NCT00088465|537580062|FG000|Overall Study|Withdrawal by Subject|290|||
149028020|NCT00088465|537580062|FG000|Overall Study|Adverse Event|77|||
149028021|NCT00088465|537580062|FG000|Overall Study|Lost to Follow-up|57|||
149028022|NCT00088465|537580062|FG000|Overall Study|Physician Decision|45|||
149028023|NCT00088465|537580062|FG000|Overall Study|Sponsor Decision|37|||
149028024|NCT00088465|537580062|FG000|Overall Study|Lack of Efficacy|27|||
149028025|NCT00088465|537580062|FG000|Overall Study|Protocol Violation|17|||
149028026|NCT00088465|537580062|FG000|Overall Study|Death|11|||
149028027|NCT00448864|537580063|FG000|Overall Study|Death|1|||
149028028|NCT00448864|537580064|FG001|Overall Study|Death|0|||
149028029|NCT00448864|537580065|FG002|Overall Study|Death|0|||
149028030|NCT00448864|537580063|FG000|Overall Study|Lost to Follow-up|3|||
149028031|NCT00448864|537580064|FG001|Overall Study|Lost to Follow-up|1|||
149028032|NCT00448864|537580065|FG002|Overall Study|Lost to Follow-up|0|||
149028033|NCT00448864|537580063|FG000|Overall Study|Physician Decision|1|||
149028034|NCT00448864|537580064|FG001|Overall Study|Physician Decision|0|||
149028035|NCT00448864|537580065|FG002|Overall Study|Physician Decision|1|||
149028036|NCT00448864|537580063|FG000|Overall Study|Withdrawal by Subject|0|||
149028037|NCT00448864|537580064|FG001|Overall Study|Withdrawal by Subject|2|||
149028038|NCT00448864|537580065|FG002|Overall Study|Withdrawal by Subject|0|||
149028039|NCT00448864|537580063|FG000|Overall Study|Protocol Violation|0|||
149028040|NCT00448864|537580064|FG001|Overall Study|Protocol Violation|2|||
149028041|NCT00448864|537580065|FG002|Overall Study|Protocol Violation|0|||
148769563|NCT01867710|536629435|FG000|Overall Study|Study Terminated by Sponsor|9|||
148769564|NCT01867710|536629436|FG001|Overall Study|Study Terminated by Sponsor|13|||
148769565|NCT01867710|536629437|FG002|Overall Study|Study Terminated by Sponsor|8|||
148769566|NCT01867710|536629438|FG003|Overall Study|Study Terminated by Sponsor|16|||
148769567|NCT01867710|536629435|FG000|Overall Study|Biochemical progression|0|||
148980318|NCT01752933|537407956|FG000|Treatment|Disease Progression|3|||
148980319|NCT01752933|537407957|FG001|Treatment|Disease Progression|29|||
148980320|NCT01752933|537407956|FG000|Treatment|Withdrawal by Subject|0|||
148980321|NCT01752933|537407957|FG001|Treatment|Withdrawal by Subject|5|||
148980322|NCT01752933|537407956|FG000|Treatment|Adverse Event|1|||
148980323|NCT01752933|537407957|FG001|Treatment|Adverse Event|4|||
148980324|NCT01752933|537407956|FG000|Treatment|Physician Decision|0|||
148980325|NCT01752933|537407957|FG001|Treatment|Physician Decision|3|||
148980326|NCT01752933|537407956|FG000|Treatment|Death|0|||
148980327|NCT01752933|537407957|FG001|Treatment|Death|2|||
148980328|NCT01752933|537407956|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
148980329|NCT01752933|537407957|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
148980330|NCT01752933|537407956|FG000|Treatment|Patient noncompliant|0|||
148980331|NCT01752933|537407957|FG001|Treatment|Patient noncompliant|1|||
148980332|NCT01752933|537407956|FG000|Treatment|Patient unable to travel to appointments|0|||
148980333|NCT01752933|537407957|FG001|Treatment|Patient unable to travel to appointments|1|||
148980334|NCT01752933|537407956|FG000|Overall Study and Follow-up|Death|4|||
148980335|NCT01752933|537407957|FG001|Overall Study and Follow-up|Death|34|||
148980336|NCT01752933|537407956|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
148980337|NCT01752933|537407957|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
148980338|NCT01752933|537407956|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
148980339|NCT01752933|537407957|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
148980340|NCT01752933|537407956|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
148980341|NCT01752933|537407957|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
148980342|NCT01649856|537407962|FG000|Overall Study|Withdrawal by Subject|14|||
148980343|NCT01649856|537407963|FG001|Overall Study|Withdrawal by Subject|14|||
148980344|NCT01649856|537407962|FG000|Overall Study|Protocol Violation|4|||
148980345|NCT01649856|537407963|FG001|Overall Study|Protocol Violation|4|||
148980346|NCT01649856|537407962|FG000|Overall Study|Treatment Failure|1|||
148980347|NCT01649856|537407963|FG001|Overall Study|Treatment Failure|1|||
148980348|NCT01649856|537407962|FG000|Overall Study|Death|69|||
148980349|NCT01649856|537407963|FG001|Overall Study|Death|34|||
148980350|NCT01649856|537407962|FG000|Overall Study|Stable or Progressed Disease|5|||
148980351|NCT01649856|537407963|FG001|Overall Study|Stable or Progressed Disease|3|||
148980352|NCT01649856|537407962|FG000|Overall Study|Lost to Follow-up|20|||
148980353|NCT01649856|537407963|FG001|Overall Study|Lost to Follow-up|16|||
148980354|NCT01649856|537407962|FG000|Overall Study|Lack of Compliance|6|||
148980355|NCT01649856|537407963|FG001|Overall Study|Lack of Compliance|1|||
148980356|NCT01649856|537407962|FG000|Overall Study|Other|20|||
149028042|NCT01390857|537580066|FG000|Overall Study|Protocol Violation|2|||
149028043|NCT01390857|537580066|FG000|Overall Study|Lost to Follow-up|1|||
148769568|NCT01867710|536629436|FG001|Overall Study|Biochemical progression|1|||
148980357|NCT01649856|537407963|FG001|Overall Study|Other|5|||
148980358|NCT00179647|537407964|FG000|Overall Study|Adverse Event|294|||
148980359|NCT00179647|537407964|FG000|Overall Study|Lack of Efficacy|478|||
149028044|NCT01390857|537580066|FG000|Overall Study|No Visit after the First Visit|7|||
149028045|NCT02757885|537580067|FG000|Overall Study|Screen Failures|4|||
149028046|NCT01474538|537580069|FG000|Treatment Period 1|Death|1|||
149028047|NCT01474538|537580070|FG001|Treatment Period 1|Death|0|||
148980360|NCT00179647|537407964|FG000|Overall Study|Withdrawal by Subject|83|||
148980361|NCT00179647|537407964|FG000|Overall Study|Lost to Follow-up|4|||
148980362|NCT00179647|537407964|FG000|Overall Study|Death|94|||
148980363|NCT00179647|537407964|FG000|Overall Study|Other|960|||
148980364|NCT00622635|537407965|FG000|Treatment Period 1|Adverse Event|0|||
148980365|NCT00622635|537407966|FG001|Treatment Period 1|Adverse Event|0|||
148980366|NCT00622635|537407967|FG002|Treatment Period 1|Adverse Event|1|||
148980367|NCT00622635|537407968|FG003|Treatment Period 1|Adverse Event|0|||
148980368|NCT00622635|537407969|FG004|Treatment Period 1|Adverse Event|0|||
148980369|NCT00622635|537407970|FG005|Treatment Period 1|Adverse Event|0|||
148980370|NCT00622635|537407965|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148980371|NCT00622635|537407966|FG001|Treatment Period 1|Withdrawal by Subject|1|||
148980372|NCT00622635|537407967|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148980373|NCT00622635|537407968|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148980374|NCT00622635|537407969|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148980375|NCT00622635|537407970|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148980376|NCT00622635|537407965|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
148980377|NCT00622635|537407966|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
148980378|NCT00622635|537407967|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
148980379|NCT00622635|537407968|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
148980380|NCT00622635|537407969|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
148980381|NCT00622635|537407970|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
148980382|NCT00622635|537407965|FG000|Treatment Period 2|Adverse Event|1|||
148980383|NCT00622635|537407966|FG001|Treatment Period 2|Adverse Event|0|||
148980384|NCT00622635|537407967|FG002|Treatment Period 2|Adverse Event|0|||
148980385|NCT00622635|537407968|FG003|Treatment Period 2|Adverse Event|0|||
148980386|NCT00622635|537407969|FG004|Treatment Period 2|Adverse Event|0|||
148980387|NCT00622635|537407970|FG005|Treatment Period 2|Adverse Event|0|||
148980388|NCT00622635|537407965|FG000|Treatment Period 3|Adverse Event|0|||
148980389|NCT00622635|537407966|FG001|Treatment Period 3|Adverse Event|0|||
148980390|NCT00622635|537407967|FG002|Treatment Period 3|Adverse Event|0|||
148980391|NCT00622635|537407968|FG003|Treatment Period 3|Adverse Event|2|||
148980392|NCT00622635|537407969|FG004|Treatment Period 3|Adverse Event|0|||
148980393|NCT00622635|537407970|FG005|Treatment Period 3|Adverse Event|0|||
148980394|NCT00622635|537407965|FG000|Treatment Period 3|Withdrawal by Subject|0|||
148980395|NCT00622635|537407966|FG001|Treatment Period 3|Withdrawal by Subject|0|||
148980396|NCT00622635|537407967|FG002|Treatment Period 3|Withdrawal by Subject|0|||
148980397|NCT00622635|537407968|FG003|Treatment Period 3|Withdrawal by Subject|1|||
148980398|NCT00622635|537407969|FG004|Treatment Period 3|Withdrawal by Subject|0|||
148980399|NCT00622635|537407970|FG005|Treatment Period 3|Withdrawal by Subject|0|||
148980400|NCT00281840|537407971|FG000|Overall Study|Adverse Event|12|||
148980401|NCT00281840|537407971|FG000|Overall Study|Physician Decision|6|||
148980402|NCT00281840|537407971|FG000|Overall Study|Withdrawal by Subject|3|||
148980403|NCT00281840|537407971|FG000|Overall Study|Disease Progression|2|||
148980404|NCT00281840|537407971|FG000|Overall Study|exceed maximum delay in treatment|1|||
148980405|NCT00281840|537407971|FG000|Overall Study|Complicating Disease|1|||
148980406|NCT00835406|537407972|FG000|Period: First Intervention|Adverse Event|0|||
148980407|NCT00835406|537407973|FG001|Period: First Intervention|Adverse Event|1|||
148980408|NCT00835406|537407972|FG000|Period: First Intervention|Withdrawal by Subject|2|||
148980409|NCT00835406|537407973|FG001|Period: First Intervention|Withdrawal by Subject|0|||
148980410|NCT00835406|537407972|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
148980411|NCT00835406|537407973|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
148980412|NCT02138214|537407976|FG000|Overall Study|Withdrawal by Subject|0|||
148980413|NCT02138214|537407977|FG001|Overall Study|Withdrawal by Subject|1|||
148980414|NCT02138214|537407978|FG002|Overall Study|Withdrawal by Subject|0|||
148980415|NCT02138214|537407976|FG000|Overall Study|Lost to Follow-up|0|||
148980416|NCT02138214|537407977|FG001|Overall Study|Lost to Follow-up|2|||
148980417|NCT02138214|537407978|FG002|Overall Study|Lost to Follow-up|4|||
148980418|NCT02138214|537407976|FG000|Overall Study|Screen Failure|0|||
148980419|NCT02138214|537407977|FG001|Overall Study|Screen Failure|1|||
148980420|NCT02138214|537407978|FG002|Overall Study|Screen Failure|0|||
148980421|NCT02185768|537407979|FG000|Overall Study|Patients were not treated|2|||
148980422|NCT02550652|537407987|FG000|Overall Study|Death|1|||
148980423|NCT02550652|537407988|FG001|Overall Study|Death|4|||
148980424|NCT02550652|537407987|FG000|Overall Study|Lack of Efficacy|1|||
148980425|NCT02550652|537407988|FG001|Overall Study|Lack of Efficacy|0|||
148980426|NCT02550652|537407987|FG000|Overall Study|Withdrawal by Subject|4|||
148980427|NCT02550652|537407988|FG001|Overall Study|Withdrawal by Subject|7|||
148980428|NCT02550652|537407987|FG000|Overall Study|Post Trial Access|1|||
148980429|NCT02550652|537407988|FG001|Overall Study|Post Trial Access|0|||
148980430|NCT02550652|537407987|FG000|Overall Study|Lost to Follow-up|1|||
148980431|NCT02550652|537407988|FG001|Overall Study|Lost to Follow-up|3|||
148980432|NCT02550652|537407987|FG000|Overall Study|Physician Decision|0|||
148980433|NCT02550652|537407988|FG001|Overall Study|Physician Decision|2|||
148980434|NCT02550652|537407987|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
149028048|NCT01474538|537580069|FG000|Treatment Period 1|Physician Decision|1|||
149028049|NCT01474538|537580070|FG001|Treatment Period 1|Physician Decision|0|||
148980435|NCT02550652|537407988|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
148980436|NCT03027466|537407989|FG000|Overall Study|Opting out of the app|1869|||
148980437|NCT03027466|537407990|FG001|Overall Study|Opting out of the app|1819|||
148980438|NCT03027466|537407991|FG002|Overall Study|Opting out of the app|1743|||
148980439|NCT03027466|537407992|FG003|Overall Study|Opting out of the app|1821|||
148980440|NCT02486406|537407993|FG000|Overall Study|Withdrew consent|1|||
148980441|NCT02486406|537407994|FG001|Overall Study|Withdrew consent|0|||
148980442|NCT02486406|537407995|FG002|Overall Study|Withdrew consent|0|||
148980443|NCT02486406|537407996|FG003|Overall Study|Withdrew consent|1|||
148980444|NCT02486406|537407993|FG000|Overall Study|Lost to Follow-up|1|||
148980445|NCT02486406|537407994|FG001|Overall Study|Lost to Follow-up|3|||
148980446|NCT02486406|537407995|FG002|Overall Study|Lost to Follow-up|1|||
148980447|NCT02486406|537407996|FG003|Overall Study|Lost to Follow-up|3|||
148980448|NCT02486406|537407993|FG000|Overall Study|Other, not specified|0|||
148980449|NCT02486406|537407994|FG001|Overall Study|Other, not specified|0|||
148980450|NCT02486406|537407995|FG002|Overall Study|Other, not specified|1|||
148980451|NCT02486406|537407996|FG003|Overall Study|Other, not specified|0|||
148980452|NCT01858194|537407997|FG000|Overall Study|Total Artificial Heart Implant|0|||
148980453|NCT01858194|537407998|FG001|Overall Study|Total Artificial Heart Implant|1|||
148980454|NCT01858194|537407997|FG000|Overall Study|Lost to Follow-up|0|||
148980455|NCT01858194|537407998|FG001|Overall Study|Lost to Follow-up|1|||
148980456|NCT02158039|537407999|FG000|Overall Study|Withdrawal by Subject|1|||
148980457|NCT02158039|537407999|FG000|Overall Study|Screen Failure|9|||
148980458|NCT03062891|537408011|FG000|Overall Study|Withdrawal by Subject|2|||
148980459|NCT03062891|537408012|FG001|Overall Study|Withdrawal by Subject|0|||
148980460|NCT03062891|537408011|FG000|Overall Study|Lost to Follow-up|50|||
148980461|NCT03062891|537408012|FG001|Overall Study|Lost to Follow-up|38|||
148980462|NCT01079234|537408018|FG000|Main: Week 0 to 26|Adverse Event|5|||
148980463|NCT01079234|537408019|FG001|Main: Week 0 to 26|Adverse Event|4|||
148980464|NCT01079234|537408020|FG002|Main: Week 0 to 26|Adverse Event|1|||
148980465|NCT01079234|537408021|FG003|Main: Week 0 to 26|Adverse Event|0|||
148980466|NCT01079234|537408018|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
148980467|NCT01079234|537408019|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
148980468|NCT01079234|537408020|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
148980469|NCT01079234|537408021|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
148980470|NCT01079234|537408018|FG000|Main: Week 0 to 26|Protocol Violation|6|||
148980471|NCT01079234|537408019|FG001|Main: Week 0 to 26|Protocol Violation|2|||
148980472|NCT01079234|537408020|FG002|Main: Week 0 to 26|Protocol Violation|4|||
148980473|NCT01079234|537408021|FG003|Main: Week 0 to 26|Protocol Violation|0|||
148980474|NCT01079234|537408018|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
148980475|NCT01079234|537408019|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
148980476|NCT01079234|537408020|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
148980477|NCT01079234|537408021|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
148980478|NCT01079234|537408018|FG000|Main: Week 0 to 26|Unclassified|7|||
148980479|NCT01079234|537408019|FG001|Main: Week 0 to 26|Unclassified|13|||
148980480|NCT01079234|537408020|FG002|Main: Week 0 to 26|Unclassified|4|||
148980481|NCT01079234|537408021|FG003|Main: Week 0 to 26|Unclassified|0|||
148980482|NCT01079234|537408018|FG000|Extension: Week 27 to 52|Adverse Event|0|||
148980483|NCT01079234|537408019|FG001|Extension: Week 27 to 52|Adverse Event|0|||
148980484|NCT01079234|537408020|FG002|Extension: Week 27 to 52|Adverse Event|1|||
148980485|NCT01079234|537408021|FG003|Extension: Week 27 to 52|Adverse Event|0|||
148980486|NCT01079234|537408018|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
148980487|NCT01079234|537408019|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
148980488|NCT01079234|537408020|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
148980489|NCT01079234|537408021|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
148980490|NCT01079234|537408018|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
148980491|NCT01079234|537408019|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
148980492|NCT01079234|537408020|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
148980493|NCT01079234|537408021|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
148980494|NCT01079234|537408018|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
148980495|NCT01079234|537408019|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
148980496|NCT01079234|537408020|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
148980497|NCT01079234|537408021|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
148980498|NCT01079234|537408018|FG000|Extension: Week 27 to 52|Unclassified|0|||
148980499|NCT01079234|537408019|FG001|Extension: Week 27 to 52|Unclassified|0|||
148980500|NCT01079234|537408020|FG002|Extension: Week 27 to 52|Unclassified|4|||
148980501|NCT01079234|537408021|FG003|Extension: Week 27 to 52|Unclassified|7|||
148980502|NCT02047604|537408031|FG000|Overall Study|Withdrawal by Subject|0|||
148980503|NCT02047604|537408032|FG001|Overall Study|Withdrawal by Subject|0|||
148980504|NCT02047604|537408033|FG002|Overall Study|Withdrawal by Subject|0|||
148980505|NCT02047604|537408034|FG003|Overall Study|Withdrawal by Subject|0|||
148980506|NCT02047604|537408035|FG004|Overall Study|Withdrawal by Subject|1|||
148980507|NCT02047604|537408036|FG005|Overall Study|Withdrawal by Subject|1|||
148980508|NCT00983814|537408037|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
148980509|NCT00983814|537408038|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
148980510|NCT00983814|537408039|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
148831058|NCT00023595|536860314|FG002|10 Year Follow up|Lost to Follow-up|3|||
148831059|NCT00023595|536860315|FG003|10 Year Follow up|Lost to Follow-up|0|||
148831060|NCT00023595|536860316|FG004|10 Year Follow up|Lost to Follow-up|0|||
148831061|NCT01309230|536860317|FG000|Overall Study|Withdrawal by Subject|0|||
148831062|NCT01309230|536860318|FG001|Overall Study|Withdrawal by Subject|2|||
148831063|NCT01309230|536860317|FG000|Overall Study|Observation arm closed|0|||
148831064|NCT01309230|536860318|FG001|Overall Study|Observation arm closed|2|||
148831065|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
148831066|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
148831067|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
148831068|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
148831069|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
148831070|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
148831071|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
148831072|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
148831073|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
148831074|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
148831075|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
148831076|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
148831077|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
148831078|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
148831079|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
148831080|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
148831081|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
148831082|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
148831083|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
148831084|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
148831085|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
148831086|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
148831087|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
148831088|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
148831089|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
148831090|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
148831091|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
148831092|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
148831093|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
148831094|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
148831095|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
148831096|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
148831097|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
148831098|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
148831099|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
148831100|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
148831101|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
148831102|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
148831103|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
148831104|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
148831105|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
148831106|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
148831107|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
148831108|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
148831109|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
148831110|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
148831111|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
148831112|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
148831113|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
148831114|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
148831115|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
148831116|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
148831117|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
148831118|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
148980511|NCT00983814|537408037|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
148980512|NCT00983814|537408038|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
148980513|NCT00983814|537408039|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
148980514|NCT00983814|537408037|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
148831119|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
148831120|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
148831121|NCT01362790|536860321|FG000|Pilot Phase & Phase 2|Death on study|0|||
148831122|NCT01362790|536860322|FG001|Pilot Phase & Phase 2|Death on study|0|||
148980515|NCT00983814|537408038|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
148831123|NCT01362790|536860323|FG002|Pilot Phase & Phase 2|Death on study|0|||
148831124|NCT01362790|536860324|FG003|Pilot Phase & Phase 2|Death on study|1|||
148831125|NCT01362790|536860325|FG004|Pilot Phase & Phase 2|Death on study|0|||
148831126|NCT01362790|536860326|FG005|Pilot Phase & Phase 2|Death on study|0|||
148831127|NCT01362790|536860327|FG006|Pilot Phase & Phase 2|Death on study|0|||
148831128|NCT01362790|536860321|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
148831129|NCT01362790|536860322|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
148831130|NCT01362790|536860323|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
148831131|NCT01362790|536860324|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
148831132|NCT01362790|536860325|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
148831133|NCT01362790|536860326|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
148831134|NCT01362790|536860327|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
148831135|NCT01362790|536860321|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
148831136|NCT01362790|536860322|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
148831137|NCT01362790|536860323|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
148831138|NCT01362790|536860324|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
148831139|NCT01362790|536860325|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
148831140|NCT01362790|536860326|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
148831141|NCT01362790|536860327|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
148831142|NCT01362790|536860321|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
148831143|NCT01362790|536860322|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
148831144|NCT01362790|536860323|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
148831145|NCT01362790|536860324|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
148831146|NCT01362790|536860325|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
148831147|NCT01362790|536860326|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
148831148|NCT01362790|536860327|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
148831149|NCT00437073|536860328|FG000|Overall Study|Sponsor Terminated Study|1|||
148831150|NCT00437073|536860329|FG001|Overall Study|Sponsor Terminated Study|0|||
148831151|NCT00437073|536860328|FG000|Overall Study|Physician Decision|0|||
148831152|NCT00437073|536860329|FG001|Overall Study|Physician Decision|1|||
148831153|NCT03485157|536860330|FG000|Double Blind Phase|Lost to Follow-up|4|||
148831154|NCT03485157|536860331|FG001|Double Blind Phase|Lost to Follow-up|4|||
148831155|NCT03485157|536860330|FG000|Double Blind Phase|Adverse Event|2|||
148831156|NCT03485157|536860331|FG001|Double Blind Phase|Adverse Event|1|||
148831157|NCT03485157|536860330|FG000|Double Blind Phase|Withdrawal by Subject|6|||
148831158|NCT03485157|536860331|FG001|Double Blind Phase|Withdrawal by Subject|9|||
148831159|NCT03485157|536860330|FG000|Double Blind Phase|Removal by PI|3|||
148831160|NCT03485157|536860331|FG001|Double Blind Phase|Removal by PI|7|||
148831161|NCT03485157|536860330|FG000|Open Label Phase|Lost to Follow-up|1|||
148831162|NCT03485157|536860331|FG001|Open Label Phase|Lost to Follow-up|2|||
148831163|NCT03485157|536860330|FG000|Open Label Phase|Adverse Event|0|||
148831164|NCT03485157|536860331|FG001|Open Label Phase|Adverse Event|1|||
148831165|NCT03485157|536860330|FG000|Open Label Phase|Withdrawal by Subject|1|||
148831166|NCT03485157|536860331|FG001|Open Label Phase|Withdrawal by Subject|2|||
148831167|NCT03485157|536860330|FG000|Open Label Phase|Removal by PI|2|||
148831168|NCT03485157|536860331|FG001|Open Label Phase|Removal by PI|0|||
148831169|NCT01849276|536860332|FG000|Followed for Survival for 5 Years|Death|1|||
148831170|NCT01849276|536860332|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
148831171|NCT00539500|536860333|FG000|Overall Study|Disease Progression|1|||
148831172|NCT00539500|536860333|FG000|Overall Study|Lost to Follow-up|2|||
148831173|NCT02011542|536860334|FG000|Overall Study|Physician Decision|1|||
148831174|NCT02904096|536860335|FG000|Overall Study|Adverse Event|1|||
148831175|NCT02904096|536860336|FG001|Overall Study|Adverse Event|0|||
148831176|NCT02904096|536860335|FG000|Overall Study|Withdrawal by Subject|4|||
148831177|NCT02904096|536860336|FG001|Overall Study|Withdrawal by Subject|3|||
148831178|NCT02904096|536860335|FG000|Overall Study|Lost to Follow-up|10|||
148831179|NCT02904096|536860336|FG001|Overall Study|Lost to Follow-up|17|||
148831180|NCT02904096|536860335|FG000|Overall Study|Non-compliant|3|||
148831181|NCT02904096|536860336|FG001|Overall Study|Non-compliant|1|||
148831182|NCT02904096|536860335|FG000|Overall Study|Sponsor instructed|1|||
148831183|NCT02904096|536860336|FG001|Overall Study|Sponsor instructed|0|||
148831184|NCT00663260|536860338|FG000|Overall Study|Lack of Efficacy|2|||
148831185|NCT00663260|536860339|FG001|Overall Study|Lack of Efficacy|0|||
148831186|NCT00663260|536860340|FG002|Overall Study|Lack of Efficacy|0|||
148980516|NCT00983814|537408039|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
148980517|NCT00983814|537408037|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
148980518|NCT00983814|537408038|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
148980519|NCT00983814|537408039|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
148831187|NCT00663260|536860338|FG000|Overall Study|Adverse Event|12|||
148980520|NCT00983814|537408037|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
148831188|NCT00663260|536860339|FG001|Overall Study|Adverse Event|7|||
148980521|NCT00983814|537408038|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
148980522|NCT00983814|537408039|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
148831189|NCT00663260|536860340|FG002|Overall Study|Adverse Event|6|||
148831190|NCT00663260|536860338|FG000|Overall Study|Withdrawal by Subject|3|||
148831191|NCT00663260|536860339|FG001|Overall Study|Withdrawal by Subject|1|||
148831192|NCT00663260|536860340|FG002|Overall Study|Withdrawal by Subject|6|||
148831193|NCT00663260|536860338|FG000|Overall Study|Death|1|||
148831194|NCT00663260|536860339|FG001|Overall Study|Death|0|||
148831195|NCT00663260|536860340|FG002|Overall Study|Death|1|||
148831196|NCT00663260|536860338|FG000|Overall Study|Lost to Follow-up|0|||
148831197|NCT00663260|536860339|FG001|Overall Study|Lost to Follow-up|1|||
148831198|NCT00663260|536860340|FG002|Overall Study|Lost to Follow-up|0|||
148831199|NCT00663260|536860338|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
148831200|NCT00663260|536860339|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
148831201|NCT00663260|536860340|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
148831202|NCT01979185|536860344|FG000|Period 2|Other|0|||
148831203|NCT01979185|536860345|FG001|Period 2|Other|1|||
148831204|NCT00980798|536860346|FG000|Overall Study|Adverse Event|7|||
148831205|NCT00980798|536860347|FG001|Overall Study|Adverse Event|36|||
148831206|NCT00980798|536860346|FG000|Overall Study|Lack of Efficacy|16|||
148831207|NCT00980798|536860347|FG001|Overall Study|Lack of Efficacy|5|||
148831208|NCT00980798|536860346|FG000|Overall Study|Lost to Follow-up|0|||
148831209|NCT00980798|536860347|FG001|Overall Study|Lost to Follow-up|1|||
148831210|NCT00980798|536860346|FG000|Overall Study|Physician Decision|2|||
148831211|NCT00980798|536860347|FG001|Overall Study|Physician Decision|1|||
148831212|NCT00980798|536860346|FG000|Overall Study|Withdrawal by Subject|8|||
148831213|NCT00980798|536860347|FG001|Overall Study|Withdrawal by Subject|11|||
148831214|NCT00980798|536860346|FG000|Overall Study|Other|0|||
148831215|NCT00980798|536860347|FG001|Overall Study|Other|1|||
148831216|NCT02402647|536860348|FG000|Overall Study|Lost to Follow-up|13|||
148831217|NCT02402647|536860349|FG001|Overall Study|Lost to Follow-up|7|||
148831218|NCT02402647|536860348|FG000|Overall Study|Protocol Violation|1|||
148831219|NCT02402647|536860349|FG001|Overall Study|Protocol Violation|1|||
148831220|NCT02402647|536860348|FG000|Overall Study|scheduled and timed out|2|||
148831221|NCT02402647|536860349|FG001|Overall Study|scheduled and timed out|1|||
148831222|NCT02402647|536860348|FG000|Overall Study|medical illness|2|||
148831223|NCT02402647|536860349|FG001|Overall Study|medical illness|4|||
148831224|NCT02402647|536860348|FG000|Overall Study|Moved|2|||
148831225|NCT02402647|536860349|FG001|Overall Study|Moved|0|||
148831226|NCT02402647|536860348|FG000|Overall Study|loved one illness|1|||
148831227|NCT02402647|536860349|FG001|Overall Study|loved one illness|0|||
148831228|NCT02402647|536860348|FG000|Overall Study|deceased preexisting condition|2|||
148831229|NCT02402647|536860349|FG001|Overall Study|deceased preexisting condition|0|||
148831230|NCT02402647|536860348|FG000|Overall Study|Other|2|||
148831231|NCT02402647|536860349|FG001|Overall Study|Other|1|||
148831232|NCT03211416|536860358|FG000|Overall Study|Adverse Event|7|||
148831233|NCT03211416|536860358|FG000|Overall Study|Lack of Efficacy|2|||
148831234|NCT03211416|536860358|FG000|Overall Study|Physician Decision|1|||
148831235|NCT02496000|536860363|FG000|Overall Study|Withdrawal by Subject|1|||
148831236|NCT02496000|536860364|FG001|Overall Study|Withdrawal by Subject|2|||
148831237|NCT02496000|536860365|FG002|Overall Study|Withdrawal by Subject|0|||
148831238|NCT02496000|536860363|FG000|Overall Study|Lost to Follow-up|1|||
148831239|NCT02496000|536860364|FG001|Overall Study|Lost to Follow-up|0|||
148831240|NCT02496000|536860365|FG002|Overall Study|Lost to Follow-up|1|||
148831241|NCT02496000|536860363|FG000|Overall Study|Protocol Violation|0|||
148831242|NCT02496000|536860364|FG001|Overall Study|Protocol Violation|0|||
148831243|NCT02496000|536860365|FG002|Overall Study|Protocol Violation|1|||
148831244|NCT02496000|536860363|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
148831245|NCT02496000|536860364|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
148769569|NCT01867710|536629437|FG002|Overall Study|Biochemical progression|0|||
148769570|NCT01867710|536629438|FG003|Overall Study|Biochemical progression|0|||
148769571|NCT01867710|536629435|FG000|Overall Study|Clinical progression|0|||
148769572|NCT01867710|536629436|FG001|Overall Study|Clinical progression|0|||
148769573|NCT01867710|536629437|FG002|Overall Study|Clinical progression|1|||
148769574|NCT01867710|536629438|FG003|Overall Study|Clinical progression|0|||
148769575|NCT01867710|536629435|FG000|Overall Study|Disease progression|1|||
148769576|NCT01867710|536629436|FG001|Overall Study|Disease progression|0|||
148769577|NCT01867710|536629437|FG002|Overall Study|Disease progression|0|||
148769578|NCT01867710|536629438|FG003|Overall Study|Disease progression|0|||
148769579|NCT01867710|536629435|FG000|Overall Study|Patient decision|0|||
148769580|NCT01867710|536629436|FG001|Overall Study|Patient decision|0|||
148769581|NCT01867710|536629437|FG002|Overall Study|Patient decision|0|||
148769582|NCT01867710|536629438|FG003|Overall Study|Patient decision|1|||
148769583|NCT01867710|536629435|FG000|Overall Study|Patient to follow subsequent treatment|0|||
148769584|NCT01867710|536629436|FG001|Overall Study|Patient to follow subsequent treatment|1|||
148831246|NCT02496000|536860365|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
148831247|NCT02496000|536860363|FG000|Overall Study|undetermined|0|||
148831248|NCT02496000|536860364|FG001|Overall Study|undetermined|1|||
148831249|NCT02496000|536860365|FG002|Overall Study|undetermined|0|||
148831250|NCT02255656|536860366|FG000|Overall Study|Adverse Event|11|||
148831251|NCT02255656|536860366|FG000|Overall Study|Poor compliance to protocol|3|||
148831252|NCT02255656|536860366|FG000|Overall Study|Lost to Follow-up|30|||
148980523|NCT02707640|537408040|FG000|Overall Study|Adverse Event|4|||
148980524|NCT02707640|537408041|FG001|Overall Study|Adverse Event|2|||
148980525|NCT02707640|537408040|FG000|Overall Study|Death|1|||
148980526|NCT02707640|537408041|FG001|Overall Study|Death|2|||
148980527|NCT02707640|537408040|FG000|Overall Study|Physician Decision|2|||
148980528|NCT02707640|537408041|FG001|Overall Study|Physician Decision|0|||
148980529|NCT02707640|537408040|FG000|Overall Study|Withdrawal by Subject|0|||
148980530|NCT02707640|537408041|FG001|Overall Study|Withdrawal by Subject|1|||
148980531|NCT02707640|537408040|FG000|Overall Study|Participant's Personal Decision|1|||
148980532|NCT02707640|537408041|FG001|Overall Study|Participant's Personal Decision|2|||
148980533|NCT02707640|537408040|FG000|Overall Study|Sponsor Discretion|1|||
148980534|NCT02707640|537408041|FG001|Overall Study|Sponsor Discretion|0|||
148980535|NCT02517905|537408042|FG000|Overall Study|Lost to Follow-up|4|||
148980536|NCT02517905|537408043|FG001|Overall Study|Lost to Follow-up|0|||
148980537|NCT02517905|537408042|FG000|Overall Study|Withdrawal by Subject|4|||
148980538|NCT02517905|537408043|FG001|Overall Study|Withdrawal by Subject|0|||
148980539|NCT02517905|537408042|FG000|Overall Study|Screen failure|2|||
148980540|NCT02517905|537408043|FG001|Overall Study|Screen failure|2|||
148980541|NCT01994395|537408049|FG000|Overall Study|Withdrawal by Subject|1|||
148980542|NCT01994395|537408050|FG001|Overall Study|Withdrawal by Subject|2|||
148980543|NCT00459134|537408051|FG000|Overall Study|Physician Decision|1|||
148980544|NCT00459134|537408052|FG001|Overall Study|Physician Decision|1|||
148980545|NCT00459134|537408051|FG000|Overall Study|Withdrawal by Subject|8|||
148980546|NCT00459134|537408052|FG001|Overall Study|Withdrawal by Subject|7|||
148980547|NCT00459134|537408051|FG000|Overall Study|Lost to Follow-up|6|||
148980548|NCT00459134|537408052|FG001|Overall Study|Lost to Follow-up|7|||
148980549|NCT00459134|537408051|FG000|Overall Study|Surgery|1|||
148980550|NCT00459134|537408052|FG001|Overall Study|Surgery|2|||
148980551|NCT00459134|537408051|FG000|Overall Study|Toxicity|4|||
148980552|NCT00459134|537408052|FG001|Overall Study|Toxicity|5|||
148980553|NCT00459134|537408051|FG000|Overall Study|Progression|1|||
148980554|NCT00459134|537408052|FG001|Overall Study|Progression|0|||
148980555|NCT00459134|537408051|FG000|Overall Study|Multiple Reasons|2|||
148980556|NCT00459134|537408052|FG001|Overall Study|Multiple Reasons|3|||
148980557|NCT00829621|537408053|FG000|Overall Study|Death|1|||
148980558|NCT00829621|537408054|FG001|Overall Study|Death|0|||
148980559|NCT00829621|537408053|FG000|Overall Study|Lost to Follow-up|3|||
148980560|NCT00829621|537408054|FG001|Overall Study|Lost to Follow-up|4|||
148980561|NCT01755416|537408055|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
148980562|NCT01755416|537408056|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
148980563|NCT01976845|537408057|FG000|Overall Study|Physician Decision|8|||
148980564|NCT01976845|537408058|FG001|Overall Study|Physician Decision|8|||
148980565|NCT01976845|537408059|FG002|Overall Study|Physician Decision|3|||
148980566|NCT00441337|537408060|FG000|Overall Study|Disease Progression|6|||
148980567|NCT00441337|537408061|FG001|Overall Study|Disease Progression|6|||
148980568|NCT00441337|537408062|FG002|Overall Study|Disease Progression|4|||
148980569|NCT00441337|537408063|FG003|Overall Study|Disease Progression|18|||
148980570|NCT00441337|537408060|FG000|Overall Study|Lost to Follow-up|0|||
148980571|NCT00441337|537408061|FG001|Overall Study|Lost to Follow-up|0|||
148980572|NCT00441337|537408062|FG002|Overall Study|Lost to Follow-up|0|||
148980573|NCT00441337|537408063|FG003|Overall Study|Lost to Follow-up|1|||
148980574|NCT00441337|537408060|FG000|Overall Study|Sponsor Decision|0|||
148980575|NCT00441337|537408061|FG001|Overall Study|Sponsor Decision|0|||
148980576|NCT00441337|537408062|FG002|Overall Study|Sponsor Decision|1|||
148980577|NCT00441337|537408063|FG003|Overall Study|Sponsor Decision|2|||
148980578|NCT00441337|537408060|FG000|Overall Study|Did not meet inclusion criteria|0|||
148980579|NCT00441337|537408061|FG001|Overall Study|Did not meet inclusion criteria|0|||
148980580|NCT00441337|537408062|FG002|Overall Study|Did not meet inclusion criteria|1|||
148980581|NCT00441337|537408063|FG003|Overall Study|Did not meet inclusion criteria|0|||
148980582|NCT01818336|537409317|FG000|Overall Study|Declined retest visit|0|||
148980583|NCT01818336|537409318|FG001|Overall Study|Declined retest visit|11|||
148980584|NCT01818336|537409317|FG000|Overall Study|Lost to Follow-up|0|||
148980585|NCT01818336|537409318|FG001|Overall Study|Lost to Follow-up|1|||
148769585|NCT01867710|536629437|FG002|Overall Study|Patient to follow subsequent treatment|0|||
148980586|NCT03042312|537409321|FG000|Overall Study|Administrative Reason|1|||
148980587|NCT03042312|537409322|FG001|Overall Study|Administrative Reason|1|||
148980588|NCT03042312|537409321|FG000|Overall Study|Adverse Event|0|||
148980589|NCT03042312|537409322|FG001|Overall Study|Adverse Event|1|||
148980590|NCT03042312|537409321|FG000|Overall Study|Lost to Follow-up|1|||
148980591|NCT03042312|537409322|FG001|Overall Study|Lost to Follow-up|3|||
148980592|NCT03042312|537409321|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
148769586|NCT01867710|536629438|FG003|Overall Study|Patient to follow subsequent treatment|0|||
148769587|NCT01867710|536629435|FG000|Overall Study|Progressive disease|1|||
148769588|NCT01867710|536629436|FG001|Overall Study|Progressive disease|0|||
148769589|NCT01867710|536629437|FG002|Overall Study|Progressive disease|0|||
148769590|NCT01867710|536629438|FG003|Overall Study|Progressive disease|0|||
148769591|NCT01867710|536629435|FG000|Overall Study|Protocol Violation|0|||
148980593|NCT03042312|537409322|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
148769592|NCT01867710|536629436|FG001|Overall Study|Protocol Violation|0|||
148769593|NCT01867710|536629437|FG002|Overall Study|Protocol Violation|0|||
148769594|NCT01867710|536629438|FG003|Overall Study|Protocol Violation|1|||
148769595|NCT01867710|536629435|FG000|Overall Study|PSA-progression|0|||
148769596|NCT01867710|536629436|FG001|Overall Study|PSA-progression|1|||
148769597|NCT01867710|536629437|FG002|Overall Study|PSA-progression|0|||
148769598|NCT01867710|536629438|FG003|Overall Study|PSA-progression|0|||
148769599|NCT01867710|536629435|FG000|Overall Study|Study medication no longer effective|0|||
148769600|NCT01867710|536629436|FG001|Overall Study|Study medication no longer effective|1|||
148769601|NCT01867710|536629437|FG002|Overall Study|Study medication no longer effective|0|||
148769602|NCT01867710|536629438|FG003|Overall Study|Study medication no longer effective|0|||
148769603|NCT01471340|536629442|FG000|Overall Study|Death|5|||
148769604|NCT01471340|536629443|FG001|Overall Study|Death|4|||
148769605|NCT01471340|536629442|FG000|Overall Study|Lost to Follow-up|0|||
148769606|NCT01471340|536629443|FG001|Overall Study|Lost to Follow-up|1|||
148769607|NCT01471340|536629442|FG000|Overall Study|Investigational site closure|0|||
148769608|NCT01471340|536629443|FG001|Overall Study|Investigational site closure|1|||
148769609|NCT01471340|536629442|FG000|Overall Study|Invalid informed consent|1|||
148769610|NCT01471340|536629443|FG001|Overall Study|Invalid informed consent|0|||
148769611|NCT00526669|536629444|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
148769612|NCT00526669|536629445|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
148769613|NCT00526669|536629444|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
148769614|NCT00526669|536629445|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
148769615|NCT00526669|536629444|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
148769616|NCT00526669|536629445|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
148769617|NCT00526669|536629444|FG000|Combined Treatment Phase|Death|0|||
148769618|NCT00526669|536629445|FG001|Combined Treatment Phase|Death|2|||
148769619|NCT03499899|536629446|FG000|Overall Study|Adverse Event|2|||
148769620|NCT03499899|536629447|FG001|Overall Study|Adverse Event|3|||
148769621|NCT03499899|536629448|FG002|Overall Study|Adverse Event|3|||
148769622|NCT03499899|536629446|FG000|Overall Study|Death|0|||
148769623|NCT03499899|536629447|FG001|Overall Study|Death|0|||
148769624|NCT03499899|536629448|FG002|Overall Study|Death|1|||
148769625|NCT03499899|536629446|FG000|Overall Study|Physician Decision|3|||
148769626|NCT03499899|536629447|FG001|Overall Study|Physician Decision|6|||
148769627|NCT03499899|536629448|FG002|Overall Study|Physician Decision|6|||
148769628|NCT03499899|536629446|FG000|Overall Study|Progressive disease|15|||
148769629|NCT03499899|536629447|FG001|Overall Study|Progressive disease|23|||
148769630|NCT03499899|536629448|FG002|Overall Study|Progressive disease|23|||
148769631|NCT03499899|536629446|FG000|Overall Study|Patient decision|0|||
148769632|NCT03499899|536629447|FG001|Overall Study|Patient decision|1|||
148769633|NCT03499899|536629448|FG002|Overall Study|Patient decision|1|||
148769634|NCT03499899|536629446|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
148769635|NCT03499899|536629447|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
148769636|NCT03499899|536629448|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
148769637|NCT01981954|536629453|FG000|Titration Period|Protocol Deviation|1|||
148769638|NCT01981954|536629453|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
148769639|NCT01609543|536629462|FG000|Overall Study|Disease Progression|28|||
148769640|NCT01609543|536629462|FG000|Overall Study|Adverse Event|5|||
148769641|NCT01609543|536629462|FG000|Overall Study|Withdrawal by Subject|1|||
148769642|NCT01609543|536629462|FG000|Overall Study|Protocol Violation|1|||
148769643|NCT01609543|536629462|FG000|Overall Study|Death|7|||
148769644|NCT02218736|536629464|FG000|Overall Study|Withdrawal by Subject|10|||
148769645|NCT02218736|536629465|FG001|Overall Study|Withdrawal by Subject|9|||
148769646|NCT02218736|536629464|FG000|Overall Study|Protocol Violation|2|||
148769647|NCT02218736|536629465|FG001|Overall Study|Protocol Violation|0|||
148769648|NCT04463251|536629468|FG000|Overall Study|Death|1|||
148769649|NCT04463251|536629469|FG001|Overall Study|Death|0|||
148769650|NCT04463251|536629470|FG002|Overall Study|Death|1|||
148769651|NCT04463251|536629468|FG000|Overall Study|Adverse Event|0|||
148769652|NCT04463251|536629469|FG001|Overall Study|Adverse Event|1|||
148769653|NCT04463251|536629470|FG002|Overall Study|Adverse Event|0|||
148769654|NCT04463251|536629468|FG000|Overall Study|Lost to Follow-up|0|||
148831253|NCT02255656|536860366|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
148831254|NCT02255656|536860366|FG000|Overall Study|Other|126|||
148980594|NCT03042312|537409321|FG000|Overall Study|Withdrawal by Subject|4|||
148980595|NCT03042312|537409322|FG001|Overall Study|Withdrawal by Subject|5|||
148980596|NCT04258839|537409325|FG000|Overall Study|Adverse Event|2|||
148980597|NCT04258839|537409326|FG001|Overall Study|Adverse Event|4|||
148769655|NCT04463251|536629469|FG001|Overall Study|Lost to Follow-up|1|||
148769656|NCT04463251|536629470|FG002|Overall Study|Lost to Follow-up|0|||
148769657|NCT04463251|536629468|FG000|Overall Study|Withdrawal by Subject|0|||
148769658|NCT04463251|536629469|FG001|Overall Study|Withdrawal by Subject|2|||
148769659|NCT04463251|536629470|FG002|Overall Study|Withdrawal by Subject|2|||
148769660|NCT01827267|536629473|FG000|Overall Study|Did not receive study drug|1|||
148769661|NCT01827267|536629474|FG001|Overall Study|Did not receive study drug|1|||
148831255|NCT01877278|536860367|FG000|Overall Study|Lost to Follow-up|3|||
148831256|NCT01877278|536860368|FG001|Overall Study|Lost to Follow-up|3|||
148831257|NCT04727151|536860369|FG000|Overall Study|Death|0|||
148831258|NCT04727151|536860370|FG001|Overall Study|Death|0|||
148831259|NCT04727151|536860371|FG002|Overall Study|Death|0|||
148831260|NCT04727151|536860372|FG003|Overall Study|Death|0|||
148831261|NCT04727151|536860373|FG004|Overall Study|Death|3|||
148831262|NCT04727151|536860369|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
148831263|NCT04727151|536860370|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
148831264|NCT04727151|536860371|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
148831265|NCT04727151|536860372|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
148831266|NCT04727151|536860373|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
148831267|NCT03510715|536860374|FG000|Overall Study|Adverse Event|1|||
148831268|NCT03510715|536860375|FG001|Overall Study|Adverse Event|0|||
148831269|NCT02095106|536862268|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
148831270|NCT02095106|536862269|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
148831271|NCT01381679|536862275|FG000|Overall Study|Adverse Event|3|||
148831272|NCT01381679|536862275|FG000|Overall Study|Lost to Follow-up|885|||
148831273|NCT04023487|536862276|FG000|Overall Study|Lost to Follow-up|5|||
148831274|NCT04023487|536862277|FG001|Overall Study|Lost to Follow-up|4|||
148831275|NCT04023487|536862276|FG000|Overall Study|Pregnancy|1|||
148831276|NCT04023487|536862277|FG001|Overall Study|Pregnancy|2|||
148831277|NCT04023487|536862276|FG000|Overall Study|Withdrawal by Subject|4|||
148831278|NCT04023487|536862277|FG001|Overall Study|Withdrawal by Subject|5|||
148831279|NCT04023487|536862276|FG000|Overall Study|Partially completed testing|8|||
148831280|NCT04023487|536862277|FG001|Overall Study|Partially completed testing|4|||
148831281|NCT04770285|536862279|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
148831282|NCT04770285|536862280|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
148831283|NCT04770285|536862279|FG000|Overall Study|Lack of Efficacy|0|||
148831284|NCT04770285|536862280|FG001|Overall Study|Lack of Efficacy|1|||
148831285|NCT04770285|536862279|FG000|Overall Study|Lost to Follow-up|11|||
148831286|NCT04770285|536862280|FG001|Overall Study|Lost to Follow-up|8|||
148831287|NCT04770285|536862279|FG000|Overall Study|Protocol Deviation|6|||
148831288|NCT04770285|536862280|FG001|Overall Study|Protocol Deviation|6|||
148831289|NCT04770285|536862279|FG000|Overall Study|Technical Problem|0|||
148831290|NCT04770285|536862280|FG001|Overall Study|Technical Problem|1|||
148831291|NCT04770285|536862279|FG000|Overall Study|Withdrawal by Subject|9|||
148831292|NCT04770285|536862280|FG001|Overall Study|Withdrawal by Subject|8|||
148831293|NCT04770285|536862279|FG000|Overall Study|Reason Not Specified|0|||
148831294|NCT04770285|536862280|FG001|Overall Study|Reason Not Specified|1|||
148831295|NCT03766399|536862281|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831296|NCT03766399|536862282|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831297|NCT03766399|536862283|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831298|NCT03766399|536862284|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831299|NCT03766399|536862285|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831300|NCT03766399|536862286|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831301|NCT03766399|536862287|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831302|NCT03766399|536862288|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831303|NCT03766399|536862289|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831304|NCT03766399|536862290|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831305|NCT03766399|536862291|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831306|NCT03766399|536862292|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831307|NCT03766399|536862293|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831308|NCT03766399|536862294|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
148831309|NCT03766399|536862295|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831310|NCT03766399|536862296|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831311|NCT03766399|536862297|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831312|NCT03766399|536862298|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
148831313|NCT05030766|536862299|FG000|Phase 1 Participants|Lost to Follow-up|12|||
148831314|NCT05030766|536862300|FG001|Phase 1 Participants|Lost to Follow-up|22|||
148831315|NCT05030766|536862301|FG002|Phase 1 Participants|Lost to Follow-up|0|||
148831316|NCT05030766|536862302|FG003|Phase 1 Participants|Lost to Follow-up|0|||
148831317|NCT05030766|536862299|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
148831318|NCT05030766|536862300|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
148831319|NCT05030766|536862301|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
148831320|NCT05030766|536862302|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
148831321|NCT05030766|536862299|FG000|Phase 2 Participants|Lost to Follow-up|0|||
148831322|NCT05030766|536862300|FG001|Phase 2 Participants|Lost to Follow-up|0|||
148831323|NCT05030766|536862301|FG002|Phase 2 Participants|Lost to Follow-up|6|||
148831324|NCT05030766|536862302|FG003|Phase 2 Participants|Lost to Follow-up|2|||
148831325|NCT00645658|536862303|FG000|Overall Study|Withdrawal by Subject|1|||
148831326|NCT00645658|536862304|FG001|Overall Study|Withdrawal by Subject|0|||
148831327|NCT00645658|536862303|FG000|Overall Study|Did not complete all assesments|0|||
148831328|NCT00645658|536862304|FG001|Overall Study|Did not complete all assesments|2|||
148980598|NCT04258839|537409325|FG000|Overall Study|Lack of Efficacy|0|||
148980599|NCT04258839|537409326|FG001|Overall Study|Lack of Efficacy|2|||
148980600|NCT04258839|537409325|FG000|Overall Study|Lost to Follow-up|2|||
148980601|NCT04258839|537409326|FG001|Overall Study|Lost to Follow-up|0|||
148980602|NCT04258839|537409325|FG000|Overall Study|Withdrawal by Subject|1|||
148980603|NCT04258839|537409326|FG001|Overall Study|Withdrawal by Subject|2|||
148980604|NCT04258839|537409325|FG000|Overall Study|Withdrawal by Caregiver|5|||
148980605|NCT04258839|537409326|FG001|Overall Study|Withdrawal by Caregiver|6|||
148980606|NCT04258839|537409325|FG000|Overall Study|Reason not Specified|0|||
148980607|NCT04258839|537409326|FG001|Overall Study|Reason not Specified|1|||
148980608|NCT02293005|537409327|FG000|Overall Study|Adverse Event|2|||
148980609|NCT02293005|537409327|FG000|Overall Study|Death|4|||
148980610|NCT02293005|537409327|FG000|Overall Study|Lost to Follow-up|1|||
148980611|NCT02293005|537409327|FG000|Overall Study|Withdrawal by Subject|2|||
148980612|NCT02293005|537409327|FG000|Overall Study|Progression|17|||
148980613|NCT03328897|537409328|FG000|Randomized-treatment Epoch|Adverse Event|4|||
148980614|NCT03328897|537409329|FG001|Randomized-treatment Epoch|Adverse Event|1|||
148980615|NCT03328897|537409330|FG002|Randomized-treatment Epoch|Adverse Event|1|||
148980616|NCT03328897|537409328|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
148980617|NCT03328897|537409329|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
148980618|NCT03328897|537409330|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
148980619|NCT03328897|537409328|FG000|Randomized-treatment Epoch|Pregnancy|3|||
148980620|NCT03328897|537409329|FG001|Randomized-treatment Epoch|Pregnancy|0|||
148980621|NCT03328897|537409330|FG002|Randomized-treatment Epoch|Pregnancy|0|||
148980622|NCT03328897|537409328|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
148980623|NCT03328897|537409329|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
148980624|NCT03328897|537409330|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
148980625|NCT03328897|537409328|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
148980626|NCT03328897|537409329|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
148980627|NCT03328897|537409330|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
148980628|NCT03328897|537409328|FG000|Follow-up Epoch|Adverse Event|4|||
148980629|NCT03328897|537409329|FG001|Follow-up Epoch|Adverse Event|0|||
148980630|NCT03328897|537409330|FG002|Follow-up Epoch|Adverse Event|1|||
148980631|NCT03328897|537409328|FG000|Follow-up Epoch|Lack of Efficacy|1|||
148980632|NCT03328897|537409329|FG001|Follow-up Epoch|Lack of Efficacy|1|||
148980633|NCT03328897|537409330|FG002|Follow-up Epoch|Lack of Efficacy|1|||
148980634|NCT03328897|537409328|FG000|Follow-up Epoch|Lost to Follow-up|0|||
148980635|NCT03328897|537409329|FG001|Follow-up Epoch|Lost to Follow-up|1|||
148980636|NCT03328897|537409330|FG002|Follow-up Epoch|Lost to Follow-up|0|||
148980637|NCT03328897|537409328|FG000|Follow-up Epoch|Pregnancy|1|||
148980638|NCT03328897|537409329|FG001|Follow-up Epoch|Pregnancy|0|||
148980639|NCT03328897|537409330|FG002|Follow-up Epoch|Pregnancy|0|||
148980640|NCT03328897|537409328|FG000|Follow-up Epoch|Patient/guardian decision|2|||
148980641|NCT03328897|537409329|FG001|Follow-up Epoch|Patient/guardian decision|1|||
148980642|NCT03328897|537409330|FG002|Follow-up Epoch|Patient/guardian decision|0|||
148980643|NCT00608829|537409331|FG000|Overall Study|Death|6|||
148980644|NCT00608829|537409331|FG000|Overall Study|Withdrawal by Subject|4|||
148980645|NCT00608829|537409331|FG000|Overall Study|Subject refuses to follow up or return.|5|||
148980646|NCT02805257|537409332|FG000|Overall Study|Lost to Follow-up|7|||
148980647|NCT02805257|537409333|FG001|Overall Study|Lost to Follow-up|6|||
148980648|NCT02805257|537409332|FG000|Overall Study|Death|0|||
148980649|NCT02805257|537409333|FG001|Overall Study|Death|1|||
148980650|NCT00612066|537409334|FG000|Overall Study|Adverse Event|1|||
148980651|NCT01043874|537409336|FG000|Overall Study|Adverse Event|3|||
148980652|NCT01043874|537409336|FG000|Overall Study|Withdrawal by Subject|1|||
148980653|NCT01043874|537409336|FG000|Overall Study|Lack of Efficacy|1|||
148980654|NCT01043874|537409336|FG000|Overall Study|Administrative Problems|1|||
148980655|NCT02648698|537409339|FG000|Overall Study|Protocol Violation|1|||
148980656|NCT02648698|537409340|FG001|Overall Study|Protocol Violation|5|||
148980657|NCT00966940|537409341|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
148980658|NCT00966940|537409342|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
148980659|NCT00966940|537409341|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
148980660|NCT00966940|537409342|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
148980661|NCT01774903|537409343|FG000|Overall Study|Adverse Event|7|||
148980662|NCT01774903|537409343|FG000|Overall Study|Withdrawal by Subject|2|||
148980663|NCT01774903|537409343|FG000|Overall Study|Lack of Efficacy|1|||
148980664|NCT01774903|537409343|FG000|Overall Study|Ineligible to continue the trial|1|||
149028050|NCT01474538|537580069|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148831329|NCT03895372|536862307|FG000|Investigational Treatment Period|Adverse Event|1|||
148980665|NCT00924950|537409344|FG000|Overall Study|Lost to Follow-up|2|||
148980666|NCT00982319|537409345|FG000|Overall Study|Surgery date change|1|||
148980667|NCT00982319|537409346|FG001|Overall Study|Surgery date change|0|||
149028051|NCT01474538|537580070|FG001|Treatment Period 1|Withdrawal by Subject|3|||
148980668|NCT00982319|537409345|FG000|Overall Study|Preop values out of acceptable range|1|||
148980669|NCT00982319|537409346|FG001|Overall Study|Preop values out of acceptable range|1|||
148980670|NCT00982319|537409345|FG000|Overall Study|Pregnancy|0|||
148831330|NCT03895372|536862308|FG001|Investigational Treatment Period|Adverse Event|0|||
148831331|NCT03895372|536862309|FG002|Investigational Treatment Period|Adverse Event|0|||
148831332|NCT03895372|536862310|FG003|Investigational Treatment Period|Adverse Event|0|||
148831333|NCT03895372|536862311|FG004|Investigational Treatment Period|Adverse Event|0|||
148831334|NCT03895372|536862312|FG005|Investigational Treatment Period|Adverse Event|0|||
148831335|NCT03895372|536862313|FG006|Investigational Treatment Period|Adverse Event|4|||
148831336|NCT03895372|536862314|FG007|Investigational Treatment Period|Adverse Event|3|||
148831337|NCT03895372|536862307|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
148831338|NCT03895372|536862308|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
148831339|NCT03895372|536862309|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
148831340|NCT03895372|536862310|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
148831341|NCT03895372|536862311|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
148831342|NCT03895372|536862312|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
148831343|NCT03895372|536862313|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
148831344|NCT03895372|536862314|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
148831345|NCT03895372|536862307|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
148831346|NCT03895372|536862308|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
148831347|NCT03895372|536862309|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
148831348|NCT03895372|536862310|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
148831349|NCT03895372|536862311|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
148831350|NCT03895372|536862312|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
148831351|NCT03895372|536862313|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
148831352|NCT03895372|536862314|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
148831353|NCT03895372|536862307|FG000|Investigational Treatment Period|Other|0|||
148831354|NCT03895372|536862308|FG001|Investigational Treatment Period|Other|0|||
148831355|NCT03895372|536862309|FG002|Investigational Treatment Period|Other|0|||
148831356|NCT03895372|536862310|FG003|Investigational Treatment Period|Other|0|||
148831357|NCT03895372|536862311|FG004|Investigational Treatment Period|Other|0|||
148831358|NCT03895372|536862312|FG005|Investigational Treatment Period|Other|1|||
148831359|NCT03895372|536862313|FG006|Investigational Treatment Period|Other|0|||
148831360|NCT03895372|536862314|FG007|Investigational Treatment Period|Other|2|||
148831361|NCT03895372|536862307|FG000|Investigational Treatment Period|Protocol Violation|0|||
148831362|NCT03895372|536862308|FG001|Investigational Treatment Period|Protocol Violation|0|||
148831363|NCT03895372|536862309|FG002|Investigational Treatment Period|Protocol Violation|0|||
148831364|NCT03895372|536862310|FG003|Investigational Treatment Period|Protocol Violation|1|||
148831365|NCT03895372|536862311|FG004|Investigational Treatment Period|Protocol Violation|0|||
148831366|NCT03895372|536862312|FG005|Investigational Treatment Period|Protocol Violation|0|||
148831367|NCT03895372|536862313|FG006|Investigational Treatment Period|Protocol Violation|0|||
148831368|NCT03895372|536862314|FG007|Investigational Treatment Period|Protocol Violation|0|||
148831369|NCT03895372|536862307|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
148831370|NCT03895372|536862308|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
148831371|NCT03895372|536862309|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
148831372|NCT03895372|536862310|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
148831373|NCT03895372|536862311|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
148831374|NCT03895372|536862312|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
148831375|NCT03895372|536862313|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
148831376|NCT03895372|536862314|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
148831377|NCT03895372|536862307|FG000|Extension Treatment Period|Adverse Event|0|||
148831378|NCT03895372|536862308|FG001|Extension Treatment Period|Adverse Event|1|||
148831379|NCT03895372|536862309|FG002|Extension Treatment Period|Adverse Event|0|||
148831380|NCT03895372|536862310|FG003|Extension Treatment Period|Adverse Event|1|||
148831381|NCT03895372|536862311|FG004|Extension Treatment Period|Adverse Event|0|||
148831382|NCT03895372|536862312|FG005|Extension Treatment Period|Adverse Event|0|||
148831383|NCT03895372|536862313|FG006|Extension Treatment Period|Adverse Event|3|||
148831384|NCT03895372|536862314|FG007|Extension Treatment Period|Adverse Event|3|||
148831385|NCT03895372|536862307|FG000|Extension Treatment Period|Other|1|||
148831386|NCT03895372|536862308|FG001|Extension Treatment Period|Other|3|||
148831387|NCT03895372|536862309|FG002|Extension Treatment Period|Other|0|||
148831388|NCT03895372|536862310|FG003|Extension Treatment Period|Other|0|||
148831389|NCT03895372|536862311|FG004|Extension Treatment Period|Other|1|||
148831390|NCT03895372|536862312|FG005|Extension Treatment Period|Other|0|||
149028052|NCT01474538|537580069|FG000|Treatment Period 1|Protocol Violation|0|||
148831391|NCT03895372|536862313|FG006|Extension Treatment Period|Other|0|||
148831392|NCT03895372|536862314|FG007|Extension Treatment Period|Other|2|||
148831393|NCT03895372|536862307|FG000|Extension Treatment Period|Pregnancy|0|||
148831394|NCT03895372|536862308|FG001|Extension Treatment Period|Pregnancy|0|||
148831395|NCT03895372|536862309|FG002|Extension Treatment Period|Pregnancy|0|||
148831396|NCT03895372|536862310|FG003|Extension Treatment Period|Pregnancy|0|||
148831397|NCT03895372|536862311|FG004|Extension Treatment Period|Pregnancy|1|||
148831398|NCT03895372|536862312|FG005|Extension Treatment Period|Pregnancy|0|||
148831399|NCT03895372|536862313|FG006|Extension Treatment Period|Pregnancy|0|||
148980671|NCT00982319|537409346|FG001|Overall Study|Pregnancy|1|||
148980672|NCT03603964|537409349|FG000|Overall Study|Death|9|||
148980673|NCT03603964|537409349|FG000|Overall Study|Withdrawal by participant|7|||
148980674|NCT03603964|537409349|FG000|Overall Study|Study terminated by Sponsor|19|||
148980675|NCT00563797|537409350|FG000|Overall Study|Lost to Follow-up|7|||
148980676|NCT00563797|537409351|FG001|Overall Study|Lost to Follow-up|2|||
148980677|NCT00530023|537409352|FG000|Overall Study|Withdrawal by Subject|0|||
148980678|NCT00530023|537409353|FG001|Overall Study|Withdrawal by Subject|1|||
148980679|NCT04632940|537409370|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
148980680|NCT04632940|537409371|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
148980681|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
148980682|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
148980683|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
148980684|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
148980685|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
148980686|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
148980687|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
148980688|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
148980689|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
148980690|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
148980691|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Other than specified|0|||
148980692|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Other than specified|1|||
148980693|NCT04632940|537409370|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
148980694|NCT04632940|537409371|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
148831400|NCT03895372|536862314|FG007|Extension Treatment Period|Pregnancy|0|||
148831401|NCT03895372|536862307|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
148831402|NCT03895372|536862308|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
148831403|NCT03895372|536862309|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
148831404|NCT03895372|536862310|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
148831405|NCT03895372|536862311|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
148831406|NCT03895372|536862312|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
148831407|NCT03895372|536862313|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
148831408|NCT03895372|536862314|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
148831409|NCT05205616|536862317|FG000|Overall Study|Lost to Follow-up|4|||
148831410|NCT05205616|536862318|FG001|Overall Study|Lost to Follow-up|4|||
148831411|NCT02657343|536862321|FG000|Overall Study|Death|0|||
148831412|NCT02657343|536862322|FG001|Overall Study|Death|2|||
148831413|NCT02657343|536862323|FG002|Overall Study|Death|0|||
148831414|NCT02657343|536862324|FG003|Overall Study|Death|0|||
148831415|NCT02657343|536862325|FG004|Overall Study|Death|0|||
148831416|NCT02657343|536862326|FG005|Overall Study|Death|0|||
148831417|NCT02657343|536862321|FG000|Overall Study|Patient went to hospice|1|||
148831418|NCT02657343|536862322|FG001|Overall Study|Patient went to hospice|0|||
148831419|NCT02657343|536862323|FG002|Overall Study|Patient went to hospice|0|||
148831420|NCT02657343|536862324|FG003|Overall Study|Patient went to hospice|0|||
148831421|NCT02657343|536862325|FG004|Overall Study|Patient went to hospice|0|||
148831422|NCT02657343|536862326|FG005|Overall Study|Patient went to hospice|0|||
148831423|NCT02657343|536862321|FG000|Overall Study|Withdrawal by Subject|0|||
148831424|NCT02657343|536862322|FG001|Overall Study|Withdrawal by Subject|0|||
148831425|NCT02657343|536862323|FG002|Overall Study|Withdrawal by Subject|0|||
148831426|NCT02657343|536862324|FG003|Overall Study|Withdrawal by Subject|0|||
148831427|NCT02657343|536862325|FG004|Overall Study|Withdrawal by Subject|1|||
148831428|NCT02657343|536862326|FG005|Overall Study|Withdrawal by Subject|0|||
148831429|NCT02607722|536862327|FG000|Overall Study|No data reliability|1|||
148831430|NCT02607722|536862327|FG000|Overall Study|no patient visit|18|||
148831431|NCT02607722|536862327|FG000|Overall Study|missing info in CRF|13|||
148831432|NCT02607722|536862327|FG000|Overall Study|Withdrawal by Subject|616|||
148831433|NCT02607722|536862327|FG000|Overall Study|Lost to Follow-up|312|||
148831434|NCT02607722|536862327|FG000|Overall Study|Improved|22|||
148831435|NCT02607722|536862327|FG000|Overall Study|Lack of Efficacy|316|||
148831436|NCT02607722|536862327|FG000|Overall Study|Adverse Event|2553|||
148831437|NCT02607722|536862327|FG000|Overall Study|Not treated|1|||
148831438|NCT02607722|536862327|FG000|Overall Study|No CRF collected|138|||
148831439|NCT02607722|536862327|FG000|Overall Study|without CRF|4225|||
148831440|NCT02607722|536862327|FG000|Overall Study|Physician Decision|367|||
148831441|NCT04347538|536862328|FG000|Overall Study|Lost to Follow-up|4|||
148831442|NCT04347538|536862329|FG001|Overall Study|Lost to Follow-up|5|||
148831443|NCT04347538|536862330|FG002|Overall Study|Lost to Follow-up|7|||
148831444|NCT02135133|536862331|FG000|Overall Study|Adverse Event|10|||
148831445|NCT02135133|536862331|FG000|Overall Study|regulatory mandate|5|||
148831446|NCT02259231|536862332|FG000|Overall Study|Adverse Event|1|||
148831447|NCT02259231|536862333|FG001|Overall Study|Adverse Event|1|||
148831448|NCT02259231|536862334|FG002|Overall Study|Adverse Event|2|||
148980695|NCT00887341|537409374|FG000|Overall Study|Refused treatment|1|||
148980696|NCT00887341|537409375|FG001|Overall Study|Refused treatment|0|||
148831449|NCT02259231|536862335|FG003|Overall Study|Adverse Event|0|||
148769662|NCT01827267|536629473|FG000|Overall Study|Physician Decision|1|||
148769663|NCT01827267|536629474|FG001|Overall Study|Physician Decision|0|||
148769664|NCT01827267|536629473|FG000|Overall Study|Disease Progression|1|||
148769665|NCT01827267|536629474|FG001|Overall Study|Disease Progression|1|||
148769666|NCT01827267|536629473|FG000|Overall Study|Sponsor Discontinued Study|2|||
148769667|NCT01827267|536629474|FG001|Overall Study|Sponsor Discontinued Study|8|||
148769668|NCT01827267|536629473|FG000|Overall Study|Still on study|0|||
148769669|NCT01827267|536629474|FG001|Overall Study|Still on study|2|||
148769670|NCT03070002|536629475|FG000|Follow up for 2 Years|Death|1|||
148769671|NCT04520997|536629478|FG000|Overall Study|Lost to Follow-up|1|||
148769672|NCT04520997|536629479|FG001|Overall Study|Lost to Follow-up|1|||
148769673|NCT04520997|536629478|FG000|Overall Study|Withdrawal by Subject|1|||
148769674|NCT04520997|536629479|FG001|Overall Study|Withdrawal by Subject|0|||
148769675|NCT04520997|536629478|FG000|Overall Study|Not Treated|0|||
148769676|NCT04520997|536629479|FG001|Overall Study|Not Treated|1|||
148769677|NCT03689374|536629482|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
148769678|NCT03689374|536629483|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
148769679|NCT03689374|536629484|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
148769680|NCT03689374|536629482|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
148769681|NCT03689374|536629483|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
148769682|NCT03689374|536629484|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
148769683|NCT03689374|536629482|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
148769684|NCT03689374|536629483|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
148769685|NCT03689374|536629484|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
148769686|NCT03689374|536629482|FG000|Treatment Period (Week 0 to 52)|Death|0|||
148769687|NCT03689374|536629483|FG001|Treatment Period (Week 0 to 52)|Death|11|||
148769688|NCT03689374|536629484|FG002|Treatment Period (Week 0 to 52)|Death|1|||
148769689|NCT05367973|536629485|FG000|Overall Study|Adverse Event|0|||
148769690|NCT05367973|536629486|FG001|Overall Study|Adverse Event|2|||
148769691|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
148769692|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
148769693|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
148769694|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
148769695|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Death|0|||
148769696|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Death|0|||
148769697|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Death|1|||
148769698|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Death|0|||
148769699|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
148769700|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
148769701|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
148769702|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
148769703|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
148769704|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
148769705|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
148769706|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
148769707|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
148769708|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
148769709|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
148769710|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
148769711|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
148769712|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
148769713|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
148769714|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
148769715|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
148769716|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
148769717|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
148769718|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
148769719|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
148769720|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
148769721|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
148769722|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
148769723|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
148769724|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
148769725|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148769726|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
148769727|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
148769728|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
148769729|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
148769730|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
148831450|NCT02259231|536862336|FG004|Overall Study|Adverse Event|0|||
149028053|NCT01474538|537580070|FG001|Treatment Period 1|Protocol Violation|1|||
149028054|NCT01474538|537580069|FG000|Treatment Period 2|Death|1|||
149028055|NCT01474538|537580070|FG001|Treatment Period 2|Death|0|||
148769731|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
148769732|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
148769733|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
148769734|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
148769735|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Other|8|||
148769736|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Other|14|||
148769737|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Other|8|||
148769738|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Other|23|||
148769739|NCT01106677|536632672|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
148769740|NCT01106677|536632673|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
148769741|NCT01106677|536632674|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
148769742|NCT01106677|536632675|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
148769743|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
148769744|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
148769745|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
148769746|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
148769747|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Death|0|||
148769748|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Death|0|||
148769749|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Death|0|||
148769750|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Death|1|||
148769751|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
148769752|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
148769753|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
148769754|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
148769755|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
148769756|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
148769757|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
148769758|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
148769759|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
148769760|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
148769761|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
148769762|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
148769763|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
148769764|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148769765|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148769766|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
148769767|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
148769768|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
148769769|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
148769770|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
148769771|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
148769772|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
148769773|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
148769774|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
148769775|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148769776|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148769777|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
148769778|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
148769779|NCT01106677|536632672|FG000|Extension Period: Week 26 to Week 52|Other|6|||
148769780|NCT01106677|536632673|FG001|Extension Period: Week 26 to Week 52|Other|5|||
148769781|NCT01106677|536632674|FG002|Extension Period: Week 26 to Week 52|Other|8|||
148769782|NCT01106677|536632675|FG003|Extension Period: Week 26 to Week 52|Other|5|||
148769783|NCT03875092|536632676|FG000|Overall Study|Adverse Event|2|||
148769784|NCT03875092|536632677|FG001|Overall Study|Adverse Event|5|||
148769785|NCT03875092|536632676|FG000|Overall Study|Death|44|||
148769786|NCT03875092|536632677|FG001|Overall Study|Death|51|||
148769787|NCT03875092|536632676|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
148769788|NCT03875092|536632677|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
148769789|NCT04114357|536632678|FG000|Baseline-Randomization|Adverse Event|2|||
148769790|NCT04114357|536632679|FG001|Baseline-Randomization|Adverse Event|1|||
148769791|NCT04114357|536632678|FG000|Baseline-Randomization|Lost to Follow-up|1|||
148769792|NCT04114357|536632679|FG001|Baseline-Randomization|Lost to Follow-up|1|||
148769793|NCT04114357|536632678|FG000|Cross-over|Adverse Event|0|||
149028056|NCT01474538|537580069|FG000|Treatment Period 2|Adverse Event|1|||
149028057|NCT01474538|537580070|FG001|Treatment Period 2|Adverse Event|1|||
148831451|NCT02259231|536862337|FG005|Overall Study|Adverse Event|0|||
148831452|NCT02259231|536862338|FG006|Overall Study|Adverse Event|0|||
148831453|NCT02259231|536862332|FG000|Overall Study|Progressive Disease|4|||
148831454|NCT02259231|536862333|FG001|Overall Study|Progressive Disease|5|||
148831455|NCT02259231|536862334|FG002|Overall Study|Progressive Disease|4|||
148831456|NCT02259231|536862335|FG003|Overall Study|Progressive Disease|5|||
148831457|NCT02259231|536862336|FG004|Overall Study|Progressive Disease|4|||
148831458|NCT02259231|536862337|FG005|Overall Study|Progressive Disease|5|||
148831459|NCT02259231|536862338|FG006|Overall Study|Progressive Disease|4|||
148831460|NCT02259231|536862332|FG000|Overall Study|Sponsor termination of study|1|||
148831461|NCT02259231|536862333|FG001|Overall Study|Sponsor termination of study|0|||
148831462|NCT02259231|536862334|FG002|Overall Study|Sponsor termination of study|0|||
148831463|NCT02259231|536862335|FG003|Overall Study|Sponsor termination of study|1|||
148831464|NCT02259231|536862336|FG004|Overall Study|Sponsor termination of study|2|||
148831465|NCT02259231|536862337|FG005|Overall Study|Sponsor termination of study|1|||
148831466|NCT02259231|536862338|FG006|Overall Study|Sponsor termination of study|1|||
148831467|NCT03238196|536862339|FG000|Overall Study|Adverse Event|3|||
148831468|NCT03238196|536862340|FG001|Overall Study|Adverse Event|0|||
148831469|NCT03238196|536862341|FG002|Overall Study|Adverse Event|2|||
148831470|NCT03238196|536862342|FG003|Overall Study|Adverse Event|2|||
148831471|NCT03238196|536862339|FG000|Overall Study|Withdrawal by Subject|4|||
148831472|NCT03238196|536862340|FG001|Overall Study|Withdrawal by Subject|1|||
148831473|NCT03238196|536862341|FG002|Overall Study|Withdrawal by Subject|1|||
148769794|NCT04114357|536632679|FG001|Cross-over|Adverse Event|1|||
148769795|NCT03693612|536632680|FG000|Overall Study|Lost to Follow-up|0|||
148769796|NCT03693612|536632681|FG001|Overall Study|Lost to Follow-up|0|||
148769797|NCT03693612|536632682|FG002|Overall Study|Lost to Follow-up|0|||
148769798|NCT03693612|536632683|FG003|Overall Study|Lost to Follow-up|0|||
148769799|NCT03693612|536632684|FG004|Overall Study|Lost to Follow-up|1|||
148769800|NCT03693612|536632685|FG005|Overall Study|Lost to Follow-up|0|||
148769801|NCT03693612|536632686|FG006|Overall Study|Lost to Follow-up|0|||
148769802|NCT03693612|536632680|FG000|Overall Study|Withdrawal by Subject|0|||
148769803|NCT03693612|536632681|FG001|Overall Study|Withdrawal by Subject|0|||
148769804|NCT03693612|536632682|FG002|Overall Study|Withdrawal by Subject|1|||
148769805|NCT03693612|536632683|FG003|Overall Study|Withdrawal by Subject|0|||
148769806|NCT03693612|536632684|FG004|Overall Study|Withdrawal by Subject|2|||
148769807|NCT03693612|536632685|FG005|Overall Study|Withdrawal by Subject|0|||
148769808|NCT03693612|536632686|FG006|Overall Study|Withdrawal by Subject|0|||
148769809|NCT03693612|536632680|FG000|Overall Study|Study Terminated by Sponsor|0|||
148769810|NCT03693612|536632681|FG001|Overall Study|Study Terminated by Sponsor|1|||
148769811|NCT03693612|536632682|FG002|Overall Study|Study Terminated by Sponsor|0|||
148769812|NCT03693612|536632683|FG003|Overall Study|Study Terminated by Sponsor|0|||
148769813|NCT03693612|536632684|FG004|Overall Study|Study Terminated by Sponsor|3|||
148769814|NCT03693612|536632685|FG005|Overall Study|Study Terminated by Sponsor|0|||
148769815|NCT03693612|536632686|FG006|Overall Study|Study Terminated by Sponsor|0|||
148769816|NCT01669174|536632693|FG000|Overall Study|Subject withdrew consent|2|||
148769817|NCT01669174|536632694|FG001|Overall Study|Subject withdrew consent|2|||
148769818|NCT01669174|536632693|FG000|Overall Study|Lost to Follow-up|1|||
148769819|NCT01669174|536632694|FG001|Overall Study|Lost to Follow-up|0|||
148769820|NCT01669174|536632693|FG000|Overall Study|Adverse Event|2|||
148769821|NCT01669174|536632694|FG001|Overall Study|Adverse Event|2|||
148769822|NCT01669174|536632693|FG000|Overall Study|Administrative problems|1|||
148769823|NCT01669174|536632694|FG001|Overall Study|Administrative problems|2|||
148769824|NCT01953601|536632695|FG000|Part 1 (Base Study)|Adverse Event|24|||
148769825|NCT01953601|536632696|FG001|Part 1 (Base Study)|Adverse Event|37|||
148769826|NCT01953601|536632697|FG002|Part 1 (Base Study)|Adverse Event|15|||
148769827|NCT01953601|536632695|FG000|Part 1 (Base Study)|Death|2|||
148769828|NCT01953601|536632696|FG001|Part 1 (Base Study)|Death|0|||
148769829|NCT01953601|536632697|FG002|Part 1 (Base Study)|Death|3|||
148769830|NCT01953601|536632695|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
148769831|NCT01953601|536632696|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
148769832|NCT01953601|536632697|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
148769833|NCT01953601|536632695|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
148769834|NCT01953601|536632696|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
148769835|NCT01953601|536632697|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
148769836|NCT01953601|536632695|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
148769837|NCT01953601|536632696|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
148769838|NCT01953601|536632697|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
148769839|NCT01953601|536632695|FG000|Part 1 (Base Study)|Physician Decision|3|||
148769840|NCT01953601|536632696|FG001|Part 1 (Base Study)|Physician Decision|7|||
148769841|NCT01953601|536632697|FG002|Part 1 (Base Study)|Physician Decision|4|||
148769842|NCT01953601|536632695|FG000|Part 1 (Base Study)|Screen failure|1|||
148769843|NCT01953601|536632696|FG001|Part 1 (Base Study)|Screen failure|0|||
148769844|NCT01953601|536632697|FG002|Part 1 (Base Study)|Screen failure|1|||
148769845|NCT01953601|536632695|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
148831474|NCT03238196|536862342|FG003|Overall Study|Withdrawal by Subject|0|||
148831475|NCT03238196|536862339|FG000|Overall Study|Disease progression|14|||
148831476|NCT03238196|536862340|FG001|Overall Study|Disease progression|2|||
148831477|NCT03238196|536862341|FG002|Overall Study|Disease progression|3|||
148831478|NCT03238196|536862342|FG003|Overall Study|Disease progression|2|||
148831479|NCT03238196|536862339|FG000|Overall Study|Still on treatment|1|||
148831480|NCT03238196|536862340|FG001|Overall Study|Still on treatment|0|||
148831481|NCT03238196|536862341|FG002|Overall Study|Still on treatment|0|||
148831482|NCT03238196|536862342|FG003|Overall Study|Still on treatment|0|||
148831483|NCT04562090|536862343|FG000|Overall Study|Withdrawal by Subject|3|||
148831484|NCT04562090|536862344|FG001|Overall Study|Withdrawal by Subject|4|||
148831485|NCT04562090|536862343|FG000|Overall Study|Protocol Violation|2|||
148831486|NCT04562090|536862344|FG001|Overall Study|Protocol Violation|0|||
148831487|NCT04562090|536862343|FG000|Overall Study|Lack of Efficacy|0|||
148831488|NCT04562090|536862344|FG001|Overall Study|Lack of Efficacy|1|||
148831489|NCT04562090|536862343|FG000|Overall Study|Adverse Event|1|||
148831490|NCT04562090|536862344|FG001|Overall Study|Adverse Event|4|||
149028058|NCT01474538|537580069|FG000|Treatment Period 2|Withdrawal by Subject|2|||
149028059|NCT01474538|537580070|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149028060|NCT01474538|537580069|FG000|Treatment Period 2|Sponsor decision|1|||
149028061|NCT01474538|537580070|FG001|Treatment Period 2|Sponsor decision|0|||
149028062|NCT01474538|537580069|FG000|Treatment Period 2|Physician Decision|0|||
149028063|NCT01474538|537580070|FG001|Treatment Period 2|Physician Decision|1|||
149028064|NCT01474538|537580069|FG000|Treatment Period 2|Protocol Violation|1|||
149028065|NCT01474538|537580070|FG001|Treatment Period 2|Protocol Violation|0|||
149028066|NCT04565249|537580071|FG000|Overall Study|Death|0|||
149028067|NCT04565249|537580072|FG001|Overall Study|Death|0|||
149028068|NCT04565249|537580073|FG002|Overall Study|Death|0|||
149028069|NCT04565249|537580074|FG003|Overall Study|Death|1|||
149028070|NCT01289119|537580078|FG000|Overall Study|Adverse Event|2|||
149028071|NCT01289119|537580079|FG001|Overall Study|Adverse Event|1|||
149028072|NCT01289119|537580080|FG002|Overall Study|Adverse Event|0|||
149028073|NCT01289119|537580081|FG003|Overall Study|Adverse Event|2|||
149028074|NCT01289119|537580082|FG004|Overall Study|Adverse Event|1|||
149028075|NCT01289119|537580083|FG005|Overall Study|Adverse Event|0|||
149028076|NCT01289119|537580078|FG000|Overall Study|Major Protocol Deviation|2|||
149028077|NCT01289119|537580079|FG001|Overall Study|Major Protocol Deviation|1|||
149028078|NCT01289119|537580080|FG002|Overall Study|Major Protocol Deviation|3|||
149028079|NCT01289119|537580081|FG003|Overall Study|Major Protocol Deviation|0|||
148769846|NCT01953601|536632696|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
148769847|NCT01953601|536632697|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
148769848|NCT01953601|536632695|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
148769849|NCT01953601|536632696|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
148769850|NCT01953601|536632697|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
148769851|NCT01953601|536632695|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
148769852|NCT01953601|536632696|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
148769853|NCT01953601|536632697|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
148769854|NCT01953601|536632695|FG000|Part 1 (Base Study)|Subject moved|2|||
148769855|NCT01953601|536632696|FG001|Part 1 (Base Study)|Subject moved|2|||
148769856|NCT01953601|536632697|FG002|Part 1 (Base Study)|Subject moved|1|||
148769857|NCT01953601|536632695|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
148769858|NCT01953601|536632696|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
148769859|NCT01953601|536632697|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
148769860|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Adverse Event|1|||
148769861|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Adverse Event|1|||
148769862|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Adverse Event|10|||
148769863|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Death|0|||
148769864|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Death|3|||
148769865|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Death|0|||
148769866|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
148769867|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
148769868|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
148769869|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
148769870|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
148769871|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
148769872|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Physician Decision|2|||
148769873|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Physician Decision|0|||
148769874|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Physician Decision|2|||
148831491|NCT04562090|536862343|FG000|Overall Study|Miscellaneous|0|||
148831492|NCT04562090|536862344|FG001|Overall Study|Miscellaneous|3|||
148831493|NCT00847730|536862345|FG000|Overall Study|Multiple interruptions in therapy|8|||
148831494|NCT04938427|536862348|FG000|Overall Study|Adverse Event|5|||
149028080|NCT01289119|537580082|FG004|Overall Study|Major Protocol Deviation|2|||
149028081|NCT01289119|537580083|FG005|Overall Study|Major Protocol Deviation|1|||
149028082|NCT01289119|537580078|FG000|Overall Study|Lost to Follow-up|0|||
149028083|NCT01289119|537580079|FG001|Overall Study|Lost to Follow-up|3|||
148831495|NCT04938427|536862349|FG001|Overall Study|Adverse Event|19|||
148831496|NCT04938427|536862348|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
148831497|NCT04938427|536862349|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148831498|NCT04938427|536862348|FG000|Overall Study|Withdrawal by Subject|1|||
148831499|NCT04938427|536862349|FG001|Overall Study|Withdrawal by Subject|0|||
148831500|NCT04938427|536862348|FG000|Overall Study|Reason Not Specified|2|||
148831501|NCT04938427|536862349|FG001|Overall Study|Reason Not Specified|1|||
148831502|NCT03633058|536862358|FG000|Overall Study|Adverse Event|0|||
148831503|NCT03633058|536862359|FG001|Overall Study|Adverse Event|0|||
148831504|NCT03633058|536862360|FG002|Overall Study|Adverse Event|1|||
148831505|NCT03633058|536862361|FG003|Overall Study|Adverse Event|0|||
148831506|NCT03312543|536862364|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
148831507|NCT03312543|536862365|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
148831508|NCT03312543|536862364|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
148831509|NCT03312543|536862365|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
148831510|NCT03312543|536862364|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
148831511|NCT03312543|536862365|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
148831512|NCT03312543|536862364|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
148831513|NCT03312543|536862365|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
148980697|NCT00887341|537409374|FG000|Overall Study|Withdrawal by Subject|1|||
148980698|NCT00887341|537409375|FG001|Overall Study|Withdrawal by Subject|1|||
148980699|NCT00887341|537409374|FG000|Overall Study|Adverse Event|0|||
148980700|NCT00887341|537409375|FG001|Overall Study|Adverse Event|1|||
148980701|NCT00887341|537409374|FG000|Overall Study|Lost to Follow-up|0|||
148980702|NCT00887341|537409375|FG001|Overall Study|Lost to Follow-up|1|||
148980703|NCT01591681|537409378|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
148980704|NCT01591681|537409378|FG000|Overall Study|Failed to use system during run-in|1|||
148980705|NCT00235989|537409384|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
148980706|NCT00235989|537409385|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
148980707|NCT00235989|537409386|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
148980708|NCT00235989|537409387|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
148980709|NCT00235989|537409388|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
148980710|NCT00235989|537409389|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
148980711|NCT00235989|537409384|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
148980712|NCT00235989|537409385|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
148980713|NCT00235989|537409386|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
148980714|NCT00235989|537409387|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
148980715|NCT00235989|537409388|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
148980716|NCT00235989|537409389|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
148980717|NCT00235989|537409384|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
148980718|NCT00235989|537409385|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
148980719|NCT00235989|537409386|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
148980720|NCT00235989|537409387|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
148980721|NCT00235989|537409388|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
148980722|NCT00235989|537409389|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
148980723|NCT00235989|537409384|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
148980724|NCT00235989|537409385|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
148980725|NCT00235989|537409386|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
148980726|NCT00235989|537409387|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
148980727|NCT00235989|537409388|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
148980728|NCT00235989|537409389|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
148980729|NCT00235989|537409384|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
148980730|NCT00235989|537409385|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
148980731|NCT00235989|537409386|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
148980732|NCT00235989|537409387|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
148980733|NCT00235989|537409388|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
148980734|NCT00235989|537409389|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
148980735|NCT01071512|537409402|FG000|Overall Study|Adverse Event|1|||
148980736|NCT01071512|537409402|FG000|Overall Study|Development of antibodies to drug|2|||
148980737|NCT01071512|537409402|FG000|Overall Study|positive anti-JC virus antibody test|2|||
148831514|NCT03312543|536862364|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
148980738|NCT02316717|537409408|FG000|Overall Study|Adverse Event|2|||
148980739|NCT02316717|537409409|FG001|Overall Study|Adverse Event|2|||
148980740|NCT02316717|537409410|FG002|Overall Study|Adverse Event|0|||
148980741|NCT02316717|537409408|FG000|Overall Study|Lost to Follow-up|1|||
148980742|NCT02316717|537409409|FG001|Overall Study|Lost to Follow-up|2|||
148980743|NCT02316717|537409410|FG002|Overall Study|Lost to Follow-up|1|||
149028084|NCT01289119|537580080|FG002|Overall Study|Lost to Follow-up|0|||
149028085|NCT01289119|537580081|FG003|Overall Study|Lost to Follow-up|0|||
149028086|NCT01289119|537580082|FG004|Overall Study|Lost to Follow-up|0|||
148980744|NCT02316717|537409408|FG000|Overall Study|Non compliance|3|||
148980745|NCT02316717|537409409|FG001|Overall Study|Non compliance|1|||
149028087|NCT01289119|537580083|FG005|Overall Study|Lost to Follow-up|1|||
149028088|NCT01289119|537580078|FG000|Overall Study|Withdrawal by Subject|4|||
148769875|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
148769876|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
148769877|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
148769878|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
148769879|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
148769880|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
148769881|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
148769882|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
148769883|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
148769884|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Subject moved|0|||
148769885|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Subject moved|0|||
148769886|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Subject moved|1|||
148769887|NCT01953601|536632695|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
148769888|NCT01953601|536632696|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
148769889|NCT01953601|536632697|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
148769890|NCT04310397|536632704|FG000|Overall Study|Lack of Efficacy|3|||
148769891|NCT04310397|536632704|FG000|Overall Study|Withdrawal by Subject|1|||
148769892|NCT00723255|536632705|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
148769893|NCT00723255|536632705|FG000|Overall Study|Ineligible: Second primary|1|||
148769894|NCT00723255|536632705|FG000|Overall Study|Ineligible: Wrong Primary|2|||
148769895|NCT00614523|536632706|FG000|Overall Study|Adverse Event|4|||
148769896|NCT00614523|536632707|FG001|Overall Study|Adverse Event|20|||
148769897|NCT00614523|536632706|FG000|Overall Study|Death|5|||
148769898|NCT00614523|536632707|FG001|Overall Study|Death|8|||
148769899|NCT00614523|536632706|FG000|Overall Study|Lack of Efficacy|9|||
148769900|NCT00614523|536632707|FG001|Overall Study|Lack of Efficacy|11|||
148769901|NCT00614523|536632706|FG000|Overall Study|Lost to Follow-up|0|||
148769902|NCT00614523|536632707|FG001|Overall Study|Lost to Follow-up|1|||
148769903|NCT00614523|536632706|FG000|Overall Study|Protocol Violation|3|||
148769904|NCT00614523|536632707|FG001|Overall Study|Protocol Violation|2|||
148769905|NCT00614523|536632706|FG000|Overall Study|Withdrawal by Subject|12|||
148769906|NCT00614523|536632707|FG001|Overall Study|Withdrawal by Subject|22|||
148769907|NCT00614523|536632706|FG000|Overall Study|Other|6|||
148769908|NCT00614523|536632707|FG001|Overall Study|Other|11|||
148769909|NCT00614523|536632706|FG000|Overall Study|Ineligibility Determined|1|||
148769910|NCT00614523|536632707|FG001|Overall Study|Ineligibility Determined|2|||
148769911|NCT00614523|536632706|FG000|Overall Study|Disease Progression|0|||
148769912|NCT00614523|536632707|FG001|Overall Study|Disease Progression|8|||
148769913|NCT00614523|536632706|FG000|Overall Study|Administrative Decision|23|||
148769914|NCT00614523|536632707|FG001|Overall Study|Administrative Decision|46|||
148769915|NCT03962790|536632708|FG000|Period 1|Adverse Event|0|||
148769916|NCT03962790|536632709|FG001|Period 1|Adverse Event|1|||
148769917|NCT03962790|536632708|FG000|Period 1|Failed to meet all eligibility criteria|1|||
148769918|NCT03962790|536632709|FG001|Period 1|Failed to meet all eligibility criteria|1|||
148769919|NCT03962790|536632708|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
148769920|NCT03962790|536632709|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
148769921|NCT03962790|536632708|FG000|Period 1|Withdrawal by Subject|1|||
148769922|NCT03962790|536632709|FG001|Period 1|Withdrawal by Subject|0|||
148769923|NCT00452673|536632716|FG000|Dose Escalation Period|Disease Progression|6|||
148769924|NCT00452673|536632717|FG001|Dose Escalation Period|Disease Progression|6|||
148769925|NCT00452673|536632718|FG002|Dose Escalation Period|Disease Progression|2|||
148769926|NCT00452673|536632719|FG003|Dose Escalation Period|Disease Progression|6|||
148769927|NCT00452673|536632720|FG004|Dose Escalation Period|Disease Progression|0|||
148769928|NCT00452673|536632716|FG000|Dose Escalation Period|study drug toxicity|1|||
148769929|NCT00452673|536632717|FG001|Dose Escalation Period|study drug toxicity|3|||
148769930|NCT00452673|536632718|FG002|Dose Escalation Period|study drug toxicity|3|||
148769931|NCT00452673|536632719|FG003|Dose Escalation Period|study drug toxicity|1|||
148769932|NCT00452673|536632720|FG004|Dose Escalation Period|study drug toxicity|0|||
148769933|NCT00452673|536632716|FG000|Dose Escalation Period|Other|0|||
148769934|NCT00452673|536632717|FG001|Dose Escalation Period|Other|0|||
148769935|NCT00452673|536632718|FG002|Dose Escalation Period|Other|1|||
148769936|NCT00452673|536632719|FG003|Dose Escalation Period|Other|0|||
148769937|NCT00452673|536632720|FG004|Dose Escalation Period|Other|0|||
148769938|NCT00452673|536632716|FG000|Dose Escalation Period|Adverse Event|0|||
148769939|NCT00452673|536632717|FG001|Dose Escalation Period|Adverse Event|0|||
148769940|NCT00452673|536632718|FG002|Dose Escalation Period|Adverse Event|0|||
148769941|NCT00452673|536632719|FG003|Dose Escalation Period|Adverse Event|1|||
148769942|NCT00452673|536632720|FG004|Dose Escalation Period|Adverse Event|0|||
148769943|NCT00452673|536632716|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
148769944|NCT00452673|536632717|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
148769945|NCT00452673|536632718|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
148769946|NCT00452673|536632719|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
148831515|NCT03312543|536862365|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
148831516|NCT03312543|536862364|FG000|Regression (Week 12 to Week 24)|Death|0|||
148831517|NCT03312543|536862365|FG001|Regression (Week 12 to Week 24)|Death|1|||
148831518|NCT04507269|536862366|FG000|Overall Study|Withdrawal by Subject|1|||
148831519|NCT04507269|536862367|FG001|Overall Study|Withdrawal by Subject|1|||
148831520|NCT04507269|536862368|FG002|Overall Study|Withdrawal by Subject|0|||
148831521|NCT04507269|536862369|FG003|Overall Study|Withdrawal by Subject|0|||
148831522|NCT04507269|536862370|FG004|Overall Study|Withdrawal by Subject|0|||
148831523|NCT04507269|536862371|FG005|Overall Study|Withdrawal by Subject|0|||
148831524|NCT04507269|536862366|FG000|Overall Study|Lost to Follow-up|0|||
148831525|NCT04507269|536862367|FG001|Overall Study|Lost to Follow-up|0|||
148831526|NCT04507269|536862368|FG002|Overall Study|Lost to Follow-up|0|||
148831527|NCT04507269|536862369|FG003|Overall Study|Lost to Follow-up|0|||
148831528|NCT04507269|536862370|FG004|Overall Study|Lost to Follow-up|1|||
148831529|NCT04507269|536862371|FG005|Overall Study|Lost to Follow-up|0|||
148831530|NCT05852340|536862372|FG000|Period 5|Not completing the meal|0|||
148831531|NCT05852340|536862373|FG001|Period 5|Not completing the meal|1|||
148831532|NCT05852340|536862374|FG002|Period 5|Not completing the meal|0|||
148831533|NCT05852340|536862375|FG003|Period 5|Not completing the meal|0|||
148831534|NCT05852340|536862372|FG000|Period 5|Adverse Event|0|||
148831535|NCT05852340|536862373|FG001|Period 5|Adverse Event|0|||
148831536|NCT05852340|536862374|FG002|Period 5|Adverse Event|0|||
148831537|NCT05852340|536862375|FG003|Period 5|Adverse Event|1|||
148831538|NCT01722669|536862378|FG000|Overall Study|Withdrawal by Subject|0|||
148831539|NCT01722669|536862379|FG001|Overall Study|Withdrawal by Subject|0|||
148831540|NCT01722669|536862380|FG002|Overall Study|Withdrawal by Subject|0|||
148831541|NCT01722669|536862381|FG003|Overall Study|Withdrawal by Subject|0|||
148831542|NCT01722669|536862382|FG004|Overall Study|Withdrawal by Subject|0|||
148831543|NCT01722669|536862383|FG005|Overall Study|Withdrawal by Subject|2|||
148831544|NCT05318287|536862388|FG000|Overall Study|Lost to Follow-up|8|||
148831545|NCT04144517|536862391|FG000|Overall Study|Physician Decision|0|||
148831546|NCT04144517|536862392|FG001|Overall Study|Physician Decision|1|||
148831547|NCT04144517|536862391|FG000|Overall Study|Other|2|||
148831548|NCT04144517|536862392|FG001|Overall Study|Other|2|||
148831549|NCT04144517|536862391|FG000|Overall Study|Death|6|||
148831550|NCT04144517|536862392|FG001|Overall Study|Death|3|||
148831551|NCT02457793|536862396|FG000|Overall Study|Reason not specified|0|||
148831552|NCT02457793|536862397|FG001|Overall Study|Reason not specified|0|||
148831553|NCT02457793|536862398|FG002|Overall Study|Reason not specified|0|||
148831554|NCT02457793|536862399|FG003|Overall Study|Reason not specified|1|||
148831555|NCT02457793|536862400|FG004|Overall Study|Reason not specified|1|||
148831556|NCT02457793|536862401|FG005|Overall Study|Reason not specified|1|||
148831557|NCT02457793|536862396|FG000|Overall Study|Withdrawal by Subject|0|||
148831558|NCT02457793|536862397|FG001|Overall Study|Withdrawal by Subject|4|||
148831559|NCT02457793|536862398|FG002|Overall Study|Withdrawal by Subject|2|||
148831560|NCT02457793|536862399|FG003|Overall Study|Withdrawal by Subject|2|||
148831561|NCT02457793|536862400|FG004|Overall Study|Withdrawal by Subject|2|||
148831562|NCT02457793|536862401|FG005|Overall Study|Withdrawal by Subject|2|||
148831563|NCT02457793|536862396|FG000|Overall Study|Adverse Event|0|||
148831564|NCT02457793|536862397|FG001|Overall Study|Adverse Event|0|||
148831565|NCT02457793|536862398|FG002|Overall Study|Adverse Event|0|||
148831566|NCT02457793|536862399|FG003|Overall Study|Adverse Event|1|||
148831567|NCT02457793|536862400|FG004|Overall Study|Adverse Event|0|||
148831568|NCT02457793|536862401|FG005|Overall Study|Adverse Event|0|||
148980746|NCT02316717|537409410|FG002|Overall Study|Non compliance|0|||
148980747|NCT02316717|537409408|FG000|Overall Study|Protocol Violation|2|||
148980748|NCT02316717|537409409|FG001|Overall Study|Protocol Violation|0|||
148980749|NCT02316717|537409410|FG002|Overall Study|Protocol Violation|0|||
148980750|NCT02316717|537409408|FG000|Overall Study|Withdrawal by Subject|2|||
148980751|NCT02316717|537409409|FG001|Overall Study|Withdrawal by Subject|1|||
148980752|NCT02316717|537409410|FG002|Overall Study|Withdrawal by Subject|1|||
148980753|NCT02316717|537409408|FG000|Overall Study|Death|0|||
148980754|NCT02316717|537409409|FG001|Overall Study|Death|0|||
148980755|NCT02316717|537409410|FG002|Overall Study|Death|1|||
148980756|NCT02316717|537409408|FG000|Overall Study|Physician Decision|0|||
148980757|NCT02316717|537409409|FG001|Overall Study|Physician Decision|1|||
148980758|NCT02316717|537409410|FG002|Overall Study|Physician Decision|0|||
148980759|NCT02316717|537409408|FG000|Overall Study|TBC|1|||
148980760|NCT02316717|537409409|FG001|Overall Study|TBC|0|||
148980761|NCT02316717|537409410|FG002|Overall Study|TBC|0|||
148831569|NCT02457793|536862396|FG000|Overall Study|Physician Decision|1|||
148980762|NCT00298831|537409411|FG000|Overall Study|Adverse Event|1|||
148980763|NCT00298831|537409411|FG000|Overall Study|Lost to Follow-up|3|||
148831570|NCT02457793|536862397|FG001|Overall Study|Physician Decision|0|||
148831571|NCT02457793|536862398|FG002|Overall Study|Physician Decision|1|||
148831572|NCT02457793|536862399|FG003|Overall Study|Physician Decision|1|||
148831573|NCT02457793|536862400|FG004|Overall Study|Physician Decision|1|||
148980764|NCT00298831|537409411|FG000|Overall Study|Withdrawal by Subject|1|||
148980765|NCT00298831|537409411|FG000|Overall Study|Participants did not receive treatment|27|||
148980766|NCT00437034|537409412|FG000|Overall Study|Adverse Event|1|||
148831574|NCT02457793|536862401|FG005|Overall Study|Physician Decision|3|||
148831575|NCT03814044|536862406|FG000|Overall Study|Protocol deviation|1|||
148831576|NCT02757768|536862407|FG000|Overall Study|Randomized Never Received Study Drug|3|||
148831577|NCT02757768|536862408|FG001|Overall Study|Randomized Never Received Study Drug|4|||
148831578|NCT02757768|536862407|FG000|Overall Study|Adverse Event|5|||
148831579|NCT02757768|536862408|FG001|Overall Study|Adverse Event|3|||
148831580|NCT02757768|536862407|FG000|Overall Study|Lack of Efficacy|2|||
148831581|NCT02757768|536862408|FG001|Overall Study|Lack of Efficacy|1|||
148831582|NCT02757768|536862407|FG000|Overall Study|Lost to Follow-up|1|||
148831583|NCT02757768|536862408|FG001|Overall Study|Lost to Follow-up|0|||
148831584|NCT02757768|536862407|FG000|Overall Study|Protocol Deviation|2|||
148831585|NCT02757768|536862408|FG001|Overall Study|Protocol Deviation|9|||
148831586|NCT02757768|536862407|FG000|Overall Study|Withdrawal by Subject|16|||
148831587|NCT02757768|536862408|FG001|Overall Study|Withdrawal by Subject|9|||
148831588|NCT02757768|536862407|FG000|Overall Study|Miscellaneous|4|||
148831589|NCT02757768|536862408|FG001|Overall Study|Miscellaneous|2|||
148831590|NCT00835367|536862420|FG000|Washout|Adverse Event|2|||
148831591|NCT00835367|536862421|FG001|Washout|Adverse Event|0|||
148831592|NCT00835367|536862420|FG000|Washout|Withdrawal by Subject|1|||
148831593|NCT00835367|536862421|FG001|Washout|Withdrawal by Subject|0|||
148831594|NCT00835367|536862420|FG000|Second Intervention|Adverse Event|1|||
148831595|NCT00835367|536862421|FG001|Second Intervention|Adverse Event|1|||
148831596|NCT05929326|536862422|FG000|Overall Study|unqualified sample|2|||
148831597|NCT05929326|536862423|FG001|Overall Study|unqualified sample|3|||
148831598|NCT05929326|536862424|FG002|Overall Study|unqualified sample|7|||
148831599|NCT04890509|536862425|FG000|Overall Study|Death|4|||
148831600|NCT04890509|536862426|FG001|Overall Study|Death|4|||
148831601|NCT02495883|536862435|FG000|Overall Study|Excessive head motion|1|||
148831602|NCT02495883|536862436|FG001|Overall Study|Excessive head motion|0|||
148831603|NCT03557502|536862437|FG000|Protocol 2|Withdrawal by Subject|1|||
148831604|NCT03557502|536862438|FG001|Protocol 2|Withdrawal by Subject|1|||
148831605|NCT03557502|536862437|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
148831606|NCT03557502|536862438|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
148831607|NCT00964678|536862443|FG000|Overall Study|Physician Decision|4|||
148831608|NCT03359395|536862444|FG000|First Intervention A / B|Withdrawal by Subject|1|||
148831609|NCT03359395|536862445|FG001|First Intervention A / B|Withdrawal by Subject|0|||
148831610|NCT03359395|536862444|FG000|First Intervention A / B|Lost to Follow-up|2|||
148831611|NCT03359395|536862445|FG001|First Intervention A / B|Lost to Follow-up|3|||
148831612|NCT03359395|536862444|FG000|Second Intervention B/A|Exclusion criteria|0|||
148831613|NCT03359395|536862445|FG001|Second Intervention B/A|Exclusion criteria|1|||
148831614|NCT03359395|536862444|FG000|Second Intervention B/A|Lost to Follow-up|3|||
148831615|NCT03359395|536862445|FG001|Second Intervention B/A|Lost to Follow-up|2|||
148831616|NCT03164356|536862446|FG000|Overall Study|Lost to Follow-up|1|||
148831617|NCT03164356|536862447|FG001|Overall Study|Lost to Follow-up|1|||
148831618|NCT03164356|536862448|FG002|Overall Study|Lost to Follow-up|2|||
148831619|NCT03164356|536862449|FG003|Overall Study|Lost to Follow-up|1|||
148831620|NCT03164356|536862446|FG000|Overall Study|Physician Decision|0|||
148831621|NCT03164356|536862447|FG001|Overall Study|Physician Decision|0|||
148980767|NCT00437034|537409412|FG000|Overall Study|Disease progression during treatment|5|||
148980768|NCT01978184|537409413|FG000|Overall Study|Progressive disease|5|||
148980769|NCT01978184|537409414|FG001|Overall Study|Progressive disease|5|||
148980770|NCT01978184|537409413|FG000|Overall Study|Other than PDA|2|||
148980771|NCT01978184|537409414|FG001|Overall Study|Other than PDA|2|||
148980772|NCT01978184|537409413|FG000|Overall Study|Physician Decision|0|||
148980773|NCT01978184|537409414|FG001|Overall Study|Physician Decision|3|||
148980774|NCT01978184|537409413|FG000|Overall Study|Noncompliance|1|||
148980775|NCT01978184|537409414|FG001|Overall Study|Noncompliance|2|||
148980776|NCT01978184|537409413|FG000|Overall Study|Death|1|||
148980777|NCT01978184|537409414|FG001|Overall Study|Death|0|||
148980778|NCT01978184|537409413|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
148980779|NCT01978184|537409414|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
148980780|NCT03146650|537409418|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
148980781|NCT03146650|537409418|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
148831622|NCT03164356|536862448|FG002|Overall Study|Physician Decision|3|||
148831623|NCT03164356|536862449|FG003|Overall Study|Physician Decision|0|||
148831624|NCT03164356|536862446|FG000|Overall Study|Protocol Violation|2|||
148831625|NCT03164356|536862447|FG001|Overall Study|Protocol Violation|1|||
148831626|NCT03164356|536862448|FG002|Overall Study|Protocol Violation|0|||
148831627|NCT03164356|536862449|FG003|Overall Study|Protocol Violation|0|||
148831628|NCT03164356|536862446|FG000|Overall Study|Withdrawal by Subject|1|||
148831629|NCT03164356|536862447|FG001|Overall Study|Withdrawal by Subject|0|||
148831630|NCT03164356|536862448|FG002|Overall Study|Withdrawal by Subject|0|||
148831631|NCT03164356|536862449|FG003|Overall Study|Withdrawal by Subject|0|||
148831632|NCT03164356|536862446|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
148980782|NCT03146650|537409418|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
148980783|NCT03146650|537409418|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
148831633|NCT03164356|536862447|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
148831634|NCT03164356|536862448|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
148831635|NCT03164356|536862449|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
148831636|NCT03164356|536862446|FG000|Overall Study|Subject Incarcerated|0|||
148831637|NCT03164356|536862447|FG001|Overall Study|Subject Incarcerated|1|||
148831638|NCT03164356|536862448|FG002|Overall Study|Subject Incarcerated|0|||
148831639|NCT03164356|536862449|FG003|Overall Study|Subject Incarcerated|0|||
148831640|NCT03164356|536862446|FG000|Overall Study|Prosthetist unable to participate|0|||
148831641|NCT03164356|536862447|FG001|Overall Study|Prosthetist unable to participate|2|||
148831642|NCT03164356|536862448|FG002|Overall Study|Prosthetist unable to participate|1|||
148831643|NCT03164356|536862449|FG003|Overall Study|Prosthetist unable to participate|0|||
148831644|NCT02520154|536862456|FG000|Overall Study|Death|1|||
148831645|NCT02520154|536862456|FG000|Overall Study|Withdrawal by Subject|2|||
148831646|NCT02520154|536862456|FG000|Overall Study|Physician Decision|2|||
148831647|NCT05943990|536862460|FG000|Overall Study|Study Terminated by Sponsor|0|||
148831648|NCT05943990|536862461|FG001|Overall Study|Study Terminated by Sponsor|0|||
148831649|NCT05943990|536862462|FG002|Overall Study|Study Terminated by Sponsor|1|||
148831650|NCT04976777|536864350|FG000|Overall Study|COVID-19 Infection|1|||
148831651|NCT04976777|536864351|FG001|Overall Study|COVID-19 Infection|0|||
148831652|NCT00936936|536864352|FG000|Overall Study|Adverse Event|7|||
148831653|NCT00936936|536864353|FG001|Overall Study|Adverse Event|1|||
148831654|NCT00936936|536864352|FG000|Overall Study|Disease Progression|2|||
148831655|NCT00936936|536864353|FG001|Overall Study|Disease Progression|2|||
148831656|NCT00936936|536864352|FG000|Overall Study|Unrelated|3|||
148831657|NCT00936936|536864353|FG001|Overall Study|Unrelated|1|||
148831658|NCT02278003|536864354|FG000|Overall Study|Withdrawal by Subject|11|||
148831659|NCT02278003|536864355|FG001|Overall Study|Withdrawal by Subject|0|||
148831660|NCT02278003|536864354|FG000|Overall Study|Not Treated|1|||
148831661|NCT02278003|536864355|FG001|Overall Study|Not Treated|0|||
148831662|NCT02278003|536864354|FG000|Overall Study|Recognition task improperly completed|7|||
148831663|NCT02278003|536864355|FG001|Overall Study|Recognition task improperly completed|0|||
148831664|NCT00442702|536864358|FG000|Titration Period|Adverse Event|2|||
148831665|NCT00442702|536864359|FG001|Titration Period|Adverse Event|0|||
148831666|NCT00442702|536864358|FG000|Titration Period|Death|3|||
148831667|NCT00442702|536864359|FG001|Titration Period|Death|2|||
148831668|NCT00442702|536864358|FG000|Titration Period|Insufficient Therapeutic Response|1|||
148831669|NCT00442702|536864359|FG001|Titration Period|Insufficient Therapeutic Response|0|||
148831670|NCT00442702|536864358|FG000|Titration Period|Refused Treatment|4|||
148831671|NCT00442702|536864359|FG001|Titration Period|Refused Treatment|1|||
148831672|NCT00442702|536864358|FG000|Titration Period|Failure to return|1|||
148831673|NCT00442702|536864359|FG001|Titration Period|Failure to return|0|||
148831674|NCT00442702|536864358|FG000|Titration Period|Hospitalized in another hospital|1|||
148831675|NCT00442702|536864359|FG001|Titration Period|Hospitalized in another hospital|0|||
148831676|NCT00442702|536864358|FG000|Evaluation Period|Adverse Event|1|||
148831677|NCT00442702|536864359|FG001|Evaluation Period|Adverse Event|0|||
148831678|NCT00442702|536864358|FG000|Evaluation Period|Death|1|||
148831679|NCT00442702|536864359|FG001|Evaluation Period|Death|1|||
148831680|NCT00442702|536864358|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
148831681|NCT00442702|536864359|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
148831682|NCT00442702|536864358|FG000|Evaluation Period|Refused treatment|1|||
148831683|NCT00442702|536864359|FG001|Evaluation Period|Refused treatment|1|||
148980784|NCT03146650|537409418|FG000|2 Year Follow-up|Death|11|||
148769947|NCT00452673|536632720|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
148769948|NCT00452673|536632716|FG000|Dose Expansion Period|Disease Progression|0|||
148769949|NCT00452673|536632717|FG001|Dose Expansion Period|Disease Progression|0|||
148769950|NCT00452673|536632718|FG002|Dose Expansion Period|Disease Progression|0|||
148769951|NCT00452673|536632719|FG003|Dose Expansion Period|Disease Progression|0|||
148769952|NCT00452673|536632720|FG004|Dose Expansion Period|Disease Progression|19|||
148769953|NCT00452673|536632716|FG000|Dose Expansion Period|Other|0|||
148769954|NCT00452673|536632717|FG001|Dose Expansion Period|Other|0|||
148769955|NCT00452673|536632718|FG002|Dose Expansion Period|Other|0|||
148769956|NCT00452673|536632719|FG003|Dose Expansion Period|Other|0|||
148769957|NCT00452673|536632720|FG004|Dose Expansion Period|Other|2|||
148769958|NCT04429555|536632737|FG000|Overall Study|Death|0|||
148769959|NCT04429555|536632738|FG001|Overall Study|Death|2|||
148769960|NCT04429555|536632737|FG000|Overall Study|Other|2|||
148769961|NCT04429555|536632738|FG001|Overall Study|Other|0|||
148769962|NCT04720911|536632743|FG000|Overall Study|Withdrawal by Subject|0|||
148831684|NCT00442702|536864358|FG000|Evaluation Period|Renal transplant|0|||
148831685|NCT00442702|536864359|FG001|Evaluation Period|Renal transplant|1|||
148831686|NCT00442702|536864358|FG000|Evaluation Period|Failure to return|1|||
148831687|NCT00442702|536864359|FG001|Evaluation Period|Failure to return|0|||
148831688|NCT00442702|536864358|FG000|Evaluation Period|Site closure|0|||
148769963|NCT04720911|536632744|FG001|Overall Study|Withdrawal by Subject|1|||
148769964|NCT04720911|536632745|FG002|Overall Study|Withdrawal by Subject|0|||
148769965|NCT00090220|536632746|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
149028089|NCT01289119|537580079|FG001|Overall Study|Withdrawal by Subject|2|||
149028090|NCT01289119|537580080|FG002|Overall Study|Withdrawal by Subject|4|||
149028091|NCT01289119|537580081|FG003|Overall Study|Withdrawal by Subject|3|||
149028092|NCT01289119|537580082|FG004|Overall Study|Withdrawal by Subject|1|||
149028093|NCT01289119|537580083|FG005|Overall Study|Withdrawal by Subject|1|||
149028094|NCT01289119|537580078|FG000|Overall Study|Pregnancy|0|||
149028095|NCT01289119|537580079|FG001|Overall Study|Pregnancy|1|||
149028096|NCT01289119|537580080|FG002|Overall Study|Pregnancy|0|||
149028097|NCT01289119|537580081|FG003|Overall Study|Pregnancy|0|||
149028098|NCT01289119|537580082|FG004|Overall Study|Pregnancy|0|||
149028099|NCT01289119|537580083|FG005|Overall Study|Pregnancy|0|||
149028100|NCT01289119|537580078|FG000|Overall Study|Lack of Efficacy|0|||
149028101|NCT01289119|537580079|FG001|Overall Study|Lack of Efficacy|1|||
149028102|NCT01289119|537580080|FG002|Overall Study|Lack of Efficacy|1|||
149028103|NCT01289119|537580081|FG003|Overall Study|Lack of Efficacy|1|||
149028104|NCT01289119|537580082|FG004|Overall Study|Lack of Efficacy|1|||
149028105|NCT01289119|537580083|FG005|Overall Study|Lack of Efficacy|1|||
149028106|NCT01289119|537580078|FG000|Overall Study|Other|1|||
149028107|NCT01289119|537580079|FG001|Overall Study|Other|0|||
149028108|NCT01289119|537580080|FG002|Overall Study|Other|1|||
149028109|NCT01289119|537580081|FG003|Overall Study|Other|0|||
149028110|NCT01289119|537580082|FG004|Overall Study|Other|0|||
149028111|NCT01289119|537580083|FG005|Overall Study|Other|0|||
149028112|NCT01704846|537580084|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149028113|NCT01704846|537580085|FG001|Treatment Period 2|Withdrawal by Subject|1|||
149028114|NCT00530335|537580086|FG000|Overall Study|Adverse Event|3|||
149028115|NCT00530335|537580086|FG000|Overall Study|Protocol Violation|1|||
149028116|NCT00530335|537580086|FG000|Overall Study|Withdrawal by Subject|1|||
149028117|NCT00530335|537580086|FG000|Overall Study|Physician Decision|1|||
149028118|NCT01244984|537580087|FG000|Overall Study|Adverse Event|2|||
149028119|NCT01244984|537580088|FG001|Overall Study|Adverse Event|11|||
149028120|NCT01244984|537580089|FG002|Overall Study|Adverse Event|2|||
149028121|NCT01244984|537580087|FG000|Overall Study|Protocol Violation|1|||
149028122|NCT01244984|537580088|FG001|Overall Study|Protocol Violation|0|||
149028123|NCT01244984|537580089|FG002|Overall Study|Protocol Violation|0|||
149028124|NCT01244984|537580087|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
149028125|NCT01244984|537580088|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
149028126|NCT01244984|537580089|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
149028127|NCT01244984|537580087|FG000|Overall Study|Withdrawal by Subject|1|||
149028128|NCT01244984|537580088|FG001|Overall Study|Withdrawal by Subject|2|||
149028129|NCT01244984|537580089|FG002|Overall Study|Withdrawal by Subject|2|||
149028130|NCT01360840|537580093|FG000|Overall Study|Ongoing at data cut-off|10|||
149028131|NCT01360840|537580094|FG001|Overall Study|Ongoing at data cut-off|10|||
149028132|NCT01360840|537580095|FG002|Overall Study|Ongoing at data cut-off|9|||
149028133|NCT01982760|537580098|FG000|Overall Study|Physician Decision|1|||
149028134|NCT01982760|537580099|FG001|Overall Study|Physician Decision|0|||
149028135|NCT00821236|537580100|FG000|Overall Study|Lost to Follow-up|3|||
149028136|NCT00282438|537580104|FG000|Overall Study|Lack of Efficacy|1|||
149028137|NCT00282438|537580105|FG001|Overall Study|Lack of Efficacy|0|||
149028138|NCT00282438|537580104|FG000|Overall Study|Death|0|||
149028139|NCT00282438|537580105|FG001|Overall Study|Death|1|||
149028140|NCT02397889|537580106|FG000|Overall Study|Physician Decision|1|||
149028141|NCT02397889|537580107|FG001|Overall Study|Physician Decision|0|||
149028142|NCT04668144|537580115|FG000|Overall Study|Protocol Violation|0|||
149028143|NCT04668144|537580116|FG001|Overall Study|Protocol Violation|1|||
149028144|NCT04668144|537580117|FG002|Overall Study|Protocol Violation|2|||
149028145|NCT02282527|537580120|FG000|Overall Study|Lost to Follow-up|0|||
149028146|NCT02282527|537580121|FG001|Overall Study|Lost to Follow-up|1|||
149028147|NCT02282527|537580120|FG000|Overall Study|Lack of home health aid|1|||
149028148|NCT02282527|537580121|FG001|Overall Study|Lack of home health aid|0|||
149028149|NCT01872611|537580122|FG000|Overall Study|Adverse Event|3|||
149028150|NCT01872611|537580123|FG001|Overall Study|Adverse Event|1|||
149028151|NCT01872611|537580122|FG000|Overall Study|Adverse Event, prior to treatment|0|||
149028152|NCT01872611|537580123|FG001|Overall Study|Adverse Event, prior to treatment|1|||
149028153|NCT01872611|537580122|FG000|Overall Study|Death|0|||
149028154|NCT01872611|537580123|FG001|Overall Study|Death|1|||
149028155|NCT01872611|537580122|FG000|Overall Study|Death, prior to treatment|0|||
149028156|NCT01872611|537580123|FG001|Overall Study|Death, prior to treatment|1|||
149028157|NCT01872611|537580122|FG000|Overall Study|Lost to Follow-up|8|||
149028158|NCT01872611|537580123|FG001|Overall Study|Lost to Follow-up|1|||
149028159|NCT01872611|537580122|FG000|Overall Study|Physician Decision|1|||
149028160|NCT01872611|537580123|FG001|Overall Study|Physician Decision|0|||
149028161|NCT01872611|537580122|FG000|Overall Study|Withdrawal by Subject|6|||
149028162|NCT01872611|537580123|FG001|Overall Study|Withdrawal by Subject|1|||
149028163|NCT01872611|537580122|FG000|Overall Study|Reason not provided|6|||
149028164|NCT01872611|537580123|FG001|Overall Study|Reason not provided|6|||
149028165|NCT03537651|537580124|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
149028166|NCT03537651|537580124|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
149028167|NCT03537651|537580124|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
148831689|NCT00442702|536864359|FG001|Evaluation Period|Site closure|1|||
148831690|NCT04123704|536864371|FG000|Overall Study|Disease progression|2|||
148831691|NCT03440385|536864372|FG000|Overall Study|Other Reason|4|||
148831692|NCT03440385|536864373|FG001|Overall Study|Other Reason|1|||
148831693|NCT03440385|536864372|FG000|Overall Study|Site Closed|1|||
148831694|NCT03440385|536864373|FG001|Overall Study|Site Closed|0|||
148831695|NCT03440385|536864372|FG000|Overall Study|Lost to Follow-up|2|||
148831696|NCT03440385|536864373|FG001|Overall Study|Lost to Follow-up|0|||
148831697|NCT03440385|536864372|FG000|Overall Study|Withdrawal by Subject|12|||
148831698|NCT03440385|536864373|FG001|Overall Study|Withdrawal by Subject|6|||
148831699|NCT03440385|536864372|FG000|Overall Study|Lack of Efficacy|9|||
148831700|NCT03440385|536864373|FG001|Overall Study|Lack of Efficacy|2|||
148831701|NCT03440385|536864372|FG000|Overall Study|Adverse Event|15|||
148831702|NCT03440385|536864373|FG001|Overall Study|Adverse Event|11|||
148831703|NCT00730327|536864374|FG000|Overall Study|Lost to Follow-up|14|||
148831704|NCT00730327|536864375|FG001|Overall Study|Lost to Follow-up|16|||
148831705|NCT00730327|536864374|FG000|Overall Study|Adverse Event|8|||
148831706|NCT00730327|536864375|FG001|Overall Study|Adverse Event|1|||
148831707|NCT00730327|536864374|FG000|Overall Study|Withdrawal by Subject|3|||
148831708|NCT00730327|536864375|FG001|Overall Study|Withdrawal by Subject|13|||
148831709|NCT00730327|536864374|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
148831710|NCT00730327|536864375|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
148831711|NCT03122184|536864377|FG000|Overall Study|Lost to Follow-up|4|||
148831712|NCT03122184|536864378|FG001|Overall Study|Lost to Follow-up|6|||
148831713|NCT03122184|536864377|FG000|Overall Study|Withdrawal by Subject|3|||
148831714|NCT03122184|536864378|FG001|Overall Study|Withdrawal by Subject|0|||
148831715|NCT03122184|536864377|FG000|Overall Study|Terminated due to cognitive problem|1|||
148831716|NCT03122184|536864378|FG001|Overall Study|Terminated due to cognitive problem|0|||
148831717|NCT01497197|536864381|FG000|Overall Study|Lost to Follow-up|1|||
148831718|NCT01497197|536864382|FG001|Overall Study|Lost to Follow-up|0|||
148831719|NCT01497197|536864381|FG000|Overall Study|Protocol Violation|0|||
148831720|NCT01497197|536864382|FG001|Overall Study|Protocol Violation|2|||
148831721|NCT01497197|536864381|FG000|Overall Study|Withdrawal by Subject|2|||
148831722|NCT01497197|536864382|FG001|Overall Study|Withdrawal by Subject|1|||
148831723|NCT01497197|536864381|FG000|Overall Study|Excessive/lack of response to treatment|1|||
148831724|NCT01497197|536864382|FG001|Overall Study|Excessive/lack of response to treatment|0|||
148831725|NCT01497197|536864381|FG000|Overall Study|Risk of OHSS|1|||
148831726|NCT01497197|536864382|FG001|Overall Study|Risk of OHSS|0|||
148831727|NCT01497197|536864381|FG000|Overall Study|No oocytes retrieved|3|||
148831728|NCT01497197|536864382|FG001|Overall Study|No oocytes retrieved|2|||
148831729|NCT01497197|536864381|FG000|Overall Study|No fertilisation|6|||
148831730|NCT01497197|536864382|FG001|Overall Study|No fertilisation|5|||
148831731|NCT01497197|536864381|FG000|Overall Study|Intention to freeze all embryos|0|||
148831732|NCT01497197|536864382|FG001|Overall Study|Intention to freeze all embryos|1|||
148831733|NCT01497197|536864381|FG000|Overall Study|All embryos discarded|0|||
148831734|NCT01497197|536864382|FG001|Overall Study|All embryos discarded|3|||
148831735|NCT01497197|536864381|FG000|Overall Study|Other|3|||
148831736|NCT01497197|536864382|FG001|Overall Study|Other|1|||
148831737|NCT00565747|536864390|FG000|Overall Study|No embryo transfer|67|||
148831738|NCT00565747|536864391|FG001|Overall Study|No embryo transfer|73|||
148831739|NCT04734210|536864394|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
148831740|NCT04734210|536864395|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
148831741|NCT04734210|536864396|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
148831742|NCT04734210|536864394|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
148831743|NCT04734210|536864395|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
148831744|NCT04734210|536864396|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
148831745|NCT04734210|536864394|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
148831746|NCT04734210|536864395|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
148831747|NCT04734210|536864396|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
148831748|NCT04734210|536864394|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
148831749|NCT04734210|536864395|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
148831750|NCT04734210|536864396|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
148831751|NCT02684461|536864397|FG000|Overall Study|Adverse Event|1|||
148831752|NCT02684461|536864398|FG001|Overall Study|Adverse Event|0|||
148831753|NCT02684461|536864399|FG002|Overall Study|Adverse Event|0|||
148831754|NCT02684461|536864397|FG000|Overall Study|Lack of Efficacy|1|||
148831755|NCT02684461|536864398|FG001|Overall Study|Lack of Efficacy|2|||
148831756|NCT02684461|536864399|FG002|Overall Study|Lack of Efficacy|0|||
148831757|NCT02390076|536864400|FG000|Overall Study|Lost to Follow-up|2|||
148980785|NCT03146650|537409418|FG000|2 Year Follow-up|Still in follow-up|7|||
148980786|NCT03146650|537409418|FG000|2 Year Follow-up|Lost to Follow-up|1|||
148980787|NCT02460198|537409419|FG000|Overall Study|Adverse Event|1|||
148980788|NCT02460198|537409420|FG001|Overall Study|Adverse Event|3|||
148980789|NCT02460198|537409419|FG000|Overall Study|Death|36|||
148980790|NCT02460198|537409420|FG001|Overall Study|Death|28|||
148980791|NCT02460198|537409419|FG000|Overall Study|Lost to Follow-up|1|||
148980792|NCT02460198|537409420|FG001|Overall Study|Lost to Follow-up|1|||
148980793|NCT02460198|537409419|FG000|Overall Study|Transferred to Extension Study|15|||
148980794|NCT02460198|537409420|FG001|Overall Study|Transferred to Extension Study|15|||
148980795|NCT02460198|537409419|FG000|Overall Study|Withdrawal by Subject|2|||
148980796|NCT02460198|537409420|FG001|Overall Study|Withdrawal by Subject|4|||
148980797|NCT02460198|537409419|FG000|Overall Study|Site Terminated By Sponsor|0|||
148980798|NCT02460198|537409420|FG001|Overall Study|Site Terminated By Sponsor|1|||
148980799|NCT02460198|537409419|FG000|Overall Study|Did Not Continue on Extension Study|6|||
148831758|NCT02390076|536864401|FG001|Overall Study|Lost to Follow-up|1|||
148831759|NCT02390076|536864402|FG002|Overall Study|Lost to Follow-up|4|||
148831760|NCT04507204|536864403|FG000|Overall Study|Adverse Event|8|||
148831761|NCT04507204|536864404|FG001|Overall Study|Adverse Event|13|||
148831762|NCT04507204|536864403|FG000|Overall Study|Death|0|||
148831763|NCT04507204|536864404|FG001|Overall Study|Death|1|||
148831764|NCT04507204|536864403|FG000|Overall Study|Lost to Follow-up|15|||
148831765|NCT04507204|536864404|FG001|Overall Study|Lost to Follow-up|14|||
148831766|NCT04507204|536864403|FG000|Overall Study|Poor Compliance with Protocol|2|||
148831767|NCT04507204|536864404|FG001|Overall Study|Poor Compliance with Protocol|4|||
148831768|NCT04507204|536864403|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
148831769|NCT04507204|536864404|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
148831770|NCT04507204|536864403|FG000|Overall Study|Withdrawal of Patient Consent|21|||
148831771|NCT04507204|536864404|FG001|Overall Study|Withdrawal of Patient Consent|13|||
148831772|NCT03580044|536864405|FG000|Overall Study|Death|2|||
148831773|NCT03580044|536864406|FG001|Overall Study|Death|1|||
148831774|NCT03580044|536864405|FG000|Overall Study|Withdrawal by Subject|1|||
148831775|NCT03580044|536864406|FG001|Overall Study|Withdrawal by Subject|1|||
148831776|NCT01206517|536864409|FG000|Overall Study|Withdrawal by Subject|0|||
148831777|NCT01206517|536864410|FG001|Overall Study|Withdrawal by Subject|0|||
148831778|NCT01206517|536864411|FG002|Overall Study|Withdrawal by Subject|2|||
148831779|NCT01206517|536864412|FG003|Overall Study|Withdrawal by Subject|0|||
148831780|NCT01206517|536864413|FG004|Overall Study|Withdrawal by Subject|1|||
148831781|NCT01206517|536864414|FG005|Overall Study|Withdrawal by Subject|0|||
148831782|NCT03493958|536864415|FG000|Overall Study|Withdrawal by Subject|6|||
148831783|NCT03493958|536864415|FG000|Overall Study|Lost to Follow-up|7|||
148831784|NCT03493958|536864415|FG000|Overall Study|Did not complete all required study procedures|2|||
148831785|NCT01029535|536864416|FG000|Overall Study|Lost to Follow-up|24|||
148831786|NCT01029535|536864416|FG000|Overall Study|Protocol Violation|2|||
148831787|NCT01029535|536864416|FG000|Overall Study|Participant Withdrew Consent|2|||
148831788|NCT01029535|536864416|FG000|Overall Study|Adverse Event|1|||
148831789|NCT01029535|536864416|FG000|Overall Study|Use of Another Treatment|1|||
148831790|NCT01029535|536864416|FG000|Overall Study|Death|1|||
148831791|NCT01358734|536864419|FG000|Overall Study|Adverse Event|4|||
148831792|NCT01358734|536864420|FG001|Overall Study|Adverse Event|7|||
148831793|NCT01358734|536864421|FG002|Overall Study|Adverse Event|3|||
148831794|NCT01358734|536864419|FG000|Overall Study|Lack of Efficacy|0|||
148831795|NCT01358734|536864420|FG001|Overall Study|Lack of Efficacy|1|||
148831796|NCT01358734|536864421|FG002|Overall Study|Lack of Efficacy|3|||
148831797|NCT01358734|536864419|FG000|Overall Study|Withdrawal by Subject|1|||
148831798|NCT01358734|536864420|FG001|Overall Study|Withdrawal by Subject|6|||
148831799|NCT01358734|536864421|FG002|Overall Study|Withdrawal by Subject|3|||
148831800|NCT01358734|536864419|FG000|Overall Study|Death|3|||
148831801|NCT01358734|536864420|FG001|Overall Study|Death|7|||
148831802|NCT01358734|536864421|FG002|Overall Study|Death|2|||
148831803|NCT01358734|536864419|FG000|Overall Study|Progressive Disease|5|||
148831804|NCT01358734|536864420|FG001|Overall Study|Progressive Disease|13|||
148831805|NCT01358734|536864421|FG002|Overall Study|Progressive Disease|16|||
148831806|NCT01358734|536864419|FG000|Overall Study|Non-compliance with study drug|0|||
148831807|NCT01358734|536864420|FG001|Overall Study|Non-compliance with study drug|0|||
148831808|NCT01358734|536864421|FG002|Overall Study|Non-compliance with study drug|1|||
148980800|NCT02460198|537409420|FG001|Overall Study|Did Not Continue on Extension Study|11|||
148831809|NCT01358734|536864419|FG000|Overall Study|Other|2|||
148831810|NCT01358734|536864420|FG001|Overall Study|Other|5|||
148831811|NCT01358734|536864421|FG002|Overall Study|Other|4|||
148831812|NCT01358734|536864419|FG000|Overall Study|Protocol Violation|0|||
148831813|NCT01358734|536864420|FG001|Overall Study|Protocol Violation|0|||
148831814|NCT01358734|536864421|FG002|Overall Study|Protocol Violation|2|||
148831815|NCT01822925|536864422|FG000|Overall Study|Adverse Event|1|||
148980801|NCT00931307|537409421|FG000|Overall Study|Lack of Efficacy|12|||
148831816|NCT01822925|536864423|FG001|Overall Study|Adverse Event|1|||
148980802|NCT00931307|537409421|FG000|Overall Study|Biomicroscopy|1|||
148980803|NCT00691210|537409422|FG000|Overall Study|Progression of Disease|0|||
148980804|NCT00691210|537409423|FG001|Overall Study|Progression of Disease|0|||
148980805|NCT00691210|537409424|FG002|Overall Study|Progression of Disease|0|||
148831817|NCT01822925|536864424|FG002|Overall Study|Adverse Event|1|||
148831818|NCT01822925|536864425|FG003|Overall Study|Adverse Event|1|||
148831819|NCT01822925|536864422|FG000|Overall Study|Lost to Follow-up|0|||
148831820|NCT01822925|536864423|FG001|Overall Study|Lost to Follow-up|1|||
148831821|NCT01822925|536864424|FG002|Overall Study|Lost to Follow-up|0|||
148831822|NCT01822925|536864425|FG003|Overall Study|Lost to Follow-up|0|||
148831823|NCT01822925|536864422|FG000|Overall Study|Protocol Violation|1|||
148831824|NCT01822925|536864423|FG001|Overall Study|Protocol Violation|0|||
148831825|NCT01822925|536864424|FG002|Overall Study|Protocol Violation|0|||
148831826|NCT01822925|536864425|FG003|Overall Study|Protocol Violation|1|||
148831827|NCT01822925|536864422|FG000|Overall Study|Withdrawal by Subject|2|||
148831828|NCT01822925|536864423|FG001|Overall Study|Withdrawal by Subject|0|||
148831829|NCT01822925|536864424|FG002|Overall Study|Withdrawal by Subject|2|||
148831830|NCT01822925|536864425|FG003|Overall Study|Withdrawal by Subject|2|||
148831831|NCT01822925|536864422|FG000|Overall Study|Taking prohibited medication|2|||
148831832|NCT01822925|536864423|FG001|Overall Study|Taking prohibited medication|0|||
148831833|NCT01822925|536864424|FG002|Overall Study|Taking prohibited medication|0|||
148831834|NCT01822925|536864425|FG003|Overall Study|Taking prohibited medication|1|||
148831835|NCT03243084|536864429|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
148831836|NCT03243084|536864430|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
148831837|NCT00553254|536864433|FG000|Overall Study|Death|3|||
148831838|NCT00553254|536864434|FG001|Overall Study|Death|6|||
148831839|NCT00553254|536864435|FG002|Overall Study|Death|25|||
148831840|NCT00553254|536864433|FG000|Overall Study|Lost to Follow-up|0|||
148831841|NCT00553254|536864434|FG001|Overall Study|Lost to Follow-up|0|||
148831842|NCT00553254|536864435|FG002|Overall Study|Lost to Follow-up|2|||
148831843|NCT00553254|536864433|FG000|Overall Study|Withdrawal by Subject|2|||
148831844|NCT00553254|536864434|FG001|Overall Study|Withdrawal by Subject|0|||
148831845|NCT00553254|536864435|FG002|Overall Study|Withdrawal by Subject|2|||
148831846|NCT00553254|536864433|FG000|Overall Study|Study terminated by Sponsor|0|||
148831847|NCT00553254|536864434|FG001|Overall Study|Study terminated by Sponsor|0|||
148831848|NCT00553254|536864435|FG002|Overall Study|Study terminated by Sponsor|1|||
148831849|NCT00553254|536864433|FG000|Overall Study|Other|1|||
148831850|NCT00553254|536864434|FG001|Overall Study|Other|0|||
148831851|NCT00553254|536864435|FG002|Overall Study|Other|13|||
148831852|NCT02314923|536864438|FG000|Overall Study|Death|0|||
148831853|NCT02314923|536864439|FG001|Overall Study|Death|0|||
148831854|NCT02314923|536864440|FG002|Overall Study|Death|0|||
148831855|NCT02314923|536864441|FG003|Overall Study|Death|1|||
148831856|NCT02314923|536864442|FG004|Overall Study|Death|0|||
148831857|NCT02314923|536864443|FG005|Overall Study|Death|0|||
148831858|NCT02314923|536864444|FG006|Overall Study|Death|0|||
148831859|NCT02314923|536864445|FG007|Overall Study|Death|0|||
148831860|NCT02314923|536864446|FG008|Overall Study|Death|0|||
148831861|NCT02314923|536864447|FG009|Overall Study|Death|0|||
148831862|NCT02314923|536864438|FG000|Overall Study|Lost to Follow-up|2|||
148831863|NCT02314923|536864439|FG001|Overall Study|Lost to Follow-up|3|||
148831864|NCT02314923|536864440|FG002|Overall Study|Lost to Follow-up|1|||
148831865|NCT02314923|536864441|FG003|Overall Study|Lost to Follow-up|0|||
148831866|NCT02314923|536864442|FG004|Overall Study|Lost to Follow-up|0|||
148831867|NCT02314923|536864443|FG005|Overall Study|Lost to Follow-up|0|||
148831868|NCT02314923|536864444|FG006|Overall Study|Lost to Follow-up|3|||
148831869|NCT02314923|536864445|FG007|Overall Study|Lost to Follow-up|4|||
148831870|NCT02314923|536864446|FG008|Overall Study|Lost to Follow-up|2|||
148831871|NCT02314923|536864447|FG009|Overall Study|Lost to Follow-up|0|||
148831872|NCT02314923|536864438|FG000|Overall Study|Withdrawal by Subject|0|||
148831873|NCT02314923|536864439|FG001|Overall Study|Withdrawal by Subject|0|||
148831874|NCT02314923|536864440|FG002|Overall Study|Withdrawal by Subject|1|||
148831875|NCT02314923|536864441|FG003|Overall Study|Withdrawal by Subject|0|||
148831876|NCT02314923|536864442|FG004|Overall Study|Withdrawal by Subject|1|||
148831877|NCT02314923|536864443|FG005|Overall Study|Withdrawal by Subject|0|||
148980806|NCT00691210|537409425|FG003|Overall Study|Progression of Disease|2|||
148980807|NCT00691210|537409426|FG004|Overall Study|Progression of Disease|0|||
148980808|NCT00691210|537409427|FG005|Overall Study|Progression of Disease|0|||
148980809|NCT00691210|537409428|FG006|Overall Study|Progression of Disease|0|||
148831878|NCT02314923|536864444|FG006|Overall Study|Withdrawal by Subject|1|||
148831879|NCT02314923|536864445|FG007|Overall Study|Withdrawal by Subject|0|||
148831880|NCT02314923|536864446|FG008|Overall Study|Withdrawal by Subject|0|||
148831881|NCT02314923|536864447|FG009|Overall Study|Withdrawal by Subject|0|||
148831882|NCT02314923|536864438|FG000|Overall Study|Physician Decision|0|||
148831883|NCT02314923|536864439|FG001|Overall Study|Physician Decision|1|||
148831884|NCT02314923|536864440|FG002|Overall Study|Physician Decision|0|||
148831885|NCT02314923|536864441|FG003|Overall Study|Physician Decision|0|||
148831886|NCT02314923|536864442|FG004|Overall Study|Physician Decision|0|||
148831887|NCT02314923|536864443|FG005|Overall Study|Physician Decision|0|||
148831888|NCT02314923|536864444|FG006|Overall Study|Physician Decision|0|||
148831889|NCT02314923|536864445|FG007|Overall Study|Physician Decision|0|||
148831890|NCT02314923|536864446|FG008|Overall Study|Physician Decision|0|||
148980810|NCT00691210|537409429|FG007|Overall Study|Progression of Disease|0|||
148980811|NCT00691210|537409422|FG000|Overall Study|Lack of Efficacy|0|||
148980812|NCT00691210|537409423|FG001|Overall Study|Lack of Efficacy|0|||
148980813|NCT00691210|537409424|FG002|Overall Study|Lack of Efficacy|0|||
148980814|NCT00691210|537409425|FG003|Overall Study|Lack of Efficacy|1|||
148980815|NCT00691210|537409426|FG004|Overall Study|Lack of Efficacy|0|||
148769966|NCT00090220|536632747|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
148769967|NCT00090220|536632748|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
148769968|NCT00090220|536632749|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
148769969|NCT00090220|536632750|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
148769970|NCT00090220|536632751|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
148769971|NCT00090220|536632746|FG000|Base Study Vaccination Period|Adverse Event|6|||
148980816|NCT00691210|537409427|FG005|Overall Study|Lack of Efficacy|1|||
148980817|NCT00691210|537409428|FG006|Overall Study|Lack of Efficacy|0|||
148769972|NCT00090220|536632747|FG001|Base Study Vaccination Period|Adverse Event|1|||
148769973|NCT00090220|536632748|FG002|Base Study Vaccination Period|Adverse Event|0|||
148769974|NCT00090220|536632749|FG003|Base Study Vaccination Period|Adverse Event|0|||
148769975|NCT00090220|536632750|FG004|Base Study Vaccination Period|Adverse Event|0|||
148769976|NCT00090220|536632751|FG005|Base Study Vaccination Period|Adverse Event|0|||
148769977|NCT00090220|536632746|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
148769978|NCT00090220|536632747|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
148769979|NCT00090220|536632748|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
148769980|NCT00090220|536632749|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
148769981|NCT00090220|536632750|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
148769982|NCT00090220|536632751|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
148769983|NCT00090220|536632746|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
148769984|NCT00090220|536632747|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
148769985|NCT00090220|536632748|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
148769986|NCT00090220|536632749|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
148769987|NCT00090220|536632750|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
148769988|NCT00090220|536632751|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
148769989|NCT00090220|536632746|FG000|Base Study Vaccination Period|Patient Moved|6|||
148769990|NCT00090220|536632747|FG001|Base Study Vaccination Period|Patient Moved|2|||
148769991|NCT00090220|536632748|FG002|Base Study Vaccination Period|Patient Moved|0|||
148769992|NCT00090220|536632749|FG003|Base Study Vaccination Period|Patient Moved|0|||
148769993|NCT00090220|536632750|FG004|Base Study Vaccination Period|Patient Moved|0|||
148769994|NCT00090220|536632751|FG005|Base Study Vaccination Period|Patient Moved|0|||
148769995|NCT00090220|536632746|FG000|Base Study Vaccination Period|Other|4|||
148769996|NCT00090220|536632747|FG001|Base Study Vaccination Period|Other|4|||
148769997|NCT00090220|536632748|FG002|Base Study Vaccination Period|Other|0|||
148769998|NCT00090220|536632749|FG003|Base Study Vaccination Period|Other|0|||
148769999|NCT00090220|536632750|FG004|Base Study Vaccination Period|Other|0|||
148770000|NCT00090220|536632751|FG005|Base Study Vaccination Period|Other|0|||
148770001|NCT00090220|536632746|FG000|Base Study Follow-up Period|Adverse Event|6|||
148770002|NCT00090220|536632747|FG001|Base Study Follow-up Period|Adverse Event|1|||
148770003|NCT00090220|536632748|FG002|Base Study Follow-up Period|Adverse Event|0|||
148770004|NCT00090220|536632749|FG003|Base Study Follow-up Period|Adverse Event|0|||
148770005|NCT00090220|536632750|FG004|Base Study Follow-up Period|Adverse Event|0|||
148770006|NCT00090220|536632751|FG005|Base Study Follow-up Period|Adverse Event|0|||
148770007|NCT00090220|536632746|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
148770008|NCT00090220|536632747|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
148770009|NCT00090220|536632748|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
148770010|NCT00090220|536632749|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
148770011|NCT00090220|536632750|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
148770012|NCT00090220|536632751|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
148770013|NCT00090220|536632746|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
148770014|NCT00090220|536632747|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
148770015|NCT00090220|536632748|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
148770016|NCT00090220|536632749|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
148770017|NCT00090220|536632750|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
148770018|NCT00090220|536632751|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
148770019|NCT00090220|536632746|FG000|Base Study Follow-up Period|Patient Moved|20|||
148770020|NCT00090220|536632747|FG001|Base Study Follow-up Period|Patient Moved|28|||
148770021|NCT00090220|536632748|FG002|Base Study Follow-up Period|Patient Moved|0|||
148770022|NCT00090220|536632749|FG003|Base Study Follow-up Period|Patient Moved|0|||
148770023|NCT00090220|536632750|FG004|Base Study Follow-up Period|Patient Moved|0|||
148770024|NCT00090220|536632751|FG005|Base Study Follow-up Period|Patient Moved|0|||
148770025|NCT00090220|536632746|FG000|Base Study Follow-up Period|Other|19|||
148770026|NCT00090220|536632747|FG001|Base Study Follow-up Period|Other|21|||
148770027|NCT00090220|536632748|FG002|Base Study Follow-up Period|Other|0|||
148770028|NCT00090220|536632749|FG003|Base Study Follow-up Period|Other|0|||
148770029|NCT00090220|536632750|FG004|Base Study Follow-up Period|Other|0|||
148980818|NCT00691210|537409429|FG007|Overall Study|Lack of Efficacy|0|||
148980819|NCT01208233|537409430|FG000|Overall Study|Adverse Event|0|||
148770030|NCT00090220|536632751|FG005|Base Study Follow-up Period|Other|0|||
148770031|NCT00090220|536632746|FG000|Extension 1 (EXT1)|Adverse Event|0|||
148770032|NCT00090220|536632747|FG001|Extension 1 (EXT1)|Adverse Event|0|||
148770033|NCT00090220|536632748|FG002|Extension 1 (EXT1)|Adverse Event|4|||
148770034|NCT00090220|536632749|FG003|Extension 1 (EXT1)|Adverse Event|0|||
148770035|NCT00090220|536632750|FG004|Extension 1 (EXT1)|Adverse Event|0|||
148770036|NCT00090220|536632751|FG005|Extension 1 (EXT1)|Adverse Event|0|||
148770037|NCT00090220|536632746|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
148770038|NCT00090220|536632747|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
148770039|NCT00090220|536632748|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
148770040|NCT00090220|536632749|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
148770041|NCT00090220|536632750|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
148770042|NCT00090220|536632751|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
148770043|NCT00090220|536632746|FG000|Extension 1 (EXT1)|Moved|0|||
148770044|NCT00090220|536632747|FG001|Extension 1 (EXT1)|Moved|0|||
148770045|NCT00090220|536632748|FG002|Extension 1 (EXT1)|Moved|2|||
148770046|NCT00090220|536632749|FG003|Extension 1 (EXT1)|Moved|1|||
148770047|NCT00090220|536632750|FG004|Extension 1 (EXT1)|Moved|0|||
148770048|NCT00090220|536632751|FG005|Extension 1 (EXT1)|Moved|0|||
148770049|NCT00090220|536632746|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
148770050|NCT00090220|536632747|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
148770051|NCT00090220|536632748|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
148770052|NCT00090220|536632749|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
148770053|NCT00090220|536632750|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
148770054|NCT00090220|536632751|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
148770055|NCT00090220|536632746|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
148770056|NCT00090220|536632747|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
148770057|NCT00090220|536632748|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
148770058|NCT00090220|536632749|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
148770059|NCT00090220|536632750|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
148770060|NCT00090220|536632751|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
148770061|NCT00090220|536632746|FG000|Extension 1 (EXT1)|Other reason|0|||
148770062|NCT00090220|536632747|FG001|Extension 1 (EXT1)|Other reason|0|||
148770063|NCT00090220|536632748|FG002|Extension 1 (EXT1)|Other reason|2|||
148770064|NCT00090220|536632749|FG003|Extension 1 (EXT1)|Other reason|0|||
148770065|NCT00090220|536632750|FG004|Extension 1 (EXT1)|Other reason|0|||
148770066|NCT00090220|536632751|FG005|Extension 1 (EXT1)|Other reason|0|||
148770067|NCT00090220|536632746|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
148770068|NCT00090220|536632747|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
148770069|NCT00090220|536632748|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
148770070|NCT00090220|536632749|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
148770071|NCT00090220|536632750|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
148770072|NCT00090220|536632751|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
148770073|NCT00090220|536632746|FG000|Long-term Follow-up (EXT2)|Death|0|||
148770074|NCT00090220|536632747|FG001|Long-term Follow-up (EXT2)|Death|0|||
148770075|NCT00090220|536632748|FG002|Long-term Follow-up (EXT2)|Death|0|||
148980820|NCT01208233|537409431|FG001|Overall Study|Adverse Event|1|||
148980821|NCT01208233|537409432|FG002|Overall Study|Adverse Event|2|||
148980822|NCT01208233|537409433|FG003|Overall Study|Adverse Event|0|||
148980823|NCT01208233|537409434|FG004|Overall Study|Adverse Event|3|||
148980824|NCT01208233|537409435|FG005|Overall Study|Adverse Event|5|||
148980825|NCT01208233|537409430|FG000|Overall Study|Death|0|||
148980826|NCT01208233|537409431|FG001|Overall Study|Death|0|||
148980827|NCT01208233|537409432|FG002|Overall Study|Death|0|||
148980828|NCT01208233|537409433|FG003|Overall Study|Death|0|||
148980829|NCT01208233|537409434|FG004|Overall Study|Death|3|||
148980830|NCT01208233|537409435|FG005|Overall Study|Death|5|||
148980831|NCT01208233|537409430|FG000|Overall Study|Did not meet entrance criteria|2|||
148980832|NCT01208233|537409431|FG001|Overall Study|Did not meet entrance criteria|1|||
148980833|NCT01208233|537409432|FG002|Overall Study|Did not meet entrance criteria|1|||
148980834|NCT01208233|537409433|FG003|Overall Study|Did not meet entrance criteria|0|||
148980835|NCT01208233|537409434|FG004|Overall Study|Did not meet entrance criteria|1|||
148980836|NCT01208233|537409435|FG005|Overall Study|Did not meet entrance criteria|0|||
148980837|NCT01208233|537409430|FG000|Overall Study|Medication error without adverse event|0|||
148980838|NCT01208233|537409431|FG001|Overall Study|Medication error without adverse event|0|||
148770076|NCT00090220|536632749|FG003|Long-term Follow-up (EXT2)|Death|0|||
148770077|NCT00090220|536632750|FG004|Long-term Follow-up (EXT2)|Death|1|||
148770078|NCT00090220|536632751|FG005|Long-term Follow-up (EXT2)|Death|1|||
148770079|NCT00090220|536632746|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
148770080|NCT00090220|536632747|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
148770081|NCT00090220|536632748|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
148980839|NCT01208233|537409432|FG002|Overall Study|Medication error without adverse event|0|||
148980840|NCT01208233|537409433|FG003|Overall Study|Medication error without adverse event|0|||
148980841|NCT01208233|537409434|FG004|Overall Study|Medication error without adverse event|0|||
148980842|NCT01208233|537409435|FG005|Overall Study|Medication error without adverse event|1|||
148980843|NCT01208233|537409430|FG000|Overall Study|Study terminated by sponsor|0|||
148980844|NCT01208233|537409431|FG001|Overall Study|Study terminated by sponsor|0|||
148770082|NCT00090220|536632749|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
148770083|NCT00090220|536632750|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
148770084|NCT00090220|536632751|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
148770085|NCT00090220|536632746|FG000|Long-term Follow-up (EXT2)|Other|0|||
148770086|NCT00090220|536632747|FG001|Long-term Follow-up (EXT2)|Other|0|||
148770087|NCT00090220|536632748|FG002|Long-term Follow-up (EXT2)|Other|0|||
148770088|NCT00090220|536632749|FG003|Long-term Follow-up (EXT2)|Other|0|||
148770089|NCT00090220|536632750|FG004|Long-term Follow-up (EXT2)|Other|1|||
148770090|NCT00090220|536632751|FG005|Long-term Follow-up (EXT2)|Other|0|||
148770091|NCT00941863|536632752|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
148770092|NCT00941863|536632753|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
148770093|NCT00941863|536632754|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
148770094|NCT00941863|536632755|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
148770095|NCT00941863|536632756|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
148770096|NCT00941863|536632752|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
148770097|NCT00941863|536632753|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
148770098|NCT00941863|536632754|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
148770099|NCT00941863|536632755|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
148770100|NCT00941863|536632756|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
148770101|NCT00941863|536632752|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
148770102|NCT00941863|536632753|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
148770103|NCT00941863|536632754|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
148770104|NCT00941863|536632755|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
148770105|NCT00941863|536632756|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
148770106|NCT00941863|536632752|FG000|Until Primary Completion Date (PCD)|Death|0|||
148770107|NCT00941863|536632753|FG001|Until Primary Completion Date (PCD)|Death|0|||
148770108|NCT00941863|536632754|FG002|Until Primary Completion Date (PCD)|Death|1|||
148770109|NCT00941863|536632755|FG003|Until Primary Completion Date (PCD)|Death|2|||
148770110|NCT00941863|536632756|FG004|Until Primary Completion Date (PCD)|Death|7|||
148770111|NCT00941863|536632752|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
148770112|NCT00941863|536632753|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
148770113|NCT00941863|536632754|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
148770114|NCT00941863|536632755|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
148770115|NCT00941863|536632756|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
148770116|NCT00941863|536632752|FG000|Continued After PCD|Withdrawal by Subject|0|||
148770117|NCT00941863|536632753|FG001|Continued After PCD|Withdrawal by Subject|0|||
148770118|NCT00941863|536632754|FG002|Continued After PCD|Withdrawal by Subject|0|||
148770119|NCT00941863|536632755|FG003|Continued After PCD|Withdrawal by Subject|0|||
148770120|NCT00941863|536632756|FG004|Continued After PCD|Withdrawal by Subject|1|||
148770121|NCT00941863|536632752|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
148770122|NCT00941863|536632753|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
148770123|NCT00941863|536632754|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
148770124|NCT00941863|536632755|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
148770125|NCT00941863|536632756|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
148770126|NCT02394340|536632757|FG000|Overall Study|Failed drug screen test|1|||
148770127|NCT02394340|536632757|FG000|Overall Study|Adverse Event|1|||
148770128|NCT03315286|536632760|FG000|Overall Study|Lost to Follow-up|0|||
148770129|NCT03315286|536632761|FG001|Overall Study|Lost to Follow-up|3|||
148770130|NCT03315286|536632760|FG000|Overall Study|Withdrawal by Subject|1|||
148770131|NCT03315286|536632761|FG001|Overall Study|Withdrawal by Subject|0|||
148770132|NCT03315286|536632760|FG000|Overall Study|Protocol Violation|0|||
148770133|NCT03315286|536632761|FG001|Overall Study|Protocol Violation|1|||
148770134|NCT02828124|536632762|FG000|Overall Study|Disease Progression|1|||
148770135|NCT02828124|536632763|FG001|Overall Study|Disease Progression|2|||
148770136|NCT02828124|536632764|FG002|Overall Study|Disease Progression|1|||
148770137|NCT02828124|536632765|FG003|Overall Study|Disease Progression|4|||
148770138|NCT02828124|536632762|FG000|Overall Study|AE Unrelated to Study Drug|0|||
148770139|NCT02828124|536632763|FG001|Overall Study|AE Unrelated to Study Drug|0|||
148770140|NCT02828124|536632764|FG002|Overall Study|AE Unrelated to Study Drug|0|||
148770141|NCT02828124|536632765|FG003|Overall Study|AE Unrelated to Study Drug|1|||
148770142|NCT02828124|536632762|FG000|Overall Study|Subject Withdrew Consent|0|||
148770143|NCT02828124|536632763|FG001|Overall Study|Subject Withdrew Consent|0|||
148770144|NCT02828124|536632764|FG002|Overall Study|Subject Withdrew Consent|0|||
148770145|NCT02828124|536632765|FG003|Overall Study|Subject Withdrew Consent|1|||
148770146|NCT00747474|536632766|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770147|NCT00747474|536632767|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770148|NCT00747474|536632768|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770149|NCT00747474|536632769|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770150|NCT00747474|536632770|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770151|NCT00747474|536632771|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148831891|NCT02314923|536864447|FG009|Overall Study|Physician Decision|0|||
148831892|NCT02314923|536864438|FG000|Overall Study|Participant unavailable|0|||
148831893|NCT02314923|536864439|FG001|Overall Study|Participant unavailable|0|||
148831894|NCT02314923|536864440|FG002|Overall Study|Participant unavailable|0|||
148831895|NCT02314923|536864441|FG003|Overall Study|Participant unavailable|0|||
148831896|NCT02314923|536864442|FG004|Overall Study|Participant unavailable|0|||
148831897|NCT02314923|536864443|FG005|Overall Study|Participant unavailable|1|||
148831898|NCT02314923|536864444|FG006|Overall Study|Participant unavailable|0|||
148831899|NCT02314923|536864445|FG007|Overall Study|Participant unavailable|0|||
148831900|NCT02314923|536864446|FG008|Overall Study|Participant unavailable|0|||
148831901|NCT02314923|536864447|FG009|Overall Study|Participant unavailable|0|||
148831902|NCT02314923|536864438|FG000|Overall Study|Screen failure|0|||
148980845|NCT01208233|537409432|FG002|Overall Study|Study terminated by sponsor|0|||
148980846|NCT01208233|537409433|FG003|Overall Study|Study terminated by sponsor|0|||
148980847|NCT01208233|537409434|FG004|Overall Study|Study terminated by sponsor|10|||
148980848|NCT01208233|537409435|FG005|Overall Study|Study terminated by sponsor|7|||
148980849|NCT01208233|537409430|FG000|Overall Study|Protocol Violation|0|||
148980850|NCT01208233|537409431|FG001|Overall Study|Protocol Violation|0|||
148980851|NCT01208233|537409432|FG002|Overall Study|Protocol Violation|0|||
148980852|NCT01208233|537409433|FG003|Overall Study|Protocol Violation|0|||
148980853|NCT01208233|537409434|FG004|Overall Study|Protocol Violation|3|||
148980854|NCT01208233|537409435|FG005|Overall Study|Protocol Violation|0|||
148980855|NCT01208233|537409430|FG000|Overall Study|Other|2|||
148980856|NCT01208233|537409431|FG001|Overall Study|Other|1|||
148980857|NCT01208233|537409432|FG002|Overall Study|Other|0|||
148980858|NCT01208233|537409433|FG003|Overall Study|Other|0|||
148980859|NCT01208233|537409434|FG004|Overall Study|Other|0|||
148980860|NCT01208233|537409435|FG005|Overall Study|Other|1|||
148980861|NCT01208233|537409430|FG000|Overall Study|Withdrawal by Subject|1|||
148980862|NCT01208233|537409431|FG001|Overall Study|Withdrawal by Subject|0|||
148980863|NCT01208233|537409432|FG002|Overall Study|Withdrawal by Subject|1|||
148980864|NCT01208233|537409433|FG003|Overall Study|Withdrawal by Subject|1|||
148980865|NCT01208233|537409434|FG004|Overall Study|Withdrawal by Subject|4|||
148980866|NCT01208233|537409435|FG005|Overall Study|Withdrawal by Subject|2|||
148980867|NCT01181895|537409437|FG000|Overall Study|Adverse Event|3|||
148980868|NCT01181895|537409438|FG001|Overall Study|Adverse Event|1|||
148980869|NCT01181895|537409439|FG002|Overall Study|Adverse Event|1|||
148980870|NCT01181895|537409437|FG000|Overall Study|Lack of Efficacy|8|||
148980871|NCT01181895|537409438|FG001|Overall Study|Lack of Efficacy|9|||
148980872|NCT01181895|537409439|FG002|Overall Study|Lack of Efficacy|9|||
148980873|NCT01181895|537409437|FG000|Overall Study|Protocol Violation|2|||
148980874|NCT01181895|537409438|FG001|Overall Study|Protocol Violation|1|||
148980875|NCT01181895|537409439|FG002|Overall Study|Protocol Violation|0|||
148980876|NCT01181895|537409437|FG000|Overall Study|Lost to Follow-up|0|||
148980877|NCT01181895|537409438|FG001|Overall Study|Lost to Follow-up|1|||
148980878|NCT01181895|537409439|FG002|Overall Study|Lost to Follow-up|2|||
148980879|NCT01181895|537409437|FG000|Overall Study|Investigator Discretion|1|||
148980880|NCT01181895|537409438|FG001|Overall Study|Investigator Discretion|2|||
148980881|NCT01181895|537409439|FG002|Overall Study|Investigator Discretion|1|||
148980882|NCT01181895|537409437|FG000|Overall Study|Withdrawal by Subject|3|||
148980883|NCT01181895|537409438|FG001|Overall Study|Withdrawal by Subject|0|||
148980884|NCT01181895|537409439|FG002|Overall Study|Withdrawal by Subject|5|||
148980885|NCT05789875|537409440|FG000|Overall Study|Lost to Follow-up|6|||
148980886|NCT00023452|537409441|FG000|Overall Study|Ineligible for Study|163|||
148980887|NCT00023452|537409442|FG001|Overall Study|Ineligible for Study|159|||
148831903|NCT02314923|536864439|FG001|Overall Study|Screen failure|0|||
148831904|NCT02314923|536864440|FG002|Overall Study|Screen failure|0|||
148831905|NCT02314923|536864441|FG003|Overall Study|Screen failure|0|||
148831906|NCT02314923|536864442|FG004|Overall Study|Screen failure|0|||
148831907|NCT02314923|536864443|FG005|Overall Study|Screen failure|0|||
148831908|NCT02314923|536864444|FG006|Overall Study|Screen failure|1|||
148831909|NCT02314923|536864445|FG007|Overall Study|Screen failure|0|||
148831910|NCT02314923|536864446|FG008|Overall Study|Screen failure|0|||
148980888|NCT00023452|537409441|FG000|Overall Study|Out of Window|129|||
148980889|NCT00023452|537409442|FG001|Overall Study|Out of Window|69|||
148980890|NCT00023452|537409441|FG000|Overall Study|Death|2|||
148831911|NCT02314923|536864447|FG009|Overall Study|Screen failure|0|||
148831912|NCT02314923|536864438|FG000|Overall Study|Participant relocation|1|||
148831913|NCT02314923|536864439|FG001|Overall Study|Participant relocation|0|||
148831914|NCT02314923|536864440|FG002|Overall Study|Participant relocation|0|||
148980891|NCT00023452|537409442|FG001|Overall Study|Death|0|||
148980892|NCT00023452|537409441|FG000|Overall Study|Withdrawal by Subject|66|||
148980893|NCT00023452|537409442|FG001|Overall Study|Withdrawal by Subject|54|||
148980894|NCT00023452|537409441|FG000|Overall Study|Adverse Event|139|||
148980895|NCT00023452|537409442|FG001|Overall Study|Adverse Event|196|||
148980896|NCT00023452|537409441|FG000|Overall Study|Lost to Follow-up|293|||
148980897|NCT00023452|537409442|FG001|Overall Study|Lost to Follow-up|60|||
148980898|NCT00023452|537409441|FG000|Overall Study|Physician Decision|49|||
148980899|NCT00023452|537409442|FG001|Overall Study|Physician Decision|21|||
148980900|NCT00023452|537409441|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
148831915|NCT02314923|536864441|FG003|Overall Study|Participant relocation|0|||
148831916|NCT02314923|536864442|FG004|Overall Study|Participant relocation|0|||
148831917|NCT02314923|536864443|FG005|Overall Study|Participant relocation|0|||
148831918|NCT02314923|536864444|FG006|Overall Study|Participant relocation|0|||
148831919|NCT02314923|536864445|FG007|Overall Study|Participant relocation|1|||
148831920|NCT02314923|536864446|FG008|Overall Study|Participant relocation|0|||
148831921|NCT02314923|536864447|FG009|Overall Study|Participant relocation|0|||
148831922|NCT01055028|536864448|FG000|Screening|Screen Failure|1|||
148831923|NCT01055028|536864449|FG001|Screening|Screen Failure|1|||
148831924|NCT01055028|536864448|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
148831925|NCT01055028|536864449|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
148831926|NCT01055028|536864448|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
148831927|NCT01055028|536864449|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
148831928|NCT01055028|536864448|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
148831929|NCT01055028|536864449|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
148831930|NCT03605693|536864450|FG000|Overall Study|Lost to Follow-up|4|||
148831931|NCT03605693|536864451|FG001|Overall Study|Lost to Follow-up|0|||
148831932|NCT03605693|536864450|FG000|Overall Study|Physician Decision|1|||
148831933|NCT03605693|536864451|FG001|Overall Study|Physician Decision|0|||
148831934|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
148831935|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
148831936|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
148831937|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
148831938|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
148831939|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
148831940|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
148831941|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
148831942|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
148831943|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
148831944|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
148831945|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
148831946|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
148831947|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
148831948|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
148831949|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
148831950|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
148831951|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
148889339|NCT00101686|537074380|FG009|Overall Study|Randomized but did not receive treament|1|||
148889340|NCT00101686|537074371|FG000|Overall Study|intercurrent non-cancer related illness|0|||
148889341|NCT00101686|537074372|FG001|Overall Study|intercurrent non-cancer related illness|0|||
148889342|NCT00101686|537074373|FG002|Overall Study|intercurrent non-cancer related illness|2|||
148889343|NCT00101686|537074374|FG003|Overall Study|intercurrent non-cancer related illness|0|||
148889344|NCT00101686|537074375|FG004|Overall Study|intercurrent non-cancer related illness|1|||
148889345|NCT00101686|537074376|FG005|Overall Study|intercurrent non-cancer related illness|3|||
148889346|NCT00101686|537074377|FG006|Overall Study|intercurrent non-cancer related illness|1|||
148889347|NCT00101686|537074378|FG007|Overall Study|intercurrent non-cancer related illness|0|||
148889348|NCT00101686|537074379|FG008|Overall Study|intercurrent non-cancer related illness|1|||
148889349|NCT00101686|537074380|FG009|Overall Study|intercurrent non-cancer related illness|1|||
148889350|NCT00101686|537074371|FG000|Overall Study|Physician Decision|10|||
148889351|NCT00101686|537074372|FG001|Overall Study|Physician Decision|13|||
148889352|NCT00101686|537074373|FG002|Overall Study|Physician Decision|6|||
148889353|NCT00101686|537074374|FG003|Overall Study|Physician Decision|7|||
148889354|NCT00101686|537074375|FG004|Overall Study|Physician Decision|8|||
148889355|NCT00101686|537074376|FG005|Overall Study|Physician Decision|9|||
148889356|NCT00101686|537074377|FG006|Overall Study|Physician Decision|5|||
148889357|NCT00101686|537074378|FG007|Overall Study|Physician Decision|5|||
148889358|NCT00101686|537074379|FG008|Overall Study|Physician Decision|1|||
148889359|NCT00101686|537074380|FG009|Overall Study|Physician Decision|1|||
148889360|NCT00101686|537074371|FG000|Overall Study|Other|1|||
148889361|NCT00101686|537074372|FG001|Overall Study|Other|4|||
148889362|NCT00101686|537074373|FG002|Overall Study|Other|1|||
148889363|NCT00101686|537074374|FG003|Overall Study|Other|6|||
148889364|NCT00101686|537074375|FG004|Overall Study|Other|2|||
148889365|NCT00101686|537074376|FG005|Overall Study|Other|12|||
148889366|NCT00101686|537074377|FG006|Overall Study|Other|1|||
148889367|NCT00101686|537074378|FG007|Overall Study|Other|5|||
148889368|NCT00101686|537074379|FG008|Overall Study|Other|3|||
148889369|NCT00101686|537074380|FG009|Overall Study|Other|3|||
148889370|NCT00101686|537074371|FG000|Overall Study|Withdrawal by Subject|9|||
148889371|NCT00101686|537074372|FG001|Overall Study|Withdrawal by Subject|8|||
148831952|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
148831953|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
148831954|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
148831955|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
148831956|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
148831957|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
148831958|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
148831959|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
148831960|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
148831961|NCT03093415|536864452|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
148831962|NCT03093415|536864453|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
148831963|NCT03093415|536864454|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
148831964|NCT03093415|536864452|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
148831965|NCT03093415|536864453|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
148831966|NCT03093415|536864454|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
148831967|NCT01646827|536864457|FG000|Overall Study|Lost to Follow-up|0|||
148831968|NCT01646827|536864458|FG001|Overall Study|Lost to Follow-up|3|||
148831969|NCT01646827|536864457|FG000|Overall Study|Physician Decision|1|||
148831970|NCT01646827|536864458|FG001|Overall Study|Physician Decision|2|||
148831971|NCT01646827|536864457|FG000|Overall Study|Withdrawal by Subject|1|||
148831972|NCT01646827|536864458|FG001|Overall Study|Withdrawal by Subject|0|||
148831973|NCT05134649|536864459|FG000|Overall Study|Lost to Follow-up|12|||
148831974|NCT05134649|536864459|FG000|Overall Study|Withdrawal by Subject|14|||
148831975|NCT05134649|536864459|FG000|Overall Study|Pregnancy|1|||
148831976|NCT05134649|536864459|FG000|Overall Study|Other, not specified|3|||
148831977|NCT01472185|536864464|FG000|Overall Study|Randomized but Not Treated|0|||
148831978|NCT01472185|536864465|FG001|Overall Study|Randomized but Not Treated|1|||
148831979|NCT01472185|536864464|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
148831980|NCT01472185|536864465|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
148831981|NCT01472185|536864464|FG000|Overall Study|Hyperglycemia|5|||
148831982|NCT01472185|536864465|FG001|Overall Study|Hyperglycemia|2|||
148831983|NCT01472185|536864464|FG000|Overall Study|Investigator's Discretion|3|||
148831984|NCT01472185|536864465|FG001|Overall Study|Investigator's Discretion|1|||
148831985|NCT01472185|536864464|FG000|Overall Study|Lost to Follow-up|4|||
148831986|NCT01472185|536864465|FG001|Overall Study|Lost to Follow-up|1|||
148831987|NCT01472185|536864464|FG000|Overall Study|Protocol Violation|5|||
148831988|NCT01472185|536864465|FG001|Overall Study|Protocol Violation|1|||
148831989|NCT01472185|536864464|FG000|Overall Study|Subject Noncompliance|8|||
148831990|NCT01472185|536864465|FG001|Overall Study|Subject Noncompliance|15|||
148831991|NCT01472185|536864464|FG000|Overall Study|Subject Withdrew Consent|6|||
148831992|NCT01472185|536864465|FG001|Overall Study|Subject Withdrew Consent|3|||
148831993|NCT03232567|536864466|FG000|Overall Study|Withdrawal by Subject|0|||
148831994|NCT03232567|536864467|FG001|Overall Study|Withdrawal by Subject|1|||
148831995|NCT03232567|536864468|FG002|Overall Study|Withdrawal by Subject|0|||
148831996|NCT03232567|536864469|FG003|Overall Study|Withdrawal by Subject|0|||
148831997|NCT01153516|536864470|FG000|Overall Study|Both subjects refused surgery|2|||
148831998|NCT01153516|536864471|FG001|Overall Study|Both subjects refused surgery|0|||
148831999|NCT05837481|536864472|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
148832000|NCT05837481|536864473|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
148832001|NCT03038620|536864476|FG000|Overall Study|Lost to Follow-up|18|||
148832002|NCT03038620|536864477|FG001|Overall Study|Lost to Follow-up|23|||
148832003|NCT03038620|536864476|FG000|Overall Study|Withdrawal by Subject|0|||
148832004|NCT03038620|536864477|FG001|Overall Study|Withdrawal by Subject|15|||
148832005|NCT03038620|536864476|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
148832006|NCT03038620|536864477|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
148832007|NCT04380142|536864478|FG000|LD/CD Stabilization Period|Adverse Event|3|||
148832008|NCT04380142|536864479|FG001|LD/CD Stabilization Period|Adverse Event|0|||
148832009|NCT04380142|536864480|FG002|LD/CD Stabilization Period|Adverse Event|0|||
148832010|NCT04380142|536864478|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
148832011|NCT04380142|536864479|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
148832012|NCT04380142|536864480|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
148980901|NCT00023452|537409442|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
148980902|NCT00023452|537409441|FG000|Overall Study|Pregnant|53|||
148980903|NCT00023452|537409442|FG001|Overall Study|Pregnant|20|||
148832013|NCT04380142|536864478|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
148832014|NCT04380142|536864479|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
148980904|NCT00023452|537409441|FG000|Overall Study|Other|204|||
148980905|NCT00023452|537409442|FG001|Overall Study|Other|69|||
148980906|NCT01940705|537409446|FG000|Overall Study|Lost to Follow-up|1|||
148980907|NCT01940705|537409447|FG001|Overall Study|Lost to Follow-up|3|||
148832015|NCT04380142|536864480|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
148832016|NCT04380142|536864478|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
148832017|NCT04380142|536864479|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
148832018|NCT04380142|536864480|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
148832019|NCT04380142|536864478|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
148832020|NCT04380142|536864479|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
148832021|NCT04380142|536864480|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
148832022|NCT04380142|536864478|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
148832023|NCT04380142|536864479|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
148832024|NCT04380142|536864480|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
148832025|NCT04380142|536864478|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148832026|NCT04380142|536864479|FG001|Double-Blind Treatment Period|Adverse Event|1|||
148832027|NCT04380142|536864480|FG002|Double-Blind Treatment Period|Adverse Event|14|||
148832028|NCT04380142|536864478|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
148832029|NCT04380142|536864479|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
148832030|NCT04380142|536864480|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
148832031|NCT04380142|536864478|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
148832032|NCT04380142|536864479|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
148832033|NCT04380142|536864480|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
148832034|NCT04380142|536864478|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
148832035|NCT04380142|536864479|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
148832036|NCT04380142|536864480|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
148832037|NCT04380142|536864478|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
148832038|NCT04380142|536864479|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
148832039|NCT04380142|536864480|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
148832040|NCT04380142|536864478|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
148832041|NCT04380142|536864479|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
148832042|NCT04380142|536864480|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
148832043|NCT04875533|536864481|FG000|Overall Study|Adverse Event|6|||
148832044|NCT04875533|536864482|FG001|Overall Study|Adverse Event|4|||
148832045|NCT04875533|536864481|FG000|Overall Study|Protocol Violation|4|||
148832046|NCT04875533|536864482|FG001|Overall Study|Protocol Violation|0|||
148832047|NCT04875533|536864481|FG000|Overall Study|Withdrawal by Subject|8|||
148832048|NCT04875533|536864482|FG001|Overall Study|Withdrawal by Subject|5|||
148832049|NCT04875533|536864481|FG000|Overall Study|No longer meets eligibility criteria|1|||
148832050|NCT04875533|536864482|FG001|Overall Study|No longer meets eligibility criteria|0|||
148832051|NCT04875533|536864481|FG000|Overall Study|Other|0|||
148832052|NCT04875533|536864482|FG001|Overall Study|Other|2|||
148832053|NCT00982280|536864487|FG000|Observation Period|Not eligible to be dosed|19|||
148832054|NCT00982280|536864487|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
148832055|NCT00982280|536864487|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
148832056|NCT00982280|536864487|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
148832057|NCT00982280|536864487|FG000|Maintenance Period|Adverse Event|1|||
148832058|NCT01506726|536864488|FG000|Overall Study|Adverse Event|1|||
148832059|NCT01506726|536864489|FG001|Overall Study|Adverse Event|2|||
148832060|NCT02231580|536864490|FG000|Overall Study|Adverse Event|5|||
148832061|NCT02231580|536864491|FG001|Overall Study|Adverse Event|0|||
148832062|NCT03781570|536864492|FG000|Overall Study|Technical Issues (equipment failure)|31|||
148832063|NCT03781570|536864492|FG000|Overall Study|Withdrawal by Subject|7|||
148832064|NCT03781570|536864492|FG000|Overall Study|Physical Constraints|11|||
148832065|NCT01107496|536864493|FG000|Overall Study|Adverse Event|1|||
148832066|NCT01107496|536864494|FG001|Overall Study|Adverse Event|0|||
148832067|NCT01107496|536864493|FG000|Overall Study|Lack of Efficacy|1|||
148832068|NCT01107496|536864494|FG001|Overall Study|Lack of Efficacy|0|||
148832069|NCT01107496|536864493|FG000|Overall Study|Protocol Violation|0|||
148832070|NCT01107496|536864494|FG001|Overall Study|Protocol Violation|1|||
148832071|NCT01107496|536864493|FG000|Overall Study|Lost to Follow-up|0|||
148832072|NCT01107496|536864494|FG001|Overall Study|Lost to Follow-up|1|||
148832073|NCT01346592|536864495|FG000|Overall Study|Lost to Follow-up|62|||
148832074|NCT01346592|536864496|FG001|Overall Study|Lost to Follow-up|29|||
148832075|NCT01346592|536864497|FG002|Overall Study|Lost to Follow-up|29|||
148832076|NCT01346592|536864495|FG000|Overall Study|Protocol Violation|2|||
148832077|NCT01346592|536864496|FG001|Overall Study|Protocol Violation|1|||
148832078|NCT01346592|536864497|FG002|Overall Study|Protocol Violation|0|||
148980908|NCT01940705|537409448|FG002|Overall Study|Lost to Follow-up|2|||
148980909|NCT01940705|537409449|FG003|Overall Study|Lost to Follow-up|2|||
148832079|NCT01346592|536864495|FG000|Overall Study|Death|1|||
148832080|NCT01346592|536864496|FG001|Overall Study|Death|3|||
148832081|NCT01346592|536864497|FG002|Overall Study|Death|4|||
148832082|NCT01346592|536864495|FG000|Overall Study|Adverse Event|0|||
148832083|NCT01346592|536864496|FG001|Overall Study|Adverse Event|1|||
148832084|NCT01346592|536864497|FG002|Overall Study|Adverse Event|0|||
148832085|NCT01346592|536864495|FG000|Overall Study|Withdrawal by Subject|77|||
149028168|NCT03537651|537580124|FG000|Part A (Up to 96 Weeks)|Other|1|||
148832086|NCT01346592|536864496|FG001|Overall Study|Withdrawal by Subject|51|||
148832087|NCT01346592|536864497|FG002|Overall Study|Withdrawal by Subject|38|||
148832088|NCT01346592|536864495|FG000|Overall Study|Inappropriate enrollment|3|||
148832089|NCT01346592|536864496|FG001|Overall Study|Inappropriate enrollment|1|||
148832090|NCT01346592|536864497|FG002|Overall Study|Inappropriate enrollment|1|||
148832091|NCT01346592|536864495|FG000|Overall Study|Administrative reason|1|||
148832092|NCT01346592|536864496|FG001|Overall Study|Administrative reason|0|||
148832093|NCT01346592|536864497|FG002|Overall Study|Administrative reason|0|||
148832094|NCT01346592|536864495|FG000|Overall Study|Unable to Classify|7|||
148832095|NCT01346592|536864496|FG001|Overall Study|Unable to Classify|3|||
148832096|NCT01346592|536864497|FG002|Overall Study|Unable to Classify|6|||
148832097|NCT05185453|536864500|FG000|Overall Study|Lost to Follow-up|13|||
148832098|NCT05185453|536864501|FG001|Overall Study|Lost to Follow-up|3|||
148832099|NCT04569084|536864502|FG000|Overall Study|Adverse Event|10|||
148832100|NCT04569084|536864503|FG001|Overall Study|Adverse Event|14|||
148832101|NCT04569084|536864502|FG000|Overall Study|Death|2|||
148832102|NCT04569084|536864503|FG001|Overall Study|Death|3|||
148832103|NCT04569084|536864502|FG000|Overall Study|Lost to Follow-up|1|||
148832104|NCT04569084|536864503|FG001|Overall Study|Lost to Follow-up|1|||
148832105|NCT04569084|536864502|FG000|Overall Study|Physician Decision|3|||
148832106|NCT04569084|536864503|FG001|Overall Study|Physician Decision|3|||
148832107|NCT04569084|536864502|FG000|Overall Study|Protocol Violation|2|||
148832108|NCT04569084|536864503|FG001|Overall Study|Protocol Violation|1|||
148832109|NCT04569084|536864502|FG000|Overall Study|Withdrawal by Subject|20|||
148832110|NCT04569084|536864503|FG001|Overall Study|Withdrawal by Subject|21|||
148832111|NCT04569084|536864502|FG000|Overall Study|Study terminated by sponsor|26|||
148832112|NCT04569084|536864503|FG001|Overall Study|Study terminated by sponsor|23|||
148832113|NCT04569084|536864502|FG000|Overall Study|Other|3|||
148832114|NCT04569084|536864503|FG001|Overall Study|Other|5|||
148832115|NCT02552225|536866334|FG000|Overall Study|Withdrawal by Subject|1|||
148832116|NCT02552225|536866335|FG001|Overall Study|Withdrawal by Subject|0|||
148832117|NCT01168596|536866336|FG000|Overall Study|Withdrawal by Subject|3|||
148832118|NCT01168596|536866337|FG001|Overall Study|Withdrawal by Subject|1|||
148832119|NCT00189423|536866341|FG000|Overall Study|Death|746|||
148832120|NCT00189423|536866342|FG001|Overall Study|Death|747|||
148832121|NCT00189423|536866341|FG000|Overall Study|Withdrawal by Subject|9|||
148832122|NCT00189423|536866342|FG001|Overall Study|Withdrawal by Subject|9|||
148832123|NCT00189423|536866341|FG000|Overall Study|Lost to Follow-up|10|||
148832124|NCT00189423|536866342|FG001|Overall Study|Lost to Follow-up|10|||
148832125|NCT00183248|536866350|FG000|Overall Study|Lost to Follow-up|0|||
148832126|NCT00183248|536866351|FG001|Overall Study|Lost to Follow-up|1|||
148832127|NCT00183248|536866350|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
148832128|NCT00183248|536866351|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
148832129|NCT03898180|536866354|FG000|Overall Study|Death|178|||
148832130|NCT03898180|536866355|FG001|Overall Study|Death|173|||
148832131|NCT03898180|536866354|FG000|Overall Study|Physician Decision|1|||
148832132|NCT03898180|536866355|FG001|Overall Study|Physician Decision|0|||
148832133|NCT03898180|536866354|FG000|Overall Study|Sponsor Decision|3|||
148832134|NCT03898180|536866355|FG001|Overall Study|Sponsor Decision|0|||
148832135|NCT03898180|536866354|FG000|Overall Study|Lost to Follow-up|1|||
148832136|NCT03898180|536866355|FG001|Overall Study|Lost to Follow-up|0|||
148832137|NCT03898180|536866354|FG000|Overall Study|Withdrawal by Subject|5|||
148832138|NCT03898180|536866355|FG001|Overall Study|Withdrawal by Subject|4|||
148832139|NCT02507934|536866356|FG000|Overall Study|Lost to Follow-up|2|||
148832140|NCT02507934|536866357|FG001|Overall Study|Lost to Follow-up|0|||
148832141|NCT02507934|536866356|FG000|Overall Study|Withdrawal by Subject|2|||
148832142|NCT02507934|536866357|FG001|Overall Study|Withdrawal by Subject|0|||
148832143|NCT02836249|536866358|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
148832144|NCT02836249|536866359|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
148832145|NCT02836249|536866360|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
148770152|NCT00747474|536632772|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770153|NCT00747474|536632773|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
148770154|NCT00747474|536632774|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770155|NCT00747474|536632775|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770156|NCT00747474|536632776|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770157|NCT00747474|536632777|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
148770158|NCT02829723|536632779|FG000|Overall Study|Adverse Event|0|||
148770159|NCT02829723|536632780|FG001|Overall Study|Adverse Event|0|||
148770160|NCT02829723|536632781|FG002|Overall Study|Adverse Event|1|||
148770161|NCT02829723|536632782|FG003|Overall Study|Adverse Event|1|||
148770162|NCT02829723|536632783|FG004|Overall Study|Adverse Event|0|||
148832146|NCT02836249|536866361|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
148770163|NCT02829723|536632784|FG005|Overall Study|Adverse Event|0|||
148832147|NCT02836249|536866358|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
148832148|NCT02836249|536866359|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
148832149|NCT02836249|536866360|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
148832150|NCT02836249|536866361|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
148832151|NCT02836249|536866358|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
148832152|NCT02836249|536866359|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
148832153|NCT02836249|536866360|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
148832154|NCT02836249|536866361|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
148832155|NCT02836249|536866358|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148832156|NCT02836249|536866359|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
148832157|NCT02836249|536866360|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148832158|NCT02836249|536866361|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148832159|NCT02836249|536866358|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
148832160|NCT02836249|536866359|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
148832161|NCT02836249|536866360|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
148832162|NCT02836249|536866361|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
148832163|NCT02836249|536866358|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
148832164|NCT02836249|536866359|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
148832165|NCT02836249|536866360|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
148832166|NCT02836249|536866361|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
148832167|NCT02836249|536866358|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
148832168|NCT02836249|536866359|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
148832169|NCT02836249|536866360|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
148832170|NCT02836249|536866361|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
148832171|NCT02836249|536866358|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
148832172|NCT02836249|536866359|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
148832173|NCT02836249|536866360|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
148832174|NCT02836249|536866361|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
148832175|NCT02836249|536866358|FG000|Open-Label TAF Treatment Phase|Death|0|||
148832176|NCT02836249|536866359|FG001|Open-Label TAF Treatment Phase|Death|0|||
148832177|NCT02836249|536866360|FG002|Open-Label TAF Treatment Phase|Death|1|||
148832178|NCT02836249|536866361|FG003|Open-Label TAF Treatment Phase|Death|0|||
148832179|NCT02836249|536866358|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
148832180|NCT02836249|536866359|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
148832181|NCT02836249|536866360|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
148832182|NCT02836249|536866361|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
148832183|NCT02836249|536866358|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
148832184|NCT02836249|536866359|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
148832185|NCT02836249|536866360|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
148832186|NCT02836249|536866361|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
148832187|NCT04752566|536866362|FG000|Overall Study|Protocol Violation|0|||
148832188|NCT04752566|536866363|FG001|Overall Study|Protocol Violation|1|||
148832189|NCT04752566|536866362|FG000|Overall Study|Death|1|||
148832190|NCT04752566|536866363|FG001|Overall Study|Death|0|||
148832191|NCT04752566|536866362|FG000|Overall Study|Adverse Event|1|||
148832192|NCT04752566|536866363|FG001|Overall Study|Adverse Event|0|||
148832193|NCT04752566|536866362|FG000|Overall Study|Withdrawal by Subject|2|||
148832194|NCT04752566|536866363|FG001|Overall Study|Withdrawal by Subject|0|||
148832195|NCT04752566|536866362|FG000|Overall Study|Physician Decision|1|||
148832196|NCT04752566|536866363|FG001|Overall Study|Physician Decision|1|||
148832197|NCT03331354|536866364|FG000|Overall Study|Withdrawal by Subject|1|||
148832198|NCT03331354|536866365|FG001|Overall Study|Withdrawal by Subject|3|||
148832199|NCT03331354|536866364|FG000|Overall Study|Lost to Follow-up|3|||
148832200|NCT03331354|536866365|FG001|Overall Study|Lost to Follow-up|3|||
148832201|NCT03331354|536866364|FG000|Overall Study|Found employment before initiated active intervention|0|||
148832202|NCT03331354|536866365|FG001|Overall Study|Found employment before initiated active intervention|4|||
148832203|NCT00928668|536866366|FG000|Overall Study|Adverse Event|1|||
148832204|NCT00928668|536866367|FG001|Overall Study|Adverse Event|0|||
148832205|NCT00928668|536866368|FG002|Overall Study|Adverse Event|0|||
148832206|NCT00928668|536866369|FG003|Overall Study|Adverse Event|0|||
148832207|NCT00928668|536866370|FG004|Overall Study|Adverse Event|0|||
148832208|NCT00928668|536866366|FG000|Overall Study|Protocol Violation|0|||
148832209|NCT00928668|536866367|FG001|Overall Study|Protocol Violation|0|||
148832210|NCT00928668|536866368|FG002|Overall Study|Protocol Violation|0|||
148832211|NCT00928668|536866369|FG003|Overall Study|Protocol Violation|0|||
148832212|NCT00928668|536866370|FG004|Overall Study|Protocol Violation|1|||
148832213|NCT00928668|536866366|FG000|Overall Study|Withdrawal by Subject|0|||
148832214|NCT00928668|536866367|FG001|Overall Study|Withdrawal by Subject|1|||
148832215|NCT00928668|536866368|FG002|Overall Study|Withdrawal by Subject|1|||
148832216|NCT00928668|536866369|FG003|Overall Study|Withdrawal by Subject|0|||
148832217|NCT00928668|536866370|FG004|Overall Study|Withdrawal by Subject|0|||
148832218|NCT00928668|536866366|FG000|Overall Study|Other reasons not listed above|0|||
148832219|NCT00928668|536866367|FG001|Overall Study|Other reasons not listed above|0|||
148832220|NCT00928668|536866368|FG002|Overall Study|Other reasons not listed above|0|||
148832221|NCT00928668|536866369|FG003|Overall Study|Other reasons not listed above|1|||
148832222|NCT00928668|536866370|FG004|Overall Study|Other reasons not listed above|0|||
148832223|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
148832224|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
148832225|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
148832226|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
148832227|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
148832228|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
148832229|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
148832230|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
148832231|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
148832232|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
148832233|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
148832234|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
148832235|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
148832236|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
148832237|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
148832238|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
148832239|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
148832240|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
148832241|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
148832242|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
148832243|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
148832244|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
148832245|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
148832246|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
148832247|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
148832248|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
148832249|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
148832250|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
148832251|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
148832252|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
148832253|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
148832254|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
148832255|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
148832256|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
148832257|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
148832258|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
148832259|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
148832260|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
148832261|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
148832262|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
148832263|NCT04392154|536866371|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
148832264|NCT04392154|536866372|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
148832265|NCT04392154|536866373|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
148832266|NCT04392154|536866374|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
148832267|NCT04392154|536866371|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
148832268|NCT04392154|536866372|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
148832269|NCT04392154|536866373|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
148832270|NCT04392154|536866374|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
148832271|NCT04392154|536866371|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
148832272|NCT04392154|536866372|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
148832273|NCT04392154|536866373|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
148832274|NCT04392154|536866374|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
148832275|NCT04392154|536866371|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
148832276|NCT04392154|536866372|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
148832277|NCT04392154|536866373|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
148832278|NCT04392154|536866374|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
148832279|NCT01559935|536866375|FG000|Car Phase|Toxicity|4|||
148832280|NCT01559935|536866375|FG000|Car Phase|Death|1|||
148980910|NCT01940705|537409446|FG000|Overall Study|Withdrawal by Subject|2|||
148980911|NCT01940705|537409447|FG001|Overall Study|Withdrawal by Subject|2|||
148980912|NCT01940705|537409448|FG002|Overall Study|Withdrawal by Subject|3|||
148832281|NCT01559935|536866375|FG000|Car Phase|Lack of Efficacy|2|||
148832282|NCT01559935|536866375|FG000|Car Phase|Lost to Follow-up|1|||
148832283|NCT01559935|536866375|FG000|Car Phase|Physician Decision|1|||
148832284|NCT01559935|536866375|FG000|Car Phase|Withdrawal by Subject|2|||
148832285|NCT01559935|536866375|FG000|Car Phase|Per protocol|1|||
148832286|NCT01559935|536866375|FG000|Car Phase|Insurance|1|||
148832287|NCT01559935|536866375|FG000|Car Phase|non-compliance|1|||
148832288|NCT01559935|536866375|FG000|BiRD Phase|Toxicity|1|||
148832289|NCT01559935|536866375|FG000|BiRD Phase|Lack of Efficacy|1|||
148832290|NCT01559935|536866375|FG000|BiRD Phase|Withdrawal by Subject|2|||
148832291|NCT01559935|536866375|FG000|Maintenance Phase|Remains on study|28|||
148832292|NCT01559935|536866375|FG000|Maintenance Phase|Toxicity|1|||
148832293|NCT01559935|536866375|FG000|Maintenance Phase|Lack of Efficacy|18|||
148832294|NCT01559935|536866375|FG000|Maintenance Phase|Withdrawal by Subject|5|||
148832295|NCT01559935|536866375|FG000|Maintenance Phase|Non-compliance|2|||
148832296|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832297|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
148832298|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832299|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
148832300|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
148832301|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
148832302|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
148832303|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832304|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832305|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832306|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832307|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832308|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832309|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832310|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832311|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
148832312|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
148832313|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
148832314|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
148832315|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
148832316|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
148832317|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
148832318|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
148832319|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
148832320|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
148832321|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
148832322|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
148832323|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
148832324|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
148832325|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
148832326|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
148832327|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
148832328|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
148832329|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
148832330|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832331|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832332|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832333|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832334|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832335|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832336|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832337|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832338|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832339|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832340|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832341|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832342|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148832343|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
148980913|NCT01940705|537409449|FG003|Overall Study|Withdrawal by Subject|2|||
148832344|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
148832345|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832346|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
148832347|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
148832348|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
148832349|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
148832350|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
148980914|NCT01940705|537409446|FG000|Overall Study|Intervention not given|0|||
148980915|NCT01940705|537409447|FG001|Overall Study|Intervention not given|3|||
148980916|NCT01940705|537409448|FG002|Overall Study|Intervention not given|3|||
148832351|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832352|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148770164|NCT02829723|536632785|FG006|Overall Study|Adverse Event|0|||
148770165|NCT02829723|536632786|FG007|Overall Study|Adverse Event|1|||
148770166|NCT02829723|536632787|FG008|Overall Study|Adverse Event|0|||
148770167|NCT02829723|536632788|FG009|Overall Study|Adverse Event|0|||
148770168|NCT02829723|536632789|FG010|Overall Study|Adverse Event|0|||
148770169|NCT02829723|536632790|FG011|Overall Study|Adverse Event|0|||
148770170|NCT02829723|536632791|FG012|Overall Study|Adverse Event|0|||
148770171|NCT02829723|536632792|FG013|Overall Study|Adverse Event|0|||
148770172|NCT02829723|536632793|FG014|Overall Study|Adverse Event|1|||
148770173|NCT02829723|536632794|FG015|Overall Study|Adverse Event|1|||
148770174|NCT02829723|536632795|FG016|Overall Study|Adverse Event|1|||
148770175|NCT02829723|536632796|FG017|Overall Study|Adverse Event|2|||
148770176|NCT02829723|536632797|FG018|Overall Study|Adverse Event|1|||
148770177|NCT02829723|536632798|FG019|Overall Study|Adverse Event|1|||
148770178|NCT02829723|536632799|FG020|Overall Study|Adverse Event|3|||
148770179|NCT02829723|536632800|FG021|Overall Study|Adverse Event|0|||
148770180|NCT02829723|536632801|FG022|Overall Study|Adverse Event|0|||
148770181|NCT02829723|536632802|FG023|Overall Study|Adverse Event|1|||
148770182|NCT02829723|536632803|FG024|Overall Study|Adverse Event|1|||
148770183|NCT02829723|536632804|FG025|Overall Study|Adverse Event|3|||
148770184|NCT02829723|536632805|FG026|Overall Study|Adverse Event|5|||
148770185|NCT02829723|536632779|FG000|Overall Study|Death|1|||
148770186|NCT02829723|536632780|FG001|Overall Study|Death|0|||
148770187|NCT02829723|536632781|FG002|Overall Study|Death|1|||
148770188|NCT02829723|536632782|FG003|Overall Study|Death|1|||
148770189|NCT02829723|536632783|FG004|Overall Study|Death|0|||
148770190|NCT02829723|536632784|FG005|Overall Study|Death|0|||
148770191|NCT02829723|536632785|FG006|Overall Study|Death|2|||
148770192|NCT02829723|536632786|FG007|Overall Study|Death|0|||
148770193|NCT02829723|536632787|FG008|Overall Study|Death|1|||
148770194|NCT02829723|536632788|FG009|Overall Study|Death|0|||
148770195|NCT02829723|536632789|FG010|Overall Study|Death|0|||
148770196|NCT02829723|536632790|FG011|Overall Study|Death|0|||
148770197|NCT02829723|536632791|FG012|Overall Study|Death|2|||
148770198|NCT02829723|536632792|FG013|Overall Study|Death|1|||
148770199|NCT02829723|536632793|FG014|Overall Study|Death|0|||
148770200|NCT02829723|536632794|FG015|Overall Study|Death|0|||
148770201|NCT02829723|536632795|FG016|Overall Study|Death|0|||
148770202|NCT02829723|536632796|FG017|Overall Study|Death|0|||
148770203|NCT02829723|536632797|FG018|Overall Study|Death|0|||
148770204|NCT02829723|536632798|FG019|Overall Study|Death|0|||
148770205|NCT02829723|536632799|FG020|Overall Study|Death|0|||
148770206|NCT02829723|536632800|FG021|Overall Study|Death|2|||
148770207|NCT02829723|536632801|FG022|Overall Study|Death|0|||
148770208|NCT02829723|536632802|FG023|Overall Study|Death|0|||
148770209|NCT02829723|536632803|FG024|Overall Study|Death|0|||
148770210|NCT02829723|536632804|FG025|Overall Study|Death|1|||
148770211|NCT02829723|536632805|FG026|Overall Study|Death|2|||
148770212|NCT02829723|536632779|FG000|Overall Study|Physician Decision|0|||
148770213|NCT02829723|536632780|FG001|Overall Study|Physician Decision|0|||
148770214|NCT02829723|536632781|FG002|Overall Study|Physician Decision|0|||
148770215|NCT02829723|536632782|FG003|Overall Study|Physician Decision|0|||
148770216|NCT02829723|536632783|FG004|Overall Study|Physician Decision|0|||
148770217|NCT02829723|536632784|FG005|Overall Study|Physician Decision|0|||
148770218|NCT02829723|536632785|FG006|Overall Study|Physician Decision|0|||
148770219|NCT02829723|536632786|FG007|Overall Study|Physician Decision|0|||
148770220|NCT02829723|536632787|FG008|Overall Study|Physician Decision|0|||
148770221|NCT02829723|536632788|FG009|Overall Study|Physician Decision|1|||
148770222|NCT02829723|536632789|FG010|Overall Study|Physician Decision|1|||
148770223|NCT02829723|536632790|FG011|Overall Study|Physician Decision|0|||
148770224|NCT02829723|536632791|FG012|Overall Study|Physician Decision|0|||
148770225|NCT02829723|536632792|FG013|Overall Study|Physician Decision|1|||
148770226|NCT02829723|536632793|FG014|Overall Study|Physician Decision|0|||
148770227|NCT02829723|536632794|FG015|Overall Study|Physician Decision|0|||
148770228|NCT02829723|536632795|FG016|Overall Study|Physician Decision|2|||
148770229|NCT02829723|536632796|FG017|Overall Study|Physician Decision|0|||
148770230|NCT02829723|536632797|FG018|Overall Study|Physician Decision|0|||
148770231|NCT02829723|536632798|FG019|Overall Study|Physician Decision|0|||
148770232|NCT02829723|536632799|FG020|Overall Study|Physician Decision|0|||
148770233|NCT02829723|536632800|FG021|Overall Study|Physician Decision|0|||
148770234|NCT02829723|536632801|FG022|Overall Study|Physician Decision|1|||
148770235|NCT02829723|536632802|FG023|Overall Study|Physician Decision|1|||
148770236|NCT02829723|536632803|FG024|Overall Study|Physician Decision|1|||
148770237|NCT02829723|536632804|FG025|Overall Study|Physician Decision|1|||
148770238|NCT02829723|536632805|FG026|Overall Study|Physician Decision|3|||
148770239|NCT02829723|536632779|FG000|Overall Study|Progressive disease|4|||
148770240|NCT02829723|536632780|FG001|Overall Study|Progressive disease|6|||
148770241|NCT02829723|536632781|FG002|Overall Study|Progressive disease|3|||
148770242|NCT02829723|536632782|FG003|Overall Study|Progressive disease|3|||
148770243|NCT02829723|536632783|FG004|Overall Study|Progressive disease|3|||
148832353|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832354|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832355|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832356|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832357|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832358|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832359|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148832360|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832361|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832362|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832363|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
148832364|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832365|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832366|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
148832367|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832368|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832369|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832370|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832371|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832372|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832373|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832374|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832375|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
148832376|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832377|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832378|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
148832379|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832380|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832381|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832382|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832383|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832384|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832385|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832386|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832387|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832388|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832389|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832390|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832391|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
148832392|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
148832393|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
148832394|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
148832395|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832396|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832397|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832398|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832399|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832400|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832401|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832402|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832403|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832404|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832405|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832406|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148832407|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148980917|NCT01940705|537409449|FG003|Overall Study|Intervention not given|0|||
148832408|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
148832409|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
148832410|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
148832411|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
148832412|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
148832413|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
148832414|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
148832415|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
148980918|NCT01940705|537409446|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
148980919|NCT01940705|537409447|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
148980920|NCT01940705|537409448|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
148980921|NCT01940705|537409449|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
148980922|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
148980923|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
148980924|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
148980925|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Death|1|||
148980926|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Death|0|||
148980927|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Death|0|||
148980928|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
148980929|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
148980930|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
148980931|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
148980932|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
148980933|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
148980934|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
148980935|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
148980936|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
148980937|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
148980938|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
148980939|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
148980940|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
148980941|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
148980942|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
148980943|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
148980944|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
148980945|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
148980946|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
148980947|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
148980948|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
148980949|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
148980950|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
148980951|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
148980952|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
148980953|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
148980954|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
148980955|NCT03655236|537409452|FG000|Subject Disposition in Part 1 Period|Other|0|||
148980956|NCT03655236|537409453|FG001|Subject Disposition in Part 1 Period|Other|2|||
148980957|NCT03655236|537409454|FG002|Subject Disposition in Part 1 Period|Other|2|||
148980958|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
148980959|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
148980960|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
148980961|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
148980962|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
148980963|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
148980964|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
148980965|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
148980966|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
148832416|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
148832417|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
148832418|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
148832419|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
148832420|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
148832421|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
148832422|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
148832423|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
148832424|NCT02958865|536866377|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832425|NCT02958865|536866378|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832426|NCT02958865|536866379|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832427|NCT02958865|536866380|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832428|NCT02958865|536866381|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
148832429|NCT02958865|536866382|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832430|NCT02958865|536866383|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832431|NCT02958865|536866384|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832432|NCT02958865|536866385|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832433|NCT02958865|536866386|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832434|NCT02958865|536866387|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832435|NCT02958865|536866388|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832436|NCT02958865|536866389|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832437|NCT02958865|536866390|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832438|NCT02958865|536866391|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832439|NCT02958865|536866392|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148832440|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832441|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832442|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832443|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832444|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832445|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832446|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832447|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
148832448|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
148832449|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
148832450|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
148832451|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
148832452|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
148832453|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
148832454|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
148832455|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
148832456|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832457|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832458|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832459|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832460|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832461|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832462|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832463|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832464|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
148832465|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
148832466|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832467|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
148832468|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832469|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
148832470|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
148832471|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
148832472|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832473|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832474|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832475|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832476|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832477|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832478|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832479|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832480|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832481|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
148832482|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832483|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832484|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832485|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832486|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
148832487|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
148832488|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832489|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832490|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832491|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832492|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832493|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832494|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832495|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832496|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832497|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148832498|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
148770244|NCT02829723|536632784|FG005|Overall Study|Progressive disease|5|||
148770245|NCT02829723|536632785|FG006|Overall Study|Progressive disease|4|||
148770246|NCT02829723|536632786|FG007|Overall Study|Progressive disease|6|||
148770247|NCT02829723|536632787|FG008|Overall Study|Progressive disease|8|||
148770248|NCT02829723|536632788|FG009|Overall Study|Progressive disease|4|||
148770249|NCT02829723|536632789|FG010|Overall Study|Progressive disease|9|||
148770250|NCT02829723|536632790|FG011|Overall Study|Progressive disease|0|||
148770251|NCT02829723|536632791|FG012|Overall Study|Progressive disease|3|||
148770252|NCT02829723|536632792|FG013|Overall Study|Progressive disease|4|||
148770253|NCT02829723|536632793|FG014|Overall Study|Progressive disease|2|||
148770254|NCT02829723|536632794|FG015|Overall Study|Progressive disease|4|||
148770255|NCT02829723|536632795|FG016|Overall Study|Progressive disease|5|||
148770256|NCT02829723|536632796|FG017|Overall Study|Progressive disease|3|||
148770257|NCT02829723|536632797|FG018|Overall Study|Progressive disease|4|||
148770258|NCT02829723|536632798|FG019|Overall Study|Progressive disease|4|||
148770259|NCT02829723|536632799|FG020|Overall Study|Progressive disease|7|||
148770260|NCT02829723|536632800|FG021|Overall Study|Progressive disease|6|||
148770261|NCT02829723|536632801|FG022|Overall Study|Progressive disease|3|||
148770262|NCT02829723|536632802|FG023|Overall Study|Progressive disease|3|||
148770263|NCT02829723|536632803|FG024|Overall Study|Progressive disease|3|||
148770264|NCT02829723|536632804|FG025|Overall Study|Progressive disease|16|||
148770265|NCT02829723|536632805|FG026|Overall Study|Progressive disease|10|||
148770266|NCT02829723|536632779|FG000|Overall Study|Subject/guardian decision|0|||
148770267|NCT02829723|536632780|FG001|Overall Study|Subject/guardian decision|1|||
148770268|NCT02829723|536632781|FG002|Overall Study|Subject/guardian decision|0|||
148770269|NCT02829723|536632782|FG003|Overall Study|Subject/guardian decision|1|||
148770270|NCT02829723|536632783|FG004|Overall Study|Subject/guardian decision|0|||
148770271|NCT02829723|536632784|FG005|Overall Study|Subject/guardian decision|0|||
148770272|NCT02829723|536632785|FG006|Overall Study|Subject/guardian decision|0|||
148770273|NCT02829723|536632786|FG007|Overall Study|Subject/guardian decision|1|||
148770274|NCT02829723|536632787|FG008|Overall Study|Subject/guardian decision|0|||
148770275|NCT02829723|536632788|FG009|Overall Study|Subject/guardian decision|0|||
148770276|NCT02829723|536632789|FG010|Overall Study|Subject/guardian decision|0|||
148770277|NCT02829723|536632790|FG011|Overall Study|Subject/guardian decision|0|||
148770278|NCT02829723|536632791|FG012|Overall Study|Subject/guardian decision|0|||
148770279|NCT02829723|536632792|FG013|Overall Study|Subject/guardian decision|0|||
148770280|NCT02829723|536632793|FG014|Overall Study|Subject/guardian decision|1|||
148770281|NCT02829723|536632794|FG015|Overall Study|Subject/guardian decision|0|||
148770282|NCT02829723|536632795|FG016|Overall Study|Subject/guardian decision|1|||
148770283|NCT02829723|536632796|FG017|Overall Study|Subject/guardian decision|0|||
148770284|NCT02829723|536632797|FG018|Overall Study|Subject/guardian decision|1|||
148770285|NCT02829723|536632798|FG019|Overall Study|Subject/guardian decision|0|||
148770286|NCT02829723|536632799|FG020|Overall Study|Subject/guardian decision|1|||
148770287|NCT02829723|536632800|FG021|Overall Study|Subject/guardian decision|0|||
148770288|NCT02829723|536632801|FG022|Overall Study|Subject/guardian decision|0|||
148770289|NCT02829723|536632802|FG023|Overall Study|Subject/guardian decision|1|||
148770290|NCT02829723|536632803|FG024|Overall Study|Subject/guardian decision|0|||
148770291|NCT02829723|536632804|FG025|Overall Study|Subject/guardian decision|1|||
148770292|NCT02829723|536632805|FG026|Overall Study|Subject/guardian decision|1|||
148770293|NCT02829723|536632779|FG000|Overall Study|Study terminated by sponsor|0|||
148770294|NCT02829723|536632780|FG001|Overall Study|Study terminated by sponsor|0|||
148770295|NCT02829723|536632781|FG002|Overall Study|Study terminated by sponsor|0|||
148770296|NCT02829723|536632782|FG003|Overall Study|Study terminated by sponsor|0|||
148770297|NCT02829723|536632783|FG004|Overall Study|Study terminated by sponsor|0|||
148770298|NCT02829723|536632784|FG005|Overall Study|Study terminated by sponsor|0|||
148770299|NCT02829723|536632785|FG006|Overall Study|Study terminated by sponsor|0|||
148770300|NCT02829723|536632786|FG007|Overall Study|Study terminated by sponsor|0|||
148770301|NCT02829723|536632787|FG008|Overall Study|Study terminated by sponsor|0|||
148770302|NCT02829723|536632788|FG009|Overall Study|Study terminated by sponsor|0|||
148770303|NCT02829723|536632789|FG010|Overall Study|Study terminated by sponsor|0|||
148770304|NCT02829723|536632790|FG011|Overall Study|Study terminated by sponsor|0|||
148770305|NCT02829723|536632791|FG012|Overall Study|Study terminated by sponsor|0|||
148770306|NCT02829723|536632792|FG013|Overall Study|Study terminated by sponsor|0|||
148770307|NCT02829723|536632793|FG014|Overall Study|Study terminated by sponsor|0|||
148770308|NCT02829723|536632794|FG015|Overall Study|Study terminated by sponsor|0|||
148770309|NCT02829723|536632795|FG016|Overall Study|Study terminated by sponsor|0|||
148770310|NCT02829723|536632796|FG017|Overall Study|Study terminated by sponsor|0|||
148770311|NCT02829723|536632797|FG018|Overall Study|Study terminated by sponsor|0|||
148770312|NCT02829723|536632798|FG019|Overall Study|Study terminated by sponsor|0|||
148770313|NCT02829723|536632799|FG020|Overall Study|Study terminated by sponsor|0|||
148770314|NCT02829723|536632800|FG021|Overall Study|Study terminated by sponsor|1|||
148770315|NCT02829723|536632801|FG022|Overall Study|Study terminated by sponsor|0|||
148770316|NCT02829723|536632802|FG023|Overall Study|Study terminated by sponsor|0|||
148980967|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
148770317|NCT02829723|536632803|FG024|Overall Study|Study terminated by sponsor|0|||
148770318|NCT02829723|536632804|FG025|Overall Study|Study terminated by sponsor|0|||
148770319|NCT02829723|536632805|FG026|Overall Study|Study terminated by sponsor|0|||
148832499|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
148832500|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
148832501|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
148832502|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
148832503|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
148832504|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
148832505|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
148832506|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
148832507|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
148832508|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
148832509|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
148832510|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
148832511|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
148832512|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
148832513|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
148832514|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
148832515|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
148832516|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
148832517|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
148832518|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
148832519|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
148832520|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832521|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832522|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832523|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832524|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832525|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832526|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832527|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832528|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832529|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832530|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832531|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832532|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832533|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
148832534|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832535|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
148832536|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832537|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832538|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832539|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832540|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832541|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832542|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832543|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832544|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832545|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832546|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832547|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832548|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832549|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
148832550|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832551|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
148832552|NCT02958865|536866377|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832553|NCT02958865|536866378|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832554|NCT02958865|536866379|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832555|NCT02958865|536866380|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832556|NCT02958865|536866381|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832557|NCT02958865|536866382|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832558|NCT02958865|536866383|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832559|NCT02958865|536866384|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832560|NCT02958865|536866385|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832561|NCT02958865|536866386|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
148832562|NCT02958865|536866387|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832563|NCT02958865|536866388|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832564|NCT02958865|536866389|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832565|NCT02958865|536866390|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832566|NCT02958865|536866391|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832567|NCT02958865|536866392|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
148832568|NCT02661815|536866393|FG000|Overall Study|Withdrawal by Subject|1|||
148832569|NCT02661815|536866394|FG001|Overall Study|Withdrawal by Subject|0|||
148832570|NCT02661815|536866395|FG002|Overall Study|Withdrawal by Subject|0|||
148832571|NCT02661815|536866396|FG003|Overall Study|Withdrawal by Subject|0|||
148832572|NCT01767987|536866397|FG000|Overall Study|Physician Decision|4|||
148832573|NCT01767987|536866398|FG001|Overall Study|Physician Decision|1|||
148832574|NCT04581395|536866399|FG000|Overall Study|Protocol Violation|4|||
148832575|NCT04581395|536866400|FG001|Overall Study|Protocol Violation|3|||
148832576|NCT04581395|536866401|FG002|Overall Study|Protocol Violation|2|||
148832577|NCT04581395|536866399|FG000|Overall Study|Physician Decision|0|||
148832578|NCT04581395|536866400|FG001|Overall Study|Physician Decision|1|||
148832579|NCT04581395|536866401|FG002|Overall Study|Physician Decision|0|||
148832580|NCT00815633|536866411|FG000|Overall Study|study terminated|1|||
148832581|NCT00654355|536866413|FG000|Overall Study|Lost to Follow-up|2|||
148832582|NCT00654355|536866414|FG001|Overall Study|Lost to Follow-up|2|||
148832583|NCT01605097|536866417|FG000|Overall Study|Protocol Violation|1|||
148832584|NCT02038647|536866420|FG000|Overall Study|Progressive Disease|50|||
148832585|NCT02038647|536866421|FG001|Overall Study|Progressive Disease|59|||
148832586|NCT02038647|536866420|FG000|Overall Study|Adverse Event|18|||
148832587|NCT02038647|536866421|FG001|Overall Study|Adverse Event|10|||
148832588|NCT02038647|536866420|FG000|Overall Study|Symptomatic Deterioration|7|||
148832589|NCT02038647|536866421|FG001|Overall Study|Symptomatic Deterioration|7|||
148832590|NCT02038647|536866420|FG000|Overall Study|Withdrawal by Subject|5|||
148832591|NCT02038647|536866421|FG001|Overall Study|Withdrawal by Subject|2|||
148832592|NCT02038647|536866420|FG000|Overall Study|Not Reported|0|||
148832593|NCT02038647|536866421|FG001|Overall Study|Not Reported|1|||
148832594|NCT02038647|536866420|FG000|Overall Study|Ongoing at Datacut|9|||
148832595|NCT02038647|536866421|FG001|Overall Study|Ongoing at Datacut|10|||
148832596|NCT02284893|536866422|FG000|26 Week (Short Term)|Adverse Event|1|||
148832597|NCT02284893|536866423|FG001|26 Week (Short Term)|Adverse Event|9|||
148832598|NCT02284893|536866422|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
148832599|NCT02284893|536866423|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
148832600|NCT02284893|536866422|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
148832601|NCT02284893|536866423|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
148832602|NCT02284893|536866422|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
148832603|NCT02284893|536866423|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
148832604|NCT02284893|536866422|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
148832605|NCT02284893|536866423|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
148832606|NCT02284893|536866422|FG000|26 Week (Short Term)|Other|1|||
148832607|NCT02284893|536866423|FG001|26 Week (Short Term)|Other|1|||
148832608|NCT02284893|536866422|FG000|52 Week (Long Term)|Adverse Event|3|||
148832609|NCT02284893|536866423|FG001|52 Week (Long Term)|Adverse Event|1|||
148832610|NCT02284893|536866422|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
148832611|NCT02284893|536866423|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
148832612|NCT02284893|536866422|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
148832613|NCT02284893|536866423|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
148832614|NCT02284893|536866422|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
148832615|NCT02284893|536866423|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
148832616|NCT02284893|536866422|FG000|52 Week (Long Term)|Non-Compliance|2|||
148832617|NCT02284893|536866423|FG001|52 Week (Long Term)|Non-Compliance|3|||
148832618|NCT02757430|536866424|FG000|Overall Study|Physician Decision|6|||
148832619|NCT02757430|536866424|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
148832620|NCT02757430|536866424|FG000|Overall Study|No informed consent|1|||
148832621|NCT02757430|536866424|FG000|Overall Study|No procedure performed|2|||
148832622|NCT03078868|536866427|FG000|Overall Study|Physician Decision|3|||
148832623|NCT01983111|536866428|FG000|Overall Study|Withdrawal by Subject|8|||
148832624|NCT01983111|536866429|FG001|Overall Study|Withdrawal by Subject|6|||
148832625|NCT01983111|536866428|FG000|Overall Study|Adverse Event|4|||
148832626|NCT01983111|536866429|FG001|Overall Study|Adverse Event|0|||
148832627|NCT01983111|536866428|FG000|Overall Study|Protocol Violation|0|||
148832628|NCT01983111|536866429|FG001|Overall Study|Protocol Violation|1|||
148832629|NCT00105066|536866433|FG000|Overall Study|Adverse Event|2|||
148832630|NCT00105066|536866434|FG001|Overall Study|Adverse Event|5|||
148832631|NCT02106832|536866445|FG000|Overall Study|Adverse Event|1|||
148832632|NCT02106832|536866446|FG001|Overall Study|Adverse Event|2|||
148832633|NCT02106832|536866447|FG002|Overall Study|Adverse Event|3|||
148832634|NCT02106832|536866448|FG003|Overall Study|Adverse Event|0|||
148832635|NCT02106832|536866445|FG000|Overall Study|Death|4|||
148832636|NCT02106832|536866446|FG001|Overall Study|Death|4|||
148832637|NCT02106832|536866447|FG002|Overall Study|Death|1|||
148832638|NCT02106832|536866448|FG003|Overall Study|Death|4|||
148832639|NCT02106832|536866445|FG000|Overall Study|Deterioration of general conditions|0|||
148832640|NCT02106832|536866446|FG001|Overall Study|Deterioration of general conditions|0|||
148832641|NCT02106832|536866447|FG002|Overall Study|Deterioration of general conditions|1|||
148832642|NCT02106832|536866448|FG003|Overall Study|Deterioration of general conditions|0|||
148832643|NCT02106832|536866445|FG000|Overall Study|Lost to Follow-up|0|||
148832644|NCT02106832|536866446|FG001|Overall Study|Lost to Follow-up|1|||
148832645|NCT02106832|536866447|FG002|Overall Study|Lost to Follow-up|1|||
148832646|NCT02106832|536866448|FG003|Overall Study|Lost to Follow-up|3|||
148980968|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
148832647|NCT02106832|536866445|FG000|Overall Study|Physician Decision|1|||
148832648|NCT02106832|536866446|FG001|Overall Study|Physician Decision|0|||
148832649|NCT02106832|536866447|FG002|Overall Study|Physician Decision|0|||
148832650|NCT02106832|536866448|FG003|Overall Study|Physician Decision|0|||
148832651|NCT02106832|536866445|FG000|Overall Study|Protocol Violation|0|||
148832652|NCT02106832|536866446|FG001|Overall Study|Protocol Violation|0|||
148832653|NCT02106832|536866447|FG002|Overall Study|Protocol Violation|0|||
148832654|NCT02106832|536866448|FG003|Overall Study|Protocol Violation|1|||
148832655|NCT02106832|536866445|FG000|Overall Study|Withdrawal by Subject|17|||
148832656|NCT02106832|536866446|FG001|Overall Study|Withdrawal by Subject|17|||
148832657|NCT02106832|536866447|FG002|Overall Study|Withdrawal by Subject|10|||
148832658|NCT02106832|536866448|FG003|Overall Study|Withdrawal by Subject|7|||
148832659|NCT02106832|536866445|FG000|Overall Study|Technical problems|0|||
148832660|NCT02106832|536866446|FG001|Overall Study|Technical problems|1|||
148832661|NCT02106832|536866447|FG002|Overall Study|Technical problems|0|||
148832662|NCT02106832|536866448|FG003|Overall Study|Technical problems|0|||
148832663|NCT01968980|536866465|FG000|Overall Study|Death|0|||
148832664|NCT01968980|536866466|FG001|Overall Study|Death|1|||
148832665|NCT01968980|536866465|FG000|Overall Study|Adverse Event|1|||
148832666|NCT01968980|536866466|FG001|Overall Study|Adverse Event|3|||
148832667|NCT01968980|536866465|FG000|Overall Study|Does not meet entry criteria|1|||
148832668|NCT01968980|536866466|FG001|Overall Study|Does not meet entry criteria|3|||
148832669|NCT01968980|536866465|FG000|Overall Study|Withdrawal by Subject|13|||
148832670|NCT01968980|536866466|FG001|Overall Study|Withdrawal by Subject|5|||
148832671|NCT01968980|536866465|FG000|Overall Study|Other unspecified|1|||
148832672|NCT01968980|536866466|FG001|Overall Study|Other unspecified|2|||
148832673|NCT00265122|536866467|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
148832674|NCT00265122|536866468|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
148832675|NCT00265122|536866469|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
148832676|NCT00265122|536866470|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
148832677|NCT00265122|536866471|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
148832678|NCT00265122|536866472|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
148832679|NCT00265122|536866467|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
148832680|NCT00265122|536866468|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
148832681|NCT00265122|536866469|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
148832682|NCT00265122|536866470|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
148832683|NCT00265122|536866471|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
148832684|NCT00265122|536866472|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
148832685|NCT00265122|536866467|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
148832686|NCT00265122|536866468|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
148832687|NCT00265122|536866469|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
148832688|NCT00265122|536866470|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
148832689|NCT00265122|536866471|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
148832690|NCT00265122|536866472|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
148832691|NCT00265122|536866467|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
148832692|NCT00265122|536866468|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
148832693|NCT00265122|536866469|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
148832694|NCT00265122|536866470|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
148980969|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
148980970|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
148980971|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
148980972|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
148980973|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
148980974|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
148980975|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
148980976|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
148980977|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
148980978|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
148980979|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
148832695|NCT00265122|536866471|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
148832696|NCT00265122|536866472|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
148832697|NCT00265122|536866467|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
148832698|NCT00265122|536866468|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
148832699|NCT00265122|536866469|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
148832700|NCT00265122|536866470|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
148832701|NCT00265122|536866471|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
148832702|NCT00265122|536866472|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
148832703|NCT00265122|536866467|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
148832704|NCT00265122|536866468|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
148832705|NCT00265122|536866469|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
148832706|NCT00265122|536866470|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
148832707|NCT00265122|536866471|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
148832708|NCT00265122|536866472|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
148832709|NCT04716894|536866473|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
148832710|NCT04716894|536866473|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
148832711|NCT01467466|536866486|FG000|Overall Study|Withdrawal by Subject|15|||
148832712|NCT01467466|536866487|FG001|Overall Study|Withdrawal by Subject|18|||
148832713|NCT01467466|536866488|FG002|Overall Study|Withdrawal by Subject|13|||
148832714|NCT01467466|536866489|FG003|Overall Study|Withdrawal by Subject|11|||
148832715|NCT01467466|536866486|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
148832716|NCT01467466|536866487|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
148832717|NCT01467466|536866488|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
148832718|NCT01467466|536866489|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
148832719|NCT01467466|536866486|FG000|Overall Study|Procedure Cancelled|46|||
148832720|NCT01467466|536866487|FG001|Overall Study|Procedure Cancelled|45|||
148832721|NCT01467466|536866488|FG002|Overall Study|Procedure Cancelled|25|||
148832722|NCT01467466|536866489|FG003|Overall Study|Procedure Cancelled|29|||
148832723|NCT01467466|536866486|FG000|Overall Study|No Endpoint Blood Draw|38|||
148832724|NCT01467466|536866487|FG001|Overall Study|No Endpoint Blood Draw|32|||
148832725|NCT01467466|536866488|FG002|Overall Study|No Endpoint Blood Draw|51|||
148832726|NCT01467466|536866489|FG003|Overall Study|No Endpoint Blood Draw|43|||
148832727|NCT03261505|536866496|FG000|Overall Study|Withdrawal by Subject|2|||
148832728|NCT03261505|536866497|FG001|Overall Study|Withdrawal by Subject|3|||
148832729|NCT03261505|536866498|FG002|Overall Study|Withdrawal by Subject|4|||
148832730|NCT03261505|536866499|FG003|Overall Study|Withdrawal by Subject|3|||
148832731|NCT03261505|536866496|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
148832732|NCT03261505|536866497|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
148832733|NCT03261505|536866498|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
148832734|NCT03261505|536866499|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
148832735|NCT03261505|536866496|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
148832736|NCT03261505|536866497|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
148832737|NCT03261505|536866498|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
148832738|NCT03261505|536866499|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
148832739|NCT03261505|536866496|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
148832740|NCT03261505|536866497|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
148832741|NCT03261505|536866498|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
148832742|NCT03261505|536866499|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
148832743|NCT04724837|536866507|FG000|Overall Study|Other|4|||
148832744|NCT04724837|536866508|FG001|Overall Study|Other|16|||
148832745|NCT04724837|536866509|FG002|Overall Study|Other|0|||
148832746|NCT04724837|536866507|FG000|Overall Study|Withdrawal by Subject|2|||
148832747|NCT04724837|536866508|FG001|Overall Study|Withdrawal by Subject|9|||
148832748|NCT04724837|536866509|FG002|Overall Study|Withdrawal by Subject|9|||
148832749|NCT04724837|536866507|FG000|Overall Study|Adverse Event|2|||
148832750|NCT04724837|536866508|FG001|Overall Study|Adverse Event|7|||
148832751|NCT04724837|536866509|FG002|Overall Study|Adverse Event|4|||
148832752|NCT04724837|536866507|FG000|Overall Study|Lost to Follow-up|0|||
148832753|NCT04724837|536866508|FG001|Overall Study|Lost to Follow-up|1|||
148832754|NCT04724837|536866509|FG002|Overall Study|Lost to Follow-up|3|||
148832755|NCT04724837|536866507|FG000|Overall Study|Physician Decision|1|||
148832756|NCT04724837|536866508|FG001|Overall Study|Physician Decision|2|||
148832757|NCT04724837|536866509|FG002|Overall Study|Physician Decision|0|||
148832758|NCT04724837|536866507|FG000|Overall Study|Death|0|||
148832759|NCT04724837|536866508|FG001|Overall Study|Death|0|||
148832760|NCT04724837|536866509|FG002|Overall Study|Death|1|||
148832761|NCT04724837|536866507|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
148832762|NCT04724837|536866508|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
148832763|NCT04724837|536866509|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
148832764|NCT04724837|536866507|FG000|Overall Study|Study Terminated by Sponsor|0|||
148832765|NCT04724837|536866508|FG001|Overall Study|Study Terminated by Sponsor|1|||
148980980|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
148832766|NCT04724837|536866509|FG002|Overall Study|Study Terminated by Sponsor|0|||
148832767|NCT03620981|536866510|FG000|Overall Study|Adverse Event|14|||
149028169|NCT03537651|537580124|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
148832768|NCT03620981|536866511|FG001|Overall Study|Adverse Event|38|||
148832769|NCT03620981|536866512|FG002|Overall Study|Adverse Event|25|||
148832770|NCT03620981|536866510|FG000|Overall Study|Lack of Efficacy|2|||
148832771|NCT03620981|536866511|FG001|Overall Study|Lack of Efficacy|1|||
148832772|NCT03620981|536866512|FG002|Overall Study|Lack of Efficacy|1|||
148832773|NCT03620981|536866510|FG000|Overall Study|Physician Decision|7|||
148832774|NCT03620981|536866511|FG001|Overall Study|Physician Decision|4|||
148832775|NCT03620981|536866512|FG002|Overall Study|Physician Decision|4|||
148832776|NCT03620981|536866510|FG000|Overall Study|Protocol Violation|1|||
148832777|NCT03620981|536866511|FG001|Overall Study|Protocol Violation|2|||
148832778|NCT03620981|536866512|FG002|Overall Study|Protocol Violation|1|||
148832779|NCT03620981|536866510|FG000|Overall Study|Withdrawal by Legal Representative|2|||
148832780|NCT03620981|536866511|FG001|Overall Study|Withdrawal by Legal Representative|1|||
148832781|NCT03620981|536866512|FG002|Overall Study|Withdrawal by Legal Representative|1|||
148832782|NCT03620981|536866510|FG000|Overall Study|Withdrawal by Care Giver|2|||
148832783|NCT03620981|536866511|FG001|Overall Study|Withdrawal by Care Giver|0|||
148832784|NCT03620981|536866512|FG002|Overall Study|Withdrawal by Care Giver|1|||
148832785|NCT03620981|536866510|FG000|Overall Study|Non-compliance with Study Drug|1|||
148832786|NCT03620981|536866511|FG001|Overall Study|Non-compliance with Study Drug|1|||
148832787|NCT03620981|536866512|FG002|Overall Study|Non-compliance with Study Drug|0|||
148832788|NCT00071032|536866513|FG000|Overall Study|Lost to Follow-up|1|||
148832789|NCT00071032|536866514|FG001|Overall Study|Lost to Follow-up|1|||
148832790|NCT00071032|536866513|FG000|Overall Study|Withdrawal by Subject|8|||
148832791|NCT00071032|536866514|FG001|Overall Study|Withdrawal by Subject|6|||
148832792|NCT00071032|536866513|FG000|Overall Study|Missing Primary Outcome|0|||
148832793|NCT00071032|536866514|FG001|Overall Study|Missing Primary Outcome|1|||
148832794|NCT02420717|536866515|FG000|Overall Study|Did not receive all study medication|2|||
148832795|NCT02420717|536866516|FG001|Overall Study|Did not receive all study medication|0|||
148832796|NCT02420717|536866517|FG002|Overall Study|Did not receive all study medication|0|||
148832797|NCT04116489|536866518|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
148832798|NCT04116489|536866518|FG000|Overall Study|Withdrawal by Subject|1|||
148832799|NCT06022107|536866538|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
148832800|NCT06022107|536866538|FG000|Overall Study|Dropped out of study for higher level of care|1|||
148832801|NCT06022107|536866538|FG000|Overall Study|Lost to Follow-up|2|||
148832802|NCT02333799|536867951|FG000|Treatment Period|Withdrawal by Subject|1|||
148832803|NCT02333799|536867951|FG000|Treatment Period|Death|6|||
148832804|NCT02333799|536867951|FG000|6 Month Follow Up Period|Physician Decision|1|||
148832805|NCT02333799|536867951|FG000|6 Month Follow Up Period|Death|1|||
148832806|NCT02333799|536867951|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
148832807|NCT02333799|536867951|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
148832808|NCT05484895|536867952|FG000|Overall Study|Lost to Follow-up|63|||
148832809|NCT05484895|536867953|FG001|Overall Study|Lost to Follow-up|64|||
148832810|NCT00876447|536867957|FG000|Overall Study|Other miscellaneous reasons|3|||
148832811|NCT00876447|536867958|FG001|Overall Study|Other miscellaneous reasons|8|||
148832812|NCT00876447|536867957|FG000|Overall Study|Site closure|19|||
148832813|NCT00876447|536867958|FG001|Overall Study|Site closure|14|||
148832814|NCT00876447|536867957|FG000|Overall Study|Protocol Violation|9|||
148832815|NCT00876447|536867958|FG001|Overall Study|Protocol Violation|3|||
148832816|NCT00876447|536867957|FG000|Overall Study|Personal reasons|30|||
148832817|NCT00876447|536867958|FG001|Overall Study|Personal reasons|28|||
148832818|NCT00876447|536867957|FG000|Overall Study|Lost to Follow-up|6|||
148832819|NCT00876447|536867958|FG001|Overall Study|Lost to Follow-up|15|||
148832820|NCT00876447|536867957|FG000|Overall Study|Pregnancy|4|||
148832821|NCT00876447|536867958|FG001|Overall Study|Pregnancy|2|||
148832822|NCT00876447|536867957|FG000|Overall Study|Lack of Efficacy|5|||
148832823|NCT00876447|536867958|FG001|Overall Study|Lack of Efficacy|3|||
148832824|NCT00876447|536867957|FG000|Overall Study|Adverse Event|4|||
148832825|NCT00876447|536867958|FG001|Overall Study|Adverse Event|8|||
148832826|NCT02297516|536867961|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
148832827|NCT02297516|536867962|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
148832828|NCT02297516|536867961|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
148832829|NCT02297516|536867962|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
148832830|NCT02297516|536867961|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
148832831|NCT02297516|536867962|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
148832832|NCT00710593|536867963|FG000|Overall Study|Incarceration|1|||
148832833|NCT00710593|536867964|FG001|Overall Study|Incarceration|0|||
148832834|NCT00710593|536867963|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
148832835|NCT00710593|536867964|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
148832836|NCT00710593|536867963|FG000|Overall Study|Lost to Follow-up|3|||
148832837|NCT00710593|536867964|FG001|Overall Study|Lost to Follow-up|1|||
148832838|NCT00710593|536867963|FG000|Overall Study|Moved out of area|1|||
148832839|NCT00710593|536867964|FG001|Overall Study|Moved out of area|0|||
148770320|NCT02989649|536632806|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
148770321|NCT02989649|536632806|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
148770322|NCT02989649|536632806|FG000|Overall Study|Lost For Observation During Study|3|||
148770323|NCT02989649|536632806|FG000|Overall Study|Reason Not Specified|13|||
148770324|NCT00256854|536632807|FG000|Overall Study|Withdrawal by Subject|2|||
148770325|NCT00256854|536632808|FG001|Overall Study|Withdrawal by Subject|3|||
148770326|NCT00256854|536632809|FG002|Overall Study|Withdrawal by Subject|0|||
148770327|NCT00256854|536632810|FG003|Overall Study|Withdrawal by Subject|0|||
148770328|NCT00256854|536632811|FG004|Overall Study|Withdrawal by Subject|0|||
148770329|NCT00256854|536632812|FG005|Overall Study|Withdrawal by Subject|0|||
148770330|NCT00256854|536632807|FG000|Overall Study|Lack of Efficacy|1|||
148770331|NCT00256854|536632808|FG001|Overall Study|Lack of Efficacy|0|||
148770332|NCT00256854|536632809|FG002|Overall Study|Lack of Efficacy|0|||
148770333|NCT00256854|536632810|FG003|Overall Study|Lack of Efficacy|0|||
148770334|NCT00256854|536632811|FG004|Overall Study|Lack of Efficacy|0|||
148770335|NCT00256854|536632812|FG005|Overall Study|Lack of Efficacy|0|||
148770336|NCT00256854|536632807|FG000|Overall Study|Protocol Violation|0|||
148770337|NCT00256854|536632808|FG001|Overall Study|Protocol Violation|1|||
148770338|NCT00256854|536632809|FG002|Overall Study|Protocol Violation|1|||
148770339|NCT00256854|536632810|FG003|Overall Study|Protocol Violation|1|||
148770340|NCT00256854|536632811|FG004|Overall Study|Protocol Violation|0|||
148770341|NCT00256854|536632812|FG005|Overall Study|Protocol Violation|0|||
148770342|NCT00256854|536632807|FG000|Overall Study|Adverse Event|0|||
148770343|NCT00256854|536632808|FG001|Overall Study|Adverse Event|0|||
148770344|NCT00256854|536632809|FG002|Overall Study|Adverse Event|2|||
148770345|NCT00256854|536632810|FG003|Overall Study|Adverse Event|2|||
148770346|NCT00256854|536632811|FG004|Overall Study|Adverse Event|0|||
148770347|NCT00256854|536632812|FG005|Overall Study|Adverse Event|1|||
148770348|NCT00256854|536632807|FG000|Overall Study|Not compliant with the study drug|0|||
148770349|NCT00256854|536632808|FG001|Overall Study|Not compliant with the study drug|0|||
148770350|NCT00256854|536632809|FG002|Overall Study|Not compliant with the study drug|0|||
148770351|NCT00256854|536632810|FG003|Overall Study|Not compliant with the study drug|0|||
148770352|NCT00256854|536632811|FG004|Overall Study|Not compliant with the study drug|1|||
148770353|NCT00256854|536632812|FG005|Overall Study|Not compliant with the study drug|0|||
148770354|NCT02353442|536632813|FG000|Overall Study|Withdrawal by Subject|3|||
148770355|NCT02353442|536632814|FG001|Overall Study|Withdrawal by Subject|4|||
148770356|NCT03990571|536632816|FG000|Overall Study|Withdrawal by Subject|1|||
148770357|NCT03990571|536632816|FG000|Overall Study|Insurance Issues|3|||
148770358|NCT03990571|536632816|FG000|Overall Study|Covid Restrictions|2|||
148770359|NCT03514485|536632817|FG000|Overall Study|Lost to Follow-up|5|||
148770360|NCT03514485|536632818|FG001|Overall Study|Lost to Follow-up|3|||
148770361|NCT03514485|536632819|FG002|Overall Study|Lost to Follow-up|2|||
148770362|NCT03514485|536632820|FG003|Overall Study|Lost to Follow-up|0|||
148770363|NCT03514485|536632821|FG004|Overall Study|Lost to Follow-up|1|||
148770364|NCT03514485|536632822|FG005|Overall Study|Lost to Follow-up|4|||
148770365|NCT03514485|536632817|FG000|Overall Study|Withdrawal by Subject|0|||
148770366|NCT03514485|536632818|FG001|Overall Study|Withdrawal by Subject|1|||
148770367|NCT03514485|536632819|FG002|Overall Study|Withdrawal by Subject|3|||
148770368|NCT03514485|536632820|FG003|Overall Study|Withdrawal by Subject|1|||
148770369|NCT03514485|536632821|FG004|Overall Study|Withdrawal by Subject|2|||
148770370|NCT03514485|536632822|FG005|Overall Study|Withdrawal by Subject|1|||
148770371|NCT03075891|536632824|FG000|Overall Study|Withdrawal by Subject|3|||
148770372|NCT03075891|536632825|FG001|Overall Study|Withdrawal by Subject|6|||
148770373|NCT03075891|536632824|FG000|Overall Study|Lost to Follow-up|1|||
148770374|NCT03075891|536632825|FG001|Overall Study|Lost to Follow-up|0|||
148770375|NCT03075891|536632824|FG000|Overall Study|Pregnancy|3|||
148770376|NCT03075891|536632825|FG001|Overall Study|Pregnancy|1|||
148770377|NCT03075891|536632824|FG000|Overall Study|visits not performed (no time)|1|||
148770378|NCT03075891|536632825|FG001|Overall Study|visits not performed (no time)|0|||
148770379|NCT03075891|536632824|FG000|Overall Study|Drug abuse relapse issue|0|||
148770380|NCT03075891|536632825|FG001|Overall Study|Drug abuse relapse issue|1|||
148770381|NCT03075891|536632824|FG000|Overall Study|Participant requiring study withdrawal|0|||
148770382|NCT03075891|536632825|FG001|Overall Study|Participant requiring study withdrawal|1|||
148770383|NCT03075891|536632824|FG000|Overall Study|Adverse event, non-fatal|1|||
148770384|NCT03075891|536632825|FG001|Overall Study|Adverse event, non-fatal|4|||
148770385|NCT02004886|536632826|FG000|Overall Study|Adverse Event|0|||
148980981|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
148980982|NCT03655236|537409452|FG000|Subject Disposition in Part 2 Period|Other|1|||
148770386|NCT02004886|536632827|FG001|Overall Study|Adverse Event|1|||
148980983|NCT03655236|537409453|FG001|Subject Disposition in Part 2 Period|Other|0|||
148770387|NCT02004886|536632828|FG002|Overall Study|Adverse Event|0|||
148770388|NCT02004886|536632829|FG003|Overall Study|Adverse Event|0|||
148770389|NCT02004886|536632826|FG000|Overall Study|Unable to attend future visits|1|||
148770390|NCT02004886|536632827|FG001|Overall Study|Unable to attend future visits|0|||
148770391|NCT02004886|536632828|FG002|Overall Study|Unable to attend future visits|0|||
148770392|NCT02004886|536632829|FG003|Overall Study|Unable to attend future visits|0|||
148770393|NCT00638443|536632830|FG000|First Intervention|Adverse Event|2|||
148770394|NCT00638443|536632831|FG001|First Intervention|Adverse Event|1|||
148770395|NCT00282113|536632833|FG000|Overall Study|Removed at parents request|1|||
148770396|NCT00282113|536632834|FG001|Overall Study|Removed at parents request|0|||
148770397|NCT00282113|536632835|FG002|Overall Study|Removed at parents request|0|||
148770398|NCT02387957|536632836|FG000|Overall Study|The study was discontinued|21|||
148770399|NCT02387957|536632837|FG001|Overall Study|The study was discontinued|21|||
148770400|NCT02387957|536632838|FG002|Overall Study|The study was discontinued|20|||
148770401|NCT02294396|536632839|FG000|Overall Study|Adverse Event|26|||
148770402|NCT02294396|536632840|FG001|Overall Study|Adverse Event|25|||
148770403|NCT02294396|536632841|FG002|Overall Study|Adverse Event|21|||
148770404|NCT02294396|536632842|FG003|Overall Study|Adverse Event|24|||
148770405|NCT02294396|536632839|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
148770406|NCT02294396|536632840|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
148770407|NCT02294396|536632841|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
148770408|NCT02294396|536632842|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
148770409|NCT02294396|536632839|FG000|Overall Study|Withdrawal by Subject|8|||
148770410|NCT02294396|536632840|FG001|Overall Study|Withdrawal by Subject|6|||
148770411|NCT02294396|536632841|FG002|Overall Study|Withdrawal by Subject|6|||
148770412|NCT02294396|536632842|FG003|Overall Study|Withdrawal by Subject|8|||
148770413|NCT02294396|536632839|FG000|Overall Study|Lost to Follow-up|0|||
148770414|NCT02294396|536632840|FG001|Overall Study|Lost to Follow-up|0|||
148770415|NCT02294396|536632841|FG002|Overall Study|Lost to Follow-up|1|||
148770416|NCT02294396|536632842|FG003|Overall Study|Lost to Follow-up|1|||
148770417|NCT02294396|536632839|FG000|Overall Study|Protocol Deviation|3|||
148770418|NCT02294396|536632840|FG001|Overall Study|Protocol Deviation|2|||
148770419|NCT02294396|536632841|FG002|Overall Study|Protocol Deviation|2|||
148770420|NCT02294396|536632842|FG003|Overall Study|Protocol Deviation|1|||
148770421|NCT02294396|536632839|FG000|Overall Study|Miscellaneous|2|||
148770422|NCT02294396|536632840|FG001|Overall Study|Miscellaneous|0|||
148770423|NCT02294396|536632841|FG002|Overall Study|Miscellaneous|5|||
148770424|NCT02294396|536632842|FG003|Overall Study|Miscellaneous|2|||
148770425|NCT02949843|536632843|FG000|Overall Study|Withdrawal by Subject|0|||
148770426|NCT02949843|536632844|FG001|Overall Study|Withdrawal by Subject|1|||
148770427|NCT02949843|536632845|FG002|Overall Study|Withdrawal by Subject|1|||
148770428|NCT02120833|536632846|FG000|Overall Study|Adverse Event|1|||
148770429|NCT02120833|536632847|FG001|Overall Study|Adverse Event|0|||
148770430|NCT02120833|536632846|FG000|Overall Study|Withdrawal by Subject|2|||
148770431|NCT02120833|536632847|FG001|Overall Study|Withdrawal by Subject|0|||
148770432|NCT02120833|536632846|FG000|Overall Study|Lost to Follow-up|1|||
148770433|NCT02120833|536632847|FG001|Overall Study|Lost to Follow-up|1|||
148770434|NCT03613649|536632848|FG000|Second Treatment|Lost to Follow-up|0|||
148770435|NCT03613649|536632849|FG001|Second Treatment|Lost to Follow-up|0|||
148770436|NCT03613649|536632850|FG002|Second Treatment|Lost to Follow-up|1|||
148770437|NCT03613649|536632851|FG003|Second Treatment|Lost to Follow-up|0|||
148770438|NCT03613649|536632852|FG004|Second Treatment|Lost to Follow-up|0|||
148770439|NCT03613649|536632853|FG005|Second Treatment|Lost to Follow-up|0|||
148770440|NCT03613649|536632854|FG006|Second Treatment|Lost to Follow-up|0|||
148770441|NCT03613649|536632855|FG007|Second Treatment|Lost to Follow-up|0|||
148770442|NCT03613649|536632856|FG008|Second Treatment|Lost to Follow-up|0|||
148770443|NCT03613649|536632857|FG009|Second Treatment|Lost to Follow-up|0|||
148770444|NCT03613649|536632858|FG010|Second Treatment|Lost to Follow-up|0|||
148770445|NCT03613649|536632859|FG011|Second Treatment|Lost to Follow-up|0|||
148770446|NCT03613649|536632848|FG000|Second Treatment|Withdrawal by Subject|0|||
148770447|NCT03613649|536632849|FG001|Second Treatment|Withdrawal by Subject|0|||
148770448|NCT03613649|536632850|FG002|Second Treatment|Withdrawal by Subject|0|||
148770449|NCT03613649|536632851|FG003|Second Treatment|Withdrawal by Subject|0|||
148770450|NCT03613649|536632852|FG004|Second Treatment|Withdrawal by Subject|1|||
148770451|NCT03613649|536632853|FG005|Second Treatment|Withdrawal by Subject|0|||
148770452|NCT03613649|536632854|FG006|Second Treatment|Withdrawal by Subject|0|||
148770453|NCT03613649|536632855|FG007|Second Treatment|Withdrawal by Subject|0|||
148770454|NCT03613649|536632856|FG008|Second Treatment|Withdrawal by Subject|0|||
148770455|NCT03613649|536632857|FG009|Second Treatment|Withdrawal by Subject|0|||
148770456|NCT03613649|536632858|FG010|Second Treatment|Withdrawal by Subject|0|||
148770457|NCT03613649|536632859|FG011|Second Treatment|Withdrawal by Subject|0|||
148770458|NCT03613649|536632848|FG000|Third Treatment|Lost to Follow-up|0|||
148770459|NCT03613649|536632849|FG001|Third Treatment|Lost to Follow-up|0|||
148770460|NCT03613649|536632850|FG002|Third Treatment|Lost to Follow-up|0|||
148770461|NCT03613649|536632851|FG003|Third Treatment|Lost to Follow-up|0|||
148770462|NCT03613649|536632852|FG004|Third Treatment|Lost to Follow-up|1|||
148770463|NCT03613649|536632853|FG005|Third Treatment|Lost to Follow-up|0|||
148770464|NCT03613649|536632854|FG006|Third Treatment|Lost to Follow-up|0|||
148770465|NCT03613649|536632855|FG007|Third Treatment|Lost to Follow-up|0|||
149028170|NCT03537651|537580124|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
149028171|NCT03537651|537580124|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
148770466|NCT03613649|536632856|FG008|Third Treatment|Lost to Follow-up|0|||
148980984|NCT03655236|537409454|FG002|Subject Disposition in Part 2 Period|Other|0|||
148980985|NCT00672477|537411519|FG000|Overall Study|Adverse Event|10|||
148770467|NCT03613649|536632857|FG009|Third Treatment|Lost to Follow-up|0|||
148770468|NCT03613649|536632858|FG010|Third Treatment|Lost to Follow-up|0|||
148770469|NCT03613649|536632859|FG011|Third Treatment|Lost to Follow-up|1|||
148770470|NCT03613649|536632848|FG000|Third Treatment|Protocol Violation|0|||
148770471|NCT03613649|536632849|FG001|Third Treatment|Protocol Violation|0|||
148770472|NCT03613649|536632850|FG002|Third Treatment|Protocol Violation|0|||
148770473|NCT03613649|536632851|FG003|Third Treatment|Protocol Violation|0|||
148770474|NCT03613649|536632852|FG004|Third Treatment|Protocol Violation|0|||
148770475|NCT03613649|536632853|FG005|Third Treatment|Protocol Violation|0|||
148770476|NCT03613649|536632854|FG006|Third Treatment|Protocol Violation|1|||
148770477|NCT03613649|536632855|FG007|Third Treatment|Protocol Violation|0|||
148770478|NCT03613649|536632856|FG008|Third Treatment|Protocol Violation|0|||
148770479|NCT03613649|536632857|FG009|Third Treatment|Protocol Violation|0|||
148770480|NCT03613649|536632858|FG010|Third Treatment|Protocol Violation|0|||
148770481|NCT03613649|536632859|FG011|Third Treatment|Protocol Violation|1|||
148770482|NCT03613649|536632848|FG000|Fourth Treatment|Protocol Violation|1|||
148770483|NCT03613649|536632849|FG001|Fourth Treatment|Protocol Violation|0|||
148770484|NCT03613649|536632850|FG002|Fourth Treatment|Protocol Violation|0|||
148770485|NCT03613649|536632851|FG003|Fourth Treatment|Protocol Violation|0|||
148770486|NCT03613649|536632852|FG004|Fourth Treatment|Protocol Violation|1|||
148770487|NCT03613649|536632853|FG005|Fourth Treatment|Protocol Violation|0|||
148770488|NCT03613649|536632854|FG006|Fourth Treatment|Protocol Violation|0|||
148770489|NCT03613649|536632855|FG007|Fourth Treatment|Protocol Violation|0|||
148770490|NCT03613649|536632856|FG008|Fourth Treatment|Protocol Violation|0|||
148770491|NCT03613649|536632857|FG009|Fourth Treatment|Protocol Violation|0|||
148770492|NCT03613649|536632858|FG010|Fourth Treatment|Protocol Violation|0|||
148770493|NCT03613649|536632859|FG011|Fourth Treatment|Protocol Violation|0|||
148770494|NCT03613649|536632848|FG000|Fourth Treatment|Physician Decision|0|||
148770495|NCT03613649|536632849|FG001|Fourth Treatment|Physician Decision|0|||
148770496|NCT03613649|536632850|FG002|Fourth Treatment|Physician Decision|0|||
148770497|NCT03613649|536632851|FG003|Fourth Treatment|Physician Decision|0|||
148770498|NCT03613649|536632852|FG004|Fourth Treatment|Physician Decision|0|||
148770499|NCT03613649|536632853|FG005|Fourth Treatment|Physician Decision|0|||
148770500|NCT03613649|536632854|FG006|Fourth Treatment|Physician Decision|1|||
148770501|NCT03613649|536632855|FG007|Fourth Treatment|Physician Decision|0|||
148770502|NCT03613649|536632856|FG008|Fourth Treatment|Physician Decision|0|||
148770503|NCT03613649|536632857|FG009|Fourth Treatment|Physician Decision|0|||
148770504|NCT03613649|536632858|FG010|Fourth Treatment|Physician Decision|0|||
148770505|NCT03613649|536632859|FG011|Fourth Treatment|Physician Decision|0|||
148770506|NCT03429244|536632862|FG000|Overall Study|Withdrawal by Subject|2|||
148770507|NCT03429244|536632863|FG001|Overall Study|Withdrawal by Subject|1|||
148770508|NCT03429244|536632864|FG002|Overall Study|Withdrawal by Subject|1|||
148770509|NCT01046903|536632871|FG000|Overall Study|Lost to Follow-up|16|||
148770510|NCT01046903|536632871|FG000|Overall Study|Adverse Event|4|||
148770511|NCT01046903|536632871|FG000|Overall Study|Withdrawal by Subject|3|||
148770512|NCT01046903|536632871|FG000|Overall Study|Other|5|||
148770513|NCT01343277|536632872|FG000|Overall Study|Other|3|||
148770514|NCT01343277|536632873|FG001|Overall Study|Other|3|||
148770515|NCT01343277|536632872|FG000|Overall Study|Withdrawal by Subject|18|||
148770516|NCT01343277|536632873|FG001|Overall Study|Withdrawal by Subject|13|||
148770517|NCT01343277|536632872|FG000|Overall Study|Physician Decision|1|||
148770518|NCT01343277|536632873|FG001|Overall Study|Physician Decision|2|||
148770519|NCT01343277|536632872|FG000|Overall Study|Death|10|||
148770520|NCT01343277|536632873|FG001|Overall Study|Death|1|||
148770521|NCT01343277|536632872|FG000|Overall Study|Adverse Event|67|||
148770522|NCT01343277|536632873|FG001|Overall Study|Adverse Event|13|||
148770523|NCT01343277|536632872|FG000|Overall Study|Disease progression|270|||
148770524|NCT01343277|536632873|FG001|Overall Study|Disease progression|138|||
148770525|NCT01343277|536632872|FG000|Overall Study|Randomized not treated|6|||
148770526|NCT01343277|536632873|FG001|Overall Study|Randomized not treated|21|||
148770527|NCT01343277|536632872|FG000|Overall Study|Treatment ongoing|8|||
148770528|NCT01343277|536632873|FG001|Overall Study|Treatment ongoing|2|||
148770529|NCT01343277|536632872|FG000|Overall Study|Subsequent anticancer therapy|1|||
148770530|NCT01343277|536632873|FG001|Overall Study|Subsequent anticancer therapy|0|||
148980986|NCT00672477|537411520|FG001|Overall Study|Adverse Event|7|||
148770531|NCT01894100|536632874|FG000|Overall Study|Lost to Follow-up|0|||
148770532|NCT01894100|536632875|FG001|Overall Study|Lost to Follow-up|1|||
148770533|NCT01894100|536632874|FG000|Overall Study|Withdrawal by Subject|3|||
148770534|NCT01894100|536632875|FG001|Overall Study|Withdrawal by Subject|0|||
148770535|NCT01094301|536632876|FG000|Trial Stage|Withdrawal by Subject|1|||
148770536|NCT01094301|536632876|FG000|Implant Stage|Adverse Event|1|||
148770537|NCT01094301|536632876|FG000|Implant Stage|Protocol Violation|1|||
148770538|NCT01094301|536632876|FG000|Implant Stage|Withdrawal by Subject|2|||
148770539|NCT01094301|536632876|FG000|Implant Stage|No return of pain|4|||
148770540|NCT00135512|536632877|FG000|Overall Study|Adverse Event|56|||
148770541|NCT00135512|536632877|FG000|Overall Study|Lack of Efficacy|25|||
148770542|NCT00135512|536632877|FG000|Overall Study|Other|42|||
148770543|NCT04013672|536632879|FG000|Overall Study|Withdrawal by Subject|3|||
148770544|NCT04013672|536632880|FG001|Overall Study|Withdrawal by Subject|0|||
148770545|NCT04013672|536632879|FG000|Overall Study|Death|1|||
148770546|NCT04013672|536632880|FG001|Overall Study|Death|0|||
148770547|NCT04013672|536632879|FG000|Overall Study|Physician Decision|5|||
148770548|NCT04013672|536632880|FG001|Overall Study|Physician Decision|0|||
148770549|NCT00430573|536632881|FG000|Overall Study|Withdrawal by Subject|5|||
148770550|NCT05020665|536632884|FG000|Overall Study|Study terminated by Sponsor|5|||
148770551|NCT05020665|536632885|FG001|Overall Study|Study terminated by Sponsor|4|||
148770552|NCT05020665|536632884|FG000|Overall Study|Death|2|||
148770553|NCT05020665|536632885|FG001|Overall Study|Death|1|||
148770554|NCT05020665|536632884|FG000|Overall Study|Physician Decision|0|||
148770555|NCT05020665|536632885|FG001|Overall Study|Physician Decision|1|||
148770556|NCT05020665|536632884|FG000|Overall Study|Withdrawal by Subject|0|||
148770557|NCT05020665|536632885|FG001|Overall Study|Withdrawal by Subject|1|||
148770558|NCT05020665|536632884|FG000|Overall Study|Reason not specified|1|||
148770559|NCT05020665|536632885|FG001|Overall Study|Reason not specified|0|||
148770560|NCT04740827|536632889|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
148770561|NCT04740827|536632890|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
148770562|NCT04740827|536632889|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
148770563|NCT04740827|536632890|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
148770564|NCT04740827|536632889|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
148770565|NCT04740827|536632890|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
148770566|NCT04740827|536632889|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
148770567|NCT04740827|536632890|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
148770568|NCT04740827|536632889|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
148770569|NCT04740827|536632890|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
148770570|NCT04740827|536632889|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
148770571|NCT04740827|536632890|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
148770572|NCT02147158|536632891|FG000|Treatment Course 1|Adverse Event|1|||
148770573|NCT02147158|536632892|FG001|Treatment Course 1|Adverse Event|4|||
148770574|NCT02147158|536632893|FG002|Treatment Course 1|Adverse Event|3|||
148770575|NCT02147158|536632894|FG003|Treatment Course 1|Adverse Event|4|||
148770576|NCT02147158|536632895|FG004|Treatment Course 1|Adverse Event|1|||
148770577|NCT02147158|536632896|FG005|Treatment Course 1|Adverse Event|2|||
148770578|NCT02147158|536632891|FG000|Treatment Course 1|Lost to Follow-up|2|||
148770579|NCT02147158|536632892|FG001|Treatment Course 1|Lost to Follow-up|4|||
148770580|NCT02147158|536632893|FG002|Treatment Course 1|Lost to Follow-up|3|||
148770581|NCT02147158|536632894|FG003|Treatment Course 1|Lost to Follow-up|3|||
148770582|NCT02147158|536632895|FG004|Treatment Course 1|Lost to Follow-up|2|||
148770583|NCT02147158|536632896|FG005|Treatment Course 1|Lost to Follow-up|4|||
148980987|NCT00672477|537411519|FG000|Overall Study|Death|7|||
148980988|NCT00672477|537411520|FG001|Overall Study|Death|11|||
148770584|NCT02147158|536632891|FG000|Treatment Course 1|Protocol Violation|0|||
148770585|NCT02147158|536632892|FG001|Treatment Course 1|Protocol Violation|0|||
148770586|NCT02147158|536632893|FG002|Treatment Course 1|Protocol Violation|1|||
148770587|NCT02147158|536632894|FG003|Treatment Course 1|Protocol Violation|1|||
148770588|NCT02147158|536632895|FG004|Treatment Course 1|Protocol Violation|0|||
148770589|NCT02147158|536632896|FG005|Treatment Course 1|Protocol Violation|0|||
148770590|NCT02147158|536632891|FG000|Treatment Course 1|Withdrawal of Consent|1|||
148770591|NCT02147158|536632892|FG001|Treatment Course 1|Withdrawal of Consent|1|||
148770592|NCT02147158|536632893|FG002|Treatment Course 1|Withdrawal of Consent|1|||
148770593|NCT02147158|536632894|FG003|Treatment Course 1|Withdrawal of Consent|5|||
148770594|NCT02147158|536632895|FG004|Treatment Course 1|Withdrawal of Consent|3|||
148770595|NCT02147158|536632896|FG005|Treatment Course 1|Withdrawal of Consent|2|||
148770596|NCT02147158|536632891|FG000|Off-Treatment Interval 1|Adverse Event|1|||
148770597|NCT02147158|536632892|FG001|Off-Treatment Interval 1|Adverse Event|0|||
148770598|NCT02147158|536632893|FG002|Off-Treatment Interval 1|Adverse Event|0|||
148770599|NCT02147158|536632894|FG003|Off-Treatment Interval 1|Adverse Event|1|||
148770600|NCT02147158|536632895|FG004|Off-Treatment Interval 1|Adverse Event|0|||
148770601|NCT02147158|536632896|FG005|Off-Treatment Interval 1|Adverse Event|0|||
148770602|NCT02147158|536632891|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
148770603|NCT02147158|536632892|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
148770604|NCT02147158|536632893|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
148770605|NCT02147158|536632894|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
148770606|NCT02147158|536632895|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
148770607|NCT02147158|536632896|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
148770608|NCT02147158|536632891|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
148770609|NCT02147158|536632892|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
148770610|NCT02147158|536632893|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
148770611|NCT02147158|536632894|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
148770612|NCT02147158|536632895|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
148770613|NCT02147158|536632896|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
148770614|NCT02147158|536632891|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
148770615|NCT02147158|536632892|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
148770616|NCT02147158|536632893|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
148770617|NCT02147158|536632894|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
148770618|NCT02147158|536632895|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
148770619|NCT02147158|536632896|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
148770620|NCT02147158|536632891|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
148770621|NCT02147158|536632892|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
148770622|NCT02147158|536632893|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
148770623|NCT02147158|536632894|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
148770624|NCT02147158|536632895|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
148770625|NCT02147158|536632896|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
148770626|NCT02147158|536632891|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
148770627|NCT02147158|536632892|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
148770628|NCT02147158|536632893|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
148770629|NCT02147158|536632894|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
148770630|NCT02147158|536632895|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
148770631|NCT02147158|536632896|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
148770632|NCT02147158|536632891|FG000|Treatment Course 2|Adverse Event|0|||
148770633|NCT02147158|536632892|FG001|Treatment Course 2|Adverse Event|4|||
148770634|NCT02147158|536632893|FG002|Treatment Course 2|Adverse Event|2|||
148770635|NCT02147158|536632894|FG003|Treatment Course 2|Adverse Event|1|||
148770636|NCT02147158|536632895|FG004|Treatment Course 2|Adverse Event|0|||
148770637|NCT02147158|536632896|FG005|Treatment Course 2|Adverse Event|1|||
148770638|NCT02147158|536632891|FG000|Treatment Course 2|Withdrawal of Consent|0|||
148770639|NCT02147158|536632892|FG001|Treatment Course 2|Withdrawal of Consent|1|||
148770640|NCT02147158|536632893|FG002|Treatment Course 2|Withdrawal of Consent|2|||
148770641|NCT02147158|536632894|FG003|Treatment Course 2|Withdrawal of Consent|3|||
148770642|NCT02147158|536632895|FG004|Treatment Course 2|Withdrawal of Consent|0|||
148770643|NCT02147158|536632896|FG005|Treatment Course 2|Withdrawal of Consent|0|||
148770644|NCT02147158|536632891|FG000|Treatment Course 2|Lost to Follow-up|1|||
148770645|NCT02147158|536632892|FG001|Treatment Course 2|Lost to Follow-up|0|||
148770646|NCT02147158|536632893|FG002|Treatment Course 2|Lost to Follow-up|1|||
148770647|NCT02147158|536632894|FG003|Treatment Course 2|Lost to Follow-up|1|||
148770648|NCT02147158|536632895|FG004|Treatment Course 2|Lost to Follow-up|0|||
148770649|NCT02147158|536632896|FG005|Treatment Course 2|Lost to Follow-up|1|||
148770650|NCT02147158|536632891|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
148770651|NCT02147158|536632892|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
148770652|NCT02147158|536632893|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
148770653|NCT02147158|536632894|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
148770654|NCT02147158|536632895|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
148770655|NCT02147158|536632896|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
148770656|NCT02147158|536632891|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
148770657|NCT02147158|536632892|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
148770658|NCT02147158|536632893|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
148770659|NCT02147158|536632894|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
148770660|NCT02147158|536632895|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
148770661|NCT02147158|536632896|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
148770662|NCT02147158|536632891|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
148770663|NCT02147158|536632892|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
148770664|NCT02147158|536632893|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
148770665|NCT02147158|536632894|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
148770666|NCT02147158|536632895|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
148770667|NCT02147158|536632896|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
148770668|NCT02147158|536632891|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
148770669|NCT02147158|536632892|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
148770670|NCT02147158|536632893|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
148770671|NCT02147158|536632894|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
148770672|NCT02147158|536632895|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
148770673|NCT02147158|536632896|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
148770674|NCT02147158|536632891|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
148770675|NCT02147158|536632892|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
148770676|NCT02147158|536632893|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
148770677|NCT02147158|536632894|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
148770678|NCT02147158|536632895|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
148770679|NCT02147158|536632896|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
148770680|NCT00940823|536632897|FG000|Overall Study|Death|8|||
148770681|NCT00940823|536632898|FG001|Overall Study|Death|12|||
148770682|NCT00940823|536632897|FG000|Overall Study|Lost to Follow-up|27|||
148770683|NCT00940823|536632898|FG001|Overall Study|Lost to Follow-up|20|||
148770684|NCT01082211|536632899|FG000|Overall Study|Protocol Violation|4|||
148980989|NCT00672477|537411519|FG000|Overall Study|Physician Decision|2|||
148770685|NCT01082211|536632899|FG000|Overall Study|No protocol treatment received|3|||
148770686|NCT04999163|536632900|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
148770687|NCT04999163|536632901|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
148770688|NCT04999163|536632900|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
148770689|NCT04999163|536632901|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
148770690|NCT04999163|536632900|FG000|Overall Study|Withdrawal by Subject|1|||
148980990|NCT00672477|537411520|FG001|Overall Study|Physician Decision|0|||
148980991|NCT00672477|537411519|FG000|Overall Study|Protocol Violation|1|||
148980992|NCT00672477|537411520|FG001|Overall Study|Protocol Violation|1|||
148770691|NCT04999163|536632901|FG001|Overall Study|Withdrawal by Subject|0|||
148770692|NCT06366087|536634529|FG000|Overall Study|Withdrawal by Subject|0|||
148770693|NCT06366087|536634530|FG001|Overall Study|Withdrawal by Subject|1|||
148770694|NCT00860249|536634531|FG000|Overall Study|trial was terminated prior to completion|21|||
148770695|NCT00860249|536634532|FG001|Overall Study|trial was terminated prior to completion|18|||
148770696|NCT00860249|536634533|FG002|Overall Study|trial was terminated prior to completion|21|||
148770697|NCT00519428|536634534|FG000|Overall Study|Adverse Event|5|||
148770698|NCT00519428|536634535|FG001|Overall Study|Adverse Event|2|||
148770699|NCT00519428|536634536|FG002|Overall Study|Adverse Event|10|||
148770700|NCT00519428|536634534|FG000|Overall Study|Lost to Follow-up|7|||
148770701|NCT00519428|536634535|FG001|Overall Study|Lost to Follow-up|7|||
148770702|NCT00519428|536634536|FG002|Overall Study|Lost to Follow-up|6|||
148770703|NCT00519428|536634534|FG000|Overall Study|Withdrawal by Subject|8|||
148770704|NCT00519428|536634535|FG001|Overall Study|Withdrawal by Subject|3|||
148770705|NCT00519428|536634536|FG002|Overall Study|Withdrawal by Subject|7|||
148770706|NCT00519428|536634534|FG000|Overall Study|unstated|1|||
148770707|NCT00519428|536634535|FG001|Overall Study|unstated|3|||
148770708|NCT00519428|536634536|FG002|Overall Study|unstated|2|||
148770709|NCT01275755|536634537|FG000|Double-blind Treatment Period|Adverse Event|0|||
148770710|NCT01275755|536634538|FG001|Double-blind Treatment Period|Adverse Event|2|||
148770711|NCT01275755|536634537|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
148770712|NCT01275755|536634538|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
148770713|NCT01275755|536634537|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
148770714|NCT01275755|536634538|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
148770715|NCT01275755|536634537|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
148770716|NCT01275755|536634538|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
148770717|NCT02703272|536634546|FG000|Overall Study|Death|4|||
148770718|NCT02703272|536634547|FG001|Overall Study|Death|9|||
148770719|NCT02703272|536634548|FG002|Overall Study|Death|19|||
148770720|NCT02703272|536634549|FG003|Overall Study|Death|10|||
148770721|NCT02703272|536634546|FG000|Overall Study|Withdrawal by Subject|0|||
148770722|NCT02703272|536634547|FG001|Overall Study|Withdrawal by Subject|0|||
148770723|NCT02703272|536634548|FG002|Overall Study|Withdrawal by Subject|4|||
148770724|NCT02703272|536634549|FG003|Overall Study|Withdrawal by Subject|2|||
148770725|NCT02703272|536634546|FG000|Overall Study|Study Terminated by Sponsor|6|||
148770726|NCT02703272|536634547|FG001|Overall Study|Study Terminated by Sponsor|1|||
148770727|NCT02703272|536634548|FG002|Overall Study|Study Terminated by Sponsor|12|||
148770728|NCT02703272|536634549|FG003|Overall Study|Study Terminated by Sponsor|4|||
148770729|NCT02703272|536634546|FG000|Overall Study|Other|1|||
148770730|NCT02703272|536634547|FG001|Overall Study|Other|0|||
148770731|NCT02703272|536634548|FG002|Overall Study|Other|0|||
148770732|NCT02703272|536634549|FG003|Overall Study|Other|0|||
148770733|NCT02048826|536634550|FG000|Overall Study|Withdrawal by Subject|1|||
148770734|NCT02048826|536634551|FG001|Overall Study|Withdrawal by Subject|0|||
148770735|NCT04470544|536634552|FG000|Overall Study|Withdrawal by Subject|4|||
148770736|NCT04470544|536634553|FG001|Overall Study|Withdrawal by Subject|6|||
148770737|NCT00712881|536634556|FG000|Overall Study|Adverse Event|3|||
148770738|NCT00712881|536634557|FG001|Overall Study|Adverse Event|3|||
148770739|NCT00712881|536634556|FG000|Overall Study|Withdrawal by Subject|1|||
148770740|NCT00712881|536634557|FG001|Overall Study|Withdrawal by Subject|1|||
148770741|NCT00712881|536634556|FG000|Overall Study|Disease Progression|2|||
148770742|NCT00712881|536634557|FG001|Overall Study|Disease Progression|1|||
148770743|NCT00712881|536634556|FG000|Overall Study|Lost to Follow-up|1|||
148770744|NCT00712881|536634557|FG001|Overall Study|Lost to Follow-up|1|||
148770745|NCT00712881|536634556|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
148770746|NCT00712881|536634557|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
148770747|NCT00712881|536634556|FG000|Overall Study|Protocol Violation|1|||
148770748|NCT00712881|536634557|FG001|Overall Study|Protocol Violation|1|||
148980993|NCT00672477|537411519|FG000|Overall Study|Withdrawal by Subject|5|||
148980994|NCT00672477|537411520|FG001|Overall Study|Withdrawal by Subject|3|||
148980995|NCT00672477|537411519|FG000|Overall Study|Lack of Efficacy|1|||
148770749|NCT00712881|536634556|FG000|Overall Study|Randomized but not treated|1|||
148770750|NCT00712881|536634557|FG001|Overall Study|Randomized but not treated|0|||
148770751|NCT02222545|536634560|FG000|Overall Study|Adverse Event|1|||
148770752|NCT02222545|536634561|FG001|Overall Study|Adverse Event|0|||
148770753|NCT02222545|536634562|FG002|Overall Study|Adverse Event|2|||
148770754|NCT02222545|536634560|FG000|Overall Study|Death|0|||
148770755|NCT02222545|536634561|FG001|Overall Study|Death|0|||
148770756|NCT02222545|536634562|FG002|Overall Study|Death|9|||
148770757|NCT02222545|536634560|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
148770758|NCT02222545|536634561|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
148770759|NCT02222545|536634562|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
148770760|NCT02222545|536634560|FG000|Overall Study|Withdrawal by Subject|0|||
148770761|NCT02222545|536634561|FG001|Overall Study|Withdrawal by Subject|0|||
148770762|NCT02222545|536634562|FG002|Overall Study|Withdrawal by Subject|3|||
148770763|NCT02222545|536634560|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
148770764|NCT02222545|536634561|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
148770765|NCT02222545|536634562|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
148770766|NCT00537316|536634564|FG000|Part 1|Adverse Event|7|||
148770767|NCT00537316|536634565|FG001|Part 1|Adverse Event|11|||
148770768|NCT00537316|536634566|FG002|Part 1|Adverse Event|8|||
148770769|NCT00537316|536634567|FG003|Part 1|Adverse Event|0|||
148770770|NCT00537316|536634568|FG004|Part 1|Adverse Event|0|||
148770771|NCT00537316|536634569|FG005|Part 1|Adverse Event|0|||
148770772|NCT00537316|536634570|FG006|Part 1|Adverse Event|0|||
148770773|NCT00537316|536634564|FG000|Part 1|Protocol defined clinical event|1|||
148770774|NCT00537316|536634565|FG001|Part 1|Protocol defined clinical event|0|||
148770775|NCT00537316|536634566|FG002|Part 1|Protocol defined clinical event|0|||
148770776|NCT00537316|536634567|FG003|Part 1|Protocol defined clinical event|0|||
148770777|NCT00537316|536634568|FG004|Part 1|Protocol defined clinical event|0|||
148770778|NCT00537316|536634569|FG005|Part 1|Protocol defined clinical event|0|||
148770779|NCT00537316|536634570|FG006|Part 1|Protocol defined clinical event|0|||
148770780|NCT00537316|536634564|FG000|Part 1|Lost to Follow-up|1|||
148770781|NCT00537316|536634565|FG001|Part 1|Lost to Follow-up|0|||
148770782|NCT00537316|536634566|FG002|Part 1|Lost to Follow-up|0|||
148770783|NCT00537316|536634567|FG003|Part 1|Lost to Follow-up|0|||
148770784|NCT00537316|536634568|FG004|Part 1|Lost to Follow-up|0|||
148770785|NCT00537316|536634569|FG005|Part 1|Lost to Follow-up|0|||
148770786|NCT00537316|536634570|FG006|Part 1|Lost to Follow-up|0|||
148770787|NCT00537316|536634564|FG000|Part 1|Withdrawal by Subject|3|||
148770788|NCT00537316|536634565|FG001|Part 1|Withdrawal by Subject|8|||
148770789|NCT00537316|536634566|FG002|Part 1|Withdrawal by Subject|4|||
148770790|NCT00537316|536634567|FG003|Part 1|Withdrawal by Subject|0|||
148770791|NCT00537316|536634568|FG004|Part 1|Withdrawal by Subject|0|||
148770792|NCT00537316|536634569|FG005|Part 1|Withdrawal by Subject|0|||
148770793|NCT00537316|536634570|FG006|Part 1|Withdrawal by Subject|0|||
148770794|NCT00537316|536634564|FG000|Part 1|Protocol Violation|1|||
148770795|NCT00537316|536634565|FG001|Part 1|Protocol Violation|5|||
148770796|NCT00537316|536634566|FG002|Part 1|Protocol Violation|1|||
148770797|NCT00537316|536634567|FG003|Part 1|Protocol Violation|0|||
148770798|NCT00537316|536634568|FG004|Part 1|Protocol Violation|0|||
148770799|NCT00537316|536634569|FG005|Part 1|Protocol Violation|0|||
148770800|NCT00537316|536634570|FG006|Part 1|Protocol Violation|0|||
148832840|NCT00710593|536867963|FG000|Overall Study|Failure to adhere or complete study eval|1|||
148832841|NCT00710593|536867964|FG001|Overall Study|Failure to adhere or complete study eval|1|||
148832842|NCT00710593|536867963|FG000|Overall Study|Protocol Violation|1|||
148832843|NCT00710593|536867964|FG001|Overall Study|Protocol Violation|1|||
148832844|NCT00710593|536867963|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
148832845|NCT00710593|536867964|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
148832846|NCT04490278|536867965|FG000|Overall Study|Lost to Follow-up|6|||
148832847|NCT00366457|536867968|FG000|Overall Study|never began study therapy|2|||
148832848|NCT02538614|536867969|FG000|Overall Study|Progressive Disease|2|||
148832849|NCT02829996|536867970|FG000|Overall Study|Withdrawal by Subject|1|||
148770801|NCT00537316|536634564|FG000|Part 1|Did not meet protocol eligibility|1|||
148770802|NCT00537316|536634565|FG001|Part 1|Did not meet protocol eligibility|3|||
148770803|NCT00537316|536634566|FG002|Part 1|Did not meet protocol eligibility|2|||
148770804|NCT00537316|536634567|FG003|Part 1|Did not meet protocol eligibility|0|||
148770805|NCT00537316|536634568|FG004|Part 1|Did not meet protocol eligibility|0|||
148770806|NCT00537316|536634569|FG005|Part 1|Did not meet protocol eligibility|0|||
148770807|NCT00537316|536634570|FG006|Part 1|Did not meet protocol eligibility|0|||
148770808|NCT00537316|536634564|FG000|Part 1|Administrative|0|||
148770809|NCT00537316|536634565|FG001|Part 1|Administrative|0|||
148770810|NCT00537316|536634566|FG002|Part 1|Administrative|2|||
148770811|NCT00537316|536634567|FG003|Part 1|Administrative|0|||
148770812|NCT00537316|536634568|FG004|Part 1|Administrative|0|||
148770813|NCT00537316|536634569|FG005|Part 1|Administrative|0|||
148770814|NCT00537316|536634570|FG006|Part 1|Administrative|0|||
148770815|NCT00537316|536634564|FG000|Part 2|Never entered follow-up|0|||
148770816|NCT00537316|536634565|FG001|Part 2|Never entered follow-up|0|||
148770817|NCT00537316|536634566|FG002|Part 2|Never entered follow-up|0|||
148770818|NCT00537316|536634567|FG003|Part 2|Never entered follow-up|0|||
148832850|NCT02829996|536867971|FG001|Overall Study|Withdrawal by Subject|0|||
148832851|NCT02829996|536867972|FG002|Overall Study|Withdrawal by Subject|0|||
148770819|NCT00537316|536634568|FG004|Part 2|Never entered follow-up|0|||
148770820|NCT00537316|536634569|FG005|Part 2|Never entered follow-up|0|||
148770821|NCT00537316|536634570|FG006|Part 2|Never entered follow-up|1|||
148770822|NCT00537316|536634564|FG000|Part 2|Adverse Event|4|||
148770823|NCT00537316|536634565|FG001|Part 2|Adverse Event|0|||
148770824|NCT00537316|536634566|FG002|Part 2|Adverse Event|2|||
148770825|NCT00537316|536634567|FG003|Part 2|Adverse Event|0|||
148770826|NCT00537316|536634568|FG004|Part 2|Adverse Event|0|||
148770827|NCT00537316|536634569|FG005|Part 2|Adverse Event|0|||
148770828|NCT00537316|536634570|FG006|Part 2|Adverse Event|0|||
148770829|NCT00537316|536634564|FG000|Part 2|Lost to Follow-up|1|||
148770830|NCT00537316|536634565|FG001|Part 2|Lost to Follow-up|0|||
148770831|NCT00537316|536634566|FG002|Part 2|Lost to Follow-up|2|||
148770832|NCT00537316|536634567|FG003|Part 2|Lost to Follow-up|0|||
148770833|NCT00537316|536634568|FG004|Part 2|Lost to Follow-up|0|||
148770834|NCT00537316|536634569|FG005|Part 2|Lost to Follow-up|0|||
148770835|NCT00537316|536634570|FG006|Part 2|Lost to Follow-up|0|||
148770836|NCT00537316|536634564|FG000|Part 2|Withdrawal by Subject|5|||
148770837|NCT00537316|536634565|FG001|Part 2|Withdrawal by Subject|1|||
148770838|NCT00537316|536634566|FG002|Part 2|Withdrawal by Subject|4|||
148770839|NCT00537316|536634567|FG003|Part 2|Withdrawal by Subject|0|||
148770840|NCT00537316|536634568|FG004|Part 2|Withdrawal by Subject|0|||
148832852|NCT02829996|536867973|FG003|Overall Study|Withdrawal by Subject|0|||
148832853|NCT02829996|536867974|FG004|Overall Study|Withdrawal by Subject|0|||
148832854|NCT01517984|536867988|FG000|Overall Study|Lost to Follow-up|0|||
148832855|NCT01517984|536867989|FG001|Overall Study|Lost to Follow-up|1|||
148832856|NCT01517984|536867990|FG002|Overall Study|Lost to Follow-up|0|||
148832857|NCT01517984|536867991|FG003|Overall Study|Lost to Follow-up|0|||
148832858|NCT01517984|536867988|FG000|Overall Study|Withdrawal by Subject|1|||
148832859|NCT01517984|536867989|FG001|Overall Study|Withdrawal by Subject|8|||
148832860|NCT01517984|536867990|FG002|Overall Study|Withdrawal by Subject|4|||
148832861|NCT01517984|536867991|FG003|Overall Study|Withdrawal by Subject|1|||
148832862|NCT01517984|536867988|FG000|Overall Study|Screen Failure|4|||
148832863|NCT01517984|536867989|FG001|Overall Study|Screen Failure|0|||
148832864|NCT01517984|536867990|FG002|Overall Study|Screen Failure|0|||
148832865|NCT01517984|536867991|FG003|Overall Study|Screen Failure|0|||
148832866|NCT01517984|536867988|FG000|Overall Study|Ineligible for randomization|0|||
148832867|NCT01517984|536867989|FG001|Overall Study|Ineligible for randomization|14|||
148832868|NCT01517984|536867990|FG002|Overall Study|Ineligible for randomization|0|||
148832869|NCT01517984|536867991|FG003|Overall Study|Ineligible for randomization|0|||
148832870|NCT04903288|536867992|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
148832871|NCT04903288|536867992|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
148832872|NCT04903288|536867992|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
148832873|NCT04903288|536867992|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
148832874|NCT00904371|536867993|FG000|Overall Study|Adverse Event|2|||
148832875|NCT00904371|536867993|FG000|Overall Study|Lost to Follow-up|4|||
148832876|NCT00904371|536867993|FG000|Overall Study|Discontinued at target blood pressure|2|||
148832877|NCT00904371|536867993|FG000|Overall Study|Continued with Tritace|1|||
148832878|NCT04617860|536868003|FG000|Overall Study|Adverse Event|0|||
148832879|NCT04617860|536868004|FG001|Overall Study|Adverse Event|2|||
148832880|NCT04617860|536868005|FG002|Overall Study|Adverse Event|2|||
148832881|NCT04617860|536868003|FG000|Overall Study|Withdrawal by Subject|0|||
148832882|NCT04617860|536868004|FG001|Overall Study|Withdrawal by Subject|0|||
148832883|NCT04617860|536868005|FG002|Overall Study|Withdrawal by Subject|2|||
148832884|NCT04617860|536868003|FG000|Overall Study|Physician Decision|0|||
148832885|NCT04617860|536868004|FG001|Overall Study|Physician Decision|1|||
149028172|NCT03537651|537580124|FG000|Part B (Up to 192 Weeks)|Other|1|||
148770841|NCT00537316|536634569|FG005|Part 2|Withdrawal by Subject|0|||
148832886|NCT04617860|536868005|FG002|Overall Study|Physician Decision|0|||
148832887|NCT04617860|536868003|FG000|Overall Study|Sponsor Decision|0|||
148832888|NCT04617860|536868004|FG001|Overall Study|Sponsor Decision|3|||
148832889|NCT04617860|536868005|FG002|Overall Study|Sponsor Decision|1|||
148832890|NCT04617860|536868003|FG000|Overall Study|Termination of Study by Sponsor|8|||
148832891|NCT04617860|536868004|FG001|Overall Study|Termination of Study by Sponsor|4|||
148832892|NCT04617860|536868005|FG002|Overall Study|Termination of Study by Sponsor|13|||
148832893|NCT02300233|536868006|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
148832894|NCT02300233|536868007|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
148832895|NCT02300233|536868008|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
148832896|NCT02300233|536868006|FG000|Overall Study|Withdrawal by Subject|1|||
148832897|NCT02300233|536868007|FG001|Overall Study|Withdrawal by Subject|0|||
148832898|NCT02300233|536868008|FG002|Overall Study|Withdrawal by Subject|3|||
148832899|NCT02300233|536868006|FG000|Overall Study|Investigator Judgement|0|||
148832900|NCT02300233|536868007|FG001|Overall Study|Investigator Judgement|0|||
148770842|NCT00537316|536634570|FG006|Part 2|Withdrawal by Subject|0|||
148770843|NCT00537316|536634564|FG000|Part 2|Administrative|16|||
148770844|NCT00537316|536634565|FG001|Part 2|Administrative|8|||
148770845|NCT00537316|536634566|FG002|Part 2|Administrative|24|||
148770846|NCT00537316|536634567|FG003|Part 2|Administrative|3|||
148770847|NCT00537316|536634568|FG004|Part 2|Administrative|1|||
148770848|NCT00537316|536634569|FG005|Part 2|Administrative|4|||
148770849|NCT00537316|536634570|FG006|Part 2|Administrative|1|||
148832901|NCT02300233|536868008|FG002|Overall Study|Investigator Judgement|1|||
148832902|NCT02300233|536868006|FG000|Overall Study|Reason Not Specified|0|||
148832903|NCT02300233|536868007|FG001|Overall Study|Reason Not Specified|0|||
148832904|NCT02300233|536868008|FG002|Overall Study|Reason Not Specified|5|||
148832905|NCT05805150|536868009|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
148832906|NCT05805150|536868010|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
148832907|NCT00862940|536868022|FG000|Overall Study|Adverse Event|15|||
148832908|NCT00862940|536868023|FG001|Overall Study|Adverse Event|12|||
148832909|NCT00862940|536868022|FG000|Overall Study|Lack of Efficacy|1|||
148832910|NCT00862940|536868023|FG001|Overall Study|Lack of Efficacy|3|||
148832911|NCT00862940|536868022|FG000|Overall Study|Protocol Violation|2|||
148832912|NCT00862940|536868023|FG001|Overall Study|Protocol Violation|5|||
148832913|NCT00862940|536868022|FG000|Overall Study|Withdrawal by Subject|4|||
148832914|NCT00862940|536868023|FG001|Overall Study|Withdrawal by Subject|6|||
148832915|NCT00862940|536868022|FG000|Overall Study|Non-compliance|4|||
148832916|NCT00862940|536868023|FG001|Overall Study|Non-compliance|0|||
148832917|NCT00862940|536868022|FG000|Overall Study|Lost to Follow-up|0|||
148832918|NCT00862940|536868023|FG001|Overall Study|Lost to Follow-up|1|||
148832919|NCT00862940|536868022|FG000|Overall Study|Administrative or other reason(s)|4|||
148832920|NCT00862940|536868023|FG001|Overall Study|Administrative or other reason(s)|3|||
148832921|NCT00879398|536868024|FG000|Overall Study|Visit Stop|399|||
148832922|NCT00879398|536868024|FG000|Overall Study|Lack of Efficacy|64|||
148832923|NCT00879398|536868024|FG000|Overall Study|Adverse Event|41|||
148832924|NCT00879398|536868024|FG000|Overall Study|Other Reasons|171|||
148832925|NCT03773484|536868033|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
148832926|NCT04079738|536868034|FG000|Study Treatment|Death|1|||
148832927|NCT04079738|536868035|FG001|Study Treatment|Death|0|||
148832928|NCT04079738|536868036|FG002|Study Treatment|Death|0|||
148832929|NCT04079738|536868037|FG003|Study Treatment|Death|0|||
148832930|NCT04079738|536868034|FG000|Study Treatment|Adverse Event|2|||
148832931|NCT04079738|536868035|FG001|Study Treatment|Adverse Event|0|||
148832932|NCT04079738|536868036|FG002|Study Treatment|Adverse Event|0|||
148832933|NCT04079738|536868037|FG003|Study Treatment|Adverse Event|0|||
148832934|NCT04079738|536868034|FG000|Study Treatment|withdrawal before treatment|1|||
148832935|NCT04079738|536868035|FG001|Study Treatment|withdrawal before treatment|0|||
148832936|NCT04079738|536868036|FG002|Study Treatment|withdrawal before treatment|0|||
148832937|NCT04079738|536868037|FG003|Study Treatment|withdrawal before treatment|0|||
148832938|NCT04079738|536868034|FG000|Study Treatment|symptomatic deterioration|2|||
148832939|NCT04079738|536868035|FG001|Study Treatment|symptomatic deterioration|0|||
148832940|NCT04079738|536868036|FG002|Study Treatment|symptomatic deterioration|0|||
148832941|NCT04079738|536868037|FG003|Study Treatment|symptomatic deterioration|0|||
148832942|NCT04079738|536868034|FG000|Study Treatment|Disease Progression|1|||
148832943|NCT04079738|536868035|FG001|Study Treatment|Disease Progression|0|||
148832944|NCT04079738|536868036|FG002|Study Treatment|Disease Progression|0|||
148832945|NCT04079738|536868037|FG003|Study Treatment|Disease Progression|0|||
148832946|NCT04079738|536868034|FG000|Study Treatment|withdrawal after treatment|1|||
148832947|NCT04079738|536868035|FG001|Study Treatment|withdrawal after treatment|0|||
148832948|NCT04079738|536868036|FG002|Study Treatment|withdrawal after treatment|0|||
148832949|NCT04079738|536868037|FG003|Study Treatment|withdrawal after treatment|0|||
148832950|NCT04079738|536868034|FG000|Follow up|Withdrawal by Subject|3|||
148832951|NCT04079738|536868035|FG001|Follow up|Withdrawal by Subject|0|||
148832952|NCT04079738|536868036|FG002|Follow up|Withdrawal by Subject|0|||
148832953|NCT04079738|536868037|FG003|Follow up|Withdrawal by Subject|0|||
148832954|NCT04079738|536868034|FG000|Follow up|Death|5|||
148832955|NCT04079738|536868035|FG001|Follow up|Death|0|||
148832956|NCT04079738|536868036|FG002|Follow up|Death|0|||
148832957|NCT04079738|536868037|FG003|Follow up|Death|0|||
148832958|NCT05552859|536868038|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
148832959|NCT05552859|536868039|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
148832960|NCT04251533|536868040|FG000|Overall Study|Progressive disease|33|||
148832961|NCT04251533|536868041|FG001|Overall Study|Progressive disease|29|||
148980996|NCT00672477|537411520|FG001|Overall Study|Lack of Efficacy|1|||
148980997|NCT00672477|537411519|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
148980998|NCT00672477|537411520|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
148980999|NCT01782131|537411521|FG000|Overall Study|Death|93|||
148981000|NCT01782131|537411522|FG001|Overall Study|Death|96|||
148981001|NCT01782131|537411521|FG000|Overall Study|Lost to Follow-up|1|||
148981002|NCT01782131|537411522|FG001|Overall Study|Lost to Follow-up|3|||
148981003|NCT01782131|537411521|FG000|Overall Study|Withdrawal by Subject|10|||
148981004|NCT01782131|537411522|FG001|Overall Study|Withdrawal by Subject|10|||
148981005|NCT01782131|537411521|FG000|Overall Study|Randomized but not treated|5|||
148981006|NCT01782131|537411522|FG001|Overall Study|Randomized but not treated|5|||
148832962|NCT04251533|536868042|FG002|Overall Study|Progressive disease|22|||
148832963|NCT04251533|536868040|FG000|Overall Study|Death|5|||
148981007|NCT01782131|537411521|FG000|Overall Study|Reason not provided|0|||
148832964|NCT04251533|536868041|FG001|Overall Study|Death|1|||
148832965|NCT04251533|536868042|FG002|Overall Study|Death|3|||
148832966|NCT04251533|536868040|FG000|Overall Study|Physician Decision|3|||
148832967|NCT04251533|536868041|FG001|Overall Study|Physician Decision|2|||
148832968|NCT04251533|536868042|FG002|Overall Study|Physician Decision|4|||
148832969|NCT04251533|536868040|FG000|Overall Study|Participant decision|1|||
148832970|NCT04251533|536868041|FG001|Overall Study|Participant decision|3|||
148832971|NCT04251533|536868042|FG002|Overall Study|Participant decision|1|||
148832972|NCT04251533|536868040|FG000|Overall Study|Adverse Event|2|||
148832973|NCT04251533|536868041|FG001|Overall Study|Adverse Event|1|||
148832974|NCT04251533|536868042|FG002|Overall Study|Adverse Event|1|||
148832975|NCT00210132|536868047|FG000|Overall Study|Protocol Violation|1|||
148832976|NCT00210132|536868048|FG001|Overall Study|Protocol Violation|4|||
148832977|NCT02711202|536868049|FG000|Overall Study|Adverse Event|3|||
148832978|NCT02711202|536868050|FG001|Overall Study|Adverse Event|0|||
148832979|NCT02711202|536868049|FG000|Overall Study|graft loss|1|||
148832980|NCT02711202|536868050|FG001|Overall Study|graft loss|0|||
148832981|NCT01889251|536868051|FG000|Overall Study|Adverse Event|1|||
148832982|NCT01889251|536868052|FG001|Overall Study|Adverse Event|0|||
148832983|NCT05852470|536868054|FG000|Overall Study|Withdrawal by Subject|0|||
148832984|NCT05852470|536868055|FG001|Overall Study|Withdrawal by Subject|1|||
148832985|NCT06071104|536868056|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
148832986|NCT01903863|536868059|FG000|Overall Study|Physician Decision|2|||
148832987|NCT01903863|536868060|FG001|Overall Study|Physician Decision|0|||
148832988|NCT01344226|536868065|FG000|Overall Study|Protocol Violation|2|||
148832989|NCT01344226|536868065|FG000|Overall Study|Withdrawal by Subject|3|||
148832990|NCT01344226|536868065|FG000|Overall Study|Lack of Efficacy|3|||
148832991|NCT03909971|536868072|FG000|Overall Study|Participant transition to rollover study|26|||
148832992|NCT03909971|536868073|FG001|Overall Study|Participant transition to rollover study|9|||
148832993|NCT03909971|536868072|FG000|Overall Study|Global Deterioration of Health Status|2|||
148832994|NCT03909971|536868073|FG001|Overall Study|Global Deterioration of Health Status|2|||
148832995|NCT03909971|536868072|FG000|Overall Study|Progressive Disease|28|||
148832996|NCT03909971|536868073|FG001|Overall Study|Progressive Disease|21|||
148832997|NCT03909971|536868072|FG000|Overall Study|Death|6|||
148832998|NCT03909971|536868073|FG001|Overall Study|Death|6|||
148832999|NCT03909971|536868072|FG000|Overall Study|Adverse Event|1|||
148833000|NCT03909971|536868073|FG001|Overall Study|Adverse Event|2|||
148833001|NCT03909971|536868072|FG000|Overall Study|Withdrawal by Subject|2|||
148833002|NCT03909971|536868073|FG001|Overall Study|Withdrawal by Subject|1|||
148833003|NCT03909971|536868072|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
148833004|NCT03909971|536868073|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
148770850|NCT02651155|536634571|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
148770851|NCT02651155|536634572|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
148770852|NCT02651155|536634571|FG000|Overall Study|Voluntary Withdrawal|5|||
148770853|NCT02651155|536634572|FG001|Overall Study|Voluntary Withdrawal|0|||
148770854|NCT04533412|536634573|FG000|Overall Study|Withdrawal by Subject|1|||
148770855|NCT04533412|536634574|FG001|Overall Study|Withdrawal by Subject|1|||
148770856|NCT04533412|536634573|FG000|Overall Study|Lost to Follow-up|1|||
148770857|NCT04533412|536634574|FG001|Overall Study|Lost to Follow-up|4|||
148770858|NCT05113979|536634575|FG000|Overall Study|Death|2|||
148770859|NCT05113979|536634575|FG000|Overall Study|Lost to Follow-up|1|||
148770860|NCT03452488|536634582|FG000|Overall Study|Adverse Event|4|||
148770861|NCT03452488|536634583|FG001|Overall Study|Adverse Event|6|||
148770862|NCT03452488|536634584|FG002|Overall Study|Adverse Event|1|||
148770863|NCT03452488|536634582|FG000|Overall Study|Death|0|||
148770864|NCT03452488|536634583|FG001|Overall Study|Death|0|||
148770865|NCT03452488|536634584|FG002|Overall Study|Death|1|||
148770866|NCT03452488|536634582|FG000|Overall Study|Lost to Follow-up|1|||
148770867|NCT03452488|536634583|FG001|Overall Study|Lost to Follow-up|2|||
148833005|NCT03909971|536868072|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
148833006|NCT03909971|536868073|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
148833007|NCT05177354|536868074|FG000|Implant to 30-day Visit|Physician Decision|1|||
148833008|NCT05177354|536868074|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
148833009|NCT05177354|536868074|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
148770868|NCT03452488|536634584|FG002|Overall Study|Lost to Follow-up|0|||
148770869|NCT03452488|536634582|FG000|Overall Study|PI Decision|1|||
148833010|NCT05177354|536868074|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
148833011|NCT03734536|536868075|FG000|Overall Study|Withdrew Consent|1|||
148833012|NCT03734536|536868076|FG001|Overall Study|Withdrew Consent|5|||
148833013|NCT03734536|536868075|FG000|Overall Study|Lost to Follow-up|10|||
148833014|NCT03734536|536868076|FG001|Overall Study|Lost to Follow-up|7|||
148833015|NCT06028464|536868077|FG000|Washout|Positive drug test.|1|||
148981008|NCT01782131|537411522|FG001|Overall Study|Reason not provided|1|||
148770870|NCT03452488|536634583|FG001|Overall Study|PI Decision|0|||
148770871|NCT03452488|536634584|FG002|Overall Study|PI Decision|0|||
148770872|NCT03452488|536634582|FG000|Overall Study|Withdrew consent|4|||
148770873|NCT03452488|536634583|FG001|Overall Study|Withdrew consent|2|||
148981009|NCT01627249|537411523|FG000|Overall Study|Death|3|||
149028173|NCT02696785|537580127|FG000|Blinded Treatment Period|Adverse Event|0|||
149028174|NCT02696785|537580128|FG001|Blinded Treatment Period|Adverse Event|1|||
149028175|NCT02696785|537580129|FG002|Blinded Treatment Period|Adverse Event|3|||
149028176|NCT02696785|537580130|FG003|Blinded Treatment Period|Adverse Event|0|||
149028177|NCT02696785|537580127|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
149028178|NCT02696785|537580128|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
149028179|NCT02696785|537580129|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
149028180|NCT02696785|537580130|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
149028181|NCT02696785|537580127|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
149028182|NCT02696785|537580128|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
149028183|NCT02696785|537580129|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
149028184|NCT02696785|537580130|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
149028185|NCT02696785|537580127|FG000|Blinded Treatment Period|Screen Failure|1|||
149028186|NCT02696785|537580128|FG001|Blinded Treatment Period|Screen Failure|0|||
149028187|NCT02696785|537580129|FG002|Blinded Treatment Period|Screen Failure|0|||
149028188|NCT02696785|537580130|FG003|Blinded Treatment Period|Screen Failure|0|||
149028189|NCT02696785|537580127|FG000|Washout Period|Withdrawal by Subject|0|||
149028190|NCT02696785|537580128|FG001|Washout Period|Withdrawal by Subject|1|||
149028191|NCT02696785|537580129|FG002|Washout Period|Withdrawal by Subject|0|||
149028192|NCT02696785|537580130|FG003|Washout Period|Withdrawal by Subject|0|||
149028193|NCT02696785|537580127|FG000|Washout Period|Lack of Efficacy|0|||
149028194|NCT02696785|537580128|FG001|Washout Period|Lack of Efficacy|1|||
149028195|NCT02696785|537580129|FG002|Washout Period|Lack of Efficacy|0|||
148770874|NCT03452488|536634584|FG002|Overall Study|Withdrew consent|2|||
148770875|NCT03452488|536634582|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
148770876|NCT03452488|536634583|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
148770877|NCT03452488|536634584|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
148770878|NCT03452488|536634582|FG000|Overall Study|Other|0|||
148770879|NCT03452488|536634583|FG001|Overall Study|Other|2|||
148770880|NCT03452488|536634584|FG002|Overall Study|Other|2|||
148770881|NCT04016779|536634585|FG000|Overall Study|Adverse Event|9|||
148770882|NCT04016779|536634586|FG001|Overall Study|Adverse Event|17|||
148770883|NCT04016779|536634585|FG000|Overall Study|Lack of Efficacy|4|||
148770884|NCT04016779|536634586|FG001|Overall Study|Lack of Efficacy|1|||
148770885|NCT04016779|536634585|FG000|Overall Study|Lost to Follow-up|5|||
148770886|NCT04016779|536634586|FG001|Overall Study|Lost to Follow-up|14|||
148770887|NCT04016779|536634585|FG000|Overall Study|Physician Decision|1|||
148770888|NCT04016779|536634586|FG001|Overall Study|Physician Decision|3|||
148770889|NCT04016779|536634585|FG000|Overall Study|Withdrawal by Subject|6|||
148770890|NCT04016779|536634586|FG001|Overall Study|Withdrawal by Subject|8|||
148770891|NCT04016779|536634585|FG000|Overall Study|Non-compliance with Study Drug|2|||
148770892|NCT04016779|536634586|FG001|Overall Study|Non-compliance with Study Drug|3|||
148770893|NCT04016779|536634585|FG000|Overall Study|Other, Multiple categories|17|||
148770894|NCT04016779|536634586|FG001|Overall Study|Other, Multiple categories|17|||
148770895|NCT00330343|536634587|FG000|Overall Study|Lost to Follow-up|5|||
148770896|NCT00281632|536634588|FG000|Overall Study|Adverse Event|7|||
148770897|NCT00281632|536634588|FG000|Overall Study|Withdrawal by Subject|2|||
148770898|NCT00281632|536634588|FG000|Overall Study|Disease Progression|22|||
148770899|NCT00281632|536634588|FG000|Overall Study|Death|1|||
148770900|NCT00281632|536634588|FG000|Overall Study|Physician Decision|1|||
148770901|NCT00281632|536634588|FG000|Overall Study|Ongoing|3|||
148770902|NCT06586788|536634589|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
148770903|NCT02980341|536634590|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
148770904|NCT02980341|536634591|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
148770905|NCT02980341|536634592|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
148770906|NCT02980341|536634593|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
148770907|NCT02980341|536634594|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
148770908|NCT02980341|536634595|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
148770909|NCT02980341|536634596|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
148770910|NCT02980341|536634597|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
148770911|NCT02980341|536634598|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
148770912|NCT02980341|536634599|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
148770913|NCT02980341|536634600|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
148770914|NCT02980341|536634590|FG000|Dose Escalation|Clinical progression|0|||
148770915|NCT02980341|536634591|FG001|Dose Escalation|Clinical progression|0|||
148770916|NCT02980341|536634592|FG002|Dose Escalation|Clinical progression|2|||
148770917|NCT02980341|536634593|FG003|Dose Escalation|Clinical progression|1|||
148770918|NCT02980341|536634594|FG004|Dose Escalation|Clinical progression|0|||
148770919|NCT02980341|536634595|FG005|Dose Escalation|Clinical progression|0|||
148770920|NCT02980341|536634596|FG006|Dose Escalation|Clinical progression|0|||
148770921|NCT02980341|536634597|FG007|Dose Escalation|Clinical progression|0|||
149028196|NCT02696785|537580130|FG003|Washout Period|Lack of Efficacy|0|||
149028197|NCT02696785|537580127|FG000|Extended Treatment Period|Adverse Event|2|||
149028198|NCT02696785|537580128|FG001|Extended Treatment Period|Adverse Event|3|||
148770922|NCT02980341|536634598|FG008|Dose Escalation|Clinical progression|0|||
148770923|NCT02980341|536634599|FG009|Dose Escalation|Clinical progression|0|||
148770924|NCT02980341|536634600|FG010|Dose Escalation|Clinical progression|0|||
148770925|NCT02980341|536634590|FG000|Dose Escalation|Adverse Event|0|||
148770926|NCT02980341|536634591|FG001|Dose Escalation|Adverse Event|0|||
148770927|NCT02980341|536634592|FG002|Dose Escalation|Adverse Event|1|||
148770928|NCT02980341|536634593|FG003|Dose Escalation|Adverse Event|2|||
148770929|NCT02980341|536634594|FG004|Dose Escalation|Adverse Event|2|||
148770930|NCT02980341|536634595|FG005|Dose Escalation|Adverse Event|0|||
148770931|NCT02980341|536634596|FG006|Dose Escalation|Adverse Event|0|||
148770932|NCT02980341|536634597|FG007|Dose Escalation|Adverse Event|0|||
148770933|NCT02980341|536634598|FG008|Dose Escalation|Adverse Event|0|||
148770934|NCT02980341|536634599|FG009|Dose Escalation|Adverse Event|0|||
148770935|NCT02980341|536634600|FG010|Dose Escalation|Adverse Event|0|||
148770936|NCT02980341|536634590|FG000|Dose Escalation|Withdrawal by Subject|0|||
148770937|NCT02980341|536634591|FG001|Dose Escalation|Withdrawal by Subject|0|||
148770938|NCT02980341|536634592|FG002|Dose Escalation|Withdrawal by Subject|1|||
148770939|NCT02980341|536634593|FG003|Dose Escalation|Withdrawal by Subject|0|||
148770940|NCT02980341|536634594|FG004|Dose Escalation|Withdrawal by Subject|0|||
148770941|NCT02980341|536634595|FG005|Dose Escalation|Withdrawal by Subject|0|||
148770942|NCT02980341|536634596|FG006|Dose Escalation|Withdrawal by Subject|0|||
148770943|NCT02980341|536634597|FG007|Dose Escalation|Withdrawal by Subject|0|||
148770944|NCT02980341|536634598|FG008|Dose Escalation|Withdrawal by Subject|0|||
148770945|NCT02980341|536634599|FG009|Dose Escalation|Withdrawal by Subject|0|||
148770946|NCT02980341|536634600|FG010|Dose Escalation|Withdrawal by Subject|0|||
148770947|NCT02980341|536634590|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770948|NCT02980341|536634591|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770949|NCT02980341|536634592|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770950|NCT02980341|536634593|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
148770951|NCT02980341|536634594|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770952|NCT02980341|536634595|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770953|NCT02980341|536634596|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770954|NCT02980341|536634597|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770955|NCT02980341|536634598|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
148770956|NCT02980341|536634599|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
148833016|NCT03448393|536868081|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833017|NCT03448393|536868082|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833018|NCT03448393|536868083|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
148833019|NCT03448393|536868084|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833020|NCT03448393|536868085|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833021|NCT03448393|536868086|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833022|NCT03448393|536868087|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833023|NCT03448393|536868088|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
148833024|NCT03448393|536868089|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
148833025|NCT03448393|536868081|FG000|Dose Expansion|Not treated - screen failure|0|||
148833026|NCT03448393|536868082|FG001|Dose Expansion|Not treated - screen failure|0|||
148833027|NCT03448393|536868083|FG002|Dose Expansion|Not treated - screen failure|0|||
148833028|NCT03448393|536868084|FG003|Dose Expansion|Not treated - screen failure|0|||
148981010|NCT01627249|537411524|FG001|Overall Study|Death|5|||
148981011|NCT01627249|537411525|FG002|Overall Study|Death|3|||
148981012|NCT01627249|537411523|FG000|Overall Study|Withdrawal by Subject|12|||
148981013|NCT01627249|537411524|FG001|Overall Study|Withdrawal by Subject|6|||
148981014|NCT01627249|537411525|FG002|Overall Study|Withdrawal by Subject|9|||
148981015|NCT01627249|537411523|FG000|Overall Study|Missed Visit|1|||
148981016|NCT01627249|537411524|FG001|Overall Study|Missed Visit|1|||
148981017|NCT01627249|537411525|FG002|Overall Study|Missed Visit|0|||
148981018|NCT00796718|537411526|FG000|Overall Study|Adverse Event|2|||
148981019|NCT00796718|537411526|FG000|Overall Study|Exclusion Criteria|1|||
148981020|NCT00796718|537411526|FG000|Overall Study|Lost to Follow-up|5|||
148981021|NCT00796718|537411526|FG000|Overall Study|Withdrawal by Informed Consent|1|||
148981022|NCT03266588|537411527|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
148981023|NCT03266588|537411528|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
148981024|NCT03266588|537411529|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
148981025|NCT03266588|537411527|FG000|Observational Period|Withdrawal by Subject|44|||
148770957|NCT02980341|536634600|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
148981026|NCT03266588|537411528|FG001|Observational Period|Withdrawal by Subject|22|||
148981027|NCT03266588|537411529|FG002|Observational Period|Withdrawal by Subject|13|||
148770958|NCT02980341|536634590|FG000|Dose Escalation|Due to investigator's decision|0|||
148770959|NCT02980341|536634591|FG001|Dose Escalation|Due to investigator's decision|0|||
148770960|NCT02980341|536634592|FG002|Dose Escalation|Due to investigator's decision|0|||
148833029|NCT03448393|536868085|FG004|Dose Expansion|Not treated - screen failure|0|||
149028199|NCT02696785|537580129|FG002|Extended Treatment Period|Adverse Event|2|||
149028200|NCT02696785|537580130|FG003|Extended Treatment Period|Adverse Event|1|||
148833030|NCT03448393|536868086|FG005|Dose Expansion|Not treated - screen failure|0|||
148833031|NCT03448393|536868087|FG006|Dose Expansion|Not treated - screen failure|0|||
148833032|NCT03448393|536868088|FG007|Dose Expansion|Not treated - screen failure|0|||
148833033|NCT03448393|536868089|FG008|Dose Expansion|Not treated - screen failure|7|||
148833034|NCT03612570|536868094|FG000|Overall Study|Lost to Follow-up|1|||
148833035|NCT03537508|536868095|FG000|Overall Study|Adverse Event|2|||
148770961|NCT02980341|536634593|FG003|Dose Escalation|Due to investigator's decision|0|||
148770962|NCT02980341|536634594|FG004|Dose Escalation|Due to investigator's decision|1|||
148770963|NCT02980341|536634595|FG005|Dose Escalation|Due to investigator's decision|0|||
148770964|NCT02980341|536634596|FG006|Dose Escalation|Due to investigator's decision|0|||
148770965|NCT02980341|536634597|FG007|Dose Escalation|Due to investigator's decision|0|||
148770966|NCT02980341|536634598|FG008|Dose Escalation|Due to investigator's decision|0|||
148770967|NCT02980341|536634599|FG009|Dose Escalation|Due to investigator's decision|0|||
148770968|NCT02980341|536634600|FG010|Dose Escalation|Due to investigator's decision|0|||
148770969|NCT02980341|536634590|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770970|NCT02980341|536634591|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
148833036|NCT03537508|536868096|FG001|Overall Study|Adverse Event|1|||
148833037|NCT03537508|536868095|FG000|Overall Study|Protocol Violation|65|||
148833038|NCT03537508|536868096|FG001|Overall Study|Protocol Violation|48|||
148833039|NCT03537508|536868095|FG000|Overall Study|Lost to Follow-up|86|||
148770971|NCT02980341|536634592|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770972|NCT02980341|536634593|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
148981028|NCT03266588|537411527|FG000|Observational Period|Non-compliance|18|||
148981029|NCT03266588|537411528|FG001|Observational Period|Non-compliance|12|||
148981030|NCT03266588|537411529|FG002|Observational Period|Non-compliance|10|||
148981031|NCT03266588|537411527|FG000|Observational Period|Lost to Follow-up|8|||
148981032|NCT03266588|537411528|FG001|Observational Period|Lost to Follow-up|12|||
148981033|NCT03266588|537411529|FG002|Observational Period|Lost to Follow-up|4|||
148981034|NCT03266588|537411527|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
148981035|NCT03266588|537411528|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
148981036|NCT03266588|537411529|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
148981037|NCT03266588|537411527|FG000|Observational Period|Protocol Deviation|1|||
148981038|NCT03266588|537411528|FG001|Observational Period|Protocol Deviation|0|||
148981039|NCT03266588|537411529|FG002|Observational Period|Protocol Deviation|0|||
148981040|NCT03266588|537411527|FG000|Observational Period|Other Reasons|3|||
148981041|NCT03266588|537411528|FG001|Observational Period|Other Reasons|0|||
148981042|NCT03266588|537411529|FG002|Observational Period|Other Reasons|1|||
148981043|NCT03266588|537411527|FG000|Long-term Treatment Period|Adverse Event|33|||
148981044|NCT03266588|537411528|FG001|Long-term Treatment Period|Adverse Event|17|||
148981045|NCT03266588|537411529|FG002|Long-term Treatment Period|Adverse Event|8|||
148981046|NCT03266588|537411527|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
148981047|NCT03266588|537411528|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
148981048|NCT03266588|537411529|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
148981049|NCT03266588|537411527|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
148981050|NCT03266588|537411528|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
148981051|NCT03266588|537411529|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
148981052|NCT03266588|537411527|FG000|Long-term Treatment Period|Non-Compliance|126|||
148981053|NCT03266588|537411528|FG001|Long-term Treatment Period|Non-Compliance|57|||
148981054|NCT03266588|537411529|FG002|Long-term Treatment Period|Non-Compliance|7|||
148981055|NCT03266588|537411527|FG000|Long-term Treatment Period|Pregnancy|11|||
148981056|NCT03266588|537411528|FG001|Long-term Treatment Period|Pregnancy|5|||
148770973|NCT02980341|536634594|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770974|NCT02980341|536634595|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
148833040|NCT03537508|536868096|FG001|Overall Study|Lost to Follow-up|60|||
148833041|NCT03537508|536868095|FG000|Overall Study|Withdrawal by parent/guardian|263|||
148833042|NCT03537508|536868096|FG001|Overall Study|Withdrawal by parent/guardian|149|||
148981057|NCT03266588|537411529|FG002|Long-term Treatment Period|Pregnancy|0|||
148981058|NCT03266588|537411527|FG000|Long-term Treatment Period|Protocol Deviation|17|||
148981059|NCT03266588|537411528|FG001|Long-term Treatment Period|Protocol Deviation|10|||
148981060|NCT03266588|537411529|FG002|Long-term Treatment Period|Protocol Deviation|4|||
149028201|NCT02696785|537580127|FG000|Extended Treatment Period|Lack of Efficacy|0|||
148770975|NCT02980341|536634596|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
148833043|NCT01972659|536868097|FG000|Overall Study|Protocol Violation|2|||
148833044|NCT01972659|536868098|FG001|Overall Study|Protocol Violation|2|||
148981061|NCT03266588|537411527|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
148981062|NCT03266588|537411528|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
148981063|NCT03266588|537411529|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
149028202|NCT02696785|537580128|FG001|Extended Treatment Period|Lack of Efficacy|1|||
148981064|NCT03266588|537411527|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
148770976|NCT02980341|536634597|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770977|NCT02980341|536634598|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770978|NCT02980341|536634599|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770979|NCT02980341|536634600|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
148770980|NCT02980341|536634590|FG000|Dose Finding|Adverse Event|0|||
148770981|NCT02980341|536634591|FG001|Dose Finding|Adverse Event|0|||
148770982|NCT02980341|536634592|FG002|Dose Finding|Adverse Event|0|||
148770983|NCT02980341|536634593|FG003|Dose Finding|Adverse Event|0|||
148770984|NCT02980341|536634594|FG004|Dose Finding|Adverse Event|0|||
148770985|NCT02980341|536634595|FG005|Dose Finding|Adverse Event|3|||
148770986|NCT02980341|536634596|FG006|Dose Finding|Adverse Event|0|||
148770987|NCT02980341|536634597|FG007|Dose Finding|Adverse Event|0|||
148770988|NCT02980341|536634598|FG008|Dose Finding|Adverse Event|0|||
148770989|NCT02980341|536634599|FG009|Dose Finding|Adverse Event|0|||
148770990|NCT02980341|536634600|FG010|Dose Finding|Adverse Event|0|||
148833045|NCT01972659|536868097|FG000|Overall Study|problems realted to acceleromyograph|2|||
148833046|NCT01972659|536868098|FG001|Overall Study|problems realted to acceleromyograph|1|||
148833047|NCT05715827|536868106|FG000|Overall Study|Physician Decision|0|||
148833048|NCT05715827|536868107|FG001|Overall Study|Physician Decision|1|||
148833049|NCT05715827|536868106|FG000|Overall Study|console communication error|0|||
148833050|NCT05715827|536868107|FG001|Overall Study|console communication error|1|||
148833051|NCT05847686|536870476|FG000|Overall Study|Withdrawal by Subject|3|||
148833052|NCT04795531|536870477|FG000|Overall Study|Withdrawal by Subject|4|||
148833053|NCT04795531|536870478|FG001|Overall Study|Withdrawal by Subject|4|||
148833054|NCT04795531|536870477|FG000|Overall Study|Lost to Follow-up|0|||
148833055|NCT04795531|536870478|FG001|Overall Study|Lost to Follow-up|1|||
148833056|NCT04795531|536870477|FG000|Overall Study|Physician Decision|0|||
148833057|NCT04795531|536870478|FG001|Overall Study|Physician Decision|2|||
148833058|NCT04795531|536870477|FG000|Overall Study|Death|2|||
148833059|NCT04795531|536870478|FG001|Overall Study|Death|1|||
148833060|NCT04887831|536870479|FG000|Overall Study|Death|26|||
148833061|NCT04887831|536870480|FG001|Overall Study|Death|26|||
148833062|NCT04887831|536870479|FG000|Overall Study|Lost to Follow-up|0|||
149028203|NCT02696785|537580129|FG002|Extended Treatment Period|Lack of Efficacy|0|||
149028204|NCT02696785|537580130|FG003|Extended Treatment Period|Lack of Efficacy|0|||
149028205|NCT02696785|537580127|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
149028206|NCT02696785|537580128|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
149028207|NCT02696785|537580129|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
149028208|NCT02696785|537580130|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
149028209|NCT02696785|537580127|FG000|Follow-up Period|Adverse Event|0|||
149028210|NCT02696785|537580128|FG001|Follow-up Period|Adverse Event|0|||
149028211|NCT02696785|537580129|FG002|Follow-up Period|Adverse Event|8|||
149028212|NCT02696785|537580130|FG003|Follow-up Period|Adverse Event|2|||
149028213|NCT02696785|537580127|FG000|Follow-up Period|Lost to Follow-up|0|||
149028214|NCT02696785|537580128|FG001|Follow-up Period|Lost to Follow-up|0|||
149028215|NCT02696785|537580129|FG002|Follow-up Period|Lost to Follow-up|0|||
149028216|NCT02696785|537580130|FG003|Follow-up Period|Lost to Follow-up|1|||
149028217|NCT02696785|537580127|FG000|Follow-up Period|Lack of Efficacy|0|||
149028218|NCT02696785|537580128|FG001|Follow-up Period|Lack of Efficacy|0|||
149028219|NCT02696785|537580129|FG002|Follow-up Period|Lack of Efficacy|0|||
149028220|NCT02696785|537580130|FG003|Follow-up Period|Lack of Efficacy|1|||
149028221|NCT02696785|537580127|FG000|Follow-up Period|Withdrawal by Subject|1|||
149028222|NCT02696785|537580128|FG001|Follow-up Period|Withdrawal by Subject|0|||
149028223|NCT02696785|537580129|FG002|Follow-up Period|Withdrawal by Subject|5|||
149028224|NCT02696785|537580130|FG003|Follow-up Period|Withdrawal by Subject|4|||
149028225|NCT04863898|537580134|FG000|Overall Study|Away from study clinic during intervention training period|2|||
149028226|NCT04863898|537580134|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
149028227|NCT04863898|537580134|FG000|Overall Study|Lost to Follow-up|3|||
149028228|NCT04863898|537580134|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
149028229|NCT04863898|537580134|FG000|Overall Study|No longer employed at clinic|3|||
149028230|NCT03285711|537580135|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
149028231|NCT03285711|537580136|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
149028232|NCT03285711|537580137|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
149028233|NCT03285711|537580138|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
149028234|NCT03285711|537580135|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
148770991|NCT02980341|536634590|FG000|Dose Finding|Withdrawal by Subject|0|||
148770992|NCT02980341|536634591|FG001|Dose Finding|Withdrawal by Subject|0|||
148833063|NCT04887831|536870480|FG001|Overall Study|Lost to Follow-up|1|||
148833064|NCT04887831|536870479|FG000|Overall Study|Withdrawal by Subject|2|||
148770993|NCT02980341|536634592|FG002|Dose Finding|Withdrawal by Subject|0|||
148770994|NCT02980341|536634593|FG003|Dose Finding|Withdrawal by Subject|0|||
148770995|NCT02980341|536634594|FG004|Dose Finding|Withdrawal by Subject|0|||
148770996|NCT02980341|536634595|FG005|Dose Finding|Withdrawal by Subject|1|||
148833065|NCT04887831|536870480|FG001|Overall Study|Withdrawal by Subject|1|||
148833066|NCT04887831|536870479|FG000|Overall Study|Study Terminated by Sponsor|18|||
148833067|NCT04887831|536870480|FG001|Overall Study|Study Terminated by Sponsor|17|||
148833068|NCT04887831|536870479|FG000|Overall Study|Other|1|||
148833069|NCT04887831|536870480|FG001|Overall Study|Other|0|||
148833070|NCT03396445|536870481|FG000|Treatment Period|Death|2|||
148833071|NCT03396445|536870482|FG001|Treatment Period|Death|2|||
148833072|NCT03396445|536870483|FG002|Treatment Period|Death|1|||
148833073|NCT03396445|536870484|FG003|Treatment Period|Death|1|||
148833074|NCT03396445|536870485|FG004|Treatment Period|Death|3|||
148833075|NCT03396445|536870486|FG005|Treatment Period|Death|2|||
148833076|NCT03396445|536870487|FG006|Treatment Period|Death|5|||
148833077|NCT03396445|536870488|FG007|Treatment Period|Death|3|||
148833078|NCT03396445|536870489|FG008|Treatment Period|Death|3|||
148833079|NCT03396445|536870490|FG009|Treatment Period|Death|3|||
148833080|NCT03396445|536870491|FG010|Treatment Period|Death|7|||
148833081|NCT03396445|536870492|FG011|Treatment Period|Death|12|||
148770997|NCT02980341|536634596|FG006|Dose Finding|Withdrawal by Subject|1|||
148770998|NCT02980341|536634597|FG007|Dose Finding|Withdrawal by Subject|0|||
148833082|NCT03396445|536870493|FG012|Treatment Period|Death|28|||
148833083|NCT03396445|536870494|FG013|Treatment Period|Death|14|||
148833084|NCT03396445|536870495|FG014|Treatment Period|Death|10|||
148833085|NCT03396445|536870496|FG015|Treatment Period|Death|8|||
148833086|NCT03396445|536870497|FG016|Treatment Period|Death|18|||
148833087|NCT03396445|536870498|FG017|Treatment Period|Death|0|||
148833088|NCT03396445|536870499|FG018|Treatment Period|Death|0|||
148981065|NCT03266588|537411528|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
148770999|NCT02980341|536634598|FG008|Dose Finding|Withdrawal by Subject|0|||
148771000|NCT02980341|536634599|FG009|Dose Finding|Withdrawal by Subject|0|||
148771001|NCT02980341|536634600|FG010|Dose Finding|Withdrawal by Subject|0|||
148771002|NCT02980341|536634590|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771003|NCT02980341|536634591|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771004|NCT02980341|536634592|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771005|NCT02980341|536634593|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771006|NCT02980341|536634594|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771007|NCT02980341|536634595|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771008|NCT02980341|536634596|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
148771009|NCT02980341|536634597|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
148771010|NCT02980341|536634598|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
148771011|NCT02980341|536634599|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
148771012|NCT02980341|536634600|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
148771013|NCT02980341|536634590|FG000|Dose Expansion|Clinical progression|0|||
148771014|NCT02980341|536634591|FG001|Dose Expansion|Clinical progression|0|||
148771015|NCT02980341|536634592|FG002|Dose Expansion|Clinical progression|0|||
148771016|NCT02980341|536634593|FG003|Dose Expansion|Clinical progression|0|||
148771017|NCT02980341|536634594|FG004|Dose Expansion|Clinical progression|0|||
148981066|NCT03266588|537411529|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
148981067|NCT03266588|537411527|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
148981068|NCT03266588|537411528|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
148981069|NCT03266588|537411529|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
148981070|NCT03266588|537411527|FG000|Long-term Treatment Period|Other Reasons|5|||
148981071|NCT03266588|537411528|FG001|Long-term Treatment Period|Other Reasons|0|||
148981072|NCT03266588|537411529|FG002|Long-term Treatment Period|Other Reasons|0|||
148981073|NCT03266588|537411527|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
148981074|NCT03266588|537411528|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
148981075|NCT03266588|537411529|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
148981076|NCT02627677|537411531|FG000|Overall Study|Adverse event (not progressive disease)|1|||
148981077|NCT02627677|537411532|FG001|Overall Study|Adverse event (not progressive disease)|4|||
148981078|NCT02627677|537411533|FG002|Overall Study|Adverse event (not progressive disease)|1|||
148981079|NCT02627677|537411531|FG000|Overall Study|Progressive disease|1|||
148981080|NCT02627677|537411532|FG001|Overall Study|Progressive disease|3|||
148981081|NCT02627677|537411533|FG002|Overall Study|Progressive disease|0|||
148981082|NCT02627677|537411531|FG000|Overall Study|Lack of Efficacy|1|||
148981083|NCT02627677|537411532|FG001|Overall Study|Lack of Efficacy|2|||
148771018|NCT02980341|536634595|FG005|Dose Expansion|Clinical progression|0|||
148771019|NCT02980341|536634596|FG006|Dose Expansion|Clinical progression|0|||
148771020|NCT02980341|536634597|FG007|Dose Expansion|Clinical progression|4|||
148833089|NCT03396445|536870500|FG019|Treatment Period|Death|0|||
148833090|NCT03396445|536870501|FG020|Treatment Period|Death|0|||
148981084|NCT02627677|537411533|FG002|Overall Study|Lack of Efficacy|0|||
148981085|NCT02627677|537411531|FG000|Overall Study|Lost to Follow-up|0|||
148771021|NCT02980341|536634598|FG008|Dose Expansion|Clinical progression|3|||
148771022|NCT02980341|536634599|FG009|Dose Expansion|Clinical progression|1|||
148833091|NCT03396445|536870502|FG021|Treatment Period|Death|0|||
148833092|NCT03396445|536870503|FG022|Treatment Period|Death|0|||
148833093|NCT03396445|536870504|FG023|Treatment Period|Death|0|||
148833094|NCT03396445|536870505|FG024|Treatment Period|Death|0|||
148833095|NCT03396445|536870506|FG025|Treatment Period|Death|0|||
148833096|NCT03396445|536870481|FG000|Treatment Period|Lost to Follow-up|0|||
148833097|NCT03396445|536870482|FG001|Treatment Period|Lost to Follow-up|0|||
148833098|NCT03396445|536870483|FG002|Treatment Period|Lost to Follow-up|0|||
148833099|NCT03396445|536870484|FG003|Treatment Period|Lost to Follow-up|0|||
148833100|NCT03396445|536870485|FG004|Treatment Period|Lost to Follow-up|0|||
148833101|NCT03396445|536870486|FG005|Treatment Period|Lost to Follow-up|0|||
148833102|NCT03396445|536870487|FG006|Treatment Period|Lost to Follow-up|0|||
148833103|NCT03396445|536870488|FG007|Treatment Period|Lost to Follow-up|0|||
148833104|NCT03396445|536870489|FG008|Treatment Period|Lost to Follow-up|0|||
148833105|NCT03396445|536870490|FG009|Treatment Period|Lost to Follow-up|0|||
148833106|NCT03396445|536870491|FG010|Treatment Period|Lost to Follow-up|0|||
148833107|NCT03396445|536870492|FG011|Treatment Period|Lost to Follow-up|0|||
148833108|NCT03396445|536870493|FG012|Treatment Period|Lost to Follow-up|1|||
148833109|NCT03396445|536870494|FG013|Treatment Period|Lost to Follow-up|0|||
148833110|NCT03396445|536870495|FG014|Treatment Period|Lost to Follow-up|1|||
148833111|NCT03396445|536870496|FG015|Treatment Period|Lost to Follow-up|0|||
148833112|NCT03396445|536870497|FG016|Treatment Period|Lost to Follow-up|0|||
148833113|NCT03396445|536870498|FG017|Treatment Period|Lost to Follow-up|0|||
148833114|NCT03396445|536870499|FG018|Treatment Period|Lost to Follow-up|0|||
148833115|NCT03396445|536870500|FG019|Treatment Period|Lost to Follow-up|0|||
148833116|NCT03396445|536870501|FG020|Treatment Period|Lost to Follow-up|0|||
148833117|NCT03396445|536870502|FG021|Treatment Period|Lost to Follow-up|0|||
148833118|NCT03396445|536870503|FG022|Treatment Period|Lost to Follow-up|0|||
148833119|NCT03396445|536870504|FG023|Treatment Period|Lost to Follow-up|0|||
148833120|NCT03396445|536870505|FG024|Treatment Period|Lost to Follow-up|0|||
148833121|NCT03396445|536870506|FG025|Treatment Period|Lost to Follow-up|0|||
148833122|NCT03396445|536870481|FG000|Treatment Period|Physician Decision|0|||
148833123|NCT03396445|536870482|FG001|Treatment Period|Physician Decision|0|||
148833124|NCT03396445|536870483|FG002|Treatment Period|Physician Decision|0|||
148833125|NCT03396445|536870484|FG003|Treatment Period|Physician Decision|0|||
148833126|NCT03396445|536870485|FG004|Treatment Period|Physician Decision|1|||
148833127|NCT03396445|536870486|FG005|Treatment Period|Physician Decision|0|||
148833128|NCT03396445|536870487|FG006|Treatment Period|Physician Decision|0|||
148833129|NCT03396445|536870488|FG007|Treatment Period|Physician Decision|0|||
148833130|NCT03396445|536870489|FG008|Treatment Period|Physician Decision|0|||
148833131|NCT03396445|536870490|FG009|Treatment Period|Physician Decision|1|||
148833132|NCT03396445|536870491|FG010|Treatment Period|Physician Decision|0|||
148833133|NCT03396445|536870492|FG011|Treatment Period|Physician Decision|0|||
148833134|NCT03396445|536870493|FG012|Treatment Period|Physician Decision|0|||
148833135|NCT03396445|536870494|FG013|Treatment Period|Physician Decision|0|||
148833136|NCT03396445|536870495|FG014|Treatment Period|Physician Decision|0|||
148833137|NCT03396445|536870496|FG015|Treatment Period|Physician Decision|0|||
148833138|NCT03396445|536870497|FG016|Treatment Period|Physician Decision|0|||
148833139|NCT03396445|536870498|FG017|Treatment Period|Physician Decision|0|||
148833140|NCT03396445|536870499|FG018|Treatment Period|Physician Decision|0|||
148833141|NCT03396445|536870500|FG019|Treatment Period|Physician Decision|0|||
148833142|NCT03396445|536870501|FG020|Treatment Period|Physician Decision|0|||
148833143|NCT03396445|536870502|FG021|Treatment Period|Physician Decision|0|||
148833144|NCT03396445|536870503|FG022|Treatment Period|Physician Decision|0|||
148833145|NCT03396445|536870504|FG023|Treatment Period|Physician Decision|0|||
148833146|NCT03396445|536870505|FG024|Treatment Period|Physician Decision|0|||
148833147|NCT03396445|536870506|FG025|Treatment Period|Physician Decision|0|||
148833148|NCT03396445|536870481|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833149|NCT03396445|536870482|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833150|NCT03396445|536870483|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833151|NCT03396445|536870484|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833152|NCT03396445|536870485|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833153|NCT03396445|536870486|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833154|NCT03396445|536870487|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833155|NCT03396445|536870488|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833156|NCT03396445|536870489|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833157|NCT03396445|536870490|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833158|NCT03396445|536870491|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
149028235|NCT03285711|537580136|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
149028236|NCT03285711|537580137|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
148833159|NCT03396445|536870492|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833160|NCT03396445|536870493|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
148833161|NCT03396445|536870494|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833162|NCT03396445|536870495|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
148833163|NCT03396445|536870496|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833164|NCT03396445|536870497|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833165|NCT03396445|536870498|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833166|NCT03396445|536870499|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833167|NCT03396445|536870500|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833168|NCT03396445|536870501|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833169|NCT03396445|536870502|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833170|NCT03396445|536870503|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148981086|NCT02627677|537411532|FG001|Overall Study|Lost to Follow-up|0|||
148981087|NCT02627677|537411533|FG002|Overall Study|Lost to Follow-up|1|||
148833171|NCT03396445|536870504|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833172|NCT03396445|536870505|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833173|NCT03396445|536870506|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
148833174|NCT03396445|536870481|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
148833175|NCT03396445|536870482|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
148833176|NCT03396445|536870483|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
148833177|NCT03396445|536870484|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
148833178|NCT03396445|536870485|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
148833179|NCT03396445|536870486|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833180|NCT03396445|536870487|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
148833181|NCT03396445|536870488|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833182|NCT03396445|536870489|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833183|NCT03396445|536870490|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833184|NCT03396445|536870491|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833185|NCT03396445|536870492|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833186|NCT03396445|536870493|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833187|NCT03396445|536870494|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833188|NCT03396445|536870495|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833189|NCT03396445|536870496|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833190|NCT03396445|536870497|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833191|NCT03396445|536870498|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833192|NCT03396445|536870499|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833193|NCT03396445|536870500|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833194|NCT03396445|536870501|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833195|NCT03396445|536870502|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833196|NCT03396445|536870503|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833197|NCT03396445|536870504|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833198|NCT03396445|536870505|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833199|NCT03396445|536870506|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
148833200|NCT03396445|536870481|FG000|Treatment Period|Withdrawal by Subject|0|||
148771023|NCT02980341|536634600|FG010|Dose Expansion|Clinical progression|4|||
148771024|NCT02980341|536634590|FG000|Dose Expansion|Adverse Event|0|||
148771025|NCT02980341|536634591|FG001|Dose Expansion|Adverse Event|0|||
148771026|NCT02980341|536634592|FG002|Dose Expansion|Adverse Event|0|||
148771027|NCT02980341|536634593|FG003|Dose Expansion|Adverse Event|0|||
148771028|NCT02980341|536634594|FG004|Dose Expansion|Adverse Event|0|||
148771029|NCT02980341|536634595|FG005|Dose Expansion|Adverse Event|0|||
148771030|NCT02980341|536634596|FG006|Dose Expansion|Adverse Event|0|||
148771031|NCT02980341|536634597|FG007|Dose Expansion|Adverse Event|3|||
148771032|NCT02980341|536634598|FG008|Dose Expansion|Adverse Event|0|||
148771033|NCT02980341|536634599|FG009|Dose Expansion|Adverse Event|1|||
148771034|NCT02980341|536634600|FG010|Dose Expansion|Adverse Event|3|||
148771035|NCT02980341|536634590|FG000|Dose Expansion|Death|0|||
148771036|NCT02980341|536634591|FG001|Dose Expansion|Death|0|||
148771037|NCT02980341|536634592|FG002|Dose Expansion|Death|0|||
148771038|NCT02980341|536634593|FG003|Dose Expansion|Death|0|||
148771039|NCT02980341|536634594|FG004|Dose Expansion|Death|0|||
148771040|NCT02980341|536634595|FG005|Dose Expansion|Death|0|||
148771041|NCT02980341|536634596|FG006|Dose Expansion|Death|0|||
148771042|NCT02980341|536634597|FG007|Dose Expansion|Death|0|||
148771043|NCT02980341|536634598|FG008|Dose Expansion|Death|2|||
148771044|NCT02980341|536634599|FG009|Dose Expansion|Death|1|||
148771045|NCT02980341|536634600|FG010|Dose Expansion|Death|0|||
148771046|NCT02980341|536634590|FG000|Dose Expansion|Withdrawal by Subject|0|||
148771047|NCT02980341|536634591|FG001|Dose Expansion|Withdrawal by Subject|0|||
148771048|NCT02980341|536634592|FG002|Dose Expansion|Withdrawal by Subject|0|||
148771049|NCT02980341|536634593|FG003|Dose Expansion|Withdrawal by Subject|0|||
148771050|NCT02980341|536634594|FG004|Dose Expansion|Withdrawal by Subject|0|||
148771051|NCT02980341|536634595|FG005|Dose Expansion|Withdrawal by Subject|0|||
148771052|NCT02980341|536634596|FG006|Dose Expansion|Withdrawal by Subject|0|||
148771053|NCT02980341|536634597|FG007|Dose Expansion|Withdrawal by Subject|2|||
148771054|NCT02980341|536634598|FG008|Dose Expansion|Withdrawal by Subject|0|||
148771055|NCT02980341|536634599|FG009|Dose Expansion|Withdrawal by Subject|1|||
148771056|NCT02980341|536634600|FG010|Dose Expansion|Withdrawal by Subject|0|||
148771057|NCT02980341|536634590|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771058|NCT02980341|536634591|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771059|NCT02980341|536634592|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771060|NCT02980341|536634593|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771061|NCT02980341|536634594|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771062|NCT02980341|536634595|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771063|NCT02980341|536634596|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771064|NCT02980341|536634597|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
148771065|NCT02980341|536634598|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771066|NCT02980341|536634599|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771067|NCT02980341|536634600|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
148771068|NCT02980341|536634590|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771069|NCT02980341|536634591|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771070|NCT02980341|536634592|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771071|NCT02980341|536634593|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771072|NCT02980341|536634594|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771073|NCT02980341|536634595|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771074|NCT02980341|536634596|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771075|NCT02980341|536634597|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771076|NCT02980341|536634598|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
148771077|NCT02980341|536634599|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771078|NCT02980341|536634600|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
148771079|NCT02980341|536634590|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771080|NCT02980341|536634591|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771081|NCT02980341|536634592|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771082|NCT02980341|536634593|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771083|NCT02980341|536634594|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771084|NCT02980341|536634595|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771085|NCT02980341|536634596|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771086|NCT02980341|536634597|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771087|NCT02980341|536634598|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
148771088|NCT02980341|536634599|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771089|NCT02980341|536634600|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
148771090|NCT02980341|536634590|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771091|NCT02980341|536634591|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771092|NCT02980341|536634592|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771093|NCT02980341|536634593|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771094|NCT02980341|536634594|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771095|NCT02980341|536634595|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771096|NCT02980341|536634596|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771097|NCT02980341|536634597|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771098|NCT02980341|536634598|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771099|NCT02980341|536634599|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
148771100|NCT02980341|536634600|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
148771101|NCT02691936|536634606|FG000|Overall Study|Withdrawal by Subject|2|||
148771102|NCT02691936|536634607|FG001|Overall Study|Withdrawal by Subject|5|||
148771103|NCT01878084|536634608|FG000|Overall Study|Physician Decision|2|||
148771104|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
148771105|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
148771106|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
148771107|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
148771108|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
148771109|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
148771110|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
148771111|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
148771112|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
148771113|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
148771114|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Death|1|||
148771115|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Death|0|||
148771116|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
148771117|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
148771118|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
148771119|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
148771120|NCT01876784|536634609|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
148771121|NCT01876784|536634610|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
148771122|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
148771123|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
148771124|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Adverse Event|2|||
148771125|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Adverse Event|6|||
148771126|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
148771127|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
148771128|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Progressive disease|4|||
148771129|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Progressive disease|35|||
148771130|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
148771131|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
148771132|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
148771133|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
148771134|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Death|0|||
148771135|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Death|1|||
148771136|NCT01876784|536634609|FG000|Open-label Period (31 Months)|Other than specified above|9|||
148771137|NCT01876784|536634610|FG001|Open-label Period (31 Months)|Other than specified above|18|||
148771138|NCT00749684|536634611|FG000|Overall Study|Death|1|||
148771139|NCT00749684|536634611|FG000|Overall Study|Adverse Event|27|||
148771140|NCT00749684|536634611|FG000|Overall Study|Participant's Wish|10|||
148771141|NCT00749684|536634611|FG000|Overall Study|Not Documented|1|||
148771142|NCT00749684|536634611|FG000|Overall Study|Progressive Desease|31|||
148771143|NCT00749684|536634611|FG000|Overall Study|Therapy according to protocol + AE|2|||
148771144|NCT00749684|536634611|FG000|Overall Study|AE+discontinuation on participants wish|1|||
148771145|NCT00749684|536634611|FG000|Overall Study|Missing|9|||
148771146|NCT03696108|536634612|FG000|Overall Study|Physician Decision|1|||
148771147|NCT03696108|536634613|FG001|Overall Study|Physician Decision|0|||
148771148|NCT03696108|536634612|FG000|Overall Study|Withdrawal by Subject|3|||
148771149|NCT03696108|536634613|FG001|Overall Study|Withdrawal by Subject|6|||
148771150|NCT05239494|536634615|FG000|Overall Study|Lost to Follow-up|1|||
148771151|NCT02892422|536634618|FG000|Overall Study|Enrolled not treated|4|||
148771152|NCT02892422|536634618|FG000|Overall Study|Adverse Event|38|||
148771153|NCT02892422|536634618|FG000|Overall Study|Lack of Efficacy|32|||
148771154|NCT02892422|536634618|FG000|Overall Study|Non-compliance with study drug|11|||
148771155|NCT02892422|536634618|FG000|Overall Study|Protocol Violation|4|||
148771156|NCT02892422|536634618|FG000|Overall Study|Withdrawal by Subject|56|||
148771157|NCT02892422|536634618|FG000|Overall Study|Lost to Follow-up|5|||
148771158|NCT02892422|536634618|FG000|Overall Study|sponsor information 16159A results|21|||
148771159|NCT02892422|536634618|FG000|Overall Study|withdrawal of consent|13|||
148771160|NCT02892422|536634618|FG000|Overall Study|exclusion criteria met|3|||
148771161|NCT02892422|536634618|FG000|Overall Study|moving elsewhere|4|||
148771162|NCT02892422|536634618|FG000|Overall Study|non-compliance|10|||
148981088|NCT02627677|537411531|FG000|Overall Study|Pregnancy|0|||
148771163|NCT02892422|536634618|FG000|Overall Study|patient legally incapable|1|||
148771164|NCT02892422|536634618|FG000|Overall Study|patient decision|7|||
148771165|NCT02892422|536634618|FG000|Overall Study|Investigator decision|1|||
148771166|NCT03089697|536634619|FG000|Overall Study|Adverse Event|1|||
148771167|NCT03089697|536634620|FG001|Overall Study|Adverse Event|2|||
148771168|NCT03089697|536634619|FG000|Overall Study|Withdrawal by Subject|1|||
148771169|NCT03089697|536634620|FG001|Overall Study|Withdrawal by Subject|0|||
148771170|NCT00373958|536634632|FG000|Infant Series|Withdrawal by Subject|13|||
148981089|NCT02627677|537411532|FG001|Overall Study|Pregnancy|1|||
148771171|NCT00373958|536634633|FG001|Infant Series|Withdrawal by Subject|15|||
148771172|NCT00373958|536634632|FG000|Infant Series|Failed to return|8|||
148771173|NCT00373958|536634633|FG001|Infant Series|Failed to return|13|||
148771174|NCT00373958|536634632|FG000|Infant Series|Lost to Follow-up|6|||
148771175|NCT00373958|536634633|FG001|Infant Series|Lost to Follow-up|5|||
148771176|NCT00373958|536634632|FG000|Infant Series|Protocol Violation|3|||
148771177|NCT00373958|536634633|FG001|Infant Series|Protocol Violation|7|||
148771178|NCT00373958|536634632|FG000|Infant Series|Lost Kaiser coverage|4|||
148771179|NCT00373958|536634633|FG001|Infant Series|Lost Kaiser coverage|0|||
148771180|NCT00373958|536634632|FG000|Infant Series|Child relocated|1|||
148771181|NCT00373958|536634633|FG001|Infant Series|Child relocated|0|||
148771182|NCT00373958|536634632|FG000|Infant Series|Consent was not received|1|||
148771183|NCT00373958|536634633|FG001|Infant Series|Consent was not received|0|||
148771184|NCT00373958|536634632|FG000|Infant Series|Adverse Event|3|||
148771185|NCT00373958|536634633|FG001|Infant Series|Adverse Event|1|||
148771186|NCT00373958|536634632|FG000|Infant Series|Physician Decision|1|||
148771187|NCT00373958|536634633|FG001|Infant Series|Physician Decision|1|||
148771188|NCT00373958|536634632|FG000|Toddler Dose|Lost to Follow-up|5|||
148771189|NCT00373958|536634633|FG001|Toddler Dose|Lost to Follow-up|8|||
148771190|NCT00373958|536634632|FG000|Toddler Dose|Withdrawal by Subject|2|||
148771191|NCT00373958|536634633|FG001|Toddler Dose|Withdrawal by Subject|2|||
148771192|NCT00373958|536634632|FG000|Toddler Dose|Failed to return|1|||
148771193|NCT00373958|536634633|FG001|Toddler Dose|Failed to return|2|||
148771194|NCT00373958|536634632|FG000|Toddler Dose|Protocol Violation|0|||
148771195|NCT00373958|536634633|FG001|Toddler Dose|Protocol Violation|1|||
148771196|NCT00373958|536634632|FG000|Toddler Dose|Withdrawn after infant series|22|||
148771197|NCT00373958|536634633|FG001|Toddler Dose|Withdrawn after infant series|25|||
148771198|NCT00492648|536634636|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
148771199|NCT00492648|536634637|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
148771200|NCT03382834|536634638|FG000|Step 1|Lost to Follow-up|0|||
148771201|NCT03382834|536634639|FG001|Step 1|Lost to Follow-up|1|||
148771202|NCT03382834|536634638|FG000|Step 2|Death|1|||
148771203|NCT03382834|536634639|FG001|Step 2|Death|0|||
148771204|NCT03382834|536634638|FG000|Step 2|Lost to Follow-up|2|||
148771205|NCT03382834|536634639|FG001|Step 2|Lost to Follow-up|2|||
148771206|NCT03382834|536634638|FG000|Step 2|Site Terminated by Sponsor|1|||
148771207|NCT03382834|536634639|FG001|Step 2|Site Terminated by Sponsor|0|||
148771208|NCT01500187|536634641|FG000|Overall Study|Lost to Follow-up|6|||
148771209|NCT01500187|536634642|FG001|Overall Study|Lost to Follow-up|0|||
148771210|NCT00750139|536634643|FG000|Overall Study|Adverse Event|1|||
148771211|NCT00750139|536634644|FG001|Overall Study|Adverse Event|2|||
148771212|NCT00750139|536634645|FG002|Overall Study|Adverse Event|0|||
148771213|NCT00750139|536634646|FG003|Overall Study|Adverse Event|1|||
148771214|NCT00750139|536634643|FG000|Overall Study|Lost to Follow-up|17|||
148771215|NCT00750139|536634644|FG001|Overall Study|Lost to Follow-up|12|||
148771216|NCT00750139|536634645|FG002|Overall Study|Lost to Follow-up|15|||
148771217|NCT00750139|536634646|FG003|Overall Study|Lost to Follow-up|6|||
148771218|NCT00750139|536634643|FG000|Overall Study|Withdrawal by Subject|3|||
148771219|NCT00750139|536634644|FG001|Overall Study|Withdrawal by Subject|2|||
148771220|NCT00750139|536634645|FG002|Overall Study|Withdrawal by Subject|6|||
148771221|NCT00750139|536634646|FG003|Overall Study|Withdrawal by Subject|2|||
148771222|NCT00750139|536634643|FG000|Overall Study|Physician Decision|1|||
148771223|NCT00750139|536634644|FG001|Overall Study|Physician Decision|1|||
148771224|NCT00750139|536634645|FG002|Overall Study|Physician Decision|0|||
148771225|NCT00750139|536634646|FG003|Overall Study|Physician Decision|0|||
148771226|NCT00750139|536634643|FG000|Overall Study|Non-compliance|1|||
148771227|NCT00750139|536634644|FG001|Overall Study|Non-compliance|0|||
148771228|NCT00750139|536634645|FG002|Overall Study|Non-compliance|1|||
148771229|NCT00750139|536634646|FG003|Overall Study|Non-compliance|3|||
148771230|NCT00750139|536634643|FG000|Overall Study|Termination by sponsor|4|||
148771231|NCT00750139|536634644|FG001|Overall Study|Termination by sponsor|0|||
148771232|NCT00750139|536634645|FG002|Overall Study|Termination by sponsor|0|||
148771233|NCT00750139|536634646|FG003|Overall Study|Termination by sponsor|1|||
148771234|NCT00750139|536634643|FG000|Overall Study|Non-specific|62|||
148771235|NCT00750139|536634644|FG001|Overall Study|Non-specific|42|||
148771236|NCT00750139|536634645|FG002|Overall Study|Non-specific|79|||
148771237|NCT00750139|536634646|FG003|Overall Study|Non-specific|33|||
148771238|NCT00595517|536634647|FG000|Overall Study|Adverse Event|6|||
148771239|NCT00595517|536634647|FG000|Overall Study|Withdrawal by Subject|4|||
148771240|NCT00595517|536634647|FG000|Overall Study|Protocol Violation|2|||
148771241|NCT00595517|536634647|FG000|Overall Study|Recurrence of ulcer|5|||
148771242|NCT00595517|536634647|FG000|Overall Study|usage of prohibited treatment|1|||
148771243|NCT00595517|536634647|FG000|Overall Study|No intention to attend regularly|1|||
148771244|NCT00658775|536634648|FG000|Overall Study|Adverse Event|4|||
148771245|NCT00658775|536634649|FG001|Overall Study|Adverse Event|6|||
148771246|NCT00658775|536634648|FG000|Overall Study|Lost to Follow-up|17|||
148771247|NCT00658775|536634649|FG001|Overall Study|Lost to Follow-up|18|||
148771248|NCT00658775|536634648|FG000|Overall Study|Withdrawal by Subject|6|||
148981090|NCT02627677|537411533|FG002|Overall Study|Pregnancy|0|||
148771249|NCT00658775|536634649|FG001|Overall Study|Withdrawal by Subject|4|||
148771250|NCT00658775|536634648|FG000|Overall Study|Withdrawal of consent|8|||
148771251|NCT00658775|536634649|FG001|Overall Study|Withdrawal of consent|7|||
148771252|NCT00658775|536634648|FG000|Overall Study|Other|7|||
148771253|NCT00658775|536634649|FG001|Overall Study|Other|8|||
148771254|NCT01435460|536634657|FG000|Overall Study|Adverse Event|2|||
148771255|NCT01435460|536634658|FG001|Overall Study|Adverse Event|1|||
148771256|NCT01435460|536634657|FG000|Overall Study|Lost to Follow-up|6|||
148771257|NCT01435460|536634658|FG001|Overall Study|Lost to Follow-up|1|||
148771258|NCT01435460|536634657|FG000|Overall Study|Withdrawal by Subject|1|||
148771259|NCT01435460|536634658|FG001|Overall Study|Withdrawal by Subject|3|||
148771260|NCT01435460|536634657|FG000|Overall Study|Protocol Violation|0|||
148771261|NCT01435460|536634658|FG001|Overall Study|Protocol Violation|1|||
148771262|NCT01435460|536634657|FG000|Overall Study|Did not meet eligibility criteria|2|||
148771263|NCT01435460|536634658|FG001|Overall Study|Did not meet eligibility criteria|0|||
148771264|NCT01706939|536634659|FG000|Pre Randomization|Screen Failure|1|||
148771265|NCT01706939|536634660|FG001|Pre Randomization|Screen Failure|0|||
148771266|NCT01706939|536634661|FG002|Pre Randomization|Screen Failure|0|||
148771267|NCT01706939|536634659|FG000|Pre Randomization|Ineligible for Randomization|1|||
148771268|NCT01706939|536634660|FG001|Pre Randomization|Ineligible for Randomization|0|||
148771269|NCT01706939|536634661|FG002|Pre Randomization|Ineligible for Randomization|0|||
148771270|NCT01706939|536634659|FG000|Pre Randomization|Withdrawal by Subject|1|||
148771271|NCT01706939|536634660|FG001|Pre Randomization|Withdrawal by Subject|0|||
148771272|NCT01706939|536634661|FG002|Pre Randomization|Withdrawal by Subject|0|||
148771273|NCT01706939|536634659|FG000|Randomization|Insufficient QoL survey compliance|0|||
148771274|NCT01706939|536634660|FG001|Randomization|Insufficient QoL survey compliance|1|||
148771275|NCT01706939|536634661|FG002|Randomization|Insufficient QoL survey compliance|1|||
148771276|NCT01706939|536634659|FG000|Randomization|Progression of disease|0|||
148771277|NCT01706939|536634660|FG001|Randomization|Progression of disease|2|||
148771278|NCT01706939|536634661|FG002|Randomization|Progression of disease|1|||
148771279|NCT01868022|536634662|FG000|Overall Study|Withdrawal by Subject|0|||
148771280|NCT01868022|536634663|FG001|Overall Study|Withdrawal by Subject|0|||
148771281|NCT01868022|536634664|FG002|Overall Study|Withdrawal by Subject|1|||
148771282|NCT01868022|536634665|FG003|Overall Study|Withdrawal by Subject|1|||
148771283|NCT01868022|536634666|FG004|Overall Study|Withdrawal by Subject|0|||
148771284|NCT01868022|536634667|FG005|Overall Study|Withdrawal by Subject|0|||
148771285|NCT01868022|536634668|FG006|Overall Study|Withdrawal by Subject|0|||
148771286|NCT01868022|536634669|FG007|Overall Study|Withdrawal by Subject|1|||
148771287|NCT01868022|536634670|FG008|Overall Study|Withdrawal by Subject|0|||
148771288|NCT01868022|536634662|FG000|Overall Study|Adverse Event|0|||
148771289|NCT01868022|536634663|FG001|Overall Study|Adverse Event|0|||
148771290|NCT01868022|536634664|FG002|Overall Study|Adverse Event|0|||
148771291|NCT01868022|536634665|FG003|Overall Study|Adverse Event|0|||
148771292|NCT01868022|536634666|FG004|Overall Study|Adverse Event|2|||
148771293|NCT01868022|536634667|FG005|Overall Study|Adverse Event|0|||
148771294|NCT01868022|536634668|FG006|Overall Study|Adverse Event|0|||
148771295|NCT01868022|536634669|FG007|Overall Study|Adverse Event|2|||
148771296|NCT01868022|536634670|FG008|Overall Study|Adverse Event|2|||
148771297|NCT01868022|536634662|FG000|Overall Study|Physician Decision|0|||
148771298|NCT01868022|536634663|FG001|Overall Study|Physician Decision|0|||
148771299|NCT01868022|536634664|FG002|Overall Study|Physician Decision|0|||
148771300|NCT01868022|536634665|FG003|Overall Study|Physician Decision|0|||
148833201|NCT03396445|536870482|FG001|Treatment Period|Withdrawal by Subject|0|||
148833202|NCT03396445|536870483|FG002|Treatment Period|Withdrawal by Subject|0|||
148833203|NCT03396445|536870484|FG003|Treatment Period|Withdrawal by Subject|0|||
148833204|NCT03396445|536870485|FG004|Treatment Period|Withdrawal by Subject|0|||
148833205|NCT03396445|536870486|FG005|Treatment Period|Withdrawal by Subject|0|||
149028237|NCT03285711|537580138|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
148771301|NCT01868022|536634666|FG004|Overall Study|Physician Decision|0|||
148771302|NCT01868022|536634667|FG005|Overall Study|Physician Decision|1|||
148771303|NCT01868022|536634668|FG006|Overall Study|Physician Decision|0|||
148771304|NCT01868022|536634669|FG007|Overall Study|Physician Decision|2|||
148771305|NCT01868022|536634670|FG008|Overall Study|Physician Decision|0|||
148771306|NCT01868022|536634662|FG000|Overall Study|Study closed/terminated|0|||
148771307|NCT01868022|536634663|FG001|Overall Study|Study closed/terminated|0|||
148771308|NCT01868022|536634664|FG002|Overall Study|Study closed/terminated|0|||
148771309|NCT01868022|536634665|FG003|Overall Study|Study closed/terminated|0|||
148771310|NCT01868022|536634666|FG004|Overall Study|Study closed/terminated|0|||
148771311|NCT01868022|536634667|FG005|Overall Study|Study closed/terminated|0|||
148833206|NCT03396445|536870487|FG006|Treatment Period|Withdrawal by Subject|0|||
149028238|NCT03285711|537580135|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
148771312|NCT01868022|536634668|FG006|Overall Study|Study closed/terminated|0|||
148771313|NCT01868022|536634669|FG007|Overall Study|Study closed/terminated|1|||
148771314|NCT01868022|536634670|FG008|Overall Study|Study closed/terminated|0|||
148771315|NCT01868022|536634662|FG000|Overall Study|Ongoing|0|||
148771316|NCT01868022|536634663|FG001|Overall Study|Ongoing|0|||
148771317|NCT01868022|536634664|FG002|Overall Study|Ongoing|0|||
148833207|NCT03396445|536870488|FG007|Treatment Period|Withdrawal by Subject|0|||
148833208|NCT03396445|536870489|FG008|Treatment Period|Withdrawal by Subject|0|||
148833209|NCT03396445|536870490|FG009|Treatment Period|Withdrawal by Subject|0|||
148833210|NCT03396445|536870491|FG010|Treatment Period|Withdrawal by Subject|0|||
148833211|NCT03396445|536870492|FG011|Treatment Period|Withdrawal by Subject|0|||
148833212|NCT03396445|536870493|FG012|Treatment Period|Withdrawal by Subject|0|||
148833213|NCT03396445|536870494|FG013|Treatment Period|Withdrawal by Subject|0|||
148833214|NCT03396445|536870495|FG014|Treatment Period|Withdrawal by Subject|1|||
148833215|NCT03396445|536870496|FG015|Treatment Period|Withdrawal by Subject|0|||
148833216|NCT03396445|536870497|FG016|Treatment Period|Withdrawal by Subject|1|||
148833217|NCT03396445|536870498|FG017|Treatment Period|Withdrawal by Subject|0|||
148833218|NCT03396445|536870499|FG018|Treatment Period|Withdrawal by Subject|0|||
148833219|NCT03396445|536870500|FG019|Treatment Period|Withdrawal by Subject|0|||
148833220|NCT03396445|536870501|FG020|Treatment Period|Withdrawal by Subject|0|||
148833221|NCT03396445|536870502|FG021|Treatment Period|Withdrawal by Subject|0|||
148833222|NCT03396445|536870503|FG022|Treatment Period|Withdrawal by Subject|0|||
148833223|NCT03396445|536870504|FG023|Treatment Period|Withdrawal by Subject|0|||
148833224|NCT03396445|536870505|FG024|Treatment Period|Withdrawal by Subject|0|||
148833225|NCT03396445|536870506|FG025|Treatment Period|Withdrawal by Subject|0|||
148833226|NCT03396445|536870481|FG000|Switch-over Period|Death|0|||
148833227|NCT03396445|536870482|FG001|Switch-over Period|Death|0|||
148833228|NCT03396445|536870483|FG002|Switch-over Period|Death|0|||
148833229|NCT03396445|536870484|FG003|Switch-over Period|Death|0|||
148833230|NCT03396445|536870485|FG004|Switch-over Period|Death|0|||
148833231|NCT03396445|536870486|FG005|Switch-over Period|Death|0|||
148833232|NCT03396445|536870487|FG006|Switch-over Period|Death|0|||
148833233|NCT03396445|536870488|FG007|Switch-over Period|Death|0|||
148833234|NCT03396445|536870489|FG008|Switch-over Period|Death|0|||
148833235|NCT03396445|536870490|FG009|Switch-over Period|Death|0|||
148833236|NCT03396445|536870491|FG010|Switch-over Period|Death|0|||
148833237|NCT03396445|536870492|FG011|Switch-over Period|Death|0|||
148833238|NCT03396445|536870493|FG012|Switch-over Period|Death|0|||
148833239|NCT03396445|536870494|FG013|Switch-over Period|Death|0|||
148833240|NCT03396445|536870495|FG014|Switch-over Period|Death|0|||
148833241|NCT03396445|536870496|FG015|Switch-over Period|Death|0|||
148833242|NCT03396445|536870497|FG016|Switch-over Period|Death|0|||
148833243|NCT03396445|536870498|FG017|Switch-over Period|Death|0|||
148833244|NCT03396445|536870499|FG018|Switch-over Period|Death|1|||
148833245|NCT03396445|536870500|FG019|Switch-over Period|Death|2|||
148833246|NCT03396445|536870501|FG020|Switch-over Period|Death|2|||
148833247|NCT03396445|536870502|FG021|Switch-over Period|Death|1|||
148833248|NCT03396445|536870503|FG022|Switch-over Period|Death|2|||
148833249|NCT03396445|536870504|FG023|Switch-over Period|Death|0|||
148833250|NCT03396445|536870505|FG024|Switch-over Period|Death|1|||
148833251|NCT03396445|536870506|FG025|Switch-over Period|Death|6|||
148833252|NCT03396445|536870481|FG000|Switch-over Period|Lost to Follow-up|0|||
148833253|NCT03396445|536870482|FG001|Switch-over Period|Lost to Follow-up|0|||
148833254|NCT03396445|536870483|FG002|Switch-over Period|Lost to Follow-up|0|||
148833255|NCT03396445|536870484|FG003|Switch-over Period|Lost to Follow-up|0|||
148833256|NCT03396445|536870485|FG004|Switch-over Period|Lost to Follow-up|0|||
148833257|NCT03396445|536870486|FG005|Switch-over Period|Lost to Follow-up|0|||
148833258|NCT03396445|536870487|FG006|Switch-over Period|Lost to Follow-up|0|||
148833259|NCT03396445|536870488|FG007|Switch-over Period|Lost to Follow-up|0|||
148833260|NCT03396445|536870489|FG008|Switch-over Period|Lost to Follow-up|0|||
148833261|NCT03396445|536870490|FG009|Switch-over Period|Lost to Follow-up|0|||
148833262|NCT03396445|536870491|FG010|Switch-over Period|Lost to Follow-up|0|||
148833263|NCT03396445|536870492|FG011|Switch-over Period|Lost to Follow-up|0|||
148833264|NCT03396445|536870493|FG012|Switch-over Period|Lost to Follow-up|0|||
148833265|NCT03396445|536870494|FG013|Switch-over Period|Lost to Follow-up|0|||
148833266|NCT03396445|536870495|FG014|Switch-over Period|Lost to Follow-up|0|||
148833267|NCT03396445|536870496|FG015|Switch-over Period|Lost to Follow-up|0|||
148833268|NCT03396445|536870497|FG016|Switch-over Period|Lost to Follow-up|0|||
148833269|NCT03396445|536870498|FG017|Switch-over Period|Lost to Follow-up|0|||
148833270|NCT03396445|536870499|FG018|Switch-over Period|Lost to Follow-up|0|||
148833271|NCT03396445|536870500|FG019|Switch-over Period|Lost to Follow-up|0|||
148833272|NCT03396445|536870501|FG020|Switch-over Period|Lost to Follow-up|0|||
148833273|NCT03396445|536870502|FG021|Switch-over Period|Lost to Follow-up|0|||
148833274|NCT03396445|536870503|FG022|Switch-over Period|Lost to Follow-up|0|||
148833275|NCT03396445|536870504|FG023|Switch-over Period|Lost to Follow-up|1|||
148833276|NCT03396445|536870505|FG024|Switch-over Period|Lost to Follow-up|0|||
148833277|NCT03396445|536870506|FG025|Switch-over Period|Lost to Follow-up|0|||
148833278|NCT04622592|536870507|FG000|Overall Study|Death|0|||
148833279|NCT04622592|536870508|FG001|Overall Study|Death|0|||
148833280|NCT04622592|536870509|FG002|Overall Study|Death|1|||
148833281|NCT04622592|536870510|FG003|Overall Study|Death|0|||
148833282|NCT04622592|536870511|FG004|Overall Study|Death|0|||
148833283|NCT04622592|536870512|FG005|Overall Study|Death|0|||
148833284|NCT04622592|536870513|FG006|Overall Study|Death|0|||
148833285|NCT04622592|536870514|FG007|Overall Study|Death|1|||
148833286|NCT04622592|536870507|FG000|Overall Study|Lost to Follow-up|0|||
148833287|NCT04622592|536870508|FG001|Overall Study|Lost to Follow-up|0|||
148833288|NCT04622592|536870509|FG002|Overall Study|Lost to Follow-up|0|||
148833289|NCT04622592|536870510|FG003|Overall Study|Lost to Follow-up|3|||
148833290|NCT04622592|536870511|FG004|Overall Study|Lost to Follow-up|1|||
148833291|NCT04622592|536870512|FG005|Overall Study|Lost to Follow-up|0|||
148833292|NCT04622592|536870513|FG006|Overall Study|Lost to Follow-up|2|||
148833293|NCT04622592|536870514|FG007|Overall Study|Lost to Follow-up|2|||
148833294|NCT04622592|536870507|FG000|Overall Study|Physician Decision|0|||
148833295|NCT04622592|536870508|FG001|Overall Study|Physician Decision|0|||
148833296|NCT04622592|536870509|FG002|Overall Study|Physician Decision|0|||
148833297|NCT04622592|536870510|FG003|Overall Study|Physician Decision|0|||
148833298|NCT04622592|536870511|FG004|Overall Study|Physician Decision|1|||
148833299|NCT04622592|536870512|FG005|Overall Study|Physician Decision|0|||
148833300|NCT04622592|536870513|FG006|Overall Study|Physician Decision|0|||
148833301|NCT04622592|536870514|FG007|Overall Study|Physician Decision|0|||
148833302|NCT04622592|536870507|FG000|Overall Study|Withdrawal by Subject|1|||
148833303|NCT04622592|536870508|FG001|Overall Study|Withdrawal by Subject|0|||
148833304|NCT04622592|536870509|FG002|Overall Study|Withdrawal by Subject|2|||
148833305|NCT04622592|536870510|FG003|Overall Study|Withdrawal by Subject|0|||
148833306|NCT04622592|536870511|FG004|Overall Study|Withdrawal by Subject|0|||
148833307|NCT04622592|536870512|FG005|Overall Study|Withdrawal by Subject|0|||
148833308|NCT04622592|536870513|FG006|Overall Study|Withdrawal by Subject|1|||
148833309|NCT04622592|536870514|FG007|Overall Study|Withdrawal by Subject|4|||
148833310|NCT04622592|536870507|FG000|Overall Study|Other than specified above|0|||
148833311|NCT04622592|536870508|FG001|Overall Study|Other than specified above|0|||
148833312|NCT04622592|536870509|FG002|Overall Study|Other than specified above|1|||
148833313|NCT04622592|536870510|FG003|Overall Study|Other than specified above|0|||
148833314|NCT04622592|536870511|FG004|Overall Study|Other than specified above|0|||
148833315|NCT04622592|536870512|FG005|Overall Study|Other than specified above|0|||
148833316|NCT04622592|536870513|FG006|Overall Study|Other than specified above|0|||
148833317|NCT04622592|536870514|FG007|Overall Study|Other than specified above|0|||
148833318|NCT01664624|536870516|FG000|Overall Study|Adverse Event|0|||
148833319|NCT01664624|536870517|FG001|Overall Study|Adverse Event|1|||
148833320|NCT01664624|536870518|FG002|Overall Study|Adverse Event|0|||
148833321|NCT01664624|536870519|FG003|Overall Study|Adverse Event|0|||
148833322|NCT00573768|536870523|FG000|Overall Study|Adverse Event|1|||
148833323|NCT00573768|536870524|FG001|Overall Study|Adverse Event|1|||
148833324|NCT00573768|536870525|FG002|Overall Study|Adverse Event|2|||
148833325|NCT00573768|536870523|FG000|Overall Study|Protocol Violation|1|||
148833326|NCT00573768|536870524|FG001|Overall Study|Protocol Violation|0|||
148833327|NCT00573768|536870525|FG002|Overall Study|Protocol Violation|1|||
148833328|NCT00573768|536870523|FG000|Overall Study|Withdrawal by Subject|0|||
148833329|NCT00573768|536870524|FG001|Overall Study|Withdrawal by Subject|1|||
148833330|NCT00573768|536870525|FG002|Overall Study|Withdrawal by Subject|0|||
148833331|NCT00573768|536870523|FG000|Overall Study|Lost to Follow-up|0|||
148833332|NCT00573768|536870524|FG001|Overall Study|Lost to Follow-up|0|||
148833333|NCT00573768|536870525|FG002|Overall Study|Lost to Follow-up|1|||
148833334|NCT00806585|536870528|FG000|Overall Study|Study terminated by Sponsor|0|||
148833335|NCT00806585|536870529|FG001|Overall Study|Study terminated by Sponsor|0|||
148833336|NCT00806585|536870530|FG002|Overall Study|Study terminated by Sponsor|1|||
148833337|NCT00806585|536870531|FG003|Overall Study|Study terminated by Sponsor|2|||
148833338|NCT00806585|536870532|FG004|Overall Study|Study terminated by Sponsor|0|||
148833339|NCT00806585|536870528|FG000|Overall Study|Protocol Violation|3|||
148833340|NCT00806585|536870529|FG001|Overall Study|Protocol Violation|1|||
148833341|NCT00806585|536870530|FG002|Overall Study|Protocol Violation|2|||
148833342|NCT00806585|536870531|FG003|Overall Study|Protocol Violation|0|||
148833343|NCT00806585|536870532|FG004|Overall Study|Protocol Violation|0|||
148833344|NCT00806585|536870528|FG000|Overall Study|Physician Decision|0|||
148833345|NCT00806585|536870529|FG001|Overall Study|Physician Decision|2|||
148833346|NCT00806585|536870530|FG002|Overall Study|Physician Decision|3|||
148833347|NCT00806585|536870531|FG003|Overall Study|Physician Decision|0|||
148833348|NCT00806585|536870532|FG004|Overall Study|Physician Decision|1|||
148833349|NCT00806585|536870528|FG000|Overall Study|Lost to Follow-up|2|||
148833350|NCT00806585|536870529|FG001|Overall Study|Lost to Follow-up|1|||
148833351|NCT00806585|536870530|FG002|Overall Study|Lost to Follow-up|2|||
148833352|NCT00806585|536870531|FG003|Overall Study|Lost to Follow-up|2|||
148833353|NCT00806585|536870532|FG004|Overall Study|Lost to Follow-up|5|||
148833354|NCT00806585|536870528|FG000|Overall Study|Lack of Efficacy|1|||
148833355|NCT00806585|536870529|FG001|Overall Study|Lack of Efficacy|0|||
148833356|NCT00806585|536870530|FG002|Overall Study|Lack of Efficacy|0|||
148833357|NCT00806585|536870531|FG003|Overall Study|Lack of Efficacy|0|||
148833358|NCT00806585|536870532|FG004|Overall Study|Lack of Efficacy|0|||
148833359|NCT00806585|536870528|FG000|Overall Study|Adverse Event|1|||
148833360|NCT00806585|536870529|FG001|Overall Study|Adverse Event|5|||
148833361|NCT00806585|536870530|FG002|Overall Study|Adverse Event|3|||
148833362|NCT00806585|536870531|FG003|Overall Study|Adverse Event|4|||
148833363|NCT00806585|536870532|FG004|Overall Study|Adverse Event|2|||
148833364|NCT00806585|536870528|FG000|Overall Study|Withdrawal by Subject|10|||
148833365|NCT00806585|536870529|FG001|Overall Study|Withdrawal by Subject|8|||
148771318|NCT01868022|536634665|FG003|Overall Study|Ongoing|0|||
148771319|NCT01868022|536634666|FG004|Overall Study|Ongoing|0|||
148771320|NCT01868022|536634667|FG005|Overall Study|Ongoing|0|||
148771321|NCT01868022|536634668|FG006|Overall Study|Ongoing|0|||
148771322|NCT01868022|536634669|FG007|Overall Study|Ongoing|3|||
148771323|NCT01868022|536634670|FG008|Overall Study|Ongoing|0|||
148771324|NCT02504827|536634671|FG000|Overall Study|Could not produce sputum|1|||
148771325|NCT03386994|536634672|FG000|Overall Study|Lung transplant|1|||
148771326|NCT03386994|536634672|FG000|Overall Study|Adverse Event|14|||
148771327|NCT03386994|536634672|FG000|Overall Study|Lost to Follow-up|4|||
148771328|NCT03386994|536634672|FG000|Overall Study|Withdrawal by Subject|3|||
148771329|NCT03386994|536634672|FG000|Overall Study|Death|16|||
148771330|NCT03033602|536634679|FG000|Overall Study|Withdrawal by Subject|11|||
148771331|NCT03033602|536634680|FG001|Overall Study|Withdrawal by Subject|21|||
148771332|NCT03033602|536634679|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
148771333|NCT03033602|536634680|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
148771334|NCT03425396|536634681|FG000|Overall Study|Lost to Follow-up|2|||
148771335|NCT03425396|536634682|FG001|Overall Study|Lost to Follow-up|5|||
148771336|NCT03425396|536634683|FG002|Overall Study|Lost to Follow-up|2|||
148771337|NCT03425396|536634684|FG003|Overall Study|Lost to Follow-up|0|||
148771338|NCT03425396|536634685|FG004|Overall Study|Lost to Follow-up|0|||
148771339|NCT03425396|536634681|FG000|Overall Study|Withdrawal by Subject|0|||
148771340|NCT03425396|536634682|FG001|Overall Study|Withdrawal by Subject|1|||
148771341|NCT03425396|536634683|FG002|Overall Study|Withdrawal by Subject|0|||
148771342|NCT03425396|536634684|FG003|Overall Study|Withdrawal by Subject|1|||
148771343|NCT03425396|536634685|FG004|Overall Study|Withdrawal by Subject|0|||
148771344|NCT03425396|536634681|FG000|Overall Study|Other|0|||
148771345|NCT03425396|536634682|FG001|Overall Study|Other|1|||
148771346|NCT03425396|536634683|FG002|Overall Study|Other|1|||
148771347|NCT03425396|536634684|FG003|Overall Study|Other|0|||
148771348|NCT03425396|536634685|FG004|Overall Study|Other|1|||
148771349|NCT01441765|536634686|FG000|Overall Study|Death|1|||
148771350|NCT01441765|536634687|FG001|Overall Study|Death|0|||
148771351|NCT03634033|536636641|FG000|Overall Study|Did not have a post-assessment|384|||
148771352|NCT03634033|536636642|FG001|Overall Study|Did not have a post-assessment|291|||
148771353|NCT03634033|536636643|FG002|Overall Study|Did not have a post-assessment|114|||
148771354|NCT03634033|536636644|FG003|Overall Study|Did not have a post-assessment|161|||
148771355|NCT03634033|536636645|FG004|Overall Study|Did not have a post-assessment|5|||
148771356|NCT03634033|536636646|FG005|Overall Study|Did not have a post-assessment|0|||
148771357|NCT03634033|536636647|FG006|Overall Study|Did not have a post-assessment|0|||
148771358|NCT03634033|536636641|FG000|Overall Study|Death|0|||
148771359|NCT03634033|536636642|FG001|Overall Study|Death|0|||
148771360|NCT03634033|536636643|FG002|Overall Study|Death|0|||
148771361|NCT03634033|536636644|FG003|Overall Study|Death|0|||
148771362|NCT03634033|536636645|FG004|Overall Study|Death|0|||
148771363|NCT03634033|536636646|FG005|Overall Study|Death|7|||
148771364|NCT03634033|536636647|FG006|Overall Study|Death|7|||
148771365|NCT03634033|536636641|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
148771366|NCT03634033|536636642|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
148771367|NCT03634033|536636643|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
148771368|NCT03634033|536636644|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
148771369|NCT03634033|536636645|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
148771370|NCT03634033|536636646|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
148771371|NCT03634033|536636647|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
148771372|NCT03634033|536636641|FG000|Overall Study|Lost to Follow-up|0|||
148771373|NCT03634033|536636642|FG001|Overall Study|Lost to Follow-up|0|||
148771374|NCT03634033|536636643|FG002|Overall Study|Lost to Follow-up|0|||
148771375|NCT03634033|536636644|FG003|Overall Study|Lost to Follow-up|0|||
148771376|NCT03634033|536636645|FG004|Overall Study|Lost to Follow-up|0|||
148771377|NCT03634033|536636646|FG005|Overall Study|Lost to Follow-up|1|||
148771378|NCT03634033|536636647|FG006|Overall Study|Lost to Follow-up|2|||
148771379|NCT03634033|536636641|FG000|Overall Study|Withdrawal by Subject|0|||
148771380|NCT03634033|536636642|FG001|Overall Study|Withdrawal by Subject|0|||
148771381|NCT03634033|536636643|FG002|Overall Study|Withdrawal by Subject|0|||
148771382|NCT03634033|536636644|FG003|Overall Study|Withdrawal by Subject|0|||
148771383|NCT03634033|536636645|FG004|Overall Study|Withdrawal by Subject|0|||
148771384|NCT03634033|536636646|FG005|Overall Study|Withdrawal by Subject|0|||
148771385|NCT03634033|536636647|FG006|Overall Study|Withdrawal by Subject|1|||
148771386|NCT01397786|536636650|FG000|Phase A|Lost to Follow-up|0|||
148771387|NCT01397786|536636651|FG001|Phase A|Lost to Follow-up|0|||
148771388|NCT01397786|536636652|FG002|Phase A|Lost to Follow-up|6|||
148771389|NCT01397786|536636650|FG000|Phase A|Adverse Event|0|||
148771390|NCT01397786|536636651|FG001|Phase A|Adverse Event|0|||
148771391|NCT01397786|536636652|FG002|Phase A|Adverse Event|8|||
148771392|NCT01397786|536636650|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
148771393|NCT01397786|536636651|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
148771394|NCT01397786|536636652|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
148771395|NCT01397786|536636650|FG000|Phase A|Physician Decision|0|||
148771396|NCT01397786|536636651|FG001|Phase A|Physician Decision|0|||
148771397|NCT01397786|536636652|FG002|Phase A|Physician Decision|1|||
148771398|NCT01397786|536636650|FG000|Phase A|Withdrawal by Subject|0|||
148771399|NCT01397786|536636651|FG001|Phase A|Withdrawal by Subject|0|||
148771400|NCT01397786|536636652|FG002|Phase A|Withdrawal by Subject|5|||
148771401|NCT01397786|536636650|FG000|Phase A|Lack of Efficacy|0|||
148771402|NCT01397786|536636651|FG001|Phase A|Lack of Efficacy|0|||
148771403|NCT01397786|536636652|FG002|Phase A|Lack of Efficacy|1|||
148771404|NCT01397786|536636650|FG000|Phase B|Lost to Follow-up|22|||
148771405|NCT01397786|536636651|FG001|Phase B|Lost to Follow-up|12|||
148771406|NCT01397786|536636652|FG002|Phase B|Lost to Follow-up|22|||
148771407|NCT01397786|536636650|FG000|Phase B|Adverse Event|109|||
148771408|NCT01397786|536636651|FG001|Phase B|Adverse Event|23|||
148771409|NCT01397786|536636652|FG002|Phase B|Adverse Event|27|||
148771410|NCT01397786|536636650|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
148771411|NCT01397786|536636651|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
148771412|NCT01397786|536636652|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
148771413|NCT01397786|536636650|FG000|Phase B|Physician Decision|9|||
148771414|NCT01397786|536636651|FG001|Phase B|Physician Decision|1|||
148833366|NCT00806585|536870530|FG002|Overall Study|Withdrawal by Subject|9|||
148833367|NCT00806585|536870531|FG003|Overall Study|Withdrawal by Subject|3|||
148833368|NCT00806585|536870532|FG004|Overall Study|Withdrawal by Subject|11|||
148833369|NCT00806585|536870528|FG000|Overall Study|Completion status unknown|15|||
148833370|NCT00806585|536870529|FG001|Overall Study|Completion status unknown|14|||
148833371|NCT00806585|536870530|FG002|Overall Study|Completion status unknown|12|||
148833372|NCT00806585|536870531|FG003|Overall Study|Completion status unknown|4|||
148833373|NCT00806585|536870532|FG004|Overall Study|Completion status unknown|12|||
148833374|NCT00833690|536870535|FG000|Overall Study|Withdrawal by Subject|1|||
148833375|NCT00833690|536870536|FG001|Overall Study|Withdrawal by Subject|0|||
148833376|NCT00833690|536870537|FG002|Overall Study|Withdrawal by Subject|0|||
148833377|NCT00833690|536870535|FG000|Overall Study|Discontinued study drug|3|||
148833378|NCT00833690|536870536|FG001|Overall Study|Discontinued study drug|2|||
148833379|NCT00833690|536870537|FG002|Overall Study|Discontinued study drug|0|||
148833380|NCT04138056|536870547|FG000|Primary Study|Lost to Follow-up|3|||
148833381|NCT04138056|536870548|FG001|Primary Study|Lost to Follow-up|4|||
148833382|NCT04138056|536870549|FG002|Primary Study|Lost to Follow-up|1|||
148833383|NCT04138056|536870550|FG003|Primary Study|Lost to Follow-up|1|||
148771415|NCT01397786|536636652|FG002|Phase B|Physician Decision|3|||
148771416|NCT01397786|536636650|FG000|Phase B|Withdrawal by Subject|102|||
148771417|NCT01397786|536636651|FG001|Phase B|Withdrawal by Subject|45|||
148771418|NCT01397786|536636652|FG002|Phase B|Withdrawal by Subject|30|||
148771419|NCT01397786|536636650|FG000|Phase B|Protocol Deviation|1|||
148771420|NCT01397786|536636651|FG001|Phase B|Protocol Deviation|2|||
148771421|NCT01397786|536636652|FG002|Phase B|Protocol Deviation|4|||
148771422|NCT01397786|536636650|FG000|Phase B|Lack of Efficacy|22|||
148771423|NCT01397786|536636651|FG001|Phase B|Lack of Efficacy|7|||
148771424|NCT01397786|536636652|FG002|Phase B|Lack of Efficacy|14|||
148771425|NCT02836236|536636659|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
148771426|NCT02836236|536636660|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
148771427|NCT02836236|536636661|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
148771428|NCT02836236|536636662|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
148771429|NCT02836236|536636659|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
148771430|NCT02836236|536636660|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
148771431|NCT02836236|536636661|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
148771432|NCT02836236|536636662|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
148771433|NCT02836236|536636659|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
148771434|NCT02836236|536636660|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
148771435|NCT02836236|536636661|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
148771436|NCT02836236|536636662|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
148771437|NCT02836236|536636659|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
148771438|NCT02836236|536636660|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
148771439|NCT02836236|536636661|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
148771440|NCT02836236|536636662|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
148771441|NCT02836236|536636659|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
148771442|NCT02836236|536636660|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
148833384|NCT04138056|536870551|FG004|Primary Study|Lost to Follow-up|4|||
148833385|NCT04138056|536870547|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
148833386|NCT04138056|536870548|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
148771443|NCT02836236|536636661|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
148771444|NCT02836236|536636662|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
148771445|NCT02836236|536636659|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
148771446|NCT02836236|536636660|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
148771447|NCT02836236|536636661|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
148771448|NCT02836236|536636662|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
148771449|NCT02836236|536636659|FG000|Open-Label TAF Treatment Phase|Death|0|||
148771450|NCT02836236|536636660|FG001|Open-Label TAF Treatment Phase|Death|0|||
148771451|NCT02836236|536636661|FG002|Open-Label TAF Treatment Phase|Death|1|||
148771452|NCT02836236|536636662|FG003|Open-Label TAF Treatment Phase|Death|1|||
148771453|NCT02836236|536636659|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
148771454|NCT02836236|536636660|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
148771455|NCT02836236|536636661|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
148771456|NCT02836236|536636662|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
148771457|NCT00174967|536636666|FG000|Overall Study|Adverse Event|1|||
148771458|NCT00174967|536636667|FG001|Overall Study|Adverse Event|2|||
148771459|NCT00174967|536636668|FG002|Overall Study|Adverse Event|2|||
148771460|NCT00174967|536636669|FG003|Overall Study|Adverse Event|1|||
148771461|NCT00174967|536636666|FG000|Overall Study|Gout Flare|0|||
148771462|NCT00174967|536636667|FG001|Overall Study|Gout Flare|0|||
148771463|NCT00174967|536636668|FG002|Overall Study|Gout Flare|0|||
148771464|NCT00174967|536636669|FG003|Overall Study|Gout Flare|1|||
148771465|NCT00174967|536636666|FG000|Overall Study|Other|0|||
148771466|NCT00174967|536636667|FG001|Overall Study|Other|1|||
148771467|NCT00174967|536636668|FG002|Overall Study|Other|0|||
148771468|NCT00174967|536636669|FG003|Overall Study|Other|0|||
148771469|NCT04420585|536636670|FG000|Overall Study|Adverse Event|1|||
148771470|NCT04420585|536636670|FG000|Overall Study|Never initiated medication|2|||
148771471|NCT00477750|536636671|FG000|Overall Study|Currently Receiving Treatment|11|||
148771472|NCT03558152|536636672|FG000|Overall Study|Adverse Event|0|||
148771473|NCT03558152|536636673|FG001|Overall Study|Adverse Event|0|||
148771474|NCT03558152|536636674|FG002|Overall Study|Adverse Event|1|||
148771475|NCT03558152|536636675|FG003|Overall Study|Adverse Event|1|||
148771476|NCT03558152|536636676|FG004|Overall Study|Adverse Event|2|||
148771477|NCT03558152|536636677|FG005|Overall Study|Adverse Event|1|||
148771478|NCT03558152|536636678|FG006|Overall Study|Adverse Event|1|||
148771479|NCT03558152|536636679|FG007|Overall Study|Adverse Event|0|||
148771480|NCT03558152|536636672|FG000|Overall Study|Death|0|||
148771481|NCT03558152|536636673|FG001|Overall Study|Death|0|||
148771482|NCT03558152|536636674|FG002|Overall Study|Death|0|||
148771483|NCT03558152|536636675|FG003|Overall Study|Death|0|||
148771484|NCT03558152|536636676|FG004|Overall Study|Death|1|||
148771485|NCT03558152|536636677|FG005|Overall Study|Death|0|||
148771486|NCT03558152|536636678|FG006|Overall Study|Death|0|||
148771487|NCT03558152|536636679|FG007|Overall Study|Death|0|||
148771488|NCT03558152|536636672|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
148771489|NCT03558152|536636673|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771490|NCT03558152|536636674|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771491|NCT03558152|536636675|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771492|NCT03558152|536636676|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771493|NCT03558152|536636677|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771494|NCT03558152|536636678|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771495|NCT03558152|536636679|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
148771496|NCT03558152|536636672|FG000|Overall Study|Miscalculation in mmcs|0|||
148771497|NCT03558152|536636673|FG001|Overall Study|Miscalculation in mmcs|0|||
148771498|NCT03558152|536636674|FG002|Overall Study|Miscalculation in mmcs|0|||
148771499|NCT03558152|536636675|FG003|Overall Study|Miscalculation in mmcs|0|||
148771500|NCT03558152|536636676|FG004|Overall Study|Miscalculation in mmcs|0|||
148771501|NCT03558152|536636677|FG005|Overall Study|Miscalculation in mmcs|0|||
148771502|NCT03558152|536636678|FG006|Overall Study|Miscalculation in mmcs|1|||
148771503|NCT03558152|536636679|FG007|Overall Study|Miscalculation in mmcs|0|||
148771504|NCT03558152|536636672|FG000|Overall Study|Mistake in calculation|0|||
148771505|NCT03558152|536636673|FG001|Overall Study|Mistake in calculation|0|||
148771506|NCT03558152|536636674|FG002|Overall Study|Mistake in calculation|0|||
148771507|NCT03558152|536636675|FG003|Overall Study|Mistake in calculation|1|||
148771508|NCT03558152|536636676|FG004|Overall Study|Mistake in calculation|0|||
148771509|NCT03558152|536636677|FG005|Overall Study|Mistake in calculation|0|||
148771510|NCT03558152|536636678|FG006|Overall Study|Mistake in calculation|0|||
148771511|NCT03558152|536636679|FG007|Overall Study|Mistake in calculation|0|||
148771512|NCT03558152|536636672|FG000|Overall Study|Mistake in evaluation of disease status|0|||
148771513|NCT03558152|536636673|FG001|Overall Study|Mistake in evaluation of disease status|0|||
148771514|NCT03558152|536636674|FG002|Overall Study|Mistake in evaluation of disease status|0|||
148833387|NCT04138056|536870549|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
148833388|NCT04138056|536870550|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
148833389|NCT04138056|536870551|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
148771515|NCT03558152|536636675|FG003|Overall Study|Mistake in evaluation of disease status|0|||
148771516|NCT03558152|536636676|FG004|Overall Study|Mistake in evaluation of disease status|0|||
148771517|NCT03558152|536636677|FG005|Overall Study|Mistake in evaluation of disease status|0|||
148771518|NCT03558152|536636678|FG006|Overall Study|Mistake in evaluation of disease status|0|||
148771519|NCT03558152|536636679|FG007|Overall Study|Mistake in evaluation of disease status|1|||
148771520|NCT03558152|536636672|FG000|Overall Study|Physician Decision|0|||
148771521|NCT03558152|536636673|FG001|Overall Study|Physician Decision|0|||
148771522|NCT03558152|536636674|FG002|Overall Study|Physician Decision|0|||
148771523|NCT03558152|536636675|FG003|Overall Study|Physician Decision|0|||
148771524|NCT03558152|536636676|FG004|Overall Study|Physician Decision|0|||
148771525|NCT03558152|536636677|FG005|Overall Study|Physician Decision|0|||
148771526|NCT03558152|536636678|FG006|Overall Study|Physician Decision|1|||
148771527|NCT03558152|536636679|FG007|Overall Study|Physician Decision|0|||
148771528|NCT03558152|536636672|FG000|Overall Study|Withdrawal by Subject|2|||
148771529|NCT03558152|536636673|FG001|Overall Study|Withdrawal by Subject|3|||
148771530|NCT03558152|536636674|FG002|Overall Study|Withdrawal by Subject|2|||
148771531|NCT03558152|536636675|FG003|Overall Study|Withdrawal by Subject|1|||
148771532|NCT03558152|536636676|FG004|Overall Study|Withdrawal by Subject|1|||
148771533|NCT03558152|536636677|FG005|Overall Study|Withdrawal by Subject|1|||
148771534|NCT03558152|536636678|FG006|Overall Study|Withdrawal by Subject|3|||
148771535|NCT03558152|536636679|FG007|Overall Study|Withdrawal by Subject|2|||
148771536|NCT03558152|536636672|FG000|Overall Study|Lack of Efficacy|11|||
148771537|NCT03558152|536636673|FG001|Overall Study|Lack of Efficacy|11|||
148771538|NCT03558152|536636674|FG002|Overall Study|Lack of Efficacy|10|||
148771539|NCT03558152|536636675|FG003|Overall Study|Lack of Efficacy|11|||
148771540|NCT03558152|536636676|FG004|Overall Study|Lack of Efficacy|14|||
148771541|NCT03558152|536636677|FG005|Overall Study|Lack of Efficacy|12|||
148771542|NCT03558152|536636678|FG006|Overall Study|Lack of Efficacy|14|||
148771543|NCT03558152|536636679|FG007|Overall Study|Lack of Efficacy|13|||
148771544|NCT03558152|536636672|FG000|Overall Study|Protocol Violation|1|||
148771545|NCT03558152|536636673|FG001|Overall Study|Protocol Violation|1|||
148771546|NCT03558152|536636674|FG002|Overall Study|Protocol Violation|0|||
148771547|NCT03558152|536636675|FG003|Overall Study|Protocol Violation|1|||
148771548|NCT03558152|536636676|FG004|Overall Study|Protocol Violation|1|||
148771549|NCT03558152|536636677|FG005|Overall Study|Protocol Violation|0|||
148771550|NCT03558152|536636678|FG006|Overall Study|Protocol Violation|2|||
148833390|NCT04138056|536870547|FG000|Extension Study|Lost to Follow-up|1|||
148833391|NCT04138056|536870548|FG001|Extension Study|Lost to Follow-up|2|||
148833392|NCT04138056|536870549|FG002|Extension Study|Lost to Follow-up|1|||
148833393|NCT04138056|536870550|FG003|Extension Study|Lost to Follow-up|0|||
148833394|NCT04138056|536870551|FG004|Extension Study|Lost to Follow-up|1|||
148833395|NCT02706392|536870552|FG000|Overall Study|Death|1|||
148833396|NCT02706392|536870553|FG001|Overall Study|Death|0|||
148833397|NCT02706392|536870554|FG002|Overall Study|Death|2|||
148833398|NCT02706392|536870555|FG003|Overall Study|Death|2|||
148833399|NCT02706392|536870556|FG004|Overall Study|Death|5|||
148833400|NCT02706392|536870557|FG005|Overall Study|Death|2|||
148833401|NCT01276106|536870562|FG000|Overall Study|Adverse Event|3|||
148833402|NCT01276106|536870563|FG001|Overall Study|Adverse Event|3|||
148833403|NCT01276106|536870564|FG002|Overall Study|Adverse Event|11|||
148833404|NCT01276106|536870565|FG003|Overall Study|Adverse Event|3|||
148833405|NCT01276106|536870562|FG000|Overall Study|Withdrawal by Subject|6|||
148833406|NCT01276106|536870563|FG001|Overall Study|Withdrawal by Subject|3|||
148833407|NCT01276106|536870564|FG002|Overall Study|Withdrawal by Subject|1|||
148833408|NCT01276106|536870565|FG003|Overall Study|Withdrawal by Subject|6|||
148833409|NCT01276106|536870562|FG000|Overall Study|Lack of Efficacy|0|||
148833410|NCT01276106|536870563|FG001|Overall Study|Lack of Efficacy|1|||
148833411|NCT01276106|536870564|FG002|Overall Study|Lack of Efficacy|0|||
148833412|NCT01276106|536870565|FG003|Overall Study|Lack of Efficacy|1|||
148833413|NCT01276106|536870562|FG000|Overall Study|Lost to Follow-up|2|||
148833414|NCT01276106|536870563|FG001|Overall Study|Lost to Follow-up|1|||
148833415|NCT01276106|536870564|FG002|Overall Study|Lost to Follow-up|1|||
148833416|NCT01276106|536870565|FG003|Overall Study|Lost to Follow-up|0|||
148833417|NCT01276106|536870562|FG000|Overall Study|Physician Decision|0|||
148833418|NCT01276106|536870563|FG001|Overall Study|Physician Decision|0|||
148833419|NCT01276106|536870564|FG002|Overall Study|Physician Decision|1|||
148833420|NCT01276106|536870565|FG003|Overall Study|Physician Decision|1|||
148833421|NCT01276106|536870562|FG000|Overall Study|Protocol Violation|1|||
149028239|NCT03285711|537580136|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
148833422|NCT01276106|536870563|FG001|Overall Study|Protocol Violation|1|||
148833423|NCT01276106|536870564|FG002|Overall Study|Protocol Violation|0|||
148771551|NCT03558152|536636679|FG007|Overall Study|Protocol Violation|0|||
148771552|NCT00601172|536636680|FG000|Overall Study|Adverse Event|43|||
148771553|NCT00601172|536636681|FG001|Overall Study|Adverse Event|32|||
148771554|NCT00601172|536636680|FG000|Overall Study|Lack of Efficacy|11|||
148771555|NCT00601172|536636681|FG001|Overall Study|Lack of Efficacy|12|||
148771556|NCT00601172|536636680|FG000|Overall Study|Protocol Violation|2|||
148771557|NCT00601172|536636681|FG001|Overall Study|Protocol Violation|5|||
148771558|NCT00601172|536636680|FG000|Overall Study|Lost to Follow-up|4|||
148771559|NCT00601172|536636681|FG001|Overall Study|Lost to Follow-up|3|||
148833424|NCT01276106|536870565|FG003|Overall Study|Protocol Violation|2|||
148833425|NCT01276106|536870562|FG000|Overall Study|Insufficient therapeutic effects|0|||
148833426|NCT01276106|536870563|FG001|Overall Study|Insufficient therapeutic effects|0|||
148833427|NCT01276106|536870564|FG002|Overall Study|Insufficient therapeutic effects|2|||
148833428|NCT01276106|536870565|FG003|Overall Study|Insufficient therapeutic effects|0|||
148833429|NCT01242514|536870566|FG000|Overall Study|e.g., project closure|1042|||
148771560|NCT00601172|536636680|FG000|Overall Study|Physician Decision|27|||
148771561|NCT00601172|536636681|FG001|Overall Study|Physician Decision|28|||
148771562|NCT00601172|536636680|FG000|Overall Study|Withdrawal by Subject|35|||
148771563|NCT00601172|536636681|FG001|Overall Study|Withdrawal by Subject|27|||
148833430|NCT01242514|536870567|FG001|Overall Study|e.g., project closure|305|||
148833431|NCT01242514|536870568|FG002|Overall Study|e.g., project closure|171|||
148771564|NCT00601172|536636680|FG000|Overall Study|Did not meet continuation criteria|19|||
148771565|NCT00601172|536636681|FG001|Overall Study|Did not meet continuation criteria|20|||
148771566|NCT04434469|536636685|FG000|Overall Study|Death|2|||
148771567|NCT04434469|536636686|FG001|Overall Study|Death|3|||
148771568|NCT04434469|536636687|FG002|Overall Study|Death|2|||
148771569|NCT04434469|536636688|FG003|Overall Study|Death|2|||
148771570|NCT04434469|536636689|FG004|Overall Study|Death|2|||
148771571|NCT04434469|536636690|FG005|Overall Study|Death|0|||
148771572|NCT04434469|536636685|FG000|Overall Study|Lost to Follow-up|0|||
148771573|NCT04434469|536636686|FG001|Overall Study|Lost to Follow-up|0|||
148771574|NCT04434469|536636687|FG002|Overall Study|Lost to Follow-up|0|||
148833432|NCT01242514|536870566|FG000|Overall Study|Subject decision|33|||
148833433|NCT01242514|536870567|FG001|Overall Study|Subject decision|8|||
148833434|NCT01242514|536870568|FG002|Overall Study|Subject decision|2|||
148833435|NCT01242514|536870566|FG000|Overall Study|Severe non-compliance to protocol|5|||
148833436|NCT01242514|536870567|FG001|Overall Study|Severe non-compliance to protocol|2|||
148833437|NCT01242514|536870568|FG002|Overall Study|Severe non-compliance to protocol|1|||
148833438|NCT01242514|536870566|FG000|Overall Study|Lack of therapeutic response|99|||
148833439|NCT01242514|536870567|FG001|Overall Study|Lack of therapeutic response|16|||
148833440|NCT01242514|536870568|FG002|Overall Study|Lack of therapeutic response|10|||
148833441|NCT01242514|536870566|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
148771575|NCT04434469|536636688|FG003|Overall Study|Lost to Follow-up|1|||
148771576|NCT04434469|536636689|FG004|Overall Study|Lost to Follow-up|1|||
148771577|NCT04434469|536636690|FG005|Overall Study|Lost to Follow-up|0|||
148771578|NCT04434469|536636685|FG000|Overall Study|Study terminated by sponsor|1|||
148771579|NCT04434469|536636686|FG001|Overall Study|Study terminated by sponsor|1|||
148771580|NCT04434469|536636687|FG002|Overall Study|Study terminated by sponsor|1|||
148771581|NCT04434469|536636688|FG003|Overall Study|Study terminated by sponsor|2|||
148771582|NCT04434469|536636689|FG004|Overall Study|Study terminated by sponsor|3|||
148771583|NCT04434469|536636690|FG005|Overall Study|Study terminated by sponsor|3|||
148771584|NCT04434469|536636685|FG000|Overall Study|Withdrawal by Subject|0|||
148833442|NCT01242514|536870567|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
148833443|NCT01242514|536870568|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
148833444|NCT01242514|536870566|FG000|Overall Study|Lost to Follow-up|14|||
148833445|NCT01242514|536870567|FG001|Overall Study|Lost to Follow-up|5|||
148833446|NCT01242514|536870568|FG002|Overall Study|Lost to Follow-up|4|||
148833447|NCT01242514|536870566|FG000|Overall Study|Adverse Event|129|||
148833448|NCT01242514|536870567|FG001|Overall Study|Adverse Event|18|||
148833449|NCT01242514|536870568|FG002|Overall Study|Adverse Event|19|||
148833450|NCT00787150|536870570|FG000|Overall Study|Adverse Event|4|||
148833451|NCT00787150|536870571|FG001|Overall Study|Adverse Event|4|||
148833452|NCT00787150|536870572|FG002|Overall Study|Adverse Event|4|||
148833453|NCT00787150|536870570|FG000|Overall Study|Physician Decision|1|||
148833454|NCT00787150|536870571|FG001|Overall Study|Physician Decision|2|||
148833455|NCT00787150|536870572|FG002|Overall Study|Physician Decision|1|||
148771585|NCT04434469|536636686|FG001|Overall Study|Withdrawal by Subject|0|||
148771586|NCT04434469|536636687|FG002|Overall Study|Withdrawal by Subject|1|||
148771587|NCT04434469|536636688|FG003|Overall Study|Withdrawal by Subject|0|||
148771588|NCT04434469|536636689|FG004|Overall Study|Withdrawal by Subject|0|||
148771589|NCT04434469|536636690|FG005|Overall Study|Withdrawal by Subject|0|||
148771590|NCT01936181|536636697|FG000|Randomised, Double-blind|Adverse Event|27|||
148771591|NCT01936181|536636698|FG001|Randomised, Double-blind|Adverse Event|21|||
148771592|NCT01936181|536636699|FG002|Randomised, Double-blind|Adverse Event|0|||
148771593|NCT01936181|536636700|FG003|Randomised, Double-blind|Adverse Event|0|||
148771594|NCT01936181|536636697|FG000|Randomised, Double-blind|Protocol Violation|1|||
148771595|NCT01936181|536636698|FG001|Randomised, Double-blind|Protocol Violation|5|||
148833456|NCT00787150|536870570|FG000|Overall Study|Withdrawal by Subject|2|||
148833457|NCT00787150|536870571|FG001|Overall Study|Withdrawal by Subject|1|||
148981091|NCT02627677|537411531|FG000|Overall Study|Study Terminated by Sponsor|5|||
148833458|NCT00787150|536870572|FG002|Overall Study|Withdrawal by Subject|0|||
148981092|NCT02627677|537411532|FG001|Overall Study|Study Terminated by Sponsor|10|||
148981093|NCT02627677|537411533|FG002|Overall Study|Study Terminated by Sponsor|6|||
148771596|NCT01936181|536636699|FG002|Randomised, Double-blind|Protocol Violation|0|||
148771597|NCT01936181|536636700|FG003|Randomised, Double-blind|Protocol Violation|0|||
148771598|NCT01936181|536636697|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
148771599|NCT01936181|536636698|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
148771600|NCT01936181|536636699|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
148771601|NCT01936181|536636700|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
148833459|NCT00787150|536870570|FG000|Overall Study|Dosing incorrect study durg|2|||
148981094|NCT02627677|537411531|FG000|Overall Study|Physician Decision|0|||
148981095|NCT02627677|537411532|FG001|Overall Study|Physician Decision|0|||
148771602|NCT01936181|536636697|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
148771603|NCT01936181|536636698|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
148771604|NCT01936181|536636699|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
148771605|NCT01936181|536636700|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
148771606|NCT01936181|536636697|FG000|Randomised, Double-blind|Pregnancy|0|||
148771607|NCT01936181|536636698|FG001|Randomised, Double-blind|Pregnancy|1|||
148771608|NCT01936181|536636699|FG002|Randomised, Double-blind|Pregnancy|0|||
148771609|NCT01936181|536636700|FG003|Randomised, Double-blind|Pregnancy|0|||
148771610|NCT01936181|536636697|FG000|Randomised, Double-blind|Physician Decision|4|||
148771611|NCT01936181|536636698|FG001|Randomised, Double-blind|Physician Decision|4|||
148771612|NCT01936181|536636699|FG002|Randomised, Double-blind|Physician Decision|0|||
148771613|NCT01936181|536636700|FG003|Randomised, Double-blind|Physician Decision|0|||
148771614|NCT01936181|536636697|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
148771615|NCT01936181|536636698|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
148771616|NCT01936181|536636699|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
148771617|NCT01936181|536636700|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
148771618|NCT01936181|536636697|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
148771619|NCT01936181|536636698|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
148771620|NCT01936181|536636699|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
148771621|NCT01936181|536636700|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
148771622|NCT01936181|536636697|FG000|Transition-extension|Adverse Event|3|||
148771623|NCT01936181|536636698|FG001|Transition-extension|Adverse Event|0|||
148771624|NCT01936181|536636699|FG002|Transition-extension|Adverse Event|3|||
148771625|NCT01936181|536636700|FG003|Transition-extension|Adverse Event|1|||
148771626|NCT01936181|536636697|FG000|Transition-extension|Lost to Follow-up|3|||
148771627|NCT01936181|536636698|FG001|Transition-extension|Lost to Follow-up|0|||
148771628|NCT01936181|536636699|FG002|Transition-extension|Lost to Follow-up|1|||
148771629|NCT01936181|536636700|FG003|Transition-extension|Lost to Follow-up|2|||
148771630|NCT01936181|536636697|FG000|Transition-extension|Physician Decision|2|||
148771631|NCT01936181|536636698|FG001|Transition-extension|Physician Decision|0|||
148771632|NCT01936181|536636699|FG002|Transition-extension|Physician Decision|0|||
148771633|NCT01936181|536636700|FG003|Transition-extension|Physician Decision|1|||
148771634|NCT01936181|536636697|FG000|Transition-extension|Withdrawal by Subject|7|||
148771635|NCT01936181|536636698|FG001|Transition-extension|Withdrawal by Subject|0|||
148771636|NCT01936181|536636699|FG002|Transition-extension|Withdrawal by Subject|2|||
148771637|NCT01936181|536636700|FG003|Transition-extension|Withdrawal by Subject|1|||
148771638|NCT00900757|536636701|FG000|Overall Study|screen failure|19|||
148771639|NCT00976820|536636703|FG000|Overall Study|Lost to Follow-up|5|||
148771640|NCT00976820|536636704|FG001|Overall Study|Lost to Follow-up|16|||
148771641|NCT00976820|536636705|FG002|Overall Study|Lost to Follow-up|2|||
148771642|NCT00976820|536636706|FG003|Overall Study|Lost to Follow-up|3|||
148771643|NCT00976820|536636703|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
148771644|NCT00976820|536636704|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
148771645|NCT00976820|536636705|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
148771646|NCT00976820|536636706|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
148771647|NCT00976820|536636703|FG000|Overall Study|Withdrawal by Subject|2|||
148771648|NCT00976820|536636704|FG001|Overall Study|Withdrawal by Subject|4|||
148771649|NCT00976820|536636705|FG002|Overall Study|Withdrawal by Subject|1|||
148771650|NCT00976820|536636706|FG003|Overall Study|Withdrawal by Subject|4|||
148771651|NCT00968981|536636707|FG000|Overall Study|Adverse Event|2|||
148771652|NCT00968981|536636708|FG001|Overall Study|Adverse Event|0|||
148771653|NCT00968981|536636709|FG002|Overall Study|Adverse Event|0|||
148771654|NCT00968981|536636707|FG000|Overall Study|Disease Progression|14|||
148771655|NCT00968981|536636708|FG001|Overall Study|Disease Progression|16|||
148771656|NCT00968981|536636709|FG002|Overall Study|Disease Progression|13|||
148771657|NCT00968981|536636707|FG000|Overall Study|Lost to Follow-up|0|||
148771658|NCT00968981|536636708|FG001|Overall Study|Lost to Follow-up|0|||
148771659|NCT00968981|536636709|FG002|Overall Study|Lost to Follow-up|1|||
148771660|NCT00968981|536636707|FG000|Overall Study|Physician Decision|5|||
148771661|NCT00968981|536636708|FG001|Overall Study|Physician Decision|3|||
148771662|NCT00968981|536636709|FG002|Overall Study|Physician Decision|5|||
148771663|NCT00968981|536636707|FG000|Overall Study|Withdrawal by Subject|1|||
148771664|NCT00968981|536636708|FG001|Overall Study|Withdrawal by Subject|3|||
148771665|NCT00968981|536636709|FG002|Overall Study|Withdrawal by Subject|3|||
148771666|NCT01489254|536636712|FG000|Double-blind Part|Adverse Event|7|||
148771667|NCT01489254|536636713|FG001|Double-blind Part|Adverse Event|2|||
148771668|NCT01489254|536636714|FG002|Double-blind Part|Adverse Event|2|||
148833460|NCT00787150|536870571|FG001|Overall Study|Dosing incorrect study durg|0|||
148981096|NCT02627677|537411533|FG002|Overall Study|Physician Decision|2|||
148771669|NCT01489254|536636715|FG003|Double-blind Part|Adverse Event|0|||
148771670|NCT01489254|536636712|FG000|Double-blind Part|Pregnancy|1|||
148771671|NCT01489254|536636713|FG001|Double-blind Part|Pregnancy|3|||
148771672|NCT01489254|536636714|FG002|Double-blind Part|Pregnancy|0|||
148771673|NCT01489254|536636715|FG003|Double-blind Part|Pregnancy|0|||
148771674|NCT01489254|536636712|FG000|Double-blind Part|Withdrawal by Subject|12|||
148771675|NCT01489254|536636713|FG001|Double-blind Part|Withdrawal by Subject|20|||
148771676|NCT01489254|536636714|FG002|Double-blind Part|Withdrawal by Subject|1|||
148771677|NCT01489254|536636715|FG003|Double-blind Part|Withdrawal by Subject|0|||
148771678|NCT01489254|536636712|FG000|Double-blind Part|Lost to Follow-up|1|||
148771679|NCT01489254|536636713|FG001|Double-blind Part|Lost to Follow-up|2|||
148771680|NCT01489254|536636714|FG002|Double-blind Part|Lost to Follow-up|0|||
148771681|NCT01489254|536636715|FG003|Double-blind Part|Lost to Follow-up|0|||
148771682|NCT01489254|536636712|FG000|Double-blind Part|Other reasons for not completing study|4|||
148771683|NCT01489254|536636713|FG001|Double-blind Part|Other reasons for not completing study|6|||
148771684|NCT01489254|536636714|FG002|Double-blind Part|Other reasons for not completing study|0|||
148771685|NCT01489254|536636715|FG003|Double-blind Part|Other reasons for not completing study|0|||
148771686|NCT01489254|536636712|FG000|Open-label Extension Part|Adverse Event|0|||
148771687|NCT01489254|536636713|FG001|Open-label Extension Part|Adverse Event|0|||
148771688|NCT01489254|536636714|FG002|Open-label Extension Part|Adverse Event|0|||
148771689|NCT01489254|536636715|FG003|Open-label Extension Part|Adverse Event|10|||
148771690|NCT01489254|536636712|FG000|Open-label Extension Part|Pregnancy|0|||
148771691|NCT01489254|536636713|FG001|Open-label Extension Part|Pregnancy|0|||
148771692|NCT01489254|536636714|FG002|Open-label Extension Part|Pregnancy|0|||
148771693|NCT01489254|536636715|FG003|Open-label Extension Part|Pregnancy|3|||
148771694|NCT01489254|536636712|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
148771695|NCT01489254|536636713|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
148771696|NCT01489254|536636714|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
148771697|NCT01489254|536636715|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
148771698|NCT01489254|536636712|FG000|Open-label Extension Part|Protocol Violation|0|||
148771699|NCT01489254|536636713|FG001|Open-label Extension Part|Protocol Violation|0|||
148771700|NCT01489254|536636714|FG002|Open-label Extension Part|Protocol Violation|0|||
148771701|NCT01489254|536636715|FG003|Open-label Extension Part|Protocol Violation|1|||
148771702|NCT01489254|536636712|FG000|Open-label Extension Part|Lost to Follow-up|0|||
148771703|NCT01489254|536636713|FG001|Open-label Extension Part|Lost to Follow-up|0|||
148771704|NCT01489254|536636714|FG002|Open-label Extension Part|Lost to Follow-up|0|||
148771705|NCT01489254|536636715|FG003|Open-label Extension Part|Lost to Follow-up|9|||
148771706|NCT01489254|536636712|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
148771707|NCT01489254|536636713|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
148771708|NCT01489254|536636714|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
148771709|NCT01489254|536636715|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
148771710|NCT01194531|536636718|FG000|Overall Study|Withdrawal by Subject|1|||
148771711|NCT01194531|536636719|FG001|Overall Study|Withdrawal by Subject|0|||
148771712|NCT01194531|536636718|FG000|Overall Study|Protocol Violation|4|||
148771713|NCT01194531|536636719|FG001|Overall Study|Protocol Violation|1|||
148771714|NCT01194531|536636718|FG000|Overall Study|Physician Decision|0|||
148771715|NCT01194531|536636719|FG001|Overall Study|Physician Decision|2|||
148771716|NCT03891862|536636720|FG000|Open-label Period|Adverse Event|2|||
148771717|NCT03891862|536636721|FG001|Open-label Period|Adverse Event|0|||
148771718|NCT03891862|536636722|FG002|Open-label Period|Adverse Event|0|||
148771719|NCT03891862|536636720|FG000|Open-label Period|Protocol Violation|5|||
148771720|NCT03891862|536636721|FG001|Open-label Period|Protocol Violation|0|||
148771721|NCT03891862|536636722|FG002|Open-label Period|Protocol Violation|0|||
148771722|NCT03891862|536636720|FG000|Open-label Period|Withdrawal by Subject|6|||
148771723|NCT03891862|536636721|FG001|Open-label Period|Withdrawal by Subject|0|||
148771724|NCT03891862|536636722|FG002|Open-label Period|Withdrawal by Subject|0|||
148771725|NCT03891862|536636720|FG000|Open-label Period|Death|1|||
148771726|NCT03891862|536636721|FG001|Open-label Period|Death|0|||
148771727|NCT03891862|536636722|FG002|Open-label Period|Death|0|||
148771728|NCT03891862|536636720|FG000|Open-label Period|Lost to Follow-up|2|||
148771729|NCT03891862|536636721|FG001|Open-label Period|Lost to Follow-up|0|||
148771730|NCT03891862|536636722|FG002|Open-label Period|Lost to Follow-up|0|||
148771731|NCT03891862|536636720|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
148771732|NCT03891862|536636721|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
148771733|NCT03891862|536636722|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
148771734|NCT03891862|536636720|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
148771735|NCT03891862|536636721|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
148771736|NCT03891862|536636722|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
148771737|NCT03891862|536636720|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
148771738|NCT03891862|536636721|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
148771739|NCT03891862|536636722|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
148771740|NCT03891862|536636720|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
148771741|NCT03891862|536636721|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
148771742|NCT03891862|536636722|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
148771743|NCT01053962|536636723|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
148771744|NCT01053962|536636724|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
148771745|NCT01053962|536636725|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
148771746|NCT01053962|536636726|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
148771747|NCT01053962|536636727|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
148771748|NCT01053962|536636723|FG000|Pretreatment Period|Venipuncture Failure|0|||
148771749|NCT01053962|536636724|FG001|Pretreatment Period|Venipuncture Failure|0|||
148771750|NCT01053962|536636725|FG002|Pretreatment Period|Venipuncture Failure|1|||
148771751|NCT01053962|536636726|FG003|Pretreatment Period|Venipuncture Failure|0|||
148771752|NCT01053962|536636727|FG004|Pretreatment Period|Venipuncture Failure|0|||
148771753|NCT01053962|536636723|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
148771754|NCT01053962|536636724|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
148771755|NCT01053962|536636725|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
148771756|NCT01053962|536636726|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
148771757|NCT01053962|536636727|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
148771758|NCT01053962|536636723|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
148771759|NCT01053962|536636724|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
148771760|NCT01053962|536636725|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
148771761|NCT01053962|536636726|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
148771762|NCT01053962|536636727|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
148771763|NCT01053962|536636723|FG000|Treatment Period|Lack of Efficacy|0|||
148771764|NCT01053962|536636724|FG001|Treatment Period|Lack of Efficacy|0|||
148771765|NCT01053962|536636725|FG002|Treatment Period|Lack of Efficacy|0|||
148771766|NCT01053962|536636726|FG003|Treatment Period|Lack of Efficacy|0|||
148771767|NCT01053962|536636727|FG004|Treatment Period|Lack of Efficacy|1|||
148771768|NCT01053962|536636723|FG000|Treatment Period|Adverse Event|0|||
148771769|NCT01053962|536636724|FG001|Treatment Period|Adverse Event|0|||
148771770|NCT01053962|536636725|FG002|Treatment Period|Adverse Event|0|||
148771771|NCT01053962|536636726|FG003|Treatment Period|Adverse Event|0|||
148771772|NCT01053962|536636727|FG004|Treatment Period|Adverse Event|1|||
148771773|NCT01053962|536636723|FG000|Treatment Period|Withdrawal by Subject|0|||
148771774|NCT01053962|536636724|FG001|Treatment Period|Withdrawal by Subject|0|||
148771775|NCT01053962|536636725|FG002|Treatment Period|Withdrawal by Subject|0|||
148771776|NCT01053962|536636726|FG003|Treatment Period|Withdrawal by Subject|0|||
148771777|NCT01053962|536636727|FG004|Treatment Period|Withdrawal by Subject|1|||
148771778|NCT01053962|536636723|FG000|Treatment Period|Noncompliance with protocol|1|||
148771779|NCT01053962|536636724|FG001|Treatment Period|Noncompliance with protocol|0|||
148771780|NCT01053962|536636725|FG002|Treatment Period|Noncompliance with protocol|0|||
148771781|NCT01053962|536636726|FG003|Treatment Period|Noncompliance with protocol|0|||
148771782|NCT01053962|536636727|FG004|Treatment Period|Noncompliance with protocol|0|||
148771783|NCT04603482|536636729|FG000|Overall Study|Lost to Follow-up|15|||
148771784|NCT04603482|536636730|FG001|Overall Study|Lost to Follow-up|15|||
148771785|NCT04603482|536636731|FG002|Overall Study|Lost to Follow-up|15|||
148771786|NCT00732758|536636732|FG000|Overall Study|Lost to Follow-up|8|||
148771787|NCT00732758|536636733|FG001|Overall Study|Lost to Follow-up|16|||
148771788|NCT02693171|536636734|FG000|Overall Study|Adverse Event|1|||
148771789|NCT02693171|536636734|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
148771790|NCT01167881|536636735|FG000|Overall Study|Adverse Event|47|||
148771791|NCT01167881|536636736|FG001|Overall Study|Adverse Event|51|||
148771792|NCT01167881|536636735|FG000|Overall Study|Lack of Efficacy|4|||
148771793|NCT01167881|536636736|FG001|Overall Study|Lack of Efficacy|7|||
148771794|NCT01167881|536636735|FG000|Overall Study|Non compliant with protocol|9|||
148771795|NCT01167881|536636736|FG001|Overall Study|Non compliant with protocol|18|||
148771796|NCT01167881|536636735|FG000|Overall Study|Lost to Follow-up|19|||
148771797|NCT01167881|536636736|FG001|Overall Study|Lost to Follow-up|20|||
148771798|NCT01167881|536636735|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
148771799|NCT01167881|536636736|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
148771800|NCT01167881|536636735|FG000|Overall Study|Not treated|4|||
148771801|NCT01167881|536636736|FG001|Overall Study|Not treated|0|||
148771802|NCT01167881|536636735|FG000|Overall Study|Other not defined above|31|||
148771803|NCT01167881|536636736|FG001|Overall Study|Other not defined above|55|||
148771804|NCT01992653|536636737|FG000|Overall Study|Death|0|||
148771805|NCT01992653|536636738|FG001|Overall Study|Death|0|||
148771806|NCT01992653|536636739|FG002|Overall Study|Death|1|||
148771807|NCT01992653|536636740|FG003|Overall Study|Death|0|||
148771808|NCT01992653|536636741|FG004|Overall Study|Death|1|||
148771809|NCT01992653|536636742|FG005|Overall Study|Death|0|||
148771810|NCT01992653|536636743|FG006|Overall Study|Death|4|||
148771811|NCT01992653|536636744|FG007|Overall Study|Death|2|||
148771812|NCT01992653|536636737|FG000|Overall Study|Lost to Follow-up|0|||
148771813|NCT01992653|536636738|FG001|Overall Study|Lost to Follow-up|0|||
148771814|NCT01992653|536636739|FG002|Overall Study|Lost to Follow-up|0|||
148771815|NCT01992653|536636740|FG003|Overall Study|Lost to Follow-up|0|||
148771816|NCT01992653|536636741|FG004|Overall Study|Lost to Follow-up|0|||
148771817|NCT01992653|536636742|FG005|Overall Study|Lost to Follow-up|0|||
148771818|NCT01992653|536636743|FG006|Overall Study|Lost to Follow-up|0|||
148771819|NCT01992653|536636744|FG007|Overall Study|Lost to Follow-up|1|||
148771820|NCT01992653|536636737|FG000|Overall Study|Study Completed|0|||
148771821|NCT01992653|536636738|FG001|Overall Study|Study Completed|0|||
148771822|NCT01992653|536636739|FG002|Overall Study|Study Completed|0|||
148771823|NCT01992653|536636740|FG003|Overall Study|Study Completed|0|||
148771824|NCT01992653|536636741|FG004|Overall Study|Study Completed|0|||
148771825|NCT01992653|536636742|FG005|Overall Study|Study Completed|0|||
148771826|NCT01992653|536636743|FG006|Overall Study|Study Completed|0|||
148771827|NCT01992653|536636744|FG007|Overall Study|Study Completed|1|||
148771828|NCT01992653|536636737|FG000|Overall Study|Disease Progression|0|||
148771829|NCT01992653|536636738|FG001|Overall Study|Disease Progression|0|||
148771830|NCT01992653|536636739|FG002|Overall Study|Disease Progression|0|||
148771831|NCT01992653|536636740|FG003|Overall Study|Disease Progression|0|||
148771832|NCT01992653|536636741|FG004|Overall Study|Disease Progression|0|||
148771833|NCT01992653|536636742|FG005|Overall Study|Disease Progression|0|||
148771834|NCT01992653|536636743|FG006|Overall Study|Disease Progression|4|||
148771835|NCT01992653|536636744|FG007|Overall Study|Disease Progression|0|||
148771836|NCT00977314|536636745|FG000|Overall Study|Withdrawal by Subject|1|||
148771837|NCT00977314|536636746|FG001|Overall Study|Withdrawal by Subject|0|||
148771838|NCT00977314|536636745|FG000|Overall Study|Physician Decision|1|||
148771839|NCT00977314|536636746|FG001|Overall Study|Physician Decision|0|||
148771840|NCT02107859|536636747|FG000|Overall Study|Withdrawal by Subject|14|||
148771841|NCT02107859|536636747|FG000|Overall Study|Adverse Event|3|||
148771842|NCT02107859|536636747|FG000|Overall Study|Study closure|41|||
148771843|NCT02107859|536636747|FG000|Overall Study|Other than specified|3|||
148771844|NCT00556933|536636757|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
148771845|NCT00556933|536636758|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
148771846|NCT00556933|536636759|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
148771847|NCT00556933|536636760|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
148771848|NCT00556933|536636757|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
148771849|NCT00556933|536636758|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
148771850|NCT00556933|536636759|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
148771851|NCT00556933|536636760|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
148771852|NCT00556933|536636757|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
148771853|NCT00556933|536636758|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
148771854|NCT00556933|536636759|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
148771855|NCT00556933|536636760|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
148771856|NCT00556933|536636757|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
148771857|NCT00556933|536636758|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
148771858|NCT00556933|536636759|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
148771859|NCT00556933|536636760|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
148771860|NCT00556933|536636757|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
148771861|NCT00556933|536636758|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
148771862|NCT00556933|536636759|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
148771863|NCT00556933|536636760|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
148771864|NCT00556933|536636757|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
148771865|NCT00556933|536636758|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
148771866|NCT00556933|536636759|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
148771867|NCT00556933|536636760|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
148771868|NCT00556933|536636757|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
148771869|NCT00556933|536636758|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
148771870|NCT00556933|536636759|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
148771871|NCT00556933|536636760|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
148771872|NCT00556933|536636757|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
148771873|NCT00556933|536636758|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
148771874|NCT00556933|536636759|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
148771875|NCT00556933|536636760|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
148771876|NCT00556933|536636757|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
148771877|NCT00556933|536636758|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
148771878|NCT00556933|536636759|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
148771879|NCT00556933|536636760|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
148771880|NCT00556933|536636757|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
148771881|NCT00556933|536636758|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
148771882|NCT00556933|536636759|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
148771883|NCT00556933|536636760|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
148771884|NCT00556933|536636757|FG000|CNI Withdrawal vs. Minimization|Death|0|||
148771885|NCT00556933|536636758|FG001|CNI Withdrawal vs. Minimization|Death|0|||
148771886|NCT00556933|536636759|FG002|CNI Withdrawal vs. Minimization|Death|0|||
148771887|NCT00556933|536636760|FG003|CNI Withdrawal vs. Minimization|Death|1|||
148771888|NCT03887442|536636761|FG000|Overall Study|Adverse Event|1|||
148771889|NCT03887442|536636762|FG001|Overall Study|Adverse Event|0|||
148771890|NCT00022698|536636765|FG000|Overall Study|Adverse Event|5|||
148771891|NCT00022698|536636766|FG001|Overall Study|Adverse Event|9|||
148771892|NCT00022698|536636765|FG000|Overall Study|Death|0|||
148771893|NCT00022698|536636766|FG001|Overall Study|Death|2|||
148771894|NCT00022698|536636765|FG000|Overall Study|Failure to return|0|||
148771895|NCT00022698|536636766|FG001|Overall Study|Failure to return|1|||
148771896|NCT00022698|536636765|FG000|Overall Study|Refused treatment|0|||
148771897|NCT00022698|536636766|FG001|Overall Study|Refused treatment|2|||
148771898|NCT00022698|536636765|FG000|Overall Study|Insufficient therapeutic response|2|||
148771899|NCT00022698|536636766|FG001|Overall Study|Insufficient therapeutic response|14|||
148771900|NCT00022698|536636765|FG000|Overall Study|Administrative /other|1|||
148771901|NCT00022698|536636766|FG001|Overall Study|Administrative /other|7|||
148771902|NCT01628198|536636767|FG000|Overall Study|Lost to Follow-up|7|||
148771903|NCT01628198|536636767|FG000|Overall Study|Withdrawal by Subject|10|||
148771904|NCT01628198|536636767|FG000|Overall Study|Screen failure|1|||
148771905|NCT01743560|536636769|FG000|Overall Study|Disease progression|26|||
148771906|NCT01743560|536636769|FG000|Overall Study|Adverse Event|8|||
148771907|NCT01743560|536636769|FG000|Overall Study|Death|3|||
148771908|NCT01743560|536636769|FG000|Overall Study|Withdrawal by Subject|2|||
148771909|NCT01743560|536636769|FG000|Overall Study|Protocol Violation|1|||
148771910|NCT01743560|536636769|FG000|Overall Study|>1 dose of study drug|3|||
148771911|NCT00877487|536636772|FG000|Open-label Treatment Phase|Adverse Event|1|||
148771912|NCT00877487|536636773|FG001|Open-label Treatment Phase|Adverse Event|0|||
148771913|NCT00877487|536636772|FG000|Open-label Treatment Phase|Protocol Violation|3|||
148771914|NCT00877487|536636773|FG001|Open-label Treatment Phase|Protocol Violation|0|||
148771915|NCT00877487|536636772|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
148771916|NCT00877487|536636773|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
148771917|NCT00877487|536636772|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
148771918|NCT00877487|536636773|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
148771919|NCT00877487|536636772|FG000|Open-label Treatment Phase|Out of country for business|1|||
148771920|NCT00877487|536636773|FG001|Open-label Treatment Phase|Out of country for business|0|||
148771921|NCT00877487|536636772|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
148771922|NCT00877487|536636773|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
148771923|NCT00877487|536636772|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
148771924|NCT00877487|536636773|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
148771925|NCT00877487|536636772|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
148771926|NCT00877487|536636773|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
148771927|NCT00877487|536636772|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
148771928|NCT00877487|536636773|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
148771929|NCT01516008|536636774|FG000|Overall Study|Adverse Event|0|||
148771930|NCT01516008|536636775|FG001|Overall Study|Adverse Event|2|||
148771931|NCT01516008|536636776|FG002|Overall Study|Adverse Event|7|||
148771932|NCT01516008|536636774|FG000|Overall Study|Lack of Efficacy|44|||
148771933|NCT01516008|536636775|FG001|Overall Study|Lack of Efficacy|14|||
148771934|NCT01516008|536636776|FG002|Overall Study|Lack of Efficacy|10|||
148771935|NCT01516008|536636774|FG000|Overall Study|Protocol Violation|1|||
148771936|NCT01516008|536636775|FG001|Overall Study|Protocol Violation|0|||
148771937|NCT01516008|536636776|FG002|Overall Study|Protocol Violation|0|||
148771938|NCT01516008|536636774|FG000|Overall Study|Reason not specified|0|||
148771939|NCT01516008|536636775|FG001|Overall Study|Reason not specified|0|||
148771940|NCT01516008|536636776|FG002|Overall Study|Reason not specified|1|||
148771941|NCT01217476|536636777|FG000|Overall Study|Adverse Event|6|||
148771942|NCT01217476|536636778|FG001|Overall Study|Adverse Event|1|||
148771943|NCT01217476|536636777|FG000|Overall Study|Physician Decision|0|||
148771944|NCT01217476|536636778|FG001|Overall Study|Physician Decision|1|||
148771945|NCT01217476|536636777|FG000|Overall Study|Withdrawal by Subject|3|||
148771946|NCT01217476|536636778|FG001|Overall Study|Withdrawal by Subject|3|||
148771947|NCT01217476|536636777|FG000|Overall Study|Surgery on the Target Limb|0|||
148771948|NCT01217476|536636778|FG001|Overall Study|Surgery on the Target Limb|2|||
148771949|NCT01217476|536636777|FG000|Overall Study|Protocol Deviation|1|||
148771950|NCT01217476|536636778|FG001|Overall Study|Protocol Deviation|0|||
148771951|NCT01217476|536636777|FG000|Overall Study|Other|2|||
148771952|NCT01217476|536636778|FG001|Overall Study|Other|0|||
148771953|NCT00986921|536636783|FG000|Overall Study|Physician Decision|1|||
148771954|NCT00986921|536636784|FG001|Overall Study|Physician Decision|0|||
148771955|NCT00813813|536636785|FG000|Overall Study|Withdrawal by Subject|1|||
148771956|NCT00813813|536636786|FG001|Overall Study|Withdrawal by Subject|1|||
148771957|NCT00813813|536636785|FG000|Overall Study|Lost to Follow-up|2|||
148771958|NCT00813813|536636786|FG001|Overall Study|Lost to Follow-up|7|||
148771959|NCT00813813|536636785|FG000|Overall Study|Other|0|||
148771960|NCT00813813|536636786|FG001|Overall Study|Other|1|||
148771961|NCT04445714|536636787|FG000|Overall Study|Discontinuation of the study|14|||
148771962|NCT04445714|536636787|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
148771963|NCT04445714|536636787|FG000|Overall Study|Withdrawal of Informed Consent|8|||
148771964|NCT02805660|536636788|FG000|Overall Study|Death|5|||
148771965|NCT02805660|536636789|FG001|Overall Study|Death|2|||
148771966|NCT02805660|536636790|FG002|Overall Study|Death|9|||
148771967|NCT02805660|536636791|FG003|Overall Study|Death|5|||
148771968|NCT02805660|536636792|FG004|Overall Study|Death|0|||
148771969|NCT02805660|536636793|FG005|Overall Study|Death|14|||
148833461|NCT00787150|536870572|FG002|Overall Study|Dosing incorrect study durg|0|||
148833462|NCT01380080|536870574|FG000|Overall Study|Death|36|||
148833463|NCT01380080|536870575|FG001|Overall Study|Death|44|||
148833464|NCT01380080|536870574|FG000|Overall Study|Site is closing|28|||
148833465|NCT01380080|536870575|FG001|Overall Study|Site is closing|31|||
149028240|NCT03285711|537580137|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
148833466|NCT01380080|536870574|FG000|Overall Study|Not able to get to clinic|7|||
148833467|NCT01380080|536870575|FG001|Overall Study|Not able to get to clinic|1|||
148833468|NCT01380080|536870574|FG000|Overall Study|Not willing to adhere to requirements|6|||
148833469|NCT01380080|536870575|FG001|Overall Study|Not willing to adhere to requirements|2|||
148833470|NCT01380080|536870574|FG000|Overall Study|Withdrawal by Subject|5|||
148833471|NCT01380080|536870575|FG001|Overall Study|Withdrawal by Subject|2|||
148833472|NCT01380080|536870574|FG000|Overall Study|Lost to Follow-up|3|||
148833473|NCT01380080|536870575|FG001|Overall Study|Lost to Follow-up|3|||
148833474|NCT02303821|536870576|FG000|Overall Study|Withdrawal by Subject|0|||
148833475|NCT02303821|536870577|FG001|Overall Study|Withdrawal by Subject|0|||
148833476|NCT02303821|536870578|FG002|Overall Study|Withdrawal by Subject|0|||
148833477|NCT02303821|536870579|FG003|Overall Study|Withdrawal by Subject|0|||
148833478|NCT02303821|536870580|FG004|Overall Study|Withdrawal by Subject|0|||
149028241|NCT03285711|537580138|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
149028242|NCT03285711|537580135|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
149028243|NCT03285711|537580136|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
149028244|NCT03285711|537580137|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
149028245|NCT03285711|537580138|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
149028246|NCT02431533|537580139|FG000|Overall Study|Withdrawal by Subject|1|||
148771970|NCT02805660|536636794|FG006|Overall Study|Death|12|||
148771971|NCT02805660|536636788|FG000|Overall Study|Lost to Follow-up|0|||
148771972|NCT02805660|536636789|FG001|Overall Study|Lost to Follow-up|1|||
148771973|NCT02805660|536636790|FG002|Overall Study|Lost to Follow-up|1|||
148771974|NCT02805660|536636791|FG003|Overall Study|Lost to Follow-up|2|||
148771975|NCT02805660|536636792|FG004|Overall Study|Lost to Follow-up|0|||
148771976|NCT02805660|536636793|FG005|Overall Study|Lost to Follow-up|0|||
148771977|NCT02805660|536636794|FG006|Overall Study|Lost to Follow-up|0|||
148771978|NCT02805660|536636788|FG000|Overall Study|Withdrawal by Subject|0|||
148771979|NCT02805660|536636789|FG001|Overall Study|Withdrawal by Subject|0|||
148771980|NCT02805660|536636790|FG002|Overall Study|Withdrawal by Subject|0|||
148771981|NCT02805660|536636791|FG003|Overall Study|Withdrawal by Subject|3|||
148771982|NCT02805660|536636792|FG004|Overall Study|Withdrawal by Subject|1|||
148771983|NCT02805660|536636793|FG005|Overall Study|Withdrawal by Subject|0|||
148771984|NCT02805660|536636794|FG006|Overall Study|Withdrawal by Subject|2|||
148771985|NCT02805660|536636788|FG000|Overall Study|Study terminated by Sponsor|0|||
148771986|NCT02805660|536636789|FG001|Overall Study|Study terminated by Sponsor|0|||
148771987|NCT02805660|536636790|FG002|Overall Study|Study terminated by Sponsor|1|||
148771988|NCT02805660|536636791|FG003|Overall Study|Study terminated by Sponsor|4|||
148771989|NCT02805660|536636792|FG004|Overall Study|Study terminated by Sponsor|2|||
148771990|NCT02805660|536636793|FG005|Overall Study|Study terminated by Sponsor|3|||
148771991|NCT02805660|536636794|FG006|Overall Study|Study terminated by Sponsor|1|||
148771992|NCT02805660|536636788|FG000|Overall Study|Miscellaneous|0|||
148771993|NCT02805660|536636789|FG001|Overall Study|Miscellaneous|1|||
148771994|NCT02805660|536636790|FG002|Overall Study|Miscellaneous|0|||
148771995|NCT02805660|536636791|FG003|Overall Study|Miscellaneous|4|||
148771996|NCT02805660|536636792|FG004|Overall Study|Miscellaneous|0|||
148771997|NCT02805660|536636793|FG005|Overall Study|Miscellaneous|6|||
148771998|NCT02805660|536636794|FG006|Overall Study|Miscellaneous|4|||
148771999|NCT01684943|536636799|FG000|Overall Study|Inadequate Venous Access|3|||
148772000|NCT01684943|536636800|FG001|Overall Study|Inadequate Venous Access|0|||
148772001|NCT01684943|536636801|FG002|Overall Study|Inadequate Venous Access|0|||
148772002|NCT01684943|536636799|FG000|Overall Study|Principal Investigator Determination|1|||
148772003|NCT01684943|536636800|FG001|Overall Study|Principal Investigator Determination|0|||
149028247|NCT02431533|537580140|FG001|Overall Study|Withdrawal by Subject|3|||
148772004|NCT01684943|536636801|FG002|Overall Study|Principal Investigator Determination|0|||
148772005|NCT01684943|536636799|FG000|Overall Study|Excluded from Analysis|1|||
148772006|NCT01684943|536636800|FG001|Overall Study|Excluded from Analysis|1|||
148772007|NCT01684943|536636801|FG002|Overall Study|Excluded from Analysis|1|||
148833479|NCT02303821|536870581|FG005|Overall Study|Withdrawal by Subject|0|||
148772008|NCT01684943|536636799|FG000|Overall Study|Lost to Follow-up|3|||
148772009|NCT01684943|536636800|FG001|Overall Study|Lost to Follow-up|0|||
148772010|NCT01684943|536636801|FG002|Overall Study|Lost to Follow-up|0|||
148772011|NCT01684943|536636799|FG000|Overall Study|Planning Pregnancy|1|||
148772012|NCT01684943|536636800|FG001|Overall Study|Planning Pregnancy|0|||
148772013|NCT01684943|536636801|FG002|Overall Study|Planning Pregnancy|0|||
148772014|NCT01672710|536636803|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
148772015|NCT01672710|536636804|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
148833480|NCT02303821|536870582|FG006|Overall Study|Withdrawal by Subject|0|||
148833481|NCT02303821|536870583|FG007|Overall Study|Withdrawal by Subject|2|||
148833482|NCT02303821|536870576|FG000|Overall Study|Death|0|||
149028248|NCT02431533|537580139|FG000|Overall Study|Developed Exclusionary criteria|1|||
149028249|NCT02431533|537580140|FG001|Overall Study|Developed Exclusionary criteria|0|||
148772016|NCT01672710|536636803|FG000|3 Month Follow up|Lost to Follow-up|2|||
148772017|NCT01672710|536636804|FG001|3 Month Follow up|Lost to Follow-up|3|||
148772018|NCT01672710|536636803|FG000|3 Month Follow up|follow up due after termination date|4|||
148772019|NCT01672710|536636804|FG001|3 Month Follow up|follow up due after termination date|1|||
148772020|NCT02122887|536636805|FG000|Overall Study|Withdrawal by Subject|20|||
148772021|NCT02122887|536636806|FG001|Overall Study|Withdrawal by Subject|2|||
148772022|NCT03725761|536636807|FG000|Overall Study|still on study|1|||
148772023|NCT03781583|536638495|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
148772024|NCT03781583|536638496|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
148772025|NCT03781583|536638497|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
148772026|NCT03781583|536638498|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
148772027|NCT03781583|536638495|FG000|Overall Study|Technology did not work for that person in that environment|1|||
148772028|NCT03781583|536638496|FG001|Overall Study|Technology did not work for that person in that environment|0|||
148772029|NCT03781583|536638497|FG002|Overall Study|Technology did not work for that person in that environment|0|||
148772030|NCT03781583|536638498|FG003|Overall Study|Technology did not work for that person in that environment|0|||
148772031|NCT03781583|536638495|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
148772032|NCT03781583|536638496|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
148772033|NCT03781583|536638497|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
148772034|NCT03781583|536638498|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
148772035|NCT03781583|536638495|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
148772036|NCT03781583|536638496|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
148772037|NCT03781583|536638497|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
148772038|NCT03781583|536638498|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
148772039|NCT01938430|536638499|FG000|Overall Study|Randomized but Not Treated|0|||
148772040|NCT01938430|536638500|FG001|Overall Study|Randomized but Not Treated|0|||
148772041|NCT01938430|536638501|FG002|Overall Study|Randomized but Not Treated|0|||
148772042|NCT01938430|536638502|FG003|Overall Study|Randomized but Not Treated|0|||
148772043|NCT01938430|536638503|FG004|Overall Study|Randomized but Not Treated|0|||
148772044|NCT01938430|536638504|FG005|Overall Study|Randomized but Not Treated|0|||
148772045|NCT01938430|536638505|FG006|Overall Study|Randomized but Not Treated|0|||
148772046|NCT01938430|536638506|FG007|Overall Study|Randomized but Not Treated|0|||
148772047|NCT01938430|536638507|FG008|Overall Study|Randomized but Not Treated|0|||
148772048|NCT01938430|536638508|FG009|Overall Study|Randomized but Not Treated|0|||
148772049|NCT01938430|536638509|FG010|Overall Study|Randomized but Not Treated|1|||
148772050|NCT01938430|536638510|FG011|Overall Study|Randomized but Not Treated|0|||
148772051|NCT01938430|536638511|FG012|Overall Study|Randomized but Not Treated|0|||
148772052|NCT01938430|536638512|FG013|Overall Study|Randomized but Not Treated|1|||
148772053|NCT01938430|536638499|FG000|Overall Study|Adverse Event|0|||
148772054|NCT01938430|536638500|FG001|Overall Study|Adverse Event|0|||
148772055|NCT01938430|536638501|FG002|Overall Study|Adverse Event|0|||
148772056|NCT01938430|536638502|FG003|Overall Study|Adverse Event|0|||
148772057|NCT01938430|536638503|FG004|Overall Study|Adverse Event|0|||
148772058|NCT01938430|536638504|FG005|Overall Study|Adverse Event|0|||
148772059|NCT01938430|536638505|FG006|Overall Study|Adverse Event|1|||
148772060|NCT01938430|536638506|FG007|Overall Study|Adverse Event|0|||
148772061|NCT01938430|536638507|FG008|Overall Study|Adverse Event|0|||
148772062|NCT01938430|536638508|FG009|Overall Study|Adverse Event|0|||
148772063|NCT01938430|536638509|FG010|Overall Study|Adverse Event|0|||
148772064|NCT01938430|536638510|FG011|Overall Study|Adverse Event|0|||
148772065|NCT01938430|536638511|FG012|Overall Study|Adverse Event|0|||
148772066|NCT01938430|536638512|FG013|Overall Study|Adverse Event|0|||
148772067|NCT01938430|536638499|FG000|Overall Study|Death|1|||
148772068|NCT01938430|536638500|FG001|Overall Study|Death|2|||
148772069|NCT01938430|536638501|FG002|Overall Study|Death|2|||
148772070|NCT01938430|536638502|FG003|Overall Study|Death|1|||
148772071|NCT01938430|536638503|FG004|Overall Study|Death|0|||
148772072|NCT01938430|536638504|FG005|Overall Study|Death|0|||
148772073|NCT01938430|536638505|FG006|Overall Study|Death|1|||
148772074|NCT01938430|536638506|FG007|Overall Study|Death|1|||
148772075|NCT01938430|536638507|FG008|Overall Study|Death|2|||
148772076|NCT01938430|536638508|FG009|Overall Study|Death|3|||
148772077|NCT01938430|536638509|FG010|Overall Study|Death|0|||
148833483|NCT02303821|536870577|FG001|Overall Study|Death|2|||
148833484|NCT02303821|536870578|FG002|Overall Study|Death|0|||
148833485|NCT02303821|536870579|FG003|Overall Study|Death|0|||
148833486|NCT02303821|536870580|FG004|Overall Study|Death|0|||
148833487|NCT02303821|536870581|FG005|Overall Study|Death|3|||
149028250|NCT00235495|537580150|FG000|Overall Study|Death|52|||
148981097|NCT02627677|537411531|FG000|Overall Study|Withdrawal by Subject|2|||
148772078|NCT01938430|536638510|FG011|Overall Study|Death|0|||
148772079|NCT01938430|536638511|FG012|Overall Study|Death|0|||
148772080|NCT01938430|536638512|FG013|Overall Study|Death|0|||
148772081|NCT01938430|536638499|FG000|Overall Study|Investigator's Discretion|0|||
148772082|NCT01938430|536638500|FG001|Overall Study|Investigator's Discretion|0|||
148772083|NCT01938430|536638501|FG002|Overall Study|Investigator's Discretion|1|||
148772084|NCT01938430|536638502|FG003|Overall Study|Investigator's Discretion|0|||
148772085|NCT01938430|536638503|FG004|Overall Study|Investigator's Discretion|0|||
148772086|NCT01938430|536638504|FG005|Overall Study|Investigator's Discretion|0|||
148772087|NCT01938430|536638505|FG006|Overall Study|Investigator's Discretion|0|||
148772088|NCT01938430|536638506|FG007|Overall Study|Investigator's Discretion|0|||
148772089|NCT01938430|536638507|FG008|Overall Study|Investigator's Discretion|0|||
148772090|NCT01938430|536638508|FG009|Overall Study|Investigator's Discretion|0|||
148772091|NCT01938430|536638509|FG010|Overall Study|Investigator's Discretion|0|||
148772092|NCT01938430|536638510|FG011|Overall Study|Investigator's Discretion|0|||
148772093|NCT01938430|536638511|FG012|Overall Study|Investigator's Discretion|0|||
148772094|NCT01938430|536638512|FG013|Overall Study|Investigator's Discretion|0|||
148772095|NCT01938430|536638499|FG000|Overall Study|Lack of Efficacy|3|||
148772096|NCT01938430|536638500|FG001|Overall Study|Lack of Efficacy|1|||
148772097|NCT01938430|536638501|FG002|Overall Study|Lack of Efficacy|1|||
148772098|NCT01938430|536638502|FG003|Overall Study|Lack of Efficacy|1|||
148772099|NCT01938430|536638503|FG004|Overall Study|Lack of Efficacy|0|||
148772100|NCT01938430|536638504|FG005|Overall Study|Lack of Efficacy|0|||
148772101|NCT01938430|536638505|FG006|Overall Study|Lack of Efficacy|0|||
148772102|NCT01938430|536638506|FG007|Overall Study|Lack of Efficacy|0|||
148772103|NCT01938430|536638507|FG008|Overall Study|Lack of Efficacy|1|||
148772104|NCT01938430|536638508|FG009|Overall Study|Lack of Efficacy|0|||
148772105|NCT01938430|536638509|FG010|Overall Study|Lack of Efficacy|2|||
148772106|NCT01938430|536638510|FG011|Overall Study|Lack of Efficacy|1|||
148772107|NCT01938430|536638511|FG012|Overall Study|Lack of Efficacy|0|||
148772108|NCT01938430|536638512|FG013|Overall Study|Lack of Efficacy|0|||
148772109|NCT01938430|536638499|FG000|Overall Study|Lost to Follow-up|0|||
148772110|NCT01938430|536638500|FG001|Overall Study|Lost to Follow-up|0|||
148772111|NCT01938430|536638501|FG002|Overall Study|Lost to Follow-up|1|||
148772112|NCT01938430|536638502|FG003|Overall Study|Lost to Follow-up|0|||
148772113|NCT01938430|536638503|FG004|Overall Study|Lost to Follow-up|0|||
148772114|NCT01938430|536638504|FG005|Overall Study|Lost to Follow-up|1|||
148772115|NCT01938430|536638505|FG006|Overall Study|Lost to Follow-up|0|||
148772116|NCT01938430|536638506|FG007|Overall Study|Lost to Follow-up|0|||
148772117|NCT01938430|536638507|FG008|Overall Study|Lost to Follow-up|0|||
148772118|NCT01938430|536638508|FG009|Overall Study|Lost to Follow-up|0|||
148772119|NCT01938430|536638509|FG010|Overall Study|Lost to Follow-up|0|||
148772120|NCT01938430|536638510|FG011|Overall Study|Lost to Follow-up|0|||
148772121|NCT01938430|536638511|FG012|Overall Study|Lost to Follow-up|0|||
148772122|NCT01938430|536638512|FG013|Overall Study|Lost to Follow-up|0|||
148772123|NCT01938430|536638499|FG000|Overall Study|Withdrew Consent|0|||
148772124|NCT01938430|536638500|FG001|Overall Study|Withdrew Consent|0|||
148772125|NCT01938430|536638501|FG002|Overall Study|Withdrew Consent|0|||
148772126|NCT01938430|536638502|FG003|Overall Study|Withdrew Consent|0|||
148772127|NCT01938430|536638503|FG004|Overall Study|Withdrew Consent|0|||
148772128|NCT01938430|536638504|FG005|Overall Study|Withdrew Consent|0|||
148772129|NCT01938430|536638505|FG006|Overall Study|Withdrew Consent|0|||
148772130|NCT01938430|536638506|FG007|Overall Study|Withdrew Consent|0|||
148772131|NCT01938430|536638507|FG008|Overall Study|Withdrew Consent|1|||
148772132|NCT01938430|536638508|FG009|Overall Study|Withdrew Consent|0|||
148772133|NCT01938430|536638509|FG010|Overall Study|Withdrew Consent|0|||
148772134|NCT01938430|536638510|FG011|Overall Study|Withdrew Consent|0|||
148772135|NCT01938430|536638511|FG012|Overall Study|Withdrew Consent|0|||
148772136|NCT01938430|536638512|FG013|Overall Study|Withdrew Consent|0|||
148772137|NCT02822573|536638515|FG000|Overall Study|Lost to Follow-up|5|||
148772138|NCT02822573|536638516|FG001|Overall Study|Lost to Follow-up|3|||
148772139|NCT02822573|536638515|FG000|Overall Study|Physician Decision|1|||
148772140|NCT02822573|536638516|FG001|Overall Study|Physician Decision|1|||
148772141|NCT02822573|536638515|FG000|Overall Study|Withdrawal by Subject|9|||
148772142|NCT02822573|536638516|FG001|Overall Study|Withdrawal by Subject|5|||
148772143|NCT02822573|536638515|FG000|Overall Study|Protocol Violation|6|||
148981098|NCT02627677|537411532|FG001|Overall Study|Withdrawal by Subject|1|||
148981099|NCT02627677|537411533|FG002|Overall Study|Withdrawal by Subject|1|||
148981100|NCT02627677|537411531|FG000|Overall Study|Reason not Specified|0|||
148981101|NCT02627677|537411532|FG001|Overall Study|Reason not Specified|0|||
148772144|NCT02822573|536638516|FG001|Overall Study|Protocol Violation|4|||
148772145|NCT02822573|536638515|FG000|Overall Study|Too sick or ill|2|||
148772146|NCT02822573|536638516|FG001|Overall Study|Too sick or ill|1|||
148772147|NCT02822573|536638515|FG000|Overall Study|Disease Progression|1|||
148772148|NCT02822573|536638516|FG001|Overall Study|Disease Progression|1|||
148772149|NCT02822573|536638515|FG000|Overall Study|No reason given|6|||
148772150|NCT02822573|536638516|FG001|Overall Study|No reason given|4|||
148772151|NCT04143594|536638517|FG000|Overall Study|Withdrew consent|3|||
148772152|NCT04143594|536638518|FG001|Overall Study|Withdrew consent|10|||
148772153|NCT04143594|536638519|FG002|Overall Study|Withdrew consent|3|||
148772154|NCT04143594|536638520|FG003|Overall Study|Withdrew consent|1|||
148772155|NCT04143594|536638517|FG000|Overall Study|Lost to Follow-up|3|||
148772156|NCT04143594|536638518|FG001|Overall Study|Lost to Follow-up|5|||
148772157|NCT04143594|536638519|FG002|Overall Study|Lost to Follow-up|11|||
148772158|NCT04143594|536638520|FG003|Overall Study|Lost to Follow-up|0|||
148772159|NCT04143594|536638517|FG000|Overall Study|Investigator's discretion|2|||
148772160|NCT04143594|536638518|FG001|Overall Study|Investigator's discretion|2|||
148772161|NCT04143594|536638519|FG002|Overall Study|Investigator's discretion|0|||
148772162|NCT04143594|536638520|FG003|Overall Study|Investigator's discretion|0|||
148772163|NCT04143594|536638517|FG000|Overall Study|Randomized but never treated|0|||
148772164|NCT04143594|536638518|FG001|Overall Study|Randomized but never treated|0|||
148772165|NCT04143594|536638519|FG002|Overall Study|Randomized but never treated|0|||
148772166|NCT04143594|536638520|FG003|Overall Study|Randomized but never treated|1|||
148772167|NCT04143594|536638517|FG000|Overall Study|Death|1|||
148772168|NCT04143594|536638518|FG001|Overall Study|Death|0|||
148772169|NCT04143594|536638519|FG002|Overall Study|Death|1|||
148772170|NCT04143594|536638520|FG003|Overall Study|Death|0|||
148772171|NCT04143594|536638517|FG000|Overall Study|Adverse Event|1|||
148772172|NCT04143594|536638518|FG001|Overall Study|Adverse Event|0|||
148772173|NCT04143594|536638519|FG002|Overall Study|Adverse Event|0|||
148772174|NCT04143594|536638520|FG003|Overall Study|Adverse Event|0|||
148772175|NCT04143594|536638517|FG000|Overall Study|Pregnancy|0|||
148772176|NCT04143594|536638518|FG001|Overall Study|Pregnancy|0|||
148772177|NCT04143594|536638519|FG002|Overall Study|Pregnancy|1|||
148772178|NCT04143594|536638520|FG003|Overall Study|Pregnancy|0|||
148772179|NCT04143594|536638517|FG000|Overall Study|Lack of Efficacy|1|||
148772180|NCT04143594|536638518|FG001|Overall Study|Lack of Efficacy|1|||
148772181|NCT04143594|536638519|FG002|Overall Study|Lack of Efficacy|0|||
148772182|NCT04143594|536638520|FG003|Overall Study|Lack of Efficacy|0|||
148772183|NCT00308087|536638521|FG000|Overall Study|Progressive Disease|19|||
148772184|NCT00308087|536638522|FG001|Overall Study|Progressive Disease|21|||
148772185|NCT00308087|536638521|FG000|Overall Study|Study Closure|11|||
148772186|NCT00308087|536638522|FG001|Overall Study|Study Closure|12|||
148772187|NCT00308087|536638521|FG000|Overall Study|Withdrawal by Subject|2|||
148772188|NCT00308087|536638522|FG001|Overall Study|Withdrawal by Subject|1|||
148772189|NCT00308087|536638521|FG000|Overall Study|Other|4|||
148772190|NCT00308087|536638522|FG001|Overall Study|Other|3|||
148772191|NCT01044290|536638523|FG000|Follow-up 1|Death|3|||
148772192|NCT01044290|536638524|FG001|Follow-up 1|Death|3|||
148772193|NCT01044290|536638525|FG002|Follow-up 1|Death|1|||
148772194|NCT01044290|536638523|FG000|Follow-up 1|Withdrawal by Subject|2|||
148772195|NCT01044290|536638524|FG001|Follow-up 1|Withdrawal by Subject|2|||
148772196|NCT01044290|536638525|FG002|Follow-up 1|Withdrawal by Subject|0|||
148772197|NCT01044290|536638523|FG000|Follow-Up 2|Death|0|||
148772198|NCT01044290|536638524|FG001|Follow-Up 2|Death|1|||
148772199|NCT01044290|536638525|FG002|Follow-Up 2|Death|1|||
148772200|NCT01044290|536638523|FG000|Follow-Up 2|Withdrawal by Subject|0|||
148772201|NCT01044290|536638524|FG001|Follow-Up 2|Withdrawal by Subject|1|||
148772202|NCT01044290|536638525|FG002|Follow-Up 2|Withdrawal by Subject|1|||
148772203|NCT04323306|536638526|FG000|Overall Study|Physician Decision|1|||
148772204|NCT04323306|536638527|FG001|Overall Study|Physician Decision|0|||
148772205|NCT04323306|536638528|FG002|Overall Study|Physician Decision|0|||
148772206|NCT04323306|536638529|FG003|Overall Study|Physician Decision|0|||
148772207|NCT04323306|536638530|FG004|Overall Study|Physician Decision|0|||
148772208|NCT04323306|536638531|FG005|Overall Study|Physician Decision|0|||
148772209|NCT04323306|536638532|FG006|Overall Study|Physician Decision|0|||
148772210|NCT04323306|536638533|FG007|Overall Study|Physician Decision|0|||
148772211|NCT04323306|536638534|FG008|Overall Study|Physician Decision|0|||
148772212|NCT04323306|536638526|FG000|Overall Study|Withdrawal by Subject|0|||
148772213|NCT04323306|536638527|FG001|Overall Study|Withdrawal by Subject|0|||
148981102|NCT02627677|537411533|FG002|Overall Study|Reason not Specified|1|||
148981103|NCT02627677|537411531|FG000|Overall Study|Randomized but not Treated|1|||
148981104|NCT02627677|537411532|FG001|Overall Study|Randomized but not Treated|0|||
148981105|NCT02627677|537411533|FG002|Overall Study|Randomized but not Treated|0|||
148772214|NCT04323306|536638528|FG002|Overall Study|Withdrawal by Subject|0|||
148772215|NCT04323306|536638529|FG003|Overall Study|Withdrawal by Subject|0|||
148772216|NCT04323306|536638530|FG004|Overall Study|Withdrawal by Subject|0|||
148772217|NCT04323306|536638531|FG005|Overall Study|Withdrawal by Subject|1|||
148772218|NCT04323306|536638532|FG006|Overall Study|Withdrawal by Subject|3|||
148772219|NCT04323306|536638533|FG007|Overall Study|Withdrawal by Subject|0|||
148772220|NCT04323306|536638534|FG008|Overall Study|Withdrawal by Subject|1|||
148772221|NCT01646021|536638537|FG000|Overall Study|Death|77|||
148772222|NCT01646021|536638538|FG001|Overall Study|Death|83|||
148772223|NCT01646021|536638537|FG000|Overall Study|Study Terminated by Sponsor|50|||
148772224|NCT01646021|536638538|FG001|Overall Study|Study Terminated by Sponsor|41|||
148981106|NCT00317772|537411534|FG000|Overall Study|Adverse Event|0|||
148772225|NCT01646021|536638537|FG000|Overall Study|Lost to Follow-up|2|||
148772226|NCT01646021|536638538|FG001|Overall Study|Lost to Follow-up|2|||
148772227|NCT01646021|536638537|FG000|Overall Study|Withdrawal by Subject|10|||
148772228|NCT01646021|536638538|FG001|Overall Study|Withdrawal by Subject|15|||
148772229|NCT01967706|536638541|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
148772230|NCT01967706|536638542|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
148772231|NCT01967706|536638543|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
148772232|NCT01967706|536638544|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
148772233|NCT00725608|536638547|FG000|Overall Study|Lost to Follow-up|60|||
148772234|NCT00725608|536638547|FG000|Overall Study|Adverse Event|14|||
148772235|NCT00725608|536638547|FG000|Overall Study|Individual reasons|86|||
148772236|NCT00725608|536638547|FG000|Overall Study|Other|7|||
148772237|NCT03047720|536638551|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
148772238|NCT03047720|536638552|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
148772239|NCT00614120|536638553|FG000|Overall Study|Adverse Event|9|||
148772240|NCT00614120|536638554|FG001|Overall Study|Adverse Event|22|||
148772241|NCT00614120|536638555|FG002|Overall Study|Adverse Event|30|||
148772242|NCT00614120|536638556|FG003|Overall Study|Adverse Event|3|||
148772243|NCT00614120|536638553|FG000|Overall Study|Lack of Efficacy|3|||
148772244|NCT00614120|536638554|FG001|Overall Study|Lack of Efficacy|3|||
148772245|NCT00614120|536638555|FG002|Overall Study|Lack of Efficacy|2|||
148772246|NCT00614120|536638556|FG003|Overall Study|Lack of Efficacy|2|||
148772247|NCT00614120|536638553|FG000|Overall Study|Protocol Violation|2|||
148772248|NCT00614120|536638554|FG001|Overall Study|Protocol Violation|5|||
148772249|NCT00614120|536638555|FG002|Overall Study|Protocol Violation|3|||
148772250|NCT00614120|536638556|FG003|Overall Study|Protocol Violation|1|||
148772251|NCT00614120|536638553|FG000|Overall Study|Withdrawal criteria|1|||
148772252|NCT00614120|536638554|FG001|Overall Study|Withdrawal criteria|0|||
148772253|NCT00614120|536638555|FG002|Overall Study|Withdrawal criteria|0|||
148772254|NCT00614120|536638556|FG003|Overall Study|Withdrawal criteria|0|||
148772255|NCT00614120|536638553|FG000|Overall Study|Withdrawal by Subject|9|||
148833488|NCT02303821|536870582|FG006|Overall Study|Death|41|||
148833489|NCT02303821|536870583|FG007|Overall Study|Death|29|||
148772256|NCT00614120|536638554|FG001|Overall Study|Withdrawal by Subject|10|||
148833490|NCT02303821|536870576|FG000|Overall Study|Lost to Follow-up|0|||
148833491|NCT02303821|536870577|FG001|Overall Study|Lost to Follow-up|0|||
148833492|NCT02303821|536870578|FG002|Overall Study|Lost to Follow-up|0|||
148833493|NCT02303821|536870579|FG003|Overall Study|Lost to Follow-up|0|||
148833494|NCT02303821|536870580|FG004|Overall Study|Lost to Follow-up|0|||
148833495|NCT02303821|536870581|FG005|Overall Study|Lost to Follow-up|0|||
148833496|NCT02303821|536870582|FG006|Overall Study|Lost to Follow-up|1|||
148833497|NCT02303821|536870583|FG007|Overall Study|Lost to Follow-up|0|||
148833498|NCT02303821|536870576|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833499|NCT02303821|536870577|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833500|NCT02303821|536870578|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833501|NCT02303821|536870579|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833502|NCT02303821|536870580|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833503|NCT02303821|536870581|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833504|NCT02303821|536870582|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
148833505|NCT02303821|536870583|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
148833506|NCT02303821|536870576|FG000|Overall Study|Decision by sponsor|0|||
148833507|NCT02303821|536870577|FG001|Overall Study|Decision by sponsor|0|||
148833508|NCT02303821|536870578|FG002|Overall Study|Decision by sponsor|0|||
148981107|NCT00317772|537411535|FG001|Overall Study|Adverse Event|0|||
148981108|NCT00317772|537411536|FG002|Overall Study|Adverse Event|0|||
148981109|NCT00317772|537411537|FG003|Overall Study|Adverse Event|2|||
148772257|NCT00614120|536638555|FG002|Overall Study|Withdrawal by Subject|16|||
148772258|NCT00614120|536638556|FG003|Overall Study|Withdrawal by Subject|3|||
148772259|NCT00614120|536638553|FG000|Overall Study|Did not meet trial criteria|0|||
148772260|NCT00614120|536638554|FG001|Overall Study|Did not meet trial criteria|1|||
148772261|NCT00614120|536638555|FG002|Overall Study|Did not meet trial criteria|1|||
148772262|NCT00614120|536638556|FG003|Overall Study|Did not meet trial criteria|1|||
148981110|NCT00317772|537411534|FG000|Overall Study|Disease Progression|2|||
148981111|NCT00317772|537411535|FG001|Overall Study|Disease Progression|2|||
148981112|NCT00317772|537411536|FG002|Overall Study|Disease Progression|1|||
148981113|NCT00317772|537411537|FG003|Overall Study|Disease Progression|7|||
148981114|NCT02886572|537411538|FG000|Overall Study|Death|8|||
148772263|NCT00614120|536638553|FG000|Overall Study|hCG positive (not pregnant)|0|||
148772264|NCT00614120|536638554|FG001|Overall Study|hCG positive (not pregnant)|0|||
148772265|NCT00614120|536638555|FG002|Overall Study|hCG positive (not pregnant)|1|||
148981115|NCT00009737|537411545|FG000|Overall Study|Adverse Event|112|||
148772266|NCT00614120|536638556|FG003|Overall Study|hCG positive (not pregnant)|0|||
148772267|NCT00614120|536638553|FG000|Overall Study|Hypoglycaemia|0|||
148833509|NCT02303821|536870579|FG003|Overall Study|Decision by sponsor|0|||
148833510|NCT02303821|536870580|FG004|Overall Study|Decision by sponsor|0|||
148833511|NCT02303821|536870581|FG005|Overall Study|Decision by sponsor|1|||
148981116|NCT00009737|537411546|FG001|Overall Study|Adverse Event|75|||
148772268|NCT00614120|536638554|FG001|Overall Study|Hypoglycaemia|0|||
148772269|NCT00614120|536638555|FG002|Overall Study|Hypoglycaemia|0|||
148772270|NCT00614120|536638556|FG003|Overall Study|Hypoglycaemia|1|||
148833512|NCT02303821|536870582|FG006|Overall Study|Decision by sponsor|0|||
148772271|NCT00614120|536638553|FG000|Overall Study|Lack of trial product|3|||
148772272|NCT00614120|536638554|FG001|Overall Study|Lack of trial product|3|||
148772273|NCT00614120|536638555|FG002|Overall Study|Lack of trial product|2|||
148772274|NCT00614120|536638556|FG003|Overall Study|Lack of trial product|0|||
148772275|NCT00614120|536638553|FG000|Overall Study|Late syphilis, latent|1|||
148772276|NCT00614120|536638554|FG001|Overall Study|Late syphilis, latent|0|||
148772277|NCT00614120|536638555|FG002|Overall Study|Late syphilis, latent|0|||
148772278|NCT00614120|536638556|FG003|Overall Study|Late syphilis, latent|0|||
148772279|NCT00614120|536638553|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
148772280|NCT00614120|536638554|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
148772281|NCT00614120|536638555|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
148772282|NCT00614120|536638556|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
148772283|NCT00614120|536638553|FG000|Overall Study|Lost to Follow-up|1|||
148772284|NCT00614120|536638554|FG001|Overall Study|Lost to Follow-up|2|||
148772285|NCT00614120|536638555|FG002|Overall Study|Lost to Follow-up|3|||
148772286|NCT00614120|536638556|FG003|Overall Study|Lost to Follow-up|4|||
148772287|NCT01154088|536638557|FG000|Overall Study|Lost to Follow-up|4|||
148772288|NCT01154088|536638558|FG001|Overall Study|Lost to Follow-up|6|||
148772289|NCT01154088|536638559|FG002|Overall Study|Lost to Follow-up|7|||
148772290|NCT05129137|536638562|FG000|Second Period|Adverse Event|1|||
148772291|NCT05129137|536638563|FG001|Second Period|Adverse Event|0|||
148772292|NCT05129137|536638564|FG002|Second Period|Adverse Event|0|||
148772293|NCT05129137|536638565|FG003|Second Period|Adverse Event|0|||
148772294|NCT05129137|536638562|FG000|Second Period|Protocol Violation|0|||
148772295|NCT05129137|536638563|FG001|Second Period|Protocol Violation|0|||
148772296|NCT05129137|536638564|FG002|Second Period|Protocol Violation|0|||
148772297|NCT05129137|536638565|FG003|Second Period|Protocol Violation|1|||
148772298|NCT05129137|536638562|FG000|Third Period|Protocol Violation|0|||
148772299|NCT05129137|536638563|FG001|Third Period|Protocol Violation|0|||
148772300|NCT05129137|536638564|FG002|Third Period|Protocol Violation|0|||
148772301|NCT05129137|536638565|FG003|Third Period|Protocol Violation|1|||
148772302|NCT05129137|536638562|FG000|Forth Period|Protocol Violation|0|||
148772303|NCT05129137|536638563|FG001|Forth Period|Protocol Violation|1|||
148772304|NCT05129137|536638564|FG002|Forth Period|Protocol Violation|0|||
148772305|NCT05129137|536638565|FG003|Forth Period|Protocol Violation|0|||
148772306|NCT05129137|536638562|FG000|Forth Period|Withdrawal by Subject|0|||
148772307|NCT05129137|536638563|FG001|Forth Period|Withdrawal by Subject|0|||
148772308|NCT05129137|536638564|FG002|Forth Period|Withdrawal by Subject|1|||
148772309|NCT05129137|536638565|FG003|Forth Period|Withdrawal by Subject|0|||
148772310|NCT01084668|536638566|FG000|Overall Study|Lack of Efficacy|5|||
148772311|NCT01084668|536638566|FG000|Overall Study|Withdrawal by Subject|2|||
148772312|NCT01084668|536638566|FG000|Overall Study|Pregnancy|1|||
148772313|NCT01084668|536638566|FG000|Overall Study|Non-compliance|1|||
148772314|NCT01869699|536638568|FG000|Overall Study|Withdrawal by Subject|1|||
148772315|NCT01869699|536638569|FG001|Overall Study|Withdrawal by Subject|0|||
148772316|NCT01475851|536638572|FG000|Overall Study|Protocol defined stopping criteria|1|||
148772317|NCT01475851|536638573|FG001|Overall Study|Protocol defined stopping criteria|0|||
148772318|NCT02447497|536638576|FG000|Overall Study|Did not meet treatment day baseline.|6|||
148772319|NCT02447497|536638577|FG001|Overall Study|Did not meet treatment day baseline.|5|||
148772320|NCT02447497|536638578|FG002|Overall Study|Did not meet treatment day baseline.|2|||
148772321|NCT02447497|536638579|FG003|Overall Study|Did not meet treatment day baseline.|2|||
148772322|NCT02447497|536638576|FG000|Overall Study|Dressing was compromised|0|||
148772323|NCT02447497|536638577|FG001|Overall Study|Dressing was compromised|1|||
148772324|NCT02447497|536638578|FG002|Overall Study|Dressing was compromised|0|||
148772325|NCT02447497|536638579|FG003|Overall Study|Dressing was compromised|0|||
148772326|NCT01552915|536638580|FG000|Overall Study|Adverse Event|3|||
148772327|NCT01552915|536638581|FG001|Overall Study|Adverse Event|14|||
148772328|NCT01552915|536638582|FG002|Overall Study|Adverse Event|3|||
148772329|NCT01552915|536638580|FG000|Overall Study|Lost to Follow-up|4|||
148772330|NCT01552915|536638581|FG001|Overall Study|Lost to Follow-up|6|||
148772331|NCT01552915|536638582|FG002|Overall Study|Lost to Follow-up|5|||
148772332|NCT01552915|536638580|FG000|Overall Study|Withdrawal by Subject|6|||
148772333|NCT01552915|536638581|FG001|Overall Study|Withdrawal by Subject|4|||
148772334|NCT01552915|536638582|FG002|Overall Study|Withdrawal by Subject|5|||
148772335|NCT01552915|536638580|FG000|Overall Study|Protocol Violation|0|||
148772336|NCT01552915|536638581|FG001|Overall Study|Protocol Violation|4|||
148772337|NCT01552915|536638582|FG002|Overall Study|Protocol Violation|4|||
148772338|NCT01552915|536638580|FG000|Overall Study|Lack of Efficacy|8|||
148772339|NCT01552915|536638581|FG001|Overall Study|Lack of Efficacy|1|||
148772340|NCT01552915|536638582|FG002|Overall Study|Lack of Efficacy|4|||
148772341|NCT01552915|536638580|FG000|Overall Study|Other|2|||
148772342|NCT01552915|536638581|FG001|Overall Study|Other|0|||
148772343|NCT01552915|536638582|FG002|Overall Study|Other|6|||
148772344|NCT04240457|536638586|FG000|Overall Study|Lost to Follow-up|5|||
148772345|NCT04240457|536638587|FG001|Overall Study|Lost to Follow-up|1|||
148772346|NCT02858180|536638588|FG000|Overall Study|Lost to Follow-up|0|||
148772347|NCT02858180|536638589|FG001|Overall Study|Lost to Follow-up|2|||
148772348|NCT00844480|536638590|FG000|Overall Study|Withdrawal by Subject|2|||
148772349|NCT00844480|536638591|FG001|Overall Study|Withdrawal by Subject|3|||
148772350|NCT01054196|536638593|FG000|Overall Study|Physician Decision|0|||
148772351|NCT01054196|536638594|FG001|Overall Study|Physician Decision|0|||
148772352|NCT01054196|536638595|FG002|Overall Study|Physician Decision|0|||
148772353|NCT01054196|536638596|FG003|Overall Study|Physician Decision|1|||
148772354|NCT01054196|536638597|FG004|Overall Study|Physician Decision|0|||
148772355|NCT01054196|536638598|FG005|Overall Study|Physician Decision|0|||
148772356|NCT01054196|536638599|FG006|Overall Study|Physician Decision|1|||
148772357|NCT00179673|536638601|FG000|Overall Study|Adverse Event|7|||
148772358|NCT00179673|536638601|FG000|Overall Study|Lack of Efficacy|15|||
148772359|NCT00179673|536638601|FG000|Overall Study|Withdrawal by Subject|3|||
148772360|NCT00179673|536638601|FG000|Overall Study|Death|4|||
148772361|NCT00179673|536638601|FG000|Overall Study|Other Observations and options|14|||
148772362|NCT00319592|536638603|FG000|Overall Study|Protocol Violation|1|||
148772363|NCT00319592|536638604|FG001|Overall Study|Protocol Violation|0|||
148772364|NCT00319592|536638603|FG000|Overall Study|Physician Decision|0|||
148772365|NCT00319592|536638604|FG001|Overall Study|Physician Decision|1|||
148772366|NCT01820572|536638611|FG000|Randomization|Not Treated|2|||
148772367|NCT01820572|536638612|FG001|Randomization|Not Treated|1|||
148772368|NCT01820572|536638611|FG000|Treatment Period|Adverse Event|12|||
148772369|NCT01820572|536638612|FG001|Treatment Period|Adverse Event|7|||
148772370|NCT01820572|536638611|FG000|Treatment Period|Death|3|||
148772371|NCT01820572|536638612|FG001|Treatment Period|Death|3|||
148772372|NCT01820572|536638611|FG000|Treatment Period|Lack of Efficacy|1|||
148772373|NCT01820572|536638612|FG001|Treatment Period|Lack of Efficacy|0|||
148772374|NCT01820572|536638611|FG000|Treatment Period|poor/non compliance|0|||
148772375|NCT01820572|536638612|FG001|Treatment Period|poor/non compliance|3|||
148772376|NCT01820572|536638611|FG000|Treatment Period|request to discontinue|6|||
148772377|NCT01820572|536638612|FG001|Treatment Period|request to discontinue|11|||
148772378|NCT01820572|536638611|FG000|Treatment Period|No longer meets study criteria|3|||
148772379|NCT01820572|536638612|FG001|Treatment Period|No longer meets study criteria|10|||
148772380|NCT01820572|536638611|FG000|Treatment Period|withdrew consent|1|||
148772381|NCT01820572|536638612|FG001|Treatment Period|withdrew consent|2|||
148772382|NCT04439214|536638618|FG000|Overall Study|Adverse Event|13|||
148772383|NCT04439214|536638618|FG000|Overall Study|Disease progression|16|||
148772384|NCT04439214|536638618|FG000|Overall Study|Death|1|||
148772385|NCT04439214|536638618|FG000|Overall Study|Withdrawal by Subject|2|||
148772386|NCT04439214|536638618|FG000|Overall Study|Declining health|1|||
148772387|NCT04439214|536638618|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
148772388|NCT04439214|536638618|FG000|Overall Study|Ineligible|5|||
148772389|NCT02235077|536638619|FG000|Overall Study|Death|5|||
148772390|NCT02235077|536638620|FG001|Overall Study|Death|7|||
148772391|NCT02235077|536638619|FG000|Overall Study|Lost to Follow-up|5|||
148772392|NCT02235077|536638620|FG001|Overall Study|Lost to Follow-up|6|||
148772393|NCT02235077|536638619|FG000|Overall Study|Withdrawal by Subject|8|||
148772394|NCT02235077|536638620|FG001|Overall Study|Withdrawal by Subject|5|||
148772395|NCT02235077|536638619|FG000|Overall Study|Physician Decision|0|||
148772396|NCT02235077|536638620|FG001|Overall Study|Physician Decision|1|||
148772397|NCT03852628|536638621|FG000|Overall Study|Lost to Follow-up|7|||
148772398|NCT03852628|536638622|FG001|Overall Study|Lost to Follow-up|6|||
148772399|NCT03852628|536638621|FG000|Overall Study|Lack of Efficacy|6|||
148772400|NCT03852628|536638622|FG001|Overall Study|Lack of Efficacy|6|||
148772401|NCT02964208|536638623|FG000|Overall Study|Death|103|||
148772402|NCT02964208|536638623|FG000|Overall Study|Withdrawal by Subject|6|||
148772403|NCT02964208|536638623|FG000|Overall Study|Lost to Follow-up|6|||
148772404|NCT02964208|536638623|FG000|Overall Study|Unsuccessful Procedure|5|||
148772405|NCT02964208|536638623|FG000|Overall Study|Device Explant|1|||
148772406|NCT02964208|536638623|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
148772407|NCT01758731|536638624|FG000|Overall Study|Physician Decision|1|||
148772408|NCT02572076|536638626|FG000|Overall Study|Protocol Violation|1|||
148772409|NCT02778074|536638627|FG000|Overall Study|Lost to Follow-up|7|||
148772410|NCT02778074|536638628|FG001|Overall Study|Lost to Follow-up|10|||
148772411|NCT02396420|536638631|FG000|Overall Study|Death|1|||
148772412|NCT01273623|536638634|FG000|Overall Study|did not meet IVUS criteria|29|||
148772413|NCT01493284|536638637|FG000|Overall Study|Death|29|||
148772414|NCT01493284|536638637|FG000|Overall Study|Withdrawal by Subject|32|||
148772415|NCT00325156|536638638|FG000|Overall Study|Protocol Violation|8|||
148772416|NCT00325156|536638638|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
148772417|NCT00325156|536638638|FG000|Overall Study|Migrated/moved from study area|12|||
149028251|NCT00235495|537580151|FG001|Overall Study|Death|42|||
148772418|NCT00325156|536638638|FG000|Overall Study|Adverse event, non-fatal|3|||
148772419|NCT00325156|536638638|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
148772420|NCT00325156|536638638|FG000|Overall Study|Other|1|||
148772421|NCT00325156|536638638|FG000|Overall Study|Withdrawal by Subject|31|||
148772422|NCT03489707|536638639|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
148772423|NCT03489707|536638640|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
148772424|NCT03489707|536638639|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
148772425|NCT03489707|536638640|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
148772426|NCT04064411|536638641|FG000|Overall Study|Adverse Event|29|||
148772427|NCT04064411|536638642|FG001|Overall Study|Adverse Event|19|||
148772428|NCT04064411|536638641|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
148772429|NCT04064411|536638642|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
148772430|NCT04064411|536638641|FG000|Overall Study|Protocol Deviation|0|||
148772431|NCT04064411|536638642|FG001|Overall Study|Protocol Deviation|2|||
148772432|NCT04064411|536638641|FG000|Overall Study|Withdrawal by Subject|25|||
148772433|NCT04064411|536638642|FG001|Overall Study|Withdrawal by Subject|29|||
148772434|NCT04064411|536638641|FG000|Overall Study|Lost to Follow-up|5|||
148772435|NCT04064411|536638642|FG001|Overall Study|Lost to Follow-up|2|||
148772436|NCT04064411|536638641|FG000|Overall Study|Other than Specified|4|||
148772437|NCT04064411|536638642|FG001|Overall Study|Other than Specified|1|||
148772438|NCT04064411|536638641|FG000|Overall Study|Death|1|||
148772439|NCT04064411|536638642|FG001|Overall Study|Death|0|||
148772440|NCT03395184|536638643|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
148772441|NCT03395184|536638644|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
148772442|NCT03395184|536638645|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
148833513|NCT02303821|536870583|FG007|Overall Study|Decision by sponsor|0|||
148833514|NCT02303821|536870576|FG000|Overall Study|Protocol-specified criteria|0|||
148833515|NCT02303821|536870577|FG001|Overall Study|Protocol-specified criteria|1|||
148833516|NCT02303821|536870578|FG002|Overall Study|Protocol-specified criteria|0|||
148833517|NCT02303821|536870579|FG003|Overall Study|Protocol-specified criteria|0|||
148833518|NCT02303821|536870580|FG004|Overall Study|Protocol-specified criteria|0|||
148833519|NCT02303821|536870581|FG005|Overall Study|Protocol-specified criteria|1|||
148833520|NCT02303821|536870582|FG006|Overall Study|Protocol-specified criteria|0|||
148833521|NCT02303821|536870583|FG007|Overall Study|Protocol-specified criteria|0|||
148833522|NCT00432965|536870584|FG000|Overall Study|Lost to Follow-up|22|||
148833523|NCT00432965|536870585|FG001|Overall Study|Lost to Follow-up|19|||
148833524|NCT00432965|536870584|FG000|Overall Study|Withdrawal by Subject|13|||
148833525|NCT00432965|536870585|FG001|Overall Study|Withdrawal by Subject|13|||
148833526|NCT00432965|536870584|FG000|Overall Study|Physician Decision|14|||
148833527|NCT00432965|536870585|FG001|Overall Study|Physician Decision|13|||
148833528|NCT00432965|536870584|FG000|Overall Study|Lack of Efficacy|8|||
148833529|NCT00432965|536870585|FG001|Overall Study|Lack of Efficacy|13|||
148833530|NCT00432965|536870584|FG000|Overall Study|Non-compliance|7|||
148772443|NCT03395184|536638646|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
148772444|NCT03395184|536638647|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
148772445|NCT03395184|536638648|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
148772446|NCT03395184|536638649|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
148772447|NCT03395184|536638643|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
148772448|NCT03395184|536638644|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
148772449|NCT03395184|536638645|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
148772450|NCT03395184|536638646|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
148772451|NCT03395184|536638647|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
148772452|NCT03395184|536638648|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
148772453|NCT03395184|536638649|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
148772454|NCT03395184|536638643|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
148833531|NCT00432965|536870585|FG001|Overall Study|Non-compliance|0|||
148833532|NCT00432965|536870584|FG000|Overall Study|Adverse Event|22|||
148833533|NCT00432965|536870585|FG001|Overall Study|Adverse Event|19|||
148833534|NCT00432965|536870584|FG000|Overall Study|Death|3|||
148833535|NCT00432965|536870585|FG001|Overall Study|Death|4|||
148833536|NCT00432965|536870584|FG000|Overall Study|Exclusionary Methods|1|||
148833537|NCT00432965|536870585|FG001|Overall Study|Exclusionary Methods|2|||
148833538|NCT00432965|536870584|FG000|Overall Study|Incomplete Data|4|||
148833539|NCT00432965|536870585|FG001|Overall Study|Incomplete Data|3|||
148833540|NCT03636022|536870589|FG000|Overall Study|Withdrawal by Subject|1|||
148833541|NCT03636022|536870590|FG001|Overall Study|Withdrawal by Subject|3|||
148772455|NCT03395184|536638644|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
148833542|NCT01587196|536870591|FG000|Overall Study|Lost to Follow-up|50|||
148833543|NCT01587196|536870591|FG000|Overall Study|Withdrawal by Subject|4|||
148833544|NCT00642759|536870592|FG000|Overall Study|Protocol Violation|1|||
148833545|NCT00643279|536870595|FG000|Overall Study|Death|13|||
148833546|NCT00643279|536870596|FG001|Overall Study|Death|11|||
148833547|NCT00643279|536870595|FG000|Overall Study|Withdrawal by Subject|3|||
148833548|NCT00643279|536870596|FG001|Overall Study|Withdrawal by Subject|0|||
148833549|NCT00643279|536870595|FG000|Overall Study|Lost to Follow-up|0|||
148833550|NCT00643279|536870596|FG001|Overall Study|Lost to Follow-up|1|||
148833551|NCT00643279|536870595|FG000|Overall Study|Physician Decision|0|||
148833552|NCT00643279|536870596|FG001|Overall Study|Physician Decision|1|||
148833553|NCT04846868|536870597|FG000|Overall Study|Adverse Event|12|||
148772456|NCT03395184|536638645|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
148772457|NCT03395184|536638646|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
148772458|NCT03395184|536638647|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
148772459|NCT03395184|536638648|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
148772460|NCT03395184|536638649|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
148772461|NCT03395184|536638643|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
148772462|NCT03395184|536638644|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
148772463|NCT03395184|536638645|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
148772464|NCT03395184|536638646|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
148772465|NCT03395184|536638647|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
148772466|NCT03395184|536638648|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
148772467|NCT03395184|536638649|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
148772468|NCT03395184|536638643|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
148772469|NCT03395184|536638644|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148772470|NCT03395184|536638645|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
148772471|NCT03395184|536638646|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148772472|NCT03395184|536638647|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148772473|NCT03395184|536638648|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148772474|NCT03395184|536638649|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
148772475|NCT03395184|536638643|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
148772476|NCT03395184|536638644|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
148772477|NCT03395184|536638645|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
148772478|NCT03395184|536638646|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
148772479|NCT03395184|536638647|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
148772480|NCT03395184|536638648|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
148772481|NCT03395184|536638649|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
148772482|NCT03395184|536638643|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
148772483|NCT03395184|536638644|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
148772484|NCT03395184|536638645|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
148772485|NCT03395184|536638646|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
148772486|NCT03395184|536638647|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
148772487|NCT03395184|536638648|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
148772488|NCT03395184|536638649|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
148772489|NCT03395184|536638643|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
148772490|NCT03395184|536638644|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
148772491|NCT03395184|536638645|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
148772492|NCT03395184|536638646|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
148772493|NCT03395184|536638647|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
148772494|NCT03395184|536638648|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
148772495|NCT03395184|536638649|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
148772496|NCT03395184|536638643|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
148772497|NCT03395184|536638644|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
148772498|NCT03395184|536638645|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
148772499|NCT03395184|536638646|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
148772500|NCT03395184|536638647|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
148772501|NCT03395184|536638648|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
148772502|NCT03395184|536638649|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
148772503|NCT03395184|536638643|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
148772504|NCT03395184|536638644|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
148772505|NCT03395184|536638645|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
148772506|NCT03395184|536638646|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
148772507|NCT03395184|536638647|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
148772508|NCT03395184|536638648|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
148772509|NCT03395184|536638649|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
148772510|NCT03395184|536638643|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
148772511|NCT03395184|536638644|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
148772512|NCT03395184|536638645|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
148772513|NCT03395184|536638646|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
148772514|NCT03395184|536638647|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
148772515|NCT03395184|536638648|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
148772516|NCT03395184|536638649|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
148772517|NCT03395184|536638643|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
148772518|NCT03395184|536638644|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
148772519|NCT03395184|536638645|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
148833554|NCT04846868|536870598|FG001|Overall Study|Adverse Event|11|||
148833555|NCT04846868|536870597|FG000|Overall Study|Protocol deviation|6|||
148772520|NCT03395184|536638646|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
148772521|NCT03395184|536638647|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
148772522|NCT03395184|536638648|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
148772523|NCT03395184|536638649|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
148772524|NCT03963232|536638653|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
148772525|NCT03963232|536638654|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
148772526|NCT03963232|536638653|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
148772527|NCT03963232|536638654|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
148772528|NCT03963232|536638653|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
148772529|NCT03963232|536638654|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
148772530|NCT03963232|536638653|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
148772531|NCT03963232|536638654|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
148772532|NCT03963232|536638653|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
148772533|NCT03963232|536638654|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
148772534|NCT03963232|536638653|FG000|Open-Label Treatment Phase|Adverse Event|1|||
148772535|NCT03963232|536638654|FG001|Open-Label Treatment Phase|Adverse Event|2|||
148772536|NCT03963232|536638653|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
148772537|NCT03963232|536638654|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
148772538|NCT03963232|536638653|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
148772539|NCT03963232|536638654|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
148772540|NCT03963232|536638653|FG000|Open-Label Treatment Phase|Pregnancy|1|||
148772541|NCT03963232|536638654|FG001|Open-Label Treatment Phase|Pregnancy|0|||
148772542|NCT03963232|536638653|FG000|Follow-up Phase|Withdrawal by Subject|7|||
148772543|NCT03963232|536638654|FG001|Follow-up Phase|Withdrawal by Subject|5|||
148772544|NCT03963232|536638653|FG000|Follow-up Phase|Protocol Violation|0|||
148772545|NCT03963232|536638654|FG001|Follow-up Phase|Protocol Violation|2|||
148772546|NCT03963232|536638653|FG000|Follow-up Phase|Adverse Event|0|||
148772547|NCT03963232|536638654|FG001|Follow-up Phase|Adverse Event|1|||
148772548|NCT03963232|536638653|FG000|Follow-up Phase|Lost to Follow-up|0|||
148772549|NCT03963232|536638654|FG001|Follow-up Phase|Lost to Follow-up|1|||
148772550|NCT00356135|536638655|FG000|Overall Study|Protocol Violation|1|||
148772551|NCT00356135|536638656|FG001|Overall Study|Protocol Violation|0|||
148772552|NCT00356135|536638657|FG002|Overall Study|Protocol Violation|0|||
148772553|NCT00356135|536638655|FG000|Overall Study|Adverse Event|1|||
148772554|NCT00356135|536638656|FG001|Overall Study|Adverse Event|0|||
148772555|NCT00356135|536638657|FG002|Overall Study|Adverse Event|0|||
148772556|NCT00356135|536638655|FG000|Overall Study|Lost to Follow-up|0|||
148772557|NCT00356135|536638656|FG001|Overall Study|Lost to Follow-up|0|||
148772558|NCT00356135|536638657|FG002|Overall Study|Lost to Follow-up|1|||
148772559|NCT00356135|536638655|FG000|Overall Study|Physician Decision|1|||
148772560|NCT00356135|536638656|FG001|Overall Study|Physician Decision|1|||
148772561|NCT00356135|536638657|FG002|Overall Study|Physician Decision|1|||
148772562|NCT00356135|536638655|FG000|Overall Study|Subject non-compliance|1|||
148772563|NCT00356135|536638656|FG001|Overall Study|Subject non-compliance|1|||
148772564|NCT00356135|536638657|FG002|Overall Study|Subject non-compliance|3|||
148772565|NCT03617770|536638658|FG000|Overall Study|Lost to Follow-up|1|||
148772566|NCT03617770|536638659|FG001|Overall Study|Lost to Follow-up|0|||
148772567|NCT03512210|536638660|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
148772568|NCT03512210|536638660|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
148772569|NCT03512210|536638660|FG000|Step 2:Post-MINMON|Death|2|||
148772570|NCT03512210|536638660|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
148772571|NCT03512210|536638660|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
148772572|NCT05033262|536638663|FG000|Overall Study|Lost to Follow-up|1|||
148772573|NCT05033262|536638664|FG001|Overall Study|Lost to Follow-up|0|||
148772574|NCT05033262|536638665|FG002|Overall Study|Lost to Follow-up|0|||
148772575|NCT05033262|536638666|FG003|Overall Study|Lost to Follow-up|1|||
148772576|NCT05270395|536638667|FG000|Overall Study|Lost to Follow-up|2|||
148772577|NCT05270395|536638668|FG001|Overall Study|Lost to Follow-up|2|||
148772578|NCT05270395|536638667|FG000|Overall Study|Death|1|||
148772579|NCT05270395|536638668|FG001|Overall Study|Death|2|||
148772580|NCT05270395|536638667|FG000|Overall Study|Study Team Withdrew|1|||
148772581|NCT05270395|536638668|FG001|Overall Study|Study Team Withdrew|0|||
148772582|NCT00784550|536641054|FG000|Overall Study|Adverse Event|12|||
148772583|NCT00784550|536641055|FG001|Overall Study|Adverse Event|10|||
148772584|NCT00784550|536641054|FG000|Overall Study|Lack of Efficacy|0|||
148772585|NCT00784550|536641055|FG001|Overall Study|Lack of Efficacy|1|||
148772586|NCT00784550|536641054|FG000|Overall Study|Protocol Violation|10|||
148772587|NCT00784550|536641055|FG001|Overall Study|Protocol Violation|10|||
148772588|NCT00784550|536641054|FG000|Overall Study|Lost to Follow-up|8|||
148833556|NCT04846868|536870598|FG001|Overall Study|Protocol deviation|2|||
148772589|NCT00784550|536641055|FG001|Overall Study|Lost to Follow-up|5|||
148772590|NCT00784550|536641054|FG000|Overall Study|Physician Decision|2|||
148772591|NCT00784550|536641055|FG001|Overall Study|Physician Decision|3|||
148772592|NCT00784550|536641054|FG000|Overall Study|Withdrawal by Subject|4|||
148772593|NCT00784550|536641055|FG001|Overall Study|Withdrawal by Subject|13|||
148772594|NCT00743288|536641056|FG000|Overall Study|Adverse Event|1|||
148772595|NCT00743288|536641057|FG001|Overall Study|Adverse Event|1|||
148772596|NCT00743288|536641058|FG002|Overall Study|Adverse Event|2|||
148772597|NCT00743288|536641059|FG003|Overall Study|Adverse Event|2|||
148772598|NCT00743288|536641060|FG004|Overall Study|Adverse Event|1|||
148772599|NCT00743288|536641061|FG005|Overall Study|Adverse Event|1|||
148772600|NCT00743288|536641062|FG006|Overall Study|Adverse Event|2|||
148981117|NCT00009737|537411545|FG000|Overall Study|Death|4|||
148981118|NCT00009737|537411546|FG001|Overall Study|Death|6|||
148981119|NCT00009737|537411545|FG000|Overall Study|Lack of Efficacy|17|||
148981120|NCT00009737|537411546|FG001|Overall Study|Lack of Efficacy|15|||
148981121|NCT00009737|537411545|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
148981122|NCT00009737|537411546|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
148981123|NCT00009737|537411545|FG000|Overall Study|Other Protocol Violation|1|||
148981124|NCT00009737|537411546|FG001|Overall Study|Other Protocol Violation|0|||
148981125|NCT00009737|537411545|FG000|Overall Study|Refused Treatment|15|||
148981126|NCT00009737|537411546|FG001|Overall Study|Refused Treatment|16|||
148981127|NCT00009737|537411545|FG000|Overall Study|Lost to Follow-up|1|||
148981128|NCT00009737|537411546|FG001|Overall Study|Lost to Follow-up|1|||
148981129|NCT00009737|537411545|FG000|Overall Study|Administrative/Other Reasons|7|||
148981130|NCT00009737|537411546|FG001|Overall Study|Administrative/Other Reasons|1|||
148981131|NCT01163682|537411548|FG000|Overall Study|Lost to Follow-up|6|||
148981132|NCT01163682|537411549|FG001|Overall Study|Lost to Follow-up|9|||
148981133|NCT01931839|537411550|FG000|Overall Study|Death|0|||
148981134|NCT01931839|537411551|FG001|Overall Study|Death|1|||
148981135|NCT01931839|537411552|FG002|Overall Study|Death|2|||
148981136|NCT01931839|537411553|FG003|Overall Study|Death|0|||
148981137|NCT01931839|537411554|FG004|Overall Study|Death|0|||
148981138|NCT01931839|537411555|FG005|Overall Study|Death|0|||
148981139|NCT01931839|537411556|FG006|Overall Study|Death|0|||
148981140|NCT01931839|537411550|FG000|Overall Study|Physician Decision|1|||
148981141|NCT01931839|537411551|FG001|Overall Study|Physician Decision|0|||
148981142|NCT01931839|537411552|FG002|Overall Study|Physician Decision|1|||
148981143|NCT01931839|537411553|FG003|Overall Study|Physician Decision|0|||
148981144|NCT01931839|537411554|FG004|Overall Study|Physician Decision|0|||
148981145|NCT01931839|537411555|FG005|Overall Study|Physician Decision|0|||
148981146|NCT01931839|537411556|FG006|Overall Study|Physician Decision|1|||
148981147|NCT01931839|537411550|FG000|Overall Study|Withdrawal of consent|0|||
148981148|NCT01931839|537411551|FG001|Overall Study|Withdrawal of consent|0|||
148981149|NCT01931839|537411552|FG002|Overall Study|Withdrawal of consent|0|||
148981150|NCT01931839|537411553|FG003|Overall Study|Withdrawal of consent|0|||
148981151|NCT01931839|537411554|FG004|Overall Study|Withdrawal of consent|1|||
148981152|NCT01931839|537411555|FG005|Overall Study|Withdrawal of consent|0|||
148981153|NCT01931839|537411556|FG006|Overall Study|Withdrawal of consent|0|||
148981154|NCT01931839|537411550|FG000|Overall Study|Adverse Event|9|||
148981155|NCT01931839|537411551|FG001|Overall Study|Adverse Event|4|||
148981156|NCT01931839|537411552|FG002|Overall Study|Adverse Event|1|||
148981157|NCT01931839|537411553|FG003|Overall Study|Adverse Event|3|||
148981158|NCT01931839|537411554|FG004|Overall Study|Adverse Event|0|||
148981159|NCT01931839|537411555|FG005|Overall Study|Adverse Event|0|||
148981160|NCT01931839|537411556|FG006|Overall Study|Adverse Event|1|||
148981161|NCT01931839|537411550|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
148981162|NCT01931839|537411551|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
148981163|NCT01931839|537411552|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
148981164|NCT01931839|537411553|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
148981165|NCT01931839|537411554|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
148981166|NCT01931839|537411555|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
148981167|NCT01931839|537411556|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
148981168|NCT01931839|537411550|FG000|Overall Study|Other non-compliance|15|||
148981169|NCT01931839|537411551|FG001|Overall Study|Other non-compliance|9|||
148981170|NCT01931839|537411552|FG002|Overall Study|Other non-compliance|12|||
148981171|NCT01931839|537411553|FG003|Overall Study|Other non-compliance|3|||
148981172|NCT01931839|537411554|FG004|Overall Study|Other non-compliance|0|||
148981173|NCT01931839|537411555|FG005|Overall Study|Other non-compliance|3|||
148981174|NCT01931839|537411556|FG006|Overall Study|Other non-compliance|0|||
148981175|NCT01931839|537411550|FG000|Overall Study|Lost to Follow-up|1|||
148981176|NCT01931839|537411551|FG001|Overall Study|Lost to Follow-up|2|||
148981177|NCT01931839|537411552|FG002|Overall Study|Lost to Follow-up|4|||
148981178|NCT01931839|537411553|FG003|Overall Study|Lost to Follow-up|5|||
148981179|NCT01931839|537411554|FG004|Overall Study|Lost to Follow-up|0|||
148981180|NCT01931839|537411555|FG005|Overall Study|Lost to Follow-up|0|||
148981181|NCT01931839|537411556|FG006|Overall Study|Lost to Follow-up|0|||
148981182|NCT01931839|537411550|FG000|Overall Study|Other|4|||
148981183|NCT01931839|537411551|FG001|Overall Study|Other|2|||
148981184|NCT01931839|537411552|FG002|Overall Study|Other|6|||
148981185|NCT01931839|537411553|FG003|Overall Study|Other|0|||
148981186|NCT01931839|537411554|FG004|Overall Study|Other|0|||
149028252|NCT00235495|537580150|FG000|Overall Study|Withdrawal by Subject|5|||
148981187|NCT01931839|537411555|FG005|Overall Study|Other|0|||
148981188|NCT01931839|537411556|FG006|Overall Study|Other|0|||
148981189|NCT03224468|537411557|FG000|Overall Study|Did not obtain MM card|53|||
148981190|NCT03224468|537411558|FG001|Overall Study|Did not obtain MM card|0|||
148981191|NCT03224468|537411557|FG000|Overall Study|Lost to Follow-up|4|||
148981192|NCT03224468|537411558|FG001|Overall Study|Lost to Follow-up|11|||
148981193|NCT03224468|537411557|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
148772601|NCT00743288|536641056|FG000|Overall Study|Withdrawal by Subject|0|||
148833557|NCT04846868|536870597|FG000|Overall Study|Perceived lack of efficacy|3|||
148833558|NCT04846868|536870598|FG001|Overall Study|Perceived lack of efficacy|2|||
148833559|NCT04846868|536870597|FG000|Overall Study|Change of residence|2|||
148833560|NCT04846868|536870598|FG001|Overall Study|Change of residence|3|||
148772602|NCT00743288|536641057|FG001|Overall Study|Withdrawal by Subject|0|||
148772603|NCT00743288|536641058|FG002|Overall Study|Withdrawal by Subject|1|||
148772604|NCT00743288|536641059|FG003|Overall Study|Withdrawal by Subject|0|||
148772605|NCT00743288|536641060|FG004|Overall Study|Withdrawal by Subject|0|||
148772606|NCT00743288|536641061|FG005|Overall Study|Withdrawal by Subject|1|||
148772607|NCT00743288|536641062|FG006|Overall Study|Withdrawal by Subject|1|||
148772608|NCT00743288|536641056|FG000|Overall Study|Progressive disease (PD)|2|||
148772609|NCT00743288|536641057|FG001|Overall Study|Progressive disease (PD)|0|||
148772610|NCT00743288|536641058|FG002|Overall Study|Progressive disease (PD)|1|||
148772611|NCT00743288|536641059|FG003|Overall Study|Progressive disease (PD)|4|||
148772612|NCT00743288|536641060|FG004|Overall Study|Progressive disease (PD)|5|||
148772613|NCT00743288|536641061|FG005|Overall Study|Progressive disease (PD)|3|||
148772614|NCT00743288|536641062|FG006|Overall Study|Progressive disease (PD)|6|||
148772615|NCT00743288|536641056|FG000|Overall Study|Worsening of condition (Not PD)|0|||
148772616|NCT00743288|536641057|FG001|Overall Study|Worsening of condition (Not PD)|2|||
148772617|NCT00743288|536641058|FG002|Overall Study|Worsening of condition (Not PD)|1|||
148772618|NCT00743288|536641059|FG003|Overall Study|Worsening of condition (Not PD)|1|||
148772619|NCT00743288|536641060|FG004|Overall Study|Worsening of condition (Not PD)|0|||
148772620|NCT00743288|536641061|FG005|Overall Study|Worsening of condition (Not PD)|0|||
148772621|NCT00743288|536641062|FG006|Overall Study|Worsening of condition (Not PD)|0|||
148772622|NCT05903924|536641063|FG000|Overall Study|Lost to Follow-up|1|||
148772623|NCT05903924|536641064|FG001|Overall Study|Lost to Follow-up|0|||
148772624|NCT05903924|536641065|FG002|Overall Study|Lost to Follow-up|0|||
148772625|NCT00688701|536641066|FG000|Overall Study|Adverse Event|1|||
148772626|NCT00688701|536641067|FG001|Overall Study|Adverse Event|0|||
148772627|NCT00688701|536641068|FG002|Overall Study|Adverse Event|5|||
148772628|NCT00688701|536641069|FG003|Overall Study|Adverse Event|3|||
148772629|NCT00688701|536641066|FG000|Overall Study|Lack of Efficacy|0|||
148772630|NCT00688701|536641067|FG001|Overall Study|Lack of Efficacy|1|||
148772631|NCT00688701|536641068|FG002|Overall Study|Lack of Efficacy|0|||
148772632|NCT00688701|536641069|FG003|Overall Study|Lack of Efficacy|0|||
148772633|NCT00688701|536641066|FG000|Overall Study|Withdrawal by Subject|3|||
148772634|NCT00688701|536641067|FG001|Overall Study|Withdrawal by Subject|3|||
148772635|NCT00688701|536641068|FG002|Overall Study|Withdrawal by Subject|4|||
148772636|NCT00688701|536641069|FG003|Overall Study|Withdrawal by Subject|8|||
148772637|NCT00688701|536641066|FG000|Overall Study|Poor compliance to protocol|0|||
148772638|NCT00688701|536641067|FG001|Overall Study|Poor compliance to protocol|1|||
148772639|NCT00688701|536641068|FG002|Overall Study|Poor compliance to protocol|1|||
148772640|NCT00688701|536641069|FG003|Overall Study|Poor compliance to protocol|0|||
148772641|NCT04166591|536641075|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
148772642|NCT04166591|536641076|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
148772643|NCT04166591|536641077|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
148772644|NCT04166591|536641078|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
148772645|NCT04166591|536641075|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
148772646|NCT04166591|536641076|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
148772647|NCT04166591|536641077|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
148772648|NCT04166591|536641078|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
148772649|NCT03030989|536641079|FG000|Overall Study|Fever|2|||
148772650|NCT03030989|536641080|FG001|Overall Study|Fever|2|||
148772651|NCT03030989|536641079|FG000|Overall Study|Rash|2|||
148772652|NCT03030989|536641080|FG001|Overall Study|Rash|1|||
148772653|NCT03030989|536641079|FG000|Overall Study|Fatigue/Overwhelmed|1|||
148981194|NCT03224468|537411558|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
148772654|NCT03030989|536641080|FG001|Overall Study|Fatigue/Overwhelmed|5|||
148772655|NCT03030989|536641079|FG000|Overall Study|Positive Blood Cultures|2|||
148772656|NCT03030989|536641080|FG001|Overall Study|Positive Blood Cultures|1|||
148833561|NCT04846868|536870597|FG000|Overall Study|Burden of study procedures|1|||
148833562|NCT04846868|536870598|FG001|Overall Study|Burden of study procedures|1|||
148833563|NCT04846868|536870597|FG000|Overall Study|No reason available|2|||
148833564|NCT04846868|536870598|FG001|Overall Study|No reason available|5|||
148833565|NCT04846868|536870597|FG000|Overall Study|Other reason listed|20|||
148833566|NCT04846868|536870598|FG001|Overall Study|Other reason listed|10|||
148833567|NCT04846868|536870597|FG000|Overall Study|Not treated|0|||
148833568|NCT04846868|536870598|FG001|Overall Study|Not treated|1|||
148772657|NCT03030989|536641079|FG000|Overall Study|Line Removed|0|||
148772658|NCT03030989|536641080|FG001|Overall Study|Line Removed|2|||
148772659|NCT03030989|536641079|FG000|Overall Study|No longer interested|5|||
148772660|NCT03030989|536641080|FG001|Overall Study|No longer interested|3|||
148833569|NCT04116853|536870599|FG000|Overall Study|Adverse Event|1|||
148833570|NCT04116853|536870600|FG001|Overall Study|Adverse Event|3|||
148981195|NCT01978119|537411559|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
148833571|NCT04116853|536870599|FG000|Overall Study|Lost to Follow-up|2|||
148833572|NCT04116853|536870600|FG001|Overall Study|Lost to Follow-up|0|||
148833573|NCT04116853|536870599|FG000|Overall Study|Incarceration|0|||
148833574|NCT04116853|536870600|FG001|Overall Study|Incarceration|1|||
148833575|NCT04116853|536870599|FG000|Overall Study|Pregnancy|1|||
148833576|NCT04116853|536870600|FG001|Overall Study|Pregnancy|1|||
148833577|NCT04116853|536870599|FG000|Overall Study|Began Other Weight Loss program|4|||
148833578|NCT04116853|536870600|FG001|Overall Study|Began Other Weight Loss program|8|||
148833579|NCT04116853|536870599|FG000|Overall Study|Began Anti-Obesity Medication|3|||
148833580|NCT04116853|536870600|FG001|Overall Study|Began Anti-Obesity Medication|3|||
148833581|NCT04116853|536870599|FG000|Overall Study|Protocol Violation|0|||
148833582|NCT04116853|536870600|FG001|Overall Study|Protocol Violation|1|||
148833583|NCT05212168|536870601|FG000|Overall Study|Lost to Follow-up|0|||
148833584|NCT05212168|536870602|FG001|Overall Study|Lost to Follow-up|3|||
148833585|NCT05212168|536870601|FG000|Overall Study|Study terminated by sponsor|30|||
148833586|NCT05212168|536870602|FG001|Overall Study|Study terminated by sponsor|27|||
148833587|NCT05212168|536870601|FG000|Overall Study|Other|4|||
148833588|NCT05212168|536870602|FG001|Overall Study|Other|7|||
148833589|NCT03274466|536870603|FG000|Overall Study|Withdrawal by Subject|7|||
148833590|NCT03274466|536870604|FG001|Overall Study|Withdrawal by Subject|3|||
148833591|NCT03274466|536870603|FG000|Overall Study|Protocol Specified Withdrawal|5|||
148833592|NCT03274466|536870604|FG001|Overall Study|Protocol Specified Withdrawal|11|||
148833593|NCT03274466|536870603|FG000|Overall Study|Lost to Follow-up|5|||
148833594|NCT03274466|536870604|FG001|Overall Study|Lost to Follow-up|7|||
148833595|NCT03274466|536870603|FG000|Overall Study|Subject Non-compliance|0|||
148833596|NCT03274466|536870604|FG001|Overall Study|Subject Non-compliance|1|||
148833597|NCT03274466|536870603|FG000|Overall Study|Adverse Event|3|||
148833598|NCT03274466|536870604|FG001|Overall Study|Adverse Event|3|||
148833599|NCT03274466|536870603|FG000|Overall Study|Physician Decision|0|||
148833600|NCT03274466|536870604|FG001|Overall Study|Physician Decision|1|||
148833601|NCT03274466|536870603|FG000|Overall Study|Protocol Violation|3|||
148833602|NCT03274466|536870604|FG001|Overall Study|Protocol Violation|3|||
148833603|NCT00618787|536870608|FG000|Overall Study|Adverse Event|0|||
148833604|NCT00618787|536870609|FG001|Overall Study|Adverse Event|1|||
148833605|NCT00618787|536870608|FG000|Overall Study|Withdrawal by Subject|2|||
148833606|NCT00618787|536870609|FG001|Overall Study|Withdrawal by Subject|1|||
148833607|NCT00618787|536870608|FG000|Overall Study|Lost to Follow-up|1|||
148833608|NCT00618787|536870609|FG001|Overall Study|Lost to Follow-up|0|||
148833609|NCT01107886|536870610|FG000|Overall Study|Lost to Follow-up|15|||
148833610|NCT01107886|536870611|FG001|Overall Study|Lost to Follow-up|13|||
148833611|NCT01107886|536870610|FG000|Overall Study|Withdrawal by Subject|180|||
148833612|NCT01107886|536870611|FG001|Overall Study|Withdrawal by Subject|196|||
148833613|NCT01107886|536870610|FG000|Overall Study|Administrative withdrawal of consent|7|||
148833614|NCT01107886|536870611|FG001|Overall Study|Administrative withdrawal of consent|5|||
148833615|NCT01346176|536870612|FG000|Recruited|Protocol Violation|1|||
148833616|NCT01346176|536870613|FG001|Recruited|Protocol Violation|0|||
148833617|NCT01346176|536870614|FG002|Recruited|Protocol Violation|0|||
148833618|NCT01346176|536870612|FG000|Completed Advance Directive|Death|3|||
149028253|NCT00235495|537580151|FG001|Overall Study|Withdrawal by Subject|3|||
148772661|NCT02730377|536641081|FG000|Overall Study|Other|5|||
148772662|NCT02730377|536641082|FG001|Overall Study|Other|4|||
148772663|NCT02730377|536641081|FG000|Overall Study|Death|1|||
148772664|NCT02730377|536641082|FG001|Overall Study|Death|8|||
148772665|NCT02730377|536641081|FG000|Overall Study|Inadequate glycaemic control|368|||
148772666|NCT02730377|536641082|FG001|Overall Study|Inadequate glycaemic control|473|||
148772667|NCT02730377|536641081|FG000|Overall Study|Adverse Event|79|||
148772668|NCT02730377|536641082|FG001|Overall Study|Adverse Event|41|||
148772669|NCT02730377|536641081|FG000|Overall Study|Protocol Violation|23|||
148772670|NCT02730377|536641082|FG001|Overall Study|Protocol Violation|30|||
148772671|NCT02730377|536641081|FG000|Overall Study|Lack of Efficacy|4|||
148772672|NCT02730377|536641082|FG001|Overall Study|Lack of Efficacy|13|||
148772673|NCT02730377|536641081|FG000|Overall Study|Pregnancy|0|||
148772674|NCT02730377|536641082|FG001|Overall Study|Pregnancy|1|||
148772675|NCT02730377|536641081|FG000|Overall Study|Withdrawal by Subject|45|||
148772676|NCT02730377|536641082|FG001|Overall Study|Withdrawal by Subject|42|||
148772677|NCT02730377|536641081|FG000|Overall Study|Lost to Follow-up|25|||
148772678|NCT02730377|536641082|FG001|Overall Study|Lost to Follow-up|21|||
148772679|NCT03917472|536641083|FG000|Overall Study|Physician Decision|4|||
148772680|NCT03917472|536641084|FG001|Overall Study|Physician Decision|0|||
148833619|NCT01346176|536870613|FG001|Completed Advance Directive|Death|2|||
148772681|NCT03917472|536641083|FG000|Overall Study|Adverse Event|3|||
148833620|NCT01346176|536870614|FG002|Completed Advance Directive|Death|2|||
148833621|NCT01346176|536870612|FG000|Completed Advance Directive|Became Ineligible|3|||
148833622|NCT01346176|536870613|FG001|Completed Advance Directive|Became Ineligible|0|||
148772682|NCT03917472|536641084|FG001|Overall Study|Adverse Event|1|||
148833623|NCT01346176|536870614|FG002|Completed Advance Directive|Became Ineligible|1|||
148833624|NCT01346176|536870612|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
148772683|NCT03917472|536641083|FG000|Overall Study|Death|7|||
149028254|NCT00235495|537580150|FG000|Overall Study|Lost to Follow-up|11|||
149028255|NCT00235495|537580151|FG001|Overall Study|Lost to Follow-up|13|||
149028256|NCT00235495|537580150|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
149028257|NCT00235495|537580151|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
149028258|NCT02320253|537580152|FG000|Overall Study|Withdrawal by Subject|3|||
149028259|NCT02320253|537580153|FG001|Overall Study|Withdrawal by Subject|0|||
149028260|NCT02320253|537580154|FG002|Overall Study|Withdrawal by Subject|0|||
149028261|NCT02320253|537580152|FG000|Overall Study|Lost to Follow-up|2|||
149028262|NCT02320253|537580153|FG001|Overall Study|Lost to Follow-up|2|||
149028263|NCT02320253|537580154|FG002|Overall Study|Lost to Follow-up|1|||
149028264|NCT02320253|537580152|FG000|Overall Study|Death|1|||
149028265|NCT02320253|537580153|FG001|Overall Study|Death|0|||
149028266|NCT02320253|537580154|FG002|Overall Study|Death|1|||
149028267|NCT05750745|537580155|FG000|Overall Study|Adverse Event|1|||
149028268|NCT05750745|537580156|FG001|Overall Study|Adverse Event|0|||
149028269|NCT05750745|537580157|FG002|Overall Study|Adverse Event|0|||
149028270|NCT05750745|537580155|FG000|Overall Study|Protocol Violation|1|||
149028271|NCT05750745|537580156|FG001|Overall Study|Protocol Violation|0|||
149028272|NCT05750745|537580157|FG002|Overall Study|Protocol Violation|0|||
149028273|NCT05750745|537580155|FG000|Overall Study|Withdrawal by Subject|0|||
149028274|NCT05750745|537580156|FG001|Overall Study|Withdrawal by Subject|1|||
149028275|NCT05750745|537580157|FG002|Overall Study|Withdrawal by Subject|0|||
149028276|NCT05780047|537580159|FG000|Overall Study|Did not submit baseline urine test kit|226|||
149028277|NCT05780047|537580159|FG000|Overall Study|Lost to Follow-up|34|||
149028278|NCT05780047|537580159|FG000|Overall Study|Did not submit second urine test kit|124|||
149028279|NCT03590743|537580166|FG000|Overall Study|Withdrawal by Subject|0|||
149028280|NCT03590743|537580167|FG001|Overall Study|Withdrawal by Subject|1|||
149028281|NCT01190176|537580168|FG000|Overall Study|Withdrawal by Subject|1|||
149028282|NCT01190176|537580168|FG000|Overall Study|Lost to Follow-up|1|||
149028283|NCT02909101|537580169|FG000|Overall Study|Lost to Follow-up|1|||
149028284|NCT02909101|537580170|FG001|Overall Study|Lost to Follow-up|1|||
149028285|NCT02189863|537580171|FG000|First 2 Weeks|Motion Sickness|4|||
149028286|NCT02189863|537580172|FG001|First 2 Weeks|Motion Sickness|2|||
149028287|NCT03697460|537580173|FG000|Overall Study|Withdrawal by Subject|3|||
149028288|NCT01959880|537580178|FG000|Overall Study|Withdrawal by Subject|11|||
149028289|NCT01959880|537580179|FG001|Overall Study|Withdrawal by Subject|13|||
149028290|NCT01959880|537580180|FG002|Overall Study|Withdrawal by Subject|8|||
149028291|NCT01959880|537580181|FG003|Overall Study|Withdrawal by Subject|7|||
149028292|NCT01959880|537580178|FG000|Overall Study|Death|1|||
149028293|NCT01959880|537580179|FG001|Overall Study|Death|10|||
149028294|NCT01959880|537580180|FG002|Overall Study|Death|1|||
148833625|NCT01346176|536870613|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
148981196|NCT01978119|537411560|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
148981197|NCT01978119|537411559|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
148981198|NCT01978119|537411560|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
148981199|NCT01978119|537411559|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
148981200|NCT01978119|537411560|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
148981201|NCT00812812|537411561|FG000|Overall Study|Adverse Event|2|||
148981202|NCT00812812|537411562|FG001|Overall Study|Adverse Event|1|||
148981203|NCT00812812|537411561|FG000|Overall Study|Lack of Efficacy|1|||
148981204|NCT00812812|537411562|FG001|Overall Study|Lack of Efficacy|0|||
148981205|NCT00812812|537411561|FG000|Overall Study|Lost to Follow-up|0|||
148981206|NCT00812812|537411562|FG001|Overall Study|Lost to Follow-up|1|||
148981207|NCT00812812|537411561|FG000|Overall Study|Withdrawal by Subject|0|||
148981208|NCT00812812|537411562|FG001|Overall Study|Withdrawal by Subject|2|||
148981209|NCT03095417|537411563|FG000|Overall Study|missed|1|||
148981210|NCT03095417|537411564|FG001|Overall Study|missed|2|||
148981211|NCT03095417|537411565|FG002|Overall Study|missed|0|||
148981212|NCT03095417|537411566|FG003|Overall Study|missed|1|||
148981213|NCT03095417|537411563|FG000|Overall Study|Lost to Follow-up|2|||
148981214|NCT03095417|537411564|FG001|Overall Study|Lost to Follow-up|2|||
149028295|NCT01959880|537580181|FG003|Overall Study|Death|2|||
149028296|NCT01959880|537580178|FG000|Overall Study|Lost to Follow-up|95|||
149028297|NCT01959880|537580179|FG001|Overall Study|Lost to Follow-up|18|||
149028298|NCT01959880|537580180|FG002|Overall Study|Lost to Follow-up|15|||
149028299|NCT01959880|537580181|FG003|Overall Study|Lost to Follow-up|8|||
149028300|NCT01959880|537580178|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
149028301|NCT01959880|537580179|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
149028302|NCT01959880|537580180|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
149028303|NCT01959880|537580181|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
149028304|NCT01959880|537580178|FG000|Overall Study|Study completed early-FDA approved|1003|||
149028305|NCT01959880|537580179|FG001|Overall Study|Study completed early-FDA approved|311|||
149028306|NCT01959880|537580180|FG002|Overall Study|Study completed early-FDA approved|179|||
149028307|NCT01959880|537580181|FG003|Overall Study|Study completed early-FDA approved|152|||
149028308|NCT00569946|537581913|FG000|Overall Study|Adverse Event|16|||
148981215|NCT03095417|537411565|FG002|Overall Study|Lost to Follow-up|1|||
148833626|NCT01346176|536870614|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
148833627|NCT01346176|536870612|FG000|Completed Satisfaction Survey|Death|3|||
148833628|NCT01346176|536870613|FG001|Completed Satisfaction Survey|Death|0|||
148833629|NCT01346176|536870614|FG002|Completed Satisfaction Survey|Death|2|||
148833630|NCT01346176|536870612|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
148833631|NCT01346176|536870613|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
148833632|NCT01346176|536870614|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
148833633|NCT01994876|536870615|FG000|Test Period 1|Withdrawal by Subject|0|||
148833634|NCT01994876|536870616|FG001|Test Period 1|Withdrawal by Subject|1|||
148833635|NCT01994876|536870615|FG000|Test Period 1|Adverse Event|0|||
148833636|NCT01994876|536870616|FG001|Test Period 1|Adverse Event|1|||
148833637|NCT01994876|536870615|FG000|Test Period 2|Adverse Event|1|||
148833638|NCT01994876|536870616|FG001|Test Period 2|Adverse Event|0|||
148833639|NCT01994876|536870615|FG000|Test Period 2|Protocol Violation|0|||
148833640|NCT01994876|536870616|FG001|Test Period 2|Protocol Violation|1|||
148833641|NCT05819398|536870617|FG000|Overall Study|Withdrawal by Subject|11|||
148833642|NCT05819398|536870618|FG001|Overall Study|Withdrawal by Subject|7|||
148833643|NCT05819398|536870619|FG002|Overall Study|Withdrawal by Subject|6|||
148833644|NCT05819398|536870620|FG003|Overall Study|Withdrawal by Subject|6|||
148833645|NCT05819398|536870617|FG000|Overall Study|Lost to Follow-up|0|||
148833646|NCT05819398|536870618|FG001|Overall Study|Lost to Follow-up|2|||
148833647|NCT05819398|536870619|FG002|Overall Study|Lost to Follow-up|0|||
148833648|NCT05819398|536870620|FG003|Overall Study|Lost to Follow-up|1|||
148833649|NCT05819398|536870617|FG000|Overall Study|Adverse Event|1|||
148833650|NCT05819398|536870618|FG001|Overall Study|Adverse Event|3|||
148833651|NCT05819398|536870619|FG002|Overall Study|Adverse Event|4|||
148833652|NCT05819398|536870620|FG003|Overall Study|Adverse Event|5|||
148833653|NCT05819398|536870617|FG000|Overall Study|Other than listed|0|||
148833654|NCT05819398|536870618|FG001|Overall Study|Other than listed|2|||
148833655|NCT05819398|536870619|FG002|Overall Study|Other than listed|2|||
148833656|NCT05819398|536870620|FG003|Overall Study|Other than listed|0|||
148833657|NCT05819398|536870617|FG000|Overall Study|Lack of Efficacy|0|||
148833658|NCT05819398|536870618|FG001|Overall Study|Lack of Efficacy|1|||
148833659|NCT05819398|536870619|FG002|Overall Study|Lack of Efficacy|0|||
148833660|NCT05819398|536870620|FG003|Overall Study|Lack of Efficacy|0|||
148833661|NCT05819398|536870617|FG000|Overall Study|Study terminated by sponsor|20|||
148833662|NCT05819398|536870618|FG001|Overall Study|Study terminated by sponsor|18|||
148833663|NCT05819398|536870619|FG002|Overall Study|Study terminated by sponsor|20|||
148833664|NCT05819398|536870620|FG003|Overall Study|Study terminated by sponsor|22|||
148833665|NCT04522973|536870621|FG000|Overall Study|Lost to Follow-up|4|||
148833666|NCT04522973|536870621|FG000|Overall Study|Could not adhere to study schedule|1|||
148833667|NCT01649869|536870622|FG000|Overall Study|Family member illness|1|||
148833668|NCT01649869|536870623|FG001|Overall Study|Family member illness|0|||
148833669|NCT01649869|536870622|FG000|Overall Study|Required treatment outside protocol|1|||
148833670|NCT01649869|536870623|FG001|Overall Study|Required treatment outside protocol|0|||
148833671|NCT01649869|536870622|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
148833672|NCT01649869|536870623|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
148833673|NCT02776735|536870624|FG000|Overall Study|Adverse Event|0|||
148833674|NCT02776735|536870625|FG001|Overall Study|Adverse Event|0|||
148833675|NCT02776735|536870626|FG002|Overall Study|Adverse Event|0|||
148833676|NCT02776735|536870627|FG003|Overall Study|Adverse Event|1|||
148833677|NCT02776735|536870628|FG004|Overall Study|Adverse Event|0|||
148772684|NCT03917472|536641084|FG001|Overall Study|Death|5|||
148772685|NCT03917472|536641083|FG000|Overall Study|Withdrawal by Subject|11|||
148772686|NCT03917472|536641084|FG001|Overall Study|Withdrawal by Subject|4|||
148772687|NCT03917472|536641083|FG000|Overall Study|Lost to Follow-up|10|||
148772688|NCT03917472|536641084|FG001|Overall Study|Lost to Follow-up|5|||
148772689|NCT02706886|536641085|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
148772690|NCT02706886|536641086|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
148833678|NCT02776735|536870629|FG005|Overall Study|Adverse Event|1|||
148833679|NCT02776735|536870624|FG000|Overall Study|Lost to Follow-up|0|||
148833680|NCT02776735|536870625|FG001|Overall Study|Lost to Follow-up|0|||
148833681|NCT02776735|536870626|FG002|Overall Study|Lost to Follow-up|0|||
148833682|NCT02776735|536870627|FG003|Overall Study|Lost to Follow-up|1|||
148833683|NCT02776735|536870628|FG004|Overall Study|Lost to Follow-up|0|||
148833684|NCT02776735|536870629|FG005|Overall Study|Lost to Follow-up|0|||
148833685|NCT02776735|536870624|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148833686|NCT02776735|536870625|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148833687|NCT02776735|536870626|FG002|Overall Study|Withdrawal by parent/guardian|2|||
148772691|NCT02706886|536641087|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
148772692|NCT02706886|536641088|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
148772693|NCT02706886|536641089|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
148772694|NCT02706886|536641090|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
148833688|NCT02776735|536870627|FG003|Overall Study|Withdrawal by parent/guardian|2|||
148833689|NCT02776735|536870628|FG004|Overall Study|Withdrawal by parent/guardian|0|||
148833690|NCT02776735|536870629|FG005|Overall Study|Withdrawal by parent/guardian|0|||
148772695|NCT02706886|536641091|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
148833691|NCT02776735|536870624|FG000|Overall Study|Withdrawal by Subject|1|||
148833692|NCT02776735|536870625|FG001|Overall Study|Withdrawal by Subject|0|||
148833693|NCT02776735|536870626|FG002|Overall Study|Withdrawal by Subject|0|||
148833694|NCT02776735|536870627|FG003|Overall Study|Withdrawal by Subject|0|||
148833695|NCT02776735|536870628|FG004|Overall Study|Withdrawal by Subject|0|||
148833696|NCT02776735|536870629|FG005|Overall Study|Withdrawal by Subject|1|||
148833697|NCT02776735|536870624|FG000|Overall Study|Other|0|||
148833698|NCT02776735|536870625|FG001|Overall Study|Other|0|||
148833699|NCT02776735|536870626|FG002|Overall Study|Other|3|||
148833700|NCT02776735|536870627|FG003|Overall Study|Other|0|||
148833701|NCT02776735|536870628|FG004|Overall Study|Other|0|||
148833702|NCT02776735|536870629|FG005|Overall Study|Other|0|||
148833703|NCT03716830|536872498|FG000|Overall Study|Withdrawal by Subject|2|||
148833704|NCT03716830|536872499|FG001|Overall Study|Withdrawal by Subject|2|||
148833705|NCT03716830|536872500|FG002|Overall Study|Withdrawal by Subject|6|||
148833706|NCT03716830|536872501|FG003|Overall Study|Withdrawal by Subject|5|||
148833707|NCT03716830|536872498|FG000|Overall Study|Adverse Event|1|||
148833708|NCT03716830|536872499|FG001|Overall Study|Adverse Event|2|||
148833709|NCT03716830|536872500|FG002|Overall Study|Adverse Event|0|||
148833710|NCT03716830|536872501|FG003|Overall Study|Adverse Event|1|||
148833711|NCT03716830|536872498|FG000|Overall Study|Lost to Follow-up|1|||
148833712|NCT03716830|536872499|FG001|Overall Study|Lost to Follow-up|1|||
148833713|NCT03716830|536872500|FG002|Overall Study|Lost to Follow-up|0|||
148833714|NCT03716830|536872501|FG003|Overall Study|Lost to Follow-up|0|||
148833715|NCT05489328|536872502|FG000|Overall Study|Lost to Follow-up|0|||
148833716|NCT05489328|536872503|FG001|Overall Study|Lost to Follow-up|0|||
148833717|NCT05489328|536872504|FG002|Overall Study|Lost to Follow-up|1|||
148833718|NCT05489328|536872505|FG003|Overall Study|Lost to Follow-up|0|||
148833719|NCT05489328|536872506|FG004|Overall Study|Lost to Follow-up|2|||
148833720|NCT05489328|536872507|FG005|Overall Study|Lost to Follow-up|0|||
148833721|NCT05489328|536872508|FG006|Overall Study|Lost to Follow-up|0|||
148833722|NCT05489328|536872509|FG007|Overall Study|Lost to Follow-up|1|||
148833723|NCT05489328|536872510|FG008|Overall Study|Lost to Follow-up|0|||
148833724|NCT05489328|536872502|FG000|Overall Study|Withdrawal by Subject|0|||
148833725|NCT05489328|536872503|FG001|Overall Study|Withdrawal by Subject|0|||
148833726|NCT05489328|536872504|FG002|Overall Study|Withdrawal by Subject|0|||
148833727|NCT05489328|536872505|FG003|Overall Study|Withdrawal by Subject|0|||
148833728|NCT05489328|536872506|FG004|Overall Study|Withdrawal by Subject|0|||
148833729|NCT05489328|536872507|FG005|Overall Study|Withdrawal by Subject|0|||
148833730|NCT05489328|536872508|FG006|Overall Study|Withdrawal by Subject|1|||
148833731|NCT05489328|536872509|FG007|Overall Study|Withdrawal by Subject|1|||
148833732|NCT05489328|536872510|FG008|Overall Study|Withdrawal by Subject|0|||
148833733|NCT05489328|536872502|FG000|Overall Study|Other|0|||
148833734|NCT05489328|536872503|FG001|Overall Study|Other|0|||
148833735|NCT05489328|536872504|FG002|Overall Study|Other|0|||
148833736|NCT05489328|536872505|FG003|Overall Study|Other|0|||
148833737|NCT05489328|536872506|FG004|Overall Study|Other|0|||
148833738|NCT05489328|536872507|FG005|Overall Study|Other|0|||
148833739|NCT05489328|536872508|FG006|Overall Study|Other|0|||
148833740|NCT05489328|536872509|FG007|Overall Study|Other|1|||
148833741|NCT05489328|536872510|FG008|Overall Study|Other|1|||
148833742|NCT03021486|536872511|FG000|Overall Study|Withdrawal by Subject|1|||
148833743|NCT03021486|536872512|FG001|Overall Study|Withdrawal by Subject|1|||
148833744|NCT03021486|536872513|FG002|Overall Study|Withdrawal by Subject|3|||
148833745|NCT03021486|536872511|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
148833746|NCT03021486|536872512|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
148833747|NCT03021486|536872513|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
148833748|NCT01323192|536872514|FG000|Overall Study|Adverse Event|6|||
148833749|NCT01323192|536872515|FG001|Overall Study|Adverse Event|1|||
148833750|NCT01323192|536872514|FG000|Overall Study|Withdrawal by Subject|3|||
148833751|NCT01323192|536872515|FG001|Overall Study|Withdrawal by Subject|1|||
148833752|NCT01323192|536872514|FG000|Overall Study|Noncompliance with study medication|0|||
148833753|NCT01323192|536872515|FG001|Overall Study|Noncompliance with study medication|3|||
148833754|NCT01323192|536872514|FG000|Overall Study|Nonmedical reasons|0|||
148833755|NCT01323192|536872515|FG001|Overall Study|Nonmedical reasons|1|||
148833756|NCT02276040|536872521|FG000|Overall Study|Physician Decision|15|||
148833757|NCT02835690|536872522|FG000|Overall Study|Death|12|||
148833758|NCT02835690|536872523|FG001|Overall Study|Death|11|||
148833759|NCT02835690|536872524|FG002|Overall Study|Death|13|||
148833760|NCT02835690|536872522|FG000|Overall Study|Transferred to Extension Study|2|||
148833761|NCT02835690|536872523|FG001|Overall Study|Transferred to Extension Study|2|||
148833762|NCT02835690|536872524|FG002|Overall Study|Transferred to Extension Study|1|||
148833763|NCT02835690|536872522|FG000|Overall Study|Did Not Continue on Extension Study|0|||
148833764|NCT02835690|536872523|FG001|Overall Study|Did Not Continue on Extension Study|0|||
148833765|NCT02835690|536872524|FG002|Overall Study|Did Not Continue on Extension Study|1|||
148833766|NCT02835690|536872522|FG000|Overall Study|Not Treated|0|||
148833767|NCT02835690|536872523|FG001|Overall Study|Not Treated|2|||
148833768|NCT02835690|536872524|FG002|Overall Study|Not Treated|0|||
148833769|NCT03674281|536872525|FG000|Overall Study|screen failure|2|||
148833770|NCT03674281|536872526|FG001|Overall Study|screen failure|0|||
148833771|NCT03674281|536872527|FG002|Overall Study|screen failure|0|||
148833772|NCT03674281|536872525|FG000|Overall Study|Withdrawal by Subject|1|||
148833773|NCT03674281|536872526|FG001|Overall Study|Withdrawal by Subject|3|||
148833774|NCT03674281|536872527|FG002|Overall Study|Withdrawal by Subject|3|||
148833775|NCT00582907|536872528|FG000|1st Course|Withdrawal by Subject|1|||
148833776|NCT00582907|536872529|FG001|1st Course|Withdrawal by Subject|0|||
148833777|NCT00582907|536872530|FG002|1st Course|Withdrawal by Subject|0|||
148833778|NCT00582907|536872531|FG003|1st Course|Withdrawal by Subject|0|||
148833779|NCT00582907|536872528|FG000|1st Course|Lost to Follow-up|0|||
148833780|NCT00582907|536872529|FG001|1st Course|Lost to Follow-up|0|||
148833781|NCT00582907|536872530|FG002|1st Course|Lost to Follow-up|0|||
148833782|NCT00582907|536872531|FG003|1st Course|Lost to Follow-up|1|||
148833783|NCT00582907|536872528|FG000|2nd Course|Lack of Efficacy|1|||
148833784|NCT00582907|536872529|FG001|2nd Course|Lack of Efficacy|0|||
148833785|NCT00582907|536872530|FG002|2nd Course|Lack of Efficacy|0|||
148833786|NCT00582907|536872531|FG003|2nd Course|Lack of Efficacy|0|||
148833787|NCT01441960|536872534|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
148833788|NCT01441960|536872535|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
148833789|NCT01441960|536872534|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
148833790|NCT01441960|536872535|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
148833791|NCT01441960|536872534|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
148833792|NCT01441960|536872535|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
148833793|NCT03309202|536872538|FG000|Overall Study|Lost to Follow-up|1|||
148833794|NCT03309202|536872539|FG001|Overall Study|Lost to Follow-up|0|||
148833795|NCT03309202|536872540|FG002|Overall Study|Lost to Follow-up|0|||
148833796|NCT03309202|536872541|FG003|Overall Study|Lost to Follow-up|0|||
148833797|NCT00415636|536872542|FG000|Overall Study|Symptomatic deterioration|1|||
148833798|NCT00415636|536872543|FG001|Overall Study|Symptomatic deterioration|0|||
148833799|NCT00415636|536872544|FG002|Overall Study|Symptomatic deterioration|1|||
148833800|NCT00415636|536872545|FG003|Overall Study|Symptomatic deterioration|2|||
148833801|NCT00415636|536872546|FG004|Overall Study|Symptomatic deterioration|0|||
148833802|NCT00415636|536872547|FG005|Overall Study|Symptomatic deterioration|1|||
148833803|NCT00415636|536872542|FG000|Overall Study|Adverse Event|0|||
148833804|NCT00415636|536872543|FG001|Overall Study|Adverse Event|0|||
148833805|NCT00415636|536872544|FG002|Overall Study|Adverse Event|0|||
148833806|NCT00415636|536872545|FG003|Overall Study|Adverse Event|1|||
148833807|NCT00415636|536872546|FG004|Overall Study|Adverse Event|1|||
148833808|NCT00415636|536872547|FG005|Overall Study|Adverse Event|0|||
148833809|NCT00415636|536872542|FG000|Overall Study|Withdrawal by Subject|0|||
148833810|NCT00415636|536872543|FG001|Overall Study|Withdrawal by Subject|0|||
148833811|NCT00415636|536872544|FG002|Overall Study|Withdrawal by Subject|0|||
148833812|NCT00415636|536872545|FG003|Overall Study|Withdrawal by Subject|0|||
148833813|NCT00415636|536872546|FG004|Overall Study|Withdrawal by Subject|1|||
148833814|NCT00415636|536872547|FG005|Overall Study|Withdrawal by Subject|0|||
148833815|NCT00415636|536872542|FG000|Overall Study|Disease progression|0|||
148833816|NCT00415636|536872543|FG001|Overall Study|Disease progression|0|||
148833817|NCT00415636|536872544|FG002|Overall Study|Disease progression|0|||
148833818|NCT00415636|536872545|FG003|Overall Study|Disease progression|3|||
148833819|NCT00415636|536872546|FG004|Overall Study|Disease progression|0|||
148833820|NCT00415636|536872547|FG005|Overall Study|Disease progression|1|||
148833821|NCT01263119|536872548|FG000|Period 1|Protocol Violation|2|||
148833822|NCT01263119|536872548|FG000|Period 2|Adverse Event|2|||
148833823|NCT02138825|536872549|FG000|Main Study Treatment|Adverse Event|11|||
148833824|NCT02138825|536872550|FG001|Main Study Treatment|Adverse Event|3|||
148833825|NCT02138825|536872549|FG000|Main Study Treatment|Death|1|||
148833826|NCT02138825|536872550|FG001|Main Study Treatment|Death|2|||
148833827|NCT02138825|536872549|FG000|Main Study Treatment|Protocol Violation|2|||
148833828|NCT02138825|536872550|FG001|Main Study Treatment|Protocol Violation|2|||
148833829|NCT02138825|536872549|FG000|Main Study Treatment|Sponsor decision|12|||
148833830|NCT02138825|536872550|FG001|Main Study Treatment|Sponsor decision|18|||
148833831|NCT02138825|536872549|FG000|Main Study Treatment|Study terminated by sponsor|10|||
148833832|NCT02138825|536872550|FG001|Main Study Treatment|Study terminated by sponsor|9|||
148833833|NCT02138825|536872549|FG000|Main Study Treatment|Withdrawal by Subject|3|||
148833834|NCT02138825|536872550|FG001|Main Study Treatment|Withdrawal by Subject|1|||
148833835|NCT02138825|536872549|FG000|Main Study Treatment|Medical decision|1|||
148833836|NCT02138825|536872550|FG001|Main Study Treatment|Medical decision|0|||
148833837|NCT02138825|536872549|FG000|Long-term Extension|Study termination by sponsor|32|||
148833838|NCT02138825|536872550|FG001|Long-term Extension|Study termination by sponsor|38|||
148833839|NCT02138825|536872549|FG000|Safety Follow-up|Adverse Event|4|||
148833840|NCT02138825|536872550|FG001|Safety Follow-up|Adverse Event|3|||
148833841|NCT02138825|536872549|FG000|Safety Follow-up|Death|11|||
148833842|NCT02138825|536872550|FG001|Safety Follow-up|Death|5|||
148833843|NCT02138825|536872549|FG000|Safety Follow-up|Withdrawal by Subject|5|||
148833844|NCT02138825|536872550|FG001|Safety Follow-up|Withdrawal by Subject|3|||
148833845|NCT02138825|536872549|FG000|Safety Follow-up|clinic worsening|1|||
148833846|NCT02138825|536872550|FG001|Safety Follow-up|clinic worsening|0|||
148772696|NCT02706886|536641092|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
148772697|NCT02706886|536641093|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
148772698|NCT01154296|536641094|FG000|Randomization and Intervention|Decided to decline|1|||
148772699|NCT01154296|536641095|FG001|Randomization and Intervention|Decided to decline|1|||
148772700|NCT01154296|536641094|FG000|Randomization and Intervention|Declined by staff|1|||
148772701|NCT01154296|536641095|FG001|Randomization and Intervention|Declined by staff|0|||
148772702|NCT01154296|536641094|FG000|Randomization and Intervention|Did not return|1|||
148772703|NCT01154296|536641095|FG001|Randomization and Intervention|Did not return|0|||
148772704|NCT01154296|536641094|FG000|Randomization and Intervention|Left before test|0|||
148772705|NCT01154296|536641095|FG001|Randomization and Intervention|Left before test|1|||
148772706|NCT01154296|536641094|FG000|Randomization and Intervention|Left clinic early|2|||
148772707|NCT01154296|536641095|FG001|Randomization and Intervention|Left clinic early|0|||
148772708|NCT01154296|536641094|FG000|6-month Follow-up|Lost contact|269|||
148772709|NCT01154296|536641095|FG001|6-month Follow-up|Lost contact|275|||
148772710|NCT01154296|536641094|FG000|6-month Follow-up|Incarcerated|37|||
148772711|NCT01154296|536641095|FG001|6-month Follow-up|Incarcerated|32|||
148772712|NCT01154296|536641094|FG000|6-month Follow-up|Withdrew consent|14|||
148772713|NCT01154296|536641095|FG001|6-month Follow-up|Withdrew consent|15|||
148772714|NCT01154296|536641094|FG000|6-month Follow-up|Death|3|||
148772715|NCT01154296|536641095|FG001|6-month Follow-up|Death|2|||
148772716|NCT01154296|536641094|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
148772717|NCT01154296|536641095|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
148772718|NCT02759055|536641096|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
148772719|NCT02759055|536641097|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
148772720|NCT04934189|536641098|FG000|Overall Study|Lost to Follow-up|4|||
148772721|NCT04934189|536641098|FG000|Overall Study|Withdrawal by Subject|17|||
148772722|NCT00970632|536641104|FG000|Overall Study|Adverse Event|2|||
148772723|NCT00970632|536641105|FG001|Overall Study|Adverse Event|2|||
148772724|NCT00970632|536641106|FG002|Overall Study|Adverse Event|1|||
148772725|NCT00970632|536641104|FG000|Overall Study|Lack of Efficacy|3|||
148772726|NCT00970632|536641105|FG001|Overall Study|Lack of Efficacy|0|||
148772727|NCT00970632|536641106|FG002|Overall Study|Lack of Efficacy|0|||
148772728|NCT00970632|536641104|FG000|Overall Study|Lost to Follow-up|3|||
148772729|NCT00970632|536641105|FG001|Overall Study|Lost to Follow-up|0|||
148772730|NCT00970632|536641106|FG002|Overall Study|Lost to Follow-up|2|||
148772731|NCT00970632|536641104|FG000|Overall Study|Protocol Violation|8|||
148772732|NCT00970632|536641105|FG001|Overall Study|Protocol Violation|5|||
148772733|NCT00970632|536641106|FG002|Overall Study|Protocol Violation|8|||
148772734|NCT00970632|536641104|FG000|Overall Study|Withdrawal by Subject|7|||
148772735|NCT00970632|536641105|FG001|Overall Study|Withdrawal by Subject|6|||
148772736|NCT00970632|536641106|FG002|Overall Study|Withdrawal by Subject|4|||
148772737|NCT00970632|536641104|FG000|Overall Study|Entry criteria not met|0|||
148772738|NCT00970632|536641105|FG001|Overall Study|Entry criteria not met|2|||
148772739|NCT00970632|536641106|FG002|Overall Study|Entry criteria not met|2|||
148772740|NCT00970632|536641104|FG000|Overall Study|Sponsor decision|1|||
148772741|NCT00970632|536641105|FG001|Overall Study|Sponsor decision|0|||
148772742|NCT00970632|536641106|FG002|Overall Study|Sponsor decision|1|||
148772743|NCT01346189|536641107|FG000|Overall Study|Withdrawal by Subject|7|||
148772744|NCT01346189|536641108|FG001|Overall Study|Withdrawal by Subject|5|||
148772745|NCT01346189|536641109|FG002|Overall Study|Withdrawal by Subject|3|||
148772746|NCT01346189|536641110|FG003|Overall Study|Withdrawal by Subject|5|||
148772747|NCT01346189|536641107|FG000|Overall Study|Physician Decision|4|||
148772748|NCT01346189|536641108|FG001|Overall Study|Physician Decision|0|||
148772749|NCT01346189|536641109|FG002|Overall Study|Physician Decision|0|||
148772750|NCT01346189|536641110|FG003|Overall Study|Physician Decision|0|||
148772751|NCT01346189|536641107|FG000|Overall Study|Moved|3|||
148772752|NCT01346189|536641108|FG001|Overall Study|Moved|0|||
148772753|NCT01346189|536641109|FG002|Overall Study|Moved|4|||
148772754|NCT01346189|536641110|FG003|Overall Study|Moved|0|||
148772755|NCT01346189|536641107|FG000|Overall Study|Other|2|||
148772756|NCT01346189|536641108|FG001|Overall Study|Other|4|||
148772757|NCT01346189|536641109|FG002|Overall Study|Other|7|||
148772758|NCT01346189|536641110|FG003|Overall Study|Other|3|||
148772759|NCT01346189|536641107|FG000|Overall Study|Death|0|||
148772760|NCT01346189|536641108|FG001|Overall Study|Death|3|||
148772761|NCT01346189|536641109|FG002|Overall Study|Death|0|||
148772762|NCT01346189|536641110|FG003|Overall Study|Death|0|||
148772763|NCT01346189|536641107|FG000|Overall Study|Non-health system primary care physician|0|||
148772764|NCT01346189|536641108|FG001|Overall Study|Non-health system primary care physician|5|||
148772765|NCT01346189|536641109|FG002|Overall Study|Non-health system primary care physician|0|||
148772766|NCT01346189|536641110|FG003|Overall Study|Non-health system primary care physician|0|||
148772767|NCT01346189|536641107|FG000|Overall Study|Travel|0|||
148772768|NCT01346189|536641108|FG001|Overall Study|Travel|0|||
148772769|NCT01346189|536641109|FG002|Overall Study|Travel|0|||
148772770|NCT01346189|536641110|FG003|Overall Study|Travel|3|||
148772771|NCT03320850|536641111|FG000|Overall Study|Lost to Follow-up|0|||
148772772|NCT03320850|536641112|FG001|Overall Study|Lost to Follow-up|0|||
148981216|NCT03095417|537411566|FG003|Overall Study|Lost to Follow-up|0|||
148981217|NCT03095417|537411563|FG000|Overall Study|refusal|0|||
148981218|NCT03095417|537411564|FG001|Overall Study|refusal|1|||
148981219|NCT03095417|537411565|FG002|Overall Study|refusal|0|||
148981220|NCT03095417|537411566|FG003|Overall Study|refusal|1|||
148981221|NCT03095417|537411563|FG000|Overall Study|Withdrawal by Subject|8|||
148772773|NCT03320850|536641113|FG002|Overall Study|Lost to Follow-up|0|||
148772774|NCT03320850|536641114|FG003|Overall Study|Lost to Follow-up|0|||
148772775|NCT03320850|536641115|FG004|Overall Study|Lost to Follow-up|1|||
148772776|NCT03320850|536641116|FG005|Overall Study|Lost to Follow-up|2|||
148772777|NCT03320850|536641117|FG006|Overall Study|Lost to Follow-up|2|||
148772778|NCT03320850|536641118|FG007|Overall Study|Lost to Follow-up|0|||
148772779|NCT03320850|536641119|FG008|Overall Study|Lost to Follow-up|6|||
148772780|NCT03320850|536641120|FG009|Overall Study|Lost to Follow-up|4|||
148772781|NCT03320850|536641111|FG000|Overall Study|Withdrawal by Subject|0|||
148772782|NCT03320850|536641112|FG001|Overall Study|Withdrawal by Subject|0|||
148772783|NCT03320850|536641113|FG002|Overall Study|Withdrawal by Subject|0|||
148772784|NCT03320850|536641114|FG003|Overall Study|Withdrawal by Subject|0|||
148772785|NCT03320850|536641115|FG004|Overall Study|Withdrawal by Subject|1|||
148772786|NCT03320850|536641116|FG005|Overall Study|Withdrawal by Subject|2|||
148772787|NCT03320850|536641117|FG006|Overall Study|Withdrawal by Subject|4|||
148772788|NCT03320850|536641118|FG007|Overall Study|Withdrawal by Subject|5|||
148772789|NCT03320850|536641119|FG008|Overall Study|Withdrawal by Subject|2|||
148772790|NCT03320850|536641120|FG009|Overall Study|Withdrawal by Subject|1|||
148772791|NCT03320850|536641111|FG000|Overall Study|Lack of Efficacy|0|||
148772792|NCT03320850|536641112|FG001|Overall Study|Lack of Efficacy|0|||
148772793|NCT03320850|536641113|FG002|Overall Study|Lack of Efficacy|0|||
148772794|NCT03320850|536641114|FG003|Overall Study|Lack of Efficacy|1|||
148772795|NCT03320850|536641115|FG004|Overall Study|Lack of Efficacy|0|||
148772796|NCT03320850|536641116|FG005|Overall Study|Lack of Efficacy|1|||
148772797|NCT03320850|536641117|FG006|Overall Study|Lack of Efficacy|0|||
148772798|NCT03320850|536641118|FG007|Overall Study|Lack of Efficacy|2|||
148772799|NCT03320850|536641119|FG008|Overall Study|Lack of Efficacy|0|||
148772800|NCT03320850|536641120|FG009|Overall Study|Lack of Efficacy|3|||
148772801|NCT03320850|536641111|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
148772802|NCT03320850|536641112|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
148772803|NCT03320850|536641113|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
148772804|NCT03320850|536641114|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
148772805|NCT03320850|536641115|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
148772806|NCT03320850|536641116|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
148772807|NCT03320850|536641117|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
148772808|NCT03320850|536641118|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
148772809|NCT03320850|536641119|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
148772810|NCT03320850|536641120|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
148772811|NCT03320850|536641111|FG000|Overall Study|Adverse Event|0|||
148772812|NCT03320850|536641112|FG001|Overall Study|Adverse Event|0|||
148772813|NCT03320850|536641113|FG002|Overall Study|Adverse Event|0|||
148772814|NCT03320850|536641114|FG003|Overall Study|Adverse Event|0|||
148772815|NCT03320850|536641115|FG004|Overall Study|Adverse Event|0|||
148772816|NCT03320850|536641116|FG005|Overall Study|Adverse Event|2|||
148772817|NCT03320850|536641117|FG006|Overall Study|Adverse Event|1|||
148772818|NCT03320850|536641118|FG007|Overall Study|Adverse Event|0|||
148772819|NCT03320850|536641119|FG008|Overall Study|Adverse Event|2|||
148772820|NCT03320850|536641120|FG009|Overall Study|Adverse Event|0|||
148772821|NCT03320850|536641111|FG000|Overall Study|Reason Not Specified|0|||
148772822|NCT03320850|536641112|FG001|Overall Study|Reason Not Specified|0|||
148772823|NCT03320850|536641113|FG002|Overall Study|Reason Not Specified|0|||
148772824|NCT03320850|536641114|FG003|Overall Study|Reason Not Specified|0|||
148772825|NCT03320850|536641115|FG004|Overall Study|Reason Not Specified|0|||
148772826|NCT03320850|536641116|FG005|Overall Study|Reason Not Specified|1|||
148772827|NCT03320850|536641117|FG006|Overall Study|Reason Not Specified|0|||
148772828|NCT03320850|536641118|FG007|Overall Study|Reason Not Specified|0|||
148772829|NCT03320850|536641119|FG008|Overall Study|Reason Not Specified|0|||
148772830|NCT03320850|536641120|FG009|Overall Study|Reason Not Specified|1|||
148772831|NCT01286168|536641127|FG000|Overall Study|Withdrawal by Subject|1|||
148772832|NCT01286168|536641127|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
148772833|NCT01424514|536641128|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
148772834|NCT01424514|536641129|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
148772835|NCT01424514|536641128|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
148772836|NCT01424514|536641129|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
148772837|NCT02487771|536641132|FG000|Overall Study|Lost to Follow-up|2|||
148772838|NCT02487771|536641133|FG001|Overall Study|Lost to Follow-up|3|||
148772839|NCT02487771|536641132|FG000|Overall Study|Moved out of area|5|||
148981222|NCT03095417|537411564|FG001|Overall Study|Withdrawal by Subject|2|||
148981223|NCT03095417|537411565|FG002|Overall Study|Withdrawal by Subject|5|||
148981224|NCT03095417|537411566|FG003|Overall Study|Withdrawal by Subject|4|||
148833847|NCT02138825|536872549|FG000|Safety Follow-up|withdrawal by PI|1|||
148833848|NCT02138825|536872550|FG001|Safety Follow-up|withdrawal by PI|0|||
148833849|NCT02138825|536872549|FG000|Safety Follow-up|logistical difficulties|0|||
148833850|NCT02138825|536872550|FG001|Safety Follow-up|logistical difficulties|1|||
148833851|NCT02138825|536872549|FG000|Safety Follow-up|progressive disease|0|||
148833852|NCT02138825|536872550|FG001|Safety Follow-up|progressive disease|2|||
148833853|NCT02138825|536872549|FG000|Safety Follow-up|too unwell to attend the visit|0|||
148833854|NCT02138825|536872550|FG001|Safety Follow-up|too unwell to attend the visit|1|||
148833855|NCT02138825|536872549|FG000|Safety Follow-up|treatment unblinded|0|||
148833856|NCT02138825|536872550|FG001|Safety Follow-up|treatment unblinded|1|||
148833857|NCT02138825|536872549|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
148833858|NCT02138825|536872550|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
148833859|NCT04562116|536872553|FG000|Overall Study|Lost to Follow-up|1|||
148833860|NCT04562116|536872553|FG000|Overall Study|Withdrawal by Subject|3|||
148833861|NCT04462471|536872561|FG000|Overall Study|Adverse Event|0|||
148833862|NCT04462471|536872562|FG001|Overall Study|Adverse Event|1|||
148833863|NCT04462471|536872563|FG002|Overall Study|Adverse Event|0|||
148833864|NCT04462471|536872564|FG003|Overall Study|Adverse Event|0|||
148833865|NCT04462471|536872561|FG000|Overall Study|Disease progression|1|||
148833866|NCT04462471|536872562|FG001|Overall Study|Disease progression|0|||
148833867|NCT04462471|536872563|FG002|Overall Study|Disease progression|0|||
148833868|NCT04462471|536872564|FG003|Overall Study|Disease progression|0|||
148833869|NCT03502200|536872567|FG000|Overall Study|Adverse Event|1|||
148833870|NCT03502200|536872568|FG001|Overall Study|Adverse Event|0|||
148833871|NCT03502200|536872567|FG000|Overall Study|Lost to Follow-up|36|||
148833872|NCT03502200|536872568|FG001|Overall Study|Lost to Follow-up|38|||
148833873|NCT03502200|536872567|FG000|Overall Study|Study Team Decision|1|||
148833874|NCT03502200|536872568|FG001|Overall Study|Study Team Decision|1|||
148833875|NCT03502200|536872567|FG000|Overall Study|Withdrawal by Subject|5|||
148833876|NCT03502200|536872568|FG001|Overall Study|Withdrawal by Subject|7|||
148833877|NCT03502200|536872567|FG000|Overall Study|Death|0|||
148833878|NCT03502200|536872568|FG001|Overall Study|Death|2|||
148833879|NCT00855335|536872569|FG000|Overall Study|Lost to Follow-up|0|||
148833880|NCT00855335|536872570|FG001|Overall Study|Lost to Follow-up|0|||
148833881|NCT00855335|536872571|FG002|Overall Study|Lost to Follow-up|3|||
148833882|NCT00855335|536872572|FG003|Overall Study|Lost to Follow-up|1|||
148833883|NCT00855335|536872573|FG004|Overall Study|Lost to Follow-up|0|||
148833884|NCT00855335|536872569|FG000|Overall Study|Withdrawal by Subject|0|||
148833885|NCT00855335|536872570|FG001|Overall Study|Withdrawal by Subject|0|||
148833886|NCT00855335|536872571|FG002|Overall Study|Withdrawal by Subject|0|||
148833887|NCT00855335|536872572|FG003|Overall Study|Withdrawal by Subject|1|||
148833888|NCT00855335|536872573|FG004|Overall Study|Withdrawal by Subject|0|||
148833889|NCT00855335|536872569|FG000|Overall Study|Adverse Event|2|||
148833890|NCT00855335|536872570|FG001|Overall Study|Adverse Event|0|||
148833891|NCT00855335|536872571|FG002|Overall Study|Adverse Event|0|||
148833892|NCT00855335|536872572|FG003|Overall Study|Adverse Event|0|||
148833893|NCT00855335|536872573|FG004|Overall Study|Adverse Event|0|||
148833894|NCT00855335|536872569|FG000|Overall Study|Physician Decision|1|||
148833895|NCT00855335|536872570|FG001|Overall Study|Physician Decision|1|||
148833896|NCT00855335|536872571|FG002|Overall Study|Physician Decision|0|||
148833897|NCT00855335|536872572|FG003|Overall Study|Physician Decision|0|||
148833898|NCT00855335|536872573|FG004|Overall Study|Physician Decision|0|||
148833899|NCT00855335|536872569|FG000|Overall Study|Other|2|||
148833900|NCT00855335|536872570|FG001|Overall Study|Other|1|||
148833901|NCT00855335|536872571|FG002|Overall Study|Other|2|||
148833902|NCT00855335|536872572|FG003|Overall Study|Other|5|||
148833903|NCT00855335|536872573|FG004|Overall Study|Other|1|||
148833904|NCT02526290|536872580|FG000|Overall Study|Adverse Event|3|||
148833905|NCT02526290|536872580|FG000|Overall Study|Withdrawal by Subject|4|||
148833906|NCT02526290|536872580|FG000|Overall Study|Physician Decision|1|||
148833907|NCT02082977|536872581|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
148833908|NCT02082977|536872582|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
148833909|NCT02082977|536872583|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
148833910|NCT02082977|536872584|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
148833911|NCT02082977|536872585|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
148833912|NCT02082977|536872586|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
148833913|NCT02082977|536872587|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
148833914|NCT02082977|536872588|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
148833915|NCT02082977|536872589|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
148833916|NCT02082977|536872590|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
148833917|NCT02082977|536872581|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833918|NCT02082977|536872582|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833919|NCT02082977|536872583|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833920|NCT02082977|536872584|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833921|NCT02082977|536872585|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833922|NCT02082977|536872586|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833923|NCT02082977|536872587|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833924|NCT02082977|536872588|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
148981225|NCT03095417|537411563|FG000|Overall Study|Physician Decision|1|||
149028309|NCT00569946|537581913|FG000|Overall Study|Objective Progression or Relapse|42|||
149028310|NCT00569946|537581913|FG000|Overall Study|Global Deterioration of Health Status|1|||
149028311|NCT00587288|537581914|FG000|Overall Study|Adverse Event|0|||
148772840|NCT02487771|536641133|FG001|Overall Study|Moved out of area|6|||
148772841|NCT02487771|536641132|FG000|Overall Study|Withdrawal by Subject|3|||
148772842|NCT02487771|536641133|FG001|Overall Study|Withdrawal by Subject|5|||
148772843|NCT04598451|536641134|FG000|Overall Study|Adverse Event|3|||
148772844|NCT04598451|536641135|FG001|Overall Study|Adverse Event|2|||
148772845|NCT04598451|536641134|FG000|Overall Study|Withdrawal by Subject|3|||
148772846|NCT04598451|536641135|FG001|Overall Study|Withdrawal by Subject|7|||
148772847|NCT04598451|536641134|FG000|Overall Study|Lost to Follow-up|2|||
148772848|NCT04598451|536641135|FG001|Overall Study|Lost to Follow-up|0|||
148772849|NCT04598451|536641134|FG000|Overall Study|Physician Decision|4|||
148772850|NCT04598451|536641135|FG001|Overall Study|Physician Decision|1|||
148772851|NCT04598451|536641134|FG000|Overall Study|Requires Prohibited Medication|1|||
148772852|NCT04598451|536641135|FG001|Overall Study|Requires Prohibited Medication|0|||
148772853|NCT04598451|536641134|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
148772854|NCT04598451|536641135|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
148772855|NCT02002533|536641136|FG000|Overall Study|Withdrawal by Subject|6|||
148772856|NCT02002533|536641137|FG001|Overall Study|Withdrawal by Subject|13|||
148772857|NCT02002533|536641136|FG000|Overall Study|Protocol Violation|0|||
148772858|NCT02002533|536641137|FG001|Overall Study|Protocol Violation|1|||
148772859|NCT02002533|536641136|FG000|Overall Study|Adverse Event|0|||
148772860|NCT02002533|536641137|FG001|Overall Study|Adverse Event|3|||
148772861|NCT02002533|536641136|FG000|Overall Study|Lost to Follow-up|0|||
148772862|NCT02002533|536641137|FG001|Overall Study|Lost to Follow-up|1|||
148772863|NCT01871402|536641147|FG000|Overall Study|Lost to Follow-up|1|||
148772864|NCT01871402|536641148|FG001|Overall Study|Lost to Follow-up|0|||
148772865|NCT01871402|536641147|FG000|Overall Study|Withdrawal by Subject|0|||
148772866|NCT01871402|536641148|FG001|Overall Study|Withdrawal by Subject|2|||
148772867|NCT01871402|536641147|FG000|Overall Study|Non-compliance|0|||
148772868|NCT01871402|536641148|FG001|Overall Study|Non-compliance|1|||
148772869|NCT04594941|536641149|FG000|Overall Study|Other|0|||
148772870|NCT04594941|536641150|FG001|Overall Study|Other|3|||
148772871|NCT04594941|536641151|FG002|Overall Study|Other|1|||
148772872|NCT04594941|536641152|FG003|Overall Study|Other|0|||
148772873|NCT00231114|536641153|FG000|Randomized|Withdrawal by Subject|6|||
148772874|NCT00231114|536641154|FG001|Randomized|Withdrawal by Subject|3|||
148772875|NCT00231114|536641153|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
148772876|NCT00231114|536641154|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
148772877|NCT00231114|536641153|FG000|Post-Treatment Period|Lost to Follow-up|6|||
148772878|NCT00231114|536641154|FG001|Post-Treatment Period|Lost to Follow-up|1|||
148772879|NCT00231114|536641153|FG000|Post-Treatment Period|Physician Decision|1|||
148772880|NCT00231114|536641154|FG001|Post-Treatment Period|Physician Decision|0|||
148772881|NCT00231114|536641153|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
148772882|NCT00231114|536641154|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
148772883|NCT02005692|536641155|FG000|Overall Study|Protocol Violation|1|||
148772884|NCT02005692|536641155|FG000|Overall Study|Withdrawal by Subject|1|||
148772885|NCT02005692|536641155|FG000|Overall Study|Discharged earlier than anticipated|5|||
148772886|NCT01194999|536641156|FG000|Overall Study|Lost to Follow-up|17|||
148772887|NCT02682823|536641157|FG000|Overall Study|Withdrawal by Subject|0|||
148772888|NCT02682823|536641158|FG001|Overall Study|Withdrawal by Subject|0|||
148772889|NCT02682823|536641159|FG002|Overall Study|Withdrawal by Subject|1|||
148772890|NCT02682823|536641160|FG003|Overall Study|Withdrawal by Subject|0|||
148772891|NCT02682823|536641161|FG004|Overall Study|Withdrawal by Subject|1|||
148772892|NCT02682823|536641157|FG000|Overall Study|Protocol Deviation|0|||
148772893|NCT02682823|536641158|FG001|Overall Study|Protocol Deviation|1|||
148772894|NCT02682823|536641159|FG002|Overall Study|Protocol Deviation|0|||
148772895|NCT02682823|536641160|FG003|Overall Study|Protocol Deviation|0|||
148772896|NCT02682823|536641161|FG004|Overall Study|Protocol Deviation|0|||
148772897|NCT02682823|536641157|FG000|Overall Study|Adverse Event|0|||
148772898|NCT02682823|536641158|FG001|Overall Study|Adverse Event|0|||
148772899|NCT02682823|536641159|FG002|Overall Study|Adverse Event|0|||
148772900|NCT02682823|536641160|FG003|Overall Study|Adverse Event|1|||
148772901|NCT02682823|536641161|FG004|Overall Study|Adverse Event|0|||
148772902|NCT05139303|536641162|FG000|Overall Study|Lost to Follow-up|3|||
148772903|NCT05139303|536641163|FG001|Overall Study|Lost to Follow-up|0|||
148772904|NCT05139303|536641162|FG000|Overall Study|Adverse Event|1|||
148772905|NCT05139303|536641163|FG001|Overall Study|Adverse Event|0|||
148772906|NCT03875482|536641164|FG000|Overall Study|Adverse Event|0|||
148772907|NCT03875482|536641165|FG001|Overall Study|Adverse Event|1|||
148772908|NCT03875482|536641164|FG000|Overall Study|Withdrew consent|5|||
149028312|NCT00587288|537581915|FG001|Overall Study|Adverse Event|1|||
148772909|NCT03875482|536641165|FG001|Overall Study|Withdrew consent|6|||
148772910|NCT03875482|536641164|FG000|Overall Study|Lost to Follow-up|8|||
148772911|NCT03875482|536641165|FG001|Overall Study|Lost to Follow-up|2|||
149028313|NCT00587288|537581914|FG000|Overall Study|Lack of Efficacy|2|||
148772912|NCT03875482|536641164|FG000|Overall Study|Lack of Efficacy|0|||
148772913|NCT03875482|536641165|FG001|Overall Study|Lack of Efficacy|11|||
148772914|NCT00631410|536641166|FG000|Overall Study|Adverse Event|1|||
148772915|NCT00631410|536641167|FG001|Overall Study|Adverse Event|3|||
148772916|NCT00631410|536641166|FG000|Overall Study|Objective Progression or Relapse|4|||
148772917|NCT00631410|536641167|FG001|Overall Study|Objective Progression or Relapse|3|||
148772918|NCT00631410|536641166|FG000|Overall Study|Surgery|1|||
148772919|NCT00631410|536641167|FG001|Overall Study|Surgery|0|||
148772920|NCT00782184|536641180|FG000|Overall Study|Adverse Event|1|||
148772921|NCT00782184|536641181|FG001|Overall Study|Adverse Event|2|||
148772922|NCT00782184|536641180|FG000|Overall Study|Protocol Violation|0|||
148772923|NCT00782184|536641181|FG001|Overall Study|Protocol Violation|1|||
148772924|NCT00782184|536641180|FG000|Overall Study|Withdrawal by Subject|3|||
148772925|NCT00782184|536641181|FG001|Overall Study|Withdrawal by Subject|2|||
148772926|NCT00890084|536641182|FG000|Overall Study|Adverse Event|16|||
148772927|NCT00890084|536641182|FG000|Overall Study|Lost to Follow-up|126|||
148772928|NCT02738879|536641183|FG000|Overall Study|Adverse Event|1|||
148772929|NCT02738879|536641184|FG001|Overall Study|Adverse Event|1|||
148772930|NCT02738879|536641183|FG000|Overall Study|Death|0|||
148772931|NCT02738879|536641184|FG001|Overall Study|Death|2|||
148772932|NCT02738879|536641183|FG000|Overall Study|Lost to Follow-up|1|||
148772933|NCT02738879|536641184|FG001|Overall Study|Lost to Follow-up|5|||
148772934|NCT02738879|536641183|FG000|Overall Study|Protocol Violation|1|||
148772935|NCT02738879|536641184|FG001|Overall Study|Protocol Violation|3|||
148772936|NCT02738879|536641183|FG000|Overall Study|Physician Decision|3|||
148772937|NCT02738879|536641184|FG001|Overall Study|Physician Decision|4|||
148772938|NCT02738879|536641183|FG000|Overall Study|Pregnancy|0|||
148772939|NCT02738879|536641184|FG001|Overall Study|Pregnancy|1|||
148772940|NCT02738879|536641183|FG000|Overall Study|Screen Failure|1|||
148772941|NCT02738879|536641184|FG001|Overall Study|Screen Failure|2|||
148772942|NCT02738879|536641183|FG000|Overall Study|Site Discontinued Study Participation|1|||
148772943|NCT02738879|536641184|FG001|Overall Study|Site Discontinued Study Participation|0|||
148772944|NCT02738879|536641183|FG000|Overall Study|Withdrawal by Subject|5|||
148772945|NCT02738879|536641184|FG001|Overall Study|Withdrawal by Subject|7|||
148772946|NCT01438294|536641185|FG000|Overall Study|Lost to Follow-up|3|||
148772947|NCT01438294|536641186|FG001|Overall Study|Lost to Follow-up|7|||
148772948|NCT01075646|536641190|FG000|Overall Study|Lost to Follow-up|4|||
148772949|NCT01075646|536641191|FG001|Overall Study|Lost to Follow-up|3|||
148772950|NCT01075646|536641192|FG002|Overall Study|Lost to Follow-up|1|||
148772951|NCT01075646|536641193|FG003|Overall Study|Lost to Follow-up|2|||
148772952|NCT01730534|536641194|FG000|Overall Study|Withdrawal by Subject|97|||
148772953|NCT01730534|536641195|FG001|Overall Study|Withdrawal by Subject|127|||
148772954|NCT01730534|536641194|FG000|Overall Study|Lost to Follow-up|12|||
148772955|NCT01730534|536641195|FG001|Overall Study|Lost to Follow-up|18|||
148772956|NCT01647516|536641199|FG000|Induction Period (IP)|Physician Decision|2|||
148772957|NCT01647516|536641200|FG001|Induction Period (IP)|Physician Decision|0|||
148772958|NCT01647516|536641201|FG002|Induction Period (IP)|Physician Decision|0|||
148772959|NCT01647516|536641202|FG003|Induction Period (IP)|Physician Decision|0|||
148772960|NCT01647516|536641203|FG004|Induction Period (IP)|Physician Decision|0|||
148772961|NCT01647516|536641204|FG005|Induction Period (IP)|Physician Decision|0|||
148772962|NCT01647516|536641199|FG000|Induction Period (IP)|Adverse Event|1|||
148772963|NCT01647516|536641200|FG001|Induction Period (IP)|Adverse Event|2|||
148772964|NCT01647516|536641201|FG002|Induction Period (IP)|Adverse Event|0|||
148772965|NCT01647516|536641202|FG003|Induction Period (IP)|Adverse Event|0|||
148772966|NCT01647516|536641203|FG004|Induction Period (IP)|Adverse Event|0|||
148772967|NCT01647516|536641204|FG005|Induction Period (IP)|Adverse Event|0|||
148772968|NCT01647516|536641199|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
148772969|NCT01647516|536641200|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
148772970|NCT01647516|536641201|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
148772971|NCT01647516|536641202|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
148772972|NCT01647516|536641203|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
148772973|NCT01647516|536641204|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
148772974|NCT01647516|536641199|FG000|Induction Period (IP)|Participant Choice|0|||
148772975|NCT01647516|536641200|FG001|Induction Period (IP)|Participant Choice|0|||
148772976|NCT01647516|536641201|FG002|Induction Period (IP)|Participant Choice|1|||
148772977|NCT01647516|536641202|FG003|Induction Period (IP)|Participant Choice|0|||
148772978|NCT01647516|536641203|FG004|Induction Period (IP)|Participant Choice|0|||
148772979|NCT01647516|536641204|FG005|Induction Period (IP)|Participant Choice|0|||
148772980|NCT01647516|536641199|FG000|Induction Period (IP)|Lack of Efficacy|1|||
148772981|NCT01647516|536641200|FG001|Induction Period (IP)|Lack of Efficacy|0|||
148772982|NCT01647516|536641201|FG002|Induction Period (IP)|Lack of Efficacy|0|||
148772983|NCT01647516|536641202|FG003|Induction Period (IP)|Lack of Efficacy|0|||
148772984|NCT01647516|536641203|FG004|Induction Period (IP)|Lack of Efficacy|0|||
148772985|NCT01647516|536641204|FG005|Induction Period (IP)|Lack of Efficacy|0|||
148772986|NCT01647516|536641199|FG000|Induction Period (IP)|No study drug received|1|||
148772987|NCT01647516|536641200|FG001|Induction Period (IP)|No study drug received|1|||
148772988|NCT01647516|536641201|FG002|Induction Period (IP)|No study drug received|0|||
149028314|NCT00587288|537581915|FG001|Overall Study|Lack of Efficacy|8|||
149028315|NCT00587288|537581914|FG000|Overall Study|Protocol Violation|1|||
149028316|NCT00587288|537581915|FG001|Overall Study|Protocol Violation|0|||
149028317|NCT00797862|537581916|FG000|Overall Study|Adverse Event|86|||
149028318|NCT00797862|537581917|FG001|Overall Study|Adverse Event|44|||
148772989|NCT01647516|536641202|FG003|Induction Period (IP)|No study drug received|0|||
148772990|NCT01647516|536641203|FG004|Induction Period (IP)|No study drug received|0|||
148772991|NCT01647516|536641204|FG005|Induction Period (IP)|No study drug received|0|||
148772992|NCT01647516|536641199|FG000|Maintenance Period (MP)|Adverse Event|2|||
148772993|NCT01647516|536641200|FG001|Maintenance Period (MP)|Adverse Event|1|||
148772994|NCT01647516|536641201|FG002|Maintenance Period (MP)|Adverse Event|0|||
148772995|NCT01647516|536641202|FG003|Maintenance Period (MP)|Adverse Event|0|||
148772996|NCT01647516|536641203|FG004|Maintenance Period (MP)|Adverse Event|0|||
148772997|NCT01647516|536641204|FG005|Maintenance Period (MP)|Adverse Event|0|||
148772998|NCT01647516|536641199|FG000|Maintenance Period (MP)|Non-compliance|1|||
148772999|NCT01647516|536641200|FG001|Maintenance Period (MP)|Non-compliance|0|||
148773000|NCT01647516|536641201|FG002|Maintenance Period (MP)|Non-compliance|0|||
148773001|NCT01647516|536641202|FG003|Maintenance Period (MP)|Non-compliance|0|||
148773002|NCT01647516|536641203|FG004|Maintenance Period (MP)|Non-compliance|0|||
148773003|NCT01647516|536641204|FG005|Maintenance Period (MP)|Non-compliance|0|||
148773004|NCT01647516|536641199|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
148773005|NCT01647516|536641200|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
148773006|NCT01647516|536641201|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
148773007|NCT01647516|536641202|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
148773008|NCT01647516|536641203|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
148773009|NCT01647516|536641204|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
148773010|NCT01647516|536641199|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
148773011|NCT01647516|536641200|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
148773012|NCT01647516|536641201|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
148773013|NCT01647516|536641202|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
148773014|NCT01647516|536641203|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
148773015|NCT01647516|536641204|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
148773016|NCT01647516|536641199|FG000|Open-Label Period|Adverse Event|0|||
148773017|NCT01647516|536641200|FG001|Open-Label Period|Adverse Event|0|||
148773018|NCT01647516|536641201|FG002|Open-Label Period|Adverse Event|0|||
148773019|NCT01647516|536641202|FG003|Open-Label Period|Adverse Event|5|||
148773020|NCT01647516|536641203|FG004|Open-Label Period|Adverse Event|6|||
148773021|NCT01647516|536641204|FG005|Open-Label Period|Adverse Event|3|||
148773022|NCT01647516|536641199|FG000|Open-Label Period|Pregnancy|0|||
148773023|NCT01647516|536641200|FG001|Open-Label Period|Pregnancy|0|||
148773024|NCT01647516|536641201|FG002|Open-Label Period|Pregnancy|0|||
148773025|NCT01647516|536641202|FG003|Open-Label Period|Pregnancy|0|||
148773026|NCT01647516|536641203|FG004|Open-Label Period|Pregnancy|0|||
148773027|NCT01647516|536641204|FG005|Open-Label Period|Pregnancy|1|||
148773028|NCT01647516|536641199|FG000|Open-Label Period|Non-compliance|0|||
148773029|NCT01647516|536641200|FG001|Open-Label Period|Non-compliance|0|||
148773030|NCT01647516|536641201|FG002|Open-Label Period|Non-compliance|0|||
148773031|NCT01647516|536641202|FG003|Open-Label Period|Non-compliance|1|||
148773032|NCT01647516|536641203|FG004|Open-Label Period|Non-compliance|0|||
148773033|NCT01647516|536641204|FG005|Open-Label Period|Non-compliance|1|||
148773034|NCT01647516|536641199|FG000|Open-Label Period|Physician Decision|0|||
148773035|NCT01647516|536641200|FG001|Open-Label Period|Physician Decision|0|||
148773036|NCT01647516|536641201|FG002|Open-Label Period|Physician Decision|0|||
148773037|NCT01647516|536641202|FG003|Open-Label Period|Physician Decision|1|||
148773038|NCT01647516|536641203|FG004|Open-Label Period|Physician Decision|1|||
148773039|NCT01647516|536641204|FG005|Open-Label Period|Physician Decision|0|||
148773040|NCT01647516|536641199|FG000|Open-Label Period|Withdrawal by Subject|0|||
148773041|NCT01647516|536641200|FG001|Open-Label Period|Withdrawal by Subject|0|||
148773042|NCT01647516|536641201|FG002|Open-Label Period|Withdrawal by Subject|0|||
148773043|NCT01647516|536641202|FG003|Open-Label Period|Withdrawal by Subject|9|||
148773044|NCT01647516|536641203|FG004|Open-Label Period|Withdrawal by Subject|11|||
148773045|NCT01647516|536641204|FG005|Open-Label Period|Withdrawal by Subject|6|||
148773046|NCT01647516|536641199|FG000|Open-Label Period|Lost to Follow-up|0|||
148773047|NCT01647516|536641200|FG001|Open-Label Period|Lost to Follow-up|0|||
148773048|NCT01647516|536641201|FG002|Open-Label Period|Lost to Follow-up|0|||
148773049|NCT01647516|536641202|FG003|Open-Label Period|Lost to Follow-up|1|||
148773050|NCT01647516|536641203|FG004|Open-Label Period|Lost to Follow-up|0|||
148833925|NCT02082977|536872589|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148773051|NCT01647516|536641204|FG005|Open-Label Period|Lost to Follow-up|1|||
148773052|NCT01647516|536641199|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
148773053|NCT01647516|536641200|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
148773054|NCT01647516|536641201|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
148773055|NCT01647516|536641202|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
148773056|NCT01647516|536641203|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
149028319|NCT00797862|537581918|FG002|Overall Study|Adverse Event|58|||
148833926|NCT02082977|536872590|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
148833927|NCT02082977|536872581|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833928|NCT02082977|536872582|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833929|NCT02082977|536872583|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833930|NCT02082977|536872584|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833931|NCT02082977|536872585|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833932|NCT02082977|536872586|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
148833933|NCT02082977|536872587|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833934|NCT02082977|536872588|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833935|NCT02082977|536872589|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833936|NCT02082977|536872590|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
148833937|NCT02082977|536872581|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
148833938|NCT02082977|536872582|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
148833939|NCT02082977|536872583|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
148833940|NCT02082977|536872584|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
148833941|NCT02082977|536872585|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
148833942|NCT02082977|536872586|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
148833943|NCT02082977|536872587|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
148833944|NCT02082977|536872588|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
148833945|NCT02082977|536872589|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
148833946|NCT02082977|536872590|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
148833947|NCT02082977|536872581|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833948|NCT02082977|536872582|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833949|NCT02082977|536872583|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833950|NCT02082977|536872584|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833951|NCT02082977|536872585|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833952|NCT02082977|536872586|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833953|NCT02082977|536872587|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833954|NCT02082977|536872588|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
148833955|NCT02082977|536872589|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833956|NCT02082977|536872590|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
148833957|NCT00049543|536872591|FG000|Overall Study|still on treatment|2|||
148833958|NCT00049543|536872592|FG001|Overall Study|still on treatment|9|||
148833959|NCT00619866|536872593|FG000|Weeks 1 - 12|Adverse Event|0|||
148833960|NCT00619866|536872594|FG001|Weeks 1 - 12|Adverse Event|1|||
148833961|NCT00619866|536872595|FG002|Weeks 1 - 12|Adverse Event|2|||
148833962|NCT00619866|536872596|FG003|Weeks 1 - 12|Adverse Event|0|||
148833963|NCT00619866|536872597|FG004|Weeks 1 - 12|Adverse Event|0|||
148833964|NCT00619866|536872593|FG000|Weeks 1 - 12|Non-compliance|0|||
148833965|NCT00619866|536872594|FG001|Weeks 1 - 12|Non-compliance|0|||
148833966|NCT00619866|536872595|FG002|Weeks 1 - 12|Non-compliance|1|||
148833967|NCT00619866|536872596|FG003|Weeks 1 - 12|Non-compliance|0|||
148833968|NCT00619866|536872597|FG004|Weeks 1 - 12|Non-compliance|0|||
148833969|NCT00619866|536872593|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
148833970|NCT00619866|536872594|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
148833971|NCT00619866|536872595|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
148833972|NCT00619866|536872596|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
148833973|NCT00619866|536872597|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
148773057|NCT01647516|536641204|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
148773058|NCT01647516|536641199|FG000|Open-Label Period|Lack of Efficacy|0|||
148773059|NCT01647516|536641200|FG001|Open-Label Period|Lack of Efficacy|0|||
148773060|NCT01647516|536641201|FG002|Open-Label Period|Lack of Efficacy|0|||
148773061|NCT01647516|536641202|FG003|Open-Label Period|Lack of Efficacy|7|||
148773062|NCT01647516|536641203|FG004|Open-Label Period|Lack of Efficacy|9|||
148773063|NCT01647516|536641204|FG005|Open-Label Period|Lack of Efficacy|10|||
148773064|NCT01647516|536641199|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
148773065|NCT01647516|536641200|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
148773066|NCT01647516|536641201|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
148773067|NCT01647516|536641202|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
148773068|NCT01647516|536641203|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
148773069|NCT01647516|536641204|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
148773070|NCT01647516|536641199|FG000|Open-Label Period|No completion / discontinuation visit|0|||
148773071|NCT01647516|536641200|FG001|Open-Label Period|No completion / discontinuation visit|0|||
148773072|NCT01647516|536641201|FG002|Open-Label Period|No completion / discontinuation visit|0|||
148773073|NCT01647516|536641202|FG003|Open-Label Period|No completion / discontinuation visit|0|||
148833974|NCT00619866|536872593|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
148833975|NCT00619866|536872594|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
148833976|NCT00619866|536872595|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
148833977|NCT00619866|536872596|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
148833978|NCT00619866|536872597|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
148833979|NCT00619866|536872593|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
148833980|NCT00619866|536872594|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
148833981|NCT00619866|536872595|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
148773074|NCT01647516|536641203|FG004|Open-Label Period|No completion / discontinuation visit|2|||
148773075|NCT01647516|536641204|FG005|Open-Label Period|No completion / discontinuation visit|1|||
148773076|NCT01676896|536641205|FG000|Overall Study|Withdrawal by Subject|12|||
148773077|NCT01676896|536641206|FG001|Overall Study|Withdrawal by Subject|7|||
148773078|NCT01676896|536641207|FG002|Overall Study|Withdrawal by Subject|19|||
148773079|NCT01613222|536641210|FG000|Overall Study|Physician Decision|1|||
148773080|NCT01613222|536641210|FG000|Overall Study|Unable to place arterial line|1|||
148773081|NCT01613222|536641210|FG000|Overall Study|Reused disposable sensors|10|||
148773082|NCT01895608|536641211|FG000|Overall Study|change in health status|0|||
148773083|NCT01895608|536641212|FG001|Overall Study|change in health status|1|||
148773084|NCT01895608|536641213|FG002|Overall Study|change in health status|1|||
148773085|NCT01895608|536641214|FG003|Overall Study|change in health status|0|||
148773086|NCT01895608|536641211|FG000|Overall Study|Withdrawal by Subject|0|||
148773087|NCT01895608|536641212|FG001|Overall Study|Withdrawal by Subject|0|||
148773088|NCT01895608|536641213|FG002|Overall Study|Withdrawal by Subject|2|||
148773089|NCT01895608|536641214|FG003|Overall Study|Withdrawal by Subject|0|||
148773090|NCT03505593|536641215|FG000|Overall Study|Withdrawal by Subject|1|||
148773091|NCT03505593|536641215|FG000|Overall Study|Died before procedure|1|||
148773092|NCT03505593|536641215|FG000|Overall Study|Anatomical abnormality|1|||
148773093|NCT03505593|536641215|FG000|Overall Study|Unable to pass through esophagus|1|||
148773094|NCT03505593|536641215|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
148773095|NCT01023256|536641217|FG000|Overall Study|Protocol Violation|2|||
148773096|NCT01023256|536641218|FG001|Overall Study|Protocol Violation|3|||
148773097|NCT01023256|536641219|FG002|Overall Study|Protocol Violation|0|||
148773098|NCT01023256|536641220|FG003|Overall Study|Protocol Violation|0|||
148773099|NCT01023256|536641217|FG000|Overall Study|Randomized but not treated|1|||
148773100|NCT01023256|536641218|FG001|Overall Study|Randomized but not treated|0|||
148773101|NCT01023256|536641219|FG002|Overall Study|Randomized but not treated|1|||
148773102|NCT01023256|536641220|FG003|Overall Study|Randomized but not treated|0|||
148773103|NCT01023256|536641217|FG000|Overall Study|Other|1|||
148773104|NCT01023256|536641218|FG001|Overall Study|Other|0|||
148773105|NCT01023256|536641219|FG002|Overall Study|Other|0|||
148773106|NCT01023256|536641220|FG003|Overall Study|Other|2|||
148773107|NCT01023256|536641217|FG000|Overall Study|Adverse Event|0|||
148773108|NCT01023256|536641218|FG001|Overall Study|Adverse Event|0|||
148773109|NCT01023256|536641219|FG002|Overall Study|Adverse Event|0|||
148773110|NCT01023256|536641220|FG003|Overall Study|Adverse Event|1|||
148773111|NCT01023256|536641217|FG000|Overall Study|Withdrawal by Subject|0|||
148773112|NCT01023256|536641218|FG001|Overall Study|Withdrawal by Subject|0|||
148773113|NCT01023256|536641219|FG002|Overall Study|Withdrawal by Subject|0|||
148773114|NCT01023256|536641220|FG003|Overall Study|Withdrawal by Subject|2|||
148773115|NCT01322035|536641221|FG000|Overall Study|Lost to Follow-up|8|||
148773116|NCT01322035|536641222|FG001|Overall Study|Lost to Follow-up|3|||
148773117|NCT04569968|536641223|FG000|Overall Study|Lost to Follow-up|2|||
148773118|NCT04569968|536641224|FG001|Overall Study|Lost to Follow-up|5|||
148773119|NCT04569968|536641223|FG000|Overall Study|Story of head and/or neck surgery|2|||
148773120|NCT04569968|536641224|FG001|Overall Study|Story of head and/or neck surgery|2|||
148773121|NCT04569968|536641223|FG000|Overall Study|Time of stroke onset|8|||
148773122|NCT04569968|536641224|FG001|Overall Study|Time of stroke onset|7|||
148773123|NCT04569968|536641223|FG000|Overall Study|Type of strokr|12|||
148773124|NCT04569968|536641224|FG001|Overall Study|Type of strokr|8|||
148773125|NCT04569968|536641223|FG000|Overall Study|Cooperation|8|||
148773126|NCT04569968|536641224|FG001|Overall Study|Cooperation|8|||
148773127|NCT04569968|536641223|FG000|Overall Study|Age interval|17|||
148773128|NCT04569968|536641224|FG001|Overall Study|Age interval|6|||
148773129|NCT04569968|536641223|FG000|Overall Study|Denial of participation to the study|0|||
148773130|NCT04569968|536641224|FG001|Overall Study|Denial of participation to the study|3|||
148773131|NCT04569968|536641223|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
148773132|NCT04569968|536641224|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
148773133|NCT04569968|536641223|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
148773134|NCT04569968|536641224|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
148773135|NCT04569968|536641223|FG000|Overall Study|Quarantine|1|||
148773136|NCT04569968|536641224|FG001|Overall Study|Quarantine|0|||
148773137|NCT04569968|536641223|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
148773138|NCT04569968|536641224|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
148773139|NCT04569968|536641223|FG000|Overall Study|Repetitive stroke|8|||
148773140|NCT04569968|536641224|FG001|Overall Study|Repetitive stroke|0|||
148773141|NCT04569968|536641223|FG000|Overall Study|Insufficient mastication|1|||
148773142|NCT04569968|536641224|FG001|Overall Study|Insufficient mastication|0|||
148773143|NCT04569968|536641223|FG000|Overall Study|Infection|1|||
148773144|NCT04569968|536641224|FG001|Overall Study|Infection|0|||
148773145|NCT00727844|536641225|FG000|Initial Randomization|Physician Decision|2|||
148773146|NCT00727844|536641226|FG001|Initial Randomization|Physician Decision|0|||
148773147|NCT00727844|536641227|FG002|Initial Randomization|Physician Decision|0|||
148773148|NCT00727844|536641228|FG003|Initial Randomization|Physician Decision|0|||
148981226|NCT03095417|537411564|FG001|Overall Study|Physician Decision|2|||
148773149|NCT00979420|536641233|FG000|Overall Study|Adverse Event|1|||
148773150|NCT00979420|536641234|FG001|Overall Study|Adverse Event|0|||
148773151|NCT00979420|536641235|FG002|Overall Study|Adverse Event|0|||
148773152|NCT00979420|536641236|FG003|Overall Study|Adverse Event|0|||
148773153|NCT00979420|536641233|FG000|Overall Study|Lack of Efficacy|3|||
148773154|NCT00979420|536641234|FG001|Overall Study|Lack of Efficacy|0|||
148773155|NCT00979420|536641235|FG002|Overall Study|Lack of Efficacy|1|||
148773156|NCT00979420|536641236|FG003|Overall Study|Lack of Efficacy|1|||
148773157|NCT00979420|536641233|FG000|Overall Study|Other reasons not related to Viramune|3|||
148773158|NCT00979420|536641234|FG001|Overall Study|Other reasons not related to Viramune|0|||
148773159|NCT00979420|536641235|FG002|Overall Study|Other reasons not related to Viramune|0|||
148773160|NCT00979420|536641236|FG003|Overall Study|Other reasons not related to Viramune|1|||
148773161|NCT01295827|536641246|FG000|Overall Study|Adverse Event|1|||
148773162|NCT01295827|536641247|FG001|Overall Study|Adverse Event|2|||
148773163|NCT01295827|536641248|FG002|Overall Study|Adverse Event|2|||
148773164|NCT01295827|536641249|FG003|Overall Study|Adverse Event|1|||
148773165|NCT01295827|536641250|FG004|Overall Study|Adverse Event|1|||
148773166|NCT01295827|536641251|FG005|Overall Study|Adverse Event|4|||
148773167|NCT01295827|536641252|FG006|Overall Study|Adverse Event|15|||
148773168|NCT01295827|536641253|FG007|Overall Study|Adverse Event|49|||
148773169|NCT01295827|536641254|FG008|Overall Study|Adverse Event|22|||
148773170|NCT01295827|536641255|FG009|Overall Study|Adverse Event|7|||
148773171|NCT01295827|536641256|FG010|Overall Study|Adverse Event|50|||
148773172|NCT01295827|536641257|FG011|Overall Study|Adverse Event|21|||
148773173|NCT01295827|536641258|FG012|Overall Study|Adverse Event|0|||
148773174|NCT01295827|536641259|FG013|Overall Study|Adverse Event|0|||
148773175|NCT01295827|536641260|FG014|Overall Study|Adverse Event|0|||
148773176|NCT01295827|536641246|FG000|Overall Study|Lost to Follow-up|0|||
148773177|NCT01295827|536641247|FG001|Overall Study|Lost to Follow-up|0|||
148773178|NCT01295827|536641248|FG002|Overall Study|Lost to Follow-up|3|||
148773179|NCT01295827|536641249|FG003|Overall Study|Lost to Follow-up|0|||
148773180|NCT01295827|536641250|FG004|Overall Study|Lost to Follow-up|1|||
148773181|NCT01295827|536641251|FG005|Overall Study|Lost to Follow-up|0|||
148773182|NCT01295827|536641252|FG006|Overall Study|Lost to Follow-up|4|||
148773183|NCT01295827|536641253|FG007|Overall Study|Lost to Follow-up|8|||
148773184|NCT01295827|536641254|FG008|Overall Study|Lost to Follow-up|7|||
148773185|NCT01295827|536641255|FG009|Overall Study|Lost to Follow-up|4|||
148773186|NCT01295827|536641256|FG010|Overall Study|Lost to Follow-up|7|||
148773187|NCT01295827|536641257|FG011|Overall Study|Lost to Follow-up|3|||
148773188|NCT01295827|536641258|FG012|Overall Study|Lost to Follow-up|0|||
148773189|NCT01295827|536641259|FG013|Overall Study|Lost to Follow-up|0|||
148773190|NCT01295827|536641260|FG014|Overall Study|Lost to Follow-up|0|||
148773191|NCT01295827|536641246|FG000|Overall Study|Not Reported|0|||
148773192|NCT01295827|536641247|FG001|Overall Study|Not Reported|0|||
148773193|NCT01295827|536641248|FG002|Overall Study|Not Reported|0|||
148773194|NCT01295827|536641249|FG003|Overall Study|Not Reported|1|||
148773195|NCT01295827|536641250|FG004|Overall Study|Not Reported|0|||
148773196|NCT01295827|536641251|FG005|Overall Study|Not Reported|0|||
148773197|NCT01295827|536641252|FG006|Overall Study|Not Reported|24|||
148773198|NCT01295827|536641253|FG007|Overall Study|Not Reported|58|||
148773199|NCT01295827|536641254|FG008|Overall Study|Not Reported|41|||
148773200|NCT01295827|536641255|FG009|Overall Study|Not Reported|2|||
148773201|NCT01295827|536641256|FG010|Overall Study|Not Reported|23|||
148773202|NCT01295827|536641257|FG011|Overall Study|Not Reported|13|||
148773203|NCT01295827|536641258|FG012|Overall Study|Not Reported|0|||
148773204|NCT01295827|536641259|FG013|Overall Study|Not Reported|0|||
148773205|NCT01295827|536641260|FG014|Overall Study|Not Reported|0|||
148773206|NCT01295827|536641246|FG000|Overall Study|Progressive Disease|2|||
148773207|NCT01295827|536641247|FG001|Overall Study|Progressive Disease|1|||
148773208|NCT01295827|536641248|FG002|Overall Study|Progressive Disease|5|||
148773209|NCT01295827|536641249|FG003|Overall Study|Progressive Disease|2|||
148773210|NCT01295827|536641250|FG004|Overall Study|Progressive Disease|0|||
148773211|NCT01295827|536641251|FG005|Overall Study|Progressive Disease|1|||
148773212|NCT01295827|536641252|FG006|Overall Study|Progressive Disease|87|||
148773213|NCT01295827|536641253|FG007|Overall Study|Progressive Disease|144|||
148773214|NCT01295827|536641254|FG008|Overall Study|Progressive Disease|85|||
148773215|NCT01295827|536641255|FG009|Overall Study|Progressive Disease|40|||
148773216|NCT01295827|536641256|FG010|Overall Study|Progressive Disease|175|||
148773217|NCT01295827|536641257|FG011|Overall Study|Progressive Disease|136|||
148773218|NCT01295827|536641258|FG012|Overall Study|Progressive Disease|0|||
148773219|NCT01295827|536641259|FG013|Overall Study|Progressive Disease|0|||
148773220|NCT01295827|536641260|FG014|Overall Study|Progressive Disease|0|||
148773221|NCT01295827|536641246|FG000|Overall Study|Screen Failure|0|||
148773222|NCT01295827|536641247|FG001|Overall Study|Screen Failure|0|||
148981227|NCT03095417|537411565|FG002|Overall Study|Physician Decision|2|||
148773223|NCT01295827|536641248|FG002|Overall Study|Screen Failure|0|||
148773224|NCT01295827|536641249|FG003|Overall Study|Screen Failure|0|||
148773225|NCT01295827|536641250|FG004|Overall Study|Screen Failure|0|||
148773226|NCT01295827|536641251|FG005|Overall Study|Screen Failure|0|||
148773227|NCT01295827|536641252|FG006|Overall Study|Screen Failure|2|||
148773228|NCT01295827|536641253|FG007|Overall Study|Screen Failure|2|||
148773229|NCT01295827|536641254|FG008|Overall Study|Screen Failure|2|||
148773230|NCT01295827|536641255|FG009|Overall Study|Screen Failure|0|||
148773231|NCT01295827|536641256|FG010|Overall Study|Screen Failure|1|||
148773232|NCT01295827|536641257|FG011|Overall Study|Screen Failure|0|||
148773233|NCT01295827|536641258|FG012|Overall Study|Screen Failure|0|||
148773234|NCT01295827|536641259|FG013|Overall Study|Screen Failure|0|||
148773235|NCT01295827|536641260|FG014|Overall Study|Screen Failure|0|||
148773236|NCT01295827|536641246|FG000|Overall Study|Withdrawal by Subject|1|||
148773237|NCT01295827|536641247|FG001|Overall Study|Withdrawal by Subject|0|||
148773238|NCT01295827|536641248|FG002|Overall Study|Withdrawal by Subject|2|||
148773239|NCT01295827|536641249|FG003|Overall Study|Withdrawal by Subject|0|||
148773240|NCT01295827|536641250|FG004|Overall Study|Withdrawal by Subject|0|||
148773241|NCT01295827|536641251|FG005|Overall Study|Withdrawal by Subject|1|||
148773242|NCT01295827|536641252|FG006|Overall Study|Withdrawal by Subject|13|||
148773243|NCT01295827|536641253|FG007|Overall Study|Withdrawal by Subject|35|||
148773244|NCT01295827|536641254|FG008|Overall Study|Withdrawal by Subject|11|||
148773245|NCT01295827|536641255|FG009|Overall Study|Withdrawal by Subject|2|||
148773246|NCT01295827|536641256|FG010|Overall Study|Withdrawal by Subject|18|||
148773247|NCT01295827|536641257|FG011|Overall Study|Withdrawal by Subject|13|||
148773248|NCT01295827|536641258|FG012|Overall Study|Withdrawal by Subject|0|||
148773249|NCT01295827|536641259|FG013|Overall Study|Withdrawal by Subject|0|||
148773250|NCT01295827|536641260|FG014|Overall Study|Withdrawal by Subject|0|||
148773251|NCT01295827|536641246|FG000|Overall Study|Other|0|||
148773252|NCT01295827|536641247|FG001|Overall Study|Other|0|||
148773253|NCT01295827|536641248|FG002|Overall Study|Other|0|||
148773254|NCT01295827|536641249|FG003|Overall Study|Other|0|||
148773255|NCT01295827|536641250|FG004|Overall Study|Other|0|||
148773256|NCT01295827|536641251|FG005|Overall Study|Other|0|||
148773257|NCT01295827|536641252|FG006|Overall Study|Other|1|||
148773258|NCT01295827|536641253|FG007|Overall Study|Other|1|||
148773259|NCT01295827|536641254|FG008|Overall Study|Other|1|||
148773260|NCT01295827|536641255|FG009|Overall Study|Other|0|||
148773261|NCT01295827|536641256|FG010|Overall Study|Other|2|||
148773262|NCT01295827|536641257|FG011|Overall Study|Other|0|||
148773263|NCT01295827|536641258|FG012|Overall Study|Other|0|||
148773264|NCT01295827|536641259|FG013|Overall Study|Other|0|||
148773265|NCT01295827|536641260|FG014|Overall Study|Other|0|||
148773266|NCT01668173|536641261|FG000|Overall Study|Adverse Event|3|||
148773267|NCT01668173|536641261|FG000|Overall Study|Trial suspension|4|||
148773268|NCT00746564|536641264|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
148773269|NCT02640677|536641269|FG000|Overall Study|Lost to Follow-up|1|||
148773270|NCT02640677|536641269|FG000|Overall Study|Withdrawal by Subject|1|||
148773271|NCT00957268|536641273|FG000|Overall Study|Voluntary Withdrawal|0|||
148773272|NCT00957268|536641274|FG001|Overall Study|Voluntary Withdrawal|0|||
148773273|NCT00957268|536641275|FG002|Overall Study|Voluntary Withdrawal|1|||
148773274|NCT00957268|536641276|FG003|Overall Study|Voluntary Withdrawal|0|||
148773275|NCT00957268|536641277|FG004|Overall Study|Voluntary Withdrawal|0|||
148773276|NCT01817582|536641280|FG000|Overall Study|Withdrawal by Subject|0|||
148773277|NCT01817582|536641281|FG001|Overall Study|Withdrawal by Subject|1|||
148773278|NCT01817582|536641282|FG002|Overall Study|Withdrawal by Subject|0|||
148773279|NCT01817582|536641280|FG000|Overall Study|Participant revealed masked treatment|1|||
148773280|NCT01817582|536641281|FG001|Overall Study|Participant revealed masked treatment|0|||
148773281|NCT01817582|536641282|FG002|Overall Study|Participant revealed masked treatment|0|||
148773282|NCT01817582|536641280|FG000|Overall Study|Randomized but exclusion criteria met|1|||
148773283|NCT01817582|536641281|FG001|Overall Study|Randomized but exclusion criteria met|0|||
148773284|NCT01817582|536641282|FG002|Overall Study|Randomized but exclusion criteria met|0|||
148773285|NCT03053063|536641283|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
148773286|NCT03053063|536641284|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
148773287|NCT03053063|536641285|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
148773288|NCT03053063|536641286|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
148773289|NCT03053063|536641283|FG000|Randomized Phase|Withdrew consent|8|||
148773290|NCT03053063|536641284|FG001|Randomized Phase|Withdrew consent|11|||
148773291|NCT03053063|536641285|FG002|Randomized Phase|Withdrew consent|5|||
148773292|NCT03053063|536641286|FG003|Randomized Phase|Withdrew consent|0|||
148773293|NCT03053063|536641283|FG000|Randomized Phase|Investigator's Discretion|8|||
148773294|NCT03053063|536641284|FG001|Randomized Phase|Investigator's Discretion|6|||
148773295|NCT03053063|536641285|FG002|Randomized Phase|Investigator's Discretion|2|||
148773296|NCT03053063|536641286|FG003|Randomized Phase|Investigator's Discretion|0|||
148773297|NCT03053063|536641283|FG000|Randomized Phase|Lost to Follow-up|3|||
148773298|NCT03053063|536641284|FG001|Randomized Phase|Lost to Follow-up|5|||
148773299|NCT03053063|536641285|FG002|Randomized Phase|Lost to Follow-up|1|||
148773300|NCT03053063|536641286|FG003|Randomized Phase|Lost to Follow-up|0|||
148773301|NCT03053063|536641283|FG000|Randomized Phase|Adverse Event|0|||
148773302|NCT03053063|536641284|FG001|Randomized Phase|Adverse Event|1|||
148773303|NCT03053063|536641285|FG002|Randomized Phase|Adverse Event|0|||
148773304|NCT03053063|536641286|FG003|Randomized Phase|Adverse Event|0|||
148833982|NCT00619866|536872596|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
148833983|NCT00619866|536872597|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
148833984|NCT00619866|536872593|FG000|Weeks 1 - 12|Sponsor Decision|0|||
148833985|NCT00619866|536872594|FG001|Weeks 1 - 12|Sponsor Decision|1|||
148833986|NCT00619866|536872595|FG002|Weeks 1 - 12|Sponsor Decision|0|||
148833987|NCT00619866|536872596|FG003|Weeks 1 - 12|Sponsor Decision|0|||
148833988|NCT00619866|536872597|FG004|Weeks 1 - 12|Sponsor Decision|0|||
148833989|NCT00619866|536872593|FG000|Weeks 13 - 24|Adverse Event|0|||
148833990|NCT00619866|536872594|FG001|Weeks 13 - 24|Adverse Event|0|||
148833991|NCT00619866|536872595|FG002|Weeks 13 - 24|Adverse Event|2|||
148833992|NCT00619866|536872596|FG003|Weeks 13 - 24|Adverse Event|1|||
148833993|NCT00619866|536872597|FG004|Weeks 13 - 24|Adverse Event|0|||
148833994|NCT00619866|536872593|FG000|Weeks 13 - 24|Protocol Deviation|0|||
148833995|NCT00619866|536872594|FG001|Weeks 13 - 24|Protocol Deviation|0|||
148833996|NCT00619866|536872595|FG002|Weeks 13 - 24|Protocol Deviation|0|||
148833997|NCT00619866|536872596|FG003|Weeks 13 - 24|Protocol Deviation|1|||
148833998|NCT00619866|536872597|FG004|Weeks 13 - 24|Protocol Deviation|0|||
148833999|NCT00619866|536872593|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
148834000|NCT00619866|536872594|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
148834001|NCT00619866|536872595|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
148834002|NCT00619866|536872596|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
148834003|NCT00619866|536872597|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
148834004|NCT00619866|536872593|FG000|Weeks 13 - 24|Non-compliance|0|||
148834005|NCT00619866|536872594|FG001|Weeks 13 - 24|Non-compliance|1|||
148834006|NCT00619866|536872595|FG002|Weeks 13 - 24|Non-compliance|1|||
148834007|NCT00619866|536872596|FG003|Weeks 13 - 24|Non-compliance|0|||
148834008|NCT00619866|536872597|FG004|Weeks 13 - 24|Non-compliance|0|||
148834009|NCT00619866|536872593|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
148834010|NCT00619866|536872594|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
148834011|NCT00619866|536872595|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
148834012|NCT00619866|536872596|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
148834013|NCT00619866|536872597|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
148834014|NCT05901636|536872615|FG000|Overall Study|Lost to Follow-up|0|||
148834015|NCT05901636|536872616|FG001|Overall Study|Lost to Follow-up|1|||
148834016|NCT05901636|536872617|FG002|Overall Study|Lost to Follow-up|0|||
148834017|NCT05901636|536872618|FG003|Overall Study|Lost to Follow-up|1|||
148834018|NCT05901636|536872619|FG004|Overall Study|Lost to Follow-up|1|||
148834019|NCT05901636|536872620|FG005|Overall Study|Lost to Follow-up|3|||
148834020|NCT05901636|536872621|FG006|Overall Study|Lost to Follow-up|1|||
148834021|NCT05901636|536872615|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
148834022|NCT05901636|536872616|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
148834023|NCT05901636|536872617|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
148834024|NCT05901636|536872618|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
148834025|NCT05901636|536872619|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
148834026|NCT05901636|536872620|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
148834027|NCT05901636|536872621|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
148834028|NCT05901636|536872615|FG000|Overall Study|Withdrawal by Subject|1|||
148834029|NCT05901636|536872616|FG001|Overall Study|Withdrawal by Subject|1|||
148834030|NCT05901636|536872617|FG002|Overall Study|Withdrawal by Subject|0|||
148834031|NCT05901636|536872618|FG003|Overall Study|Withdrawal by Subject|0|||
148834032|NCT05901636|536872619|FG004|Overall Study|Withdrawal by Subject|1|||
148834033|NCT05901636|536872620|FG005|Overall Study|Withdrawal by Subject|1|||
148834034|NCT05901636|536872621|FG006|Overall Study|Withdrawal by Subject|0|||
148834035|NCT05901636|536872615|FG000|Overall Study|Other|0|||
148834036|NCT05901636|536872616|FG001|Overall Study|Other|0|||
148834037|NCT05901636|536872617|FG002|Overall Study|Other|1|||
148834038|NCT05901636|536872618|FG003|Overall Study|Other|1|||
148834039|NCT05901636|536872619|FG004|Overall Study|Other|0|||
148834040|NCT05901636|536872620|FG005|Overall Study|Other|0|||
148834041|NCT05901636|536872621|FG006|Overall Study|Other|0|||
148834042|NCT02302222|536872622|FG000|Overall Study|Physician Decision|0|||
148834043|NCT02302222|536872623|FG001|Overall Study|Physician Decision|4|||
148834044|NCT02302222|536872622|FG000|Overall Study|Lost to Follow-up|1|||
148834045|NCT02302222|536872623|FG001|Overall Study|Lost to Follow-up|0|||
148834046|NCT02302222|536872622|FG000|Overall Study|Treatment discontinued before day 5|0|||
148834047|NCT02302222|536872623|FG001|Overall Study|Treatment discontinued before day 5|1|||
148834048|NCT02302222|536872622|FG000|Overall Study|Withdrawn prior to any treatment|0|||
148834049|NCT02302222|536872623|FG001|Overall Study|Withdrawn prior to any treatment|1|||
148834050|NCT03193801|536872624|FG000|Overall Study|Physician Decision|2|||
148834051|NCT03193801|536872624|FG000|Overall Study|Withdrawal by Subject|1|||
148834052|NCT03138564|536872625|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
148834053|NCT03138564|536872626|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
148834054|NCT03138564|536872625|FG000|Overall Study|Lost to Follow-up|16|||
148834055|NCT03138564|536872626|FG001|Overall Study|Lost to Follow-up|2|||
148834056|NCT03138564|536872625|FG000|Overall Study|Withdrawal by Subject|48|||
148834057|NCT03138564|536872626|FG001|Overall Study|Withdrawal by Subject|4|||
148834058|NCT03138564|536872625|FG000|Overall Study|No longer met eligibility criteria|2|||
148834059|NCT03138564|536872626|FG001|Overall Study|No longer met eligibility criteria|0|||
148834060|NCT03138564|536872625|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
148834061|NCT03138564|536872626|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
148834062|NCT03138564|536872625|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
148834063|NCT03138564|536872626|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
148834064|NCT03138564|536872625|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
148834065|NCT03138564|536872626|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
148834066|NCT03138564|536872625|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
148834067|NCT03138564|536872626|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
148834068|NCT03330847|536872630|FG000|Overall Study|Patients ongoing study|62|||
148834069|NCT03330847|536872631|FG001|Overall Study|Patients ongoing study|65|||
148834070|NCT03330847|536872632|FG002|Overall Study|Patients ongoing study|15|||
148834071|NCT05211596|536872635|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
148834072|NCT05211596|536872635|FG000|Baseline to 6 Months|Death|1|||
148834073|NCT05211596|536872635|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
148834074|NCT05211596|536872635|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
148834075|NCT02769481|536872636|FG000|Overall Study|Protocol Violation|1|||
148834076|NCT02769481|536872637|FG001|Overall Study|Protocol Violation|0|||
148834077|NCT02769481|536872636|FG000|Overall Study|Adverse Event|3|||
148834078|NCT02769481|536872637|FG001|Overall Study|Adverse Event|6|||
148834079|NCT02769481|536872636|FG000|Overall Study|Entry Criteria Not Met|1|||
148834080|NCT02769481|536872637|FG001|Overall Study|Entry Criteria Not Met|2|||
148834081|NCT02769481|536872636|FG000|Overall Study|Withdrawal by Subject|14|||
148834082|NCT02769481|536872637|FG001|Overall Study|Withdrawal by Subject|16|||
148834083|NCT02769481|536872636|FG000|Overall Study|Lost to Follow-up|9|||
148834084|NCT02769481|536872637|FG001|Overall Study|Lost to Follow-up|9|||
148834085|NCT02769481|536872636|FG000|Overall Study|Physician Decision|0|||
148834086|NCT02769481|536872637|FG001|Overall Study|Physician Decision|1|||
148834087|NCT02769481|536872636|FG000|Overall Study|Terminated by Sponsor|1|||
148834088|NCT02769481|536872637|FG001|Overall Study|Terminated by Sponsor|0|||
148834089|NCT02769481|536872636|FG000|Overall Study|Death|0|||
148834090|NCT02769481|536872637|FG001|Overall Study|Death|1|||
148834091|NCT02769481|536872636|FG000|Overall Study|Undefined|4|||
148834092|NCT02769481|536872637|FG001|Overall Study|Undefined|1|||
148834093|NCT06272383|536872638|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
148834094|NCT06272383|536872639|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
148834095|NCT04398706|536872640|FG000|Overall Study|Adverse Event|0|||
148834096|NCT04398706|536872641|FG001|Overall Study|Adverse Event|0|||
148834097|NCT04398706|536872642|FG002|Overall Study|Adverse Event|0|||
148834098|NCT04398706|536872643|FG003|Overall Study|Adverse Event|0|||
148834099|NCT04398706|536872644|FG004|Overall Study|Adverse Event|0|||
148834100|NCT04398706|536872645|FG005|Overall Study|Adverse Event|1|||
148834101|NCT04398706|536872646|FG006|Overall Study|Adverse Event|1|||
148834102|NCT04398706|536872647|FG007|Overall Study|Adverse Event|0|||
148834103|NCT04398706|536872640|FG000|Overall Study|Lost to Follow-up|0|||
148834104|NCT04398706|536872641|FG001|Overall Study|Lost to Follow-up|1|||
148834105|NCT04398706|536872642|FG002|Overall Study|Lost to Follow-up|2|||
148834106|NCT04398706|536872643|FG003|Overall Study|Lost to Follow-up|1|||
148834107|NCT04398706|536872644|FG004|Overall Study|Lost to Follow-up|6|||
148834108|NCT04398706|536872645|FG005|Overall Study|Lost to Follow-up|3|||
148834109|NCT04398706|536872646|FG006|Overall Study|Lost to Follow-up|8|||
148834110|NCT04398706|536872647|FG007|Overall Study|Lost to Follow-up|2|||
148834111|NCT04398706|536872640|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148834112|NCT04398706|536872641|FG001|Overall Study|Withdrawal by parent/guardian|2|||
148834113|NCT04398706|536872642|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148834114|NCT04398706|536872643|FG003|Overall Study|Withdrawal by parent/guardian|2|||
148834115|NCT04398706|536872644|FG004|Overall Study|Withdrawal by parent/guardian|19|||
148834116|NCT04398706|536872645|FG005|Overall Study|Withdrawal by parent/guardian|23|||
148834117|NCT04398706|536872646|FG006|Overall Study|Withdrawal by parent/guardian|13|||
148834118|NCT04398706|536872647|FG007|Overall Study|Withdrawal by parent/guardian|11|||
148834119|NCT04398706|536872640|FG000|Overall Study|Protocol deviation|0|||
148834120|NCT04398706|536872641|FG001|Overall Study|Protocol deviation|1|||
148834121|NCT04398706|536872642|FG002|Overall Study|Protocol deviation|0|||
148834122|NCT04398706|536872643|FG003|Overall Study|Protocol deviation|0|||
148834123|NCT04398706|536872644|FG004|Overall Study|Protocol deviation|6|||
148834124|NCT04398706|536872645|FG005|Overall Study|Protocol deviation|4|||
148834125|NCT04398706|536872646|FG006|Overall Study|Protocol deviation|6|||
148834126|NCT04398706|536872647|FG007|Overall Study|Protocol deviation|3|||
148834127|NCT05201807|536874304|FG000|Overall Study|Adverse Event|1|||
148834128|NCT05201807|536874304|FG000|Overall Study|COVID-19 Related|1|||
148834129|NCT01209767|536874308|FG000|Overall Study|Withdrawal by Subject|1|||
148834130|NCT01209767|536874308|FG000|Overall Study|Lost to Follow-up|3|||
148834131|NCT01702298|536874309|FG000|Overall Study|Withdrawal by Subject|1|||
148834132|NCT02367456|536874314|FG000|Overall Study|Death|8|||
148834133|NCT02367456|536874315|FG001|Overall Study|Death|24|||
148834134|NCT02367456|536874316|FG002|Overall Study|Death|17|||
148834135|NCT02367456|536874314|FG000|Overall Study|Lost to Follow-up|1|||
148834136|NCT02367456|536874315|FG001|Overall Study|Lost to Follow-up|3|||
148834137|NCT02367456|536874316|FG002|Overall Study|Lost to Follow-up|1|||
148834138|NCT02367456|536874314|FG000|Overall Study|Other reason|3|||
148834139|NCT02367456|536874315|FG001|Overall Study|Other reason|3|||
148834140|NCT02367456|536874316|FG002|Overall Study|Other reason|9|||
148834141|NCT02367456|536874314|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
148834142|NCT02367456|536874315|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
148834143|NCT02367456|536874316|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
148834144|NCT02862574|536874317|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148834145|NCT02862574|536874318|FG001|Double-Blind Treatment Period|Adverse Event|1|||
148834146|NCT02862574|536874319|FG002|Double-Blind Treatment Period|Adverse Event|0|||
148834147|NCT02862574|536874317|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
148834148|NCT02862574|536874318|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
148834149|NCT02862574|536874319|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
148834150|NCT02862574|536874317|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
148834151|NCT02862574|536874318|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
148834152|NCT02862574|536874319|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
148834153|NCT04573972|536874320|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
148834154|NCT04573972|536874321|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
148834155|NCT05067335|536874324|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
148834156|NCT05067335|536874325|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
148834157|NCT05067335|536874326|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
148834158|NCT05067335|536874327|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
148834159|NCT05067335|536874324|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
148834160|NCT05067335|536874325|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
148834161|NCT05067335|536874326|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
148834162|NCT05067335|536874327|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
148834163|NCT05067335|536874324|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
148834164|NCT05067335|536874325|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
148834165|NCT05067335|536874326|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
148834166|NCT05067335|536874327|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
148834167|NCT05067335|536874324|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
148834168|NCT05067335|536874325|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
148834169|NCT05067335|536874326|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
148834170|NCT05067335|536874327|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
148834171|NCT05067335|536874324|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
148834172|NCT05067335|536874325|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
148834173|NCT05067335|536874326|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
148834174|NCT05067335|536874327|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
148834175|NCT05067335|536874324|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
148834176|NCT05067335|536874325|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
148834177|NCT05067335|536874326|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
148834178|NCT05067335|536874327|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
148834179|NCT05067335|536874324|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
148834180|NCT05067335|536874325|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
148834181|NCT05067335|536874326|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
148834182|NCT05067335|536874327|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
148834183|NCT05067335|536874324|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
148834184|NCT05067335|536874325|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
148834185|NCT05067335|536874326|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
148834186|NCT05067335|536874327|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
148834187|NCT05067335|536874324|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
148834188|NCT05067335|536874325|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
148834189|NCT05067335|536874326|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
149028320|NCT00797862|537581916|FG000|Overall Study|Abnormal Test Procedure Result|0|||
149028321|NCT00797862|537581917|FG001|Overall Study|Abnormal Test Procedure Result|1|||
149028322|NCT00797862|537581918|FG002|Overall Study|Abnormal Test Procedure Result|1|||
148834190|NCT05067335|536874327|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
148834191|NCT05067335|536874324|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
148834192|NCT05067335|536874325|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
148981228|NCT03095417|537411566|FG003|Overall Study|Physician Decision|2|||
148981229|NCT03095417|537411563|FG000|Overall Study|Death|1|||
148981230|NCT03095417|537411564|FG001|Overall Study|Death|2|||
148981231|NCT03095417|537411565|FG002|Overall Study|Death|1|||
148981232|NCT03095417|537411566|FG003|Overall Study|Death|3|||
148773305|NCT03053063|536641283|FG000|Randomized Phase|Randomized but Never Treated|1|||
148773306|NCT03053063|536641284|FG001|Randomized Phase|Randomized but Never Treated|3|||
148773307|NCT03053063|536641285|FG002|Randomized Phase|Randomized but Never Treated|2|||
148773308|NCT03053063|536641286|FG003|Randomized Phase|Randomized but Never Treated|0|||
148773309|NCT03053063|536641283|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
148773310|NCT03053063|536641284|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
148773311|NCT03053063|536641285|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
148773312|NCT03053063|536641286|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
148773313|NCT03053063|536641283|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
148773314|NCT03053063|536641284|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
148773315|NCT03053063|536641285|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
148773316|NCT03053063|536641286|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
148773317|NCT03053063|536641283|FG000|Open-Label Phase|Death|0|||
148773318|NCT03053063|536641284|FG001|Open-Label Phase|Death|0|||
148773319|NCT03053063|536641285|FG002|Open-Label Phase|Death|0|||
148773320|NCT03053063|536641286|FG003|Open-Label Phase|Death|2|||
148773321|NCT03053063|536641283|FG000|Open-Label Phase|Investigator's discretion|0|||
148773322|NCT03053063|536641284|FG001|Open-Label Phase|Investigator's discretion|0|||
148773323|NCT03053063|536641285|FG002|Open-Label Phase|Investigator's discretion|0|||
148773324|NCT03053063|536641286|FG003|Open-Label Phase|Investigator's discretion|2|||
148773325|NCT03055494|536642934|FG000|Overall Study|Lost to Follow-up|6|||
148773326|NCT03055494|536642935|FG001|Overall Study|Lost to Follow-up|0|||
148773327|NCT03055494|536642934|FG000|Overall Study|Physician Decision|2|||
148773328|NCT03055494|536642935|FG001|Overall Study|Physician Decision|0|||
148773329|NCT03055494|536642934|FG000|Overall Study|Withdrawal by Subject|1|||
148773330|NCT03055494|536642935|FG001|Overall Study|Withdrawal by Subject|0|||
148773331|NCT03055494|536642934|FG000|Overall Study|Adverse Event|0|||
148773332|NCT03055494|536642935|FG001|Overall Study|Adverse Event|1|||
148773333|NCT03055494|536642934|FG000|Overall Study|Non-compliance with study treatment|1|||
148773334|NCT03055494|536642935|FG001|Overall Study|Non-compliance with study treatment|0|||
148773335|NCT03197467|536642938|FG000|Overall Study|Withdrawal by Subject|1|||
148773336|NCT02653170|536642943|FG000|Overall Study|Withdrawal by Subject|3|||
148773337|NCT02653170|536642944|FG001|Overall Study|Withdrawal by Subject|8|||
148773338|NCT02653170|536642945|FG002|Overall Study|Withdrawal by Subject|3|||
148773339|NCT02653170|536642943|FG000|Overall Study|withdrawn by study team|2|||
148773340|NCT02653170|536642944|FG001|Overall Study|withdrawn by study team|4|||
148773341|NCT02653170|536642945|FG002|Overall Study|withdrawn by study team|5|||
148773342|NCT02653170|536642943|FG000|Overall Study|Lost to Follow-up|12|||
148773343|NCT02653170|536642944|FG001|Overall Study|Lost to Follow-up|4|||
148773344|NCT02653170|536642945|FG002|Overall Study|Lost to Follow-up|10|||
148773345|NCT02086448|536642946|FG000|Overall Study|Withdrawal by Subject|1|||
148773346|NCT02086448|536642947|FG001|Overall Study|Withdrawal by Subject|0|||
148773347|NCT02086448|536642948|FG002|Overall Study|Withdrawal by Subject|0|||
148773348|NCT02086448|536642949|FG003|Overall Study|Withdrawal by Subject|2|||
148773349|NCT01942486|536642958|FG000|Overall Study|Lost to Follow-up|27|||
148773350|NCT03728426|536642959|FG000|Overall Study|Death|3|||
148773351|NCT02424630|536642960|FG000|Overall Study|No rotator cuff tear|1|||
148773352|NCT02424630|536642961|FG001|Overall Study|No rotator cuff tear|2|||
148773353|NCT02424630|536642960|FG000|Overall Study|Open procedure|0|||
148773354|NCT02424630|536642961|FG001|Overall Study|Open procedure|1|||
148773355|NCT02637895|536642962|FG000|Overall Study|Lost to Follow-up|4|||
148773356|NCT02637895|536642963|FG001|Overall Study|Lost to Follow-up|0|||
148773357|NCT02637895|536642962|FG000|Overall Study|Protocol Violation|0|||
148773358|NCT02637895|536642963|FG001|Overall Study|Protocol Violation|1|||
148773359|NCT02637895|536642962|FG000|Overall Study|Lack of Efficacy|1|||
148773360|NCT02637895|536642963|FG001|Overall Study|Lack of Efficacy|0|||
148773361|NCT02637895|536642962|FG000|Overall Study|Withdrawal by Subject|1|||
148773362|NCT02637895|536642963|FG001|Overall Study|Withdrawal by Subject|1|||
148773363|NCT02637895|536642962|FG000|Overall Study|Abnormal baseline lab|0|||
148773364|NCT02637895|536642963|FG001|Overall Study|Abnormal baseline lab|1|||
148773365|NCT02031640|536642964|FG000|Screening Period|Adverse Event|1|||
148773366|NCT02031640|536642965|FG001|Screening Period|Adverse Event|0|||
148773367|NCT02031640|536642966|FG002|Screening Period|Adverse Event|0|||
148773368|NCT02031640|536642967|FG003|Screening Period|Adverse Event|0|||
148773369|NCT02031640|536642968|FG004|Screening Period|Adverse Event|0|||
148773370|NCT02031640|536642969|FG005|Screening Period|Adverse Event|0|||
148773371|NCT02031640|536642964|FG000|Screening Period|Withdrawal by Subject|29|||
148981233|NCT02571452|537411567|FG000|Overall Study Treatment|Protocol Violation|0|||
148773372|NCT02031640|536642965|FG001|Screening Period|Withdrawal by Subject|0|||
148981234|NCT02571452|537411568|FG001|Overall Study Treatment|Protocol Violation|1|||
148981235|NCT02571452|537411567|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
148981236|NCT02571452|537411568|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
149028323|NCT00797862|537581916|FG000|Overall Study|Lack of Efficacy|1|||
149028324|NCT00797862|537581917|FG001|Overall Study|Lack of Efficacy|7|||
149028325|NCT00797862|537581918|FG002|Overall Study|Lack of Efficacy|6|||
149028326|NCT00797862|537581916|FG000|Overall Study|No longer required study medication|1|||
149028327|NCT00797862|537581917|FG001|Overall Study|No longer required study medication|0|||
149028328|NCT00797862|537581918|FG002|Overall Study|No longer required study medication|0|||
149028329|NCT00797862|537581916|FG000|Overall Study|Withdrawal by Subject|14|||
149028330|NCT00797862|537581917|FG001|Overall Study|Withdrawal by Subject|7|||
149028331|NCT00797862|537581918|FG002|Overall Study|Withdrawal by Subject|7|||
149028332|NCT00797862|537581916|FG000|Overall Study|Lost to Follow-up|11|||
149028333|NCT00797862|537581917|FG001|Overall Study|Lost to Follow-up|0|||
149028334|NCT00797862|537581918|FG002|Overall Study|Lost to Follow-up|5|||
149028335|NCT00797862|537581916|FG000|Overall Study|Administrative Problem|4|||
149028336|NCT00797862|537581917|FG001|Overall Study|Administrative Problem|0|||
149028337|NCT00797862|537581918|FG002|Overall Study|Administrative Problem|0|||
149028338|NCT00797862|537581916|FG000|Overall Study|Protocol Violation|4|||
149028339|NCT00797862|537581917|FG001|Overall Study|Protocol Violation|6|||
149028340|NCT00797862|537581918|FG002|Overall Study|Protocol Violation|8|||
149028341|NCT00797862|537581916|FG000|Overall Study|Mis-randomized|3|||
149028342|NCT00797862|537581917|FG001|Overall Study|Mis-randomized|3|||
149028343|NCT00797862|537581918|FG002|Overall Study|Mis-randomized|1|||
149028344|NCT05074498|537581921|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
149028345|NCT05074498|537581922|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
149028346|NCT05074498|537581923|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
149028347|NCT05074498|537581924|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
149028348|NCT05074498|537581925|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
149028349|NCT05074498|537581926|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
149028350|NCT05074498|537581921|FG000|Part 1 (Upto Day 104)|Other|1|||
149028351|NCT05074498|537581922|FG001|Part 1 (Upto Day 104)|Other|0|||
149028352|NCT05074498|537581923|FG002|Part 1 (Upto Day 104)|Other|0|||
149028353|NCT05074498|537581924|FG003|Part 1 (Upto Day 104)|Other|0|||
149028354|NCT05074498|537581925|FG004|Part 1 (Upto Day 104)|Other|0|||
149028355|NCT05074498|537581926|FG005|Part 1 (Upto Day 104)|Other|0|||
149028356|NCT05074498|537581921|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
149028357|NCT05074498|537581922|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
149028358|NCT05074498|537581923|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
149028359|NCT05074498|537581924|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
149028360|NCT05074498|537581925|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
149028361|NCT05074498|537581926|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
148981237|NCT02571452|537411567|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
148981238|NCT02571452|537411568|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
148981239|NCT01877421|537411569|FG000|Phase 2|Lost to Follow-up|0|||
148981240|NCT01877421|537411570|FG001|Phase 2|Lost to Follow-up|0|||
148981241|NCT01877421|537411571|FG002|Phase 2|Lost to Follow-up|0|||
148981242|NCT01877421|537411572|FG003|Phase 2|Lost to Follow-up|0|||
148981243|NCT01877421|537411573|FG004|Phase 2|Lost to Follow-up|0|||
148981244|NCT01877421|537411574|FG005|Phase 2|Lost to Follow-up|0|||
148981245|NCT01877421|537411575|FG006|Phase 2|Lost to Follow-up|1|||
148981246|NCT01877421|537411576|FG007|Phase 2|Lost to Follow-up|0|||
149028362|NCT05074498|537581921|FG000|Part 2 (Upto Day 104)|Death|0|||
149028363|NCT05074498|537581922|FG001|Part 2 (Upto Day 104)|Death|0|||
149028364|NCT05074498|537581923|FG002|Part 2 (Upto Day 104)|Death|0|||
149028365|NCT05074498|537581924|FG003|Part 2 (Upto Day 104)|Death|0|||
149028366|NCT05074498|537581925|FG004|Part 2 (Upto Day 104)|Death|1|||
149028367|NCT05074498|537581926|FG005|Part 2 (Upto Day 104)|Death|0|||
148981247|NCT01877421|537411577|FG008|Phase 2|Lost to Follow-up|0|||
148981248|NCT01877421|537411578|FG009|Phase 2|Lost to Follow-up|0|||
148981249|NCT01877421|537411579|FG010|Phase 2|Lost to Follow-up|0|||
149028368|NCT05074498|537581921|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
149028369|NCT05074498|537581922|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
149028370|NCT05074498|537581923|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
149028371|NCT05074498|537581924|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
149028372|NCT05074498|537581925|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
149028373|NCT05074498|537581926|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
149028374|NCT05074498|537581921|FG000|Part 2 (Upto Day 104)|Other|0|||
149028375|NCT05074498|537581922|FG001|Part 2 (Upto Day 104)|Other|0|||
149028376|NCT05074498|537581923|FG002|Part 2 (Upto Day 104)|Other|0|||
149028377|NCT05074498|537581924|FG003|Part 2 (Upto Day 104)|Other|0|||
149028378|NCT05074498|537581925|FG004|Part 2 (Upto Day 104)|Other|1|||
149028379|NCT05074498|537581926|FG005|Part 2 (Upto Day 104)|Other|0|||
149028380|NCT01240356|537581927|FG000|Overall Study|Withdrawal by Subject|2|||
149028381|NCT01240356|537581928|FG001|Overall Study|Withdrawal by Subject|0|||
149028382|NCT01240356|537581927|FG000|Overall Study|MRI contraindication|1|||
149028383|NCT01240356|537581928|FG001|Overall Study|MRI contraindication|0|||
149028384|NCT01306331|537581929|FG000|Overall Study|Adverse Event|28|||
148981250|NCT01877421|537411580|FG011|Phase 2|Lost to Follow-up|0|||
149028385|NCT01306331|537581930|FG001|Overall Study|Adverse Event|25|||
149028386|NCT01306331|537581929|FG000|Overall Study|Lost to Follow-up|321|||
148773373|NCT02031640|536642966|FG002|Screening Period|Withdrawal by Subject|0|||
148773374|NCT02031640|536642967|FG003|Screening Period|Withdrawal by Subject|0|||
148773375|NCT02031640|536642968|FG004|Screening Period|Withdrawal by Subject|0|||
148773376|NCT02031640|536642969|FG005|Screening Period|Withdrawal by Subject|0|||
148773377|NCT02031640|536642964|FG000|Screening Period|Inclusion criteria not met|312|||
148773378|NCT02031640|536642965|FG001|Screening Period|Inclusion criteria not met|0|||
148773379|NCT02031640|536642966|FG002|Screening Period|Inclusion criteria not met|0|||
148773380|NCT02031640|536642967|FG003|Screening Period|Inclusion criteria not met|0|||
148773381|NCT02031640|536642968|FG004|Screening Period|Inclusion criteria not met|0|||
148773382|NCT02031640|536642969|FG005|Screening Period|Inclusion criteria not met|0|||
148773383|NCT02031640|536642964|FG000|Screening Period|Exclusion criteria met|30|||
148773384|NCT02031640|536642965|FG001|Screening Period|Exclusion criteria met|0|||
148773385|NCT02031640|536642966|FG002|Screening Period|Exclusion criteria met|0|||
148773386|NCT02031640|536642967|FG003|Screening Period|Exclusion criteria met|0|||
148773387|NCT02031640|536642968|FG004|Screening Period|Exclusion criteria met|0|||
148773388|NCT02031640|536642969|FG005|Screening Period|Exclusion criteria met|0|||
148773389|NCT02031640|536642964|FG000|Screening Period|Lost to Follow-up|14|||
148773390|NCT02031640|536642965|FG001|Screening Period|Lost to Follow-up|0|||
148773391|NCT02031640|536642966|FG002|Screening Period|Lost to Follow-up|0|||
148773392|NCT02031640|536642967|FG003|Screening Period|Lost to Follow-up|0|||
148773393|NCT02031640|536642968|FG004|Screening Period|Lost to Follow-up|0|||
148773394|NCT02031640|536642969|FG005|Screening Period|Lost to Follow-up|0|||
148773395|NCT02031640|536642964|FG000|Screening Period|Enrollment closed|26|||
148773396|NCT02031640|536642965|FG001|Screening Period|Enrollment closed|0|||
148773397|NCT02031640|536642966|FG002|Screening Period|Enrollment closed|0|||
148773398|NCT02031640|536642967|FG003|Screening Period|Enrollment closed|0|||
148773399|NCT02031640|536642968|FG004|Screening Period|Enrollment closed|0|||
148773400|NCT02031640|536642969|FG005|Screening Period|Enrollment closed|0|||
148773401|NCT02031640|536642964|FG000|Run-In Period|Adverse Event|4|||
148773402|NCT02031640|536642965|FG001|Run-In Period|Adverse Event|0|||
148773403|NCT02031640|536642966|FG002|Run-In Period|Adverse Event|0|||
148773404|NCT02031640|536642967|FG003|Run-In Period|Adverse Event|0|||
148773405|NCT02031640|536642968|FG004|Run-In Period|Adverse Event|0|||
148773406|NCT02031640|536642969|FG005|Run-In Period|Adverse Event|0|||
148773407|NCT02031640|536642964|FG000|Run-In Period|Withdrawal by Subject|17|||
148773408|NCT02031640|536642965|FG001|Run-In Period|Withdrawal by Subject|0|||
148773409|NCT02031640|536642966|FG002|Run-In Period|Withdrawal by Subject|0|||
148773410|NCT02031640|536642967|FG003|Run-In Period|Withdrawal by Subject|0|||
148834193|NCT05067335|536874326|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
148834194|NCT05067335|536874327|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
148834195|NCT02724839|536874328|FG000|Overall Study|Withdrawal by Subject|1|||
148834196|NCT02724839|536874329|FG001|Overall Study|Withdrawal by Subject|1|||
148834197|NCT02724839|536874330|FG002|Overall Study|Withdrawal by Subject|0|||
148834198|NCT02724839|536874328|FG000|Overall Study|Lost to Follow-up|0|||
148834199|NCT02724839|536874329|FG001|Overall Study|Lost to Follow-up|3|||
148834200|NCT02724839|536874330|FG002|Overall Study|Lost to Follow-up|2|||
148834201|NCT02724839|536874328|FG000|Overall Study|Physician Decision|0|||
148834202|NCT02724839|536874329|FG001|Overall Study|Physician Decision|0|||
148834203|NCT02724839|536874330|FG002|Overall Study|Physician Decision|3|||
148834204|NCT00949533|536874331|FG000|Overall Study|Lost to Follow-up|0|||
148834205|NCT00949533|536874332|FG001|Overall Study|Lost to Follow-up|1|||
148834206|NCT01493089|536874333|FG000|Overall Study|Protocol Violation|2|||
148834207|NCT01493089|536874334|FG001|Overall Study|Protocol Violation|2|||
148834208|NCT01493089|536874333|FG000|Overall Study|Withdrawal by Subject|1|||
148834209|NCT01493089|536874334|FG001|Overall Study|Withdrawal by Subject|0|||
148834210|NCT01493089|536874333|FG000|Overall Study|Physician Decision|0|||
148834211|NCT01493089|536874334|FG001|Overall Study|Physician Decision|1|||
148834212|NCT00583219|536874339|FG000|Phase 2|Withdrawal by Subject|1|||
148834213|NCT02090764|536874340|FG000|Overall Study|Adverse Event|1|||
148834214|NCT02090764|536874341|FG001|Overall Study|Adverse Event|3|||
148834215|NCT02090764|536874340|FG000|Overall Study|Lack of Efficacy|0|||
148834216|NCT02090764|536874341|FG001|Overall Study|Lack of Efficacy|13|||
148834217|NCT02090764|536874340|FG000|Overall Study|Withdrawal by Subject|2|||
148981251|NCT01877421|537411581|FG012|Phase 2|Lost to Follow-up|0|||
148981252|NCT01877421|537411582|FG013|Phase 2|Lost to Follow-up|0|||
148981253|NCT01877421|537411583|FG014|Phase 2|Lost to Follow-up|0|||
148981254|NCT01877421|537411584|FG015|Phase 2|Lost to Follow-up|0|||
148773411|NCT02031640|536642968|FG004|Run-In Period|Withdrawal by Subject|0|||
148773412|NCT02031640|536642969|FG005|Run-In Period|Withdrawal by Subject|0|||
148834218|NCT02090764|536874341|FG001|Overall Study|Withdrawal by Subject|1|||
148834219|NCT02090764|536874340|FG000|Overall Study|Intercurrent illness and other|1|||
148834220|NCT02090764|536874341|FG001|Overall Study|Intercurrent illness and other|1|||
148834221|NCT02090764|536874340|FG000|Overall Study|Lost to Follow-up|2|||
148834222|NCT02090764|536874341|FG001|Overall Study|Lost to Follow-up|2|||
148981255|NCT01877421|537411585|FG016|Phase 2|Lost to Follow-up|0|||
148773413|NCT02031640|536642964|FG000|Run-In Period|Inclusion criteria not met|38|||
149028387|NCT01306331|537581930|FG001|Overall Study|Lost to Follow-up|323|||
149028388|NCT01306331|537581929|FG000|Overall Study|Physician Decision|26|||
149028389|NCT01306331|537581930|FG001|Overall Study|Physician Decision|22|||
149028390|NCT01306331|537581929|FG000|Overall Study|Pregnancy|136|||
149028391|NCT01306331|537581930|FG001|Overall Study|Pregnancy|151|||
149028392|NCT01306331|537581929|FG000|Overall Study|Protocol Violation|154|||
149028393|NCT01306331|537581930|FG001|Overall Study|Protocol Violation|124|||
149028394|NCT01306331|537581929|FG000|Overall Study|Withdrawal by Subject|163|||
149028395|NCT01306331|537581930|FG001|Overall Study|Withdrawal by Subject|152|||
149028396|NCT01306331|537581929|FG000|Overall Study|Not sexually active|29|||
149028397|NCT01306331|537581930|FG001|Overall Study|Not sexually active|28|||
149028398|NCT01306331|537581929|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
149028399|NCT01306331|537581930|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
149028400|NCT01306331|537581929|FG000|Overall Study|Other|34|||
149028401|NCT01306331|537581930|FG001|Overall Study|Other|32|||
149028402|NCT04048135|537581931|FG000|Overall Study|Withdrawal by Subject|1|||
149028403|NCT04048135|537581932|FG001|Overall Study|Withdrawal by Subject|1|||
149028404|NCT04048135|537581933|FG002|Overall Study|Withdrawal by Subject|1|||
149028405|NCT04048135|537581934|FG003|Overall Study|Withdrawal by Subject|2|||
149028406|NCT04048135|537581935|FG004|Overall Study|Withdrawal by Subject|0|||
149028407|NCT04048135|537581936|FG005|Overall Study|Withdrawal by Subject|0|||
149028408|NCT04048135|537581937|FG006|Overall Study|Withdrawal by Subject|1|||
149028409|NCT04048135|537581938|FG007|Overall Study|Withdrawal by Subject|1|||
149028410|NCT04048135|537581931|FG000|Overall Study|Adverse Event|0|||
149028411|NCT04048135|537581932|FG001|Overall Study|Adverse Event|0|||
149028412|NCT04048135|537581933|FG002|Overall Study|Adverse Event|0|||
149028413|NCT04048135|537581934|FG003|Overall Study|Adverse Event|1|||
149028414|NCT04048135|537581935|FG004|Overall Study|Adverse Event|1|||
149028415|NCT04048135|537581936|FG005|Overall Study|Adverse Event|0|||
149028416|NCT04048135|537581937|FG006|Overall Study|Adverse Event|0|||
149028417|NCT04048135|537581938|FG007|Overall Study|Adverse Event|0|||
149028418|NCT04048135|537581931|FG000|Overall Study|Protocol Violation|0|||
149028419|NCT04048135|537581932|FG001|Overall Study|Protocol Violation|0|||
149028420|NCT04048135|537581933|FG002|Overall Study|Protocol Violation|0|||
149028421|NCT04048135|537581934|FG003|Overall Study|Protocol Violation|0|||
149028422|NCT04048135|537581935|FG004|Overall Study|Protocol Violation|0|||
149028423|NCT04048135|537581936|FG005|Overall Study|Protocol Violation|1|||
149028424|NCT04048135|537581937|FG006|Overall Study|Protocol Violation|0|||
149028425|NCT04048135|537581938|FG007|Overall Study|Protocol Violation|0|||
149028426|NCT00409708|537581939|FG000|Treatment|Abnormal test procedure result(s)|1|||
149028427|NCT00409708|537581940|FG001|Treatment|Abnormal test procedure result(s)|0|||
149028428|NCT00409708|537581939|FG000|Treatment|Lack of Efficacy|0|||
149028429|NCT00409708|537581940|FG001|Treatment|Lack of Efficacy|1|||
149028430|NCT00409708|537581939|FG000|Treatment|Protocol Violation|6|||
149028431|NCT00409708|537581940|FG001|Treatment|Protocol Violation|2|||
149028432|NCT00409708|537581939|FG000|Treatment|Withdrawal by Subject|3|||
149028433|NCT00409708|537581940|FG001|Treatment|Withdrawal by Subject|8|||
149028434|NCT00409708|537581939|FG000|Treatment|Lost to Follow-up|0|||
149028435|NCT00409708|537581940|FG001|Treatment|Lost to Follow-up|6|||
149028436|NCT00409708|537581939|FG000|Treatment|Administrative problems|5|||
149028437|NCT00409708|537581940|FG001|Treatment|Administrative problems|0|||
149028438|NCT00409708|537581939|FG000|Washout|Lack of Efficacy|9|||
149028439|NCT00409708|537581940|FG001|Washout|Lack of Efficacy|1|||
149028440|NCT00409708|537581939|FG000|Washout|Protocol Violation|0|||
149028441|NCT00409708|537581940|FG001|Washout|Protocol Violation|1|||
149028442|NCT00409708|537581939|FG000|Washout|Withdrawal by Subject|11|||
149028443|NCT00409708|537581940|FG001|Washout|Withdrawal by Subject|5|||
149028444|NCT00409708|537581939|FG000|Washout|Lost to Follow-up|1|||
149028445|NCT00409708|537581940|FG001|Washout|Lost to Follow-up|3|||
149028446|NCT02688621|537581941|FG000|Overall Study|Pregnancy|1|||
149028447|NCT02688621|537581942|FG001|Overall Study|Pregnancy|3|||
149028448|NCT02688621|537581941|FG000|Overall Study|Lost to Follow-up|38|||
149028449|NCT02688621|537581942|FG001|Overall Study|Lost to Follow-up|15|||
149028450|NCT02688621|537581941|FG000|Overall Study|Withdrawal by Subject|1|||
149028451|NCT02688621|537581942|FG001|Overall Study|Withdrawal by Subject|0|||
149028452|NCT02950545|537581945|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
149028453|NCT02950545|537581946|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
149028454|NCT02950545|537581947|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
149028455|NCT02950545|537581948|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
149028456|NCT02950545|537581949|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
149028457|NCT02950545|537581950|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
149028458|NCT02950545|537581945|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
149028459|NCT02950545|537581946|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
149028460|NCT02950545|537581947|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
149028461|NCT02950545|537581948|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
149028462|NCT02950545|537581949|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
149028463|NCT02950545|537581950|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
149028464|NCT02950545|537581945|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
148981256|NCT01877421|537411586|FG017|Phase 2|Lost to Follow-up|0|||
148981257|NCT01877421|537411569|FG000|Phase 2|Withdrawal by Subject|0|||
148981258|NCT01877421|537411570|FG001|Phase 2|Withdrawal by Subject|0|||
148981259|NCT01877421|537411571|FG002|Phase 2|Withdrawal by Subject|0|||
148981260|NCT01877421|537411572|FG003|Phase 2|Withdrawal by Subject|0|||
148773414|NCT02031640|536642965|FG001|Run-In Period|Inclusion criteria not met|0|||
148773415|NCT02031640|536642966|FG002|Run-In Period|Inclusion criteria not met|0|||
148773416|NCT02031640|536642967|FG003|Run-In Period|Inclusion criteria not met|0|||
148773417|NCT02031640|536642968|FG004|Run-In Period|Inclusion criteria not met|0|||
148773418|NCT02031640|536642969|FG005|Run-In Period|Inclusion criteria not met|0|||
148773419|NCT02031640|536642964|FG000|Run-In Period|Exclusion criteria met|8|||
148773420|NCT02031640|536642965|FG001|Run-In Period|Exclusion criteria met|0|||
148773421|NCT02031640|536642966|FG002|Run-In Period|Exclusion criteria met|0|||
148773422|NCT02031640|536642967|FG003|Run-In Period|Exclusion criteria met|0|||
148773423|NCT02031640|536642968|FG004|Run-In Period|Exclusion criteria met|0|||
148773424|NCT02031640|536642969|FG005|Run-In Period|Exclusion criteria met|0|||
148773425|NCT02031640|536642964|FG000|Run-In Period|Randomization criteria not met|85|||
148773426|NCT02031640|536642965|FG001|Run-In Period|Randomization criteria not met|0|||
148773427|NCT02031640|536642966|FG002|Run-In Period|Randomization criteria not met|0|||
148773428|NCT02031640|536642967|FG003|Run-In Period|Randomization criteria not met|0|||
148773429|NCT02031640|536642968|FG004|Run-In Period|Randomization criteria not met|0|||
148773430|NCT02031640|536642969|FG005|Run-In Period|Randomization criteria not met|0|||
148773431|NCT02031640|536642964|FG000|Run-In Period|Various administrative reasons|17|||
148773432|NCT02031640|536642965|FG001|Run-In Period|Various administrative reasons|0|||
148773433|NCT02031640|536642966|FG002|Run-In Period|Various administrative reasons|0|||
148773434|NCT02031640|536642967|FG003|Run-In Period|Various administrative reasons|0|||
148773435|NCT02031640|536642968|FG004|Run-In Period|Various administrative reasons|0|||
148773436|NCT02031640|536642969|FG005|Run-In Period|Various administrative reasons|0|||
148773437|NCT02031640|536642964|FG000|Double-blind Treatment Period|Protocol deviation|0|||
148773438|NCT02031640|536642965|FG001|Double-blind Treatment Period|Protocol deviation|2|||
148773439|NCT02031640|536642966|FG002|Double-blind Treatment Period|Protocol deviation|0|||
148773440|NCT02031640|536642967|FG003|Double-blind Treatment Period|Protocol deviation|1|||
148773441|NCT02031640|536642968|FG004|Double-blind Treatment Period|Protocol deviation|3|||
148773442|NCT02031640|536642969|FG005|Double-blind Treatment Period|Protocol deviation|1|||
148773443|NCT02031640|536642964|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
148773444|NCT02031640|536642965|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
148773445|NCT02031640|536642966|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
148773446|NCT02031640|536642967|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
148773447|NCT02031640|536642968|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
148773448|NCT02031640|536642969|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
148773449|NCT02031640|536642964|FG000|Double-blind Treatment Period|Non-compliance|0|||
148773450|NCT02031640|536642965|FG001|Double-blind Treatment Period|Non-compliance|1|||
148773451|NCT02031640|536642966|FG002|Double-blind Treatment Period|Non-compliance|0|||
148773452|NCT02031640|536642967|FG003|Double-blind Treatment Period|Non-compliance|1|||
148773453|NCT02031640|536642968|FG004|Double-blind Treatment Period|Non-compliance|1|||
148773454|NCT02031640|536642969|FG005|Double-blind Treatment Period|Non-compliance|0|||
148773455|NCT02031640|536642964|FG000|Double-blind Treatment Period|Adverse Event|0|||
148773456|NCT02031640|536642965|FG001|Double-blind Treatment Period|Adverse Event|0|||
148773457|NCT02031640|536642966|FG002|Double-blind Treatment Period|Adverse Event|0|||
148773458|NCT02031640|536642967|FG003|Double-blind Treatment Period|Adverse Event|2|||
148773459|NCT02031640|536642968|FG004|Double-blind Treatment Period|Adverse Event|0|||
148773460|NCT02031640|536642969|FG005|Double-blind Treatment Period|Adverse Event|0|||
148773461|NCT02031640|536642964|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
148773462|NCT02031640|536642965|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
148773463|NCT02031640|536642966|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
148773464|NCT02031640|536642967|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
148773465|NCT02031640|536642968|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
148773466|NCT02031640|536642969|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
148773467|NCT02031640|536642964|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
148773468|NCT02031640|536642965|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
148773469|NCT02031640|536642966|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
148773470|NCT02031640|536642967|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
148773471|NCT02031640|536642968|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
148773472|NCT02031640|536642969|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
148773473|NCT01895270|536642972|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
148773474|NCT01895270|536642973|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
148773475|NCT01895270|536642972|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
148773476|NCT01895270|536642973|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
148773477|NCT01895270|536642972|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
148773478|NCT01895270|536642973|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
148834223|NCT02037529|536874342|FG000|Overall Study|Withdrawal by Subject|1|||
148834224|NCT02037529|536874343|FG001|Overall Study|Withdrawal by Subject|3|||
148981261|NCT01877421|537411573|FG004|Phase 2|Withdrawal by Subject|0|||
148981262|NCT01877421|537411574|FG005|Phase 2|Withdrawal by Subject|0|||
148981263|NCT01877421|537411575|FG006|Phase 2|Withdrawal by Subject|0|||
148981264|NCT01877421|537411576|FG007|Phase 2|Withdrawal by Subject|0|||
148981265|NCT01877421|537411577|FG008|Phase 2|Withdrawal by Subject|1|||
148981266|NCT01877421|537411578|FG009|Phase 2|Withdrawal by Subject|0|||
148981267|NCT01877421|537411579|FG010|Phase 2|Withdrawal by Subject|1|||
148981268|NCT01877421|537411580|FG011|Phase 2|Withdrawal by Subject|0|||
148981269|NCT01877421|537411581|FG012|Phase 2|Withdrawal by Subject|1|||
148981270|NCT01877421|537411582|FG013|Phase 2|Withdrawal by Subject|0|||
148981271|NCT01877421|537411583|FG014|Phase 2|Withdrawal by Subject|0|||
148981272|NCT01877421|537411584|FG015|Phase 2|Withdrawal by Subject|1|||
148981273|NCT01877421|537411585|FG016|Phase 2|Withdrawal by Subject|0|||
148981274|NCT01877421|537411586|FG017|Phase 2|Withdrawal by Subject|0|||
148981275|NCT01877421|537411569|FG000|Phase 2|Protocol Violation|0|||
148981276|NCT01877421|537411570|FG001|Phase 2|Protocol Violation|0|||
148981277|NCT01877421|537411571|FG002|Phase 2|Protocol Violation|0|||
148981278|NCT01877421|537411572|FG003|Phase 2|Protocol Violation|0|||
148981279|NCT01877421|537411573|FG004|Phase 2|Protocol Violation|0|||
148981280|NCT01877421|537411574|FG005|Phase 2|Protocol Violation|0|||
148981281|NCT01877421|537411575|FG006|Phase 2|Protocol Violation|0|||
148981282|NCT01877421|537411576|FG007|Phase 2|Protocol Violation|0|||
148981283|NCT01877421|537411577|FG008|Phase 2|Protocol Violation|0|||
148981284|NCT01877421|537411578|FG009|Phase 2|Protocol Violation|0|||
148981285|NCT01877421|537411579|FG010|Phase 2|Protocol Violation|1|||
148981286|NCT01877421|537411580|FG011|Phase 2|Protocol Violation|0|||
148981287|NCT01877421|537411581|FG012|Phase 2|Protocol Violation|0|||
148981288|NCT01877421|537411582|FG013|Phase 2|Protocol Violation|0|||
148981289|NCT01877421|537411583|FG014|Phase 2|Protocol Violation|0|||
148981290|NCT01877421|537411584|FG015|Phase 2|Protocol Violation|0|||
148981291|NCT01877421|537411585|FG016|Phase 2|Protocol Violation|0|||
148981292|NCT01877421|537411586|FG017|Phase 2|Protocol Violation|0|||
148981293|NCT00908960|537411587|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
148981294|NCT00908960|537411588|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
148981295|NCT00908960|537411589|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
148981296|NCT01158924|537411591|FG000|Overall Study|Withdrawal by Subject|1|||
148981297|NCT01158924|537411592|FG001|Overall Study|Withdrawal by Subject|2|||
148981298|NCT01158924|537411591|FG000|Overall Study|Lost to Follow-up|0|||
148981299|NCT01158924|537411592|FG001|Overall Study|Lost to Follow-up|1|||
148981300|NCT03795922|537411593|FG000|Overall Study|Adverse Event|2|||
148981301|NCT03795922|537411594|FG001|Overall Study|Adverse Event|1|||
148981302|NCT03795922|537411593|FG000|Overall Study|Withdrawal by Subject|5|||
148981303|NCT03795922|537411594|FG001|Overall Study|Withdrawal by Subject|13|||
148981304|NCT03795922|537411593|FG000|Overall Study|Lost to Follow-up|2|||
148981305|NCT03795922|537411594|FG001|Overall Study|Lost to Follow-up|3|||
148981306|NCT03795922|537411593|FG000|Overall Study|Pregnancy|0|||
148981307|NCT03795922|537411594|FG001|Overall Study|Pregnancy|1|||
148981308|NCT03795922|537411593|FG000|Overall Study|Physician Decision|1|||
148981309|NCT03795922|537411594|FG001|Overall Study|Physician Decision|2|||
148981310|NCT03795922|537411593|FG000|Overall Study|Protocol Violation|0|||
148981311|NCT03795922|537411594|FG001|Overall Study|Protocol Violation|1|||
148981312|NCT03795922|537411593|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
148981313|NCT03795922|537411594|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
148981314|NCT02480621|537411599|FG000|Randomization|Withdrawal by Subject|1|||
148981315|NCT02480621|537411600|FG001|Randomization|Withdrawal by Subject|0|||
148981316|NCT02480621|537411599|FG000|Randomization|Surgeon did not give intervention|0|||
148981317|NCT02480621|537411600|FG001|Randomization|Surgeon did not give intervention|1|||
148981318|NCT02480621|537411599|FG000|Follow Up|Lost to Follow-up|4|||
148981319|NCT02480621|537411600|FG001|Follow Up|Lost to Follow-up|2|||
148981320|NCT00684424|537411603|FG000|Overall Study|Adverse Event|1|||
148981321|NCT00684424|537411603|FG000|Overall Study|Lost to Follow-up|2|||
148834225|NCT02037529|536874342|FG000|Overall Study|Adverse Event|0|||
148981322|NCT00684424|537411603|FG000|Overall Study|Other|2|||
148981323|NCT01334866|537411610|FG000|Overall Study|Withdrawal by Subject|10|||
148834226|NCT02037529|536874343|FG001|Overall Study|Adverse Event|1|||
148834227|NCT02131766|536874344|FG000|Overall Study|Withdrawal by Subject|4|||
148981324|NCT01334866|537411610|FG000|Overall Study|Lost to Follow-up|3|||
148981325|NCT01334866|537411610|FG000|Overall Study|Physician Decision|3|||
148981326|NCT01334866|537411610|FG000|Overall Study|medically necessary prior to procedure|2|||
148834228|NCT00718315|536874345|FG000|Overall Study|Adverse Event|1|||
148981327|NCT01334866|537411610|FG000|Overall Study|medically necessary post-procedure|1|||
148981328|NCT00958880|537411613|FG000|Overall Study|Lost to Follow-up|2|||
148981329|NCT00958880|537411614|FG001|Overall Study|Lost to Follow-up|2|||
148981330|NCT01971346|537411615|FG000|Overall Study|Protocol Violation|3|||
148981331|NCT01971346|537411615|FG000|Overall Study|Lost to Follow-up|2|||
148834229|NCT00718315|536874346|FG001|Overall Study|Adverse Event|2|||
148981332|NCT01971346|537411615|FG000|Overall Study|Withdrawal by Subject|2|||
148834230|NCT00718315|536874347|FG002|Overall Study|Adverse Event|3|||
148834231|NCT00718315|536874345|FG000|Overall Study|Death|6|||
148834232|NCT00718315|536874346|FG001|Overall Study|Death|6|||
148834233|NCT00718315|536874347|FG002|Overall Study|Death|5|||
148834234|NCT00718315|536874345|FG000|Overall Study|Lost to Follow-up|2|||
148834235|NCT00718315|536874346|FG001|Overall Study|Lost to Follow-up|3|||
148834236|NCT00718315|536874347|FG002|Overall Study|Lost to Follow-up|4|||
148834237|NCT00718315|536874345|FG000|Overall Study|Protocol Violation|5|||
148834238|NCT00718315|536874346|FG001|Overall Study|Protocol Violation|5|||
148834239|NCT00718315|536874347|FG002|Overall Study|Protocol Violation|3|||
148834240|NCT00718315|536874345|FG000|Overall Study|Erlotinib dose decreased|4|||
148834241|NCT00718315|536874346|FG001|Overall Study|Erlotinib dose decreased|3|||
149028465|NCT02950545|537581946|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
148773479|NCT01895270|536642972|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
148773480|NCT01895270|536642973|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
148773481|NCT01895270|536642972|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
148773482|NCT01895270|536642973|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
148773483|NCT01895270|536642972|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
148773484|NCT01895270|536642973|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
148773485|NCT01895270|536642972|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
148773486|NCT01895270|536642973|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
148773487|NCT02091375|536642979|FG000|Overall Study|Adverse Event|8|||
148773488|NCT02091375|536642980|FG001|Overall Study|Adverse Event|1|||
148773489|NCT02091375|536642979|FG000|Overall Study|Lost to Follow-up|0|||
148773490|NCT02091375|536642980|FG001|Overall Study|Lost to Follow-up|1|||
148773491|NCT02091375|536642979|FG000|Overall Study|Withdrawal by Subject|0|||
148773492|NCT02091375|536642980|FG001|Overall Study|Withdrawal by Subject|1|||
148773493|NCT02091375|536642979|FG000|Overall Study|Withdrawn by the investigator|1|||
148773494|NCT02091375|536642980|FG001|Overall Study|Withdrawn by the investigator|0|||
148773495|NCT03085238|536642981|FG000|Overall Study|Adverse Event|2|||
148773496|NCT03085238|536642981|FG000|Overall Study|Death|2|||
148773497|NCT05896527|536642982|FG000|Overall Study|Withdrawal by Subject|11|||
148773498|NCT05896527|536642983|FG001|Overall Study|Withdrawal by Subject|10|||
148773499|NCT05896527|536642984|FG002|Overall Study|Withdrawal by Subject|4|||
148773500|NCT05896527|536642985|FG003|Overall Study|Withdrawal by Subject|3|||
148773501|NCT05896527|536642986|FG004|Overall Study|Withdrawal by Subject|2|||
148773502|NCT05896527|536642982|FG000|Overall Study|Lost to Follow-up|0|||
148773503|NCT05896527|536642983|FG001|Overall Study|Lost to Follow-up|2|||
148773504|NCT05896527|536642984|FG002|Overall Study|Lost to Follow-up|2|||
148773505|NCT05896527|536642985|FG003|Overall Study|Lost to Follow-up|2|||
148773506|NCT05896527|536642986|FG004|Overall Study|Lost to Follow-up|1|||
148773507|NCT05896527|536642982|FG000|Overall Study|Significant protocol noncompliance|0|||
148773508|NCT05896527|536642983|FG001|Overall Study|Significant protocol noncompliance|1|||
148773509|NCT05896527|536642984|FG002|Overall Study|Significant protocol noncompliance|0|||
148773510|NCT05896527|536642985|FG003|Overall Study|Significant protocol noncompliance|0|||
148773511|NCT05896527|536642986|FG004|Overall Study|Significant protocol noncompliance|0|||
148773512|NCT05896527|536642982|FG000|Overall Study|Eligibility criteria not met|1|||
148773513|NCT05896527|536642983|FG001|Overall Study|Eligibility criteria not met|0|||
148773514|NCT05896527|536642984|FG002|Overall Study|Eligibility criteria not met|0|||
148773515|NCT05896527|536642985|FG003|Overall Study|Eligibility criteria not met|0|||
148773516|NCT05896527|536642986|FG004|Overall Study|Eligibility criteria not met|0|||
148773517|NCT05896527|536642982|FG000|Overall Study|Sponsor's decision|0|||
148773518|NCT05896527|536642983|FG001|Overall Study|Sponsor's decision|0|||
148773519|NCT05896527|536642984|FG002|Overall Study|Sponsor's decision|0|||
148773520|NCT05896527|536642985|FG003|Overall Study|Sponsor's decision|1|||
148773521|NCT05896527|536642986|FG004|Overall Study|Sponsor's decision|0|||
148773522|NCT05896527|536642982|FG000|Overall Study|Investigator's decision|0|||
148773523|NCT05896527|536642983|FG001|Overall Study|Investigator's decision|1|||
148773524|NCT05896527|536642984|FG002|Overall Study|Investigator's decision|0|||
148773525|NCT05896527|536642985|FG003|Overall Study|Investigator's decision|0|||
148773526|NCT05896527|536642986|FG004|Overall Study|Investigator's decision|0|||
148773527|NCT05896527|536642982|FG000|Overall Study|Pregnancy of his partner|0|||
148773528|NCT05896527|536642983|FG001|Overall Study|Pregnancy of his partner|0|||
148773529|NCT05896527|536642984|FG002|Overall Study|Pregnancy of his partner|0|||
148773530|NCT05896527|536642985|FG003|Overall Study|Pregnancy of his partner|1|||
148773531|NCT05896527|536642986|FG004|Overall Study|Pregnancy of his partner|0|||
148773532|NCT01279070|536642987|FG000|Overall Study|Withdrawal by Subject|2|||
148773533|NCT01279070|536642988|FG001|Overall Study|Withdrawal by Subject|3|||
148773534|NCT01279070|536642987|FG000|Overall Study|Acute exacerbation|3|||
148773535|NCT01279070|536642988|FG001|Overall Study|Acute exacerbation|1|||
148834242|NCT00718315|536874347|FG002|Overall Study|Erlotinib dose decreased|1|||
148834243|NCT00718315|536874345|FG000|Overall Study|Use of Minocyclin|1|||
148773536|NCT01741792|536642989|FG000|Overall Study|Death|6|||
148773537|NCT01741792|536642990|FG001|Overall Study|Death|1|||
148834244|NCT00718315|536874346|FG001|Overall Study|Use of Minocyclin|1|||
148773538|NCT01741792|536642991|FG002|Overall Study|Death|12|||
148834245|NCT00718315|536874347|FG002|Overall Study|Use of Minocyclin|1|||
148834246|NCT00718315|536874345|FG000|Overall Study|Disease progression|0|||
148834247|NCT00718315|536874346|FG001|Overall Study|Disease progression|1|||
148834248|NCT00718315|536874347|FG002|Overall Study|Disease progression|1|||
148834249|NCT00718315|536874345|FG000|Overall Study|Other|0|||
148834250|NCT00718315|536874346|FG001|Overall Study|Other|0|||
148834251|NCT00718315|536874347|FG002|Overall Study|Other|1|||
148834252|NCT00718315|536874345|FG000|Overall Study|Use of ATB and Corticoids|0|||
148834253|NCT00718315|536874346|FG001|Overall Study|Use of ATB and Corticoids|1|||
148834254|NCT00718315|536874347|FG002|Overall Study|Use of ATB and Corticoids|2|||
148834255|NCT00673920|536874354|FG000|Baseline up to Week 48|Withdrew consent|1|||
148834256|NCT00673920|536874355|FG001|Baseline up to Week 48|Withdrew consent|0|||
148834257|NCT00673920|536874356|FG002|Baseline up to Week 48|Withdrew consent|2|||
148834258|NCT00673920|536874357|FG003|Baseline up to Week 48|Withdrew consent|0|||
148834259|NCT00673920|536874358|FG004|Baseline up to Week 48|Withdrew consent|0|||
148834260|NCT00673920|536874359|FG005|Baseline up to Week 48|Withdrew consent|0|||
148834261|NCT00673920|536874360|FG006|Baseline up to Week 48|Withdrew consent|0|||
148834262|NCT00673920|536874361|FG007|Baseline up to Week 48|Withdrew consent|0|||
148834263|NCT00673920|536874354|FG000|Baseline up to Week 48|Refused treatment|1|||
148834264|NCT00673920|536874355|FG001|Baseline up to Week 48|Refused treatment|0|||
148834265|NCT00673920|536874356|FG002|Baseline up to Week 48|Refused treatment|0|||
148834266|NCT00673920|536874357|FG003|Baseline up to Week 48|Refused treatment|0|||
148834267|NCT00673920|536874358|FG004|Baseline up to Week 48|Refused treatment|0|||
148834268|NCT00673920|536874359|FG005|Baseline up to Week 48|Refused treatment|0|||
148834269|NCT00673920|536874360|FG006|Baseline up to Week 48|Refused treatment|0|||
148834270|NCT00673920|536874361|FG007|Baseline up to Week 48|Refused treatment|0|||
148834271|NCT00673920|536874354|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
148834272|NCT00673920|536874355|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
148834273|NCT00673920|536874356|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
148834274|NCT00673920|536874357|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
148834275|NCT00673920|536874358|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
148834276|NCT00673920|536874359|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
148834277|NCT00673920|536874360|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
148834278|NCT00673920|536874361|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
148834279|NCT00673920|536874354|FG000|Baseline up to Week 48|Protocol Violation|0|||
148834280|NCT00673920|536874355|FG001|Baseline up to Week 48|Protocol Violation|0|||
148834281|NCT00673920|536874356|FG002|Baseline up to Week 48|Protocol Violation|1|||
148834282|NCT00673920|536874357|FG003|Baseline up to Week 48|Protocol Violation|0|||
148834283|NCT00673920|536874358|FG004|Baseline up to Week 48|Protocol Violation|0|||
148834284|NCT00673920|536874359|FG005|Baseline up to Week 48|Protocol Violation|0|||
148834285|NCT00673920|536874360|FG006|Baseline up to Week 48|Protocol Violation|0|||
148834286|NCT00673920|536874361|FG007|Baseline up to Week 48|Protocol Violation|0|||
148834287|NCT00673920|536874354|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834288|NCT00673920|536874355|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834289|NCT00673920|536874356|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
148834290|NCT00673920|536874357|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834291|NCT00673920|536874358|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834292|NCT00673920|536874359|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834293|NCT00673920|536874360|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834294|NCT00673920|536874361|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
148834295|NCT00673920|536874354|FG000|Baseline up to Week 48|Administrative/Other|0|||
148834296|NCT00673920|536874355|FG001|Baseline up to Week 48|Administrative/Other|1|||
148834297|NCT00673920|536874356|FG002|Baseline up to Week 48|Administrative/Other|2|||
148834298|NCT00673920|536874357|FG003|Baseline up to Week 48|Administrative/Other|0|||
148834299|NCT00673920|536874358|FG004|Baseline up to Week 48|Administrative/Other|0|||
148834300|NCT00673920|536874359|FG005|Baseline up to Week 48|Administrative/Other|0|||
148834301|NCT00673920|536874360|FG006|Baseline up to Week 48|Administrative/Other|0|||
148834302|NCT00673920|536874361|FG007|Baseline up to Week 48|Administrative/Other|0|||
148834303|NCT00673920|536874354|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
148834304|NCT00673920|536874355|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
148834305|NCT00673920|536874356|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
148834306|NCT00673920|536874357|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
148981333|NCT01971346|537411615|FG000|Overall Study|Physician Decision|1|||
148834307|NCT00673920|536874358|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
148834308|NCT00673920|536874359|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
148834309|NCT00673920|536874360|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
148834310|NCT00673920|536874361|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
148834311|NCT00673920|536874354|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834312|NCT00673920|536874355|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834313|NCT00673920|536874356|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834314|NCT00673920|536874357|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834315|NCT00673920|536874358|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834316|NCT00673920|536874359|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834317|NCT00673920|536874360|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
148834318|NCT00673920|536874361|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
148834319|NCT00673920|536874354|FG000|Week 24 to Week 48|Failure to return|0|||
148834320|NCT00673920|536874355|FG001|Week 24 to Week 48|Failure to return|0|||
148834321|NCT00673920|536874356|FG002|Week 24 to Week 48|Failure to return|0|||
148834322|NCT00673920|536874357|FG003|Week 24 to Week 48|Failure to return|0|||
148834323|NCT00673920|536874358|FG004|Week 24 to Week 48|Failure to return|0|||
148834324|NCT00673920|536874359|FG005|Week 24 to Week 48|Failure to return|1|||
148834325|NCT00673920|536874360|FG006|Week 24 to Week 48|Failure to return|0|||
148834326|NCT00673920|536874361|FG007|Week 24 to Week 48|Failure to return|0|||
148834327|NCT00673920|536874354|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834328|NCT00673920|536874355|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834329|NCT00673920|536874356|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834330|NCT00673920|536874357|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834331|NCT00673920|536874358|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834332|NCT00673920|536874359|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
148834333|NCT00673920|536874360|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834334|NCT00673920|536874361|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
148834335|NCT00673920|536874354|FG000|Week 24 to Week 48|Death|0|||
148834336|NCT00673920|536874355|FG001|Week 24 to Week 48|Death|0|||
148834337|NCT00673920|536874356|FG002|Week 24 to Week 48|Death|0|||
148834338|NCT00673920|536874357|FG003|Week 24 to Week 48|Death|0|||
148834339|NCT00673920|536874358|FG004|Week 24 to Week 48|Death|0|||
148834340|NCT00673920|536874359|FG005|Week 24 to Week 48|Death|1|||
148834341|NCT00673920|536874360|FG006|Week 24 to Week 48|Death|0|||
148834342|NCT00673920|536874361|FG007|Week 24 to Week 48|Death|0|||
148834343|NCT00673920|536874354|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
148834344|NCT00673920|536874355|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
148834345|NCT00673920|536874356|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
148834346|NCT00673920|536874357|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
148834347|NCT00673920|536874358|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
148834348|NCT00673920|536874359|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
148834349|NCT00673920|536874360|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
148834350|NCT00673920|536874361|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
148981334|NCT04187196|537411620|FG000|Overall Study|Screen Failure|2|||
148981335|NCT04187196|537411621|FG001|Overall Study|Screen Failure|0|||
148981336|NCT01687166|537411622|FG000|Overall Study|Attempt subject|2|||
148981337|NCT01687166|537411623|FG001|Overall Study|Attempt subject|3|||
148981338|NCT01687166|537411624|FG002|Overall Study|Attempt subject|2|||
148981339|NCT01687166|537411625|FG003|Overall Study|Attempt subject|0|||
148981340|NCT01687166|537411622|FG000|Overall Study|Did not meet eligibility criteria|4|||
148981341|NCT01687166|537411623|FG001|Overall Study|Did not meet eligibility criteria|6|||
148981342|NCT01687166|537411624|FG002|Overall Study|Did not meet eligibility criteria|1|||
148981343|NCT01687166|537411625|FG003|Overall Study|Did not meet eligibility criteria|1|||
148981344|NCT01687166|537411622|FG000|Overall Study|Adverse Event|2|||
148981345|NCT01687166|537411623|FG001|Overall Study|Adverse Event|1|||
148981346|NCT01687166|537411624|FG002|Overall Study|Adverse Event|0|||
148981347|NCT01687166|537411625|FG003|Overall Study|Adverse Event|0|||
148981348|NCT01687166|537411622|FG000|Overall Study|Physician Decision|3|||
148981349|NCT01687166|537411623|FG001|Overall Study|Physician Decision|2|||
148981350|NCT01687166|537411624|FG002|Overall Study|Physician Decision|1|||
148981351|NCT01687166|537411625|FG003|Overall Study|Physician Decision|0|||
148981352|NCT01687166|537411622|FG000|Overall Study|Withdrawal by Subject|11|||
148981353|NCT01687166|537411623|FG001|Overall Study|Withdrawal by Subject|4|||
148981354|NCT01687166|537411624|FG002|Overall Study|Withdrawal by Subject|3|||
148981355|NCT01687166|537411625|FG003|Overall Study|Withdrawal by Subject|0|||
148981356|NCT01687166|537411622|FG000|Overall Study|Lost to Follow-up|2|||
148981357|NCT01687166|537411623|FG001|Overall Study|Lost to Follow-up|5|||
148981358|NCT01687166|537411624|FG002|Overall Study|Lost to Follow-up|1|||
148981359|NCT01687166|537411625|FG003|Overall Study|Lost to Follow-up|0|||
148981360|NCT01687166|537411622|FG000|Overall Study|Equipment/Device Availability|0|||
148981361|NCT01687166|537411623|FG001|Overall Study|Equipment/Device Availability|1|||
148981362|NCT01687166|537411624|FG002|Overall Study|Equipment/Device Availability|0|||
148981363|NCT01687166|537411625|FG003|Overall Study|Equipment/Device Availability|0|||
148981364|NCT01687166|537411622|FG000|Overall Study|Death|1|||
149028466|NCT02950545|537581947|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
148834351|NCT03746015|536874367|FG000|Overall Study|Withdrawal of Consent|1|||
148981365|NCT01687166|537411623|FG001|Overall Study|Death|1|||
148981366|NCT01687166|537411624|FG002|Overall Study|Death|0|||
148981367|NCT01687166|537411625|FG003|Overall Study|Death|0|||
148981368|NCT01687166|537411622|FG000|Overall Study|Protocol Violation|1|||
148981369|NCT01687166|537411623|FG001|Overall Study|Protocol Violation|1|||
148834352|NCT03746015|536874368|FG001|Overall Study|Withdrawal of Consent|0|||
148981370|NCT01687166|537411624|FG002|Overall Study|Protocol Violation|1|||
148834353|NCT03746015|536874369|FG002|Overall Study|Withdrawal of Consent|0|||
148834354|NCT03097289|536874376|FG000|Overall Study|Adverse Event|1|||
148834355|NCT03097289|536874376|FG000|Overall Study|Equipment failure|2|||
148834356|NCT03097289|536874376|FG000|Overall Study|Collected platelet product unusable|3|||
148834357|NCT03510273|536874379|FG000|Overall Study|Withdrawal by Subject|2|||
148834358|NCT03510273|536874379|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
148834359|NCT03510273|536874379|FG000|Overall Study|Moved away from study area|4|||
148834360|NCT02589938|536874382|FG000|Overall Study|Withdrawal by Subject|11|||
148834361|NCT02589938|536874383|FG001|Overall Study|Withdrawal by Subject|5|||
148834362|NCT02589938|536874384|FG002|Overall Study|Withdrawal by Subject|6|||
148834363|NCT02589938|536874382|FG000|Overall Study|Lost to Follow-up|3|||
148834364|NCT02589938|536874383|FG001|Overall Study|Lost to Follow-up|3|||
148834365|NCT02589938|536874384|FG002|Overall Study|Lost to Follow-up|3|||
148834366|NCT02589938|536874382|FG000|Overall Study|Death|1|||
148834367|NCT02589938|536874383|FG001|Overall Study|Death|0|||
148834368|NCT02589938|536874384|FG002|Overall Study|Death|1|||
148834369|NCT02589938|536874382|FG000|Overall Study|Protocol Violation|6|||
148834370|NCT02589938|536874383|FG001|Overall Study|Protocol Violation|2|||
148834371|NCT02589938|536874384|FG002|Overall Study|Protocol Violation|3|||
148834372|NCT02589938|536874382|FG000|Overall Study|Physician Decision|1|||
148834373|NCT02589938|536874383|FG001|Overall Study|Physician Decision|0|||
148834374|NCT02589938|536874384|FG002|Overall Study|Physician Decision|0|||
148834375|NCT02589938|536874382|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
148834376|NCT02589938|536874383|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
148834377|NCT02589938|536874384|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
148834378|NCT00485173|536874385|FG000|Overall Study|Death|4|||
148834379|NCT00485173|536874386|FG001|Overall Study|Death|3|||
148834380|NCT00485173|536874385|FG000|Overall Study|Lost to Follow-up|32|||
148834381|NCT00485173|536874386|FG001|Overall Study|Lost to Follow-up|61|||
148834382|NCT01121757|536874387|FG000|First Drug|Death|1|||
148834383|NCT01121757|536874388|FG001|First Drug|Death|0|||
148834384|NCT01121757|536874387|FG000|First Drug|Disease Progression|0|||
148834385|NCT01121757|536874388|FG001|First Drug|Disease Progression|2|||
148834386|NCT01121757|536874387|FG000|Combination|Physician Decision|0|||
148834387|NCT01121757|536874388|FG001|Combination|Physician Decision|1|||
148834388|NCT01121757|536874387|FG000|Combination|Disease Progression|2|||
148834389|NCT01121757|536874388|FG001|Combination|Disease Progression|0|||
148834390|NCT00829244|536874389|FG000|Overall Study|Adverse Event|1|||
148834391|NCT00829244|536874390|FG001|Overall Study|Adverse Event|3|||
148834392|NCT00829244|536874389|FG000|Overall Study|Protocol Violation|1|||
148834393|NCT00829244|536874390|FG001|Overall Study|Protocol Violation|0|||
148834394|NCT00829244|536874389|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
148834395|NCT00829244|536874390|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
148834396|NCT00829244|536874389|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
148834397|NCT00829244|536874390|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
148834398|NCT00829244|536874389|FG000|Overall Study|No fertilization|2|||
148834399|NCT00829244|536874390|FG001|Overall Study|No fertilization|2|||
148834400|NCT00829244|536874389|FG000|Overall Study|All embryos discarded|0|||
148834401|NCT00829244|536874390|FG001|Overall Study|All embryos discarded|3|||
148834402|NCT00829244|536874389|FG000|Overall Study|No embryo cleavage|0|||
148834403|NCT00829244|536874390|FG001|Overall Study|No embryo cleavage|2|||
148834404|NCT04222673|536874391|FG000|Overall Study|Lost to Follow-up|5|||
148834405|NCT03213509|536874395|FG000|Overall Study|Did not consent for verbal autopsy|4|||
148834406|NCT03213509|536874396|FG001|Overall Study|Did not consent for verbal autopsy|5|||
148834407|NCT02297412|536874397|FG000|Overall Study|Canceled|1|||
148834408|NCT02297412|536874398|FG001|Overall Study|Canceled|1|||
148834409|NCT04756531|536874405|FG000|Overall Study|Adverse Event|0|||
148834410|NCT04756531|536874406|FG001|Overall Study|Adverse Event|0|||
148834411|NCT04756531|536874407|FG002|Overall Study|Adverse Event|0|||
148834412|NCT04756531|536874408|FG003|Overall Study|Adverse Event|0|||
148834413|NCT04756531|536874409|FG004|Overall Study|Adverse Event|1|||
148834414|NCT04756531|536874410|FG005|Overall Study|Adverse Event|0|||
148834415|NCT04756531|536874411|FG006|Overall Study|Adverse Event|0|||
148834416|NCT04756531|536874412|FG007|Overall Study|Adverse Event|0|||
148834417|NCT04756531|536874413|FG008|Overall Study|Adverse Event|0|||
148834418|NCT04756531|536874414|FG009|Overall Study|Adverse Event|0|||
148834419|NCT04756531|536874415|FG010|Overall Study|Adverse Event|0|||
148981371|NCT01687166|537411625|FG003|Overall Study|Protocol Violation|0|||
148834420|NCT04756531|536874416|FG011|Overall Study|Adverse Event|0|||
148834421|NCT04756531|536874417|FG012|Overall Study|Adverse Event|0|||
148834422|NCT04756531|536874418|FG013|Overall Study|Adverse Event|0|||
148834423|NCT04756531|536874419|FG014|Overall Study|Adverse Event|0|||
148834424|NCT04756531|536874420|FG015|Overall Study|Adverse Event|0|||
148834425|NCT04756531|536874421|FG016|Overall Study|Adverse Event|0|||
148834426|NCT04756531|536874422|FG017|Overall Study|Adverse Event|0|||
148834427|NCT04756531|536874405|FG000|Overall Study|Withdrawal by Subject|0|||
148834428|NCT04756531|536874406|FG001|Overall Study|Withdrawal by Subject|0|||
149028467|NCT02950545|537581948|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
149028468|NCT02950545|537581949|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
149028469|NCT02950545|537581950|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
149028470|NCT02950545|537581945|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
149028471|NCT02950545|537581946|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
149028472|NCT02950545|537581947|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
149028473|NCT02950545|537581948|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
149028474|NCT02950545|537581949|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
149028475|NCT02950545|537581950|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
149028476|NCT02950545|537581945|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
149028477|NCT02950545|537581946|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
149028478|NCT02950545|537581947|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
149028479|NCT02950545|537581948|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
149028480|NCT02950545|537581949|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
149028481|NCT02950545|537581950|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
149028482|NCT03398356|537581951|FG000|Before Treatment|Lost to Follow-up|1|||
149028483|NCT03398356|537581952|FG001|Before Treatment|Lost to Follow-up|2|||
149028484|NCT03398356|537581953|FG002|Before Treatment|Lost to Follow-up|0|||
149028485|NCT03398356|537581951|FG000|Before Treatment|drug intolerance|2|||
149028486|NCT03398356|537581952|FG001|Before Treatment|drug intolerance|1|||
149028487|NCT03398356|537581953|FG002|Before Treatment|drug intolerance|0|||
149028488|NCT03398356|537581951|FG000|Before Treatment|Withdrawal by Subject|0|||
149028489|NCT03398356|537581952|FG001|Before Treatment|Withdrawal by Subject|5|||
149028490|NCT03398356|537581953|FG002|Before Treatment|Withdrawal by Subject|0|||
149028491|NCT03398356|537581951|FG000|Before Treatment|Physician Decision|0|||
149028492|NCT03398356|537581952|FG001|Before Treatment|Physician Decision|0|||
149028493|NCT03398356|537581953|FG002|Before Treatment|Physician Decision|11|||
149028494|NCT03398356|537581951|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
149028495|NCT03398356|537581952|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
149028496|NCT03398356|537581953|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
149028497|NCT01928940|537581961|FG000|Overall Study|Adverse Event|0|||
149028498|NCT01928940|537581962|FG001|Overall Study|Adverse Event|1|||
149028499|NCT02954055|537581963|FG000|Overall Study|Did not initiate therapy|6|||
149028500|NCT02954055|537581964|FG001|Overall Study|Did not initiate therapy|1|||
149028501|NCT01352507|537581969|FG000|Treatment Period 1|Adverse Event|3|||
149028502|NCT01352507|537581970|FG001|Treatment Period 1|Adverse Event|0|||
149028503|NCT01352507|537581969|FG000|Treatment Period 1|Lost to Follow-up|3|||
149028504|NCT01352507|537581970|FG001|Treatment Period 1|Lost to Follow-up|4|||
149028505|NCT01352507|537581969|FG000|Treatment Period 1|Withdrawal by Subject|7|||
149028506|NCT01352507|537581970|FG001|Treatment Period 1|Withdrawal by Subject|5|||
149028507|NCT01352507|537581969|FG000|Treatment Period 1|Physician Decision|1|||
149028508|NCT01352507|537581970|FG001|Treatment Period 1|Physician Decision|0|||
149028509|NCT01352507|537581969|FG000|Washout Period|Withdrawal by Subject|0|||
149028510|NCT01352507|537581970|FG001|Washout Period|Withdrawal by Subject|1|||
149028511|NCT01352507|537581969|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
149028512|NCT01352507|537581970|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
149028513|NCT01352507|537581969|FG000|Treatment Period 2|Withdrawal by Subject|4|||
149028514|NCT01352507|537581970|FG001|Treatment Period 2|Withdrawal by Subject|3|||
149028515|NCT01352507|537581969|FG000|Treatment Period 2|Lack of Efficacy|1|||
149028516|NCT01352507|537581970|FG001|Treatment Period 2|Lack of Efficacy|0|||
149028517|NCT01119703|537581971|FG000|Overall Study|Adverse Event|0|||
149028518|NCT01119703|537581972|FG001|Overall Study|Adverse Event|1|||
149028519|NCT02095158|537581976|FG000|Overall Study|Adverse Event|14|||
149028520|NCT02095158|537581976|FG000|Overall Study|Lack of Efficacy|3|||
149028521|NCT02095158|537581976|FG000|Overall Study|Pregnancy|1|||
149028522|NCT02095158|537581976|FG000|Overall Study|Lost to Follow-up|20|||
149028523|NCT02095158|537581976|FG000|Overall Study|Personal Reasons|35|||
149028524|NCT02095158|537581976|FG000|Overall Study|Protocol Violation|1|||
149028525|NCT02095158|537581976|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149028526|NCT01941316|537581977|FG000|Overall Study|Adverse Event|0|||
149028527|NCT01941316|537581978|FG001|Overall Study|Adverse Event|1|||
149028528|NCT01941316|537581979|FG002|Overall Study|Adverse Event|0|||
149028529|NCT01941316|537581980|FG003|Overall Study|Adverse Event|7|||
149028530|NCT01941316|537581977|FG000|Overall Study|Progressive Disease|3|||
149028531|NCT01941316|537581978|FG001|Overall Study|Progressive Disease|6|||
149028532|NCT01941316|537581979|FG002|Overall Study|Progressive Disease|2|||
149028533|NCT01941316|537581980|FG003|Overall Study|Progressive Disease|29|||
148773539|NCT00507819|536642993|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
148773540|NCT00507819|536642994|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
148773541|NCT03261674|536642995|FG000|Overall Study|Lost to Follow-up|6|||
148773542|NCT03261674|536642996|FG001|Overall Study|Lost to Follow-up|7|||
148773543|NCT03261674|536642995|FG000|Overall Study|Protocol Violation|1|||
148773544|NCT03261674|536642996|FG001|Overall Study|Protocol Violation|4|||
148773545|NCT03261674|536642995|FG000|Overall Study|Withdrawal by Subject|1|||
148773546|NCT03261674|536642996|FG001|Overall Study|Withdrawal by Subject|4|||
148773547|NCT03261674|536642995|FG000|Overall Study|Physician Decision|1|||
148773548|NCT03261674|536642996|FG001|Overall Study|Physician Decision|0|||
148773549|NCT00623935|536642999|FG000|Overall Study|Death|1|||
148773550|NCT00623935|536642999|FG000|Overall Study|Patient Declined Transplant|1|||
148773551|NCT04507256|536643000|FG000|Overall Study|Withdrawal by Subject|1|||
148773552|NCT04507256|536643001|FG001|Overall Study|Withdrawal by Subject|0|||
148773553|NCT04507256|536643002|FG002|Overall Study|Withdrawal by Subject|0|||
148773554|NCT04507256|536643003|FG003|Overall Study|Withdrawal by Subject|1|||
148773555|NCT04507256|536643004|FG004|Overall Study|Withdrawal by Subject|0|||
148773556|NCT04507256|536643005|FG005|Overall Study|Withdrawal by Subject|0|||
148773557|NCT02256982|536643006|FG000|Overall Study|Disease Progression|0|||
148773558|NCT02256982|536643007|FG001|Overall Study|Disease Progression|1|||
148773559|NCT03614078|536643008|FG000|Overall Study|Withdrawal by Subject|2|||
148773560|NCT03614078|536643009|FG001|Overall Study|Withdrawal by Subject|2|||
148773561|NCT03614078|536643010|FG002|Overall Study|Withdrawal by Subject|3|||
148773562|NCT03614078|536643008|FG000|Overall Study|Participant Did Not Return for Visit|0|||
148773563|NCT03614078|536643009|FG001|Overall Study|Participant Did Not Return for Visit|1|||
148773564|NCT03614078|536643010|FG002|Overall Study|Participant Did Not Return for Visit|0|||
148773565|NCT03614078|536643008|FG000|Overall Study|High Neutrophils|0|||
148773566|NCT03614078|536643009|FG001|Overall Study|High Neutrophils|0|||
148773567|NCT03614078|536643010|FG002|Overall Study|High Neutrophils|2|||
148773568|NCT03614078|536643008|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
148773569|NCT03614078|536643009|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
148773570|NCT03614078|536643010|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
148773571|NCT03614078|536643008|FG000|Overall Study|Exacerbation of Psoriasis|0|||
148773572|NCT03614078|536643009|FG001|Overall Study|Exacerbation of Psoriasis|1|||
148773573|NCT03614078|536643010|FG002|Overall Study|Exacerbation of Psoriasis|0|||
148773574|NCT03614078|536643008|FG000|Overall Study|Adverse Event|0|||
148773575|NCT03614078|536643009|FG001|Overall Study|Adverse Event|2|||
148773576|NCT03614078|536643010|FG002|Overall Study|Adverse Event|0|||
148773577|NCT03614078|536643008|FG000|Overall Study|Dizziness and Rash|0|||
148773578|NCT03614078|536643009|FG001|Overall Study|Dizziness and Rash|1|||
148773579|NCT03614078|536643010|FG002|Overall Study|Dizziness and Rash|0|||
148773580|NCT04964544|536643013|FG000|Overall Study|Screen failure or other uncategorised|10|||
148773581|NCT04964544|536643013|FG000|Overall Study|Physician Decision|4|||
148773582|NCT04964544|536643013|FG000|Overall Study|Lost to Follow-up|9|||
148773583|NCT04964544|536643013|FG000|Overall Study|Withdrawal by Subject|18|||
148773584|NCT04964544|536643013|FG000|Overall Study|Death|1|||
148773585|NCT02855359|536643018|FG000|Overall Study|Death|2|||
148773586|NCT02855359|536643019|FG001|Overall Study|Death|2|||
148773587|NCT02855359|536643020|FG002|Overall Study|Death|0|||
148773588|NCT02855359|536643021|FG003|Overall Study|Death|0|||
148773589|NCT02855359|536643018|FG000|Overall Study|Study Termination by Sponsor|9|||
148773590|NCT02855359|536643019|FG001|Overall Study|Study Termination by Sponsor|11|||
148773591|NCT02855359|536643020|FG002|Overall Study|Study Termination by Sponsor|0|||
148773592|NCT02855359|536643021|FG003|Overall Study|Study Termination by Sponsor|0|||
148773593|NCT03155178|536643022|FG000|Overall Study|Did not meet treatment day baseline|7|||
148773594|NCT03155178|536643023|FG001|Overall Study|Did not meet treatment day baseline|7|||
148773595|NCT03155178|536643024|FG002|Overall Study|Did not meet treatment day baseline|7|||
148773596|NCT03155178|536643025|FG003|Overall Study|Did not meet treatment day baseline|7|||
148773597|NCT04712019|536643026|FG000|Overall Study|Withdrawal by Subject|2|||
148773598|NCT04712019|536643027|FG001|Overall Study|Withdrawal by Subject|2|||
148773599|NCT04712019|536643026|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
148773600|NCT04712019|536643027|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
148773601|NCT02347891|536643033|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
148773602|NCT02347891|536643034|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
148773603|NCT02347891|536643033|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
148773604|NCT02347891|536643034|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
148773605|NCT02541669|536643037|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
148773606|NCT02541669|536643038|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
148773607|NCT02541669|536643039|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
148773608|NCT02541669|536643040|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
148773609|NCT02541669|536643041|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
148773610|NCT00834639|536643042|FG000|Second Intervention|Physician Decision|0|||
148773611|NCT00834639|536643043|FG001|Second Intervention|Physician Decision|2|||
148773612|NCT04739722|536643044|FG000|Overall Study|Lost to Follow-up|5301|||
148773613|NCT04739722|536643044|FG000|Overall Study|Withdrawal by Subject|42|||
148773614|NCT04739722|536643044|FG000|Overall Study|Non Average-risk|1157|||
148773615|NCT03729570|536643046|FG000|Overall Study|Lost to Follow-up|16|||
148773616|NCT03729570|536643047|FG001|Overall Study|Lost to Follow-up|20|||
148773617|NCT03729570|536643046|FG000|Overall Study|Seroconversion|5|||
148773618|NCT03729570|536643047|FG001|Overall Study|Seroconversion|0|||
148773619|NCT03729570|536643046|FG000|Overall Study|Moved out of the city|1|||
148834429|NCT04756531|536874407|FG002|Overall Study|Withdrawal by Subject|0|||
148773620|NCT03729570|536643047|FG001|Overall Study|Moved out of the city|0|||
148834430|NCT04756531|536874408|FG003|Overall Study|Withdrawal by Subject|0|||
148834431|NCT04756531|536874409|FG004|Overall Study|Withdrawal by Subject|0|||
148834432|NCT04756531|536874410|FG005|Overall Study|Withdrawal by Subject|0|||
148834433|NCT04756531|536874411|FG006|Overall Study|Withdrawal by Subject|1|||
148834434|NCT04756531|536874412|FG007|Overall Study|Withdrawal by Subject|0|||
148834435|NCT04756531|536874413|FG008|Overall Study|Withdrawal by Subject|0|||
148834436|NCT04756531|536874414|FG009|Overall Study|Withdrawal by Subject|0|||
148834437|NCT04756531|536874415|FG010|Overall Study|Withdrawal by Subject|0|||
148834438|NCT04756531|536874416|FG011|Overall Study|Withdrawal by Subject|0|||
148834439|NCT04756531|536874417|FG012|Overall Study|Withdrawal by Subject|0|||
148834440|NCT04756531|536874418|FG013|Overall Study|Withdrawal by Subject|0|||
148834441|NCT04756531|536874419|FG014|Overall Study|Withdrawal by Subject|0|||
148834442|NCT04756531|536874420|FG015|Overall Study|Withdrawal by Subject|0|||
148834443|NCT04756531|536874421|FG016|Overall Study|Withdrawal by Subject|0|||
148834444|NCT04756531|536874422|FG017|Overall Study|Withdrawal by Subject|0|||
148834445|NCT04237584|536874423|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
148834446|NCT04237584|536874424|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
148834447|NCT04237584|536874425|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
148834448|NCT04237584|536874426|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
148834449|NCT04237584|536874423|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
148834450|NCT04237584|536874424|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
148834451|NCT04237584|536874425|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
148834452|NCT04237584|536874426|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
148834453|NCT04237584|536874423|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
148834454|NCT04237584|536874424|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
148834455|NCT04237584|536874425|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
148834456|NCT04237584|536874426|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
148834457|NCT04237584|536874423|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
148834458|NCT04237584|536874424|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
148834459|NCT04237584|536874425|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
148834460|NCT04237584|536874426|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
148834461|NCT04237584|536874423|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
148834462|NCT04237584|536874424|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
148834463|NCT04237584|536874425|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
148834464|NCT04237584|536874426|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
148834465|NCT05239221|536874427|FG000|Overall Study|Adverse Event|0|||
148834466|NCT05239221|536874428|FG001|Overall Study|Adverse Event|0|||
148834467|NCT05239221|536874429|FG002|Overall Study|Adverse Event|0|||
148834468|NCT05239221|536874430|FG003|Overall Study|Adverse Event|0|||
148834469|NCT05239221|536874431|FG004|Overall Study|Adverse Event|0|||
148834470|NCT05239221|536874432|FG005|Overall Study|Adverse Event|0|||
148834471|NCT05239221|536874433|FG006|Overall Study|Adverse Event|1|||
148834472|NCT05239221|536874434|FG007|Overall Study|Adverse Event|0|||
148834473|NCT05239221|536874435|FG008|Overall Study|Adverse Event|0|||
148834474|NCT05239221|536874436|FG009|Overall Study|Adverse Event|0|||
148834475|NCT05239221|536874437|FG010|Overall Study|Adverse Event|1|||
148834476|NCT05239221|536874438|FG011|Overall Study|Adverse Event|1|||
148834477|NCT05239221|536874439|FG012|Overall Study|Adverse Event|0|||
148834478|NCT05239221|536874440|FG013|Overall Study|Adverse Event|0|||
148834479|NCT05239221|536874441|FG014|Overall Study|Adverse Event|0|||
148834480|NCT05239221|536874442|FG015|Overall Study|Adverse Event|0|||
148834481|NCT05239221|536874427|FG000|Overall Study|Withdrawal by Subject|0|||
148834482|NCT05239221|536874428|FG001|Overall Study|Withdrawal by Subject|0|||
148834483|NCT05239221|536874429|FG002|Overall Study|Withdrawal by Subject|0|||
148834484|NCT05239221|536874430|FG003|Overall Study|Withdrawal by Subject|0|||
148834485|NCT05239221|536874431|FG004|Overall Study|Withdrawal by Subject|0|||
148834486|NCT05239221|536874432|FG005|Overall Study|Withdrawal by Subject|0|||
148834487|NCT05239221|536874433|FG006|Overall Study|Withdrawal by Subject|0|||
148834488|NCT05239221|536874434|FG007|Overall Study|Withdrawal by Subject|0|||
148834489|NCT05239221|536874435|FG008|Overall Study|Withdrawal by Subject|0|||
148834490|NCT05239221|536874436|FG009|Overall Study|Withdrawal by Subject|0|||
148834491|NCT05239221|536874437|FG010|Overall Study|Withdrawal by Subject|1|||
148834492|NCT05239221|536874438|FG011|Overall Study|Withdrawal by Subject|0|||
148834493|NCT05239221|536874439|FG012|Overall Study|Withdrawal by Subject|0|||
148834494|NCT05239221|536874440|FG013|Overall Study|Withdrawal by Subject|0|||
148834495|NCT05239221|536874441|FG014|Overall Study|Withdrawal by Subject|0|||
148834496|NCT05239221|536874442|FG015|Overall Study|Withdrawal by Subject|1|||
148834497|NCT02581930|536874443|FG000|Overall Study|Withdrawal by Subject|1|||
148834498|NCT02581930|536874443|FG000|Overall Study|patient declined further treatment|1|||
148834499|NCT01400412|536874444|FG000|Overall Study|Lost to Follow-up|4|||
148834500|NCT01400412|536874445|FG001|Overall Study|Lost to Follow-up|7|||
148981372|NCT01687166|537411622|FG000|Overall Study|Subject moved out of state|0|||
149028534|NCT01941316|537581977|FG000|Overall Study|Withdrawal by Subject|0|||
149028535|NCT01941316|537581978|FG001|Overall Study|Withdrawal by Subject|2|||
148773621|NCT03729570|536643046|FG000|Overall Study|Time Conflict|1|||
148773622|NCT03729570|536643047|FG001|Overall Study|Time Conflict|0|||
148773623|NCT03729570|536643046|FG000|Overall Study|Time Commitment|2|||
148773624|NCT03729570|536643047|FG001|Overall Study|Time Commitment|0|||
148773625|NCT03729570|536643046|FG000|Overall Study|Bad Experience|0|||
148773626|NCT03729570|536643047|FG001|Overall Study|Bad Experience|1|||
148773627|NCT03729570|536643046|FG000|Overall Study|No reason provided|2|||
148773628|NCT03729570|536643047|FG001|Overall Study|No reason provided|1|||
148773629|NCT03729570|536643046|FG000|Overall Study|Family Conflict|0|||
148773630|NCT03729570|536643047|FG001|Overall Study|Family Conflict|1|||
148773631|NCT03729570|536643046|FG000|Overall Study|Did not want to continue taking medications|0|||
148773632|NCT03729570|536643047|FG001|Overall Study|Did not want to continue taking medications|1|||
148773633|NCT03729570|536643046|FG000|Overall Study|Found another PrEP provider|1|||
148773634|NCT03729570|536643047|FG001|Overall Study|Found another PrEP provider|0|||
148773635|NCT03729570|536643046|FG000|Overall Study|Did not enjoy being in the control group|0|||
148773636|NCT03729570|536643047|FG001|Overall Study|Did not enjoy being in the control group|1|||
148773637|NCT00278148|536643050|FG000|Phase II - Expansion Phase|Disease progression|0|||
148773638|NCT00278148|536643051|FG001|Phase II - Expansion Phase|Disease progression|0|||
148773639|NCT00278148|536643052|FG002|Phase II - Expansion Phase|Disease progression|4|||
148773640|NCT00278148|536643050|FG000|Phase II - Expansion Phase|Adverse Event|0|||
148773641|NCT00278148|536643051|FG001|Phase II - Expansion Phase|Adverse Event|0|||
148773642|NCT00278148|536643052|FG002|Phase II - Expansion Phase|Adverse Event|2|||
148773643|NCT02083185|536643054|FG000|Overall Study|Lost to Follow-up|0|||
148773644|NCT02083185|536643055|FG001|Overall Study|Lost to Follow-up|3|||
148773645|NCT02083185|536643056|FG002|Overall Study|Lost to Follow-up|0|||
148773646|NCT02083185|536643054|FG000|Overall Study|Withdrawal by Subject|9|||
148773647|NCT02083185|536643055|FG001|Overall Study|Withdrawal by Subject|15|||
148773648|NCT02083185|536643056|FG002|Overall Study|Withdrawal by Subject|1|||
148773649|NCT02083185|536643054|FG000|Overall Study|Death|2|||
148773650|NCT02083185|536643055|FG001|Overall Study|Death|2|||
148773651|NCT02083185|536643056|FG002|Overall Study|Death|1|||
148773652|NCT02083185|536643054|FG000|Overall Study|Reason not Specified|9|||
148773653|NCT02083185|536643055|FG001|Overall Study|Reason not Specified|6|||
148773654|NCT02083185|536643056|FG002|Overall Study|Reason not Specified|5|||
148773655|NCT02083185|536643054|FG000|Overall Study|Study Terminated by Sponsor|0|||
148773656|NCT02083185|536643055|FG001|Overall Study|Study Terminated by Sponsor|1|||
148773657|NCT02083185|536643056|FG002|Overall Study|Study Terminated by Sponsor|0|||
148773658|NCT02083185|536643054|FG000|Overall Study|Did not Receive Study Drug|0|||
148773659|NCT02083185|536643055|FG001|Overall Study|Did not Receive Study Drug|2|||
148773660|NCT02083185|536643056|FG002|Overall Study|Did not Receive Study Drug|0|||
148773661|NCT03419598|536643057|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
148773662|NCT00985959|536643061|FG000|Overall Study|Adverse Event|0|||
148773663|NCT00985959|536643062|FG001|Overall Study|Adverse Event|0|||
148773664|NCT00985959|536643063|FG002|Overall Study|Adverse Event|19|||
148773665|NCT00985959|536643061|FG000|Overall Study|Withdrawal by Subject|0|||
148773666|NCT00985959|536643062|FG001|Overall Study|Withdrawal by Subject|0|||
148773667|NCT00985959|536643063|FG002|Overall Study|Withdrawal by Subject|8|||
148773668|NCT00985959|536643061|FG000|Overall Study|Progressive disease|1|||
148773669|NCT00985959|536643062|FG001|Overall Study|Progressive disease|2|||
148773670|NCT00985959|536643063|FG002|Overall Study|Progressive disease|8|||
148773671|NCT00985959|536643061|FG000|Overall Study|Unrecovered toxicity|0|||
148773672|NCT00985959|536643062|FG001|Overall Study|Unrecovered toxicity|0|||
148773673|NCT00985959|536643063|FG002|Overall Study|Unrecovered toxicity|7|||
148773674|NCT00985959|536643061|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
148773675|NCT00985959|536643062|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
148773676|NCT00985959|536643063|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
148773677|NCT00985959|536643061|FG000|Overall Study|Complete response observed over 2 cycles|0|||
148773678|NCT00985959|536643062|FG001|Overall Study|Complete response observed over 2 cycles|1|||
148773679|NCT00985959|536643063|FG002|Overall Study|Complete response observed over 2 cycles|4|||
148773680|NCT00985959|536643061|FG000|Overall Study|Other|0|||
148773681|NCT00985959|536643062|FG001|Overall Study|Other|0|||
148773682|NCT00985959|536643063|FG002|Overall Study|Other|11|||
148773683|NCT00471718|536643064|FG000|Overall Study|Adverse Event|3|||
148773684|NCT00471718|536643064|FG000|Overall Study|other complicating disease|1|||
148773685|NCT00471718|536643064|FG000|Overall Study|disease progression|22|||
149028536|NCT01941316|537581979|FG002|Overall Study|Withdrawal by Subject|1|||
148773686|NCT00471718|536643064|FG000|Overall Study|Withdrawal by Subject|1|||
148773687|NCT01446237|536643065|FG000|Overall Study|Adverse Event|1|||
148773688|NCT01446237|536643065|FG000|Overall Study|Lost to Follow-up|2|||
148773689|NCT01446237|536643065|FG000|Overall Study|Withdrawal by Subject|7|||
148773690|NCT01931956|536643066|FG000|Overall Study|Death|42|||
148773691|NCT01931956|536643067|FG001|Overall Study|Death|7|||
148773692|NCT01931956|536643068|FG002|Overall Study|Death|379|||
148773693|NCT01931956|536643069|FG003|Overall Study|Death|96|||
148981373|NCT01687166|537411623|FG001|Overall Study|Subject moved out of state|1|||
148981374|NCT01687166|537411624|FG002|Overall Study|Subject moved out of state|0|||
148981375|NCT01687166|537411625|FG003|Overall Study|Subject moved out of state|0|||
148981376|NCT01687166|537411622|FG000|Overall Study|Patient unable to be compliant|1|||
148981377|NCT01687166|537411623|FG001|Overall Study|Patient unable to be compliant|0|||
148981378|NCT01687166|537411624|FG002|Overall Study|Patient unable to be compliant|0|||
148981379|NCT01687166|537411625|FG003|Overall Study|Patient unable to be compliant|0|||
148981380|NCT01687166|537411622|FG000|Overall Study|Physician choice to use different device|1|||
148981381|NCT01687166|537411623|FG001|Overall Study|Physician choice to use different device|2|||
148981382|NCT01687166|537411624|FG002|Overall Study|Physician choice to use different device|4|||
148981383|NCT01687166|537411625|FG003|Overall Study|Physician choice to use different device|0|||
148981384|NCT01687166|537411622|FG000|Overall Study|Insurance|0|||
148981385|NCT01687166|537411623|FG001|Overall Study|Insurance|0|||
148981386|NCT01687166|537411624|FG002|Overall Study|Insurance|1|||
148981387|NCT01687166|537411625|FG003|Overall Study|Insurance|1|||
148981388|NCT02755831|537411626|FG000|Overall Study|Lost to Follow-up|3|||
148981389|NCT02755831|537411627|FG001|Overall Study|Lost to Follow-up|3|||
148981390|NCT02296112|537411628|FG000|Overall Study|Disease progression|7|||
148981391|NCT02296112|537411628|FG000|Overall Study|Toxicity|1|||
148981392|NCT02296112|537411628|FG000|Overall Study|Began an alternate therapy|1|||
148981393|NCT01516879|537411629|FG000|Overall Study|Withdrawal by Subject|9|||
148981394|NCT01516879|537411630|FG001|Overall Study|Withdrawal by Subject|11|||
148981395|NCT01516879|537411629|FG000|Overall Study|Death|0|||
148981396|NCT01516879|537411630|FG001|Overall Study|Death|2|||
148981397|NCT01516879|537411629|FG000|Overall Study|Lost to Follow-up|2|||
148981398|NCT01516879|537411630|FG001|Overall Study|Lost to Follow-up|11|||
148981399|NCT01516879|537411629|FG000|Overall Study|Other|5|||
148981400|NCT01516879|537411630|FG001|Overall Study|Other|10|||
148981401|NCT00183872|537411631|FG000|Overall Study|Death|3|||
148981402|NCT00183872|537411631|FG000|Overall Study|Adverse Event|9|||
148981403|NCT00183872|537411631|FG000|Overall Study|Withdrawal by Subject|2|||
148981404|NCT00183872|537411631|FG000|Overall Study|Drug delayed more than 28 days|2|||
148981405|NCT02052466|537411632|FG000|Overall Study|Withdrawal by Subject|1|||
148981406|NCT02052466|537411632|FG000|Overall Study|Acromial fracture|1|||
148981407|NCT01720069|537411633|FG000|Overall Study|Could not use e-diary correctly|0|||
148981408|NCT01720069|537411634|FG001|Overall Study|Could not use e-diary correctly|1|||
148981409|NCT01720069|537411635|FG002|Overall Study|Could not use e-diary correctly|1|||
148981410|NCT01720069|537411633|FG000|Overall Study|Randomised without baseline values|0|||
148981411|NCT01720069|537411634|FG001|Overall Study|Randomised without baseline values|0|||
148981412|NCT01720069|537411635|FG002|Overall Study|Randomised without baseline values|1|||
148981413|NCT01720069|537411633|FG000|Overall Study|Adverse Event|0|||
148981414|NCT01720069|537411634|FG001|Overall Study|Adverse Event|0|||
148981415|NCT01720069|537411635|FG002|Overall Study|Adverse Event|1|||
148981416|NCT01720069|537411633|FG000|Overall Study|Lack of Efficacy|0|||
148981417|NCT01720069|537411634|FG001|Overall Study|Lack of Efficacy|4|||
149028537|NCT01941316|537581980|FG003|Overall Study|Withdrawal by Subject|8|||
148773694|NCT01931956|536643066|FG000|Overall Study|Withdrawal by Subject|5|||
148773695|NCT01931956|536643067|FG001|Overall Study|Withdrawal by Subject|0|||
148773696|NCT01931956|536643068|FG002|Overall Study|Withdrawal by Subject|70|||
148773697|NCT01931956|536643069|FG003|Overall Study|Withdrawal by Subject|30|||
148773698|NCT01931956|536643066|FG000|Overall Study|Lost to Follow-up|2|||
148773699|NCT01931956|536643067|FG001|Overall Study|Lost to Follow-up|0|||
148773700|NCT01931956|536643068|FG002|Overall Study|Lost to Follow-up|11|||
148773701|NCT01931956|536643069|FG003|Overall Study|Lost to Follow-up|7|||
148773702|NCT01931956|536643066|FG000|Overall Study|Expected|2|||
148773703|NCT01931956|536643067|FG001|Overall Study|Expected|0|||
148773704|NCT01931956|536643068|FG002|Overall Study|Expected|6|||
148773705|NCT01931956|536643069|FG003|Overall Study|Expected|0|||
148773706|NCT01931956|536643066|FG000|Overall Study|Not due|0|||
148773707|NCT01931956|536643067|FG001|Overall Study|Not due|0|||
148773708|NCT01931956|536643068|FG002|Overall Study|Not due|21|||
148773709|NCT01931956|536643069|FG003|Overall Study|Not due|0|||
148773710|NCT00072280|536643070|FG000|Treatment|Found ineligible|1|||
148773711|NCT00072280|536643071|FG001|Treatment|Found ineligible|2|||
148773712|NCT00072280|536643070|FG000|Follow-up|Early termination of study|2|||
148773713|NCT00072280|536643071|FG001|Follow-up|Early termination of study|2|||
148773714|NCT03226769|536643072|FG000|Overall Study|Withdrawal by Subject|0|||
148773715|NCT03226769|536643073|FG001|Overall Study|Withdrawal by Subject|1|||
148773716|NCT02272842|536643080|FG000|Overall Study|Lost to Follow-up|8|||
148773717|NCT02272842|536643081|FG001|Overall Study|Lost to Follow-up|8|||
148773718|NCT02272842|536643080|FG000|Overall Study|Withdrawal by Subject|8|||
148773719|NCT02272842|536643081|FG001|Overall Study|Withdrawal by Subject|2|||
148773720|NCT04338269|536644943|FG000|Overall Study|Death|86|||
148773721|NCT04338269|536644944|FG001|Overall Study|Death|89|||
148773722|NCT04338269|536644943|FG000|Overall Study|Lost to Follow-up|1|||
148981418|NCT01720069|537411635|FG002|Overall Study|Lack of Efficacy|0|||
148981419|NCT01720069|537411633|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
148981420|NCT01720069|537411634|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
148834501|NCT01400412|536874444|FG000|Overall Study|Withdrawal by Subject|3|||
148834502|NCT01400412|536874445|FG001|Overall Study|Withdrawal by Subject|4|||
148834503|NCT01400412|536874444|FG000|Overall Study|Unable to complete|3|||
148834504|NCT01400412|536874445|FG001|Overall Study|Unable to complete|3|||
148834505|NCT01400412|536874444|FG000|Overall Study|Never started study treatment|0|||
148834506|NCT01400412|536874445|FG001|Overall Study|Never started study treatment|3|||
148834507|NCT01083602|536876076|FG000|Overall Study|Adverse Event|11|||
148834508|NCT01083602|536876076|FG000|Overall Study|New Cancer Therapy|2|||
148834509|NCT01083602|536876076|FG000|Overall Study|Death|1|||
148834510|NCT01083602|536876076|FG000|Overall Study|Withdrawal by Subject|5|||
148834511|NCT01083602|536876076|FG000|Overall Study|Lack of Efficacy|36|||
148834512|NCT01657370|536876077|FG000|Overall Study|Withdrawal by Subject|0|||
148834513|NCT01657370|536876078|FG001|Overall Study|Withdrawal by Subject|0|||
148834514|NCT01657370|536876079|FG002|Overall Study|Withdrawal by Subject|1|||
148834515|NCT01657370|536876080|FG003|Overall Study|Withdrawal by Subject|0|||
148834516|NCT01657370|536876081|FG004|Overall Study|Withdrawal by Subject|0|||
148834517|NCT01657370|536876082|FG005|Overall Study|Withdrawal by Subject|1|||
148834518|NCT01657370|536876077|FG000|Overall Study|Physician Decision|2|||
148834519|NCT01657370|536876078|FG001|Overall Study|Physician Decision|3|||
148834520|NCT01657370|536876079|FG002|Overall Study|Physician Decision|1|||
148834521|NCT01657370|536876080|FG003|Overall Study|Physician Decision|2|||
148834522|NCT01657370|536876081|FG004|Overall Study|Physician Decision|5|||
148834523|NCT01657370|536876082|FG005|Overall Study|Physician Decision|0|||
148834524|NCT01657370|536876077|FG000|Overall Study|Lack of Qualifying Event|1|||
148834525|NCT01657370|536876078|FG001|Overall Study|Lack of Qualifying Event|0|||
148834526|NCT01657370|536876079|FG002|Overall Study|Lack of Qualifying Event|3|||
148834527|NCT01657370|536876080|FG003|Overall Study|Lack of Qualifying Event|2|||
148834528|NCT01657370|536876081|FG004|Overall Study|Lack of Qualifying Event|1|||
148834529|NCT01657370|536876082|FG005|Overall Study|Lack of Qualifying Event|2|||
148834530|NCT01657370|536876077|FG000|Overall Study|Adverse Event|0|||
148834531|NCT01657370|536876078|FG001|Overall Study|Adverse Event|0|||
148834532|NCT01657370|536876079|FG002|Overall Study|Adverse Event|0|||
148834533|NCT01657370|536876080|FG003|Overall Study|Adverse Event|0|||
148834534|NCT01657370|536876081|FG004|Overall Study|Adverse Event|1|||
148834535|NCT01657370|536876082|FG005|Overall Study|Adverse Event|0|||
148834536|NCT01657370|536876077|FG000|Overall Study|Protocol Violation|1|||
148834537|NCT01657370|536876078|FG001|Overall Study|Protocol Violation|1|||
148981421|NCT01720069|537411635|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
148981422|NCT01720069|537411633|FG000|Overall Study|Withdrawal by Subject|0|||
148981423|NCT01720069|537411634|FG001|Overall Study|Withdrawal by Subject|2|||
148981424|NCT01720069|537411635|FG002|Overall Study|Withdrawal by Subject|1|||
148981425|NCT01720069|537411633|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
148981426|NCT01720069|537411634|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
148981427|NCT01720069|537411635|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
149028538|NCT01941316|537581977|FG000|Overall Study|Death|0|||
149028539|NCT01941316|537581978|FG001|Overall Study|Death|0|||
148834538|NCT01657370|536876079|FG002|Overall Study|Protocol Violation|1|||
148981428|NCT01720069|537411633|FG000|Overall Study|Non-compliance on using e-diary|0|||
148981429|NCT01720069|537411634|FG001|Overall Study|Non-compliance on using e-diary|0|||
148981430|NCT01720069|537411635|FG002|Overall Study|Non-compliance on using e-diary|1|||
148773723|NCT04338269|536644944|FG001|Overall Study|Lost to Follow-up|2|||
148773724|NCT04338269|536644943|FG000|Overall Study|Physician Decision|1|||
148773725|NCT04338269|536644944|FG001|Overall Study|Physician Decision|0|||
148773726|NCT04338269|536644943|FG000|Overall Study|Withdrawal by Subject|14|||
148773727|NCT04338269|536644944|FG001|Overall Study|Withdrawal by Subject|11|||
148773728|NCT03339726|536644945|FG000|Overall Study|Withdrawal by Subject|1|||
148773729|NCT03339726|536644946|FG001|Overall Study|Withdrawal by Subject|0|||
148773730|NCT03339726|536644947|FG002|Overall Study|Withdrawal by Subject|0|||
148773731|NCT03339726|536644945|FG000|Overall Study|Lost to Follow-up|0|||
148773732|NCT03339726|536644946|FG001|Overall Study|Lost to Follow-up|1|||
148773733|NCT03339726|536644947|FG002|Overall Study|Lost to Follow-up|0|||
148773734|NCT03960021|536644953|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
148773735|NCT02203851|536644954|FG000|Overall Study|Lost to Follow-up|4|||
148834539|NCT01657370|536876080|FG003|Overall Study|Protocol Violation|1|||
148834540|NCT01657370|536876081|FG004|Overall Study|Protocol Violation|0|||
148981431|NCT01720069|537411633|FG000|Overall Study|Lost to Follow-up|0|||
148981432|NCT01720069|537411634|FG001|Overall Study|Lost to Follow-up|0|||
148773736|NCT02203851|536644954|FG000|Overall Study|Withdrawal by Subject|6|||
148773737|NCT02203851|536644954|FG000|Overall Study|Other|1|||
148834541|NCT01657370|536876082|FG005|Overall Study|Protocol Violation|0|||
148834542|NCT01657370|536876077|FG000|Overall Study|Lost to Follow-up|2|||
148834543|NCT01657370|536876078|FG001|Overall Study|Lost to Follow-up|0|||
148834544|NCT01657370|536876079|FG002|Overall Study|Lost to Follow-up|1|||
148834545|NCT01657370|536876080|FG003|Overall Study|Lost to Follow-up|0|||
148834546|NCT01657370|536876081|FG004|Overall Study|Lost to Follow-up|0|||
148834547|NCT01657370|536876082|FG005|Overall Study|Lost to Follow-up|1|||
148834548|NCT04043286|536876083|FG000|Overall Study|Withdrawal by Subject|2|||
148834549|NCT04043286|536876084|FG001|Overall Study|Withdrawal by Subject|2|||
148834550|NCT03698279|536876085|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148834551|NCT03698279|536876086|FG001|Overall Study|Withdrawal by parent/guardian|1|||
148834552|NCT03698279|536876087|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148834553|NCT03698279|536876088|FG003|Overall Study|Withdrawal by parent/guardian|1|||
148834554|NCT03698279|536876089|FG004|Overall Study|Withdrawal by parent/guardian|0|||
148834555|NCT03698279|536876090|FG005|Overall Study|Withdrawal by parent/guardian|0|||
148834556|NCT03698279|536876085|FG000|Overall Study|Protocol deviation|1|||
148834557|NCT03698279|536876086|FG001|Overall Study|Protocol deviation|0|||
148834558|NCT03698279|536876087|FG002|Overall Study|Protocol deviation|1|||
148834559|NCT03698279|536876088|FG003|Overall Study|Protocol deviation|0|||
148834560|NCT03698279|536876089|FG004|Overall Study|Protocol deviation|0|||
148834561|NCT03698279|536876090|FG005|Overall Study|Protocol deviation|0|||
148834562|NCT03698279|536876085|FG000|Overall Study|Withdrawal by Subject|0|||
148834563|NCT03698279|536876086|FG001|Overall Study|Withdrawal by Subject|0|||
148834564|NCT03698279|536876087|FG002|Overall Study|Withdrawal by Subject|1|||
148834565|NCT03698279|536876088|FG003|Overall Study|Withdrawal by Subject|0|||
148834566|NCT03698279|536876089|FG004|Overall Study|Withdrawal by Subject|0|||
148834567|NCT03698279|536876090|FG005|Overall Study|Withdrawal by Subject|0|||
148834568|NCT03698279|536876085|FG000|Overall Study|Lost to Follow-up|3|||
148834569|NCT03698279|536876086|FG001|Overall Study|Lost to Follow-up|1|||
148834570|NCT03698279|536876087|FG002|Overall Study|Lost to Follow-up|4|||
148834571|NCT03698279|536876088|FG003|Overall Study|Lost to Follow-up|5|||
148834572|NCT03698279|536876089|FG004|Overall Study|Lost to Follow-up|0|||
148834573|NCT03698279|536876090|FG005|Overall Study|Lost to Follow-up|0|||
148834574|NCT00560508|536876092|FG000|12 Week Double-blind Period|Adverse Event|3|||
148834575|NCT00560508|536876093|FG001|12 Week Double-blind Period|Adverse Event|2|||
148834576|NCT00560508|536876092|FG000|12 Week Double-blind Period|Protocol Violation|1|||
148834577|NCT00560508|536876093|FG001|12 Week Double-blind Period|Protocol Violation|0|||
148834578|NCT00560508|536876092|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
148834579|NCT00560508|536876093|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
148834580|NCT00560508|536876092|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
148834581|NCT00560508|536876093|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
148834582|NCT00560508|536876092|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
148834583|NCT00560508|536876093|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
148834584|NCT00560508|536876092|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
148834585|NCT00560508|536876093|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
148834586|NCT00560508|536876092|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
148834587|NCT00560508|536876093|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
148834588|NCT02410772|536876099|FG000|Overall Study|Death|3|||
148834589|NCT02410772|536876100|FG001|Overall Study|Death|4|||
148834590|NCT02410772|536876101|FG002|Overall Study|Death|8|||
148834591|NCT02410772|536876099|FG000|Overall Study|Lost to Follow-up|31|||
148834592|NCT02410772|536876100|FG001|Overall Study|Lost to Follow-up|23|||
148834593|NCT02410772|536876101|FG002|Overall Study|Lost to Follow-up|22|||
148834594|NCT02410772|536876099|FG000|Overall Study|Pregnancy|8|||
148834595|NCT02410772|536876100|FG001|Overall Study|Pregnancy|4|||
148834596|NCT02410772|536876101|FG002|Overall Study|Pregnancy|5|||
148834597|NCT02410772|536876099|FG000|Overall Study|Protocol Violation|8|||
148834598|NCT02410772|536876100|FG001|Overall Study|Protocol Violation|8|||
148834599|NCT02410772|536876101|FG002|Overall Study|Protocol Violation|4|||
148834600|NCT02410772|536876099|FG000|Overall Study|Baseline Drug Resistance|49|||
148834601|NCT02410772|536876100|FG001|Overall Study|Baseline Drug Resistance|40|||
148834602|NCT02410772|536876101|FG002|Overall Study|Baseline Drug Resistance|51|||
148834603|NCT02410772|536876099|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
148834604|NCT02410772|536876100|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
148834605|NCT02410772|536876101|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
148834606|NCT02410772|536876099|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
148834607|NCT02410772|536876100|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
148834608|NCT02410772|536876101|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
148834609|NCT01645176|536876102|FG000|Overall Study|Lack of Efficacy|4|||
148834610|NCT01645176|536876102|FG000|Overall Study|did not complete final MRI|1|||
148834611|NCT02164864|536876103|FG000|Overall Study|Trial disease worsening|7|||
148834612|NCT02164864|536876104|FG001|Overall Study|Trial disease worsening|5|||
148834613|NCT02164864|536876105|FG002|Overall Study|Trial disease worsening|1|||
148834614|NCT02164864|536876103|FG000|Overall Study|Other pre-existing disease worsening|6|||
148834615|NCT02164864|536876104|FG001|Overall Study|Other pre-existing disease worsening|4|||
148834616|NCT02164864|536876105|FG002|Overall Study|Other pre-existing disease worsening|9|||
148834617|NCT02164864|536876103|FG000|Overall Study|Other Adverse Event (AE)|52|||
148834618|NCT02164864|536876104|FG001|Overall Study|Other Adverse Event (AE)|32|||
148834619|NCT02164864|536876105|FG002|Overall Study|Other Adverse Event (AE)|49|||
148834620|NCT02164864|536876103|FG000|Overall Study|Protocol Violation|2|||
148834621|NCT02164864|536876104|FG001|Overall Study|Protocol Violation|4|||
148834622|NCT02164864|536876105|FG002|Overall Study|Protocol Violation|1|||
148834623|NCT02164864|536876103|FG000|Overall Study|Lost to Follow-up|4|||
148981433|NCT01720069|537411635|FG002|Overall Study|Lost to Follow-up|1|||
148773738|NCT01482065|536644965|FG000|Overall Study|Withdrawal by Subject|0|||
148773739|NCT01482065|536644966|FG001|Overall Study|Withdrawal by Subject|1|||
148773740|NCT00761280|536644967|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
148773741|NCT00761280|536644968|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
148773742|NCT00761280|536644967|FG000|Randomization to First Dose|Sponsor decision|1|||
148773743|NCT00761280|536644968|FG001|Randomization to First Dose|Sponsor decision|0|||
148773744|NCT00761280|536644967|FG000|Randomization to First Dose|Other|1|||
148773745|NCT00761280|536644968|FG001|Randomization to First Dose|Other|0|||
148773746|NCT00761280|536644967|FG000|First Dose to End of Study|End of trial|5|||
148773747|NCT00761280|536644968|FG001|First Dose to End of Study|End of trial|5|||
148773748|NCT00761280|536644967|FG000|First Dose to End of Study|Progressive disease|5|||
148773749|NCT00761280|536644968|FG001|First Dose to End of Study|Progressive disease|3|||
148773750|NCT00761280|536644967|FG000|First Dose to End of Study|Sponsor decision|1|||
148773751|NCT00761280|536644968|FG001|First Dose to End of Study|Sponsor decision|2|||
148773752|NCT00761280|536644967|FG000|First Dose to End of Study|Death|1|||
148773753|NCT00761280|536644968|FG001|First Dose to End of Study|Death|0|||
148773754|NCT00761280|536644967|FG000|First Dose to End of Study|Lost to Follow-up|0|||
148773755|NCT00761280|536644968|FG001|First Dose to End of Study|Lost to Follow-up|1|||
148773756|NCT02045862|536644973|FG000|Overall Study|Death|0|||
148773757|NCT02045862|536644974|FG001|Overall Study|Death|0|||
148773758|NCT02045862|536644975|FG002|Overall Study|Death|1|||
148773759|NCT02045862|536644973|FG000|Overall Study|Miscellaneous|5|||
148773760|NCT02045862|536644974|FG001|Overall Study|Miscellaneous|0|||
148773761|NCT02045862|536644975|FG002|Overall Study|Miscellaneous|8|||
148773762|NCT02045862|536644973|FG000|Overall Study|Withdrawal by Patient|18|||
148773763|NCT02045862|536644974|FG001|Overall Study|Withdrawal by Patient|27|||
148773764|NCT02045862|536644975|FG002|Overall Study|Withdrawal by Patient|57|||
148773765|NCT02045862|536644973|FG000|Overall Study|Protocol Violation|0|||
148773766|NCT02045862|536644974|FG001|Overall Study|Protocol Violation|0|||
148773767|NCT02045862|536644975|FG002|Overall Study|Protocol Violation|6|||
148773768|NCT02045862|536644973|FG000|Overall Study|Lack of Efficacy|8|||
148773769|NCT02045862|536644974|FG001|Overall Study|Lack of Efficacy|4|||
148773770|NCT02045862|536644975|FG002|Overall Study|Lack of Efficacy|13|||
148834624|NCT02164864|536876104|FG001|Overall Study|Lost to Follow-up|3|||
148834625|NCT02164864|536876105|FG002|Overall Study|Lost to Follow-up|2|||
148834626|NCT02164864|536876103|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
148834627|NCT02164864|536876104|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
148834628|NCT02164864|536876105|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
148834629|NCT02164864|536876103|FG000|Overall Study|Other than stated|3|||
148834630|NCT02164864|536876104|FG001|Overall Study|Other than stated|4|||
148834631|NCT02164864|536876105|FG002|Overall Study|Other than stated|14|||
148834632|NCT01870869|536876106|FG000|Overall Study|Implanted with nonstudy device|1|||
148834633|NCT01870869|536876107|FG001|Overall Study|Implanted with nonstudy device|3|||
148834634|NCT01870869|536876108|FG002|Overall Study|Implanted with nonstudy device|14|||
148834635|NCT01870869|536876109|FG003|Overall Study|Implanted with nonstudy device|4|||
148834636|NCT01870869|536876106|FG000|Overall Study|Death|0|||
148834637|NCT01870869|536876107|FG001|Overall Study|Death|0|||
148834638|NCT01870869|536876108|FG002|Overall Study|Death|7|||
148834639|NCT01870869|536876109|FG003|Overall Study|Death|1|||
148834640|NCT01870869|536876106|FG000|Overall Study|Subject choice|6|||
148834641|NCT01870869|536876107|FG001|Overall Study|Subject choice|2|||
148834642|NCT01870869|536876108|FG002|Overall Study|Subject choice|22|||
148834643|NCT01870869|536876109|FG003|Overall Study|Subject choice|8|||
148834644|NCT01870869|536876106|FG000|Overall Study|Lost to Follow-up|10|||
148834645|NCT01870869|536876107|FG001|Overall Study|Lost to Follow-up|2|||
148834646|NCT01870869|536876108|FG002|Overall Study|Lost to Follow-up|25|||
148834647|NCT01870869|536876109|FG003|Overall Study|Lost to Follow-up|3|||
148834648|NCT01870869|536876106|FG000|Overall Study|Reason not Specified|1|||
148834649|NCT01870869|536876107|FG001|Overall Study|Reason not Specified|2|||
148981434|NCT00508742|537411636|FG000|Period 1: Infant Series|Adverse Event|5|||
148981435|NCT00508742|537411637|FG001|Period 1: Infant Series|Adverse Event|4|||
148834650|NCT01870869|536876108|FG002|Overall Study|Reason not Specified|20|||
148981436|NCT00508742|537411636|FG000|Period 1: Infant Series|Protocol Violation|1|||
148773771|NCT02045862|536644973|FG000|Overall Study|Randomized but not Received Study Drug|0|||
148773772|NCT02045862|536644974|FG001|Overall Study|Randomized but not Received Study Drug|2|||
148773773|NCT02045862|536644975|FG002|Overall Study|Randomized but not Received Study Drug|8|||
148773774|NCT02045862|536644973|FG000|Overall Study|Adverse Event|7|||
148773775|NCT02045862|536644974|FG001|Overall Study|Adverse Event|5|||
148773776|NCT02045862|536644975|FG002|Overall Study|Adverse Event|27|||
148834651|NCT01870869|536876109|FG003|Overall Study|Reason not Specified|4|||
148834652|NCT01870869|536876106|FG000|Overall Study|Not evaluable|10|||
148773777|NCT02045862|536644973|FG000|Overall Study|Lost to Follow-up|1|||
148773778|NCT02045862|536644974|FG001|Overall Study|Lost to Follow-up|2|||
148834653|NCT01870869|536876107|FG001|Overall Study|Not evaluable|5|||
148834654|NCT01870869|536876108|FG002|Overall Study|Not evaluable|42|||
148834655|NCT01870869|536876109|FG003|Overall Study|Not evaluable|10|||
148834656|NCT00557193|536876110|FG000|Induction|Adverse Event|2|||
148834657|NCT00557193|536876111|FG001|Induction|Adverse Event|0|||
148834658|NCT00557193|536876112|FG002|Induction|Adverse Event|0|||
148834659|NCT00557193|536876113|FG003|Induction|Adverse Event|0|||
148834660|NCT00557193|536876114|FG004|Induction|Adverse Event|0|||
148834661|NCT00557193|536876115|FG005|Induction|Adverse Event|0|||
148834662|NCT00557193|536876110|FG000|Induction|Death|6|||
148834663|NCT00557193|536876111|FG001|Induction|Death|0|||
148834664|NCT00557193|536876112|FG002|Induction|Death|0|||
148834665|NCT00557193|536876113|FG003|Induction|Death|0|||
148834666|NCT00557193|536876114|FG004|Induction|Death|0|||
148834667|NCT00557193|536876115|FG005|Induction|Death|0|||
148834668|NCT00557193|536876110|FG000|Induction|Physician Decision|3|||
148834669|NCT00557193|536876111|FG001|Induction|Physician Decision|0|||
148981437|NCT00508742|537411637|FG001|Period 1: Infant Series|Protocol Violation|0|||
148981438|NCT00508742|537411636|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
148981439|NCT00508742|537411637|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
148981440|NCT00508742|537411636|FG000|Period 1: Infant Series|Physician Decision|1|||
148981441|NCT00508742|537411637|FG001|Period 1: Infant Series|Physician Decision|0|||
148981442|NCT00508742|537411636|FG000|Period 1: Infant Series|Other|4|||
148981443|NCT00508742|537411637|FG001|Period 1: Infant Series|Other|1|||
148981444|NCT00508742|537411636|FG000|Period 2: After Infant Series|Adverse Event|2|||
148981445|NCT00508742|537411637|FG001|Period 2: After Infant Series|Adverse Event|6|||
148981446|NCT00508742|537411636|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
148981447|NCT00508742|537411637|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
148981448|NCT00508742|537411636|FG000|Period 2: After Infant Series|Protocol Violation|1|||
148981449|NCT00508742|537411637|FG001|Period 2: After Infant Series|Protocol Violation|0|||
148981450|NCT00508742|537411636|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
148981451|NCT00508742|537411637|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
148981452|NCT00508742|537411636|FG000|Period 2: After Infant Series|Failed to Return|1|||
148981453|NCT00508742|537411637|FG001|Period 2: After Infant Series|Failed to Return|0|||
148981454|NCT00508742|537411636|FG000|Period 2: After Infant Series|Other|2|||
148981455|NCT00508742|537411637|FG001|Period 2: After Infant Series|Other|1|||
148981456|NCT00508742|537411636|FG000|Period 3: Toddler Dose|Adverse Event|1|||
148981457|NCT00508742|537411637|FG001|Period 3: Toddler Dose|Adverse Event|0|||
148981458|NCT00508742|537411636|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
148981459|NCT00508742|537411637|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
148981460|NCT00508742|537411636|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
148981461|NCT00508742|537411637|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
148981462|NCT00508742|537411636|FG000|Period 3: Toddler Dose|Other|5|||
148981463|NCT00508742|537411637|FG001|Period 3: Toddler Dose|Other|4|||
148981464|NCT04568122|537411638|FG000|Overall Study|Lost to Follow-up|48|||
148981465|NCT04568122|537411639|FG001|Overall Study|Lost to Follow-up|44|||
148981466|NCT04568122|537411640|FG002|Overall Study|Lost to Follow-up|4|||
148981467|NCT04568122|537411641|FG003|Overall Study|Lost to Follow-up|0|||
148981468|NCT04568122|537411642|FG004|Overall Study|Lost to Follow-up|0|||
148981469|NCT00595582|537411649|FG000|Overall Study|Pilot study that PI terminated|2|||
148981470|NCT00595582|537411649|FG000|Overall Study|Lost to Follow-up|1|||
148981471|NCT00595582|537411649|FG000|Overall Study|Adverse Event|2|||
148981472|NCT00595582|537411649|FG000|Overall Study|Physician Decision|5|||
148981473|NCT02460224|537411652|FG000|Overall Study|Adverse Event|0|||
148981474|NCT02460224|537411653|FG001|Overall Study|Adverse Event|0|||
148981475|NCT02460224|537411654|FG002|Overall Study|Adverse Event|0|||
148981476|NCT02460224|537411655|FG003|Overall Study|Adverse Event|0|||
148981477|NCT02460224|537411656|FG004|Overall Study|Adverse Event|0|||
148981478|NCT02460224|537411657|FG005|Overall Study|Adverse Event|0|||
148981479|NCT02460224|537411658|FG006|Overall Study|Adverse Event|1|||
148981480|NCT02460224|537411659|FG007|Overall Study|Adverse Event|0|||
148981481|NCT02460224|537411660|FG008|Overall Study|Adverse Event|0|||
148981482|NCT02460224|537411661|FG009|Overall Study|Adverse Event|0|||
148981483|NCT02460224|537411662|FG010|Overall Study|Adverse Event|0|||
148981484|NCT02460224|537411663|FG011|Overall Study|Adverse Event|0|||
148981485|NCT02460224|537411664|FG012|Overall Study|Adverse Event|1|||
148834670|NCT00557193|536876112|FG002|Induction|Physician Decision|0|||
148834671|NCT00557193|536876113|FG003|Induction|Physician Decision|0|||
148981486|NCT02460224|537411665|FG013|Overall Study|Adverse Event|0|||
148981487|NCT02460224|537411666|FG014|Overall Study|Adverse Event|0|||
148981488|NCT02460224|537411667|FG015|Overall Study|Adverse Event|0|||
148981489|NCT02460224|537411668|FG016|Overall Study|Adverse Event|1|||
148981490|NCT02460224|537411669|FG017|Overall Study|Adverse Event|0|||
148981491|NCT02460224|537411670|FG018|Overall Study|Adverse Event|1|||
148981492|NCT02460224|537411671|FG019|Overall Study|Adverse Event|0|||
148981493|NCT02460224|537411672|FG020|Overall Study|Adverse Event|1|||
148981494|NCT02460224|537411673|FG021|Overall Study|Adverse Event|1|||
148834672|NCT00557193|536876114|FG004|Induction|Physician Decision|0|||
148834673|NCT00557193|536876115|FG005|Induction|Physician Decision|0|||
148834674|NCT00557193|536876110|FG000|Induction|Withdrawal by Subject|1|||
148834675|NCT00557193|536876111|FG001|Induction|Withdrawal by Subject|0|||
148834676|NCT00557193|536876112|FG002|Induction|Withdrawal by Subject|0|||
148834677|NCT00557193|536876113|FG003|Induction|Withdrawal by Subject|0|||
148834678|NCT00557193|536876114|FG004|Induction|Withdrawal by Subject|0|||
148834679|NCT00557193|536876115|FG005|Induction|Withdrawal by Subject|0|||
148834680|NCT00557193|536876110|FG000|Induction|Refusal of Further Protocol Therapy|2|||
148834681|NCT00557193|536876111|FG001|Induction|Refusal of Further Protocol Therapy|0|||
148834682|NCT00557193|536876112|FG002|Induction|Refusal of Further Protocol Therapy|0|||
148834683|NCT00557193|536876113|FG003|Induction|Refusal of Further Protocol Therapy|0|||
148834684|NCT00557193|536876114|FG004|Induction|Refusal of Further Protocol Therapy|0|||
148834685|NCT00557193|536876115|FG005|Induction|Refusal of Further Protocol Therapy|0|||
148834686|NCT00557193|536876110|FG000|Induction|Ineligible|8|||
148834687|NCT00557193|536876111|FG001|Induction|Ineligible|0|||
148834688|NCT00557193|536876112|FG002|Induction|Ineligible|0|||
148834689|NCT00557193|536876113|FG003|Induction|Ineligible|0|||
148834690|NCT00557193|536876114|FG004|Induction|Ineligible|0|||
148834691|NCT00557193|536876115|FG005|Induction|Ineligible|0|||
148834692|NCT00557193|536876110|FG000|Induction|Inevaluable for post Induction|2|||
148834693|NCT00557193|536876111|FG001|Induction|Inevaluable for post Induction|0|||
148834694|NCT00557193|536876112|FG002|Induction|Inevaluable for post Induction|0|||
148834695|NCT00557193|536876113|FG003|Induction|Inevaluable for post Induction|0|||
148834696|NCT00557193|536876114|FG004|Induction|Inevaluable for post Induction|0|||
148834697|NCT00557193|536876115|FG005|Induction|Inevaluable for post Induction|0|||
148834698|NCT00557193|536876110|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
148834699|NCT00557193|536876111|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
148834700|NCT00557193|536876112|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
148834701|NCT00557193|536876113|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
148834702|NCT00557193|536876114|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
148834703|NCT00557193|536876115|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
148834704|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
148834705|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
148834706|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
148834707|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
148834708|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
148981495|NCT02460224|537411674|FG022|Overall Study|Adverse Event|1|||
148981496|NCT02460224|537411675|FG023|Overall Study|Adverse Event|0|||
148773779|NCT02045862|536644975|FG002|Overall Study|Lost to Follow-up|6|||
148773780|NCT02833844|536644983|FG000|Double-Blind Period|Withdrawal by Subject|2|||
148773781|NCT02833844|536644984|FG001|Double-Blind Period|Withdrawal by Subject|3|||
148773782|NCT02833844|536644983|FG000|Double-Blind Period|Protocol Violation|0|||
148773783|NCT02833844|536644984|FG001|Double-Blind Period|Protocol Violation|4|||
148773784|NCT02833844|536644983|FG000|Open-Label Period|Death|0|||
148773785|NCT02833844|536644984|FG001|Open-Label Period|Death|2|||
148773786|NCT02833844|536644983|FG000|Open-Label Period|Lost to Follow-up|1|||
148773787|NCT02833844|536644984|FG001|Open-Label Period|Lost to Follow-up|0|||
148981497|NCT02460224|537411676|FG024|Overall Study|Adverse Event|0|||
148981498|NCT02460224|537411677|FG025|Overall Study|Adverse Event|0|||
148981499|NCT02460224|537411678|FG026|Overall Study|Adverse Event|11|||
148981500|NCT02460224|537411679|FG027|Overall Study|Adverse Event|1|||
148981501|NCT02460224|537411680|FG028|Overall Study|Adverse Event|6|||
148981502|NCT02460224|537411652|FG000|Overall Study|Death|0|||
148981503|NCT02460224|537411653|FG001|Overall Study|Death|0|||
148981504|NCT02460224|537411654|FG002|Overall Study|Death|0|||
148981505|NCT02460224|537411655|FG003|Overall Study|Death|0|||
148981506|NCT02460224|537411656|FG004|Overall Study|Death|0|||
148981507|NCT02460224|537411657|FG005|Overall Study|Death|2|||
148981508|NCT02460224|537411658|FG006|Overall Study|Death|1|||
148981509|NCT02460224|537411659|FG007|Overall Study|Death|0|||
148773788|NCT02833844|536644983|FG000|Open-Label Period|Withdrawal by Subject|1|||
148773789|NCT02833844|536644984|FG001|Open-Label Period|Withdrawal by Subject|0|||
148773790|NCT01899742|536644987|FG000|Overall Study|Adverse Event|5|||
148773791|NCT01899742|536644988|FG001|Overall Study|Adverse Event|4|||
148773792|NCT01899742|536644987|FG000|Overall Study|Lack of Efficacy|1|||
148773793|NCT01899742|536644988|FG001|Overall Study|Lack of Efficacy|5|||
148773794|NCT01899742|536644987|FG000|Overall Study|Protocol Violation|2|||
148981510|NCT02460224|537411660|FG008|Overall Study|Death|0|||
148981511|NCT02460224|537411661|FG009|Overall Study|Death|1|||
148981512|NCT02460224|537411662|FG010|Overall Study|Death|0|||
148773795|NCT01899742|536644988|FG001|Overall Study|Protocol Violation|2|||
148773796|NCT01899742|536644987|FG000|Overall Study|Withdrawal by Subject|9|||
148773797|NCT01899742|536644988|FG001|Overall Study|Withdrawal by Subject|5|||
148773798|NCT02662764|536644989|FG000|Overall Study|Adverse Event|6|||
148773799|NCT02662764|536644989|FG000|Overall Study|Lack of Efficacy|8|||
148981513|NCT02460224|537411663|FG011|Overall Study|Death|0|||
148773800|NCT02662764|536644989|FG000|Overall Study|Protocol Violation|1|||
148773801|NCT02662764|536644989|FG000|Overall Study|Withdrawal by Subject|5|||
148834709|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
148981514|NCT02460224|537411664|FG012|Overall Study|Death|0|||
148981515|NCT02460224|537411665|FG013|Overall Study|Death|1|||
148773802|NCT02662764|536644989|FG000|Overall Study|Device failure|4|||
148773803|NCT02662764|536644989|FG000|Overall Study|Patient changed treatment|1|||
148773804|NCT02662764|536644989|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
148773805|NCT00089778|536644996|FG000|Overall Study|Protocol Violation|0|||
148773806|NCT00089778|536644997|FG001|Overall Study|Protocol Violation|0|||
148773807|NCT00089778|536644998|FG002|Overall Study|Protocol Violation|1|||
148773808|NCT00177307|536644999|FG000|Overall Study|Withdrawal by Subject|1|||
148773809|NCT01968707|536645005|FG000|Overall Study|Did not meet treatment day baseline|49|||
148773810|NCT01968707|536645006|FG001|Overall Study|Did not meet treatment day baseline|12|||
148773811|NCT01968707|536645007|FG002|Overall Study|Did not meet treatment day baseline|41|||
148773812|NCT01968707|536645008|FG003|Overall Study|Did not meet treatment day baseline|44|||
148773813|NCT01968707|536645009|FG004|Overall Study|Did not meet treatment day baseline|36|||
148773814|NCT01968707|536645010|FG005|Overall Study|Did not meet treatment day baseline|11|||
148773815|NCT01968707|536645011|FG006|Overall Study|Did not meet treatment day baseline|34|||
148773816|NCT01968707|536645012|FG007|Overall Study|Did not meet treatment day baseline|35|||
148773817|NCT01104246|536645013|FG000|Overall Study|Withdrawal by Subject|1|||
148773818|NCT01104246|536645013|FG000|Overall Study|did not meet inclusion criteria|4|||
148773819|NCT01083186|536645014|FG000|Overall Study|Lost to Follow-up|48|||
148773820|NCT01083186|536645014|FG000|Overall Study|Consent Withdrawal|7|||
148773821|NCT01083186|536645014|FG000|Overall Study|Death|3|||
148773822|NCT01083186|536645014|FG000|Overall Study|Adverse Event|3|||
148773823|NCT01083186|536645014|FG000|Overall Study|Lack of Efficacy|2|||
148773824|NCT01083186|536645014|FG000|Overall Study|Hemodialysis Initiation|28|||
148773825|NCT01083186|536645014|FG000|Overall Study|Administrative Reasons|2|||
148773826|NCT01083186|536645014|FG000|Overall Study|Non-compliance to Study Treatment|1|||
148773827|NCT01867294|536645021|FG000|Overall Study|Withdrawal by Subject|1|||
148773828|NCT01867294|536645022|FG001|Overall Study|Withdrawal by Subject|1|||
148773829|NCT01867294|536645023|FG002|Overall Study|Withdrawal by Subject|0|||
148834710|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
148834711|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
148834712|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
148834713|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
148834714|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
148834715|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
148834716|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
148834717|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
148834718|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
148834719|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
148834720|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
148834721|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
148834722|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
148834723|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
148834724|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
148834725|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
148834726|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
148834727|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
148834728|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
148834729|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
148834730|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
148834731|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
148834732|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
148834733|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
148834734|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
148834735|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
148834736|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
148834737|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
148834738|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
148834739|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
148834740|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
148834741|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
148834742|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
148773830|NCT01867294|536645024|FG003|Overall Study|Withdrawal by Subject|0|||
148773831|NCT00380081|536645025|FG000|Overall Study|Withdrawal by Subject|0|||
148773832|NCT00380081|536645026|FG001|Overall Study|Withdrawal by Subject|0|||
148773833|NCT00380081|536645027|FG002|Overall Study|Withdrawal by Subject|0|||
148773834|NCT00380081|536645028|FG003|Overall Study|Withdrawal by Subject|0|||
148773835|NCT00380081|536645029|FG004|Overall Study|Withdrawal by Subject|1|||
148773836|NCT00380081|536645030|FG005|Overall Study|Withdrawal by Subject|0|||
148834743|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
148834744|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
148834745|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
148834746|NCT00557193|536876110|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
148834747|NCT00557193|536876111|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
148834748|NCT00557193|536876112|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
148834749|NCT00557193|536876113|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
148834750|NCT00557193|536876114|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
148834751|NCT00557193|536876115|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
148834752|NCT00652834|536876116|FG000|Overall Study|Withdrawal by Subject|3|||
148834753|NCT00652834|536876116|FG000|Overall Study|Lost to Follow-up|2|||
148834754|NCT01948427|536876117|FG000|Overall Study|Serious Adverse Event|3|||
148834755|NCT01948427|536876118|FG001|Overall Study|Serious Adverse Event|0|||
148834756|NCT01948427|536876119|FG002|Overall Study|Serious Adverse Event|0|||
148834757|NCT01948427|536876120|FG003|Overall Study|Serious Adverse Event|0|||
148834758|NCT01948427|536876121|FG004|Overall Study|Serious Adverse Event|1|||
148834759|NCT01948427|536876117|FG000|Overall Study|Investigator Request|0|||
148834760|NCT01948427|536876118|FG001|Overall Study|Investigator Request|8|||
148834761|NCT01948427|536876119|FG002|Overall Study|Investigator Request|0|||
148834762|NCT01948427|536876120|FG003|Overall Study|Investigator Request|0|||
148834763|NCT01948427|536876121|FG004|Overall Study|Investigator Request|6|||
148834764|NCT01948427|536876117|FG000|Overall Study|Lost to Follow-up|1|||
148834765|NCT01948427|536876118|FG001|Overall Study|Lost to Follow-up|0|||
148834766|NCT01948427|536876119|FG002|Overall Study|Lost to Follow-up|0|||
148834767|NCT01948427|536876120|FG003|Overall Study|Lost to Follow-up|0|||
148834768|NCT01948427|536876121|FG004|Overall Study|Lost to Follow-up|4|||
148834769|NCT01948427|536876117|FG000|Overall Study|Withdrawal by Subject|2|||
148834770|NCT01948427|536876118|FG001|Overall Study|Withdrawal by Subject|0|||
148834771|NCT01948427|536876119|FG002|Overall Study|Withdrawal by Subject|0|||
148834772|NCT01948427|536876120|FG003|Overall Study|Withdrawal by Subject|0|||
148834773|NCT01948427|536876121|FG004|Overall Study|Withdrawal by Subject|1|||
148981516|NCT02460224|537411666|FG014|Overall Study|Death|0|||
148773837|NCT00380081|536645025|FG000|Overall Study|Family Emergency|0|||
148773838|NCT00380081|536645026|FG001|Overall Study|Family Emergency|0|||
148773839|NCT00380081|536645027|FG002|Overall Study|Family Emergency|0|||
148773840|NCT00380081|536645028|FG003|Overall Study|Family Emergency|0|||
148773841|NCT00380081|536645029|FG004|Overall Study|Family Emergency|0|||
148773842|NCT00380081|536645030|FG005|Overall Study|Family Emergency|1|||
148773843|NCT02017912|536645031|FG000|Overall Study|Withdrawal by Subject|2|||
148773844|NCT02017912|536645032|FG001|Overall Study|Withdrawal by Subject|1|||
148773845|NCT02017912|536645031|FG000|Overall Study|miscellaneous|1|||
148773846|NCT02017912|536645032|FG001|Overall Study|miscellaneous|1|||
148773847|NCT05007041|536645033|FG000|Overall Study|Missing Diary Entries|0|||
148773848|NCT05007041|536645034|FG001|Overall Study|Missing Diary Entries|1|||
148773849|NCT01546168|536645037|FG000|Overall Study|Lost to Follow-up|1|||
148773850|NCT01546168|536645038|FG001|Overall Study|Lost to Follow-up|0|||
148773851|NCT01546168|536645037|FG000|Overall Study|Withdrawal by Subject|1|||
148773852|NCT01546168|536645038|FG001|Overall Study|Withdrawal by Subject|0|||
148773853|NCT01546168|536645037|FG000|Overall Study|ineligible after signing consent|2|||
148773854|NCT01546168|536645038|FG001|Overall Study|ineligible after signing consent|0|||
148773855|NCT00423189|536645039|FG000|Overall Study|Death|0|||
148773856|NCT00423189|536645040|FG001|Overall Study|Death|1|||
148773857|NCT00423189|536645041|FG002|Overall Study|Death|0|||
148773858|NCT00070018|536645046|FG000|Overall Study|Adverse Event|2|||
148773859|NCT00070018|536645046|FG000|Overall Study|Lack of Efficacy|1|||
148773860|NCT00070018|536645046|FG000|Overall Study|Withdrawal by Subject|1|||
148773861|NCT00574249|536645056|FG000|Overall Study|Adverse Event|6|||
148773862|NCT00574249|536645057|FG001|Overall Study|Adverse Event|18|||
148773863|NCT00574249|536645056|FG000|Overall Study|Lack of Efficacy|5|||
148773864|NCT00574249|536645057|FG001|Overall Study|Lack of Efficacy|3|||
148773865|NCT00574249|536645056|FG000|Overall Study|Lost to Follow-up|4|||
148773866|NCT00574249|536645057|FG001|Overall Study|Lost to Follow-up|3|||
148773867|NCT00574249|536645056|FG000|Overall Study|Protocol Violation|5|||
148773868|NCT00574249|536645057|FG001|Overall Study|Protocol Violation|2|||
148773869|NCT00574249|536645056|FG000|Overall Study|History of carcinoma|1|||
148773870|NCT00574249|536645057|FG001|Overall Study|History of carcinoma|0|||
148773871|NCT00574249|536645056|FG000|Overall Study|Withdrawal by Subject|3|||
148773872|NCT00574249|536645057|FG001|Overall Study|Withdrawal by Subject|0|||
148834774|NCT01948427|536876117|FG000|Overall Study|Other, Not Specified|1|||
148834775|NCT01948427|536876118|FG001|Overall Study|Other, Not Specified|9|||
148834776|NCT01948427|536876119|FG002|Overall Study|Other, Not Specified|0|||
148834777|NCT01948427|536876120|FG003|Overall Study|Other, Not Specified|0|||
148834778|NCT01948427|536876121|FG004|Overall Study|Other, Not Specified|2|||
148834779|NCT00402987|536876122|FG000|Overall Study|Lack of Efficacy|0|||
148834780|NCT00402987|536876123|FG001|Overall Study|Lack of Efficacy|0|||
148834781|NCT00402987|536876124|FG002|Overall Study|Lack of Efficacy|1|||
148773873|NCT00574249|536645056|FG000|Overall Study|Physician Decision|1|||
148773874|NCT00574249|536645057|FG001|Overall Study|Physician Decision|0|||
148773875|NCT00574249|536645056|FG000|Overall Study|Pregnancy|1|||
148773876|NCT00574249|536645057|FG001|Overall Study|Pregnancy|0|||
148773877|NCT00574249|536645056|FG000|Overall Study|Excluded by company|0|||
148773878|NCT00574249|536645057|FG001|Overall Study|Excluded by company|1|||
148773879|NCT00574249|536645056|FG000|Overall Study|PPD test taken twice|0|||
148773880|NCT00574249|536645057|FG001|Overall Study|PPD test taken twice|1|||
148773881|NCT03197870|536645059|FG000|Overall Study|Adverse Event|9|||
148773882|NCT03197870|536645060|FG001|Overall Study|Adverse Event|4|||
148773883|NCT03197870|536645061|FG002|Overall Study|Adverse Event|6|||
148773884|NCT03197870|536645059|FG000|Overall Study|Withdrawal by Subject|2|||
148773885|NCT03197870|536645060|FG001|Overall Study|Withdrawal by Subject|3|||
148773886|NCT03197870|536645061|FG002|Overall Study|Withdrawal by Subject|0|||
148773887|NCT03197870|536645059|FG000|Overall Study|Lost to Follow-up|2|||
148773888|NCT03197870|536645060|FG001|Overall Study|Lost to Follow-up|2|||
148773889|NCT03197870|536645061|FG002|Overall Study|Lost to Follow-up|0|||
148773890|NCT03197870|536645059|FG000|Overall Study|data not available|1|||
148773891|NCT03197870|536645060|FG001|Overall Study|data not available|1|||
148773892|NCT03197870|536645061|FG002|Overall Study|data not available|0|||
148773893|NCT01618019|536645062|FG000|Overall Study|Withdrawal by Subject|14|||
148773894|NCT01618019|536645063|FG001|Overall Study|Withdrawal by Subject|14|||
148773895|NCT01542034|536645064|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
148773896|NCT01542034|536645065|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
148773897|NCT01542034|536645064|FG000|Overall Study|Administrative decision|0|||
148773898|NCT01542034|536645065|FG001|Overall Study|Administrative decision|3|||
148773899|NCT01542034|536645064|FG000|Overall Study|Subject Noncompliance|1|||
148773900|NCT01542034|536645065|FG001|Overall Study|Subject Noncompliance|0|||
148773901|NCT01542034|536645064|FG000|Overall Study|Adverse Event|2|||
148773902|NCT01542034|536645065|FG001|Overall Study|Adverse Event|2|||
148773903|NCT01542034|536645064|FG000|Overall Study|Lost to Follow-up|7|||
148773904|NCT01542034|536645065|FG001|Overall Study|Lost to Follow-up|6|||
148773905|NCT01508130|536645069|FG000|Overall Study|Adverse Event|81|||
148773906|NCT01508130|536645070|FG001|Overall Study|Adverse Event|28|||
148773907|NCT01508130|536645069|FG000|Overall Study|Death|3|||
148773908|NCT01508130|536645070|FG001|Overall Study|Death|1|||
148773909|NCT01508130|536645069|FG000|Overall Study|Protocol Violation|2|||
148773910|NCT01508130|536645070|FG001|Overall Study|Protocol Violation|0|||
148773911|NCT01508130|536645069|FG000|Overall Study|Lost to Follow-up|25|||
148773912|NCT01508130|536645070|FG001|Overall Study|Lost to Follow-up|2|||
148773913|NCT01508130|536645069|FG000|Overall Study|Withdrawal by Subject|3|||
148773914|NCT01508130|536645070|FG001|Overall Study|Withdrawal by Subject|3|||
148773915|NCT01508130|536645069|FG000|Overall Study|Subject's substantial non-compliance|25|||
148773916|NCT01508130|536645070|FG001|Overall Study|Subject's substantial non-compliance|9|||
148773917|NCT01508130|536645069|FG000|Overall Study|Insufficient therapeutic response|74|||
148773918|NCT01508130|536645070|FG001|Overall Study|Insufficient therapeutic response|23|||
148773919|NCT01508130|536645069|FG000|Overall Study|Administrative|14|||
148773920|NCT01508130|536645070|FG001|Overall Study|Administrative|3|||
148773921|NCT01680159|536645071|FG000|Screening Period|Not meet criteria for dose-up period|7|||
148773922|NCT01680159|536645071|FG000|Increased Dose Period|Adverse Event|6|||
148773923|NCT01680159|536645071|FG000|Increased Dose Period|Withdrawal by Subject|2|||
148773924|NCT02783729|536645075|FG000|Overall Study|Lack of Efficacy|1|||
148773925|NCT02783729|536645076|FG001|Overall Study|Lack of Efficacy|0|||
148773926|NCT02783729|536645077|FG002|Overall Study|Lack of Efficacy|0|||
148773927|NCT02783729|536645078|FG003|Overall Study|Lack of Efficacy|0|||
148773928|NCT02783729|536645075|FG000|Overall Study|Adverse Event|2|||
148773929|NCT02783729|536645076|FG001|Overall Study|Adverse Event|6|||
148773930|NCT02783729|536645077|FG002|Overall Study|Adverse Event|2|||
148773931|NCT02783729|536645078|FG003|Overall Study|Adverse Event|3|||
148773932|NCT02783729|536645075|FG000|Overall Study|Other|1|||
148773933|NCT02783729|536645076|FG001|Overall Study|Other|6|||
148773934|NCT02783729|536645077|FG002|Overall Study|Other|2|||
148981517|NCT02460224|537411667|FG015|Overall Study|Death|0|||
148981518|NCT02460224|537411668|FG016|Overall Study|Death|2|||
148773935|NCT02783729|536645078|FG003|Overall Study|Other|3|||
148773936|NCT02783729|536645075|FG000|Overall Study|Withdrawal by Subject|2|||
148773937|NCT02783729|536645076|FG001|Overall Study|Withdrawal by Subject|3|||
148773938|NCT02783729|536645077|FG002|Overall Study|Withdrawal by Subject|1|||
148773939|NCT02783729|536645078|FG003|Overall Study|Withdrawal by Subject|2|||
148773940|NCT02783729|536645075|FG000|Overall Study|Participant's choice|2|||
148773941|NCT02783729|536645076|FG001|Overall Study|Participant's choice|1|||
148773942|NCT02783729|536645077|FG002|Overall Study|Participant's choice|2|||
148773943|NCT02783729|536645078|FG003|Overall Study|Participant's choice|1|||
148773944|NCT02783729|536645075|FG000|Overall Study|Lost to Follow-up|2|||
148773945|NCT02783729|536645076|FG001|Overall Study|Lost to Follow-up|1|||
148773946|NCT02783729|536645077|FG002|Overall Study|Lost to Follow-up|1|||
148773947|NCT02783729|536645078|FG003|Overall Study|Lost to Follow-up|0|||
148773948|NCT02288091|536645083|FG000|Overall Study|Lost to Follow-up|1|||
148773949|NCT02288091|536645083|FG000|Overall Study|Screen fail|7|||
148773950|NCT04021121|536645084|FG000|Overall Study|Death|3|||
148773951|NCT04021121|536645085|FG001|Overall Study|Death|3|||
148773952|NCT04021121|536645086|FG002|Overall Study|Death|5|||
148773953|NCT04021121|536645087|FG003|Overall Study|Death|4|||
148773954|NCT00978250|536645091|FG000|Overall Study|Late determination of ineligibility|0|||
148773955|NCT00978250|536645092|FG001|Overall Study|Late determination of ineligibility|1|||
148773956|NCT00978250|536645093|FG002|Overall Study|Late determination of ineligibility|0|||
148773957|NCT00978250|536645094|FG003|Overall Study|Late determination of ineligibility|1|||
148773958|NCT03843632|536645097|FG000|Overall Study|Withdrawal by Subject|1|||
148773959|NCT03843632|536645098|FG001|Overall Study|Withdrawal by Subject|0|||
148773960|NCT03843632|536645099|FG002|Overall Study|Withdrawal by Subject|0|||
148773961|NCT03843632|536645100|FG003|Overall Study|Withdrawal by Subject|0|||
148773962|NCT03403751|536645101|FG000|Overall Study|Death|5|||
148773963|NCT03403751|536645102|FG001|Overall Study|Death|6|||
148773964|NCT03403751|536645101|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
148773965|NCT03403751|536645102|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
148773966|NCT05036668|536645105|FG000|Overall Study|lost to follow Up|0|||
148773967|NCT05036668|536645106|FG001|Overall Study|lost to follow Up|0|||
148773968|NCT05036668|536645107|FG002|Overall Study|lost to follow Up|1|||
148773969|NCT00387010|536645109|FG000|Dose Titration Period|Adverse Event|12|||
148773970|NCT00387010|536645109|FG000|Dose Titration Period|Lack of Efficacy|5|||
148773971|NCT00387010|536645109|FG000|Dose Titration Period|Withdrawal by Subject|3|||
148773972|NCT00387010|536645109|FG000|Dose Titration Period|Protocol Violation|1|||
148773973|NCT00387010|536645109|FG000|Dose Titration Period|Lost to Follow-up|2|||
148773974|NCT00387010|536645109|FG000|Dose Titration Period|Noncompliance with study medication|8|||
148773975|NCT00387010|536645109|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
148773976|NCT00387010|536645109|FG000|Treatment Period|Adverse Event|4|||
148773977|NCT00387010|536645109|FG000|Treatment Period|Withdrawal by Subject|1|||
148834782|NCT00402987|536876125|FG003|Overall Study|Lack of Efficacy|0|||
148834783|NCT01668004|536876126|FG000|Overall Study|Adverse Event|7|||
148834784|NCT01668004|536876126|FG000|Overall Study|Withdrawal by Subject|2|||
148834785|NCT01668004|536876126|FG000|Overall Study|Lost to Follow-up|5|||
148834786|NCT01668004|536876126|FG000|Overall Study|Lack of Efficacy|9|||
148834787|NCT01668004|536876126|FG000|Overall Study|Non-compliance with treatment|2|||
148834788|NCT00419744|536876127|FG000|Overall Study|Adverse Event|39|||
148834789|NCT00419744|536876128|FG001|Overall Study|Adverse Event|40|||
148834790|NCT00419744|536876129|FG002|Overall Study|Adverse Event|50|||
148834791|NCT00419744|536876127|FG000|Overall Study|Withdrawal by Subject|45|||
148834792|NCT00419744|536876128|FG001|Overall Study|Withdrawal by Subject|49|||
148834793|NCT00419744|536876129|FG002|Overall Study|Withdrawal by Subject|52|||
148834794|NCT00419744|536876127|FG000|Overall Study|Lost to Follow-up|8|||
148834795|NCT00419744|536876128|FG001|Overall Study|Lost to Follow-up|10|||
148834796|NCT00419744|536876129|FG002|Overall Study|Lost to Follow-up|6|||
148834797|NCT00419744|536876127|FG000|Overall Study|Protocol Violation|4|||
148834798|NCT00419744|536876128|FG001|Overall Study|Protocol Violation|7|||
148834799|NCT00419744|536876129|FG002|Overall Study|Protocol Violation|8|||
148834800|NCT00419744|536876127|FG000|Overall Study|Randomized in error|9|||
148834801|NCT00419744|536876128|FG001|Overall Study|Randomized in error|6|||
148834802|NCT00419744|536876129|FG002|Overall Study|Randomized in error|7|||
148834803|NCT00419744|536876127|FG000|Overall Study|Moving out of state|2|||
148834804|NCT00419744|536876128|FG001|Overall Study|Moving out of state|0|||
148834805|NCT00419744|536876129|FG002|Overall Study|Moving out of state|1|||
148834806|NCT00419744|536876127|FG000|Overall Study|Physician Decision|10|||
148834807|NCT00419744|536876128|FG001|Overall Study|Physician Decision|5|||
148834808|NCT00419744|536876129|FG002|Overall Study|Physician Decision|6|||
148834809|NCT00419744|536876127|FG000|Overall Study|Spirometry mouthpiece issues|0|||
148834810|NCT00419744|536876128|FG001|Overall Study|Spirometry mouthpiece issues|1|||
148834811|NCT00419744|536876129|FG002|Overall Study|Spirometry mouthpiece issues|2|||
148834812|NCT00419744|536876127|FG000|Overall Study|Incorrect medication kit dispensed|0|||
148834813|NCT00419744|536876128|FG001|Overall Study|Incorrect medication kit dispensed|0|||
148834814|NCT00419744|536876129|FG002|Overall Study|Incorrect medication kit dispensed|1|||
148834815|NCT02448381|536876137|FG000|Overall Study|Adverse Event|2|||
148773978|NCT00387010|536645109|FG000|Treatment Period|Noncompliance with study medication|2|||
148773979|NCT00387010|536645109|FG000|Treatment Period|Noncompliance with study procedures|3|||
148773980|NCT00387010|536645109|FG000|Treatment Period|Participant reported study drug stolen|1|||
148773981|NCT00520481|536645110|FG000|Overall Study|Adverse Event|4|||
148834816|NCT02448381|536876138|FG001|Overall Study|Adverse Event|0|||
148834817|NCT02448381|536876137|FG000|Overall Study|Lost to Follow-up|16|||
148773982|NCT00520481|536645111|FG001|Overall Study|Adverse Event|1|||
148773983|NCT00520481|536645110|FG000|Overall Study|Withdrawal by Subject|3|||
148834818|NCT02448381|536876138|FG001|Overall Study|Lost to Follow-up|9|||
148834819|NCT02448381|536876137|FG000|Overall Study|Physician Decision|1|||
148834820|NCT02448381|536876138|FG001|Overall Study|Physician Decision|1|||
148834821|NCT02448381|536876137|FG000|Overall Study|Pregnancy|1|||
148834822|NCT02448381|536876138|FG001|Overall Study|Pregnancy|0|||
148834823|NCT02448381|536876137|FG000|Overall Study|Withdrawal by Subject|13|||
148834824|NCT02448381|536876138|FG001|Overall Study|Withdrawal by Subject|9|||
148834825|NCT02448381|536876137|FG000|Overall Study|Noncompliance with Study Procedures|2|||
148834826|NCT02448381|536876138|FG001|Overall Study|Noncompliance with Study Procedures|0|||
148834827|NCT01500317|536876139|FG000|Overall Study|Withdrawal by Subject|3|||
148834828|NCT01500317|536876140|FG001|Overall Study|Withdrawal by Subject|2|||
148834829|NCT01500317|536876141|FG002|Overall Study|Withdrawal by Subject|0|||
148834830|NCT00976456|536876142|FG000|Overall Study|Adverse Event|17|||
148834831|NCT00976456|536876143|FG001|Overall Study|Adverse Event|22|||
148834832|NCT00976456|536876142|FG000|Overall Study|Death|7|||
148834833|NCT00976456|536876143|FG001|Overall Study|Death|9|||
148834834|NCT00976456|536876142|FG000|Overall Study|Lack of Efficacy|5|||
148834835|NCT00976456|536876143|FG001|Overall Study|Lack of Efficacy|2|||
148834836|NCT00976456|536876142|FG000|Overall Study|Withdrawal by Subject|3|||
148834837|NCT00976456|536876143|FG001|Overall Study|Withdrawal by Subject|1|||
148834838|NCT00976456|536876142|FG000|Overall Study|screening failure, unknown|11|||
148834839|NCT00976456|536876143|FG001|Overall Study|screening failure, unknown|4|||
148834840|NCT00335829|536876144|FG000|Overall Study|Withdrawal by Subject|1|||
148834841|NCT00335829|536876144|FG000|Overall Study|Lost to Follow-up|1|||
148834842|NCT00335829|536876144|FG000|Overall Study|Adverse Event|1|||
148834843|NCT00754572|536876145|FG000|Overall Study|Adverse Event|19|||
148834844|NCT00754572|536876145|FG000|Overall Study|Other|39|||
148834845|NCT00754572|536876145|FG000|Overall Study|Protocol Violation|3|||
148834846|NCT00754572|536876145|FG000|Overall Study|Withdrawal by Subject|3|||
148834847|NCT00754572|536876145|FG000|Overall Study|Lack of Efficacy|2|||
148834848|NCT00754572|536876145|FG000|Overall Study|Death|1|||
148834849|NCT00754572|536876145|FG000|Overall Study|Administrative Reason|3|||
148834850|NCT00754572|536876145|FG000|Overall Study|Lost to Follow-up|1|||
148834851|NCT04856527|536876151|FG000|Overall Study|Unable to complete experimental task|2|||
148834852|NCT04856527|536876152|FG001|Overall Study|Unable to complete experimental task|0|||
148834853|NCT01463527|536876155|FG000|Overall Study|Protocol Violation|1|||
148834854|NCT01463527|536876156|FG001|Overall Study|Protocol Violation|1|||
148834855|NCT01463527|536876155|FG000|Overall Study|Crying >20% of sedation|5|||
148834856|NCT01463527|536876156|FG001|Overall Study|Crying >20% of sedation|6|||
148834857|NCT01493414|536876157|FG000|Overall Study|Adverse Event|405|||
148834858|NCT01493414|536876157|FG000|Overall Study|Disease progression|204|||
148834859|NCT01493414|536876157|FG000|Overall Study|Death|101|||
148834860|NCT01493414|536876157|FG000|Overall Study|Physician Decision|93|||
148834861|NCT01493414|536876157|FG000|Overall Study|Withdrawal by Subject|79|||
148834862|NCT01493414|536876157|FG000|Overall Study|Protocol deviation|27|||
148834863|NCT01493414|536876157|FG000|Overall Study|Administrative problems|25|||
148834864|NCT01493414|536876157|FG000|Overall Study|Lost to Follow-up|16|||
148834865|NCT04165824|536876160|FG000|Overall Study|Adverse Event|23|||
148834866|NCT04165824|536876160|FG000|Overall Study|Physician Decision|1|||
148834867|NCT04165824|536876160|FG000|Overall Study|Withdrawal by Subject|17|||
148834868|NCT04165824|536876160|FG000|Overall Study|Other|5|||
148834869|NCT04403919|536876161|FG000|Overall Study|Lost to Follow-up|0|||
148834870|NCT04403919|536876162|FG001|Overall Study|Lost to Follow-up|0|||
148834871|NCT04403919|536876163|FG002|Overall Study|Lost to Follow-up|0|||
148834872|NCT04403919|536876164|FG003|Overall Study|Lost to Follow-up|1|||
148834873|NCT04846231|536876166|FG000|Overall Study|Lost to Follow-up|1|||
148834874|NCT04846231|536876167|FG001|Overall Study|Lost to Follow-up|0|||
148834875|NCT04846231|536876168|FG002|Overall Study|Lost to Follow-up|0|||
148834876|NCT04846231|536876169|FG003|Overall Study|Lost to Follow-up|0|||
148834877|NCT04846231|536876170|FG004|Overall Study|Lost to Follow-up|0|||
148981519|NCT02460224|537411669|FG017|Overall Study|Death|1|||
148981520|NCT02460224|537411670|FG018|Overall Study|Death|0|||
148981521|NCT02460224|537411671|FG019|Overall Study|Death|2|||
148981522|NCT02460224|537411672|FG020|Overall Study|Death|0|||
148981523|NCT02460224|537411673|FG021|Overall Study|Death|0|||
148981524|NCT02460224|537411674|FG022|Overall Study|Death|0|||
148981525|NCT02460224|537411675|FG023|Overall Study|Death|0|||
148834878|NCT04846231|536876171|FG005|Overall Study|Lost to Follow-up|0|||
148834879|NCT04846231|536876172|FG006|Overall Study|Lost to Follow-up|0|||
148834880|NCT04846231|536876173|FG007|Overall Study|Lost to Follow-up|1|||
148834881|NCT04846231|536876166|FG000|Overall Study|Withdrawal by Subject|0|||
148834882|NCT04846231|536876167|FG001|Overall Study|Withdrawal by Subject|1|||
148834883|NCT04846231|536876168|FG002|Overall Study|Withdrawal by Subject|2|||
148834884|NCT04846231|536876169|FG003|Overall Study|Withdrawal by Subject|1|||
148834885|NCT04846231|536876170|FG004|Overall Study|Withdrawal by Subject|0|||
148981526|NCT02460224|537411676|FG024|Overall Study|Death|1|||
148981527|NCT02460224|537411677|FG025|Overall Study|Death|1|||
148981528|NCT02460224|537411678|FG026|Overall Study|Death|5|||
148981529|NCT02460224|537411679|FG027|Overall Study|Death|0|||
148981530|NCT02460224|537411680|FG028|Overall Study|Death|1|||
148981531|NCT02460224|537411652|FG000|Overall Study|Lost to Follow-up|0|||
148981532|NCT02460224|537411653|FG001|Overall Study|Lost to Follow-up|0|||
148834886|NCT04846231|536876171|FG005|Overall Study|Withdrawal by Subject|0|||
148834887|NCT04846231|536876172|FG006|Overall Study|Withdrawal by Subject|0|||
148981533|NCT02460224|537411654|FG002|Overall Study|Lost to Follow-up|0|||
148981534|NCT02460224|537411655|FG003|Overall Study|Lost to Follow-up|0|||
148981535|NCT02460224|537411656|FG004|Overall Study|Lost to Follow-up|0|||
148834888|NCT04846231|536876173|FG007|Overall Study|Withdrawal by Subject|0|||
148834889|NCT04846231|536876166|FG000|Overall Study|Protocol Violation|0|||
148834890|NCT04846231|536876167|FG001|Overall Study|Protocol Violation|1|||
148834891|NCT04846231|536876168|FG002|Overall Study|Protocol Violation|0|||
148834892|NCT04846231|536876169|FG003|Overall Study|Protocol Violation|0|||
148834893|NCT04846231|536876170|FG004|Overall Study|Protocol Violation|0|||
148834894|NCT04846231|536876171|FG005|Overall Study|Protocol Violation|0|||
148834895|NCT04846231|536876172|FG006|Overall Study|Protocol Violation|0|||
148834896|NCT04846231|536876173|FG007|Overall Study|Protocol Violation|0|||
148834897|NCT04846231|536876166|FG000|Overall Study|Adverse Event|0|||
148834898|NCT04846231|536876167|FG001|Overall Study|Adverse Event|0|||
148834899|NCT04846231|536876168|FG002|Overall Study|Adverse Event|0|||
148834900|NCT04846231|536876169|FG003|Overall Study|Adverse Event|0|||
148834901|NCT04846231|536876170|FG004|Overall Study|Adverse Event|0|||
148834902|NCT04846231|536876171|FG005|Overall Study|Adverse Event|0|||
148834903|NCT04846231|536876172|FG006|Overall Study|Adverse Event|1|||
148834904|NCT04846231|536876173|FG007|Overall Study|Adverse Event|1|||
148834905|NCT05448950|536876174|FG000|Overall Study|Death|2|||
148834906|NCT05448950|536876174|FG000|Overall Study|Withdrawal by Subject|1|||
148834907|NCT05448950|536876174|FG000|Overall Study|AVG abandoned|4|||
148834908|NCT02303262|536876175|FG000|Overall Study|Withdrawal by Subject|2|||
148834909|NCT01728246|536876178|FG000|Overall Study|Participant needed rescue medication|1|||
148834910|NCT01728246|536876179|FG001|Overall Study|Participant needed rescue medication|5|||
148834911|NCT01728246|536876178|FG000|Overall Study|Protocol Violation|1|||
148834912|NCT01728246|536876179|FG001|Overall Study|Protocol Violation|0|||
148834913|NCT01728246|536876178|FG000|Overall Study|Withdrawal by Subject|2|||
148834914|NCT01728246|536876179|FG001|Overall Study|Withdrawal by Subject|3|||
148834915|NCT01728246|536876178|FG000|Overall Study|Lost to Follow-up|23|||
148834916|NCT01728246|536876179|FG001|Overall Study|Lost to Follow-up|22|||
148834917|NCT01728246|536876178|FG000|Overall Study|Lack of Efficacy|1|||
148834918|NCT01728246|536876179|FG001|Overall Study|Lack of Efficacy|1|||
148834919|NCT01728246|536876178|FG000|Overall Study|Adverse Event|8|||
148834920|NCT01728246|536876179|FG001|Overall Study|Adverse Event|5|||
148834921|NCT01143402|536876180|FG000|Overall Study|Rapid clinical decline|1|||
148834922|NCT01143402|536876181|FG001|Overall Study|Rapid clinical decline|1|||
148834923|NCT01143402|536876182|FG002|Overall Study|Rapid clinical decline|0|||
148834924|NCT01143402|536876180|FG000|Overall Study|Not Treated|0|||
148834925|NCT01143402|536876181|FG001|Overall Study|Not Treated|0|||
148834926|NCT01143402|536876182|FG002|Overall Study|Not Treated|1|||
148834927|NCT01959932|536876186|FG000|Overall Study|Withdrawal by Subject|1|||
148834928|NCT01959932|536876187|FG001|Overall Study|Withdrawal by Subject|0|||
148834929|NCT01959932|536876188|FG002|Overall Study|Withdrawal by Subject|0|||
148834930|NCT00397540|536876189|FG000|Overall Study|short follow-up duration < 12 months|1|||
148834931|NCT00397540|536876190|FG001|Overall Study|short follow-up duration < 12 months|0|||
148834932|NCT01656161|536876191|FG000|Overall Study|Death|3|||
148834933|NCT01656161|536876191|FG000|Overall Study|Adverse Event|2|||
148834934|NCT01656161|536876191|FG000|Overall Study|Protocol Violation|1|||
148834935|NCT01656161|536876191|FG000|Overall Study|Withdrawal by Subject|1|||
148834936|NCT00776230|536876194|FG000|Overall Study|Lost to Follow-up|2|||
148834937|NCT00776230|536876195|FG001|Overall Study|Lost to Follow-up|1|||
148834938|NCT00776230|536876196|FG002|Overall Study|Lost to Follow-up|5|||
148834939|NCT00776230|536876194|FG000|Overall Study|Not vaccinated at Day 0|1|||
148834940|NCT00776230|536876195|FG001|Overall Study|Not vaccinated at Day 0|0|||
148834941|NCT00776230|536876196|FG002|Overall Study|Not vaccinated at Day 0|0|||
148834942|NCT00776230|536876194|FG000|Overall Study|Withdrawal by Subject|0|||
148834943|NCT00776230|536876195|FG001|Overall Study|Withdrawal by Subject|1|||
148981536|NCT02460224|537411657|FG005|Overall Study|Lost to Follow-up|0|||
148981537|NCT02460224|537411658|FG006|Overall Study|Lost to Follow-up|0|||
148981538|NCT02460224|537411659|FG007|Overall Study|Lost to Follow-up|0|||
148981539|NCT02460224|537411660|FG008|Overall Study|Lost to Follow-up|0|||
148981540|NCT02460224|537411661|FG009|Overall Study|Lost to Follow-up|0|||
148834944|NCT00776230|536876196|FG002|Overall Study|Withdrawal by Subject|0|||
148834945|NCT00776230|536876194|FG000|Overall Study|Subject missed Visit 4|0|||
148834946|NCT00776230|536876195|FG001|Overall Study|Subject missed Visit 4|1|||
148834947|NCT00776230|536876196|FG002|Overall Study|Subject missed Visit 4|0|||
148834948|NCT01215851|536876197|FG000|Treatment Period|Adverse Event|1|||
148834949|NCT01215851|536876198|FG001|Treatment Period|Adverse Event|1|||
148834950|NCT01215851|536876199|FG002|Treatment Period|Adverse Event|1|||
148834951|NCT01215851|536876200|FG003|Treatment Period|Adverse Event|3|||
148981541|NCT02460224|537411662|FG010|Overall Study|Lost to Follow-up|0|||
148981542|NCT02460224|537411663|FG011|Overall Study|Lost to Follow-up|0|||
148834952|NCT01215851|536876201|FG004|Treatment Period|Adverse Event|0|||
148834953|NCT01215851|536876202|FG005|Treatment Period|Adverse Event|1|||
148834954|NCT01215851|536876197|FG000|Follow up Period|Lost to Follow-up|0|||
148834955|NCT01215851|536876198|FG001|Follow up Period|Lost to Follow-up|0|||
148834956|NCT01215851|536876199|FG002|Follow up Period|Lost to Follow-up|0|||
148834957|NCT01215851|536876200|FG003|Follow up Period|Lost to Follow-up|0|||
148834958|NCT01215851|536876201|FG004|Follow up Period|Lost to Follow-up|0|||
148981543|NCT02460224|537411664|FG012|Overall Study|Lost to Follow-up|0|||
149028540|NCT01941316|537581979|FG002|Overall Study|Death|0|||
149028541|NCT01941316|537581980|FG003|Overall Study|Death|3|||
149028542|NCT01941316|537581977|FG000|Overall Study|Physician Decision|0|||
149028543|NCT01941316|537581978|FG001|Overall Study|Physician Decision|0|||
149028544|NCT01941316|537581979|FG002|Overall Study|Physician Decision|0|||
149028545|NCT01941316|537581980|FG003|Overall Study|Physician Decision|3|||
149028546|NCT01941316|537581977|FG000|Overall Study|Protocol Violation|0|||
149028547|NCT01941316|537581978|FG001|Overall Study|Protocol Violation|0|||
149028548|NCT01941316|537581979|FG002|Overall Study|Protocol Violation|0|||
149028549|NCT01941316|537581980|FG003|Overall Study|Protocol Violation|3|||
149028550|NCT01941316|537581977|FG000|Overall Study|Intercurrent illness|0|||
149028551|NCT01941316|537581978|FG001|Overall Study|Intercurrent illness|0|||
149028552|NCT01941316|537581979|FG002|Overall Study|Intercurrent illness|0|||
149028553|NCT01941316|537581980|FG003|Overall Study|Intercurrent illness|1|||
149028554|NCT01941316|537581977|FG000|Overall Study|Other, not specified|0|||
149028555|NCT01941316|537581978|FG001|Overall Study|Other, not specified|0|||
149028556|NCT01941316|537581979|FG002|Overall Study|Other, not specified|0|||
149028557|NCT01941316|537581980|FG003|Overall Study|Other, not specified|1|||
149028558|NCT02775435|537581981|FG000|Overall Study|Adverse Event|32|||
149028559|NCT02775435|537581982|FG001|Overall Study|Adverse Event|27|||
149028560|NCT02775435|537581981|FG000|Overall Study|Lost to Follow-up|2|||
149028561|NCT02775435|537581982|FG001|Overall Study|Lost to Follow-up|2|||
149028562|NCT02775435|537581981|FG000|Overall Study|Sponsor decision|44|||
149028563|NCT02775435|537581982|FG001|Overall Study|Sponsor decision|19|||
149028564|NCT02775435|537581981|FG000|Overall Study|Withdrawal by Subject|4|||
149028565|NCT02775435|537581982|FG001|Overall Study|Withdrawal by Subject|9|||
149028566|NCT02775435|537581981|FG000|Overall Study|Death|196|||
149028567|NCT02775435|537581982|FG001|Overall Study|Death|224|||
149028568|NCT00941031|537581983|FG000|Induction Period|Lack of Efficacy|2|||
149028569|NCT00941031|537581984|FG001|Induction Period|Lack of Efficacy|1|||
149028570|NCT00941031|537581985|FG002|Induction Period|Lack of Efficacy|0|||
149028571|NCT00941031|537581986|FG003|Induction Period|Lack of Efficacy|5|||
149028572|NCT00941031|537581987|FG004|Induction Period|Lack of Efficacy|0|||
149028573|NCT00941031|537581988|FG005|Induction Period|Lack of Efficacy|0|||
149028574|NCT00941031|537581989|FG006|Induction Period|Lack of Efficacy|0|||
149028575|NCT00941031|537581983|FG000|Induction Period|Withdrawal by Subject|1|||
149028576|NCT00941031|537581984|FG001|Induction Period|Withdrawal by Subject|2|||
149028577|NCT00941031|537581985|FG002|Induction Period|Withdrawal by Subject|2|||
149028578|NCT00941031|537581986|FG003|Induction Period|Withdrawal by Subject|2|||
149028579|NCT00941031|537581987|FG004|Induction Period|Withdrawal by Subject|0|||
149028580|NCT00941031|537581988|FG005|Induction Period|Withdrawal by Subject|0|||
149028581|NCT00941031|537581989|FG006|Induction Period|Withdrawal by Subject|0|||
149028582|NCT00941031|537581983|FG000|Induction Period|Adminstative Problems|1|||
149028583|NCT00941031|537581984|FG001|Induction Period|Adminstative Problems|1|||
149028584|NCT00941031|537581985|FG002|Induction Period|Adminstative Problems|1|||
149028585|NCT00941031|537581986|FG003|Induction Period|Adminstative Problems|0|||
149028586|NCT00941031|537581987|FG004|Induction Period|Adminstative Problems|0|||
149028587|NCT00941031|537581988|FG005|Induction Period|Adminstative Problems|0|||
149028588|NCT00941031|537581989|FG006|Induction Period|Adminstative Problems|0|||
149028589|NCT00941031|537581983|FG000|Induction Period|Adverse Event|1|||
149028590|NCT00941031|537581984|FG001|Induction Period|Adverse Event|0|||
148834959|NCT01215851|536876202|FG005|Follow up Period|Lost to Follow-up|1|||
148834960|NCT04583618|536876210|FG000|Overall Study|Adverse Event|0|||
148834961|NCT04583618|536876211|FG001|Overall Study|Adverse Event|0|||
148834962|NCT04583618|536876212|FG002|Overall Study|Adverse Event|1|||
148834963|NCT04583618|536876213|FG003|Overall Study|Adverse Event|0|||
148834964|NCT04583618|536876214|FG004|Overall Study|Adverse Event|0|||
148834965|NCT04583618|536876210|FG000|Overall Study|Protocol deviation|1|||
148834966|NCT04583618|536876211|FG001|Overall Study|Protocol deviation|1|||
148834967|NCT04583618|536876212|FG002|Overall Study|Protocol deviation|1|||
148834968|NCT04583618|536876213|FG003|Overall Study|Protocol deviation|0|||
148834969|NCT04583618|536876214|FG004|Overall Study|Protocol deviation|0|||
148834970|NCT04583618|536876210|FG000|Overall Study|Withdrawal by Subject|2|||
148834971|NCT04583618|536876211|FG001|Overall Study|Withdrawal by Subject|1|||
148834972|NCT04583618|536876212|FG002|Overall Study|Withdrawal by Subject|3|||
148834973|NCT04583618|536876213|FG003|Overall Study|Withdrawal by Subject|1|||
148834974|NCT04583618|536876214|FG004|Overall Study|Withdrawal by Subject|1|||
148834975|NCT04583618|536876210|FG000|Overall Study|Lost to Follow-up|0|||
148834976|NCT04583618|536876211|FG001|Overall Study|Lost to Follow-up|1|||
148834977|NCT04583618|536876212|FG002|Overall Study|Lost to Follow-up|3|||
148834978|NCT04583618|536876213|FG003|Overall Study|Lost to Follow-up|1|||
148834979|NCT04583618|536876214|FG004|Overall Study|Lost to Follow-up|1|||
148834980|NCT00016354|536876217|FG000|Overall Study|Lack of Efficacy|0|||
148834981|NCT00016354|536876218|FG001|Overall Study|Lack of Efficacy|0|||
148834982|NCT00016354|536876219|FG002|Overall Study|Lack of Efficacy|0|||
149028591|NCT00941031|537581985|FG002|Induction Period|Adverse Event|3|||
149028592|NCT00941031|537581986|FG003|Induction Period|Adverse Event|2|||
149028593|NCT00941031|537581987|FG004|Induction Period|Adverse Event|0|||
149028594|NCT00941031|537581988|FG005|Induction Period|Adverse Event|0|||
148981544|NCT02460224|537411665|FG013|Overall Study|Lost to Follow-up|0|||
148981545|NCT02460224|537411666|FG014|Overall Study|Lost to Follow-up|0|||
148981546|NCT02460224|537411667|FG015|Overall Study|Lost to Follow-up|0|||
148981547|NCT02460224|537411668|FG016|Overall Study|Lost to Follow-up|0|||
148981548|NCT02460224|537411669|FG017|Overall Study|Lost to Follow-up|0|||
148981549|NCT02460224|537411670|FG018|Overall Study|Lost to Follow-up|0|||
148981550|NCT02460224|537411671|FG019|Overall Study|Lost to Follow-up|0|||
148981551|NCT02460224|537411672|FG020|Overall Study|Lost to Follow-up|0|||
148981552|NCT02460224|537411673|FG021|Overall Study|Lost to Follow-up|0|||
148981553|NCT02460224|537411674|FG022|Overall Study|Lost to Follow-up|1|||
148981554|NCT02460224|537411675|FG023|Overall Study|Lost to Follow-up|0|||
148981555|NCT02460224|537411676|FG024|Overall Study|Lost to Follow-up|0|||
148981556|NCT02460224|537411677|FG025|Overall Study|Lost to Follow-up|0|||
148981557|NCT02460224|537411678|FG026|Overall Study|Lost to Follow-up|0|||
148981558|NCT02460224|537411679|FG027|Overall Study|Lost to Follow-up|0|||
148981559|NCT02460224|537411680|FG028|Overall Study|Lost to Follow-up|0|||
148981560|NCT02460224|537411652|FG000|Overall Study|Physician Decision|0|||
148981561|NCT02460224|537411653|FG001|Overall Study|Physician Decision|1|||
148981562|NCT02460224|537411654|FG002|Overall Study|Physician Decision|0|||
148981563|NCT02460224|537411655|FG003|Overall Study|Physician Decision|0|||
148981564|NCT02460224|537411656|FG004|Overall Study|Physician Decision|1|||
148981565|NCT02460224|537411657|FG005|Overall Study|Physician Decision|0|||
148981566|NCT02460224|537411658|FG006|Overall Study|Physician Decision|0|||
148981567|NCT02460224|537411659|FG007|Overall Study|Physician Decision|1|||
148834983|NCT00016354|536876220|FG003|Overall Study|Lack of Efficacy|0|||
148834984|NCT00016354|536876221|FG004|Overall Study|Lack of Efficacy|0|||
148834985|NCT00016354|536876222|FG005|Overall Study|Lack of Efficacy|0|||
148834986|NCT00016354|536876223|FG006|Overall Study|Lack of Efficacy|0|||
148834987|NCT00016354|536876224|FG007|Overall Study|Lack of Efficacy|1|||
148834988|NCT03110562|536876225|FG000|Initial Treatment Period|Disease Progression|1|||
148834989|NCT03110562|536876226|FG001|Initial Treatment Period|Disease Progression|1|||
148834990|NCT03110562|536876227|FG002|Initial Treatment Period|Disease Progression|0|||
148834991|NCT03110562|536876228|FG003|Initial Treatment Period|Disease Progression|0|||
148834992|NCT03110562|536876225|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
148834993|NCT03110562|536876226|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
148834994|NCT03110562|536876227|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
148834995|NCT03110562|536876228|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
148834996|NCT03110562|536876225|FG000|Initial Treatment Period|Adverse Event|1|||
148834997|NCT03110562|536876226|FG001|Initial Treatment Period|Adverse Event|0|||
148834998|NCT03110562|536876227|FG002|Initial Treatment Period|Adverse Event|0|||
148834999|NCT03110562|536876228|FG003|Initial Treatment Period|Adverse Event|0|||
148835000|NCT03110562|536876225|FG000|Initial Treatment Period|Death|74|||
148835001|NCT03110562|536876226|FG001|Initial Treatment Period|Death|82|||
148835002|NCT03110562|536876227|FG002|Initial Treatment Period|Death|0|||
148835003|NCT03110562|536876228|FG003|Initial Treatment Period|Death|0|||
148835004|NCT03110562|536876225|FG000|Initial Treatment Period|Lost to Follow-up|13|||
148835005|NCT03110562|536876226|FG001|Initial Treatment Period|Lost to Follow-up|8|||
148835006|NCT03110562|536876227|FG002|Initial Treatment Period|Lost to Follow-up|0|||
148835007|NCT03110562|536876228|FG003|Initial Treatment Period|Lost to Follow-up|0|||
148835008|NCT03110562|536876225|FG000|Initial Treatment Period|Protocol Deviation|1|||
148835009|NCT03110562|536876226|FG001|Initial Treatment Period|Protocol Deviation|0|||
148835010|NCT03110562|536876227|FG002|Initial Treatment Period|Protocol Deviation|0|||
148835011|NCT03110562|536876228|FG003|Initial Treatment Period|Protocol Deviation|0|||
148835012|NCT03110562|536876225|FG000|Initial Treatment Period|Physician Decision|2|||
148835013|NCT03110562|536876226|FG001|Initial Treatment Period|Physician Decision|1|||
148835014|NCT03110562|536876227|FG002|Initial Treatment Period|Physician Decision|0|||
148835015|NCT03110562|536876228|FG003|Initial Treatment Period|Physician Decision|0|||
148835016|NCT03110562|536876225|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
148835017|NCT03110562|536876226|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
148835018|NCT03110562|536876227|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
148835019|NCT03110562|536876228|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
148835020|NCT03110562|536876225|FG000|Initial Treatment Period|Other|5|||
148835021|NCT03110562|536876226|FG001|Initial Treatment Period|Other|4|||
148835022|NCT03110562|536876227|FG002|Initial Treatment Period|Other|0|||
148835023|NCT03110562|536876228|FG003|Initial Treatment Period|Other|0|||
148835024|NCT03110562|536876225|FG000|Initial Treatment Period|Randomized but never treated|0|||
148835025|NCT03110562|536876226|FG001|Initial Treatment Period|Randomized but never treated|3|||
148835026|NCT03110562|536876227|FG002|Initial Treatment Period|Randomized but never treated|0|||
148835027|NCT03110562|536876228|FG003|Initial Treatment Period|Randomized but never treated|0|||
148981568|NCT02460224|537411660|FG008|Overall Study|Physician Decision|0|||
148981569|NCT02460224|537411661|FG009|Overall Study|Physician Decision|0|||
148981570|NCT02460224|537411662|FG010|Overall Study|Physician Decision|0|||
148981571|NCT02460224|537411663|FG011|Overall Study|Physician Decision|1|||
148981572|NCT02460224|537411664|FG012|Overall Study|Physician Decision|0|||
148981573|NCT02460224|537411665|FG013|Overall Study|Physician Decision|1|||
148835028|NCT03110562|536876225|FG000|Crossover Period|Disease Progression|0|||
148835029|NCT03110562|536876226|FG001|Crossover Period|Disease Progression|0|||
148835030|NCT03110562|536876227|FG002|Crossover Period|Disease Progression|1|||
148835031|NCT03110562|536876228|FG003|Crossover Period|Disease Progression|0|||
148835032|NCT03110562|536876225|FG000|Crossover Period|Withdrawal by Subject|0|||
148835033|NCT03110562|536876226|FG001|Crossover Period|Withdrawal by Subject|0|||
148835034|NCT03110562|536876227|FG002|Crossover Period|Withdrawal by Subject|8|||
148835035|NCT03110562|536876228|FG003|Crossover Period|Withdrawal by Subject|6|||
148835036|NCT03110562|536876225|FG000|Crossover Period|Death|0|||
148835037|NCT03110562|536876226|FG001|Crossover Period|Death|0|||
148835038|NCT03110562|536876227|FG002|Crossover Period|Death|37|||
148835039|NCT03110562|536876228|FG003|Crossover Period|Death|3|||
148835040|NCT03110562|536876225|FG000|Crossover Period|Lost to Follow-up|0|||
148835041|NCT03110562|536876226|FG001|Crossover Period|Lost to Follow-up|0|||
148835042|NCT03110562|536876227|FG002|Crossover Period|Lost to Follow-up|0|||
148835043|NCT03110562|536876228|FG003|Crossover Period|Lost to Follow-up|1|||
148835044|NCT03110562|536876225|FG000|Crossover Period|Other|0|||
148835045|NCT03110562|536876226|FG001|Crossover Period|Other|0|||
148835046|NCT03110562|536876227|FG002|Crossover Period|Other|1|||
148835047|NCT03110562|536876228|FG003|Crossover Period|Other|1|||
148835048|NCT03110562|536876225|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
148835049|NCT03110562|536876226|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
148835050|NCT03110562|536876227|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
148835051|NCT03110562|536876228|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
148835052|NCT03189719|536876234|FG000|Overall Study|Death|325|||
148835053|NCT03189719|536876235|FG001|Overall Study|Death|361|||
148835054|NCT03189719|536876234|FG000|Overall Study|Physician Decision|1|||
148835055|NCT03189719|536876235|FG001|Overall Study|Physician Decision|0|||
148835056|NCT03189719|536876234|FG000|Overall Study|Sponsor Decision|40|||
148835057|NCT03189719|536876235|FG001|Overall Study|Sponsor Decision|12|||
148835058|NCT03189719|536876234|FG000|Overall Study|Withdrawal by Subject|7|||
148835059|NCT03189719|536876235|FG001|Overall Study|Withdrawal by Subject|3|||
148835060|NCT03012880|536876236|FG000|Overall Study|Withdrawal by Subject|1|||
148835061|NCT03012880|536876237|FG001|Overall Study|Withdrawal by Subject|0|||
148835062|NCT03012880|536876236|FG000|Overall Study|Ineligible|1|||
148835063|NCT03012880|536876237|FG001|Overall Study|Ineligible|0|||
148835064|NCT01355627|536876238|FG000|Overall Study|Request By the Patient to Discontinue|5|||
148835065|NCT01355627|536876239|FG001|Overall Study|Request By the Patient to Discontinue|7|||
148835066|NCT01355627|536876238|FG000|Overall Study|Lost to Follow-up|8|||
148835067|NCT01355627|536876239|FG001|Overall Study|Lost to Follow-up|7|||
148835068|NCT01355627|536876238|FG000|Overall Study|Fatal Adverse Event|19|||
148835069|NCT01355627|536876239|FG001|Overall Study|Fatal Adverse Event|23|||
148835070|NCT01355627|536876238|FG000|Overall Study|Other|1|||
148835071|NCT01355627|536876239|FG001|Overall Study|Other|1|||
148835072|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
148835073|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
148835074|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
148835075|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
148835076|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
148835077|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
148835078|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
148835079|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
148835080|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
148835081|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
148835082|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
148835083|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
148835084|NCT04532749|536876240|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
148835085|NCT04532749|536876241|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
148835086|NCT04532749|536876240|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
148981574|NCT02460224|537411666|FG014|Overall Study|Physician Decision|0|||
148981575|NCT02460224|537411667|FG015|Overall Study|Physician Decision|0|||
148981576|NCT02460224|537411668|FG016|Overall Study|Physician Decision|2|||
148981577|NCT02460224|537411669|FG017|Overall Study|Physician Decision|1|||
148981578|NCT02460224|537411670|FG018|Overall Study|Physician Decision|1|||
148835087|NCT04532749|536876241|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
148835088|NCT04532749|536876240|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
148835089|NCT04532749|536876241|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
148835090|NCT04532749|536876240|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
148835091|NCT04532749|536876241|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
148835092|NCT05643495|536876246|FG000|Overall Study|Adverse Event|0|||
148981579|NCT02460224|537411671|FG019|Overall Study|Physician Decision|2|||
148835093|NCT05643495|536876247|FG001|Overall Study|Adverse Event|1|||
148835094|NCT05643495|536876246|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
148835095|NCT05643495|536876247|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
148981580|NCT02460224|537411672|FG020|Overall Study|Physician Decision|1|||
148981581|NCT02460224|537411673|FG021|Overall Study|Physician Decision|1|||
148981582|NCT02460224|537411674|FG022|Overall Study|Physician Decision|0|||
148981583|NCT02460224|537411675|FG023|Overall Study|Physician Decision|0|||
148981584|NCT02460224|537411676|FG024|Overall Study|Physician Decision|1|||
148981585|NCT02460224|537411677|FG025|Overall Study|Physician Decision|0|||
148981586|NCT02460224|537411678|FG026|Overall Study|Physician Decision|14|||
148981587|NCT02460224|537411679|FG027|Overall Study|Physician Decision|1|||
148981588|NCT02460224|537411680|FG028|Overall Study|Physician Decision|6|||
148981589|NCT02460224|537411652|FG000|Overall Study|Progressive disease|15|||
148981590|NCT02460224|537411653|FG001|Overall Study|Progressive disease|11|||
148981591|NCT02460224|537411654|FG002|Overall Study|Progressive disease|5|||
148981592|NCT02460224|537411655|FG003|Overall Study|Progressive disease|6|||
148981593|NCT02460224|537411656|FG004|Overall Study|Progressive disease|3|||
148981594|NCT02460224|537411657|FG005|Overall Study|Progressive disease|26|||
148981595|NCT02460224|537411658|FG006|Overall Study|Progressive disease|28|||
148981596|NCT02460224|537411659|FG007|Overall Study|Progressive disease|4|||
148981597|NCT02460224|537411660|FG008|Overall Study|Progressive disease|5|||
148981598|NCT02460224|537411661|FG009|Overall Study|Progressive disease|9|||
148981599|NCT02460224|537411662|FG010|Overall Study|Progressive disease|5|||
148981600|NCT02460224|537411663|FG011|Overall Study|Progressive disease|4|||
148981601|NCT02460224|537411664|FG012|Overall Study|Progressive disease|5|||
148981602|NCT02460224|537411665|FG013|Overall Study|Progressive disease|4|||
148981603|NCT02460224|537411666|FG014|Overall Study|Progressive disease|5|||
148981604|NCT02460224|537411667|FG015|Overall Study|Progressive disease|5|||
148981605|NCT02460224|537411668|FG016|Overall Study|Progressive disease|15|||
148981606|NCT02460224|537411669|FG017|Overall Study|Progressive disease|3|||
148981607|NCT02460224|537411670|FG018|Overall Study|Progressive disease|8|||
148981608|NCT02460224|537411671|FG019|Overall Study|Progressive disease|3|||
148981609|NCT02460224|537411672|FG020|Overall Study|Progressive disease|4|||
148981610|NCT02460224|537411673|FG021|Overall Study|Progressive disease|9|||
148981611|NCT02460224|537411674|FG022|Overall Study|Progressive disease|4|||
148981612|NCT02460224|537411675|FG023|Overall Study|Progressive disease|11|||
148981613|NCT02460224|537411676|FG024|Overall Study|Progressive disease|4|||
148981614|NCT02460224|537411677|FG025|Overall Study|Progressive disease|5|||
148981615|NCT02460224|537411678|FG026|Overall Study|Progressive disease|85|||
148981616|NCT02460224|537411679|FG027|Overall Study|Progressive disease|17|||
148981617|NCT02460224|537411680|FG028|Overall Study|Progressive disease|77|||
148981618|NCT02460224|537411652|FG000|Overall Study|Subject/guardian decision|2|||
148981619|NCT02460224|537411653|FG001|Overall Study|Subject/guardian decision|0|||
148981620|NCT02460224|537411654|FG002|Overall Study|Subject/guardian decision|1|||
148981621|NCT02460224|537411655|FG003|Overall Study|Subject/guardian decision|0|||
148981622|NCT02460224|537411656|FG004|Overall Study|Subject/guardian decision|2|||
148981623|NCT02460224|537411657|FG005|Overall Study|Subject/guardian decision|2|||
148981624|NCT02460224|537411658|FG006|Overall Study|Subject/guardian decision|0|||
148981625|NCT02460224|537411659|FG007|Overall Study|Subject/guardian decision|0|||
148981626|NCT02460224|537411660|FG008|Overall Study|Subject/guardian decision|1|||
148981627|NCT02460224|537411661|FG009|Overall Study|Subject/guardian decision|1|||
148981628|NCT02460224|537411662|FG010|Overall Study|Subject/guardian decision|0|||
148981629|NCT02460224|537411663|FG011|Overall Study|Subject/guardian decision|1|||
148981630|NCT02460224|537411664|FG012|Overall Study|Subject/guardian decision|0|||
148981631|NCT02460224|537411665|FG013|Overall Study|Subject/guardian decision|0|||
148981632|NCT02460224|537411666|FG014|Overall Study|Subject/guardian decision|0|||
148981633|NCT02460224|537411667|FG015|Overall Study|Subject/guardian decision|1|||
148835096|NCT00529633|536877983|FG000|Overall Study|Withdrawal by Subject|1|||
148835097|NCT00529633|536877984|FG001|Overall Study|Withdrawal by Subject|1|||
148835098|NCT01334918|536877985|FG000|Overall Study|Did not receive study drug|6|||
148835099|NCT01334918|536877986|FG001|Overall Study|Did not receive study drug|0|||
148835100|NCT01334918|536877985|FG000|Overall Study|Adverse Event|2|||
148835101|NCT01334918|536877986|FG001|Overall Study|Adverse Event|0|||
148835102|NCT01334918|536877985|FG000|Overall Study|Withdrawal by Subject|0|||
148835103|NCT01334918|536877986|FG001|Overall Study|Withdrawal by Subject|1|||
148835104|NCT01897493|536877991|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
148835105|NCT02777086|536877995|FG000|Overall Study|Lost to Follow-up|96|||
148835106|NCT02777086|536877996|FG001|Overall Study|Lost to Follow-up|99|||
148835107|NCT01133665|536877997|FG000|Overall Study|Physician Decision|2|||
148981634|NCT02460224|537411668|FG016|Overall Study|Subject/guardian decision|0|||
148981635|NCT02460224|537411669|FG017|Overall Study|Subject/guardian decision|1|||
148981636|NCT02460224|537411670|FG018|Overall Study|Subject/guardian decision|2|||
148981637|NCT02460224|537411671|FG019|Overall Study|Subject/guardian decision|0|||
148981638|NCT02460224|537411672|FG020|Overall Study|Subject/guardian decision|0|||
148981639|NCT02460224|537411673|FG021|Overall Study|Subject/guardian decision|1|||
148981640|NCT02460224|537411674|FG022|Overall Study|Subject/guardian decision|0|||
148981641|NCT02460224|537411675|FG023|Overall Study|Subject/guardian decision|0|||
148981642|NCT02460224|537411676|FG024|Overall Study|Subject/guardian decision|0|||
148981643|NCT02460224|537411677|FG025|Overall Study|Subject/guardian decision|0|||
148981644|NCT02460224|537411678|FG026|Overall Study|Subject/guardian decision|6|||
148981645|NCT02460224|537411679|FG027|Overall Study|Subject/guardian decision|2|||
148835108|NCT01819272|536877998|FG000|Overall Study|Adverse Event|1|||
148835109|NCT01819272|536877999|FG001|Overall Study|Adverse Event|0|||
148835110|NCT01819272|536878000|FG002|Overall Study|Adverse Event|0|||
148981646|NCT02460224|537411680|FG028|Overall Study|Subject/guardian decision|3|||
148981647|NCT02797262|537411681|FG000|Overall Study|Withdrawal by Subject|5|||
148981648|NCT02797262|537411682|FG001|Overall Study|Withdrawal by Subject|1|||
148981649|NCT02797262|537411681|FG000|Overall Study|Lost to Follow-up|10|||
148981650|NCT02797262|537411682|FG001|Overall Study|Lost to Follow-up|7|||
148981651|NCT02797262|537411681|FG000|Overall Study|Death|1|||
148981652|NCT02797262|537411682|FG001|Overall Study|Death|2|||
148981653|NCT02797262|537411681|FG000|Overall Study|Adverse Event|1|||
148981654|NCT02797262|537411682|FG001|Overall Study|Adverse Event|0|||
148981655|NCT02797262|537411681|FG000|Overall Study|COVID-19|2|||
148981656|NCT02797262|537411682|FG001|Overall Study|COVID-19|1|||
148981657|NCT02797262|537411681|FG000|Overall Study|Out-of-country|1|||
148981658|NCT02797262|537411682|FG001|Overall Study|Out-of-country|0|||
148981659|NCT01600586|537411683|FG000|Overall Study|Physician Decision|3|||
148981660|NCT01600586|537411684|FG001|Overall Study|Physician Decision|3|||
148981661|NCT00965848|537411689|FG000|Overall Study|Protocol Violation|3|||
148981662|NCT00965848|537411690|FG001|Overall Study|Protocol Violation|0|||
148981663|NCT00965848|537411691|FG002|Overall Study|Protocol Violation|1|||
148981664|NCT00965848|537411689|FG000|Overall Study|Death|11|||
148981665|NCT00965848|537411690|FG001|Overall Study|Death|1|||
148981666|NCT00965848|537411691|FG002|Overall Study|Death|5|||
148981667|NCT00965848|537411689|FG000|Overall Study|Lost to Follow-up|0|||
148981668|NCT00965848|537411690|FG001|Overall Study|Lost to Follow-up|0|||
148981669|NCT00965848|537411691|FG002|Overall Study|Lost to Follow-up|1|||
148981670|NCT00965848|537411689|FG000|Overall Study|Withdrawal by Subject|1|||
148981671|NCT00965848|537411690|FG001|Overall Study|Withdrawal by Subject|0|||
148981672|NCT00965848|537411691|FG002|Overall Study|Withdrawal by Subject|0|||
148981673|NCT00965848|537411689|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
148981674|NCT00965848|537411690|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
148981675|NCT00965848|537411691|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
148981676|NCT00965848|537411689|FG000|Overall Study|Not Clinically Evaluable|7|||
148981677|NCT00965848|537411690|FG001|Overall Study|Not Clinically Evaluable|1|||
148981678|NCT00965848|537411691|FG002|Overall Study|Not Clinically Evaluable|1|||
148981679|NCT00965848|537411689|FG000|Overall Study|Other|5|||
148981680|NCT00965848|537411690|FG001|Overall Study|Other|0|||
148981681|NCT00965848|537411691|FG002|Overall Study|Other|1|||
148981682|NCT00813761|537411692|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
148981683|NCT00813761|537411693|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
148981684|NCT00813761|537411694|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
148981685|NCT00813761|537411695|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
148981686|NCT00813761|537411692|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
148981687|NCT00813761|537411693|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
148981688|NCT00813761|537411694|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
148981689|NCT00813761|537411695|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
148981690|NCT00813761|537411692|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
148981691|NCT00813761|537411693|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
148981692|NCT00813761|537411694|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
148981693|NCT00813761|537411695|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
148981694|NCT00813761|537411692|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
148981695|NCT00813761|537411693|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
148981696|NCT00813761|537411694|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
148981697|NCT00813761|537411695|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
148981698|NCT00813761|537411692|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
148981699|NCT00813761|537411693|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
148981700|NCT00813761|537411694|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
148981701|NCT00813761|537411695|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
148981702|NCT00813761|537411692|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
148981703|NCT00813761|537411693|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
148981704|NCT00813761|537411694|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
148981705|NCT00813761|537411695|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
148981706|NCT00813761|537411692|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
148981707|NCT00813761|537411693|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
148981708|NCT00813761|537411694|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
148981709|NCT00813761|537411695|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
148981710|NCT00813761|537411692|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
148981711|NCT00813761|537411693|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
148981712|NCT00813761|537411694|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
148981713|NCT00813761|537411695|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
148981714|NCT00813761|537411692|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
148835111|NCT01819272|536878001|FG003|Overall Study|Adverse Event|2|||
148981715|NCT00813761|537411693|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
148835112|NCT01819272|536878002|FG004|Overall Study|Adverse Event|0|||
148835113|NCT01819272|536878003|FG005|Overall Study|Adverse Event|0|||
148981716|NCT00813761|537411694|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
148981717|NCT00813761|537411695|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
148981718|NCT00813761|537411692|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
148981719|NCT00813761|537411693|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
148981720|NCT00813761|537411694|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
148981721|NCT00813761|537411695|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
148835114|NCT01819272|536877998|FG000|Overall Study|Lost to Follow-up|3|||
148835115|NCT01819272|536877999|FG001|Overall Study|Lost to Follow-up|0|||
148835116|NCT01819272|536878000|FG002|Overall Study|Lost to Follow-up|1|||
148835117|NCT01819272|536878001|FG003|Overall Study|Lost to Follow-up|0|||
148835118|NCT01819272|536878002|FG004|Overall Study|Lost to Follow-up|0|||
148835119|NCT01819272|536878003|FG005|Overall Study|Lost to Follow-up|3|||
148835120|NCT01819272|536877998|FG000|Overall Study|Protocol Violation|0|||
148835121|NCT01819272|536877999|FG001|Overall Study|Protocol Violation|0|||
148835122|NCT01819272|536878000|FG002|Overall Study|Protocol Violation|0|||
148835123|NCT01819272|536878001|FG003|Overall Study|Protocol Violation|1|||
148835124|NCT01819272|536878002|FG004|Overall Study|Protocol Violation|2|||
148835125|NCT01819272|536878003|FG005|Overall Study|Protocol Violation|3|||
148835126|NCT01819272|536877998|FG000|Overall Study|Physician Decision|0|||
148835127|NCT01819272|536877999|FG001|Overall Study|Physician Decision|1|||
148835128|NCT01819272|536878000|FG002|Overall Study|Physician Decision|0|||
148835129|NCT01819272|536878001|FG003|Overall Study|Physician Decision|0|||
148835130|NCT01819272|536878002|FG004|Overall Study|Physician Decision|0|||
148835131|NCT01819272|536878003|FG005|Overall Study|Physician Decision|0|||
148835132|NCT01819272|536877998|FG000|Overall Study|Withdrawal of Consent|0|||
148835133|NCT01819272|536877999|FG001|Overall Study|Withdrawal of Consent|1|||
148835134|NCT01819272|536878000|FG002|Overall Study|Withdrawal of Consent|2|||
148835135|NCT01819272|536878001|FG003|Overall Study|Withdrawal of Consent|1|||
148835136|NCT01819272|536878002|FG004|Overall Study|Withdrawal of Consent|0|||
148835137|NCT01819272|536878003|FG005|Overall Study|Withdrawal of Consent|1|||
148835138|NCT01819272|536877998|FG000|Overall Study|Loss of Glucose Control|2|||
148835139|NCT01819272|536877999|FG001|Overall Study|Loss of Glucose Control|1|||
148835140|NCT01819272|536878000|FG002|Overall Study|Loss of Glucose Control|0|||
148835141|NCT01819272|536878001|FG003|Overall Study|Loss of Glucose Control|1|||
148835142|NCT01819272|536878002|FG004|Overall Study|Loss of Glucose Control|2|||
148835143|NCT01819272|536878003|FG005|Overall Study|Loss of Glucose Control|0|||
148835144|NCT00805389|536878004|FG000|Overall Study|Adverse Event|0|||
148835145|NCT00805389|536878005|FG001|Overall Study|Adverse Event|0|||
148835146|NCT00805389|536878006|FG002|Overall Study|Adverse Event|1|||
148835147|NCT00805389|536878007|FG003|Overall Study|Adverse Event|2|||
148835148|NCT00805389|536878008|FG004|Overall Study|Adverse Event|0|||
148835149|NCT00805389|536878004|FG000|Overall Study|Lost to Follow-up|4|||
148835150|NCT00805389|536878005|FG001|Overall Study|Lost to Follow-up|3|||
148835151|NCT00805389|536878006|FG002|Overall Study|Lost to Follow-up|6|||
148835152|NCT00805389|536878007|FG003|Overall Study|Lost to Follow-up|10|||
148835153|NCT00805389|536878008|FG004|Overall Study|Lost to Follow-up|9|||
148835154|NCT00805389|536878004|FG000|Overall Study|Protocol Violation|0|||
148835155|NCT00805389|536878005|FG001|Overall Study|Protocol Violation|0|||
148835156|NCT00805389|536878006|FG002|Overall Study|Protocol Violation|1|||
148835157|NCT00805389|536878007|FG003|Overall Study|Protocol Violation|0|||
148835158|NCT00805389|536878008|FG004|Overall Study|Protocol Violation|0|||
148835159|NCT00805389|536878004|FG000|Overall Study|Withdrawal by Subject|3|||
148835160|NCT00805389|536878005|FG001|Overall Study|Withdrawal by Subject|2|||
148835161|NCT00805389|536878006|FG002|Overall Study|Withdrawal by Subject|4|||
148835162|NCT00805389|536878007|FG003|Overall Study|Withdrawal by Subject|5|||
148835163|NCT00805389|536878008|FG004|Overall Study|Withdrawal by Subject|4|||
148835164|NCT01784029|536878013|FG000|Overall Study|Lost to Follow-up|19|||
148835165|NCT01784029|536878014|FG001|Overall Study|Lost to Follow-up|20|||
148835166|NCT01784029|536878015|FG002|Overall Study|Lost to Follow-up|22|||
148835167|NCT00069641|536878018|FG000|Overall Study|Death|1|||
148835168|NCT00069641|536878019|FG001|Overall Study|Death|0|||
148835169|NCT00069641|536878020|FG002|Overall Study|Death|1|||
148981722|NCT00813761|537411692|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
148981723|NCT00813761|537411693|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
148835170|NCT03186638|536878021|FG000|Overall Study|Withdrawal by Subject|4|||
148835171|NCT03186638|536878022|FG001|Overall Study|Withdrawal by Subject|4|||
148835172|NCT03186638|536878021|FG000|Overall Study|Withdrawn due to medical problem|3|||
148835173|NCT03186638|536878022|FG001|Overall Study|Withdrawn due to medical problem|2|||
148835174|NCT03186638|536878021|FG000|Overall Study|Lost to Follow-up|1|||
148835175|NCT03186638|536878022|FG001|Overall Study|Lost to Follow-up|0|||
148835176|NCT02239926|536878023|FG000|Overall Study|Withdrawal by Subject|0|||
148835177|NCT02239926|536878024|FG001|Overall Study|Withdrawal by Subject|1|||
148835178|NCT02704208|536878025|FG000|Overall Study|Lost to Follow-up|42|||
148835179|NCT02704208|536878026|FG001|Overall Study|Lost to Follow-up|37|||
148835180|NCT04388826|536878027|FG000|Overall Study|Lost to Follow-up|3|||
148835181|NCT04388826|536878028|FG001|Overall Study|Lost to Follow-up|2|||
148835182|NCT04388826|536878027|FG000|Overall Study|Adverse Event|1|||
148835183|NCT04388826|536878028|FG001|Overall Study|Adverse Event|0|||
148981724|NCT00813761|537411694|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
148981725|NCT00813761|537411695|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
148981726|NCT00813761|537411692|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
148981727|NCT00813761|537411693|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
148981728|NCT00813761|537411694|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
148981729|NCT00813761|537411695|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
148981730|NCT00555438|537411698|FG000|10 Days Post-operative|Death|4|||
148981731|NCT00555438|537411698|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
148981732|NCT02758236|537411701|FG000|Overall Study|Investigator discretion|43|||
148981733|NCT02447991|537411702|FG000|Overall Study|Withdrawn by subject - no data|0|||
148981734|NCT02447991|537411703|FG001|Overall Study|Withdrawn by subject - no data|2|||
148981735|NCT02447991|537411702|FG000|Overall Study|Withdrawn by Subject - with data|4|||
148981736|NCT02447991|537411703|FG001|Overall Study|Withdrawn by Subject - with data|4|||
148981737|NCT02447991|537411702|FG000|Overall Study|Lost to Follow-up - no data|3|||
148981738|NCT02447991|537411703|FG001|Overall Study|Lost to Follow-up - no data|6|||
148981739|NCT02447991|537411702|FG000|Overall Study|Lost to follow-up - with data|0|||
148981740|NCT02447991|537411703|FG001|Overall Study|Lost to follow-up - with data|3|||
148981741|NCT02447991|537411702|FG000|Overall Study|End of study - no treatment results|3|||
148981742|NCT02447991|537411703|FG001|Overall Study|End of study - no treatment results|6|||
148981743|NCT02447991|537411702|FG000|Overall Study|End of study - partial treatment results|0|||
148981744|NCT02447991|537411703|FG001|Overall Study|End of study - partial treatment results|9|||
148981745|NCT02770391|537411710|FG000|Overall Study|Lost to Follow-up|2|||
148981746|NCT02770391|537411710|FG000|Overall Study|Withdrawal by Subject|1|||
148981747|NCT02770391|537411710|FG000|Overall Study|Surgery delayed unevaluable|2|||
148981748|NCT02770391|537411710|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
148981749|NCT03333486|537411713|FG000|Overall Study|Withdrawal by Subject|1|||
148981750|NCT03333486|537411713|FG000|Overall Study|Lost to Follow-up|1|||
148981751|NCT03136068|537413170|FG000|Overall Study|Lost to Follow-up|1|||
148981752|NCT03136068|537413171|FG001|Overall Study|Lost to Follow-up|1|||
148981753|NCT03136068|537413170|FG000|Overall Study|Protocol Violation|1|||
148981754|NCT03136068|537413171|FG001|Overall Study|Protocol Violation|0|||
148981755|NCT01071395|537413172|FG000|Overall Study|Withdrawal by Subject|2|||
148981756|NCT01071395|537413173|FG001|Overall Study|Withdrawal by Subject|1|||
148981757|NCT01071395|537413172|FG000|Overall Study|Adverse Event|3|||
148981758|NCT01071395|537413173|FG001|Overall Study|Adverse Event|1|||
148981759|NCT01337089|537413176|FG000|Overall Study|Adverse Event|237|||
148981760|NCT01337089|537413176|FG000|Overall Study|Withdrawal by Subject|129|||
148981761|NCT01337089|537413176|FG000|Overall Study|Withdrawal by Investigator|33|||
148981762|NCT01337089|537413176|FG000|Overall Study|Met Withdrawal Criteria|3|||
148981763|NCT01337089|537413176|FG000|Overall Study|Lost to Follow-up|2|||
148981764|NCT04419493|537413177|FG000|Wash-out After Period 1|Adverse Event|1|||
148981765|NCT04419493|537413178|FG001|Wash-out After Period 1|Adverse Event|2|||
148981766|NCT04419493|537413179|FG002|Wash-out After Period 1|Adverse Event|1|||
148981767|NCT04419493|537413180|FG003|Wash-out After Period 1|Adverse Event|0|||
148981768|NCT00524134|537413181|FG000|Overall Study|Withdrawal by Subject|1|||
148981769|NCT00524134|537413181|FG000|Overall Study|Physician Decision|1|||
148981770|NCT01040871|537413185|FG000|Overall Study|Adverse Event|6|||
148981771|NCT01040871|537413186|FG001|Overall Study|Adverse Event|2|||
148981772|NCT01040871|537413185|FG000|Overall Study|Withdrawal by Subject|2|||
148981773|NCT01040871|537413186|FG001|Overall Study|Withdrawal by Subject|0|||
148981774|NCT01040871|537413185|FG000|Overall Study|Death|1|||
148981775|NCT01040871|537413186|FG001|Overall Study|Death|3|||
148981776|NCT01040871|537413185|FG000|Overall Study|Lack of Efficacy|1|||
148981777|NCT01040871|537413186|FG001|Overall Study|Lack of Efficacy|1|||
148981778|NCT01040871|537413185|FG000|Overall Study|drug supply issue|1|||
148981779|NCT01040871|537413186|FG001|Overall Study|drug supply issue|0|||
148981780|NCT01040871|537413185|FG000|Overall Study|Randomized and Not Treated|2|||
148981781|NCT01040871|537413186|FG001|Overall Study|Randomized and Not Treated|1|||
148981782|NCT03087591|537413188|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
148981783|NCT03087591|537413188|FG000|Overall Study|Withdrawal by Subject|1|||
148981784|NCT01073618|537413191|FG000|Overall Study|Death|208|||
148981785|NCT01073618|537413191|FG000|Overall Study|Adverse Event|19|||
148981786|NCT01073618|537413191|FG000|Overall Study|Other|80|||
148981787|NCT02696850|537413192|FG000|Overall Study|Withdrawal by Subject|3|||
149028595|NCT00941031|537581989|FG006|Induction Period|Adverse Event|0|||
149028596|NCT00941031|537581983|FG000|Maintenance Period|Withdrawal by Subject|0|||
148981788|NCT02696850|537413193|FG001|Overall Study|Withdrawal by Subject|3|||
148981789|NCT02696850|537413192|FG000|Overall Study|Lost to Follow-up|8|||
148981790|NCT02696850|537413193|FG001|Overall Study|Lost to Follow-up|5|||
148981791|NCT00673049|537413196|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
148981792|NCT00673049|537413197|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
148981793|NCT00673049|537413198|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
148981794|NCT00673049|537413199|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
148981795|NCT00673049|537413196|FG000|Before Progression on Erlotinib|Death|235|||
149028597|NCT00941031|537581984|FG001|Maintenance Period|Withdrawal by Subject|0|||
149028598|NCT00941031|537581985|FG002|Maintenance Period|Withdrawal by Subject|0|||
149028599|NCT00941031|537581986|FG003|Maintenance Period|Withdrawal by Subject|0|||
148835184|NCT04047446|536878029|FG000|Overall Study|Physician Decision|1|||
148835185|NCT04047446|536878030|FG001|Overall Study|Physician Decision|0|||
148835186|NCT00329420|536878031|FG000|Re-induction Phase|Lack of Efficacy|0|||
148835187|NCT00329420|536878032|FG001|Re-induction Phase|Lack of Efficacy|1|||
148835188|NCT00329420|536878033|FG002|Re-induction Phase|Lack of Efficacy|0|||
148835189|NCT00329420|536878031|FG000|Re-induction Phase|Withdrawal of Consent|0|||
148835190|NCT00329420|536878032|FG001|Re-induction Phase|Withdrawal of Consent|0|||
148835191|NCT00329420|536878033|FG002|Re-induction Phase|Withdrawal of Consent|1|||
148835192|NCT00329420|536878031|FG000|Re-induction Phase|Did not respond to re-induction|6|||
148835193|NCT00329420|536878032|FG001|Re-induction Phase|Did not respond to re-induction|5|||
148835194|NCT00329420|536878033|FG002|Re-induction Phase|Did not respond to re-induction|7|||
148835195|NCT00329420|536878031|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
148835196|NCT00329420|536878032|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
148835197|NCT00329420|536878033|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
148835198|NCT00329420|536878031|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
148835199|NCT00329420|536878032|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
148835200|NCT00329420|536878033|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
148835201|NCT00329420|536878031|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
148835202|NCT00329420|536878032|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
148835203|NCT00329420|536878033|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
148835204|NCT03386773|536878035|FG000|Overall Study|Lost to Follow-up|24|||
148835205|NCT03386773|536878036|FG001|Overall Study|Lost to Follow-up|33|||
148835206|NCT03386773|536878035|FG000|Overall Study|Withdrawal by Subject|3|||
148835207|NCT03386773|536878036|FG001|Overall Study|Withdrawal by Subject|2|||
148835208|NCT03983421|536878037|FG000|Overall Study|Lost to Follow-up|1|||
148835209|NCT03639610|536878038|FG000|Overall Study|Adverse Event|7|||
148835210|NCT03639610|536878039|FG001|Overall Study|Adverse Event|1|||
148835211|NCT03639610|536878040|FG002|Overall Study|Adverse Event|0|||
148835212|NCT03639610|536878038|FG000|Overall Study|Physician Decision|3|||
148835213|NCT03639610|536878039|FG001|Overall Study|Physician Decision|1|||
148835214|NCT03639610|536878040|FG002|Overall Study|Physician Decision|0|||
148835215|NCT03639610|536878038|FG000|Overall Study|Disease progression|8|||
148835216|NCT03639610|536878039|FG001|Overall Study|Disease progression|5|||
148835217|NCT03639610|536878040|FG002|Overall Study|Disease progression|3|||
148835218|NCT03639610|536878038|FG000|Overall Study|Study terminated by sponsor|2|||
148835219|NCT03639610|536878039|FG001|Overall Study|Study terminated by sponsor|1|||
148835220|NCT03639610|536878040|FG002|Overall Study|Study terminated by sponsor|1|||
148835221|NCT03639610|536878038|FG000|Overall Study|Patient request to stop treatment|1|||
148835222|NCT03639610|536878039|FG001|Overall Study|Patient request to stop treatment|2|||
148835223|NCT03639610|536878040|FG002|Overall Study|Patient request to stop treatment|0|||
148835224|NCT00892008|536878041|FG000|Overall Study|Death|5|||
148835225|NCT00892008|536878041|FG000|Overall Study|Lack of Efficacy|3|||
148835226|NCT00892008|536878041|FG000|Overall Study|Lost to Follow-up|142|||
148835227|NCT00892008|536878041|FG000|Overall Study|Other|378|||
148835228|NCT00892008|536878041|FG000|Overall Study|Adverse Event|37|||
148835229|NCT05878067|536878045|FG000|Overall Study|Lost to Follow-up|2|||
148835230|NCT01198587|536878050|FG000|Overall Study|Lost to Follow-up|8|||
148835231|NCT01198587|536878051|FG001|Overall Study|Lost to Follow-up|0|||
148835232|NCT01198587|536878052|FG002|Overall Study|Lost to Follow-up|9|||
148835233|NCT01198587|536878053|FG003|Overall Study|Lost to Follow-up|0|||
148835234|NCT01959529|536878054|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
148835235|NCT01959529|536878055|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
148835236|NCT01959529|536878054|FG000|Overall Study|Lost to Follow-up|4|||
148835237|NCT01959529|536878055|FG001|Overall Study|Lost to Follow-up|1|||
148835238|NCT01959529|536878054|FG000|Overall Study|Other|70|||
148835239|NCT01959529|536878055|FG001|Overall Study|Other|68|||
148835240|NCT01959529|536878054|FG000|Overall Study|Hypoglycaemia|1|||
148835241|NCT01959529|536878055|FG001|Overall Study|Hypoglycaemia|1|||
149028600|NCT00941031|537581987|FG004|Maintenance Period|Withdrawal by Subject|6|||
149028601|NCT00941031|537581988|FG005|Maintenance Period|Withdrawal by Subject|2|||
148835242|NCT01959529|536878054|FG000|Overall Study|Lack of glycaemic control|1|||
148835243|NCT01959529|536878055|FG001|Overall Study|Lack of glycaemic control|1|||
148835244|NCT02234362|536878056|FG000|Overall Study|Not eligible after first screening visit|17|||
148835245|NCT02234362|536878056|FG000|Overall Study|Lost to Follow-up|6|||
148835246|NCT02234362|536878056|FG000|Overall Study|Withdrawal by Subject|3|||
148835247|NCT00560417|536878064|FG000|Overall Study|Adverse Event|3|||
148835248|NCT00560417|536878065|FG001|Overall Study|Adverse Event|2|||
148835249|NCT00560417|536878064|FG000|Overall Study|Entry Criteria Not Met|1|||
148835250|NCT00560417|536878065|FG001|Overall Study|Entry Criteria Not Met|0|||
148835251|NCT00560417|536878064|FG000|Overall Study|Lost to Follow-up|0|||
148835252|NCT00560417|536878065|FG001|Overall Study|Lost to Follow-up|1|||
148835253|NCT00560417|536878064|FG000|Overall Study|Physician Decision|2|||
148835254|NCT00560417|536878065|FG001|Overall Study|Physician Decision|6|||
148835255|NCT00560417|536878064|FG000|Overall Study|Protocol Violation|6|||
148835256|NCT00560417|536878065|FG001|Overall Study|Protocol Violation|5|||
148835257|NCT00560417|536878064|FG000|Overall Study|Sponsor Decision|2|||
148835258|NCT00560417|536878065|FG001|Overall Study|Sponsor Decision|0|||
148835259|NCT00560417|536878064|FG000|Overall Study|Withdrawal by Subject|3|||
148835260|NCT00560417|536878065|FG001|Overall Study|Withdrawal by Subject|3|||
148835261|NCT02569853|536878066|FG000|Overall Study|Adverse Event|2|||
148835262|NCT02569853|536878067|FG001|Overall Study|Adverse Event|0|||
148835263|NCT02569853|536878066|FG000|Overall Study|Withdrawal by Subject|3|||
148835264|NCT02569853|536878067|FG001|Overall Study|Withdrawal by Subject|2|||
148835265|NCT02569853|536878066|FG000|Overall Study|Lost to Follow-up|3|||
148835266|NCT02569853|536878067|FG001|Overall Study|Lost to Follow-up|3|||
148835267|NCT02569853|536878066|FG000|Overall Study|Protocol Violation|1|||
148835268|NCT02569853|536878067|FG001|Overall Study|Protocol Violation|1|||
148835269|NCT02569853|536878066|FG000|Overall Study|Did not experience migraine attack|10|||
148835270|NCT02569853|536878067|FG001|Overall Study|Did not experience migraine attack|7|||
148835271|NCT02569853|536878066|FG000|Overall Study|Physician Decision|1|||
148835272|NCT02569853|536878067|FG001|Overall Study|Physician Decision|1|||
148835273|NCT00261833|536878068|FG000|Overall Study|Death|1|||
148835274|NCT00261833|536878069|FG001|Overall Study|Death|3|||
148835275|NCT00261833|536878068|FG000|Overall Study|Adverse Event|1|||
148835276|NCT00261833|536878069|FG001|Overall Study|Adverse Event|4|||
148835277|NCT00261833|536878068|FG000|Overall Study|Withdrawal by Subject|5|||
148835278|NCT00261833|536878069|FG001|Overall Study|Withdrawal by Subject|7|||
148835279|NCT00261833|536878068|FG000|Overall Study|Protocol Violation|0|||
148835280|NCT00261833|536878069|FG001|Overall Study|Protocol Violation|1|||
148835281|NCT00261833|536878068|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
148835282|NCT00261833|536878069|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
148835283|NCT00261833|536878068|FG000|Overall Study|Lung transplantation|1|||
148835284|NCT00261833|536878069|FG001|Overall Study|Lung transplantation|1|||
148835285|NCT00261833|536878068|FG000|Overall Study|Missing reason|1|||
148835286|NCT00261833|536878069|FG001|Overall Study|Missing reason|0|||
148835287|NCT00261833|536878068|FG000|Overall Study|Not interested in being participant|0|||
148835288|NCT00261833|536878069|FG001|Overall Study|Not interested in being participant|1|||
148835289|NCT00622726|536878070|FG000|March, 2008 to August, 2010|Death|5|||
148835290|NCT00622726|536878071|FG001|March, 2008 to August, 2010|Death|2|||
148835291|NCT00622726|536878070|FG000|August, 2010 to April, 2013|Death|1|||
148835292|NCT00622726|536878071|FG001|August, 2010 to April, 2013|Death|5|||
148835293|NCT02434081|536878074|FG000|Overall Study|Death (never started treatment)|2|||
148835294|NCT02434081|536878074|FG000|Overall Study|Death|2|||
148835295|NCT02434081|536878074|FG000|Overall Study|Progression|20|||
148835296|NCT02434081|536878074|FG000|Overall Study|Adverse Event|20|||
148835297|NCT02434081|536878074|FG000|Overall Study|Physician Decision|2|||
148835298|NCT02434081|536878074|FG000|Overall Study|Withdrawal by Subject|1|||
148835299|NCT02434081|536878074|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
148835300|NCT00854360|536878077|FG000|Overall Study|Adverse Event|0|||
148835301|NCT00854360|536878078|FG001|Overall Study|Adverse Event|1|||
148835302|NCT00854360|536878079|FG002|Overall Study|Adverse Event|2|||
148835303|NCT00854360|536878080|FG003|Overall Study|Adverse Event|6|||
148835304|NCT00854360|536878077|FG000|Overall Study|Withdrawal by Subject|0|||
148835305|NCT00854360|536878078|FG001|Overall Study|Withdrawal by Subject|0|||
148835306|NCT00854360|536878079|FG002|Overall Study|Withdrawal by Subject|0|||
148835307|NCT00854360|536878080|FG003|Overall Study|Withdrawal by Subject|1|||
148835308|NCT00854360|536878077|FG000|Overall Study|Pregnancy|0|||
148835309|NCT00854360|536878078|FG001|Overall Study|Pregnancy|1|||
148835310|NCT00854360|536878079|FG002|Overall Study|Pregnancy|0|||
148835311|NCT00854360|536878080|FG003|Overall Study|Pregnancy|0|||
148835312|NCT00854360|536878077|FG000|Overall Study|Lack of Efficacy|2|||
148835313|NCT00854360|536878078|FG001|Overall Study|Lack of Efficacy|1|||
148835314|NCT00854360|536878079|FG002|Overall Study|Lack of Efficacy|0|||
148835315|NCT00854360|536878080|FG003|Overall Study|Lack of Efficacy|0|||
148835316|NCT00854360|536878077|FG000|Overall Study|Other|0|||
148835317|NCT00854360|536878078|FG001|Overall Study|Other|0|||
148835318|NCT00854360|536878079|FG002|Overall Study|Other|0|||
148981796|NCT00673049|537413197|FG001|Before Progression on Erlotinib|Death|167|||
148981797|NCT00673049|537413198|FG002|Before Progression on Erlotinib|Death|1|||
148981798|NCT00673049|537413199|FG003|Before Progression on Erlotinib|Death|0|||
148835319|NCT00854360|536878080|FG003|Overall Study|Other|3|||
148835320|NCT02271880|536878082|FG000|Overall Study|Premature discontinuation of study|3|||
148981799|NCT00673049|537413196|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
148835321|NCT02271880|536878083|FG001|Overall Study|Premature discontinuation of study|4|||
148835322|NCT00474903|536878084|FG000|Overall Study|Protocol Violation|1|||
148835323|NCT00474903|536878085|FG001|Overall Study|Protocol Violation|5|||
148835324|NCT00474903|536878086|FG002|Overall Study|Protocol Violation|2|||
148835325|NCT00399529|536878087|FG000|Overall Study|Off Study Prior to Treatment|2|||
148835326|NCT01170663|536878088|FG000|Overall Study|Lost to Follow-up|3|||
148835327|NCT01170663|536878089|FG001|Overall Study|Lost to Follow-up|9|||
148835328|NCT01170663|536878088|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
148981800|NCT00673049|537413197|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
148981801|NCT00673049|537413198|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
148981802|NCT00673049|537413199|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
148981803|NCT00673049|537413196|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
148981804|NCT00673049|537413197|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
148981805|NCT00673049|537413198|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
148981806|NCT00673049|537413199|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
149028602|NCT00941031|537581989|FG006|Maintenance Period|Withdrawal by Subject|13|||
148981807|NCT00673049|537413196|FG000|Before Progression on Erlotinib|Other|1|||
149028603|NCT00941031|537581983|FG000|Maintenance Period|Administrative Problems|0|||
148773984|NCT00520481|536645111|FG001|Overall Study|Withdrawal by Subject|0|||
148773985|NCT00381043|536645121|FG000|Overall Study|Lost to Follow-up|8|||
148773986|NCT00381043|536645122|FG001|Overall Study|Lost to Follow-up|6|||
148773987|NCT00381043|536645121|FG000|Overall Study|Withdrawal by Subject|3|||
148773988|NCT00381043|536645122|FG001|Overall Study|Withdrawal by Subject|1|||
148773989|NCT00381043|536645121|FG000|Overall Study|wanted more care|0|||
148773990|NCT00381043|536645122|FG001|Overall Study|wanted more care|1|||
148773991|NCT00381043|536645121|FG000|Overall Study|incarcerated|1|||
148773992|NCT00381043|536645122|FG001|Overall Study|incarcerated|0|||
148773993|NCT02847494|536645123|FG000|Overall Study|Lost to Follow-up|8|||
148773994|NCT02847494|536645124|FG001|Overall Study|Lost to Follow-up|5|||
148773995|NCT03666533|536646902|FG000|Overall Study|Lost to Follow-up|2|||
148773996|NCT03666533|536646903|FG001|Overall Study|Lost to Follow-up|2|||
148773997|NCT02017717|536646904|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148773998|NCT02017717|536646905|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148773999|NCT02017717|536646906|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148774000|NCT02017717|536646907|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148774001|NCT02017717|536646908|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148774002|NCT02017717|536646909|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148774003|NCT02017717|536646910|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148774004|NCT02017717|536646911|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
148774005|NCT02017717|536646912|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
148774006|NCT02017717|536646904|FG000|Before Treatment Period|Participant request to stop therapy|0|||
148774007|NCT02017717|536646905|FG001|Before Treatment Period|Participant request to stop therapy|0|||
148774008|NCT02017717|536646906|FG002|Before Treatment Period|Participant request to stop therapy|0|||
148774009|NCT02017717|536646907|FG003|Before Treatment Period|Participant request to stop therapy|0|||
148774010|NCT02017717|536646908|FG004|Before Treatment Period|Participant request to stop therapy|0|||
148774011|NCT02017717|536646909|FG005|Before Treatment Period|Participant request to stop therapy|0|||
148774012|NCT02017717|536646910|FG006|Before Treatment Period|Participant request to stop therapy|0|||
148774013|NCT02017717|536646911|FG007|Before Treatment Period|Participant request to stop therapy|0|||
148774014|NCT02017717|536646912|FG008|Before Treatment Period|Participant request to stop therapy|5|||
148774015|NCT02017717|536646904|FG000|Before Treatment Period|Participant withdrew consent|0|||
148774016|NCT02017717|536646905|FG001|Before Treatment Period|Participant withdrew consent|0|||
148774017|NCT02017717|536646906|FG002|Before Treatment Period|Participant withdrew consent|0|||
148774018|NCT02017717|536646907|FG003|Before Treatment Period|Participant withdrew consent|0|||
148774019|NCT02017717|536646908|FG004|Before Treatment Period|Participant withdrew consent|0|||
148774020|NCT02017717|536646909|FG005|Before Treatment Period|Participant withdrew consent|0|||
148774021|NCT02017717|536646910|FG006|Before Treatment Period|Participant withdrew consent|2|||
148774022|NCT02017717|536646911|FG007|Before Treatment Period|Participant withdrew consent|0|||
148774023|NCT02017717|536646912|FG008|Before Treatment Period|Participant withdrew consent|11|||
148774024|NCT02017717|536646904|FG000|Before Treatment Period|Lost to Follow-up|0|||
148774025|NCT02017717|536646905|FG001|Before Treatment Period|Lost to Follow-up|0|||
148774026|NCT02017717|536646906|FG002|Before Treatment Period|Lost to Follow-up|0|||
148774027|NCT02017717|536646907|FG003|Before Treatment Period|Lost to Follow-up|0|||
148774028|NCT02017717|536646908|FG004|Before Treatment Period|Lost to Follow-up|0|||
148774029|NCT02017717|536646909|FG005|Before Treatment Period|Lost to Follow-up|0|||
148774030|NCT02017717|536646910|FG006|Before Treatment Period|Lost to Follow-up|0|||
148774031|NCT02017717|536646911|FG007|Before Treatment Period|Lost to Follow-up|0|||
148774032|NCT02017717|536646912|FG008|Before Treatment Period|Lost to Follow-up|1|||
148774033|NCT02017717|536646904|FG000|Before Treatment Period|Participant no longer met criteria|0|||
148774034|NCT02017717|536646905|FG001|Before Treatment Period|Participant no longer met criteria|0|||
148774035|NCT02017717|536646906|FG002|Before Treatment Period|Participant no longer met criteria|0|||
148774036|NCT02017717|536646907|FG003|Before Treatment Period|Participant no longer met criteria|0|||
148774037|NCT02017717|536646908|FG004|Before Treatment Period|Participant no longer met criteria|0|||
148774038|NCT02017717|536646909|FG005|Before Treatment Period|Participant no longer met criteria|1|||
148774039|NCT02017717|536646910|FG006|Before Treatment Period|Participant no longer met criteria|0|||
148981808|NCT00673049|537413197|FG001|Before Progression on Erlotinib|Other|2|||
148981809|NCT00673049|537413198|FG002|Before Progression on Erlotinib|Other|0|||
148835329|NCT01170663|536878089|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
148835330|NCT02006927|536878090|FG000|Overall Study|Adverse Event|2|||
148835331|NCT02006927|536878090|FG000|Overall Study|Withdrawal by Subject|1|||
148835332|NCT02735200|536878091|FG000|Overall Study|Lost to Follow-up|0|||
148835333|NCT02735200|536878092|FG001|Overall Study|Lost to Follow-up|5|||
148835334|NCT02735200|536878091|FG000|Overall Study|Withdrawal by Subject|8|||
148835335|NCT02735200|536878092|FG001|Overall Study|Withdrawal by Subject|0|||
148835336|NCT02746809|536878093|FG000|Enrollment|Inclusion Exclusion not met|9|||
148835337|NCT02746809|536878093|FG000|Enrollment|Withdrawal by Subject|1|||
148835338|NCT02746809|536878093|FG000|Enrollment|Expected Enrollment Met|2|||
148835339|NCT02746809|536878093|FG000|Procedure|Death|1|||
148835340|NCT02746809|536878093|FG000|1-Month|Death|5|||
148835341|NCT02746809|536878093|FG000|6-Month|Death|2|||
148835342|NCT02746809|536878093|FG000|6-Month|Withdrawal by Subject|1|||
148835343|NCT02746809|536878093|FG000|12-Month|Death|3|||
148835344|NCT02746809|536878093|FG000|12-Month|Withdrawal by Subject|2|||
148835345|NCT02746809|536878093|FG000|24-Month|Death|1|||
148835346|NCT02746809|536878093|FG000|24-Month|Withdrawal by Subject|1|||
148835347|NCT02746809|536878093|FG000|36-Month|Death|8|||
148835348|NCT02746809|536878093|FG000|36-Month|Withdrawal by Subject|1|||
148835349|NCT02746809|536878093|FG000|48-Month|Death|7|||
148835350|NCT02746809|536878093|FG000|48-Month|Withdrawal by Subject|1|||
148835351|NCT02746809|536878093|FG000|60-Month|Death|1|||
148835352|NCT02746809|536878093|FG000|60-Month|Lost to Follow-up|2|||
148835353|NCT01164007|536878094|FG000|Overall Study|Adverse Event|5|||
148835354|NCT01164007|536878094|FG000|Overall Study|Progression of Disease|30|||
148835355|NCT01164007|536878094|FG000|Overall Study|Protocol Violation|1|||
148835356|NCT01164007|536878094|FG000|Overall Study|Withdrawal by Subject|1|||
148835357|NCT01164007|536878094|FG000|Overall Study|Medical Decision|3|||
148835358|NCT00894387|536878097|FG000|Overall Study|Adverse Event|44|||
148835359|NCT00894387|536878098|FG001|Overall Study|Adverse Event|45|||
148835360|NCT00894387|536878097|FG000|Overall Study|Abnormal Laboratory values|2|||
148835361|NCT00894387|536878098|FG001|Overall Study|Abnormal Laboratory values|2|||
148835362|NCT00894387|536878097|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148835363|NCT00894387|536878098|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
148835364|NCT00894387|536878097|FG000|Overall Study|Lost to Follow-up|3|||
148835365|NCT00894387|536878098|FG001|Overall Study|Lost to Follow-up|5|||
148835366|NCT00894387|536878097|FG000|Overall Study|Administrative problems|2|||
148835367|NCT00894387|536878098|FG001|Overall Study|Administrative problems|2|||
148835368|NCT00894387|536878097|FG000|Overall Study|Death|77|||
148835369|NCT00894387|536878098|FG001|Overall Study|Death|76|||
148835370|NCT00894387|536878097|FG000|Overall Study|Protocol Deviation|4|||
148835371|NCT00894387|536878098|FG001|Overall Study|Protocol Deviation|0|||
148835372|NCT00894387|536878097|FG000|Overall Study|Patient's request|25|||
148835373|NCT00894387|536878098|FG001|Overall Study|Patient's request|30|||
148835374|NCT00894387|536878097|FG000|Overall Study|Other (Missing)|5|||
148835375|NCT00894387|536878098|FG001|Overall Study|Other (Missing)|3|||
148835376|NCT00894387|536878097|FG000|Overall Study|Mis-randomized|13|||
148835377|NCT00894387|536878098|FG001|Overall Study|Mis-randomized|9|||
148835378|NCT00894387|536878097|FG000|Overall Study|GCP non-compliance|0|||
148835379|NCT00894387|536878098|FG001|Overall Study|GCP non-compliance|2|||
148835380|NCT00744861|536878099|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
148835381|NCT00744861|536878100|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
148835382|NCT00744861|536878101|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
148835383|NCT00744861|536878102|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
148835384|NCT00744861|536878099|FG000|Feasibility Stage 1|Pregnancy|0|||
148981810|NCT00673049|537413199|FG003|Before Progression on Erlotinib|Other|0|||
148981811|NCT00673049|537413196|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
148981812|NCT00673049|537413197|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
148981813|NCT00673049|537413198|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
148835385|NCT00744861|536878100|FG001|Feasibility Stage 1|Pregnancy|1|||
148835386|NCT00744861|536878101|FG002|Feasibility Stage 1|Pregnancy|0|||
148835387|NCT00744861|536878102|FG003|Feasibility Stage 1|Pregnancy|0|||
148835388|NCT00744861|536878099|FG000|Pivotal Stage 2|Adverse Event|0|||
148835389|NCT00744861|536878100|FG001|Pivotal Stage 2|Adverse Event|0|||
148835390|NCT00744861|536878101|FG002|Pivotal Stage 2|Adverse Event|6|||
148835391|NCT00744861|536878102|FG003|Pivotal Stage 2|Adverse Event|11|||
148835392|NCT00744861|536878099|FG000|Pivotal Stage 2|Death|0|||
148835393|NCT00744861|536878100|FG001|Pivotal Stage 2|Death|0|||
148835394|NCT00744861|536878101|FG002|Pivotal Stage 2|Death|0|||
148835395|NCT00744861|536878102|FG003|Pivotal Stage 2|Death|1|||
148835396|NCT00744861|536878099|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
148835397|NCT00744861|536878100|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
148835398|NCT00744861|536878101|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
148835399|NCT00744861|536878102|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
148835400|NCT00744861|536878099|FG000|Pivotal Stage 2|Physician Decision|0|||
148835401|NCT00744861|536878100|FG001|Pivotal Stage 2|Physician Decision|0|||
148835402|NCT00744861|536878101|FG002|Pivotal Stage 2|Physician Decision|3|||
148835403|NCT00744861|536878102|FG003|Pivotal Stage 2|Physician Decision|1|||
148835404|NCT00744861|536878099|FG000|Pivotal Stage 2|Protocol Violation|0|||
148835405|NCT00744861|536878100|FG001|Pivotal Stage 2|Protocol Violation|0|||
148835406|NCT00744861|536878101|FG002|Pivotal Stage 2|Protocol Violation|0|||
148835407|NCT00744861|536878102|FG003|Pivotal Stage 2|Protocol Violation|1|||
148835408|NCT00744861|536878099|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
148835409|NCT00744861|536878100|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
148835410|NCT00744861|536878101|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
148835411|NCT00744861|536878102|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
148835412|NCT00744861|536878099|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
148835413|NCT00744861|536878100|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
148835414|NCT00744861|536878101|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
148835415|NCT00744861|536878102|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
148835416|NCT02493764|536878103|FG000|Overall Study|Adverse Event|2|||
148835417|NCT02493764|536878104|FG001|Overall Study|Adverse Event|2|||
148835418|NCT02493764|536878103|FG000|Overall Study|Death|44|||
148835419|NCT02493764|536878104|FG001|Overall Study|Death|58|||
148835420|NCT02493764|536878103|FG000|Overall Study|Lost to Follow-up|2|||
148835421|NCT02493764|536878104|FG001|Overall Study|Lost to Follow-up|1|||
148835422|NCT02493764|536878103|FG000|Overall Study|Protocol Violation|6|||
148835423|NCT02493764|536878104|FG001|Overall Study|Protocol Violation|7|||
148835424|NCT02493764|536878103|FG000|Overall Study|Physician Decision|1|||
148835425|NCT02493764|536878104|FG001|Overall Study|Physician Decision|1|||
148835426|NCT02493764|536878103|FG000|Overall Study|Participant moved|17|||
148835427|NCT02493764|536878104|FG001|Overall Study|Participant moved|5|||
148835428|NCT02493764|536878103|FG000|Overall Study|Withdrawal parent/guardian|0|||
148835429|NCT02493764|536878104|FG001|Overall Study|Withdrawal parent/guardian|1|||
148835430|NCT02493764|536878103|FG000|Overall Study|Withdrawal by Subject|11|||
148835431|NCT02493764|536878104|FG001|Overall Study|Withdrawal by Subject|7|||
148835432|NCT01561976|536878105|FG000|Period 1|Adverse Event|0|||
148835433|NCT01561976|536878106|FG001|Period 1|Adverse Event|0|||
148835434|NCT01561976|536878107|FG002|Period 1|Adverse Event|1|||
148835435|NCT01561976|536878108|FG003|Period 1|Adverse Event|0|||
148835436|NCT01561976|536878109|FG004|Period 1|Adverse Event|0|||
148835437|NCT01561976|536878110|FG005|Period 1|Adverse Event|0|||
148835438|NCT01561976|536878105|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
148835439|NCT01561976|536878106|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
148835440|NCT01561976|536878107|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
148835441|NCT01561976|536878108|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
148835442|NCT01561976|536878109|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
148835443|NCT01561976|536878110|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
148835444|NCT01561976|536878105|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148835445|NCT01561976|536878106|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148835446|NCT01561976|536878107|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148835447|NCT01561976|536878108|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148835448|NCT01561976|536878109|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
148835449|NCT01561976|536878110|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
148835450|NCT01561976|536878105|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
148835451|NCT01561976|536878106|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
148835452|NCT01561976|536878107|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
148835453|NCT01561976|536878108|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
148835454|NCT01561976|536878109|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
148835455|NCT01561976|536878110|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
148835456|NCT01977222|536878113|FG000|Overall Study|Withdrawal by Subject|1|||
148835457|NCT02980107|536878116|FG000|Overall Study|Withdrawal by Subject|51|||
148835458|NCT02980107|536878117|FG001|Overall Study|Withdrawal by Subject|62|||
148835459|NCT01038323|536878122|FG000|Overall Study|Withdrawal by Subject|3|||
148835460|NCT01038323|536878123|FG001|Overall Study|Withdrawal by Subject|2|||
148835461|NCT01038323|536878124|FG002|Overall Study|Withdrawal by Subject|4|||
148835462|NCT04696146|536879426|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
148835463|NCT04696146|536879427|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
148835464|NCT04696146|536879426|FG000|Overall Study|Off hours issue with product|1|||
148835465|NCT04696146|536879427|FG001|Overall Study|Off hours issue with product|0|||
148835466|NCT01576783|536879430|FG000|Overall Study|Change in Medical Care|1|||
148835467|NCT01576783|536879431|FG001|Overall Study|Change in Medical Care|0|||
148835468|NCT01576783|536879430|FG000|Overall Study|Lost to Follow-up|14|||
148835469|NCT01576783|536879431|FG001|Overall Study|Lost to Follow-up|16|||
148835470|NCT01576783|536879430|FG000|Overall Study|Withdrawal by Subject|5|||
148835471|NCT01576783|536879431|FG001|Overall Study|Withdrawal by Subject|1|||
148835472|NCT01732536|536879432|FG000|Overall Study|Withdrawal by Subject|1|||
148835473|NCT01732536|536879433|FG001|Overall Study|Withdrawal by Subject|1|||
148835474|NCT05111145|536879434|FG000|Overall Study|Commercial drug is available for participant|76|||
148835475|NCT05111145|536879434|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
148835476|NCT01276704|536879435|FG000|Overall Study|Lost to Follow-up|2|||
148835477|NCT01276704|536879436|FG001|Overall Study|Lost to Follow-up|3|||
148835478|NCT01276704|536879435|FG000|Overall Study|Non-compliant|2|||
148835479|NCT01276704|536879436|FG001|Overall Study|Non-compliant|2|||
148835480|NCT01276704|536879435|FG000|Overall Study|Withdrawal by Subject|7|||
148835481|NCT01276704|536879436|FG001|Overall Study|Withdrawal by Subject|1|||
148835482|NCT01276704|536879435|FG000|Overall Study|Physician Decision|3|||
148835483|NCT01276704|536879436|FG001|Overall Study|Physician Decision|5|||
148835484|NCT01359956|536879437|FG000|Overall Study|Death|58|||
148835485|NCT01359956|536879438|FG001|Overall Study|Death|60|||
148835486|NCT01359956|536879439|FG002|Overall Study|Death|66|||
148835487|NCT01359956|536879440|FG003|Overall Study|Death|57|||
148835488|NCT01359956|536879437|FG000|Overall Study|Lost to Follow-up|3|||
148835489|NCT01359956|536879438|FG001|Overall Study|Lost to Follow-up|4|||
148835490|NCT01359956|536879439|FG002|Overall Study|Lost to Follow-up|1|||
148835491|NCT01359956|536879440|FG003|Overall Study|Lost to Follow-up|1|||
148835492|NCT03728933|536879441|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
148835493|NCT03728933|536879442|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148835494|NCT03728933|536879443|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
148835495|NCT03728933|536879441|FG000|Overall Study|Withdrawal by Subject|0|||
148835496|NCT03728933|536879442|FG001|Overall Study|Withdrawal by Subject|0|||
148835497|NCT03728933|536879443|FG002|Overall Study|Withdrawal by Subject|1|||
148835498|NCT03728933|536879441|FG000|Overall Study|Lost to Follow-up|0|||
148835499|NCT03728933|536879442|FG001|Overall Study|Lost to Follow-up|1|||
148835500|NCT03728933|536879443|FG002|Overall Study|Lost to Follow-up|0|||
148835501|NCT03728933|536879441|FG000|Overall Study|Adverse Event|1|||
148835502|NCT03728933|536879442|FG001|Overall Study|Adverse Event|0|||
148835503|NCT03728933|536879443|FG002|Overall Study|Adverse Event|0|||
148835504|NCT00370292|536879444|FG000|Overall Study|Disease Progression|4|||
148835505|NCT00370292|536879444|FG000|Overall Study|Adverse Event|7|||
148835506|NCT00370292|536879444|FG000|Overall Study|Physician Decision|2|||
148835507|NCT00276419|536879445|FG000|First Intervention|Adverse Event|1|||
148835508|NCT00276419|536879446|FG001|First Intervention|Adverse Event|0|||
148835509|NCT00276419|536879445|FG000|First Intervention|Withdrawal by Subject|0|||
148835510|NCT00276419|536879446|FG001|First Intervention|Withdrawal by Subject|2|||
148835511|NCT03801525|536879447|FG000|Overall Study|Adverse Event|17|||
148835512|NCT03801525|536879448|FG001|Overall Study|Adverse Event|1|||
148835513|NCT03801525|536879449|FG002|Overall Study|Adverse Event|0|||
148835514|NCT03801525|536879447|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
148835515|NCT03801525|536879448|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
148835516|NCT03801525|536879449|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
148835517|NCT03801525|536879447|FG000|Overall Study|Death|29|||
148835518|NCT03801525|536879448|FG001|Overall Study|Death|1|||
148835519|NCT03801525|536879449|FG002|Overall Study|Death|4|||
148835520|NCT03801525|536879447|FG000|Overall Study|Disease Progression|6|||
148835521|NCT03801525|536879448|FG001|Overall Study|Disease Progression|0|||
148835522|NCT03801525|536879449|FG002|Overall Study|Disease Progression|1|||
148835523|NCT03801525|536879447|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
148835524|NCT03801525|536879448|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
148835525|NCT03801525|536879449|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
148835526|NCT03801525|536879447|FG000|Overall Study|Investigator Decision|18|||
148835527|NCT03801525|536879448|FG001|Overall Study|Investigator Decision|1|||
148835528|NCT03801525|536879449|FG002|Overall Study|Investigator Decision|0|||
148835529|NCT03801525|536879447|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
148835530|NCT03801525|536879448|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
148835531|NCT03801525|536879449|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
148835532|NCT03801525|536879447|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
148835533|NCT03801525|536879448|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
148835534|NCT03801525|536879449|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
148835535|NCT03801525|536879447|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
148835536|NCT03801525|536879448|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
148835537|NCT03801525|536879449|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
148835538|NCT03801525|536879447|FG000|Overall Study|Withdrawal of Subject Consent|38|||
148835539|NCT03801525|536879448|FG001|Overall Study|Withdrawal of Subject Consent|2|||
148835540|NCT03801525|536879449|FG002|Overall Study|Withdrawal of Subject Consent|1|||
148835541|NCT03801525|536879447|FG000|Overall Study|Reason not Specified|4|||
148835542|NCT03801525|536879448|FG001|Overall Study|Reason not Specified|0|||
148835543|NCT03801525|536879449|FG002|Overall Study|Reason not Specified|4|||
148835544|NCT03545672|536879452|FG000|Overall Study|Uncertain diagnosis|2|||
148835545|NCT03545672|536879453|FG001|Overall Study|Uncertain diagnosis|1|||
148835546|NCT03545672|536879452|FG000|Overall Study|Protocol Violation|2|||
148835547|NCT03545672|536879453|FG001|Overall Study|Protocol Violation|2|||
148835548|NCT01628913|536879454|FG000|Overall Study|Adverse Event|12|||
148835549|NCT01628913|536879455|FG001|Overall Study|Adverse Event|5|||
148835550|NCT01628913|536879454|FG000|Overall Study|Disease Progression|11|||
148835551|NCT01628913|536879455|FG001|Overall Study|Disease Progression|14|||
148835552|NCT01628913|536879454|FG000|Overall Study|Protocol Violation|1|||
148835553|NCT01628913|536879455|FG001|Overall Study|Protocol Violation|0|||
148835554|NCT01628913|536879454|FG000|Overall Study|Death|1|||
148835555|NCT01628913|536879455|FG001|Overall Study|Death|0|||
148835556|NCT01628913|536879454|FG000|Overall Study|study terminated by Sponsor|4|||
148835557|NCT01628913|536879455|FG001|Overall Study|study terminated by Sponsor|9|||
148835558|NCT01628913|536879454|FG000|Overall Study|Withdrawal by Subject|1|||
148835559|NCT01628913|536879455|FG001|Overall Study|Withdrawal by Subject|0|||
148835560|NCT01628913|536879454|FG000|Overall Study|Physician Decision|1|||
148835561|NCT01628913|536879455|FG001|Overall Study|Physician Decision|3|||
148835562|NCT00742625|536879460|FG000|Remission Induction|Progression|6|||
148835563|NCT00742625|536879460|FG000|Remission Induction|Failed induction|8|||
148835564|NCT00742625|536879460|FG000|Remission Induction|Adverse Event|3|||
148835565|NCT00742625|536879460|FG000|Remission Induction|Death|10|||
148835566|NCT00742625|536879460|FG000|Remission Induction|Refusal|5|||
148835567|NCT00742625|536879460|FG000|Remission Induction|Non protocol treatment|17|||
148835568|NCT00742625|536879460|FG000|Remission Induction|Other, not specified|5|||
148835569|NCT00742625|536879460|FG000|Consolidation|Progression|5|||
148835570|NCT00742625|536879460|FG000|Consolidation|Adverse Event|1|||
148835571|NCT00742625|536879460|FG000|Consolidation|Death|1|||
148835572|NCT00742625|536879460|FG000|Consolidation|Refused|1|||
148835573|NCT00742625|536879460|FG000|Consolidation|Non protocol therapy|13|||
148835574|NCT02519842|536879461|FG000|Base Study: Cycle 1|Screening Failure|1|||
148835575|NCT02519842|536879462|FG001|Base Study: Cycle 1|Screening Failure|1|||
148835576|NCT02519842|536879463|FG002|Base Study: Cycle 1|Screening Failure|0|||
148835577|NCT02519842|536879461|FG000|Base Study: Cycle 1|Adverse Event|1|||
148835578|NCT02519842|536879462|FG001|Base Study: Cycle 1|Adverse Event|0|||
148835579|NCT02519842|536879463|FG002|Base Study: Cycle 1|Adverse Event|0|||
148835580|NCT02519842|536879461|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
148835581|NCT02519842|536879462|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
148835582|NCT02519842|536879463|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
148835583|NCT02519842|536879461|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
148835584|NCT02519842|536879462|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
148835585|NCT02519842|536879463|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
148835586|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
148835587|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
148835588|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
148835589|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
148835590|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
148835591|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
148835592|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148835593|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
148835594|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
148835595|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
148835596|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
148835597|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
148835598|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Death|0|||
148835599|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Death|0|||
148835600|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Death|1|||
148835601|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
148835602|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
148835603|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
148835604|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
148835605|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
149028604|NCT00941031|537581984|FG001|Maintenance Period|Administrative Problems|0|||
149028605|NCT00941031|537581985|FG002|Maintenance Period|Administrative Problems|0|||
149028606|NCT00941031|537581986|FG003|Maintenance Period|Administrative Problems|0|||
149028607|NCT00941031|537581987|FG004|Maintenance Period|Administrative Problems|1|||
148835606|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
148835607|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
148835608|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
148835609|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
148835610|NCT02519842|536879461|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
148835611|NCT02519842|536879462|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
148835612|NCT02519842|536879463|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
148835613|NCT01612676|536879467|FG000|Overall Study|Adverse Event|2|||
148835614|NCT01612676|536879468|FG001|Overall Study|Adverse Event|3|||
148835615|NCT01612676|536879469|FG002|Overall Study|Adverse Event|1|||
148835616|NCT01612676|536879470|FG003|Overall Study|Adverse Event|3|||
148835617|NCT01612676|536879467|FG000|Overall Study|Protocol Violation|0|||
148835618|NCT01612676|536879468|FG001|Overall Study|Protocol Violation|1|||
148835619|NCT01612676|536879469|FG002|Overall Study|Protocol Violation|0|||
148981814|NCT00673049|537413199|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
148981815|NCT00673049|537413196|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
148981816|NCT00673049|537413197|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
148981817|NCT00673049|537413198|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
148981818|NCT00673049|537413199|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
148981819|NCT00673049|537413196|FG000|After Progression on Erlotinib|Death|0|||
148981820|NCT00673049|537413197|FG001|After Progression on Erlotinib|Death|0|||
148981821|NCT00673049|537413198|FG002|After Progression on Erlotinib|Death|0|||
148981822|NCT00673049|537413199|FG003|After Progression on Erlotinib|Death|71|||
148981823|NCT00673049|537413196|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
148981824|NCT00673049|537413197|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
148981825|NCT00673049|537413198|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
148981826|NCT00673049|537413199|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
148981827|NCT00673049|537413196|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
148981828|NCT00673049|537413197|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
148981829|NCT00673049|537413198|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
148981830|NCT00673049|537413199|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
148981831|NCT00673049|537413196|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
148981832|NCT00673049|537413197|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
148981833|NCT00673049|537413198|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
148981834|NCT00673049|537413199|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
148981835|NCT02621606|537413200|FG000|Overall Study|Withdrawal by Subject|0|||
148981836|NCT02621606|537413201|FG001|Overall Study|Withdrawal by Subject|1|||
148981837|NCT02621606|537413202|FG002|Overall Study|Withdrawal by Subject|0|||
148981838|NCT02044510|537413203|FG000|Overall Study|Adverse Event|1|||
148981839|NCT02044510|537413204|FG001|Overall Study|Adverse Event|2|||
148981840|NCT01175824|537413205|FG000|Overall Study|Adverse Event|2|||
148981841|NCT01175824|537413206|FG001|Overall Study|Adverse Event|1|||
148981842|NCT01175824|537413205|FG000|Overall Study|Lack of Efficacy|2|||
148981843|NCT01175824|537413206|FG001|Overall Study|Lack of Efficacy|0|||
148981844|NCT01175824|537413205|FG000|Overall Study|Lost to Follow-up|0|||
148981845|NCT01175824|537413206|FG001|Overall Study|Lost to Follow-up|1|||
148981846|NCT01175824|537413205|FG000|Overall Study|Physician Decision|0|||
148981847|NCT01175824|537413206|FG001|Overall Study|Physician Decision|4|||
148981848|NCT01175824|537413205|FG000|Overall Study|Protocol Violation|2|||
148981849|NCT01175824|537413206|FG001|Overall Study|Protocol Violation|5|||
148981850|NCT01175824|537413205|FG000|Overall Study|Withdrawal by Subject|3|||
148981851|NCT01175824|537413206|FG001|Overall Study|Withdrawal by Subject|7|||
148981852|NCT01175824|537413205|FG000|Overall Study|Sponsor Decision|1|||
148981853|NCT01175824|537413206|FG001|Overall Study|Sponsor Decision|0|||
148981854|NCT01175824|537413205|FG000|Overall Study|Entry Criteria Not Met|6|||
148981855|NCT01175824|537413206|FG001|Overall Study|Entry Criteria Not Met|4|||
148981856|NCT03455855|537413207|FG000|Overall Study|Lost to Follow-up|4|||
148981857|NCT03455855|537413208|FG001|Overall Study|Lost to Follow-up|2|||
148981858|NCT02979535|537413209|FG000|Overall Study|Non compliance with the protocol|78|||
148981859|NCT02979535|537413210|FG001|Overall Study|Non compliance with the protocol|82|||
148981860|NCT02979535|537413209|FG000|Overall Study|Consent withdrawn by participant|11|||
148981861|NCT02979535|537413210|FG001|Overall Study|Consent withdrawn by participant|18|||
148981862|NCT02979535|537413209|FG000|Overall Study|Lost to Follow-up|6|||
148981863|NCT02979535|537413210|FG001|Overall Study|Lost to Follow-up|1|||
148981864|NCT04820673|537413214|FG000|Overall Study|Adverse Event|6|||
148981865|NCT04820673|537413214|FG000|Overall Study|Due to Lack of Effectiveness|1|||
148981866|NCT04820673|537413214|FG000|Overall Study|Pregnancy|1|||
148981867|NCT04820673|537413214|FG000|Overall Study|Voluntary Withdrawal|20|||
148981868|NCT04820673|537413214|FG000|Overall Study|Lost to Follow-up|10|||
148981869|NCT00587587|537413215|FG000|Overall Study|Lost to Follow-up|6|||
148981870|NCT00587587|537413216|FG001|Overall Study|Lost to Follow-up|1|||
148981871|NCT01933334|537413225|FG000|Overall Study|Adverse Event|5|||
148981872|NCT01933334|537413226|FG001|Overall Study|Adverse Event|1|||
148981873|NCT01933334|537413225|FG000|Overall Study|Withdrawal by Subject|0|||
148981874|NCT01933334|537413226|FG001|Overall Study|Withdrawal by Subject|1|||
148981875|NCT00767000|537413227|FG000|54-week Study|Adverse Event|4|||
148981876|NCT00767000|537413228|FG001|54-week Study|Adverse Event|6|||
148981877|NCT00767000|537413229|FG002|54-week Study|Adverse Event|6|||
148981878|NCT00767000|537413230|FG003|54-week Study|Adverse Event|8|||
148981879|NCT00767000|537413231|FG004|54-week Study|Adverse Event|4|||
148981880|NCT00767000|537413227|FG000|54-week Study|Creaninine/creatinine clearance|2|||
148981881|NCT00767000|537413228|FG001|54-week Study|Creaninine/creatinine clearance|1|||
148981882|NCT00767000|537413229|FG002|54-week Study|Creaninine/creatinine clearance|2|||
148981883|NCT00767000|537413230|FG003|54-week Study|Creaninine/creatinine clearance|2|||
148981884|NCT00767000|537413231|FG004|54-week Study|Creaninine/creatinine clearance|4|||
148981885|NCT00767000|537413227|FG000|54-week Study|Hyperglycemia|0|||
148981886|NCT00767000|537413228|FG001|54-week Study|Hyperglycemia|0|||
148981887|NCT00767000|537413229|FG002|54-week Study|Hyperglycemia|1|||
148835620|NCT01612676|536879470|FG003|Overall Study|Protocol Violation|0|||
148835621|NCT05200845|536879474|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
148835622|NCT05200845|536879475|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
148835623|NCT05200845|536879476|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
148835624|NCT05200845|536879477|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
148835625|NCT05200845|536879474|FG000|Overall Study|Withdrawal by Subject|0|||
148835626|NCT05200845|536879475|FG001|Overall Study|Withdrawal by Subject|1|||
148835627|NCT05200845|536879476|FG002|Overall Study|Withdrawal by Subject|1|||
148835628|NCT05200845|536879477|FG003|Overall Study|Withdrawal by Subject|0|||
148981888|NCT00767000|537413230|FG003|54-week Study|Hyperglycemia|0|||
148981889|NCT00767000|537413231|FG004|54-week Study|Hyperglycemia|1|||
148981890|NCT00767000|537413227|FG000|54-week Study|Hypoglycemia|0|||
148981891|NCT00767000|537413228|FG001|54-week Study|Hypoglycemia|1|||
148981892|NCT00767000|537413229|FG002|54-week Study|Hypoglycemia|0|||
148981893|NCT00767000|537413230|FG003|54-week Study|Hypoglycemia|0|||
148981894|NCT00767000|537413231|FG004|54-week Study|Hypoglycemia|0|||
148981895|NCT00767000|537413227|FG000|54-week Study|Interruption of study medication|0|||
148981896|NCT00767000|537413228|FG001|54-week Study|Interruption of study medication|0|||
148981897|NCT00767000|537413229|FG002|54-week Study|Interruption of study medication|1|||
148981898|NCT00767000|537413230|FG003|54-week Study|Interruption of study medication|0|||
148981899|NCT00767000|537413231|FG004|54-week Study|Interruption of study medication|0|||
148981900|NCT00767000|537413227|FG000|54-week Study|Lack of Efficacy|2|||
148981901|NCT00767000|537413228|FG001|54-week Study|Lack of Efficacy|0|||
148981902|NCT00767000|537413229|FG002|54-week Study|Lack of Efficacy|1|||
148981903|NCT00767000|537413230|FG003|54-week Study|Lack of Efficacy|0|||
148981904|NCT00767000|537413231|FG004|54-week Study|Lack of Efficacy|5|||
148981905|NCT00767000|537413227|FG000|54-week Study|Lost to Follow-up|4|||
148981906|NCT00767000|537413228|FG001|54-week Study|Lost to Follow-up|0|||
148981907|NCT00767000|537413229|FG002|54-week Study|Lost to Follow-up|1|||
148981908|NCT00767000|537413230|FG003|54-week Study|Lost to Follow-up|4|||
148981909|NCT00767000|537413231|FG004|54-week Study|Lost to Follow-up|2|||
148981910|NCT00767000|537413227|FG000|54-week Study|Physician Decision|4|||
148981911|NCT00767000|537413228|FG001|54-week Study|Physician Decision|0|||
148981912|NCT00767000|537413229|FG002|54-week Study|Physician Decision|1|||
148774040|NCT02017717|536646911|FG007|Before Treatment Period|Participant no longer met criteria|1|||
148774041|NCT02017717|536646912|FG008|Before Treatment Period|Participant no longer met criteria|2|||
148774042|NCT02017717|536646904|FG000|Before Treatment Period|other reason|0|||
148774043|NCT02017717|536646905|FG001|Before Treatment Period|other reason|0|||
148774044|NCT02017717|536646906|FG002|Before Treatment Period|other reason|0|||
148774045|NCT02017717|536646907|FG003|Before Treatment Period|other reason|0|||
148774046|NCT02017717|536646908|FG004|Before Treatment Period|other reason|0|||
148774047|NCT02017717|536646909|FG005|Before Treatment Period|other reason|0|||
148774048|NCT02017717|536646910|FG006|Before Treatment Period|other reason|0|||
148774049|NCT02017717|536646911|FG007|Before Treatment Period|other reason|0|||
148774050|NCT02017717|536646912|FG008|Before Treatment Period|other reason|1|||
148774051|NCT02017717|536646904|FG000|Treatment Period|Disease progression|7|||
148774052|NCT02017717|536646905|FG001|Treatment Period|Disease progression|9|||
148774053|NCT02017717|536646906|FG002|Treatment Period|Disease progression|12|||
148774054|NCT02017717|536646907|FG003|Treatment Period|Disease progression|20|||
148774055|NCT02017717|536646908|FG004|Treatment Period|Disease progression|26|||
148774056|NCT02017717|536646909|FG005|Treatment Period|Disease progression|16|||
148774057|NCT02017717|536646910|FG006|Treatment Period|Disease progression|22|||
148774058|NCT02017717|536646911|FG007|Treatment Period|Disease progression|165|||
148774059|NCT02017717|536646912|FG008|Treatment Period|Disease progression|135|||
148774060|NCT02017717|536646904|FG000|Treatment Period|Study drug toxicity|3|||
148774061|NCT02017717|536646905|FG001|Treatment Period|Study drug toxicity|0|||
148774062|NCT02017717|536646906|FG002|Treatment Period|Study drug toxicity|1|||
148774063|NCT02017717|536646907|FG003|Treatment Period|Study drug toxicity|4|||
148774064|NCT02017717|536646908|FG004|Treatment Period|Study drug toxicity|4|||
148774065|NCT02017717|536646909|FG005|Treatment Period|Study drug toxicity|5|||
148774066|NCT02017717|536646910|FG006|Treatment Period|Study drug toxicity|3|||
148774067|NCT02017717|536646911|FG007|Treatment Period|Study drug toxicity|7|||
148774068|NCT02017717|536646912|FG008|Treatment Period|Study drug toxicity|11|||
148774069|NCT02017717|536646904|FG000|Treatment Period|Death|0|||
148774070|NCT02017717|536646905|FG001|Treatment Period|Death|0|||
148774071|NCT02017717|536646906|FG002|Treatment Period|Death|1|||
148774072|NCT02017717|536646907|FG003|Treatment Period|Death|0|||
148774073|NCT02017717|536646908|FG004|Treatment Period|Death|0|||
148774074|NCT02017717|536646909|FG005|Treatment Period|Death|2|||
148774075|NCT02017717|536646910|FG006|Treatment Period|Death|0|||
148774076|NCT02017717|536646911|FG007|Treatment Period|Death|0|||
148774077|NCT02017717|536646912|FG008|Treatment Period|Death|0|||
148835629|NCT02412670|536879478|FG000|Overall Study|Adverse Event|4|||
148835630|NCT02412670|536879479|FG001|Overall Study|Adverse Event|1|||
148835631|NCT02412670|536879478|FG000|Overall Study|Physician Decision|1|||
148835632|NCT02412670|536879479|FG001|Overall Study|Physician Decision|0|||
149028608|NCT00941031|537581988|FG005|Maintenance Period|Administrative Problems|0|||
149028609|NCT00941031|537581989|FG006|Maintenance Period|Administrative Problems|1|||
149028610|NCT00941031|537581983|FG000|Maintenance Period|Protocol Violation|0|||
149028611|NCT00941031|537581984|FG001|Maintenance Period|Protocol Violation|0|||
149028612|NCT00941031|537581985|FG002|Maintenance Period|Protocol Violation|0|||
149028613|NCT00941031|537581986|FG003|Maintenance Period|Protocol Violation|0|||
149028614|NCT00941031|537581987|FG004|Maintenance Period|Protocol Violation|0|||
149028615|NCT00941031|537581988|FG005|Maintenance Period|Protocol Violation|0|||
149028616|NCT00941031|537581989|FG006|Maintenance Period|Protocol Violation|1|||
149028617|NCT00941031|537581983|FG000|Maintenance Period|Adverse Event|0|||
149028618|NCT00941031|537581984|FG001|Maintenance Period|Adverse Event|0|||
149028619|NCT00941031|537581985|FG002|Maintenance Period|Adverse Event|0|||
149028620|NCT00941031|537581986|FG003|Maintenance Period|Adverse Event|0|||
148981913|NCT00767000|537413230|FG003|54-week Study|Physician Decision|1|||
148981914|NCT00767000|537413231|FG004|54-week Study|Physician Decision|1|||
148981915|NCT00767000|537413227|FG000|54-week Study|Progressive disease|0|||
148981916|NCT00767000|537413228|FG001|54-week Study|Progressive disease|0|||
148981917|NCT00767000|537413229|FG002|54-week Study|Progressive disease|1|||
148981918|NCT00767000|537413230|FG003|54-week Study|Progressive disease|0|||
148981919|NCT00767000|537413231|FG004|54-week Study|Progressive disease|0|||
148981920|NCT00767000|537413227|FG000|54-week Study|Protocol Violation|0|||
148981921|NCT00767000|537413228|FG001|54-week Study|Protocol Violation|0|||
148981922|NCT00767000|537413229|FG002|54-week Study|Protocol Violation|1|||
148981923|NCT00767000|537413230|FG003|54-week Study|Protocol Violation|2|||
148981924|NCT00767000|537413231|FG004|54-week Study|Protocol Violation|0|||
148981925|NCT00767000|537413227|FG000|54-week Study|Withdrawal by Subject|2|||
148981926|NCT00767000|537413228|FG001|54-week Study|Withdrawal by Subject|3|||
148981927|NCT00767000|537413229|FG002|54-week Study|Withdrawal by Subject|5|||
148981928|NCT00767000|537413230|FG003|54-week Study|Withdrawal by Subject|11|||
148981929|NCT00767000|537413231|FG004|54-week Study|Withdrawal by Subject|13|||
148981930|NCT00767000|537413227|FG000|54-week Study|Study terminated by sponsor|90|||
148981931|NCT00767000|537413228|FG001|54-week Study|Study terminated by sponsor|102|||
148981932|NCT00767000|537413229|FG002|54-week Study|Study terminated by sponsor|89|||
148981933|NCT00767000|537413230|FG003|54-week Study|Study terminated by sponsor|196|||
148981934|NCT00767000|537413231|FG004|54-week Study|Study terminated by sponsor|194|||
148981935|NCT00767000|537413227|FG000|54-week Study|Reason not reported|0|||
148981936|NCT00767000|537413228|FG001|54-week Study|Reason not reported|0|||
148981937|NCT00767000|537413229|FG002|54-week Study|Reason not reported|0|||
148981938|NCT00767000|537413230|FG003|54-week Study|Reason not reported|1|||
148981939|NCT00767000|537413231|FG004|54-week Study|Reason not reported|0|||
148981940|NCT00767000|537413227|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
148981941|NCT00767000|537413228|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
148981942|NCT00767000|537413229|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
148981943|NCT00767000|537413230|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
148981944|NCT00767000|537413231|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
148981945|NCT02039505|537413233|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
148981946|NCT02039505|537413234|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
148981947|NCT02039505|537413235|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
148981948|NCT02039505|537413236|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
148981949|NCT02039505|537413237|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
148981950|NCT02039505|537413238|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
148981951|NCT02039505|537413239|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
148981952|NCT02039505|537413233|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
148981953|NCT02039505|537413234|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
148981954|NCT02039505|537413235|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
148981955|NCT02039505|537413236|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
148981956|NCT02039505|537413237|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
149028621|NCT00941031|537581987|FG004|Maintenance Period|Adverse Event|0|||
149028622|NCT00941031|537581988|FG005|Maintenance Period|Adverse Event|2|||
149028623|NCT00941031|537581989|FG006|Maintenance Period|Adverse Event|8|||
148774078|NCT02017717|536646904|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
148774079|NCT02017717|536646905|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
148774080|NCT02017717|536646906|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
148774081|NCT02017717|536646907|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
149028624|NCT00941031|537581983|FG000|Maintenance Period|Lost to Follow-up|0|||
149028625|NCT00941031|537581984|FG001|Maintenance Period|Lost to Follow-up|0|||
148774082|NCT02017717|536646908|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
148774083|NCT02017717|536646909|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
148981957|NCT02039505|537413238|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
148981958|NCT02039505|537413239|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
148981959|NCT02039505|537413233|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
149028626|NCT00941031|537581985|FG002|Maintenance Period|Lost to Follow-up|0|||
148835633|NCT02412670|536879478|FG000|Overall Study|Withdrawal by Subject|1|||
148835634|NCT02412670|536879479|FG001|Overall Study|Withdrawal by Subject|0|||
148835635|NCT02412670|536879478|FG000|Overall Study|Ineligible|1|||
148835636|NCT02412670|536879479|FG001|Overall Study|Ineligible|0|||
148835637|NCT00565409|536879482|FG000|Period 1 Open Label|Adverse Event|17|||
148835638|NCT00565409|536879483|FG001|Period 1 Open Label|Adverse Event|0|||
148835639|NCT00565409|536879484|FG002|Period 1 Open Label|Adverse Event|0|||
148835640|NCT00565409|536879485|FG003|Period 1 Open Label|Adverse Event|0|||
148835641|NCT00565409|536879482|FG000|Period 1 Open Label|Death|2|||
148835642|NCT00565409|536879483|FG001|Period 1 Open Label|Death|0|||
148835643|NCT00565409|536879484|FG002|Period 1 Open Label|Death|0|||
148835644|NCT00565409|536879485|FG003|Period 1 Open Label|Death|0|||
148835645|NCT00565409|536879482|FG000|Period 1 Open Label|Lost to Follow-up|1|||
148835646|NCT00565409|536879483|FG001|Period 1 Open Label|Lost to Follow-up|0|||
148835647|NCT00565409|536879484|FG002|Period 1 Open Label|Lost to Follow-up|0|||
148835648|NCT00565409|536879485|FG003|Period 1 Open Label|Lost to Follow-up|0|||
148835649|NCT00565409|536879482|FG000|Period 1 Open Label|Other|21|||
148835650|NCT00565409|536879483|FG001|Period 1 Open Label|Other|0|||
148835651|NCT00565409|536879484|FG002|Period 1 Open Label|Other|0|||
148835652|NCT00565409|536879485|FG003|Period 1 Open Label|Other|0|||
148835653|NCT00565409|536879482|FG000|Period 1 Open Label|Protocol Violation|14|||
148835654|NCT00565409|536879483|FG001|Period 1 Open Label|Protocol Violation|0|||
148835655|NCT00565409|536879484|FG002|Period 1 Open Label|Protocol Violation|0|||
148835656|NCT00565409|536879485|FG003|Period 1 Open Label|Protocol Violation|0|||
148835657|NCT00565409|536879482|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
148835658|NCT00565409|536879483|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
148835659|NCT00565409|536879484|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
148835660|NCT00565409|536879485|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
148835661|NCT00565409|536879482|FG000|Period 1 Open Label|no conclusion of participation record|1|||
148835662|NCT00565409|536879483|FG001|Period 1 Open Label|no conclusion of participation record|0|||
148835663|NCT00565409|536879484|FG002|Period 1 Open Label|no conclusion of participation record|0|||
148835664|NCT00565409|536879485|FG003|Period 1 Open Label|no conclusion of participation record|0|||
148835665|NCT00565409|536879482|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
148835666|NCT00565409|536879483|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
148835667|NCT00565409|536879484|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
148835668|NCT00565409|536879485|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
148835669|NCT00565409|536879482|FG000|Period 2 Double-Blind|Adverse Event|0|||
148835670|NCT00565409|536879483|FG001|Period 2 Double-Blind|Adverse Event|7|||
148835671|NCT00565409|536879484|FG002|Period 2 Double-Blind|Adverse Event|4|||
148835672|NCT00565409|536879485|FG003|Period 2 Double-Blind|Adverse Event|5|||
148835673|NCT00565409|536879482|FG000|Period 2 Double-Blind|Death|0|||
148774084|NCT02017717|536646910|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
148774085|NCT02017717|536646911|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
148774086|NCT02017717|536646912|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
148774087|NCT02017717|536646904|FG000|Treatment Period|Participant request to stop therapy|0|||
148774088|NCT02017717|536646905|FG001|Treatment Period|Participant request to stop therapy|0|||
148774089|NCT02017717|536646906|FG002|Treatment Period|Participant request to stop therapy|3|||
148774090|NCT02017717|536646907|FG003|Treatment Period|Participant request to stop therapy|6|||
148774091|NCT02017717|536646908|FG004|Treatment Period|Participant request to stop therapy|0|||
148774092|NCT02017717|536646909|FG005|Treatment Period|Participant request to stop therapy|2|||
148774093|NCT02017717|536646910|FG006|Treatment Period|Participant request to stop therapy|1|||
148774094|NCT02017717|536646911|FG007|Treatment Period|Participant request to stop therapy|4|||
148774095|NCT02017717|536646912|FG008|Treatment Period|Participant request to stop therapy|7|||
148774096|NCT02017717|536646904|FG000|Treatment Period|Participant withdrew consent|0|||
148774097|NCT02017717|536646905|FG001|Treatment Period|Participant withdrew consent|0|||
148774098|NCT02017717|536646906|FG002|Treatment Period|Participant withdrew consent|1|||
148774099|NCT02017717|536646907|FG003|Treatment Period|Participant withdrew consent|0|||
148774100|NCT02017717|536646908|FG004|Treatment Period|Participant withdrew consent|0|||
148774101|NCT02017717|536646909|FG005|Treatment Period|Participant withdrew consent|2|||
148774102|NCT02017717|536646910|FG006|Treatment Period|Participant withdrew consent|0|||
148774103|NCT02017717|536646911|FG007|Treatment Period|Participant withdrew consent|1|||
148774104|NCT02017717|536646912|FG008|Treatment Period|Participant withdrew consent|4|||
148774105|NCT02017717|536646904|FG000|Treatment Period|Participant no longer met criteria|0|||
148774106|NCT02017717|536646905|FG001|Treatment Period|Participant no longer met criteria|0|||
148774107|NCT02017717|536646906|FG002|Treatment Period|Participant no longer met criteria|0|||
148774108|NCT02017717|536646907|FG003|Treatment Period|Participant no longer met criteria|0|||
148774109|NCT02017717|536646908|FG004|Treatment Period|Participant no longer met criteria|0|||
148774110|NCT02017717|536646909|FG005|Treatment Period|Participant no longer met criteria|0|||
148774111|NCT02017717|536646910|FG006|Treatment Period|Participant no longer met criteria|0|||
148774112|NCT02017717|536646911|FG007|Treatment Period|Participant no longer met criteria|0|||
148835674|NCT00565409|536879483|FG001|Period 2 Double-Blind|Death|2|||
148835675|NCT00565409|536879484|FG002|Period 2 Double-Blind|Death|0|||
148835676|NCT00565409|536879485|FG003|Period 2 Double-Blind|Death|0|||
148835677|NCT00565409|536879482|FG000|Period 2 Double-Blind|Protocol Violation|0|||
148835678|NCT00565409|536879483|FG001|Period 2 Double-Blind|Protocol Violation|4|||
148835679|NCT00565409|536879484|FG002|Period 2 Double-Blind|Protocol Violation|6|||
148835680|NCT00565409|536879485|FG003|Period 2 Double-Blind|Protocol Violation|2|||
148835681|NCT00565409|536879482|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
148835682|NCT00565409|536879483|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
148835683|NCT00565409|536879484|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
148835684|NCT00565409|536879485|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
148835685|NCT00565409|536879482|FG000|Period 2 Double-Blind|Other|0|||
148835686|NCT00565409|536879483|FG001|Period 2 Double-Blind|Other|4|||
148835687|NCT00565409|536879484|FG002|Period 2 Double-Blind|Other|5|||
148835688|NCT00565409|536879485|FG003|Period 2 Double-Blind|Other|9|||
148835689|NCT00565409|536879482|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
148835690|NCT00565409|536879483|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
148835691|NCT00565409|536879484|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
148835692|NCT00565409|536879485|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
148835693|NCT04064905|536879486|FG000|Overall Study|Lost to Follow-up|0|||
148835694|NCT04064905|536879487|FG001|Overall Study|Lost to Follow-up|3|||
148835695|NCT04064905|536879488|FG002|Overall Study|Lost to Follow-up|1|||
148835696|NCT04064905|536879489|FG003|Overall Study|Lost to Follow-up|4|||
148835697|NCT04064905|536879490|FG004|Overall Study|Lost to Follow-up|2|||
148835698|NCT01448616|536879491|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
148835699|NCT01448616|536879492|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
148835700|NCT01448616|536879493|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
148835701|NCT01448616|536879494|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
148835702|NCT01448616|536879491|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
148835703|NCT01448616|536879492|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
148835704|NCT01448616|536879493|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
148835705|NCT01448616|536879494|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
148835706|NCT01448616|536879491|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
148835707|NCT01448616|536879492|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
148835708|NCT01448616|536879493|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
148835709|NCT01448616|536879494|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
148835710|NCT01448616|536879491|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
148835711|NCT01448616|536879492|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
148835712|NCT01448616|536879493|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
148835713|NCT01448616|536879494|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
148835714|NCT01448616|536879491|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
148835715|NCT01448616|536879492|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
148835716|NCT01448616|536879493|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
148835717|NCT01448616|536879494|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
148835718|NCT00431964|536879495|FG000|Overall Study|Adverse Event|1|||
148835719|NCT00431964|536879496|FG001|Overall Study|Adverse Event|0|||
148835720|NCT00431964|536879495|FG000|Overall Study|Lost to Follow-up|1|||
148835721|NCT00431964|536879496|FG001|Overall Study|Lost to Follow-up|2|||
148835722|NCT00431964|536879495|FG000|Overall Study|Physician Decision|2|||
148835723|NCT00431964|536879496|FG001|Overall Study|Physician Decision|2|||
148835724|NCT00431964|536879495|FG000|Overall Study|Withdrawal by Subject|2|||
148835725|NCT00431964|536879496|FG001|Overall Study|Withdrawal by Subject|1|||
148835726|NCT00431964|536879495|FG000|Overall Study|Parental Consent Withdrawn|0|||
148835727|NCT00431964|536879496|FG001|Overall Study|Parental Consent Withdrawn|2|||
148835728|NCT00431964|536879495|FG000|Overall Study|Due to Unstable Health|0|||
148835729|NCT00431964|536879496|FG001|Overall Study|Due to Unstable Health|1|||
148835730|NCT02170064|536879497|FG000|Overall Study|Withdrawal by Subject|5|||
148835731|NCT02170064|536879498|FG001|Overall Study|Withdrawal by Subject|1|||
148835732|NCT02170064|536879499|FG002|Overall Study|Withdrawal by Subject|1|||
148835733|NCT02170064|536879497|FG000|Overall Study|Physician Decision|1|||
148835734|NCT02170064|536879498|FG001|Overall Study|Physician Decision|1|||
148835735|NCT02170064|536879499|FG002|Overall Study|Physician Decision|0|||
148835736|NCT04211363|536879500|FG000|Overall Study|Adverse Event|5|||
148835737|NCT04211363|536879501|FG001|Overall Study|Adverse Event|2|||
148835738|NCT04211363|536879500|FG000|Overall Study|Physician Decision|0|||
148835739|NCT04211363|536879501|FG001|Overall Study|Physician Decision|1|||
148835740|NCT04211363|536879500|FG000|Overall Study|Protocol Violation|1|||
148835741|NCT04211363|536879501|FG001|Overall Study|Protocol Violation|0|||
148835742|NCT04211363|536879500|FG000|Overall Study|Pregnancy|1|||
148835743|NCT04211363|536879501|FG001|Overall Study|Pregnancy|0|||
148835744|NCT04211363|536879500|FG000|Overall Study|Lost to Follow-up|12|||
148835745|NCT04211363|536879501|FG001|Overall Study|Lost to Follow-up|4|||
148835746|NCT04211363|536879500|FG000|Overall Study|Withdrawal by Subject|11|||
148835747|NCT04211363|536879501|FG001|Overall Study|Withdrawal by Subject|11|||
148835748|NCT04211363|536879500|FG000|Overall Study|Other|1|||
148835749|NCT04211363|536879501|FG001|Overall Study|Other|2|||
148835750|NCT03961308|536879502|FG000|Overall Study|Withdrawal by Subject|1|||
148835751|NCT03961308|536879503|FG001|Overall Study|Withdrawal by Subject|0|||
148835752|NCT03961308|536879502|FG000|Overall Study|Other|1|||
148835753|NCT03961308|536879503|FG001|Overall Study|Other|0|||
148835754|NCT03961308|536879502|FG000|Overall Study|Lost to Follow-up|0|||
148835755|NCT03961308|536879503|FG001|Overall Study|Lost to Follow-up|1|||
148835756|NCT03961308|536879502|FG000|Overall Study|Adverse Event|0|||
148835757|NCT03961308|536879503|FG001|Overall Study|Adverse Event|1|||
148835758|NCT00659425|536879506|FG000|Overall Study|Disease progression|1|||
148835759|NCT00659425|536879507|FG001|Overall Study|Disease progression|0|||
148835760|NCT00659425|536879508|FG002|Overall Study|Disease progression|0|||
148835761|NCT00659425|536879509|FG003|Overall Study|Disease progression|1|||
148835762|NCT00659425|536879510|FG004|Overall Study|Disease progression|0|||
148835763|NCT00659425|536879511|FG005|Overall Study|Disease progression|2|||
148835764|NCT00659425|536879512|FG006|Overall Study|Disease progression|4|||
148835765|NCT00659425|536879513|FG007|Overall Study|Disease progression|3|||
148835766|NCT00659425|536879514|FG008|Overall Study|Disease progression|5|||
148835767|NCT00659425|536879515|FG009|Overall Study|Disease progression|3|||
148835768|NCT00659425|536879506|FG000|Overall Study|Death|0|||
148835769|NCT00659425|536879507|FG001|Overall Study|Death|0|||
148835770|NCT00659425|536879508|FG002|Overall Study|Death|0|||
148835771|NCT00659425|536879509|FG003|Overall Study|Death|1|||
148835772|NCT00659425|536879510|FG004|Overall Study|Death|0|||
148835773|NCT00659425|536879511|FG005|Overall Study|Death|0|||
148835774|NCT00659425|536879512|FG006|Overall Study|Death|1|||
148835775|NCT00659425|536879513|FG007|Overall Study|Death|0|||
148835776|NCT00659425|536879514|FG008|Overall Study|Death|0|||
148835777|NCT00659425|536879515|FG009|Overall Study|Death|0|||
148835778|NCT00659425|536879506|FG000|Overall Study|Adverse Event|0|||
148835779|NCT00659425|536879507|FG001|Overall Study|Adverse Event|0|||
148835780|NCT00659425|536879508|FG002|Overall Study|Adverse Event|0|||
148835781|NCT00659425|536879509|FG003|Overall Study|Adverse Event|0|||
148835782|NCT00659425|536879510|FG004|Overall Study|Adverse Event|0|||
148835783|NCT00659425|536879511|FG005|Overall Study|Adverse Event|1|||
148835784|NCT00659425|536879512|FG006|Overall Study|Adverse Event|0|||
148835785|NCT00659425|536879513|FG007|Overall Study|Adverse Event|3|||
148835786|NCT00659425|536879514|FG008|Overall Study|Adverse Event|1|||
148835787|NCT00659425|536879515|FG009|Overall Study|Adverse Event|4|||
148835788|NCT00659425|536879506|FG000|Overall Study|Investigator Discretion|0|||
148835789|NCT00659425|536879507|FG001|Overall Study|Investigator Discretion|0|||
148835790|NCT00659425|536879508|FG002|Overall Study|Investigator Discretion|0|||
148835791|NCT00659425|536879509|FG003|Overall Study|Investigator Discretion|0|||
148835792|NCT00659425|536879510|FG004|Overall Study|Investigator Discretion|0|||
148835793|NCT00659425|536879511|FG005|Overall Study|Investigator Discretion|1|||
148835794|NCT00659425|536879512|FG006|Overall Study|Investigator Discretion|0|||
148835795|NCT00659425|536879513|FG007|Overall Study|Investigator Discretion|3|||
148835796|NCT00659425|536879514|FG008|Overall Study|Investigator Discretion|0|||
148835797|NCT00659425|536879515|FG009|Overall Study|Investigator Discretion|0|||
148835798|NCT00659425|536879506|FG000|Overall Study|Other|0|||
148835799|NCT00659425|536879507|FG001|Overall Study|Other|1|||
148835800|NCT00659425|536879508|FG002|Overall Study|Other|1|||
148835801|NCT00659425|536879509|FG003|Overall Study|Other|2|||
148835802|NCT00659425|536879510|FG004|Overall Study|Other|4|||
148835803|NCT00659425|536879511|FG005|Overall Study|Other|0|||
148835804|NCT00659425|536879512|FG006|Overall Study|Other|3|||
148835805|NCT00659425|536879513|FG007|Overall Study|Other|2|||
148835806|NCT00659425|536879514|FG008|Overall Study|Other|0|||
148835807|NCT00659425|536879515|FG009|Overall Study|Other|6|||
148835808|NCT03358030|536879516|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
148835809|NCT03358030|536879517|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
148835810|NCT03358030|536879518|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
148835811|NCT03358030|536879519|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
148835812|NCT03358030|536879516|FG000|Overall Study|Ineligibility|0|||
148835813|NCT03358030|536879517|FG001|Overall Study|Ineligibility|0|||
148835814|NCT03358030|536879518|FG002|Overall Study|Ineligibility|0|||
148835815|NCT03358030|536879519|FG003|Overall Study|Ineligibility|2|||
148835816|NCT03358030|536879516|FG000|Overall Study|Voluntary Withdrawal|1|||
148981960|NCT02039505|537413234|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
148835817|NCT03358030|536879517|FG001|Overall Study|Voluntary Withdrawal|1|||
148981961|NCT02039505|537413235|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
148981962|NCT02039505|537413236|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
148835818|NCT03358030|536879518|FG002|Overall Study|Voluntary Withdrawal|3|||
148835819|NCT03358030|536879519|FG003|Overall Study|Voluntary Withdrawal|1|||
148835820|NCT03358030|536879516|FG000|Overall Study|Other|0|||
148835821|NCT03358030|536879517|FG001|Overall Study|Other|0|||
148835822|NCT03358030|536879518|FG002|Overall Study|Other|1|||
148835823|NCT03358030|536879519|FG003|Overall Study|Other|0|||
148835824|NCT03342560|536879520|FG000|Overall Study|Lost to Follow-up|2|||
148835825|NCT02604511|536879521|FG000|Overall Study|Adverse Event|3|||
149028627|NCT00941031|537581986|FG003|Maintenance Period|Lost to Follow-up|0|||
149028628|NCT00941031|537581987|FG004|Maintenance Period|Lost to Follow-up|2|||
149028629|NCT00941031|537581988|FG005|Maintenance Period|Lost to Follow-up|2|||
149028630|NCT00941031|537581989|FG006|Maintenance Period|Lost to Follow-up|7|||
149028631|NCT00941031|537581983|FG000|Maintenance Period|Lack of Efficacy|0|||
149028632|NCT00941031|537581984|FG001|Maintenance Period|Lack of Efficacy|0|||
149028633|NCT00941031|537581985|FG002|Maintenance Period|Lack of Efficacy|0|||
149028634|NCT00941031|537581986|FG003|Maintenance Period|Lack of Efficacy|0|||
149028635|NCT00941031|537581987|FG004|Maintenance Period|Lack of Efficacy|0|||
149028636|NCT00941031|537581988|FG005|Maintenance Period|Lack of Efficacy|0|||
149028637|NCT00941031|537581989|FG006|Maintenance Period|Lack of Efficacy|13|||
149028638|NCT04555044|537581992|FG000|Overall Study|Adverse Event|0|||
149028639|NCT04555044|537581993|FG001|Overall Study|Adverse Event|1|||
149028640|NCT03885596|537581994|FG000|Overall Study|Withdrawal by Subject|2|||
149028641|NCT03885596|537581995|FG001|Overall Study|Withdrawal by Subject|1|||
148835826|NCT02604511|536879521|FG000|Overall Study|Disease Progression|4|||
149028642|NCT03885596|537581996|FG002|Overall Study|Withdrawal by Subject|0|||
149028643|NCT03885596|537581997|FG003|Overall Study|Withdrawal by Subject|0|||
149028644|NCT01835899|537581998|FG000|Overall Study|Adverse Event|0|||
149028645|NCT01835899|537581999|FG001|Overall Study|Adverse Event|0|||
149028646|NCT01835899|537582000|FG002|Overall Study|Adverse Event|1|||
149028647|NCT01835899|537581998|FG000|Overall Study|Other than stated above|0|||
149028648|NCT01835899|537581999|FG001|Overall Study|Other than stated above|1|||
149028649|NCT01835899|537582000|FG002|Overall Study|Other than stated above|0|||
149028650|NCT02939183|537582005|FG000|Overall Study|Death|0|||
149028651|NCT02939183|537582006|FG001|Overall Study|Death|0|||
149028652|NCT02939183|537582007|FG002|Overall Study|Death|1|||
149028653|NCT02939183|537582008|FG003|Overall Study|Death|0|||
149028654|NCT02939183|537582009|FG004|Overall Study|Death|0|||
149028655|NCT02939183|537582010|FG005|Overall Study|Death|2|||
149028656|NCT02939183|537582011|FG006|Overall Study|Death|1|||
149028657|NCT02939183|537582012|FG007|Overall Study|Death|0|||
149028658|NCT02939183|537582013|FG008|Overall Study|Death|0|||
149028659|NCT02939183|537582005|FG000|Overall Study|Sponsor decision|0|||
149028660|NCT02939183|537582006|FG001|Overall Study|Sponsor decision|1|||
149028661|NCT02939183|537582007|FG002|Overall Study|Sponsor decision|0|||
149028662|NCT02939183|537582008|FG003|Overall Study|Sponsor decision|1|||
149028663|NCT02939183|537582009|FG004|Overall Study|Sponsor decision|2|||
149028664|NCT02939183|537582010|FG005|Overall Study|Sponsor decision|0|||
149028665|NCT02939183|537582011|FG006|Overall Study|Sponsor decision|3|||
149028666|NCT02939183|537582012|FG007|Overall Study|Sponsor decision|1|||
149028667|NCT02939183|537582013|FG008|Overall Study|Sponsor decision|4|||
149028668|NCT02939183|537582005|FG000|Overall Study|Withdrawal by Subject|0|||
149028669|NCT02939183|537582006|FG001|Overall Study|Withdrawal by Subject|2|||
149028670|NCT02939183|537582007|FG002|Overall Study|Withdrawal by Subject|0|||
149028671|NCT02939183|537582008|FG003|Overall Study|Withdrawal by Subject|1|||
149028672|NCT02939183|537582009|FG004|Overall Study|Withdrawal by Subject|0|||
149028673|NCT02939183|537582010|FG005|Overall Study|Withdrawal by Subject|0|||
149028674|NCT02939183|537582011|FG006|Overall Study|Withdrawal by Subject|2|||
149028675|NCT02939183|537582012|FG007|Overall Study|Withdrawal by Subject|2|||
149028676|NCT02939183|537582013|FG008|Overall Study|Withdrawal by Subject|2|||
149028677|NCT02939183|537582005|FG000|Overall Study|Not treated due to adverse event|0|||
149028678|NCT02939183|537582006|FG001|Overall Study|Not treated due to adverse event|0|||
149028679|NCT02939183|537582007|FG002|Overall Study|Not treated due to adverse event|0|||
149028680|NCT02939183|537582008|FG003|Overall Study|Not treated due to adverse event|1|||
149028681|NCT02939183|537582009|FG004|Overall Study|Not treated due to adverse event|0|||
148835827|NCT02604511|536879521|FG000|Overall Study|Withdrawal by Subject|3|||
148835828|NCT02604511|536879521|FG000|Overall Study|Participant ineligible|1|||
148835829|NCT02604511|536879521|FG000|Overall Study|Intercurrent illness|1|||
148835830|NCT03770286|536879522|FG000|Overall Study|Lost to Follow-up|6|||
148835831|NCT03770286|536879523|FG001|Overall Study|Lost to Follow-up|4|||
148835832|NCT03770286|536879524|FG002|Overall Study|Lost to Follow-up|3|||
148835833|NCT03770286|536879522|FG000|Overall Study|Protocol Violation|1|||
148835834|NCT03770286|536879523|FG001|Overall Study|Protocol Violation|0|||
148835835|NCT03770286|536879524|FG002|Overall Study|Protocol Violation|2|||
148835836|NCT02781558|536879527|FG000|Overall Study|Lost to Follow-up|2|||
148835837|NCT02781558|536879528|FG001|Overall Study|Lost to Follow-up|2|||
148835838|NCT02781558|536879527|FG000|Overall Study|Adverse Event|1|||
149028682|NCT02939183|537582010|FG005|Overall Study|Not treated due to adverse event|0|||
149028683|NCT02939183|537582011|FG006|Overall Study|Not treated due to adverse event|1|||
149028684|NCT02939183|537582012|FG007|Overall Study|Not treated due to adverse event|0|||
149028685|NCT02939183|537582013|FG008|Overall Study|Not treated due to adverse event|0|||
149028686|NCT04639947|537582016|FG000|Overall Study|Screen fail|1|||
149028687|NCT00614744|537582019|FG000|Overall Study|Lost to Follow-up|5|||
149028688|NCT00614744|537582020|FG001|Overall Study|Lost to Follow-up|4|||
149028689|NCT00614744|537582019|FG000|Overall Study|Incomplete for Behavior Issues|0|||
149028690|NCT00614744|537582020|FG001|Overall Study|Incomplete for Behavior Issues|2|||
149028691|NCT01740557|537582021|FG000|Overall Study|Ineligible|1|||
148835839|NCT02781558|536879528|FG001|Overall Study|Adverse Event|0|||
148835840|NCT02257528|536879529|FG000|Overall Study|Never received study treatment|1|||
148835841|NCT00404248|536879530|FG000|Overall Study|pts declining status|0|||
148835842|NCT00404248|536879531|FG001|Overall Study|pts declining status|1|||
148835843|NCT00404248|536879532|FG002|Overall Study|pts declining status|0|||
148835844|NCT00404248|536879533|FG003|Overall Study|pts declining status|0|||
148835845|NCT00404248|536879534|FG004|Overall Study|pts declining status|0|||
148835846|NCT00404248|536879535|FG005|Overall Study|pts declining status|0|||
148835847|NCT00404248|536879536|FG006|Overall Study|pts declining status|0|||
148835848|NCT00404248|536879537|FG007|Overall Study|pts declining status|0|||
148981963|NCT02039505|537413237|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
148981964|NCT02039505|537413238|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
148981965|NCT02039505|537413239|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
148981966|NCT02039505|537413233|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
148981967|NCT02039505|537413234|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
148981968|NCT02039505|537413235|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
148835849|NCT00404248|536879538|FG008|Overall Study|pts declining status|0|||
148835850|NCT00789555|536879539|FG000|Overall Study|Protocol Amendment|78|||
148835851|NCT00789555|536879540|FG001|Overall Study|Protocol Amendment|76|||
148835852|NCT00789555|536879541|FG002|Overall Study|Protocol Amendment|80|||
148835853|NCT00789555|536879539|FG000|Overall Study|Adverse Event|17|||
148835854|NCT00789555|536879540|FG001|Overall Study|Adverse Event|7|||
148835855|NCT00789555|536879541|FG002|Overall Study|Adverse Event|10|||
148835856|NCT00789555|536879539|FG000|Overall Study|Lost to Follow-up|9|||
148835857|NCT00789555|536879540|FG001|Overall Study|Lost to Follow-up|10|||
148835858|NCT00789555|536879541|FG002|Overall Study|Lost to Follow-up|18|||
148835859|NCT00789555|536879539|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
148835860|NCT00789555|536879540|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
148835861|NCT00789555|536879541|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
148835862|NCT00789555|536879539|FG000|Overall Study|Treatment failure|11|||
148835863|NCT00789555|536879540|FG001|Overall Study|Treatment failure|8|||
148835864|NCT00789555|536879541|FG002|Overall Study|Treatment failure|12|||
148835865|NCT00789555|536879539|FG000|Overall Study|Protocol Violation|6|||
148835866|NCT00789555|536879540|FG001|Overall Study|Protocol Violation|9|||
148835867|NCT00789555|536879541|FG002|Overall Study|Protocol Violation|13|||
148835868|NCT00698841|536879542|FG000|Overall Study|Withdrawal by Subject|2|||
148835869|NCT00698841|536879542|FG000|Overall Study|Adverse Event|3|||
148835870|NCT00698841|536879542|FG000|Overall Study|Disease progression|7|||
148835871|NCT00698841|536879542|FG000|Overall Study|Failure to meet eligibility criteria|2|||
148835872|NCT00698841|536879542|FG000|Overall Study|Study drug toxicity|2|||
148835873|NCT00698841|536879542|FG000|Overall Study|Other|2|||
148835874|NCT04646005|536879543|FG000|Overall Study|Adverse Event|1|||
148835875|NCT04646005|536879543|FG000|Overall Study|Progressive Disease|71|||
148835876|NCT04646005|536879543|FG000|Overall Study|Death|20|||
148835877|NCT04646005|536879543|FG000|Overall Study|Withdrawal by Subject|12|||
148835878|NCT04646005|536879543|FG000|Overall Study|Sponsor Request|9|||
148835879|NCT01150357|536879547|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
148835880|NCT01150357|536879548|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
148835881|NCT01150357|536879549|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
148835882|NCT01150357|536879547|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
148981969|NCT02039505|537413236|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
148981970|NCT02039505|537413237|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
148981971|NCT02039505|537413238|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
148981972|NCT02039505|537413239|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
148981973|NCT02039505|537413233|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
148981974|NCT02039505|537413234|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
148981975|NCT02039505|537413235|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
148981976|NCT02039505|537413236|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
148981977|NCT02039505|537413237|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
148981978|NCT02039505|537413238|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
148981979|NCT02039505|537413239|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
148835883|NCT01150357|536879548|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
148835884|NCT01150357|536879549|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
148835885|NCT01150357|536879547|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
148835886|NCT01150357|536879548|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
149028692|NCT01740557|537582021|FG000|Overall Study|Screen failure|1|||
149028693|NCT00490555|537582022|FG000|Overall Study|noncompliant with drug administration|0|||
148835887|NCT01150357|536879549|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
148835888|NCT01150357|536879547|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
148835889|NCT01150357|536879548|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
148835890|NCT01150357|536879549|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
148835891|NCT01150357|536879547|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
148835892|NCT01150357|536879548|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
148835893|NCT01150357|536879549|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
148835894|NCT01150357|536879547|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
148835895|NCT01150357|536879548|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
148835896|NCT01150357|536879549|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
148835897|NCT01150357|536879547|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
148835898|NCT01150357|536879548|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
148835899|NCT01150357|536879549|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
148835900|NCT02661672|536879550|FG000|Overall Study|Lost to Follow-up|1|||
148835901|NCT02661672|536879550|FG000|Overall Study|Death|4|||
148835902|NCT02114177|536880564|FG000|Overall Study|Lost to Follow-up|1|||
148835903|NCT02114177|536880565|FG001|Overall Study|Lost to Follow-up|2|||
148835904|NCT02114177|536880564|FG000|Overall Study|Withdrawal by Subject|6|||
148835905|NCT02114177|536880565|FG001|Overall Study|Withdrawal by Subject|1|||
148835906|NCT02114177|536880564|FG000|Overall Study|Other|2|||
148835907|NCT02114177|536880565|FG001|Overall Study|Other|1|||
148835908|NCT03376516|536880566|FG000|Overall Study|Not treated|1|||
148835909|NCT03376516|536880566|FG000|Overall Study|Consent withdrawn|1|||
148835910|NCT02986074|536880567|FG000|First Trial Period|Adverse Event|1|||
148835911|NCT02986074|536880568|FG001|First Trial Period|Adverse Event|0|||
148835912|NCT02986074|536880569|FG002|First Trial Period|Adverse Event|0|||
148835913|NCT02986074|536880570|FG003|First Trial Period|Adverse Event|0|||
148835914|NCT02986074|536880567|FG000|Follow up Period|system explant|0|||
148835915|NCT02986074|536880568|FG001|Follow up Period|system explant|0|||
148835916|NCT02986074|536880569|FG002|Follow up Period|system explant|1|||
148835917|NCT02986074|536880570|FG003|Follow up Period|system explant|2|||
148835918|NCT02986074|536880567|FG000|Follow up Period|Physician Decision|0|||
148835919|NCT02986074|536880568|FG001|Follow up Period|Physician Decision|0|||
148835920|NCT02986074|536880569|FG002|Follow up Period|Physician Decision|0|||
148835921|NCT02986074|536880570|FG003|Follow up Period|Physician Decision|1|||
148835922|NCT02415556|536880571|FG000|Overall Study|Adverse Event|3|||
148835923|NCT02415556|536880572|FG001|Overall Study|Adverse Event|4|||
148835924|NCT02415556|536880573|FG002|Overall Study|Adverse Event|2|||
148835925|NCT02415556|536880574|FG003|Overall Study|Adverse Event|4|||
148835926|NCT02415556|536880571|FG000|Overall Study|Lost to Follow-up|4|||
148835927|NCT02415556|536880572|FG001|Overall Study|Lost to Follow-up|5|||
148835928|NCT02415556|536880573|FG002|Overall Study|Lost to Follow-up|4|||
148835929|NCT02415556|536880574|FG003|Overall Study|Lost to Follow-up|1|||
148835930|NCT02415556|536880571|FG000|Overall Study|Withdrawal by Subject|13|||
148835931|NCT02415556|536880572|FG001|Overall Study|Withdrawal by Subject|4|||
148835932|NCT02415556|536880573|FG002|Overall Study|Withdrawal by Subject|14|||
148835933|NCT02415556|536880574|FG003|Overall Study|Withdrawal by Subject|12|||
148835934|NCT02415556|536880571|FG000|Overall Study|Physician Decision|1|||
148835935|NCT02415556|536880572|FG001|Overall Study|Physician Decision|3|||
148835936|NCT02415556|536880573|FG002|Overall Study|Physician Decision|1|||
148835937|NCT02415556|536880574|FG003|Overall Study|Physician Decision|2|||
148835938|NCT02415556|536880571|FG000|Overall Study|Censored - study completion|4|||
148835939|NCT02415556|536880572|FG001|Overall Study|Censored - study completion|5|||
148835940|NCT02415556|536880573|FG002|Overall Study|Censored - study completion|1|||
148835941|NCT02415556|536880574|FG003|Overall Study|Censored - study completion|0|||
148835942|NCT02415556|536880571|FG000|Overall Study|Family-related issues|0|||
148835943|NCT02415556|536880572|FG001|Overall Study|Family-related issues|0|||
148835944|NCT02415556|536880573|FG002|Overall Study|Family-related issues|0|||
148835945|NCT02415556|536880574|FG003|Overall Study|Family-related issues|1|||
148835946|NCT01146613|536880575|FG000|Overall Study|Lost to Follow-up|3|||
148835947|NCT01146613|536880576|FG001|Overall Study|Lost to Follow-up|8|||
148835948|NCT01146613|536880575|FG000|Overall Study|Lack of Efficacy|0|||
148835949|NCT01146613|536880576|FG001|Overall Study|Lack of Efficacy|1|||
148835950|NCT01146613|536880575|FG000|Overall Study|Death|1|||
148981980|NCT02039505|537413233|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
148981981|NCT02039505|537413234|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
148981982|NCT02039505|537413235|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
148981983|NCT02039505|537413236|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
148981984|NCT02039505|537413237|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
148835951|NCT01146613|536880576|FG001|Overall Study|Death|0|||
148835952|NCT01146613|536880575|FG000|Overall Study|Physician Decision|1|||
148835953|NCT01146613|536880576|FG001|Overall Study|Physician Decision|0|||
148835954|NCT01146613|536880575|FG000|Overall Study|Withdrawal by Subject|0|||
148835955|NCT01146613|536880576|FG001|Overall Study|Withdrawal by Subject|3|||
148835956|NCT01146613|536880575|FG000|Overall Study|schedule conflict|1|||
148835957|NCT01146613|536880576|FG001|Overall Study|schedule conflict|0|||
148835958|NCT01146613|536880575|FG000|Overall Study|Outpatient detox|1|||
148835959|NCT01146613|536880576|FG001|Overall Study|Outpatient detox|0|||
148835960|NCT00320606|536880577|FG000|Overall Study|Adverse Event|1|||
148835961|NCT00320606|536880577|FG000|Overall Study|Protocol Violation|1|||
148835962|NCT00320606|536880577|FG000|Overall Study|Withdrawal by Subject|1|||
148835963|NCT03984825|536880578|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
148835964|NCT03984825|536880578|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
148835965|NCT03984825|536880578|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
148835966|NCT02115321|536880583|FG000|Overall Study|Death|1|||
148835967|NCT02115321|536880584|FG001|Overall Study|Death|0|||
148835968|NCT01908140|536880586|FG000|Overall Study|Other or Progressive Disease|5|||
148835969|NCT01908140|536880587|FG001|Overall Study|Other or Progressive Disease|12|||
148835970|NCT01908140|536880586|FG000|Overall Study|Lack of Efficacy|7|||
148835971|NCT01908140|536880587|FG001|Overall Study|Lack of Efficacy|5|||
148835972|NCT01908140|536880586|FG000|Overall Study|Withdrawal by Subject|23|||
148835973|NCT01908140|536880587|FG001|Overall Study|Withdrawal by Subject|24|||
148835974|NCT01908140|536880586|FG000|Overall Study|Lost to Follow-up|1|||
148835975|NCT01908140|536880587|FG001|Overall Study|Lost to Follow-up|6|||
148835976|NCT01908140|536880586|FG000|Overall Study|Protocol Violation|8|||
148835977|NCT01908140|536880587|FG001|Overall Study|Protocol Violation|9|||
148835978|NCT01908140|536880586|FG000|Overall Study|Adverse Event|22|||
148835979|NCT01908140|536880587|FG001|Overall Study|Adverse Event|23|||
148835980|NCT02639390|536880588|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
148835981|NCT02639390|536880589|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
148835982|NCT00698828|536880592|FG000|Overall Study|Adverse Event|3|||
148835983|NCT00698828|536880593|FG001|Overall Study|Adverse Event|4|||
148835984|NCT00698828|536880594|FG002|Overall Study|Adverse Event|4|||
148835985|NCT00698828|536880592|FG000|Overall Study|Death|0|||
148835986|NCT00698828|536880593|FG001|Overall Study|Death|0|||
148835987|NCT00698828|536880594|FG002|Overall Study|Death|1|||
148835988|NCT00698828|536880592|FG000|Overall Study|Exacerbation of COPD|1|||
148835989|NCT00698828|536880593|FG001|Overall Study|Exacerbation of COPD|3|||
148835990|NCT00698828|536880594|FG002|Overall Study|Exacerbation of COPD|0|||
148835991|NCT00698828|536880592|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
148835992|NCT00698828|536880593|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
148835993|NCT00698828|536880594|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
148835994|NCT00698828|536880592|FG000|Overall Study|Investigator/Sponsor decision|1|||
148835995|NCT00698828|536880593|FG001|Overall Study|Investigator/Sponsor decision|0|||
148835996|NCT00698828|536880594|FG002|Overall Study|Investigator/Sponsor decision|2|||
148835997|NCT00698828|536880592|FG000|Overall Study|Lost to Follow-up|1|||
148835998|NCT00698828|536880593|FG001|Overall Study|Lost to Follow-up|1|||
148835999|NCT00698828|536880594|FG002|Overall Study|Lost to Follow-up|0|||
148836000|NCT00698828|536880592|FG000|Overall Study|Withdrew consent|0|||
148836001|NCT00698828|536880593|FG001|Overall Study|Withdrew consent|7|||
148836002|NCT00698828|536880594|FG002|Overall Study|Withdrew consent|4|||
148836003|NCT00698828|536880592|FG000|Overall Study|Withdrew consent (not treated)|2|||
148836004|NCT00698828|536880593|FG001|Overall Study|Withdrew consent (not treated)|0|||
148836005|NCT00698828|536880594|FG002|Overall Study|Withdrew consent (not treated)|0|||
148836006|NCT02013609|536880595|FG000|Overall Study|Withdrawal by Subject|9|||
148836007|NCT02013609|536880595|FG000|Overall Study|Lost to Follow-up|3|||
148836008|NCT02013609|536880595|FG000|Overall Study|Adverse Event|3|||
148836009|NCT02013609|536880595|FG000|Overall Study|Met Withdrawal Criteria|3|||
148836010|NCT01816295|536880596|FG000|Double Blind Phase|Adverse Event|11|||
148836011|NCT01816295|536880597|FG001|Double Blind Phase|Adverse Event|8|||
148836012|NCT01816295|536880596|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
148836013|NCT01816295|536880597|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
148836014|NCT01816295|536880596|FG000|Double Blind Phase|Lost to Follow-up|3|||
148836015|NCT01816295|536880597|FG001|Double Blind Phase|Lost to Follow-up|5|||
148836016|NCT01816295|536880596|FG000|Double Blind Phase|Physician Decision|2|||
148836017|NCT01816295|536880597|FG001|Double Blind Phase|Physician Decision|2|||
148836018|NCT01816295|536880596|FG000|Double Blind Phase|Protocol Violation|17|||
148836019|NCT01816295|536880597|FG001|Double Blind Phase|Protocol Violation|11|||
148836020|NCT01816295|536880596|FG000|Double Blind Phase|Sponsor Decision|8|||
148836021|NCT01816295|536880597|FG001|Double Blind Phase|Sponsor Decision|8|||
148836022|NCT01816295|536880596|FG000|Double Blind Phase|Withdrawal by Subject|22|||
148836023|NCT01816295|536880597|FG001|Double Blind Phase|Withdrawal by Subject|20|||
148836024|NCT01816295|536880596|FG000|OLE Phase|Adverse Event|17|||
148836025|NCT01816295|536880597|FG001|OLE Phase|Adverse Event|15|||
148836026|NCT01816295|536880596|FG000|OLE Phase|Death|1|||
148836027|NCT01816295|536880597|FG001|OLE Phase|Death|0|||
148836028|NCT01816295|536880596|FG000|OLE Phase|Entry Criteria Not Met|3|||
148836029|NCT01816295|536880597|FG001|OLE Phase|Entry Criteria Not Met|5|||
148836030|NCT01816295|536880596|FG000|OLE Phase|Lost to Follow-up|5|||
148836031|NCT01816295|536880597|FG001|OLE Phase|Lost to Follow-up|5|||
148836032|NCT01816295|536880596|FG000|OLE Phase|Physician Decision|3|||
148836033|NCT01816295|536880597|FG001|OLE Phase|Physician Decision|1|||
148836034|NCT01816295|536880596|FG000|OLE Phase|Protocol Violation|4|||
148836035|NCT01816295|536880597|FG001|OLE Phase|Protocol Violation|4|||
148836036|NCT01816295|536880596|FG000|OLE Phase|Sponsor Decision|7|||
148836037|NCT01816295|536880597|FG001|OLE Phase|Sponsor Decision|9|||
148836038|NCT01816295|536880596|FG000|OLE Phase|Withdrawal by Subject|10|||
148836039|NCT01816295|536880597|FG001|OLE Phase|Withdrawal by Subject|10|||
148981985|NCT02039505|537413238|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
148981986|NCT02039505|537413239|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
148981987|NCT02039505|537413233|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
148981988|NCT02039505|537413234|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
148981989|NCT02039505|537413235|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
148981990|NCT02039505|537413236|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
148981991|NCT02039505|537413237|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
148981992|NCT02039505|537413238|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
148981993|NCT02039505|537413239|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
148981994|NCT02039505|537413233|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
148981995|NCT02039505|537413234|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
148981996|NCT02039505|537413235|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
148981997|NCT02039505|537413236|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
148981998|NCT02039505|537413237|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
148981999|NCT02039505|537413238|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
148836040|NCT01816295|536880596|FG000|OLE Phase|Lack of Efficacy|3|||
148836041|NCT01816295|536880597|FG001|OLE Phase|Lack of Efficacy|7|||
148836042|NCT01119287|536880598|FG000|Overall Study|Patient Decision, not related to AE|0|||
148836043|NCT01119287|536880599|FG001|Overall Study|Patient Decision, not related to AE|0|||
148836044|NCT01119287|536880600|FG002|Overall Study|Patient Decision, not related to AE|2|||
148836045|NCT01119287|536880601|FG003|Overall Study|Patient Decision, not related to AE|2|||
148836046|NCT01119287|536880602|FG004|Overall Study|Patient Decision, not related to AE|1|||
148836047|NCT01119287|536880603|FG005|Overall Study|Patient Decision, not related to AE|0|||
148836048|NCT01076010|536880606|FG000|Overall Study|Death|15|||
148836049|NCT01076010|536880607|FG001|Overall Study|Death|1|||
148836050|NCT01076010|536880608|FG002|Overall Study|Death|0|||
148836051|NCT01076010|536880606|FG000|Overall Study|Adverse Event|7|||
148836052|NCT01076010|536880607|FG001|Overall Study|Adverse Event|2|||
148836053|NCT01076010|536880608|FG002|Overall Study|Adverse Event|0|||
148836054|NCT01076010|536880606|FG000|Overall Study|Progressive disease|90|||
148836055|NCT01076010|536880607|FG001|Overall Study|Progressive disease|30|||
148836056|NCT01076010|536880608|FG002|Overall Study|Progressive disease|1|||
148836057|NCT01076010|536880606|FG000|Overall Study|Lack of Efficacy|4|||
148836058|NCT01076010|536880607|FG001|Overall Study|Lack of Efficacy|0|||
148836059|NCT01076010|536880608|FG002|Overall Study|Lack of Efficacy|0|||
148836060|NCT01076010|536880606|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
148836061|NCT01076010|536880607|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
148836062|NCT01076010|536880608|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
148836063|NCT01076010|536880606|FG000|Overall Study|Significant Surgical Procedure|0|||
148836064|NCT01076010|536880607|FG001|Overall Study|Significant Surgical Procedure|1|||
148836065|NCT01076010|536880608|FG002|Overall Study|Significant Surgical Procedure|0|||
148836066|NCT01076010|536880606|FG000|Overall Study|Protocol Violation|0|||
148836067|NCT01076010|536880607|FG001|Overall Study|Protocol Violation|1|||
148836068|NCT01076010|536880608|FG002|Overall Study|Protocol Violation|0|||
148836069|NCT01076010|536880606|FG000|Overall Study|Noncompliance|1|||
148836070|NCT01076010|536880607|FG001|Overall Study|Noncompliance|1|||
148836071|NCT01076010|536880608|FG002|Overall Study|Noncompliance|0|||
148836072|NCT01076010|536880606|FG000|Overall Study|Withdrawal by Subject|3|||
148836073|NCT01076010|536880607|FG001|Overall Study|Withdrawal by Subject|0|||
148836074|NCT01076010|536880608|FG002|Overall Study|Withdrawal by Subject|1|||
148836075|NCT01076010|536880606|FG000|Overall Study|Other|5|||
148836076|NCT01076010|536880607|FG001|Overall Study|Other|2|||
148836077|NCT01076010|536880608|FG002|Overall Study|Other|0|||
148836078|NCT01156844|536880609|FG000|Overall Study|Adverse Event|0|||
148836079|NCT01156844|536880610|FG001|Overall Study|Adverse Event|0|||
148836080|NCT01156844|536880611|FG002|Overall Study|Adverse Event|1|||
148836081|NCT01156844|536880612|FG003|Overall Study|Adverse Event|1|||
148836082|NCT01156844|536880609|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148836083|NCT01156844|536880610|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148836084|NCT01156844|536880611|FG002|Overall Study|Abnormal test procedure result(s)|2|||
148836085|NCT01156844|536880612|FG003|Overall Study|Abnormal test procedure result(s)|2|||
148836086|NCT01156844|536880609|FG000|Overall Study|Withdrawal by Subject|0|||
148836087|NCT01156844|536880610|FG001|Overall Study|Withdrawal by Subject|0|||
148836088|NCT01156844|536880611|FG002|Overall Study|Withdrawal by Subject|2|||
148836089|NCT01156844|536880612|FG003|Overall Study|Withdrawal by Subject|2|||
148836090|NCT01156844|536880609|FG000|Overall Study|Lost to Follow-up|0|||
148836091|NCT01156844|536880610|FG001|Overall Study|Lost to Follow-up|0|||
148836092|NCT01156844|536880611|FG002|Overall Study|Lost to Follow-up|1|||
148836093|NCT01156844|536880612|FG003|Overall Study|Lost to Follow-up|0|||
148836094|NCT01156844|536880609|FG000|Overall Study|Administrative problems|0|||
148836095|NCT01156844|536880610|FG001|Overall Study|Administrative problems|1|||
148836096|NCT01156844|536880611|FG002|Overall Study|Administrative problems|0|||
148836097|NCT01156844|536880612|FG003|Overall Study|Administrative problems|1|||
148836098|NCT01156844|536880609|FG000|Overall Study|Protocol deviation|2|||
148836099|NCT01156844|536880610|FG001|Overall Study|Protocol deviation|0|||
148836100|NCT01156844|536880611|FG002|Overall Study|Protocol deviation|0|||
148836101|NCT01156844|536880612|FG003|Overall Study|Protocol deviation|0|||
148836102|NCT00945659|536880614|FG000|Overall Study|Lost to Follow-up|7|||
148836103|NCT00945659|536880615|FG001|Overall Study|Lost to Follow-up|20|||
148836104|NCT00945659|536880616|FG002|Overall Study|Lost to Follow-up|17|||
148836105|NCT04067011|536880617|FG000|Overall Study|Not Treated|8|||
148836106|NCT04067011|536880618|FG001|Overall Study|Not Treated|7|||
148836107|NCT04067011|536880619|FG002|Overall Study|Not Treated|5|||
148836108|NCT04067011|536880617|FG000|Overall Study|Adverse Event|2|||
148836109|NCT04067011|536880618|FG001|Overall Study|Adverse Event|1|||
148836110|NCT04067011|536880619|FG002|Overall Study|Adverse Event|0|||
148836111|NCT04067011|536880617|FG000|Overall Study|Withdrawal by Subject|6|||
148836112|NCT04067011|536880618|FG001|Overall Study|Withdrawal by Subject|2|||
148836113|NCT04067011|536880619|FG002|Overall Study|Withdrawal by Subject|1|||
148836114|NCT04067011|536880617|FG000|Overall Study|Lost to Follow-up|0|||
148836115|NCT04067011|536880618|FG001|Overall Study|Lost to Follow-up|0|||
148836116|NCT04067011|536880619|FG002|Overall Study|Lost to Follow-up|1|||
148836117|NCT04067011|536880617|FG000|Overall Study|Physician Decision|1|||
148836118|NCT04067011|536880618|FG001|Overall Study|Physician Decision|1|||
148836119|NCT04067011|536880619|FG002|Overall Study|Physician Decision|0|||
148836120|NCT04067011|536880617|FG000|Overall Study|Other Reasons|2|||
148836121|NCT04067011|536880618|FG001|Overall Study|Other Reasons|0|||
148836122|NCT04067011|536880619|FG002|Overall Study|Other Reasons|1|||
148836123|NCT04067011|536880617|FG000|Overall Study|Missing|0|||
148836124|NCT04067011|536880618|FG001|Overall Study|Missing|2|||
148836125|NCT04067011|536880619|FG002|Overall Study|Missing|0|||
148836126|NCT02284191|536880626|FG000|Overall Study|Withdrawal by Subject|1|||
148836127|NCT02284191|536880627|FG001|Overall Study|Withdrawal by Subject|3|||
148836128|NCT02284191|536880626|FG000|Overall Study|Lost to Follow-up|1|||
148836129|NCT02284191|536880627|FG001|Overall Study|Lost to Follow-up|0|||
148836130|NCT02257684|536880628|FG000|Overall Study|Adverse Event|2|||
148836131|NCT02257684|536880628|FG000|Overall Study|Lack of Efficacy|1|||
148836132|NCT02257684|536880628|FG000|Overall Study|Sponsor's Decision|1|||
148836133|NCT00760552|536880629|FG000|Overall Study|Death|2|||
148836134|NCT00760552|536880630|FG001|Overall Study|Death|0|||
148836135|NCT00760552|536880629|FG000|Overall Study|Lost to Follow-up|11|||
148836136|NCT00760552|536880630|FG001|Overall Study|Lost to Follow-up|10|||
148836137|NCT01736917|536880637|FG000|Overall Study|Adverse Event|1|||
148836138|NCT01736917|536880637|FG000|Overall Study|Protocol Violation|10|||
148836139|NCT01734902|536880642|FG000|Overall Study|Other than listed|0|||
148836140|NCT01734902|536880643|FG001|Overall Study|Other than listed|2|||
148836141|NCT02293551|536880648|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
148836142|NCT02293551|536880649|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
148836143|NCT02293551|536880650|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
148836144|NCT02293551|536880651|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
148836145|NCT02293551|536880652|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
148836146|NCT02293551|536880653|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
148836147|NCT02293551|536880648|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
148836148|NCT02293551|536880649|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
148836149|NCT02293551|536880650|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
148836150|NCT02293551|536880651|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
148836151|NCT02293551|536880652|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
148836152|NCT02293551|536880653|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
148836153|NCT02293551|536880648|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
148836154|NCT02293551|536880649|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
148836155|NCT02293551|536880650|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
148836156|NCT02293551|536880651|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
149028694|NCT00490555|537582023|FG001|Overall Study|noncompliant with drug administration|0|||
149028695|NCT00490555|537582024|FG002|Overall Study|noncompliant with drug administration|2|||
149028696|NCT00490555|537582025|FG003|Overall Study|noncompliant with drug administration|0|||
149028697|NCT00603538|537582026|FG000|Overall Study|Adverse Event|0|||
149028698|NCT00603538|537582027|FG001|Overall Study|Adverse Event|4|||
149028699|NCT00603538|537582028|FG002|Overall Study|Adverse Event|2|||
149028700|NCT00603538|537582026|FG000|Overall Study|Objective progression or relapse|3|||
149028701|NCT00603538|537582027|FG001|Overall Study|Objective progression or relapse|0|||
149028702|NCT00603538|537582028|FG002|Overall Study|Objective progression or relapse|0|||
149028703|NCT04794179|537582030|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
148836157|NCT02293551|536880652|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
148836158|NCT02293551|536880653|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
148836159|NCT02936323|536880654|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
148836160|NCT02936323|536880655|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
148836161|NCT02936323|536880656|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
148836162|NCT02936323|536880657|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
148836163|NCT02936323|536880658|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
149028704|NCT04794179|537582031|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
149028705|NCT01096056|537582034|FG000|Overall Study|Lost to Follow-up|0|||
149028706|NCT01096056|537582035|FG001|Overall Study|Lost to Follow-up|1|||
149028707|NCT03568162|537582036|FG000|Overall Study|Adverse Event|0|||
149028708|NCT03568162|537582037|FG001|Overall Study|Adverse Event|1|||
149028709|NCT03568162|537582038|FG002|Overall Study|Adverse Event|2|||
149028710|NCT03568162|537582039|FG003|Overall Study|Adverse Event|0|||
149028711|NCT03568162|537582040|FG004|Overall Study|Adverse Event|0|||
149028712|NCT03568162|537582041|FG005|Overall Study|Adverse Event|1|||
149028713|NCT03568162|537582036|FG000|Overall Study|Death|0|||
149028714|NCT03568162|537582037|FG001|Overall Study|Death|0|||
149028715|NCT03568162|537582038|FG002|Overall Study|Death|0|||
149028716|NCT03568162|537582039|FG003|Overall Study|Death|0|||
149028717|NCT03568162|537582040|FG004|Overall Study|Death|1|||
148836164|NCT02936323|536880659|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
148836165|NCT02936323|536880660|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
148836166|NCT02936323|536880661|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
148836167|NCT02936323|536880662|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
148836168|NCT02936323|536880663|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
148836169|NCT02936323|536880654|FG000|Phase 1 Dose Escalation|Death|2|||
148836170|NCT02936323|536880655|FG001|Phase 1 Dose Escalation|Death|1|||
148836171|NCT02936323|536880656|FG002|Phase 1 Dose Escalation|Death|3|||
148836172|NCT02936323|536880657|FG003|Phase 1 Dose Escalation|Death|1|||
148836173|NCT02936323|536880658|FG004|Phase 1 Dose Escalation|Death|2|||
148836174|NCT02936323|536880659|FG005|Phase 1 Dose Escalation|Death|3|||
148836175|NCT02936323|536880660|FG006|Phase 1 Dose Escalation|Death|3|||
148836176|NCT02936323|536880661|FG007|Phase 1 Dose Escalation|Death|0|||
148836177|NCT02936323|536880662|FG008|Phase 1 Dose Escalation|Death|0|||
148836178|NCT02936323|536880663|FG009|Phase 1 Dose Escalation|Death|0|||
148836179|NCT02936323|536880654|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836180|NCT02936323|536880655|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836181|NCT02936323|536880656|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836182|NCT02936323|536880657|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836183|NCT02936323|536880658|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836184|NCT02936323|536880659|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
148836185|NCT02936323|536880660|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836186|NCT02936323|536880661|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836187|NCT02936323|536880662|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836188|NCT02936323|536880663|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
148836189|NCT02936323|536880654|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836190|NCT02936323|536880655|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836191|NCT02936323|536880656|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836192|NCT02936323|536880657|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836193|NCT02936323|536880658|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836194|NCT02936323|536880659|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836195|NCT02936323|536880660|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
148836196|NCT02936323|536880661|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
148836197|NCT02936323|536880662|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
148836198|NCT02936323|536880663|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
148836199|NCT02936323|536880654|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
148836200|NCT02936323|536880655|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
148836201|NCT02936323|536880656|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
148836202|NCT02936323|536880657|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
148836203|NCT02936323|536880658|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
148836204|NCT02936323|536880659|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
148836205|NCT02936323|536880660|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
148836206|NCT02936323|536880661|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
148836207|NCT02936323|536880662|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
148836208|NCT02936323|536880663|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
148836209|NCT02936323|536880654|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836210|NCT02936323|536880655|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836211|NCT02936323|536880656|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836212|NCT02936323|536880657|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836213|NCT02936323|536880658|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836214|NCT02936323|536880659|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836215|NCT02936323|536880660|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836216|NCT02936323|536880661|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
148836217|NCT02936323|536880662|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
149028718|NCT03568162|537582041|FG005|Overall Study|Death|0|||
149028719|NCT03568162|537582036|FG000|Overall Study|Lost to Follow-up|3|||
149028720|NCT03568162|537582037|FG001|Overall Study|Lost to Follow-up|2|||
149028721|NCT03568162|537582038|FG002|Overall Study|Lost to Follow-up|4|||
149028722|NCT03568162|537582039|FG003|Overall Study|Lost to Follow-up|2|||
148836218|NCT02936323|536880663|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
148836219|NCT02936323|536880654|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836220|NCT02936323|536880655|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836221|NCT02936323|536880656|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836222|NCT02936323|536880657|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836223|NCT02936323|536880658|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836224|NCT02936323|536880659|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836225|NCT02936323|536880660|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836226|NCT02936323|536880661|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836227|NCT02936323|536880662|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
148836228|NCT02936323|536880663|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
148836229|NCT02936323|536880654|FG000|Phase 2a Dose Expansion|Death|0|||
148836230|NCT02936323|536880655|FG001|Phase 2a Dose Expansion|Death|0|||
148836231|NCT02936323|536880656|FG002|Phase 2a Dose Expansion|Death|0|||
148836232|NCT02936323|536880657|FG003|Phase 2a Dose Expansion|Death|0|||
148836233|NCT02936323|536880658|FG004|Phase 2a Dose Expansion|Death|0|||
148836234|NCT02936323|536880659|FG005|Phase 2a Dose Expansion|Death|0|||
148836235|NCT02936323|536880660|FG006|Phase 2a Dose Expansion|Death|0|||
148836236|NCT02936323|536880661|FG007|Phase 2a Dose Expansion|Death|4|||
148836237|NCT02936323|536880662|FG008|Phase 2a Dose Expansion|Death|8|||
148836238|NCT02936323|536880663|FG009|Phase 2a Dose Expansion|Death|10|||
148836239|NCT00545779|536880666|FG000|Overall Study|Violation of selection criteria at entry|8|||
148836240|NCT00545779|536880666|FG000|Overall Study|Other protocol violation|1|||
148836241|NCT00545779|536880666|FG000|Overall Study|Did not cooperate|7|||
148836242|NCT00545779|536880666|FG000|Overall Study|Withdrawal by Subject|20|||
148836243|NCT00545779|536880666|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
148836244|NCT00545779|536880666|FG000|Overall Study|Failure to return|3|||
148836245|NCT01542788|536880667|FG000|Overall Study|Randomized but Not Treated|2|||
148836246|NCT01542788|536880668|FG001|Overall Study|Randomized but Not Treated|0|||
148836247|NCT01542788|536880667|FG000|Overall Study|Lack of Efficacy|41|||
148836248|NCT01542788|536880668|FG001|Overall Study|Lack of Efficacy|71|||
148836249|NCT01542788|536880667|FG000|Overall Study|Lost to Follow-up|5|||
148836250|NCT01542788|536880668|FG001|Overall Study|Lost to Follow-up|0|||
148836251|NCT01542788|536880667|FG000|Overall Study|Death|3|||
148836252|NCT01542788|536880668|FG001|Overall Study|Death|0|||
148836253|NCT01542788|536880667|FG000|Overall Study|Protocol Violation|2|||
148836254|NCT01542788|536880668|FG001|Overall Study|Protocol Violation|0|||
148836255|NCT01542788|536880667|FG000|Overall Study|Physician Decision|1|||
148836256|NCT01542788|536880668|FG001|Overall Study|Physician Decision|0|||
148836257|NCT01542788|536880667|FG000|Overall Study|Withdrawal by Subject|1|||
148836258|NCT01542788|536880668|FG001|Overall Study|Withdrawal by Subject|0|||
148836259|NCT01729039|536880669|FG000|Overall Study|disqualified|2|||
148836260|NCT01729039|536880670|FG001|Overall Study|disqualified|5|||
148836261|NCT01729039|536880669|FG000|Overall Study|Withdrawal by Subject|8|||
148836262|NCT01729039|536880670|FG001|Overall Study|Withdrawal by Subject|7|||
148836263|NCT05788991|536880672|FG000|Overall Study|Not treated with study medication|1|||
148836264|NCT05788991|536880673|FG001|Overall Study|Not treated with study medication|3|||
148836265|NCT05788991|536880672|FG000|Overall Study|Withdrawal by Subject|1|||
148836266|NCT05788991|536880673|FG001|Overall Study|Withdrawal by Subject|0|||
148836267|NCT05788991|536880672|FG000|Overall Study|Lack of Efficacy|0|||
148836268|NCT05788991|536880673|FG001|Overall Study|Lack of Efficacy|1|||
148836269|NCT05788991|536880672|FG000|Overall Study|Protocol Violation|1|||
148836270|NCT05788991|536880673|FG001|Overall Study|Protocol Violation|2|||
148836271|NCT04464473|536880674|FG000|Overall Study|New piercing could not be removed for scanning|0|||
148836272|NCT04464473|536880675|FG001|Overall Study|New piercing could not be removed for scanning|0|||
148836273|NCT04464473|536880676|FG002|Overall Study|New piercing could not be removed for scanning|0|||
148836274|NCT04464473|536880677|FG003|Overall Study|New piercing could not be removed for scanning|1|||
148836275|NCT04464473|536880678|FG004|Overall Study|New piercing could not be removed for scanning|0|||
148836276|NCT04464473|536880679|FG005|Overall Study|New piercing could not be removed for scanning|0|||
148836277|NCT04464473|536880674|FG000|Overall Study|Adverse Event|0|||
148836278|NCT04464473|536880675|FG001|Overall Study|Adverse Event|0|||
148836279|NCT04464473|536880676|FG002|Overall Study|Adverse Event|0|||
148836280|NCT04464473|536880677|FG003|Overall Study|Adverse Event|1|||
148836281|NCT04464473|536880678|FG004|Overall Study|Adverse Event|0|||
148836282|NCT04464473|536880679|FG005|Overall Study|Adverse Event|0|||
148836283|NCT04464473|536880674|FG000|Overall Study|Lost to Follow-up|0|||
148836284|NCT04464473|536880675|FG001|Overall Study|Lost to Follow-up|0|||
148836285|NCT04464473|536880676|FG002|Overall Study|Lost to Follow-up|0|||
148836286|NCT04464473|536880677|FG003|Overall Study|Lost to Follow-up|1|||
148836287|NCT04464473|536880678|FG004|Overall Study|Lost to Follow-up|0|||
148836288|NCT04464473|536880679|FG005|Overall Study|Lost to Follow-up|0|||
148836289|NCT03802396|536880680|FG000|Overall Study|Withdrawal by Subject|2|||
148836290|NCT03802396|536880681|FG001|Overall Study|Withdrawal by Subject|0|||
148836291|NCT03802396|536880680|FG000|Overall Study|Surgery Cancelled|1|||
148836292|NCT03802396|536880681|FG001|Overall Study|Surgery Cancelled|0|||
148836293|NCT03586973|536880682|FG000|Overall Study|Death|15|||
148982000|NCT02039505|537413239|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
148982001|NCT02039505|537413233|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
148982002|NCT02039505|537413234|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
148982003|NCT02039505|537413235|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
148982004|NCT02039505|537413236|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
148982005|NCT02039505|537413237|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
148982006|NCT02039505|537413238|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
148982007|NCT02039505|537413239|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
148982008|NCT02039505|537413233|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
148982009|NCT02039505|537413234|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
148982010|NCT02039505|537413235|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
148982011|NCT02039505|537413236|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
148982012|NCT02039505|537413237|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
148982013|NCT02039505|537413238|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
148982014|NCT02039505|537413239|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
148836294|NCT03586973|536880683|FG001|Overall Study|Death|8|||
148836295|NCT03586973|536880682|FG000|Overall Study|Site Terminated by Sponsor|3|||
148836296|NCT03586973|536880683|FG001|Overall Study|Site Terminated by Sponsor|6|||
148836297|NCT03586973|536880682|FG000|Overall Study|Withdrawal by Subject|1|||
148836298|NCT03586973|536880683|FG001|Overall Study|Withdrawal by Subject|0|||
148836299|NCT03586973|536880682|FG000|Overall Study|Lost to Follow-up|1|||
148836300|NCT03586973|536880683|FG001|Overall Study|Lost to Follow-up|0|||
148836301|NCT01770743|536882499|FG000|Overall Study|Adverse Event|1|||
148836302|NCT01770743|536882500|FG001|Overall Study|Adverse Event|0|||
148836303|NCT01770743|536882501|FG002|Overall Study|Adverse Event|0|||
148836304|NCT01770743|536882502|FG003|Overall Study|Adverse Event|0|||
148836305|NCT01770743|536882503|FG004|Overall Study|Adverse Event|0|||
148836306|NCT01770743|536882499|FG000|Overall Study|Withdrawal by Subject|0|||
148836307|NCT01770743|536882500|FG001|Overall Study|Withdrawal by Subject|0|||
148836308|NCT01770743|536882501|FG002|Overall Study|Withdrawal by Subject|1|||
148836309|NCT01770743|536882502|FG003|Overall Study|Withdrawal by Subject|1|||
148836310|NCT01770743|536882503|FG004|Overall Study|Withdrawal by Subject|1|||
148836311|NCT01770743|536882499|FG000|Overall Study|Lost to Follow-up|0|||
148836312|NCT01770743|536882500|FG001|Overall Study|Lost to Follow-up|2|||
148836313|NCT01770743|536882501|FG002|Overall Study|Lost to Follow-up|0|||
148836314|NCT01770743|536882502|FG003|Overall Study|Lost to Follow-up|0|||
148836315|NCT01770743|536882503|FG004|Overall Study|Lost to Follow-up|1|||
148836316|NCT01770743|536882499|FG000|Overall Study|Sponsor Terminated Subject|1|||
148836317|NCT01770743|536882500|FG001|Overall Study|Sponsor Terminated Subject|0|||
148836318|NCT01770743|536882501|FG002|Overall Study|Sponsor Terminated Subject|0|||
148836319|NCT01770743|536882502|FG003|Overall Study|Sponsor Terminated Subject|1|||
148836320|NCT01770743|536882503|FG004|Overall Study|Sponsor Terminated Subject|0|||
148836321|NCT01770743|536882499|FG000|Overall Study|Moving Out of State|0|||
148836322|NCT01770743|536882500|FG001|Overall Study|Moving Out of State|1|||
148836323|NCT01770743|536882501|FG002|Overall Study|Moving Out of State|0|||
148836324|NCT01770743|536882502|FG003|Overall Study|Moving Out of State|0|||
148836325|NCT01770743|536882503|FG004|Overall Study|Moving Out of State|0|||
148836326|NCT00652743|536882504|FG000|Months 12-18|Lost to Follow-up|1|||
148836327|NCT00652743|536882505|FG001|Months 12-18|Lost to Follow-up|2|||
148836328|NCT00652743|536882506|FG002|Months 12-18|Lost to Follow-up|7|||
148836329|NCT00652743|536882504|FG000|Months 24-30|Other|5|||
148836330|NCT00652743|536882505|FG001|Months 24-30|Other|1|||
148836331|NCT00652743|536882506|FG002|Months 24-30|Other|11|||
148836332|NCT00652743|536882504|FG000|Months 36-42|Serious Adverse Events|0|||
148836333|NCT00652743|536882505|FG001|Months 36-42|Serious Adverse Events|1|||
148836334|NCT00652743|536882506|FG002|Months 36-42|Serious Adverse Events|1|||
148836335|NCT00652743|536882504|FG000|Months 36-42|Withdrawal by Subject|1|||
148836336|NCT00652743|536882505|FG001|Months 36-42|Withdrawal by Subject|1|||
148836337|NCT00652743|536882506|FG002|Months 36-42|Withdrawal by Subject|0|||
148836338|NCT00652743|536882504|FG000|Months 36-42|Lost to Follow-up|0|||
148836339|NCT00652743|536882505|FG001|Months 36-42|Lost to Follow-up|1|||
148836340|NCT00652743|536882506|FG002|Months 36-42|Lost to Follow-up|0|||
148836341|NCT00652743|536882504|FG000|Months 36-42|Migrated/moved from study area|1|||
148836342|NCT00652743|536882505|FG001|Months 36-42|Migrated/moved from study area|0|||
149028723|NCT03568162|537582040|FG004|Overall Study|Lost to Follow-up|3|||
148836343|NCT00652743|536882506|FG002|Months 36-42|Migrated/moved from study area|0|||
148836344|NCT00652743|536882504|FG000|Months 36-42|Other|4|||
148836345|NCT00652743|536882505|FG001|Months 36-42|Other|2|||
148836346|NCT00652743|536882506|FG002|Months 36-42|Other|8|||
148836347|NCT01585025|536882507|FG000|Overall Study|Withdrawal by Subject|0|||
148836348|NCT01585025|536882508|FG001|Overall Study|Withdrawal by Subject|3|||
148836349|NCT01585025|536882509|FG002|Overall Study|Withdrawal by Subject|4|||
148836350|NCT02336815|536882510|FG000|Overall Study|Disease Progression|45|||
148836351|NCT02336815|536882511|FG001|Overall Study|Disease Progression|70|||
148836352|NCT02336815|536882510|FG000|Overall Study|Adverse Event|18|||
148836353|NCT02336815|536882511|FG001|Overall Study|Adverse Event|39|||
148836354|NCT02336815|536882510|FG000|Overall Study|Physician Decision|11|||
148836355|NCT02336815|536882511|FG001|Overall Study|Physician Decision|4|||
148836356|NCT02336815|536882510|FG000|Overall Study|Withdrawal by Subject|3|||
148836357|NCT02336815|536882511|FG001|Overall Study|Withdrawal by Subject|2|||
148836358|NCT02336815|536882510|FG000|Overall Study|Lost to Follow-up|1|||
148836359|NCT02336815|536882511|FG001|Overall Study|Lost to Follow-up|3|||
148836360|NCT02336815|536882510|FG000|Overall Study|Other|1|||
148836361|NCT02336815|536882511|FG001|Overall Study|Other|5|||
148836362|NCT00952705|536882512|FG000|Overall Study|Lost to Follow-up|24|||
148836363|NCT00952705|536882513|FG001|Overall Study|Lost to Follow-up|8|||
148836364|NCT00952705|536882514|FG002|Overall Study|Lost to Follow-up|9|||
148836365|NCT00952705|536882512|FG000|Overall Study|Withdrawal by Subject|2|||
148836366|NCT00952705|536882513|FG001|Overall Study|Withdrawal by Subject|1|||
148836367|NCT00952705|536882514|FG002|Overall Study|Withdrawal by Subject|1|||
148836368|NCT00952705|536882512|FG000|Overall Study|Death|2|||
148836369|NCT00952705|536882513|FG001|Overall Study|Death|0|||
148836370|NCT00952705|536882514|FG002|Overall Study|Death|0|||
148836371|NCT00952705|536882512|FG000|Overall Study|Incarcerated post dose|5|||
148836372|NCT00952705|536882513|FG001|Overall Study|Incarcerated post dose|0|||
148836373|NCT00952705|536882514|FG002|Overall Study|Incarcerated post dose|0|||
148836374|NCT00952705|536882512|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
148836375|NCT00952705|536882513|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
148836376|NCT00952705|536882514|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
148836377|NCT00140140|536882515|FG000|Overall Study|Unacceptable toxicity|1|||
148836378|NCT00140140|536882516|FG001|Overall Study|Unacceptable toxicity|1|||
148836379|NCT00140140|536882517|FG002|Overall Study|Unacceptable toxicity|2|||
148836380|NCT00140140|536882515|FG000|Overall Study|Physician Decision|1|||
148836381|NCT00140140|536882516|FG001|Overall Study|Physician Decision|1|||
148836382|NCT00140140|536882517|FG002|Overall Study|Physician Decision|0|||
148836383|NCT01581684|536882518|FG000|Overall Study|Other reason not defined|0|||
148836384|NCT01581684|536882519|FG001|Overall Study|Other reason not defined|0|||
148836385|NCT01581684|536882520|FG002|Overall Study|Other reason not defined|0|||
148836386|NCT01581684|536882521|FG003|Overall Study|Other reason not defined|0|||
148836387|NCT01581684|536882522|FG004|Overall Study|Other reason not defined|0|||
148836388|NCT01581684|536882523|FG005|Overall Study|Other reason not defined|0|||
148836389|NCT01581684|536882524|FG006|Overall Study|Other reason not defined|0|||
148836390|NCT01581684|536882525|FG007|Overall Study|Other reason not defined|0|||
148836391|NCT01581684|536882526|FG008|Overall Study|Other reason not defined|1|||
148836392|NCT01581684|536882527|FG009|Overall Study|Other reason not defined|0|||
148836393|NCT00598650|536882528|FG000|Overall Study|Withdrawal by Subject|3|||
148836394|NCT00598650|536882528|FG000|Overall Study|Adverse Event|18|||
148836395|NCT00598650|536882528|FG000|Overall Study|No treatment for 3 weeks|1|||
148836396|NCT00598650|536882528|FG000|Overall Study|Not eligible|1|||
148836397|NCT00598650|536882528|FG000|Overall Study|Prohibited Concomitant Medication|2|||
148836398|NCT00598650|536882528|FG000|Overall Study|Physician Decision|2|||
148836399|NCT03289143|536882529|FG000|Overall Study|Caregiver Unavailability|1|||
148836400|NCT03289143|536882530|FG001|Overall Study|Caregiver Unavailability|1|||
148836401|NCT03289143|536882531|FG002|Overall Study|Caregiver Unavailability|0|||
148836402|NCT03289143|536882532|FG003|Overall Study|Caregiver Unavailability|0|||
148836403|NCT03289143|536882529|FG000|Overall Study|Research Department Closure|0|||
148836404|NCT03289143|536882530|FG001|Overall Study|Research Department Closure|0|||
148836405|NCT03289143|536882531|FG002|Overall Study|Research Department Closure|1|||
148836406|NCT03289143|536882532|FG003|Overall Study|Research Department Closure|0|||
148836407|NCT03289143|536882529|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
148836408|NCT03289143|536882530|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
148836409|NCT03289143|536882531|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
148836410|NCT03289143|536882532|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
148836411|NCT03289143|536882529|FG000|Overall Study|Medical Monitor Decision|1|||
148836412|NCT03289143|536882530|FG001|Overall Study|Medical Monitor Decision|0|||
148836413|NCT03289143|536882531|FG002|Overall Study|Medical Monitor Decision|0|||
148836414|NCT03289143|536882532|FG003|Overall Study|Medical Monitor Decision|0|||
148836415|NCT03289143|536882529|FG000|Overall Study|Participant Non-Compliance|0|||
148836416|NCT03289143|536882530|FG001|Overall Study|Participant Non-Compliance|0|||
148836417|NCT03289143|536882531|FG002|Overall Study|Participant Non-Compliance|1|||
148836418|NCT03289143|536882532|FG003|Overall Study|Participant Non-Compliance|0|||
148836419|NCT03289143|536882529|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
148836420|NCT03289143|536882530|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
148836421|NCT03289143|536882531|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
148836422|NCT03289143|536882532|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
148836423|NCT03289143|536882529|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
148836424|NCT03289143|536882530|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
148836425|NCT03289143|536882531|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
148982015|NCT02039505|537413233|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
148982016|NCT02039505|537413234|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
148982017|NCT02039505|537413235|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
148982018|NCT02039505|537413236|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
148982019|NCT02039505|537413237|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
148982020|NCT02039505|537413238|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
148982021|NCT02039505|537413239|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
148982022|NCT01343082|537413242|FG000|The run-in Period|Not meeting criteria|3|||
148982023|NCT01343082|537413243|FG001|The run-in Period|Not meeting criteria|4|||
148982024|NCT01343082|537413244|FG002|The run-in Period|Not meeting criteria|5|||
148982025|NCT01343082|537413242|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
148982026|NCT01343082|537413243|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
148982027|NCT01343082|537413244|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
148982028|NCT01343082|537413242|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
148982029|NCT01343082|537413243|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
148982030|NCT01343082|537413244|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
148982031|NCT01343082|537413242|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
148982032|NCT01343082|537413243|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
148982033|NCT01343082|537413244|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
148982034|NCT01343082|537413242|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
148982035|NCT01343082|537413243|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
148982036|NCT01343082|537413244|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
148982037|NCT04265755|537413245|FG000|Overall Study|Withdrawal by Subject|39|||
148982038|NCT04265755|537413245|FG000|Overall Study|Decision by sponsor|2|||
148982039|NCT04265755|537413245|FG000|Overall Study|Lost to Follow-up|11|||
148982040|NCT04265755|537413245|FG000|Overall Study|Death|1|||
148982041|NCT03614793|537413249|FG000|Overall Study|Lost to Follow-up|1|||
148982042|NCT03614793|537413250|FG001|Overall Study|Lost to Follow-up|2|||
148982043|NCT03614793|537413249|FG000|Overall Study|Lack of Efficacy|0|||
148982044|NCT03614793|537413250|FG001|Overall Study|Lack of Efficacy|5|||
148982045|NCT03614793|537413249|FG000|Overall Study|Withdrawal by Subject|0|||
148982046|NCT03614793|537413250|FG001|Overall Study|Withdrawal by Subject|1|||
148982047|NCT03614793|537413249|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
148982048|NCT03614793|537413250|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
148982049|NCT02082522|537413251|FG000|Overall Study|Sponsor termination|5|||
148982050|NCT02082522|537413252|FG001|Overall Study|Sponsor termination|3|||
148982051|NCT02082522|537413251|FG000|Overall Study|Withdrawal by Subject|2|||
148982052|NCT02082522|537413252|FG001|Overall Study|Withdrawal by Subject|4|||
148982053|NCT02082522|537413251|FG000|Overall Study|Death|1|||
148982054|NCT02082522|537413252|FG001|Overall Study|Death|0|||
148982055|NCT02082522|537413251|FG000|Overall Study|Lost to Follow-up|1|||
148982056|NCT02082522|537413252|FG001|Overall Study|Lost to Follow-up|0|||
148982057|NCT02082522|537413251|FG000|Overall Study|Physician Decision|3|||
148982058|NCT02082522|537413252|FG001|Overall Study|Physician Decision|1|||
148982059|NCT02082522|537413251|FG000|Overall Study|Disease progression|2|||
148982060|NCT02082522|537413252|FG001|Overall Study|Disease progression|2|||
148982061|NCT02082522|537413251|FG000|Overall Study|Chemotherapy change|1|||
148982062|NCT02082522|537413252|FG001|Overall Study|Chemotherapy change|3|||
148982063|NCT01863446|537413253|FG000|Overall Study|Withdrawal by Subject|1|||
148982064|NCT01863446|537413254|FG001|Overall Study|Withdrawal by Subject|0|||
148982065|NCT01863446|537413255|FG002|Overall Study|Withdrawal by Subject|1|||
148982066|NCT01863446|537413256|FG003|Overall Study|Withdrawal by Subject|2|||
148982067|NCT01863446|537413253|FG000|Overall Study|Physician Decision|0|||
148982068|NCT01863446|537413254|FG001|Overall Study|Physician Decision|0|||
148982069|NCT01863446|537413255|FG002|Overall Study|Physician Decision|1|||
148982070|NCT01863446|537413256|FG003|Overall Study|Physician Decision|0|||
148982071|NCT00633984|537413257|FG000|Overall Study|Lost to Follow-up|0|||
148982072|NCT00633984|537413258|FG001|Overall Study|Lost to Follow-up|6|||
148982073|NCT00633984|537413257|FG000|Overall Study|Withdrawal by Subject|8|||
148982074|NCT00633984|537413258|FG001|Overall Study|Withdrawal by Subject|7|||
148982075|NCT00633984|537413257|FG000|Overall Study|Hospitalized|1|||
148982076|NCT00633984|537413258|FG001|Overall Study|Hospitalized|0|||
148982077|NCT02554773|537413259|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
148982078|NCT02554773|537413260|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
148982079|NCT02554773|537413259|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
148982080|NCT02554773|537413260|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
148982081|NCT02554773|537413259|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
148982082|NCT02554773|537413260|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
148982083|NCT02554773|537413259|FG000|Original Dose Regimen (SAS 1)|Death|1|||
148982084|NCT02554773|537413260|FG001|Original Dose Regimen (SAS 1)|Death|0|||
148982085|NCT02554773|537413259|FG000|Original Dose Regimen (SAS 1)|Other|4|||
148982086|NCT02554773|537413260|FG001|Original Dose Regimen (SAS 1)|Other|0|||
148982087|NCT02554773|537413259|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
148982088|NCT02554773|537413260|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
148982089|NCT02554773|537413259|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
148982090|NCT02554773|537413260|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
148982091|NCT02554773|537413259|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
148982092|NCT02554773|537413260|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
148982093|NCT02554773|537413259|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
148982094|NCT02554773|537413260|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
148982095|NCT02496884|537413261|FG000|Overall Study|Counted twice as enrolled|2|||
148982096|NCT02496884|537413262|FG001|Overall Study|Counted twice as enrolled|0|||
148982097|NCT02496884|537413263|FG002|Overall Study|Counted twice as enrolled|0|||
148982098|NCT02496884|537413264|FG003|Overall Study|Counted twice as enrolled|0|||
148982099|NCT02496884|537413261|FG000|Overall Study|Withdrawal by Subject|0|||
148982100|NCT02496884|537413262|FG001|Overall Study|Withdrawal by Subject|3|||
148982101|NCT02496884|537413263|FG002|Overall Study|Withdrawal by Subject|0|||
148982102|NCT02496884|537413264|FG003|Overall Study|Withdrawal by Subject|0|||
148982103|NCT00097591|537413265|FG000|Overall Study|Withdrawal of consent|342|||
148982104|NCT00097591|537413266|FG001|Overall Study|Withdrawal of consent|323|||
148982105|NCT00097591|537413265|FG000|Overall Study|Less than 6 months on study drug|9|||
148982106|NCT00097591|537413266|FG001|Overall Study|Less than 6 months on study drug|7|||
148982107|NCT00097591|537413265|FG000|Overall Study|Unable to attend termination visit|53|||
148982108|NCT00097591|537413266|FG001|Overall Study|Unable to attend termination visit|51|||
148982109|NCT00097591|537413265|FG000|Overall Study|Lost to follow up|6|||
148982110|NCT00097591|537413266|FG001|Overall Study|Lost to follow up|10|||
148982111|NCT00097591|537413265|FG000|Overall Study|Other|0|||
148982112|NCT00097591|537413266|FG001|Overall Study|Other|3|||
148982113|NCT01168999|537413271|FG000|Overall Study|Lost to Follow-up|2|||
148982114|NCT01168999|537413272|FG001|Overall Study|Lost to Follow-up|1|||
148982115|NCT01168999|537413273|FG002|Overall Study|Lost to Follow-up|0|||
148982116|NCT01168999|537413274|FG003|Overall Study|Lost to Follow-up|0|||
148982117|NCT04317586|537413275|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
148982118|NCT04317586|537413275|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
148982119|NCT01276327|537413276|FG000|Overall Study|Adverse Event|1|||
148982120|NCT01276327|537413277|FG001|Overall Study|Adverse Event|3|||
148982121|NCT01276327|537413276|FG000|Overall Study|Withdrawal by Subject|1|||
148982122|NCT01276327|537413277|FG001|Overall Study|Withdrawal by Subject|0|||
148982123|NCT00807092|537413278|FG000|Overall Study|Adverse Event|0|||
148982124|NCT00807092|537413279|FG001|Overall Study|Adverse Event|1|||
148982125|NCT00807092|537413278|FG000|Overall Study|Protocol Violation|0|||
148982126|NCT00807092|537413279|FG001|Overall Study|Protocol Violation|2|||
148982127|NCT00807092|537413278|FG000|Overall Study|Withdrawal by Subject|1|||
148982128|NCT00807092|537413279|FG001|Overall Study|Withdrawal by Subject|0|||
148982129|NCT00807092|537413278|FG000|Overall Study|CGMS data collection failed|0|||
148982130|NCT00807092|537413279|FG001|Overall Study|CGMS data collection failed|1|||
148982131|NCT01794949|537413280|FG000|Overall Study|Lost to Follow-up|1|||
148982132|NCT01794949|537413281|FG001|Overall Study|Lost to Follow-up|0|||
148982133|NCT03766646|537413282|FG000|Overall Study|Withdrawal by Subject|1|||
148982134|NCT03766646|537413283|FG001|Overall Study|Withdrawal by Subject|0|||
148982135|NCT03766646|537413282|FG000|Overall Study|Protocol Violation|0|||
148982136|NCT03766646|537413283|FG001|Overall Study|Protocol Violation|3|||
148982137|NCT01416805|537413291|FG000|Overall Study|Lost to Follow-up|4|||
148982138|NCT01416805|537413292|FG001|Overall Study|Lost to Follow-up|4|||
148982139|NCT03653429|537413293|FG000|Overall Study|Physician Decision|4|||
148982140|NCT03653429|537413294|FG001|Overall Study|Physician Decision|10|||
148982141|NCT01700946|537413301|FG000|Overall Study|Lost to Follow-up|1|||
148982142|NCT01700946|537413302|FG001|Overall Study|Lost to Follow-up|0|||
148982143|NCT01700946|537413301|FG000|Overall Study|Physician Decision|7|||
148982144|NCT01700946|537413302|FG001|Overall Study|Physician Decision|12|||
148982145|NCT01700946|537413301|FG000|Overall Study|Withdrawal by Subject|0|||
148982146|NCT01700946|537413302|FG001|Overall Study|Withdrawal by Subject|2|||
148982147|NCT01700946|537413301|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
148982148|NCT01700946|537413302|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
148982149|NCT01700946|537413301|FG000|Overall Study|Relapse|2|||
148982150|NCT01700946|537413302|FG001|Overall Study|Relapse|1|||
148982151|NCT01700946|537413301|FG000|Overall Study|Unacceptable toxicity|1|||
148982152|NCT01700946|537413302|FG001|Overall Study|Unacceptable toxicity|0|||
148982153|NCT03056690|537413305|FG000|Overall Study|Adverse Event|3|||
148982154|NCT03056690|537413306|FG001|Overall Study|Adverse Event|2|||
148982155|NCT03056690|537413305|FG000|Overall Study|Lack of Efficacy|1|||
148982156|NCT03056690|537413306|FG001|Overall Study|Lack of Efficacy|2|||
148982157|NCT03056690|537413305|FG000|Overall Study|Lost to Follow-up|3|||
148982158|NCT03056690|537413306|FG001|Overall Study|Lost to Follow-up|2|||
148982159|NCT03056690|537413305|FG000|Overall Study|Protocol Violation|2|||
148982160|NCT03056690|537413306|FG001|Overall Study|Protocol Violation|2|||
148982161|NCT03056690|537413305|FG000|Overall Study|Withdrawal by Subject|3|||
148982162|NCT03056690|537413306|FG001|Overall Study|Withdrawal by Subject|6|||
148982163|NCT03056690|537413305|FG000|Overall Study|Non-compliance with Study Drug|1|||
148836426|NCT03289143|536882532|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
148836427|NCT03289143|536882529|FG000|Overall Study|Caregiver Passed Away|1|||
148836428|NCT03289143|536882530|FG001|Overall Study|Caregiver Passed Away|0|||
148836429|NCT03289143|536882531|FG002|Overall Study|Caregiver Passed Away|0|||
148836430|NCT03289143|536882532|FG003|Overall Study|Caregiver Passed Away|0|||
148836431|NCT03289143|536882529|FG000|Overall Study|Physician Decision|0|||
148836432|NCT03289143|536882530|FG001|Overall Study|Physician Decision|2|||
148836433|NCT03289143|536882531|FG002|Overall Study|Physician Decision|2|||
148836434|NCT03289143|536882532|FG003|Overall Study|Physician Decision|2|||
148836435|NCT03289143|536882529|FG000|Overall Study|Protocol Deviation|2|||
148836436|NCT03289143|536882530|FG001|Overall Study|Protocol Deviation|1|||
148836437|NCT03289143|536882531|FG002|Overall Study|Protocol Deviation|3|||
148836438|NCT03289143|536882532|FG003|Overall Study|Protocol Deviation|1|||
148836439|NCT03289143|536882529|FG000|Overall Study|Study Terminated By Sponsor|101|||
148836440|NCT03289143|536882530|FG001|Overall Study|Study Terminated By Sponsor|75|||
148836441|NCT03289143|536882531|FG002|Overall Study|Study Terminated By Sponsor|100|||
148836442|NCT03289143|536882532|FG003|Overall Study|Study Terminated By Sponsor|69|||
148836443|NCT03289143|536882529|FG000|Overall Study|Withdrawal by Subject|14|||
148836444|NCT03289143|536882530|FG001|Overall Study|Withdrawal by Subject|6|||
148836445|NCT03289143|536882531|FG002|Overall Study|Withdrawal by Subject|14|||
148836446|NCT03289143|536882532|FG003|Overall Study|Withdrawal by Subject|12|||
148836447|NCT03289143|536882529|FG000|Overall Study|Adverse Event|10|||
148836448|NCT03289143|536882530|FG001|Overall Study|Adverse Event|7|||
148836449|NCT03289143|536882531|FG002|Overall Study|Adverse Event|6|||
148836450|NCT03289143|536882532|FG003|Overall Study|Adverse Event|5|||
148836451|NCT03289143|536882529|FG000|Overall Study|Death|2|||
148836452|NCT03289143|536882530|FG001|Overall Study|Death|0|||
148836453|NCT03289143|536882531|FG002|Overall Study|Death|2|||
148836454|NCT03289143|536882532|FG003|Overall Study|Death|1|||
148836455|NCT03289143|536882529|FG000|Overall Study|Lost to Follow-up|2|||
148836456|NCT03289143|536882530|FG001|Overall Study|Lost to Follow-up|1|||
148836457|NCT03289143|536882531|FG002|Overall Study|Lost to Follow-up|1|||
148836458|NCT03289143|536882532|FG003|Overall Study|Lost to Follow-up|0|||
148836459|NCT03289143|536882529|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
148836460|NCT03289143|536882530|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
148836461|NCT03289143|536882531|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
148836462|NCT03289143|536882532|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
148836463|NCT03289143|536882529|FG000|Overall Study|Withdrawal by Caregiver|0|||
148836464|NCT03289143|536882530|FG001|Overall Study|Withdrawal by Caregiver|1|||
148836465|NCT03289143|536882531|FG002|Overall Study|Withdrawal by Caregiver|0|||
148836466|NCT03289143|536882532|FG003|Overall Study|Withdrawal by Caregiver|0|||
148836467|NCT03289143|536882529|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
148982164|NCT03056690|537413306|FG001|Overall Study|Non-compliance with Study Drug|0|||
148982165|NCT03056690|537413305|FG000|Overall Study|Miscellaneous|1|||
148836468|NCT03289143|536882530|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
148836469|NCT03289143|536882531|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
148836470|NCT03289143|536882532|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
148836471|NCT03289143|536882529|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
148836472|NCT03289143|536882530|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
148836473|NCT03289143|536882531|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
148836474|NCT03289143|536882532|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
148836475|NCT00730756|536882533|FG000|Overall Study|Adverse Event|2|||
148836476|NCT00730756|536882534|FG001|Overall Study|Adverse Event|0|||
148836477|NCT00730756|536882533|FG000|Overall Study|Lack of Efficacy|1|||
148836478|NCT00730756|536882534|FG001|Overall Study|Lack of Efficacy|1|||
148836479|NCT00730756|536882533|FG000|Overall Study|Protocol Deviation|1|||
148836480|NCT00730756|536882534|FG001|Overall Study|Protocol Deviation|2|||
148836481|NCT00730756|536882533|FG000|Overall Study|Lost to Follow-up|0|||
148836482|NCT00730756|536882534|FG001|Overall Study|Lost to Follow-up|1|||
148836483|NCT00730756|536882533|FG000|Overall Study|Withdrew Consent|0|||
148836484|NCT00730756|536882534|FG001|Overall Study|Withdrew Consent|1|||
148836485|NCT00948688|536882535|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
148836486|NCT00948688|536882536|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
148836487|NCT00948688|536882535|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
148836488|NCT00948688|536882536|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
148836489|NCT00948688|536882535|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
148836490|NCT00948688|536882536|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
148836491|NCT00524121|536882539|FG000|Overall Study|Disease progression|6|||
148836492|NCT00524121|536882539|FG000|Overall Study|Adverse Event|4|||
148836493|NCT00524121|536882539|FG000|Overall Study|Patient refused|2|||
148836494|NCT00524121|536882539|FG000|Overall Study|Other|1|||
148836495|NCT00524121|536882539|FG000|Overall Study|Death|1|||
148836496|NCT00524121|536882539|FG000|Overall Study|Not treated (became ineligible)|4|||
148982166|NCT03056690|537413306|FG001|Overall Study|Miscellaneous|2|||
148982167|NCT02617589|537413311|FG000|Randomization|Request to Discontinue Study Treatment|1|||
149028724|NCT03568162|537582041|FG005|Overall Study|Lost to Follow-up|2|||
149028725|NCT03568162|537582036|FG000|Overall Study|Physician Decision|0|||
149028726|NCT03568162|537582037|FG001|Overall Study|Physician Decision|1|||
149028727|NCT03568162|537582038|FG002|Overall Study|Physician Decision|1|||
149028728|NCT03568162|537582039|FG003|Overall Study|Physician Decision|0|||
149028729|NCT03568162|537582040|FG004|Overall Study|Physician Decision|1|||
149028730|NCT03568162|537582041|FG005|Overall Study|Physician Decision|0|||
149028731|NCT03568162|537582036|FG000|Overall Study|Pregnancy|0|||
149028732|NCT03568162|537582037|FG001|Overall Study|Pregnancy|0|||
149028733|NCT03568162|537582038|FG002|Overall Study|Pregnancy|0|||
149028734|NCT03568162|537582039|FG003|Overall Study|Pregnancy|1|||
149028735|NCT03568162|537582040|FG004|Overall Study|Pregnancy|0|||
149028736|NCT03568162|537582041|FG005|Overall Study|Pregnancy|0|||
149028737|NCT03568162|537582036|FG000|Overall Study|Protocol Violation|1|||
149028738|NCT03568162|537582037|FG001|Overall Study|Protocol Violation|0|||
149028739|NCT03568162|537582038|FG002|Overall Study|Protocol Violation|1|||
149028740|NCT03568162|537582039|FG003|Overall Study|Protocol Violation|1|||
149028741|NCT03568162|537582040|FG004|Overall Study|Protocol Violation|1|||
149028742|NCT03568162|537582041|FG005|Overall Study|Protocol Violation|1|||
149028743|NCT03568162|537582036|FG000|Overall Study|Withdrawal by Subject|15|||
149028744|NCT03568162|537582037|FG001|Overall Study|Withdrawal by Subject|15|||
149028745|NCT03568162|537582038|FG002|Overall Study|Withdrawal by Subject|26|||
149028746|NCT03568162|537582039|FG003|Overall Study|Withdrawal by Subject|22|||
149028747|NCT03568162|537582040|FG004|Overall Study|Withdrawal by Subject|6|||
149028748|NCT03568162|537582041|FG005|Overall Study|Withdrawal by Subject|9|||
149028749|NCT03568162|537582036|FG000|Overall Study|Others|3|||
149028750|NCT03568162|537582037|FG001|Overall Study|Others|4|||
149028751|NCT03568162|537582038|FG002|Overall Study|Others|1|||
149028752|NCT03568162|537582039|FG003|Overall Study|Others|4|||
149028753|NCT03568162|537582040|FG004|Overall Study|Others|2|||
149028754|NCT03568162|537582041|FG005|Overall Study|Others|1|||
149028755|NCT00768066|537582042|FG000|Overall Study|Did not receive study product injection.|3|||
149028756|NCT00768066|537582043|FG001|Overall Study|Did not receive study product injection.|3|||
149028757|NCT00768066|537582044|FG002|Overall Study|Did not receive study product injection.|0|||
149028758|NCT04831775|537582045|FG000|Overall Study|Lost to Follow-up|11|||
149028759|NCT04831775|537582046|FG001|Overall Study|Lost to Follow-up|13|||
149028760|NCT00337818|537582047|FG000|Overall Study|Lost to Follow-up|289|||
149028761|NCT00337818|537582048|FG001|Overall Study|Lost to Follow-up|91|||
149028762|NCT00337818|537582049|FG002|Overall Study|Lost to Follow-up|107|||
149028763|NCT03115346|537582052|FG000|Overall Study|Did not have AAA surgery|28|||
149028764|NCT03115346|537582053|FG001|Overall Study|Did not have AAA surgery|15|||
149028765|NCT03115346|537582052|FG000|Overall Study|Death|3|||
149028766|NCT03115346|537582053|FG001|Overall Study|Death|1|||
149028767|NCT03115346|537582052|FG000|Overall Study|Withdrawal by Subject|0|||
149028768|NCT03115346|537582053|FG001|Overall Study|Withdrawal by Subject|3|||
149028769|NCT03115346|537582052|FG000|Overall Study|Lost to Follow-up|0|||
149028770|NCT03115346|537582053|FG001|Overall Study|Lost to Follow-up|3|||
149028771|NCT00725010|537582059|FG000|Overall Study|Toxicity|9|||
149028772|NCT00725010|537582059|FG000|Overall Study|Tumor Progression|7|||
149028773|NCT00725010|537582059|FG000|Overall Study|Withdrawal by Subject|2|||
149028774|NCT00725010|537582059|FG000|Overall Study|Death|1|||
149028775|NCT00725010|537582059|FG000|Overall Study|Lost to Follow-up|1|||
149028776|NCT00725010|537582059|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
149028777|NCT00725010|537582059|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
149028778|NCT00725010|537582059|FG000|Overall Study|No further documentation|1|||
149028779|NCT00725010|537582059|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
149028780|NCT03499600|537582060|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
149028781|NCT03499600|537582061|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
149028782|NCT02414828|537582062|FG000|Overall Study|Lost to Follow-up|0|||
149028783|NCT02414828|537582063|FG001|Overall Study|Lost to Follow-up|1|||
149028784|NCT02414828|537582064|FG002|Overall Study|Lost to Follow-up|1|||
149028785|NCT02414828|537582065|FG003|Overall Study|Lost to Follow-up|2|||
149028786|NCT00389519|537582070|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
149028787|NCT00389519|537582071|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
149028788|NCT00389519|537582072|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
149028789|NCT00389519|537582073|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
149028790|NCT00389519|537582070|FG000|Placebo Run-In|Withdrawal by Subject|19|||
149028791|NCT00389519|537582071|FG001|Placebo Run-In|Withdrawal by Subject|0|||
149028792|NCT00389519|537582072|FG002|Placebo Run-In|Withdrawal by Subject|0|||
149028793|NCT00389519|537582073|FG003|Placebo Run-In|Withdrawal by Subject|0|||
149028794|NCT00389519|537582070|FG000|Placebo Run-In|Reason not specified|40|||
149028795|NCT00389519|537582071|FG001|Placebo Run-In|Reason not specified|0|||
149028796|NCT00389519|537582072|FG002|Placebo Run-In|Reason not specified|0|||
149028797|NCT00389519|537582073|FG003|Placebo Run-In|Reason not specified|0|||
149028798|NCT00389519|537582070|FG000|Randomized|Did not receive study drug|2|||
149028799|NCT00389519|537582071|FG001|Randomized|Did not receive study drug|0|||
149028800|NCT00389519|537582072|FG002|Randomized|Did not receive study drug|0|||
149028801|NCT00389519|537582073|FG003|Randomized|Did not receive study drug|0|||
149028802|NCT00389519|537582070|FG000|Treated|Adverse Event|1|||
149028803|NCT00389519|537582071|FG001|Treated|Adverse Event|0|||
149028804|NCT00389519|537582072|FG002|Treated|Adverse Event|0|||
149028805|NCT00389519|537582073|FG003|Treated|Adverse Event|2|||
149028806|NCT00389519|537582070|FG000|Treated|Reason not specified|1|||
149028807|NCT00389519|537582071|FG001|Treated|Reason not specified|1|||
149028808|NCT00389519|537582072|FG002|Treated|Reason not specified|0|||
149028809|NCT00389519|537582073|FG003|Treated|Reason not specified|2|||
149028810|NCT03425539|537582074|FG000|Overall Study|Randomized but not treated|0|||
149028811|NCT03425539|537582075|FG001|Overall Study|Randomized but not treated|1|||
149028812|NCT03425539|537582074|FG000|Overall Study|Adverse Event|2|||
149028813|NCT03425539|537582075|FG001|Overall Study|Adverse Event|2|||
149028814|NCT03425539|537582074|FG000|Overall Study|Withdrawal by Subject|3|||
149028815|NCT03425539|537582075|FG001|Overall Study|Withdrawal by Subject|0|||
149028816|NCT03425539|537582074|FG000|Overall Study|Lost to Follow-up|0|||
149028817|NCT03425539|537582075|FG001|Overall Study|Lost to Follow-up|1|||
149028818|NCT01080131|537582076|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
149028819|NCT01080131|537582077|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
149028820|NCT01080131|537582076|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
149028821|NCT01080131|537582077|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
149028822|NCT01080131|537582076|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
149028823|NCT01080131|537582077|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
149028824|NCT01080131|537582076|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
149028825|NCT01080131|537582077|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
149028826|NCT01080131|537582076|FG000|Core Study (0- 12 Weeks)|Death|1|||
148982168|NCT02617589|537413312|FG001|Randomization|Request to Discontinue Study Treatment|3|||
148982169|NCT02617589|537413311|FG000|Randomization|Participant Withdrew Consent|1|||
148982170|NCT02617589|537413312|FG001|Randomization|Participant Withdrew Consent|2|||
148982171|NCT02617589|537413311|FG000|Treatment|Other Reasons|3|||
148982172|NCT02617589|537413312|FG001|Treatment|Other Reasons|3|||
148982173|NCT02617589|537413311|FG000|Treatment|Poor/Non Compliance|1|||
148982174|NCT02617589|537413312|FG001|Treatment|Poor/Non Compliance|1|||
148982175|NCT02617589|537413311|FG000|Treatment|Maximum Clinical Benefit|0|||
148982176|NCT02617589|537413312|FG001|Treatment|Maximum Clinical Benefit|2|||
148982177|NCT02617589|537413311|FG000|Treatment|Participant Withdrew Consent|2|||
148982178|NCT02617589|537413312|FG001|Treatment|Participant Withdrew Consent|6|||
148982179|NCT02617589|537413311|FG000|Treatment|Participant Request to Discontinue|12|||
148982180|NCT02617589|537413312|FG001|Treatment|Participant Request to Discontinue|21|||
148982181|NCT02617589|537413311|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
148982182|NCT02617589|537413312|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
148982183|NCT02617589|537413311|FG000|Treatment|Death|1|||
148982184|NCT02617589|537413312|FG001|Treatment|Death|1|||
148982185|NCT02617589|537413311|FG000|Treatment|Study Drug Toxicity|27|||
148982186|NCT02617589|537413312|FG001|Treatment|Study Drug Toxicity|20|||
148982187|NCT02617589|537413311|FG000|Treatment|Disease Progression|216|||
148982188|NCT02617589|537413312|FG001|Treatment|Disease Progression|136|||
148982189|NCT01975389|537413313|FG000|Overall Study|Adverse Event|10|||
148982190|NCT01975389|537413314|FG001|Overall Study|Adverse Event|6|||
148982191|NCT01975389|537413313|FG000|Overall Study|Death|61|||
148982192|NCT01975389|537413314|FG001|Overall Study|Death|54|||
148982193|NCT01975389|537413313|FG000|Overall Study|Lost to Follow-up|81|||
148982194|NCT01975389|537413314|FG001|Overall Study|Lost to Follow-up|86|||
148982195|NCT01975389|537413313|FG000|Overall Study|Withdrawal by Subject|90|||
148982196|NCT01975389|537413314|FG001|Overall Study|Withdrawal by Subject|76|||
148982197|NCT01975389|537413313|FG000|Overall Study|Other|6|||
148982198|NCT01975389|537413314|FG001|Overall Study|Other|9|||
148982199|NCT01975389|537413313|FG000|Overall Study|Randomized, not treated|4|||
148982200|NCT01975389|537413314|FG001|Overall Study|Randomized, not treated|5|||
148982201|NCT02127307|537413315|FG000|Overall Study|Protocol Violation|36|||
148982202|NCT02127307|537413315|FG000|Overall Study|Lost to Follow-up|2|||
148982203|NCT02127307|537413315|FG000|Overall Study|Death|101|||
148982204|NCT02127307|537413315|FG000|Overall Study|Other than specified above|169|||
148982205|NCT01312961|537413316|FG000|Overall Study|Adverse Event|3|||
148982206|NCT01312961|537413317|FG001|Overall Study|Adverse Event|3|||
148982207|NCT01312961|537413316|FG000|Overall Study|Lack of Efficacy|11|||
149028827|NCT01080131|537582077|FG001|Core Study (0- 12 Weeks)|Death|0|||
149028828|NCT01080131|537582076|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
149028829|NCT01080131|537582077|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
149028830|NCT01080131|537582076|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
149028831|NCT01080131|537582077|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
149028832|NCT01080131|537582076|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
148982208|NCT01312961|537413317|FG001|Overall Study|Lack of Efficacy|1|||
148982209|NCT01312961|537413316|FG000|Overall Study|Poor compliance to protocol|1|||
148982210|NCT01312961|537413317|FG001|Overall Study|Poor compliance to protocol|0|||
148982211|NCT01312961|537413316|FG000|Overall Study|Other than specified above|2|||
148982212|NCT01312961|537413317|FG001|Overall Study|Other than specified above|3|||
149028833|NCT01080131|537582077|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
149028834|NCT01080131|537582076|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
149028835|NCT01080131|537582077|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
149028836|NCT01080131|537582076|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
149028837|NCT01080131|537582077|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
149028838|NCT01080131|537582076|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
149028839|NCT01080131|537582077|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
149028840|NCT01080131|537582076|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
149028841|NCT01080131|537582077|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
149028842|NCT01080131|537582076|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
149028843|NCT01080131|537582077|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
149028844|NCT00299702|537582080|FG000|Overall Study|Death|1|||
149028845|NCT00299702|537582081|FG001|Overall Study|Death|0|||
149028846|NCT00299702|537582080|FG000|Overall Study|Adverse Event|0|||
149028847|NCT00299702|537582081|FG001|Overall Study|Adverse Event|4|||
149028848|NCT00299702|537582080|FG000|Overall Study|Lost to Follow-up|18|||
149028849|NCT00299702|537582081|FG001|Overall Study|Lost to Follow-up|10|||
149028850|NCT00299702|537582080|FG000|Overall Study|Withdrawal by Subject|25|||
149028851|NCT00299702|537582081|FG001|Overall Study|Withdrawal by Subject|23|||
149028852|NCT00299702|537582080|FG000|Overall Study|Pregnancy|0|||
149028853|NCT00299702|537582081|FG001|Overall Study|Pregnancy|1|||
149028854|NCT00299702|537582080|FG000|Overall Study|Insufficient Response|4|||
149028855|NCT00299702|537582081|FG001|Overall Study|Insufficient Response|3|||
149028856|NCT00299702|537582080|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
149028857|NCT00299702|537582081|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
148836497|NCT00524121|536882539|FG000|Overall Study|Not treated (changed mind)|1|||
148836498|NCT01128569|536882540|FG000|Washout Period 1|Adverse Event|0|||
148836499|NCT01128569|536882541|FG001|Washout Period 1|Adverse Event|0|||
148836500|NCT01128569|536882542|FG002|Washout Period 1|Adverse Event|1|||
148836501|NCT01128569|536882543|FG003|Washout Period 1|Adverse Event|0|||
148836502|NCT01128569|536882544|FG004|Washout Period 1|Adverse Event|0|||
148836503|NCT01128569|536882545|FG005|Washout Period 1|Adverse Event|0|||
148836504|NCT01128569|536882540|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148836505|NCT01128569|536882541|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148836506|NCT01128569|536882542|FG002|Treatment Period 2|Withdrawal by Subject|0|||
148836507|NCT01128569|536882543|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148836508|NCT01128569|536882544|FG004|Treatment Period 2|Withdrawal by Subject|0|||
149028858|NCT01560949|537582082|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
149028859|NCT01560949|537582082|FG000|Surgery Phase|Physician Decision|3|||
149028860|NCT00751036|537582083|FG000|Overall Study|Disease Progression|28|||
149028861|NCT00751036|537582084|FG001|Overall Study|Disease Progression|29|||
148836509|NCT01128569|536882545|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149028862|NCT00751036|537582083|FG000|Overall Study|Adverse Event|6|||
149028863|NCT00751036|537582084|FG001|Overall Study|Adverse Event|4|||
149028864|NCT00751036|537582083|FG000|Overall Study|Administrative Problems|3|||
149028865|NCT00751036|537582084|FG001|Overall Study|Administrative Problems|4|||
149028866|NCT00751036|537582083|FG000|Overall Study|Withdrawal by Subject|5|||
149028867|NCT00751036|537582084|FG001|Overall Study|Withdrawal by Subject|2|||
149028868|NCT00751036|537582083|FG000|Overall Study|Death|3|||
149028869|NCT00751036|537582084|FG001|Overall Study|Death|3|||
149028870|NCT00751036|537582083|FG000|Overall Study|Lost to Follow-up|0|||
149028871|NCT00751036|537582084|FG001|Overall Study|Lost to Follow-up|1|||
149028872|NCT00751036|537582083|FG000|Overall Study|Protocol Violation|1|||
149028873|NCT00751036|537582084|FG001|Overall Study|Protocol Violation|0|||
149028874|NCT00751036|537582083|FG000|Overall Study|Missing end of Treatment Page|2|||
149028875|NCT00751036|537582084|FG001|Overall Study|Missing end of Treatment Page|3|||
149028876|NCT04580407|537582085|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
149028877|NCT04155424|537582096|FG000|Overall Study|Other than specified|3|||
149028878|NCT04155424|537582096|FG000|Overall Study|Withdrawal by Subject|1|||
149028879|NCT04155424|537582096|FG000|Overall Study|Adverse Event|1|||
149028880|NCT01677936|537583735|FG000|Overall Study|Lost to Follow-up|4|||
148836510|NCT01865487|536882549|FG000|Overall Study|Lost to Follow-up|0|||
148836511|NCT01865487|536882550|FG001|Overall Study|Lost to Follow-up|0|||
148836512|NCT01865487|536882551|FG002|Overall Study|Lost to Follow-up|0|||
148836513|NCT01865487|536882552|FG003|Overall Study|Lost to Follow-up|1|||
149028881|NCT01677936|537583736|FG001|Overall Study|Lost to Follow-up|1|||
149028882|NCT01677936|537583735|FG000|Overall Study|Protocol Violation|3|||
149028883|NCT01677936|537583736|FG001|Overall Study|Protocol Violation|0|||
149028884|NCT01677936|537583735|FG000|Overall Study|Adverse Event|1|||
149028885|NCT01677936|537583736|FG001|Overall Study|Adverse Event|0|||
148836514|NCT01865487|536882553|FG004|Overall Study|Lost to Follow-up|0|||
148836515|NCT01865487|536882554|FG005|Overall Study|Lost to Follow-up|0|||
149028886|NCT01677936|537583735|FG000|Overall Study|Lost to Follow-up|1|||
149028887|NCT01677936|537583736|FG001|Overall Study|Lost to Follow-up|0|||
149028888|NCT01677936|537583735|FG000|Overall Study|Protocol Violation|0|||
149028889|NCT01677936|537583736|FG001|Overall Study|Protocol Violation|4|||
148836516|NCT01865487|536882555|FG006|Overall Study|Lost to Follow-up|1|||
148836517|NCT01865487|536882556|FG007|Overall Study|Lost to Follow-up|0|||
148836518|NCT01865487|536882557|FG008|Overall Study|Lost to Follow-up|0|||
148836519|NCT01865487|536882558|FG009|Overall Study|Lost to Follow-up|0|||
148836520|NCT01865487|536882549|FG000|Overall Study|Withdrawal by Subject|0|||
149028890|NCT03837028|537583737|FG000|Overall Study|Lost to Follow-up|4|||
149028891|NCT03837028|537583738|FG001|Overall Study|Lost to Follow-up|0|||
149028892|NCT03837028|537583739|FG002|Overall Study|Lost to Follow-up|2|||
149028893|NCT03837028|537583740|FG003|Overall Study|Lost to Follow-up|0|||
149028894|NCT03837028|537583737|FG000|Overall Study|Withdrawal by Subject|12|||
149028895|NCT03837028|537583738|FG001|Overall Study|Withdrawal by Subject|11|||
149028896|NCT03837028|537583739|FG002|Overall Study|Withdrawal by Subject|11|||
149028897|NCT03837028|537583740|FG003|Overall Study|Withdrawal by Subject|7|||
149028898|NCT00157014|537583741|FG000|Overall Study|Death|4|||
149028899|NCT00157014|537583742|FG001|Overall Study|Death|2|||
149028900|NCT00157014|537583743|FG002|Overall Study|Death|1|||
149028901|NCT00157014|537583744|FG003|Overall Study|Death|1|||
149028902|NCT00157014|537583741|FG000|Overall Study|Physician Decision|0|||
149028903|NCT00157014|537583742|FG001|Overall Study|Physician Decision|1|||
149028904|NCT00157014|537583743|FG002|Overall Study|Physician Decision|0|||
149028905|NCT00157014|537583744|FG003|Overall Study|Physician Decision|0|||
149028906|NCT00157014|537583741|FG000|Overall Study|Medications withdrawn on family request|0|||
149028907|NCT00157014|537583742|FG001|Overall Study|Medications withdrawn on family request|1|||
149028908|NCT00157014|537583743|FG002|Overall Study|Medications withdrawn on family request|0|||
149028909|NCT00157014|537583744|FG003|Overall Study|Medications withdrawn on family request|0|||
149028910|NCT00157014|537583741|FG000|Overall Study|Patient withdrawn by investigator|1|||
148836521|NCT01865487|536882550|FG001|Overall Study|Withdrawal by Subject|0|||
148836522|NCT01865487|536882551|FG002|Overall Study|Withdrawal by Subject|0|||
148836523|NCT01865487|536882552|FG003|Overall Study|Withdrawal by Subject|0|||
148836524|NCT01865487|536882553|FG004|Overall Study|Withdrawal by Subject|1|||
148836525|NCT01865487|536882554|FG005|Overall Study|Withdrawal by Subject|0|||
148836526|NCT01865487|536882555|FG006|Overall Study|Withdrawal by Subject|0|||
148836527|NCT01865487|536882556|FG007|Overall Study|Withdrawal by Subject|0|||
148836528|NCT01865487|536882557|FG008|Overall Study|Withdrawal by Subject|0|||
148836529|NCT01865487|536882558|FG009|Overall Study|Withdrawal by Subject|0|||
148836530|NCT01213082|536882559|FG000|Overall Study|Lost to Follow-up|6|||
148836531|NCT01213082|536882560|FG001|Overall Study|Lost to Follow-up|7|||
148836532|NCT01213082|536882561|FG002|Overall Study|Lost to Follow-up|4|||
148836533|NCT01213082|536882559|FG000|Overall Study|Physician Decision|0|||
148836534|NCT01213082|536882560|FG001|Overall Study|Physician Decision|0|||
148836535|NCT01213082|536882561|FG002|Overall Study|Physician Decision|1|||
148836536|NCT01627691|536882565|FG000|Overall Study|Death|11|||
148836537|NCT01627691|536882565|FG000|Overall Study|Lost to Follow-up|3|||
148982213|NCT03246529|537413319|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
148982214|NCT03246529|537413320|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
148982215|NCT03246529|537413321|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
148836538|NCT01627691|536882565|FG000|Overall Study|Withdrawal by Subject|1|||
148836539|NCT01627691|536882565|FG000|Overall Study|Missed the visit|3|||
148836540|NCT03218917|536882566|FG000|Overall Study|Adverse Event|3|||
148836541|NCT03218917|536882567|FG001|Overall Study|Adverse Event|3|||
148836542|NCT03218917|536882568|FG002|Overall Study|Adverse Event|2|||
148836543|NCT03218917|536882566|FG000|Overall Study|Subject withdrew consent|2|||
148836544|NCT03218917|536882567|FG001|Overall Study|Subject withdrew consent|4|||
148982216|NCT03246529|537413319|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
148982217|NCT03246529|537413320|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
148982218|NCT03246529|537413321|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
148982219|NCT03246529|537413319|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
148982220|NCT03246529|537413320|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
148982221|NCT03246529|537413321|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
148982222|NCT03246529|537413319|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
148982223|NCT03246529|537413320|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
148982224|NCT03246529|537413321|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
148836545|NCT03218917|536882568|FG002|Overall Study|Subject withdrew consent|10|||
148836546|NCT03218917|536882566|FG000|Overall Study|Physician Decision|0|||
148836547|NCT03218917|536882567|FG001|Overall Study|Physician Decision|1|||
148836548|NCT03218917|536882568|FG002|Overall Study|Physician Decision|1|||
148836549|NCT03218917|536882566|FG000|Overall Study|Lost to Follow-up|1|||
148836550|NCT03218917|536882567|FG001|Overall Study|Lost to Follow-up|0|||
149028911|NCT00157014|537583742|FG001|Overall Study|Patient withdrawn by investigator|0|||
149028912|NCT00157014|537583743|FG002|Overall Study|Patient withdrawn by investigator|0|||
149028913|NCT00157014|537583744|FG003|Overall Study|Patient withdrawn by investigator|0|||
148836551|NCT03218917|536882568|FG002|Overall Study|Lost to Follow-up|0|||
148836552|NCT03218917|536882566|FG000|Overall Study|Reason Missing|0|||
148836553|NCT03218917|536882567|FG001|Overall Study|Reason Missing|2|||
148836554|NCT03218917|536882568|FG002|Overall Study|Reason Missing|0|||
148836555|NCT03218917|536882566|FG000|Overall Study|Death|0|||
148836556|NCT03218917|536882567|FG001|Overall Study|Death|1|||
148836557|NCT03218917|536882568|FG002|Overall Study|Death|0|||
148836558|NCT03218917|536882566|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148836559|NCT03218917|536882567|FG001|Overall Study|Non-Compliance with Study Drug|1|||
148836560|NCT03218917|536882568|FG002|Overall Study|Non-Compliance with Study Drug|0|||
148836561|NCT01307449|536882569|FG000|Overall Study|Adverse Event|1|||
148836562|NCT01307449|536882570|FG001|Overall Study|Adverse Event|0|||
148836563|NCT01307449|536882571|FG002|Overall Study|Adverse Event|0|||
148836564|NCT01307449|536882572|FG003|Overall Study|Adverse Event|0|||
148836565|NCT05209386|536882573|FG000|Overall Study|Withdrawal by Subject|8|||
148836566|NCT05209386|536882573|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
148836567|NCT03440008|536882576|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
148836568|NCT03440008|536882577|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
148836569|NCT03440008|536882576|FG000|Overall Study|Withdrawal by Subject|1|||
148836570|NCT03440008|536882577|FG001|Overall Study|Withdrawal by Subject|0|||
148836571|NCT01570387|536882585|FG000|Overall Study|Adverse Event|1|||
148836572|NCT01570387|536882586|FG001|Overall Study|Adverse Event|0|||
148836573|NCT01570387|536882587|FG002|Overall Study|Adverse Event|0|||
148836574|NCT01570387|536882588|FG003|Overall Study|Adverse Event|0|||
148836575|NCT01570387|536882585|FG000|Overall Study|Death|0|||
148836576|NCT01570387|536882586|FG001|Overall Study|Death|0|||
148836577|NCT01570387|536882587|FG002|Overall Study|Death|0|||
148836578|NCT01570387|536882588|FG003|Overall Study|Death|1|||
148836579|NCT01570387|536882585|FG000|Overall Study|Withdrawal by Subject|0|||
148836580|NCT01570387|536882586|FG001|Overall Study|Withdrawal by Subject|0|||
148836581|NCT01570387|536882587|FG002|Overall Study|Withdrawal by Subject|0|||
148836582|NCT01570387|536882588|FG003|Overall Study|Withdrawal by Subject|1|||
148836583|NCT03139448|536882589|FG000|Overall Study|Lack of Efficacy|6|||
148836584|NCT03139448|536882590|FG001|Overall Study|Lack of Efficacy|7|||
148836585|NCT03139448|536882589|FG000|Overall Study|Location of procedure changed|2|||
148836586|NCT03139448|536882590|FG001|Overall Study|Location of procedure changed|8|||
148836587|NCT03139448|536882589|FG000|Overall Study|Withdrawal by Subject|3|||
148836588|NCT03139448|536882590|FG001|Overall Study|Withdrawal by Subject|6|||
148836589|NCT03139448|536882589|FG000|Overall Study|Screen fail|1|||
148836590|NCT03139448|536882590|FG001|Overall Study|Screen fail|3|||
148836591|NCT03139448|536882589|FG000|Overall Study|Physician Decision|0|||
148836592|NCT03139448|536882590|FG001|Overall Study|Physician Decision|2|||
148836593|NCT02943473|536882591|FG000|Overall Study|enrolled but not dosed|1|||
148836594|NCT02943473|536882591|FG000|Overall Study|screen failure|1|||
148836595|NCT02943473|536882591|FG000|Overall Study|Physician Decision|4|||
148836596|NCT01567722|536882594|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
148836597|NCT01567722|536882595|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
148836598|NCT01567722|536882596|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
148836599|NCT01567722|536882594|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
148836600|NCT01567722|536882595|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
148836601|NCT01567722|536882596|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
148836602|NCT01567722|536882594|FG000|Overall Study|Protocol closure by the OCG|2|||
148836603|NCT01567722|536882595|FG001|Overall Study|Protocol closure by the OCG|0|||
148836604|NCT01567722|536882596|FG002|Overall Study|Protocol closure by the OCG|0|||
148836605|NCT01567722|536882594|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
148836606|NCT01567722|536882595|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
148836607|NCT01567722|536882596|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
148836608|NCT03323164|536882600|FG000|Overall Study|Poor quality imaging/scans|2|||
148836609|NCT03323164|536882601|FG001|Overall Study|Poor quality imaging/scans|2|||
148836610|NCT01823289|536882602|FG000|Overall Study|Lost to Follow-up|5|||
148836611|NCT01823289|536882602|FG000|Overall Study|Adverse Event|5|||
148836612|NCT01823289|536882602|FG000|Overall Study|Lack of Efficacy|1|||
148836613|NCT01823289|536882602|FG000|Overall Study|Physician Decision|9|||
148836614|NCT01823289|536882602|FG000|Overall Study|Administered contraindicated medicine|1|||
148982225|NCT03246529|537413319|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
148982226|NCT03246529|537413320|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
148982227|NCT03246529|537413321|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
148836615|NCT01823289|536882602|FG000|Overall Study|Transaminase increased more than 3 times|1|||
148836616|NCT01823289|536882602|FG000|Overall Study|Drug affected efficacy and safety|1|||
148836617|NCT01823289|536882602|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
148836618|NCT01911260|536882609|FG000|Supplementation Period|transference or evasion of school|7|||
148836619|NCT01911260|536882610|FG001|Supplementation Period|transference or evasion of school|9|||
148836620|NCT01911260|536882611|FG002|Supplementation Period|transference or evasion of school|7|||
148836621|NCT01911260|536882612|FG003|Supplementation Period|transference or evasion of school|6|||
148836622|NCT01911260|536882609|FG000|Supplementation Period|Adverse Event|2|||
148836623|NCT01911260|536882610|FG001|Supplementation Period|Adverse Event|0|||
148836624|NCT01911260|536882611|FG002|Supplementation Period|Adverse Event|1|||
148836625|NCT01911260|536882612|FG003|Supplementation Period|Adverse Event|0|||
148836626|NCT01911260|536882609|FG000|Supplementation Period|refused to receive supplement|1|||
148836627|NCT01911260|536882610|FG001|Supplementation Period|refused to receive supplement|0|||
148836628|NCT01911260|536882611|FG002|Supplementation Period|refused to receive supplement|1|||
148836629|NCT01911260|536882612|FG003|Supplementation Period|refused to receive supplement|0|||
148836630|NCT01911260|536882609|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
148836631|NCT01911260|536882610|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
148836632|NCT01911260|536882611|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
148836633|NCT01911260|536882612|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
148836634|NCT01911260|536882609|FG000|Follow-up Period|transference or evasion of school|13|||
148774113|NCT02017717|536646912|FG008|Treatment Period|Participant no longer met criteria|1|||
148774114|NCT02017717|536646904|FG000|Treatment Period|Other reasons|0|||
148774115|NCT02017717|536646905|FG001|Treatment Period|Other reasons|0|||
148774116|NCT02017717|536646906|FG002|Treatment Period|Other reasons|0|||
148774117|NCT02017717|536646907|FG003|Treatment Period|Other reasons|1|||
148774118|NCT02017717|536646908|FG004|Treatment Period|Other reasons|0|||
148774119|NCT02017717|536646909|FG005|Treatment Period|Other reasons|1|||
148836635|NCT01911260|536882610|FG001|Follow-up Period|transference or evasion of school|20|||
148836636|NCT01911260|536882611|FG002|Follow-up Period|transference or evasion of school|15|||
148836637|NCT01911260|536882612|FG003|Follow-up Period|transference or evasion of school|12|||
148836638|NCT00654732|536882613|FG000|Overall Study|Adverse Event|4|||
148836639|NCT00654732|536882614|FG001|Overall Study|Adverse Event|6|||
148836640|NCT00060944|536882615|FG000|Overall Study|Adverse Event|12|||
148836641|NCT00060944|536882616|FG001|Overall Study|Adverse Event|10|||
148836642|NCT00060944|536882615|FG000|Overall Study|Death|2|||
148836643|NCT00060944|536882616|FG001|Overall Study|Death|3|||
148836644|NCT00060944|536882615|FG000|Overall Study|Withdrawal by Subject|18|||
148836645|NCT00060944|536882616|FG001|Overall Study|Withdrawal by Subject|5|||
148836646|NCT00060944|536882615|FG000|Overall Study|Disease Progression|93|||
148836647|NCT00060944|536882616|FG001|Overall Study|Disease Progression|94|||
148836648|NCT00060944|536882615|FG000|Overall Study|Lost to Follow-up|1|||
148836649|NCT00060944|536882616|FG001|Overall Study|Lost to Follow-up|0|||
148836650|NCT00060944|536882615|FG000|Overall Study|Subject Ineligible To Continue|2|||
148836651|NCT00060944|536882616|FG001|Overall Study|Subject Ineligible To Continue|1|||
148836652|NCT00060944|536882615|FG000|Overall Study|Treatment Switch|0|||
148836653|NCT00060944|536882616|FG001|Overall Study|Treatment Switch|13|||
148836654|NCT00060944|536882615|FG000|Overall Study|Other|2|||
148836655|NCT00060944|536882616|FG001|Overall Study|Other|4|||
148836656|NCT00060944|536882615|FG000|Overall Study|randomized but not treated|6|||
148836657|NCT00060944|536882616|FG001|Overall Study|randomized but not treated|4|||
148836658|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
148836659|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
148836660|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
148836661|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Death|0|||
148836662|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Death|0|||
148836663|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Death|1|||
148836664|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
148836665|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
148836666|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
148836667|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
148836668|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
148836669|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
148836670|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
148836671|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
148836672|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
148836673|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Graft loss|0|||
148836674|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Graft loss|0|||
148836675|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Graft loss|7|||
148836676|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
148836677|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
148836678|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
148836679|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
148836680|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
148836681|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
148774120|NCT02017717|536646910|FG006|Treatment Period|Other reasons|1|||
148774121|NCT02017717|536646911|FG007|Treatment Period|Other reasons|1|||
148836682|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
148836683|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
148982228|NCT03246529|537413319|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
148982229|NCT03246529|537413320|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
148982230|NCT03246529|537413321|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
148982231|NCT03246529|537413319|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
148982232|NCT03246529|537413320|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
148982233|NCT03246529|537413321|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
148982234|NCT03246529|537413319|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
148982235|NCT03246529|537413320|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
148982236|NCT03246529|537413321|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
148982237|NCT03246529|537413319|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
148982238|NCT03246529|537413320|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
148982239|NCT03246529|537413321|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
148982240|NCT03003676|537415276|FG000|Overall Study|Lack of Efficacy|5|||
148982241|NCT03003676|537415277|FG001|Overall Study|Lack of Efficacy|7|||
148982242|NCT03003676|537415276|FG000|Overall Study|Withdrawal by Subject|0|||
148982243|NCT03003676|537415277|FG001|Overall Study|Withdrawal by Subject|1|||
148982244|NCT03003676|537415276|FG000|Overall Study|Hepatitis B infection|1|||
148982245|NCT03003676|537415277|FG001|Overall Study|Hepatitis B infection|0|||
148982246|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
148982247|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
148982248|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
148982249|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
148982250|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
148982251|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
148982252|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
148982253|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
148982254|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
148982255|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
148982256|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
148982257|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
148982258|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
148982259|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
148982260|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
148982261|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
148982262|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
148982263|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
148982264|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982265|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
148982266|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
148982267|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982268|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982269|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982270|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982271|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982272|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
148982273|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
148982274|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
148982275|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
148982276|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
148982277|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
148982278|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
148982279|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
148982280|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
148982281|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
148982282|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982283|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
148982284|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982285|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982286|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982287|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982288|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982289|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982290|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
148982291|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
148982292|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148836684|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
148836685|NCT00956293|536882621|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
148836686|NCT00956293|536882622|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
148836687|NCT00956293|536882623|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
148836688|NCT00956293|536882621|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
148836689|NCT00956293|536882622|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
148836690|NCT00956293|536882623|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
148836691|NCT00956293|536882621|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
148836692|NCT00956293|536882622|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
148836693|NCT00956293|536882623|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
148836694|NCT00956293|536882621|FG000|Main Period (Randomization)|Adverse Event|0|||
148836695|NCT00956293|536882622|FG001|Main Period (Randomization)|Adverse Event|15|||
148836696|NCT00956293|536882623|FG002|Main Period (Randomization)|Adverse Event|0|||
148836697|NCT00956293|536882621|FG000|Follow-up Period|Follow-up period was terminated.|20|||
148836698|NCT00956293|536882622|FG001|Follow-up Period|Follow-up period was terminated.|32|||
148836699|NCT00956293|536882623|FG002|Follow-up Period|Follow-up period was terminated.|0|||
148836700|NCT02359903|536882624|FG000|Overall Study|Adverse Event|0|||
148836701|NCT02359903|536882625|FG001|Overall Study|Adverse Event|2|||
148836702|NCT03383666|536882626|FG000|Overall Study|Withdrawal by Subject|2|||
148836703|NCT03383666|536882626|FG000|Overall Study|Lost to Follow-up|2|||
148836704|NCT02536664|536882627|FG000|Overall Study|Inadequate completion of documentation|2|||
148836705|NCT02536664|536882628|FG001|Overall Study|Inadequate completion of documentation|4|||
148836706|NCT02536664|536882627|FG000|Overall Study|Progression|13|||
148836707|NCT02536664|536882628|FG001|Overall Study|Progression|18|||
148836708|NCT02536664|536882627|FG000|Overall Study|Death due to lymphoma|2|||
148836709|NCT02536664|536882628|FG001|Overall Study|Death due to lymphoma|1|||
148836710|NCT02536664|536882627|FG000|Overall Study|Death due to other reason|3|||
148836711|NCT02536664|536882628|FG001|Overall Study|Death due to other reason|2|||
148836712|NCT02536664|536882627|FG000|Overall Study|Intolerability|8|||
148836713|NCT02536664|536882628|FG001|Overall Study|Intolerability|6|||
148836714|NCT02536664|536882627|FG000|Overall Study|Withdrawal by Subject|8|||
148836715|NCT02536664|536882628|FG001|Overall Study|Withdrawal by Subject|5|||
148836716|NCT02536664|536882627|FG000|Overall Study|Other|18|||
148836717|NCT02536664|536882628|FG001|Overall Study|Other|24|||
148836718|NCT02536664|536882627|FG000|Overall Study|Missing|53|||
148836719|NCT02536664|536882628|FG001|Overall Study|Missing|20|||
148836720|NCT03507127|536882636|FG000|Overall Study|Withdrawal by Subject|1|||
148836721|NCT03507127|536882637|FG001|Overall Study|Withdrawal by Subject|0|||
148836722|NCT03507127|536882636|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
148836723|NCT03507127|536882637|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
148836724|NCT01240863|536882638|FG000|Open-label Titration Period|Adverse Event|47|||
148836725|NCT01240863|536882639|FG001|Open-label Titration Period|Adverse Event|0|||
148836726|NCT01240863|536882640|FG002|Open-label Titration Period|Adverse Event|0|||
148836727|NCT01240863|536882638|FG000|Open-label Titration Period|Lack of Efficacy|19|||
148836728|NCT01240863|536882639|FG001|Open-label Titration Period|Lack of Efficacy|0|||
148836729|NCT01240863|536882640|FG002|Open-label Titration Period|Lack of Efficacy|0|||
148836730|NCT01240863|536882638|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
148836731|NCT01240863|536882639|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
148836732|NCT01240863|536882640|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
148836733|NCT01240863|536882638|FG000|Open-label Titration Period|Protocol Violation|7|||
148836734|NCT01240863|536882639|FG001|Open-label Titration Period|Protocol Violation|0|||
148836735|NCT01240863|536882640|FG002|Open-label Titration Period|Protocol Violation|0|||
148836736|NCT01240863|536882638|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
148982293|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982294|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982295|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982296|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982297|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982298|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982299|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
148982300|NCT01172938|537415282|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
148982301|NCT01172938|537415283|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
148982302|NCT01172938|537415284|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
148836737|NCT01240863|536882639|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
148836738|NCT01240863|536882640|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
148836739|NCT01240863|536882638|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
148982303|NCT01172938|537415285|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
148836740|NCT01240863|536882639|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
148982304|NCT01172938|537415286|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
148982305|NCT01172938|537415287|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
148982306|NCT01172938|537415288|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
148836741|NCT01240863|536882640|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
148982307|NCT01172938|537415289|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
148982308|NCT01172938|537415290|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
148982309|NCT01172938|537415282|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
148982310|NCT01172938|537415283|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
148982311|NCT01172938|537415284|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
148982312|NCT01172938|537415285|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
148982313|NCT01172938|537415286|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
148982314|NCT01172938|537415287|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
148982315|NCT01172938|537415288|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
148982316|NCT01172938|537415289|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
148982317|NCT01172938|537415290|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
148982318|NCT01172938|537415282|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
148982319|NCT01172938|537415283|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
148982320|NCT01172938|537415284|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
148982321|NCT01172938|537415285|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
148982322|NCT01172938|537415286|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
148982323|NCT01172938|537415287|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
148982324|NCT01172938|537415288|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
148982325|NCT01172938|537415289|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
148982326|NCT01172938|537415290|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
148982327|NCT01172938|537415282|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982328|NCT01172938|537415283|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982329|NCT01172938|537415284|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
148836742|NCT01240863|536882638|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
148836743|NCT01240863|536882639|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
148836744|NCT01240863|536882640|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
148836745|NCT01240863|536882638|FG000|Open-label Titration Period|Other|7|||
148836746|NCT01240863|536882639|FG001|Open-label Titration Period|Other|0|||
148836747|NCT01240863|536882640|FG002|Open-label Titration Period|Other|0|||
148836748|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
148836749|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
148836750|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
148836751|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
148836752|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
148836753|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
148836754|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
148836755|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
148836756|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
148836757|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
148982330|NCT01172938|537415285|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982331|NCT01172938|537415286|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982332|NCT01172938|537415287|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982333|NCT01172938|537415288|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982334|NCT01172938|537415289|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982335|NCT01172938|537415290|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
148982336|NCT01172938|537415282|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
148982337|NCT01172938|537415283|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
148982338|NCT01172938|537415284|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
148982339|NCT01172938|537415285|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
148982340|NCT01172938|537415286|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
148982341|NCT01172938|537415287|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
148982342|NCT01172938|537415288|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
148982343|NCT01172938|537415289|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
148982344|NCT01172938|537415290|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
148982345|NCT01172938|537415282|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
148982346|NCT01172938|537415283|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
148982347|NCT01172938|537415284|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
148982348|NCT01172938|537415285|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
148982349|NCT01172938|537415286|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
148836758|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
148836759|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
148836760|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
149028914|NCT00157014|537583741|FG000|Overall Study|Patient unable to return in nursing home|1|||
149028915|NCT00157014|537583742|FG001|Overall Study|Patient unable to return in nursing home|0|||
149028916|NCT00157014|537583743|FG002|Overall Study|Patient unable to return in nursing home|0|||
149028917|NCT00157014|537583744|FG003|Overall Study|Patient unable to return in nursing home|0|||
149028918|NCT00157014|537583741|FG000|Overall Study|Patient would not receive transplant|0|||
149028919|NCT00157014|537583742|FG001|Overall Study|Patient would not receive transplant|1|||
149028920|NCT00157014|537583743|FG002|Overall Study|Patient would not receive transplant|0|||
149028921|NCT00157014|537583744|FG003|Overall Study|Patient would not receive transplant|0|||
149028922|NCT00157014|537583741|FG000|Overall Study|Withdrawal by Subject|1|||
149028923|NCT00157014|537583742|FG001|Overall Study|Withdrawal by Subject|0|||
149028924|NCT00157014|537583743|FG002|Overall Study|Withdrawal by Subject|0|||
149028925|NCT00157014|537583744|FG003|Overall Study|Withdrawal by Subject|0|||
149028926|NCT01362491|537583745|FG000|Overall Study|Ineligible|1|||
149028927|NCT01362491|537583746|FG001|Overall Study|Ineligible|0|||
149028928|NCT01362491|537583747|FG002|Overall Study|Ineligible|0|||
149028929|NCT00886613|537583752|FG000|Overall Study|Protocol deviation (Part B)|1|||
149028930|NCT00886613|537583753|FG001|Overall Study|Protocol deviation (Part B)|0|||
149028931|NCT00886613|537583754|FG002|Overall Study|Protocol deviation (Part B)|0|||
149028932|NCT00886613|537583752|FG000|Overall Study|Lost to follow-up (Part B)|1|||
149028933|NCT00886613|537583753|FG001|Overall Study|Lost to follow-up (Part B)|0|||
149028934|NCT00886613|537583754|FG002|Overall Study|Lost to follow-up (Part B)|1|||
149028935|NCT00886613|537583752|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
149028936|NCT00886613|537583753|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
149028937|NCT00886613|537583754|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
149028938|NCT04577183|537583758|FG000|Overall Study|Death|1|||
149028939|NCT04577183|537583758|FG000|Overall Study|Withdrawal by Subject|3|||
149028940|NCT04577183|537583758|FG000|Overall Study|Early termination|2|||
149028941|NCT02072226|537583763|FG000|Overall Study|Lost to Follow-up|11|||
149028942|NCT02072226|537583764|FG001|Overall Study|Lost to Follow-up|7|||
149028943|NCT02072226|537583763|FG000|Overall Study|Patient Non-compliance|2|||
149028944|NCT02072226|537583764|FG001|Overall Study|Patient Non-compliance|3|||
149028945|NCT02072226|537583763|FG000|Overall Study|Death|1|||
149028946|NCT02072226|537583764|FG001|Overall Study|Death|0|||
149028947|NCT02072226|537583763|FG000|Overall Study|Patient Withdrawal of Consent|1|||
149028948|NCT02072226|537583764|FG001|Overall Study|Patient Withdrawal of Consent|0|||
149028949|NCT03255018|537583766|FG000|Overall Study|Death on study|0|||
149028950|NCT03255018|537583767|FG001|Overall Study|Death on study|5|||
149028951|NCT03255018|537583766|FG000|Overall Study|Withdrawal by Subject|0|||
149028952|NCT03255018|537583767|FG001|Overall Study|Withdrawal by Subject|2|||
149028953|NCT01720043|537583769|FG000|Overall Study|Withdrawal by Subject|1|||
149028954|NCT01688973|537583770|FG000|Overall Study|Ineligible|2|||
149028955|NCT01688973|537583771|FG001|Overall Study|Ineligible|3|||
149028956|NCT01124162|537583774|FG000|First Intervention|Adverse Event|2|||
149028957|NCT01124162|537583775|FG001|First Intervention|Adverse Event|0|||
149028958|NCT01124162|537583774|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
149028959|NCT01124162|537583775|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149028960|NCT03613129|537583783|FG000|Pre-treatment Assessment|Protocol Violation|2|||
149028961|NCT03613129|537583784|FG001|Pre-treatment Assessment|Protocol Violation|0|||
149028962|NCT03613129|537583785|FG002|Pre-treatment Assessment|Protocol Violation|0|||
149028963|NCT03613129|537583786|FG003|Pre-treatment Assessment|Protocol Violation|0|||
149028964|NCT03613129|537583787|FG004|Pre-treatment Assessment|Protocol Violation|0|||
149028965|NCT03613129|537583783|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
149028966|NCT03613129|537583784|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
149028967|NCT03613129|537583785|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
149028968|NCT03613129|537583786|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
149028969|NCT03613129|537583787|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
149028970|NCT00938340|537583788|FG000|Overall Study|Withdrawal by Subject|3|||
149028971|NCT00938340|537583788|FG000|Overall Study|Protocol Violation|1|||
149028972|NCT00938340|537583788|FG000|Overall Study|Adverse Event|1|||
149028973|NCT02534896|537583789|FG000|Overall Study|Adverse Event|2|||
149028974|NCT02534896|537583790|FG001|Overall Study|Adverse Event|1|||
149028975|NCT02534896|537583791|FG002|Overall Study|Adverse Event|1|||
149028976|NCT02534896|537583789|FG000|Overall Study|Insufficient therapeutic response|2|||
149028977|NCT02534896|537583790|FG001|Overall Study|Insufficient therapeutic response|0|||
149028978|NCT02534896|537583791|FG002|Overall Study|Insufficient therapeutic response|0|||
149028979|NCT00711646|537583794|FG000|Overall Study|Adverse Event|6|||
149028980|NCT00711646|537583795|FG001|Overall Study|Adverse Event|1|||
149028981|NCT00711646|537583794|FG000|Overall Study|Withdrawal by Subject|4|||
149028982|NCT00711646|537583795|FG001|Overall Study|Withdrawal by Subject|0|||
149028983|NCT00711646|537583794|FG000|Overall Study|Protocol Violation|0|||
149028984|NCT00711646|537583795|FG001|Overall Study|Protocol Violation|1|||
149028985|NCT00711646|537583794|FG000|Overall Study|Lost to Follow-up|1|||
149028986|NCT00711646|537583795|FG001|Overall Study|Lost to Follow-up|0|||
149028987|NCT00711646|537583794|FG000|Overall Study|administrative decision|0|||
149028988|NCT00711646|537583795|FG001|Overall Study|administrative decision|1|||
149028989|NCT00711646|537583794|FG000|Overall Study|patient non-compliance|1|||
148836761|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
148836762|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
148836763|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
148836764|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
148836765|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
148836766|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
148836767|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
148836768|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
148836769|NCT01240863|536882638|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
148836770|NCT01240863|536882639|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
148836771|NCT01240863|536882640|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
148836772|NCT00746811|536882645|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
148836773|NCT00746811|536882646|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
148836774|NCT02505425|536882650|FG000|Overall Study|Lost to Follow-up|41|||
148836775|NCT02505425|536882651|FG001|Overall Study|Lost to Follow-up|61|||
148836776|NCT02505425|536882652|FG002|Overall Study|Lost to Follow-up|31|||
148836777|NCT02505425|536882653|FG003|Overall Study|Lost to Follow-up|19|||
148836778|NCT02505425|536882650|FG000|Overall Study|Withdrawal by Subject|39|||
148836779|NCT02505425|536882651|FG001|Overall Study|Withdrawal by Subject|9|||
148836780|NCT02505425|536882652|FG002|Overall Study|Withdrawal by Subject|19|||
148836781|NCT02505425|536882653|FG003|Overall Study|Withdrawal by Subject|7|||
148836782|NCT02505425|536882650|FG000|Overall Study|Death|8|||
148836783|NCT02505425|536882651|FG001|Overall Study|Death|12|||
148836784|NCT02505425|536882652|FG002|Overall Study|Death|0|||
148836785|NCT02505425|536882653|FG003|Overall Study|Death|0|||
148836786|NCT02031302|536882654|FG000|Overall Study|Death|115|||
148836787|NCT02031302|536882655|FG001|Overall Study|Death|0|||
148836788|NCT02031302|536882654|FG000|Overall Study|Not treated with study valve system|18|||
148836789|NCT02031302|536882655|FG001|Overall Study|Not treated with study valve system|0|||
148836790|NCT02031302|536882654|FG000|Overall Study|Missed Follow Up|27|||
148836791|NCT02031302|536882655|FG001|Overall Study|Missed Follow Up|0|||
148836792|NCT02031302|536882654|FG000|Overall Study|Lost to Follow-up|4|||
148836793|NCT02031302|536882655|FG001|Overall Study|Lost to Follow-up|0|||
148836794|NCT01405196|536882661|FG000|Overall Study|Study Terminated by Sponsor|0|||
148836795|NCT01405196|536882662|FG001|Overall Study|Study Terminated by Sponsor|0|||
148836796|NCT01405196|536882663|FG002|Overall Study|Study Terminated by Sponsor|9|||
148836797|NCT01405196|536882664|FG003|Overall Study|Study Terminated by Sponsor|0|||
148836798|NCT01405196|536882661|FG000|Overall Study|Other|2|||
148836799|NCT01405196|536882662|FG001|Overall Study|Other|2|||
148836800|NCT01405196|536882663|FG002|Overall Study|Other|5|||
148836801|NCT01405196|536882664|FG003|Overall Study|Other|0|||
148836802|NCT01405196|536882661|FG000|Overall Study|Withdrawal by Subject|4|||
148836803|NCT01405196|536882662|FG001|Overall Study|Withdrawal by Subject|6|||
148836804|NCT01405196|536882663|FG002|Overall Study|Withdrawal by Subject|3|||
148836805|NCT01405196|536882664|FG003|Overall Study|Withdrawal by Subject|6|||
148836806|NCT01405196|536882661|FG000|Overall Study|Adverse Event|2|||
148836807|NCT01405196|536882662|FG001|Overall Study|Adverse Event|2|||
148836808|NCT01405196|536882663|FG002|Overall Study|Adverse Event|0|||
148836809|NCT01405196|536882664|FG003|Overall Study|Adverse Event|2|||
148836810|NCT01405196|536882661|FG000|Overall Study|Death|1|||
148836811|NCT01405196|536882662|FG001|Overall Study|Death|0|||
148836812|NCT01405196|536882663|FG002|Overall Study|Death|3|||
148836813|NCT01405196|536882664|FG003|Overall Study|Death|0|||
148836814|NCT01405196|536882661|FG000|Overall Study|Lost to Follow-up|2|||
148982350|NCT01172938|537415287|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
148982351|NCT01172938|537415288|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
148982352|NCT01172938|537415289|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
148982353|NCT01172938|537415290|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
148982354|NCT01172938|537415282|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
148982355|NCT01172938|537415283|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
148982356|NCT01172938|537415284|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
149028990|NCT00711646|537583795|FG001|Overall Study|patient non-compliance|0|||
148836815|NCT01405196|536882662|FG001|Overall Study|Lost to Follow-up|2|||
148836816|NCT01405196|536882663|FG002|Overall Study|Lost to Follow-up|3|||
148836817|NCT01405196|536882664|FG003|Overall Study|Lost to Follow-up|1|||
148836818|NCT04704193|536882667|FG000|Overall Study|Withdrawal by Subject|1|||
148836819|NCT00542178|536882668|FG000|Overall Study|did not complete year 4 follow-up|75|||
148836820|NCT00542178|536882669|FG001|Overall Study|did not complete year 4 follow-up|80|||
148836821|NCT00542178|536882670|FG002|Overall Study|did not complete year 4 follow-up|74|||
148836822|NCT00542178|536882671|FG003|Overall Study|did not complete year 4 follow-up|62|||
148836823|NCT00542178|536882672|FG004|Overall Study|did not complete year 4 follow-up|64|||
149028991|NCT00269399|537583796|FG000|Overall Study|Lack of Efficacy|27|||
148836824|NCT00542178|536882673|FG005|Overall Study|did not complete year 4 follow-up|89|||
148836825|NCT00542178|536882674|FG006|Overall Study|did not complete year 4 follow-up|87|||
148836826|NCT00542178|536882675|FG007|Overall Study|did not complete year 4 follow-up|85|||
148836827|NCT02611037|536882678|FG000|Overall Study|Withdrawal prior to treatment|2|||
148836828|NCT02611037|536882679|FG001|Overall Study|Withdrawal prior to treatment|0|||
148836829|NCT00829998|536882680|FG000|Washout|Adverse Event|0|||
148836830|NCT00829998|536882681|FG001|Washout|Adverse Event|1|||
148836831|NCT05270863|536882682|FG000|Visit 2 First Intervention|Randomization error|0|||
148836832|NCT05270863|536882683|FG001|Visit 2 First Intervention|Randomization error|0|||
148836833|NCT05270863|536882684|FG002|Visit 2 First Intervention|Randomization error|0|||
148836834|NCT05270863|536882685|FG003|Visit 2 First Intervention|Randomization error|1|||
148836835|NCT05270863|536882686|FG004|Visit 2 First Intervention|Randomization error|0|||
148836836|NCT05270863|536882687|FG005|Visit 2 First Intervention|Randomization error|0|||
148836837|NCT05270863|536882682|FG000|First Washout|Withdrawal by Subject|0|||
148836838|NCT05270863|536882683|FG001|First Washout|Withdrawal by Subject|0|||
148836839|NCT05270863|536882684|FG002|First Washout|Withdrawal by Subject|0|||
148836840|NCT05270863|536882685|FG003|First Washout|Withdrawal by Subject|0|||
148836841|NCT05270863|536882686|FG004|First Washout|Withdrawal by Subject|1|||
148836842|NCT05270863|536882687|FG005|First Washout|Withdrawal by Subject|1|||
148836843|NCT05270863|536882682|FG000|First Washout|Lost to Follow-up|0|||
148836844|NCT05270863|536882683|FG001|First Washout|Lost to Follow-up|0|||
148836845|NCT05270863|536882684|FG002|First Washout|Lost to Follow-up|0|||
148836846|NCT05270863|536882685|FG003|First Washout|Lost to Follow-up|0|||
148836847|NCT05270863|536882686|FG004|First Washout|Lost to Follow-up|0|||
148836848|NCT05270863|536882687|FG005|First Washout|Lost to Follow-up|1|||
148836849|NCT05270863|536882682|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
148836850|NCT05270863|536882683|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
148836851|NCT05270863|536882684|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
148836852|NCT05270863|536882685|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
148836853|NCT05270863|536882686|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
148836854|NCT05270863|536882687|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
148836855|NCT05270863|536882682|FG000|Second Washout|Withdrawal by Subject|1|||
148836856|NCT05270863|536882683|FG001|Second Washout|Withdrawal by Subject|1|||
148836857|NCT05270863|536882684|FG002|Second Washout|Withdrawal by Subject|0|||
148836858|NCT05270863|536882685|FG003|Second Washout|Withdrawal by Subject|0|||
148836859|NCT05270863|536882686|FG004|Second Washout|Withdrawal by Subject|0|||
148836860|NCT05270863|536882687|FG005|Second Washout|Withdrawal by Subject|0|||
148836861|NCT05270863|536882682|FG000|Second Washout|Lost to Follow-up|0|||
148836862|NCT05270863|536882683|FG001|Second Washout|Lost to Follow-up|0|||
148836863|NCT05270863|536882684|FG002|Second Washout|Lost to Follow-up|0|||
148836864|NCT05270863|536882685|FG003|Second Washout|Lost to Follow-up|1|||
148836865|NCT05270863|536882686|FG004|Second Washout|Lost to Follow-up|0|||
148836866|NCT05270863|536882687|FG005|Second Washout|Lost to Follow-up|0|||
148836867|NCT04712669|536882688|FG000|Double Blind Phase|Adverse Event|4|||
148836868|NCT04712669|536882689|FG001|Double Blind Phase|Adverse Event|4|||
148836869|NCT04712669|536882690|FG002|Double Blind Phase|Adverse Event|3|||
148836870|NCT04712669|536882691|FG003|Double Blind Phase|Adverse Event|0|||
148836871|NCT04712669|536882692|FG004|Double Blind Phase|Adverse Event|0|||
148836872|NCT04712669|536882693|FG005|Double Blind Phase|Adverse Event|0|||
148836873|NCT04712669|536882694|FG006|Double Blind Phase|Adverse Event|0|||
148836874|NCT04712669|536882695|FG007|Double Blind Phase|Adverse Event|0|||
148836875|NCT04712669|536882688|FG000|Double Blind Phase|Physician Decision|1|||
148836876|NCT04712669|536882689|FG001|Double Blind Phase|Physician Decision|0|||
148836877|NCT04712669|536882690|FG002|Double Blind Phase|Physician Decision|0|||
148836878|NCT04712669|536882691|FG003|Double Blind Phase|Physician Decision|0|||
148836879|NCT04712669|536882692|FG004|Double Blind Phase|Physician Decision|0|||
148836880|NCT04712669|536882693|FG005|Double Blind Phase|Physician Decision|0|||
148836881|NCT04712669|536882694|FG006|Double Blind Phase|Physician Decision|0|||
148836882|NCT04712669|536882695|FG007|Double Blind Phase|Physician Decision|0|||
148836883|NCT04712669|536882688|FG000|Double Blind Phase|Withdrawal by Subject|3|||
148836884|NCT04712669|536882689|FG001|Double Blind Phase|Withdrawal by Subject|6|||
148836885|NCT04712669|536882690|FG002|Double Blind Phase|Withdrawal by Subject|0|||
148836886|NCT04712669|536882691|FG003|Double Blind Phase|Withdrawal by Subject|0|||
148836887|NCT04712669|536882692|FG004|Double Blind Phase|Withdrawal by Subject|0|||
148836888|NCT04712669|536882693|FG005|Double Blind Phase|Withdrawal by Subject|0|||
148836889|NCT04712669|536882694|FG006|Double Blind Phase|Withdrawal by Subject|0|||
148836890|NCT04712669|536882695|FG007|Double Blind Phase|Withdrawal by Subject|0|||
148836891|NCT04712669|536882688|FG000|Double Blind Phase|Termination by Sponsor|0|||
148836892|NCT04712669|536882689|FG001|Double Blind Phase|Termination by Sponsor|0|||
148836893|NCT04712669|536882690|FG002|Double Blind Phase|Termination by Sponsor|1|||
148836894|NCT04712669|536882691|FG003|Double Blind Phase|Termination by Sponsor|0|||
148836895|NCT04712669|536882692|FG004|Double Blind Phase|Termination by Sponsor|0|||
148836896|NCT04712669|536882693|FG005|Double Blind Phase|Termination by Sponsor|0|||
148836897|NCT04712669|536882694|FG006|Double Blind Phase|Termination by Sponsor|0|||
148836898|NCT04712669|536882695|FG007|Double Blind Phase|Termination by Sponsor|0|||
148836899|NCT04712669|536882688|FG000|Open Label Phase|Adverse Event|0|||
148836900|NCT04712669|536882689|FG001|Open Label Phase|Adverse Event|0|||
148836901|NCT04712669|536882690|FG002|Open Label Phase|Adverse Event|0|||
148836902|NCT04712669|536882691|FG003|Open Label Phase|Adverse Event|1|||
148836903|NCT04712669|536882692|FG004|Open Label Phase|Adverse Event|1|||
148836904|NCT04712669|536882693|FG005|Open Label Phase|Adverse Event|3|||
148836905|NCT04712669|536882694|FG006|Open Label Phase|Adverse Event|1|||
148836906|NCT04712669|536882695|FG007|Open Label Phase|Adverse Event|2|||
148836907|NCT04712669|536882688|FG000|Open Label Phase|Death|0|||
148836908|NCT04712669|536882689|FG001|Open Label Phase|Death|0|||
148836909|NCT04712669|536882690|FG002|Open Label Phase|Death|0|||
148836910|NCT04712669|536882691|FG003|Open Label Phase|Death|1|||
148836911|NCT04712669|536882692|FG004|Open Label Phase|Death|0|||
148836912|NCT04712669|536882693|FG005|Open Label Phase|Death|0|||
148836913|NCT04712669|536882694|FG006|Open Label Phase|Death|0|||
148836914|NCT04712669|536882695|FG007|Open Label Phase|Death|0|||
148836915|NCT04712669|536882688|FG000|Open Label Phase|Lack of Efficacy|0|||
148836916|NCT04712669|536882689|FG001|Open Label Phase|Lack of Efficacy|0|||
148836917|NCT04712669|536882690|FG002|Open Label Phase|Lack of Efficacy|0|||
148836918|NCT04712669|536882691|FG003|Open Label Phase|Lack of Efficacy|0|||
148836919|NCT04712669|536882692|FG004|Open Label Phase|Lack of Efficacy|1|||
148836920|NCT04712669|536882693|FG005|Open Label Phase|Lack of Efficacy|0|||
148836921|NCT04712669|536882694|FG006|Open Label Phase|Lack of Efficacy|0|||
148836922|NCT04712669|536882695|FG007|Open Label Phase|Lack of Efficacy|0|||
148836923|NCT04712669|536882688|FG000|Open Label Phase|Lost to Follow-up|0|||
148836924|NCT04712669|536882689|FG001|Open Label Phase|Lost to Follow-up|0|||
148836925|NCT04712669|536882690|FG002|Open Label Phase|Lost to Follow-up|0|||
148836926|NCT04712669|536882691|FG003|Open Label Phase|Lost to Follow-up|0|||
148836927|NCT04712669|536882692|FG004|Open Label Phase|Lost to Follow-up|0|||
148836928|NCT04712669|536882693|FG005|Open Label Phase|Lost to Follow-up|0|||
148836929|NCT04712669|536882694|FG006|Open Label Phase|Lost to Follow-up|1|||
148836930|NCT04712669|536882695|FG007|Open Label Phase|Lost to Follow-up|1|||
148836931|NCT04712669|536882688|FG000|Open Label Phase|Physician Decision|0|||
148836932|NCT04712669|536882689|FG001|Open Label Phase|Physician Decision|0|||
148836933|NCT04712669|536882690|FG002|Open Label Phase|Physician Decision|0|||
148836934|NCT04712669|536882691|FG003|Open Label Phase|Physician Decision|1|||
148836935|NCT04712669|536882692|FG004|Open Label Phase|Physician Decision|0|||
148836936|NCT04712669|536882693|FG005|Open Label Phase|Physician Decision|0|||
148836937|NCT04712669|536882694|FG006|Open Label Phase|Physician Decision|0|||
148836938|NCT04712669|536882695|FG007|Open Label Phase|Physician Decision|0|||
148836939|NCT04712669|536882688|FG000|Open Label Phase|Withdrawal by Subject|0|||
148836940|NCT04712669|536882689|FG001|Open Label Phase|Withdrawal by Subject|0|||
148836941|NCT04712669|536882690|FG002|Open Label Phase|Withdrawal by Subject|0|||
148836942|NCT04712669|536882691|FG003|Open Label Phase|Withdrawal by Subject|1|||
148836943|NCT04712669|536882692|FG004|Open Label Phase|Withdrawal by Subject|5|||
148836944|NCT04712669|536882693|FG005|Open Label Phase|Withdrawal by Subject|5|||
148836945|NCT04712669|536882694|FG006|Open Label Phase|Withdrawal by Subject|0|||
148836946|NCT04712669|536882695|FG007|Open Label Phase|Withdrawal by Subject|4|||
148836947|NCT04712669|536882688|FG000|Open Label Phase|Termination by Sponsor|0|||
148836948|NCT04712669|536882689|FG001|Open Label Phase|Termination by Sponsor|0|||
148836949|NCT04712669|536882690|FG002|Open Label Phase|Termination by Sponsor|0|||
148836950|NCT04712669|536882691|FG003|Open Label Phase|Termination by Sponsor|11|||
148836951|NCT04712669|536882692|FG004|Open Label Phase|Termination by Sponsor|9|||
148836952|NCT04712669|536882693|FG005|Open Label Phase|Termination by Sponsor|14|||
148836953|NCT04712669|536882694|FG006|Open Label Phase|Termination by Sponsor|0|||
148836954|NCT04712669|536882695|FG007|Open Label Phase|Termination by Sponsor|14|||
148836955|NCT04577404|536882696|FG000|Overall Study|Adverse Event|31|||
148836956|NCT04577404|536882696|FG000|Overall Study|Death|1|||
148836957|NCT04577404|536882696|FG000|Overall Study|Lack of Efficacy|3|||
148836958|NCT04577404|536882696|FG000|Overall Study|Physician Decision|7|||
148836959|NCT04577404|536882696|FG000|Overall Study|Withdrawal by Subject|21|||
148836960|NCT04577404|536882696|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
148836961|NCT00503984|536884192|FG000|Overall Study|Protocol Violation|0|||
148836962|NCT00503984|536884193|FG001|Overall Study|Protocol Violation|1|||
148836963|NCT00503984|536884194|FG002|Overall Study|Protocol Violation|0|||
148836964|NCT00503984|536884195|FG003|Overall Study|Protocol Violation|0|||
148836965|NCT00503984|536884196|FG004|Overall Study|Protocol Violation|0|||
148836966|NCT00503984|536884197|FG005|Overall Study|Protocol Violation|0|||
148836967|NCT00503984|536884192|FG000|Overall Study|Adverse Event|0|||
148836968|NCT00503984|536884193|FG001|Overall Study|Adverse Event|1|||
148836969|NCT00503984|536884194|FG002|Overall Study|Adverse Event|0|||
148836970|NCT00503984|536884195|FG003|Overall Study|Adverse Event|0|||
148836971|NCT00503984|536884196|FG004|Overall Study|Adverse Event|0|||
148836972|NCT00503984|536884197|FG005|Overall Study|Adverse Event|0|||
148836973|NCT00503984|536884192|FG000|Overall Study|Death|0|||
148836974|NCT00503984|536884193|FG001|Overall Study|Death|0|||
148836975|NCT00503984|536884194|FG002|Overall Study|Death|0|||
148836976|NCT00503984|536884195|FG003|Overall Study|Death|0|||
148836977|NCT00503984|536884196|FG004|Overall Study|Death|1|||
148836978|NCT00503984|536884197|FG005|Overall Study|Death|0|||
148836979|NCT01246960|536884200|FG000|Overall Study|Lost to Follow-up|3|||
148836980|NCT01246960|536884201|FG001|Overall Study|Lost to Follow-up|1|||
149028992|NCT00269399|537583797|FG001|Overall Study|Lack of Efficacy|10|||
149028993|NCT00269399|537583796|FG000|Overall Study|Adverse Event|10|||
149028994|NCT00269399|537583797|FG001|Overall Study|Adverse Event|4|||
149028995|NCT00269399|537583796|FG000|Overall Study|Withdrawal by Subject|2|||
149028996|NCT00269399|537583797|FG001|Overall Study|Withdrawal by Subject|5|||
149028997|NCT00269399|537583796|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
149028998|NCT00269399|537583797|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
149028999|NCT00269399|537583796|FG000|Overall Study|Other|0|||
149029000|NCT00269399|537583797|FG001|Overall Study|Other|4|||
149029001|NCT00269399|537583796|FG000|Overall Study|Development of exclusion criteria|0|||
149029002|NCT00269399|537583797|FG001|Overall Study|Development of exclusion criteria|1|||
149029003|NCT03441360|537583798|FG000|Overall Study|Radiological disease progression|5|||
149029004|NCT03441360|537583799|FG001|Overall Study|Radiological disease progression|6|||
149029005|NCT03441360|537583800|FG002|Overall Study|Radiological disease progression|4|||
149029006|NCT03441360|537583798|FG000|Overall Study|Clinical disease progression|2|||
149029007|NCT03441360|537583799|FG001|Overall Study|Clinical disease progression|2|||
149029008|NCT03441360|537583800|FG002|Overall Study|Clinical disease progression|0|||
149029009|NCT03441360|537583798|FG000|Overall Study|Adverse Event|1|||
149029010|NCT03441360|537583799|FG001|Overall Study|Adverse Event|0|||
149029011|NCT03441360|537583800|FG002|Overall Study|Adverse Event|1|||
149029012|NCT04381494|537583801|FG000|Overall Study|Early termination of trial|19|||
149029013|NCT04381494|537583801|FG000|Overall Study|Investigator's discretion|1|||
149029014|NCT04381494|537583801|FG000|Overall Study|Withdrawal by Subject|9|||
149029015|NCT04381494|537583801|FG000|Overall Study|NSCLC disease progression|4|||
149029016|NCT04381494|537583801|FG000|Overall Study|Device-Related Adverse Event|2|||
149029017|NCT03396835|537583802|FG000|Overall Study|Withdrawn prior to completion|1|||
149029018|NCT03396835|537583802|FG000|Overall Study|Did not meet criteria for data analysis|1|||
149029019|NCT01451814|537583803|FG000|Overall Study|Withdrawal by Subject|1|||
149029020|NCT01451814|537583804|FG001|Overall Study|Withdrawal by Subject|1|||
149029021|NCT01451814|537583803|FG000|Overall Study|Lost to Follow-up|5|||
149029022|NCT01451814|537583804|FG001|Overall Study|Lost to Follow-up|4|||
149029023|NCT03439124|537583805|FG000|Overall Study|Adverse Event|2|||
149029024|NCT03439124|537583806|FG001|Overall Study|Adverse Event|0|||
149029025|NCT03439124|537583805|FG000|Overall Study|Lost to Follow-up|1|||
149029026|NCT03439124|537583806|FG001|Overall Study|Lost to Follow-up|0|||
149029027|NCT03439124|537583805|FG000|Overall Study|Other reasons|1|||
149029028|NCT03439124|537583806|FG001|Overall Study|Other reasons|0|||
149029029|NCT04353037|537583808|FG000|Overall Study|Lost to Follow-up|0|||
149029030|NCT04353037|537583809|FG001|Overall Study|Lost to Follow-up|1|||
149029031|NCT04353037|537583810|FG002|Overall Study|Lost to Follow-up|2|||
149029032|NCT04353037|537583811|FG003|Overall Study|Lost to Follow-up|3|||
149029033|NCT04353037|537583808|FG000|Overall Study|Withdrawal by Subject|0|||
149029034|NCT04353037|537583809|FG001|Overall Study|Withdrawal by Subject|2|||
149029035|NCT04353037|537583810|FG002|Overall Study|Withdrawal by Subject|3|||
149029036|NCT04353037|537583811|FG003|Overall Study|Withdrawal by Subject|5|||
149029037|NCT04353037|537583808|FG000|Overall Study|Adverse Event|0|||
149029038|NCT04353037|537583809|FG001|Overall Study|Adverse Event|0|||
149029039|NCT04353037|537583810|FG002|Overall Study|Adverse Event|2|||
149029040|NCT04353037|537583811|FG003|Overall Study|Adverse Event|0|||
149029041|NCT04353037|537583808|FG000|Overall Study|Exposure Change|0|||
148836981|NCT01246960|536884200|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
148836982|NCT01246960|536884201|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
148836983|NCT02122380|536884203|FG000|First Intervention (30 Days)|Adverse Event|1|||
148836984|NCT02122380|536884204|FG001|First Intervention (30 Days)|Adverse Event|0|||
148836985|NCT02122380|536884203|FG000|First Intervention (30 Days)|Physician Decision|0|||
148836986|NCT02122380|536884204|FG001|First Intervention (30 Days)|Physician Decision|1|||
148836987|NCT02122380|536884203|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
148836988|NCT02122380|536884204|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
148836989|NCT02122380|536884203|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
148836990|NCT02122380|536884204|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
148836991|NCT02122380|536884203|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
148836992|NCT02122380|536884204|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
148836993|NCT04102007|536884205|FG000|Overall Study|Adverse Event|4|||
148836994|NCT04102007|536884205|FG000|Overall Study|Lost to Follow-up|3|||
149029042|NCT04353037|537583809|FG001|Overall Study|Exposure Change|0|||
149029043|NCT04353037|537583810|FG002|Overall Study|Exposure Change|0|||
149029044|NCT04353037|537583811|FG003|Overall Study|Exposure Change|2|||
149029045|NCT03710564|537583812|FG000|Overall Study|Study Terminated by Sponsor|104|||
149029046|NCT03710564|537583813|FG001|Overall Study|Study Terminated by Sponsor|55|||
149029047|NCT03710564|537583812|FG000|Overall Study|Withdrawal by Subject|57|||
149029048|NCT03710564|537583813|FG001|Overall Study|Withdrawal by Subject|25|||
148836995|NCT04102007|536884205|FG000|Overall Study|Withdrawal by Subject|12|||
149029049|NCT03710564|537583812|FG000|Overall Study|Death|10|||
149029050|NCT03710564|537583813|FG001|Overall Study|Death|4|||
149029051|NCT03710564|537583812|FG000|Overall Study|Lost to Follow-up|5|||
149029052|NCT03710564|537583813|FG001|Overall Study|Lost to Follow-up|4|||
148836996|NCT04102007|536884205|FG000|Overall Study|Eligibility Violation|5|||
148836997|NCT04102007|536884205|FG000|Overall Study|Lack of Efficacy|6|||
148836998|NCT04102007|536884205|FG000|Overall Study|Protocol Deviation|5|||
148836999|NCT04102007|536884205|FG000|Overall Study|Protocol Compliance|1|||
148837000|NCT04102007|536884205|FG000|Overall Study|Withdrew Treatment|2|||
148837001|NCT04102007|536884205|FG000|Overall Study|Pregnancy|1|||
148837002|NCT05173974|536884206|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
148837003|NCT05173974|536884207|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
148837004|NCT05173974|536884208|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
148837005|NCT05173974|536884209|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
148837006|NCT05173974|536884206|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
148837007|NCT05173974|536884207|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
148837008|NCT05173974|536884208|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
148837009|NCT05173974|536884209|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
148774122|NCT02017717|536646912|FG008|Treatment Period|Other reasons|1|||
148774123|NCT02017717|536646904|FG000|Treatment Period|Maximum clinical benefit|0|||
148774124|NCT02017717|536646905|FG001|Treatment Period|Maximum clinical benefit|0|||
148774125|NCT02017717|536646906|FG002|Treatment Period|Maximum clinical benefit|0|||
148837010|NCT01840943|536884210|FG000|Overall Study|Withdrawal by Subject|5|||
148837011|NCT01840943|536884211|FG001|Overall Study|Withdrawal by Subject|6|||
148837012|NCT01840943|536884210|FG000|Overall Study|Physician Decision|4|||
148837013|NCT01840943|536884211|FG001|Overall Study|Physician Decision|2|||
148837014|NCT01840943|536884210|FG000|Overall Study|Lost to Follow-up|4|||
148837015|NCT01840943|536884211|FG001|Overall Study|Lost to Follow-up|4|||
148837016|NCT01446874|536884212|FG000|Overall Study|Not eligible|1|||
148837017|NCT01446874|536884213|FG001|Overall Study|Not eligible|0|||
148837018|NCT01446874|536884214|FG002|Overall Study|Not eligible|0|||
148837019|NCT01446874|536884212|FG000|Overall Study|No surgery/No qualifying surgery|1|||
148837020|NCT01446874|536884213|FG001|Overall Study|No surgery/No qualifying surgery|0|||
148982357|NCT01172938|537415285|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
148982358|NCT01172938|537415286|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
148982359|NCT01172938|537415287|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
148982360|NCT01172938|537415288|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
148982361|NCT01172938|537415289|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
148982362|NCT01172938|537415290|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
148982363|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
148982364|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
148982365|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
148982366|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
148982367|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
148982368|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
148982369|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
148982370|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
148982371|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
148982372|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
148982373|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
148774126|NCT02017717|536646907|FG003|Treatment Period|Maximum clinical benefit|0|||
148774127|NCT02017717|536646908|FG004|Treatment Period|Maximum clinical benefit|0|||
148774128|NCT02017717|536646909|FG005|Treatment Period|Maximum clinical benefit|0|||
148774129|NCT02017717|536646910|FG006|Treatment Period|Maximum clinical benefit|0|||
148774130|NCT02017717|536646911|FG007|Treatment Period|Maximum clinical benefit|0|||
148774131|NCT02017717|536646912|FG008|Treatment Period|Maximum clinical benefit|1|||
148774132|NCT02017717|536646904|FG000|Treatment Period|Not reported|0|||
148774133|NCT02017717|536646905|FG001|Treatment Period|Not reported|1|||
148774134|NCT02017717|536646906|FG002|Treatment Period|Not reported|0|||
148774135|NCT02017717|536646907|FG003|Treatment Period|Not reported|0|||
148774136|NCT02017717|536646908|FG004|Treatment Period|Not reported|0|||
148774137|NCT02017717|536646909|FG005|Treatment Period|Not reported|0|||
148774138|NCT02017717|536646910|FG006|Treatment Period|Not reported|0|||
148774139|NCT02017717|536646911|FG007|Treatment Period|Not reported|0|||
148774140|NCT02017717|536646912|FG008|Treatment Period|Not reported|0|||
148774141|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
148774142|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
148774143|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
148774144|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
148774145|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
148774146|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
148774147|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
148774148|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
148774149|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
148774150|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
148837021|NCT01446874|536884214|FG002|Overall Study|No surgery/No qualifying surgery|12|||
148837022|NCT01446874|536884212|FG000|Overall Study|Non-compliance|0|||
148837023|NCT01446874|536884213|FG001|Overall Study|Non-compliance|4|||
148837024|NCT01446874|536884214|FG002|Overall Study|Non-compliance|0|||
148837025|NCT01446874|536884212|FG000|Overall Study|Antibiotics for pre-op infection|0|||
148837026|NCT01446874|536884213|FG001|Overall Study|Antibiotics for pre-op infection|0|||
148837027|NCT01446874|536884214|FG002|Overall Study|Antibiotics for pre-op infection|2|||
148837028|NCT01446874|536884212|FG000|Overall Study|Withdrawal by Subject|0|||
148837029|NCT01446874|536884213|FG001|Overall Study|Withdrawal by Subject|0|||
148837030|NCT01446874|536884214|FG002|Overall Study|Withdrawal by Subject|4|||
148837031|NCT01135992|536884215|FG000|Overall Study|Adverse Event|1|||
148837032|NCT01135992|536884215|FG000|Overall Study|Lack of Efficacy|1|||
148837033|NCT01135992|536884215|FG000|Overall Study|Protocol Violation|2|||
148837034|NCT01135992|536884215|FG000|Overall Study|Withdrawal criteria|10|||
148837035|NCT01135992|536884215|FG000|Overall Study|Unclassified|7|||
148837036|NCT01977898|536884216|FG000|Overall Study|Non functioning catheter|1|||
148837037|NCT01977898|536884217|FG001|Overall Study|Non functioning catheter|1|||
148837038|NCT02660229|536884221|FG000|Overall Study|Adverse Event|2|||
148837039|NCT02660229|536884222|FG001|Overall Study|Adverse Event|0|||
148837040|NCT02660229|536884221|FG000|Overall Study|Withdrawal by Subject|0|||
148837041|NCT02660229|536884222|FG001|Overall Study|Withdrawal by Subject|1|||
148837042|NCT01466491|536884226|FG000|Overall Study|Protocol Violation|0|||
148837043|NCT01466491|536884227|FG001|Overall Study|Protocol Violation|3|||
148837044|NCT01466491|536884228|FG002|Overall Study|Protocol Violation|2|||
148837045|NCT01466491|536884229|FG003|Overall Study|Protocol Violation|0|||
148837046|NCT01466491|536884226|FG000|Overall Study|Missing Data|0|||
148837047|NCT01466491|536884227|FG001|Overall Study|Missing Data|0|||
148837048|NCT01466491|536884228|FG002|Overall Study|Missing Data|1|||
148837049|NCT01466491|536884229|FG003|Overall Study|Missing Data|0|||
148837050|NCT01049373|536884230|FG000|Overall Study|Protocol Violation|9|||
148837051|NCT01049373|536884231|FG001|Overall Study|Protocol Violation|9|||
148837052|NCT01049373|536884230|FG000|Overall Study|Withdrawal by Subject|8|||
148837053|NCT01049373|536884231|FG001|Overall Study|Withdrawal by Subject|5|||
148837054|NCT01049373|536884230|FG000|Overall Study|Adverse Event|3|||
148837055|NCT01049373|536884231|FG001|Overall Study|Adverse Event|3|||
148837056|NCT01049373|536884230|FG000|Overall Study|Lost to Follow-up|9|||
148837057|NCT01049373|536884231|FG001|Overall Study|Lost to Follow-up|4|||
148837058|NCT01049373|536884230|FG000|Overall Study|no evaluable study values|9|||
148837059|NCT01049373|536884231|FG001|Overall Study|no evaluable study values|21|||
148837060|NCT01049373|536884230|FG000|Overall Study|Other|1|||
148837061|NCT01049373|536884231|FG001|Overall Study|Other|1|||
148837062|NCT01049373|536884230|FG000|Overall Study|Non-cooperation|0|||
148837063|NCT01049373|536884231|FG001|Overall Study|Non-cooperation|1|||
148837064|NCT01693367|536884232|FG000|Overall Study|Withdrawal by Subject|1|||
148837065|NCT01693367|536884233|FG001|Overall Study|Withdrawal by Subject|1|||
148837066|NCT01693367|536884232|FG000|Overall Study|Physician Decision|0|||
148837067|NCT01693367|536884233|FG001|Overall Study|Physician Decision|1|||
148837068|NCT03610048|536884234|FG000|Overall Study|Study terminated by sponsor|84|||
148837069|NCT03610048|536884234|FG000|Overall Study|Adverse Event|32|||
148837070|NCT03610048|536884234|FG000|Overall Study|Withdrawal by Subject|31|||
148837071|NCT03610048|536884234|FG000|Overall Study|Lost to Follow-up|8|||
148837072|NCT03610048|536884234|FG000|Overall Study|Other|4|||
148837073|NCT03610048|536884234|FG000|Overall Study|Physician Decision|1|||
148837074|NCT03610048|536884234|FG000|Overall Study|Pregnancy|1|||
148837075|NCT01155050|536884235|FG000|Overall Study|Lost to Follow-up|15|||
148837076|NCT01155050|536884236|FG001|Overall Study|Lost to Follow-up|20|||
148837077|NCT01155050|536884237|FG002|Overall Study|Lost to Follow-up|19|||
149029053|NCT03710564|537583812|FG000|Overall Study|Protocol Violation|3|||
149029054|NCT03710564|537583813|FG001|Overall Study|Protocol Violation|2|||
149029055|NCT03710564|537583812|FG000|Overall Study|Adverse Event|3|||
149029056|NCT03710564|537583813|FG001|Overall Study|Adverse Event|0|||
148837078|NCT01155050|536884238|FG003|Overall Study|Lost to Follow-up|22|||
148837079|NCT02136914|536884239|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
148837080|NCT02136914|536884240|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
148837081|NCT02136914|536884239|FG000|Overall Study|Withdrawal by Subject|3|||
148837082|NCT02136914|536884240|FG001|Overall Study|Withdrawal by Subject|10|||
148837083|NCT02136914|536884239|FG000|Overall Study|Subject Unwilling to Proceed|7|||
148837084|NCT02136914|536884240|FG001|Overall Study|Subject Unwilling to Proceed|2|||
148837085|NCT02136914|536884239|FG000|Overall Study|Lost to Follow-up|1|||
148837086|NCT02136914|536884240|FG001|Overall Study|Lost to Follow-up|1|||
148837087|NCT02136914|536884239|FG000|Overall Study|Did Not Receive Study Drug|2|||
148837088|NCT02136914|536884240|FG001|Overall Study|Did Not Receive Study Drug|0|||
148837089|NCT02136914|536884239|FG000|Overall Study|Lack of Efficacy|1|||
148837090|NCT02136914|536884240|FG001|Overall Study|Lack of Efficacy|0|||
148837091|NCT02136914|536884239|FG000|Overall Study|Death|0|||
148837092|NCT02136914|536884240|FG001|Overall Study|Death|1|||
148837093|NCT00329030|536884243|FG000|Overall Study|Withdrawal by Subject|1|||
148837094|NCT00329030|536884244|FG001|Overall Study|Withdrawal by Subject|3|||
148837095|NCT00329030|536884243|FG000|Overall Study|Progressive Disease|6|||
148837096|NCT00329030|536884244|FG001|Overall Study|Progressive Disease|2|||
149029057|NCT03710564|537583812|FG000|Overall Study|Physician Decision|2|||
149029058|NCT03710564|537583813|FG001|Overall Study|Physician Decision|3|||
149029059|NCT02993471|537583815|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
149029060|NCT02993471|537583815|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
149029061|NCT00920686|537583817|FG000|Overall Study|Lost to Follow-up|2|||
149029062|NCT00920686|537583818|FG001|Overall Study|Lost to Follow-up|3|||
149029063|NCT00920686|537583819|FG002|Overall Study|Lost to Follow-up|1|||
149029064|NCT00920686|537583817|FG000|Overall Study|Study drug dosing criteria not met|17|||
149029065|NCT00920686|537583818|FG001|Overall Study|Study drug dosing criteria not met|19|||
149029066|NCT00920686|537583819|FG002|Overall Study|Study drug dosing criteria not met|12|||
149029067|NCT03006341|537583820|FG000|Overall Study|Not linked in the EMR|25069|||
149029068|NCT03006341|537583821|FG001|Overall Study|Not linked in the EMR|67505|||
149029069|NCT03006341|537583822|FG002|Overall Study|Not linked in the EMR|30993|||
149029070|NCT03006341|537583823|FG003|Overall Study|Not linked in the EMR|10685|||
149029071|NCT03101592|537583826|FG000|Overall Study|participant files could not be located|111|||
149029072|NCT03101592|537583827|FG001|Overall Study|participant files could not be located|170|||
149029073|NCT03101592|537583828|FG002|Overall Study|participant files could not be located|118|||
149029074|NCT00647348|537583830|FG000|Overall Study|Lost to Follow-up|3|||
149029075|NCT00647348|537583831|FG001|Overall Study|Lost to Follow-up|6|||
149029076|NCT00619151|537583832|FG000|Overall Study|Study terminated prior to followup|1|||
149029077|NCT00619151|537583833|FG001|Overall Study|Study terminated prior to followup|0|||
149029078|NCT00631917|537583835|FG000|Overall Study|Adverse Event|34|||
149029079|NCT00631917|537583836|FG001|Overall Study|Adverse Event|45|||
149029080|NCT00631917|537583835|FG000|Overall Study|Abnormal laboratory value(s)|2|||
149029081|NCT00631917|537583836|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149029082|NCT00631917|537583835|FG000|Overall Study|Abnormal test procedure result(s)|3|||
149029083|NCT00631917|537583836|FG001|Overall Study|Abnormal test procedure result(s)|2|||
149029084|NCT00631917|537583835|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
149029085|NCT00631917|537583836|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
149029086|NCT00631917|537583835|FG000|Overall Study|No longer required study drug|0|||
149029087|NCT00631917|537583836|FG001|Overall Study|No longer required study drug|1|||
149029088|NCT00631917|537583835|FG000|Overall Study|Protocol deviation|6|||
149029089|NCT00631917|537583836|FG001|Overall Study|Protocol deviation|5|||
149029090|NCT00631917|537583835|FG000|Overall Study|Subject withdrew consent|25|||
149029091|NCT00631917|537583836|FG001|Overall Study|Subject withdrew consent|33|||
149029092|NCT00631917|537583835|FG000|Overall Study|Lost to Follow-up|7|||
149029093|NCT00631917|537583836|FG001|Overall Study|Lost to Follow-up|7|||
149029094|NCT00631917|537583835|FG000|Overall Study|Administrative problems|2|||
149029095|NCT00631917|537583836|FG001|Overall Study|Administrative problems|0|||
149029096|NCT00631917|537583835|FG000|Overall Study|Death|1|||
149029097|NCT00631917|537583836|FG001|Overall Study|Death|0|||
149029098|NCT05487703|537583839|FG000|Overall Study|Other|19|||
149029099|NCT05487703|537583839|FG000|Overall Study|Participant not well|5|||
149029100|NCT05487703|537583839|FG000|Overall Study|Insurance Reasons|6|||
149029101|NCT05487703|537583839|FG000|Overall Study|Physician Decision|19|||
148837097|NCT00329030|536884243|FG000|Overall Study|Ineligible Pathology|1|||
148837098|NCT00329030|536884244|FG001|Overall Study|Ineligible Pathology|1|||
148837099|NCT00325143|536884245|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
148837100|NCT00325143|536884245|FG000|Overall Study|Migrated/moved from study area|1|||
148837101|NCT00325143|536884245|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
148837102|NCT00325143|536884245|FG000|Overall Study|Withdrawal by Subject|8|||
148837103|NCT02286895|536884246|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
148837104|NCT02286895|536884247|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
148837105|NCT02286895|536884246|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
148837106|NCT02286895|536884247|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
148837107|NCT02286895|536884246|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
148837108|NCT02286895|536884247|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
149029102|NCT05487703|537583839|FG000|Overall Study|Lack of Efficacy|60|||
149029103|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
149029104|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
148837109|NCT03036852|536884248|FG000|Overall Study|Death|2|||
149029105|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
149029106|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Death|3|||
148837110|NCT03036852|536884248|FG000|Overall Study|Lack of Efficacy|2|||
148837111|NCT03036852|536884248|FG000|Overall Study|Adverse Event|1|||
149029107|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Death|0|||
149029108|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Death|0|||
149029109|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
149029110|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
149029111|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
149029112|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
148837112|NCT03036852|536884248|FG000|Overall Study|Lost to Follow-up|1|||
148837113|NCT00399035|536884251|FG000|Overall Study|Death|289|||
148837114|NCT00399035|536884252|FG001|Overall Study|Death|141|||
148837115|NCT00399035|536884253|FG002|Overall Study|Death|234|||
148837116|NCT00399035|536884251|FG000|Overall Study|Lost to Follow-up|2|||
148837117|NCT00399035|536884252|FG001|Overall Study|Lost to Follow-up|1|||
148837118|NCT00399035|536884253|FG002|Overall Study|Lost to Follow-up|5|||
148837119|NCT00399035|536884251|FG000|Overall Study|Withdrawal by Subject|19|||
148837120|NCT00399035|536884252|FG001|Overall Study|Withdrawal by Subject|15|||
148837121|NCT00399035|536884253|FG002|Overall Study|Withdrawal by Subject|12|||
148837122|NCT00399035|536884251|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
148837123|NCT00399035|536884252|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
148837124|NCT00399035|536884253|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
148837125|NCT00399035|536884251|FG000|Overall Study|Severe non-compliance with protocol|2|||
148837126|NCT00399035|536884252|FG001|Overall Study|Severe non-compliance with protocol|1|||
148837127|NCT00399035|536884253|FG002|Overall Study|Severe non-compliance with protocol|0|||
148837128|NCT02949011|536884260|FG000|Overall Study|Adverse Event|6|||
148837129|NCT02949011|536884261|FG001|Overall Study|Adverse Event|7|||
148837130|NCT02949011|536884262|FG002|Overall Study|Adverse Event|3|||
148837131|NCT02949011|536884260|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
148837132|NCT02949011|536884261|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
148837133|NCT02949011|536884262|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
148837134|NCT02949011|536884260|FG000|Overall Study|Protocol Deviation|5|||
148837135|NCT02949011|536884261|FG001|Overall Study|Protocol Deviation|3|||
148837136|NCT02949011|536884262|FG002|Overall Study|Protocol Deviation|3|||
148837137|NCT02949011|536884260|FG000|Overall Study|Lack of Efficacy|0|||
148837138|NCT02949011|536884261|FG001|Overall Study|Lack of Efficacy|2|||
148837139|NCT02949011|536884262|FG002|Overall Study|Lack of Efficacy|0|||
148837140|NCT02949011|536884260|FG000|Overall Study|Withdrawal by Subject|13|||
148837141|NCT02949011|536884261|FG001|Overall Study|Withdrawal by Subject|13|||
148837142|NCT02949011|536884262|FG002|Overall Study|Withdrawal by Subject|21|||
148837143|NCT02949011|536884260|FG000|Overall Study|Lost to Follow-up|7|||
148837144|NCT02949011|536884261|FG001|Overall Study|Lost to Follow-up|5|||
148837145|NCT02949011|536884262|FG002|Overall Study|Lost to Follow-up|5|||
148837146|NCT02949011|536884260|FG000|Overall Study|Death|0|||
148837147|NCT02949011|536884261|FG001|Overall Study|Death|0|||
148837148|NCT02949011|536884262|FG002|Overall Study|Death|1|||
148837149|NCT02949011|536884260|FG000|Overall Study|Miscellaneous|2|||
148837150|NCT02949011|536884261|FG001|Overall Study|Miscellaneous|4|||
148837151|NCT02949011|536884262|FG002|Overall Study|Miscellaneous|6|||
148837152|NCT01541371|536884263|FG000|Overall Study|Withdrawal by Subject|14|||
148837153|NCT01541371|536884263|FG000|Overall Study|Lost to Follow-up|21|||
148837154|NCT01541371|536884263|FG000|Overall Study|Adverse Event|15|||
148837155|NCT01541371|536884263|FG000|Overall Study|Lack of Efficacy|12|||
148837156|NCT01541371|536884263|FG000|Overall Study|Protocol Violation|6|||
148837157|NCT01541371|536884263|FG000|Overall Study|Study medication non-compliance|3|||
148837158|NCT01541371|536884263|FG000|Overall Study|Other|6|||
148837159|NCT02441218|536884264|FG000|Overall Study|Death|503|||
148837160|NCT02441218|536884265|FG001|Overall Study|Death|553|||
148837161|NCT02441218|536884264|FG000|Overall Study|Withdrawal by Subject|73|||
148837162|NCT02441218|536884265|FG001|Overall Study|Withdrawal by Subject|58|||
148837163|NCT02441218|536884264|FG000|Overall Study|Lost to Follow-up|2|||
148837164|NCT02441218|536884265|FG001|Overall Study|Lost to Follow-up|1|||
148837165|NCT00163189|536884268|FG000|Overall Study|Other|6|||
148837166|NCT00163189|536884268|FG000|Overall Study|Lost to Follow-up|1|||
148837167|NCT00163189|536884268|FG000|Overall Study|Protocol Violation|2|||
148837168|NCT00163189|536884268|FG000|Overall Study|Death|3|||
148837169|NCT00163189|536884268|FG000|Overall Study|Adverse Event|6|||
148837170|NCT00163189|536884268|FG000|Overall Study|Lack of Efficacy|7|||
148837171|NCT00163189|536884268|FG000|Overall Study|Study terminated by sponsor|11|||
148837172|NCT00163189|536884268|FG000|Overall Study|Withdrawal by Subject|11|||
148837173|NCT00163189|536884268|FG000|Overall Study|Did not meet continuation criterion|16|||
148837174|NCT03435380|536884269|FG000|Overall Study|Death|1|||
148837175|NCT03435380|536884270|FG001|Overall Study|Death|2|||
148837176|NCT03435380|536884271|FG002|Overall Study|Death|1|||
148837177|NCT03435380|536884269|FG000|Overall Study|Lost to Follow-up|12|||
148837178|NCT03435380|536884270|FG001|Overall Study|Lost to Follow-up|8|||
148837179|NCT03435380|536884271|FG002|Overall Study|Lost to Follow-up|6|||
148837180|NCT03435380|536884269|FG000|Overall Study|Physician Decision|1|||
148837181|NCT03435380|536884270|FG001|Overall Study|Physician Decision|0|||
148837182|NCT03435380|536884271|FG002|Overall Study|Physician Decision|0|||
148837183|NCT03435380|536884269|FG000|Overall Study|Withdrawal by Subject|0|||
148837184|NCT03435380|536884270|FG001|Overall Study|Withdrawal by Subject|1|||
148837185|NCT03435380|536884271|FG002|Overall Study|Withdrawal by Subject|1|||
148837186|NCT03435380|536884269|FG000|Overall Study|Ineligible|0|||
148837187|NCT03435380|536884270|FG001|Overall Study|Ineligible|1|||
148837188|NCT03435380|536884271|FG002|Overall Study|Ineligible|1|||
148837189|NCT02431325|536884272|FG000|Overall Study|Adverse Event|3|||
148837190|NCT02431325|536884273|FG001|Overall Study|Adverse Event|0|||
148837191|NCT02431325|536884272|FG000|Overall Study|Lost to Follow-up|0|||
148837192|NCT02431325|536884273|FG001|Overall Study|Lost to Follow-up|1|||
148837193|NCT02431325|536884272|FG000|Overall Study|Withdrawal by Subject|1|||
148837194|NCT02431325|536884273|FG001|Overall Study|Withdrawal by Subject|2|||
148837195|NCT02431325|536884272|FG000|Overall Study|Declined to take study medication|1|||
148837196|NCT02431325|536884273|FG001|Overall Study|Declined to take study medication|0|||
148837197|NCT02431325|536884272|FG000|Overall Study|Withdrew before starting study medication|1|||
148837198|NCT02431325|536884273|FG001|Overall Study|Withdrew before starting study medication|0|||
148837199|NCT02431325|536884272|FG000|Overall Study|Placebo shortage|2|||
148837200|NCT02431325|536884273|FG001|Overall Study|Placebo shortage|0|||
148837201|NCT03338400|536884274|FG000|Overall Study|Lost to Follow-up|1|||
148837202|NCT03338400|536884275|FG001|Overall Study|Lost to Follow-up|2|||
148837203|NCT01531998|536884281|FG000|Overall Study|Withdrawal by Subject|3|||
148837204|NCT01130337|536884287|FG000|Overall Study|Withdrawal by Subject|3|||
148837205|NCT01130337|536884287|FG000|Overall Study|Principal investigator decision|1|||
148837206|NCT01130337|536884287|FG000|Overall Study|Death|1|||
148837207|NCT01130337|536884287|FG000|Overall Study|Disease progression|1|||
148837208|NCT01130337|536884287|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
148837209|NCT01130337|536884287|FG000|Overall Study|Surgical resection (R2)|1|||
148837210|NCT03886493|536884288|FG000|Overall Study|Adverse Event|1|||
148837211|NCT00181844|536884289|FG000|Signed Consent|Withdrawal by Subject|5|||
148837212|NCT00181844|536884289|FG000|Signed Consent|Did not meet entrance criteria|7|||
148837213|NCT00181844|536884289|FG000|Exposed to Study Medication|Adverse Event|10|||
148837214|NCT00181844|536884289|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
148837215|NCT00181844|536884289|FG000|Exposed to Study Medication|Non-compliance|2|||
148837216|NCT00181844|536884289|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
148837217|NCT00181844|536884289|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
148837218|NCT00107276|536884291|FG000|Overall Study|Progression|46|||
148837219|NCT00107276|536884291|FG000|Overall Study|Adverse Event|6|||
148837220|NCT00107276|536884291|FG000|Overall Study|M.D. decision|2|||
148837221|NCT00107276|536884291|FG000|Overall Study|Patient refusal|1|||
148837222|NCT00107276|536884291|FG000|Overall Study|Death|1|||
148837223|NCT00107276|536884291|FG000|Overall Study|Ineligible|16|||
148837224|NCT03179761|536884292|FG000|Overall Study|Death|2|||
148837225|NCT03179761|536884293|FG001|Overall Study|Death|5|||
148837226|NCT03179761|536884292|FG000|Overall Study|Lost to Follow-up|2|||
148837227|NCT03179761|536884293|FG001|Overall Study|Lost to Follow-up|2|||
148837228|NCT03179761|536884292|FG000|Overall Study|Protocol Violation|1|||
148837229|NCT03179761|536884293|FG001|Overall Study|Protocol Violation|0|||
148837230|NCT03179761|536884292|FG000|Overall Study|Withdrawal by Subject|1|||
148837231|NCT03179761|536884293|FG001|Overall Study|Withdrawal by Subject|4|||
148837232|NCT03179761|536884292|FG000|Overall Study|Investigator Request|0|||
148837233|NCT03179761|536884293|FG001|Overall Study|Investigator Request|2|||
148837234|NCT04661033|536884294|FG000|Overall Study|Adverse Event|0|||
148837235|NCT04661033|536884295|FG001|Overall Study|Adverse Event|0|||
148837236|NCT04661033|536884296|FG002|Overall Study|Adverse Event|1|||
148837237|NCT04661033|536884297|FG003|Overall Study|Adverse Event|0|||
148837238|NCT04661033|536884294|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
148837239|NCT04661033|536884295|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
148837240|NCT04661033|536884296|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
148837241|NCT04661033|536884297|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
148837242|NCT04661033|536884294|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
148837243|NCT04661033|536884295|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
148837244|NCT04661033|536884296|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
148837245|NCT04661033|536884297|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
148837246|NCT04661033|536884294|FG000|Overall Study|Early discontinuation as per PI|1|||
148837247|NCT04661033|536884295|FG001|Overall Study|Early discontinuation as per PI|0|||
148837248|NCT04661033|536884296|FG002|Overall Study|Early discontinuation as per PI|0|||
148837249|NCT04661033|536884297|FG003|Overall Study|Early discontinuation as per PI|0|||
148837250|NCT01816984|536884298|FG000|Overall Study|declining health status|1|||
148837251|NCT05899829|536884299|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
148837252|NCT05899829|536884300|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
148837253|NCT05899829|536884299|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
148837254|NCT05899829|536884300|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
149029113|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
148837255|NCT00867035|536884301|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
148837256|NCT00867035|536884302|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
148837257|NCT00867035|536884301|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
148837258|NCT00867035|536884302|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
149029114|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
149029115|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
148837259|NCT02993263|536884303|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
148837260|NCT02561962|536884311|FG000|Overall Study|Withdrawal by Subject|1|||
148837261|NCT02561962|536884312|FG001|Overall Study|Withdrawal by Subject|0|||
148982374|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
148982375|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
148982376|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
148982377|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
148982378|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
148982379|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
148982380|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
148982381|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982382|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982383|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
148982384|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982385|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982386|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982387|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982388|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982389|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
148982390|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
148982391|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
148982392|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
148982393|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
148982394|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
148982395|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
148982396|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
148982397|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
148982398|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
148982399|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982400|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982401|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
148982402|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982403|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982404|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982405|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982406|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982407|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
148982408|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
148982409|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
148982410|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
148982411|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
148982412|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
148982413|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
148982414|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
148982415|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
148982416|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
148982417|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982418|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
148982419|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982420|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982421|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982422|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982423|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982424|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
148982425|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
148982426|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982427|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
148982428|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982429|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982430|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982431|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982432|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982433|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982434|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
148982435|NCT01172938|537415282|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982436|NCT01172938|537415283|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982437|NCT01172938|537415284|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982438|NCT01172938|537415285|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148837262|NCT02561962|536884313|FG002|Overall Study|Withdrawal by Subject|0|||
148837263|NCT02561962|536884314|FG003|Overall Study|Withdrawal by Subject|0|||
148837264|NCT02561962|536884315|FG004|Overall Study|Withdrawal by Subject|1|||
148837265|NCT02561962|536884316|FG005|Overall Study|Withdrawal by Subject|1|||
148837266|NCT02561962|536884317|FG006|Overall Study|Withdrawal by Subject|2|||
148837267|NCT02561962|536884318|FG007|Overall Study|Withdrawal by Subject|1|||
148837268|NCT02561962|536884319|FG008|Overall Study|Withdrawal by Subject|0|||
148837269|NCT02561962|536884311|FG000|Overall Study|Decision by sponsor|0|||
148837270|NCT02561962|536884312|FG001|Overall Study|Decision by sponsor|0|||
148837271|NCT02561962|536884313|FG002|Overall Study|Decision by sponsor|0|||
148837272|NCT02561962|536884314|FG003|Overall Study|Decision by sponsor|0|||
148837273|NCT02561962|536884315|FG004|Overall Study|Decision by sponsor|1|||
148837274|NCT02561962|536884316|FG005|Overall Study|Decision by sponsor|1|||
148837275|NCT02561962|536884317|FG006|Overall Study|Decision by sponsor|0|||
148837276|NCT02561962|536884318|FG007|Overall Study|Decision by sponsor|3|||
148837277|NCT02561962|536884319|FG008|Overall Study|Decision by sponsor|0|||
148837278|NCT02561962|536884311|FG000|Overall Study|Lost to Follow-up|0|||
148837279|NCT02561962|536884312|FG001|Overall Study|Lost to Follow-up|0|||
148837280|NCT02561962|536884313|FG002|Overall Study|Lost to Follow-up|0|||
148837281|NCT02561962|536884314|FG003|Overall Study|Lost to Follow-up|0|||
148837282|NCT02561962|536884315|FG004|Overall Study|Lost to Follow-up|0|||
148837283|NCT02561962|536884316|FG005|Overall Study|Lost to Follow-up|1|||
148837284|NCT02561962|536884317|FG006|Overall Study|Lost to Follow-up|0|||
148837285|NCT02561962|536884318|FG007|Overall Study|Lost to Follow-up|0|||
148837286|NCT02561962|536884319|FG008|Overall Study|Lost to Follow-up|0|||
148889070|NCT02800863|537072347|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
148889071|NCT03957551|537072348|FG000|Overall Study|Adverse Event|2|||
148889072|NCT03957551|537072349|FG001|Overall Study|Adverse Event|2|||
148889073|NCT03957551|537072350|FG002|Overall Study|Adverse Event|6|||
148889074|NCT03957551|537072348|FG000|Overall Study|Physician Decision|1|||
148889075|NCT03957551|537072349|FG001|Overall Study|Physician Decision|0|||
148889076|NCT03957551|537072350|FG002|Overall Study|Physician Decision|2|||
148889077|NCT03957551|537072348|FG000|Overall Study|Withdrawal by Subject|1|||
148889078|NCT03957551|537072349|FG001|Overall Study|Withdrawal by Subject|0|||
148889079|NCT03957551|537072350|FG002|Overall Study|Withdrawal by Subject|2|||
148889080|NCT03957551|537072348|FG000|Overall Study|Disease progression|1|||
148889081|NCT03957551|537072349|FG001|Overall Study|Disease progression|0|||
148889082|NCT03957551|537072350|FG002|Overall Study|Disease progression|8|||
148889083|NCT03775486|537072358|FG000|Initial Therapy Phase|Other reason provided|0|||
148889084|NCT03775486|537072359|FG001|Initial Therapy Phase|Other reason provided|15|||
148889085|NCT03775486|537072358|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
148889086|NCT03775486|537072359|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
148889087|NCT03775486|537072358|FG000|Initial Therapy Phase|Protocol Violation|0|||
148889088|NCT03775486|537072359|FG001|Initial Therapy Phase|Protocol Violation|2|||
148889089|NCT03775486|537072358|FG000|Initial Therapy Phase|Adverse Event|0|||
148889090|NCT03775486|537072359|FG001|Initial Therapy Phase|Adverse Event|34|||
148889091|NCT03775486|537072358|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
148889092|NCT03775486|537072359|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
148889093|NCT03775486|537072358|FG000|Maintenance Phase|Withdrawal by Subject|13|||
148889094|NCT03775486|537072359|FG001|Maintenance Phase|Withdrawal by Subject|12|||
148889095|NCT03775486|537072358|FG000|Maintenance Phase|Death|44|||
148889096|NCT03775486|537072359|FG001|Maintenance Phase|Death|45|||
148889097|NCT01572480|537072360|FG000|Participants Enrolled|Withdrawal by Subject|1|||
148889098|NCT01572480|537072360|FG000|Drug Administration|Discontinued drug/Off Study|1|||
148889099|NCT01572480|537072360|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
148889100|NCT01572480|537072360|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
148889101|NCT04194944|537072361|FG000|Overall Study|Lost to Follow-up|3|||
148889102|NCT04194944|537072362|FG001|Overall Study|Lost to Follow-up|0|||
148889103|NCT04194944|537072361|FG000|Overall Study|Withdrawal by Subject|2|||
148889104|NCT04194944|537072362|FG001|Overall Study|Withdrawal by Subject|2|||
148889105|NCT04194944|537072361|FG000|Overall Study|On Treatment|93|||
148889106|NCT04194944|537072362|FG001|Overall Study|On Treatment|30|||
148889107|NCT00801216|537072363|FG000|Overall Study|Screening Failure|2|||
148889108|NCT05214768|537072364|FG000|Induction Period|Withdrawal by Subject|1|||
148889109|NCT05214768|537072365|FG001|Induction Period|Withdrawal by Subject|0|||
148889110|NCT05214768|537072366|FG002|Induction Period|Withdrawal by Subject|0|||
148889111|NCT05214768|537072367|FG003|Induction Period|Withdrawal by Subject|0|||
148889112|NCT05214768|537072368|FG004|Induction Period|Withdrawal by Subject|0|||
148889113|NCT05214768|537072369|FG005|Induction Period|Withdrawal by Subject|0|||
148889114|NCT05214768|537072364|FG000|Induction Period|Physician Decision|1|||
148889115|NCT05214768|537072365|FG001|Induction Period|Physician Decision|0|||
148889116|NCT05214768|537072366|FG002|Induction Period|Physician Decision|0|||
148889117|NCT05214768|537072367|FG003|Induction Period|Physician Decision|0|||
148889118|NCT05214768|537072368|FG004|Induction Period|Physician Decision|0|||
148889119|NCT05214768|537072369|FG005|Induction Period|Physician Decision|0|||
148889120|NCT05214768|537072364|FG000|Maintenance Period|Other Reasons|0|||
148837287|NCT00639457|536886036|FG000|Overall Study|Withdrawal by Subject|2|||
148837288|NCT00639457|536886037|FG001|Overall Study|Withdrawal by Subject|3|||
148837289|NCT03235050|536886038|FG000|Overall Study|Adverse Event|0|||
148837290|NCT03235050|536886039|FG001|Overall Study|Adverse Event|0|||
148837291|NCT03235050|536886040|FG002|Overall Study|Adverse Event|1|||
148837292|NCT03235050|536886041|FG003|Overall Study|Adverse Event|4|||
148837293|NCT03235050|536886042|FG004|Overall Study|Adverse Event|1|||
148837294|NCT03235050|536886038|FG000|Overall Study|Death|0|||
148837295|NCT03235050|536886039|FG001|Overall Study|Death|0|||
148837296|NCT03235050|536886040|FG002|Overall Study|Death|0|||
148837297|NCT03235050|536886041|FG003|Overall Study|Death|2|||
148837298|NCT03235050|536886042|FG004|Overall Study|Death|1|||
148837299|NCT03235050|536886038|FG000|Overall Study|Lost to Follow-up|1|||
148837300|NCT03235050|536886039|FG001|Overall Study|Lost to Follow-up|2|||
148837301|NCT03235050|536886040|FG002|Overall Study|Lost to Follow-up|1|||
148837302|NCT03235050|536886041|FG003|Overall Study|Lost to Follow-up|2|||
148837303|NCT03235050|536886042|FG004|Overall Study|Lost to Follow-up|0|||
148837304|NCT03235050|536886038|FG000|Overall Study|Withdrawal by Subject|3|||
148837305|NCT03235050|536886039|FG001|Overall Study|Withdrawal by Subject|2|||
148837306|NCT03235050|536886040|FG002|Overall Study|Withdrawal by Subject|2|||
148837307|NCT03235050|536886041|FG003|Overall Study|Withdrawal by Subject|5|||
148837308|NCT03235050|536886042|FG004|Overall Study|Withdrawal by Subject|7|||
148837309|NCT03235050|536886038|FG000|Overall Study|Other reasons|0|||
148837310|NCT03235050|536886039|FG001|Overall Study|Other reasons|1|||
148837311|NCT03235050|536886040|FG002|Overall Study|Other reasons|0|||
148837312|NCT03235050|536886041|FG003|Overall Study|Other reasons|1|||
148837313|NCT03235050|536886042|FG004|Overall Study|Other reasons|2|||
148837314|NCT00105534|536886046|FG000|Overall Study|Adverse Event|2|||
148837315|NCT00105534|536886047|FG001|Overall Study|Adverse Event|5|||
148837316|NCT00105534|536886046|FG000|Overall Study|Protocol Violation|1|||
148837317|NCT00105534|536886047|FG001|Overall Study|Protocol Violation|4|||
148837318|NCT00105534|536886046|FG000|Overall Study|Withdrawal by Subject|6|||
148837319|NCT00105534|536886047|FG001|Overall Study|Withdrawal by Subject|6|||
148837320|NCT00105534|536886046|FG000|Overall Study|Lost to Follow-up|5|||
148837321|NCT00105534|536886047|FG001|Overall Study|Lost to Follow-up|1|||
148837322|NCT00105534|536886046|FG000|Overall Study|Lack of Efficacy|7|||
148837323|NCT00105534|536886047|FG001|Overall Study|Lack of Efficacy|15|||
148837324|NCT00105534|536886046|FG000|Overall Study|Treatment unmasked|1|||
148837325|NCT00105534|536886047|FG001|Overall Study|Treatment unmasked|0|||
148837326|NCT00105534|536886046|FG000|Overall Study|Other Reason|0|||
148837327|NCT00105534|536886047|FG001|Overall Study|Other Reason|2|||
148837328|NCT02935192|536886048|FG000|Overall Study|Withdrawal by Subject|8|||
148837329|NCT02935192|536886049|FG001|Overall Study|Withdrawal by Subject|4|||
148837330|NCT02465931|536886051|FG000|Overall Study|Lost to Follow-up|9|||
148837331|NCT02465931|536886052|FG001|Overall Study|Lost to Follow-up|11|||
148837332|NCT02465931|536886051|FG000|Overall Study|Protocol Violation|1|||
148837333|NCT02465931|536886052|FG001|Overall Study|Protocol Violation|0|||
148837334|NCT02465931|536886051|FG000|Overall Study|Withdrawal by Subject|1|||
148837335|NCT02465931|536886052|FG001|Overall Study|Withdrawal by Subject|0|||
148982439|NCT01172938|537415286|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982440|NCT01172938|537415287|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982441|NCT01172938|537415288|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982442|NCT01172938|537415289|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
148982443|NCT01172938|537415290|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
148982444|NCT01172938|537415282|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
148982445|NCT01172938|537415283|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
148982446|NCT01172938|537415284|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
148982447|NCT01172938|537415285|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
148982448|NCT01172938|537415286|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
148982449|NCT01172938|537415287|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
148982450|NCT01172938|537415288|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
148982451|NCT01172938|537415289|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
148837336|NCT00492557|536886053|FG000|Overall Study|Subject request|12|||
148837337|NCT00492557|536886054|FG001|Overall Study|Subject request|11|||
148837338|NCT00492557|536886053|FG000|Overall Study|Protocol Violation|7|||
148982452|NCT01172938|537415290|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
148837339|NCT00492557|536886054|FG001|Overall Study|Protocol Violation|8|||
148837340|NCT00492557|536886053|FG000|Overall Study|Other|2|||
148837341|NCT00492557|536886054|FG001|Overall Study|Other|2|||
148837342|NCT00492557|536886053|FG000|Overall Study|Death|1|||
148837343|NCT00492557|536886054|FG001|Overall Study|Death|1|||
148837344|NCT00492557|536886053|FG000|Overall Study|Adverse Event|1|||
148837345|NCT00492557|536886054|FG001|Overall Study|Adverse Event|0|||
148837346|NCT00492557|536886053|FG000|Overall Study|Failed to return|1|||
148837347|NCT00492557|536886054|FG001|Overall Study|Failed to return|0|||
148837348|NCT00492557|536886053|FG000|Overall Study|Lost to Follow-up|0|||
148837349|NCT00492557|536886054|FG001|Overall Study|Lost to Follow-up|1|||
148837350|NCT03423121|536886059|FG000|Overall Study|Lost to Follow-up|2|||
148837351|NCT03423121|536886060|FG001|Overall Study|Lost to Follow-up|6|||
148837352|NCT03423121|536886059|FG000|Overall Study|Adverse Event|1|||
148837353|NCT03423121|536886060|FG001|Overall Study|Adverse Event|0|||
148837354|NCT01354223|536886061|FG000|Overall Study|Withdrawal by Subject|3|||
148837355|NCT01354223|536886062|FG001|Overall Study|Withdrawal by Subject|1|||
148837356|NCT01126190|536886063|FG000|Double-Blind Phase|Death|0|||
148837357|NCT01126190|536886064|FG001|Double-Blind Phase|Death|1|||
148837358|NCT01126190|536886065|FG002|Double-Blind Phase|Death|0|||
148837359|NCT01126190|536886063|FG000|Double-Blind Phase|Adverse Event|1|||
148837360|NCT01126190|536886064|FG001|Double-Blind Phase|Adverse Event|2|||
148837361|NCT01126190|536886065|FG002|Double-Blind Phase|Adverse Event|0|||
148837362|NCT01126190|536886063|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
148837363|NCT01126190|536886064|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
148837364|NCT01126190|536886065|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
148837365|NCT01126190|536886063|FG000|Double-Blind Phase|Request of Investigator|1|||
148837366|NCT01126190|536886064|FG001|Double-Blind Phase|Request of Investigator|0|||
148837367|NCT01126190|536886065|FG002|Double-Blind Phase|Request of Investigator|0|||
148837368|NCT01126190|536886063|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
148837369|NCT01126190|536886064|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
148837370|NCT01126190|536886065|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
148837371|NCT01126190|536886063|FG000|Double-Blind Phase|Non-compliance|1|||
148837372|NCT01126190|536886064|FG001|Double-Blind Phase|Non-compliance|0|||
148837373|NCT01126190|536886065|FG002|Double-Blind Phase|Non-compliance|0|||
148837374|NCT01126190|536886063|FG000|Double-Blind Phase|Lost to Follow-up|1|||
148837375|NCT01126190|536886064|FG001|Double-Blind Phase|Lost to Follow-up|3|||
148837376|NCT01126190|536886065|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148837377|NCT01126190|536886063|FG000|Open-Label Phase|Death|0|||
148837378|NCT01126190|536886064|FG001|Open-Label Phase|Death|0|||
148837379|NCT01126190|536886065|FG002|Open-Label Phase|Death|1|||
148837380|NCT01126190|536886063|FG000|Open-Label Phase|Adverse Event|0|||
148837381|NCT01126190|536886064|FG001|Open-Label Phase|Adverse Event|0|||
148837382|NCT01126190|536886065|FG002|Open-Label Phase|Adverse Event|4|||
148837383|NCT01126190|536886063|FG000|Open-Label Phase|Withdrawal by Subject|0|||
148837384|NCT01126190|536886064|FG001|Open-Label Phase|Withdrawal by Subject|0|||
148837385|NCT01126190|536886065|FG002|Open-Label Phase|Withdrawal by Subject|6|||
148837386|NCT01114737|536886066|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
148837387|NCT01114737|536886067|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
148837388|NCT01114737|536886066|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
148837389|NCT01114737|536886067|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
148837390|NCT01114737|536886066|FG000|Randomized Treatment Period|Pregnancy|1|||
148837391|NCT01114737|536886067|FG001|Randomized Treatment Period|Pregnancy|0|||
148837392|NCT01114737|536886066|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
148837393|NCT01114737|536886067|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
148837394|NCT01114737|536886066|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
148837395|NCT01114737|536886067|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
148837396|NCT01114737|536886066|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
148837397|NCT01114737|536886067|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
148837398|NCT02727322|536886070|FG000|Overall Study|Withdrawal by Subject|1|||
148837399|NCT02727322|536886071|FG001|Overall Study|Withdrawal by Subject|1|||
148837400|NCT02727322|536886070|FG000|Overall Study|Protocol Violation|1|||
148837401|NCT02727322|536886071|FG001|Overall Study|Protocol Violation|0|||
148837402|NCT02903823|536886072|FG000|Overall Study|Physician Decision|5|||
148837403|NCT02903823|536886072|FG000|Overall Study|Could not advance catheter|1|||
148837404|NCT02903823|536886072|FG000|Overall Study|Catheter dislodgement|1|||
148837405|NCT02852967|536886073|FG000|Overall Study|Adverse Event|3|||
148837406|NCT02852967|536886074|FG001|Overall Study|Adverse Event|1|||
148837407|NCT02852967|536886075|FG002|Overall Study|Adverse Event|0|||
148837408|NCT02852967|536886076|FG003|Overall Study|Adverse Event|1|||
148837409|NCT02852967|536886077|FG004|Overall Study|Adverse Event|0|||
148837410|NCT02852967|536886073|FG000|Overall Study|Death|1|||
148837411|NCT02852967|536886074|FG001|Overall Study|Death|0|||
148837412|NCT02852967|536886075|FG002|Overall Study|Death|0|||
148837413|NCT02852967|536886076|FG003|Overall Study|Death|0|||
148837414|NCT02852967|536886077|FG004|Overall Study|Death|0|||
148837415|NCT02852967|536886073|FG000|Overall Study|Lost to Follow-up|1|||
148837416|NCT02852967|536886074|FG001|Overall Study|Lost to Follow-up|2|||
148837417|NCT02852967|536886075|FG002|Overall Study|Lost to Follow-up|3|||
148837418|NCT02852967|536886076|FG003|Overall Study|Lost to Follow-up|4|||
148837419|NCT02852967|536886077|FG004|Overall Study|Lost to Follow-up|4|||
148837420|NCT02852967|536886073|FG000|Overall Study|Withdrawal by Subject|6|||
148837421|NCT02852967|536886074|FG001|Overall Study|Withdrawal by Subject|12|||
148837422|NCT02852967|536886075|FG002|Overall Study|Withdrawal by Subject|7|||
148837423|NCT02852967|536886076|FG003|Overall Study|Withdrawal by Subject|10|||
148837424|NCT02852967|536886077|FG004|Overall Study|Withdrawal by Subject|10|||
148837425|NCT02852967|536886073|FG000|Overall Study|SAE|0|||
148837426|NCT02852967|536886074|FG001|Overall Study|SAE|0|||
148837427|NCT02852967|536886075|FG002|Overall Study|SAE|0|||
148837428|NCT02852967|536886076|FG003|Overall Study|SAE|3|||
148837429|NCT02852967|536886077|FG004|Overall Study|SAE|0|||
148837430|NCT02852967|536886073|FG000|Overall Study|Elevated Liver Enzymes|2|||
148837431|NCT02852967|536886074|FG001|Overall Study|Elevated Liver Enzymes|0|||
148837432|NCT02852967|536886075|FG002|Overall Study|Elevated Liver Enzymes|0|||
148837433|NCT02852967|536886076|FG003|Overall Study|Elevated Liver Enzymes|2|||
148837434|NCT02852967|536886077|FG004|Overall Study|Elevated Liver Enzymes|2|||
148837435|NCT02852967|536886073|FG000|Overall Study|Physician Decision|0|||
148837436|NCT02852967|536886074|FG001|Overall Study|Physician Decision|0|||
148837437|NCT02852967|536886075|FG002|Overall Study|Physician Decision|0|||
148837438|NCT02852967|536886076|FG003|Overall Study|Physician Decision|1|||
148837439|NCT02852967|536886077|FG004|Overall Study|Physician Decision|0|||
148837440|NCT02852967|536886073|FG000|Overall Study|Lack of Efficacy|0|||
148837441|NCT02852967|536886074|FG001|Overall Study|Lack of Efficacy|1|||
148837442|NCT02852967|536886075|FG002|Overall Study|Lack of Efficacy|0|||
148837443|NCT02852967|536886076|FG003|Overall Study|Lack of Efficacy|0|||
148837444|NCT02852967|536886077|FG004|Overall Study|Lack of Efficacy|0|||
148837445|NCT02852967|536886073|FG000|Overall Study|Non-compliance|0|||
148837446|NCT02852967|536886074|FG001|Overall Study|Non-compliance|0|||
148837447|NCT02852967|536886075|FG002|Overall Study|Non-compliance|1|||
148837448|NCT02852967|536886076|FG003|Overall Study|Non-compliance|1|||
148837449|NCT02852967|536886077|FG004|Overall Study|Non-compliance|0|||
148837450|NCT02852967|536886073|FG000|Overall Study|Dispensing Drug Violation|0|||
148837451|NCT02852967|536886074|FG001|Overall Study|Dispensing Drug Violation|0|||
148837452|NCT02852967|536886075|FG002|Overall Study|Dispensing Drug Violation|1|||
148837453|NCT02852967|536886076|FG003|Overall Study|Dispensing Drug Violation|0|||
148837454|NCT02852967|536886077|FG004|Overall Study|Dispensing Drug Violation|0|||
148837455|NCT02852967|536886073|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
148837456|NCT02852967|536886074|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
148837457|NCT02852967|536886075|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
148837458|NCT02852967|536886076|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
148837459|NCT02852967|536886077|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
148837460|NCT01123148|536886078|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
148837461|NCT01123148|536886078|FG000|Overall Study|Didn't meet milestone criteria|1|||
148837462|NCT01008618|536886079|FG000|Period 1 (Titration Period)|Physician Decision|2|||
148837463|NCT01008618|536886080|FG001|Period 1 (Titration Period)|Physician Decision|0|||
148837464|NCT01008618|536886081|FG002|Period 1 (Titration Period)|Physician Decision|0|||
148837465|NCT01008618|536886079|FG000|Period 1 (Titration Period)|Adverse Event|33|||
148837466|NCT01008618|536886080|FG001|Period 1 (Titration Period)|Adverse Event|0|||
148837467|NCT01008618|536886081|FG002|Period 1 (Titration Period)|Adverse Event|0|||
148837468|NCT01008618|536886079|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
148837469|NCT01008618|536886080|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
148837470|NCT01008618|536886081|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
148837471|NCT01008618|536886079|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
148837472|NCT01008618|536886080|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
148837473|NCT01008618|536886081|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
148837474|NCT01008618|536886079|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
148837475|NCT01008618|536886080|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
148837476|NCT01008618|536886081|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
148837477|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
148837478|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
148837479|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
148837480|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
148837481|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
148837482|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
148837483|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
148837484|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
148837485|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
148837486|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
148837487|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
148837488|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
148837489|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
148837490|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
148837491|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
148837492|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
148837493|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
148837494|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
148837495|NCT01008618|536886079|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
148837496|NCT01008618|536886080|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
148837497|NCT01008618|536886081|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
148837498|NCT02581891|536886085|FG000|Overall Study|Adverse Event|4|||
148837499|NCT02581891|536886086|FG001|Overall Study|Adverse Event|6|||
148837500|NCT02581891|536886085|FG000|Overall Study|Death|3|||
148837501|NCT02581891|536886086|FG001|Overall Study|Death|4|||
148837502|NCT02581891|536886085|FG000|Overall Study|Lost to Follow-up|1|||
148837503|NCT02581891|536886086|FG001|Overall Study|Lost to Follow-up|2|||
148837504|NCT02581891|536886085|FG000|Overall Study|Physician Decision|0|||
148837505|NCT02581891|536886086|FG001|Overall Study|Physician Decision|1|||
148837506|NCT02581891|536886085|FG000|Overall Study|Withdrawal by Subject|4|||
148837507|NCT02581891|536886086|FG001|Overall Study|Withdrawal by Subject|5|||
148837508|NCT02581891|536886085|FG000|Overall Study|Other Reasons|3|||
148837509|NCT02581891|536886086|FG001|Overall Study|Other Reasons|1|||
148837510|NCT02581891|536886085|FG000|Overall Study|Discontinued during followup|1|||
148837511|NCT02581891|536886086|FG001|Overall Study|Discontinued during followup|0|||
148837512|NCT02927795|536886087|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
148837513|NCT02927795|536886087|FG000|Overall Study|Not Treated|4|||
148837514|NCT03498716|536886099|FG000|Overall Study|Withdrawal by Subject|88|||
148837515|NCT03498716|536886100|FG001|Overall Study|Withdrawal by Subject|73|||
148837516|NCT03498716|536886099|FG000|Overall Study|Study Terminated By Sponsor|933|||
148837517|NCT03498716|536886100|FG001|Overall Study|Study Terminated By Sponsor|927|||
148837518|NCT03498716|536886099|FG000|Overall Study|Lost to Follow-up|15|||
148837519|NCT03498716|536886100|FG001|Overall Study|Lost to Follow-up|26|||
148837520|NCT03498716|536886099|FG000|Overall Study|Disease Relapse|0|||
148837521|NCT03498716|536886100|FG001|Overall Study|Disease Relapse|1|||
148837522|NCT03498716|536886099|FG000|Overall Study|Death|58|||
148837523|NCT03498716|536886100|FG001|Overall Study|Death|72|||
148837524|NCT03498716|536886099|FG000|Overall Study|Physician Decision|4|||
148837525|NCT03498716|536886100|FG001|Overall Study|Physician Decision|2|||
148837526|NCT01987557|536886104|FG000|Overall Study|Protocol Violation|1|||
148837527|NCT01987557|536886105|FG001|Overall Study|Protocol Violation|0|||
148837528|NCT01987557|536886106|FG002|Overall Study|Protocol Violation|1|||
148837529|NCT01987557|536886104|FG000|Overall Study|Withdrawal by Subject|2|||
148837530|NCT01987557|536886105|FG001|Overall Study|Withdrawal by Subject|1|||
148837531|NCT01987557|536886106|FG002|Overall Study|Withdrawal by Subject|2|||
148837532|NCT01987557|536886104|FG000|Overall Study|Adverse Event|0|||
148837533|NCT01987557|536886105|FG001|Overall Study|Adverse Event|2|||
148837534|NCT01987557|536886106|FG002|Overall Study|Adverse Event|0|||
148837535|NCT01812057|536886116|FG000|Overall Study|Protocol Violation|1|||
148837536|NCT01812057|536886117|FG001|Overall Study|Protocol Violation|0|||
148837537|NCT01812057|536886116|FG000|Overall Study|Physician Decision|1|||
148837538|NCT01812057|536886117|FG001|Overall Study|Physician Decision|0|||
148837539|NCT01880957|536886122|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
148837540|NCT01880957|536886123|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
148837541|NCT01880957|536886122|FG000|Overall Study|Lost to Follow-up|11|||
148837542|NCT01880957|536886123|FG001|Overall Study|Lost to Follow-up|0|||
148837543|NCT01880957|536886122|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
148837544|NCT01880957|536886123|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
148837545|NCT01854528|536886124|FG000|Overall Study|Adverse Event|0|||
148837546|NCT01854528|536886125|FG001|Overall Study|Adverse Event|4|||
148837547|NCT01854528|536886124|FG000|Overall Study|Withdrawal by Subject|0|||
148837548|NCT01854528|536886125|FG001|Overall Study|Withdrawal by Subject|2|||
148837549|NCT01854528|536886124|FG000|Overall Study|Virologic Failure|0|||
148837550|NCT01854528|536886125|FG001|Overall Study|Virologic Failure|9|||
148837551|NCT00518180|536886126|FG000|Overall Study|Withdrawal by Subject|29|||
148837552|NCT00518180|536886127|FG001|Overall Study|Withdrawal by Subject|30|||
148837553|NCT00518180|536886128|FG002|Overall Study|Withdrawal by Subject|42|||
148837554|NCT00518180|536886126|FG000|Overall Study|Lost to Follow-up|30|||
148837555|NCT00518180|536886127|FG001|Overall Study|Lost to Follow-up|28|||
148837556|NCT00518180|536886128|FG002|Overall Study|Lost to Follow-up|34|||
148837557|NCT00518180|536886126|FG000|Overall Study|Administrative reason|0|||
148837558|NCT00518180|536886127|FG001|Overall Study|Administrative reason|2|||
148837559|NCT00518180|536886128|FG002|Overall Study|Administrative reason|2|||
148837560|NCT00518180|536886126|FG000|Overall Study|Protocol Violation|5|||
148837561|NCT00518180|536886127|FG001|Overall Study|Protocol Violation|7|||
148837562|NCT00518180|536886128|FG002|Overall Study|Protocol Violation|4|||
148837563|NCT00518180|536886126|FG000|Overall Study|Unable to classify|0|||
148982453|NCT01172938|537415282|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
148982454|NCT01172938|537415283|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
148837564|NCT00518180|536886127|FG001|Overall Study|Unable to classify|2|||
148837565|NCT00518180|536886128|FG002|Overall Study|Unable to classify|0|||
148837566|NCT00518180|536886126|FG000|Overall Study|Adverse Event|1|||
148837567|NCT00518180|536886127|FG001|Overall Study|Adverse Event|0|||
148837568|NCT00518180|536886128|FG002|Overall Study|Adverse Event|0|||
148837569|NCT02951780|536886129|FG000|Period 1|Adverse Event|0|||
148837570|NCT02951780|536886130|FG001|Period 1|Adverse Event|0|||
148837571|NCT02951780|536886131|FG002|Period 1|Adverse Event|0|||
148837572|NCT02951780|536886132|FG003|Period 1|Adverse Event|1|||
148837573|NCT02951780|536886133|FG004|Period 1|Adverse Event|0|||
148837574|NCT02951780|536886134|FG005|Period 1|Adverse Event|0|||
148837575|NCT02951780|536886135|FG006|Period 1|Adverse Event|0|||
148837576|NCT02951780|536886136|FG007|Period 1|Adverse Event|0|||
148837577|NCT02951780|536886137|FG008|Period 1|Adverse Event|0|||
148837578|NCT02951780|536886129|FG000|Period 1|Scheduling Conflicts|0|||
148837579|NCT02951780|536886130|FG001|Period 1|Scheduling Conflicts|0|||
148837580|NCT02951780|536886131|FG002|Period 1|Scheduling Conflicts|0|||
148837581|NCT02951780|536886132|FG003|Period 1|Scheduling Conflicts|0|||
148837582|NCT02951780|536886133|FG004|Period 1|Scheduling Conflicts|0|||
148837583|NCT02951780|536886134|FG005|Period 1|Scheduling Conflicts|0|||
148837584|NCT02951780|536886135|FG006|Period 1|Scheduling Conflicts|0|||
148837585|NCT02951780|536886136|FG007|Period 1|Scheduling Conflicts|1|||
148837586|NCT02951780|536886137|FG008|Period 1|Scheduling Conflicts|0|||
148837587|NCT02951780|536886129|FG000|Period 2|Scheduling Conflicts|0|||
148837588|NCT02951780|536886130|FG001|Period 2|Scheduling Conflicts|0|||
148837589|NCT02951780|536886131|FG002|Period 2|Scheduling Conflicts|0|||
148837590|NCT02951780|536886132|FG003|Period 2|Scheduling Conflicts|0|||
148837591|NCT02951780|536886133|FG004|Period 2|Scheduling Conflicts|0|||
148837592|NCT02951780|536886134|FG005|Period 2|Scheduling Conflicts|0|||
148837593|NCT02951780|536886135|FG006|Period 2|Scheduling Conflicts|0|||
148837594|NCT02951780|536886136|FG007|Period 2|Scheduling Conflicts|1|||
148837595|NCT02951780|536886137|FG008|Period 2|Scheduling Conflicts|0|||
148837596|NCT02289469|536886140|FG000|Overall Study|Unable to match a control|6|||
148837597|NCT02289469|536886141|FG001|Overall Study|Unable to match a control|0|||
148837598|NCT03508050|536886144|FG000|Overall Study|Pleural adhesions|1|||
148837599|NCT03508050|536886145|FG001|Overall Study|Pleural adhesions|0|||
148837600|NCT03508050|536886144|FG000|Overall Study|Mucus plug|1|||
148837601|NCT03508050|536886145|FG001|Overall Study|Mucus plug|0|||
148837602|NCT03508050|536886144|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
148837603|NCT03508050|536886145|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
148837604|NCT03508050|536886144|FG000|Overall Study|Sustained desaturation|0|||
148837605|NCT03508050|536886145|FG001|Overall Study|Sustained desaturation|1|||
148837606|NCT01082614|536886146|FG000|Overall Study|Adverse Event|1|||
148837607|NCT01082614|536886147|FG001|Overall Study|Adverse Event|4|||
148837608|NCT01082614|536886146|FG000|Overall Study|Equipment Malfunction|0|||
148837609|NCT01082614|536886147|FG001|Overall Study|Equipment Malfunction|1|||
148837610|NCT01082614|536886146|FG000|Overall Study|Physician Decision|2|||
148837611|NCT01082614|536886147|FG001|Overall Study|Physician Decision|0|||
148837612|NCT03710889|536886152|FG000|Overall Study|Adverse Event|2|||
148837613|NCT03710889|536886152|FG000|Overall Study|Protocol Deviation|1|||
148837614|NCT00421148|536886153|FG000|Overall Study|Lost to Follow-up|0|||
148837615|NCT00421148|536886154|FG001|Overall Study|Lost to Follow-up|0|||
148837616|NCT00421148|536886155|FG002|Overall Study|Lost to Follow-up|0|||
148837617|NCT00421148|536886156|FG003|Overall Study|Lost to Follow-up|0|||
148837618|NCT00421148|536886157|FG004|Overall Study|Lost to Follow-up|0|||
148837619|NCT00421148|536886158|FG005|Overall Study|Lost to Follow-up|0|||
148837620|NCT00421148|536886159|FG006|Overall Study|Lost to Follow-up|0|||
148837621|NCT00421148|536886160|FG007|Overall Study|Lost to Follow-up|0|||
148837622|NCT00421148|536886161|FG008|Overall Study|Lost to Follow-up|0|||
148837623|NCT00421148|536886162|FG009|Overall Study|Lost to Follow-up|0|||
148837624|NCT00421148|536886163|FG010|Overall Study|Lost to Follow-up|0|||
148837625|NCT00421148|536886164|FG011|Overall Study|Lost to Follow-up|0|||
148837626|NCT00421148|536886165|FG012|Overall Study|Lost to Follow-up|0|||
148837627|NCT00421148|536886166|FG013|Overall Study|Lost to Follow-up|0|||
148837628|NCT00421148|536886167|FG014|Overall Study|Lost to Follow-up|0|||
148837629|NCT00421148|536886168|FG015|Overall Study|Lost to Follow-up|0|||
148837630|NCT00421148|536886169|FG016|Overall Study|Lost to Follow-up|0|||
148837631|NCT00421148|536886170|FG017|Overall Study|Lost to Follow-up|1|||
148837632|NCT00421148|536886171|FG018|Overall Study|Lost to Follow-up|0|||
148837633|NCT00421148|536886172|FG019|Overall Study|Lost to Follow-up|0|||
148982455|NCT01172938|537415284|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
148982456|NCT01172938|537415285|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
148837634|NCT00421148|536886153|FG000|Overall Study|Withdrawal by Subject|0|||
148837635|NCT00421148|536886154|FG001|Overall Study|Withdrawal by Subject|0|||
148837636|NCT00421148|536886155|FG002|Overall Study|Withdrawal by Subject|0|||
148837637|NCT00421148|536886156|FG003|Overall Study|Withdrawal by Subject|0|||
148837638|NCT00421148|536886157|FG004|Overall Study|Withdrawal by Subject|0|||
148837639|NCT00421148|536886158|FG005|Overall Study|Withdrawal by Subject|0|||
148837640|NCT00421148|536886159|FG006|Overall Study|Withdrawal by Subject|0|||
148837641|NCT00421148|536886160|FG007|Overall Study|Withdrawal by Subject|0|||
148837642|NCT00421148|536886161|FG008|Overall Study|Withdrawal by Subject|0|||
148837643|NCT00421148|536886162|FG009|Overall Study|Withdrawal by Subject|0|||
148837644|NCT00421148|536886163|FG010|Overall Study|Withdrawal by Subject|0|||
148837645|NCT00421148|536886164|FG011|Overall Study|Withdrawal by Subject|0|||
148837646|NCT00421148|536886165|FG012|Overall Study|Withdrawal by Subject|0|||
148837647|NCT00421148|536886166|FG013|Overall Study|Withdrawal by Subject|0|||
148837648|NCT00421148|536886167|FG014|Overall Study|Withdrawal by Subject|0|||
148837649|NCT00421148|536886168|FG015|Overall Study|Withdrawal by Subject|0|||
148837650|NCT00421148|536886169|FG016|Overall Study|Withdrawal by Subject|0|||
148837651|NCT00421148|536886170|FG017|Overall Study|Withdrawal by Subject|1|||
148837652|NCT00421148|536886171|FG018|Overall Study|Withdrawal by Subject|0|||
148837653|NCT00421148|536886172|FG019|Overall Study|Withdrawal by Subject|0|||
148837654|NCT00421148|536886153|FG000|Overall Study|Protocol Violation|0|||
148837655|NCT00421148|536886154|FG001|Overall Study|Protocol Violation|0|||
148837656|NCT00421148|536886155|FG002|Overall Study|Protocol Violation|0|||
148837657|NCT00421148|536886156|FG003|Overall Study|Protocol Violation|0|||
148837658|NCT00421148|536886157|FG004|Overall Study|Protocol Violation|0|||
148837659|NCT00421148|536886158|FG005|Overall Study|Protocol Violation|1|||
148837660|NCT00421148|536886159|FG006|Overall Study|Protocol Violation|0|||
148837661|NCT00421148|536886160|FG007|Overall Study|Protocol Violation|0|||
148837662|NCT00421148|536886161|FG008|Overall Study|Protocol Violation|0|||
148837663|NCT00421148|536886162|FG009|Overall Study|Protocol Violation|0|||
148837664|NCT00421148|536886163|FG010|Overall Study|Protocol Violation|0|||
148837665|NCT00421148|536886164|FG011|Overall Study|Protocol Violation|0|||
148837666|NCT00421148|536886165|FG012|Overall Study|Protocol Violation|0|||
148837667|NCT00421148|536886166|FG013|Overall Study|Protocol Violation|0|||
148837668|NCT00421148|536886167|FG014|Overall Study|Protocol Violation|0|||
148837669|NCT00421148|536886168|FG015|Overall Study|Protocol Violation|0|||
148837670|NCT00421148|536886169|FG016|Overall Study|Protocol Violation|0|||
148837671|NCT00421148|536886170|FG017|Overall Study|Protocol Violation|0|||
148837672|NCT00421148|536886171|FG018|Overall Study|Protocol Violation|1|||
148837673|NCT00421148|536886172|FG019|Overall Study|Protocol Violation|0|||
148837674|NCT04881760|536886173|FG000|Overall Study|Adverse Event|0|||
148837675|NCT04881760|536886174|FG001|Overall Study|Adverse Event|1|||
148837676|NCT04881760|536886175|FG002|Overall Study|Adverse Event|1|||
148837677|NCT04881760|536886176|FG003|Overall Study|Adverse Event|0|||
148837678|NCT04881760|536886177|FG004|Overall Study|Adverse Event|1|||
148837679|NCT04881760|536886178|FG005|Overall Study|Adverse Event|1|||
148837680|NCT04881760|536886179|FG006|Overall Study|Adverse Event|2|||
148837681|NCT04881760|536886173|FG000|Overall Study|Death|0|||
148837682|NCT04881760|536886174|FG001|Overall Study|Death|0|||
148837683|NCT04881760|536886175|FG002|Overall Study|Death|0|||
148837684|NCT04881760|536886176|FG003|Overall Study|Death|1|||
148837685|NCT04881760|536886177|FG004|Overall Study|Death|0|||
148837686|NCT04881760|536886178|FG005|Overall Study|Death|0|||
148837687|NCT04881760|536886179|FG006|Overall Study|Death|0|||
148837688|NCT04881760|536886173|FG000|Overall Study|Lost to Follow-up|5|||
148837689|NCT04881760|536886174|FG001|Overall Study|Lost to Follow-up|7|||
148837690|NCT04881760|536886175|FG002|Overall Study|Lost to Follow-up|5|||
148837691|NCT04881760|536886176|FG003|Overall Study|Lost to Follow-up|1|||
148837692|NCT04881760|536886177|FG004|Overall Study|Lost to Follow-up|2|||
148837693|NCT04881760|536886178|FG005|Overall Study|Lost to Follow-up|4|||
148837694|NCT04881760|536886179|FG006|Overall Study|Lost to Follow-up|4|||
148837695|NCT04881760|536886173|FG000|Overall Study|Withdrawal by Subject|13|||
148837696|NCT04881760|536886174|FG001|Overall Study|Withdrawal by Subject|1|||
148837697|NCT04881760|536886175|FG002|Overall Study|Withdrawal by Subject|1|||
148837698|NCT04881760|536886176|FG003|Overall Study|Withdrawal by Subject|4|||
148837699|NCT04881760|536886177|FG004|Overall Study|Withdrawal by Subject|2|||
148837700|NCT04881760|536886178|FG005|Overall Study|Withdrawal by Subject|1|||
148837701|NCT04881760|536886179|FG006|Overall Study|Withdrawal by Subject|2|||
148837702|NCT04881760|536886173|FG000|Overall Study|Randomized but Never Treated|0|||
148837703|NCT04881760|536886174|FG001|Overall Study|Randomized but Never Treated|0|||
148837704|NCT04881760|536886175|FG002|Overall Study|Randomized but Never Treated|0|||
148837705|NCT04881760|536886176|FG003|Overall Study|Randomized but Never Treated|1|||
148837706|NCT04881760|536886177|FG004|Overall Study|Randomized but Never Treated|0|||
148837707|NCT04881760|536886178|FG005|Overall Study|Randomized but Never Treated|0|||
148837708|NCT04881760|536886179|FG006|Overall Study|Randomized but Never Treated|0|||
148837709|NCT04881760|536886173|FG000|Overall Study|Inadvertent Enrollment|2|||
148837710|NCT04881760|536886174|FG001|Overall Study|Inadvertent Enrollment|0|||
148982457|NCT01172938|537415286|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
148982458|NCT01172938|537415287|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
148982459|NCT01172938|537415288|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
148837711|NCT04881760|536886175|FG002|Overall Study|Inadvertent Enrollment|0|||
148837712|NCT04881760|536886176|FG003|Overall Study|Inadvertent Enrollment|0|||
148837713|NCT04881760|536886177|FG004|Overall Study|Inadvertent Enrollment|0|||
148837714|NCT04881760|536886178|FG005|Overall Study|Inadvertent Enrollment|0|||
148837715|NCT04881760|536886179|FG006|Overall Study|Inadvertent Enrollment|0|||
148837716|NCT04881760|536886173|FG000|Overall Study|Site Closure|0|||
148837717|NCT04881760|536886174|FG001|Overall Study|Site Closure|0|||
148837718|NCT04881760|536886175|FG002|Overall Study|Site Closure|0|||
148837719|NCT04881760|536886176|FG003|Overall Study|Site Closure|1|||
148837720|NCT04881760|536886177|FG004|Overall Study|Site Closure|0|||
148837721|NCT04881760|536886178|FG005|Overall Study|Site Closure|0|||
148837722|NCT04881760|536886179|FG006|Overall Study|Site Closure|0|||
148837723|NCT01538199|536886180|FG000|Overall Study|Lost to Follow-up|1|||
148837724|NCT01538199|536886181|FG001|Overall Study|Lost to Follow-up|2|||
148837725|NCT01538199|536886182|FG002|Overall Study|Lost to Follow-up|1|||
148837726|NCT01538199|536886183|FG003|Overall Study|Lost to Follow-up|0|||
148982460|NCT01172938|537415289|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
148982461|NCT01172938|537415290|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
148837727|NCT01538199|536886180|FG000|Overall Study|participant did not have time|1|||
148837728|NCT01538199|536886181|FG001|Overall Study|participant did not have time|0|||
148837729|NCT01538199|536886182|FG002|Overall Study|participant did not have time|0|||
148837730|NCT01538199|536886183|FG003|Overall Study|participant did not have time|2|||
148837731|NCT01538199|536886180|FG000|Overall Study|Lack of Efficacy|0|||
148837732|NCT01538199|536886181|FG001|Overall Study|Lack of Efficacy|1|||
148837733|NCT01538199|536886182|FG002|Overall Study|Lack of Efficacy|0|||
148837734|NCT01538199|536886183|FG003|Overall Study|Lack of Efficacy|0|||
148837735|NCT02081586|536886184|FG000|Overall Study|Lost to Follow-up|0|||
148837736|NCT02081586|536886185|FG001|Overall Study|Lost to Follow-up|1|||
148837737|NCT02081586|536886186|FG002|Overall Study|Lost to Follow-up|0|||
148837738|NCT02081586|536886187|FG003|Overall Study|Lost to Follow-up|1|||
148837739|NCT02081586|536886184|FG000|Overall Study|Head injury not related to study|0|||
148837740|NCT02081586|536886185|FG001|Overall Study|Head injury not related to study|0|||
148837741|NCT02081586|536886186|FG002|Overall Study|Head injury not related to study|1|||
148837742|NCT02081586|536886187|FG003|Overall Study|Head injury not related to study|0|||
148837743|NCT04540367|536886193|FG000|Overall Study|Withdrawal by Subject|0|||
148837744|NCT04540367|536886194|FG001|Overall Study|Withdrawal by Subject|0|||
148837745|NCT04540367|536886195|FG002|Overall Study|Withdrawal by Subject|0|||
148837746|NCT04540367|536886196|FG003|Overall Study|Withdrawal by Subject|2|||
148837747|NCT04540367|536886193|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
148837748|NCT04540367|536886194|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
148837749|NCT04540367|536886195|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
148837750|NCT04540367|536886196|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
148837751|NCT04540367|536886193|FG000|Overall Study|Adverse Event|0|||
148837752|NCT04540367|536886194|FG001|Overall Study|Adverse Event|0|||
148837753|NCT04540367|536886195|FG002|Overall Study|Adverse Event|1|||
148837754|NCT04540367|536886196|FG003|Overall Study|Adverse Event|1|||
148837755|NCT01816048|536886200|FG000|Overall Study|Adverse Event|1|||
148837756|NCT01816048|536886200|FG000|Overall Study|Death|1|||
148837757|NCT01816048|536886200|FG000|Overall Study|Withdrawal by Subject|1|||
148837758|NCT01816048|536886200|FG000|Overall Study|Disease Progression|3|||
148837759|NCT02121509|536886203|FG000|Washout Period (35 Days)|Adverse Event|1|||
148837760|NCT02121509|536886204|FG001|Washout Period (35 Days)|Adverse Event|1|||
148837761|NCT02121509|536886205|FG002|Washout Period (35 Days)|Adverse Event|0|||
148837762|NCT02121509|536886206|FG003|Washout Period (35 Days)|Adverse Event|0|||
148837763|NCT02121509|536886203|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
148837764|NCT02121509|536886204|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
148837765|NCT02121509|536886205|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
148837766|NCT02121509|536886206|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
148837767|NCT02121509|536886203|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
148837768|NCT02121509|536886204|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
148837769|NCT02121509|536886205|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
148837770|NCT02121509|536886206|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
148837771|NCT00636181|536886209|FG000|Overall Study|Withdrawal by Subject|8|||
148837772|NCT00636181|536886210|FG001|Overall Study|Withdrawal by Subject|6|||
148837773|NCT00636181|536886211|FG002|Overall Study|Withdrawal by Subject|10|||
148837774|NCT04549454|536886214|FG000|T1 to T2|Lost to Follow-up|22|||
148837775|NCT04549454|536886215|FG001|T1 to T2|Lost to Follow-up|26|||
148837776|NCT04549454|536886214|FG000|T1 to T3|Lost to Follow-up|31|||
148837777|NCT04549454|536886215|FG001|T1 to T3|Lost to Follow-up|36|||
148837778|NCT05076045|536886227|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
148837779|NCT05076045|536886228|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
148837780|NCT03402841|536886239|FG000|Overall Study|Withdrawal by Subject|3|||
148837781|NCT03402841|536886239|FG000|Overall Study|Lost to Follow-up|2|||
148837782|NCT03402841|536886239|FG000|Overall Study|Death|146|||
148837783|NCT02735421|536888291|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
148837784|NCT02735421|536888291|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
148837785|NCT02735421|536888291|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
148982462|NCT01172938|537415282|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
148982463|NCT01172938|537415283|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
148837786|NCT02735421|536888291|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
148837787|NCT02735421|536888291|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
148837788|NCT02735421|536888291|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
148837789|NCT02735421|536888291|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
148837790|NCT03549338|536888292|FG000|Overall Study|Progressive Disease|1|||
148837791|NCT03549338|536888293|FG001|Overall Study|Progressive Disease|0|||
148837792|NCT03549338|536888294|FG002|Overall Study|Progressive Disease|0|||
148837793|NCT03549338|536888292|FG000|Overall Study|Clinical Progression|0|||
148837794|NCT03549338|536888293|FG001|Overall Study|Clinical Progression|1|||
148837795|NCT03549338|536888294|FG002|Overall Study|Clinical Progression|0|||
148837796|NCT01492426|536888295|FG000|Treatment|Death|0|||
148837797|NCT01492426|536888296|FG001|Treatment|Death|1|||
148837798|NCT01492426|536888295|FG000|Treatment|Other|1|||
148837799|NCT01492426|536888296|FG001|Treatment|Other|0|||
148837800|NCT01492426|536888295|FG000|Treatment|Adverse Event|25|||
148837801|NCT01492426|536888296|FG001|Treatment|Adverse Event|25|||
148837802|NCT01492426|536888295|FG000|Treatment|Lack of Efficacy|38|||
148837803|NCT01492426|536888296|FG001|Treatment|Lack of Efficacy|5|||
148837804|NCT01492426|536888295|FG000|Treatment|Participant withdrew consent|1|||
148837805|NCT01492426|536888296|FG001|Treatment|Participant withdrew consent|2|||
148837806|NCT01492426|536888295|FG000|Treatment|Poor compliance/noncompliance|1|||
148837807|NCT01492426|536888296|FG001|Treatment|Poor compliance/noncompliance|0|||
148837808|NCT01492426|536888295|FG000|Treatment|Subject requested discontinue study drug|7|||
148837809|NCT01492426|536888296|FG001|Treatment|Subject requested discontinue study drug|3|||
148837810|NCT01492426|536888295|FG000|Treatment|Lost to Follow-up|9|||
148837811|NCT01492426|536888296|FG001|Treatment|Lost to Follow-up|4|||
148837812|NCT01492426|536888295|FG000|Treatment|Participant does not meet study criteria|1|||
148837813|NCT01492426|536888296|FG001|Treatment|Participant does not meet study criteria|0|||
148837814|NCT01492426|536888295|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
148837815|NCT01492426|536888296|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
148837816|NCT01492426|536888295|FG000|Follow-Up|Death|1|||
148837817|NCT01492426|536888296|FG001|Follow-Up|Death|0|||
148837818|NCT01492426|536888295|FG000|Follow-Up|Other|4|||
148837819|NCT01492426|536888296|FG001|Follow-Up|Other|2|||
148837820|NCT01492426|536888295|FG000|Follow-Up|Participant Withdrew Consent|6|||
148837821|NCT01492426|536888296|FG001|Follow-Up|Participant Withdrew Consent|1|||
148837822|NCT01492426|536888295|FG000|Follow-Up|Lost to Follow-up|12|||
148837823|NCT01492426|536888296|FG001|Follow-Up|Lost to Follow-up|6|||
148837824|NCT00269113|536888297|FG000|Overall Study|Adverse Event|14|||
148837825|NCT00269113|536888298|FG001|Overall Study|Adverse Event|7|||
148837826|NCT00269113|536888297|FG000|Overall Study|Lack of Efficacy|35|||
148837827|NCT00269113|536888298|FG001|Overall Study|Lack of Efficacy|18|||
148837828|NCT00269113|536888297|FG000|Overall Study|Early Improvement|2|||
148837829|NCT00269113|536888298|FG001|Overall Study|Early Improvement|0|||
148837830|NCT00269113|536888297|FG000|Overall Study|Withdrawal by Subject|0|||
148837831|NCT00269113|536888298|FG001|Overall Study|Withdrawal by Subject|2|||
148837832|NCT00269113|536888297|FG000|Overall Study|Death|6|||
148837833|NCT00269113|536888298|FG001|Overall Study|Death|2|||
148837834|NCT00269113|536888297|FG000|Overall Study|Lost to Follow-up|2|||
148837835|NCT00269113|536888298|FG001|Overall Study|Lost to Follow-up|1|||
148837836|NCT00269113|536888297|FG000|Overall Study|Protocol Violation|15|||
148837837|NCT00269113|536888298|FG001|Overall Study|Protocol Violation|5|||
148837838|NCT00269113|536888297|FG000|Overall Study|Other|0|||
148837839|NCT00269113|536888298|FG001|Overall Study|Other|2|||
148837840|NCT00322049|536888299|FG000|Overall Study|Moved out of area|0|||
148837841|NCT00322049|536888300|FG001|Overall Study|Moved out of area|0|||
148837842|NCT00322049|536888301|FG002|Overall Study|Moved out of area|0|||
148837843|NCT00322049|536888302|FG003|Overall Study|Moved out of area|1|||
148837844|NCT00322049|536888299|FG000|Overall Study|Infected with Dengue during study|0|||
148837845|NCT00322049|536888300|FG001|Overall Study|Infected with Dengue during study|1|||
148837846|NCT00322049|536888301|FG002|Overall Study|Infected with Dengue during study|0|||
148837847|NCT00322049|536888302|FG003|Overall Study|Infected with Dengue during study|0|||
148837848|NCT01173679|536888303|FG000|Overall Study|Death|1|||
148837849|NCT02026011|536888304|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
148837850|NCT02026011|536888305|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
148837851|NCT02026011|536888304|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
148982464|NCT01172938|537415284|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
148837852|NCT02026011|536888305|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
148837853|NCT02026011|536888304|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
148837854|NCT02026011|536888305|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
148837855|NCT02026011|536888304|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
148982465|NCT01172938|537415285|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
148982466|NCT01172938|537415286|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
148982467|NCT01172938|537415287|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
148982468|NCT01172938|537415288|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
148837856|NCT02026011|536888305|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
148837857|NCT00755807|536888308|FG000|Acute Phase|Adverse Event|16|||
148837858|NCT00755807|536888309|FG001|Acute Phase|Adverse Event|5|||
148837859|NCT00755807|536888308|FG000|Acute Phase|Protocol Violation|1|||
148837860|NCT00755807|536888309|FG001|Acute Phase|Protocol Violation|3|||
148837861|NCT00755807|536888308|FG000|Acute Phase|Withdrawal by Subject|1|||
148837862|NCT00755807|536888309|FG001|Acute Phase|Withdrawal by Subject|2|||
148837863|NCT00755807|536888308|FG000|Acute Phase|Lack of Efficacy|0|||
148837864|NCT00755807|536888309|FG001|Acute Phase|Lack of Efficacy|1|||
148837865|NCT00755807|536888308|FG000|Acute Phase|Physician Decision|0|||
148837866|NCT00755807|536888309|FG001|Acute Phase|Physician Decision|1|||
148982469|NCT01172938|537415289|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
148982470|NCT01172938|537415290|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
148982471|NCT01172938|537415282|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982472|NCT01172938|537415283|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
148982473|NCT01172938|537415284|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982474|NCT01172938|537415285|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982475|NCT01172938|537415286|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982476|NCT01172938|537415287|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982477|NCT01172938|537415288|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982478|NCT01172938|537415289|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982479|NCT01172938|537415290|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
148982480|NCT01172938|537415282|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982481|NCT01172938|537415283|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982482|NCT01172938|537415284|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
148982483|NCT01172938|537415285|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982484|NCT01172938|537415286|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982485|NCT01172938|537415287|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982486|NCT01172938|537415288|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982487|NCT01172938|537415289|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982488|NCT01172938|537415290|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
148982489|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
148982490|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
148982491|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
148982492|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
148982493|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
148982494|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
148982495|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
148982496|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
148982497|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
148982498|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
148982499|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
148982500|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
148982501|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
148982502|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
148982503|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
148982504|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
148982505|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
148982506|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
148982507|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
148982508|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
148982509|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
148982510|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
148982511|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
148982512|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
148982513|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
148982514|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
148982515|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
148982516|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982517|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982518|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
148982519|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982520|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982521|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982522|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982523|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
148982524|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
148982525|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148982526|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148982527|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148837867|NCT00755807|536888308|FG000|Open-label Extension Phase|Adverse Event|7|||
148837868|NCT00755807|536888309|FG001|Open-label Extension Phase|Adverse Event|7|||
148837869|NCT00755807|536888308|FG000|Open-label Extension Phase|Protocol Violation|5|||
148837870|NCT00755807|536888309|FG001|Open-label Extension Phase|Protocol Violation|2|||
148837871|NCT00755807|536888308|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
148982528|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
149029116|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
149029117|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
149029118|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
149029119|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
149029120|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
149029121|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
149029122|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
149029123|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
149029124|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Other|1|||
149029125|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Other|0|||
149029126|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Other|0|||
149029127|NCT02403323|537583840|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
149029128|NCT02403323|537583841|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
149029129|NCT02403323|537583842|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
149029130|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
149029131|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
149029132|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
149029133|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
149029134|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
149029135|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
149029136|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
149029137|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
149029138|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
149029139|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
149029140|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
149029141|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
149029142|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
149029143|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
149029144|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
149029145|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
149029146|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
149029147|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
149029148|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
148837872|NCT00755807|536888309|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
148837873|NCT00755807|536888308|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
148837874|NCT00755807|536888309|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
148837875|NCT00755807|536888308|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
148837876|NCT00755807|536888309|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
148837877|NCT00755807|536888308|FG000|Open-label Extension Phase|Sponsor Decision|0|||
148837878|NCT00755807|536888309|FG001|Open-label Extension Phase|Sponsor Decision|1|||
148837879|NCT00939107|536888312|FG000|Overall Study|Lost to Follow-up|14|||
148837880|NCT00939107|536888313|FG001|Overall Study|Lost to Follow-up|12|||
148837881|NCT05010070|536888314|FG000|Overall Study|Lost to Follow-up|1|||
148837882|NCT05010070|536888314|FG000|Overall Study|Withdrawal by Subject|1|||
148837883|NCT00529243|536888315|FG000|Overall Study|Adverse Event|1|||
148837884|NCT00529243|536888315|FG000|Overall Study|Death|1|||
148837885|NCT00529243|536888315|FG000|Overall Study|Relocated|1|||
148837886|NCT02921789|536888316|FG000|Overall Study|Adverse Event|0|||
148837887|NCT02921789|536888317|FG001|Overall Study|Adverse Event|1|||
148837888|NCT02921789|536888316|FG000|Overall Study|Lost to Follow-up|1|||
148837889|NCT02921789|536888317|FG001|Overall Study|Lost to Follow-up|0|||
148837890|NCT02921789|536888316|FG000|Overall Study|Protocol Deviation|2|||
148837891|NCT02921789|536888317|FG001|Overall Study|Protocol Deviation|0|||
148837892|NCT02921789|536888316|FG000|Overall Study|Withdrawal by Subject|2|||
148837893|NCT02921789|536888317|FG001|Overall Study|Withdrawal by Subject|1|||
148837894|NCT02921789|536888316|FG000|Overall Study|Miscellaneous|3|||
148837895|NCT02921789|536888317|FG001|Overall Study|Miscellaneous|2|||
148837896|NCT04099277|536888318|FG000|Overall Study|Physician Decision|1|||
148837897|NCT04099277|536888318|FG000|Overall Study|Withdrawal by Subject|1|||
148837898|NCT01621178|536888319|FG000|Overall Study|Adverse Event|5|||
148837899|NCT01621178|536888320|FG001|Overall Study|Adverse Event|2|||
148837900|NCT01621178|536888321|FG002|Overall Study|Adverse Event|8|||
148837901|NCT01621178|536888319|FG000|Overall Study|Death|6|||
148837902|NCT01621178|536888320|FG001|Overall Study|Death|7|||
148837903|NCT01621178|536888321|FG002|Overall Study|Death|2|||
148837904|NCT01621178|536888319|FG000|Overall Study|Lost to Follow-up|1|||
148837905|NCT01621178|536888320|FG001|Overall Study|Lost to Follow-up|2|||
148837906|NCT01621178|536888321|FG002|Overall Study|Lost to Follow-up|1|||
148837907|NCT01621178|536888319|FG000|Overall Study|Withdrawal by Subject|14|||
148837908|NCT01621178|536888320|FG001|Overall Study|Withdrawal by Subject|17|||
148837909|NCT01621178|536888321|FG002|Overall Study|Withdrawal by Subject|18|||
148837910|NCT01621178|536888319|FG000|Overall Study|Physician Decision|5|||
148837911|NCT01621178|536888320|FG001|Overall Study|Physician Decision|2|||
148837912|NCT01621178|536888321|FG002|Overall Study|Physician Decision|7|||
148837913|NCT02896257|536888322|FG000|Providers|Without eligible patients|21|||
148837914|NCT02896257|536888323|FG001|Providers|Without eligible patients|28|||
148837915|NCT02896257|536888322|FG000|Patients|PFT entry criteria not met|43|||
148837916|NCT02896257|536888323|FG001|Patients|PFT entry criteria not met|50|||
148837917|NCT02896257|536888322|FG000|Patients|No capacity to review|8|||
148837918|NCT02896257|536888323|FG001|Patients|No capacity to review|11|||
148837919|NCT02896257|536888322|FG000|Patients|Appointment rescheduled/cancelled|5|||
148837920|NCT02896257|536888323|FG001|Patients|Appointment rescheduled/cancelled|7|||
148837921|NCT02896257|536888322|FG000|Patients|PCP not assigned a clinic|4|||
148837922|NCT02896257|536888323|FG001|Patients|PCP not assigned a clinic|0|||
148837923|NCT02896257|536888322|FG000|Patients|No history of COPD|0|||
148837924|NCT02896257|536888323|FG001|Patients|No history of COPD|1|||
148837925|NCT02896257|536888322|FG000|Patients|Deceased between review and index date|0|||
148837926|NCT02896257|536888323|FG001|Patients|Deceased between review and index date|1|||
148837927|NCT02896257|536888322|FG000|Patients|No ICS Rx upon review|1|||
148837928|NCT02896257|536888323|FG001|Patients|No ICS Rx upon review|1|||
148837929|NCT02896257|536888322|FG000|Patients|Protocol Violation|2|||
148837930|NCT02896257|536888323|FG001|Patients|Protocol Violation|1|||
148837931|NCT02896257|536888322|FG000|Patients|Hospice care|0|||
148837932|NCT02896257|536888323|FG001|Patients|Hospice care|1|||
148837933|NCT03423602|536888328|FG000|Overall Study|Death|1|||
148837934|NCT03423602|536888328|FG000|Overall Study|Lost to Follow-up|6|||
148837935|NCT03423602|536888328|FG000|Overall Study|Protocol Violation|1|||
148837936|NCT03423602|536888328|FG000|Overall Study|Withdrawal by Subject|4|||
148837937|NCT04778592|536888329|FG000|Overall Study|Adverse Event|1|||
148837938|NCT04778592|536888330|FG001|Overall Study|Adverse Event|2|||
148837939|NCT04778592|536888329|FG000|Overall Study|Withdrawal by Subject|1|||
148837940|NCT04778592|536888330|FG001|Overall Study|Withdrawal by Subject|2|||
148837941|NCT01192126|536888331|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
148837942|NCT01192126|536888332|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
148837943|NCT01192126|536888331|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
148837944|NCT01192126|536888332|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
148837945|NCT03759600|536888340|FG000|Overall Study|Adverse Event|2|||
148837946|NCT03759600|536888340|FG000|Overall Study|Progressive Disease|15|||
148837947|NCT03759600|536888340|FG000|Overall Study|Site Terminated by Sponsor|3|||
148837948|NCT02580877|536888341|FG000|Overall Study|Withdrawal by Subject|1|||
148837949|NCT02580877|536888342|FG001|Overall Study|Withdrawal by Subject|3|||
148837950|NCT02580877|536888341|FG000|Overall Study|Adverse Event|0|||
148837951|NCT02580877|536888342|FG001|Overall Study|Adverse Event|1|||
148837952|NCT03046446|536888343|FG000|Overall Study|Lack of Efficacy|7|||
148837953|NCT03046446|536888343|FG000|Overall Study|Adverse Event|6|||
148837954|NCT03046446|536888343|FG000|Overall Study|Lost to Follow-up|3|||
148837955|NCT03046446|536888343|FG000|Overall Study|Withdrawal by Subject|14|||
148837956|NCT03046446|536888343|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
148837957|NCT03046446|536888343|FG000|Overall Study|Disease Progression (see caveats)|25|||
148837958|NCT03046446|536888343|FG000|Overall Study|Non OA related knee surgery|1|||
148837959|NCT02808897|536888344|FG000|Overall Study|Lost to Follow-up|9|||
148837960|NCT02808897|536888345|FG001|Overall Study|Lost to Follow-up|11|||
148837961|NCT01496287|536888346|FG000|Overall Study|Lost to Follow-up|1|||
148837962|NCT01496287|536888346|FG000|Overall Study|Incomplete anesthesia|5|||
148837963|NCT03012334|536888347|FG000|Period 1|Withdrawal by Subject|0|||
148837964|NCT03012334|536888348|FG001|Period 1|Withdrawal by Subject|0|||
148837965|NCT03012334|536888349|FG002|Period 1|Withdrawal by Subject|0|||
148837966|NCT03012334|536888350|FG003|Period 1|Withdrawal by Subject|0|||
148837967|NCT03012334|536888351|FG004|Period 1|Withdrawal by Subject|0|||
148837968|NCT03012334|536888352|FG005|Period 1|Withdrawal by Subject|0|||
148837969|NCT03012334|536888353|FG006|Period 1|Withdrawal by Subject|0|||
148837970|NCT03012334|536888354|FG007|Period 1|Withdrawal by Subject|0|||
148837971|NCT03012334|536888355|FG008|Period 1|Withdrawal by Subject|0|||
148837972|NCT03012334|536888356|FG009|Period 1|Withdrawal by Subject|1|||
148837973|NCT03012334|536888347|FG000|Period 2|Withdrawal by Subject|0|||
148837974|NCT03012334|536888348|FG001|Period 2|Withdrawal by Subject|1|||
148837975|NCT03012334|536888349|FG002|Period 2|Withdrawal by Subject|0|||
148837976|NCT03012334|536888350|FG003|Period 2|Withdrawal by Subject|0|||
148837977|NCT03012334|536888351|FG004|Period 2|Withdrawal by Subject|0|||
148837978|NCT03012334|536888352|FG005|Period 2|Withdrawal by Subject|0|||
148837979|NCT03012334|536888353|FG006|Period 2|Withdrawal by Subject|0|||
148837980|NCT03012334|536888354|FG007|Period 2|Withdrawal by Subject|0|||
148837981|NCT03012334|536888355|FG008|Period 2|Withdrawal by Subject|0|||
148837982|NCT03012334|536888356|FG009|Period 2|Withdrawal by Subject|0|||
148837983|NCT03012334|536888347|FG000|Period 2|Protocol Violation|0|||
148837984|NCT03012334|536888348|FG001|Period 2|Protocol Violation|0|||
148837985|NCT03012334|536888349|FG002|Period 2|Protocol Violation|1|||
148837986|NCT03012334|536888350|FG003|Period 2|Protocol Violation|0|||
148837987|NCT03012334|536888351|FG004|Period 2|Protocol Violation|0|||
148837988|NCT03012334|536888352|FG005|Period 2|Protocol Violation|0|||
148837989|NCT03012334|536888353|FG006|Period 2|Protocol Violation|0|||
148837990|NCT03012334|536888354|FG007|Period 2|Protocol Violation|1|||
148837991|NCT03012334|536888355|FG008|Period 2|Protocol Violation|0|||
148837992|NCT03012334|536888356|FG009|Period 2|Protocol Violation|0|||
148837993|NCT03012334|536888347|FG000|Period 4|Non-Compliance|0|||
148837994|NCT03012334|536888348|FG001|Period 4|Non-Compliance|0|||
148837995|NCT03012334|536888349|FG002|Period 4|Non-Compliance|0|||
148837996|NCT03012334|536888350|FG003|Period 4|Non-Compliance|0|||
148837997|NCT03012334|536888351|FG004|Period 4|Non-Compliance|0|||
148837998|NCT03012334|536888352|FG005|Period 4|Non-Compliance|0|||
148837999|NCT03012334|536888353|FG006|Period 4|Non-Compliance|1|||
148838000|NCT03012334|536888354|FG007|Period 4|Non-Compliance|0|||
148838001|NCT03012334|536888355|FG008|Period 4|Non-Compliance|0|||
148838002|NCT03012334|536888356|FG009|Period 4|Non-Compliance|0|||
148838003|NCT03012334|536888347|FG000|Period 4|Adverse Event|0|||
148838004|NCT03012334|536888348|FG001|Period 4|Adverse Event|0|||
148838005|NCT03012334|536888349|FG002|Period 4|Adverse Event|0|||
148838006|NCT03012334|536888350|FG003|Period 4|Adverse Event|0|||
148838007|NCT03012334|536888351|FG004|Period 4|Adverse Event|0|||
148838008|NCT03012334|536888352|FG005|Period 4|Adverse Event|0|||
148838009|NCT03012334|536888353|FG006|Period 4|Adverse Event|0|||
148838010|NCT03012334|536888354|FG007|Period 4|Adverse Event|0|||
148838011|NCT03012334|536888355|FG008|Period 4|Adverse Event|1|||
148838012|NCT03012334|536888356|FG009|Period 4|Adverse Event|0|||
148838013|NCT01823107|536888357|FG000|Overall Study|Withdrawal by Subject|1|||
148838014|NCT00256126|536888358|FG000|Overall Study|Adverse Event|1|||
148838015|NCT00256126|536888359|FG001|Overall Study|Adverse Event|0|||
148838016|NCT00256126|536888358|FG000|Overall Study|Other|1|||
148838017|NCT00256126|536888359|FG001|Overall Study|Other|2|||
148838018|NCT04108273|536888371|FG000|Overall Study|COVID Pandemic|1|||
148838019|NCT04108273|536888372|FG001|Overall Study|COVID Pandemic|0|||
148838020|NCT00800735|536888373|FG000|Overall Study|Administrative/Other|2|||
148838021|NCT00800735|536888373|FG000|Overall Study|Insufficient Therapeutic Response|2|||
148838022|NCT00800735|536888373|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
148838023|NCT00800735|536888373|FG000|Overall Study|Withdrew Consent|3|||
148838024|NCT02154061|536888374|FG000|Overall Study|Pregnancy|1|||
148838025|NCT02154061|536888375|FG001|Overall Study|Pregnancy|0|||
148838026|NCT02154061|536888374|FG000|Overall Study|enrolled but not vaccinated|1|||
148838027|NCT02154061|536888375|FG001|Overall Study|enrolled but not vaccinated|0|||
148838028|NCT00506142|536888376|FG000|Overall Study|Adverse Event|8|||
148838029|NCT00506142|536888377|FG001|Overall Study|Adverse Event|7|||
148838030|NCT00506142|536888376|FG000|Overall Study|Lack of Efficacy|21|||
148838031|NCT00506142|536888377|FG001|Overall Study|Lack of Efficacy|7|||
148838032|NCT00506142|536888376|FG000|Overall Study|Withdrawal by Subject|4|||
148838033|NCT00506142|536888377|FG001|Overall Study|Withdrawal by Subject|5|||
148838034|NCT00506142|536888376|FG000|Overall Study|Physician Decision|1|||
148838035|NCT00506142|536888377|FG001|Overall Study|Physician Decision|0|||
148838036|NCT00506142|536888376|FG000|Overall Study|New health condition|1|||
148838037|NCT00506142|536888377|FG001|Overall Study|New health condition|0|||
148838038|NCT01936831|536888383|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838039|NCT01936831|536888384|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838040|NCT01936831|536888385|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838041|NCT01936831|536888386|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838042|NCT01936831|536888387|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838043|NCT01936831|536888388|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
148838044|NCT01936831|536888389|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838045|NCT01936831|536888390|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838046|NCT01936831|536888391|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
148838047|NCT02133573|536888392|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
148838048|NCT02133573|536888393|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
148838049|NCT02133573|536888392|FG000|Overall Study|Child Deaths|3|||
148838050|NCT02133573|536888393|FG001|Overall Study|Child Deaths|5|||
148838051|NCT02133573|536888392|FG000|Overall Study|Child Declined Follow Ups|2|||
148838052|NCT02133573|536888393|FG001|Overall Study|Child Declined Follow Ups|1|||
149029149|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
148838053|NCT02133573|536888392|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
148838054|NCT02133573|536888393|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
148838055|NCT00454116|536888395|FG000|Overall Study|Adverse Event|5|||
148838056|NCT00454116|536888396|FG001|Overall Study|Adverse Event|11|||
148838057|NCT00454116|536888397|FG002|Overall Study|Adverse Event|9|||
148838058|NCT00454116|536888395|FG000|Overall Study|Condition under investigation worsened|17|||
148838059|NCT00454116|536888396|FG001|Overall Study|Condition under investigation worsened|13|||
148838060|NCT00454116|536888397|FG002|Overall Study|Condition under investigation worsened|18|||
148838061|NCT00454116|536888395|FG000|Overall Study|Withdrawal by Subject|3|||
149029150|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
148838062|NCT00454116|536888396|FG001|Overall Study|Withdrawal by Subject|3|||
148838063|NCT00454116|536888397|FG002|Overall Study|Withdrawal by Subject|1|||
148838064|NCT00454116|536888395|FG000|Overall Study|Other|2|||
148838065|NCT00454116|536888396|FG001|Overall Study|Other|2|||
148838066|NCT00454116|536888397|FG002|Overall Study|Other|0|||
148838067|NCT03500211|536888404|FG000|Overall Study|Withdrawal by Subject|1|||
148838068|NCT03500211|536888405|FG001|Overall Study|Withdrawal by Subject|1|||
148838069|NCT01917318|536888406|FG000|First Treatment|Withdrawal by Subject|0|||
148838070|NCT01917318|536888407|FG001|First Treatment|Withdrawal by Subject|1|||
148838071|NCT04460183|536888408|FG000|Overall Study|Lost to Follow-up|3|||
148838072|NCT04460183|536888409|FG001|Overall Study|Lost to Follow-up|1|||
148838073|NCT04460183|536888408|FG000|Overall Study|Withdrawal by Subject|1|||
148838074|NCT04460183|536888409|FG001|Overall Study|Withdrawal by Subject|0|||
148838075|NCT01534481|536888413|FG000|Overall Study|Lost to Follow-up|29|||
148838076|NCT01534481|536888414|FG001|Overall Study|Lost to Follow-up|24|||
148838077|NCT01534481|536888413|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
148838078|NCT01534481|536888414|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
148838079|NCT05525910|536888415|FG000|Period 4|Per sponsor due to study timelines|0|||
148838080|NCT05525910|536888416|FG001|Period 4|Per sponsor due to study timelines|0|||
148838081|NCT05525910|536888417|FG002|Period 4|Per sponsor due to study timelines|1|||
148838082|NCT05525910|536888418|FG003|Period 4|Per sponsor due to study timelines|1|||
148838083|NCT05525910|536888419|FG004|Period 4|Per sponsor due to study timelines|1|||
148838084|NCT01832727|536888421|FG000|Overall Study|Adverse Event|4|||
148838085|NCT01832727|536888422|FG001|Overall Study|Adverse Event|6|||
148838086|NCT01832727|536888423|FG002|Overall Study|Adverse Event|1|||
148838087|NCT01832727|536888424|FG003|Overall Study|Adverse Event|0|||
148838088|NCT01832727|536888425|FG004|Overall Study|Adverse Event|1|||
148838089|NCT01832727|536888426|FG005|Overall Study|Adverse Event|1|||
148838090|NCT01832727|536888427|FG006|Overall Study|Adverse Event|2|||
148838091|NCT01832727|536888428|FG007|Overall Study|Adverse Event|1|||
148838092|NCT01832727|536888429|FG008|Overall Study|Adverse Event|9|||
148838093|NCT01832727|536888421|FG000|Overall Study|Disease progression|3|||
148838094|NCT01832727|536888422|FG001|Overall Study|Disease progression|0|||
148838095|NCT01832727|536888423|FG002|Overall Study|Disease progression|2|||
148838096|NCT01832727|536888424|FG003|Overall Study|Disease progression|1|||
148838097|NCT01832727|536888425|FG004|Overall Study|Disease progression|3|||
148838098|NCT01832727|536888426|FG005|Overall Study|Disease progression|3|||
148838099|NCT01832727|536888427|FG006|Overall Study|Disease progression|6|||
148838100|NCT01832727|536888428|FG007|Overall Study|Disease progression|2|||
148838101|NCT01832727|536888429|FG008|Overall Study|Disease progression|7|||
148838102|NCT01832727|536888421|FG000|Overall Study|Lost to Follow-up|0|||
148838103|NCT01832727|536888422|FG001|Overall Study|Lost to Follow-up|0|||
148838104|NCT01832727|536888423|FG002|Overall Study|Lost to Follow-up|0|||
148838105|NCT01832727|536888424|FG003|Overall Study|Lost to Follow-up|1|||
148838106|NCT01832727|536888425|FG004|Overall Study|Lost to Follow-up|0|||
148838107|NCT01832727|536888426|FG005|Overall Study|Lost to Follow-up|0|||
148838108|NCT01832727|536888427|FG006|Overall Study|Lost to Follow-up|0|||
148838109|NCT01832727|536888428|FG007|Overall Study|Lost to Follow-up|0|||
148838110|NCT01832727|536888429|FG008|Overall Study|Lost to Follow-up|0|||
148838111|NCT01832727|536888421|FG000|Overall Study|Physician Decision|1|||
148838112|NCT01832727|536888422|FG001|Overall Study|Physician Decision|0|||
148838113|NCT01832727|536888423|FG002|Overall Study|Physician Decision|0|||
148838114|NCT01832727|536888424|FG003|Overall Study|Physician Decision|1|||
148838115|NCT01832727|536888425|FG004|Overall Study|Physician Decision|0|||
148838116|NCT01832727|536888426|FG005|Overall Study|Physician Decision|1|||
148838117|NCT01832727|536888427|FG006|Overall Study|Physician Decision|0|||
148838118|NCT01832727|536888428|FG007|Overall Study|Physician Decision|0|||
148838119|NCT01832727|536888429|FG008|Overall Study|Physician Decision|0|||
148838120|NCT01832727|536888421|FG000|Overall Study|Withdrawal by Subject|1|||
148838121|NCT01832727|536888422|FG001|Overall Study|Withdrawal by Subject|1|||
148838122|NCT01832727|536888423|FG002|Overall Study|Withdrawal by Subject|0|||
148838123|NCT01832727|536888424|FG003|Overall Study|Withdrawal by Subject|1|||
148838124|NCT01832727|536888425|FG004|Overall Study|Withdrawal by Subject|0|||
148838125|NCT01832727|536888426|FG005|Overall Study|Withdrawal by Subject|1|||
148838126|NCT01832727|536888427|FG006|Overall Study|Withdrawal by Subject|0|||
148838127|NCT01832727|536888428|FG007|Overall Study|Withdrawal by Subject|2|||
148982529|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148982530|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148982531|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148982532|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
148838128|NCT01832727|536888429|FG008|Overall Study|Withdrawal by Subject|1|||
148838129|NCT01832727|536888421|FG000|Overall Study|Study terminated by sponsor|0|||
148838130|NCT01832727|536888422|FG001|Overall Study|Study terminated by sponsor|0|||
148838131|NCT01832727|536888423|FG002|Overall Study|Study terminated by sponsor|0|||
148838132|NCT01832727|536888424|FG003|Overall Study|Study terminated by sponsor|0|||
148838133|NCT01832727|536888425|FG004|Overall Study|Study terminated by sponsor|0|||
148838134|NCT01832727|536888426|FG005|Overall Study|Study terminated by sponsor|0|||
148838135|NCT01832727|536888427|FG006|Overall Study|Study terminated by sponsor|0|||
148838136|NCT01832727|536888428|FG007|Overall Study|Study terminated by sponsor|1|||
148838137|NCT01832727|536888429|FG008|Overall Study|Study terminated by sponsor|1|||
148838138|NCT01133847|536888434|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
148838139|NCT01133847|536888435|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
148838140|NCT01133847|536888436|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
148838141|NCT01133847|536888434|FG000|Follow-Up Phase|Lost to Follow-up|1|||
148838142|NCT01133847|536888435|FG001|Follow-Up Phase|Lost to Follow-up|3|||
148838143|NCT01133847|536888436|FG002|Follow-Up Phase|Lost to Follow-up|7|||
148838144|NCT04436744|536888437|FG000|Overall Study|Adverse Event|1|||
148838145|NCT04436744|536888438|FG001|Overall Study|Adverse Event|1|||
148838146|NCT04436744|536888437|FG000|Overall Study|Death|1|||
148838147|NCT04436744|536888438|FG001|Overall Study|Death|0|||
148838148|NCT04436744|536888437|FG000|Overall Study|Lost to Follow-up|0|||
148838149|NCT04436744|536888438|FG001|Overall Study|Lost to Follow-up|2|||
148838150|NCT04436744|536888437|FG000|Overall Study|Physician Decision|0|||
148838151|NCT04436744|536888438|FG001|Overall Study|Physician Decision|1|||
148838152|NCT04436744|536888437|FG000|Overall Study|Progressive Disease|0|||
148838153|NCT04436744|536888438|FG001|Overall Study|Progressive Disease|4|||
148838154|NCT04436744|536888437|FG000|Overall Study|Protocol Deviation|1|||
148838155|NCT04436744|536888438|FG001|Overall Study|Protocol Deviation|1|||
148838156|NCT04436744|536888437|FG000|Overall Study|Withdrawal by Subject|1|||
148838157|NCT04436744|536888438|FG001|Overall Study|Withdrawal by Subject|2|||
148838158|NCT02961244|536888441|FG000|Overall Study|Protocol Violation|0|||
148838159|NCT02961244|536888442|FG001|Overall Study|Protocol Violation|1|||
148838160|NCT02961244|536888441|FG000|Overall Study|Withdrawal by Subject|1|||
148838161|NCT02961244|536888442|FG001|Overall Study|Withdrawal by Subject|2|||
148838162|NCT02961244|536888441|FG000|Overall Study|Surgery plan change after study approval|0|||
148838163|NCT02961244|536888442|FG001|Overall Study|Surgery plan change after study approval|2|||
148838164|NCT02961244|536888441|FG000|Overall Study|Lost to Follow-up|0|||
148838165|NCT02961244|536888442|FG001|Overall Study|Lost to Follow-up|2|||
148838166|NCT02961244|536888441|FG000|Overall Study|İnadequate data|0|||
148838167|NCT02961244|536888442|FG001|Overall Study|İnadequate data|2|||
148838168|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
148838169|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
148838170|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
148838171|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
148838172|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
148838173|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
148838174|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
148838175|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
148838176|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
148838177|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
148838178|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
148838179|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
148838180|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
148838181|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
148838182|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
148838183|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
148838184|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
148838185|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
148838186|NCT03789292|536888443|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
148838187|NCT03789292|536888444|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
148838188|NCT03789292|536888445|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
148838189|NCT03789292|536888443|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
148838190|NCT03789292|536888444|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
148838191|NCT03789292|536888445|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
148838192|NCT03789292|536888443|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
148838193|NCT03789292|536888444|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
148838194|NCT03789292|536888445|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
148838195|NCT03789292|536888443|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
148838196|NCT03789292|536888444|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
148838197|NCT03789292|536888445|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
148838198|NCT03789292|536888443|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
148838199|NCT03789292|536888444|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
148838200|NCT03789292|536888445|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
148838201|NCT03789292|536888443|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
148838202|NCT03789292|536888444|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
148838203|NCT03789292|536888445|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
148838204|NCT03789292|536888443|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
148889121|NCT05214768|537072365|FG001|Maintenance Period|Other Reasons|0|||
148838205|NCT03789292|536888444|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
148838206|NCT03789292|536888445|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
148838207|NCT00967616|536888446|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
148838208|NCT00967616|536888447|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
148838209|NCT00967616|536888446|FG000|Overall Study|Death|0|||
148838210|NCT00967616|536888447|FG001|Overall Study|Death|3|||
148838211|NCT00967616|536888446|FG000|Overall Study|Withdrawal by Subject|8|||
148838212|NCT00967616|536888447|FG001|Overall Study|Withdrawal by Subject|4|||
148838213|NCT00967616|536888446|FG000|Overall Study|Progressive Disease|31|||
148838214|NCT00967616|536888447|FG001|Overall Study|Progressive Disease|18|||
148838215|NCT00967616|536888446|FG000|Overall Study|Other|8|||
148838216|NCT00967616|536888447|FG001|Overall Study|Other|8|||
148838217|NCT00967616|536888446|FG000|Overall Study|Protocol Violation|1|||
148838218|NCT00967616|536888447|FG001|Overall Study|Protocol Violation|0|||
148838219|NCT01696643|536888448|FG000|Overall Study|Adverse Event|15|||
148838220|NCT01696643|536888449|FG001|Overall Study|Adverse Event|7|||
148838221|NCT01696643|536888448|FG000|Overall Study|Death|1|||
148838222|NCT01696643|536888449|FG001|Overall Study|Death|2|||
148838223|NCT01696643|536888448|FG000|Overall Study|Lack of Efficacy|3|||
148838224|NCT01696643|536888449|FG001|Overall Study|Lack of Efficacy|0|||
148838225|NCT01696643|536888448|FG000|Overall Study|Lost to Follow-up|67|||
148838226|NCT01696643|536888449|FG001|Overall Study|Lost to Follow-up|67|||
148838227|NCT01696643|536888448|FG000|Overall Study|Physician Decision|3|||
148838228|NCT01696643|536888449|FG001|Overall Study|Physician Decision|2|||
148838229|NCT01696643|536888448|FG000|Overall Study|Pregnancy|0|||
148838230|NCT01696643|536888449|FG001|Overall Study|Pregnancy|1|||
148838231|NCT01696643|536888448|FG000|Overall Study|Protocol Violation|7|||
148838232|NCT01696643|536888449|FG001|Overall Study|Protocol Violation|7|||
148838233|NCT01696643|536888448|FG000|Overall Study|Study Terminated by Sponsor|286|||
148838234|NCT01696643|536888449|FG001|Overall Study|Study Terminated by Sponsor|294|||
148838235|NCT01696643|536888448|FG000|Overall Study|Withdrawal by Subject|142|||
148838236|NCT01696643|536888449|FG001|Overall Study|Withdrawal by Subject|149|||
148838237|NCT01696643|536888448|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
148838238|NCT01696643|536888449|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
148838239|NCT01696643|536888448|FG000|Overall Study|Site Error|2|||
148838240|NCT01696643|536888449|FG001|Overall Study|Site Error|1|||
148838241|NCT01696643|536888448|FG000|Overall Study|Participant Incarcerated|0|||
148838242|NCT01696643|536888449|FG001|Overall Study|Participant Incarcerated|1|||
148838243|NCT01696643|536888448|FG000|Overall Study|Medical Monitor Decision|0|||
148838244|NCT01696643|536888449|FG001|Overall Study|Medical Monitor Decision|2|||
148838245|NCT01696643|536888448|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
149029151|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
149029152|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
149029153|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
149029154|NCT02403323|537583840|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
149029155|NCT02403323|537583841|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
149029156|NCT02403323|537583842|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
149029157|NCT00197236|537583846|FG000|Overall Study|Adverse Event|1|||
149029158|NCT00197236|537583847|FG001|Overall Study|Adverse Event|0|||
149029159|NCT00197236|537583848|FG002|Overall Study|Adverse Event|1|||
149029160|NCT00197236|537583846|FG000|Overall Study|Lost to Follow-up|5|||
149029161|NCT00197236|537583847|FG001|Overall Study|Lost to Follow-up|14|||
149029162|NCT00197236|537583848|FG002|Overall Study|Lost to Follow-up|6|||
149029163|NCT00197236|537583846|FG000|Overall Study|Protocol Violation|0|||
149029164|NCT00197236|537583847|FG001|Overall Study|Protocol Violation|0|||
149029165|NCT00197236|537583848|FG002|Overall Study|Protocol Violation|1|||
149029166|NCT00197236|537583846|FG000|Overall Study|Withdrawal by Subject|7|||
149029167|NCT00197236|537583847|FG001|Overall Study|Withdrawal by Subject|3|||
148838246|NCT01696643|536888449|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
149029168|NCT00197236|537583848|FG002|Overall Study|Withdrawal by Subject|11|||
149029169|NCT00197236|537583846|FG000|Overall Study|Study drug/medication expiration|1|||
149029170|NCT00197236|537583847|FG001|Overall Study|Study drug/medication expiration|0|||
149029171|NCT00197236|537583848|FG002|Overall Study|Study drug/medication expiration|3|||
149029172|NCT00197236|537583846|FG000|Overall Study|Returned out of specified time window|0|||
149029173|NCT00197236|537583847|FG001|Overall Study|Returned out of specified time window|0|||
149029174|NCT00197236|537583848|FG002|Overall Study|Returned out of specified time window|1|||
149029175|NCT01076335|537583849|FG000|Overall Study|Withdrawal by Subject|3|||
149029176|NCT01076335|537583849|FG000|Overall Study|Withdrawal without treatment|1|||
148838247|NCT00575666|536888450|FG000|Overall Study|Withdrawal by Subject|3|||
148838248|NCT00575666|536888451|FG001|Overall Study|Withdrawal by Subject|2|||
148838249|NCT00575666|536888450|FG000|Overall Study|Physician Decision|1|||
148838250|NCT00575666|536888451|FG001|Overall Study|Physician Decision|1|||
148838251|NCT00508482|536888452|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
149029177|NCT02616263|537583851|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
148889122|NCT05214768|537072366|FG002|Maintenance Period|Other Reasons|1|||
148838252|NCT00508482|536888453|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
148838253|NCT00508482|536888454|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
148838254|NCT00508482|536888452|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
148838255|NCT00508482|536888453|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
148838256|NCT00508482|536888454|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
148838257|NCT00508482|536888452|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
148838258|NCT00508482|536888453|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
148838259|NCT00508482|536888454|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
148838260|NCT04067492|536888462|FG000|Overall Study|Lost to Follow-up|0|||
148838261|NCT04067492|536888463|FG001|Overall Study|Lost to Follow-up|0|||
148838262|NCT04067492|536888464|FG002|Overall Study|Lost to Follow-up|0|||
148838263|NCT04067492|536888465|FG003|Overall Study|Lost to Follow-up|0|||
148838264|NCT04067492|536888466|FG004|Overall Study|Lost to Follow-up|0|||
148838265|NCT04067492|536888467|FG005|Overall Study|Lost to Follow-up|1|||
148838266|NCT04067492|536888462|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
148838267|NCT04067492|536888463|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
148838268|NCT04067492|536888464|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
148838269|NCT04067492|536888465|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
148838270|NCT04067492|536888466|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
148838271|NCT04067492|536888467|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
148838272|NCT04067492|536888462|FG000|Overall Study|COVID-19 epidemiological situation|0|||
148838273|NCT04067492|536888463|FG001|Overall Study|COVID-19 epidemiological situation|0|||
148838274|NCT04067492|536888464|FG002|Overall Study|COVID-19 epidemiological situation|0|||
148838275|NCT04067492|536888465|FG003|Overall Study|COVID-19 epidemiological situation|1|||
148838276|NCT04067492|536888466|FG004|Overall Study|COVID-19 epidemiological situation|0|||
148838277|NCT04067492|536888467|FG005|Overall Study|COVID-19 epidemiological situation|0|||
148838278|NCT03950856|536888475|FG000|Overall Study|Death|1|||
148838279|NCT03950856|536888476|FG001|Overall Study|Death|2|||
148838280|NCT03950856|536888477|FG002|Overall Study|Death|0|||
148838281|NCT03950856|536888478|FG003|Overall Study|Death|0|||
148838282|NCT03950856|536888475|FG000|Overall Study|Lost to Follow-up|5|||
148838283|NCT03950856|536888476|FG001|Overall Study|Lost to Follow-up|6|||
148838284|NCT03950856|536888477|FG002|Overall Study|Lost to Follow-up|8|||
148838285|NCT03950856|536888478|FG003|Overall Study|Lost to Follow-up|2|||
148838286|NCT03950856|536888475|FG000|Overall Study|Protocol Violation|2|||
148838287|NCT03950856|536888476|FG001|Overall Study|Protocol Violation|0|||
148838288|NCT03950856|536888477|FG002|Overall Study|Protocol Violation|0|||
148838289|NCT03950856|536888478|FG003|Overall Study|Protocol Violation|1|||
148838290|NCT03950856|536888475|FG000|Overall Study|Withdrawal by Subject|4|||
148838291|NCT03950856|536888476|FG001|Overall Study|Withdrawal by Subject|1|||
148838292|NCT03950856|536888477|FG002|Overall Study|Withdrawal by Subject|3|||
148838293|NCT03950856|536888478|FG003|Overall Study|Withdrawal by Subject|1|||
148838294|NCT03950856|536888475|FG000|Overall Study|Unable to phone|7|||
148838295|NCT03950856|536888476|FG001|Overall Study|Unable to phone|6|||
148838296|NCT03950856|536888477|FG002|Overall Study|Unable to phone|7|||
148838297|NCT03950856|536888478|FG003|Overall Study|Unable to phone|2|||
148838298|NCT00656370|536888479|FG000|Overall Study|Screen Failures|7|||
148838299|NCT00656370|536888479|FG000|Overall Study|Alternates|3|||
148838300|NCT03984188|536888481|FG000|Overall Study|Death|2|||
148838301|NCT03984188|536888482|FG001|Overall Study|Death|4|||
148838302|NCT03984188|536888481|FG000|Overall Study|Physician Decision|0|||
148838303|NCT03984188|536888482|FG001|Overall Study|Physician Decision|2|||
148838304|NCT03984188|536888481|FG000|Overall Study|Lost to Follow-up|3|||
148838305|NCT03984188|536888482|FG001|Overall Study|Lost to Follow-up|2|||
148838306|NCT03984188|536888481|FG000|Overall Study|Withdrawal by Subject|6|||
148838307|NCT03984188|536888482|FG001|Overall Study|Withdrawal by Subject|0|||
148838308|NCT03384875|536888483|FG000|Overall Study|Death|1|||
148838309|NCT03384875|536888484|FG001|Overall Study|Death|1|||
148838310|NCT03384875|536888485|FG002|Overall Study|Death|0|||
148838311|NCT03384875|536888483|FG000|Overall Study|Reason not provided|1|||
148838312|NCT03384875|536888484|FG001|Overall Study|Reason not provided|0|||
148838313|NCT03384875|536888485|FG002|Overall Study|Reason not provided|0|||
148838314|NCT01978145|536890131|FG000|Treatment Period 1|Adverse Event|1|||
148838315|NCT01978145|536890132|FG001|Treatment Period 1|Adverse Event|9|||
148838316|NCT01978145|536890131|FG000|Treatment Period 1|Physician Decision|1|||
148838317|NCT01978145|536890132|FG001|Treatment Period 1|Physician Decision|0|||
148838318|NCT01978145|536890131|FG000|Treatment Period 1|Withdrawal by Subject|5|||
148838319|NCT01978145|536890132|FG001|Treatment Period 1|Withdrawal by Subject|4|||
148838320|NCT01978145|536890131|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
148838321|NCT01978145|536890132|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
148838322|NCT01978145|536890131|FG000|Washout Period 1|Adverse Event|0|||
149029178|NCT02616263|537583852|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
148838323|NCT01978145|536890132|FG001|Washout Period 1|Adverse Event|1|||
148838324|NCT01978145|536890131|FG000|Washout Period 1|Withdrawal by Subject|1|||
148838325|NCT01978145|536890132|FG001|Washout Period 1|Withdrawal by Subject|1|||
148838326|NCT01978145|536890131|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
148838327|NCT01978145|536890132|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
148838328|NCT01978145|536890131|FG000|Treatment Period 2|Adverse Event|3|||
148838329|NCT01978145|536890132|FG001|Treatment Period 2|Adverse Event|3|||
148838330|NCT01978145|536890131|FG000|Treatment Period 2|Protocol Violation|0|||
148838331|NCT01978145|536890132|FG001|Treatment Period 2|Protocol Violation|1|||
148838332|NCT01978145|536890131|FG000|Treatment Period 2|Lost to Follow-up|1|||
148838333|NCT01978145|536890132|FG001|Treatment Period 2|Lost to Follow-up|1|||
148838334|NCT01978145|536890131|FG000|Treatment Period 2|Withdrawal by Subject|7|||
148838335|NCT01978145|536890132|FG001|Treatment Period 2|Withdrawal by Subject|4|||
148838336|NCT01978145|536890131|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
148838337|NCT01978145|536890132|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
148838338|NCT01250054|536890133|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
148838339|NCT01250054|536890134|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
148838340|NCT00427011|536890144|FG000|Overall Study|Adverse Event|10|||
148838341|NCT00427011|536890144|FG000|Overall Study|Withdrawal by Subject|1|||
148838342|NCT00427011|536890144|FG000|Overall Study|Lack of Efficacy|2|||
148838343|NCT00427011|536890144|FG000|Overall Study|Other|12|||
148838344|NCT00288015|536890145|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
148838345|NCT00288015|536890145|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
148838346|NCT00288015|536890145|FG000|First Response Assessment|Withdrawal by Subject|1|||
148838347|NCT00288015|536890145|FG000|First Response Assessment|Death|1|||
148838348|NCT00288015|536890145|FG000|First Response Assessment|Physician Decision|2|||
148838349|NCT00288015|536890145|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
148838350|NCT00288015|536890145|FG000|Follow up for Survival x 2 Years|Death|13|||
148838351|NCT00288015|536890145|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
148838352|NCT00288015|536890145|FG000|Follow up for Survival x 2 Years|Other|9|||
148838353|NCT00443703|536890146|FG000|Overall Study|Never Treated|3|||
148838354|NCT00443703|536890147|FG001|Overall Study|Never Treated|1|||
148838355|NCT00443703|536890146|FG000|Overall Study|Adverse Event|7|||
148838356|NCT00443703|536890147|FG001|Overall Study|Adverse Event|3|||
148838357|NCT00443703|536890146|FG000|Overall Study|Lack of Efficacy|3|||
148838358|NCT00443703|536890147|FG001|Overall Study|Lack of Efficacy|1|||
148838359|NCT00443703|536890146|FG000|Overall Study|Lost to Follow-up|0|||
148838360|NCT00443703|536890147|FG001|Overall Study|Lost to Follow-up|4|||
148838361|NCT00443703|536890146|FG000|Overall Study|Physician Decision|4|||
148838362|NCT00443703|536890147|FG001|Overall Study|Physician Decision|2|||
148838363|NCT00443703|536890146|FG000|Overall Study|Protocol Violation|1|||
148838364|NCT00443703|536890147|FG001|Overall Study|Protocol Violation|1|||
148838365|NCT00443703|536890146|FG000|Overall Study|Withdrawal by Subject|9|||
148838366|NCT00443703|536890147|FG001|Overall Study|Withdrawal by Subject|6|||
148838367|NCT00443703|536890146|FG000|Overall Study|Progressive Disease|1|||
148838368|NCT00443703|536890147|FG001|Overall Study|Progressive Disease|0|||
148838369|NCT01047007|536890148|FG000|Overall Study|Adverse Event|0|||
148838370|NCT01047007|536890149|FG001|Overall Study|Adverse Event|2|||
148838371|NCT01047007|536890150|FG002|Overall Study|Adverse Event|1|||
148838372|NCT01047007|536890151|FG003|Overall Study|Adverse Event|0|||
148838373|NCT01047007|536890148|FG000|Overall Study|Progressive Disease|2|||
148838374|NCT01047007|536890149|FG001|Overall Study|Progressive Disease|4|||
148838375|NCT01047007|536890150|FG002|Overall Study|Progressive Disease|1|||
148838376|NCT01047007|536890151|FG003|Overall Study|Progressive Disease|0|||
148838377|NCT03257358|536890153|FG000|Overall Study|Adverse Event|25|||
148838378|NCT03257358|536890154|FG001|Overall Study|Adverse Event|12|||
148838379|NCT03257358|536890153|FG000|Overall Study|Lack of Efficacy|1|||
148838380|NCT03257358|536890154|FG001|Overall Study|Lack of Efficacy|1|||
148838381|NCT03257358|536890153|FG000|Overall Study|Lost to Follow-up|12|||
148838382|NCT03257358|536890154|FG001|Overall Study|Lost to Follow-up|4|||
148838383|NCT03257358|536890153|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
148838384|NCT03257358|536890154|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
148838385|NCT03257358|536890153|FG000|Overall Study|Physician Decision|2|||
148838386|NCT03257358|536890154|FG001|Overall Study|Physician Decision|2|||
148838387|NCT03257358|536890153|FG000|Overall Study|Protocol Violation|5|||
148838388|NCT03257358|536890154|FG001|Overall Study|Protocol Violation|3|||
148838389|NCT03257358|536890153|FG000|Overall Study|Technical problems|4|||
148838390|NCT03257358|536890154|FG001|Overall Study|Technical problems|1|||
148838391|NCT03257358|536890153|FG000|Overall Study|Withdrawal by Subject|8|||
148838392|NCT03257358|536890154|FG001|Overall Study|Withdrawal by Subject|3|||
148838393|NCT03257358|536890153|FG000|Overall Study|Withdrawal of informed consent|9|||
148838394|NCT03257358|536890154|FG001|Overall Study|Withdrawal of informed consent|5|||
148838395|NCT03257358|536890153|FG000|Overall Study|New therapy for study indication|1|||
148838396|NCT03257358|536890154|FG001|Overall Study|New therapy for study indication|0|||
148838397|NCT03257358|536890153|FG000|Overall Study|No longer requires treatment|0|||
148838398|NCT03257358|536890154|FG001|Overall Study|No longer requires treatment|1|||
148838399|NCT01669902|536890155|FG000|Overall Study|Adverse Event|11|||
148838400|NCT01669902|536890155|FG000|Overall Study|Lack of Efficacy|10|||
148838401|NCT01669902|536890155|FG000|Overall Study|Other|8|||
148838402|NCT00305877|536890156|FG000|Overall Study|Lack of Efficacy|6|||
148838403|NCT00305877|536890157|FG001|Overall Study|Lack of Efficacy|9|||
148838404|NCT00305877|536890156|FG000|Overall Study|Adverse Event|9|||
148838405|NCT00305877|536890157|FG001|Overall Study|Adverse Event|14|||
148838406|NCT00305877|536890156|FG000|Overall Study|Death|0|||
148838407|NCT00305877|536890157|FG001|Overall Study|Death|1|||
148838408|NCT00305877|536890156|FG000|Overall Study|Withdrawal by Subject|4|||
148838409|NCT00305877|536890157|FG001|Overall Study|Withdrawal by Subject|2|||
148838410|NCT00305877|536890156|FG000|Overall Study|Physician Decision|1|||
148838411|NCT00305877|536890157|FG001|Overall Study|Physician Decision|1|||
148838412|NCT00305877|536890156|FG000|Overall Study|Never start treatment|2|||
148982533|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
148982534|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
148982535|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
148982536|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
148982537|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
148982538|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
148982539|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
148982540|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
148982541|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
148982542|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
148982543|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982544|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982545|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
148982546|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982547|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982548|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982549|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982550|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982551|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
148982552|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982553|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
148982554|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982555|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982556|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982557|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982558|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982559|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
148982560|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
148982561|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
148982562|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
148982563|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
148982564|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
148982565|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
148982566|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
148982567|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
148982568|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
148982569|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
148982570|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982571|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982572|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
148982573|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982574|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982575|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982576|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982577|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982578|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
148982579|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982580|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982581|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
148982582|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982583|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982584|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982585|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982586|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148838413|NCT00305877|536890157|FG001|Overall Study|Never start treatment|5|||
149029179|NCT02616263|537583851|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
149029180|NCT02616263|537583852|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
148838414|NCT00305877|536890156|FG000|Overall Study|Ineligible|2|||
148838415|NCT00305877|536890157|FG001|Overall Study|Ineligible|1|||
148838416|NCT00305877|536890156|FG000|Overall Study|Transportation issue with daily RT|0|||
148838417|NCT00305877|536890157|FG001|Overall Study|Transportation issue with daily RT|1|||
148838418|NCT01248793|536890158|FG000|Overall Study|Lost to Follow-up|0|||
148838419|NCT01248793|536890159|FG001|Overall Study|Lost to Follow-up|1|||
148838420|NCT01248793|536890158|FG000|Overall Study|Adverse Event|1|||
148838421|NCT01248793|536890159|FG001|Overall Study|Adverse Event|1|||
148838422|NCT01248793|536890158|FG000|Overall Study|Protocol Violation|0|||
148838423|NCT01248793|536890159|FG001|Overall Study|Protocol Violation|1|||
148838424|NCT01248793|536890158|FG000|Overall Study|Withdrawal by Subject|3|||
148838425|NCT01248793|536890159|FG001|Overall Study|Withdrawal by Subject|3|||
148838426|NCT00355030|536890166|FG000|Study Period 1 Treatment|Adverse Event|1|||
148838427|NCT00355030|536890167|FG001|Study Period 1 Treatment|Adverse Event|1|||
148838428|NCT00355030|536890166|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
148838429|NCT00355030|536890167|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
148838430|NCT00355030|536890166|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
148838431|NCT00355030|536890167|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
148838432|NCT00355030|536890166|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
148838433|NCT00355030|536890167|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
148838434|NCT00355030|536890166|FG000|Study Period 1 Treatment|Physician Decision|0|||
148838435|NCT00355030|536890167|FG001|Study Period 1 Treatment|Physician Decision|1|||
148838436|NCT00355030|536890166|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
148838437|NCT00355030|536890167|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
148838438|NCT00355030|536890166|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
148838439|NCT00355030|536890167|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
148838440|NCT00355030|536890166|FG000|Study Period 1 Treatment|Other|2|||
148838441|NCT00355030|536890167|FG001|Study Period 1 Treatment|Other|6|||
148838442|NCT00355030|536890166|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
148838443|NCT00355030|536890167|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
148838444|NCT00355030|536890166|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
148838445|NCT00355030|536890167|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
148838446|NCT00339040|536890168|FG000|Stage I|Not able to attend clinic|1|||
148838447|NCT00339040|536890169|FG001|Stage I|Not able to attend clinic|0|||
148838448|NCT00339040|536890168|FG000|Stage I|Protocol Violation|1|||
148838449|NCT00339040|536890169|FG001|Stage I|Protocol Violation|1|||
148838450|NCT00339040|536890168|FG000|Stage II|Lost to Follow-up|3|||
148838451|NCT00339040|536890169|FG001|Stage II|Lost to Follow-up|0|||
148838452|NCT00339040|536890168|FG000|Stage II|Withdrawal by Subject|1|||
148838453|NCT00339040|536890169|FG001|Stage II|Withdrawal by Subject|2|||
148838454|NCT00339040|536890168|FG000|Stage II|Protocol Violation|3|||
148838455|NCT00339040|536890169|FG001|Stage II|Protocol Violation|0|||
148838456|NCT00339040|536890168|FG000|Stage II|Not able to attend clinic|1|||
148838457|NCT00339040|536890169|FG001|Stage II|Not able to attend clinic|0|||
148838458|NCT00339040|536890168|FG000|Stage II|Site closing|2|||
148838459|NCT00339040|536890169|FG001|Stage II|Site closing|0|||
148838460|NCT01747915|536890170|FG000|Overall Study|Other|1|||
148838461|NCT01747915|536890171|FG001|Overall Study|Other|1|||
148838462|NCT01747915|536890172|FG002|Overall Study|Other|1|||
148838463|NCT01747915|536890170|FG000|Overall Study|Adverse Event|8|||
148838464|NCT01747915|536890171|FG001|Overall Study|Adverse Event|5|||
148838465|NCT01747915|536890172|FG002|Overall Study|Adverse Event|2|||
148838466|NCT01747915|536890170|FG000|Overall Study|Death|0|||
148838467|NCT01747915|536890171|FG001|Overall Study|Death|0|||
148838468|NCT01747915|536890172|FG002|Overall Study|Death|1|||
148838469|NCT01747915|536890170|FG000|Overall Study|Lack of Efficacy|0|||
149029181|NCT02616263|537583851|FG000|6 Month to 1.5 Year|Death|1|||
149029182|NCT02616263|537583852|FG001|6 Month to 1.5 Year|Death|0|||
149029183|NCT02616263|537583851|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
148838470|NCT01747915|536890171|FG001|Overall Study|Lack of Efficacy|1|||
148838471|NCT01747915|536890172|FG002|Overall Study|Lack of Efficacy|0|||
148838472|NCT01747915|536890170|FG000|Overall Study|Lost to Follow-up|1|||
148838473|NCT01747915|536890171|FG001|Overall Study|Lost to Follow-up|0|||
148838474|NCT01747915|536890172|FG002|Overall Study|Lost to Follow-up|0|||
148838475|NCT01747915|536890170|FG000|Overall Study|Withdrawal by Subject|4|||
148838476|NCT01747915|536890171|FG001|Overall Study|Withdrawal by Subject|4|||
148838477|NCT01747915|536890172|FG002|Overall Study|Withdrawal by Subject|1|||
149029184|NCT02616263|537583852|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
149029185|NCT02616263|537583851|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
148838478|NCT01747915|536890170|FG000|Overall Study|Protocol Violation|1|||
148838479|NCT01747915|536890171|FG001|Overall Study|Protocol Violation|0|||
148838480|NCT01747915|536890172|FG002|Overall Study|Protocol Violation|0|||
148838481|NCT01747915|536890170|FG000|Overall Study|Pregnancy|0|||
148838482|NCT01747915|536890171|FG001|Overall Study|Pregnancy|0|||
148838483|NCT01747915|536890172|FG002|Overall Study|Pregnancy|1|||
148838484|NCT01462929|536890173|FG000|Overall Study|Adverse Event|3|||
148838485|NCT01462929|536890174|FG001|Overall Study|Adverse Event|3|||
148838486|NCT01462929|536890175|FG002|Overall Study|Adverse Event|4|||
148838487|NCT01462929|536890173|FG000|Overall Study|Withdrawal by Subject|2|||
148838488|NCT01462929|536890174|FG001|Overall Study|Withdrawal by Subject|1|||
148838489|NCT01462929|536890175|FG002|Overall Study|Withdrawal by Subject|0|||
148838490|NCT01462929|536890173|FG000|Overall Study|Lack of Efficacy|0|||
148838491|NCT01462929|536890174|FG001|Overall Study|Lack of Efficacy|0|||
148838492|NCT01462929|536890175|FG002|Overall Study|Lack of Efficacy|1|||
148838493|NCT02391311|536890180|FG000|Overall Study|Lost to Follow-up|2|||
148838494|NCT02391311|536890181|FG001|Overall Study|Lost to Follow-up|1|||
148838495|NCT02391311|536890180|FG000|Overall Study|deemed ineligible after baseline|1|||
148838496|NCT02391311|536890181|FG001|Overall Study|deemed ineligible after baseline|1|||
148838497|NCT01309204|536890184|FG000|Overall Study|Adverse Event|48|||
148838498|NCT01309204|536890185|FG001|Overall Study|Adverse Event|58|||
148838499|NCT01309204|536890184|FG000|Overall Study|Lost to Follow-up|2|||
148838500|NCT01309204|536890185|FG001|Overall Study|Lost to Follow-up|2|||
148838501|NCT01309204|536890184|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
148838502|NCT01309204|536890185|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
148838503|NCT01309204|536890184|FG000|Overall Study|Inadequate control of IOP|4|||
148838504|NCT01309204|536890185|FG001|Overall Study|Inadequate control of IOP|4|||
148838505|NCT01309204|536890184|FG000|Overall Study|Other|4|||
148838506|NCT01309204|536890185|FG001|Overall Study|Other|1|||
148838507|NCT03183063|536890186|FG000|Overall Study|Withdrawal by Subject|2|||
148838508|NCT03183063|536890187|FG001|Overall Study|Withdrawal by Subject|0|||
148838509|NCT03183063|536890188|FG002|Overall Study|Withdrawal by Subject|0|||
148838510|NCT03183063|536890186|FG000|Overall Study|Physician Decision|3|||
148838511|NCT03183063|536890187|FG001|Overall Study|Physician Decision|4|||
148838512|NCT03183063|536890188|FG002|Overall Study|Physician Decision|4|||
148838513|NCT00688467|536890189|FG000|Treatment Period 1|Adverse Event|2|||
148838514|NCT00688467|536890190|FG001|Treatment Period 1|Adverse Event|1|||
148838515|NCT00688467|536890189|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
148838516|NCT00688467|536890190|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
148838517|NCT00688467|536890189|FG000|Treatment Period 2|Protocol Violation|0|||
148838518|NCT00688467|536890190|FG001|Treatment Period 2|Protocol Violation|1|||
148838519|NCT00688467|536890189|FG000|Treatment Period 2|Adverse Event|0|||
148838520|NCT00688467|536890190|FG001|Treatment Period 2|Adverse Event|1|||
148838521|NCT00690794|536890195|FG000|Overall Study|Adverse Event|12|||
148838522|NCT00690794|536890196|FG001|Overall Study|Adverse Event|10|||
148838523|NCT00690794|536890195|FG000|Overall Study|Lost to Follow-up|1|||
148838524|NCT00690794|536890196|FG001|Overall Study|Lost to Follow-up|4|||
148838525|NCT00690794|536890195|FG000|Overall Study|Withdrawal by Subject|0|||
148838526|NCT00690794|536890196|FG001|Overall Study|Withdrawal by Subject|9|||
148838527|NCT00690794|536890195|FG000|Overall Study|Protocol Violation|6|||
148838528|NCT00690794|536890196|FG001|Overall Study|Protocol Violation|7|||
148838529|NCT00690794|536890195|FG000|Overall Study|Noncompliance|1|||
148838530|NCT00690794|536890196|FG001|Overall Study|Noncompliance|2|||
148838531|NCT00690794|536890195|FG000|Overall Study|Other not specified|1|||
148838532|NCT00690794|536890196|FG001|Overall Study|Other not specified|3|||
148838533|NCT01073293|536890197|FG000|Overall Study|Lost to Follow-up|0|||
148838534|NCT01073293|536890198|FG001|Overall Study|Lost to Follow-up|1|||
148838535|NCT01073293|536890197|FG000|Overall Study|Withdrawal by Subject|5|||
148838536|NCT01073293|536890198|FG001|Overall Study|Withdrawal by Subject|10|||
148838537|NCT00305448|536890199|FG000|Overall Study|Protocol Violation|0|||
148838538|NCT00305448|536890200|FG001|Overall Study|Protocol Violation|1|||
148838539|NCT00305448|536890201|FG002|Overall Study|Protocol Violation|0|||
148838540|NCT00305448|536890199|FG000|Overall Study|Withdrawal by Subject|2|||
149029186|NCT02616263|537583852|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
149029187|NCT02616263|537583851|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
149029188|NCT02616263|537583852|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
148838541|NCT00305448|536890200|FG001|Overall Study|Withdrawal by Subject|0|||
149029189|NCT05015478|537583853|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
149029190|NCT05015478|537583854|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
149029191|NCT05015478|537583855|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
149029192|NCT05015478|537583856|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
149029193|NCT04319094|537583857|FG000|Baseline|Lost to Follow-up|4|||
149029194|NCT04319094|537583858|FG001|Baseline|Lost to Follow-up|5|||
148838542|NCT00305448|536890201|FG002|Overall Study|Withdrawal by Subject|1|||
148838543|NCT00305448|536890199|FG000|Overall Study|Adverse Event|1|||
148838544|NCT00305448|536890200|FG001|Overall Study|Adverse Event|0|||
148838545|NCT00305448|536890201|FG002|Overall Study|Adverse Event|1|||
148838546|NCT00305448|536890199|FG000|Overall Study|Disease Progression|27|||
148838547|NCT00305448|536890200|FG001|Overall Study|Disease Progression|31|||
148838548|NCT00305448|536890201|FG002|Overall Study|Disease Progression|28|||
148838549|NCT00305448|536890199|FG000|Overall Study|Subjective Disease Progression|1|||
148838550|NCT00305448|536890200|FG001|Overall Study|Subjective Disease Progression|2|||
148838551|NCT00305448|536890201|FG002|Overall Study|Subjective Disease Progression|2|||
148838552|NCT00305448|536890199|FG000|Overall Study|Tumor Marker Elevation|0|||
148838553|NCT00305448|536890200|FG001|Overall Study|Tumor Marker Elevation|0|||
148838554|NCT00305448|536890201|FG002|Overall Study|Tumor Marker Elevation|1|||
148838555|NCT00077974|536890202|FG000|Overall Study|Adverse Event|22|||
148838556|NCT00077974|536890202|FG000|Overall Study|Protocol Violation|1|||
148838557|NCT00077974|536890202|FG000|Overall Study|Withdrawal by Subject|3|||
148838558|NCT00077974|536890202|FG000|Overall Study|Lack of Efficacy|76|||
148838559|NCT00077974|536890202|FG000|Overall Study|Decision of Sponsor|2|||
148838560|NCT01343888|536890203|FG000|Overall Study|Adverse Event|12|||
148838561|NCT01343888|536890204|FG001|Overall Study|Adverse Event|22|||
148838562|NCT01343888|536890205|FG002|Overall Study|Adverse Event|5|||
148838563|NCT01343888|536890203|FG000|Overall Study|Lack of Efficacy|9|||
148838564|NCT01343888|536890204|FG001|Overall Study|Lack of Efficacy|9|||
148838565|NCT01343888|536890205|FG002|Overall Study|Lack of Efficacy|13|||
148838566|NCT01343888|536890203|FG000|Overall Study|Lost to Follow-up|0|||
148838567|NCT01343888|536890204|FG001|Overall Study|Lost to Follow-up|2|||
148838568|NCT01343888|536890205|FG002|Overall Study|Lost to Follow-up|1|||
148838569|NCT01343888|536890203|FG000|Overall Study|Protocol Violation|0|||
148838570|NCT01343888|536890204|FG001|Overall Study|Protocol Violation|2|||
148838571|NCT01343888|536890205|FG002|Overall Study|Protocol Violation|0|||
148838572|NCT01343888|536890203|FG000|Overall Study|Withdrawal by Subject|4|||
148838573|NCT01343888|536890204|FG001|Overall Study|Withdrawal by Subject|4|||
148838574|NCT01343888|536890205|FG002|Overall Study|Withdrawal by Subject|2|||
148838575|NCT01343888|536890203|FG000|Overall Study|other than stated above|0|||
148838576|NCT01343888|536890204|FG001|Overall Study|other than stated above|0|||
148838577|NCT01343888|536890205|FG002|Overall Study|other than stated above|1|||
148838578|NCT00558636|536890206|FG000|Treatment|Adverse Event|9|||
148838579|NCT00558636|536890207|FG001|Treatment|Adverse Event|2|||
148838580|NCT00558636|536890206|FG000|Treatment|Withdrawal by Subject|2|||
148838581|NCT00558636|536890207|FG001|Treatment|Withdrawal by Subject|0|||
148838582|NCT00558636|536890206|FG000|Treatment|Premature termination of the study|35|||
148838583|NCT00558636|536890207|FG001|Treatment|Premature termination of the study|37|||
148838584|NCT00558636|536890206|FG000|Treatment|Disease progression|1|||
148838585|NCT00558636|536890207|FG001|Treatment|Disease progression|5|||
148838586|NCT00558636|536890206|FG000|Follow-up|Premature termination of the study|12|||
148838587|NCT00558636|536890207|FG001|Follow-up|Premature termination of the study|7|||
148838588|NCT01990742|536890208|FG000|Overall Study|Withdrawal by facility|407|||
148838589|NCT01990742|536890209|FG001|Overall Study|Withdrawal by facility|1083|||
148838590|NCT01990742|536890208|FG000|Overall Study|Facility closed|0|||
148838591|NCT01990742|536890209|FG001|Overall Study|Facility closed|270|||
148838592|NCT03443687|536890210|FG000|Overall Study|Lost to Follow-up|3|||
148838593|NCT03443687|536890211|FG001|Overall Study|Lost to Follow-up|5|||
148838594|NCT03443687|536890210|FG000|Overall Study|Withdrawal by Subject|1|||
148838595|NCT03443687|536890211|FG001|Overall Study|Withdrawal by Subject|0|||
148838596|NCT03443687|536890210|FG000|Overall Study|Discontinued intervention|1|||
148838597|NCT03443687|536890211|FG001|Overall Study|Discontinued intervention|1|||
148838598|NCT00487981|536890215|FG000|Overall Study|Hypothyroidism diagnosis|1|||
148838599|NCT02808429|536890220|FG000|Overall Study|Lost to Follow-up|1|||
148838600|NCT02808429|536890221|FG001|Overall Study|Lost to Follow-up|0|||
148838601|NCT02808429|536890222|FG002|Overall Study|Lost to Follow-up|0|||
148838602|NCT02808429|536890220|FG000|Overall Study|Protocol Violation|0|||
148838603|NCT02808429|536890221|FG001|Overall Study|Protocol Violation|1|||
148838604|NCT02808429|536890222|FG002|Overall Study|Protocol Violation|0|||
148838605|NCT02808429|536890220|FG000|Overall Study|Premature study termination by sponsor|2|||
148838606|NCT02808429|536890221|FG001|Overall Study|Premature study termination by sponsor|0|||
148838607|NCT02808429|536890222|FG002|Overall Study|Premature study termination by sponsor|1|||
148838608|NCT02808429|536890220|FG000|Overall Study|Relocation|0|||
148838609|NCT02808429|536890221|FG001|Overall Study|Relocation|0|||
148838610|NCT02808429|536890222|FG002|Overall Study|Relocation|1|||
148838611|NCT01788943|536890223|FG000|Overall Study|Withdrawal by Subject|1|||
148838612|NCT01788943|536890224|FG001|Overall Study|Withdrawal by Subject|0|||
148838613|NCT00811954|536890225|FG000|Overall Study|Death|10|||
148838614|NCT00811954|536890226|FG001|Overall Study|Death|6|||
148838615|NCT00811954|536890227|FG002|Overall Study|Death|13|||
148838616|NCT00811954|536890225|FG000|Overall Study|Lost to Follow-up|29|||
148838617|NCT00811954|536890226|FG001|Overall Study|Lost to Follow-up|23|||
148838618|NCT00811954|536890227|FG002|Overall Study|Lost to Follow-up|34|||
148838619|NCT00811954|536890225|FG000|Overall Study|Not able to get to clinic|28|||
148838620|NCT00811954|536890226|FG001|Overall Study|Not able to get to clinic|35|||
148838621|NCT00811954|536890227|FG002|Overall Study|Not able to get to clinic|30|||
148838622|NCT00811954|536890225|FG000|Overall Study|Not willing to adhere to requirements|12|||
148838623|NCT00811954|536890226|FG001|Overall Study|Not willing to adhere to requirements|2|||
148838624|NCT00811954|536890227|FG002|Overall Study|Not willing to adhere to requirements|16|||
148838625|NCT00811954|536890225|FG000|Overall Study|Withdraw consent prior study completion|4|||
148838626|NCT00811954|536890226|FG001|Overall Study|Withdraw consent prior study completion|6|||
148838627|NCT00811954|536890227|FG002|Overall Study|Withdraw consent prior study completion|5|||
149029195|NCT04319094|537583857|FG000|Baseline|Protocol Violation|0|||
149029196|NCT04319094|537583858|FG001|Baseline|Protocol Violation|3|||
149029197|NCT04319094|537583857|FG000|Baseline|Withdrawal by Subject|2|||
149029198|NCT04319094|537583858|FG001|Baseline|Withdrawal by Subject|1|||
149029199|NCT04319094|537583857|FG000|Post-Intervention|Death|0|||
149029200|NCT04319094|537583858|FG001|Post-Intervention|Death|1|||
149029201|NCT04319094|537583857|FG000|Post-Intervention|Lost to Follow-up|4|||
149029202|NCT04319094|537583858|FG001|Post-Intervention|Lost to Follow-up|4|||
149029203|NCT04319094|537583857|FG000|Post-Intervention|Withdrawal by Subject|8|||
149029204|NCT04319094|537583858|FG001|Post-Intervention|Withdrawal by Subject|5|||
149029205|NCT04319094|537583857|FG000|Post-Intervention|Incomplete Data Collection|1|||
149029206|NCT04319094|537583858|FG001|Post-Intervention|Incomplete Data Collection|3|||
149029207|NCT04319094|537583857|FG000|3-month|Death|1|||
149029208|NCT04319094|537583858|FG001|3-month|Death|0|||
149029209|NCT04319094|537583857|FG000|3-month|Lost to Follow-up|2|||
149029210|NCT04319094|537583858|FG001|3-month|Lost to Follow-up|2|||
149029211|NCT04319094|537583857|FG000|3-month|Withdrawal by Subject|0|||
149029212|NCT04319094|537583858|FG001|3-month|Withdrawal by Subject|3|||
149029213|NCT04319094|537583857|FG000|3-month|Incomplete data collection|9|||
149029214|NCT04319094|537583858|FG001|3-month|Incomplete data collection|7|||
149029215|NCT04319094|537583857|FG000|6-month|Lost to Follow-up|1|||
149029216|NCT04319094|537583858|FG001|6-month|Lost to Follow-up|1|||
149029217|NCT04319094|537583857|FG000|6-month|Withdrawal by Subject|0|||
149029218|NCT04319094|537583858|FG001|6-month|Withdrawal by Subject|3|||
149029219|NCT04319094|537583857|FG000|6-month|Incomplete data collection|14|||
149029220|NCT04319094|537583858|FG001|6-month|Incomplete data collection|9|||
149029221|NCT04319094|537583857|FG000|9-month|Lost to Follow-up|8|||
149029222|NCT04319094|537583858|FG001|9-month|Lost to Follow-up|4|||
149029223|NCT04319094|537583857|FG000|9-month|Withdrawal by Subject|0|||
149029224|NCT04319094|537583858|FG001|9-month|Withdrawal by Subject|1|||
149029225|NCT04319094|537583857|FG000|9-month|Incomplete data collection|8|||
149029226|NCT04319094|537583858|FG001|9-month|Incomplete data collection|5|||
149029227|NCT04319094|537583857|FG000|12-month|Lost to Follow-up|11|||
149029228|NCT04319094|537583858|FG001|12-month|Lost to Follow-up|8|||
149029229|NCT00654238|537583861|FG000|Overall Study|Screen Failures|4|||
149029230|NCT00877851|537583862|FG000|Overall Study|Lost to Follow-up|5|||
149029231|NCT00877851|537583863|FG001|Overall Study|Lost to Follow-up|5|||
149029232|NCT00877851|537583862|FG000|Overall Study|computer problem|3|||
149029233|NCT00877851|537583863|FG001|Overall Study|computer problem|0|||
149029234|NCT00877851|537583862|FG000|Overall Study|no longer interested in participating|1|||
149029235|NCT00877851|537583863|FG001|Overall Study|no longer interested in participating|0|||
149029236|NCT03424239|537583864|FG000|Overall Study|Withdrawal by Subject|2|||
149029237|NCT00770211|537583865|FG000|Overall Study|Lost to Follow-up|1|||
149029238|NCT00770211|537583866|FG001|Overall Study|Lost to Follow-up|0|||
149029239|NCT00770211|537583865|FG000|Overall Study|Withdrawal by Subject|0|||
149029240|NCT00770211|537583866|FG001|Overall Study|Withdrawal by Subject|2|||
149029241|NCT00318656|537583867|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
149029242|NCT00318656|537583868|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
149029243|NCT00318656|537583867|FG000|Overall Study|Did not receive any treatment|0|||
149029244|NCT00318656|537583868|FG001|Overall Study|Did not receive any treatment|1|||
149029245|NCT01446003|537583869|FG000|Period 1|Protocol Violation|2|||
149029246|NCT01446003|537583870|FG001|Period 1|Protocol Violation|0|||
149029247|NCT01446003|537583869|FG000|Period 2|Adverse Event|1|||
149029248|NCT01446003|537583870|FG001|Period 2|Adverse Event|0|||
149029249|NCT03905135|537583872|FG000|Dose Escalation|Adverse Event|1|||
149029250|NCT03905135|537583873|FG001|Dose Escalation|Adverse Event|1|||
149029251|NCT03905135|537583872|FG000|Dose Escalation|Progressive disease|3|||
148838628|NCT00811954|536890225|FG000|Overall Study|Site Closure|4|||
149029252|NCT03905135|537583873|FG001|Dose Escalation|Progressive disease|1|||
149029253|NCT03905135|537583872|FG000|Dose Escalation|Intercurrent illness|1|||
149029254|NCT03905135|537583873|FG001|Dose Escalation|Intercurrent illness|0|||
149029255|NCT02042443|537583876|FG000|Overall Study|Adverse Event|2|||
149029256|NCT02042443|537583877|FG001|Overall Study|Adverse Event|1|||
149029257|NCT02042443|537583876|FG000|Overall Study|Withdrawal by Subject|0|||
149029258|NCT02042443|537583877|FG001|Overall Study|Withdrawal by Subject|1|||
149029259|NCT02042443|537583876|FG000|Overall Study|Progression|21|||
149029260|NCT02042443|537583877|FG001|Overall Study|Progression|17|||
149029261|NCT02042443|537583876|FG000|Overall Study|not protocol specified|1|||
149029262|NCT02042443|537583877|FG001|Overall Study|not protocol specified|1|||
149029263|NCT02042443|537583876|FG000|Overall Study|Not eligible/not analyzable|3|||
149029264|NCT02042443|537583877|FG001|Overall Study|Not eligible/not analyzable|6|||
149029265|NCT01007149|537583880|FG000|Overall Study|Administrative problems|0|||
149029266|NCT01007149|537583881|FG001|Overall Study|Administrative problems|1|||
149029267|NCT02784704|537583882|FG000|Overall Study|Adverse Event|4|||
149029268|NCT02784704|537583883|FG001|Overall Study|Adverse Event|2|||
149029269|NCT02784704|537583882|FG000|Overall Study|Lost to Follow-up|6|||
149029270|NCT02784704|537583883|FG001|Overall Study|Lost to Follow-up|4|||
149029271|NCT02784704|537583882|FG000|Overall Study|Withdrawal by Subject|1|||
149029272|NCT02784704|537583883|FG001|Overall Study|Withdrawal by Subject|3|||
149029273|NCT02784704|537583882|FG000|Overall Study|Subject Non Compliance|2|||
148838629|NCT00811954|536890226|FG001|Overall Study|Site Closure|0|||
148838630|NCT00811954|536890227|FG002|Overall Study|Site Closure|1|||
148838631|NCT00811954|536890225|FG000|Overall Study|Severe Debilitation|2|||
148838632|NCT00811954|536890226|FG001|Overall Study|Severe Debilitation|0|||
148838633|NCT00811954|536890227|FG002|Overall Study|Severe Debilitation|1|||
148838634|NCT00811954|536890225|FG000|Overall Study|Complete Protocol: No follow-up|0|||
148838635|NCT00811954|536890226|FG001|Overall Study|Complete Protocol: No follow-up|0|||
148838636|NCT00811954|536890227|FG002|Overall Study|Complete Protocol: No follow-up|1|||
148838637|NCT00186628|536890229|FG000|Overall Study|Death|2|||
148838638|NCT00186628|536890229|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
148838639|NCT01374425|536890232|FG000|Overall Study|Radiographic Disease Progression|86|||
148838640|NCT01374425|536890233|FG001|Overall Study|Radiographic Disease Progression|81|||
148838641|NCT01374425|536890232|FG000|Overall Study|Clinical Disease Progression|9|||
148838642|NCT01374425|536890233|FG001|Overall Study|Clinical Disease Progression|6|||
148838643|NCT01374425|536890232|FG000|Overall Study|Adverse Event|29|||
148838644|NCT01374425|536890233|FG001|Overall Study|Adverse Event|18|||
148838645|NCT01374425|536890232|FG000|Overall Study|Death (Progression of Disease)|1|||
148838646|NCT01374425|536890233|FG001|Overall Study|Death (Progression of Disease)|0|||
148838647|NCT01374425|536890232|FG000|Overall Study|Death (Adverse Event)|2|||
148838648|NCT01374425|536890233|FG001|Overall Study|Death (Adverse Event)|4|||
148838649|NCT01374425|536890232|FG000|Overall Study|Withdrawal by Subject|6|||
148838650|NCT01374425|536890233|FG001|Overall Study|Withdrawal by Subject|7|||
148838651|NCT01374425|536890232|FG000|Overall Study|Refused Treatment|10|||
148838652|NCT01374425|536890233|FG001|Overall Study|Refused Treatment|24|||
148838653|NCT01374425|536890232|FG000|Overall Study|Protocol Violation|2|||
148838654|NCT01374425|536890233|FG001|Overall Study|Protocol Violation|3|||
148838655|NCT01374425|536890232|FG000|Overall Study|Sponsor Decision|0|||
148838656|NCT01374425|536890233|FG001|Overall Study|Sponsor Decision|1|||
148838657|NCT01374425|536890232|FG000|Overall Study|Lost to Follow-up|2|||
148838658|NCT01374425|536890233|FG001|Overall Study|Lost to Follow-up|1|||
148838659|NCT01374425|536890232|FG000|Overall Study|Other|41|||
148838660|NCT01374425|536890233|FG001|Overall Study|Other|43|||
148838661|NCT00546481|536890234|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
148838662|NCT00546481|536890235|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
148838663|NCT00546481|536890236|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
148838664|NCT00546481|536890234|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
148838665|NCT00546481|536890235|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
148838666|NCT00546481|536890236|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
148838667|NCT00546481|536890234|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
148838668|NCT00546481|536890235|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
148838669|NCT00546481|536890236|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
148838670|NCT00546481|536890234|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
148838671|NCT00546481|536890235|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
148838672|NCT00546481|536890236|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
148838673|NCT00546481|536890234|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
148838674|NCT00546481|536890235|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
148838675|NCT00546481|536890236|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
148838676|NCT00546481|536890234|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
148838677|NCT00546481|536890235|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
148838678|NCT00546481|536890236|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
148838679|NCT00546481|536890234|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
148838680|NCT00546481|536890235|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
148838681|NCT00546481|536890236|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
148838682|NCT00546481|536890234|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
148838683|NCT00546481|536890235|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
148838684|NCT00546481|536890236|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
148838685|NCT00546481|536890234|FG000|Maintenance Phase (CERA)|Other Reason|0|||
148838686|NCT00546481|536890235|FG001|Maintenance Phase (CERA)|Other Reason|0|||
148838687|NCT00546481|536890236|FG002|Maintenance Phase (CERA)|Other Reason|1|||
148838688|NCT02761642|536890239|FG000|Overall Study|Did not Receive Study Treatment|3|||
148838689|NCT02761642|536890239|FG000|Overall Study|Adverse Event|13|||
148838690|NCT02761642|536890239|FG000|Overall Study|Withdrawal by Subject|2|||
148838691|NCT02761642|536890239|FG000|Overall Study|Non-compliant|7|||
148838692|NCT02761642|536890239|FG000|Overall Study|Death|3|||
148838693|NCT02761642|536890239|FG000|Overall Study|Lack of Efficacy|20|||
148838694|NCT02761642|536890239|FG000|Overall Study|Physician Decision|1|||
148838695|NCT02761642|536890239|FG000|Overall Study|Reason Unspecified|21|||
148838696|NCT00950651|536890240|FG000|Overall Study|Adverse Event|17|||
148838697|NCT00950651|536890241|FG001|Overall Study|Adverse Event|20|||
148838698|NCT00950651|536890240|FG000|Overall Study|Death|1|||
148982587|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
148982588|NCT01172938|537415282|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148838699|NCT00950651|536890241|FG001|Overall Study|Death|0|||
148838700|NCT00950651|536890240|FG000|Overall Study|Lack of Efficacy|2|||
148838701|NCT00950651|536890241|FG001|Overall Study|Lack of Efficacy|2|||
148838702|NCT00950651|536890240|FG000|Overall Study|Protocol Violation|3|||
148838703|NCT00950651|536890241|FG001|Overall Study|Protocol Violation|4|||
148838704|NCT00950651|536890240|FG000|Overall Study|Withdrawal by Subject|8|||
148838705|NCT00950651|536890241|FG001|Overall Study|Withdrawal by Subject|9|||
148838706|NCT03783780|536890242|FG000|Overall Study|Withdrawn prior to completion|1|||
148838707|NCT02850978|536890249|FG000|Overall Study|Uncollectable CRF|27|||
148838708|NCT02850978|536890249|FG000|Overall Study|No visit since the first visit|35|||
148838709|NCT02850978|536890249|FG000|Overall Study|Adverse Event|81|||
148838710|NCT02850978|536890249|FG000|Overall Study|Lack of Efficacy|40|||
148838711|NCT02850978|536890249|FG000|Overall Study|Improvement in condition|34|||
148838712|NCT02850978|536890249|FG000|Overall Study|Lost to Follow-up|121|||
148838713|NCT02850978|536890249|FG000|Overall Study|Reason not listed|88|||
148838714|NCT00570713|536890250|FG000|Overall Study|Adverse Event|16|||
148838715|NCT00570713|536890251|FG001|Overall Study|Adverse Event|9|||
148838716|NCT00570713|536890250|FG000|Overall Study|Death|7|||
148838717|NCT00570713|536890251|FG001|Overall Study|Death|7|||
148838718|NCT00570713|536890250|FG000|Overall Study|Lack of Efficacy|40|||
148838719|NCT00570713|536890251|FG001|Overall Study|Lack of Efficacy|49|||
148838720|NCT00570713|536890250|FG000|Overall Study|Physician Decision|2|||
148838721|NCT00570713|536890251|FG001|Overall Study|Physician Decision|2|||
148838722|NCT00570713|536890250|FG000|Overall Study|Withdrawal by Subject|3|||
148838723|NCT00570713|536890251|FG001|Overall Study|Withdrawal by Subject|3|||
148838724|NCT00570713|536890250|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
148838725|NCT00570713|536890251|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
148838726|NCT02765399|536890252|FG000|Overall Study|Nausea|1|||
148838727|NCT02765399|536890253|FG001|Overall Study|Nausea|0|||
148838728|NCT00120627|536890260|FG000|Overall Study|Withdrawal by Subject|5|||
148838729|NCT00120627|536890261|FG001|Overall Study|Withdrawal by Subject|5|||
148838730|NCT04016714|536890262|FG000|Overall Study|Death|1|||
148838731|NCT04016714|536890263|FG001|Overall Study|Death|0|||
148838732|NCT04016714|536890262|FG000|Overall Study|Lost to Follow-up|3|||
148838733|NCT04016714|536890263|FG001|Overall Study|Lost to Follow-up|1|||
148838734|NCT04016714|536890262|FG000|Overall Study|Physician Decision|3|||
148838735|NCT04016714|536890263|FG001|Overall Study|Physician Decision|3|||
148838736|NCT04016714|536890262|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
148838737|NCT04016714|536890263|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
148838738|NCT01677988|536890264|FG000|Overall Study|Lack of Efficacy|2|||
148838739|NCT01822665|536890265|FG000|Overall Study|Adverse Event|3|||
148838740|NCT01822665|536890265|FG000|Overall Study|Other Reason|5|||
148838741|NCT00271544|536890266|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
148838742|NCT00271544|536890266|FG000|Overall Study|Model 4196 lead not attempted|9|||
148838743|NCT00271544|536890266|FG000|Overall Study|Implant not attempted|4|||
148838744|NCT00907621|536890270|FG000|Overall Study|Lost to Follow-up|6|||
148838745|NCT00907621|536890271|FG001|Overall Study|Lost to Follow-up|3|||
148838746|NCT00907621|536890270|FG000|Overall Study|intercurrent febrile illness|1|||
148838747|NCT00907621|536890271|FG001|Overall Study|intercurrent febrile illness|1|||
148838748|NCT00902330|536890273|FG000|Overall Study|Too overwhelmed by treatment|2|||
148838749|NCT00902330|536890274|FG001|Overall Study|Too overwhelmed by treatment|5|||
148838750|NCT00902330|536890273|FG000|Overall Study|Adverse Event|1|||
148838751|NCT00902330|536890274|FG001|Overall Study|Adverse Event|0|||
148838752|NCT00902330|536890273|FG000|Overall Study|No post baseline data|1|||
148838753|NCT00902330|536890274|FG001|Overall Study|No post baseline data|0|||
148838754|NCT00165789|536890275|FG000|Overall Study|Adverse Event|0|||
148838755|NCT00165789|536890276|FG001|Overall Study|Adverse Event|3|||
148838756|NCT00165789|536890277|FG002|Overall Study|Adverse Event|0|||
148838757|NCT00165789|536890278|FG003|Overall Study|Adverse Event|12|||
148838758|NCT00165789|536890275|FG000|Overall Study|Withdrawal by Subject|0|||
148838759|NCT00165789|536890276|FG001|Overall Study|Withdrawal by Subject|1|||
148838760|NCT00165789|536890277|FG002|Overall Study|Withdrawal by Subject|1|||
148838761|NCT00165789|536890278|FG003|Overall Study|Withdrawal by Subject|2|||
148838762|NCT04290624|536890279|FG000|Overall Study|Adverse Event|1|||
148838763|NCT04290624|536890280|FG001|Overall Study|Adverse Event|0|||
148838764|NCT01847443|536890281|FG000|Study Period 1|Withdrawal by Subject|0|||
148838765|NCT01847443|536890282|FG001|Study Period 1|Withdrawal by Subject|1|||
148838766|NCT01847443|536890283|FG002|Study Period 1|Withdrawal by Subject|0|||
148838767|NCT01847443|536890284|FG003|Study Period 1|Withdrawal by Subject|0|||
148838768|NCT01847443|536890281|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
148838769|NCT01847443|536890282|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
148838770|NCT01847443|536890283|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
148838771|NCT01847443|536890284|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
148838772|NCT01847443|536890281|FG000|Washout Period Before Study Period 2|Other reason|1|||
148838773|NCT01847443|536890282|FG001|Washout Period Before Study Period 2|Other reason|0|||
148838774|NCT01847443|536890283|FG002|Washout Period Before Study Period 2|Other reason|0|||
148838775|NCT01847443|536890284|FG003|Washout Period Before Study Period 2|Other reason|0|||
148838776|NCT01847443|536890281|FG000|Washout Period Before Study Period 3|Other reason|1|||
148838777|NCT01847443|536890282|FG001|Washout Period Before Study Period 3|Other reason|0|||
148838778|NCT01847443|536890283|FG002|Washout Period Before Study Period 3|Other reason|0|||
148838779|NCT01847443|536890284|FG003|Washout Period Before Study Period 3|Other reason|0|||
148838780|NCT01847443|536890281|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
148838781|NCT01847443|536890282|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
148838782|NCT01847443|536890283|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
148838783|NCT01847443|536890284|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
148838784|NCT01847443|536890281|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
148838785|NCT01847443|536890282|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
148838786|NCT01847443|536890283|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
148838787|NCT01847443|536890284|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
148838788|NCT03571971|536890285|FG000|Overall Study|Lost to Follow-up|2|||
148838789|NCT03571971|536890286|FG001|Overall Study|Lost to Follow-up|2|||
148838790|NCT03571971|536890285|FG000|Overall Study|Protocol Violation|2|||
148838791|NCT03571971|536890286|FG001|Overall Study|Protocol Violation|3|||
148838792|NCT03571971|536890285|FG000|Overall Study|Withdrawal by Subject|2|||
148838793|NCT03571971|536890286|FG001|Overall Study|Withdrawal by Subject|0|||
148838794|NCT03571971|536890285|FG000|Overall Study|Incomplete primary outcome data|2|||
148838795|NCT03571971|536890286|FG001|Overall Study|Incomplete primary outcome data|0|||
148838796|NCT03247829|536891737|FG000|Overall Study|Death|3|||
148838797|NCT03247829|536891738|FG001|Overall Study|Death|4|||
148838798|NCT03247829|536891737|FG000|Overall Study|Enter Hospice Care|1|||
148838799|NCT03247829|536891738|FG001|Overall Study|Enter Hospice Care|0|||
148838800|NCT03247829|536891737|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
148838801|NCT03247829|536891738|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
148838802|NCT03247829|536891737|FG000|Overall Study|LVAD Explant|1|||
148838803|NCT03247829|536891738|FG001|Overall Study|LVAD Explant|1|||
148838804|NCT03247829|536891737|FG000|Overall Study|Transplant|1|||
148838805|NCT03247829|536891738|FG001|Overall Study|Transplant|1|||
148838806|NCT00272792|536891740|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
148838807|NCT00272792|536891741|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
148838808|NCT00272792|536891740|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
148838809|NCT00272792|536891741|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
148838810|NCT00272792|536891740|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
148838811|NCT00272792|536891741|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
148838812|NCT00272792|536891740|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
148838813|NCT00272792|536891741|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
148838814|NCT02332187|536891747|FG000|Overall Study|Withdrawal by Subject|2|||
148838815|NCT02332187|536891748|FG001|Overall Study|Withdrawal by Subject|2|||
148838816|NCT02332187|536891747|FG000|Overall Study|Adverse Event|0|||
148838817|NCT02332187|536891748|FG001|Overall Study|Adverse Event|1|||
148838818|NCT00457392|536891749|FG000|Overall Study|Objective Progression or Relapse|229|||
148838819|NCT00457392|536891750|FG001|Overall Study|Objective Progression or Relapse|296|||
148838820|NCT00457392|536891749|FG000|Overall Study|Death|106|||
148838821|NCT00457392|536891750|FG001|Overall Study|Death|106|||
148838822|NCT00457392|536891749|FG000|Overall Study|Adverse Event|84|||
148838823|NCT00457392|536891750|FG001|Overall Study|Adverse Event|41|||
148838824|NCT00457392|536891749|FG000|Overall Study|Global Deterioration of Health Status|22|||
148838825|NCT00457392|536891750|FG001|Overall Study|Global Deterioration of Health Status|8|||
148838826|NCT00457392|536891749|FG000|Overall Study|Withdrawal by Subject|14|||
148838827|NCT00457392|536891750|FG001|Overall Study|Withdrawal by Subject|8|||
148838828|NCT00457392|536891749|FG000|Overall Study|Lost to Follow-up|6|||
148838829|NCT00457392|536891750|FG001|Overall Study|Lost to Follow-up|7|||
148838830|NCT00457392|536891749|FG000|Overall Study|Protocol Violation|4|||
148838831|NCT00457392|536891750|FG001|Overall Study|Protocol Violation|3|||
148838832|NCT00457392|536891749|FG000|Overall Study|Other|7|||
148838833|NCT00457392|536891750|FG001|Overall Study|Other|4|||
148838834|NCT00457392|536891749|FG000|Overall Study|Study Terminated by Sponsor|1|||
148838835|NCT00457392|536891750|FG001|Overall Study|Study Terminated by Sponsor|4|||
148838836|NCT00457392|536891749|FG000|Overall Study|Randomized, Not Treated|7|||
148838837|NCT00457392|536891750|FG001|Overall Study|Randomized, Not Treated|3|||
148838838|NCT00980148|536891751|FG000|Overall Study|Discharged from facility|89|||
148838839|NCT00980148|536891752|FG001|Overall Study|Discharged from facility|96|||
148838840|NCT00980148|536891751|FG000|Overall Study|Received other antichlamydia treatment|20|||
148838841|NCT00980148|536891752|FG001|Overall Study|Received other antichlamydia treatment|14|||
148838842|NCT00980148|536891751|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
148838843|NCT00980148|536891752|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
148838844|NCT00980148|536891751|FG000|Overall Study|Various other reasons|8|||
148838845|NCT00980148|536891752|FG001|Overall Study|Various other reasons|9|||
148838846|NCT00925002|536891753|FG000|Overall Study|Other|1|||
148838847|NCT00925002|536891754|FG001|Overall Study|Other|4|||
148838848|NCT00925002|536891755|FG002|Overall Study|Other|0|||
148838849|NCT00925002|536891753|FG000|Overall Study|Death|1|||
148838850|NCT00925002|536891754|FG001|Overall Study|Death|1|||
148838851|NCT00925002|536891755|FG002|Overall Study|Death|5|||
148838852|NCT00925002|536891753|FG000|Overall Study|Adverse Event|3|||
148838853|NCT00925002|536891754|FG001|Overall Study|Adverse Event|1|||
148838854|NCT00925002|536891755|FG002|Overall Study|Adverse Event|2|||
148838855|NCT00925002|536891753|FG000|Overall Study|Participant withdrew consent|1|||
148838856|NCT00925002|536891754|FG001|Overall Study|Participant withdrew consent|3|||
148838857|NCT00925002|536891755|FG002|Overall Study|Participant withdrew consent|3|||
148838858|NCT00002766|536891756|FG000|Overall Study|Withdrawal by Subject|0|||
148838859|NCT00002766|536891757|FG001|Overall Study|Withdrawal by Subject|1|||
148838860|NCT00002766|536891756|FG000|Overall Study|Patient Not Treated|1|||
148838861|NCT00002766|536891757|FG001|Overall Study|Patient Not Treated|2|||
148838862|NCT00002766|536891756|FG000|Overall Study|Adverse Event|1|||
148838863|NCT00002766|536891757|FG001|Overall Study|Adverse Event|1|||
148838864|NCT00002766|536891756|FG000|Overall Study|Protocol Violation|1|||
148838865|NCT00002766|536891757|FG001|Overall Study|Protocol Violation|0|||
148838866|NCT00328172|536891760|FG000|Overall Study|Adverse Event|3|||
148838867|NCT00328172|536891761|FG001|Overall Study|Adverse Event|2|||
148838868|NCT00328172|536891762|FG002|Overall Study|Adverse Event|1|||
148838869|NCT00328172|536891763|FG003|Overall Study|Adverse Event|2|||
148838870|NCT00328172|536891764|FG004|Overall Study|Adverse Event|1|||
148838871|NCT00328172|536891760|FG000|Overall Study|Protocol Violation|0|||
148838872|NCT00328172|536891761|FG001|Overall Study|Protocol Violation|1|||
148838873|NCT00328172|536891762|FG002|Overall Study|Protocol Violation|1|||
148838874|NCT00328172|536891763|FG003|Overall Study|Protocol Violation|0|||
148838875|NCT00328172|536891764|FG004|Overall Study|Protocol Violation|0|||
148838876|NCT00328172|536891760|FG000|Overall Study|Lost to Follow-up|1|||
148838877|NCT00328172|536891761|FG001|Overall Study|Lost to Follow-up|1|||
148838878|NCT00328172|536891762|FG002|Overall Study|Lost to Follow-up|2|||
148838879|NCT00328172|536891763|FG003|Overall Study|Lost to Follow-up|1|||
148838880|NCT00328172|536891764|FG004|Overall Study|Lost to Follow-up|1|||
148838881|NCT00328172|536891760|FG000|Overall Study|Withdrawal by Subject|1|||
148838882|NCT00328172|536891761|FG001|Overall Study|Withdrawal by Subject|1|||
148838883|NCT00328172|536891762|FG002|Overall Study|Withdrawal by Subject|1|||
148838884|NCT00328172|536891763|FG003|Overall Study|Withdrawal by Subject|6|||
148838885|NCT00328172|536891764|FG004|Overall Study|Withdrawal by Subject|0|||
148838886|NCT00328172|536891760|FG000|Overall Study|Lack of Efficacy|14|||
148838887|NCT00328172|536891761|FG001|Overall Study|Lack of Efficacy|9|||
148838888|NCT00328172|536891762|FG002|Overall Study|Lack of Efficacy|4|||
148838889|NCT00328172|536891763|FG003|Overall Study|Lack of Efficacy|4|||
148838890|NCT00328172|536891764|FG004|Overall Study|Lack of Efficacy|3|||
148838891|NCT00328172|536891760|FG000|Overall Study|Other reason (not specified)|3|||
148838892|NCT00328172|536891761|FG001|Overall Study|Other reason (not specified)|0|||
148838893|NCT00328172|536891762|FG002|Overall Study|Other reason (not specified)|1|||
148838894|NCT00328172|536891763|FG003|Overall Study|Other reason (not specified)|0|||
148838895|NCT00328172|536891764|FG004|Overall Study|Other reason (not specified)|0|||
148838896|NCT03848416|536891767|FG000|Overall Study|Withdrawal by Subject|1|||
148838897|NCT03848416|536891768|FG001|Overall Study|Withdrawal by Subject|0|||
148838898|NCT03848416|536891769|FG002|Overall Study|Withdrawal by Subject|0|||
148838899|NCT03848416|536891767|FG000|Overall Study|Death|0|||
148838900|NCT03848416|536891768|FG001|Overall Study|Death|0|||
148838901|NCT03848416|536891769|FG002|Overall Study|Death|1|||
148838902|NCT00856609|536891774|FG000|Overall Study|Adverse Event|1|||
148838903|NCT00856609|536891775|FG001|Overall Study|Adverse Event|0|||
148838904|NCT00783432|536891776|FG000|Overall Study|Adverse Event|22|||
148838905|NCT00783432|536891777|FG001|Overall Study|Adverse Event|17|||
148838906|NCT00783432|536891776|FG000|Overall Study|Lack of Efficacy|20|||
148838907|NCT00783432|536891777|FG001|Overall Study|Lack of Efficacy|21|||
148838908|NCT00783432|536891776|FG000|Overall Study|Lost to Follow-up|11|||
148838909|NCT00783432|536891777|FG001|Overall Study|Lost to Follow-up|6|||
148838910|NCT00783432|536891776|FG000|Overall Study|Withdrawal by Subject|23|||
148838911|NCT00783432|536891777|FG001|Overall Study|Withdrawal by Subject|20|||
148838912|NCT00783432|536891776|FG000|Overall Study|subject moved|3|||
148838913|NCT00783432|536891777|FG001|Overall Study|subject moved|5|||
149029274|NCT02784704|537583883|FG001|Overall Study|Subject Non Compliance|0|||
148838914|NCT00783432|536891776|FG000|Overall Study|Protocol Violation|6|||
148838915|NCT00783432|536891777|FG001|Overall Study|Protocol Violation|9|||
148838916|NCT01436110|536891778|FG000|Overall Study|Lack of Efficacy|23|||
148838917|NCT01436110|536891779|FG001|Overall Study|Lack of Efficacy|14|||
148838918|NCT01436110|536891780|FG002|Overall Study|Lack of Efficacy|9|||
148838919|NCT01436110|536891778|FG000|Overall Study|Withdrawal by Subject|6|||
148838920|NCT01436110|536891779|FG001|Overall Study|Withdrawal by Subject|8|||
148838921|NCT01436110|536891780|FG002|Overall Study|Withdrawal by Subject|4|||
148838922|NCT01436110|536891778|FG000|Overall Study|Adverse Event|2|||
148838923|NCT01436110|536891779|FG001|Overall Study|Adverse Event|1|||
148838924|NCT01436110|536891780|FG002|Overall Study|Adverse Event|2|||
148838925|NCT01436110|536891778|FG000|Overall Study|Physician Decision|3|||
148838926|NCT01436110|536891779|FG001|Overall Study|Physician Decision|1|||
148838927|NCT01436110|536891780|FG002|Overall Study|Physician Decision|1|||
148838928|NCT01436110|536891778|FG000|Overall Study|Lost to Follow-up|1|||
148838929|NCT01436110|536891779|FG001|Overall Study|Lost to Follow-up|1|||
148838930|NCT01436110|536891780|FG002|Overall Study|Lost to Follow-up|3|||
148838931|NCT01436110|536891778|FG000|Overall Study|Protocol Violation|3|||
148838932|NCT01436110|536891779|FG001|Overall Study|Protocol Violation|1|||
148838933|NCT01436110|536891780|FG002|Overall Study|Protocol Violation|1|||
148838934|NCT01436110|536891778|FG000|Overall Study|Did Not Receive Trial Medication|1|||
148838935|NCT01436110|536891779|FG001|Overall Study|Did Not Receive Trial Medication|0|||
148838936|NCT01436110|536891780|FG002|Overall Study|Did Not Receive Trial Medication|3|||
148838937|NCT03273907|536891781|FG000|Overall Study|Death|1|||
148838938|NCT03273907|536891781|FG000|Overall Study|Lost to Follow-up|4|||
148838939|NCT03273907|536891781|FG000|Overall Study|Withdrawal by Subject|2|||
148838940|NCT03273907|536891781|FG000|Overall Study|COVID 19|2|||
148838941|NCT01088503|536891782|FG000|Overall Study|Withdrawal by Subject|118|||
148838942|NCT01088503|536891783|FG001|Overall Study|Withdrawal by Subject|327|||
148838943|NCT01088503|536891784|FG002|Overall Study|Withdrawal by Subject|10|||
148838944|NCT01088503|536891782|FG000|Overall Study|Death|64|||
148838945|NCT01088503|536891783|FG001|Overall Study|Death|358|||
148838946|NCT01088503|536891784|FG002|Overall Study|Death|7|||
148838947|NCT00110214|536891785|FG000|Overall Study|Never started treatment|21|||
148838948|NCT00110214|536891786|FG001|Overall Study|Never started treatment|20|||
148838949|NCT00110214|536891785|FG000|Overall Study|Disease progression or death|260|||
148838950|NCT00110214|536891786|FG001|Overall Study|Disease progression or death|151|||
148838951|NCT00110214|536891785|FG000|Overall Study|Adverse Event|115|||
148838952|NCT00110214|536891786|FG001|Overall Study|Adverse Event|192|||
148838953|NCT00110214|536891785|FG000|Overall Study|Refused further treatment|52|||
148838954|NCT00110214|536891786|FG001|Overall Study|Refused further treatment|65|||
148838955|NCT00110214|536891785|FG000|Overall Study|Other (not specified)|61|||
148838956|NCT00110214|536891786|FG001|Overall Study|Other (not specified)|75|||
148838957|NCT01847092|536891787|FG000|Overall Study|Adverse Event|12|||
148838958|NCT01847092|536891788|FG001|Overall Study|Adverse Event|3|||
148838959|NCT01847092|536891787|FG000|Overall Study|Withdrawal by Subject|5|||
148838960|NCT01847092|536891788|FG001|Overall Study|Withdrawal by Subject|5|||
148838961|NCT01847092|536891787|FG000|Overall Study|Protocol Specified|8|||
148838962|NCT01847092|536891788|FG001|Overall Study|Protocol Specified|0|||
148838963|NCT01847092|536891787|FG000|Overall Study|Physician Decision|1|||
148838964|NCT01847092|536891788|FG001|Overall Study|Physician Decision|1|||
148838965|NCT01847092|536891787|FG000|Overall Study|Protocol Violation|0|||
148838966|NCT01847092|536891788|FG001|Overall Study|Protocol Violation|2|||
148838967|NCT03604497|536891790|FG000|Overall Study|Protocol Violation|52|||
148838968|NCT01016067|536891791|FG000|Overall Study|Lost to Follow-up|1|||
148838969|NCT01016067|536891792|FG001|Overall Study|Lost to Follow-up|2|||
148838970|NCT01016067|536891791|FG000|Overall Study|Physician Decision|1|||
148838971|NCT01016067|536891792|FG001|Overall Study|Physician Decision|1|||
148838972|NCT01016067|536891791|FG000|Overall Study|Withdrew due to Relocation|0|||
148838973|NCT01016067|536891792|FG001|Overall Study|Withdrew due to Relocation|1|||
148838974|NCT01331681|536891794|FG000|Overall Study|Adverse Event|10|||
148838975|NCT01331681|536891795|FG001|Overall Study|Adverse Event|13|||
148838976|NCT01331681|536891796|FG002|Overall Study|Adverse Event|10|||
148838977|NCT01331681|536891794|FG000|Overall Study|Death|6|||
148838978|NCT01331681|536891795|FG001|Overall Study|Death|6|||
148838979|NCT01331681|536891796|FG002|Overall Study|Death|2|||
148838980|NCT01331681|536891794|FG000|Overall Study|Lack of Efficacy|0|||
148838981|NCT01331681|536891795|FG001|Overall Study|Lack of Efficacy|1|||
148838982|NCT01331681|536891796|FG002|Overall Study|Lack of Efficacy|0|||
148838983|NCT01331681|536891794|FG000|Overall Study|Withdrawal by Subject|12|||
148838984|NCT01331681|536891795|FG001|Overall Study|Withdrawal by Subject|8|||
148838985|NCT01331681|536891796|FG002|Overall Study|Withdrawal by Subject|15|||
148838986|NCT01331681|536891794|FG000|Overall Study|Protocol Violation|1|||
148838987|NCT01331681|536891795|FG001|Overall Study|Protocol Violation|1|||
148838988|NCT01331681|536891796|FG002|Overall Study|Protocol Violation|0|||
148838989|NCT01331681|536891794|FG000|Overall Study|Lost to Follow-up|2|||
148838990|NCT01331681|536891795|FG001|Overall Study|Lost to Follow-up|4|||
148838991|NCT01331681|536891796|FG002|Overall Study|Lost to Follow-up|1|||
148838992|NCT01331681|536891794|FG000|Overall Study|Physician Decision|2|||
148838993|NCT01331681|536891795|FG001|Overall Study|Physician Decision|0|||
148838994|NCT01331681|536891796|FG002|Overall Study|Physician Decision|4|||
148838995|NCT01331681|536891794|FG000|Overall Study|Therapeutic procedure required|1|||
148838996|NCT01331681|536891795|FG001|Overall Study|Therapeutic procedure required|0|||
148838997|NCT01331681|536891796|FG002|Overall Study|Therapeutic procedure required|0|||
148838998|NCT01331681|536891794|FG000|Overall Study|Sponsor decision|1|||
148838999|NCT01331681|536891795|FG001|Overall Study|Sponsor decision|1|||
148839000|NCT01331681|536891796|FG002|Overall Study|Sponsor decision|0|||
148839001|NCT01331681|536891794|FG000|Overall Study|Switching to other therapy|0|||
148839002|NCT01331681|536891795|FG001|Overall Study|Switching to other therapy|0|||
148839003|NCT01331681|536891796|FG002|Overall Study|Switching to other therapy|1|||
148839004|NCT01331681|536891794|FG000|Overall Study|Not Received Study Treatment|0|||
148839005|NCT01331681|536891795|FG001|Overall Study|Not Received Study Treatment|0|||
148889123|NCT05214768|537072367|FG003|Maintenance Period|Other Reasons|1|||
149029275|NCT01913340|537583884|FG000|Overall Study|Death|2|||
149029276|NCT01913340|537583885|FG001|Overall Study|Death|5|||
149029277|NCT01913340|537583884|FG000|Overall Study|Lost to Follow-up|1|||
149029278|NCT01913340|537583885|FG001|Overall Study|Lost to Follow-up|1|||
149029279|NCT01516892|537583887|FG000|Overall Study|Adverse Event|25|||
149029280|NCT01516892|537583887|FG000|Overall Study|Lack of Efficacy|35|||
149029281|NCT01516892|537583887|FG000|Overall Study|Pregnancy|5|||
149029282|NCT01516892|537583887|FG000|Overall Study|Lost to Follow-up|82|||
149029283|NCT01516892|537583887|FG000|Overall Study|Subject Withdrew Consent|92|||
149029284|NCT01516892|537583887|FG000|Overall Study|Protocol Violation|60|||
149029285|NCT01516892|537583887|FG000|Overall Study|Other Miscellaneous Reasons|43|||
149029286|NCT01516892|537583887|FG000|Overall Study|Missing|1|||
149029287|NCT04867902|537586490|FG000|Overall Study|Lost to Follow-up|1|||
149029288|NCT04867902|537586490|FG000|Overall Study|Withdrawal by Subject|2|||
148982589|NCT01172938|537415283|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982590|NCT01172938|537415284|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982591|NCT01172938|537415285|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982592|NCT01172938|537415286|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982593|NCT01172938|537415287|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982594|NCT01172938|537415288|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982595|NCT01172938|537415289|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
148982596|NCT01172938|537415290|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
148982597|NCT01033747|537415291|FG000|Overall Study|Adverse Event|9|||
148982598|NCT01033747|537415292|FG001|Overall Study|Adverse Event|4|||
148982599|NCT01033747|537415291|FG000|Overall Study|Abnormal Laboratory Value|1|||
149029289|NCT04867902|537586490|FG000|Overall Study|Protocol Violation|1|||
149029290|NCT05355116|537586491|FG000|Overall Study|Withdrawal by Subject|2|||
149029291|NCT02501629|537586492|FG000|Overall Study|Death|0|||
149029292|NCT02501629|537586493|FG001|Overall Study|Death|1|||
149029293|NCT02501629|537586492|FG000|Overall Study|Withdrawn from study by sponsor|1|||
149029294|NCT02501629|537586493|FG001|Overall Study|Withdrawn from study by sponsor|0|||
149029295|NCT02501629|537586492|FG000|Overall Study|Early termination by sponsor|1|||
149029296|NCT02501629|537586493|FG001|Overall Study|Early termination by sponsor|0|||
149029297|NCT02501629|537586492|FG000|Overall Study|Withdrawal by Subject|3|||
149029298|NCT02501629|537586493|FG001|Overall Study|Withdrawal by Subject|5|||
149029299|NCT02501629|537586492|FG000|Overall Study|Subject did not return to site|0|||
149029300|NCT02501629|537586493|FG001|Overall Study|Subject did not return to site|1|||
148982600|NCT01033747|537415292|FG001|Overall Study|Abnormal Laboratory Value|0|||
148982601|NCT01033747|537415291|FG000|Overall Study|Abnormal test procedure|0|||
148982602|NCT01033747|537415292|FG001|Overall Study|Abnormal test procedure|1|||
148982603|NCT01033747|537415291|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
148982604|NCT01033747|537415292|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
148982605|NCT01033747|537415291|FG000|Overall Study|Protocol Violation|1|||
148982606|NCT01033747|537415292|FG001|Overall Study|Protocol Violation|0|||
148982607|NCT01033747|537415291|FG000|Overall Study|Withdrawal by Subject|9|||
148982608|NCT01033747|537415292|FG001|Overall Study|Withdrawal by Subject|6|||
148982609|NCT01033747|537415291|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
148982610|NCT01033747|537415292|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
148982611|NCT01033747|537415291|FG000|Overall Study|Stopped at end of Extension 1|2|||
148982612|NCT01033747|537415292|FG001|Overall Study|Stopped at end of Extension 1|0|||
148982613|NCT02956629|537415293|FG000|Overall Study|Adverse Event|0|||
148982614|NCT02956629|537415294|FG001|Overall Study|Adverse Event|0|||
148982615|NCT02956629|537415295|FG002|Overall Study|Adverse Event|1|||
149029301|NCT00868231|537586496|FG000|Treatment Period 1|Adverse Event|0|||
148839006|NCT01331681|536891796|FG002|Overall Study|Not Received Study Treatment|2|||
148839007|NCT00658541|536891800|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
148839008|NCT00658541|536891801|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
148839009|NCT00658541|536891800|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
148839010|NCT00658541|536891801|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
148839011|NCT04828707|536891802|FG000|Overall Study|Lost to Follow-up|3|||
148839012|NCT04828707|536891803|FG001|Overall Study|Lost to Follow-up|2|||
148839013|NCT04828707|536891802|FG000|Overall Study|Withdrawal by Subject|2|||
148839014|NCT04828707|536891803|FG001|Overall Study|Withdrawal by Subject|1|||
148839015|NCT01188967|536891807|FG000|Overall Study|Withdrawal by Subject|1|||
148839016|NCT01188967|536891808|FG001|Overall Study|Withdrawal by Subject|1|||
148839017|NCT01188967|536891807|FG000|Overall Study|Physician Decision|1|||
148982616|NCT02956629|537415296|FG003|Overall Study|Adverse Event|0|||
148982617|NCT02956629|537415297|FG004|Overall Study|Adverse Event|0|||
148982618|NCT02956629|537415298|FG005|Overall Study|Adverse Event|0|||
149029302|NCT00868231|537586497|FG001|Treatment Period 1|Adverse Event|0|||
149029303|NCT00868231|537586498|FG002|Treatment Period 1|Adverse Event|0|||
149029304|NCT00868231|537586499|FG003|Treatment Period 1|Adverse Event|0|||
149029305|NCT00868231|537586500|FG004|Treatment Period 1|Adverse Event|1|||
148982619|NCT02956629|537415293|FG000|Overall Study|Lost to Follow-up|2|||
148982620|NCT02956629|537415294|FG001|Overall Study|Lost to Follow-up|5|||
148982621|NCT02956629|537415295|FG002|Overall Study|Lost to Follow-up|3|||
148839018|NCT01188967|536891808|FG001|Overall Study|Physician Decision|1|||
148839019|NCT01188967|536891807|FG000|Overall Study|Lost to Follow-up|3|||
148839020|NCT01188967|536891808|FG001|Overall Study|Lost to Follow-up|2|||
148839021|NCT00523978|536891811|FG000|Overall Study|Withdrawal by Subject|3|||
148839022|NCT00523978|536891812|FG001|Overall Study|Withdrawal by Subject|7|||
148839023|NCT00523978|536891811|FG000|Overall Study|Screen Failures|5|||
148839024|NCT00523978|536891812|FG001|Overall Study|Screen Failures|1|||
148839025|NCT00523978|536891811|FG000|Overall Study|Death|1|||
148839026|NCT00523978|536891812|FG001|Overall Study|Death|0|||
148839027|NCT00461708|536891813|FG000|Overall Study|Adverse Event|17|||
148839028|NCT00461708|536891814|FG001|Overall Study|Adverse Event|7|||
148839029|NCT00461708|536891813|FG000|Overall Study|Lack of Efficacy|68|||
148839030|NCT00461708|536891814|FG001|Overall Study|Lack of Efficacy|20|||
148839031|NCT00461708|536891813|FG000|Overall Study|Physician Decision|10|||
148839032|NCT00461708|536891814|FG001|Overall Study|Physician Decision|4|||
148839033|NCT00461708|536891813|FG000|Overall Study|Withdrawal by Subject|8|||
148839034|NCT00461708|536891814|FG001|Overall Study|Withdrawal by Subject|2|||
148839035|NCT00461708|536891813|FG000|Overall Study|Other|4|||
148839036|NCT00461708|536891814|FG001|Overall Study|Other|4|||
148839037|NCT00461708|536891813|FG000|Overall Study|Death|8|||
148839038|NCT00461708|536891814|FG001|Overall Study|Death|1|||
148839039|NCT00501644|536891815|FG000|Overall Study|Adverse Event|4|||
148839040|NCT00501644|536891815|FG000|Overall Study|Withdrawal by Subject|1|||
148839041|NCT02394561|536891816|FG000|CORE Phase|Adverse Event|7|||
148839042|NCT02394561|536891817|FG001|CORE Phase|Adverse Event|9|||
148839043|NCT02394561|536891816|FG000|CORE Phase|Death|0|||
148839044|NCT02394561|536891817|FG001|CORE Phase|Death|1|||
148839045|NCT02394561|536891816|FG000|CORE Phase|Pregnancy|1|||
148839046|NCT02394561|536891817|FG001|CORE Phase|Pregnancy|0|||
148839047|NCT02394561|536891816|FG000|CORE Phase|Lost to Follow-up|1|||
148839048|NCT02394561|536891817|FG001|CORE Phase|Lost to Follow-up|0|||
148839049|NCT02394561|536891816|FG000|CORE Phase|Physician Decision|1|||
148839050|NCT02394561|536891817|FG001|CORE Phase|Physician Decision|1|||
148839051|NCT02394561|536891816|FG000|CORE Phase|Withdrawal by Subject|2|||
148839052|NCT02394561|536891817|FG001|CORE Phase|Withdrawal by Subject|2|||
148839053|NCT02394561|536891816|FG000|CORE Phase|Lack of Efficacy|1|||
148839054|NCT02394561|536891817|FG001|CORE Phase|Lack of Efficacy|6|||
148839055|NCT02394561|536891816|FG000|Extension Phase|Adverse Event|6|||
148839056|NCT02394561|536891817|FG001|Extension Phase|Adverse Event|1|||
148839057|NCT02394561|536891816|FG000|Extension Phase|Death|0|||
148839058|NCT02394561|536891817|FG001|Extension Phase|Death|1|||
148839059|NCT02394561|536891816|FG000|Extension Phase|Protocol Violation|1|||
148839060|NCT02394561|536891817|FG001|Extension Phase|Protocol Violation|0|||
148839061|NCT02394561|536891816|FG000|Extension Phase|Lost to Follow-up|1|||
148839062|NCT02394561|536891817|FG001|Extension Phase|Lost to Follow-up|0|||
148839063|NCT02394561|536891816|FG000|Extension Phase|Physician Decision|0|||
148839064|NCT02394561|536891817|FG001|Extension Phase|Physician Decision|2|||
148839065|NCT02394561|536891816|FG000|Extension Phase|Withdrawal by Subject|0|||
148839066|NCT02394561|536891817|FG001|Extension Phase|Withdrawal by Subject|5|||
148839067|NCT02394561|536891816|FG000|Extension Phase|Lack of Efficacy|3|||
148839068|NCT02394561|536891817|FG001|Extension Phase|Lack of Efficacy|3|||
148839069|NCT02553629|536891818|FG000|Overall Study|Logistic reasons|3|||
148839070|NCT02553629|536891819|FG001|Overall Study|Logistic reasons|6|||
148839071|NCT03434834|536891820|FG000|Overall Study|unable to swallow OCT probe|16|||
148839072|NCT04577781|536891824|FG000|Overall Study|Adverse Event|2|||
148839073|NCT04577781|536891825|FG001|Overall Study|Adverse Event|2|||
148839074|NCT04577781|536891824|FG000|Overall Study|Physician Decision|1|||
148982622|NCT02956629|537415296|FG003|Overall Study|Lost to Follow-up|1|||
148982623|NCT02956629|537415297|FG004|Overall Study|Lost to Follow-up|0|||
148982624|NCT02956629|537415298|FG005|Overall Study|Lost to Follow-up|1|||
148982625|NCT02956629|537415293|FG000|Overall Study|Withdrawal by Subject|3|||
148982626|NCT02956629|537415294|FG001|Overall Study|Withdrawal by Subject|1|||
148982627|NCT02956629|537415295|FG002|Overall Study|Withdrawal by Subject|0|||
148982628|NCT02956629|537415296|FG003|Overall Study|Withdrawal by Subject|0|||
148839075|NCT04577781|536891825|FG001|Overall Study|Physician Decision|0|||
148839076|NCT01657305|536891828|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
148839077|NCT01657305|536891828|FG000|Overall Study|Withdrawal by Subject|4|||
148839078|NCT01657305|536891828|FG000|Overall Study|Adverse Event|1|||
148982629|NCT02956629|537415297|FG004|Overall Study|Withdrawal by Subject|0|||
148982630|NCT02956629|537415298|FG005|Overall Study|Withdrawal by Subject|0|||
148839079|NCT01657305|536891828|FG000|Overall Study|Lost to Follow-up|1|||
148839080|NCT01657305|536891828|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
148839081|NCT04103450|536891831|FG000|Overall Study|Adverse Event|4|||
148982631|NCT00003498|537415299|FG000|Overall Study|Not evaluable.|4|||
148982632|NCT02647658|537415303|FG000|Overall Study|Consent refusal|15|||
148982633|NCT02647658|537415304|FG001|Overall Study|Consent refusal|24|||
148839082|NCT04103450|536891832|FG001|Overall Study|Adverse Event|2|||
148839083|NCT04103450|536891831|FG000|Overall Study|Lack of Efficacy|3|||
148839084|NCT04103450|536891832|FG001|Overall Study|Lack of Efficacy|0|||
148839085|NCT04103450|536891831|FG000|Overall Study|Withdrawal by Subject|5|||
148839086|NCT04103450|536891832|FG001|Overall Study|Withdrawal by Subject|3|||
148839087|NCT04103450|536891831|FG000|Overall Study|Lost to Follow-up|1|||
148839088|NCT04103450|536891832|FG001|Overall Study|Lost to Follow-up|2|||
148839089|NCT04103450|536891831|FG000|Overall Study|Physician Decision|1|||
148839090|NCT04103450|536891832|FG001|Overall Study|Physician Decision|2|||
148839091|NCT04103450|536891831|FG000|Overall Study|Protocol Violation|1|||
148839092|NCT04103450|536891832|FG001|Overall Study|Protocol Violation|0|||
148839093|NCT04103450|536891831|FG000|Overall Study|Other|1|||
148839094|NCT04103450|536891832|FG001|Overall Study|Other|1|||
148839095|NCT00696878|536891833|FG000|Overall Study|Adverse Event|8|||
148839096|NCT00696878|536891833|FG000|Overall Study|Withdrawal by Subject|87|||
148839097|NCT00696878|536891833|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
148839098|NCT00696878|536891833|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
148839099|NCT00696878|536891833|FG000|Overall Study|Trial stopped|32|||
148839100|NCT00696878|536891833|FG000|Overall Study|Other reason (not specified)|55|||
148839101|NCT02259114|536891834|FG000|Overall Study|Progressive Disease|14|||
148839102|NCT02259114|536891835|FG001|Overall Study|Progressive Disease|2|||
148839103|NCT02259114|536891836|FG002|Overall Study|Progressive Disease|10|||
148839104|NCT02259114|536891837|FG003|Overall Study|Progressive Disease|2|||
148839105|NCT02259114|536891838|FG004|Overall Study|Progressive Disease|5|||
148839106|NCT02259114|536891834|FG000|Overall Study|Adverse Event|2|||
148839107|NCT02259114|536891835|FG001|Overall Study|Adverse Event|1|||
148839108|NCT02259114|536891836|FG002|Overall Study|Adverse Event|0|||
148839109|NCT02259114|536891837|FG003|Overall Study|Adverse Event|0|||
148839110|NCT02259114|536891838|FG004|Overall Study|Adverse Event|1|||
148839111|NCT02259114|536891834|FG000|Overall Study|Death|3|||
148839112|NCT02259114|536891835|FG001|Overall Study|Death|0|||
148839113|NCT02259114|536891836|FG002|Overall Study|Death|1|||
148839114|NCT02259114|536891837|FG003|Overall Study|Death|0|||
148839115|NCT02259114|536891838|FG004|Overall Study|Death|0|||
148839116|NCT02259114|536891834|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
148839117|NCT02259114|536891835|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
148839118|NCT02259114|536891836|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
148839119|NCT02259114|536891837|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
148839120|NCT02259114|536891838|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
148839121|NCT02259114|536891834|FG000|Overall Study|Withdrawal by Subject|0|||
148839122|NCT02259114|536891835|FG001|Overall Study|Withdrawal by Subject|0|||
148839123|NCT02259114|536891836|FG002|Overall Study|Withdrawal by Subject|1|||
148839124|NCT02259114|536891837|FG003|Overall Study|Withdrawal by Subject|1|||
148839125|NCT02259114|536891838|FG004|Overall Study|Withdrawal by Subject|0|||
148839126|NCT02259114|536891834|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
148839127|NCT02259114|536891835|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
148839128|NCT02259114|536891836|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
148839129|NCT02259114|536891837|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
148839130|NCT02259114|536891838|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
148839131|NCT02259114|536891834|FG000|Overall Study|Not Treated|1|||
148839132|NCT02259114|536891835|FG001|Overall Study|Not Treated|0|||
148839133|NCT02259114|536891836|FG002|Overall Study|Not Treated|0|||
148839134|NCT02259114|536891837|FG003|Overall Study|Not Treated|0|||
148839135|NCT02259114|536891838|FG004|Overall Study|Not Treated|0|||
148839136|NCT03937479|536891839|FG000|Overall Study|Adverse Event|2|||
148839137|NCT03937479|536891840|FG001|Overall Study|Adverse Event|3|||
148839138|NCT03937479|536891841|FG002|Overall Study|Adverse Event|0|||
148839139|NCT03937479|536891842|FG003|Overall Study|Adverse Event|0|||
148839140|NCT03937479|536891843|FG004|Overall Study|Adverse Event|1|||
148839141|NCT03937479|536891839|FG000|Overall Study|Withdrawal by Subject|3|||
148839142|NCT03937479|536891840|FG001|Overall Study|Withdrawal by Subject|5|||
148839143|NCT03937479|536891841|FG002|Overall Study|Withdrawal by Subject|2|||
148839144|NCT03937479|536891842|FG003|Overall Study|Withdrawal by Subject|2|||
148839145|NCT03937479|536891843|FG004|Overall Study|Withdrawal by Subject|1|||
148839146|NCT03937479|536891839|FG000|Overall Study|Protocol Violation|5|||
148839147|NCT03937479|536891840|FG001|Overall Study|Protocol Violation|6|||
148839148|NCT03937479|536891841|FG002|Overall Study|Protocol Violation|4|||
148839149|NCT03937479|536891842|FG003|Overall Study|Protocol Violation|3|||
148839150|NCT03937479|536891843|FG004|Overall Study|Protocol Violation|2|||
148839151|NCT03937479|536891839|FG000|Overall Study|Lost to Follow-up|0|||
148839152|NCT03937479|536891840|FG001|Overall Study|Lost to Follow-up|1|||
148839153|NCT03937479|536891841|FG002|Overall Study|Lost to Follow-up|0|||
148839154|NCT03937479|536891842|FG003|Overall Study|Lost to Follow-up|1|||
148839155|NCT03937479|536891843|FG004|Overall Study|Lost to Follow-up|0|||
148839156|NCT03937479|536891839|FG000|Overall Study|Physician Decision|0|||
148839157|NCT03937479|536891840|FG001|Overall Study|Physician Decision|0|||
148982634|NCT00803023|537415309|FG000|Overall Study|Adverse Event|5|||
148839158|NCT03937479|536891841|FG002|Overall Study|Physician Decision|1|||
148839159|NCT03937479|536891842|FG003|Overall Study|Physician Decision|0|||
148839160|NCT03937479|536891843|FG004|Overall Study|Physician Decision|1|||
148839161|NCT00940602|536891849|FG000|Overall Study|Administrative problems|1|||
148839162|NCT00940602|536891850|FG001|Overall Study|Administrative problems|1|||
148839163|NCT00940602|536891849|FG000|Overall Study|Patient/guardian decision|13|||
148839164|NCT00940602|536891850|FG001|Overall Study|Patient/guardian decision|28|||
148839165|NCT00940602|536891849|FG000|Overall Study|Physician Decision|8|||
148839166|NCT00940602|536891850|FG001|Overall Study|Physician Decision|5|||
148839167|NCT00940602|536891849|FG000|Overall Study|Pregnancy|1|||
148839168|NCT00940602|536891850|FG001|Overall Study|Pregnancy|0|||
148839169|NCT00940602|536891849|FG000|Overall Study|Protocol Deviation (untreated)|1|||
148839170|NCT00940602|536891850|FG001|Overall Study|Protocol Deviation (untreated)|0|||
148839171|NCT00940602|536891849|FG000|Overall Study|Disease progression|8|||
148839172|NCT00940602|536891850|FG001|Overall Study|Disease progression|2|||
148839173|NCT00940602|536891849|FG000|Overall Study|Death|38|||
148839174|NCT00940602|536891850|FG001|Overall Study|Death|19|||
148839175|NCT00940602|536891849|FG000|Overall Study|Lost to Follow-up|3|||
148839176|NCT00940602|536891850|FG001|Overall Study|Lost to Follow-up|1|||
148839177|NCT00940602|536891849|FG000|Overall Study|Patient withdrew consent|26|||
148839178|NCT00940602|536891850|FG001|Overall Study|Patient withdrew consent|13|||
148839179|NCT00940602|536891849|FG000|Overall Study|Adverse Event|7|||
148839180|NCT00940602|536891850|FG001|Overall Study|Adverse Event|2|||
148839181|NCT00940602|536891849|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
148839182|NCT00940602|536891850|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
148839183|NCT01378117|536891851|FG000|Overall Study|withdrawal|2|||
148839184|NCT01378117|536891852|FG001|Overall Study|withdrawal|1|||
148839185|NCT01378117|536891853|FG002|Overall Study|withdrawal|2|||
148839186|NCT01378117|536891851|FG000|Overall Study|discharged before med given|2|||
148839187|NCT01378117|536891852|FG001|Overall Study|discharged before med given|0|||
148839188|NCT01378117|536891853|FG002|Overall Study|discharged before med given|1|||
148839189|NCT01463033|536891855|FG000|Overall Study|Lost to Follow-up|4|||
148839190|NCT01463033|536891856|FG001|Overall Study|Lost to Follow-up|4|||
148839191|NCT01463033|536891855|FG000|Overall Study|Death|3|||
148839192|NCT01463033|536891856|FG001|Overall Study|Death|2|||
148839193|NCT00244621|536891861|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
148839194|NCT00244621|536891862|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
148839195|NCT00244621|536891863|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
148839196|NCT00244621|536891861|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
148839197|NCT00244621|536891862|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
148839198|NCT00244621|536891863|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
148839199|NCT00244621|536891861|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
148839200|NCT00244621|536891862|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
148839201|NCT00244621|536891863|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
148839202|NCT00244621|536891861|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
148839203|NCT00244621|536891862|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
148839204|NCT00244621|536891863|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
148839205|NCT00244621|536891861|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
148839206|NCT00244621|536891862|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
148839207|NCT00244621|536891863|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
148839208|NCT00244621|536891861|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
148839209|NCT00244621|536891862|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
148839210|NCT00244621|536891863|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
148839211|NCT00244621|536891861|FG000|Open-label Treatment Period|Adverse Event|0|||
148839212|NCT00244621|536891862|FG001|Open-label Treatment Period|Adverse Event|0|||
148839213|NCT00244621|536891863|FG002|Open-label Treatment Period|Adverse Event|1|||
148839214|NCT00244621|536891861|FG000|Open-label Treatment Period|Moved abroad|0|||
148839215|NCT00244621|536891862|FG001|Open-label Treatment Period|Moved abroad|0|||
148839216|NCT00244621|536891863|FG002|Open-label Treatment Period|Moved abroad|1|||
148839217|NCT01847755|536891864|FG000|Overall Study|Adverse Event|2|||
148839218|NCT01847755|536891864|FG000|Overall Study|Withdrawal by Subject|2|||
148839219|NCT01847755|536891864|FG000|Overall Study|Physician Decision|1|||
148839220|NCT01193101|536891870|FG000|Overall Study|Adverse Event|0|||
148982635|NCT00803023|537415310|FG001|Overall Study|Adverse Event|4|||
148982636|NCT00803023|537415311|FG002|Overall Study|Adverse Event|8|||
148982637|NCT00803023|537415312|FG003|Overall Study|Adverse Event|6|||
148982638|NCT00803023|537415309|FG000|Overall Study|Withdrawal by Subject|0|||
148982639|NCT00803023|537415310|FG001|Overall Study|Withdrawal by Subject|2|||
148982640|NCT00803023|537415311|FG002|Overall Study|Withdrawal by Subject|0|||
148982641|NCT00803023|537415312|FG003|Overall Study|Withdrawal by Subject|0|||
148982642|NCT00803023|537415309|FG000|Overall Study|Lost to Follow-up|0|||
148982643|NCT00803023|537415310|FG001|Overall Study|Lost to Follow-up|1|||
148982644|NCT00803023|537415311|FG002|Overall Study|Lost to Follow-up|2|||
148839221|NCT01193101|536891871|FG001|Overall Study|Adverse Event|1|||
148839222|NCT01193101|536891872|FG002|Overall Study|Adverse Event|1|||
148839223|NCT01193101|536891873|FG003|Overall Study|Adverse Event|3|||
148839224|NCT01193101|536891870|FG000|Overall Study|Lack of Efficacy|3|||
148839225|NCT01193101|536891871|FG001|Overall Study|Lack of Efficacy|1|||
148839226|NCT01193101|536891872|FG002|Overall Study|Lack of Efficacy|0|||
148839227|NCT01193101|536891873|FG003|Overall Study|Lack of Efficacy|8|||
148839228|NCT01193101|536891870|FG000|Overall Study|Withdrawal by Subject|2|||
148839229|NCT01193101|536891871|FG001|Overall Study|Withdrawal by Subject|4|||
148839230|NCT01193101|536891872|FG002|Overall Study|Withdrawal by Subject|1|||
148839231|NCT01193101|536891873|FG003|Overall Study|Withdrawal by Subject|1|||
148839232|NCT01193101|536891870|FG000|Overall Study|Administrative problems|0|||
148839233|NCT01193101|536891871|FG001|Overall Study|Administrative problems|0|||
148839234|NCT01193101|536891872|FG002|Overall Study|Administrative problems|1|||
148839235|NCT01193101|536891873|FG003|Overall Study|Administrative problems|0|||
148839236|NCT01193101|536891870|FG000|Overall Study|Abnormal test procedure results|0|||
148839237|NCT01193101|536891871|FG001|Overall Study|Abnormal test procedure results|1|||
148839238|NCT01193101|536891872|FG002|Overall Study|Abnormal test procedure results|0|||
148839239|NCT01193101|536891873|FG003|Overall Study|Abnormal test procedure results|0|||
148839240|NCT02347085|536891874|FG000|Overall Study|Adverse Event|2|||
148839241|NCT02347085|536891874|FG000|Overall Study|Lack of Efficacy|1|||
148839242|NCT02347085|536891874|FG000|Overall Study|Withdrawal by Subject|4|||
148839243|NCT02347085|536891874|FG000|Overall Study|Lost to Follow-up|1|||
148839244|NCT02347085|536891874|FG000|Overall Study|Protocol Criteria|2|||
148839245|NCT00114127|536891878|FG000|Overall Study|Adverse Event|2|||
148839246|NCT00114127|536891879|FG001|Overall Study|Adverse Event|1|||
148839247|NCT00114127|536891878|FG000|Overall Study|Lost to Follow-up|1|||
148839248|NCT00114127|536891879|FG001|Overall Study|Lost to Follow-up|0|||
148982645|NCT00803023|537415312|FG003|Overall Study|Lost to Follow-up|1|||
148982646|NCT00803023|537415309|FG000|Overall Study|Lack of Efficacy|0|||
148982647|NCT00803023|537415310|FG001|Overall Study|Lack of Efficacy|1|||
148982648|NCT00803023|537415311|FG002|Overall Study|Lack of Efficacy|1|||
148982649|NCT00803023|537415312|FG003|Overall Study|Lack of Efficacy|1|||
148839249|NCT00114127|536891878|FG000|Overall Study|Withdrawal by Subject|1|||
148839250|NCT00114127|536891879|FG001|Overall Study|Withdrawal by Subject|3|||
148839251|NCT03188263|536891880|FG000|Overall Study|Withdrawal by Subject|3|||
148839252|NCT03188263|536891881|FG001|Overall Study|Withdrawal by Subject|0|||
148839253|NCT03188263|536891880|FG000|Overall Study|Physician Decision|1|||
148839254|NCT03188263|536891881|FG001|Overall Study|Physician Decision|0|||
148839255|NCT02779777|536891882|FG000|Overall Study|Disease Progression|1|||
148839256|NCT02779777|536891883|FG001|Overall Study|Disease Progression|0|||
148839257|NCT02779777|536891884|FG002|Overall Study|Disease Progression|0|||
148839258|NCT02779777|536891882|FG000|Overall Study|Adverse Event|3|||
148839259|NCT02779777|536891883|FG001|Overall Study|Adverse Event|1|||
148839260|NCT02779777|536891884|FG002|Overall Study|Adverse Event|0|||
148839261|NCT02779777|536891882|FG000|Overall Study|Physician Decision|9|||
148839262|NCT02779777|536891883|FG001|Overall Study|Physician Decision|0|||
148839263|NCT02779777|536891884|FG002|Overall Study|Physician Decision|1|||
148839264|NCT02779777|536891882|FG000|Overall Study|Withdrawal by Subject|1|||
148839265|NCT02779777|536891883|FG001|Overall Study|Withdrawal by Subject|0|||
148839266|NCT02779777|536891884|FG002|Overall Study|Withdrawal by Subject|0|||
148839267|NCT02103062|536891889|FG000|Overall Study|Adverse Event|1|||
148839268|NCT02103062|536891890|FG001|Overall Study|Adverse Event|2|||
148839269|NCT02103062|536891889|FG000|Overall Study|Progressive Disease|17|||
148839270|NCT02103062|536891890|FG001|Overall Study|Progressive Disease|20|||
148839271|NCT02103062|536891889|FG000|Overall Study|Death|0|||
148839272|NCT02103062|536891890|FG001|Overall Study|Death|1|||
148839273|NCT01182298|536891891|FG000|Overall Study|Lack of Efficacy|4|||
148839274|NCT01182298|536891891|FG000|Overall Study|Withdrawal by Subject|2|||
148839275|NCT03391882|536891892|FG000|Study Overall|Adverse Event|3|||
148839276|NCT03391882|536891893|FG001|Study Overall|Adverse Event|6|||
148839277|NCT03391882|536891894|FG002|Study Overall|Adverse Event|1|||
148839278|NCT03391882|536891895|FG003|Study Overall|Adverse Event|1|||
148839279|NCT03391882|536891896|FG004|Study Overall|Adverse Event|3|||
148839280|NCT03391882|536891897|FG005|Study Overall|Adverse Event|1|||
148839281|NCT03391882|536891892|FG000|Study Overall|Lack of Efficacy|13|||
148839282|NCT03391882|536891893|FG001|Study Overall|Lack of Efficacy|9|||
148839283|NCT03391882|536891894|FG002|Study Overall|Lack of Efficacy|0|||
148839284|NCT03391882|536891895|FG003|Study Overall|Lack of Efficacy|0|||
148839285|NCT03391882|536891896|FG004|Study Overall|Lack of Efficacy|0|||
148839286|NCT03391882|536891897|FG005|Study Overall|Lack of Efficacy|0|||
148839287|NCT03391882|536891892|FG000|Study Overall|Withdrawal by Subject|3|||
148839288|NCT03391882|536891893|FG001|Study Overall|Withdrawal by Subject|3|||
148839289|NCT03391882|536891894|FG002|Study Overall|Withdrawal by Subject|2|||
148839290|NCT03391882|536891895|FG003|Study Overall|Withdrawal by Subject|2|||
148839291|NCT03391882|536891896|FG004|Study Overall|Withdrawal by Subject|1|||
148839292|NCT03391882|536891897|FG005|Study Overall|Withdrawal by Subject|3|||
148839293|NCT03391882|536891892|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
148839294|NCT03391882|536891893|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
148839295|NCT03391882|536891894|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
148839296|NCT03391882|536891895|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
148839297|NCT03391882|536891896|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
148839298|NCT03391882|536891897|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
148839299|NCT03391882|536891892|FG000|Study Overall|Protocol Violation|1|||
148839300|NCT03391882|536891893|FG001|Study Overall|Protocol Violation|0|||
148839301|NCT03391882|536891894|FG002|Study Overall|Protocol Violation|0|||
148839302|NCT03391882|536891895|FG003|Study Overall|Protocol Violation|0|||
148839303|NCT03391882|536891896|FG004|Study Overall|Protocol Violation|0|||
148839304|NCT03391882|536891897|FG005|Study Overall|Protocol Violation|0|||
148839305|NCT03391882|536891892|FG000|Part A - Titration Phase|Adverse Event|3|||
148839306|NCT03391882|536891893|FG001|Part A - Titration Phase|Adverse Event|6|||
148839307|NCT03391882|536891894|FG002|Part A - Titration Phase|Adverse Event|0|||
148839308|NCT03391882|536891895|FG003|Part A - Titration Phase|Adverse Event|0|||
148839309|NCT03391882|536891896|FG004|Part A - Titration Phase|Adverse Event|0|||
148839310|NCT03391882|536891897|FG005|Part A - Titration Phase|Adverse Event|0|||
148839311|NCT03391882|536891892|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
148839312|NCT03391882|536891893|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
148839313|NCT03391882|536891894|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
148839314|NCT03391882|536891895|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
148839315|NCT03391882|536891896|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
148839316|NCT03391882|536891897|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
148839317|NCT03391882|536891892|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
148839318|NCT03391882|536891893|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
148839319|NCT03391882|536891894|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
148839320|NCT03391882|536891895|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
148839321|NCT03391882|536891896|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
148839322|NCT03391882|536891897|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
148839323|NCT03391882|536891892|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
148839324|NCT03391882|536891893|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
148839325|NCT03391882|536891894|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
148839326|NCT03391882|536891895|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
148839327|NCT03391882|536891896|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
148839328|NCT03391882|536891897|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
148839329|NCT03391882|536891892|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
148839330|NCT03391882|536891893|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
148839331|NCT03391882|536891894|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
148839332|NCT03391882|536891895|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
148839333|NCT03391882|536891896|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
148839334|NCT03391882|536891897|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
148839335|NCT03391882|536891892|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
148839336|NCT03391882|536891893|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
148839337|NCT03391882|536891894|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
148839338|NCT03391882|536891895|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
148839339|NCT03391882|536891896|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
148839340|NCT03391882|536891897|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
148839341|NCT03391882|536891892|FG000|Part B - Treatment Phase|Adverse Event|0|||
148839342|NCT03391882|536891893|FG001|Part B - Treatment Phase|Adverse Event|0|||
148839343|NCT03391882|536891894|FG002|Part B - Treatment Phase|Adverse Event|1|||
148839344|NCT03391882|536891895|FG003|Part B - Treatment Phase|Adverse Event|1|||
148839345|NCT03391882|536891896|FG004|Part B - Treatment Phase|Adverse Event|3|||
148839346|NCT03391882|536891897|FG005|Part B - Treatment Phase|Adverse Event|1|||
148839347|NCT03391882|536891892|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
148839348|NCT03391882|536891893|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
148839349|NCT03391882|536891894|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
148839350|NCT03391882|536891895|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
148839351|NCT03391882|536891896|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
148839352|NCT03391882|536891897|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
148839353|NCT01280968|536891898|FG000|Overall Study|Lost to Follow-up|8|||
148839354|NCT01280968|536891899|FG001|Overall Study|Lost to Follow-up|2|||
148839355|NCT01280968|536891898|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
148839356|NCT01280968|536891899|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
148839357|NCT01280968|536891898|FG000|Overall Study|Commuting Problems|2|||
148839358|NCT01280968|536891899|FG001|Overall Study|Commuting Problems|0|||
148839359|NCT01280968|536891898|FG000|Overall Study|Anxiety|2|||
148839360|NCT01280968|536891899|FG001|Overall Study|Anxiety|0|||
148839361|NCT01280968|536891898|FG000|Overall Study|Adverse Event|1|||
148839362|NCT01280968|536891899|FG001|Overall Study|Adverse Event|0|||
148839363|NCT01280968|536891898|FG000|Overall Study|Scheduling Conflicts|1|||
148982650|NCT01542528|537415313|FG000|Overall Study|Lost to Follow-up|2|||
148982651|NCT01542528|537415314|FG001|Overall Study|Lost to Follow-up|1|||
148982652|NCT01542528|537415313|FG000|Overall Study|Physician Decision|1|||
148982653|NCT01542528|537415314|FG001|Overall Study|Physician Decision|0|||
148839364|NCT01280968|536891899|FG001|Overall Study|Scheduling Conflicts|1|||
148839365|NCT01280968|536891898|FG000|Overall Study|Pre-existing Neurological Condition|1|||
148839366|NCT01280968|536891899|FG001|Overall Study|Pre-existing Neurological Condition|0|||
148839367|NCT01280968|536891898|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
148839368|NCT01280968|536891899|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
148839369|NCT00038948|536891900|FG000|Overall Study|Adverse Event|131|||
148839370|NCT00038948|536891901|FG001|Overall Study|Adverse Event|43|||
149029306|NCT00868231|537586501|FG005|Treatment Period 1|Adverse Event|0|||
148839371|NCT00038948|536891900|FG000|Overall Study|Lost to Follow-up|4|||
148839372|NCT00038948|536891901|FG001|Overall Study|Lost to Follow-up|4|||
148839373|NCT00038948|536891900|FG000|Overall Study|Nonmedical event|5|||
148839374|NCT00038948|536891901|FG001|Overall Study|Nonmedical event|7|||
148839375|NCT00038948|536891900|FG000|Overall Study|Withdrawal by Subject|23|||
148839376|NCT00038948|536891901|FG001|Overall Study|Withdrawal by Subject|10|||
148839377|NCT00038948|536891900|FG000|Overall Study|Protocol Violation|3|||
148839378|NCT00038948|536891901|FG001|Overall Study|Protocol Violation|7|||
148839379|NCT00038948|536891900|FG000|Overall Study|Lack of Efficacy|3|||
148839380|NCT00038948|536891901|FG001|Overall Study|Lack of Efficacy|6|||
148839381|NCT01783444|536893822|FG000|Treatment Phase|Adverse Event|9|||
148839382|NCT01783444|536893823|FG001|Treatment Phase|Adverse Event|20|||
148839383|NCT01783444|536893824|FG002|Treatment Phase|Adverse Event|19|||
148839384|NCT01783444|536893822|FG000|Treatment Phase|Disease Progression|76|||
148839385|NCT01783444|536893823|FG001|Treatment Phase|Disease Progression|66|||
148839386|NCT01783444|536893824|FG002|Treatment Phase|Disease Progression|64|||
148839387|NCT01783444|536893822|FG000|Treatment Phase|Death|2|||
148839388|NCT01783444|536893823|FG001|Treatment Phase|Death|2|||
148839389|NCT01783444|536893824|FG002|Treatment Phase|Death|2|||
148839390|NCT01783444|536893822|FG000|Treatment Phase|Protocol Violation|1|||
148839391|NCT01783444|536893823|FG001|Treatment Phase|Protocol Violation|1|||
148839392|NCT01783444|536893824|FG002|Treatment Phase|Protocol Violation|2|||
148839393|NCT01783444|536893822|FG000|Treatment Phase|Withdrawal by Subject|6|||
148839394|NCT01783444|536893823|FG001|Treatment Phase|Withdrawal by Subject|8|||
148839395|NCT01783444|536893824|FG002|Treatment Phase|Withdrawal by Subject|9|||
148839396|NCT01783444|536893822|FG000|Treatment Phase|Administrative problems|2|||
148839397|NCT01783444|536893823|FG001|Treatment Phase|Administrative problems|0|||
148839398|NCT01783444|536893824|FG002|Treatment Phase|Administrative problems|1|||
148839399|NCT01783444|536893822|FG000|Treatment Phase|Physician Decision|8|||
148839400|NCT01783444|536893823|FG001|Treatment Phase|Physician Decision|6|||
148839401|NCT01783444|536893824|FG002|Treatment Phase|Physician Decision|5|||
148839402|NCT01783444|536893822|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
148839403|NCT01783444|536893823|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
148839404|NCT01783444|536893824|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
148839405|NCT01783444|536893822|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
148839406|NCT01783444|536893823|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
148839407|NCT01783444|536893824|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
148839408|NCT01783444|536893822|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
148839409|NCT01783444|536893823|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
148839410|NCT01783444|536893824|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
148839411|NCT01783444|536893822|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
148839412|NCT01783444|536893823|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
148839413|NCT01783444|536893824|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
148839414|NCT01783444|536893822|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
148839415|NCT01783444|536893823|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
148839416|NCT01783444|536893824|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
148839417|NCT01783444|536893822|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
148839418|NCT01783444|536893823|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
148839419|NCT01783444|536893824|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
148839420|NCT00517699|536893825|FG000|Overall Study|Withdrawal by Subject|1|||
148839421|NCT00517699|536893825|FG000|Overall Study|Lack of Efficacy|1|||
148839422|NCT00517699|536893825|FG000|Overall Study|Administrative error|1|||
148839423|NCT00517699|536893825|FG000|Overall Study|Study terminated by Sponsor|2|||
148839424|NCT00887159|536893826|FG000|Overall Study|Disease progression|6|||
148839425|NCT00887159|536893827|FG001|Overall Study|Disease progression|39|||
148839426|NCT00887159|536893828|FG002|Overall Study|Disease progression|33|||
148839427|NCT00887159|536893826|FG000|Overall Study|Adverse Event|3|||
148839428|NCT00887159|536893827|FG001|Overall Study|Adverse Event|4|||
148839429|NCT00887159|536893828|FG002|Overall Study|Adverse Event|17|||
148839430|NCT00887159|536893826|FG000|Overall Study|Death|2|||
148839431|NCT00887159|536893827|FG001|Overall Study|Death|2|||
148839432|NCT00887159|536893828|FG002|Overall Study|Death|0|||
148839433|NCT00887159|536893826|FG000|Overall Study|Withdrawal by Subject|4|||
148839434|NCT00887159|536893827|FG001|Overall Study|Withdrawal by Subject|4|||
148839435|NCT00887159|536893828|FG002|Overall Study|Withdrawal by Subject|2|||
148839436|NCT00887159|536893826|FG000|Overall Study|Alternative therapy|2|||
148839437|NCT00887159|536893827|FG001|Overall Study|Alternative therapy|0|||
148839438|NCT00887159|536893828|FG002|Overall Study|Alternative therapy|0|||
148839439|NCT00887159|536893826|FG000|Overall Study|Physician Decision|1|||
148839440|NCT00887159|536893827|FG001|Overall Study|Physician Decision|1|||
148839441|NCT00887159|536893828|FG002|Overall Study|Physician Decision|0|||
148839442|NCT00887159|536893826|FG000|Overall Study|Sympomatic deterioration|1|||
148839443|NCT00887159|536893827|FG001|Overall Study|Sympomatic deterioration|0|||
148839444|NCT00887159|536893828|FG002|Overall Study|Sympomatic deterioration|0|||
148839445|NCT00887159|536893826|FG000|Overall Study|Treatment delayed|1|||
148839446|NCT00887159|536893827|FG001|Overall Study|Treatment delayed|1|||
148839447|NCT00887159|536893828|FG002|Overall Study|Treatment delayed|0|||
148839448|NCT00887159|536893826|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
148839449|NCT00887159|536893827|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
148839450|NCT00887159|536893828|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
148839451|NCT00887159|536893826|FG000|Overall Study|Received more tx instead of observation|1|||
148839452|NCT00887159|536893827|FG001|Overall Study|Received more tx instead of observation|0|||
148839453|NCT00887159|536893828|FG002|Overall Study|Received more tx instead of observation|0|||
148839454|NCT00887159|536893826|FG000|Overall Study|Ineligible|5|||
148839455|NCT00887159|536893827|FG001|Overall Study|Ineligible|1|||
148839456|NCT00887159|536893828|FG002|Overall Study|Ineligible|0|||
148839457|NCT00887159|536893826|FG000|Overall Study|Never started assigned therapy|3|||
148839458|NCT00887159|536893827|FG001|Overall Study|Never started assigned therapy|3|||
148839459|NCT00887159|536893828|FG002|Overall Study|Never started assigned therapy|4|||
148839460|NCT06164691|536893831|FG000|Overall Study|Withdrawal by Subject|2|||
148839461|NCT06164691|536893832|FG001|Overall Study|Withdrawal by Subject|0|||
148839462|NCT06164691|536893833|FG002|Overall Study|Withdrawal by Subject|0|||
148839463|NCT00812955|536893834|FG000|Overall Study|Adverse Event|7|||
148839464|NCT00812955|536893835|FG001|Overall Study|Adverse Event|6|||
148839465|NCT00812955|536893836|FG002|Overall Study|Adverse Event|3|||
148839466|NCT00812955|536893837|FG003|Overall Study|Adverse Event|4|||
148839467|NCT00812955|536893834|FG000|Overall Study|Lost to Follow-up|2|||
148839468|NCT00812955|536893835|FG001|Overall Study|Lost to Follow-up|1|||
148839469|NCT00812955|536893836|FG002|Overall Study|Lost to Follow-up|1|||
148839470|NCT00812955|536893837|FG003|Overall Study|Lost to Follow-up|2|||
148839471|NCT00812955|536893834|FG000|Overall Study|Withdrawal by Subject|1|||
148839472|NCT00812955|536893835|FG001|Overall Study|Withdrawal by Subject|0|||
148839473|NCT00812955|536893836|FG002|Overall Study|Withdrawal by Subject|1|||
148839474|NCT00812955|536893837|FG003|Overall Study|Withdrawal by Subject|2|||
148839475|NCT00812955|536893834|FG000|Overall Study|randomized in error|0|||
148839476|NCT00812955|536893835|FG001|Overall Study|randomized in error|0|||
148839477|NCT00812955|536893836|FG002|Overall Study|randomized in error|1|||
148839478|NCT00812955|536893837|FG003|Overall Study|randomized in error|0|||
148839479|NCT01673646|536893841|FG000|Overall Study|Adverse Event|2|||
148839480|NCT01673646|536893842|FG001|Overall Study|Adverse Event|1|||
148839481|NCT01673646|536893843|FG002|Overall Study|Adverse Event|1|||
148839482|NCT01673646|536893841|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148839483|NCT01673646|536893842|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148839484|NCT01673646|536893843|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
148839485|NCT01673646|536893841|FG000|Overall Study|Condition no longer requires study drug|0|||
148839486|NCT01673646|536893842|FG001|Overall Study|Condition no longer requires study drug|1|||
148839487|NCT01673646|536893843|FG002|Overall Study|Condition no longer requires study drug|0|||
148839488|NCT01673646|536893841|FG000|Overall Study|Withdrawal by Subject|0|||
148839489|NCT01673646|536893842|FG001|Overall Study|Withdrawal by Subject|2|||
148839490|NCT01673646|536893843|FG002|Overall Study|Withdrawal by Subject|2|||
148839491|NCT01673646|536893841|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
148839492|NCT01673646|536893842|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
148839493|NCT01673646|536893843|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
148839494|NCT01063348|536893844|FG000|Overall Study|Lost to Follow-up|3|||
148839495|NCT01063348|536893845|FG001|Overall Study|Lost to Follow-up|10|||
148839496|NCT00269087|536893846|FG000|Overall Study|Adverse Event|20|||
148839497|NCT00269087|536893846|FG000|Overall Study|Withdrawal by Subject|1|||
148839498|NCT00269087|536893846|FG000|Overall Study|Exacerbation of COPD|13|||
148839499|NCT01876381|536893849|FG000|Overall Study|Lack of Efficacy|5|||
148839500|NCT01876381|536893849|FG000|Overall Study|Physician Decision|1|||
148839501|NCT01876381|536893849|FG000|Overall Study|Withdrawal by Subject|1|||
148839502|NCT00332696|536893850|FG000|Overall Study|Death|24|||
148839503|NCT00332696|536893851|FG001|Overall Study|Death|14|||
148839504|NCT00332696|536893850|FG000|Overall Study|Insufficient therapeutic effect|4|||
148839505|NCT00332696|536893851|FG001|Overall Study|Insufficient therapeutic effect|11|||
148839506|NCT00332696|536893850|FG000|Overall Study|Adverse Event|1|||
148839507|NCT00332696|536893851|FG001|Overall Study|Adverse Event|2|||
148839508|NCT00332696|536893850|FG000|Overall Study|Condition does not justify treatment|0|||
148839509|NCT00332696|536893851|FG001|Overall Study|Condition does not justify treatment|2|||
148839510|NCT00332696|536893850|FG000|Overall Study|Lost to Follow-up|0|||
148839511|NCT00332696|536893851|FG001|Overall Study|Lost to Follow-up|1|||
148839512|NCT00332696|536893850|FG000|Overall Study|Withdrawal by Subject|1|||
148839513|NCT00332696|536893851|FG001|Overall Study|Withdrawal by Subject|0|||
148839514|NCT01464879|536893854|FG000|Overall Study|Physician Decision|1|||
148839515|NCT01464879|536893854|FG000|Overall Study|Non-compliance|1|||
148839516|NCT02712788|536893859|FG000|Overall Study|Physician Decision|1|||
148839517|NCT02712788|536893860|FG001|Overall Study|Physician Decision|0|||
148839518|NCT02712788|536893859|FG000|Overall Study|Protocol Violation|1|||
148839519|NCT02712788|536893860|FG001|Overall Study|Protocol Violation|0|||
148839520|NCT01368614|536893861|FG000|Screening Period|Screen Failure|58|||
148839521|NCT01368614|536893862|FG001|Screening Period|Screen Failure|0|||
148839522|NCT01368614|536893863|FG002|Screening Period|Screen Failure|0|||
148839523|NCT01368614|536893864|FG003|Screening Period|Screen Failure|0|||
148839524|NCT01368614|536893861|FG000|Study Period|Withdrawal by Subject|0|||
148839525|NCT01368614|536893862|FG001|Study Period|Withdrawal by Subject|1|||
148839526|NCT01368614|536893863|FG002|Study Period|Withdrawal by Subject|1|||
148839527|NCT01368614|536893864|FG003|Study Period|Withdrawal by Subject|3|||
148839528|NCT01368614|536893861|FG000|Study Period|Lost to Follow-up|0|||
148839529|NCT01368614|536893862|FG001|Study Period|Lost to Follow-up|0|||
148839530|NCT01368614|536893863|FG002|Study Period|Lost to Follow-up|1|||
148839531|NCT01368614|536893864|FG003|Study Period|Lost to Follow-up|0|||
148839532|NCT02271529|536893865|FG000|Overall Study|Withdrawal by Subject|1|||
148839533|NCT01904721|536893867|FG000|Overall Study|Other Reasons|0|||
148839534|NCT01904721|536893868|FG001|Overall Study|Other Reasons|0|||
148839535|NCT01904721|536893869|FG002|Overall Study|Other Reasons|1|||
148839536|NCT01904721|536893870|FG003|Overall Study|Other Reasons|1|||
148839537|NCT01904721|536893871|FG004|Overall Study|Other Reasons|2|||
148839538|NCT01904721|536893872|FG005|Overall Study|Other Reasons|2|||
148839539|NCT01904721|536893873|FG006|Overall Study|Other Reasons|2|||
148839540|NCT01904721|536893867|FG000|Overall Study|Personal Reasons|0|||
148839541|NCT01904721|536893868|FG001|Overall Study|Personal Reasons|0|||
148839542|NCT01904721|536893869|FG002|Overall Study|Personal Reasons|0|||
148839543|NCT01904721|536893870|FG003|Overall Study|Personal Reasons|0|||
148839544|NCT01904721|536893871|FG004|Overall Study|Personal Reasons|2|||
148839545|NCT01904721|536893872|FG005|Overall Study|Personal Reasons|3|||
148839546|NCT01904721|536893873|FG006|Overall Study|Personal Reasons|3|||
148839547|NCT01904721|536893867|FG000|Overall Study|Lost to Follow-up|0|||
148839548|NCT01904721|536893868|FG001|Overall Study|Lost to Follow-up|0|||
148839549|NCT01904721|536893869|FG002|Overall Study|Lost to Follow-up|0|||
148839550|NCT01904721|536893870|FG003|Overall Study|Lost to Follow-up|0|||
148839551|NCT01904721|536893871|FG004|Overall Study|Lost to Follow-up|1|||
148839552|NCT01904721|536893872|FG005|Overall Study|Lost to Follow-up|3|||
148839553|NCT01904721|536893873|FG006|Overall Study|Lost to Follow-up|1|||
148839554|NCT01904721|536893867|FG000|Overall Study|Lack of Efficacy|0|||
148839555|NCT01904721|536893868|FG001|Overall Study|Lack of Efficacy|0|||
148839556|NCT01904721|536893869|FG002|Overall Study|Lack of Efficacy|0|||
148839557|NCT01904721|536893870|FG003|Overall Study|Lack of Efficacy|0|||
148839558|NCT01904721|536893871|FG004|Overall Study|Lack of Efficacy|0|||
148839559|NCT01904721|536893872|FG005|Overall Study|Lack of Efficacy|0|||
148839560|NCT01904721|536893873|FG006|Overall Study|Lack of Efficacy|1|||
148839561|NCT01904721|536893867|FG000|Overall Study|Adverse Event|0|||
148839562|NCT01904721|536893868|FG001|Overall Study|Adverse Event|0|||
148839563|NCT01904721|536893869|FG002|Overall Study|Adverse Event|0|||
148839564|NCT01904721|536893870|FG003|Overall Study|Adverse Event|0|||
148839565|NCT01904721|536893871|FG004|Overall Study|Adverse Event|3|||
148839566|NCT01904721|536893872|FG005|Overall Study|Adverse Event|1|||
148839567|NCT01904721|536893873|FG006|Overall Study|Adverse Event|0|||
148839568|NCT01957865|536893874|FG000|Overall Study|Found HIV negative|0|||
148839569|NCT01957865|536893875|FG001|Overall Study|Found HIV negative|0|||
148839570|NCT01957865|536893876|FG002|Overall Study|Found HIV negative|1|||
148839571|NCT01957865|536893874|FG000|Overall Study|Lost to Follow-up|0|||
148839572|NCT01957865|536893875|FG001|Overall Study|Lost to Follow-up|2|||
148839573|NCT01957865|536893876|FG002|Overall Study|Lost to Follow-up|2|||
148839574|NCT00811720|536893880|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
148839575|NCT00811720|536893881|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
148839576|NCT00811720|536893880|FG000|All Treated Patients|Adverse Event|20|||
148982654|NCT01542528|537415313|FG000|Overall Study|Withdrawal by Subject|9|||
148982655|NCT01542528|537415314|FG001|Overall Study|Withdrawal by Subject|6|||
148982656|NCT05282004|537415315|FG000|Overall Study|Adverse Event|2|||
148982657|NCT04808609|537415316|FG000|Overall Study|Lost to Follow-up|0|||
148839577|NCT00811720|536893881|FG001|All Treated Patients|Adverse Event|62|||
148982658|NCT04808609|537415317|FG001|Overall Study|Lost to Follow-up|2|||
148982659|NCT04808609|537415316|FG000|Overall Study|Administrative Withdrawal|0|||
148982660|NCT04808609|537415317|FG001|Overall Study|Administrative Withdrawal|1|||
148982661|NCT01993719|537415319|FG000|First Drug Administration|Not treated|1|||
148839578|NCT00811720|536893880|FG000|All Treated Patients|Lack of Efficacy|22|||
148839579|NCT00811720|536893881|FG001|All Treated Patients|Lack of Efficacy|18|||
148839580|NCT00811720|536893880|FG000|All Treated Patients|Non-compliance|0|||
148839581|NCT00811720|536893881|FG001|All Treated Patients|Non-compliance|14|||
148839582|NCT00811720|536893880|FG000|All Treated Patients|Protocol Violation|9|||
148839583|NCT00811720|536893881|FG001|All Treated Patients|Protocol Violation|16|||
148839584|NCT00811720|536893880|FG000|All Treated Patients|Withdrawal by Subject|28|||
148839585|NCT00811720|536893881|FG001|All Treated Patients|Withdrawal by Subject|34|||
148839586|NCT00811720|536893880|FG000|All Treated Patients|Lost to Follow-up|10|||
148839587|NCT00811720|536893881|FG001|All Treated Patients|Lost to Follow-up|16|||
148839588|NCT00811720|536893880|FG000|All Treated Patients|Other Reason|7|||
148839589|NCT00811720|536893881|FG001|All Treated Patients|Other Reason|4|||
148839590|NCT01077063|536893882|FG000|Overall Study|Adverse Event|3|||
148839591|NCT01077063|536893883|FG001|Overall Study|Adverse Event|0|||
148839592|NCT01077063|536893882|FG000|Overall Study|Death|1|||
148839593|NCT01077063|536893883|FG001|Overall Study|Death|1|||
148839594|NCT01077063|536893882|FG000|Overall Study|Withdrawal by Subject|0|||
148839595|NCT01077063|536893883|FG001|Overall Study|Withdrawal by Subject|2|||
148839596|NCT02750930|536893884|FG000|Overall Study|Study closed/terminated|8|||
148839597|NCT00553631|536893885|FG000|Overall Study|Withdrawal by Subject|0|||
148839598|NCT00553631|536893886|FG001|Overall Study|Withdrawal by Subject|1|||
148839599|NCT00553631|536893885|FG000|Overall Study|Lost to Follow-up|1|||
148839600|NCT00553631|536893886|FG001|Overall Study|Lost to Follow-up|0|||
148839601|NCT03768427|536893887|FG000|Overall Study|Death|0|||
148839602|NCT03768427|536893888|FG001|Overall Study|Death|0|||
148839603|NCT03768427|536893889|FG002|Overall Study|Death|1|||
148839604|NCT03768427|536893890|FG003|Overall Study|Death|0|||
148839605|NCT03768427|536893887|FG000|Overall Study|Lost to Follow-up|2|||
148839606|NCT03768427|536893888|FG001|Overall Study|Lost to Follow-up|0|||
148839607|NCT03768427|536893889|FG002|Overall Study|Lost to Follow-up|0|||
148839608|NCT03768427|536893890|FG003|Overall Study|Lost to Follow-up|0|||
148839609|NCT03768427|536893887|FG000|Overall Study|Physician Decision|3|||
148839610|NCT03768427|536893888|FG001|Overall Study|Physician Decision|2|||
148839611|NCT03768427|536893889|FG002|Overall Study|Physician Decision|4|||
148839612|NCT03768427|536893890|FG003|Overall Study|Physician Decision|4|||
148839613|NCT03768427|536893887|FG000|Overall Study|Withdrawal by Subject|7|||
148839614|NCT03768427|536893888|FG001|Overall Study|Withdrawal by Subject|2|||
148839615|NCT03768427|536893889|FG002|Overall Study|Withdrawal by Subject|6|||
148839616|NCT03768427|536893890|FG003|Overall Study|Withdrawal by Subject|7|||
148839617|NCT02756403|536893893|FG000|Overall Study|Unable to swallow medication|0|||
148839618|NCT02756403|536893894|FG001|Overall Study|Unable to swallow medication|1|||
148839619|NCT02756403|536893895|FG002|Overall Study|Unable to swallow medication|1|||
148839620|NCT02756403|536893896|FG003|Overall Study|Unable to swallow medication|1|||
148839621|NCT02756403|536893893|FG000|Overall Study|Did not complete Procedure|0|||
148839622|NCT02756403|536893894|FG001|Overall Study|Did not complete Procedure|1|||
148839623|NCT02756403|536893895|FG002|Overall Study|Did not complete Procedure|0|||
148839624|NCT02756403|536893896|FG003|Overall Study|Did not complete Procedure|0|||
148839625|NCT02756403|536893893|FG000|Overall Study|Changed Mind About Procedure|0|||
148839626|NCT02756403|536893894|FG001|Overall Study|Changed Mind About Procedure|0|||
148839627|NCT02756403|536893895|FG002|Overall Study|Changed Mind About Procedure|1|||
148839628|NCT02756403|536893896|FG003|Overall Study|Changed Mind About Procedure|0|||
148839629|NCT02756403|536893893|FG000|Overall Study|Protocol Violation|0|||
148839630|NCT02756403|536893894|FG001|Overall Study|Protocol Violation|1|||
148839631|NCT02756403|536893895|FG002|Overall Study|Protocol Violation|0|||
148839632|NCT02756403|536893896|FG003|Overall Study|Protocol Violation|1|||
148839633|NCT01644643|536893897|FG000|Overall Study|Death|1|||
148839634|NCT01644643|536893898|FG001|Overall Study|Death|0|||
148839635|NCT01644643|536893899|FG002|Overall Study|Death|3|||
148839636|NCT01644643|536893900|FG003|Overall Study|Death|3|||
148839637|NCT01644643|536893897|FG000|Overall Study|Lost to Follow-up|0|||
148839638|NCT01644643|536893898|FG001|Overall Study|Lost to Follow-up|0|||
148839639|NCT01644643|536893899|FG002|Overall Study|Lost to Follow-up|0|||
148839640|NCT01644643|536893900|FG003|Overall Study|Lost to Follow-up|4|||
148839641|NCT01644643|536893897|FG000|Overall Study|Withdrawal by Subject|1|||
148839642|NCT01644643|536893898|FG001|Overall Study|Withdrawal by Subject|0|||
148839643|NCT01644643|536893899|FG002|Overall Study|Withdrawal by Subject|2|||
148839644|NCT01644643|536893900|FG003|Overall Study|Withdrawal by Subject|1|||
148839645|NCT01644643|536893897|FG000|Overall Study|Other Eligibility criteria|0|||
148839646|NCT01644643|536893898|FG001|Overall Study|Other Eligibility criteria|0|||
148839647|NCT01644643|536893899|FG002|Overall Study|Other Eligibility criteria|0|||
148839648|NCT01644643|536893900|FG003|Overall Study|Other Eligibility criteria|2|||
148839649|NCT00527618|536893901|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
148839650|NCT00527618|536893902|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
148839651|NCT00527618|536893901|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
148839652|NCT00527618|536893902|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
148839653|NCT00527618|536893901|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
148839654|NCT00527618|536893902|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
148982662|NCT01993719|537415320|FG001|First Drug Administration|Not treated|0|||
148982663|NCT01993719|537415321|FG002|First Drug Administration|Not treated|0|||
148982664|NCT01993719|537415322|FG003|First Drug Administration|Not treated|0|||
148839655|NCT00527618|536893901|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
148839656|NCT00527618|536893902|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
148839657|NCT00527618|536893901|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
148839658|NCT00527618|536893902|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
148839659|NCT00527618|536893901|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
148982665|NCT01993719|537415323|FG004|First Drug Administration|Not treated|0|||
148982666|NCT02461589|537415338|FG000|Overall Study|Withdrawal by Subject|5|||
148839660|NCT00527618|536893902|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
148839661|NCT01490918|536893903|FG000|Overall Study|Lost to Follow-up|2|||
148839662|NCT01490918|536893904|FG001|Overall Study|Lost to Follow-up|1|||
148839663|NCT01490918|536893905|FG002|Overall Study|Lost to Follow-up|0|||
148839664|NCT01490918|536893903|FG000|Overall Study|Withdrawal by Subject|7|||
148839665|NCT01490918|536893904|FG001|Overall Study|Withdrawal by Subject|8|||
148839666|NCT01490918|536893905|FG002|Overall Study|Withdrawal by Subject|3|||
148839667|NCT01490918|536893903|FG000|Overall Study|Adverse Event|0|||
148839668|NCT01490918|536893904|FG001|Overall Study|Adverse Event|0|||
148839669|NCT01490918|536893905|FG002|Overall Study|Adverse Event|1|||
148839670|NCT01490918|536893903|FG000|Overall Study|other cause|4|||
148839671|NCT01490918|536893904|FG001|Overall Study|other cause|5|||
148839672|NCT01490918|536893905|FG002|Overall Study|other cause|8|||
148839673|NCT00776789|536893910|FG000|Overall Study|Consent refusal|2|||
148839674|NCT00776789|536893911|FG001|Overall Study|Consent refusal|2|||
148839675|NCT00776789|536893910|FG000|Overall Study|Poor quality video|1|||
148839676|NCT00776789|536893911|FG001|Overall Study|Poor quality video|1|||
148839677|NCT00648037|536893912|FG000|Overall Study|Not Treated|1|||
148839678|NCT00648037|536893912|FG000|Overall Study|Withdrawal by Subject|1|||
148839679|NCT00648037|536893912|FG000|Overall Study|Adverse Event|11|||
148839680|NCT00648037|536893912|FG000|Overall Study|Relapse|2|||
148839681|NCT00648037|536893912|FG000|Overall Study|Other|1|||
148839682|NCT02967679|536893913|FG000|Overall Study|Adverse Event|1|||
148839683|NCT00699413|536893916|FG000|Overall Study|Withdrawal by Subject|0|||
148839684|NCT00699413|536893917|FG001|Overall Study|Withdrawal by Subject|2|||
148839685|NCT00699413|536893916|FG000|Overall Study|Study terminated by sponsor|4|||
148839686|NCT00699413|536893917|FG001|Overall Study|Study terminated by sponsor|2|||
148839687|NCT00881894|536893918|FG000|Overall Study|Consent withdrawn|0|||
148839688|NCT00881894|536893919|FG001|Overall Study|Consent withdrawn|1|||
148839689|NCT00881894|536893918|FG000|Overall Study|Other reasons for premature termination|1|||
148839690|NCT00881894|536893919|FG001|Overall Study|Other reasons for premature termination|2|||
148839691|NCT00469833|536893921|FG000|Overall Study|No IV access|2|||
148839692|NCT01253369|536893922|FG000|Overall Study|Adverse Event|4|||
148839693|NCT01253369|536893922|FG000|Overall Study|Withdrawal by Subject|2|||
148839694|NCT01253369|536893922|FG000|Overall Study|Death|1|||
148839695|NCT01253369|536893922|FG000|Overall Study|Progressive disease|23|||
148839696|NCT01253369|536893922|FG000|Overall Study|Not Evaluable|3|||
148839697|NCT03289533|536893923|FG000|Overall Study|Death|12|||
148839698|NCT03289533|536893923|FG000|Overall Study|Terminated from study by sponsor|10|||
148839699|NCT00539240|536893924|FG000|Overall Study|Withdrawal by Subject|0|||
148839700|NCT00539240|536893925|FG001|Overall Study|Withdrawal by Subject|2|||
148839701|NCT00539240|536893926|FG002|Overall Study|Withdrawal by Subject|0|||
148839702|NCT00539240|536893924|FG000|Overall Study|Protocol Violation|1|||
148839703|NCT00539240|536893925|FG001|Overall Study|Protocol Violation|1|||
148982667|NCT02461589|537415339|FG001|Overall Study|Withdrawal by Subject|1|||
148982668|NCT02461589|537415340|FG002|Overall Study|Withdrawal by Subject|3|||
148982669|NCT02461589|537415341|FG003|Overall Study|Withdrawal by Subject|2|||
148982670|NCT02461589|537415342|FG004|Overall Study|Withdrawal by Subject|1|||
148982671|NCT02461589|537415343|FG005|Overall Study|Withdrawal by Subject|2|||
148982672|NCT02461589|537415344|FG006|Overall Study|Withdrawal by Subject|1|||
148982673|NCT02461589|537415345|FG007|Overall Study|Withdrawal by Subject|3|||
148982674|NCT02461589|537415346|FG008|Overall Study|Withdrawal by Subject|3|||
148982675|NCT02461589|537415347|FG009|Overall Study|Withdrawal by Subject|1|||
148982676|NCT02461589|537415338|FG000|Overall Study|Lost to Follow-up|0|||
148982677|NCT02461589|537415339|FG001|Overall Study|Lost to Follow-up|0|||
148982678|NCT02461589|537415340|FG002|Overall Study|Lost to Follow-up|2|||
148839704|NCT00539240|536893926|FG002|Overall Study|Protocol Violation|4|||
148839705|NCT00539240|536893924|FG000|Overall Study|Lost to Follow-up|2|||
148839706|NCT00539240|536893925|FG001|Overall Study|Lost to Follow-up|3|||
148982679|NCT02461589|537415341|FG003|Overall Study|Lost to Follow-up|3|||
148982680|NCT02461589|537415342|FG004|Overall Study|Lost to Follow-up|1|||
148982681|NCT02461589|537415343|FG005|Overall Study|Lost to Follow-up|1|||
148982682|NCT02461589|537415344|FG006|Overall Study|Lost to Follow-up|3|||
148982683|NCT02461589|537415345|FG007|Overall Study|Lost to Follow-up|1|||
148982684|NCT02461589|537415346|FG008|Overall Study|Lost to Follow-up|3|||
148839707|NCT00539240|536893926|FG002|Overall Study|Lost to Follow-up|1|||
148839708|NCT00539240|536893924|FG000|Overall Study|Adverse Event|3|||
148839709|NCT00539240|536893925|FG001|Overall Study|Adverse Event|1|||
148839710|NCT00539240|536893926|FG002|Overall Study|Adverse Event|10|||
148982685|NCT02461589|537415347|FG009|Overall Study|Lost to Follow-up|1|||
148839711|NCT01284959|536893928|FG000|Overall Study|Withdrawal by Subject|1|||
148839712|NCT01284959|536893929|FG001|Overall Study|Withdrawal by Subject|0|||
148839713|NCT01284959|536893930|FG002|Overall Study|Withdrawal by Subject|0|||
148839714|NCT01284959|536893928|FG000|Overall Study|Adverse Event|0|||
148839715|NCT01284959|536893929|FG001|Overall Study|Adverse Event|0|||
148982686|NCT02461589|537415338|FG000|Overall Study|Death|0|||
148839716|NCT01284959|536893930|FG002|Overall Study|Adverse Event|1|||
148839717|NCT01055613|536893931|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
148839718|NCT01055613|536893932|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148982687|NCT02461589|537415339|FG001|Overall Study|Death|0|||
148982688|NCT02461589|537415340|FG002|Overall Study|Death|0|||
148839719|NCT01055613|536893931|FG000|Overall Study|Unacceptable lens fit|1|||
148839720|NCT01055613|536893932|FG001|Overall Study|Unacceptable lens fit|0|||
148839721|NCT01055613|536893931|FG000|Overall Study|Discomfort|2|||
148839722|NCT01055613|536893932|FG001|Overall Study|Discomfort|1|||
148839723|NCT01055613|536893931|FG000|Overall Study|Lost to Follow-up|1|||
148839724|NCT01055613|536893932|FG001|Overall Study|Lost to Follow-up|1|||
148839725|NCT01055613|536893931|FG000|Overall Study|Protocol Violation|1|||
148839726|NCT01055613|536893932|FG001|Overall Study|Protocol Violation|1|||
148839727|NCT01055613|536893931|FG000|Overall Study|Subject Disinterest|1|||
148839728|NCT01055613|536893932|FG001|Overall Study|Subject Disinterest|1|||
148839729|NCT00363311|536893933|FG000|Overall Study|Adverse Event|6|||
148839730|NCT00363311|536893934|FG001|Overall Study|Adverse Event|4|||
148839731|NCT00363311|536893933|FG000|Overall Study|Lost to Follow-up|3|||
148839732|NCT00363311|536893934|FG001|Overall Study|Lost to Follow-up|0|||
148839733|NCT00363311|536893933|FG000|Overall Study|Protocol Violation|1|||
148839734|NCT00363311|536893934|FG001|Overall Study|Protocol Violation|2|||
148839735|NCT00363311|536893933|FG000|Overall Study|Withdrawal by Subject|12|||
148839736|NCT00363311|536893934|FG001|Overall Study|Withdrawal by Subject|6|||
148839737|NCT00363311|536893933|FG000|Overall Study|Physician Decision|1|||
148839738|NCT00363311|536893934|FG001|Overall Study|Physician Decision|1|||
148839739|NCT00363311|536893933|FG000|Overall Study|Sponsor Terminated Study|2|||
148839740|NCT00363311|536893934|FG001|Overall Study|Sponsor Terminated Study|2|||
148839741|NCT00363311|536893933|FG000|Overall Study|Disease Progression|46|||
148839742|NCT00363311|536893934|FG001|Overall Study|Disease Progression|26|||
148839743|NCT00363311|536893933|FG000|Overall Study|Non-Compliance|1|||
148839744|NCT00363311|536893934|FG001|Overall Study|Non-Compliance|1|||
148839745|NCT00363311|536893933|FG000|Overall Study|Participant Refused Biopsy|1|||
148839746|NCT00363311|536893934|FG001|Overall Study|Participant Refused Biopsy|0|||
148839747|NCT00363311|536893933|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
148839748|NCT00363311|536893934|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
148839749|NCT00363311|536893933|FG000|Overall Study|Participant Opted for Treatment|1|||
148839750|NCT00363311|536893934|FG001|Overall Study|Participant Opted for Treatment|0|||
148839751|NCT00363311|536893933|FG000|Overall Study|Participant Moved to Another Country|1|||
148839752|NCT00363311|536893934|FG001|Overall Study|Participant Moved to Another Country|0|||
148839753|NCT00363311|536893933|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
148839754|NCT00363311|536893934|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
148839755|NCT00363311|536893933|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
148839756|NCT00363311|536893934|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
148839757|NCT00363311|536893933|FG000|Overall Study|Participant Moved to Louisiana|0|||
148839758|NCT00363311|536893934|FG001|Overall Study|Participant Moved to Louisiana|1|||
148839759|NCT02629861|536893936|FG000|Overall Study|Adverse Event|7|||
148839760|NCT02629861|536893937|FG001|Overall Study|Adverse Event|5|||
148839761|NCT02629861|536893938|FG002|Overall Study|Adverse Event|4|||
148839762|NCT02629861|536893936|FG000|Overall Study|Withdrawal by Subject|5|||
148839763|NCT02629861|536893937|FG001|Overall Study|Withdrawal by Subject|8|||
148839764|NCT02629861|536893938|FG002|Overall Study|Withdrawal by Subject|13|||
148839765|NCT02629861|536893936|FG000|Overall Study|Protocol Violation|2|||
148839766|NCT02629861|536893937|FG001|Overall Study|Protocol Violation|3|||
148839767|NCT02629861|536893938|FG002|Overall Study|Protocol Violation|7|||
148839768|NCT02629861|536893936|FG000|Overall Study|Lost to Follow-up|12|||
148839769|NCT02629861|536893937|FG001|Overall Study|Lost to Follow-up|9|||
148839770|NCT02629861|536893938|FG002|Overall Study|Lost to Follow-up|4|||
148839771|NCT02629861|536893936|FG000|Overall Study|Other|1|||
148839772|NCT02629861|536893937|FG001|Overall Study|Other|1|||
148839773|NCT02629861|536893938|FG002|Overall Study|Other|0|||
148839774|NCT02629861|536893936|FG000|Overall Study|Pregnancy|2|||
148839775|NCT02629861|536893937|FG001|Overall Study|Pregnancy|1|||
148839776|NCT02629861|536893938|FG002|Overall Study|Pregnancy|0|||
148839777|NCT00730886|536893939|FG000|Overall Study|Lost to Follow-up|1|||
148839778|NCT00730886|536893940|FG001|Overall Study|Lost to Follow-up|0|||
148839779|NCT00730886|536893939|FG000|Overall Study|Physician Decision|1|||
148839780|NCT00730886|536893940|FG001|Overall Study|Physician Decision|0|||
148839781|NCT01991483|536893941|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
148839782|NCT01991483|536893942|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
148839783|NCT01991483|536893943|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
148839784|NCT01991483|536893944|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
148839785|NCT01991483|536893941|FG000|Dose Level 600 mg|Physician Decision|0|||
148839786|NCT01991483|536893942|FG001|Dose Level 600 mg|Physician Decision|0|||
148839787|NCT01991483|536893943|FG002|Dose Level 600 mg|Physician Decision|1|||
148839788|NCT01991483|536893944|FG003|Dose Level 600 mg|Physician Decision|0|||
148839789|NCT01991483|536893941|FG000|Dose Level 1000 mg|Protocol Violation|0|||
148839790|NCT01991483|536893942|FG001|Dose Level 1000 mg|Protocol Violation|0|||
148839791|NCT01991483|536893943|FG002|Dose Level 1000 mg|Protocol Violation|0|||
148839792|NCT01991483|536893944|FG003|Dose Level 1000 mg|Protocol Violation|1|||
148839793|NCT02030821|536893947|FG000|Overall Study|Physician Decision|2|||
148839794|NCT02030821|536893948|FG001|Overall Study|Physician Decision|2|||
148839795|NCT02030821|536893949|FG002|Overall Study|Physician Decision|5|||
148839796|NCT02030821|536893950|FG003|Overall Study|Physician Decision|2|||
148839797|NCT00716274|536893951|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
148839798|NCT00716274|536893952|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
148839799|NCT00716274|536893953|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
148839800|NCT00716274|536893954|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
148839801|NCT00716274|536893955|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
148839802|NCT00716274|536893956|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
148839803|NCT00716274|536893951|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
148839804|NCT00716274|536893952|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
148839805|NCT00716274|536893953|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
148839806|NCT00716274|536893954|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
148839807|NCT00716274|536893955|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
148839808|NCT00716274|536893956|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
148839809|NCT00716274|536893951|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
148839810|NCT00716274|536893952|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
148839811|NCT00716274|536893953|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
148839812|NCT00716274|536893954|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
148839813|NCT00716274|536893955|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
148839814|NCT00716274|536893956|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
148839815|NCT00716274|536893951|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
148839816|NCT00716274|536893952|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
148839817|NCT00716274|536893953|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
148839818|NCT00716274|536893954|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
148839819|NCT00716274|536893955|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
148839820|NCT00716274|536893956|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
148839821|NCT00716274|536893951|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
148839822|NCT00716274|536893952|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
148839823|NCT00716274|536893953|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
148839824|NCT00716274|536893954|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
148839825|NCT00716274|536893955|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
148839826|NCT00716274|536893956|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
148839827|NCT00716274|536893951|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
148839828|NCT00716274|536893952|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
148839829|NCT00716274|536893953|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
148839830|NCT00716274|536893954|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
148839831|NCT00716274|536893955|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
148839832|NCT00716274|536893956|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
148839833|NCT00716274|536893951|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
148839834|NCT00716274|536893952|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
148839835|NCT00716274|536893953|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
148839836|NCT00716274|536893954|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
148839837|NCT00716274|536893955|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
148839838|NCT00716274|536893956|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
148839839|NCT00716274|536893951|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
148839840|NCT00716274|536893952|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
148839841|NCT00716274|536893953|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
148839842|NCT00716274|536893954|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
148839843|NCT00716274|536893955|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
148839844|NCT00716274|536893956|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
148839845|NCT00716274|536893951|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
148839846|NCT00716274|536893952|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
148839847|NCT00716274|536893953|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
148839848|NCT00716274|536893954|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
148839849|NCT00716274|536893955|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
148839850|NCT00716274|536893956|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
148839851|NCT00716274|536893951|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
148839852|NCT00716274|536893952|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
148839853|NCT00716274|536893953|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
148839854|NCT00716274|536893954|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
148839855|NCT00716274|536893955|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
148839856|NCT00716274|536893956|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
148839857|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
148839858|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
148839859|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
148839860|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
148839861|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
148839862|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
148839863|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
148839864|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
148839865|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
148839866|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
148839867|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
148839868|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
148839869|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
148839870|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
148839871|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
148839872|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
148839873|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
148839874|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
148839875|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
148839876|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
148839877|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
148839878|NCT04021290|536893957|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
148839879|NCT04021290|536893958|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
148839880|NCT04021290|536893959|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
148839881|NCT04021290|536893957|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
148839882|NCT04021290|536893958|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
148839883|NCT04021290|536893959|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
148839884|NCT04021290|536893957|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
148839885|NCT04021290|536893958|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
148839886|NCT04021290|536893959|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
148839887|NCT04021290|536893957|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
148839888|NCT04021290|536893958|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
148839889|NCT04021290|536893959|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
148839890|NCT04021290|536893957|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
148839891|NCT04021290|536893958|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
148839892|NCT04021290|536893959|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
148839893|NCT00543985|536893962|FG000|Overall Study|Withdrawal by Subject|4|||
148839894|NCT01634152|536893963|FG000|Overall Study|Adverse Event|2|||
148839895|NCT01634152|536893964|FG001|Overall Study|Adverse Event|0|||
148839896|NCT01634152|536893965|FG002|Overall Study|Adverse Event|2|||
148839897|NCT01634152|536893963|FG000|Overall Study|Consent withdrawn not due to AE|1|||
148839898|NCT01634152|536893964|FG001|Overall Study|Consent withdrawn not due to AE|0|||
148839899|NCT01634152|536893965|FG002|Overall Study|Consent withdrawn not due to AE|1|||
148839900|NCT01634152|536893963|FG000|Overall Study|Not treated|0|||
148839901|NCT01634152|536893964|FG001|Overall Study|Not treated|1|||
148839902|NCT01634152|536893965|FG002|Overall Study|Not treated|0|||
148839903|NCT01634152|536893963|FG000|Overall Study|Other reason not defined above|1|||
148839904|NCT01634152|536893964|FG001|Overall Study|Other reason not defined above|0|||
148839905|NCT01634152|536893965|FG002|Overall Study|Other reason not defined above|1|||
148839906|NCT00279214|536893968|FG000|Overall Study|Physician Decision|3|||
148839907|NCT00279214|536893969|FG001|Overall Study|Physician Decision|2|||
148839908|NCT00953706|536893972|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
148839909|NCT00953706|536893973|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
148839910|NCT00953706|536893974|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
148839911|NCT00953706|536893975|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
148839912|NCT00953706|536893972|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
148839913|NCT00953706|536893973|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
148839914|NCT00953706|536893974|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
148839915|NCT00953706|536893975|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
148839916|NCT00953706|536893972|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
148839917|NCT00953706|536893973|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
148839918|NCT00953706|536893974|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
148839919|NCT00953706|536893975|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
148839920|NCT00953706|536893972|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
148839921|NCT00953706|536893973|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
148839922|NCT00953706|536893974|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
148839923|NCT00953706|536893975|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
148839924|NCT00953706|536893972|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
148982689|NCT02461589|537415341|FG003|Overall Study|Death|0|||
148839925|NCT00953706|536893973|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
148839926|NCT00953706|536893974|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
148839927|NCT00953706|536893975|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
148839928|NCT00953706|536893972|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
148839929|NCT00953706|536893973|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
148839930|NCT00953706|536893974|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
148839931|NCT00953706|536893975|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
148839932|NCT00953706|536893972|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
148839933|NCT00953706|536893973|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
148839934|NCT00953706|536893974|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
148839935|NCT00953706|536893975|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
148839936|NCT00953706|536893972|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
148839937|NCT00953706|536893973|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
148839938|NCT00953706|536893974|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
148839939|NCT00953706|536893975|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
148839940|NCT00953706|536893972|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
148839941|NCT00953706|536893973|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
148839942|NCT00953706|536893974|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
148839943|NCT00953706|536893975|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
148839944|NCT00953706|536893972|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
148839945|NCT00953706|536893973|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
148839946|NCT00953706|536893974|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
148839947|NCT00953706|536893975|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
148839948|NCT00953706|536893972|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
148839949|NCT00953706|536893973|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
148839950|NCT00953706|536893974|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
148839951|NCT00953706|536893975|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
148839952|NCT01404234|536893976|FG000|Overall Study|Withdrawal by Subject|2|||
148839953|NCT02670473|536893977|FG000|Overall Study|Withdrawal by Subject|1|||
148839954|NCT01214837|536893978|FG000|Overall Study|Death|0|||
148839955|NCT01214837|536893979|FG001|Overall Study|Death|0|||
148839956|NCT01214837|536893980|FG002|Overall Study|Death|1|||
148839957|NCT01214837|536893978|FG000|Overall Study|Adverse Event|1|||
148839958|NCT01214837|536893979|FG001|Overall Study|Adverse Event|2|||
148839959|NCT01214837|536893980|FG002|Overall Study|Adverse Event|1|||
148839960|NCT01214837|536893978|FG000|Overall Study|Withdrawal by Subject|27|||
148839961|NCT01214837|536893979|FG001|Overall Study|Withdrawal by Subject|36|||
148839962|NCT01214837|536893980|FG002|Overall Study|Withdrawal by Subject|28|||
148839963|NCT01214837|536893978|FG000|Overall Study|Lost to Follow-up|20|||
148839964|NCT01214837|536893979|FG001|Overall Study|Lost to Follow-up|15|||
148839965|NCT01214837|536893980|FG002|Overall Study|Lost to Follow-up|21|||
148839966|NCT01214837|536893978|FG000|Overall Study|Inappropriate Enrolment|0|||
148839967|NCT01214837|536893979|FG001|Overall Study|Inappropriate Enrolment|1|||
148839968|NCT01214837|536893980|FG002|Overall Study|Inappropriate Enrolment|2|||
148839969|NCT01214837|536893978|FG000|Overall Study|Administrative Reason|2|||
148839970|NCT01214837|536893979|FG001|Overall Study|Administrative Reason|6|||
148839971|NCT01214837|536893980|FG002|Overall Study|Administrative Reason|4|||
148839972|NCT01214837|536893978|FG000|Overall Study|Protocol Violation|3|||
148839973|NCT01214837|536893979|FG001|Overall Study|Protocol Violation|1|||
148839974|NCT01214837|536893980|FG002|Overall Study|Protocol Violation|5|||
148839975|NCT01214837|536893978|FG000|Overall Study|Unable to Classify|1|||
148839976|NCT01214837|536893979|FG001|Overall Study|Unable to Classify|3|||
148839977|NCT01214837|536893980|FG002|Overall Study|Unable to Classify|0|||
148839978|NCT05414175|536893981|FG000|Overall Study|Withdrawal by Subject|1|||
148839979|NCT05414175|536893981|FG000|Overall Study|Other Reasons|1|||
148839980|NCT00457626|536893983|FG000|Overall Study|Adverse Event|3|||
148839981|NCT00457626|536893983|FG000|Overall Study|Administrative Problems|2|||
148839982|NCT00457626|536893983|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
148839983|NCT03559270|536893986|FG000|Overall Study|Adverse Event|6|||
148839984|NCT03559270|536893987|FG001|Overall Study|Adverse Event|5|||
148839985|NCT03559270|536893988|FG002|Overall Study|Adverse Event|3|||
148839986|NCT03559270|536893989|FG003|Overall Study|Adverse Event|0|||
148839987|NCT03559270|536893986|FG000|Overall Study|Lack of Efficacy|34|||
148839988|NCT03559270|536893987|FG001|Overall Study|Lack of Efficacy|52|||
148839989|NCT03559270|536893988|FG002|Overall Study|Lack of Efficacy|37|||
148839990|NCT03559270|536893989|FG003|Overall Study|Lack of Efficacy|2|||
148839991|NCT03559270|536893986|FG000|Overall Study|Death|0|||
148839992|NCT03559270|536893987|FG001|Overall Study|Death|2|||
148839993|NCT03559270|536893988|FG002|Overall Study|Death|0|||
148839994|NCT03559270|536893989|FG003|Overall Study|Death|0|||
148839995|NCT03559270|536893986|FG000|Overall Study|Lost to Follow-up|16|||
148839996|NCT03559270|536893987|FG001|Overall Study|Lost to Follow-up|4|||
148839997|NCT03559270|536893988|FG002|Overall Study|Lost to Follow-up|12|||
148839998|NCT03559270|536893989|FG003|Overall Study|Lost to Follow-up|3|||
148839999|NCT03559270|536893986|FG000|Overall Study|Sponsor Decision|38|||
148840000|NCT03559270|536893987|FG001|Overall Study|Sponsor Decision|31|||
148840001|NCT03559270|536893988|FG002|Overall Study|Sponsor Decision|35|||
148840002|NCT03559270|536893989|FG003|Overall Study|Sponsor Decision|18|||
148840003|NCT03559270|536893986|FG000|Overall Study|Withdrawal by Subject|19|||
148840004|NCT03559270|536893987|FG001|Overall Study|Withdrawal by Subject|21|||
148840005|NCT03559270|536893988|FG002|Overall Study|Withdrawal by Subject|18|||
148840006|NCT03559270|536893989|FG003|Overall Study|Withdrawal by Subject|7|||
148840007|NCT03559270|536893986|FG000|Overall Study|Physician Decision|3|||
148840008|NCT03559270|536893987|FG001|Overall Study|Physician Decision|2|||
148840009|NCT03559270|536893988|FG002|Overall Study|Physician Decision|1|||
148840010|NCT03559270|536893989|FG003|Overall Study|Physician Decision|0|||
148840011|NCT03559270|536893986|FG000|Overall Study|Pregnancy|0|||
148840012|NCT03559270|536893987|FG001|Overall Study|Pregnancy|1|||
148840013|NCT03559270|536893988|FG002|Overall Study|Pregnancy|0|||
148840014|NCT03559270|536893989|FG003|Overall Study|Pregnancy|0|||
148840015|NCT03559270|536893986|FG000|Overall Study|Protocol Violation|1|||
148840016|NCT03559270|536893987|FG001|Overall Study|Protocol Violation|0|||
148840017|NCT03559270|536893988|FG002|Overall Study|Protocol Violation|2|||
148840018|NCT03559270|536893989|FG003|Overall Study|Protocol Violation|0|||
148840019|NCT00552071|536895591|FG000|Overall Study|Adverse Event|1|||
148840020|NCT00552071|536895592|FG001|Overall Study|Adverse Event|0|||
148840021|NCT00552071|536895591|FG000|Overall Study|Lack of Efficacy|1|||
148840022|NCT00552071|536895592|FG001|Overall Study|Lack of Efficacy|0|||
148840023|NCT00552071|536895591|FG000|Overall Study|Physician Decision|1|||
148840024|NCT00552071|536895592|FG001|Overall Study|Physician Decision|0|||
148840025|NCT00552071|536895591|FG000|Overall Study|Pregnancy|1|||
148840026|NCT00552071|536895592|FG001|Overall Study|Pregnancy|0|||
148840027|NCT00552071|536895591|FG000|Overall Study|Death|0|||
148840028|NCT00552071|536895592|FG001|Overall Study|Death|1|||
148840029|NCT00552071|536895591|FG000|Overall Study|Withdrawal by Subject|0|||
148840030|NCT00552071|536895592|FG001|Overall Study|Withdrawal by Subject|1|||
148840031|NCT00937495|536895597|FG000|Overall Study|Protocol Violation|2|||
148840032|NCT00441272|536895598|FG000|Overall Study|Study terminated prior to enrollment|25|||
148840033|NCT00441272|536895599|FG001|Overall Study|Study terminated prior to enrollment|25|||
148840034|NCT00954447|536895600|FG000|Overall Study|Adverse Event|33|||
148840035|NCT00954447|536895601|FG001|Overall Study|Adverse Event|25|||
148840036|NCT00954447|536895600|FG000|Overall Study|Lack of Efficacy|17|||
148840037|NCT00954447|536895601|FG001|Overall Study|Lack of Efficacy|3|||
148840038|NCT00954447|536895600|FG000|Overall Study|Protocol Violation|5|||
148840039|NCT00954447|536895601|FG001|Overall Study|Protocol Violation|7|||
148840040|NCT00954447|536895600|FG000|Overall Study|Lost to Follow-up|8|||
148840041|NCT00954447|536895601|FG001|Overall Study|Lost to Follow-up|14|||
148840042|NCT00954447|536895600|FG000|Overall Study|Withdrawal by Subject|26|||
148840043|NCT00954447|536895601|FG001|Overall Study|Withdrawal by Subject|21|||
148840044|NCT00954447|536895600|FG000|Overall Study|Other|21|||
148840045|NCT00954447|536895601|FG001|Overall Study|Other|18|||
148840046|NCT04592341|536895602|FG000|Overall Study|Physician Decision|5|||
148840047|NCT04592341|536895602|FG000|Overall Study|Study Terminated by Sponsor|5|||
148840048|NCT04592341|536895602|FG000|Overall Study|Withdrawal by Subject|53|||
148840049|NCT04592341|536895602|FG000|Overall Study|Lost to Follow-up|3|||
148840050|NCT04592341|536895602|FG000|Overall Study|Death|1|||
148840051|NCT04592341|536895602|FG000|Overall Study|Adverse Event|5|||
148840052|NCT04592341|536895602|FG000|Overall Study|other|4|||
148840053|NCT00692003|536895603|FG000|Overall Study|Sponsor Decision|5|||
148840054|NCT00692003|536895604|FG001|Overall Study|Sponsor Decision|1|||
148840055|NCT01535287|536895607|FG000|Overall Study|drug not prepared in time|5|||
148840056|NCT01535287|536895608|FG001|Overall Study|drug not prepared in time|6|||
148840057|NCT03341637|536895609|FG000|Overall Study|Lost to Follow-up|1|||
148840058|NCT03341637|536895610|FG001|Overall Study|Lost to Follow-up|0|||
148840059|NCT03341637|536895609|FG000|Overall Study|Withdrawal by Subject|3|||
148840060|NCT03341637|536895610|FG001|Overall Study|Withdrawal by Subject|3|||
148982690|NCT02461589|537415342|FG004|Overall Study|Death|0|||
148982691|NCT02461589|537415343|FG005|Overall Study|Death|0|||
148982692|NCT02461589|537415344|FG006|Overall Study|Death|0|||
148982693|NCT02461589|537415345|FG007|Overall Study|Death|1|||
148982694|NCT02461589|537415346|FG008|Overall Study|Death|0|||
148982695|NCT02461589|537415347|FG009|Overall Study|Death|0|||
148982696|NCT02461589|537415338|FG000|Overall Study|Unclassified|0|||
148840061|NCT03341637|536895609|FG000|Overall Study|Reason not Specified|1|||
148840062|NCT03341637|536895610|FG001|Overall Study|Reason not Specified|1|||
148840063|NCT01815424|536895621|FG000|Week 0 to 16|Adverse Event|1|||
148840064|NCT01815424|536895622|FG001|Week 0 to 16|Adverse Event|3|||
148840065|NCT01815424|536895623|FG002|Week 0 to 16|Adverse Event|3|||
148982697|NCT02461589|537415339|FG001|Overall Study|Unclassified|0|||
148982698|NCT02461589|537415340|FG002|Overall Study|Unclassified|0|||
148840066|NCT01815424|536895624|FG003|Week 0 to 16|Adverse Event|0|||
148840067|NCT01815424|536895625|FG004|Week 0 to 16|Adverse Event|0|||
148840068|NCT01815424|536895621|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
148840069|NCT01815424|536895622|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
148840070|NCT01815424|536895623|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
148840071|NCT01815424|536895624|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
148840072|NCT01815424|536895625|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
148840073|NCT01815424|536895621|FG000|Week 0 to 16|Lost to Follow-up|0|||
148840074|NCT01815424|536895622|FG001|Week 0 to 16|Lost to Follow-up|1|||
148982699|NCT02461589|537415341|FG003|Overall Study|Unclassified|0|||
148982700|NCT02461589|537415342|FG004|Overall Study|Unclassified|0|||
148982701|NCT02461589|537415343|FG005|Overall Study|Unclassified|0|||
148982702|NCT02461589|537415344|FG006|Overall Study|Unclassified|1|||
148982703|NCT02461589|537415345|FG007|Overall Study|Unclassified|0|||
148982704|NCT02461589|537415346|FG008|Overall Study|Unclassified|0|||
148982705|NCT02461589|537415347|FG009|Overall Study|Unclassified|2|||
148982706|NCT02461589|537415338|FG000|Overall Study|Missing follow-up information|1|||
148982707|NCT02461589|537415339|FG001|Overall Study|Missing follow-up information|1|||
148982708|NCT02461589|537415340|FG002|Overall Study|Missing follow-up information|0|||
148982709|NCT02461589|537415341|FG003|Overall Study|Missing follow-up information|0|||
148982710|NCT02461589|537415342|FG004|Overall Study|Missing follow-up information|0|||
148982711|NCT02461589|537415343|FG005|Overall Study|Missing follow-up information|0|||
148982712|NCT02461589|537415344|FG006|Overall Study|Missing follow-up information|1|||
148982713|NCT02461589|537415345|FG007|Overall Study|Missing follow-up information|0|||
148982714|NCT02461589|537415346|FG008|Overall Study|Missing follow-up information|0|||
148982715|NCT02461589|537415347|FG009|Overall Study|Missing follow-up information|0|||
148982716|NCT02461589|537415338|FG000|Overall Study|Withdrawal from trial before exposure|0|||
148982717|NCT02461589|537415339|FG001|Overall Study|Withdrawal from trial before exposure|0|||
148982718|NCT02461589|537415340|FG002|Overall Study|Withdrawal from trial before exposure|0|||
148982719|NCT02461589|537415341|FG003|Overall Study|Withdrawal from trial before exposure|0|||
148982720|NCT02461589|537415342|FG004|Overall Study|Withdrawal from trial before exposure|0|||
148982721|NCT02461589|537415343|FG005|Overall Study|Withdrawal from trial before exposure|0|||
148982722|NCT02461589|537415344|FG006|Overall Study|Withdrawal from trial before exposure|0|||
148982723|NCT02461589|537415345|FG007|Overall Study|Withdrawal from trial before exposure|0|||
148982724|NCT02461589|537415346|FG008|Overall Study|Withdrawal from trial before exposure|0|||
148982725|NCT02461589|537415347|FG009|Overall Study|Withdrawal from trial before exposure|1|||
148982726|NCT04713748|537415348|FG000|Overall Study|Not enough kits allocated|35|||
148982727|NCT00406029|537415353|FG000|Overall Study|Adverse Event|12|||
148982728|NCT00406029|537415354|FG001|Overall Study|Adverse Event|2|||
148982729|NCT00406029|537415355|FG002|Overall Study|Adverse Event|5|||
148982730|NCT00406029|537415356|FG003|Overall Study|Adverse Event|10|||
148982731|NCT00406029|537415357|FG004|Overall Study|Adverse Event|7|||
148982732|NCT00406029|537415353|FG000|Overall Study|Withdrawal by Subject|3|||
148982733|NCT00406029|537415354|FG001|Overall Study|Withdrawal by Subject|4|||
148982734|NCT00406029|537415355|FG002|Overall Study|Withdrawal by Subject|2|||
148982735|NCT00406029|537415356|FG003|Overall Study|Withdrawal by Subject|2|||
148982736|NCT00406029|537415357|FG004|Overall Study|Withdrawal by Subject|0|||
148982737|NCT00406029|537415353|FG000|Overall Study|Protocol Violation|1|||
148982738|NCT00406029|537415354|FG001|Overall Study|Protocol Violation|2|||
148982739|NCT00406029|537415355|FG002|Overall Study|Protocol Violation|0|||
148982740|NCT00406029|537415356|FG003|Overall Study|Protocol Violation|2|||
148982741|NCT00406029|537415357|FG004|Overall Study|Protocol Violation|0|||
148982742|NCT00406029|537415353|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
148982743|NCT00406029|537415354|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
148982744|NCT00406029|537415355|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
148982745|NCT00406029|537415356|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
148982746|NCT00406029|537415357|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
148982747|NCT00406029|537415353|FG000|Overall Study|Randomized in Error|0|||
148982748|NCT00406029|537415354|FG001|Overall Study|Randomized in Error|0|||
148982749|NCT00406029|537415355|FG002|Overall Study|Randomized in Error|2|||
148982750|NCT00406029|537415356|FG003|Overall Study|Randomized in Error|3|||
148982751|NCT00406029|537415357|FG004|Overall Study|Randomized in Error|1|||
148982752|NCT04067141|537415358|FG000|First Intervention|Withdrawal by Subject|0|||
148982753|NCT04067141|537415359|FG001|First Intervention|Withdrawal by Subject|1|||
148982754|NCT04067141|537415358|FG000|Second Intervention|Adverse Event|0|||
148982755|NCT04067141|537415359|FG001|Second Intervention|Adverse Event|2|||
148982756|NCT01557946|537415360|FG000|Overall Study|Adverse Event|3|||
148982757|NCT01557946|537415361|FG001|Overall Study|Adverse Event|0|||
148982758|NCT01038921|537415363|FG000|Overall Study|Withdrawal by Subject|1|||
148982759|NCT01038921|537415364|FG001|Overall Study|Withdrawal by Subject|0|||
148982760|NCT01038921|537415363|FG000|Overall Study|Physician Decision|1|||
148982761|NCT01038921|537415364|FG001|Overall Study|Physician Decision|0|||
148982762|NCT01709227|537415365|FG000|Overall Study|Physician Decision|1|||
148982763|NCT01709227|537415366|FG001|Overall Study|Physician Decision|0|||
148982764|NCT01709227|537415365|FG000|Overall Study|Pleural Peritoneal communication|0|||
148982765|NCT01709227|537415366|FG001|Overall Study|Pleural Peritoneal communication|9|||
148982766|NCT03295201|537415370|FG000|Overall Study|Lost to Follow-up|1|||
148982767|NCT03295201|537415371|FG001|Overall Study|Lost to Follow-up|1|||
148982768|NCT03295201|537415370|FG000|Overall Study|Hospital admission|0|||
148982769|NCT03295201|537415371|FG001|Overall Study|Hospital admission|1|||
148982770|NCT00572572|537415372|FG000|Overall Study|Withdrawal by Subject|3|||
148982771|NCT00572572|537415373|FG001|Overall Study|Withdrawal by Subject|6|||
148982772|NCT01831089|537415374|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
148982773|NCT01831089|537415375|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
148982774|NCT01831089|537415376|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
148982775|NCT01831089|537415377|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
148982776|NCT01831089|537415378|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
148982777|NCT01831089|537415379|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
148982778|NCT01831089|537415374|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
148982779|NCT01831089|537415375|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
148982780|NCT01831089|537415376|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
148982781|NCT01831089|537415377|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
148982782|NCT01831089|537415378|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
148982783|NCT01831089|537415379|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
148982784|NCT01831089|537415374|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
148982785|NCT01831089|537415375|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
148982786|NCT01831089|537415376|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
148982787|NCT01831089|537415377|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
148982788|NCT01831089|537415378|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
148982789|NCT01831089|537415379|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
148982790|NCT01831089|537415374|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
148982791|NCT01831089|537415375|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
148982792|NCT01831089|537415376|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
148982793|NCT01831089|537415377|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
148982794|NCT01831089|537415378|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
148982795|NCT01831089|537415379|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
148982796|NCT01831089|537415374|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
148982797|NCT01831089|537415375|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
148982798|NCT01831089|537415376|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
148982799|NCT01831089|537415377|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
148982800|NCT01831089|537415378|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
148982801|NCT01831089|537415379|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
148982802|NCT01831089|537415374|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
148982803|NCT01831089|537415375|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
148982804|NCT01831089|537415376|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
148982805|NCT01831089|537415377|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
148982806|NCT01831089|537415378|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
148982807|NCT01831089|537415379|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
148982808|NCT01831089|537415374|FG000|Cohort III: Dose Level 3|Global end of study|0|||
148982809|NCT01831089|537415375|FG001|Cohort III: Dose Level 3|Global end of study|0|||
148982810|NCT01831089|537415376|FG002|Cohort III: Dose Level 3|Global end of study|1|||
148982811|NCT01831089|537415377|FG003|Cohort III: Dose Level 3|Global end of study|0|||
148982812|NCT01831089|537415378|FG004|Cohort III: Dose Level 3|Global end of study|0|||
148982813|NCT01831089|537415379|FG005|Cohort III: Dose Level 3|Global end of study|0|||
148982814|NCT01831089|537415374|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
148982815|NCT01831089|537415375|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
148982816|NCT01831089|537415376|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
148982817|NCT01831089|537415377|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
148982818|NCT01831089|537415378|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
148982819|NCT01831089|537415379|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
148982820|NCT01831089|537415374|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
148982821|NCT01831089|537415375|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
148982822|NCT01831089|537415376|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
148982823|NCT01831089|537415377|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
148982824|NCT01831089|537415378|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
148982825|NCT01831089|537415379|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
148982826|NCT01831089|537415374|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
148982827|NCT01831089|537415375|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
148982828|NCT01831089|537415376|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
148982829|NCT01831089|537415377|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
148982830|NCT01831089|537415378|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
148982831|NCT01831089|537415379|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
148982832|NCT01831089|537415374|FG000|Cohort V: Dose Level 5|Death|0|||
148982833|NCT01831089|537415375|FG001|Cohort V: Dose Level 5|Death|0|||
148982834|NCT01831089|537415376|FG002|Cohort V: Dose Level 5|Death|0|||
148982835|NCT01831089|537415377|FG003|Cohort V: Dose Level 5|Death|0|||
148982836|NCT01831089|537415378|FG004|Cohort V: Dose Level 5|Death|1|||
148982837|NCT01831089|537415379|FG005|Cohort V: Dose Level 5|Death|0|||
148982838|NCT01831089|537415374|FG000|Cohort V: Dose Level 5|Global end of study|0|||
148982839|NCT01831089|537415375|FG001|Cohort V: Dose Level 5|Global end of study|0|||
149029307|NCT00868231|537586496|FG000|Treatment Period 2|Adverse Event|1|||
148774151|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
148774152|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
148774153|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
148840075|NCT01815424|536895623|FG002|Week 0 to 16|Lost to Follow-up|0|||
148982840|NCT01831089|537415376|FG002|Cohort V: Dose Level 5|Global end of study|0|||
148982841|NCT01831089|537415377|FG003|Cohort V: Dose Level 5|Global end of study|0|||
148982842|NCT01831089|537415378|FG004|Cohort V: Dose Level 5|Global end of study|2|||
148982843|NCT01831089|537415379|FG005|Cohort V: Dose Level 5|Global end of study|0|||
148982844|NCT01831089|537415374|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
148982845|NCT01831089|537415375|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
148982846|NCT01831089|537415376|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
148982847|NCT01831089|537415377|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
148982848|NCT01831089|537415378|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
148982849|NCT01831089|537415379|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
148982850|NCT01831089|537415374|FG000|Cohort B: Arm B|Progressive disease|0|||
148982851|NCT01831089|537415375|FG001|Cohort B: Arm B|Progressive disease|0|||
148982852|NCT01831089|537415376|FG002|Cohort B: Arm B|Progressive disease|0|||
148982853|NCT01831089|537415377|FG003|Cohort B: Arm B|Progressive disease|0|||
148982854|NCT01831089|537415378|FG004|Cohort B: Arm B|Progressive disease|0|||
148982855|NCT01831089|537415379|FG005|Cohort B: Arm B|Progressive disease|8|||
148982856|NCT01831089|537415374|FG000|Cohort B: Arm B|Physician Decision|0|||
148982857|NCT01831089|537415375|FG001|Cohort B: Arm B|Physician Decision|0|||
148982858|NCT01831089|537415376|FG002|Cohort B: Arm B|Physician Decision|0|||
148982859|NCT01831089|537415377|FG003|Cohort B: Arm B|Physician Decision|0|||
148982860|NCT01831089|537415378|FG004|Cohort B: Arm B|Physician Decision|0|||
148982861|NCT01831089|537415379|FG005|Cohort B: Arm B|Physician Decision|2|||
148982862|NCT01831089|537415374|FG000|Cohort B: Arm B|Never treated|0|||
148982863|NCT01831089|537415375|FG001|Cohort B: Arm B|Never treated|0|||
148982864|NCT01831089|537415376|FG002|Cohort B: Arm B|Never treated|0|||
148982865|NCT01831089|537415377|FG003|Cohort B: Arm B|Never treated|0|||
148982866|NCT01831089|537415378|FG004|Cohort B: Arm B|Never treated|0|||
148982867|NCT01831089|537415379|FG005|Cohort B: Arm B|Never treated|2|||
148982868|NCT01831089|537415374|FG000|Cohort B: Arm B|Adverse Event|0|||
148982869|NCT01831089|537415375|FG001|Cohort B: Arm B|Adverse Event|0|||
148982870|NCT01831089|537415376|FG002|Cohort B: Arm B|Adverse Event|0|||
148982871|NCT01831089|537415377|FG003|Cohort B: Arm B|Adverse Event|0|||
148982872|NCT01831089|537415378|FG004|Cohort B: Arm B|Adverse Event|0|||
148982873|NCT01831089|537415379|FG005|Cohort B: Arm B|Adverse Event|1|||
148982874|NCT01831089|537415374|FG000|Cohort B: Arm B|Global end of study|0|||
148982875|NCT01831089|537415375|FG001|Cohort B: Arm B|Global end of study|0|||
148982876|NCT01831089|537415376|FG002|Cohort B: Arm B|Global end of study|0|||
148982877|NCT01831089|537415377|FG003|Cohort B: Arm B|Global end of study|0|||
148982878|NCT01831089|537415378|FG004|Cohort B: Arm B|Global end of study|0|||
148982879|NCT01831089|537415379|FG005|Cohort B: Arm B|Global end of study|1|||
148982880|NCT00889421|537415380|FG000|Overall Study|Lack of Efficacy|3|||
148982881|NCT01958918|537415381|FG000|Overall Study|Death|1|||
148982882|NCT01958918|537415382|FG001|Overall Study|Death|3|||
148982883|NCT01958918|537415381|FG000|Overall Study|Lost to Follow-up|4|||
148982884|NCT01958918|537415382|FG001|Overall Study|Lost to Follow-up|7|||
148982885|NCT01958918|537415381|FG000|Overall Study|Withdrawal by Subject|13|||
148982886|NCT01958918|537415382|FG001|Overall Study|Withdrawal by Subject|8|||
148982887|NCT01958918|537415381|FG000|Overall Study|Lack of Efficacy|13|||
148982888|NCT01958918|537415382|FG001|Overall Study|Lack of Efficacy|10|||
148982889|NCT01958918|537415381|FG000|Overall Study|Adverse Event|12|||
148982890|NCT01958918|537415382|FG001|Overall Study|Adverse Event|12|||
148840076|NCT01815424|536895624|FG003|Week 0 to 16|Lost to Follow-up|0|||
148840077|NCT01815424|536895625|FG004|Week 0 to 16|Lost to Follow-up|0|||
148840078|NCT01815424|536895621|FG000|Week 0 to 16|Withdrawal by Subject|0|||
148840079|NCT01815424|536895622|FG001|Week 0 to 16|Withdrawal by Subject|0|||
148840080|NCT01815424|536895623|FG002|Week 0 to 16|Withdrawal by Subject|1|||
148840081|NCT01815424|536895624|FG003|Week 0 to 16|Withdrawal by Subject|0|||
148840082|NCT01815424|536895625|FG004|Week 0 to 16|Withdrawal by Subject|0|||
148840083|NCT01815424|536895621|FG000|Week 0 to 16|Other|1|||
148840084|NCT01815424|536895622|FG001|Week 0 to 16|Other|0|||
148982891|NCT01958918|537415381|FG000|Overall Study|administrative problems|0|||
148982892|NCT01958918|537415382|FG001|Overall Study|administrative problems|2|||
148982893|NCT02114892|537415386|FG000|Overall Study|Lost to Follow-up|1|||
148982894|NCT02114892|537415387|FG001|Overall Study|Lost to Follow-up|2|||
148982895|NCT02013765|537415391|FG000|Overall Study|Trial was terminated by sponsor|1|||
148840085|NCT01815424|536895623|FG002|Week 0 to 16|Other|3|||
148840086|NCT01815424|536895624|FG003|Week 0 to 16|Other|0|||
148840087|NCT01815424|536895625|FG004|Week 0 to 16|Other|0|||
148840088|NCT01815424|536895621|FG000|Week 0 to 16|Protocol Violation|1|||
148840089|NCT01815424|536895622|FG001|Week 0 to 16|Protocol Violation|0|||
148982896|NCT04479618|537415392|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
148982897|NCT04479618|537415393|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
148982898|NCT04479618|537415394|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
148982899|NCT04479618|537415392|FG000|Overall Study|Lack of Efficacy|1|||
148982900|NCT04479618|537415393|FG001|Overall Study|Lack of Efficacy|0|||
148982901|NCT04479618|537415394|FG002|Overall Study|Lack of Efficacy|0|||
148840090|NCT01815424|536895623|FG002|Week 0 to 16|Protocol Violation|0|||
148840091|NCT01815424|536895624|FG003|Week 0 to 16|Protocol Violation|0|||
148840092|NCT01815424|536895625|FG004|Week 0 to 16|Protocol Violation|0|||
148840093|NCT01815424|536895621|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
148840094|NCT01815424|536895622|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
148840095|NCT01815424|536895623|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
148840096|NCT01815424|536895624|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
148840097|NCT01815424|536895625|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
148840098|NCT01815424|536895621|FG000|Week 16 to 52|Other|0|||
148840099|NCT01815424|536895622|FG001|Week 16 to 52|Other|1|||
148840100|NCT01815424|536895623|FG002|Week 16 to 52|Other|0|||
148840101|NCT01815424|536895624|FG003|Week 16 to 52|Other|0|||
148840102|NCT01815424|536895625|FG004|Week 16 to 52|Other|0|||
148840103|NCT01815424|536895621|FG000|Week 16 to 52|Adverse Event|0|||
148840104|NCT01815424|536895622|FG001|Week 16 to 52|Adverse Event|0|||
148840105|NCT01815424|536895623|FG002|Week 16 to 52|Adverse Event|0|||
148840106|NCT01815424|536895624|FG003|Week 16 to 52|Adverse Event|0|||
148840107|NCT01815424|536895625|FG004|Week 16 to 52|Adverse Event|1|||
148840108|NCT01815424|536895621|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
148840109|NCT01815424|536895622|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
148840110|NCT01815424|536895623|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
148840111|NCT01815424|536895624|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
148840112|NCT01815424|536895625|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
148840113|NCT01815424|536895621|FG000|Week 16 to 52|Lost to Follow-up|0|||
148840114|NCT01815424|536895622|FG001|Week 16 to 52|Lost to Follow-up|2|||
148840115|NCT01815424|536895623|FG002|Week 16 to 52|Lost to Follow-up|0|||
148840116|NCT01815424|536895624|FG003|Week 16 to 52|Lost to Follow-up|2|||
148840117|NCT01815424|536895625|FG004|Week 16 to 52|Lost to Follow-up|1|||
148982902|NCT04479618|537415392|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
148982903|NCT04479618|537415393|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
148982904|NCT04479618|537415394|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
148982905|NCT04479618|537415392|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
148982906|NCT04479618|537415393|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
148982907|NCT04479618|537415394|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
148982908|NCT04479618|537415392|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
148982909|NCT04479618|537415393|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
148982910|NCT04479618|537415394|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
148982911|NCT04479618|537415392|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
148982912|NCT04479618|537415393|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
148982913|NCT04479618|537415394|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
148982914|NCT00659269|537415401|FG000|Overall Study|Physician Decision|1|||
148982915|NCT00659269|537415402|FG001|Overall Study|Physician Decision|1|||
148982916|NCT00718042|537415404|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
148982917|NCT00718042|537415405|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
148982918|NCT00718042|537415406|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
148982919|NCT00718042|537415407|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
148982920|NCT00718042|537415408|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
148982921|NCT00718042|537415409|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
148982922|NCT00718042|537415404|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
148982923|NCT00718042|537415405|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
148982924|NCT00718042|537415406|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
148982925|NCT00718042|537415407|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
148982926|NCT00718042|537415408|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
148982927|NCT00718042|537415409|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
148982928|NCT00718042|537415404|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
148982929|NCT00718042|537415405|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
148982930|NCT00718042|537415406|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
148982931|NCT00718042|537415407|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
148982932|NCT00718042|537415408|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
148982933|NCT00718042|537415409|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
148982934|NCT00718042|537415404|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
148840118|NCT01815424|536895621|FG000|Week 16 to 52|Withdrawal by Subject|1|||
148840119|NCT01815424|536895622|FG001|Week 16 to 52|Withdrawal by Subject|2|||
148840120|NCT01815424|536895623|FG002|Week 16 to 52|Withdrawal by Subject|0|||
148840121|NCT01815424|536895624|FG003|Week 16 to 52|Withdrawal by Subject|0|||
148840122|NCT01815424|536895625|FG004|Week 16 to 52|Withdrawal by Subject|0|||
148840123|NCT04723355|536895626|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
148840124|NCT04723355|536895626|FG000|Overall Study|Errors in the informed consent form|2|||
148840125|NCT03374358|536895627|FG000|Overall Study|Withdrawal by Subject|0|||
148840126|NCT03374358|536895628|FG001|Overall Study|Withdrawal by Subject|2|||
148840127|NCT01127633|536895629|FG000|Overall Study|Adverse Event|74|||
148840128|NCT01127633|536895630|FG001|Overall Study|Adverse Event|73|||
148840129|NCT01127633|536895629|FG000|Overall Study|Death|40|||
148840130|NCT01127633|536895630|FG001|Overall Study|Death|43|||
148840131|NCT01127633|536895629|FG000|Overall Study|Lost to Follow-up|4|||
148840132|NCT01127633|536895630|FG001|Overall Study|Lost to Follow-up|0|||
148840133|NCT01127633|536895629|FG000|Overall Study|Parent/Caregiver Decision|246|||
148840134|NCT01127633|536895630|FG001|Overall Study|Parent/Caregiver Decision|228|||
148840135|NCT01127633|536895629|FG000|Overall Study|Physician Decision|60|||
148840136|NCT01127633|536895630|FG001|Overall Study|Physician Decision|45|||
148840137|NCT01127633|536895629|FG000|Overall Study|Withdrawal by Subject|57|||
148840138|NCT01127633|536895630|FG001|Overall Study|Withdrawal by Subject|72|||
148840139|NCT01127633|536895629|FG000|Overall Study|Sponsor Decision|163|||
148840140|NCT01127633|536895630|FG001|Overall Study|Sponsor Decision|195|||
148840141|NCT01127633|536895629|FG000|Overall Study|Protocol Violation|8|||
148840142|NCT01127633|536895630|FG001|Overall Study|Protocol Violation|16|||
148840143|NCT01127633|536895629|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
148840144|NCT01127633|536895630|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
148840145|NCT01127633|536895629|FG000|Overall Study|Not treated|1|||
148840146|NCT01127633|536895630|FG001|Overall Study|Not treated|0|||
148840147|NCT02805790|536895632|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
148840148|NCT02805790|536895633|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
148889124|NCT05214768|537072368|FG004|Maintenance Period|Other Reasons|0|||
148889125|NCT05214768|537072369|FG005|Maintenance Period|Other Reasons|0|||
148889126|NCT05214768|537072364|FG000|Maintenance Period|Withdrawal by Subject|0|||
148889127|NCT05214768|537072365|FG001|Maintenance Period|Withdrawal by Subject|0|||
148889128|NCT05214768|537072366|FG002|Maintenance Period|Withdrawal by Subject|0|||
148889129|NCT05214768|537072367|FG003|Maintenance Period|Withdrawal by Subject|1|||
148889130|NCT05214768|537072368|FG004|Maintenance Period|Withdrawal by Subject|0|||
148889131|NCT05214768|537072369|FG005|Maintenance Period|Withdrawal by Subject|0|||
148889132|NCT05214768|537072364|FG000|Maintenance Period|Lack of Efficacy|0|||
148889133|NCT05214768|537072365|FG001|Maintenance Period|Lack of Efficacy|0|||
148889134|NCT05214768|537072366|FG002|Maintenance Period|Lack of Efficacy|1|||
148889135|NCT05214768|537072367|FG003|Maintenance Period|Lack of Efficacy|0|||
148889136|NCT05214768|537072368|FG004|Maintenance Period|Lack of Efficacy|1|||
148889137|NCT05214768|537072369|FG005|Maintenance Period|Lack of Efficacy|0|||
148889138|NCT05214768|537072364|FG000|Open Label Extension Period|Physician Decision|0|||
148889139|NCT05214768|537072365|FG001|Open Label Extension Period|Physician Decision|0|||
148889140|NCT05214768|537072366|FG002|Open Label Extension Period|Physician Decision|0|||
148889141|NCT05214768|537072367|FG003|Open Label Extension Period|Physician Decision|0|||
148889142|NCT05214768|537072368|FG004|Open Label Extension Period|Physician Decision|0|||
148889143|NCT05214768|537072369|FG005|Open Label Extension Period|Physician Decision|1|||
148889144|NCT05214768|537072364|FG000|Open Label Extension Period|Lack of Efficacy|0|||
148889145|NCT05214768|537072365|FG001|Open Label Extension Period|Lack of Efficacy|0|||
148889146|NCT05214768|537072366|FG002|Open Label Extension Period|Lack of Efficacy|0|||
148889147|NCT05214768|537072367|FG003|Open Label Extension Period|Lack of Efficacy|0|||
148889148|NCT05214768|537072368|FG004|Open Label Extension Period|Lack of Efficacy|0|||
148889149|NCT05214768|537072369|FG005|Open Label Extension Period|Lack of Efficacy|1|||
148889150|NCT05214768|537072364|FG000|Open Label Extension Period|Ongoing Study|0|||
148889151|NCT05214768|537072365|FG001|Open Label Extension Period|Ongoing Study|0|||
148889152|NCT05214768|537072366|FG002|Open Label Extension Period|Ongoing Study|0|||
148889153|NCT05214768|537072367|FG003|Open Label Extension Period|Ongoing Study|0|||
148889154|NCT05214768|537072368|FG004|Open Label Extension Period|Ongoing Study|0|||
148889155|NCT05214768|537072369|FG005|Open Label Extension Period|Ongoing Study|42|||
148889156|NCT05481359|537072370|FG000|Overall Study|Lost to Follow-up|3|||
148889157|NCT05481359|537072370|FG000|Overall Study|Withdrawal by Subject|1|||
148889158|NCT06235905|537072375|FG000|Overall Study|Adverse Event|1|||
148889159|NCT06235905|537072375|FG000|Overall Study|Non-compliant with protocol procedures|1|||
148889160|NCT00319254|537072376|FG000|Overall Study|Withdrawal by Subject|4|||
148889161|NCT00319254|537072376|FG000|Overall Study|Death|46|||
148889162|NCT00319254|537072376|FG000|Overall Study|Lost to Follow-up|2|||
148889163|NCT00319254|537072376|FG000|Overall Study|Enrolled, Not Treated|2|||
148889164|NCT04177212|537072378|FG000|Overall Study|Withdrawal by Subject|9|||
148889165|NCT04177212|537072379|FG001|Overall Study|Withdrawal by Subject|7|||
148889166|NCT04177212|537072378|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
148889167|NCT04177212|537072379|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
148889168|NCT04177212|537072378|FG000|Overall Study|Physician Decision|1|||
148889169|NCT04177212|537072379|FG001|Overall Study|Physician Decision|0|||
148889170|NCT04177212|537072378|FG000|Overall Study|Lost to Follow-up|0|||
148889171|NCT04177212|537072379|FG001|Overall Study|Lost to Follow-up|3|||
148889172|NCT04177212|537072378|FG000|Overall Study|Adverse Event|0|||
148889173|NCT04177212|537072379|FG001|Overall Study|Adverse Event|1|||
148889174|NCT04177212|537072378|FG000|Overall Study|Other|1|||
148840149|NCT01881009|536895639|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
148840150|NCT01881009|536895640|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
148840151|NCT05518461|536895642|FG000|Overall Study|Lost to Follow-up|25|||
148840152|NCT03326063|536895644|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
148840153|NCT03326063|536895645|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
148840154|NCT00382174|536895646|FG000|Overall Study|Lost to Follow-up|1|||
148840155|NCT00382174|536895647|FG001|Overall Study|Lost to Follow-up|4|||
148840156|NCT00382174|536895648|FG002|Overall Study|Lost to Follow-up|5|||
148840157|NCT00382174|536895646|FG000|Overall Study|Adverse Event|1|||
148840158|NCT00382174|536895647|FG001|Overall Study|Adverse Event|4|||
148840159|NCT00382174|536895648|FG002|Overall Study|Adverse Event|5|||
148840160|NCT00382174|536895646|FG000|Overall Study|Withdrawal by Subject|1|||
148840161|NCT00382174|536895647|FG001|Overall Study|Withdrawal by Subject|4|||
148840162|NCT00382174|536895648|FG002|Overall Study|Withdrawal by Subject|5|||
148840163|NCT00382174|536895646|FG000|Overall Study|Non compliance|1|||
148840164|NCT00382174|536895647|FG001|Overall Study|Non compliance|0|||
148840165|NCT00382174|536895648|FG002|Overall Study|Non compliance|1|||
148840166|NCT00382174|536895646|FG000|Overall Study|Physician Decision|0|||
148840167|NCT00382174|536895647|FG001|Overall Study|Physician Decision|2|||
148840168|NCT00382174|536895648|FG002|Overall Study|Physician Decision|2|||
148840169|NCT00382174|536895646|FG000|Overall Study|Failed to meet criteria|0|||
148840170|NCT00382174|536895647|FG001|Overall Study|Failed to meet criteria|1|||
148840171|NCT00382174|536895648|FG002|Overall Study|Failed to meet criteria|1|||
148840172|NCT00382174|536895646|FG000|Overall Study|Wounds merged|0|||
148840173|NCT00382174|536895647|FG001|Overall Study|Wounds merged|2|||
148840174|NCT00382174|536895648|FG002|Overall Study|Wounds merged|2|||
148840175|NCT02230189|536895649|FG000|Overall Study|Withdrawal by Subject|3|||
148840176|NCT02230189|536895650|FG001|Overall Study|Withdrawal by Subject|0|||
148840177|NCT02230189|536895651|FG002|Overall Study|Withdrawal by Subject|1|||
148840178|NCT02230189|536895649|FG000|Overall Study|Lost to Follow-up|1|||
148840179|NCT02230189|536895650|FG001|Overall Study|Lost to Follow-up|0|||
148840180|NCT02230189|536895651|FG002|Overall Study|Lost to Follow-up|0|||
148840181|NCT02230189|536895649|FG000|Overall Study|Physician Decision|1|||
148840182|NCT02230189|536895650|FG001|Overall Study|Physician Decision|0|||
148840183|NCT02230189|536895651|FG002|Overall Study|Physician Decision|0|||
148840184|NCT03824392|536895652|FG000|Overall Study|Adverse Event|1|||
148840185|NCT03824392|536895653|FG001|Overall Study|Adverse Event|0|||
148840186|NCT03824392|536895654|FG002|Overall Study|Adverse Event|0|||
148840187|NCT03824392|536895655|FG003|Overall Study|Adverse Event|0|||
148840188|NCT03824392|536895652|FG000|Overall Study|Investigator Decision|0|||
148840189|NCT03824392|536895653|FG001|Overall Study|Investigator Decision|1|||
148840190|NCT03824392|536895654|FG002|Overall Study|Investigator Decision|0|||
148840191|NCT03824392|536895655|FG003|Overall Study|Investigator Decision|0|||
148840192|NCT03824392|536895652|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
148840193|NCT03824392|536895653|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
148840194|NCT03824392|536895654|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
148840195|NCT03824392|536895655|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
148840196|NCT03894891|536895658|FG000|Overall Study|Withdrawal by Subject|1|||
148840197|NCT03894891|536895658|FG000|Overall Study|Completed protocol treatment per protocol|5|||
148840198|NCT01030822|536895665|FG000|Overall Study|Moved/migrated from study area|6|||
148840199|NCT01030822|536895666|FG001|Overall Study|Moved/migrated from study area|7|||
148840200|NCT01030822|536895667|FG002|Overall Study|Moved/migrated from study area|3|||
148840201|NCT01030822|536895665|FG000|Overall Study|Withdrawal by Subject|16|||
148840202|NCT01030822|536895666|FG001|Overall Study|Withdrawal by Subject|13|||
148840203|NCT01030822|536895667|FG002|Overall Study|Withdrawal by Subject|16|||
148840204|NCT01030822|536895665|FG000|Overall Study|Lost to Follow-up|9|||
148840205|NCT01030822|536895666|FG001|Overall Study|Lost to Follow-up|4|||
148840206|NCT01030822|536895667|FG002|Overall Study|Lost to Follow-up|7|||
148840207|NCT00401843|536895668|FG000|Overall Study|Achieved Complete Response|1|||
148840208|NCT00401843|536895669|FG001|Overall Study|Achieved Complete Response|5|||
148840209|NCT00401843|536895670|FG002|Overall Study|Achieved Complete Response|11|||
148840210|NCT00401843|536895668|FG000|Overall Study|Adverse Event|7|||
148840211|NCT00401843|536895669|FG001|Overall Study|Adverse Event|26|||
148840212|NCT00401843|536895670|FG002|Overall Study|Adverse Event|27|||
148840213|NCT00401843|536895668|FG000|Overall Study|Death|0|||
148840214|NCT00401843|536895669|FG001|Overall Study|Death|8|||
148840215|NCT00401843|536895670|FG002|Overall Study|Death|10|||
148840216|NCT00401843|536895668|FG000|Overall Study|Disease progression|10|||
148840217|NCT00401843|536895669|FG001|Overall Study|Disease progression|60|||
148982935|NCT00718042|537415405|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
148982936|NCT00718042|537415406|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
148840218|NCT00401843|536895670|FG002|Overall Study|Disease progression|49|||
148840219|NCT00401843|536895668|FG000|Overall Study|End of Study|1|||
148840220|NCT00401843|536895669|FG001|Overall Study|End of Study|1|||
148840221|NCT00401843|536895670|FG002|Overall Study|End of Study|2|||
148840222|NCT00401843|536895668|FG000|Overall Study|Lost to Follow-up|0|||
148840223|NCT00401843|536895669|FG001|Overall Study|Lost to Follow-up|0|||
148840224|NCT00401843|536895670|FG002|Overall Study|Lost to Follow-up|2|||
148840225|NCT00401843|536895668|FG000|Overall Study|Other Unspecified|0|||
148840226|NCT00401843|536895669|FG001|Overall Study|Other Unspecified|3|||
148840227|NCT00401843|536895670|FG002|Overall Study|Other Unspecified|5|||
148840228|NCT00401843|536895668|FG000|Overall Study|Physician Decision|0|||
148840229|NCT00401843|536895669|FG001|Overall Study|Physician Decision|16|||
148840230|NCT00401843|536895670|FG002|Overall Study|Physician Decision|10|||
148840231|NCT00401843|536895668|FG000|Overall Study|Protocol Violation|0|||
148840232|NCT00401843|536895669|FG001|Overall Study|Protocol Violation|0|||
148840233|NCT00401843|536895670|FG002|Overall Study|Protocol Violation|1|||
148840234|NCT00401843|536895668|FG000|Overall Study|Withdrawal by Subject|1|||
148840235|NCT00401843|536895669|FG001|Overall Study|Withdrawal by Subject|5|||
148840236|NCT00401843|536895670|FG002|Overall Study|Withdrawal by Subject|5|||
148840237|NCT00401843|536895668|FG000|Overall Study|Withdrawal of consent to study agent|1|||
148840238|NCT00401843|536895669|FG001|Overall Study|Withdrawal of consent to study agent|15|||
148840239|NCT00401843|536895670|FG002|Overall Study|Withdrawal of consent to study agent|17|||
148840240|NCT00401843|536895668|FG000|Overall Study|Randomized but not Treated|0|||
148840241|NCT00401843|536895669|FG001|Overall Study|Randomized but not Treated|2|||
148840242|NCT00401843|536895670|FG002|Overall Study|Randomized but not Treated|3|||
148840243|NCT00401843|536895668|FG000|Overall Study|Received incorrect treatment|0|||
148840244|NCT00401843|536895669|FG001|Overall Study|Received incorrect treatment|3|||
148840245|NCT00401843|536895670|FG002|Overall Study|Received incorrect treatment|0|||
148840246|NCT00959907|536895683|FG000|Overall Study|Protocol Violation|0|||
148840247|NCT00959907|536895684|FG001|Overall Study|Protocol Violation|1|||
148840248|NCT00959907|536895683|FG000|Overall Study|Adverse Event|1|||
148840249|NCT00959907|536895684|FG001|Overall Study|Adverse Event|0|||
148840250|NCT00959907|536895683|FG000|Overall Study|Withdrawal by Subject|2|||
148840251|NCT00959907|536895684|FG001|Overall Study|Withdrawal by Subject|0|||
148840252|NCT03958331|536895685|FG000|Overall Study|Withdrawal by Subject|3|||
148840253|NCT03958331|536895686|FG001|Overall Study|Withdrawal by Subject|1|||
148840254|NCT03958331|536895687|FG002|Overall Study|Withdrawal by Subject|5|||
148840255|NCT03958331|536895685|FG000|Overall Study|Weaned from medicine|2|||
148840256|NCT03958331|536895686|FG001|Overall Study|Weaned from medicine|0|||
148840257|NCT03958331|536895687|FG002|Overall Study|Weaned from medicine|0|||
148840258|NCT03958331|536895685|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
148840259|NCT03958331|536895686|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
148840260|NCT03958331|536895687|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
148840261|NCT01932788|536895693|FG000|Overall Study|Protocol Violation|18|||
148840262|NCT01932788|536895694|FG001|Overall Study|Protocol Violation|0|||
148840263|NCT01932788|536895693|FG000|Overall Study|Lost to Follow-up|18|||
148840264|NCT01932788|536895694|FG001|Overall Study|Lost to Follow-up|46|||
148840265|NCT01932788|536895693|FG000|Overall Study|Lack of Efficacy|2|||
148840266|NCT01932788|536895694|FG001|Overall Study|Lack of Efficacy|0|||
148840267|NCT01932788|536895693|FG000|Overall Study|Withdrawal by Subject|0|||
148840268|NCT01932788|536895694|FG001|Overall Study|Withdrawal by Subject|5|||
148840269|NCT01171677|536895695|FG000|Overall Study|Withdrawal by Subject|0|||
148840270|NCT01171677|536895696|FG001|Overall Study|Withdrawal by Subject|3|||
148840271|NCT01171677|536895695|FG000|Overall Study|Adverse Event|1|||
148840272|NCT01171677|536895696|FG001|Overall Study|Adverse Event|0|||
148840273|NCT01171677|536895695|FG000|Overall Study|completed <70% IntenSati classes|5|||
148840274|NCT01171677|536895696|FG001|Overall Study|completed <70% IntenSati classes|0|||
148840275|NCT03092479|536895715|FG000|Overall Study|Lost to Follow-up|3|||
148840276|NCT03092479|536895716|FG001|Overall Study|Lost to Follow-up|2|||
148840277|NCT03092479|536895715|FG000|Overall Study|Withdrawal by Subject|4|||
148840278|NCT03092479|536895716|FG001|Overall Study|Withdrawal by Subject|0|||
148840279|NCT04422431|536895719|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
148840280|NCT04422431|536895719|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
148840281|NCT04422431|536895719|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
148840282|NCT04422431|536895719|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
148840283|NCT04422431|536895719|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
148840284|NCT04422431|536895719|FG000|Extension Period (48 Weeks)|Other than specified|2|||
148840285|NCT03913130|536895720|FG000|Overall Study|Sponsor Decision|1|||
148840286|NCT01174563|536895721|FG000|Overall Study|Progressive Disease|45|||
148840287|NCT01174563|536895721|FG000|Overall Study|Death|5|||
148840288|NCT01174563|536895721|FG000|Overall Study|Investigator's Discretion|5|||
148840289|NCT01174563|536895721|FG000|Overall Study|Participant Withdrew Consent|3|||
148840290|NCT01174563|536895721|FG000|Overall Study|Rash Adverse Event|1|||
148840291|NCT01174563|536895721|FG000|Overall Study|Sponsor's decision|1|||
148982937|NCT00718042|537415407|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
148982938|NCT00718042|537415408|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
148982939|NCT00718042|537415409|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
148840292|NCT00444106|536895722|FG000|Overall Study|Lost to Follow-up|2|||
148840293|NCT00444106|536895723|FG001|Overall Study|Lost to Follow-up|1|||
148840294|NCT00444106|536895724|FG002|Overall Study|Lost to Follow-up|0|||
148840295|NCT00444106|536895722|FG000|Overall Study|Abnormal Test Procedure Results|0|||
148840296|NCT00444106|536895723|FG001|Overall Study|Abnormal Test Procedure Results|0|||
148840297|NCT00444106|536895724|FG002|Overall Study|Abnormal Test Procedure Results|1|||
148840298|NCT01152437|536895726|FG000|Overall Study|Other Adverse Event|8|||
148840299|NCT01152437|536895727|FG001|Overall Study|Other Adverse Event|1|||
148840300|NCT01152437|536895728|FG002|Overall Study|Other Adverse Event|7|||
148840301|NCT01152437|536895726|FG000|Overall Study|Not treated|0|||
148840302|NCT01152437|536895727|FG001|Overall Study|Not treated|1|||
148840303|NCT01152437|536895728|FG002|Overall Study|Not treated|2|||
148840304|NCT01152437|536895726|FG000|Overall Study|Progressive disease|27|||
148840305|NCT01152437|536895727|FG001|Overall Study|Progressive disease|13|||
148840306|NCT01152437|536895728|FG002|Overall Study|Progressive disease|32|||
148840307|NCT01152437|536895726|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
148840308|NCT01152437|536895727|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
148840309|NCT01152437|536895728|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
148840310|NCT02015039|536895729|FG000|Overall Study|Not eligible|0|||
148840311|NCT02015039|536895730|FG001|Overall Study|Not eligible|1|||
148840312|NCT01900665|536895735|FG000|Placebo Controlled Period|Death|9|||
148840313|NCT01900665|536895736|FG001|Placebo Controlled Period|Death|16|||
148840314|NCT01900665|536895735|FG000|Placebo Controlled Period|Adverse Event|48|||
148840315|NCT01900665|536895736|FG001|Placebo Controlled Period|Adverse Event|39|||
148840316|NCT01900665|536895735|FG000|Placebo Controlled Period|Protocol Violation|1|||
148840317|NCT01900665|536895736|FG001|Placebo Controlled Period|Protocol Violation|7|||
148840318|NCT01900665|536895735|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
148840319|NCT01900665|536895736|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
148840320|NCT01900665|536895735|FG000|Placebo Controlled Period|Physician Decision|11|||
148840321|NCT01900665|536895736|FG001|Placebo Controlled Period|Physician Decision|7|||
148840322|NCT01900665|536895735|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
148840323|NCT01900665|536895736|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
148840324|NCT01900665|536895735|FG000|Placebo Controlled Period|Caregiver Decision|33|||
148840325|NCT01900665|536895736|FG001|Placebo Controlled Period|Caregiver Decision|41|||
148840326|NCT01900665|536895735|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
148840327|NCT01900665|536895736|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
148840328|NCT01900665|536895735|FG000|Open Label Period|Adverse Event|16|||
148840329|NCT01900665|536895736|FG001|Open Label Period|Adverse Event|20|||
148840330|NCT01900665|536895735|FG000|Open Label Period|Death|5|||
148840331|NCT01900665|536895736|FG001|Open Label Period|Death|6|||
148840332|NCT01900665|536895735|FG000|Open Label Period|Lost to Follow-up|1|||
148840333|NCT01900665|536895736|FG001|Open Label Period|Lost to Follow-up|1|||
148840334|NCT01900665|536895735|FG000|Open Label Period|Parent/Caregiver Decision|33|||
148840335|NCT01900665|536895736|FG001|Open Label Period|Parent/Caregiver Decision|34|||
148840336|NCT01900665|536895735|FG000|Open Label Period|Physician Decision|4|||
148840337|NCT01900665|536895736|FG001|Open Label Period|Physician Decision|4|||
148840338|NCT01900665|536895735|FG000|Open Label Period|Protocol Violation|0|||
148840339|NCT01900665|536895736|FG001|Open Label Period|Protocol Violation|1|||
148840340|NCT01900665|536895735|FG000|Open Label Period|Sponsor Decision|802|||
148840341|NCT01900665|536895736|FG001|Open Label Period|Sponsor Decision|765|||
148840342|NCT01900665|536895735|FG000|Open Label Period|Withdrawal by Subject|20|||
148840343|NCT01900665|536895736|FG001|Open Label Period|Withdrawal by Subject|28|||
148840344|NCT02317627|536895738|FG000|Overall Study|Withdrawal by Subject|0|||
148840345|NCT02317627|536895739|FG001|Overall Study|Withdrawal by Subject|1|||
148840346|NCT02317627|536895740|FG002|Overall Study|Withdrawal by Subject|1|||
148840347|NCT02317627|536895738|FG000|Overall Study|Lost to Follow-up|2|||
148840348|NCT02317627|536895739|FG001|Overall Study|Lost to Follow-up|0|||
148840349|NCT02317627|536895740|FG002|Overall Study|Lost to Follow-up|0|||
148840350|NCT02317627|536895738|FG000|Overall Study|Stopped by Investigator|0|||
148840351|NCT02317627|536895739|FG001|Overall Study|Stopped by Investigator|1|||
148840352|NCT02317627|536895740|FG002|Overall Study|Stopped by Investigator|0|||
148840353|NCT02317627|536895738|FG000|Overall Study|Adverse Event|0|||
148840354|NCT02317627|536895739|FG001|Overall Study|Adverse Event|2|||
148840355|NCT02317627|536895740|FG002|Overall Study|Adverse Event|3|||
148840356|NCT02317627|536895738|FG000|Overall Study|Non-compliance with study drug|0|||
148840357|NCT02317627|536895739|FG001|Overall Study|Non-compliance with study drug|1|||
148840358|NCT02317627|536895740|FG002|Overall Study|Non-compliance with study drug|0|||
148840359|NCT04749914|536895741|FG000|Period 1|Adverse Event|1|||
148840360|NCT04749914|536895742|FG001|Period 1|Adverse Event|0|||
148840361|NCT04749914|536895743|FG002|Period 1|Adverse Event|0|||
148840362|NCT04749914|536895744|FG003|Period 1|Adverse Event|0|||
148840363|NCT04749914|536895741|FG000|Period 1|Withdrawal by Subject|1|||
148840364|NCT04749914|536895742|FG001|Period 1|Withdrawal by Subject|0|||
148840365|NCT04749914|536895743|FG002|Period 1|Withdrawal by Subject|1|||
148840366|NCT04749914|536895744|FG003|Period 1|Withdrawal by Subject|0|||
148840367|NCT04046939|536895745|FG000|Primary Assessment Period|Adverse Event|1|||
148840368|NCT04046939|536895746|FG001|Primary Assessment Period|Adverse Event|0|||
148840369|NCT04046939|536895747|FG002|Primary Assessment Period|Adverse Event|0|||
148840370|NCT04046939|536895748|FG003|Primary Assessment Period|Adverse Event|0|||
148840371|NCT04046939|536895745|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
148840372|NCT04046939|536895746|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
148840373|NCT04046939|536895747|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
148840374|NCT04046939|536895748|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
148840375|NCT04046939|536895745|FG000|Primary Assessment Period|Physician Decision|0|||
148840376|NCT04046939|536895746|FG001|Primary Assessment Period|Physician Decision|0|||
148840377|NCT04046939|536895747|FG002|Primary Assessment Period|Physician Decision|1|||
148840378|NCT04046939|536895748|FG003|Primary Assessment Period|Physician Decision|0|||
148840379|NCT04046939|536895745|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
148840380|NCT04046939|536895746|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
148840381|NCT04046939|536895747|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
148840382|NCT04046939|536895748|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
148840383|NCT00403130|536895749|FG000|2 Years From Start of Treatment|Not Eligible|3|||
148840384|NCT00403130|536895749|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
148840385|NCT00403130|536895749|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
148840386|NCT00403130|536895749|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
148840387|NCT01897532|536895751|FG000|Discontinuation From Treatment|Not Treated|7|||
148840388|NCT01897532|536895752|FG001|Discontinuation From Treatment|Not Treated|5|||
148840389|NCT01897532|536895751|FG000|Discontinuation From Treatment|Other reason than specified|196|||
148840390|NCT01897532|536895752|FG001|Discontinuation From Treatment|Other reason than specified|176|||
148840391|NCT01897532|536895751|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
148840392|NCT01897532|536895752|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
148840393|NCT01897532|536895751|FG000|Discontinuation From Treatment|Non compliance|24|||
148840394|NCT01897532|536895752|FG001|Discontinuation From Treatment|Non compliance|15|||
148840395|NCT01897532|536895751|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
148840396|NCT01897532|536895752|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
148840397|NCT01897532|536895751|FG000|Discontinuation From Trial|Not Treated|7|||
148840398|NCT01897532|536895752|FG001|Discontinuation From Trial|Not Treated|5|||
148840399|NCT01897532|536895751|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
148840400|NCT01897532|536895752|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
148840401|NCT01088906|536895757|FG000|Overall Study|Inclusion error|1|||
148840402|NCT01088906|536895757|FG000|Overall Study|Did not receive study treatment|3|||
148840403|NCT01088906|536895757|FG000|Overall Study|Missing data|1|||
148840404|NCT00027560|536895758|FG000|Overall Study|Withdrawal by Subject|1|||
148840405|NCT04790279|536897838|FG000|Overall Study|Did not meet medication start criteria|27|||
148840406|NCT04790279|536897839|FG001|Overall Study|Did not meet medication start criteria|15|||
148840407|NCT04790279|536897838|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
148840408|NCT04790279|536897839|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
148840409|NCT04790279|536897838|FG000|Overall Study|Protocol Violation|8|||
148840410|NCT04790279|536897839|FG001|Overall Study|Protocol Violation|3|||
148840411|NCT04790279|536897838|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
148840412|NCT04790279|536897839|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
148840413|NCT00678288|536897856|FG000|Overall Study|Adverse Event|0|||
148840414|NCT00678288|536897857|FG001|Overall Study|Adverse Event|2|||
148840415|NCT00678288|536897856|FG000|Overall Study|Withdrawal by Subject|1|||
148840416|NCT00678288|536897857|FG001|Overall Study|Withdrawal by Subject|1|||
148840417|NCT00678288|536897856|FG000|Overall Study|Study terminated by the sponsor|2|||
148840418|NCT00678288|536897857|FG001|Overall Study|Study terminated by the sponsor|0|||
148840419|NCT00678288|536897856|FG000|Overall Study|Not compliant with study medication|0|||
148840420|NCT00678288|536897857|FG001|Overall Study|Not compliant with study medication|1|||
148840421|NCT00678288|536897856|FG000|Overall Study|Switch to commercial drug|0|||
148840422|NCT00678288|536897857|FG001|Overall Study|Switch to commercial drug|1|||
148840423|NCT00678288|536897856|FG000|Overall Study|Reason not reported|1|||
148840424|NCT00678288|536897857|FG001|Overall Study|Reason not reported|0|||
148840425|NCT00678288|536897856|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
148840426|NCT00678288|536897857|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
148840427|NCT04472650|536897866|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
148840428|NCT04472650|536897867|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
148840429|NCT01713582|536897870|FG000|Overall Study|Disease progression|3|||
148840430|NCT01713582|536897871|FG001|Overall Study|Disease progression|3|||
148840431|NCT01713582|536897872|FG002|Overall Study|Disease progression|3|||
148840432|NCT01713582|536897873|FG003|Overall Study|Disease progression|2|||
148840433|NCT01713582|536897874|FG004|Overall Study|Disease progression|3|||
148840434|NCT01713582|536897875|FG005|Overall Study|Disease progression|3|||
148840435|NCT01713582|536897876|FG006|Overall Study|Disease progression|3|||
148840436|NCT01713582|536897877|FG007|Overall Study|Disease progression|3|||
148840437|NCT01713582|536897878|FG008|Overall Study|Disease progression|3|||
148840438|NCT01713582|536897879|FG009|Overall Study|Disease progression|11|||
148840439|NCT01713582|536897880|FG010|Overall Study|Disease progression|10|||
148840440|NCT01713582|536897881|FG011|Overall Study|Disease progression|5|||
148840441|NCT01713582|536897882|FG012|Overall Study|Disease progression|3|||
148840442|NCT01713582|536897883|FG013|Overall Study|Disease progression|3|||
148840443|NCT01713582|536897884|FG014|Overall Study|Disease progression|6|||
148840444|NCT01713582|536897885|FG015|Overall Study|Disease progression|6|||
148840445|NCT01713582|536897886|FG016|Overall Study|Disease progression|5|||
148840446|NCT01713582|536897887|FG017|Overall Study|Disease progression|2|||
148840447|NCT01713582|536897888|FG018|Overall Study|Disease progression|3|||
148840448|NCT01713582|536897889|FG019|Overall Study|Disease progression|5|||
148840449|NCT01713582|536897890|FG020|Overall Study|Disease progression|15|||
148840450|NCT01713582|536897870|FG000|Overall Study|Death|0|||
148840451|NCT01713582|536897871|FG001|Overall Study|Death|0|||
148840452|NCT01713582|536897872|FG002|Overall Study|Death|0|||
148840453|NCT01713582|536897873|FG003|Overall Study|Death|1|||
148840454|NCT01713582|536897874|FG004|Overall Study|Death|1|||
148840455|NCT01713582|536897875|FG005|Overall Study|Death|3|||
148840456|NCT01713582|536897876|FG006|Overall Study|Death|3|||
148840457|NCT01713582|536897877|FG007|Overall Study|Death|2|||
148840458|NCT01713582|536897878|FG008|Overall Study|Death|3|||
148840459|NCT01713582|536897879|FG009|Overall Study|Death|4|||
148840460|NCT01713582|536897880|FG010|Overall Study|Death|3|||
148840461|NCT01713582|536897881|FG011|Overall Study|Death|0|||
148840462|NCT01713582|536897882|FG012|Overall Study|Death|0|||
148840463|NCT01713582|536897883|FG013|Overall Study|Death|0|||
148840464|NCT01713582|536897884|FG014|Overall Study|Death|0|||
148840465|NCT01713582|536897885|FG015|Overall Study|Death|0|||
148840466|NCT01713582|536897886|FG016|Overall Study|Death|0|||
148840467|NCT01713582|536897887|FG017|Overall Study|Death|0|||
148840468|NCT01713582|536897888|FG018|Overall Study|Death|0|||
148840469|NCT01713582|536897889|FG019|Overall Study|Death|0|||
148840470|NCT01713582|536897890|FG020|Overall Study|Death|0|||
148840471|NCT01713582|536897870|FG000|Overall Study|Adverse event-related|0|||
148840472|NCT01713582|536897871|FG001|Overall Study|Adverse event-related|0|||
148840473|NCT01713582|536897872|FG002|Overall Study|Adverse event-related|0|||
148840474|NCT01713582|536897873|FG003|Overall Study|Adverse event-related|0|||
148840475|NCT01713582|536897874|FG004|Overall Study|Adverse event-related|0|||
148840476|NCT01713582|536897875|FG005|Overall Study|Adverse event-related|0|||
148840477|NCT01713582|536897876|FG006|Overall Study|Adverse event-related|0|||
148840478|NCT01713582|536897877|FG007|Overall Study|Adverse event-related|0|||
148840479|NCT01713582|536897878|FG008|Overall Study|Adverse event-related|0|||
148840480|NCT01713582|536897879|FG009|Overall Study|Adverse event-related|1|||
148840481|NCT01713582|536897880|FG010|Overall Study|Adverse event-related|1|||
148840482|NCT01713582|536897881|FG011|Overall Study|Adverse event-related|0|||
148840483|NCT01713582|536897882|FG012|Overall Study|Adverse event-related|0|||
148840484|NCT01713582|536897883|FG013|Overall Study|Adverse event-related|0|||
148840485|NCT01713582|536897884|FG014|Overall Study|Adverse event-related|0|||
148840486|NCT01713582|536897885|FG015|Overall Study|Adverse event-related|0|||
148840487|NCT01713582|536897886|FG016|Overall Study|Adverse event-related|0|||
148840488|NCT01713582|536897887|FG017|Overall Study|Adverse event-related|0|||
148840489|NCT01713582|536897888|FG018|Overall Study|Adverse event-related|1|||
148840490|NCT01713582|536897889|FG019|Overall Study|Adverse event-related|0|||
148840491|NCT01713582|536897890|FG020|Overall Study|Adverse event-related|0|||
148840492|NCT01713582|536897870|FG000|Overall Study|Adverse event-unrelated|0|||
148840493|NCT01713582|536897871|FG001|Overall Study|Adverse event-unrelated|0|||
148840494|NCT01713582|536897872|FG002|Overall Study|Adverse event-unrelated|0|||
148840495|NCT01713582|536897873|FG003|Overall Study|Adverse event-unrelated|0|||
148840496|NCT01713582|536897874|FG004|Overall Study|Adverse event-unrelated|0|||
148840497|NCT01713582|536897875|FG005|Overall Study|Adverse event-unrelated|1|||
148840498|NCT01713582|536897876|FG006|Overall Study|Adverse event-unrelated|1|||
148840499|NCT01713582|536897877|FG007|Overall Study|Adverse event-unrelated|1|||
148840500|NCT01713582|536897878|FG008|Overall Study|Adverse event-unrelated|0|||
148840501|NCT01713582|536897879|FG009|Overall Study|Adverse event-unrelated|0|||
148840502|NCT01713582|536897880|FG010|Overall Study|Adverse event-unrelated|0|||
148840503|NCT01713582|536897881|FG011|Overall Study|Adverse event-unrelated|0|||
148840504|NCT01713582|536897882|FG012|Overall Study|Adverse event-unrelated|0|||
148840505|NCT01713582|536897883|FG013|Overall Study|Adverse event-unrelated|1|||
148840506|NCT01713582|536897884|FG014|Overall Study|Adverse event-unrelated|1|||
148840507|NCT01713582|536897885|FG015|Overall Study|Adverse event-unrelated|0|||
148840508|NCT01713582|536897886|FG016|Overall Study|Adverse event-unrelated|0|||
148840509|NCT01713582|536897887|FG017|Overall Study|Adverse event-unrelated|0|||
148840510|NCT01713582|536897888|FG018|Overall Study|Adverse event-unrelated|0|||
148840511|NCT01713582|536897889|FG019|Overall Study|Adverse event-unrelated|0|||
148840512|NCT01713582|536897890|FG020|Overall Study|Adverse event-unrelated|0|||
148840513|NCT01713582|536897870|FG000|Overall Study|Withdrawal of consent|0|||
148840514|NCT01713582|536897871|FG001|Overall Study|Withdrawal of consent|0|||
148840515|NCT01713582|536897872|FG002|Overall Study|Withdrawal of consent|1|||
148840516|NCT01713582|536897873|FG003|Overall Study|Withdrawal of consent|0|||
148840517|NCT01713582|536897874|FG004|Overall Study|Withdrawal of consent|0|||
148840518|NCT01713582|536897875|FG005|Overall Study|Withdrawal of consent|1|||
148840519|NCT01713582|536897876|FG006|Overall Study|Withdrawal of consent|0|||
148840520|NCT01713582|536897877|FG007|Overall Study|Withdrawal of consent|0|||
148840521|NCT01713582|536897878|FG008|Overall Study|Withdrawal of consent|0|||
148840522|NCT01713582|536897879|FG009|Overall Study|Withdrawal of consent|1|||
148840523|NCT01713582|536897880|FG010|Overall Study|Withdrawal of consent|0|||
148840524|NCT01713582|536897881|FG011|Overall Study|Withdrawal of consent|0|||
148840525|NCT01713582|536897882|FG012|Overall Study|Withdrawal of consent|0|||
148840526|NCT01713582|536897883|FG013|Overall Study|Withdrawal of consent|0|||
148840527|NCT01713582|536897884|FG014|Overall Study|Withdrawal of consent|0|||
148840528|NCT01713582|536897885|FG015|Overall Study|Withdrawal of consent|0|||
148840529|NCT01713582|536897886|FG016|Overall Study|Withdrawal of consent|0|||
148840530|NCT01713582|536897887|FG017|Overall Study|Withdrawal of consent|0|||
148840531|NCT01713582|536897888|FG018|Overall Study|Withdrawal of consent|1|||
148840532|NCT01713582|536897889|FG019|Overall Study|Withdrawal of consent|0|||
148840533|NCT01713582|536897890|FG020|Overall Study|Withdrawal of consent|0|||
148840534|NCT01713582|536897870|FG000|Overall Study|Lack of Efficacy|0|||
148840535|NCT01713582|536897871|FG001|Overall Study|Lack of Efficacy|0|||
148840536|NCT01713582|536897872|FG002|Overall Study|Lack of Efficacy|0|||
148840537|NCT01713582|536897873|FG003|Overall Study|Lack of Efficacy|0|||
148840538|NCT01713582|536897874|FG004|Overall Study|Lack of Efficacy|0|||
148840539|NCT01713582|536897875|FG005|Overall Study|Lack of Efficacy|0|||
148840540|NCT01713582|536897876|FG006|Overall Study|Lack of Efficacy|0|||
148840541|NCT01713582|536897877|FG007|Overall Study|Lack of Efficacy|0|||
148840542|NCT01713582|536897878|FG008|Overall Study|Lack of Efficacy|0|||
148840543|NCT01713582|536897879|FG009|Overall Study|Lack of Efficacy|1|||
148840544|NCT01713582|536897880|FG010|Overall Study|Lack of Efficacy|2|||
148840545|NCT01713582|536897881|FG011|Overall Study|Lack of Efficacy|0|||
148840546|NCT01713582|536897882|FG012|Overall Study|Lack of Efficacy|0|||
148840547|NCT01713582|536897883|FG013|Overall Study|Lack of Efficacy|0|||
148840548|NCT01713582|536897884|FG014|Overall Study|Lack of Efficacy|0|||
148840549|NCT01713582|536897885|FG015|Overall Study|Lack of Efficacy|0|||
148840550|NCT01713582|536897886|FG016|Overall Study|Lack of Efficacy|0|||
148840551|NCT01713582|536897887|FG017|Overall Study|Lack of Efficacy|0|||
148840552|NCT01713582|536897888|FG018|Overall Study|Lack of Efficacy|0|||
148840553|NCT01713582|536897889|FG019|Overall Study|Lack of Efficacy|0|||
148840554|NCT01713582|536897890|FG020|Overall Study|Lack of Efficacy|0|||
148840555|NCT01713582|536897870|FG000|Overall Study|Withdrawal by Subject|0|||
148840556|NCT01713582|536897871|FG001|Overall Study|Withdrawal by Subject|0|||
148840557|NCT01713582|536897872|FG002|Overall Study|Withdrawal by Subject|0|||
148840558|NCT01713582|536897873|FG003|Overall Study|Withdrawal by Subject|0|||
148840559|NCT01713582|536897874|FG004|Overall Study|Withdrawal by Subject|0|||
148840560|NCT01713582|536897875|FG005|Overall Study|Withdrawal by Subject|0|||
148840561|NCT01713582|536897876|FG006|Overall Study|Withdrawal by Subject|0|||
148840562|NCT01713582|536897877|FG007|Overall Study|Withdrawal by Subject|0|||
148840563|NCT01713582|536897878|FG008|Overall Study|Withdrawal by Subject|0|||
148840564|NCT01713582|536897879|FG009|Overall Study|Withdrawal by Subject|0|||
148840565|NCT01713582|536897880|FG010|Overall Study|Withdrawal by Subject|0|||
148840566|NCT01713582|536897881|FG011|Overall Study|Withdrawal by Subject|0|||
148840567|NCT01713582|536897882|FG012|Overall Study|Withdrawal by Subject|0|||
148840568|NCT01713582|536897883|FG013|Overall Study|Withdrawal by Subject|0|||
148840569|NCT01713582|536897884|FG014|Overall Study|Withdrawal by Subject|0|||
148840570|NCT01713582|536897885|FG015|Overall Study|Withdrawal by Subject|0|||
148840571|NCT01713582|536897886|FG016|Overall Study|Withdrawal by Subject|0|||
148840572|NCT01713582|536897887|FG017|Overall Study|Withdrawal by Subject|1|||
148840573|NCT01713582|536897888|FG018|Overall Study|Withdrawal by Subject|0|||
148840574|NCT01713582|536897889|FG019|Overall Study|Withdrawal by Subject|0|||
148840575|NCT01713582|536897890|FG020|Overall Study|Withdrawal by Subject|0|||
148840576|NCT01713582|536897870|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
148840577|NCT01713582|536897871|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
148840578|NCT01713582|536897872|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
148840579|NCT01713582|536897873|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
148840580|NCT01713582|536897874|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
148840581|NCT01713582|536897875|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
148840582|NCT01713582|536897876|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
148840583|NCT01713582|536897877|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
148840584|NCT01713582|536897878|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
148840585|NCT01713582|536897879|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
148840586|NCT01713582|536897880|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
148840587|NCT01713582|536897881|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
148840588|NCT01713582|536897882|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
148840589|NCT01713582|536897883|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
148840590|NCT01713582|536897884|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
148840591|NCT01713582|536897885|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
148840592|NCT01713582|536897886|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
148840593|NCT01713582|536897887|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
148982940|NCT00718042|537415404|FG000|Donor Follow-up|Lost to Follow-up|13|||
148982941|NCT00718042|537415405|FG001|Donor Follow-up|Lost to Follow-up|0|||
148774154|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
148774155|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
148774156|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
148774157|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
148774158|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
148774159|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
148774160|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
148774161|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
148774162|NCT04488419|536646913|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
148774163|NCT04488419|536646914|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
148774164|NCT04488419|536646915|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
148774165|NCT04488419|536646913|FG000|Primary Analysis Population|Adverse Event|6|||
148774166|NCT04488419|536646914|FG001|Primary Analysis Population|Adverse Event|9|||
148774167|NCT04488419|536646915|FG002|Primary Analysis Population|Adverse Event|0|||
148774168|NCT04488419|536646913|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
148774169|NCT04488419|536646914|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
148774170|NCT04488419|536646915|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
148774171|NCT04488419|536646913|FG000|Primary Analysis Population|Protocol Violation|1|||
148774172|NCT04488419|536646914|FG001|Primary Analysis Population|Protocol Violation|1|||
148774173|NCT04488419|536646915|FG002|Primary Analysis Population|Protocol Violation|0|||
148774174|NCT04488419|536646913|FG000|Primary Analysis Population|Undetermined|7|||
148774175|NCT04488419|536646914|FG001|Primary Analysis Population|Undetermined|3|||
148774176|NCT04488419|536646915|FG002|Primary Analysis Population|Undetermined|0|||
148774177|NCT04488419|536646913|FG000|Primary Analysis Population|>1 Reason|2|||
148774178|NCT04488419|536646914|FG001|Primary Analysis Population|>1 Reason|4|||
148774179|NCT04488419|536646915|FG002|Primary Analysis Population|>1 Reason|0|||
148774180|NCT04327661|536646918|FG000|Overall Study|Withdrawal by Subject|1|||
148774181|NCT04327661|536646919|FG001|Overall Study|Withdrawal by Subject|0|||
148774182|NCT04327661|536646920|FG002|Overall Study|Withdrawal by Subject|0|||
148774183|NCT02677038|536646928|FG000|Overall Study|Physician Decision|1|||
148774184|NCT02677038|536646928|FG000|Overall Study|Withdrawal by Subject|1|||
148774185|NCT02777970|536646935|FG000|Overall Study|Lost to Follow-up|0|||
148774186|NCT02777970|536646936|FG001|Overall Study|Lost to Follow-up|1|||
148774187|NCT02777970|536646937|FG002|Overall Study|Lost to Follow-up|0|||
148774188|NCT02777970|536646935|FG000|Overall Study|Protocol Violation|1|||
148774189|NCT02777970|536646936|FG001|Overall Study|Protocol Violation|0|||
148774190|NCT02777970|536646937|FG002|Overall Study|Protocol Violation|0|||
148774191|NCT05845567|536646938|FG000|Overall Study|Withdrawal by Subject|1|||
148774192|NCT02062944|536646944|FG000|Overall Study|Lost to Follow-up|1|||
148774193|NCT02062944|536646944|FG000|Overall Study|New hemotological disorder identified|1|||
148774194|NCT02062944|536646944|FG000|Overall Study|Uncontrolled Hypertension|1|||
148774195|NCT02062944|536646944|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
148774196|NCT01740128|536646945|FG000|Overall Study|Pregnancy|0|||
148774197|NCT01740128|536646946|FG001|Overall Study|Pregnancy|1|||
148774198|NCT01740128|536646945|FG000|Overall Study|Protocol Violation|1|||
148774199|NCT01740128|536646946|FG001|Overall Study|Protocol Violation|2|||
148774200|NCT01740128|536646945|FG000|Overall Study|Lost to Follow-up|2|||
148774201|NCT01740128|536646946|FG001|Overall Study|Lost to Follow-up|2|||
148774202|NCT01740128|536646945|FG000|Overall Study|Withdrawal by Subject|1|||
148774203|NCT01740128|536646946|FG001|Overall Study|Withdrawal by Subject|0|||
148774204|NCT01740128|536646945|FG000|Overall Study|Insufficient protocol compliance|2|||
148774205|NCT01740128|536646946|FG001|Overall Study|Insufficient protocol compliance|2|||
148774206|NCT02658734|536646949|FG000|Overall Study|Adverse Event|2|||
148774207|NCT02658734|536646949|FG000|Overall Study|Death|4|||
148774208|NCT02658734|536646949|FG000|Overall Study|Lost to Follow-up|7|||
148774209|NCT02658734|536646949|FG000|Overall Study|Withdrawal of Consent|16|||
148774210|NCT02658734|536646949|FG000|Overall Study|Disease Progression|28|||
148774211|NCT02231879|536646950|FG000|Overall Study|Adverse Event|2|||
148774212|NCT02231879|536646951|FG001|Overall Study|Adverse Event|1|||
148774213|NCT02231879|536646950|FG000|Overall Study|Lack of Efficacy|0|||
148774214|NCT02231879|536646951|FG001|Overall Study|Lack of Efficacy|1|||
148774215|NCT00459706|536646952|FG000|Overall Study|Adverse Event|19|||
148774216|NCT00459706|536646953|FG001|Overall Study|Adverse Event|13|||
148774217|NCT00459706|536646952|FG000|Overall Study|Withdrawal by Subject|1|||
148774218|NCT00459706|536646953|FG001|Overall Study|Withdrawal by Subject|6|||
148774219|NCT00459706|536646952|FG000|Overall Study|Physician Decision|2|||
148774220|NCT00459706|536646953|FG001|Overall Study|Physician Decision|0|||
148774221|NCT00459706|536646952|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
148774222|NCT00459706|536646953|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
148774223|NCT00459706|536646952|FG000|Overall Study|Protocol Violation|2|||
148774224|NCT00459706|536646953|FG001|Overall Study|Protocol Violation|1|||
148774225|NCT00459706|536646952|FG000|Overall Study|Failed to Return|1|||
148982942|NCT00718042|537415406|FG002|Donor Follow-up|Lost to Follow-up|0|||
148982943|NCT00718042|537415407|FG003|Donor Follow-up|Lost to Follow-up|0|||
148982944|NCT00718042|537415408|FG004|Donor Follow-up|Lost to Follow-up|19|||
148982945|NCT00718042|537415409|FG005|Donor Follow-up|Lost to Follow-up|0|||
148982946|NCT04327934|537415410|FG000|Overall Study|Did not qualify|7|||
148982947|NCT04327934|537415411|FG001|Overall Study|Did not qualify|4|||
148840594|NCT01713582|536897888|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
148840595|NCT01713582|536897889|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
148840596|NCT01713582|536897890|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
148840597|NCT01713582|536897870|FG000|Overall Study|Disease progression and adverse event|0|||
148840598|NCT01713582|536897871|FG001|Overall Study|Disease progression and adverse event|0|||
148840599|NCT01713582|536897872|FG002|Overall Study|Disease progression and adverse event|0|||
148840600|NCT01713582|536897873|FG003|Overall Study|Disease progression and adverse event|0|||
148840601|NCT01713582|536897874|FG004|Overall Study|Disease progression and adverse event|0|||
148840602|NCT01713582|536897875|FG005|Overall Study|Disease progression and adverse event|0|||
148840603|NCT01713582|536897876|FG006|Overall Study|Disease progression and adverse event|0|||
148840604|NCT01713582|536897877|FG007|Overall Study|Disease progression and adverse event|0|||
148840605|NCT01713582|536897878|FG008|Overall Study|Disease progression and adverse event|0|||
148840606|NCT01713582|536897879|FG009|Overall Study|Disease progression and adverse event|0|||
148840607|NCT01713582|536897880|FG010|Overall Study|Disease progression and adverse event|0|||
148840608|NCT01713582|536897881|FG011|Overall Study|Disease progression and adverse event|0|||
148840609|NCT01713582|536897882|FG012|Overall Study|Disease progression and adverse event|0|||
148840610|NCT01713582|536897883|FG013|Overall Study|Disease progression and adverse event|0|||
148840611|NCT01713582|536897884|FG014|Overall Study|Disease progression and adverse event|0|||
148840612|NCT01713582|536897885|FG015|Overall Study|Disease progression and adverse event|0|||
148840613|NCT01713582|536897886|FG016|Overall Study|Disease progression and adverse event|1|||
148840614|NCT01713582|536897887|FG017|Overall Study|Disease progression and adverse event|0|||
148840615|NCT01713582|536897888|FG018|Overall Study|Disease progression and adverse event|0|||
148840616|NCT01713582|536897889|FG019|Overall Study|Disease progression and adverse event|0|||
148840617|NCT01713582|536897890|FG020|Overall Study|Disease progression and adverse event|0|||
148840618|NCT04776161|536897892|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
148840619|NCT04776161|536897893|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
148840620|NCT04776161|536897894|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
148840621|NCT04776161|536897892|FG000|Overall Study|Withdrawal by Subject|1|||
148840622|NCT04776161|536897893|FG001|Overall Study|Withdrawal by Subject|0|||
148840623|NCT04776161|536897894|FG002|Overall Study|Withdrawal by Subject|1|||
148840624|NCT04776161|536897892|FG000|Overall Study|Adverse Event|0|||
148840625|NCT04776161|536897893|FG001|Overall Study|Adverse Event|1|||
148840626|NCT04776161|536897894|FG002|Overall Study|Adverse Event|1|||
148840627|NCT00342628|536897897|FG000|Overall Study|Withdrawal by Subject|19|||
148840628|NCT00342628|536897898|FG001|Overall Study|Withdrawal by Subject|19|||
148840629|NCT00342628|536897899|FG002|Overall Study|Withdrawal by Subject|18|||
148840630|NCT00342628|536897897|FG000|Overall Study|Death|1|||
148840631|NCT00342628|536897898|FG001|Overall Study|Death|1|||
148840632|NCT00342628|536897899|FG002|Overall Study|Death|0|||
148840633|NCT00342628|536897897|FG000|Overall Study|moved residence|0|||
148840634|NCT00342628|536897898|FG001|Overall Study|moved residence|1|||
148840635|NCT00342628|536897899|FG002|Overall Study|moved residence|1|||
148840636|NCT01475721|536897900|FG000|Overall Study|Death|3|||
148840637|NCT01475721|536897901|FG001|Overall Study|Death|6|||
148840638|NCT01475721|536897900|FG000|Overall Study|Withdrawal by Subject|8|||
148840639|NCT01475721|536897901|FG001|Overall Study|Withdrawal by Subject|8|||
148840640|NCT01048242|536897902|FG000|Overall Study|See study flow chart|4|||
148840641|NCT01048242|536897903|FG001|Overall Study|See study flow chart|2|||
148840642|NCT02364037|536897904|FG000|Overall Study|Withdrawal by Subject|7|||
148840643|NCT02364037|536897905|FG001|Overall Study|Withdrawal by Subject|4|||
148840644|NCT02364037|536897904|FG000|Overall Study|Lost to Follow-up|37|||
148840645|NCT02364037|536897905|FG001|Overall Study|Lost to Follow-up|49|||
148840646|NCT01772550|536897906|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
148840647|NCT01772550|536897907|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
148840648|NCT01772550|536897908|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
148840649|NCT01772550|536897906|FG000|Overall Study|Adverse Event|0|||
148840650|NCT01772550|536897907|FG001|Overall Study|Adverse Event|0|||
148840651|NCT01772550|536897908|FG002|Overall Study|Adverse Event|1|||
148840652|NCT00559104|536897909|FG000|Overall Study|Lack of Efficacy|9|||
148840653|NCT00559104|536897910|FG001|Overall Study|Lack of Efficacy|0|||
148840654|NCT00387088|536897911|FG000|Overall Study|Adverse Event|143|||
148840655|NCT00387088|536897912|FG001|Overall Study|Adverse Event|156|||
148840656|NCT00387088|536897911|FG000|Overall Study|Protocol Violation|47|||
148840657|NCT00387088|536897912|FG001|Overall Study|Protocol Violation|35|||
148840658|NCT00387088|536897911|FG000|Overall Study|Withdrawal by Subject|20|||
148840659|NCT00387088|536897912|FG001|Overall Study|Withdrawal by Subject|35|||
148840660|NCT00387088|536897911|FG000|Overall Study|Lack of Efficacy|28|||
148982948|NCT04327934|537415410|FG000|Overall Study|Physician Decision|0|||
148982949|NCT04327934|537415411|FG001|Overall Study|Physician Decision|1|||
148982950|NCT02443298|537415412|FG000|Overall Study|Adverse Event|3|||
148982951|NCT02443298|537415413|FG001|Overall Study|Adverse Event|3|||
148982952|NCT02443298|537415412|FG000|Overall Study|Withdrawal by Subject|1|||
148982953|NCT02443298|537415413|FG001|Overall Study|Withdrawal by Subject|2|||
148982954|NCT01047683|537415414|FG000|Overall Study|Adverse Event|3|||
148982955|NCT01047683|537415415|FG001|Overall Study|Adverse Event|1|||
148982956|NCT01047683|537415416|FG002|Overall Study|Adverse Event|0|||
148982957|NCT01047683|537415414|FG000|Overall Study|Withdrew Consent|1|||
148982958|NCT01047683|537415415|FG001|Overall Study|Withdrew Consent|4|||
148982959|NCT01047683|537415416|FG002|Overall Study|Withdrew Consent|2|||
148982960|NCT01047683|537415414|FG000|Overall Study|Lost to Follow-up|0|||
148982961|NCT01047683|537415415|FG001|Overall Study|Lost to Follow-up|1|||
148982962|NCT01047683|537415416|FG002|Overall Study|Lost to Follow-up|0|||
148982963|NCT01047683|537415414|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
148982964|NCT01047683|537415415|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
148982965|NCT01047683|537415416|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
148982966|NCT01260922|537415430|FG000|First Intervention|Withdrawal by Subject|0|||
148982967|NCT01260922|537415431|FG001|First Intervention|Withdrawal by Subject|1|||
148982968|NCT01260922|537415430|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
148982969|NCT01260922|537415431|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
148982970|NCT01260922|537415430|FG000|Second Intervention|Emesis|0|||
148982971|NCT01260922|537415431|FG001|Second Intervention|Emesis|2|||
148982972|NCT02822794|537415432|FG000|Overall Study|Withdrew Consent|1|||
148982973|NCT02822794|537415433|FG001|Overall Study|Withdrew Consent|0|||
148982974|NCT04788147|537415434|FG000|Overall Study|Screen Failure|3|||
148982975|NCT04788147|537415435|FG001|Overall Study|Screen Failure|10|||
148982976|NCT04788147|537415434|FG000|Overall Study|Incomplete RMRS image session|2|||
148982977|NCT04788147|537415435|FG001|Overall Study|Incomplete RMRS image session|0|||
148982978|NCT00781326|537415440|FG000|Phase I|Adverse Event|1|||
148982979|NCT00781326|537415440|FG000|Phase I|Withdrawal by Subject|1|||
148982980|NCT00781326|537415440|FG000|Phase I|Physician Decision|2|||
148982981|NCT05101252|537415441|FG000|Overall Study|Unsatisfactory Test Article|1|||
148982982|NCT05101252|537415442|FG001|Overall Study|Unsatisfactory Test Article|0|||
148982983|NCT05101252|537415441|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
148982984|NCT05101252|537415442|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
148982985|NCT05101252|537415441|FG000|Overall Study|Withdrew Consent during study|0|||
148982986|NCT05101252|537415442|FG001|Overall Study|Withdrew Consent during study|1|||
148982987|NCT05101252|537415441|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
148982988|NCT05101252|537415442|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
148982989|NCT03732248|537415443|FG000|Overall Study|Withdrawal by Subject|1|||
148982990|NCT03732248|537415444|FG001|Overall Study|Withdrawal by Subject|0|||
148982991|NCT01243944|537415452|FG000|Overall Study|Adverse Event|15|||
148982992|NCT01243944|537415453|FG001|Overall Study|Adverse Event|13|||
148982993|NCT01243944|537415452|FG000|Overall Study|Lost to Follow-up|2|||
148982994|NCT01243944|537415453|FG001|Overall Study|Lost to Follow-up|1|||
148982995|NCT01243944|537415452|FG000|Overall Study|Physician Decision|2|||
148982996|NCT01243944|537415453|FG001|Overall Study|Physician Decision|7|||
148982997|NCT01243944|537415452|FG000|Overall Study|Disease progression|12|||
148982998|NCT01243944|537415453|FG001|Overall Study|Disease progression|11|||
148982999|NCT01243944|537415452|FG000|Overall Study|Protocol deviation|1|||
148983000|NCT01243944|537415453|FG001|Overall Study|Protocol deviation|1|||
148983001|NCT01243944|537415452|FG000|Overall Study|Participant decision|10|||
148983002|NCT01243944|537415453|FG001|Overall Study|Participant decision|15|||
148983003|NCT01243944|537415452|FG000|Overall Study|Death|2|||
148983004|NCT01243944|537415453|FG001|Overall Study|Death|3|||
148983005|NCT01243944|537415452|FG000|Overall Study|Non-compliance with study treatment|1|||
148983006|NCT01243944|537415453|FG001|Overall Study|Non-compliance with study treatment|0|||
148983007|NCT01731171|537415457|FG000|Overall Study|Withdrawal by Subject|4|||
148983008|NCT01731171|537415458|FG001|Overall Study|Withdrawal by Subject|1|||
148983009|NCT01731171|537415457|FG000|Overall Study|Lost to Follow-up|3|||
148983010|NCT01731171|537415458|FG001|Overall Study|Lost to Follow-up|2|||
148983011|NCT01731171|537415457|FG000|Overall Study|Moved out of Area|0|||
148774226|NCT00459706|536646953|FG001|Overall Study|Failed to Return|0|||
148774227|NCT00459706|536646952|FG000|Overall Study|Other|0|||
148774228|NCT00459706|536646953|FG001|Overall Study|Other|1|||
148983012|NCT01731171|537415458|FG001|Overall Study|Moved out of Area|2|||
148983013|NCT01731171|537415457|FG000|Overall Study|Terminated for Lack of Adherence|0|||
148983014|NCT01731171|537415458|FG001|Overall Study|Terminated for Lack of Adherence|1|||
148983015|NCT01731171|537415457|FG000|Overall Study|Terminated for Safety Reasons|0|||
148983016|NCT01731171|537415458|FG001|Overall Study|Terminated for Safety Reasons|1|||
148983017|NCT00403546|537415461|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
148983018|NCT00403546|537415462|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
148983019|NCT00403546|537415463|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
148983020|NCT00403546|537415461|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
148983021|NCT00403546|537415462|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
148983022|NCT00403546|537415463|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
148983023|NCT00403546|537415461|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
148983024|NCT00403546|537415462|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
148983025|NCT00403546|537415463|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
148983026|NCT00403546|537415461|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
148983027|NCT00403546|537415462|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
148983028|NCT00403546|537415463|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
148983029|NCT00403546|537415461|FG000|Screening Phase|Screening Failure|22|||
148983030|NCT00403546|537415462|FG001|Screening Phase|Screening Failure|0|||
148983031|NCT00403546|537415463|FG002|Screening Phase|Screening Failure|0|||
148983032|NCT00403546|537415461|FG000|Screening Phase|Adverse Event|1|||
148983033|NCT00403546|537415462|FG001|Screening Phase|Adverse Event|0|||
148983034|NCT00403546|537415463|FG002|Screening Phase|Adverse Event|0|||
148983035|NCT00403546|537415461|FG000|Screening Phase|Terminated Prior to Randomization|5|||
148983036|NCT00403546|537415462|FG001|Screening Phase|Terminated Prior to Randomization|0|||
148983037|NCT00403546|537415463|FG002|Screening Phase|Terminated Prior to Randomization|0|||
148983038|NCT00403546|537415461|FG000|Randomized Trial|Early Terminations|0|||
148983039|NCT00403546|537415462|FG001|Randomized Trial|Early Terminations|17|||
148983040|NCT00403546|537415463|FG002|Randomized Trial|Early Terminations|16|||
148983041|NCT02604589|537415467|FG000|Overall Study|catheter dislodgement|0|||
148983042|NCT02604589|537415468|FG001|Overall Study|catheter dislodgement|0|||
148983043|NCT02604589|537415469|FG002|Overall Study|catheter dislodgement|1|||
148983044|NCT00793910|537415470|FG000|Overall Study|discarded study pills|0|||
148983045|NCT00793910|537415471|FG001|Overall Study|discarded study pills|1|||
148983046|NCT00793910|537415470|FG000|Overall Study|did not pick up medications|1|||
148983047|NCT00793910|537415471|FG001|Overall Study|did not pick up medications|1|||
148983048|NCT00793910|537415470|FG000|Overall Study|ineligible based on entry criteria|2|||
148983049|NCT00793910|537415471|FG001|Overall Study|ineligible based on entry criteria|3|||
148983050|NCT00793910|537415470|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
148983051|NCT00793910|537415471|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
148983052|NCT00793910|537415470|FG000|Overall Study|Withdrawal by Subject|0|||
148983053|NCT00793910|537415471|FG001|Overall Study|Withdrawal by Subject|1|||
148983054|NCT05061446|537415479|FG000|Overall Study|Adverse Event|2|||
148983055|NCT05061446|537415480|FG001|Overall Study|Adverse Event|0|||
148983056|NCT05061446|537415481|FG002|Overall Study|Adverse Event|0|||
148983057|NCT05061446|537415479|FG000|Overall Study|Participant no longer available due to personal reason|0|||
148983058|NCT05061446|537415480|FG001|Overall Study|Participant no longer available due to personal reason|1|||
148983059|NCT05061446|537415481|FG002|Overall Study|Participant no longer available due to personal reason|0|||
148774229|NCT00189306|536646954|FG000|Treatment Period|Withdrawal by Subject|2|||
148774230|NCT00189306|536646954|FG000|Treatment Period|Adverse Event|2|||
148774231|NCT00189306|536646954|FG000|Treatment Period|Protocol Violation|1|||
148774232|NCT00189306|536646954|FG000|Posttreatment Period|Death|1|||
148774233|NCT00189306|536646954|FG000|Posttreatment Period|Withdrawal by Subject|2|||
148774234|NCT00189306|536646954|FG000|Posttreatment Period|Noncompliance|1|||
148774235|NCT00189306|536646954|FG000|Posttreatment Period|Target lesion excised|1|||
148774236|NCT00189306|536646954|FG000|Posttreatment Period|Protocol Violation|1|||
148774237|NCT00189306|536646954|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
148774238|NCT00189306|536646954|FG000|Posttreatment Period|Local skin reaction/sign|1|||
148774239|NCT00189306|536646954|FG000|Long-Term Follow-up|Adverse Event|2|||
148774240|NCT00189306|536646954|FG000|Long-Term Follow-up|Death|4|||
148774241|NCT00189306|536646954|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
148774242|NCT00189306|536646954|FG000|Long-Term Follow-up|Intercurrent disease|2|||
148774243|NCT00189306|536646954|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
148774244|NCT00189306|536646954|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
148774245|NCT03640481|536646955|FG000|Overall Study|Death|14|||
148774246|NCT03640481|536646956|FG001|Overall Study|Death|14|||
148774247|NCT03640481|536646957|FG002|Overall Study|Death|0|||
148774248|NCT03640481|536646958|FG003|Overall Study|Death|0|||
148774249|NCT03640481|536646955|FG000|Overall Study|Lost to Follow-up|2|||
148774250|NCT03640481|536646956|FG001|Overall Study|Lost to Follow-up|0|||
148774251|NCT03640481|536646957|FG002|Overall Study|Lost to Follow-up|0|||
148774252|NCT03640481|536646958|FG003|Overall Study|Lost to Follow-up|0|||
148774253|NCT03640481|536646955|FG000|Overall Study|Site terminated by sponsor|1|||
148774254|NCT03640481|536646956|FG001|Overall Study|Site terminated by sponsor|3|||
148774255|NCT03640481|536646957|FG002|Overall Study|Site terminated by sponsor|0|||
148774256|NCT03640481|536646958|FG003|Overall Study|Site terminated by sponsor|0|||
148774257|NCT03640481|536646955|FG000|Overall Study|Study terminated by sponsor|29|||
148774258|NCT03640481|536646956|FG001|Overall Study|Study terminated by sponsor|42|||
148774259|NCT03640481|536646957|FG002|Overall Study|Study terminated by sponsor|1|||
148774260|NCT03640481|536646958|FG003|Overall Study|Study terminated by sponsor|0|||
148774261|NCT03640481|536646955|FG000|Overall Study|Withdrawal by Subject|5|||
148774262|NCT03640481|536646956|FG001|Overall Study|Withdrawal by Subject|4|||
148774263|NCT03640481|536646957|FG002|Overall Study|Withdrawal by Subject|0|||
148774264|NCT03640481|536646958|FG003|Overall Study|Withdrawal by Subject|1|||
148983060|NCT02610140|537415482|FG000|Randomization and Treatment Period|Radiological progression|23|||
148983061|NCT02610140|537415483|FG001|Randomization and Treatment Period|Radiological progression|15|||
148983062|NCT02610140|537415482|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
148983063|NCT02610140|537415483|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
148983064|NCT02610140|537415482|FG000|Randomization and Treatment Period|Protocol Violation|1|||
148983065|NCT02610140|537415483|FG001|Randomization and Treatment Period|Protocol Violation|0|||
148983066|NCT02610140|537415482|FG000|Randomization and Treatment Period|Physician Decision|0|||
148983067|NCT02610140|537415483|FG001|Randomization and Treatment Period|Physician Decision|1|||
148983068|NCT02610140|537415482|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
148983069|NCT02610140|537415483|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
148983070|NCT02610140|537415482|FG000|Randomization and Treatment Period|Death|7|||
148983071|NCT02610140|537415483|FG001|Randomization and Treatment Period|Death|1|||
148983072|NCT02610140|537415482|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
148983073|NCT02610140|537415483|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
148983074|NCT02610140|537415482|FG000|Randomization and Treatment Period|Adverse Event|44|||
148983075|NCT02610140|537415483|FG001|Randomization and Treatment Period|Adverse Event|13|||
148983076|NCT02610140|537415482|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
148983077|NCT02610140|537415483|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
148983078|NCT02610140|537415482|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
148983079|NCT02610140|537415483|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
148983080|NCT02610140|537415482|FG000|Randomization and Treatment Period|Not treated|3|||
148983081|NCT02610140|537415483|FG001|Randomization and Treatment Period|Not treated|10|||
148983082|NCT02610140|537415482|FG000|Safety Follow-up|Other|0|||
148983083|NCT02610140|537415483|FG001|Safety Follow-up|Other|2|||
148983084|NCT02610140|537415482|FG000|Safety Follow-up|Lost to Follow-up|1|||
148983085|NCT02610140|537415483|FG001|Safety Follow-up|Lost to Follow-up|0|||
148983086|NCT02610140|537415482|FG000|Safety Follow-up|No follow-up|5|||
148983087|NCT02610140|537415483|FG001|Safety Follow-up|No follow-up|3|||
148840661|NCT00387088|536897912|FG001|Overall Study|Lack of Efficacy|67|||
148840662|NCT00387088|536897911|FG000|Overall Study|Lost to Follow-up|22|||
148840663|NCT00387088|536897912|FG001|Overall Study|Lost to Follow-up|28|||
148840664|NCT00387088|536897911|FG000|Overall Study|Other|58|||
148840665|NCT00387088|536897912|FG001|Overall Study|Other|52|||
148840666|NCT00856323|536897917|FG000|Overall Study|Withdrawal by Subject|2|||
148840667|NCT01639469|536897920|FG000|Overall Study|Death|4|||
148840668|NCT01639469|536897921|FG001|Overall Study|Death|2|||
148840669|NCT01639469|536897920|FG000|Overall Study|Lost to Follow-up|1|||
148840670|NCT01639469|536897921|FG001|Overall Study|Lost to Follow-up|1|||
148840671|NCT00420381|536897922|FG000|Overall Study|Protocol Violation|1|||
148840672|NCT01428219|536897923|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
148840673|NCT02078752|536897924|FG000|Overall Study|Death|0|||
148840674|NCT02078752|536897925|FG001|Overall Study|Death|3|||
148840675|NCT02078752|536897926|FG002|Overall Study|Death|0|||
148840676|NCT02078752|536897927|FG003|Overall Study|Death|0|||
148840677|NCT02078752|536897928|FG004|Overall Study|Death|0|||
148840678|NCT02078752|536897929|FG005|Overall Study|Death|1|||
148840679|NCT02078752|536897930|FG006|Overall Study|Death|0|||
148840680|NCT02078752|536897931|FG007|Overall Study|Death|1|||
148840681|NCT02078752|536897932|FG008|Overall Study|Death|0|||
148840682|NCT02078752|536897933|FG009|Overall Study|Death|4|||
148840683|NCT02078752|536897924|FG000|Overall Study|Lost to Follow-up|1|||
148840684|NCT02078752|536897925|FG001|Overall Study|Lost to Follow-up|0|||
148840685|NCT02078752|536897926|FG002|Overall Study|Lost to Follow-up|0|||
148840686|NCT02078752|536897927|FG003|Overall Study|Lost to Follow-up|1|||
148840687|NCT02078752|536897928|FG004|Overall Study|Lost to Follow-up|0|||
148840688|NCT02078752|536897929|FG005|Overall Study|Lost to Follow-up|0|||
148840689|NCT02078752|536897930|FG006|Overall Study|Lost to Follow-up|0|||
148840690|NCT02078752|536897931|FG007|Overall Study|Lost to Follow-up|0|||
148840691|NCT02078752|536897932|FG008|Overall Study|Lost to Follow-up|0|||
148840692|NCT02078752|536897933|FG009|Overall Study|Lost to Follow-up|0|||
148840693|NCT02078752|536897924|FG000|Overall Study|Withdrawal by Subject|1|||
148840694|NCT02078752|536897925|FG001|Overall Study|Withdrawal by Subject|1|||
148840695|NCT02078752|536897926|FG002|Overall Study|Withdrawal by Subject|1|||
148840696|NCT02078752|536897927|FG003|Overall Study|Withdrawal by Subject|1|||
148840697|NCT02078752|536897928|FG004|Overall Study|Withdrawal by Subject|0|||
148840698|NCT02078752|536897929|FG005|Overall Study|Withdrawal by Subject|3|||
148840699|NCT02078752|536897930|FG006|Overall Study|Withdrawal by Subject|2|||
148840700|NCT02078752|536897931|FG007|Overall Study|Withdrawal by Subject|1|||
148840701|NCT02078752|536897932|FG008|Overall Study|Withdrawal by Subject|0|||
148840702|NCT02078752|536897933|FG009|Overall Study|Withdrawal by Subject|1|||
148840703|NCT02078752|536897924|FG000|Overall Study|Other|0|||
148840704|NCT02078752|536897925|FG001|Overall Study|Other|3|||
148840705|NCT02078752|536897926|FG002|Overall Study|Other|0|||
148840706|NCT02078752|536897927|FG003|Overall Study|Other|0|||
148840707|NCT02078752|536897928|FG004|Overall Study|Other|1|||
148840708|NCT02078752|536897929|FG005|Overall Study|Other|0|||
148840709|NCT02078752|536897930|FG006|Overall Study|Other|0|||
148840710|NCT02078752|536897931|FG007|Overall Study|Other|1|||
148840711|NCT02078752|536897932|FG008|Overall Study|Other|0|||
148840712|NCT02078752|536897933|FG009|Overall Study|Other|0|||
148840713|NCT02078752|536897924|FG000|Overall Study|Study terminated by sponsor|0|||
148840714|NCT02078752|536897925|FG001|Overall Study|Study terminated by sponsor|0|||
148840715|NCT02078752|536897926|FG002|Overall Study|Study terminated by sponsor|0|||
148840716|NCT02078752|536897927|FG003|Overall Study|Study terminated by sponsor|0|||
148840717|NCT02078752|536897928|FG004|Overall Study|Study terminated by sponsor|0|||
148840718|NCT02078752|536897929|FG005|Overall Study|Study terminated by sponsor|0|||
148840719|NCT02078752|536897930|FG006|Overall Study|Study terminated by sponsor|0|||
148840720|NCT02078752|536897931|FG007|Overall Study|Study terminated by sponsor|0|||
148840721|NCT02078752|536897932|FG008|Overall Study|Study terminated by sponsor|0|||
148840722|NCT02078752|536897933|FG009|Overall Study|Study terminated by sponsor|5|||
148840723|NCT00775268|536897941|FG000|Baseline|Drug not synthesize dose|1|||
148840724|NCT00775268|536897942|FG001|Baseline|Drug not synthesize dose|0|||
148840725|NCT00775268|536897941|FG000|Baseline|Not treated-ineligible per CT|0|||
148840726|NCT00775268|536897942|FG001|Baseline|Not treated-ineligible per CT|1|||
148840727|NCT00775268|536897941|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
148840728|NCT00775268|536897942|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
148840729|NCT00775268|536897941|FG000|After Completion|Participant missed scan appointment|1|||
148840730|NCT00775268|536897942|FG001|After Completion|Participant missed scan appointment|0|||
148840731|NCT00825994|536897943|FG000|Overall Study|Withdrawal by Subject|2|||
148840732|NCT00825994|536897943|FG000|Overall Study|Lost to Follow-up|1|||
148840733|NCT00825994|536897943|FG000|Overall Study|Protocol Violation|1|||
148840734|NCT00825994|536897943|FG000|Overall Study|Placebo Responder at V2|1|||
148840735|NCT01244035|536897944|FG000|Part 1: Period 1|Adverse Event|0|||
148840736|NCT01244035|536897945|FG001|Part 1: Period 1|Adverse Event|0|||
148840737|NCT01244035|536897946|FG002|Part 1: Period 1|Adverse Event|0|||
148840738|NCT01244035|536897947|FG003|Part 1: Period 1|Adverse Event|0|||
148840739|NCT01244035|536897948|FG004|Part 1: Period 1|Adverse Event|0|||
148840740|NCT01244035|536897949|FG005|Part 1: Period 1|Adverse Event|1|||
148840741|NCT01244035|536897944|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
148840742|NCT01244035|536897945|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
148840743|NCT01244035|536897946|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
148840744|NCT01244035|536897947|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
148840745|NCT01244035|536897948|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
148840746|NCT01244035|536897949|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
148840747|NCT01244035|536897944|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
148840748|NCT01244035|536897945|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
148840749|NCT01244035|536897946|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
148840750|NCT01244035|536897947|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
148840751|NCT01244035|536897948|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
148840752|NCT01244035|536897949|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
148840753|NCT01244035|536897944|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
148840754|NCT01244035|536897945|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
148840755|NCT01244035|536897946|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
148840756|NCT01244035|536897947|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
148840757|NCT01244035|536897948|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
148840758|NCT01244035|536897949|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
148840759|NCT01244035|536897944|FG000|Part 1: Period 3|Adverse Event|0|||
148840760|NCT01244035|536897945|FG001|Part 1: Period 3|Adverse Event|0|||
148840761|NCT01244035|536897946|FG002|Part 1: Period 3|Adverse Event|0|||
148840762|NCT01244035|536897947|FG003|Part 1: Period 3|Adverse Event|0|||
148840763|NCT01244035|536897948|FG004|Part 1: Period 3|Adverse Event|0|||
148840764|NCT01244035|536897949|FG005|Part 1: Period 3|Adverse Event|1|||
148840765|NCT01244035|536897944|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
148840766|NCT01244035|536897945|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
148840767|NCT01244035|536897946|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
148840768|NCT01244035|536897947|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
148840769|NCT01244035|536897948|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
148840770|NCT01244035|536897949|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
148840771|NCT01244035|536897944|FG000|Part 1: Period 3|Protocol Deviation|0|||
148840772|NCT01244035|536897945|FG001|Part 1: Period 3|Protocol Deviation|1|||
148840773|NCT01244035|536897946|FG002|Part 1: Period 3|Protocol Deviation|0|||
148840774|NCT01244035|536897947|FG003|Part 1: Period 3|Protocol Deviation|0|||
148840775|NCT01244035|536897948|FG004|Part 1: Period 3|Protocol Deviation|0|||
148840776|NCT01244035|536897949|FG005|Part 1: Period 3|Protocol Deviation|0|||
148840777|NCT01833494|536897951|FG000|Overall Study|Adverse Event|24|||
148840778|NCT01833494|536897951|FG000|Overall Study|Physician Decision|6|||
148840779|NCT01833494|536897951|FG000|Overall Study|Withdrawal by Subject|6|||
148840780|NCT01833494|536897951|FG000|Overall Study|Decrease in serum phosphorus|4|||
148840781|NCT01833494|536897951|FG000|Overall Study|Decrease in serum calcium|4|||
148840782|NCT01833494|536897951|FG000|Overall Study|Increase in serum ferritin|1|||
148840783|NCT01694433|536897956|FG000|Overall Study|Adverse Event|7|||
148840784|NCT01694433|536897957|FG001|Overall Study|Adverse Event|0|||
148840785|NCT01694433|536897956|FG000|Overall Study|Physician Decision|1|||
148840786|NCT01694433|536897957|FG001|Overall Study|Physician Decision|0|||
148840787|NCT01694433|536897956|FG000|Overall Study|Withdrawal by Subject|3|||
148840788|NCT01694433|536897957|FG001|Overall Study|Withdrawal by Subject|4|||
148840789|NCT00374595|536897960|FG000|Overall Study|Death|23|||
148840790|NCT00374595|536897960|FG000|Overall Study|Withdrawal by Subject|39|||
148840791|NCT00374595|536897960|FG000|Overall Study|Lost to Follow-up|3|||
148840792|NCT00374595|536897960|FG000|Overall Study|too much time commitment|1|||
148840793|NCT00374595|536897960|FG000|Overall Study|transfer care to other clinical site|1|||
148840794|NCT00374595|536897960|FG000|Overall Study|relocation|3|||
148840795|NCT03745768|536897962|FG000|Overall Study|discontinued study|2|||
148840796|NCT03745768|536897963|FG001|Overall Study|discontinued study|0|||
148840797|NCT00443118|536897964|FG000|Overall Study|unknown primary outcome|3|||
148840798|NCT00443118|536897965|FG001|Overall Study|unknown primary outcome|1|||
148840799|NCT00443118|536897966|FG002|Overall Study|unknown primary outcome|0|||
148840800|NCT00443118|536897964|FG000|Overall Study|Withdrawal by Subject|1|||
148840801|NCT00443118|536897965|FG001|Overall Study|Withdrawal by Subject|0|||
148840802|NCT00443118|536897966|FG002|Overall Study|Withdrawal by Subject|0|||
148840803|NCT04512001|536897969|FG000|Week 0 to Week 24|Adverse Event|14|||
148840804|NCT04512001|536897970|FG001|Week 0 to Week 24|Adverse Event|10|||
148840805|NCT04512001|536897971|FG002|Week 0 to Week 24|Adverse Event|0|||
148840806|NCT04512001|536897972|FG003|Week 0 to Week 24|Adverse Event|0|||
148840807|NCT04512001|536897973|FG004|Week 0 to Week 24|Adverse Event|0|||
148840808|NCT04512001|536897969|FG000|Week 0 to Week 24|Death|0|||
148840809|NCT04512001|536897970|FG001|Week 0 to Week 24|Death|2|||
148840810|NCT04512001|536897971|FG002|Week 0 to Week 24|Death|0|||
148840811|NCT04512001|536897972|FG003|Week 0 to Week 24|Death|0|||
148840812|NCT04512001|536897973|FG004|Week 0 to Week 24|Death|0|||
148840813|NCT04512001|536897969|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
148840814|NCT04512001|536897970|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
148840815|NCT04512001|536897971|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
148840816|NCT04512001|536897972|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
148840817|NCT04512001|536897973|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
148840818|NCT04512001|536897969|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
148840819|NCT04512001|536897970|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
148840820|NCT04512001|536897971|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
148840821|NCT04512001|536897972|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
148840822|NCT04512001|536897973|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
148840823|NCT04512001|536897969|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
148840824|NCT04512001|536897970|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
148840825|NCT04512001|536897971|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
148840826|NCT04512001|536897972|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
148840827|NCT04512001|536897973|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
148840828|NCT04512001|536897969|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
148840829|NCT04512001|536897970|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
148840830|NCT04512001|536897971|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
148840831|NCT04512001|536897972|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
148840832|NCT04512001|536897973|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
148840833|NCT04512001|536897969|FG000|Week 24 to Week 63|Adverse Event|0|||
148840834|NCT04512001|536897970|FG001|Week 24 to Week 63|Adverse Event|0|||
148840835|NCT04512001|536897971|FG002|Week 24 to Week 63|Adverse Event|13|||
148840836|NCT04512001|536897972|FG003|Week 24 to Week 63|Adverse Event|8|||
148840837|NCT04512001|536897973|FG004|Week 24 to Week 63|Adverse Event|6|||
148840838|NCT04512001|536897969|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
148840839|NCT04512001|536897970|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
148840840|NCT04512001|536897971|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
148840841|NCT04512001|536897972|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
148840842|NCT04512001|536897973|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
148840843|NCT04512001|536897969|FG000|Week 24 to Week 63|Death|0|||
148840844|NCT04512001|536897970|FG001|Week 24 to Week 63|Death|0|||
148840845|NCT04512001|536897971|FG002|Week 24 to Week 63|Death|0|||
148840846|NCT04512001|536897972|FG003|Week 24 to Week 63|Death|1|||
148840847|NCT04512001|536897973|FG004|Week 24 to Week 63|Death|1|||
148840848|NCT04512001|536897969|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
148840849|NCT04512001|536897970|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
148840850|NCT04512001|536897971|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
148840851|NCT04512001|536897972|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
148840852|NCT04512001|536897973|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
148840853|NCT04512001|536897969|FG000|Week 24 to Week 63|Miscellaneous|0|||
148840854|NCT04512001|536897970|FG001|Week 24 to Week 63|Miscellaneous|0|||
148840855|NCT04512001|536897971|FG002|Week 24 to Week 63|Miscellaneous|3|||
148840856|NCT04512001|536897972|FG003|Week 24 to Week 63|Miscellaneous|2|||
148840857|NCT04512001|536897973|FG004|Week 24 to Week 63|Miscellaneous|1|||
148840858|NCT02776683|536897974|FG000|Pre-switch Period|Protocol Violation|1|||
148840859|NCT02776683|536897975|FG001|Pre-switch Period|Protocol Violation|0|||
148840860|NCT02776683|536897974|FG000|Pre-switch Period|Adverse Event|21|||
148840861|NCT02776683|536897975|FG001|Pre-switch Period|Adverse Event|0|||
148840862|NCT02776683|536897974|FG000|Pre-switch Period|Withdrawal by Subject|9|||
148840863|NCT02776683|536897975|FG001|Pre-switch Period|Withdrawal by Subject|0|||
148840864|NCT02776683|536897974|FG000|Pre-switch Period|Physician Decision|7|||
148840865|NCT02776683|536897975|FG001|Pre-switch Period|Physician Decision|0|||
148840866|NCT02776683|536897974|FG000|Pre-switch Period|Progressive disease|39|||
148840867|NCT02776683|536897975|FG001|Pre-switch Period|Progressive disease|0|||
148840868|NCT02776683|536897974|FG000|Pre-switch Period|Other than listed|3|||
148840869|NCT02776683|536897975|FG001|Pre-switch Period|Other than listed|0|||
148840870|NCT02776683|536897974|FG000|Post-switch Period|Adverse Event|0|||
148840871|NCT02776683|536897975|FG001|Post-switch Period|Adverse Event|3|||
148840872|NCT02776683|536897974|FG000|Post-switch Period|Withdrawal by Subject|0|||
148840873|NCT02776683|536897975|FG001|Post-switch Period|Withdrawal by Subject|2|||
148840874|NCT02776683|536897974|FG000|Post-switch Period|Physician Decision|0|||
148840875|NCT02776683|536897975|FG001|Post-switch Period|Physician Decision|3|||
148840876|NCT02776683|536897974|FG000|Post-switch Period|Progressive disease|0|||
148840877|NCT02776683|536897975|FG001|Post-switch Period|Progressive disease|20|||
148840878|NCT02776683|536897974|FG000|Post-switch Period|Other than listed|0|||
148840879|NCT02776683|536897975|FG001|Post-switch Period|Other than listed|15|||
148840880|NCT00616642|536897976|FG000|Overall Study|Withdrawal by Subject|0|||
148840881|NCT00616642|536897977|FG001|Overall Study|Withdrawal by Subject|1|||
148840882|NCT04232943|536897979|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
148840883|NCT04232943|536897980|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
148840884|NCT04232943|536897981|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
148840885|NCT04232943|536897979|FG000|Overall Study|Withdrawal by Subject|1|||
148840886|NCT04232943|536897980|FG001|Overall Study|Withdrawal by Subject|1|||
148840887|NCT04232943|536897981|FG002|Overall Study|Withdrawal by Subject|0|||
148840888|NCT01664247|536897986|FG000|Overall Study|Adverse Event|5|||
148840889|NCT01664247|536897987|FG001|Overall Study|Adverse Event|3|||
148840890|NCT01664247|536897986|FG000|Overall Study|Protocol Violation|3|||
148840891|NCT01664247|536897987|FG001|Overall Study|Protocol Violation|5|||
148840892|NCT01664247|536897986|FG000|Overall Study|Withdrawal Criteria|1|||
149029308|NCT00868231|537586497|FG001|Treatment Period 2|Adverse Event|0|||
149029309|NCT00868231|537586498|FG002|Treatment Period 2|Adverse Event|0|||
149029310|NCT00868231|537586499|FG003|Treatment Period 2|Adverse Event|0|||
149029311|NCT00868231|537586500|FG004|Treatment Period 2|Adverse Event|0|||
149029312|NCT00868231|537586501|FG005|Treatment Period 2|Adverse Event|0|||
149029313|NCT00868231|537586496|FG000|Treatment Period 3|Adverse Event|0|||
149029314|NCT00868231|537586497|FG001|Treatment Period 3|Adverse Event|0|||
149029315|NCT00868231|537586498|FG002|Treatment Period 3|Adverse Event|1|||
149029316|NCT00868231|537586499|FG003|Treatment Period 3|Adverse Event|0|||
149029317|NCT00868231|537586500|FG004|Treatment Period 3|Adverse Event|0|||
149029318|NCT00868231|537586501|FG005|Treatment Period 3|Adverse Event|0|||
149029319|NCT03120676|537586502|FG000|Overall Study|Not treated|1|||
149029320|NCT01168401|537586503|FG000|Overall Study|Lost to Follow-up|1|||
149029321|NCT01168401|537586504|FG001|Overall Study|Lost to Follow-up|1|||
149029322|NCT01168401|537586505|FG002|Overall Study|Lost to Follow-up|2|||
149029323|NCT01168401|537586506|FG003|Overall Study|Lost to Follow-up|1|||
149029324|NCT01168401|537586507|FG004|Overall Study|Lost to Follow-up|0|||
149029325|NCT01168401|537586508|FG005|Overall Study|Lost to Follow-up|0|||
149029326|NCT01168401|537586509|FG006|Overall Study|Lost to Follow-up|0|||
149029327|NCT01168401|537586510|FG007|Overall Study|Lost to Follow-up|0|||
149029328|NCT01168401|537586511|FG008|Overall Study|Lost to Follow-up|0|||
149029329|NCT01168401|537586512|FG009|Overall Study|Lost to Follow-up|0|||
149029330|NCT01168401|537586513|FG010|Overall Study|Lost to Follow-up|0|||
149029331|NCT01168401|537586503|FG000|Overall Study|Withdrawal by Subject|0|||
149029332|NCT01168401|537586504|FG001|Overall Study|Withdrawal by Subject|0|||
149029333|NCT01168401|537586505|FG002|Overall Study|Withdrawal by Subject|0|||
149029334|NCT01168401|537586506|FG003|Overall Study|Withdrawal by Subject|1|||
149029335|NCT01168401|537586507|FG004|Overall Study|Withdrawal by Subject|0|||
149029336|NCT01168401|537586508|FG005|Overall Study|Withdrawal by Subject|0|||
149029337|NCT01168401|537586509|FG006|Overall Study|Withdrawal by Subject|0|||
149029338|NCT01168401|537586510|FG007|Overall Study|Withdrawal by Subject|0|||
149029339|NCT01168401|537586511|FG008|Overall Study|Withdrawal by Subject|0|||
149029340|NCT01168401|537586512|FG009|Overall Study|Withdrawal by Subject|0|||
149029341|NCT01168401|537586513|FG010|Overall Study|Withdrawal by Subject|0|||
149029342|NCT00672256|537586518|FG000|Overall Study|PI dropped, bad data|44|||
149029343|NCT01801930|537586519|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
149029344|NCT01801930|537586520|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
148840893|NCT01664247|536897987|FG001|Overall Study|Withdrawal Criteria|4|||
148840894|NCT01664247|536897986|FG000|Overall Study|Unclassified|5|||
148840895|NCT01664247|536897987|FG001|Overall Study|Unclassified|29|||
148840896|NCT01000506|536897994|FG000|Overall Study|Adverse Event|6|||
148840897|NCT01000506|536897995|FG001|Overall Study|Adverse Event|5|||
148840898|NCT01000506|536897996|FG002|Overall Study|Adverse Event|8|||
149029345|NCT01801930|537586521|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
148840899|NCT01000506|536897997|FG003|Overall Study|Adverse Event|9|||
148840900|NCT01000506|536897994|FG000|Overall Study|Lack of Efficacy|8|||
148840901|NCT01000506|536897995|FG001|Overall Study|Lack of Efficacy|6|||
148840902|NCT01000506|536897996|FG002|Overall Study|Lack of Efficacy|4|||
148840903|NCT01000506|536897997|FG003|Overall Study|Lack of Efficacy|4|||
148840904|NCT01000506|536897994|FG000|Overall Study|Protocol Violation|1|||
148840905|NCT01000506|536897995|FG001|Overall Study|Protocol Violation|1|||
148840906|NCT01000506|536897996|FG002|Overall Study|Protocol Violation|0|||
148840907|NCT01000506|536897997|FG003|Overall Study|Protocol Violation|0|||
148840908|NCT01000506|536897994|FG000|Overall Study|Lost to Follow-up|1|||
148840909|NCT01000506|536897995|FG001|Overall Study|Lost to Follow-up|1|||
148840910|NCT01000506|536897996|FG002|Overall Study|Lost to Follow-up|4|||
148840911|NCT01000506|536897997|FG003|Overall Study|Lost to Follow-up|0|||
148983088|NCT02610140|537415482|FG000|Safety Follow-up|Death|12|||
148983089|NCT02610140|537415483|FG001|Safety Follow-up|Death|2|||
148983090|NCT02610140|537415482|FG000|Safety Follow-up|Deterioration of general conditions|15|||
148983091|NCT02610140|537415483|FG001|Safety Follow-up|Deterioration of general conditions|5|||
148983092|NCT02610140|537415482|FG000|Safety Follow-up|Withdrawal by Subject|12|||
148983093|NCT02610140|537415483|FG001|Safety Follow-up|Withdrawal by Subject|12|||
148983094|NCT02610140|537415482|FG000|Active Follow-up|Progressive disease - radiological|30|||
148983095|NCT02610140|537415483|FG001|Active Follow-up|Progressive disease - radiological|22|||
148983096|NCT02610140|537415482|FG000|Active Follow-up|Death|8|||
148983097|NCT02610140|537415483|FG001|Active Follow-up|Death|1|||
148983098|NCT02610140|537415482|FG000|Active Follow-up|Withdrawal by Subject|4|||
148983099|NCT02610140|537415483|FG001|Active Follow-up|Withdrawal by Subject|0|||
148983100|NCT02610140|537415482|FG000|Active Follow-up|Progressive disease - clinical|1|||
148983101|NCT02610140|537415483|FG001|Active Follow-up|Progressive disease - clinical|2|||
148983102|NCT02610140|537415482|FG000|Active Follow-up|Deterioration of general conditions|1|||
148983103|NCT02610140|537415483|FG001|Active Follow-up|Deterioration of general conditions|0|||
148983104|NCT02610140|537415482|FG000|Active Follow-up|Ongoing but not completed|4|||
148983105|NCT02610140|537415483|FG001|Active Follow-up|Ongoing but not completed|1|||
148983106|NCT02610140|537415482|FG000|Long-term Follow-up|Death|86|||
148983107|NCT02610140|537415483|FG001|Long-term Follow-up|Death|44|||
148983108|NCT02610140|537415482|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
148983109|NCT02610140|537415483|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
148983110|NCT02610140|537415482|FG000|Long-term Follow-up|Lost to Follow-up|1|||
148983111|NCT02610140|537415483|FG001|Long-term Follow-up|Lost to Follow-up|2|||
148983112|NCT02610140|537415482|FG000|Long-term Follow-up|Ongoing but not completed|30|||
148983113|NCT02610140|537415483|FG001|Long-term Follow-up|Ongoing but not completed|17|||
148983114|NCT00061048|537415486|FG000|Overall Study|Adverse Event|2|||
148983115|NCT00061048|537415486|FG000|Overall Study|disease progression|20|||
148983116|NCT00432380|537417284|FG000|Overall Study|Migrated/moved from study area|3|||
148983117|NCT00432380|537417285|FG001|Overall Study|Migrated/moved from study area|4|||
148983118|NCT00432380|537417286|FG002|Overall Study|Migrated/moved from study area|1|||
148983119|NCT00432380|537417284|FG000|Overall Study|Adverse Event|1|||
148983120|NCT00432380|537417285|FG001|Overall Study|Adverse Event|0|||
148983121|NCT00432380|537417286|FG002|Overall Study|Adverse Event|0|||
148983122|NCT03422003|537417290|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
148983123|NCT03422003|537417291|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
148983124|NCT03422003|537417290|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
148983125|NCT03422003|537417291|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
148983126|NCT01404312|537417292|FG000|Overall Study|Death|21|||
148983127|NCT01404312|537417293|FG001|Overall Study|Death|27|||
148983128|NCT01404312|537417292|FG000|Overall Study|Withdrawal by Subject|15|||
148983129|NCT01404312|537417293|FG001|Overall Study|Withdrawal by Subject|18|||
148983130|NCT01404312|537417292|FG000|Overall Study|Participant Unable to get to clinic|93|||
148983131|NCT01404312|537417293|FG001|Overall Study|Participant Unable to get to clinic|103|||
148983132|NCT01404312|537417292|FG000|Overall Study|Lost to Follow-up|115|||
148983133|NCT01404312|537417293|FG001|Overall Study|Lost to Follow-up|111|||
148983134|NCT01404312|537417292|FG000|Overall Study|Site closed|22|||
148983135|NCT01404312|537417293|FG001|Overall Study|Site closed|21|||
148983136|NCT01404312|537417292|FG000|Overall Study|Participant not willing to adhere to req|31|||
148983137|NCT01404312|537417293|FG001|Overall Study|Participant not willing to adhere to req|29|||
148983138|NCT01404312|537417292|FG000|Overall Study|Severe debilitation, unable to continue|1|||
148983139|NCT01404312|537417293|FG001|Overall Study|Severe debilitation, unable to continue|2|||
148983140|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Adverse Event|5|||
148983141|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Adverse Event|8|||
148840912|NCT01000506|536897994|FG000|Overall Study|Physician Decision|1|||
148840913|NCT01000506|536897995|FG001|Overall Study|Physician Decision|3|||
148840914|NCT01000506|536897996|FG002|Overall Study|Physician Decision|3|||
148840915|NCT01000506|536897997|FG003|Overall Study|Physician Decision|3|||
148840916|NCT01000506|536897994|FG000|Overall Study|Withdrawal by Subject|11|||
148983142|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Adverse Event|4|||
148983143|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Adverse Event|8|||
149029346|NCT01801930|537586522|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
149029347|NCT01801930|537586519|FG000|Overall Study|DLT occurs|0|||
149029348|NCT01801930|537586520|FG001|Overall Study|DLT occurs|1|||
149029349|NCT01801930|537586521|FG002|Overall Study|DLT occurs|0|||
149029350|NCT01801930|537586522|FG003|Overall Study|DLT occurs|0|||
149029351|NCT00991276|537586532|FG000|First Intervention Period|Adverse Event|0|||
149029352|NCT00991276|537586533|FG001|First Intervention Period|Adverse Event|1|||
149029353|NCT00991276|537586534|FG002|First Intervention Period|Adverse Event|0|||
149029354|NCT00991276|537586535|FG003|First Intervention Period|Adverse Event|1|||
149029355|NCT00991276|537586536|FG004|First Intervention Period|Adverse Event|0|||
149029356|NCT00991276|537586537|FG005|First Intervention Period|Adverse Event|0|||
149029357|NCT00991276|537586532|FG000|First Intervention Period|Protocol Violation|0|||
149029358|NCT00991276|537586533|FG001|First Intervention Period|Protocol Violation|0|||
149029359|NCT00991276|537586534|FG002|First Intervention Period|Protocol Violation|0|||
149029360|NCT00991276|537586535|FG003|First Intervention Period|Protocol Violation|0|||
149029361|NCT00991276|537586536|FG004|First Intervention Period|Protocol Violation|2|||
149029362|NCT00991276|537586537|FG005|First Intervention Period|Protocol Violation|0|||
149029363|NCT00991276|537586532|FG000|First Intervention Period|Insufficient clinical response|0|||
149029364|NCT00991276|537586533|FG001|First Intervention Period|Insufficient clinical response|0|||
149029365|NCT00991276|537586534|FG002|First Intervention Period|Insufficient clinical response|0|||
149029366|NCT00991276|537586535|FG003|First Intervention Period|Insufficient clinical response|0|||
149029367|NCT00991276|537586536|FG004|First Intervention Period|Insufficient clinical response|1|||
149029368|NCT00991276|537586537|FG005|First Intervention Period|Insufficient clinical response|0|||
149029369|NCT00991276|537586532|FG000|First Intervention Period|Other|0|||
149029370|NCT00991276|537586533|FG001|First Intervention Period|Other|0|||
149029371|NCT00991276|537586534|FG002|First Intervention Period|Other|0|||
149029372|NCT00991276|537586535|FG003|First Intervention Period|Other|1|||
149029373|NCT00991276|537586536|FG004|First Intervention Period|Other|1|||
149029374|NCT00991276|537586537|FG005|First Intervention Period|Other|0|||
149029375|NCT00991276|537586532|FG000|First Intervention Period|Withdrawal by Subject|0|||
149029376|NCT00991276|537586533|FG001|First Intervention Period|Withdrawal by Subject|1|||
149029377|NCT00991276|537586534|FG002|First Intervention Period|Withdrawal by Subject|0|||
149029378|NCT00991276|537586535|FG003|First Intervention Period|Withdrawal by Subject|1|||
149029379|NCT00991276|537586536|FG004|First Intervention Period|Withdrawal by Subject|0|||
149029380|NCT00991276|537586537|FG005|First Intervention Period|Withdrawal by Subject|1|||
149029381|NCT00991276|537586532|FG000|First Intervention Period|Lost to Follow-up|0|||
149029382|NCT00991276|537586533|FG001|First Intervention Period|Lost to Follow-up|1|||
149029383|NCT00991276|537586534|FG002|First Intervention Period|Lost to Follow-up|0|||
149029384|NCT00991276|537586535|FG003|First Intervention Period|Lost to Follow-up|1|||
149029385|NCT00991276|537586536|FG004|First Intervention Period|Lost to Follow-up|0|||
149029386|NCT00991276|537586537|FG005|First Intervention Period|Lost to Follow-up|0|||
149029387|NCT00991276|537586532|FG000|Second Intervention Period|Adverse Event|0|||
149029388|NCT00991276|537586533|FG001|Second Intervention Period|Adverse Event|2|||
149029389|NCT00991276|537586534|FG002|Second Intervention Period|Adverse Event|0|||
149029390|NCT00991276|537586535|FG003|Second Intervention Period|Adverse Event|1|||
149029391|NCT00991276|537586536|FG004|Second Intervention Period|Adverse Event|1|||
149029392|NCT00991276|537586537|FG005|Second Intervention Period|Adverse Event|0|||
149029393|NCT00991276|537586532|FG000|Second Intervention Period|Protocol Violation|1|||
148840917|NCT01000506|536897995|FG001|Overall Study|Withdrawal by Subject|8|||
148840918|NCT01000506|536897996|FG002|Overall Study|Withdrawal by Subject|2|||
148840919|NCT01000506|536897997|FG003|Overall Study|Withdrawal by Subject|7|||
148840920|NCT03064074|536897998|FG000|Overall Study|Physician Decision|0|||
148840921|NCT03064074|536897999|FG001|Overall Study|Physician Decision|0|||
148840922|NCT03064074|536898000|FG002|Overall Study|Physician Decision|0|||
148840923|NCT03064074|536898001|FG003|Overall Study|Physician Decision|1|||
148840924|NCT02216526|536898007|FG000|Overall Study|Adverse Event|1|||
149029394|NCT00991276|537586533|FG001|Second Intervention Period|Protocol Violation|0|||
149029395|NCT00991276|537586534|FG002|Second Intervention Period|Protocol Violation|0|||
149029396|NCT00991276|537586535|FG003|Second Intervention Period|Protocol Violation|0|||
149029397|NCT00991276|537586536|FG004|Second Intervention Period|Protocol Violation|0|||
149029398|NCT00991276|537586537|FG005|Second Intervention Period|Protocol Violation|0|||
149029399|NCT00991276|537586532|FG000|Second Intervention Period|Other|0|||
149029400|NCT00991276|537586533|FG001|Second Intervention Period|Other|0|||
149029401|NCT00991276|537586534|FG002|Second Intervention Period|Other|0|||
149029402|NCT00991276|537586535|FG003|Second Intervention Period|Other|1|||
149029403|NCT00991276|537586536|FG004|Second Intervention Period|Other|0|||
149029404|NCT00991276|537586537|FG005|Second Intervention Period|Other|1|||
149029405|NCT00991276|537586532|FG000|Third Intervention Period|Protocol Violation|1|||
148840925|NCT02216526|536898008|FG001|Overall Study|Adverse Event|1|||
149029406|NCT00991276|537586533|FG001|Third Intervention Period|Protocol Violation|0|||
149029407|NCT00991276|537586534|FG002|Third Intervention Period|Protocol Violation|0|||
149029408|NCT00991276|537586535|FG003|Third Intervention Period|Protocol Violation|0|||
148840926|NCT02216526|536898009|FG002|Overall Study|Adverse Event|0|||
148840927|NCT02216526|536898007|FG000|Overall Study|Death|0|||
148840928|NCT02216526|536898008|FG001|Overall Study|Death|1|||
148840929|NCT02216526|536898009|FG002|Overall Study|Death|3|||
148840930|NCT02216526|536898007|FG000|Overall Study|Protocol Violation|2|||
148840931|NCT02216526|536898008|FG001|Overall Study|Protocol Violation|0|||
148840932|NCT02216526|536898009|FG002|Overall Study|Protocol Violation|2|||
148840933|NCT02216526|536898007|FG000|Overall Study|Hospitalization|2|||
148840934|NCT02216526|536898008|FG001|Overall Study|Hospitalization|1|||
148840935|NCT02216526|536898009|FG002|Overall Study|Hospitalization|3|||
148840936|NCT02750514|536898010|FG000|Track 1|Disease progression|20|||
148840937|NCT02750514|536898011|FG001|Track 1|Disease progression|1|||
148840938|NCT02750514|536898012|FG002|Track 1|Disease progression|0|||
148840939|NCT02750514|536898013|FG003|Track 1|Disease progression|1|||
148840940|NCT02750514|536898014|FG004|Track 1|Disease progression|0|||
148840941|NCT02750514|536898010|FG000|Track 1|Adverse event unrelated to study drug|1|||
148840942|NCT02750514|536898011|FG001|Track 1|Adverse event unrelated to study drug|0|||
148840943|NCT02750514|536898012|FG002|Track 1|Adverse event unrelated to study drug|0|||
148840944|NCT02750514|536898013|FG003|Track 1|Adverse event unrelated to study drug|0|||
148840945|NCT02750514|536898014|FG004|Track 1|Adverse event unrelated to study drug|0|||
148840946|NCT02750514|536898010|FG000|Track 1|Study drug toxicity|4|||
148840947|NCT02750514|536898011|FG001|Track 1|Study drug toxicity|1|||
148840948|NCT02750514|536898012|FG002|Track 1|Study drug toxicity|0|||
148840949|NCT02750514|536898013|FG003|Track 1|Study drug toxicity|1|||
148840950|NCT02750514|536898014|FG004|Track 1|Study drug toxicity|0|||
148840951|NCT02750514|536898010|FG000|Track 1|Participant request to discontinue|1|||
148840952|NCT02750514|536898011|FG001|Track 1|Participant request to discontinue|0|||
148840953|NCT02750514|536898012|FG002|Track 1|Participant request to discontinue|0|||
148840954|NCT02750514|536898013|FG003|Track 1|Participant request to discontinue|0|||
148840955|NCT02750514|536898014|FG004|Track 1|Participant request to discontinue|0|||
148840956|NCT02750514|536898010|FG000|Track 1|Other reasons|1|||
148840957|NCT02750514|536898011|FG001|Track 1|Other reasons|0|||
148840958|NCT02750514|536898012|FG002|Track 1|Other reasons|0|||
148840959|NCT02750514|536898013|FG003|Track 1|Other reasons|0|||
148840960|NCT02750514|536898014|FG004|Track 1|Other reasons|0|||
148840961|NCT02750514|536898010|FG000|Track 2|Disease progression|4|||
148840962|NCT02750514|536898011|FG001|Track 2|Disease progression|5|||
148840963|NCT02750514|536898012|FG002|Track 2|Disease progression|2|||
148840964|NCT02750514|536898013|FG003|Track 2|Disease progression|5|||
148840965|NCT02750514|536898014|FG004|Track 2|Disease progression|0|||
148840966|NCT02750514|536898010|FG000|Track 2|Adverse event unrelated to study drug|1|||
148840967|NCT02750514|536898011|FG001|Track 2|Adverse event unrelated to study drug|0|||
148840968|NCT02750514|536898012|FG002|Track 2|Adverse event unrelated to study drug|0|||
148840969|NCT02750514|536898013|FG003|Track 2|Adverse event unrelated to study drug|0|||
148840970|NCT02750514|536898014|FG004|Track 2|Adverse event unrelated to study drug|0|||
148840971|NCT02750514|536898010|FG000|Track 2|Study drug toxicity|1|||
148840972|NCT02750514|536898011|FG001|Track 2|Study drug toxicity|2|||
148840973|NCT02750514|536898012|FG002|Track 2|Study drug toxicity|0|||
148840974|NCT02750514|536898013|FG003|Track 2|Study drug toxicity|2|||
148840975|NCT02750514|536898014|FG004|Track 2|Study drug toxicity|0|||
148840976|NCT02750514|536898010|FG000|Track 2|Participant withdrew consent|0|||
148840977|NCT02750514|536898011|FG001|Track 2|Participant withdrew consent|1|||
148840978|NCT02750514|536898012|FG002|Track 2|Participant withdrew consent|0|||
148840979|NCT02750514|536898013|FG003|Track 2|Participant withdrew consent|0|||
148840980|NCT02750514|536898014|FG004|Track 2|Participant withdrew consent|0|||
148840981|NCT02750514|536898010|FG000|Track 3|Disease progression|0|||
148840982|NCT02750514|536898011|FG001|Track 3|Disease progression|24|||
148840983|NCT02750514|536898012|FG002|Track 3|Disease progression|13|||
148840984|NCT02750514|536898013|FG003|Track 3|Disease progression|14|||
148840985|NCT02750514|536898014|FG004|Track 3|Disease progression|0|||
148840986|NCT02750514|536898010|FG000|Track 3|Adverse event unrelated to study drug|0|||
148840987|NCT02750514|536898011|FG001|Track 3|Adverse event unrelated to study drug|1|||
148840988|NCT02750514|536898012|FG002|Track 3|Adverse event unrelated to study drug|1|||
148840989|NCT02750514|536898013|FG003|Track 3|Adverse event unrelated to study drug|1|||
148840990|NCT02750514|536898014|FG004|Track 3|Adverse event unrelated to study drug|0|||
148840991|NCT02750514|536898010|FG000|Track 3|Study drug toxicity|0|||
148983144|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
148840992|NCT02750514|536898011|FG001|Track 3|Study drug toxicity|3|||
148840993|NCT02750514|536898012|FG002|Track 3|Study drug toxicity|0|||
148840994|NCT02750514|536898013|FG003|Track 3|Study drug toxicity|1|||
148840995|NCT02750514|536898014|FG004|Track 3|Study drug toxicity|0|||
148840996|NCT02750514|536898010|FG000|Track 3|Participant request to discontinue|0|||
148840997|NCT02750514|536898011|FG001|Track 3|Participant request to discontinue|2|||
148840998|NCT02750514|536898012|FG002|Track 3|Participant request to discontinue|0|||
148840999|NCT02750514|536898013|FG003|Track 3|Participant request to discontinue|0|||
148841000|NCT02750514|536898014|FG004|Track 3|Participant request to discontinue|0|||
148841001|NCT02750514|536898010|FG000|Track 3|Participant withdrew consent|0|||
148841002|NCT02750514|536898011|FG001|Track 3|Participant withdrew consent|3|||
148841003|NCT02750514|536898012|FG002|Track 3|Participant withdrew consent|1|||
148983145|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
148841004|NCT02750514|536898013|FG003|Track 3|Participant withdrew consent|0|||
148841005|NCT02750514|536898014|FG004|Track 3|Participant withdrew consent|0|||
148841006|NCT02750514|536898010|FG000|Track 3|Other reasons|0|||
148841007|NCT02750514|536898011|FG001|Track 3|Other reasons|3|||
148841008|NCT02750514|536898012|FG002|Track 3|Other reasons|0|||
148841009|NCT02750514|536898013|FG003|Track 3|Other reasons|0|||
148841010|NCT02750514|536898014|FG004|Track 3|Other reasons|0|||
148841011|NCT02750514|536898010|FG000|Track 4|Study drug toxicity|0|||
148841012|NCT02750514|536898011|FG001|Track 4|Study drug toxicity|6|||
148841013|NCT02750514|536898012|FG002|Track 4|Study drug toxicity|0|||
148841014|NCT02750514|536898013|FG003|Track 4|Study drug toxicity|5|||
148841015|NCT02750514|536898014|FG004|Track 4|Study drug toxicity|0|||
148841016|NCT02750514|536898010|FG000|Track 4|Participant request to discontinue|0|||
148841017|NCT02750514|536898011|FG001|Track 4|Participant request to discontinue|1|||
148841018|NCT02750514|536898012|FG002|Track 4|Participant request to discontinue|0|||
148841019|NCT02750514|536898013|FG003|Track 4|Participant request to discontinue|1|||
148841020|NCT02750514|536898014|FG004|Track 4|Participant request to discontinue|0|||
148841021|NCT02750514|536898010|FG000|Track 4|Participant withdrew consent|0|||
148841022|NCT02750514|536898011|FG001|Track 4|Participant withdrew consent|1|||
148841023|NCT02750514|536898012|FG002|Track 4|Participant withdrew consent|0|||
148841024|NCT02750514|536898013|FG003|Track 4|Participant withdrew consent|0|||
148841025|NCT02750514|536898014|FG004|Track 4|Participant withdrew consent|0|||
148841026|NCT02750514|536898010|FG000|Track 4|Other reasons|0|||
148841027|NCT02750514|536898011|FG001|Track 4|Other reasons|5|||
148841028|NCT02750514|536898012|FG002|Track 4|Other reasons|0|||
148841029|NCT02750514|536898013|FG003|Track 4|Other reasons|3|||
148841030|NCT02750514|536898014|FG004|Track 4|Other reasons|0|||
148841031|NCT02750514|536898010|FG000|Track 4|Disease progression|0|||
148841032|NCT02750514|536898011|FG001|Track 4|Disease progression|33|||
148841033|NCT02750514|536898012|FG002|Track 4|Disease progression|0|||
148841034|NCT02750514|536898013|FG003|Track 4|Disease progression|32|||
148841035|NCT02750514|536898014|FG004|Track 4|Disease progression|0|||
148841036|NCT02750514|536898010|FG000|Track 4|Adverse event unrelated to study drug|0|||
148841037|NCT02750514|536898011|FG001|Track 4|Adverse event unrelated to study drug|5|||
148841038|NCT02750514|536898012|FG002|Track 4|Adverse event unrelated to study drug|0|||
148841039|NCT02750514|536898013|FG003|Track 4|Adverse event unrelated to study drug|0|||
148841040|NCT02750514|536898014|FG004|Track 4|Adverse event unrelated to study drug|0|||
148841041|NCT02750514|536898010|FG000|Track 4|Death|0|||
148841042|NCT02750514|536898011|FG001|Track 4|Death|0|||
148841043|NCT02750514|536898012|FG002|Track 4|Death|0|||
148841044|NCT02750514|536898013|FG003|Track 4|Death|1|||
148841045|NCT02750514|536898014|FG004|Track 4|Death|0|||
148841046|NCT02750514|536898010|FG000|Track 5|Disease progression|0|||
148841047|NCT02750514|536898011|FG001|Track 5|Disease progression|0|||
148841048|NCT02750514|536898012|FG002|Track 5|Disease progression|0|||
148841049|NCT02750514|536898013|FG003|Track 5|Disease progression|0|||
148841050|NCT02750514|536898014|FG004|Track 5|Disease progression|34|||
148841051|NCT02750514|536898010|FG000|Track 5|Adverse event unrelated to study drug|0|||
148841052|NCT02750514|536898011|FG001|Track 5|Adverse event unrelated to study drug|0|||
148841053|NCT02750514|536898012|FG002|Track 5|Adverse event unrelated to study drug|0|||
148841054|NCT02750514|536898013|FG003|Track 5|Adverse event unrelated to study drug|0|||
148841055|NCT02750514|536898014|FG004|Track 5|Adverse event unrelated to study drug|2|||
148841056|NCT02750514|536898010|FG000|Track 5|Study drug toxicity|0|||
148841057|NCT02750514|536898011|FG001|Track 5|Study drug toxicity|0|||
148841058|NCT02750514|536898012|FG002|Track 5|Study drug toxicity|0|||
148841059|NCT02750514|536898013|FG003|Track 5|Study drug toxicity|0|||
148841060|NCT02750514|536898014|FG004|Track 5|Study drug toxicity|2|||
148841061|NCT02750514|536898010|FG000|Track 5|Participant request to discontinue|0|||
148841062|NCT02750514|536898011|FG001|Track 5|Participant request to discontinue|0|||
148841063|NCT02750514|536898012|FG002|Track 5|Participant request to discontinue|0|||
148841064|NCT02750514|536898013|FG003|Track 5|Participant request to discontinue|0|||
148841065|NCT02750514|536898014|FG004|Track 5|Participant request to discontinue|3|||
148841066|NCT02750514|536898010|FG000|Track 5|Other reasons|0|||
148841067|NCT02750514|536898011|FG001|Track 5|Other reasons|0|||
148841068|NCT02750514|536898012|FG002|Track 5|Other reasons|0|||
148841069|NCT02750514|536898013|FG003|Track 5|Other reasons|0|||
148841070|NCT02750514|536898014|FG004|Track 5|Other reasons|2|||
148983146|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
148841071|NCT01882465|536898015|FG000|Period 1|Lens Discomfort|0|||
148841072|NCT01882465|536898016|FG001|Period 1|Lens Discomfort|0|||
148841073|NCT01882465|536898017|FG002|Period 1|Lens Discomfort|0|||
148841074|NCT01882465|536898018|FG003|Period 1|Lens Discomfort|1|||
148841075|NCT01882465|536898019|FG004|Period 1|Lens Discomfort|0|||
148841076|NCT01882465|536898020|FG005|Period 1|Lens Discomfort|0|||
148841077|NCT01882465|536898021|FG006|Period 1|Lens Discomfort|0|||
148841078|NCT01882465|536898015|FG000|Period 1|Withdrawal by Subject|0|||
148841079|NCT01882465|536898016|FG001|Period 1|Withdrawal by Subject|0|||
148841080|NCT01882465|536898017|FG002|Period 1|Withdrawal by Subject|0|||
148841081|NCT01882465|536898018|FG003|Period 1|Withdrawal by Subject|0|||
149029409|NCT00991276|537586536|FG004|Third Intervention Period|Protocol Violation|0|||
149029410|NCT00991276|537586537|FG005|Third Intervention Period|Protocol Violation|0|||
149029411|NCT00991276|537586532|FG000|Third Intervention Period|Other|0|||
149029412|NCT00991276|537586533|FG001|Third Intervention Period|Other|0|||
149029413|NCT00991276|537586534|FG002|Third Intervention Period|Other|0|||
149029414|NCT00991276|537586535|FG003|Third Intervention Period|Other|0|||
149029415|NCT00991276|537586536|FG004|Third Intervention Period|Other|0|||
149029416|NCT00991276|537586537|FG005|Third Intervention Period|Other|1|||
148841082|NCT01882465|536898019|FG004|Period 1|Withdrawal by Subject|0|||
148841083|NCT01882465|536898020|FG005|Period 1|Withdrawal by Subject|0|||
148841084|NCT01882465|536898021|FG006|Period 1|Withdrawal by Subject|1|||
148841085|NCT01882465|536898015|FG000|Period 2|Protocol Violation|0|||
148841086|NCT01882465|536898016|FG001|Period 2|Protocol Violation|0|||
148841087|NCT01882465|536898017|FG002|Period 2|Protocol Violation|0|||
148841088|NCT01882465|536898018|FG003|Period 2|Protocol Violation|0|||
148841089|NCT01882465|536898019|FG004|Period 2|Protocol Violation|1|||
148841090|NCT01882465|536898020|FG005|Period 2|Protocol Violation|0|||
148841091|NCT01882465|536898021|FG006|Period 2|Protocol Violation|0|||
148841092|NCT00532844|536898022|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
148841093|NCT00532844|536898023|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
148841094|NCT00532844|536898022|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
148841095|NCT00532844|536898023|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
148841096|NCT00532844|536898022|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
148841097|NCT00532844|536898023|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
148841098|NCT00532844|536898022|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
148841099|NCT00532844|536898023|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
148841100|NCT00532844|536898022|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
148983147|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
148983148|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
148983149|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
148983150|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
148983151|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
148983152|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Physician Decision|1|||
148983153|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Physician Decision|0|||
148983154|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Physician Decision|0|||
148983155|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Physician Decision|0|||
148983156|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
148983157|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
148983158|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
148983159|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
148983160|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Pregnancy|0|||
148983161|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Pregnancy|1|||
148983162|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Pregnancy|0|||
148983163|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Pregnancy|0|||
148983164|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
148983165|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
148983166|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
148983167|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
148983168|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Death|0|||
148983169|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Death|1|||
148983170|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Death|0|||
148983171|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Death|0|||
148983172|NCT00071487|537417295|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
148983173|NCT00071487|537417296|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
148983174|NCT00071487|537417297|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
148983175|NCT00071487|537417298|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
148983176|NCT00071487|537417295|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
148983177|NCT00071487|537417296|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
148983178|NCT00071487|537417297|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
148983179|NCT00071487|537417298|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
148983180|NCT00071487|537417295|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
148983181|NCT00071487|537417296|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
148983182|NCT00071487|537417297|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
148983183|NCT00071487|537417298|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
148983184|NCT00071487|537417295|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
148983185|NCT00071487|537417296|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
148983186|NCT00071487|537417297|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
149029417|NCT00991276|537586532|FG000|Third Intervention Period|Adverse Event|0|||
149029418|NCT00991276|537586533|FG001|Third Intervention Period|Adverse Event|0|||
149029419|NCT00991276|537586534|FG002|Third Intervention Period|Adverse Event|1|||
148841101|NCT00532844|536898023|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
148841102|NCT04389866|536898025|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
148841103|NCT04389866|536898026|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
148841104|NCT01824290|536898030|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
148841105|NCT01824290|536898031|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
148841106|NCT01824290|536898032|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
148841107|NCT01824290|536898033|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
148841108|NCT01824290|536898030|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
148841109|NCT01824290|536898031|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
148841110|NCT01824290|536898032|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
148841111|NCT01824290|536898033|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
148841112|NCT01824290|536898030|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
148841113|NCT01824290|536898031|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
148841114|NCT01824290|536898032|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
148841115|NCT01824290|536898033|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
148841116|NCT01824290|536898030|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
148841117|NCT01824290|536898031|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
148841118|NCT01824290|536898032|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
148841119|NCT01824290|536898033|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
148841120|NCT01824290|536898030|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
148841121|NCT01824290|536898031|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
148841122|NCT01824290|536898032|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
148841123|NCT01824290|536898033|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
148841124|NCT01824290|536898030|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
148841125|NCT01824290|536898031|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
148841126|NCT01824290|536898032|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
148841127|NCT01824290|536898033|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
148841128|NCT00800982|536898034|FG000|Overall Study|Lost to Follow-up|1|||
148841129|NCT00800982|536898035|FG001|Overall Study|Lost to Follow-up|2|||
148841130|NCT00800982|536898034|FG000|Overall Study|Withdrawal by Subject|0|||
148841131|NCT00800982|536898035|FG001|Overall Study|Withdrawal by Subject|1|||
148841132|NCT00800982|536898034|FG000|Overall Study|Patient moved out of state|1|||
148841133|NCT00800982|536898035|FG001|Overall Study|Patient moved out of state|0|||
148841134|NCT04940130|536898038|FG000|Overall Study|Travel|1|||
148841135|NCT04940130|536898039|FG001|Overall Study|Travel|0|||
148841136|NCT04940130|536898040|FG002|Overall Study|Travel|2|||
148841137|NCT04940130|536898038|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
148841138|NCT04940130|536898039|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
148841139|NCT04940130|536898040|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
148841140|NCT04940130|536898038|FG000|Overall Study|Adverse Event|0|||
148841141|NCT04940130|536898039|FG001|Overall Study|Adverse Event|0|||
148841142|NCT04940130|536898040|FG002|Overall Study|Adverse Event|2|||
148841143|NCT04940130|536898038|FG000|Overall Study|Disease progression/treatment failure|0|||
148841144|NCT04940130|536898039|FG001|Overall Study|Disease progression/treatment failure|0|||
148841145|NCT04940130|536898040|FG002|Overall Study|Disease progression/treatment failure|1|||
148841146|NCT04940130|536898038|FG000|Overall Study|Participant refusal|0|||
148841147|NCT04940130|536898039|FG001|Overall Study|Participant refusal|0|||
148841148|NCT04940130|536898040|FG002|Overall Study|Participant refusal|1|||
148841149|NCT02240121|536898041|FG000|Overall Study|Protocol Violation|1|||
148841150|NCT02240121|536898042|FG001|Overall Study|Protocol Violation|2|||
148841151|NCT02240121|536898041|FG000|Overall Study|Physician Decision|0|||
148841152|NCT02240121|536898042|FG001|Overall Study|Physician Decision|1|||
148841153|NCT02240121|536898041|FG000|Overall Study|Change in protocol interpretation|1|||
148841154|NCT02240121|536898042|FG001|Overall Study|Change in protocol interpretation|0|||
148841155|NCT02240121|536898041|FG000|Overall Study|Lack of Efficacy|2|||
148841156|NCT02240121|536898042|FG001|Overall Study|Lack of Efficacy|3|||
148841157|NCT02240121|536898041|FG000|Overall Study|Site closed|1|||
148841158|NCT02240121|536898042|FG001|Overall Study|Site closed|1|||
148841159|NCT02240121|536898041|FG000|Overall Study|Pregnancy|1|||
148841160|NCT02240121|536898042|FG001|Overall Study|Pregnancy|0|||
148983187|NCT00071487|537417298|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
148983188|NCT00071487|537417295|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
148983189|NCT00071487|537417296|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
148983190|NCT00071487|537417297|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
148841161|NCT02240121|536898041|FG000|Overall Study|Adverse Event|2|||
148983191|NCT00071487|537417298|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
148983192|NCT00071487|537417295|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
148841162|NCT02240121|536898042|FG001|Overall Study|Adverse Event|4|||
148841163|NCT02240121|536898041|FG000|Overall Study|Withdrawal by Subject|6|||
148841164|NCT02240121|536898042|FG001|Overall Study|Withdrawal by Subject|2|||
148841165|NCT02240121|536898041|FG000|Overall Study|Lost to Follow-up|3|||
148841166|NCT02240121|536898042|FG001|Overall Study|Lost to Follow-up|4|||
148983193|NCT00071487|537417296|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
148841167|NCT02240121|536898041|FG000|Overall Study|Other than specified|1|||
148983194|NCT00071487|537417297|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
149029420|NCT00991276|537586535|FG003|Third Intervention Period|Adverse Event|0|||
149029421|NCT00991276|537586536|FG004|Third Intervention Period|Adverse Event|0|||
149029422|NCT00991276|537586537|FG005|Third Intervention Period|Adverse Event|0|||
148841168|NCT02240121|536898042|FG001|Overall Study|Other than specified|3|||
148841169|NCT00251693|536898045|FG000|Overall Study|Adverse Event|17|||
148841170|NCT00251693|536898046|FG001|Overall Study|Adverse Event|9|||
148841171|NCT00251693|536898047|FG002|Overall Study|Adverse Event|9|||
148841172|NCT00251693|536898045|FG000|Overall Study|Protocol Violation|2|||
148841173|NCT00251693|536898046|FG001|Overall Study|Protocol Violation|0|||
148841174|NCT00251693|536898047|FG002|Overall Study|Protocol Violation|2|||
148841175|NCT00251693|536898045|FG000|Overall Study|Lost to Follow-up|12|||
148841176|NCT00251693|536898046|FG001|Overall Study|Lost to Follow-up|7|||
149029423|NCT00991276|537586532|FG000|Third Intervention Period|Withdrawal by Subject|0|||
149029424|NCT00991276|537586533|FG001|Third Intervention Period|Withdrawal by Subject|0|||
149029425|NCT00991276|537586534|FG002|Third Intervention Period|Withdrawal by Subject|0|||
148841177|NCT00251693|536898047|FG002|Overall Study|Lost to Follow-up|8|||
148841178|NCT00251693|536898045|FG000|Overall Study|Withdrawal by Subject|11|||
148841179|NCT00251693|536898046|FG001|Overall Study|Withdrawal by Subject|17|||
148841180|NCT00251693|536898047|FG002|Overall Study|Withdrawal by Subject|14|||
148841181|NCT00251693|536898045|FG000|Overall Study|Lack of Efficacy|0|||
148841182|NCT00251693|536898046|FG001|Overall Study|Lack of Efficacy|1|||
148841183|NCT00251693|536898047|FG002|Overall Study|Lack of Efficacy|0|||
148841184|NCT00251693|536898045|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
148841185|NCT00251693|536898046|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
148841186|NCT00251693|536898047|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
149029426|NCT00991276|537586535|FG003|Third Intervention Period|Withdrawal by Subject|1|||
149029427|NCT00991276|537586536|FG004|Third Intervention Period|Withdrawal by Subject|0|||
149029428|NCT00991276|537586537|FG005|Third Intervention Period|Withdrawal by Subject|0|||
149029429|NCT01268891|537586539|FG000|Overall Study|Adverse Event|3|||
149029430|NCT01268891|537586540|FG001|Overall Study|Adverse Event|7|||
149029431|NCT01268891|537586539|FG000|Overall Study|Lack of Efficacy|1|||
149029432|NCT01268891|537586540|FG001|Overall Study|Lack of Efficacy|0|||
149029433|NCT01268891|537586539|FG000|Overall Study|Withdrawal of Consent|3|||
149029434|NCT01268891|537586540|FG001|Overall Study|Withdrawal of Consent|1|||
149029435|NCT01268891|537586539|FG000|Overall Study|Administrative or other reason(s)|1|||
149029436|NCT01268891|537586540|FG001|Overall Study|Administrative or other reason(s)|0|||
149029437|NCT03441984|537586542|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029438|NCT03441984|537586543|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029439|NCT03441984|537586544|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
149029440|NCT03441984|537586545|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029441|NCT03441984|537586546|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029442|NCT03441984|537586547|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029443|NCT03441984|537586548|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029444|NCT03441984|537586549|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029445|NCT03441984|537586550|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029446|NCT03441984|537586551|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029447|NCT03441984|537586552|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029448|NCT03441984|537586553|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
149029449|NCT04088188|537586557|FG000|Overall Study|Withdrawal by Subject|2|||
149029450|NCT04088188|537586558|FG001|Overall Study|Withdrawal by Subject|0|||
149029451|NCT04088188|537586557|FG000|Overall Study|Adverse Event|2|||
149029452|NCT04088188|537586558|FG001|Overall Study|Adverse Event|0|||
149029453|NCT03124108|537586559|FG000|Overall Study|Adverse Event|0|||
149029454|NCT03124108|537586560|FG001|Overall Study|Adverse Event|1|||
149029455|NCT03124108|537586561|FG002|Overall Study|Adverse Event|0|||
149029456|NCT01670019|537586571|FG000|Overall Study|Adverse Event|3|||
148841187|NCT00251693|536898045|FG000|Overall Study|Noncompliant|0|||
148841188|NCT00251693|536898046|FG001|Overall Study|Noncompliant|0|||
148841189|NCT00251693|536898047|FG002|Overall Study|Noncompliant|2|||
148841190|NCT00251693|536898045|FG000|Overall Study|Possible Barrett's esophagus|3|||
148841191|NCT00251693|536898046|FG001|Overall Study|Possible Barrett's esophagus|5|||
148841192|NCT00251693|536898047|FG002|Overall Study|Possible Barrett's esophagus|2|||
148841193|NCT00251693|536898045|FG000|Overall Study|Subject request/subject unavailable|1|||
149029457|NCT01670019|537586572|FG001|Overall Study|Adverse Event|0|||
149029458|NCT01670019|537586571|FG000|Overall Study|Withdrawal by Subject|6|||
149029459|NCT01670019|537586572|FG001|Overall Study|Withdrawal by Subject|0|||
148841194|NCT00251693|536898046|FG001|Overall Study|Subject request/subject unavailable|2|||
148841195|NCT00251693|536898047|FG002|Overall Study|Subject request/subject unavailable|0|||
148841196|NCT00251693|536898045|FG000|Overall Study|Abnormal laboratory findings|0|||
148841197|NCT00251693|536898046|FG001|Overall Study|Abnormal laboratory findings|0|||
149029460|NCT00746330|537586573|FG000|Period 1|Abnormal test procedure result|0|||
148841198|NCT00251693|536898047|FG002|Overall Study|Abnormal laboratory findings|1|||
148983195|NCT00071487|537417298|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
148983196|NCT00071487|537417295|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
148983197|NCT00071487|537417296|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
148983198|NCT00071487|537417297|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
148983199|NCT00071487|537417298|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
148774265|NCT03640481|536646955|FG000|Overall Study|Other|26|||
148774266|NCT03640481|536646956|FG001|Overall Study|Other|12|||
148774267|NCT03640481|536646957|FG002|Overall Study|Other|1|||
148774268|NCT03640481|536646958|FG003|Overall Study|Other|0|||
148774269|NCT03640481|536646955|FG000|Overall Study|Randomized, but not treated|1|||
148774270|NCT03640481|536646956|FG001|Overall Study|Randomized, but not treated|3|||
148774271|NCT03640481|536646957|FG002|Overall Study|Randomized, but not treated|0|||
148774272|NCT03640481|536646958|FG003|Overall Study|Randomized, but not treated|0|||
148774273|NCT00535847|536646959|FG000|Overall Study|Adverse Event|5|||
148774274|NCT00535847|536646960|FG001|Overall Study|Adverse Event|3|||
148774275|NCT00535847|536646961|FG002|Overall Study|Adverse Event|2|||
148774276|NCT00535847|536646959|FG000|Overall Study|Non compliance|1|||
148774277|NCT00535847|536646960|FG001|Overall Study|Non compliance|1|||
148774278|NCT00535847|536646961|FG002|Overall Study|Non compliance|0|||
148774279|NCT00535847|536646959|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
148774280|NCT00535847|536646960|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
148774281|NCT00535847|536646961|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
148774282|NCT02850016|536646964|FG000|Overall Study|Withdrawal by Subject|1|||
148774283|NCT02850016|536646965|FG001|Overall Study|Withdrawal by Subject|2|||
148774284|NCT00976209|536646966|FG000|Treatment Period 1|Protocol Violation|1|||
148774285|NCT00976209|536646967|FG001|Treatment Period 1|Protocol Violation|0|||
148774286|NCT00976209|536646966|FG000|Treatment Period 1|Lost to Follow-up|2|||
148774287|NCT00976209|536646967|FG001|Treatment Period 1|Lost to Follow-up|0|||
148774288|NCT00976209|536646966|FG000|Treatment Period 1|Other|0|||
148774289|NCT00976209|536646967|FG001|Treatment Period 1|Other|1|||
148774290|NCT00976209|536646966|FG000|Wash-out Period|Adverse Event|1|||
148774291|NCT00976209|536646967|FG001|Wash-out Period|Adverse Event|2|||
148774292|NCT00976209|536646966|FG000|Wash-out Period|Lost to Follow-up|1|||
148774293|NCT00976209|536646967|FG001|Wash-out Period|Lost to Follow-up|0|||
148774294|NCT00976209|536646966|FG000|Wash-out Period|Protocol Violation|1|||
148774295|NCT00976209|536646967|FG001|Wash-out Period|Protocol Violation|0|||
148774296|NCT00976209|536646966|FG000|Wash-out Period|Other|1|||
148774297|NCT00976209|536646967|FG001|Wash-out Period|Other|0|||
148774298|NCT00976209|536646966|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148774299|NCT00976209|536646967|FG001|Treatment Period 2|Withdrawal by Subject|1|||
148774300|NCT00976209|536646966|FG000|Treatment Period 2|Lost to Follow-up|0|||
148774301|NCT00976209|536646967|FG001|Treatment Period 2|Lost to Follow-up|1|||
148774302|NCT01252563|536646968|FG000|Overall Study|Contract Deviation|41|||
148774303|NCT01252563|536646968|FG000|Overall Study|Centralized Registration Deviation|30|||
148774304|NCT01252563|536646968|FG000|Overall Study|Lost to Follow-up|161|||
148774305|NCT01252563|536646968|FG000|Overall Study|No visit after first day of treatment|194|||
148774306|NCT01252563|536646968|FG000|Overall Study|No drug administration|6|||
148774307|NCT02029989|536646973|FG000|Overall Study|Withdrawal by Subject|1|||
148774308|NCT02029989|536646974|FG001|Overall Study|Withdrawal by Subject|0|||
148774309|NCT02029989|536646973|FG000|Overall Study|Withdrawal: Fear of needles|1|||
148774310|NCT02029989|536646974|FG001|Overall Study|Withdrawal: Fear of needles|0|||
148774311|NCT02029989|536646973|FG000|Overall Study|Change of location|2|||
148774312|NCT02029989|536646974|FG001|Overall Study|Change of location|3|||
148774313|NCT02029989|536646973|FG000|Overall Study|Physician Decision|2|||
148774314|NCT02029989|536646974|FG001|Overall Study|Physician Decision|0|||
148774315|NCT02029989|536646973|FG000|Overall Study|Lost to Follow-up|9|||
148774316|NCT02029989|536646974|FG001|Overall Study|Lost to Follow-up|7|||
148774317|NCT02029989|536646973|FG000|Overall Study|Death|0|||
148774318|NCT02029989|536646974|FG001|Overall Study|Death|1|||
148774319|NCT02029989|536646973|FG000|Overall Study|Protocol Violation|1|||
148774320|NCT02029989|536646974|FG001|Overall Study|Protocol Violation|0|||
148774321|NCT02880865|536646976|FG000|Overall Study|Adverse Event|1|||
148774322|NCT02880865|536646977|FG001|Overall Study|Adverse Event|0|||
148774323|NCT02880865|536646976|FG000|Overall Study|Withdrawal by Subject|0|||
148774324|NCT02880865|536646977|FG001|Overall Study|Withdrawal by Subject|2|||
148774325|NCT02880865|536646976|FG000|Overall Study|Physician Decision|0|||
148774326|NCT02880865|536646977|FG001|Overall Study|Physician Decision|1|||
148774327|NCT03045276|536646980|FG000|Intervention Phase|Withdrawal by Subject|7|||
148774328|NCT03045276|536646981|FG001|Intervention Phase|Withdrawal by Subject|2|||
148774329|NCT03045276|536646982|FG002|Intervention Phase|Withdrawal by Subject|3|||
148774330|NCT03045276|536646983|FG003|Intervention Phase|Withdrawal by Subject|7|||
148774331|NCT03045276|536646980|FG000|Intervention Phase|Developed exclusionary criteria|3|||
148774332|NCT03045276|536646981|FG001|Intervention Phase|Developed exclusionary criteria|3|||
148774333|NCT03045276|536646982|FG002|Intervention Phase|Developed exclusionary criteria|0|||
148983200|NCT00581945|537417299|FG000|Overall Study|Adverse Event|4|||
148983201|NCT00581945|537417300|FG001|Overall Study|Adverse Event|4|||
148983202|NCT00581945|537417299|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148983203|NCT00581945|537417300|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148983204|NCT00581945|537417299|FG000|Overall Study|Withdrawal by Subject|2|||
148983205|NCT00581945|537417300|FG001|Overall Study|Withdrawal by Subject|6|||
148983206|NCT00581945|537417299|FG000|Overall Study|Death|1|||
148983207|NCT00581945|537417300|FG001|Overall Study|Death|0|||
148983208|NCT02032901|537417301|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
148983209|NCT02032901|537417302|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
148983210|NCT02032901|537417301|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
148983211|NCT02032901|537417302|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
148983212|NCT01722331|537417303|FG000|Part 1|Adverse Event|5|||
148983213|NCT01722331|537417304|FG001|Part 1|Adverse Event|0|||
148983214|NCT01722331|537417305|FG002|Part 1|Adverse Event|0|||
148983215|NCT01722331|537417306|FG003|Part 1|Adverse Event|0|||
148983216|NCT01722331|537417307|FG004|Part 1|Adverse Event|0|||
148983217|NCT01722331|537417308|FG005|Part 1|Adverse Event|0|||
148983218|NCT01722331|537417309|FG006|Part 1|Adverse Event|0|||
148983219|NCT01722331|537417303|FG000|Part 1|Lack of Efficacy|0|||
148983220|NCT01722331|537417304|FG001|Part 1|Lack of Efficacy|0|||
148983221|NCT01722331|537417305|FG002|Part 1|Lack of Efficacy|1|||
148983222|NCT01722331|537417306|FG003|Part 1|Lack of Efficacy|0|||
148983223|NCT01722331|537417307|FG004|Part 1|Lack of Efficacy|2|||
148983224|NCT01722331|537417308|FG005|Part 1|Lack of Efficacy|0|||
148983225|NCT01722331|537417309|FG006|Part 1|Lack of Efficacy|0|||
148983226|NCT01722331|537417303|FG000|Part 1|Lost to Follow-up|1|||
148983227|NCT01722331|537417304|FG001|Part 1|Lost to Follow-up|0|||
148983228|NCT01722331|537417305|FG002|Part 1|Lost to Follow-up|2|||
148983229|NCT01722331|537417306|FG003|Part 1|Lost to Follow-up|0|||
148983230|NCT01722331|537417307|FG004|Part 1|Lost to Follow-up|1|||
148983231|NCT01722331|537417308|FG005|Part 1|Lost to Follow-up|0|||
148983232|NCT01722331|537417309|FG006|Part 1|Lost to Follow-up|0|||
148983233|NCT01722331|537417303|FG000|Part 1|Physician Decision|0|||
148983234|NCT01722331|537417304|FG001|Part 1|Physician Decision|0|||
148983235|NCT01722331|537417305|FG002|Part 1|Physician Decision|3|||
148983236|NCT01722331|537417306|FG003|Part 1|Physician Decision|0|||
148983237|NCT01722331|537417307|FG004|Part 1|Physician Decision|1|||
148983238|NCT01722331|537417308|FG005|Part 1|Physician Decision|0|||
148983239|NCT01722331|537417309|FG006|Part 1|Physician Decision|0|||
148983240|NCT01722331|537417303|FG000|Part 1|Pregnancy|1|||
148983241|NCT01722331|537417304|FG001|Part 1|Pregnancy|0|||
148983242|NCT01722331|537417305|FG002|Part 1|Pregnancy|0|||
148983243|NCT01722331|537417306|FG003|Part 1|Pregnancy|0|||
148983244|NCT01722331|537417307|FG004|Part 1|Pregnancy|0|||
148983245|NCT01722331|537417308|FG005|Part 1|Pregnancy|0|||
148983246|NCT01722331|537417309|FG006|Part 1|Pregnancy|0|||
148983247|NCT01722331|537417303|FG000|Part 1|Progressive Disease|0|||
148983248|NCT01722331|537417304|FG001|Part 1|Progressive Disease|0|||
148983249|NCT01722331|537417305|FG002|Part 1|Progressive Disease|0|||
148983250|NCT01722331|537417306|FG003|Part 1|Progressive Disease|0|||
148983251|NCT01722331|537417307|FG004|Part 1|Progressive Disease|1|||
148983252|NCT01722331|537417308|FG005|Part 1|Progressive Disease|0|||
148983253|NCT01722331|537417309|FG006|Part 1|Progressive Disease|0|||
148983254|NCT01722331|537417303|FG000|Part 1|Protocol Violation|1|||
148983255|NCT01722331|537417304|FG001|Part 1|Protocol Violation|0|||
148983256|NCT01722331|537417305|FG002|Part 1|Protocol Violation|0|||
148983257|NCT01722331|537417306|FG003|Part 1|Protocol Violation|0|||
148983258|NCT01722331|537417307|FG004|Part 1|Protocol Violation|1|||
148983259|NCT01722331|537417308|FG005|Part 1|Protocol Violation|0|||
148983260|NCT01722331|537417309|FG006|Part 1|Protocol Violation|0|||
148983261|NCT01722331|537417303|FG000|Part 1|Withdrawal by Subject|2|||
148841199|NCT01595529|536898048|FG000|Overall Study|Adverse Event|2|||
148983262|NCT01722331|537417304|FG001|Part 1|Withdrawal by Subject|0|||
148841200|NCT01595529|536898049|FG001|Overall Study|Adverse Event|0|||
148841201|NCT01595529|536898048|FG000|Overall Study|Subject Non-Compliant|2|||
148983263|NCT01722331|537417305|FG002|Part 1|Withdrawal by Subject|3|||
148983264|NCT01722331|537417306|FG003|Part 1|Withdrawal by Subject|0|||
148983265|NCT01722331|537417307|FG004|Part 1|Withdrawal by Subject|3|||
148983266|NCT01722331|537417308|FG005|Part 1|Withdrawal by Subject|0|||
148983267|NCT01722331|537417309|FG006|Part 1|Withdrawal by Subject|0|||
148983268|NCT01722331|537417303|FG000|Part 2|Adverse Event|3|||
148983269|NCT01722331|537417304|FG001|Part 2|Adverse Event|0|||
148841202|NCT01595529|536898049|FG001|Overall Study|Subject Non-Compliant|0|||
148841203|NCT01595529|536898048|FG000|Overall Study|Lost to Follow-up|8|||
148983270|NCT01722331|537417305|FG002|Part 2|Adverse Event|0|||
148983271|NCT01722331|537417306|FG003|Part 2|Adverse Event|0|||
148983272|NCT01722331|537417307|FG004|Part 2|Adverse Event|0|||
148983273|NCT01722331|537417308|FG005|Part 2|Adverse Event|1|||
148983274|NCT01722331|537417309|FG006|Part 2|Adverse Event|0|||
148983275|NCT01722331|537417303|FG000|Part 2|Lack of Efficacy|3|||
148983276|NCT01722331|537417304|FG001|Part 2|Lack of Efficacy|0|||
148983277|NCT01722331|537417305|FG002|Part 2|Lack of Efficacy|11|||
148983278|NCT01722331|537417306|FG003|Part 2|Lack of Efficacy|0|||
148983279|NCT01722331|537417307|FG004|Part 2|Lack of Efficacy|0|||
148983280|NCT01722331|537417308|FG005|Part 2|Lack of Efficacy|3|||
148983281|NCT01722331|537417309|FG006|Part 2|Lack of Efficacy|3|||
148983282|NCT01722331|537417303|FG000|Part 2|Lost to Follow-up|0|||
148983283|NCT01722331|537417304|FG001|Part 2|Lost to Follow-up|0|||
148983284|NCT01722331|537417305|FG002|Part 2|Lost to Follow-up|3|||
148983285|NCT01722331|537417306|FG003|Part 2|Lost to Follow-up|0|||
148983286|NCT01722331|537417307|FG004|Part 2|Lost to Follow-up|0|||
148983287|NCT01722331|537417308|FG005|Part 2|Lost to Follow-up|1|||
148983288|NCT01722331|537417309|FG006|Part 2|Lost to Follow-up|1|||
148983289|NCT01722331|537417303|FG000|Part 2|Non-Compliance with Study Drug|1|||
148983290|NCT01722331|537417304|FG001|Part 2|Non-Compliance with Study Drug|0|||
148983291|NCT01722331|537417305|FG002|Part 2|Non-Compliance with Study Drug|1|||
148983292|NCT01722331|537417306|FG003|Part 2|Non-Compliance with Study Drug|0|||
148983293|NCT01722331|537417307|FG004|Part 2|Non-Compliance with Study Drug|0|||
148983294|NCT01722331|537417308|FG005|Part 2|Non-Compliance with Study Drug|0|||
148983295|NCT01722331|537417309|FG006|Part 2|Non-Compliance with Study Drug|0|||
148983296|NCT01722331|537417303|FG000|Part 2|Physician Decision|0|||
148983297|NCT01722331|537417304|FG001|Part 2|Physician Decision|0|||
148983298|NCT01722331|537417305|FG002|Part 2|Physician Decision|2|||
148983299|NCT01722331|537417306|FG003|Part 2|Physician Decision|0|||
148983300|NCT01722331|537417307|FG004|Part 2|Physician Decision|0|||
148983301|NCT01722331|537417308|FG005|Part 2|Physician Decision|0|||
148983302|NCT01722331|537417309|FG006|Part 2|Physician Decision|0|||
148983303|NCT01722331|537417303|FG000|Part 2|Pregnancy|0|||
148983304|NCT01722331|537417304|FG001|Part 2|Pregnancy|0|||
148983305|NCT01722331|537417305|FG002|Part 2|Pregnancy|0|||
148983306|NCT01722331|537417306|FG003|Part 2|Pregnancy|0|||
148983307|NCT01722331|537417307|FG004|Part 2|Pregnancy|0|||
148983308|NCT01722331|537417308|FG005|Part 2|Pregnancy|1|||
148983309|NCT01722331|537417309|FG006|Part 2|Pregnancy|0|||
148983310|NCT01722331|537417303|FG000|Part 2|Progressive Disease|0|||
148983311|NCT01722331|537417304|FG001|Part 2|Progressive Disease|0|||
148983312|NCT01722331|537417305|FG002|Part 2|Progressive Disease|1|||
148983313|NCT01722331|537417306|FG003|Part 2|Progressive Disease|0|||
148983314|NCT01722331|537417307|FG004|Part 2|Progressive Disease|0|||
148983315|NCT01722331|537417308|FG005|Part 2|Progressive Disease|0|||
148983316|NCT01722331|537417309|FG006|Part 2|Progressive Disease|0|||
148983317|NCT01722331|537417303|FG000|Part 2|Protocol Violation|1|||
148983318|NCT01722331|537417304|FG001|Part 2|Protocol Violation|0|||
148983319|NCT01722331|537417305|FG002|Part 2|Protocol Violation|0|||
148983320|NCT01722331|537417306|FG003|Part 2|Protocol Violation|0|||
148983321|NCT01722331|537417307|FG004|Part 2|Protocol Violation|0|||
148983322|NCT01722331|537417308|FG005|Part 2|Protocol Violation|0|||
148983323|NCT01722331|537417309|FG006|Part 2|Protocol Violation|0|||
148983324|NCT01722331|537417303|FG000|Part 2|Withdrawal by Subject|5|||
148983325|NCT01722331|537417304|FG001|Part 2|Withdrawal by Subject|0|||
148983326|NCT01722331|537417305|FG002|Part 2|Withdrawal by Subject|3|||
148983327|NCT01722331|537417306|FG003|Part 2|Withdrawal by Subject|0|||
148983328|NCT01722331|537417307|FG004|Part 2|Withdrawal by Subject|0|||
148983329|NCT01722331|537417308|FG005|Part 2|Withdrawal by Subject|2|||
148983330|NCT01722331|537417309|FG006|Part 2|Withdrawal by Subject|2|||
148983331|NCT01722331|537417303|FG000|Part 2|Other Protocol Specified Criteria|6|||
148983332|NCT01722331|537417304|FG001|Part 2|Other Protocol Specified Criteria|0|||
148983333|NCT01722331|537417305|FG002|Part 2|Other Protocol Specified Criteria|10|||
148983334|NCT01722331|537417306|FG003|Part 2|Other Protocol Specified Criteria|0|||
148983335|NCT01722331|537417307|FG004|Part 2|Other Protocol Specified Criteria|0|||
148983336|NCT01722331|537417308|FG005|Part 2|Other Protocol Specified Criteria|2|||
148983337|NCT01722331|537417309|FG006|Part 2|Other Protocol Specified Criteria|1|||
148983338|NCT01722331|537417303|FG000|Part 3|Adverse Event|2|||
148983339|NCT01722331|537417304|FG001|Part 3|Adverse Event|2|||
148983340|NCT01722331|537417305|FG002|Part 3|Adverse Event|0|||
148983341|NCT01722331|537417306|FG003|Part 3|Adverse Event|1|||
148983342|NCT01722331|537417307|FG004|Part 3|Adverse Event|0|||
148983343|NCT01722331|537417308|FG005|Part 3|Adverse Event|0|||
148983344|NCT01722331|537417309|FG006|Part 3|Adverse Event|0|||
148983345|NCT01722331|537417303|FG000|Part 3|Death|1|||
148983346|NCT01722331|537417304|FG001|Part 3|Death|0|||
148983347|NCT01722331|537417305|FG002|Part 3|Death|0|||
148983348|NCT01722331|537417306|FG003|Part 3|Death|0|||
148983349|NCT01722331|537417307|FG004|Part 3|Death|0|||
148983350|NCT01722331|537417308|FG005|Part 3|Death|0|||
148983351|NCT01722331|537417309|FG006|Part 3|Death|0|||
148983352|NCT01722331|537417303|FG000|Part 3|Lack of Efficacy|1|||
148983353|NCT01722331|537417304|FG001|Part 3|Lack of Efficacy|0|||
148983354|NCT01722331|537417305|FG002|Part 3|Lack of Efficacy|0|||
148983355|NCT01722331|537417306|FG003|Part 3|Lack of Efficacy|0|||
148983356|NCT01722331|537417307|FG004|Part 3|Lack of Efficacy|0|||
148983357|NCT01722331|537417308|FG005|Part 3|Lack of Efficacy|0|||
148983358|NCT01722331|537417309|FG006|Part 3|Lack of Efficacy|0|||
148983359|NCT01722331|537417303|FG000|Part 3|Lost to Follow-up|3|||
148983360|NCT01722331|537417304|FG001|Part 3|Lost to Follow-up|4|||
148983361|NCT01722331|537417305|FG002|Part 3|Lost to Follow-up|0|||
148983362|NCT01722331|537417306|FG003|Part 3|Lost to Follow-up|0|||
148983363|NCT01722331|537417307|FG004|Part 3|Lost to Follow-up|0|||
148983364|NCT01722331|537417308|FG005|Part 3|Lost to Follow-up|1|||
148983365|NCT01722331|537417309|FG006|Part 3|Lost to Follow-up|0|||
149029461|NCT00746330|537586574|FG001|Period 1|Abnormal test procedure result|0|||
149029462|NCT00746330|537586575|FG002|Period 1|Abnormal test procedure result|1|||
149029463|NCT00746330|537586576|FG003|Period 1|Abnormal test procedure result|0|||
149029464|NCT04939428|537586579|FG000|Overall Study|Death|0|||
149029465|NCT04939428|537586580|FG001|Overall Study|Death|1|||
148841204|NCT01595529|536898049|FG001|Overall Study|Lost to Follow-up|14|||
148841205|NCT01595529|536898048|FG000|Overall Study|Protocol Violation|1|||
148841206|NCT01595529|536898049|FG001|Overall Study|Protocol Violation|2|||
148841207|NCT01595529|536898048|FG000|Overall Study|Physician Decision|1|||
148841208|NCT01595529|536898049|FG001|Overall Study|Physician Decision|0|||
148841209|NCT01595529|536898048|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
148841210|NCT01595529|536898049|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
148841211|NCT01595529|536898048|FG000|Overall Study|Administrative Decision|1|||
148841212|NCT01595529|536898049|FG001|Overall Study|Administrative Decision|0|||
148841213|NCT01595529|536898048|FG000|Overall Study|Entry Failure/Screening Failure|6|||
148841214|NCT01595529|536898049|FG001|Overall Study|Entry Failure/Screening Failure|1|||
148841215|NCT01508910|536898050|FG000|Treatment|Death|2|||
148841216|NCT01508910|536898051|FG001|Treatment|Death|3|||
148841217|NCT01508910|536898052|FG002|Treatment|Death|2|||
148841218|NCT01508910|536898053|FG003|Treatment|Death|0|||
148841219|NCT01508910|536898050|FG000|Treatment|Lost to Follow-up|0|||
148841220|NCT01508910|536898051|FG001|Treatment|Lost to Follow-up|0|||
148841221|NCT01508910|536898052|FG002|Treatment|Lost to Follow-up|2|||
148841222|NCT01508910|536898053|FG003|Treatment|Lost to Follow-up|1|||
148841223|NCT01508910|536898050|FG000|Treatment|Withdrawal by Subject|0|||
148841224|NCT01508910|536898051|FG001|Treatment|Withdrawal by Subject|1|||
148841225|NCT01508910|536898052|FG002|Treatment|Withdrawal by Subject|6|||
148841226|NCT01508910|536898053|FG003|Treatment|Withdrawal by Subject|1|||
148841227|NCT01508910|536898050|FG000|Treatment|Sponsor Decision|0|||
148841228|NCT01508910|536898051|FG001|Treatment|Sponsor Decision|0|||
148841229|NCT01508910|536898052|FG002|Treatment|Sponsor Decision|0|||
148841230|NCT01508910|536898053|FG003|Treatment|Sponsor Decision|1|||
148841231|NCT05653700|536898060|FG000|Overall Study|Non Responders|9|||
148841232|NCT05653700|536898061|FG001|Overall Study|Non Responders|0|||
148841233|NCT01085214|536898064|FG000|Overall Study|Alternate treatment required|1|||
148841234|NCT02549989|536899490|FG000|Overall Study|Adverse Event|4|||
148841235|NCT02549989|536899490|FG000|Overall Study|Death|1|||
148841236|NCT02549989|536899490|FG000|Overall Study|Lack of Efficacy|19|||
148841237|NCT02549989|536899490|FG000|Overall Study|Withdrawal by Subject|3|||
148841238|NCT01856322|536899491|FG000|Overall Study|off study due to lack of accrual|0|||
148841239|NCT01856322|536899492|FG001|Overall Study|off study due to lack of accrual|0|||
148841240|NCT01856322|536899493|FG002|Overall Study|off study due to lack of accrual|3|||
148841241|NCT02628444|536899497|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
148841242|NCT02628444|536899498|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841243|NCT02628444|536899499|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841244|NCT02628444|536899500|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841245|NCT02628444|536899501|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841246|NCT02628444|536899502|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841247|NCT02628444|536899503|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841248|NCT02628444|536899504|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
148841249|NCT02628444|536899505|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
149029466|NCT04939428|537586581|FG002|Overall Study|Death|0|||
149029467|NCT04939428|537586579|FG000|Overall Study|Lost to Follow-up|0|||
149029468|NCT04939428|537586580|FG001|Overall Study|Lost to Follow-up|5|||
149029469|NCT04939428|537586581|FG002|Overall Study|Lost to Follow-up|0|||
149029470|NCT04939428|537586579|FG000|Overall Study|Physician Decision|1|||
148841250|NCT02628444|536899497|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
148841251|NCT02628444|536899498|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
148841252|NCT02628444|536899499|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
148841253|NCT02628444|536899500|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
148841254|NCT02628444|536899501|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
148841255|NCT02628444|536899502|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
148841256|NCT02628444|536899503|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
149029471|NCT04939428|537586580|FG001|Overall Study|Physician Decision|0|||
149029472|NCT04939428|537586581|FG002|Overall Study|Physician Decision|0|||
149029473|NCT04939428|537586579|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149029474|NCT04939428|537586580|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148841257|NCT02628444|536899504|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
148889175|NCT04177212|537072379|FG001|Overall Study|Other|2|||
149029475|NCT04939428|537586581|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149029476|NCT04939428|537586579|FG000|Overall Study|Withdrawal by Subject|10|||
149029477|NCT04939428|537586580|FG001|Overall Study|Withdrawal by Subject|11|||
148841258|NCT02628444|536899505|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
148841259|NCT02628444|536899497|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
148841260|NCT02628444|536899498|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
148841261|NCT02628444|536899499|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
148841262|NCT02628444|536899500|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841263|NCT02628444|536899501|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841264|NCT02628444|536899502|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841265|NCT02628444|536899503|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841266|NCT02628444|536899504|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841267|NCT02628444|536899505|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841268|NCT02628444|536899497|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
148841269|NCT02628444|536899498|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
148841270|NCT02628444|536899499|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
148841271|NCT02628444|536899500|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
148841272|NCT02628444|536899501|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
148841273|NCT02628444|536899502|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
148841274|NCT02628444|536899503|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
148841275|NCT02628444|536899504|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
148841276|NCT02628444|536899505|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
148841277|NCT02628444|536899497|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
148841278|NCT02628444|536899498|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
148841279|NCT02628444|536899499|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
148841280|NCT02628444|536899500|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
148841281|NCT02628444|536899501|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
148841282|NCT02628444|536899502|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
148841283|NCT02628444|536899503|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
148841284|NCT02628444|536899504|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
148841285|NCT02628444|536899505|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
148841286|NCT02628444|536899497|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841287|NCT02628444|536899498|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841288|NCT02628444|536899499|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841289|NCT02628444|536899500|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
148841290|NCT02628444|536899501|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841291|NCT02628444|536899502|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841292|NCT02628444|536899503|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841293|NCT02628444|536899504|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841294|NCT02628444|536899505|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
148841295|NCT02628444|536899497|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
148841296|NCT02628444|536899498|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
148841297|NCT02628444|536899499|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
148841298|NCT02628444|536899500|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
148841299|NCT02628444|536899501|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
148841300|NCT02628444|536899502|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
148841301|NCT02628444|536899503|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
148841302|NCT02628444|536899504|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
148841303|NCT02628444|536899505|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
148841304|NCT02628444|536899497|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841305|NCT02628444|536899498|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841306|NCT02628444|536899499|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
148841307|NCT02628444|536899500|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
148841308|NCT02628444|536899501|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
148841309|NCT02628444|536899502|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
148841310|NCT02628444|536899503|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
148841311|NCT02628444|536899504|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
148841312|NCT02628444|536899505|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
148841313|NCT02628444|536899497|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
148841314|NCT02628444|536899498|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
148841315|NCT02628444|536899499|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
148841316|NCT02628444|536899500|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
148841317|NCT02628444|536899501|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
148774334|NCT03045276|536646983|FG003|Intervention Phase|Developed exclusionary criteria|0|||
148774335|NCT03045276|536646980|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
148774336|NCT03045276|536646981|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
148774337|NCT03045276|536646982|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
148774338|NCT03045276|536646983|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
148774339|NCT03045276|536646980|FG000|Follow-Up Phase|Lost to Follow-up|0|||
148774340|NCT03045276|536646981|FG001|Follow-Up Phase|Lost to Follow-up|1|||
148774341|NCT03045276|536646982|FG002|Follow-Up Phase|Lost to Follow-up|0|||
148774342|NCT03045276|536646983|FG003|Follow-Up Phase|Lost to Follow-up|1|||
148774343|NCT03045276|536646980|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
148774344|NCT03045276|536646981|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
148774345|NCT03045276|536646982|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
148774346|NCT03045276|536646983|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
148774347|NCT02294175|536647002|FG000|Overall Study|Withdrawal by Subject|1|||
148774348|NCT02294175|536647003|FG001|Overall Study|Withdrawal by Subject|2|||
148774349|NCT02294175|536647002|FG000|Overall Study|pt taking excluded medication|3|||
148774350|NCT02294175|536647003|FG001|Overall Study|pt taking excluded medication|1|||
148774351|NCT02294175|536647002|FG000|Overall Study|Protocol Violation|1|||
148774352|NCT02294175|536647003|FG001|Overall Study|Protocol Violation|0|||
148774353|NCT02294175|536647002|FG000|Overall Study|Lost to Follow-up|0|||
148774354|NCT02294175|536647003|FG001|Overall Study|Lost to Follow-up|1|||
148774355|NCT02294175|536647002|FG000|Overall Study|wound healed|0|||
148774356|NCT02294175|536647003|FG001|Overall Study|wound healed|2|||
148774357|NCT01901653|536647004|FG000|Overall Study|Death|2|||
148774358|NCT01901653|536647005|FG001|Overall Study|Death|1|||
148774359|NCT01901653|536647006|FG002|Overall Study|Death|8|||
148774360|NCT01901653|536647007|FG003|Overall Study|Death|3|||
148774361|NCT01901653|536647008|FG004|Overall Study|Death|2|||
148774362|NCT01901653|536647009|FG005|Overall Study|Death|2|||
148774363|NCT01901653|536647010|FG006|Overall Study|Death|6|||
148774364|NCT01901653|536647011|FG007|Overall Study|Death|9|||
148774365|NCT01901653|536647012|FG008|Overall Study|Death|1|||
148774366|NCT01901653|536647013|FG009|Overall Study|Death|16|||
148774367|NCT01901653|536647014|FG010|Overall Study|Death|2|||
148774368|NCT01901653|536647015|FG011|Overall Study|Death|15|||
148774369|NCT01901653|536647016|FG012|Overall Study|Death|4|||
148774370|NCT01901653|536647004|FG000|Overall Study|Lost to Follow-up|1|||
148774371|NCT01901653|536647005|FG001|Overall Study|Lost to Follow-up|0|||
148774372|NCT01901653|536647006|FG002|Overall Study|Lost to Follow-up|2|||
148774373|NCT01901653|536647007|FG003|Overall Study|Lost to Follow-up|0|||
148774374|NCT01901653|536647008|FG004|Overall Study|Lost to Follow-up|0|||
148774375|NCT01901653|536647009|FG005|Overall Study|Lost to Follow-up|1|||
148774376|NCT01901653|536647010|FG006|Overall Study|Lost to Follow-up|0|||
148774377|NCT01901653|536647011|FG007|Overall Study|Lost to Follow-up|1|||
148774378|NCT01901653|536647012|FG008|Overall Study|Lost to Follow-up|0|||
148774379|NCT01901653|536647013|FG009|Overall Study|Lost to Follow-up|0|||
148774380|NCT01901653|536647014|FG010|Overall Study|Lost to Follow-up|0|||
148774381|NCT01901653|536647015|FG011|Overall Study|Lost to Follow-up|0|||
148774382|NCT01901653|536647016|FG012|Overall Study|Lost to Follow-up|0|||
148774383|NCT01901653|536647004|FG000|Overall Study|Withdrawal by Subject|0|||
148774384|NCT01901653|536647005|FG001|Overall Study|Withdrawal by Subject|0|||
148774385|NCT01901653|536647006|FG002|Overall Study|Withdrawal by Subject|0|||
148774386|NCT01901653|536647007|FG003|Overall Study|Withdrawal by Subject|0|||
148774387|NCT01901653|536647008|FG004|Overall Study|Withdrawal by Subject|0|||
148774388|NCT01901653|536647009|FG005|Overall Study|Withdrawal by Subject|0|||
148774389|NCT01901653|536647010|FG006|Overall Study|Withdrawal by Subject|1|||
148774390|NCT01901653|536647011|FG007|Overall Study|Withdrawal by Subject|0|||
148774391|NCT01901653|536647012|FG008|Overall Study|Withdrawal by Subject|0|||
148774392|NCT01901653|536647013|FG009|Overall Study|Withdrawal by Subject|0|||
148774393|NCT01901653|536647014|FG010|Overall Study|Withdrawal by Subject|0|||
148774394|NCT01901653|536647015|FG011|Overall Study|Withdrawal by Subject|0|||
148774395|NCT01901653|536647016|FG012|Overall Study|Withdrawal by Subject|0|||
148774396|NCT01901653|536647004|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
148774397|NCT01901653|536647005|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
148774398|NCT01901653|536647006|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
148774399|NCT01901653|536647007|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
148774400|NCT01901653|536647008|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
148774401|NCT01901653|536647009|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
148774402|NCT01901653|536647010|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
148774403|NCT01901653|536647011|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
148774404|NCT01901653|536647012|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
148774405|NCT01901653|536647013|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
148774406|NCT01901653|536647014|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
148774407|NCT01901653|536647015|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
148774408|NCT01901653|536647016|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
148774409|NCT02548351|536647017|FG000|Overall Study|Withdrawal by Subject|149|||
148774410|NCT02548351|536647018|FG001|Overall Study|Withdrawal by Subject|154|||
148774411|NCT02548351|536647019|FG002|Overall Study|Withdrawal by Subject|152|||
148774412|NCT02548351|536647017|FG000|Overall Study|Death|11|||
148774413|NCT02548351|536647018|FG001|Overall Study|Death|15|||
148774414|NCT02548351|536647019|FG002|Overall Study|Death|12|||
148774415|NCT02548351|536647017|FG000|Overall Study|Adverse Event|22|||
148774416|NCT02548351|536647018|FG001|Overall Study|Adverse Event|56|||
148774417|NCT02548351|536647019|FG002|Overall Study|Adverse Event|36|||
148774418|NCT02548351|536647017|FG000|Overall Study|Study Terminated by Sponsor|549|||
148774419|NCT02548351|536647018|FG001|Overall Study|Study Terminated by Sponsor|509|||
148774420|NCT02548351|536647019|FG002|Overall Study|Study Terminated by Sponsor|528|||
148774421|NCT02548351|536647017|FG000|Overall Study|Site Closure|14|||
148774422|NCT02548351|536647018|FG001|Overall Study|Site Closure|5|||
148774423|NCT02548351|536647019|FG002|Overall Study|Site Closure|7|||
148774424|NCT02548351|536647017|FG000|Overall Study|Non-compliance with Study Drug|4|||
148774425|NCT02548351|536647018|FG001|Overall Study|Non-compliance with Study Drug|2|||
148774426|NCT02548351|536647019|FG002|Overall Study|Non-compliance with Study Drug|0|||
148774427|NCT02548351|536647017|FG000|Overall Study|Protocol Violation|2|||
148774428|NCT02548351|536647018|FG001|Overall Study|Protocol Violation|1|||
148774429|NCT02548351|536647019|FG002|Overall Study|Protocol Violation|2|||
148774430|NCT02548351|536647017|FG000|Overall Study|Physician Decision|11|||
148774431|NCT02548351|536647018|FG001|Overall Study|Physician Decision|18|||
148774432|NCT02548351|536647019|FG002|Overall Study|Physician Decision|11|||
148774433|NCT02548351|536647017|FG000|Overall Study|Lost to Follow-up|43|||
148774434|NCT02548351|536647018|FG001|Overall Study|Lost to Follow-up|50|||
148774435|NCT02548351|536647019|FG002|Overall Study|Lost to Follow-up|57|||
148774436|NCT02548351|536647017|FG000|Overall Study|Other|19|||
148774437|NCT02548351|536647018|FG001|Overall Study|Other|16|||
148774438|NCT02548351|536647019|FG002|Overall Study|Other|20|||
148774439|NCT02548351|536647017|FG000|Overall Study|Missing|1|||
148774440|NCT02548351|536647018|FG001|Overall Study|Missing|1|||
148774441|NCT02548351|536647019|FG002|Overall Study|Missing|0|||
148774442|NCT01744184|536647020|FG000|Overall Study|Adverse Event|1|||
148774443|NCT01744184|536647021|FG001|Overall Study|Adverse Event|0|||
148774444|NCT01744184|536647020|FG000|Overall Study|Withdrawal by Subject|0|||
148774445|NCT01744184|536647021|FG001|Overall Study|Withdrawal by Subject|1|||
148774446|NCT02841280|536647025|FG000|Overall Study|Adverse Event|2|||
148774447|NCT02841280|536647026|FG001|Overall Study|Adverse Event|1|||
148774448|NCT02841280|536647025|FG000|Overall Study|Death|1|||
148774449|NCT02841280|536647026|FG001|Overall Study|Death|0|||
148774450|NCT02841280|536647025|FG000|Overall Study|Lost to Follow-up|2|||
148774451|NCT02841280|536647026|FG001|Overall Study|Lost to Follow-up|2|||
148774452|NCT02841280|536647025|FG000|Overall Study|Withdrawal by Subject|7|||
148774453|NCT02841280|536647026|FG001|Overall Study|Withdrawal by Subject|3|||
148774454|NCT02841280|536647025|FG000|Overall Study|Stop Point: BP above threshold|2|||
148774455|NCT02841280|536647026|FG001|Overall Study|Stop Point: BP above threshold|0|||
148774456|NCT04553471|536647027|FG000|Overall Study|Did not start treatment on protocol|3|||
148774457|NCT04553471|536647027|FG000|Overall Study|Death|1|||
148774458|NCT01340027|536647029|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
148774459|NCT01340027|536647030|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
148774460|NCT01340027|536647031|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
148774461|NCT01340027|536647032|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
148774462|NCT01340027|536647033|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
148774463|NCT01340027|536647034|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
148774464|NCT01340027|536647035|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
148774465|NCT01340027|536647036|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
148774466|NCT01340027|536647037|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
148774467|NCT01340027|536647038|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
148774468|NCT01340027|536647039|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
148774469|NCT01340027|536647040|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
148774470|NCT01340027|536647029|FG000|Overall Study|Adverse Event|0|||
148774471|NCT01340027|536647030|FG001|Overall Study|Adverse Event|1|||
148774472|NCT01340027|536647031|FG002|Overall Study|Adverse Event|2|||
148774473|NCT01340027|536647032|FG003|Overall Study|Adverse Event|0|||
148774474|NCT01340027|536647033|FG004|Overall Study|Adverse Event|1|||
148774475|NCT01340027|536647034|FG005|Overall Study|Adverse Event|2|||
148774476|NCT01340027|536647035|FG006|Overall Study|Adverse Event|2|||
148774477|NCT01340027|536647036|FG007|Overall Study|Adverse Event|1|||
148774478|NCT01340027|536647037|FG008|Overall Study|Adverse Event|4|||
148774479|NCT01340027|536647038|FG009|Overall Study|Adverse Event|1|||
148774480|NCT01340027|536647039|FG010|Overall Study|Adverse Event|1|||
148774481|NCT01340027|536647040|FG011|Overall Study|Adverse Event|3|||
148774482|NCT01340027|536647029|FG000|Overall Study|Lack of Efficacy|0|||
148774483|NCT01340027|536647030|FG001|Overall Study|Lack of Efficacy|0|||
148774484|NCT01340027|536647031|FG002|Overall Study|Lack of Efficacy|0|||
148774485|NCT01340027|536647032|FG003|Overall Study|Lack of Efficacy|0|||
148774486|NCT01340027|536647033|FG004|Overall Study|Lack of Efficacy|0|||
148774487|NCT01340027|536647034|FG005|Overall Study|Lack of Efficacy|0|||
148841318|NCT02628444|536899502|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
148841319|NCT02628444|536899503|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
148983366|NCT01722331|537417303|FG000|Part 3|Non-Compliance with Study Drug|0|||
148983367|NCT01722331|537417304|FG001|Part 3|Non-Compliance with Study Drug|1|||
148983368|NCT01722331|537417305|FG002|Part 3|Non-Compliance with Study Drug|0|||
148983369|NCT01722331|537417306|FG003|Part 3|Non-Compliance with Study Drug|0|||
148983370|NCT01722331|537417307|FG004|Part 3|Non-Compliance with Study Drug|0|||
148983371|NCT01722331|537417308|FG005|Part 3|Non-Compliance with Study Drug|0|||
148983372|NCT01722331|537417309|FG006|Part 3|Non-Compliance with Study Drug|0|||
148983373|NCT01722331|537417303|FG000|Part 3|Physician Decision|1|||
148983374|NCT01722331|537417304|FG001|Part 3|Physician Decision|1|||
148983375|NCT01722331|537417305|FG002|Part 3|Physician Decision|0|||
148983376|NCT01722331|537417306|FG003|Part 3|Physician Decision|0|||
148983377|NCT01722331|537417307|FG004|Part 3|Physician Decision|0|||
148983378|NCT01722331|537417308|FG005|Part 3|Physician Decision|0|||
148983379|NCT01722331|537417309|FG006|Part 3|Physician Decision|1|||
148983380|NCT01722331|537417303|FG000|Part 3|Protocol Violation|2|||
148983381|NCT01722331|537417304|FG001|Part 3|Protocol Violation|1|||
148983382|NCT01722331|537417305|FG002|Part 3|Protocol Violation|0|||
148983383|NCT01722331|537417306|FG003|Part 3|Protocol Violation|0|||
148983384|NCT01722331|537417307|FG004|Part 3|Protocol Violation|0|||
148983385|NCT01722331|537417308|FG005|Part 3|Protocol Violation|0|||
148983386|NCT01722331|537417309|FG006|Part 3|Protocol Violation|0|||
148983387|NCT01722331|537417303|FG000|Part 3|Withdrawal by Subject|4|||
148983388|NCT01722331|537417304|FG001|Part 3|Withdrawal by Subject|7|||
148983389|NCT01722331|537417305|FG002|Part 3|Withdrawal by Subject|0|||
148983390|NCT01722331|537417306|FG003|Part 3|Withdrawal by Subject|0|||
148983391|NCT01722331|537417307|FG004|Part 3|Withdrawal by Subject|0|||
148983392|NCT01722331|537417308|FG005|Part 3|Withdrawal by Subject|2|||
148983393|NCT01722331|537417309|FG006|Part 3|Withdrawal by Subject|1|||
148983394|NCT01722331|537417303|FG000|Part 3|Other Protocol Specified Criteria|1|||
148983395|NCT01722331|537417304|FG001|Part 3|Other Protocol Specified Criteria|1|||
148983396|NCT01722331|537417305|FG002|Part 3|Other Protocol Specified Criteria|0|||
148983397|NCT01722331|537417306|FG003|Part 3|Other Protocol Specified Criteria|0|||
148983398|NCT01722331|537417307|FG004|Part 3|Other Protocol Specified Criteria|0|||
148983399|NCT01722331|537417308|FG005|Part 3|Other Protocol Specified Criteria|0|||
148983400|NCT01722331|537417309|FG006|Part 3|Other Protocol Specified Criteria|0|||
148983401|NCT01154166|537417322|FG000|Overall Study|Adverse Event|14|||
148983402|NCT01154166|537417323|FG001|Overall Study|Adverse Event|9|||
148983403|NCT01154166|537417322|FG000|Overall Study|Lost to Follow-up|1|||
148983404|NCT01154166|537417323|FG001|Overall Study|Lost to Follow-up|1|||
148983405|NCT01154166|537417322|FG000|Overall Study|Protocol Violation|4|||
148983406|NCT01154166|537417323|FG001|Overall Study|Protocol Violation|1|||
148983407|NCT01154166|537417322|FG000|Overall Study|Withdrawal by Subject|10|||
148983408|NCT01154166|537417323|FG001|Overall Study|Withdrawal by Subject|1|||
148983409|NCT01154166|537417322|FG000|Overall Study|Lack of Efficacy|3|||
148983410|NCT01154166|537417323|FG001|Overall Study|Lack of Efficacy|0|||
148983411|NCT01154166|537417322|FG000|Overall Study|Disease Progression|1|||
148983412|NCT01154166|537417323|FG001|Overall Study|Disease Progression|0|||
148983413|NCT01154166|537417322|FG000|Overall Study|Poor Compliance|1|||
148983414|NCT01154166|537417323|FG001|Overall Study|Poor Compliance|0|||
148983415|NCT01375049|537417324|FG000|Overall Study|Adverse Event|2|||
148983416|NCT01375049|537417324|FG000|Overall Study|Lost to Follow-up|1|||
148983417|NCT01375049|537417324|FG000|Overall Study|Withdrawal by Subject|2|||
148983418|NCT01375049|537417324|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
148983419|NCT01575561|537417325|FG000|Overall Study|Adverse Event|9|||
148983420|NCT01575561|537417325|FG000|Overall Study|Lack of Efficacy|8|||
148983421|NCT01575561|537417325|FG000|Overall Study|Lost to Follow-up|6|||
148983422|NCT01575561|537417325|FG000|Overall Study|Protocol Violation|4|||
148983423|NCT01575561|537417325|FG000|Overall Study|Withdrawal by Subject|11|||
148983424|NCT01575561|537417325|FG000|Overall Study|administration|1|||
148841320|NCT02628444|536899504|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
148841321|NCT02628444|536899505|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
148983425|NCT02840877|537417326|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
148983426|NCT02840877|537417326|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
148983427|NCT02840877|537417326|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
148983428|NCT02840877|537417326|FG000|Baseline to 12 Weeks|Death|1|||
148983429|NCT02840877|537417326|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
148983430|NCT02840877|537417326|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
148841322|NCT02628444|536899497|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
148983431|NCT02840877|537417326|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
148983432|NCT02840877|537417326|FG000|12 Weeks to 6 Months|Treatment failure|1|||
148983433|NCT02840877|537417326|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
148983434|NCT02840877|537417326|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
148983435|NCT02840877|537417326|FG000|12 Weeks to 6 Months|Death|1|||
148983436|NCT02840877|537417326|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
148983437|NCT02840877|537417326|FG000|6 Months to 18 Months|Treatment failure|7|||
148983438|NCT02840877|537417326|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
148841323|NCT02628444|536899498|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
148841324|NCT02628444|536899499|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
148841325|NCT02628444|536899500|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
148841326|NCT02628444|536899501|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
148841327|NCT02628444|536899502|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
148841328|NCT02628444|536899503|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
148983439|NCT02840877|537417326|FG000|6 Months to 18 Months|Moved/transferred out|6|||
148841329|NCT02628444|536899504|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
148841330|NCT02628444|536899505|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
148841331|NCT02079909|536899506|FG000|Overall Study|Adverse Event|23|||
148841332|NCT02079909|536899507|FG001|Overall Study|Adverse Event|23|||
148841333|NCT02079909|536899508|FG002|Overall Study|Adverse Event|7|||
148841334|NCT02079909|536899506|FG000|Overall Study|Withdrawal by Subject|9|||
148841335|NCT02079909|536899507|FG001|Overall Study|Withdrawal by Subject|17|||
148841336|NCT02079909|536899508|FG002|Overall Study|Withdrawal by Subject|4|||
148841337|NCT02079909|536899506|FG000|Overall Study|Lost to Follow-up|2|||
148841338|NCT02079909|536899507|FG001|Overall Study|Lost to Follow-up|3|||
148841339|NCT02079909|536899508|FG002|Overall Study|Lost to Follow-up|1|||
148841340|NCT02079909|536899506|FG000|Overall Study|Death|2|||
148841341|NCT02079909|536899507|FG001|Overall Study|Death|2|||
148841342|NCT02079909|536899508|FG002|Overall Study|Death|0|||
148841343|NCT02079909|536899506|FG000|Overall Study|Lack of Efficacy|0|||
148841344|NCT02079909|536899507|FG001|Overall Study|Lack of Efficacy|0|||
148841345|NCT02079909|536899508|FG002|Overall Study|Lack of Efficacy|1|||
148841346|NCT02079909|536899506|FG000|Overall Study|Protocol Violation|0|||
148841347|NCT02079909|536899507|FG001|Overall Study|Protocol Violation|1|||
148841348|NCT02079909|536899508|FG002|Overall Study|Protocol Violation|1|||
148841349|NCT02079909|536899506|FG000|Overall Study|Physician Decision|0|||
148841350|NCT02079909|536899507|FG001|Overall Study|Physician Decision|1|||
148841351|NCT02079909|536899508|FG002|Overall Study|Physician Decision|1|||
148841352|NCT02079909|536899506|FG000|Overall Study|Relocation etc.|2|||
148841353|NCT02079909|536899507|FG001|Overall Study|Relocation etc.|2|||
148841354|NCT02079909|536899508|FG002|Overall Study|Relocation etc.|3|||
148841355|NCT00720356|536899511|FG000|Registration to Study|Determined to have methylated MGMT|67|||
148841356|NCT00720356|536899511|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
148841357|NCT00720356|536899511|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
148841358|NCT00720356|536899511|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
148841359|NCT00720356|536899511|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
148841360|NCT00720356|536899511|FG000|Follow up Until Death|Withdrawal by Subject|1|||
148841361|NCT00720356|536899511|FG000|Follow up Until Death|Alive at last data collection|4|||
148841362|NCT02237001|536899514|FG000|Overall Study|Lost to Follow-up|2|||
148841363|NCT02237001|536899514|FG000|Overall Study|Withdrawal by Subject|1|||
148841364|NCT02237001|536899514|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
148983440|NCT02840877|537417326|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
148983441|NCT02840877|537417326|FG000|6 Months to 18 Months|Death|4|||
148841365|NCT02237001|536899514|FG000|Overall Study|Re-operation|4|||
148841366|NCT02237001|536899514|FG000|Overall Study|Incarceration|1|||
148841367|NCT03427814|536899515|FG000|Overall Study|Withdrawal by Subject|4|||
148841368|NCT03427814|536899516|FG001|Overall Study|Withdrawal by Subject|4|||
148841369|NCT03427814|536899515|FG000|Overall Study|Lost to Follow-up|0|||
148841370|NCT03427814|536899516|FG001|Overall Study|Lost to Follow-up|2|||
148841371|NCT03427814|536899515|FG000|Overall Study|Death|42|||
148841372|NCT03427814|536899516|FG001|Overall Study|Death|31|||
148841373|NCT03427814|536899515|FG000|Overall Study|Sponsor's Decision|1|||
148841374|NCT03427814|536899516|FG001|Overall Study|Sponsor's Decision|0|||
148841375|NCT03427814|536899515|FG000|Overall Study|Investigator's Decision|1|||
148841376|NCT03427814|536899516|FG001|Overall Study|Investigator's Decision|2|||
148841377|NCT03427814|536899515|FG000|Overall Study|Disease progression|1|||
148841378|NCT03427814|536899516|FG001|Overall Study|Disease progression|0|||
148841379|NCT03427814|536899515|FG000|Overall Study|Treatment Completed|0|||
148983442|NCT02840877|537417326|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
148983443|NCT02840877|537417326|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
148983444|NCT02840877|537417326|FG000|6 Months to 18 Months|Still in study.|14|||
148841380|NCT03427814|536899516|FG001|Overall Study|Treatment Completed|1|||
148841381|NCT03427814|536899515|FG000|Overall Study|Sponsor's Decision to End study|21|||
148841382|NCT03427814|536899516|FG001|Overall Study|Sponsor's Decision to End study|25|||
148841383|NCT03427814|536899515|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
148983445|NCT02530619|537417336|FG000|Registered for Study|Withdrawal by Subject|2|||
148841384|NCT03427814|536899516|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
148841385|NCT03846427|536899517|FG000|Overall Study|Death|13|||
148841386|NCT03846427|536899517|FG000|Overall Study|Withdrawal by Subject|3|||
148841387|NCT03846427|536899517|FG000|Overall Study|Physician Decision|1|||
148841388|NCT01334554|536899518|FG000|Overall Study|Adverse Event|4|||
148841389|NCT01334554|536899519|FG001|Overall Study|Adverse Event|2|||
148841390|NCT02393859|536899521|FG000|Overall Study|Decision by Sponsor|2|||
149029478|NCT04939428|537586581|FG002|Overall Study|Withdrawal by Subject|0|||
149029479|NCT04939428|537586579|FG000|Overall Study|Unkown|6|||
149029480|NCT04939428|537586580|FG001|Overall Study|Unkown|3|||
149029481|NCT04939428|537586581|FG002|Overall Study|Unkown|0|||
149029482|NCT04939428|537586579|FG000|Overall Study|Discotinued per protocol|0|||
149029483|NCT04939428|537586580|FG001|Overall Study|Discotinued per protocol|0|||
149029484|NCT04939428|537586581|FG002|Overall Study|Discotinued per protocol|902|||
149029485|NCT03781804|537586584|FG000|Overall Study|Adverse Event|2|||
149029486|NCT03781804|537586585|FG001|Overall Study|Adverse Event|2|||
149029487|NCT03781804|537586586|FG002|Overall Study|Adverse Event|3|||
149029488|NCT03781804|537586584|FG000|Overall Study|Lost to Follow-up|1|||
149029489|NCT03781804|537586585|FG001|Overall Study|Lost to Follow-up|1|||
149029490|NCT03781804|537586586|FG002|Overall Study|Lost to Follow-up|2|||
149029491|NCT03781804|537586584|FG000|Overall Study|Lack of Efficacy|4|||
149029492|NCT03781804|537586585|FG001|Overall Study|Lack of Efficacy|2|||
149029493|NCT03781804|537586586|FG002|Overall Study|Lack of Efficacy|9|||
149029494|NCT03781804|537586584|FG000|Overall Study|Protocol Violation|0|||
149029495|NCT03781804|537586585|FG001|Overall Study|Protocol Violation|0|||
149029496|NCT03781804|537586586|FG002|Overall Study|Protocol Violation|1|||
149029497|NCT03781804|537586584|FG000|Overall Study|Withdrawal by Subject|0|||
149029498|NCT03781804|537586585|FG001|Overall Study|Withdrawal by Subject|1|||
149029499|NCT03781804|537586586|FG002|Overall Study|Withdrawal by Subject|1|||
149029500|NCT03781804|537586584|FG000|Overall Study|Reason not provided|2|||
149029501|NCT03781804|537586585|FG001|Overall Study|Reason not provided|2|||
149029502|NCT03781804|537586586|FG002|Overall Study|Reason not provided|0|||
149029503|NCT03717194|537586587|FG000|Overall Study|Withdrawal by Subject|2|||
149029504|NCT03717194|537586588|FG001|Overall Study|Withdrawal by Subject|4|||
149029505|NCT03717194|537586587|FG000|Overall Study|Adverse Event|1|||
149029506|NCT03717194|537586588|FG001|Overall Study|Adverse Event|1|||
149029507|NCT00445692|537586590|FG000|Overall Study|Adverse Event|11|||
149029508|NCT00445692|537586590|FG000|Overall Study|Lack of Efficacy|5|||
149029509|NCT00430677|537586591|FG000|Short-term Period|Death|1|||
149029510|NCT00430677|537586592|FG001|Short-term Period|Death|1|||
149029511|NCT00430677|537586593|FG002|Short-term Period|Death|5|||
149029512|NCT00430677|537586591|FG000|Short-term Period|Adverse Event|15|||
149029513|NCT00430677|537586592|FG001|Short-term Period|Adverse Event|13|||
149029514|NCT00430677|537586593|FG002|Short-term Period|Adverse Event|9|||
149029515|NCT00430677|537586591|FG000|Short-term Period|Lack of Efficacy|5|||
149029516|NCT00430677|537586592|FG001|Short-term Period|Lack of Efficacy|6|||
149029517|NCT00430677|537586593|FG002|Short-term Period|Lack of Efficacy|4|||
149029518|NCT00430677|537586591|FG000|Short-term Period|Withdrawal by Subject|1|||
149029519|NCT00430677|537586592|FG001|Short-term Period|Withdrawal by Subject|1|||
149029520|NCT00430677|537586593|FG002|Short-term Period|Withdrawal by Subject|2|||
149029521|NCT00430677|537586591|FG000|Short-term Period|Participant no longer met study criteria|1|||
149029522|NCT00430677|537586592|FG001|Short-term Period|Participant no longer met study criteria|1|||
149029523|NCT00430677|537586593|FG002|Short-term Period|Participant no longer met study criteria|2|||
149029524|NCT00430677|537586591|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
149029525|NCT00430677|537586592|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
149029526|NCT00430677|537586593|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
149029527|NCT00430677|537586591|FG000|Short-term Period|Pregnancy|0|||
149029528|NCT00430677|537586592|FG001|Short-term Period|Pregnancy|2|||
149029529|NCT00430677|537586593|FG002|Short-term Period|Pregnancy|0|||
149029530|NCT00430677|537586591|FG000|Long-term Extension Period|Death|1|||
149029531|NCT00430677|537586592|FG001|Long-term Extension Period|Death|0|||
149029532|NCT00430677|537586593|FG002|Long-term Extension Period|Death|0|||
149029533|NCT00430677|537586591|FG000|Long-term Extension Period|Adverse Event|3|||
149029534|NCT00430677|537586592|FG001|Long-term Extension Period|Adverse Event|2|||
149029535|NCT00430677|537586593|FG002|Long-term Extension Period|Adverse Event|5|||
149029536|NCT00430677|537586591|FG000|Long-term Extension Period|Lack of Efficacy|5|||
149029537|NCT00430677|537586592|FG001|Long-term Extension Period|Lack of Efficacy|3|||
149029538|NCT00430677|537586593|FG002|Long-term Extension Period|Lack of Efficacy|8|||
149029539|NCT00430677|537586591|FG000|Long-term Extension Period|Lost to Follow-up|1|||
149029540|NCT00430677|537586592|FG001|Long-term Extension Period|Lost to Follow-up|1|||
149029541|NCT00430677|537586593|FG002|Long-term Extension Period|Lost to Follow-up|1|||
149029542|NCT00430677|537586591|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
149029543|NCT00430677|537586592|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
149029544|NCT00430677|537586593|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
149029545|NCT00430677|537586591|FG000|Long-term Extension Period|Pregnancy|1|||
149029546|NCT00430677|537586592|FG001|Long-term Extension Period|Pregnancy|1|||
149029547|NCT00430677|537586593|FG002|Long-term Extension Period|Pregnancy|0|||
149029548|NCT00430677|537586591|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
149029549|NCT00430677|537586592|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
149029550|NCT00430677|537586593|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
149029551|NCT00430677|537586591|FG000|Long-term Extension Period|Other|2|||
149029552|NCT00430677|537586592|FG001|Long-term Extension Period|Other|1|||
149029553|NCT00430677|537586593|FG002|Long-term Extension Period|Other|1|||
148841391|NCT02393859|536899522|FG001|Overall Study|Decision by Sponsor|4|||
148841392|NCT02393859|536899521|FG000|Overall Study|Withdrawal by Subject|11|||
148841393|NCT02393859|536899522|FG001|Overall Study|Withdrawal by Subject|6|||
148841394|NCT02393859|536899521|FG000|Overall Study|Death|27|||
148841395|NCT02393859|536899522|FG001|Overall Study|Death|10|||
148841396|NCT02393859|536899521|FG000|Overall Study|Lost to Follow-up|1|||
148841397|NCT02393859|536899522|FG001|Overall Study|Lost to Follow-up|1|||
148841398|NCT01944020|536899523|FG000|Overall Study|Withdrawal by Subject|5|||
148841399|NCT01944020|536899524|FG001|Overall Study|Withdrawal by Subject|0|||
148841400|NCT01979614|536899525|FG000|Overall Study|Adverse Event|1|||
148841401|NCT01979614|536899526|FG001|Overall Study|Adverse Event|1|||
148841402|NCT00661830|536899527|FG000|Overall Study|Death|37|||
148841403|NCT00661830|536899528|FG001|Overall Study|Death|33|||
148841404|NCT00661830|536899527|FG000|Overall Study|Lost to Follow-up|1|||
148841405|NCT00661830|536899528|FG001|Overall Study|Lost to Follow-up|3|||
148841406|NCT00661830|536899527|FG000|Overall Study|Withdrawal by Subject|1|||
148841407|NCT00661830|536899528|FG001|Overall Study|Withdrawal by Subject|1|||
148841408|NCT00661830|536899527|FG000|Overall Study|Other reason|1|||
148841409|NCT00661830|536899528|FG001|Overall Study|Other reason|5|||
148841410|NCT00488514|536899529|FG000|Overall Study|Adverse Event|41|||
148841411|NCT00488514|536899529|FG000|Overall Study|Lost to Follow-up|44|||
148841412|NCT00488514|536899529|FG000|Overall Study|Protocol Violation|32|||
148841413|NCT00488514|536899529|FG000|Overall Study|Withdrawal by Subject|106|||
148841414|NCT00488514|536899529|FG000|Overall Study|Lack of Efficacy|28|||
148841415|NCT00488514|536899529|FG000|Overall Study|Did not meet criteria for treatment|30|||
148841416|NCT00488514|536899529|FG000|Overall Study|Postive drug screen|1|||
148841417|NCT00488514|536899529|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
148841418|NCT00488514|536899529|FG000|Overall Study|Investigator decision|1|||
148841419|NCT00488514|536899529|FG000|Overall Study|Participant had too few migraines|5|||
148841420|NCT00488514|536899529|FG000|Overall Study|Increase in number of migraines|2|||
148841421|NCT00488514|536899529|FG000|Overall Study|Increased use of concomitant medication|1|||
148841422|NCT04971967|536899534|FG000|Overall Study|Lost to Follow-up|6|||
148841423|NCT04971967|536899535|FG001|Overall Study|Lost to Follow-up|7|||
148841424|NCT00682929|536899538|FG000|Overall Study|Adverse Event|4|||
148841425|NCT00682929|536899539|FG001|Overall Study|Adverse Event|1|||
148841426|NCT00682929|536899540|FG002|Overall Study|Adverse Event|1|||
148841427|NCT00682929|536899538|FG000|Overall Study|Withdrawal by Subject|1|||
148983446|NCT02530619|537417336|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
148841428|NCT00682929|536899539|FG001|Overall Study|Withdrawal by Subject|2|||
148841429|NCT00682929|536899540|FG002|Overall Study|Withdrawal by Subject|1|||
148841430|NCT00682929|536899538|FG000|Overall Study|dosing compliance < 80%|0|||
148841431|NCT00682929|536899539|FG001|Overall Study|dosing compliance < 80%|2|||
148841432|NCT00682929|536899540|FG002|Overall Study|dosing compliance < 80%|0|||
148841433|NCT00682929|536899538|FG000|Overall Study|lag in DEA renewal|1|||
148841434|NCT00682929|536899539|FG001|Overall Study|lag in DEA renewal|0|||
148841435|NCT00682929|536899540|FG002|Overall Study|lag in DEA renewal|0|||
148841436|NCT00938912|536899541|FG000|Overall Study|Withdrawal by Subject|28|||
148841437|NCT00938912|536899541|FG000|Overall Study|Lost to Follow-up|4|||
148841438|NCT00938912|536899541|FG000|Overall Study|Lack of Efficacy|43|||
148841439|NCT00938912|536899541|FG000|Overall Study|Adverse event, non-fatal|24|||
148841440|NCT00938912|536899541|FG000|Overall Study|Adverse event, fatal|1|||
148841441|NCT00938912|536899541|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
148841442|NCT00938912|536899541|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
148841443|NCT00938912|536899541|FG000|Overall Study|Participant needed prohibit medication|1|||
148841444|NCT00938912|536899541|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
148841445|NCT00938912|536899541|FG000|Overall Study|Did not meet Eligibility criteria|1|||
148841446|NCT00938912|536899541|FG000|Overall Study|Participant relocated not related to AE|1|||
148841447|NCT00938912|536899541|FG000|Overall Study|Participant moved to another city|1|||
148841448|NCT00938912|536899541|FG000|Overall Study|Participant experienced break through seizures|1|||
148841449|NCT00938912|536899541|FG000|Overall Study|No longer wished to participate in the study|1|||
148841450|NCT00938912|536899541|FG000|Overall Study|Protocol Deviation|2|||
148983447|NCT02530619|537417336|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
148983448|NCT02530619|537417336|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
148983449|NCT02530619|537417336|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
148983450|NCT02530619|537417336|FG000|Follow-up Period (6 Months)|Death|4|||
148841451|NCT00803738|536899542|FG000|Overall Study|Adverse Event|3|||
148841452|NCT00803738|536899543|FG001|Overall Study|Adverse Event|5|||
148841453|NCT00803738|536899542|FG000|Overall Study|Lost to Follow-up|4|||
148841454|NCT00803738|536899543|FG001|Overall Study|Lost to Follow-up|4|||
148841455|NCT00803738|536899542|FG000|Overall Study|Protocol Violation|18|||
148841456|NCT00803738|536899543|FG001|Overall Study|Protocol Violation|10|||
148841457|NCT00803738|536899542|FG000|Overall Study|Withdrawal by Subject|1|||
148841458|NCT00803738|536899543|FG001|Overall Study|Withdrawal by Subject|4|||
148841459|NCT00803738|536899542|FG000|Overall Study|Lack of Efficacy|10|||
148841460|NCT00803738|536899543|FG001|Overall Study|Lack of Efficacy|16|||
148841461|NCT00803738|536899542|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
148841462|NCT00803738|536899543|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
148841463|NCT00803738|536899542|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
148841464|NCT00803738|536899543|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
148841465|NCT02897115|536899546|FG000|Overall Study|Early termination of study by sponsor|11|||
148841466|NCT02897115|536899547|FG001|Overall Study|Early termination of study by sponsor|8|||
148841467|NCT01119443|536899549|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
148841468|NCT01119443|536899550|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
148841469|NCT02329743|536899551|FG000|Overall Study|Adverse Event|1|||
148841470|NCT02329743|536899552|FG001|Overall Study|Adverse Event|1|||
148841471|NCT02329743|536899553|FG002|Overall Study|Adverse Event|3|||
148841472|NCT02329743|536899551|FG000|Overall Study|Lost to Follow-up|1|||
148841473|NCT02329743|536899552|FG001|Overall Study|Lost to Follow-up|0|||
148841474|NCT02329743|536899553|FG002|Overall Study|Lost to Follow-up|1|||
148841475|NCT02329743|536899551|FG000|Overall Study|Withdrawal by Subject|4|||
148841476|NCT02329743|536899552|FG001|Overall Study|Withdrawal by Subject|4|||
148841477|NCT02329743|536899553|FG002|Overall Study|Withdrawal by Subject|1|||
148841478|NCT02329743|536899551|FG000|Overall Study|Other|0|||
148841479|NCT02329743|536899552|FG001|Overall Study|Other|2|||
148841480|NCT02329743|536899553|FG002|Overall Study|Other|3|||
148841481|NCT02071771|536899554|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
148841482|NCT02071771|536899555|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
148983451|NCT02530619|537417336|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
148983452|NCT02530619|537417336|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
148983453|NCT01854554|537417347|FG000|Overall Study|Denial of Insurance Coverage|12|||
148983454|NCT01854554|537417348|FG001|Overall Study|Denial of Insurance Coverage|0|||
148983455|NCT01854554|537417347|FG000|Overall Study|Decided to get treatment locally|1|||
148983456|NCT01854554|537417348|FG001|Overall Study|Decided to get treatment locally|5|||
148983457|NCT01854554|537417347|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
148983458|NCT01854554|537417348|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
148983459|NCT01854554|537417347|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
148983460|NCT01854554|537417348|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
148983461|NCT01854554|537417347|FG000|Overall Study|Progression|0|||
148983462|NCT01854554|537417348|FG001|Overall Study|Progression|1|||
148983463|NCT01854554|537417347|FG000|Overall Study|Lost to Follow-up|0|||
148983464|NCT01854554|537417348|FG001|Overall Study|Lost to Follow-up|1|||
148983465|NCT02819726|537417351|FG000|Part A (All Participants)|Lost to Follow-up|0|||
148983466|NCT02819726|537417352|FG001|Part A (All Participants)|Lost to Follow-up|1|||
148983467|NCT02819726|537417353|FG002|Part A (All Participants)|Lost to Follow-up|0|||
148983468|NCT02819726|537417354|FG003|Part A (All Participants)|Lost to Follow-up|0|||
148983469|NCT02819726|537417351|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
148983470|NCT02819726|537417352|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
148983471|NCT02819726|537417353|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
148983472|NCT02819726|537417354|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
148983473|NCT02819726|537417351|FG000|Part A (All Participants)|Protocol non-compliance|3|||
148983474|NCT02819726|537417352|FG001|Part A (All Participants)|Protocol non-compliance|4|||
148983475|NCT02819726|537417353|FG002|Part A (All Participants)|Protocol non-compliance|5|||
148983476|NCT02819726|537417354|FG003|Part A (All Participants)|Protocol non-compliance|0|||
148983477|NCT02819726|537417351|FG000|Part B (All Participants)|Lost to Follow-up|1|||
148983478|NCT02819726|537417352|FG001|Part B (All Participants)|Lost to Follow-up|1|||
148983479|NCT02819726|537417353|FG002|Part B (All Participants)|Lost to Follow-up|2|||
148983480|NCT02819726|537417354|FG003|Part B (All Participants)|Lost to Follow-up|2|||
148983481|NCT02819726|537417351|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
148983482|NCT02819726|537417352|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
148983483|NCT02819726|537417353|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
148983484|NCT02819726|537417354|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
148983485|NCT02819726|537417351|FG000|Part B (All Participants)|Protocol non-compliance|0|||
148983486|NCT02819726|537417352|FG001|Part B (All Participants)|Protocol non-compliance|0|||
148983487|NCT02819726|537417353|FG002|Part B (All Participants)|Protocol non-compliance|1|||
148983488|NCT02819726|537417354|FG003|Part B (All Participants)|Protocol non-compliance|0|||
148983489|NCT00359762|537417355|FG000|Period II|Adverse Event|17|||
148983490|NCT00359762|537417356|FG001|Period II|Adverse Event|0|||
148983491|NCT00359762|537417357|FG002|Period II|Adverse Event|0|||
148983492|NCT00359762|537417358|FG003|Period II|Adverse Event|0|||
148983493|NCT00359762|537417359|FG004|Period II|Adverse Event|49|||
148983494|NCT00359762|537417355|FG000|Period II|Protocol Violation|18|||
148983495|NCT00359762|537417356|FG001|Period II|Protocol Violation|0|||
148983496|NCT00359762|537417357|FG002|Period II|Protocol Violation|0|||
148841483|NCT02071771|536899554|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
148841484|NCT02071771|536899555|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
148841485|NCT03432494|536899566|FG000|Overall Study|Death|1|||
148841486|NCT03432494|536899566|FG000|Overall Study|Noncompliance|1|||
148983497|NCT00359762|537417358|FG003|Period II|Protocol Violation|0|||
148983498|NCT00359762|537417359|FG004|Period II|Protocol Violation|11|||
148841487|NCT00592631|536899568|FG000|Overall Study|Lost to Follow-up|0|||
148841488|NCT00592631|536899569|FG001|Overall Study|Lost to Follow-up|2|||
148841489|NCT01023217|536899572|FG000|Overall Study|Withdrawal by Subject|1|||
148841490|NCT01023217|536899573|FG001|Overall Study|Withdrawal by Subject|0|||
148841491|NCT00400517|536899574|FG000|Overall Study|Withdrawal by Subject|1|||
148841492|NCT00400517|536899574|FG000|Overall Study|Physician Decision|1|||
148841493|NCT02298868|536899575|FG000|Overall Study|Adverse Event|1|||
148841494|NCT02298868|536899575|FG000|Overall Study|Death|1|||
148841495|NCT02298868|536899575|FG000|Overall Study|Patient underwent transplant|1|||
148841496|NCT01194245|536899576|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
148841497|NCT01194245|536899577|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
148841498|NCT01194245|536899578|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
148841499|NCT01194245|536899579|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
148841500|NCT01194245|536899580|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
148841501|NCT01194245|536899576|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
148841502|NCT01194245|536899577|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
148841503|NCT01194245|536899578|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
148841504|NCT01194245|536899579|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
148841505|NCT01194245|536899580|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
148841506|NCT01194245|536899576|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
148841507|NCT01194245|536899577|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
148841508|NCT01194245|536899578|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
148841509|NCT01194245|536899579|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
148841510|NCT01194245|536899580|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
148841511|NCT01194245|536899576|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
148841512|NCT01194245|536899577|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
148841513|NCT01194245|536899578|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
148841514|NCT01194245|536899579|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
148841515|NCT01194245|536899580|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
148841516|NCT01194245|536899576|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148841517|NCT01194245|536899577|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148841518|NCT01194245|536899578|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148841519|NCT01194245|536899579|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148841520|NCT01194245|536899580|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
148841521|NCT01194245|536899576|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148841522|NCT01194245|536899577|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148841523|NCT01194245|536899578|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
148841524|NCT01194245|536899579|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
148841525|NCT01194245|536899580|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
148841526|NCT01118780|536899581|FG000|Overall Study|Adverse Event|15|||
148841527|NCT01118780|536899582|FG001|Overall Study|Adverse Event|15|||
148841528|NCT01118780|536899581|FG000|Overall Study|Death|1|||
148841529|NCT01118780|536899582|FG001|Overall Study|Death|0|||
148841530|NCT01118780|536899581|FG000|Overall Study|Lack of Efficacy|2|||
148841531|NCT01118780|536899582|FG001|Overall Study|Lack of Efficacy|6|||
148841532|NCT01118780|536899581|FG000|Overall Study|Physician Decision|2|||
148841533|NCT01118780|536899582|FG001|Overall Study|Physician Decision|0|||
148841534|NCT01118780|536899581|FG000|Overall Study|Protocol Violation|3|||
148841535|NCT01118780|536899582|FG001|Overall Study|Protocol Violation|6|||
148841536|NCT01118780|536899581|FG000|Overall Study|Withdrawal by Subject|13|||
148841537|NCT01118780|536899582|FG001|Overall Study|Withdrawal by Subject|8|||
148841538|NCT03962855|536899583|FG000|Overall Study|Death|0|||
148841539|NCT03962855|536899584|FG001|Overall Study|Death|1|||
148841540|NCT03962855|536899583|FG000|Overall Study|Lost to Follow-up|0|||
148841541|NCT03962855|536899584|FG001|Overall Study|Lost to Follow-up|1|||
148841542|NCT03962855|536899583|FG000|Overall Study|Adverse Event|0|||
148841543|NCT03962855|536899584|FG001|Overall Study|Adverse Event|1|||
148841544|NCT03962855|536899583|FG000|Overall Study|Physician Decision|0|||
148841545|NCT03962855|536899584|FG001|Overall Study|Physician Decision|2|||
148841546|NCT02457247|536899585|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
148841547|NCT02457247|536899586|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
148841548|NCT02457247|536899587|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
148841549|NCT02457247|536899588|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
148841550|NCT02457247|536899585|FG000|Period 1|Significant Protocol Deviation|1|||
148841551|NCT02457247|536899586|FG001|Period 1|Significant Protocol Deviation|1|||
148841552|NCT02457247|536899587|FG002|Period 1|Significant Protocol Deviation|0|||
148841553|NCT02457247|536899588|FG003|Period 1|Significant Protocol Deviation|0|||
148841554|NCT02457247|536899585|FG000|Period 1|Voluntary Withdrawal|1|||
148841555|NCT02457247|536899586|FG001|Period 1|Voluntary Withdrawal|0|||
148841556|NCT02457247|536899587|FG002|Period 1|Voluntary Withdrawal|0|||
148841557|NCT02457247|536899588|FG003|Period 1|Voluntary Withdrawal|0|||
148841558|NCT02457247|536899585|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
148841559|NCT02457247|536899586|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
148841560|NCT02457247|536899587|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
148841561|NCT02457247|536899588|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
148841562|NCT02457247|536899585|FG000|Period 2|Significant Protocol Deviation|1|||
148841563|NCT02457247|536899586|FG001|Period 2|Significant Protocol Deviation|0|||
148841564|NCT02457247|536899587|FG002|Period 2|Significant Protocol Deviation|0|||
148841565|NCT02457247|536899588|FG003|Period 2|Significant Protocol Deviation|0|||
148841566|NCT02457247|536899585|FG000|Period 2|Lost to Follow-up|0|||
148841567|NCT02457247|536899586|FG001|Period 2|Lost to Follow-up|1|||
148841568|NCT02457247|536899587|FG002|Period 2|Lost to Follow-up|0|||
148841569|NCT02457247|536899588|FG003|Period 2|Lost to Follow-up|0|||
148841570|NCT02457247|536899585|FG000|Period 2|Voluntary Withdrawal|1|||
148841571|NCT02457247|536899586|FG001|Period 2|Voluntary Withdrawal|1|||
148841572|NCT02457247|536899587|FG002|Period 2|Voluntary Withdrawal|0|||
148841573|NCT02457247|536899588|FG003|Period 2|Voluntary Withdrawal|0|||
148841574|NCT03192137|536899593|FG000|Overall Study|Adverse Event|10|||
148841575|NCT03192137|536899594|FG001|Overall Study|Adverse Event|11|||
148841576|NCT03192137|536899593|FG000|Overall Study|Physician Decision|1|||
148841577|NCT03192137|536899594|FG001|Overall Study|Physician Decision|0|||
148841578|NCT03192137|536899593|FG000|Overall Study|Lack of Efficacy|20|||
148841579|NCT03192137|536899594|FG001|Overall Study|Lack of Efficacy|37|||
148841580|NCT03192137|536899593|FG000|Overall Study|Withdrawal by Subject|3|||
148841581|NCT03192137|536899594|FG001|Overall Study|Withdrawal by Subject|3|||
148841582|NCT03192137|536899593|FG000|Overall Study|Protocol Violation|4|||
148841583|NCT03192137|536899594|FG001|Overall Study|Protocol Violation|3|||
148841584|NCT03192137|536899593|FG000|Overall Study|Surgery Cancelled|4|||
148841585|NCT03192137|536899594|FG001|Overall Study|Surgery Cancelled|1|||
148841586|NCT03192137|536899593|FG000|Overall Study|Other - Various Administrative Reasons|8|||
148841587|NCT03192137|536899594|FG001|Overall Study|Other - Various Administrative Reasons|3|||
148841588|NCT01261975|536899595|FG000|Overall Study|Surgical complication|1|||
148841589|NCT00833027|536899598|FG000|Overall Study|Adverse Event|33|||
148841590|NCT00833027|536899598|FG000|Overall Study|Death|1|||
148841591|NCT00833027|536899598|FG000|Overall Study|Lack of Efficacy|12|||
148841592|NCT00833027|536899598|FG000|Overall Study|Lost to Follow-up|24|||
148841593|NCT00833027|536899598|FG000|Overall Study|Protocol Violation|115|||
148841594|NCT00833027|536899598|FG000|Overall Study|Withdrawal by Subject|16|||
148841595|NCT00833027|536899598|FG000|Overall Study|Missing|10|||
148841596|NCT01342094|536899599|FG000|Overall Study|Adverse Event|5|||
148841597|NCT01342094|536899600|FG001|Overall Study|Adverse Event|0|||
148841598|NCT01342094|536899599|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
148841599|NCT01342094|536899600|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
148841600|NCT01342094|536899599|FG000|Overall Study|Withdrawal by Subject|0|||
148841601|NCT01342094|536899600|FG001|Overall Study|Withdrawal by Subject|2|||
148841602|NCT02806414|536899601|FG000|Overall Study|Lost to Follow-up|2|||
148841603|NCT01985022|536899606|FG000|Overall Study|Lost to Follow-up|0|||
148841604|NCT01985022|536899607|FG001|Overall Study|Lost to Follow-up|1|||
148841605|NCT01985022|536899606|FG000|Overall Study|Protocol Violation|0|||
148841606|NCT01985022|536899607|FG001|Overall Study|Protocol Violation|1|||
148841607|NCT01985022|536899606|FG000|Overall Study|Withdrawal by Subject|4|||
148841608|NCT01985022|536899607|FG001|Overall Study|Withdrawal by Subject|1|||
148841609|NCT00806260|536899610|FG000|Period 1 (1 Day)|Adverse Event|0|||
148841610|NCT00806260|536899611|FG001|Period 1 (1 Day)|Adverse Event|0|||
148841611|NCT00806260|536899612|FG002|Period 1 (1 Day)|Adverse Event|0|||
148841612|NCT00806260|536899613|FG003|Period 1 (1 Day)|Adverse Event|0|||
148841613|NCT00806260|536899614|FG004|Period 1 (1 Day)|Adverse Event|3|||
148841614|NCT00806260|536899615|FG005|Period 1 (1 Day)|Adverse Event|0|||
148841615|NCT00806260|536899610|FG000|Period 2|Adverse Event|0|||
148841616|NCT00806260|536899611|FG001|Period 2|Adverse Event|0|||
148841617|NCT00806260|536899612|FG002|Period 2|Adverse Event|0|||
148841618|NCT00806260|536899613|FG003|Period 2|Adverse Event|1|||
148841619|NCT00806260|536899614|FG004|Period 2|Adverse Event|0|||
148983499|NCT00359762|537417355|FG000|Period II|Physician Decision|17|||
148983500|NCT00359762|537417356|FG001|Period II|Physician Decision|0|||
148983501|NCT00359762|537417357|FG002|Period II|Physician Decision|0|||
148983502|NCT00359762|537417358|FG003|Period II|Physician Decision|0|||
148841620|NCT00806260|536899615|FG005|Period 2|Adverse Event|0|||
148841621|NCT00806260|536899610|FG000|Period 2|Protocol Violation|1|||
148841622|NCT00806260|536899611|FG001|Period 2|Protocol Violation|0|||
148841623|NCT00806260|536899612|FG002|Period 2|Protocol Violation|1|||
148841624|NCT00806260|536899613|FG003|Period 2|Protocol Violation|0|||
148774488|NCT01340027|536647035|FG006|Overall Study|Lack of Efficacy|1|||
148774489|NCT01340027|536647036|FG007|Overall Study|Lack of Efficacy|1|||
148774490|NCT01340027|536647037|FG008|Overall Study|Lack of Efficacy|1|||
148774491|NCT01340027|536647038|FG009|Overall Study|Lack of Efficacy|0|||
148774492|NCT01340027|536647039|FG010|Overall Study|Lack of Efficacy|0|||
148774493|NCT01340027|536647040|FG011|Overall Study|Lack of Efficacy|0|||
148774494|NCT01340027|536647029|FG000|Overall Study|Lost to Follow-up|0|||
148774495|NCT01340027|536647030|FG001|Overall Study|Lost to Follow-up|1|||
148774496|NCT01340027|536647031|FG002|Overall Study|Lost to Follow-up|0|||
148774497|NCT01340027|536647032|FG003|Overall Study|Lost to Follow-up|0|||
148983503|NCT00359762|537417359|FG004|Period II|Physician Decision|23|||
148841625|NCT00806260|536899614|FG004|Period 2|Protocol Violation|0|||
148841626|NCT00806260|536899615|FG005|Period 2|Protocol Violation|0|||
148841627|NCT00806260|536899610|FG000|Period 2|Need to take concomitant medication|1|||
148841628|NCT00806260|536899611|FG001|Period 2|Need to take concomitant medication|0|||
148841629|NCT00806260|536899612|FG002|Period 2|Need to take concomitant medication|0|||
148841630|NCT00806260|536899613|FG003|Period 2|Need to take concomitant medication|0|||
148841631|NCT00806260|536899614|FG004|Period 2|Need to take concomitant medication|0|||
148841632|NCT00806260|536899615|FG005|Period 2|Need to take concomitant medication|0|||
148841633|NCT00806260|536899610|FG000|Period 2|sponsor request|0|||
148841634|NCT00806260|536899611|FG001|Period 2|sponsor request|0|||
148841635|NCT00806260|536899612|FG002|Period 2|sponsor request|1|||
148841636|NCT00806260|536899613|FG003|Period 2|sponsor request|1|||
148841637|NCT00806260|536899614|FG004|Period 2|sponsor request|0|||
148841638|NCT00806260|536899615|FG005|Period 2|sponsor request|0|||
148841639|NCT00806260|536899610|FG000|Period 3|Protocol Violation|0|||
148841640|NCT00806260|536899611|FG001|Period 3|Protocol Violation|1|||
148841641|NCT00806260|536899612|FG002|Period 3|Protocol Violation|1|||
148841642|NCT00806260|536899613|FG003|Period 3|Protocol Violation|0|||
148841643|NCT00806260|536899614|FG004|Period 3|Protocol Violation|0|||
148841644|NCT00806260|536899615|FG005|Period 3|Protocol Violation|0|||
148841645|NCT00806260|536899610|FG000|Period 3|Pregnancy|1|||
148841646|NCT00806260|536899611|FG001|Period 3|Pregnancy|0|||
148841647|NCT00806260|536899612|FG002|Period 3|Pregnancy|0|||
148841648|NCT00806260|536899613|FG003|Period 3|Pregnancy|0|||
148841649|NCT00806260|536899614|FG004|Period 3|Pregnancy|0|||
148841650|NCT00806260|536899615|FG005|Period 3|Pregnancy|0|||
148841651|NCT00237042|536899616|FG000|Treatment|Became ineligible post-randomization|0|||
148841652|NCT00237042|536899617|FG001|Treatment|Became ineligible post-randomization|1|||
148841653|NCT00237042|536899618|FG002|Treatment|Became ineligible post-randomization|16|||
148841654|NCT00237042|536899616|FG000|Treatment|Moved out of state|1|||
148841655|NCT00237042|536899617|FG001|Treatment|Moved out of state|1|||
148841656|NCT00237042|536899618|FG002|Treatment|Moved out of state|1|||
148841657|NCT00237042|536899616|FG000|Treatment|Completed no treatment|5|||
148841658|NCT00237042|536899617|FG001|Treatment|Completed no treatment|5|||
148841659|NCT00237042|536899618|FG002|Treatment|Completed no treatment|21|||
148841660|NCT00237042|536899616|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
148841661|NCT00237042|536899617|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
148841662|NCT00237042|536899618|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
148841663|NCT00237042|536899616|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
148841664|NCT00237042|536899617|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
148841665|NCT00237042|536899618|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
148841666|NCT01074931|536899619|FG000|Overall Study|Economic reasons|1|||
148841667|NCT01074931|536899619|FG000|Overall Study|Death|5|||
148841668|NCT03132467|536899620|FG000|Overall Study|Adverse Event|2|||
148841669|NCT03132467|536899620|FG000|Overall Study|Withdrawal by Subject|2|||
148841670|NCT05223673|536899621|FG000|Overall Study|Protocol Violation|1|||
148841671|NCT05223673|536899621|FG000|Overall Study|Study termination|6|||
148841672|NCT01333722|536901449|FG000|Overall Study|Lack of Efficacy|0|||
148841673|NCT01333722|536901450|FG001|Overall Study|Lack of Efficacy|2|||
148841674|NCT01333722|536901449|FG000|Overall Study|Withdrawal by Subject|0|||
148841675|NCT01333722|536901450|FG001|Overall Study|Withdrawal by Subject|1|||
148841676|NCT00784368|536901451|FG000|Overall Study|Physician Decision|0|||
148841677|NCT00784368|536901452|FG001|Overall Study|Physician Decision|0|||
148841678|NCT00784368|536901453|FG002|Overall Study|Physician Decision|6|||
148841679|NCT00784368|536901451|FG000|Overall Study|Lack of Efficacy|2|||
148841680|NCT00784368|536901452|FG001|Overall Study|Lack of Efficacy|0|||
148841681|NCT00784368|536901453|FG002|Overall Study|Lack of Efficacy|1|||
148841682|NCT00784368|536901451|FG000|Overall Study|Adverse Event|6|||
148841683|NCT00784368|536901452|FG001|Overall Study|Adverse Event|9|||
148841684|NCT00784368|536901453|FG002|Overall Study|Adverse Event|2|||
148841685|NCT00784368|536901451|FG000|Overall Study|Diagnosis of fever|0|||
148983504|NCT00359762|537417355|FG000|Period II|Death|2|||
148983505|NCT00359762|537417356|FG001|Period II|Death|0|||
148983506|NCT00359762|537417357|FG002|Period II|Death|0|||
148983507|NCT00359762|537417358|FG003|Period II|Death|0|||
148983508|NCT00359762|537417359|FG004|Period II|Death|4|||
148983509|NCT00359762|537417355|FG000|Period II|Lack of Efficacy|11|||
148983510|NCT00359762|537417356|FG001|Period II|Lack of Efficacy|0|||
148983511|NCT00359762|537417357|FG002|Period II|Lack of Efficacy|0|||
148983512|NCT00359762|537417358|FG003|Period II|Lack of Efficacy|0|||
148983513|NCT00359762|537417359|FG004|Period II|Lack of Efficacy|8|||
148983514|NCT00359762|537417355|FG000|Period II|Lost to follow up|5|||
148983515|NCT00359762|537417356|FG001|Period II|Lost to follow up|0|||
148841686|NCT00784368|536901452|FG001|Overall Study|Diagnosis of fever|0|||
148841687|NCT00784368|536901453|FG002|Overall Study|Diagnosis of fever|1|||
148841688|NCT00784368|536901451|FG000|Overall Study|Worsening of complications|0|||
148841689|NCT00784368|536901452|FG001|Overall Study|Worsening of complications|0|||
148983516|NCT00359762|537417357|FG002|Period II|Lost to follow up|0|||
148983517|NCT00359762|537417358|FG003|Period II|Lost to follow up|0|||
148983518|NCT00359762|537417359|FG004|Period II|Lost to follow up|5|||
148841690|NCT00784368|536901453|FG002|Overall Study|Worsening of complications|1|||
148841691|NCT00784368|536901451|FG000|Overall Study|Worsening of symptoms|0|||
148841692|NCT00784368|536901452|FG001|Overall Study|Worsening of symptoms|1|||
148841693|NCT00784368|536901453|FG002|Overall Study|Worsening of symptoms|0|||
148841694|NCT00784368|536901451|FG000|Overall Study|Withdrawal of informed consent|0|||
148841695|NCT00784368|536901452|FG001|Overall Study|Withdrawal of informed consent|1|||
148841696|NCT00784368|536901453|FG002|Overall Study|Withdrawal of informed consent|0|||
148841697|NCT00628446|536901456|FG000|Overall Study|Lost to Follow-up|3|||
148841698|NCT00628446|536901456|FG000|Overall Study|Withdrawal by Subject|1|||
148841699|NCT00628446|536901456|FG000|Overall Study|Protocol Violation|3|||
148841700|NCT00756275|536901457|FG000|Overall Study|Lost to Follow-up|25|||
148841701|NCT00756275|536901458|FG001|Overall Study|Lost to Follow-up|21|||
148841702|NCT00756275|536901457|FG000|Overall Study|Withdrawal by Subject|4|||
148889176|NCT01279681|537072380|FG000|Overall Study|Disease Progression|9|||
148889177|NCT01279681|537072381|FG001|Overall Study|Disease Progression|6|||
148983519|NCT00359762|537417355|FG000|Period II|Entry Criteria Not Met|8|||
148983520|NCT00359762|537417356|FG001|Period II|Entry Criteria Not Met|0|||
148983521|NCT00359762|537417357|FG002|Period II|Entry Criteria Not Met|0|||
148983522|NCT00359762|537417358|FG003|Period II|Entry Criteria Not Met|0|||
148983523|NCT00359762|537417359|FG004|Period II|Entry Criteria Not Met|4|||
148983524|NCT00359762|537417355|FG000|Period II|Subject Decision|50|||
148889178|NCT01279681|537072380|FG000|Overall Study|Withdrawal by Subject|3|||
148889179|NCT01279681|537072381|FG001|Overall Study|Withdrawal by Subject|4|||
148889180|NCT01279681|537072380|FG000|Overall Study|Adverse Event|2|||
148889181|NCT01279681|537072381|FG001|Overall Study|Adverse Event|3|||
148889182|NCT01279681|537072380|FG000|Overall Study|Death|0|||
148889183|NCT01279681|537072381|FG001|Overall Study|Death|1|||
148889184|NCT01279681|537072380|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
148889185|NCT01279681|537072381|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
148889186|NCT01279681|537072380|FG000|Overall Study|Physician Decision|1|||
148889187|NCT01279681|537072381|FG001|Overall Study|Physician Decision|0|||
148889188|NCT01279681|537072380|FG000|Overall Study|Other Reason|0|||
148889189|NCT01279681|537072381|FG001|Overall Study|Other Reason|2|||
148889190|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
148889191|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
148889192|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
148889193|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
148889194|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
148889195|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
148889196|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
148889197|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
148889198|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
148889199|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
148889200|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
148889201|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
148889202|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
148889203|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
148889204|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
148889205|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
148889206|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
148889207|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
148889208|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
148889209|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
148889210|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
148889211|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
148889212|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
148889213|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
148889214|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
148889215|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
148889216|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
148889217|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
148889218|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
148889219|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
148889220|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
148889221|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
148889222|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
148889223|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
148889224|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
148841703|NCT00756275|536901458|FG001|Overall Study|Withdrawal by Subject|7|||
148841704|NCT00399568|536901461|FG000|Overall Study|Adverse Event|1|||
148841705|NCT00399568|536901462|FG001|Overall Study|Adverse Event|2|||
148841706|NCT00399568|536901461|FG000|Overall Study|Withdrawal by Subject|7|||
148841707|NCT00399568|536901462|FG001|Overall Study|Withdrawal by Subject|3|||
148841708|NCT00399568|536901461|FG000|Overall Study|Protocol non-compliance|2|||
148841709|NCT00399568|536901462|FG001|Overall Study|Protocol non-compliance|2|||
148841710|NCT00399568|536901461|FG000|Overall Study|Lost to Follow-up|2|||
148841711|NCT00399568|536901462|FG001|Overall Study|Lost to Follow-up|2|||
148841712|NCT00856635|536901467|FG000|Overall Study|Lost to Follow-up|2|||
148841713|NCT00856635|536901468|FG001|Overall Study|Lost to Follow-up|5|||
148841714|NCT00856635|536901467|FG000|Overall Study|Pregnancy|1|||
148841715|NCT00856635|536901468|FG001|Overall Study|Pregnancy|0|||
148841716|NCT00856635|536901467|FG000|Overall Study|Withdrawal by Subject|3|||
148841717|NCT00856635|536901468|FG001|Overall Study|Withdrawal by Subject|1|||
148841718|NCT00856635|536901467|FG000|Overall Study|Serious Adverse Event|1|||
148841719|NCT00856635|536901468|FG001|Overall Study|Serious Adverse Event|0|||
148841720|NCT00856635|536901467|FG000|Overall Study|Other|1|||
148841721|NCT00856635|536901468|FG001|Overall Study|Other|0|||
148841722|NCT00856635|536901467|FG000|Overall Study|Discontinued at Randomization|2|||
148841723|NCT00856635|536901468|FG001|Overall Study|Discontinued at Randomization|2|||
148841724|NCT02383862|536901469|FG000|3 Month Follow up|Lost to Follow-up|23|||
148841725|NCT02383862|536901470|FG001|3 Month Follow up|Lost to Follow-up|21|||
148841726|NCT00347932|536901471|FG000|Overall Study|Adverse Event|4|||
148841727|NCT00347932|536901472|FG001|Overall Study|Adverse Event|5|||
148841728|NCT00347932|536901471|FG000|Overall Study|Lack of Efficacy|3|||
148841729|NCT00347932|536901472|FG001|Overall Study|Lack of Efficacy|14|||
148841730|NCT00347932|536901471|FG000|Overall Study|Lost to Follow-up|10|||
148841731|NCT00347932|536901472|FG001|Overall Study|Lost to Follow-up|9|||
148841732|NCT00347932|536901471|FG000|Overall Study|Withdrawal by Subject|10|||
148841733|NCT00347932|536901472|FG001|Overall Study|Withdrawal by Subject|16|||
148841734|NCT00347932|536901471|FG000|Overall Study|Did not meet inclusion criteria|4|||
148841735|NCT00347932|536901472|FG001|Overall Study|Did not meet inclusion criteria|8|||
148841736|NCT03389308|536901475|FG000|Overall Study|Withdrawal by Subject|5|||
148841737|NCT03389308|536901475|FG000|Overall Study|Lost to Follow-up|3|||
148841738|NCT03389308|536901475|FG000|Overall Study|Adverse Event|2|||
148841739|NCT03389308|536901475|FG000|Overall Study|Sponsor Request|2|||
148841740|NCT03198767|536901476|FG000|Overall Study|Protocol Violation|0|||
148841741|NCT03198767|536901477|FG001|Overall Study|Protocol Violation|0|||
148841742|NCT03198767|536901478|FG002|Overall Study|Protocol Violation|0|||
148841743|NCT03198767|536901479|FG003|Overall Study|Protocol Violation|6|||
148841744|NCT03198767|536901480|FG004|Overall Study|Protocol Violation|0|||
148841745|NCT03198767|536901481|FG005|Overall Study|Protocol Violation|0|||
148841746|NCT03198767|536901482|FG006|Overall Study|Protocol Violation|0|||
148841747|NCT01891396|536901483|FG000|Overall Study|Withdrawal by Subject|4|||
148841748|NCT01891396|536901484|FG001|Overall Study|Withdrawal by Subject|4|||
148841749|NCT01891396|536901485|FG002|Overall Study|Withdrawal by Subject|3|||
148841750|NCT01891396|536901483|FG000|Overall Study|Lost to Follow-up|0|||
148841751|NCT01891396|536901484|FG001|Overall Study|Lost to Follow-up|1|||
148841752|NCT01891396|536901485|FG002|Overall Study|Lost to Follow-up|0|||
148841753|NCT02820844|536901487|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
148841754|NCT02820844|536901488|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
148841755|NCT02820844|536901489|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
148841756|NCT02820844|536901490|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
148841757|NCT02820844|536901491|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
148841758|NCT02820844|536901492|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
148841759|NCT02820844|536901487|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
148841760|NCT02820844|536901488|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
148841761|NCT02820844|536901489|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
148983525|NCT00359762|537417356|FG001|Period II|Subject Decision|0|||
148841762|NCT02820844|536901490|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
148841763|NCT02820844|536901491|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
148841764|NCT02820844|536901492|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
148983526|NCT00359762|537417357|FG002|Period II|Subject Decision|0|||
148841765|NCT02820844|536901487|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
148841766|NCT02820844|536901488|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
148841767|NCT02820844|536901489|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
148841768|NCT02820844|536901490|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
148841769|NCT02820844|536901491|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
148841770|NCT02820844|536901492|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
148841771|NCT02820844|536901487|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
148841772|NCT02820844|536901488|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
148983527|NCT00359762|537417358|FG003|Period II|Subject Decision|0|||
148841773|NCT02820844|536901489|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
148983528|NCT00359762|537417359|FG004|Period II|Subject Decision|70|||
148841774|NCT02820844|536901490|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
148841775|NCT02820844|536901491|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
148841776|NCT02820844|536901492|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
148841777|NCT02820844|536901487|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
148841778|NCT02820844|536901488|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
148841779|NCT02820844|536901489|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
148841780|NCT02820844|536901490|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
148841781|NCT02820844|536901491|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
148841782|NCT02820844|536901492|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
148841783|NCT02820844|536901487|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
148841784|NCT02820844|536901488|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
148841785|NCT02820844|536901489|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
148841786|NCT02820844|536901490|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
148841787|NCT02820844|536901491|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
148841788|NCT02820844|536901492|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
148841789|NCT02820844|536901487|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
148841790|NCT02820844|536901488|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
148841791|NCT02820844|536901489|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
148841792|NCT02820844|536901490|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
148841793|NCT02820844|536901491|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
148841794|NCT02820844|536901492|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
148841795|NCT02820844|536901487|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841796|NCT02820844|536901488|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841797|NCT02820844|536901489|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
148841798|NCT02820844|536901490|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
148841799|NCT02820844|536901491|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841800|NCT02820844|536901492|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841801|NCT02820844|536901487|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
148841802|NCT02820844|536901488|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
148841803|NCT02820844|536901489|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
148841804|NCT02820844|536901490|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
148841805|NCT02820844|536901491|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
148841806|NCT02820844|536901492|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
148841807|NCT02820844|536901487|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841808|NCT02820844|536901488|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841809|NCT02820844|536901489|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841810|NCT02820844|536901490|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841811|NCT02820844|536901491|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
148841812|NCT02820844|536901492|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
148841813|NCT02266147|536901493|FG000|PART 1: Dose Escalation|Physician Decision|0|||
148841814|NCT02266147|536901494|FG001|PART 1: Dose Escalation|Physician Decision|0|||
148841815|NCT02266147|536901495|FG002|PART 1: Dose Escalation|Physician Decision|1|||
148841816|NCT02266147|536901496|FG003|PART 1: Dose Escalation|Physician Decision|0|||
148841817|NCT02266147|536901493|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
148841818|NCT02266147|536901494|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
148841819|NCT02266147|536901495|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
148841820|NCT02266147|536901496|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
148841821|NCT02266147|536901493|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
148841822|NCT02266147|536901494|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
148841823|NCT02266147|536901495|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
148841824|NCT02266147|536901496|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
148841825|NCT02266147|536901493|FG000|PART 1: Dose Escalation|Other|1|||
148841826|NCT02266147|536901494|FG001|PART 1: Dose Escalation|Other|1|||
148841827|NCT02266147|536901495|FG002|PART 1: Dose Escalation|Other|0|||
148841828|NCT02266147|536901496|FG003|PART 1: Dose Escalation|Other|0|||
148841829|NCT02266147|536901493|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
148841830|NCT02266147|536901494|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
148841831|NCT02266147|536901495|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
148841832|NCT02266147|536901496|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
148841833|NCT02266147|536901493|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
148841834|NCT02266147|536901494|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
148841835|NCT02266147|536901495|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
148841836|NCT02266147|536901496|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
148841837|NCT00413660|536901497|FG000|Up To Week 12|Adverse Event|1|||
148841838|NCT00413660|536901498|FG001|Up To Week 12|Adverse Event|3|||
148841839|NCT00413660|536901499|FG002|Up To Week 12|Adverse Event|1|||
149029554|NCT00430677|537586591|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
149029555|NCT00430677|537586592|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
149029556|NCT00430677|537586593|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
149029557|NCT02040844|537586594|FG000|Overall Study|Adverse Event|0|||
148841840|NCT00413660|536901500|FG003|Up To Week 12|Adverse Event|4|||
148983529|NCT00359762|537417355|FG000|Period III|Protocol Violation|0|||
148983530|NCT00359762|537417356|FG001|Period III|Protocol Violation|5|||
148983531|NCT00359762|537417357|FG002|Period III|Protocol Violation|3|||
148983532|NCT00359762|537417358|FG003|Period III|Protocol Violation|8|||
148983533|NCT00359762|537417359|FG004|Period III|Protocol Violation|0|||
148983534|NCT00359762|537417355|FG000|Period III|Adverse Event|0|||
148983535|NCT00359762|537417356|FG001|Period III|Adverse Event|3|||
148983536|NCT00359762|537417357|FG002|Period III|Adverse Event|4|||
148983537|NCT00359762|537417358|FG003|Period III|Adverse Event|10|||
148983538|NCT00359762|537417359|FG004|Period III|Adverse Event|0|||
148983539|NCT00359762|537417355|FG000|Period III|Physician Decision|0|||
148983540|NCT00359762|537417356|FG001|Period III|Physician Decision|5|||
148983541|NCT00359762|537417357|FG002|Period III|Physician Decision|9|||
148983542|NCT00359762|537417358|FG003|Period III|Physician Decision|15|||
148983543|NCT00359762|537417359|FG004|Period III|Physician Decision|0|||
148983544|NCT00359762|537417355|FG000|Period III|Lack of Efficacy|0|||
148983545|NCT00359762|537417356|FG001|Period III|Lack of Efficacy|7|||
148983546|NCT00359762|537417357|FG002|Period III|Lack of Efficacy|5|||
148983547|NCT00359762|537417358|FG003|Period III|Lack of Efficacy|9|||
148983548|NCT00359762|537417359|FG004|Period III|Lack of Efficacy|0|||
148983549|NCT00359762|537417355|FG000|Period III|Lost to follow up|0|||
148983550|NCT00359762|537417356|FG001|Period III|Lost to follow up|1|||
148983551|NCT00359762|537417357|FG002|Period III|Lost to follow up|1|||
148983552|NCT00359762|537417358|FG003|Period III|Lost to follow up|2|||
148983553|NCT00359762|537417359|FG004|Period III|Lost to follow up|0|||
148983554|NCT00359762|537417355|FG000|Period III|Entry Criteria Not Met|0|||
148983555|NCT00359762|537417356|FG001|Period III|Entry Criteria Not Met|1|||
148983556|NCT00359762|537417357|FG002|Period III|Entry Criteria Not Met|0|||
148983557|NCT00359762|537417358|FG003|Period III|Entry Criteria Not Met|1|||
148983558|NCT00359762|537417359|FG004|Period III|Entry Criteria Not Met|0|||
148983559|NCT00359762|537417355|FG000|Period III|Subject Decision|0|||
148983560|NCT00359762|537417356|FG001|Period III|Subject Decision|7|||
148983561|NCT00359762|537417357|FG002|Period III|Subject Decision|8|||
148983562|NCT00359762|537417358|FG003|Period III|Subject Decision|20|||
148983563|NCT00359762|537417359|FG004|Period III|Subject Decision|0|||
148983564|NCT04382326|537417364|FG000|Overall Study|Adverse Event, not serious|1|||
148983565|NCT04382326|537417365|FG001|Overall Study|Adverse Event, not serious|2|||
148983566|NCT04382326|537417364|FG000|Overall Study|Other|1|||
148983567|NCT04382326|537417365|FG001|Overall Study|Other|0|||
148983568|NCT04382326|537417364|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
148983569|NCT04382326|537417365|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
148983570|NCT04382326|537417364|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
148983571|NCT04382326|537417365|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
148983572|NCT04382326|537417364|FG000|Overall Study|Protocol Violation|29|||
148983573|NCT04382326|537417365|FG001|Overall Study|Protocol Violation|23|||
148983574|NCT04382326|537417364|FG000|Overall Study|Physician Decision|0|||
148983575|NCT04382326|537417365|FG001|Overall Study|Physician Decision|1|||
148983576|NCT04382326|537417364|FG000|Overall Study|Lost to Follow-up|48|||
148983577|NCT04382326|537417365|FG001|Overall Study|Lost to Follow-up|63|||
148983578|NCT04382326|537417364|FG000|Overall Study|Adverse Event, non-fatal|1|||
148983579|NCT04382326|537417365|FG001|Overall Study|Adverse Event, non-fatal|1|||
148983580|NCT02828111|537417366|FG000|Overall Study|Withdrawal by Subject|0|||
148983581|NCT02828111|537417367|FG001|Overall Study|Withdrawal by Subject|0|||
148983582|NCT02828111|537417368|FG002|Overall Study|Withdrawal by Subject|2|||
149029558|NCT02040844|537586595|FG001|Overall Study|Adverse Event|0|||
149029559|NCT02040844|537586596|FG002|Overall Study|Adverse Event|1|||
148841841|NCT00413660|536901501|FG004|Up To Week 12|Adverse Event|6|||
148841842|NCT00413660|536901502|FG005|Up To Week 12|Adverse Event|4|||
148983583|NCT02828111|537417369|FG003|Overall Study|Withdrawal by Subject|0|||
148983584|NCT02828111|537417370|FG004|Overall Study|Withdrawal by Subject|0|||
148983585|NCT02828111|537417366|FG000|Overall Study|Lost to Follow-up|0|||
148983586|NCT02828111|537417367|FG001|Overall Study|Lost to Follow-up|0|||
148983587|NCT02828111|537417368|FG002|Overall Study|Lost to Follow-up|0|||
148983588|NCT02828111|537417369|FG003|Overall Study|Lost to Follow-up|1|||
148841843|NCT00413660|536901503|FG006|Up To Week 12|Adverse Event|1|||
148983589|NCT02828111|537417370|FG004|Overall Study|Lost to Follow-up|1|||
148983590|NCT00534352|537417371|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
148983591|NCT00534352|537417371|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
148983592|NCT00534352|537417371|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
148983593|NCT00534352|537417371|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
148983594|NCT00534352|537417371|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
148983595|NCT00534352|537417371|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
148983596|NCT00833924|537417376|FG000|Overall Study|Death|21|||
148983597|NCT00833924|537417376|FG000|Overall Study|Conversion|2|||
148841844|NCT00413660|536901504|FG007|Up To Week 12|Adverse Event|0|||
148841845|NCT00413660|536901505|FG008|Up To Week 12|Adverse Event|0|||
148841846|NCT00413660|536901506|FG009|Up To Week 12|Adverse Event|0|||
148841847|NCT00413660|536901507|FG010|Up To Week 12|Adverse Event|0|||
148841848|NCT00413660|536901497|FG000|Up To Week 12|Lack of Efficacy|2|||
148841849|NCT00413660|536901498|FG001|Up To Week 12|Lack of Efficacy|0|||
148841850|NCT00413660|536901499|FG002|Up To Week 12|Lack of Efficacy|0|||
149029560|NCT02040844|537586594|FG000|Overall Study|Withdrawal by Subject|16|||
149029561|NCT02040844|537586595|FG001|Overall Study|Withdrawal by Subject|22|||
149029562|NCT02040844|537586596|FG002|Overall Study|Withdrawal by Subject|25|||
148841851|NCT00413660|536901500|FG003|Up To Week 12|Lack of Efficacy|0|||
148841852|NCT00413660|536901501|FG004|Up To Week 12|Lack of Efficacy|0|||
148841853|NCT00413660|536901502|FG005|Up To Week 12|Lack of Efficacy|0|||
148841854|NCT00413660|536901503|FG006|Up To Week 12|Lack of Efficacy|5|||
148841855|NCT00413660|536901504|FG007|Up To Week 12|Lack of Efficacy|0|||
148841856|NCT00413660|536901505|FG008|Up To Week 12|Lack of Efficacy|0|||
148841857|NCT00413660|536901506|FG009|Up To Week 12|Lack of Efficacy|0|||
148841858|NCT00413660|536901507|FG010|Up To Week 12|Lack of Efficacy|0|||
148841859|NCT00413660|536901497|FG000|Up To Week 12|Lost to Follow-up|0|||
148841860|NCT00413660|536901498|FG001|Up To Week 12|Lost to Follow-up|1|||
148841861|NCT00413660|536901499|FG002|Up To Week 12|Lost to Follow-up|0|||
148841862|NCT00413660|536901500|FG003|Up To Week 12|Lost to Follow-up|0|||
148841863|NCT00413660|536901501|FG004|Up To Week 12|Lost to Follow-up|1|||
148841864|NCT00413660|536901502|FG005|Up To Week 12|Lost to Follow-up|0|||
148841865|NCT00413660|536901503|FG006|Up To Week 12|Lost to Follow-up|0|||
148841866|NCT00413660|536901504|FG007|Up To Week 12|Lost to Follow-up|0|||
148841867|NCT00413660|536901505|FG008|Up To Week 12|Lost to Follow-up|0|||
148841868|NCT00413660|536901506|FG009|Up To Week 12|Lost to Follow-up|0|||
148841869|NCT00413660|536901507|FG010|Up To Week 12|Lost to Follow-up|0|||
148841870|NCT00413660|536901497|FG000|Up To Week 12|Withdrawal by Subject|0|||
148841871|NCT00413660|536901498|FG001|Up To Week 12|Withdrawal by Subject|2|||
148841872|NCT00413660|536901499|FG002|Up To Week 12|Withdrawal by Subject|0|||
148841873|NCT00413660|536901500|FG003|Up To Week 12|Withdrawal by Subject|2|||
148841874|NCT00413660|536901501|FG004|Up To Week 12|Withdrawal by Subject|0|||
148841875|NCT00413660|536901502|FG005|Up To Week 12|Withdrawal by Subject|2|||
148841876|NCT00413660|536901503|FG006|Up To Week 12|Withdrawal by Subject|2|||
148841877|NCT00413660|536901504|FG007|Up To Week 12|Withdrawal by Subject|0|||
148841878|NCT00413660|536901505|FG008|Up To Week 12|Withdrawal by Subject|0|||
148841879|NCT00413660|536901506|FG009|Up To Week 12|Withdrawal by Subject|0|||
148841880|NCT00413660|536901507|FG010|Up To Week 12|Withdrawal by Subject|0|||
148841881|NCT00413660|536901497|FG000|Up To Week 12|Randomized, Not Treated|1|||
148841882|NCT00413660|536901498|FG001|Up To Week 12|Randomized, Not Treated|0|||
148841883|NCT00413660|536901499|FG002|Up To Week 12|Randomized, Not Treated|0|||
148841884|NCT00413660|536901500|FG003|Up To Week 12|Randomized, Not Treated|1|||
148841885|NCT00413660|536901501|FG004|Up To Week 12|Randomized, Not Treated|0|||
148841886|NCT00413660|536901502|FG005|Up To Week 12|Randomized, Not Treated|0|||
148841887|NCT00413660|536901503|FG006|Up To Week 12|Randomized, Not Treated|0|||
148841888|NCT00413660|536901504|FG007|Up To Week 12|Randomized, Not Treated|0|||
148841889|NCT00413660|536901505|FG008|Up To Week 12|Randomized, Not Treated|0|||
148841890|NCT00413660|536901506|FG009|Up To Week 12|Randomized, Not Treated|0|||
148841891|NCT00413660|536901507|FG010|Up To Week 12|Randomized, Not Treated|0|||
148841892|NCT00413660|536901497|FG000|Up To Week 12|Other|3|||
148841893|NCT00413660|536901498|FG001|Up To Week 12|Other|1|||
148841894|NCT00413660|536901499|FG002|Up To Week 12|Other|6|||
148841895|NCT00413660|536901500|FG003|Up To Week 12|Other|1|||
148841896|NCT00413660|536901501|FG004|Up To Week 12|Other|2|||
148841897|NCT00413660|536901502|FG005|Up To Week 12|Other|4|||
148841898|NCT00413660|536901503|FG006|Up To Week 12|Other|3|||
148841899|NCT00413660|536901504|FG007|Up To Week 12|Other|0|||
148841900|NCT00413660|536901505|FG008|Up To Week 12|Other|0|||
148841901|NCT00413660|536901506|FG009|Up To Week 12|Other|0|||
148841902|NCT00413660|536901507|FG010|Up To Week 12|Other|0|||
148841903|NCT00413660|536901497|FG000|Post Week 12|Adverse Event|2|||
148841904|NCT00413660|536901498|FG001|Post Week 12|Adverse Event|0|||
148841905|NCT00413660|536901499|FG002|Post Week 12|Adverse Event|2|||
148841906|NCT00413660|536901500|FG003|Post Week 12|Adverse Event|1|||
148841907|NCT00413660|536901501|FG004|Post Week 12|Adverse Event|4|||
148841908|NCT00413660|536901502|FG005|Post Week 12|Adverse Event|2|||
148841909|NCT00413660|536901503|FG006|Post Week 12|Adverse Event|2|||
148841910|NCT00413660|536901504|FG007|Post Week 12|Adverse Event|0|||
148841911|NCT00413660|536901505|FG008|Post Week 12|Adverse Event|0|||
148841912|NCT00413660|536901506|FG009|Post Week 12|Adverse Event|0|||
148841913|NCT00413660|536901507|FG010|Post Week 12|Adverse Event|0|||
148841914|NCT00413660|536901497|FG000|Post Week 12|Lack of Efficacy|0|||
148841915|NCT00413660|536901498|FG001|Post Week 12|Lack of Efficacy|0|||
148841916|NCT00413660|536901499|FG002|Post Week 12|Lack of Efficacy|1|||
148841917|NCT00413660|536901500|FG003|Post Week 12|Lack of Efficacy|0|||
148841918|NCT00413660|536901501|FG004|Post Week 12|Lack of Efficacy|0|||
148841919|NCT00413660|536901502|FG005|Post Week 12|Lack of Efficacy|0|||
148841920|NCT00413660|536901503|FG006|Post Week 12|Lack of Efficacy|0|||
148841921|NCT00413660|536901504|FG007|Post Week 12|Lack of Efficacy|0|||
148841922|NCT00413660|536901505|FG008|Post Week 12|Lack of Efficacy|0|||
148841923|NCT00413660|536901506|FG009|Post Week 12|Lack of Efficacy|1|||
148841924|NCT00413660|536901507|FG010|Post Week 12|Lack of Efficacy|0|||
148841925|NCT00413660|536901497|FG000|Post Week 12|Lost to Follow-up|0|||
148841926|NCT00413660|536901498|FG001|Post Week 12|Lost to Follow-up|1|||
148841927|NCT00413660|536901499|FG002|Post Week 12|Lost to Follow-up|1|||
148841928|NCT00413660|536901500|FG003|Post Week 12|Lost to Follow-up|0|||
148841929|NCT00413660|536901501|FG004|Post Week 12|Lost to Follow-up|0|||
148774498|NCT01340027|536647033|FG004|Overall Study|Lost to Follow-up|0|||
148774499|NCT01340027|536647034|FG005|Overall Study|Lost to Follow-up|0|||
148774500|NCT01340027|536647035|FG006|Overall Study|Lost to Follow-up|1|||
148774501|NCT01340027|536647036|FG007|Overall Study|Lost to Follow-up|0|||
148774502|NCT01340027|536647037|FG008|Overall Study|Lost to Follow-up|0|||
148774503|NCT01340027|536647038|FG009|Overall Study|Lost to Follow-up|1|||
148774504|NCT01340027|536647039|FG010|Overall Study|Lost to Follow-up|0|||
148774505|NCT01340027|536647040|FG011|Overall Study|Lost to Follow-up|0|||
148841930|NCT00413660|536901502|FG005|Post Week 12|Lost to Follow-up|0|||
148983598|NCT00833924|537417376|FG000|Overall Study|Lost to Follow-up|2|||
148983599|NCT00833924|537417376|FG000|Overall Study|Withdrawal by Subject|13|||
148983600|NCT00833924|537417376|FG000|Overall Study|In study follow-up|71|||
148983601|NCT01485861|537417377|FG000|Phase Ib|Death|1|||
148983602|NCT01485861|537417378|FG001|Phase Ib|Death|0|||
148983603|NCT01485861|537417379|FG002|Phase Ib|Death|0|||
148774506|NCT01340027|536647029|FG000|Overall Study|Protocol Violation|1|||
148841931|NCT00413660|536901503|FG006|Post Week 12|Lost to Follow-up|0|||
148841932|NCT00413660|536901504|FG007|Post Week 12|Lost to Follow-up|0|||
148841933|NCT00413660|536901505|FG008|Post Week 12|Lost to Follow-up|0|||
148841934|NCT00413660|536901506|FG009|Post Week 12|Lost to Follow-up|0|||
148841935|NCT00413660|536901507|FG010|Post Week 12|Lost to Follow-up|0|||
148841936|NCT00413660|536901497|FG000|Post Week 12|Withdrawal by Subject|0|||
148841937|NCT00413660|536901498|FG001|Post Week 12|Withdrawal by Subject|1|||
148841938|NCT00413660|536901499|FG002|Post Week 12|Withdrawal by Subject|1|||
148841939|NCT00413660|536901500|FG003|Post Week 12|Withdrawal by Subject|0|||
148841940|NCT00413660|536901501|FG004|Post Week 12|Withdrawal by Subject|1|||
148841941|NCT00413660|536901502|FG005|Post Week 12|Withdrawal by Subject|0|||
148841942|NCT00413660|536901503|FG006|Post Week 12|Withdrawal by Subject|0|||
148841943|NCT00413660|536901504|FG007|Post Week 12|Withdrawal by Subject|0|||
148841944|NCT00413660|536901505|FG008|Post Week 12|Withdrawal by Subject|0|||
148841945|NCT00413660|536901506|FG009|Post Week 12|Withdrawal by Subject|0|||
148841946|NCT00413660|536901507|FG010|Post Week 12|Withdrawal by Subject|1|||
148841947|NCT00413660|536901497|FG000|Post Week 12|Other|1|||
148841948|NCT00413660|536901498|FG001|Post Week 12|Other|2|||
148841949|NCT00413660|536901499|FG002|Post Week 12|Other|3|||
148841950|NCT00413660|536901500|FG003|Post Week 12|Other|0|||
148841951|NCT00413660|536901501|FG004|Post Week 12|Other|1|||
148841952|NCT00413660|536901502|FG005|Post Week 12|Other|1|||
148841953|NCT00413660|536901503|FG006|Post Week 12|Other|1|||
148841954|NCT00413660|536901504|FG007|Post Week 12|Other|0|||
148841955|NCT00413660|536901505|FG008|Post Week 12|Other|0|||
148841956|NCT00413660|536901506|FG009|Post Week 12|Other|0|||
148841957|NCT00413660|536901507|FG010|Post Week 12|Other|0|||
148841958|NCT03896477|536901510|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
148841959|NCT03896477|536901511|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
148841960|NCT03896477|536901512|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
148841961|NCT03896477|536901510|FG000|Overall Study|Parent Requested Withdrawal|8|||
148841962|NCT03896477|536901511|FG001|Overall Study|Parent Requested Withdrawal|12|||
148841963|NCT03896477|536901512|FG002|Overall Study|Parent Requested Withdrawal|9|||
148841964|NCT03896477|536901510|FG000|Overall Study|Adverse Event|0|||
148841965|NCT03896477|536901511|FG001|Overall Study|Adverse Event|0|||
148841966|NCT03896477|536901512|FG002|Overall Study|Adverse Event|1|||
148841967|NCT03896477|536901510|FG000|Overall Study|Death|1|||
148841968|NCT03896477|536901511|FG001|Overall Study|Death|0|||
148841969|NCT03896477|536901512|FG002|Overall Study|Death|0|||
148841970|NCT03896477|536901510|FG000|Overall Study|Other|5|||
148841971|NCT03896477|536901511|FG001|Overall Study|Other|6|||
148841972|NCT03896477|536901512|FG002|Overall Study|Other|7|||
148841973|NCT03896477|536901510|FG000|Overall Study|Lost to Follow-up|2|||
148841974|NCT03896477|536901511|FG001|Overall Study|Lost to Follow-up|1|||
148841975|NCT03896477|536901512|FG002|Overall Study|Lost to Follow-up|1|||
148841976|NCT01106157|536901513|FG000|Overall Study|Withdrawal by Subject|1|||
148841977|NCT01106157|536901514|FG001|Overall Study|Withdrawal by Subject|0|||
148841978|NCT02141672|536901518|FG000|Overall Study|Adverse Event|0|||
148841979|NCT02141672|536901519|FG001|Overall Study|Adverse Event|1|||
148774507|NCT01340027|536647030|FG001|Overall Study|Protocol Violation|2|||
148774508|NCT01340027|536647031|FG002|Overall Study|Protocol Violation|0|||
148841980|NCT02141672|536901520|FG002|Overall Study|Adverse Event|0|||
148841981|NCT02141672|536901518|FG000|Overall Study|Death|10|||
148841982|NCT02141672|536901519|FG001|Overall Study|Death|2|||
148841983|NCT02141672|536901520|FG002|Overall Study|Death|1|||
148983604|NCT01485861|537417380|FG003|Phase Ib|Death|0|||
148983605|NCT01485861|537417381|FG004|Phase Ib|Death|0|||
148983606|NCT01485861|537417382|FG005|Phase Ib|Death|0|||
148983607|NCT01485861|537417377|FG000|Phase Ib|Physician Decision|1|||
148983608|NCT01485861|537417378|FG001|Phase Ib|Physician Decision|1|||
148774509|NCT01340027|536647032|FG003|Overall Study|Protocol Violation|0|||
148774510|NCT01340027|536647033|FG004|Overall Study|Protocol Violation|6|||
148774511|NCT01340027|536647034|FG005|Overall Study|Protocol Violation|0|||
148774512|NCT01340027|536647035|FG006|Overall Study|Protocol Violation|0|||
148774513|NCT01340027|536647036|FG007|Overall Study|Protocol Violation|1|||
148774514|NCT01340027|536647037|FG008|Overall Study|Protocol Violation|2|||
148774515|NCT01340027|536647038|FG009|Overall Study|Protocol Violation|2|||
148774516|NCT01340027|536647039|FG010|Overall Study|Protocol Violation|0|||
148774517|NCT01340027|536647040|FG011|Overall Study|Protocol Violation|0|||
148774518|NCT01340027|536647029|FG000|Overall Study|Withdrawal by Subject|4|||
148774519|NCT01340027|536647030|FG001|Overall Study|Withdrawal by Subject|3|||
148774520|NCT01340027|536647031|FG002|Overall Study|Withdrawal by Subject|1|||
148774521|NCT01340027|536647032|FG003|Overall Study|Withdrawal by Subject|3|||
148774522|NCT01340027|536647033|FG004|Overall Study|Withdrawal by Subject|3|||
148774523|NCT01340027|536647034|FG005|Overall Study|Withdrawal by Subject|2|||
148774524|NCT01340027|536647035|FG006|Overall Study|Withdrawal by Subject|3|||
148774525|NCT01340027|536647036|FG007|Overall Study|Withdrawal by Subject|4|||
148774526|NCT01340027|536647037|FG008|Overall Study|Withdrawal by Subject|1|||
148774527|NCT01340027|536647038|FG009|Overall Study|Withdrawal by Subject|2|||
148774528|NCT01340027|536647039|FG010|Overall Study|Withdrawal by Subject|0|||
148774529|NCT01340027|536647040|FG011|Overall Study|Withdrawal by Subject|1|||
148774530|NCT01340027|536647029|FG000|Overall Study|Miscellaneous|0|||
148774531|NCT01340027|536647030|FG001|Overall Study|Miscellaneous|0|||
148774532|NCT01340027|536647031|FG002|Overall Study|Miscellaneous|0|||
148774533|NCT01340027|536647032|FG003|Overall Study|Miscellaneous|1|||
148774534|NCT01340027|536647033|FG004|Overall Study|Miscellaneous|0|||
148774535|NCT01340027|536647034|FG005|Overall Study|Miscellaneous|0|||
148774536|NCT01340027|536647035|FG006|Overall Study|Miscellaneous|0|||
148774537|NCT01340027|536647036|FG007|Overall Study|Miscellaneous|0|||
148774538|NCT01340027|536647037|FG008|Overall Study|Miscellaneous|0|||
148774539|NCT01340027|536647038|FG009|Overall Study|Miscellaneous|0|||
148774540|NCT01340027|536647039|FG010|Overall Study|Miscellaneous|1|||
148774541|NCT01340027|536647040|FG011|Overall Study|Miscellaneous|0|||
148774542|NCT00833482|536647041|FG000|Days 11-20|Adverse Event|0|||
148774543|NCT00833482|536647042|FG001|Days 11-20|Adverse Event|2|||
148774544|NCT00833482|536647043|FG002|Days 11-20|Adverse Event|0|||
148774545|NCT00833482|536647044|FG003|Days 11-20|Adverse Event|0|||
148774546|NCT00833482|536647045|FG004|Days 11-20|Adverse Event|0|||
148774547|NCT00833482|536647046|FG005|Days 11-20|Adverse Event|0|||
148774548|NCT00833482|536647041|FG000|Days 11-20|Withdrawal by Subject|0|||
148774549|NCT00833482|536647042|FG001|Days 11-20|Withdrawal by Subject|1|||
148774550|NCT00833482|536647043|FG002|Days 11-20|Withdrawal by Subject|0|||
148774551|NCT00833482|536647044|FG003|Days 11-20|Withdrawal by Subject|0|||
148774552|NCT00833482|536647045|FG004|Days 11-20|Withdrawal by Subject|0|||
148774553|NCT00833482|536647046|FG005|Days 11-20|Withdrawal by Subject|0|||
148774554|NCT00833482|536647041|FG000|Days 21-30|Adverse Event|0|||
148774555|NCT00833482|536647042|FG001|Days 21-30|Adverse Event|0|||
148774556|NCT00833482|536647043|FG002|Days 21-30|Adverse Event|1|||
148774557|NCT00833482|536647044|FG003|Days 21-30|Adverse Event|0|||
148774558|NCT00833482|536647045|FG004|Days 21-30|Adverse Event|0|||
148774559|NCT00833482|536647046|FG005|Days 21-30|Adverse Event|0|||
148774560|NCT00833482|536647041|FG000|Days 21-30|Withdrawal by Subject|0|||
148774561|NCT00833482|536647042|FG001|Days 21-30|Withdrawal by Subject|0|||
148774562|NCT00833482|536647043|FG002|Days 21-30|Withdrawal by Subject|0|||
148774563|NCT00833482|536647044|FG003|Days 21-30|Withdrawal by Subject|0|||
148774564|NCT00833482|536647045|FG004|Days 21-30|Withdrawal by Subject|1|||
148774565|NCT00833482|536647046|FG005|Days 21-30|Withdrawal by Subject|0|||
148774566|NCT02496091|536647047|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
148774567|NCT02600845|536647058|FG000|Overall Study|Reason Not Specified|3|||
148774568|NCT02600845|536647058|FG000|Overall Study|Non-compliance with Study Procedures|10|||
148774569|NCT02600845|536647058|FG000|Overall Study|Consent Withdrawal|5|||
148774570|NCT01944670|536648605|FG000|Overall Study|Lost to Follow-up|2|||
148774571|NCT04161079|536648606|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
148774572|NCT02515994|536648607|FG000|Overall Study|Protocol Violation|3|||
148774573|NCT02515994|536648608|FG001|Overall Study|Protocol Violation|5|||
148774574|NCT02515994|536648607|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
148774575|NCT02515994|536648608|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
148774576|NCT02515994|536648607|FG000|Overall Study|Adverse Event|3|||
148774577|NCT02515994|536648608|FG001|Overall Study|Adverse Event|1|||
148774578|NCT02515994|536648607|FG000|Overall Study|Withdrawal by Subject|2|||
148774579|NCT02515994|536648608|FG001|Overall Study|Withdrawal by Subject|0|||
148774580|NCT04045132|536648611|FG000|Overall Study|Lost to Follow-up|3|||
148774581|NCT04045132|536648612|FG001|Overall Study|Lost to Follow-up|6|||
148774582|NCT01632150|536648613|FG000|Overall Study|Disease progression|27|||
148774583|NCT01632150|536648613|FG000|Overall Study|Study drug toxicity|1|||
149029563|NCT02040844|537586594|FG000|Overall Study|Lost to Follow-up|12|||
149029564|NCT02040844|537586595|FG001|Overall Study|Lost to Follow-up|9|||
149029565|NCT02040844|537586596|FG002|Overall Study|Lost to Follow-up|13|||
149029566|NCT02040844|537586594|FG000|Overall Study|Missing|13|||
149029567|NCT02040844|537586595|FG001|Overall Study|Missing|3|||
149029568|NCT02040844|537586596|FG002|Overall Study|Missing|2|||
149029569|NCT02040844|537586594|FG000|Overall Study|Non-specified|8|||
149029570|NCT02040844|537586595|FG001|Overall Study|Non-specified|2|||
149029571|NCT02040844|537586596|FG002|Overall Study|Non-specified|5|||
149029572|NCT02040844|537586594|FG000|Overall Study|Concomitant medication|1|||
149029573|NCT02040844|537586595|FG001|Overall Study|Concomitant medication|3|||
149029574|NCT02040844|537586596|FG002|Overall Study|Concomitant medication|1|||
149029575|NCT00946192|537586597|FG000|Overall Study|Lost to Follow-up|6|||
149029576|NCT00946192|537586598|FG001|Overall Study|Lost to Follow-up|11|||
149029577|NCT00946192|537586599|FG002|Overall Study|Lost to Follow-up|9|||
149029578|NCT00946192|537586597|FG000|Overall Study|Withdrawal by Subject|10|||
149029579|NCT00946192|537586598|FG001|Overall Study|Withdrawal by Subject|7|||
149029580|NCT00946192|537586599|FG002|Overall Study|Withdrawal by Subject|3|||
149029581|NCT00946192|537586597|FG000|Overall Study|Did not start medication|2|||
149029582|NCT00946192|537586598|FG001|Overall Study|Did not start medication|0|||
149029583|NCT00946192|537586599|FG002|Overall Study|Did not start medication|0|||
149029584|NCT02014558|537586600|FG000|Overall Study|Never Received Study Drug|0|||
149029585|NCT02014558|537586601|FG001|Overall Study|Never Received Study Drug|0|||
149029586|NCT02014558|537586602|FG002|Overall Study|Never Received Study Drug|0|||
149029587|NCT02014558|537586603|FG003|Overall Study|Never Received Study Drug|0|||
149029588|NCT02014558|537586604|FG004|Overall Study|Never Received Study Drug|1|||
149029589|NCT02014558|537586605|FG005|Overall Study|Never Received Study Drug|0|||
149029590|NCT02014558|537586606|FG006|Overall Study|Never Received Study Drug|1|||
149029591|NCT02014558|537586607|FG007|Overall Study|Never Received Study Drug|0|||
149029592|NCT02014558|537586608|FG008|Overall Study|Never Received Study Drug|2|||
149029593|NCT02014558|537586609|FG009|Overall Study|Never Received Study Drug|0|||
149029594|NCT02014558|537586610|FG010|Overall Study|Never Received Study Drug|2|||
149029595|NCT02014558|537586611|FG011|Overall Study|Never Received Study Drug|2|||
149029596|NCT02014558|537586612|FG012|Overall Study|Never Received Study Drug|0|||
149029597|NCT02014558|537586600|FG000|Overall Study|Adverse Event|0|||
149029598|NCT02014558|537586601|FG001|Overall Study|Adverse Event|0|||
149029599|NCT02014558|537586602|FG002|Overall Study|Adverse Event|0|||
149029600|NCT02014558|537586603|FG003|Overall Study|Adverse Event|0|||
149029601|NCT02014558|537586604|FG004|Overall Study|Adverse Event|1|||
149029602|NCT02014558|537586605|FG005|Overall Study|Adverse Event|0|||
149029603|NCT02014558|537586606|FG006|Overall Study|Adverse Event|0|||
149029604|NCT02014558|537586607|FG007|Overall Study|Adverse Event|0|||
149029605|NCT02014558|537586608|FG008|Overall Study|Adverse Event|2|||
149029606|NCT02014558|537586609|FG009|Overall Study|Adverse Event|2|||
149029607|NCT02014558|537586610|FG010|Overall Study|Adverse Event|5|||
149029608|NCT02014558|537586611|FG011|Overall Study|Adverse Event|21|||
149029609|NCT02014558|537586612|FG012|Overall Study|Adverse Event|3|||
149029610|NCT02014558|537586600|FG000|Overall Study|Death|1|||
149029611|NCT02014558|537586601|FG001|Overall Study|Death|0|||
149029612|NCT02014558|537586602|FG002|Overall Study|Death|0|||
149029613|NCT02014558|537586603|FG003|Overall Study|Death|0|||
149029614|NCT02014558|537586604|FG004|Overall Study|Death|0|||
149029615|NCT02014558|537586605|FG005|Overall Study|Death|0|||
149029616|NCT02014558|537586606|FG006|Overall Study|Death|1|||
149029617|NCT02014558|537586607|FG007|Overall Study|Death|1|||
149029618|NCT02014558|537586608|FG008|Overall Study|Death|2|||
149029619|NCT02014558|537586609|FG009|Overall Study|Death|5|||
149029620|NCT02014558|537586610|FG010|Overall Study|Death|5|||
149029621|NCT02014558|537586611|FG011|Overall Study|Death|19|||
149029622|NCT02014558|537586612|FG012|Overall Study|Death|2|||
149029623|NCT02014558|537586600|FG000|Overall Study|Lack of Efficacy|1|||
149029624|NCT02014558|537586601|FG001|Overall Study|Lack of Efficacy|2|||
149029625|NCT02014558|537586602|FG002|Overall Study|Lack of Efficacy|1|||
149029626|NCT02014558|537586603|FG003|Overall Study|Lack of Efficacy|1|||
149029627|NCT02014558|537586604|FG004|Overall Study|Lack of Efficacy|0|||
149029628|NCT02014558|537586605|FG005|Overall Study|Lack of Efficacy|0|||
149029629|NCT02014558|537586606|FG006|Overall Study|Lack of Efficacy|1|||
149029630|NCT02014558|537586607|FG007|Overall Study|Lack of Efficacy|3|||
149029631|NCT02014558|537586608|FG008|Overall Study|Lack of Efficacy|3|||
149029632|NCT02014558|537586609|FG009|Overall Study|Lack of Efficacy|3|||
149029633|NCT02014558|537586610|FG010|Overall Study|Lack of Efficacy|16|||
149029634|NCT02014558|537586611|FG011|Overall Study|Lack of Efficacy|8|||
149029635|NCT02014558|537586612|FG012|Overall Study|Lack of Efficacy|5|||
149029636|NCT02014558|537586600|FG000|Overall Study|Lost to Follow-up|0|||
149029637|NCT02014558|537586601|FG001|Overall Study|Lost to Follow-up|0|||
149029638|NCT02014558|537586602|FG002|Overall Study|Lost to Follow-up|0|||
149029639|NCT02014558|537586603|FG003|Overall Study|Lost to Follow-up|0|||
149029640|NCT02014558|537586604|FG004|Overall Study|Lost to Follow-up|0|||
149029641|NCT02014558|537586605|FG005|Overall Study|Lost to Follow-up|0|||
149029642|NCT02014558|537586606|FG006|Overall Study|Lost to Follow-up|0|||
149029643|NCT02014558|537586607|FG007|Overall Study|Lost to Follow-up|0|||
149029644|NCT02014558|537586608|FG008|Overall Study|Lost to Follow-up|0|||
149029645|NCT02014558|537586609|FG009|Overall Study|Lost to Follow-up|0|||
149029646|NCT02014558|537586610|FG010|Overall Study|Lost to Follow-up|1|||
149029647|NCT02014558|537586611|FG011|Overall Study|Lost to Follow-up|0|||
149029648|NCT02014558|537586612|FG012|Overall Study|Lost to Follow-up|0|||
149029649|NCT02014558|537586600|FG000|Overall Study|Progressive Disease|1|||
149029650|NCT02014558|537586601|FG001|Overall Study|Progressive Disease|0|||
149029651|NCT02014558|537586602|FG002|Overall Study|Progressive Disease|1|||
149029652|NCT02014558|537586603|FG003|Overall Study|Progressive Disease|1|||
149029653|NCT02014558|537586604|FG004|Overall Study|Progressive Disease|1|||
149029654|NCT02014558|537586605|FG005|Overall Study|Progressive Disease|2|||
149029655|NCT02014558|537586606|FG006|Overall Study|Progressive Disease|1|||
149029656|NCT02014558|537586607|FG007|Overall Study|Progressive Disease|6|||
149029657|NCT02014558|537586608|FG008|Overall Study|Progressive Disease|5|||
149029658|NCT02014558|537586609|FG009|Overall Study|Progressive Disease|6|||
149029659|NCT02014558|537586610|FG010|Overall Study|Progressive Disease|22|||
149029660|NCT02014558|537586611|FG011|Overall Study|Progressive Disease|31|||
149029661|NCT02014558|537586612|FG012|Overall Study|Progressive Disease|6|||
149029662|NCT02014558|537586600|FG000|Overall Study|Withdrawal by Subject|0|||
149029663|NCT02014558|537586601|FG001|Overall Study|Withdrawal by Subject|0|||
149029664|NCT02014558|537586602|FG002|Overall Study|Withdrawal by Subject|0|||
149029665|NCT02014558|537586603|FG003|Overall Study|Withdrawal by Subject|0|||
149029666|NCT02014558|537586604|FG004|Overall Study|Withdrawal by Subject|1|||
149029667|NCT02014558|537586605|FG005|Overall Study|Withdrawal by Subject|0|||
149029668|NCT02014558|537586606|FG006|Overall Study|Withdrawal by Subject|0|||
149029669|NCT02014558|537586607|FG007|Overall Study|Withdrawal by Subject|0|||
149029670|NCT02014558|537586608|FG008|Overall Study|Withdrawal by Subject|0|||
149029671|NCT02014558|537586609|FG009|Overall Study|Withdrawal by Subject|2|||
149029672|NCT02014558|537586610|FG010|Overall Study|Withdrawal by Subject|6|||
149029673|NCT02014558|537586611|FG011|Overall Study|Withdrawal by Subject|10|||
149029674|NCT02014558|537586612|FG012|Overall Study|Withdrawal by Subject|0|||
149029675|NCT02014558|537586600|FG000|Overall Study|Miscellaneous|2|||
149029676|NCT02014558|537586601|FG001|Overall Study|Miscellaneous|1|||
149029677|NCT02014558|537586602|FG002|Overall Study|Miscellaneous|1|||
149029678|NCT02014558|537586603|FG003|Overall Study|Miscellaneous|1|||
149029679|NCT02014558|537586604|FG004|Overall Study|Miscellaneous|0|||
149029680|NCT02014558|537586605|FG005|Overall Study|Miscellaneous|1|||
149029681|NCT02014558|537586606|FG006|Overall Study|Miscellaneous|0|||
149029682|NCT02014558|537586607|FG007|Overall Study|Miscellaneous|1|||
149029683|NCT02014558|537586608|FG008|Overall Study|Miscellaneous|1|||
149029684|NCT02014558|537586609|FG009|Overall Study|Miscellaneous|3|||
149029685|NCT02014558|537586610|FG010|Overall Study|Miscellaneous|12|||
149029686|NCT02014558|537586611|FG011|Overall Study|Miscellaneous|11|||
149029687|NCT02014558|537586612|FG012|Overall Study|Miscellaneous|1|||
149029688|NCT02068885|537586617|FG000|Overall Study|Withdrew|3|||
149029689|NCT02068885|537586618|FG001|Overall Study|Withdrew|5|||
149029690|NCT02068885|537586619|FG002|Overall Study|Withdrew|8|||
149029691|NCT00681811|537586620|FG000|Overall Study|Adverse Event|1|||
149029692|NCT00681811|537586621|FG001|Overall Study|Adverse Event|1|||
149029693|NCT00681811|537586620|FG000|Overall Study|Withdrawal by Subject|2|||
149029694|NCT00681811|537586621|FG001|Overall Study|Withdrawal by Subject|2|||
149029695|NCT00681811|537586620|FG000|Overall Study|Non-compliance|0|||
148841984|NCT02141672|536901518|FG000|Overall Study|Lack of Efficacy|0|||
148841985|NCT02141672|536901519|FG001|Overall Study|Lack of Efficacy|0|||
148841986|NCT02141672|536901520|FG002|Overall Study|Lack of Efficacy|2|||
148841987|NCT02141672|536901518|FG000|Overall Study|Lost to Follow-up|1|||
148841988|NCT02141672|536901519|FG001|Overall Study|Lost to Follow-up|1|||
148841989|NCT02141672|536901520|FG002|Overall Study|Lost to Follow-up|3|||
148841990|NCT02141672|536901518|FG000|Overall Study|Physician Decision|1|||
148841991|NCT02141672|536901519|FG001|Overall Study|Physician Decision|2|||
148841992|NCT02141672|536901520|FG002|Overall Study|Physician Decision|5|||
148841993|NCT02141672|536901518|FG000|Overall Study|Protocol Violation|0|||
148841994|NCT02141672|536901519|FG001|Overall Study|Protocol Violation|0|||
148841995|NCT02141672|536901520|FG002|Overall Study|Protocol Violation|1|||
148841996|NCT02141672|536901518|FG000|Overall Study|Withdrawal by Subject|3|||
148841997|NCT02141672|536901519|FG001|Overall Study|Withdrawal by Subject|2|||
148841998|NCT02141672|536901520|FG002|Overall Study|Withdrawal by Subject|5|||
148841999|NCT02141672|536901518|FG000|Overall Study|refused to follow-up|1|||
148842000|NCT02141672|536901519|FG001|Overall Study|refused to follow-up|0|||
148842001|NCT02141672|536901520|FG002|Overall Study|refused to follow-up|1|||
148842002|NCT02954887|536901521|FG000|Overall Study|Withdrawal by Subject|3|||
148842003|NCT02954887|536901521|FG000|Overall Study|Lack of Efficacy|3|||
148842004|NCT02954887|536901521|FG000|Overall Study|Other|1|||
149029696|NCT00681811|537586621|FG001|Overall Study|Non-compliance|1|||
149029697|NCT00828919|537586622|FG000|Overall Study|Death|0|||
148842005|NCT02803203|536901522|FG000|Overall Study|Adverse Event|4|||
149029698|NCT00828919|537586623|FG001|Overall Study|Death|1|||
149029699|NCT00828919|537586624|FG002|Overall Study|Death|2|||
149029700|NCT00828919|537586625|FG003|Overall Study|Death|0|||
148842006|NCT02803203|536901522|FG000|Overall Study|Death|4|||
148842007|NCT02803203|536901522|FG000|Overall Study|Progressive disease|29|||
148842008|NCT02803203|536901522|FG000|Overall Study|Withdrawal by Subject|8|||
148842009|NCT02803203|536901522|FG000|Overall Study|Complete resection of target disease|2|||
148842010|NCT02803203|536901522|FG000|Overall Study|Switched to commercial Osi|1|||
148842011|NCT02803203|536901522|FG000|Overall Study|Participant moved away|1|||
148842012|NCT02948582|536901525|FG000|Washout Period 1|Adverse Event|0|||
148842013|NCT02948582|536901526|FG001|Washout Period 1|Adverse Event|2|||
148842014|NCT02948582|536901527|FG002|Washout Period 1|Adverse Event|0|||
148842015|NCT02948582|536901528|FG003|Washout Period 1|Adverse Event|0|||
148842016|NCT02948582|536901529|FG004|Washout Period 1|Adverse Event|0|||
148842017|NCT02948582|536901530|FG005|Washout Period 1|Adverse Event|0|||
148842018|NCT02948582|536901525|FG000|Washout Period 1|Protocol Violation|0|||
148842019|NCT02948582|536901526|FG001|Washout Period 1|Protocol Violation|0|||
148842020|NCT02948582|536901527|FG002|Washout Period 1|Protocol Violation|0|||
148842021|NCT02948582|536901528|FG003|Washout Period 1|Protocol Violation|0|||
148842022|NCT02948582|536901529|FG004|Washout Period 1|Protocol Violation|0|||
148842023|NCT02948582|536901530|FG005|Washout Period 1|Protocol Violation|1|||
148842024|NCT02948582|536901525|FG000|Washout Period 2|Adverse Event|0|||
148842025|NCT02948582|536901526|FG001|Washout Period 2|Adverse Event|1|||
148842026|NCT02948582|536901527|FG002|Washout Period 2|Adverse Event|0|||
148842027|NCT02948582|536901528|FG003|Washout Period 2|Adverse Event|0|||
148842028|NCT02948582|536901529|FG004|Washout Period 2|Adverse Event|0|||
148842029|NCT02948582|536901530|FG005|Washout Period 2|Adverse Event|0|||
148842030|NCT02948582|536901525|FG000|Washout Period 2|personal reasons|0|||
148842031|NCT02948582|536901526|FG001|Washout Period 2|personal reasons|0|||
148842032|NCT02948582|536901527|FG002|Washout Period 2|personal reasons|0|||
148842033|NCT02948582|536901528|FG003|Washout Period 2|personal reasons|1|||
148842034|NCT02948582|536901529|FG004|Washout Period 2|personal reasons|0|||
148842035|NCT02948582|536901530|FG005|Washout Period 2|personal reasons|0|||
148842036|NCT02948582|536901525|FG000|Washout Period 4|Adverse Event|1|||
148842037|NCT02948582|536901526|FG001|Washout Period 4|Adverse Event|0|||
148842038|NCT02948582|536901527|FG002|Washout Period 4|Adverse Event|1|||
148842039|NCT02948582|536901528|FG003|Washout Period 4|Adverse Event|0|||
148842040|NCT02948582|536901529|FG004|Washout Period 4|Adverse Event|0|||
148842041|NCT02948582|536901530|FG005|Washout Period 4|Adverse Event|0|||
148842042|NCT00846846|536901533|FG000|Overall Study|Death|56|||
148842043|NCT00846846|536901533|FG000|Overall Study|Withdrawal by Subject|19|||
148842044|NCT04419467|536901534|FG000|Overall Study|Not treated with IP|0|||
148842045|NCT04419467|536901535|FG001|Overall Study|Not treated with IP|0|||
148842046|NCT04419467|536901536|FG002|Overall Study|Not treated with IP|2|||
148842047|NCT04419467|536901534|FG000|Overall Study|Adverse Event|0|||
148842048|NCT04419467|536901535|FG001|Overall Study|Adverse Event|2|||
148842049|NCT04419467|536901536|FG002|Overall Study|Adverse Event|0|||
148842050|NCT04419467|536901534|FG000|Overall Study|Death|1|||
148842051|NCT04419467|536901535|FG001|Overall Study|Death|0|||
148842052|NCT04419467|536901536|FG002|Overall Study|Death|0|||
148842053|NCT04419467|536901534|FG000|Overall Study|Lost to Follow-up|0|||
148842054|NCT04419467|536901535|FG001|Overall Study|Lost to Follow-up|1|||
148842055|NCT04419467|536901536|FG002|Overall Study|Lost to Follow-up|2|||
148842056|NCT04419467|536901534|FG000|Overall Study|Withdrawal by Subject|0|||
148842057|NCT04419467|536901535|FG001|Overall Study|Withdrawal by Subject|0|||
148842058|NCT04419467|536901536|FG002|Overall Study|Withdrawal by Subject|4|||
148842059|NCT04419467|536901534|FG000|Overall Study|Pandemic related|0|||
148842060|NCT04419467|536901535|FG001|Overall Study|Pandemic related|0|||
148842061|NCT04419467|536901536|FG002|Overall Study|Pandemic related|1|||
148842062|NCT04419467|536901534|FG000|Overall Study|Reason not known|1|||
148842063|NCT04419467|536901535|FG001|Overall Study|Reason not known|0|||
148842064|NCT04419467|536901536|FG002|Overall Study|Reason not known|0|||
148842065|NCT00600067|536901547|FG000|Overall Study|Adverse Event|0|||
148842066|NCT00600067|536901548|FG001|Overall Study|Adverse Event|1|||
148842067|NCT00600067|536901547|FG000|Overall Study|Lost to Follow-up|2|||
148842068|NCT00600067|536901548|FG001|Overall Study|Lost to Follow-up|3|||
148842069|NCT00600067|536901547|FG000|Overall Study|protocol non-compliance|0|||
148842070|NCT00600067|536901548|FG001|Overall Study|protocol non-compliance|3|||
148842071|NCT00600067|536901547|FG000|Overall Study|Lack of Efficacy|1|||
148842072|NCT00600067|536901548|FG001|Overall Study|Lack of Efficacy|0|||
148842073|NCT04571060|536901559|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
148842074|NCT04571060|536901560|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
148842075|NCT04571060|536901559|FG000|Overall Study|Never treated migraine|47|||
148842076|NCT04571060|536901560|FG001|Overall Study|Never treated migraine|36|||
148842077|NCT04571060|536901559|FG000|Overall Study|Protocol Violation|4|||
148842078|NCT04571060|536901560|FG001|Overall Study|Protocol Violation|2|||
148842079|NCT04571060|536901559|FG000|Overall Study|Withdrawal by Subject|6|||
148842080|NCT04571060|536901560|FG001|Overall Study|Withdrawal by Subject|2|||
148842081|NCT04571060|536901559|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
148842082|NCT04571060|536901560|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
148842083|NCT01220401|536901568|FG000|Overall Study|Withdrawal by Subject|2|||
148842084|NCT01220401|536901568|FG000|Overall Study|Protocol Violation|1|||
148842085|NCT03069716|536901571|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
148842086|NCT03069716|536901572|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
148842087|NCT03069716|536901573|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
148842088|NCT03069716|536901571|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
148842089|NCT03069716|536901572|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
148842090|NCT03069716|536901573|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
148842091|NCT03069716|536901571|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
148842092|NCT03069716|536901572|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
148842093|NCT03069716|536901573|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
148842094|NCT03069716|536901571|FG000|Randomized Treatment|Withdrawal by Subject|0|||
148842095|NCT03069716|536901572|FG001|Randomized Treatment|Withdrawal by Subject|2|||
148842096|NCT03069716|536901573|FG002|Randomized Treatment|Withdrawal by Subject|0|||
148842097|NCT02573948|536901578|FG000|Longitudinal Cohort|Death|9|||
148842098|NCT02573948|536901578|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
148842099|NCT02573948|536901578|FG000|Longitudinal Cohort|Incarcerated|25|||
148842100|NCT01673126|536901579|FG000|Overall Study|change of diagnosis|4|||
148842101|NCT01673126|536901580|FG001|Overall Study|change of diagnosis|3|||
148842102|NCT01913327|536901591|FG000|Overall Study|Withdrawal by Subject|0|||
148842103|NCT01913327|536901592|FG001|Overall Study|Withdrawal by Subject|1|||
148842104|NCT00810277|536903018|FG000|Overall Study|Adverse Event|1|||
148842105|NCT00532129|536903021|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
148842106|NCT00532129|536903021|FG000|Treatment Period|Physician Decision|15|||
148842107|NCT00532129|536903021|FG000|Treatment Period|Disease progression|3|||
148842108|NCT00532129|536903021|FG000|Treatment Period|Protocol Violation|1|||
148842109|NCT00532129|536903021|FG000|Treatment Period|Other|5|||
148842110|NCT00532129|536903021|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
148842111|NCT00532129|536903021|FG000|Follow-up Period|Disease progression|57|||
148842112|NCT00532129|536903021|FG000|Follow-up Period|Lost to Follow-up|1|||
148842113|NCT00532129|536903021|FG000|Follow-up Period|Other|6|||
148842114|NCT04551898|536903022|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
148842115|NCT04551898|536903023|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
148842116|NCT04551898|536903024|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
148842117|NCT04551898|536903025|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
148842118|NCT04551898|536903022|FG000|Overall Study|Withdrawal by Subject|5|||
148842119|NCT04551898|536903023|FG001|Overall Study|Withdrawal by Subject|1|||
148842120|NCT04551898|536903024|FG002|Overall Study|Withdrawal by Subject|2|||
148842121|NCT04551898|536903025|FG003|Overall Study|Withdrawal by Subject|2|||
148842122|NCT04551898|536903022|FG000|Overall Study|Lost to Follow-up|2|||
148842123|NCT04551898|536903023|FG001|Overall Study|Lost to Follow-up|1|||
148842124|NCT04551898|536903024|FG002|Overall Study|Lost to Follow-up|2|||
148842125|NCT04551898|536903025|FG003|Overall Study|Lost to Follow-up|2|||
148842126|NCT04551898|536903022|FG000|Overall Study|Death|1|||
148842127|NCT04551898|536903023|FG001|Overall Study|Death|0|||
148842128|NCT04551898|536903024|FG002|Overall Study|Death|0|||
148842129|NCT04551898|536903025|FG003|Overall Study|Death|0|||
148842130|NCT04551898|536903022|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
148842131|NCT04551898|536903023|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
148842132|NCT04551898|536903024|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
148842133|NCT04551898|536903025|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
148842134|NCT03145064|536903026|FG000|Overall Study|Death|24|||
148842135|NCT03145064|536903026|FG000|Overall Study|Lost to Follow-up|3|||
148842136|NCT03145064|536903026|FG000|Overall Study|Withdrawal by Subject|6|||
148842137|NCT03145064|536903026|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
148842138|NCT03145064|536903026|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
148842139|NCT00456755|536903035|FG000|Overall Study|Lost to Follow-up|2|||
148842140|NCT00456755|536903036|FG001|Overall Study|Lost to Follow-up|1|||
148842141|NCT01453036|536903041|FG000|Overall Study|Lost to Follow-up|26|||
148842142|NCT01453036|536903042|FG001|Overall Study|Lost to Follow-up|115|||
148842143|NCT01453036|536903043|FG002|Overall Study|Lost to Follow-up|31|||
148842144|NCT04072835|536903044|FG000|Overall Study|Overall trial ended|603|||
148842145|NCT04072835|536903044|FG000|Overall Study|Ablation|97|||
148842146|NCT04072835|536903044|FG000|Overall Study|Withdrawal of consent|66|||
148842147|NCT04072835|536903044|FG000|Overall Study|Physician Decision|50|||
148842148|NCT04072835|536903044|FG000|Overall Study|Lost to Follow-up|39|||
148842149|NCT04072835|536903044|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
148842150|NCT04072835|536903044|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
148842151|NCT04072835|536903044|FG000|Overall Study|Adverse Event|25|||
148842152|NCT04072835|536903044|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
148842153|NCT04072835|536903044|FG000|Overall Study|Death|11|||
148842154|NCT04072835|536903044|FG000|Overall Study|Participant felt the drug did not work|8|||
148842155|NCT04072835|536903044|FG000|Overall Study|Participant tolerability|5|||
148842156|NCT04072835|536903044|FG000|Overall Study|Missing|5|||
149029701|NCT00828919|537586626|FG004|Overall Study|Death|0|||
149029702|NCT00828919|537586622|FG000|Overall Study|Adverse Event|2|||
149029703|NCT00828919|537586623|FG001|Overall Study|Adverse Event|2|||
149029704|NCT00828919|537586624|FG002|Overall Study|Adverse Event|2|||
149029705|NCT00828919|537586625|FG003|Overall Study|Adverse Event|1|||
149029706|NCT00828919|537586626|FG004|Overall Study|Adverse Event|3|||
149029707|NCT00828919|537586622|FG000|Overall Study|Objective progression or relapse|4|||
149029708|NCT00828919|537586623|FG001|Overall Study|Objective progression or relapse|4|||
149029709|NCT00828919|537586624|FG002|Overall Study|Objective progression or relapse|11|||
149029710|NCT00828919|537586625|FG003|Overall Study|Objective progression or relapse|0|||
149029711|NCT00828919|537586626|FG004|Overall Study|Objective progression or relapse|5|||
149029712|NCT00828919|537586622|FG000|Overall Study|No longer willing to participate in study|0|||
149029713|NCT00828919|537586623|FG001|Overall Study|No longer willing to participate in study|0|||
149029714|NCT00828919|537586624|FG002|Overall Study|No longer willing to participate in study|2|||
149029715|NCT00828919|537586625|FG003|Overall Study|No longer willing to participate in study|0|||
149029716|NCT00828919|537586626|FG004|Overall Study|No longer willing to participate in study|0|||
149029717|NCT00828919|537586622|FG000|Overall Study|Insufficient Clinical Response|0|||
149029718|NCT00828919|537586623|FG001|Overall Study|Insufficient Clinical Response|1|||
149029719|NCT00828919|537586624|FG002|Overall Study|Insufficient Clinical Response|2|||
149029720|NCT00828919|537586625|FG003|Overall Study|Insufficient Clinical Response|0|||
149029721|NCT00828919|537586626|FG004|Overall Study|Insufficient Clinical Response|0|||
149029722|NCT00828919|537586622|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
149029723|NCT00828919|537586623|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
149029724|NCT00828919|537586624|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
149029725|NCT00828919|537586625|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
149029726|NCT00828919|537586626|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
149029727|NCT00828919|537586622|FG000|Overall Study|Other|1|||
149029728|NCT00828919|537586623|FG001|Overall Study|Other|0|||
149029729|NCT00828919|537586624|FG002|Overall Study|Other|1|||
149029730|NCT00828919|537586625|FG003|Overall Study|Other|1|||
149029731|NCT00828919|537586626|FG004|Overall Study|Other|0|||
149029732|NCT00828919|537586622|FG000|Overall Study|Lost to Follow-up|0|||
149029733|NCT00828919|537586623|FG001|Overall Study|Lost to Follow-up|1|||
149029734|NCT00828919|537586624|FG002|Overall Study|Lost to Follow-up|0|||
149029735|NCT00828919|537586625|FG003|Overall Study|Lost to Follow-up|0|||
149029736|NCT00828919|537586626|FG004|Overall Study|Lost to Follow-up|0|||
149029737|NCT01562743|537586627|FG000|Overall Study|Adverse Event|29|||
149029738|NCT01562743|537586627|FG000|Overall Study|Lack of Efficacy|3|||
149029739|NCT01562743|537586627|FG000|Overall Study|Withdrawal by Subject|13|||
149029740|NCT01562743|537586627|FG000|Overall Study|Protocol Violation|1|||
149029741|NCT01562743|537586627|FG000|Overall Study|Discontinuation criteria|2|||
149029742|NCT01562743|537586627|FG000|Overall Study|Lost to Follow-up|2|||
148842157|NCT04072835|536903044|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
148842158|NCT04072835|536903044|FG000|Overall Study|Pregnancy|3|||
148842159|NCT01336712|536903045|FG000|Overall Study|Death|2|||
148842160|NCT01336712|536903045|FG000|Overall Study|Lack of Efficacy|1|||
148842161|NCT02477527|536903046|FG000|Overall Study|Lost to Follow-up|2|||
148842162|NCT02477527|536903046|FG000|Overall Study|Withdrawal by Subject|1|||
148842163|NCT02477527|536903046|FG000|Overall Study|Screen Failure|3|||
148842164|NCT04567524|536903047|FG000|Overall Study|Adverse Event|1|||
148842165|NCT04567524|536903048|FG001|Overall Study|Adverse Event|1|||
148842166|NCT04567524|536903049|FG002|Overall Study|Adverse Event|0|||
148842167|NCT04567524|536903050|FG003|Overall Study|Adverse Event|0|||
148842168|NCT04567524|536903047|FG000|Overall Study|Withdrawal by Subject|2|||
148842169|NCT04567524|536903048|FG001|Overall Study|Withdrawal by Subject|0|||
148842170|NCT04567524|536903049|FG002|Overall Study|Withdrawal by Subject|0|||
148842171|NCT04567524|536903050|FG003|Overall Study|Withdrawal by Subject|1|||
148842172|NCT01147393|536903051|FG000|Dose Level 1|Dose limiting Toxicity|2|||
149029743|NCT01562743|537586627|FG000|Overall Study|Physician Decision|2|||
149029744|NCT05567159|537586628|FG000|Overall Study|Adverse Event|4|||
149029745|NCT05567159|537586628|FG000|Overall Study|Physician Decision|3|||
149029746|NCT05567159|537586628|FG000|Overall Study|Protocol deviation|1|||
149029747|NCT04159506|537586629|FG000|Overall Study|Lost to Follow-up|2|||
149029748|NCT04159506|537586630|FG001|Overall Study|Lost to Follow-up|5|||
149029749|NCT02449044|537586631|FG000|Overall Study|Lost to Follow-up|2|||
149029750|NCT02449044|537586631|FG000|Overall Study|Withdrawal by Subject|13|||
148842173|NCT01147393|536903051|FG000|Dose Level -1|Dose Limited Toxicity|1|||
148842174|NCT00570323|536903054|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
148842175|NCT00570323|536903055|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
148842176|NCT00570323|536903054|FG000|Started Treatment After Randomization|Protocol Violation|1|||
149029751|NCT02449044|537586631|FG000|Overall Study|Adverse Event|30|||
149029752|NCT02449044|537586631|FG000|Overall Study|Met Withdrawal Criteria|7|||
149029753|NCT02449044|537586631|FG000|Overall Study|Physician Decision|9|||
149029754|NCT02449044|537586631|FG000|Overall Study|Sponsor Discontinued Trial|3|||
148842177|NCT00570323|536903055|FG001|Started Treatment After Randomization|Protocol Violation|0|||
148842178|NCT00570323|536903054|FG000|Started Treatment After Randomization|Physician Decision|1|||
148842179|NCT00570323|536903055|FG001|Started Treatment After Randomization|Physician Decision|0|||
148842180|NCT00570323|536903054|FG000|Complete Study After Start|Lost to Follow-up|0|||
148842181|NCT00570323|536903055|FG001|Complete Study After Start|Lost to Follow-up|1|||
148842182|NCT00570323|536903054|FG000|Complete Study After Start|Withdrawal by Subject|2|||
148842183|NCT00570323|536903055|FG001|Complete Study After Start|Withdrawal by Subject|0|||
148842184|NCT00570323|536903054|FG000|Complete Study After Start|Physician Decision|1|||
148842185|NCT00570323|536903055|FG001|Complete Study After Start|Physician Decision|0|||
148842186|NCT04263766|536903056|FG000|Overall Study|Withdrawal by Subject|6|||
148842187|NCT04263766|536903057|FG001|Overall Study|Withdrawal by Subject|4|||
148842188|NCT04263766|536903056|FG000|Overall Study|Lack of Efficacy|1|||
148842189|NCT04263766|536903057|FG001|Overall Study|Lack of Efficacy|3|||
148842190|NCT02639247|536903060|FG000|Overall Study|Lost to Follow-up|2|||
148842191|NCT02639247|536903061|FG001|Overall Study|Lost to Follow-up|1|||
148842192|NCT02639247|536903060|FG000|Overall Study|Death|2|||
148842193|NCT02639247|536903061|FG001|Overall Study|Death|0|||
148842194|NCT02639247|536903060|FG000|Overall Study|Withdrew Consent|0|||
148842195|NCT02639247|536903061|FG001|Overall Study|Withdrew Consent|1|||
148774584|NCT01632150|536648613|FG000|Overall Study|Unrelated adverse event|7|||
148774585|NCT01632150|536648613|FG000|Overall Study|Withdrawal by Subject|2|||
148774586|NCT01632150|536648613|FG000|Overall Study|Patient underwent autologous transplant|1|||
148774587|NCT01632150|536648613|FG000|Overall Study|Moved to compassionate program|2|||
148774588|NCT02879994|536648616|FG000|Overall Study|off treatment early|7|||
148774589|NCT02879994|536648616|FG000|Overall Study|Adverse Event|2|||
148774590|NCT02879994|536648616|FG000|Overall Study|Death|2|||
148774591|NCT02143791|536648617|FG000|Enrolled|Withdrawal by Subject|4|||
148774592|NCT02143791|536648617|FG000|Trial Stimulation|Lack of Efficacy|21|||
148774593|NCT02143791|536648617|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
148774594|NCT02143791|536648617|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
148774595|NCT02143791|536648617|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
148774596|NCT02143791|536648617|FG000|Any Programming (3-6 Months)|Missing Data|1|||
148774597|NCT02143791|536648617|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
148774598|NCT03408444|536648624|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
148774599|NCT03408444|536648625|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
148774600|NCT03408444|536648626|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
148774601|NCT03408444|536648627|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
148774602|NCT03408444|536648624|FG000|Overall Study|Lens Discomfort|0|||
148774603|NCT03408444|536648625|FG001|Overall Study|Lens Discomfort|1|||
148774604|NCT03408444|536648626|FG002|Overall Study|Lens Discomfort|0|||
148774605|NCT03408444|536648627|FG003|Overall Study|Lens Discomfort|0|||
148774606|NCT03408444|536648624|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
148774607|NCT03408444|536648625|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
148774608|NCT03408444|536648626|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
148774609|NCT03408444|536648627|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
148774610|NCT03408444|536648624|FG000|Overall Study|Withdrawal by Subject|0|||
148774611|NCT03408444|536648625|FG001|Overall Study|Withdrawal by Subject|2|||
148774612|NCT03408444|536648626|FG002|Overall Study|Withdrawal by Subject|3|||
148774613|NCT03408444|536648627|FG003|Overall Study|Withdrawal by Subject|0|||
148774614|NCT03408444|536648624|FG000|Overall Study|Lost to Follow-up|0|||
148774615|NCT03408444|536648625|FG001|Overall Study|Lost to Follow-up|0|||
148774616|NCT03408444|536648626|FG002|Overall Study|Lost to Follow-up|1|||
148774617|NCT03408444|536648627|FG003|Overall Study|Lost to Follow-up|0|||
148774618|NCT03408444|536648624|FG000|Overall Study|Adverse Event|0|||
148774619|NCT03408444|536648625|FG001|Overall Study|Adverse Event|0|||
148774620|NCT03408444|536648626|FG002|Overall Study|Adverse Event|0|||
148774621|NCT03408444|536648627|FG003|Overall Study|Adverse Event|1|||
148774622|NCT03408444|536648624|FG000|Overall Study|Lens Handling Difficulties|0|||
148774623|NCT03408444|536648625|FG001|Overall Study|Lens Handling Difficulties|0|||
148774624|NCT03408444|536648626|FG002|Overall Study|Lens Handling Difficulties|1|||
148774625|NCT03408444|536648627|FG003|Overall Study|Lens Handling Difficulties|0|||
148774626|NCT03408444|536648624|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
148774627|NCT03408444|536648625|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
148774628|NCT03408444|536648626|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
148774629|NCT03408444|536648627|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
148774630|NCT04984681|536648628|FG000|Overall Study|Lost to Follow-up|3|||
148774631|NCT04984681|536648629|FG001|Overall Study|Lost to Follow-up|1|||
148774632|NCT01214252|536648630|FG000|Overall Study|Not eligible per protocol|82|||
148774633|NCT01473394|536648631|FG000|Overall Study|Adverse Event|13|||
148774634|NCT01473394|536648632|FG001|Overall Study|Adverse Event|16|||
148774635|NCT01473394|536648631|FG000|Overall Study|Insufficient Therapeutic Response|4|||
148842196|NCT02639247|536903060|FG000|Overall Study|Protocol Violation|1|||
148842197|NCT02639247|536903061|FG001|Overall Study|Protocol Violation|0|||
148983609|NCT01485861|537417379|FG002|Phase Ib|Physician Decision|0|||
148842198|NCT03462758|536903063|FG000|Overall Study|Chose no or other method of contraception|20|||
148842199|NCT03462758|536903064|FG001|Overall Study|Chose no or other method of contraception|23|||
148842200|NCT03462758|536903063|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
148842201|NCT03462758|536903064|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
148842202|NCT03462758|536903063|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
148842203|NCT03462758|536903064|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
148842204|NCT03462758|536903063|FG000|Overall Study|Medical contraindication|2|||
148842205|NCT03462758|536903064|FG001|Overall Study|Medical contraindication|2|||
148842206|NCT03462758|536903063|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
148842207|NCT03462758|536903064|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
148842208|NCT00573391|536903065|FG000|Overall Study|study stopped|2|||
148842209|NCT00573391|536903066|FG001|Overall Study|study stopped|2|||
148842210|NCT00573391|536903065|FG000|Overall Study|Death|1|||
148842211|NCT00573391|536903066|FG001|Overall Study|Death|0|||
148842212|NCT00589797|536903068|FG000|Overall Study|Death|1|||
148842213|NCT00589797|536903069|FG001|Overall Study|Death|0|||
148842214|NCT00589797|536903068|FG000|Overall Study|Lost to Follow-up|12|||
148842215|NCT00589797|536903069|FG001|Overall Study|Lost to Follow-up|9|||
148842216|NCT00589797|536903068|FG000|Overall Study|Physician Decision|8|||
148842217|NCT00589797|536903069|FG001|Overall Study|Physician Decision|3|||
148842218|NCT00589797|536903068|FG000|Overall Study|Withdrawal by Subject|6|||
148842219|NCT00589797|536903069|FG001|Overall Study|Withdrawal by Subject|5|||
148842220|NCT00589797|536903068|FG000|Overall Study|Non-Randomized Training Subjects|46|||
148842221|NCT00589797|536903069|FG001|Overall Study|Non-Randomized Training Subjects|6|||
148842222|NCT03230318|536903070|FG000|Overall Study|Radiographic disease progression|72|||
148842223|NCT03230318|536903071|FG001|Overall Study|Radiographic disease progression|19|||
148842224|NCT03230318|536903070|FG000|Overall Study|Clinical progression|17|||
148842225|NCT03230318|536903071|FG001|Overall Study|Clinical progression|7|||
148842226|NCT03230318|536903070|FG000|Overall Study|Adverse Event|5|||
148842227|NCT03230318|536903071|FG001|Overall Study|Adverse Event|3|||
148842228|NCT03230318|536903070|FG000|Overall Study|Physician Decision|2|||
148842229|NCT03230318|536903071|FG001|Overall Study|Physician Decision|3|||
148842230|NCT03230318|536903070|FG000|Overall Study|Death|3|||
148842231|NCT03230318|536903071|FG001|Overall Study|Death|2|||
148842232|NCT03230318|536903070|FG000|Overall Study|Lost to Follow-up|1|||
148842233|NCT03230318|536903071|FG001|Overall Study|Lost to Follow-up|0|||
148842234|NCT03230318|536903070|FG000|Overall Study|Withdrawal by Subject|1|||
148842235|NCT03230318|536903071|FG001|Overall Study|Withdrawal by Subject|3|||
148842236|NCT03230318|536903070|FG000|Overall Study|Other|3|||
148842237|NCT03230318|536903071|FG001|Overall Study|Other|7|||
148842238|NCT04011735|536903072|FG000|Overall Study|Withdrawal by Subject|1|||
148842239|NCT04011735|536903073|FG001|Overall Study|Withdrawal by Subject|0|||
148842240|NCT04011735|536903074|FG002|Overall Study|Withdrawal by Subject|1|||
148842241|NCT04011735|536903072|FG000|Overall Study|Met exclusion criteria after study entry|0|||
148842242|NCT04011735|536903073|FG001|Overall Study|Met exclusion criteria after study entry|1|||
148842243|NCT04011735|536903074|FG002|Overall Study|Met exclusion criteria after study entry|0|||
148842244|NCT02651116|536903078|FG000|Overall Study|Adverse Event|0|||
148842245|NCT02651116|536903079|FG001|Overall Study|Adverse Event|1|||
148842246|NCT02651116|536903078|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
148842247|NCT02651116|536903079|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
148842248|NCT00041470|536903087|FG000|Overall Study|Loss of Funding|38|||
148842249|NCT00739310|536903088|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
148842250|NCT00739310|536903088|FG000|Overall Study|Withdrawal by Subject|1|||
148842251|NCT00739310|536903088|FG000|Overall Study|Lost to Follow-up|2|||
148842252|NCT01061385|536903089|FG000|Overall Study|Lost to Follow-up|1|||
148842253|NCT01061385|536903090|FG001|Overall Study|Lost to Follow-up|0|||
148842254|NCT01061385|536903089|FG000|Overall Study|subject decision not related to AE|0|||
148842255|NCT01061385|536903090|FG001|Overall Study|subject decision not related to AE|1|||
148842256|NCT00533429|536903091|FG000|Overall Study|Adverse Event|3|||
148842257|NCT00533429|536903092|FG001|Overall Study|Adverse Event|1|||
148842258|NCT00533429|536903091|FG000|Overall Study|Death|1|||
148842259|NCT00533429|536903092|FG001|Overall Study|Death|0|||
148842260|NCT00533429|536903091|FG000|Overall Study|Withdrawal by Subject|2|||
148842261|NCT00533429|536903092|FG001|Overall Study|Withdrawal by Subject|0|||
148983610|NCT01485861|537417380|FG003|Phase Ib|Physician Decision|0|||
148983611|NCT01485861|537417381|FG004|Phase Ib|Physician Decision|0|||
148842262|NCT00533429|536903091|FG000|Overall Study|Progressive Disease|12|||
148842263|NCT00533429|536903092|FG001|Overall Study|Progressive Disease|13|||
148842264|NCT00533429|536903091|FG000|Overall Study|Symptomatic deterioration|1|||
148842265|NCT00533429|536903092|FG001|Overall Study|Symptomatic deterioration|2|||
148842266|NCT02343302|536903099|FG000|Overall Study|Physician Decision|1|||
148842267|NCT02343302|536903100|FG001|Overall Study|Physician Decision|1|||
148842268|NCT01299389|536903101|FG000|Double-blind|Adverse Event|45|||
148842269|NCT01299389|536903102|FG001|Double-blind|Adverse Event|27|||
148842270|NCT01299389|536903103|FG002|Double-blind|Adverse Event|0|||
148842271|NCT01299389|536903104|FG003|Double-blind|Adverse Event|0|||
148983612|NCT01485861|537417382|FG005|Phase Ib|Physician Decision|0|||
148842272|NCT01299389|536903101|FG000|Double-blind|Lack of Efficacy|45|||
148842273|NCT01299389|536903102|FG001|Double-blind|Lack of Efficacy|21|||
148842274|NCT01299389|536903103|FG002|Double-blind|Lack of Efficacy|0|||
148842275|NCT01299389|536903104|FG003|Double-blind|Lack of Efficacy|0|||
148842276|NCT01299389|536903101|FG000|Double-blind|Lost to Follow-up|2|||
148842277|NCT01299389|536903102|FG001|Double-blind|Lost to Follow-up|1|||
148842278|NCT01299389|536903103|FG002|Double-blind|Lost to Follow-up|0|||
148842279|NCT01299389|536903104|FG003|Double-blind|Lost to Follow-up|0|||
148842280|NCT01299389|536903101|FG000|Double-blind|Withdrawal by Subject|16|||
148842281|NCT01299389|536903102|FG001|Double-blind|Withdrawal by Subject|13|||
148842282|NCT01299389|536903103|FG002|Double-blind|Withdrawal by Subject|0|||
148842283|NCT01299389|536903104|FG003|Double-blind|Withdrawal by Subject|0|||
148842284|NCT01299389|536903101|FG000|Double-blind|Other|1|||
148842285|NCT01299389|536903102|FG001|Double-blind|Other|1|||
148842286|NCT01299389|536903103|FG002|Double-blind|Other|0|||
148842287|NCT01299389|536903104|FG003|Double-blind|Other|0|||
148842288|NCT01299389|536903101|FG000|Double-blind|"fail to meet study population criteria"|0|||
148842289|NCT01299389|536903102|FG001|Double-blind|"fail to meet study population criteria"|1|||
148842290|NCT01299389|536903103|FG002|Double-blind|"fail to meet study population criteria"|0|||
148842291|NCT01299389|536903104|FG003|Double-blind|"fail to meet study population criteria"|0|||
148842292|NCT01299389|536903101|FG000|Post-observational|Other|0|||
148842293|NCT01299389|536903102|FG001|Post-observational|Other|0|||
148842294|NCT01299389|536903103|FG002|Post-observational|Other|12|||
148842295|NCT01299389|536903104|FG003|Post-observational|Other|6|||
148842296|NCT02834819|536903105|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
148842297|NCT02834819|536903106|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
148842298|NCT02041299|536903110|FG000|Overall Study|Adverse Event|9|||
148842299|NCT02041299|536903111|FG001|Overall Study|Adverse Event|3|||
148842300|NCT02041299|536903110|FG000|Overall Study|Lost to Follow-up|4|||
148842301|NCT02041299|536903111|FG001|Overall Study|Lost to Follow-up|1|||
148842302|NCT02041299|536903110|FG000|Overall Study|Physician Decision|1|||
148842303|NCT02041299|536903111|FG001|Overall Study|Physician Decision|1|||
148842304|NCT02041299|536903110|FG000|Overall Study|Withdrawal by Subject|13|||
148842305|NCT02041299|536903111|FG001|Overall Study|Withdrawal by Subject|7|||
148842306|NCT02041299|536903110|FG000|Overall Study|Protocol Violation|11|||
148842307|NCT02041299|536903111|FG001|Overall Study|Protocol Violation|4|||
148842308|NCT02041299|536903110|FG000|Overall Study|Termination of the study|7|||
148842309|NCT02041299|536903111|FG001|Overall Study|Termination of the study|3|||
148842310|NCT02041299|536903110|FG000|Overall Study|Required bone marrow transplant|0|||
148842311|NCT02041299|536903111|FG001|Overall Study|Required bone marrow transplant|1|||
148842312|NCT02041299|536903110|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
148842313|NCT02041299|536903111|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
148842314|NCT01635998|536903112|FG000|Overall Study|Death|1|||
148842315|NCT01635998|536903113|FG001|Overall Study|Death|1|||
148842316|NCT01635998|536903112|FG000|Overall Study|Lost to Follow-up|2|||
148842317|NCT01635998|536903113|FG001|Overall Study|Lost to Follow-up|1|||
148842318|NCT01635998|536903112|FG000|Overall Study|Withdrawal by Subject|1|||
148842319|NCT01635998|536903113|FG001|Overall Study|Withdrawal by Subject|5|||
148842320|NCT02389465|536903114|FG000|Overall Study|Lost to Follow-up|1|||
148842321|NCT02389465|536903115|FG001|Overall Study|Lost to Follow-up|3|||
148842322|NCT02389465|536903116|FG002|Overall Study|Lost to Follow-up|3|||
148842323|NCT02389465|536903117|FG003|Overall Study|Lost to Follow-up|0|||
148842324|NCT02389465|536903114|FG000|Overall Study|Physician Decision|0|||
148842325|NCT02389465|536903115|FG001|Overall Study|Physician Decision|0|||
148842326|NCT02389465|536903116|FG002|Overall Study|Physician Decision|0|||
148842327|NCT02389465|536903117|FG003|Overall Study|Physician Decision|1|||
148842328|NCT02389465|536903114|FG000|Overall Study|Withdrawal by Subject|0|||
148842329|NCT02389465|536903115|FG001|Overall Study|Withdrawal by Subject|1|||
148842330|NCT02389465|536903116|FG002|Overall Study|Withdrawal by Subject|2|||
148842331|NCT02389465|536903117|FG003|Overall Study|Withdrawal by Subject|2|||
148842332|NCT01925768|536903118|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
148842333|NCT01925768|536903119|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148842334|NCT01925768|536903118|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
148842335|NCT01925768|536903119|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
148842336|NCT01925768|536903118|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
148842337|NCT01925768|536903119|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
148842338|NCT01925768|536903118|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
148842339|NCT01925768|536903119|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
148842340|NCT01925768|536903118|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
148983613|NCT01485861|537417377|FG000|Phase Ib|Adverse Event|0|||
148983614|NCT01485861|537417378|FG001|Phase Ib|Adverse Event|4|||
148842341|NCT01925768|536903119|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
148842342|NCT01925768|536903118|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
148842343|NCT01925768|536903119|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
148983615|NCT01485861|537417379|FG002|Phase Ib|Adverse Event|0|||
148983616|NCT01485861|537417380|FG003|Phase Ib|Adverse Event|0|||
148842344|NCT01925768|536903118|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
148842345|NCT01925768|536903119|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
148842346|NCT01925768|536903118|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
148842347|NCT01925768|536903119|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
148842348|NCT01925768|536903118|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
148842349|NCT01925768|536903119|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
148842350|NCT01925768|536903118|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
148842351|NCT01925768|536903119|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
148842352|NCT01925768|536903118|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
148842353|NCT01925768|536903119|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
148842354|NCT00087698|536903124|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
148842355|NCT00087698|536903124|FG000|Overall Study|Death from Other Causes|3|||
148842356|NCT00087698|536903124|FG000|Overall Study|Adverse Event|4|||
148842357|NCT00087698|536903124|FG000|Overall Study|Withdrawal by Subject|4|||
148842358|NCT00087698|536903124|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
148842359|NCT00087698|536903124|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
148842360|NCT00087698|536903124|FG000|Overall Study|Clinical Relapse|1|||
148842361|NCT00087698|536903124|FG000|Overall Study|Death from Study Disease|2|||
148842362|NCT00087698|536903124|FG000|Overall Study|Death from Study Drug Toxicity|2|||
148842363|NCT00087698|536903124|FG000|Overall Study|Protocol Violation|1|||
148842364|NCT03943290|536903128|FG000|Overall Study|Sponsor Terminated Study|6|||
148842365|NCT03943290|536903129|FG001|Overall Study|Sponsor Terminated Study|1|||
148842366|NCT03943290|536903130|FG002|Overall Study|Sponsor Terminated Study|11|||
148842367|NCT03943290|536903131|FG003|Overall Study|Sponsor Terminated Study|6|||
148842368|NCT03943290|536903132|FG004|Overall Study|Sponsor Terminated Study|7|||
148842369|NCT03943290|536903133|FG005|Overall Study|Sponsor Terminated Study|6|||
148842370|NCT03943290|536903134|FG006|Overall Study|Sponsor Terminated Study|6|||
148842371|NCT03943290|536903135|FG007|Overall Study|Sponsor Terminated Study|7|||
148842372|NCT03943290|536903136|FG008|Overall Study|Sponsor Terminated Study|8|||
148842373|NCT03943290|536903128|FG000|Overall Study|Lost to Follow-up|1|||
148842374|NCT03943290|536903129|FG001|Overall Study|Lost to Follow-up|0|||
148842375|NCT03943290|536903130|FG002|Overall Study|Lost to Follow-up|1|||
148842376|NCT03943290|536903131|FG003|Overall Study|Lost to Follow-up|0|||
148842377|NCT03943290|536903132|FG004|Overall Study|Lost to Follow-up|0|||
148842378|NCT03943290|536903133|FG005|Overall Study|Lost to Follow-up|0|||
148842379|NCT03943290|536903134|FG006|Overall Study|Lost to Follow-up|0|||
148842380|NCT03943290|536903135|FG007|Overall Study|Lost to Follow-up|1|||
148842381|NCT03943290|536903136|FG008|Overall Study|Lost to Follow-up|0|||
148842382|NCT03943290|536903128|FG000|Overall Study|Withdrawal by Subject|0|||
148842383|NCT03943290|536903129|FG001|Overall Study|Withdrawal by Subject|0|||
148842384|NCT03943290|536903130|FG002|Overall Study|Withdrawal by Subject|1|||
148842385|NCT03943290|536903131|FG003|Overall Study|Withdrawal by Subject|0|||
148842386|NCT03943290|536903132|FG004|Overall Study|Withdrawal by Subject|0|||
148842387|NCT03943290|536903133|FG005|Overall Study|Withdrawal by Subject|0|||
148842388|NCT03943290|536903134|FG006|Overall Study|Withdrawal by Subject|0|||
148842389|NCT03943290|536903135|FG007|Overall Study|Withdrawal by Subject|0|||
148842390|NCT03943290|536903136|FG008|Overall Study|Withdrawal by Subject|0|||
148842391|NCT00955474|536903139|FG000|Overall Study|Physician Decision|7|||
148842392|NCT00955474|536903140|FG001|Overall Study|Physician Decision|5|||
148842393|NCT04179305|536903142|FG000|Overall Study|Death|1|||
148842394|NCT04179305|536903143|FG001|Overall Study|Death|1|||
148842395|NCT04179305|536903144|FG002|Overall Study|Death|0|||
148842396|NCT04179305|536903145|FG003|Overall Study|Death|0|||
148842397|NCT04179305|536903142|FG000|Overall Study|Lost to Follow-up|1|||
148842398|NCT04179305|536903143|FG001|Overall Study|Lost to Follow-up|1|||
148842399|NCT04179305|536903144|FG002|Overall Study|Lost to Follow-up|0|||
148842400|NCT04179305|536903145|FG003|Overall Study|Lost to Follow-up|0|||
148983617|NCT01485861|537417381|FG004|Phase Ib|Adverse Event|0|||
148983618|NCT01485861|537417382|FG005|Phase Ib|Adverse Event|0|||
148983619|NCT01485861|537417377|FG000|Phase Ib|Progression of disease|5|||
148983620|NCT01485861|537417378|FG001|Phase Ib|Progression of disease|0|||
148842401|NCT04179305|536903142|FG000|Overall Study|Withdrawal by Subject|0|||
148842402|NCT04179305|536903143|FG001|Overall Study|Withdrawal by Subject|1|||
148842403|NCT04179305|536903144|FG002|Overall Study|Withdrawal by Subject|0|||
148842404|NCT04179305|536903145|FG003|Overall Study|Withdrawal by Subject|0|||
148842405|NCT04179305|536903142|FG000|Overall Study|Did not have scan|1|||
148842406|NCT04179305|536903143|FG001|Overall Study|Did not have scan|0|||
148842407|NCT04179305|536903144|FG002|Overall Study|Did not have scan|0|||
148983621|NCT01485861|537417379|FG002|Phase Ib|Progression of disease|0|||
148842408|NCT04179305|536903145|FG003|Overall Study|Did not have scan|0|||
148842409|NCT04179305|536903142|FG000|Overall Study|In hospice care|3|||
148842410|NCT04179305|536903143|FG001|Overall Study|In hospice care|0|||
148842411|NCT04179305|536903144|FG002|Overall Study|In hospice care|0|||
148842412|NCT04179305|536903145|FG003|Overall Study|In hospice care|0|||
148842413|NCT03386435|536903148|FG000|Overall Study|Protocol Violation|5|||
148983622|NCT01485861|537417380|FG003|Phase Ib|Progression of disease|0|||
148983623|NCT01485861|537417381|FG004|Phase Ib|Progression of disease|0|||
148983624|NCT01485861|537417382|FG005|Phase Ib|Progression of disease|0|||
148983625|NCT01485861|537417377|FG000|Phase Ib|Other|3|||
148983626|NCT01485861|537417378|FG001|Phase Ib|Other|0|||
148983627|NCT01485861|537417379|FG002|Phase Ib|Other|0|||
148842414|NCT03386435|536903149|FG001|Overall Study|Protocol Violation|7|||
148842415|NCT04068922|536903150|FG000|Overall Study|Lost to Follow-up|5|||
148842416|NCT04068922|536903150|FG000|Overall Study|Withdrawal by Subject|7|||
148842417|NCT04068922|536903150|FG000|Overall Study|Adverse Event|1|||
148842418|NCT00625586|536903151|FG000|Overall Study|Adverse Event|1|||
148842419|NCT00625586|536903151|FG000|Overall Study|Progressive disease|1|||
148842420|NCT03542266|536903152|FG000|Treatment Phase|Withdrawal by Subject|1|||
148842421|NCT03542266|536903152|FG000|Treatment Phase|Adverse Event|1|||
148842422|NCT03542266|536903152|FG000|Treatment Phase|PD|1|||
148842423|NCT00657267|536903158|FG000|Overall Study|Progressive disease|45|||
148842424|NCT00657267|536903158|FG000|Overall Study|Adverse Event|9|||
148842425|NCT02737501|536903159|FG000|Randomized Phase|Died|41|||
148842426|NCT02737501|536903160|FG001|Randomized Phase|Died|29|||
148842427|NCT02737501|536903161|FG002|Randomized Phase|Died|0|||
148842428|NCT02737501|536903159|FG000|Randomized Phase|Withdrawal by Subject|16|||
148842429|NCT02737501|536903160|FG001|Randomized Phase|Withdrawal by Subject|6|||
148842430|NCT02737501|536903161|FG002|Randomized Phase|Withdrawal by Subject|0|||
148842431|NCT02737501|536903159|FG000|Randomized Phase|Lost to Follow-up|0|||
148842432|NCT02737501|536903160|FG001|Randomized Phase|Lost to Follow-up|1|||
148842433|NCT02737501|536903161|FG002|Randomized Phase|Lost to Follow-up|0|||
148842434|NCT02737501|536903159|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
148842435|NCT02737501|536903160|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
148842436|NCT02737501|536903161|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
148842437|NCT02737501|536903159|FG000|Randomized Phase|Reason not Specified|1|||
148842438|NCT02737501|536903160|FG001|Randomized Phase|Reason not Specified|1|||
148842439|NCT02737501|536903161|FG002|Randomized Phase|Reason not Specified|0|||
148842440|NCT02737501|536903159|FG000|Randomized Phase|Never Treated|1|||
148842441|NCT02737501|536903160|FG001|Randomized Phase|Never Treated|1|||
148842442|NCT02737501|536903161|FG002|Randomized Phase|Never Treated|0|||
148842443|NCT02737501|536903159|FG000|Crossover Phase|Died|0|||
148842444|NCT02737501|536903160|FG001|Crossover Phase|Died|0|||
148842445|NCT02737501|536903161|FG002|Crossover Phase|Died|22|||
148842446|NCT02737501|536903159|FG000|Crossover Phase|Withdrew Consent|0|||
148842447|NCT02737501|536903160|FG001|Crossover Phase|Withdrew Consent|0|||
148842448|NCT02737501|536903161|FG002|Crossover Phase|Withdrew Consent|9|||
148842449|NCT02737501|536903159|FG000|Crossover Phase|Physician Decision|0|||
148842450|NCT02737501|536903160|FG001|Crossover Phase|Physician Decision|0|||
148842451|NCT02737501|536903161|FG002|Crossover Phase|Physician Decision|1|||
148842452|NCT02737501|536903159|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
148842453|NCT02737501|536903160|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
148842454|NCT02737501|536903161|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
148842455|NCT01070979|536903162|FG000|Overall Study|Adverse Event|2|||
148842456|NCT01070979|536903163|FG001|Overall Study|Adverse Event|3|||
148842457|NCT01070979|536903164|FG002|Overall Study|Adverse Event|3|||
148842458|NCT01070979|536903162|FG000|Overall Study|Lost to Follow-up|2|||
148842459|NCT01070979|536903163|FG001|Overall Study|Lost to Follow-up|1|||
148842460|NCT01070979|536903164|FG002|Overall Study|Lost to Follow-up|1|||
148842461|NCT01070979|536903162|FG000|Overall Study|Protocol Violation|0|||
148842462|NCT01070979|536903163|FG001|Overall Study|Protocol Violation|2|||
148842463|NCT01070979|536903164|FG002|Overall Study|Protocol Violation|6|||
148842464|NCT01070979|536903162|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
148842465|NCT01070979|536903163|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
148842466|NCT01070979|536903164|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
148842467|NCT01070979|536903162|FG000|Overall Study|Withdrawal by Subject|3|||
148842468|NCT01070979|536903163|FG001|Overall Study|Withdrawal by Subject|1|||
148842469|NCT01070979|536903164|FG002|Overall Study|Withdrawal by Subject|1|||
148842470|NCT01070979|536903162|FG000|Overall Study|No study drug taken|0|||
148842471|NCT01070979|536903163|FG001|Overall Study|No study drug taken|1|||
148842472|NCT01070979|536903164|FG002|Overall Study|No study drug taken|0|||
148983628|NCT01485861|537417380|FG003|Phase Ib|Other|0|||
148842473|NCT00142792|536903165|FG000|Overall Study|Death|0|||
148842474|NCT00142792|536903166|FG001|Overall Study|Death|0|||
148842475|NCT00142792|536903167|FG002|Overall Study|Death|1|||
148842476|NCT00142792|536903165|FG000|Overall Study|Withdrawal by Subject|3|||
148842477|NCT00142792|536903166|FG001|Overall Study|Withdrawal by Subject|2|||
148983629|NCT01485861|537417381|FG004|Phase Ib|Other|0|||
148842478|NCT00142792|536903167|FG002|Overall Study|Withdrawal by Subject|3|||
148842479|NCT00142792|536903165|FG000|Overall Study|Lost to Follow-up|8|||
148842480|NCT00142792|536903166|FG001|Overall Study|Lost to Follow-up|11|||
148983630|NCT01485861|537417382|FG005|Phase Ib|Other|0|||
148842481|NCT00142792|536903167|FG002|Overall Study|Lost to Follow-up|7|||
148842482|NCT00142792|536903165|FG000|Overall Study|No category|1|||
148842483|NCT00142792|536903166|FG001|Overall Study|No category|2|||
148983631|NCT01485861|537417377|FG000|Phase Ib|Withdrawal by Subject|4|||
148983632|NCT01485861|537417378|FG001|Phase Ib|Withdrawal by Subject|1|||
149029755|NCT02501811|537586633|FG000|Overall Study|Death|1|||
149029756|NCT02501811|537586634|FG001|Overall Study|Death|3|||
149029757|NCT02501811|537586635|FG002|Overall Study|Death|2|||
149029758|NCT02501811|537586636|FG003|Overall Study|Death|3|||
149029759|NCT02501811|537586633|FG000|Overall Study|Withdrawal by Subject|3|||
149029760|NCT02501811|537586634|FG001|Overall Study|Withdrawal by Subject|3|||
149029761|NCT02501811|537586635|FG002|Overall Study|Withdrawal by Subject|2|||
149029762|NCT02501811|537586636|FG003|Overall Study|Withdrawal by Subject|3|||
149029763|NCT02501811|537586633|FG000|Overall Study|Lost to Follow-up|0|||
149029764|NCT02501811|537586634|FG001|Overall Study|Lost to Follow-up|0|||
149029765|NCT02501811|537586635|FG002|Overall Study|Lost to Follow-up|2|||
149029766|NCT02501811|537586636|FG003|Overall Study|Lost to Follow-up|1|||
149029767|NCT00662909|537586637|FG000|Overall Study|Adverse Event|17|||
149029768|NCT00662909|537586638|FG001|Overall Study|Adverse Event|18|||
149029769|NCT00662909|537586639|FG002|Overall Study|Adverse Event|19|||
149029770|NCT00662909|537586637|FG000|Overall Study|Lack of Efficacy|9|||
149029771|NCT00662909|537586638|FG001|Overall Study|Lack of Efficacy|1|||
149029772|NCT00662909|537586639|FG002|Overall Study|Lack of Efficacy|5|||
149029773|NCT00662909|537586637|FG000|Overall Study|Withdrawal by Subject|29|||
149029774|NCT00662909|537586638|FG001|Overall Study|Withdrawal by Subject|22|||
149029775|NCT00662909|537586639|FG002|Overall Study|Withdrawal by Subject|16|||
149029776|NCT00662909|537586637|FG000|Overall Study|Lost to Follow-up|2|||
149029777|NCT00662909|537586638|FG001|Overall Study|Lost to Follow-up|9|||
149029778|NCT00662909|537586639|FG002|Overall Study|Lost to Follow-up|3|||
149029779|NCT00662909|537586637|FG000|Overall Study|Protocol Violation|7|||
149029780|NCT00662909|537586638|FG001|Overall Study|Protocol Violation|4|||
149029781|NCT00662909|537586639|FG002|Overall Study|Protocol Violation|5|||
149029782|NCT00662909|537586637|FG000|Overall Study|Randomized- never received study drug|1|||
149029783|NCT00662909|537586638|FG001|Overall Study|Randomized- never received study drug|0|||
149029784|NCT00662909|537586639|FG002|Overall Study|Randomized- never received study drug|0|||
149029785|NCT00662909|537586637|FG000|Overall Study|Non-compliance with study procedures|3|||
149029786|NCT00662909|537586638|FG001|Overall Study|Non-compliance with study procedures|3|||
149029787|NCT00662909|537586639|FG002|Overall Study|Non-compliance with study procedures|2|||
149029788|NCT00662909|537586637|FG000|Overall Study|Physician Decision|1|||
149029789|NCT00662909|537586638|FG001|Overall Study|Physician Decision|1|||
149029790|NCT00662909|537586639|FG002|Overall Study|Physician Decision|2|||
149029791|NCT00662909|537586637|FG000|Overall Study|Eligibility criterion not met|0|||
149029792|NCT00662909|537586638|FG001|Overall Study|Eligibility criterion not met|1|||
149029793|NCT00662909|537586639|FG002|Overall Study|Eligibility criterion not met|1|||
149029794|NCT02738840|537587876|FG000|Overall Study|MRI Scan not Performed|5|||
149029795|NCT02738840|537587876|FG000|Overall Study|Lost to Follow-up|1|||
149029796|NCT02738840|537587876|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
149029797|NCT02738840|537587876|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
149029798|NCT01311648|537587879|FG000|Main Study|Protocol Violation|0|||
149029799|NCT01311648|537587880|FG001|Main Study|Protocol Violation|1|||
149029800|NCT01311648|537587879|FG000|Main Study|Adverse Event|0|||
149029801|NCT01311648|537587880|FG001|Main Study|Adverse Event|1|||
149029802|NCT01311648|537587879|FG000|Main Study|Inhibitor management|0|||
149029803|NCT01311648|537587880|FG001|Main Study|Inhibitor management|17|||
149029804|NCT01311648|537587879|FG000|Main Study|Withdrawal by Subject|0|||
148842484|NCT00142792|536903167|FG002|Overall Study|No category|1|||
148842485|NCT04819113|536903168|FG000|Overall Study|Withdrawal by parent/guardian|3|||
148842486|NCT04819113|536903168|FG000|Overall Study|Lost to Follow-up|1|||
148842487|NCT04819113|536903168|FG000|Overall Study|Withdrawn before vaccination|2|||
148842488|NCT00437268|536903169|FG000|Overall Study|Adverse Event|1|||
148842489|NCT00437268|536903170|FG001|Overall Study|Adverse Event|1|||
149029805|NCT01311648|537587880|FG001|Main Study|Withdrawal by Subject|2|||
149029806|NCT01311648|537587879|FG000|Extension Study|Physician Decision|0|||
148842490|NCT00437268|536903169|FG000|Overall Study|Withdrawal by Subject|2|||
148842491|NCT00437268|536903170|FG001|Overall Study|Withdrawal by Subject|2|||
148842492|NCT00437268|536903169|FG000|Overall Study|Progressive disease|9|||
149029807|NCT01311648|537587880|FG001|Extension Study|Physician Decision|1|||
149029808|NCT01311648|537587879|FG000|Extension Study|ITI therapy with marketed product|0|||
149029809|NCT01311648|537587880|FG001|Extension Study|ITI therapy with marketed product|1|||
149029810|NCT01311648|537587879|FG000|Extension Study|Incorrect visit planning|0|||
149029811|NCT01311648|537587880|FG001|Extension Study|Incorrect visit planning|1|||
149029812|NCT01311648|537587879|FG000|Extension Study|Family's decision|0|||
149029813|NCT01311648|537587880|FG001|Extension Study|Family's decision|1|||
149029814|NCT01311648|537587879|FG000|Extension Study|Failure of ITI therapy|0|||
149029815|NCT01311648|537587880|FG001|Extension Study|Failure of ITI therapy|3|||
149029816|NCT01311648|537587879|FG000|Extension Study|Long travel|0|||
149029817|NCT01311648|537587880|FG001|Extension Study|Long travel|1|||
149029818|NCT01311648|537587879|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
149029819|NCT01311648|537587880|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
148842493|NCT00437268|536903170|FG001|Overall Study|Progressive disease|9|||
149029820|NCT01311648|537587879|FG000|Extension Study|Withdrawal by Subject|0|||
149029821|NCT01311648|537587880|FG001|Extension Study|Withdrawal by Subject|1|||
148983633|NCT01485861|537417379|FG002|Phase Ib|Withdrawal by Subject|0|||
148983634|NCT01485861|537417380|FG003|Phase Ib|Withdrawal by Subject|0|||
148983635|NCT01485861|537417381|FG004|Phase Ib|Withdrawal by Subject|0|||
148983636|NCT01485861|537417382|FG005|Phase Ib|Withdrawal by Subject|0|||
148983637|NCT01485861|537417377|FG000|Phase II|Death|0|||
148983638|NCT01485861|537417378|FG001|Phase II|Death|0|||
148983639|NCT01485861|537417379|FG002|Phase II|Death|67|||
148983640|NCT01485861|537417380|FG003|Phase II|Death|71|||
148983641|NCT01485861|537417381|FG004|Phase II|Death|68|||
148983642|NCT01485861|537417382|FG005|Phase II|Death|0|||
148983643|NCT01485861|537417377|FG000|Phase II|Progression of Disease|0|||
148983644|NCT01485861|537417378|FG001|Phase II|Progression of Disease|0|||
148983645|NCT01485861|537417379|FG002|Phase II|Progression of Disease|1|||
148983646|NCT01485861|537417380|FG003|Phase II|Progression of Disease|0|||
148983647|NCT01485861|537417381|FG004|Phase II|Progression of Disease|0|||
148983648|NCT01485861|537417382|FG005|Phase II|Progression of Disease|0|||
148983649|NCT01485861|537417377|FG000|Phase II|Other|0|||
148983650|NCT01485861|537417378|FG001|Phase II|Other|0|||
148983651|NCT01485861|537417379|FG002|Phase II|Other|0|||
148842494|NCT00437268|536903169|FG000|Overall Study|Physician Decision|1|||
148842495|NCT00437268|536903170|FG001|Overall Study|Physician Decision|0|||
148842496|NCT00437268|536903169|FG000|Overall Study|Death|0|||
148842497|NCT00437268|536903170|FG001|Overall Study|Death|1|||
148842498|NCT00444925|536903175|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
148842499|NCT00444925|536903176|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
148842500|NCT00444925|536903177|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
148842501|NCT00444925|536903175|FG000|Double-blind Treatment Period|Death|2|||
148842502|NCT00444925|536903176|FG001|Double-blind Treatment Period|Death|0|||
148842503|NCT00444925|536903177|FG002|Double-blind Treatment Period|Death|0|||
148842504|NCT00444925|536903175|FG000|Double-blind Treatment Period|Adverse Event|6|||
148842505|NCT00444925|536903176|FG001|Double-blind Treatment Period|Adverse Event|28|||
148842506|NCT00444925|536903177|FG002|Double-blind Treatment Period|Adverse Event|44|||
148842507|NCT00444925|536903175|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
148842508|NCT00444925|536903176|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
148842509|NCT00444925|536903177|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
148842510|NCT00444925|536903175|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
148842511|NCT00444925|536903176|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
148842512|NCT00444925|536903177|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
148842513|NCT00444925|536903175|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
148842514|NCT00444925|536903176|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
148842515|NCT00444925|536903177|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
148842516|NCT00444925|536903175|FG000|Double-blind Treatment Period|Other|7|||
148842517|NCT00444925|536903176|FG001|Double-blind Treatment Period|Other|7|||
148842518|NCT00444925|536903177|FG002|Double-blind Treatment Period|Other|12|||
148842519|NCT01396187|536905016|FG000|Overall Study|Adverse Event|0|||
148842520|NCT01396187|536905017|FG001|Overall Study|Adverse Event|1|||
148842521|NCT01396187|536905018|FG002|Overall Study|Adverse Event|0|||
148842522|NCT01396187|536905019|FG003|Overall Study|Adverse Event|0|||
148842523|NCT01396187|536905020|FG004|Overall Study|Adverse Event|0|||
148842524|NCT01396187|536905016|FG000|Overall Study|Withdrawal by Subject|0|||
148842525|NCT01396187|536905017|FG001|Overall Study|Withdrawal by Subject|1|||
148842526|NCT01396187|536905018|FG002|Overall Study|Withdrawal by Subject|1|||
148842527|NCT01396187|536905019|FG003|Overall Study|Withdrawal by Subject|0|||
148842528|NCT01396187|536905020|FG004|Overall Study|Withdrawal by Subject|0|||
148842529|NCT01396187|536905016|FG000|Overall Study|Other|1|||
148842530|NCT01396187|536905017|FG001|Overall Study|Other|1|||
148842531|NCT01396187|536905018|FG002|Overall Study|Other|0|||
148842532|NCT01396187|536905019|FG003|Overall Study|Other|0|||
148842533|NCT01396187|536905020|FG004|Overall Study|Other|1|||
148842534|NCT01898286|536905021|FG000|Overall Study|Withdrawal by Subject|1|||
148842535|NCT01898286|536905021|FG000|Overall Study|Protocol Violation|1|||
148842536|NCT01898286|536905021|FG000|Overall Study|Lost to Follow-up|1|||
148842537|NCT02257242|536905022|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
148983652|NCT01485861|537417380|FG003|Phase II|Other|1|||
148983653|NCT01485861|537417381|FG004|Phase II|Other|0|||
148983654|NCT01485861|537417382|FG005|Phase II|Other|0|||
148983655|NCT01485861|537417377|FG000|Phase II|Withdrawal by Subject|0|||
148983656|NCT01485861|537417378|FG001|Phase II|Withdrawal by Subject|0|||
148842538|NCT02257242|536905023|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842539|NCT02257242|536905024|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842540|NCT02257242|536905025|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148983657|NCT01485861|537417379|FG002|Phase II|Withdrawal by Subject|6|||
148983658|NCT01485861|537417380|FG003|Phase II|Withdrawal by Subject|3|||
148983659|NCT01485861|537417381|FG004|Phase II|Withdrawal by Subject|4|||
148983660|NCT01485861|537417382|FG005|Phase II|Withdrawal by Subject|0|||
148983661|NCT01485861|537417377|FG000|Phase II|Lost to Follow-up|0|||
148842541|NCT02257242|536905026|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842542|NCT02257242|536905027|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842543|NCT02257242|536905028|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842544|NCT02257242|536905029|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842545|NCT02257242|536905030|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
148842546|NCT00551031|536905034|FG000|Overall Study|Adverse Event|0|||
148842547|NCT00551031|536905035|FG001|Overall Study|Adverse Event|1|||
148842548|NCT00551031|536905036|FG002|Overall Study|Adverse Event|0|||
148842549|NCT00551031|536905037|FG003|Overall Study|Adverse Event|0|||
148842550|NCT00551031|536905038|FG004|Overall Study|Adverse Event|0|||
148842551|NCT00551031|536905034|FG000|Overall Study|Protocol Violation|1|||
148842552|NCT00551031|536905035|FG001|Overall Study|Protocol Violation|1|||
148842553|NCT00551031|536905036|FG002|Overall Study|Protocol Violation|0|||
148842554|NCT00551031|536905037|FG003|Overall Study|Protocol Violation|0|||
148842555|NCT00551031|536905038|FG004|Overall Study|Protocol Violation|0|||
148842556|NCT00551031|536905034|FG000|Overall Study|Lost to Follow-up|0|||
148842557|NCT00551031|536905035|FG001|Overall Study|Lost to Follow-up|1|||
148842558|NCT00551031|536905036|FG002|Overall Study|Lost to Follow-up|0|||
148842559|NCT00551031|536905037|FG003|Overall Study|Lost to Follow-up|1|||
148842560|NCT00551031|536905038|FG004|Overall Study|Lost to Follow-up|1|||
148842561|NCT00551031|536905034|FG000|Overall Study|Withdrawal by Subject|0|||
148842562|NCT00551031|536905035|FG001|Overall Study|Withdrawal by Subject|4|||
148842563|NCT00551031|536905036|FG002|Overall Study|Withdrawal by Subject|1|||
148842564|NCT00551031|536905037|FG003|Overall Study|Withdrawal by Subject|2|||
148842565|NCT00551031|536905038|FG004|Overall Study|Withdrawal by Subject|0|||
148842566|NCT00551031|536905034|FG000|Overall Study|Serious Adverse Event|0|||
148842567|NCT00551031|536905035|FG001|Overall Study|Serious Adverse Event|2|||
148842568|NCT00551031|536905036|FG002|Overall Study|Serious Adverse Event|1|||
148842569|NCT00551031|536905037|FG003|Overall Study|Serious Adverse Event|0|||
148842570|NCT00551031|536905038|FG004|Overall Study|Serious Adverse Event|0|||
148842571|NCT00551031|536905034|FG000|Overall Study|Did not receive vaccine|1|||
148842572|NCT00551031|536905035|FG001|Overall Study|Did not receive vaccine|2|||
148842573|NCT00551031|536905036|FG002|Overall Study|Did not receive vaccine|0|||
148842574|NCT00551031|536905037|FG003|Overall Study|Did not receive vaccine|0|||
148842575|NCT00551031|536905038|FG004|Overall Study|Did not receive vaccine|0|||
148842576|NCT02964273|536905040|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
148842577|NCT02964273|536905041|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
148842578|NCT02964273|536905042|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
148842579|NCT02964273|536905043|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
148842580|NCT02964273|536905040|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
148842581|NCT02964273|536905041|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
148842582|NCT02964273|536905042|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
148842583|NCT02964273|536905043|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
148842584|NCT02964273|536905040|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
148842585|NCT02964273|536905041|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
148842586|NCT02964273|536905042|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
148842587|NCT02964273|536905043|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
148842588|NCT02964273|536905040|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
148842589|NCT02964273|536905041|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
148842590|NCT02964273|536905042|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
148842591|NCT02964273|536905043|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
148842592|NCT02964273|536905040|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
148842593|NCT02964273|536905041|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
148842594|NCT02964273|536905042|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
148842595|NCT02964273|536905043|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
148842596|NCT02964273|536905040|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
148842597|NCT02964273|536905041|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
148842598|NCT02964273|536905042|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
148842599|NCT02964273|536905043|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
148842600|NCT00841776|536905045|FG000|Overall Study|Lack of Efficacy|0|||
148842601|NCT00841776|536905046|FG001|Overall Study|Lack of Efficacy|1|||
148842602|NCT00841776|536905045|FG000|Overall Study|Lost to Follow-up|2|||
148842603|NCT00841776|536905046|FG001|Overall Study|Lost to Follow-up|1|||
148983662|NCT01485861|537417378|FG001|Phase II|Lost to Follow-up|0|||
148983663|NCT01485861|537417379|FG002|Phase II|Lost to Follow-up|2|||
148983664|NCT01485861|537417380|FG003|Phase II|Lost to Follow-up|3|||
148983665|NCT01485861|537417381|FG004|Phase II|Lost to Follow-up|5|||
148983666|NCT01485861|537417382|FG005|Phase II|Lost to Follow-up|0|||
148983667|NCT01485861|537417377|FG000|Phase II|Study Ended|0|||
148842604|NCT00841776|536905045|FG000|Overall Study|Withdrawal by Subject|0|||
148842605|NCT00841776|536905046|FG001|Overall Study|Withdrawal by Subject|1|||
148842606|NCT04245449|536905047|FG000|Overall Study|COVID shutdown|7|||
148842607|NCT01976299|536905048|FG000|Overall Study|Withdrawal by Subject|3|||
148842608|NCT01976299|536905049|FG001|Overall Study|Withdrawal by Subject|1|||
148842609|NCT01976299|536905048|FG000|Overall Study|Death|4|||
148842610|NCT01976299|536905049|FG001|Overall Study|Death|2|||
148842611|NCT01976299|536905048|FG000|Overall Study|Lost to Follow-up|7|||
148842612|NCT01976299|536905049|FG001|Overall Study|Lost to Follow-up|1|||
148842613|NCT01976299|536905048|FG000|Overall Study|See clarification above in comments|9|||
148842614|NCT01976299|536905049|FG001|Overall Study|See clarification above in comments|2|||
148842615|NCT03692403|536905050|FG000|Overall Study|Withdrawal by Subject|1|||
148842616|NCT03692403|536905051|FG001|Overall Study|Withdrawal by Subject|0|||
148842617|NCT03692403|536905052|FG002|Overall Study|Withdrawal by Subject|1|||
148842618|NCT03692403|536905053|FG003|Overall Study|Withdrawal by Subject|0|||
148842619|NCT03692403|536905050|FG000|Overall Study|Adverse Event|0|||
148842620|NCT03692403|536905051|FG001|Overall Study|Adverse Event|0|||
148842621|NCT03692403|536905052|FG002|Overall Study|Adverse Event|0|||
148842622|NCT03692403|536905053|FG003|Overall Study|Adverse Event|1|||
148842623|NCT03692403|536905050|FG000|Overall Study|Pregnancy|0|||
148842624|NCT03692403|536905051|FG001|Overall Study|Pregnancy|1|||
148842625|NCT03692403|536905052|FG002|Overall Study|Pregnancy|0|||
148842626|NCT03692403|536905053|FG003|Overall Study|Pregnancy|0|||
148842627|NCT03692403|536905050|FG000|Overall Study|Other|0|||
148842628|NCT03692403|536905051|FG001|Overall Study|Other|0|||
148842629|NCT03692403|536905052|FG002|Overall Study|Other|1|||
148842630|NCT03692403|536905053|FG003|Overall Study|Other|0|||
148842631|NCT02848092|536905055|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
148842632|NCT02848092|536905056|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
148842633|NCT02848092|536905055|FG000|1-month Post-training Follow-up|Adverse Event|2|||
148842634|NCT02848092|536905056|FG001|1-month Post-training Follow-up|Adverse Event|1|||
148842635|NCT02848092|536905055|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
148842636|NCT02848092|536905056|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
148842637|NCT02848092|536905055|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
148842638|NCT02848092|536905056|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
148842639|NCT02848092|536905055|FG000|1-month Post-training Follow-up|fatigue|0|||
148842640|NCT02848092|536905056|FG001|1-month Post-training Follow-up|fatigue|1|||
148842641|NCT02848092|536905055|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
148842642|NCT02848092|536905056|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
148842643|NCT02848092|536905055|FG000|6-month Post-training Follow-up|Adverse Event|1|||
148842644|NCT02848092|536905056|FG001|6-month Post-training Follow-up|Adverse Event|1|||
148842645|NCT02848092|536905055|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
148842646|NCT02848092|536905056|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
148842647|NCT02848092|536905055|FG000|6-month Post-training Follow-up|frustrated with task|1|||
148842648|NCT02848092|536905056|FG001|6-month Post-training Follow-up|frustrated with task|0|||
148842649|NCT02848092|536905055|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
148842650|NCT02848092|536905056|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
148842651|NCT02848092|536905055|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
148842652|NCT02848092|536905056|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
148842653|NCT01349673|536905071|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
148842654|NCT01349673|536905071|FG000|Overall Study|No Longer Qualified For Study|1|||
148842655|NCT01349673|536905071|FG000|Overall Study|Site Closure|10|||
148842656|NCT01349673|536905071|FG000|Overall Study|Withdrawal by Subject|21|||
148842657|NCT01349673|536905071|FG000|Overall Study|Lost to Follow-up|6|||
148842658|NCT01349673|536905071|FG000|Overall Study|Adverse Event|17|||
148842659|NCT01349673|536905071|FG000|Overall Study|Study Terminated By Sponsor|50|||
148842660|NCT01349673|536905071|FG000|Overall Study|Lack of Efficacy|8|||
148842661|NCT01665911|536905074|FG000|Overall Study|Protocol Violation|4|||
148842662|NCT01665911|536905074|FG000|Overall Study|Withdrawal by Subject|1|||
148842663|NCT01665911|536905074|FG000|Overall Study|Adverse Event|1|||
148842664|NCT03688919|536905075|FG000|Overall Study|Lost to Follow-up|2|||
148842665|NCT03688919|536905076|FG001|Overall Study|Lost to Follow-up|1|||
148842666|NCT03688919|536905075|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
148842667|NCT03688919|536905076|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
148842668|NCT01724216|536905077|FG000|Overall Study|Scan was not completed|1|||
148842669|NCT01484496|536905082|FG000|Period 1|Protocol Violation|3|||
148842670|NCT01484496|536905083|FG001|Period 1|Protocol Violation|4|||
148842671|NCT01484496|536905084|FG002|Period 1|Protocol Violation|0|||
148842672|NCT01484496|536905085|FG003|Period 1|Protocol Violation|0|||
148842673|NCT01484496|536905082|FG000|Period 1|Physician Decision|5|||
148842674|NCT01484496|536905083|FG001|Period 1|Physician Decision|1|||
148842675|NCT01484496|536905084|FG002|Period 1|Physician Decision|0|||
148842676|NCT01484496|536905085|FG003|Period 1|Physician Decision|0|||
148842677|NCT01484496|536905082|FG000|Period 1|Lack of Efficacy|10|||
148842678|NCT01484496|536905083|FG001|Period 1|Lack of Efficacy|15|||
148983668|NCT01485861|537417378|FG001|Phase II|Study Ended|0|||
148983669|NCT01485861|537417379|FG002|Phase II|Study Ended|7|||
148983670|NCT01485861|537417380|FG003|Phase II|Study Ended|8|||
148983671|NCT01485861|537417381|FG004|Phase II|Study Ended|6|||
148983672|NCT01485861|537417382|FG005|Phase II|Study Ended|0|||
148983673|NCT01485861|537417377|FG000|Safety Phase|Death|0|||
148983674|NCT01485861|537417378|FG001|Safety Phase|Death|0|||
148983675|NCT01485861|537417379|FG002|Safety Phase|Death|0|||
148983676|NCT01485861|537417380|FG003|Safety Phase|Death|0|||
148983677|NCT01485861|537417381|FG004|Safety Phase|Death|0|||
148983678|NCT01485861|537417382|FG005|Safety Phase|Death|2|||
148983679|NCT01485861|537417377|FG000|Safety Phase|Adverse Event|0|||
148983680|NCT01485861|537417378|FG001|Safety Phase|Adverse Event|0|||
148983681|NCT01485861|537417379|FG002|Safety Phase|Adverse Event|0|||
148983682|NCT01485861|537417380|FG003|Safety Phase|Adverse Event|0|||
148983683|NCT01485861|537417381|FG004|Safety Phase|Adverse Event|0|||
148983684|NCT01485861|537417382|FG005|Safety Phase|Adverse Event|1|||
148983685|NCT01485861|537417377|FG000|Safety Phase|Other|0|||
148983686|NCT01485861|537417378|FG001|Safety Phase|Other|0|||
148983687|NCT01485861|537417379|FG002|Safety Phase|Other|0|||
148983688|NCT01485861|537417380|FG003|Safety Phase|Other|0|||
148983689|NCT01485861|537417381|FG004|Safety Phase|Other|0|||
148983690|NCT01485861|537417382|FG005|Safety Phase|Other|5|||
148983691|NCT01485861|537417377|FG000|Safety Phase|Progression of Disease|0|||
148983692|NCT01485861|537417378|FG001|Safety Phase|Progression of Disease|0|||
148983693|NCT01485861|537417379|FG002|Safety Phase|Progression of Disease|0|||
148983694|NCT01485861|537417380|FG003|Safety Phase|Progression of Disease|0|||
148983695|NCT01485861|537417381|FG004|Safety Phase|Progression of Disease|0|||
148983696|NCT01485861|537417382|FG005|Safety Phase|Progression of Disease|9|||
148983697|NCT01485861|537417377|FG000|Safety Phase|Withdrawal by Subject|0|||
148983698|NCT01485861|537417378|FG001|Safety Phase|Withdrawal by Subject|0|||
148983699|NCT01485861|537417379|FG002|Safety Phase|Withdrawal by Subject|0|||
148983700|NCT01485861|537417380|FG003|Safety Phase|Withdrawal by Subject|0|||
148983701|NCT01485861|537417381|FG004|Safety Phase|Withdrawal by Subject|0|||
148983702|NCT01485861|537417382|FG005|Safety Phase|Withdrawal by Subject|6|||
148983703|NCT01485861|537417377|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
148983704|NCT01485861|537417378|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
148983705|NCT01485861|537417379|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
148983706|NCT01485861|537417380|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
148983707|NCT01485861|537417381|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
148983708|NCT01485861|537417382|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
148983709|NCT02266381|537417385|FG000|Overall Study|Physician Decision|3|||
148983710|NCT02266381|537417386|FG001|Overall Study|Physician Decision|5|||
148983711|NCT02266381|537417387|FG002|Overall Study|Physician Decision|4|||
148983712|NCT02401672|537417388|FG000|Overall Study|Withdrawal by Subject|1|||
148983713|NCT02401672|537417389|FG001|Overall Study|Withdrawal by Subject|3|||
148983714|NCT04796610|537417390|FG000|Overall Study|Withdrawal by Subject|1|||
148983715|NCT04796610|537417391|FG001|Overall Study|Withdrawal by Subject|0|||
148983716|NCT04796610|537417392|FG002|Overall Study|Withdrawal by Subject|0|||
148983717|NCT04796610|537417393|FG003|Overall Study|Withdrawal by Subject|0|||
148983718|NCT04796610|537417390|FG000|Overall Study|Lost to Follow-up|2|||
148983719|NCT04796610|537417391|FG001|Overall Study|Lost to Follow-up|0|||
148983720|NCT04796610|537417392|FG002|Overall Study|Lost to Follow-up|1|||
148774636|NCT01473394|536648632|FG001|Overall Study|Insufficient Therapeutic Response|1|||
148774637|NCT01473394|536648631|FG000|Overall Study|Protocol Violation|7|||
148774638|NCT01473394|536648632|FG001|Overall Study|Protocol Violation|5|||
148774639|NCT01473394|536648631|FG000|Overall Study|Withdrew Consent|12|||
148774640|NCT01473394|536648632|FG001|Overall Study|Withdrew Consent|10|||
148774641|NCT01473394|536648631|FG000|Overall Study|Lost to Follow-up|9|||
148774642|NCT01473394|536648632|FG001|Overall Study|Lost to Follow-up|11|||
148774643|NCT00552032|536648633|FG000|Overall Study|Withdrawal by Subject|2|||
148774644|NCT00552032|536648634|FG001|Overall Study|Withdrawal by Subject|2|||
148774645|NCT00552032|536648633|FG000|Overall Study|Protocol Violation|7|||
148774646|NCT00552032|536648634|FG001|Overall Study|Protocol Violation|12|||
148774647|NCT00552032|536648633|FG000|Overall Study|Lost to Follow-up|8|||
148774648|NCT00552032|536648634|FG001|Overall Study|Lost to Follow-up|5|||
148774649|NCT03391232|536648635|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
148774650|NCT03391232|536648636|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
148774651|NCT03391232|536648635|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
148774652|NCT03391232|536648636|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
148774653|NCT02091960|536648637|FG000|Overall Study|Death|7|||
148774654|NCT02091960|536648637|FG000|Overall Study|Withdrawal by Subject|1|||
148774655|NCT02091960|536648637|FG000|Overall Study|Miscellaneous Reasons|37|||
148774656|NCT02691013|536648638|FG000|Overall Study|Withdrawal by Subject|3|||
148983721|NCT04796610|537417393|FG003|Overall Study|Lost to Follow-up|1|||
148983722|NCT01459796|537417394|FG000|Overall Study|Non compliance with protocol|2|||
148983723|NCT01459796|537417395|FG001|Overall Study|Non compliance with protocol|4|||
148983724|NCT01459796|537417394|FG000|Overall Study|Adverse Event|5|||
148842679|NCT01484496|536905084|FG002|Period 1|Lack of Efficacy|0|||
148842680|NCT01484496|536905085|FG003|Period 1|Lack of Efficacy|0|||
148842681|NCT01484496|536905082|FG000|Period 1|Adverse Event|25|||
148842682|NCT01484496|536905083|FG001|Period 1|Adverse Event|40|||
148842683|NCT01484496|536905084|FG002|Period 1|Adverse Event|0|||
148842684|NCT01484496|536905085|FG003|Period 1|Adverse Event|0|||
148842685|NCT01484496|536905082|FG000|Period 1|Withdrawal by Subject|15|||
148842686|NCT01484496|536905083|FG001|Period 1|Withdrawal by Subject|12|||
148842687|NCT01484496|536905084|FG002|Period 1|Withdrawal by Subject|0|||
148842688|NCT01484496|536905085|FG003|Period 1|Withdrawal by Subject|0|||
148842689|NCT01484496|536905082|FG000|Period 1|Lost to Follow-up|2|||
148842690|NCT01484496|536905083|FG001|Period 1|Lost to Follow-up|6|||
148842691|NCT01484496|536905084|FG002|Period 1|Lost to Follow-up|0|||
148842692|NCT01484496|536905085|FG003|Period 1|Lost to Follow-up|0|||
148842693|NCT01484496|536905082|FG000|Period 1|Positive Pregnancy|1|||
148842694|NCT01484496|536905083|FG001|Period 1|Positive Pregnancy|6|||
148842695|NCT01484496|536905084|FG002|Period 1|Positive Pregnancy|0|||
148842696|NCT01484496|536905085|FG003|Period 1|Positive Pregnancy|0|||
148842697|NCT01484496|536905082|FG000|Period 1|Treatment Failure|3|||
148842698|NCT01484496|536905083|FG001|Period 1|Treatment Failure|6|||
148842699|NCT01484496|536905084|FG002|Period 1|Treatment Failure|0|||
148842700|NCT01484496|536905085|FG003|Period 1|Treatment Failure|0|||
148842701|NCT01484496|536905082|FG000|Period 1|Lack of Compliance|2|||
148842702|NCT01484496|536905083|FG001|Period 1|Lack of Compliance|1|||
148842703|NCT01484496|536905084|FG002|Period 1|Lack of Compliance|0|||
148842704|NCT01484496|536905085|FG003|Period 1|Lack of Compliance|0|||
148842705|NCT01484496|536905082|FG000|Period 1|Unable to Visit Site|0|||
148842706|NCT01484496|536905083|FG001|Period 1|Unable to Visit Site|2|||
148842707|NCT01484496|536905084|FG002|Period 1|Unable to Visit Site|0|||
148842708|NCT01484496|536905085|FG003|Period 1|Unable to Visit Site|0|||
148842709|NCT01484496|536905082|FG000|Period 2|Lack of Efficacy|0|||
148842710|NCT01484496|536905083|FG001|Period 2|Lack of Efficacy|0|||
148842711|NCT01484496|536905084|FG002|Period 2|Lack of Efficacy|1|||
148842712|NCT01484496|536905085|FG003|Period 2|Lack of Efficacy|3|||
148842713|NCT01484496|536905082|FG000|Period 2|Adverse Event|0|||
148842714|NCT01484496|536905083|FG001|Period 2|Adverse Event|0|||
148842715|NCT01484496|536905084|FG002|Period 2|Adverse Event|5|||
148842716|NCT01484496|536905085|FG003|Period 2|Adverse Event|13|||
148842717|NCT01484496|536905082|FG000|Period 2|Other|0|||
148842718|NCT01484496|536905083|FG001|Period 2|Other|0|||
148842719|NCT01484496|536905084|FG002|Period 2|Other|9|||
148842720|NCT01484496|536905085|FG003|Period 2|Other|6|||
148842721|NCT00506779|536905086|FG000|Overall Study|Withdrawal by Subject|1|||
148842722|NCT00506779|536905087|FG001|Overall Study|Withdrawal by Subject|0|||
148842723|NCT00506779|536905088|FG002|Overall Study|Withdrawal by Subject|1|||
148842724|NCT00506779|536905089|FG003|Overall Study|Withdrawal by Subject|0|||
148842725|NCT00506779|536905086|FG000|Overall Study|Adverse Event|0|||
148842726|NCT00506779|536905087|FG001|Overall Study|Adverse Event|1|||
148842727|NCT00506779|536905088|FG002|Overall Study|Adverse Event|1|||
148842728|NCT00506779|536905089|FG003|Overall Study|Adverse Event|1|||
148842729|NCT01645735|536905090|FG000|Overall Study|Physician Decision|2|||
148842730|NCT01645735|536905091|FG001|Overall Study|Physician Decision|0|||
148842731|NCT01645735|536905090|FG000|Overall Study|Withdrawal by Subject|1|||
148842732|NCT01645735|536905091|FG001|Overall Study|Withdrawal by Subject|0|||
148842733|NCT01645735|536905090|FG000|Overall Study|Protocol Violation|1|||
148842734|NCT01645735|536905091|FG001|Overall Study|Protocol Violation|0|||
148842735|NCT01645735|536905090|FG000|Overall Study|Adverse Event|0|||
148842736|NCT01645735|536905091|FG001|Overall Study|Adverse Event|1|||
148842737|NCT01456130|536905092|FG000|Overall Study|Adverse Event|4|||
148842738|NCT01456130|536905092|FG000|Overall Study|Voluntary Withdrawal|1|||
148842739|NCT01456130|536905092|FG000|Overall Study|Lack of Efficacy|4|||
148842740|NCT01456130|536905092|FG000|Overall Study|Other|1|||
148842741|NCT01791517|536905095|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
148842742|NCT01791517|536905096|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
148842743|NCT01791517|536905097|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
148842744|NCT01791517|536905098|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
148842745|NCT01791517|536905099|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
148842746|NCT01791517|536905100|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
148842747|NCT01791517|536905101|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
148842748|NCT01791517|536905102|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
148842749|NCT01791517|536905103|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
148842750|NCT01791517|536905104|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
148842751|NCT01791517|536905105|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
148842752|NCT01791517|536905106|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
148842753|NCT01791517|536905095|FG000|Phase I: Period 1|Adverse Event|0|||
148842754|NCT01791517|536905096|FG001|Phase I: Period 1|Adverse Event|0|||
148842755|NCT01791517|536905097|FG002|Phase I: Period 1|Adverse Event|1|||
148842756|NCT01791517|536905098|FG003|Phase I: Period 1|Adverse Event|1|||
148842757|NCT01791517|536905099|FG004|Phase I: Period 1|Adverse Event|0|||
148842758|NCT01791517|536905100|FG005|Phase I: Period 1|Adverse Event|0|||
148842759|NCT01791517|536905101|FG006|Phase I: Period 1|Adverse Event|0|||
148842760|NCT01791517|536905102|FG007|Phase I: Period 1|Adverse Event|0|||
148842761|NCT01791517|536905103|FG008|Phase I: Period 1|Adverse Event|0|||
148842762|NCT01791517|536905104|FG009|Phase I: Period 1|Adverse Event|0|||
148842763|NCT01791517|536905105|FG010|Phase I: Period 1|Adverse Event|0|||
148842764|NCT01791517|536905106|FG011|Phase I: Period 1|Adverse Event|0|||
148842765|NCT01791517|536905095|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
148842766|NCT01791517|536905096|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842767|NCT01791517|536905097|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842768|NCT01791517|536905098|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842769|NCT01791517|536905099|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842770|NCT01791517|536905100|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842771|NCT01791517|536905101|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842772|NCT01791517|536905102|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842773|NCT01791517|536905103|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842774|NCT01791517|536905104|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842775|NCT01791517|536905105|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842776|NCT01791517|536905106|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
148842777|NCT01791517|536905095|FG000|Phase I: Period 1|Protocol Violation|0|||
148842778|NCT01791517|536905096|FG001|Phase I: Period 1|Protocol Violation|1|||
148842779|NCT01791517|536905097|FG002|Phase I: Period 1|Protocol Violation|0|||
148842780|NCT01791517|536905098|FG003|Phase I: Period 1|Protocol Violation|0|||
148842781|NCT01791517|536905099|FG004|Phase I: Period 1|Protocol Violation|0|||
148842782|NCT01791517|536905100|FG005|Phase I: Period 1|Protocol Violation|0|||
148842783|NCT01791517|536905101|FG006|Phase I: Period 1|Protocol Violation|0|||
148842784|NCT01791517|536905102|FG007|Phase I: Period 1|Protocol Violation|0|||
148842785|NCT01791517|536905103|FG008|Phase I: Period 1|Protocol Violation|0|||
148842786|NCT01791517|536905104|FG009|Phase I: Period 1|Protocol Violation|0|||
148842787|NCT01791517|536905105|FG010|Phase I: Period 1|Protocol Violation|0|||
148842788|NCT01791517|536905106|FG011|Phase I: Period 1|Protocol Violation|0|||
148842789|NCT01791517|536905095|FG000|Phase I: Period 1|Lost to Follow-up|0|||
148842790|NCT01791517|536905096|FG001|Phase I: Period 1|Lost to Follow-up|0|||
148842791|NCT01791517|536905097|FG002|Phase I: Period 1|Lost to Follow-up|0|||
148842792|NCT01791517|536905098|FG003|Phase I: Period 1|Lost to Follow-up|1|||
148842793|NCT01791517|536905099|FG004|Phase I: Period 1|Lost to Follow-up|0|||
148842794|NCT01791517|536905100|FG005|Phase I: Period 1|Lost to Follow-up|0|||
148842795|NCT01791517|536905101|FG006|Phase I: Period 1|Lost to Follow-up|1|||
148842796|NCT01791517|536905102|FG007|Phase I: Period 1|Lost to Follow-up|0|||
148842797|NCT01791517|536905103|FG008|Phase I: Period 1|Lost to Follow-up|1|||
148842798|NCT01791517|536905104|FG009|Phase I: Period 1|Lost to Follow-up|1|||
148842799|NCT01791517|536905105|FG010|Phase I: Period 1|Lost to Follow-up|0|||
148842800|NCT01791517|536905106|FG011|Phase I: Period 1|Lost to Follow-up|0|||
148842801|NCT01791517|536905095|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842802|NCT01791517|536905096|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842803|NCT01791517|536905097|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842804|NCT01791517|536905098|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842805|NCT01791517|536905099|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842806|NCT01791517|536905100|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842807|NCT01791517|536905101|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842808|NCT01791517|536905102|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842809|NCT01791517|536905103|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842810|NCT01791517|536905104|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842811|NCT01791517|536905105|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
148842812|NCT01791517|536905106|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
148842813|NCT01791517|536905095|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
148842814|NCT01791517|536905096|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842815|NCT01791517|536905097|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842816|NCT01791517|536905098|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842817|NCT01791517|536905099|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842818|NCT01791517|536905100|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842819|NCT01791517|536905101|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842820|NCT01791517|536905102|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842821|NCT01791517|536905103|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842822|NCT01791517|536905104|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842823|NCT01791517|536905105|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842824|NCT01791517|536905106|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
148842825|NCT01791517|536905095|FG000|Phase I: Period 2|Protocol Violation|0|||
148842826|NCT01791517|536905096|FG001|Phase I: Period 2|Protocol Violation|0|||
148842827|NCT01791517|536905097|FG002|Phase I: Period 2|Protocol Violation|0|||
148842828|NCT01791517|536905098|FG003|Phase I: Period 2|Protocol Violation|1|||
148842829|NCT01791517|536905099|FG004|Phase I: Period 2|Protocol Violation|0|||
148842830|NCT01791517|536905100|FG005|Phase I: Period 2|Protocol Violation|0|||
148842831|NCT01791517|536905101|FG006|Phase I: Period 2|Protocol Violation|0|||
148842832|NCT01791517|536905102|FG007|Phase I: Period 2|Protocol Violation|0|||
148842833|NCT01791517|536905103|FG008|Phase I: Period 2|Protocol Violation|0|||
148842834|NCT01791517|536905104|FG009|Phase I: Period 2|Protocol Violation|0|||
148842835|NCT01791517|536905105|FG010|Phase I: Period 2|Protocol Violation|0|||
148842836|NCT01791517|536905106|FG011|Phase I: Period 2|Protocol Violation|0|||
148842837|NCT01791517|536905095|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
148842838|NCT01791517|536905096|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
148842839|NCT01791517|536905097|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
148842840|NCT01791517|536905098|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
148842841|NCT01791517|536905099|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
148842842|NCT01791517|536905100|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
148842843|NCT01791517|536905101|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
148842844|NCT01791517|536905102|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
148842845|NCT01791517|536905103|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
148842846|NCT01791517|536905104|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
148842847|NCT01791517|536905105|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
148842848|NCT01791517|536905106|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
148842849|NCT01791517|536905095|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842850|NCT01791517|536905096|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842851|NCT01791517|536905097|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842852|NCT01791517|536905098|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842853|NCT01791517|536905099|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842854|NCT01791517|536905100|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842855|NCT01791517|536905101|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842856|NCT01791517|536905102|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842857|NCT01791517|536905103|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842858|NCT01791517|536905104|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842859|NCT01791517|536905105|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
148842860|NCT01791517|536905106|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
148842861|NCT01791517|536905095|FG000|Phase I: Period 2|Lens Discomfort|0|||
148842862|NCT01791517|536905096|FG001|Phase I: Period 2|Lens Discomfort|0|||
148842863|NCT01791517|536905097|FG002|Phase I: Period 2|Lens Discomfort|0|||
148842864|NCT01791517|536905098|FG003|Phase I: Period 2|Lens Discomfort|0|||
148842865|NCT01791517|536905099|FG004|Phase I: Period 2|Lens Discomfort|0|||
148842866|NCT01791517|536905100|FG005|Phase I: Period 2|Lens Discomfort|1|||
148842867|NCT01791517|536905101|FG006|Phase I: Period 2|Lens Discomfort|0|||
148842868|NCT01791517|536905102|FG007|Phase I: Period 2|Lens Discomfort|0|||
148842869|NCT01791517|536905103|FG008|Phase I: Period 2|Lens Discomfort|0|||
148842870|NCT01791517|536905104|FG009|Phase I: Period 2|Lens Discomfort|0|||
148842871|NCT01791517|536905105|FG010|Phase I: Period 2|Lens Discomfort|0|||
148842872|NCT01791517|536905106|FG011|Phase I: Period 2|Lens Discomfort|0|||
148842873|NCT01791517|536905095|FG000|Phase I: Period 2|Lost to Follow-up|0|||
148842874|NCT01791517|536905096|FG001|Phase I: Period 2|Lost to Follow-up|3|||
148842875|NCT01791517|536905097|FG002|Phase I: Period 2|Lost to Follow-up|2|||
148842876|NCT01791517|536905098|FG003|Phase I: Period 2|Lost to Follow-up|0|||
148842877|NCT01791517|536905099|FG004|Phase I: Period 2|Lost to Follow-up|0|||
148842878|NCT01791517|536905100|FG005|Phase I: Period 2|Lost to Follow-up|0|||
148842879|NCT01791517|536905101|FG006|Phase I: Period 2|Lost to Follow-up|0|||
148842880|NCT01791517|536905102|FG007|Phase I: Period 2|Lost to Follow-up|0|||
148842881|NCT01791517|536905103|FG008|Phase I: Period 2|Lost to Follow-up|0|||
148842882|NCT01791517|536905104|FG009|Phase I: Period 2|Lost to Follow-up|0|||
148842883|NCT01791517|536905105|FG010|Phase I: Period 2|Lost to Follow-up|0|||
148842884|NCT01791517|536905106|FG011|Phase I: Period 2|Lost to Follow-up|0|||
148842885|NCT01791517|536905095|FG000|Phase I: Period 3|Lens Discomfort|0|||
148842886|NCT01791517|536905096|FG001|Phase I: Period 3|Lens Discomfort|0|||
148983725|NCT01459796|537417395|FG001|Overall Study|Adverse Event|5|||
148983726|NCT01459796|537417394|FG000|Overall Study|Withdrawal by Subject|6|||
148983727|NCT01459796|537417395|FG001|Overall Study|Withdrawal by Subject|3|||
148983728|NCT01459796|537417394|FG000|Overall Study|Lost to Follow-up|5|||
148983729|NCT01459796|537417395|FG001|Overall Study|Lost to Follow-up|4|||
148983730|NCT01459796|537417394|FG000|Overall Study|Reason unspecified|1|||
148842887|NCT01791517|536905097|FG002|Phase I: Period 3|Lens Discomfort|0|||
148842888|NCT01791517|536905098|FG003|Phase I: Period 3|Lens Discomfort|0|||
148842889|NCT01791517|536905099|FG004|Phase I: Period 3|Lens Discomfort|0|||
148842890|NCT01791517|536905100|FG005|Phase I: Period 3|Lens Discomfort|0|||
148842891|NCT01791517|536905101|FG006|Phase I: Period 3|Lens Discomfort|0|||
148842892|NCT01791517|536905102|FG007|Phase I: Period 3|Lens Discomfort|0|||
148842893|NCT01791517|536905103|FG008|Phase I: Period 3|Lens Discomfort|0|||
148842894|NCT01791517|536905104|FG009|Phase I: Period 3|Lens Discomfort|0|||
148842895|NCT01791517|536905105|FG010|Phase I: Period 3|Lens Discomfort|0|||
148842896|NCT01791517|536905106|FG011|Phase I: Period 3|Lens Discomfort|1|||
148842897|NCT01791517|536905095|FG000|Phase I: Period 3|Lost to Follow-up|0|||
148842898|NCT01791517|536905096|FG001|Phase I: Period 3|Lost to Follow-up|1|||
148842899|NCT01791517|536905097|FG002|Phase I: Period 3|Lost to Follow-up|0|||
148842900|NCT01791517|536905098|FG003|Phase I: Period 3|Lost to Follow-up|0|||
148842901|NCT01791517|536905099|FG004|Phase I: Period 3|Lost to Follow-up|1|||
148842902|NCT01791517|536905100|FG005|Phase I: Period 3|Lost to Follow-up|0|||
148842903|NCT01791517|536905101|FG006|Phase I: Period 3|Lost to Follow-up|0|||
148842904|NCT01791517|536905102|FG007|Phase I: Period 3|Lost to Follow-up|0|||
148842905|NCT01791517|536905103|FG008|Phase I: Period 3|Lost to Follow-up|0|||
148842906|NCT01791517|536905104|FG009|Phase I: Period 3|Lost to Follow-up|0|||
148842907|NCT01791517|536905105|FG010|Phase I: Period 3|Lost to Follow-up|0|||
148842908|NCT01791517|536905106|FG011|Phase I: Period 3|Lost to Follow-up|0|||
148842909|NCT01791517|536905095|FG000|Phase I: Period 3|Adverse Event|0|||
148842910|NCT01791517|536905096|FG001|Phase I: Period 3|Adverse Event|0|||
148842911|NCT01791517|536905097|FG002|Phase I: Period 3|Adverse Event|0|||
148842912|NCT01791517|536905098|FG003|Phase I: Period 3|Adverse Event|1|||
148842913|NCT01791517|536905099|FG004|Phase I: Period 3|Adverse Event|0|||
148842914|NCT01791517|536905100|FG005|Phase I: Period 3|Adverse Event|0|||
148842915|NCT01791517|536905101|FG006|Phase I: Period 3|Adverse Event|0|||
148842916|NCT01791517|536905102|FG007|Phase I: Period 3|Adverse Event|0|||
148842917|NCT01791517|536905103|FG008|Phase I: Period 3|Adverse Event|0|||
148842918|NCT01791517|536905104|FG009|Phase I: Period 3|Adverse Event|0|||
148842919|NCT01791517|536905105|FG010|Phase I: Period 3|Adverse Event|0|||
148842920|NCT01791517|536905106|FG011|Phase I: Period 3|Adverse Event|0|||
148842921|NCT01791517|536905095|FG000|Phase II|Lost to Follow-up|1|||
148842922|NCT01791517|536905096|FG001|Phase II|Lost to Follow-up|0|||
148842923|NCT01791517|536905097|FG002|Phase II|Lost to Follow-up|1|||
148842924|NCT01791517|536905098|FG003|Phase II|Lost to Follow-up|0|||
148842925|NCT01791517|536905099|FG004|Phase II|Lost to Follow-up|1|||
148842926|NCT01791517|536905100|FG005|Phase II|Lost to Follow-up|2|||
148842927|NCT01791517|536905101|FG006|Phase II|Lost to Follow-up|0|||
148842928|NCT01791517|536905102|FG007|Phase II|Lost to Follow-up|1|||
148842929|NCT01791517|536905103|FG008|Phase II|Lost to Follow-up|1|||
148842930|NCT01791517|536905104|FG009|Phase II|Lost to Follow-up|1|||
148842931|NCT01791517|536905105|FG010|Phase II|Lost to Follow-up|0|||
148842932|NCT01791517|536905106|FG011|Phase II|Lost to Follow-up|0|||
148842933|NCT01791517|536905095|FG000|Phase II|Withdrawal by Subject|1|||
148842934|NCT01791517|536905096|FG001|Phase II|Withdrawal by Subject|0|||
148842935|NCT01791517|536905097|FG002|Phase II|Withdrawal by Subject|0|||
148842936|NCT01791517|536905098|FG003|Phase II|Withdrawal by Subject|0|||
148842937|NCT01791517|536905099|FG004|Phase II|Withdrawal by Subject|0|||
148842938|NCT01791517|536905100|FG005|Phase II|Withdrawal by Subject|2|||
148842939|NCT01791517|536905101|FG006|Phase II|Withdrawal by Subject|0|||
148842940|NCT01791517|536905102|FG007|Phase II|Withdrawal by Subject|1|||
148842941|NCT01791517|536905103|FG008|Phase II|Withdrawal by Subject|0|||
148842942|NCT01791517|536905104|FG009|Phase II|Withdrawal by Subject|0|||
148842943|NCT01791517|536905105|FG010|Phase II|Withdrawal by Subject|1|||
148842944|NCT01791517|536905106|FG011|Phase II|Withdrawal by Subject|0|||
148842945|NCT01791517|536905095|FG000|Phase II|Lack of Efficacy|0|||
148842946|NCT01791517|536905096|FG001|Phase II|Lack of Efficacy|0|||
148842947|NCT01791517|536905097|FG002|Phase II|Lack of Efficacy|0|||
148842948|NCT01791517|536905098|FG003|Phase II|Lack of Efficacy|0|||
148842949|NCT01791517|536905099|FG004|Phase II|Lack of Efficacy|1|||
148842950|NCT01791517|536905100|FG005|Phase II|Lack of Efficacy|0|||
148842951|NCT01791517|536905101|FG006|Phase II|Lack of Efficacy|0|||
148842952|NCT01791517|536905102|FG007|Phase II|Lack of Efficacy|0|||
148842953|NCT01791517|536905103|FG008|Phase II|Lack of Efficacy|0|||
148842954|NCT01791517|536905104|FG009|Phase II|Lack of Efficacy|0|||
148842955|NCT01791517|536905105|FG010|Phase II|Lack of Efficacy|0|||
148842956|NCT01791517|536905106|FG011|Phase II|Lack of Efficacy|0|||
148842957|NCT01791517|536905095|FG000|Phase II|Adverse Event|0|||
148842958|NCT01791517|536905096|FG001|Phase II|Adverse Event|0|||
148842959|NCT01791517|536905097|FG002|Phase II|Adverse Event|0|||
148842960|NCT01791517|536905098|FG003|Phase II|Adverse Event|0|||
148842961|NCT01791517|536905099|FG004|Phase II|Adverse Event|0|||
148842962|NCT01791517|536905100|FG005|Phase II|Adverse Event|0|||
148842963|NCT01791517|536905101|FG006|Phase II|Adverse Event|2|||
148842964|NCT01791517|536905102|FG007|Phase II|Adverse Event|1|||
148842965|NCT01791517|536905103|FG008|Phase II|Adverse Event|0|||
148842966|NCT01791517|536905104|FG009|Phase II|Adverse Event|1|||
148842967|NCT01791517|536905105|FG010|Phase II|Adverse Event|0|||
148842968|NCT01791517|536905106|FG011|Phase II|Adverse Event|0|||
148842969|NCT01791517|536905095|FG000|Phase II|Lens Handling Difficulties|0|||
148842970|NCT01791517|536905096|FG001|Phase II|Lens Handling Difficulties|0|||
148842971|NCT01791517|536905097|FG002|Phase II|Lens Handling Difficulties|0|||
148842972|NCT01791517|536905098|FG003|Phase II|Lens Handling Difficulties|0|||
148842973|NCT01791517|536905099|FG004|Phase II|Lens Handling Difficulties|0|||
148842974|NCT01791517|536905100|FG005|Phase II|Lens Handling Difficulties|0|||
148842975|NCT01791517|536905101|FG006|Phase II|Lens Handling Difficulties|0|||
148842976|NCT01791517|536905102|FG007|Phase II|Lens Handling Difficulties|0|||
148842977|NCT01791517|536905103|FG008|Phase II|Lens Handling Difficulties|1|||
148842978|NCT01791517|536905104|FG009|Phase II|Lens Handling Difficulties|0|||
148842979|NCT01791517|536905105|FG010|Phase II|Lens Handling Difficulties|0|||
148842980|NCT01791517|536905106|FG011|Phase II|Lens Handling Difficulties|0|||
148842981|NCT01791517|536905095|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
148842982|NCT01791517|536905096|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
148842983|NCT01791517|536905097|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
148842984|NCT01791517|536905098|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
148842985|NCT01791517|536905099|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
148842986|NCT01791517|536905100|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
148842987|NCT01791517|536905101|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
148842988|NCT01791517|536905102|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
148842989|NCT01791517|536905103|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
148842990|NCT01791517|536905104|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
148842991|NCT01791517|536905105|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
148842992|NCT01791517|536905106|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
148842993|NCT01791517|536905095|FG000|Phase II|Pre-Existing Ocular Issue|0|||
148842994|NCT01791517|536905096|FG001|Phase II|Pre-Existing Ocular Issue|0|||
148842995|NCT01791517|536905097|FG002|Phase II|Pre-Existing Ocular Issue|0|||
148842996|NCT01791517|536905098|FG003|Phase II|Pre-Existing Ocular Issue|0|||
148842997|NCT01791517|536905099|FG004|Phase II|Pre-Existing Ocular Issue|0|||
148842998|NCT01791517|536905100|FG005|Phase II|Pre-Existing Ocular Issue|0|||
148842999|NCT01791517|536905101|FG006|Phase II|Pre-Existing Ocular Issue|0|||
148843000|NCT01791517|536905102|FG007|Phase II|Pre-Existing Ocular Issue|0|||
148843001|NCT01791517|536905103|FG008|Phase II|Pre-Existing Ocular Issue|0|||
148843002|NCT01791517|536905104|FG009|Phase II|Pre-Existing Ocular Issue|0|||
148843003|NCT01791517|536905105|FG010|Phase II|Pre-Existing Ocular Issue|0|||
148843004|NCT01791517|536905106|FG011|Phase II|Pre-Existing Ocular Issue|1|||
148843005|NCT02688192|536905112|FG000|Overall Study|Lost to Follow-up|11|||
148843006|NCT02688192|536905113|FG001|Overall Study|Lost to Follow-up|5|||
148843007|NCT02688192|536905112|FG000|Overall Study|Physician Decision|1|||
148843008|NCT02688192|536905113|FG001|Overall Study|Physician Decision|0|||
148843009|NCT02817594|536905114|FG000|Overall Study|Withdrawal by Subject|1|||
148843010|NCT02817594|536905114|FG000|Overall Study|Other|1|||
148843011|NCT02817594|536905114|FG000|Overall Study|Did Not Receive Treatment|1|||
148843012|NCT02413996|536905120|FG000|Overall Study|not comfortable with the intervention|9|||
148843013|NCT02413996|536905121|FG001|Overall Study|not comfortable with the intervention|2|||
148843014|NCT01459666|536905126|FG000|Overall Study|PI left institution|5|||
148843015|NCT01459666|536905127|FG001|Overall Study|PI left institution|4|||
148843016|NCT01492088|536905128|FG000|Overall Study|Withdrawal by Patient|0|||
148843017|NCT01492088|536905129|FG001|Overall Study|Withdrawal by Patient|2|||
148843018|NCT01492088|536905130|FG002|Overall Study|Withdrawal by Patient|0|||
148843019|NCT01492088|536905128|FG000|Overall Study|Death|1|||
148843020|NCT01492088|536905129|FG001|Overall Study|Death|6|||
148843021|NCT01492088|536905130|FG002|Overall Study|Death|2|||
148843022|NCT01492088|536905128|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
148843023|NCT01492088|536905129|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
148843024|NCT01492088|536905130|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
148843025|NCT01492088|536905128|FG000|Overall Study|Alive at Last Follow-up|0|||
148843026|NCT01492088|536905129|FG001|Overall Study|Alive at Last Follow-up|6|||
148843027|NCT01492088|536905130|FG002|Overall Study|Alive at Last Follow-up|11|||
148843028|NCT02379052|536905131|FG000|Overall Study|Protocol Violation|0|||
148843029|NCT02379052|536905132|FG001|Overall Study|Protocol Violation|1|||
148843030|NCT02379052|536905131|FG000|Overall Study|Adverse Event|0|||
148843031|NCT02379052|536905132|FG001|Overall Study|Adverse Event|1|||
148843032|NCT02379052|536905131|FG000|Overall Study|Physician Decision|1|||
148843033|NCT02379052|536905132|FG001|Overall Study|Physician Decision|1|||
148843034|NCT02379052|536905131|FG000|Overall Study|Withdrawal by Subject|2|||
148843035|NCT02379052|536905132|FG001|Overall Study|Withdrawal by Subject|0|||
148843036|NCT02379052|536905131|FG000|Overall Study|Lost to Follow-up|2|||
148843037|NCT02379052|536905132|FG001|Overall Study|Lost to Follow-up|1|||
148843038|NCT02379052|536905131|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
148843039|NCT02379052|536905132|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
148843040|NCT02379052|536905131|FG000|Overall Study|Subject was Incarcerated|0|||
148843041|NCT02379052|536905132|FG001|Overall Study|Subject was Incarcerated|1|||
148843042|NCT00127855|536905133|FG000|Primary Vaccination Course|Adverse Event|0|||
148843043|NCT00127855|536905134|FG001|Primary Vaccination Course|Adverse Event|0|||
148843044|NCT00127855|536905135|FG002|Primary Vaccination Course|Adverse Event|1|||
148843045|NCT00127855|536905136|FG003|Primary Vaccination Course|Adverse Event|0|||
148843046|NCT00127855|536905137|FG004|Primary Vaccination Course|Adverse Event|0|||
148843047|NCT00127855|536905133|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
148843048|NCT00127855|536905134|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
148843049|NCT00127855|536905135|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
148843050|NCT00127855|536905136|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
148843051|NCT00127855|536905137|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
148843052|NCT00127855|536905133|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
148843053|NCT00127855|536905134|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
148843054|NCT00127855|536905135|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
148843055|NCT00127855|536905136|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
148843056|NCT00127855|536905137|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
148843057|NCT00127855|536905133|FG000|Primary Vaccination Course|Other|0|||
148843058|NCT00127855|536905134|FG001|Primary Vaccination Course|Other|0|||
149029822|NCT01311648|537587879|FG000|Extension Study|Inhibitor management|0|||
148843059|NCT00127855|536905135|FG002|Primary Vaccination Course|Other|0|||
148843060|NCT00127855|536905136|FG003|Primary Vaccination Course|Other|0|||
148843061|NCT00127855|536905137|FG004|Primary Vaccination Course|Other|1|||
148843062|NCT01887717|536905138|FG000|Overall Study|Withdrawal by Subject|1|||
148843063|NCT01887717|536905139|FG001|Overall Study|Withdrawal by Subject|7|||
148843064|NCT01887717|536905138|FG000|Overall Study|Physician Decision|0|||
148843065|NCT01887717|536905139|FG001|Overall Study|Physician Decision|2|||
148843066|NCT01887717|536905138|FG000|Overall Study|Administrative reasons|5|||
148843067|NCT01887717|536905139|FG001|Overall Study|Administrative reasons|2|||
148843068|NCT02655887|536905142|FG000|Overall Study|Lost to Follow-up|3|||
148843069|NCT02655887|536905142|FG000|Overall Study|Death|4|||
148843070|NCT02655887|536905142|FG000|Overall Study|Withdrawal by Subject|3|||
148843071|NCT02655887|536905142|FG000|Overall Study|Missed 12-month follow-up visit|4|||
148843072|NCT00920556|536905143|FG000|Overall Study|Adverse Event|16|||
148843073|NCT00920556|536905143|FG000|Overall Study|Physician Decision|7|||
148843074|NCT00920556|536905143|FG000|Overall Study|Withdrawal by Subject|1|||
148843075|NCT04245709|536905144|FG000|Overall Study|Adverse Event|13|||
148843076|NCT04245709|536905144|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
148843077|NCT03637491|536905145|FG000|Overall Study|Death|9|||
148843078|NCT03637491|536905146|FG001|Overall Study|Death|9|||
148843079|NCT03637491|536905147|FG002|Overall Study|Death|5|||
148843080|NCT03637491|536905148|FG003|Overall Study|Death|3|||
148843081|NCT03637491|536905145|FG000|Overall Study|Lost to Follow-up|0|||
148843082|NCT03637491|536905146|FG001|Overall Study|Lost to Follow-up|1|||
148843083|NCT03637491|536905147|FG002|Overall Study|Lost to Follow-up|0|||
148843084|NCT03637491|536905148|FG003|Overall Study|Lost to Follow-up|1|||
148843085|NCT03637491|536905145|FG000|Overall Study|Study Terminated By Sponsor|0|||
148843086|NCT03637491|536905146|FG001|Overall Study|Study Terminated By Sponsor|2|||
148843087|NCT03637491|536905147|FG002|Overall Study|Study Terminated By Sponsor|1|||
148843088|NCT03637491|536905148|FG003|Overall Study|Study Terminated By Sponsor|0|||
148843089|NCT03637491|536905145|FG000|Overall Study|Withdrawal by Subject|1|||
148843090|NCT03637491|536905146|FG001|Overall Study|Withdrawal by Subject|0|||
148843091|NCT03637491|536905147|FG002|Overall Study|Withdrawal by Subject|1|||
148843092|NCT03637491|536905148|FG003|Overall Study|Withdrawal by Subject|2|||
148843093|NCT00889707|536905153|FG000|Overall Study|Adverse Event|1|||
148843094|NCT00889707|536905154|FG001|Overall Study|Adverse Event|0|||
148843095|NCT00889707|536905153|FG000|Overall Study|Withdrawal by Subject|4|||
148843096|NCT00889707|536905154|FG001|Overall Study|Withdrawal by Subject|3|||
148843097|NCT00889707|536905153|FG000|Overall Study|Lost to Follow-up|0|||
148843098|NCT00889707|536905154|FG001|Overall Study|Lost to Follow-up|2|||
148843099|NCT00889707|536905153|FG000|Overall Study|Lack of Efficacy|2|||
148843100|NCT00889707|536905154|FG001|Overall Study|Lack of Efficacy|5|||
148843101|NCT02185534|536905155|FG000|First Period|Withdrawal by Subject|0|||
148843102|NCT02185534|536905156|FG001|First Period|Withdrawal by Subject|0|||
148843103|NCT02185534|536905157|FG002|First Period|Withdrawal by Subject|0|||
148843104|NCT02185534|536905158|FG003|First Period|Withdrawal by Subject|1|||
148843105|NCT02185534|536905159|FG004|First Period|Withdrawal by Subject|0|||
148843106|NCT02185534|536905160|FG005|First Period|Withdrawal by Subject|0|||
148843107|NCT02185534|536905155|FG000|First Washout Period|Withdrawal by Subject|1|||
148843108|NCT02185534|536905156|FG001|First Washout Period|Withdrawal by Subject|0|||
148843109|NCT02185534|536905157|FG002|First Washout Period|Withdrawal by Subject|0|||
148843110|NCT02185534|536905158|FG003|First Washout Period|Withdrawal by Subject|0|||
148843111|NCT02185534|536905159|FG004|First Washout Period|Withdrawal by Subject|1|||
148843112|NCT02185534|536905160|FG005|First Washout Period|Withdrawal by Subject|0|||
148843113|NCT02185534|536905155|FG000|First Washout Period|Protocol Violation|0|||
148843114|NCT02185534|536905156|FG001|First Washout Period|Protocol Violation|0|||
148843115|NCT02185534|536905157|FG002|First Washout Period|Protocol Violation|0|||
148843116|NCT02185534|536905158|FG003|First Washout Period|Protocol Violation|0|||
148843117|NCT02185534|536905159|FG004|First Washout Period|Protocol Violation|0|||
148843118|NCT02185534|536905160|FG005|First Washout Period|Protocol Violation|1|||
148843119|NCT03465722|536905161|FG000|Overall Study|Withdrawal by Subject|21|||
148843120|NCT03465722|536905162|FG001|Overall Study|Withdrawal by Subject|14|||
148843121|NCT03465722|536905161|FG000|Overall Study|Death|89|||
148843122|NCT03465722|536905162|FG001|Overall Study|Death|87|||
148843123|NCT03465722|536905161|FG000|Overall Study|Lost to Follow-up|5|||
148843124|NCT03465722|536905162|FG001|Overall Study|Lost to Follow-up|3|||
148843125|NCT03465722|536905161|FG000|Overall Study|Administrative/Other|33|||
148843126|NCT03465722|536905162|FG001|Overall Study|Administrative/Other|32|||
148843127|NCT03465722|536905161|FG000|Overall Study|Not treated|1|||
148843128|NCT03465722|536905162|FG001|Overall Study|Not treated|2|||
148843129|NCT03465722|536905161|FG000|Overall Study|Sponsor decision|91|||
148843130|NCT03465722|536905162|FG001|Overall Study|Sponsor decision|98|||
148843131|NCT01151020|536905163|FG000|Overall Study|Death|25|||
148843132|NCT01151020|536905163|FG000|Overall Study|Conversion to open repair|1|||
148843133|NCT01151020|536905163|FG000|Overall Study|Lost to Follow-up|4|||
148843134|NCT01151020|536905163|FG000|Overall Study|Withdrawal by Subject|22|||
148843135|NCT01151020|536905163|FG000|Overall Study|Patients did not receive the device|2|||
148843136|NCT00003631|536905164|FG000|Overall Study|Patient not treated|1|||
148843137|NCT00003631|536905165|FG001|Overall Study|Patient not treated|0|||
148843138|NCT00003631|536905166|FG002|Overall Study|Patient not treated|1|||
148843139|NCT00003631|536905164|FG000|Overall Study|Protocol Violation|1|||
148843140|NCT00003631|536905165|FG001|Overall Study|Protocol Violation|0|||
148843141|NCT00003631|536905166|FG002|Overall Study|Protocol Violation|0|||
148843142|NCT00003631|536905164|FG000|Overall Study|Adverse Event|1|||
148843143|NCT00003631|536905165|FG001|Overall Study|Adverse Event|1|||
148843144|NCT00003631|536905166|FG002|Overall Study|Adverse Event|5|||
148843145|NCT00003631|536905164|FG000|Overall Study|Death|0|||
148843146|NCT00003631|536905165|FG001|Overall Study|Death|0|||
148843147|NCT00003631|536905166|FG002|Overall Study|Death|1|||
148843148|NCT00003631|536905164|FG000|Overall Study|Evaluable for toxicity only|0|||
148843149|NCT00003631|536905165|FG001|Overall Study|Evaluable for toxicity only|0|||
148843150|NCT00003631|536905166|FG002|Overall Study|Evaluable for toxicity only|2|||
148843151|NCT04339413|536905167|FG000|Overall Study|Reason Not Specified|2|||
148843152|NCT04339413|536905168|FG001|Overall Study|Reason Not Specified|7|||
148843153|NCT04339413|536905167|FG000|Overall Study|Study Terminated by Sponsor|30|||
148843154|NCT04339413|536905168|FG001|Overall Study|Study Terminated by Sponsor|33|||
148843155|NCT04339413|536905167|FG000|Overall Study|Progressive Disease|9|||
148843156|NCT04339413|536905168|FG001|Overall Study|Progressive Disease|6|||
148843157|NCT04339413|536905167|FG000|Overall Study|Withdrawal by Subject|9|||
148843158|NCT04339413|536905168|FG001|Overall Study|Withdrawal by Subject|10|||
148843159|NCT04339413|536905167|FG000|Overall Study|Physician Decision|3|||
148843160|NCT04339413|536905168|FG001|Overall Study|Physician Decision|1|||
148843161|NCT04339413|536905167|FG000|Overall Study|Death|2|||
148843162|NCT04339413|536905168|FG001|Overall Study|Death|0|||
148843163|NCT04339413|536905167|FG000|Overall Study|Adverse Event|3|||
148843164|NCT04339413|536905168|FG001|Overall Study|Adverse Event|0|||
148843165|NCT01853462|536905173|FG000|Overall Study|Withdrawal by Subject|1|||
148843166|NCT01853462|536905174|FG001|Overall Study|Withdrawal by Subject|1|||
148843167|NCT00003869|536905176|FG000|Overall Study|Adverse Event|14|||
148843168|NCT00003869|536905177|FG001|Overall Study|Adverse Event|3|||
148843169|NCT00003869|536905176|FG000|Overall Study|Withdrawal by Subject|21|||
148843170|NCT00003869|536905177|FG001|Overall Study|Withdrawal by Subject|3|||
148843171|NCT00003869|536905176|FG000|Overall Study|Death|1|||
148843172|NCT00003869|536905177|FG001|Overall Study|Death|2|||
148843173|NCT00003869|536905176|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
148843174|NCT00003869|536905177|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
148843175|NCT02382991|536905189|FG000|Overall Study|Adverse Event|1|||
148843176|NCT02382991|536905190|FG001|Overall Study|Adverse Event|2|||
148843177|NCT02382991|536905189|FG000|Overall Study|Lost to Follow-up|1|||
148843178|NCT02382991|536905190|FG001|Overall Study|Lost to Follow-up|0|||
148843179|NCT02382991|536905189|FG000|Overall Study|Withdrawal by Subject|0|||
148843180|NCT02382991|536905190|FG001|Overall Study|Withdrawal by Subject|1|||
148843181|NCT04267926|536906543|FG000|Overall Study|abnormal labs. No longer eligible|0|||
148843182|NCT04267926|536906544|FG001|Overall Study|abnormal labs. No longer eligible|0|||
148843183|NCT04267926|536906545|FG002|Overall Study|abnormal labs. No longer eligible|1|||
148843184|NCT04267926|536906543|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
148843185|NCT04267926|536906544|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
148843186|NCT04267926|536906545|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
148843187|NCT03718325|536906546|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
148843188|NCT03718325|536906547|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
148843189|NCT03718325|536906548|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
148843190|NCT03718325|536906546|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
148843191|NCT03718325|536906547|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
148843192|NCT03718325|536906548|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
148843193|NCT03073525|536906549|FG000|Overall Study|Withdrawal by Subject|0|||
148843194|NCT03073525|536906550|FG001|Overall Study|Withdrawal by Subject|0|||
148843195|NCT03073525|536906551|FG002|Overall Study|Withdrawal by Subject|3|||
148843196|NCT00564733|536906556|FG000|Overall Study|Withdrawal by Subject|4|||
148843197|NCT00564733|536906556|FG000|Overall Study|Ineligible|5|||
148843198|NCT05197049|536906560|FG000|Overall Study|Death|0|||
148843199|NCT05197049|536906561|FG001|Overall Study|Death|1|||
148843200|NCT05197049|536906562|FG002|Overall Study|Death|0|||
148843201|NCT05197049|536906560|FG000|Overall Study|Lost to Follow-up|3|||
148843202|NCT05197049|536906561|FG001|Overall Study|Lost to Follow-up|1|||
148843203|NCT05197049|536906562|FG002|Overall Study|Lost to Follow-up|0|||
148843204|NCT05197049|536906560|FG000|Overall Study|Withdrawal by Subject|15|||
148983731|NCT01459796|537417395|FG001|Overall Study|Reason unspecified|2|||
148983732|NCT01459796|537417394|FG000|Overall Study|Decision by the sponsor|75|||
148983733|NCT01459796|537417395|FG001|Overall Study|Decision by the sponsor|108|||
148983734|NCT00733824|537417396|FG000|Phase I|Withdrawal by Subject|1|||
148983735|NCT00733824|537417397|FG001|Phase I|Withdrawal by Subject|0|||
148983736|NCT00733824|537417398|FG002|Phase I|Withdrawal by Subject|0|||
148983737|NCT00733824|537417399|FG003|Phase I|Withdrawal by Subject|0|||
148843205|NCT05197049|536906561|FG001|Overall Study|Withdrawal by Subject|3|||
148843206|NCT05197049|536906562|FG002|Overall Study|Withdrawal by Subject|1|||
148843207|NCT05197049|536906560|FG000|Overall Study|GCP non-compliance|1|||
148843208|NCT05197049|536906561|FG001|Overall Study|GCP non-compliance|2|||
148843209|NCT05197049|536906562|FG002|Overall Study|GCP non-compliance|0|||
148843210|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
148843211|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
148843212|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
148843213|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
148843214|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
148843215|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
148843216|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
148843217|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
148843218|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
148843219|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
148843220|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
148843221|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
148843222|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
148843223|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
148843224|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
148843225|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
148843226|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
148843227|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
148843228|NCT02831855|536906563|FG000|Open Label Phase (24 Weeks)|Other|4|||
148843229|NCT02831855|536906564|FG001|Open Label Phase (24 Weeks)|Other|0|||
148843230|NCT02831855|536906565|FG002|Open Label Phase (24 Weeks)|Other|0|||
148843231|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
148843232|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
148843233|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
148843234|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Death|0|||
148843235|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Death|0|||
148843236|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Death|2|||
148843237|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
148843238|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
148843239|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
148843240|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
148843241|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
148843242|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
148843243|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
148843244|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
148843245|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
148843246|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Other|0|||
148843247|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Other|2|||
148843248|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Other|5|||
148843249|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
148843250|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
148843251|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
148843252|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
148843253|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
148843254|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
148843255|NCT02831855|536906563|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
148843256|NCT02831855|536906564|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
148843257|NCT02831855|536906565|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
148843258|NCT00075764|536906566|FG000|Overall Study|Adverse Event|5|||
148843259|NCT00075764|536906567|FG001|Overall Study|Adverse Event|12|||
148843260|NCT00075764|536906566|FG000|Overall Study|Death|4|||
148843261|NCT00075764|536906567|FG001|Overall Study|Death|8|||
148843262|NCT00075764|536906566|FG000|Overall Study|Withdrawal by Subject|28|||
148843263|NCT00075764|536906567|FG001|Overall Study|Withdrawal by Subject|18|||
148843264|NCT00075764|536906566|FG000|Overall Study|Progression|269|||
148843265|NCT00075764|536906567|FG001|Overall Study|Progression|274|||
148843266|NCT00075764|536906566|FG000|Overall Study|Still on treatment|8|||
148843267|NCT00075764|536906567|FG001|Overall Study|Still on treatment|15|||
148843268|NCT00075764|536906566|FG000|Overall Study|Delinquent|4|||
148843269|NCT00075764|536906567|FG001|Overall Study|Delinquent|2|||
148843270|NCT00075764|536906566|FG000|Overall Study|Not protocol specified|27|||
148843271|NCT00075764|536906567|FG001|Overall Study|Not protocol specified|19|||
148843272|NCT00075764|536906566|FG000|Overall Study|Under review|0|||
148843273|NCT00075764|536906567|FG001|Overall Study|Under review|1|||
148843274|NCT02010593|536906571|FG000|Overall Study|Lost to Follow-up|1|||
148843275|NCT02010593|536906572|FG001|Overall Study|Lost to Follow-up|0|||
148843276|NCT02010593|536906571|FG000|Overall Study|Physician Decision|1|||
148843277|NCT02010593|536906572|FG001|Overall Study|Physician Decision|0|||
148843278|NCT02010593|536906571|FG000|Overall Study|Unable to adhere to visit schedule|0|||
148843279|NCT02010593|536906572|FG001|Overall Study|Unable to adhere to visit schedule|2|||
148843280|NCT01773967|536906573|FG000|Overall Study|Lost to Follow-up|15|||
148843281|NCT01773967|536906574|FG001|Overall Study|Lost to Follow-up|13|||
148843282|NCT01135459|536906575|FG000|Overall Study|Adverse Event|8|||
148843283|NCT01135459|536906576|FG001|Overall Study|Adverse Event|10|||
148843284|NCT01135459|536906575|FG000|Overall Study|Lack of Efficacy|3|||
148843285|NCT01135459|536906576|FG001|Overall Study|Lack of Efficacy|1|||
148843286|NCT01135459|536906575|FG000|Overall Study|Withdrawal by Subject|2|||
148843287|NCT01135459|536906576|FG001|Overall Study|Withdrawal by Subject|3|||
148843288|NCT01135459|536906575|FG000|Overall Study|Protocol Violation|5|||
148843289|NCT01135459|536906576|FG001|Overall Study|Protocol Violation|3|||
148843290|NCT01135459|536906575|FG000|Overall Study|Lost to Follow-up|2|||
148843291|NCT01135459|536906576|FG001|Overall Study|Lost to Follow-up|1|||
148843292|NCT01135459|536906575|FG000|Overall Study|Non-compliance to study procedures|0|||
148843293|NCT01135459|536906576|FG001|Overall Study|Non-compliance to study procedures|1|||
148843294|NCT01135459|536906575|FG000|Overall Study|Other than specified|1|||
148843295|NCT01135459|536906576|FG001|Overall Study|Other than specified|1|||
148843296|NCT02236572|536906577|FG000|Overall Study|Withdrawal by Subject|1|||
148843297|NCT02236572|536906577|FG000|Overall Study|Protocol Violation|1|||
148843298|NCT02236572|536906577|FG000|Overall Study|Lost to Follow-up|1|||
148843299|NCT01057693|536906578|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
148843300|NCT01057693|536906579|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
148843301|NCT01057693|536906580|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
148843302|NCT01057693|536906578|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
148843303|NCT01057693|536906579|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
148843304|NCT01057693|536906580|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
148843305|NCT01057693|536906578|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
148843306|NCT01057693|536906579|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
148843307|NCT01057693|536906580|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
148843308|NCT01057693|536906578|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
148843309|NCT01057693|536906579|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
148843310|NCT01057693|536906580|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
148843311|NCT01057693|536906578|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
148843312|NCT01057693|536906579|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
148843313|NCT01057693|536906580|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
148843314|NCT01057693|536906578|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
148843315|NCT01057693|536906579|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
148843316|NCT01057693|536906580|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
148843317|NCT01057693|536906578|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
148843318|NCT01057693|536906579|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
148843319|NCT01057693|536906580|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
148843320|NCT01057693|536906578|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
148843321|NCT01057693|536906579|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
148843322|NCT01057693|536906580|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
148843323|NCT01057693|536906578|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
148843324|NCT01057693|536906579|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
148843325|NCT01057693|536906580|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
148843326|NCT01057693|536906578|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
148843327|NCT01057693|536906579|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
148843328|NCT01057693|536906580|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
148843329|NCT01057693|536906578|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
148843330|NCT01057693|536906579|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
148843331|NCT01057693|536906580|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
148843332|NCT01057693|536906578|FG000|Between Single-Blind and Double-Blind|Other|6|||
148843333|NCT01057693|536906579|FG001|Between Single-Blind and Double-Blind|Other|0|||
148843334|NCT01057693|536906580|FG002|Between Single-Blind and Double-Blind|Other|0|||
148843335|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
148843336|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
148843337|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
148843338|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
148843339|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
148843340|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
148843341|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
148843342|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
148843343|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
148843344|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
148843345|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
148843346|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
148983738|NCT00733824|537417400|FG004|Phase I|Withdrawal by Subject|0|||
148983739|NCT00701051|537417401|FG000|Screening|Failed Screening|40|||
148983740|NCT00701051|537417402|FG001|Screening|Failed Screening|0|||
148983741|NCT00701051|537417403|FG002|Screening|Failed Screening|0|||
148983742|NCT00701051|537417401|FG000|Screening|Time conflicts|19|||
148983743|NCT00701051|537417402|FG001|Screening|Time conflicts|0|||
148983744|NCT00701051|537417403|FG002|Screening|Time conflicts|0|||
148983745|NCT00701051|537417401|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
148983746|NCT00701051|537417402|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
148983747|NCT00701051|537417403|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
148983748|NCT01410110|537417405|FG000|Overall Study|Withdrawal by Subject|4|||
148983749|NCT01410110|537417406|FG001|Overall Study|Withdrawal by Subject|2|||
148983750|NCT03634579|537417407|FG000|Overall Study|study termination|9|||
148983751|NCT05857527|537417410|FG000|Overall Study|Withdrawal by Subject|0|||
148983752|NCT05857527|537417411|FG001|Overall Study|Withdrawal by Subject|1|||
148983753|NCT02799082|537417412|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
148983754|NCT02799082|537417413|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
148983755|NCT02799082|537417412|FG000|Overall Study|Protocol Violation|0|||
148983756|NCT02799082|537417413|FG001|Overall Study|Protocol Violation|1|||
148983757|NCT00861341|537417414|FG000|Overall Study|Withdrawal by Subject|2|||
148983758|NCT01337297|537417425|FG000|Overall Study|They entered to single anodal tDCS|4|||
148983759|NCT01337297|537417426|FG001|Overall Study|They entered to single anodal tDCS|3|||
148983760|NCT01337297|537417425|FG000|Overall Study|Lost to Follow-up|1|||
148983761|NCT01337297|537417426|FG001|Overall Study|Lost to Follow-up|3|||
148983762|NCT02778204|537417427|FG000|Overall Study|Adverse Event|1|||
148983763|NCT02778204|537417428|FG001|Overall Study|Adverse Event|0|||
148983764|NCT02778204|537417429|FG002|Overall Study|Adverse Event|0|||
148983765|NCT02778204|537417430|FG003|Overall Study|Adverse Event|0|||
148983766|NCT02778204|537417427|FG000|Overall Study|Withdrawal by Subject|0|||
148983767|NCT02778204|537417428|FG001|Overall Study|Withdrawal by Subject|0|||
148983768|NCT02778204|537417429|FG002|Overall Study|Withdrawal by Subject|1|||
148983769|NCT02778204|537417430|FG003|Overall Study|Withdrawal by Subject|2|||
148983770|NCT02778204|537417427|FG000|Overall Study|Lost to Follow-up|1|||
148983771|NCT02778204|537417428|FG001|Overall Study|Lost to Follow-up|0|||
148983772|NCT02778204|537417429|FG002|Overall Study|Lost to Follow-up|2|||
148983773|NCT02778204|537417430|FG003|Overall Study|Lost to Follow-up|1|||
148983774|NCT02778204|537417427|FG000|Overall Study|Protocol Violation|0|||
148983775|NCT02778204|537417428|FG001|Overall Study|Protocol Violation|0|||
148983776|NCT02778204|537417429|FG002|Overall Study|Protocol Violation|1|||
148983777|NCT02778204|537417430|FG003|Overall Study|Protocol Violation|0|||
148983778|NCT02778204|537417427|FG000|Overall Study|Eligibility Violation|0|||
148983779|NCT02778204|537417428|FG001|Overall Study|Eligibility Violation|0|||
148983780|NCT02778204|537417429|FG002|Overall Study|Eligibility Violation|0|||
148983781|NCT02778204|537417430|FG003|Overall Study|Eligibility Violation|1|||
148983782|NCT04122443|537417431|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
148983783|NCT04122443|537417432|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
148983784|NCT04122443|537417433|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
148983785|NCT04122443|537417431|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
148983786|NCT04122443|537417432|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
148983787|NCT04122443|537417433|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
148983788|NCT01072201|537417434|FG000|Overall Study|Lost to Follow-up|0|||
148983789|NCT01072201|537417435|FG001|Overall Study|Lost to Follow-up|1|||
148983790|NCT00360334|537417436|FG000|Overall Study|Adverse Event|7|||
148983791|NCT00360334|537417437|FG001|Overall Study|Adverse Event|4|||
148983792|NCT00360334|537417436|FG000|Overall Study|Protocol Violation|1|||
148983793|NCT00360334|537417437|FG001|Overall Study|Protocol Violation|1|||
148983794|NCT00360334|537417436|FG000|Overall Study|Physician Decision|2|||
148983795|NCT00360334|537417437|FG001|Overall Study|Physician Decision|3|||
148983796|NCT00360334|537417436|FG000|Overall Study|Lack of Efficacy|0|||
148983797|NCT00360334|537417437|FG001|Overall Study|Lack of Efficacy|1|||
148983798|NCT00360334|537417436|FG000|Overall Study|Entry criterion not met|1|||
148983799|NCT00360334|537417437|FG001|Overall Study|Entry criterion not met|2|||
148983800|NCT00360334|537417436|FG000|Overall Study|Subject decision|8|||
148983801|NCT00360334|537417437|FG001|Overall Study|Subject decision|2|||
148983802|NCT01916304|537417438|FG000|Overall Study|Screening failure|17|||
148983803|NCT01898793|537417439|FG000|Overall Study|Death|2|||
148983804|NCT01898793|537417440|FG001|Overall Study|Death|1|||
148983805|NCT01898793|537417441|FG002|Overall Study|Death|4|||
148983806|NCT01898793|537417442|FG003|Overall Study|Death|0|||
148983807|NCT01898793|537417443|FG004|Overall Study|Death|0|||
148983808|NCT01898793|537417444|FG005|Overall Study|Death|0|||
148983809|NCT01898793|537417445|FG006|Overall Study|Death|0|||
149029823|NCT01311648|537587880|FG001|Extension Study|Inhibitor management|2|||
149029824|NCT05526911|537587886|FG000|Overall Study|Adverse Event|2|||
148983810|NCT00766415|537417446|FG000|Overall Study|Withdrawal by Subject|0|||
148983811|NCT00766415|537417447|FG001|Overall Study|Withdrawal by Subject|1|||
148983812|NCT01114516|537417448|FG000|Overall Study|Lost to Follow-up|2|||
148843347|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
148843348|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
148843349|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
148843350|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
148843351|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
148843352|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
148843353|NCT01057693|536906578|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
148843354|NCT01057693|536906579|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
148843355|NCT01057693|536906580|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
148843356|NCT00709319|536906581|FG000|Overall Study|Death|4|||
148843357|NCT00709319|536906581|FG000|Overall Study|Withdrawal by Subject|2|||
148843358|NCT00579553|536906585|FG000|Overall Study|Lost to Follow-up|16|||
148843359|NCT00579553|536906586|FG001|Overall Study|Lost to Follow-up|13|||
148843360|NCT00090779|536906587|FG000|Step 1|Withdrawal by Subject|4|||
148843361|NCT00090779|536906588|FG001|Step 1|Withdrawal by Subject|2|||
148843362|NCT00090779|536906587|FG000|Step 1|Lost to Follow-up|3|||
148843363|NCT00090779|536906588|FG001|Step 1|Lost to Follow-up|2|||
148843364|NCT00090779|536906587|FG000|Step 1|Death|0|||
148843365|NCT00090779|536906588|FG001|Step 1|Death|2|||
148843366|NCT00090779|536906587|FG000|Step 1|Physician Decision|1|||
148843367|NCT00090779|536906588|FG001|Step 1|Physician Decision|0|||
148843368|NCT00090779|536906587|FG000|Step 1|Pregnancy|1|||
148843369|NCT00090779|536906588|FG001|Step 1|Pregnancy|0|||
148843370|NCT00090779|536906587|FG000|Step 1|Non-compliance to study requirements|0|||
148843371|NCT00090779|536906588|FG001|Step 1|Non-compliance to study requirements|1|||
148843372|NCT00090779|536906587|FG000|Step 1|Subject relocated|2|||
148843373|NCT00090779|536906588|FG001|Step 1|Subject relocated|8|||
148843374|NCT00090779|536906587|FG000|Step 2|Off study per study closure|6|||
148843375|NCT00090779|536906588|FG001|Step 2|Off study per study closure|16|||
148843376|NCT00090779|536906587|FG000|Step 2|Subject relocated|0|||
148843377|NCT00090779|536906588|FG001|Step 2|Subject relocated|1|||
148843378|NCT00090779|536906587|FG000|Step 2|Non-compliance to study requirements|0|||
148843379|NCT00090779|536906588|FG001|Step 2|Non-compliance to study requirements|1|||
148843380|NCT00090779|536906587|FG000|Step 3|Initiation of ART and off extended study|3|||
148843381|NCT00090779|536906588|FG001|Step 3|Initiation of ART and off extended study|2|||
148843382|NCT00090779|536906587|FG000|Step 3|Off extended study due to study closure|4|||
148843383|NCT00090779|536906588|FG001|Step 3|Off extended study due to study closure|3|||
148843384|NCT04860869|536906591|FG000|Overall Study|Withdrawal by Subject|1|||
148843385|NCT04860869|536906592|FG001|Overall Study|Withdrawal by Subject|0|||
148843386|NCT00590967|536906596|FG000|Overall Study|Withdrawal by Subject|1|||
148843387|NCT00590967|536906597|FG001|Overall Study|Withdrawal by Subject|1|||
148843388|NCT00590967|536906596|FG000|Overall Study|Ineligible|1|||
148843389|NCT00590967|536906597|FG001|Overall Study|Ineligible|0|||
148843390|NCT00590967|536906596|FG000|Overall Study|Poor performance status|0|||
148843391|NCT00590967|536906597|FG001|Overall Study|Poor performance status|1|||
148843392|NCT00590967|536906596|FG000|Overall Study|Non-compliant|0|||
148843393|NCT00590967|536906597|FG001|Overall Study|Non-compliant|2|||
148843394|NCT00590967|536906596|FG000|Overall Study|Did not sign consent form|0|||
148843395|NCT00590967|536906597|FG001|Overall Study|Did not sign consent form|1|||
148843396|NCT00590967|536906596|FG000|Overall Study|Did not receive chemo per protocol|1|||
148843397|NCT00590967|536906597|FG001|Overall Study|Did not receive chemo per protocol|0|||
148843398|NCT01881789|536906598|FG000|Overall Study|Withdrawal by Subject|0|||
148843399|NCT01881789|536906599|FG001|Overall Study|Withdrawal by Subject|2|||
148843400|NCT01881789|536906600|FG002|Overall Study|Withdrawal by Subject|1|||
148843401|NCT01881789|536906601|FG003|Overall Study|Withdrawal by Subject|0|||
148843402|NCT01881789|536906602|FG004|Overall Study|Withdrawal by Subject|1|||
148843403|NCT01881789|536906603|FG005|Overall Study|Withdrawal by Subject|1|||
148843404|NCT01881789|536906598|FG000|Overall Study|Study Terminated by Sponsor|0|||
148843405|NCT01881789|536906599|FG001|Overall Study|Study Terminated by Sponsor|0|||
148843406|NCT01881789|536906600|FG002|Overall Study|Study Terminated by Sponsor|0|||
148843407|NCT01881789|536906601|FG003|Overall Study|Study Terminated by Sponsor|0|||
148843408|NCT01881789|536906602|FG004|Overall Study|Study Terminated by Sponsor|0|||
148843409|NCT01881789|536906603|FG005|Overall Study|Study Terminated by Sponsor|1|||
148843410|NCT01881789|536906598|FG000|Overall Study|Other|3|||
148843411|NCT01881789|536906599|FG001|Overall Study|Other|5|||
148843412|NCT01881789|536906600|FG002|Overall Study|Other|2|||
148843413|NCT01881789|536906601|FG003|Overall Study|Other|3|||
148843414|NCT01881789|536906602|FG004|Overall Study|Other|1|||
148843415|NCT01881789|536906603|FG005|Overall Study|Other|1|||
148843416|NCT02148263|536906606|FG000|Overall Study|Withdrawal by Subject|3|||
148843417|NCT02148263|536906607|FG001|Overall Study|Withdrawal by Subject|2|||
148843418|NCT01964378|536906608|FG000|Overall Study|Disc. due to death before first dosing|0|||
148843419|NCT01964378|536906609|FG001|Overall Study|Disc. due to death before first dosing|1|||
148983813|NCT01114516|537417449|FG001|Overall Study|Lost to Follow-up|1|||
148983814|NCT03779841|537417450|FG000|Randomized Population|Did Not Receive Treatment|3|||
148983815|NCT03779841|537417451|FG001|Randomized Population|Did Not Receive Treatment|1|||
148843420|NCT01964378|536906608|FG000|Overall Study|Disc. due to AE before first dosing|1|||
148843421|NCT01964378|536906609|FG001|Overall Study|Disc. due to AE before first dosing|0|||
148843422|NCT01964378|536906608|FG000|Overall Study|Death|3|||
148843423|NCT01964378|536906609|FG001|Overall Study|Death|2|||
148843424|NCT01964378|536906608|FG000|Overall Study|Adverse Event|12|||
148843425|NCT01964378|536906609|FG001|Overall Study|Adverse Event|5|||
148843426|NCT01964378|536906608|FG000|Overall Study|Lack of Efficacy|0|||
148843427|NCT01964378|536906609|FG001|Overall Study|Lack of Efficacy|1|||
148843428|NCT01964378|536906608|FG000|Overall Study|Protocol Violation|0|||
148843429|NCT01964378|536906609|FG001|Overall Study|Protocol Violation|1|||
148843430|NCT01964378|536906608|FG000|Overall Study|Lost to Follow-up|0|||
148843431|NCT01964378|536906609|FG001|Overall Study|Lost to Follow-up|1|||
148843432|NCT01964378|536906608|FG000|Overall Study|Withdrawal by Subject|7|||
148843433|NCT01964378|536906609|FG001|Overall Study|Withdrawal by Subject|5|||
148843434|NCT01964378|536906608|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
148843435|NCT01964378|536906609|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
148843436|NCT01964378|536906608|FG000|Overall Study|Other|1|||
148843437|NCT01964378|536906609|FG001|Overall Study|Other|2|||
148843438|NCT00326599|536906610|FG000|Overall Study|Withdrawal by Subject|1|||
148843439|NCT00326599|536906611|FG001|Overall Study|Withdrawal by Subject|0|||
148843440|NCT00326599|536906612|FG002|Overall Study|Withdrawal by Subject|5|||
148843441|NCT00326599|536906613|FG003|Overall Study|Withdrawal by Subject|2|||
148843442|NCT00326599|536906610|FG000|Overall Study|Adverse Event|1|||
148843443|NCT00326599|536906611|FG001|Overall Study|Adverse Event|0|||
148843444|NCT00326599|536906612|FG002|Overall Study|Adverse Event|32|||
148843445|NCT00326599|536906613|FG003|Overall Study|Adverse Event|3|||
148843446|NCT00326599|536906610|FG000|Overall Study|Disease Progression|3|||
148843447|NCT00326599|536906611|FG001|Overall Study|Disease Progression|1|||
148843448|NCT00326599|536906612|FG002|Overall Study|Disease Progression|13|||
148843449|NCT00326599|536906613|FG003|Overall Study|Disease Progression|11|||
148843450|NCT00326599|536906610|FG000|Overall Study|Alternate Treatment|1|||
148843451|NCT00326599|536906611|FG001|Overall Study|Alternate Treatment|0|||
148843452|NCT00326599|536906612|FG002|Overall Study|Alternate Treatment|0|||
148843453|NCT00326599|536906613|FG003|Overall Study|Alternate Treatment|0|||
148843454|NCT00326599|536906610|FG000|Overall Study|Death|0|||
148983816|NCT03779841|537417452|FG002|Randomized Population|Did Not Receive Treatment|0|||
148983817|NCT03779841|537417450|FG000|Treated (Safety) Population|Adverse Event|1|||
148983818|NCT03779841|537417451|FG001|Treated (Safety) Population|Adverse Event|1|||
148983819|NCT03779841|537417452|FG002|Treated (Safety) Population|Adverse Event|0|||
148983820|NCT03779841|537417450|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
148983821|NCT03779841|537417451|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
148843455|NCT00326599|536906611|FG001|Overall Study|Death|0|||
148843456|NCT00326599|536906612|FG002|Overall Study|Death|1|||
148843457|NCT00326599|536906613|FG003|Overall Study|Death|2|||
148843458|NCT00326599|536906610|FG000|Overall Study|Other Unspecified Reason|0|||
148843459|NCT00326599|536906611|FG001|Overall Study|Other Unspecified Reason|0|||
148843460|NCT00326599|536906612|FG002|Overall Study|Other Unspecified Reason|2|||
148843461|NCT00326599|536906613|FG003|Overall Study|Other Unspecified Reason|1|||
148843462|NCT03364231|536906614|FG000|Overall Study|Adverse Event|1|||
148843463|NCT03364231|536906615|FG001|Overall Study|Adverse Event|4|||
148843464|NCT03364231|536906614|FG000|Overall Study|Death|1|||
148843465|NCT03364231|536906615|FG001|Overall Study|Death|0|||
148843466|NCT03364231|536906614|FG000|Overall Study|Investigator Decision|2|||
148843467|NCT03364231|536906615|FG001|Overall Study|Investigator Decision|2|||
148843468|NCT03364231|536906614|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
148843469|NCT03364231|536906615|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
148843470|NCT03364231|536906614|FG000|Overall Study|Withdrawal of Subject Consent|1|||
148843471|NCT03364231|536906615|FG001|Overall Study|Withdrawal of Subject Consent|0|||
148843472|NCT03364231|536906614|FG000|Overall Study|Reason Not Specified|1|||
148983822|NCT03779841|537417452|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
149029825|NCT05025449|537587887|FG000|Overall Study|Withdrawal by Subject|1|||
148843473|NCT03364231|536906615|FG001|Overall Study|Reason Not Specified|0|||
148843474|NCT03364231|536906614|FG000|Overall Study|Disease Progression|0|||
148983823|NCT03779841|537417450|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
149029826|NCT05025449|537587887|FG000|Overall Study|Patient emergently taken to operating room|1|||
148843475|NCT03364231|536906615|FG001|Overall Study|Disease Progression|6|||
148843476|NCT02012218|536906621|FG000|Overall Study|Withdrawal by Subject|1|||
148843477|NCT02012218|536906622|FG001|Overall Study|Withdrawal by Subject|0|||
148843478|NCT02012218|536906623|FG002|Overall Study|Withdrawal by Subject|1|||
148843479|NCT02012218|536906624|FG003|Overall Study|Withdrawal by Subject|1|||
148843480|NCT02012218|536906625|FG004|Overall Study|Withdrawal by Subject|1|||
148843481|NCT02012218|536906621|FG000|Overall Study|Adverse Event|1|||
148843482|NCT02012218|536906622|FG001|Overall Study|Adverse Event|0|||
148843483|NCT02012218|536906623|FG002|Overall Study|Adverse Event|0|||
148843484|NCT02012218|536906624|FG003|Overall Study|Adverse Event|1|||
148983824|NCT03779841|537417451|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
148843485|NCT02012218|536906625|FG004|Overall Study|Adverse Event|0|||
148843486|NCT02012218|536906621|FG000|Overall Study|Lost to Follow-up|0|||
148843487|NCT02012218|536906622|FG001|Overall Study|Lost to Follow-up|1|||
148843488|NCT02012218|536906623|FG002|Overall Study|Lost to Follow-up|1|||
148843489|NCT02012218|536906624|FG003|Overall Study|Lost to Follow-up|0|||
148843490|NCT02012218|536906625|FG004|Overall Study|Lost to Follow-up|0|||
148843491|NCT02012218|536906621|FG000|Overall Study|Protocol Specified|1|||
148843492|NCT02012218|536906622|FG001|Overall Study|Protocol Specified|0|||
148843493|NCT02012218|536906623|FG002|Overall Study|Protocol Specified|0|||
148843494|NCT02012218|536906624|FG003|Overall Study|Protocol Specified|0|||
148843495|NCT02012218|536906625|FG004|Overall Study|Protocol Specified|0|||
148843496|NCT02012218|536906621|FG000|Overall Study|Protocol Deviation|1|||
148843497|NCT02012218|536906622|FG001|Overall Study|Protocol Deviation|0|||
148843498|NCT02012218|536906623|FG002|Overall Study|Protocol Deviation|0|||
148843499|NCT02012218|536906624|FG003|Overall Study|Protocol Deviation|0|||
148843500|NCT02012218|536906625|FG004|Overall Study|Protocol Deviation|0|||
148843501|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Death|2|||
148843502|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
148843503|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
148843504|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Physician Decision|1|||
148843505|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
148843506|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
148843507|NCT00786422|536906626|FG000|Rivaroxaban Treatment|Adverse Event|2|||
148843508|NCT00786422|536906626|FG000|Follow-up Period|Death|1|||
148843509|NCT00786422|536906626|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
148843510|NCT03484429|536906627|FG000|Overall Study|Withdrawal by Subject|1|||
148843511|NCT03484429|536906628|FG001|Overall Study|Withdrawal by Subject|0|||
148843512|NCT03484429|536906627|FG000|Overall Study|Adverse Event|2|||
148843513|NCT03484429|536906628|FG001|Overall Study|Adverse Event|0|||
148843514|NCT04466384|536906629|FG000|First Phase|Protocol Violation|1|||
148843515|NCT04466384|536906630|FG001|First Phase|Protocol Violation|0|||
148843516|NCT04466384|536906629|FG000|First Phase|Missing data|1|||
148843517|NCT04466384|536906630|FG001|First Phase|Missing data|0|||
148843518|NCT04466384|536906629|FG000|Cross Over Phase|Physician Decision|1|||
148843519|NCT04466384|536906630|FG001|Cross Over Phase|Physician Decision|0|||
148843520|NCT04466384|536906629|FG000|Cross Over Phase|Withdrawal by Subject|0|||
148843521|NCT04466384|536906630|FG001|Cross Over Phase|Withdrawal by Subject|1|||
148843522|NCT02268383|536906631|FG000|Overall Study|Death|12|||
148843523|NCT02268383|536906631|FG000|Overall Study|Lost to Follow-up|2|||
148843524|NCT02268383|536906631|FG000|Overall Study|Withdrawal by Subject|9|||
148843525|NCT02268383|536906631|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
148843526|NCT02268383|536906631|FG000|Overall Study|Protocol deviation|3|||
148843527|NCT02268383|536906631|FG000|Overall Study|Sponsor decision|22|||
148843528|NCT02268383|536906631|FG000|Overall Study|Not reported|12|||
148843529|NCT00943761|536906632|FG000|Overall Study|Lost to Follow-up|2|||
148843530|NCT00943761|536906633|FG001|Overall Study|Lost to Follow-up|0|||
148843531|NCT00943761|536906632|FG000|Overall Study|Withdrawal by Subject|2|||
148843532|NCT00943761|536906633|FG001|Overall Study|Withdrawal by Subject|1|||
148843533|NCT01342926|536906634|FG000|Overall Study|Adverse Event|5|||
148843534|NCT01342926|536906635|FG001|Overall Study|Adverse Event|8|||
148843535|NCT01342926|536906636|FG002|Overall Study|Adverse Event|10|||
148843536|NCT01342926|536906637|FG003|Overall Study|Adverse Event|7|||
148843537|NCT01342926|536906634|FG000|Overall Study|Lost to Follow-up|0|||
148843538|NCT01342926|536906635|FG001|Overall Study|Lost to Follow-up|1|||
148843539|NCT01342926|536906636|FG002|Overall Study|Lost to Follow-up|1|||
148843540|NCT01342926|536906637|FG003|Overall Study|Lost to Follow-up|0|||
148843541|NCT01342926|536906634|FG000|Overall Study|Investigator Discretion|2|||
148843542|NCT01342926|536906635|FG001|Overall Study|Investigator Discretion|2|||
148843543|NCT01342926|536906636|FG002|Overall Study|Investigator Discretion|0|||
148843544|NCT01342926|536906637|FG003|Overall Study|Investigator Discretion|0|||
148843545|NCT01342926|536906634|FG000|Overall Study|Withdrawal by Subject|2|||
148843546|NCT01342926|536906635|FG001|Overall Study|Withdrawal by Subject|4|||
148843547|NCT01342926|536906636|FG002|Overall Study|Withdrawal by Subject|3|||
148843548|NCT01342926|536906637|FG003|Overall Study|Withdrawal by Subject|5|||
148843549|NCT04162470|536906638|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
148983825|NCT03779841|537417452|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
148983826|NCT03779841|537417450|FG000|Treated (Safety) Population|Death|1|||
148983827|NCT03779841|537417451|FG001|Treated (Safety) Population|Death|0|||
148983828|NCT03779841|537417452|FG002|Treated (Safety) Population|Death|2|||
148843550|NCT03382912|536906639|FG000|Overall Study|Physician Decision|0|||
148843551|NCT03382912|536906640|FG001|Overall Study|Physician Decision|1|||
148843552|NCT03382912|536906639|FG000|Overall Study|Sponsor Decision|6|||
148843553|NCT03382912|536906640|FG001|Overall Study|Sponsor Decision|6|||
148843554|NCT03382912|536906639|FG000|Overall Study|Withdrawal by Subject|0|||
148843555|NCT03382912|536906640|FG001|Overall Study|Withdrawal by Subject|5|||
148843556|NCT04570384|536906643|FG000|Overall Study|Adverse Event|2|||
148983829|NCT01632579|537417453|FG000|Washout Period|Adverse Event|1|||
148843557|NCT04570384|536906644|FG001|Overall Study|Adverse Event|1|||
148843558|NCT04570384|536906643|FG000|Overall Study|Death|2|||
148843559|NCT04570384|536906644|FG001|Overall Study|Death|5|||
148843560|NCT04570384|536906643|FG000|Overall Study|Lost to Follow-up|1|||
148843561|NCT04570384|536906644|FG001|Overall Study|Lost to Follow-up|0|||
148843562|NCT04570384|536906643|FG000|Overall Study|Other|1|||
148843563|NCT04570384|536906644|FG001|Overall Study|Other|0|||
148843564|NCT04570384|536906643|FG000|Overall Study|Protocol Violation|0|||
148843565|NCT04570384|536906644|FG001|Overall Study|Protocol Violation|1|||
148843566|NCT04570384|536906643|FG000|Overall Study|Sponsor Decision|1|||
148843567|NCT04570384|536906644|FG001|Overall Study|Sponsor Decision|0|||
148843568|NCT04570384|536906643|FG000|Overall Study|Withdrawal by Subject|4|||
148843569|NCT04570384|536906644|FG001|Overall Study|Withdrawal by Subject|2|||
148843570|NCT00326001|536906645|FG000|Overall Study|Adverse Event|4|||
148843571|NCT00326001|536906646|FG001|Overall Study|Adverse Event|5|||
148843572|NCT00326001|536906645|FG000|Overall Study|Physician Decision|3|||
148843573|NCT00326001|536906646|FG001|Overall Study|Physician Decision|3|||
148983830|NCT01632579|537417454|FG001|Washout Period|Adverse Event|0|||
148983831|NCT01632579|537417455|FG002|Washout Period|Adverse Event|0|||
148983832|NCT01632579|537417456|FG003|Washout Period|Adverse Event|0|||
148983833|NCT01632579|537417457|FG004|Washout Period|Adverse Event|0|||
148983834|NCT01632579|537417458|FG005|Washout Period|Adverse Event|0|||
148983835|NCT01632579|537417459|FG006|Washout Period|Adverse Event|0|||
148983836|NCT01632579|537417460|FG007|Washout Period|Adverse Event|0|||
148983837|NCT01632579|537417461|FG008|Washout Period|Adverse Event|0|||
148983838|NCT01632579|537417453|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
148983839|NCT01632579|537417454|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
148983840|NCT01632579|537417455|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
148983841|NCT01632579|537417456|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
148983842|NCT01632579|537417457|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
148983843|NCT01632579|537417458|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
148983844|NCT01632579|537417459|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
148983845|NCT01632579|537417460|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
148983846|NCT01632579|537417461|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
148983847|NCT00898677|537417462|FG000|Overall Study|Adverse Event|0|||
148983848|NCT00898677|537417463|FG001|Overall Study|Adverse Event|0|||
148983849|NCT00898677|537417464|FG002|Overall Study|Adverse Event|1|||
148983850|NCT00898677|537417465|FG003|Overall Study|Adverse Event|0|||
148983851|NCT00898677|537417462|FG000|Overall Study|Lost to Follow-up|0|||
148983852|NCT00898677|537417463|FG001|Overall Study|Lost to Follow-up|0|||
148983853|NCT00898677|537417464|FG002|Overall Study|Lost to Follow-up|2|||
148983854|NCT00898677|537417465|FG003|Overall Study|Lost to Follow-up|0|||
148983855|NCT00898677|537417462|FG000|Overall Study|Protocol Violation|1|||
148983856|NCT00898677|537417463|FG001|Overall Study|Protocol Violation|1|||
148983857|NCT00898677|537417464|FG002|Overall Study|Protocol Violation|2|||
148983858|NCT00898677|537417465|FG003|Overall Study|Protocol Violation|0|||
148983859|NCT00898677|537417462|FG000|Overall Study|Withdrawal by Subject|0|||
148983860|NCT00898677|537417463|FG001|Overall Study|Withdrawal by Subject|0|||
148983861|NCT00898677|537417464|FG002|Overall Study|Withdrawal by Subject|0|||
148983862|NCT00898677|537417465|FG003|Overall Study|Withdrawal by Subject|1|||
148983863|NCT00898677|537417462|FG000|Overall Study|Not Treated: Adverse Event|0|||
148983864|NCT00898677|537417463|FG001|Overall Study|Not Treated: Adverse Event|2|||
148983865|NCT00898677|537417464|FG002|Overall Study|Not Treated: Adverse Event|1|||
148983866|NCT00898677|537417465|FG003|Overall Study|Not Treated: Adverse Event|0|||
148983867|NCT00898677|537417462|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
148983868|NCT00898677|537417463|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
148983869|NCT00898677|537417464|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
148983870|NCT00898677|537417465|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
148983871|NCT00898677|537417462|FG000|Overall Study|Not Treated: Pregnancy|0|||
148983872|NCT00898677|537417463|FG001|Overall Study|Not Treated: Pregnancy|0|||
148983873|NCT00898677|537417464|FG002|Overall Study|Not Treated: Pregnancy|1|||
148983874|NCT00898677|537417465|FG003|Overall Study|Not Treated: Pregnancy|0|||
148983875|NCT00898677|537417462|FG000|Overall Study|Not Treated: Protocol Violation|2|||
148843574|NCT03265145|536906647|FG000|Overall Study|Protocol Violation|2|||
148843575|NCT03265145|536906648|FG001|Overall Study|Protocol Violation|0|||
148843576|NCT03265145|536906647|FG000|Overall Study|Adverse Event|1|||
148843577|NCT03265145|536906648|FG001|Overall Study|Adverse Event|0|||
148843578|NCT03265145|536906647|FG000|Overall Study|Withdrawal by Subject|23|||
148843579|NCT03265145|536906648|FG001|Overall Study|Withdrawal by Subject|19|||
148843580|NCT03265145|536906647|FG000|Overall Study|Death|12|||
148983876|NCT00898677|537417463|FG001|Overall Study|Not Treated: Protocol Violation|0|||
148983877|NCT00898677|537417464|FG002|Overall Study|Not Treated: Protocol Violation|2|||
148983878|NCT00898677|537417465|FG003|Overall Study|Not Treated: Protocol Violation|0|||
148983879|NCT00898677|537417462|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
148983880|NCT00898677|537417463|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
148983881|NCT00898677|537417464|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
148843581|NCT03265145|536906648|FG001|Overall Study|Death|12|||
148843582|NCT03265145|536906647|FG000|Overall Study|Lost to Follow-up|13|||
148843583|NCT03265145|536906648|FG001|Overall Study|Lost to Follow-up|9|||
148843584|NCT03265145|536906647|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
148843585|NCT03265145|536906648|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
148843586|NCT03265145|536906647|FG000|Overall Study|Switched back to previous medication|1|||
148843587|NCT03265145|536906648|FG001|Overall Study|Switched back to previous medication|0|||
148843588|NCT03265145|536906647|FG000|Overall Study|Did not want to take medication|1|||
148843589|NCT03265145|536906648|FG001|Overall Study|Did not want to take medication|0|||
148843590|NCT03265145|536906647|FG000|Overall Study|Subject could not afford medication|0|||
148843591|NCT03265145|536906648|FG001|Overall Study|Subject could not afford medication|1|||
148843592|NCT03265145|536906647|FG000|Overall Study|Site closed|2|||
148843593|NCT03265145|536906648|FG001|Overall Study|Site closed|3|||
148843594|NCT03265145|536906647|FG000|Overall Study|Incorrectly randomized|16|||
148843595|NCT03265145|536906648|FG001|Overall Study|Incorrectly randomized|6|||
148843596|NCT03265145|536906647|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
148843597|NCT03265145|536906648|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
148843598|NCT03265145|536906647|FG000|Overall Study|Physician Decision|0|||
148843599|NCT03265145|536906648|FG001|Overall Study|Physician Decision|3|||
148843600|NCT03265145|536906647|FG000|Overall Study|Subject transferred to another facility|0|||
148843601|NCT03265145|536906648|FG001|Overall Study|Subject transferred to another facility|1|||
148843602|NCT04409834|536906649|FG000|Overall Study|Death|55|||
148843603|NCT04409834|536906650|FG001|Overall Study|Death|62|||
148843604|NCT02112656|536906654|FG000|Overall Study|Death|78|||
148843605|NCT02112656|536906655|FG001|Overall Study|Death|82|||
148843606|NCT02112656|536906654|FG000|Overall Study|Withdrawal by Subject|9|||
148843607|NCT02112656|536906655|FG001|Overall Study|Withdrawal by Subject|11|||
148843608|NCT02112656|536906654|FG000|Overall Study|Lost to Follow-up|2|||
148843609|NCT02112656|536906655|FG001|Overall Study|Lost to Follow-up|4|||
148843610|NCT02112656|536906654|FG000|Overall Study|Noncompliance|1|||
148843611|NCT02112656|536906655|FG001|Overall Study|Noncompliance|2|||
148843612|NCT04749745|536906656|FG000|Overall Study|Withdrawal by Subject|1|||
148843613|NCT04749745|536906657|FG001|Overall Study|Withdrawal by Subject|0|||
148843614|NCT01365455|536906662|FG000|Induction Period|Adverse Event|5|||
148843615|NCT01365455|536906663|FG001|Induction Period|Adverse Event|3|||
148843616|NCT01365455|536906664|FG002|Induction Period|Adverse Event|4|||
148843617|NCT01365455|536906665|FG003|Induction Period|Adverse Event|0|||
148843618|NCT01365455|536906666|FG004|Induction Period|Adverse Event|0|||
148843619|NCT01365455|536906662|FG000|Induction Period|Lack of Efficacy|1|||
148843620|NCT01365455|536906663|FG001|Induction Period|Lack of Efficacy|1|||
148843621|NCT01365455|536906664|FG002|Induction Period|Lack of Efficacy|0|||
148843622|NCT01365455|536906665|FG003|Induction Period|Lack of Efficacy|0|||
148843623|NCT01365455|536906666|FG004|Induction Period|Lack of Efficacy|0|||
148843624|NCT01365455|536906662|FG000|Induction Period|Pregnancy|0|||
148843625|NCT01365455|536906663|FG001|Induction Period|Pregnancy|1|||
148843626|NCT01365455|536906664|FG002|Induction Period|Pregnancy|0|||
148843627|NCT01365455|536906665|FG003|Induction Period|Pregnancy|0|||
148843628|NCT01365455|536906666|FG004|Induction Period|Pregnancy|0|||
148843629|NCT01365455|536906662|FG000|Induction Period|Protocol deviation|0|||
148843630|NCT01365455|536906663|FG001|Induction Period|Protocol deviation|1|||
148843631|NCT01365455|536906664|FG002|Induction Period|Protocol deviation|1|||
148843632|NCT01365455|536906665|FG003|Induction Period|Protocol deviation|0|||
148843633|NCT01365455|536906666|FG004|Induction Period|Protocol deviation|0|||
148843634|NCT01365455|536906662|FG000|Induction Period|Subject/guardian decision|9|||
148843635|NCT01365455|536906663|FG001|Induction Period|Subject/guardian decision|1|||
148843636|NCT01365455|536906664|FG002|Induction Period|Subject/guardian decision|8|||
148843637|NCT01365455|536906665|FG003|Induction Period|Subject/guardian decision|0|||
148843638|NCT01365455|536906666|FG004|Induction Period|Subject/guardian decision|0|||
148843639|NCT01365455|536906662|FG000|Induction Period|Lost to Follow-up|0|||
148843640|NCT01365455|536906663|FG001|Induction Period|Lost to Follow-up|0|||
148843641|NCT01365455|536906664|FG002|Induction Period|Lost to Follow-up|3|||
148843642|NCT01365455|536906665|FG003|Induction Period|Lost to Follow-up|0|||
148843643|NCT01365455|536906666|FG004|Induction Period|Lost to Follow-up|0|||
148843644|NCT01365455|536906662|FG000|Maintenance Period|Adverse Event|12|||
148843645|NCT01365455|536906663|FG001|Maintenance Period|Adverse Event|5|||
148843646|NCT01365455|536906664|FG002|Maintenance Period|Adverse Event|1|||
148843647|NCT01365455|536906665|FG003|Maintenance Period|Adverse Event|2|||
148843648|NCT01365455|536906666|FG004|Maintenance Period|Adverse Event|4|||
148843649|NCT01365455|536906662|FG000|Maintenance Period|Lack of Efficacy|10|||
148843650|NCT01365455|536906663|FG001|Maintenance Period|Lack of Efficacy|2|||
148843651|NCT01365455|536906664|FG002|Maintenance Period|Lack of Efficacy|0|||
148843652|NCT01365455|536906665|FG003|Maintenance Period|Lack of Efficacy|2|||
148843653|NCT01365455|536906666|FG004|Maintenance Period|Lack of Efficacy|2|||
148843654|NCT01365455|536906662|FG000|Maintenance Period|Lost to Follow-up|2|||
148843655|NCT01365455|536906663|FG001|Maintenance Period|Lost to Follow-up|4|||
148843656|NCT01365455|536906664|FG002|Maintenance Period|Lost to Follow-up|0|||
148843657|NCT01365455|536906665|FG003|Maintenance Period|Lost to Follow-up|0|||
148843658|NCT01365455|536906666|FG004|Maintenance Period|Lost to Follow-up|3|||
148843659|NCT01365455|536906662|FG000|Maintenance Period|Non-compliance with study treatment|0|||
148843660|NCT01365455|536906663|FG001|Maintenance Period|Non-compliance with study treatment|0|||
148843661|NCT01365455|536906664|FG002|Maintenance Period|Non-compliance with study treatment|0|||
148843662|NCT01365455|536906665|FG003|Maintenance Period|Non-compliance with study treatment|1|||
148843663|NCT01365455|536906666|FG004|Maintenance Period|Non-compliance with study treatment|0|||
148843664|NCT01365455|536906662|FG000|Maintenance Period|Physician Decision|0|||
148843665|NCT01365455|536906663|FG001|Maintenance Period|Physician Decision|1|||
148843666|NCT01365455|536906664|FG002|Maintenance Period|Physician Decision|0|||
148843667|NCT01365455|536906665|FG003|Maintenance Period|Physician Decision|0|||
148843668|NCT01365455|536906666|FG004|Maintenance Period|Physician Decision|1|||
148843669|NCT01365455|536906662|FG000|Maintenance Period|Pregnancy|0|||
148843670|NCT01365455|536906663|FG001|Maintenance Period|Pregnancy|4|||
148843671|NCT01365455|536906664|FG002|Maintenance Period|Pregnancy|0|||
148843672|NCT01365455|536906665|FG003|Maintenance Period|Pregnancy|0|||
148843673|NCT01365455|536906666|FG004|Maintenance Period|Pregnancy|2|||
148843674|NCT01365455|536906662|FG000|Maintenance Period|Protocol deviation|1|||
148843675|NCT01365455|536906663|FG001|Maintenance Period|Protocol deviation|1|||
148843676|NCT01365455|536906664|FG002|Maintenance Period|Protocol deviation|0|||
148843677|NCT01365455|536906665|FG003|Maintenance Period|Protocol deviation|0|||
148843678|NCT01365455|536906666|FG004|Maintenance Period|Protocol deviation|0|||
148843679|NCT01365455|536906662|FG000|Maintenance Period|Subject/guardian decision|4|||
148843680|NCT01365455|536906663|FG001|Maintenance Period|Subject/guardian decision|6|||
148843681|NCT01365455|536906664|FG002|Maintenance Period|Subject/guardian decision|2|||
148843682|NCT01365455|536906665|FG003|Maintenance Period|Subject/guardian decision|4|||
148843683|NCT01365455|536906666|FG004|Maintenance Period|Subject/guardian decision|1|||
148843684|NCT03965403|536906667|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
148843685|NCT02685826|536906670|FG000|Overall Study|Adverse Event|2|||
148843686|NCT02685826|536906671|FG001|Overall Study|Adverse Event|0|||
148843687|NCT02685826|536906672|FG002|Overall Study|Adverse Event|1|||
148843688|NCT02685826|536906670|FG000|Overall Study|Progressive Disease|2|||
148843689|NCT02685826|536906671|FG001|Overall Study|Progressive Disease|1|||
148843690|NCT02685826|536906672|FG002|Overall Study|Progressive Disease|0|||
148843691|NCT02685826|536906670|FG000|Overall Study|Withdrawal by Subject|2|||
148843692|NCT02685826|536906671|FG001|Overall Study|Withdrawal by Subject|0|||
148843693|NCT02685826|536906672|FG002|Overall Study|Withdrawal by Subject|0|||
148843694|NCT02685826|536906670|FG000|Overall Study|Full Clinical Hold by FDA|19|||
148843695|NCT02685826|536906671|FG001|Overall Study|Full Clinical Hold by FDA|9|||
148843696|NCT02685826|536906672|FG002|Overall Study|Full Clinical Hold by FDA|20|||
148843697|NCT02489318|536907849|FG000|Randomized|Withdrawal by Subject|0|||
148843698|NCT02489318|536907850|FG001|Randomized|Withdrawal by Subject|1|||
148843699|NCT02489318|536907849|FG000|Treated|Adverse Event|19|||
148843700|NCT02489318|536907850|FG001|Treated|Adverse Event|62|||
148843701|NCT02489318|536907849|FG000|Treated|Death|13|||
148843702|NCT02489318|536907850|FG001|Treated|Death|11|||
148843703|NCT02489318|536907849|FG000|Treated|Physician Decision|4|||
148843704|NCT02489318|536907850|FG001|Treated|Physician Decision|6|||
148843705|NCT02489318|536907849|FG000|Treated|Protocol Violation|1|||
148843706|NCT02489318|536907850|FG001|Treated|Protocol Violation|2|||
148843707|NCT02489318|536907849|FG000|Treated|Withdrawal by Subject|37|||
148843708|NCT02489318|536907850|FG001|Treated|Withdrawal by Subject|36|||
148843709|NCT02489318|536907849|FG000|Treated|Other: Progressive Disease|245|||
148843710|NCT02489318|536907850|FG001|Treated|Other: Progressive Disease|138|||
148843711|NCT02489318|536907849|FG000|Treated|Other|0|||
148843712|NCT02489318|536907850|FG001|Treated|Other|2|||
148843713|NCT02489318|536907849|FG000|Treated|Ongoing|0|||
148843714|NCT02489318|536907850|FG001|Treated|Ongoing|267|||
148843715|NCT01306643|536907851|FG000|Overall Study|Adverse Event|5|||
148843716|NCT01306643|536907851|FG000|Overall Study|Disease Progression|7|||
148843717|NCT01306643|536907851|FG000|Overall Study|Other: Change in Eligibility Status|1|||
149029827|NCT00256308|537587888|FG000|Overall Study|Death|2|||
149029828|NCT01537133|537587889|FG000|Overall Study|Withdrawal by Subject|2|||
149029829|NCT01537133|537587890|FG001|Overall Study|Withdrawal by Subject|0|||
148843718|NCT03801928|536907852|FG000|Overall Study|Adverse Event|1|||
148843719|NCT03801928|536907853|FG001|Overall Study|Adverse Event|0|||
148843720|NCT03801928|536907854|FG002|Overall Study|Adverse Event|1|||
148843721|NCT03801928|536907855|FG003|Overall Study|Adverse Event|2|||
148843722|NCT03801928|536907856|FG004|Overall Study|Adverse Event|0|||
148843723|NCT03801928|536907857|FG005|Overall Study|Adverse Event|2|||
148843724|NCT03801928|536907852|FG000|Overall Study|Lack of Efficacy|0|||
148843725|NCT03801928|536907853|FG001|Overall Study|Lack of Efficacy|0|||
148843726|NCT03801928|536907854|FG002|Overall Study|Lack of Efficacy|1|||
148843727|NCT03801928|536907855|FG003|Overall Study|Lack of Efficacy|0|||
148843728|NCT03801928|536907856|FG004|Overall Study|Lack of Efficacy|0|||
148843729|NCT03801928|536907857|FG005|Overall Study|Lack of Efficacy|0|||
148843730|NCT03801928|536907852|FG000|Overall Study|Lost to Follow-up|5|||
148843731|NCT03801928|536907853|FG001|Overall Study|Lost to Follow-up|1|||
149029830|NCT01537133|537587891|FG002|Overall Study|Withdrawal by Subject|0|||
148843732|NCT03801928|536907854|FG002|Overall Study|Lost to Follow-up|1|||
148843733|NCT03801928|536907855|FG003|Overall Study|Lost to Follow-up|4|||
148843734|NCT03801928|536907856|FG004|Overall Study|Lost to Follow-up|4|||
148843735|NCT03801928|536907857|FG005|Overall Study|Lost to Follow-up|2|||
148843736|NCT03801928|536907852|FG000|Overall Study|Withdrawal by Subject|0|||
148843737|NCT03801928|536907853|FG001|Overall Study|Withdrawal by Subject|0|||
148843738|NCT03801928|536907854|FG002|Overall Study|Withdrawal by Subject|2|||
148843739|NCT03801928|536907855|FG003|Overall Study|Withdrawal by Subject|1|||
148843740|NCT03801928|536907856|FG004|Overall Study|Withdrawal by Subject|0|||
148843741|NCT03801928|536907857|FG005|Overall Study|Withdrawal by Subject|0|||
148843742|NCT03801928|536907852|FG000|Overall Study|Other|0|||
148843743|NCT03801928|536907853|FG001|Overall Study|Other|2|||
148843744|NCT03801928|536907854|FG002|Overall Study|Other|0|||
148843745|NCT03801928|536907855|FG003|Overall Study|Other|1|||
148843746|NCT03801928|536907856|FG004|Overall Study|Other|0|||
148843747|NCT03801928|536907857|FG005|Overall Study|Other|1|||
148843748|NCT02370368|536907860|FG000|Overall Study|Adverse Event|1|||
148843749|NCT02370368|536907861|FG001|Overall Study|Adverse Event|2|||
148843750|NCT02370368|536907860|FG000|Overall Study|Withdrawal by Subject|5|||
148843751|NCT02370368|536907861|FG001|Overall Study|Withdrawal by Subject|4|||
148843752|NCT04908683|536907862|FG000|Overall Study|Failure to meet continuation criteria|34|||
148843753|NCT04908683|536907863|FG001|Overall Study|Failure to meet continuation criteria|22|||
148843754|NCT04908683|536907862|FG000|Overall Study|Initiated prohibited medication|3|||
148843755|NCT04908683|536907863|FG001|Overall Study|Initiated prohibited medication|0|||
148843756|NCT04908683|536907862|FG000|Overall Study|Randomized by mistake|1|||
148843757|NCT04908683|536907863|FG001|Overall Study|Randomized by mistake|0|||
148843758|NCT04908683|536907862|FG000|Overall Study|Lost to Follow-up|679|||
148843759|NCT04908683|536907863|FG001|Overall Study|Lost to Follow-up|341|||
148843760|NCT04908683|536907862|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
148843761|NCT04908683|536907863|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
148843762|NCT04908683|536907862|FG000|Overall Study|Physician Decision|44|||
148843763|NCT04908683|536907863|FG001|Overall Study|Physician Decision|35|||
148843764|NCT04908683|536907862|FG000|Overall Study|Technical problems|12|||
148843765|NCT04908683|536907863|FG001|Overall Study|Technical problems|9|||
148843766|NCT04908683|536907862|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
148843767|NCT04908683|536907863|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
148843768|NCT04908683|536907862|FG000|Overall Study|Protocol Violation|2|||
148843769|NCT04908683|536907863|FG001|Overall Study|Protocol Violation|0|||
148843770|NCT04908683|536907862|FG000|Overall Study|Withdrawal by Subject|1188|||
148843771|NCT04908683|536907863|FG001|Overall Study|Withdrawal by Subject|570|||
148843772|NCT04908683|536907862|FG000|Overall Study|Site Closure by Sponsor|6|||
148843773|NCT04908683|536907863|FG001|Overall Study|Site Closure by Sponsor|3|||
148843774|NCT04908683|536907862|FG000|Overall Study|Adverse Event|21|||
148843775|NCT04908683|536907863|FG001|Overall Study|Adverse Event|11|||
148843776|NCT04908683|536907862|FG000|Overall Study|Death|101|||
148843777|NCT04908683|536907863|FG001|Overall Study|Death|61|||
148843778|NCT04908683|536907862|FG000|Overall Study|Sponsor's decision|14398|||
148843779|NCT04908683|536907863|FG001|Overall Study|Sponsor's decision|7205|||
148843780|NCT04908683|536907862|FG000|Overall Study|Other|92|||
148843781|NCT04908683|536907863|FG001|Overall Study|Other|50|||
148843782|NCT04908683|536907862|FG000|Overall Study|Randomized not vaccinated|108|||
148843783|NCT04908683|536907863|FG001|Overall Study|Randomized not vaccinated|52|||
148843784|NCT00442416|536907864|FG000|Overall Study|Adverse Event|4|||
148843785|NCT00442416|536907865|FG001|Overall Study|Adverse Event|1|||
148843786|NCT00442416|536907864|FG000|Overall Study|Death|1|||
148843787|NCT00442416|536907865|FG001|Overall Study|Death|0|||
148843788|NCT00442416|536907864|FG000|Overall Study|Lack of Efficacy|2|||
148843789|NCT00442416|536907865|FG001|Overall Study|Lack of Efficacy|0|||
148843790|NCT00442416|536907864|FG000|Overall Study|Protocol Violation|2|||
148843791|NCT00442416|536907865|FG001|Overall Study|Protocol Violation|3|||
148843792|NCT00442416|536907864|FG000|Overall Study|Withdrew consent|1|||
149029831|NCT01537133|537587892|FG003|Overall Study|Withdrawal by Subject|0|||
149029832|NCT01537133|537587889|FG000|Overall Study|Lost to Follow-up|1|||
149029833|NCT01537133|537587890|FG001|Overall Study|Lost to Follow-up|0|||
148843793|NCT00442416|536907865|FG001|Overall Study|Withdrew consent|2|||
148843794|NCT00442416|536907864|FG000|Overall Study|Administrative/Other|27|||
148843795|NCT00442416|536907865|FG001|Overall Study|Administrative/Other|33|||
148843796|NCT01737762|536907868|FG000|Overall Study|Adverse Event|2|||
148843797|NCT01737762|536907869|FG001|Overall Study|Adverse Event|2|||
149029834|NCT01537133|537587891|FG002|Overall Study|Lost to Follow-up|0|||
148843798|NCT01737762|536907868|FG000|Overall Study|Lost to Follow-up|1|||
148843799|NCT01737762|536907869|FG001|Overall Study|Lost to Follow-up|0|||
148843800|NCT01737762|536907868|FG000|Overall Study|Withdrawal by Subject|2|||
148843801|NCT01737762|536907869|FG001|Overall Study|Withdrawal by Subject|2|||
148843802|NCT01737762|536907868|FG000|Overall Study|Progressive disease|1|||
148843803|NCT01737762|536907869|FG001|Overall Study|Progressive disease|2|||
148843804|NCT01737762|536907868|FG000|Overall Study|Physician Decision|1|||
149029835|NCT01537133|537587892|FG003|Overall Study|Lost to Follow-up|0|||
149029836|NCT00762463|537587894|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
149029837|NCT00762463|537587895|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
149029838|NCT00762463|537587896|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
149029839|NCT00762463|537587897|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
149029840|NCT00762463|537587894|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
149029841|NCT00762463|537587895|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
149029842|NCT00762463|537587896|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
149029843|NCT00762463|537587897|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
149029844|NCT00762463|537587894|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
149029845|NCT00762463|537587895|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
149029846|NCT00762463|537587896|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
149029847|NCT00762463|537587897|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
149029848|NCT00762463|537587894|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
149029849|NCT00762463|537587895|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
149029850|NCT00762463|537587896|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
149029851|NCT00762463|537587897|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
149029852|NCT00762463|537587894|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
149029853|NCT00762463|537587895|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
149029854|NCT00762463|537587896|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
148843805|NCT01737762|536907869|FG001|Overall Study|Physician Decision|1|||
148843806|NCT01737762|536907868|FG000|Overall Study|Moved from area|2|||
148843807|NCT01737762|536907869|FG001|Overall Study|Moved from area|1|||
148843808|NCT01737762|536907868|FG000|Overall Study|Trial termination|11|||
148843809|NCT01737762|536907869|FG001|Overall Study|Trial termination|9|||
148843810|NCT00503425|536907870|FG000|Overall Study|Participant files lost|6|||
148843811|NCT00503425|536907870|FG000|Overall Study|Adverse Event|5|||
148843812|NCT00503425|536907870|FG000|Overall Study|Lack of Efficacy|25|||
148843813|NCT00503425|536907870|FG000|Overall Study|Withdrawal by Subject|8|||
148843814|NCT00503425|536907870|FG000|Overall Study|Lost to Follow-up|3|||
148843815|NCT00503425|536907870|FG000|Overall Study|Death|3|||
148843816|NCT00503425|536907870|FG000|Overall Study|Missing Data/Unknown|4|||
148843817|NCT03328832|536907871|FG000|Overall Study|Lost to Follow-up|0|||
148843818|NCT03328832|536907872|FG001|Overall Study|Lost to Follow-up|1|||
148843819|NCT04872569|536907878|FG000|Overall Study|Withdrawal by Subject|2|||
148843820|NCT00714948|536907883|FG000|Overall Study|Adverse Event|2|||
148843821|NCT02708680|536907886|FG000|Overall Study|Withdrawal by Subject|4|||
148843822|NCT02708680|536907887|FG001|Overall Study|Withdrawal by Subject|12|||
148843823|NCT02708680|536907888|FG002|Overall Study|Withdrawal by Subject|12|||
148843824|NCT02708680|536907886|FG000|Overall Study|Death|4|||
148843825|NCT02708680|536907887|FG001|Overall Study|Death|19|||
148843826|NCT02708680|536907888|FG002|Overall Study|Death|21|||
148843827|NCT02708680|536907886|FG000|Overall Study|Lost to Follow-up|0|||
148843828|NCT02708680|536907887|FG001|Overall Study|Lost to Follow-up|3|||
148843829|NCT02708680|536907888|FG002|Overall Study|Lost to Follow-up|3|||
148843830|NCT02708680|536907886|FG000|Overall Study|Study Terminated By Sponsor|0|||
148843831|NCT02708680|536907887|FG001|Overall Study|Study Terminated By Sponsor|5|||
148843832|NCT02708680|536907888|FG002|Overall Study|Study Terminated By Sponsor|4|||
148843833|NCT02708680|536907886|FG000|Overall Study|Other than Specified|0|||
148843834|NCT02708680|536907887|FG001|Overall Study|Other than Specified|0|||
148843835|NCT02708680|536907888|FG002|Overall Study|Other than Specified|1|||
148843836|NCT02708680|536907886|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
148843837|NCT02708680|536907887|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
148843838|NCT02708680|536907888|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
148843839|NCT03390504|536907891|FG000|Overall Study|Lost to Follow-up|2|||
148843840|NCT03390504|536907892|FG001|Overall Study|Lost to Follow-up|4|||
148843841|NCT03390504|536907893|FG002|Overall Study|Lost to Follow-up|0|||
148843842|NCT03390504|536907894|FG003|Overall Study|Lost to Follow-up|1|||
148843843|NCT03390504|536907891|FG000|Overall Study|Withdrawal by Subject|3|||
148843844|NCT03390504|536907892|FG001|Overall Study|Withdrawal by Subject|15|||
148843845|NCT03390504|536907893|FG002|Overall Study|Withdrawal by Subject|5|||
148843846|NCT03390504|536907894|FG003|Overall Study|Withdrawal by Subject|2|||
148843847|NCT03390504|536907891|FG000|Overall Study|Other|1|||
148843848|NCT03390504|536907892|FG001|Overall Study|Other|2|||
148843849|NCT03390504|536907893|FG002|Overall Study|Other|2|||
148843850|NCT03390504|536907894|FG003|Overall Study|Other|6|||
148843851|NCT00980538|536907895|FG000|Overall Study|Lost to Follow-up|20|||
148843852|NCT00980538|536907895|FG000|Overall Study|Sponsor's Decision|4|||
148843853|NCT00980538|536907895|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
148843854|NCT00980538|536907895|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
148843855|NCT00980538|536907895|FG000|Overall Study|Switch to Commercially Available Medication|25|||
148843856|NCT00980538|536907895|FG000|Overall Study|Participant Non-Compliant|9|||
148843857|NCT00980538|536907895|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
148983882|NCT00898677|537417465|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
148983883|NCT00898677|537417462|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
148983884|NCT00898677|537417463|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
148774657|NCT02691013|536648639|FG001|Overall Study|Withdrawal by Subject|0|||
148774658|NCT02111785|536648643|FG000|Overall Study|Death|0|||
148774659|NCT02111785|536648644|FG001|Overall Study|Death|1|||
148774660|NCT02111785|536648645|FG002|Overall Study|Death|0|||
148774661|NCT02111785|536648646|FG003|Overall Study|Death|0|||
148774662|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Adverse Event|6|||
148774663|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Adverse Event|14|||
148774664|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Death|3|||
148774665|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Death|1|||
148774666|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
148774667|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
148774668|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
148774669|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
148774670|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
148774671|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
148774672|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
148774673|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
148774674|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
148774675|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
148774676|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Physician Decision|2|||
148774677|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Physician Decision|4|||
148774678|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Pregnancy|2|||
148774679|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Pregnancy|1|||
148774680|NCT02275780|536648649|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
148774681|NCT02275780|536648650|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
148774682|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
148774683|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
148774684|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
148774685|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
148774686|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
148774687|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
148774688|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
148774689|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
148774690|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
148774691|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
148774692|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
148774693|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
148774694|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
148774695|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
148774696|NCT02275780|536648649|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
148774697|NCT02275780|536648650|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
148774698|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
148774699|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
148774700|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
148774701|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
148774702|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
148774703|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
148774704|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
148774705|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
148774706|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
148774707|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
148774708|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
148774709|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
148774710|NCT02275780|536648649|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
148774711|NCT02275780|536648650|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
148774712|NCT02275780|536648649|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
148774713|NCT02275780|536648650|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
148774714|NCT02275780|536648649|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
148774715|NCT02275780|536648650|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
148774716|NCT02275780|536648649|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
148774717|NCT02275780|536648650|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
148774718|NCT02275780|536648649|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
148774719|NCT02275780|536648650|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
148774720|NCT02275780|536648649|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
148843858|NCT00980538|536907895|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
148843859|NCT00980538|536907895|FG000|Overall Study|Other|60|||
148843860|NCT00980538|536907895|FG000|Overall Study|Other|1|||
148843861|NCT00707993|536907896|FG000|Overall Study|Adverse Event|16|||
148843862|NCT00707993|536907897|FG001|Overall Study|Adverse Event|20|||
148843863|NCT00707993|536907896|FG000|Overall Study|Protocol Violation|4|||
148843864|NCT00707993|536907897|FG001|Overall Study|Protocol Violation|7|||
148843865|NCT00707993|536907896|FG000|Overall Study|Lost to Follow-up|0|||
148843866|NCT00707993|536907897|FG001|Overall Study|Lost to Follow-up|4|||
148843867|NCT00707993|536907896|FG000|Overall Study|Withdrawal by Subject|12|||
148843868|NCT00707993|536907897|FG001|Overall Study|Withdrawal by Subject|16|||
148843869|NCT00707993|536907896|FG000|Overall Study|Hyperglycemic Rescue|55|||
148843870|NCT00707993|536907897|FG001|Overall Study|Hyperglycemic Rescue|47|||
148843871|NCT00707993|536907896|FG000|Overall Study|Other|2|||
148843872|NCT00707993|536907897|FG001|Overall Study|Other|0|||
148843873|NCT03654274|536907898|FG000|Overall Study|Adverse Event|19|||
148843874|NCT03654274|536907899|FG001|Overall Study|Adverse Event|23|||
148843875|NCT03654274|536907900|FG002|Overall Study|Adverse Event|24|||
148843876|NCT03654274|536907898|FG000|Overall Study|Protocol Deviation|0|||
148843877|NCT03654274|536907899|FG001|Overall Study|Protocol Deviation|2|||
148843878|NCT03654274|536907900|FG002|Overall Study|Protocol Deviation|0|||
148843879|NCT03654274|536907898|FG000|Overall Study|Lost to Follow-up|8|||
148843880|NCT03654274|536907899|FG001|Overall Study|Lost to Follow-up|6|||
148843881|NCT03654274|536907900|FG002|Overall Study|Lost to Follow-up|5|||
148843882|NCT03654274|536907898|FG000|Overall Study|Withdrawal by Subject|46|||
148843883|NCT03654274|536907899|FG001|Overall Study|Withdrawal by Subject|25|||
148843884|NCT03654274|536907900|FG002|Overall Study|Withdrawal by Subject|33|||
148843885|NCT03654274|536907898|FG000|Overall Study|Lack of Efficacy|4|||
148843886|NCT03654274|536907899|FG001|Overall Study|Lack of Efficacy|5|||
148983885|NCT00898677|537417464|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
148983886|NCT00898677|537417465|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
148983887|NCT00898677|537417462|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
148983888|NCT00898677|537417463|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
148983889|NCT00898677|537417464|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
148983890|NCT00898677|537417465|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
148983891|NCT00898677|537417462|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
148983892|NCT00898677|537417463|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
148983893|NCT00898677|537417464|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
148983894|NCT00898677|537417465|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
148983895|NCT00898677|537417462|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
148983896|NCT00898677|537417463|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
148983897|NCT00898677|537417464|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
148983898|NCT00898677|537417465|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
148983899|NCT00898677|537417462|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
148983900|NCT00898677|537417463|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
148983901|NCT00898677|537417464|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
148983902|NCT00898677|537417465|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
148983903|NCT00898677|537417462|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
148983904|NCT00898677|537417463|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
148983905|NCT00898677|537417464|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
148983906|NCT00898677|537417465|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
148983907|NCT00836875|537417468|FG000|Overall Study|Death|3|||
148983908|NCT00836875|537417469|FG001|Overall Study|Death|2|||
148983909|NCT00836875|537417468|FG000|Overall Study|Withdrawal by Subject|0|||
148983910|NCT00836875|537417469|FG001|Overall Study|Withdrawal by Subject|1|||
148983911|NCT06748040|537417470|FG000|Overall Study|Death|3|||
148983912|NCT06748040|537417471|FG001|Overall Study|Death|4|||
148983913|NCT06748040|537417470|FG000|Overall Study|Lost to Follow-up|134|||
148983914|NCT06748040|537417471|FG001|Overall Study|Lost to Follow-up|132|||
148983915|NCT06748040|537417470|FG000|Overall Study|Withdrawal by Subject|3|||
148843887|NCT03654274|536907900|FG002|Overall Study|Lack of Efficacy|7|||
148843888|NCT03654274|536907898|FG000|Overall Study|Pregnancy|2|||
148843889|NCT03654274|536907899|FG001|Overall Study|Pregnancy|2|||
148843890|NCT03654274|536907900|FG002|Overall Study|Pregnancy|1|||
148843891|NCT03654274|536907898|FG000|Overall Study|Other|27|||
148843892|NCT03654274|536907899|FG001|Overall Study|Other|29|||
148843893|NCT03654274|536907900|FG002|Overall Study|Other|32|||
148843894|NCT03654274|536907898|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
148983916|NCT06748040|537417471|FG001|Overall Study|Withdrawal by Subject|5|||
148983917|NCT03794089|537419319|FG000|Overall Study|Lost to Follow-up|4|||
148983918|NCT03794089|537419320|FG001|Overall Study|Lost to Follow-up|1|||
148983919|NCT03794089|537419319|FG000|Overall Study|Withdrawal by Subject|2|||
148983920|NCT03794089|537419320|FG001|Overall Study|Withdrawal by Subject|0|||
148983921|NCT00129987|537419321|FG000|1st Educational Session|Withdrawal by Subject|141|||
148843895|NCT03654274|536907899|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
148843896|NCT03654274|536907900|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
148843897|NCT01265992|536907903|FG000|Overall Study|Lost to Follow-up|1|||
148843898|NCT01265992|536907903|FG000|Overall Study|Withdrawal by Subject|1|||
148843899|NCT01265992|536907903|FG000|Overall Study|Adverse Event|1|||
148843900|NCT01265992|536907903|FG000|Overall Study|Administrative reasons|2|||
148843901|NCT01265992|536907903|FG000|Overall Study|Stopped treatment|3|||
148843902|NCT01265992|536907903|FG000|Overall Study|Did not receive treatment|1|||
148843903|NCT01102491|536907904|FG000|Overall Study|Protocol Violation|11|||
148843904|NCT01102491|536907905|FG001|Overall Study|Protocol Violation|12|||
148843905|NCT02454530|536907906|FG000|Overall Study|Other|8|||
148843906|NCT02454530|536907907|FG001|Overall Study|Other|13|||
148843907|NCT02454530|536907906|FG000|Overall Study|Missing information|56|||
148843908|NCT02454530|536907907|FG001|Overall Study|Missing information|69|||
148843909|NCT02454530|536907906|FG000|Overall Study|Death|2|||
148843910|NCT02454530|536907907|FG001|Overall Study|Death|41|||
148843911|NCT02454530|536907906|FG000|Overall Study|Lost to Follow-up|4|||
148843912|NCT02454530|536907907|FG001|Overall Study|Lost to Follow-up|4|||
148843913|NCT05005273|536907908|FG000|Overall Study|Study Terminated|1|||
148843914|NCT05005273|536907909|FG001|Overall Study|Study Terminated|0|||
148843915|NCT02137070|536907911|FG000|Overall Study|Adverse Event|12|||
148843916|NCT02137070|536907912|FG001|Overall Study|Adverse Event|3|||
148843917|NCT02137070|536907911|FG000|Overall Study|Death|2|||
148843918|NCT02137070|536907912|FG001|Overall Study|Death|0|||
148983922|NCT00129987|537419322|FG001|1st Educational Session|Withdrawal by Subject|109|||
148983923|NCT00129987|537419321|FG000|1 Year|Withdrawal by Subject|32|||
148983924|NCT00129987|537419322|FG001|1 Year|Withdrawal by Subject|21|||
148983925|NCT00116805|537419323|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
148983926|NCT00116805|537419324|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
148983927|NCT00116805|537419323|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
148983928|NCT00116805|537419324|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
148983929|NCT00116805|537419323|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
148983930|NCT00116805|537419324|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
148983931|NCT00116805|537419323|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
148983932|NCT00116805|537419324|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
148983933|NCT00116805|537419323|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
148983934|NCT00116805|537419324|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
148983935|NCT00116805|537419323|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
148983936|NCT00116805|537419324|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
148983937|NCT00116805|537419323|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
148983938|NCT00116805|537419324|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
148983939|NCT00116805|537419323|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
148983940|NCT00116805|537419324|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
148983941|NCT00116805|537419323|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
148983942|NCT00116805|537419324|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
148983943|NCT00116805|537419323|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
148983944|NCT00116805|537419324|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
148983945|NCT00116805|537419323|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
148983946|NCT00116805|537419324|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
148983947|NCT00116805|537419323|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
148983948|NCT00116805|537419324|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
148983949|NCT00116805|537419323|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
148983950|NCT00116805|537419324|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
148983951|NCT00116805|537419323|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
148983952|NCT00116805|537419324|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
148983953|NCT00116805|537419323|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
148983954|NCT00116805|537419324|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
148983955|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
148983956|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
148983957|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
148983958|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
148983959|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
148983960|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
148983961|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
148983962|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
148983963|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
148843919|NCT02137070|536907911|FG000|Overall Study|Lost to Follow-up|24|||
148843920|NCT02137070|536907912|FG001|Overall Study|Lost to Follow-up|9|||
148843921|NCT02137070|536907911|FG000|Overall Study|Physician Decision|0|||
148843922|NCT02137070|536907912|FG001|Overall Study|Physician Decision|1|||
148843923|NCT02137070|536907911|FG000|Overall Study|Protocol Violation|18|||
148843924|NCT02137070|536907912|FG001|Overall Study|Protocol Violation|4|||
148843925|NCT02137070|536907911|FG000|Overall Study|Withdrawal by Subject|18|||
148843926|NCT02137070|536907912|FG001|Overall Study|Withdrawal by Subject|1|||
148843927|NCT03960684|536907913|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
148843928|NCT02151786|536907914|FG000|Overall Study|Unavailability of Case Report Form|26|||
148843929|NCT02151786|536907914|FG000|Overall Study|Outside the Contract Period|1|||
148843930|NCT02151786|536907914|FG000|Overall Study|Randomized, not Treated|1|||
148843931|NCT02151786|536907914|FG000|Overall Study|Unavailability of Information|8|||
148843932|NCT03533660|536907915|FG000|Overall Study|Withdrawal by Subject|2|||
148843933|NCT03533660|536907916|FG001|Overall Study|Withdrawal by Subject|2|||
148843934|NCT03533660|536907915|FG000|Overall Study|Death|2|||
148843935|NCT03533660|536907916|FG001|Overall Study|Death|4|||
148843936|NCT03533660|536907915|FG000|Overall Study|Adverse Event|0|||
148843937|NCT03533660|536907916|FG001|Overall Study|Adverse Event|2|||
148843938|NCT03761056|536907917|FG000|Overall Study|Death|8|||
148843939|NCT03761056|536907917|FG000|Overall Study|Enrolled but never treated|2|||
148843940|NCT03761056|536907917|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
148843941|NCT03761056|536907917|FG000|Overall Study|Investigator decision|1|||
148843942|NCT00996658|536907918|FG000|Overall Study|Adverse Event|2|||
148843943|NCT00996658|536907919|FG001|Overall Study|Adverse Event|5|||
148843944|NCT00996658|536907918|FG000|Overall Study|Protocol Violation|0|||
148843945|NCT00996658|536907919|FG001|Overall Study|Protocol Violation|1|||
148843946|NCT00996658|536907918|FG000|Overall Study|Lost to Follow-up|2|||
148843947|NCT00996658|536907919|FG001|Overall Study|Lost to Follow-up|5|||
148843948|NCT00996658|536907918|FG000|Overall Study|Non-compliance issues|3|||
148843949|NCT00996658|536907919|FG001|Overall Study|Non-compliance issues|3|||
148843950|NCT00996658|536907918|FG000|Overall Study|Other|9|||
148843951|NCT00996658|536907919|FG001|Overall Study|Other|7|||
148843952|NCT03941483|536907922|FG000|Overall Study|Miscellaneous|2|||
148843953|NCT03941483|536907923|FG001|Overall Study|Miscellaneous|3|||
148843954|NCT03941483|536907924|FG002|Overall Study|Miscellaneous|0|||
148843955|NCT03941483|536907922|FG000|Overall Study|Study Terminated by Sponsor|1|||
148843956|NCT03941483|536907923|FG001|Overall Study|Study Terminated by Sponsor|0|||
148843957|NCT03941483|536907924|FG002|Overall Study|Study Terminated by Sponsor|0|||
148843958|NCT03941483|536907922|FG000|Overall Study|Withdrawal by Subject|1|||
148843959|NCT03941483|536907923|FG001|Overall Study|Withdrawal by Subject|4|||
148843960|NCT03941483|536907924|FG002|Overall Study|Withdrawal by Subject|1|||
148843961|NCT03941483|536907922|FG000|Overall Study|Lost to Follow-up|2|||
148843962|NCT03941483|536907923|FG001|Overall Study|Lost to Follow-up|1|||
148843963|NCT03941483|536907924|FG002|Overall Study|Lost to Follow-up|8|||
148843964|NCT03941483|536907922|FG000|Overall Study|Death|3|||
148843965|NCT03941483|536907923|FG001|Overall Study|Death|2|||
148843966|NCT03941483|536907924|FG002|Overall Study|Death|6|||
148843967|NCT03154476|536907929|FG000|Overall Study|Lost to Follow-up|4|||
148843968|NCT03154476|536907930|FG001|Overall Study|Lost to Follow-up|4|||
148843969|NCT01444430|536907931|FG000|Overall Study|Withdrawal by Subject|53|||
148843970|NCT01444430|536907932|FG001|Overall Study|Withdrawal by Subject|72|||
148843971|NCT01444430|536907931|FG000|Overall Study|Death|6|||
148843972|NCT01444430|536907932|FG001|Overall Study|Death|8|||
148843973|NCT01444430|536907931|FG000|Overall Study|Lost to Follow-up|2|||
148843974|NCT01444430|536907932|FG001|Overall Study|Lost to Follow-up|0|||
148843975|NCT01444430|536907931|FG000|Overall Study|CRF termination module not completed.|0|||
148843976|NCT01444430|536907932|FG001|Overall Study|CRF termination module not completed.|1|||
148843977|NCT03816176|536907933|FG000|Overall Study|Miscellaneous|5|||
148843978|NCT03816176|536907933|FG000|Overall Study|Lack of Efficacy|4|||
148843979|NCT03816176|536907933|FG000|Overall Study|Adverse Event|3|||
148843980|NCT00972023|536909234|FG000|Overall Study|Withdrawal by Subject|1|||
148843981|NCT02595879|536909236|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
148843982|NCT02595879|536909237|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
148843983|NCT01147965|536909238|FG000|Overall Study|Progressive Disease|3|||
148983964|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
148983965|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
148983966|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
148983967|NCT00116805|537419323|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
148983968|NCT00116805|537419324|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
148843984|NCT01147965|536909239|FG001|Overall Study|Progressive Disease|3|||
148843985|NCT01147965|536909240|FG002|Overall Study|Progressive Disease|5|||
148843986|NCT01147965|536909241|FG003|Overall Study|Progressive Disease|9|||
148843987|NCT01147965|536909242|FG004|Overall Study|Progressive Disease|5|||
148843988|NCT01147965|536909243|FG005|Overall Study|Progressive Disease|5|||
148843989|NCT01147965|536909238|FG000|Overall Study|Death|0|||
148843990|NCT01147965|536909239|FG001|Overall Study|Death|0|||
148843991|NCT01147965|536909240|FG002|Overall Study|Death|1|||
148843992|NCT01147965|536909241|FG003|Overall Study|Death|1|||
148843993|NCT01147965|536909242|FG004|Overall Study|Death|0|||
148843994|NCT01147965|536909243|FG005|Overall Study|Death|2|||
148843995|NCT01147965|536909238|FG000|Overall Study|Withdrawal by Subject|0|||
148843996|NCT01147965|536909239|FG001|Overall Study|Withdrawal by Subject|0|||
148843997|NCT01147965|536909240|FG002|Overall Study|Withdrawal by Subject|1|||
148843998|NCT01147965|536909241|FG003|Overall Study|Withdrawal by Subject|1|||
148843999|NCT01147965|536909242|FG004|Overall Study|Withdrawal by Subject|0|||
148844000|NCT01147965|536909243|FG005|Overall Study|Withdrawal by Subject|0|||
148844001|NCT01147965|536909238|FG000|Overall Study|Administration Of Alternative Therapy|0|||
148844002|NCT01147965|536909239|FG001|Overall Study|Administration Of Alternative Therapy|0|||
148844003|NCT01147965|536909240|FG002|Overall Study|Administration Of Alternative Therapy|0|||
148844004|NCT01147965|536909241|FG003|Overall Study|Administration Of Alternative Therapy|0|||
148844005|NCT01147965|536909242|FG004|Overall Study|Administration Of Alternative Therapy|0|||
148844006|NCT01147965|536909243|FG005|Overall Study|Administration Of Alternative Therapy|1|||
148844007|NCT01147965|536909238|FG000|Overall Study|Other|0|||
148844008|NCT01147965|536909239|FG001|Overall Study|Other|0|||
148844009|NCT01147965|536909240|FG002|Overall Study|Other|0|||
148844010|NCT01147965|536909241|FG003|Overall Study|Other|3|||
148844011|NCT01147965|536909242|FG004|Overall Study|Other|1|||
148844012|NCT01147965|536909243|FG005|Overall Study|Other|0|||
148844013|NCT01650831|536909244|FG000|Overall Study|Screen failure|1|||
148844014|NCT04988295|536909245|FG000|Overall Study|Withdrawal by Subject|9|||
148844015|NCT04988295|536909246|FG001|Overall Study|Withdrawal by Subject|29|||
148844016|NCT04988295|536909247|FG002|Overall Study|Withdrawal by Subject|6|||
148844017|NCT04988295|536909248|FG003|Overall Study|Withdrawal by Subject|0|||
148844018|NCT04988295|536909245|FG000|Overall Study|Lost to Follow-up|1|||
148844019|NCT04988295|536909246|FG001|Overall Study|Lost to Follow-up|0|||
148844020|NCT04988295|536909247|FG002|Overall Study|Lost to Follow-up|0|||
148844021|NCT04988295|536909248|FG003|Overall Study|Lost to Follow-up|0|||
148844022|NCT04988295|536909245|FG000|Overall Study|Study participation ongoing|186|||
148844023|NCT04988295|536909246|FG001|Overall Study|Study participation ongoing|169|||
148844024|NCT04988295|536909247|FG002|Overall Study|Study participation ongoing|99|||
148844025|NCT04988295|536909248|FG003|Overall Study|Study participation ongoing|119|||
148844026|NCT01465386|536909253|FG000|Overall Study|Lack of Efficacy|3|||
148844027|NCT01465386|536909253|FG000|Overall Study|Adverse Event|1|||
148844028|NCT02479880|536909256|FG000|Overall Study|Study Terminated by Sponsor|13|||
148844029|NCT02479880|536909257|FG001|Overall Study|Study Terminated by Sponsor|12|||
148844030|NCT02479880|536909256|FG000|Overall Study|Pregnancy|0|||
148844031|NCT02479880|536909257|FG001|Overall Study|Pregnancy|1|||
148844032|NCT00355368|536909258|FG000|Overall Study|Protocol Violation|8|||
148844033|NCT00355368|536909259|FG001|Overall Study|Protocol Violation|7|||
148844034|NCT00355368|536909258|FG000|Overall Study|cardiac arrest prior to intubation|2|||
148844035|NCT00355368|536909259|FG001|Overall Study|cardiac arrest prior to intubation|2|||
148844036|NCT01279044|536909260|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
148844037|NCT01279044|536909261|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
148844038|NCT01279044|536909262|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
148844039|NCT01279044|536909260|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
148844040|NCT01279044|536909261|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
148844041|NCT01279044|536909262|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
148844042|NCT01279044|536909260|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
148844043|NCT01279044|536909261|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
148844044|NCT01279044|536909262|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
148844045|NCT01408277|536909263|FG000|Overall Study|Adverse Event|3|||
148844046|NCT01408277|536909264|FG001|Overall Study|Adverse Event|4|||
148844047|NCT01408277|536909263|FG000|Overall Study|Lost to Follow-up|1|||
148844048|NCT01408277|536909264|FG001|Overall Study|Lost to Follow-up|0|||
148844049|NCT01408277|536909263|FG000|Overall Study|Withdrawal by Subject|2|||
148844050|NCT01408277|536909264|FG001|Overall Study|Withdrawal by Subject|0|||
148844051|NCT01408277|536909263|FG000|Overall Study|Protocol Violation|2|||
148844052|NCT01408277|536909264|FG001|Overall Study|Protocol Violation|0|||
148844053|NCT02840253|536909265|FG000|Overall Study|Unsuccessful block|4|||
148844054|NCT02763059|536909268|FG000|Overall Study|Lost to Follow-up|4|||
148844055|NCT02763059|536909269|FG001|Overall Study|Lost to Follow-up|1|||
148844056|NCT02763059|536909270|FG002|Overall Study|Lost to Follow-up|6|||
148844057|NCT02763059|536909268|FG000|Overall Study|Withdrawal by Subject|1|||
148844058|NCT02763059|536909269|FG001|Overall Study|Withdrawal by Subject|0|||
148844059|NCT02763059|536909270|FG002|Overall Study|Withdrawal by Subject|3|||
148844060|NCT03369665|536909271|FG000|Overall Study|Adverse Event|3|||
148844061|NCT03369665|536909271|FG000|Overall Study|Lost to Follow-up|7|||
148844062|NCT03369665|536909271|FG000|Overall Study|Withdrawal by Subject|15|||
148844063|NCT03369665|536909271|FG000|Overall Study|Progression Disease|2|||
148844064|NCT03369665|536909271|FG000|Overall Study|Not classified|3|||
148844065|NCT03901963|536909272|FG000|Overall Study|Lost to Follow-up|1|||
148844066|NCT03901963|536909273|FG001|Overall Study|Lost to Follow-up|1|||
148844067|NCT03901963|536909272|FG000|Overall Study|Physician Decision|1|||
148844068|NCT03901963|536909273|FG001|Overall Study|Physician Decision|2|||
148844069|NCT03901963|536909272|FG000|Overall Study|Protocol Violation|1|||
148844070|NCT03901963|536909273|FG001|Overall Study|Protocol Violation|1|||
148844071|NCT03901963|536909272|FG000|Overall Study|Withdrawal by Subject|4|||
148844072|NCT03901963|536909273|FG001|Overall Study|Withdrawal by Subject|11|||
148844073|NCT03901963|536909272|FG000|Overall Study|Ongoing|84|||
148844074|NCT03901963|536909273|FG001|Overall Study|Ongoing|73|||
148844075|NCT03901963|536909272|FG000|Overall Study|Randomized but not treated|3|||
148844076|NCT03901963|536909273|FG001|Overall Study|Randomized but not treated|3|||
148844077|NCT05226598|536909279|FG000|Overall Study|Death|186|||
148844078|NCT05226598|536909280|FG001|Overall Study|Death|191|||
148844079|NCT05226598|536909279|FG000|Overall Study|Withdrawal by Subject|6|||
148844080|NCT05226598|536909280|FG001|Overall Study|Withdrawal by Subject|6|||
148844081|NCT05226598|536909279|FG000|Overall Study|Ongoing|174|||
148844082|NCT05226598|536909280|FG001|Overall Study|Ongoing|176|||
148844083|NCT02959463|536909281|FG000|Overall Study|Adverse Event|1|||
148844084|NCT02959463|536909282|FG001|Overall Study|Adverse Event|1|||
148844085|NCT02959463|536909281|FG000|Overall Study|Death|1|||
148844086|NCT02959463|536909282|FG001|Overall Study|Death|0|||
148844087|NCT02959463|536909281|FG000|Overall Study|Withdrawal by Subject|1|||
148844088|NCT02959463|536909282|FG001|Overall Study|Withdrawal by Subject|0|||
148844089|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
148844090|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
148844091|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
148844092|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
148844093|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
148844094|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
148844095|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
148844096|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
148844097|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
148844098|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
148844099|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
148844100|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
148844101|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
148844102|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
148844103|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
148844104|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
148844105|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
148844106|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
148844107|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
148844108|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
148844109|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
148844110|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
148844111|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
148844112|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
148844113|NCT01672879|536909283|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
148844114|NCT01672879|536909284|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
148844115|NCT01672879|536909285|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
148844116|NCT01672879|536909283|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
148844117|NCT01672879|536909284|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
148844118|NCT01672879|536909285|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
148844119|NCT01672879|536909283|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
148844120|NCT01672879|536909284|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
148844121|NCT01672879|536909285|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
148844122|NCT01672879|536909283|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
148844123|NCT01672879|536909284|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
148844124|NCT01672879|536909285|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
148844125|NCT01672879|536909283|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
148844126|NCT01672879|536909284|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
148844127|NCT01672879|536909285|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
148844128|NCT01775553|536909286|FG000|Overall Study|Adverse Event|1|||
148844129|NCT01775553|536909286|FG000|Overall Study|Disease Progression|12|||
148844130|NCT03748641|536909287|FG000|Overall Study|Ongoing|155|||
148844131|NCT03748641|536909288|FG001|Overall Study|Ongoing|148|||
148844132|NCT03748641|536909289|FG002|Overall Study|Ongoing|66|||
148844133|NCT03748641|536909290|FG003|Overall Study|Ongoing|79|||
148844134|NCT03748641|536909291|FG004|Overall Study|Ongoing|84|||
148983969|NCT00116805|537419323|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
148983970|NCT00116805|537419324|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
148844135|NCT03748641|536909287|FG000|Overall Study|Death|54|||
148844136|NCT03748641|536909288|FG001|Overall Study|Death|59|||
148844137|NCT03748641|536909289|FG002|Overall Study|Death|51|||
148844138|NCT03748641|536909290|FG003|Overall Study|Death|42|||
148844139|NCT03748641|536909291|FG004|Overall Study|Death|9|||
148844140|NCT03748641|536909287|FG000|Overall Study|Lost to Follow-up|0|||
148844141|NCT03748641|536909288|FG001|Overall Study|Lost to Follow-up|2|||
148844142|NCT03748641|536909289|FG002|Overall Study|Lost to Follow-up|1|||
148844143|NCT03748641|536909290|FG003|Overall Study|Lost to Follow-up|0|||
148844144|NCT03748641|536909291|FG004|Overall Study|Lost to Follow-up|0|||
148844145|NCT03748641|536909287|FG000|Overall Study|Withdrawal by Subject|3|||
148844146|NCT03748641|536909288|FG001|Overall Study|Withdrawal by Subject|2|||
148844147|NCT03748641|536909289|FG002|Overall Study|Withdrawal by Subject|5|||
148844148|NCT03748641|536909290|FG003|Overall Study|Withdrawal by Subject|3|||
148844149|NCT03748641|536909291|FG004|Overall Study|Withdrawal by Subject|2|||
148844150|NCT04834726|536909292|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
148844151|NCT04834726|536909293|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
148844152|NCT04834726|536909294|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
148844153|NCT04834726|536909295|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
148844154|NCT04834726|536909296|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
148844155|NCT04834726|536909297|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
148844156|NCT04834726|536909298|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
148844157|NCT04834726|536909299|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
148844158|NCT04834726|536909300|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
148844159|NCT03810014|536909301|FG000|Overall Study|Pregnancy|2|||
148844160|NCT03810014|536909302|FG001|Overall Study|Pregnancy|2|||
148844161|NCT03810014|536909303|FG002|Overall Study|Pregnancy|0|||
148844162|NCT03810014|536909304|FG003|Overall Study|Pregnancy|2|||
148844163|NCT03606486|536909308|FG000|Overall Study|Unable to collect sample|5|||
148844164|NCT02503085|536909322|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
148844165|NCT02503085|536909323|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
148844166|NCT02503085|536909324|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
148844167|NCT02503085|536909325|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
148844168|NCT01162473|536909330|FG000|Overall Study|Adverse Event|2|||
148844169|NCT01162473|536909331|FG001|Overall Study|Adverse Event|1|||
148844170|NCT01162473|536909330|FG000|Overall Study|Withdrawal by Subject|0|||
148844171|NCT01162473|536909331|FG001|Overall Study|Withdrawal by Subject|4|||
148844172|NCT01144416|536909332|FG000|Intervention Period|Adverse Event|5|||
148844173|NCT01144416|536909333|FG001|Intervention Period|Adverse Event|6|||
148844174|NCT01144416|536909332|FG000|Intervention Period|Insufficient ovarian response|11|||
148844175|NCT01144416|536909333|FG001|Intervention Period|Insufficient ovarian response|17|||
148844176|NCT01144416|536909332|FG000|Intervention Period|Risk of OHSS|0|||
148844177|NCT01144416|536909333|FG001|Intervention Period|Risk of OHSS|1|||
148983971|NCT00116805|537419323|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
148983972|NCT00116805|537419324|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
148983973|NCT00116805|537419323|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
148983974|NCT00116805|537419324|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
148983975|NCT00116805|537419323|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
148983976|NCT00116805|537419324|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
148774721|NCT02275780|536648650|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
148774722|NCT02275780|536648649|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
148774723|NCT02275780|536648650|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
148774724|NCT01054300|536648651|FG000|Period 1|Adverse Event|1|||
148774725|NCT01054300|536648652|FG001|Period 1|Adverse Event|0|||
148774726|NCT01054300|536648653|FG002|Period 1|Adverse Event|0|||
148774727|NCT01054300|536648654|FG003|Period 1|Adverse Event|0|||
148774728|NCT01054300|536648651|FG000|Period 2|Withdrawal by Subject|0|||
148774729|NCT01054300|536648652|FG001|Period 2|Withdrawal by Subject|0|||
148774730|NCT01054300|536648653|FG002|Period 2|Withdrawal by Subject|1|||
148774731|NCT01054300|536648654|FG003|Period 2|Withdrawal by Subject|0|||
148774732|NCT00738881|536648655|FG000|Overall Study|Withdrawal by Subject|0|||
148774733|NCT00738881|536648656|FG001|Overall Study|Withdrawal by Subject|2|||
148774734|NCT00759785|536648657|FG000|Overall Study|Participant sample not evaluable|11|||
148774735|NCT00759785|536648658|FG001|Overall Study|Participant sample not evaluable|2|||
148774736|NCT00759785|536648657|FG000|Overall Study|Participant sample lost|0|||
148774737|NCT00759785|536648658|FG001|Overall Study|Participant sample lost|1|||
148774738|NCT00759785|536648657|FG000|Overall Study|Protocol Violation|1|||
148774739|NCT00759785|536648658|FG001|Overall Study|Protocol Violation|0|||
148774740|NCT00759785|536648657|FG000|Overall Study|Physician Decision|0|||
148774741|NCT00759785|536648658|FG001|Overall Study|Physician Decision|1|||
148774742|NCT00759785|536648657|FG000|Overall Study|Withdrawal by Subject|0|||
148774743|NCT00759785|536648658|FG001|Overall Study|Withdrawal by Subject|1|||
148774744|NCT03671564|536648659|FG000|Overall Study|Progressive Disease|3|||
148774745|NCT03671564|536648660|FG001|Overall Study|Progressive Disease|5|||
148774746|NCT03671564|536648661|FG002|Overall Study|Progressive Disease|3|||
148774747|NCT03671564|536648659|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
148774748|NCT03671564|536648660|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
148774749|NCT03671564|536648661|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
148774750|NCT03671564|536648659|FG000|Overall Study|Withdrawal by Subject|1|||
148774751|NCT03671564|536648660|FG001|Overall Study|Withdrawal by Subject|1|||
148774752|NCT03671564|536648661|FG002|Overall Study|Withdrawal by Subject|0|||
148774753|NCT01282164|536648662|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
148774754|NCT01282164|536648663|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
148774755|NCT04521621|536648664|FG000|Overall Study|Death|17|||
148774756|NCT04521621|536648665|FG001|Overall Study|Death|8|||
148774757|NCT04521621|536648666|FG002|Overall Study|Death|8|||
148774758|NCT04521621|536648667|FG003|Overall Study|Death|5|||
148774759|NCT04521621|536648668|FG004|Overall Study|Death|2|||
148774760|NCT04521621|536648669|FG005|Overall Study|Death|7|||
148774761|NCT04521621|536648670|FG006|Overall Study|Death|0|||
148774762|NCT04521621|536648671|FG007|Overall Study|Death|0|||
148774763|NCT04521621|536648664|FG000|Overall Study|Study Terminated by Sponsor|4|||
148774764|NCT04521621|536648665|FG001|Overall Study|Study Terminated by Sponsor|6|||
148774765|NCT04521621|536648666|FG002|Overall Study|Study Terminated by Sponsor|8|||
148774766|NCT04521621|536648667|FG003|Overall Study|Study Terminated by Sponsor|0|||
148774767|NCT04521621|536648668|FG004|Overall Study|Study Terminated by Sponsor|1|||
148774768|NCT04521621|536648669|FG005|Overall Study|Study Terminated by Sponsor|7|||
148774769|NCT04521621|536648670|FG006|Overall Study|Study Terminated by Sponsor|0|||
148774770|NCT04521621|536648671|FG007|Overall Study|Study Terminated by Sponsor|0|||
148774771|NCT04521621|536648664|FG000|Overall Study|Withdrawal by Subject|0|||
148774772|NCT04521621|536648665|FG001|Overall Study|Withdrawal by Subject|0|||
148774773|NCT04521621|536648666|FG002|Overall Study|Withdrawal by Subject|1|||
148774774|NCT04521621|536648667|FG003|Overall Study|Withdrawal by Subject|1|||
148774775|NCT04521621|536648668|FG004|Overall Study|Withdrawal by Subject|0|||
148774776|NCT04521621|536648669|FG005|Overall Study|Withdrawal by Subject|0|||
148774777|NCT04521621|536648670|FG006|Overall Study|Withdrawal by Subject|0|||
148844178|NCT01144416|536909332|FG000|Intervention Period|Too high ovarian response|4|||
148844179|NCT01144416|536909333|FG001|Intervention Period|Too high ovarian response|2|||
148844180|NCT01144416|536909332|FG000|Intervention Period|No/too few/bad oocytes|7|||
148844181|NCT01144416|536909333|FG001|Intervention Period|No/too few/bad oocytes|5|||
148844182|NCT01144416|536909332|FG000|Intervention Period|No or abnormal fertilization|25|||
148844183|NCT01144416|536909333|FG001|Intervention Period|No or abnormal fertilization|10|||
148844184|NCT01144416|536909332|FG000|Intervention Period|No/too few/bad quality embryos|3|||
148844185|NCT01144416|536909333|FG001|Intervention Period|No/too few/bad quality embryos|3|||
148844186|NCT01144416|536909332|FG000|Intervention Period|Other|7|||
148844187|NCT01144416|536909333|FG001|Intervention Period|Other|5|||
148844188|NCT00124072|536909334|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
148774778|NCT04521621|536648671|FG007|Overall Study|Withdrawal by Subject|0|||
148774779|NCT04521621|536648664|FG000|Overall Study|Allocated in error without study intervention|1|||
148774780|NCT04521621|536648665|FG001|Overall Study|Allocated in error without study intervention|0|||
148774781|NCT04521621|536648666|FG002|Overall Study|Allocated in error without study intervention|0|||
148774782|NCT04521621|536648667|FG003|Overall Study|Allocated in error without study intervention|0|||
148774783|NCT04521621|536648668|FG004|Overall Study|Allocated in error without study intervention|0|||
148774784|NCT04521621|536648669|FG005|Overall Study|Allocated in error without study intervention|0|||
148774785|NCT04521621|536648670|FG006|Overall Study|Allocated in error without study intervention|0|||
148774786|NCT04521621|536648671|FG007|Overall Study|Allocated in error without study intervention|0|||
148844189|NCT00124072|536909335|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
148844190|NCT00124072|536909336|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
148844191|NCT00124072|536909337|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
148844192|NCT00124072|536909334|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
148844193|NCT00124072|536909335|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
148844194|NCT00124072|536909336|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
148844195|NCT00124072|536909337|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
148844196|NCT00124072|536909334|FG000|Overall Study|Death|499|||
148844197|NCT00124072|536909335|FG001|Overall Study|Death|484|||
148844198|NCT00124072|536909336|FG002|Overall Study|Death|471|||
148844199|NCT00124072|536909337|FG003|Overall Study|Death|480|||
148844200|NCT02534883|536909338|FG000|Overall Study|Early Termination|8|||
148844201|NCT02534883|536909339|FG001|Overall Study|Early Termination|3|||
148844202|NCT00886769|536909340|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
148844203|NCT00886769|536909341|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
148774787|NCT05178641|536648676|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
148844204|NCT00778336|536909342|FG000|Index Procedure-Discharge|Death|6|||
148844205|NCT00778336|536909343|FG001|Index Procedure-Discharge|Death|3|||
148844206|NCT00778336|536909344|FG002|Index Procedure-Discharge|Death|2|||
148844207|NCT00778336|536909345|FG003|Index Procedure-Discharge|Death|0|||
148844208|NCT00778336|536909342|FG000|3 Month Follow Up|Lost to Follow-up|15|||
148844209|NCT00778336|536909343|FG001|3 Month Follow Up|Lost to Follow-up|20|||
148983977|NCT00116805|537419323|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
148983978|NCT00116805|537419324|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
148774788|NCT05178641|536648677|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
148844210|NCT00778336|536909344|FG002|3 Month Follow Up|Lost to Follow-up|3|||
148844211|NCT00778336|536909345|FG003|3 Month Follow Up|Lost to Follow-up|0|||
148844212|NCT00778336|536909342|FG000|3 Month Follow Up|Death|8|||
149005488|NCT03217747|537497893|FG001|Overall Study|Removal of sole target lesion|0|||
148844213|NCT00778336|536909343|FG001|3 Month Follow Up|Death|3|||
148844214|NCT00778336|536909344|FG002|3 Month Follow Up|Death|2|||
148844215|NCT00778336|536909345|FG003|3 Month Follow Up|Death|0|||
148844216|NCT00414076|536909346|FG000|Overall Study|Progression|1|||
148844217|NCT00414076|536909347|FG001|Overall Study|Progression|2|||
148844218|NCT00414076|536909346|FG000|Overall Study|Withdrawal by Subject|1|||
148844219|NCT00414076|536909347|FG001|Overall Study|Withdrawal by Subject|3|||
148844220|NCT00414076|536909346|FG000|Overall Study|Adverse Event|1|||
148844221|NCT00414076|536909347|FG001|Overall Study|Adverse Event|0|||
148844222|NCT04417257|536909348|FG000|Pilot Phase 2|Adverse Event|2|||
148844223|NCT04417257|536909349|FG001|Pilot Phase 2|Adverse Event|0|||
148844224|NCT04417257|536909348|FG000|Pilot Phase 2|Death|14|||
148844225|NCT04417257|536909349|FG001|Pilot Phase 2|Death|11|||
148844226|NCT04417257|536909348|FG000|Pilot Phase 2|Lost to Follow-up|3|||
148844227|NCT04417257|536909349|FG001|Pilot Phase 2|Lost to Follow-up|5|||
148844228|NCT04417257|536909348|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
148844229|NCT04417257|536909349|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
148844230|NCT04417257|536909348|FG000|Pilot Phase 2|Hepatic impairment|1|||
148844231|NCT04417257|536909349|FG001|Pilot Phase 2|Hepatic impairment|0|||
148844232|NCT04417257|536909348|FG000|Pilot Phase 2|Unblinding|1|||
148844233|NCT04417257|536909349|FG001|Pilot Phase 2|Unblinding|0|||
148844234|NCT04417257|536909348|FG000|Pilot Phase 2|All other|0|||
148844235|NCT04417257|536909349|FG001|Pilot Phase 2|All other|2|||
148844236|NCT04417257|536909348|FG000|Phase 3 Extension|Death|3|||
148844237|NCT04417257|536909349|FG001|Phase 3 Extension|Death|1|||
148844238|NCT04417257|536909348|FG000|Phase 3 Extension|Lost to Follow-up|4|||
148844239|NCT04417257|536909349|FG001|Phase 3 Extension|Lost to Follow-up|2|||
148844240|NCT04417257|536909348|FG000|Phase 3 Extension|Patient withdrawal|2|||
148844241|NCT04417257|536909349|FG001|Phase 3 Extension|Patient withdrawal|2|||
148844242|NCT04417257|536909348|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
148844243|NCT04417257|536909349|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
148844244|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
148844245|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
148844246|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
148844247|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
148844248|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
148844249|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
148844250|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
148844251|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
148844252|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
148844253|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
148844254|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
148844255|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
148774789|NCT05178641|536648676|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
148774790|NCT05178641|536648677|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
148774791|NCT02122770|536648681|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
148774792|NCT02122770|536648682|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
148774793|NCT02122770|536648683|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
148774794|NCT02122770|536648684|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
148774795|NCT02122770|536648685|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
148774796|NCT02122770|536648686|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
148774797|NCT02122770|536648681|FG000|Part A: Drug-drug Interaction 2|Other|0|||
148774798|NCT02122770|536648682|FG001|Part A: Drug-drug Interaction 2|Other|0|||
148844256|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
148844257|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
148844258|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
148983979|NCT00116805|537419323|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
148983980|NCT00116805|537419324|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
148983981|NCT00116805|537419323|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
148774799|NCT02122770|536648683|FG002|Part A: Drug-drug Interaction 2|Other|1|||
148774800|NCT02122770|536648684|FG003|Part A: Drug-drug Interaction 2|Other|0|||
148774801|NCT02122770|536648685|FG004|Part A: Drug-drug Interaction 2|Other|0|||
148774802|NCT02122770|536648686|FG005|Part A: Drug-drug Interaction 2|Other|0|||
148774803|NCT02122770|536648681|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
148774804|NCT02122770|536648682|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
148774805|NCT02122770|536648683|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
148774806|NCT02122770|536648684|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
148774807|NCT02122770|536648685|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
148844259|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
148844260|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
148844261|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
148844262|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
148844263|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
148844264|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
148844265|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
148844266|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
148844267|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
148844268|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
148844269|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
148844270|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
148844271|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
148844272|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
148844273|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
148844274|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
148844275|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
148844276|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
148844277|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
148844278|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
148844279|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
148844280|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
148844281|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
148774808|NCT02122770|536648686|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
148774809|NCT02122770|536648681|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
148774810|NCT02122770|536648682|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
148774811|NCT02122770|536648683|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
148774812|NCT02122770|536648684|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
148774813|NCT02122770|536648685|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
148774814|NCT02122770|536648686|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
148774815|NCT02122770|536648681|FG000|Part B: Standard of Care|Adverse Event|0|||
148774816|NCT02122770|536648682|FG001|Part B: Standard of Care|Adverse Event|0|||
148774817|NCT02122770|536648683|FG002|Part B: Standard of Care|Adverse Event|0|||
148774818|NCT02122770|536648684|FG003|Part B: Standard of Care|Adverse Event|0|||
148774819|NCT02122770|536648685|FG004|Part B: Standard of Care|Adverse Event|4|||
148774820|NCT02122770|536648686|FG005|Part B: Standard of Care|Adverse Event|1|||
148774821|NCT02122770|536648681|FG000|Part B: Standard of Care|Other|0|||
148774822|NCT02122770|536648682|FG001|Part B: Standard of Care|Other|0|||
148774823|NCT02122770|536648683|FG002|Part B: Standard of Care|Other|0|||
148774824|NCT02122770|536648684|FG003|Part B: Standard of Care|Other|0|||
148774825|NCT02122770|536648685|FG004|Part B: Standard of Care|Other|0|||
148774826|NCT02122770|536648686|FG005|Part B: Standard of Care|Other|2|||
148774827|NCT02122770|536648681|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
148774828|NCT02122770|536648682|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
148774829|NCT02122770|536648683|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
148774830|NCT02122770|536648684|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
148774831|NCT02122770|536648685|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
148774832|NCT02122770|536648686|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
148774833|NCT02122770|536648681|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
148774834|NCT02122770|536648682|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
148844282|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
148844283|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
148844284|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
148844285|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
148844286|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
148844287|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
148844288|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
148844289|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
148844290|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
148844291|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
148844292|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
148844293|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
148844294|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
148983982|NCT00116805|537419324|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
148983983|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
148983984|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
148983985|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
148983986|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
148774835|NCT02122770|536648683|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
148774836|NCT02122770|536648684|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
148774837|NCT02122770|536648685|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
148774838|NCT02122770|536648686|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
148844295|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
148844296|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
148844297|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
148844298|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
148844299|NCT04951622|536909350|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
148844300|NCT04951622|536909351|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
148844301|NCT04951622|536909352|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
148844302|NCT04951622|536909353|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
148844303|NCT04951622|536909354|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
148844304|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
148844305|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
148844306|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
148844307|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
148774839|NCT02122770|536648681|FG000|Part B: Standard of Care|Progressive Disease|0|||
148774840|NCT02122770|536648682|FG001|Part B: Standard of Care|Progressive Disease|0|||
148774841|NCT02122770|536648683|FG002|Part B: Standard of Care|Progressive Disease|0|||
148774842|NCT02122770|536648684|FG003|Part B: Standard of Care|Progressive Disease|0|||
148774843|NCT02122770|536648685|FG004|Part B: Standard of Care|Progressive Disease|10|||
148774844|NCT02122770|536648686|FG005|Part B: Standard of Care|Progressive Disease|8|||
148774845|NCT02474589|536648687|FG000|Overall Study|Adverse Event|6|||
148774846|NCT02474589|536648688|FG001|Overall Study|Adverse Event|2|||
148774847|NCT02474589|536648687|FG000|Overall Study|Lost to Follow-up|6|||
148774848|NCT02474589|536648688|FG001|Overall Study|Lost to Follow-up|1|||
148774849|NCT02474589|536648687|FG000|Overall Study|Protocol Violation|4|||
148774850|NCT02474589|536648688|FG001|Overall Study|Protocol Violation|1|||
148774851|NCT02474589|536648687|FG000|Overall Study|Withdrawal by Subject|4|||
148774852|NCT02474589|536648688|FG001|Overall Study|Withdrawal by Subject|0|||
148774853|NCT02474589|536648687|FG000|Overall Study|Inability to complete study procedures|5|||
148774854|NCT02474589|536648688|FG001|Overall Study|Inability to complete study procedures|1|||
148774855|NCT01041976|536648689|FG000|Overall Study|Withdrawal by Subject|3|||
148774856|NCT01041976|536648690|FG001|Overall Study|Withdrawal by Subject|0|||
148774857|NCT01041976|536648689|FG000|Overall Study|Incarceration|2|||
148774858|NCT01041976|536648690|FG001|Overall Study|Incarceration|0|||
148774859|NCT01041976|536648689|FG000|Overall Study|Death|0|||
148774860|NCT01041976|536648690|FG001|Overall Study|Death|4|||
148774861|NCT01258075|536648694|FG000|Overall Study|Adverse Event|8|||
148774862|NCT01258075|536648695|FG001|Overall Study|Adverse Event|3|||
148774863|NCT01258075|536648694|FG000|Overall Study|Lost to Follow-up|11|||
148774864|NCT01258075|536648695|FG001|Overall Study|Lost to Follow-up|6|||
148774865|NCT01258075|536648694|FG000|Overall Study|Withdrawal by Subject|10|||
148774866|NCT01258075|536648695|FG001|Overall Study|Withdrawal by Subject|7|||
148844308|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
148844309|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
148844310|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
148844311|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
148844312|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
148844313|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
148844314|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
148844315|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
148844316|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
148844317|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
148844318|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
148844319|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
148844320|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
148844321|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
148844322|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
148844323|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
148844324|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
148844325|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
148983987|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
148983988|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
148774867|NCT01258075|536648694|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
148774868|NCT01258075|536648695|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
148774869|NCT01258075|536648694|FG000|Overall Study|Other|12|||
148774870|NCT01258075|536648695|FG001|Overall Study|Other|5|||
148774871|NCT02939716|536648696|FG000|Overall Study|scanner failure|0|||
148774872|NCT02939716|536648697|FG001|Overall Study|scanner failure|0|||
148774873|NCT02939716|536648698|FG002|Overall Study|scanner failure|0|||
148844326|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
148844327|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
148844328|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
148844329|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
148844330|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
148844331|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
148844332|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
148844333|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
148844334|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
148844335|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
148844336|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
148844337|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
148844338|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
148844339|NCT04951622|536909350|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
149029855|NCT00762463|537587897|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
149029856|NCT00762463|537587894|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
149029857|NCT00762463|537587895|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
148774874|NCT02939716|536648699|FG003|Overall Study|scanner failure|1|||
148774875|NCT02939716|536648700|FG004|Overall Study|scanner failure|1|||
148774876|NCT02939716|536648701|FG005|Overall Study|scanner failure|1|||
148774877|NCT02951533|536648702|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
148774878|NCT02951533|536648703|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
148774879|NCT02951533|536648704|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
148774880|NCT02951533|536648702|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
148774881|NCT02951533|536648703|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
148774882|NCT02951533|536648704|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
148774883|NCT02951533|536648702|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
148774884|NCT02951533|536648703|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
148774885|NCT02951533|536648704|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
148774886|NCT02951533|536648702|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
148774887|NCT02951533|536648703|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
148774888|NCT02951533|536648704|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
148774889|NCT02951533|536648702|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
148774890|NCT02951533|536648703|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
148774891|NCT02951533|536648704|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
148774892|NCT02951533|536648702|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
148774893|NCT02951533|536648703|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
148774894|NCT02951533|536648704|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
148774895|NCT02951533|536648702|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
148774896|NCT02951533|536648703|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
148774897|NCT02951533|536648704|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
148774898|NCT02951533|536648702|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
148774899|NCT02951533|536648703|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
148774900|NCT02951533|536648704|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
148774901|NCT02951533|536648702|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
148774902|NCT02951533|536648703|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
148774903|NCT02951533|536648704|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
148774904|NCT02951533|536648702|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
148774905|NCT02951533|536648703|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
148774906|NCT02951533|536648704|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
148774907|NCT02951533|536648702|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
148774908|NCT02951533|536648703|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
148774909|NCT02951533|536648704|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
148774910|NCT02375555|536648710|FG000|Induction Period|Adverse Event|7|||
148774911|NCT02375555|536648710|FG000|Induction Period|Withdrawal by Subject|2|||
148774912|NCT02375555|536648710|FG000|Induction Period|Other|1|||
148774913|NCT02375555|536648710|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
148774914|NCT02375555|536648710|FG000|Maintenance Period|Adverse Event|2|||
148774915|NCT02375555|536648710|FG000|Maintenance Period|Withdrawal by Subject|4|||
149029858|NCT00762463|537587896|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
148774916|NCT02375555|536648710|FG000|Maintenance Period|Death|1|||
148774917|NCT02375555|536648710|FG000|Maintenance Period|Disease Progression|5|||
148774918|NCT02375555|536648710|FG000|Maintenance Period|Patient Non-compliance|1|||
148774919|NCT02375555|536648710|FG000|Maintenance Period|Still on maintenance|16|||
148774920|NCT02091986|536648713|FG000|Overall Study|7 rand in error 1 patient decision|2|||
148844340|NCT04951622|536909351|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
148844341|NCT04951622|536909352|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
148774921|NCT02091986|536648714|FG001|Overall Study|7 rand in error 1 patient decision|3|||
148774922|NCT02091986|536648715|FG002|Overall Study|7 rand in error 1 patient decision|3|||
148774923|NCT02091986|536648713|FG000|Overall Study|Lost to Follow-up|1|||
148774924|NCT02091986|536648714|FG001|Overall Study|Lost to Follow-up|0|||
148774925|NCT02091986|536648715|FG002|Overall Study|Lost to Follow-up|0|||
148774926|NCT02091986|536648713|FG000|Overall Study|Withdrawal by Subject|4|||
148774927|NCT02091986|536648714|FG001|Overall Study|Withdrawal by Subject|8|||
148774928|NCT02091986|536648715|FG002|Overall Study|Withdrawal by Subject|3|||
148774929|NCT02091986|536648713|FG000|Overall Study|Adverse Event|0|||
148774930|NCT02091986|536648714|FG001|Overall Study|Adverse Event|0|||
148774931|NCT02091986|536648715|FG002|Overall Study|Adverse Event|2|||
148774932|NCT00125242|536648716|FG000|Overall Study|did not qualify|7|||
148774933|NCT00125242|536648717|FG001|Overall Study|did not qualify|2|||
148774934|NCT01664949|536648720|FG000|Overall Study|Adverse Event|11|||
148774935|NCT01664949|536648721|FG001|Overall Study|Adverse Event|12|||
148774936|NCT01664949|536648720|FG000|Overall Study|Lack of Efficacy|1|||
148774937|NCT01664949|536648721|FG001|Overall Study|Lack of Efficacy|1|||
148774938|NCT01664949|536648720|FG000|Overall Study|Lost to Follow-up|1|||
148774939|NCT01664949|536648721|FG001|Overall Study|Lost to Follow-up|2|||
148774940|NCT01664949|536648720|FG000|Overall Study|Personal Reasons|3|||
148774941|NCT01664949|536648721|FG001|Overall Study|Personal Reasons|4|||
148774942|NCT01664949|536648720|FG000|Overall Study|Protocol Violation|5|||
148774943|NCT01664949|536648721|FG001|Overall Study|Protocol Violation|5|||
148774944|NCT01664949|536648720|FG000|Overall Study|Other Miscellaneous Reasons|3|||
148774945|NCT01664949|536648721|FG001|Overall Study|Other Miscellaneous Reasons|1|||
148774946|NCT02727777|536648722|FG000|Overall Study|Screen Failure|2|||
148774947|NCT02727777|536648723|FG001|Overall Study|Screen Failure|0|||
148774948|NCT02727777|536648724|FG002|Overall Study|Screen Failure|0|||
148774949|NCT02727777|536648722|FG000|Overall Study|Progressive disease|2|||
148774950|NCT02727777|536648723|FG001|Overall Study|Progressive disease|0|||
148774951|NCT02727777|536648724|FG002|Overall Study|Progressive disease|0|||
148774952|NCT01738503|536648725|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
148774953|NCT01738503|536648726|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
148774954|NCT01738503|536648727|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
148774955|NCT01738503|536648728|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
148774956|NCT01738503|536648729|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
148774957|NCT01738503|536648730|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
148774958|NCT01738503|536648731|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
148774959|NCT01738503|536648725|FG000|Treatment Period|Adverse Event|0|||
148774960|NCT01738503|536648726|FG001|Treatment Period|Adverse Event|1|||
148774961|NCT01738503|536648727|FG002|Treatment Period|Adverse Event|0|||
148774962|NCT01738503|536648728|FG003|Treatment Period|Adverse Event|1|||
148774963|NCT01738503|536648729|FG004|Treatment Period|Adverse Event|2|||
148774964|NCT01738503|536648730|FG005|Treatment Period|Adverse Event|2|||
148774965|NCT01738503|536648731|FG006|Treatment Period|Adverse Event|2|||
148774966|NCT01738503|536648725|FG000|Treatment Period|Lost to Follow-up|0|||
148774967|NCT01738503|536648726|FG001|Treatment Period|Lost to Follow-up|0|||
148774968|NCT01738503|536648727|FG002|Treatment Period|Lost to Follow-up|3|||
148774969|NCT01738503|536648728|FG003|Treatment Period|Lost to Follow-up|4|||
148774970|NCT01738503|536648729|FG004|Treatment Period|Lost to Follow-up|1|||
148774971|NCT01738503|536648730|FG005|Treatment Period|Lost to Follow-up|1|||
148774972|NCT01738503|536648731|FG006|Treatment Period|Lost to Follow-up|5|||
148774973|NCT01738503|536648725|FG000|Treatment Period|Withdrawal by Subject|0|||
148774974|NCT01738503|536648726|FG001|Treatment Period|Withdrawal by Subject|1|||
148774975|NCT01738503|536648727|FG002|Treatment Period|Withdrawal by Subject|0|||
148774976|NCT01738503|536648728|FG003|Treatment Period|Withdrawal by Subject|1|||
148774977|NCT01738503|536648729|FG004|Treatment Period|Withdrawal by Subject|1|||
148774978|NCT01738503|536648730|FG005|Treatment Period|Withdrawal by Subject|1|||
148774979|NCT01738503|536648731|FG006|Treatment Period|Withdrawal by Subject|1|||
148774980|NCT01738503|536648725|FG000|Treatment Period|Protocol Violation|0|||
148774981|NCT01738503|536648726|FG001|Treatment Period|Protocol Violation|3|||
148774982|NCT01738503|536648727|FG002|Treatment Period|Protocol Violation|1|||
148774983|NCT01738503|536648728|FG003|Treatment Period|Protocol Violation|0|||
148774984|NCT01738503|536648729|FG004|Treatment Period|Protocol Violation|4|||
148774985|NCT01738503|536648730|FG005|Treatment Period|Protocol Violation|2|||
148774986|NCT01738503|536648731|FG006|Treatment Period|Protocol Violation|0|||
148774987|NCT01738503|536648725|FG000|Treatment Period|Other|0|||
148844342|NCT04951622|536909353|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
148844343|NCT04951622|536909354|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
148844344|NCT03670355|536909358|FG000|Overall Study|Adverse Event|1|||
148844345|NCT03670355|536909359|FG001|Overall Study|Adverse Event|0|||
148844346|NCT03670355|536909358|FG000|Overall Study|Unable to comply with study procedures|0|||
148774988|NCT01738503|536648726|FG001|Treatment Period|Other|0|||
148774989|NCT01738503|536648727|FG002|Treatment Period|Other|1|||
148774990|NCT01738503|536648728|FG003|Treatment Period|Other|0|||
148774991|NCT01738503|536648729|FG004|Treatment Period|Other|0|||
148844347|NCT03670355|536909359|FG001|Overall Study|Unable to comply with study procedures|1|||
148844348|NCT03670355|536909358|FG000|Overall Study|Participant refused|0|||
148844349|NCT03670355|536909359|FG001|Overall Study|Participant refused|1|||
148844350|NCT03517436|536909360|FG000|Overall Study|Death|3|||
148844351|NCT03517436|536909360|FG000|Overall Study|Withdrawal by Subject|4|||
148774992|NCT01738503|536648730|FG005|Treatment Period|Other|0|||
148774993|NCT01738503|536648731|FG006|Treatment Period|Other|0|||
148774994|NCT01738503|536648725|FG000|PET Imaging Sub-study|Adverse Event|0|||
148774995|NCT01738503|536648726|FG001|PET Imaging Sub-study|Adverse Event|0|||
148774996|NCT01738503|536648727|FG002|PET Imaging Sub-study|Adverse Event|0|||
148774997|NCT01738503|536648728|FG003|PET Imaging Sub-study|Adverse Event|0|||
148774998|NCT01738503|536648729|FG004|PET Imaging Sub-study|Adverse Event|0|||
148774999|NCT01738503|536648730|FG005|PET Imaging Sub-study|Adverse Event|1|||
148775000|NCT01738503|536648731|FG006|PET Imaging Sub-study|Adverse Event|0|||
148775001|NCT01738503|536648725|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
148775002|NCT01738503|536648726|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
148844352|NCT03517436|536909360|FG000|Overall Study|Did not receive study valve.|1|||
148844353|NCT04181827|536909361|FG000|Overall Study|Ongoing|124|||
148844354|NCT04181827|536909362|FG001|Overall Study|Ongoing|157|||
148844355|NCT04181827|536909361|FG000|Overall Study|Death|82|||
148844356|NCT04181827|536909362|FG001|Overall Study|Death|50|||
148844357|NCT04181827|536909361|FG000|Overall Study|Lost to Follow-up|0|||
148844358|NCT04181827|536909362|FG001|Overall Study|Lost to Follow-up|1|||
148844359|NCT04181827|536909361|FG000|Overall Study|Withdrawal by Subject|5|||
148844360|NCT04181827|536909362|FG001|Overall Study|Withdrawal by Subject|0|||
148844361|NCT04587869|536909365|FG000|Overall Study|Death|1|||
148844362|NCT04587869|536909366|FG001|Overall Study|Death|0|||
148844363|NCT04587869|536909365|FG000|Overall Study|Lost to Follow-up|27|||
148844364|NCT04587869|536909366|FG001|Overall Study|Lost to Follow-up|34|||
148844365|NCT04587869|536909365|FG000|Overall Study|Grant Termination|13|||
148844366|NCT04587869|536909366|FG001|Overall Study|Grant Termination|25|||
148844367|NCT04587869|536909365|FG000|Overall Study|too busy|2|||
148844368|NCT04587869|536909366|FG001|Overall Study|too busy|0|||
148844369|NCT04587869|536909365|FG000|Overall Study|Withdrawal by Subject|2|||
148844370|NCT04587869|536909366|FG001|Overall Study|Withdrawal by Subject|2|||
148844371|NCT04587869|536909365|FG000|Overall Study|Other|1|||
148844372|NCT04587869|536909366|FG001|Overall Study|Other|0|||
148844373|NCT04538664|536909369|FG000|Overall Study|Withdrawal by Subject|5|||
148844374|NCT04538664|536909370|FG001|Overall Study|Withdrawal by Subject|9|||
148844375|NCT04538664|536909369|FG000|Overall Study|Lost to Follow-up|2|||
148844376|NCT04538664|536909370|FG001|Overall Study|Lost to Follow-up|1|||
148844377|NCT04538664|536909369|FG000|Overall Study|Ongoing|106|||
148844378|NCT04538664|536909370|FG001|Overall Study|Ongoing|115|||
148844379|NCT03929913|536909371|FG000|Overall Study|Death|4|||
148844380|NCT03929913|536909371|FG000|Overall Study|Lost to Follow-up|1|||
148844381|NCT03929913|536909371|FG000|Overall Study|Failed Procedure|2|||
148844382|NCT01544348|536909372|FG000|Overall Study|Lost to Follow-up|1|||
148844383|NCT01544348|536909373|FG001|Overall Study|Lost to Follow-up|0|||
148844384|NCT01544348|536909374|FG002|Overall Study|Lost to Follow-up|0|||
148844385|NCT01544348|536909375|FG003|Overall Study|Lost to Follow-up|0|||
148844386|NCT01544348|536909376|FG004|Overall Study|Lost to Follow-up|0|||
148844387|NCT01544348|536909377|FG005|Overall Study|Lost to Follow-up|0|||
148844388|NCT01544348|536909378|FG006|Overall Study|Lost to Follow-up|1|||
148844389|NCT01544348|536909379|FG007|Overall Study|Lost to Follow-up|0|||
148844390|NCT01544348|536909372|FG000|Overall Study|Withdrawal by Subject|1|||
148844391|NCT01544348|536909373|FG001|Overall Study|Withdrawal by Subject|0|||
148844392|NCT01544348|536909374|FG002|Overall Study|Withdrawal by Subject|0|||
148844393|NCT01544348|536909375|FG003|Overall Study|Withdrawal by Subject|0|||
148844394|NCT01544348|536909376|FG004|Overall Study|Withdrawal by Subject|1|||
148844395|NCT01544348|536909377|FG005|Overall Study|Withdrawal by Subject|2|||
148844396|NCT01544348|536909378|FG006|Overall Study|Withdrawal by Subject|1|||
148844397|NCT01544348|536909379|FG007|Overall Study|Withdrawal by Subject|0|||
148844398|NCT01544348|536909372|FG000|Overall Study|Physician Decision|0|||
148844399|NCT01544348|536909373|FG001|Overall Study|Physician Decision|0|||
148775003|NCT01738503|536648727|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
148844400|NCT01544348|536909374|FG002|Overall Study|Physician Decision|0|||
148844401|NCT01544348|536909375|FG003|Overall Study|Physician Decision|0|||
148775004|NCT01738503|536648728|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
148844402|NCT01544348|536909376|FG004|Overall Study|Physician Decision|0|||
148844403|NCT01544348|536909377|FG005|Overall Study|Physician Decision|1|||
148844404|NCT01544348|536909378|FG006|Overall Study|Physician Decision|0|||
148844405|NCT01544348|536909379|FG007|Overall Study|Physician Decision|0|||
148844406|NCT01445847|536909380|FG000|Overall Study|Protocol Violation|13|||
148844407|NCT01445847|536909381|FG001|Overall Study|Protocol Violation|14|||
148844408|NCT01445847|536909380|FG000|Overall Study|Missed Data|1|||
148844409|NCT01445847|536909381|FG001|Overall Study|Missed Data|0|||
148844410|NCT03381287|536909386|FG000|Overall Study|Withdrawal by Subject|0|||
148844411|NCT03381287|536909387|FG001|Overall Study|Withdrawal by Subject|1|||
148844412|NCT03381287|536909388|FG002|Overall Study|Withdrawal by Subject|0|||
148844413|NCT03381287|536909389|FG003|Overall Study|Withdrawal by Subject|0|||
148844414|NCT03381287|536909386|FG000|Overall Study|Adverse Event|0|||
148775005|NCT01738503|536648729|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
148775006|NCT01738503|536648730|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
148775007|NCT01738503|536648731|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
148775008|NCT01970475|536648736|FG000|Overall Study|Withdrawal by Subject|11|||
148775009|NCT01970475|536648737|FG001|Overall Study|Withdrawal by Subject|6|||
148775010|NCT01970475|536648736|FG000|Overall Study|Adverse Event|7|||
148775011|NCT01970475|536648737|FG001|Overall Study|Adverse Event|3|||
148775012|NCT01970475|536648736|FG000|Overall Study|Lost to Follow-up|2|||
148775013|NCT01970475|536648737|FG001|Overall Study|Lost to Follow-up|2|||
148775014|NCT01970475|536648736|FG000|Overall Study|Protocol Violation|1|||
148775015|NCT01970475|536648737|FG001|Overall Study|Protocol Violation|0|||
148775016|NCT02234596|536648738|FG000|Overall Study|Participant not treated|2|||
148775017|NCT04852679|536648741|FG000|Main Intervention Period|Withdrawal by Subject|3|||
148775018|NCT04852679|536648741|FG000|Main Intervention Period|Adverse Event|1|||
148775019|NCT04852679|536648741|FG000|Main Intervention Period|Progressive Disease|16|||
148775020|NCT04852679|536648741|FG000|Main Intervention Period|Refused study visit|1|||
148775021|NCT04852679|536648741|FG000|Independent Injection Period|Missed study visit|1|||
148775022|NCT01294696|536648744|FG000|Overall Study|Screening failures|7|||
148775023|NCT01294696|536648744|FG000|Overall Study|Protocol Violation|8|||
148775024|NCT01294696|536648744|FG000|Overall Study|Missing BPI Response|7|||
148775025|NCT01294696|536648744|FG000|Overall Study|Site closure|52|||
148775026|NCT05072106|536651226|FG000|Overall Study|Progressive disease|3|||
148775027|NCT05072106|536651227|FG001|Overall Study|Progressive disease|3|||
148775028|NCT05072106|536651226|FG000|Overall Study|Compassionate use|3|||
148775029|NCT05072106|536651227|FG001|Overall Study|Compassionate use|1|||
148775030|NCT05072106|536651226|FG000|Overall Study|Withdrawal by Subject|1|||
148775031|NCT05072106|536651227|FG001|Overall Study|Withdrawal by Subject|0|||
148775032|NCT04240886|536651228|FG000|Treatment Phase|Death|4|||
148775033|NCT04240886|536651228|FG000|Treatment Phase|Discontinuation by Subject|1|||
148775034|NCT04240886|536651228|FG000|Treatment Phase|Adverse Event|5|||
148775035|NCT04240886|536651228|FG000|Follow-up Phase|Withdrawal by Subject|1|||
148775036|NCT04240886|536651228|FG000|Follow-up Phase|Discontinuation by Subject|1|||
148775037|NCT04240886|536651228|FG000|Follow-up Phase|Death|2|||
148775038|NCT04743804|536651231|FG000|Overall Study|Other|1|||
148844415|NCT03381287|536909387|FG001|Overall Study|Adverse Event|0|||
148844416|NCT03381287|536909388|FG002|Overall Study|Adverse Event|0|||
148844417|NCT03381287|536909389|FG003|Overall Study|Adverse Event|1|||
148844418|NCT03381287|536909386|FG000|Overall Study|Physician Decision|0|||
148844419|NCT03381287|536909387|FG001|Overall Study|Physician Decision|0|||
148983989|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
148983990|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
148983991|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
148983992|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
148983993|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
148983994|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
148775039|NCT04743804|536651232|FG001|Overall Study|Other|0|||
148775040|NCT04743804|536651231|FG000|Overall Study|Withdrawal by Subject|0|||
148775041|NCT04743804|536651232|FG001|Overall Study|Withdrawal by Subject|1|||
148775042|NCT04743804|536651231|FG000|Overall Study|Study Terminated by Sponsor|1|||
148775043|NCT04743804|536651232|FG001|Overall Study|Study Terminated by Sponsor|4|||
148775044|NCT04743804|536651231|FG000|Overall Study|Physician Decision|0|||
148775045|NCT04743804|536651232|FG001|Overall Study|Physician Decision|1|||
148775046|NCT04743804|536651231|FG000|Overall Study|Death|3|||
148775047|NCT04743804|536651232|FG001|Overall Study|Death|0|||
148775048|NCT04063657|536651234|FG000|Overall Study|Lost to Follow-up|1|||
148775049|NCT04063657|536651235|FG001|Overall Study|Lost to Follow-up|0|||
148844420|NCT03381287|536909388|FG002|Overall Study|Physician Decision|0|||
148844421|NCT03381287|536909389|FG003|Overall Study|Physician Decision|1|||
148844422|NCT01837680|536909392|FG000|Overall Study|Lost to Follow-up|2|||
148844423|NCT01837680|536909393|FG001|Overall Study|Lost to Follow-up|2|||
148844424|NCT01837680|536909392|FG000|Overall Study|lack of insurance|0|||
148775086|NCT01995175|536651247|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
148775087|NCT01995175|536651247|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
148775088|NCT01995175|536651247|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
148775089|NCT01995175|536651247|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
148775090|NCT01995175|536651247|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
148775091|NCT01995175|536651247|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
148775092|NCT01995175|536651247|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
148775093|NCT01995175|536651247|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
148775094|NCT01995175|536651247|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
148775095|NCT00984061|536651248|FG000|Clarithromycin Alone|Protocol Violation|1|||
148775096|NCT04777201|536651252|FG000|Main Study|Withdrawal by Subject|19|||
148775097|NCT04777201|536651253|FG001|Main Study|Withdrawal by Subject|27|||
148775098|NCT04777201|536651254|FG002|Main Study|Withdrawal by Subject|0|||
148775099|NCT04777201|536651252|FG000|Main Study|Death|13|||
148775100|NCT04777201|536651253|FG001|Main Study|Death|27|||
148775101|NCT04777201|536651254|FG002|Main Study|Death|0|||
148775102|NCT04777201|536651252|FG000|Main Study|Subject missed the safety follow-up visit|9|||
148775103|NCT04777201|536651253|FG001|Main Study|Subject missed the safety follow-up visit|10|||
148775104|NCT04777201|536651254|FG002|Main Study|Subject missed the safety follow-up visit|0|||
148775105|NCT04777201|536651252|FG000|Main Study|Physician Decision|8|||
148775106|NCT04777201|536651253|FG001|Main Study|Physician Decision|10|||
148775107|NCT04777201|536651254|FG002|Main Study|Physician Decision|0|||
148775108|NCT04777201|536651252|FG000|Main Study|Adverse Event|8|||
148775109|NCT04777201|536651253|FG001|Main Study|Adverse Event|8|||
148775110|NCT04777201|536651254|FG002|Main Study|Adverse Event|0|||
148775111|NCT04777201|536651252|FG000|Main Study|Lost to Follow-up|9|||
148775112|NCT04777201|536651253|FG001|Main Study|Lost to Follow-up|4|||
148775113|NCT04777201|536651254|FG002|Main Study|Lost to Follow-up|0|||
148775114|NCT04777201|536651252|FG000|Main Study|Reason not specified|3|||
148775115|NCT04777201|536651253|FG001|Main Study|Reason not specified|3|||
148775116|NCT04777201|536651254|FG002|Main Study|Reason not specified|0|||
148775117|NCT04777201|536651252|FG000|Main Study|Lack of Efficacy|1|||
148775118|NCT04777201|536651253|FG001|Main Study|Lack of Efficacy|1|||
148775119|NCT04777201|536651254|FG002|Main Study|Lack of Efficacy|0|||
149029859|NCT00762463|537587897|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
149029860|NCT00762463|537587894|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
149029861|NCT00762463|537587895|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
148775120|NCT04777201|536651252|FG000|Main Study|Protocol Violation|1|||
149029862|NCT00762463|537587896|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
149029863|NCT00762463|537587897|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
148775121|NCT04777201|536651253|FG001|Main Study|Protocol Violation|0|||
148775122|NCT04777201|536651254|FG002|Main Study|Protocol Violation|0|||
148775123|NCT04777201|536651252|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
148775124|NCT04777201|536651253|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
148775125|NCT04777201|536651254|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
149029864|NCT00762463|537587894|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
148775126|NCT04777201|536651252|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
148775127|NCT04777201|536651253|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
148775128|NCT04777201|536651254|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
148775129|NCT04777201|536651252|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
148775130|NCT04777201|536651253|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
148775131|NCT04777201|536651254|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
148775132|NCT04777201|536651252|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
148775133|NCT04777201|536651253|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
148775134|NCT04777201|536651254|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
148775135|NCT04777201|536651252|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
148775136|NCT04777201|536651253|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
148775137|NCT04777201|536651254|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
148775138|NCT04777201|536651252|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
148775139|NCT04777201|536651253|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
148775140|NCT04777201|536651254|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
148775141|NCT03409107|536651262|FG000|Overall Study|Withdrawal by Subject|4|||
148775142|NCT03409107|536651263|FG001|Overall Study|Withdrawal by Subject|2|||
148775143|NCT03409107|536651262|FG000|Overall Study|Physician Decision|1|||
148775144|NCT03409107|536651263|FG001|Overall Study|Physician Decision|0|||
148775145|NCT03409107|536651262|FG000|Overall Study|Lost to Follow-up|7|||
148775146|NCT03409107|536651263|FG001|Overall Study|Lost to Follow-up|2|||
148775147|NCT03409107|536651262|FG000|Overall Study|Adverse Event|5|||
148775148|NCT03409107|536651263|FG001|Overall Study|Adverse Event|3|||
148775149|NCT01185509|536651264|FG000|Overall Study|Progression/Relapse|9|||
148775150|NCT01185509|536651265|FG001|Overall Study|Progression/Relapse|15|||
148775151|NCT01185509|536651264|FG000|Overall Study|Physician Decision|2|||
148775152|NCT01185509|536651265|FG001|Overall Study|Physician Decision|2|||
148775153|NCT01185509|536651264|FG000|Overall Study|Withdrawal by Subject|0|||
148775154|NCT01185509|536651265|FG001|Overall Study|Withdrawal by Subject|1|||
148775155|NCT01185509|536651264|FG000|Overall Study|Death|0|||
148775156|NCT01185509|536651265|FG001|Overall Study|Death|1|||
148775157|NCT01185509|536651264|FG000|Overall Study|Intercurrent Illness|0|||
148775158|NCT01185509|536651265|FG001|Overall Study|Intercurrent Illness|1|||
148775159|NCT00916344|536651266|FG000|Overall Study|Death|2|||
148775160|NCT00916344|536651266|FG000|Overall Study|ICD upgrade|1|||
148775161|NCT00916344|536651266|FG000|Overall Study|Drop-out|5|||
148775162|NCT00108485|536651278|FG000|Overall Study|Withdrawal by Subject|3|||
148775163|NCT00108485|536651279|FG001|Overall Study|Withdrawal by Subject|0|||
148775164|NCT00108485|536651278|FG000|Overall Study|Lost to Follow-up|0|||
148775165|NCT00108485|536651279|FG001|Overall Study|Lost to Follow-up|2|||
148775166|NCT02370667|536651284|FG000|Overall Study|Lost to Follow-up|0|||
148775167|NCT02370667|536651285|FG001|Overall Study|Lost to Follow-up|1|||
148775168|NCT02370667|536651286|FG002|Overall Study|Lost to Follow-up|0|||
148775169|NCT00705718|536651287|FG000|Overall Study|Death|6|||
148775170|NCT00705718|536651288|FG001|Overall Study|Death|6|||
148775171|NCT00705718|536651287|FG000|Overall Study|Not due for Visit|0|||
148775172|NCT00705718|536651288|FG001|Overall Study|Not due for Visit|12|||
148775173|NCT00705718|536651287|FG000|Overall Study|Follow up not done|1|||
148775174|NCT00705718|536651288|FG001|Overall Study|Follow up not done|4|||
148775175|NCT02954653|536651289|FG000|Overall Study|Death|3|||
148775176|NCT02954653|536651290|FG001|Overall Study|Death|1|||
148775177|NCT02954653|536651291|FG002|Overall Study|Death|0|||
148775178|NCT02954653|536651292|FG003|Overall Study|Death|0|||
148775179|NCT02954653|536651293|FG004|Overall Study|Death|0|||
148775180|NCT02954653|536651294|FG005|Overall Study|Death|0|||
148775181|NCT02954653|536651295|FG006|Overall Study|Death|0|||
148775182|NCT02954653|536651296|FG007|Overall Study|Death|0|||
148775183|NCT02954653|536651297|FG008|Overall Study|Death|0|||
148775184|NCT02954653|536651289|FG000|Overall Study|Randomized but did not receive treatment|1|||
148775185|NCT02954653|536651290|FG001|Overall Study|Randomized but did not receive treatment|0|||
148775186|NCT02954653|536651291|FG002|Overall Study|Randomized but did not receive treatment|0|||
148775187|NCT02954653|536651292|FG003|Overall Study|Randomized but did not receive treatment|0|||
148775188|NCT02954653|536651293|FG004|Overall Study|Randomized but did not receive treatment|0|||
148775189|NCT02954653|536651294|FG005|Overall Study|Randomized but did not receive treatment|0|||
148775190|NCT02954653|536651295|FG006|Overall Study|Randomized but did not receive treatment|0|||
148775191|NCT02954653|536651296|FG007|Overall Study|Randomized but did not receive treatment|0|||
148775192|NCT02954653|536651297|FG008|Overall Study|Randomized but did not receive treatment|0|||
148775193|NCT02954653|536651289|FG000|Overall Study|Started another anti-cancer therapy|0|||
148775194|NCT02954653|536651290|FG001|Overall Study|Started another anti-cancer therapy|1|||
148775195|NCT02954653|536651291|FG002|Overall Study|Started another anti-cancer therapy|0|||
148775196|NCT02954653|536651292|FG003|Overall Study|Started another anti-cancer therapy|0|||
148775197|NCT02954653|536651293|FG004|Overall Study|Started another anti-cancer therapy|0|||
148775198|NCT02954653|536651294|FG005|Overall Study|Started another anti-cancer therapy|0|||
148775199|NCT02954653|536651295|FG006|Overall Study|Started another anti-cancer therapy|0|||
148775200|NCT02954653|536651296|FG007|Overall Study|Started another anti-cancer therapy|0|||
148775201|NCT02954653|536651297|FG008|Overall Study|Started another anti-cancer therapy|0|||
148775202|NCT02954653|536651289|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
148775203|NCT02954653|536651290|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
148775204|NCT02954653|536651291|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
148775205|NCT02954653|536651292|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
148775206|NCT02954653|536651293|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
148775207|NCT02954653|536651294|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
148775208|NCT02954653|536651295|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
148775209|NCT02954653|536651296|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
148775210|NCT02954653|536651297|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
148775211|NCT03054064|536651298|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
148775212|NCT03054064|536651298|FG000|Overall Study|Investigator Decision|2|||
148775213|NCT03054064|536651298|FG000|Overall Study|Bladder Issue|1|||
148775214|NCT03054064|536651298|FG000|Overall Study|High Blood Pressure|1|||
148775215|NCT03054064|536651298|FG000|Overall Study|Change in Status|1|||
148775216|NCT01459718|536651301|FG000|Overall Study|Physician Decision|1|||
148775217|NCT01459718|536651301|FG000|Overall Study|Lost to Follow-up|1|||
148775218|NCT01459718|536651301|FG000|Overall Study|Adverse Event|1|||
148775219|NCT01500213|536651302|FG000|Overall Study|Adverse Event|35|||
148775220|NCT01500213|536651303|FG001|Overall Study|Adverse Event|35|||
148775221|NCT01500213|536651302|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
148775222|NCT01500213|536651303|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
148775223|NCT01500213|536651302|FG000|Overall Study|Withdrawal by Subject|28|||
148844425|NCT01837680|536909393|FG001|Overall Study|lack of insurance|2|||
148844426|NCT01837680|536909392|FG000|Overall Study|allergic reaction|6|||
148844427|NCT01837680|536909393|FG001|Overall Study|allergic reaction|0|||
148844428|NCT01837680|536909392|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
148983995|NCT00116805|537419323|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
148983996|NCT00116805|537419324|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
148775224|NCT01500213|536651303|FG001|Overall Study|Withdrawal by Subject|37|||
148775225|NCT01500213|536651302|FG000|Overall Study|Death|7|||
148775226|NCT01500213|536651303|FG001|Overall Study|Death|3|||
148775227|NCT01500213|536651302|FG000|Overall Study|Disease Progression|13|||
148775228|NCT01500213|536651303|FG001|Overall Study|Disease Progression|21|||
148775229|NCT01500213|536651302|FG000|Overall Study|Protocol Violation|19|||
148775230|NCT01500213|536651303|FG001|Overall Study|Protocol Violation|19|||
148775231|NCT01500213|536651302|FG000|Overall Study|Physician Decision|12|||
148775232|NCT01500213|536651303|FG001|Overall Study|Physician Decision|10|||
148775233|NCT01500213|536651302|FG000|Overall Study|Lack of Efficacy|9|||
148775234|NCT01500213|536651303|FG001|Overall Study|Lack of Efficacy|7|||
148775235|NCT01500213|536651302|FG000|Overall Study|Lost to Follow-up|3|||
148775236|NCT01500213|536651303|FG001|Overall Study|Lost to Follow-up|6|||
148775237|NCT01500213|536651302|FG000|Overall Study|Other Reasons|7|||
148775238|NCT01500213|536651303|FG001|Overall Study|Other Reasons|5|||
148775239|NCT00785213|536651304|FG000|Quinine Sulfate Alone|Adverse Event|4|||
148775240|NCT00785213|536651304|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
148775241|NCT02386345|536651305|FG000|Overall Study|Not treated|14|||
148775242|NCT02386345|536651305|FG000|Overall Study|Lost to Follow-up|1|||
148775243|NCT02386345|536651305|FG000|Overall Study|Adverse Event|5|||
148775244|NCT02386345|536651305|FG000|Overall Study|Repeat Procedure|10|||
148775245|NCT02386345|536651305|FG000|Overall Study|Did not complete 12-month follow-up|72|||
148775246|NCT02612610|536651306|FG000|Overall Study|Withdrawal by Subject|1|||
148775247|NCT02612610|536651307|FG001|Overall Study|Withdrawal by Subject|1|||
148775248|NCT02612610|536651308|FG002|Overall Study|Withdrawal by Subject|0|||
148775249|NCT02612610|536651309|FG003|Overall Study|Withdrawal by Subject|2|||
148775250|NCT02612610|536651306|FG000|Overall Study|Adverse Event|2|||
148775251|NCT02612610|536651307|FG001|Overall Study|Adverse Event|2|||
148775252|NCT02612610|536651308|FG002|Overall Study|Adverse Event|3|||
148775253|NCT02612610|536651309|FG003|Overall Study|Adverse Event|10|||
148775254|NCT02612610|536651306|FG000|Overall Study|Lost to Follow-up|0|||
148775255|NCT02612610|536651307|FG001|Overall Study|Lost to Follow-up|1|||
148775256|NCT02612610|536651308|FG002|Overall Study|Lost to Follow-up|0|||
148983997|NCT00116805|537419323|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
148775257|NCT02612610|536651309|FG003|Overall Study|Lost to Follow-up|0|||
148775258|NCT02612610|536651306|FG000|Overall Study|Protocol Violation|0|||
148775259|NCT02612610|536651307|FG001|Overall Study|Protocol Violation|1|||
148775260|NCT02612610|536651308|FG002|Overall Study|Protocol Violation|1|||
148775261|NCT02612610|536651309|FG003|Overall Study|Protocol Violation|0|||
148775262|NCT02612610|536651306|FG000|Overall Study|Lack of Efficacy|1|||
148775263|NCT02612610|536651307|FG001|Overall Study|Lack of Efficacy|2|||
148775264|NCT02612610|536651308|FG002|Overall Study|Lack of Efficacy|0|||
148775265|NCT02612610|536651309|FG003|Overall Study|Lack of Efficacy|1|||
148775266|NCT02612610|536651306|FG000|Overall Study|Physician Decision|0|||
148844429|NCT01837680|536909393|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
148844430|NCT03008070|536909394|FG000|Overall Study|Adverse Event|3|||
148844431|NCT03008070|536909395|FG001|Overall Study|Adverse Event|3|||
148775267|NCT02612610|536651307|FG001|Overall Study|Physician Decision|1|||
148775268|NCT02612610|536651308|FG002|Overall Study|Physician Decision|0|||
148775269|NCT02612610|536651309|FG003|Overall Study|Physician Decision|0|||
148775270|NCT02612610|536651306|FG000|Overall Study|Noncompliance|1|||
148775271|NCT02612610|536651307|FG001|Overall Study|Noncompliance|0|||
148775272|NCT02612610|536651308|FG002|Overall Study|Noncompliance|0|||
148775273|NCT02612610|536651309|FG003|Overall Study|Noncompliance|0|||
148775274|NCT02612610|536651306|FG000|Overall Study|Cough Improvement|0|||
148775275|NCT02612610|536651307|FG001|Overall Study|Cough Improvement|0|||
148775276|NCT02612610|536651308|FG002|Overall Study|Cough Improvement|1|||
148775277|NCT02612610|536651309|FG003|Overall Study|Cough Improvement|0|||
148775278|NCT01801280|536651310|FG000|Period 1|Withdrawal by Subject|0|||
148775279|NCT01801280|536651311|FG001|Period 1|Withdrawal by Subject|1|||
148775280|NCT01801280|536651312|FG002|Period 1|Withdrawal by Subject|0|||
148775281|NCT01801280|536651313|FG003|Period 1|Withdrawal by Subject|0|||
148775282|NCT01801280|536651310|FG000|Period 2|Withdrawal by Subject|1|||
148775283|NCT01801280|536651311|FG001|Period 2|Withdrawal by Subject|0|||
148775284|NCT01801280|536651312|FG002|Period 2|Withdrawal by Subject|0|||
148775285|NCT01801280|536651313|FG003|Period 2|Withdrawal by Subject|0|||
148775286|NCT01801280|536651310|FG000|Period 4|Protocol Violation|0|||
148775287|NCT01801280|536651311|FG001|Period 4|Protocol Violation|0|||
148775288|NCT01801280|536651312|FG002|Period 4|Protocol Violation|1|||
148775289|NCT01801280|536651313|FG003|Period 4|Protocol Violation|0|||
148775290|NCT00176644|536651314|FG000|Overall Study|Withdrawal by Subject|1|||
148775291|NCT01546571|536651315|FG000|Overall Study|Adverse Event|1|||
148775292|NCT01546571|536651316|FG001|Overall Study|Adverse Event|0|||
148775293|NCT01546571|536651317|FG002|Overall Study|Adverse Event|0|||
148775294|NCT01546571|536651318|FG003|Overall Study|Adverse Event|1|||
148775295|NCT01546571|536651319|FG004|Overall Study|Adverse Event|0|||
148775296|NCT01546571|536651315|FG000|Overall Study|assigned placebo in Part A|0|||
148775297|NCT01546571|536651316|FG001|Overall Study|assigned placebo in Part A|0|||
148775298|NCT01546571|536651317|FG002|Overall Study|assigned placebo in Part A|22|||
148775299|NCT01546571|536651318|FG003|Overall Study|assigned placebo in Part A|0|||
148775300|NCT01546571|536651319|FG004|Overall Study|assigned placebo in Part A|0|||
148775301|NCT01546571|536651315|FG000|Overall Study|Death|0|||
148775302|NCT01546571|536651316|FG001|Overall Study|Death|1|||
148775303|NCT01546571|536651317|FG002|Overall Study|Death|0|||
148775304|NCT01546571|536651318|FG003|Overall Study|Death|0|||
148775305|NCT01546571|536651319|FG004|Overall Study|Death|0|||
148775306|NCT01546571|536651315|FG000|Overall Study|Lost to Follow-up|0|||
148775307|NCT01546571|536651316|FG001|Overall Study|Lost to Follow-up|0|||
148775308|NCT01546571|536651317|FG002|Overall Study|Lost to Follow-up|2|||
148775309|NCT01546571|536651318|FG003|Overall Study|Lost to Follow-up|2|||
148775310|NCT01546571|536651319|FG004|Overall Study|Lost to Follow-up|3|||
148775311|NCT01546571|536651315|FG000|Overall Study|Pregnancy|0|||
148775312|NCT01546571|536651316|FG001|Overall Study|Pregnancy|0|||
148775313|NCT01546571|536651317|FG002|Overall Study|Pregnancy|0|||
148775314|NCT01546571|536651318|FG003|Overall Study|Pregnancy|1|||
148775315|NCT01546571|536651319|FG004|Overall Study|Pregnancy|0|||
148775316|NCT01546571|536651315|FG000|Overall Study|Disease Progression|20|||
148775317|NCT01546571|536651316|FG001|Overall Study|Disease Progression|18|||
148775318|NCT01546571|536651317|FG002|Overall Study|Disease Progression|15|||
148775319|NCT01546571|536651318|FG003|Overall Study|Disease Progression|73|||
148775320|NCT01546571|536651319|FG004|Overall Study|Disease Progression|37|||
148775321|NCT01546571|536651315|FG000|Overall Study|Withdrawal by Subject|1|||
148775322|NCT01546571|536651316|FG001|Overall Study|Withdrawal by Subject|2|||
148775323|NCT01546571|536651317|FG002|Overall Study|Withdrawal by Subject|4|||
148775324|NCT01546571|536651318|FG003|Overall Study|Withdrawal by Subject|9|||
148775325|NCT01546571|536651319|FG004|Overall Study|Withdrawal by Subject|2|||
148775326|NCT01546571|536651315|FG000|Overall Study|Intercurrent Illness|1|||
148775327|NCT01546571|536651316|FG001|Overall Study|Intercurrent Illness|2|||
148775328|NCT01546571|536651317|FG002|Overall Study|Intercurrent Illness|0|||
148775329|NCT01546571|536651318|FG003|Overall Study|Intercurrent Illness|0|||
148775330|NCT01546571|536651319|FG004|Overall Study|Intercurrent Illness|0|||
148775331|NCT01546571|536651315|FG000|Overall Study|Other Cancers|0|||
148775332|NCT01546571|536651316|FG001|Overall Study|Other Cancers|0|||
148775333|NCT01546571|536651317|FG002|Overall Study|Other Cancers|0|||
148775334|NCT01546571|536651318|FG003|Overall Study|Other Cancers|3|||
148775335|NCT01546571|536651319|FG004|Overall Study|Other Cancers|1|||
148775336|NCT01546571|536651315|FG000|Overall Study|Other|0|||
148775337|NCT01546571|536651316|FG001|Overall Study|Other|0|||
148775338|NCT01546571|536651317|FG002|Overall Study|Other|3|||
148775339|NCT01546571|536651318|FG003|Overall Study|Other|0|||
148775340|NCT01546571|536651319|FG004|Overall Study|Other|0|||
148775341|NCT01866657|536651322|FG000|Overall Study|Surgery canceled|2|||
148775342|NCT01866657|536651323|FG001|Overall Study|Surgery canceled|0|||
148775343|NCT01880086|536651329|FG000|Overall Study|Lost to Follow-up|1|||
148775344|NCT01880086|536651330|FG001|Overall Study|Lost to Follow-up|1|||
148775345|NCT03973918|536651336|FG000|Overall Study|Adverse Event|0|||
148775346|NCT03973918|536651337|FG001|Overall Study|Adverse Event|0|||
148775347|NCT03973918|536651338|FG002|Overall Study|Adverse Event|0|||
148775348|NCT03973918|536651339|FG003|Overall Study|Adverse Event|1|||
148775349|NCT03973918|536651336|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
148775350|NCT03973918|536651337|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
148775351|NCT03973918|536651338|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
148775352|NCT03973918|536651339|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
148775353|NCT05174949|536651342|FG000|Overall Study|Physician Decision|1|||
148775354|NCT05174949|536651343|FG001|Overall Study|Physician Decision|2|||
148775355|NCT05174949|536651344|FG002|Overall Study|Physician Decision|0|||
148775356|NCT05174949|536651345|FG003|Overall Study|Physician Decision|1|||
148775357|NCT05174949|536651346|FG004|Overall Study|Physician Decision|0|||
148775358|NCT05174949|536651347|FG005|Overall Study|Physician Decision|0|||
148775359|NCT05174949|536651342|FG000|Overall Study|Withdrawal by Subject|0|||
148775360|NCT05174949|536651343|FG001|Overall Study|Withdrawal by Subject|1|||
148775361|NCT05174949|536651344|FG002|Overall Study|Withdrawal by Subject|0|||
148775362|NCT05174949|536651345|FG003|Overall Study|Withdrawal by Subject|0|||
148775363|NCT05174949|536651346|FG004|Overall Study|Withdrawal by Subject|0|||
148775364|NCT05174949|536651347|FG005|Overall Study|Withdrawal by Subject|0|||
148775365|NCT05174949|536651342|FG000|Overall Study|Lost to Follow-up|0|||
148775366|NCT05174949|536651343|FG001|Overall Study|Lost to Follow-up|0|||
148775367|NCT05174949|536651344|FG002|Overall Study|Lost to Follow-up|0|||
148775368|NCT05174949|536651345|FG003|Overall Study|Lost to Follow-up|1|||
148775369|NCT05174949|536651346|FG004|Overall Study|Lost to Follow-up|0|||
148775370|NCT05174949|536651347|FG005|Overall Study|Lost to Follow-up|0|||
148775371|NCT04351373|536651348|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
148775372|NCT01123941|536651356|FG000|Overall Study|Lost to Follow-up|2|||
148775373|NCT01123941|536651357|FG001|Overall Study|Lost to Follow-up|1|||
148775374|NCT05083923|536651365|FG000|Overall Study|Adverse Event|2|||
148775375|NCT05083923|536651366|FG001|Overall Study|Adverse Event|0|||
148775376|NCT05083923|536651365|FG000|Overall Study|Lack of Efficacy|1|||
148775377|NCT05083923|536651366|FG001|Overall Study|Lack of Efficacy|3|||
148775378|NCT05083923|536651365|FG000|Overall Study|Withdrawal by Subject|2|||
148775379|NCT05083923|536651366|FG001|Overall Study|Withdrawal by Subject|6|||
148775380|NCT05083923|536651365|FG000|Overall Study|Reason Not Specified|0|||
148775381|NCT05083923|536651366|FG001|Overall Study|Reason Not Specified|1|||
148775382|NCT01537068|536651371|FG000|Overall Study|Lost to Follow-up|2|||
148775383|NCT01537068|536651372|FG001|Overall Study|Lost to Follow-up|1|||
148775384|NCT01537068|536651371|FG000|Overall Study|Adverse Event|0|||
148775385|NCT01537068|536651372|FG001|Overall Study|Adverse Event|1|||
148775386|NCT01537068|536651371|FG000|Overall Study|Withdrawal by Subject|1|||
148775387|NCT01537068|536651372|FG001|Overall Study|Withdrawal by Subject|1|||
148775388|NCT01537068|536651371|FG000|Overall Study|Lack of Efficacy|1|||
148775389|NCT01537068|536651372|FG001|Overall Study|Lack of Efficacy|0|||
148775390|NCT03802565|536651373|FG000|Overall Study|Adverse Event|0|||
148775391|NCT03802565|536651374|FG001|Overall Study|Adverse Event|1|||
148775392|NCT03802565|536651375|FG002|Overall Study|Adverse Event|2|||
148775393|NCT03802565|536651376|FG003|Overall Study|Adverse Event|1|||
148775394|NCT03802565|536651377|FG004|Overall Study|Adverse Event|1|||
148775395|NCT03802565|536651373|FG000|Overall Study|Withdrawal by Subject|2|||
148775396|NCT03802565|536651374|FG001|Overall Study|Withdrawal by Subject|2|||
148775397|NCT03802565|536651375|FG002|Overall Study|Withdrawal by Subject|2|||
148775398|NCT03802565|536651376|FG003|Overall Study|Withdrawal by Subject|0|||
148775399|NCT03802565|536651377|FG004|Overall Study|Withdrawal by Subject|1|||
148775400|NCT03802565|536651373|FG000|Overall Study|Protocol Violation|2|||
148775401|NCT03802565|536651374|FG001|Overall Study|Protocol Violation|1|||
148775402|NCT03802565|536651375|FG002|Overall Study|Protocol Violation|4|||
148775403|NCT03802565|536651376|FG003|Overall Study|Protocol Violation|5|||
148775404|NCT03802565|536651377|FG004|Overall Study|Protocol Violation|1|||
148775405|NCT03802565|536651373|FG000|Overall Study|Lost to Follow-up|0|||
148775406|NCT03802565|536651374|FG001|Overall Study|Lost to Follow-up|0|||
148775407|NCT03802565|536651375|FG002|Overall Study|Lost to Follow-up|1|||
148775408|NCT03802565|536651376|FG003|Overall Study|Lost to Follow-up|0|||
148775409|NCT03802565|536651377|FG004|Overall Study|Lost to Follow-up|0|||
148775410|NCT03802565|536651373|FG000|Overall Study|Subjects Related to Each Other|1|||
148775411|NCT03802565|536651374|FG001|Overall Study|Subjects Related to Each Other|0|||
148775412|NCT03802565|536651375|FG002|Overall Study|Subjects Related to Each Other|0|||
148775413|NCT03802565|536651376|FG003|Overall Study|Subjects Related to Each Other|2|||
148775414|NCT03802565|536651377|FG004|Overall Study|Subjects Related to Each Other|1|||
148775415|NCT03802565|536651373|FG000|Overall Study|Elevated Enzymes|0|||
149029865|NCT00762463|537587895|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
148775416|NCT03802565|536651374|FG001|Overall Study|Elevated Enzymes|0|||
148775417|NCT03802565|536651375|FG002|Overall Study|Elevated Enzymes|0|||
148775418|NCT03802565|536651376|FG003|Overall Study|Elevated Enzymes|0|||
148775419|NCT03802565|536651377|FG004|Overall Study|Elevated Enzymes|2|||
148775420|NCT03099694|536651378|FG000|Overall Study|Withdrawal by Subject|11|||
148775421|NCT03099694|536651379|FG001|Overall Study|Withdrawal by Subject|13|||
149029866|NCT00762463|537587896|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
148775422|NCT03099694|536651378|FG000|Overall Study|Lost to Follow-up|9|||
148775423|NCT03099694|536651379|FG001|Overall Study|Lost to Follow-up|5|||
148775424|NCT00794040|536651385|FG000|Overall Study|Withdrawal by Subject|3|||
148775425|NCT00794040|536651386|FG001|Overall Study|Withdrawal by Subject|4|||
148775426|NCT00794040|536651385|FG000|Overall Study|Physician Decision|0|||
148775427|NCT00794040|536651386|FG001|Overall Study|Physician Decision|1|||
148775428|NCT04696354|536651387|FG000|Overall Study|Study termination|6|||
148775429|NCT04696354|536651388|FG001|Overall Study|Study termination|6|||
148775430|NCT03005327|536651389|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
148775431|NCT03005327|536651390|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
148775432|NCT03005327|536651391|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
148775433|NCT03005327|536651392|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
148775434|NCT03005327|536651389|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148775435|NCT03005327|536651390|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
148775436|NCT03005327|536651391|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148775437|NCT03005327|536651392|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
148775438|NCT04687072|536651393|FG000|Overall Study|Adverse Event|2|||
148775439|NCT04687072|536651394|FG001|Overall Study|Adverse Event|0|||
148775440|NCT04687072|536651393|FG000|Overall Study|Death|1|||
148775441|NCT04687072|536651394|FG001|Overall Study|Death|0|||
148775442|NCT04687072|536651393|FG000|Overall Study|Lack of Efficacy|2|||
148775443|NCT04687072|536651394|FG001|Overall Study|Lack of Efficacy|1|||
148775444|NCT04687072|536651393|FG000|Overall Study|Physician Decision|1|||
148775445|NCT04687072|536651394|FG001|Overall Study|Physician Decision|0|||
148775446|NCT04687072|536651393|FG000|Overall Study|Pregnancy|1|||
148775447|NCT04687072|536651394|FG001|Overall Study|Pregnancy|0|||
148775448|NCT04687072|536651393|FG000|Overall Study|Requires Prohibited Medication|2|||
148775449|NCT04687072|536651394|FG001|Overall Study|Requires Prohibited Medication|0|||
148775450|NCT04687072|536651393|FG000|Overall Study|Withdrawal of Consent|11|||
148775451|NCT04687072|536651394|FG001|Overall Study|Withdrawal of Consent|6|||
148775452|NCT04687072|536651393|FG000|Overall Study|Miscellaneous|4|||
148775453|NCT04687072|536651394|FG001|Overall Study|Miscellaneous|1|||
148775454|NCT01263782|536651395|FG000|Overall Study|Death|0|||
148775455|NCT01263782|536651396|FG001|Overall Study|Death|0|||
148775456|NCT01263782|536651397|FG002|Overall Study|Death|1|||
148775457|NCT01263782|536651398|FG003|Overall Study|Death|0|||
148775458|NCT01263782|536651395|FG000|Overall Study|Progressive disease|0|||
148775459|NCT01263782|536651396|FG001|Overall Study|Progressive disease|0|||
148775460|NCT01263782|536651397|FG002|Overall Study|Progressive disease|0|||
148775461|NCT01263782|536651398|FG003|Overall Study|Progressive disease|1|||
148775462|NCT01263782|536651395|FG000|Overall Study|Too early|0|||
148775463|NCT01263782|536651396|FG001|Overall Study|Too early|0|||
148775464|NCT01263782|536651397|FG002|Overall Study|Too early|1|||
148775465|NCT01263782|536651398|FG003|Overall Study|Too early|0|||
148775466|NCT01263782|536651395|FG000|Overall Study|Inevaluable|0|||
148775467|NCT01263782|536651396|FG001|Overall Study|Inevaluable|0|||
148775468|NCT01263782|536651397|FG002|Overall Study|Inevaluable|1|||
148775469|NCT01263782|536651398|FG003|Overall Study|Inevaluable|0|||
148775470|NCT00915876|536651399|FG000|Overall Study|Adverse Event|0|||
148775471|NCT00915876|536651400|FG001|Overall Study|Adverse Event|1|||
148775472|NCT04545567|536651404|FG000|Overall Study|tested positive for SARS-co-V2|1|||
148775473|NCT04545567|536651405|FG001|Overall Study|tested positive for SARS-co-V2|1|||
148775474|NCT04545567|536651404|FG000|Overall Study|Withdrawal by Subject|0|||
148983998|NCT00116805|537419324|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
148983999|NCT00116805|537419323|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
148984000|NCT00116805|537419324|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
148984001|NCT00116805|537419323|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
148984002|NCT00116805|537419324|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
148775475|NCT04545567|536651405|FG001|Overall Study|Withdrawal by Subject|1|||
148775476|NCT03626363|536651409|FG000|Overall Study|Protocol Violation|4|||
148775477|NCT03626363|536651410|FG001|Overall Study|Protocol Violation|0|||
148775478|NCT03626363|536651409|FG000|Overall Study|Lost to Follow-up|5|||
148775479|NCT03626363|536651410|FG001|Overall Study|Lost to Follow-up|7|||
148775480|NCT02419612|536651411|FG000|Short-term Treatment Period|Adverse Event|1|||
148775481|NCT02419612|536651412|FG001|Short-term Treatment Period|Adverse Event|1|||
148775482|NCT02419612|536651411|FG000|Short-term Treatment Period|Death|0|||
148984003|NCT00116805|537419323|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
148775483|NCT02419612|536651412|FG001|Short-term Treatment Period|Death|2|||
148775484|NCT02419612|536651411|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
148775485|NCT02419612|536651412|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
148984004|NCT00116805|537419324|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
148775486|NCT02419612|536651411|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
148775487|NCT02419612|536651412|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
148775488|NCT02419612|536651411|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
148775489|NCT02419612|536651412|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
148775490|NCT02419612|536651411|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
148775491|NCT02419612|536651412|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
148775492|NCT02419612|536651411|FG000|Short-term Treatment Period|Worsening of liver function|0|||
148775493|NCT02419612|536651412|FG001|Short-term Treatment Period|Worsening of liver function|1|||
148775494|NCT02419612|536651411|FG000|Short-term Treatment Period|Subject moved out of state|0|||
148775495|NCT02419612|536651412|FG001|Short-term Treatment Period|Subject moved out of state|1|||
148775496|NCT02419612|536651411|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
148775497|NCT02419612|536651412|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
148775498|NCT02419612|536651411|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
148775499|NCT02419612|536651412|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
148775500|NCT02419612|536651411|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
148775501|NCT02419612|536651412|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
148775502|NCT02419612|536651411|FG000|Long-term Treatment Period|Death|0|||
148775503|NCT02419612|536651412|FG001|Long-term Treatment Period|Death|1|||
148984005|NCT00116805|537419323|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
148984006|NCT00116805|537419324|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
148984007|NCT00116805|537419323|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
148984008|NCT00116805|537419324|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
148984009|NCT00116805|537419323|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
148984010|NCT00116805|537419324|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
148984011|NCT00116805|537419323|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
148984012|NCT00116805|537419324|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
148984013|NCT00116805|537419323|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
148984014|NCT00116805|537419324|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
148984015|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
148984016|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
148984017|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
148984018|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
148984019|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Adverse Event|5|||
148984020|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Adverse Event|3|||
148984021|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Adverse Event|4|||
148984022|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Adverse Event|10|||
148984023|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
148984024|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
148984025|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
148984026|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
148984027|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
148984028|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
148984029|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
148984030|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
148984031|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Pregnancy|5|||
148984032|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Pregnancy|0|||
148984033|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Pregnancy|3|||
148984034|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Pregnancy|2|||
148984035|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Non-compliance|1|||
148984036|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Non-compliance|4|||
148984037|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Non-compliance|0|||
148775504|NCT02419612|536651411|FG000|Long-term Treatment Period|Adverse Event|0|||
148775505|NCT02419612|536651412|FG001|Long-term Treatment Period|Adverse Event|5|||
148775506|NCT02419612|536651411|FG000|Long-term Treatment Period|Other|4|||
148984038|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Non-compliance|3|||
148984039|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Other|0|||
148984040|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Other|3|||
148984041|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Other|3|||
148984042|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Other|1|||
148984043|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
148984044|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
148984045|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
148984046|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
148984047|NCT01760954|537419325|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
148984048|NCT01760954|537419326|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
148984049|NCT01760954|537419327|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
148984050|NCT01760954|537419328|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
148984051|NCT01760954|537419325|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
148984052|NCT01760954|537419326|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
148984053|NCT01760954|537419327|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
148984054|NCT01760954|537419328|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
148984055|NCT01760954|537419325|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
148775507|NCT02419612|536651412|FG001|Long-term Treatment Period|Other|4|||
148775508|NCT02419612|536651411|FG000|Long-term Treatment Period|Subject Decision|2|||
148775509|NCT02419612|536651412|FG001|Long-term Treatment Period|Subject Decision|4|||
148775510|NCT02419612|536651411|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
148775511|NCT02419612|536651412|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
148775512|NCT00533702|536651413|FG000|Overall Study|Withdrawal by Subject|3|||
148775513|NCT00533702|536651414|FG001|Overall Study|Withdrawal by Subject|1|||
148775514|NCT00533702|536651413|FG000|Overall Study|Found ineligible after randomization|2|||
148775515|NCT00533702|536651414|FG001|Overall Study|Found ineligible after randomization|1|||
148775516|NCT01095978|536651415|FG000|Overall Study|Did not take Klacid SR|2|||
148775517|NCT01095978|536651415|FG000|Overall Study|Adverse Event|1|||
148775518|NCT00965341|536651416|FG000|Overall Study|Withdrew consent|1|||
148775519|NCT00965341|536651417|FG001|Overall Study|Withdrew consent|5|||
148775520|NCT00965341|536651416|FG000|Overall Study|Lost to Follow-up|1|||
148775521|NCT00965341|536651417|FG001|Overall Study|Lost to Follow-up|0|||
148775522|NCT00965341|536651416|FG000|Overall Study|Transportation issues|4|||
148775523|NCT00965341|536651417|FG001|Overall Study|Transportation issues|3|||
148775524|NCT00960986|536651423|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
148775525|NCT00960986|536651424|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
148775526|NCT00960986|536651425|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
148775527|NCT00960986|536651426|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
148775528|NCT00960986|536651423|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
148775529|NCT00960986|536651424|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
148775530|NCT00960986|536651425|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
148775531|NCT00960986|536651426|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
148775532|NCT00960986|536651423|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
148775533|NCT00960986|536651424|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
148775534|NCT00960986|536651425|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
148775535|NCT00960986|536651426|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
148775536|NCT00960986|536651423|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
148775537|NCT00960986|536651424|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
148775538|NCT00960986|536651425|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
148775539|NCT00960986|536651426|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
148775540|NCT00960986|536651423|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
148775541|NCT00960986|536651424|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
148775542|NCT00960986|536651425|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
148775543|NCT00960986|536651426|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
148775544|NCT00960986|536651423|FG000|Period 3 (7-week Therapy Period)|Death|0|||
148775545|NCT00960986|536651424|FG001|Period 3 (7-week Therapy Period)|Death|0|||
148775546|NCT00960986|536651425|FG002|Period 3 (7-week Therapy Period)|Death|1|||
148775547|NCT00960986|536651426|FG003|Period 3 (7-week Therapy Period)|Death|0|||
148775548|NCT00960986|536651423|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
148775549|NCT00960986|536651424|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
148775550|NCT00960986|536651425|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
148775551|NCT00960986|536651426|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
148775552|NCT00960986|536651423|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
148775553|NCT00960986|536651424|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
148775554|NCT00960986|536651425|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
148775555|NCT00960986|536651426|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
148775556|NCT00960986|536651423|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
148775557|NCT00960986|536651424|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
148775558|NCT00960986|536651425|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
148775559|NCT00960986|536651426|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
148775560|NCT00960986|536651423|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
148775561|NCT00960986|536651424|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
148775562|NCT00960986|536651425|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
148775563|NCT00960986|536651426|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
148775564|NCT01984892|536651427|FG000|Overall Study|Progressive disease|7|||
148775565|NCT04464720|536651428|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
148775566|NCT04413552|536651434|FG000|Overall Study|Adverse Event|0|||
148775567|NCT04413552|536651435|FG001|Overall Study|Adverse Event|0|||
148775568|NCT04413552|536651436|FG002|Overall Study|Adverse Event|0|||
148775569|NCT04413552|536651437|FG003|Overall Study|Adverse Event|0|||
148775570|NCT04413552|536651438|FG004|Overall Study|Adverse Event|0|||
148775571|NCT04413552|536651439|FG005|Overall Study|Adverse Event|0|||
148775572|NCT04413552|536651440|FG006|Overall Study|Adverse Event|1|||
148775573|NCT04413552|536651441|FG007|Overall Study|Adverse Event|0|||
148775574|NCT04413552|536651442|FG008|Overall Study|Adverse Event|0|||
148775575|NCT04413552|536651443|FG009|Overall Study|Adverse Event|0|||
148775576|NCT01794793|536651446|FG000|Treatment Period|Withdrawal by Subject|24|||
148775577|NCT01794793|536651446|FG000|Treatment Period|Lack of Efficacy|22|||
148775578|NCT01794793|536651446|FG000|Treatment Period|Adverse Event|17|||
148775579|NCT01794793|536651446|FG000|Treatment Period|Physician Decision|14|||
148775580|NCT01794793|536651446|FG000|Treatment Period|Lost to Follow-up|7|||
148775581|NCT01794793|536651446|FG000|Treatment Period|Death|6|||
148775582|NCT01794793|536651446|FG000|Treatment Period|Protocol Violation|5|||
148775583|NCT01794793|536651446|FG000|Treatment Period|administrative problem|3|||
148775584|NCT01794793|536651446|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
148775585|NCT01794793|536651446|FG000|Post-treatment Follow-up|Adverse Event|8|||
148775586|NCT01794793|536651446|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
148775587|NCT01794793|536651446|FG000|Post-treatment Follow-up|administrative problem|5|||
148775588|NCT01794793|536651446|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
148775589|NCT01794793|536651446|FG000|Post-treatment Follow-up|Protocol Violation|3|||
148775590|NCT02417961|536653278|FG000|Overall Study|Adverse Event|1|||
148775591|NCT02417961|536653278|FG000|Overall Study|Lost to Follow-up|1|||
148775592|NCT02417961|536653278|FG000|Overall Study|Withdrawal by Subject|2|||
148775593|NCT05079750|536653279|FG000|Overall Study|Lost to Follow-up|0|||
148775594|NCT05079750|536653280|FG001|Overall Study|Lost to Follow-up|0|||
148775595|NCT05079750|536653281|FG002|Overall Study|Lost to Follow-up|1|||
148775596|NCT05091346|536653282|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
148775597|NCT05091346|536653283|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
148775598|NCT05091346|536653284|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
148775599|NCT05091346|536653285|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
148984056|NCT01760954|537419326|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
148984057|NCT01760954|537419327|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
148984058|NCT01760954|537419328|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
148984059|NCT01760954|537419325|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
148984060|NCT01760954|537419326|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
148984061|NCT01760954|537419327|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
148984062|NCT01760954|537419328|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
148984063|NCT01760954|537419325|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
148984064|NCT01760954|537419326|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
148984065|NCT01760954|537419327|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
148775600|NCT05091346|536653286|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
148775601|NCT05091346|536653282|FG000|Overall Study|Death|6|||
148775602|NCT05091346|536653283|FG001|Overall Study|Death|5|||
148775603|NCT05091346|536653284|FG002|Overall Study|Death|8|||
148775604|NCT05091346|536653285|FG003|Overall Study|Death|16|||
148775605|NCT05091346|536653286|FG004|Overall Study|Death|26|||
148775606|NCT05091346|536653282|FG000|Overall Study|Lost to Follow-up|0|||
148775607|NCT05091346|536653283|FG001|Overall Study|Lost to Follow-up|0|||
148775608|NCT05091346|536653284|FG002|Overall Study|Lost to Follow-up|0|||
148775609|NCT05091346|536653285|FG003|Overall Study|Lost to Follow-up|1|||
148775610|NCT05091346|536653286|FG004|Overall Study|Lost to Follow-up|0|||
148775611|NCT05091346|536653282|FG000|Overall Study|Withdrawal by Subject|0|||
148775612|NCT05091346|536653283|FG001|Overall Study|Withdrawal by Subject|1|||
148775613|NCT05091346|536653284|FG002|Overall Study|Withdrawal by Subject|2|||
148775614|NCT05091346|536653285|FG003|Overall Study|Withdrawal by Subject|2|||
148775615|NCT05091346|536653286|FG004|Overall Study|Withdrawal by Subject|1|||
148775616|NCT00197002|536653287|FG000|Overall Study|Adverse Event|0|||
148775617|NCT00197002|536653288|FG001|Overall Study|Adverse Event|1|||
148984066|NCT01760954|537419328|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
148984067|NCT01760954|537419325|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
148984068|NCT01760954|537419326|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
148984069|NCT01760954|537419327|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
148984070|NCT01760954|537419328|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
148984071|NCT01760954|537419325|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
148984072|NCT01760954|537419326|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
148984073|NCT01760954|537419327|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
148984074|NCT01760954|537419328|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
148984075|NCT01159938|537419329|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
148984076|NCT01159938|537419330|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
148984077|NCT01159938|537419331|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
148984078|NCT01159938|537419332|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
148984079|NCT01159938|537419333|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
148984080|NCT02318329|537419340|FG000|Overall Study|Progressive Disease|2|||
148984081|NCT02318329|537419341|FG001|Overall Study|Progressive Disease|3|||
148984082|NCT02318329|537419342|FG002|Overall Study|Progressive Disease|2|||
148984083|NCT02318329|537419343|FG003|Overall Study|Progressive Disease|3|||
148984084|NCT02318329|537419344|FG004|Overall Study|Progressive Disease|3|||
148775618|NCT00197002|536653289|FG002|Overall Study|Adverse Event|0|||
148775619|NCT00197002|536653287|FG000|Overall Study|Protocol Violation|1|||
148775620|NCT00197002|536653288|FG001|Overall Study|Protocol Violation|0|||
148775621|NCT00197002|536653289|FG002|Overall Study|Protocol Violation|2|||
148775622|NCT00197002|536653287|FG000|Overall Study|Withdrawal by Subject|9|||
148775623|NCT00197002|536653288|FG001|Overall Study|Withdrawal by Subject|5|||
148775624|NCT00197002|536653289|FG002|Overall Study|Withdrawal by Subject|7|||
148775625|NCT00197002|536653287|FG000|Overall Study|Migrated/moved from study area|3|||
148775626|NCT00197002|536653288|FG001|Overall Study|Migrated/moved from study area|5|||
148775627|NCT00197002|536653289|FG002|Overall Study|Migrated/moved from study area|1|||
148775628|NCT00197002|536653287|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
148775629|NCT00197002|536653288|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
148775630|NCT00197002|536653289|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
148984085|NCT02318329|537419345|FG005|Overall Study|Progressive Disease|3|||
148984086|NCT02318329|537419346|FG006|Overall Study|Progressive Disease|1|||
148984087|NCT02318329|537419347|FG007|Overall Study|Progressive Disease|1|||
148984088|NCT02318329|537419348|FG008|Overall Study|Progressive Disease|5|||
148984089|NCT02318329|537419349|FG009|Overall Study|Progressive Disease|39|||
148984090|NCT02318329|537419340|FG000|Overall Study|Death|0|||
148984091|NCT02318329|537419341|FG001|Overall Study|Death|0|||
148984092|NCT02318329|537419342|FG002|Overall Study|Death|0|||
148984093|NCT02318329|537419343|FG003|Overall Study|Death|0|||
148984094|NCT02318329|537419344|FG004|Overall Study|Death|0|||
148984095|NCT02318329|537419345|FG005|Overall Study|Death|0|||
148984096|NCT02318329|537419346|FG006|Overall Study|Death|0|||
148984097|NCT02318329|537419347|FG007|Overall Study|Death|0|||
148984098|NCT02318329|537419348|FG008|Overall Study|Death|0|||
148984099|NCT02318329|537419349|FG009|Overall Study|Death|5|||
148984100|NCT02318329|537419340|FG000|Overall Study|Lost to Follow-up|0|||
148984101|NCT02318329|537419341|FG001|Overall Study|Lost to Follow-up|0|||
148984102|NCT02318329|537419342|FG002|Overall Study|Lost to Follow-up|0|||
148984103|NCT02318329|537419343|FG003|Overall Study|Lost to Follow-up|0|||
148984104|NCT02318329|537419344|FG004|Overall Study|Lost to Follow-up|0|||
148984105|NCT02318329|537419345|FG005|Overall Study|Lost to Follow-up|0|||
148984106|NCT02318329|537419346|FG006|Overall Study|Lost to Follow-up|0|||
148984107|NCT02318329|537419347|FG007|Overall Study|Lost to Follow-up|0|||
148984108|NCT02318329|537419348|FG008|Overall Study|Lost to Follow-up|0|||
148984109|NCT02318329|537419349|FG009|Overall Study|Lost to Follow-up|1|||
148984110|NCT02318329|537419340|FG000|Overall Study|Withdrawal by Subject|0|||
148984111|NCT02318329|537419341|FG001|Overall Study|Withdrawal by Subject|0|||
148984112|NCT02318329|537419342|FG002|Overall Study|Withdrawal by Subject|0|||
148984113|NCT02318329|537419343|FG003|Overall Study|Withdrawal by Subject|0|||
148984114|NCT02318329|537419344|FG004|Overall Study|Withdrawal by Subject|0|||
148984115|NCT02318329|537419345|FG005|Overall Study|Withdrawal by Subject|0|||
148984116|NCT02318329|537419346|FG006|Overall Study|Withdrawal by Subject|0|||
148984117|NCT02318329|537419347|FG007|Overall Study|Withdrawal by Subject|0|||
148984118|NCT02318329|537419348|FG008|Overall Study|Withdrawal by Subject|0|||
148984119|NCT02318329|537419349|FG009|Overall Study|Withdrawal by Subject|6|||
148984120|NCT02318329|537419340|FG000|Overall Study|Other|1|||
148984121|NCT02318329|537419341|FG001|Overall Study|Other|1|||
148984122|NCT02318329|537419342|FG002|Overall Study|Other|1|||
148984123|NCT02318329|537419343|FG003|Overall Study|Other|0|||
148984124|NCT02318329|537419344|FG004|Overall Study|Other|0|||
148984125|NCT02318329|537419345|FG005|Overall Study|Other|0|||
148984126|NCT02318329|537419346|FG006|Overall Study|Other|0|||
148984127|NCT02318329|537419347|FG007|Overall Study|Other|0|||
148984128|NCT02318329|537419348|FG008|Overall Study|Other|1|||
148984129|NCT02318329|537419349|FG009|Overall Study|Other|1|||
148984130|NCT00982020|537419358|FG000|Overall Study|Adverse Event|19|||
148984131|NCT00982020|537419359|FG001|Overall Study|Adverse Event|15|||
148984132|NCT00982020|537419358|FG000|Overall Study|Withdrawal by Subject|11|||
148984133|NCT00982020|537419359|FG001|Overall Study|Withdrawal by Subject|14|||
148984134|NCT00982020|537419358|FG000|Overall Study|Lost to Follow-up|5|||
148984135|NCT00982020|537419359|FG001|Overall Study|Lost to Follow-up|11|||
148984136|NCT00982020|537419358|FG000|Overall Study|Lack of Efficacy|10|||
148984137|NCT00982020|537419359|FG001|Overall Study|Lack of Efficacy|4|||
148984138|NCT00982020|537419358|FG000|Overall Study|Parent/Caregiver Decision|5|||
148984139|NCT00982020|537419359|FG001|Overall Study|Parent/Caregiver Decision|5|||
148984140|NCT00982020|537419358|FG000|Overall Study|Treatment Non-compliance|3|||
148984141|NCT00982020|537419359|FG001|Overall Study|Treatment Non-compliance|6|||
148984142|NCT00982020|537419358|FG000|Overall Study|Physician Decision|2|||
148984143|NCT00982020|537419359|FG001|Overall Study|Physician Decision|5|||
148984144|NCT00982020|537419358|FG000|Overall Study|Entry Criteria Not Met|2|||
148984145|NCT00982020|537419359|FG001|Overall Study|Entry Criteria Not Met|1|||
148984146|NCT00982020|537419358|FG000|Overall Study|Protocol Violation|0|||
148984147|NCT00982020|537419359|FG001|Overall Study|Protocol Violation|2|||
148984148|NCT00982020|537419358|FG000|Overall Study|Clinical Relapse|0|||
148984149|NCT00982020|537419359|FG001|Overall Study|Clinical Relapse|1|||
148984150|NCT00353704|537419360|FG000|Overall Study|Protocol Violation|3|||
148984151|NCT00353704|537419361|FG001|Overall Study|Protocol Violation|1|||
148984152|NCT02525133|537419362|FG000|Overall Study|Adverse Event|0|||
148984153|NCT02525133|537419363|FG001|Overall Study|Adverse Event|1|||
149029867|NCT00762463|537587897|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
149029868|NCT00531479|537587898|FG000|Overall Study|Death|68|||
149029869|NCT00531479|537587899|FG001|Overall Study|Death|71|||
149029870|NCT00531479|537587898|FG000|Overall Study|Lost to Follow-up|0|||
149029871|NCT00531479|537587899|FG001|Overall Study|Lost to Follow-up|2|||
149029872|NCT00531479|537587898|FG000|Overall Study|Other|0|||
149029873|NCT00531479|537587899|FG001|Overall Study|Other|1|||
149029874|NCT00531479|537587898|FG000|Overall Study|Withdrawal by Subject|6|||
149029875|NCT00531479|537587899|FG001|Overall Study|Withdrawal by Subject|6|||
149029876|NCT00531479|537587898|FG000|Overall Study|Did not receive treatment|2|||
149029877|NCT00531479|537587899|FG001|Overall Study|Did not receive treatment|3|||
149029878|NCT04358549|537587902|FG000|Overall Study|Adverse Event|0|||
149029879|NCT04358549|537587903|FG001|Overall Study|Adverse Event|1|||
149029880|NCT04358549|537587902|FG000|Overall Study|Death|1|||
149029881|NCT04358549|537587903|FG001|Overall Study|Death|0|||
149029882|NCT04358549|537587902|FG000|Overall Study|Lost to Follow-up|2|||
149029883|NCT04358549|537587903|FG001|Overall Study|Lost to Follow-up|1|||
149029884|NCT04358549|537587902|FG000|Overall Study|Withdrawal by Subject|6|||
149029885|NCT04358549|537587903|FG001|Overall Study|Withdrawal by Subject|6|||
149029886|NCT04358549|537587902|FG000|Overall Study|Start remdesivir|1|||
149029887|NCT04358549|537587903|FG001|Overall Study|Start remdesivir|0|||
149029888|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
149029889|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
149029890|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
149029891|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
149029892|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Adverse Event|198|||
149029893|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Adverse Event|0|||
149029894|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Adverse Event|0|||
149029895|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Adverse Event|0|||
149029896|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Death|62|||
149029897|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Death|0|||
149029898|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Death|0|||
149029899|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Death|0|||
149029900|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
149029901|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
149029902|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
149029903|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
149029904|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Complicating disease|13|||
149029905|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Complicating disease|0|||
149029906|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Complicating disease|0|||
149029907|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Complicating disease|0|||
149029908|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
149029909|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
149029910|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
149029911|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
149029912|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
149029913|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
149029914|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
149029915|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
149029916|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Non-compliance|4|||
149029917|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Non-compliance|0|||
149029918|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Non-compliance|0|||
149029919|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Non-compliance|0|||
149029920|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Pain|4|||
149029921|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Pain|0|||
149029922|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Pain|0|||
149029923|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Pain|0|||
149029924|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
149029925|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
149029926|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
149029927|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
149029928|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Hospice care|1|||
149029929|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Hospice care|0|||
149029930|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Hospice care|0|||
149029931|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Hospice care|0|||
149029932|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Physician Decision|1|||
149029933|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Physician Decision|0|||
149029934|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Physician Decision|0|||
149029935|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Physician Decision|0|||
149029936|NCT01107626|537587907|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
149029937|NCT01107626|537587908|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
149029938|NCT01107626|537587909|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
149029939|NCT01107626|537587910|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
149029940|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
148775631|NCT00197002|536653287|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
148775632|NCT00197002|536653288|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
148775633|NCT00197002|536653289|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
148775634|NCT00197002|536653287|FG000|Overall Study|Others|3|||
148775635|NCT00197002|536653288|FG001|Overall Study|Others|1|||
148775636|NCT00197002|536653289|FG002|Overall Study|Others|1|||
148775637|NCT03569293|536653292|FG000|Overall Study|Adverse Event|4|||
148775638|NCT03569293|536653293|FG001|Overall Study|Adverse Event|1|||
148775639|NCT03569293|536653294|FG002|Overall Study|Adverse Event|5|||
148775640|NCT03569293|536653295|FG003|Overall Study|Adverse Event|1|||
148775641|NCT03569293|536653296|FG004|Overall Study|Adverse Event|0|||
148775642|NCT03569293|536653297|FG005|Overall Study|Adverse Event|0|||
148775643|NCT03569293|536653292|FG000|Overall Study|Withdrawal by Subject|16|||
148775644|NCT03569293|536653293|FG001|Overall Study|Withdrawal by Subject|2|||
148775645|NCT03569293|536653294|FG002|Overall Study|Withdrawal by Subject|4|||
148775646|NCT03569293|536653295|FG003|Overall Study|Withdrawal by Subject|1|||
148775647|NCT03569293|536653296|FG004|Overall Study|Withdrawal by Subject|0|||
148775648|NCT03569293|536653297|FG005|Overall Study|Withdrawal by Subject|0|||
148775649|NCT03569293|536653292|FG000|Overall Study|Lost to Follow-up|1|||
148775650|NCT03569293|536653293|FG001|Overall Study|Lost to Follow-up|3|||
148775651|NCT03569293|536653294|FG002|Overall Study|Lost to Follow-up|1|||
148775652|NCT03569293|536653295|FG003|Overall Study|Lost to Follow-up|1|||
148775653|NCT03569293|536653296|FG004|Overall Study|Lost to Follow-up|0|||
148775654|NCT03569293|536653297|FG005|Overall Study|Lost to Follow-up|0|||
148775655|NCT03569293|536653292|FG000|Overall Study|Other|8|||
148775656|NCT03569293|536653293|FG001|Overall Study|Other|2|||
148775657|NCT03569293|536653294|FG002|Overall Study|Other|1|||
148775658|NCT03569293|536653295|FG003|Overall Study|Other|1|||
148775659|NCT03569293|536653296|FG004|Overall Study|Other|0|||
148775660|NCT03569293|536653297|FG005|Overall Study|Other|0|||
148775661|NCT03569293|536653292|FG000|Overall Study|Ongoing at Time of Analysis|8|||
148775662|NCT03569293|536653293|FG001|Overall Study|Ongoing at Time of Analysis|1|||
148775663|NCT03569293|536653294|FG002|Overall Study|Ongoing at Time of Analysis|3|||
148775664|NCT03569293|536653295|FG003|Overall Study|Ongoing at Time of Analysis|0|||
148775665|NCT03569293|536653296|FG004|Overall Study|Ongoing at Time of Analysis|0|||
148775666|NCT03569293|536653297|FG005|Overall Study|Ongoing at Time of Analysis|0|||
148775667|NCT04542499|536653310|FG000|Overall Study|Adverse Event|23|||
148775668|NCT04542499|536653311|FG001|Overall Study|Adverse Event|43|||
148775669|NCT04542499|536653310|FG000|Overall Study|Lack of Efficacy|5|||
148775670|NCT04542499|536653311|FG001|Overall Study|Lack of Efficacy|2|||
148775671|NCT04542499|536653310|FG000|Overall Study|Lost to Follow-up|3|||
148775672|NCT04542499|536653311|FG001|Overall Study|Lost to Follow-up|4|||
148775673|NCT04542499|536653310|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
148775674|NCT04542499|536653311|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
148775675|NCT04542499|536653310|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
148775676|NCT04542499|536653311|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
148775677|NCT04542499|536653310|FG000|Overall Study|Non-Compliance with Study Drug|0|||
148775678|NCT04542499|536653311|FG001|Overall Study|Non-Compliance with Study Drug|2|||
148775679|NCT04542499|536653310|FG000|Overall Study|Physician Decision|0|||
148775680|NCT04542499|536653311|FG001|Overall Study|Physician Decision|1|||
148775681|NCT04542499|536653310|FG000|Overall Study|Site Terminated by Sponsor|3|||
148775682|NCT04542499|536653311|FG001|Overall Study|Site Terminated by Sponsor|5|||
148775683|NCT04542499|536653310|FG000|Overall Study|Withdrawal by Subject|12|||
148775684|NCT04542499|536653311|FG001|Overall Study|Withdrawal by Subject|33|||
148775685|NCT04542499|536653310|FG000|Overall Study|Other|2|||
148775686|NCT04542499|536653311|FG001|Overall Study|Other|2|||
148775687|NCT04035434|536653317|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775688|NCT04035434|536653318|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
148775689|NCT04035434|536653319|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775690|NCT04035434|536653320|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
148775691|NCT04035434|536653321|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
148775692|NCT04035434|536653322|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775693|NCT04035434|536653323|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775694|NCT04035434|536653324|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775695|NCT04035434|536653325|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775696|NCT04035434|536653326|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775697|NCT04035434|536653327|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
148775698|NCT04035434|536653328|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
148775699|NCT04035434|536653329|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775700|NCT04035434|536653317|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
148775701|NCT04035434|536653318|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
148775702|NCT04035434|536653319|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
148775703|NCT04035434|536653320|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
148775704|NCT04035434|536653321|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
148775705|NCT04035434|536653322|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
148775706|NCT04035434|536653323|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
148775707|NCT04035434|536653324|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
148775708|NCT04035434|536653325|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
148775709|NCT04035434|536653326|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
148775710|NCT04035434|536653327|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
148775711|NCT04035434|536653328|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
148775712|NCT04035434|536653329|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
148775713|NCT04035434|536653317|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775714|NCT04035434|536653318|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
148775715|NCT04035434|536653319|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
148775716|NCT04035434|536653320|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775717|NCT04035434|536653321|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
148775718|NCT04035434|536653322|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
148775719|NCT04035434|536653323|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775720|NCT04035434|536653324|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775721|NCT04035434|536653325|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
148775722|NCT04035434|536653326|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
148775723|NCT04035434|536653327|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775724|NCT04035434|536653328|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
148775725|NCT04035434|536653329|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
148775726|NCT04035434|536653317|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775727|NCT04035434|536653318|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775728|NCT04035434|536653319|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775729|NCT04035434|536653320|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
148775730|NCT04035434|536653321|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775731|NCT04035434|536653322|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775732|NCT04035434|536653323|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775733|NCT04035434|536653324|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775734|NCT04035434|536653325|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775735|NCT04035434|536653326|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775736|NCT04035434|536653327|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775737|NCT04035434|536653328|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775738|NCT04035434|536653329|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
148775739|NCT04035434|536653317|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775740|NCT04035434|536653318|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775741|NCT04035434|536653319|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775742|NCT04035434|536653320|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775743|NCT04035434|536653321|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775744|NCT04035434|536653322|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
148775745|NCT04035434|536653323|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
148775746|NCT04035434|536653324|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775747|NCT04035434|536653325|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775748|NCT04035434|536653326|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775749|NCT04035434|536653327|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775750|NCT04035434|536653328|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775751|NCT04035434|536653329|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
148775752|NCT04035434|536653317|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775753|NCT04035434|536653318|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775754|NCT04035434|536653319|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775755|NCT04035434|536653320|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775756|NCT04035434|536653321|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775757|NCT04035434|536653322|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
148775758|NCT04035434|536653323|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
148775759|NCT04035434|536653324|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775760|NCT04035434|536653325|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775761|NCT04035434|536653326|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775762|NCT04035434|536653327|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775763|NCT04035434|536653328|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775764|NCT04035434|536653329|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
148775765|NCT04035434|536653317|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775766|NCT04035434|536653318|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775767|NCT04035434|536653319|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775768|NCT04035434|536653320|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148844432|NCT03008070|536909396|FG002|Overall Study|Adverse Event|3|||
148844433|NCT03008070|536909394|FG000|Overall Study|Lost to Follow-up|1|||
148844434|NCT03008070|536909395|FG001|Overall Study|Lost to Follow-up|1|||
148775769|NCT04035434|536653321|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775770|NCT04035434|536653322|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
148775771|NCT04035434|536653323|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
148775772|NCT04035434|536653324|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775773|NCT04035434|536653325|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775774|NCT04035434|536653326|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775775|NCT04035434|536653327|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775776|NCT04035434|536653328|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775777|NCT04035434|536653329|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
148775778|NCT04488497|536653330|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
148775779|NCT04488497|536653331|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
148775780|NCT04488497|536653330|FG000|Intervention|Physician Decision|2|||
148775781|NCT04488497|536653331|FG001|Intervention|Physician Decision|1|||
148775782|NCT04488497|536653330|FG000|Intervention|Withdrawal by Subject|5|||
148775783|NCT04488497|536653331|FG001|Intervention|Withdrawal by Subject|6|||
148775784|NCT04488497|536653330|FG000|Intervention|Lost to Follow-up|2|||
148775785|NCT04488497|536653331|FG001|Intervention|Lost to Follow-up|0|||
148775786|NCT04488497|536653330|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
148775787|NCT04488497|536653331|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
148775788|NCT04488497|536653330|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
148775789|NCT04488497|536653331|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
148775790|NCT01877551|536653343|FG000|Overall Study|Physician Decision|0|||
148775791|NCT01877551|536653344|FG001|Overall Study|Physician Decision|1|||
148775792|NCT00348790|536653345|FG000|Completed Treatment|Withdrawal by Subject|4|||
148775793|NCT00348790|536653345|FG000|Completed Treatment|Disease progression|14|||
148775794|NCT00348790|536653345|FG000|Completed Treatment|Adverse Event|4|||
148775795|NCT00348790|536653345|FG000|Completed Treatment|Required surgery|2|||
148775796|NCT00348790|536653345|FG000|Completed Treatment|Unable to travel to study site|1|||
148775797|NCT03602391|536653348|FG000|Overall Study|COVID-19|7|||
148775798|NCT03602391|536653349|FG001|Overall Study|COVID-19|6|||
148775799|NCT00878969|536653352|FG000|Overall Study|Physician Decision|5|||
148775800|NCT00878969|536653353|FG001|Overall Study|Physician Decision|3|||
148775801|NCT00878969|536653354|FG002|Overall Study|Physician Decision|2|||
148775802|NCT00878969|536653352|FG000|Overall Study|Withdrawal by Subject|1|||
148775803|NCT00878969|536653353|FG001|Overall Study|Withdrawal by Subject|6|||
148775804|NCT00878969|536653354|FG002|Overall Study|Withdrawal by Subject|3|||
148775805|NCT00878969|536653352|FG000|Overall Study|kidney transplant|2|||
148775806|NCT00878969|536653353|FG001|Overall Study|kidney transplant|3|||
148775807|NCT00878969|536653354|FG002|Overall Study|kidney transplant|2|||
148775808|NCT00878969|536653352|FG000|Overall Study|Adverse Event|3|||
148775809|NCT00878969|536653353|FG001|Overall Study|Adverse Event|1|||
148775810|NCT00878969|536653354|FG002|Overall Study|Adverse Event|2|||
148775811|NCT00878969|536653352|FG000|Overall Study|Lost to Follow-up|2|||
148775812|NCT00878969|536653353|FG001|Overall Study|Lost to Follow-up|1|||
148775813|NCT00878969|536653354|FG002|Overall Study|Lost to Follow-up|0|||
148775814|NCT00878969|536653352|FG000|Overall Study|Protocol Violation|2|||
148775815|NCT00878969|536653353|FG001|Overall Study|Protocol Violation|0|||
148775816|NCT00878969|536653354|FG002|Overall Study|Protocol Violation|0|||
148775817|NCT00878969|536653352|FG000|Overall Study|Death|0|||
148775818|NCT00878969|536653353|FG001|Overall Study|Death|0|||
148775819|NCT00878969|536653354|FG002|Overall Study|Death|2|||
148775820|NCT00878969|536653352|FG000|Overall Study|Pregnancy|0|||
148775821|NCT00878969|536653353|FG001|Overall Study|Pregnancy|1|||
148775822|NCT00878969|536653354|FG002|Overall Study|Pregnancy|0|||
148775823|NCT00655733|536653355|FG000|Overall Study|Lost to Follow-up|2|||
148775824|NCT00655733|536653356|FG001|Overall Study|Lost to Follow-up|2|||
148775825|NCT00655733|536653355|FG000|Overall Study|Adverse Event|2|||
148775826|NCT00655733|536653356|FG001|Overall Study|Adverse Event|2|||
148775827|NCT00655733|536653355|FG000|Overall Study|Withdrawal by Subject|3|||
148775828|NCT00655733|536653356|FG001|Overall Study|Withdrawal by Subject|3|||
148775829|NCT00655733|536653355|FG000|Overall Study|Physician Decision|0|||
148775830|NCT00655733|536653356|FG001|Overall Study|Physician Decision|1|||
148775831|NCT02035748|536653357|FG000|Overall Study|Adverse Event|5|||
148775832|NCT02035748|536653357|FG000|Overall Study|Death|3|||
148844435|NCT03008070|536909396|FG002|Overall Study|Lost to Follow-up|0|||
148844436|NCT03008070|536909394|FG000|Overall Study|Non compliance|0|||
148775833|NCT02035748|536653357|FG000|Overall Study|Lost to Follow-up|2|||
148775834|NCT02035748|536653357|FG000|Overall Study|Physician Decision|3|||
148775835|NCT02035748|536653357|FG000|Overall Study|Withdrawal by Subject|6|||
148844437|NCT03008070|536909395|FG001|Overall Study|Non compliance|1|||
148844438|NCT03008070|536909396|FG002|Overall Study|Non compliance|1|||
148844439|NCT03008070|536909394|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
148844440|NCT03008070|536909395|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
148844441|NCT03008070|536909396|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
148844442|NCT03008070|536909394|FG000|Overall Study|Withdrawal by Subject|2|||
148844443|NCT03008070|536909395|FG001|Overall Study|Withdrawal by Subject|0|||
148844444|NCT03008070|536909396|FG002|Overall Study|Withdrawal by Subject|1|||
148844445|NCT03008070|536909394|FG000|Overall Study|Use of prohibited drug|0|||
148844446|NCT03008070|536909395|FG001|Overall Study|Use of prohibited drug|0|||
148844447|NCT03008070|536909396|FG002|Overall Study|Use of prohibited drug|2|||
148844448|NCT04487080|536909403|FG000|Overall Study|Withdrawal by Subject|19|||
148844449|NCT04487080|536909404|FG001|Overall Study|Withdrawal by Subject|18|||
148844450|NCT04487080|536909405|FG002|Overall Study|Withdrawal by Subject|13|||
148844451|NCT04487080|536909403|FG000|Overall Study|Lost to Follow-up|3|||
148844452|NCT04487080|536909404|FG001|Overall Study|Lost to Follow-up|1|||
148844453|NCT04487080|536909405|FG002|Overall Study|Lost to Follow-up|0|||
148844454|NCT04487080|536909403|FG000|Overall Study|Ongoing|313|||
148844455|NCT04487080|536909404|FG001|Overall Study|Ongoing|297|||
148844456|NCT04487080|536909405|FG002|Overall Study|Ongoing|149|||
148984154|NCT02525133|537419362|FG000|Overall Study|Death|0|||
148984155|NCT02525133|537419363|FG001|Overall Study|Death|1|||
148844457|NCT03451851|536909406|FG000|PCP: Week 0 -16|Adverse Event|1|||
148844458|NCT03451851|536909407|FG001|PCP: Week 0 -16|Adverse Event|0|||
148844459|NCT03451851|536909408|FG002|PCP: Week 0 -16|Adverse Event|0|||
148844460|NCT03451851|536909409|FG003|PCP: Week 0 -16|Adverse Event|0|||
148844461|NCT03451851|536909410|FG004|PCP: Week 0 -16|Adverse Event|0|||
148844462|NCT03451851|536909411|FG005|PCP: Week 0 -16|Adverse Event|0|||
148844463|NCT03451851|536909412|FG006|PCP: Week 0 -16|Adverse Event|1|||
148844464|NCT03451851|536909413|FG007|PCP: Week 0 -16|Adverse Event|0|||
148844465|NCT03451851|536909406|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
148844466|NCT03451851|536909407|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
148844467|NCT03451851|536909408|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
148844468|NCT03451851|536909409|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
148844469|NCT03451851|536909410|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
148844470|NCT03451851|536909411|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
148844471|NCT03451851|536909412|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
148844472|NCT03451851|536909413|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
148775836|NCT02035748|536653357|FG000|Overall Study|Progressive Disease|1|||
148775837|NCT01088243|536653359|FG000|Overall Study|Adverse Event|1|||
148775838|NCT01088243|536653360|FG001|Overall Study|Adverse Event|0|||
148775839|NCT00526331|536653374|FG000|Overall Study|Sponsor Termination|55|||
148775840|NCT01043705|536653375|FG000|Overall Study|Death|28|||
148775841|NCT01043705|536653376|FG001|Overall Study|Death|60|||
148775842|NCT01043705|536653377|FG002|Overall Study|Death|26|||
148844473|NCT03451851|536909406|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844474|NCT03451851|536909407|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844475|NCT03451851|536909408|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
148844476|NCT03451851|536909409|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844477|NCT03451851|536909410|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844478|NCT03451851|536909411|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844479|NCT03451851|536909412|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844480|NCT03451851|536909413|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
148844481|NCT03451851|536909406|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
148984156|NCT02525133|537419362|FG000|Overall Study|did not meet randomization criteria|1|||
148984157|NCT02525133|537419363|FG001|Overall Study|did not meet randomization criteria|0|||
148984158|NCT02525133|537419362|FG000|Overall Study|Lost to Follow-up|5|||
148984159|NCT02525133|537419363|FG001|Overall Study|Lost to Follow-up|1|||
148984160|NCT02525133|537419362|FG000|Overall Study|randomized not enrolled|3|||
148984161|NCT02525133|537419363|FG001|Overall Study|randomized not enrolled|0|||
148984162|NCT02525133|537419362|FG000|Overall Study|Withdrawal by Subject|1|||
148775843|NCT01043705|536653375|FG000|Overall Study|Lost to Follow-up|27|||
148775844|NCT01043705|536653376|FG001|Overall Study|Lost to Follow-up|12|||
148775845|NCT01043705|536653377|FG002|Overall Study|Lost to Follow-up|0|||
148775846|NCT01043705|536653375|FG000|Overall Study|Multiple Reasons|4|||
148775847|NCT01043705|536653376|FG001|Overall Study|Multiple Reasons|7|||
148775848|NCT01043705|536653377|FG002|Overall Study|Multiple Reasons|0|||
148775849|NCT01043705|536653375|FG000|Overall Study|Protocol Violation|2|||
148775850|NCT01043705|536653376|FG001|Overall Study|Protocol Violation|1|||
148775851|NCT01043705|536653377|FG002|Overall Study|Protocol Violation|0|||
148775852|NCT01043705|536653375|FG000|Overall Study|Withdrawal by Subject|8|||
148775853|NCT01043705|536653376|FG001|Overall Study|Withdrawal by Subject|6|||
148775854|NCT01043705|536653377|FG002|Overall Study|Withdrawal by Subject|0|||
148775855|NCT01043705|536653375|FG000|Overall Study|Site Closure|8|||
148775856|NCT01043705|536653376|FG001|Overall Study|Site Closure|0|||
148775857|NCT01043705|536653377|FG002|Overall Study|Site Closure|0|||
148775858|NCT01043705|536653375|FG000|Overall Study|Subsequent Procedure|9|||
148775859|NCT01043705|536653376|FG001|Overall Study|Subsequent Procedure|24|||
148775860|NCT01043705|536653377|FG002|Overall Study|Subsequent Procedure|29|||
148775861|NCT01043705|536653375|FG000|Overall Study|Adverse Event|0|||
148775862|NCT01043705|536653376|FG001|Overall Study|Adverse Event|2|||
148775863|NCT01043705|536653377|FG002|Overall Study|Adverse Event|0|||
148775864|NCT01043705|536653375|FG000|Overall Study|Screen Fail|21|||
148775865|NCT01043705|536653376|FG001|Overall Study|Screen Fail|0|||
148775866|NCT01043705|536653377|FG002|Overall Study|Screen Fail|0|||
148775867|NCT01043705|536653375|FG000|Overall Study|Other|0|||
148775868|NCT01043705|536653376|FG001|Overall Study|Other|19|||
148775869|NCT01043705|536653377|FG002|Overall Study|Other|25|||
148844482|NCT03451851|536909407|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
148844483|NCT03451851|536909408|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
148844484|NCT03451851|536909409|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
148844485|NCT03451851|536909410|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
148844486|NCT03451851|536909411|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
148844487|NCT03451851|536909412|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
148844488|NCT03451851|536909413|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
148844489|NCT03451851|536909406|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844490|NCT03451851|536909407|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844491|NCT03451851|536909408|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844492|NCT03451851|536909409|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844493|NCT03451851|536909410|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
148844494|NCT03451851|536909411|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844495|NCT03451851|536909412|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844496|NCT03451851|536909413|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
148844497|NCT03451851|536909406|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148844498|NCT03451851|536909407|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148844499|NCT03451851|536909408|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148844500|NCT03451851|536909409|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148844501|NCT03451851|536909410|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
148844502|NCT03451851|536909411|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148775870|NCT02003963|536653379|FG000|Overall Study|Lost to Follow-up|2|||
148775871|NCT02003963|536653380|FG001|Overall Study|Lost to Follow-up|1|||
148775872|NCT00581542|536653381|FG000|Overall Study|they met an exclusion criteria|2|||
148775873|NCT00581542|536653382|FG001|Overall Study|they met an exclusion criteria|2|||
148775874|NCT00581542|536653381|FG000|Overall Study|Lost to Follow-up|9|||
148775875|NCT00581542|536653382|FG001|Overall Study|Lost to Follow-up|21|||
148775876|NCT05020366|536653383|FG000|Overall Study|Lost to Follow-up|2|||
148775877|NCT05020366|536653384|FG001|Overall Study|Lost to Follow-up|0|||
148844503|NCT03451851|536909412|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148844504|NCT03451851|536909413|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
148844505|NCT03581292|536909414|FG000|Overall Study|Physician Decision|9|||
148844506|NCT03581292|536909415|FG001|Overall Study|Physician Decision|5|||
148844507|NCT03581292|536909414|FG000|Overall Study|Withdrawal by Subject|3|||
148844508|NCT03581292|536909415|FG001|Overall Study|Withdrawal by Subject|0|||
148844509|NCT03581292|536909414|FG000|Overall Study|Withdrawal before Therapy Start|1|||
148844510|NCT03581292|536909415|FG001|Overall Study|Withdrawal before Therapy Start|0|||
148844511|NCT03052608|536911318|FG000|Treatment Phase|Adverse Event|10|||
148844512|NCT03052608|536911319|FG001|Treatment Phase|Adverse Event|12|||
148844513|NCT03052608|536911318|FG000|Treatment Phase|Death|6|||
148984163|NCT02525133|537419363|FG001|Overall Study|Withdrawal by Subject|0|||
148984164|NCT02613481|537419364|FG000|Overall Study|Lost to Follow-up|7|||
148984165|NCT02613481|537419364|FG000|Overall Study|Withdrawal by Subject|2|||
148984166|NCT01762761|537419365|FG000|Overall Study|Adverse Event|15|||
148984167|NCT01762761|537419366|FG001|Overall Study|Adverse Event|17|||
148775878|NCT05020366|536653383|FG000|Overall Study|Withdrawal by Subject|2|||
148775879|NCT05020366|536653384|FG001|Overall Study|Withdrawal by Subject|0|||
148775880|NCT04050124|536653387|FG000|Overall Study|Death|1|||
148775881|NCT04050124|536653388|FG001|Overall Study|Death|0|||
148775882|NCT04601103|536653389|FG000|Overall Study|Needed crown & cleaning|0|||
148775883|NCT04601103|536653390|FG001|Overall Study|Needed crown & cleaning|0|||
148775884|NCT04601103|536653391|FG002|Overall Study|Needed crown & cleaning|1|||
148984168|NCT01762761|537419365|FG000|Overall Study|Lack of Efficacy|9|||
148984169|NCT01762761|537419366|FG001|Overall Study|Lack of Efficacy|25|||
148984170|NCT01762761|537419365|FG000|Overall Study|Protocol Violation|1|||
148984171|NCT01762761|537419366|FG001|Overall Study|Protocol Violation|1|||
148984172|NCT01762761|537419365|FG000|Overall Study|Study closed/terminated|0|||
148984173|NCT01762761|537419366|FG001|Overall Study|Study closed/terminated|2|||
148984174|NCT01762761|537419365|FG000|Overall Study|Lost to Follow-up|3|||
148984175|NCT01762761|537419366|FG001|Overall Study|Lost to Follow-up|6|||
148984176|NCT01762761|537419365|FG000|Overall Study|Physician Decision|4|||
148775885|NCT04601103|536653389|FG000|Overall Study|study was terminated|18|||
148775886|NCT04601103|536653390|FG001|Overall Study|study was terminated|18|||
148775887|NCT04601103|536653391|FG002|Overall Study|study was terminated|16|||
148775888|NCT06011161|536653394|FG000|Overall Study|Withdrawal by Subject|2|||
148775889|NCT06011161|536653394|FG000|Overall Study|Lost to Follow-up|5|||
148775890|NCT04442269|536653395|FG000|Overall Study|Adverse Event|1|||
148775891|NCT04442269|536653396|FG001|Overall Study|Adverse Event|0|||
148775892|NCT04442269|536653395|FG000|Overall Study|Death|0|||
148775893|NCT04442269|536653396|FG001|Overall Study|Death|1|||
148775894|NCT04442269|536653395|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
148775895|NCT04442269|536653396|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
148775896|NCT04442269|536653395|FG000|Overall Study|Lost to Follow-up|1|||
148775897|NCT04442269|536653396|FG001|Overall Study|Lost to Follow-up|0|||
149029941|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
149029942|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
149029943|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
149029944|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
149029945|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
149029946|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
149029947|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
148775898|NCT04442269|536653395|FG000|Overall Study|Withdrawal by Subject|3|||
148775899|NCT04442269|536653396|FG001|Overall Study|Withdrawal by Subject|2|||
148775900|NCT04442269|536653395|FG000|Overall Study|Protocol Deviation|0|||
148775901|NCT04442269|536653396|FG001|Overall Study|Protocol Deviation|1|||
148775902|NCT04442269|536653395|FG000|Overall Study|Travel Limitations|1|||
148844514|NCT03052608|536911319|FG001|Treatment Phase|Death|4|||
148844515|NCT03052608|536911318|FG000|Treatment Phase|Withdrawal by Subject|4|||
148844516|NCT03052608|536911319|FG001|Treatment Phase|Withdrawal by Subject|12|||
148844517|NCT03052608|536911318|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
148844518|NCT03052608|536911319|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
148844519|NCT03052608|536911318|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
148844520|NCT03052608|536911319|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
148844521|NCT03052608|536911318|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
148844522|NCT03052608|536911319|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
148844523|NCT03052608|536911318|FG000|Treatment Phase|Ongoing|103|||
148844524|NCT03052608|536911319|FG001|Treatment Phase|Ongoing|31|||
148844525|NCT03052608|536911318|FG000|Long-Term Follow-up Phase|Death|23|||
148844526|NCT03052608|536911319|FG001|Long-Term Follow-up Phase|Death|28|||
148844527|NCT03052608|536911318|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
148844528|NCT03052608|536911319|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
148844529|NCT03052608|536911318|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
148844530|NCT03052608|536911319|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
149029948|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Death|0|||
148775903|NCT04442269|536653396|FG001|Overall Study|Travel Limitations|1|||
148775904|NCT00430352|536653397|FG000|Overall Study|Disease progression|58|||
148775905|NCT00430352|536653397|FG000|Overall Study|Withdrawal by Subject|11|||
148775906|NCT00430352|536653397|FG000|Overall Study|Adverse Event|16|||
148775907|NCT00430352|536653397|FG000|Overall Study|Death|5|||
148775908|NCT00430352|536653397|FG000|Overall Study|Other|48|||
148775909|NCT04326439|536653398|FG000|Overall Study|Withdrawal by Subject|1|||
148775910|NCT04326439|536653399|FG001|Overall Study|Withdrawal by Subject|0|||
148775911|NCT04326439|536653398|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
148775912|NCT04326439|536653399|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
148775913|NCT04326439|536653398|FG000|Overall Study|Relapse after Induction 2|0|||
148775914|NCT04326439|536653399|FG001|Overall Study|Relapse after Induction 2|1|||
148775915|NCT04326439|536653398|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
148775916|NCT04326439|536653399|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
148775917|NCT02291601|536653402|FG000|Abdomen|Did not qualify|333|||
148775918|NCT02291601|536653403|FG001|Abdomen|Did not qualify|54|||
148775919|NCT02291601|536653404|FG002|Abdomen|Did not qualify|339|||
148775920|NCT02291601|536653402|FG000|Groin|Did not qualify|183|||
148775921|NCT02291601|536653403|FG001|Groin|Did not qualify|30|||
148775922|NCT02291601|536653404|FG002|Groin|Did not qualify|177|||
148775923|NCT00347919|536653410|FG000|Overall Study|Lost to Follow-up|11|||
148775924|NCT00347919|536653411|FG001|Overall Study|Lost to Follow-up|13|||
148775925|NCT00347919|536653412|FG002|Overall Study|Lost to Follow-up|0|||
148775926|NCT00347919|536653410|FG000|Overall Study|Withdrawal by Subject|6|||
148775927|NCT00347919|536653411|FG001|Overall Study|Withdrawal by Subject|8|||
148775928|NCT00347919|536653412|FG002|Overall Study|Withdrawal by Subject|0|||
149029949|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Death|8|||
148775929|NCT00347919|536653410|FG000|Overall Study|Physician Decision|1|||
148775930|NCT00347919|536653411|FG001|Overall Study|Physician Decision|1|||
148775931|NCT00347919|536653412|FG002|Overall Study|Physician Decision|0|||
149029950|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Death|2|||
148775932|NCT00347919|536653410|FG000|Overall Study|Sponsor terminated study|15|||
148844531|NCT03052608|536911318|FG000|Long-Term Follow-up Phase|Ongoing|122|||
148775933|NCT00347919|536653411|FG001|Overall Study|Sponsor terminated study|10|||
148775934|NCT00347919|536653412|FG002|Overall Study|Sponsor terminated study|16|||
149029951|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Death|13|||
148984177|NCT01762761|537419366|FG001|Overall Study|Physician Decision|6|||
148984178|NCT01762761|537419365|FG000|Overall Study|Withdrawal by Subject|7|||
148775935|NCT00347919|536653410|FG000|Overall Study|Death|35|||
148775936|NCT00347919|536653411|FG001|Overall Study|Death|42|||
148775937|NCT00347919|536653412|FG002|Overall Study|Death|19|||
148775938|NCT00347919|536653410|FG000|Overall Study|Par. Started Other Treatment|1|||
148775939|NCT00347919|536653411|FG001|Overall Study|Par. Started Other Treatment|1|||
148775940|NCT00347919|536653412|FG002|Overall Study|Par. Started Other Treatment|1|||
148775941|NCT00347919|536653410|FG000|Overall Study|Missing|2|||
148775942|NCT00347919|536653411|FG001|Overall Study|Missing|1|||
148775943|NCT00347919|536653412|FG002|Overall Study|Missing|2|||
148775944|NCT01597375|536653413|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
148775945|NCT01597375|536653414|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
148775946|NCT01597375|536653413|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
148775947|NCT01597375|536653414|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
148775948|NCT01597375|536653413|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
148775949|NCT01597375|536653414|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
148775950|NCT01597375|536653413|FG000|Washout (2 Weeks)|Adverse Event|1|||
148775951|NCT01597375|536653414|FG001|Washout (2 Weeks)|Adverse Event|0|||
148775952|NCT01597375|536653413|FG000|Second Intervention|Failed to react at both Aspirin|1|||
148775953|NCT01597375|536653414|FG001|Second Intervention|Failed to react at both Aspirin|1|||
148775954|NCT02225366|536653417|FG000|Overall Study|Lack of Efficacy|1|||
148775955|NCT02225366|536653418|FG001|Overall Study|Lack of Efficacy|0|||
148775956|NCT01190267|536653419|FG000|Overall Study|Adverse Event|10|||
148775957|NCT01190267|536653420|FG001|Overall Study|Adverse Event|0|||
148775958|NCT01190267|536653419|FG000|Overall Study|Treatment Failure|8|||
148775959|NCT01190267|536653420|FG001|Overall Study|Treatment Failure|2|||
148775960|NCT01190267|536653419|FG000|Overall Study|Lost to Follow-up|2|||
148775961|NCT01190267|536653420|FG001|Overall Study|Lost to Follow-up|0|||
148775962|NCT01190267|536653419|FG000|Overall Study|Withdrawal by Subject|13|||
148775963|NCT01190267|536653420|FG001|Overall Study|Withdrawal by Subject|1|||
148775964|NCT01190267|536653419|FG000|Overall Study|Protocol Violation|8|||
148775965|NCT01190267|536653420|FG001|Overall Study|Protocol Violation|1|||
148775966|NCT04017832|536653421|FG000|Overall Study|Withdrawal by Subject|13|||
148775967|NCT04017832|536653422|FG001|Overall Study|Withdrawal by Subject|12|||
148775968|NCT04017832|536653423|FG002|Overall Study|Withdrawal by Subject|21|||
148775969|NCT04017832|536653424|FG003|Overall Study|Withdrawal by Subject|7|||
148775970|NCT04017832|536653421|FG000|Overall Study|Lost to Follow-up|0|||
148775971|NCT04017832|536653422|FG001|Overall Study|Lost to Follow-up|3|||
148775972|NCT04017832|536653423|FG002|Overall Study|Lost to Follow-up|3|||
148775973|NCT04017832|536653424|FG003|Overall Study|Lost to Follow-up|1|||
148775974|NCT04017832|536653421|FG000|Overall Study|Physician Decision|1|||
148775975|NCT04017832|536653422|FG001|Overall Study|Physician Decision|1|||
148775976|NCT04017832|536653423|FG002|Overall Study|Physician Decision|1|||
148775977|NCT04017832|536653424|FG003|Overall Study|Physician Decision|1|||
148775978|NCT04017832|536653421|FG000|Overall Study|Death|2|||
148775979|NCT04017832|536653422|FG001|Overall Study|Death|2|||
148775980|NCT04017832|536653423|FG002|Overall Study|Death|1|||
148775981|NCT04017832|536653424|FG003|Overall Study|Death|0|||
148775982|NCT01419080|536653425|FG000|Overall Study|Withdrawal by Subject|75|||
148775983|NCT01419080|536653425|FG000|Overall Study|Death|30|||
148775984|NCT01419080|536653425|FG000|Overall Study|Lost to Follow-up|23|||
148775985|NCT01419080|536653425|FG000|Overall Study|Too Ill|3|||
148775986|NCT02537431|536653438|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
148775987|NCT01077739|536653441|FG000|Overall Study|Premature withdrawal|1|||
148775988|NCT01077739|536653442|FG001|Overall Study|Premature withdrawal|3|||
148775989|NCT01077739|536653441|FG000|Overall Study|Withdrawal by Subject|1|||
148775990|NCT01077739|536653442|FG001|Overall Study|Withdrawal by Subject|0|||
148775991|NCT01077739|536653441|FG000|Overall Study|Death|0|||
148775992|NCT01077739|536653442|FG001|Overall Study|Death|3|||
148775993|NCT01077739|536653441|FG000|Overall Study|Unacceptable toxicity|1|||
148775994|NCT01077739|536653442|FG001|Overall Study|Unacceptable toxicity|2|||
148775995|NCT01077739|536653441|FG000|Overall Study|Other|2|||
148775996|NCT01077739|536653442|FG001|Overall Study|Other|2|||
148775997|NCT00877071|536653443|FG000|Overall Study|disease progression|2|||
148984179|NCT01762761|537419366|FG001|Overall Study|Withdrawal by Subject|8|||
148775998|NCT05723328|536653444|FG000|Overall Study|Investigator's Decision|5|||
148775999|NCT05723328|536653445|FG001|Overall Study|Investigator's Decision|2|||
148776000|NCT03495154|536653447|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
148776001|NCT03495154|536653447|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
148776002|NCT03495154|536653447|FG000|Overall Study|Screen Failures During Surgery|6|||
148776003|NCT03495154|536653447|FG000|Overall Study|Death|2|||
148776004|NCT03495154|536653447|FG000|Overall Study|Lost to Follow-up|16|||
148776005|NCT03495154|536653447|FG000|Overall Study|Withdrawal by Subject|2|||
148776006|NCT03495154|536653447|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
148776007|NCT03839459|536655044|FG000|Overall Study|Withdrawal by Subject|2|||
148776008|NCT03839459|536655044|FG000|Overall Study|progression of disease|3|||
148776009|NCT03036098|536655045|FG000|Pre-Treatment|Other Reasons|1|||
148776010|NCT03036098|536655046|FG001|Pre-Treatment|Other Reasons|2|||
148776011|NCT03036098|536655047|FG002|Pre-Treatment|Other Reasons|0|||
148776012|NCT03036098|536655048|FG003|Pre-Treatment|Other Reasons|5|||
148776013|NCT03036098|536655045|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
148776014|NCT03036098|536655046|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
148776015|NCT03036098|536655047|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
148776016|NCT03036098|536655048|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
148776017|NCT03036098|536655045|FG000|Pre-Treatment|Withdrawal by Subject|1|||
148776018|NCT03036098|536655046|FG001|Pre-Treatment|Withdrawal by Subject|14|||
148776019|NCT03036098|536655047|FG002|Pre-Treatment|Withdrawal by Subject|0|||
148776020|NCT03036098|536655048|FG003|Pre-Treatment|Withdrawal by Subject|5|||
148776021|NCT03036098|536655045|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
148776022|NCT03036098|536655046|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
148844532|NCT03052608|536911319|FG001|Long-Term Follow-up Phase|Ongoing|99|||
148844533|NCT02522429|536911322|FG000|Overall Study|Lost to Follow-up|8|||
148844534|NCT02522429|536911322|FG000|Overall Study|Adverse Event|2|||
148844535|NCT02522429|536911322|FG000|Overall Study|Death|1|||
148844536|NCT02522429|536911322|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
148844537|NCT00600106|536911323|FG000|Overall Study|Withdrawal by Subject|1|||
148844538|NCT00600106|536911324|FG001|Overall Study|Withdrawal by Subject|1|||
148844539|NCT05554146|536911327|FG000|Overall Study|Adverse Event|0|||
148844540|NCT05554146|536911328|FG001|Overall Study|Adverse Event|1|||
148844541|NCT05554146|536911329|FG002|Overall Study|Adverse Event|0|||
148844542|NCT05554146|536911330|FG003|Overall Study|Adverse Event|0|||
148844543|NCT05554146|536911327|FG000|Overall Study|Protocol Violation|0|||
148844544|NCT05554146|536911328|FG001|Overall Study|Protocol Violation|1|||
148844545|NCT05554146|536911329|FG002|Overall Study|Protocol Violation|0|||
148844546|NCT05554146|536911330|FG003|Overall Study|Protocol Violation|0|||
148844547|NCT05554146|536911327|FG000|Overall Study|No longer interested in participating|0|||
148844548|NCT05554146|536911328|FG001|Overall Study|No longer interested in participating|0|||
148844549|NCT05554146|536911329|FG002|Overall Study|No longer interested in participating|1|||
148844550|NCT05554146|536911330|FG003|Overall Study|No longer interested in participating|0|||
148844551|NCT05554146|536911327|FG000|Overall Study|Lost to Follow-up|1|||
148844552|NCT05554146|536911328|FG001|Overall Study|Lost to Follow-up|0|||
148844553|NCT05554146|536911329|FG002|Overall Study|Lost to Follow-up|0|||
148844554|NCT05554146|536911330|FG003|Overall Study|Lost to Follow-up|0|||
148844555|NCT05887908|536911333|FG000|Overall Study|Adverse Event|6|||
148844556|NCT05887908|536911334|FG001|Overall Study|Adverse Event|1|||
148844557|NCT05887908|536911335|FG002|Overall Study|Adverse Event|1|||
148844558|NCT05887908|536911333|FG000|Overall Study|Physician Decision|4|||
148844559|NCT05887908|536911334|FG001|Overall Study|Physician Decision|1|||
148844560|NCT05887908|536911335|FG002|Overall Study|Physician Decision|0|||
148844561|NCT05887908|536911333|FG000|Overall Study|Withdrawal by Subject|3|||
148844562|NCT05887908|536911334|FG001|Overall Study|Withdrawal by Subject|2|||
148844563|NCT05887908|536911335|FG002|Overall Study|Withdrawal by Subject|3|||
148844564|NCT05887908|536911333|FG000|Overall Study|Ineligibility after the start of the study|4|||
148844565|NCT05887908|536911334|FG001|Overall Study|Ineligibility after the start of the study|1|||
148844566|NCT05887908|536911335|FG002|Overall Study|Ineligibility after the start of the study|0|||
148844567|NCT05887908|536911333|FG000|Overall Study|Subject non-compliance|4|||
148844568|NCT05887908|536911334|FG001|Overall Study|Subject non-compliance|0|||
148844569|NCT05887908|536911335|FG002|Overall Study|Subject non-compliance|4|||
148844570|NCT05887908|536911333|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
148844571|NCT05887908|536911334|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
148844572|NCT05887908|536911335|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
148844573|NCT05887908|536911333|FG000|Overall Study|Pregnancy|0|||
148844574|NCT05887908|536911334|FG001|Overall Study|Pregnancy|1|||
148844575|NCT05887908|536911335|FG002|Overall Study|Pregnancy|0|||
148844576|NCT05887908|536911333|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
148844577|NCT05887908|536911334|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
148844578|NCT05887908|536911335|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
148844579|NCT05887908|536911333|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
148844580|NCT05887908|536911334|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
148844581|NCT05887908|536911335|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
148844582|NCT05887908|536911333|FG000|Overall Study|Other Reason|3|||
148844583|NCT05887908|536911334|FG001|Overall Study|Other Reason|3|||
148844584|NCT05887908|536911335|FG002|Overall Study|Other Reason|3|||
148844585|NCT02197572|536911340|FG000|Overall Study|Progressive Disease|28|||
148844586|NCT02197572|536911340|FG000|Overall Study|Withdrawal by Subject|9|||
148844587|NCT02197572|536911340|FG000|Overall Study|Adverse Event|3|||
148844588|NCT02197572|536911340|FG000|Overall Study|Reason Not Specified|4|||
148776023|NCT03036098|536655047|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
148776024|NCT03036098|536655048|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
148844589|NCT03783962|536911347|FG000|Overall Study|Lost to Follow-up|3|||
148844590|NCT03783962|536911348|FG001|Overall Study|Lost to Follow-up|6|||
148844591|NCT03783962|536911347|FG000|Overall Study|Protocol Violation|0|||
148844592|NCT03783962|536911348|FG001|Overall Study|Protocol Violation|1|||
148844593|NCT04423939|536911349|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
148844594|NCT04423939|536911350|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
148844595|NCT04423939|536911349|FG000|Overall Study|Death|3|||
148844596|NCT04423939|536911350|FG001|Overall Study|Death|0|||
148844597|NCT04423939|536911349|FG000|Overall Study|Withdrawal by Subject|3|||
148844598|NCT04423939|536911350|FG001|Overall Study|Withdrawal by Subject|0|||
148844599|NCT04423939|536911349|FG000|Overall Study|Caregiver to patient who died|0|||
148844600|NCT04423939|536911350|FG001|Overall Study|Caregiver to patient who died|3|||
148844601|NCT04423939|536911349|FG000|Overall Study|Caregiver to patient who withdrew|0|||
148844602|NCT04423939|536911350|FG001|Overall Study|Caregiver to patient who withdrew|3|||
148844603|NCT04024436|536911351|FG000|Overall Study|Death|10|||
148844604|NCT04024436|536911352|FG001|Overall Study|Death|14|||
148844605|NCT04024436|536911353|FG002|Overall Study|Death|2|||
148844606|NCT04024436|536911354|FG003|Overall Study|Death|7|||
148844607|NCT04024436|536911351|FG000|Overall Study|Loss to follow up|1|||
148844608|NCT04024436|536911352|FG001|Overall Study|Loss to follow up|0|||
148844609|NCT04024436|536911353|FG002|Overall Study|Loss to follow up|0|||
148844610|NCT04024436|536911354|FG003|Overall Study|Loss to follow up|1|||
148844611|NCT04024436|536911351|FG000|Overall Study|Withdrawal of consent|2|||
148844612|NCT04024436|536911352|FG001|Overall Study|Withdrawal of consent|0|||
148844613|NCT04024436|536911353|FG002|Overall Study|Withdrawal of consent|0|||
148844614|NCT04024436|536911354|FG003|Overall Study|Withdrawal of consent|1|||
148844615|NCT04024436|536911351|FG000|Overall Study|Study termination by sponsor|4|||
148844616|NCT04024436|536911352|FG001|Overall Study|Study termination by sponsor|6|||
148844617|NCT04024436|536911353|FG002|Overall Study|Study termination by sponsor|2|||
148844618|NCT04024436|536911354|FG003|Overall Study|Study termination by sponsor|11|||
148844619|NCT04024436|536911351|FG000|Overall Study|Reason Not Specified|0|||
148844620|NCT04024436|536911352|FG001|Overall Study|Reason Not Specified|1|||
148844621|NCT04024436|536911353|FG002|Overall Study|Reason Not Specified|0|||
148844622|NCT04024436|536911354|FG003|Overall Study|Reason Not Specified|2|||
148844623|NCT01169337|536911355|FG000|Overall Study|Lack of Efficacy|5|||
148844624|NCT01169337|536911356|FG001|Overall Study|Lack of Efficacy|7|||
148844625|NCT01169337|536911357|FG002|Overall Study|Lack of Efficacy|0|||
148844626|NCT01169337|536911355|FG000|Overall Study|Adverse Event|12|||
148844627|NCT01169337|536911356|FG001|Overall Study|Adverse Event|18|||
148844628|NCT01169337|536911357|FG002|Overall Study|Adverse Event|0|||
148844629|NCT01169337|536911355|FG000|Overall Study|Death|2|||
148844630|NCT01169337|536911356|FG001|Overall Study|Death|0|||
148844631|NCT01169337|536911357|FG002|Overall Study|Death|0|||
148844632|NCT01169337|536911355|FG000|Overall Study|Withdrawal by Subject|11|||
148844633|NCT01169337|536911356|FG001|Overall Study|Withdrawal by Subject|11|||
148844634|NCT01169337|536911357|FG002|Overall Study|Withdrawal by Subject|6|||
148844635|NCT01169337|536911355|FG000|Overall Study|Noncompliance|2|||
148844636|NCT01169337|536911356|FG001|Overall Study|Noncompliance|0|||
148844637|NCT01169337|536911357|FG002|Overall Study|Noncompliance|0|||
148844638|NCT01169337|536911355|FG000|Overall Study|Other complicating disease|1|||
148844639|NCT01169337|536911356|FG001|Overall Study|Other complicating disease|1|||
148844640|NCT01169337|536911357|FG002|Overall Study|Other complicating disease|0|||
148844641|NCT01169337|536911355|FG000|Overall Study|Physician Decision|1|||
148844642|NCT01169337|536911356|FG001|Overall Study|Physician Decision|5|||
148844643|NCT01169337|536911357|FG002|Overall Study|Physician Decision|0|||
148844644|NCT01169337|536911355|FG000|Overall Study|Alternative therapy|0|||
148844645|NCT01169337|536911356|FG001|Overall Study|Alternative therapy|2|||
148844646|NCT01169337|536911357|FG002|Overall Study|Alternative therapy|0|||
148844647|NCT01169337|536911355|FG000|Overall Study|Changed hospital|0|||
148844648|NCT01169337|536911356|FG001|Overall Study|Changed hospital|1|||
148844649|NCT01169337|536911357|FG002|Overall Study|Changed hospital|0|||
148844650|NCT01169337|536911355|FG000|Overall Study|Never started treatment|0|||
148844651|NCT01169337|536911356|FG001|Overall Study|Never started treatment|2|||
148844652|NCT01169337|536911357|FG002|Overall Study|Never started treatment|0|||
148844653|NCT01169337|536911355|FG000|Overall Study|Reason not reported|1|||
148844654|NCT01169337|536911356|FG001|Overall Study|Reason not reported|0|||
148844655|NCT01169337|536911357|FG002|Overall Study|Reason not reported|0|||
148844656|NCT01169337|536911355|FG000|Overall Study|Continuing lenalidomide|9|||
148844657|NCT01169337|536911356|FG001|Overall Study|Continuing lenalidomide|43|||
148844658|NCT01169337|536911357|FG002|Overall Study|Continuing lenalidomide|0|||
148844659|NCT01134614|536911358|FG000|Overall Study|Still on treatment as of March 2013|21|||
148844660|NCT01134614|536911359|FG001|Overall Study|Still on treatment as of March 2013|13|||
148844661|NCT01134614|536911358|FG000|Overall Study|Progressive disease|60|||
148844662|NCT01134614|536911359|FG001|Overall Study|Progressive disease|54|||
148844663|NCT01134614|536911358|FG000|Overall Study|Adverse Event|26|||
148844664|NCT01134614|536911359|FG001|Overall Study|Adverse Event|39|||
148844665|NCT01134614|536911358|FG000|Overall Study|Death|5|||
148844666|NCT01134614|536911359|FG001|Overall Study|Death|8|||
148844667|NCT01134614|536911358|FG000|Overall Study|Withdrawal by Subject|3|||
148844668|NCT01134614|536911359|FG001|Overall Study|Withdrawal by Subject|2|||
148844669|NCT01134614|536911358|FG000|Overall Study|Alternative therapy|2|||
148844670|NCT01134614|536911359|FG001|Overall Study|Alternative therapy|0|||
148776025|NCT03036098|536655045|FG000|Treatment|Disease Progression|130|||
148776026|NCT03036098|536655046|FG001|Treatment|Disease Progression|77|||
148776027|NCT03036098|536655047|FG002|Treatment|Disease Progression|168|||
148776028|NCT03036098|536655048|FG003|Treatment|Disease Progression|50|||
148776029|NCT03036098|536655045|FG000|Treatment|Study Drug Toxicity|95|||
148776030|NCT03036098|536655046|FG001|Treatment|Study Drug Toxicity|45|||
148776031|NCT03036098|536655047|FG002|Treatment|Study Drug Toxicity|26|||
148776032|NCT03036098|536655048|FG003|Treatment|Study Drug Toxicity|22|||
148776033|NCT03036098|536655045|FG000|Treatment|Death|9|||
148776034|NCT03036098|536655046|FG001|Treatment|Death|3|||
148844671|NCT01134614|536911358|FG000|Overall Study|Complicating disease|2|||
148844672|NCT01134614|536911359|FG001|Overall Study|Complicating disease|1|||
148984180|NCT02317575|537419367|FG000|Period 1|Difficulty with venous cannulation|0|||
148984181|NCT02317575|537419368|FG001|Period 1|Difficulty with venous cannulation|1|||
148984182|NCT02317575|537419369|FG002|Period 1|Difficulty with venous cannulation|0|||
148984183|NCT02317575|537419370|FG003|Period 1|Difficulty with venous cannulation|0|||
148844673|NCT01134614|536911358|FG000|Overall Study|Physician's decision|0|||
148844674|NCT01134614|536911359|FG001|Overall Study|Physician's decision|1|||
148844675|NCT01134614|536911358|FG000|Overall Study|Never started treatment|4|||
148844676|NCT01134614|536911359|FG001|Overall Study|Never started treatment|1|||
148844677|NCT01134614|536911358|FG000|Overall Study|Pt received tx not allowed on study|0|||
148844678|NCT01134614|536911359|FG001|Overall Study|Pt received tx not allowed on study|1|||
148844679|NCT01134614|536911358|FG000|Overall Study|Symptomatic deterioration|0|||
148844680|NCT01134614|536911359|FG001|Overall Study|Symptomatic deterioration|1|||
148844681|NCT01134614|536911358|FG000|Overall Study|Patient in hospice care|0|||
148844682|NCT01134614|536911359|FG001|Overall Study|Patient in hospice care|1|||
148844683|NCT00540592|536911360|FG000|Overall Study|Adverse Event|0|||
148844684|NCT00540592|536911361|FG001|Overall Study|Adverse Event|1|||
148844685|NCT00540592|536911362|FG002|Overall Study|Adverse Event|0|||
148844686|NCT00540592|536911363|FG003|Overall Study|Adverse Event|0|||
148844687|NCT00540592|536911364|FG004|Overall Study|Adverse Event|1|||
148844688|NCT00540592|536911365|FG005|Overall Study|Adverse Event|0|||
148844689|NCT00540592|536911366|FG006|Overall Study|Adverse Event|0|||
148844690|NCT00540592|536911367|FG007|Overall Study|Adverse Event|1|||
148844691|NCT00540592|536911368|FG008|Overall Study|Adverse Event|1|||
148844692|NCT00540592|536911369|FG009|Overall Study|Adverse Event|2|||
148844693|NCT00540592|536911360|FG000|Overall Study|Lost to Follow-up|2|||
148844694|NCT00540592|536911361|FG001|Overall Study|Lost to Follow-up|0|||
148844695|NCT00540592|536911362|FG002|Overall Study|Lost to Follow-up|0|||
148844696|NCT00540592|536911363|FG003|Overall Study|Lost to Follow-up|0|||
148844697|NCT00540592|536911364|FG004|Overall Study|Lost to Follow-up|0|||
148844698|NCT00540592|536911365|FG005|Overall Study|Lost to Follow-up|0|||
148844699|NCT00540592|536911366|FG006|Overall Study|Lost to Follow-up|0|||
148844700|NCT00540592|536911367|FG007|Overall Study|Lost to Follow-up|0|||
148844701|NCT00540592|536911368|FG008|Overall Study|Lost to Follow-up|0|||
148844702|NCT00540592|536911369|FG009|Overall Study|Lost to Follow-up|0|||
148844703|NCT00540592|536911360|FG000|Overall Study|Withdrawal by Subject|0|||
148844704|NCT00540592|536911361|FG001|Overall Study|Withdrawal by Subject|0|||
148844705|NCT00540592|536911362|FG002|Overall Study|Withdrawal by Subject|1|||
148844706|NCT00540592|536911363|FG003|Overall Study|Withdrawal by Subject|1|||
148844707|NCT00540592|536911364|FG004|Overall Study|Withdrawal by Subject|0|||
148844708|NCT00540592|536911365|FG005|Overall Study|Withdrawal by Subject|0|||
148844709|NCT00540592|536911366|FG006|Overall Study|Withdrawal by Subject|0|||
148844710|NCT00540592|536911367|FG007|Overall Study|Withdrawal by Subject|0|||
148844711|NCT00540592|536911368|FG008|Overall Study|Withdrawal by Subject|0|||
148844712|NCT00540592|536911369|FG009|Overall Study|Withdrawal by Subject|0|||
148844713|NCT02168101|536911374|FG000|Overall Study|Death|2|||
148984184|NCT02317575|537419371|FG004|Period 1|Difficulty with venous cannulation|0|||
148984185|NCT02317575|537419367|FG000|Period 1|Withdrawal by Subject|1|||
148776035|NCT03036098|536655047|FG002|Treatment|Death|1|||
148844714|NCT02168101|536911375|FG001|Overall Study|Death|2|||
148844715|NCT02168101|536911376|FG002|Overall Study|Death|1|||
148844716|NCT05507567|536911377|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
148844717|NCT05507567|536911378|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
148844718|NCT05507567|536911379|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
148844719|NCT05507567|536911377|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
148844720|NCT05507567|536911378|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
148844721|NCT05507567|536911379|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
148844722|NCT05507567|536911377|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
148984186|NCT02317575|537419368|FG001|Period 1|Withdrawal by Subject|0|||
148984187|NCT02317575|537419369|FG002|Period 1|Withdrawal by Subject|0|||
148776036|NCT03036098|536655048|FG003|Treatment|Death|2|||
148844723|NCT05507567|536911378|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
148844724|NCT05507567|536911379|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
148844725|NCT05507567|536911377|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
148844726|NCT05507567|536911378|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
148844727|NCT05507567|536911379|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
148844728|NCT01722994|536911382|FG000|Overall Study|Missing data|25|||
148844729|NCT01722994|536911383|FG001|Overall Study|Missing data|17|||
148844730|NCT01206140|536911384|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
148844731|NCT01206140|536911385|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
148844732|NCT01803880|536911386|FG000|Overall Study|Adverse Event|1|||
148844733|NCT01803880|536911387|FG001|Overall Study|Adverse Event|0|||
148844734|NCT01803880|536911388|FG002|Overall Study|Adverse Event|0|||
148844735|NCT01803880|536911386|FG000|Overall Study|Withdrawal by Subject|1|||
148844736|NCT01803880|536911387|FG001|Overall Study|Withdrawal by Subject|1|||
148844737|NCT01803880|536911388|FG002|Overall Study|Withdrawal by Subject|4|||
148844738|NCT01803880|536911386|FG000|Overall Study|Physician Decision|0|||
148844739|NCT01803880|536911387|FG001|Overall Study|Physician Decision|0|||
148844740|NCT01803880|536911388|FG002|Overall Study|Physician Decision|1|||
148844741|NCT01803880|536911386|FG000|Overall Study|Unable to return for follow-up visits|0|||
148844742|NCT01803880|536911387|FG001|Overall Study|Unable to return for follow-up visits|1|||
148844743|NCT01803880|536911388|FG002|Overall Study|Unable to return for follow-up visits|2|||
148844744|NCT01803880|536911386|FG000|Overall Study|Lost to Follow-up|1|||
148844745|NCT01803880|536911387|FG001|Overall Study|Lost to Follow-up|2|||
148844746|NCT01803880|536911388|FG002|Overall Study|Lost to Follow-up|3|||
148844747|NCT01803880|536911386|FG000|Overall Study|Protocol Violation|1|||
148844748|NCT01803880|536911387|FG001|Overall Study|Protocol Violation|0|||
148844749|NCT01803880|536911388|FG002|Overall Study|Protocol Violation|0|||
148844750|NCT01803880|536911386|FG000|Overall Study|Early study termination|0|||
148844751|NCT01803880|536911387|FG001|Overall Study|Early study termination|6|||
148844752|NCT01803880|536911388|FG002|Overall Study|Early study termination|5|||
148844753|NCT01803880|536911386|FG000|Overall Study|Incomplete data entry by sites|2|||
148844754|NCT01803880|536911387|FG001|Overall Study|Incomplete data entry by sites|0|||
148844755|NCT01803880|536911388|FG002|Overall Study|Incomplete data entry by sites|0|||
148844756|NCT01766037|536911390|FG000|Overall Study|Adverse Event|1|||
148844757|NCT01766037|536911391|FG001|Overall Study|Adverse Event|0|||
148844758|NCT01766037|536911390|FG000|Overall Study|Lack of Efficacy|1|||
148844759|NCT01766037|536911391|FG001|Overall Study|Lack of Efficacy|0|||
148844760|NCT01766037|536911390|FG000|Overall Study|Lost to Follow-up|0|||
148844761|NCT01766037|536911391|FG001|Overall Study|Lost to Follow-up|10|||
148844762|NCT01766037|536911390|FG000|Overall Study|Physician Decision|0|||
148844763|NCT01766037|536911391|FG001|Overall Study|Physician Decision|1|||
148844764|NCT01766037|536911390|FG000|Overall Study|Withdrawal by Subject|18|||
148844765|NCT01766037|536911391|FG001|Overall Study|Withdrawal by Subject|16|||
148844766|NCT01766037|536911390|FG000|Overall Study|Moved from area|5|||
148844767|NCT01766037|536911391|FG001|Overall Study|Moved from area|0|||
148844768|NCT01766037|536911390|FG000|Overall Study|medical - unrelated|1|||
148844769|NCT01766037|536911391|FG001|Overall Study|medical - unrelated|2|||
148844770|NCT01766037|536911390|FG000|Overall Study|nausea / discomfort|3|||
148844771|NCT01766037|536911391|FG001|Overall Study|nausea / discomfort|0|||
148844772|NCT05384834|536911398|FG000|Overall Study|Lost to Follow-up|43|||
148844773|NCT05384834|536911398|FG000|Overall Study|Withdrawal by Subject|5|||
148844774|NCT03951766|536911399|FG000|Treatment Phase|Lost to Follow-up|1|||
148844775|NCT03951766|536911399|FG000|Follow-up Phase|Lost to Follow-up|10|||
148844776|NCT04188509|536911402|FG000|Overall Study|Adverse Event|2|||
148844777|NCT04188509|536911402|FG000|Overall Study|Lost to Follow-up|1|||
148844778|NCT04188509|536911402|FG000|Overall Study|Withdrawal of Consent|1|||
148844779|NCT04188509|536911402|FG000|Overall Study|Discretion of Investigator|1|||
148844780|NCT04188509|536911402|FG000|Overall Study|Noncompliance|3|||
148844781|NCT04188509|536911402|FG000|Overall Study|Sponsor Decision|127|||
148844782|NCT04188509|536911402|FG000|Overall Study|Other|2|||
148844783|NCT04847843|536911403|FG000|Overall Study|Scheduling Conflicts|6|||
148844784|NCT04847843|536911404|FG001|Overall Study|Scheduling Conflicts|9|||
148844785|NCT04847843|536911403|FG000|Overall Study|Withdrawal by Subject|1|||
148844786|NCT04847843|536911404|FG001|Overall Study|Withdrawal by Subject|0|||
148844787|NCT04847843|536911403|FG000|Overall Study|Lost to Follow-up|1|||
148844788|NCT04847843|536911404|FG001|Overall Study|Lost to Follow-up|1|||
148844789|NCT04847843|536911403|FG000|Overall Study|Pregnancy|0|||
148844790|NCT04847843|536911404|FG001|Overall Study|Pregnancy|2|||
148844791|NCT04847843|536911403|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
148844792|NCT04847843|536911404|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
148844793|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
148844794|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
148844795|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
148844796|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
148844797|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
148984188|NCT02317575|537419370|FG003|Period 1|Withdrawal by Subject|0|||
148984189|NCT02317575|537419371|FG004|Period 1|Withdrawal by Subject|0|||
148984190|NCT04096560|537419372|FG000|Overall Study|Reason not Specified|1|||
148984191|NCT04096560|537419373|FG001|Overall Study|Reason not Specified|0|||
148984192|NCT04096560|537419374|FG002|Overall Study|Reason not Specified|0|||
148984193|NCT04096560|537419375|FG003|Overall Study|Reason not Specified|0|||
148984194|NCT04096560|537419376|FG004|Overall Study|Reason not Specified|1|||
148984195|NCT04096560|537419377|FG005|Overall Study|Reason not Specified|1|||
148776037|NCT03036098|536655045|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
148776038|NCT03036098|536655046|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
148776039|NCT03036098|536655047|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
148776040|NCT03036098|536655048|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
148776041|NCT03036098|536655045|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
148776042|NCT03036098|536655046|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
148776043|NCT03036098|536655047|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
148776044|NCT03036098|536655048|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
148776045|NCT03036098|536655045|FG000|Treatment|Withdrawal by Subject|2|||
148776046|NCT03036098|536655046|FG001|Treatment|Withdrawal by Subject|9|||
148776047|NCT03036098|536655047|FG002|Treatment|Withdrawal by Subject|2|||
148776048|NCT03036098|536655048|FG003|Treatment|Withdrawal by Subject|4|||
148776049|NCT03036098|536655045|FG000|Treatment|Maximum Clinical Benefit|6|||
148776050|NCT03036098|536655046|FG001|Treatment|Maximum Clinical Benefit|1|||
148776051|NCT03036098|536655047|FG002|Treatment|Maximum Clinical Benefit|6|||
148776052|NCT03036098|536655048|FG003|Treatment|Maximum Clinical Benefit|10|||
148776053|NCT03036098|536655045|FG000|Treatment|Poor/Non Compliance|1|||
148776054|NCT03036098|536655046|FG001|Treatment|Poor/Non Compliance|2|||
148776055|NCT03036098|536655047|FG002|Treatment|Poor/Non Compliance|0|||
148776056|NCT03036098|536655048|FG003|Treatment|Poor/Non Compliance|1|||
148776057|NCT03036098|536655045|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
148776058|NCT03036098|536655046|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
148776059|NCT03036098|536655047|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
148776060|NCT03036098|536655048|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
148776061|NCT03036098|536655045|FG000|Treatment|Administrative Reason by Sponsor|1|||
148776062|NCT03036098|536655046|FG001|Treatment|Administrative Reason by Sponsor|0|||
148776063|NCT03036098|536655047|FG002|Treatment|Administrative Reason by Sponsor|2|||
148776064|NCT03036098|536655048|FG003|Treatment|Administrative Reason by Sponsor|1|||
148776065|NCT03036098|536655045|FG000|Treatment|Other Reasons|31|||
148776066|NCT03036098|536655046|FG001|Treatment|Other Reasons|5|||
148776067|NCT03036098|536655047|FG002|Treatment|Other Reasons|21|||
148776068|NCT03036098|536655048|FG003|Treatment|Other Reasons|8|||
148776069|NCT03036098|536655045|FG000|Treatment|Ongoing Treatment|0|||
148776070|NCT03036098|536655046|FG001|Treatment|Ongoing Treatment|0|||
148776071|NCT03036098|536655047|FG002|Treatment|Ongoing Treatment|23|||
148776072|NCT03036098|536655048|FG003|Treatment|Ongoing Treatment|0|||
148776073|NCT02276053|536655049|FG000|Overall Study|Death|2|||
148776074|NCT02276053|536655049|FG000|Overall Study|Adverse Event|5|||
148776075|NCT02276053|536655049|FG000|Overall Study|Lack of Efficacy|2|||
148776076|NCT02276053|536655049|FG000|Overall Study|Withdrawal by Subject|1|||
148776077|NCT02276053|536655049|FG000|Overall Study|Patient does not meet selection criteria|3|||
148776078|NCT02276053|536655049|FG000|Overall Study|Patient needs to increase baseline AED|1|||
148776079|NCT01632904|536655050|FG000|Overall Study|Adverse Event|4|||
148776080|NCT01632904|536655051|FG001|Overall Study|Adverse Event|1|||
148776081|NCT01632904|536655050|FG000|Overall Study|Physician Decision|0|||
148776082|NCT01632904|536655051|FG001|Overall Study|Physician Decision|1|||
148776083|NCT01632904|536655050|FG000|Overall Study|Subject decision|3|||
148776084|NCT01632904|536655051|FG001|Overall Study|Subject decision|2|||
148776085|NCT01632904|536655050|FG000|Overall Study|Disease Progression|0|||
148776086|NCT01632904|536655051|FG001|Overall Study|Disease Progression|1|||
148776087|NCT01632904|536655050|FG000|Overall Study|Reason for discontinuation not available|0|||
148776088|NCT01632904|536655051|FG001|Overall Study|Reason for discontinuation not available|1|||
148776089|NCT02059434|536655055|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
148776090|NCT02059434|536655056|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
148776091|NCT02059434|536655057|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
148776092|NCT02059434|536655058|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
148776093|NCT02059434|536655059|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
148984196|NCT04096560|537419378|FG006|Overall Study|Reason not Specified|1|||
148776094|NCT02059434|536655060|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
148776095|NCT02059434|536655061|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
148776096|NCT02059434|536655062|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
148776097|NCT02059434|536655063|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
148776098|NCT02059434|536655055|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
148776099|NCT02059434|536655056|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
148776100|NCT02059434|536655057|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
149029952|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
149029953|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
149029954|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
149029955|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
148776101|NCT02059434|536655058|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
148776102|NCT02059434|536655059|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
148776103|NCT02059434|536655060|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
148776104|NCT02059434|536655061|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
149029956|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
149029957|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
149029958|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
149029959|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
149029960|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
149029961|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
149029962|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
149029963|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
149029964|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
149029965|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
148776105|NCT02059434|536655062|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
148776106|NCT02059434|536655063|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
148776107|NCT02059434|536655055|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
148776108|NCT02059434|536655056|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
148776109|NCT02059434|536655057|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
148776110|NCT02059434|536655058|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
148776111|NCT02059434|536655059|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
148776112|NCT02059434|536655060|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
148776113|NCT02059434|536655061|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
148776114|NCT02059434|536655062|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
148776115|NCT02059434|536655063|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
148776116|NCT02059434|536655055|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
148776117|NCT02059434|536655056|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
148776118|NCT02059434|536655057|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
148776119|NCT02059434|536655058|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
148776120|NCT02059434|536655059|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
148776121|NCT02059434|536655060|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
148776122|NCT02059434|536655061|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
148776123|NCT02059434|536655062|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
148776124|NCT02059434|536655063|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
148776125|NCT02059434|536655055|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776126|NCT02059434|536655056|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776127|NCT02059434|536655057|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776128|NCT02059434|536655058|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776129|NCT02059434|536655059|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776130|NCT02059434|536655060|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776131|NCT02059434|536655061|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776132|NCT02059434|536655062|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
148776133|NCT02059434|536655063|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
148776134|NCT02907593|536655066|FG000|Overall Study|Withdrawal by Subject|0|||
148776135|NCT02907593|536655067|FG001|Overall Study|Withdrawal by Subject|0|||
148776136|NCT02907593|536655068|FG002|Overall Study|Withdrawal by Subject|1|||
148776137|NCT02907593|536655069|FG003|Overall Study|Withdrawal by Subject|0|||
148776138|NCT05128773|536655070|FG000|Overall Study|Sponsor decision to terminate study|3|||
148776139|NCT04697056|536655071|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
148776140|NCT04697056|536655072|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
148776141|NCT01451164|536655073|FG000|Overall Study|Adverse Event|19|||
148776142|NCT01451164|536655074|FG001|Overall Study|Adverse Event|12|||
148776143|NCT01451164|536655075|FG002|Overall Study|Adverse Event|18|||
148776144|NCT01451164|536655076|FG003|Overall Study|Adverse Event|21|||
148776145|NCT01451164|536655073|FG000|Overall Study|Withdrawal Criteria|1|||
148776146|NCT01451164|536655074|FG001|Overall Study|Withdrawal Criteria|1|||
149029966|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
148776147|NCT01451164|536655075|FG002|Overall Study|Withdrawal Criteria|1|||
148776148|NCT01451164|536655076|FG003|Overall Study|Withdrawal Criteria|1|||
148889372|NCT00101686|537074373|FG002|Overall Study|Withdrawal by Subject|6|||
148776149|NCT01451164|536655073|FG000|Overall Study|Physician Decision|2|||
148776150|NCT01451164|536655074|FG001|Overall Study|Physician Decision|0|||
148776151|NCT01451164|536655075|FG002|Overall Study|Physician Decision|1|||
148776152|NCT01451164|536655076|FG003|Overall Study|Physician Decision|0|||
148776153|NCT01451164|536655073|FG000|Overall Study|Withdrawal by Subject|14|||
149029967|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
148776154|NCT01451164|536655074|FG001|Overall Study|Withdrawal by Subject|11|||
148776155|NCT01451164|536655075|FG002|Overall Study|Withdrawal by Subject|16|||
148776156|NCT01451164|536655076|FG003|Overall Study|Withdrawal by Subject|17|||
148776157|NCT01451164|536655073|FG000|Overall Study|Protocol Violation|0|||
148776158|NCT01451164|536655074|FG001|Overall Study|Protocol Violation|1|||
148776159|NCT01451164|536655075|FG002|Overall Study|Protocol Violation|0|||
148776160|NCT01451164|536655076|FG003|Overall Study|Protocol Violation|0|||
148776161|NCT01451164|536655073|FG000|Overall Study|Lack of Efficacy|7|||
148776162|NCT01451164|536655074|FG001|Overall Study|Lack of Efficacy|9|||
148776163|NCT01451164|536655075|FG002|Overall Study|Lack of Efficacy|9|||
148776164|NCT01451164|536655076|FG003|Overall Study|Lack of Efficacy|7|||
148776165|NCT02659514|536655077|FG000|Overall Study|Adverse Event|3|||
148776166|NCT02659514|536655078|FG001|Overall Study|Adverse Event|12|||
148776167|NCT02659514|536655077|FG000|Overall Study|Disease Progression|23|||
148776168|NCT02659514|536655078|FG001|Overall Study|Disease Progression|13|||
148776169|NCT02659514|536655077|FG000|Overall Study|Withdrawal by Subject|0|||
148776170|NCT02659514|536655078|FG001|Overall Study|Withdrawal by Subject|4|||
148776171|NCT02659514|536655077|FG000|Overall Study|Lost to Follow-up|0|||
148776172|NCT02659514|536655078|FG001|Overall Study|Lost to Follow-up|1|||
148776173|NCT02659514|536655077|FG000|Overall Study|Death|6|||
148776174|NCT02659514|536655078|FG001|Overall Study|Death|1|||
148776175|NCT02659514|536655077|FG000|Overall Study|Reason Unspecified|0|||
148776176|NCT02659514|536655078|FG001|Overall Study|Reason Unspecified|3|||
148844798|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
148844799|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
148844800|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
148844801|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
148776177|NCT04186806|536655081|FG000|Period 1: 7 Days|Adverse Event|1|||
148776178|NCT04186806|536655082|FG001|Period 1: 7 Days|Adverse Event|0|||
148776179|NCT03687372|536655083|FG000|Overall Study|Lost to Follow-up|12|||
148776180|NCT03687372|536655084|FG001|Overall Study|Lost to Follow-up|21|||
148776181|NCT03687372|536655083|FG000|Overall Study|Withdrawal by Subject|4|||
148776182|NCT03687372|536655084|FG001|Overall Study|Withdrawal by Subject|17|||
148776183|NCT03687372|536655083|FG000|Overall Study|Investigator Decision|1|||
148776184|NCT03687372|536655084|FG001|Overall Study|Investigator Decision|1|||
148776185|NCT04495816|536655085|FG000|Overall Study|Lost to Follow-up|10|||
148776186|NCT04495816|536655086|FG001|Overall Study|Lost to Follow-up|4|||
148776187|NCT04495816|536655085|FG000|Overall Study|Withdrawal by Subject|3|||
148776188|NCT04495816|536655086|FG001|Overall Study|Withdrawal by Subject|5|||
148776189|NCT06137703|536655088|FG000|Overall Study|Other|0|||
148776190|NCT06137703|536655089|FG001|Overall Study|Other|1|||
148776191|NCT06137703|536655090|FG002|Overall Study|Other|0|||
148776192|NCT06137703|536655091|FG003|Overall Study|Other|0|||
148844802|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
148776193|NCT06137703|536655088|FG000|Overall Study|Adverse Event|0|||
148776194|NCT06137703|536655089|FG001|Overall Study|Adverse Event|0|||
148776195|NCT06137703|536655090|FG002|Overall Study|Adverse Event|1|||
148776196|NCT06137703|536655091|FG003|Overall Study|Adverse Event|0|||
148776197|NCT00741091|536655094|FG000|Overall Study|Death|13|||
148776198|NCT00741091|536655094|FG000|Overall Study|Lost to Follow-up|16|||
148776199|NCT00741091|536655094|FG000|Overall Study|Withdrawal by Subject|6|||
148776200|NCT00741091|536655094|FG000|Overall Study|Missed Visit|22|||
148776201|NCT01801358|536655095|FG000|Overall Study|Adverse Event|0|||
148776202|NCT01801358|536655096|FG001|Overall Study|Adverse Event|2|||
148776203|NCT01801358|536655097|FG002|Overall Study|Adverse Event|1|||
148776204|NCT01801358|536655098|FG003|Overall Study|Adverse Event|0|||
148776205|NCT01801358|536655099|FG004|Overall Study|Adverse Event|0|||
148776206|NCT01801358|536655100|FG005|Overall Study|Adverse Event|1|||
148776207|NCT01801358|536655095|FG000|Overall Study|Physician Decision|0|||
148776208|NCT01801358|536655096|FG001|Overall Study|Physician Decision|0|||
148776209|NCT01801358|536655097|FG002|Overall Study|Physician Decision|1|||
148776210|NCT01801358|536655098|FG003|Overall Study|Physician Decision|0|||
148776211|NCT01801358|536655099|FG004|Overall Study|Physician Decision|0|||
148776212|NCT01801358|536655100|FG005|Overall Study|Physician Decision|0|||
148776213|NCT01801358|536655095|FG000|Overall Study|Progressive Disease|6|||
148776214|NCT01801358|536655096|FG001|Overall Study|Progressive Disease|4|||
148776215|NCT01801358|536655097|FG002|Overall Study|Progressive Disease|4|||
148776216|NCT01801358|536655098|FG003|Overall Study|Progressive Disease|5|||
148776217|NCT01801358|536655099|FG004|Overall Study|Progressive Disease|6|||
148776218|NCT01801358|536655100|FG005|Overall Study|Progressive Disease|5|||
148776219|NCT01801358|536655095|FG000|Overall Study|Withdrawal by Subject|0|||
148776220|NCT01801358|536655096|FG001|Overall Study|Withdrawal by Subject|0|||
148776221|NCT01801358|536655097|FG002|Overall Study|Withdrawal by Subject|0|||
148776222|NCT01801358|536655098|FG003|Overall Study|Withdrawal by Subject|1|||
148776223|NCT01801358|536655099|FG004|Overall Study|Withdrawal by Subject|0|||
148776224|NCT01801358|536655100|FG005|Overall Study|Withdrawal by Subject|2|||
148776225|NCT03787303|536655101|FG000|Overall Study|Death|1|||
148776226|NCT03787303|536655101|FG000|Overall Study|Premature Termination of Study|1|||
148776227|NCT01527487|536655102|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
148776228|NCT01527487|536655103|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
148776229|NCT01527487|536655102|FG000|Overall Study|Disease Progression|4|||
148776230|NCT01527487|536655103|FG001|Overall Study|Disease Progression|1|||
148776231|NCT01527487|536655102|FG000|Overall Study|Adverse Event|1|||
148776232|NCT01527487|536655103|FG001|Overall Study|Adverse Event|1|||
148776233|NCT01527487|536655102|FG000|Overall Study|Death|0|||
148776234|NCT01527487|536655103|FG001|Overall Study|Death|1|||
148776235|NCT01384019|536655104|FG000|Overall Study|Withdrawal by Subject|3|||
148776236|NCT01384019|536655105|FG001|Overall Study|Withdrawal by Subject|0|||
148776237|NCT01384019|536655104|FG000|Overall Study|Death|1|||
148776238|NCT01384019|536655105|FG001|Overall Study|Death|0|||
148776239|NCT01384019|536655104|FG000|Overall Study|MRI refusal|6|||
148776240|NCT01384019|536655105|FG001|Overall Study|MRI refusal|6|||
148776241|NCT01826370|536655108|FG000|Overall Study|Protocol Violation|6|||
148776242|NCT01826370|536655108|FG000|Overall Study|Lost to Follow-up|12|||
148776243|NCT01826370|536655108|FG000|Overall Study|Other reason not defined above|2|||
148776244|NCT00597506|536655115|FG000|Overall Study|Subject is being followed for survival|1|||
148776245|NCT03199612|536655118|FG000|Overall Study|Adverse Event|1|||
148776246|NCT03199612|536655119|FG001|Overall Study|Adverse Event|0|||
148776247|NCT01259375|536655120|FG000|Overall Study|Adverse Event|1|||
148776248|NCT00628095|536655121|FG000|Overall Study|Adverse Event|5|||
148776249|NCT00628095|536655122|FG001|Overall Study|Adverse Event|3|||
148984197|NCT04096560|537419379|FG007|Overall Study|Reason not Specified|0|||
148984198|NCT04096560|537419372|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
148984199|NCT04096560|537419373|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
148984200|NCT04096560|537419374|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
148776250|NCT00628095|536655121|FG000|Overall Study|Lack of Efficacy|0|||
148776251|NCT00628095|536655122|FG001|Overall Study|Lack of Efficacy|3|||
148776252|NCT00628095|536655121|FG000|Overall Study|Withdrawal by Subject|2|||
148776253|NCT00628095|536655122|FG001|Overall Study|Withdrawal by Subject|0|||
148776254|NCT00628095|536655121|FG000|Overall Study|Other|0|||
148776255|NCT00628095|536655122|FG001|Overall Study|Other|1|||
148776256|NCT00478699|536655127|FG000|Overall Study|Inclusion Error|1|||
148776257|NCT00478699|536655128|FG001|Overall Study|Inclusion Error|7|||
148776258|NCT00478699|536655127|FG000|Overall Study|Not receive study treatment|6|||
148776259|NCT00478699|536655128|FG001|Overall Study|Not receive study treatment|30|||
148776260|NCT03932331|536655139|FG000|Overall Study|Death|0|||
148776261|NCT03932331|536655140|FG001|Overall Study|Death|7|||
148776262|NCT03932331|536655141|FG002|Overall Study|Death|2|||
148776263|NCT03932331|536655139|FG000|Overall Study|Withdrawal by Subject|0|||
148776264|NCT03932331|536655140|FG001|Overall Study|Withdrawal by Subject|3|||
148776265|NCT03932331|536655141|FG002|Overall Study|Withdrawal by Subject|0|||
148776266|NCT03932331|536655139|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
148776267|NCT03932331|536655140|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
148844803|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
148844804|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
148844805|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
148844806|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
148776268|NCT03932331|536655141|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
148776269|NCT03932331|536655139|FG000|Overall Study|Progressive disease|3|||
148776270|NCT03932331|536655140|FG001|Overall Study|Progressive disease|0|||
148776271|NCT03932331|536655141|FG002|Overall Study|Progressive disease|0|||
148776272|NCT03932331|536655139|FG000|Overall Study|Lung infection|1|||
148776273|NCT03932331|536655140|FG001|Overall Study|Lung infection|0|||
148776274|NCT03932331|536655141|FG002|Overall Study|Lung infection|0|||
148776275|NCT03932331|536655139|FG000|Overall Study|Other|0|||
148776276|NCT03932331|536655140|FG001|Overall Study|Other|0|||
148776277|NCT03932331|536655141|FG002|Overall Study|Other|58|||
148776278|NCT03379753|536655142|FG000|Overall Study|Withdrawal by Subject|2|||
148776279|NCT03379753|536655143|FG001|Overall Study|Withdrawal by Subject|1|||
148776280|NCT03379753|536655142|FG000|Overall Study|not having correct procedure|1|||
148776281|NCT03379753|536655143|FG001|Overall Study|not having correct procedure|2|||
148776282|NCT03379753|536655142|FG000|Overall Study|No primary outcome|12|||
148776283|NCT03379753|536655143|FG001|Overall Study|No primary outcome|22|||
148776284|NCT01032239|536655144|FG000|Overall Study|Lost to Follow-up|3|||
148776285|NCT01032239|536655145|FG001|Overall Study|Lost to Follow-up|2|||
148776286|NCT01032239|536655144|FG000|Overall Study|Withdrawal by Subject|2|||
148776287|NCT01032239|536655145|FG001|Overall Study|Withdrawal by Subject|3|||
148776288|NCT01032239|536655144|FG000|Overall Study|Death|1|||
148776289|NCT01032239|536655145|FG001|Overall Study|Death|0|||
148776290|NCT01032239|536655144|FG000|Overall Study|Protocol Violation|1|||
148776291|NCT01032239|536655145|FG001|Overall Study|Protocol Violation|0|||
148776292|NCT04713592|536655152|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
148776293|NCT04713592|536655153|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
148776294|NCT04713592|536655154|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
148776295|NCT04713592|536655155|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
148776296|NCT04713592|536655152|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
148776297|NCT04713592|536655153|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
148776298|NCT04713592|536655154|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
148776299|NCT04713592|536655155|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
148776300|NCT04713592|536655152|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
148844807|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
148844808|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
148844809|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
148844810|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
148844811|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
148844812|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
148984201|NCT04096560|537419375|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
148984202|NCT04096560|537419376|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
148776301|NCT04713592|536655153|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
148776302|NCT04713592|536655154|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
148776303|NCT04713592|536655155|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
148776304|NCT04713592|536655152|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148776305|NCT04713592|536655153|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
148776306|NCT04713592|536655154|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
148776307|NCT04713592|536655155|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
148776308|NCT04713592|536655152|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
148776309|NCT04713592|536655153|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
148776310|NCT04713592|536655154|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
148776311|NCT04713592|536655155|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
148776312|NCT04713592|536655152|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148776313|NCT04713592|536655153|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
148776314|NCT04713592|536655154|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
148776315|NCT04713592|536655155|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
148776316|NCT04713592|536655152|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
148776317|NCT04713592|536655153|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
148776318|NCT04713592|536655154|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
148776319|NCT04713592|536655155|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
148776320|NCT03782298|536655160|FG000|Overall Study|Protocol Deviation|4|||
148776321|NCT01382225|536655161|FG000|Overall Study|Adverse Event|3|||
148776322|NCT01382225|536655162|FG001|Overall Study|Adverse Event|2|||
148776323|NCT01382225|536655161|FG000|Overall Study|Protocol Violation|2|||
148776324|NCT01382225|536655162|FG001|Overall Study|Protocol Violation|1|||
148776325|NCT01382225|536655161|FG000|Overall Study|Subject Withdrew Consent|5|||
148776326|NCT01382225|536655162|FG001|Overall Study|Subject Withdrew Consent|2|||
148776327|NCT01382225|536655161|FG000|Overall Study|Other|4|||
148776328|NCT01382225|536655162|FG001|Overall Study|Other|2|||
148776329|NCT01797081|536655163|FG000|Overall Study|Adverse Event|1|||
148776330|NCT01797081|536655164|FG001|Overall Study|Adverse Event|0|||
148776331|NCT01797081|536655165|FG002|Overall Study|Adverse Event|1|||
148776332|NCT01797081|536655166|FG003|Overall Study|Adverse Event|0|||
148776333|NCT01797081|536655163|FG000|Overall Study|Pregnancy|1|||
148984203|NCT04096560|537419377|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
148984204|NCT04096560|537419378|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
148984205|NCT04096560|537419379|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
148984206|NCT04096560|537419372|FG000|Overall Study|Study Terminated by Sponsor|0|||
148984207|NCT04096560|537419373|FG001|Overall Study|Study Terminated by Sponsor|0|||
148984208|NCT04096560|537419374|FG002|Overall Study|Study Terminated by Sponsor|0|||
148984209|NCT04096560|537419375|FG003|Overall Study|Study Terminated by Sponsor|5|||
148984210|NCT04096560|537419376|FG004|Overall Study|Study Terminated by Sponsor|6|||
148984211|NCT04096560|537419377|FG005|Overall Study|Study Terminated by Sponsor|4|||
148984212|NCT04096560|537419378|FG006|Overall Study|Study Terminated by Sponsor|6|||
148984213|NCT04096560|537419379|FG007|Overall Study|Study Terminated by Sponsor|1|||
148984214|NCT04096560|537419372|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148776334|NCT01797081|536655164|FG001|Overall Study|Pregnancy|0|||
148776335|NCT01797081|536655165|FG002|Overall Study|Pregnancy|0|||
148776336|NCT01797081|536655166|FG003|Overall Study|Pregnancy|0|||
148776337|NCT01797081|536655163|FG000|Overall Study|Personal Reasons|12|||
148776338|NCT01797081|536655164|FG001|Overall Study|Personal Reasons|4|||
148776339|NCT01797081|536655165|FG002|Overall Study|Personal Reasons|4|||
148776340|NCT01797081|536655166|FG003|Overall Study|Personal Reasons|8|||
148776341|NCT01797081|536655163|FG000|Overall Study|Protocol Violation|0|||
148776342|NCT01797081|536655164|FG001|Overall Study|Protocol Violation|0|||
148984215|NCT04096560|537419373|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148776343|NCT01797081|536655165|FG002|Overall Study|Protocol Violation|0|||
148776344|NCT01797081|536655166|FG003|Overall Study|Protocol Violation|1|||
148776345|NCT01793688|536655177|FG000|Overall Study|Protocol Violation|2|||
148844813|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
148844814|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
148844815|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
148844816|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
148844817|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Other|6|||
148844818|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Other|0|||
148844819|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Other|0|||
148844820|NCT05615220|536911405|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
148844821|NCT05615220|536911406|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
148844822|NCT05615220|536911407|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
148844823|NCT05615220|536911405|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
148844824|NCT05615220|536911406|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
148844825|NCT05615220|536911407|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
148844826|NCT05615220|536911405|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
148844827|NCT05615220|536911406|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
148844828|NCT05615220|536911407|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
148844829|NCT05615220|536911405|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
148844830|NCT05615220|536911406|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
148844831|NCT05615220|536911407|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
148844832|NCT05615220|536911405|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
148844833|NCT05615220|536911406|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
148844834|NCT05615220|536911407|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
148844835|NCT05615220|536911405|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
148844836|NCT05615220|536911406|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
148844837|NCT05615220|536911407|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
148844838|NCT01282866|536911415|FG000|Overall Study|Adverse Event|1|||
148844839|NCT01541865|536911417|FG000|Overall Study|Lost to Follow-up|11|||
148844840|NCT01541865|536911417|FG000|Overall Study|Withdrawal by Subject|9|||
148844841|NCT01541865|536911417|FG000|Overall Study|Adverse Event|1|||
148844842|NCT01541865|536911417|FG000|Overall Study|Protocol Violation|1|||
148844843|NCT00049257|536911421|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
148844844|NCT00049257|536911421|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
148844845|NCT00049257|536911421|FG000|Carboplatin, Paclitaxel|Death|2|||
148844846|NCT00049257|536911421|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
148844847|NCT03462719|536911426|FG000|Overall Study|Withdrawal by Subject|4|||
148844848|NCT03462719|536911427|FG001|Overall Study|Withdrawal by Subject|3|||
148844849|NCT03462719|536911426|FG000|Overall Study|Ongoing|87|||
148844850|NCT03462719|536911427|FG001|Overall Study|Ongoing|72|||
148844851|NCT04108208|536911428|FG000|Overall Study|Withdrawal by Subject|2|||
148844852|NCT04108208|536911429|FG001|Overall Study|Withdrawal by Subject|6|||
148844853|NCT04108208|536911428|FG000|Overall Study|other-ongoing|20|||
148844854|NCT04108208|536911429|FG001|Overall Study|other-ongoing|40|||
148844855|NCT04108208|536911428|FG000|Overall Study|Death|1|||
148844856|NCT04108208|536911429|FG001|Overall Study|Death|4|||
148844857|NCT04108208|536911428|FG000|Overall Study|Lost to Follow-up|2|||
148776346|NCT02484651|536655178|FG000|Overall Study|Patients' data files were corrupted.|1|||
148776347|NCT02484651|536655179|FG001|Overall Study|Patients' data files were corrupted.|1|||
148776348|NCT02484651|536655178|FG000|Overall Study|BIS monitoring failed.|1|||
148776349|NCT02484651|536655179|FG001|Overall Study|BIS monitoring failed.|1|||
148776350|NCT02484651|536655178|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
148776351|NCT02484651|536655179|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
148776352|NCT03649178|536655180|FG000|Overall Study|Adverse Event|1|||
148776353|NCT03649178|536655181|FG001|Overall Study|Adverse Event|2|||
148776354|NCT03649178|536655180|FG000|Overall Study|Withdrawal by Subject|0|||
148776355|NCT03649178|536655181|FG001|Overall Study|Withdrawal by Subject|2|||
148776356|NCT03649178|536655180|FG000|Overall Study|COVID regulation required halt in protocol|1|||
148776357|NCT03649178|536655181|FG001|Overall Study|COVID regulation required halt in protocol|0|||
148776358|NCT03003494|536655183|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
148776359|NCT00954512|536655185|FG000|Overall Study|Withdrawal by Subject|0|||
148776360|NCT00954512|536655186|FG001|Overall Study|Withdrawal by Subject|0|||
148776361|NCT00954512|536655187|FG002|Overall Study|Withdrawal by Subject|0|||
148776362|NCT00954512|536655188|FG003|Overall Study|Withdrawal by Subject|0|||
148844858|NCT04108208|536911429|FG001|Overall Study|Lost to Follow-up|0|||
148844859|NCT04271540|536911430|FG000|Overall Study|Lost to Follow-up|1|||
148844860|NCT04271540|536911430|FG000|Overall Study|Screen Fail|5|||
148844861|NCT03307785|536911431|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
148984216|NCT04096560|537419374|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148776363|NCT00954512|536655189|FG004|Overall Study|Withdrawal by Subject|0|||
148776364|NCT00954512|536655190|FG005|Overall Study|Withdrawal by Subject|1|||
148776365|NCT00954512|536655185|FG000|Overall Study|Adverse Event|0|||
148776366|NCT00954512|536655186|FG001|Overall Study|Adverse Event|0|||
148776367|NCT00954512|536655187|FG002|Overall Study|Adverse Event|0|||
148776368|NCT00954512|536655188|FG003|Overall Study|Adverse Event|0|||
148776369|NCT00954512|536655189|FG004|Overall Study|Adverse Event|1|||
148776370|NCT00954512|536655190|FG005|Overall Study|Adverse Event|2|||
148776371|NCT00954512|536655185|FG000|Overall Study|Physician Decision|0|||
148776372|NCT00954512|536655186|FG001|Overall Study|Physician Decision|1|||
148776373|NCT00954512|536655187|FG002|Overall Study|Physician Decision|0|||
148776374|NCT00954512|536655188|FG003|Overall Study|Physician Decision|1|||
148776375|NCT00954512|536655189|FG004|Overall Study|Physician Decision|0|||
148776376|NCT00954512|536655190|FG005|Overall Study|Physician Decision|0|||
148776377|NCT00954512|536655185|FG000|Overall Study|Symptomatic Deterioration|0|||
148776378|NCT00954512|536655186|FG001|Overall Study|Symptomatic Deterioration|1|||
148776379|NCT00954512|536655187|FG002|Overall Study|Symptomatic Deterioration|0|||
148776380|NCT00954512|536655188|FG003|Overall Study|Symptomatic Deterioration|0|||
148776381|NCT00954512|536655189|FG004|Overall Study|Symptomatic Deterioration|2|||
148776382|NCT00954512|536655190|FG005|Overall Study|Symptomatic Deterioration|0|||
148776383|NCT00954512|536655185|FG000|Overall Study|Progression of Disease|2|||
148776384|NCT00954512|536655186|FG001|Overall Study|Progression of Disease|1|||
148776385|NCT00954512|536655187|FG002|Overall Study|Progression of Disease|0|||
148844862|NCT03307785|536911432|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844863|NCT03307785|536911433|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844864|NCT03307785|536911434|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844865|NCT03307785|536911435|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844866|NCT03307785|536911436|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844867|NCT03307785|536911437|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844868|NCT03307785|536911438|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844869|NCT03307785|536911439|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844870|NCT03307785|536911440|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844871|NCT03307785|536911441|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844872|NCT03307785|536911442|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844873|NCT03307785|536911443|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
148844874|NCT03307785|536911431|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
148844875|NCT03307785|536911432|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
148844876|NCT03307785|536911433|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844877|NCT03307785|536911434|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844878|NCT03307785|536911435|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844879|NCT03307785|536911436|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844880|NCT03307785|536911437|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844881|NCT03307785|536911438|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844882|NCT03307785|536911439|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844883|NCT03307785|536911440|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844884|NCT03307785|536911441|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844885|NCT03307785|536911442|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844886|NCT03307785|536911443|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
148844887|NCT03307785|536911431|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
148844888|NCT03307785|536911432|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
148844889|NCT03307785|536911433|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844890|NCT03307785|536911434|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844891|NCT03307785|536911435|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844892|NCT03307785|536911436|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844893|NCT03307785|536911437|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844894|NCT03307785|536911438|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844895|NCT03307785|536911439|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844896|NCT03307785|536911440|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844897|NCT03307785|536911441|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844898|NCT03307785|536911442|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844899|NCT03307785|536911443|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
148844900|NCT03307785|536911431|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
148844901|NCT03307785|536911432|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
148844902|NCT03307785|536911433|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844903|NCT03307785|536911434|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844904|NCT03307785|536911435|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148776386|NCT00954512|536655188|FG003|Overall Study|Progression of Disease|1|||
148776387|NCT00954512|536655189|FG004|Overall Study|Progression of Disease|1|||
148776388|NCT00954512|536655190|FG005|Overall Study|Progression of Disease|1|||
148776389|NCT05685732|536655191|FG000|Overall Study|Withdrawal by Subject|2|||
148844905|NCT03307785|536911436|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844906|NCT03307785|536911437|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844907|NCT03307785|536911438|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844908|NCT03307785|536911439|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844909|NCT03307785|536911440|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844910|NCT03307785|536911441|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844911|NCT03307785|536911442|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844912|NCT03307785|536911443|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
148844913|NCT03307785|536911431|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844914|NCT03307785|536911432|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844915|NCT03307785|536911433|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
148844916|NCT03307785|536911434|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844917|NCT03307785|536911435|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844918|NCT03307785|536911436|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844919|NCT03307785|536911437|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844920|NCT03307785|536911438|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844921|NCT03307785|536911439|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844922|NCT03307785|536911440|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844923|NCT03307785|536911441|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844924|NCT03307785|536911442|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844925|NCT03307785|536911443|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
148844926|NCT03307785|536911431|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844927|NCT03307785|536911432|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844928|NCT03307785|536911433|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
148844929|NCT03307785|536911434|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844930|NCT03307785|536911435|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844931|NCT03307785|536911436|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844932|NCT03307785|536911437|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844933|NCT03307785|536911438|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844934|NCT03307785|536911439|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844935|NCT03307785|536911440|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844936|NCT03307785|536911441|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844937|NCT03307785|536911442|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844938|NCT03307785|536911443|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
148844939|NCT03307785|536911431|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844940|NCT03307785|536911432|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844941|NCT03307785|536911433|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
148844942|NCT03307785|536911434|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844943|NCT03307785|536911435|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844944|NCT03307785|536911436|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844945|NCT03307785|536911437|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844946|NCT03307785|536911438|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844947|NCT03307785|536911439|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844948|NCT03307785|536911440|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844949|NCT03307785|536911441|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844950|NCT03307785|536911442|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844951|NCT03307785|536911443|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
148844952|NCT03307785|536911431|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844953|NCT03307785|536911432|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844954|NCT03307785|536911433|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
148844955|NCT03307785|536911434|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844956|NCT03307785|536911435|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844957|NCT03307785|536911436|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844958|NCT03307785|536911437|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844959|NCT03307785|536911438|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844960|NCT03307785|536911439|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844961|NCT03307785|536911440|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148984217|NCT04096560|537419375|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148984218|NCT04096560|537419376|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148984219|NCT04096560|537419377|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148984220|NCT04096560|537419378|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
148844962|NCT03307785|536911441|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148984221|NCT04096560|537419379|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
148984222|NCT00096941|537419380|FG000|Overall Study|disease progression|3|||
148984223|NCT04111497|537419381|FG000|Overall Study|relapse of primary disease|1|||
148984224|NCT04111497|537419381|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
148984225|NCT02543346|537419382|FG000|Second Priming Visit|Withdrawal by Subject|0|||
148984226|NCT02543346|537419383|FG001|Second Priming Visit|Withdrawal by Subject|2|||
148984227|NCT02543346|537419384|FG002|Second Priming Visit|Withdrawal by Subject|2|||
148984228|NCT02543346|537419385|FG003|Second Priming Visit|Withdrawal by Subject|2|||
148984229|NCT02543346|537419382|FG000|Second Priming Visit|Adverse Event|1|||
148984230|NCT02543346|537419383|FG001|Second Priming Visit|Adverse Event|0|||
148984231|NCT02543346|537419384|FG002|Second Priming Visit|Adverse Event|0|||
148984232|NCT02543346|537419385|FG003|Second Priming Visit|Adverse Event|0|||
148984233|NCT01748994|537419386|FG000|Overall Study|Lost to Follow-up|8|||
148984234|NCT01748994|537419387|FG001|Overall Study|Lost to Follow-up|6|||
148984235|NCT02141516|537419388|FG000|Overall Study|Adverse Event|0|||
148984236|NCT02141516|537419389|FG001|Overall Study|Adverse Event|1|||
148984237|NCT02141516|537419390|FG002|Overall Study|Adverse Event|0|||
148984238|NCT02141516|537419388|FG000|Overall Study|Lost to Follow-up|0|||
148984239|NCT02141516|537419389|FG001|Overall Study|Lost to Follow-up|1|||
148984240|NCT02141516|537419390|FG002|Overall Study|Lost to Follow-up|0|||
148984241|NCT02141516|537419388|FG000|Overall Study|Other|0|||
148984242|NCT02141516|537419389|FG001|Overall Study|Other|3|||
148984243|NCT02141516|537419390|FG002|Overall Study|Other|0|||
148984244|NCT04496258|537419391|FG000|Overall Study|Withdrawal by Subject|2|||
148984245|NCT04496258|537419392|FG001|Overall Study|Withdrawal by Subject|1|||
148984246|NCT03169153|537419393|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
149029968|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
149029969|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
148844963|NCT03307785|536911442|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844964|NCT03307785|536911443|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
148844965|NCT03307785|536911431|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844966|NCT03307785|536911432|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844967|NCT03307785|536911433|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
148844968|NCT03307785|536911434|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844969|NCT03307785|536911435|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844970|NCT03307785|536911436|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844971|NCT03307785|536911437|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844972|NCT03307785|536911438|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844973|NCT03307785|536911439|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844974|NCT03307785|536911440|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844975|NCT03307785|536911441|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844976|NCT03307785|536911442|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844977|NCT03307785|536911443|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
148844978|NCT03307785|536911431|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844979|NCT03307785|536911432|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844980|NCT03307785|536911433|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844981|NCT03307785|536911434|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
148844982|NCT03307785|536911435|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
148844983|NCT03307785|536911436|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844984|NCT03307785|536911437|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844985|NCT03307785|536911438|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844986|NCT03307785|536911439|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844987|NCT03307785|536911440|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844988|NCT03307785|536911441|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844989|NCT03307785|536911442|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844990|NCT03307785|536911443|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
148844991|NCT03307785|536911431|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
148844992|NCT03307785|536911432|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
148844993|NCT03307785|536911433|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
148844994|NCT03307785|536911434|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
148844995|NCT03307785|536911435|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
148844996|NCT03307785|536911436|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
148844997|NCT03307785|536911437|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
148984247|NCT03169153|537419394|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
148844998|NCT03307785|536911438|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
148844999|NCT03307785|536911439|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
148845000|NCT03307785|536911440|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
148984248|NCT03169153|537419393|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
148984249|NCT03169153|537419394|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
148984250|NCT03169153|537419393|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
148845001|NCT03307785|536911441|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
148845002|NCT03307785|536911442|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
148845003|NCT03307785|536911443|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
148845004|NCT03307785|536911431|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845005|NCT03307785|536911432|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845006|NCT03307785|536911433|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845007|NCT03307785|536911434|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
148845008|NCT03307785|536911435|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845009|NCT03307785|536911436|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845010|NCT03307785|536911437|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845011|NCT03307785|536911438|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845012|NCT03307785|536911439|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845013|NCT03307785|536911440|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845014|NCT03307785|536911441|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845015|NCT03307785|536911442|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845016|NCT03307785|536911443|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
148845017|NCT03307785|536911431|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845018|NCT03307785|536911432|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845019|NCT03307785|536911433|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845020|NCT03307785|536911434|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845021|NCT03307785|536911435|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
148845022|NCT03307785|536911436|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845023|NCT03307785|536911437|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845024|NCT03307785|536911438|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845025|NCT03307785|536911439|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845026|NCT03307785|536911440|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845027|NCT03307785|536911441|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845028|NCT03307785|536911442|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845029|NCT03307785|536911443|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
148845030|NCT03307785|536911431|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845031|NCT03307785|536911432|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845032|NCT03307785|536911433|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845033|NCT03307785|536911434|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845034|NCT03307785|536911435|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845035|NCT03307785|536911436|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
148845036|NCT03307785|536911437|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845037|NCT03307785|536911438|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845038|NCT03307785|536911439|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845039|NCT03307785|536911440|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845040|NCT03307785|536911441|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845041|NCT03307785|536911442|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845042|NCT03307785|536911443|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
148845043|NCT03307785|536911431|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845044|NCT03307785|536911432|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845045|NCT03307785|536911433|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845046|NCT03307785|536911434|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845047|NCT03307785|536911435|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845048|NCT03307785|536911436|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
148845049|NCT03307785|536911437|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845050|NCT03307785|536911438|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845051|NCT03307785|536911439|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845052|NCT03307785|536911440|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845053|NCT03307785|536911441|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845054|NCT03307785|536911442|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845055|NCT03307785|536911443|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
148845056|NCT03307785|536911431|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845057|NCT03307785|536911432|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845058|NCT03307785|536911433|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845059|NCT03307785|536911434|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845060|NCT03307785|536911435|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845061|NCT03307785|536911436|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
148845062|NCT03307785|536911437|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845063|NCT03307785|536911438|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845064|NCT03307785|536911439|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845065|NCT03307785|536911440|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845066|NCT03307785|536911441|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845067|NCT03307785|536911442|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845068|NCT03307785|536911443|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
148845069|NCT03307785|536911431|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845070|NCT03307785|536911432|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845071|NCT03307785|536911433|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845072|NCT03307785|536911434|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845073|NCT03307785|536911435|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845074|NCT03307785|536911436|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
148845075|NCT03307785|536911437|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845076|NCT03307785|536911438|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845077|NCT03307785|536911439|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845078|NCT03307785|536911440|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845079|NCT03307785|536911441|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845080|NCT03307785|536911442|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845081|NCT03307785|536911443|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
148845082|NCT03307785|536911431|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845083|NCT03307785|536911432|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845084|NCT03307785|536911433|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845085|NCT03307785|536911434|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845086|NCT03307785|536911435|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845087|NCT03307785|536911436|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
148984251|NCT03169153|537419394|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
148984252|NCT03169153|537419393|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
148845088|NCT03307785|536911437|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845089|NCT03307785|536911438|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845090|NCT03307785|536911439|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845091|NCT03307785|536911440|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845092|NCT03307785|536911441|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845093|NCT03307785|536911442|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845094|NCT03307785|536911443|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
148845095|NCT03307785|536911431|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845096|NCT03307785|536911432|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845097|NCT03307785|536911433|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845098|NCT03307785|536911434|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845099|NCT03307785|536911435|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845100|NCT03307785|536911436|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845101|NCT03307785|536911437|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
148845102|NCT03307785|536911438|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845103|NCT03307785|536911439|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845104|NCT03307785|536911440|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845105|NCT03307785|536911441|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845106|NCT03307785|536911442|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845107|NCT03307785|536911443|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
148845108|NCT03307785|536911431|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845109|NCT03307785|536911432|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148984253|NCT03169153|537419394|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
148984254|NCT01603875|537419400|FG000|Overall Study|Preexisting rabies antibody|3|||
148984255|NCT01603875|537419401|FG001|Overall Study|Preexisting rabies antibody|4|||
148984256|NCT01603875|537419402|FG002|Overall Study|Preexisting rabies antibody|3|||
148984257|NCT01603875|537419400|FG000|Overall Study|Lost to Follow-up|4|||
148984258|NCT01603875|537419401|FG001|Overall Study|Lost to Follow-up|3|||
148984259|NCT01603875|537419402|FG002|Overall Study|Lost to Follow-up|6|||
148984260|NCT01603875|537419400|FG000|Overall Study|Protocol Violation|0|||
148984261|NCT01603875|537419401|FG001|Overall Study|Protocol Violation|1|||
148984262|NCT01603875|537419402|FG002|Overall Study|Protocol Violation|0|||
148984263|NCT01652716|537419403|FG000|Overall Study|Loss of glucose control|1|||
148984264|NCT01652716|537419404|FG001|Overall Study|Loss of glucose control|0|||
148984265|NCT01652716|537419403|FG000|Overall Study|Administrative|0|||
148984266|NCT01652716|537419404|FG001|Overall Study|Administrative|2|||
148984267|NCT01652716|537419403|FG000|Overall Study|Investigator decision|1|||
149029970|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
148845110|NCT03307785|536911433|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845111|NCT03307785|536911434|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845112|NCT03307785|536911435|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845113|NCT03307785|536911436|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845114|NCT03307785|536911437|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
148845115|NCT03307785|536911438|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845116|NCT03307785|536911439|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845117|NCT03307785|536911440|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845118|NCT03307785|536911441|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845119|NCT03307785|536911442|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845120|NCT03307785|536911443|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
148845121|NCT03307785|536911431|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845122|NCT03307785|536911432|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845123|NCT03307785|536911433|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845124|NCT03307785|536911434|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845125|NCT03307785|536911435|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845126|NCT03307785|536911436|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845127|NCT03307785|536911437|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845128|NCT03307785|536911438|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
148845129|NCT03307785|536911439|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845130|NCT03307785|536911440|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845131|NCT03307785|536911441|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845132|NCT03307785|536911442|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845133|NCT03307785|536911443|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
148845134|NCT03307785|536911431|FG000|PACT Phase: Up to 19 Months|Death|0|||
148845135|NCT03307785|536911432|FG001|PACT Phase: Up to 19 Months|Death|0|||
148845136|NCT03307785|536911433|FG002|PACT Phase: Up to 19 Months|Death|0|||
148845137|NCT03307785|536911434|FG003|PACT Phase: Up to 19 Months|Death|0|||
148845138|NCT03307785|536911435|FG004|PACT Phase: Up to 19 Months|Death|0|||
148845139|NCT03307785|536911436|FG005|PACT Phase: Up to 19 Months|Death|0|||
148845140|NCT03307785|536911437|FG006|PACT Phase: Up to 19 Months|Death|0|||
148845141|NCT03307785|536911438|FG007|PACT Phase: Up to 19 Months|Death|0|||
148845142|NCT03307785|536911439|FG008|PACT Phase: Up to 19 Months|Death|0|||
148845143|NCT03307785|536911440|FG009|PACT Phase: Up to 19 Months|Death|0|||
148845144|NCT03307785|536911441|FG010|PACT Phase: Up to 19 Months|Death|0|||
148845145|NCT03307785|536911442|FG011|PACT Phase: Up to 19 Months|Death|0|||
148845146|NCT03307785|536911443|FG012|PACT Phase: Up to 19 Months|Death|1|||
148845147|NCT01402869|536911451|FG000|Overall Study|Required Tooth Extraction|0|||
148845148|NCT01402869|536911452|FG001|Overall Study|Required Tooth Extraction|0|||
148845149|NCT01402869|536911453|FG002|Overall Study|Required Tooth Extraction|1|||
148845150|NCT00642707|536911454|FG000|Overall Study|Adverse Event|0|||
148845151|NCT00642707|536911455|FG001|Overall Study|Adverse Event|0|||
148845152|NCT00642707|536911456|FG002|Overall Study|Adverse Event|0|||
148845153|NCT00642707|536911457|FG003|Overall Study|Adverse Event|2|||
148845154|NCT00642707|536911454|FG000|Overall Study|Withdrawal by Subject|1|||
148845155|NCT00642707|536911455|FG001|Overall Study|Withdrawal by Subject|0|||
148845156|NCT00642707|536911456|FG002|Overall Study|Withdrawal by Subject|0|||
148845157|NCT00642707|536911457|FG003|Overall Study|Withdrawal by Subject|0|||
148845158|NCT02891226|536911458|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
148845159|NCT02891226|536911459|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
148845160|NCT02891226|536911460|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
148845161|NCT02891226|536911461|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845162|NCT02891226|536911462|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845163|NCT02891226|536911463|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845164|NCT02891226|536911464|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845165|NCT02891226|536911465|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845166|NCT02891226|536911466|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845167|NCT02891226|536911467|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845168|NCT02891226|536911468|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845169|NCT02891226|536911469|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845170|NCT02891226|536911470|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845171|NCT02891226|536911471|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845172|NCT02891226|536911472|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845173|NCT02891226|536911473|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
148845174|NCT02891226|536911458|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
148845175|NCT02891226|536911459|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
148845176|NCT02891226|536911460|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845177|NCT02891226|536911461|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845178|NCT02891226|536911462|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845179|NCT02891226|536911463|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845180|NCT02891226|536911464|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845181|NCT02891226|536911465|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845182|NCT02891226|536911466|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845183|NCT02891226|536911467|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845184|NCT02891226|536911468|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845185|NCT02891226|536911469|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845186|NCT02891226|536911470|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845187|NCT02891226|536911471|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845188|NCT02891226|536911472|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845189|NCT02891226|536911473|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
148845190|NCT02891226|536911458|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845191|NCT02891226|536911459|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845192|NCT02891226|536911460|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845193|NCT02891226|536911461|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
148845194|NCT02891226|536911462|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845195|NCT02891226|536911463|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845196|NCT02891226|536911464|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845197|NCT02891226|536911465|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845198|NCT02891226|536911466|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845199|NCT02891226|536911467|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845200|NCT02891226|536911468|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845201|NCT02891226|536911469|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845202|NCT02891226|536911470|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845203|NCT02891226|536911471|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845204|NCT02891226|536911472|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845205|NCT02891226|536911473|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
148845206|NCT02891226|536911458|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845207|NCT02891226|536911459|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845208|NCT02891226|536911460|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
148845209|NCT02891226|536911461|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845210|NCT02891226|536911462|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845211|NCT02891226|536911463|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845212|NCT02891226|536911464|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845213|NCT02891226|536911465|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845214|NCT02891226|536911466|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845215|NCT02891226|536911467|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845216|NCT02891226|536911468|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845217|NCT02891226|536911469|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845218|NCT02891226|536911470|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845219|NCT02891226|536911471|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845220|NCT02891226|536911472|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845221|NCT02891226|536911473|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
148845222|NCT02891226|536911458|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845223|NCT02891226|536911459|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845224|NCT02891226|536911460|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845225|NCT02891226|536911461|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
148845226|NCT02891226|536911462|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845227|NCT02891226|536911463|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845228|NCT02891226|536911464|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845229|NCT02891226|536911465|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845230|NCT02891226|536911466|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845231|NCT02891226|536911467|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845232|NCT02891226|536911468|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845233|NCT02891226|536911469|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845234|NCT02891226|536911470|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845235|NCT02891226|536911471|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845236|NCT02891226|536911472|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845237|NCT02891226|536911473|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
148845238|NCT02891226|536911458|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845239|NCT02891226|536911459|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845240|NCT02891226|536911460|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845241|NCT02891226|536911461|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
148845242|NCT02891226|536911462|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845243|NCT02891226|536911463|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845244|NCT02891226|536911464|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845245|NCT02891226|536911465|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845246|NCT02891226|536911466|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845247|NCT02891226|536911467|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845248|NCT02891226|536911468|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845249|NCT02891226|536911469|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845250|NCT02891226|536911470|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845251|NCT02891226|536911471|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845252|NCT02891226|536911472|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845253|NCT02891226|536911473|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
148845254|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845255|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845256|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845257|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845258|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845259|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845260|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
148845261|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
148845262|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
148845263|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
148845264|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845265|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845266|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845267|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845268|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845269|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
148845270|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845271|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845272|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845273|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845274|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845275|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
148845276|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845277|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845278|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845279|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
148845280|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845281|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845282|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845283|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845284|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845285|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
148845286|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845287|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845288|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845289|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845290|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845291|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845292|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
148845293|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
148845294|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
148845295|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
148845296|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845297|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845298|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845299|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845300|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845301|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
148845302|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845303|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845304|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845305|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845306|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
148845307|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845308|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845309|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845310|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845311|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845312|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845313|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845314|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845315|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845316|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845317|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
148845318|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845319|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845320|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
149029971|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
148845321|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845322|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845323|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845324|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
148845325|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845326|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845327|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845328|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845329|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845330|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845331|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845332|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845333|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
148845334|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845335|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845336|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845337|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845338|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845339|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845340|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845341|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
148845342|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
148845343|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
148845344|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845345|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845346|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845347|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845348|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845349|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
148845350|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845351|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845352|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845353|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845354|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845355|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845356|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845357|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
148845358|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845359|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845360|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845361|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845362|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845363|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845364|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845365|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
148845366|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845367|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845368|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845369|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845370|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845371|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845372|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845373|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845374|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
148845375|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845376|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845377|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845378|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845379|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845380|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845381|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
148845382|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845383|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845384|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845385|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845386|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845387|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845388|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845389|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845390|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845391|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
148845392|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845393|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845394|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845395|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845396|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845397|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
148845398|NCT02891226|536911458|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845399|NCT02891226|536911459|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845400|NCT02891226|536911460|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845401|NCT02891226|536911461|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845402|NCT02891226|536911462|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845403|NCT02891226|536911463|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845404|NCT02891226|536911464|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845405|NCT02891226|536911465|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845406|NCT02891226|536911466|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845407|NCT02891226|536911467|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
148845408|NCT02891226|536911468|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845409|NCT02891226|536911469|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845410|NCT02891226|536911470|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845411|NCT02891226|536911471|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845412|NCT02891226|536911472|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845413|NCT02891226|536911473|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
148845414|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845415|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845416|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845417|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845418|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845419|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845420|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845421|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845422|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845423|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845424|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
148845425|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845426|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845427|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845428|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845429|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
148845430|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845431|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845432|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845433|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845434|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845435|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845436|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845437|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845438|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845439|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845440|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
148845441|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845442|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845443|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845444|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845445|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
148845446|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148984268|NCT01652716|537419404|FG001|Overall Study|Investigator decision|4|||
148984269|NCT01652716|537419403|FG000|Overall Study|Lost to Follow-up|12|||
148845447|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148984270|NCT01652716|537419404|FG001|Overall Study|Lost to Follow-up|11|||
148845448|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845449|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845450|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845451|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845452|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845453|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845454|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845455|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845456|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
148845457|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845458|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845459|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845460|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845461|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
148845462|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845463|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845464|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845465|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845466|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845467|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845468|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845469|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845470|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845471|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845472|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
148845473|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845474|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845475|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845476|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845477|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
148845478|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845479|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845480|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845481|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845482|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845483|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845484|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845485|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845486|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845487|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845488|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
148845489|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845490|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845491|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845492|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845493|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
148845494|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845495|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845496|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845497|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845498|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845499|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845500|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845501|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845502|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845503|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845504|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
148845505|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845506|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845507|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845508|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845509|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
148845510|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845511|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845512|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845513|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845514|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845515|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845516|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845517|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845518|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845519|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845520|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
148845521|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845522|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845523|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845524|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845525|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
148845526|NCT02891226|536911458|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845527|NCT02891226|536911459|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845528|NCT02891226|536911460|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845529|NCT02891226|536911461|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845530|NCT02891226|536911462|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845531|NCT02891226|536911463|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845532|NCT02891226|536911464|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845533|NCT02891226|536911465|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845534|NCT02891226|536911466|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845535|NCT02891226|536911467|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845536|NCT02891226|536911468|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
148845537|NCT02891226|536911469|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845538|NCT02891226|536911470|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845539|NCT02891226|536911471|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845540|NCT02891226|536911472|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845541|NCT02891226|536911473|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
148845542|NCT02891226|536911458|FG000|Follow-up Period|Withdrawal by Subject|0|||
148845543|NCT02891226|536911459|FG001|Follow-up Period|Withdrawal by Subject|0|||
148845544|NCT02891226|536911460|FG002|Follow-up Period|Withdrawal by Subject|0|||
148845545|NCT02891226|536911461|FG003|Follow-up Period|Withdrawal by Subject|0|||
148845546|NCT02891226|536911462|FG004|Follow-up Period|Withdrawal by Subject|0|||
148845547|NCT02891226|536911463|FG005|Follow-up Period|Withdrawal by Subject|0|||
148845548|NCT02891226|536911464|FG006|Follow-up Period|Withdrawal by Subject|0|||
148845549|NCT02891226|536911465|FG007|Follow-up Period|Withdrawal by Subject|0|||
148845550|NCT02891226|536911466|FG008|Follow-up Period|Withdrawal by Subject|0|||
148845551|NCT02891226|536911467|FG009|Follow-up Period|Withdrawal by Subject|0|||
148845552|NCT02891226|536911468|FG010|Follow-up Period|Withdrawal by Subject|0|||
148845553|NCT02891226|536911469|FG011|Follow-up Period|Withdrawal by Subject|1|||
148845554|NCT02891226|536911470|FG012|Follow-up Period|Withdrawal by Subject|0|||
148845555|NCT02891226|536911471|FG013|Follow-up Period|Withdrawal by Subject|0|||
148845556|NCT02891226|536911472|FG014|Follow-up Period|Withdrawal by Subject|1|||
148845557|NCT02891226|536911473|FG015|Follow-up Period|Withdrawal by Subject|1|||
148845558|NCT02842086|536911478|FG000|Overall Study|Randomized but Never Treated|6|||
148845559|NCT02842086|536911479|FG001|Overall Study|Randomized but Never Treated|6|||
148845560|NCT02842086|536911478|FG000|Overall Study|Still in Double-Blind Phase|7|||
148845561|NCT02842086|536911479|FG001|Overall Study|Still in Double-Blind Phase|3|||
148845562|NCT02842086|536911478|FG000|Overall Study|Adverse Event|18|||
148845563|NCT02842086|536911479|FG001|Overall Study|Adverse Event|20|||
148845564|NCT02842086|536911478|FG000|Overall Study|Death|3|||
148845565|NCT02842086|536911479|FG001|Overall Study|Death|3|||
148845566|NCT02842086|536911478|FG000|Overall Study|Investigator's Discretion|9|||
148845567|NCT02842086|536911479|FG001|Overall Study|Investigator's Discretion|13|||
148845568|NCT02842086|536911478|FG000|Overall Study|Non-Compliance with Study Drug|9|||
148845569|NCT02842086|536911479|FG001|Overall Study|Non-Compliance with Study Drug|8|||
148845570|NCT02842086|536911478|FG000|Overall Study|Protocol Violation|8|||
148845571|NCT02842086|536911479|FG001|Overall Study|Protocol Violation|4|||
148845572|NCT02842086|536911478|FG000|Overall Study|Withdrew Consent|205|||
148845573|NCT02842086|536911479|FG001|Overall Study|Withdrew Consent|194|||
148845574|NCT02842086|536911478|FG000|Overall Study|Lost to Follow-up|274|||
148845575|NCT02842086|536911479|FG001|Overall Study|Lost to Follow-up|236|||
148845576|NCT02842086|536911478|FG000|Overall Study|HIV-1 Infection|5|||
148845577|NCT02842086|536911479|FG001|Overall Study|HIV-1 Infection|6|||
148845578|NCT07214935|536911480|FG000|Overall Study|Adverse Event|1|||
148845579|NCT07214935|536911481|FG001|Overall Study|Adverse Event|1|||
148845580|NCT07214935|536911482|FG002|Overall Study|Adverse Event|1|||
148845581|NCT07214935|536911483|FG003|Overall Study|Adverse Event|0|||
148845582|NCT07214935|536911480|FG000|Overall Study|Lost to Follow-up|0|||
148845583|NCT07214935|536911481|FG001|Overall Study|Lost to Follow-up|1|||
148845584|NCT07214935|536911482|FG002|Overall Study|Lost to Follow-up|0|||
148845585|NCT07214935|536911483|FG003|Overall Study|Lost to Follow-up|0|||
148845586|NCT07214935|536911480|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
148845587|NCT07214935|536911481|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
148845588|NCT07214935|536911482|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
148845589|NCT07214935|536911483|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
148845590|NCT07214935|536911480|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
148845591|NCT07214935|536911481|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
148845592|NCT07214935|536911482|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
148845593|NCT07214935|536911483|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
148845594|NCT01142388|536912380|FG000|Overall Study|Lack of Efficacy|21|||
148845595|NCT01142388|536912381|FG001|Overall Study|Lack of Efficacy|31|||
148845596|NCT01142388|536912380|FG000|Overall Study|Adverse Event|9|||
148845597|NCT01142388|536912381|FG001|Overall Study|Adverse Event|5|||
148845598|NCT01142388|536912380|FG000|Overall Study|Death|3|||
148845599|NCT01142388|536912381|FG001|Overall Study|Death|2|||
148845600|NCT01142388|536912380|FG000|Overall Study|Withdrawal by Subject|5|||
148845601|NCT01142388|536912381|FG001|Overall Study|Withdrawal by Subject|3|||
148845602|NCT01142388|536912380|FG000|Overall Study|Alternative therapy|1|||
148845603|NCT01142388|536912381|FG001|Overall Study|Alternative therapy|0|||
148845604|NCT01142388|536912380|FG000|Overall Study|Other complications|0|||
148845605|NCT01142388|536912381|FG001|Overall Study|Other complications|2|||
148845606|NCT01142388|536912380|FG000|Overall Study|Other|1|||
148845607|NCT01142388|536912381|FG001|Overall Study|Other|1|||
148845608|NCT01142388|536912380|FG000|Overall Study|Never started therapy|7|||
148845609|NCT01142388|536912381|FG001|Overall Study|Never started therapy|3|||
148845610|NCT04667949|536912382|FG000|Overall Study|Adverse Event|0|||
148845611|NCT04667949|536912383|FG001|Overall Study|Adverse Event|2|||
148845612|NCT04667949|536912382|FG000|Overall Study|Lost to Follow-up|0|||
148845613|NCT04667949|536912383|FG001|Overall Study|Lost to Follow-up|1|||
148845614|NCT04667949|536912382|FG000|Overall Study|Physician Decision|0|||
148845615|NCT04667949|536912383|FG001|Overall Study|Physician Decision|2|||
148845616|NCT04667949|536912382|FG000|Overall Study|Subject decision|1|||
148845617|NCT04667949|536912383|FG001|Overall Study|Subject decision|7|||
148845618|NCT02213926|536912384|FG000|Overall Study|Death|59|||
148845619|NCT02213926|536912384|FG000|Overall Study|Withdrawal by Subject|10|||
148845620|NCT02213926|536912384|FG000|Overall Study|study terminated by sponsor|51|||
148845621|NCT02213926|536912384|FG000|Overall Study|Lost to Follow-up|3|||
148845622|NCT02213926|536912384|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
148845623|NCT01273038|536912385|FG000|Second Intervention (14 Days)|Adverse Event|0|||
148845624|NCT01273038|536912386|FG001|Second Intervention (14 Days)|Adverse Event|1|||
148845625|NCT01273038|536912385|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
148845626|NCT01273038|536912386|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
148845627|NCT03458325|536912387|FG000|Overall Study|Withdrawal by Subject|1|||
148845628|NCT02630693|536912388|FG000|Overall Study|No receive treatment|0|||
148845629|NCT02630693|536912389|FG001|Overall Study|No receive treatment|1|||
148845630|NCT00175916|536912390|FG000|Overall Study|Death|19|||
148845631|NCT00175916|536912390|FG000|Overall Study|Adverse Event|81|||
148845632|NCT00175916|536912390|FG000|Overall Study|Lack of Efficacy|354|||
148845633|NCT00175916|536912390|FG000|Overall Study|Lost to Follow-up|17|||
148845634|NCT00175916|536912390|FG000|Overall Study|Subject Choice|98|||
148845635|NCT00175916|536912390|FG000|Overall Study|Lack of compliance|8|||
148845636|NCT00175916|536912390|FG000|Overall Study|Patient cannot record seizures|1|||
148845637|NCT00175916|536912390|FG000|Overall Study|Sponsor decision|17|||
148845638|NCT00175916|536912390|FG000|Overall Study|Vigabatrin intake|1|||
148845639|NCT00175916|536912390|FG000|Overall Study|Suicidal behaviour|1|||
148984271|NCT01652716|537419403|FG000|Overall Study|Protocol Violation|2|||
148984272|NCT01652716|537419404|FG001|Overall Study|Protocol Violation|1|||
148845640|NCT00175916|536912390|FG000|Overall Study|Withdrawal by Subject|1|||
148845641|NCT00175916|536912390|FG000|Overall Study|Seizure - free|4|||
148845642|NCT00175916|536912390|FG000|Overall Study|Administrative reason|1|||
148845643|NCT00175916|536912390|FG000|Overall Study|Pregnancy|1|||
148845644|NCT00175916|536912390|FG000|Overall Study|Patient's request|2|||
148984273|NCT01652716|537419403|FG000|Overall Study|Adverse Event|7|||
148984274|NCT01652716|537419404|FG001|Overall Study|Adverse Event|10|||
148845645|NCT00175916|536912390|FG000|Overall Study|Treating physiciant's choice|1|||
148845646|NCT00175916|536912390|FG000|Overall Study|Moved overseas|1|||
148845647|NCT00175916|536912390|FG000|Overall Study|Loss of job and economic burden|1|||
148845648|NCT00175916|536912390|FG000|Overall Study|Site was closed|9|||
148984275|NCT01652716|537419403|FG000|Overall Study|Withdrawal by Subject|33|||
148845649|NCT00175916|536912390|FG000|Overall Study|Patient went to prison|1|||
148845650|NCT04503551|536912391|FG000|Overall Study|Withdrawal by Subject|5|||
148845651|NCT04503551|536912392|FG001|Overall Study|Withdrawal by Subject|3|||
148845652|NCT04503551|536912391|FG000|Overall Study|Physician Decision|1|||
148845653|NCT04503551|536912392|FG001|Overall Study|Physician Decision|0|||
148845654|NCT04503551|536912391|FG000|Overall Study|Death|0|||
148845655|NCT04503551|536912392|FG001|Overall Study|Death|1|||
148845656|NCT04503551|536912391|FG000|Overall Study|Lost to Follow-up|1|||
148845657|NCT04503551|536912392|FG001|Overall Study|Lost to Follow-up|2|||
148845658|NCT04503551|536912391|FG000|Overall Study|Ongoing at Week 52|99|||
148845659|NCT04503551|536912392|FG001|Overall Study|Ongoing at Week 52|62|||
148845660|NCT01871545|536912398|FG000|Overall Study|Death|2|||
148845661|NCT01871545|536912399|FG001|Overall Study|Death|0|||
148845662|NCT01871545|536912398|FG000|Overall Study|Lack of Efficacy|11|||
148845663|NCT01871545|536912399|FG001|Overall Study|Lack of Efficacy|2|||
148845664|NCT01871545|536912398|FG000|Overall Study|Physician Decision|4|||
148845665|NCT01871545|536912399|FG001|Overall Study|Physician Decision|0|||
148845666|NCT01871545|536912398|FG000|Overall Study|Withdrawal by Subject|0|||
148845667|NCT01871545|536912399|FG001|Overall Study|Withdrawal by Subject|1|||
148845668|NCT01523743|536912400|FG000|Period 1|Adverse Event|1|||
148845669|NCT01523743|536912401|FG001|Period 1|Adverse Event|0|||
148845670|NCT01523743|536912400|FG000|Period 1|Withdrawal by Subject|6|||
148845671|NCT01523743|536912401|FG001|Period 1|Withdrawal by Subject|2|||
148845672|NCT01523743|536912400|FG000|Period 1|Lost to Follow-up|1|||
148845673|NCT01523743|536912401|FG001|Period 1|Lost to Follow-up|0|||
148845674|NCT01523743|536912400|FG000|Period 1|Lack of Efficacy|1|||
148845675|NCT01523743|536912401|FG001|Period 1|Lack of Efficacy|0|||
148845676|NCT01523743|536912400|FG000|Period 1|Felt unable to empty bladder|1|||
148845677|NCT01523743|536912401|FG001|Period 1|Felt unable to empty bladder|0|||
148845678|NCT01523743|536912400|FG000|Period 2|Withdrawal by Subject|0|||
148845679|NCT01523743|536912401|FG001|Period 2|Withdrawal by Subject|2|||
148845680|NCT01523743|536912400|FG000|Period 2|Adverse Event|1|||
148845681|NCT01523743|536912401|FG001|Period 2|Adverse Event|0|||
148845682|NCT05710640|536912402|FG000|Overall Study|Physician Decision|0|||
148845683|NCT05710640|536912403|FG001|Overall Study|Physician Decision|1|||
148845684|NCT05710640|536912402|FG000|Overall Study|Withdrawal by Subject|1|||
148845685|NCT05710640|536912403|FG001|Overall Study|Withdrawal by Subject|0|||
148845686|NCT05710640|536912402|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
148845687|NCT05710640|536912403|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
148845688|NCT04158375|536912404|FG000|Overall Study|Withdrawal by Subject|0|||
148845689|NCT04158375|536912405|FG001|Overall Study|Withdrawal by Subject|3|||
148845690|NCT04158375|536912406|FG002|Overall Study|Withdrawal by Subject|0|||
148845691|NCT02734004|536912407|FG000|Overall Study|Death|36|||
148845692|NCT02734004|536912408|FG001|Overall Study|Death|24|||
148845693|NCT02734004|536912409|FG002|Overall Study|Death|26|||
148845694|NCT02734004|536912410|FG003|Overall Study|Death|35|||
148845695|NCT02734004|536912411|FG004|Overall Study|Death|13|||
148845696|NCT02734004|536912412|FG005|Overall Study|Death|17|||
148845697|NCT02734004|536912413|FG006|Overall Study|Death|20|||
148845698|NCT02734004|536912407|FG000|Overall Study|Lost to Follow-up|1|||
148845699|NCT02734004|536912408|FG001|Overall Study|Lost to Follow-up|1|||
148845700|NCT02734004|536912409|FG002|Overall Study|Lost to Follow-up|0|||
148845701|NCT02734004|536912410|FG003|Overall Study|Lost to Follow-up|0|||
148845702|NCT02734004|536912411|FG004|Overall Study|Lost to Follow-up|1|||
148845703|NCT02734004|536912412|FG005|Overall Study|Lost to Follow-up|0|||
148845704|NCT02734004|536912413|FG006|Overall Study|Lost to Follow-up|0|||
148845705|NCT02734004|536912407|FG000|Overall Study|Withdrawal by Subject|3|||
148845706|NCT02734004|536912408|FG001|Overall Study|Withdrawal by Subject|1|||
148845707|NCT02734004|536912409|FG002|Overall Study|Withdrawal by Subject|1|||
148845708|NCT02734004|536912410|FG003|Overall Study|Withdrawal by Subject|1|||
148984276|NCT01652716|537419404|FG001|Overall Study|Withdrawal by Subject|18|||
148845709|NCT02734004|536912411|FG004|Overall Study|Withdrawal by Subject|3|||
148845710|NCT02734004|536912412|FG005|Overall Study|Withdrawal by Subject|0|||
148845711|NCT02734004|536912413|FG006|Overall Study|Withdrawal by Subject|2|||
148845712|NCT02734004|536912407|FG000|Overall Study|Other|0|||
148845713|NCT02734004|536912408|FG001|Overall Study|Other|8|||
148845714|NCT02734004|536912409|FG002|Overall Study|Other|7|||
148845715|NCT02734004|536912410|FG003|Overall Study|Other|4|||
148845716|NCT02734004|536912411|FG004|Overall Study|Other|34|||
148845717|NCT02734004|536912412|FG005|Overall Study|Other|14|||
148845718|NCT02734004|536912413|FG006|Overall Study|Other|10|||
148845719|NCT01393899|536912424|FG000|Overall Study|Study terminated by sponsor|1|||
148845720|NCT01393899|536912425|FG001|Overall Study|Study terminated by sponsor|0|||
148845721|NCT01393899|536912426|FG002|Overall Study|Study terminated by sponsor|1|||
148845722|NCT01393899|536912424|FG000|Overall Study|Other|1|||
148845723|NCT01393899|536912425|FG001|Overall Study|Other|0|||
148845724|NCT01393899|536912426|FG002|Overall Study|Other|0|||
148845725|NCT01393899|536912424|FG000|Overall Study|Withdrawal by Subject|2|||
148845726|NCT01393899|536912425|FG001|Overall Study|Withdrawal by Subject|2|||
148845727|NCT01393899|536912426|FG002|Overall Study|Withdrawal by Subject|1|||
148845728|NCT01393899|536912424|FG000|Overall Study|Lost to Follow-up|0|||
148845729|NCT01393899|536912425|FG001|Overall Study|Lost to Follow-up|0|||
148845730|NCT01393899|536912426|FG002|Overall Study|Lost to Follow-up|1|||
148845731|NCT01393899|536912424|FG000|Overall Study|Does not meet entrance criteria|1|||
148845732|NCT01393899|536912425|FG001|Overall Study|Does not meet entrance criteria|0|||
148845733|NCT01393899|536912426|FG002|Overall Study|Does not meet entrance criteria|1|||
148845734|NCT01393899|536912424|FG000|Overall Study|Lack of Efficacy|26|||
148845735|NCT01393899|536912425|FG001|Overall Study|Lack of Efficacy|21|||
148845736|NCT01393899|536912426|FG002|Overall Study|Lack of Efficacy|16|||
148845737|NCT01393899|536912424|FG000|Overall Study|Adverse Event|1|||
148845738|NCT01393899|536912425|FG001|Overall Study|Adverse Event|5|||
148845739|NCT01393899|536912426|FG002|Overall Study|Adverse Event|3|||
148845740|NCT04721158|536912427|FG000|Overall Study|Lost to Follow-up|4|||
148845741|NCT04721158|536912427|FG000|Overall Study|Device did not connect|1|||
148845742|NCT00132301|536912428|FG000|Overall Study|Death|7|||
148845743|NCT00132301|536912429|FG001|Overall Study|Death|6|||
148845744|NCT00132301|536912428|FG000|Overall Study|Withdrawal by Subject|5|||
148845745|NCT00132301|536912429|FG001|Overall Study|Withdrawal by Subject|2|||
148845746|NCT00132301|536912428|FG000|Overall Study|Physician Decision|1|||
148845747|NCT00132301|536912429|FG001|Overall Study|Physician Decision|1|||
148845748|NCT00132301|536912428|FG000|Overall Study|Lost to Follow-up|5|||
148845749|NCT00132301|536912429|FG001|Overall Study|Lost to Follow-up|3|||
148845750|NCT00132301|536912428|FG000|Overall Study|Other|1|||
148845751|NCT00132301|536912429|FG001|Overall Study|Other|1|||
148845752|NCT00132301|536912428|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
148845753|NCT00132301|536912429|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
148845754|NCT01890265|536912436|FG000|Overall Study|Other (Unspecified reason)|0|||
148845755|NCT01890265|536912437|FG001|Overall Study|Other (Unspecified reason)|1|||
148845756|NCT01890265|536912438|FG002|Overall Study|Other (Unspecified reason)|0|||
148845757|NCT01890265|536912439|FG003|Overall Study|Other (Unspecified reason)|0|||
148845758|NCT01890265|536912440|FG004|Overall Study|Other (Unspecified reason)|0|||
148845759|NCT01890265|536912441|FG005|Overall Study|Other (Unspecified reason)|0|||
148845760|NCT01890265|536912436|FG000|Overall Study|Progressive disease|6|||
148845761|NCT01890265|536912437|FG001|Overall Study|Progressive disease|6|||
148845762|NCT01890265|536912438|FG002|Overall Study|Progressive disease|0|||
148845763|NCT01890265|536912439|FG003|Overall Study|Progressive disease|0|||
148845764|NCT01890265|536912440|FG004|Overall Study|Progressive disease|0|||
148845765|NCT01890265|536912441|FG005|Overall Study|Progressive disease|0|||
148845766|NCT01890265|536912436|FG000|Overall Study|Adverse Event|2|||
148845767|NCT01890265|536912437|FG001|Overall Study|Adverse Event|1|||
148845768|NCT01890265|536912438|FG002|Overall Study|Adverse Event|0|||
148845769|NCT01890265|536912439|FG003|Overall Study|Adverse Event|0|||
148845770|NCT01890265|536912440|FG004|Overall Study|Adverse Event|0|||
148845771|NCT01890265|536912441|FG005|Overall Study|Adverse Event|0|||
148845772|NCT01890265|536912436|FG000|Overall Study|Death|2|||
148845773|NCT01890265|536912437|FG001|Overall Study|Death|3|||
148845774|NCT01890265|536912438|FG002|Overall Study|Death|1|||
148845775|NCT01890265|536912439|FG003|Overall Study|Death|0|||
148845776|NCT01890265|536912440|FG004|Overall Study|Death|0|||
148845777|NCT01890265|536912441|FG005|Overall Study|Death|0|||
148845778|NCT01890265|536912436|FG000|Overall Study|Withdrawal by Subject|0|||
148845779|NCT01890265|536912437|FG001|Overall Study|Withdrawal by Subject|2|||
148845780|NCT01890265|536912438|FG002|Overall Study|Withdrawal by Subject|3|||
148845781|NCT01890265|536912439|FG003|Overall Study|Withdrawal by Subject|0|||
148845782|NCT01890265|536912440|FG004|Overall Study|Withdrawal by Subject|2|||
148845783|NCT01890265|536912441|FG005|Overall Study|Withdrawal by Subject|0|||
148845784|NCT04585269|536912444|FG000|Intervention|Withdrawal by Subject|9|||
148845785|NCT04585269|536912445|FG001|Intervention|Withdrawal by Subject|0|||
148845786|NCT04585269|536912444|FG000|Intervention|Unable to schedule|15|||
148845787|NCT04585269|536912445|FG001|Intervention|Unable to schedule|0|||
148845788|NCT04585269|536912444|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
148845789|NCT04585269|536912445|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
148845790|NCT04585269|536912444|FG000|FU Time 2 (3 months)|Death|2|||
148845791|NCT04585269|536912445|FG001|FU Time 2 (3 months)|Death|2|||
148984277|NCT04382612|537419407|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
148984278|NCT04666441|537419408|FG000|Overall Study|Lost to Follow-up|1|||
148845792|NCT04585269|536912444|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
148845793|NCT04585269|536912445|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
148845794|NCT04585269|536912444|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
148845795|NCT04585269|536912445|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
148845796|NCT04585269|536912444|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
148984279|NCT04666441|537419409|FG001|Overall Study|Lost to Follow-up|4|||
148845797|NCT04585269|536912445|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
148845798|NCT04585269|536912444|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
148845799|NCT04585269|536912445|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
148845800|NCT04585269|536912444|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
148845801|NCT04585269|536912445|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
148845802|NCT05526521|536912449|FG000|Overall Study|Withdrawal by Subject|0|||
148845803|NCT05526521|536912450|FG001|Overall Study|Withdrawal by Subject|1|||
148845804|NCT05526521|536912451|FG002|Overall Study|Withdrawal by Subject|0|||
148845805|NCT05526521|536912452|FG003|Overall Study|Withdrawal by Subject|0|||
148845806|NCT03919929|536912453|FG000|Overall Study|Withdrawal by Subject|0|||
148845807|NCT03919929|536912454|FG001|Overall Study|Withdrawal by Subject|4|||
148845808|NCT03919929|536912453|FG000|Overall Study|Screen Failure|0|||
148845809|NCT03919929|536912454|FG001|Overall Study|Screen Failure|5|||
148845810|NCT00325130|536912458|FG000|Overall Study|Lost to Follow-up|6|||
148845811|NCT00325130|536912459|FG001|Overall Study|Lost to Follow-up|14|||
148845812|NCT00325130|536912458|FG000|Overall Study|Withdrawal by Subject|12|||
148845813|NCT00325130|536912459|FG001|Overall Study|Withdrawal by Subject|14|||
148845814|NCT00325130|536912458|FG000|Overall Study|Protocol Deviation|0|||
148845815|NCT00325130|536912459|FG001|Overall Study|Protocol Deviation|1|||
148845816|NCT00325130|536912458|FG000|Overall Study|Moved|0|||
148845817|NCT00325130|536912459|FG001|Overall Study|Moved|1|||
148845818|NCT00325130|536912458|FG000|Overall Study|Patient Discontinued for Other|1|||
148845819|NCT00325130|536912459|FG001|Overall Study|Patient Discontinued for Other|0|||
148845820|NCT01671956|536912462|FG000|Overall Study|Disease progression|0|||
148845821|NCT01671956|536912463|FG001|Overall Study|Disease progression|1|||
148845822|NCT01671956|536912462|FG000|Overall Study|Withdrawal by Subject|1|||
148845823|NCT01671956|536912463|FG001|Overall Study|Withdrawal by Subject|1|||
148845824|NCT01671956|536912462|FG000|Overall Study|Adverse Event|1|||
148845825|NCT01671956|536912463|FG001|Overall Study|Adverse Event|0|||
148845826|NCT00928187|536912465|FG000|Overall Study|Death|1|||
148845827|NCT00928187|536912466|FG001|Overall Study|Death|2|||
148845828|NCT00928187|536912467|FG002|Overall Study|Death|3|||
148845829|NCT00928187|536912465|FG000|Overall Study|Lost to Follow-up|1|||
148845830|NCT00928187|536912466|FG001|Overall Study|Lost to Follow-up|2|||
148845831|NCT00928187|536912467|FG002|Overall Study|Lost to Follow-up|1|||
148845832|NCT00928187|536912465|FG000|Overall Study|Withdrawal by Subject|0|||
148845833|NCT00928187|536912466|FG001|Overall Study|Withdrawal by Subject|1|||
148845834|NCT00928187|536912467|FG002|Overall Study|Withdrawal by Subject|1|||
148845835|NCT00928187|536912465|FG000|Overall Study|Protocol Violation|0|||
148845836|NCT00928187|536912466|FG001|Overall Study|Protocol Violation|1|||
148845837|NCT00928187|536912467|FG002|Overall Study|Protocol Violation|0|||
148845838|NCT02524145|536912471|FG000|Overall Study|Withdrawal by Subject|2|||
148845839|NCT02524145|536912472|FG001|Overall Study|Withdrawal by Subject|2|||
148845840|NCT02524145|536912473|FG002|Overall Study|Withdrawal by Subject|3|||
148845841|NCT05730725|536913773|FG000|Overall Study|Withdrawal by Subject|3|||
148845842|NCT05730725|536913774|FG001|Overall Study|Withdrawal by Subject|0|||
148845843|NCT05730725|536913775|FG002|Overall Study|Withdrawal by Subject|0|||
148845844|NCT05730725|536913776|FG003|Overall Study|Withdrawal by Subject|1|||
148845845|NCT05730725|536913773|FG000|Overall Study|Not Reported|1|||
148845846|NCT05730725|536913774|FG001|Overall Study|Not Reported|1|||
148845847|NCT05730725|536913775|FG002|Overall Study|Not Reported|1|||
148845848|NCT05730725|536913776|FG003|Overall Study|Not Reported|1|||
148845849|NCT05265728|536913777|FG000|Overall Study|Adverse Event|1|||
148845850|NCT05265728|536913777|FG000|Overall Study|Study Terminated by Sponsor|5|||
148984280|NCT04666441|537419410|FG002|Overall Study|Lost to Follow-up|1|||
148984281|NCT04666441|537419411|FG003|Overall Study|Lost to Follow-up|3|||
148845851|NCT05265728|536913777|FG000|Overall Study|Withdrawal by Subject|2|||
148845852|NCT01566149|536913778|FG000|Overall Study|Adverse Event|0|||
148845853|NCT01566149|536913779|FG001|Overall Study|Adverse Event|1|||
148845854|NCT01566149|536913778|FG000|Overall Study|Non-compliance with study medication|2|||
148845855|NCT01566149|536913779|FG001|Overall Study|Non-compliance with study medication|0|||
148845856|NCT01566149|536913778|FG000|Overall Study|Protocol Violation|0|||
148845857|NCT01566149|536913779|FG001|Overall Study|Protocol Violation|1|||
148845858|NCT01566149|536913778|FG000|Overall Study|Withdrawal by Subject|1|||
148845859|NCT01566149|536913779|FG001|Overall Study|Withdrawal by Subject|0|||
148845860|NCT03687957|536913787|FG000|Overall Study|Withdrawal by Subject|0|||
148845861|NCT03687957|536913788|FG001|Overall Study|Withdrawal by Subject|0|||
148845862|NCT03687957|536913789|FG002|Overall Study|Withdrawal by Subject|0|||
148845863|NCT03687957|536913790|FG003|Overall Study|Withdrawal by Subject|2|||
148845864|NCT03687957|536913791|FG004|Overall Study|Withdrawal by Subject|0|||
148845865|NCT03687957|536913792|FG005|Overall Study|Withdrawal by Subject|0|||
148984282|NCT04666441|537419412|FG004|Overall Study|Lost to Follow-up|0|||
148984283|NCT04666441|537419413|FG005|Overall Study|Lost to Follow-up|2|||
148845866|NCT03687957|536913793|FG006|Overall Study|Withdrawal by Subject|3|||
148845867|NCT03687957|536913794|FG007|Overall Study|Withdrawal by Subject|1|||
148845868|NCT03687957|536913795|FG008|Overall Study|Withdrawal by Subject|1|||
148845869|NCT03687957|536913796|FG009|Overall Study|Withdrawal by Subject|0|||
148845870|NCT03687957|536913787|FG000|Overall Study|Disease progression|0|||
148845871|NCT03687957|536913788|FG001|Overall Study|Disease progression|1|||
148984284|NCT04666441|537419414|FG006|Overall Study|Lost to Follow-up|2|||
148845872|NCT03687957|536913789|FG002|Overall Study|Disease progression|1|||
148845873|NCT03687957|536913790|FG003|Overall Study|Disease progression|2|||
148845874|NCT03687957|536913791|FG004|Overall Study|Disease progression|2|||
148984285|NCT04666441|537419415|FG007|Overall Study|Lost to Follow-up|2|||
148984286|NCT04666441|537419408|FG000|Overall Study|Subject Decision|1|||
148984287|NCT04666441|537419409|FG001|Overall Study|Subject Decision|1|||
148845875|NCT03687957|536913792|FG005|Overall Study|Disease progression|0|||
148845876|NCT03687957|536913793|FG006|Overall Study|Disease progression|2|||
148845877|NCT03687957|536913794|FG007|Overall Study|Disease progression|1|||
148845878|NCT03687957|536913795|FG008|Overall Study|Disease progression|0|||
148845879|NCT03687957|536913796|FG009|Overall Study|Disease progression|0|||
148845880|NCT03687957|536913787|FG000|Overall Study|Physician Decision|0|||
148845881|NCT03687957|536913788|FG001|Overall Study|Physician Decision|0|||
148845882|NCT03687957|536913789|FG002|Overall Study|Physician Decision|0|||
148845883|NCT03687957|536913790|FG003|Overall Study|Physician Decision|2|||
148845884|NCT03687957|536913791|FG004|Overall Study|Physician Decision|1|||
148845885|NCT03687957|536913792|FG005|Overall Study|Physician Decision|0|||
148845886|NCT03687957|536913793|FG006|Overall Study|Physician Decision|1|||
148845887|NCT03687957|536913794|FG007|Overall Study|Physician Decision|0|||
148845888|NCT03687957|536913795|FG008|Overall Study|Physician Decision|0|||
148845889|NCT03687957|536913796|FG009|Overall Study|Physician Decision|0|||
148845890|NCT03687957|536913787|FG000|Overall Study|New malignancy|0|||
148845891|NCT03687957|536913788|FG001|Overall Study|New malignancy|0|||
148845892|NCT03687957|536913789|FG002|Overall Study|New malignancy|0|||
148845893|NCT03687957|536913790|FG003|Overall Study|New malignancy|0|||
148845894|NCT03687957|536913791|FG004|Overall Study|New malignancy|1|||
148845895|NCT03687957|536913792|FG005|Overall Study|New malignancy|0|||
148845896|NCT03687957|536913793|FG006|Overall Study|New malignancy|0|||
148845897|NCT03687957|536913794|FG007|Overall Study|New malignancy|0|||
148845898|NCT03687957|536913795|FG008|Overall Study|New malignancy|0|||
148845899|NCT03687957|536913796|FG009|Overall Study|New malignancy|0|||
148845900|NCT03687957|536913787|FG000|Overall Study|Adverse Event|0|||
148845901|NCT03687957|536913788|FG001|Overall Study|Adverse Event|0|||
148845902|NCT03687957|536913789|FG002|Overall Study|Adverse Event|0|||
148845903|NCT03687957|536913790|FG003|Overall Study|Adverse Event|0|||
148845904|NCT03687957|536913791|FG004|Overall Study|Adverse Event|0|||
148845905|NCT03687957|536913792|FG005|Overall Study|Adverse Event|2|||
148845906|NCT03687957|536913793|FG006|Overall Study|Adverse Event|0|||
148845907|NCT03687957|536913794|FG007|Overall Study|Adverse Event|3|||
148845908|NCT03687957|536913795|FG008|Overall Study|Adverse Event|0|||
148845909|NCT03687957|536913796|FG009|Overall Study|Adverse Event|0|||
148845910|NCT03687957|536913787|FG000|Overall Study|Patient went on hospice|0|||
148845911|NCT03687957|536913788|FG001|Overall Study|Patient went on hospice|0|||
148845912|NCT03687957|536913789|FG002|Overall Study|Patient went on hospice|0|||
148845913|NCT03687957|536913790|FG003|Overall Study|Patient went on hospice|0|||
148845914|NCT03687957|536913791|FG004|Overall Study|Patient went on hospice|0|||
148845915|NCT03687957|536913792|FG005|Overall Study|Patient went on hospice|0|||
148845916|NCT03687957|536913793|FG006|Overall Study|Patient went on hospice|1|||
148845917|NCT03687957|536913794|FG007|Overall Study|Patient went on hospice|0|||
148845918|NCT03687957|536913795|FG008|Overall Study|Patient went on hospice|0|||
148845919|NCT03687957|536913796|FG009|Overall Study|Patient went on hospice|0|||
148845920|NCT03687957|536913787|FG000|Overall Study|Death|0|||
148845921|NCT03687957|536913788|FG001|Overall Study|Death|0|||
148845922|NCT03687957|536913789|FG002|Overall Study|Death|0|||
148845923|NCT03687957|536913790|FG003|Overall Study|Death|0|||
148845924|NCT03687957|536913791|FG004|Overall Study|Death|0|||
148845925|NCT03687957|536913792|FG005|Overall Study|Death|0|||
148845926|NCT03687957|536913793|FG006|Overall Study|Death|0|||
148845927|NCT03687957|536913794|FG007|Overall Study|Death|1|||
148845928|NCT03687957|536913795|FG008|Overall Study|Death|0|||
148845929|NCT03687957|536913796|FG009|Overall Study|Death|0|||
148845930|NCT01693250|536913805|FG000|Overall Study|Lost to Follow-up|2|||
148845931|NCT01693250|536913806|FG001|Overall Study|Lost to Follow-up|2|||
148845932|NCT02297815|536913814|FG000|Overall Study|Lost to Follow-up|236|||
148845933|NCT02297815|536913815|FG001|Overall Study|Lost to Follow-up|140|||
148845934|NCT00620373|536913820|FG000|Overall Study|Unverified cancer status|33|||
148845935|NCT01897727|536913821|FG000|Overall Study|Exclusion: central sleep apnea|0|||
148845936|NCT01897727|536913822|FG001|Overall Study|Exclusion: central sleep apnea|1|||
148845937|NCT01061723|536913823|FG000|Overall Study|Adverse Event|0|||
148845938|NCT01061723|536913824|FG001|Overall Study|Adverse Event|2|||
148845939|NCT01061723|536913825|FG002|Overall Study|Adverse Event|5|||
148845940|NCT01061723|536913826|FG003|Overall Study|Adverse Event|5|||
148845941|NCT01061723|536913827|FG004|Overall Study|Adverse Event|2|||
148845942|NCT01061723|536913828|FG005|Overall Study|Adverse Event|6|||
148845943|NCT01061723|536913823|FG000|Overall Study|Lack of Efficacy|2|||
148984288|NCT04666441|537419410|FG002|Overall Study|Subject Decision|3|||
148845944|NCT01061723|536913824|FG001|Overall Study|Lack of Efficacy|3|||
148845945|NCT01061723|536913825|FG002|Overall Study|Lack of Efficacy|4|||
148845946|NCT01061723|536913826|FG003|Overall Study|Lack of Efficacy|2|||
148845947|NCT01061723|536913827|FG004|Overall Study|Lack of Efficacy|1|||
148845948|NCT01061723|536913828|FG005|Overall Study|Lack of Efficacy|1|||
148845949|NCT01061723|536913823|FG000|Overall Study|Randomized but not treated|0|||
148845950|NCT01061723|536913824|FG001|Overall Study|Randomized but not treated|0|||
148984289|NCT04666441|537419411|FG003|Overall Study|Subject Decision|1|||
148845951|NCT01061723|536913825|FG002|Overall Study|Randomized but not treated|0|||
148845952|NCT01061723|536913826|FG003|Overall Study|Randomized but not treated|0|||
148845953|NCT01061723|536913827|FG004|Overall Study|Randomized but not treated|0|||
148845954|NCT01061723|536913828|FG005|Overall Study|Randomized but not treated|1|||
148845955|NCT01061723|536913823|FG000|Overall Study|Other than specified above|2|||
148845956|NCT01061723|536913824|FG001|Overall Study|Other than specified above|1|||
148845957|NCT01061723|536913825|FG002|Overall Study|Other than specified above|1|||
148845958|NCT01061723|536913826|FG003|Overall Study|Other than specified above|1|||
148845959|NCT01061723|536913827|FG004|Overall Study|Other than specified above|0|||
148845960|NCT01061723|536913828|FG005|Overall Study|Other than specified above|1|||
148845961|NCT00293813|536913829|FG000|Overall Study|Physician Decision|0|||
148845962|NCT00293813|536913830|FG001|Overall Study|Physician Decision|1|||
148845963|NCT00293813|536913831|FG002|Overall Study|Physician Decision|0|||
148845964|NCT00293813|536913829|FG000|Overall Study|Adverse Event|3|||
148845965|NCT00293813|536913830|FG001|Overall Study|Adverse Event|1|||
148845966|NCT00293813|536913831|FG002|Overall Study|Adverse Event|1|||
148845967|NCT00293813|536913829|FG000|Overall Study|Withdrawal by Subject|7|||
148845968|NCT00293813|536913830|FG001|Overall Study|Withdrawal by Subject|4|||
148845969|NCT00293813|536913831|FG002|Overall Study|Withdrawal by Subject|4|||
148845970|NCT00293813|536913829|FG000|Overall Study|Lost to Follow-up|3|||
148845971|NCT00293813|536913830|FG001|Overall Study|Lost to Follow-up|2|||
148845972|NCT00293813|536913831|FG002|Overall Study|Lost to Follow-up|3|||
148845973|NCT00293813|536913829|FG000|Overall Study|Noncompliance|0|||
148845974|NCT00293813|536913830|FG001|Overall Study|Noncompliance|1|||
148845975|NCT00293813|536913831|FG002|Overall Study|Noncompliance|0|||
148845976|NCT00460655|536913836|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
148845977|NCT00460655|536913837|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
148845978|NCT00460655|536913838|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
148845979|NCT00460655|536913839|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
148845980|NCT00460655|536913836|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
148845981|NCT00460655|536913837|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
148845982|NCT00460655|536913838|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
148845983|NCT00460655|536913839|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
148845984|NCT00460655|536913836|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
148845985|NCT00460655|536913837|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
148845986|NCT00460655|536913838|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
148845987|NCT00460655|536913839|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
148845988|NCT00460655|536913836|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
148845989|NCT00460655|536913837|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
148845990|NCT00460655|536913838|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
148845991|NCT00460655|536913839|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
148845992|NCT00460655|536913836|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
148845993|NCT00460655|536913837|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
148845994|NCT00460655|536913838|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
148845995|NCT00460655|536913839|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
148984290|NCT04666441|537419412|FG004|Overall Study|Subject Decision|0|||
148984291|NCT04666441|537419413|FG005|Overall Study|Subject Decision|1|||
148984292|NCT04666441|537419414|FG006|Overall Study|Subject Decision|3|||
148984293|NCT04666441|537419415|FG007|Overall Study|Subject Decision|2|||
148984294|NCT01328002|537419417|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
148984295|NCT01328002|537419418|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
148984296|NCT01328002|537419417|FG000|Open-Label Period|Adverse Event|8|||
148845996|NCT00460655|536913836|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
148845997|NCT00460655|536913837|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
148845998|NCT00460655|536913838|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
148845999|NCT00460655|536913839|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
148846000|NCT03650413|536913840|FG000|Overall Study|Adverse Event|1|||
148846001|NCT03650413|536913840|FG000|Overall Study|Lack of Efficacy|17|||
148846002|NCT03650413|536913840|FG000|Overall Study|Other|9|||
148846003|NCT03650413|536913840|FG000|Overall Study|Physician Decision|2|||
148846004|NCT03650413|536913840|FG000|Overall Study|Study Terminated By Sponsor|16|||
148846005|NCT03650413|536913840|FG000|Overall Study|Withdrawal by Subject|16|||
148846006|NCT00910910|536913841|FG000|Overall Study|Adverse Event|63|||
148846007|NCT00910910|536913842|FG001|Overall Study|Adverse Event|35|||
148846008|NCT00910910|536913841|FG000|Overall Study|PD without histologic change|27|||
148846009|NCT00910910|536913842|FG001|Overall Study|PD without histologic change|23|||
148846010|NCT00910910|536913841|FG000|Overall Study|PD with histologic change|0|||
148846011|NCT00910910|536913842|FG001|Overall Study|PD with histologic change|2|||
148846012|NCT00910910|536913841|FG000|Overall Study|Withdrawal by Subject|7|||
148846013|NCT00910910|536913842|FG001|Overall Study|Withdrawal by Subject|5|||
148846014|NCT00910910|536913841|FG000|Overall Study|Lost to Follow-up|2|||
148984297|NCT01328002|537419418|FG001|Open-Label Period|Adverse Event|0|||
148846015|NCT00910910|536913842|FG001|Overall Study|Lost to Follow-up|2|||
148846016|NCT00910910|536913841|FG000|Overall Study|Death|9|||
148846017|NCT00910910|536913842|FG001|Overall Study|Death|3|||
148846018|NCT00910910|536913841|FG000|Overall Study|Protocol Violation|2|||
148846019|NCT00910910|536913842|FG001|Overall Study|Protocol Violation|2|||
148846020|NCT00910910|536913841|FG000|Overall Study|Completed 13 cycles of treatment|0|||
148846021|NCT00910910|536913842|FG001|Overall Study|Completed 13 cycles of treatment|118|||
148846022|NCT00910910|536913841|FG000|Overall Study|Other|114|||
148846023|NCT00910910|536913842|FG001|Overall Study|Other|32|||
148846024|NCT00910910|536913841|FG000|Overall Study|Untreated before cycle 1|1|||
148846025|NCT00910910|536913842|FG001|Overall Study|Untreated before cycle 1|2|||
148846026|NCT01973231|536913843|FG000|Overall Study|Protocol Violation|1|||
148846027|NCT01973231|536913844|FG001|Overall Study|Protocol Violation|1|||
148846028|NCT01973231|536913843|FG000|Overall Study|Lost to Follow-up|1|||
148846029|NCT01973231|536913844|FG001|Overall Study|Lost to Follow-up|1|||
148846030|NCT01973231|536913843|FG000|Overall Study|unclassified|2|||
148846031|NCT01973231|536913844|FG001|Overall Study|unclassified|1|||
148846032|NCT01973231|536913843|FG000|Overall Study|Withdrawal by Subject|7|||
148846033|NCT01973231|536913844|FG001|Overall Study|Withdrawal by Subject|9|||
148846034|NCT05338710|536913846|FG000|Overall Study|Withdrawal by Subject|3|||
148846035|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
148846036|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
148846037|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846038|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846039|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846040|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846041|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846042|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846043|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846044|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
148846045|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
148846046|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
148846047|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846048|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846049|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846050|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846051|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846052|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846053|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846054|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
148846055|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
148846056|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846057|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846058|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846059|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846060|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846061|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846062|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846063|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846064|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
148846065|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
148846066|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
148846067|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846068|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846069|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846070|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846071|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846072|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846073|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846074|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
148846075|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846076|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
148846077|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846078|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846079|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846080|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148984298|NCT01328002|537419417|FG000|Open-Label Period|Lack of Efficacy|3|||
148984299|NCT01328002|537419418|FG001|Open-Label Period|Lack of Efficacy|0|||
148846081|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846082|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846083|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148984300|NCT01328002|537419417|FG000|Open-Label Period|Protocol Violation|2|||
149029972|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
149029973|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
149029974|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
149029975|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
149029976|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
149029977|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
149029978|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
149029979|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
149029980|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
149029981|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
148846084|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
148846085|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
148846086|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
148846087|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846088|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846089|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846090|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846091|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846092|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846093|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846094|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
148846095|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
148846096|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
148984301|NCT01328002|537419418|FG001|Open-Label Period|Protocol Violation|0|||
148984302|NCT01328002|537419417|FG000|Open-Label Period|Withdrawal by Subject|9|||
148984303|NCT01328002|537419418|FG001|Open-Label Period|Withdrawal by Subject|0|||
148984304|NCT01328002|537419417|FG000|Open-Label Period|Lost to Follow-up|6|||
148984305|NCT01328002|537419418|FG001|Open-Label Period|Lost to Follow-up|0|||
148984306|NCT01328002|537419417|FG000|Open-Label Period|Other Reason|2|||
148984307|NCT01328002|537419418|FG001|Open-Label Period|Other Reason|0|||
148984308|NCT01328002|537419417|FG000|Double-Blind Period|Adverse Event|1|||
148984309|NCT01328002|537419418|FG001|Double-Blind Period|Adverse Event|0|||
148984310|NCT01328002|537419417|FG000|Double-Blind Period|Lack of Efficacy|1|||
148984311|NCT01328002|537419418|FG001|Double-Blind Period|Lack of Efficacy|0|||
148984312|NCT03149328|537419419|FG000|Overall Study|Withdrawal by Subject|30|||
148984313|NCT03149328|537419420|FG001|Overall Study|Withdrawal by Subject|26|||
148984314|NCT03149328|537419419|FG000|Overall Study|Changed Dialysis Modality|18|||
148984315|NCT03149328|537419420|FG001|Overall Study|Changed Dialysis Modality|1|||
148984316|NCT03149328|537419419|FG000|Overall Study|Transplant|9|||
148984317|NCT03149328|537419420|FG001|Overall Study|Transplant|1|||
148984318|NCT03149328|537419419|FG000|Overall Study|Lost to Follow-up|25|||
148984319|NCT03149328|537419420|FG001|Overall Study|Lost to Follow-up|16|||
148984320|NCT03149328|537419419|FG000|Overall Study|Left Study Site|1|||
148984321|NCT03149328|537419420|FG001|Overall Study|Left Study Site|2|||
148984322|NCT03149328|537419419|FG000|Overall Study|Language Barrier|1|||
148984323|NCT03149328|537419420|FG001|Overall Study|Language Barrier|0|||
148984324|NCT01306617|537419424|FG000|Overall Study|Adverse Event|1|||
148984325|NCT01306617|537419425|FG001|Overall Study|Adverse Event|0|||
148984326|NCT01306617|537419426|FG002|Overall Study|Adverse Event|0|||
148984327|NCT01306617|537419424|FG000|Overall Study|Virologic Failure|0|||
148984328|NCT01306617|537419425|FG001|Overall Study|Virologic Failure|0|||
148984329|NCT01306617|537419426|FG002|Overall Study|Virologic Failure|5|||
148984330|NCT01306617|537419424|FG000|Overall Study|Non-compliance|0|||
148984331|NCT01306617|537419425|FG001|Overall Study|Non-compliance|1|||
148984332|NCT01306617|537419426|FG002|Overall Study|Non-compliance|0|||
148984333|NCT01578551|537419427|FG000|Overall Study|Adverse Event|1|||
148984334|NCT01578551|537419428|FG001|Overall Study|Adverse Event|0|||
148984335|NCT04028388|537419436|FG000|Overall Study|Evaluations missing|3|||
148984336|NCT04028388|537419437|FG001|Overall Study|Evaluations missing|6|||
148984337|NCT04028388|537419436|FG000|Overall Study|Not started|2|||
148984338|NCT04028388|537419437|FG001|Overall Study|Not started|0|||
148984339|NCT01312467|537419446|FG000|Overall Study|Adverse Event|4|||
148984340|NCT01312467|537419446|FG000|Overall Study|Lost to Follow-up|1|||
148984341|NCT01312467|537419446|FG000|Overall Study|Withdrawal by Subject|2|||
148984342|NCT01312467|537419446|FG000|Overall Study|Deported to country of origin|1|||
148984343|NCT01312467|537419446|FG000|Overall Study|Another medical condition|1|||
148984344|NCT01312467|537419446|FG000|Overall Study|Ineligible|4|||
148984345|NCT02752048|537419447|FG000|Overall Study|Withdrawal by Subject|0|||
149029982|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
148984346|NCT02752048|537419448|FG001|Overall Study|Withdrawal by Subject|0|||
148984347|NCT02752048|537419449|FG002|Overall Study|Withdrawal by Subject|3|||
148984348|NCT01431508|537419450|FG000|Overall Study|Lack of Efficacy|1|||
148984349|NCT01431508|537419450|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
148984350|NCT00132769|537419451|FG000|Overall Study|Withdrawal by Subject|1|||
148984351|NCT00132769|537419452|FG001|Overall Study|Withdrawal by Subject|3|||
148984352|NCT00132769|537419451|FG000|Overall Study|Lack of Efficacy|7|||
148984353|NCT00132769|537419452|FG001|Overall Study|Lack of Efficacy|6|||
148984354|NCT00132769|537419451|FG000|Overall Study|Adverse Event|2|||
148984355|NCT00132769|537419452|FG001|Overall Study|Adverse Event|1|||
148984356|NCT00132769|537419451|FG000|Overall Study|Protocol Violation|1|||
148984357|NCT00132769|537419452|FG001|Overall Study|Protocol Violation|1|||
148984358|NCT00129259|537419453|FG000|Overall Study|Lost to Follow-up|1|||
148984359|NCT00129259|537419454|FG001|Overall Study|Lost to Follow-up|1|||
148984360|NCT00129259|537419453|FG000|Overall Study|Withdrawal by Subject|2|||
148984361|NCT00129259|537419454|FG001|Overall Study|Withdrawal by Subject|1|||
148984362|NCT00129259|537419453|FG000|Overall Study|Only available minimal phone assessments|0|||
148984363|NCT00129259|537419454|FG001|Overall Study|Only available minimal phone assessments|1|||
148984364|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984365|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984366|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984367|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984368|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
148776390|NCT05685732|536655192|FG001|Overall Study|Withdrawal by Subject|0|||
148776391|NCT05685732|536655193|FG002|Overall Study|Withdrawal by Subject|2|||
148776392|NCT05685732|536655194|FG003|Overall Study|Withdrawal by Subject|3|||
148776393|NCT05685732|536655191|FG000|Overall Study|Protocol Violation|1|||
148776394|NCT05685732|536655192|FG001|Overall Study|Protocol Violation|2|||
148776395|NCT05685732|536655193|FG002|Overall Study|Protocol Violation|4|||
148776396|NCT05685732|536655194|FG003|Overall Study|Protocol Violation|1|||
148776397|NCT05685732|536655191|FG000|Overall Study|Lost to Follow-up|5|||
148776398|NCT05685732|536655192|FG001|Overall Study|Lost to Follow-up|1|||
148776399|NCT05685732|536655193|FG002|Overall Study|Lost to Follow-up|3|||
148776400|NCT05685732|536655194|FG003|Overall Study|Lost to Follow-up|1|||
148776401|NCT05685732|536655191|FG000|Overall Study|Adverse Event|2|||
148776402|NCT05685732|536655192|FG001|Overall Study|Adverse Event|1|||
148776403|NCT05685732|536655193|FG002|Overall Study|Adverse Event|0|||
148776404|NCT05685732|536655194|FG003|Overall Study|Adverse Event|0|||
148776405|NCT05685732|536655191|FG000|Overall Study|Physician Decision|1|||
148776406|NCT05685732|536655192|FG001|Overall Study|Physician Decision|0|||
148776407|NCT05685732|536655193|FG002|Overall Study|Physician Decision|0|||
148776408|NCT05685732|536655194|FG003|Overall Study|Physician Decision|0|||
148776409|NCT02640404|536655195|FG000|Overall Study|Protocol Violation|1|||
148776410|NCT02640404|536655196|FG001|Overall Study|Protocol Violation|0|||
148776411|NCT02640404|536655195|FG000|Overall Study|Withdrawal by Subject|1|||
148776412|NCT02640404|536655196|FG001|Overall Study|Withdrawal by Subject|0|||
148776413|NCT04908202|536655198|FG000|Pre-Treatment Period|OTHER REASONS|3|||
148776414|NCT04908202|536655199|FG001|Pre-Treatment Period|OTHER REASONS|1|||
148776415|NCT04908202|536655200|FG002|Pre-Treatment Period|OTHER REASONS|0|||
148776416|NCT04908202|536655201|FG003|Pre-Treatment Period|OTHER REASONS|0|||
148776417|NCT04908202|536655198|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
148776418|NCT04908202|536655199|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776419|NCT04908202|536655200|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776420|NCT04908202|536655201|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776421|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
148776422|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
148776423|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
148776424|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
148776425|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
148776426|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
148776427|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
148776428|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
148776429|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
148776430|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
148776431|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
148776432|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
148776433|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
148776434|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
148776435|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776436|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776437|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
148776438|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
148776439|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
148776440|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
148776441|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
148776442|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
148846097|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846098|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846099|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846100|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846101|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846102|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846103|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846104|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
148846105|NCT01194219|536913847|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
148846106|NCT01194219|536913848|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
148846107|NCT01194219|536913849|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846108|NCT01194219|536913850|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846109|NCT01194219|536913851|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846110|NCT01194219|536913852|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846111|NCT01194219|536913853|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846112|NCT01194219|536913854|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846113|NCT01194219|536913855|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846114|NCT01194219|536913856|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
148846115|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846116|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846117|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
148846118|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
148846119|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846120|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846121|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846122|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846123|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846124|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
148846125|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846126|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846127|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
148846128|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
148846129|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846130|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846131|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846132|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846133|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846134|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
148846135|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846136|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846137|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
148846138|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
148846139|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846140|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846141|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846142|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846143|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846144|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
148846145|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846146|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846147|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
148846148|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
148846149|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846150|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846151|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846152|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846153|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846154|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
148846155|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846156|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846157|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
148846158|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846159|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846160|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846161|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846162|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846163|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148984369|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984370|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984371|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
148984372|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
148984373|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984374|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
148984375|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
148984376|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984377|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984378|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148776443|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
148776444|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
148776445|NCT04908202|536655198|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
148776446|NCT04908202|536655199|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
148776447|NCT04908202|536655200|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
148776448|NCT04908202|536655201|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
148776449|NCT04908202|536655198|FG000|Active Treatment Period|OTHER REASONS|0|||
148776450|NCT04908202|536655199|FG001|Active Treatment Period|OTHER REASONS|0|||
148776451|NCT04908202|536655200|FG002|Active Treatment Period|OTHER REASONS|1|||
148776452|NCT04908202|536655201|FG003|Active Treatment Period|OTHER REASONS|3|||
148776453|NCT04908202|536655198|FG000|Active Treatment Period|Lack of Efficacy|0|||
148776454|NCT04908202|536655199|FG001|Active Treatment Period|Lack of Efficacy|0|||
148776455|NCT04908202|536655200|FG002|Active Treatment Period|Lack of Efficacy|4|||
148776456|NCT04908202|536655201|FG003|Active Treatment Period|Lack of Efficacy|5|||
148776457|NCT04908202|536655198|FG000|Active Treatment Period|Adverse Event|0|||
148776458|NCT04908202|536655199|FG001|Active Treatment Period|Adverse Event|0|||
148776459|NCT04908202|536655200|FG002|Active Treatment Period|Adverse Event|5|||
148776460|NCT04908202|536655201|FG003|Active Treatment Period|Adverse Event|8|||
148776461|NCT04908202|536655198|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
148776462|NCT04908202|536655199|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
148776463|NCT04908202|536655200|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
148776464|NCT04908202|536655201|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
148776465|NCT04908202|536655198|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776466|NCT04908202|536655199|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
148776467|NCT04908202|536655200|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
148776468|NCT04908202|536655201|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
148776469|NCT04908202|536655198|FG000|Active Treatment Period|Lost to Follow-up|0|||
148776470|NCT04908202|536655199|FG001|Active Treatment Period|Lost to Follow-up|0|||
148776471|NCT04908202|536655200|FG002|Active Treatment Period|Lost to Follow-up|2|||
148776472|NCT04908202|536655201|FG003|Active Treatment Period|Lost to Follow-up|2|||
148776473|NCT04908202|536655198|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
148776474|NCT04908202|536655199|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
148776475|NCT04908202|536655200|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
148776476|NCT04908202|536655201|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
148776477|NCT04908202|536655198|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
148776478|NCT04908202|536655199|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
148776479|NCT04908202|536655200|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
148776480|NCT04908202|536655201|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
148776481|NCT04908202|536655198|FG000|Active Treatment Period|ONGOING Treatment|0|||
148776482|NCT04908202|536655199|FG001|Active Treatment Period|ONGOING Treatment|0|||
148776483|NCT04908202|536655200|FG002|Active Treatment Period|ONGOING Treatment|117|||
148776484|NCT04908202|536655201|FG003|Active Treatment Period|ONGOING Treatment|114|||
148776485|NCT05397171|536655202|FG000|Overall Study|Death|2|||
148776486|NCT05397171|536655203|FG001|Overall Study|Death|3|||
148776487|NCT05397171|536655204|FG002|Overall Study|Death|3|||
148776488|NCT05397171|536655202|FG000|Overall Study|Study Terminated By Sponsor|1|||
148776489|NCT05397171|536655203|FG001|Overall Study|Study Terminated By Sponsor|2|||
148776490|NCT05397171|536655204|FG002|Overall Study|Study Terminated By Sponsor|3|||
148776491|NCT05397171|536655202|FG000|Overall Study|Withdrawal by Subject|0|||
148776492|NCT05397171|536655203|FG001|Overall Study|Withdrawal by Subject|1|||
148776493|NCT05397171|536655204|FG002|Overall Study|Withdrawal by Subject|1|||
148776494|NCT02100670|536655205|FG000|Overall Study|Adverse Event|10|||
148776495|NCT02100670|536655206|FG001|Overall Study|Adverse Event|3|||
148776496|NCT02100670|536655207|FG002|Overall Study|Adverse Event|3|||
148776497|NCT02100670|536655208|FG003|Overall Study|Adverse Event|0|||
148776498|NCT02100670|536655205|FG000|Overall Study|Lost to Follow-up|1|||
148776499|NCT02100670|536655206|FG001|Overall Study|Lost to Follow-up|0|||
148776500|NCT02100670|536655207|FG002|Overall Study|Lost to Follow-up|0|||
148776501|NCT02100670|536655208|FG003|Overall Study|Lost to Follow-up|0|||
148776502|NCT02100670|536655205|FG000|Overall Study|Protocol Violation|0|||
148776503|NCT02100670|536655206|FG001|Overall Study|Protocol Violation|1|||
148984379|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
148984380|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
148984381|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
148984382|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
148984383|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
148984384|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
148984385|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
148984386|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
148984387|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
148984388|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
148984389|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
148984390|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
148984391|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
148984392|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
148984393|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
148984394|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
148984395|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
148846164|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
148846165|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846166|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846167|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846168|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
148846169|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846170|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846171|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846172|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846173|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846174|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
148846175|NCT01194219|536913847|FG000|Maintenance Phase Weeks16-32|Other|0|||
148846176|NCT01194219|536913848|FG001|Maintenance Phase Weeks16-32|Other|0|||
148846177|NCT01194219|536913849|FG002|Maintenance Phase Weeks16-32|Other|2|||
148846178|NCT01194219|536913850|FG003|Maintenance Phase Weeks16-32|Other|1|||
148846179|NCT01194219|536913851|FG004|Maintenance Phase Weeks16-32|Other|0|||
148846180|NCT01194219|536913852|FG005|Maintenance Phase Weeks16-32|Other|0|||
148846181|NCT01194219|536913853|FG006|Maintenance Phase Weeks16-32|Other|0|||
148846182|NCT01194219|536913854|FG007|Maintenance Phase Weeks16-32|Other|0|||
148846183|NCT01194219|536913855|FG008|Maintenance Phase Weeks16-32|Other|0|||
148846184|NCT01194219|536913856|FG009|Maintenance Phase Weeks16-32|Other|0|||
148846185|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148846186|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148846187|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148846188|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148846189|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148846190|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
148846191|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
148846192|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
148846193|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148846194|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
148984396|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984397|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984398|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984399|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984400|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984401|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
148984402|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
148984403|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984404|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984405|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
148984406|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
148984407|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
148984408|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984409|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984410|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984411|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
148984412|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984413|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148846195|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
148846196|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
148846197|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
148846198|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
148846199|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
148846200|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
148846201|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
148846202|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
148846203|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
148846204|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
148846205|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846206|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846207|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846208|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846209|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
148846210|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846211|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
148846212|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846213|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846214|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
148846215|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846216|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846217|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846218|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846219|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
148846220|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846221|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
148846222|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
148846223|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846224|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
148846225|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846226|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846227|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846228|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846229|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
148846230|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
148846231|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
148846232|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846233|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846234|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
148846235|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846236|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846237|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846238|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846239|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846240|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846241|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846242|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
148846243|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846244|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
148846245|NCT01194219|536913847|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846246|NCT01194219|536913848|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846247|NCT01194219|536913849|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846248|NCT01194219|536913850|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846249|NCT01194219|536913851|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148984414|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984415|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148776504|NCT02100670|536655207|FG002|Overall Study|Protocol Violation|0|||
148776505|NCT02100670|536655208|FG003|Overall Study|Protocol Violation|1|||
148776506|NCT02100670|536655205|FG000|Overall Study|Withdrawal of Consent|0|||
148776507|NCT02100670|536655206|FG001|Overall Study|Withdrawal of Consent|1|||
148776508|NCT02100670|536655207|FG002|Overall Study|Withdrawal of Consent|1|||
148776509|NCT02100670|536655208|FG003|Overall Study|Withdrawal of Consent|0|||
148776510|NCT02100670|536655205|FG000|Overall Study|No swelling no pain|1|||
148776511|NCT02100670|536655206|FG001|Overall Study|No swelling no pain|0|||
148846250|NCT01194219|536913852|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846251|NCT01194219|536913853|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
148846252|NCT01194219|536913854|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846253|NCT01194219|536913855|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846254|NCT01194219|536913856|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
148846255|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846256|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846257|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
149029983|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
148846258|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846259|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846260|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846261|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846262|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
148846263|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
148846264|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
148846265|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846266|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846267|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846268|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846269|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846270|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846271|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846272|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
148846273|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
148846274|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
148846275|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846276|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846277|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846278|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846279|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846280|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846281|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846282|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
148846283|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
148846284|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
148846285|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846286|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846287|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846288|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846289|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846290|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846291|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846292|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
148846293|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
148846294|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
148846295|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
148846296|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
148846297|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
148846298|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
148846299|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
148846300|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
148846301|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
148846302|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
148846303|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
148846304|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
148846305|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846306|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846307|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846308|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846309|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846310|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846311|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846312|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
148846313|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
148846314|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
148846315|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
149029984|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
148984416|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984417|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
148984418|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984419|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984420|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984421|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984422|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984423|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
148984424|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984425|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984426|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984427|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
148984428|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984429|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148846316|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846317|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846318|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846319|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846320|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846321|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846322|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846323|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
148846324|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
148846325|NCT01194219|536913847|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846326|NCT01194219|536913848|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846327|NCT01194219|536913849|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846328|NCT01194219|536913850|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846329|NCT01194219|536913851|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846330|NCT01194219|536913852|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846331|NCT01194219|536913853|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846332|NCT01194219|536913854|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
148846333|NCT01194219|536913855|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
148846334|NCT01194219|536913856|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
148846335|NCT01081951|536913857|FG000|Overall Study|Death|54|||
148846336|NCT01081951|536913858|FG001|Overall Study|Death|47|||
148846337|NCT01081951|536913857|FG000|Overall Study|Withdrawal by Subject|2|||
148846338|NCT01081951|536913858|FG001|Overall Study|Withdrawal by Subject|6|||
148846339|NCT01081951|536913857|FG000|Overall Study|Allocated treatment but did not take it|0|||
148846340|NCT01081951|536913858|FG001|Overall Study|Allocated treatment but did not take it|1|||
148846341|NCT01081951|536913857|FG000|Overall Study|Lost to Follow-up|0|||
148846342|NCT01081951|536913858|FG001|Overall Study|Lost to Follow-up|1|||
148846343|NCT01152788|536913861|FG000|Overall Study|Withdrawal by Subject|0|||
148846344|NCT01152788|536913862|FG001|Overall Study|Withdrawal by Subject|3|||
148846345|NCT01152788|536913861|FG000|Overall Study|No treatment|0|||
148846346|NCT01152788|536913862|FG001|Overall Study|No treatment|1|||
148846347|NCT03782064|536913866|FG000|Overall Study|Lack of Efficacy|2|||
148846348|NCT03782064|536913866|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
148846349|NCT00363142|536913867|FG000|Overall Study|Adverse Event|2|||
148846350|NCT00363142|536913868|FG001|Overall Study|Adverse Event|0|||
148846351|NCT00363142|536913867|FG000|Overall Study|Lack of Efficacy|0|||
148846352|NCT00363142|536913868|FG001|Overall Study|Lack of Efficacy|1|||
148846353|NCT00363142|536913867|FG000|Overall Study|Lost to Follow-up|1|||
148846354|NCT00363142|536913868|FG001|Overall Study|Lost to Follow-up|0|||
148846355|NCT00363142|536913867|FG000|Overall Study|Non-compliance|1|||
148846356|NCT00363142|536913868|FG001|Overall Study|Non-compliance|1|||
148846357|NCT00363142|536913867|FG000|Overall Study|Withdrawal by Subject|3|||
148984430|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984431|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984432|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148846358|NCT00363142|536913868|FG001|Overall Study|Withdrawal by Subject|1|||
148846359|NCT00049322|536913872|FG000|Overall Study|disease burden|0|||
148846360|NCT00049322|536913873|FG001|Overall Study|disease burden|3|||
148846361|NCT00049322|536913872|FG000|Overall Study|Adverse Event|1|||
148846362|NCT00049322|536913873|FG001|Overall Study|Adverse Event|0|||
148846363|NCT00049322|536913872|FG000|Overall Study|refused angio|0|||
148846364|NCT00049322|536913873|FG001|Overall Study|refused angio|3|||
148846365|NCT03994211|536913874|FG000|Core Phase|Adverse Event|0|||
148846366|NCT03994211|536913875|FG001|Core Phase|Adverse Event|1|||
148846367|NCT03994211|536913876|FG002|Core Phase|Adverse Event|0|||
148846368|NCT03994211|536913874|FG000|Extension Phase|Adverse Event|0|||
148846369|NCT03994211|536913875|FG001|Extension Phase|Adverse Event|0|||
148846370|NCT03994211|536913876|FG002|Extension Phase|Adverse Event|1|||
148846371|NCT03994211|536913874|FG000|Extension Phase|Physician Decision|0|||
148846372|NCT03994211|536913875|FG001|Extension Phase|Physician Decision|0|||
148846373|NCT03994211|536913876|FG002|Extension Phase|Physician Decision|1|||
148846374|NCT03994211|536913874|FG000|Extension Phase|Progressive Disease|0|||
148846375|NCT03994211|536913875|FG001|Extension Phase|Progressive Disease|0|||
148846376|NCT03994211|536913876|FG002|Extension Phase|Progressive Disease|20|||
148846377|NCT03994211|536913874|FG000|Extension Phase|Withdrawal by Subject|0|||
148846378|NCT03994211|536913875|FG001|Extension Phase|Withdrawal by Subject|0|||
148846379|NCT03994211|536913876|FG002|Extension Phase|Withdrawal by Subject|2|||
148846380|NCT02625220|536913877|FG000|Overall Study|Adverse Event|2|||
148846381|NCT02625220|536913877|FG000|Overall Study|Lost to Follow-up|2|||
148846382|NCT02625220|536913877|FG000|Overall Study|Protocol Violation|1|||
148846383|NCT02625220|536913877|FG000|Overall Study|Study discontinued at site|2|||
148846384|NCT01140867|536913878|FG000|Overall Study|Adverse Event|22|||
148846385|NCT01140867|536913878|FG000|Overall Study|Lack of Efficacy|3|||
148846386|NCT01140867|536913878|FG000|Overall Study|Lost to Follow-up|2|||
148846387|NCT01140867|536913878|FG000|Overall Study|Withdrawal by Subject|1|||
148846388|NCT01140867|536913878|FG000|Overall Study|Protocol Violation|1|||
148846389|NCT01140867|536913878|FG000|Overall Study|Uncooperative patient|2|||
148846390|NCT01140867|536913878|FG000|Overall Study|Medication Noncompliance|2|||
148846391|NCT01926444|536913879|FG000|Overall Study|Colonoscopy not performed|0|||
148846392|NCT01926444|536913880|FG001|Overall Study|Colonoscopy not performed|0|||
148846393|NCT01926444|536913881|FG002|Overall Study|Colonoscopy not performed|4|||
148846394|NCT01926444|536913882|FG003|Overall Study|Colonoscopy not performed|2|||
148846395|NCT01272037|536913883|FG000|Overall Study|Death|25|||
148846396|NCT01272037|536913884|FG001|Overall Study|Death|28|||
148846397|NCT01272037|536913883|FG000|Overall Study|Adverse Event|12|||
148846398|NCT01272037|536913884|FG001|Overall Study|Adverse Event|7|||
148846399|NCT01272037|536913883|FG000|Overall Study|Withdrawal by Subject|175|||
148846400|NCT01272037|536913884|FG001|Overall Study|Withdrawal by Subject|93|||
148846401|NCT01272037|536913883|FG000|Overall Study|Disease progression|70|||
148846402|NCT01272037|536913884|FG001|Overall Study|Disease progression|111|||
148846403|NCT01272037|536913883|FG000|Overall Study|Other reason|42|||
148846404|NCT01272037|536913884|FG001|Overall Study|Other reason|41|||
148846405|NCT01272037|536913883|FG000|Overall Study|Delinquent data|24|||
148846406|NCT01272037|536913884|FG001|Overall Study|Delinquent data|19|||
148846407|NCT01272037|536913883|FG000|Overall Study|Reason under review|33|||
148846408|NCT01272037|536913884|FG001|Overall Study|Reason under review|29|||
148846409|NCT01272037|536913883|FG000|Overall Study|On treatment|626|||
148846410|NCT01272037|536913884|FG001|Overall Study|On treatment|632|||
148846411|NCT03035864|536913885|FG000|Treatment Period|Adverse Event|1|||
148846412|NCT03035864|536913886|FG001|Treatment Period|Adverse Event|0|||
148846413|NCT03035864|536913885|FG000|Treatment Period|Other|3|||
148846414|NCT03035864|536913886|FG001|Treatment Period|Other|1|||
148846415|NCT03035864|536913885|FG000|Follow-up Period|Adverse Event|1|||
148846416|NCT03035864|536913886|FG001|Follow-up Period|Adverse Event|0|||
148846417|NCT03035864|536913885|FG000|Follow-up Period|Lost to Follow-up|6|||
148846418|NCT03035864|536913886|FG001|Follow-up Period|Lost to Follow-up|2|||
148846419|NCT03035864|536913885|FG000|Follow-up Period|Physician Decision|1|||
148846420|NCT03035864|536913886|FG001|Follow-up Period|Physician Decision|0|||
148846421|NCT03035864|536913885|FG000|Follow-up Period|Other|3|||
148846422|NCT03035864|536913886|FG001|Follow-up Period|Other|2|||
148846423|NCT02720523|536913887|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
148846424|NCT02720523|536913888|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
148846425|NCT02720523|536913889|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
148846426|NCT02720523|536913890|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
148846427|NCT02720523|536913891|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
148846428|NCT02720523|536913892|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
148846429|NCT02720523|536913893|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
148984433|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
148984434|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148846430|NCT02720523|536913887|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
148846431|NCT02720523|536913888|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148846432|NCT02720523|536913889|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148846433|NCT02720523|536913890|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148846434|NCT02720523|536913891|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148846435|NCT02720523|536913892|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148846436|NCT02720523|536913893|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
148846437|NCT02720523|536913887|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
148846438|NCT02720523|536913888|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
148846439|NCT02720523|536913889|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
148846440|NCT02720523|536913890|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
148846441|NCT02720523|536913891|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
148984435|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148846442|NCT02720523|536913892|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
148846443|NCT02720523|536913893|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
148846444|NCT02720523|536913887|FG000|Period 1: Placebo-controlled Period|Other|0|||
148846445|NCT02720523|536913888|FG001|Period 1: Placebo-controlled Period|Other|0|||
148846446|NCT02720523|536913889|FG002|Period 1: Placebo-controlled Period|Other|1|||
148846447|NCT02720523|536913890|FG003|Period 1: Placebo-controlled Period|Other|1|||
148846448|NCT02720523|536913891|FG004|Period 1: Placebo-controlled Period|Other|0|||
148846449|NCT02720523|536913892|FG005|Period 1: Placebo-controlled Period|Other|0|||
148846450|NCT02720523|536913893|FG006|Period 1: Placebo-controlled Period|Other|0|||
148846451|NCT02720523|536913887|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
148846452|NCT02720523|536913888|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
148846453|NCT02720523|536913889|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
148846454|NCT02720523|536913890|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
148846455|NCT02720523|536913891|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
148846456|NCT02720523|536913892|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
148846457|NCT02720523|536913893|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
148846458|NCT02720523|536913887|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
148846459|NCT02720523|536913888|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
148846460|NCT02720523|536913889|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
148846461|NCT02720523|536913890|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
148846462|NCT02720523|536913891|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
148846463|NCT02720523|536913892|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
148846464|NCT02720523|536913893|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
148846465|NCT02720523|536913887|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
148846466|NCT02720523|536913888|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
148846467|NCT02720523|536913889|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
148846468|NCT02720523|536913890|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
148846469|NCT02720523|536913891|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
148846470|NCT02720523|536913892|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
148846471|NCT02720523|536913893|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
148846472|NCT02720523|536913887|FG000|Period 2: Long-term Extension Period|Other|0|||
148846473|NCT02720523|536913888|FG001|Period 2: Long-term Extension Period|Other|0|||
148846474|NCT02720523|536913889|FG002|Period 2: Long-term Extension Period|Other|0|||
148846475|NCT02720523|536913890|FG003|Period 2: Long-term Extension Period|Other|0|||
148846476|NCT02720523|536913891|FG004|Period 2: Long-term Extension Period|Other|2|||
148846477|NCT02720523|536913892|FG005|Period 2: Long-term Extension Period|Other|0|||
148846478|NCT02720523|536913893|FG006|Period 2: Long-term Extension Period|Other|3|||
148846479|NCT00100802|536913899|FG000|Overall Study|Adverse Event|9|||
148846480|NCT00100802|536913899|FG000|Overall Study|Death|1|||
148846481|NCT00100802|536913899|FG000|Overall Study|Lack of Efficacy|47|||
148846482|NCT00100802|536913899|FG000|Overall Study|Physician Decision|5|||
148846483|NCT00100802|536913899|FG000|Overall Study|Protocol Violation|1|||
148846484|NCT00100802|536913899|FG000|Overall Study|Withdrawal by Subject|5|||
148846485|NCT00100802|536913899|FG000|Overall Study|Ineligible|12|||
148846486|NCT00316706|536915123|FG000|Overall Study|Lost to Follow-up|38|||
148846487|NCT00316706|536915124|FG001|Overall Study|Lost to Follow-up|48|||
148846488|NCT03640325|536915130|FG000|Overall Study|Withdrawal by Subject|4|||
148846489|NCT03640325|536915131|FG001|Overall Study|Withdrawal by Subject|1|||
148846490|NCT03640325|536915132|FG002|Overall Study|Withdrawal by Subject|0|||
148846491|NCT03640325|536915130|FG000|Overall Study|Lost to Follow-up|4|||
148846492|NCT03640325|536915131|FG001|Overall Study|Lost to Follow-up|5|||
148846493|NCT03640325|536915132|FG002|Overall Study|Lost to Follow-up|21|||
148846494|NCT03640325|536915130|FG000|Overall Study|Death|5|||
148846495|NCT03640325|536915131|FG001|Overall Study|Death|5|||
148846496|NCT03640325|536915132|FG002|Overall Study|Death|0|||
148846497|NCT03493451|536915133|FG000|Overall Study|Death|11|||
148846498|NCT03493451|536915134|FG001|Overall Study|Death|26|||
148984436|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984437|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984438|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984439|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984440|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984441|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148846499|NCT03493451|536915135|FG002|Overall Study|Death|3|||
148846500|NCT03493451|536915133|FG000|Overall Study|Lost to Follow-up|1|||
148846501|NCT03493451|536915134|FG001|Overall Study|Lost to Follow-up|4|||
148846502|NCT03493451|536915135|FG002|Overall Study|Lost to Follow-up|1|||
148846503|NCT03493451|536915133|FG000|Overall Study|Withdrawal by Subject|1|||
148984442|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148846504|NCT03493451|536915134|FG001|Overall Study|Withdrawal by Subject|1|||
148846505|NCT03493451|536915135|FG002|Overall Study|Withdrawal by Subject|2|||
148846506|NCT03493451|536915133|FG000|Overall Study|Progressive Disease|1|||
148846507|NCT03493451|536915134|FG001|Overall Study|Progressive Disease|0|||
148846508|NCT03493451|536915135|FG002|Overall Study|Progressive Disease|0|||
148846509|NCT03493451|536915133|FG000|Overall Study|Transferred to long term extension study|8|||
148846510|NCT03493451|536915134|FG001|Overall Study|Transferred to long term extension study|13|||
148846511|NCT03493451|536915135|FG002|Overall Study|Transferred to long term extension study|5|||
148846512|NCT01133756|536915138|FG000|Overall Study|Adverse Event|1|||
148846513|NCT01133756|536915139|FG001|Overall Study|Adverse Event|2|||
148846514|NCT01133756|536915140|FG002|Overall Study|Adverse Event|1|||
148846515|NCT01133756|536915138|FG000|Overall Study|Investigator Decision|1|||
148846516|NCT01133756|536915139|FG001|Overall Study|Investigator Decision|0|||
148846517|NCT01133756|536915140|FG002|Overall Study|Investigator Decision|0|||
148846518|NCT01133756|536915138|FG000|Overall Study|Withdrawal by Subject|0|||
148846519|NCT01133756|536915139|FG001|Overall Study|Withdrawal by Subject|1|||
148846520|NCT01133756|536915140|FG002|Overall Study|Withdrawal by Subject|0|||
148846521|NCT01133756|536915138|FG000|Overall Study|Progression of Disease|0|||
148846522|NCT01133756|536915139|FG001|Overall Study|Progression of Disease|0|||
148846523|NCT01133756|536915140|FG002|Overall Study|Progression of Disease|1|||
148846524|NCT03941873|536915147|FG000|Overall Study|Death|0|||
148846525|NCT03941873|536915148|FG001|Overall Study|Death|12|||
148846526|NCT03941873|536915149|FG002|Overall Study|Death|2|||
148846527|NCT03941873|536915150|FG003|Overall Study|Death|53|||
148846528|NCT03941873|536915147|FG000|Overall Study|Withdrawal by Subject|1|||
148846529|NCT03941873|536915148|FG001|Overall Study|Withdrawal by Subject|1|||
148846530|NCT03941873|536915149|FG002|Overall Study|Withdrawal by Subject|0|||
148846531|NCT03941873|536915150|FG003|Overall Study|Withdrawal by Subject|5|||
148846532|NCT03941873|536915147|FG000|Overall Study|Lost to Follow-up|1|||
148846533|NCT03941873|536915148|FG001|Overall Study|Lost to Follow-up|2|||
148846534|NCT03941873|536915149|FG002|Overall Study|Lost to Follow-up|0|||
148846535|NCT03941873|536915150|FG003|Overall Study|Lost to Follow-up|0|||
148846536|NCT03941873|536915147|FG000|Overall Study|Sponsor Decision|0|||
148846537|NCT03941873|536915148|FG001|Overall Study|Sponsor Decision|6|||
148846538|NCT03941873|536915149|FG002|Overall Study|Sponsor Decision|0|||
148846539|NCT03941873|536915150|FG003|Overall Study|Sponsor Decision|15|||
148846540|NCT03276728|536915151|FG000|Overall Study|Lost to Follow-up|0|||
148846541|NCT03276728|536915152|FG001|Overall Study|Lost to Follow-up|0|||
148846542|NCT03276728|536915153|FG002|Overall Study|Lost to Follow-up|2|||
148846543|NCT03276728|536915154|FG003|Overall Study|Lost to Follow-up|2|||
148846544|NCT03276728|536915155|FG004|Overall Study|Lost to Follow-up|0|||
148846545|NCT03276728|536915156|FG005|Overall Study|Lost to Follow-up|0|||
148846546|NCT03276728|536915157|FG006|Overall Study|Lost to Follow-up|0|||
148846547|NCT03276728|536915158|FG007|Overall Study|Lost to Follow-up|0|||
148846548|NCT03276728|536915151|FG000|Overall Study|Withdrawal by Subject|0|||
148846549|NCT03276728|536915152|FG001|Overall Study|Withdrawal by Subject|0|||
148846550|NCT03276728|536915153|FG002|Overall Study|Withdrawal by Subject|0|||
148846551|NCT03276728|536915154|FG003|Overall Study|Withdrawal by Subject|3|||
148846552|NCT03276728|536915155|FG004|Overall Study|Withdrawal by Subject|0|||
148846553|NCT03276728|536915156|FG005|Overall Study|Withdrawal by Subject|0|||
148846554|NCT03276728|536915157|FG006|Overall Study|Withdrawal by Subject|0|||
148846555|NCT03276728|536915158|FG007|Overall Study|Withdrawal by Subject|0|||
148846556|NCT03276728|536915151|FG000|Overall Study|Decision by sponsor|0|||
148846557|NCT03276728|536915152|FG001|Overall Study|Decision by sponsor|0|||
148846558|NCT03276728|536915153|FG002|Overall Study|Decision by sponsor|0|||
148846559|NCT03276728|536915154|FG003|Overall Study|Decision by sponsor|0|||
148846560|NCT03276728|536915155|FG004|Overall Study|Decision by sponsor|1|||
148846561|NCT03276728|536915156|FG005|Overall Study|Decision by sponsor|0|||
148846562|NCT03276728|536915157|FG006|Overall Study|Decision by sponsor|2|||
148846563|NCT03276728|536915158|FG007|Overall Study|Decision by sponsor|1|||
148846564|NCT02982772|536915161|FG000|Intervention|Lost to Follow-up|19|||
148846565|NCT02982772|536915162|FG001|Intervention|Lost to Follow-up|13|||
148846566|NCT02982772|536915161|FG000|1M Follow-Up|Lost to Follow-up|21|||
148846567|NCT02982772|536915162|FG001|1M Follow-Up|Lost to Follow-up|18|||
148846568|NCT02982772|536915161|FG000|3M Follow-Up|Lost to Follow-up|17|||
148846569|NCT02982772|536915162|FG001|3M Follow-Up|Lost to Follow-up|11|||
148846570|NCT02982772|536915161|FG000|6M Follow-Up|Lost to Follow-up|11|||
148846571|NCT02982772|536915162|FG001|6M Follow-Up|Lost to Follow-up|9|||
148846572|NCT02982772|536915161|FG000|12M Follow-Up|Lost to Follow-up|11|||
148846573|NCT02982772|536915162|FG001|12M Follow-Up|Lost to Follow-up|5|||
148846574|NCT01234480|536915163|FG000|Overall Study|Pregnancy|88|||
148846575|NCT01234480|536915163|FG000|Overall Study|>36/Normal History|50|||
148846576|NCT01234480|536915163|FG000|Overall Study|Age|3|||
148846577|NCT01234480|536915163|FG000|Overall Study|HPV Vaccine History|28|||
148846578|NCT01234480|536915163|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
148846579|NCT01234480|536915163|FG000|Overall Study|Hysterectomy|2|||
148846580|NCT01234480|536915163|FG000|Overall Study|Hysterectomy post enrollment|1|||
148846581|NCT01234480|536915163|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
148846582|NCT01234480|536915163|FG000|Overall Study|Informed Consent Form Violation|30|||
148846583|NCT01234480|536915163|FG000|Overall Study|Incorrect Visit|3|||
148846584|NCT01234480|536915163|FG000|Overall Study|No Florida Lab License|20|||
148846585|NCT01234480|536915163|FG000|Overall Study|Out of Window|42|||
148846586|NCT01234480|536915163|FG000|Overall Study|Sample Processing/Storage|92|||
148846587|NCT01234480|536915163|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
148846588|NCT01234480|536915163|FG000|Overall Study|Site/Subject non-compliance|44|||
148846589|NCT01234480|536915163|FG000|Overall Study|Missing Sample|9|||
148846590|NCT02974140|536915164|FG000|Overall Study|Adverse Event|2|||
148846591|NCT02974140|536915164|FG000|Overall Study|Lost to Follow-up|1|||
148846592|NCT02974140|536915164|FG000|Overall Study|Study Terminated by Sponsor|36|||
148846593|NCT00617084|536915165|FG000|Overall Study|Withdrawal by Subject|5|||
148846594|NCT00617084|536915166|FG001|Overall Study|Withdrawal by Subject|7|||
148846595|NCT00617084|536915165|FG000|Overall Study|Missed 12 Months visit|16|||
148846596|NCT00617084|536915166|FG001|Overall Study|Missed 12 Months visit|19|||
148846597|NCT03370419|536915167|FG000|Overall Study|Lost to Follow-up|16|||
148846598|NCT00310375|536915172|FG000|Primary Reporting Phase|Adverse Event|28|||
148846599|NCT00310375|536915173|FG001|Primary Reporting Phase|Adverse Event|22|||
148846600|NCT00310375|536915174|FG002|Primary Reporting Phase|Adverse Event|0|||
148846601|NCT00310375|536915172|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
148846602|NCT00310375|536915173|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
148846603|NCT00310375|536915174|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
148846604|NCT00310375|536915172|FG000|Primary Reporting Phase|Pregnancy|2|||
148846605|NCT00310375|536915173|FG001|Primary Reporting Phase|Pregnancy|2|||
148846606|NCT00310375|536915174|FG002|Primary Reporting Phase|Pregnancy|0|||
148846607|NCT00310375|536915172|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
148846608|NCT00310375|536915173|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
148846609|NCT00310375|536915174|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
148846610|NCT00310375|536915172|FG000|Primary Reporting Phase|Protocol Violation|8|||
148846611|NCT00310375|536915173|FG001|Primary Reporting Phase|Protocol Violation|5|||
148846612|NCT00310375|536915174|FG002|Primary Reporting Phase|Protocol Violation|0|||
148846613|NCT00310375|536915172|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
148846614|NCT00310375|536915173|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
148846615|NCT00310375|536915174|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
148846616|NCT00310375|536915172|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
148846617|NCT00310375|536915173|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
148846618|NCT00310375|536915174|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
148846619|NCT00310375|536915172|FG000|Primary Reporting Phase|Physician Decision|5|||
148846620|NCT00310375|536915173|FG001|Primary Reporting Phase|Physician Decision|3|||
148846621|NCT00310375|536915174|FG002|Primary Reporting Phase|Physician Decision|0|||
148846622|NCT00310375|536915172|FG000|Primary Reporting Phase|Request of the sponsor|2|||
148846623|NCT00310375|536915173|FG001|Primary Reporting Phase|Request of the sponsor|2|||
148846624|NCT00310375|536915174|FG002|Primary Reporting Phase|Request of the sponsor|0|||
148846625|NCT00310375|536915172|FG000|Primary Reporting Phase|Failed to return|1|||
148846626|NCT00310375|536915173|FG001|Primary Reporting Phase|Failed to return|3|||
148846627|NCT00310375|536915174|FG002|Primary Reporting Phase|Failed to return|0|||
148846628|NCT00310375|536915172|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
148846629|NCT00310375|536915173|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
148846630|NCT00310375|536915174|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
148846631|NCT00310375|536915172|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
148846632|NCT00310375|536915173|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
148846633|NCT00310375|536915174|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
148846634|NCT00310375|536915172|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
148846635|NCT00310375|536915173|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
148846636|NCT00310375|536915174|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
148846637|NCT00310375|536915172|FG000|Primary Reporting Phase|Site closure|3|||
148846638|NCT00310375|536915173|FG001|Primary Reporting Phase|Site closure|0|||
148846639|NCT00310375|536915174|FG002|Primary Reporting Phase|Site closure|0|||
148846640|NCT00310375|536915172|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
148846641|NCT00310375|536915173|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
148846642|NCT00310375|536915174|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
148846643|NCT00310375|536915172|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
148846644|NCT00310375|536915173|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
148846645|NCT00310375|536915174|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
148846646|NCT00310375|536915172|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
148846647|NCT00310375|536915173|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
148846648|NCT00310375|536915174|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
148846649|NCT00310375|536915172|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
148846650|NCT00310375|536915173|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
148846651|NCT00310375|536915174|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
148984443|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
148984444|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984445|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148846652|NCT03726658|536915176|FG000|Overall Study|Lost to Follow-up|0|||
148846653|NCT03726658|536915177|FG001|Overall Study|Lost to Follow-up|0|||
148846654|NCT03726658|536915178|FG002|Overall Study|Lost to Follow-up|2|||
148846655|NCT03726658|536915179|FG003|Overall Study|Lost to Follow-up|0|||
148846656|NCT03726658|536915180|FG004|Overall Study|Lost to Follow-up|0|||
148846657|NCT03726658|536915181|FG005|Overall Study|Lost to Follow-up|1|||
148846658|NCT03726658|536915182|FG006|Overall Study|Lost to Follow-up|1|||
148846659|NCT03726658|536915176|FG000|Overall Study|Withdrawal by Subject|1|||
148846660|NCT03726658|536915177|FG001|Overall Study|Withdrawal by Subject|0|||
148846661|NCT03726658|536915178|FG002|Overall Study|Withdrawal by Subject|0|||
148846662|NCT03726658|536915179|FG003|Overall Study|Withdrawal by Subject|0|||
148846663|NCT03726658|536915180|FG004|Overall Study|Withdrawal by Subject|6|||
148846664|NCT03726658|536915181|FG005|Overall Study|Withdrawal by Subject|4|||
148846665|NCT03726658|536915182|FG006|Overall Study|Withdrawal by Subject|2|||
148846666|NCT03726658|536915176|FG000|Overall Study|Pregnancy|0|||
148846667|NCT03726658|536915177|FG001|Overall Study|Pregnancy|0|||
148846668|NCT03726658|536915178|FG002|Overall Study|Pregnancy|0|||
148846669|NCT03726658|536915179|FG003|Overall Study|Pregnancy|0|||
148846670|NCT03726658|536915180|FG004|Overall Study|Pregnancy|0|||
148846671|NCT03726658|536915181|FG005|Overall Study|Pregnancy|0|||
148846672|NCT03726658|536915182|FG006|Overall Study|Pregnancy|1|||
148846673|NCT03726658|536915176|FG000|Overall Study|Not Reported|0|||
148846674|NCT03726658|536915177|FG001|Overall Study|Not Reported|0|||
148846675|NCT03726658|536915178|FG002|Overall Study|Not Reported|0|||
148846676|NCT03726658|536915179|FG003|Overall Study|Not Reported|0|||
148846677|NCT03726658|536915180|FG004|Overall Study|Not Reported|0|||
148846678|NCT03726658|536915181|FG005|Overall Study|Not Reported|0|||
148846679|NCT03726658|536915182|FG006|Overall Study|Not Reported|1|||
148846680|NCT00412958|536915183|FG000|Overall Study|Withdrawal by Subject|3|||
148846681|NCT00412958|536915184|FG001|Overall Study|Withdrawal by Subject|0|||
148846682|NCT00412958|536915185|FG002|Overall Study|Withdrawal by Subject|0|||
148846683|NCT00412958|536915186|FG003|Overall Study|Withdrawal by Subject|1|||
148846684|NCT00412958|536915183|FG000|Overall Study|Adverse Event|0|||
148846685|NCT00412958|536915184|FG001|Overall Study|Adverse Event|1|||
148846686|NCT00412958|536915185|FG002|Overall Study|Adverse Event|0|||
148846687|NCT00412958|536915186|FG003|Overall Study|Adverse Event|0|||
148846688|NCT00412958|536915183|FG000|Overall Study|Lost to Follow-up|0|||
148846689|NCT00412958|536915184|FG001|Overall Study|Lost to Follow-up|1|||
148846690|NCT00412958|536915185|FG002|Overall Study|Lost to Follow-up|0|||
148846691|NCT00412958|536915186|FG003|Overall Study|Lost to Follow-up|0|||
148846692|NCT00412958|536915183|FG000|Overall Study|Death|0|||
148846693|NCT00412958|536915184|FG001|Overall Study|Death|1|||
148846694|NCT00412958|536915185|FG002|Overall Study|Death|0|||
148846695|NCT00412958|536915186|FG003|Overall Study|Death|0|||
148846696|NCT00412958|536915183|FG000|Overall Study|Transport issue|0|||
148846697|NCT00412958|536915184|FG001|Overall Study|Transport issue|1|||
148846698|NCT00412958|536915185|FG002|Overall Study|Transport issue|0|||
148846699|NCT00412958|536915186|FG003|Overall Study|Transport issue|0|||
148846700|NCT01318135|536915187|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
148846701|NCT01318135|536915188|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846702|NCT01318135|536915189|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846703|NCT01318135|536915190|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846704|NCT01318135|536915191|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846705|NCT01318135|536915192|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846706|NCT01318135|536915193|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846707|NCT01318135|536915194|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
148846708|NCT01318135|536915187|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
148846709|NCT01318135|536915188|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846710|NCT01318135|536915189|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846711|NCT01318135|536915190|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846712|NCT01318135|536915191|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846713|NCT01318135|536915192|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846714|NCT01318135|536915193|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846715|NCT01318135|536915194|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
148846716|NCT01318135|536915187|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
148846717|NCT01318135|536915188|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
148846718|NCT01318135|536915189|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
148846719|NCT01318135|536915190|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
148846720|NCT01318135|536915191|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
148846721|NCT01318135|536915192|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
148846722|NCT01318135|536915193|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
148846723|NCT01318135|536915194|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
148846724|NCT01318135|536915187|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
148846725|NCT01318135|536915188|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
148846726|NCT01318135|536915189|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
148984446|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984447|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148776512|NCT02100670|536655207|FG002|Overall Study|No swelling no pain|0|||
148776513|NCT02100670|536655208|FG003|Overall Study|No swelling no pain|0|||
148776514|NCT02100670|536655205|FG000|Overall Study|Poor Efficacy|0|||
148776515|NCT02100670|536655206|FG001|Overall Study|Poor Efficacy|1|||
148776516|NCT02100670|536655207|FG002|Overall Study|Poor Efficacy|0|||
148776517|NCT02100670|536655208|FG003|Overall Study|Poor Efficacy|0|||
148776518|NCT02100670|536655205|FG000|Overall Study|Physician Decision|0|||
148776519|NCT02100670|536655206|FG001|Overall Study|Physician Decision|1|||
148776520|NCT02100670|536655207|FG002|Overall Study|Physician Decision|0|||
148776521|NCT02100670|536655208|FG003|Overall Study|Physician Decision|0|||
148776522|NCT02100670|536655205|FG000|Overall Study|Withdrawal by Subject|1|||
148776523|NCT02100670|536655206|FG001|Overall Study|Withdrawal by Subject|0|||
148776524|NCT02100670|536655207|FG002|Overall Study|Withdrawal by Subject|0|||
148776525|NCT02100670|536655208|FG003|Overall Study|Withdrawal by Subject|0|||
148776526|NCT01390428|536656772|FG000|Overall Study|Elective Surgery|0|||
148776527|NCT01390428|536656773|FG001|Overall Study|Elective Surgery|0|||
148776528|NCT01390428|536656774|FG002|Overall Study|Elective Surgery|0|||
148776529|NCT01390428|536656775|FG003|Overall Study|Elective Surgery|0|||
148776530|NCT01390428|536656776|FG004|Overall Study|Elective Surgery|1|||
148776531|NCT01390428|536656777|FG005|Overall Study|Elective Surgery|0|||
148776532|NCT01390428|536656772|FG000|Overall Study|Withdrawal by Subject|0|||
148776533|NCT01390428|536656773|FG001|Overall Study|Withdrawal by Subject|0|||
148776534|NCT01390428|536656774|FG002|Overall Study|Withdrawal by Subject|1|||
148776535|NCT01390428|536656775|FG003|Overall Study|Withdrawal by Subject|0|||
148776536|NCT01390428|536656776|FG004|Overall Study|Withdrawal by Subject|0|||
148776537|NCT01390428|536656777|FG005|Overall Study|Withdrawal by Subject|0|||
148776538|NCT05897827|536656780|FG000|Overall Study|Lost to Follow-up|33|||
148776539|NCT05897827|536656781|FG001|Overall Study|Lost to Follow-up|14|||
148776540|NCT05897827|536656780|FG000|Overall Study|Withdrawal by Subject|1|||
148776541|NCT05897827|536656781|FG001|Overall Study|Withdrawal by Subject|1|||
148776542|NCT05376241|536656782|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
148776543|NCT05376241|536656782|FG000|Overall Study|103 did not complete the survey|103|||
148776544|NCT05376241|536656782|FG000|Overall Study|17 failed 2 attention check questions|17|||
148776545|NCT01004406|536656785|FG000|Overall Study|Withdrawal by Subject|2|||
148776546|NCT01004406|536656786|FG001|Overall Study|Withdrawal by Subject|0|||
148776547|NCT01004406|536656785|FG000|Overall Study|Lost to Follow-up|1|||
148776548|NCT01004406|536656786|FG001|Overall Study|Lost to Follow-up|0|||
148776549|NCT02928770|536656787|FG000|Overall Study|Withdrawal by Subject|2|||
148776550|NCT03201874|536656788|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
148776551|NCT03201874|536656789|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
148776552|NCT03201874|536656788|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
148776553|NCT03201874|536656789|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
148776554|NCT05562934|536656798|FG000|Overall Study|Adverse Event|0|||
148776555|NCT05562934|536656799|FG001|Overall Study|Adverse Event|2|||
148776556|NCT05562934|536656800|FG002|Overall Study|Adverse Event|0|||
148776557|NCT05562934|536656801|FG003|Overall Study|Adverse Event|0|||
148776558|NCT05562934|536656802|FG004|Overall Study|Adverse Event|2|||
148776559|NCT05562934|536656798|FG000|Overall Study|Lost to Follow-up|0|||
148776560|NCT05562934|536656799|FG001|Overall Study|Lost to Follow-up|0|||
148776561|NCT05562934|536656800|FG002|Overall Study|Lost to Follow-up|0|||
148776562|NCT05562934|536656801|FG003|Overall Study|Lost to Follow-up|0|||
148776563|NCT05562934|536656802|FG004|Overall Study|Lost to Follow-up|1|||
148776564|NCT05562934|536656798|FG000|Overall Study|Protocol Violation|0|||
148776565|NCT05562934|536656799|FG001|Overall Study|Protocol Violation|0|||
148776566|NCT05562934|536656800|FG002|Overall Study|Protocol Violation|0|||
148776567|NCT05562934|536656801|FG003|Overall Study|Protocol Violation|1|||
148776568|NCT05562934|536656802|FG004|Overall Study|Protocol Violation|1|||
148776569|NCT05562934|536656798|FG000|Overall Study|Withdrawal by Subject|0|||
148776570|NCT05562934|536656799|FG001|Overall Study|Withdrawal by Subject|0|||
148776571|NCT05562934|536656800|FG002|Overall Study|Withdrawal by Subject|1|||
148776572|NCT05562934|536656801|FG003|Overall Study|Withdrawal by Subject|1|||
148776573|NCT05562934|536656802|FG004|Overall Study|Withdrawal by Subject|0|||
148776574|NCT01668966|536656813|FG000|Overall Study|Withdrawal by Subject|1|||
148776575|NCT01668966|536656813|FG000|Overall Study|Death|1|||
148776576|NCT01668966|536656813|FG000|Overall Study|Not treated|2|||
148776577|NCT00345878|536656818|FG000|Overall Study|Adverse Event|1|||
148776578|NCT00345878|536656819|FG001|Overall Study|Adverse Event|0|||
148776579|NCT00345878|536656818|FG000|Overall Study|Lost to Follow-up|2|||
148776580|NCT00345878|536656819|FG001|Overall Study|Lost to Follow-up|1|||
148776581|NCT00345878|536656818|FG000|Overall Study|Other|1|||
148776582|NCT00345878|536656819|FG001|Overall Study|Other|0|||
148846727|NCT01318135|536915190|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
148846728|NCT01318135|536915191|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
148846729|NCT01318135|536915192|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
148846730|NCT01318135|536915193|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
148846731|NCT01318135|536915194|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
148846732|NCT01318135|536915187|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
148846733|NCT01318135|536915188|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
148846734|NCT01318135|536915189|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
148846735|NCT01318135|536915190|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
148846736|NCT01318135|536915191|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
148846737|NCT01318135|536915192|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
148846738|NCT01318135|536915193|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
148846739|NCT01318135|536915194|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
148846740|NCT01318135|536915187|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
148846741|NCT01318135|536915188|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
148846742|NCT01318135|536915189|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
148846743|NCT01318135|536915190|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
148846744|NCT01318135|536915191|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
148846745|NCT01318135|536915192|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
148846746|NCT01318135|536915193|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
148846747|NCT01318135|536915194|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
148846748|NCT01318135|536915187|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846749|NCT01318135|536915188|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846750|NCT01318135|536915189|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846751|NCT01318135|536915190|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846752|NCT01318135|536915191|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846753|NCT01318135|536915192|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846754|NCT01318135|536915193|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
148846755|NCT01318135|536915194|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
148846756|NCT02528942|536915198|FG000|Overall Study|Did not meet imaging criteria|9|||
148846757|NCT02528942|536915198|FG000|Overall Study|Lost to Follow-up|25|||
148846758|NCT00881530|536915199|FG000|Overall Study|Adverse Event|5|||
148846759|NCT00881530|536915200|FG001|Overall Study|Adverse Event|1|||
148846760|NCT00881530|536915201|FG002|Overall Study|Adverse Event|1|||
148846761|NCT00881530|536915202|FG003|Overall Study|Adverse Event|4|||
148846762|NCT00881530|536915203|FG004|Overall Study|Adverse Event|10|||
148846763|NCT00881530|536915204|FG005|Overall Study|Adverse Event|2|||
148846764|NCT00881530|536915199|FG000|Overall Study|Lack of Efficacy|1|||
148846765|NCT00881530|536915200|FG001|Overall Study|Lack of Efficacy|0|||
148846766|NCT00881530|536915201|FG002|Overall Study|Lack of Efficacy|0|||
148846767|NCT00881530|536915202|FG003|Overall Study|Lack of Efficacy|0|||
148846768|NCT00881530|536915203|FG004|Overall Study|Lack of Efficacy|1|||
148984448|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148846769|NCT00881530|536915204|FG005|Overall Study|Lack of Efficacy|1|||
148846770|NCT00881530|536915199|FG000|Overall Study|Not compliant with the protocol|0|||
148846771|NCT00881530|536915200|FG001|Overall Study|Not compliant with the protocol|0|||
148846772|NCT00881530|536915201|FG002|Overall Study|Not compliant with the protocol|0|||
148846773|NCT00881530|536915202|FG003|Overall Study|Not compliant with the protocol|0|||
148846774|NCT00881530|536915203|FG004|Overall Study|Not compliant with the protocol|2|||
148846775|NCT00881530|536915204|FG005|Overall Study|Not compliant with the protocol|0|||
148846776|NCT00881530|536915199|FG000|Overall Study|Lost to Follow-up|0|||
148846777|NCT00881530|536915200|FG001|Overall Study|Lost to Follow-up|1|||
148846778|NCT00881530|536915201|FG002|Overall Study|Lost to Follow-up|1|||
148846779|NCT00881530|536915202|FG003|Overall Study|Lost to Follow-up|3|||
148846780|NCT00881530|536915203|FG004|Overall Study|Lost to Follow-up|1|||
148846781|NCT00881530|536915204|FG005|Overall Study|Lost to Follow-up|0|||
148846782|NCT00881530|536915199|FG000|Overall Study|Refused to continue medication|7|||
148846783|NCT00881530|536915200|FG001|Overall Study|Refused to continue medication|2|||
148846784|NCT00881530|536915201|FG002|Overall Study|Refused to continue medication|1|||
148846785|NCT00881530|536915202|FG003|Overall Study|Refused to continue medication|2|||
148846786|NCT00881530|536915203|FG004|Overall Study|Refused to continue medication|0|||
148846787|NCT00881530|536915204|FG005|Overall Study|Refused to continue medication|0|||
148846788|NCT00881530|536915199|FG000|Overall Study|Other reason not defined above|1|||
148846789|NCT00881530|536915200|FG001|Overall Study|Other reason not defined above|1|||
148846790|NCT00881530|536915201|FG002|Overall Study|Other reason not defined above|2|||
148846791|NCT00881530|536915202|FG003|Overall Study|Other reason not defined above|0|||
148846792|NCT00881530|536915203|FG004|Overall Study|Other reason not defined above|0|||
148846793|NCT00881530|536915204|FG005|Overall Study|Other reason not defined above|2|||
148846794|NCT00763256|536915206|FG000|Overall Study|Didn't return for appointments|7|||
148846795|NCT00763256|536915207|FG001|Overall Study|Didn't return for appointments|10|||
148846796|NCT00995436|536915209|FG000|Overall Study|Withdrawal by Subject|2|||
148846797|NCT00995436|536915210|FG001|Overall Study|Withdrawal by Subject|5|||
148846798|NCT00995436|536915211|FG002|Overall Study|Withdrawal by Subject|0|||
148846799|NCT00289289|536915214|FG000|Overall Study|Withdrawal by Subject|5|||
148846800|NCT00289289|536915215|FG001|Overall Study|Withdrawal by Subject|3|||
148846801|NCT00289289|536915216|FG002|Overall Study|Withdrawal by Subject|15|||
148846802|NCT00289289|536915214|FG000|Overall Study|Lost to Follow-up|1|||
148846803|NCT00289289|536915215|FG001|Overall Study|Lost to Follow-up|0|||
148846804|NCT00289289|536915216|FG002|Overall Study|Lost to Follow-up|1|||
148846805|NCT00289289|536915214|FG000|Overall Study|Death|4|||
148846806|NCT00289289|536915215|FG001|Overall Study|Death|2|||
148846807|NCT00289289|536915216|FG002|Overall Study|Death|5|||
148846808|NCT00289289|536915214|FG000|Overall Study|No implant attempted|0|||
148846809|NCT00289289|536915215|FG001|Overall Study|No implant attempted|0|||
148846810|NCT00289289|536915216|FG002|Overall Study|No implant attempted|1|||
148846811|NCT00289289|536915214|FG000|Overall Study|Physician Decision|1|||
148846812|NCT00289289|536915215|FG001|Overall Study|Physician Decision|0|||
148846813|NCT00289289|536915216|FG002|Overall Study|Physician Decision|6|||
148846814|NCT00289289|536915214|FG000|Overall Study|Non-study device implanted|2|||
148846815|NCT00289289|536915215|FG001|Overall Study|Non-study device implanted|1|||
148846816|NCT00289289|536915216|FG002|Overall Study|Non-study device implanted|3|||
148846817|NCT00289289|536915214|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
148846818|NCT00289289|536915215|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
148846819|NCT00289289|536915216|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
148846820|NCT00289289|536915214|FG000|Overall Study|Other Exit Reason|6|||
148846821|NCT00289289|536915215|FG001|Overall Study|Other Exit Reason|4|||
148846822|NCT00289289|536915216|FG002|Overall Study|Other Exit Reason|12|||
148846823|NCT00577707|536915217|FG000|Overall Study|Withdrawal by Subject|3|||
148846824|NCT03299244|536915218|FG000|Overall Study|Withdrawal by Subject|34|||
148846825|NCT03299244|536915219|FG001|Overall Study|Withdrawal by Subject|29|||
148846826|NCT03299244|536915218|FG000|Overall Study|Decision by Sponsor|4|||
148846827|NCT03299244|536915219|FG001|Overall Study|Decision by Sponsor|5|||
148846828|NCT03299244|536915218|FG000|Overall Study|Death|9|||
148846829|NCT03299244|536915219|FG001|Overall Study|Death|4|||
148846830|NCT03146663|536915220|FG000|Overall Study|Did not receive study treatment|1|||
148846831|NCT03146663|536915221|FG001|Overall Study|Did not receive study treatment|1|||
148846832|NCT03666988|536915222|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
148846833|NCT03666988|536915223|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
148846834|NCT03666988|536915224|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
148846835|NCT03666988|536915225|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
148846836|NCT03666988|536915226|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
148846837|NCT03666988|536915227|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
148846838|NCT03666988|536915222|FG000|Part 1 (Up to 28 Months)|Other|0|||
148846839|NCT03666988|536915223|FG001|Part 1 (Up to 28 Months)|Other|1|||
148846840|NCT03666988|536915224|FG002|Part 1 (Up to 28 Months)|Other|1|||
148846841|NCT03666988|536915225|FG003|Part 1 (Up to 28 Months)|Other|0|||
148846842|NCT03666988|536915226|FG004|Part 1 (Up to 28 Months)|Other|0|||
148846843|NCT03666988|536915227|FG005|Part 1 (Up to 28 Months)|Other|0|||
148846844|NCT03666988|536915222|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
148846845|NCT03666988|536915223|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
148846846|NCT03666988|536915224|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
148846847|NCT03666988|536915225|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
148846848|NCT03666988|536915226|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
148846849|NCT03666988|536915227|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
148846850|NCT03666988|536915222|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
148846851|NCT03666988|536915223|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
148846852|NCT03666988|536915224|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
148846853|NCT03666988|536915225|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
148846854|NCT03666988|536915226|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
148846855|NCT03666988|536915227|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
148846856|NCT03666988|536915222|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
148846857|NCT03666988|536915223|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
148846858|NCT03666988|536915224|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
148846859|NCT03666988|536915225|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
148846860|NCT03666988|536915226|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
148846861|NCT03666988|536915227|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
148846862|NCT02709720|536915228|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
148846863|NCT02709720|536915228|FG000|Overall Study|Protocol Violation|1|||
148846864|NCT02709720|536915228|FG000|Overall Study|Not take study medication|1|||
148846865|NCT04266912|536915240|FG000|Overall Study|Withdrawal by Subject|1|||
148846866|NCT04266912|536915241|FG001|Overall Study|Withdrawal by Subject|0|||
148846867|NCT04266912|536915242|FG002|Overall Study|Withdrawal by Subject|0|||
148846868|NCT04266912|536915243|FG003|Overall Study|Withdrawal by Subject|0|||
148846869|NCT04266912|536915240|FG000|Overall Study|Progression|6|||
148846870|NCT04266912|536915241|FG001|Overall Study|Progression|6|||
148846871|NCT04266912|536915242|FG002|Overall Study|Progression|0|||
148846872|NCT04266912|536915243|FG003|Overall Study|Progression|10|||
148846873|NCT05696444|536915244|FG000|Treatment|Physician Decision|0|||
148846874|NCT05696444|536915245|FG001|Treatment|Physician Decision|1|||
148846875|NCT05696444|536915246|FG002|Treatment|Physician Decision|0|||
148846876|NCT05696444|536915244|FG000|30 Days|Death|1|||
148846877|NCT05696444|536915245|FG001|30 Days|Death|1|||
148846878|NCT05696444|536915246|FG002|30 Days|Death|0|||
148846879|NCT05696444|536915244|FG000|30 Days|Missed Visit|1|||
148846880|NCT05696444|536915245|FG001|30 Days|Missed Visit|1|||
148846881|NCT05696444|536915246|FG002|30 Days|Missed Visit|1|||
148846882|NCT05200572|536915247|FG000|Overall Study|Withdrawal by Subject|14|||
148846883|NCT05823974|536916926|FG000|Overall Study|Lost to Follow-up|0|||
148846884|NCT05823974|536916927|FG001|Overall Study|Lost to Follow-up|3|||
148846885|NCT05823974|536916928|FG002|Overall Study|Lost to Follow-up|1|||
148846886|NCT05823974|536916929|FG003|Overall Study|Lost to Follow-up|0|||
148846887|NCT05823974|536916930|FG004|Overall Study|Lost to Follow-up|1|||
148846888|NCT05823974|536916931|FG005|Overall Study|Lost to Follow-up|0|||
148846889|NCT05823974|536916932|FG006|Overall Study|Lost to Follow-up|1|||
148846890|NCT05823974|536916933|FG007|Overall Study|Lost to Follow-up|0|||
148846891|NCT05823974|536916934|FG008|Overall Study|Lost to Follow-up|0|||
148846892|NCT05823974|536916935|FG009|Overall Study|Lost to Follow-up|1|||
148846893|NCT05823974|536916936|FG010|Overall Study|Lost to Follow-up|1|||
148846894|NCT05823974|536916937|FG011|Overall Study|Lost to Follow-up|0|||
148846895|NCT05823974|536916938|FG012|Overall Study|Lost to Follow-up|1|||
148846896|NCT05823974|536916939|FG013|Overall Study|Lost to Follow-up|2|||
148846897|NCT05823974|536916940|FG014|Overall Study|Lost to Follow-up|1|||
148846898|NCT05823974|536916941|FG015|Overall Study|Lost to Follow-up|1|||
148846899|NCT05823974|536916942|FG016|Overall Study|Lost to Follow-up|1|||
148846900|NCT05823974|536916943|FG017|Overall Study|Lost to Follow-up|0|||
148846901|NCT05823974|536916944|FG018|Overall Study|Lost to Follow-up|0|||
148846902|NCT05823974|536916945|FG019|Overall Study|Lost to Follow-up|2|||
148846903|NCT05823974|536916946|FG020|Overall Study|Lost to Follow-up|0|||
148846904|NCT05823974|536916926|FG000|Overall Study|Physician Decision|0|||
148846905|NCT05823974|536916927|FG001|Overall Study|Physician Decision|0|||
148846906|NCT05823974|536916928|FG002|Overall Study|Physician Decision|0|||
148846907|NCT05823974|536916929|FG003|Overall Study|Physician Decision|0|||
148846908|NCT05823974|536916930|FG004|Overall Study|Physician Decision|0|||
148846909|NCT05823974|536916931|FG005|Overall Study|Physician Decision|0|||
148846910|NCT05823974|536916932|FG006|Overall Study|Physician Decision|0|||
148846911|NCT05823974|536916933|FG007|Overall Study|Physician Decision|0|||
148846912|NCT05823974|536916934|FG008|Overall Study|Physician Decision|0|||
148846913|NCT05823974|536916935|FG009|Overall Study|Physician Decision|0|||
148846914|NCT05823974|536916936|FG010|Overall Study|Physician Decision|0|||
148846915|NCT05823974|536916937|FG011|Overall Study|Physician Decision|0|||
148846916|NCT05823974|536916938|FG012|Overall Study|Physician Decision|0|||
148846917|NCT05823974|536916939|FG013|Overall Study|Physician Decision|0|||
148846918|NCT05823974|536916940|FG014|Overall Study|Physician Decision|0|||
148846919|NCT05823974|536916941|FG015|Overall Study|Physician Decision|1|||
148846920|NCT05823974|536916942|FG016|Overall Study|Physician Decision|0|||
148846921|NCT05823974|536916943|FG017|Overall Study|Physician Decision|1|||
148846922|NCT05823974|536916944|FG018|Overall Study|Physician Decision|1|||
148846923|NCT05823974|536916945|FG019|Overall Study|Physician Decision|0|||
148846924|NCT05823974|536916946|FG020|Overall Study|Physician Decision|0|||
148846925|NCT05823974|536916926|FG000|Overall Study|Withdrawal by Subject|1|||
148846926|NCT05823974|536916927|FG001|Overall Study|Withdrawal by Subject|1|||
148846927|NCT05823974|536916928|FG002|Overall Study|Withdrawal by Subject|2|||
148846928|NCT05823974|536916929|FG003|Overall Study|Withdrawal by Subject|0|||
148846929|NCT05823974|536916930|FG004|Overall Study|Withdrawal by Subject|2|||
148846930|NCT05823974|536916931|FG005|Overall Study|Withdrawal by Subject|3|||
148846931|NCT05823974|536916932|FG006|Overall Study|Withdrawal by Subject|1|||
148846932|NCT05823974|536916933|FG007|Overall Study|Withdrawal by Subject|1|||
148846933|NCT05823974|536916934|FG008|Overall Study|Withdrawal by Subject|2|||
148846934|NCT05823974|536916935|FG009|Overall Study|Withdrawal by Subject|1|||
148846935|NCT05823974|536916936|FG010|Overall Study|Withdrawal by Subject|1|||
148846936|NCT05823974|536916937|FG011|Overall Study|Withdrawal by Subject|0|||
148846937|NCT05823974|536916938|FG012|Overall Study|Withdrawal by Subject|0|||
148846938|NCT05823974|536916939|FG013|Overall Study|Withdrawal by Subject|1|||
148846939|NCT05823974|536916940|FG014|Overall Study|Withdrawal by Subject|1|||
148846940|NCT05823974|536916941|FG015|Overall Study|Withdrawal by Subject|3|||
148846941|NCT05823974|536916942|FG016|Overall Study|Withdrawal by Subject|0|||
148984449|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984450|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148846942|NCT05823974|536916943|FG017|Overall Study|Withdrawal by Subject|2|||
148846943|NCT05823974|536916944|FG018|Overall Study|Withdrawal by Subject|2|||
148846944|NCT05823974|536916945|FG019|Overall Study|Withdrawal by Subject|0|||
148846945|NCT05823974|536916946|FG020|Overall Study|Withdrawal by Subject|1|||
148846946|NCT05823974|536916926|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846947|NCT05823974|536916927|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846948|NCT05823974|536916928|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148846949|NCT05823974|536916929|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846950|NCT05823974|536916930|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846951|NCT05823974|536916931|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846952|NCT05823974|536916932|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846953|NCT05823974|536916933|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846954|NCT05823974|536916934|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846955|NCT05823974|536916935|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846956|NCT05823974|536916936|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846957|NCT05823974|536916937|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846958|NCT05823974|536916938|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846959|NCT05823974|536916939|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846960|NCT05823974|536916940|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
148846961|NCT05823974|536916941|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846962|NCT05823974|536916942|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846963|NCT05823974|536916943|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846964|NCT05823974|536916944|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846965|NCT05823974|536916945|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846966|NCT05823974|536916946|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
148846967|NCT05823974|536916926|FG000|Overall Study|Other|0|||
148846968|NCT05823974|536916927|FG001|Overall Study|Other|1|||
148846969|NCT05823974|536916928|FG002|Overall Study|Other|1|||
148846970|NCT05823974|536916929|FG003|Overall Study|Other|1|||
148846971|NCT05823974|536916930|FG004|Overall Study|Other|0|||
148846972|NCT05823974|536916931|FG005|Overall Study|Other|1|||
148846973|NCT05823974|536916932|FG006|Overall Study|Other|1|||
148846974|NCT05823974|536916933|FG007|Overall Study|Other|1|||
148846975|NCT05823974|536916934|FG008|Overall Study|Other|1|||
148846976|NCT05823974|536916935|FG009|Overall Study|Other|0|||
148846977|NCT05823974|536916936|FG010|Overall Study|Other|0|||
148846978|NCT05823974|536916937|FG011|Overall Study|Other|0|||
148846979|NCT05823974|536916938|FG012|Overall Study|Other|2|||
148846980|NCT05823974|536916939|FG013|Overall Study|Other|1|||
148846981|NCT05823974|536916940|FG014|Overall Study|Other|0|||
148846982|NCT05823974|536916941|FG015|Overall Study|Other|1|||
148846983|NCT05823974|536916942|FG016|Overall Study|Other|0|||
148846984|NCT05823974|536916943|FG017|Overall Study|Other|0|||
148846985|NCT05823974|536916944|FG018|Overall Study|Other|0|||
148846986|NCT05823974|536916945|FG019|Overall Study|Other|0|||
148846987|NCT05823974|536916946|FG020|Overall Study|Other|0|||
148846988|NCT00283803|536916947|FG000|Overall Study|Physician Decision|9|||
148846989|NCT00283803|536916947|FG000|Overall Study|Withdrawal by Subject|4|||
148846990|NCT01127607|536916948|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
148846991|NCT01127607|536916949|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
148846992|NCT01127607|536916948|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
148846993|NCT01127607|536916949|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
148846994|NCT01238991|536916953|FG000|Overall Study|Adverse Event|1|||
148846995|NCT01238991|536916954|FG001|Overall Study|Adverse Event|0|||
148846996|NCT01238991|536916955|FG002|Overall Study|Adverse Event|3|||
148846997|NCT01238991|536916956|FG003|Overall Study|Adverse Event|1|||
148846998|NCT01238991|536916957|FG004|Overall Study|Adverse Event|1|||
148846999|NCT01238991|536916958|FG005|Overall Study|Adverse Event|0|||
148847000|NCT01238991|536916959|FG006|Overall Study|Adverse Event|1|||
148847001|NCT01238991|536916960|FG007|Overall Study|Adverse Event|1|||
148847002|NCT01238991|536916961|FG008|Overall Study|Adverse Event|0|||
148847003|NCT01238991|536916962|FG009|Overall Study|Adverse Event|0|||
148847004|NCT01238991|536916953|FG000|Overall Study|Death|0|||
148847005|NCT01238991|536916954|FG001|Overall Study|Death|0|||
148847006|NCT01238991|536916955|FG002|Overall Study|Death|0|||
148847007|NCT01238991|536916956|FG003|Overall Study|Death|1|||
148847008|NCT01238991|536916957|FG004|Overall Study|Death|0|||
148847009|NCT01238991|536916958|FG005|Overall Study|Death|0|||
148847010|NCT01238991|536916959|FG006|Overall Study|Death|0|||
148847011|NCT01238991|536916960|FG007|Overall Study|Death|0|||
148847012|NCT01238991|536916961|FG008|Overall Study|Death|0|||
148847013|NCT01238991|536916962|FG009|Overall Study|Death|0|||
148847014|NCT01238991|536916953|FG000|Overall Study|Lack of Efficacy|0|||
148847015|NCT01238991|536916954|FG001|Overall Study|Lack of Efficacy|0|||
148847016|NCT01238991|536916955|FG002|Overall Study|Lack of Efficacy|1|||
148847017|NCT01238991|536916956|FG003|Overall Study|Lack of Efficacy|0|||
148847018|NCT01238991|536916957|FG004|Overall Study|Lack of Efficacy|0|||
148847019|NCT01238991|536916958|FG005|Overall Study|Lack of Efficacy|0|||
148847020|NCT01238991|536916959|FG006|Overall Study|Lack of Efficacy|0|||
148984451|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148847021|NCT01238991|536916960|FG007|Overall Study|Lack of Efficacy|0|||
148847022|NCT01238991|536916961|FG008|Overall Study|Lack of Efficacy|1|||
148847023|NCT01238991|536916962|FG009|Overall Study|Lack of Efficacy|0|||
148847024|NCT01238991|536916953|FG000|Overall Study|Withdrawal by Subject|0|||
148847025|NCT01238991|536916954|FG001|Overall Study|Withdrawal by Subject|0|||
148847026|NCT01238991|536916955|FG002|Overall Study|Withdrawal by Subject|1|||
148847027|NCT01238991|536916956|FG003|Overall Study|Withdrawal by Subject|0|||
148847028|NCT01238991|536916957|FG004|Overall Study|Withdrawal by Subject|0|||
148847029|NCT01238991|536916958|FG005|Overall Study|Withdrawal by Subject|0|||
148847030|NCT01238991|536916959|FG006|Overall Study|Withdrawal by Subject|0|||
148847031|NCT01238991|536916960|FG007|Overall Study|Withdrawal by Subject|0|||
148847032|NCT01238991|536916961|FG008|Overall Study|Withdrawal by Subject|0|||
148847033|NCT01238991|536916962|FG009|Overall Study|Withdrawal by Subject|0|||
148847034|NCT01238991|536916953|FG000|Overall Study|Study Terminated by Sponsor|0|||
148847035|NCT01238991|536916954|FG001|Overall Study|Study Terminated by Sponsor|0|||
148847036|NCT01238991|536916955|FG002|Overall Study|Study Terminated by Sponsor|0|||
148847037|NCT01238991|536916956|FG003|Overall Study|Study Terminated by Sponsor|0|||
148847038|NCT01238991|536916957|FG004|Overall Study|Study Terminated by Sponsor|1|||
148847039|NCT01238991|536916958|FG005|Overall Study|Study Terminated by Sponsor|0|||
148847040|NCT01238991|536916959|FG006|Overall Study|Study Terminated by Sponsor|7|||
148847041|NCT01238991|536916960|FG007|Overall Study|Study Terminated by Sponsor|4|||
148847042|NCT01238991|536916961|FG008|Overall Study|Study Terminated by Sponsor|2|||
148847043|NCT01238991|536916962|FG009|Overall Study|Study Terminated by Sponsor|2|||
148847044|NCT01238991|536916953|FG000|Overall Study|Caregiver's request|0|||
148847045|NCT01238991|536916954|FG001|Overall Study|Caregiver's request|0|||
148847046|NCT01238991|536916955|FG002|Overall Study|Caregiver's request|0|||
148847047|NCT01238991|536916956|FG003|Overall Study|Caregiver's request|0|||
148847048|NCT01238991|536916957|FG004|Overall Study|Caregiver's request|0|||
148847049|NCT01238991|536916958|FG005|Overall Study|Caregiver's request|0|||
148847050|NCT01238991|536916959|FG006|Overall Study|Caregiver's request|0|||
148847051|NCT01238991|536916960|FG007|Overall Study|Caregiver's request|0|||
148847052|NCT01238991|536916961|FG008|Overall Study|Caregiver's request|1|||
148847053|NCT01238991|536916962|FG009|Overall Study|Caregiver's request|0|||
148847054|NCT01238991|536916953|FG000|Overall Study|Admission to a nursing home|1|||
148847055|NCT01238991|536916954|FG001|Overall Study|Admission to a nursing home|0|||
148847056|NCT01238991|536916955|FG002|Overall Study|Admission to a nursing home|1|||
148847057|NCT01238991|536916956|FG003|Overall Study|Admission to a nursing home|0|||
148847058|NCT01238991|536916957|FG004|Overall Study|Admission to a nursing home|0|||
148847059|NCT01238991|536916958|FG005|Overall Study|Admission to a nursing home|0|||
148847060|NCT01238991|536916959|FG006|Overall Study|Admission to a nursing home|0|||
148847061|NCT01238991|536916960|FG007|Overall Study|Admission to a nursing home|0|||
148847062|NCT01238991|536916961|FG008|Overall Study|Admission to a nursing home|0|||
148847063|NCT01238991|536916962|FG009|Overall Study|Admission to a nursing home|0|||
148847064|NCT00662831|536916966|FG000|Overall Study|Death|4|||
148847065|NCT00662831|536916967|FG001|Overall Study|Death|1|||
148847066|NCT00662831|536916966|FG000|Overall Study|Lack of Efficacy|6|||
148847067|NCT00662831|536916967|FG001|Overall Study|Lack of Efficacy|6|||
148847068|NCT00662831|536916966|FG000|Overall Study|Lost to Follow-up|1|||
148847069|NCT00662831|536916967|FG001|Overall Study|Lost to Follow-up|0|||
148847070|NCT00662831|536916966|FG000|Overall Study|Withdrawal by Subject|2|||
148847071|NCT00662831|536916967|FG001|Overall Study|Withdrawal by Subject|1|||
148847072|NCT00662831|536916966|FG000|Overall Study|Other|62|||
148847073|NCT00662831|536916967|FG001|Overall Study|Other|31|||
148847074|NCT00662831|536916966|FG000|Overall Study|Protocol Violation|8|||
148847075|NCT00662831|536916967|FG001|Overall Study|Protocol Violation|4|||
148847076|NCT00662831|536916966|FG000|Overall Study|Adverse Event|23|||
148847077|NCT00662831|536916967|FG001|Overall Study|Adverse Event|16|||
148847078|NCT01961297|536916968|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
148847079|NCT01961297|536916969|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
148847080|NCT02482298|536916970|FG000|Overall Study|Withdrawal by Subject|2|||
148847081|NCT02482298|536916971|FG001|Overall Study|Withdrawal by Subject|1|||
148847082|NCT02482298|536916972|FG002|Overall Study|Withdrawal by Subject|2|||
148847083|NCT02482298|536916970|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
148847084|NCT02482298|536916971|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
148847085|NCT02482298|536916972|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
148847086|NCT02482298|536916970|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
148847087|NCT02482298|536916971|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
148847088|NCT02482298|536916972|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
148847089|NCT02482298|536916970|FG000|Overall Study|Lost to Follow-up|0|||
148847090|NCT02482298|536916971|FG001|Overall Study|Lost to Follow-up|1|||
148847091|NCT02482298|536916972|FG002|Overall Study|Lost to Follow-up|0|||
148847092|NCT03053440|536916977|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
148847093|NCT03053440|536916978|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
148847094|NCT03053440|536916977|FG000|Overall Study|Death|18|||
148847095|NCT03053440|536916978|FG001|Overall Study|Death|14|||
148847096|NCT03053440|536916977|FG000|Overall Study|Withdrawal by Subject|9|||
148847097|NCT03053440|536916978|FG001|Overall Study|Withdrawal by Subject|8|||
148847098|NCT03053440|536916977|FG000|Overall Study|Lost to Follow-up|1|||
148847099|NCT03053440|536916978|FG001|Overall Study|Lost to Follow-up|0|||
148847100|NCT03053440|536916977|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
148847101|NCT03053440|536916978|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
148776583|NCT04076059|536656822|FG000|Double Blind Phase|Progressive disease|22|||
148776584|NCT04076059|536656823|FG001|Double Blind Phase|Progressive disease|26|||
148776585|NCT04076059|536656824|FG002|Double Blind Phase|Progressive disease|0|||
148776586|NCT04076059|536656822|FG000|Double Blind Phase|Withdrawal by Subject|4|||
148776587|NCT04076059|536656823|FG001|Double Blind Phase|Withdrawal by Subject|11|||
148776588|NCT04076059|536656824|FG002|Double Blind Phase|Withdrawal by Subject|0|||
148776589|NCT04076059|536656822|FG000|Double Blind Phase|Death|1|||
148776590|NCT04076059|536656823|FG001|Double Blind Phase|Death|1|||
148776591|NCT04076059|536656824|FG002|Double Blind Phase|Death|0|||
148776592|NCT04076059|536656822|FG000|Double Blind Phase|Lost to Follow-up|1|||
148776593|NCT04076059|536656823|FG001|Double Blind Phase|Lost to Follow-up|0|||
148776594|NCT04076059|536656824|FG002|Double Blind Phase|Lost to Follow-up|0|||
148776595|NCT04076059|536656822|FG000|Double Blind Phase|Adverse Event|5|||
148776596|NCT04076059|536656823|FG001|Double Blind Phase|Adverse Event|1|||
148776597|NCT04076059|536656824|FG002|Double Blind Phase|Adverse Event|0|||
148776598|NCT04076059|536656822|FG000|Double Blind Phase|Ongoing Participants|82|||
148776599|NCT04076059|536656823|FG001|Double Blind Phase|Ongoing Participants|18|||
148776600|NCT04076059|536656824|FG002|Double Blind Phase|Ongoing Participants|0|||
148776601|NCT04076059|536656822|FG000|Double Blind Phase|Miscellaneous|3|||
148776602|NCT04076059|536656823|FG001|Double Blind Phase|Miscellaneous|1|||
148776603|NCT04076059|536656824|FG002|Double Blind Phase|Miscellaneous|0|||
148776604|NCT04076059|536656822|FG000|Double Blind Phase|Protocol Deviation|1|||
148776605|NCT04076059|536656823|FG001|Double Blind Phase|Protocol Deviation|1|||
148776606|NCT04076059|536656824|FG002|Double Blind Phase|Protocol Deviation|0|||
148776607|NCT04076059|536656822|FG000|Double Blind Phase|Did not take study drug|1|||
148776608|NCT04076059|536656823|FG001|Double Blind Phase|Did not take study drug|1|||
148776609|NCT04076059|536656824|FG002|Double Blind Phase|Did not take study drug|0|||
148776610|NCT04076059|536656822|FG000|Open Label Phase|Progressive disease|0|||
148776611|NCT04076059|536656823|FG001|Open Label Phase|Progressive disease|0|||
148776612|NCT04076059|536656824|FG002|Open Label Phase|Progressive disease|7|||
148776613|NCT04076059|536656822|FG000|Open Label Phase|Withdrawal by Subject|0|||
148776614|NCT04076059|536656823|FG001|Open Label Phase|Withdrawal by Subject|0|||
148776615|NCT04076059|536656824|FG002|Open Label Phase|Withdrawal by Subject|3|||
148776616|NCT04076059|536656822|FG000|Open Label Phase|Death|0|||
148776617|NCT04076059|536656823|FG001|Open Label Phase|Death|0|||
148776618|NCT04076059|536656824|FG002|Open Label Phase|Death|2|||
148776619|NCT04076059|536656822|FG000|Open Label Phase|Ongoing Participants|0|||
148776620|NCT04076059|536656823|FG001|Open Label Phase|Ongoing Participants|0|||
148776621|NCT04076059|536656824|FG002|Open Label Phase|Ongoing Participants|11|||
148776622|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Death|117|||
148776623|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Death|197|||
148776624|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
148776625|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
148776626|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
148776627|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
148776628|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
148776629|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
148776630|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
148776631|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
148776632|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
148776633|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
148776634|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
148776635|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
148776636|NCT02677896|536656825|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
148776637|NCT02677896|536656826|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
148776638|NCT02677896|536656825|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
148776639|NCT02677896|536656826|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
148776640|NCT02677896|536656825|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
148776641|NCT02677896|536656826|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
148776642|NCT02677896|536656825|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
148776643|NCT02677896|536656826|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
148776644|NCT02677896|536656825|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
148776645|NCT02677896|536656826|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
148776646|NCT02677896|536656825|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
148776647|NCT02677896|536656826|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
148776648|NCT02677896|536656825|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
148776649|NCT02677896|536656826|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
148776650|NCT01120249|536656838|FG000|Overall Study|No protocol treatment received|21|||
148776651|NCT01120249|536656839|FG001|Overall Study|No protocol treatment received|15|||
148776652|NCT01120249|536656838|FG000|Overall Study|Disease recurrence|107|||
148776653|NCT01120249|536656839|FG001|Overall Study|Disease recurrence|57|||
148776654|NCT01120249|536656838|FG000|Overall Study|Death|1|||
148847102|NCT03053440|536916977|FG000|Overall Study|Physician Decision|2|||
148847103|NCT03053440|536916978|FG001|Overall Study|Physician Decision|1|||
148847104|NCT03053440|536916977|FG000|Overall Study|Participant Randomized but died before dosing|1|||
148847105|NCT03053440|536916978|FG001|Overall Study|Participant Randomized but died before dosing|0|||
148847106|NCT01188551|536916979|FG000|Overall Study|Pharmacy issues|1|||
148847107|NCT01188551|536916980|FG001|Overall Study|Pharmacy issues|0|||
148847108|NCT01188551|536916981|FG002|Overall Study|Pharmacy issues|0|||
148847109|NCT01188551|536916982|FG003|Overall Study|Pharmacy issues|0|||
148847110|NCT01582009|536916983|FG000|Overall Study|Withdrawal by Subject|1|||
148847111|NCT01582009|536916983|FG000|Overall Study|Physician Decision|1|||
148847112|NCT00391053|536916986|FG000|Overall Study|Serious Adverse Events|1|||
148847113|NCT00391053|536916987|FG001|Overall Study|Serious Adverse Events|0|||
148847114|NCT00391053|536916988|FG002|Overall Study|Serious Adverse Events|1|||
148847115|NCT00391053|536916989|FG003|Overall Study|Serious Adverse Events|4|||
148847116|NCT00391053|536916986|FG000|Overall Study|Protocol Violation|2|||
148847117|NCT00391053|536916987|FG001|Overall Study|Protocol Violation|0|||
148847118|NCT00391053|536916988|FG002|Overall Study|Protocol Violation|0|||
148847119|NCT00391053|536916989|FG003|Overall Study|Protocol Violation|0|||
148847120|NCT00391053|536916986|FG000|Overall Study|Lost to Follow-up|1|||
148847121|NCT00391053|536916987|FG001|Overall Study|Lost to Follow-up|0|||
148847122|NCT00391053|536916988|FG002|Overall Study|Lost to Follow-up|0|||
148847123|NCT00391053|536916989|FG003|Overall Study|Lost to Follow-up|5|||
148847124|NCT00391053|536916986|FG000|Overall Study|Withdrawal by Subject|5|||
148847125|NCT00391053|536916987|FG001|Overall Study|Withdrawal by Subject|1|||
148847126|NCT00391053|536916988|FG002|Overall Study|Withdrawal by Subject|1|||
148847127|NCT00391053|536916989|FG003|Overall Study|Withdrawal by Subject|1|||
148847128|NCT02140970|536916991|FG000|Overall Study|Lost to Follow-up|1|||
148847129|NCT02140970|536916992|FG001|Overall Study|Lost to Follow-up|2|||
148847130|NCT02140970|536916991|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
148847131|NCT02140970|536916992|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
148847132|NCT02140970|536916991|FG000|Overall Study|Did not meet inclusion criteria|0|||
148847133|NCT02140970|536916992|FG001|Overall Study|Did not meet inclusion criteria|1|||
148847134|NCT03050450|536916993|FG000|Overall Study|Physician Decision|1|||
148847135|NCT03050450|536916994|FG001|Overall Study|Physician Decision|0|||
148847136|NCT03050450|536916995|FG002|Overall Study|Physician Decision|0|||
148847137|NCT03050450|536916996|FG003|Overall Study|Physician Decision|0|||
148847138|NCT03050450|536916997|FG004|Overall Study|Physician Decision|0|||
148847139|NCT03592771|536916998|FG000|Overall Study|Adverse Event|2|||
148847140|NCT03592771|536916999|FG001|Overall Study|Adverse Event|0|||
148847141|NCT03592771|536917000|FG002|Overall Study|Adverse Event|1|||
148847142|NCT03592771|536916998|FG000|Overall Study|Death|0|||
148847143|NCT03592771|536916999|FG001|Overall Study|Death|1|||
148847144|NCT03592771|536917000|FG002|Overall Study|Death|1|||
148847145|NCT03592771|536916998|FG000|Overall Study|Lost to Follow-up|5|||
148847146|NCT03592771|536916999|FG001|Overall Study|Lost to Follow-up|11|||
148847147|NCT03592771|536917000|FG002|Overall Study|Lost to Follow-up|15|||
148847148|NCT03592771|536916998|FG000|Overall Study|Withdrawal by Subject|0|||
148847149|NCT03592771|536916999|FG001|Overall Study|Withdrawal by Subject|2|||
148847150|NCT03592771|536917000|FG002|Overall Study|Withdrawal by Subject|0|||
148847151|NCT00735553|536917001|FG000|Overall Study|Study prematurely terminated|77|||
148847152|NCT05069597|536917002|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
148847153|NCT05069597|536917003|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
148847154|NCT02705105|536917004|FG000|Treatment|Objective Disease Progression|1|||
148847155|NCT02705105|536917005|FG001|Treatment|Objective Disease Progression|50|||
148847156|NCT02705105|536917004|FG000|Treatment|Withdrawal by Subject|3|||
148847157|NCT02705105|536917005|FG001|Treatment|Withdrawal by Subject|5|||
148847158|NCT02705105|536917004|FG000|Treatment|Adverse Event|0|||
148847159|NCT02705105|536917005|FG001|Treatment|Adverse Event|17|||
148847160|NCT02705105|536917004|FG000|Treatment|Clinical Disease Progression|0|||
148847161|NCT02705105|536917005|FG001|Treatment|Clinical Disease Progression|32|||
148847162|NCT02705105|536917004|FG000|Treatment|Physician Decision|0|||
148847163|NCT02705105|536917005|FG001|Treatment|Physician Decision|3|||
148847164|NCT02705105|536917004|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
148847165|NCT02705105|536917005|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
148847166|NCT02705105|536917004|FG000|Follow-Up|Death|3|||
148847167|NCT02705105|536917005|FG001|Follow-Up|Death|68|||
148847168|NCT02705105|536917004|FG000|Follow-Up|Withdrawal by Subject|1|||
148847169|NCT02705105|536917005|FG001|Follow-Up|Withdrawal by Subject|14|||
148847170|NCT02705105|536917004|FG000|Follow-Up|Study Terminated|0|||
148847171|NCT02705105|536917005|FG001|Follow-Up|Study Terminated|26|||
148847172|NCT02705105|536917004|FG000|Follow-Up|Discontinued per Amendment 3|0|||
148847173|NCT02705105|536917005|FG001|Follow-Up|Discontinued per Amendment 3|2|||
148847174|NCT04556591|536917007|FG000|Overall Study|Lost to Follow-up|1|||
148847175|NCT04556591|536917008|FG001|Overall Study|Lost to Follow-up|0|||
148847176|NCT04556591|536917007|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
148847177|NCT04556591|536917008|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
148847178|NCT03332173|536917009|FG000|Overall Study|Death|7|||
148847179|NCT03332173|536917009|FG000|Overall Study|Withdrawal by Subject|6|||
148847180|NCT03332173|536917009|FG000|Overall Study|Lost to Follow-up|2|||
148847181|NCT03332173|536917009|FG000|Overall Study|Transferred to long-term extension study|29|||
148847182|NCT02553928|536917010|FG000|Overall Study|Adverse Event|2|||
148847183|NCT02553928|536917011|FG001|Overall Study|Adverse Event|1|||
148847184|NCT02553928|536917010|FG000|Overall Study|Lost to Follow-up|0|||
148847185|NCT02553928|536917011|FG001|Overall Study|Lost to Follow-up|1|||
148847186|NCT02553928|536917010|FG000|Overall Study|Administrative reason(s)|0|||
148847187|NCT02553928|536917011|FG001|Overall Study|Administrative reason(s)|1|||
148847188|NCT01485796|536917012|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
148847189|NCT01485796|536917012|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
148847190|NCT01485796|536917012|FG000|Period 2: Epoch 2|Adverse Event|3|||
148847191|NCT01485796|536917012|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
148847192|NCT01485796|536917012|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
148847193|NCT01485796|536917012|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
148847194|NCT01485796|536917012|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
148847195|NCT01485796|536917012|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
148847196|NCT04830215|536917013|FG000|Overall Study|Adverse Event|6|||
148847197|NCT04830215|536917013|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
148847198|NCT04830215|536917013|FG000|Overall Study|Withdrawal by Subject|3|||
148847199|NCT04830215|536917013|FG000|Overall Study|Protocol Deviation|1|||
148847200|NCT00211172|536917018|FG000|Overall Study|Died or lost health plan eligibility|39|||
148847201|NCT00211172|536917019|FG001|Overall Study|Died or lost health plan eligibility|32|||
148847202|NCT00770562|536917020|FG000|Overall Study|Did not take treatment|1|||
148847203|NCT00770562|536917021|FG001|Overall Study|Did not take treatment|1|||
148847204|NCT01643408|536917022|FG000|Overall Study|Adverse Event|12|||
148847205|NCT01643408|536917022|FG000|Overall Study|Other|2|||
148847206|NCT00292045|536917026|FG000|Core Study (Through Week 13)|Adverse Event|1|||
148847207|NCT00292045|536917026|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
148847208|NCT04474197|536917027|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
148847209|NCT04474197|536917028|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
148847210|NCT04474197|536917029|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
148847211|NCT04474197|536917030|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
148847212|NCT00606411|536917031|FG000|Overall Study|Adverse Event|1|||
148847213|NCT00606411|536917032|FG001|Overall Study|Adverse Event|2|||
148847214|NCT00606411|536917031|FG000|Overall Study|Lack of Adherence|1|||
148847215|NCT00606411|536917032|FG001|Overall Study|Lack of Adherence|1|||
148847216|NCT00606411|536917031|FG000|Overall Study|Lack of Efficacy|1|||
148847217|NCT00606411|536917032|FG001|Overall Study|Lack of Efficacy|1|||
148847218|NCT00606411|536917031|FG000|Overall Study|Withdrawal by Subject|2|||
148847219|NCT00606411|536917032|FG001|Overall Study|Withdrawal by Subject|0|||
148847220|NCT00606411|536917031|FG000|Overall Study|Lost to Follow-up|1|||
148847221|NCT00606411|536917032|FG001|Overall Study|Lost to Follow-up|2|||
148847222|NCT00606411|536917031|FG000|Overall Study|Move out of state|0|||
148847223|NCT00606411|536917032|FG001|Overall Study|Move out of state|1|||
148847224|NCT00624468|536917034|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
148847225|NCT00624468|536917035|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
148847226|NCT00624468|536917036|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
148847227|NCT00624468|536917037|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
148847228|NCT00624468|536917034|FG000|Double-blind Period|Withdrew Prematurely|1|||
148847229|NCT00624468|536917035|FG001|Double-blind Period|Withdrew Prematurely|1|||
148847230|NCT00624468|536917036|FG002|Double-blind Period|Withdrew Prematurely|0|||
148847231|NCT00624468|536917037|FG003|Double-blind Period|Withdrew Prematurely|0|||
148847232|NCT00624468|536917034|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
148847233|NCT00624468|536917035|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
148847234|NCT00624468|536917036|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
148847235|NCT00624468|536917037|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
148847236|NCT00624468|536917034|FG000|Safety Follow-up (SFU) Period|Other|0|||
148847237|NCT00624468|536917035|FG001|Safety Follow-up (SFU) Period|Other|0|||
148847238|NCT00624468|536917036|FG002|Safety Follow-up (SFU) Period|Other|1|||
148847239|NCT00624468|536917037|FG003|Safety Follow-up (SFU) Period|Other|1|||
148847240|NCT00635349|536917039|FG000|Overall Study|Other|8|||
148847241|NCT00635349|536917040|FG001|Overall Study|Other|6|||
148847242|NCT00635349|536917039|FG000|Overall Study|Protocol Violation|18|||
148847243|NCT00635349|536917040|FG001|Overall Study|Protocol Violation|22|||
148847244|NCT00635349|536917039|FG000|Overall Study|Withdrawal by Subject|3|||
148847245|NCT00635349|536917040|FG001|Overall Study|Withdrawal by Subject|8|||
148847246|NCT00635349|536917039|FG000|Overall Study|Lost to Follow-up|4|||
148847247|NCT00635349|536917040|FG001|Overall Study|Lost to Follow-up|3|||
148847248|NCT00635349|536917039|FG000|Overall Study|Adverse Event|11|||
148847249|NCT00635349|536917040|FG001|Overall Study|Adverse Event|9|||
148847250|NCT02569476|536917043|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
148847251|NCT02569476|536917043|FG000|Overall Study|Death|33|||
148847252|NCT02569476|536917043|FG000|Overall Study|Withdrawal by Subject|9|||
148984452|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
148984453|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984454|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984455|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984456|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984457|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984458|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984459|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
148984460|NCT01609556|537419458|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
148984461|NCT01609556|537419459|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984462|NCT01609556|537419460|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984463|NCT01609556|537419461|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984464|NCT01609556|537419462|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984465|NCT01609556|537419463|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
148984466|NCT01609556|537419464|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984467|NCT01609556|537419465|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984468|NCT01609556|537419466|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984469|NCT01609556|537419467|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984470|NCT01609556|537419468|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
148984471|NCT01609556|537419469|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984472|NCT01609556|537419470|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984473|NCT01609556|537419471|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984474|NCT01609556|537419472|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148984475|NCT01609556|537419473|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
148847253|NCT02569476|536917043|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
148847254|NCT02569476|536917043|FG000|Overall Study|Palliative care|1|||
148847255|NCT02569476|536917043|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
148847256|NCT02569476|536917043|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
148847257|NCT01071954|536917044|FG000|Overall Study|Noncompliance|4|||
148847258|NCT01071954|536917044|FG000|Overall Study|Adverse Event|1|||
148847259|NCT01071954|536917044|FG000|Overall Study|Withdrawal by Subject|11|||
148847260|NCT01071954|536917044|FG000|Overall Study|Requirement for Alternative Therapy|5|||
148847261|NCT01071954|536917044|FG000|Overall Study|Administrative Decision|5|||
148847262|NCT01071954|536917044|FG000|Overall Study|Protocol Specified Criteria|1|||
148847263|NCT01434654|536917045|FG000|Overall Study|Withdrawal by Subject|1|||
148847264|NCT01434654|536917046|FG001|Overall Study|Withdrawal by Subject|0|||
148847265|NCT01434654|536917045|FG000|Overall Study|Lost to Follow-up|1|||
148847266|NCT01434654|536917046|FG001|Overall Study|Lost to Follow-up|0|||
148847267|NCT00703963|536917047|FG000|Overall Study|Withdrawal by Subject|7|||
148847268|NCT00703963|536917048|FG001|Overall Study|Withdrawal by Subject|13|||
148847269|NCT00703963|536917047|FG000|Overall Study|Physician Decision|0|||
148847270|NCT00703963|536917048|FG001|Overall Study|Physician Decision|1|||
148847271|NCT01340664|536917049|FG000|Overall Study|Adverse Event|0|||
148847272|NCT01340664|536917050|FG001|Overall Study|Adverse Event|1|||
148847273|NCT01340664|536917051|FG002|Overall Study|Adverse Event|7|||
148847274|NCT01340664|536917049|FG000|Overall Study|Lost to Follow-up|2|||
148847275|NCT01340664|536917050|FG001|Overall Study|Lost to Follow-up|0|||
148847276|NCT01340664|536917051|FG002|Overall Study|Lost to Follow-up|2|||
148847277|NCT01340664|536917049|FG000|Overall Study|Withdrawal by Subject|2|||
148847278|NCT01340664|536917050|FG001|Overall Study|Withdrawal by Subject|4|||
148847279|NCT01340664|536917051|FG002|Overall Study|Withdrawal by Subject|0|||
148847280|NCT01340664|536917049|FG000|Overall Study|Glycemic withdrawal criteria|2|||
148847281|NCT01340664|536917050|FG001|Overall Study|Glycemic withdrawal criteria|0|||
148847282|NCT01340664|536917051|FG002|Overall Study|Glycemic withdrawal criteria|0|||
148847283|NCT01340664|536917049|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
148847284|NCT01340664|536917050|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
148847285|NCT01340664|536917051|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
148847286|NCT01340664|536917049|FG000|Overall Study|Other|1|||
148984476|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984477|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984478|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984479|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984480|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984481|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
149029985|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
149029986|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
148847287|NCT01340664|536917050|FG001|Overall Study|Other|2|||
148847288|NCT01340664|536917051|FG002|Overall Study|Other|2|||
148847289|NCT03900728|536917053|FG000|Overall Study|No text responses|0|||
148847290|NCT03900728|536917054|FG001|Overall Study|No text responses|0|||
148847291|NCT03900728|536917055|FG002|Overall Study|No text responses|4|||
148984482|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984483|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984484|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984485|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148984486|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148847292|NCT02969915|536917060|FG000|Overall Study|Death|104|||
148847293|NCT02969915|536917061|FG001|Overall Study|Death|125|||
148847294|NCT02969915|536917060|FG000|Overall Study|Lost to Follow-up|108|||
148847295|NCT02969915|536917061|FG001|Overall Study|Lost to Follow-up|112|||
148847296|NCT02969915|536917060|FG000|Overall Study|Censored due to COVID-19|481|||
148847297|NCT02969915|536917061|FG001|Overall Study|Censored due to COVID-19|471|||
148847298|NCT02520388|536917062|FG000|Overall Study|Physician Decision|1|||
148847299|NCT02520388|536917063|FG001|Overall Study|Physician Decision|0|||
148847300|NCT02520388|536917062|FG000|Overall Study|Subject or parent/guardian request|0|||
148847301|NCT02520388|536917063|FG001|Overall Study|Subject or parent/guardian request|6|||
148847302|NCT02520388|536917062|FG000|Overall Study|Adverse Event|1|||
148847303|NCT02520388|536917063|FG001|Overall Study|Adverse Event|4|||
148847304|NCT02520388|536917062|FG000|Overall Study|Lost to Follow-up|3|||
148847305|NCT02520388|536917063|FG001|Overall Study|Lost to Follow-up|2|||
148984487|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
148847306|NCT02520388|536917062|FG000|Overall Study|Other (reason not defined)|4|||
148847307|NCT02520388|536917063|FG001|Overall Study|Other (reason not defined)|4|||
148847308|NCT05588440|536917066|FG000|Overall Study|Sponsor Decision|2|||
148847309|NCT05588440|536917067|FG001|Overall Study|Sponsor Decision|0|||
148847310|NCT05588440|536917068|FG002|Overall Study|Sponsor Decision|1|||
148847311|NCT05588440|536917066|FG000|Overall Study|Death|1|||
148847312|NCT05588440|536917067|FG001|Overall Study|Death|1|||
148847313|NCT05588440|536917068|FG002|Overall Study|Death|1|||
148847314|NCT05588440|536917066|FG000|Overall Study|Screen Fail|0|||
148847315|NCT05588440|536917067|FG001|Overall Study|Screen Fail|1|||
148847316|NCT05588440|536917068|FG002|Overall Study|Screen Fail|1|||
148847317|NCT05588440|536917066|FG000|Overall Study|Withdrawal by Subject|0|||
148847318|NCT05588440|536917067|FG001|Overall Study|Withdrawal by Subject|0|||
148847319|NCT05588440|536917068|FG002|Overall Study|Withdrawal by Subject|1|||
148847320|NCT01154452|536917069|FG000|Phase Ib|Not Treated|1|||
148847321|NCT01154452|536917070|FG001|Phase Ib|Not Treated|0|||
148847322|NCT01154452|536917071|FG002|Phase Ib|Not Treated|0|||
148847323|NCT01154452|536917072|FG003|Phase Ib|Not Treated|0|||
148847324|NCT01154452|536917069|FG000|Phase Ib|Adverse Event|2|||
148847325|NCT01154452|536917070|FG001|Phase Ib|Adverse Event|1|||
148847326|NCT01154452|536917071|FG002|Phase Ib|Adverse Event|0|||
148847327|NCT01154452|536917072|FG003|Phase Ib|Adverse Event|0|||
148847328|NCT01154452|536917069|FG000|Phase II|Withdrawal by Subject|0|||
148847329|NCT01154452|536917070|FG001|Phase II|Withdrawal by Subject|0|||
148847330|NCT01154452|536917071|FG002|Phase II|Withdrawal by Subject|1|||
148847331|NCT01154452|536917072|FG003|Phase II|Withdrawal by Subject|2|||
148847332|NCT01154452|536917069|FG000|Phase II|Adverse Event|0|||
148847333|NCT01154452|536917070|FG001|Phase II|Adverse Event|0|||
148847334|NCT01154452|536917071|FG002|Phase II|Adverse Event|4|||
148847335|NCT01154452|536917072|FG003|Phase II|Adverse Event|4|||
148847336|NCT03706430|536917077|FG000|Overall Study|No A-Line placed|5|||
148847337|NCT03706430|536917077|FG000|Overall Study|Subject had gel nail polish|1|||
148847338|NCT03706430|536917077|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
148847339|NCT03706430|536917077|FG000|Overall Study|Cancelled Case|6|||
148847340|NCT03706430|536917077|FG000|Overall Study|Physician Decision|2|||
148847341|NCT00145626|536917078|FG000|Overall Study|Did not have NK infusions|2|||
148847342|NCT00145626|536917078|FG000|Overall Study|Turned 2 years old before treatment|1|||
148847343|NCT00145626|536917078|FG000|Overall Study|Death|1|||
148847344|NCT00145626|536917078|FG000|Overall Study|Withdrawal by Subject|1|||
148847345|NCT01392573|536917079|FG000|Overall Study|Adverse Event|1|||
148984488|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
148847346|NCT01392573|536917080|FG001|Overall Study|Adverse Event|3|||
148847347|NCT01392573|536917079|FG000|Overall Study|Lack of Efficacy|1|||
148847348|NCT01392573|536917080|FG001|Overall Study|Lack of Efficacy|2|||
148847349|NCT01392573|536917079|FG000|Overall Study|Protocol Violation|0|||
148984489|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
148984490|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
148984491|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
148984492|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984493|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148847350|NCT01392573|536917080|FG001|Overall Study|Protocol Violation|2|||
148847351|NCT01392573|536917079|FG000|Overall Study|Withdrawal Criteria|13|||
148847352|NCT01392573|536917080|FG001|Overall Study|Withdrawal Criteria|15|||
148847353|NCT01392573|536917079|FG000|Overall Study|Site closure|8|||
148847354|NCT01392573|536917080|FG001|Overall Study|Site closure|7|||
148847355|NCT01392573|536917079|FG000|Overall Study|Unclassified|9|||
148847356|NCT01392573|536917080|FG001|Overall Study|Unclassified|6|||
148847357|NCT00436436|536917081|FG000|Overall Study|Progression|4|||
148847358|NCT00436436|536917081|FG000|Overall Study|Adverse Event|2|||
148847359|NCT00436436|536917081|FG000|Overall Study|Death|6|||
148847360|NCT00200967|536917083|FG000|First Treatment Period|Withdrawal by Subject|5|||
148847361|NCT00200967|536917084|FG001|First Treatment Period|Withdrawal by Subject|1|||
148847362|NCT00200967|536917083|FG000|First Treatment Period|Pregnancy|1|||
148847363|NCT00200967|536917084|FG001|First Treatment Period|Pregnancy|0|||
148847364|NCT00200967|536917083|FG000|Wash-out Period|Lost to Follow-up|0|||
148847365|NCT00200967|536917084|FG001|Wash-out Period|Lost to Follow-up|1|||
148847366|NCT00200967|536917083|FG000|Second Treatment Period|Withdrawal by Subject|1|||
148847367|NCT00200967|536917084|FG001|Second Treatment Period|Withdrawal by Subject|2|||
148847368|NCT00200967|536917083|FG000|Run-out Period|Lost to Follow-up|1|||
148847369|NCT00200967|536917084|FG001|Run-out Period|Lost to Follow-up|0|||
148847370|NCT00980460|536917085|FG000|Overall Study|Death|0|||
148847371|NCT00980460|536917086|FG001|Overall Study|Death|0|||
148984494|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984495|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984496|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984497|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984498|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984499|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984500|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984501|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
149029987|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
149029988|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
149029989|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
148847372|NCT00980460|536917087|FG002|Overall Study|Death|1|||
148847373|NCT00980460|536917088|FG003|Overall Study|Death|2|||
148847374|NCT00980460|536917089|FG004|Overall Study|Death|1|||
148847375|NCT00980460|536917085|FG000|Overall Study|Lack of Efficacy|0|||
148847376|NCT00980460|536917086|FG001|Overall Study|Lack of Efficacy|0|||
148847377|NCT00980460|536917087|FG002|Overall Study|Lack of Efficacy|10|||
148847378|NCT00980460|536917088|FG003|Overall Study|Lack of Efficacy|6|||
148847379|NCT00980460|536917089|FG004|Overall Study|Lack of Efficacy|8|||
148847380|NCT00980460|536917085|FG000|Overall Study|Lost to Follow-up|0|||
148847381|NCT00980460|536917086|FG001|Overall Study|Lost to Follow-up|0|||
148847382|NCT00980460|536917087|FG002|Overall Study|Lost to Follow-up|0|||
148847383|NCT00980460|536917088|FG003|Overall Study|Lost to Follow-up|1|||
148847384|NCT00980460|536917089|FG004|Overall Study|Lost to Follow-up|0|||
148847385|NCT00980460|536917085|FG000|Overall Study|Physician Decision|0|||
148847386|NCT00980460|536917086|FG001|Overall Study|Physician Decision|0|||
148847387|NCT00980460|536917087|FG002|Overall Study|Physician Decision|11|||
148847388|NCT00980460|536917088|FG003|Overall Study|Physician Decision|5|||
148847389|NCT00980460|536917089|FG004|Overall Study|Physician Decision|3|||
148847390|NCT00980460|536917085|FG000|Overall Study|Withdrawal by Subject|0|||
148847391|NCT00980460|536917086|FG001|Overall Study|Withdrawal by Subject|0|||
148847392|NCT00980460|536917087|FG002|Overall Study|Withdrawal by Subject|1|||
148847393|NCT00980460|536917088|FG003|Overall Study|Withdrawal by Subject|0|||
148847394|NCT00980460|536917089|FG004|Overall Study|Withdrawal by Subject|0|||
148847395|NCT00980460|536917085|FG000|Overall Study|Ineligible|0|||
148847396|NCT00980460|536917086|FG001|Overall Study|Ineligible|2|||
148847397|NCT00980460|536917087|FG002|Overall Study|Ineligible|3|||
148847398|NCT00980460|536917088|FG003|Overall Study|Ineligible|1|||
148847399|NCT00980460|536917089|FG004|Overall Study|Ineligible|4|||
148847400|NCT00980460|536917085|FG000|Overall Study|Refusal of further therapy|0|||
148847401|NCT00980460|536917086|FG001|Overall Study|Refusal of further therapy|2|||
148847402|NCT00980460|536917087|FG002|Overall Study|Refusal of further therapy|3|||
148847403|NCT00980460|536917088|FG003|Overall Study|Refusal of further therapy|2|||
148847404|NCT00980460|536917089|FG004|Overall Study|Refusal of further therapy|0|||
148847405|NCT00980460|536917085|FG000|Overall Study|No therapy within 42 days of resection|0|||
148847406|NCT00980460|536917086|FG001|Overall Study|No therapy within 42 days of resection|0|||
148984502|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148984503|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
148847407|NCT00980460|536917087|FG002|Overall Study|No therapy within 42 days of resection|3|||
148847408|NCT00980460|536917088|FG003|Overall Study|No therapy within 42 days of resection|1|||
148847409|NCT00980460|536917089|FG004|Overall Study|No therapy within 42 days of resection|0|||
148984504|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
148984505|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
148984506|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
148847410|NCT00980460|536917085|FG000|Overall Study|No transplant by protocol timepoints|0|||
148847411|NCT00980460|536917086|FG001|Overall Study|No transplant by protocol timepoints|0|||
148984507|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
148984508|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148847412|NCT00980460|536917087|FG002|Overall Study|No transplant by protocol timepoints|3|||
148847413|NCT00980460|536917088|FG003|Overall Study|No transplant by protocol timepoints|0|||
148847414|NCT00980460|536917089|FG004|Overall Study|No transplant by protocol timepoints|0|||
148984509|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984510|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148847415|NCT02744612|536918879|FG000|Overall Study|Withdrawal by Subject|0|||
148847416|NCT02744612|536918880|FG001|Overall Study|Withdrawal by Subject|2|||
148847417|NCT02220855|536918882|FG000|Overall Study|Adverse Event|8|||
148847418|NCT02220855|536918882|FG000|Overall Study|Disease Progression|5|||
148847419|NCT02220855|536918882|FG000|Overall Study|Withdrawal by Subject|1|||
148847420|NCT03419897|536918883|FG000|Overall Study|Death|180|||
148847421|NCT03419897|536918883|FG000|Overall Study|Lost to Follow-up|1|||
148847422|NCT03419897|536918883|FG000|Overall Study|Withdrawal by Subject|6|||
148847423|NCT03419897|536918883|FG000|Overall Study|Sponsor Decision|61|||
148847424|NCT03419897|536918883|FG000|Overall Study|Physician Decision|1|||
148847425|NCT01945216|536918886|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
148847426|NCT01945216|536918886|FG000|Overall Study|Protocol Violation|42|||
148847427|NCT01945216|536918886|FG000|Overall Study|CRF not assured by investigators|5|||
148847428|NCT01905943|536918892|FG000|Overall Study|Withdrawal of consent|90|||
148847429|NCT01905943|536918892|FG000|Overall Study|Lost to Follow-up|16|||
148847430|NCT01905943|536918892|FG000|Overall Study|Investigator discretion|7|||
148847431|NCT01905943|536918892|FG000|Overall Study|Death|186|||
148847432|NCT01905943|536918892|FG000|Overall Study|Adverse Event|3|||
148847433|NCT01905943|536918892|FG000|Overall Study|Other|12|||
148847434|NCT02574078|536918895|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847435|NCT02574078|536918896|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847436|NCT02574078|536918897|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847437|NCT02574078|536918898|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847438|NCT02574078|536918899|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847439|NCT02574078|536918900|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
148847440|NCT02574078|536918901|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
148847441|NCT02574078|536918902|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847442|NCT02574078|536918903|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
148847443|NCT02574078|536918904|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847444|NCT02574078|536918905|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847445|NCT02574078|536918906|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847446|NCT02574078|536918907|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
148847447|NCT02574078|536918895|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
148847448|NCT02574078|536918896|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
148847449|NCT02574078|536918897|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
148847450|NCT02574078|536918898|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
148847451|NCT02574078|536918899|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
148847452|NCT02574078|536918900|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
148847453|NCT02574078|536918901|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
148847454|NCT02574078|536918902|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
148847455|NCT02574078|536918903|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
148847456|NCT02574078|536918904|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
148847457|NCT02574078|536918905|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
148847458|NCT02574078|536918906|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
148847459|NCT02574078|536918907|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
148847460|NCT02574078|536918895|FG000|Pre-Treatment Period|Other reasons|0|||
148847461|NCT02574078|536918896|FG001|Pre-Treatment Period|Other reasons|0|||
148847462|NCT02574078|536918897|FG002|Pre-Treatment Period|Other reasons|0|||
148847463|NCT02574078|536918898|FG003|Pre-Treatment Period|Other reasons|0|||
148847464|NCT02574078|536918899|FG004|Pre-Treatment Period|Other reasons|0|||
148847465|NCT02574078|536918900|FG005|Pre-Treatment Period|Other reasons|0|||
148847466|NCT02574078|536918901|FG006|Pre-Treatment Period|Other reasons|2|||
148847467|NCT02574078|536918902|FG007|Pre-Treatment Period|Other reasons|0|||
148847468|NCT02574078|536918903|FG008|Pre-Treatment Period|Other reasons|0|||
148847469|NCT02574078|536918904|FG009|Pre-Treatment Period|Other reasons|0|||
148847470|NCT02574078|536918905|FG010|Pre-Treatment Period|Other reasons|2|||
148847471|NCT02574078|536918906|FG011|Pre-Treatment Period|Other reasons|0|||
148847472|NCT02574078|536918907|FG012|Pre-Treatment Period|Other reasons|0|||
148847473|NCT02574078|536918895|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
148847474|NCT02574078|536918896|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
148847475|NCT02574078|536918897|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
148847476|NCT02574078|536918898|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
148847477|NCT02574078|536918899|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
148847478|NCT02574078|536918900|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
148847479|NCT02574078|536918901|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
148984511|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148847480|NCT02574078|536918902|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
148847481|NCT02574078|536918903|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
148984512|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148847482|NCT02574078|536918904|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
148847483|NCT02574078|536918905|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
148847484|NCT02574078|536918906|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
148847485|NCT02574078|536918907|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
148847486|NCT02574078|536918895|FG000|Treatment Period|Disease progression|6|||
148847487|NCT02574078|536918896|FG001|Treatment Period|Disease progression|4|||
148847488|NCT02574078|536918897|FG002|Treatment Period|Disease progression|7|||
148847489|NCT02574078|536918898|FG003|Treatment Period|Disease progression|18|||
148847490|NCT02574078|536918899|FG004|Treatment Period|Disease progression|16|||
148847491|NCT02574078|536918900|FG005|Treatment Period|Disease progression|26|||
148847492|NCT02574078|536918901|FG006|Treatment Period|Disease progression|5|||
148847493|NCT02574078|536918902|FG007|Treatment Period|Disease progression|9|||
148847494|NCT02574078|536918903|FG008|Treatment Period|Disease progression|8|||
148847495|NCT02574078|536918904|FG009|Treatment Period|Disease progression|5|||
148847496|NCT02574078|536918905|FG010|Treatment Period|Disease progression|20|||
148847497|NCT02574078|536918906|FG011|Treatment Period|Disease progression|29|||
148847498|NCT02574078|536918907|FG012|Treatment Period|Disease progression|2|||
148847499|NCT02574078|536918895|FG000|Treatment Period|Study drug toxicity|1|||
148847500|NCT02574078|536918896|FG001|Treatment Period|Study drug toxicity|1|||
148847501|NCT02574078|536918897|FG002|Treatment Period|Study drug toxicity|0|||
148847502|NCT02574078|536918898|FG003|Treatment Period|Study drug toxicity|5|||
148847503|NCT02574078|536918899|FG004|Treatment Period|Study drug toxicity|3|||
148847504|NCT02574078|536918900|FG005|Treatment Period|Study drug toxicity|1|||
148847505|NCT02574078|536918901|FG006|Treatment Period|Study drug toxicity|2|||
148847506|NCT02574078|536918902|FG007|Treatment Period|Study drug toxicity|0|||
148847507|NCT02574078|536918903|FG008|Treatment Period|Study drug toxicity|2|||
148847508|NCT02574078|536918904|FG009|Treatment Period|Study drug toxicity|1|||
148847509|NCT02574078|536918905|FG010|Treatment Period|Study drug toxicity|16|||
148847510|NCT02574078|536918906|FG011|Treatment Period|Study drug toxicity|2|||
148847511|NCT02574078|536918907|FG012|Treatment Period|Study drug toxicity|4|||
148847512|NCT02574078|536918895|FG000|Treatment Period|Death|2|||
148847513|NCT02574078|536918896|FG001|Treatment Period|Death|0|||
148847514|NCT02574078|536918897|FG002|Treatment Period|Death|0|||
148847515|NCT02574078|536918898|FG003|Treatment Period|Death|0|||
148847516|NCT02574078|536918899|FG004|Treatment Period|Death|1|||
148847517|NCT02574078|536918900|FG005|Treatment Period|Death|1|||
148847518|NCT02574078|536918901|FG006|Treatment Period|Death|1|||
148847519|NCT02574078|536918902|FG007|Treatment Period|Death|1|||
148847520|NCT02574078|536918903|FG008|Treatment Period|Death|7|||
148847521|NCT02574078|536918904|FG009|Treatment Period|Death|1|||
148847522|NCT02574078|536918905|FG010|Treatment Period|Death|0|||
148847523|NCT02574078|536918906|FG011|Treatment Period|Death|2|||
148847524|NCT02574078|536918907|FG012|Treatment Period|Death|1|||
148847525|NCT02574078|536918895|FG000|Treatment Period|Adverse event unrelated to drug|0|||
148847526|NCT02574078|536918896|FG001|Treatment Period|Adverse event unrelated to drug|0|||
148847527|NCT02574078|536918897|FG002|Treatment Period|Adverse event unrelated to drug|1|||
148847528|NCT02574078|536918898|FG003|Treatment Period|Adverse event unrelated to drug|0|||
148847529|NCT02574078|536918899|FG004|Treatment Period|Adverse event unrelated to drug|2|||
148847530|NCT02574078|536918900|FG005|Treatment Period|Adverse event unrelated to drug|3|||
148847531|NCT02574078|536918901|FG006|Treatment Period|Adverse event unrelated to drug|0|||
148847532|NCT02574078|536918902|FG007|Treatment Period|Adverse event unrelated to drug|0|||
148847533|NCT02574078|536918903|FG008|Treatment Period|Adverse event unrelated to drug|1|||
148847534|NCT02574078|536918904|FG009|Treatment Period|Adverse event unrelated to drug|2|||
148847535|NCT02574078|536918905|FG010|Treatment Period|Adverse event unrelated to drug|4|||
148847536|NCT02574078|536918906|FG011|Treatment Period|Adverse event unrelated to drug|1|||
148847537|NCT02574078|536918907|FG012|Treatment Period|Adverse event unrelated to drug|0|||
148847538|NCT02574078|536918895|FG000|Treatment Period|Administrative reason by Sponsor|0|||
148847539|NCT02574078|536918896|FG001|Treatment Period|Administrative reason by Sponsor|1|||
148847540|NCT02574078|536918897|FG002|Treatment Period|Administrative reason by Sponsor|0|||
148847541|NCT02574078|536918898|FG003|Treatment Period|Administrative reason by Sponsor|0|||
148847542|NCT02574078|536918899|FG004|Treatment Period|Administrative reason by Sponsor|0|||
148847543|NCT02574078|536918900|FG005|Treatment Period|Administrative reason by Sponsor|0|||
148847544|NCT02574078|536918901|FG006|Treatment Period|Administrative reason by Sponsor|1|||
148847545|NCT02574078|536918902|FG007|Treatment Period|Administrative reason by Sponsor|0|||
148847546|NCT02574078|536918903|FG008|Treatment Period|Administrative reason by Sponsor|0|||
148847547|NCT02574078|536918904|FG009|Treatment Period|Administrative reason by Sponsor|0|||
148847548|NCT02574078|536918905|FG010|Treatment Period|Administrative reason by Sponsor|0|||
148847549|NCT02574078|536918906|FG011|Treatment Period|Administrative reason by Sponsor|0|||
148847550|NCT02574078|536918907|FG012|Treatment Period|Administrative reason by Sponsor|3|||
148847551|NCT02574078|536918895|FG000|Treatment Period|Other reasons|1|||
148847552|NCT02574078|536918896|FG001|Treatment Period|Other reasons|0|||
148847553|NCT02574078|536918897|FG002|Treatment Period|Other reasons|1|||
148847554|NCT02574078|536918898|FG003|Treatment Period|Other reasons|3|||
148847555|NCT02574078|536918899|FG004|Treatment Period|Other reasons|3|||
148847556|NCT02574078|536918900|FG005|Treatment Period|Other reasons|1|||
148847557|NCT02574078|536918901|FG006|Treatment Period|Other reasons|2|||
148847558|NCT02574078|536918902|FG007|Treatment Period|Other reasons|1|||
148847559|NCT02574078|536918903|FG008|Treatment Period|Other reasons|3|||
148847560|NCT02574078|536918904|FG009|Treatment Period|Other reasons|1|||
148847561|NCT02574078|536918905|FG010|Treatment Period|Other reasons|1|||
148847562|NCT02574078|536918906|FG011|Treatment Period|Other reasons|3|||
148847563|NCT02574078|536918907|FG012|Treatment Period|Other reasons|1|||
148847564|NCT02574078|536918895|FG000|Treatment Period|Participant request to stop drug|0|||
148847565|NCT02574078|536918896|FG001|Treatment Period|Participant request to stop drug|0|||
148847566|NCT02574078|536918897|FG002|Treatment Period|Participant request to stop drug|0|||
148847567|NCT02574078|536918898|FG003|Treatment Period|Participant request to stop drug|2|||
148847568|NCT02574078|536918899|FG004|Treatment Period|Participant request to stop drug|4|||
148847569|NCT02574078|536918900|FG005|Treatment Period|Participant request to stop drug|0|||
148847570|NCT02574078|536918901|FG006|Treatment Period|Participant request to stop drug|1|||
148847571|NCT02574078|536918902|FG007|Treatment Period|Participant request to stop drug|0|||
148847572|NCT02574078|536918903|FG008|Treatment Period|Participant request to stop drug|3|||
148847573|NCT02574078|536918904|FG009|Treatment Period|Participant request to stop drug|2|||
148847574|NCT02574078|536918905|FG010|Treatment Period|Participant request to stop drug|2|||
148847575|NCT02574078|536918906|FG011|Treatment Period|Participant request to stop drug|4|||
148847576|NCT02574078|536918907|FG012|Treatment Period|Participant request to stop drug|1|||
148847577|NCT02574078|536918895|FG000|Treatment Period|Participant withdrew consent|0|||
148847578|NCT02574078|536918896|FG001|Treatment Period|Participant withdrew consent|0|||
148847579|NCT02574078|536918897|FG002|Treatment Period|Participant withdrew consent|0|||
148847580|NCT02574078|536918898|FG003|Treatment Period|Participant withdrew consent|0|||
148847581|NCT02574078|536918899|FG004|Treatment Period|Participant withdrew consent|1|||
148847582|NCT02574078|536918900|FG005|Treatment Period|Participant withdrew consent|1|||
148847583|NCT02574078|536918901|FG006|Treatment Period|Participant withdrew consent|0|||
148847584|NCT02574078|536918902|FG007|Treatment Period|Participant withdrew consent|1|||
148847585|NCT02574078|536918903|FG008|Treatment Period|Participant withdrew consent|0|||
148847586|NCT02574078|536918904|FG009|Treatment Period|Participant withdrew consent|2|||
148847587|NCT02574078|536918905|FG010|Treatment Period|Participant withdrew consent|1|||
148847588|NCT02574078|536918906|FG011|Treatment Period|Participant withdrew consent|4|||
148847589|NCT02574078|536918907|FG012|Treatment Period|Participant withdrew consent|1|||
148847590|NCT02574078|536918895|FG000|Treatment Period|Participant no longer meets criteria|0|||
148847591|NCT02574078|536918896|FG001|Treatment Period|Participant no longer meets criteria|0|||
148847592|NCT02574078|536918897|FG002|Treatment Period|Participant no longer meets criteria|0|||
148847593|NCT02574078|536918898|FG003|Treatment Period|Participant no longer meets criteria|0|||
148847594|NCT02574078|536918899|FG004|Treatment Period|Participant no longer meets criteria|1|||
148847595|NCT02574078|536918900|FG005|Treatment Period|Participant no longer meets criteria|0|||
148847596|NCT02574078|536918901|FG006|Treatment Period|Participant no longer meets criteria|0|||
148847597|NCT02574078|536918902|FG007|Treatment Period|Participant no longer meets criteria|0|||
148847598|NCT02574078|536918903|FG008|Treatment Period|Participant no longer meets criteria|0|||
148847599|NCT02574078|536918904|FG009|Treatment Period|Participant no longer meets criteria|1|||
148847600|NCT02574078|536918905|FG010|Treatment Period|Participant no longer meets criteria|1|||
148847601|NCT02574078|536918906|FG011|Treatment Period|Participant no longer meets criteria|1|||
148847602|NCT02574078|536918907|FG012|Treatment Period|Participant no longer meets criteria|0|||
148847603|NCT02574078|536918895|FG000|Treatment Period|Lost to Follow-up|0|||
148847604|NCT02574078|536918896|FG001|Treatment Period|Lost to Follow-up|0|||
148847605|NCT02574078|536918897|FG002|Treatment Period|Lost to Follow-up|0|||
148847606|NCT02574078|536918898|FG003|Treatment Period|Lost to Follow-up|0|||
148984513|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984514|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984515|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984516|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984517|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984518|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984519|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
148984520|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
148984521|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
148984522|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
148984523|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
148984524|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984525|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984526|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984527|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984528|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984529|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984530|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984531|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148847607|NCT02574078|536918899|FG004|Treatment Period|Lost to Follow-up|0|||
148847608|NCT02574078|536918900|FG005|Treatment Period|Lost to Follow-up|0|||
148847609|NCT02574078|536918901|FG006|Treatment Period|Lost to Follow-up|0|||
148847610|NCT02574078|536918902|FG007|Treatment Period|Lost to Follow-up|0|||
148847611|NCT02574078|536918903|FG008|Treatment Period|Lost to Follow-up|0|||
148847612|NCT02574078|536918904|FG009|Treatment Period|Lost to Follow-up|1|||
148847613|NCT02574078|536918905|FG010|Treatment Period|Lost to Follow-up|0|||
148847614|NCT02574078|536918906|FG011|Treatment Period|Lost to Follow-up|1|||
148847615|NCT02574078|536918907|FG012|Treatment Period|Lost to Follow-up|0|||
148847616|NCT02574078|536918895|FG000|Treatment Period|Maximum clinical benefit|0|||
148847617|NCT02574078|536918896|FG001|Treatment Period|Maximum clinical benefit|0|||
148847618|NCT02574078|536918897|FG002|Treatment Period|Maximum clinical benefit|0|||
148847619|NCT02574078|536918898|FG003|Treatment Period|Maximum clinical benefit|0|||
148847620|NCT02574078|536918899|FG004|Treatment Period|Maximum clinical benefit|0|||
148847621|NCT02574078|536918900|FG005|Treatment Period|Maximum clinical benefit|0|||
148847622|NCT02574078|536918901|FG006|Treatment Period|Maximum clinical benefit|0|||
148847623|NCT02574078|536918902|FG007|Treatment Period|Maximum clinical benefit|0|||
148847624|NCT02574078|536918903|FG008|Treatment Period|Maximum clinical benefit|0|||
148847625|NCT02574078|536918904|FG009|Treatment Period|Maximum clinical benefit|1|||
148847626|NCT02574078|536918905|FG010|Treatment Period|Maximum clinical benefit|0|||
148847627|NCT02574078|536918906|FG011|Treatment Period|Maximum clinical benefit|0|||
148847628|NCT02574078|536918907|FG012|Treatment Period|Maximum clinical benefit|0|||
148847629|NCT02222688|536918908|FG000|Overall Study|Withdrawal by Subject|0|||
148847630|NCT02222688|536918909|FG001|Overall Study|Withdrawal by Subject|0|||
148847631|NCT02222688|536918910|FG002|Overall Study|Withdrawal by Subject|0|||
148847632|NCT02222688|536918911|FG003|Overall Study|Withdrawal by Subject|2|||
148847633|NCT02222688|536918912|FG004|Overall Study|Withdrawal by Subject|1|||
148847634|NCT02222688|536918913|FG005|Overall Study|Withdrawal by Subject|0|||
148847635|NCT02222688|536918914|FG006|Overall Study|Withdrawal by Subject|1|||
148847636|NCT02222688|536918908|FG000|Overall Study|Disease progression|1|||
148847637|NCT02222688|536918909|FG001|Overall Study|Disease progression|0|||
148847638|NCT02222688|536918910|FG002|Overall Study|Disease progression|0|||
148847639|NCT02222688|536918911|FG003|Overall Study|Disease progression|0|||
148847640|NCT02222688|536918912|FG004|Overall Study|Disease progression|0|||
148847641|NCT02222688|536918913|FG005|Overall Study|Disease progression|0|||
148847642|NCT02222688|536918914|FG006|Overall Study|Disease progression|0|||
148847643|NCT05935878|536918915|FG000|Overall Study|Death|1|||
148847644|NCT05935878|536918916|FG001|Overall Study|Death|2|||
148847645|NCT05935878|536918915|FG000|Overall Study|Withdrawal by Subject|5|||
148847646|NCT05935878|536918916|FG001|Overall Study|Withdrawal by Subject|5|||
148847647|NCT05935878|536918915|FG000|Overall Study|Revision of implant|1|||
148847648|NCT05935878|536918916|FG001|Overall Study|Revision of implant|1|||
148984532|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984533|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984534|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984535|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984536|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
148984537|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984538|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984539|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
148984540|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984541|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984542|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984543|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148847649|NCT05935878|536918915|FG000|Overall Study|Mobile bearing dislocation|0|||
148847650|NCT05935878|536918916|FG001|Overall Study|Mobile bearing dislocation|1|||
148847651|NCT00294671|536918921|FG000|Overall Study|Lack of Efficacy|11|||
148847652|NCT00294671|536918922|FG001|Overall Study|Lack of Efficacy|23|||
148847653|NCT00294671|536918921|FG000|Overall Study|Liver transplant|7|||
148847654|NCT00294671|536918922|FG001|Overall Study|Liver transplant|9|||
148847655|NCT00294671|536918921|FG000|Overall Study|Drug related adverse event (AE)|4|||
148847656|NCT00294671|536918922|FG001|Overall Study|Drug related adverse event (AE)|2|||
148847657|NCT00294671|536918921|FG000|Overall Study|Non-drug related AE|3|||
148984544|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984545|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984546|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984547|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984548|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984549|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148847658|NCT00294671|536918922|FG001|Overall Study|Non-drug related AE|2|||
148847659|NCT00294671|536918921|FG000|Overall Study|Lost to Follow-up|1|||
148847660|NCT00294671|536918922|FG001|Overall Study|Lost to Follow-up|3|||
148847661|NCT00294671|536918921|FG000|Overall Study|Non-compliance|1|||
148847662|NCT00294671|536918922|FG001|Overall Study|Non-compliance|0|||
148847663|NCT00294671|536918921|FG000|Overall Study|Death|0|||
148847664|NCT00294671|536918922|FG001|Overall Study|Death|1|||
148847665|NCT01734785|536918931|FG000|Open-Label Period|Adverse Event|0|||
148847666|NCT01734785|536918932|FG001|Open-Label Period|Adverse Event|0|||
148847667|NCT01734785|536918933|FG002|Open-Label Period|Adverse Event|0|||
148847668|NCT01734785|536918934|FG003|Open-Label Period|Adverse Event|9|||
148847669|NCT01734785|536918931|FG000|Open-Label Period|Lack of Efficacy|0|||
148847670|NCT01734785|536918932|FG001|Open-Label Period|Lack of Efficacy|0|||
148847671|NCT01734785|536918933|FG002|Open-Label Period|Lack of Efficacy|0|||
148847672|NCT01734785|536918934|FG003|Open-Label Period|Lack of Efficacy|1|||
148847673|NCT01734785|536918931|FG000|Open-Label Period|Protocol Violation|0|||
148847674|NCT01734785|536918932|FG001|Open-Label Period|Protocol Violation|0|||
148847675|NCT01734785|536918933|FG002|Open-Label Period|Protocol Violation|0|||
148847676|NCT01734785|536918934|FG003|Open-Label Period|Protocol Violation|13|||
148847677|NCT01734785|536918931|FG000|Open-Label Period|Lost to Follow-up|0|||
148847678|NCT01734785|536918932|FG001|Open-Label Period|Lost to Follow-up|0|||
148847679|NCT01734785|536918933|FG002|Open-Label Period|Lost to Follow-up|0|||
148847680|NCT01734785|536918934|FG003|Open-Label Period|Lost to Follow-up|14|||
148847681|NCT01734785|536918931|FG000|Open-Label Period|Withdrawal by Subject|0|||
148847682|NCT01734785|536918932|FG001|Open-Label Period|Withdrawal by Subject|0|||
148847683|NCT01734785|536918933|FG002|Open-Label Period|Withdrawal by Subject|0|||
148847684|NCT01734785|536918934|FG003|Open-Label Period|Withdrawal by Subject|12|||
148847685|NCT01734785|536918931|FG000|Open-Label Period|Other Reasons|0|||
148847686|NCT01734785|536918932|FG001|Open-Label Period|Other Reasons|0|||
148847687|NCT01734785|536918933|FG002|Open-Label Period|Other Reasons|0|||
148847688|NCT01734785|536918934|FG003|Open-Label Period|Other Reasons|224|||
148847689|NCT01734785|536918931|FG000|Double-Blind Period|Adverse Event|0|||
148847690|NCT01734785|536918932|FG001|Double-Blind Period|Adverse Event|3|||
148847691|NCT01734785|536918933|FG002|Double-Blind Period|Adverse Event|2|||
148847692|NCT01734785|536918934|FG003|Double-Blind Period|Adverse Event|0|||
148847693|NCT01734785|536918931|FG000|Double-Blind Period|Lack of Efficacy|0|||
148847694|NCT01734785|536918932|FG001|Double-Blind Period|Lack of Efficacy|1|||
148847695|NCT01734785|536918933|FG002|Double-Blind Period|Lack of Efficacy|0|||
148847696|NCT01734785|536918934|FG003|Double-Blind Period|Lack of Efficacy|0|||
148847697|NCT01734785|536918931|FG000|Double-Blind Period|Protocol Violation|0|||
148847698|NCT01734785|536918932|FG001|Double-Blind Period|Protocol Violation|1|||
148847699|NCT01734785|536918933|FG002|Double-Blind Period|Protocol Violation|1|||
148847700|NCT01734785|536918934|FG003|Double-Blind Period|Protocol Violation|0|||
148847701|NCT01734785|536918931|FG000|Double-Blind Period|Lost to Follow-up|2|||
148847702|NCT01734785|536918932|FG001|Double-Blind Period|Lost to Follow-up|4|||
148847703|NCT01734785|536918933|FG002|Double-Blind Period|Lost to Follow-up|2|||
148847704|NCT01734785|536918934|FG003|Double-Blind Period|Lost to Follow-up|0|||
148847705|NCT01734785|536918931|FG000|Double-Blind Period|Withdrawal by Subject|2|||
148847706|NCT01734785|536918932|FG001|Double-Blind Period|Withdrawal by Subject|0|||
148847707|NCT01734785|536918933|FG002|Double-Blind Period|Withdrawal by Subject|0|||
148847708|NCT01734785|536918934|FG003|Double-Blind Period|Withdrawal by Subject|0|||
148847709|NCT01734785|536918931|FG000|Double-Blind Period|Not treated|1|||
148847710|NCT01734785|536918932|FG001|Double-Blind Period|Not treated|0|||
148847711|NCT01734785|536918933|FG002|Double-Blind Period|Not treated|0|||
148847712|NCT01734785|536918934|FG003|Double-Blind Period|Not treated|0|||
148847713|NCT02397915|536918935|FG000|Period 1|Protocol Violation|0|||
148847714|NCT02397915|536918936|FG001|Period 1|Protocol Violation|1|||
148847715|NCT02397915|536918937|FG002|Period 1|Protocol Violation|0|||
148847716|NCT02397915|536918938|FG003|Period 1|Protocol Violation|0|||
148847717|NCT02397915|536918935|FG000|Period 1|Physician Decision|1|||
148847718|NCT02397915|536918936|FG001|Period 1|Physician Decision|0|||
148847719|NCT02397915|536918937|FG002|Period 1|Physician Decision|0|||
148847720|NCT02397915|536918938|FG003|Period 1|Physician Decision|0|||
148847721|NCT00368745|536918939|FG000|Double-blind Treatment Period|Adverse Event|6|||
148847722|NCT00368745|536918940|FG001|Double-blind Treatment Period|Adverse Event|6|||
148847723|NCT00368745|536918939|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
148847724|NCT00368745|536918940|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
148847725|NCT00368745|536918939|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
148847726|NCT00368745|536918940|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
148847727|NCT00368745|536918939|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
148847728|NCT00368745|536918940|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
148847729|NCT00368745|536918939|FG000|Double-blind Treatment Period|Other|7|||
148847730|NCT00368745|536918940|FG001|Double-blind Treatment Period|Other|6|||
148847731|NCT03292874|536918941|FG000|Overall Study|Due to pandemic|5|||
148847732|NCT03782259|536918947|FG000|Overall Study|Lost to Follow-up|1|||
148847733|NCT03782259|536918948|FG001|Overall Study|Lost to Follow-up|1|||
148847734|NCT03782259|536918947|FG000|Overall Study|Moved out of state|0|||
148847735|NCT03782259|536918948|FG001|Overall Study|Moved out of state|2|||
148847736|NCT03782259|536918947|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
148847737|NCT03782259|536918948|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
148847738|NCT03782259|536918947|FG000|Overall Study|Subject discontinued intervention|1|||
148847739|NCT03782259|536918948|FG001|Overall Study|Subject discontinued intervention|0|||
148847740|NCT00131352|536918949|FG000|Initial Treatment Period|Adverse Event|1|||
148847741|NCT00131352|536918950|FG001|Initial Treatment Period|Adverse Event|3|||
148847742|NCT00131352|536918949|FG000|Initial Treatment Period|Non-compliant|1|||
148847743|NCT00131352|536918950|FG001|Initial Treatment Period|Non-compliant|2|||
148847744|NCT00131352|536918949|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
148847745|NCT00131352|536918950|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
148847746|NCT00131352|536918949|FG000|Initial Treatment Period|Lack of Efficacy|6|||
148847747|NCT00131352|536918950|FG001|Initial Treatment Period|Lack of Efficacy|4|||
148847748|NCT00131352|536918949|FG000|Initial Treatment Period|Other|0|||
148847749|NCT00131352|536918950|FG001|Initial Treatment Period|Other|2|||
148847750|NCT00131352|536918949|FG000|Repeat Treatment Period|Adverse Event|1|||
148847751|NCT00131352|536918950|FG001|Repeat Treatment Period|Adverse Event|0|||
148847752|NCT00131352|536918949|FG000|Repeat Treatment Period|Other|1|||
148847753|NCT00131352|536918950|FG001|Repeat Treatment Period|Other|0|||
148847754|NCT02526212|536918951|FG000|Overall Study|Incarceration|1|||
148847755|NCT02526212|536918952|FG001|Overall Study|Incarceration|0|||
148847756|NCT02526212|536918951|FG000|Overall Study|Lost to Follow-up|1|||
148847757|NCT02526212|536918952|FG001|Overall Study|Lost to Follow-up|0|||
148847758|NCT02526212|536918951|FG000|Overall Study|Death|0|||
148847759|NCT02526212|536918952|FG001|Overall Study|Death|1|||
148847760|NCT00040742|536918953|FG000|Overall Study|Death|0|||
148847761|NCT00040742|536918954|FG001|Overall Study|Death|0|||
148847762|NCT00040742|536918955|FG002|Overall Study|Death|1|||
148847763|NCT00040742|536918956|FG003|Overall Study|Death|0|||
148847764|NCT00040742|536918953|FG000|Overall Study|Adverse Event|15|||
148847765|NCT00040742|536918954|FG001|Overall Study|Adverse Event|16|||
148847766|NCT00040742|536918955|FG002|Overall Study|Adverse Event|21|||
148847767|NCT00040742|536918956|FG003|Overall Study|Adverse Event|9|||
148847768|NCT00040742|536918953|FG000|Overall Study|Withdrawal by Subject|7|||
148847769|NCT00040742|536918954|FG001|Overall Study|Withdrawal by Subject|15|||
148847770|NCT00040742|536918955|FG002|Overall Study|Withdrawal by Subject|10|||
148847771|NCT00040742|536918956|FG003|Overall Study|Withdrawal by Subject|13|||
148847772|NCT00040742|536918953|FG000|Overall Study|Chemotoxicity|4|||
148847773|NCT00040742|536918954|FG001|Overall Study|Chemotoxicity|3|||
148847774|NCT00040742|536918955|FG002|Overall Study|Chemotoxicity|5|||
148847775|NCT00040742|536918956|FG003|Overall Study|Chemotoxicity|2|||
148847776|NCT00040742|536918953|FG000|Overall Study|Incomplete Forms|6|||
148847777|NCT00040742|536918954|FG001|Overall Study|Incomplete Forms|10|||
148847778|NCT00040742|536918955|FG002|Overall Study|Incomplete Forms|4|||
148847779|NCT00040742|536918956|FG003|Overall Study|Incomplete Forms|5|||
148847780|NCT00040742|536918953|FG000|Overall Study|Other medical|7|||
148847781|NCT00040742|536918954|FG001|Overall Study|Other medical|5|||
148847782|NCT00040742|536918955|FG002|Overall Study|Other medical|5|||
148847783|NCT00040742|536918956|FG003|Overall Study|Other medical|5|||
148847784|NCT00645840|536918957|FG000|Overall Study|Protocol Violation|3|||
148847785|NCT01823198|536918958|FG000|Overall Study|Physician Decision|0|||
148847786|NCT01823198|536918959|FG001|Overall Study|Physician Decision|1|||
148847787|NCT01823198|536918960|FG002|Overall Study|Physician Decision|0|||
148847788|NCT01823198|536918961|FG003|Overall Study|Physician Decision|0|||
148847789|NCT01823198|536918962|FG004|Overall Study|Physician Decision|0|||
148847790|NCT01823198|536918963|FG005|Overall Study|Physician Decision|3|||
148847791|NCT01823198|536918964|FG006|Overall Study|Physician Decision|3|||
148847792|NCT02441101|536918967|FG000|Overall Study|Withdrawal by Subject|1|||
148847793|NCT02441101|536918968|FG001|Overall Study|Withdrawal by Subject|0|||
148847794|NCT02441101|536918967|FG000|Overall Study|Lost to Follow-up|1|||
148847795|NCT02441101|536918968|FG001|Overall Study|Lost to Follow-up|0|||
148847796|NCT02441101|536918967|FG000|Overall Study|PI relocated and study terminated|1|||
148847797|NCT02441101|536918968|FG001|Overall Study|PI relocated and study terminated|0|||
148984550|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984551|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
148984552|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
148984553|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
148984554|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
148847798|NCT03012828|536918970|FG000|Overall Study|Lost to Follow-up|1|||
148847799|NCT03012828|536918971|FG001|Overall Study|Lost to Follow-up|0|||
148984555|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
148984556|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984557|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984558|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984559|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984560|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984561|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984562|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984563|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148847800|NCT03012828|536918972|FG002|Overall Study|Lost to Follow-up|1|||
148847801|NCT03012828|536918973|FG003|Overall Study|Lost to Follow-up|0|||
148847802|NCT03012828|536918974|FG004|Overall Study|Lost to Follow-up|1|||
148847803|NCT03012828|536918975|FG005|Overall Study|Lost to Follow-up|0|||
148847804|NCT03012828|536918970|FG000|Overall Study|Withdrawal by Subject|0|||
148847805|NCT03012828|536918971|FG001|Overall Study|Withdrawal by Subject|0|||
148847806|NCT03012828|536918972|FG002|Overall Study|Withdrawal by Subject|1|||
148847807|NCT03012828|536918973|FG003|Overall Study|Withdrawal by Subject|0|||
148847808|NCT03012828|536918974|FG004|Overall Study|Withdrawal by Subject|0|||
148847809|NCT03012828|536918975|FG005|Overall Study|Withdrawal by Subject|1|||
148847810|NCT03012828|536918970|FG000|Overall Study|Non-compliance with protocol|0|||
148847811|NCT03012828|536918971|FG001|Overall Study|Non-compliance with protocol|0|||
148847812|NCT03012828|536918972|FG002|Overall Study|Non-compliance with protocol|0|||
148847813|NCT03012828|536918973|FG003|Overall Study|Non-compliance with protocol|0|||
148847814|NCT03012828|536918974|FG004|Overall Study|Non-compliance with protocol|1|||
148847815|NCT03012828|536918975|FG005|Overall Study|Non-compliance with protocol|0|||
148847816|NCT03012828|536918970|FG000|Overall Study|Delay to last visit would delay DBL|0|||
148847817|NCT03012828|536918971|FG001|Overall Study|Delay to last visit would delay DBL|0|||
148847818|NCT03012828|536918972|FG002|Overall Study|Delay to last visit would delay DBL|0|||
148847819|NCT03012828|536918973|FG003|Overall Study|Delay to last visit would delay DBL|0|||
148847820|NCT03012828|536918974|FG004|Overall Study|Delay to last visit would delay DBL|0|||
148847821|NCT03012828|536918975|FG005|Overall Study|Delay to last visit would delay DBL|1|||
148847822|NCT04599803|536918976|FG000|Overall Study|Withdrawal by Subject|5|||
148847823|NCT04599803|536918976|FG000|Overall Study|Lost to Follow-up|26|||
148847824|NCT02544750|536918977|FG000|Overall Study|Physician Decision|3|||
148847825|NCT02544750|536918978|FG001|Overall Study|Physician Decision|1|||
148847826|NCT02544750|536918977|FG000|Overall Study|Other reasons|69|||
148847827|NCT02544750|536918978|FG001|Overall Study|Other reasons|39|||
148847828|NCT02544750|536918977|FG000|Overall Study|Met withdrawal criteria|2|||
148847829|NCT02544750|536918978|FG001|Overall Study|Met withdrawal criteria|2|||
148847830|NCT02544750|536918977|FG000|Overall Study|Transition To Commercial Product|1|||
148847831|NCT02544750|536918978|FG001|Overall Study|Transition To Commercial Product|0|||
148847832|NCT02544750|536918977|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
148847833|NCT02544750|536918978|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
148847834|NCT02544750|536918977|FG000|Overall Study|Adverse Event|8|||
148847835|NCT02544750|536918978|FG001|Overall Study|Adverse Event|10|||
148847836|NCT02544750|536918977|FG000|Overall Study|Withdrawal by Subject|10|||
148847837|NCT02544750|536918978|FG001|Overall Study|Withdrawal by Subject|4|||
148847838|NCT02544750|536918977|FG000|Overall Study|Lost to Follow-up|1|||
148847839|NCT02544750|536918978|FG001|Overall Study|Lost to Follow-up|0|||
148847840|NCT04396795|536918979|FG000|Month 1|Lost to Follow-up|2|||
148847841|NCT04396795|536918980|FG001|Month 1|Lost to Follow-up|3|||
148847842|NCT04396795|536918979|FG000|Month 3|Lost to Follow-up|1|||
148847843|NCT04396795|536918980|FG001|Month 3|Lost to Follow-up|3|||
148847844|NCT04396795|536918979|FG000|Month 6|Lost to Follow-up|3|||
148847845|NCT04396795|536918980|FG001|Month 6|Lost to Follow-up|3|||
148847846|NCT01637584|536918981|FG000|Overall Study|Withdrawal by Subject|1|||
148847847|NCT01637584|536918982|FG001|Overall Study|Withdrawal by Subject|3|||
148847848|NCT02366923|536918983|FG000|Overall Study|Withdrawal by Subject|1|||
148847849|NCT02366923|536918983|FG000|Overall Study|Positive Slit Lamp Findings|2|||
148847850|NCT02366923|536918983|FG000|Overall Study|High Astigmatism|3|||
148847851|NCT02484443|536918984|FG000|Overall Study|Lack of Efficacy|28|||
148847852|NCT02484443|536918984|FG000|Overall Study|Physician Decision|2|||
148847853|NCT02484443|536918984|FG000|Overall Study|Ineligible|2|||
148847854|NCT02595866|536918985|FG000|Overall Study|Adverse Event|2|||
148847855|NCT02595866|536918986|FG001|Overall Study|Adverse Event|5|||
148847856|NCT02595866|536918985|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
148847857|NCT02595866|536918986|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
148847858|NCT02595866|536918985|FG000|Overall Study|Death|0|||
148847859|NCT02595866|536918986|FG001|Overall Study|Death|1|||
148847860|NCT02595866|536918985|FG000|Overall Study|Incarceration|1|||
148847861|NCT02595866|536918986|FG001|Overall Study|Incarceration|0|||
148847862|NCT02595866|536918985|FG000|Overall Study|Lack of Efficacy|17|||
148847863|NCT02595866|536918986|FG001|Overall Study|Lack of Efficacy|7|||
148847864|NCT02595866|536918985|FG000|Overall Study|Physician Decision|4|||
148847865|NCT02595866|536918986|FG001|Overall Study|Physician Decision|3|||
148847866|NCT02595866|536918985|FG000|Overall Study|Switched to Alternative Treatment|1|||
148847867|NCT02595866|536918986|FG001|Overall Study|Switched to Alternative Treatment|0|||
148847868|NCT02595866|536918985|FG000|Overall Study|Study Terminated|0|||
148984564|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984565|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148847869|NCT02595866|536918986|FG001|Overall Study|Study Terminated|4|||
148847870|NCT02595866|536918985|FG000|Overall Study|Withdrawal by Subject|6|||
148847871|NCT02595866|536918986|FG001|Overall Study|Withdrawal by Subject|1|||
148847872|NCT01232127|536918987|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
148847873|NCT01232127|536918988|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
148847874|NCT01232127|536918989|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
148847875|NCT02375373|536918990|FG000|Overall Study|Withdrawal by Subject|11|||
148847876|NCT02725476|536918991|FG000|Overall Study|Physician Decision|2|||
148847877|NCT02725476|536918992|FG001|Overall Study|Physician Decision|0|||
148847878|NCT02725476|536918991|FG000|Overall Study|Adverse Event|1|||
148847879|NCT02725476|536918992|FG001|Overall Study|Adverse Event|1|||
148847880|NCT01445613|536918993|FG000|30-day Follow-up|Withdrawal by Subject|6|||
148847881|NCT01445613|536918993|FG000|30-day Follow-up|Physician Decision|3|||
148847882|NCT01445613|536918993|FG000|30-day Follow-up|Missed visit|23|||
148847883|NCT01445613|536918993|FG000|30-day Follow-up|Death|3|||
148847884|NCT01445613|536918993|FG000|1-year Follow-up|Withdrawal by Subject|12|||
148847885|NCT01445613|536918993|FG000|1-year Follow-up|Missed visit|29|||
148847886|NCT01445613|536918993|FG000|1-year Follow-up|Lost to Follow-up|2|||
148847887|NCT01445613|536918993|FG000|1-year Follow-up|Death|30|||
148847888|NCT01445613|536918993|FG000|1-year Follow-up|Physician Decision|2|||
148847889|NCT01445613|536918993|FG000|1-year Follow-up|Received a non-study stent|2|||
148847890|NCT00407602|536918994|FG000|Overall Study|Death - unrelated to device|1|||
148847891|NCT00407602|536918994|FG000|Overall Study|Device explanted|5|||
148847892|NCT00407602|536918994|FG000|Overall Study|Withdrawal by Subject|1|||
148847893|NCT00431444|536918995|FG000|Overall Study|Protocol Violation|1|||
148847894|NCT00431444|536918996|FG001|Overall Study|Protocol Violation|4|||
148847895|NCT00431444|536918995|FG000|Overall Study|Adverse Event|2|||
148847896|NCT00431444|536918996|FG001|Overall Study|Adverse Event|1|||
148847897|NCT00431444|536918995|FG000|Overall Study|Withdrawal by Subject|1|||
148847898|NCT00431444|536918996|FG001|Overall Study|Withdrawal by Subject|1|||
148847899|NCT00431444|536918995|FG000|Overall Study|Lost to Follow-up|1|||
148847900|NCT00431444|536918996|FG001|Overall Study|Lost to Follow-up|0|||
148847901|NCT00431444|536918995|FG000|Overall Study|Administrative Problems|0|||
148847902|NCT00431444|536918996|FG001|Overall Study|Administrative Problems|1|||
148847903|NCT02517398|536919015|FG000|Overall Study|Death|2|||
148847904|NCT02517398|536919016|FG001|Overall Study|Death|3|||
148847905|NCT02517398|536919017|FG002|Overall Study|Death|4|||
148847906|NCT02517398|536919018|FG003|Overall Study|Death|2|||
148847907|NCT02517398|536919019|FG004|Overall Study|Death|3|||
148847908|NCT02517398|536919020|FG005|Overall Study|Death|8|||
148847909|NCT02517398|536919021|FG006|Overall Study|Death|3|||
148847910|NCT02517398|536919022|FG007|Overall Study|Death|2|||
148847911|NCT02517398|536919023|FG008|Overall Study|Death|6|||
148847912|NCT02517398|536919024|FG009|Overall Study|Death|24|||
148847913|NCT02517398|536919025|FG010|Overall Study|Death|53|||
148847914|NCT02517398|536919026|FG011|Overall Study|Death|25|||
148847915|NCT02517398|536919027|FG012|Overall Study|Death|73|||
148847916|NCT02517398|536919028|FG013|Overall Study|Death|29|||
148847917|NCT02517398|536919029|FG014|Overall Study|Death|26|||
148847918|NCT02517398|536919030|FG015|Overall Study|Death|23|||
148847919|NCT02517398|536919031|FG016|Overall Study|Death|26|||
148847920|NCT02517398|536919032|FG017|Overall Study|Death|25|||
148847921|NCT02517398|536919033|FG018|Overall Study|Death|22|||
148847922|NCT02517398|536919034|FG019|Overall Study|Death|7|||
148847923|NCT02517398|536919035|FG020|Overall Study|Death|26|||
148847924|NCT02517398|536919036|FG021|Overall Study|Death|30|||
148847925|NCT02517398|536919037|FG022|Overall Study|Death|20|||
148847926|NCT02517398|536919015|FG000|Overall Study|Other|0|||
148847927|NCT02517398|536919016|FG001|Overall Study|Other|0|||
148847928|NCT02517398|536919017|FG002|Overall Study|Other|0|||
148847929|NCT02517398|536919018|FG003|Overall Study|Other|1|||
148847930|NCT02517398|536919019|FG004|Overall Study|Other|0|||
148847931|NCT02517398|536919020|FG005|Overall Study|Other|0|||
148847932|NCT02517398|536919021|FG006|Overall Study|Other|0|||
148847933|NCT02517398|536919022|FG007|Overall Study|Other|0|||
148847934|NCT02517398|536919023|FG008|Overall Study|Other|0|||
148847935|NCT02517398|536919024|FG009|Overall Study|Other|1|||
148847936|NCT02517398|536919025|FG010|Overall Study|Other|0|||
148847937|NCT02517398|536919026|FG011|Overall Study|Other|0|||
148847938|NCT02517398|536919027|FG012|Overall Study|Other|0|||
148847939|NCT02517398|536919028|FG013|Overall Study|Other|1|||
148847940|NCT02517398|536919029|FG014|Overall Study|Other|0|||
148847941|NCT02517398|536919030|FG015|Overall Study|Other|1|||
148984566|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148847942|NCT02517398|536919031|FG016|Overall Study|Other|1|||
148847943|NCT02517398|536919032|FG017|Overall Study|Other|0|||
148847944|NCT02517398|536919033|FG018|Overall Study|Other|0|||
148847945|NCT02517398|536919034|FG019|Overall Study|Other|1|||
148847946|NCT02517398|536919035|FG020|Overall Study|Other|0|||
148847947|NCT02517398|536919036|FG021|Overall Study|Other|0|||
148847948|NCT02517398|536919037|FG022|Overall Study|Other|0|||
148847949|NCT02517398|536919015|FG000|Overall Study|Lost to Follow-up|0|||
148847950|NCT02517398|536919016|FG001|Overall Study|Lost to Follow-up|0|||
148847951|NCT02517398|536919017|FG002|Overall Study|Lost to Follow-up|0|||
148847952|NCT02517398|536919018|FG003|Overall Study|Lost to Follow-up|0|||
148847953|NCT02517398|536919019|FG004|Overall Study|Lost to Follow-up|0|||
148847954|NCT02517398|536919020|FG005|Overall Study|Lost to Follow-up|0|||
148847955|NCT02517398|536919021|FG006|Overall Study|Lost to Follow-up|0|||
149029990|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
149029991|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
149029992|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Pain|0|||
149029993|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Pain|0|||
149029994|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Pain|0|||
148847956|NCT02517398|536919022|FG007|Overall Study|Lost to Follow-up|0|||
148847957|NCT02517398|536919023|FG008|Overall Study|Lost to Follow-up|0|||
148847958|NCT02517398|536919024|FG009|Overall Study|Lost to Follow-up|1|||
148847959|NCT02517398|536919025|FG010|Overall Study|Lost to Follow-up|0|||
148847960|NCT02517398|536919026|FG011|Overall Study|Lost to Follow-up|2|||
148847961|NCT02517398|536919027|FG012|Overall Study|Lost to Follow-up|2|||
148847962|NCT02517398|536919028|FG013|Overall Study|Lost to Follow-up|0|||
148847963|NCT02517398|536919029|FG014|Overall Study|Lost to Follow-up|1|||
148847964|NCT02517398|536919030|FG015|Overall Study|Lost to Follow-up|1|||
148847965|NCT02517398|536919031|FG016|Overall Study|Lost to Follow-up|0|||
148847966|NCT02517398|536919032|FG017|Overall Study|Lost to Follow-up|3|||
148847967|NCT02517398|536919033|FG018|Overall Study|Lost to Follow-up|1|||
148847968|NCT02517398|536919034|FG019|Overall Study|Lost to Follow-up|0|||
148847969|NCT02517398|536919035|FG020|Overall Study|Lost to Follow-up|1|||
148847970|NCT02517398|536919036|FG021|Overall Study|Lost to Follow-up|0|||
148847971|NCT02517398|536919037|FG022|Overall Study|Lost to Follow-up|2|||
148847972|NCT02517398|536919015|FG000|Overall Study|Withdrew Consent|0|||
148847973|NCT02517398|536919016|FG001|Overall Study|Withdrew Consent|0|||
148847974|NCT02517398|536919017|FG002|Overall Study|Withdrew Consent|0|||
148847975|NCT02517398|536919018|FG003|Overall Study|Withdrew Consent|0|||
148847976|NCT02517398|536919019|FG004|Overall Study|Withdrew Consent|0|||
148847977|NCT02517398|536919020|FG005|Overall Study|Withdrew Consent|0|||
148847978|NCT02517398|536919021|FG006|Overall Study|Withdrew Consent|1|||
148847979|NCT02517398|536919022|FG007|Overall Study|Withdrew Consent|0|||
148847980|NCT02517398|536919023|FG008|Overall Study|Withdrew Consent|0|||
148847981|NCT02517398|536919024|FG009|Overall Study|Withdrew Consent|2|||
148847982|NCT02517398|536919025|FG010|Overall Study|Withdrew Consent|7|||
148847983|NCT02517398|536919026|FG011|Overall Study|Withdrew Consent|1|||
148847984|NCT02517398|536919027|FG012|Overall Study|Withdrew Consent|5|||
148847985|NCT02517398|536919028|FG013|Overall Study|Withdrew Consent|4|||
148847986|NCT02517398|536919029|FG014|Overall Study|Withdrew Consent|2|||
148847987|NCT02517398|536919030|FG015|Overall Study|Withdrew Consent|5|||
148847988|NCT02517398|536919031|FG016|Overall Study|Withdrew Consent|4|||
148847989|NCT02517398|536919032|FG017|Overall Study|Withdrew Consent|2|||
148847990|NCT02517398|536919033|FG018|Overall Study|Withdrew Consent|3|||
148847991|NCT02517398|536919034|FG019|Overall Study|Withdrew Consent|2|||
148847992|NCT02517398|536919035|FG020|Overall Study|Withdrew Consent|9|||
148847993|NCT02517398|536919036|FG021|Overall Study|Withdrew Consent|3|||
148847994|NCT02517398|536919037|FG022|Overall Study|Withdrew Consent|1|||
148847995|NCT02131662|536919044|FG000|Overall Study|Protocol Violation|1|||
148847996|NCT02131662|536919045|FG001|Overall Study|Protocol Violation|0|||
148847997|NCT02131662|536919046|FG002|Overall Study|Protocol Violation|0|||
148847998|NCT02131662|536919047|FG003|Overall Study|Protocol Violation|0|||
148847999|NCT02131662|536919048|FG004|Overall Study|Protocol Violation|0|||
148848000|NCT02131662|536919044|FG000|Overall Study|Other|2|||
148848001|NCT02131662|536919045|FG001|Overall Study|Other|4|||
148848002|NCT02131662|536919046|FG002|Overall Study|Other|3|||
148848003|NCT02131662|536919047|FG003|Overall Study|Other|3|||
148848004|NCT02131662|536919048|FG004|Overall Study|Other|4|||
148848005|NCT02131662|536919044|FG000|Overall Study|Adverse Event|0|||
148848006|NCT02131662|536919045|FG001|Overall Study|Adverse Event|1|||
148848007|NCT02131662|536919046|FG002|Overall Study|Adverse Event|1|||
148848008|NCT02131662|536919047|FG003|Overall Study|Adverse Event|1|||
148848009|NCT02131662|536919048|FG004|Overall Study|Adverse Event|3|||
148848010|NCT02131662|536919044|FG000|Overall Study|Pregnancy|0|||
148848011|NCT02131662|536919045|FG001|Overall Study|Pregnancy|1|||
148848012|NCT02131662|536919046|FG002|Overall Study|Pregnancy|0|||
148848013|NCT02131662|536919047|FG003|Overall Study|Pregnancy|1|||
148848014|NCT02131662|536919048|FG004|Overall Study|Pregnancy|0|||
148848015|NCT02131662|536919044|FG000|Overall Study|Wish for pregnancy|0|||
148848016|NCT02131662|536919045|FG001|Overall Study|Wish for pregnancy|0|||
148848017|NCT02131662|536919046|FG002|Overall Study|Wish for pregnancy|0|||
148848018|NCT02131662|536919047|FG003|Overall Study|Wish for pregnancy|0|||
148848019|NCT02131662|536919048|FG004|Overall Study|Wish for pregnancy|1|||
148848020|NCT02131662|536919044|FG000|Overall Study|Lack of Efficacy|1|||
148848021|NCT02131662|536919045|FG001|Overall Study|Lack of Efficacy|0|||
148848022|NCT02131662|536919046|FG002|Overall Study|Lack of Efficacy|0|||
148848023|NCT02131662|536919047|FG003|Overall Study|Lack of Efficacy|0|||
148848024|NCT02131662|536919048|FG004|Overall Study|Lack of Efficacy|1|||
148848025|NCT02131662|536919044|FG000|Overall Study|Withdrawal by Subject|1|||
148848026|NCT02131662|536919045|FG001|Overall Study|Withdrawal by Subject|5|||
148848027|NCT02131662|536919046|FG002|Overall Study|Withdrawal by Subject|1|||
148848028|NCT02131662|536919047|FG003|Overall Study|Withdrawal by Subject|5|||
148848029|NCT02131662|536919048|FG004|Overall Study|Withdrawal by Subject|6|||
148848030|NCT02131662|536919044|FG000|Overall Study|Lost to Follow-up|1|||
148848031|NCT02131662|536919045|FG001|Overall Study|Lost to Follow-up|3|||
148848032|NCT02131662|536919046|FG002|Overall Study|Lost to Follow-up|0|||
148848033|NCT02131662|536919047|FG003|Overall Study|Lost to Follow-up|9|||
148848034|NCT02131662|536919048|FG004|Overall Study|Lost to Follow-up|0|||
148848035|NCT02131662|536919044|FG000|Overall Study|Not treated|2|||
148848036|NCT02131662|536919045|FG001|Overall Study|Not treated|0|||
148848037|NCT02131662|536919046|FG002|Overall Study|Not treated|2|||
148848038|NCT02131662|536919047|FG003|Overall Study|Not treated|2|||
148848039|NCT02131662|536919048|FG004|Overall Study|Not treated|3|||
148848040|NCT03554018|536919049|FG000|Overall Study|Lost to Follow-up|3|||
148848041|NCT03554018|536919050|FG001|Overall Study|Lost to Follow-up|7|||
148848042|NCT02142803|536919052|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
148848043|NCT02142803|536919053|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
148848044|NCT02142803|536919054|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
148848045|NCT02142803|536919055|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
148848046|NCT00130039|536919056|FG000|Overall Study|Withdrawal by Subject|15|||
148848047|NCT00130039|536919057|FG001|Overall Study|Withdrawal by Subject|11|||
148848048|NCT00130039|536919056|FG000|Overall Study|Lost to Follow-up|3|||
148848049|NCT00130039|536919057|FG001|Overall Study|Lost to Follow-up|1|||
148848050|NCT00130039|536919056|FG000|Overall Study|Adverse Event|4|||
148848051|NCT00130039|536919057|FG001|Overall Study|Adverse Event|2|||
148848052|NCT00130039|536919056|FG000|Overall Study|Physician Decision|3|||
148848053|NCT00130039|536919057|FG001|Overall Study|Physician Decision|0|||
148848054|NCT00130039|536919056|FG000|Overall Study|clinical events without follow up MRI|5|||
148848055|NCT00130039|536919057|FG001|Overall Study|clinical events without follow up MRI|4|||
148848056|NCT01928433|536919058|FG000|Overall Study|Adverse Event|5|||
148848057|NCT01928433|536919059|FG001|Overall Study|Adverse Event|2|||
148848058|NCT01928433|536919060|FG002|Overall Study|Adverse Event|5|||
148848059|NCT01928433|536919058|FG000|Overall Study|Protocol Violation|0|||
148848060|NCT01928433|536919059|FG001|Overall Study|Protocol Violation|0|||
148848061|NCT01928433|536919060|FG002|Overall Study|Protocol Violation|2|||
148848062|NCT01928433|536919058|FG000|Overall Study|Lack of Efficacy|5|||
148848063|NCT01928433|536919059|FG001|Overall Study|Lack of Efficacy|4|||
148848064|NCT01928433|536919060|FG002|Overall Study|Lack of Efficacy|4|||
148848065|NCT01928433|536919058|FG000|Overall Study|Withdrawal by Subject|0|||
148848066|NCT01928433|536919059|FG001|Overall Study|Withdrawal by Subject|4|||
148848067|NCT01928433|536919060|FG002|Overall Study|Withdrawal by Subject|0|||
148848068|NCT01928433|536919058|FG000|Overall Study|Negative screening urine culture|7|||
148848069|NCT01928433|536919059|FG001|Overall Study|Negative screening urine culture|6|||
148848070|NCT01928433|536919060|FG002|Overall Study|Negative screening urine culture|10|||
148848071|NCT01928433|536919058|FG000|Overall Study|Lost to Follow-up|0|||
148848072|NCT01928433|536919059|FG001|Overall Study|Lost to Follow-up|2|||
148848073|NCT01928433|536919060|FG002|Overall Study|Lost to Follow-up|3|||
148848074|NCT01928433|536919058|FG000|Overall Study|Other reasons|3|||
148848075|NCT01928433|536919059|FG001|Overall Study|Other reasons|3|||
148848076|NCT01928433|536919060|FG002|Overall Study|Other reasons|4|||
148848077|NCT01740687|536919061|FG000|Overall Study|Lost to Follow-up|11|||
148848078|NCT01740687|536919061|FG000|Overall Study|Withdrawal by Subject|2|||
148848079|NCT01740687|536919061|FG000|Overall Study|other reason|22|||
148848080|NCT01740687|536919061|FG000|Overall Study|treatment not received|2|||
148848081|NCT01016132|536919063|FG000|Overall Study|Discomfort|1|||
148848082|NCT01198574|536919064|FG000|Overall Study|Resigned from schools|4|||
148848083|NCT01198574|536919065|FG001|Overall Study|Resigned from schools|1|||
148848084|NCT01198574|536919066|FG002|Overall Study|Resigned from schools|1|||
148848085|NCT01198574|536919067|FG003|Overall Study|Resigned from schools|4|||
148848086|NCT00556439|536919068|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
148848087|NCT00556439|536919069|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
148848088|NCT00556439|536919070|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
148848089|NCT00556439|536919071|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
148848090|NCT00556439|536919068|FG000|Study Entry to Week 12|Physician Decision|1|||
148848091|NCT00556439|536919069|FG001|Study Entry to Week 12|Physician Decision|0|||
148848092|NCT00556439|536919070|FG002|Study Entry to Week 12|Physician Decision|0|||
148848093|NCT00556439|536919071|FG003|Study Entry to Week 12|Physician Decision|0|||
148984567|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984568|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984569|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984570|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
148984571|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
148984572|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848094|NCT00556439|536919068|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
148848095|NCT00556439|536919069|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
148848096|NCT00556439|536919070|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
148848097|NCT00556439|536919071|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
148848098|NCT00556439|536919068|FG000|Study Entry to Week 12|Recurrent infection|1|||
148848099|NCT00556439|536919069|FG001|Study Entry to Week 12|Recurrent infection|0|||
148984573|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
148984574|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848100|NCT00556439|536919070|FG002|Study Entry to Week 12|Recurrent infection|0|||
148848101|NCT00556439|536919071|FG003|Study Entry to Week 12|Recurrent infection|0|||
148848102|NCT00556439|536919068|FG000|Study Entry to Week 12|Malignancy|0|||
148848103|NCT00556439|536919069|FG001|Study Entry to Week 12|Malignancy|0|||
148848104|NCT00556439|536919070|FG002|Study Entry to Week 12|Malignancy|1|||
148848105|NCT00556439|536919071|FG003|Study Entry to Week 12|Malignancy|0|||
148848106|NCT00556439|536919068|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
148848107|NCT00556439|536919069|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
148848108|NCT00556439|536919070|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
148848109|NCT00556439|536919071|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
148848110|NCT00556439|536919068|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
148848111|NCT00556439|536919069|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
148848112|NCT00556439|536919070|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
148848113|NCT00556439|536919071|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
148848114|NCT00556439|536919068|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
148848115|NCT00556439|536919069|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
148848116|NCT00556439|536919070|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
148848117|NCT00556439|536919071|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
148848118|NCT00556439|536919068|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
148848119|NCT00556439|536919069|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
148848120|NCT00556439|536919070|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
148848121|NCT00556439|536919071|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
148848122|NCT02100423|536919072|FG000|Overall Study|Death|1|||
148848123|NCT02100423|536919072|FG000|Overall Study|Withdrawal by Subject|3|||
148848124|NCT02100423|536919072|FG000|Overall Study|Adverse Event|1|||
148848125|NCT02100423|536919072|FG000|Overall Study|Physician Decision|1|||
148848126|NCT03107052|536921153|FG000|Overall Study|Adverse Event|6|||
148848127|NCT03107052|536921154|FG001|Overall Study|Adverse Event|1|||
148848128|NCT03107052|536921155|FG002|Overall Study|Adverse Event|2|||
148848129|NCT03107052|536921153|FG000|Overall Study|Withdrawal by Subject|9|||
148848130|NCT03107052|536921154|FG001|Overall Study|Withdrawal by Subject|5|||
148848131|NCT03107052|536921155|FG002|Overall Study|Withdrawal by Subject|8|||
148848132|NCT03107052|536921153|FG000|Overall Study|Protocol Violation|6|||
148848133|NCT03107052|536921154|FG001|Overall Study|Protocol Violation|0|||
148848134|NCT03107052|536921155|FG002|Overall Study|Protocol Violation|3|||
148848135|NCT03107052|536921153|FG000|Overall Study|Lost to Follow-up|4|||
148848136|NCT03107052|536921154|FG001|Overall Study|Lost to Follow-up|0|||
148848137|NCT03107052|536921155|FG002|Overall Study|Lost to Follow-up|1|||
148848138|NCT03107052|536921153|FG000|Overall Study|Lack of Efficacy|23|||
148848139|NCT03107052|536921154|FG001|Overall Study|Lack of Efficacy|7|||
148848140|NCT03107052|536921155|FG002|Overall Study|Lack of Efficacy|4|||
148848141|NCT03107052|536921153|FG000|Overall Study|Other than specified|4|||
148848142|NCT03107052|536921154|FG001|Overall Study|Other than specified|2|||
148848143|NCT03107052|536921155|FG002|Overall Study|Other than specified|0|||
148848144|NCT03107052|536921153|FG000|Overall Study|Study terminated due to futility|67|||
148848145|NCT03107052|536921154|FG001|Overall Study|Study terminated due to futility|31|||
148848146|NCT03107052|536921155|FG002|Overall Study|Study terminated due to futility|23|||
148848147|NCT03015363|536921156|FG000|Overall Study|Physician Decision|14|||
148848148|NCT03015363|536921156|FG000|Overall Study|Withdrawal by Subject|3|||
148848149|NCT00958360|536921157|FG000|Overall Study|Withdrawal by Subject|3|||
148848150|NCT00958360|536921158|FG001|Overall Study|Withdrawal by Subject|1|||
148848151|NCT00958360|536921157|FG000|Overall Study|Death|6|||
148848152|NCT00958360|536921158|FG001|Overall Study|Death|7|||
148848153|NCT00958360|536921157|FG000|Overall Study|Physician Decision|2|||
148848154|NCT00958360|536921158|FG001|Overall Study|Physician Decision|1|||
148848155|NCT00958360|536921157|FG000|Overall Study|Lost to Follow-up|0|||
148848156|NCT00958360|536921158|FG001|Overall Study|Lost to Follow-up|1|||
148848157|NCT00078806|536921159|FG000|Part 1A|Adverse Event|2|||
148848158|NCT00078806|536921160|FG001|Part 1A|Adverse Event|0|||
148848159|NCT00078806|536921161|FG002|Part 1A|Adverse Event|0|||
148848160|NCT00078806|536921162|FG003|Part 1A|Adverse Event|0|||
148848161|NCT00078806|536921159|FG000|Part 1A|Lack of Efficacy|7|||
148848162|NCT00078806|536921160|FG001|Part 1A|Lack of Efficacy|0|||
148848163|NCT00078806|536921161|FG002|Part 1A|Lack of Efficacy|0|||
148848164|NCT00078806|536921162|FG003|Part 1A|Lack of Efficacy|0|||
148848165|NCT00078806|536921159|FG000|Part 1A|Other|1|||
148848166|NCT00078806|536921160|FG001|Part 1A|Other|0|||
148848167|NCT00078806|536921161|FG002|Part 1A|Other|0|||
148848168|NCT00078806|536921162|FG003|Part 1A|Other|0|||
148848169|NCT00078806|536921159|FG000|Part 1B|Adverse Event|1|||
148848170|NCT00078806|536921160|FG001|Part 1B|Adverse Event|0|||
148848171|NCT00078806|536921161|FG002|Part 1B|Adverse Event|0|||
148848172|NCT00078806|536921162|FG003|Part 1B|Adverse Event|0|||
148848173|NCT00078806|536921159|FG000|Part 1B|Lack of Efficacy|7|||
148848174|NCT00078806|536921160|FG001|Part 1B|Lack of Efficacy|0|||
148848175|NCT00078806|536921161|FG002|Part 1B|Lack of Efficacy|0|||
148848176|NCT00078806|536921162|FG003|Part 1B|Lack of Efficacy|0|||
148848177|NCT00078806|536921159|FG000|Part 2|Adverse Event|0|||
148848178|NCT00078806|536921160|FG001|Part 2|Adverse Event|1|||
148848179|NCT00078806|536921161|FG002|Part 2|Adverse Event|0|||
148848180|NCT00078806|536921162|FG003|Part 2|Adverse Event|0|||
148848181|NCT02013778|536921163|FG000|Overall Study|Death|4|||
148848182|NCT02013778|536921163|FG000|Overall Study|Withdrawal by Subject|1|||
148848183|NCT02013778|536921163|FG000|Overall Study|Physician Decision|1|||
148848184|NCT02013778|536921163|FG000|Overall Study|Adverse Event|1|||
148848185|NCT02719691|536921166|FG000|Overall Study|Physician Decision|0|||
148848186|NCT02719691|536921167|FG001|Overall Study|Physician Decision|0|||
148848187|NCT02719691|536921168|FG002|Overall Study|Physician Decision|1|||
148848188|NCT02719691|536921169|FG003|Overall Study|Physician Decision|0|||
148848189|NCT02719691|536921170|FG004|Overall Study|Physician Decision|0|||
148848190|NCT02719691|536921171|FG005|Overall Study|Physician Decision|0|||
148848191|NCT02719691|536921172|FG006|Overall Study|Physician Decision|0|||
148848192|NCT02719691|536921166|FG000|Overall Study|Withdrawal by Subject|0|||
148848193|NCT02719691|536921167|FG001|Overall Study|Withdrawal by Subject|0|||
148848194|NCT02719691|536921168|FG002|Overall Study|Withdrawal by Subject|0|||
148848195|NCT02719691|536921169|FG003|Overall Study|Withdrawal by Subject|0|||
148848196|NCT02719691|536921170|FG004|Overall Study|Withdrawal by Subject|0|||
148848197|NCT02719691|536921171|FG005|Overall Study|Withdrawal by Subject|1|||
148848198|NCT02719691|536921172|FG006|Overall Study|Withdrawal by Subject|0|||
148848199|NCT00861757|536921175|FG000|Overall Study|Adverse Event|1|||
148848200|NCT00861757|536921176|FG001|Overall Study|Adverse Event|5|||
148848201|NCT00861757|536921177|FG002|Overall Study|Adverse Event|7|||
148848202|NCT00861757|536921178|FG003|Overall Study|Adverse Event|2|||
148848203|NCT00861757|536921175|FG000|Overall Study|Entry Criteria Not Met|1|||
148848204|NCT00861757|536921176|FG001|Overall Study|Entry Criteria Not Met|2|||
148848205|NCT00861757|536921177|FG002|Overall Study|Entry Criteria Not Met|1|||
148848206|NCT00861757|536921178|FG003|Overall Study|Entry Criteria Not Met|1|||
148848207|NCT00861757|536921175|FG000|Overall Study|Lack of Efficacy|3|||
148848208|NCT00861757|536921176|FG001|Overall Study|Lack of Efficacy|1|||
148848209|NCT00861757|536921177|FG002|Overall Study|Lack of Efficacy|0|||
148848210|NCT00861757|536921178|FG003|Overall Study|Lack of Efficacy|1|||
148848211|NCT00861757|536921175|FG000|Overall Study|Lost to Follow-up|1|||
148848212|NCT00861757|536921176|FG001|Overall Study|Lost to Follow-up|0|||
148848213|NCT00861757|536921177|FG002|Overall Study|Lost to Follow-up|1|||
148848214|NCT00861757|536921178|FG003|Overall Study|Lost to Follow-up|1|||
148848215|NCT00861757|536921175|FG000|Overall Study|Physician Decision|0|||
148848216|NCT00861757|536921176|FG001|Overall Study|Physician Decision|0|||
148848217|NCT00861757|536921177|FG002|Overall Study|Physician Decision|0|||
148848218|NCT00861757|536921178|FG003|Overall Study|Physician Decision|1|||
148848219|NCT00861757|536921175|FG000|Overall Study|Protocol Violation|2|||
148848220|NCT00861757|536921176|FG001|Overall Study|Protocol Violation|2|||
148848221|NCT00861757|536921177|FG002|Overall Study|Protocol Violation|4|||
148848222|NCT00861757|536921178|FG003|Overall Study|Protocol Violation|1|||
148848223|NCT00861757|536921175|FG000|Overall Study|Withdrawal by Subject|1|||
148848224|NCT00861757|536921176|FG001|Overall Study|Withdrawal by Subject|5|||
148848225|NCT00861757|536921177|FG002|Overall Study|Withdrawal by Subject|5|||
148848226|NCT00861757|536921178|FG003|Overall Study|Withdrawal by Subject|2|||
148848227|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
148848228|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
148848229|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
148848230|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
148848231|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
148848232|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
148848233|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
148848234|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
148848235|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
148848236|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
148848237|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
148848238|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
148848239|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
148848240|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
148848241|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
148848242|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
148848243|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
148848244|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
148848245|NCT03308968|536921179|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
148848246|NCT03308968|536921180|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
148848247|NCT03308968|536921181|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
148848248|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
148848249|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
148848250|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
148848251|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
148984575|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848252|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
148848253|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
148848254|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
148848255|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
148848256|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
148848257|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
148848258|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
148848259|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
148848260|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
148848261|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
148848262|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
148848263|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
148848264|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
148848265|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
148848266|NCT03308968|536921179|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
148848267|NCT03308968|536921180|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
148848268|NCT03308968|536921181|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
148848269|NCT01521923|536921187|FG000|Overall Study|AE, serious fatal|1|||
148848270|NCT01521923|536921188|FG001|Overall Study|AE, serious fatal|0|||
148848271|NCT01521923|536921189|FG002|Overall Study|AE, serious fatal|0|||
148848272|NCT01521923|536921190|FG003|Overall Study|AE, serious fatal|0|||
148848273|NCT01521923|536921187|FG000|Overall Study|SAE, non-fatal|0|||
148848274|NCT01521923|536921188|FG001|Overall Study|SAE, non-fatal|2|||
148848275|NCT01521923|536921189|FG002|Overall Study|SAE, non-fatal|2|||
148848276|NCT01521923|536921190|FG003|Overall Study|SAE, non-fatal|0|||
148848277|NCT01521923|536921187|FG000|Overall Study|AE, non-serious, non-fatal|1|||
148848278|NCT01521923|536921188|FG001|Overall Study|AE, non-serious, non-fatal|3|||
148848279|NCT01521923|536921189|FG002|Overall Study|AE, non-serious, non-fatal|6|||
148848280|NCT01521923|536921190|FG003|Overall Study|AE, non-serious, non-fatal|2|||
148848281|NCT01521923|536921187|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
148848282|NCT01521923|536921188|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
148848283|NCT01521923|536921189|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
148848284|NCT01521923|536921190|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
148848285|NCT01521923|536921187|FG000|Overall Study|Lack of Efficacy|1|||
148848286|NCT01521923|536921188|FG001|Overall Study|Lack of Efficacy|1|||
148848287|NCT01521923|536921189|FG002|Overall Study|Lack of Efficacy|0|||
148848288|NCT01521923|536921190|FG003|Overall Study|Lack of Efficacy|0|||
148848289|NCT01521923|536921187|FG000|Overall Study|Protocol Violation|0|||
148848290|NCT01521923|536921188|FG001|Overall Study|Protocol Violation|0|||
148848291|NCT01521923|536921189|FG002|Overall Study|Protocol Violation|1|||
148848292|NCT01521923|536921190|FG003|Overall Study|Protocol Violation|0|||
148848293|NCT01521923|536921187|FG000|Overall Study|Lost to Follow-up|1|||
148848294|NCT01521923|536921188|FG001|Overall Study|Lost to Follow-up|0|||
148848295|NCT01521923|536921189|FG002|Overall Study|Lost to Follow-up|2|||
148848296|NCT01521923|536921190|FG003|Overall Study|Lost to Follow-up|1|||
148848297|NCT01521923|536921187|FG000|Overall Study|Withdrawal by Subject|1|||
148848298|NCT01521923|536921188|FG001|Overall Study|Withdrawal by Subject|1|||
148848299|NCT01521923|536921189|FG002|Overall Study|Withdrawal by Subject|1|||
148848300|NCT01521923|536921190|FG003|Overall Study|Withdrawal by Subject|2|||
148848301|NCT01521923|536921187|FG000|Overall Study|Other|2|||
148848302|NCT01521923|536921188|FG001|Overall Study|Other|1|||
148848303|NCT01521923|536921189|FG002|Overall Study|Other|3|||
148848304|NCT01521923|536921190|FG003|Overall Study|Other|6|||
148848305|NCT01521923|536921187|FG000|Overall Study|AE, captured in Period 1|0|||
148848306|NCT01521923|536921188|FG001|Overall Study|AE, captured in Period 1|1|||
148848307|NCT01521923|536921189|FG002|Overall Study|AE, captured in Period 1|0|||
148848308|NCT01521923|536921190|FG003|Overall Study|AE, captured in Period 1|1|||
148848309|NCT03037476|536921191|FG000|Overall Study|Lost to Follow-up|63|||
148848310|NCT03037476|536921192|FG001|Overall Study|Lost to Follow-up|46|||
148848311|NCT02141633|536921193|FG000|Overall Study|Physician Decision|1|||
148984576|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848312|NCT02141633|536921194|FG001|Overall Study|Physician Decision|0|||
148848313|NCT02403817|536921197|FG000|Overall Study|Withdrawal by Subject|5|||
148848314|NCT02403817|536921198|FG001|Overall Study|Withdrawal by Subject|0|||
148984577|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848315|NCT01498692|536921204|FG000|Overall Study|Death|4|||
148848316|NCT01498692|536921204|FG000|Overall Study|Withdrawal by Subject|1|||
148848317|NCT01498692|536921204|FG000|Overall Study|Missed 12-month visit|3|||
148848318|NCT01947283|536921205|FG000|Overall Study|Death|1|||
148848319|NCT01947283|536921206|FG001|Overall Study|Death|1|||
148848320|NCT01947283|536921207|FG002|Overall Study|Death|1|||
148848321|NCT01947283|536921208|FG003|Overall Study|Death|0|||
148848322|NCT01947283|536921209|FG004|Overall Study|Death|0|||
148848323|NCT01947283|536921210|FG005|Overall Study|Death|0|||
148848324|NCT01947283|536921211|FG006|Overall Study|Death|0|||
148984578|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
148984579|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
148984580|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848325|NCT01947283|536921205|FG000|Overall Study|Lost to Follow-up|4|||
148848326|NCT01947283|536921206|FG001|Overall Study|Lost to Follow-up|6|||
148848327|NCT01947283|536921207|FG002|Overall Study|Lost to Follow-up|5|||
148848328|NCT01947283|536921208|FG003|Overall Study|Lost to Follow-up|5|||
148848329|NCT01947283|536921209|FG004|Overall Study|Lost to Follow-up|0|||
148848330|NCT01947283|536921210|FG005|Overall Study|Lost to Follow-up|2|||
148848331|NCT01947283|536921211|FG006|Overall Study|Lost to Follow-up|5|||
148848332|NCT01947283|536921205|FG000|Overall Study|Withdrawal by Subject|10|||
148848333|NCT01947283|536921206|FG001|Overall Study|Withdrawal by Subject|8|||
148848334|NCT01947283|536921207|FG002|Overall Study|Withdrawal by Subject|4|||
148848335|NCT01947283|536921208|FG003|Overall Study|Withdrawal by Subject|1|||
148848336|NCT01947283|536921209|FG004|Overall Study|Withdrawal by Subject|0|||
148848337|NCT01947283|536921210|FG005|Overall Study|Withdrawal by Subject|0|||
148848338|NCT01947283|536921211|FG006|Overall Study|Withdrawal by Subject|2|||
148848339|NCT01947283|536921205|FG000|Overall Study|No Clinical Recording|12|||
148848340|NCT01947283|536921206|FG001|Overall Study|No Clinical Recording|6|||
148848341|NCT01947283|536921207|FG002|Overall Study|No Clinical Recording|8|||
148848342|NCT01947283|536921208|FG003|Overall Study|No Clinical Recording|10|||
148848343|NCT01947283|536921209|FG004|Overall Study|No Clinical Recording|0|||
148848344|NCT01947283|536921210|FG005|Overall Study|No Clinical Recording|0|||
148848345|NCT01947283|536921211|FG006|Overall Study|No Clinical Recording|0|||
148848346|NCT01947283|536921205|FG000|Overall Study|Non-coding Clinical Recording language|0|||
148848347|NCT01947283|536921206|FG001|Overall Study|Non-coding Clinical Recording language|0|||
148848348|NCT01947283|536921207|FG002|Overall Study|Non-coding Clinical Recording language|0|||
148848349|NCT01947283|536921208|FG003|Overall Study|Non-coding Clinical Recording language|1|||
148848350|NCT01947283|536921209|FG004|Overall Study|Non-coding Clinical Recording language|0|||
148848351|NCT01947283|536921210|FG005|Overall Study|Non-coding Clinical Recording language|0|||
148848352|NCT01947283|536921211|FG006|Overall Study|Non-coding Clinical Recording language|0|||
148848353|NCT01947283|536921205|FG000|Overall Study|Missing Follow-up Assessment|2|||
148848354|NCT01947283|536921206|FG001|Overall Study|Missing Follow-up Assessment|2|||
148848355|NCT01947283|536921207|FG002|Overall Study|Missing Follow-up Assessment|3|||
148848356|NCT01947283|536921208|FG003|Overall Study|Missing Follow-up Assessment|0|||
148848357|NCT01947283|536921209|FG004|Overall Study|Missing Follow-up Assessment|0|||
148848358|NCT01947283|536921210|FG005|Overall Study|Missing Follow-up Assessment|2|||
148848359|NCT01947283|536921211|FG006|Overall Study|Missing Follow-up Assessment|0|||
148848360|NCT01947283|536921205|FG000|Overall Study|No patients were enrolled in study|0|||
148848361|NCT01947283|536921206|FG001|Overall Study|No patients were enrolled in study|0|||
148848362|NCT01947283|536921207|FG002|Overall Study|No patients were enrolled in study|0|||
148848363|NCT01947283|536921208|FG003|Overall Study|No patients were enrolled in study|0|||
148848364|NCT01947283|536921209|FG004|Overall Study|No patients were enrolled in study|0|||
148848365|NCT01947283|536921210|FG005|Overall Study|No patients were enrolled in study|3|||
148848366|NCT01947283|536921211|FG006|Overall Study|No patients were enrolled in study|1|||
148848367|NCT04908384|536921212|FG000|Overall Study|Lost to Follow-up|4|||
148848368|NCT04908384|536921213|FG001|Overall Study|Lost to Follow-up|4|||
148848369|NCT04908384|536921214|FG002|Overall Study|Lost to Follow-up|0|||
148848370|NCT04908384|536921215|FG003|Overall Study|Lost to Follow-up|0|||
148848371|NCT00430989|536921216|FG000|Overall Study|Lost to Follow-up|2|||
148848372|NCT00430989|536921217|FG001|Overall Study|Lost to Follow-up|3|||
148848373|NCT00430989|536921216|FG000|Overall Study|Withdrawal by Subject|15|||
148848374|NCT00430989|536921217|FG001|Overall Study|Withdrawal by Subject|14|||
148848375|NCT00430989|536921216|FG000|Overall Study|Protocol Violation|30|||
148848376|NCT00430989|536921217|FG001|Overall Study|Protocol Violation|37|||
148848377|NCT00430989|536921216|FG000|Overall Study|Not eligible|13|||
148848378|NCT00430989|536921217|FG001|Overall Study|Not eligible|6|||
148848379|NCT05002985|536921218|FG000|Overall Study|Withdrawal by Subject|1|||
148848380|NCT00603941|536921222|FG000|Overall Study|Disease progression|6|||
148848381|NCT00603941|536921223|FG001|Overall Study|Disease progression|7|||
148984581|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
148984582|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
148848382|NCT00603941|536921224|FG002|Overall Study|Disease progression|1|||
148848383|NCT00603941|536921222|FG000|Overall Study|Adverse Event|1|||
148848384|NCT00603941|536921223|FG001|Overall Study|Adverse Event|0|||
148848385|NCT00603941|536921224|FG002|Overall Study|Adverse Event|1|||
148848386|NCT00603941|536921222|FG000|Overall Study|Physician Decision|0|||
148848387|NCT00603941|536921223|FG001|Overall Study|Physician Decision|1|||
148848388|NCT00603941|536921224|FG002|Overall Study|Physician Decision|0|||
148848389|NCT00603941|536921222|FG000|Overall Study|Withdrawal by Subject|0|||
148848390|NCT00603941|536921223|FG001|Overall Study|Withdrawal by Subject|2|||
148848391|NCT00603941|536921224|FG002|Overall Study|Withdrawal by Subject|0|||
148848392|NCT00833469|536921225|FG000|Overall Study|Withdrawal by Subject|1|||
148848393|NCT00833469|536921225|FG000|Overall Study|Lost to Follow-up|1|||
148848394|NCT01642901|536921226|FG000|12-month Follow-up|Withdrawal by Subject|1|||
148848395|NCT01642901|536921227|FG001|12-month Follow-up|Withdrawal by Subject|0|||
148848396|NCT02707965|536921228|FG000|Overall Study|Withdrawal by Subject|0|||
148848397|NCT02707965|536921229|FG001|Overall Study|Withdrawal by Subject|0|||
148848398|NCT02707965|536921230|FG002|Overall Study|Withdrawal by Subject|1|||
148848399|NCT02707965|536921231|FG003|Overall Study|Withdrawal by Subject|0|||
148848400|NCT02707965|536921232|FG004|Overall Study|Withdrawal by Subject|0|||
148848401|NCT02707965|536921233|FG005|Overall Study|Withdrawal by Subject|0|||
148848402|NCT02707965|536921234|FG006|Overall Study|Withdrawal by Subject|0|||
148848403|NCT02707965|536921235|FG007|Overall Study|Withdrawal by Subject|2|||
148848404|NCT02707965|536921236|FG008|Overall Study|Withdrawal by Subject|0|||
148848405|NCT02707965|536921237|FG009|Overall Study|Withdrawal by Subject|0|||
148848406|NCT02707965|536921238|FG010|Overall Study|Withdrawal by Subject|0|||
148848407|NCT02707965|536921239|FG011|Overall Study|Withdrawal by Subject|0|||
148848408|NCT02707965|536921240|FG012|Overall Study|Withdrawal by Subject|0|||
148848409|NCT02707965|536921241|FG013|Overall Study|Withdrawal by Subject|0|||
148848410|NCT02707965|536921242|FG014|Overall Study|Withdrawal by Subject|0|||
148848411|NCT02707965|536921243|FG015|Overall Study|Withdrawal by Subject|0|||
148848412|NCT02707965|536921228|FG000|Overall Study|PI decisions|0|||
148848413|NCT02707965|536921229|FG001|Overall Study|PI decisions|0|||
148848414|NCT02707965|536921230|FG002|Overall Study|PI decisions|0|||
148848415|NCT02707965|536921231|FG003|Overall Study|PI decisions|0|||
148848416|NCT02707965|536921232|FG004|Overall Study|PI decisions|0|||
148848417|NCT02707965|536921233|FG005|Overall Study|PI decisions|0|||
148848418|NCT02707965|536921234|FG006|Overall Study|PI decisions|0|||
148848419|NCT02707965|536921235|FG007|Overall Study|PI decisions|0|||
148848420|NCT02707965|536921236|FG008|Overall Study|PI decisions|0|||
148848421|NCT02707965|536921237|FG009|Overall Study|PI decisions|0|||
148848422|NCT02707965|536921238|FG010|Overall Study|PI decisions|0|||
148848423|NCT02707965|536921239|FG011|Overall Study|PI decisions|0|||
148848424|NCT02707965|536921240|FG012|Overall Study|PI decisions|0|||
148848425|NCT02707965|536921241|FG013|Overall Study|PI decisions|0|||
148848426|NCT02707965|536921242|FG014|Overall Study|PI decisions|2|||
148848427|NCT02707965|536921243|FG015|Overall Study|PI decisions|0|||
148848428|NCT02707965|536921228|FG000|Overall Study|Protocol deviation|1|||
148848429|NCT02707965|536921229|FG001|Overall Study|Protocol deviation|1|||
148984583|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
148984584|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
148984585|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
148984586|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
148984587|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
148984588|NCT01609556|537419458|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984589|NCT01609556|537419459|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984590|NCT01609556|537419460|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984591|NCT01609556|537419461|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984592|NCT01609556|537419462|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984593|NCT01609556|537419463|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984594|NCT01609556|537419464|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984595|NCT01609556|537419465|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984596|NCT01609556|537419466|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984597|NCT01609556|537419467|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984598|NCT01609556|537419468|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984599|NCT01609556|537419469|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984600|NCT01609556|537419470|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
148984601|NCT01609556|537419471|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984602|NCT01609556|537419472|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984603|NCT01609556|537419473|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
148984604|NCT02199691|537419476|FG000|Overall Study|Protocol Violation|3|||
148984605|NCT02199691|537419477|FG001|Overall Study|Protocol Violation|3|||
148984606|NCT02199691|537419478|FG002|Overall Study|Protocol Violation|6|||
148984607|NCT02199691|537419479|FG003|Overall Study|Protocol Violation|7|||
148984608|NCT02199691|537419476|FG000|Overall Study|Withdrawal by Subject|5|||
148984609|NCT02199691|537419477|FG001|Overall Study|Withdrawal by Subject|3|||
148984610|NCT02199691|537419478|FG002|Overall Study|Withdrawal by Subject|12|||
148984611|NCT02199691|537419479|FG003|Overall Study|Withdrawal by Subject|13|||
148984612|NCT02199691|537419476|FG000|Overall Study|Lost to Follow-up|2|||
148984613|NCT02199691|537419477|FG001|Overall Study|Lost to Follow-up|1|||
148984614|NCT02199691|537419478|FG002|Overall Study|Lost to Follow-up|9|||
148984615|NCT02199691|537419479|FG003|Overall Study|Lost to Follow-up|10|||
148984616|NCT00774995|537419483|FG000|Overall Study|Protocol Violation|0|||
148984617|NCT00774995|537419484|FG001|Overall Study|Protocol Violation|0|||
148984618|NCT00774995|537419485|FG002|Overall Study|Protocol Violation|1|||
148984619|NCT00774995|537419486|FG003|Overall Study|Protocol Violation|0|||
148848430|NCT02707965|536921230|FG002|Overall Study|Protocol deviation|0|||
148848431|NCT02707965|536921231|FG003|Overall Study|Protocol deviation|0|||
148848432|NCT02707965|536921232|FG004|Overall Study|Protocol deviation|0|||
148848433|NCT02707965|536921233|FG005|Overall Study|Protocol deviation|0|||
148848434|NCT02707965|536921234|FG006|Overall Study|Protocol deviation|0|||
148848435|NCT02707965|536921235|FG007|Overall Study|Protocol deviation|1|||
148848436|NCT02707965|536921236|FG008|Overall Study|Protocol deviation|0|||
148848437|NCT02707965|536921237|FG009|Overall Study|Protocol deviation|0|||
148848438|NCT02707965|536921238|FG010|Overall Study|Protocol deviation|0|||
148848439|NCT02707965|536921239|FG011|Overall Study|Protocol deviation|0|||
148848440|NCT02707965|536921240|FG012|Overall Study|Protocol deviation|0|||
148848441|NCT02707965|536921241|FG013|Overall Study|Protocol deviation|0|||
148848442|NCT02707965|536921242|FG014|Overall Study|Protocol deviation|0|||
148848443|NCT02707965|536921243|FG015|Overall Study|Protocol deviation|0|||
148848444|NCT02943070|536921244|FG000|Overall Study|Physician Decision|1|||
148848445|NCT02943070|536921244|FG000|Overall Study|Adverse Event|2|||
148848446|NCT02943070|536921244|FG000|Overall Study|Death|2|||
148848447|NCT02943070|536921244|FG000|Overall Study|Withdrawal by Subject|3|||
148848448|NCT02943070|536921244|FG000|Overall Study|Lost to Follow-up|4|||
148848449|NCT02943070|536921244|FG000|Overall Study|Retreatment or TURP|13|||
148848450|NCT02943070|536921244|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
148848451|NCT00570778|536921245|FG000|Overall Study|Protocol deviation|2|||
148848452|NCT00570778|536921246|FG001|Overall Study|Protocol deviation|1|||
148848453|NCT00570778|536921247|FG002|Overall Study|Protocol deviation|2|||
148848454|NCT00570778|536921248|FG003|Overall Study|Protocol deviation|2|||
148848455|NCT00570778|536921245|FG000|Overall Study|Adverse Event|0|||
148848456|NCT00570778|536921246|FG001|Overall Study|Adverse Event|1|||
148848457|NCT00570778|536921247|FG002|Overall Study|Adverse Event|4|||
148848458|NCT00570778|536921248|FG003|Overall Study|Adverse Event|1|||
148848459|NCT00570778|536921245|FG000|Overall Study|Subject withdrew consent|0|||
148848460|NCT00570778|536921246|FG001|Overall Study|Subject withdrew consent|1|||
148848461|NCT00570778|536921247|FG002|Overall Study|Subject withdrew consent|0|||
148848462|NCT00570778|536921248|FG003|Overall Study|Subject withdrew consent|1|||
148848463|NCT00570778|536921245|FG000|Overall Study|Abnormal test procedure|1|||
148848464|NCT00570778|536921246|FG001|Overall Study|Abnormal test procedure|0|||
148848465|NCT00570778|536921247|FG002|Overall Study|Abnormal test procedure|0|||
148848466|NCT00570778|536921248|FG003|Overall Study|Abnormal test procedure|0|||
148848467|NCT00570778|536921245|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
148848468|NCT00570778|536921246|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148848469|NCT00570778|536921247|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
148848470|NCT00570778|536921248|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
148848471|NCT00570778|536921245|FG000|Overall Study|Lost to Follow-up|0|||
148848472|NCT00570778|536921246|FG001|Overall Study|Lost to Follow-up|0|||
148848473|NCT00570778|536921247|FG002|Overall Study|Lost to Follow-up|1|||
148848474|NCT00570778|536921248|FG003|Overall Study|Lost to Follow-up|0|||
148848475|NCT00570778|536921245|FG000|Overall Study|Subject no longer requires study drug|0|||
148848476|NCT00570778|536921246|FG001|Overall Study|Subject no longer requires study drug|1|||
148848477|NCT00570778|536921247|FG002|Overall Study|Subject no longer requires study drug|0|||
148848478|NCT00570778|536921248|FG003|Overall Study|Subject no longer requires study drug|0|||
148848479|NCT00711594|536921249|FG000|Overall Study|Progressive disease|2|||
148848480|NCT00711594|536921250|FG001|Overall Study|Progressive disease|2|||
148848481|NCT00711594|536921251|FG002|Overall Study|Progressive disease|6|||
148848482|NCT00711594|536921252|FG003|Overall Study|Progressive disease|44|||
148848483|NCT00711594|536921249|FG000|Overall Study|Other Adverse Event|1|||
148848484|NCT00711594|536921250|FG001|Overall Study|Other Adverse Event|0|||
148848485|NCT00711594|536921251|FG002|Overall Study|Other Adverse Event|0|||
148848486|NCT00711594|536921252|FG003|Overall Study|Other Adverse Event|16|||
148848487|NCT00711594|536921249|FG000|Overall Study|Withdrawal by Subject|0|||
148848488|NCT00711594|536921250|FG001|Overall Study|Withdrawal by Subject|1|||
148848489|NCT00711594|536921251|FG002|Overall Study|Withdrawal by Subject|0|||
148848490|NCT00711594|536921252|FG003|Overall Study|Withdrawal by Subject|2|||
148848491|NCT01014767|536921253|FG000|Overall Study|PI left institution, data unavailable|12|||
148848492|NCT01014767|536921254|FG001|Overall Study|PI left institution, data unavailable|1|||
148848493|NCT01014767|536921255|FG002|Overall Study|PI left institution, data unavailable|4|||
148848494|NCT01014767|536921256|FG003|Overall Study|PI left institution, data unavailable|1|||
148848495|NCT01709110|536921257|FG000|Overall Study|Adverse Event|56|||
148848496|NCT01709110|536921258|FG001|Overall Study|Adverse Event|48|||
148848497|NCT01709110|536921257|FG000|Overall Study|Death|14|||
148848498|NCT01709110|536921258|FG001|Overall Study|Death|6|||
148848499|NCT01709110|536921257|FG000|Overall Study|Lost to Follow-up|7|||
148848500|NCT01709110|536921258|FG001|Overall Study|Lost to Follow-up|5|||
148848501|NCT01709110|536921257|FG000|Overall Study|Protocol Violation|4|||
148848502|NCT01709110|536921258|FG001|Overall Study|Protocol Violation|6|||
148848503|NCT01709110|536921257|FG000|Overall Study|Withdrawal by Subject|96|||
148848504|NCT01709110|536921258|FG001|Overall Study|Withdrawal by Subject|89|||
148848505|NCT01709110|536921257|FG000|Overall Study|Physician Decision|4|||
148848506|NCT01709110|536921258|FG001|Overall Study|Physician Decision|10|||
148848507|NCT01709110|536921257|FG000|Overall Study|Sponsor Decision|2|||
148848508|NCT01709110|536921258|FG001|Overall Study|Sponsor Decision|2|||
148848509|NCT01709110|536921257|FG000|Overall Study|Lack of Efficacy|1|||
148848510|NCT01709110|536921258|FG001|Overall Study|Lack of Efficacy|1|||
148848511|NCT01709110|536921257|FG000|Overall Study|Caregiver Decision|1|||
148848512|NCT01709110|536921258|FG001|Overall Study|Caregiver Decision|1|||
148848513|NCT00485758|536921262|FG000|Overall Study|Adverse Event|102|||
148848514|NCT00485758|536921263|FG001|Overall Study|Adverse Event|31|||
148848515|NCT00485758|536921262|FG000|Overall Study|Death|0|||
148848516|NCT00485758|536921263|FG001|Overall Study|Death|1|||
148848517|NCT00485758|536921262|FG000|Overall Study|Lost to Follow-up|5|||
148848518|NCT00485758|536921263|FG001|Overall Study|Lost to Follow-up|1|||
148848519|NCT00485758|536921262|FG000|Overall Study|Physician Decision|3|||
148848520|NCT00485758|536921263|FG001|Overall Study|Physician Decision|3|||
148848521|NCT00485758|536921262|FG000|Overall Study|Protocol Violation|11|||
148848522|NCT00485758|536921263|FG001|Overall Study|Protocol Violation|2|||
148848523|NCT00485758|536921262|FG000|Overall Study|Withdrawal by Subject|32|||
148848524|NCT00485758|536921263|FG001|Overall Study|Withdrawal by Subject|27|||
148848525|NCT00485758|536921262|FG000|Overall Study|Study Terminated by Sponsor|3|||
148848526|NCT00485758|536921263|FG001|Overall Study|Study Terminated by Sponsor|0|||
148848527|NCT00984165|536921264|FG000|Overall Study|Death on study|2|||
148848528|NCT00984165|536921265|FG001|Overall Study|Death on study|0|||
148848529|NCT00984165|536921266|FG002|Overall Study|Death on study|0|||
148848530|NCT00984165|536921267|FG003|Overall Study|Death on study|0|||
148984620|NCT01209624|537419492|FG000|Overall Study|Death|2|||
148984621|NCT01209624|537419492|FG000|Overall Study|Adverse Event|13|||
148984622|NCT01209624|537419492|FG000|Overall Study|Lack of Efficacy|17|||
149029995|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Pain|1|||
149029996|NCT01107626|537587907|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
149029997|NCT01107626|537587908|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
149029998|NCT01107626|537587909|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
149029999|NCT01107626|537587910|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
149030000|NCT03467724|537587911|FG000|Overall Study|Lost to Follow-up|5|||
149030001|NCT03467724|537587911|FG000|Overall Study|Withdrawal by Subject|1|||
149030002|NCT03467724|537587911|FG000|Overall Study|Protocol Violation|1|||
149030003|NCT03467724|537587911|FG000|Overall Study|Adverse Event|1|||
149030004|NCT04310579|537587912|FG000|Overall Study|Adverse Event|0|||
149030005|NCT04310579|537587913|FG001|Overall Study|Adverse Event|0|||
149030006|NCT04310579|537587914|FG002|Overall Study|Adverse Event|0|||
148984623|NCT01209624|537419492|FG000|Overall Study|Lost to Follow-up|290|||
149030007|NCT04310579|537587915|FG003|Overall Study|Adverse Event|0|||
149030008|NCT04310579|537587916|FG004|Overall Study|Adverse Event|0|||
149030009|NCT04310579|537587917|FG005|Overall Study|Adverse Event|0|||
149030010|NCT04310579|537587918|FG006|Overall Study|Adverse Event|2|||
148984624|NCT01209624|537419492|FG000|Overall Study|Other|4|||
148984625|NCT03403634|537419497|FG000|Overall Study|Disease progression|3|||
148984626|NCT03403634|537419497|FG000|Overall Study|Did not meet eligibility criteria|4|||
148984627|NCT03964454|537419498|FG000|Overall Study|Lost to Follow-up|13|||
148984628|NCT03964454|537419499|FG001|Overall Study|Lost to Follow-up|7|||
148984629|NCT03964454|537419498|FG000|Overall Study|Withdrawal by Subject|4|||
148984630|NCT03964454|537419499|FG001|Overall Study|Withdrawal by Subject|11|||
148984631|NCT01539291|537421486|FG000|Study GS-US-312-0116|Adverse Event|9|||
148984632|NCT01539291|537421487|FG001|Study GS-US-312-0116|Adverse Event|0|||
148984633|NCT01539291|537421488|FG002|Study GS-US-312-0116|Adverse Event|0|||
148984634|NCT01539291|537421489|FG003|Study GS-US-312-0116|Adverse Event|0|||
148984635|NCT01539291|537421486|FG000|Study GS-US-312-0116|Physician Decision|1|||
148984636|NCT01539291|537421487|FG001|Study GS-US-312-0116|Physician Decision|0|||
148984637|NCT01539291|537421488|FG002|Study GS-US-312-0116|Physician Decision|0|||
148984638|NCT01539291|537421489|FG003|Study GS-US-312-0116|Physician Decision|0|||
148984639|NCT01539291|537421486|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
148984640|NCT01539291|537421487|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
148984641|NCT01539291|537421488|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
148984642|NCT01539291|537421489|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
148984643|NCT01539291|537421486|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
148984644|NCT01539291|537421487|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
149030011|NCT04310579|537587919|FG007|Overall Study|Adverse Event|0|||
149030012|NCT04310579|537587920|FG008|Overall Study|Adverse Event|1|||
149030013|NCT04310579|537587921|FG009|Overall Study|Adverse Event|1|||
148984645|NCT01539291|537421488|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
148984646|NCT01539291|537421489|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
148984647|NCT01539291|537421486|FG000|Study GS-US-312-0116|Other|1|||
149030014|NCT04310579|537587922|FG010|Overall Study|Adverse Event|0|||
148848531|NCT00984165|536921264|FG000|Overall Study|Disease progression on study|5|||
148848532|NCT00984165|536921265|FG001|Overall Study|Disease progression on study|1|||
148848533|NCT00984165|536921266|FG002|Overall Study|Disease progression on study|0|||
148848534|NCT00984165|536921267|FG003|Overall Study|Disease progression on study|0|||
148848535|NCT00984165|536921264|FG000|Overall Study|Death of recipient|0|||
149030015|NCT04310579|537587912|FG000|Overall Study|Withdrawal by Subject|0|||
149030016|NCT04310579|537587913|FG001|Overall Study|Withdrawal by Subject|0|||
149030017|NCT04310579|537587914|FG002|Overall Study|Withdrawal by Subject|0|||
148848536|NCT00984165|536921265|FG001|Overall Study|Death of recipient|0|||
148848537|NCT00984165|536921266|FG002|Overall Study|Death of recipient|0|||
148848538|NCT00984165|536921267|FG003|Overall Study|Death of recipient|1|||
148848539|NCT00984165|536921264|FG000|Overall Study|New protocol|0|||
148848540|NCT00984165|536921265|FG001|Overall Study|New protocol|0|||
148848541|NCT00984165|536921266|FG002|Overall Study|New protocol|0|||
148848542|NCT00984165|536921267|FG003|Overall Study|New protocol|1|||
148848543|NCT00984165|536921264|FG000|Overall Study|P+/donor pair removed from protocol|0|||
148848544|NCT00984165|536921265|FG001|Overall Study|P+/donor pair removed from protocol|0|||
148848545|NCT00984165|536921266|FG002|Overall Study|P+/donor pair removed from protocol|0|||
148848546|NCT00984165|536921267|FG003|Overall Study|P+/donor pair removed from protocol|1|||
148848547|NCT00984165|536921264|FG000|Overall Study|removed with a pair recipient|0|||
148848548|NCT00984165|536921265|FG001|Overall Study|removed with a pair recipient|0|||
148848549|NCT00984165|536921266|FG002|Overall Study|removed with a pair recipient|0|||
148848550|NCT00984165|536921267|FG003|Overall Study|removed with a pair recipient|1|||
148848551|NCT00135330|536921268|FG000|Overall Study|Adverse Event|2|||
148848552|NCT00135330|536921269|FG001|Overall Study|Adverse Event|5|||
148848553|NCT00135330|536921270|FG002|Overall Study|Adverse Event|1|||
148848554|NCT00135330|536921268|FG000|Overall Study|Lost to Follow-up|0|||
148848555|NCT00135330|536921269|FG001|Overall Study|Lost to Follow-up|2|||
148848556|NCT00135330|536921270|FG002|Overall Study|Lost to Follow-up|3|||
148848557|NCT00135330|536921268|FG000|Overall Study|Physician Decision|1|||
148848558|NCT00135330|536921269|FG001|Overall Study|Physician Decision|1|||
148848559|NCT00135330|536921270|FG002|Overall Study|Physician Decision|0|||
148848560|NCT00135330|536921268|FG000|Overall Study|Protocol Violation|4|||
148848561|NCT00135330|536921269|FG001|Overall Study|Protocol Violation|3|||
148848562|NCT00135330|536921270|FG002|Overall Study|Protocol Violation|3|||
148848563|NCT00135330|536921268|FG000|Overall Study|Patient Decision|5|||
148848564|NCT00135330|536921269|FG001|Overall Study|Patient Decision|1|||
148848565|NCT00135330|536921270|FG002|Overall Study|Patient Decision|4|||
148848566|NCT00135330|536921268|FG000|Overall Study|Sponsor Decision|0|||
148848567|NCT00135330|536921269|FG001|Overall Study|Sponsor Decision|1|||
148848568|NCT00135330|536921270|FG002|Overall Study|Sponsor Decision|0|||
148848569|NCT01390298|536921281|FG000|Overall Study|Death|1|||
148848570|NCT01390298|536921281|FG000|Overall Study|long term ICU admission|1|||
148848571|NCT01390298|536921281|FG000|Overall Study|Withdrawal by Subject|14|||
148848572|NCT01390298|536921281|FG000|Overall Study|Lost to Follow-up|7|||
148848573|NCT01390298|536921281|FG000|Overall Study|Surgery cancelled|1|||
148848574|NCT02443337|536921282|FG000|Overall Study|Adverse Event|0|||
148848575|NCT02443337|536921283|FG001|Overall Study|Adverse Event|1|||
148848576|NCT02443337|536921282|FG000|Overall Study|Clinical Progressive Disease|3|||
148848577|NCT02443337|536921283|FG001|Overall Study|Clinical Progressive Disease|0|||
148848578|NCT02443337|536921282|FG000|Overall Study|Withdrawal by Subject|2|||
148848579|NCT02443337|536921283|FG001|Overall Study|Withdrawal by Subject|1|||
148848580|NCT02096952|536921284|FG000|Overall Study|Adverse Event|1|||
148848581|NCT02446769|536921295|FG000|Screening Period|Screen Failure|11|||
148848582|NCT02446769|536921296|FG001|Screening Period|Screen Failure|0|||
148848583|NCT02446769|536921297|FG002|Screening Period|Screen Failure|0|||
148848584|NCT02446769|536921295|FG000|Study Period|Randomized in Error|0|||
148848585|NCT02446769|536921296|FG001|Study Period|Randomized in Error|2|||
148848586|NCT02446769|536921297|FG002|Study Period|Randomized in Error|0|||
148848587|NCT04482439|536921298|FG000|Overall Study|Lost to Follow-up|1|||
148848588|NCT04482439|536921298|FG000|Overall Study|Unrelated illness|1|||
148848589|NCT03072043|536921301|FG000|Overall Study|Death|0|||
148848590|NCT03072043|536921302|FG001|Overall Study|Death|0|||
148848591|NCT03072043|536921303|FG002|Overall Study|Death|3|||
148848592|NCT03072043|536921301|FG000|Overall Study|Adverse Event|0|||
148848593|NCT03072043|536921302|FG001|Overall Study|Adverse Event|0|||
148848594|NCT03072043|536921303|FG002|Overall Study|Adverse Event|2|||
148848595|NCT03072043|536921301|FG000|Overall Study|Withdrawal by Subject|0|||
148848596|NCT03072043|536921302|FG001|Overall Study|Withdrawal by Subject|0|||
148848597|NCT03072043|536921303|FG002|Overall Study|Withdrawal by Subject|4|||
148984648|NCT01539291|537421487|FG001|Study GS-US-312-0116|Other|0|||
148984649|NCT01539291|537421488|FG002|Study GS-US-312-0116|Other|0|||
148984650|NCT01539291|537421489|FG003|Study GS-US-312-0116|Other|0|||
148984651|NCT01539291|537421486|FG000|Study GS-US-312-0117|Adverse Event|22|||
148848598|NCT00402324|536921304|FG000|Overall Study|Lost to Follow-up|11|||
148848599|NCT00402324|536921305|FG001|Overall Study|Lost to Follow-up|11|||
148848600|NCT00402324|536921304|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
148848601|NCT00402324|536921305|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
148848602|NCT00402324|536921304|FG000|Overall Study|Protocol Violation|8|||
148848603|NCT00402324|536921305|FG001|Overall Study|Protocol Violation|7|||
148848604|NCT00402324|536921304|FG000|Overall Study|Withdrawal by Subject|5|||
148848605|NCT00402324|536921305|FG001|Overall Study|Withdrawal by Subject|2|||
148848606|NCT00402324|536921304|FG000|Overall Study|Physician Decision|2|||
148848607|NCT00402324|536921305|FG001|Overall Study|Physician Decision|4|||
148848608|NCT00402324|536921304|FG000|Overall Study|Sponsor Decision|4|||
148848609|NCT00402324|536921305|FG001|Overall Study|Sponsor Decision|5|||
148848610|NCT00402324|536921304|FG000|Overall Study|Lack of Efficacy|1|||
148848611|NCT00402324|536921305|FG001|Overall Study|Lack of Efficacy|4|||
148848612|NCT00402324|536921304|FG000|Overall Study|Adverse Event|6|||
148848613|NCT00402324|536921305|FG001|Overall Study|Adverse Event|4|||
148848614|NCT00402324|536921304|FG000|Overall Study|Death|1|||
148848615|NCT00402324|536921305|FG001|Overall Study|Death|0|||
148848616|NCT01277822|536921306|FG000|Overall Study|Adverse Event|2|||
148848617|NCT01277822|536921307|FG001|Overall Study|Adverse Event|1|||
148848618|NCT01277822|536921306|FG000|Overall Study|Withdrawal by Subject|6|||
148848619|NCT01277822|536921307|FG001|Overall Study|Withdrawal by Subject|7|||
148848620|NCT01277822|536921306|FG000|Overall Study|Physician Decision|1|||
148848621|NCT01277822|536921307|FG001|Overall Study|Physician Decision|1|||
148848622|NCT01277822|536921306|FG000|Overall Study|Protocol Violation|1|||
148848623|NCT01277822|536921307|FG001|Overall Study|Protocol Violation|0|||
148848624|NCT01277822|536921306|FG000|Overall Study|Lost to Follow-up|2|||
148848625|NCT01277822|536921307|FG001|Overall Study|Lost to Follow-up|1|||
148848626|NCT01277822|536921306|FG000|Overall Study|Contraindicated medication used|2|||
148848627|NCT01277822|536921307|FG001|Overall Study|Contraindicated medication used|1|||
148848628|NCT01277822|536921306|FG000|Overall Study|Participant moved|1|||
148848629|NCT01277822|536921307|FG001|Overall Study|Participant moved|0|||
148848630|NCT02923531|536921308|FG000|Overall Study|Adverse Event|4|||
148848631|NCT02923531|536921308|FG000|Overall Study|Clinical Deterioration|1|||
148848632|NCT02923531|536921308|FG000|Overall Study|Disease Progression|3|||
148848633|NCT02923531|536921308|FG000|Overall Study|Study Termination|1|||
148848634|NCT00997984|536921309|FG000|Overall Study|Adverse Event|1|||
148848635|NCT00997984|536921310|FG001|Overall Study|Adverse Event|8|||
148848636|NCT00997984|536921311|FG002|Overall Study|Adverse Event|8|||
148848637|NCT00997984|536921309|FG000|Overall Study|Protocol Violation|1|||
148848638|NCT00997984|536921310|FG001|Overall Study|Protocol Violation|3|||
148848639|NCT00997984|536921311|FG002|Overall Study|Protocol Violation|0|||
148848640|NCT00997984|536921309|FG000|Overall Study|Withdrawal by Subject|6|||
148848641|NCT00997984|536921310|FG001|Overall Study|Withdrawal by Subject|9|||
148848642|NCT00997984|536921311|FG002|Overall Study|Withdrawal by Subject|5|||
148848643|NCT00997984|536921309|FG000|Overall Study|Lost to Follow-up|8|||
148848644|NCT00997984|536921310|FG001|Overall Study|Lost to Follow-up|5|||
148848645|NCT00997984|536921311|FG002|Overall Study|Lost to Follow-up|4|||
148848646|NCT00997984|536921309|FG000|Overall Study|Lack of Efficacy|20|||
148848647|NCT00997984|536921310|FG001|Overall Study|Lack of Efficacy|6|||
148848648|NCT00997984|536921311|FG002|Overall Study|Lack of Efficacy|3|||
148848649|NCT00997984|536921309|FG000|Overall Study|Met exclusion criteria|1|||
148848650|NCT00997984|536921310|FG001|Overall Study|Met exclusion criteria|0|||
148848651|NCT00997984|536921311|FG002|Overall Study|Met exclusion criteria|0|||
148848652|NCT00997984|536921309|FG000|Overall Study|non-compliance|0|||
148848653|NCT00997984|536921310|FG001|Overall Study|non-compliance|2|||
148848654|NCT00997984|536921311|FG002|Overall Study|non-compliance|3|||
148848655|NCT00997984|536921309|FG000|Overall Study|Wrong medication dispensed|0|||
148848656|NCT00997984|536921310|FG001|Overall Study|Wrong medication dispensed|1|||
148848657|NCT00997984|536921311|FG002|Overall Study|Wrong medication dispensed|0|||
148848658|NCT00997984|536921309|FG000|Overall Study|Suicidal ideation|0|||
148848659|NCT00997984|536921310|FG001|Overall Study|Suicidal ideation|0|||
148848660|NCT00997984|536921311|FG002|Overall Study|Suicidal ideation|1|||
148848661|NCT00997984|536921309|FG000|Overall Study|Work schedule|0|||
148848662|NCT00997984|536921310|FG001|Overall Study|Work schedule|0|||
148848663|NCT00997984|536921311|FG002|Overall Study|Work schedule|2|||
148848664|NCT02997865|536921313|FG000|Overall Study|Death|2|||
148848665|NCT02997865|536921314|FG001|Overall Study|Death|1|||
148848666|NCT02997865|536921313|FG000|Overall Study|Lost to Follow-up|6|||
148848667|NCT02997865|536921314|FG001|Overall Study|Lost to Follow-up|3|||
148848668|NCT02997865|536921313|FG000|Overall Study|Withdrawal by Subject|5|||
148848669|NCT02997865|536921314|FG001|Overall Study|Withdrawal by Subject|0|||
148848670|NCT01119066|536921315|FG000|Overall Study|Withdrawal by Subject|4|||
148848671|NCT01119066|536921316|FG001|Overall Study|Withdrawal by Subject|6|||
148848672|NCT01119066|536921317|FG002|Overall Study|Withdrawal by Subject|0|||
148848673|NCT01119066|536921318|FG003|Overall Study|Withdrawal by Subject|0|||
148848674|NCT01119066|536921315|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
148848675|NCT01119066|536921316|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
148848676|NCT01119066|536921317|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
148848677|NCT01119066|536921318|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
148848678|NCT01119066|536921315|FG000|Overall Study|Relapse identified before transplant|1|||
148848679|NCT01119066|536921316|FG001|Overall Study|Relapse identified before transplant|0|||
148848680|NCT01119066|536921317|FG002|Overall Study|Relapse identified before transplant|0|||
148848681|NCT01119066|536921318|FG003|Overall Study|Relapse identified before transplant|0|||
148848682|NCT01119066|536921315|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
148889373|NCT00101686|537074374|FG003|Overall Study|Withdrawal by Subject|8|||
148889374|NCT00101686|537074375|FG004|Overall Study|Withdrawal by Subject|8|||
148889375|NCT00101686|537074376|FG005|Overall Study|Withdrawal by Subject|7|||
148889376|NCT00101686|537074377|FG006|Overall Study|Withdrawal by Subject|7|||
148848683|NCT01119066|536921316|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
148848684|NCT01119066|536921317|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
148848685|NCT01119066|536921318|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
149030018|NCT04310579|537587915|FG003|Overall Study|Withdrawal by Subject|0|||
149030019|NCT04310579|537587916|FG004|Overall Study|Withdrawal by Subject|0|||
149030020|NCT04310579|537587917|FG005|Overall Study|Withdrawal by Subject|1|||
149030021|NCT04310579|537587918|FG006|Overall Study|Withdrawal by Subject|0|||
149030022|NCT04310579|537587919|FG007|Overall Study|Withdrawal by Subject|0|||
149030023|NCT04310579|537587920|FG008|Overall Study|Withdrawal by Subject|0|||
149030024|NCT04310579|537587921|FG009|Overall Study|Withdrawal by Subject|0|||
149030025|NCT04310579|537587922|FG010|Overall Study|Withdrawal by Subject|0|||
149030026|NCT04310579|537587912|FG000|Overall Study|Positive COVID-19 test|0|||
149030027|NCT04310579|537587913|FG001|Overall Study|Positive COVID-19 test|0|||
148848686|NCT01119066|536921315|FG000|Overall Study|Relapse identified before transplant|0|||
148848687|NCT01119066|536921316|FG001|Overall Study|Relapse identified before transplant|4|||
148848688|NCT01119066|536921317|FG002|Overall Study|Relapse identified before transplant|0|||
148848689|NCT01119066|536921318|FG003|Overall Study|Relapse identified before transplant|0|||
148848690|NCT00295646|536921322|FG000|Overall Study|Protocol Violation|18|||
148848691|NCT00295646|536921323|FG001|Overall Study|Protocol Violation|20|||
148848692|NCT00295646|536921324|FG002|Overall Study|Protocol Violation|20|||
148848693|NCT00295646|536921325|FG003|Overall Study|Protocol Violation|18|||
148848694|NCT00295646|536921322|FG000|Overall Study|Withdrawal by Subject|8|||
148848695|NCT00295646|536921323|FG001|Overall Study|Withdrawal by Subject|9|||
148848696|NCT00295646|536921324|FG002|Overall Study|Withdrawal by Subject|11|||
148848697|NCT00295646|536921325|FG003|Overall Study|Withdrawal by Subject|14|||
148848698|NCT00295646|536921322|FG000|Overall Study|Lost to Follow-up|0|||
148848699|NCT00295646|536921323|FG001|Overall Study|Lost to Follow-up|5|||
148848700|NCT00295646|536921324|FG002|Overall Study|Lost to Follow-up|1|||
148848701|NCT00295646|536921325|FG003|Overall Study|Lost to Follow-up|5|||
148848702|NCT00295646|536921322|FG000|Overall Study|Death|9|||
148848703|NCT00295646|536921323|FG001|Overall Study|Death|7|||
148848704|NCT00295646|536921324|FG002|Overall Study|Death|18|||
148848705|NCT00295646|536921325|FG003|Overall Study|Death|8|||
148848706|NCT02243371|536921330|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
148848707|NCT02243371|536921331|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
148848708|NCT02243371|536921330|FG000|Overall Study|Death (unrelated)|2|||
148848709|NCT02243371|536921331|FG001|Overall Study|Death (unrelated)|4|||
148848710|NCT02243371|536921330|FG000|Overall Study|Adverse Event (unrelated)|0|||
148848711|NCT02243371|536921331|FG001|Overall Study|Adverse Event (unrelated)|1|||
148848712|NCT02243371|536921330|FG000|Overall Study|Lack of Clinical Benefit|0|||
148848713|NCT02243371|536921331|FG001|Overall Study|Lack of Clinical Benefit|1|||
148848714|NCT02243371|536921330|FG000|Overall Study|Withdrawal by Subject|0|||
148848715|NCT02243371|536921331|FG001|Overall Study|Withdrawal by Subject|2|||
148848716|NCT01945996|536921332|FG000|Overall Study|Lost to Follow-up|3|||
148848717|NCT01945996|536921333|FG001|Overall Study|Lost to Follow-up|5|||
148848718|NCT00271856|536921334|FG000|Overall Study|Withdrawal by Subject|1|||
148848719|NCT00271856|536921335|FG001|Overall Study|Withdrawal by Subject|7|||
148848720|NCT00271856|536921334|FG000|Overall Study|Lost to Follow-up|10|||
148848721|NCT00271856|536921335|FG001|Overall Study|Lost to Follow-up|11|||
148848722|NCT01509846|536921336|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
148848723|NCT01509846|536921337|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
148848724|NCT01509846|536921338|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
148848725|NCT01509846|536921339|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
148848726|NCT01509846|536921340|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
148848727|NCT01509846|536921336|FG000|Received Vaccination 2|Illness|0|||
148848728|NCT01509846|536921337|FG001|Received Vaccination 2|Illness|0|||
148848729|NCT01509846|536921338|FG002|Received Vaccination 2|Illness|0|||
148848730|NCT01509846|536921339|FG003|Received Vaccination 2|Illness|0|||
148848731|NCT01509846|536921340|FG004|Received Vaccination 2|Illness|1|||
148848732|NCT01509846|536921336|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
148848733|NCT01509846|536921337|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
148848734|NCT01509846|536921338|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
148848735|NCT01509846|536921339|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
148848736|NCT01509846|536921340|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
149030028|NCT04310579|537587914|FG002|Overall Study|Positive COVID-19 test|0|||
148848737|NCT01509846|536921336|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
148848738|NCT01509846|536921337|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
148848739|NCT01509846|536921338|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
148848740|NCT01509846|536921339|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
148848741|NCT01509846|536921340|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
148848742|NCT01509846|536921336|FG000|Received Vaccination 3|Pregnancy|0|||
148848743|NCT01509846|536921337|FG001|Received Vaccination 3|Pregnancy|0|||
148848744|NCT01509846|536921338|FG002|Received Vaccination 3|Pregnancy|0|||
148848745|NCT01509846|536921339|FG003|Received Vaccination 3|Pregnancy|1|||
149030029|NCT04310579|537587915|FG003|Overall Study|Positive COVID-19 test|0|||
149030030|NCT04310579|537587916|FG004|Overall Study|Positive COVID-19 test|0|||
148776655|NCT01120249|536656839|FG001|Overall Study|Death|0|||
148776656|NCT01120249|536656838|FG000|Overall Study|Adverse Event|40|||
148776657|NCT01120249|536656839|FG001|Overall Study|Adverse Event|276|||
148776658|NCT01120249|536656838|FG000|Overall Study|Participant refusal|34|||
148776659|NCT01120249|536656839|FG001|Overall Study|Participant refusal|42|||
148776660|NCT01120249|536656838|FG000|Overall Study|Other reasons, not protocol specified|29|||
148776661|NCT01120249|536656839|FG001|Overall Study|Other reasons, not protocol specified|22|||
148776662|NCT01701193|536656840|FG000|Overall Study|Withdrawal by Subject|2|||
148776663|NCT01701193|536656841|FG001|Overall Study|Withdrawal by Subject|2|||
148776664|NCT01701193|536656842|FG002|Overall Study|Withdrawal by Subject|1|||
148776665|NCT01701193|536656843|FG003|Overall Study|Withdrawal by Subject|2|||
148776666|NCT01701193|536656840|FG000|Overall Study|Adverse Event|1|||
148776667|NCT01701193|536656841|FG001|Overall Study|Adverse Event|0|||
148776668|NCT01701193|536656842|FG002|Overall Study|Adverse Event|0|||
148776669|NCT01701193|536656843|FG003|Overall Study|Adverse Event|0|||
148776670|NCT01482962|536656844|FG000|Overall Study|Progressive Disease|65|||
148776671|NCT01482962|536656845|FG001|Overall Study|Progressive Disease|53|||
148776672|NCT01482962|536656844|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
148776673|NCT01482962|536656845|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
148776674|NCT01482962|536656844|FG000|Overall Study|Adverse Event|18|||
148776675|NCT01482962|536656845|FG001|Overall Study|Adverse Event|22|||
148776676|NCT01482962|536656844|FG000|Overall Study|Withdrawal by Participant|8|||
148776677|NCT01482962|536656845|FG001|Overall Study|Withdrawal by Participant|13|||
148776678|NCT01482962|536656844|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
148776679|NCT01482962|536656845|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
148776680|NCT01482962|536656844|FG000|Overall Study|Other Reason|1|||
148776681|NCT01482962|536656845|FG001|Overall Study|Other Reason|5|||
148776682|NCT01482962|536656844|FG000|Overall Study|Study Terminated by Sponsor|5|||
148776683|NCT01482962|536656845|FG001|Overall Study|Study Terminated by Sponsor|2|||
148776684|NCT01482962|536656844|FG000|Overall Study|Did not Receive Study Drug|1|||
148776685|NCT01482962|536656845|FG001|Overall Study|Did not Receive Study Drug|6|||
148776686|NCT03536949|536656856|FG000|Overall Study|Adverse Event|4|||
148776687|NCT03536949|536656857|FG001|Overall Study|Adverse Event|0|||
148776688|NCT03536949|536656856|FG000|Overall Study|Lost to Follow-up|2|||
148776689|NCT03536949|536656857|FG001|Overall Study|Lost to Follow-up|1|||
148776690|NCT03536949|536656856|FG000|Overall Study|Withdrawal by Subject|6|||
148776691|NCT03536949|536656857|FG001|Overall Study|Withdrawal by Subject|0|||
148776692|NCT03536949|536656856|FG000|Overall Study|Non-compliance|2|||
148776693|NCT03536949|536656857|FG001|Overall Study|Non-compliance|1|||
148776694|NCT04329091|536656860|FG000|Overall Study|Physician Decision|5|||
148776695|NCT01210495|536656863|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
148776696|NCT01210495|536656864|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
148776697|NCT01210495|536656865|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
148776698|NCT01210495|536656866|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
148776699|NCT01210495|536656863|FG000|Overall Study|Death|14|||
148776700|NCT01210495|536656864|FG001|Overall Study|Death|7|||
148776701|NCT01210495|536656865|FG002|Overall Study|Death|112|||
148776702|NCT01210495|536656866|FG003|Overall Study|Death|54|||
148776703|NCT01210495|536656863|FG000|Overall Study|Study Terminated by Sponsor|0|||
148776704|NCT01210495|536656864|FG001|Overall Study|Study Terminated by Sponsor|0|||
148776705|NCT01210495|536656865|FG002|Overall Study|Study Terminated by Sponsor|4|||
148776706|NCT01210495|536656866|FG003|Overall Study|Study Terminated by Sponsor|11|||
148776707|NCT01210495|536656863|FG000|Overall Study|Lost to Follow-up|0|||
148776708|NCT01210495|536656864|FG001|Overall Study|Lost to Follow-up|0|||
148776709|NCT01210495|536656865|FG002|Overall Study|Lost to Follow-up|1|||
148776710|NCT01210495|536656866|FG003|Overall Study|Lost to Follow-up|1|||
148776711|NCT01210495|536656863|FG000|Overall Study|Other unspecified|0|||
148776712|NCT01210495|536656864|FG001|Overall Study|Other unspecified|0|||
148776713|NCT01210495|536656865|FG002|Overall Study|Other unspecified|6|||
148776714|NCT01210495|536656866|FG003|Overall Study|Other unspecified|0|||
148776715|NCT00767039|536656871|FG000|Overall Study|Death|5|||
148776716|NCT00767039|536656872|FG001|Overall Study|Death|2|||
148776717|NCT04416737|536656873|FG000|Week 1 (First Injection)|Physician Decision|0|||
148776718|NCT04416737|536656874|FG001|Week 1 (First Injection)|Physician Decision|1|||
148776719|NCT03332628|536656875|FG000|Overall Study|Physician Decision|2|||
148776720|NCT01472757|536656876|FG000|Overall Study|Withdrawal by Subject|1|||
148776721|NCT01472757|536656877|FG001|Overall Study|Withdrawal by Subject|2|||
148776722|NCT01472757|536656878|FG002|Overall Study|Withdrawal by Subject|2|||
148776723|NCT01472757|536656879|FG003|Overall Study|Withdrawal by Subject|0|||
148776724|NCT01472757|536656876|FG000|Overall Study|Asthma exacerbation|4|||
148776725|NCT01472757|536656877|FG001|Overall Study|Asthma exacerbation|1|||
148776726|NCT01472757|536656878|FG002|Overall Study|Asthma exacerbation|2|||
148776727|NCT01472757|536656879|FG003|Overall Study|Asthma exacerbation|1|||
148848746|NCT01509846|536921340|FG004|Received Vaccination 3|Pregnancy|0|||
148848747|NCT01509846|536921336|FG000|Received Vaccination 3|Lost to Follow-up|0|||
148848748|NCT01509846|536921337|FG001|Received Vaccination 3|Lost to Follow-up|0|||
148848749|NCT01509846|536921338|FG002|Received Vaccination 3|Lost to Follow-up|1|||
148848750|NCT01509846|536921339|FG003|Received Vaccination 3|Lost to Follow-up|0|||
148848751|NCT01509846|536921340|FG004|Received Vaccination 3|Lost to Follow-up|0|||
148848752|NCT04677543|536921342|FG000|Overall Study|Withdrawal by Subject|4|||
148848753|NCT04677543|536921343|FG001|Overall Study|Withdrawal by Subject|1|||
148848754|NCT04677543|536921342|FG000|Overall Study|Physician Decision|0|||
148848755|NCT04677543|536921343|FG001|Overall Study|Physician Decision|1|||
148848756|NCT04677543|536921342|FG000|Overall Study|Adverse Event|0|||
148848757|NCT04677543|536921343|FG001|Overall Study|Adverse Event|1|||
148848758|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
148848759|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
148848760|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
148848761|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
148848762|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
148848763|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
148848764|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
148848765|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
148848766|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
148848767|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
148848768|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
148848769|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
148848770|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
148848771|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
148848772|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
148848773|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
148848774|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
148848775|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
148848776|NCT03162796|536921344|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
148984652|NCT01539291|537421487|FG001|Study GS-US-312-0117|Adverse Event|1|||
148984653|NCT01539291|537421488|FG002|Study GS-US-312-0117|Adverse Event|9|||
148984654|NCT01539291|537421489|FG003|Study GS-US-312-0117|Adverse Event|12|||
148984655|NCT01539291|537421486|FG000|Study GS-US-312-0117|Physician Decision|9|||
148984656|NCT01539291|537421487|FG001|Study GS-US-312-0117|Physician Decision|0|||
148984657|NCT01539291|537421488|FG002|Study GS-US-312-0117|Physician Decision|6|||
148848777|NCT03162796|536921345|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
148848778|NCT03162796|536921346|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
148848779|NCT03162796|536921344|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
148848780|NCT03162796|536921345|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
148848781|NCT03162796|536921346|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
148848782|NCT03162796|536921344|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
148848783|NCT03162796|536921345|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
148848784|NCT03162796|536921346|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
148848785|NCT03162796|536921344|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
148848786|NCT03162796|536921345|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
148848787|NCT03162796|536921346|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
148848788|NCT03162796|536921344|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
148848789|NCT03162796|536921345|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
148848790|NCT03162796|536921346|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
148848791|NCT02342288|536921347|FG000|Overall Study|no protocol anesthesiologist available|3|||
148848792|NCT02342288|536921348|FG001|Overall Study|no protocol anesthesiologist available|2|||
148848793|NCT02342288|536921347|FG000|Overall Study|anesthesia leak in system|1|||
148848794|NCT02342288|536921348|FG001|Overall Study|anesthesia leak in system|0|||
148848795|NCT02342288|536921347|FG000|Overall Study|Withdrawal by Subject|1|||
148848796|NCT02342288|536921348|FG001|Overall Study|Withdrawal by Subject|0|||
148848797|NCT02342288|536921347|FG000|Overall Study|coordinator contaminated with blood|0|||
148848798|NCT02342288|536921348|FG001|Overall Study|coordinator contaminated with blood|1|||
148848799|NCT02342288|536921347|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
148848800|NCT02342288|536921348|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
148848801|NCT02342288|536921347|FG000|Overall Study|coordinator not available|0|||
148848802|NCT02342288|536921348|FG001|Overall Study|coordinator not available|2|||
148848803|NCT03744910|536922716|FG000|Overall Study|Withdrew Consent|1|||
148848804|NCT03744910|536922717|FG001|Overall Study|Withdrew Consent|8|||
148848805|NCT03744910|536922716|FG000|Overall Study|Physician Decision|5|||
148848806|NCT03744910|536922717|FG001|Overall Study|Physician Decision|4|||
148848807|NCT03744910|536922716|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
148984658|NCT01539291|537421489|FG003|Study GS-US-312-0117|Physician Decision|4|||
148984659|NCT01539291|537421486|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
148848808|NCT03744910|536922717|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
148848809|NCT03744910|536922716|FG000|Overall Study|Lost to Follow-up|0|||
148848810|NCT03744910|536922717|FG001|Overall Study|Lost to Follow-up|1|||
148848811|NCT03744910|536922716|FG000|Overall Study|Other-unspecified|4|||
148848812|NCT03744910|536922717|FG001|Overall Study|Other-unspecified|1|||
148848813|NCT03280303|536922718|FG000|Overall Study|Death|505|||
148848814|NCT03280303|536922718|FG000|Overall Study|Study terminated by sponsor|383|||
148848815|NCT03280303|536922718|FG000|Overall Study|Other|148|||
148848816|NCT03280303|536922718|FG000|Overall Study|No longer willing to participate in study|101|||
148848817|NCT03280303|536922718|FG000|Overall Study|Lost to follow up|39|||
148848818|NCT03280303|536922718|FG000|Overall Study|Adverse Event|20|||
148848819|NCT00500357|536922724|FG000|Overall Study|Death|1|||
148848820|NCT02263326|536922725|FG000|Overall Study|Lost to Follow-up|1|||
148848821|NCT02263326|536922726|FG001|Overall Study|Lost to Follow-up|1|||
148848822|NCT01893411|536922727|FG000|Overall Study|Protocol Violation|1|||
148848823|NCT01893411|536922728|FG001|Overall Study|Protocol Violation|0|||
148848824|NCT01893411|536922729|FG002|Overall Study|Protocol Violation|0|||
148848825|NCT01893411|536922727|FG000|Overall Study|Physician Decision|1|||
148848826|NCT01893411|536922728|FG001|Overall Study|Physician Decision|1|||
148848827|NCT01893411|536922729|FG002|Overall Study|Physician Decision|2|||
148848828|NCT01893411|536922727|FG000|Overall Study|Lack of Efficacy|2|||
148848829|NCT01893411|536922728|FG001|Overall Study|Lack of Efficacy|1|||
148848830|NCT01893411|536922729|FG002|Overall Study|Lack of Efficacy|0|||
148848831|NCT01893411|536922727|FG000|Overall Study|Other|3|||
148848832|NCT01893411|536922728|FG001|Overall Study|Other|1|||
148848833|NCT01893411|536922729|FG002|Overall Study|Other|3|||
148848834|NCT01893411|536922727|FG000|Overall Study|Adverse Event|1|||
148848835|NCT01893411|536922728|FG001|Overall Study|Adverse Event|0|||
148848836|NCT01893411|536922729|FG002|Overall Study|Adverse Event|0|||
148848837|NCT01893411|536922727|FG000|Overall Study|Withdrawal by Subject|7|||
148848838|NCT01893411|536922728|FG001|Overall Study|Withdrawal by Subject|4|||
148848839|NCT01893411|536922729|FG002|Overall Study|Withdrawal by Subject|3|||
148848840|NCT01893411|536922727|FG000|Overall Study|Lost to Follow-up|2|||
148848841|NCT01893411|536922728|FG001|Overall Study|Lost to Follow-up|0|||
148848842|NCT01893411|536922729|FG002|Overall Study|Lost to Follow-up|1|||
148848843|NCT00161616|536922730|FG000|Overall Study|Withdrawal by Subject|6|||
148848844|NCT00161616|536922731|FG001|Overall Study|Withdrawal by Subject|5|||
148848845|NCT00161616|536922730|FG000|Overall Study|Physician Decision|1|||
148848846|NCT00161616|536922731|FG001|Overall Study|Physician Decision|0|||
148848847|NCT00161616|536922730|FG000|Overall Study|Death|1|||
148848848|NCT00161616|536922731|FG001|Overall Study|Death|1|||
148848849|NCT00161616|536922730|FG000|Overall Study|Lost to Follow-up|17|||
148848850|NCT00161616|536922731|FG001|Overall Study|Lost to Follow-up|13|||
148848851|NCT00161616|536922730|FG000|Overall Study|Protocol deviation|1|||
148848852|NCT00161616|536922731|FG001|Overall Study|Protocol deviation|0|||
148848853|NCT00933608|536922733|FG000|Overall Study|Adverse Event|4|||
148848854|NCT00933608|536922734|FG001|Overall Study|Adverse Event|2|||
148848855|NCT00933608|536922733|FG000|Overall Study|Physician Decision|1|||
148848856|NCT00933608|536922734|FG001|Overall Study|Physician Decision|0|||
148848857|NCT00336284|536922735|FG000|Overall Study|Death|52|||
148848858|NCT00336284|536922736|FG001|Overall Study|Death|26|||
148848859|NCT00336284|536922735|FG000|Overall Study|Lost to Follow-up|82|||
148848860|NCT00336284|536922736|FG001|Overall Study|Lost to Follow-up|61|||
148848861|NCT00336284|536922735|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
148848862|NCT00336284|536922736|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
148848863|NCT00473889|536922740|FG000|Overall Study|Did not receive study medication|1|||
148848864|NCT00473889|536922741|FG001|Overall Study|Did not receive study medication|4|||
148848865|NCT00473889|536922740|FG000|Overall Study|Adverse Event|30|||
148848866|NCT00473889|536922741|FG001|Overall Study|Adverse Event|17|||
148848867|NCT00473889|536922740|FG000|Overall Study|Protocol Violation|4|||
148848868|NCT00473889|536922741|FG001|Overall Study|Protocol Violation|2|||
148848869|NCT00473889|536922740|FG000|Overall Study|Lack of Efficacy|28|||
148848870|NCT00473889|536922741|FG001|Overall Study|Lack of Efficacy|29|||
148848871|NCT00473889|536922740|FG000|Overall Study|Lost to Follow-up|2|||
148848872|NCT00473889|536922741|FG001|Overall Study|Lost to Follow-up|1|||
148848873|NCT00473889|536922740|FG000|Overall Study|Physician Decision|10|||
148848874|NCT00473889|536922741|FG001|Overall Study|Physician Decision|5|||
148848875|NCT00473889|536922740|FG000|Overall Study|Trial Terminated|3|||
148848876|NCT00473889|536922741|FG001|Overall Study|Trial Terminated|6|||
148848877|NCT00473889|536922740|FG000|Overall Study|Withdrawal by Subject|5|||
148848878|NCT00473889|536922741|FG001|Overall Study|Withdrawal by Subject|0|||
148848879|NCT04729972|536922742|FG000|Overall Study|Adverse Event|1|||
148848880|NCT00590122|536922743|FG000|Overall Study|swallowed oral dissolving dose|1|||
148848881|NCT00590122|536922744|FG001|Overall Study|swallowed oral dissolving dose|0|||
148848882|NCT01208324|536922745|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
148848883|NCT01208324|536922746|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
148848884|NCT01208324|536922747|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
148848885|NCT01208324|536922748|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
148848886|NCT01701362|536922749|FG000|Overall Study|Adverse events not related to study drug|1|||
148848887|NCT01701362|536922750|FG001|Overall Study|Adverse events not related to study drug|6|||
148984660|NCT01539291|537421487|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
148984661|NCT01539291|537421488|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
148984662|NCT01539291|537421489|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
148984663|NCT01539291|537421486|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
148984664|NCT01539291|537421487|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
148984665|NCT01539291|537421488|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
148848888|NCT01701362|536922749|FG000|Overall Study|Adverse events related to study drug|12|||
148848889|NCT01701362|536922750|FG001|Overall Study|Adverse events related to study drug|10|||
148848890|NCT01701362|536922749|FG000|Overall Study|Protocol Violation|5|||
148848891|NCT01701362|536922750|FG001|Overall Study|Protocol Violation|3|||
148848892|NCT01701362|536922749|FG000|Overall Study|No longer willing to participate|8|||
148848893|NCT01701362|536922750|FG001|Overall Study|No longer willing to participate|14|||
148848894|NCT01701362|536922749|FG000|Overall Study|Lost to Follow-up|6|||
148848895|NCT01701362|536922750|FG001|Overall Study|Lost to Follow-up|9|||
148848896|NCT01701362|536922749|FG000|Overall Study|Insufficient clinical response|6|||
148848897|NCT01701362|536922750|FG001|Overall Study|Insufficient clinical response|6|||
148848898|NCT01701362|536922749|FG000|Overall Study|Death|0|||
148848899|NCT01701362|536922750|FG001|Overall Study|Death|1|||
148848900|NCT01701362|536922749|FG000|Overall Study|Randomized but not treated|1|||
148848901|NCT01701362|536922750|FG001|Overall Study|Randomized but not treated|2|||
148848902|NCT01701362|536922749|FG000|Overall Study|Reasons other than those mentioned above|3|||
148848903|NCT01701362|536922750|FG001|Overall Study|Reasons other than those mentioned above|5|||
148848904|NCT00249808|536922751|FG000|Overall Study|Other|27|||
148848905|NCT00249808|536922751|FG000|Overall Study|Protocol Violation|3|||
148848906|NCT00249808|536922751|FG000|Overall Study|Lost to Follow-up|8|||
148848907|NCT00249808|536922751|FG000|Overall Study|Adverse Event|81|||
148848908|NCT00249808|536922751|FG000|Overall Study|Lack of Efficacy|52|||
148848909|NCT00249808|536922751|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
148848910|NCT00443872|536922752|FG000|Overall Study|Protocol Violation|7|||
148848911|NCT00443872|536922752|FG000|Overall Study|Lost to Follow-up|2|||
148848912|NCT00443872|536922752|FG000|Overall Study|Adverse Event|8|||
148848913|NCT04123093|536922762|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
148848914|NCT04123093|536922763|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
148848915|NCT04123093|536922762|FG000|Phase 2|Physician Decision|0|||
148848916|NCT04123093|536922763|FG001|Phase 2|Physician Decision|1|||
148848917|NCT04123093|536922762|FG000|Phase 2|Withdrawal by Subject|0|||
148848918|NCT04123093|536922763|FG001|Phase 2|Withdrawal by Subject|1|||
148848919|NCT02229825|536922764|FG000|Overall Study|Personal Reasons|0|||
148848920|NCT02229825|536922765|FG001|Overall Study|Personal Reasons|1|||
148848921|NCT02229825|536922764|FG000|Overall Study|Refused continuing medication|7|||
148848922|NCT02229825|536922765|FG001|Overall Study|Refused continuing medication|6|||
148848923|NCT02229825|536922764|FG000|Overall Study|Lost to Follow-up|1|||
148848924|NCT02229825|536922765|FG001|Overall Study|Lost to Follow-up|2|||
148848925|NCT02229825|536922764|FG000|Overall Study|Protocol Violation|1|||
148848926|NCT02229825|536922765|FG001|Overall Study|Protocol Violation|1|||
148848927|NCT02229825|536922764|FG000|Overall Study|Lack of Efficacy|4|||
148848928|NCT02229825|536922765|FG001|Overall Study|Lack of Efficacy|10|||
148848929|NCT02229825|536922764|FG000|Overall Study|Adverse Event|11|||
148848930|NCT02229825|536922765|FG001|Overall Study|Adverse Event|9|||
148848931|NCT02229825|536922764|FG000|Overall Study|Not treated|0|||
148848932|NCT02229825|536922765|FG001|Overall Study|Not treated|1|||
148848933|NCT03520920|536922772|FG000|Overall Study|Death|13|||
148848934|NCT03520920|536922773|FG001|Overall Study|Death|1|||
148848935|NCT03520920|536922774|FG002|Overall Study|Death|0|||
148848936|NCT03520920|536922772|FG000|Overall Study|Withdrawal by Subject|2|||
148848937|NCT03520920|536922773|FG001|Overall Study|Withdrawal by Subject|1|||
148848938|NCT03520920|536922774|FG002|Overall Study|Withdrawal by Subject|0|||
148848939|NCT03520920|536922772|FG000|Overall Study|Study Terminated by the Sponsor|5|||
148848940|NCT03520920|536922773|FG001|Overall Study|Study Terminated by the Sponsor|14|||
148848941|NCT03520920|536922774|FG002|Overall Study|Study Terminated by the Sponsor|5|||
148848942|NCT00988052|536922775|FG000|Overall Study|Missing|1|||
148848943|NCT00988052|536922776|FG001|Overall Study|Missing|0|||
148848944|NCT00988052|536922775|FG000|Overall Study|Teva requested subject withdrawal|3|||
148848945|NCT00988052|536922776|FG001|Overall Study|Teva requested subject withdrawal|1|||
148848946|NCT00988052|536922775|FG000|Overall Study|Death|1|||
148848947|NCT00988052|536922776|FG001|Overall Study|Death|3|||
148848948|NCT00988052|536922775|FG000|Overall Study|Protocol Violation|6|||
148848949|NCT00988052|536922776|FG001|Overall Study|Protocol Violation|5|||
148848950|NCT00988052|536922775|FG000|Overall Study|Pregnancy|6|||
148848951|NCT00988052|536922776|FG001|Overall Study|Pregnancy|6|||
148848952|NCT00988052|536922775|FG000|Overall Study|Lack of Efficacy|8|||
148848953|NCT00988052|536922776|FG001|Overall Study|Lack of Efficacy|7|||
148848954|NCT00988052|536922775|FG000|Overall Study|Lost to Follow-up|6|||
148848955|NCT00988052|536922776|FG001|Overall Study|Lost to Follow-up|11|||
148848956|NCT00988052|536922775|FG000|Overall Study|Physician Decision|27|||
148984666|NCT01539291|537421489|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
148848957|NCT00988052|536922776|FG001|Overall Study|Physician Decision|28|||
148848958|NCT00988052|536922775|FG000|Overall Study|Adverse Event|35|||
148848959|NCT00988052|536922776|FG001|Overall Study|Adverse Event|28|||
148848960|NCT00988052|536922775|FG000|Overall Study|Withdrawal by Subject|90|||
148848961|NCT00988052|536922776|FG001|Overall Study|Withdrawal by Subject|91|||
148848962|NCT00988052|536922775|FG000|Overall Study|Study terminated by sponsor|240|||
148848963|NCT00988052|536922776|FG001|Overall Study|Study terminated by sponsor|236|||
148848964|NCT01437111|536922779|FG000|Overall Study|Adverse Event|2|||
148848965|NCT01437111|536922779|FG000|Overall Study|Withdrawal by Subject|4|||
148848966|NCT01437111|536922779|FG000|Overall Study|Not reported|5|||
148848967|NCT01437111|536922779|FG000|Overall Study|Physician Decision|1|||
148848968|NCT01437111|536922779|FG000|Overall Study|Lost to Follow-up|5|||
148848969|NCT01437111|536922779|FG000|Overall Study|Protocol Violation|1|||
148848970|NCT02131311|536922780|FG000|Overall Study|Adverse Event|2|||
148848971|NCT02131311|536922780|FG000|Overall Study|Protocol Violation|1|||
148848972|NCT02131311|536922780|FG000|Overall Study|Lost to Follow-up|1|||
148848973|NCT02623205|536922784|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
148848974|NCT02623205|536922785|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
148848975|NCT02473471|536922786|FG000|Overall Study|poor oral hygiene|2|||
148848976|NCT02473471|536922786|FG000|Overall Study|Lost to Follow-up|1|||
148848977|NCT03082677|536922787|FG000|Overall Study|Not Treated|2|||
148848978|NCT01667133|536922788|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
148848979|NCT01667133|536922789|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
148848980|NCT01667133|536922790|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
148848981|NCT01667133|536922791|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
148848982|NCT01667133|536922792|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
148848983|NCT01667133|536922793|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
148848984|NCT01667133|536922794|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
148848985|NCT01667133|536922795|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
148848986|NCT01667133|536922796|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
148848987|NCT01667133|536922797|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
148848988|NCT01667133|536922798|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
148848989|NCT01667133|536922799|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
148848990|NCT01667133|536922788|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848991|NCT01667133|536922789|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848992|NCT01667133|536922790|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
148848993|NCT01667133|536922791|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848994|NCT01667133|536922792|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848995|NCT01667133|536922793|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848996|NCT01667133|536922794|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848997|NCT01667133|536922795|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848998|NCT01667133|536922796|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148848999|NCT01667133|536922797|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148849000|NCT01667133|536922798|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148849001|NCT01667133|536922799|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
148849002|NCT01667133|536922788|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
148849003|NCT01667133|536922789|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
148849004|NCT01667133|536922790|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
148849005|NCT01667133|536922791|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
148849006|NCT01667133|536922792|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
148849007|NCT01667133|536922793|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
148849008|NCT01667133|536922794|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
148849009|NCT01667133|536922795|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
148849010|NCT01667133|536922796|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
148849011|NCT01667133|536922797|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
148849012|NCT01667133|536922798|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
148849013|NCT01667133|536922799|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
148849014|NCT01667133|536922788|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849015|NCT01667133|536922789|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849016|NCT01667133|536922790|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849017|NCT01667133|536922791|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
148984667|NCT01539291|537421486|FG000|Study GS-US-312-0117|Other|2|||
148849018|NCT01667133|536922792|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849019|NCT01667133|536922793|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148984668|NCT01539291|537421487|FG001|Study GS-US-312-0117|Other|1|||
148849020|NCT01667133|536922794|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849021|NCT01667133|536922795|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849022|NCT01667133|536922796|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849023|NCT01667133|536922797|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849024|NCT01667133|536922798|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849025|NCT01667133|536922799|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
148849026|NCT01667133|536922788|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
148849027|NCT01667133|536922789|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
148849028|NCT01667133|536922790|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
148849029|NCT01667133|536922791|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
148849030|NCT01667133|536922792|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
148849031|NCT01667133|536922793|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
148849032|NCT01667133|536922794|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
148849033|NCT01667133|536922795|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
148849034|NCT01667133|536922796|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
148849035|NCT01667133|536922797|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
148849036|NCT01667133|536922798|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
148849037|NCT01667133|536922799|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
148849038|NCT01667133|536922788|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849039|NCT01667133|536922789|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849040|NCT01667133|536922790|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849041|NCT01667133|536922791|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849042|NCT01667133|536922792|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849043|NCT01667133|536922793|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849044|NCT01667133|536922794|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849045|NCT01667133|536922795|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849046|NCT01667133|536922796|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849047|NCT01667133|536922797|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
148849048|NCT01667133|536922798|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849049|NCT01667133|536922799|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
148849050|NCT01667133|536922788|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
148849051|NCT01667133|536922789|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
149030031|NCT04310579|537587917|FG005|Overall Study|Positive COVID-19 test|0|||
149030032|NCT04310579|537587918|FG006|Overall Study|Positive COVID-19 test|0|||
149030033|NCT04310579|537587919|FG007|Overall Study|Positive COVID-19 test|0|||
149030034|NCT04310579|537587920|FG008|Overall Study|Positive COVID-19 test|0|||
149030035|NCT04310579|537587921|FG009|Overall Study|Positive COVID-19 test|0|||
149030036|NCT04310579|537587922|FG010|Overall Study|Positive COVID-19 test|1|||
149030037|NCT02236559|537587926|FG000|Overall Study|Met Exclusion|3|||
149030038|NCT02236559|537587927|FG001|Overall Study|Met Exclusion|6|||
149030039|NCT02236559|537587926|FG000|Overall Study|Did not Meet Inclusion|3|||
149030040|NCT02236559|537587927|FG001|Overall Study|Did not Meet Inclusion|3|||
149030041|NCT02236559|537587926|FG000|Overall Study|Subject Did Not Consent|4|||
149030042|NCT02236559|537587927|FG001|Overall Study|Subject Did Not Consent|2|||
149030043|NCT02236559|537587926|FG000|Overall Study|Physician Decision|1|||
149030044|NCT02236559|537587927|FG001|Overall Study|Physician Decision|1|||
148849052|NCT01667133|536922790|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
148849053|NCT01667133|536922791|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
148849054|NCT01667133|536922792|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
148849055|NCT01667133|536922793|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
148849056|NCT01667133|536922794|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
148849057|NCT01667133|536922795|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
148849058|NCT01667133|536922796|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
148849059|NCT01667133|536922797|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
148849060|NCT01667133|536922798|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
148849061|NCT01667133|536922799|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
148849062|NCT01667133|536922788|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849063|NCT01667133|536922789|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849064|NCT01667133|536922790|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849065|NCT01667133|536922791|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849066|NCT01667133|536922792|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849067|NCT01667133|536922793|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849068|NCT01667133|536922794|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849069|NCT01667133|536922795|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849070|NCT01667133|536922796|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849071|NCT01667133|536922797|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
148849072|NCT01667133|536922798|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849073|NCT01667133|536922799|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
148849074|NCT01667133|536922788|FG000|Phase 2: Dose-expansion|Death|0|||
148849075|NCT01667133|536922789|FG001|Phase 2: Dose-expansion|Death|0|||
148849076|NCT01667133|536922790|FG002|Phase 2: Dose-expansion|Death|0|||
148849077|NCT01667133|536922791|FG003|Phase 2: Dose-expansion|Death|0|||
148849078|NCT01667133|536922792|FG004|Phase 2: Dose-expansion|Death|0|||
148849079|NCT01667133|536922793|FG005|Phase 2: Dose-expansion|Death|0|||
149030045|NCT02236559|537587926|FG000|Overall Study|Withdrawal by Subject|1|||
149030046|NCT02236559|537587927|FG001|Overall Study|Withdrawal by Subject|0|||
148849080|NCT01667133|536922794|FG006|Phase 2: Dose-expansion|Death|0|||
148849081|NCT01667133|536922795|FG007|Phase 2: Dose-expansion|Death|0|||
148849082|NCT01667133|536922796|FG008|Phase 2: Dose-expansion|Death|0|||
148849083|NCT01667133|536922797|FG009|Phase 2: Dose-expansion|Death|1|||
148849084|NCT01667133|536922798|FG010|Phase 2: Dose-expansion|Death|0|||
148849085|NCT01667133|536922799|FG011|Phase 2: Dose-expansion|Death|0|||
149030047|NCT02049866|537587928|FG000|Overall Study|Withdrawal by Subject|1|||
148849086|NCT01667133|536922788|FG000|Phase 2: Dose-expansion|Other|0|||
148849087|NCT01667133|536922789|FG001|Phase 2: Dose-expansion|Other|0|||
148849088|NCT01667133|536922790|FG002|Phase 2: Dose-expansion|Other|0|||
148849089|NCT01667133|536922791|FG003|Phase 2: Dose-expansion|Other|0|||
148849090|NCT01667133|536922792|FG004|Phase 2: Dose-expansion|Other|0|||
148849091|NCT01667133|536922793|FG005|Phase 2: Dose-expansion|Other|0|||
148849092|NCT01667133|536922794|FG006|Phase 2: Dose-expansion|Other|0|||
148849093|NCT01667133|536922795|FG007|Phase 2: Dose-expansion|Other|0|||
148849094|NCT01667133|536922796|FG008|Phase 2: Dose-expansion|Other|0|||
148849095|NCT01667133|536922797|FG009|Phase 2: Dose-expansion|Other|0|||
148849096|NCT01667133|536922798|FG010|Phase 2: Dose-expansion|Other|0|||
148849097|NCT01667133|536922799|FG011|Phase 2: Dose-expansion|Other|1|||
148849098|NCT00255723|536922806|FG000|Overall Study|Adverse Event|1|||
148849099|NCT00255723|536922807|FG001|Overall Study|Adverse Event|1|||
148849100|NCT00255723|536922806|FG000|Overall Study|Death|0|||
148849101|NCT00255723|536922807|FG001|Overall Study|Death|1|||
148849102|NCT00255723|536922806|FG000|Overall Study|Response Data Not Available|1|||
148849103|NCT00255723|536922807|FG001|Overall Study|Response Data Not Available|0|||
148849104|NCT03711370|536922809|FG000|Overall Study|Lost to Follow-up|16|||
148849105|NCT03711370|536922810|FG001|Overall Study|Lost to Follow-up|10|||
148849106|NCT03711370|536922809|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
148849107|NCT03711370|536922810|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
148849108|NCT04188834|536922811|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
148849109|NCT00553436|536922812|FG000|Overall Study|Conversion to another procedure|1|||
148849110|NCT02455336|536922815|FG000|Overall Study|Withdrawal by Subject|0|||
148849111|NCT02455336|536922816|FG001|Overall Study|Withdrawal by Subject|2|||
148849112|NCT02455336|536922815|FG000|Overall Study|Adverse Event|3|||
148849113|NCT02455336|536922816|FG001|Overall Study|Adverse Event|0|||
148849114|NCT02455336|536922815|FG000|Overall Study|Non-responder to treatment|2|||
148849115|NCT02455336|536922816|FG001|Overall Study|Non-responder to treatment|0|||
148849116|NCT00391430|536922817|FG000|Overall Study|Withdrawal by Subject|3|||
148849117|NCT00391430|536922818|FG001|Overall Study|Withdrawal by Subject|0|||
148849118|NCT00391430|536922819|FG002|Overall Study|Withdrawal by Subject|12|||
148849119|NCT00429182|536922822|FG000|Overall Study|Not evaluable, Disease Progression|2|||
148849120|NCT00429182|536922822|FG000|Overall Study|Not eligible|5|||
148849121|NCT03497039|536922823|FG000|Overall Study|Withdrawal by Subject|1|||
148849122|NCT03497039|536922824|FG001|Overall Study|Withdrawal by Subject|0|||
148849123|NCT03497039|536922823|FG000|Overall Study|Protocol Violation|0|||
148849124|NCT03497039|536922824|FG001|Overall Study|Protocol Violation|1|||
148849125|NCT00861692|536922826|FG000|Overall Study|Death|6|||
148849126|NCT01963767|536922829|FG000|Overall Study|Withdrawal by Subject|4|||
148849127|NCT01963767|536922830|FG001|Overall Study|Withdrawal by Subject|2|||
148849128|NCT01963767|536922829|FG000|Overall Study|Adverse Event|2|||
148849129|NCT01963767|536922830|FG001|Overall Study|Adverse Event|0|||
148849130|NCT02949024|536922833|FG000|Overall Study|Withdrawal by Subject|0|||
148849131|NCT02949024|536922834|FG001|Overall Study|Withdrawal by Subject|1|||
148849132|NCT01082081|536922835|FG000|Overall Study|Lost to Follow-up|0|||
148849133|NCT01082081|536922836|FG001|Overall Study|Lost to Follow-up|0|||
148849134|NCT01082081|536922837|FG002|Overall Study|Lost to Follow-up|1|||
148849135|NCT01082081|536922835|FG000|Overall Study|Withdrawal by Subject|0|||
148849136|NCT01082081|536922836|FG001|Overall Study|Withdrawal by Subject|0|||
148849137|NCT01082081|536922837|FG002|Overall Study|Withdrawal by Subject|1|||
148849138|NCT01082081|536922835|FG000|Overall Study|Other Reason|0|||
148849139|NCT01082081|536922836|FG001|Overall Study|Other Reason|1|||
148849140|NCT01082081|536922837|FG002|Overall Study|Other Reason|0|||
148849141|NCT00670930|536922838|FG000|Overall Study|Adminstrative Problem|0|||
148849142|NCT00670930|536922839|FG001|Overall Study|Adminstrative Problem|1|||
148984669|NCT01539291|537421488|FG002|Study GS-US-312-0117|Other|1|||
148984670|NCT01539291|537421489|FG003|Study GS-US-312-0117|Other|1|||
148984671|NCT04450264|537421490|FG000|Overall Study|Incomplete survey|13|||
148984672|NCT04450264|537421491|FG001|Overall Study|Incomplete survey|19|||
148849143|NCT00670930|536922838|FG000|Overall Study|Lost to Follow-up|1|||
148849144|NCT00670930|536922839|FG001|Overall Study|Lost to Follow-up|0|||
148849145|NCT01575808|536922841|FG000|Overall Study|Death|2|||
148849146|NCT01575808|536922842|FG001|Overall Study|Death|0|||
148849147|NCT01575808|536922841|FG000|Overall Study|Withdrawal by Subject|1|||
148849148|NCT01575808|536922842|FG001|Overall Study|Withdrawal by Subject|0|||
148849149|NCT03159468|536922845|FG000|Overall Study|Withdrawal by Subject|0|||
148849150|NCT03159468|536922846|FG001|Overall Study|Withdrawal by Subject|0|||
148849151|NCT03159468|536922847|FG002|Overall Study|Withdrawal by Subject|3|||
148849152|NCT03159468|536922848|FG003|Overall Study|Withdrawal by Subject|0|||
148849153|NCT03159468|536922849|FG004|Overall Study|Withdrawal by Subject|0|||
148984673|NCT03985423|537421496|FG000|Overall Study|Adverse Event|1|||
148849154|NCT03159468|536922850|FG005|Overall Study|Withdrawal by Subject|0|||
148849155|NCT00912782|536922854|FG000|Overall Study|Death|2|||
148849156|NCT00912782|536922855|FG001|Overall Study|Death|1|||
148849157|NCT00912782|536922854|FG000|Overall Study|Lost to Follow-up|0|||
148984674|NCT03985423|537421496|FG000|Overall Study|Death|2|||
148849158|NCT00912782|536922855|FG001|Overall Study|Lost to Follow-up|1|||
148849159|NCT00912782|536922854|FG000|Overall Study|Did not receive vascular access type|1|||
148849160|NCT00912782|536922855|FG001|Overall Study|Did not receive vascular access type|2|||
148849161|NCT00912782|536922854|FG000|Overall Study|Relocated before study completion|0|||
148849162|NCT00912782|536922855|FG001|Overall Study|Relocated before study completion|1|||
148849163|NCT00854724|536924667|FG000|First Intervention|Withdrawal by Subject|1|||
148849164|NCT00854724|536924668|FG001|First Intervention|Withdrawal by Subject|1|||
148849165|NCT00854724|536924667|FG000|Washout|Protocol Violation|1|||
148849166|NCT00854724|536924668|FG001|Washout|Protocol Violation|0|||
148849167|NCT00854724|536924667|FG000|Washout|Withdrawal by Subject|0|||
148849168|NCT00854724|536924668|FG001|Washout|Withdrawal by Subject|1|||
148849169|NCT00854724|536924667|FG000|Second Intervention|Protocol Violation|1|||
148849170|NCT00854724|536924668|FG001|Second Intervention|Protocol Violation|0|||
148849171|NCT00854724|536924667|FG000|Second Intervention|Physician Decision|0|||
148849172|NCT00854724|536924668|FG001|Second Intervention|Physician Decision|1|||
148849173|NCT03654040|536924678|FG000|Overall Study|Death|1|||
148849174|NCT03654040|536924679|FG001|Overall Study|Death|0|||
148849175|NCT03654040|536924678|FG000|Overall Study|Withdrawal by Subject|1|||
148849176|NCT03654040|536924679|FG001|Overall Study|Withdrawal by Subject|0|||
148849177|NCT03654040|536924678|FG000|Overall Study|Study terminated by sponsor|8|||
148849178|NCT03654040|536924679|FG001|Overall Study|Study terminated by sponsor|2|||
148849179|NCT03654040|536924678|FG000|Overall Study|Failure to initiate study therapy|2|||
148849180|NCT03654040|536924679|FG001|Overall Study|Failure to initiate study therapy|0|||
148849181|NCT03654040|536924678|FG000|Overall Study|Transplanted at another center|2|||
148849182|NCT03654040|536924679|FG001|Overall Study|Transplanted at another center|0|||
148849183|NCT03654040|536924678|FG000|Overall Study|Failure to meet eligibility criteria|14|||
148849184|NCT03654040|536924679|FG001|Overall Study|Failure to meet eligibility criteria|2|||
148849185|NCT03654040|536924678|FG000|Overall Study|No longer transplant candidate|1|||
148849186|NCT03654040|536924679|FG001|Overall Study|No longer transplant candidate|0|||
148849187|NCT03654040|536924678|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
148849188|NCT03654040|536924679|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
148849189|NCT03654040|536924678|FG000|Overall Study|Recipient ineligible|0|||
148849190|NCT03654040|536924679|FG001|Overall Study|Recipient ineligible|2|||
148849191|NCT03654040|536924678|FG000|Overall Study|Received deceased liver|0|||
148849192|NCT03654040|536924679|FG001|Overall Study|Received deceased liver|1|||
148849193|NCT02789345|536924680|FG000|Overall Study|Adverse Event|0|||
148849194|NCT02789345|536924681|FG001|Overall Study|Adverse Event|0|||
148849195|NCT02789345|536924682|FG002|Overall Study|Adverse Event|1|||
148849196|NCT02789345|536924680|FG000|Overall Study|Death|0|||
148849197|NCT02789345|536924681|FG001|Overall Study|Death|0|||
148849198|NCT02789345|536924682|FG002|Overall Study|Death|1|||
148849199|NCT02789345|536924680|FG000|Overall Study|Physician Decision|2|||
148849200|NCT02789345|536924681|FG001|Overall Study|Physician Decision|0|||
148849201|NCT02789345|536924682|FG002|Overall Study|Physician Decision|1|||
148984675|NCT03985423|537421496|FG000|Overall Study|Physician Decision|1|||
148984676|NCT03985423|537421496|FG000|Overall Study|Withdrawal by Subject|2|||
148984677|NCT03985423|537421496|FG000|Overall Study|Lack of insurance and citizenship|1|||
148984678|NCT01045447|537421507|FG000|Overall Study|Adverse Event|0|||
148984679|NCT01045447|537421508|FG001|Overall Study|Adverse Event|1|||
148984680|NCT01045447|537421507|FG000|Overall Study|Lack of Efficacy|3|||
148984681|NCT01045447|537421508|FG001|Overall Study|Lack of Efficacy|1|||
148984682|NCT01045447|537421507|FG000|Overall Study|Protocol Violation|6|||
148984683|NCT01045447|537421508|FG001|Overall Study|Protocol Violation|3|||
148984684|NCT01045447|537421507|FG000|Overall Study|Withdrawal Criteria|10|||
148984685|NCT01045447|537421508|FG001|Overall Study|Withdrawal Criteria|10|||
148984686|NCT01045447|537421507|FG000|Overall Study|Unclassified|17|||
148984687|NCT01045447|537421508|FG001|Overall Study|Unclassified|13|||
148984688|NCT03320070|537421509|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
148984689|NCT03320070|537421510|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
148984690|NCT03320070|537421509|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
148984691|NCT03320070|537421510|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
148849202|NCT02789345|536924680|FG000|Overall Study|Progressive Disease|1|||
148849203|NCT02789345|536924681|FG001|Overall Study|Progressive Disease|3|||
148849204|NCT02789345|536924682|FG002|Overall Study|Progressive Disease|14|||
148849205|NCT00700622|536924689|FG000|Overall Study|Adverse Event|4|||
148849206|NCT00700622|536924690|FG001|Overall Study|Adverse Event|0|||
148849207|NCT00700622|536924689|FG000|Overall Study|Lost to Follow-up|0|||
148849208|NCT00700622|536924690|FG001|Overall Study|Lost to Follow-up|1|||
148849209|NCT00700622|536924689|FG000|Overall Study|Physician Decision|2|||
148849210|NCT00700622|536924690|FG001|Overall Study|Physician Decision|1|||
148849211|NCT00700622|536924689|FG000|Overall Study|Protocol Violation|0|||
148849212|NCT00700622|536924690|FG001|Overall Study|Protocol Violation|1|||
148984692|NCT03320070|537421509|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
148984693|NCT03320070|537421510|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
148984694|NCT03320070|537421509|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
148984695|NCT03320070|537421510|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
149030048|NCT04582877|537587931|FG000|Overall Study|Did not use device measurement|5|||
149030049|NCT04582877|537587931|FG000|Overall Study|No fractional flow reserve test results|2|||
149030050|NCT04582877|537587931|FG000|Overall Study|Protocol Violation|1|||
149030051|NCT00003656|537587932|FG000|Overall Study|Adverse Event|0|||
149030052|NCT00003656|537587933|FG001|Overall Study|Adverse Event|1|||
149030053|NCT00763282|537587936|FG000|Overall Study|Withdrawal by Subject|6|||
149030054|NCT00763282|537587937|FG001|Overall Study|Withdrawal by Subject|5|||
149030055|NCT00763282|537587936|FG000|Overall Study|Death|4|||
149030056|NCT00763282|537587937|FG001|Overall Study|Death|3|||
149030057|NCT00763282|537587936|FG000|Overall Study|Lost to Follow-up|22|||
149030058|NCT00763282|537587937|FG001|Overall Study|Lost to Follow-up|26|||
149030059|NCT00742274|537587938|FG000|Overall Study|Death|1|||
149030060|NCT00742274|537587939|FG001|Overall Study|Death|0|||
149030061|NCT00742274|537587938|FG000|Overall Study|Withdrawal by Subject|1|||
149030062|NCT00742274|537587939|FG001|Overall Study|Withdrawal by Subject|2|||
149030063|NCT00742274|537587938|FG000|Overall Study|Removed for medical reasons|1|||
149030064|NCT00742274|537587939|FG001|Overall Study|Removed for medical reasons|1|||
149030065|NCT02219490|537587945|FG000|Overall Study|Adverse Event|24|||
149030066|NCT02219490|537587945|FG000|Overall Study|Withdrew consent|96|||
149030067|NCT02219490|537587945|FG000|Overall Study|Lost to Follow-up|126|||
149030068|NCT02219490|537587945|FG000|Overall Study|COVID-19 infection|2|||
149030069|NCT02219490|537587945|FG000|Overall Study|COVID-19 logistical restrictions|33|||
149030070|NCT02219490|537587945|FG000|Overall Study|Other, not specified|57|||
149030071|NCT00335556|537587946|FG000|Overall Study|Death|0|||
149030072|NCT00335556|537587947|FG001|Overall Study|Death|5|||
149030073|NCT00335556|537587948|FG002|Overall Study|Death|0|||
149030074|NCT00335556|537587949|FG003|Overall Study|Death|0|||
149030075|NCT00335556|537587950|FG004|Overall Study|Death|1|||
149030076|NCT00335556|537587951|FG005|Overall Study|Death|0|||
149030077|NCT00335556|537587946|FG000|Overall Study|Lack of Efficacy|0|||
149030078|NCT00335556|537587947|FG001|Overall Study|Lack of Efficacy|19|||
149030079|NCT00335556|537587948|FG002|Overall Study|Lack of Efficacy|3|||
149030080|NCT00335556|537587949|FG003|Overall Study|Lack of Efficacy|3|||
149030081|NCT00335556|537587950|FG004|Overall Study|Lack of Efficacy|0|||
149030082|NCT00335556|537587951|FG005|Overall Study|Lack of Efficacy|1|||
149030083|NCT00335556|537587946|FG000|Overall Study|Physician Decision|0|||
149030084|NCT00335556|537587947|FG001|Overall Study|Physician Decision|6|||
149030085|NCT00335556|537587948|FG002|Overall Study|Physician Decision|2|||
149030086|NCT00335556|537587949|FG003|Overall Study|Physician Decision|1|||
149030087|NCT00335556|537587950|FG004|Overall Study|Physician Decision|0|||
149030088|NCT00335556|537587951|FG005|Overall Study|Physician Decision|0|||
149030089|NCT00335556|537587946|FG000|Overall Study|Ineligible|2|||
149030090|NCT00335556|537587947|FG001|Overall Study|Ineligible|0|||
149030091|NCT00335556|537587948|FG002|Overall Study|Ineligible|0|||
149030092|NCT00335556|537587949|FG003|Overall Study|Ineligible|0|||
149030093|NCT00335556|537587950|FG004|Overall Study|Ineligible|0|||
149030094|NCT00335556|537587951|FG005|Overall Study|Ineligible|0|||
149030095|NCT00335556|537587946|FG000|Overall Study|Refusal of further protocol therapy|0|||
149030096|NCT00335556|537587947|FG001|Overall Study|Refusal of further protocol therapy|4|||
149030097|NCT00335556|537587948|FG002|Overall Study|Refusal of further protocol therapy|0|||
149030098|NCT00335556|537587949|FG003|Overall Study|Refusal of further protocol therapy|1|||
149030099|NCT00335556|537587950|FG004|Overall Study|Refusal of further protocol therapy|0|||
149030100|NCT00335556|537587951|FG005|Overall Study|Refusal of further protocol therapy|0|||
149030101|NCT02365298|537587952|FG000|Period 2|incorrect Rx dispensed|1|||
149030102|NCT02365298|537587953|FG001|Period 2|incorrect Rx dispensed|0|||
149030103|NCT02365298|537587952|FG000|Period 2|Discontinued at request of Sponsor|1|||
149030104|NCT02365298|537587953|FG001|Period 2|Discontinued at request of Sponsor|0|||
149030105|NCT02365298|537587952|FG000|Period 2|Test Article longer available|0|||
149030106|NCT02365298|537587953|FG001|Period 2|Test Article longer available|1|||
149030107|NCT02365298|537587952|FG000|Period 2|Protocol Violation|0|||
149030108|NCT02365298|537587953|FG001|Period 2|Protocol Violation|1|||
149030109|NCT03736785|537587956|FG000|Overall Study|Adverse Event|1|||
149030110|NCT03736785|537587957|FG001|Overall Study|Adverse Event|1|||
149030111|NCT03736785|537587958|FG002|Overall Study|Adverse Event|1|||
149030112|NCT03736785|537587956|FG000|Overall Study|Death|1|||
149030113|NCT03736785|537587957|FG001|Overall Study|Death|0|||
149030114|NCT03736785|537587958|FG002|Overall Study|Death|1|||
149030115|NCT03736785|537587956|FG000|Overall Study|Lost to Follow-up|0|||
149030116|NCT03736785|537587957|FG001|Overall Study|Lost to Follow-up|2|||
149030117|NCT03736785|537587958|FG002|Overall Study|Lost to Follow-up|3|||
149030118|NCT03736785|537587956|FG000|Overall Study|Non compliance with study drug|1|||
149030119|NCT03736785|537587957|FG001|Overall Study|Non compliance with study drug|1|||
149030120|NCT03736785|537587958|FG002|Overall Study|Non compliance with study drug|0|||
149030121|NCT03736785|537587956|FG000|Overall Study|Physician Decision|0|||
149030122|NCT03736785|537587957|FG001|Overall Study|Physician Decision|1|||
149030123|NCT03736785|537587958|FG002|Overall Study|Physician Decision|1|||
149030124|NCT03736785|537587956|FG000|Overall Study|Protocol Violation|1|||
149030125|NCT03736785|537587957|FG001|Overall Study|Protocol Violation|4|||
149030126|NCT03736785|537587958|FG002|Overall Study|Protocol Violation|3|||
149030127|NCT03736785|537587956|FG000|Overall Study|Sponsor Decision|1|||
148849213|NCT00700622|536924689|FG000|Overall Study|Withdrawal by Subject|4|||
148849214|NCT00700622|536924690|FG001|Overall Study|Withdrawal by Subject|1|||
148849215|NCT00700622|536924689|FG000|Overall Study|Other|3|||
148849216|NCT00700622|536924690|FG001|Overall Study|Other|1|||
148849217|NCT00383331|536924691|FG000|Overall Study|Protocol Violation|0|||
148849218|NCT00383331|536924692|FG001|Overall Study|Protocol Violation|1|||
148849219|NCT02253433|536924693|FG000|Overall Study|Unable to Contact|9|||
148849220|NCT02253433|536924694|FG001|Overall Study|Unable to Contact|16|||
148849221|NCT02253433|536924693|FG000|Overall Study|Death|1|||
148849222|NCT02253433|536924694|FG001|Overall Study|Death|1|||
148849223|NCT02253433|536924693|FG000|Overall Study|No Longer Interested|3|||
148849224|NCT02253433|536924694|FG001|Overall Study|No Longer Interested|15|||
148849225|NCT02253433|536924693|FG000|Overall Study|Out of Study Area|2|||
148849226|NCT02253433|536924694|FG001|Overall Study|Out of Study Area|7|||
148849227|NCT02253433|536924693|FG000|Overall Study|Uncomfortable with home visitors|0|||
148849228|NCT02253433|536924694|FG001|Overall Study|Uncomfortable with home visitors|3|||
148849229|NCT02253433|536924693|FG000|Overall Study|Unstable Housing/Homeless|0|||
148849230|NCT02253433|536924694|FG001|Overall Study|Unstable Housing/Homeless|7|||
148849231|NCT02253433|536924693|FG000|Overall Study|Too Busy|0|||
148849232|NCT02253433|536924694|FG001|Overall Study|Too Busy|4|||
148849233|NCT02253433|536924693|FG000|Overall Study|Medical or Other Concerns|1|||
148849234|NCT02253433|536924694|FG001|Overall Study|Medical or Other Concerns|2|||
148849235|NCT00372619|536924708|FG000|Overall Study|Ineligible|0|||
148849236|NCT00372619|536924709|FG001|Overall Study|Ineligible|0|||
148849237|NCT00372619|536924710|FG002|Overall Study|Ineligible|0|||
148984696|NCT03320070|537421509|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
148984697|NCT03320070|537421510|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
148984698|NCT03320070|537421509|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
148984699|NCT03320070|537421510|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
148984700|NCT00262834|537421511|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
148984701|NCT00262834|537421512|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
148984702|NCT00466193|537421513|FG000|Overall Study|Adverse Event|0|||
148984703|NCT00466193|537421514|FG001|Overall Study|Adverse Event|1|||
148984704|NCT00466193|537421513|FG000|Overall Study|Lost to Follow-up|2|||
148984705|NCT00466193|537421514|FG001|Overall Study|Lost to Follow-up|4|||
148984706|NCT00466193|537421513|FG000|Overall Study|Physician Decision|1|||
148984707|NCT00466193|537421514|FG001|Overall Study|Physician Decision|0|||
148984708|NCT00466193|537421513|FG000|Overall Study|Protocol Violation|1|||
148984709|NCT00466193|537421514|FG001|Overall Study|Protocol Violation|1|||
148984710|NCT00466193|537421513|FG000|Overall Study|Withdrawal by Subject|7|||
148984711|NCT00466193|537421514|FG001|Overall Study|Withdrawal by Subject|2|||
148984712|NCT00466193|537421513|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
148984713|NCT00466193|537421514|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
148984714|NCT01075074|537421515|FG000|Overall Study|Surgeon changed to open incisional case|1|||
148984715|NCT01075074|537421516|FG001|Overall Study|Surgeon changed to open incisional case|2|||
148984716|NCT01075074|537421517|FG002|Overall Study|Surgeon changed to open incisional case|2|||
148984717|NCT02416791|537421518|FG000|6 Months|Lost to Follow-up|0|||
148984718|NCT02416791|537421519|FG001|6 Months|Lost to Follow-up|0|||
148984719|NCT02416791|537421520|FG002|6 Months|Lost to Follow-up|1|||
148984720|NCT01054729|537421521|FG000|Overall Study|Randomized but Not Treated|0|||
148984721|NCT01054729|537421522|FG001|Overall Study|Randomized but Not Treated|1|||
148984722|NCT01054729|537421523|FG002|Overall Study|Randomized but Not Treated|0|||
148984723|NCT01054729|537421524|FG003|Overall Study|Randomized but Not Treated|0|||
148984724|NCT01054729|537421521|FG000|Overall Study|Adverse Event|1|||
148984725|NCT01054729|537421522|FG001|Overall Study|Adverse Event|1|||
148984726|NCT01054729|537421523|FG002|Overall Study|Adverse Event|2|||
148984727|NCT01054729|537421524|FG003|Overall Study|Adverse Event|1|||
148984728|NCT01054729|537421521|FG000|Overall Study|Withdrawal by Subject|1|||
148984729|NCT01054729|537421522|FG001|Overall Study|Withdrawal by Subject|0|||
148849238|NCT00372619|536924711|FG003|Overall Study|Ineligible|0|||
148849239|NCT00372619|536924712|FG004|Overall Study|Ineligible|0|||
148849240|NCT00372619|536924713|FG005|Overall Study|Ineligible|2|||
148849241|NCT00372619|536924714|FG006|Overall Study|Ineligible|0|||
148849242|NCT00372619|536924708|FG000|Overall Study|Inevaluable|0|||
148849243|NCT00372619|536924709|FG001|Overall Study|Inevaluable|0|||
148849244|NCT00372619|536924710|FG002|Overall Study|Inevaluable|0|||
148984730|NCT01054729|537421523|FG002|Overall Study|Withdrawal by Subject|1|||
148984731|NCT01054729|537421524|FG003|Overall Study|Withdrawal by Subject|0|||
148984732|NCT01054729|537421521|FG000|Overall Study|Lost to Follow-up|0|||
148984733|NCT01054729|537421522|FG001|Overall Study|Lost to Follow-up|1|||
148984734|NCT01054729|537421523|FG002|Overall Study|Lost to Follow-up|0|||
148984735|NCT01054729|537421524|FG003|Overall Study|Lost to Follow-up|0|||
148984736|NCT01054729|537421521|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
148984737|NCT01054729|537421522|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
148984738|NCT01054729|537421523|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
148849245|NCT00372619|536924711|FG003|Overall Study|Inevaluable|0|||
148849246|NCT00372619|536924712|FG004|Overall Study|Inevaluable|0|||
148849247|NCT00372619|536924713|FG005|Overall Study|Inevaluable|1|||
148849248|NCT00372619|536924714|FG006|Overall Study|Inevaluable|0|||
148849249|NCT00066222|536924715|FG000|Overall Study|No protocol treatment received|1|||
148849250|NCT00405392|536924716|FG000|Overall Study|Adverse Event|15|||
148849251|NCT00405392|536924717|FG001|Overall Study|Adverse Event|14|||
148849252|NCT00405392|536924716|FG000|Overall Study|Did not meet Eligibility criteria|7|||
148849253|NCT00405392|536924717|FG001|Overall Study|Did not meet Eligibility criteria|2|||
148849254|NCT00405392|536924716|FG000|Overall Study|Withdrawal by Subject|4|||
148849255|NCT00405392|536924717|FG001|Overall Study|Withdrawal by Subject|3|||
148849256|NCT00405392|536924716|FG000|Overall Study|Lost to Follow-up|1|||
148849257|NCT00405392|536924717|FG001|Overall Study|Lost to Follow-up|2|||
148849258|NCT00405392|536924716|FG000|Overall Study|Data missing|2|||
148849259|NCT00405392|536924717|FG001|Overall Study|Data missing|0|||
148849260|NCT00405392|536924716|FG000|Overall Study|Non-compliance|0|||
148849261|NCT00405392|536924717|FG001|Overall Study|Non-compliance|1|||
148849262|NCT00405392|536924716|FG000|Overall Study|Other|1|||
148849263|NCT00405392|536924717|FG001|Overall Study|Other|5|||
148849264|NCT01703091|536924729|FG000|Overall Study|Adverse Event|5|||
148849265|NCT01703091|536924730|FG001|Overall Study|Adverse Event|3|||
148849266|NCT01703091|536924729|FG000|Overall Study|Physician Decision|2|||
148849267|NCT01703091|536924730|FG001|Overall Study|Physician Decision|1|||
148849268|NCT01703091|536924729|FG000|Overall Study|Withdrawal by Subject|1|||
148849269|NCT01703091|536924730|FG001|Overall Study|Withdrawal by Subject|0|||
148849270|NCT01703091|536924729|FG000|Overall Study|Sponsor Decision|1|||
148849271|NCT01703091|536924730|FG001|Overall Study|Sponsor Decision|0|||
148849272|NCT05420961|536924733|FG000|Overall Study|Withdrawal by Subject|2|||
148849273|NCT05420961|536924734|FG001|Overall Study|Withdrawal by Subject|1|||
148849274|NCT05420961|536924735|FG002|Overall Study|Withdrawal by Subject|1|||
148849275|NCT05420961|536924736|FG003|Overall Study|Withdrawal by Subject|0|||
148849276|NCT05420961|536924737|FG004|Overall Study|Withdrawal by Subject|0|||
148849277|NCT05420961|536924733|FG000|Overall Study|Lost to Follow-up|0|||
148849278|NCT05420961|536924734|FG001|Overall Study|Lost to Follow-up|0|||
148849279|NCT05420961|536924735|FG002|Overall Study|Lost to Follow-up|1|||
148849280|NCT05420961|536924736|FG003|Overall Study|Lost to Follow-up|0|||
148849281|NCT05420961|536924737|FG004|Overall Study|Lost to Follow-up|0|||
148849282|NCT05420961|536924733|FG000|Overall Study|Randomized by mistake without study treatment|0|||
148849283|NCT05420961|536924734|FG001|Overall Study|Randomized by mistake without study treatment|0|||
148849284|NCT05420961|536924735|FG002|Overall Study|Randomized by mistake without study treatment|1|||
148849285|NCT05420961|536924736|FG003|Overall Study|Randomized by mistake without study treatment|0|||
148849286|NCT05420961|536924737|FG004|Overall Study|Randomized by mistake without study treatment|1|||
148849287|NCT00803361|536924738|FG000|Overall Study|Adverse Event|13|||
148849288|NCT00803361|536924739|FG001|Overall Study|Adverse Event|3|||
148849289|NCT00803361|536924738|FG000|Overall Study|Lack of Efficacy|4|||
148849290|NCT00803361|536924739|FG001|Overall Study|Lack of Efficacy|13|||
148849291|NCT00803361|536924738|FG000|Overall Study|Lost to Follow-up|1|||
148849292|NCT00803361|536924739|FG001|Overall Study|Lost to Follow-up|2|||
148849293|NCT00803361|536924738|FG000|Overall Study|Physician Decision|1|||
148849294|NCT00803361|536924739|FG001|Overall Study|Physician Decision|0|||
148849295|NCT00803361|536924738|FG000|Overall Study|Protocol Violation|2|||
148849296|NCT00803361|536924739|FG001|Overall Study|Protocol Violation|4|||
148849297|NCT00803361|536924738|FG000|Overall Study|Withdrawal by Subject|5|||
148849298|NCT00803361|536924739|FG001|Overall Study|Withdrawal by Subject|6|||
148849299|NCT03902392|536924740|FG000|Overall Study|Lost to Follow-up|7|||
148849300|NCT03902392|536924741|FG001|Overall Study|Lost to Follow-up|7|||
148849301|NCT03799952|536924742|FG000|Overall Study|Program was too easy, discontinued|1|||
148849302|NCT03799952|536924743|FG001|Overall Study|Program was too easy, discontinued|0|||
148849303|NCT03799952|536924742|FG000|Overall Study|Lost to Follow-up|0|||
148849304|NCT03799952|536924743|FG001|Overall Study|Lost to Follow-up|2|||
148849305|NCT03248167|536924744|FG000|Overall Study|Withdrawal by Subject|2|||
148849306|NCT03248167|536924745|FG001|Overall Study|Withdrawal by Subject|2|||
148849307|NCT03248167|536924744|FG000|Overall Study|Physician Decision|0|||
148849308|NCT03248167|536924745|FG001|Overall Study|Physician Decision|1|||
148849309|NCT03248167|536924744|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
148849310|NCT03248167|536924745|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
148849311|NCT03248167|536924744|FG000|Overall Study|Lost to Follow-up|1|||
148849312|NCT03248167|536924745|FG001|Overall Study|Lost to Follow-up|0|||
148849313|NCT02689206|536924747|FG000|Overall Study|Adverse Event|0|||
148849314|NCT02689206|536924748|FG001|Overall Study|Adverse Event|0|||
148849315|NCT02689206|536924749|FG002|Overall Study|Adverse Event|1|||
148849316|NCT02689206|536924750|FG003|Overall Study|Adverse Event|0|||
148849317|NCT02689206|536924751|FG004|Overall Study|Adverse Event|2|||
148849318|NCT02689206|536924747|FG000|Overall Study|Protocol Violation|1|||
148849319|NCT02689206|536924748|FG001|Overall Study|Protocol Violation|0|||
148849320|NCT02689206|536924749|FG002|Overall Study|Protocol Violation|0|||
148849321|NCT02689206|536924750|FG003|Overall Study|Protocol Violation|1|||
148849322|NCT02689206|536924751|FG004|Overall Study|Protocol Violation|2|||
148849323|NCT02689206|536924747|FG000|Overall Study|Other: Reached stopping criteria|0|||
148849324|NCT02689206|536924748|FG001|Overall Study|Other: Reached stopping criteria|1|||
148849325|NCT02689206|536924749|FG002|Overall Study|Other: Reached stopping criteria|2|||
148849326|NCT02689206|536924750|FG003|Overall Study|Other: Reached stopping criteria|3|||
148849327|NCT02689206|536924751|FG004|Overall Study|Other: Reached stopping criteria|4|||
148849328|NCT02689206|536924747|FG000|Overall Study|Physician Decision|1|||
148849329|NCT02689206|536924748|FG001|Overall Study|Physician Decision|0|||
148849330|NCT02689206|536924749|FG002|Overall Study|Physician Decision|0|||
148849331|NCT02689206|536924750|FG003|Overall Study|Physician Decision|0|||
148849332|NCT02689206|536924751|FG004|Overall Study|Physician Decision|0|||
148849333|NCT02689206|536924747|FG000|Overall Study|Withdrawal by Subject|1|||
148849334|NCT02689206|536924748|FG001|Overall Study|Withdrawal by Subject|0|||
148849335|NCT02689206|536924749|FG002|Overall Study|Withdrawal by Subject|1|||
148849336|NCT02689206|536924750|FG003|Overall Study|Withdrawal by Subject|0|||
148849337|NCT02689206|536924751|FG004|Overall Study|Withdrawal by Subject|0|||
148849338|NCT02998671|536924752|FG000|Period 1|Study Terminated By Sponsor|2|||
148849339|NCT02998671|536924753|FG001|Period 1|Study Terminated By Sponsor|1|||
148849340|NCT02998671|536924754|FG002|Period 1|Study Terminated By Sponsor|0|||
148849341|NCT02998671|536924755|FG003|Period 1|Study Terminated By Sponsor|0|||
148849342|NCT02998671|536924756|FG004|Period 1|Study Terminated By Sponsor|1|||
148849343|NCT02998671|536924752|FG000|Period 1|Withdrawal by Subject|1|||
148849344|NCT02998671|536924753|FG001|Period 1|Withdrawal by Subject|2|||
148849345|NCT02998671|536924754|FG002|Period 1|Withdrawal by Subject|0|||
148849346|NCT02998671|536924755|FG003|Period 1|Withdrawal by Subject|0|||
148849347|NCT02998671|536924756|FG004|Period 1|Withdrawal by Subject|2|||
148849348|NCT02998671|536924752|FG000|Period 1|Pregnancy|1|||
148849349|NCT02998671|536924753|FG001|Period 1|Pregnancy|0|||
148849350|NCT02998671|536924754|FG002|Period 1|Pregnancy|0|||
148849351|NCT02998671|536924755|FG003|Period 1|Pregnancy|0|||
148849352|NCT02998671|536924756|FG004|Period 1|Pregnancy|0|||
148849353|NCT02998671|536924752|FG000|Period 1|Adverse Event|0|||
148849354|NCT02998671|536924753|FG001|Period 1|Adverse Event|0|||
148849355|NCT02998671|536924754|FG002|Period 1|Adverse Event|0|||
148849356|NCT02998671|536924755|FG003|Period 1|Adverse Event|0|||
148849357|NCT02998671|536924756|FG004|Period 1|Adverse Event|1|||
148849358|NCT02998671|536924752|FG000|Period 2|Adverse Event|0|||
148849359|NCT02998671|536924753|FG001|Period 2|Adverse Event|1|||
148849360|NCT02998671|536924754|FG002|Period 2|Adverse Event|0|||
148849361|NCT02998671|536924755|FG003|Period 2|Adverse Event|0|||
148849362|NCT02998671|536924756|FG004|Period 2|Adverse Event|0|||
148849363|NCT02998671|536924752|FG000|Period 2|Study Terminated By Sponsor|3|||
148849364|NCT02998671|536924753|FG001|Period 2|Study Terminated By Sponsor|5|||
148849365|NCT02998671|536924754|FG002|Period 2|Study Terminated By Sponsor|1|||
148849366|NCT02998671|536924755|FG003|Period 2|Study Terminated By Sponsor|3|||
148849367|NCT02998671|536924756|FG004|Period 2|Study Terminated By Sponsor|0|||
148849368|NCT02998671|536924752|FG000|Period 2|Withdrawal by Subject|0|||
148849369|NCT02998671|536924753|FG001|Period 2|Withdrawal by Subject|1|||
148849370|NCT02998671|536924754|FG002|Period 2|Withdrawal by Subject|0|||
148849371|NCT02998671|536924755|FG003|Period 2|Withdrawal by Subject|0|||
148849372|NCT02998671|536924756|FG004|Period 2|Withdrawal by Subject|0|||
148849373|NCT02998671|536924752|FG000|Period 2|Lost to Follow-up|0|||
148849374|NCT02998671|536924753|FG001|Period 2|Lost to Follow-up|0|||
148849375|NCT02998671|536924754|FG002|Period 2|Lost to Follow-up|0|||
148849376|NCT02998671|536924755|FG003|Period 2|Lost to Follow-up|1|||
148849377|NCT02998671|536924756|FG004|Period 2|Lost to Follow-up|0|||
148849378|NCT01479764|536924759|FG000|Randomized|Adverse Event|1|||
148849379|NCT01479764|536924760|FG001|Randomized|Adverse Event|1|||
148849380|NCT01479764|536924759|FG000|Randomized|Withdrawal by Subject|1|||
148849381|NCT01479764|536924760|FG001|Randomized|Withdrawal by Subject|0|||
148849382|NCT01479764|536924759|FG000|Treated|Lost to Follow-up|0|||
148849383|NCT01479764|536924760|FG001|Treated|Lost to Follow-up|2|||
148849384|NCT00191945|536924762|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
148849385|NCT00191945|536924763|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
148849386|NCT00191945|536924762|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
148849387|NCT00191945|536924763|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
148849388|NCT00191945|536924762|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
148849389|NCT00191945|536924763|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
148849390|NCT00191945|536924762|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
149030128|NCT03736785|537587957|FG001|Overall Study|Sponsor Decision|0|||
148849391|NCT00191945|536924763|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
148849392|NCT02063984|536924764|FG000|Overall Study|Lost to Follow-up|6|||
148849393|NCT02063984|536924765|FG001|Overall Study|Lost to Follow-up|5|||
148849394|NCT01169701|536924770|FG000|Overall Study|Lost to Follow-up|1|||
148849395|NCT01169701|536924771|FG001|Overall Study|Lost to Follow-up|1|||
148849396|NCT01169701|536924770|FG000|Overall Study|Withdrawal by Subject|1|||
148849397|NCT01169701|536924771|FG001|Overall Study|Withdrawal by Subject|3|||
148849398|NCT01169701|536924770|FG000|Overall Study|Adverse Event|1|||
148849399|NCT01169701|536924771|FG001|Overall Study|Adverse Event|2|||
148849400|NCT01169701|536924770|FG000|Overall Study|Exclusion criteria|2|||
148849401|NCT01169701|536924771|FG001|Overall Study|Exclusion criteria|0|||
148849402|NCT01169701|536924770|FG000|Overall Study|Death|0|||
148849403|NCT01169701|536924771|FG001|Overall Study|Death|1|||
148849404|NCT01169701|536924770|FG000|Overall Study|Administrative problems|0|||
148849405|NCT01169701|536924771|FG001|Overall Study|Administrative problems|1|||
148849406|NCT01169701|536924770|FG000|Overall Study|Serious adverse event|0|||
148849407|NCT01169701|536924771|FG001|Overall Study|Serious adverse event|1|||
148849408|NCT01169701|536924770|FG000|Overall Study|Sponsor decision|0|||
148984739|NCT01054729|537421524|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
148984740|NCT01054729|537421521|FG000|Overall Study|Non-responder|1|||
148984741|NCT01054729|537421522|FG001|Overall Study|Non-responder|0|||
148984742|NCT01054729|537421523|FG002|Overall Study|Non-responder|1|||
148984743|NCT01054729|537421524|FG003|Overall Study|Non-responder|1|||
148984744|NCT01054729|537421521|FG000|Overall Study|PEG/RBV Non-responder|1|||
148984745|NCT01054729|537421522|FG001|Overall Study|PEG/RBV Non-responder|0|||
148984746|NCT01054729|537421523|FG002|Overall Study|PEG/RBV Non-responder|1|||
148984747|NCT01054729|537421524|FG003|Overall Study|PEG/RBV Non-responder|0|||
148984748|NCT01054729|537421521|FG000|Overall Study|Personal/Obligations|0|||
148984749|NCT01054729|537421522|FG001|Overall Study|Personal/Obligations|1|||
148984750|NCT01054729|537421523|FG002|Overall Study|Personal/Obligations|0|||
148984751|NCT01054729|537421524|FG003|Overall Study|Personal/Obligations|0|||
148849409|NCT01169701|536924771|FG001|Overall Study|Sponsor decision|1|||
148849410|NCT01536561|536924772|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
148849411|NCT01536561|536924772|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
148849412|NCT01536561|536924772|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
148849413|NCT01536561|536924772|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
148849414|NCT01536561|536924772|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
148849415|NCT01536561|536924772|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
148849416|NCT01030952|536924773|FG000|Overall Study|Protocol Violation|0|||
148849417|NCT01030952|536924774|FG001|Overall Study|Protocol Violation|1|||
148849418|NCT01030952|536924773|FG000|Overall Study|Informed consent withdrawal|1|||
148849419|NCT01030952|536924774|FG001|Overall Study|Informed consent withdrawal|0|||
148849420|NCT01030952|536924773|FG000|Overall Study|Lost to Follow-up|0|||
148849421|NCT01030952|536924774|FG001|Overall Study|Lost to Follow-up|1|||
148849422|NCT01030952|536924773|FG000|Overall Study|Unexplained|1|||
148849423|NCT01030952|536924774|FG001|Overall Study|Unexplained|1|||
148849424|NCT02467192|536924775|FG000|Overall Study|Death|1|||
148849425|NCT02467192|536924775|FG000|Overall Study|revealed to have pneumonia before|2|||
148849426|NCT00958347|536924776|FG000|Overall Study|Death|43|||
148849427|NCT00958347|536924776|FG000|Overall Study|Withdrawal by Subject|23|||
148849428|NCT00958347|536924776|FG000|Overall Study|Lost to Follow-up|15|||
148849429|NCT00958347|536924776|FG000|Overall Study|revision/removal|10|||
148849430|NCT00958347|536924776|FG000|Overall Study|study termination|135|||
148849431|NCT05111002|536924779|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
148849432|NCT05111002|536924780|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
148849433|NCT05111002|536924779|FG000|Secondary Outcome|Lost to Follow-up|1|||
148849434|NCT05111002|536924780|FG001|Secondary Outcome|Lost to Follow-up|0|||
148849435|NCT00809926|536924781|FG000|Overall Study|Adverse Event|18|||
148849436|NCT00809926|536924782|FG001|Overall Study|Adverse Event|10|||
148849437|NCT00809926|536924781|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
148849438|NCT00809926|536924782|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
148849439|NCT00809926|536924781|FG000|Overall Study|Patient withdrew consent|8|||
148849440|NCT00809926|536924782|FG001|Overall Study|Patient withdrew consent|6|||
148849441|NCT00809926|536924781|FG000|Overall Study|Lost to Follow-up|2|||
148849442|NCT00809926|536924782|FG001|Overall Study|Lost to Follow-up|1|||
148849443|NCT00809926|536924781|FG000|Overall Study|Administrative Problems|0|||
148984752|NCT01054729|537421521|FG000|Overall Study|Subject moved|0|||
148984753|NCT01054729|537421522|FG001|Overall Study|Subject moved|0|||
148984754|NCT01054729|537421523|FG002|Overall Study|Subject moved|1|||
148984755|NCT01054729|537421524|FG003|Overall Study|Subject moved|0|||
148984756|NCT01054729|537421521|FG000|Overall Study|Lack of Efficacy|0|||
148984757|NCT01054729|537421522|FG001|Overall Study|Lack of Efficacy|0|||
148984758|NCT01054729|537421523|FG002|Overall Study|Lack of Efficacy|0|||
148984759|NCT01054729|537421524|FG003|Overall Study|Lack of Efficacy|1|||
148849444|NCT00809926|536924782|FG001|Overall Study|Administrative Problems|1|||
148849445|NCT00809926|536924781|FG000|Overall Study|Protocol deviation|0|||
148849446|NCT00809926|536924782|FG001|Overall Study|Protocol deviation|2|||
148849447|NCT04776720|536924802|FG000|Overall Study|COVID Related|4|||
148849448|NCT04776720|536924803|FG001|Overall Study|COVID Related|2|||
148849449|NCT04776720|536924802|FG000|Overall Study|Adverse Event|2|||
148849450|NCT04776720|536924803|FG001|Overall Study|Adverse Event|0|||
148849451|NCT04776720|536924802|FG000|Overall Study|Serious Adverse Event|0|||
148849452|NCT04776720|536924803|FG001|Overall Study|Serious Adverse Event|1|||
148849453|NCT04776720|536924802|FG000|Overall Study|Too Busy|3|||
148849454|NCT04776720|536924803|FG001|Overall Study|Too Busy|1|||
148849455|NCT04776720|536924802|FG000|Overall Study|Lost to Follow-up|1|||
148849456|NCT04776720|536924803|FG001|Overall Study|Lost to Follow-up|2|||
148849457|NCT04776720|536924802|FG000|Overall Study|Family|2|||
148849458|NCT04776720|536924803|FG001|Overall Study|Family|2|||
148849459|NCT04776720|536924802|FG000|Overall Study|No remote technology access|0|||
148849460|NCT04776720|536924803|FG001|Overall Study|No remote technology access|1|||
148849461|NCT04776720|536924802|FG000|Overall Study|Withdrawal by Subject|1|||
148849462|NCT04776720|536924803|FG001|Overall Study|Withdrawal by Subject|0|||
148849463|NCT04776720|536924802|FG000|Overall Study|Cannot tolerate intervention|1|||
148849464|NCT04776720|536924803|FG001|Overall Study|Cannot tolerate intervention|0|||
148849465|NCT04776720|536924802|FG000|Overall Study|Incomplete outcome data|6|||
148849466|NCT04776720|536924803|FG001|Overall Study|Incomplete outcome data|1|||
148849467|NCT02712996|536924808|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
148849468|NCT02712996|536924809|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
148849469|NCT01451749|536924813|FG000|Overall Study|Protocol Violation|14|||
148849470|NCT01451749|536924814|FG001|Overall Study|Protocol Violation|7|||
148849471|NCT01451749|536924813|FG000|Overall Study|Lost to Follow-up|15|||
148849472|NCT01451749|536924814|FG001|Overall Study|Lost to Follow-up|5|||
148849473|NCT01451749|536924813|FG000|Overall Study|Meet the exclusion criteria,and|1|||
148849474|NCT01451749|536924814|FG001|Overall Study|Meet the exclusion criteria,and|1|||
148849475|NCT01451749|536924813|FG000|Overall Study|Adverse Event|2|||
148849476|NCT01451749|536924814|FG001|Overall Study|Adverse Event|0|||
148849477|NCT01451749|536924813|FG000|Overall Study|Withdrawal by Subject|0|||
148849478|NCT01451749|536924814|FG001|Overall Study|Withdrawal by Subject|1|||
148849479|NCT00972517|536924817|FG000|Overall Study|Adverse Event|0|||
148849480|NCT00972517|536924818|FG001|Overall Study|Adverse Event|0|||
148849481|NCT00972517|536924819|FG002|Overall Study|Adverse Event|0|||
148849482|NCT00972517|536924820|FG003|Overall Study|Adverse Event|1|||
148849483|NCT00972517|536924821|FG004|Overall Study|Adverse Event|0|||
148849484|NCT00972517|536924822|FG005|Overall Study|Adverse Event|0|||
148849485|NCT00972517|536924817|FG000|Overall Study|Withdrawal by Subject|0|||
148849486|NCT00972517|536924818|FG001|Overall Study|Withdrawal by Subject|1|||
148849487|NCT00972517|536924819|FG002|Overall Study|Withdrawal by Subject|0|||
148849488|NCT00972517|536924820|FG003|Overall Study|Withdrawal by Subject|2|||
148849489|NCT00972517|536924821|FG004|Overall Study|Withdrawal by Subject|1|||
148849490|NCT00972517|536924822|FG005|Overall Study|Withdrawal by Subject|0|||
148849491|NCT02311881|536924823|FG000|Overall Study|Did not meet the study criteria|2|||
148849492|NCT02311881|536924824|FG001|Overall Study|Did not meet the study criteria|2|||
148849493|NCT02311881|536924825|FG002|Overall Study|Did not meet the study criteria|0|||
148849494|NCT02311881|536924823|FG000|Overall Study|Adverse Event|7|||
148849495|NCT02311881|536924824|FG001|Overall Study|Adverse Event|15|||
148849496|NCT02311881|536924825|FG002|Overall Study|Adverse Event|8|||
148849497|NCT02311881|536924823|FG000|Overall Study|Lost to Follow-up|3|||
148849498|NCT02311881|536924824|FG001|Overall Study|Lost to Follow-up|3|||
148849499|NCT02311881|536924825|FG002|Overall Study|Lost to Follow-up|2|||
148849500|NCT02311881|536924823|FG000|Overall Study|Protocol Violation|1|||
148849501|NCT02311881|536924824|FG001|Overall Study|Protocol Violation|2|||
148849502|NCT02311881|536924825|FG002|Overall Study|Protocol Violation|3|||
148849503|NCT02311881|536924823|FG000|Overall Study|Withdrawal of consent|14|||
148849504|NCT02311881|536924824|FG001|Overall Study|Withdrawal of consent|16|||
148849505|NCT02311881|536924825|FG002|Overall Study|Withdrawal of consent|17|||
148849506|NCT02311881|536924823|FG000|Overall Study|Other|0|||
148849507|NCT02311881|536924824|FG001|Overall Study|Other|0|||
148849508|NCT02311881|536924825|FG002|Overall Study|Other|1|||
148849509|NCT02311881|536924823|FG000|Overall Study|Lack of Efficacy|1|||
148849510|NCT02311881|536924824|FG001|Overall Study|Lack of Efficacy|2|||
148849511|NCT02311881|536924825|FG002|Overall Study|Lack of Efficacy|0|||
148849512|NCT02311881|536924823|FG000|Overall Study|Subject has border line pregnancy test|1|||
148849513|NCT02311881|536924824|FG001|Overall Study|Subject has border line pregnancy test|0|||
148849514|NCT02311881|536924825|FG002|Overall Study|Subject has border line pregnancy test|0|||
148984760|NCT01181921|537421526|FG000|Overall Study|Lost to Follow-up|1|||
148984761|NCT01992536|537421527|FG000|Overall Study|Administrative Reason|0|||
148984762|NCT01992536|537421528|FG001|Overall Study|Administrative Reason|0|||
148984763|NCT01992536|537421529|FG002|Overall Study|Administrative Reason|0|||
148849515|NCT02311881|536924823|FG000|Overall Study|Withdrawal by Subject|3|||
148849516|NCT02311881|536924824|FG001|Overall Study|Withdrawal by Subject|1|||
148849517|NCT02311881|536924825|FG002|Overall Study|Withdrawal by Subject|4|||
148849518|NCT02311881|536924823|FG000|Overall Study|Sponsor Decision|1|||
148849519|NCT02311881|536924824|FG001|Overall Study|Sponsor Decision|1|||
148984764|NCT01992536|537421530|FG003|Overall Study|Administrative Reason|0|||
148984765|NCT01992536|537421531|FG004|Overall Study|Administrative Reason|0|||
148984766|NCT01992536|537421532|FG005|Overall Study|Administrative Reason|0|||
148849520|NCT02311881|536924825|FG002|Overall Study|Sponsor Decision|1|||
148849521|NCT02311881|536924823|FG000|Overall Study|Protocol Deviation|1|||
148849522|NCT02311881|536924824|FG001|Overall Study|Protocol Deviation|0|||
148849523|NCT02311881|536924825|FG002|Overall Study|Protocol Deviation|0|||
148849524|NCT02311881|536924823|FG000|Overall Study|Non-Compliance|1|||
148849525|NCT02311881|536924824|FG001|Overall Study|Non-Compliance|0|||
148849526|NCT02311881|536924825|FG002|Overall Study|Non-Compliance|2|||
148849527|NCT02311881|536924823|FG000|Overall Study|Physician Decision|0|||
148849528|NCT02311881|536924824|FG001|Overall Study|Physician Decision|0|||
148849529|NCT02311881|536924825|FG002|Overall Study|Physician Decision|1|||
148849530|NCT02311881|536924823|FG000|Overall Study|Medical Monitor Discretion|0|||
148849531|NCT02311881|536924824|FG001|Overall Study|Medical Monitor Discretion|0|||
148849532|NCT02311881|536924825|FG002|Overall Study|Medical Monitor Discretion|1|||
148849533|NCT02311881|536924823|FG000|Overall Study|Participant taking another medication|0|||
148849534|NCT02311881|536924824|FG001|Overall Study|Participant taking another medication|0|||
148849535|NCT02311881|536924825|FG002|Overall Study|Participant taking another medication|1|||
148849536|NCT02311881|536924823|FG000|Overall Study|Serious Adverse Event|0|||
148849537|NCT02311881|536924824|FG001|Overall Study|Serious Adverse Event|1|||
148849538|NCT02311881|536924825|FG002|Overall Study|Serious Adverse Event|0|||
148849539|NCT00790582|536924832|FG000|Overall Study|Death|14|||
148849540|NCT00790582|536924833|FG001|Overall Study|Death|32|||
148849541|NCT00790582|536924832|FG000|Overall Study|Physician Decision|7|||
148849542|NCT00790582|536924833|FG001|Overall Study|Physician Decision|1|||
148849543|NCT00790582|536924832|FG000|Overall Study|Lost to Follow-up|3|||
148849544|NCT00790582|536924833|FG001|Overall Study|Lost to Follow-up|3|||
148849545|NCT00790582|536924832|FG000|Overall Study|Withdrawal by Subject|7|||
148849546|NCT00790582|536924833|FG001|Overall Study|Withdrawal by Subject|51|||
148849547|NCT00803595|536924834|FG000|Overall Study|Adverse Event|3|||
148849548|NCT00803595|536924835|FG001|Overall Study|Adverse Event|4|||
148849549|NCT00803595|536924836|FG002|Overall Study|Adverse Event|1|||
148849550|NCT00803595|536924834|FG000|Overall Study|Protocol Violation|7|||
148849551|NCT00803595|536924835|FG001|Overall Study|Protocol Violation|2|||
148849552|NCT00803595|536924836|FG002|Overall Study|Protocol Violation|12|||
148849553|NCT00803595|536924834|FG000|Overall Study|Withdrawal by Subject|5|||
148849554|NCT00803595|536924835|FG001|Overall Study|Withdrawal by Subject|2|||
148849555|NCT00803595|536924836|FG002|Overall Study|Withdrawal by Subject|3|||
148849556|NCT02195700|536924840|FG000|Overall Study|Protocol Violation|0|||
148849557|NCT02195700|536924841|FG001|Overall Study|Protocol Violation|2|||
148849558|NCT02195700|536924840|FG000|Overall Study|Noncompliance|1|||
148849559|NCT02195700|536924841|FG001|Overall Study|Noncompliance|0|||
148849560|NCT02195700|536924840|FG000|Overall Study|Adverse Event|1|||
148849561|NCT02195700|536924841|FG001|Overall Study|Adverse Event|2|||
148849562|NCT02195700|536924840|FG000|Overall Study|Withdrawal by Subject|3|||
148849563|NCT02195700|536924841|FG001|Overall Study|Withdrawal by Subject|2|||
148849564|NCT02195700|536924840|FG000|Overall Study|Lost to Follow-up|1|||
148849565|NCT02195700|536924841|FG001|Overall Study|Lost to Follow-up|1|||
148849566|NCT01027650|536924842|FG000|Overall Study|Personal Reasons|0|||
148849567|NCT01027650|536924843|FG001|Overall Study|Personal Reasons|0|||
148849568|NCT01027650|536924844|FG002|Overall Study|Personal Reasons|0|||
148849569|NCT01027650|536924845|FG003|Overall Study|Personal Reasons|0|||
148849570|NCT01027650|536924846|FG004|Overall Study|Personal Reasons|2|||
148849571|NCT01027650|536924847|FG005|Overall Study|Personal Reasons|1|||
148849572|NCT01027650|536924848|FG006|Overall Study|Personal Reasons|0|||
148849573|NCT01027650|536924849|FG007|Overall Study|Personal Reasons|0|||
148849574|NCT01027650|536924842|FG000|Overall Study|Lost to Follow-up|0|||
148849575|NCT01027650|536924843|FG001|Overall Study|Lost to Follow-up|0|||
148849576|NCT01027650|536924844|FG002|Overall Study|Lost to Follow-up|0|||
148849577|NCT01027650|536924845|FG003|Overall Study|Lost to Follow-up|0|||
148849578|NCT01027650|536924846|FG004|Overall Study|Lost to Follow-up|0|||
148849579|NCT01027650|536924847|FG005|Overall Study|Lost to Follow-up|0|||
148849580|NCT01027650|536924848|FG006|Overall Study|Lost to Follow-up|1|||
148849581|NCT01027650|536924849|FG007|Overall Study|Lost to Follow-up|0|||
148849582|NCT01027650|536924842|FG000|Overall Study|Lack of Efficacy|0|||
148849583|NCT01027650|536924843|FG001|Overall Study|Lack of Efficacy|0|||
148849584|NCT01027650|536924844|FG002|Overall Study|Lack of Efficacy|0|||
148849585|NCT01027650|536924845|FG003|Overall Study|Lack of Efficacy|0|||
148849586|NCT01027650|536924846|FG004|Overall Study|Lack of Efficacy|0|||
148849587|NCT01027650|536924847|FG005|Overall Study|Lack of Efficacy|1|||
148849588|NCT01027650|536924848|FG006|Overall Study|Lack of Efficacy|0|||
148849589|NCT01027650|536924849|FG007|Overall Study|Lack of Efficacy|0|||
148849590|NCT01042158|536924850|FG000|Overall Study|Physician Decision|1|||
148849591|NCT02712983|536927306|FG000|Treatment Phase|Adverse Event|3|||
148849592|NCT02712983|536927307|FG001|Treatment Phase|Adverse Event|1|||
148849593|NCT02712983|536927308|FG002|Treatment Phase|Adverse Event|1|||
148849594|NCT02712983|536927309|FG003|Treatment Phase|Adverse Event|4|||
148849595|NCT02712983|536927310|FG004|Treatment Phase|Adverse Event|3|||
148849596|NCT02712983|536927311|FG005|Treatment Phase|Adverse Event|0|||
148849597|NCT02712983|536927312|FG006|Treatment Phase|Adverse Event|6|||
148849598|NCT02712983|536927313|FG007|Treatment Phase|Adverse Event|6|||
148849599|NCT02712983|536927314|FG008|Treatment Phase|Adverse Event|1|||
148849600|NCT02712983|536927306|FG000|Treatment Phase|Protocol Deviation|0|||
148849601|NCT02712983|536927307|FG001|Treatment Phase|Protocol Deviation|0|||
148849602|NCT02712983|536927308|FG002|Treatment Phase|Protocol Deviation|0|||
148849603|NCT02712983|536927309|FG003|Treatment Phase|Protocol Deviation|2|||
148849604|NCT02712983|536927310|FG004|Treatment Phase|Protocol Deviation|0|||
148849605|NCT02712983|536927311|FG005|Treatment Phase|Protocol Deviation|0|||
148849606|NCT02712983|536927312|FG006|Treatment Phase|Protocol Deviation|1|||
148849607|NCT02712983|536927313|FG007|Treatment Phase|Protocol Deviation|0|||
148849608|NCT02712983|536927314|FG008|Treatment Phase|Protocol Deviation|0|||
148849609|NCT02712983|536927306|FG000|Treatment Phase|Technical Problems|0|||
148849610|NCT02712983|536927307|FG001|Treatment Phase|Technical Problems|0|||
148849611|NCT02712983|536927308|FG002|Treatment Phase|Technical Problems|0|||
148849612|NCT02712983|536927309|FG003|Treatment Phase|Technical Problems|0|||
148849613|NCT02712983|536927310|FG004|Treatment Phase|Technical Problems|0|||
148849614|NCT02712983|536927311|FG005|Treatment Phase|Technical Problems|0|||
148849615|NCT02712983|536927312|FG006|Treatment Phase|Technical Problems|1|||
148849616|NCT02712983|536927313|FG007|Treatment Phase|Technical Problems|0|||
148849617|NCT02712983|536927314|FG008|Treatment Phase|Technical Problems|0|||
148849618|NCT02712983|536927306|FG000|Treatment Phase|Physician Decision|0|||
148849619|NCT02712983|536927307|FG001|Treatment Phase|Physician Decision|0|||
148849620|NCT02712983|536927308|FG002|Treatment Phase|Physician Decision|0|||
148849621|NCT02712983|536927309|FG003|Treatment Phase|Physician Decision|0|||
148849622|NCT02712983|536927310|FG004|Treatment Phase|Physician Decision|0|||
148849623|NCT02712983|536927311|FG005|Treatment Phase|Physician Decision|0|||
148849624|NCT02712983|536927312|FG006|Treatment Phase|Physician Decision|0|||
148849625|NCT02712983|536927313|FG007|Treatment Phase|Physician Decision|1|||
148849626|NCT02712983|536927314|FG008|Treatment Phase|Physician Decision|1|||
148849627|NCT02712983|536927306|FG000|Treatment Phase|Subject Decision|2|||
148849628|NCT02712983|536927307|FG001|Treatment Phase|Subject Decision|0|||
148849629|NCT02712983|536927308|FG002|Treatment Phase|Subject Decision|0|||
148849630|NCT02712983|536927309|FG003|Treatment Phase|Subject Decision|2|||
148849631|NCT02712983|536927310|FG004|Treatment Phase|Subject Decision|1|||
148849632|NCT02712983|536927311|FG005|Treatment Phase|Subject Decision|0|||
148849633|NCT02712983|536927312|FG006|Treatment Phase|Subject Decision|1|||
148849634|NCT02712983|536927313|FG007|Treatment Phase|Subject Decision|2|||
148849635|NCT02712983|536927314|FG008|Treatment Phase|Subject Decision|0|||
148849636|NCT02712983|536927306|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148849637|NCT02712983|536927307|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
148849638|NCT02712983|536927308|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148849639|NCT02712983|536927309|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148849640|NCT02712983|536927310|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148849641|NCT02712983|536927311|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148849642|NCT02712983|536927312|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
148849643|NCT02712983|536927313|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
148849644|NCT02712983|536927314|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
148849645|NCT02712983|536927306|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849646|NCT02712983|536927307|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849647|NCT02712983|536927308|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849648|NCT02712983|536927309|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
148849649|NCT02712983|536927310|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849650|NCT02712983|536927311|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849651|NCT02712983|536927312|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849652|NCT02712983|536927313|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849653|NCT02712983|536927314|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
148849654|NCT02712983|536927306|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
148849655|NCT02712983|536927307|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
148849656|NCT02712983|536927308|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
148849657|NCT02712983|536927309|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
148849658|NCT02712983|536927310|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
148849659|NCT02712983|536927311|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
148849660|NCT02712983|536927312|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
148849661|NCT02712983|536927313|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
148849662|NCT02712983|536927314|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
148849663|NCT00948857|536927315|FG000|Overall Study|Lost to Follow-up|1|||
148849664|NCT00948857|536927316|FG001|Overall Study|Lost to Follow-up|0|||
148849665|NCT03430843|536927317|FG000|Overall Study|Death|233|||
148849666|NCT03430843|536927318|FG001|Overall Study|Death|233|||
148849667|NCT03430843|536927317|FG000|Overall Study|Sponsor Decision|17|||
148849668|NCT03430843|536927318|FG001|Overall Study|Sponsor Decision|6|||
148849669|NCT03430843|536927317|FG000|Overall Study|Withdrawal by Subject|5|||
148849670|NCT03430843|536927318|FG001|Overall Study|Withdrawal by Subject|14|||
148849671|NCT03430843|536927317|FG000|Overall Study|Lost to Follow-up|1|||
148849672|NCT03430843|536927318|FG001|Overall Study|Lost to Follow-up|3|||
148849673|NCT05360966|536927327|FG000|Overall Study|Adverse Event|5|||
148849674|NCT05360966|536927328|FG001|Overall Study|Adverse Event|5|||
148849675|NCT05360966|536927327|FG000|Overall Study|Withdrawal of Consent|5|||
148849676|NCT05360966|536927328|FG001|Overall Study|Withdrawal of Consent|3|||
148849677|NCT05360966|536927327|FG000|Overall Study|Noncompliance|2|||
148849678|NCT05360966|536927328|FG001|Overall Study|Noncompliance|1|||
148849679|NCT05360966|536927327|FG000|Overall Study|Lost to Follow-up|2|||
148849680|NCT05360966|536927328|FG001|Overall Study|Lost to Follow-up|3|||
148849681|NCT05360966|536927327|FG000|Overall Study|Protocol Deviation|2|||
148849682|NCT05360966|536927328|FG001|Overall Study|Protocol Deviation|1|||
148849683|NCT05360966|536927327|FG000|Overall Study|As specified in the Clinical Study Report|1|||
148849684|NCT05360966|536927328|FG001|Overall Study|As specified in the Clinical Study Report|3|||
148849685|NCT05396014|536927329|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
148849686|NCT05396014|536927330|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849687|NCT05396014|536927331|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849688|NCT05396014|536927332|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849689|NCT05396014|536927333|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849690|NCT05396014|536927334|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849691|NCT05396014|536927335|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849692|NCT05396014|536927336|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849693|NCT05396014|536927337|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849694|NCT05396014|536927338|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849695|NCT05396014|536927339|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849696|NCT05396014|536927340|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849697|NCT05396014|536927341|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849698|NCT05396014|536927342|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
148849699|NCT05396014|536927343|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849700|NCT05396014|536927344|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849701|NCT05396014|536927345|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849702|NCT05396014|536927346|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849703|NCT05396014|536927347|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849704|NCT05396014|536927348|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849705|NCT05396014|536927349|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849706|NCT05396014|536927350|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849707|NCT05396014|536927351|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849708|NCT05396014|536927352|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849709|NCT05396014|536927353|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849710|NCT05396014|536927354|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849711|NCT05396014|536927355|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
148849712|NCT05396014|536927356|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849713|NCT05396014|536927357|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849714|NCT05396014|536927358|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849715|NCT05396014|536927359|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849716|NCT05396014|536927360|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849717|NCT05396014|536927361|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849718|NCT05396014|536927362|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849719|NCT05396014|536927363|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849720|NCT05396014|536927364|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849721|NCT05396014|536927365|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849722|NCT05396014|536927366|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849723|NCT05396014|536927367|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849724|NCT05396014|536927368|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
148849725|NCT05396014|536927369|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849726|NCT05396014|536927370|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849727|NCT05396014|536927371|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
148849728|NCT05396014|536927329|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
148849729|NCT05396014|536927330|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849730|NCT05396014|536927331|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849731|NCT05396014|536927332|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849732|NCT05396014|536927333|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849733|NCT05396014|536927334|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849734|NCT05396014|536927335|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849735|NCT05396014|536927336|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148984767|NCT01992536|537421533|FG006|Overall Study|Administrative Reason|7|||
148984768|NCT01992536|537421534|FG007|Overall Study|Administrative Reason|0|||
148984769|NCT01992536|537421535|FG008|Overall Study|Administrative Reason|0|||
148984770|NCT01992536|537421536|FG009|Overall Study|Administrative Reason|0|||
148984771|NCT01992536|537421527|FG000|Overall Study|Lost to Follow-up|4|||
148849736|NCT05396014|536927337|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849737|NCT05396014|536927338|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849738|NCT05396014|536927339|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849739|NCT05396014|536927340|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849740|NCT05396014|536927341|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849741|NCT05396014|536927342|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
148849742|NCT05396014|536927343|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849743|NCT05396014|536927344|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849744|NCT05396014|536927345|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849745|NCT05396014|536927346|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849746|NCT05396014|536927347|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849747|NCT05396014|536927348|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849748|NCT05396014|536927349|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849749|NCT05396014|536927350|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849750|NCT05396014|536927351|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849751|NCT05396014|536927352|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849752|NCT05396014|536927353|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849753|NCT05396014|536927354|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849754|NCT05396014|536927355|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
148849755|NCT05396014|536927356|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849756|NCT05396014|536927357|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849757|NCT05396014|536927358|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849758|NCT05396014|536927359|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849759|NCT05396014|536927360|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849760|NCT05396014|536927361|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849761|NCT05396014|536927362|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849762|NCT05396014|536927363|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849763|NCT05396014|536927364|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849764|NCT05396014|536927365|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849765|NCT05396014|536927366|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849766|NCT05396014|536927367|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849767|NCT05396014|536927368|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
148849768|NCT05396014|536927369|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849769|NCT05396014|536927370|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849770|NCT05396014|536927371|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
148849771|NCT05396014|536927329|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
148849772|NCT05396014|536927330|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849773|NCT05396014|536927331|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849774|NCT05396014|536927332|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849775|NCT05396014|536927333|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849776|NCT05396014|536927334|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849777|NCT05396014|536927335|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849778|NCT05396014|536927336|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849779|NCT05396014|536927337|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849780|NCT05396014|536927338|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849781|NCT05396014|536927339|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849782|NCT05396014|536927340|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849783|NCT05396014|536927341|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849784|NCT05396014|536927342|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
148849785|NCT05396014|536927343|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849786|NCT05396014|536927344|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849787|NCT05396014|536927345|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849788|NCT05396014|536927346|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849789|NCT05396014|536927347|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849790|NCT05396014|536927348|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849791|NCT05396014|536927349|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849792|NCT05396014|536927350|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849793|NCT05396014|536927351|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849794|NCT05396014|536927352|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849795|NCT05396014|536927353|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849796|NCT05396014|536927354|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849797|NCT05396014|536927355|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
148849798|NCT05396014|536927356|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849799|NCT05396014|536927357|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849800|NCT05396014|536927358|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849801|NCT05396014|536927359|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849802|NCT05396014|536927360|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849803|NCT05396014|536927361|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849804|NCT05396014|536927362|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849805|NCT05396014|536927363|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849806|NCT05396014|536927364|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849807|NCT05396014|536927365|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849808|NCT05396014|536927366|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849809|NCT05396014|536927367|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849810|NCT05396014|536927368|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
148849811|NCT05396014|536927369|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849812|NCT05396014|536927370|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849813|NCT05396014|536927371|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
148849814|NCT05396014|536927329|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849815|NCT05396014|536927330|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849816|NCT05396014|536927331|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849817|NCT05396014|536927332|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849818|NCT05396014|536927333|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849819|NCT05396014|536927334|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849820|NCT05396014|536927335|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849821|NCT05396014|536927336|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849822|NCT05396014|536927337|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849823|NCT05396014|536927338|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849824|NCT05396014|536927339|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849825|NCT05396014|536927340|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849826|NCT05396014|536927341|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849827|NCT05396014|536927342|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849828|NCT05396014|536927343|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849829|NCT05396014|536927344|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849830|NCT05396014|536927345|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849831|NCT05396014|536927346|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849832|NCT05396014|536927347|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849833|NCT05396014|536927348|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849834|NCT05396014|536927349|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849835|NCT05396014|536927350|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849836|NCT05396014|536927351|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849837|NCT05396014|536927352|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849838|NCT05396014|536927353|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849839|NCT05396014|536927354|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849840|NCT05396014|536927355|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
148849841|NCT05396014|536927356|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849842|NCT05396014|536927357|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849843|NCT05396014|536927358|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849844|NCT05396014|536927359|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849845|NCT05396014|536927360|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849846|NCT05396014|536927361|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849847|NCT05396014|536927362|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
149030129|NCT03736785|537587958|FG002|Overall Study|Sponsor Decision|0|||
149030130|NCT03736785|537587956|FG000|Overall Study|Unknown/Missing data|3|||
149030131|NCT03736785|537587957|FG001|Overall Study|Unknown/Missing data|2|||
149030132|NCT03736785|537587958|FG002|Overall Study|Unknown/Missing data|1|||
149030133|NCT03736785|537587956|FG000|Overall Study|Withdrawal by Subject|9|||
149030134|NCT03736785|537587957|FG001|Overall Study|Withdrawal by Subject|6|||
149030135|NCT03736785|537587958|FG002|Overall Study|Withdrawal by Subject|4|||
149030136|NCT02974010|537587959|FG000|Overall Study|Lost to Follow-up|3|||
149030137|NCT02974010|537587960|FG001|Overall Study|Lost to Follow-up|1|||
149030138|NCT02974010|537587961|FG002|Overall Study|Lost to Follow-up|0|||
149030139|NCT02974010|537587962|FG003|Overall Study|Lost to Follow-up|0|||
149030140|NCT02974010|537587959|FG000|Overall Study|Withdrawal by Subject|2|||
149030141|NCT02974010|537587960|FG001|Overall Study|Withdrawal by Subject|1|||
149030142|NCT02974010|537587961|FG002|Overall Study|Withdrawal by Subject|0|||
149030143|NCT02974010|537587962|FG003|Overall Study|Withdrawal by Subject|0|||
148849848|NCT05396014|536927363|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849849|NCT05396014|536927364|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849850|NCT05396014|536927365|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849851|NCT05396014|536927366|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849852|NCT05396014|536927367|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849853|NCT05396014|536927368|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
148849854|NCT05396014|536927369|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849855|NCT05396014|536927370|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849856|NCT05396014|536927371|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
148849857|NCT05396014|536927329|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
149030144|NCT02974010|537587959|FG000|Overall Study|Adverse Event|0|||
149030145|NCT02974010|537587960|FG001|Overall Study|Adverse Event|1|||
149030146|NCT02974010|537587961|FG002|Overall Study|Adverse Event|0|||
149030147|NCT02974010|537587962|FG003|Overall Study|Adverse Event|0|||
149030148|NCT02974010|537587959|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
149030149|NCT02974010|537587960|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
148849858|NCT05396014|536927330|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849859|NCT05396014|536927331|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849860|NCT05396014|536927332|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849861|NCT05396014|536927333|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849862|NCT05396014|536927334|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849863|NCT05396014|536927335|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849864|NCT05396014|536927336|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849865|NCT05396014|536927337|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849866|NCT05396014|536927338|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849867|NCT05396014|536927339|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849868|NCT05396014|536927340|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849869|NCT05396014|536927341|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849870|NCT05396014|536927342|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849871|NCT05396014|536927343|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849872|NCT05396014|536927344|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849873|NCT05396014|536927345|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849874|NCT05396014|536927346|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849875|NCT05396014|536927347|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849876|NCT05396014|536927348|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849877|NCT05396014|536927349|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849878|NCT05396014|536927350|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849879|NCT05396014|536927351|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849880|NCT05396014|536927352|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849881|NCT05396014|536927353|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849882|NCT05396014|536927354|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849883|NCT05396014|536927355|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
148849884|NCT05396014|536927356|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849885|NCT05396014|536927357|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849886|NCT05396014|536927358|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849887|NCT05396014|536927359|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849888|NCT05396014|536927360|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849889|NCT05396014|536927361|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849890|NCT05396014|536927362|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849891|NCT05396014|536927363|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849892|NCT05396014|536927364|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849893|NCT05396014|536927365|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849894|NCT05396014|536927366|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849895|NCT05396014|536927367|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849896|NCT05396014|536927368|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849897|NCT05396014|536927369|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849898|NCT05396014|536927370|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849899|NCT05396014|536927371|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
148849900|NCT05396014|536927329|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849901|NCT05396014|536927330|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849902|NCT05396014|536927331|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849903|NCT05396014|536927332|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849904|NCT05396014|536927333|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849905|NCT05396014|536927334|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849906|NCT05396014|536927335|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849907|NCT05396014|536927336|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849908|NCT05396014|536927337|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849909|NCT05396014|536927338|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849910|NCT05396014|536927339|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849911|NCT05396014|536927340|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849912|NCT05396014|536927341|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849913|NCT05396014|536927342|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
148849914|NCT05396014|536927343|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849915|NCT05396014|536927344|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849916|NCT05396014|536927345|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849917|NCT05396014|536927346|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849918|NCT05396014|536927347|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849919|NCT05396014|536927348|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849920|NCT05396014|536927349|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148984772|NCT01992536|537421528|FG001|Overall Study|Lost to Follow-up|2|||
148984773|NCT01992536|537421529|FG002|Overall Study|Lost to Follow-up|1|||
148984774|NCT01992536|537421530|FG003|Overall Study|Lost to Follow-up|0|||
148984775|NCT01992536|537421531|FG004|Overall Study|Lost to Follow-up|0|||
148984776|NCT01992536|537421532|FG005|Overall Study|Lost to Follow-up|1|||
148984777|NCT01992536|537421533|FG006|Overall Study|Lost to Follow-up|0|||
148984778|NCT01992536|537421534|FG007|Overall Study|Lost to Follow-up|0|||
148984779|NCT01992536|537421535|FG008|Overall Study|Lost to Follow-up|1|||
148984780|NCT01992536|537421536|FG009|Overall Study|Lost to Follow-up|1|||
148984781|NCT01992536|537421527|FG000|Overall Study|Withdrawal by Subject|0|||
148984782|NCT01992536|537421528|FG001|Overall Study|Withdrawal by Subject|1|||
148984783|NCT01992536|537421529|FG002|Overall Study|Withdrawal by Subject|0|||
148984784|NCT01992536|537421530|FG003|Overall Study|Withdrawal by Subject|2|||
148984785|NCT01992536|537421531|FG004|Overall Study|Withdrawal by Subject|0|||
148984786|NCT01992536|537421532|FG005|Overall Study|Withdrawal by Subject|0|||
148984787|NCT01992536|537421533|FG006|Overall Study|Withdrawal by Subject|0|||
148984788|NCT01992536|537421534|FG007|Overall Study|Withdrawal by Subject|0|||
148984789|NCT01992536|537421535|FG008|Overall Study|Withdrawal by Subject|0|||
148984790|NCT01992536|537421536|FG009|Overall Study|Withdrawal by Subject|0|||
148984791|NCT03669081|537421537|FG000|Overall Study|Data could not be validated|1|||
148984792|NCT03669081|537421538|FG001|Overall Study|Data could not be validated|1|||
148849921|NCT05396014|536927350|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849922|NCT05396014|536927351|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849923|NCT05396014|536927352|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849924|NCT05396014|536927353|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849925|NCT05396014|536927354|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849926|NCT05396014|536927355|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849927|NCT05396014|536927356|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849928|NCT05396014|536927357|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849929|NCT05396014|536927358|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849930|NCT05396014|536927359|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849931|NCT05396014|536927360|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849932|NCT05396014|536927361|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849933|NCT05396014|536927362|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849934|NCT05396014|536927363|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849935|NCT05396014|536927364|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849936|NCT05396014|536927365|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849937|NCT05396014|536927366|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849938|NCT05396014|536927367|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849939|NCT05396014|536927368|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849940|NCT05396014|536927369|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849941|NCT05396014|536927370|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849942|NCT05396014|536927371|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
148849943|NCT05396014|536927329|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
148849944|NCT05396014|536927330|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849945|NCT05396014|536927331|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849946|NCT05396014|536927332|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849947|NCT05396014|536927333|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849948|NCT05396014|536927334|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849949|NCT05396014|536927335|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849950|NCT05396014|536927336|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849951|NCT05396014|536927337|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849952|NCT05396014|536927338|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849953|NCT05396014|536927339|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849954|NCT05396014|536927340|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849955|NCT05396014|536927341|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849956|NCT05396014|536927342|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
148849957|NCT05396014|536927343|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849958|NCT05396014|536927344|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148984793|NCT00389324|537421539|FG000|Run-In Phase|Adverse Event|1|||
148984794|NCT00389324|537421539|FG000|Run-In Phase|Lost to Follow-up|1|||
148984795|NCT00389324|537421539|FG000|Run-In Phase|Withdrawal by Subject|1|||
148984796|NCT00389324|537421539|FG000|Subcutaneous Phase|Adverse Event|2|||
148984797|NCT00389324|537421539|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
148984798|NCT00389324|537421539|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
148984799|NCT00389324|537421539|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
148984800|NCT02519504|537421540|FG000|Overall Study|Protocol Violation|6|||
148984801|NCT02519504|537421541|FG001|Overall Study|Protocol Violation|5|||
148984802|NCT02519504|537421540|FG000|Overall Study|Ineligible for direct testing|12|||
148984803|NCT02519504|537421541|FG001|Overall Study|Ineligible for direct testing|12|||
149030150|NCT02974010|537587961|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
148849959|NCT05396014|536927345|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849960|NCT05396014|536927346|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849961|NCT05396014|536927347|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849962|NCT05396014|536927348|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849963|NCT05396014|536927349|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849964|NCT05396014|536927350|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849965|NCT05396014|536927351|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849966|NCT05396014|536927352|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849967|NCT05396014|536927353|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849968|NCT05396014|536927354|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849969|NCT05396014|536927355|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849970|NCT05396014|536927356|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849971|NCT05396014|536927357|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849972|NCT05396014|536927358|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849973|NCT05396014|536927359|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849974|NCT05396014|536927360|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849975|NCT05396014|536927361|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849976|NCT05396014|536927362|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849977|NCT05396014|536927363|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849978|NCT05396014|536927364|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849979|NCT05396014|536927365|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849980|NCT05396014|536927366|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849981|NCT05396014|536927367|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849982|NCT05396014|536927368|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
148849983|NCT05396014|536927369|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849984|NCT05396014|536927370|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849985|NCT05396014|536927371|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
148849986|NCT05396014|536927329|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
148849987|NCT05396014|536927330|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849988|NCT05396014|536927331|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849989|NCT05396014|536927332|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849990|NCT05396014|536927333|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849991|NCT05396014|536927334|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849992|NCT05396014|536927335|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849993|NCT05396014|536927336|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849994|NCT05396014|536927337|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849995|NCT05396014|536927338|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849996|NCT05396014|536927339|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849997|NCT05396014|536927340|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849998|NCT05396014|536927341|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148849999|NCT05396014|536927342|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850000|NCT05396014|536927343|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850001|NCT05396014|536927344|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850002|NCT05396014|536927345|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850003|NCT05396014|536927346|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850004|NCT05396014|536927347|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850005|NCT05396014|536927348|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850006|NCT05396014|536927349|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850007|NCT05396014|536927350|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850008|NCT05396014|536927351|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850009|NCT05396014|536927352|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850010|NCT05396014|536927353|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850011|NCT05396014|536927354|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850012|NCT05396014|536927355|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
148850013|NCT05396014|536927356|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850014|NCT05396014|536927357|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850015|NCT05396014|536927358|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850016|NCT05396014|536927359|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149030151|NCT02974010|537587962|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
149030152|NCT02974010|537587959|FG000|Overall Study|Lack of Efficacy|0|||
149030153|NCT02974010|537587960|FG001|Overall Study|Lack of Efficacy|0|||
149030154|NCT02974010|537587961|FG002|Overall Study|Lack of Efficacy|1|||
148850017|NCT05396014|536927360|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850018|NCT05396014|536927361|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
149030155|NCT02974010|537587962|FG003|Overall Study|Lack of Efficacy|0|||
148850019|NCT05396014|536927362|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850020|NCT05396014|536927363|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850021|NCT05396014|536927364|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850022|NCT05396014|536927365|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850023|NCT05396014|536927366|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850024|NCT05396014|536927367|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850025|NCT05396014|536927368|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850026|NCT05396014|536927369|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850027|NCT05396014|536927370|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850028|NCT05396014|536927371|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
148850029|NCT05396014|536927329|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850030|NCT05396014|536927330|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850031|NCT05396014|536927331|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850032|NCT05396014|536927332|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850033|NCT05396014|536927333|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850034|NCT05396014|536927334|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850035|NCT05396014|536927335|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850036|NCT05396014|536927336|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850037|NCT05396014|536927337|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850038|NCT05396014|536927338|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850039|NCT05396014|536927339|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850040|NCT05396014|536927340|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850041|NCT05396014|536927341|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850042|NCT05396014|536927342|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
148850043|NCT05396014|536927343|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850044|NCT05396014|536927344|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850045|NCT05396014|536927345|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850046|NCT05396014|536927346|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850047|NCT05396014|536927347|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850048|NCT05396014|536927348|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850049|NCT05396014|536927349|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850050|NCT05396014|536927350|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850051|NCT05396014|536927351|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850052|NCT05396014|536927352|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850053|NCT05396014|536927353|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850054|NCT05396014|536927354|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850055|NCT05396014|536927355|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850056|NCT05396014|536927356|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850057|NCT05396014|536927357|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850058|NCT05396014|536927358|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850059|NCT05396014|536927359|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850060|NCT05396014|536927360|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850061|NCT05396014|536927361|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850062|NCT05396014|536927362|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850063|NCT05396014|536927363|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850064|NCT05396014|536927364|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850065|NCT05396014|536927365|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850066|NCT05396014|536927366|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850067|NCT05396014|536927367|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850068|NCT05396014|536927368|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850069|NCT05396014|536927369|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850070|NCT05396014|536927370|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850071|NCT05396014|536927371|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
148850072|NCT05396014|536927329|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850073|NCT05396014|536927330|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850074|NCT05396014|536927331|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850075|NCT05396014|536927332|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
148850076|NCT05396014|536927333|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850077|NCT05396014|536927334|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850078|NCT05396014|536927335|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850079|NCT05396014|536927336|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850080|NCT05396014|536927337|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
148850081|NCT05396014|536927338|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850082|NCT05396014|536927339|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850083|NCT05396014|536927340|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
149030156|NCT00320489|537587965|FG000|Overall Study|Adverse Event|26|||
148850084|NCT05396014|536927341|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850085|NCT05396014|536927342|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850086|NCT05396014|536927343|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850087|NCT05396014|536927344|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850088|NCT05396014|536927345|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850089|NCT05396014|536927346|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148984804|NCT02519504|537421540|FG000|Overall Study|Did not participate in direct testing|95|||
148984805|NCT02519504|537421541|FG001|Overall Study|Did not participate in direct testing|86|||
148984806|NCT02548962|537421544|FG000|Overall Study|Withdrawal by Subject|1|||
148984807|NCT02548962|537421545|FG001|Overall Study|Withdrawal by Subject|0|||
148984808|NCT04831736|537421546|FG000|Overall Study|Withdrawal by Subject|0|||
148984809|NCT04831736|537421547|FG001|Overall Study|Withdrawal by Subject|1|||
148984810|NCT03551938|537421550|FG000|3-Month Follow Up|Lost to Follow-up|39|||
148984811|NCT03551938|537421551|FG001|3-Month Follow Up|Lost to Follow-up|38|||
148984812|NCT03551938|537421550|FG000|6-Month Follow Up|Lost to Follow-up|46|||
148984813|NCT03551938|537421551|FG001|6-Month Follow Up|Lost to Follow-up|42|||
148984814|NCT03551938|537421550|FG000|9-Month Follow Up|Lost to Follow-up|44|||
148984815|NCT03551938|537421551|FG001|9-Month Follow Up|Lost to Follow-up|43|||
148984816|NCT01925183|537421552|FG000|Overall Study|Adverse Event|1|||
148984817|NCT01925183|537421553|FG001|Overall Study|Adverse Event|0|||
148984818|NCT01046110|537421554|FG000|Overall Study|Adverse Event|9|||
148984819|NCT01046110|537421555|FG001|Overall Study|Adverse Event|2|||
148984820|NCT01046110|537421554|FG000|Overall Study|Lack of Efficacy|0|||
148984821|NCT01046110|537421555|FG001|Overall Study|Lack of Efficacy|1|||
148984822|NCT01046110|537421554|FG000|Overall Study|Protocol Violation|7|||
148984823|NCT01046110|537421555|FG001|Overall Study|Protocol Violation|12|||
148984824|NCT01046110|537421554|FG000|Overall Study|Withdrawal Criteria|3|||
148984825|NCT01046110|537421555|FG001|Overall Study|Withdrawal Criteria|5|||
148984826|NCT01046110|537421554|FG000|Overall Study|Unclassified|36|||
148984827|NCT01046110|537421555|FG001|Overall Study|Unclassified|35|||
148984828|NCT02159482|537421558|FG000|Overall Study|Withdrawal by Subject|2|||
148984829|NCT02159482|537421558|FG000|Overall Study|Physician Decision|3|||
148984830|NCT01233817|537421559|FG000|Overall Study|Lost to Follow-up|1|||
148984831|NCT01233817|537421559|FG000|Overall Study|Withdrawal by Subject|2|||
148984832|NCT01430130|537421562|FG000|Overall Study|Lost to Follow-up|1|||
148984833|NCT01430130|537421562|FG000|Overall Study|Infection on Control Side of Incision|1|||
148984834|NCT03525834|537421563|FG000|Overall Study|Progressive disease|1|||
149030157|NCT00320489|537587966|FG001|Overall Study|Adverse Event|25|||
149030158|NCT00320489|537587965|FG000|Overall Study|Clinical Relapse|26|||
149030159|NCT00320489|537587966|FG001|Overall Study|Clinical Relapse|20|||
148850090|NCT05396014|536927347|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850091|NCT05396014|536927348|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850092|NCT05396014|536927349|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850093|NCT05396014|536927350|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850094|NCT05396014|536927351|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850095|NCT05396014|536927352|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850096|NCT05396014|536927353|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850097|NCT05396014|536927354|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
148850098|NCT05396014|536927355|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850099|NCT05396014|536927356|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850100|NCT05396014|536927357|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850101|NCT05396014|536927358|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850102|NCT05396014|536927359|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850103|NCT05396014|536927360|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850104|NCT05396014|536927361|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850105|NCT05396014|536927362|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850106|NCT05396014|536927363|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850107|NCT05396014|536927364|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850108|NCT05396014|536927365|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850109|NCT05396014|536927366|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850110|NCT05396014|536927367|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148850111|NCT05396014|536927368|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
148984835|NCT00614939|537421569|FG000|Overall Study|Withdrawal by Subject|10|||
148984836|NCT00614939|537421570|FG001|Overall Study|Withdrawal by Subject|17|||
148984837|NCT00614939|537421569|FG000|Overall Study|Study specific discontinuation criteris|13|||
148984838|NCT00614939|537421570|FG001|Overall Study|Study specific discontinuation criteris|16|||
148984839|NCT00614939|537421569|FG000|Overall Study|Adverse Event|2|||
148984840|NCT00614939|537421570|FG001|Overall Study|Adverse Event|5|||
148984841|NCT00614939|537421569|FG000|Overall Study|Incorrect enrollment|1|||
148984842|NCT00614939|537421570|FG001|Overall Study|Incorrect enrollment|2|||
148984843|NCT00614939|537421569|FG000|Overall Study|Death|4|||
149030160|NCT00320489|537587965|FG000|Overall Study|Death|0|||
148850112|NCT05396014|536927369|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
148850113|NCT05396014|536927370|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
148850114|NCT05396014|536927371|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
148850115|NCT05396014|536927329|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850116|NCT05396014|536927330|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850117|NCT05396014|536927331|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850118|NCT05396014|536927332|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850119|NCT05396014|536927333|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850120|NCT05396014|536927334|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850121|NCT05396014|536927335|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850122|NCT05396014|536927336|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850123|NCT05396014|536927337|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
148850124|NCT05396014|536927338|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850125|NCT05396014|536927339|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850126|NCT05396014|536927340|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850127|NCT05396014|536927341|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850128|NCT05396014|536927342|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850129|NCT05396014|536927343|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850130|NCT05396014|536927344|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850131|NCT05396014|536927345|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850132|NCT05396014|536927346|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850133|NCT05396014|536927347|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850134|NCT05396014|536927348|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850135|NCT05396014|536927349|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850136|NCT05396014|536927350|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850137|NCT05396014|536927351|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
148850138|NCT05396014|536927352|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850139|NCT05396014|536927353|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850140|NCT05396014|536927354|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850141|NCT05396014|536927355|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850142|NCT05396014|536927356|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850143|NCT05396014|536927357|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850144|NCT05396014|536927358|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850145|NCT05396014|536927359|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850146|NCT05396014|536927360|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850147|NCT05396014|536927361|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850148|NCT05396014|536927362|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850149|NCT05396014|536927363|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850150|NCT05396014|536927364|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
148850151|NCT05396014|536927365|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850152|NCT05396014|536927366|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850153|NCT05396014|536927367|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850154|NCT05396014|536927368|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
148850155|NCT05396014|536927369|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850156|NCT05396014|536927370|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
148850157|NCT05396014|536927371|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
148850158|NCT05396014|536927329|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850159|NCT05396014|536927330|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850160|NCT05396014|536927331|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850161|NCT05396014|536927332|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850162|NCT05396014|536927333|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850163|NCT05396014|536927334|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850164|NCT05396014|536927335|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850165|NCT05396014|536927336|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850166|NCT05396014|536927337|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850167|NCT05396014|536927338|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148984844|NCT00614939|537421570|FG001|Overall Study|Death|3|||
148984845|NCT00614939|537421569|FG000|Overall Study|Poor/non-compliance|4|||
148984846|NCT00614939|537421570|FG001|Overall Study|Poor/non-compliance|0|||
148984847|NCT00614939|537421569|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
148984848|NCT00614939|537421570|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
148850168|NCT05396014|536927339|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850169|NCT05396014|536927340|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850170|NCT05396014|536927341|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850171|NCT05396014|536927342|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
148850172|NCT05396014|536927343|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148984849|NCT00840970|537421571|FG000|Overall Study|Adverse Event|0|||
148850173|NCT05396014|536927344|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850174|NCT05396014|536927345|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850175|NCT05396014|536927346|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850176|NCT05396014|536927347|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850177|NCT05396014|536927348|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850178|NCT05396014|536927349|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850179|NCT05396014|536927350|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850180|NCT05396014|536927351|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850181|NCT05396014|536927352|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850182|NCT05396014|536927353|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850183|NCT05396014|536927354|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850184|NCT05396014|536927355|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
148850185|NCT05396014|536927356|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850186|NCT05396014|536927357|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850187|NCT05396014|536927358|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850188|NCT05396014|536927359|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850189|NCT05396014|536927360|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850190|NCT05396014|536927361|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850191|NCT05396014|536927362|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850192|NCT05396014|536927363|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
148850193|NCT05396014|536927364|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850194|NCT05396014|536927365|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850195|NCT05396014|536927366|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850196|NCT05396014|536927367|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850197|NCT05396014|536927368|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850198|NCT05396014|536927369|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850199|NCT05396014|536927370|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
148850200|NCT05396014|536927371|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
148850201|NCT05396014|536927329|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850202|NCT05396014|536927330|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850203|NCT05396014|536927331|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850204|NCT05396014|536927332|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850205|NCT05396014|536927333|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850206|NCT05396014|536927334|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850207|NCT05396014|536927335|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850208|NCT05396014|536927336|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850209|NCT05396014|536927337|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850210|NCT05396014|536927338|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850211|NCT05396014|536927339|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850212|NCT05396014|536927340|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850213|NCT05396014|536927341|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850214|NCT05396014|536927342|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850215|NCT05396014|536927343|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850216|NCT05396014|536927344|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850217|NCT05396014|536927345|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850218|NCT05396014|536927346|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850219|NCT05396014|536927347|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850220|NCT05396014|536927348|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850221|NCT05396014|536927349|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850222|NCT05396014|536927350|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850223|NCT05396014|536927351|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850224|NCT05396014|536927352|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850225|NCT05396014|536927353|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850226|NCT05396014|536927354|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850227|NCT05396014|536927355|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
148850228|NCT05396014|536927356|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850229|NCT05396014|536927357|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850230|NCT05396014|536927358|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850231|NCT05396014|536927359|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850232|NCT05396014|536927360|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850233|NCT05396014|536927361|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850234|NCT05396014|536927362|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850235|NCT05396014|536927363|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850236|NCT05396014|536927364|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850237|NCT05396014|536927365|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850238|NCT05396014|536927366|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148984850|NCT00840970|537421572|FG001|Overall Study|Adverse Event|0|||
148984851|NCT00840970|537421573|FG002|Overall Study|Adverse Event|1|||
148850239|NCT05396014|536927367|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850240|NCT05396014|536927368|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850241|NCT05396014|536927369|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850242|NCT05396014|536927370|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850243|NCT05396014|536927371|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
148850244|NCT03062280|536927372|FG000|Overall Study|Adverse Event|1|||
148850245|NCT03062280|536927372|FG000|Overall Study|Death|1|||
148850246|NCT03062280|536927372|FG000|Overall Study|Fertility Treatment|2|||
148850247|NCT03062280|536927372|FG000|Overall Study|Physician Decision|2|||
148850248|NCT03062280|536927372|FG000|Overall Study|Pregnancy|5|||
148850249|NCT03062280|536927372|FG000|Overall Study|Withdrawal by Subject|11|||
148850250|NCT04439539|536927373|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
148850251|NCT04439539|536927374|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
148850252|NCT04439539|536927375|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
148850253|NCT04439539|536927373|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
148850254|NCT04439539|536927374|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
148850255|NCT04439539|536927375|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
148850256|NCT04439539|536927373|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
148850257|NCT04439539|536927374|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
148850258|NCT04439539|536927375|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
148850259|NCT05258890|536927377|FG000|Overall Study|Patient withdrawal|6|||
148850260|NCT05258890|536927378|FG001|Overall Study|Patient withdrawal|7|||
148850261|NCT05258890|536927377|FG000|Overall Study|Patient lost to follow-up|10|||
148850262|NCT05258890|536927378|FG001|Overall Study|Patient lost to follow-up|3|||
148850263|NCT05258890|536927377|FG000|Overall Study|Social network member withdrawal|1|||
148850264|NCT05258890|536927378|FG001|Overall Study|Social network member withdrawal|0|||
148850265|NCT05258890|536927377|FG000|Overall Study|Social network member lost to follow-up|5|||
148850266|NCT05258890|536927378|FG001|Overall Study|Social network member lost to follow-up|0|||
148850267|NCT05959447|536927383|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
148850268|NCT05959447|536927384|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
148850269|NCT05959447|536927383|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
148850270|NCT05959447|536927384|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
148850271|NCT05959447|536927383|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
148850272|NCT05959447|536927384|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
148850273|NCT05959447|536927383|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
148850274|NCT05959447|536927384|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
148850275|NCT00566982|536927385|FG000|Overall Study|Adverse Event|6|||
148850276|NCT00566982|536927386|FG001|Overall Study|Adverse Event|48|||
148850277|NCT00566982|536927385|FG000|Overall Study|Withdrawal by Subject|1|||
148850278|NCT00566982|536927386|FG001|Overall Study|Withdrawal by Subject|14|||
148850279|NCT00566982|536927385|FG000|Overall Study|Protocol Violation|1|||
148850280|NCT00566982|536927386|FG001|Overall Study|Protocol Violation|4|||
148850281|NCT00566982|536927385|FG000|Overall Study|Lost to Follow-up|0|||
148850282|NCT00566982|536927386|FG001|Overall Study|Lost to Follow-up|1|||
148850283|NCT00566982|536927385|FG000|Overall Study|Other-family problems & doctor's request|0|||
148850284|NCT00566982|536927386|FG001|Overall Study|Other-family problems & doctor's request|2|||
148850285|NCT03379259|536927389|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
148850286|NCT03379259|536927390|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
148850287|NCT03379259|536927391|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
148850288|NCT03379259|536927392|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
148850289|NCT03379259|536927393|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
148850290|NCT03379259|536927394|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
148850291|NCT03379259|536927389|FG000|Overall Study|Death|0|||
148850292|NCT03379259|536927390|FG001|Overall Study|Death|1|||
148850293|NCT03379259|536927391|FG002|Overall Study|Death|2|||
148850294|NCT03379259|536927392|FG003|Overall Study|Death|1|||
148850295|NCT03379259|536927393|FG004|Overall Study|Death|4|||
148850296|NCT03379259|536927394|FG005|Overall Study|Death|2|||
148850297|NCT03379259|536927389|FG000|Overall Study|Withdrawal by Subject|0|||
148984852|NCT00504829|537421574|FG000|Overall Study|Protocol Violation|6|||
148850298|NCT03379259|536927390|FG001|Overall Study|Withdrawal by Subject|0|||
148850299|NCT03379259|536927391|FG002|Overall Study|Withdrawal by Subject|1|||
148850300|NCT03379259|536927392|FG003|Overall Study|Withdrawal by Subject|0|||
148850301|NCT03379259|536927393|FG004|Overall Study|Withdrawal by Subject|2|||
148850302|NCT03379259|536927394|FG005|Overall Study|Withdrawal by Subject|0|||
148850303|NCT03379259|536927389|FG000|Overall Study|Study terminated by sponsor|0|||
148850304|NCT03379259|536927390|FG001|Overall Study|Study terminated by sponsor|0|||
148850305|NCT03379259|536927391|FG002|Overall Study|Study terminated by sponsor|0|||
148850306|NCT03379259|536927392|FG003|Overall Study|Study terminated by sponsor|1|||
148850307|NCT03379259|536927393|FG004|Overall Study|Study terminated by sponsor|1|||
148850308|NCT03379259|536927394|FG005|Overall Study|Study terminated by sponsor|4|||
148850309|NCT03379259|536927389|FG000|Overall Study|Disease progression|0|||
148984853|NCT00504829|537421575|FG001|Overall Study|Protocol Violation|4|||
148984854|NCT00504829|537421576|FG002|Overall Study|Protocol Violation|10|||
148850310|NCT03379259|536927390|FG001|Overall Study|Disease progression|0|||
148850311|NCT03379259|536927391|FG002|Overall Study|Disease progression|0|||
148850312|NCT03379259|536927392|FG003|Overall Study|Disease progression|1|||
148850313|NCT03379259|536927393|FG004|Overall Study|Disease progression|0|||
148850314|NCT03379259|536927394|FG005|Overall Study|Disease progression|1|||
148850315|NCT03379259|536927389|FG000|Overall Study|Lost to Follow-up|0|||
148850316|NCT03379259|536927390|FG001|Overall Study|Lost to Follow-up|0|||
148850317|NCT03379259|536927391|FG002|Overall Study|Lost to Follow-up|0|||
148850318|NCT03379259|536927392|FG003|Overall Study|Lost to Follow-up|0|||
148850319|NCT03379259|536927393|FG004|Overall Study|Lost to Follow-up|1|||
148850320|NCT03379259|536927394|FG005|Overall Study|Lost to Follow-up|0|||
148850321|NCT03379259|536927389|FG000|Overall Study|Deteriorating condition|0|||
148850322|NCT03379259|536927390|FG001|Overall Study|Deteriorating condition|0|||
148850323|NCT03379259|536927391|FG002|Overall Study|Deteriorating condition|0|||
148850324|NCT03379259|536927392|FG003|Overall Study|Deteriorating condition|0|||
148850325|NCT03379259|536927393|FG004|Overall Study|Deteriorating condition|1|||
148850326|NCT03379259|536927394|FG005|Overall Study|Deteriorating condition|0|||
148850327|NCT02836717|536927395|FG000|Test Phase|Lack of Efficacy|14|||
148850328|NCT02836717|536927396|FG001|Test Phase|Lack of Efficacy|8|||
148850329|NCT02836717|536927397|FG002|Test Phase|Lack of Efficacy|0|||
148850330|NCT02836717|536927395|FG000|Study Phase|Adverse Event|2|||
148850331|NCT02836717|536927396|FG001|Study Phase|Adverse Event|0|||
148850332|NCT02836717|536927397|FG002|Study Phase|Adverse Event|0|||
148850333|NCT02836717|536927395|FG000|Study Phase|Lack of Efficacy|8|||
148850334|NCT02836717|536927396|FG001|Study Phase|Lack of Efficacy|6|||
148850335|NCT02836717|536927397|FG002|Study Phase|Lack of Efficacy|1|||
148850336|NCT02836717|536927395|FG000|Study Phase|Withdrawal by Subject|1|||
148850337|NCT02836717|536927396|FG001|Study Phase|Withdrawal by Subject|0|||
148850338|NCT02836717|536927397|FG002|Study Phase|Withdrawal by Subject|0|||
148850339|NCT02836717|536927395|FG000|Study Phase|Death|1|||
148850340|NCT02836717|536927396|FG001|Study Phase|Death|0|||
148850341|NCT02836717|536927397|FG002|Study Phase|Death|0|||
148850342|NCT02836717|536927395|FG000|Study Phase|abdominal surgeries|2|||
148850343|NCT02836717|536927396|FG001|Study Phase|abdominal surgeries|1|||
148850344|NCT02836717|536927397|FG002|Study Phase|abdominal surgeries|0|||
148850345|NCT01309997|536927399|FG000|Overall Study|Adverse Event|1|||
148850346|NCT01309997|536927400|FG001|Overall Study|Adverse Event|0|||
148850347|NCT01309997|536927399|FG000|Overall Study|Death|1|||
148850348|NCT01309997|536927400|FG001|Overall Study|Death|3|||
148850349|NCT01309997|536927399|FG000|Overall Study|Lack of Efficacy|2|||
148850350|NCT01309997|536927400|FG001|Overall Study|Lack of Efficacy|2|||
148850351|NCT01309997|536927399|FG000|Overall Study|Withdrawal by Subject|1|||
148850352|NCT01309997|536927400|FG001|Overall Study|Withdrawal by Subject|1|||
148850353|NCT00282087|536927401|FG000|Overall Study|Death|1|||
148850354|NCT03226249|536927402|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
148850355|NCT03226249|536927402|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
148850356|NCT03226249|536927402|FG000|Survival Follow-up|Patients still in follow-up.|30|||
148850357|NCT01532921|536927403|FG000|Overall Study|Death|3|||
148850358|NCT01532921|536927403|FG000|Overall Study|Withdrawal by Subject|2|||
148850359|NCT01532921|536927403|FG000|Overall Study|Lost to Follow-up|3|||
148850360|NCT01532921|536927403|FG000|Overall Study|Physician Decision|7|||
148850361|NCT01532921|536927403|FG000|Overall Study|Device was explanted during procedure|1|||
148984855|NCT03465540|537421577|FG000|Overall Study|Withdrawal by Subject|0|||
148984856|NCT03465540|537421578|FG001|Overall Study|Withdrawal by Subject|0|||
148984857|NCT03465540|537421579|FG002|Overall Study|Withdrawal by Subject|1|||
148984858|NCT03465540|537421580|FG003|Overall Study|Withdrawal by Subject|1|||
148984859|NCT03465540|537421581|FG004|Overall Study|Withdrawal by Subject|1|||
148984860|NCT03465540|537421582|FG005|Overall Study|Withdrawal by Subject|0|||
148984861|NCT03465540|537421577|FG000|Overall Study|Lost to Follow-up|0|||
148984862|NCT03465540|537421578|FG001|Overall Study|Lost to Follow-up|1|||
148984863|NCT03465540|537421579|FG002|Overall Study|Lost to Follow-up|0|||
148850362|NCT03462641|536927404|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
148850363|NCT03462641|536927405|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
148850364|NCT03462641|536927404|FG000|Visit 2|Withdrawal by Subject|0|||
148850365|NCT03462641|536927405|FG001|Visit 2|Withdrawal by Subject|1|||
148850366|NCT01804049|536927406|FG000|Overall Study|Adverse Event|2|||
148850367|NCT01804049|536927407|FG001|Overall Study|Adverse Event|10|||
148850368|NCT01804049|536927406|FG000|Overall Study|Lost to Follow-up|2|||
148850369|NCT01804049|536927407|FG001|Overall Study|Lost to Follow-up|1|||
148850370|NCT01804049|536927406|FG000|Overall Study|Decreased interest/personal|4|||
148850371|NCT01804049|536927407|FG001|Overall Study|Decreased interest/personal|5|||
148850372|NCT01804049|536927406|FG000|Overall Study|Other health concerns|2|||
148850373|NCT01804049|536927407|FG001|Overall Study|Other health concerns|7|||
148850374|NCT01804049|536927406|FG000|Overall Study|Moved out of area|0|||
148850375|NCT01804049|536927407|FG001|Overall Study|Moved out of area|7|||
148850376|NCT01804049|536927406|FG000|Overall Study|other MD recommended|1|||
148984864|NCT03465540|537421580|FG003|Overall Study|Lost to Follow-up|0|||
148984865|NCT03465540|537421581|FG004|Overall Study|Lost to Follow-up|1|||
148984866|NCT03465540|537421582|FG005|Overall Study|Lost to Follow-up|0|||
148984867|NCT03465540|537421577|FG000|Overall Study|Death|1|||
148984868|NCT03465540|537421578|FG001|Overall Study|Death|1|||
148984869|NCT03465540|537421579|FG002|Overall Study|Death|0|||
148984870|NCT03465540|537421580|FG003|Overall Study|Death|2|||
148984871|NCT03465540|537421581|FG004|Overall Study|Death|0|||
148984872|NCT03465540|537421582|FG005|Overall Study|Death|2|||
148984873|NCT03465540|537421577|FG000|Overall Study|Protocol specified criteria|0|||
148984874|NCT03465540|537421578|FG001|Overall Study|Protocol specified criteria|2|||
148984875|NCT03465540|537421579|FG002|Overall Study|Protocol specified criteria|2|||
148984876|NCT03465540|537421580|FG003|Overall Study|Protocol specified criteria|0|||
148984877|NCT03465540|537421581|FG004|Overall Study|Protocol specified criteria|2|||
148984878|NCT03465540|537421582|FG005|Overall Study|Protocol specified criteria|0|||
148984879|NCT01854827|537421583|FG000|Overall Study|Death|1|||
148984880|NCT00736996|537421584|FG000|Overall Study|Lost to Follow-up|1|||
148984881|NCT00736996|537421585|FG001|Overall Study|Lost to Follow-up|9|||
148984882|NCT00736996|537421586|FG002|Overall Study|Lost to Follow-up|2|||
148984883|NCT02667912|537421587|FG000|Overall Study|Death|3|||
148984884|NCT02667912|537421588|FG001|Overall Study|Death|1|||
148984885|NCT02667912|537421587|FG000|Overall Study|Withdrawal by Subject|1|||
148984886|NCT02667912|537421588|FG001|Overall Study|Withdrawal by Subject|2|||
148984887|NCT02667912|537421587|FG000|Overall Study|Withdrawal by Subject|1|||
148984888|NCT02667912|537421588|FG001|Overall Study|Withdrawal by Subject|0|||
148984889|NCT04443218|537421589|FG000|Overall Study|Exited study for other reasons|9|||
148984890|NCT04443218|537421589|FG000|Overall Study|Withdrawal by Subject|1|||
148984891|NCT04443218|537421589|FG000|Overall Study|Lost to Follow-up|4|||
148984892|NCT04443218|537421589|FG000|Overall Study|Death|19|||
148984893|NCT02660944|537421590|FG000|Overall Study|Adverse Event|3|||
148984894|NCT02660944|537421591|FG001|Overall Study|Adverse Event|4|||
148984895|NCT02660944|537421590|FG000|Overall Study|Physician Decision|3|||
148984896|NCT02660944|537421591|FG001|Overall Study|Physician Decision|1|||
148984897|NCT02660944|537421590|FG000|Overall Study|Withdrawal by Subject|5|||
148984898|NCT02660944|537421591|FG001|Overall Study|Withdrawal by Subject|3|||
148984899|NCT02660944|537421590|FG000|Overall Study|Lost to Follow-up|4|||
148984900|NCT02660944|537421591|FG001|Overall Study|Lost to Follow-up|1|||
148984901|NCT02660944|537421590|FG000|Overall Study|Subject schedule|0|||
148984902|NCT02660944|537421591|FG001|Overall Study|Subject schedule|1|||
148984903|NCT02660944|537421590|FG000|Overall Study|Exclusion criteria met|2|||
148984904|NCT02660944|537421591|FG001|Overall Study|Exclusion criteria met|0|||
148984905|NCT02843568|537421592|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
148984906|NCT02843568|537421593|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
149030161|NCT00320489|537587966|FG001|Overall Study|Death|2|||
149030162|NCT00320489|537587965|FG000|Overall Study|Entry Criteria Exclusion|2|||
149030163|NCT00320489|537587966|FG001|Overall Study|Entry Criteria Exclusion|4|||
148850377|NCT01804049|536927407|FG001|Overall Study|other MD recommended|1|||
148850378|NCT01804049|536927406|FG000|Overall Study|Enrollment in dual studies|0|||
148850379|NCT01804049|536927407|FG001|Overall Study|Enrollment in dual studies|1|||
148850380|NCT00716482|536927415|FG000|Overall Study|Lost to Follow-up|6|||
148850381|NCT00716482|536927415|FG000|Overall Study|Inadequate acquisition or analysis|50|||
148850382|NCT00716482|536927415|FG000|Overall Study|no pathology obtained|10|||
148850383|NCT00716482|536927415|FG000|Overall Study|technical/machine error|28|||
148850384|NCT00716482|536927415|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
148850385|NCT02550288|536927416|FG000|Overall Study|Adverse Event|0|||
148850386|NCT02550288|536927417|FG001|Overall Study|Adverse Event|1|||
148850387|NCT02550288|536927418|FG002|Overall Study|Adverse Event|0|||
148850388|NCT02550288|536927419|FG003|Overall Study|Adverse Event|0|||
148850389|NCT02550288|536927420|FG004|Overall Study|Adverse Event|0|||
148850390|NCT02550288|536927416|FG000|Overall Study|Physician Decision|0|||
148850391|NCT02550288|536927417|FG001|Overall Study|Physician Decision|0|||
148850392|NCT02550288|536927418|FG002|Overall Study|Physician Decision|0|||
148850393|NCT02550288|536927419|FG003|Overall Study|Physician Decision|1|||
148850394|NCT02550288|536927420|FG004|Overall Study|Physician Decision|0|||
148850395|NCT02550288|536927416|FG000|Overall Study|Protocol Violation|2|||
148850396|NCT02550288|536927417|FG001|Overall Study|Protocol Violation|2|||
148984907|NCT02843568|537421592|FG000|Overall Study|Death|3|||
148984908|NCT02843568|537421593|FG001|Overall Study|Death|3|||
148984909|NCT02843568|537421592|FG000|Overall Study|Withdrawal by Subject|1|||
148984910|NCT02843568|537421593|FG001|Overall Study|Withdrawal by Subject|1|||
148984911|NCT02843568|537421592|FG000|Overall Study|Lost to Follow-up|2|||
148984912|NCT02843568|537421593|FG001|Overall Study|Lost to Follow-up|0|||
148984913|NCT03586999|537421594|FG000|Overall Study|Lack of Efficacy|2|||
148984914|NCT02059148|537421607|FG000|Treatment 1|Protocol Violation|0|||
148984915|NCT02059148|537421608|FG001|Treatment 1|Protocol Violation|0|||
148984916|NCT02059148|537421609|FG002|Treatment 1|Protocol Violation|0|||
148984917|NCT02059148|537421610|FG003|Treatment 1|Protocol Violation|0|||
148984918|NCT02059148|537421611|FG004|Treatment 1|Protocol Violation|0|||
148984919|NCT02059148|537421612|FG005|Treatment 1|Protocol Violation|1|||
148984920|NCT01525082|537421613|FG000|Overall Study|Death|1|||
149030164|NCT00320489|537587965|FG000|Overall Study|Lack of Efficacy|16|||
148850397|NCT02550288|536927418|FG002|Overall Study|Protocol Violation|1|||
148850398|NCT02550288|536927419|FG003|Overall Study|Protocol Violation|0|||
148850399|NCT02550288|536927420|FG004|Overall Study|Protocol Violation|3|||
148850400|NCT02550288|536927416|FG000|Overall Study|Participant moved|0|||
148850401|NCT02550288|536927417|FG001|Overall Study|Participant moved|0|||
148850402|NCT02550288|536927418|FG002|Overall Study|Participant moved|0|||
148850403|NCT02550288|536927419|FG003|Overall Study|Participant moved|1|||
148850404|NCT02550288|536927420|FG004|Overall Study|Participant moved|0|||
148850405|NCT02550288|536927416|FG000|Overall Study|Withdrawal by Subject|0|||
148850406|NCT02550288|536927417|FG001|Overall Study|Withdrawal by Subject|0|||
148850407|NCT02550288|536927418|FG002|Overall Study|Withdrawal by Subject|0|||
148850408|NCT02550288|536927419|FG003|Overall Study|Withdrawal by Subject|1|||
148850409|NCT02550288|536927420|FG004|Overall Study|Withdrawal by Subject|0|||
148850410|NCT02201329|536927421|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
148850411|NCT02201329|536927421|FG000|Overall Study|Withdrawal by Subject|2|||
148850412|NCT01262638|536927422|FG000|Overall Study|Adverse Event|3|||
148850413|NCT01262638|536927423|FG001|Overall Study|Adverse Event|4|||
148850414|NCT01262638|536927424|FG002|Overall Study|Adverse Event|3|||
148850415|NCT01262638|536927425|FG003|Overall Study|Adverse Event|4|||
148850416|NCT01262638|536927422|FG000|Overall Study|Protocol Violation|1|||
148850417|NCT01262638|536927423|FG001|Overall Study|Protocol Violation|0|||
148850418|NCT01262638|536927424|FG002|Overall Study|Protocol Violation|0|||
148850419|NCT01262638|536927425|FG003|Overall Study|Protocol Violation|1|||
148850420|NCT01262638|536927422|FG000|Overall Study|Withdrawal by Subject|2|||
148850421|NCT01262638|536927423|FG001|Overall Study|Withdrawal by Subject|1|||
148850422|NCT01262638|536927424|FG002|Overall Study|Withdrawal by Subject|0|||
148850423|NCT01262638|536927425|FG003|Overall Study|Withdrawal by Subject|1|||
148850424|NCT01262638|536927422|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
148850425|NCT01262638|536927423|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
148850426|NCT01262638|536927424|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
148850427|NCT01262638|536927425|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
148850428|NCT01262638|536927422|FG000|Overall Study|Lost to Follow-up|1|||
148850429|NCT01262638|536927423|FG001|Overall Study|Lost to Follow-up|1|||
148850430|NCT01262638|536927424|FG002|Overall Study|Lost to Follow-up|1|||
148850431|NCT01262638|536927425|FG003|Overall Study|Lost to Follow-up|1|||
148850432|NCT01262638|536927422|FG000|Overall Study|Participant Went Out of Town|0|||
148850433|NCT01262638|536927423|FG001|Overall Study|Participant Went Out of Town|0|||
148850434|NCT01262638|536927424|FG002|Overall Study|Participant Went Out of Town|1|||
148850435|NCT01262638|536927425|FG003|Overall Study|Participant Went Out of Town|0|||
148850436|NCT01369199|536927426|FG000|Overall Study|Withdrawal by Subject|1|||
148850437|NCT01369199|536927426|FG000|Overall Study|Lost to Follow-up|2|||
148850438|NCT04660552|536927427|FG000|Overall Study|Withdrawal by Subject|3|||
148850439|NCT04660552|536927428|FG001|Overall Study|Withdrawal by Subject|1|||
148850440|NCT00470262|536927429|FG000|Overall Study|Withdrawal by Subject|2|||
148850441|NCT00470262|536927430|FG001|Overall Study|Withdrawal by Subject|0|||
148850442|NCT00244725|536927438|FG000|Overall Study|Lost to Follow-up|3|||
148850443|NCT00244725|536927439|FG001|Overall Study|Lost to Follow-up|4|||
148850444|NCT00244725|536927440|FG002|Overall Study|Lost to Follow-up|9|||
148850445|NCT00244725|536927441|FG003|Overall Study|Lost to Follow-up|2|||
148850446|NCT00244725|536927438|FG000|Overall Study|Withdrawal by Subject|9|||
148850447|NCT00244725|536927439|FG001|Overall Study|Withdrawal by Subject|7|||
148850448|NCT00244725|536927440|FG002|Overall Study|Withdrawal by Subject|7|||
148850449|NCT00244725|536927441|FG003|Overall Study|Withdrawal by Subject|8|||
148850450|NCT00244725|536927438|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
148850451|NCT00244725|536927439|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
148850452|NCT00244725|536927440|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
148850453|NCT00244725|536927441|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
148850454|NCT00244725|536927438|FG000|Overall Study|Physician Decision|3|||
148850455|NCT00244725|536927439|FG001|Overall Study|Physician Decision|0|||
148850456|NCT00244725|536927440|FG002|Overall Study|Physician Decision|1|||
148850457|NCT00244725|536927441|FG003|Overall Study|Physician Decision|2|||
148850458|NCT00244725|536927438|FG000|Overall Study|Adverse Events|3|||
148850459|NCT00244725|536927439|FG001|Overall Study|Adverse Events|1|||
148850460|NCT00244725|536927440|FG002|Overall Study|Adverse Events|4|||
148850461|NCT00244725|536927441|FG003|Overall Study|Adverse Events|4|||
148850462|NCT00244725|536927438|FG000|Overall Study|Withdrwal by participant|1|||
148850463|NCT00244725|536927439|FG001|Overall Study|Withdrwal by participant|0|||
148850464|NCT00244725|536927440|FG002|Overall Study|Withdrwal by participant|0|||
148850465|NCT00244725|536927441|FG003|Overall Study|Withdrwal by participant|1|||
148850466|NCT00244725|536927438|FG000|Overall Study|Liver function test abnormality|2|||
148850467|NCT00244725|536927439|FG001|Overall Study|Liver function test abnormality|0|||
148984921|NCT03880578|537421617|FG000|Overall Study|Withdrawal by Subject|0|||
148850468|NCT00244725|536927440|FG002|Overall Study|Liver function test abnormality|0|||
148984922|NCT03880578|537421618|FG001|Overall Study|Withdrawal by Subject|3|||
148984923|NCT03880578|537421619|FG002|Overall Study|Withdrawal by Subject|1|||
148984924|NCT03880578|537421617|FG000|Overall Study|Death|0|||
148984925|NCT03880578|537421618|FG001|Overall Study|Death|1|||
148984926|NCT03880578|537421619|FG002|Overall Study|Death|0|||
148984927|NCT04934670|537421620|FG000|Overall Study|Death|4|||
148984928|NCT04934670|537421621|FG001|Overall Study|Death|0|||
148984929|NCT04934670|537421620|FG000|Overall Study|Lost to Follow-up|1|||
148984930|NCT04934670|537421621|FG001|Overall Study|Lost to Follow-up|4|||
148984931|NCT01592708|537421622|FG000|Overall Study|Protocol Violation|3|||
148850469|NCT00244725|536927441|FG003|Overall Study|Liver function test abnormality|1|||
148850470|NCT00244725|536927438|FG000|Overall Study|Sponsor withdrew the participant|1|||
148850471|NCT00244725|536927439|FG001|Overall Study|Sponsor withdrew the participant|0|||
148850472|NCT00244725|536927440|FG002|Overall Study|Sponsor withdrew the participant|0|||
148850473|NCT00244725|536927441|FG003|Overall Study|Sponsor withdrew the participant|1|||
148850474|NCT00244725|536927438|FG000|Overall Study|Mediciation Error|0|||
148850475|NCT00244725|536927439|FG001|Overall Study|Mediciation Error|1|||
148850476|NCT00244725|536927440|FG002|Overall Study|Mediciation Error|0|||
148850477|NCT00244725|536927441|FG003|Overall Study|Mediciation Error|0|||
148850478|NCT00244725|536927438|FG000|Overall Study|Rehab Refused to allow participantion|0|||
148850479|NCT00244725|536927439|FG001|Overall Study|Rehab Refused to allow participantion|1|||
148850480|NCT00244725|536927440|FG002|Overall Study|Rehab Refused to allow participantion|0|||
148850481|NCT00244725|536927441|FG003|Overall Study|Rehab Refused to allow participantion|0|||
148850482|NCT00244725|536927438|FG000|Overall Study|Headache|0|||
148850483|NCT00244725|536927439|FG001|Overall Study|Headache|1|||
148850484|NCT00244725|536927440|FG002|Overall Study|Headache|0|||
148850485|NCT00244725|536927441|FG003|Overall Study|Headache|0|||
148850486|NCT00244725|536927438|FG000|Overall Study|Received prohibited medication|0|||
148850487|NCT00244725|536927439|FG001|Overall Study|Received prohibited medication|1|||
148850488|NCT00244725|536927440|FG002|Overall Study|Received prohibited medication|0|||
148850489|NCT00244725|536927441|FG003|Overall Study|Received prohibited medication|1|||
148850490|NCT00244725|536927438|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
148850491|NCT00244725|536927439|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
148850492|NCT00244725|536927440|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
148850493|NCT00244725|536927441|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
148850494|NCT00244725|536927438|FG000|Overall Study|Administrative reason|0|||
148850495|NCT00244725|536927439|FG001|Overall Study|Administrative reason|0|||
148850496|NCT00244725|536927440|FG002|Overall Study|Administrative reason|1|||
148850497|NCT00244725|536927441|FG003|Overall Study|Administrative reason|0|||
148850498|NCT00244725|536927438|FG000|Overall Study|Vomit|0|||
148850499|NCT00244725|536927439|FG001|Overall Study|Vomit|0|||
148850500|NCT00244725|536927440|FG002|Overall Study|Vomit|1|||
148850501|NCT00244725|536927441|FG003|Overall Study|Vomit|0|||
148850502|NCT00244725|536927438|FG000|Overall Study|Failed to follow-up|0|||
148850503|NCT00244725|536927439|FG001|Overall Study|Failed to follow-up|0|||
148850504|NCT00244725|536927440|FG002|Overall Study|Failed to follow-up|1|||
148850505|NCT00244725|536927441|FG003|Overall Study|Failed to follow-up|1|||
148984932|NCT01592708|537421623|FG001|Overall Study|Protocol Violation|0|||
148984933|NCT02328326|537421628|FG000|Overall Study|Withdrawal by Subject|10|||
148984934|NCT02328326|537421629|FG001|Overall Study|Withdrawal by Subject|3|||
148984935|NCT02328326|537421628|FG000|Overall Study|Death|2|||
148984936|NCT02328326|537421629|FG001|Overall Study|Death|1|||
148984937|NCT02328326|537421628|FG000|Overall Study|Lost to Follow-up|10|||
148984938|NCT02328326|537421629|FG001|Overall Study|Lost to Follow-up|4|||
148984939|NCT03433456|537421630|FG000|Overall Study|Death|1|||
148984940|NCT03433456|537421631|FG001|Overall Study|Death|1|||
148984941|NCT03433456|537421630|FG000|Overall Study|Lost to Follow-up|14|||
148984942|NCT03433456|537421631|FG001|Overall Study|Lost to Follow-up|11|||
148984943|NCT03433456|537421630|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
148984944|NCT03433456|537421631|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
148984945|NCT03251924|537421632|FG000|Overall Study|Disease Progression|6|||
148984946|NCT03251924|537421633|FG001|Overall Study|Disease Progression|6|||
148850506|NCT04004221|536927442|FG000|Overall Study|Death|89|||
148850507|NCT04004221|536927442|FG000|Overall Study|Withdrawal by Subject|5|||
148850508|NCT04004221|536927442|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
148850509|NCT04004221|536927442|FG000|Overall Study|Sponsor Decision|9|||
148850510|NCT04004221|536927442|FG000|Overall Study|Participant refused to enter LTE|1|||
148850511|NCT02122146|536927443|FG000|Part 1: Dose Escalation|Death|0|||
148984947|NCT03251924|537421634|FG002|Overall Study|Disease Progression|7|||
148984948|NCT03251924|537421635|FG003|Overall Study|Disease Progression|8|||
148984949|NCT03251924|537421636|FG004|Overall Study|Disease Progression|8|||
148984950|NCT03251924|537421637|FG005|Overall Study|Disease Progression|7|||
148984951|NCT03251924|537421638|FG006|Overall Study|Disease Progression|6|||
148984952|NCT03251924|537421639|FG007|Overall Study|Disease Progression|10|||
148984953|NCT03251924|537421640|FG008|Overall Study|Disease Progression|6|||
148984954|NCT03251924|537421632|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
148984955|NCT03251924|537421633|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
148984956|NCT03251924|537421634|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
148984957|NCT03251924|537421635|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
148850512|NCT02122146|536927444|FG001|Part 1: Dose Escalation|Death|1|||
148850513|NCT02122146|536927445|FG002|Part 1: Dose Escalation|Death|1|||
148850514|NCT02122146|536927446|FG003|Part 1: Dose Escalation|Death|0|||
148850515|NCT02122146|536927447|FG004|Part 1: Dose Escalation|Death|0|||
148850516|NCT02122146|536927448|FG005|Part 1: Dose Escalation|Death|0|||
148850517|NCT02122146|536927449|FG006|Part 1: Dose Escalation|Death|0|||
148850518|NCT02122146|536927450|FG007|Part 1: Dose Escalation|Death|0|||
148850519|NCT02122146|536927443|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
148850520|NCT02122146|536927444|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
148850521|NCT02122146|536927445|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
148850522|NCT02122146|536927446|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
148850523|NCT02122146|536927447|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
148850524|NCT02122146|536927448|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
148850525|NCT02122146|536927449|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
148850526|NCT02122146|536927450|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
148850527|NCT02122146|536927443|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850528|NCT02122146|536927444|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850529|NCT02122146|536927445|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850530|NCT02122146|536927446|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
148850531|NCT02122146|536927447|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850532|NCT02122146|536927448|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850533|NCT02122146|536927449|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850534|NCT02122146|536927450|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
148850535|NCT02122146|536927443|FG000|Part 1: Dose Escalation|Other|1|||
148850536|NCT02122146|536927444|FG001|Part 1: Dose Escalation|Other|0|||
148850537|NCT02122146|536927445|FG002|Part 1: Dose Escalation|Other|0|||
148850538|NCT02122146|536927446|FG003|Part 1: Dose Escalation|Other|0|||
148850539|NCT02122146|536927447|FG004|Part 1: Dose Escalation|Other|0|||
148850540|NCT02122146|536927448|FG005|Part 1: Dose Escalation|Other|1|||
148850541|NCT02122146|536927449|FG006|Part 1: Dose Escalation|Other|1|||
148850542|NCT02122146|536927450|FG007|Part 1: Dose Escalation|Other|2|||
148850543|NCT01970241|536927451|FG000|Overall Study|Withdrawal by Subject|2|||
148850544|NCT01970241|536927452|FG001|Overall Study|Withdrawal by Subject|0|||
148850545|NCT01970241|536927451|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
148850546|NCT01970241|536927452|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
148850547|NCT03472495|536927453|FG000|Overall Study|Treatment no longer indicated|1|||
148850548|NCT03472495|536927454|FG001|Overall Study|Treatment no longer indicated|2|||
148850549|NCT03472495|536927453|FG000|Overall Study|Physician Decision|0|||
148850550|NCT03472495|536927454|FG001|Overall Study|Physician Decision|2|||
148850551|NCT00992056|536927457|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
148850552|NCT00992056|536927458|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
148850553|NCT00992056|536927457|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
148850554|NCT00992056|536927458|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
148850555|NCT01001767|536927459|FG000|Overall Study|no baseline study performed|1|||
148850556|NCT01001767|536927460|FG001|Overall Study|no baseline study performed|0|||
148850557|NCT01001767|536927459|FG000|Overall Study|Protocol Violation|1|||
148850558|NCT01001767|536927460|FG001|Overall Study|Protocol Violation|0|||
148850559|NCT01001767|536927459|FG000|Overall Study|Lost to Follow-up|1|||
148850560|NCT01001767|536927460|FG001|Overall Study|Lost to Follow-up|0|||
148850561|NCT01001767|536927459|FG000|Overall Study|Physician Decision|1|||
148850562|NCT01001767|536927460|FG001|Overall Study|Physician Decision|0|||
148850563|NCT02584452|536927461|FG000|Overall Study|Physician Decision|1|||
148850564|NCT02584452|536927462|FG001|Overall Study|Physician Decision|1|||
148850565|NCT02584452|536927461|FG000|Overall Study|Lost to Follow-up|1|||
148850566|NCT02584452|536927462|FG001|Overall Study|Lost to Follow-up|1|||
148850567|NCT01107392|536927463|FG000|Overall Study|Adverse Event|2|||
148850568|NCT01107392|536927464|FG001|Overall Study|Adverse Event|0|||
148850569|NCT01107392|536927463|FG000|Overall Study|Personal Reasons|2|||
148850570|NCT01107392|536927464|FG001|Overall Study|Personal Reasons|3|||
148850571|NCT01107392|536927463|FG000|Overall Study|Administrative decision|1|||
148850572|NCT01107392|536927464|FG001|Overall Study|Administrative decision|0|||
148850573|NCT00851552|536927465|FG000|Overall Study|Death|2|||
148850574|NCT00851552|536927465|FG000|Overall Study|Adverse Event|1|||
148984958|NCT03251924|537421636|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
148984959|NCT03251924|537421637|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
148984960|NCT03251924|537421638|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
148850575|NCT00851552|536927465|FG000|Overall Study|Disease Progression|4|||
148850576|NCT00177294|536927466|FG000|Overall Study|Withdrawal by Subject|7|||
148850577|NCT00177294|536927467|FG001|Overall Study|Withdrawal by Subject|5|||
148850578|NCT01603043|536927468|FG000|Overall Study|Study Futility|7|||
148850579|NCT01603043|536927469|FG001|Overall Study|Study Futility|3|||
148850580|NCT04532294|536927470|FG000|Overall Study|Withdrawal by Subject|0|||
148850581|NCT04532294|536927471|FG001|Overall Study|Withdrawal by Subject|0|||
148850582|NCT04532294|536927472|FG002|Overall Study|Withdrawal by Subject|1|||
148850583|NCT04532294|536927470|FG000|Overall Study|Participants Not Dosed|0|||
148850584|NCT04532294|536927471|FG001|Overall Study|Participants Not Dosed|0|||
148850585|NCT04532294|536927472|FG002|Overall Study|Participants Not Dosed|2|||
148850586|NCT03089047|536927473|FG000|Overall Study|Lost to Follow-up|1|||
148850587|NCT03089047|536927474|FG001|Overall Study|Lost to Follow-up|0|||
148850588|NCT03599518|536927475|FG000|Overall Study|Clinical progression|0|||
148850589|NCT03599518|536927476|FG001|Overall Study|Clinical progression|0|||
148850590|NCT03599518|536927477|FG002|Overall Study|Clinical progression|0|||
148850591|NCT03599518|536927478|FG003|Overall Study|Clinical progression|0|||
148850592|NCT03599518|536927479|FG004|Overall Study|Clinical progression|1|||
148850593|NCT03599518|536927475|FG000|Overall Study|Adverse Event|0|||
148850594|NCT03599518|536927476|FG001|Overall Study|Adverse Event|0|||
148850595|NCT03599518|536927477|FG002|Overall Study|Adverse Event|0|||
148850596|NCT03599518|536927478|FG003|Overall Study|Adverse Event|0|||
148850597|NCT03599518|536927479|FG004|Overall Study|Adverse Event|1|||
148850598|NCT03599518|536927475|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
148850599|NCT03599518|536927476|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
148850600|NCT03599518|536927477|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
148850601|NCT03599518|536927478|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
148850602|NCT03599518|536927479|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
148850603|NCT03599518|536927475|FG000|Overall Study|Participant withdrawal from study treatment|0|||
148850604|NCT03599518|536927476|FG001|Overall Study|Participant withdrawal from study treatment|0|||
148850605|NCT03599518|536927477|FG002|Overall Study|Participant withdrawal from study treatment|1|||
148850606|NCT03599518|536927478|FG003|Overall Study|Participant withdrawal from study treatment|0|||
148850607|NCT03599518|536927479|FG004|Overall Study|Participant withdrawal from study treatment|0|||
148850608|NCT00375505|536927480|FG000|Overall Study|Adverse Event|1|||
148850609|NCT00375505|536927481|FG001|Overall Study|Adverse Event|2|||
148850610|NCT02146131|536927486|FG000|Overall Study|Physician Decision|61|||
148850611|NCT02146131|536927487|FG001|Overall Study|Physician Decision|56|||
148850612|NCT02567799|536927488|FG000|Concurrent Chemoradiotherapy|Death|1|||
148850613|NCT02567799|536927489|FG001|Concurrent Chemoradiotherapy|Death|0|||
148850614|NCT02567799|536927490|FG002|Concurrent Chemoradiotherapy|Death|0|||
148850615|NCT02567799|536927488|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
148850616|NCT02567799|536927489|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
148850617|NCT02567799|536927490|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
148850618|NCT02567799|536927488|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
148850619|NCT02567799|536927489|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
148850620|NCT02567799|536927490|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
148850621|NCT02567799|536927488|FG000|Follow-up|Death|1|||
148850622|NCT02567799|536927489|FG001|Follow-up|Death|0|||
148850623|NCT02567799|536927490|FG002|Follow-up|Death|1|||
148850624|NCT02567799|536927488|FG000|Follow-up|Progressive Disease|1|||
148850625|NCT02567799|536927489|FG001|Follow-up|Progressive Disease|1|||
148850626|NCT02567799|536927490|FG002|Follow-up|Progressive Disease|3|||
148850627|NCT04380753|536927493|FG000|Overall Study|Participants continuing study|4|||
148850628|NCT04380753|536927493|FG000|Overall Study|Death|2|||
148850629|NCT03306433|536927494|FG000|Overall Study|Lost to Follow-up|3|||
148850630|NCT03306433|536927494|FG000|Overall Study|Patient did not have teeth extracted|1|||
148850631|NCT03306433|536927494|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
148850632|NCT00819156|536927495|FG000|Overall Study|Adverse Event|1|||
148850633|NCT00819156|536927496|FG001|Overall Study|Adverse Event|4|||
148850634|NCT00819156|536927497|FG002|Overall Study|Adverse Event|2|||
148850635|NCT00819156|536927498|FG003|Overall Study|Adverse Event|1|||
148850636|NCT00819156|536927499|FG004|Overall Study|Adverse Event|2|||
148850637|NCT00819156|536927500|FG005|Overall Study|Adverse Event|3|||
148850638|NCT00819156|536927495|FG000|Overall Study|Withdrawal by Subject|0|||
148850639|NCT00819156|536927496|FG001|Overall Study|Withdrawal by Subject|3|||
148850640|NCT00819156|536927497|FG002|Overall Study|Withdrawal by Subject|2|||
148850641|NCT00819156|536927498|FG003|Overall Study|Withdrawal by Subject|0|||
148850642|NCT00819156|536927499|FG004|Overall Study|Withdrawal by Subject|1|||
148850643|NCT00819156|536927500|FG005|Overall Study|Withdrawal by Subject|0|||
148850644|NCT00819156|536927495|FG000|Overall Study|Protocol Violation|1|||
148850645|NCT00819156|536927496|FG001|Overall Study|Protocol Violation|0|||
148850646|NCT00819156|536927497|FG002|Overall Study|Protocol Violation|1|||
148850647|NCT00819156|536927498|FG003|Overall Study|Protocol Violation|0|||
148850648|NCT00819156|536927499|FG004|Overall Study|Protocol Violation|0|||
148850649|NCT00819156|536927500|FG005|Overall Study|Protocol Violation|1|||
148850650|NCT00819156|536927495|FG000|Overall Study|Lost to Follow-up|0|||
148850651|NCT00819156|536927496|FG001|Overall Study|Lost to Follow-up|1|||
148850652|NCT00819156|536927497|FG002|Overall Study|Lost to Follow-up|0|||
148850653|NCT00819156|536927498|FG003|Overall Study|Lost to Follow-up|0|||
148850654|NCT00819156|536927499|FG004|Overall Study|Lost to Follow-up|0|||
148850655|NCT00819156|536927500|FG005|Overall Study|Lost to Follow-up|2|||
148850656|NCT00819156|536927495|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
148850657|NCT00819156|536927496|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
148850658|NCT00819156|536927497|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
148850659|NCT00819156|536927498|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
149030165|NCT00320489|537587966|FG001|Overall Study|Lack of Efficacy|7|||
148850660|NCT00819156|536927499|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
148850661|NCT00819156|536927500|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
148850662|NCT00819156|536927495|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
148850663|NCT00819156|536927496|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
148850664|NCT00819156|536927497|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
148850665|NCT00819156|536927498|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
148850666|NCT00819156|536927499|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
148850667|NCT00819156|536927500|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
148850668|NCT00819156|536927495|FG000|Overall Study|Prostate-specific antigen progression|0|||
148850669|NCT00819156|536927496|FG001|Overall Study|Prostate-specific antigen progression|0|||
148850670|NCT00819156|536927497|FG002|Overall Study|Prostate-specific antigen progression|0|||
148850671|NCT00819156|536927498|FG003|Overall Study|Prostate-specific antigen progression|0|||
148850672|NCT00819156|536927499|FG004|Overall Study|Prostate-specific antigen progression|1|||
148850673|NCT00819156|536927500|FG005|Overall Study|Prostate-specific antigen progression|0|||
148850674|NCT01597908|536927501|FG000|Randomized Phase|Death|217|||
148850675|NCT01597908|536927502|FG001|Randomized Phase|Death|238|||
148850676|NCT01597908|536927503|FG002|Randomized Phase|Death|0|||
148850677|NCT01597908|536927501|FG000|Randomized Phase|Sponsor Decision|93|||
148850678|NCT01597908|536927502|FG001|Randomized Phase|Sponsor Decision|39|||
148850679|NCT01597908|536927503|FG002|Randomized Phase|Sponsor Decision|0|||
148850680|NCT01597908|536927501|FG000|Randomized Phase|Lost to Follow-up|9|||
148850681|NCT01597908|536927502|FG001|Randomized Phase|Lost to Follow-up|16|||
148850682|NCT01597908|536927503|FG002|Randomized Phase|Lost to Follow-up|0|||
148850683|NCT01597908|536927501|FG000|Randomized Phase|Physician Decision|6|||
148850684|NCT01597908|536927502|FG001|Randomized Phase|Physician Decision|3|||
148850685|NCT01597908|536927503|FG002|Randomized Phase|Physician Decision|0|||
148850686|NCT01597908|536927501|FG000|Randomized Phase|Withdrawal by Subject|26|||
148850687|NCT01597908|536927502|FG001|Randomized Phase|Withdrawal by Subject|22|||
148850688|NCT01597908|536927503|FG002|Randomized Phase|Withdrawal by Subject|0|||
148850689|NCT01597908|536927501|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
148850690|NCT01597908|536927502|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
148850691|NCT01597908|536927503|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
148850692|NCT01597908|536927501|FG000|Crossover Phase|Death|0|||
148850693|NCT01597908|536927502|FG001|Crossover Phase|Death|0|||
148850694|NCT01597908|536927503|FG002|Crossover Phase|Death|11|||
148850695|NCT01597908|536927501|FG000|Crossover Phase|Withdrawal by Subject|0|||
148850696|NCT01597908|536927502|FG001|Crossover Phase|Withdrawal by Subject|0|||
148850697|NCT01597908|536927503|FG002|Crossover Phase|Withdrawal by Subject|3|||
148850698|NCT01597908|536927501|FG000|Crossover Phase|Sponsor Decision|0|||
148850699|NCT01597908|536927502|FG001|Crossover Phase|Sponsor Decision|0|||
148850700|NCT01597908|536927503|FG002|Crossover Phase|Sponsor Decision|20|||
148850701|NCT02931838|536927504|FG000|Overall Study|Reason not provided by investigator|1|||
148850702|NCT02931838|536927505|FG001|Overall Study|Reason not provided by investigator|0|||
148850703|NCT02931838|536927506|FG002|Overall Study|Reason not provided by investigator|1|||
148850704|NCT02931838|536927507|FG003|Overall Study|Reason not provided by investigator|0|||
148850705|NCT02931838|536927508|FG004|Overall Study|Reason not provided by investigator|0|||
148850706|NCT02931838|536927509|FG005|Overall Study|Reason not provided by investigator|0|||
148850707|NCT02931838|536927504|FG000|Overall Study|Poor/non-compliance|0|||
148850708|NCT02931838|536927505|FG001|Overall Study|Poor/non-compliance|0|||
148850709|NCT02931838|536927506|FG002|Overall Study|Poor/non-compliance|1|||
148850710|NCT02931838|536927507|FG003|Overall Study|Poor/non-compliance|0|||
148850711|NCT02931838|536927508|FG004|Overall Study|Poor/non-compliance|0|||
148850712|NCT02931838|536927509|FG005|Overall Study|Poor/non-compliance|0|||
148850713|NCT02931838|536927504|FG000|Overall Study|Lack of Efficacy|5|||
148850714|NCT02931838|536927505|FG001|Overall Study|Lack of Efficacy|4|||
148850715|NCT02931838|536927506|FG002|Overall Study|Lack of Efficacy|0|||
148850716|NCT02931838|536927507|FG003|Overall Study|Lack of Efficacy|0|||
148850717|NCT02931838|536927508|FG004|Overall Study|Lack of Efficacy|0|||
148850718|NCT02931838|536927509|FG005|Overall Study|Lack of Efficacy|1|||
148984961|NCT03251924|537421639|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
148850719|NCT02931838|536927504|FG000|Overall Study|Lost to Follow-up|1|||
148850720|NCT02931838|536927505|FG001|Overall Study|Lost to Follow-up|0|||
148850721|NCT02931838|536927506|FG002|Overall Study|Lost to Follow-up|1|||
148984962|NCT03251924|537421640|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
148984963|NCT03251924|537421632|FG000|Overall Study|Death|0|||
148850722|NCT02931838|536927507|FG003|Overall Study|Lost to Follow-up|1|||
148850723|NCT02931838|536927508|FG004|Overall Study|Lost to Follow-up|2|||
148850724|NCT02931838|536927509|FG005|Overall Study|Lost to Follow-up|0|||
148850725|NCT02931838|536927504|FG000|Overall Study|Subject request to discontinue treatment|4|||
148850726|NCT02931838|536927505|FG001|Overall Study|Subject request to discontinue treatment|3|||
148850727|NCT02931838|536927506|FG002|Overall Study|Subject request to discontinue treatment|3|||
148850728|NCT02931838|536927507|FG003|Overall Study|Subject request to discontinue treatment|0|||
148850729|NCT02931838|536927508|FG004|Overall Study|Subject request to discontinue treatment|1|||
148850730|NCT02931838|536927509|FG005|Overall Study|Subject request to discontinue treatment|0|||
148984964|NCT03251924|537421633|FG001|Overall Study|Death|1|||
148850731|NCT02931838|536927504|FG000|Overall Study|Withdrawal by Subject|1|||
148850732|NCT02931838|536927505|FG001|Overall Study|Withdrawal by Subject|2|||
148850733|NCT02931838|536927506|FG002|Overall Study|Withdrawal by Subject|0|||
148850734|NCT02931838|536927507|FG003|Overall Study|Withdrawal by Subject|1|||
148850735|NCT02931838|536927508|FG004|Overall Study|Withdrawal by Subject|0|||
148850736|NCT02931838|536927509|FG005|Overall Study|Withdrawal by Subject|0|||
148850737|NCT02931838|536927504|FG000|Overall Study|Adverse Event|2|||
148850738|NCT02931838|536927505|FG001|Overall Study|Adverse Event|1|||
148850739|NCT02931838|536927506|FG002|Overall Study|Adverse Event|2|||
148850740|NCT02931838|536927507|FG003|Overall Study|Adverse Event|1|||
148850741|NCT02931838|536927508|FG004|Overall Study|Adverse Event|3|||
148850742|NCT02931838|536927509|FG005|Overall Study|Adverse Event|1|||
148850743|NCT00104728|536927510|FG000|Overall Study|screen failures|19|||
148850744|NCT02709577|536927511|FG000|Overall Study|non-accommodating anatomy|0|||
148850745|NCT02709577|536927512|FG001|Overall Study|non-accommodating anatomy|1|||
148850746|NCT02709577|536927513|FG002|Overall Study|non-accommodating anatomy|0|||
148850747|NCT02709577|536927514|FG003|Overall Study|non-accommodating anatomy|0|||
148850748|NCT02709577|536927511|FG000|Overall Study|procedural complication|0|||
148850749|NCT02709577|536927512|FG001|Overall Study|procedural complication|1|||
148850750|NCT02709577|536927513|FG002|Overall Study|procedural complication|0|||
148850751|NCT02709577|536927514|FG003|Overall Study|procedural complication|0|||
148850752|NCT02709577|536927511|FG000|Overall Study|Withdrawal by Subject|2|||
148850753|NCT02709577|536927512|FG001|Overall Study|Withdrawal by Subject|3|||
148850754|NCT02709577|536927513|FG002|Overall Study|Withdrawal by Subject|2|||
148850755|NCT02709577|536927514|FG003|Overall Study|Withdrawal by Subject|0|||
148850756|NCT01059864|536927515|FG000|Open-Label Run-In Phase|Adverse Event|7|||
148850757|NCT01059864|536927516|FG001|Open-Label Run-In Phase|Adverse Event|0|||
148850758|NCT01059864|536927517|FG002|Open-Label Run-In Phase|Adverse Event|0|||
148850759|NCT01059864|536927515|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
148850760|NCT01059864|536927516|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
148850761|NCT01059864|536927517|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
148850762|NCT01059864|536927515|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
148850763|NCT01059864|536927516|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
148850764|NCT01059864|536927517|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
148850765|NCT01059864|536927515|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
148984965|NCT03251924|537421634|FG002|Overall Study|Death|0|||
148984966|NCT03251924|537421635|FG003|Overall Study|Death|1|||
148984967|NCT03251924|537421636|FG004|Overall Study|Death|1|||
148984968|NCT03251924|537421637|FG005|Overall Study|Death|1|||
148984969|NCT03251924|537421638|FG006|Overall Study|Death|0|||
148984970|NCT03251924|537421639|FG007|Overall Study|Death|0|||
148984971|NCT03251924|537421640|FG008|Overall Study|Death|0|||
148984972|NCT03251924|537421632|FG000|Overall Study|Study Drug Toxicity|0|||
148984973|NCT03251924|537421633|FG001|Overall Study|Study Drug Toxicity|0|||
148984974|NCT03251924|537421634|FG002|Overall Study|Study Drug Toxicity|0|||
148984975|NCT03251924|537421635|FG003|Overall Study|Study Drug Toxicity|1|||
148984976|NCT03251924|537421636|FG004|Overall Study|Study Drug Toxicity|0|||
148984977|NCT03251924|537421637|FG005|Overall Study|Study Drug Toxicity|0|||
148984978|NCT03251924|537421638|FG006|Overall Study|Study Drug Toxicity|0|||
148984979|NCT03251924|537421639|FG007|Overall Study|Study Drug Toxicity|0|||
148984980|NCT03251924|537421640|FG008|Overall Study|Study Drug Toxicity|1|||
148984981|NCT03251924|537421632|FG000|Overall Study|Other Reasons|0|||
148984982|NCT03251924|537421633|FG001|Overall Study|Other Reasons|0|||
148984983|NCT03251924|537421634|FG002|Overall Study|Other Reasons|0|||
148984984|NCT03251924|537421635|FG003|Overall Study|Other Reasons|0|||
148984985|NCT03251924|537421636|FG004|Overall Study|Other Reasons|0|||
148984986|NCT03251924|537421637|FG005|Overall Study|Other Reasons|0|||
148984987|NCT03251924|537421638|FG006|Overall Study|Other Reasons|0|||
148850766|NCT01059864|536927516|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
148984988|NCT03251924|537421639|FG007|Overall Study|Other Reasons|0|||
148984989|NCT03251924|537421640|FG008|Overall Study|Other Reasons|1|||
148984990|NCT03251924|537421632|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149030166|NCT00320489|537587965|FG000|Overall Study|Lost to Follow-up|21|||
148850767|NCT01059864|536927517|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
148850768|NCT01059864|536927515|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
148850769|NCT01059864|536927516|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
148850770|NCT01059864|536927517|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
148850771|NCT01059864|536927515|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
148850772|NCT01059864|536927516|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
148984991|NCT03251924|537421633|FG001|Overall Study|Participant request to discontinue study treatment|0|||
148984992|NCT03251924|537421634|FG002|Overall Study|Participant request to discontinue study treatment|0|||
148984993|NCT03251924|537421635|FG003|Overall Study|Participant request to discontinue study treatment|0|||
148984994|NCT03251924|537421636|FG004|Overall Study|Participant request to discontinue study treatment|0|||
148984995|NCT03251924|537421637|FG005|Overall Study|Participant request to discontinue study treatment|0|||
148984996|NCT03251924|537421638|FG006|Overall Study|Participant request to discontinue study treatment|0|||
149030167|NCT00320489|537587966|FG001|Overall Study|Lost to Follow-up|22|||
148850773|NCT01059864|536927517|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
148850774|NCT02175277|536927518|FG000|Overall Study|Protocol-specified Criteria|1|||
148850775|NCT01519791|536928946|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
148850776|NCT01519791|536928947|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
148850777|NCT01519791|536928946|FG000|Overall Study|Protocol Violation|6|||
148850778|NCT01519791|536928947|FG001|Overall Study|Protocol Violation|19|||
148850779|NCT01519791|536928946|FG000|Overall Study|Other Reason|87|||
148850780|NCT01519791|536928947|FG001|Overall Study|Other Reason|222|||
148850781|NCT01519791|536928946|FG000|Overall Study|subjects randomized in error|2|||
148850782|NCT01519791|536928947|FG001|Overall Study|subjects randomized in error|0|||
148850783|NCT01519791|536928946|FG000|Overall Study|Lack of Efficacy|16|||
148850784|NCT01519791|536928947|FG001|Overall Study|Lack of Efficacy|20|||
148850785|NCT01519791|536928946|FG000|Overall Study|SAE, non-fatal|6|||
148850786|NCT01519791|536928947|FG001|Overall Study|SAE, non-fatal|22|||
148850787|NCT01519791|536928946|FG000|Overall Study|AE, serious fatal|0|||
148850788|NCT01519791|536928947|FG001|Overall Study|AE, serious fatal|1|||
148850789|NCT01519791|536928946|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
148850790|NCT01519791|536928947|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
148850791|NCT01519791|536928946|FG000|Overall Study|AE, non-serious non-fatal|12|||
148850792|NCT01519791|536928947|FG001|Overall Study|AE, non-serious non-fatal|31|||
148850793|NCT01519791|536928946|FG000|Overall Study|Withdrawal by Subject|15|||
148850794|NCT01519791|536928947|FG001|Overall Study|Withdrawal by Subject|37|||
148850795|NCT01519791|536928946|FG000|Overall Study|Lost to Follow-up|6|||
148850796|NCT01519791|536928947|FG001|Overall Study|Lost to Follow-up|14|||
148850797|NCT04551963|536928949|FG000|Overall Study|Physician Decision|1|||
148850798|NCT04551963|536928950|FG001|Overall Study|Physician Decision|1|||
148850799|NCT04551963|536928949|FG000|Overall Study|Death|1|||
148850800|NCT04551963|536928950|FG001|Overall Study|Death|0|||
148850801|NCT03850093|536928951|FG000|Overall Study|Withdrawal by Subject|1|||
148850802|NCT03850093|536928952|FG001|Overall Study|Withdrawal by Subject|0|||
148850803|NCT03850093|536928953|FG002|Overall Study|Withdrawal by Subject|2|||
148850804|NCT00588237|536928959|FG000|Overall Study|Evaluable for toxicity only|3|||
148850805|NCT00588237|536928959|FG000|Overall Study|Patien not treated|1|||
148984997|NCT03251924|537421639|FG007|Overall Study|Participant request to discontinue study treatment|1|||
148984998|NCT03251924|537421640|FG008|Overall Study|Participant request to discontinue study treatment|0|||
148984999|NCT00153101|537421641|FG000|Overall Study|Lost to Follow-up|14|||
148985000|NCT00153101|537421642|FG001|Overall Study|Lost to Follow-up|14|||
148985001|NCT00153101|537421643|FG002|Overall Study|Lost to Follow-up|12|||
148985002|NCT00153101|537421644|FG003|Overall Study|Lost to Follow-up|5|||
148985003|NCT00153101|537421645|FG004|Overall Study|Lost to Follow-up|5|||
148985004|NCT00153101|537421641|FG000|Overall Study|Withdrawal by Subject|3|||
148985005|NCT00153101|537421642|FG001|Overall Study|Withdrawal by Subject|4|||
148985006|NCT00153101|537421643|FG002|Overall Study|Withdrawal by Subject|3|||
148985007|NCT00153101|537421644|FG003|Overall Study|Withdrawal by Subject|3|||
148985008|NCT00153101|537421645|FG004|Overall Study|Withdrawal by Subject|5|||
148985009|NCT01440946|537421648|FG000|Overall Study|Lost to Follow-up|1|||
148985010|NCT01440946|537421649|FG001|Overall Study|Lost to Follow-up|1|||
148985011|NCT01440946|537421648|FG000|Overall Study|Physician Decision|1|||
148985012|NCT01440946|537421649|FG001|Overall Study|Physician Decision|0|||
148985013|NCT03299192|537421650|FG000|Overall Study|Fell before classes started|1|||
148985014|NCT03299192|537421651|FG001|Overall Study|Fell before classes started|0|||
148985015|NCT03299192|537421652|FG002|Overall Study|Fell before classes started|0|||
148985016|NCT03299192|537421650|FG000|Overall Study|Other|0|||
148985017|NCT03299192|537421651|FG001|Overall Study|Other|2|||
148985018|NCT03299192|537421652|FG002|Overall Study|Other|1|||
148985019|NCT00983580|537421654|FG000|Overall Study|Cancel Prior to treatment|1|||
148985020|NCT00983580|537421655|FG001|Overall Study|Cancel Prior to treatment|3|||
148985021|NCT00983580|537421654|FG000|Overall Study|Protocol Violation|1|||
148985022|NCT00983580|537421655|FG001|Overall Study|Protocol Violation|1|||
148850806|NCT01265563|536928961|FG000|Overall Study|Withdrawal by Subject|0|||
148850807|NCT01265563|536928962|FG001|Overall Study|Withdrawal by Subject|1|||
148850808|NCT01265563|536928963|FG002|Overall Study|Withdrawal by Subject|1|||
148850809|NCT01265563|536928964|FG003|Overall Study|Withdrawal by Subject|0|||
148850810|NCT01265563|536928965|FG004|Overall Study|Withdrawal by Subject|2|||
148850811|NCT03248531|536928972|FG000|Overall Study|Adverse Event|0|||
148850812|NCT03248531|536928973|FG001|Overall Study|Adverse Event|0|||
148985023|NCT00983580|537421654|FG000|Overall Study|Ineligible|3|||
148985024|NCT00983580|537421655|FG001|Overall Study|Ineligible|0|||
148985025|NCT05204134|537421659|FG000|Overall Study|Withdrawal by Subject|3|||
148985026|NCT05204134|537421659|FG000|Overall Study|Physician Decision|1|||
148985027|NCT02788175|537421660|FG000|Overall Study|Protocol Violation|3|||
148985028|NCT02788175|537421660|FG000|Overall Study|Withdrawal by Subject|4|||
148985029|NCT02788175|537421660|FG000|Overall Study|Ineligible prior to study agent|6|||
148985030|NCT00162136|537421661|FG000|Overall Study|Adverse Event|1|||
148985031|NCT00162136|537421661|FG000|Overall Study|Death|1|||
148985032|NCT00162136|537421661|FG000|Overall Study|Disease Progression/Relapse|23|||
148985033|NCT00162136|537421661|FG000|Overall Study|Investigator Request|5|||
148985034|NCT00162136|537421661|FG000|Overall Study|Study Drug Toxicity|4|||
149030168|NCT00320489|537587965|FG000|Overall Study|Physician Decision|8|||
149030169|NCT00320489|537587966|FG001|Overall Study|Physician Decision|8|||
149030170|NCT00320489|537587965|FG000|Overall Study|Protocol Violation|4|||
149030171|NCT00320489|537587966|FG001|Overall Study|Protocol Violation|4|||
149030172|NCT00320489|537587965|FG000|Overall Study|Sponsor Decision|3|||
149030173|NCT00320489|537587966|FG001|Overall Study|Sponsor Decision|3|||
149030174|NCT00320489|537587965|FG000|Overall Study|Withdrawal by Subject|39|||
149030175|NCT00320489|537587966|FG001|Overall Study|Withdrawal by Subject|41|||
149030176|NCT05650333|537587969|FG000|Treatment Period (7 Days)|Adverse Event|1|||
149030177|NCT03852433|537587972|FG000|Overall Study|Withdrawal of consent|5|||
149030178|NCT03852433|537587973|FG001|Overall Study|Withdrawal of consent|8|||
149030179|NCT03852433|537587974|FG002|Overall Study|Withdrawal of consent|1|||
149030180|NCT03852433|537587975|FG003|Overall Study|Withdrawal of consent|1|||
149030181|NCT03852433|537587972|FG000|Overall Study|Adverse Event|1|||
149030182|NCT03852433|537587973|FG001|Overall Study|Adverse Event|1|||
149030183|NCT03852433|537587974|FG002|Overall Study|Adverse Event|1|||
149030184|NCT03852433|537587975|FG003|Overall Study|Adverse Event|1|||
149030185|NCT03852433|537587972|FG000|Overall Study|Lost to Follow-up|0|||
149030186|NCT03852433|537587973|FG001|Overall Study|Lost to Follow-up|1|||
149030187|NCT03852433|537587974|FG002|Overall Study|Lost to Follow-up|0|||
149030188|NCT03852433|537587975|FG003|Overall Study|Lost to Follow-up|1|||
149030189|NCT03852433|537587972|FG000|Overall Study|Pregnancy|0|||
149030190|NCT03852433|537587973|FG001|Overall Study|Pregnancy|1|||
149030191|NCT03852433|537587974|FG002|Overall Study|Pregnancy|1|||
149030192|NCT03852433|537587975|FG003|Overall Study|Pregnancy|0|||
148850813|NCT03248531|536928974|FG002|Overall Study|Adverse Event|1|||
148850814|NCT03248531|536928972|FG000|Overall Study|Lost to Follow-up|1|||
148850815|NCT03248531|536928973|FG001|Overall Study|Lost to Follow-up|0|||
148850816|NCT03248531|536928974|FG002|Overall Study|Lost to Follow-up|5|||
148850817|NCT03248531|536928972|FG000|Overall Study|Withdrawal by Subject|3|||
148850818|NCT03248531|536928973|FG001|Overall Study|Withdrawal by Subject|3|||
148850819|NCT03248531|536928974|FG002|Overall Study|Withdrawal by Subject|2|||
148850820|NCT03248531|536928972|FG000|Overall Study|Sponsor Request|0|||
148850821|NCT03248531|536928973|FG001|Overall Study|Sponsor Request|2|||
148850822|NCT03248531|536928974|FG002|Overall Study|Sponsor Request|0|||
148850823|NCT04908865|536928975|FG000|Overall Study|Adverse Event|2|||
148850824|NCT04908865|536928975|FG000|Overall Study|Lack of Efficacy|5|||
148850825|NCT04908865|536928975|FG000|Overall Study|Lost to Follow-up|1|||
148850826|NCT01524224|536928978|FG000|Overall Study|Progressive Disease|1|||
148850827|NCT01524224|536928979|FG001|Overall Study|Progressive Disease|0|||
148850828|NCT01524224|536928980|FG002|Overall Study|Progressive Disease|2|||
148850829|NCT01524224|536928981|FG003|Overall Study|Progressive Disease|1|||
148850830|NCT01524224|536928982|FG004|Overall Study|Progressive Disease|2|||
148850831|NCT01524224|536928983|FG005|Overall Study|Progressive Disease|1|||
148850832|NCT01524224|536928984|FG006|Overall Study|Progressive Disease|1|||
148850833|NCT01524224|536928985|FG007|Overall Study|Progressive Disease|5|||
148850834|NCT01524224|536928978|FG000|Overall Study|Withdrawal by Subject|2|||
148850835|NCT01524224|536928979|FG001|Overall Study|Withdrawal by Subject|0|||
148850836|NCT01524224|536928980|FG002|Overall Study|Withdrawal by Subject|0|||
148850837|NCT01524224|536928981|FG003|Overall Study|Withdrawal by Subject|0|||
148850838|NCT01524224|536928982|FG004|Overall Study|Withdrawal by Subject|0|||
148850839|NCT01524224|536928983|FG005|Overall Study|Withdrawal by Subject|0|||
148850840|NCT01524224|536928984|FG006|Overall Study|Withdrawal by Subject|2|||
148850841|NCT01524224|536928985|FG007|Overall Study|Withdrawal by Subject|0|||
148850842|NCT01524224|536928978|FG000|Overall Study|Adverse Event|0|||
148850843|NCT01524224|536928979|FG001|Overall Study|Adverse Event|1|||
148850844|NCT01524224|536928980|FG002|Overall Study|Adverse Event|0|||
148850845|NCT01524224|536928981|FG003|Overall Study|Adverse Event|0|||
148850846|NCT01524224|536928982|FG004|Overall Study|Adverse Event|0|||
148850847|NCT01524224|536928983|FG005|Overall Study|Adverse Event|1|||
148850848|NCT01524224|536928984|FG006|Overall Study|Adverse Event|0|||
149030193|NCT03852433|537587972|FG000|Overall Study|Protocol Violation|0|||
149030194|NCT03852433|537587973|FG001|Overall Study|Protocol Violation|0|||
149030195|NCT03852433|537587974|FG002|Overall Study|Protocol Violation|1|||
148850849|NCT01524224|536928985|FG007|Overall Study|Adverse Event|0|||
148850850|NCT01524224|536928978|FG000|Overall Study|Physician Decision|0|||
148850851|NCT01524224|536928979|FG001|Overall Study|Physician Decision|0|||
148850852|NCT01524224|536928980|FG002|Overall Study|Physician Decision|0|||
148850853|NCT01524224|536928981|FG003|Overall Study|Physician Decision|1|||
148850854|NCT01524224|536928982|FG004|Overall Study|Physician Decision|1|||
148850855|NCT01524224|536928983|FG005|Overall Study|Physician Decision|0|||
148850856|NCT01524224|536928984|FG006|Overall Study|Physician Decision|0|||
148850857|NCT01524224|536928985|FG007|Overall Study|Physician Decision|1|||
148850858|NCT01524224|536928978|FG000|Overall Study|Sponsor Decision|0|||
148850859|NCT01524224|536928979|FG001|Overall Study|Sponsor Decision|0|||
148850860|NCT01524224|536928980|FG002|Overall Study|Sponsor Decision|0|||
149030196|NCT03852433|537587975|FG003|Overall Study|Protocol Violation|1|||
149030197|NCT03852433|537587972|FG000|Overall Study|Death|0|||
149030198|NCT03852433|537587973|FG001|Overall Study|Death|0|||
149030199|NCT03852433|537587974|FG002|Overall Study|Death|1|||
148850861|NCT01524224|536928981|FG003|Overall Study|Sponsor Decision|0|||
148850862|NCT01524224|536928982|FG004|Overall Study|Sponsor Decision|1|||
148850863|NCT01524224|536928983|FG005|Overall Study|Sponsor Decision|0|||
148850864|NCT01524224|536928984|FG006|Overall Study|Sponsor Decision|0|||
148850865|NCT01524224|536928985|FG007|Overall Study|Sponsor Decision|0|||
148850866|NCT03517371|536928988|FG000|Overall Study|Adverse Event|8|||
148850867|NCT03517371|536928989|FG001|Overall Study|Adverse Event|9|||
148850868|NCT03517371|536928988|FG000|Overall Study|Lost to Follow-up|1|||
148850869|NCT03517371|536928989|FG001|Overall Study|Lost to Follow-up|2|||
148850870|NCT03517371|536928988|FG000|Overall Study|Withdrawal by Subject|4|||
148850871|NCT03517371|536928989|FG001|Overall Study|Withdrawal by Subject|4|||
148850872|NCT03517371|536928988|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
148850873|NCT03517371|536928989|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
148850874|NCT03517371|536928988|FG000|Overall Study|COVID restrictions|2|||
148850875|NCT03517371|536928989|FG001|Overall Study|COVID restrictions|0|||
148850876|NCT03517371|536928988|FG000|Overall Study|Receiving DBS Surgery|0|||
148850877|NCT03517371|536928989|FG001|Overall Study|Receiving DBS Surgery|1|||
148850878|NCT05411822|536928990|FG000|Overall Study|Withdrawal by Subject|2|||
148850879|NCT05411822|536928991|FG001|Overall Study|Withdrawal by Subject|1|||
148850880|NCT05312697|536928992|FG000|Overall Study|Sponsor Terminated Trial|2|||
148850881|NCT04283656|536928993|FG000|Overall Study|Adverse Event|1|||
148850882|NCT04283656|536928994|FG001|Overall Study|Adverse Event|0|||
148850883|NCT04283656|536928993|FG000|Overall Study|Lost to Follow-up|0|||
148850884|NCT04283656|536928994|FG001|Overall Study|Lost to Follow-up|1|||
148850885|NCT02318368|536928995|FG000|Overall Study|Withdrawal by Subject|2|||
148850886|NCT02318368|536928996|FG001|Overall Study|Withdrawal by Subject|0|||
148850887|NCT02318368|536928995|FG000|Overall Study|Study terminated by the sponsor|5|||
148850888|NCT02318368|536928996|FG001|Overall Study|Study terminated by the sponsor|2|||
148850889|NCT02318368|536928995|FG000|Overall Study|Death|0|||
148850890|NCT02318368|536928996|FG001|Overall Study|Death|1|||
148850891|NCT01901614|536928997|FG000|Overall Study|Adverse Event|0|||
148850892|NCT01901614|536928998|FG001|Overall Study|Adverse Event|1|||
148850893|NCT01901614|536928997|FG000|Overall Study|Lost to Follow-up|1|||
148850894|NCT01901614|536928998|FG001|Overall Study|Lost to Follow-up|0|||
148850895|NCT01901614|536928997|FG000|Overall Study|Screen Fail|1|||
148850896|NCT01901614|536928998|FG001|Overall Study|Screen Fail|0|||
148850897|NCT03629223|536928999|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
148850898|NCT03629223|536929000|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
148850899|NCT03629223|536929001|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
148850900|NCT03629223|536929002|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
148850901|NCT03629223|536929003|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
148850902|NCT03629223|536929004|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
148850903|NCT03629223|536928999|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
148850904|NCT03629223|536929000|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
148850905|NCT03629223|536929001|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
148850906|NCT03629223|536929002|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
148850907|NCT03629223|536929003|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
148850908|NCT03629223|536929004|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
148850909|NCT03629223|536928999|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
148850910|NCT03629223|536929000|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
148850911|NCT03629223|536929001|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
148850912|NCT03629223|536929002|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
148850913|NCT03629223|536929003|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
148850914|NCT03629223|536929004|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
148850915|NCT03629223|536928999|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
148850916|NCT03629223|536929000|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
148850917|NCT03629223|536929001|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
148850918|NCT03629223|536929002|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
148850919|NCT03629223|536929003|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
148850920|NCT03629223|536929004|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
148850921|NCT03629223|536928999|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
148850922|NCT03629223|536929000|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
148850923|NCT03629223|536929001|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
148850924|NCT03629223|536929002|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
148985035|NCT00162136|537421661|FG000|Overall Study|Withdrawal by Subject|1|||
148850925|NCT03629223|536929003|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
148850926|NCT03629223|536929004|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
148850927|NCT02674464|536929005|FG000|Overall Study|Death|10|||
148850928|NCT02674464|536929006|FG001|Overall Study|Death|21|||
148985036|NCT00818441|537421662|FG000|Overall Study|Death|69|||
148850929|NCT02674464|536929005|FG000|Overall Study|Withdrawal by Subject|24|||
148850930|NCT02674464|536929006|FG001|Overall Study|Withdrawal by Subject|44|||
148850931|NCT02674464|536929005|FG000|Overall Study|Lost to Follow-up|97|||
148985037|NCT00818441|537421663|FG001|Overall Study|Death|26|||
148850932|NCT02674464|536929006|FG001|Overall Study|Lost to Follow-up|92|||
148850933|NCT02674464|536929005|FG000|Overall Study|Outside survey window|6|||
148850934|NCT02674464|536929006|FG001|Overall Study|Outside survey window|3|||
148850935|NCT00783835|536929007|FG000|Overall Study|Adverse Event|3|||
148850936|NCT00783835|536929007|FG000|Overall Study|Medical Criteria|1|||
148850937|NCT00783835|536929007|FG000|Overall Study|Withdrawal by Subject|2|||
148850938|NCT00783835|536929007|FG000|Overall Study|Lost to Follow-up|1|||
148850939|NCT00783835|536929007|FG000|Overall Study|Participant not Adherent|3|||
148850940|NCT01555073|536929008|FG000|Overall Study|Lost to Follow-up|1|||
148850941|NCT01555073|536929009|FG001|Overall Study|Lost to Follow-up|2|||
148850942|NCT01555073|536929010|FG002|Overall Study|Lost to Follow-up|0|||
148850943|NCT01555073|536929011|FG003|Overall Study|Lost to Follow-up|5|||
148850944|NCT01071252|536929014|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
148850945|NCT01071252|536929015|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
148850946|NCT01071252|536929016|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
148850947|NCT01071252|536929017|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
148850948|NCT01071252|536929018|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
148850949|NCT01071252|536929014|FG000|Overall Study|Withdrawal by Subject|8|||
148850950|NCT01071252|536929015|FG001|Overall Study|Withdrawal by Subject|2|||
148850951|NCT01071252|536929016|FG002|Overall Study|Withdrawal by Subject|1|||
148850952|NCT01071252|536929017|FG003|Overall Study|Withdrawal by Subject|2|||
148850953|NCT01071252|536929018|FG004|Overall Study|Withdrawal by Subject|3|||
148850954|NCT01071252|536929014|FG000|Overall Study|administrative problems|1|||
148850955|NCT01071252|536929015|FG001|Overall Study|administrative problems|1|||
148850956|NCT01071252|536929016|FG002|Overall Study|administrative problems|0|||
148850957|NCT01071252|536929017|FG003|Overall Study|administrative problems|2|||
148850958|NCT01071252|536929018|FG004|Overall Study|administrative problems|1|||
148850959|NCT01071252|536929014|FG000|Overall Study|Lost to Follow-up|1|||
148850960|NCT01071252|536929015|FG001|Overall Study|Lost to Follow-up|0|||
148850961|NCT01071252|536929016|FG002|Overall Study|Lost to Follow-up|1|||
148850962|NCT01071252|536929017|FG003|Overall Study|Lost to Follow-up|2|||
148850963|NCT01071252|536929018|FG004|Overall Study|Lost to Follow-up|0|||
148850964|NCT01071252|536929014|FG000|Overall Study|Adverse Event|1|||
148850965|NCT01071252|536929015|FG001|Overall Study|Adverse Event|1|||
148850966|NCT01071252|536929016|FG002|Overall Study|Adverse Event|0|||
148850967|NCT01071252|536929017|FG003|Overall Study|Adverse Event|1|||
148850968|NCT01071252|536929018|FG004|Overall Study|Adverse Event|0|||
148850969|NCT01071252|536929014|FG000|Overall Study|Death|0|||
148850970|NCT01071252|536929015|FG001|Overall Study|Death|0|||
148850971|NCT01071252|536929016|FG002|Overall Study|Death|0|||
148850972|NCT01071252|536929017|FG003|Overall Study|Death|0|||
148850973|NCT01071252|536929018|FG004|Overall Study|Death|1|||
148850974|NCT01066104|536929019|FG000|Overall Study|Adverse Event|1|||
148850975|NCT01066104|536929020|FG001|Overall Study|Adverse Event|1|||
148850976|NCT01066104|536929019|FG000|Overall Study|Protocol Violation|1|||
148850977|NCT01066104|536929020|FG001|Overall Study|Protocol Violation|0|||
148850978|NCT02038946|536929027|FG000|Overall Study|Death|5|||
148850979|NCT02038946|536929027|FG000|Overall Study|Withdrawal by Subject|3|||
148850980|NCT02038946|536929027|FG000|Overall Study|Lost to Follow-up|2|||
148850981|NCT02038946|536929027|FG000|Overall Study|Other reasons|2|||
148850982|NCT01558596|536929028|FG000|Overall Study|Withdrawal by Subject|1|||
148850983|NCT01558596|536929029|FG001|Overall Study|Withdrawal by Subject|0|||
148850984|NCT01558596|536929028|FG000|Overall Study|surgery elsewhere or cancelled|1|||
148850985|NCT01558596|536929029|FG001|Overall Study|surgery elsewhere or cancelled|1|||
148850986|NCT01558596|536929028|FG000|Overall Study|Protocol Violation|1|||
148776728|NCT01472757|536656876|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
148776729|NCT01472757|536656877|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
148776730|NCT01472757|536656878|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
148776731|NCT01472757|536656879|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
148776732|NCT01472757|536656876|FG000|Overall Study|Protocol Violation|3|||
148776733|NCT01472757|536656877|FG001|Overall Study|Protocol Violation|2|||
148776734|NCT01472757|536656878|FG002|Overall Study|Protocol Violation|4|||
148776735|NCT01472757|536656879|FG003|Overall Study|Protocol Violation|4|||
148776736|NCT01472757|536656876|FG000|Overall Study|Other reasons|1|||
148776737|NCT01472757|536656877|FG001|Overall Study|Other reasons|0|||
148776738|NCT01472757|536656878|FG002|Overall Study|Other reasons|2|||
148776739|NCT01472757|536656879|FG003|Overall Study|Other reasons|2|||
148776740|NCT04489381|536656884|FG000|Overall Study|Lost to Follow-up|2|||
148776741|NCT04489381|536656885|FG001|Overall Study|Lost to Follow-up|3|||
148776742|NCT04489381|536656884|FG000|Overall Study|Withdrawal by Subject|1|||
148776743|NCT04489381|536656885|FG001|Overall Study|Withdrawal by Subject|0|||
148776744|NCT02505334|536656888|FG000|Main Treatment Period|Adverse Event|3|||
148776745|NCT02505334|536656889|FG001|Main Treatment Period|Adverse Event|3|||
148850987|NCT01558596|536929029|FG001|Overall Study|Protocol Violation|0|||
148850988|NCT01916824|536929034|FG000|Overall Study|Lost to Follow-up|3|||
148776746|NCT02505334|536656888|FG000|Main Treatment Period|Lack of Efficacy|7|||
148850989|NCT01916824|536929035|FG001|Overall Study|Lost to Follow-up|6|||
148850990|NCT01916824|536929034|FG000|Overall Study|Physician Decision|2|||
148850991|NCT01916824|536929035|FG001|Overall Study|Physician Decision|0|||
148850992|NCT01916824|536929034|FG000|Overall Study|Withdrawal by Subject|2|||
148850993|NCT01916824|536929035|FG001|Overall Study|Withdrawal by Subject|3|||
148850994|NCT00771927|536929038|FG000|Overall Study|Adverse Event|100|||
148985038|NCT00818441|537421662|FG000|Overall Study|Other|5|||
148985039|NCT00818441|537421663|FG001|Overall Study|Other|0|||
148985040|NCT00818441|537421662|FG000|Overall Study|Lost to Follow-up|2|||
148985041|NCT00818441|537421663|FG001|Overall Study|Lost to Follow-up|1|||
148985042|NCT00818441|537421662|FG000|Overall Study|Withdrawal by Subject|2|||
148985043|NCT00818441|537421663|FG001|Overall Study|Withdrawal by Subject|0|||
148985044|NCT00818441|537421662|FG000|Overall Study|Adverse Event|0|||
148985045|NCT00818441|537421663|FG001|Overall Study|Adverse Event|1|||
148985046|NCT00818441|537421662|FG000|Overall Study|Study terminated by sponsor|11|||
148985047|NCT00818441|537421663|FG001|Overall Study|Study terminated by sponsor|2|||
148985048|NCT01075321|537423208|FG000|Overall Study|Withdrawal by Subject|0|||
148985049|NCT01075321|537423209|FG001|Overall Study|Withdrawal by Subject|0|||
148985050|NCT01075321|537423210|FG002|Overall Study|Withdrawal by Subject|1|||
148985051|NCT01075321|537423211|FG003|Overall Study|Withdrawal by Subject|1|||
148985052|NCT01075321|537423208|FG000|Overall Study|Protocol Violation|0|||
148985053|NCT01075321|537423209|FG001|Overall Study|Protocol Violation|0|||
148985054|NCT01075321|537423210|FG002|Overall Study|Protocol Violation|1|||
148985055|NCT01075321|537423211|FG003|Overall Study|Protocol Violation|0|||
148985056|NCT01075321|537423208|FG000|Overall Study|Treatment Incomplete due to progression|1|||
148985057|NCT01075321|537423209|FG001|Overall Study|Treatment Incomplete due to progression|0|||
148985058|NCT01075321|537423210|FG002|Overall Study|Treatment Incomplete due to progression|0|||
148985059|NCT01075321|537423211|FG003|Overall Study|Treatment Incomplete due to progression|0|||
148985060|NCT01075321|537423208|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
148985061|NCT01075321|537423209|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
148985062|NCT01075321|537423210|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
148985063|NCT01075321|537423211|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
148985064|NCT00003457|537423214|FG000|Overall Study|Not evaluable|9|||
148985065|NCT02246998|537423215|FG000|Overall Study|Adverse Event|0|||
148985066|NCT02246998|537423216|FG001|Overall Study|Adverse Event|1|||
148850995|NCT00771927|536929039|FG001|Overall Study|Adverse Event|105|||
148850996|NCT00771927|536929038|FG000|Overall Study|Lack of Efficacy|70|||
148850997|NCT00771927|536929039|FG001|Overall Study|Lack of Efficacy|42|||
148850998|NCT00771927|536929038|FG000|Overall Study|Lost to Follow-up|46|||
148850999|NCT00771927|536929039|FG001|Overall Study|Lost to Follow-up|46|||
148851000|NCT00771927|536929038|FG000|Overall Study|Withdrawal by Subject|16|||
148851001|NCT00771927|536929039|FG001|Overall Study|Withdrawal by Subject|17|||
148851002|NCT00771927|536929038|FG000|Overall Study|Other reason|23|||
148851003|NCT00771927|536929039|FG001|Overall Study|Other reason|27|||
148851004|NCT03835481|536929040|FG000|Double-blind Period|Other not stated below|0|||
148851005|NCT03835481|536929041|FG001|Double-blind Period|Other not stated below|0|||
148851006|NCT03835481|536929042|FG002|Double-blind Period|Other not stated below|0|||
148851007|NCT03835481|536929043|FG003|Double-blind Period|Other not stated below|1|||
148851008|NCT03835481|536929044|FG004|Double-blind Period|Other not stated below|1|||
148851009|NCT03835481|536929040|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
148851010|NCT03835481|536929041|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
148851011|NCT03835481|536929042|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
148851012|NCT03835481|536929043|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
148851013|NCT03835481|536929044|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
148851014|NCT03835481|536929040|FG000|Double-blind Period|Withdrawal by Subject|0|||
148851015|NCT03835481|536929041|FG001|Double-blind Period|Withdrawal by Subject|0|||
148851016|NCT03835481|536929042|FG002|Double-blind Period|Withdrawal by Subject|1|||
148851017|NCT03835481|536929043|FG003|Double-blind Period|Withdrawal by Subject|0|||
148851018|NCT03835481|536929044|FG004|Double-blind Period|Withdrawal by Subject|5|||
148851019|NCT03835481|536929040|FG000|Double-blind Period|Lost to Follow-up|0|||
148851020|NCT03835481|536929041|FG001|Double-blind Period|Lost to Follow-up|0|||
148851021|NCT03835481|536929042|FG002|Double-blind Period|Lost to Follow-up|0|||
148851022|NCT03835481|536929043|FG003|Double-blind Period|Lost to Follow-up|1|||
148851023|NCT03835481|536929044|FG004|Double-blind Period|Lost to Follow-up|0|||
148851024|NCT03835481|536929040|FG000|Double-blind Period|Protocol Violation|0|||
148851025|NCT03835481|536929041|FG001|Double-blind Period|Protocol Violation|2|||
148851026|NCT03835481|536929042|FG002|Double-blind Period|Protocol Violation|0|||
148985067|NCT02246998|537423217|FG002|Overall Study|Adverse Event|1|||
148985068|NCT02246998|537423218|FG003|Overall Study|Adverse Event|0|||
148985069|NCT02246998|537423215|FG000|Overall Study|Lost to Follow-up|1|||
148985070|NCT02246998|537423216|FG001|Overall Study|Lost to Follow-up|0|||
148985071|NCT02246998|537423217|FG002|Overall Study|Lost to Follow-up|0|||
148985072|NCT02246998|537423218|FG003|Overall Study|Lost to Follow-up|1|||
148985073|NCT02246998|537423215|FG000|Overall Study|Randomized but Never Dosed|1|||
148985074|NCT02246998|537423216|FG001|Overall Study|Randomized but Never Dosed|2|||
148985075|NCT02246998|537423217|FG002|Overall Study|Randomized but Never Dosed|2|||
148985076|NCT02246998|537423218|FG003|Overall Study|Randomized but Never Dosed|1|||
148851027|NCT03835481|536929043|FG003|Double-blind Period|Protocol Violation|1|||
148851028|NCT03835481|536929044|FG004|Double-blind Period|Protocol Violation|0|||
148851029|NCT03835481|536929040|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
148851030|NCT03835481|536929041|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
148851031|NCT03835481|536929042|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
148851032|NCT03835481|536929043|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
148851033|NCT03835481|536929044|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
148851034|NCT03835481|536929040|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
148851035|NCT03835481|536929041|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
148851036|NCT03835481|536929042|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
148851037|NCT03835481|536929043|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
148851038|NCT03835481|536929044|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
148851039|NCT03835481|536929040|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
148851040|NCT03835481|536929041|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
148851041|NCT03835481|536929042|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
148851042|NCT03835481|536929043|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
148851043|NCT03835481|536929044|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
148851044|NCT03835481|536929040|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
148851045|NCT03835481|536929041|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
148851046|NCT03835481|536929042|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
148851047|NCT03835481|536929043|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
148851048|NCT03835481|536929044|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
148851049|NCT03835481|536929040|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
148851050|NCT03835481|536929041|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
148851051|NCT03835481|536929042|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
148851052|NCT03835481|536929043|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
148851053|NCT03835481|536929044|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
148851054|NCT03835481|536929040|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
148851055|NCT03835481|536929041|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
148851056|NCT03835481|536929042|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
148851057|NCT03835481|536929043|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
148851058|NCT03835481|536929044|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
148851059|NCT01270880|536929051|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
148851060|NCT01221753|536929058|FG000|Overall Study|Adverse Event|1|||
148851061|NCT04552288|536929060|FG000|Overall Study|Death|3|||
148851062|NCT04552288|536929060|FG000|Overall Study|Lost to Follow-up|6|||
148851063|NCT04552288|536929060|FG000|Overall Study|Physician Decision|3|||
148985077|NCT02473614|537423219|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
148985078|NCT02473614|537423220|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
148985079|NCT01659021|537423224|FG000|Main Study|Adverse Event|2|||
148985080|NCT01659021|537423225|FG001|Main Study|Adverse Event|3|||
148985081|NCT01659021|537423224|FG000|Main Study|Lost to Follow-up|1|||
148985082|NCT01659021|537423225|FG001|Main Study|Lost to Follow-up|0|||
148985083|NCT01659021|537423224|FG000|Main Study|Unknown Reasons|2|||
148985084|NCT01659021|537423225|FG001|Main Study|Unknown Reasons|1|||
148985085|NCT01659021|537423224|FG000|Main Study|Physician Decision|34|||
148985086|NCT01659021|537423225|FG001|Main Study|Physician Decision|16|||
148985087|NCT01659021|537423224|FG000|Main Study|Withdrawal by Subject|19|||
148985088|NCT01659021|537423225|FG001|Main Study|Withdrawal by Subject|16|||
148985089|NCT01659021|537423224|FG000|Main Study|Study Terminated by Sponsor|16|||
148985090|NCT01659021|537423225|FG001|Main Study|Study Terminated by Sponsor|1|||
148985091|NCT01659021|537423224|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
148985092|NCT01659021|537423225|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
148985093|NCT01659021|537423224|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
148985094|NCT01659021|537423225|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
149030200|NCT03852433|537587975|FG003|Overall Study|Death|0|||
148851064|NCT04552288|536929060|FG000|Overall Study|Protocol Violation|9|||
148851065|NCT04552288|536929060|FG000|Overall Study|Withdrawal by Subject|6|||
148851066|NCT04552288|536929060|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
148851067|NCT03583359|536929061|FG000|Overall Study|Withdrawal by Subject|15|||
148851068|NCT03583359|536929062|FG001|Overall Study|Withdrawal by Subject|6|||
148851069|NCT03583359|536929061|FG000|Overall Study|Lost to Follow-up|12|||
148851070|NCT03583359|536929062|FG001|Overall Study|Lost to Follow-up|3|||
148851071|NCT03583359|536929061|FG000|Overall Study|Adverse Event|0|||
148985095|NCT03936244|537423226|FG000|Overall Study|Lost to Follow-up|5|||
148985096|NCT03936244|537423227|FG001|Overall Study|Lost to Follow-up|1|||
148985097|NCT03936244|537423226|FG000|Overall Study|Physician Decision|7|||
148985098|NCT03936244|537423227|FG001|Overall Study|Physician Decision|3|||
148985099|NCT01114646|537423228|FG000|Overall Study|Withdrawal by Subject|3|||
148985100|NCT01114646|537423229|FG001|Overall Study|Withdrawal by Subject|2|||
148851072|NCT03583359|536929062|FG001|Overall Study|Adverse Event|1|||
148851073|NCT03583359|536929061|FG000|Overall Study|Protocol Violation|0|||
148851074|NCT03583359|536929062|FG001|Overall Study|Protocol Violation|1|||
148851075|NCT03583359|536929061|FG000|Overall Study|Other|2|||
148851076|NCT03583359|536929062|FG001|Overall Study|Other|1|||
148851077|NCT01831466|536929068|FG000|Overall Study|Protocol Violation|1|||
148851078|NCT01831466|536929069|FG001|Overall Study|Protocol Violation|1|||
148851079|NCT01831466|536929070|FG002|Overall Study|Protocol Violation|2|||
148851080|NCT01831466|536929071|FG003|Overall Study|Protocol Violation|0|||
148851081|NCT01831466|536929072|FG004|Overall Study|Protocol Violation|0|||
148851082|NCT01831466|536929073|FG005|Overall Study|Protocol Violation|1|||
148851083|NCT01831466|536929074|FG006|Overall Study|Protocol Violation|0|||
148851084|NCT01831466|536929075|FG007|Overall Study|Protocol Violation|0|||
148851085|NCT01831466|536929076|FG008|Overall Study|Protocol Violation|0|||
148851086|NCT01831466|536929077|FG009|Overall Study|Protocol Violation|0|||
148851087|NCT01831466|536929078|FG010|Overall Study|Protocol Violation|0|||
148851088|NCT01831466|536929079|FG011|Overall Study|Protocol Violation|0|||
148851089|NCT01831466|536929068|FG000|Overall Study|Other|2|||
148851090|NCT01831466|536929069|FG001|Overall Study|Other|3|||
148851091|NCT01831466|536929070|FG002|Overall Study|Other|2|||
148851092|NCT01831466|536929071|FG003|Overall Study|Other|2|||
148851093|NCT01831466|536929072|FG004|Overall Study|Other|2|||
148851094|NCT01831466|536929073|FG005|Overall Study|Other|1|||
148851095|NCT01831466|536929074|FG006|Overall Study|Other|0|||
148851096|NCT01831466|536929075|FG007|Overall Study|Other|0|||
148851097|NCT01831466|536929076|FG008|Overall Study|Other|0|||
148851098|NCT01831466|536929077|FG009|Overall Study|Other|0|||
148851099|NCT01831466|536929078|FG010|Overall Study|Other|0|||
148851100|NCT01831466|536929079|FG011|Overall Study|Other|0|||
148851101|NCT01831466|536929068|FG000|Overall Study|Non-compliance with study treatment|2|||
148851102|NCT01831466|536929069|FG001|Overall Study|Non-compliance with study treatment|1|||
148851103|NCT01831466|536929070|FG002|Overall Study|Non-compliance with study treatment|1|||
148851104|NCT01831466|536929071|FG003|Overall Study|Non-compliance with study treatment|0|||
148851105|NCT01831466|536929072|FG004|Overall Study|Non-compliance with study treatment|0|||
148851106|NCT01831466|536929073|FG005|Overall Study|Non-compliance with study treatment|1|||
148851107|NCT01831466|536929074|FG006|Overall Study|Non-compliance with study treatment|0|||
148851108|NCT01831466|536929075|FG007|Overall Study|Non-compliance with study treatment|0|||
148851109|NCT01831466|536929076|FG008|Overall Study|Non-compliance with study treatment|0|||
148851110|NCT01831466|536929077|FG009|Overall Study|Non-compliance with study treatment|0|||
148851111|NCT01831466|536929078|FG010|Overall Study|Non-compliance with study treatment|0|||
148851112|NCT01831466|536929079|FG011|Overall Study|Non-compliance with study treatment|0|||
148851113|NCT01831466|536929068|FG000|Overall Study|Death|0|||
148851114|NCT01831466|536929069|FG001|Overall Study|Death|1|||
148851115|NCT01831466|536929070|FG002|Overall Study|Death|0|||
148851116|NCT01831466|536929071|FG003|Overall Study|Death|0|||
148851117|NCT01831466|536929072|FG004|Overall Study|Death|0|||
148851118|NCT01831466|536929073|FG005|Overall Study|Death|0|||
148851119|NCT01831466|536929074|FG006|Overall Study|Death|0|||
148851120|NCT01831466|536929075|FG007|Overall Study|Death|0|||
148851121|NCT01831466|536929076|FG008|Overall Study|Death|0|||
148851122|NCT01831466|536929077|FG009|Overall Study|Death|0|||
148851123|NCT01831466|536929078|FG010|Overall Study|Death|0|||
148985101|NCT01202773|537423234|FG000|Overall Study|Adverse Event|4|||
148851124|NCT01831466|536929079|FG011|Overall Study|Death|0|||
148851125|NCT01831466|536929068|FG000|Overall Study|Withdrawal by Subject|6|||
148851126|NCT01831466|536929069|FG001|Overall Study|Withdrawal by Subject|3|||
148851127|NCT01831466|536929070|FG002|Overall Study|Withdrawal by Subject|3|||
148851128|NCT01831466|536929071|FG003|Overall Study|Withdrawal by Subject|3|||
148851129|NCT01831466|536929072|FG004|Overall Study|Withdrawal by Subject|3|||
148851130|NCT01831466|536929073|FG005|Overall Study|Withdrawal by Subject|5|||
148851131|NCT01831466|536929074|FG006|Overall Study|Withdrawal by Subject|0|||
148985102|NCT01202773|537423235|FG001|Overall Study|Adverse Event|5|||
148851132|NCT01831466|536929075|FG007|Overall Study|Withdrawal by Subject|0|||
148851133|NCT01831466|536929076|FG008|Overall Study|Withdrawal by Subject|0|||
148851134|NCT01831466|536929077|FG009|Overall Study|Withdrawal by Subject|1|||
148851135|NCT01831466|536929078|FG010|Overall Study|Withdrawal by Subject|0|||
148851136|NCT01831466|536929079|FG011|Overall Study|Withdrawal by Subject|1|||
148851137|NCT01831466|536929068|FG000|Overall Study|Lost to Follow-up|0|||
148851138|NCT01831466|536929069|FG001|Overall Study|Lost to Follow-up|1|||
148851139|NCT01831466|536929070|FG002|Overall Study|Lost to Follow-up|4|||
148851140|NCT01831466|536929071|FG003|Overall Study|Lost to Follow-up|2|||
148851141|NCT01831466|536929072|FG004|Overall Study|Lost to Follow-up|0|||
148851142|NCT01831466|536929073|FG005|Overall Study|Lost to Follow-up|3|||
148851143|NCT01831466|536929074|FG006|Overall Study|Lost to Follow-up|0|||
148985103|NCT01202773|537423236|FG002|Overall Study|Adverse Event|5|||
148851144|NCT01831466|536929075|FG007|Overall Study|Lost to Follow-up|0|||
148851145|NCT01831466|536929076|FG008|Overall Study|Lost to Follow-up|0|||
148851146|NCT01831466|536929077|FG009|Overall Study|Lost to Follow-up|1|||
148851147|NCT01831466|536929078|FG010|Overall Study|Lost to Follow-up|0|||
148851148|NCT01831466|536929079|FG011|Overall Study|Lost to Follow-up|1|||
148851149|NCT01831466|536929068|FG000|Overall Study|Lack of Efficacy|5|||
148851150|NCT01831466|536929069|FG001|Overall Study|Lack of Efficacy|8|||
148851151|NCT01831466|536929070|FG002|Overall Study|Lack of Efficacy|7|||
148851152|NCT01831466|536929071|FG003|Overall Study|Lack of Efficacy|6|||
148851153|NCT01831466|536929072|FG004|Overall Study|Lack of Efficacy|9|||
148851154|NCT01831466|536929073|FG005|Overall Study|Lack of Efficacy|8|||
148851155|NCT01831466|536929074|FG006|Overall Study|Lack of Efficacy|1|||
148851156|NCT01831466|536929075|FG007|Overall Study|Lack of Efficacy|1|||
148851157|NCT01831466|536929076|FG008|Overall Study|Lack of Efficacy|2|||
148851158|NCT01831466|536929077|FG009|Overall Study|Lack of Efficacy|2|||
148851159|NCT01831466|536929078|FG010|Overall Study|Lack of Efficacy|2|||
148851160|NCT01831466|536929079|FG011|Overall Study|Lack of Efficacy|0|||
148851161|NCT01831466|536929068|FG000|Overall Study|Adverse Event|0|||
148851162|NCT01831466|536929069|FG001|Overall Study|Adverse Event|0|||
148851163|NCT01831466|536929070|FG002|Overall Study|Adverse Event|4|||
148851164|NCT01831466|536929071|FG003|Overall Study|Adverse Event|6|||
148851165|NCT01831466|536929072|FG004|Overall Study|Adverse Event|3|||
148851166|NCT01831466|536929073|FG005|Overall Study|Adverse Event|7|||
148851167|NCT01831466|536929074|FG006|Overall Study|Adverse Event|0|||
148851168|NCT01831466|536929075|FG007|Overall Study|Adverse Event|1|||
148851169|NCT01831466|536929076|FG008|Overall Study|Adverse Event|1|||
148851170|NCT01831466|536929077|FG009|Overall Study|Adverse Event|1|||
148851171|NCT01831466|536929078|FG010|Overall Study|Adverse Event|0|||
148851172|NCT01831466|536929079|FG011|Overall Study|Adverse Event|2|||
148851173|NCT02798315|536929080|FG000|Overall Study|Failure to return|1|||
148851174|NCT00005947|536929081|FG000|Overall Study|Death|54|||
148851175|NCT00005947|536929082|FG001|Overall Study|Death|40|||
148851176|NCT00005947|536929081|FG000|Overall Study|Patient Refused to Continue|2|||
148851177|NCT00005947|536929082|FG001|Overall Study|Patient Refused to Continue|1|||
148851178|NCT00005947|536929081|FG000|Overall Study|Site Closure|1|||
148851179|NCT00005947|536929082|FG001|Overall Study|Site Closure|0|||
148851180|NCT03335150|536929086|FG000|Overall Study|Withdrawal by Subject|10|||
148851181|NCT03335150|536929087|FG001|Overall Study|Withdrawal by Subject|4|||
148851182|NCT03335150|536929086|FG000|Overall Study|Adverse Event|0|||
148851183|NCT03335150|536929087|FG001|Overall Study|Adverse Event|1|||
148851184|NCT03292640|536929092|FG000|Overall Study|Withdrawal by Subject|17|||
148851185|NCT03292640|536929093|FG001|Overall Study|Withdrawal by Subject|16|||
148851186|NCT03292640|536929092|FG000|Overall Study|Adverse Event|20|||
148851187|NCT03292640|536929093|FG001|Overall Study|Adverse Event|2|||
148851188|NCT03292640|536929092|FG000|Overall Study|Lost to Follow-up|24|||
148851189|NCT03292640|536929093|FG001|Overall Study|Lost to Follow-up|24|||
148851190|NCT02218697|536929094|FG000|Overall Study|Adverse Event|0|||
148851191|NCT02218697|536929095|FG001|Overall Study|Adverse Event|2|||
148851192|NCT02218697|536929094|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
148851193|NCT02218697|536929095|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
148851194|NCT02218697|536929094|FG000|Overall Study|Withdrawal by Subject|2|||
148851195|NCT02218697|536929095|FG001|Overall Study|Withdrawal by Subject|3|||
148851196|NCT05356910|536929096|FG000|Overall Study|Lost to Follow-up|10|||
148851197|NCT05356910|536929097|FG001|Overall Study|Lost to Follow-up|19|||
148851198|NCT05356910|536929098|FG002|Overall Study|Lost to Follow-up|0|||
148851199|NCT05356910|536929099|FG003|Overall Study|Lost to Follow-up|0|||
148851200|NCT05356910|536929096|FG000|Overall Study|Withdrawal by Subject|4|||
148851201|NCT05356910|536929097|FG001|Overall Study|Withdrawal by Subject|2|||
148851202|NCT05356910|536929098|FG002|Overall Study|Withdrawal by Subject|0|||
148851203|NCT05356910|536929099|FG003|Overall Study|Withdrawal by Subject|0|||
148851204|NCT00703846|536929100|FG000|Overall Study|Adverse Event|8|||
148851205|NCT00703846|536929100|FG000|Overall Study|Lost to Follow-up|55|||
148851206|NCT00703846|536929100|FG000|Overall Study|Lack of Efficacy|15|||
148851207|NCT00703846|536929100|FG000|Overall Study|Noncompliance with Study Treatment|2|||
148851208|NCT00703846|536929100|FG000|Overall Study|Withdrawal by Subject|40|||
148851209|NCT00703846|536929100|FG000|Overall Study|Death|1|||
148851210|NCT00703846|536929100|FG000|Overall Study|Other|14|||
148851211|NCT00703846|536929100|FG000|Overall Study|Did Not Receive Study Drug|2|||
148851212|NCT04601532|536929101|FG000|Overall Study|Lost to Follow-up|1|||
148851213|NCT04601532|536929102|FG001|Overall Study|Lost to Follow-up|2|||
148851214|NCT04601532|536929101|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
148851215|NCT04601532|536929102|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
148851216|NCT02566785|536929103|FG000|Overall Study|Lost to Follow-up|0|||
148851217|NCT02566785|536929104|FG001|Overall Study|Lost to Follow-up|2|||
148851218|NCT02566785|536929103|FG000|Overall Study|Worsening condition|1|||
149030201|NCT03852433|537587972|FG000|Overall Study|Lack of Efficacy|0|||
148851219|NCT02566785|536929104|FG001|Overall Study|Worsening condition|1|||
148851220|NCT00837161|536929107|FG000|Overall Study|refused hysterectomy|2|||
149030202|NCT03852433|537587973|FG001|Overall Study|Lack of Efficacy|1|||
148851221|NCT00451958|536929108|FG000|CS21A (NCT00451958)|Adverse Event|21|||
148851222|NCT00451958|536929109|FG001|CS21A (NCT00451958)|Adverse Event|34|||
148851223|NCT00451958|536929110|FG002|CS21A (NCT00451958)|Adverse Event|14|||
148851224|NCT00451958|536929111|FG003|CS21A (NCT00451958)|Adverse Event|17|||
148851225|NCT00451958|536929112|FG004|CS21A (NCT00451958)|Adverse Event|0|||
148851226|NCT00451958|536929108|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
148851227|NCT00451958|536929109|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
148851228|NCT00451958|536929110|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
148851229|NCT00451958|536929111|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
148851230|NCT00451958|536929112|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
148851231|NCT00451958|536929108|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
148851232|NCT00451958|536929109|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
148851233|NCT00451958|536929110|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
148851234|NCT00451958|536929111|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
148851235|NCT00451958|536929112|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
148851236|NCT00451958|536929108|FG000|CS21A (NCT00451958)|Physician Decision|2|||
148851237|NCT00451958|536929109|FG001|CS21A (NCT00451958)|Physician Decision|4|||
148851238|NCT00451958|536929110|FG002|CS21A (NCT00451958)|Physician Decision|4|||
148851239|NCT00451958|536929111|FG003|CS21A (NCT00451958)|Physician Decision|4|||
148851240|NCT00451958|536929112|FG004|CS21A (NCT00451958)|Physician Decision|0|||
148851241|NCT00451958|536929108|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
148851242|NCT00451958|536929109|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
148851243|NCT00451958|536929110|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
148851244|NCT00451958|536929111|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
148851245|NCT00451958|536929112|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
148851246|NCT00451958|536929108|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
148851247|NCT00451958|536929109|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
148851248|NCT00451958|536929110|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
148851249|NCT00451958|536929111|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
148851250|NCT00451958|536929112|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
148851251|NCT00064259|536930595|FG000|Overall Study|Adverse Event|1|||
148851252|NCT00064259|536930596|FG001|Overall Study|Adverse Event|0|||
148851253|NCT00064259|536930597|FG002|Overall Study|Adverse Event|0|||
148851254|NCT00064259|536930598|FG003|Overall Study|Adverse Event|1|||
148851255|NCT01132651|536930601|FG000|Overall Study|Lost to Follow-up|1|||
148851256|NCT01132651|536930602|FG001|Overall Study|Lost to Follow-up|1|||
148851257|NCT03522246|536930611|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
148851258|NCT03522246|536930612|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
148851259|NCT03522246|536930613|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
148851260|NCT03522246|536930614|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
148851261|NCT03522246|536930615|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
148851262|NCT02482428|536930616|FG000|Overall Study|Lost to Follow-up|4|||
148851263|NCT02482428|536930617|FG001|Overall Study|Lost to Follow-up|9|||
148851264|NCT02482428|536930618|FG002|Overall Study|Lost to Follow-up|1|||
148851265|NCT02482428|536930619|FG003|Overall Study|Lost to Follow-up|2|||
148851266|NCT02482428|536930620|FG004|Overall Study|Lost to Follow-up|4|||
148851267|NCT02482428|536930616|FG000|Overall Study|Physician Decision|0|||
148851268|NCT02482428|536930617|FG001|Overall Study|Physician Decision|0|||
148851269|NCT02482428|536930618|FG002|Overall Study|Physician Decision|0|||
148851270|NCT02482428|536930619|FG003|Overall Study|Physician Decision|0|||
148851271|NCT02482428|536930620|FG004|Overall Study|Physician Decision|1|||
148851272|NCT02482428|536930616|FG000|Overall Study|protocol deviation|1|||
148851273|NCT02482428|536930617|FG001|Overall Study|protocol deviation|1|||
148851274|NCT02482428|536930618|FG002|Overall Study|protocol deviation|0|||
148851275|NCT02482428|536930619|FG003|Overall Study|protocol deviation|0|||
148851276|NCT02482428|536930620|FG004|Overall Study|protocol deviation|0|||
148851277|NCT02482428|536930616|FG000|Overall Study|subject/guardian decision|4|||
148851278|NCT02482428|536930617|FG001|Overall Study|subject/guardian decision|2|||
148851279|NCT02482428|536930618|FG002|Overall Study|subject/guardian decision|0|||
148851280|NCT02482428|536930619|FG003|Overall Study|subject/guardian decision|0|||
148851281|NCT02482428|536930620|FG004|Overall Study|subject/guardian decision|2|||
148851282|NCT02547038|536930621|FG000|Overall Study|Lost to Follow-up|3|||
148851283|NCT02547038|536930622|FG001|Overall Study|Lost to Follow-up|2|||
148851284|NCT00516893|536930623|FG000|Overall Study|Lost to Follow-up|4|||
148851285|NCT00516893|536930623|FG000|Overall Study|Adverse Event|3|||
148851286|NCT00516893|536930623|FG000|Overall Study|Withdrawal by Subject|2|||
148851287|NCT00516893|536930623|FG000|Overall Study|Noncompliance|2|||
148851288|NCT00516893|536930623|FG000|Overall Study|Death|1|||
148851289|NCT00516893|536930623|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
148851290|NCT00516893|536930623|FG000|Overall Study|Relocated|1|||
148851291|NCT00516893|536930623|FG000|Overall Study|Pregnancy|1|||
148851292|NCT00516893|536930623|FG000|Overall Study|Received Medication From Another Study|1|||
148851293|NCT00301262|536930626|FG000|Double Blind Phase (DB)|Adverse Event|1|||
148851294|NCT00301262|536930627|FG001|Double Blind Phase (DB)|Adverse Event|0|||
148851295|NCT00301262|536930626|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
148851296|NCT00301262|536930627|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
148851297|NCT00301262|536930626|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
148851298|NCT00301262|536930627|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
148851299|NCT00301262|536930626|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
148851300|NCT00301262|536930627|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
148851301|NCT00301262|536930626|FG000|Double Blind Phase (DB)|Other|1|||
148851302|NCT00301262|536930627|FG001|Double Blind Phase (DB)|Other|4|||
148851303|NCT00301262|536930626|FG000|Open Label Phase (OL)|Adverse Event|1|||
148851304|NCT00301262|536930627|FG001|Open Label Phase (OL)|Adverse Event|0|||
148851305|NCT00301262|536930626|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
148851306|NCT00301262|536930627|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
148851307|NCT00301262|536930626|FG000|Open Label Phase (OL)|Other|2|||
148851308|NCT00301262|536930627|FG001|Open Label Phase (OL)|Other|0|||
148851309|NCT01443364|536930628|FG000|Overall Study|Lack of Efficacy|14|||
148851310|NCT01443364|536930628|FG000|Overall Study|Lost to Follow-up|3|||
148851311|NCT01443364|536930628|FG000|Overall Study|Withdrawal by Subject|5|||
148851312|NCT01443364|536930628|FG000|Overall Study|Other Reason|4|||
148851313|NCT01443364|536930628|FG000|Overall Study|SAE, non-fatal|6|||
148851314|NCT01443364|536930628|FG000|Overall Study|AE, non-serious non-fatal|8|||
148851315|NCT01443364|536930628|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
148851316|NCT00623233|536930629|FG000|Overall Study|Adverse Event|10|||
148851317|NCT00623233|536930629|FG000|Overall Study|Physician Decision|10|||
148851318|NCT00623233|536930629|FG000|Overall Study|Lost to Follow-up|1|||
148851319|NCT00623233|536930629|FG000|Overall Study|Withdrawal by Subject|3|||
148851320|NCT00559845|536930630|FG000|Overall Study|Withdrew Consent|1|||
148851321|NCT00559845|536930630|FG000|Overall Study|Disease Progression|1|||
148851322|NCT00559845|536930630|FG000|Overall Study|Adverse Event|3|||
148851323|NCT00559845|536930630|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
148851324|NCT00559845|536930630|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
148851325|NCT00459875|536930631|FG000|Overall Study|Ineligible participant|1|||
148851326|NCT00459875|536930631|FG000|Overall Study|Adverse Event|2|||
148851327|NCT03206970|536930634|FG000|Overall Study|Death|21|||
148851328|NCT03206970|536930634|FG000|Overall Study|Withdrawal by Subject|13|||
148851329|NCT03206970|536930634|FG000|Overall Study|Lost to Follow-up|3|||
148851330|NCT03206970|536930634|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
148851331|NCT03645421|536930635|FG000|Overall Study|Adverse Event|0|||
148851332|NCT03645421|536930636|FG001|Overall Study|Adverse Event|0|||
148851333|NCT03645421|536930637|FG002|Overall Study|Adverse Event|4|||
148851334|NCT03645421|536930638|FG003|Overall Study|Adverse Event|1|||
148851335|NCT03645421|536930635|FG000|Overall Study|Withdrawal by patient|0|||
148851336|NCT03645421|536930636|FG001|Overall Study|Withdrawal by patient|0|||
148851337|NCT03645421|536930637|FG002|Overall Study|Withdrawal by patient|0|||
148851338|NCT03645421|536930638|FG003|Overall Study|Withdrawal by patient|3|||
148851339|NCT03645421|536930635|FG000|Overall Study|Study specific withdrawal criteria|0|||
148851340|NCT03645421|536930636|FG001|Overall Study|Study specific withdrawal criteria|0|||
148851341|NCT03645421|536930637|FG002|Overall Study|Study specific withdrawal criteria|1|||
148851342|NCT03645421|536930638|FG003|Overall Study|Study specific withdrawal criteria|0|||
148851343|NCT00375427|536930639|FG000|Overall Study|Adverse Event|21|||
148851344|NCT00375427|536930640|FG001|Overall Study|Adverse Event|27|||
148851345|NCT00375427|536930639|FG000|Overall Study|Abnormal test procedure result(s)|0|||
148851346|NCT00375427|536930640|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148851347|NCT00375427|536930639|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148851348|NCT00375427|536930640|FG001|Overall Study|Abnormal laboratory value(s)|2|||
148851349|NCT00375427|536930639|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
148851350|NCT00375427|536930640|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
148851351|NCT00375427|536930639|FG000|Overall Study|Patient no longer requires study drug|3|||
148851352|NCT00375427|536930640|FG001|Overall Study|Patient no longer requires study drug|7|||
148851353|NCT00375427|536930639|FG000|Overall Study|Protocol Violation|10|||
148851354|NCT00375427|536930640|FG001|Overall Study|Protocol Violation|8|||
148985104|NCT01202773|537423234|FG000|Overall Study|Lack of Efficacy|5|||
148985105|NCT01202773|537423235|FG001|Overall Study|Lack of Efficacy|4|||
148985106|NCT01202773|537423236|FG002|Overall Study|Lack of Efficacy|9|||
148985107|NCT01202773|537423234|FG000|Overall Study|Entry Criteria Not Met|2|||
148985108|NCT01202773|537423235|FG001|Overall Study|Entry Criteria Not Met|0|||
148985109|NCT01202773|537423236|FG002|Overall Study|Entry Criteria Not Met|1|||
148985110|NCT01202773|537423234|FG000|Overall Study|Lost to Follow-up|1|||
148851355|NCT00375427|536930639|FG000|Overall Study|Withdrawal by Subject|9|||
148851356|NCT00375427|536930640|FG001|Overall Study|Withdrawal by Subject|13|||
148851357|NCT00375427|536930639|FG000|Overall Study|Lost to Follow-up|1|||
148985111|NCT01202773|537423235|FG001|Overall Study|Lost to Follow-up|2|||
148985112|NCT01202773|537423236|FG002|Overall Study|Lost to Follow-up|2|||
148985113|NCT01202773|537423234|FG000|Overall Study|Withdrawal by Subject|13|||
148851358|NCT00375427|536930640|FG001|Overall Study|Lost to Follow-up|1|||
148851359|NCT00375427|536930639|FG000|Overall Study|Administrative reasons|0|||
148851360|NCT00375427|536930640|FG001|Overall Study|Administrative reasons|1|||
148985114|NCT01202773|537423235|FG001|Overall Study|Withdrawal by Subject|6|||
148985115|NCT01202773|537423236|FG002|Overall Study|Withdrawal by Subject|5|||
148851361|NCT00375427|536930639|FG000|Overall Study|Death|11|||
148851362|NCT00375427|536930640|FG001|Overall Study|Death|10|||
148851363|NCT00224120|536930642|FG000|Overall Study|Adverse Event|10|||
148985116|NCT01202773|537423234|FG000|Overall Study|Physician Decision|2|||
148985117|NCT01202773|537423235|FG001|Overall Study|Physician Decision|0|||
148985118|NCT01202773|537423236|FG002|Overall Study|Physician Decision|0|||
148851364|NCT00224120|536930643|FG001|Overall Study|Adverse Event|4|||
148851365|NCT00224120|536930642|FG000|Overall Study|Protocol Violation|1|||
148851366|NCT00224120|536930643|FG001|Overall Study|Protocol Violation|0|||
148851367|NCT00224120|536930642|FG000|Overall Study|Withdrawal by Subject|5|||
148851368|NCT00224120|536930643|FG001|Overall Study|Withdrawal by Subject|10|||
148851369|NCT00224120|536930642|FG000|Overall Study|Lack of Efficacy|0|||
148851370|NCT00224120|536930643|FG001|Overall Study|Lack of Efficacy|2|||
148851371|NCT00224120|536930642|FG000|Overall Study|Lost to Follow-up|2|||
148851372|NCT00224120|536930643|FG001|Overall Study|Lost to Follow-up|3|||
148851373|NCT00224120|536930642|FG000|Overall Study|Other|4|||
148851374|NCT00224120|536930643|FG001|Overall Study|Other|5|||
148851375|NCT00104416|536930644|FG000|Double-Blind Phase|Adverse Event|2|||
148851376|NCT00104416|536930645|FG001|Double-Blind Phase|Adverse Event|1|||
148851377|NCT00104416|536930646|FG002|Double-Blind Phase|Adverse Event|0|||
148851378|NCT00104416|536930647|FG003|Double-Blind Phase|Adverse Event|0|||
148851379|NCT00104416|536930648|FG004|Double-Blind Phase|Adverse Event|0|||
148851380|NCT00104416|536930644|FG000|Double-Blind Phase|Lost to Follow-up|0|||
148851381|NCT00104416|536930645|FG001|Double-Blind Phase|Lost to Follow-up|1|||
148851382|NCT00104416|536930646|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148851383|NCT00104416|536930647|FG003|Double-Blind Phase|Lost to Follow-up|0|||
148851384|NCT00104416|536930648|FG004|Double-Blind Phase|Lost to Follow-up|0|||
148851385|NCT00104416|536930644|FG000|Double-Blind Phase|Protocol Violation|0|||
148851386|NCT00104416|536930645|FG001|Double-Blind Phase|Protocol Violation|1|||
148851387|NCT00104416|536930646|FG002|Double-Blind Phase|Protocol Violation|0|||
148851388|NCT00104416|536930647|FG003|Double-Blind Phase|Protocol Violation|0|||
148851389|NCT00104416|536930648|FG004|Double-Blind Phase|Protocol Violation|0|||
148851390|NCT00104416|536930644|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
148851391|NCT00104416|536930645|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
148851392|NCT00104416|536930646|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
148851393|NCT00104416|536930647|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
148851394|NCT00104416|536930648|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
148851395|NCT00104416|536930644|FG000|Double-Blind Phase|Pregnancy|1|||
148851396|NCT00104416|536930645|FG001|Double-Blind Phase|Pregnancy|0|||
148851397|NCT00104416|536930646|FG002|Double-Blind Phase|Pregnancy|0|||
148851398|NCT00104416|536930647|FG003|Double-Blind Phase|Pregnancy|0|||
148851399|NCT00104416|536930648|FG004|Double-Blind Phase|Pregnancy|0|||
148851400|NCT00104416|536930644|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
148851401|NCT00104416|536930645|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
148851402|NCT00104416|536930646|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
148851403|NCT00104416|536930647|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
148851404|NCT00104416|536930648|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
148851405|NCT00104416|536930644|FG000|Continuation Phase|Adverse Event|0|||
148851406|NCT00104416|536930645|FG001|Continuation Phase|Adverse Event|0|||
148851407|NCT00104416|536930646|FG002|Continuation Phase|Adverse Event|2|||
148851408|NCT00104416|536930647|FG003|Continuation Phase|Adverse Event|0|||
148851409|NCT00104416|536930648|FG004|Continuation Phase|Adverse Event|2|||
148851410|NCT00104416|536930644|FG000|Continuation Phase|Lost to Follow-up|0|||
148851411|NCT00104416|536930645|FG001|Continuation Phase|Lost to Follow-up|0|||
148851412|NCT00104416|536930646|FG002|Continuation Phase|Lost to Follow-up|1|||
148851413|NCT00104416|536930647|FG003|Continuation Phase|Lost to Follow-up|0|||
148851414|NCT00104416|536930648|FG004|Continuation Phase|Lost to Follow-up|1|||
148851415|NCT00104416|536930644|FG000|Continuation Phase|Withdrawal by Subject|0|||
148851416|NCT00104416|536930645|FG001|Continuation Phase|Withdrawal by Subject|0|||
148851417|NCT00104416|536930646|FG002|Continuation Phase|Withdrawal by Subject|2|||
148851418|NCT00104416|536930647|FG003|Continuation Phase|Withdrawal by Subject|1|||
148851419|NCT00104416|536930648|FG004|Continuation Phase|Withdrawal by Subject|1|||
148851420|NCT00104416|536930644|FG000|Continuation Phase|Pregnancy|0|||
148851421|NCT00104416|536930645|FG001|Continuation Phase|Pregnancy|0|||
148851422|NCT00104416|536930646|FG002|Continuation Phase|Pregnancy|1|||
148851423|NCT00104416|536930647|FG003|Continuation Phase|Pregnancy|1|||
148851424|NCT00104416|536930648|FG004|Continuation Phase|Pregnancy|0|||
148851425|NCT00104416|536930644|FG000|Continuation Phase|Non-compliance|0|||
148851426|NCT00104416|536930645|FG001|Continuation Phase|Non-compliance|0|||
148851427|NCT00104416|536930646|FG002|Continuation Phase|Non-compliance|0|||
148851428|NCT00104416|536930647|FG003|Continuation Phase|Non-compliance|0|||
148851429|NCT00104416|536930648|FG004|Continuation Phase|Non-compliance|1|||
148851430|NCT00070109|536930649|FG000|Overall Study|Death|1|||
148851431|NCT00070109|536930650|FG001|Overall Study|Death|1|||
148851432|NCT00070109|536930651|FG002|Overall Study|Death|0|||
148851433|NCT00070109|536930652|FG003|Overall Study|Death|0|||
148851434|NCT00070109|536930653|FG004|Overall Study|Death|1|||
148851435|NCT00070109|536930649|FG000|Overall Study|Lack of Efficacy|6|||
148851436|NCT00070109|536930650|FG001|Overall Study|Lack of Efficacy|4|||
148851437|NCT00070109|536930651|FG002|Overall Study|Lack of Efficacy|5|||
148851438|NCT00070109|536930652|FG003|Overall Study|Lack of Efficacy|15|||
148851439|NCT00070109|536930653|FG004|Overall Study|Lack of Efficacy|5|||
148851440|NCT00070109|536930649|FG000|Overall Study|Physician Decision|1|||
148851441|NCT00070109|536930650|FG001|Overall Study|Physician Decision|0|||
148851442|NCT00070109|536930651|FG002|Overall Study|Physician Decision|0|||
148851443|NCT00070109|536930652|FG003|Overall Study|Physician Decision|0|||
148851444|NCT00070109|536930653|FG004|Overall Study|Physician Decision|0|||
148851445|NCT00070109|536930649|FG000|Overall Study|Withdrawal by Subject|0|||
148851446|NCT00070109|536930650|FG001|Overall Study|Withdrawal by Subject|1|||
148851447|NCT00070109|536930651|FG002|Overall Study|Withdrawal by Subject|1|||
148851448|NCT00070109|536930652|FG003|Overall Study|Withdrawal by Subject|0|||
148851449|NCT00070109|536930653|FG004|Overall Study|Withdrawal by Subject|0|||
148851450|NCT00070109|536930649|FG000|Overall Study|Adverse Event|0|||
148851451|NCT00070109|536930650|FG001|Overall Study|Adverse Event|0|||
148851452|NCT00070109|536930651|FG002|Overall Study|Adverse Event|2|||
148851453|NCT00070109|536930652|FG003|Overall Study|Adverse Event|4|||
148851454|NCT00070109|536930653|FG004|Overall Study|Adverse Event|2|||
148851455|NCT00070109|536930649|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
148851456|NCT00070109|536930650|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
148851457|NCT00070109|536930651|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
148851458|NCT00070109|536930652|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
148851459|NCT00070109|536930653|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
148851460|NCT01164891|536930658|FG000|Overall Study|Disease Progression|5|||
148851461|NCT01164891|536930658|FG000|Overall Study|Adverse Event|1|||
148851462|NCT00441142|536930659|FG000|Overall Study|Adverse Event|2|||
148851463|NCT00441142|536930660|FG001|Overall Study|Adverse Event|3|||
148851464|NCT00441142|536930661|FG002|Overall Study|Adverse Event|3|||
148851465|NCT00441142|536930662|FG003|Overall Study|Adverse Event|22|||
148851466|NCT00441142|536930659|FG000|Overall Study|Lack of Efficacy|3|||
148851467|NCT00441142|536930660|FG001|Overall Study|Lack of Efficacy|3|||
148851468|NCT00441142|536930661|FG002|Overall Study|Lack of Efficacy|17|||
148851469|NCT00441142|536930662|FG003|Overall Study|Lack of Efficacy|32|||
148851470|NCT00441142|536930659|FG000|Overall Study|Withdrawal by Subject|0|||
148851471|NCT00441142|536930660|FG001|Overall Study|Withdrawal by Subject|0|||
148851472|NCT00441142|536930661|FG002|Overall Study|Withdrawal by Subject|2|||
148851473|NCT00441142|536930662|FG003|Overall Study|Withdrawal by Subject|10|||
148851474|NCT00441142|536930659|FG000|Overall Study|Patient still receiving active study tx|1|||
148851475|NCT00441142|536930660|FG001|Overall Study|Patient still receiving active study tx|0|||
148851476|NCT00441142|536930661|FG002|Overall Study|Patient still receiving active study tx|0|||
148851477|NCT00441142|536930662|FG003|Overall Study|Patient still receiving active study tx|2|||
148851478|NCT00441142|536930659|FG000|Overall Study|Physician Decision|0|||
148851479|NCT00441142|536930660|FG001|Overall Study|Physician Decision|1|||
148851480|NCT00441142|536930661|FG002|Overall Study|Physician Decision|0|||
148851481|NCT00441142|536930662|FG003|Overall Study|Physician Decision|1|||
148851482|NCT00441142|536930659|FG000|Overall Study|Death|0|||
148851483|NCT00441142|536930660|FG001|Overall Study|Death|0|||
148851484|NCT00441142|536930661|FG002|Overall Study|Death|0|||
148851485|NCT00441142|536930662|FG003|Overall Study|Death|1|||
148851486|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
148851487|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
148851488|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
148851489|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
148851490|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
148851491|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
148851492|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
148851493|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
148851494|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148851495|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148851496|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148851497|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148851498|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
148851499|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
148851500|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148851501|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148851502|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148985119|NCT01202773|537423234|FG000|Overall Study|Protocol Violation|11|||
148985120|NCT01202773|537423235|FG001|Overall Study|Protocol Violation|6|||
148985121|NCT01202773|537423236|FG002|Overall Study|Protocol Violation|10|||
148985122|NCT01202773|537423234|FG000|Overall Study|Sponsor Decision|19|||
148985123|NCT01202773|537423235|FG001|Overall Study|Sponsor Decision|20|||
148851503|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148851504|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
148851505|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
148851506|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
148851507|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
148851508|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
148851509|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
148985124|NCT01202773|537423236|FG002|Overall Study|Sponsor Decision|23|||
148985125|NCT00575588|537423241|FG000|Overall Study|Adverse Event|11|||
148985126|NCT00575588|537423242|FG001|Overall Study|Adverse Event|13|||
148985127|NCT00575588|537423241|FG000|Overall Study|Withdrawal by Subject|27|||
148985128|NCT00575588|537423242|FG001|Overall Study|Withdrawal by Subject|31|||
148985129|NCT00575588|537423241|FG000|Overall Study|Lost to Follow-up|1|||
148985130|NCT00575588|537423242|FG001|Overall Study|Lost to Follow-up|3|||
148985131|NCT00575588|537423241|FG000|Overall Study|Death|4|||
148985132|NCT00575588|537423242|FG001|Overall Study|Death|2|||
148985133|NCT00575588|537423241|FG000|Overall Study|Incorrect enrollment|8|||
148985134|NCT00575588|537423242|FG001|Overall Study|Incorrect enrollment|4|||
148985135|NCT00575588|537423241|FG000|Overall Study|Study specific discontinuation criteria|203|||
148985136|NCT00575588|537423242|FG001|Overall Study|Study specific discontinuation criteria|218|||
148985137|NCT00575588|537423241|FG000|Overall Study|Severe non-compliance to protocol|5|||
148985138|NCT00575588|537423242|FG001|Overall Study|Severe non-compliance to protocol|7|||
148985139|NCT00575588|537423241|FG000|Overall Study|Safety reasons|2|||
148985140|NCT00575588|537423242|FG001|Overall Study|Safety reasons|1|||
148985141|NCT00575588|537423241|FG000|Overall Study|Elevated triglyceride|1|||
148985142|NCT00575588|537423242|FG001|Overall Study|Elevated triglyceride|0|||
148985143|NCT00575588|537423241|FG000|Overall Study|Patient moved|1|||
148985144|NCT00575588|537423242|FG001|Overall Study|Patient moved|3|||
148985145|NCT00575588|537423241|FG000|Overall Study|Impossible to determine HbA1c|0|||
148985146|NCT00575588|537423242|FG001|Overall Study|Impossible to determine HbA1c|1|||
148985147|NCT01343407|537423255|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
148985148|NCT01343407|537423256|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
148985149|NCT01343407|537423257|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
148985150|NCT01343407|537423258|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
148985151|NCT01343407|537423259|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
148985152|NCT01343407|537423260|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
148985153|NCT01343407|537423255|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
148985154|NCT01343407|537423256|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
148985155|NCT01343407|537423257|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
148985156|NCT01343407|537423258|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
148985157|NCT01343407|537423259|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
148985158|NCT01343407|537423260|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
148985159|NCT04079933|537423261|FG000|Overall Study|Withdrawal by Subject|3|||
148985160|NCT04079933|537423262|FG001|Overall Study|Withdrawal by Subject|4|||
148985161|NCT04079933|537423261|FG000|Overall Study|Lost to Follow-up|0|||
148985162|NCT04079933|537423262|FG001|Overall Study|Lost to Follow-up|1|||
148985163|NCT01986829|537423263|FG000|Overall Study|Death|1|||
148985164|NCT02504866|537423264|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
148985165|NCT02504866|537423265|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
148985166|NCT02504866|537423266|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
148985167|NCT01229436|537423267|FG000|Overall Study|Withdrawal by Subject|2|||
148985168|NCT01229436|537423267|FG000|Overall Study|Lost to Follow-up|3|||
148985169|NCT01775137|537423268|FG000|Overall Study|Death|1|||
148985170|NCT01775137|537423268|FG000|Overall Study|Protocol deviation|2|||
148985171|NCT01775137|537423268|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148985172|NCT01775137|537423268|FG000|Overall Study|Adverse Event|1|||
148985173|NCT01775137|537423268|FG000|Overall Study|Withdrawal by participants|5|||
148985174|NCT03231371|537423270|FG000|Overall Study|Withdrawal by Subject|1|||
148985175|NCT03231371|537423270|FG000|Overall Study|chose or were ineligible to have MRI|12|||
148985176|NCT02673697|537423275|FG000|Overall Study|Adverse Event|2|||
148985177|NCT02673697|537423276|FG001|Overall Study|Adverse Event|0|||
148985178|NCT02673697|537423275|FG000|Overall Study|Death|32|||
148985179|NCT02673697|537423276|FG001|Overall Study|Death|24|||
148985180|NCT02673697|537423275|FG000|Overall Study|Lost to Follow-up|5|||
148985181|NCT02673697|537423276|FG001|Overall Study|Lost to Follow-up|2|||
148985182|NCT02673697|537423275|FG000|Overall Study|Physician Decision|2|||
148985183|NCT02673697|537423276|FG001|Overall Study|Physician Decision|1|||
148985184|NCT02673697|537423275|FG000|Overall Study|Withdrawal by Subject|10|||
148985185|NCT02673697|537423276|FG001|Overall Study|Withdrawal by Subject|7|||
148985186|NCT02673697|537423275|FG000|Overall Study|Change subj medical status|1|||
148985187|NCT02673697|537423276|FG001|Overall Study|Change subj medical status|2|||
148985188|NCT02673697|537423275|FG000|Overall Study|Explant|10|||
148985189|NCT02673697|537423276|FG001|Overall Study|Explant|5|||
148985190|NCT02673697|537423275|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
148985191|NCT02673697|537423276|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
148985192|NCT00437489|537423277|FG000|Overall Study|Study terminated by sponsor|23|||
148985193|NCT00437489|537423278|FG001|Overall Study|Study terminated by sponsor|21|||
148985194|NCT00437489|537423277|FG000|Overall Study|Lost to Follow-up|0|||
148985195|NCT00437489|537423278|FG001|Overall Study|Lost to Follow-up|1|||
148985196|NCT03321981|537423280|FG000|Overall Study|Progressive Disease (PD)|15|||
148985197|NCT03321981|537423281|FG001|Overall Study|Progressive Disease (PD)|30|||
148985198|NCT03321981|537423282|FG002|Overall Study|Progressive Disease (PD)|47|||
149005489|NCT03217747|537497894|FG002|Overall Study|Removal of sole target lesion|0|||
149005490|NCT03217747|537497895|FG003|Overall Study|Removal of sole target lesion|0|||
148985199|NCT03321981|537423280|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
148985200|NCT03321981|537423281|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
148985201|NCT03321981|537423282|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
148985202|NCT03321981|537423280|FG000|Overall Study|Adverse Event|0|||
148985203|NCT03321981|537423281|FG001|Overall Study|Adverse Event|0|||
148985204|NCT03321981|537423282|FG002|Overall Study|Adverse Event|2|||
148985205|NCT03321981|537423280|FG000|Overall Study|symptomatic deterioration|0|||
148985206|NCT03321981|537423281|FG001|Overall Study|symptomatic deterioration|1|||
148985207|NCT03321981|537423282|FG002|Overall Study|symptomatic deterioration|1|||
148985208|NCT03321981|537423280|FG000|Overall Study|Lack of compliance|0|||
148985209|NCT03321981|537423281|FG001|Overall Study|Lack of compliance|1|||
148985210|NCT03321981|537423282|FG002|Overall Study|Lack of compliance|0|||
148985211|NCT03321981|537423280|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
148985212|NCT03321981|537423281|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
148985213|NCT03321981|537423282|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
148985214|NCT03321981|537423280|FG000|Overall Study|Death|0|||
148985215|NCT03321981|537423281|FG001|Overall Study|Death|1|||
148985216|NCT03321981|537423282|FG002|Overall Study|Death|0|||
148985217|NCT03321981|537423280|FG000|Overall Study|Subject withdrawal of investigational product|0|||
148985218|NCT03321981|537423281|FG001|Overall Study|Subject withdrawal of investigational product|1|||
148985219|NCT03321981|537423282|FG002|Overall Study|Subject withdrawal of investigational product|0|||
148985220|NCT03321981|537423280|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
148985221|NCT03321981|537423281|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
148985222|NCT03321981|537423282|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
148985223|NCT03321981|537423280|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
148985224|NCT03321981|537423281|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
148985225|NCT03321981|537423282|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
148985226|NCT00022516|537423290|FG000|Overall Study|Adverse Event|0|||
148985227|NCT00022516|537423291|FG001|Overall Study|Adverse Event|59|||
148985228|NCT00022516|537423290|FG000|Overall Study|Lack of Efficacy|0|||
148985229|NCT00022516|537423291|FG001|Overall Study|Lack of Efficacy|27|||
148985230|NCT00022516|537423290|FG000|Overall Study|Physician Decision|0|||
148985231|NCT00022516|537423291|FG001|Overall Study|Physician Decision|1|||
148985232|NCT00022516|537423290|FG000|Overall Study|Protocol Violation|1|||
148985233|NCT00022516|537423291|FG001|Overall Study|Protocol Violation|3|||
148985234|NCT00022516|537423290|FG000|Overall Study|Withdrawal by Subject|2|||
148985235|NCT00022516|537423291|FG001|Overall Study|Withdrawal by Subject|113|||
148985236|NCT00022516|537423290|FG000|Overall Study|Incomplete documentation|0|||
148985237|NCT00022516|537423291|FG001|Overall Study|Incomplete documentation|27|||
148985238|NCT03321019|537423292|FG000|Overall Study|Withdrawal by Subject|0|||
148985239|NCT03321019|537423293|FG001|Overall Study|Withdrawal by Subject|6|||
148985240|NCT03321019|537423292|FG000|Overall Study|Lost to Follow-up|0|||
148985241|NCT03321019|537423293|FG001|Overall Study|Lost to Follow-up|22|||
148985242|NCT02056301|537423298|FG000|Overall Study|Protocol Violation|1|||
148985243|NCT02056301|537423299|FG001|Overall Study|Protocol Violation|2|||
148985244|NCT02056301|537423298|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
148985245|NCT02056301|537423299|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
148985246|NCT02056301|537423298|FG000|Overall Study|Withdrawal by Subject|0|||
148985247|NCT02056301|537423299|FG001|Overall Study|Withdrawal by Subject|1|||
148985248|NCT02056301|537423298|FG000|Overall Study|Issues with epidural|0|||
148985249|NCT02056301|537423299|FG001|Overall Study|Issues with epidural|3|||
148985250|NCT02209324|537423301|FG000|Overall Study|Adverse Event|2|||
148985251|NCT02209324|537423301|FG000|Overall Study|Lack of Efficacy|1|||
148985252|NCT02209324|537423301|FG000|Overall Study|Lost to Follow-up|1|||
149030203|NCT03852433|537587974|FG002|Overall Study|Lack of Efficacy|0|||
149030204|NCT03852433|537587975|FG003|Overall Study|Lack of Efficacy|0|||
149030205|NCT03852433|537587972|FG000|Overall Study|Non-compliance with study drug|0|||
149030206|NCT03852433|537587973|FG001|Overall Study|Non-compliance with study drug|0|||
149030207|NCT03852433|537587974|FG002|Overall Study|Non-compliance with study drug|0|||
149030208|NCT03852433|537587975|FG003|Overall Study|Non-compliance with study drug|1|||
149030209|NCT03852433|537587972|FG000|Overall Study|Physician Decision|1|||
148985253|NCT02209324|537423301|FG000|Overall Study|Physician Decision|3|||
149030210|NCT03852433|537587973|FG001|Overall Study|Physician Decision|0|||
149030211|NCT03852433|537587974|FG002|Overall Study|Physician Decision|0|||
149030212|NCT03852433|537587975|FG003|Overall Study|Physician Decision|0|||
148985254|NCT02209324|537423301|FG000|Overall Study|Protocol Violation|14|||
148985255|NCT02209324|537423301|FG000|Overall Study|Withdrawal by Subject|8|||
148985256|NCT02209324|537423301|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
149030213|NCT03852433|537587972|FG000|Overall Study|Randomized but never treated|1|||
149030214|NCT03852433|537587973|FG001|Overall Study|Randomized but never treated|0|||
148985257|NCT02209324|537423301|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
148985258|NCT02209324|537423301|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
148985259|NCT03105362|537423302|FG000|Overall Study|Withdrawal by Subject|1|||
148985260|NCT03105362|537423302|FG000|Overall Study|Lost to Follow-up|1|||
148985261|NCT01198600|537423307|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
148985262|NCT01198600|537423308|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
148985263|NCT01198600|537423309|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
148985264|NCT01198600|537423310|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
148985265|NCT01198600|537423307|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
148985266|NCT01198600|537423308|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
148985267|NCT01198600|537423309|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
148985268|NCT01198600|537423310|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
148985269|NCT01198600|537423307|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
148985270|NCT01198600|537423308|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
148985271|NCT01198600|537423309|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
148985272|NCT01198600|537423310|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
148985273|NCT01198600|537423307|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
148985274|NCT01198600|537423308|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
148985275|NCT01198600|537423309|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
148985276|NCT01198600|537423310|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
148985277|NCT01198600|537423307|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
148985278|NCT01198600|537423308|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
148985279|NCT01198600|537423309|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
148985280|NCT01198600|537423310|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
148985281|NCT01198600|537423307|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
148985282|NCT01198600|537423308|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
148985283|NCT01198600|537423309|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
148985284|NCT01198600|537423310|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
148985285|NCT01198600|537423307|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
148985286|NCT01198600|537423308|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
148985287|NCT01198600|537423309|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
148985288|NCT01198600|537423310|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
148985289|NCT01785602|537423311|FG000|Overall Study|Withdrawal by Subject|2|||
148985290|NCT01785602|537423312|FG001|Overall Study|Withdrawal by Subject|0|||
148985291|NCT01785602|537423311|FG000|Overall Study|Lost to Follow-up|1|||
148985292|NCT01785602|537423312|FG001|Overall Study|Lost to Follow-up|1|||
148985293|NCT01785602|537423311|FG000|Overall Study|Adverse Event|3|||
148985294|NCT01785602|537423312|FG001|Overall Study|Adverse Event|5|||
148985295|NCT01785602|537423311|FG000|Overall Study|Administrative problems|7|||
148985296|NCT01785602|537423312|FG001|Overall Study|Administrative problems|3|||
148985297|NCT04177108|537423314|FG000|Overall Study|Withdrawal by Subject|4|||
148985298|NCT04177108|537423315|FG001|Overall Study|Withdrawal by Subject|8|||
148985299|NCT04177108|537423316|FG002|Overall Study|Withdrawal by Subject|9|||
148985300|NCT04177108|537423317|FG003|Overall Study|Withdrawal by Subject|11|||
148985301|NCT04177108|537423318|FG004|Overall Study|Withdrawal by Subject|13|||
148985302|NCT04177108|537423314|FG000|Overall Study|Physician Decision|23|||
148985303|NCT04177108|537423315|FG001|Overall Study|Physician Decision|15|||
148985304|NCT04177108|537423316|FG002|Overall Study|Physician Decision|18|||
148851510|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148851511|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
148851512|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148851513|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148851514|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148851515|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148851516|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
148851517|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
148851518|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
148851519|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
148985305|NCT04177108|537423317|FG003|Overall Study|Physician Decision|29|||
148985306|NCT04177108|537423318|FG004|Overall Study|Physician Decision|23|||
148985307|NCT04177108|537423314|FG000|Overall Study|Reason Not Specified|0|||
148985308|NCT04177108|537423315|FG001|Overall Study|Reason Not Specified|1|||
148985309|NCT04177108|537423316|FG002|Overall Study|Reason Not Specified|0|||
148985310|NCT04177108|537423317|FG003|Overall Study|Reason Not Specified|0|||
148985311|NCT04177108|537423318|FG004|Overall Study|Reason Not Specified|2|||
148985312|NCT04177108|537423314|FG000|Overall Study|Lost to Follow-up|0|||
148985313|NCT04177108|537423315|FG001|Overall Study|Lost to Follow-up|0|||
148985314|NCT04177108|537423316|FG002|Overall Study|Lost to Follow-up|1|||
148985315|NCT04177108|537423317|FG003|Overall Study|Lost to Follow-up|1|||
148985316|NCT04177108|537423318|FG004|Overall Study|Lost to Follow-up|1|||
148985317|NCT04177108|537423314|FG000|Overall Study|Death|16|||
148985318|NCT04177108|537423315|FG001|Overall Study|Death|19|||
148985319|NCT04177108|537423316|FG002|Overall Study|Death|13|||
148985320|NCT04177108|537423317|FG003|Overall Study|Death|17|||
148985321|NCT04177108|537423318|FG004|Overall Study|Death|18|||
148985322|NCT02041429|537423321|FG000|Overall Study|Progressive Disease|2|||
148985323|NCT02041429|537423322|FG001|Overall Study|Progressive Disease|2|||
148985324|NCT02041429|537423323|FG002|Overall Study|Progressive Disease|3|||
148985325|NCT02041429|537423324|FG003|Overall Study|Progressive Disease|2|||
148985326|NCT02041429|537423321|FG000|Overall Study|Toxicity|0|||
148985327|NCT02041429|537423322|FG001|Overall Study|Toxicity|1|||
148985328|NCT02041429|537423323|FG002|Overall Study|Toxicity|4|||
148985329|NCT02041429|537423324|FG003|Overall Study|Toxicity|2|||
148985330|NCT02041429|537423321|FG000|Overall Study|Withdrawal by Subject|0|||
148985331|NCT02041429|537423322|FG001|Overall Study|Withdrawal by Subject|1|||
148985332|NCT02041429|537423323|FG002|Overall Study|Withdrawal by Subject|0|||
148985333|NCT02041429|537423324|FG003|Overall Study|Withdrawal by Subject|0|||
148985334|NCT02041429|537423321|FG000|Overall Study|On Maintenance Therapy|1|||
148985335|NCT02041429|537423322|FG001|Overall Study|On Maintenance Therapy|0|||
148985336|NCT02041429|537423323|FG002|Overall Study|On Maintenance Therapy|0|||
148985337|NCT02041429|537423324|FG003|Overall Study|On Maintenance Therapy|2|||
148985338|NCT01427712|537423325|FG000|Overall Study|Transfer to a different hospital|2|||
148985339|NCT01427712|537423325|FG000|Overall Study|Lost to Follow-up|1|||
148985340|NCT01427712|537423325|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
148985341|NCT01427712|537423325|FG000|Overall Study|Failure to visit|1|||
148985342|NCT00784043|537423326|FG000|Overall Study|Withdrawal by Subject|8|||
148985343|NCT00784043|537423327|FG001|Overall Study|Withdrawal by Subject|5|||
148985344|NCT00784043|537423326|FG000|Overall Study|Protocol Terminated|23|||
148985345|NCT00784043|537423327|FG001|Overall Study|Protocol Terminated|1|||
148985346|NCT01143259|537423328|FG000|Overall Study|Withdrawal by Subject|3|||
148985347|NCT01143259|537423329|FG001|Overall Study|Withdrawal by Subject|2|||
148985348|NCT01143259|537423328|FG000|Overall Study|Protocol Violation|13|||
148985349|NCT01143259|537423329|FG001|Overall Study|Protocol Violation|9|||
148985350|NCT01143259|537423328|FG000|Overall Study|Screen Failure|7|||
148985351|NCT01143259|537423329|FG001|Overall Study|Screen Failure|9|||
148985352|NCT03791398|537423330|FG000|Overall Study|Progression of Disease Under Study|2|||
148985353|NCT03791398|537423331|FG001|Overall Study|Progression of Disease Under Study|0|||
148985354|NCT03791398|537423332|FG002|Overall Study|Progression of Disease Under Study|0|||
148985355|NCT00766376|537423335|FG000|Overall Study|Withdrawal by Subject|27|||
148985356|NCT02207829|537423336|FG000|Overall Study|Adverse Event|10|||
148985357|NCT02207829|537423337|FG001|Overall Study|Adverse Event|9|||
148985358|NCT02207829|537423336|FG000|Overall Study|Lack of Efficacy|7|||
148985359|NCT02207829|537423337|FG001|Overall Study|Lack of Efficacy|5|||
148985360|NCT02207829|537423336|FG000|Overall Study|Lost to Follow-up|2|||
148985361|NCT02207829|537423337|FG001|Overall Study|Lost to Follow-up|2|||
148985362|NCT02207829|537423336|FG000|Overall Study|Protocol deviation|5|||
148985363|NCT02207829|537423337|FG001|Overall Study|Protocol deviation|4|||
148985364|NCT02207829|537423336|FG000|Overall Study|Withdrew consent|18|||
148985365|NCT02207829|537423337|FG001|Overall Study|Withdrew consent|14|||
148985366|NCT01418209|537423338|FG000|Overall Study|Withdrawal by Subject|1|||
148985367|NCT01418209|537423339|FG001|Overall Study|Withdrawal by Subject|0|||
148985368|NCT01418209|537423340|FG002|Overall Study|Withdrawal by Subject|1|||
148985369|NCT01418209|537423338|FG000|Overall Study|Did not provide hot flash diary data|1|||
148985370|NCT01418209|537423339|FG001|Overall Study|Did not provide hot flash diary data|3|||
148985371|NCT01418209|537423340|FG002|Overall Study|Did not provide hot flash diary data|3|||
148985372|NCT00101101|537423341|FG000|Overall Study|never received vaccine|20|||
148985373|NCT01800903|537423342|FG000|Second Test Period|unable to catheterise|1|||
148985374|NCT01800903|537423343|FG001|Second Test Period|unable to catheterise|0|||
148985375|NCT01800903|537423344|FG002|Second Test Period|unable to catheterise|0|||
148985376|NCT01800903|537423345|FG003|Second Test Period|unable to catheterise|0|||
148985377|NCT01800903|537423346|FG004|Second Test Period|unable to catheterise|0|||
148985378|NCT01800903|537423347|FG005|Second Test Period|unable to catheterise|0|||
148985379|NCT00852397|537423349|FG000|Overall Study|Adverse Event|4|||
148985380|NCT00852397|537423350|FG001|Overall Study|Adverse Event|6|||
148985381|NCT00852397|537423351|FG002|Overall Study|Adverse Event|4|||
148985382|NCT00852397|537423349|FG000|Overall Study|Death|0|||
148985383|NCT00852397|537423350|FG001|Overall Study|Death|0|||
148985384|NCT00852397|537423351|FG002|Overall Study|Death|1|||
148985385|NCT00852397|537423349|FG000|Overall Study|Withdrawal by Subject|4|||
148985386|NCT00852397|537423350|FG001|Overall Study|Withdrawal by Subject|1|||
148985387|NCT00852397|537423351|FG002|Overall Study|Withdrawal by Subject|2|||
148985388|NCT00852397|537423349|FG000|Overall Study|Study terminated by sponsor|2|||
148985389|NCT00852397|537423350|FG001|Overall Study|Study terminated by sponsor|1|||
148985390|NCT00852397|537423351|FG002|Overall Study|Study terminated by sponsor|6|||
148985391|NCT00852397|537423349|FG000|Overall Study|Difficulty in study site visit|1|||
148985392|NCT00852397|537423350|FG001|Overall Study|Difficulty in study site visit|0|||
148985393|NCT00852397|537423351|FG002|Overall Study|Difficulty in study site visit|0|||
148985394|NCT00852397|537423349|FG000|Overall Study|Protocol Violation|0|||
148851520|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
148851521|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
148889377|NCT00101686|537074378|FG007|Overall Study|Withdrawal by Subject|7|||
148889378|NCT00101686|537074379|FG008|Overall Study|Withdrawal by Subject|8|||
148889379|NCT00101686|537074380|FG009|Overall Study|Withdrawal by Subject|9|||
148889380|NCT00296816|537074381|FG000|Overall Study|Disease Progression|37|||
148889381|NCT00296816|537074381|FG000|Overall Study|Adverse Event|18|||
148889382|NCT00296816|537074381|FG000|Overall Study|Investigator/Participant request|5|||
148889383|NCT00296816|537074381|FG000|Overall Study|Non-compliance|1|||
148889384|NCT00296816|537074381|FG000|Overall Study|Missing for end of treatment|4|||
148889385|NCT00296816|537074381|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
148889386|NCT00296816|537074381|FG000|Overall Study|Poor performance status|1|||
148889387|NCT00296816|537074381|FG000|Overall Study|Relocation to Florida|1|||
148889388|NCT00296816|537074381|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
148889389|NCT00296816|537074381|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
148889390|NCT00296816|537074381|FG000|Overall Study|Neuropathy/patient preference|1|||
148889391|NCT00296816|537074381|FG000|Overall Study|Proteinuria|1|||
148889392|NCT00296816|537074381|FG000|Overall Study|ineligibility due to radiation treatment|1|||
148889393|NCT00985465|537074382|FG000|Overall Study|Withdrawal by Subject|1|||
148889394|NCT00985465|537074383|FG001|Overall Study|Withdrawal by Subject|2|||
148889395|NCT00985465|537074382|FG000|Overall Study|Considered to be part of the other group|0|||
148889396|NCT00985465|537074383|FG001|Overall Study|Considered to be part of the other group|1|||
148889397|NCT01054456|537074384|FG000|Overall Study|Other|1|||
148889398|NCT00687401|537074386|FG000|Overall Study|Protocol Violation|7|||
148889399|NCT00687401|537074386|FG000|Overall Study|Adverse Event|6|||
148889400|NCT00687401|537074386|FG000|Overall Study|Lack of Efficacy|6|||
148889401|NCT00687401|537074386|FG000|Overall Study|Withdrawal by Subject|4|||
148889402|NCT00687401|537074386|FG000|Overall Study|Did not return for visit|3|||
148889403|NCT00687401|537074386|FG000|Overall Study|For reasons different from those above|4|||
148889404|NCT02336607|537074387|FG000|Overall Study|Physician Decision|1|||
148889405|NCT02336607|537074388|FG001|Overall Study|Physician Decision|4|||
148889406|NCT02336607|537074389|FG002|Overall Study|Physician Decision|3|||
148889407|NCT02336607|537074390|FG003|Overall Study|Physician Decision|15|||
148889408|NCT02336607|537074387|FG000|Overall Study|Lack of Efficacy|1|||
148889409|NCT02336607|537074388|FG001|Overall Study|Lack of Efficacy|0|||
148889410|NCT02336607|537074389|FG002|Overall Study|Lack of Efficacy|0|||
148889411|NCT02336607|537074390|FG003|Overall Study|Lack of Efficacy|2|||
148889412|NCT02336607|537074387|FG000|Overall Study|Lost to Follow-up|2|||
148889413|NCT02336607|537074388|FG001|Overall Study|Lost to Follow-up|1|||
148889414|NCT02336607|537074389|FG002|Overall Study|Lost to Follow-up|0|||
148889415|NCT02336607|537074390|FG003|Overall Study|Lost to Follow-up|21|||
148889416|NCT02336607|537074387|FG000|Overall Study|Protocol Violation|0|||
148889417|NCT02336607|537074388|FG001|Overall Study|Protocol Violation|1|||
148889418|NCT02336607|537074389|FG002|Overall Study|Protocol Violation|1|||
148889419|NCT02336607|537074390|FG003|Overall Study|Protocol Violation|3|||
148889420|NCT02336607|537074387|FG000|Overall Study|Adverse Event|0|||
148889421|NCT02336607|537074388|FG001|Overall Study|Adverse Event|2|||
148889422|NCT02336607|537074389|FG002|Overall Study|Adverse Event|2|||
148889423|NCT02336607|537074390|FG003|Overall Study|Adverse Event|26|||
148889424|NCT02336607|537074387|FG000|Overall Study|Withdrawal by Subject|0|||
148889425|NCT02336607|537074388|FG001|Overall Study|Withdrawal by Subject|2|||
148889426|NCT02336607|537074389|FG002|Overall Study|Withdrawal by Subject|0|||
148889427|NCT02336607|537074390|FG003|Overall Study|Withdrawal by Subject|20|||
148889428|NCT01721161|537074395|FG000|Overall Study|Adverse Event|2|||
148889429|NCT01721161|537074396|FG001|Overall Study|Adverse Event|3|||
148889430|NCT01721161|537074395|FG000|Overall Study|Lost to Follow-up|1|||
148889431|NCT01721161|537074396|FG001|Overall Study|Lost to Follow-up|2|||
148889432|NCT01721161|537074395|FG000|Overall Study|Withdrawal by Subject|1|||
148889433|NCT01721161|537074396|FG001|Overall Study|Withdrawal by Subject|1|||
148889434|NCT01721161|537074395|FG000|Overall Study|Other|0|||
148889435|NCT01721161|537074396|FG001|Overall Study|Other|1|||
148889436|NCT00148759|537074397|FG000|Overall Study|Withdrawal by Subject|1|||
148889437|NCT00148759|537074398|FG001|Overall Study|Withdrawal by Subject|1|||
148889438|NCT00148759|537074397|FG000|Overall Study|Lost to Follow-up|1|||
148889439|NCT00148759|537074398|FG001|Overall Study|Lost to Follow-up|0|||
148889440|NCT02888106|537074406|FG000|Overall Study|Withdrawal by Subject|1|||
148889441|NCT02888106|537074407|FG001|Overall Study|Withdrawal by Subject|2|||
148889442|NCT02888106|537074408|FG002|Overall Study|Withdrawal by Subject|0|||
148889443|NCT02888106|537074409|FG003|Overall Study|Withdrawal by Subject|1|||
148889444|NCT02888106|537074410|FG004|Overall Study|Withdrawal by Subject|0|||
148889445|NCT02888106|537074411|FG005|Overall Study|Withdrawal by Subject|0|||
148889446|NCT02888106|537074406|FG000|Overall Study|Lost to Follow-up|1|||
148889447|NCT02888106|537074407|FG001|Overall Study|Lost to Follow-up|0|||
148889448|NCT02888106|537074408|FG002|Overall Study|Lost to Follow-up|0|||
148985395|NCT00852397|537423350|FG001|Overall Study|Protocol Violation|0|||
148985396|NCT00852397|537423351|FG002|Overall Study|Protocol Violation|1|||
148985397|NCT01968434|537423357|FG000|Overall Study|Lost to Follow-up|3|||
148985398|NCT01968434|537423358|FG001|Overall Study|Lost to Follow-up|6|||
148985399|NCT00428610|537423359|FG000|Overall Study|Death Due to Adverse Event|3|||
148985400|NCT00428610|537423360|FG001|Overall Study|Death Due to Adverse Event|0|||
148985401|NCT00428610|537423361|FG002|Overall Study|Death Due to Adverse Event|5|||
148985402|NCT00428610|537423359|FG000|Overall Study|Death Due to Progressive Disease|0|||
148985403|NCT00428610|537423360|FG001|Overall Study|Death Due to Progressive Disease|0|||
148985404|NCT00428610|537423361|FG002|Overall Study|Death Due to Progressive Disease|2|||
148985405|NCT00428610|537423359|FG000|Overall Study|Adverse Event|2|||
148985406|NCT00428610|537423360|FG001|Overall Study|Adverse Event|3|||
148985407|NCT00428610|537423361|FG002|Overall Study|Adverse Event|2|||
148985408|NCT00428610|537423359|FG000|Overall Study|Investigator Decision|2|||
148985409|NCT00428610|537423360|FG001|Overall Study|Investigator Decision|1|||
148985410|NCT00428610|537423361|FG002|Overall Study|Investigator Decision|1|||
148985411|NCT00428610|537423359|FG000|Overall Study|Progressive Disease|42|||
148985412|NCT00428610|537423360|FG001|Overall Study|Progressive Disease|14|||
148985413|NCT00428610|537423361|FG002|Overall Study|Progressive Disease|22|||
148985414|NCT00428610|537423359|FG000|Overall Study|Withdrawal by Subject|4|||
148985415|NCT00428610|537423360|FG001|Overall Study|Withdrawal by Subject|0|||
148985416|NCT00428610|537423361|FG002|Overall Study|Withdrawal by Subject|0|||
148985417|NCT02280044|537425528|FG000|Overall Study|Planned alternate|0|||
148985418|NCT02280044|537425529|FG001|Overall Study|Planned alternate|2|||
148985419|NCT02105116|537425530|FG000|Overall Study|not eligible for step 2 of trial|5|||
148985420|NCT02105116|537425530|FG000|Overall Study|Death|1|||
148985421|NCT04837482|537425531|FG000|Period 2|Withdrawal by Subject|0|||
148985422|NCT04837482|537425532|FG001|Period 2|Withdrawal by Subject|1|||
148985423|NCT00987467|537425533|FG000|Overall Study|Lost to Follow-up|2|||
148985424|NCT02646423|537425534|FG000|Overall Study|Adverse Event|5|||
148985425|NCT02646423|537425535|FG001|Overall Study|Adverse Event|7|||
148985426|NCT02646423|537425534|FG000|Overall Study|Ineligible|2|||
148985427|NCT02646423|537425535|FG001|Overall Study|Ineligible|1|||
148985428|NCT00086346|537425539|FG000|Randomization|Did not receive test article|4|||
148985429|NCT00086346|537425540|FG001|Randomization|Did not receive test article|4|||
148985430|NCT00086346|537425539|FG000|Patients Dosed With Test Article|Adverse Event|94|||
148985431|NCT00086346|537425540|FG001|Patients Dosed With Test Article|Adverse Event|11|||
148985432|NCT00086346|537425539|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
148985433|NCT00086346|537425540|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
148985434|NCT00086346|537425539|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
148985435|NCT00086346|537425540|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
148985436|NCT00086346|537425539|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
148985437|NCT00086346|537425540|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
148985438|NCT00086346|537425539|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
148985439|NCT00086346|537425540|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
148985440|NCT00086346|537425539|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
148985441|NCT00086346|537425540|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
148985442|NCT02807948|537425541|FG000|Overall Study|Physician Decision|1|||
148985443|NCT02807948|537425542|FG001|Overall Study|Physician Decision|0|||
148985444|NCT01303627|537425545|FG000|Overall Study|the failure while performing URS|0|||
148985445|NCT01303627|537425546|FG001|Overall Study|the failure while performing URS|1|||
149030215|NCT03852433|537587974|FG002|Overall Study|Randomized but never treated|0|||
149030216|NCT03852433|537587975|FG003|Overall Study|Randomized but never treated|0|||
148851522|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
148851523|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
148851524|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
148851525|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
148851526|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
148851527|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
148851528|NCT03985943|536930663|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
148851529|NCT03985943|536930664|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
148985446|NCT00844194|537425547|FG000|Overall Study|Adverse Event|17|||
148985447|NCT00844194|537425548|FG001|Overall Study|Adverse Event|5|||
148985448|NCT00844194|537425547|FG000|Overall Study|Protocol Violation|1|||
148985449|NCT00844194|537425548|FG001|Overall Study|Protocol Violation|1|||
148985450|NCT00844194|537425547|FG000|Overall Study|Lost to Follow-up|1|||
148985451|NCT00844194|537425548|FG001|Overall Study|Lost to Follow-up|1|||
148985452|NCT00844194|537425547|FG000|Overall Study|Withdrawal by Subject|2|||
148985453|NCT00844194|537425548|FG001|Overall Study|Withdrawal by Subject|1|||
148985454|NCT00844194|537425547|FG000|Overall Study|Lack of Efficacy|3|||
148985455|NCT00844194|537425548|FG001|Overall Study|Lack of Efficacy|0|||
148985456|NCT00844194|537425547|FG000|Overall Study|Other reason (not specified)|1|||
148851530|NCT03985943|536930665|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
148851531|NCT03985943|536930666|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
148851532|NCT03985943|536930667|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
148851533|NCT03985943|536930668|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
148851534|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
148851535|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
148851536|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
148851537|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
148851538|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
148851539|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
148851540|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
148851541|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
148851542|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
148851543|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
148851544|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
148851545|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
148851546|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
148851547|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
148851548|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
148851549|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
148851550|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
148851551|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
148851552|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148851553|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148851554|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148851555|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
148851556|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
148851557|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
148851558|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
148851559|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
148851560|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
148851561|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
148851562|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
148851563|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
148851564|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
148851565|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
148851566|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
148851567|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
148851568|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
148851569|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
148851570|NCT03985943|536930663|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
148851571|NCT03985943|536930664|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
148851572|NCT03985943|536930665|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
148851573|NCT03985943|536930666|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
148851574|NCT03985943|536930667|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
148851575|NCT03985943|536930668|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
148851576|NCT00338286|536930669|FG000|Overall Study|Withdrawal by Subject|50|||
148851577|NCT00338286|536930670|FG001|Overall Study|Withdrawal by Subject|54|||
148851578|NCT00338286|536930669|FG000|Overall Study|Lost to Follow-up|80|||
148851579|NCT00338286|536930670|FG001|Overall Study|Lost to Follow-up|66|||
148851580|NCT00338286|536930669|FG000|Overall Study|Other|103|||
148851581|NCT00338286|536930670|FG001|Overall Study|Other|93|||
148851582|NCT00022763|536930675|FG000|Overall Study|Adverse Event|1|||
148851583|NCT00022763|536930676|FG001|Overall Study|Adverse Event|2|||
148851584|NCT00022763|536930675|FG000|Overall Study|Injection Site Reactions|0|||
148851585|NCT00022763|536930676|FG001|Overall Study|Injection Site Reactions|2|||
148851586|NCT00022763|536930675|FG000|Overall Study|Death|0|||
148851587|NCT00022763|536930676|FG001|Overall Study|Death|1|||
148851588|NCT00022763|536930675|FG000|Overall Study|Lost to Follow-up|0|||
148851589|NCT00022763|536930676|FG001|Overall Study|Lost to Follow-up|3|||
148985457|NCT00844194|537425548|FG001|Overall Study|Other reason (not specified)|0|||
148985458|NCT00562159|537425549|FG000|Overall Study|Adverse Event|11|||
148985459|NCT00562159|537425550|FG001|Overall Study|Adverse Event|8|||
148985460|NCT00562159|537425549|FG000|Overall Study|Lost to Follow-up|5|||
148985461|NCT00562159|537425550|FG001|Overall Study|Lost to Follow-up|4|||
148851590|NCT00022763|536930675|FG000|Overall Study|Withdrawal by Subject|4|||
148985462|NCT00562159|537425549|FG000|Overall Study|Withdrawal by Subject|9|||
148985463|NCT00562159|537425550|FG001|Overall Study|Withdrawal by Subject|8|||
148985464|NCT00562159|537425549|FG000|Overall Study|Protocol Violation|12|||
148985465|NCT00562159|537425550|FG001|Overall Study|Protocol Violation|12|||
148985466|NCT00562159|537425549|FG000|Overall Study|Did not meet protocol eligibility|1|||
148985467|NCT00562159|537425550|FG001|Overall Study|Did not meet protocol eligibility|1|||
148985468|NCT02352493|537425559|FG000|Overall Study|Pregnancy|0|||
148985469|NCT02352493|537425560|FG001|Overall Study|Pregnancy|0|||
148985470|NCT02352493|537425561|FG002|Overall Study|Pregnancy|0|||
148985471|NCT02352493|537425562|FG003|Overall Study|Pregnancy|0|||
148985472|NCT02352493|537425563|FG004|Overall Study|Pregnancy|0|||
148985473|NCT02352493|537425564|FG005|Overall Study|Pregnancy|0|||
148985474|NCT02352493|537425565|FG006|Overall Study|Pregnancy|1|||
148985475|NCT02352493|537425566|FG007|Overall Study|Pregnancy|0|||
148985476|NCT02352493|537425567|FG008|Overall Study|Pregnancy|1|||
148985477|NCT02352493|537425568|FG009|Overall Study|Pregnancy|0|||
148985478|NCT02352493|537425569|FG010|Overall Study|Pregnancy|0|||
148985479|NCT02352493|537425570|FG011|Overall Study|Pregnancy|0|||
148985480|NCT02352493|537425571|FG012|Overall Study|Pregnancy|0|||
148985481|NCT02352493|537425572|FG013|Overall Study|Pregnancy|0|||
148985482|NCT02352493|537425573|FG014|Overall Study|Pregnancy|0|||
148985483|NCT02352493|537425574|FG015|Overall Study|Pregnancy|0|||
148985484|NCT02352493|537425575|FG016|Overall Study|Pregnancy|0|||
148985485|NCT02352493|537425576|FG017|Overall Study|Pregnancy|0|||
148985486|NCT02352493|537425559|FG000|Overall Study|Withdrawal by Subject|0|||
148985487|NCT02352493|537425560|FG001|Overall Study|Withdrawal by Subject|0|||
148985488|NCT02352493|537425561|FG002|Overall Study|Withdrawal by Subject|0|||
148985489|NCT02352493|537425562|FG003|Overall Study|Withdrawal by Subject|0|||
148985490|NCT02352493|537425563|FG004|Overall Study|Withdrawal by Subject|0|||
148985491|NCT02352493|537425564|FG005|Overall Study|Withdrawal by Subject|0|||
148985492|NCT02352493|537425565|FG006|Overall Study|Withdrawal by Subject|0|||
148985493|NCT02352493|537425566|FG007|Overall Study|Withdrawal by Subject|0|||
148985494|NCT02352493|537425567|FG008|Overall Study|Withdrawal by Subject|1|||
148985495|NCT02352493|537425568|FG009|Overall Study|Withdrawal by Subject|0|||
148985496|NCT02352493|537425569|FG010|Overall Study|Withdrawal by Subject|0|||
148985497|NCT02352493|537425570|FG011|Overall Study|Withdrawal by Subject|0|||
148985498|NCT02352493|537425571|FG012|Overall Study|Withdrawal by Subject|0|||
148985499|NCT02352493|537425572|FG013|Overall Study|Withdrawal by Subject|0|||
148985500|NCT02352493|537425573|FG014|Overall Study|Withdrawal by Subject|1|||
148985501|NCT02352493|537425574|FG015|Overall Study|Withdrawal by Subject|0|||
148985502|NCT02352493|537425575|FG016|Overall Study|Withdrawal by Subject|0|||
148985503|NCT02352493|537425576|FG017|Overall Study|Withdrawal by Subject|0|||
148985504|NCT02352493|537425559|FG000|Overall Study|Lost to Follow-up|0|||
148985505|NCT02352493|537425560|FG001|Overall Study|Lost to Follow-up|0|||
148985506|NCT02352493|537425561|FG002|Overall Study|Lost to Follow-up|0|||
148985507|NCT02352493|537425562|FG003|Overall Study|Lost to Follow-up|0|||
148985508|NCT02352493|537425563|FG004|Overall Study|Lost to Follow-up|0|||
148985509|NCT02352493|537425564|FG005|Overall Study|Lost to Follow-up|0|||
148985510|NCT02352493|537425565|FG006|Overall Study|Lost to Follow-up|0|||
148985511|NCT02352493|537425566|FG007|Overall Study|Lost to Follow-up|0|||
148985512|NCT02352493|537425567|FG008|Overall Study|Lost to Follow-up|0|||
148985513|NCT02352493|537425568|FG009|Overall Study|Lost to Follow-up|1|||
148851591|NCT00022763|536930676|FG001|Overall Study|Withdrawal by Subject|7|||
148851592|NCT00022763|536930675|FG000|Overall Study|Insufficient Therapy|1|||
148851593|NCT00022763|536930676|FG001|Overall Study|Insufficient Therapy|0|||
148851594|NCT00022763|536930675|FG000|Overall Study|Admin|3|||
148851595|NCT00022763|536930676|FG001|Overall Study|Admin|2|||
148851596|NCT04075513|536930677|FG000|Overall Study|Withdrawal by Subject|2|||
148985514|NCT02352493|537425569|FG010|Overall Study|Lost to Follow-up|0|||
148985515|NCT02352493|537425570|FG011|Overall Study|Lost to Follow-up|0|||
148985516|NCT02352493|537425571|FG012|Overall Study|Lost to Follow-up|1|||
148985517|NCT02352493|537425572|FG013|Overall Study|Lost to Follow-up|2|||
148985518|NCT02352493|537425573|FG014|Overall Study|Lost to Follow-up|0|||
148985519|NCT02352493|537425574|FG015|Overall Study|Lost to Follow-up|0|||
148985520|NCT02352493|537425575|FG016|Overall Study|Lost to Follow-up|0|||
148985521|NCT02352493|537425576|FG017|Overall Study|Lost to Follow-up|0|||
148985522|NCT02162810|537425577|FG000|Overall Study|Protocol Violation|1|||
148985523|NCT02162810|537425578|FG001|Overall Study|Protocol Violation|0|||
148985524|NCT02162810|537425577|FG000|Overall Study|patients did not report compliance|4|||
148985525|NCT02162810|537425578|FG001|Overall Study|patients did not report compliance|1|||
148985526|NCT02546544|537425583|FG000|Overall Study|Disease Progression|14|||
148985527|NCT02546544|537425583|FG000|Overall Study|Adverse Event|1|||
148985528|NCT02546544|537425583|FG000|Overall Study|Withdrawal by Subject|1|||
148985529|NCT01921348|537425584|FG000|Overall Study|Withdrawal by Subject|1|||
148985530|NCT01921348|537425585|FG001|Overall Study|Withdrawal by Subject|0|||
148985531|NCT01921348|537425584|FG000|Overall Study|Lost to Follow-up|0|||
148985532|NCT01921348|537425585|FG001|Overall Study|Lost to Follow-up|2|||
148985533|NCT02223390|537425586|FG000|Overall Study|Lost to Follow-up|9|||
148985534|NCT02223390|537425587|FG001|Overall Study|Lost to Follow-up|4|||
148985535|NCT01465334|537425588|FG000|Overall Study|Disease Progression|1|||
148985536|NCT01465334|537425589|FG001|Overall Study|Disease Progression|0|||
148985537|NCT01465334|537425588|FG000|Overall Study|Adverse Event|1|||
148985538|NCT01465334|537425589|FG001|Overall Study|Adverse Event|0|||
148985539|NCT01465334|537425588|FG000|Overall Study|Richter's transformation|0|||
148985540|NCT01465334|537425589|FG001|Overall Study|Richter's transformation|3|||
148985541|NCT01465334|537425588|FG000|Overall Study|Refractory Disease|0|||
148985542|NCT01465334|537425589|FG001|Overall Study|Refractory Disease|3|||
148985543|NCT00795600|537425594|FG000|Overall Study|Adverse Event|1|||
148985544|NCT00795600|537425595|FG001|Overall Study|Adverse Event|1|||
148985545|NCT00795600|537425594|FG000|Overall Study|Protocol Violation|1|||
148985546|NCT00795600|537425595|FG001|Overall Study|Protocol Violation|2|||
148985547|NCT00795600|537425594|FG000|Overall Study|Withdrawal by Subject|1|||
148985548|NCT00795600|537425595|FG001|Overall Study|Withdrawal by Subject|0|||
148985549|NCT00795600|537425594|FG000|Overall Study|Unclassified|1|||
148985550|NCT00795600|537425595|FG001|Overall Study|Unclassified|1|||
148985551|NCT01248884|537425596|FG000|Overall Study|Withdrawal by Subject|1|||
148985552|NCT01248884|537425597|FG001|Overall Study|Withdrawal by Subject|3|||
148985553|NCT01248884|537425598|FG002|Overall Study|Withdrawal by Subject|1|||
148985554|NCT01248884|537425596|FG000|Overall Study|Adverse Event|1|||
148985555|NCT01248884|537425597|FG001|Overall Study|Adverse Event|0|||
148985556|NCT01248884|537425598|FG002|Overall Study|Adverse Event|0|||
148985557|NCT00462384|537425599|FG000|Overall Study|Adverse Event|2|||
148985558|NCT00462384|537425599|FG000|Overall Study|Death|2|||
148985559|NCT00462384|537425599|FG000|Overall Study|Withdrawal by Subject|1|||
148985560|NCT00462384|537425599|FG000|Overall Study|Other|4|||
148985561|NCT01131312|537425600|FG000|Overall Study|Lost to Follow-up|425|||
148985562|NCT01131312|537425601|FG001|Overall Study|Lost to Follow-up|229|||
148985563|NCT01131312|537425602|FG002|Overall Study|Lost to Follow-up|351|||
148985564|NCT03879798|537425603|FG000|Overall Study|Adverse Event|0|||
148985565|NCT03879798|537425604|FG001|Overall Study|Adverse Event|0|||
148985566|NCT03879798|537425605|FG002|Overall Study|Adverse Event|0|||
148985567|NCT03879798|537425606|FG003|Overall Study|Adverse Event|0|||
148985568|NCT03879798|537425607|FG004|Overall Study|Adverse Event|0|||
148985569|NCT03879798|537425608|FG005|Overall Study|Adverse Event|1|||
148985570|NCT03879798|537425603|FG000|Overall Study|Lack of Efficacy|0|||
148985571|NCT03879798|537425604|FG001|Overall Study|Lack of Efficacy|0|||
148985572|NCT03879798|537425605|FG002|Overall Study|Lack of Efficacy|0|||
148985573|NCT03879798|537425606|FG003|Overall Study|Lack of Efficacy|0|||
148985574|NCT03879798|537425607|FG004|Overall Study|Lack of Efficacy|0|||
148985575|NCT03879798|537425608|FG005|Overall Study|Lack of Efficacy|1|||
148985576|NCT03879798|537425603|FG000|Overall Study|Withdrawal by Subject|0|||
148985577|NCT03879798|537425604|FG001|Overall Study|Withdrawal by Subject|0|||
148985578|NCT03879798|537425605|FG002|Overall Study|Withdrawal by Subject|0|||
148985579|NCT03879798|537425606|FG003|Overall Study|Withdrawal by Subject|0|||
148985580|NCT03879798|537425607|FG004|Overall Study|Withdrawal by Subject|0|||
148985581|NCT03879798|537425608|FG005|Overall Study|Withdrawal by Subject|1|||
148985582|NCT03783923|537425610|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
148985583|NCT03783923|537425611|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
148985584|NCT03783923|537425610|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
148985585|NCT03783923|537425611|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
148985586|NCT03783923|537425610|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
148985587|NCT03783923|537425611|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
148985588|NCT03783923|537425610|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
148985589|NCT03783923|537425611|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
148985590|NCT03783923|537425610|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
148985591|NCT03783923|537425611|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
148985592|NCT03067441|537425612|FG000|Overall Study|Withdrawal by Subject|16|||
148985593|NCT03067441|537425613|FG001|Overall Study|Withdrawal by Subject|34|||
148985594|NCT03067441|537425612|FG000|Overall Study|Lost to Follow-up|7|||
148985595|NCT03067441|537425613|FG001|Overall Study|Lost to Follow-up|5|||
148985596|NCT03067441|537425612|FG000|Overall Study|Adverse Event|7|||
148985597|NCT03067441|537425613|FG001|Overall Study|Adverse Event|14|||
148985598|NCT03067441|537425612|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
148985599|NCT03067441|537425613|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
148985600|NCT03067441|537425612|FG000|Overall Study|Physician Decision|1|||
148985601|NCT03067441|537425613|FG001|Overall Study|Physician Decision|3|||
148985602|NCT03067441|537425612|FG000|Overall Study|Other|1|||
148985603|NCT03067441|537425613|FG001|Overall Study|Other|1|||
148985604|NCT00817089|537425614|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
148985605|NCT00817089|537425615|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
148985606|NCT00817089|537425616|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
148985607|NCT00817089|537425617|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
148985608|NCT00817089|537425614|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
149030217|NCT02524288|537587976|FG000|Overall Study|Adverse Event|115|||
148985609|NCT00817089|537425615|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
148985610|NCT00817089|537425616|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
148985611|NCT00817089|537425617|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
148985612|NCT01944046|537425624|FG000|Randomized to DB|Adverse Event|5|||
149030218|NCT02524288|537587976|FG000|Overall Study|Lost to Follow-up|216|||
148985613|NCT01944046|537425625|FG001|Randomized to DB|Adverse Event|2|||
148985614|NCT01944046|537425624|FG000|Randomized to DB|Clinical Worsening|3|||
148985615|NCT01944046|537425625|FG001|Randomized to DB|Clinical Worsening|2|||
148985616|NCT01944046|537425624|FG000|Randomized to DB|Lost to Follow-up|3|||
148985617|NCT01944046|537425625|FG001|Randomized to DB|Lost to Follow-up|3|||
148985618|NCT01944046|537425624|FG000|Randomized to DB|Withdrawal by Subject|2|||
148985619|NCT01944046|537425625|FG001|Randomized to DB|Withdrawal by Subject|4|||
148985620|NCT01944046|537425624|FG000|Randomized to DB|Physician Decision|1|||
148985621|NCT01944046|537425625|FG001|Randomized to DB|Physician Decision|2|||
148985622|NCT01944046|537425624|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
148985623|NCT01944046|537425625|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
148985624|NCT01944046|537425624|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
148985625|NCT01944046|537425625|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
148985626|NCT01944046|537425624|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
148985627|NCT01944046|537425625|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
148985628|NCT01944046|537425624|FG000|Open Label Eligible and Consented|Adverse Event|6|||
148985629|NCT01944046|537425625|FG001|Open Label Eligible and Consented|Adverse Event|1|||
148985630|NCT01944046|537425624|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
148985631|NCT01944046|537425625|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
148985632|NCT01944046|537425624|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
148985633|NCT01944046|537425625|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
148985634|NCT01767116|537425632|FG000|Overall Study|Lost to Follow-up|2|||
148985635|NCT01767116|537425633|FG001|Overall Study|Lost to Follow-up|2|||
148985636|NCT01985126|537425640|FG000|Overall Study|Death|15|||
148985637|NCT01985126|537425641|FG001|Overall Study|Death|69|||
148985638|NCT01985126|537425640|FG000|Overall Study|Lost to Follow-up|0|||
148985639|NCT01985126|537425641|FG001|Overall Study|Lost to Follow-up|8|||
148985640|NCT01985126|537425640|FG000|Overall Study|Study Terminated By Sponsor|1|||
148985641|NCT01985126|537425641|FG001|Overall Study|Study Terminated By Sponsor|22|||
148985642|NCT01985126|537425640|FG000|Overall Study|Withdrawal by Subject|2|||
148985643|NCT01985126|537425641|FG001|Overall Study|Withdrawal by Subject|7|||
148985644|NCT05799495|537425644|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
148985645|NCT05799495|537425645|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
148985646|NCT05799495|537425646|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
148985647|NCT05799495|537425647|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
148985648|NCT05799495|537425644|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
148985649|NCT05799495|537425645|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
148985650|NCT05799495|537425646|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
148985651|NCT05799495|537425647|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
148985652|NCT05799495|537425644|FG000|Treatment (Up to 5 Days)|Other|0|||
148985653|NCT05799495|537425645|FG001|Treatment (Up to 5 Days)|Other|1|||
148985654|NCT05799495|537425646|FG002|Treatment (Up to 5 Days)|Other|0|||
148985655|NCT05799495|537425647|FG003|Treatment (Up to 5 Days)|Other|0|||
148985656|NCT05799495|537425644|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
148985657|NCT05799495|537425645|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
148985658|NCT05799495|537425646|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
148985659|NCT05799495|537425647|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
148985660|NCT05799495|537425644|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
148985661|NCT05799495|537425645|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
148985662|NCT05799495|537425646|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
148985663|NCT05799495|537425647|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
148985664|NCT05799495|537425644|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148985665|NCT05799495|537425645|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148985666|NCT05799495|537425646|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
148985667|NCT05799495|537425647|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
148985668|NCT03694548|537425651|FG000|Part A Survey|Protocol Violation|3|||
148985669|NCT03694548|537425652|FG001|Part A Survey|Protocol Violation|3|||
148985670|NCT03694548|537425653|FG002|Part A Survey|Protocol Violation|0|||
148985671|NCT03694548|537425651|FG000|Part B Yoga Program|Protocol Violation|0|||
148985672|NCT03694548|537425652|FG001|Part B Yoga Program|Protocol Violation|0|||
148985673|NCT03694548|537425653|FG002|Part B Yoga Program|Protocol Violation|3|||
148985674|NCT03694548|537425651|FG000|Part B Yoga Program|Did not attend intervention|0|||
148985675|NCT03694548|537425652|FG001|Part B Yoga Program|Did not attend intervention|0|||
148985676|NCT03694548|537425653|FG002|Part B Yoga Program|Did not attend intervention|8|||
148985677|NCT00439777|537425654|FG000|Treatment Period|Death|29|||
148985678|NCT00439777|537425655|FG001|Treatment Period|Death|21|||
148985679|NCT00439777|537425654|FG000|Treatment Period|Study terminated by sponsor|125|||
148985680|NCT00439777|537425655|FG001|Treatment Period|Study terminated by sponsor|132|||
148985681|NCT00439777|537425654|FG000|Treatment Period|Site closed by investigator|0|||
148985682|NCT00439777|537425655|FG001|Treatment Period|Site closed by investigator|1|||
148985683|NCT00439777|537425654|FG000|Treatment Period|Did not take study treatment|7|||
148985684|NCT00439777|537425655|FG001|Treatment Period|Did not take study treatment|8|||
148985685|NCT00439777|537425654|FG000|Treatment Period|Adverse Event|111|||
148985686|NCT00439777|537425655|FG001|Treatment Period|Adverse Event|92|||
148985687|NCT00439777|537425654|FG000|Treatment Period|Protocol Violation|23|||
148985688|NCT00439777|537425655|FG001|Treatment Period|Protocol Violation|30|||
148985689|NCT00439777|537425654|FG000|Treatment Period|Withdrawal by Subject|66|||
148985690|NCT00439777|537425655|FG001|Treatment Period|Withdrawal by Subject|118|||
148985691|NCT00439777|537425654|FG000|Treatment Period|Lack of Efficacy|1|||
148985692|NCT00439777|537425655|FG001|Treatment Period|Lack of Efficacy|4|||
148985693|NCT00439777|537425654|FG000|Treatment Period|Lost to Follow-up|8|||
148985694|NCT00439777|537425655|FG001|Treatment Period|Lost to Follow-up|10|||
148985695|NCT00439777|537425654|FG000|Treatment Period|Protocol driven decision point|1|||
148985696|NCT00439777|537425655|FG001|Treatment Period|Protocol driven decision point|3|||
148985697|NCT00439777|537425654|FG000|Treatment Period|Physician Decision|7|||
148985698|NCT00439777|537425655|FG001|Treatment Period|Physician Decision|18|||
148985699|NCT00439777|537425654|FG000|Treatment Period|Clinical endpoint reached|26|||
148985700|NCT00439777|537425655|FG001|Treatment Period|Clinical endpoint reached|13|||
148985701|NCT00439777|537425654|FG000|Treatment Period|Technical problems|3|||
148985702|NCT00439777|537425655|FG001|Treatment Period|Technical problems|1|||
148985703|NCT00439777|537425654|FG000|Treatment Period|Participant convenience|12|||
148985704|NCT00439777|537425655|FG001|Treatment Period|Participant convenience|8|||
148985705|NCT00439777|537425654|FG000|Observational Period|Protocol Violation|0|||
148985706|NCT00439777|537425655|FG001|Observational Period|Protocol Violation|2|||
148985707|NCT00439777|537425654|FG000|Observational Period|Withdrawal by Subject|9|||
148985708|NCT00439777|537425655|FG001|Observational Period|Withdrawal by Subject|5|||
148985709|NCT00439777|537425654|FG000|Observational Period|Lost to Follow-up|1|||
148985710|NCT00439777|537425655|FG001|Observational Period|Lost to Follow-up|11|||
148985711|NCT00439777|537425654|FG000|Observational Period|Death|27|||
148985712|NCT00439777|537425655|FG001|Observational Period|Death|20|||
148985713|NCT00439777|537425654|FG000|Observational Period|Study terminated by sponsor|3|||
148985714|NCT00439777|537425655|FG001|Observational Period|Study terminated by sponsor|1|||
148985715|NCT00439777|537425654|FG000|Observational Period|Protocol driven decision point|0|||
148985716|NCT00439777|537425655|FG001|Observational Period|Protocol driven decision point|1|||
148985717|NCT00439777|537425654|FG000|Observational Period|Lack of Efficacy|1|||
148985718|NCT00439777|537425655|FG001|Observational Period|Lack of Efficacy|0|||
148985719|NCT00439777|537425654|FG000|Observational Period|Technical problems|0|||
148985720|NCT00439777|537425655|FG001|Observational Period|Technical problems|1|||
148985721|NCT00661492|537425656|FG000|Overall Study|Adverse Event|16|||
148985722|NCT00661492|537425657|FG001|Overall Study|Adverse Event|13|||
148985723|NCT00661492|537425656|FG000|Overall Study|Disease Progression|44|||
148985724|NCT00661492|537425657|FG001|Overall Study|Disease Progression|14|||
148985725|NCT00661492|537425656|FG000|Overall Study|Patient Request|6|||
148985726|NCT00661492|537425657|FG001|Overall Study|Patient Request|1|||
148985727|NCT00661492|537425656|FG000|Overall Study|Investigator Request|1|||
148985728|NCT00661492|537425657|FG001|Overall Study|Investigator Request|0|||
148985729|NCT00661492|537425656|FG000|Overall Study|Lost to Follow-up|0|||
148985730|NCT00661492|537425657|FG001|Overall Study|Lost to Follow-up|1|||
148985731|NCT00661492|537425656|FG000|Overall Study|Other|1|||
148985732|NCT00661492|537425657|FG001|Overall Study|Other|0|||
148985733|NCT01024387|537425658|FG000|Overall Study|Radiographic Progression|29|||
148985734|NCT01024387|537425658|FG000|Overall Study|Symptomatic Progression|10|||
148985735|NCT01024387|537425658|FG000|Overall Study|Physician Decision|5|||
148985736|NCT01024387|537425658|FG000|Overall Study|Withdrawal by Subject|5|||
148985737|NCT01024387|537425658|FG000|Overall Study|Death|2|||
148985738|NCT01024387|537425658|FG000|Overall Study|Prolonged Treatment Delay|1|||
148985739|NCT01024387|537425658|FG000|Overall Study|Adverse Event|3|||
148985740|NCT01024387|537425658|FG000|Overall Study|Other|5|||
148985741|NCT03855189|537425659|FG000|Overall Study|Adverse Event|5|||
148985742|NCT03855189|537425660|FG001|Overall Study|Adverse Event|2|||
148985743|NCT03855189|537425661|FG002|Overall Study|Adverse Event|4|||
148985744|NCT03855189|537425659|FG000|Overall Study|Treatment Failure|1|||
148985745|NCT03855189|537425660|FG001|Overall Study|Treatment Failure|1|||
148985746|NCT03855189|537425661|FG002|Overall Study|Treatment Failure|2|||
148985747|NCT03855189|537425659|FG000|Overall Study|Noncompliance with Protocol|0|||
148985748|NCT03855189|537425660|FG001|Overall Study|Noncompliance with Protocol|1|||
148985749|NCT03855189|537425661|FG002|Overall Study|Noncompliance with Protocol|0|||
148985750|NCT03855189|537425659|FG000|Overall Study|Did Not Return|4|||
148985751|NCT03855189|537425660|FG001|Overall Study|Did Not Return|3|||
148985752|NCT03855189|537425661|FG002|Overall Study|Did Not Return|0|||
148985753|NCT00099983|537425662|FG000|Overall Study|Lost to Follow-up|2|||
148985754|NCT00099983|537425663|FG001|Overall Study|Lost to Follow-up|3|||
148985755|NCT00099983|537425662|FG000|Overall Study|Missing Source Documents|14|||
148985756|NCT00099983|537425663|FG001|Overall Study|Missing Source Documents|15|||
148985757|NCT00099983|537425662|FG000|Overall Study|Withdrawal by Subject|3|||
148985758|NCT00099983|537425663|FG001|Overall Study|Withdrawal by Subject|2|||
148985759|NCT00099983|537425662|FG000|Overall Study|Adverse Event|1|||
148985760|NCT00099983|537425663|FG001|Overall Study|Adverse Event|1|||
148985761|NCT00099983|537425662|FG000|Overall Study|Lack of Efficacy|0|||
148985762|NCT00099983|537425663|FG001|Overall Study|Lack of Efficacy|1|||
148985763|NCT00099983|537425662|FG000|Overall Study|Unable to return for appointments|1|||
148985764|NCT00099983|537425663|FG001|Overall Study|Unable to return for appointments|1|||
148985765|NCT00099983|537425662|FG000|Overall Study|Moved|1|||
148985766|NCT00099983|537425663|FG001|Overall Study|Moved|0|||
148985767|NCT00099983|537425662|FG000|Overall Study|Other psychiatric problem|1|||
148985768|NCT00099983|537425663|FG001|Overall Study|Other psychiatric problem|0|||
148985769|NCT00099983|537425662|FG000|Overall Study|Incarcerated|0|||
148985770|NCT00099983|537425663|FG001|Overall Study|Incarcerated|1|||
148985771|NCT00099983|537425662|FG000|Overall Study|Intolerant of burden of visits|0|||
148985772|NCT00099983|537425663|FG001|Overall Study|Intolerant of burden of visits|1|||
148985773|NCT00099983|537425662|FG000|Overall Study|Other issue|1|||
148985774|NCT00099983|537425663|FG001|Overall Study|Other issue|0|||
148985775|NCT02641080|537425664|FG000|Overall Study|Physician Decision|2|||
148985776|NCT02641080|537425665|FG001|Overall Study|Physician Decision|0|||
148985777|NCT02641080|537425664|FG000|Overall Study|Withdrawal by Subject|0|||
148985778|NCT02641080|537425665|FG001|Overall Study|Withdrawal by Subject|1|||
148985779|NCT02641080|537425664|FG000|Overall Study|Rehab Center denied use of pumps|0|||
148985780|NCT02641080|537425665|FG001|Overall Study|Rehab Center denied use of pumps|3|||
148985781|NCT02641080|537425664|FG000|Overall Study|Lost to Follow-up|0|||
148985782|NCT02641080|537425665|FG001|Overall Study|Lost to Follow-up|3|||
148985783|NCT00803634|537425666|FG000|Overall Study|Withdrew Consent|1|||
148985784|NCT00803634|537425667|FG001|Overall Study|Withdrew Consent|0|||
148985785|NCT00803634|537425666|FG000|Overall Study|Lost to Follow-up|2|||
148985786|NCT00803634|537425667|FG001|Overall Study|Lost to Follow-up|3|||
148985787|NCT00803634|537425666|FG000|Overall Study|Death|3|||
148985788|NCT00803634|537425667|FG001|Overall Study|Death|2|||
148985789|NCT04307186|537425668|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
148985790|NCT04307186|537425668|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
148985791|NCT04307186|537425668|FG000|Washout 3-14 Days|Progressive disease|1|||
148985792|NCT04307186|537425668|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
148985793|NCT04307186|537425668|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
148985794|NCT03835533|537425672|FG000|Overall Study|Death|5|||
148985795|NCT03835533|537425673|FG001|Overall Study|Death|10|||
148985796|NCT03835533|537425674|FG002|Overall Study|Death|9|||
148985797|NCT03835533|537425672|FG000|Overall Study|Withdrawal by Subject|2|||
148985798|NCT03835533|537425673|FG001|Overall Study|Withdrawal by Subject|2|||
148985799|NCT03835533|537425674|FG002|Overall Study|Withdrawal by Subject|2|||
148985800|NCT03835533|537425672|FG000|Overall Study|Lost to Follow-up|1|||
148985801|NCT03835533|537425673|FG001|Overall Study|Lost to Follow-up|0|||
148985802|NCT03835533|537425674|FG002|Overall Study|Lost to Follow-up|0|||
148985803|NCT03238001|537425677|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
148985804|NCT03238001|537425677|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
148985805|NCT03238001|537425677|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
148985806|NCT03238001|537425677|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
148985807|NCT03238001|537425677|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
148985808|NCT03238001|537425677|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
148985809|NCT03238001|537425677|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
148985810|NCT03238001|537425677|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
148985811|NCT00503685|537425681|FG000|Overall Study|Adverse Event|0|||
148985812|NCT00503685|537425682|FG001|Overall Study|Adverse Event|0|||
148985813|NCT00503685|537425683|FG002|Overall Study|Adverse Event|2|||
148985814|NCT00503685|537425681|FG000|Overall Study|Withdrawal by Subject|0|||
148985815|NCT00503685|537425682|FG001|Overall Study|Withdrawal by Subject|1|||
148985816|NCT00503685|537425683|FG002|Overall Study|Withdrawal by Subject|0|||
148985817|NCT00503685|537425681|FG000|Overall Study|Protocol Violation|0|||
148985818|NCT00503685|537425682|FG001|Overall Study|Protocol Violation|1|||
148985819|NCT00503685|537425683|FG002|Overall Study|Protocol Violation|0|||
148985820|NCT00503685|537425681|FG000|Overall Study|Eligibility Criteria Not Met|0|||
148985821|NCT00503685|537425682|FG001|Overall Study|Eligibility Criteria Not Met|1|||
148985822|NCT00503685|537425683|FG002|Overall Study|Eligibility Criteria Not Met|0|||
148985823|NCT01110239|537425686|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
148985824|NCT01110239|537425687|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
148985825|NCT01110239|537425688|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
148985826|NCT01110239|537425689|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
148985827|NCT01110239|537425686|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
148985828|NCT01110239|537425687|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
148851597|NCT04075513|536930678|FG001|Overall Study|Withdrawal by Subject|2|||
148851598|NCT04075513|536930677|FG000|Overall Study|Lack of Efficacy|1|||
148851599|NCT04075513|536930678|FG001|Overall Study|Lack of Efficacy|0|||
148851600|NCT04075513|536930677|FG000|Overall Study|Lost to Follow-up|4|||
148985829|NCT01110239|537425688|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
148985830|NCT01110239|537425689|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
148985831|NCT00080223|537425690|FG000|Overall Study|Adverse Event|23|||
148985832|NCT00080223|537425690|FG000|Overall Study|Death|21|||
148985833|NCT00080223|537425690|FG000|Overall Study|Withdrawal by Subject|13|||
148851601|NCT04075513|536930678|FG001|Overall Study|Lost to Follow-up|2|||
148851602|NCT04075513|536930677|FG000|Overall Study|Switch to insulin pump|1|||
148851603|NCT04075513|536930678|FG001|Overall Study|Switch to insulin pump|0|||
148851604|NCT02141399|536930679|FG000|Overall Study|Adverse Event|158|||
148851605|NCT02141399|536930679|FG000|Overall Study|Lack of Efficacy|62|||
148851606|NCT02141399|536930679|FG000|Overall Study|Lost to Follow-up|151|||
148851607|NCT02141399|536930679|FG000|Overall Study|Non-compliance with study drug|18|||
148851608|NCT02141399|536930679|FG000|Overall Study|Other|45|||
148851609|NCT02141399|536930679|FG000|Overall Study|Physician Decision|17|||
148851610|NCT02141399|536930679|FG000|Overall Study|Pregnancy|3|||
148851611|NCT02141399|536930679|FG000|Overall Study|Protocol Violation|38|||
148851612|NCT02141399|536930679|FG000|Overall Study|Withdrawal by Subject|238|||
148851613|NCT02141399|536930679|FG000|Overall Study|Failure to meet eligibility criteria|14|||
148851614|NCT04445519|536930680|FG000|Overall Study|Due to adaptive design|3|||
148851615|NCT04445519|536930681|FG001|Overall Study|Due to adaptive design|0|||
148851616|NCT04445519|536930682|FG002|Overall Study|Due to adaptive design|0|||
148851617|NCT04445519|536930680|FG000|Overall Study|Lost to Follow-up|0|||
148851618|NCT04445519|536930681|FG001|Overall Study|Lost to Follow-up|1|||
148851619|NCT04445519|536930682|FG002|Overall Study|Lost to Follow-up|4|||
148851620|NCT04445519|536930680|FG000|Overall Study|Sponsor or IRB Decision|0|||
148851621|NCT04445519|536930681|FG001|Overall Study|Sponsor or IRB Decision|1|||
148851622|NCT04445519|536930682|FG002|Overall Study|Sponsor or IRB Decision|2|||
148851623|NCT04445519|536930680|FG000|Overall Study|Withdrawal by Subject|0|||
148851624|NCT04445519|536930681|FG001|Overall Study|Withdrawal by Subject|3|||
148851625|NCT04445519|536930682|FG002|Overall Study|Withdrawal by Subject|3|||
148851626|NCT04445519|536930680|FG000|Overall Study|Adverse Event|0|||
148851627|NCT04445519|536930681|FG001|Overall Study|Adverse Event|8|||
148851628|NCT04445519|536930682|FG002|Overall Study|Adverse Event|6|||
148851629|NCT04445519|536930680|FG000|Overall Study|Other Reason|0|||
148851630|NCT04445519|536930681|FG001|Overall Study|Other Reason|1|||
148851631|NCT04445519|536930682|FG002|Overall Study|Other Reason|1|||
148851632|NCT04445519|536930680|FG000|Overall Study|Protocol Violation|0|||
148851633|NCT04445519|536930681|FG001|Overall Study|Protocol Violation|0|||
148851634|NCT04445519|536930682|FG002|Overall Study|Protocol Violation|1|||
148851635|NCT01345929|536930683|FG000|Overall Study|Withdrawal by Subject|9|||
148851636|NCT01345929|536930684|FG001|Overall Study|Withdrawal by Subject|8|||
148851637|NCT01345929|536930683|FG000|Overall Study|Lost to Follow-up|9|||
148851638|NCT01345929|536930684|FG001|Overall Study|Lost to Follow-up|9|||
148851639|NCT01345929|536930683|FG000|Overall Study|Adverse Event|0|||
148851640|NCT01345929|536930684|FG001|Overall Study|Adverse Event|1|||
148851641|NCT01345929|536930683|FG000|Overall Study|Didn't meet eligibility criteria|2|||
148851642|NCT01345929|536930684|FG001|Overall Study|Didn't meet eligibility criteria|0|||
148851643|NCT01345929|536930683|FG000|Overall Study|40,000 CFU/ML|1|||
148851644|NCT01345929|536930684|FG001|Overall Study|40,000 CFU/ML|0|||
148851645|NCT01345929|536930683|FG000|Overall Study|Patient withdrawal|0|||
148851646|NCT01345929|536930684|FG001|Overall Study|Patient withdrawal|1|||
148851647|NCT02819297|536930689|FG000|Overall Study|Withdrawal by Subject|25|||
148851648|NCT02819297|536930690|FG001|Overall Study|Withdrawal by Subject|13|||
148851649|NCT02819297|536930689|FG000|Overall Study|Lost to Follow-up|12|||
148851650|NCT02819297|536930690|FG001|Overall Study|Lost to Follow-up|14|||
148851651|NCT02819297|536930689|FG000|Overall Study|Adverse Event|12|||
148851652|NCT02819297|536930690|FG001|Overall Study|Adverse Event|10|||
148851653|NCT02819297|536930689|FG000|Overall Study|Physician Decision|5|||
148851654|NCT02819297|536930690|FG001|Overall Study|Physician Decision|5|||
148851655|NCT02819297|536930689|FG000|Overall Study|Lack of Efficacy|5|||
148851656|NCT02819297|536930690|FG001|Overall Study|Lack of Efficacy|8|||
148985834|NCT00080223|537425690|FG000|Overall Study|Lung Transplantation|9|||
148776747|NCT02505334|536656889|FG001|Main Treatment Period|Lack of Efficacy|17|||
148776748|NCT02505334|536656888|FG000|Main Treatment Period|Protocol Violation|0|||
148776749|NCT02505334|536656889|FG001|Main Treatment Period|Protocol Violation|1|||
148776750|NCT02505334|536656888|FG000|Main Treatment Period|Withdrawal by Subject|1|||
148776751|NCT02505334|536656889|FG001|Main Treatment Period|Withdrawal by Subject|8|||
148776752|NCT02505334|536656888|FG000|Main Treatment Period|Unclassified|4|||
148776753|NCT02505334|536656889|FG001|Main Treatment Period|Unclassified|10|||
148776754|NCT02505334|536656888|FG000|Extension Treatment Period|Adverse Event|5|||
148776755|NCT02505334|536656889|FG001|Extension Treatment Period|Adverse Event|0|||
148776756|NCT02505334|536656888|FG000|Extension Treatment Period|Lack of Efficacy|4|||
148776757|NCT02505334|536656889|FG001|Extension Treatment Period|Lack of Efficacy|0|||
148776758|NCT02505334|536656888|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
148776759|NCT02505334|536656889|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
148851657|NCT02819297|536930689|FG000|Overall Study|Protocol Violation|1|||
148851658|NCT02819297|536930690|FG001|Overall Study|Protocol Violation|2|||
148851659|NCT02036580|536930693|FG000|Overall Study|Withdrawal by Subject|0|||
148851660|NCT02036580|536930694|FG001|Overall Study|Withdrawal by Subject|1|||
148851661|NCT02036580|536930695|FG002|Overall Study|Withdrawal by Subject|0|||
148851662|NCT02036580|536930693|FG000|Overall Study|Adverse Event|1|||
148851663|NCT02036580|536930694|FG001|Overall Study|Adverse Event|0|||
148851664|NCT02036580|536930695|FG002|Overall Study|Adverse Event|0|||
148985835|NCT00080223|537425690|FG000|Overall Study|Non-compliance With Study Treatment|7|||
148985836|NCT00080223|537425690|FG000|Overall Study|Participant unwilling to continue|2|||
148985837|NCT00080223|537425690|FG000|Overall Study|Physician Decision|1|||
148985846|NCT03099382|537425699|FG000|Overall Study|Protocol Violation|2|||
148985847|NCT03099382|537425700|FG001|Overall Study|Protocol Violation|3|||
148985848|NCT01337245|537425702|FG000|Overall Study|Lost to Follow-up|1|||
148985849|NCT04095858|537425705|FG000|Overall Study|Death|1|||
148985850|NCT04095858|537425706|FG001|Overall Study|Death|0|||
148985851|NCT04095858|537425705|FG000|Overall Study|Study terminated by Sponsor|2|||
148985852|NCT04095858|537425706|FG001|Overall Study|Study terminated by Sponsor|4|||
148985853|NCT01344460|537425707|FG000|Overall Study|Withdrawal by Subject|1|||
148985854|NCT01344460|537425707|FG000|Overall Study|Lost to Follow-up|2|||
148985855|NCT03483623|537425709|FG000|Overall Study|43 complete sets achieved|1|||
148985856|NCT01059617|537425712|FG000|Overall Study|Other|7|||
148776760|NCT02505334|536656888|FG000|Extension Treatment Period|Unclassified|3|||
148776761|NCT02505334|536656889|FG001|Extension Treatment Period|Unclassified|0|||
148776762|NCT01549041|536656892|FG000|Overall Study|Lack of Efficacy|2|||
148776763|NCT01549041|536656893|FG001|Overall Study|Lack of Efficacy|4|||
148776764|NCT01549041|536656892|FG000|Overall Study|Adverse Event|0|||
148776765|NCT01549041|536656893|FG001|Overall Study|Adverse Event|4|||
148776766|NCT02543892|536656894|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
148776767|NCT02543892|536656895|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
148776768|NCT02543892|536656896|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
148776769|NCT02543892|536656897|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
148776770|NCT02543892|536656898|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
148776771|NCT02543892|536656899|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
148776772|NCT02543892|536656900|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
148776773|NCT02543892|536656901|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
148776774|NCT02543892|536656894|FG000|Received Vaccination 2|Physician Decision|0|||
148776775|NCT02543892|536656895|FG001|Received Vaccination 2|Physician Decision|0|||
148776776|NCT02543892|536656896|FG002|Received Vaccination 2|Physician Decision|0|||
148776777|NCT02543892|536656897|FG003|Received Vaccination 2|Physician Decision|0|||
148776778|NCT02543892|536656898|FG004|Received Vaccination 2|Physician Decision|0|||
148776779|NCT02543892|536656899|FG005|Received Vaccination 2|Physician Decision|1|||
148776780|NCT02543892|536656900|FG006|Received Vaccination 2|Physician Decision|0|||
148776781|NCT02543892|536656901|FG007|Received Vaccination 2|Physician Decision|0|||
148776782|NCT02543892|536656894|FG000|Received Vaccination 2|Adverse Event|0|||
148776783|NCT02543892|536656895|FG001|Received Vaccination 2|Adverse Event|1|||
148776784|NCT02543892|536656896|FG002|Received Vaccination 2|Adverse Event|0|||
148776785|NCT02543892|536656897|FG003|Received Vaccination 2|Adverse Event|0|||
148776786|NCT02543892|536656898|FG004|Received Vaccination 2|Adverse Event|0|||
148776787|NCT02543892|536656899|FG005|Received Vaccination 2|Adverse Event|0|||
148776788|NCT02543892|536656900|FG006|Received Vaccination 2|Adverse Event|0|||
148776789|NCT02543892|536656901|FG007|Received Vaccination 2|Adverse Event|0|||
148776790|NCT02543892|536656894|FG000|Had Immunology Data|Withdrawal by Subject|0|||
148776791|NCT02543892|536656895|FG001|Had Immunology Data|Withdrawal by Subject|0|||
148776792|NCT02543892|536656896|FG002|Had Immunology Data|Withdrawal by Subject|0|||
148776793|NCT02543892|536656897|FG003|Had Immunology Data|Withdrawal by Subject|0|||
148776794|NCT02543892|536656898|FG004|Had Immunology Data|Withdrawal by Subject|0|||
148776795|NCT02543892|536656899|FG005|Had Immunology Data|Withdrawal by Subject|0|||
148776796|NCT02543892|536656900|FG006|Had Immunology Data|Withdrawal by Subject|1|||
148776797|NCT02543892|536656901|FG007|Had Immunology Data|Withdrawal by Subject|0|||
148776798|NCT00081731|536656902|FG000|Overall Study|scientific integrity issue|8|||
148776799|NCT00081731|536656903|FG001|Overall Study|scientific integrity issue|8|||
148776800|NCT00656851|536656906|FG000|Overall Study|Withdrawal by Subject|0|||
148776801|NCT00656851|536656907|FG001|Overall Study|Withdrawal by Subject|4|||
148776802|NCT05513703|536656909|FG000|Overall Study|Death|4|||
148776803|NCT05513703|536656909|FG000|Overall Study|Study terminated by sponsor|5|||
148985857|NCT01059617|537425713|FG001|Overall Study|Other|1|||
148985858|NCT01059617|537425714|FG002|Overall Study|Other|8|||
148985859|NCT01059617|537425715|FG003|Overall Study|Other|6|||
148985860|NCT02055352|537427580|FG000|Overall Study|Adverse Event|0|||
148985861|NCT02055352|537427581|FG001|Overall Study|Adverse Event|1|||
148985862|NCT02055352|537427580|FG000|Overall Study|Non-eligible|0|||
148985863|NCT02055352|537427581|FG001|Overall Study|Non-eligible|1|||
148985864|NCT02055352|537427580|FG000|Overall Study|Poor compliance|1|||
148985865|NCT02055352|537427581|FG001|Overall Study|Poor compliance|1|||
148985866|NCT02055352|537427580|FG000|Overall Study|Death|1|||
148985867|NCT02055352|537427581|FG001|Overall Study|Death|2|||
148985868|NCT02055352|537427580|FG000|Overall Study|Patient decision|1|||
148985869|NCT02055352|537427581|FG001|Overall Study|Patient decision|1|||
148985870|NCT02055352|537427580|FG000|Overall Study|Use of prohibited treatment|0|||
148985871|NCT02055352|537427581|FG001|Overall Study|Use of prohibited treatment|3|||
148985872|NCT02055352|537427580|FG000|Overall Study|AE, study drug would be detrimental|1|||
148985873|NCT02055352|537427581|FG001|Overall Study|AE, study drug would be detrimental|3|||
148985874|NCT02055352|537427580|FG000|Overall Study|Withdrawal of informed consent|1|||
148985875|NCT02055352|537427581|FG001|Overall Study|Withdrawal of informed consent|0|||
148985876|NCT02055352|537427580|FG000|Overall Study|Reason unknown|1|||
148985877|NCT02055352|537427581|FG001|Overall Study|Reason unknown|5|||
148985878|NCT05349617|537427584|FG000|Overall Study|Death|1|||
148985879|NCT05349617|537427585|FG001|Overall Study|Death|1|||
148985880|NCT05349617|537427584|FG000|Overall Study|Lost to Follow-up|3|||
148985881|NCT05349617|537427585|FG001|Overall Study|Lost to Follow-up|8|||
148985882|NCT05349617|537427584|FG000|Overall Study|Withdrawal by Subject|2|||
148985883|NCT05349617|537427585|FG001|Overall Study|Withdrawal by Subject|10|||
148985884|NCT00993447|537427589|FG000|Overall Study|Withdrawal by Subject|23|||
148985885|NCT00993447|537427590|FG001|Overall Study|Withdrawal by Subject|8|||
148985886|NCT00993447|537427589|FG000|Overall Study|Protocol Violation|12|||
148985887|NCT00993447|537427590|FG001|Overall Study|Protocol Violation|8|||
148985888|NCT00993447|537427589|FG000|Overall Study|Lost to Follow-up|1|||
148985889|NCT00993447|537427590|FG001|Overall Study|Lost to Follow-up|3|||
148985890|NCT00993447|537427589|FG000|Overall Study|Adverse Event|1|||
148985891|NCT00993447|537427590|FG001|Overall Study|Adverse Event|0|||
148985892|NCT00970502|537427593|FG000|Overall Study|Withdrawal by Subject|1|||
148985893|NCT01438411|537427594|FG000|Overall Study|Adverse Event|8|||
148985894|NCT01438411|537427594|FG000|Overall Study|Lost to Follow-up|1|||
148985895|NCT01438411|537427594|FG000|Overall Study|Lack of Efficacy|1|||
148985896|NCT01438411|537427594|FG000|Overall Study|Withdrawal by Subject|3|||
148985897|NCT02041195|537427597|FG000|Overall Study|Adverse Event|1|||
148985898|NCT02041195|537427598|FG001|Overall Study|Adverse Event|2|||
148985899|NCT02041195|537427599|FG002|Overall Study|Adverse Event|0|||
148985900|NCT02041195|537427600|FG003|Overall Study|Adverse Event|0|||
148985901|NCT02041195|537427601|FG004|Overall Study|Adverse Event|0|||
148985902|NCT02041195|537427602|FG005|Overall Study|Adverse Event|0|||
148985903|NCT02041195|537427603|FG006|Overall Study|Adverse Event|3|||
148985904|NCT02041195|537427604|FG007|Overall Study|Adverse Event|0|||
148985905|NCT02041195|537427597|FG000|Overall Study|Withdrawal by Subject|1|||
148985906|NCT02041195|537427598|FG001|Overall Study|Withdrawal by Subject|0|||
148985907|NCT02041195|537427599|FG002|Overall Study|Withdrawal by Subject|0|||
148985908|NCT02041195|537427600|FG003|Overall Study|Withdrawal by Subject|0|||
148985909|NCT02041195|537427601|FG004|Overall Study|Withdrawal by Subject|0|||
148985910|NCT02041195|537427602|FG005|Overall Study|Withdrawal by Subject|0|||
148985911|NCT02041195|537427603|FG006|Overall Study|Withdrawal by Subject|4|||
148985912|NCT02041195|537427604|FG007|Overall Study|Withdrawal by Subject|3|||
148985913|NCT02041195|537427597|FG000|Overall Study|Unable to comply with study visits|0|||
148985914|NCT02041195|537427598|FG001|Overall Study|Unable to comply with study visits|1|||
148985915|NCT02041195|537427599|FG002|Overall Study|Unable to comply with study visits|0|||
148985916|NCT02041195|537427600|FG003|Overall Study|Unable to comply with study visits|0|||
148985917|NCT02041195|537427601|FG004|Overall Study|Unable to comply with study visits|1|||
148985918|NCT02041195|537427602|FG005|Overall Study|Unable to comply with study visits|0|||
148985919|NCT02041195|537427603|FG006|Overall Study|Unable to comply with study visits|0|||
148985920|NCT02041195|537427604|FG007|Overall Study|Unable to comply with study visits|0|||
148985921|NCT02707055|537427605|FG000|Phase 1|Withdrawal by Subject|1|||
148985922|NCT02707055|537427606|FG001|Phase 1|Withdrawal by Subject|2|||
148985923|NCT02707055|537427605|FG000|Phase 1|Physician Decision|0|||
148985924|NCT02707055|537427606|FG001|Phase 1|Physician Decision|1|||
148985925|NCT02707055|537427605|FG000|Phase 2|Adverse Event|1|||
148985926|NCT02707055|537427606|FG001|Phase 2|Adverse Event|2|||
148985927|NCT03564496|537427607|FG000|Overall Study|Withdrawal by Subject|1|||
148985928|NCT03564496|537427608|FG001|Overall Study|Withdrawal by Subject|1|||
148985929|NCT03564496|537427609|FG002|Overall Study|Withdrawal by Subject|0|||
148985930|NCT03564496|537427607|FG000|Overall Study|Screen failure|0|||
148985931|NCT03564496|537427608|FG001|Overall Study|Screen failure|3|||
148985932|NCT03564496|537427609|FG002|Overall Study|Screen failure|0|||
148985933|NCT00674986|537427610|FG000|Overall Study|Adverse Event|2|||
148985934|NCT00674986|537427611|FG001|Overall Study|Adverse Event|1|||
148985935|NCT00674986|537427610|FG000|Overall Study|Subject withdrew consent|12|||
148776804|NCT05238025|536656910|FG000|Overall Study|Adverse Event|2|||
148985936|NCT00674986|537427611|FG001|Overall Study|Subject withdrew consent|19|||
148985937|NCT00674986|537427610|FG000|Overall Study|Lost to Follow-up|25|||
148985938|NCT00674986|537427611|FG001|Overall Study|Lost to Follow-up|53|||
148985939|NCT00674986|537427610|FG000|Overall Study|Other reasons|4|||
148985940|NCT00674986|537427611|FG001|Overall Study|Other reasons|8|||
148985941|NCT01880424|537427612|FG000|Overall Study|Adverse Event|7|||
148985942|NCT01880424|537427613|FG001|Overall Study|Adverse Event|6|||
148985943|NCT01880424|537427612|FG000|Overall Study|Lack of Efficacy|1|||
148985944|NCT01880424|537427613|FG001|Overall Study|Lack of Efficacy|4|||
148985945|NCT01880424|537427612|FG000|Overall Study|Lost to Follow-up|3|||
148985946|NCT01880424|537427613|FG001|Overall Study|Lost to Follow-up|2|||
148985947|NCT01880424|537427612|FG000|Overall Study|Protocol Violation|11|||
148985948|NCT01880424|537427613|FG001|Overall Study|Protocol Violation|13|||
148985949|NCT01880424|537427612|FG000|Overall Study|Withdrawal by Subject|10|||
148985950|NCT01880424|537427613|FG001|Overall Study|Withdrawal by Subject|30|||
148985951|NCT01880424|537427612|FG000|Overall Study|Other|1|||
148985952|NCT01880424|537427613|FG001|Overall Study|Other|0|||
148985953|NCT01175382|537427617|FG000|Overall Study|Lost to Follow-up|4|||
148985954|NCT01175382|537427618|FG001|Overall Study|Lost to Follow-up|3|||
148985955|NCT01175382|537427619|FG002|Overall Study|Lost to Follow-up|1|||
148985956|NCT01175382|537427617|FG000|Overall Study|Physician Decision|0|||
148985957|NCT01175382|537427618|FG001|Overall Study|Physician Decision|1|||
148985958|NCT01175382|537427619|FG002|Overall Study|Physician Decision|0|||
148985959|NCT01175382|537427617|FG000|Overall Study|Withdrawal by Subject|0|||
148985960|NCT01175382|537427618|FG001|Overall Study|Withdrawal by Subject|0|||
148985961|NCT01175382|537427619|FG002|Overall Study|Withdrawal by Subject|1|||
148985962|NCT01175382|537427617|FG000|Overall Study|No longer having problem|1|||
148985963|NCT01175382|537427618|FG001|Overall Study|No longer having problem|0|||
148985964|NCT01175382|537427619|FG002|Overall Study|No longer having problem|1|||
148985965|NCT01175382|537427617|FG000|Overall Study|Unable/unwilling to attend visits|3|||
148985966|NCT01175382|537427618|FG001|Overall Study|Unable/unwilling to attend visits|1|||
148985967|NCT01175382|537427619|FG002|Overall Study|Unable/unwilling to attend visits|2|||
148985968|NCT01175382|537427617|FG000|Overall Study|Unwilling to follow protocol|0|||
148985969|NCT01175382|537427618|FG001|Overall Study|Unwilling to follow protocol|1|||
148985970|NCT01175382|537427619|FG002|Overall Study|Unwilling to follow protocol|0|||
148985971|NCT01175382|537427617|FG000|Overall Study|Unable to tolerate study meds|0|||
148985972|NCT01175382|537427618|FG001|Overall Study|Unable to tolerate study meds|1|||
148985973|NCT01175382|537427619|FG002|Overall Study|Unable to tolerate study meds|1|||
148985974|NCT02511431|537427626|FG000|Treatment|Lost to Follow-up|0|||
148985975|NCT02511431|537427627|FG001|Treatment|Lost to Follow-up|0|||
148985976|NCT02511431|537427628|FG002|Treatment|Lost to Follow-up|1|||
148985977|NCT02511431|537427629|FG003|Treatment|Lost to Follow-up|0|||
148985978|NCT02511431|537427630|FG004|Treatment|Lost to Follow-up|0|||
148985979|NCT02511431|537427631|FG005|Treatment|Lost to Follow-up|1|||
148985980|NCT01751568|537427632|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
148985981|NCT01751568|537427633|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
148985982|NCT01751568|537427634|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
148985983|NCT03447769|537427636|FG000|Overall Study|Progressive disease|138|||
148985984|NCT03447769|537427637|FG001|Overall Study|Progressive disease|148|||
148985985|NCT03447769|537427636|FG000|Overall Study|Study terminated by Sponsor|60|||
148985986|NCT03447769|537427637|FG001|Overall Study|Study terminated by Sponsor|44|||
148985987|NCT03447769|537427636|FG000|Overall Study|Adverse Event|34|||
148985988|NCT03447769|537427637|FG001|Overall Study|Adverse Event|31|||
148985989|NCT03447769|537427636|FG000|Overall Study|Patient decision|27|||
148985990|NCT03447769|537427637|FG001|Overall Study|Patient decision|27|||
148985991|NCT03447769|537427636|FG000|Overall Study|Protocol deviation|4|||
148985992|NCT03447769|537427637|FG001|Overall Study|Protocol deviation|6|||
148985993|NCT03447769|537427636|FG000|Overall Study|Death|2|||
148985994|NCT03447769|537427637|FG001|Overall Study|Death|7|||
148985995|NCT03447769|537427636|FG000|Overall Study|Technical problems|1|||
148985996|NCT03447769|537427637|FG001|Overall Study|Technical problems|0|||
148985997|NCT03447769|537427636|FG000|Overall Study|Lost to Follow-up|0|||
148985998|NCT03447769|537427637|FG001|Overall Study|Lost to Follow-up|1|||
148985999|NCT03447769|537427636|FG000|Overall Study|Physician Decision|13|||
148986000|NCT03447769|537427637|FG001|Overall Study|Physician Decision|5|||
148986001|NCT03264989|537427639|FG000|Overall Study|Lost to Follow-up|1|||
148986002|NCT03264989|537427640|FG001|Overall Study|Lost to Follow-up|0|||
148986003|NCT03264989|537427639|FG000|Overall Study|New Therapy for study Indication|1|||
148986004|NCT03264989|537427640|FG001|Overall Study|New Therapy for study Indication|0|||
149030219|NCT02524288|537587976|FG000|Overall Study|Non-Compliance With Protocol|32|||
148986005|NCT03264989|537427639|FG000|Overall Study|Protocol Violation|0|||
148986006|NCT03264989|537427640|FG001|Overall Study|Protocol Violation|1|||
148986007|NCT03264989|537427639|FG000|Overall Study|Patient decision|13|||
148986008|NCT03264989|537427640|FG001|Overall Study|Patient decision|0|||
148986009|NCT03264989|537427639|FG000|Overall Study|Physician Decision|6|||
148986010|NCT03264989|537427640|FG001|Overall Study|Physician Decision|4|||
148986011|NCT03264989|537427639|FG000|Overall Study|Adverse Event|2|||
148986012|NCT03264989|537427640|FG001|Overall Study|Adverse Event|1|||
148986013|NCT03264989|537427639|FG000|Overall Study|Death|1|||
148986014|NCT03264989|537427640|FG001|Overall Study|Death|1|||
148986015|NCT03264989|537427639|FG000|Overall Study|Pregnancy|2|||
148986016|NCT03264989|537427640|FG001|Overall Study|Pregnancy|0|||
148986017|NCT03264989|537427639|FG000|Overall Study|End of Study|19|||
148776805|NCT05238025|536656911|FG001|Overall Study|Adverse Event|2|||
148986018|NCT03264989|537427640|FG001|Overall Study|End of Study|5|||
148986019|NCT00797667|537427641|FG000|Overall Study|Lack of Efficacy|0|||
148776806|NCT05238025|536656910|FG000|Overall Study|Lost to Follow-up|334|||
148776807|NCT05238025|536656911|FG001|Overall Study|Lost to Follow-up|339|||
148776808|NCT05238025|536656910|FG000|Overall Study|Withdrawal by Subject|203|||
148776809|NCT05238025|536656911|FG001|Overall Study|Withdrawal by Subject|222|||
148776810|NCT05238025|536656910|FG000|Overall Study|Physician Decision|20|||
148776811|NCT05238025|536656911|FG001|Overall Study|Physician Decision|8|||
148776812|NCT05238025|536656910|FG000|Overall Study|Protocol Violation|6|||
148776813|NCT05238025|536656911|FG001|Overall Study|Protocol Violation|2|||
148776814|NCT05238025|536656910|FG000|Overall Study|Death|38|||
148776815|NCT05238025|536656911|FG001|Overall Study|Death|32|||
148776816|NCT05238025|536656910|FG000|Overall Study|Study terminated by Sponsor|6358|||
148776817|NCT05238025|536656911|FG001|Overall Study|Study terminated by Sponsor|6358|||
148776818|NCT05238025|536656910|FG000|Overall Study|Other Reason|669|||
148776819|NCT05238025|536656911|FG001|Overall Study|Other Reason|690|||
148776820|NCT02135107|536656923|FG000|Treatment Period|Withdrawal by Subject|11|||
148776821|NCT02135107|536656924|FG001|Treatment Period|Withdrawal by Subject|0|||
148776822|NCT02135107|536656925|FG002|Treatment Period|Withdrawal by Subject|0|||
148776823|NCT02135107|536656926|FG003|Treatment Period|Withdrawal by Subject|0|||
148776824|NCT02135107|536656923|FG000|Treatment Period|Adverse Event|5|||
148776825|NCT02135107|536656924|FG001|Treatment Period|Adverse Event|2|||
148776826|NCT02135107|536656925|FG002|Treatment Period|Adverse Event|0|||
148776827|NCT02135107|536656926|FG003|Treatment Period|Adverse Event|0|||
148776828|NCT02135107|536656923|FG000|Treatment Period|Pregnancy|1|||
148776829|NCT02135107|536656924|FG001|Treatment Period|Pregnancy|0|||
148776830|NCT02135107|536656925|FG002|Treatment Period|Pregnancy|0|||
148776831|NCT02135107|536656926|FG003|Treatment Period|Pregnancy|0|||
148776832|NCT02135107|536656923|FG000|Treatment Period|Other|115|||
148776833|NCT02135107|536656924|FG001|Treatment Period|Other|24|||
148776834|NCT02135107|536656925|FG002|Treatment Period|Other|0|||
148776835|NCT02135107|536656926|FG003|Treatment Period|Other|0|||
148776836|NCT02135107|536656923|FG000|Maintenance Therapy Period|Adverse Event|0|||
148776837|NCT02135107|536656924|FG001|Maintenance Therapy Period|Adverse Event|0|||
148776838|NCT02135107|536656925|FG002|Maintenance Therapy Period|Adverse Event|3|||
148776839|NCT02135107|536656926|FG003|Maintenance Therapy Period|Adverse Event|7|||
148776840|NCT02135107|536656923|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
148776841|NCT02135107|536656924|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
148776842|NCT02135107|536656925|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
148776843|NCT02135107|536656926|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
148776844|NCT02135107|536656923|FG000|Maintenance Therapy Period|Pregnancy|0|||
148776845|NCT02135107|536656924|FG001|Maintenance Therapy Period|Pregnancy|0|||
148776846|NCT02135107|536656925|FG002|Maintenance Therapy Period|Pregnancy|0|||
148776847|NCT02135107|536656926|FG003|Maintenance Therapy Period|Pregnancy|1|||
148776848|NCT02135107|536656923|FG000|Maintenance Therapy Period|Other|0|||
148776849|NCT02135107|536656924|FG001|Maintenance Therapy Period|Other|0|||
148776850|NCT02135107|536656925|FG002|Maintenance Therapy Period|Other|7|||
148776851|NCT02135107|536656926|FG003|Maintenance Therapy Period|Other|8|||
148776852|NCT02278120|536656928|FG000|Treatment Period|Progressive disease|234|||
148776853|NCT02278120|536656929|FG001|Treatment Period|Progressive disease|260|||
148776854|NCT02278120|536656928|FG000|Treatment Period|Subject/guardian decision|23|||
148776855|NCT02278120|536656929|FG001|Treatment Period|Subject/guardian decision|20|||
148776856|NCT02278120|536656928|FG000|Treatment Period|Adverse Event|16|||
148776857|NCT02278120|536656929|FG001|Treatment Period|Adverse Event|14|||
148776858|NCT02278120|536656928|FG000|Treatment Period|Physician Decision|14|||
148776859|NCT02278120|536656929|FG001|Treatment Period|Physician Decision|27|||
148776860|NCT02278120|536656928|FG000|Treatment Period|Death|3|||
148776861|NCT02278120|536656929|FG001|Treatment Period|Death|3|||
148986020|NCT00797667|537427642|FG001|Overall Study|Lack of Efficacy|1|||
148986021|NCT00797667|537427643|FG002|Overall Study|Lack of Efficacy|0|||
148986022|NCT00797667|537427641|FG000|Overall Study|Lost to Follow-up|8|||
148986023|NCT00797667|537427642|FG001|Overall Study|Lost to Follow-up|12|||
148986024|NCT00797667|537427643|FG002|Overall Study|Lost to Follow-up|2|||
148986025|NCT00797667|537427641|FG000|Overall Study|Physician Decision|3|||
148986026|NCT00797667|537427642|FG001|Overall Study|Physician Decision|1|||
148776862|NCT02278120|536656928|FG000|Treatment Period|Lost to Follow-up|2|||
148851665|NCT00976716|536930699|FG000|Overall Study|Adverse Event|1|||
148986027|NCT00797667|537427643|FG002|Overall Study|Physician Decision|0|||
148776863|NCT02278120|536656929|FG001|Treatment Period|Lost to Follow-up|0|||
148776864|NCT02278120|536656928|FG000|Treatment Period|Protocol deviation|0|||
148776865|NCT02278120|536656929|FG001|Treatment Period|Protocol deviation|2|||
148776866|NCT02278120|536656928|FG000|Treatment Period|Study terminated as per protocol|43|||
148776867|NCT02278120|536656929|FG001|Treatment Period|Study terminated as per protocol|11|||
148776868|NCT02278120|536656928|FG000|Post-treatment Efficacy Follow-up|Death|0|||
148776869|NCT02278120|536656929|FG001|Post-treatment Efficacy Follow-up|Death|1|||
148776870|NCT02278120|536656928|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
148776871|NCT02278120|536656929|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
148851666|NCT04222699|536930700|FG000|Overall Study|Lost to Follow-up|2|||
148986028|NCT00797667|537427641|FG000|Overall Study|Pregnancy|2|||
148986029|NCT00797667|537427642|FG001|Overall Study|Pregnancy|0|||
148986030|NCT00797667|537427643|FG002|Overall Study|Pregnancy|0|||
148986031|NCT00797667|537427641|FG000|Overall Study|Protocol Violation|2|||
148986032|NCT00797667|537427642|FG001|Overall Study|Protocol Violation|7|||
148986033|NCT00797667|537427643|FG002|Overall Study|Protocol Violation|0|||
148986034|NCT00797667|537427641|FG000|Overall Study|Study Terminated by Sponsor|217|||
148986035|NCT00797667|537427642|FG001|Overall Study|Study Terminated by Sponsor|216|||
148986036|NCT00797667|537427643|FG002|Overall Study|Study Terminated by Sponsor|115|||
148986037|NCT00797667|537427641|FG000|Overall Study|Withdrawal by Subject|9|||
148986038|NCT00797667|537427642|FG001|Overall Study|Withdrawal by Subject|14|||
148986039|NCT00797667|537427643|FG002|Overall Study|Withdrawal by Subject|2|||
148986040|NCT00797667|537427641|FG000|Overall Study|Adverse Event|19|||
148986041|NCT00797667|537427642|FG001|Overall Study|Adverse Event|8|||
148986042|NCT00797667|537427643|FG002|Overall Study|Adverse Event|8|||
148986043|NCT03029208|537427644|FG000|Overall Study|Withdrawal by Subject|2|||
148986044|NCT03029208|537427645|FG001|Overall Study|Withdrawal by Subject|3|||
148986045|NCT03029208|537427644|FG000|Overall Study|Lost to Follow-up|0|||
148986046|NCT03029208|537427645|FG001|Overall Study|Lost to Follow-up|1|||
148986047|NCT03207750|537427648|FG000|Overall Study|Adverse Event|3|||
148986048|NCT03207750|537427649|FG001|Overall Study|Adverse Event|2|||
148986049|NCT03207750|537427648|FG000|Overall Study|Lost to Follow-up|21|||
148986050|NCT03207750|537427649|FG001|Overall Study|Lost to Follow-up|29|||
148986051|NCT03207750|537427648|FG000|Overall Study|Protocol Violation|0|||
148986052|NCT03207750|537427649|FG001|Overall Study|Protocol Violation|1|||
148986053|NCT03207750|537427648|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
148986054|NCT03207750|537427649|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
148986055|NCT03207750|537427648|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
148986056|NCT03207750|537427649|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
148986057|NCT03207750|537427648|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
148986058|NCT03207750|537427649|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
148986059|NCT03207750|537427648|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
148986060|NCT03207750|537427649|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
148986061|NCT03207750|537427648|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
148986062|NCT03207750|537427649|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
148986063|NCT02334748|537427650|FG000|Overall Study|Adverse Event|1|||
148986064|NCT02334748|537427650|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
148986065|NCT02334748|537427650|FG000|Overall Study|Patient no longer required study drug|2|||
148986066|NCT02334748|537427650|FG000|Overall Study|Lack of Efficacy|4|||
148986067|NCT02493361|537427651|FG000|Overall Study|Withdrawal by Subject|3|||
148986068|NCT03893448|537427654|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
148986069|NCT03893448|537427655|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
148986070|NCT03893448|537427654|FG000|Overall Study|Physician Decision|8|||
148986071|NCT03893448|537427655|FG001|Overall Study|Physician Decision|14|||
148986072|NCT03893448|537427654|FG000|Overall Study|Lost to Follow-up|34|||
148986073|NCT03893448|537427655|FG001|Overall Study|Lost to Follow-up|27|||
148986074|NCT03893448|537427654|FG000|Overall Study|Death|1|||
148986075|NCT03893448|537427655|FG001|Overall Study|Death|0|||
148986076|NCT01568047|537427664|FG000|Overall Study|Ineligibility|1|||
148986077|NCT01568047|537427665|FG001|Overall Study|Ineligibility|0|||
148986078|NCT01568047|537427666|FG002|Overall Study|Ineligibility|0|||
148986079|NCT01568047|537427667|FG003|Overall Study|Ineligibility|0|||
148986080|NCT01568047|537427664|FG000|Overall Study|Withdrawal by Subject|0|||
148986081|NCT01568047|537427665|FG001|Overall Study|Withdrawal by Subject|1|||
148986082|NCT01568047|537427666|FG002|Overall Study|Withdrawal by Subject|0|||
148986083|NCT01568047|537427667|FG003|Overall Study|Withdrawal by Subject|0|||
148986084|NCT01568047|537427664|FG000|Overall Study|Adverse Event|0|||
148986085|NCT01568047|537427665|FG001|Overall Study|Adverse Event|0|||
149030220|NCT02524288|537587976|FG000|Overall Study|Non-Compliance With Study Drug|14|||
149030221|NCT02524288|537587976|FG000|Overall Study|Pregnancy Wish|6|||
149030222|NCT02524288|537587976|FG000|Overall Study|Protocol Violation|6|||
149030223|NCT02524288|537587976|FG000|Overall Study|Screen Failure|2|||
149030224|NCT02524288|537587976|FG000|Overall Study|Site Discontinued Study Participation|1|||
149030225|NCT02524288|537587976|FG000|Overall Study|Study Terminated By Sponsor|1417|||
149030226|NCT02524288|537587976|FG000|Overall Study|Subject Moved|32|||
149030227|NCT02524288|537587976|FG000|Overall Study|Withdrawal by Subject|76|||
149030228|NCT02524288|537587976|FG000|Overall Study|Pregnancy|22|||
148986086|NCT01568047|537427666|FG002|Overall Study|Adverse Event|1|||
148986087|NCT01568047|537427667|FG003|Overall Study|Adverse Event|1|||
148986088|NCT00856583|537427668|FG000|Overall Study|Lack of Efficacy|389|||
148986089|NCT00856583|537427669|FG001|Overall Study|Lack of Efficacy|377|||
148986090|NCT00856583|537427668|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
148986091|NCT00856583|537427669|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
148986092|NCT00856583|537427668|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
148986093|NCT00856583|537427669|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
148986094|NCT00856583|537427668|FG000|Overall Study|Non-compliance|305|||
148986095|NCT00856583|537427669|FG001|Overall Study|Non-compliance|262|||
148986096|NCT00856583|537427668|FG000|Overall Study|Withdrawal by Subject|1092|||
149030229|NCT02524288|537587976|FG000|Overall Study|Physician Decision|2|||
148986097|NCT00856583|537427669|FG001|Overall Study|Withdrawal by Subject|919|||
148986098|NCT00856583|537427668|FG000|Overall Study|Physician Decision|59|||
148986099|NCT00856583|537427669|FG001|Overall Study|Physician Decision|82|||
148986100|NCT00856583|537427668|FG000|Overall Study|Pregnancy|14|||
148986101|NCT00856583|537427669|FG001|Overall Study|Pregnancy|5|||
148986102|NCT00856583|537427668|FG000|Overall Study|Other|92|||
148986103|NCT00856583|537427669|FG001|Overall Study|Other|104|||
148986104|NCT00856583|537427668|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
148986105|NCT00856583|537427669|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
148986106|NCT00305058|537427670|FG000|Overall Study|Participant too young|1|||
148986107|NCT00305058|537427671|FG001|Overall Study|Participant too young|0|||
148986108|NCT00305058|537427670|FG000|Overall Study|Missing data collection instrument|3|||
148986109|NCT00305058|537427671|FG001|Overall Study|Missing data collection instrument|2|||
148986110|NCT00305058|537427670|FG000|Overall Study|Missing outcome data|3|||
148986111|NCT00305058|537427671|FG001|Overall Study|Missing outcome data|2|||
148986112|NCT04102501|537427672|FG000|Overall Study|Withdrawal by Subject|7|||
148986113|NCT04102501|537427673|FG001|Overall Study|Withdrawal by Subject|9|||
148986114|NCT04102501|537427672|FG000|Overall Study|Adverse Event|1|||
148986115|NCT04102501|537427673|FG001|Overall Study|Adverse Event|3|||
148986116|NCT02338362|537427675|FG000|Overall Study|Withdrawal by Subject|1|||
148986117|NCT02338362|537427676|FG001|Overall Study|Withdrawal by Subject|1|||
148986118|NCT01669343|537427677|FG000|Part A: All Patients|Withdrawal by Subject|7|||
148986119|NCT01669343|537427677|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
148986120|NCT01669343|537427677|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
148986121|NCT01669343|537427677|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
148986122|NCT01669343|537427677|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
148986123|NCT02371369|537427678|FG000|Part 1|Physician Decision|0|||
148986124|NCT02371369|537427679|FG001|Part 1|Physician Decision|3|||
148986125|NCT02371369|537427678|FG000|Part 1|Adverse Event|8|||
148986126|NCT02371369|537427679|FG001|Part 1|Adverse Event|0|||
148986127|NCT02371369|537427678|FG000|Part 1|Withdrawal by Subject|1|||
148986128|NCT02371369|537427679|FG001|Part 1|Withdrawal by Subject|6|||
148986129|NCT02371369|537427678|FG000|Part 1|Disease progression|0|||
148986130|NCT02371369|537427679|FG001|Part 1|Disease progression|1|||
148986131|NCT02371369|537427678|FG000|Part 1|Protocol Violation|0|||
148986132|NCT02371369|537427679|FG001|Part 1|Protocol Violation|1|||
148986133|NCT02371369|537427678|FG000|Part 2|Adverse Event|6|||
148986134|NCT02371369|537427679|FG001|Part 2|Adverse Event|5|||
148986135|NCT02371369|537427678|FG000|Part 2|Withdrawal by Subject|16|||
148986136|NCT02371369|537427679|FG001|Part 2|Withdrawal by Subject|6|||
148986137|NCT02371369|537427678|FG000|Part 2|Investigator decision|1|||
148986138|NCT02371369|537427679|FG001|Part 2|Investigator decision|2|||
148986139|NCT02371369|537427678|FG000|Part 2|Death|0|||
148986140|NCT02371369|537427679|FG001|Part 2|Death|1|||
148986141|NCT02371369|537427678|FG000|Part 2|Disease progression|1|||
148986142|NCT02371369|537427679|FG001|Part 2|Disease progression|0|||
148986143|NCT02371369|537427678|FG000|Part 2|Subject Noncompliance|1|||
148986144|NCT02371369|537427679|FG001|Part 2|Subject Noncompliance|0|||
148986145|NCT02371369|537427678|FG000|Part 2|Lost to Follow-up|1|||
148986146|NCT02371369|537427679|FG001|Part 2|Lost to Follow-up|1|||
148986147|NCT02371369|537427678|FG000|Part 2|Subject transitioned to commercial supply|6|||
148986148|NCT02371369|537427679|FG001|Part 2|Subject transitioned to commercial supply|4|||
148986149|NCT02371369|537427678|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
148986150|NCT02371369|537427679|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
148986151|NCT02371369|537427678|FG000|Part 2|Surgical resection of tumor|1|||
148986152|NCT02371369|537427679|FG001|Part 2|Surgical resection of tumor|1|||
148986153|NCT02371369|537427678|FG000|Part 2|Other|0|||
148986154|NCT02371369|537427679|FG001|Part 2|Other|1|||
148986155|NCT06281548|537427680|FG000|Overall Study|Lost to Follow-up|3|||
148986156|NCT00586105|537427681|FG000|Overall Study|Adverse Event|4|||
148986157|NCT00586105|537427681|FG000|Overall Study|Death|2|||
148986158|NCT00586105|537427681|FG000|Overall Study|Protocol Violation|1|||
148986159|NCT00586105|537427681|FG000|Overall Study|Withdrawal by Subject|3|||
148986160|NCT00586105|537427681|FG000|Overall Study|Disease progression|19|||
148851667|NCT02993822|536930705|FG000|Overall Study|Lack of Efficacy|1|||
148986161|NCT00586105|537427681|FG000|Overall Study|Switched to commercial drug|9|||
148986162|NCT00586105|537427681|FG000|Overall Study|Reason not reported|1|||
148986163|NCT03864900|537427688|FG000|Overall Study|Withdrawal by Subject|1|||
148986164|NCT03864900|537427689|FG001|Overall Study|Withdrawal by Subject|1|||
148986165|NCT03864900|537427688|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
148986166|NCT03864900|537427689|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
148986167|NCT01866709|537427695|FG000|Overall Study|Adverse Event|1|||
148986168|NCT01866709|537427696|FG001|Overall Study|Adverse Event|0|||
148986169|NCT00499889|537427697|FG000|Overall Study|Infection prior to treatment|1|||
148986170|NCT00345397|537427698|FG000|Overall Study|Death|1|||
148986171|NCT03191903|537427702|FG000|Overall Study|Withdrawal by Subject|6|||
148986172|NCT03191903|537427703|FG001|Overall Study|Withdrawal by Subject|5|||
148986173|NCT03191903|537427704|FG002|Overall Study|Withdrawal by Subject|4|||
148986174|NCT03191903|537427702|FG000|Overall Study|Adverse Event|1|||
148986175|NCT03191903|537427703|FG001|Overall Study|Adverse Event|0|||
148986176|NCT03191903|537427704|FG002|Overall Study|Adverse Event|0|||
148986177|NCT00927927|537427710|FG000|Overall Study|Withdrawal by Subject|0|||
148986178|NCT00927927|537427711|FG001|Overall Study|Withdrawal by Subject|0|||
148986179|NCT00927927|537427712|FG002|Overall Study|Withdrawal by Subject|0|||
148986180|NCT00927927|537427713|FG003|Overall Study|Withdrawal by Subject|0|||
148986181|NCT00927927|537427714|FG004|Overall Study|Withdrawal by Subject|0|||
148986182|NCT00927927|537427715|FG005|Overall Study|Withdrawal by Subject|0|||
148986183|NCT00927927|537427716|FG006|Overall Study|Withdrawal by Subject|0|||
148986184|NCT00927927|537427717|FG007|Overall Study|Withdrawal by Subject|2|||
148986185|NCT00927927|537427718|FG008|Overall Study|Withdrawal by Subject|0|||
148986186|NCT00927927|537427719|FG009|Overall Study|Withdrawal by Subject|0|||
148986187|NCT00927927|537427720|FG010|Overall Study|Withdrawal by Subject|0|||
148986188|NCT00927927|537427721|FG011|Overall Study|Withdrawal by Subject|2|||
148986189|NCT00927927|537427722|FG012|Overall Study|Withdrawal by Subject|0|||
148986190|NCT00927927|537427723|FG013|Overall Study|Withdrawal by Subject|0|||
148986191|NCT00927927|537427724|FG014|Overall Study|Withdrawal by Subject|0|||
148986192|NCT03135522|537427731|FG000|Overall Study|Adverse Event|1|||
148986193|NCT03135522|537427732|FG001|Overall Study|Adverse Event|0|||
148986194|NCT00499369|537427733|FG000|Overall Study|Adverse Event|2|||
148986195|NCT00499369|537427734|FG001|Overall Study|Adverse Event|2|||
148986196|NCT00499369|537427735|FG002|Overall Study|Adverse Event|3|||
148986197|NCT00499369|537427736|FG003|Overall Study|Adverse Event|1|||
148986198|NCT00499369|537427737|FG004|Overall Study|Adverse Event|2|||
148986199|NCT00499369|537427733|FG000|Overall Study|Withdrawal by Subject|0|||
148986200|NCT00499369|537427734|FG001|Overall Study|Withdrawal by Subject|1|||
148986201|NCT00499369|537427735|FG002|Overall Study|Withdrawal by Subject|1|||
148986202|NCT00499369|537427736|FG003|Overall Study|Withdrawal by Subject|0|||
148986203|NCT00499369|537427737|FG004|Overall Study|Withdrawal by Subject|0|||
148986204|NCT00499369|537427733|FG000|Overall Study|Progression|10|||
148986205|NCT00499369|537427734|FG001|Overall Study|Progression|12|||
148986206|NCT00499369|537427735|FG002|Overall Study|Progression|9|||
148986207|NCT00499369|537427736|FG003|Overall Study|Progression|6|||
148986208|NCT00499369|537427737|FG004|Overall Study|Progression|10|||
148986209|NCT00499369|537427733|FG000|Overall Study|Death|0|||
148986210|NCT00499369|537427734|FG001|Overall Study|Death|1|||
148986211|NCT00499369|537427735|FG002|Overall Study|Death|0|||
148986212|NCT00499369|537427736|FG003|Overall Study|Death|0|||
148986213|NCT00499369|537427737|FG004|Overall Study|Death|0|||
148986214|NCT00499369|537427733|FG000|Overall Study|Not protocol specified|2|||
148986215|NCT00499369|537427734|FG001|Overall Study|Not protocol specified|0|||
148986216|NCT00499369|537427735|FG002|Overall Study|Not protocol specified|3|||
148986217|NCT00499369|537427736|FG003|Overall Study|Not protocol specified|1|||
148986218|NCT00499369|537427737|FG004|Overall Study|Not protocol specified|0|||
148986219|NCT00499369|537427733|FG000|Overall Study|Ineligible|2|||
148986220|NCT00499369|537427734|FG001|Overall Study|Ineligible|2|||
148986221|NCT00499369|537427735|FG002|Overall Study|Ineligible|1|||
148986222|NCT00499369|537427736|FG003|Overall Study|Ineligible|1|||
148986223|NCT00499369|537427737|FG004|Overall Study|Ineligible|0|||
148986224|NCT01898195|537427738|FG000|Smoking Abstinence|Did not have good measurements|35|||
148986225|NCT01898195|537427739|FG001|Smoking Abstinence|Did not have good measurements|38|||
148986226|NCT01898195|537427740|FG002|Smoking Abstinence|Did not have good measurements|36|||
148986227|NCT01802411|537427741|FG000|Overall Study|Death|2|||
148851668|NCT02993822|536930706|FG001|Overall Study|Lack of Efficacy|1|||
148986228|NCT01802411|537427742|FG001|Overall Study|Death|1|||
148986229|NCT01802411|537427741|FG000|Overall Study|Adverse Event|2|||
148986230|NCT01802411|537427742|FG001|Overall Study|Adverse Event|7|||
148986231|NCT01802411|537427741|FG000|Overall Study|Lack of Efficacy|8|||
148986232|NCT01802411|537427742|FG001|Overall Study|Lack of Efficacy|10|||
148986233|NCT01802411|537427741|FG000|Overall Study|Withdrawal by Subject|0|||
148986234|NCT01802411|537427742|FG001|Overall Study|Withdrawal by Subject|2|||
148986235|NCT01802411|537427741|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
148986236|NCT01802411|537427742|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
148986237|NCT01802411|537427741|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
148986238|NCT01802411|537427742|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
148986239|NCT01802411|537427741|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
148986240|NCT01802411|537427742|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
148986241|NCT03930745|537427743|FG000|Overall Study|Lost to Follow-up|10|||
148986242|NCT03930745|537427744|FG001|Overall Study|Lost to Follow-up|5|||
148986243|NCT03930745|537427743|FG000|Overall Study|Withdrawal by Subject|1|||
148986244|NCT03930745|537427744|FG001|Overall Study|Withdrawal by Subject|2|||
148986245|NCT03930745|537427743|FG000|Overall Study|Protocol Violation|2|||
148986246|NCT03930745|537427744|FG001|Overall Study|Protocol Violation|2|||
148986247|NCT03930745|537427743|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
148986248|NCT03930745|537427744|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
148986249|NCT03930745|537427743|FG000|Overall Study|Adverse Event|0|||
148986250|NCT03930745|537427744|FG001|Overall Study|Adverse Event|1|||
148986251|NCT03930745|537427743|FG000|Overall Study|Pregnancy|0|||
148986252|NCT03930745|537427744|FG001|Overall Study|Pregnancy|1|||
148986253|NCT03285477|537427745|FG000|Treatment and Response Assessment Period|Death|1|||
148986254|NCT03285477|537427746|FG001|Treatment and Response Assessment Period|Death|0|||
148986255|NCT03285477|537427745|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
148986256|NCT03285477|537427746|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
148986257|NCT03285477|537427745|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
148986258|NCT03285477|537427746|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
148986259|NCT03285477|537427745|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
148986260|NCT03285477|537427746|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
148986261|NCT03285477|537427745|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
148986262|NCT03285477|537427746|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
148986263|NCT00560833|537427759|FG000|Overall Study|Adverse Event|16|||
148986264|NCT00560833|537427760|FG001|Overall Study|Adverse Event|10|||
148986265|NCT00560833|537427761|FG002|Overall Study|Adverse Event|25|||
148986266|NCT00560833|537427762|FG003|Overall Study|Adverse Event|23|||
148986267|NCT00560833|537427763|FG004|Overall Study|Adverse Event|35|||
148986268|NCT00560833|537427759|FG000|Overall Study|Lost to Follow-up|0|||
148986269|NCT00560833|537427760|FG001|Overall Study|Lost to Follow-up|0|||
148986270|NCT00560833|537427761|FG002|Overall Study|Lost to Follow-up|1|||
148986271|NCT00560833|537427762|FG003|Overall Study|Lost to Follow-up|0|||
148986272|NCT00560833|537427763|FG004|Overall Study|Lost to Follow-up|0|||
148986273|NCT00560833|537427759|FG000|Overall Study|Lack of Efficacy|22|||
148986274|NCT00560833|537427760|FG001|Overall Study|Lack of Efficacy|9|||
148986275|NCT00560833|537427761|FG002|Overall Study|Lack of Efficacy|6|||
148986276|NCT00560833|537427762|FG003|Overall Study|Lack of Efficacy|4|||
148986277|NCT00560833|537427763|FG004|Overall Study|Lack of Efficacy|4|||
148986278|NCT00560833|537427759|FG000|Overall Study|Participant uncooperative|5|||
148986279|NCT00560833|537427760|FG001|Overall Study|Participant uncooperative|5|||
148986280|NCT00560833|537427761|FG002|Overall Study|Participant uncooperative|4|||
148986281|NCT00560833|537427762|FG003|Overall Study|Participant uncooperative|4|||
148986282|NCT00560833|537427763|FG004|Overall Study|Participant uncooperative|2|||
148986283|NCT00560833|537427759|FG000|Overall Study|Other|1|||
148986284|NCT00560833|537427760|FG001|Overall Study|Other|1|||
148986285|NCT00560833|537427761|FG002|Overall Study|Other|3|||
148986286|NCT00560833|537427762|FG003|Overall Study|Other|0|||
148986287|NCT00560833|537427763|FG004|Overall Study|Other|0|||
148986288|NCT00560833|537427759|FG000|Overall Study|Never received drug|0|||
148986289|NCT00560833|537427760|FG001|Overall Study|Never received drug|1|||
148986290|NCT00560833|537427761|FG002|Overall Study|Never received drug|0|||
148986291|NCT00560833|537427762|FG003|Overall Study|Never received drug|0|||
148986292|NCT00560833|537427763|FG004|Overall Study|Never received drug|1|||
148986293|NCT03283670|537427764|FG000|Placebo Gas|Withdrawal by Subject|2|||
148986294|NCT03283670|537427764|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
148986295|NCT03283670|537427764|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
148986296|NCT00612313|537427768|FG000|Overall Study|Withdrawal by Subject|6|||
148986297|NCT00612313|537427769|FG001|Overall Study|Withdrawal by Subject|9|||
148986298|NCT00612313|537427768|FG000|Overall Study|Lost to Follow-up|11|||
148986299|NCT00612313|537427769|FG001|Overall Study|Lost to Follow-up|4|||
148986300|NCT03864614|537427773|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
148986301|NCT03864614|537427774|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
148986302|NCT03864614|537427775|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
148986303|NCT03864614|537427776|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
148986304|NCT03864614|537427773|FG000|Overall Study|Withdrawal by Subject|72|||
148986305|NCT03864614|537427774|FG001|Overall Study|Withdrawal by Subject|100|||
148986306|NCT03864614|537427775|FG002|Overall Study|Withdrawal by Subject|1|||
148986307|NCT03864614|537427776|FG003|Overall Study|Withdrawal by Subject|21|||
148986308|NCT03864614|537427773|FG000|Overall Study|Lost to Follow-up|45|||
148986309|NCT03864614|537427774|FG001|Overall Study|Lost to Follow-up|54|||
148986310|NCT03864614|537427775|FG002|Overall Study|Lost to Follow-up|0|||
148986311|NCT03864614|537427776|FG003|Overall Study|Lost to Follow-up|9|||
148986312|NCT03864614|537427773|FG000|Overall Study|Adverse Event|42|||
148986313|NCT03864614|537427774|FG001|Overall Study|Adverse Event|30|||
148986314|NCT03864614|537427775|FG002|Overall Study|Adverse Event|1|||
148986315|NCT03864614|537427776|FG003|Overall Study|Adverse Event|9|||
148986316|NCT03864614|537427773|FG000|Overall Study|Protocol Deviation|6|||
148986317|NCT03864614|537427774|FG001|Overall Study|Protocol Deviation|26|||
148986318|NCT03864614|537427775|FG002|Overall Study|Protocol Deviation|0|||
148986319|NCT03864614|537427776|FG003|Overall Study|Protocol Deviation|1|||
148986320|NCT03864614|537427773|FG000|Overall Study|Physician Decision|7|||
148986321|NCT03864614|537427774|FG001|Overall Study|Physician Decision|10|||
148986322|NCT03864614|537427775|FG002|Overall Study|Physician Decision|1|||
148986323|NCT03864614|537427776|FG003|Overall Study|Physician Decision|5|||
148986324|NCT03864614|537427773|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
148986325|NCT03864614|537427774|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
148986326|NCT03864614|537427775|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
148986327|NCT03864614|537427776|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
148986328|NCT03864614|537427773|FG000|Overall Study|Sponsor Decision|1|||
148986329|NCT03864614|537427774|FG001|Overall Study|Sponsor Decision|2|||
148986330|NCT03864614|537427775|FG002|Overall Study|Sponsor Decision|0|||
148986331|NCT03864614|537427776|FG003|Overall Study|Sponsor Decision|0|||
148986332|NCT03864614|537427773|FG000|Overall Study|Pregnancy|0|||
148986333|NCT03864614|537427774|FG001|Overall Study|Pregnancy|1|||
148986334|NCT03864614|537427775|FG002|Overall Study|Pregnancy|0|||
148986335|NCT03864614|537427776|FG003|Overall Study|Pregnancy|0|||
148986336|NCT03864614|537427773|FG000|Overall Study|Other|7|||
148986337|NCT03864614|537427774|FG001|Overall Study|Other|9|||
148986338|NCT03864614|537427775|FG002|Overall Study|Other|1|||
148986339|NCT03864614|537427776|FG003|Overall Study|Other|4|||
148986340|NCT03864614|537427773|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
148986341|NCT03864614|537427774|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
148986342|NCT03864614|537427775|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
148986343|NCT03864614|537427776|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
148986344|NCT00136955|537430401|FG000|Overall Study|Adverse Event|8|||
148986345|NCT00136955|537430401|FG000|Overall Study|Lost to Follow-up|1|||
148986346|NCT00136955|537430401|FG000|Overall Study|Withdrawal by Subject|2|||
148986347|NCT00136955|537430401|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
148986348|NCT02239510|537430402|FG000|Overall Study|Lost to Follow-up|2|||
148986349|NCT02239510|537430403|FG001|Overall Study|Lost to Follow-up|1|||
148986350|NCT00074282|537430407|FG000|Step 1|Adverse Event|32|||
148986351|NCT00074282|537430408|FG001|Step 1|Adverse Event|0|||
148986352|NCT00074282|537430409|FG002|Step 1|Adverse Event|0|||
148986353|NCT00074282|537430407|FG000|Step 1|Death|6|||
148986354|NCT00074282|537430408|FG001|Step 1|Death|0|||
148986355|NCT00074282|537430409|FG002|Step 1|Death|0|||
148986356|NCT00074282|537430407|FG000|Step 1|Withdrawal by Subject|7|||
148986357|NCT00074282|537430408|FG001|Step 1|Withdrawal by Subject|0|||
148986358|NCT00074282|537430409|FG002|Step 1|Withdrawal by Subject|0|||
148986359|NCT00074282|537430407|FG000|Step 1|Disease progression|2|||
148986360|NCT00074282|537430408|FG001|Step 1|Disease progression|0|||
148986361|NCT00074282|537430409|FG002|Step 1|Disease progression|0|||
148986362|NCT00074282|537430407|FG000|Step 1|Alternative therapy|2|||
148986363|NCT00074282|537430408|FG001|Step 1|Alternative therapy|0|||
148986364|NCT00074282|537430409|FG002|Step 1|Alternative therapy|0|||
148986365|NCT00074282|537430407|FG000|Step 1|Other complicating disease|2|||
148986366|NCT00074282|537430408|FG001|Step 1|Other complicating disease|0|||
148986367|NCT00074282|537430409|FG002|Step 1|Other complicating disease|0|||
148986368|NCT00074282|537430407|FG000|Step 1|Physician Decision|1|||
148986369|NCT00074282|537430408|FG001|Step 1|Physician Decision|0|||
148986370|NCT00074282|537430409|FG002|Step 1|Physician Decision|0|||
148986371|NCT00074282|537430407|FG000|Step 1|Ineligible|4|||
148986372|NCT00074282|537430408|FG001|Step 1|Ineligible|0|||
148986373|NCT00074282|537430409|FG002|Step 1|Ineligible|0|||
148986374|NCT00074282|537430407|FG000|Step 1|Never started treatment|2|||
148986375|NCT00074282|537430408|FG001|Step 1|Never started treatment|0|||
148986376|NCT00074282|537430409|FG002|Step 1|Never started treatment|0|||
148986377|NCT00074282|537430407|FG000|Step 2|Adverse Event|0|||
148986378|NCT00074282|537430408|FG001|Step 2|Adverse Event|2|||
148986379|NCT00074282|537430409|FG002|Step 2|Adverse Event|12|||
148986380|NCT00074282|537430407|FG000|Step 2|Disease progression|0|||
148986381|NCT00074282|537430408|FG001|Step 2|Disease progression|0|||
148986382|NCT00074282|537430409|FG002|Step 2|Disease progression|5|||
148986383|NCT00074282|537430407|FG000|Step 2|Death|0|||
148986384|NCT00074282|537430408|FG001|Step 2|Death|0|||
148986385|NCT00074282|537430409|FG002|Step 2|Death|3|||
148986386|NCT00074282|537430407|FG000|Step 2|Withdrawal by Subject|0|||
148986387|NCT00074282|537430408|FG001|Step 2|Withdrawal by Subject|0|||
148986388|NCT00074282|537430409|FG002|Step 2|Withdrawal by Subject|2|||
148986389|NCT00074282|537430407|FG000|Step 2|Physician Decision|0|||
148986390|NCT00074282|537430408|FG001|Step 2|Physician Decision|0|||
148986391|NCT00074282|537430409|FG002|Step 2|Physician Decision|1|||
148986392|NCT00074282|537430407|FG000|Step 2|Ineligible|0|||
148986393|NCT00074282|537430408|FG001|Step 2|Ineligible|0|||
148986394|NCT00074282|537430409|FG002|Step 2|Ineligible|1|||
148986395|NCT00464542|537430410|FG000|Pre-treatment|Withdrawal by Subject|2|||
148986396|NCT03859323|537430412|FG000|Overall Study|Lost to Follow-up|0|||
148986397|NCT03859323|537430413|FG001|Overall Study|Lost to Follow-up|0|||
148986398|NCT03859323|537430414|FG002|Overall Study|Lost to Follow-up|0|||
148986399|NCT03859323|537430415|FG003|Overall Study|Lost to Follow-up|0|||
148986400|NCT03859323|537430416|FG004|Overall Study|Lost to Follow-up|0|||
148986401|NCT03859323|537430417|FG005|Overall Study|Lost to Follow-up|0|||
148986402|NCT03859323|537430418|FG006|Overall Study|Lost to Follow-up|1|||
148986403|NCT03859323|537430419|FG007|Overall Study|Lost to Follow-up|0|||
148986404|NCT03859323|537430420|FG008|Overall Study|Lost to Follow-up|0|||
148986405|NCT03859323|537430421|FG009|Overall Study|Lost to Follow-up|0|||
148986406|NCT03859323|537430422|FG010|Overall Study|Lost to Follow-up|0|||
148986407|NCT03859323|537430423|FG011|Overall Study|Lost to Follow-up|0|||
148986408|NCT03859323|537430424|FG012|Overall Study|Lost to Follow-up|0|||
148986409|NCT03859323|537430412|FG000|Overall Study|Withdrawal by Subject|0|||
148986410|NCT03859323|537430413|FG001|Overall Study|Withdrawal by Subject|0|||
148776872|NCT02278120|536656928|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
148776873|NCT02278120|536656929|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
148986411|NCT03859323|537430414|FG002|Overall Study|Withdrawal by Subject|1|||
148986412|NCT03859323|537430415|FG003|Overall Study|Withdrawal by Subject|0|||
148986413|NCT03859323|537430416|FG004|Overall Study|Withdrawal by Subject|0|||
148986414|NCT03859323|537430417|FG005|Overall Study|Withdrawal by Subject|1|||
148776874|NCT02278120|536656928|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
148776875|NCT02278120|536656929|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
148776876|NCT02278120|536656928|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
148776877|NCT02278120|536656929|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
148776878|NCT03197324|536656930|FG000|Overall Study|Adverse Event|0|||
148776879|NCT03197324|536656931|FG001|Overall Study|Adverse Event|1|||
148776880|NCT00102531|536656932|FG000|Overall Study|Adverse Event|0|||
148776881|NCT00102531|536656933|FG001|Overall Study|Adverse Event|1|||
148776882|NCT00102531|536656932|FG000|Overall Study|Disease Progression|5|||
148776883|NCT00102531|536656933|FG001|Overall Study|Disease Progression|9|||
148776884|NCT00102531|536656932|FG000|Overall Study|Physician Decision|0|||
148776885|NCT00102531|536656933|FG001|Overall Study|Physician Decision|1|||
148776886|NCT01752634|536658461|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
148776887|NCT01752634|536658462|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
148776888|NCT01752634|536658463|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
148776889|NCT01752634|536658464|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
148776890|NCT01752634|536658465|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
148776891|NCT01752634|536658466|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
148776892|NCT01752634|536658461|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
148776893|NCT01752634|536658462|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
148776894|NCT01752634|536658463|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
148776895|NCT01752634|536658464|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
148776896|NCT01752634|536658465|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
148776897|NCT01752634|536658466|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
148776898|NCT01752634|536658461|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
148776899|NCT01752634|536658462|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
148776900|NCT01752634|536658463|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
148776901|NCT01752634|536658464|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
148776902|NCT01752634|536658465|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
148776903|NCT01752634|536658466|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
148776904|NCT01752634|536658461|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
148776905|NCT01752634|536658462|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
148776906|NCT01752634|536658463|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
148776907|NCT01752634|536658464|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
148776908|NCT01752634|536658465|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
148776909|NCT01752634|536658466|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
148776910|NCT01752634|536658461|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
148776911|NCT01752634|536658462|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
148776912|NCT01752634|536658463|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
148776913|NCT01752634|536658464|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
148776914|NCT01752634|536658465|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
148776915|NCT01752634|536658466|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
148776916|NCT01752634|536658461|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
148776917|NCT01752634|536658462|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
148776918|NCT01752634|536658463|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
148776919|NCT01752634|536658464|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
148776920|NCT01752634|536658465|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
148776921|NCT01752634|536658466|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
148776922|NCT01752634|536658461|FG000|Week 24 to Week 260|Physician Decision|1|||
148776923|NCT01752634|536658462|FG001|Week 24 to Week 260|Physician Decision|2|||
148776924|NCT01752634|536658463|FG002|Week 24 to Week 260|Physician Decision|4|||
148776925|NCT01752634|536658464|FG003|Week 24 to Week 260|Physician Decision|2|||
148776926|NCT01752634|536658465|FG004|Week 24 to Week 260|Physician Decision|1|||
148776927|NCT01752634|536658466|FG005|Week 24 to Week 260|Physician Decision|0|||
148776928|NCT01752634|536658461|FG000|Week 24 to Week 260|Death|0|||
148776929|NCT01752634|536658462|FG001|Week 24 to Week 260|Death|1|||
148776930|NCT01752634|536658463|FG002|Week 24 to Week 260|Death|0|||
148776931|NCT01752634|536658464|FG003|Week 24 to Week 260|Death|0|||
148776932|NCT01752634|536658465|FG004|Week 24 to Week 260|Death|0|||
148776933|NCT01752634|536658466|FG005|Week 24 to Week 260|Death|0|||
148776934|NCT01752634|536658461|FG000|Week 24 to Week 260|Pregnancy|0|||
148776935|NCT01752634|536658462|FG001|Week 24 to Week 260|Pregnancy|0|||
148776936|NCT01752634|536658463|FG002|Week 24 to Week 260|Pregnancy|1|||
148776937|NCT01752634|536658464|FG003|Week 24 to Week 260|Pregnancy|0|||
148986415|NCT03859323|537430418|FG006|Overall Study|Withdrawal by Subject|0|||
148986416|NCT03859323|537430419|FG007|Overall Study|Withdrawal by Subject|0|||
148986417|NCT03859323|537430420|FG008|Overall Study|Withdrawal by Subject|0|||
148986418|NCT03859323|537430421|FG009|Overall Study|Withdrawal by Subject|1|||
148986419|NCT03859323|537430422|FG010|Overall Study|Withdrawal by Subject|1|||
148986420|NCT03859323|537430423|FG011|Overall Study|Withdrawal by Subject|2|||
148986421|NCT03859323|537430424|FG012|Overall Study|Withdrawal by Subject|1|||
148986422|NCT03859323|537430412|FG000|Overall Study|Pregnancy|0|||
148986423|NCT03859323|537430413|FG001|Overall Study|Pregnancy|0|||
148986424|NCT03859323|537430414|FG002|Overall Study|Pregnancy|0|||
148986425|NCT03859323|537430415|FG003|Overall Study|Pregnancy|0|||
148986426|NCT03859323|537430416|FG004|Overall Study|Pregnancy|0|||
148986427|NCT03859323|537430417|FG005|Overall Study|Pregnancy|0|||
148986428|NCT03859323|537430418|FG006|Overall Study|Pregnancy|0|||
148986429|NCT03859323|537430419|FG007|Overall Study|Pregnancy|0|||
148986430|NCT03859323|537430420|FG008|Overall Study|Pregnancy|0|||
148986431|NCT03859323|537430421|FG009|Overall Study|Pregnancy|1|||
148986432|NCT03859323|537430422|FG010|Overall Study|Pregnancy|0|||
148986433|NCT03859323|537430423|FG011|Overall Study|Pregnancy|0|||
148986434|NCT03859323|537430424|FG012|Overall Study|Pregnancy|0|||
148986435|NCT01773226|537430425|FG000|Overall Study|Withdrawal by Subject|1|||
148986436|NCT01682460|537430427|FG000|Overall Study|Withdrawal by Subject|2|||
148986437|NCT01682460|537430427|FG000|Overall Study|Did not meet inclusion criteria|2|||
148986438|NCT03811912|537430428|FG000|Overall Study|Withdrew Consent|4|||
148986439|NCT03811912|537430429|FG001|Overall Study|Withdrew Consent|2|||
148986440|NCT04401579|537430430|FG000|Overall Study|Death|23|||
148986441|NCT04401579|537430431|FG001|Overall Study|Death|36|||
148986442|NCT04401579|537430430|FG000|Overall Study|Lost to Follow-up|40|||
148986443|NCT04401579|537430431|FG001|Overall Study|Lost to Follow-up|41|||
148986444|NCT04401579|537430430|FG000|Overall Study|Withdrawal by Subject|8|||
148986445|NCT04401579|537430431|FG001|Overall Study|Withdrawal by Subject|16|||
148986446|NCT04401579|537430430|FG000|Overall Study|Physician Decision|1|||
148986447|NCT04401579|537430431|FG001|Overall Study|Physician Decision|2|||
148986448|NCT04401579|537430430|FG000|Overall Study|Became ineligible after enrollment|1|||
148986449|NCT04401579|537430431|FG001|Overall Study|Became ineligible after enrollment|1|||
148986450|NCT04401579|537430430|FG000|Overall Study|Enrolled but treatment not administered|7|||
148986451|NCT04401579|537430431|FG001|Overall Study|Enrolled but treatment not administered|9|||
148986452|NCT04401579|537430430|FG000|Overall Study|Adverse Event|2|||
148986453|NCT04401579|537430431|FG001|Overall Study|Adverse Event|1|||
148986454|NCT04401579|537430430|FG000|Overall Study|Scheduling error|1|||
148986455|NCT04401579|537430431|FG001|Overall Study|Scheduling error|2|||
148986456|NCT04401579|537430430|FG000|Overall Study|Transferred to another hospital|1|||
148986457|NCT04401579|537430431|FG001|Overall Study|Transferred to another hospital|2|||
148986458|NCT00489970|537430432|FG000|Persistence Year 9|Lost to Follow-up|2|||
148986459|NCT00489970|537430433|FG001|Persistence Year 9|Lost to Follow-up|2|||
148986460|NCT00489970|537430434|FG002|Persistence Year 9|Lost to Follow-up|3|||
148986461|NCT00489970|537430432|FG000|Persistence Year 9|Other|1|||
148986462|NCT00489970|537430433|FG001|Persistence Year 9|Other|0|||
148986463|NCT00489970|537430434|FG002|Persistence Year 9|Other|2|||
148986464|NCT01863680|537430435|FG000|Overall Study|Adverse Event|17|||
148986465|NCT01863680|537430435|FG000|Overall Study|Risk of OHSS|17|||
148986466|NCT01863680|537430435|FG000|Overall Study|Spontaneous pregnancy|2|||
148986467|NCT01863680|537430435|FG000|Overall Study|Withdrawal by Subject|1|||
148986468|NCT01863680|537430435|FG000|Overall Study|Did not undergo IVF/ET|14|||
148986469|NCT01863680|537430435|FG000|Overall Study|Other|6|||
148986470|NCT00618514|537430436|FG000|Overall Study|Lost to Follow-up|11|||
148986471|NCT00618514|537430437|FG001|Overall Study|Lost to Follow-up|12|||
148986472|NCT00618514|537430438|FG002|Overall Study|Lost to Follow-up|4|||
148986473|NCT00566228|537430443|FG000|Overall Study|Withdrawal by Subject|1|||
148986474|NCT00566228|537430444|FG001|Overall Study|Withdrawal by Subject|0|||
148986475|NCT00566228|537430443|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
148986476|NCT00566228|537430444|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
148986477|NCT00566228|537430443|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
148986478|NCT00566228|537430444|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
148986479|NCT00566228|537430443|FG000|Overall Study|progressed before infusion could occur|0|||
148986480|NCT00566228|537430444|FG001|Overall Study|progressed before infusion could occur|1|||
148986481|NCT03521635|537430447|FG000|Overall Study|Adverse Event|1|||
148986482|NCT03521635|537430448|FG001|Overall Study|Adverse Event|1|||
148986483|NCT03521635|537430447|FG000|Overall Study|Refused to complete study visit|1|||
148986484|NCT03521635|537430448|FG001|Overall Study|Refused to complete study visit|0|||
148986485|NCT03521635|537430447|FG000|Overall Study|Refused to continue trial medication|2|||
148986486|NCT03521635|537430448|FG001|Overall Study|Refused to continue trial medication|2|||
148986487|NCT03521635|537430447|FG000|Overall Study|Lost to Follow-up|0|||
148986488|NCT03521635|537430448|FG001|Overall Study|Lost to Follow-up|1|||
148986489|NCT03521635|537430447|FG000|Overall Study|Meet exclusion criteria|0|||
148986490|NCT03521635|537430448|FG001|Overall Study|Meet exclusion criteria|1|||
148986491|NCT03521635|537430447|FG000|Overall Study|Patient not taken study medicine|0|||
148986492|NCT03521635|537430448|FG001|Overall Study|Patient not taken study medicine|1|||
148986493|NCT00902304|537430451|FG000|Overall Study|Adverse Event|4|||
148986494|NCT00902304|537430452|FG001|Overall Study|Adverse Event|10|||
148986495|NCT00902304|537430453|FG002|Overall Study|Adverse Event|25|||
148986496|NCT00902304|537430451|FG000|Overall Study|Investigator discretion|3|||
148986497|NCT00902304|537430452|FG001|Overall Study|Investigator discretion|5|||
148986498|NCT00902304|537430453|FG002|Overall Study|Investigator discretion|13|||
148986499|NCT00902304|537430451|FG000|Overall Study|Lost to Follow-up|7|||
148986500|NCT00902304|537430452|FG001|Overall Study|Lost to Follow-up|7|||
148986501|NCT00902304|537430453|FG002|Overall Study|Lost to Follow-up|7|||
148986502|NCT00902304|537430451|FG000|Overall Study|Protocol Violation|9|||
148986503|NCT00902304|537430452|FG001|Overall Study|Protocol Violation|18|||
148986504|NCT00902304|537430453|FG002|Overall Study|Protocol Violation|20|||
148986505|NCT00902304|537430451|FG000|Overall Study|Withdrawal by Subject|32|||
148986506|NCT00902304|537430452|FG001|Overall Study|Withdrawal by Subject|22|||
148986507|NCT00902304|537430453|FG002|Overall Study|Withdrawal by Subject|43|||
148986508|NCT00902304|537430451|FG000|Overall Study|includes pregnancy|3|||
148986509|NCT00902304|537430452|FG001|Overall Study|includes pregnancy|9|||
148986510|NCT00902304|537430453|FG002|Overall Study|includes pregnancy|2|||
148986511|NCT02492100|537430454|FG000|Overall Study|Death|1|||
148986512|NCT05706506|537430455|FG000|Overall Study|Adverse Event|1|||
148986513|NCT05706506|537430455|FG000|Overall Study|Withdrawal by Subject|4|||
148986514|NCT05706506|537430455|FG000|Overall Study|Lost to Follow-up|2|||
148986515|NCT05706506|537430455|FG000|Overall Study|Inadvertent Enrolment|12|||
148986516|NCT05706506|537430455|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
148986517|NCT05706506|537430455|FG000|Overall Study|Participant Moved Out of State|1|||
148986518|NCT03832010|537430456|FG000|Overall Study|Withdrawal by Subject|2|||
148986519|NCT03832010|537430457|FG001|Overall Study|Withdrawal by Subject|1|||
148986520|NCT03832010|537430458|FG002|Overall Study|Withdrawal by Subject|0|||
148986521|NCT03832010|537430456|FG000|Overall Study|Lost to Follow-up|2|||
148986522|NCT03832010|537430457|FG001|Overall Study|Lost to Follow-up|1|||
148986523|NCT03832010|537430458|FG002|Overall Study|Lost to Follow-up|1|||
148986524|NCT04495374|537430462|FG000|Overall Study|Protocol Violation|2|||
148986525|NCT04495374|537430463|FG001|Overall Study|Protocol Violation|1|||
148986526|NCT03727750|537430464|FG000|Overall Study|Death|45|||
148986527|NCT03727750|537430464|FG000|Overall Study|Withdrawal by Subject|2|||
148986528|NCT03727750|537430464|FG000|Overall Study|Lost to Follow-up|1|||
148986529|NCT03727750|537430464|FG000|Overall Study|Other|1|||
148986530|NCT01054820|537430467|FG000|Overall Study|Withdrawal by Subject|2|||
148986531|NCT00321919|537430468|FG000|Overall Study|Adverse Event|17|||
148986532|NCT00321919|537430469|FG001|Overall Study|Adverse Event|10|||
148986533|NCT00321919|537430468|FG000|Overall Study|Death|21|||
148986534|NCT00321919|537430469|FG001|Overall Study|Death|17|||
148986535|NCT00321919|537430468|FG000|Overall Study|Insufficient Therapeutic Response|1|||
148986536|NCT00321919|537430469|FG001|Overall Study|Insufficient Therapeutic Response|0|||
148986537|NCT00321919|537430468|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
148986538|NCT00321919|537430469|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
148986539|NCT00321919|537430468|FG000|Overall Study|Refused Treatment|23|||
148986540|NCT00321919|537430469|FG001|Overall Study|Refused Treatment|14|||
148986541|NCT00321919|537430468|FG000|Overall Study|Other Protocol Violation|2|||
148986542|NCT00321919|537430469|FG001|Overall Study|Other Protocol Violation|3|||
148986543|NCT00321919|537430468|FG000|Overall Study|Failure to Return|3|||
148986544|NCT00321919|537430469|FG001|Overall Study|Failure to Return|1|||
148986545|NCT00321919|537430468|FG000|Overall Study|Other withdrawal reason|7|||
148986546|NCT00321919|537430469|FG001|Overall Study|Other withdrawal reason|6|||
148986547|NCT02624804|537430470|FG000|Overall Study|Screen Failure|5|||
148986548|NCT02590354|537430471|FG000|Phase 1|Active hepatitis B or C infection|1|||
148986549|NCT02590354|537430471|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
148986550|NCT02590354|537430471|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
148986551|NCT02590354|537430471|FG000|Phase 1|Subject does not want to participate|20|||
148986552|NCT02590354|537430471|FG000|Phase 1|Lost to Follow-up|1|||
148986553|NCT02590354|537430471|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
148986554|NCT00996996|537430472|FG000|Overall Study|Progressive Disease|10|||
148986555|NCT00996996|537430472|FG000|Overall Study|Non-compliance|8|||
148986556|NCT00996996|537430472|FG000|Overall Study|Lost to Follow-up|9|||
148986557|NCT00996996|537430472|FG000|Overall Study|Death|5|||
148986558|NCT00996996|537430472|FG000|Overall Study|Did Not Receive Study Medications|1|||
148986559|NCT00760929|537430473|FG000|Overall Study|Adverse Event|2|||
148986560|NCT00760929|537430474|FG001|Overall Study|Adverse Event|0|||
148986561|NCT00760929|537430475|FG002|Overall Study|Adverse Event|6|||
148986562|NCT00760929|537430476|FG003|Overall Study|Adverse Event|10|||
148986563|NCT00760929|537430473|FG000|Overall Study|Lack of Efficacy|0|||
148986564|NCT00760929|537430474|FG001|Overall Study|Lack of Efficacy|2|||
148776938|NCT01752634|536658465|FG004|Week 24 to Week 260|Pregnancy|0|||
148986565|NCT00760929|537430475|FG002|Overall Study|Lack of Efficacy|1|||
148986566|NCT00760929|537430476|FG003|Overall Study|Lack of Efficacy|0|||
148986567|NCT00760929|537430473|FG000|Overall Study|Withdrawal by Subject|1|||
148986568|NCT00760929|537430474|FG001|Overall Study|Withdrawal by Subject|0|||
148776939|NCT01752634|536658466|FG005|Week 24 to Week 260|Pregnancy|0|||
148776940|NCT01752634|536658461|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
148776941|NCT01752634|536658462|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
148776942|NCT01752634|536658463|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
148776943|NCT01752634|536658464|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
148776944|NCT01752634|536658465|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
148776945|NCT01752634|536658466|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
148776946|NCT01752634|536658461|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
148776947|NCT01752634|536658462|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
148776948|NCT01752634|536658463|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
148776949|NCT01752634|536658464|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
148776950|NCT01752634|536658465|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
148776951|NCT01752634|536658466|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
148776952|NCT01752634|536658461|FG000|Week 24 to Week 260|Adverse Event|4|||
148776953|NCT01752634|536658462|FG001|Week 24 to Week 260|Adverse Event|8|||
148776954|NCT01752634|536658463|FG002|Week 24 to Week 260|Adverse Event|8|||
148776955|NCT01752634|536658464|FG003|Week 24 to Week 260|Adverse Event|4|||
148776956|NCT01752634|536658465|FG004|Week 24 to Week 260|Adverse Event|2|||
148776957|NCT01752634|536658466|FG005|Week 24 to Week 260|Adverse Event|0|||
148776958|NCT04250714|536658473|FG000|Overall Study|Treatment - withdrawal by subject|14|||
148776959|NCT04250714|536658473|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
148776960|NCT04250714|536658473|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
148776961|NCT04250714|536658473|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
148776962|NCT04250714|536658473|FG000|Overall Study|Treatment - Death|1|||
148776963|NCT04250714|536658473|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
148776964|NCT04250714|536658473|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
148776965|NCT04250714|536658473|FG000|Overall Study|Attempt|2|||
148986569|NCT00760929|537430475|FG002|Overall Study|Withdrawal by Subject|9|||
148776966|NCT04250714|536658473|FG000|Overall Study|Intent|7|||
148776967|NCT05741346|536658474|FG000|Overall Study|Withdrawn due to termination of study|28|||
148776968|NCT05906836|536658483|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
148776969|NCT05906836|536658483|FG000|Overall Study|Lost to Follow-up|1|||
148776970|NCT04982575|536658484|FG000|Overall Study|Withdrawal by Subject|2|||
148776971|NCT04982575|536658485|FG001|Overall Study|Withdrawal by Subject|0|||
148776972|NCT04982575|536658486|FG002|Overall Study|Withdrawal by Subject|2|||
148776973|NCT04322539|536658491|FG000|Overall Study|Adverse Event|2|||
148776974|NCT04322539|536658492|FG001|Overall Study|Adverse Event|0|||
148776975|NCT04322539|536658491|FG000|Overall Study|Death|411|||
148776976|NCT04322539|536658492|FG001|Overall Study|Death|203|||
148776977|NCT04322539|536658491|FG000|Overall Study|Lost to Follow-up|3|||
148776978|NCT04322539|536658492|FG001|Overall Study|Lost to Follow-up|1|||
148776979|NCT04322539|536658491|FG000|Overall Study|Withdrawal of consent|14|||
148776980|NCT04322539|536658492|FG001|Overall Study|Withdrawal of consent|8|||
148776981|NCT04322539|536658491|FG000|Overall Study|Radiological Disease Progression|6|||
148776982|NCT04322539|536658492|FG001|Overall Study|Radiological Disease Progression|0|||
148776983|NCT04322539|536658491|FG000|Overall Study|Sponsor Decision|19|||
148776984|NCT04322539|536658492|FG001|Overall Study|Sponsor Decision|14|||
148776985|NCT04322539|536658491|FG000|Overall Study|Other|6|||
148776986|NCT04322539|536658492|FG001|Overall Study|Other|4|||
148776987|NCT01702532|536658493|FG000|Overall Study|Adverse Event|0|||
148776988|NCT01702532|536658494|FG001|Overall Study|Adverse Event|1|||
148776989|NCT03617861|536658495|FG000|Second Intervention (1 Day)|Adverse Event|0|||
148776990|NCT03617861|536658496|FG001|Second Intervention (1 Day)|Adverse Event|0|||
148776991|NCT03617861|536658497|FG002|Second Intervention (1 Day)|Adverse Event|1|||
148776992|NCT03617861|536658498|FG003|Second Intervention (1 Day)|Adverse Event|0|||
148776993|NCT00623597|536658499|FG000|Overall Study|Failed to return|1|||
148776994|NCT00623597|536658500|FG001|Overall Study|Failed to return|0|||
148776995|NCT01846221|536658501|FG000|Overall Study|Catheter Failure|2|||
148776996|NCT01846221|536658502|FG001|Overall Study|Catheter Failure|0|||
148776997|NCT01846221|536658501|FG000|Overall Study|Age Exclusion|1|||
148776998|NCT01846221|536658502|FG001|Overall Study|Age Exclusion|0|||
148986570|NCT00760929|537430476|FG003|Overall Study|Withdrawal by Subject|1|||
148986571|NCT00760929|537430473|FG000|Overall Study|Lost to Follow-up|0|||
148776999|NCT04599933|536658503|FG000|Overall Study|Adverse Event|4|||
148777000|NCT04599933|536658504|FG001|Overall Study|Adverse Event|1|||
148777001|NCT04599933|536658503|FG000|Overall Study|Withdrawal by Subject|4|||
148777002|NCT04599933|536658504|FG001|Overall Study|Withdrawal by Subject|2|||
148777003|NCT04599933|536658503|FG000|Overall Study|Lost to Follow-up|0|||
148777004|NCT04599933|536658504|FG001|Overall Study|Lost to Follow-up|1|||
148777005|NCT04599933|536658503|FG000|Overall Study|Physician Decision|0|||
148777006|NCT04599933|536658504|FG001|Overall Study|Physician Decision|1|||
148777007|NCT04599933|536658503|FG000|Overall Study|Screen Failure|1|||
148777008|NCT04599933|536658504|FG001|Overall Study|Screen Failure|2|||
148777009|NCT02963558|536658513|FG000|Overall Study|Withdrawn by investigator|1|||
148777010|NCT02963558|536658514|FG001|Overall Study|Withdrawn by investigator|0|||
148986572|NCT00760929|537430474|FG001|Overall Study|Lost to Follow-up|0|||
148777011|NCT02963558|536658513|FG000|Overall Study|Withdrawal by Subject|0|||
148777012|NCT02963558|536658514|FG001|Overall Study|Withdrawal by Subject|1|||
148777013|NCT02339155|536658515|FG000|Overall Study|Adverse Event|0|||
148777014|NCT02339155|536658516|FG001|Overall Study|Adverse Event|6|||
148777015|NCT02339155|536658515|FG000|Overall Study|Death|1|||
148777016|NCT02339155|536658516|FG001|Overall Study|Death|1|||
148777017|NCT02339155|536658515|FG000|Overall Study|Lost to Follow-up|8|||
148777018|NCT02339155|536658516|FG001|Overall Study|Lost to Follow-up|9|||
148777019|NCT02339155|536658515|FG000|Overall Study|Physician Decision|2|||
148777020|NCT02339155|536658516|FG001|Overall Study|Physician Decision|1|||
148777021|NCT02339155|536658515|FG000|Overall Study|Withdrawal by Subject|4|||
148777022|NCT02339155|536658516|FG001|Overall Study|Withdrawal by Subject|4|||
148777023|NCT03226678|536658519|FG000|Part A (Core Study Phase)|Adverse Event|0|||
148777024|NCT03226678|536658520|FG001|Part A (Core Study Phase)|Adverse Event|1|||
148777025|NCT03226678|536658521|FG002|Part A (Core Study Phase)|Adverse Event|0|||
148777026|NCT03226678|536658522|FG003|Part A (Core Study Phase)|Adverse Event|0|||
148777027|NCT03226678|536658523|FG004|Part A (Core Study Phase)|Adverse Event|0|||
148777028|NCT03226678|536658524|FG005|Part A (Core Study Phase)|Adverse Event|0|||
148777029|NCT03226678|536658519|FG000|Part A (Core Study Phase)|Death|0|||
148777030|NCT03226678|536658520|FG001|Part A (Core Study Phase)|Death|0|||
148777031|NCT03226678|536658521|FG002|Part A (Core Study Phase)|Death|1|||
148777032|NCT03226678|536658522|FG003|Part A (Core Study Phase)|Death|0|||
148777033|NCT03226678|536658523|FG004|Part A (Core Study Phase)|Death|0|||
148777034|NCT03226678|536658524|FG005|Part A (Core Study Phase)|Death|0|||
148777035|NCT03226678|536658519|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
148777036|NCT03226678|536658520|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
148777037|NCT03226678|536658521|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
148777038|NCT03226678|536658522|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
148777039|NCT03226678|536658523|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
148777040|NCT03226678|536658524|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
148777041|NCT03226678|536658519|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
148777042|NCT03226678|536658520|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
148777043|NCT03226678|536658521|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
148777044|NCT03226678|536658522|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
148777045|NCT03226678|536658523|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
148777046|NCT03226678|536658524|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
148777047|NCT03226678|536658519|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
148777048|NCT03226678|536658520|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
148777049|NCT03226678|536658521|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
148777050|NCT03226678|536658522|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
148777051|NCT03226678|536658523|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
148777052|NCT03226678|536658524|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
148777053|NCT03226678|536658519|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
148777054|NCT03226678|536658520|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
148777055|NCT03226678|536658521|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
148777056|NCT03226678|536658522|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
148777057|NCT03226678|536658523|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
148777058|NCT03226678|536658524|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
148777059|NCT03226678|536658519|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
148777060|NCT03226678|536658520|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
148777061|NCT03226678|536658521|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
148777062|NCT03226678|536658522|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
148777063|NCT03226678|536658523|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
148777064|NCT03226678|536658524|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
148777065|NCT03226678|536658519|FG000|Part B (Long-Term Extension Phase)|Death|0|||
148777066|NCT03226678|536658520|FG001|Part B (Long-Term Extension Phase)|Death|0|||
148777067|NCT03226678|536658521|FG002|Part B (Long-Term Extension Phase)|Death|0|||
148777068|NCT03226678|536658522|FG003|Part B (Long-Term Extension Phase)|Death|0|||
148777069|NCT03226678|536658523|FG004|Part B (Long-Term Extension Phase)|Death|0|||
148777070|NCT03226678|536658524|FG005|Part B (Long-Term Extension Phase)|Death|1|||
148777071|NCT03226678|536658519|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
148777072|NCT03226678|536658520|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
148777073|NCT03226678|536658521|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
148777074|NCT03226678|536658522|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
148777075|NCT03226678|536658523|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
148777076|NCT03226678|536658524|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
148777077|NCT03226678|536658519|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
148777078|NCT03226678|536658520|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
148777079|NCT03226678|536658521|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
148777080|NCT03226678|536658522|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
148777081|NCT03226678|536658523|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
148986573|NCT00760929|537430475|FG002|Overall Study|Lost to Follow-up|1|||
148986574|NCT00760929|537430476|FG003|Overall Study|Lost to Follow-up|0|||
148986575|NCT00760929|537430473|FG000|Overall Study|Progression of Disease|21|||
148986576|NCT00760929|537430474|FG001|Overall Study|Progression of Disease|26|||
148986577|NCT00760929|537430475|FG002|Overall Study|Progression of Disease|38|||
148986578|NCT00760929|537430476|FG003|Overall Study|Progression of Disease|42|||
148986579|NCT00760929|537430473|FG000|Overall Study|Other|2|||
148986580|NCT00760929|537430474|FG001|Overall Study|Other|0|||
148986581|NCT00760929|537430475|FG002|Overall Study|Other|2|||
148986582|NCT00760929|537430476|FG003|Overall Study|Other|1|||
148986583|NCT00760929|537430473|FG000|Overall Study|Death|0|||
148986584|NCT00760929|537430474|FG001|Overall Study|Death|0|||
148986585|NCT00760929|537430475|FG002|Overall Study|Death|1|||
148986586|NCT00760929|537430476|FG003|Overall Study|Death|0|||
148986587|NCT00760929|537430473|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
148986588|NCT00760929|537430474|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
148986589|NCT00760929|537430475|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
148986590|NCT00760929|537430476|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
148986591|NCT01666002|537430477|FG000|Overall Study|Lost to Follow-up|5|||
148986592|NCT01666002|537430478|FG001|Overall Study|Lost to Follow-up|0|||
148986593|NCT02265705|537430500|FG000|Treatment Period Week 0-24|Adverse Event|3|||
148986594|NCT02265705|537430501|FG001|Treatment Period Week 0-24|Adverse Event|2|||
148986595|NCT02265705|537430502|FG002|Treatment Period Week 0-24|Adverse Event|0|||
148986596|NCT02265705|537430503|FG003|Treatment Period Week 0-24|Adverse Event|0|||
148986597|NCT02265705|537430504|FG004|Treatment Period Week 0-24|Adverse Event|0|||
148986598|NCT02265705|537430505|FG005|Treatment Period Week 0-24|Adverse Event|0|||
148986599|NCT02265705|537430506|FG006|Treatment Period Week 0-24|Adverse Event|0|||
148986600|NCT02265705|537430500|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
148986601|NCT02265705|537430501|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
148986602|NCT02265705|537430502|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
148986603|NCT02265705|537430503|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
148986604|NCT02265705|537430504|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
148986605|NCT02265705|537430505|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
148986606|NCT02265705|537430506|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
148986607|NCT02265705|537430500|FG000|Treatment Period Week 0-24|Physician Decision|1|||
148986608|NCT02265705|537430501|FG001|Treatment Period Week 0-24|Physician Decision|0|||
148986609|NCT02265705|537430502|FG002|Treatment Period Week 0-24|Physician Decision|0|||
148986610|NCT02265705|537430503|FG003|Treatment Period Week 0-24|Physician Decision|0|||
148986611|NCT02265705|537430504|FG004|Treatment Period Week 0-24|Physician Decision|0|||
148986612|NCT02265705|537430505|FG005|Treatment Period Week 0-24|Physician Decision|0|||
148986613|NCT02265705|537430506|FG006|Treatment Period Week 0-24|Physician Decision|0|||
148986614|NCT02265705|537430500|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
148986615|NCT02265705|537430501|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
148986616|NCT02265705|537430502|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
148986617|NCT02265705|537430503|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
148986618|NCT02265705|537430504|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
148986619|NCT02265705|537430505|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
148986620|NCT02265705|537430506|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
148986621|NCT02265705|537430500|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
148986622|NCT02265705|537430501|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
148986623|NCT02265705|537430502|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
148986624|NCT02265705|537430503|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
148986625|NCT02265705|537430504|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
148986626|NCT02265705|537430505|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
148986627|NCT02265705|537430506|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
148986628|NCT02265705|537430500|FG000|Rescue Period|Withdrawal by Subject|0|||
148986629|NCT02265705|537430501|FG001|Rescue Period|Withdrawal by Subject|0|||
148986630|NCT02265705|537430502|FG002|Rescue Period|Withdrawal by Subject|1|||
148986631|NCT02265705|537430503|FG003|Rescue Period|Withdrawal by Subject|0|||
148777082|NCT03226678|536658524|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
148986632|NCT02265705|537430504|FG004|Rescue Period|Withdrawal by Subject|0|||
149030230|NCT00517933|537587977|FG000|Period 1|Death|2|||
149030231|NCT00517933|537587978|FG001|Period 1|Death|1|||
148986633|NCT02265705|537430505|FG005|Rescue Period|Withdrawal by Subject|0|||
148986634|NCT02265705|537430506|FG006|Rescue Period|Withdrawal by Subject|0|||
148986635|NCT02265705|537430500|FG000|Rescue Period|Death|0|||
148986636|NCT02265705|537430501|FG001|Rescue Period|Death|0|||
148986637|NCT02265705|537430502|FG002|Rescue Period|Death|1|||
148986638|NCT02265705|537430503|FG003|Rescue Period|Death|0|||
148986639|NCT02265705|537430504|FG004|Rescue Period|Death|0|||
148986640|NCT02265705|537430505|FG005|Rescue Period|Death|0|||
148986641|NCT02265705|537430506|FG006|Rescue Period|Death|0|||
148986642|NCT02265705|537430500|FG000|Rescue Period|Lack of Efficacy|0|||
148986643|NCT02265705|537430501|FG001|Rescue Period|Lack of Efficacy|0|||
148986644|NCT02265705|537430502|FG002|Rescue Period|Lack of Efficacy|1|||
149030232|NCT00517933|537587977|FG000|Period 1|Adverse Event|4|||
148777083|NCT03226678|536658519|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
148777084|NCT03226678|536658520|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
148777085|NCT03226678|536658521|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
148777086|NCT03226678|536658522|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
148777087|NCT03226678|536658523|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
148777088|NCT03226678|536658524|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
148777089|NCT03427268|536658529|FG000|Overall Study|Progressive disease|25|||
148777090|NCT03427268|536658529|FG000|Overall Study|Never treated|2|||
148777091|NCT03427268|536658529|FG000|Overall Study|Compassionate use|1|||
148777092|NCT03427268|536658529|FG000|Overall Study|Withdrawal by Subject|1|||
148777093|NCT03427268|536658529|FG000|Overall Study|Adverse Event|3|||
148777094|NCT03117881|536658530|FG000|Baseline|Withdrawal by Subject|21|||
148777095|NCT03117881|536658531|FG001|Baseline|Withdrawal by Subject|10|||
148777096|NCT03117881|536658532|FG002|Baseline|Withdrawal by Subject|0|||
148777097|NCT03117881|536658530|FG000|Baseline|Lost to Follow-up|22|||
148777098|NCT03117881|536658531|FG001|Baseline|Lost to Follow-up|25|||
148777099|NCT03117881|536658532|FG002|Baseline|Lost to Follow-up|0|||
148777100|NCT03117881|536658530|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
148777101|NCT03117881|536658531|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
148777102|NCT03117881|536658532|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
148777103|NCT03117881|536658530|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
148777104|NCT03117881|536658531|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
148777105|NCT03117881|536658532|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
148777106|NCT03117881|536658530|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
148777107|NCT03117881|536658531|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
148777108|NCT03117881|536658532|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
148777109|NCT03117881|536658530|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
148777110|NCT03117881|536658531|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
148777111|NCT03117881|536658532|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
148777112|NCT03117881|536658530|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
148777113|NCT03117881|536658531|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
148777114|NCT03117881|536658532|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
148777115|NCT03117881|536658530|FG000|6-Month Follow-Up|Did not complete test|53|||
148777116|NCT03117881|536658531|FG001|6-Month Follow-Up|Did not complete test|25|||
148777117|NCT03117881|536658532|FG002|6-Month Follow-Up|Did not complete test|7|||
148777118|NCT03117881|536658530|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
148777119|NCT03117881|536658531|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
148777120|NCT03117881|536658532|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
148777121|NCT03117881|536658530|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
148777122|NCT03117881|536658531|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
148777123|NCT03117881|536658532|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
148777124|NCT03117881|536658530|FG000|12-Month Follow-Up|Did not complete test|40|||
148777125|NCT03117881|536658531|FG001|12-Month Follow-Up|Did not complete test|0|||
148777126|NCT03117881|536658532|FG002|12-Month Follow-Up|Did not complete test|0|||
148777127|NCT00308750|536658536|FG000|Overall Study|Adverse Event|9|||
148777128|NCT00308750|536658537|FG001|Overall Study|Adverse Event|9|||
148777129|NCT00308750|536658538|FG002|Overall Study|Adverse Event|13|||
148777130|NCT00308750|536658536|FG000|Overall Study|Withdrawal by Subject|6|||
148777131|NCT00308750|536658537|FG001|Overall Study|Withdrawal by Subject|2|||
148777132|NCT00308750|536658538|FG002|Overall Study|Withdrawal by Subject|3|||
148777133|NCT00308750|536658536|FG000|Overall Study|Physician Decision|3|||
148777134|NCT00308750|536658537|FG001|Overall Study|Physician Decision|4|||
148777135|NCT00308750|536658538|FG002|Overall Study|Physician Decision|3|||
148777136|NCT00308750|536658536|FG000|Overall Study|Sponsor Decision|1|||
149030233|NCT00517933|537587978|FG001|Period 1|Adverse Event|4|||
149030234|NCT00517933|537587977|FG000|Period 1|Lost to Follow-up|2|||
148777137|NCT00308750|536658537|FG001|Overall Study|Sponsor Decision|0|||
148777138|NCT00308750|536658538|FG002|Overall Study|Sponsor Decision|0|||
148777139|NCT00308750|536658536|FG000|Overall Study|Disease Progression|47|||
148777140|NCT00308750|536658537|FG001|Overall Study|Disease Progression|24|||
148777141|NCT00308750|536658538|FG002|Overall Study|Disease Progression|28|||
148777142|NCT00308750|536658536|FG000|Overall Study|Unrelated Complication|3|||
148777143|NCT00308750|536658537|FG001|Overall Study|Unrelated Complication|0|||
148777144|NCT00308750|536658538|FG002|Overall Study|Unrelated Complication|1|||
148777145|NCT00308750|536658536|FG000|Overall Study|Death|1|||
148777146|NCT00308750|536658537|FG001|Overall Study|Death|0|||
148777147|NCT00308750|536658538|FG002|Overall Study|Death|1|||
148777148|NCT00308750|536658536|FG000|Overall Study|Protocol Violation|1|||
148777149|NCT00308750|536658537|FG001|Overall Study|Protocol Violation|0|||
148777150|NCT00308750|536658538|FG002|Overall Study|Protocol Violation|0|||
148777151|NCT00308750|536658536|FG000|Overall Study|New Primary Disease Identified|1|||
148777152|NCT00308750|536658537|FG001|Overall Study|New Primary Disease Identified|1|||
149030235|NCT00517933|537587978|FG001|Period 1|Lost to Follow-up|0|||
148777153|NCT00308750|536658538|FG002|Overall Study|New Primary Disease Identified|0|||
148777154|NCT01358578|536658539|FG000|Induction Period|Adverse Event|2|||
148986645|NCT02265705|537430503|FG003|Rescue Period|Lack of Efficacy|0|||
148986646|NCT02265705|537430504|FG004|Rescue Period|Lack of Efficacy|0|||
148986647|NCT02265705|537430505|FG005|Rescue Period|Lack of Efficacy|0|||
148986648|NCT02265705|537430506|FG006|Rescue Period|Lack of Efficacy|0|||
148986649|NCT02265705|537430500|FG000|Open Label Period|Adverse Event|0|||
148986650|NCT02265705|537430501|FG001|Open Label Period|Adverse Event|0|||
148986651|NCT02265705|537430502|FG002|Open Label Period|Adverse Event|0|||
148986652|NCT02265705|537430503|FG003|Open Label Period|Adverse Event|2|||
148986653|NCT02265705|537430504|FG004|Open Label Period|Adverse Event|2|||
148986654|NCT02265705|537430505|FG005|Open Label Period|Adverse Event|0|||
148986655|NCT02265705|537430506|FG006|Open Label Period|Adverse Event|0|||
148986656|NCT02265705|537430500|FG000|Open Label Period|Physician Decision|0|||
148986657|NCT02265705|537430501|FG001|Open Label Period|Physician Decision|0|||
148986658|NCT02265705|537430502|FG002|Open Label Period|Physician Decision|0|||
148986659|NCT02265705|537430503|FG003|Open Label Period|Physician Decision|0|||
148986660|NCT02265705|537430504|FG004|Open Label Period|Physician Decision|1|||
148986661|NCT02265705|537430505|FG005|Open Label Period|Physician Decision|0|||
148986662|NCT02265705|537430506|FG006|Open Label Period|Physician Decision|0|||
148986663|NCT02265705|537430500|FG000|Open Label Period|Withdrawal by Subject|0|||
148986664|NCT02265705|537430501|FG001|Open Label Period|Withdrawal by Subject|0|||
148986665|NCT02265705|537430502|FG002|Open Label Period|Withdrawal by Subject|0|||
148986666|NCT02265705|537430503|FG003|Open Label Period|Withdrawal by Subject|0|||
148986667|NCT02265705|537430504|FG004|Open Label Period|Withdrawal by Subject|2|||
148986668|NCT02265705|537430505|FG005|Open Label Period|Withdrawal by Subject|0|||
148986669|NCT02265705|537430506|FG006|Open Label Period|Withdrawal by Subject|0|||
148986670|NCT02265705|537430500|FG000|Follow-up Period|Sponsor Decision|0|||
148986671|NCT02265705|537430501|FG001|Follow-up Period|Sponsor Decision|0|||
148986672|NCT02265705|537430502|FG002|Follow-up Period|Sponsor Decision|0|||
148986673|NCT02265705|537430503|FG003|Follow-up Period|Sponsor Decision|0|||
148986674|NCT02265705|537430504|FG004|Follow-up Period|Sponsor Decision|0|||
148986675|NCT02265705|537430505|FG005|Follow-up Period|Sponsor Decision|1|||
148986676|NCT02265705|537430506|FG006|Follow-up Period|Sponsor Decision|6|||
148986677|NCT02265705|537430500|FG000|Follow-up Period|Adverse Event|0|||
148986678|NCT02265705|537430501|FG001|Follow-up Period|Adverse Event|0|||
148986679|NCT02265705|537430502|FG002|Follow-up Period|Adverse Event|0|||
148986680|NCT02265705|537430503|FG003|Follow-up Period|Adverse Event|0|||
148986681|NCT02265705|537430504|FG004|Follow-up Period|Adverse Event|0|||
148986682|NCT02265705|537430505|FG005|Follow-up Period|Adverse Event|0|||
148986683|NCT02265705|537430506|FG006|Follow-up Period|Adverse Event|3|||
148986684|NCT02265705|537430500|FG000|Follow-up Period|Physician Decision|0|||
148986685|NCT02265705|537430501|FG001|Follow-up Period|Physician Decision|0|||
148986686|NCT02265705|537430502|FG002|Follow-up Period|Physician Decision|0|||
148986687|NCT02265705|537430503|FG003|Follow-up Period|Physician Decision|0|||
148986688|NCT02265705|537430504|FG004|Follow-up Period|Physician Decision|0|||
148986689|NCT02265705|537430505|FG005|Follow-up Period|Physician Decision|0|||
148986690|NCT02265705|537430506|FG006|Follow-up Period|Physician Decision|1|||
148986691|NCT02265705|537430500|FG000|Follow-up Period|Withdrawal by Subject|0|||
148986692|NCT02265705|537430501|FG001|Follow-up Period|Withdrawal by Subject|0|||
148986693|NCT02265705|537430502|FG002|Follow-up Period|Withdrawal by Subject|0|||
148986694|NCT02265705|537430503|FG003|Follow-up Period|Withdrawal by Subject|0|||
148986695|NCT02265705|537430504|FG004|Follow-up Period|Withdrawal by Subject|0|||
148986696|NCT02265705|537430505|FG005|Follow-up Period|Withdrawal by Subject|0|||
148986697|NCT02265705|537430506|FG006|Follow-up Period|Withdrawal by Subject|1|||
148986698|NCT01255358|537430508|FG000|Overall Study|Adverse Event|2|||
148986699|NCT01255358|537430508|FG000|Overall Study|Protocol Violation|2|||
148986700|NCT03950739|537430509|FG000|Treatment Phase|Adverse Event|2|||
148986701|NCT03950739|537430509|FG000|Optional Extension Phase|Death|1|||
148986702|NCT03950739|537430509|FG000|Optional Extension Phase|Progressive Disease|5|||
148986703|NCT03950739|537430509|FG000|Optional Extension Phase|Adverse Event|7|||
148986704|NCT03950739|537430509|FG000|Optional Extension Phase|Lost to Follow-up|2|||
148986705|NCT03950739|537430509|FG000|Optional Extension Phase|Site Closure|2|||
148986706|NCT03950739|537430509|FG000|Optional Extension Phase|Pregnancy|1|||
148986707|NCT03625570|537430510|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
148986708|NCT03625570|537430511|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
148986709|NCT03625570|537430510|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
148986710|NCT03625570|537430511|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
148986711|NCT03625570|537430510|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
148986712|NCT03625570|537430511|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
148986713|NCT01343056|537430514|FG000|Overall Study|Lost to Follow-up|7|||
148986714|NCT01343056|537430515|FG001|Overall Study|Lost to Follow-up|5|||
148986715|NCT01343056|537430516|FG002|Overall Study|Lost to Follow-up|3|||
148986716|NCT01343056|537430517|FG003|Overall Study|Lost to Follow-up|9|||
148986717|NCT00345579|537430518|FG000|Overall Study|Adverse Event|9|||
148986718|NCT00345579|537430519|FG001|Overall Study|Adverse Event|6|||
148986719|NCT00345579|537430518|FG000|Overall Study|Protocol Violation|14|||
148986720|NCT00345579|537430519|FG001|Overall Study|Protocol Violation|5|||
148777155|NCT01358578|536658540|FG001|Induction Period|Adverse Event|4|||
148777156|NCT01358578|536658541|FG002|Induction Period|Adverse Event|2|||
148777157|NCT01358578|536658542|FG003|Induction Period|Adverse Event|6|||
148777158|NCT01358578|536658543|FG004|Induction Period|Adverse Event|0|||
148777159|NCT01358578|536658544|FG005|Induction Period|Adverse Event|0|||
148777160|NCT01358578|536658539|FG000|Induction Period|Lack of Efficacy|0|||
148777161|NCT01358578|536658540|FG001|Induction Period|Lack of Efficacy|0|||
148777162|NCT01358578|536658541|FG002|Induction Period|Lack of Efficacy|9|||
148777163|NCT01358578|536658542|FG003|Induction Period|Lack of Efficacy|1|||
148777164|NCT01358578|536658543|FG004|Induction Period|Lack of Efficacy|0|||
148777165|NCT01358578|536658544|FG005|Induction Period|Lack of Efficacy|0|||
148777166|NCT01358578|536658539|FG000|Induction Period|Lost to Follow-up|0|||
148777167|NCT01358578|536658540|FG001|Induction Period|Lost to Follow-up|0|||
148777168|NCT01358578|536658541|FG002|Induction Period|Lost to Follow-up|1|||
148777169|NCT01358578|536658542|FG003|Induction Period|Lost to Follow-up|4|||
148777170|NCT01358578|536658543|FG004|Induction Period|Lost to Follow-up|0|||
148777171|NCT01358578|536658544|FG005|Induction Period|Lost to Follow-up|0|||
148777172|NCT01358578|536658539|FG000|Induction Period|Physician Decision|2|||
148777173|NCT01358578|536658540|FG001|Induction Period|Physician Decision|1|||
148777174|NCT01358578|536658541|FG002|Induction Period|Physician Decision|2|||
148777175|NCT01358578|536658542|FG003|Induction Period|Physician Decision|0|||
148777176|NCT01358578|536658543|FG004|Induction Period|Physician Decision|0|||
148777177|NCT01358578|536658544|FG005|Induction Period|Physician Decision|0|||
148777178|NCT01358578|536658539|FG000|Induction Period|Protocol Deviation|3|||
148777179|NCT01358578|536658540|FG001|Induction Period|Protocol Deviation|5|||
148777180|NCT01358578|536658541|FG002|Induction Period|Protocol Deviation|0|||
148777181|NCT01358578|536658542|FG003|Induction Period|Protocol Deviation|3|||
148777182|NCT01358578|536658543|FG004|Induction Period|Protocol Deviation|0|||
148777183|NCT01358578|536658544|FG005|Induction Period|Protocol Deviation|0|||
148777184|NCT01358578|536658539|FG000|Induction Period|technical problems|0|||
148777185|NCT01358578|536658540|FG001|Induction Period|technical problems|0|||
148777186|NCT01358578|536658541|FG002|Induction Period|technical problems|1|||
148777187|NCT01358578|536658542|FG003|Induction Period|technical problems|1|||
148777188|NCT01358578|536658543|FG004|Induction Period|technical problems|0|||
148777189|NCT01358578|536658544|FG005|Induction Period|technical problems|0|||
148777190|NCT01358578|536658539|FG000|Induction Period|Withdrawal by Subject|5|||
148777191|NCT01358578|536658540|FG001|Induction Period|Withdrawal by Subject|5|||
148777192|NCT01358578|536658541|FG002|Induction Period|Withdrawal by Subject|10|||
148777193|NCT01358578|536658542|FG003|Induction Period|Withdrawal by Subject|6|||
148777194|NCT01358578|536658543|FG004|Induction Period|Withdrawal by Subject|0|||
148777195|NCT01358578|536658544|FG005|Induction Period|Withdrawal by Subject|0|||
148777196|NCT01358578|536658539|FG000|Maintenance Period|Adverse Event|2|||
148777197|NCT01358578|536658540|FG001|Maintenance Period|Adverse Event|7|||
148777198|NCT01358578|536658541|FG002|Maintenance Period|Adverse Event|0|||
148777199|NCT01358578|536658542|FG003|Maintenance Period|Adverse Event|6|||
148777200|NCT01358578|536658543|FG004|Maintenance Period|Adverse Event|4|||
148777201|NCT01358578|536658544|FG005|Maintenance Period|Adverse Event|3|||
148777202|NCT01358578|536658539|FG000|Maintenance Period|Lack of Efficacy|10|||
148777203|NCT01358578|536658540|FG001|Maintenance Period|Lack of Efficacy|2|||
148777204|NCT01358578|536658541|FG002|Maintenance Period|Lack of Efficacy|0|||
148777205|NCT01358578|536658542|FG003|Maintenance Period|Lack of Efficacy|11|||
148777206|NCT01358578|536658543|FG004|Maintenance Period|Lack of Efficacy|3|||
148777207|NCT01358578|536658544|FG005|Maintenance Period|Lack of Efficacy|0|||
148777208|NCT01358578|536658539|FG000|Maintenance Period|Lost to Follow-up|4|||
148777209|NCT01358578|536658540|FG001|Maintenance Period|Lost to Follow-up|0|||
148777210|NCT01358578|536658541|FG002|Maintenance Period|Lost to Follow-up|0|||
148777211|NCT01358578|536658542|FG003|Maintenance Period|Lost to Follow-up|5|||
148777212|NCT01358578|536658543|FG004|Maintenance Period|Lost to Follow-up|1|||
148777213|NCT01358578|536658544|FG005|Maintenance Period|Lost to Follow-up|1|||
148777214|NCT01358578|536658539|FG000|Maintenance Period|Non-compliance with study treatment|3|||
148986721|NCT00345579|537430518|FG000|Overall Study|Withdrawal by Subject|50|||
148777215|NCT01358578|536658540|FG001|Maintenance Period|Non-compliance with study treatment|1|||
148777216|NCT01358578|536658541|FG002|Maintenance Period|Non-compliance with study treatment|0|||
148777217|NCT01358578|536658542|FG003|Maintenance Period|Non-compliance with study treatment|2|||
148986722|NCT00345579|537430519|FG001|Overall Study|Withdrawal by Subject|17|||
148777218|NCT01358578|536658543|FG004|Maintenance Period|Non-compliance with study treatment|1|||
148777219|NCT01358578|536658544|FG005|Maintenance Period|Non-compliance with study treatment|2|||
148777220|NCT01358578|536658539|FG000|Maintenance Period|Physician Decision|0|||
148777221|NCT01358578|536658540|FG001|Maintenance Period|Physician Decision|1|||
148777222|NCT01358578|536658541|FG002|Maintenance Period|Physician Decision|0|||
148777223|NCT01358578|536658542|FG003|Maintenance Period|Physician Decision|1|||
148777224|NCT01358578|536658543|FG004|Maintenance Period|Physician Decision|0|||
148777225|NCT01358578|536658544|FG005|Maintenance Period|Physician Decision|0|||
148777226|NCT01358578|536658539|FG000|Maintenance Period|Pregnancy|1|||
148777227|NCT01358578|536658540|FG001|Maintenance Period|Pregnancy|0|||
148986723|NCT00345579|537430518|FG000|Overall Study|Lost to Follow-up|82|||
148777228|NCT01358578|536658541|FG002|Maintenance Period|Pregnancy|0|||
148777229|NCT01358578|536658542|FG003|Maintenance Period|Pregnancy|0|||
148777230|NCT01358578|536658543|FG004|Maintenance Period|Pregnancy|0|||
148777231|NCT01358578|536658544|FG005|Maintenance Period|Pregnancy|0|||
148777232|NCT01358578|536658539|FG000|Maintenance Period|Protocol deviation|7|||
148777233|NCT01358578|536658540|FG001|Maintenance Period|Protocol deviation|4|||
148777234|NCT01358578|536658541|FG002|Maintenance Period|Protocol deviation|0|||
148777235|NCT01358578|536658542|FG003|Maintenance Period|Protocol deviation|2|||
148777236|NCT01358578|536658543|FG004|Maintenance Period|Protocol deviation|2|||
148777237|NCT01358578|536658544|FG005|Maintenance Period|Protocol deviation|2|||
148777238|NCT01358578|536658539|FG000|Maintenance Period|Withdrawal by Subject|12|||
148777239|NCT01358578|536658540|FG001|Maintenance Period|Withdrawal by Subject|7|||
148777240|NCT01358578|536658541|FG002|Maintenance Period|Withdrawal by Subject|2|||
148777241|NCT01358578|536658542|FG003|Maintenance Period|Withdrawal by Subject|15|||
148777242|NCT01358578|536658543|FG004|Maintenance Period|Withdrawal by Subject|6|||
148777243|NCT01358578|536658544|FG005|Maintenance Period|Withdrawal by Subject|3|||
148777244|NCT01358578|536658539|FG000|Follow-up Period|Adverse Event|1|||
148777245|NCT01358578|536658540|FG001|Follow-up Period|Adverse Event|1|||
148777246|NCT01358578|536658541|FG002|Follow-up Period|Adverse Event|0|||
148777247|NCT01358578|536658542|FG003|Follow-up Period|Adverse Event|0|||
148777248|NCT01358578|536658543|FG004|Follow-up Period|Adverse Event|0|||
148777249|NCT01358578|536658544|FG005|Follow-up Period|Adverse Event|0|||
148777250|NCT01358578|536658539|FG000|Follow-up Period|Lack of Efficacy|3|||
148777251|NCT01358578|536658540|FG001|Follow-up Period|Lack of Efficacy|0|||
148777252|NCT01358578|536658541|FG002|Follow-up Period|Lack of Efficacy|4|||
148777253|NCT01358578|536658542|FG003|Follow-up Period|Lack of Efficacy|1|||
148777254|NCT01358578|536658543|FG004|Follow-up Period|Lack of Efficacy|0|||
148777255|NCT01358578|536658544|FG005|Follow-up Period|Lack of Efficacy|0|||
148777256|NCT01358578|536658539|FG000|Follow-up Period|Lost to Follow-up|0|||
148777257|NCT01358578|536658540|FG001|Follow-up Period|Lost to Follow-up|1|||
148777258|NCT01358578|536658541|FG002|Follow-up Period|Lost to Follow-up|0|||
148777259|NCT01358578|536658542|FG003|Follow-up Period|Lost to Follow-up|4|||
148777260|NCT01358578|536658543|FG004|Follow-up Period|Lost to Follow-up|0|||
148777261|NCT01358578|536658544|FG005|Follow-up Period|Lost to Follow-up|0|||
148777262|NCT01358578|536658539|FG000|Follow-up Period|non- compliance with study treatment|1|||
148777263|NCT01358578|536658540|FG001|Follow-up Period|non- compliance with study treatment|0|||
148777264|NCT01358578|536658541|FG002|Follow-up Period|non- compliance with study treatment|0|||
148777265|NCT01358578|536658542|FG003|Follow-up Period|non- compliance with study treatment|0|||
148777266|NCT01358578|536658543|FG004|Follow-up Period|non- compliance with study treatment|0|||
148777267|NCT01358578|536658544|FG005|Follow-up Period|non- compliance with study treatment|0|||
148777268|NCT01358578|536658539|FG000|Follow-up Period|Pregnancy|1|||
148777269|NCT01358578|536658540|FG001|Follow-up Period|Pregnancy|0|||
148777270|NCT01358578|536658541|FG002|Follow-up Period|Pregnancy|0|||
148777271|NCT01358578|536658542|FG003|Follow-up Period|Pregnancy|0|||
148777272|NCT01358578|536658543|FG004|Follow-up Period|Pregnancy|0|||
148777273|NCT01358578|536658544|FG005|Follow-up Period|Pregnancy|0|||
148777274|NCT01358578|536658539|FG000|Follow-up Period|Withdrawal by Subject|3|||
148777275|NCT01358578|536658540|FG001|Follow-up Period|Withdrawal by Subject|3|||
148777276|NCT01358578|536658541|FG002|Follow-up Period|Withdrawal by Subject|1|||
148777277|NCT01358578|536658542|FG003|Follow-up Period|Withdrawal by Subject|12|||
148777278|NCT01358578|536658543|FG004|Follow-up Period|Withdrawal by Subject|0|||
148777279|NCT01358578|536658544|FG005|Follow-up Period|Withdrawal by Subject|0|||
148777280|NCT01358578|536658539|FG000|Follow-up Period|Physician Decision|1|||
148777281|NCT01358578|536658540|FG001|Follow-up Period|Physician Decision|1|||
148777282|NCT01358578|536658541|FG002|Follow-up Period|Physician Decision|0|||
148777283|NCT01358578|536658542|FG003|Follow-up Period|Physician Decision|2|||
148777284|NCT01358578|536658543|FG004|Follow-up Period|Physician Decision|0|||
148777285|NCT01358578|536658544|FG005|Follow-up Period|Physician Decision|0|||
148777286|NCT01643798|536658545|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
148777287|NCT01643798|536658546|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
148777288|NCT03605849|536658547|FG000|Overall Study|Adverse Event|20|||
148777289|NCT03605849|536658548|FG001|Overall Study|Adverse Event|21|||
148777290|NCT03605849|536658549|FG002|Overall Study|Adverse Event|29|||
148777291|NCT03605849|536658550|FG003|Overall Study|Adverse Event|11|||
148777292|NCT03605849|536658547|FG000|Overall Study|Lack of Efficacy|4|||
148777293|NCT03605849|536658548|FG001|Overall Study|Lack of Efficacy|7|||
148777294|NCT03605849|536658549|FG002|Overall Study|Lack of Efficacy|9|||
148777295|NCT03605849|536658550|FG003|Overall Study|Lack of Efficacy|2|||
148777296|NCT03605849|536658547|FG000|Overall Study|Lost to Follow-up|8|||
148777297|NCT03605849|536658548|FG001|Overall Study|Lost to Follow-up|8|||
148777298|NCT03605849|536658549|FG002|Overall Study|Lost to Follow-up|14|||
148777299|NCT03605849|536658550|FG003|Overall Study|Lost to Follow-up|11|||
148777300|NCT03605849|536658547|FG000|Overall Study|Non-compliance With IMP|6|||
148777301|NCT03605849|536658548|FG001|Overall Study|Non-compliance With IMP|5|||
148777302|NCT03605849|536658549|FG002|Overall Study|Non-compliance With IMP|2|||
148777303|NCT03605849|536658550|FG003|Overall Study|Non-compliance With IMP|1|||
148777304|NCT03605849|536658547|FG000|Overall Study|Protocol Deviation|1|||
148777305|NCT03605849|536658548|FG001|Overall Study|Protocol Deviation|2|||
148777306|NCT03605849|536658549|FG002|Overall Study|Protocol Deviation|1|||
148777307|NCT03605849|536658550|FG003|Overall Study|Protocol Deviation|3|||
148777308|NCT03605849|536658547|FG000|Overall Study|Withdrawal by Subject|33|||
148777309|NCT03605849|536658548|FG001|Overall Study|Withdrawal by Subject|28|||
148777310|NCT03605849|536658549|FG002|Overall Study|Withdrawal by Subject|30|||
148777311|NCT03605849|536658550|FG003|Overall Study|Withdrawal by Subject|28|||
148777312|NCT03605849|536658547|FG000|Overall Study|Site Terminated by Sponsor|0|||
148777313|NCT03605849|536658548|FG001|Overall Study|Site Terminated by Sponsor|0|||
148777314|NCT03605849|536658549|FG002|Overall Study|Site Terminated by Sponsor|0|||
148777315|NCT03605849|536658550|FG003|Overall Study|Site Terminated by Sponsor|1|||
148777316|NCT03605849|536658547|FG000|Overall Study|Physician Decision|2|||
148777317|NCT03605849|536658548|FG001|Overall Study|Physician Decision|1|||
148777318|NCT03605849|536658549|FG002|Overall Study|Physician Decision|2|||
148777319|NCT03605849|536658550|FG003|Overall Study|Physician Decision|1|||
148777320|NCT03605849|536658547|FG000|Overall Study|Enrolled, but not Treated|2|||
148777321|NCT03605849|536658548|FG001|Overall Study|Enrolled, but not Treated|2|||
148777322|NCT03605849|536658549|FG002|Overall Study|Enrolled, but not Treated|3|||
148777323|NCT03605849|536658550|FG003|Overall Study|Enrolled, but not Treated|2|||
148777324|NCT03605849|536658547|FG000|Overall Study|Other (COVID-19 Related)|0|||
148777325|NCT03605849|536658548|FG001|Overall Study|Other (COVID-19 Related)|1|||
148777326|NCT03605849|536658549|FG002|Overall Study|Other (COVID-19 Related)|1|||
148777327|NCT03605849|536658550|FG003|Overall Study|Other (COVID-19 Related)|0|||
148777328|NCT03605849|536658547|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
148777329|NCT03605849|536658548|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
148777330|NCT03605849|536658549|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
148777331|NCT03605849|536658550|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
148777332|NCT02304380|536658552|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
148777333|NCT02304380|536658553|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
148777334|NCT02304380|536658554|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
148777335|NCT02304380|536658555|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
148777336|NCT02304380|536658556|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
148777337|NCT02304380|536658557|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
148777338|NCT02045732|536658560|FG000|Overall Study|At the discretion of the investigator|1|||
148777339|NCT02045732|536658561|FG001|Overall Study|At the discretion of the investigator|1|||
148777340|NCT01349322|536658562|FG000|Overall Study|Protocol Violation|45|||
148777341|NCT01349322|536658563|FG001|Overall Study|Protocol Violation|47|||
148777342|NCT05014815|536658564|FG000|Overall Study|Death|63|||
148777343|NCT05014815|536658565|FG001|Overall Study|Death|70|||
148777344|NCT05014815|536658564|FG000|Overall Study|Withdrawal by Subject|10|||
148777345|NCT05014815|536658565|FG001|Overall Study|Withdrawal by Subject|10|||
148777346|NCT05014815|536658564|FG000|Overall Study|Lost to Follow-up|4|||
148777347|NCT05014815|536658565|FG001|Overall Study|Lost to Follow-up|2|||
148777348|NCT05014815|536658564|FG000|Overall Study|Physician Decision|2|||
148777349|NCT05014815|536658565|FG001|Overall Study|Physician Decision|4|||
148777350|NCT04247880|536658566|FG000|Overall Study|Lost to Follow-up|24|||
148777351|NCT04247880|536658567|FG001|Overall Study|Lost to Follow-up|17|||
148777352|NCT04247880|536658566|FG000|Overall Study|Withdrawal by Subject|3|||
148777353|NCT04247880|536658567|FG001|Overall Study|Withdrawal by Subject|0|||
148777354|NCT06303167|536658572|FG000|Overall Study|Ineligible|1|||
148777355|NCT06303167|536658572|FG000|Overall Study|Never start protocol therapy|2|||
148777356|NCT06303167|536658572|FG000|Overall Study|Disease progression|16|||
148777357|NCT03385304|536658575|FG000|Overall Study|Death|19|||
148777358|NCT03385304|536658576|FG001|Overall Study|Death|7|||
148777359|NCT03385304|536658575|FG000|Overall Study|Lost to Follow-up|17|||
148777360|NCT03385304|536658576|FG001|Overall Study|Lost to Follow-up|14|||
148777361|NCT03385304|536658575|FG000|Overall Study|Withdrawal by Subject|3|||
148777362|NCT03385304|536658576|FG001|Overall Study|Withdrawal by Subject|2|||
148777363|NCT03385304|536658575|FG000|Overall Study|Incarceration|2|||
148777364|NCT03385304|536658576|FG001|Overall Study|Incarceration|3|||
148777365|NCT01097421|536658577|FG000|Overall Study|Adverse Event|8|||
148777366|NCT01097421|536658577|FG000|Overall Study|Protocol Violation|2|||
148777367|NCT01097421|536658577|FG000|Overall Study|Lost to Follow-up|1|||
148777368|NCT01097421|536658577|FG000|Overall Study|Withdrawal by Subject|3|||
148777369|NCT02720744|536658578|FG000|Overall Study|Protocol Violation|0|||
148777370|NCT02720744|536658579|FG001|Overall Study|Protocol Violation|2|||
148777371|NCT02720744|536658578|FG000|Overall Study|Pregnancy|2|||
148777372|NCT02720744|536658579|FG001|Overall Study|Pregnancy|0|||
148777373|NCT02720744|536658578|FG000|Overall Study|Lack of Efficacy|2|||
149030236|NCT00517933|537587977|FG000|Period 1|Underwent lung transplant|0|||
149030237|NCT00517933|537587978|FG001|Period 1|Underwent lung transplant|1|||
148777374|NCT02720744|536658579|FG001|Overall Study|Lack of Efficacy|8|||
148777375|NCT02720744|536658578|FG000|Overall Study|Adverse Event|21|||
148777376|NCT02720744|536658579|FG001|Overall Study|Adverse Event|3|||
148777377|NCT02720744|536658578|FG000|Overall Study|Withdrawal by Subject|11|||
148777378|NCT02720744|536658579|FG001|Overall Study|Withdrawal by Subject|11|||
149030238|NCT00517933|537587977|FG000|Period 2|Death|2|||
148986724|NCT00345579|537430519|FG001|Overall Study|Lost to Follow-up|36|||
148986725|NCT00345579|537430518|FG000|Overall Study|Other|9|||
148986726|NCT00345579|537430519|FG001|Overall Study|Other|1|||
148986727|NCT01732835|537430520|FG000|6-month Primary Endpoint|Did not receive device|19|||
148986728|NCT01732835|537430520|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
148986729|NCT01732835|537430520|FG000|6-month Primary Endpoint|Adverse Event|3|||
148986730|NCT01732835|537430520|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
148986731|NCT01732835|537430520|FG000|2-year Extended Follow-up|Adverse Event|3|||
148986732|NCT01732835|537430520|FG000|2-year Extended Follow-up|Death|1|||
148986733|NCT01046643|537430521|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
148986734|NCT01046643|537430522|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
148986735|NCT01046643|537430523|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
148986736|NCT01046643|537430524|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
148986737|NCT01175668|537430529|FG000|Overall Study|Withdrawal by Subject|2|||
148986738|NCT01175668|537430530|FG001|Overall Study|Withdrawal by Subject|0|||
148986739|NCT02937545|537430531|FG000|Overall Study|Withdrawal by Subject|1|||
148986740|NCT02937545|537430532|FG001|Overall Study|Withdrawal by Subject|2|||
148986741|NCT02937545|537430533|FG002|Overall Study|Withdrawal by Subject|6|||
148986742|NCT02937545|537430534|FG003|Overall Study|Withdrawal by Subject|7|||
148986743|NCT02937545|537430531|FG000|Overall Study|Lost to Follow-up|1|||
148986744|NCT02937545|537430532|FG001|Overall Study|Lost to Follow-up|0|||
148986745|NCT02937545|537430533|FG002|Overall Study|Lost to Follow-up|0|||
148986746|NCT02937545|537430534|FG003|Overall Study|Lost to Follow-up|0|||
148986747|NCT02007577|537430535|FG000|Overall Study|Adverse Event|1|||
148986748|NCT02007577|537430536|FG001|Overall Study|Adverse Event|0|||
148986749|NCT02007577|537430535|FG000|Overall Study|Withdrawal by Subject|0|||
148986750|NCT02007577|537430536|FG001|Overall Study|Withdrawal by Subject|1|||
148986751|NCT02504294|537430539|FG000|Overall Study|Adverse Event|15|||
148986752|NCT02504294|537430540|FG001|Overall Study|Adverse Event|12|||
148986753|NCT02504294|537430539|FG000|Overall Study|Withdrawal by Subject|7|||
148986754|NCT02504294|537430540|FG001|Overall Study|Withdrawal by Subject|1|||
148986755|NCT02504294|537430539|FG000|Overall Study|Protocol Violation|27|||
148777379|NCT02720744|536658578|FG000|Overall Study|Lost to follow up|2|||
148777380|NCT02720744|536658579|FG001|Overall Study|Lost to follow up|0|||
148777381|NCT02720744|536658578|FG000|Overall Study|Non Compliance with Investigational Product|0|||
148777382|NCT02720744|536658579|FG001|Overall Study|Non Compliance with Investigational Product|1|||
148777383|NCT02720744|536658578|FG000|Overall Study|Excluded Concomitant Medication|0|||
148777384|NCT02720744|536658579|FG001|Overall Study|Excluded Concomitant Medication|1|||
148777385|NCT02407457|536658580|FG000|1 Month|Death|3|||
148777386|NCT02407457|536658581|FG001|1 Month|Death|0|||
148777387|NCT02407457|536658580|FG000|1 Month|Lost to Follow-up|1|||
148777388|NCT02407457|536658581|FG001|1 Month|Lost to Follow-up|1|||
148777389|NCT02407457|536658580|FG000|1 Month|missed visit|2|||
148777390|NCT02407457|536658581|FG001|1 Month|missed visit|5|||
148777391|NCT02407457|536658580|FG000|6-Month|Death|2|||
148777392|NCT02407457|536658581|FG001|6-Month|Death|8|||
148777393|NCT02407457|536658580|FG000|6-Month|Lost to Follow-up|2|||
148777394|NCT02407457|536658581|FG001|6-Month|Lost to Follow-up|2|||
148777395|NCT02407457|536658580|FG000|6-Month|missed visit|16|||
148777396|NCT02407457|536658581|FG001|6-Month|missed visit|14|||
148777397|NCT02407457|536658580|FG000|6-Month|Open Repair|0|||
148777398|NCT02407457|536658581|FG001|6-Month|Open Repair|1|||
148777399|NCT02407457|536658580|FG000|1 Year|Death|6|||
148777400|NCT02407457|536658581|FG001|1 Year|Death|11|||
148777401|NCT02407457|536658580|FG000|1 Year|Lost to Follow-up|3|||
148777402|NCT02407457|536658581|FG001|1 Year|Lost to Follow-up|2|||
148777403|NCT02407457|536658580|FG000|1 Year|Missed Visit|24|||
148777404|NCT02407457|536658581|FG001|1 Year|Missed Visit|14|||
148777405|NCT02407457|536658580|FG000|1 Year|Open Repair|0|||
148777406|NCT02407457|536658581|FG001|1 Year|Open Repair|1|||
148777407|NCT02407457|536658580|FG000|2-year|Death|14|||
148777408|NCT02407457|536658581|FG001|2-year|Death|8|||
148777409|NCT02407457|536658580|FG000|2-year|Lost to Follow-up|7|||
148986756|NCT02504294|537430540|FG001|Overall Study|Protocol Violation|26|||
148986757|NCT02504294|537430539|FG000|Overall Study|Physician Decision|1|||
148851669|NCT02993822|536930707|FG002|Overall Study|Lack of Efficacy|0|||
148986758|NCT02504294|537430540|FG001|Overall Study|Physician Decision|2|||
148986759|NCT02504294|537430539|FG000|Overall Study|Lost to Follow-up|6|||
148777410|NCT02407457|536658581|FG001|2-year|Lost to Follow-up|10|||
148777411|NCT02407457|536658580|FG000|2-year|Missed Visit|13|||
148777412|NCT02407457|536658581|FG001|2-year|Missed Visit|15|||
148777413|NCT02407457|536658580|FG000|2-year|Open Repair|0|||
148777414|NCT02407457|536658581|FG001|2-year|Open Repair|2|||
148777415|NCT02407457|536658580|FG000|3-year|Death|11|||
148777416|NCT02407457|536658581|FG001|3-year|Death|10|||
148777417|NCT02407457|536658580|FG000|3-year|Lost to Follow-up|9|||
148777418|NCT02407457|536658581|FG001|3-year|Lost to Follow-up|10|||
148777419|NCT02407457|536658580|FG000|3-year|Missed Visit|19|||
148777420|NCT02407457|536658581|FG001|3-year|Missed Visit|16|||
148986760|NCT02504294|537430540|FG001|Overall Study|Lost to Follow-up|7|||
148986761|NCT02252211|537430546|FG000|Overall Study|Adverse Event|0|||
148986762|NCT02252211|537430547|FG001|Overall Study|Adverse Event|1|||
149030239|NCT00517933|537587978|FG001|Period 2|Death|4|||
149030240|NCT00517933|537587977|FG000|Period 2|Adverse Event|2|||
149030241|NCT00517933|537587978|FG001|Period 2|Adverse Event|4|||
149030242|NCT00517933|537587977|FG000|Period 2|Physician Decision|1|||
149030243|NCT00517933|537587978|FG001|Period 2|Physician Decision|0|||
149030244|NCT00517933|537587977|FG000|Period 2|Withdrawal by Subject|1|||
149030245|NCT00517933|537587978|FG001|Period 2|Withdrawal by Subject|3|||
149030246|NCT00517933|537587977|FG000|Period 2|Underwent lung transplant|0|||
149030247|NCT00517933|537587978|FG001|Period 2|Underwent lung transplant|2|||
149030248|NCT05096884|537587979|FG000|Overall Study|Excluded based on negative tilt table test|4|||
149030249|NCT04927975|537587980|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
149030250|NCT04927975|537587981|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
149030251|NCT04927975|537587982|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
149030252|NCT04927975|537587983|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
149030253|NCT04927975|537587984|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
149030254|NCT04927975|537587985|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
149030255|NCT04927975|537587980|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
149030256|NCT04927975|537587981|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
149030257|NCT04927975|537587982|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
149030258|NCT04927975|537587983|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
149030259|NCT04927975|537587984|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
149030260|NCT04927975|537587985|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
149030261|NCT04927975|537587980|FG000|Period 1 (Baseline-Week 24)|Death|0|||
149030262|NCT04927975|537587981|FG001|Period 1 (Baseline-Week 24)|Death|0|||
149030263|NCT04927975|537587982|FG002|Period 1 (Baseline-Week 24)|Death|0|||
149030264|NCT04927975|537587983|FG003|Period 1 (Baseline-Week 24)|Death|0|||
149030265|NCT04927975|537587984|FG004|Period 1 (Baseline-Week 24)|Death|0|||
149030266|NCT04927975|537587985|FG005|Period 1 (Baseline-Week 24)|Death|1|||
149030267|NCT04927975|537587980|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
149030268|NCT04927975|537587981|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
149030269|NCT04927975|537587982|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
149030270|NCT04927975|537587983|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
149030271|NCT04927975|537587984|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
149030272|NCT04927975|537587985|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
149030273|NCT04927975|537587980|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
149030274|NCT04927975|537587981|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
149030275|NCT04927975|537587982|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
148777421|NCT02407457|536658580|FG000|4-year|Death|18|||
148777422|NCT02407457|536658581|FG001|4-year|Death|10|||
148777423|NCT02407457|536658580|FG000|4-year|Lost to Follow-up|10|||
148777424|NCT02407457|536658581|FG001|4-year|Lost to Follow-up|12|||
148777425|NCT02407457|536658580|FG000|4-year|Missed Visit|18|||
148777426|NCT02407457|536658581|FG001|4-year|Missed Visit|16|||
148777427|NCT02407457|536658580|FG000|5-year|Death|10|||
148777428|NCT02407457|536658581|FG001|5-year|Death|3|||
148777429|NCT02407457|536658580|FG000|5-year|Lost to Follow-up|22|||
148777430|NCT02407457|536658581|FG001|5-year|Lost to Follow-up|13|||
148777431|NCT02407457|536658580|FG000|5-year|Missed Visit|9|||
148777432|NCT02407457|536658581|FG001|5-year|Missed Visit|1|||
148777433|NCT03619902|536658583|FG000|Overall Study|Termination of Study by Investigator|1|||
148777434|NCT03619902|536658583|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
148777435|NCT04450407|536658584|FG000|Overall Study|Withdrawal by Subject|10|||
148777436|NCT04450407|536658585|FG001|Overall Study|Withdrawal by Subject|1|||
148777437|NCT04450407|536658586|FG002|Overall Study|Withdrawal by Subject|4|||
148777438|NCT04450407|536658584|FG000|Overall Study|Adverse Event|0|||
148777439|NCT04450407|536658585|FG001|Overall Study|Adverse Event|0|||
148777440|NCT04450407|536658586|FG002|Overall Study|Adverse Event|1|||
148777441|NCT04450407|536658584|FG000|Overall Study|Lost to Follow-up|1|||
148777442|NCT04450407|536658585|FG001|Overall Study|Lost to Follow-up|0|||
148777443|NCT04450407|536658586|FG002|Overall Study|Lost to Follow-up|0|||
148777444|NCT04450407|536658584|FG000|Overall Study|Physician Decision|0|||
148777445|NCT04450407|536658585|FG001|Overall Study|Physician Decision|0|||
148777446|NCT04450407|536658586|FG002|Overall Study|Physician Decision|1|||
148777447|NCT04450407|536658584|FG000|Overall Study|Pregnancy|1|||
148777448|NCT04450407|536658585|FG001|Overall Study|Pregnancy|0|||
149030276|NCT04927975|537587983|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
149030277|NCT04927975|537587984|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
149030278|NCT04927975|537587985|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
149030279|NCT04678830|537587986|FG000|Overall Study|Lack of Efficacy|2|||
149030280|NCT04678830|537587987|FG001|Overall Study|Lack of Efficacy|0|||
149030281|NCT04678830|537587986|FG000|Overall Study|Withdrawal by Subject|0|||
149030282|NCT04678830|537587987|FG001|Overall Study|Withdrawal by Subject|1|||
148777449|NCT04450407|536658586|FG002|Overall Study|Pregnancy|0|||
148777450|NCT04450407|536658584|FG000|Overall Study|Protocol Violation|2|||
148777451|NCT04450407|536658585|FG001|Overall Study|Protocol Violation|0|||
148777452|NCT04450407|536658586|FG002|Overall Study|Protocol Violation|0|||
148777453|NCT04450407|536658584|FG000|Overall Study|Investigational site terminated by sponsor|3|||
148777454|NCT04450407|536658585|FG001|Overall Study|Investigational site terminated by sponsor|0|||
148777455|NCT04450407|536658586|FG002|Overall Study|Investigational site terminated by sponsor|2|||
148777456|NCT03814720|536658589|FG000|Overall Study|Lost to Follow-up|0|||
148777457|NCT03814720|536658590|FG001|Overall Study|Lost to Follow-up|1|||
148777458|NCT03814720|536658591|FG002|Overall Study|Lost to Follow-up|0|||
148777459|NCT03814720|536658592|FG003|Overall Study|Lost to Follow-up|0|||
148777460|NCT03814720|536658593|FG004|Overall Study|Lost to Follow-up|0|||
148777461|NCT00474045|536658594|FG000|Overall Study|Adverse Event|18|||
148777462|NCT00474045|536658595|FG001|Overall Study|Adverse Event|8|||
148777463|NCT00474045|536658594|FG000|Overall Study|Unclassified|1|||
148777464|NCT00474045|536658595|FG001|Overall Study|Unclassified|3|||
148777465|NCT00474045|536658594|FG000|Overall Study|Lack of Efficacy|0|||
148777466|NCT00474045|536658595|FG001|Overall Study|Lack of Efficacy|9|||
148777467|NCT00474045|536658594|FG000|Overall Study|Lost to Follow-up|1|||
148777468|NCT00474045|536658595|FG001|Overall Study|Lost to Follow-up|1|||
148777469|NCT00474045|536658594|FG000|Overall Study|Protocol Violation|10|||
148777470|NCT00474045|536658595|FG001|Overall Study|Protocol Violation|12|||
148777471|NCT00474045|536658594|FG000|Overall Study|Withdrawal by Subject|16|||
148777472|NCT00474045|536658595|FG001|Overall Study|Withdrawal by Subject|18|||
148777473|NCT00474045|536658594|FG000|Overall Study|Withdrawal criteria|60|||
148777474|NCT00474045|536658595|FG001|Overall Study|Withdrawal criteria|50|||
148777475|NCT02009397|536658598|FG000|Overall Study|Protocol Violation|6|||
148777476|NCT02009397|536658598|FG000|Overall Study|Death|8|||
148777477|NCT02009397|536658598|FG000|Overall Study|Lost to Follow-up|6|||
148777478|NCT00808639|536658603|FG000|Overall Study|Disease progression before surgery.|1|||
148777479|NCT00710684|536658606|FG000|Overall Study|Adverse Event|11|||
148777480|NCT00710684|536658607|FG001|Overall Study|Adverse Event|19|||
148777481|NCT00710684|536658608|FG002|Overall Study|Adverse Event|16|||
148777482|NCT00710684|536658606|FG000|Overall Study|Lack of Efficacy|4|||
148777483|NCT00710684|536658607|FG001|Overall Study|Lack of Efficacy|3|||
148777484|NCT00710684|536658608|FG002|Overall Study|Lack of Efficacy|5|||
148777485|NCT00710684|536658606|FG000|Overall Study|Protocol Violation|5|||
148777486|NCT00710684|536658607|FG001|Overall Study|Protocol Violation|5|||
148777487|NCT00710684|536658608|FG002|Overall Study|Protocol Violation|5|||
148777488|NCT00710684|536658606|FG000|Overall Study|Lost to Follow-up|4|||
148777489|NCT00710684|536658607|FG001|Overall Study|Lost to Follow-up|6|||
148777490|NCT00710684|536658608|FG002|Overall Study|Lost to Follow-up|7|||
148777491|NCT00710684|536658606|FG000|Overall Study|Physician Decision|0|||
148777492|NCT00710684|536658607|FG001|Overall Study|Physician Decision|2|||
148777493|NCT00710684|536658608|FG002|Overall Study|Physician Decision|4|||
148777494|NCT00710684|536658606|FG000|Overall Study|Withdrawal by Subject|24|||
148777495|NCT00710684|536658607|FG001|Overall Study|Withdrawal by Subject|18|||
148777496|NCT00710684|536658608|FG002|Overall Study|Withdrawal by Subject|11|||
148777497|NCT00710684|536658606|FG000|Overall Study|Missing|1|||
148777498|NCT00710684|536658607|FG001|Overall Study|Missing|0|||
148777499|NCT00710684|536658608|FG002|Overall Study|Missing|0|||
148777500|NCT00710684|536658606|FG000|Overall Study|Did not continue after week 24|25|||
148777501|NCT00710684|536658607|FG001|Overall Study|Did not continue after week 24|21|||
148777502|NCT00710684|536658608|FG002|Overall Study|Did not continue after week 24|16|||
148777503|NCT00514904|536658609|FG000|Overall Study|Withdrawal by Subject|3|||
148777504|NCT00514904|536658610|FG001|Overall Study|Withdrawal by Subject|2|||
148777505|NCT00514904|536658609|FG000|Overall Study|Lost to Follow-up|21|||
148777506|NCT00514904|536658610|FG001|Overall Study|Lost to Follow-up|3|||
148777507|NCT01317797|536658611|FG000|Overall Study|Other|0|||
148777508|NCT01317797|536658612|FG001|Overall Study|Other|1|||
148777509|NCT01317797|536658613|FG002|Overall Study|Other|0|||
148777510|NCT01317797|536658611|FG000|Overall Study|Withdrawal of Patient|0|||
148777511|NCT01317797|536658612|FG001|Overall Study|Withdrawal of Patient|0|||
148777512|NCT01317797|536658613|FG002|Overall Study|Withdrawal of Patient|1|||
148777513|NCT00328094|536660344|FG000|Overall Study|Physician Decision|3|||
148777514|NCT00328094|536660345|FG001|Overall Study|Physician Decision|3|||
148777515|NCT01911780|536660346|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
148777516|NCT01911780|536660347|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
148777517|NCT01911780|536660346|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
148777518|NCT01911780|536660347|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
148777519|NCT01911780|536660346|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
148777520|NCT01911780|536660347|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
148777521|NCT01911780|536660346|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
148777522|NCT01911780|536660347|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
148777523|NCT01911780|536660346|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
148777524|NCT01911780|536660347|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
148777525|NCT01911780|536660346|FG000|Extension Period (52 Weeks)|Personal reason|1|||
148777526|NCT01911780|536660347|FG001|Extension Period (52 Weeks)|Personal reason|1|||
148777527|NCT00985426|536660348|FG000|Overall Study|Adverse Event|0|||
148777528|NCT00985426|536660349|FG001|Overall Study|Adverse Event|1|||
148777529|NCT00985426|536660348|FG000|Overall Study|Subject Non-Compliance|3|||
148777530|NCT00985426|536660349|FG001|Overall Study|Subject Non-Compliance|3|||
148777531|NCT00985426|536660348|FG000|Overall Study|Withdrawal by Subject|12|||
148777532|NCT00985426|536660349|FG001|Overall Study|Withdrawal by Subject|16|||
148777533|NCT00985426|536660348|FG000|Overall Study|Lost to Follow-up|8|||
148777534|NCT00985426|536660349|FG001|Overall Study|Lost to Follow-up|10|||
148777535|NCT00985426|536660348|FG000|Overall Study|Death|7|||
148777536|NCT00985426|536660349|FG001|Overall Study|Death|3|||
148777537|NCT00985426|536660348|FG000|Overall Study|Protocol Violation|2|||
148777538|NCT00985426|536660349|FG001|Overall Study|Protocol Violation|0|||
148777539|NCT00985426|536660348|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
148777540|NCT00985426|536660349|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
148777541|NCT02052596|536660350|FG000|Active Phase|Adverse Event|3|||
148777542|NCT02052596|536660351|FG001|Active Phase|Adverse Event|2|||
148777543|NCT02052596|536660350|FG000|Active Phase|Lost to Follow-up|8|||
148777544|NCT02052596|536660351|FG001|Active Phase|Lost to Follow-up|11|||
148777545|NCT02052596|536660350|FG000|Active Phase|Protocol Violation|1|||
148777546|NCT02052596|536660351|FG001|Active Phase|Protocol Violation|2|||
148777547|NCT02052596|536660350|FG000|Active Phase|Withdrawal by Subject|3|||
148777548|NCT02052596|536660351|FG001|Active Phase|Withdrawal by Subject|4|||
148777549|NCT02052596|536660350|FG000|Active Phase|Enrolled in error|1|||
148777550|NCT02052596|536660351|FG001|Active Phase|Enrolled in error|0|||
148777551|NCT02052596|536660350|FG000|Active Phase|Lost due to Crohn's disease|0|||
148777552|NCT02052596|536660351|FG001|Active Phase|Lost due to Crohn's disease|1|||
148777553|NCT02052596|536660350|FG000|Safety Phase|Adverse Event|6|||
148777554|NCT02052596|536660351|FG001|Safety Phase|Adverse Event|3|||
148777555|NCT02052596|536660350|FG000|Safety Phase|Lost to Follow-up|11|||
148777556|NCT02052596|536660351|FG001|Safety Phase|Lost to Follow-up|18|||
148777557|NCT02052596|536660350|FG000|Safety Phase|Protocol Violation|1|||
148777558|NCT02052596|536660351|FG001|Safety Phase|Protocol Violation|2|||
148777559|NCT02052596|536660350|FG000|Safety Phase|Withdrawal by Subject|8|||
148777560|NCT02052596|536660351|FG001|Safety Phase|Withdrawal by Subject|11|||
148777561|NCT02052596|536660350|FG000|Safety Phase|Enrolled in error|1|||
148777562|NCT02052596|536660351|FG001|Safety Phase|Enrolled in error|0|||
148777563|NCT02052596|536660350|FG000|Safety Phase|Lost due to Crohn's disease|0|||
148777564|NCT02052596|536660351|FG001|Safety Phase|Lost due to Crohn's disease|1|||
148777565|NCT00558896|536660352|FG000|Overall Study|Adverse Event|1|||
148777566|NCT00558896|536660353|FG001|Overall Study|Adverse Event|1|||
148777567|NCT00558896|536660354|FG002|Overall Study|Adverse Event|1|||
148777568|NCT00558896|536660355|FG003|Overall Study|Adverse Event|3|||
148777569|NCT00558896|536660356|FG004|Overall Study|Adverse Event|4|||
148777570|NCT00558896|536660357|FG005|Overall Study|Adverse Event|10|||
148777571|NCT00558896|536660358|FG006|Overall Study|Adverse Event|3|||
148777572|NCT00558896|536660352|FG000|Overall Study|Death|3|||
148777573|NCT00558896|536660353|FG001|Overall Study|Death|0|||
148777574|NCT00558896|536660354|FG002|Overall Study|Death|2|||
148777575|NCT00558896|536660355|FG003|Overall Study|Death|3|||
148777576|NCT00558896|536660356|FG004|Overall Study|Death|2|||
148777577|NCT00558896|536660357|FG005|Overall Study|Death|2|||
148777578|NCT00558896|536660358|FG006|Overall Study|Death|6|||
148777579|NCT00558896|536660352|FG000|Overall Study|Withdrawal by Subject|2|||
148777580|NCT00558896|536660353|FG001|Overall Study|Withdrawal by Subject|1|||
148777581|NCT00558896|536660354|FG002|Overall Study|Withdrawal by Subject|1|||
148777582|NCT00558896|536660355|FG003|Overall Study|Withdrawal by Subject|1|||
148777583|NCT00558896|536660356|FG004|Overall Study|Withdrawal by Subject|1|||
148777584|NCT00558896|536660357|FG005|Overall Study|Withdrawal by Subject|5|||
148777585|NCT00558896|536660358|FG006|Overall Study|Withdrawal by Subject|5|||
148777586|NCT00558896|536660352|FG000|Overall Study|Alternative Treatment|2|||
148777587|NCT00558896|536660353|FG001|Overall Study|Alternative Treatment|2|||
148777588|NCT00558896|536660354|FG002|Overall Study|Alternative Treatment|0|||
148777589|NCT00558896|536660355|FG003|Overall Study|Alternative Treatment|2|||
148777590|NCT00558896|536660356|FG004|Overall Study|Alternative Treatment|6|||
148777591|NCT00558896|536660357|FG005|Overall Study|Alternative Treatment|7|||
148777592|NCT00558896|536660358|FG006|Overall Study|Alternative Treatment|1|||
148777593|NCT00558896|536660352|FG000|Overall Study|Physician discretion|3|||
148777594|NCT00558896|536660353|FG001|Overall Study|Physician discretion|2|||
148777595|NCT00558896|536660354|FG002|Overall Study|Physician discretion|1|||
148777596|NCT00558896|536660355|FG003|Overall Study|Physician discretion|2|||
148777597|NCT00558896|536660356|FG004|Overall Study|Physician discretion|1|||
148777598|NCT00558896|536660357|FG005|Overall Study|Physician discretion|3|||
148777599|NCT00558896|536660358|FG006|Overall Study|Physician discretion|3|||
148777600|NCT00558896|536660352|FG000|Overall Study|Continues on treatment|10|||
148777601|NCT00558896|536660353|FG001|Overall Study|Continues on treatment|1|||
148777602|NCT00558896|536660354|FG002|Overall Study|Continues on treatment|0|||
148777603|NCT00558896|536660355|FG003|Overall Study|Continues on treatment|1|||
148777604|NCT00558896|536660356|FG004|Overall Study|Continues on treatment|9|||
148777605|NCT00558896|536660357|FG005|Overall Study|Continues on treatment|25|||
148777606|NCT00558896|536660358|FG006|Overall Study|Continues on treatment|6|||
148777607|NCT00250458|536660360|FG000|Overall Study|Lost to Follow-up|4|||
148777608|NCT00250458|536660361|FG001|Overall Study|Lost to Follow-up|2|||
148777609|NCT00250458|536660360|FG000|Overall Study|Protocol Violation|0|||
149030283|NCT05550337|537587988|FG000|Overall Study|Lack of Efficacy|0|||
149030284|NCT05550337|537587989|FG001|Overall Study|Lack of Efficacy|0|||
149030285|NCT05550337|537587990|FG002|Overall Study|Lack of Efficacy|1|||
149030286|NCT05550337|537587988|FG000|Overall Study|Adverse Event|1|||
149030287|NCT05550337|537587989|FG001|Overall Study|Adverse Event|5|||
149030288|NCT05550337|537587990|FG002|Overall Study|Adverse Event|0|||
149030289|NCT05550337|537587988|FG000|Overall Study|Withdrawal by Subject|8|||
148777610|NCT00250458|536660361|FG001|Overall Study|Protocol Violation|1|||
148777611|NCT00250458|536660360|FG000|Overall Study|Withdrawal by Subject|4|||
148777612|NCT00250458|536660361|FG001|Overall Study|Withdrawal by Subject|2|||
148777613|NCT00250458|536660360|FG000|Overall Study|Lack of Migraine Attack|20|||
148777614|NCT00250458|536660361|FG001|Overall Study|Lack of Migraine Attack|9|||
148777615|NCT00250458|536660360|FG000|Overall Study|Qualifying migraine but did not treat|3|||
148777616|NCT00250458|536660361|FG001|Overall Study|Qualifying migraine but did not treat|3|||
148777617|NCT00250458|536660360|FG000|Overall Study|Other|1|||
148777618|NCT00250458|536660361|FG001|Overall Study|Other|0|||
148777619|NCT01629823|536660370|FG000|Trial Period|Missed visit|11|||
148777620|NCT01629823|536660371|FG001|Trial Period|Missed visit|9|||
148777621|NCT01629823|536660372|FG002|Trial Period|Missed visit|8|||
148777622|NCT01629823|536660370|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
148777623|NCT01629823|536660371|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
148777624|NCT01629823|536660372|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
148777625|NCT01629823|536660370|FG000|Trial Period|Pregnancy|1|||
148777626|NCT01629823|536660371|FG001|Trial Period|Pregnancy|0|||
148777627|NCT01629823|536660372|FG002|Trial Period|Pregnancy|0|||
148777628|NCT01629823|536660370|FG000|Trial Period|Adverse Event|0|||
148777629|NCT01629823|536660371|FG001|Trial Period|Adverse Event|1|||
148777630|NCT01629823|536660372|FG002|Trial Period|Adverse Event|0|||
148777631|NCT01629823|536660370|FG000|Trial Period|Out-of-window visit|0|||
148777632|NCT01629823|536660371|FG001|Trial Period|Out-of-window visit|2|||
148777633|NCT01629823|536660372|FG002|Trial Period|Out-of-window visit|0|||
148777634|NCT01629823|536660370|FG000|Trial Period|Failed to hold medication|0|||
148777635|NCT01629823|536660371|FG001|Trial Period|Failed to hold medication|0|||
148777636|NCT01629823|536660372|FG002|Trial Period|Failed to hold medication|1|||
148777637|NCT01629823|536660370|FG000|Washout Period|Safety|2|||
148777638|NCT01629823|536660371|FG001|Washout Period|Safety|5|||
148777639|NCT01629823|536660372|FG002|Washout Period|Safety|0|||
148777640|NCT01629823|536660370|FG000|Washout Period|Pregnancy|1|||
148777641|NCT01629823|536660371|FG001|Washout Period|Pregnancy|0|||
148777642|NCT01629823|536660372|FG002|Washout Period|Pregnancy|0|||
148777643|NCT01629823|536660370|FG000|Washout Period|Protocol Violation|0|||
148777644|NCT01629823|536660371|FG001|Washout Period|Protocol Violation|1|||
148777645|NCT01629823|536660372|FG002|Washout Period|Protocol Violation|0|||
148777646|NCT01199822|536660374|FG000|Overall Study|Investigator discontinued therapy|0|||
148777647|NCT01199822|536660375|FG001|Overall Study|Investigator discontinued therapy|1|||
148777648|NCT01199822|536660376|FG002|Overall Study|Investigator discontinued therapy|0|||
148777649|NCT00525902|536660377|FG000|Overall Study|Lack of Efficacy|1|||
148777650|NCT02258542|536660378|FG000|Overall Study|eg. not made to the visit|7|||
148777651|NCT02258542|536660379|FG001|Overall Study|eg. not made to the visit|4|||
148777652|NCT02258542|536660380|FG002|Overall Study|eg. not made to the visit|0|||
148777653|NCT02258542|536660381|FG003|Overall Study|eg. not made to the visit|1|||
148777654|NCT02258542|536660378|FG000|Overall Study|study specific discount. criteria|1|||
148777655|NCT02258542|536660379|FG001|Overall Study|study specific discount. criteria|1|||
148777656|NCT02258542|536660380|FG002|Overall Study|study specific discount. criteria|0|||
148777657|NCT02258542|536660381|FG003|Overall Study|study specific discount. criteria|0|||
148777658|NCT02258542|536660378|FG000|Overall Study|Withdrawal by Subject|20|||
148777659|NCT02258542|536660379|FG001|Overall Study|Withdrawal by Subject|20|||
148777660|NCT02258542|536660380|FG002|Overall Study|Withdrawal by Subject|7|||
148777661|NCT02258542|536660381|FG003|Overall Study|Withdrawal by Subject|1|||
148777662|NCT02258542|536660378|FG000|Overall Study|Lost to Follow-up|5|||
148777663|NCT02258542|536660379|FG001|Overall Study|Lost to Follow-up|12|||
148777664|NCT02258542|536660380|FG002|Overall Study|Lost to Follow-up|1|||
148777665|NCT02258542|536660381|FG003|Overall Study|Lost to Follow-up|2|||
148777666|NCT02258542|536660378|FG000|Overall Study|Death|5|||
148777667|NCT02258542|536660379|FG001|Overall Study|Death|4|||
148777668|NCT02258542|536660380|FG002|Overall Study|Death|0|||
148777669|NCT02258542|536660381|FG003|Overall Study|Death|1|||
149030290|NCT05550337|537587989|FG001|Overall Study|Withdrawal by Subject|14|||
148777670|NCT02258542|536660378|FG000|Overall Study|Adverse Event|3|||
148777671|NCT02258542|536660379|FG001|Overall Study|Adverse Event|4|||
148777672|NCT02258542|536660380|FG002|Overall Study|Adverse Event|0|||
148777673|NCT02258542|536660381|FG003|Overall Study|Adverse Event|0|||
148777674|NCT02258542|536660378|FG000|Overall Study|Protocol Violation|1|||
148777675|NCT02258542|536660379|FG001|Overall Study|Protocol Violation|2|||
148777676|NCT02258542|536660380|FG002|Overall Study|Protocol Violation|0|||
149030291|NCT05550337|537587990|FG002|Overall Study|Withdrawal by Subject|10|||
148777677|NCT02258542|536660381|FG003|Overall Study|Protocol Violation|0|||
148777678|NCT02258542|536660378|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148851670|NCT02993822|536930708|FG003|Overall Study|Lack of Efficacy|0|||
148777679|NCT02258542|536660379|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
148777680|NCT02258542|536660380|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
148777681|NCT02258542|536660381|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
148777682|NCT00480493|536660382|FG000|Overall Study|moved|2|||
148777683|NCT00480493|536660383|FG001|Overall Study|moved|7|||
148777684|NCT04027075|536660384|FG000|Overall Study|Lost to Follow-up|41|||
148777685|NCT04027075|536660385|FG001|Overall Study|Lost to Follow-up|22|||
148777686|NCT02844907|536660386|FG000|With Dexamethasone|No IV access|1|||
148777687|NCT00550862|536660387|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
148777688|NCT00550862|536660388|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
148777689|NCT00550862|536660389|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
148777690|NCT00550862|536660390|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
148777691|NCT00550862|536660391|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
148777692|NCT00550862|536660387|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
148777693|NCT00550862|536660388|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
148777694|NCT00550862|536660389|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
148777695|NCT00550862|536660390|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
148777696|NCT00550862|536660391|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
148777697|NCT00550862|536660387|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
148777698|NCT00550862|536660388|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
148777699|NCT00550862|536660389|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
148777700|NCT00550862|536660390|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
148777701|NCT00550862|536660391|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
148777702|NCT00550862|536660387|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
148777703|NCT00550862|536660388|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
148777704|NCT00550862|536660389|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
148777705|NCT00550862|536660390|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
148777706|NCT00550862|536660391|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
148777707|NCT00550862|536660387|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
148777708|NCT00550862|536660388|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
148777709|NCT00550862|536660389|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
148777710|NCT00550862|536660390|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
148777711|NCT00550862|536660391|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
148777712|NCT00550862|536660387|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
148777713|NCT00550862|536660388|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
148777714|NCT00550862|536660389|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
148777715|NCT00550862|536660390|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
148777716|NCT00550862|536660391|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
148777717|NCT00550862|536660387|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
148777718|NCT00550862|536660388|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
148777719|NCT00550862|536660389|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
148777720|NCT00550862|536660390|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
148777721|NCT00550862|536660391|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
148777722|NCT00550862|536660387|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
148777723|NCT00550862|536660388|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
148777724|NCT00550862|536660389|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
148777725|NCT00550862|536660390|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
148777726|NCT00550862|536660391|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
148777727|NCT00550862|536660387|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
148777728|NCT00550862|536660388|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
148777729|NCT00550862|536660389|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
148777730|NCT00550862|536660390|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
148777731|NCT00550862|536660391|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
148777732|NCT00550862|536660387|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
148777733|NCT00550862|536660388|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
148777734|NCT00550862|536660389|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
148777735|NCT00550862|536660390|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
148777736|NCT00550862|536660391|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
148777737|NCT00455520|536660393|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
148777738|NCT00455520|536660394|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
148777739|NCT00455520|536660393|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
148851671|NCT02993822|536930705|FG000|Overall Study|Protocol Violation|1|||
148851672|NCT02993822|536930706|FG001|Overall Study|Protocol Violation|0|||
148777740|NCT00455520|536660394|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
148777741|NCT00455520|536660393|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
148777742|NCT00455520|536660394|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
148777743|NCT00455520|536660393|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
148777744|NCT00455520|536660394|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
148777745|NCT00455520|536660393|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
148777746|NCT00455520|536660394|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
148777747|NCT00455520|536660393|FG000|Open Label Tapentadol Extended Release|All other|33|||
148777748|NCT00455520|536660394|FG001|Open Label Tapentadol Extended Release|All other|0|||
148777749|NCT00455520|536660393|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
148777750|NCT00455520|536660394|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
148777751|NCT00455520|536660393|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
148777752|NCT00455520|536660394|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
148777753|NCT00455520|536660393|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
148777754|NCT00455520|536660394|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
148777755|NCT00455520|536660393|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
148777756|NCT00455520|536660394|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
148777757|NCT00455520|536660393|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
148777758|NCT00455520|536660394|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
148851673|NCT02993822|536930707|FG002|Overall Study|Protocol Violation|0|||
148851674|NCT02993822|536930708|FG003|Overall Study|Protocol Violation|0|||
148851675|NCT02993822|536930705|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
148851676|NCT02993822|536930706|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
148851677|NCT02993822|536930707|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
148851678|NCT02993822|536930708|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
148851679|NCT02993822|536930705|FG000|Overall Study|Adverse Event|3|||
148851680|NCT02993822|536930706|FG001|Overall Study|Adverse Event|1|||
148851681|NCT02993822|536930707|FG002|Overall Study|Adverse Event|7|||
148851682|NCT02993822|536930708|FG003|Overall Study|Adverse Event|0|||
148851683|NCT02993822|536930705|FG000|Overall Study|Withdrawal by Subject|4|||
148851684|NCT02993822|536930706|FG001|Overall Study|Withdrawal by Subject|2|||
148851685|NCT02993822|536930707|FG002|Overall Study|Withdrawal by Subject|2|||
148851686|NCT02993822|536930708|FG003|Overall Study|Withdrawal by Subject|3|||
148851687|NCT02993822|536930705|FG000|Overall Study|Lost to Follow-up|1|||
148851688|NCT02993822|536930706|FG001|Overall Study|Lost to Follow-up|0|||
148851689|NCT02993822|536930707|FG002|Overall Study|Lost to Follow-up|1|||
148851690|NCT02993822|536930708|FG003|Overall Study|Lost to Follow-up|0|||
148851691|NCT01814046|536930715|FG000|Drug Administration|Death due to complications of RSV|1|||
148851692|NCT01814046|536930716|FG001|Drug Administration|Death due to complications of RSV|0|||
148851693|NCT01814046|536930717|FG002|Drug Administration|Death due to complications of RSV|0|||
148851694|NCT00564902|536930718|FG000|Overall Study|Withdrawal by Subject|0|||
148851695|NCT00564902|536930719|FG001|Overall Study|Withdrawal by Subject|3|||
148851696|NCT00564902|536930720|FG002|Overall Study|Withdrawal by Subject|4|||
148851697|NCT00564902|536930718|FG000|Overall Study|Death|1|||
148851698|NCT00564902|536930719|FG001|Overall Study|Death|1|||
148851699|NCT00564902|536930720|FG002|Overall Study|Death|0|||
148851700|NCT01659996|536930728|FG000|Overall Study|Protocol Violation|3|||
148851701|NCT01659996|536930729|FG001|Overall Study|Protocol Violation|3|||
148851702|NCT01659996|536930730|FG002|Overall Study|Protocol Violation|3|||
148851703|NCT01659996|536930728|FG000|Overall Study|Lost to Follow-up|1|||
148851704|NCT01659996|536930729|FG001|Overall Study|Lost to Follow-up|3|||
148851705|NCT01659996|536930730|FG002|Overall Study|Lost to Follow-up|2|||
148851706|NCT01659996|536930728|FG000|Overall Study|Adverse Event|0|||
148851707|NCT01659996|536930729|FG001|Overall Study|Adverse Event|0|||
148851708|NCT01659996|536930730|FG002|Overall Study|Adverse Event|1|||
148851709|NCT01659996|536930728|FG000|Overall Study|Withdrawal by Subject|4|||
148851710|NCT01659996|536930729|FG001|Overall Study|Withdrawal by Subject|1|||
148851711|NCT01659996|536930730|FG002|Overall Study|Withdrawal by Subject|5|||
148851712|NCT03206918|536930731|FG000|Overall Study|Death|11|||
148851713|NCT03206918|536930731|FG000|Overall Study|Withdrawal by Subject|5|||
148851714|NCT03206918|536930731|FG000|Overall Study|Study terminated by sponsor|12|||
148851715|NCT03206918|536930731|FG000|Overall Study|Lost to Follow-up|3|||
148851716|NCT03206918|536930731|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
148851717|NCT02701764|536930732|FG000|Overall Study|Lost to Follow-up|0|||
148851718|NCT02701764|536930733|FG001|Overall Study|Lost to Follow-up|1|||
148851719|NCT00782171|536932602|FG000|Overall Study|Lost to Follow-up|2|||
148851720|NCT00782171|536932603|FG001|Overall Study|Lost to Follow-up|2|||
148851721|NCT00782171|536932602|FG000|Overall Study|Withdrawal by Subject|2|||
149030292|NCT05550337|537587988|FG000|Overall Study|Pregnancy|0|||
149030293|NCT05550337|537587989|FG001|Overall Study|Pregnancy|0|||
148851722|NCT00782171|536932603|FG001|Overall Study|Withdrawal by Subject|1|||
148851723|NCT00782171|536932602|FG000|Overall Study|complications|3|||
148851724|NCT00782171|536932603|FG001|Overall Study|complications|1|||
149030294|NCT05550337|537587990|FG002|Overall Study|Pregnancy|1|||
148851725|NCT00782171|536932602|FG000|Overall Study|others|7|||
148851726|NCT00782171|536932603|FG001|Overall Study|others|9|||
148851727|NCT00782171|536932602|FG000|Overall Study|not eligible|8|||
148851728|NCT00782171|536932603|FG001|Overall Study|not eligible|6|||
148851729|NCT04299308|536932604|FG000|Overall Study|Withdrawal by Subject|1|||
148851730|NCT04299308|536932605|FG001|Overall Study|Withdrawal by Subject|0|||
148851731|NCT04299308|536932604|FG000|Overall Study|issue with PET image (1)|1|||
148851732|NCT04299308|536932605|FG001|Overall Study|issue with PET image (1)|0|||
148851733|NCT00814580|536932606|FG000|Overall Study|Adverse Event|6|||
148851734|NCT00814580|536932607|FG001|Overall Study|Adverse Event|15|||
148851735|NCT00814580|536932606|FG000|Overall Study|Lack of Efficacy|18|||
148851736|NCT00814580|536932607|FG001|Overall Study|Lack of Efficacy|25|||
148851737|NCT00814580|536932606|FG000|Overall Study|Protocol Violation|2|||
148851738|NCT00814580|536932607|FG001|Overall Study|Protocol Violation|0|||
148851739|NCT00814580|536932606|FG000|Overall Study|Withdrawal by Subject|2|||
148851740|NCT00814580|536932607|FG001|Overall Study|Withdrawal by Subject|2|||
148851741|NCT00814580|536932606|FG000|Overall Study|Other|1|||
148851742|NCT00814580|536932607|FG001|Overall Study|Other|3|||
148851743|NCT00814580|536932606|FG000|Overall Study|Did Not Take Drug|2|||
148851744|NCT00814580|536932607|FG001|Overall Study|Did Not Take Drug|2|||
148851745|NCT02920528|536932612|FG000|Overall Study|Incomplete Data|1|||
148851746|NCT02920528|536932613|FG001|Overall Study|Incomplete Data|1|||
148851747|NCT02920528|536932614|FG002|Overall Study|Incomplete Data|1|||
148851748|NCT02920528|536932612|FG000|Overall Study|Adverse Event|0|||
148851749|NCT02920528|536932613|FG001|Overall Study|Adverse Event|0|||
148851750|NCT02920528|536932614|FG002|Overall Study|Adverse Event|3|||
148851751|NCT02920528|536932612|FG000|Overall Study|Did not meet inclusion criteria|2|||
148851752|NCT02920528|536932613|FG001|Overall Study|Did not meet inclusion criteria|0|||
148851753|NCT02920528|536932614|FG002|Overall Study|Did not meet inclusion criteria|1|||
148851754|NCT01340625|536932615|FG000|First Intervention|Adverse Event|1|||
148851755|NCT01340625|536932616|FG001|First Intervention|Adverse Event|0|||
148851756|NCT01340625|536932615|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
148851757|NCT01340625|536932616|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
148851758|NCT01986231|536932617|FG000|Overall Study|Adverse Event|1|||
148851759|NCT02150057|536932620|FG000|Overall Study|Lost to Follow-up|6|||
148851760|NCT02150057|536932621|FG001|Overall Study|Lost to Follow-up|4|||
148851761|NCT00489424|536932622|FG000|Overall Study|Adverse Event|3|||
148851762|NCT00489424|536932623|FG001|Overall Study|Adverse Event|3|||
148851763|NCT00489424|536932624|FG002|Overall Study|Adverse Event|4|||
148851764|NCT00489424|536932622|FG000|Overall Study|Lack of Efficacy|1|||
148851765|NCT00489424|536932623|FG001|Overall Study|Lack of Efficacy|0|||
148851766|NCT00489424|536932624|FG002|Overall Study|Lack of Efficacy|0|||
148851767|NCT00489424|536932622|FG000|Overall Study|Administrative problems|0|||
148851768|NCT00489424|536932623|FG001|Overall Study|Administrative problems|2|||
148851769|NCT00489424|536932624|FG002|Overall Study|Administrative problems|1|||
148851770|NCT01558115|536932625|FG000|Overall Study|Withdrawal by Subject|3|||
148851771|NCT01558115|536932625|FG000|Overall Study|Study closed due to poor enrollment|4|||
148851772|NCT01696994|536932626|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
148851773|NCT01696994|536932627|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
148851774|NCT01696994|536932626|FG000|Overall Study|Died Before Randomization|1|||
148851775|NCT01696994|536932627|FG001|Overall Study|Died Before Randomization|2|||
148851776|NCT01696994|536932626|FG000|Overall Study|Died Before ASU (Control)|73|||
148851777|NCT01696994|536932627|FG001|Overall Study|Died Before ASU (Control)|0|||
148851778|NCT01696994|536932626|FG000|Overall Study|No Ovaries at Baseline|4807|||
148851779|NCT01696994|536932627|FG001|Overall Study|No Ovaries at Baseline|4851|||
148851780|NCT01696994|536932626|FG000|Overall Study|Refused ASU (Control)|311|||
148851781|NCT01696994|536932627|FG001|Overall Study|Refused ASU (Control)|0|||
148851782|NCT01696994|536932626|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
148851783|NCT01696994|536932627|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
148851784|NCT00880269|536932630|FG000|Overall Study|Protocol Violation|1|||
148851785|NCT00880269|536932631|FG001|Overall Study|Protocol Violation|0|||
148851786|NCT00880269|536932630|FG000|Overall Study|Disease Progression|13|||
148851787|NCT00880269|536932631|FG001|Overall Study|Disease Progression|11|||
148851788|NCT00880269|536932630|FG000|Overall Study|New Cancer Therapy|1|||
148851789|NCT00880269|536932631|FG001|Overall Study|New Cancer Therapy|0|||
148851790|NCT00880269|536932630|FG000|Overall Study|Death|4|||
148851791|NCT00880269|536932631|FG001|Overall Study|Death|2|||
148851792|NCT00880269|536932630|FG000|Overall Study|Lost to Follow-up|0|||
148851793|NCT00880269|536932631|FG001|Overall Study|Lost to Follow-up|1|||
148851794|NCT00880269|536932630|FG000|Overall Study|Withdrawal by Subject|3|||
148851795|NCT00880269|536932631|FG001|Overall Study|Withdrawal by Subject|4|||
148851796|NCT00880269|536932630|FG000|Overall Study|Adverse Event|10|||
148851797|NCT00880269|536932631|FG001|Overall Study|Adverse Event|9|||
148851798|NCT00576628|536932632|FG000|Overall Study|Adverse Event|11|||
148986763|NCT02252211|537430548|FG002|Overall Study|Adverse Event|0|||
148851799|NCT00576628|536932632|FG000|Overall Study|Death|2|||
148851800|NCT00576628|536932632|FG000|Overall Study|Failure to return|1|||
148851801|NCT00576628|536932632|FG000|Overall Study|Refused Treatment|8|||
148851802|NCT00576628|536932632|FG000|Overall Study|Pregnancy|1|||
148851803|NCT00576628|536932632|FG000|Overall Study|RBC transfusion|1|||
148851804|NCT00576628|536932632|FG000|Overall Study|Progression of Kidney Disease|1|||
148851805|NCT00576628|536932632|FG000|Overall Study|Progression of Renal Failure|1|||
148851806|NCT00576628|536932632|FG000|Overall Study|The patient move into other town|1|||
148851807|NCT00576628|536932632|FG000|Overall Study|Transplantation|1|||
148851808|NCT00576628|536932632|FG000|Overall Study|Dialysis|15|||
148851809|NCT02516982|536932636|FG000|Overall Study|Called in to antenatal appointment|32|||
148851810|NCT02516982|536932637|FG001|Overall Study|Called in to antenatal appointment|35|||
148851811|NCT02516982|536932638|FG002|Overall Study|Called in to antenatal appointment|0|||
148851812|NCT02516982|536932639|FG003|Overall Study|Called in to antenatal appointment|0|||
148851813|NCT02516982|536932636|FG000|Overall Study|Withdrawal by Subject|0|||
148851814|NCT02516982|536932637|FG001|Overall Study|Withdrawal by Subject|0|||
148851815|NCT02516982|536932638|FG002|Overall Study|Withdrawal by Subject|1|||
148851816|NCT02516982|536932639|FG003|Overall Study|Withdrawal by Subject|2|||
148851817|NCT02516982|536932636|FG000|Overall Study|Protocol Violation|0|||
148851818|NCT02516982|536932637|FG001|Overall Study|Protocol Violation|0|||
148851819|NCT02516982|536932638|FG002|Overall Study|Protocol Violation|1|||
148851820|NCT02516982|536932639|FG003|Overall Study|Protocol Violation|1|||
148851821|NCT02516982|536932636|FG000|Overall Study|Did not install the app|0|||
148851822|NCT02516982|536932637|FG001|Overall Study|Did not install the app|0|||
148851823|NCT02516982|536932638|FG002|Overall Study|Did not install the app|46|||
148851824|NCT02516982|536932639|FG003|Overall Study|Did not install the app|47|||
148851825|NCT01951586|536932646|FG000|Overall Study|Death|61|||
148851826|NCT01951586|536932647|FG001|Overall Study|Death|120|||
148851827|NCT01951586|536932646|FG000|Overall Study|Withdrawal by Subject|8|||
148851828|NCT01951586|536932647|FG001|Overall Study|Withdrawal by Subject|17|||
148851829|NCT01951586|536932646|FG000|Overall Study|Lost to Follow-up|0|||
148851830|NCT01951586|536932647|FG001|Overall Study|Lost to Follow-up|1|||
148851831|NCT01951586|536932646|FG000|Overall Study|Sponsor Decision|9|||
148851832|NCT01951586|536932647|FG001|Overall Study|Sponsor Decision|10|||
148851833|NCT00962741|536932648|FG000|Overall Study|Failed to return|3|||
148851834|NCT00962741|536932648|FG000|Overall Study|Lost to Follow-up|2|||
148851835|NCT00962741|536932648|FG000|Overall Study|Withdrawal by Subject|1|||
148851836|NCT00962741|536932648|FG000|Overall Study|Lack of Efficacy|1|||
148851837|NCT00962741|536932648|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
148851838|NCT02120781|536932649|FG000|Overall Study|Physician Decision|2|||
148851839|NCT02120781|536932650|FG001|Overall Study|Physician Decision|0|||
148851840|NCT02120781|536932649|FG000|Overall Study|Completion not documented|2|||
148851841|NCT02120781|536932650|FG001|Overall Study|Completion not documented|1|||
148851842|NCT00748618|536932651|FG000|Overall Study|Adverse Event|1|||
148851843|NCT00748618|536932652|FG001|Overall Study|Adverse Event|0|||
148851844|NCT00466947|536932653|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
148851845|NCT00466947|536932654|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
148851846|NCT00466947|536932653|FG000|Study End Analysis Period|Adverse Event|35|||
148851847|NCT00466947|536932654|FG001|Study End Analysis Period|Adverse Event|43|||
148851848|NCT00466947|536932653|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
148851849|NCT00466947|536932654|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
148851850|NCT00466947|536932653|FG000|Study End Analysis Period|Physician Decision|29|||
148851851|NCT00466947|536932654|FG001|Study End Analysis Period|Physician Decision|29|||
148851852|NCT00466947|536932653|FG000|Study End Analysis Period|Protocol Violation|9|||
148851853|NCT00466947|536932654|FG001|Study End Analysis Period|Protocol Violation|17|||
148851854|NCT00466947|536932653|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
148851855|NCT00466947|536932654|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
148851856|NCT00466947|536932653|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
148851857|NCT00466947|536932654|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
148851858|NCT00466947|536932653|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
148851859|NCT00466947|536932654|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
148851860|NCT00466947|536932653|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
148851861|NCT00466947|536932654|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
148851862|NCT01995526|536932655|FG000|Overall Study|Physician Decision|1|||
148851863|NCT02858440|536932665|FG000|Overall Study|Lost to Follow-up|3|||
148851864|NCT02858440|536932665|FG000|Overall Study|Protocol Violation|2|||
148851865|NCT02858440|536932665|FG000|Overall Study|Consent withdrawal|3|||
148851866|NCT02858440|536932665|FG000|Overall Study|Migrated/moved from study area|4|||
148851867|NCT01670279|536932666|FG000|Overall Study|Adverse Event|0|||
148851868|NCT01670279|536932667|FG001|Overall Study|Adverse Event|1|||
148851869|NCT01670279|536932668|FG002|Overall Study|Adverse Event|0|||
148851870|NCT01670279|536932669|FG003|Overall Study|Adverse Event|0|||
148851871|NCT01670279|536932666|FG000|Overall Study|Physician Decision|0|||
148851872|NCT01670279|536932667|FG001|Overall Study|Physician Decision|1|||
148851873|NCT01670279|536932668|FG002|Overall Study|Physician Decision|0|||
148851874|NCT01670279|536932669|FG003|Overall Study|Physician Decision|0|||
148851875|NCT01670279|536932666|FG000|Overall Study|Participant met withdrawal criteria|0|||
148889449|NCT02888106|537074409|FG003|Overall Study|Lost to Follow-up|1|||
148851876|NCT01670279|536932667|FG001|Overall Study|Participant met withdrawal criteria|0|||
148851877|NCT01670279|536932668|FG002|Overall Study|Participant met withdrawal criteria|0|||
148851878|NCT01670279|536932669|FG003|Overall Study|Participant met withdrawal criteria|1|||
148851879|NCT01534351|536932672|FG000|Overall Study|Study Terminated Early|1|||
148851880|NCT01534351|536932673|FG001|Overall Study|Study Terminated Early|0|||
148851881|NCT01534351|536932674|FG002|Overall Study|Study Terminated Early|0|||
148851882|NCT02702609|536932675|FG000|Overall Study|Lost to Follow-up|8|||
148851883|NCT02702609|536932676|FG001|Overall Study|Lost to Follow-up|4|||
148851884|NCT02702609|536932675|FG000|Overall Study|Physician Decision|1|||
148851885|NCT02702609|536932676|FG001|Overall Study|Physician Decision|0|||
148851886|NCT04153981|536932677|FG000|Overall Study|Death|1|||
148851887|NCT04153981|536932677|FG000|Overall Study|Withdrawal by Subject|24|||
148851888|NCT04153981|536932677|FG000|Overall Study|Lost to Follow-up|1|||
148851889|NCT04153981|536932677|FG000|Overall Study|Physician Decision|1|||
148851890|NCT04153981|536932677|FG000|Overall Study|Due to Unavailable Glucometer|1|||
148851891|NCT04153981|536932677|FG000|Overall Study|Covid 19|52|||
148851892|NCT04153981|536932677|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
148851893|NCT04153981|536932677|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
148851894|NCT02027311|536932678|FG000|Overall Study|Protocol Violation|3|||
148851895|NCT02027311|536932679|FG001|Overall Study|Protocol Violation|2|||
148851896|NCT03928418|536932680|FG000|Overall Study|Lost to Follow-up|5|||
148851897|NCT03928418|536932681|FG001|Overall Study|Lost to Follow-up|3|||
148851898|NCT03928418|536932682|FG002|Overall Study|Lost to Follow-up|5|||
148851899|NCT03928418|536932680|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
148851900|NCT03928418|536932681|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
148851901|NCT03928418|536932682|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
148851902|NCT00964002|536932683|FG000|Overall Study|Protocol Violation|8|||
148851903|NCT02091362|536932695|FG000|Period 1|Protocol Violation|1|||
148851904|NCT02091362|536932696|FG001|Period 1|Protocol Violation|0|||
148851905|NCT02091362|536932695|FG000|Period 1|Withdrawal by Subject|2|||
148851906|NCT02091362|536932696|FG001|Period 1|Withdrawal by Subject|3|||
148851907|NCT02091362|536932695|FG000|Period 1|Lost to Follow-up|0|||
148851908|NCT02091362|536932696|FG001|Period 1|Lost to Follow-up|1|||
148851909|NCT02091362|536932695|FG000|Period 1|Adverse Event|2|||
148851910|NCT02091362|536932696|FG001|Period 1|Adverse Event|0|||
148851911|NCT02091362|536932695|FG000|Wash-out|Lost to Follow-up|1|||
148851912|NCT02091362|536932696|FG001|Wash-out|Lost to Follow-up|1|||
148851913|NCT02091362|536932695|FG000|Wash-out|Withdrawal by Subject|0|||
148851914|NCT02091362|536932696|FG001|Wash-out|Withdrawal by Subject|2|||
148851915|NCT02091362|536932695|FG000|Period 2|Adverse Event|1|||
148851916|NCT02091362|536932696|FG001|Period 2|Adverse Event|0|||
148851917|NCT02091362|536932695|FG000|Period 2|Lost to Follow-up|0|||
148851918|NCT02091362|536932696|FG001|Period 2|Lost to Follow-up|1|||
148851919|NCT02091362|536932695|FG000|Period 2|Withdrawal by Subject|1|||
148851920|NCT02091362|536932696|FG001|Period 2|Withdrawal by Subject|1|||
148851921|NCT00690430|536932697|FG000|Core Phase|Abnormal Laboratory value|0|||
148851922|NCT00690430|536932698|FG001|Core Phase|Abnormal Laboratory value|1|||
148851923|NCT00690430|536932699|FG002|Core Phase|Abnormal Laboratory value|0|||
148851924|NCT00690430|536932697|FG000|Core Phase|Adverse Event|5|||
148851925|NCT00690430|536932698|FG001|Core Phase|Adverse Event|1|||
148851926|NCT00690430|536932699|FG002|Core Phase|Adverse Event|0|||
148851927|NCT00690430|536932697|FG000|Core Phase|Death|0|||
148851928|NCT00690430|536932698|FG001|Core Phase|Death|2|||
148851929|NCT00690430|536932699|FG002|Core Phase|Death|0|||
148851930|NCT00690430|536932697|FG000|Core Phase|Protocol Violation|1|||
148851931|NCT00690430|536932698|FG001|Core Phase|Protocol Violation|0|||
148851932|NCT00690430|536932699|FG002|Core Phase|Protocol Violation|0|||
148851933|NCT00690430|536932697|FG000|Core Phase|Withdrawal by Subject|3|||
148851934|NCT00690430|536932698|FG001|Core Phase|Withdrawal by Subject|3|||
148851935|NCT00690430|536932699|FG002|Core Phase|Withdrawal by Subject|0|||
148851936|NCT00690430|536932697|FG000|Core Phase|Subject no longer requires study drug|1|||
148851937|NCT00690430|536932698|FG001|Core Phase|Subject no longer requires study drug|0|||
148851938|NCT00690430|536932699|FG002|Core Phase|Subject no longer requires study drug|0|||
148851939|NCT00690430|536932697|FG000|Core Phase|Lack of Efficacy|8|||
148851940|NCT00690430|536932698|FG001|Core Phase|Lack of Efficacy|10|||
148851941|NCT00690430|536932699|FG002|Core Phase|Lack of Efficacy|0|||
148851942|NCT00690430|536932697|FG000|Core Phase|Administrative Problems|0|||
148851943|NCT00690430|536932698|FG001|Core Phase|Administrative Problems|1|||
148851944|NCT00690430|536932699|FG002|Core Phase|Administrative Problems|0|||
148851945|NCT00690430|536932697|FG000|Core Phase|Early Termination|0|||
148851946|NCT00690430|536932698|FG001|Core Phase|Early Termination|5|||
148851947|NCT00690430|536932699|FG002|Core Phase|Early Termination|0|||
148851948|NCT00690430|536932697|FG000|Extension Phase|Lack of Efficacy|3|||
148851949|NCT00690430|536932698|FG001|Extension Phase|Lack of Efficacy|1|||
148851950|NCT00690430|536932699|FG002|Extension Phase|Lack of Efficacy|4|||
149030295|NCT05550337|537587988|FG000|Overall Study|Protocol Violation|1|||
148851951|NCT00690430|536932697|FG000|Extension Phase|Abnormal Lab Values|1|||
148851952|NCT00690430|536932698|FG001|Extension Phase|Abnormal Lab Values|0|||
148851953|NCT00690430|536932699|FG002|Extension Phase|Abnormal Lab Values|0|||
148851954|NCT00690430|536932697|FG000|Extension Phase|Abnormal test procedure results|1|||
148851955|NCT00690430|536932698|FG001|Extension Phase|Abnormal test procedure results|0|||
148851956|NCT00690430|536932699|FG002|Extension Phase|Abnormal test procedure results|0|||
148851957|NCT00690430|536932697|FG000|Extension Phase|Administrative Problems|0|||
148851958|NCT00690430|536932698|FG001|Extension Phase|Administrative Problems|1|||
148851959|NCT00690430|536932699|FG002|Extension Phase|Administrative Problems|1|||
148851960|NCT00690430|536932697|FG000|Extension Phase|Adverse Event|2|||
148851961|NCT00690430|536932698|FG001|Extension Phase|Adverse Event|1|||
148851962|NCT00690430|536932699|FG002|Extension Phase|Adverse Event|2|||
148851963|NCT00690430|536932697|FG000|Extension Phase|Death|1|||
148851964|NCT00690430|536932698|FG001|Extension Phase|Death|1|||
148851965|NCT00690430|536932699|FG002|Extension Phase|Death|1|||
148851966|NCT00690430|536932697|FG000|Extension Phase|Withdrawal by Subject|0|||
148851967|NCT00690430|536932698|FG001|Extension Phase|Withdrawal by Subject|0|||
148851968|NCT00690430|536932699|FG002|Extension Phase|Withdrawal by Subject|2|||
148851969|NCT00690430|536932697|FG000|Extension Phase|Early Termination|10|||
148851970|NCT00690430|536932698|FG001|Extension Phase|Early Termination|1|||
148851971|NCT00690430|536932699|FG002|Extension Phase|Early Termination|3|||
148851972|NCT02125838|536932702|FG000|Overall Study|Lost to Follow-up|4|||
148851973|NCT02125838|536932703|FG001|Overall Study|Lost to Follow-up|4|||
148851974|NCT02565147|536932704|FG000|Overall Study|Withdrawal by Subject|5|||
148851975|NCT02565147|536932705|FG001|Overall Study|Withdrawal by Subject|1|||
148851976|NCT02565147|536932704|FG000|Overall Study|Lost to Follow-up|0|||
148851977|NCT02565147|536932705|FG001|Overall Study|Lost to Follow-up|1|||
148851978|NCT02565147|536932704|FG000|Overall Study|Death|1|||
148851979|NCT02565147|536932705|FG001|Overall Study|Death|1|||
148851980|NCT00787839|536932706|FG000|Overall Study|Failure to have the OGTT was most common|404|||
148851981|NCT02936869|536932707|FG000|Overall Study|Lost to Follow-up|1|||
148851982|NCT02936869|536932708|FG001|Overall Study|Lost to Follow-up|3|||
148851983|NCT02936869|536932707|FG000|Overall Study|Death|0|||
148851984|NCT02936869|536932708|FG001|Overall Study|Death|1|||
148851985|NCT02936869|536932707|FG000|Overall Study|Legal Case|0|||
148851986|NCT02936869|536932708|FG001|Overall Study|Legal Case|1|||
148851987|NCT02936869|536932707|FG000|Overall Study|Protocol Violation|1|||
148851988|NCT02936869|536932708|FG001|Overall Study|Protocol Violation|0|||
148851989|NCT00902850|536932710|FG000|Overall Study|Physician Decision|2|||
148851990|NCT00902850|536932711|FG001|Overall Study|Physician Decision|2|||
148851991|NCT00260832|536932712|FG000|Overall Study|Adverse Event|26|||
148851992|NCT00260832|536932713|FG001|Overall Study|Adverse Event|19|||
148851993|NCT00260832|536932712|FG000|Overall Study|Progression|116|||
148851994|NCT00260832|536932713|FG001|Overall Study|Progression|96|||
148851995|NCT00260832|536932712|FG000|Overall Study|Withdrawal by Subject|15|||
148851996|NCT00260832|536932713|FG001|Overall Study|Withdrawal by Subject|17|||
148851997|NCT00260832|536932712|FG000|Overall Study|Physician Decision|15|||
148851998|NCT00260832|536932713|FG001|Overall Study|Physician Decision|9|||
148851999|NCT00260832|536932712|FG000|Overall Study|Death|43|||
148852000|NCT00260832|536932713|FG001|Overall Study|Death|62|||
148852001|NCT00260832|536932712|FG000|Overall Study|Other|10|||
148852002|NCT00260832|536932713|FG001|Overall Study|Other|7|||
148852003|NCT00260832|536932712|FG000|Overall Study|Protocol Violation|3|||
148852004|NCT00260832|536932713|FG001|Overall Study|Protocol Violation|1|||
148852005|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
148852006|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
148852007|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
148852008|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
148852009|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
148852010|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
148852011|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
148852012|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
148852013|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148852014|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148852015|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148852016|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148852017|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148852018|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
148852019|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
148852020|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
148852021|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
148852022|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148852023|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148852024|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148852025|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
148852026|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
148852027|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
148889450|NCT02888106|537074410|FG004|Overall Study|Lost to Follow-up|0|||
148852028|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
148852029|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
148852030|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
148852031|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
148852032|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
148852033|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
148852034|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
148852035|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
148852036|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
148852037|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
148852038|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
148852039|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
148852040|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
148852041|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
148852042|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
148852043|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
148852044|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
148852045|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
148852046|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
148852047|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
148852048|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
148852049|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
148852050|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148852051|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148852052|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148852053|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
148852054|NCT03745638|536932714|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
148852055|NCT03745638|536932715|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
148852056|NCT03745638|536932716|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
148852057|NCT03745638|536932717|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
148852058|NCT03745638|536932718|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
148852059|NCT03745638|536932719|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
148852060|NCT03745638|536932720|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
148852061|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
148852062|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
148852063|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
148852064|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
148852065|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
148852066|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
148852067|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
148852068|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
148852069|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
148852070|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
148852071|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
148852072|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
148852073|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
148852074|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
148852075|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
148852076|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
148852077|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
148852078|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
148852079|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
148852080|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
148852081|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
148852082|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
148852083|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
148852084|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
148852085|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
148852086|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
148852087|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
148986764|NCT02252211|537430546|FG000|Overall Study|Progressive disease|3|||
148986765|NCT02252211|537430547|FG001|Overall Study|Progressive disease|2|||
148986766|NCT02252211|537430548|FG002|Overall Study|Progressive disease|0|||
148986767|NCT02252211|537430546|FG000|Overall Study|Withdrawal by Subject|1|||
148852088|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
148852089|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
148852090|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
148852091|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
148852092|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
148852093|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
148852094|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
148852095|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
148852096|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
148852097|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
148852098|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
148852099|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
148852100|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
148852101|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
148852102|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
148852103|NCT03745638|536932714|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
148852104|NCT03745638|536932715|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
148852105|NCT03745638|536932716|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
148852106|NCT03745638|536932717|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
148852107|NCT03745638|536932718|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
148852108|NCT03745638|536932719|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
148852109|NCT03745638|536932720|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
148852110|NCT03098433|536932721|FG000|Overall Study|Withdrawal by Subject|10|||
148852111|NCT03640507|536932722|FG000|Overall Study|Withdrawal by Subject|0|||
148852112|NCT03640507|536932723|FG001|Overall Study|Withdrawal by Subject|0|||
148852113|NCT03640507|536932724|FG002|Overall Study|Withdrawal by Subject|1|||
148852114|NCT03604172|536932726|FG000|Overall Study|Lost to Follow-up|1|||
148852115|NCT03604172|536932727|FG001|Overall Study|Lost to Follow-up|2|||
148852116|NCT02676895|536932728|FG000|Overall Study|Administrative reason|1|||
148852117|NCT02676895|536932729|FG001|Overall Study|Administrative reason|0|||
148852118|NCT02676895|536932730|FG002|Overall Study|Administrative reason|0|||
148852119|NCT02676895|536932728|FG000|Overall Study|Protocol Violation|1|||
148852120|NCT02676895|536932729|FG001|Overall Study|Protocol Violation|0|||
148852121|NCT02676895|536932730|FG002|Overall Study|Protocol Violation|0|||
148852122|NCT02676895|536932728|FG000|Overall Study|Adverse Event|0|||
148852123|NCT02676895|536932729|FG001|Overall Study|Adverse Event|3|||
148852124|NCT02676895|536932730|FG002|Overall Study|Adverse Event|1|||
148852125|NCT02676895|536932728|FG000|Overall Study|Lost to Follow-up|0|||
148852126|NCT02676895|536932729|FG001|Overall Study|Lost to Follow-up|0|||
148852127|NCT02676895|536932730|FG002|Overall Study|Lost to Follow-up|1|||
148852128|NCT02676895|536932728|FG000|Overall Study|Withdrawal by Subject|0|||
148852129|NCT02676895|536932729|FG001|Overall Study|Withdrawal by Subject|0|||
148852130|NCT02676895|536932730|FG002|Overall Study|Withdrawal by Subject|1|||
148852131|NCT03028129|536932734|FG000|Overall Study|Adverse Event|13|||
148852132|NCT03028129|536932735|FG001|Overall Study|Adverse Event|2|||
148852133|NCT03028129|536932734|FG000|Overall Study|Lost to Follow-up|50|||
148852134|NCT03028129|536932735|FG001|Overall Study|Lost to Follow-up|38|||
148852135|NCT03028129|536932734|FG000|Overall Study|Physician Decision|0|||
148852136|NCT03028129|536932735|FG001|Overall Study|Physician Decision|1|||
148852137|NCT03028129|536932734|FG000|Overall Study|Protocol Violation|1|||
148852138|NCT03028129|536932735|FG001|Overall Study|Protocol Violation|1|||
148852139|NCT03028129|536932734|FG000|Overall Study|Withdrawal by Subject|62|||
148852140|NCT03028129|536932735|FG001|Overall Study|Withdrawal by Subject|45|||
148852141|NCT00182078|536932736|FG000|Overall Study|Withdrawal by Subject|1|||
148852142|NCT00182078|536932737|FG001|Overall Study|Withdrawal by Subject|0|||
148852143|NCT00395486|536932738|FG000|Overall Study|Adverse Event|1|||
148852144|NCT00395486|536932739|FG001|Overall Study|Adverse Event|2|||
148852145|NCT00395486|536932738|FG000|Overall Study|Withdrawal by Subject|5|||
148852146|NCT00395486|536932739|FG001|Overall Study|Withdrawal by Subject|2|||
148852147|NCT00395486|536932738|FG000|Overall Study|Lost to Follow-up|0|||
148852148|NCT00395486|536932739|FG001|Overall Study|Lost to Follow-up|1|||
148852149|NCT01939977|536932741|FG000|Overall Study|Adverse Event|4|||
148852150|NCT01939977|536932742|FG001|Overall Study|Adverse Event|3|||
148852151|NCT01939977|536932741|FG000|Overall Study|Lack of Efficacy|3|||
148852152|NCT01939977|536932742|FG001|Overall Study|Lack of Efficacy|0|||
148852153|NCT01939977|536932741|FG000|Overall Study|Physician Decision|1|||
148852154|NCT01939977|536932742|FG001|Overall Study|Physician Decision|1|||
148852155|NCT01939977|536932741|FG000|Overall Study|Withdrawal by Subject|0|||
148852156|NCT01939977|536932742|FG001|Overall Study|Withdrawal by Subject|2|||
148852157|NCT01939977|536932741|FG000|Overall Study|Did not meet inclusion criteria|1|||
148852158|NCT01939977|536932742|FG001|Overall Study|Did not meet inclusion criteria|0|||
148852159|NCT01939977|536932741|FG000|Overall Study|Did not receive study medication|0|||
148852160|NCT01939977|536932742|FG001|Overall Study|Did not receive study medication|1|||
148852161|NCT02097719|536932743|FG000|Overall Study|Subject Withdrew Consent|1|||
148852162|NCT02097719|536932744|FG001|Overall Study|Subject Withdrew Consent|0|||
148852163|NCT02097719|536932743|FG000|Overall Study|Lost to Follow-up|0|||
148852164|NCT02097719|536932744|FG001|Overall Study|Lost to Follow-up|1|||
148852165|NCT02097719|536932743|FG000|Overall Study|Adverse Event|2|||
148852166|NCT02097719|536932744|FG001|Overall Study|Adverse Event|0|||
148852167|NCT01854775|536932745|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
148852168|NCT01854775|536932746|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
148852169|NCT01854775|536932747|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
148852170|NCT01854775|536932745|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
148852171|NCT01854775|536932746|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
148852172|NCT01854775|536932747|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
148852173|NCT01854775|536932745|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
148852174|NCT01854775|536932746|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
148852175|NCT01854775|536932747|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
148852176|NCT01854775|536932745|FG000|Extension Phase|Pregnancy|3|||
148852177|NCT01854775|536932746|FG001|Extension Phase|Pregnancy|0|||
148852178|NCT01854775|536932747|FG002|Extension Phase|Pregnancy|0|||
148852179|NCT01854775|536932745|FG000|Extension Phase|Investigator's Discretion|1|||
148852180|NCT01854775|536932746|FG001|Extension Phase|Investigator's Discretion|0|||
148852181|NCT01854775|536932747|FG002|Extension Phase|Investigator's Discretion|0|||
148852182|NCT01854775|536932745|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
148852183|NCT01854775|536932746|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
148852184|NCT01854775|536932747|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
148852185|NCT01854775|536932745|FG000|Extension Phase|Lost to Follow-up|2|||
148852186|NCT01854775|536932746|FG001|Extension Phase|Lost to Follow-up|0|||
148852187|NCT01854775|536932747|FG002|Extension Phase|Lost to Follow-up|0|||
148852188|NCT01854775|536932745|FG000|Extension Phase|Still on Study|32|||
148852189|NCT01854775|536932746|FG001|Extension Phase|Still on Study|47|||
148852190|NCT01854775|536932747|FG002|Extension Phase|Still on Study|18|||
148852191|NCT00984594|536932749|FG000|Overall Study|Lost to Follow-up|1|||
148852192|NCT00984594|536932750|FG001|Overall Study|Lost to Follow-up|0|||
148852193|NCT00984594|536932749|FG000|Overall Study|Withdrawal by Subject|0|||
148852194|NCT00984594|536932750|FG001|Overall Study|Withdrawal by Subject|1|||
148852195|NCT03823287|536932751|FG000|Overall Study|Withdrawal by Subject|25|||
148852196|NCT03823287|536932752|FG001|Overall Study|Withdrawal by Subject|17|||
148852197|NCT03823287|536932751|FG000|Overall Study|Death|13|||
148852198|NCT03823287|536932752|FG001|Overall Study|Death|7|||
148852199|NCT03823287|536932751|FG000|Overall Study|Lost to Follow-up|7|||
148852200|NCT03823287|536932752|FG001|Overall Study|Lost to Follow-up|8|||
148852201|NCT03823287|536932751|FG000|Overall Study|Adverse Event|6|||
148852202|NCT03823287|536932752|FG001|Overall Study|Adverse Event|8|||
148852203|NCT03823287|536932751|FG000|Overall Study|Physician Decision|5|||
148852204|NCT03823287|536932752|FG001|Overall Study|Physician Decision|2|||
148852205|NCT03823287|536932751|FG000|Overall Study|Lack of Efficacy|2|||
148852206|NCT03823287|536932752|FG001|Overall Study|Lack of Efficacy|0|||
148852207|NCT03823287|536932751|FG000|Overall Study|Other|2|||
148852208|NCT03823287|536932752|FG001|Overall Study|Other|4|||
148852209|NCT06899737|536932753|FG000|Overall Study|Lost to Follow-up|19|||
148852210|NCT06899737|536932754|FG001|Overall Study|Lost to Follow-up|7|||
148852211|NCT03110029|536932755|FG000|Overall Study|Withdrawal by Subject|1|||
148852212|NCT03110029|536932756|FG001|Overall Study|Withdrawal by Subject|1|||
148852213|NCT03281629|536932758|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
148852214|NCT03281629|536932759|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
148852215|NCT03281629|536932758|FG000|Overall Study|Death|0|||
148852216|NCT03281629|536932759|FG001|Overall Study|Death|1|||
148852217|NCT03281629|536932758|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
148852218|NCT03281629|536932759|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
148852219|NCT00334737|536932760|FG000|Hospital Phase|Death|1|||
148852220|NCT00334737|536932761|FG001|Hospital Phase|Death|2|||
148852221|NCT00334737|536932762|FG002|Hospital Phase|Death|3|||
148852222|NCT00334737|536932760|FG000|Hospital Phase|Withdrawal by Subject|0|||
149030296|NCT05550337|537587989|FG001|Overall Study|Protocol Violation|3|||
148852223|NCT00334737|536932761|FG001|Hospital Phase|Withdrawal by Subject|0|||
148852224|NCT00334737|536932762|FG002|Hospital Phase|Withdrawal by Subject|1|||
148852225|NCT00334737|536932760|FG000|Hospital Phase|Did not receive study drug|1|||
148852226|NCT00334737|536932761|FG001|Hospital Phase|Did not receive study drug|0|||
148852227|NCT00334737|536932762|FG002|Hospital Phase|Did not receive study drug|0|||
148852228|NCT00334737|536932760|FG000|Follow up Phase|Lost to Follow-up|5|||
148852229|NCT00334737|536932761|FG001|Follow up Phase|Lost to Follow-up|3|||
148852230|NCT00334737|536932762|FG002|Follow up Phase|Lost to Follow-up|6|||
148852231|NCT01456195|536934754|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
148852232|NCT01456195|536934755|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
148852233|NCT01456195|536934756|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
148852234|NCT01456195|536934754|FG000|Overall Study|Lost to Follow-up|3|||
148852235|NCT01456195|536934755|FG001|Overall Study|Lost to Follow-up|1|||
148852236|NCT01456195|536934756|FG002|Overall Study|Lost to Follow-up|3|||
148852237|NCT01456195|536934754|FG000|Overall Study|Voluntary Withdrawal|5|||
148852238|NCT01456195|536934755|FG001|Overall Study|Voluntary Withdrawal|3|||
148852239|NCT01456195|536934756|FG002|Overall Study|Voluntary Withdrawal|7|||
148852240|NCT01456195|536934754|FG000|Overall Study|Lack of Efficacy|0|||
148852241|NCT01456195|536934755|FG001|Overall Study|Lack of Efficacy|1|||
148852242|NCT01456195|536934756|FG002|Overall Study|Lack of Efficacy|0|||
148852243|NCT01456195|536934754|FG000|Overall Study|Other Reasons|2|||
148852244|NCT01456195|536934755|FG001|Overall Study|Other Reasons|1|||
148852245|NCT01456195|536934756|FG002|Overall Study|Other Reasons|3|||
148852246|NCT02908685|536934763|FG000|Part 1 OLE|Withdrawal by Subject|0|||
148852247|NCT02908685|536934764|FG001|Part 1 OLE|Withdrawal by Subject|0|||
148852248|NCT02908685|536934765|FG002|Part 1 OLE|Withdrawal by Subject|0|||
148852249|NCT02908685|536934766|FG003|Part 1 OLE|Withdrawal by Subject|0|||
148852250|NCT02908685|536934767|FG004|Part 1 OLE|Withdrawal by Subject|0|||
148852251|NCT02908685|536934768|FG005|Part 1 OLE|Withdrawal by Subject|0|||
148852252|NCT02908685|536934769|FG006|Part 1 OLE|Withdrawal by Subject|0|||
148852253|NCT02908685|536934770|FG007|Part 1 OLE|Withdrawal by Subject|0|||
148852254|NCT02908685|536934771|FG008|Part 1 OLE|Withdrawal by Subject|0|||
148852255|NCT02908685|536934772|FG009|Part 1 OLE|Withdrawal by Subject|0|||
148852256|NCT02908685|536934773|FG010|Part 1 OLE|Withdrawal by Subject|2|||
148852257|NCT02908685|536934774|FG011|Part 1 OLE|Withdrawal by Subject|1|||
148852258|NCT02908685|536934775|FG012|Part 1 OLE|Withdrawal by Subject|0|||
148852259|NCT02908685|536934776|FG013|Part 1 OLE|Withdrawal by Subject|0|||
148852260|NCT02908685|536934763|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852261|NCT02908685|536934764|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852262|NCT02908685|536934765|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852263|NCT02908685|536934766|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852264|NCT02908685|536934767|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852265|NCT02908685|536934768|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852266|NCT02908685|536934769|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852267|NCT02908685|536934770|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852268|NCT02908685|536934771|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852269|NCT02908685|536934772|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852270|NCT02908685|536934773|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852271|NCT02908685|536934774|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
148852272|NCT02908685|536934775|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
148852273|NCT02908685|536934776|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
148852274|NCT02908685|536934763|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852275|NCT02908685|536934764|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852276|NCT02908685|536934765|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852277|NCT02908685|536934766|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852278|NCT02908685|536934767|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852279|NCT02908685|536934768|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852280|NCT02908685|536934769|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852281|NCT02908685|536934770|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852282|NCT02908685|536934771|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852283|NCT02908685|536934772|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852284|NCT02908685|536934773|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852285|NCT02908685|536934774|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852286|NCT02908685|536934775|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
148852287|NCT02908685|536934776|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
148852288|NCT02908685|536934763|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852289|NCT02908685|536934764|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852290|NCT02908685|536934765|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852291|NCT02908685|536934766|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852292|NCT02908685|536934767|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852293|NCT02908685|536934768|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852294|NCT02908685|536934769|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852295|NCT02908685|536934770|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852296|NCT02908685|536934771|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852297|NCT02908685|536934772|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852298|NCT02908685|536934773|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852299|NCT02908685|536934774|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852300|NCT02908685|536934775|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
148852301|NCT02908685|536934776|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
148852302|NCT02908685|536934763|FG000|Part 2 OLE: > Month 24|Death|0|||
148852303|NCT02908685|536934764|FG001|Part 2 OLE: > Month 24|Death|0|||
148852304|NCT02908685|536934765|FG002|Part 2 OLE: > Month 24|Death|0|||
148852305|NCT02908685|536934766|FG003|Part 2 OLE: > Month 24|Death|0|||
148852306|NCT02908685|536934767|FG004|Part 2 OLE: > Month 24|Death|0|||
148852307|NCT02908685|536934768|FG005|Part 2 OLE: > Month 24|Death|0|||
148852308|NCT02908685|536934769|FG006|Part 2 OLE: > Month 24|Death|0|||
148852309|NCT02908685|536934770|FG007|Part 2 OLE: > Month 24|Death|0|||
148852310|NCT02908685|536934771|FG008|Part 2 OLE: > Month 24|Death|0|||
148852311|NCT02908685|536934772|FG009|Part 2 OLE: > Month 24|Death|0|||
148852312|NCT02908685|536934773|FG010|Part 2 OLE: > Month 24|Death|0|||
148852313|NCT02908685|536934774|FG011|Part 2 OLE: > Month 24|Death|0|||
148852314|NCT02908685|536934775|FG012|Part 2 OLE: > Month 24|Death|1|||
148852315|NCT02908685|536934776|FG013|Part 2 OLE: > Month 24|Death|0|||
148852316|NCT02908685|536934763|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
148852317|NCT02908685|536934764|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
148852318|NCT02908685|536934765|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
148852319|NCT02908685|536934766|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
148852320|NCT02908685|536934767|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
148852321|NCT02908685|536934768|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
148852322|NCT02908685|536934769|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
148852323|NCT02908685|536934770|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
148852324|NCT02908685|536934771|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
148852325|NCT02908685|536934772|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
148852326|NCT02908685|536934773|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
148852327|NCT02908685|536934774|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
148852328|NCT02908685|536934775|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
148852329|NCT02908685|536934776|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
148852330|NCT02908685|536934763|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852331|NCT02908685|536934764|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852332|NCT02908685|536934765|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852333|NCT02908685|536934766|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852334|NCT02908685|536934767|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852335|NCT02908685|536934768|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852336|NCT02908685|536934769|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852337|NCT02908685|536934770|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852338|NCT02908685|536934771|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852339|NCT02908685|536934772|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852340|NCT02908685|536934773|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852341|NCT02908685|536934774|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
148852342|NCT02908685|536934775|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
148852343|NCT02908685|536934776|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
148852344|NCT02954406|536934777|FG000|Overall Study|Adverse Event|0|||
148852345|NCT02954406|536934778|FG001|Overall Study|Adverse Event|1|||
148852346|NCT02954406|536934779|FG002|Overall Study|Adverse Event|0|||
148852347|NCT02954406|536934780|FG003|Overall Study|Adverse Event|0|||
148852348|NCT02954406|536934781|FG004|Overall Study|Adverse Event|1|||
148852349|NCT02954406|536934782|FG005|Overall Study|Adverse Event|0|||
148852350|NCT02954406|536934783|FG006|Overall Study|Adverse Event|0|||
148852351|NCT02954406|536934784|FG007|Overall Study|Adverse Event|0|||
148852352|NCT02954406|536934785|FG008|Overall Study|Adverse Event|1|||
148852353|NCT02954406|536934786|FG009|Overall Study|Adverse Event|1|||
148852354|NCT02954406|536934787|FG010|Overall Study|Adverse Event|0|||
148852355|NCT02954406|536934777|FG000|Overall Study|Progressive Disease|3|||
148852356|NCT02954406|536934778|FG001|Overall Study|Progressive Disease|4|||
148852357|NCT02954406|536934779|FG002|Overall Study|Progressive Disease|3|||
148852358|NCT02954406|536934780|FG003|Overall Study|Progressive Disease|4|||
148852359|NCT02954406|536934781|FG004|Overall Study|Progressive Disease|3|||
148852360|NCT02954406|536934782|FG005|Overall Study|Progressive Disease|3|||
148852361|NCT02954406|536934783|FG006|Overall Study|Progressive Disease|2|||
148852362|NCT02954406|536934784|FG007|Overall Study|Progressive Disease|2|||
148852363|NCT02954406|536934785|FG008|Overall Study|Progressive Disease|1|||
148852364|NCT02954406|536934786|FG009|Overall Study|Progressive Disease|1|||
148852365|NCT02954406|536934787|FG010|Overall Study|Progressive Disease|0|||
148852366|NCT02954406|536934777|FG000|Overall Study|Symptomatic Deterioration|0|||
148852367|NCT02954406|536934778|FG001|Overall Study|Symptomatic Deterioration|1|||
148852368|NCT02954406|536934779|FG002|Overall Study|Symptomatic Deterioration|0|||
148852369|NCT02954406|536934780|FG003|Overall Study|Symptomatic Deterioration|0|||
148852370|NCT02954406|536934781|FG004|Overall Study|Symptomatic Deterioration|0|||
148852371|NCT02954406|536934782|FG005|Overall Study|Symptomatic Deterioration|0|||
148852372|NCT02954406|536934783|FG006|Overall Study|Symptomatic Deterioration|0|||
148852373|NCT02954406|536934784|FG007|Overall Study|Symptomatic Deterioration|0|||
148852374|NCT02954406|536934785|FG008|Overall Study|Symptomatic Deterioration|0|||
148852375|NCT02954406|536934786|FG009|Overall Study|Symptomatic Deterioration|0|||
148852376|NCT02954406|536934787|FG010|Overall Study|Symptomatic Deterioration|0|||
148852377|NCT02954406|536934777|FG000|Overall Study|Death|0|||
148852378|NCT02954406|536934778|FG001|Overall Study|Death|0|||
148852379|NCT02954406|536934779|FG002|Overall Study|Death|0|||
148852380|NCT02954406|536934780|FG003|Overall Study|Death|0|||
148852381|NCT02954406|536934781|FG004|Overall Study|Death|1|||
148852382|NCT02954406|536934782|FG005|Overall Study|Death|0|||
148852383|NCT02954406|536934783|FG006|Overall Study|Death|0|||
148852384|NCT02954406|536934784|FG007|Overall Study|Death|0|||
148852385|NCT02954406|536934785|FG008|Overall Study|Death|1|||
148852386|NCT02954406|536934786|FG009|Overall Study|Death|1|||
148852387|NCT02954406|536934787|FG010|Overall Study|Death|0|||
148852388|NCT02954406|536934777|FG000|Overall Study|Reason Not Specified|0|||
148852389|NCT02954406|536934778|FG001|Overall Study|Reason Not Specified|0|||
148852390|NCT02954406|536934779|FG002|Overall Study|Reason Not Specified|3|||
148852391|NCT02954406|536934780|FG003|Overall Study|Reason Not Specified|2|||
148852392|NCT02954406|536934781|FG004|Overall Study|Reason Not Specified|2|||
148852393|NCT02954406|536934782|FG005|Overall Study|Reason Not Specified|0|||
148852394|NCT02954406|536934783|FG006|Overall Study|Reason Not Specified|1|||
148852395|NCT02954406|536934784|FG007|Overall Study|Reason Not Specified|0|||
148852396|NCT02954406|536934785|FG008|Overall Study|Reason Not Specified|1|||
148852397|NCT02954406|536934786|FG009|Overall Study|Reason Not Specified|0|||
148852398|NCT02954406|536934787|FG010|Overall Study|Reason Not Specified|0|||
148852399|NCT04683029|536934796|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
148852400|NCT04683029|536934797|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
148852401|NCT04683029|536934798|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
148852402|NCT04683029|536934799|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
148852403|NCT04683029|536934796|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
148852404|NCT04683029|536934797|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
148852405|NCT04683029|536934798|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
148852406|NCT04683029|536934799|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
148852407|NCT04683029|536934796|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
148852408|NCT04683029|536934797|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
148852409|NCT04683029|536934798|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
148852410|NCT04683029|536934799|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
148852411|NCT00066703|536934800|FG000|Overall Study|Adverse Event|80|||
148852412|NCT00066703|536934801|FG001|Overall Study|Adverse Event|111|||
148852413|NCT00066703|536934800|FG000|Overall Study|Death|3|||
148852414|NCT00066703|536934801|FG001|Overall Study|Death|0|||
148852415|NCT00066703|536934800|FG000|Overall Study|Lack of Efficacy|114|||
148852416|NCT00066703|536934801|FG001|Overall Study|Lack of Efficacy|69|||
148852417|NCT00066703|536934800|FG000|Overall Study|Lost to Follow-up|31|||
148852418|NCT00066703|536934801|FG001|Overall Study|Lost to Follow-up|28|||
148852419|NCT00066703|536934800|FG000|Overall Study|Withdrawal by Subject|38|||
148852420|NCT00066703|536934801|FG001|Overall Study|Withdrawal by Subject|63|||
148852421|NCT00066703|536934800|FG000|Overall Study|Treatment ongoing|346|||
148852422|NCT00066703|536934801|FG001|Overall Study|Treatment ongoing|311|||
148852423|NCT01436656|536934802|FG000|Dose Escalation|Death|1|||
148852424|NCT01436656|536934803|FG001|Dose Escalation|Death|3|||
148852425|NCT01436656|536934804|FG002|Dose Escalation|Death|1|||
148852426|NCT01436656|536934805|FG003|Dose Escalation|Death|0|||
148852427|NCT01436656|536934806|FG004|Dose Escalation|Death|2|||
148852428|NCT01436656|536934807|FG005|Dose Escalation|Death|1|||
148852429|NCT01436656|536934808|FG006|Dose Escalation|Death|1|||
148852430|NCT01436656|536934809|FG007|Dose Escalation|Death|1|||
148852431|NCT01436656|536934810|FG008|Dose Escalation|Death|1|||
148852432|NCT01436656|536934811|FG009|Dose Escalation|Death|0|||
148852433|NCT01436656|536934812|FG010|Dose Escalation|Death|0|||
148852434|NCT01436656|536934813|FG011|Dose Escalation|Death|0|||
148852435|NCT01436656|536934814|FG012|Dose Escalation|Death|0|||
148852436|NCT01436656|536934815|FG013|Dose Escalation|Death|0|||
148852437|NCT01436656|536934816|FG014|Dose Escalation|Death|0|||
148852438|NCT01436656|536934817|FG015|Dose Escalation|Death|0|||
148852439|NCT01436656|536934818|FG016|Dose Escalation|Death|0|||
148852440|NCT01436656|536934819|FG017|Dose Escalation|Death|0|||
148852441|NCT01436656|536934802|FG000|Dose Escalation|Protocol Violation|0|||
148852442|NCT01436656|536934803|FG001|Dose Escalation|Protocol Violation|0|||
148852443|NCT01436656|536934804|FG002|Dose Escalation|Protocol Violation|0|||
148852444|NCT01436656|536934805|FG003|Dose Escalation|Protocol Violation|0|||
148852445|NCT01436656|536934806|FG004|Dose Escalation|Protocol Violation|0|||
148852446|NCT01436656|536934807|FG005|Dose Escalation|Protocol Violation|1|||
148852447|NCT01436656|536934808|FG006|Dose Escalation|Protocol Violation|0|||
148852448|NCT01436656|536934809|FG007|Dose Escalation|Protocol Violation|0|||
148852449|NCT01436656|536934810|FG008|Dose Escalation|Protocol Violation|0|||
148852450|NCT01436656|536934811|FG009|Dose Escalation|Protocol Violation|0|||
149030297|NCT05550337|537587990|FG002|Overall Study|Protocol Violation|4|||
148852451|NCT01436656|536934812|FG010|Dose Escalation|Protocol Violation|0|||
148852452|NCT01436656|536934813|FG011|Dose Escalation|Protocol Violation|0|||
148852453|NCT01436656|536934814|FG012|Dose Escalation|Protocol Violation|0|||
148852454|NCT01436656|536934815|FG013|Dose Escalation|Protocol Violation|0|||
148852455|NCT01436656|536934816|FG014|Dose Escalation|Protocol Violation|0|||
148852456|NCT01436656|536934817|FG015|Dose Escalation|Protocol Violation|0|||
148852457|NCT01436656|536934818|FG016|Dose Escalation|Protocol Violation|0|||
148852458|NCT01436656|536934819|FG017|Dose Escalation|Protocol Violation|0|||
148852459|NCT01436656|536934802|FG000|Dose Escalation|Withdrawal by Subject|0|||
148852460|NCT01436656|536934803|FG001|Dose Escalation|Withdrawal by Subject|0|||
148852461|NCT01436656|536934804|FG002|Dose Escalation|Withdrawal by Subject|0|||
148852462|NCT01436656|536934805|FG003|Dose Escalation|Withdrawal by Subject|0|||
148852463|NCT01436656|536934806|FG004|Dose Escalation|Withdrawal by Subject|1|||
148852464|NCT01436656|536934807|FG005|Dose Escalation|Withdrawal by Subject|0|||
148852465|NCT01436656|536934808|FG006|Dose Escalation|Withdrawal by Subject|0|||
148852466|NCT01436656|536934809|FG007|Dose Escalation|Withdrawal by Subject|2|||
148852467|NCT01436656|536934810|FG008|Dose Escalation|Withdrawal by Subject|0|||
148852468|NCT01436656|536934811|FG009|Dose Escalation|Withdrawal by Subject|1|||
148852469|NCT01436656|536934812|FG010|Dose Escalation|Withdrawal by Subject|1|||
148852470|NCT01436656|536934813|FG011|Dose Escalation|Withdrawal by Subject|0|||
148852471|NCT01436656|536934814|FG012|Dose Escalation|Withdrawal by Subject|0|||
148852472|NCT01436656|536934815|FG013|Dose Escalation|Withdrawal by Subject|0|||
148852473|NCT01436656|536934816|FG014|Dose Escalation|Withdrawal by Subject|0|||
148852474|NCT01436656|536934817|FG015|Dose Escalation|Withdrawal by Subject|0|||
148852475|NCT01436656|536934818|FG016|Dose Escalation|Withdrawal by Subject|0|||
148852476|NCT01436656|536934819|FG017|Dose Escalation|Withdrawal by Subject|0|||
148852477|NCT01436656|536934802|FG000|Dose Escalation|Administrative problems|0|||
148852478|NCT01436656|536934803|FG001|Dose Escalation|Administrative problems|1|||
148852479|NCT01436656|536934804|FG002|Dose Escalation|Administrative problems|0|||
148852480|NCT01436656|536934805|FG003|Dose Escalation|Administrative problems|0|||
148852481|NCT01436656|536934806|FG004|Dose Escalation|Administrative problems|0|||
148852482|NCT01436656|536934807|FG005|Dose Escalation|Administrative problems|0|||
148852483|NCT01436656|536934808|FG006|Dose Escalation|Administrative problems|0|||
148852484|NCT01436656|536934809|FG007|Dose Escalation|Administrative problems|0|||
148852485|NCT01436656|536934810|FG008|Dose Escalation|Administrative problems|0|||
148852486|NCT01436656|536934811|FG009|Dose Escalation|Administrative problems|0|||
148852487|NCT01436656|536934812|FG010|Dose Escalation|Administrative problems|0|||
148852488|NCT01436656|536934813|FG011|Dose Escalation|Administrative problems|0|||
148852489|NCT01436656|536934814|FG012|Dose Escalation|Administrative problems|0|||
148852490|NCT01436656|536934815|FG013|Dose Escalation|Administrative problems|0|||
148852491|NCT01436656|536934816|FG014|Dose Escalation|Administrative problems|0|||
148852492|NCT01436656|536934817|FG015|Dose Escalation|Administrative problems|0|||
148852493|NCT01436656|536934818|FG016|Dose Escalation|Administrative problems|0|||
148852494|NCT01436656|536934819|FG017|Dose Escalation|Administrative problems|0|||
148852495|NCT01436656|536934802|FG000|Dose Escalation|Lost to Follow-up|1|||
148852496|NCT01436656|536934803|FG001|Dose Escalation|Lost to Follow-up|0|||
148852497|NCT01436656|536934804|FG002|Dose Escalation|Lost to Follow-up|0|||
148852498|NCT01436656|536934805|FG003|Dose Escalation|Lost to Follow-up|0|||
148852499|NCT01436656|536934806|FG004|Dose Escalation|Lost to Follow-up|1|||
148852500|NCT01436656|536934807|FG005|Dose Escalation|Lost to Follow-up|0|||
148852501|NCT01436656|536934808|FG006|Dose Escalation|Lost to Follow-up|0|||
148852502|NCT01436656|536934809|FG007|Dose Escalation|Lost to Follow-up|0|||
148852503|NCT01436656|536934810|FG008|Dose Escalation|Lost to Follow-up|0|||
148852504|NCT01436656|536934811|FG009|Dose Escalation|Lost to Follow-up|0|||
148852505|NCT01436656|536934812|FG010|Dose Escalation|Lost to Follow-up|0|||
148852506|NCT01436656|536934813|FG011|Dose Escalation|Lost to Follow-up|0|||
148852507|NCT01436656|536934814|FG012|Dose Escalation|Lost to Follow-up|0|||
148852508|NCT01436656|536934815|FG013|Dose Escalation|Lost to Follow-up|0|||
148852509|NCT01436656|536934816|FG014|Dose Escalation|Lost to Follow-up|0|||
148852510|NCT01436656|536934817|FG015|Dose Escalation|Lost to Follow-up|0|||
148852511|NCT01436656|536934818|FG016|Dose Escalation|Lost to Follow-up|0|||
148852512|NCT01436656|536934819|FG017|Dose Escalation|Lost to Follow-up|0|||
148852513|NCT01436656|536934802|FG000|Dose Escalation|New anti-cancer therapy|1|||
148852514|NCT01436656|536934803|FG001|Dose Escalation|New anti-cancer therapy|0|||
148852515|NCT01436656|536934804|FG002|Dose Escalation|New anti-cancer therapy|0|||
148852516|NCT01436656|536934805|FG003|Dose Escalation|New anti-cancer therapy|0|||
148852517|NCT01436656|536934806|FG004|Dose Escalation|New anti-cancer therapy|0|||
148852518|NCT01436656|536934807|FG005|Dose Escalation|New anti-cancer therapy|0|||
148852519|NCT01436656|536934808|FG006|Dose Escalation|New anti-cancer therapy|0|||
148852520|NCT01436656|536934809|FG007|Dose Escalation|New anti-cancer therapy|0|||
148852521|NCT01436656|536934810|FG008|Dose Escalation|New anti-cancer therapy|1|||
148852522|NCT01436656|536934811|FG009|Dose Escalation|New anti-cancer therapy|1|||
148852523|NCT01436656|536934812|FG010|Dose Escalation|New anti-cancer therapy|0|||
148852524|NCT01436656|536934813|FG011|Dose Escalation|New anti-cancer therapy|0|||
148852525|NCT01436656|536934814|FG012|Dose Escalation|New anti-cancer therapy|0|||
148852526|NCT01436656|536934815|FG013|Dose Escalation|New anti-cancer therapy|0|||
148852527|NCT01436656|536934816|FG014|Dose Escalation|New anti-cancer therapy|0|||
149030298|NCT05550337|537587988|FG000|Overall Study|Physician Decision|2|||
148852528|NCT01436656|536934817|FG015|Dose Escalation|New anti-cancer therapy|0|||
148852529|NCT01436656|536934818|FG016|Dose Escalation|New anti-cancer therapy|0|||
148852530|NCT01436656|536934819|FG017|Dose Escalation|New anti-cancer therapy|0|||
148852531|NCT01436656|536934802|FG000|Dose Expansion|Adverse Event|0|||
148852532|NCT01436656|536934803|FG001|Dose Expansion|Adverse Event|0|||
148852533|NCT01436656|536934804|FG002|Dose Expansion|Adverse Event|0|||
148852534|NCT01436656|536934805|FG003|Dose Expansion|Adverse Event|0|||
148852535|NCT01436656|536934806|FG004|Dose Expansion|Adverse Event|0|||
148852536|NCT01436656|536934807|FG005|Dose Expansion|Adverse Event|0|||
148852537|NCT01436656|536934808|FG006|Dose Expansion|Adverse Event|0|||
148852538|NCT01436656|536934809|FG007|Dose Expansion|Adverse Event|0|||
148852539|NCT01436656|536934810|FG008|Dose Expansion|Adverse Event|0|||
148852540|NCT01436656|536934811|FG009|Dose Expansion|Adverse Event|0|||
148852541|NCT01436656|536934812|FG010|Dose Expansion|Adverse Event|0|||
148852542|NCT01436656|536934813|FG011|Dose Expansion|Adverse Event|1|||
148852543|NCT01436656|536934814|FG012|Dose Expansion|Adverse Event|0|||
148852544|NCT01436656|536934815|FG013|Dose Expansion|Adverse Event|0|||
148852545|NCT01436656|536934816|FG014|Dose Expansion|Adverse Event|0|||
148852546|NCT01436656|536934817|FG015|Dose Expansion|Adverse Event|0|||
148852547|NCT01436656|536934818|FG016|Dose Expansion|Adverse Event|0|||
148852548|NCT01436656|536934819|FG017|Dose Expansion|Adverse Event|0|||
148852549|NCT01436656|536934802|FG000|Dose Expansion|Withdrawal by Subject|0|||
148852550|NCT01436656|536934803|FG001|Dose Expansion|Withdrawal by Subject|0|||
148852551|NCT01436656|536934804|FG002|Dose Expansion|Withdrawal by Subject|0|||
148852552|NCT01436656|536934805|FG003|Dose Expansion|Withdrawal by Subject|0|||
148852553|NCT01436656|536934806|FG004|Dose Expansion|Withdrawal by Subject|0|||
148852554|NCT01436656|536934807|FG005|Dose Expansion|Withdrawal by Subject|0|||
148852555|NCT01436656|536934808|FG006|Dose Expansion|Withdrawal by Subject|0|||
148852556|NCT01436656|536934809|FG007|Dose Expansion|Withdrawal by Subject|0|||
148852557|NCT01436656|536934810|FG008|Dose Expansion|Withdrawal by Subject|0|||
148852558|NCT01436656|536934811|FG009|Dose Expansion|Withdrawal by Subject|0|||
148852559|NCT01436656|536934812|FG010|Dose Expansion|Withdrawal by Subject|0|||
148852560|NCT01436656|536934813|FG011|Dose Expansion|Withdrawal by Subject|1|||
148852561|NCT01436656|536934814|FG012|Dose Expansion|Withdrawal by Subject|3|||
148852562|NCT01436656|536934815|FG013|Dose Expansion|Withdrawal by Subject|1|||
148852563|NCT01436656|536934816|FG014|Dose Expansion|Withdrawal by Subject|2|||
148852564|NCT01436656|536934817|FG015|Dose Expansion|Withdrawal by Subject|0|||
148852565|NCT01436656|536934818|FG016|Dose Expansion|Withdrawal by Subject|1|||
148852566|NCT01436656|536934819|FG017|Dose Expansion|Withdrawal by Subject|1|||
148852567|NCT01436656|536934802|FG000|Dose Expansion|Death|0|||
148852568|NCT01436656|536934803|FG001|Dose Expansion|Death|0|||
148852569|NCT01436656|536934804|FG002|Dose Expansion|Death|0|||
148852570|NCT01436656|536934805|FG003|Dose Expansion|Death|0|||
148852571|NCT01436656|536934806|FG004|Dose Expansion|Death|0|||
148852572|NCT01436656|536934807|FG005|Dose Expansion|Death|0|||
148852573|NCT01436656|536934808|FG006|Dose Expansion|Death|0|||
148852574|NCT01436656|536934809|FG007|Dose Expansion|Death|0|||
148852575|NCT01436656|536934810|FG008|Dose Expansion|Death|0|||
148852576|NCT01436656|536934811|FG009|Dose Expansion|Death|0|||
148852577|NCT01436656|536934812|FG010|Dose Expansion|Death|0|||
148852578|NCT01436656|536934813|FG011|Dose Expansion|Death|0|||
148852579|NCT01436656|536934814|FG012|Dose Expansion|Death|1|||
148852580|NCT01436656|536934815|FG013|Dose Expansion|Death|0|||
148852581|NCT01436656|536934816|FG014|Dose Expansion|Death|3|||
148852582|NCT01436656|536934817|FG015|Dose Expansion|Death|0|||
148852583|NCT01436656|536934818|FG016|Dose Expansion|Death|3|||
148852584|NCT01436656|536934819|FG017|Dose Expansion|Death|3|||
148852585|NCT01436656|536934802|FG000|Dose Expansion|Lost to Follow-up|0|||
148852586|NCT01436656|536934803|FG001|Dose Expansion|Lost to Follow-up|0|||
148852587|NCT01436656|536934804|FG002|Dose Expansion|Lost to Follow-up|0|||
148852588|NCT01436656|536934805|FG003|Dose Expansion|Lost to Follow-up|0|||
148852589|NCT01436656|536934806|FG004|Dose Expansion|Lost to Follow-up|0|||
148852590|NCT01436656|536934807|FG005|Dose Expansion|Lost to Follow-up|0|||
148852591|NCT01436656|536934808|FG006|Dose Expansion|Lost to Follow-up|0|||
148852592|NCT01436656|536934809|FG007|Dose Expansion|Lost to Follow-up|0|||
148852593|NCT01436656|536934810|FG008|Dose Expansion|Lost to Follow-up|0|||
149030299|NCT05550337|537587989|FG001|Overall Study|Physician Decision|1|||
149030300|NCT05550337|537587990|FG002|Overall Study|Physician Decision|1|||
149030301|NCT05550337|537587988|FG000|Overall Study|Lost to Follow-up|16|||
148852594|NCT01436656|536934811|FG009|Dose Expansion|Lost to Follow-up|0|||
148852595|NCT01436656|536934812|FG010|Dose Expansion|Lost to Follow-up|0|||
148852596|NCT01436656|536934813|FG011|Dose Expansion|Lost to Follow-up|0|||
148852597|NCT01436656|536934814|FG012|Dose Expansion|Lost to Follow-up|0|||
148852598|NCT01436656|536934815|FG013|Dose Expansion|Lost to Follow-up|0|||
148852599|NCT01436656|536934816|FG014|Dose Expansion|Lost to Follow-up|0|||
148852600|NCT01436656|536934817|FG015|Dose Expansion|Lost to Follow-up|0|||
148852601|NCT01436656|536934818|FG016|Dose Expansion|Lost to Follow-up|0|||
148852602|NCT01436656|536934819|FG017|Dose Expansion|Lost to Follow-up|3|||
148852603|NCT01436656|536934802|FG000|Dose Expansion|Disease progression|0|||
148852604|NCT01436656|536934803|FG001|Dose Expansion|Disease progression|0|||
148852605|NCT01436656|536934804|FG002|Dose Expansion|Disease progression|0|||
148852606|NCT01436656|536934805|FG003|Dose Expansion|Disease progression|0|||
148852607|NCT01436656|536934806|FG004|Dose Expansion|Disease progression|0|||
148852608|NCT01436656|536934807|FG005|Dose Expansion|Disease progression|0|||
148852609|NCT01436656|536934808|FG006|Dose Expansion|Disease progression|0|||
148852610|NCT01436656|536934809|FG007|Dose Expansion|Disease progression|0|||
148852611|NCT01436656|536934810|FG008|Dose Expansion|Disease progression|0|||
148852612|NCT01436656|536934811|FG009|Dose Expansion|Disease progression|0|||
148852613|NCT01436656|536934812|FG010|Dose Expansion|Disease progression|0|||
148852614|NCT01436656|536934813|FG011|Dose Expansion|Disease progression|3|||
148852615|NCT01436656|536934814|FG012|Dose Expansion|Disease progression|1|||
148852616|NCT01436656|536934815|FG013|Dose Expansion|Disease progression|0|||
148852617|NCT01436656|536934816|FG014|Dose Expansion|Disease progression|1|||
148852618|NCT01436656|536934817|FG015|Dose Expansion|Disease progression|0|||
148852619|NCT01436656|536934818|FG016|Dose Expansion|Disease progression|0|||
148852620|NCT01436656|536934819|FG017|Dose Expansion|Disease progression|1|||
148852621|NCT01436656|536934802|FG000|Dose Expansion|New cancer therapy|0|||
148852622|NCT01436656|536934803|FG001|Dose Expansion|New cancer therapy|0|||
148852623|NCT01436656|536934804|FG002|Dose Expansion|New cancer therapy|0|||
148852624|NCT01436656|536934805|FG003|Dose Expansion|New cancer therapy|0|||
148852625|NCT01436656|536934806|FG004|Dose Expansion|New cancer therapy|0|||
148852626|NCT01436656|536934807|FG005|Dose Expansion|New cancer therapy|0|||
148852627|NCT01436656|536934808|FG006|Dose Expansion|New cancer therapy|0|||
148852628|NCT01436656|536934809|FG007|Dose Expansion|New cancer therapy|0|||
148852629|NCT01436656|536934810|FG008|Dose Expansion|New cancer therapy|0|||
148852630|NCT01436656|536934811|FG009|Dose Expansion|New cancer therapy|0|||
148852631|NCT01436656|536934812|FG010|Dose Expansion|New cancer therapy|0|||
148852632|NCT01436656|536934813|FG011|Dose Expansion|New cancer therapy|1|||
148852633|NCT01436656|536934814|FG012|Dose Expansion|New cancer therapy|1|||
148852634|NCT01436656|536934815|FG013|Dose Expansion|New cancer therapy|0|||
148852635|NCT01436656|536934816|FG014|Dose Expansion|New cancer therapy|2|||
148852636|NCT01436656|536934817|FG015|Dose Expansion|New cancer therapy|0|||
148852637|NCT01436656|536934818|FG016|Dose Expansion|New cancer therapy|0|||
148852638|NCT01436656|536934819|FG017|Dose Expansion|New cancer therapy|0|||
148852639|NCT02003638|536934822|FG000|Overall Study|Withdrawal by Subject|1|||
148852640|NCT02003638|536934823|FG001|Overall Study|Withdrawal by Subject|0|||
148852641|NCT00654745|536934826|FG000|Overall Study|Adverse Event|12|||
148852642|NCT00654745|536934826|FG000|Overall Study|Lost to Follow-up|7|||
148852643|NCT00654745|536934826|FG000|Overall Study|Protocol Violation|11|||
148852644|NCT00654745|536934826|FG000|Overall Study|Withdrawal by Subject|10|||
148852645|NCT00654745|536934826|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
148852646|NCT01977729|536934828|FG000|Overall Study|Study terminated|1|||
148852647|NCT03286543|536934829|FG000|Consented|Screen failure before randomization|2|||
148852648|NCT03286543|536934830|FG001|Consented|Screen failure before randomization|0|||
148852649|NCT03286543|536934831|FG002|Consented|Screen failure before randomization|0|||
148852650|NCT03286543|536934829|FG000|Consented|Screen failure before enrollment|4|||
148852651|NCT03286543|536934830|FG001|Consented|Screen failure before enrollment|0|||
148852652|NCT03286543|536934831|FG002|Consented|Screen failure before enrollment|0|||
148852653|NCT03286543|536934829|FG000|Consented|TKA cancelled after enrollment|1|||
148852654|NCT03286543|536934830|FG001|Consented|TKA cancelled after enrollment|0|||
148852655|NCT03286543|536934831|FG002|Consented|TKA cancelled after enrollment|0|||
148986768|NCT02252211|537430547|FG001|Overall Study|Withdrawal by Subject|0|||
148986769|NCT02252211|537430548|FG002|Overall Study|Withdrawal by Subject|0|||
148986770|NCT02252211|537430546|FG000|Overall Study|Serious Adverse Event During Screening|1|||
148986771|NCT02252211|537430547|FG001|Overall Study|Serious Adverse Event During Screening|0|||
148986772|NCT02252211|537430548|FG002|Overall Study|Serious Adverse Event During Screening|1|||
148986773|NCT00968669|537430550|FG000|Overall Study|Lost to Follow-up|5|||
148986774|NCT00968669|537430551|FG001|Overall Study|Lost to Follow-up|2|||
148986775|NCT00968669|537430552|FG002|Overall Study|Lost to Follow-up|1|||
148986776|NCT00968669|537430553|FG003|Overall Study|Lost to Follow-up|4|||
148986777|NCT00968669|537430550|FG000|Overall Study|Withdrawal by Subject|9|||
148986778|NCT00968669|537430551|FG001|Overall Study|Withdrawal by Subject|7|||
148986779|NCT00968669|537430552|FG002|Overall Study|Withdrawal by Subject|5|||
148986780|NCT00968669|537430553|FG003|Overall Study|Withdrawal by Subject|3|||
148986781|NCT00968669|537430550|FG000|Overall Study|Pregnancy|0|||
148986782|NCT00968669|537430551|FG001|Overall Study|Pregnancy|0|||
148986783|NCT00968669|537430552|FG002|Overall Study|Pregnancy|2|||
148986784|NCT00968669|537430553|FG003|Overall Study|Pregnancy|0|||
148986785|NCT00968669|537430550|FG000|Overall Study|AE|1|||
148852656|NCT03286543|536934829|FG000|Consented|Withdrawn from study|12|||
148852657|NCT03286543|536934830|FG001|Consented|Withdrawn from study|0|||
148852658|NCT03286543|536934831|FG002|Consented|Withdrawn from study|0|||
148852659|NCT03286543|536934829|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
148852660|NCT03286543|536934830|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
148852661|NCT03286543|536934831|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
148852662|NCT03286543|536934829|FG000|Study Enrollment|Withdrawn from study|0|||
148852663|NCT03286543|536934830|FG001|Study Enrollment|Withdrawn from study|6|||
148852664|NCT03286543|536934831|FG002|Study Enrollment|Withdrawn from study|6|||
148852665|NCT05332392|536934832|FG000|Overall Study|Did not meet inclusion criteria|25|||
148852666|NCT05332392|536934832|FG000|Overall Study|Principal Investigator's decision|17|||
148852667|NCT05332392|536934832|FG000|Overall Study|Adverse Event|1|||
148986786|NCT00968669|537430551|FG001|Overall Study|AE|0|||
148986787|NCT00968669|537430552|FG002|Overall Study|AE|0|||
148986788|NCT00968669|537430553|FG003|Overall Study|AE|0|||
149030302|NCT05550337|537587989|FG001|Overall Study|Lost to Follow-up|11|||
148852668|NCT05332392|536934832|FG000|Overall Study|Subject's decision|1|||
148852669|NCT03636893|536934833|FG000|Overall Study|Death|0|||
148852670|NCT03636893|536934834|FG001|Overall Study|Death|1|||
148852671|NCT03636893|536934833|FG000|Overall Study|Protocol Violation|0|||
148852672|NCT03636893|536934834|FG001|Overall Study|Protocol Violation|3|||
148852673|NCT03636893|536934833|FG000|Overall Study|Withdrawal by Subject|1|||
148852674|NCT03636893|536934834|FG001|Overall Study|Withdrawal by Subject|2|||
148852675|NCT03636893|536934833|FG000|Overall Study|Refusal to surgery|4|||
148852676|NCT03636893|536934834|FG001|Overall Study|Refusal to surgery|3|||
148852677|NCT03636893|536934833|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
148852678|NCT03636893|536934834|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
148852679|NCT03636893|536934833|FG000|Overall Study|Adverse Event|1|||
148852680|NCT03636893|536934834|FG001|Overall Study|Adverse Event|1|||
148852681|NCT00438360|536934835|FG000|Overall Study|Adverse Event|6|||
148852682|NCT00438360|536934836|FG001|Overall Study|Adverse Event|1|||
148852683|NCT00438360|536934835|FG000|Overall Study|Lack of Efficacy|42|||
148852684|NCT00438360|536934836|FG001|Overall Study|Lack of Efficacy|27|||
148852685|NCT00438360|536934835|FG000|Overall Study|Other|24|||
148852686|NCT00438360|536934836|FG001|Overall Study|Other|15|||
148852687|NCT00758069|536934837|FG000|Overall Study|Lack of Efficacy|0|||
148852688|NCT00758069|536934838|FG001|Overall Study|Lack of Efficacy|0|||
148852689|NCT00758069|536934839|FG002|Overall Study|Lack of Efficacy|1|||
148852690|NCT00758069|536934837|FG000|Overall Study|Incorrect Study Drug|1|||
148852691|NCT00758069|536934838|FG001|Overall Study|Incorrect Study Drug|0|||
148852692|NCT00758069|536934839|FG002|Overall Study|Incorrect Study Drug|0|||
148852693|NCT04560816|536934840|FG000|Overall Study|Withdrawal by Subject|1|||
148852694|NCT04560816|536934841|FG001|Overall Study|Withdrawal by Subject|1|||
148852695|NCT04560816|536934842|FG002|Overall Study|Withdrawal by Subject|1|||
148852696|NCT04560816|536934843|FG003|Overall Study|Withdrawal by Subject|0|||
148852697|NCT04560816|536934844|FG004|Overall Study|Withdrawal by Subject|3|||
148852698|NCT04560816|536934845|FG005|Overall Study|Withdrawal by Subject|0|||
148852699|NCT04560816|536934840|FG000|Overall Study|Lost to Follow-up|1|||
148852700|NCT04560816|536934841|FG001|Overall Study|Lost to Follow-up|0|||
148852701|NCT04560816|536934842|FG002|Overall Study|Lost to Follow-up|0|||
148852702|NCT04560816|536934843|FG003|Overall Study|Lost to Follow-up|0|||
148852703|NCT04560816|536934844|FG004|Overall Study|Lost to Follow-up|0|||
148852704|NCT04560816|536934845|FG005|Overall Study|Lost to Follow-up|0|||
148852705|NCT04560816|536934840|FG000|Overall Study|Protocol Violation|1|||
148852706|NCT04560816|536934841|FG001|Overall Study|Protocol Violation|0|||
148852707|NCT04560816|536934842|FG002|Overall Study|Protocol Violation|0|||
148852708|NCT04560816|536934843|FG003|Overall Study|Protocol Violation|0|||
148852709|NCT04560816|536934844|FG004|Overall Study|Protocol Violation|0|||
148852710|NCT04560816|536934845|FG005|Overall Study|Protocol Violation|0|||
148852711|NCT02277691|536934846|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
148852712|NCT02277691|536934846|FG000|Overall Study|Voluntary Withdrawal|7|||
148852713|NCT02277691|536934846|FG000|Overall Study|Lack of Efficacy|5|||
148852714|NCT02277691|536934846|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
148852715|NCT03818607|536934847|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
148852716|NCT03818607|536934848|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
148852717|NCT03818607|536934847|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
148852718|NCT03818607|536934848|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
148852719|NCT03818607|536934847|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
148852720|NCT03818607|536934848|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
148852721|NCT01147250|536934849|FG000|Overall Study|Lost to Follow-up|14|||
148852722|NCT01147250|536934850|FG001|Overall Study|Lost to Follow-up|11|||
148852723|NCT01147250|536934849|FG000|Overall Study|Withdrawal by Subject|83|||
148852724|NCT01147250|536934850|FG001|Overall Study|Withdrawal by Subject|88|||
148852725|NCT01147250|536934849|FG000|Overall Study|Site termination by sponsor|13|||
148852726|NCT01147250|536934850|FG001|Overall Study|Site termination by sponsor|5|||
148852727|NCT01147250|536934849|FG000|Overall Study|Other than specified|0|||
148986789|NCT00968669|537430550|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
148986790|NCT00968669|537430551|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
148852728|NCT01147250|536934850|FG001|Overall Study|Other than specified|1|||
148852729|NCT02684617|536934851|FG000|Overall Study|Adverse Event|1|||
148852730|NCT02684617|536934852|FG001|Overall Study|Adverse Event|0|||
148852731|NCT02684617|536934853|FG002|Overall Study|Adverse Event|1|||
148852732|NCT02684617|536934851|FG000|Overall Study|Death|8|||
148852733|NCT02684617|536934852|FG001|Overall Study|Death|16|||
148852734|NCT02684617|536934853|FG002|Overall Study|Death|28|||
148852735|NCT02684617|536934851|FG000|Overall Study|Withdrawal by Subject|2|||
148852736|NCT02684617|536934852|FG001|Overall Study|Withdrawal by Subject|0|||
148852737|NCT02684617|536934853|FG002|Overall Study|Withdrawal by Subject|4|||
148852738|NCT02684617|536934851|FG000|Overall Study|Screen Failure|1|||
148852739|NCT02684617|536934852|FG001|Overall Study|Screen Failure|0|||
148852740|NCT02684617|536934853|FG002|Overall Study|Screen Failure|2|||
148852741|NCT02684617|536934851|FG000|Overall Study|Study Terminated by Sponsor|6|||
148852742|NCT02684617|536934852|FG001|Overall Study|Study Terminated by Sponsor|1|||
148852743|NCT02684617|536934853|FG002|Overall Study|Study Terminated by Sponsor|5|||
148852744|NCT04952597|536934854|FG000|Overall Study|Death|12|||
148852745|NCT04952597|536934855|FG001|Overall Study|Death|13|||
148852746|NCT04952597|536934856|FG002|Overall Study|Death|14|||
148852747|NCT04952597|536934854|FG000|Overall Study|Withdrawal by Subject|1|||
148852748|NCT04952597|536934855|FG001|Overall Study|Withdrawal by Subject|0|||
148852749|NCT04952597|536934856|FG002|Overall Study|Withdrawal by Subject|3|||
148852750|NCT04952597|536934854|FG000|Overall Study|Lost to Follow-up|0|||
148852751|NCT04952597|536934855|FG001|Overall Study|Lost to Follow-up|1|||
148852752|NCT04952597|536934856|FG002|Overall Study|Lost to Follow-up|1|||
148852753|NCT03249909|536934857|FG000|Overall Study|Withdrawal by Subject|3|||
148852754|NCT03249909|536934858|FG001|Overall Study|Withdrawal by Subject|0|||
148852755|NCT03249909|536934859|FG002|Overall Study|Withdrawal by Subject|0|||
148852756|NCT03249909|536934857|FG000|Overall Study|Adverse Event|3|||
148852757|NCT03249909|536934858|FG001|Overall Study|Adverse Event|0|||
148852758|NCT03249909|536934859|FG002|Overall Study|Adverse Event|0|||
148852759|NCT03249909|536934857|FG000|Overall Study|Lost to Follow-up|0|||
148852760|NCT03249909|536934858|FG001|Overall Study|Lost to Follow-up|1|||
148852761|NCT03249909|536934859|FG002|Overall Study|Lost to Follow-up|0|||
148852762|NCT00606034|536934860|FG000|Overall Study|incarceration|1|||
148852763|NCT05286658|536934862|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
148852764|NCT05286658|536934862|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
148852765|NCT00615719|536934863|FG000|Overall Study|Physician Decision|5|||
148852766|NCT00842153|536934866|FG000|Overall Study|Adverse Event|0|||
148852767|NCT00842153|536934867|FG001|Overall Study|Adverse Event|1|||
148852768|NCT00842153|536934866|FG000|Overall Study|Lost to Follow-up|1|||
148852769|NCT00842153|536934867|FG001|Overall Study|Lost to Follow-up|2|||
148852770|NCT00935493|536934869|FG000|Overall Study|Lost to Follow-up|1|||
148852771|NCT00935493|536934870|FG001|Overall Study|Lost to Follow-up|1|||
148852772|NCT00935493|536934871|FG002|Overall Study|Lost to Follow-up|1|||
148852773|NCT00935493|536934869|FG000|Overall Study|Treatment Discontinued|0|||
148852774|NCT00935493|536934870|FG001|Overall Study|Treatment Discontinued|1|||
148852775|NCT00935493|536934871|FG002|Overall Study|Treatment Discontinued|0|||
148852776|NCT01355679|536934874|FG000|Overall Study|benign tumor types found at biopsy|2|||
148852777|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
148852778|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
148852779|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
148852780|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
148852781|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Death|58|||
148852782|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Death|65|||
148852783|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Adverse Event|28|||
148852784|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Adverse Event|40|||
148852785|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Disease Progression|22|||
148852786|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Disease Progression|35|||
148852787|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Other|25|||
148852788|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Other|33|||
148852789|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
148852790|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
148852791|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Noncompliance|8|||
148852792|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Noncompliance|8|||
148852793|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
148852794|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
148852795|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
148852796|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
148852797|NCT00286091|536934881|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
148852798|NCT00286091|536934882|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
148852799|NCT00286091|536934881|FG000|Open-label Treatment Phase|Physician Decision|24|||
148852800|NCT00286091|536934882|FG001|Open-label Treatment Phase|Physician Decision|21|||
148852801|NCT00286091|536934881|FG000|Open-label Treatment Phase|Adverse Event|5|||
148852802|NCT00286091|536934882|FG001|Open-label Treatment Phase|Adverse Event|16|||
148852803|NCT00286091|536934881|FG000|Open-label Treatment Phase|Other|11|||
148852804|NCT00286091|536934882|FG001|Open-label Treatment Phase|Other|11|||
148852805|NCT00286091|536934881|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
148852806|NCT00286091|536934882|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
148852807|NCT00286091|536934881|FG000|Open-label Treatment Phase|Death|10|||
148852808|NCT00286091|536934882|FG001|Open-label Treatment Phase|Death|7|||
148986791|NCT00968669|537430552|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
148852809|NCT00286091|536934881|FG000|Open-label Treatment Phase|Disease Progression|9|||
148852810|NCT00286091|536934882|FG001|Open-label Treatment Phase|Disease Progression|3|||
148852811|NCT00286091|536934881|FG000|Open-label Treatment Phase|Noncompliance|3|||
148852812|NCT00286091|536934882|FG001|Open-label Treatment Phase|Noncompliance|1|||
148852813|NCT00286091|536934881|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
148852814|NCT00286091|536934882|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
148852815|NCT00286091|536934881|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
148852816|NCT00286091|536934882|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
148852817|NCT00286091|536934881|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
148852818|NCT00286091|536934882|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
148852819|NCT00335738|536934885|FG000|Overall Study|Physician Decision|6|||
148852820|NCT00335738|536934886|FG001|Overall Study|Physician Decision|0|||
148852821|NCT00335738|536934885|FG000|Overall Study|Withdrawal by Subject|2|||
148852822|NCT00335738|536934886|FG001|Overall Study|Withdrawal by Subject|0|||
148852823|NCT00335738|536934885|FG000|Overall Study|Ineligible|3|||
148852824|NCT00335738|536934886|FG001|Overall Study|Ineligible|4|||
148852825|NCT03423238|536934893|FG000|Overall Study|Lost to Follow-up|1|||
148852826|NCT03423238|536934894|FG001|Overall Study|Lost to Follow-up|0|||
148852827|NCT03423238|536934893|FG000|Overall Study|Withdrawal by Subject|1|||
148852828|NCT03423238|536934894|FG001|Overall Study|Withdrawal by Subject|0|||
148852829|NCT00506454|536934898|FG000|Overall Study|Withdrawal by Subject|1|||
148852830|NCT00506454|536934899|FG001|Overall Study|Withdrawal by Subject|1|||
148852831|NCT04470050|536934900|FG000|Double-blind Treatment Phase|Adverse Event|0|||
148852832|NCT04470050|536934901|FG001|Double-blind Treatment Phase|Adverse Event|0|||
148852833|NCT04470050|536934902|FG002|Double-blind Treatment Phase|Adverse Event|0|||
148852834|NCT04470050|536934903|FG003|Double-blind Treatment Phase|Adverse Event|1|||
148852835|NCT04470050|536934904|FG004|Double-blind Treatment Phase|Adverse Event|0|||
148852836|NCT04470050|536934905|FG005|Double-blind Treatment Phase|Adverse Event|0|||
148852837|NCT04470050|536934906|FG006|Double-blind Treatment Phase|Adverse Event|0|||
148852838|NCT04470050|536934900|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
148852839|NCT04470050|536934901|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
148852840|NCT04470050|536934902|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
148852841|NCT04470050|536934903|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
148852842|NCT04470050|536934904|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
148852843|NCT04470050|536934905|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
148852844|NCT04470050|536934906|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
148852845|NCT04470050|536934900|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
148852846|NCT04470050|536934901|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
148852847|NCT04470050|536934902|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
148852848|NCT04470050|536934903|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
148852849|NCT04470050|536934904|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
148852850|NCT04470050|536934905|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
148852851|NCT04470050|536934906|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
148852852|NCT01104545|536934907|FG000|Overall Study|Adverse Event|0|||
148852853|NCT01104545|536934908|FG001|Overall Study|Adverse Event|1|||
148852854|NCT01104545|536934909|FG002|Overall Study|Adverse Event|2|||
148852855|NCT01076205|536934912|FG000|Overall Study|Adverse Drug Reaction|299|||
148852856|NCT01076205|536934912|FG000|Overall Study|Lack of Effectiveness|1423|||
148852857|NCT01076205|536934912|FG000|Overall Study|Other Reason|1075|||
148852858|NCT01076205|536934912|FG000|Overall Study|Unknown Reason|71|||
148852859|NCT01076205|536934912|FG000|Overall Study|Lost to Follow-up|3151|||
148852860|NCT02443116|536934918|FG000|Part 1|Adverse Event|2|||
148852861|NCT02443116|536934919|FG001|Part 1|Adverse Event|3|||
148852862|NCT02443116|536934920|FG002|Part 1|Adverse Event|0|||
148852863|NCT02443116|536934921|FG003|Part 1|Adverse Event|0|||
148852864|NCT02443116|536934922|FG004|Part 1|Adverse Event|0|||
148852865|NCT02443116|536934923|FG005|Part 1|Adverse Event|0|||
148852866|NCT02443116|536934924|FG006|Part 1|Adverse Event|0|||
148852867|NCT02443116|536934925|FG007|Part 1|Adverse Event|0|||
148852868|NCT02443116|536934926|FG008|Part 1|Adverse Event|0|||
148852869|NCT02443116|536934918|FG000|Part 1|Withdrew informed consent|0|||
148852870|NCT02443116|536934919|FG001|Part 1|Withdrew informed consent|1|||
148852871|NCT02443116|536934920|FG002|Part 1|Withdrew informed consent|0|||
148852872|NCT02443116|536934921|FG003|Part 1|Withdrew informed consent|0|||
148852873|NCT02443116|536934922|FG004|Part 1|Withdrew informed consent|0|||
148852874|NCT02443116|536934923|FG005|Part 1|Withdrew informed consent|0|||
149030303|NCT05550337|537587990|FG002|Overall Study|Lost to Follow-up|11|||
149030304|NCT01836458|537587991|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
148852875|NCT02443116|536934924|FG006|Part 1|Withdrew informed consent|0|||
149030305|NCT01836458|537587992|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149030306|NCT01836458|537587993|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
149030307|NCT01836458|537587994|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
148852876|NCT02443116|536934925|FG007|Part 1|Withdrew informed consent|0|||
148852877|NCT02443116|536934926|FG008|Part 1|Withdrew informed consent|0|||
148852878|NCT02443116|536934918|FG000|Part 1|Lost to Follow-up|0|||
148852879|NCT02443116|536934919|FG001|Part 1|Lost to Follow-up|0|||
148852880|NCT02443116|536934920|FG002|Part 1|Lost to Follow-up|2|||
148852881|NCT02443116|536934921|FG003|Part 1|Lost to Follow-up|0|||
148852882|NCT02443116|536934922|FG004|Part 1|Lost to Follow-up|0|||
148852883|NCT02443116|536934923|FG005|Part 1|Lost to Follow-up|0|||
148852884|NCT02443116|536934924|FG006|Part 1|Lost to Follow-up|0|||
148852885|NCT02443116|536934925|FG007|Part 1|Lost to Follow-up|0|||
148852886|NCT02443116|536934926|FG008|Part 1|Lost to Follow-up|0|||
148852887|NCT02443116|536934918|FG000|Part 1|Participant moved out of state|0|||
148852888|NCT02443116|536934919|FG001|Part 1|Participant moved out of state|0|||
148852889|NCT02443116|536934920|FG002|Part 1|Participant moved out of state|1|||
148852890|NCT02443116|536934921|FG003|Part 1|Participant moved out of state|0|||
148852891|NCT02443116|536934922|FG004|Part 1|Participant moved out of state|0|||
148852892|NCT02443116|536934923|FG005|Part 1|Participant moved out of state|0|||
148852893|NCT02443116|536934924|FG006|Part 1|Participant moved out of state|0|||
148852894|NCT02443116|536934925|FG007|Part 1|Participant moved out of state|0|||
148852895|NCT02443116|536934926|FG008|Part 1|Participant moved out of state|0|||
148852896|NCT02443116|536934918|FG000|Part 1|Participant enrolled in another clinical trial|0|||
148852897|NCT02443116|536934919|FG001|Part 1|Participant enrolled in another clinical trial|0|||
148852898|NCT02443116|536934920|FG002|Part 1|Participant enrolled in another clinical trial|1|||
148852899|NCT02443116|536934921|FG003|Part 1|Participant enrolled in another clinical trial|0|||
148852900|NCT02443116|536934922|FG004|Part 1|Participant enrolled in another clinical trial|0|||
148852901|NCT02443116|536934923|FG005|Part 1|Participant enrolled in another clinical trial|0|||
148852902|NCT02443116|536934924|FG006|Part 1|Participant enrolled in another clinical trial|0|||
148852903|NCT02443116|536934925|FG007|Part 1|Participant enrolled in another clinical trial|0|||
148852904|NCT02443116|536934926|FG008|Part 1|Participant enrolled in another clinical trial|0|||
148852905|NCT02443116|536934918|FG000|Part 2|Adverse Event|0|||
148852906|NCT02443116|536934919|FG001|Part 2|Adverse Event|0|||
148852907|NCT02443116|536934920|FG002|Part 2|Adverse Event|0|||
148852908|NCT02443116|536934921|FG003|Part 2|Adverse Event|0|||
148852909|NCT02443116|536934922|FG004|Part 2|Adverse Event|1|||
148852910|NCT02443116|536934923|FG005|Part 2|Adverse Event|1|||
148852911|NCT02443116|536934924|FG006|Part 2|Adverse Event|2|||
148852912|NCT02443116|536934925|FG007|Part 2|Adverse Event|0|||
148852913|NCT02443116|536934926|FG008|Part 2|Adverse Event|0|||
148852914|NCT02443116|536934918|FG000|Part 2|Withdrew informed consent|0|||
148852915|NCT02443116|536934919|FG001|Part 2|Withdrew informed consent|0|||
148852916|NCT02443116|536934920|FG002|Part 2|Withdrew informed consent|0|||
148852917|NCT02443116|536934921|FG003|Part 2|Withdrew informed consent|0|||
148852918|NCT02443116|536934922|FG004|Part 2|Withdrew informed consent|0|||
148852919|NCT02443116|536934923|FG005|Part 2|Withdrew informed consent|1|||
148852920|NCT02443116|536934924|FG006|Part 2|Withdrew informed consent|1|||
148852921|NCT02443116|536934925|FG007|Part 2|Withdrew informed consent|0|||
148852922|NCT02443116|536934926|FG008|Part 2|Withdrew informed consent|0|||
148852923|NCT02443116|536934918|FG000|Part 2|Inability to comply with protocol|0|||
148852924|NCT02443116|536934919|FG001|Part 2|Inability to comply with protocol|0|||
148852925|NCT02443116|536934920|FG002|Part 2|Inability to comply with protocol|0|||
148852926|NCT02443116|536934921|FG003|Part 2|Inability to comply with protocol|1|||
148852927|NCT02443116|536934922|FG004|Part 2|Inability to comply with protocol|0|||
148852928|NCT02443116|536934923|FG005|Part 2|Inability to comply with protocol|0|||
148852929|NCT02443116|536934924|FG006|Part 2|Inability to comply with protocol|0|||
148852930|NCT02443116|536934925|FG007|Part 2|Inability to comply with protocol|0|||
148852931|NCT02443116|536934926|FG008|Part 2|Inability to comply with protocol|0|||
148852932|NCT02443116|536934918|FG000|Part 2|Lost to Follow-up|0|||
148852933|NCT02443116|536934919|FG001|Part 2|Lost to Follow-up|0|||
148852934|NCT02443116|536934920|FG002|Part 2|Lost to Follow-up|0|||
148852935|NCT02443116|536934921|FG003|Part 2|Lost to Follow-up|1|||
148852936|NCT02443116|536934922|FG004|Part 2|Lost to Follow-up|0|||
148852937|NCT02443116|536934923|FG005|Part 2|Lost to Follow-up|0|||
148852938|NCT02443116|536934924|FG006|Part 2|Lost to Follow-up|0|||
148852939|NCT02443116|536934925|FG007|Part 2|Lost to Follow-up|0|||
148852940|NCT02443116|536934926|FG008|Part 2|Lost to Follow-up|0|||
148852941|NCT02443116|536934918|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852942|NCT02443116|536934919|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852943|NCT02443116|536934920|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852944|NCT02443116|536934921|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852945|NCT02443116|536934922|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852946|NCT02443116|536934923|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
148852947|NCT02443116|536934924|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852948|NCT02443116|536934925|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852949|NCT02443116|536934926|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
148852950|NCT02443116|536934918|FG000|Part 3|Adverse Event|0|||
148852951|NCT02443116|536934919|FG001|Part 3|Adverse Event|0|||
148852952|NCT02443116|536934920|FG002|Part 3|Adverse Event|0|||
148852953|NCT02443116|536934921|FG003|Part 3|Adverse Event|0|||
148852954|NCT02443116|536934922|FG004|Part 3|Adverse Event|0|||
148852955|NCT02443116|536934923|FG005|Part 3|Adverse Event|0|||
148852956|NCT02443116|536934924|FG006|Part 3|Adverse Event|0|||
148852957|NCT02443116|536934925|FG007|Part 3|Adverse Event|0|||
148852958|NCT02443116|536934926|FG008|Part 3|Adverse Event|1|||
148852959|NCT02443116|536934918|FG000|Part 3|Withdrew informed consent|0|||
148852960|NCT02443116|536934919|FG001|Part 3|Withdrew informed consent|0|||
148852961|NCT02443116|536934920|FG002|Part 3|Withdrew informed consent|0|||
148852962|NCT02443116|536934921|FG003|Part 3|Withdrew informed consent|0|||
148852963|NCT02443116|536934922|FG004|Part 3|Withdrew informed consent|0|||
148852964|NCT02443116|536934923|FG005|Part 3|Withdrew informed consent|0|||
148852965|NCT02443116|536934924|FG006|Part 3|Withdrew informed consent|0|||
148852966|NCT02443116|536934925|FG007|Part 3|Withdrew informed consent|3|||
148852967|NCT02443116|536934926|FG008|Part 3|Withdrew informed consent|2|||
148852968|NCT02443116|536934918|FG000|Part 3|Lost to Follow-up|0|||
148852969|NCT02443116|536934919|FG001|Part 3|Lost to Follow-up|0|||
148852970|NCT02443116|536934920|FG002|Part 3|Lost to Follow-up|0|||
148852971|NCT02443116|536934921|FG003|Part 3|Lost to Follow-up|0|||
148852972|NCT02443116|536934922|FG004|Part 3|Lost to Follow-up|0|||
148852973|NCT02443116|536934923|FG005|Part 3|Lost to Follow-up|0|||
148852974|NCT02443116|536934924|FG006|Part 3|Lost to Follow-up|0|||
148852975|NCT02443116|536934925|FG007|Part 3|Lost to Follow-up|1|||
148852976|NCT02443116|536934926|FG008|Part 3|Lost to Follow-up|2|||
148852977|NCT01696981|536934927|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
148852978|NCT01696981|536934928|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
148852979|NCT01696981|536934927|FG000|Overall Study|Died Before Randomization|3|||
148852980|NCT01696981|536934928|FG001|Overall Study|Died Before Randomization|8|||
148852981|NCT01696981|536934927|FG000|Overall Study|Died Before ASU (Control)|278|||
148852982|NCT01696981|536934928|FG001|Overall Study|Died Before ASU (Control)|0|||
148852983|NCT01696981|536934927|FG000|Overall Study|Refused ASU (Control)|920|||
148852984|NCT01696981|536934928|FG001|Overall Study|Refused ASU (Control)|0|||
148852985|NCT01696981|536934927|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
148852986|NCT01696981|536934928|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
148852987|NCT03135431|536934935|FG000|Overall Study|Study Surgeon not available|2|||
148852988|NCT03135431|536934936|FG001|Overall Study|Study Surgeon not available|0|||
148852989|NCT01063062|536934937|FG000|Overall Study|Patient withdrew consent|0|||
148852990|NCT01063062|536934938|FG001|Overall Study|Patient withdrew consent|1|||
148852991|NCT01063062|536934937|FG000|Overall Study|Adverse Event|2|||
148852992|NCT01063062|536934938|FG001|Overall Study|Adverse Event|4|||
148852993|NCT01063062|536934937|FG000|Overall Study|Protocol Violation|5|||
148852994|NCT01063062|536934938|FG001|Overall Study|Protocol Violation|4|||
148852995|NCT01063062|536934937|FG000|Overall Study|Investigator's request|1|||
148852996|NCT01063062|536934938|FG001|Overall Study|Investigator's request|0|||
148852997|NCT01063062|536934937|FG000|Overall Study|Lost to Follow-up|0|||
148852998|NCT01063062|536934938|FG001|Overall Study|Lost to Follow-up|2|||
148852999|NCT01063062|536934937|FG000|Overall Study|Miscellaneous reason|0|||
148853000|NCT01063062|536934938|FG001|Overall Study|Miscellaneous reason|1|||
148853001|NCT02015481|536934939|FG000|Overall Study|Death|1|||
148853002|NCT02597452|536934940|FG000|Overall Study|testing incomplete|30|||
148853003|NCT03122145|536934943|FG000|Overall Study|Concurrent respiratory disease|3|||
148853004|NCT03122145|536934944|FG001|Overall Study|Concurrent respiratory disease|0|||
148853005|NCT01352221|536934949|FG000|Double-blind Phase|Adverse Event|6|||
148853006|NCT01352221|536934950|FG001|Double-blind Phase|Adverse Event|4|||
148853007|NCT01352221|536934951|FG002|Double-blind Phase|Adverse Event|0|||
148853008|NCT01352221|536934952|FG003|Double-blind Phase|Adverse Event|0|||
148853009|NCT01352221|536934949|FG000|Double-blind Phase|Withdrawal by Subject|3|||
148853010|NCT01352221|536934950|FG001|Double-blind Phase|Withdrawal by Subject|5|||
148853011|NCT01352221|536934951|FG002|Double-blind Phase|Withdrawal by Subject|0|||
148853012|NCT01352221|536934952|FG003|Double-blind Phase|Withdrawal by Subject|0|||
148853013|NCT01352221|536934949|FG000|Double-blind Phase|Lost to Follow-up|0|||
148853014|NCT01352221|536934950|FG001|Double-blind Phase|Lost to Follow-up|1|||
148853015|NCT01352221|536934951|FG002|Double-blind Phase|Lost to Follow-up|0|||
148853016|NCT01352221|536934952|FG003|Double-blind Phase|Lost to Follow-up|0|||
148853017|NCT01352221|536934949|FG000|Double-blind Phase|Protocol Violation|0|||
148853018|NCT01352221|536934950|FG001|Double-blind Phase|Protocol Violation|1|||
148853019|NCT01352221|536934951|FG002|Double-blind Phase|Protocol Violation|0|||
148853020|NCT01352221|536934952|FG003|Double-blind Phase|Protocol Violation|0|||
148853021|NCT01352221|536934949|FG000|Open-label Phase|Physician Decision|0|||
148853022|NCT01352221|536934950|FG001|Open-label Phase|Physician Decision|0|||
148853023|NCT01352221|536934951|FG002|Open-label Phase|Physician Decision|2|||
148853024|NCT01352221|536934952|FG003|Open-label Phase|Physician Decision|1|||
148853025|NCT01352221|536934949|FG000|Open-label Phase|Pregnancy|0|||
148853026|NCT01352221|536934950|FG001|Open-label Phase|Pregnancy|0|||
148853027|NCT01352221|536934951|FG002|Open-label Phase|Pregnancy|1|||
148853028|NCT01352221|536934952|FG003|Open-label Phase|Pregnancy|0|||
148853029|NCT01352221|536934949|FG000|Open-label Phase|Adverse Event|0|||
148853030|NCT01352221|536934950|FG001|Open-label Phase|Adverse Event|0|||
148853031|NCT01352221|536934951|FG002|Open-label Phase|Adverse Event|8|||
148853032|NCT01352221|536934952|FG003|Open-label Phase|Adverse Event|4|||
148853033|NCT01352221|536934949|FG000|Open-label Phase|Withdrawal by Subject|0|||
148853034|NCT01352221|536934950|FG001|Open-label Phase|Withdrawal by Subject|0|||
148853035|NCT01352221|536934951|FG002|Open-label Phase|Withdrawal by Subject|1|||
148853036|NCT01352221|536934952|FG003|Open-label Phase|Withdrawal by Subject|6|||
148853037|NCT01352221|536934949|FG000|Open-label Phase|Worsening of IBD|0|||
148853038|NCT01352221|536934950|FG001|Open-label Phase|Worsening of IBD|0|||
148853039|NCT01352221|536934951|FG002|Open-label Phase|Worsening of IBD|1|||
148853040|NCT01352221|536934952|FG003|Open-label Phase|Worsening of IBD|0|||
148853041|NCT00281099|536934953|FG000|Overall Study|Death|46|||
148853042|NCT00281099|536934954|FG001|Overall Study|Death|57|||
148853043|NCT00281099|536934953|FG000|Overall Study|Lost to Follow-up|10|||
148853044|NCT00281099|536934954|FG001|Overall Study|Lost to Follow-up|19|||
148853045|NCT00281099|536934953|FG000|Overall Study|Withdrawal by Subject|65|||
148853046|NCT00281099|536934954|FG001|Overall Study|Withdrawal by Subject|70|||
148853047|NCT00281099|536934953|FG000|Overall Study|Physician Decision|79|||
148853048|NCT00281099|536934954|FG001|Overall Study|Physician Decision|72|||
148853049|NCT00281099|536934953|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
148853050|NCT00281099|536934954|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
148853051|NCT03108521|536934958|FG000|Overall Study|Lost to Follow-up|3|||
148853052|NCT03108521|536934959|FG001|Overall Study|Lost to Follow-up|0|||
148853053|NCT03108521|536934958|FG000|Overall Study|Lack of Efficacy|2|||
148853054|NCT03108521|536934959|FG001|Overall Study|Lack of Efficacy|0|||
148853055|NCT03108521|536934958|FG000|Overall Study|Physician Decision|4|||
148853056|NCT03108521|536934959|FG001|Overall Study|Physician Decision|0|||
148853057|NCT03108521|536934958|FG000|Overall Study|Adverse Event|3|||
148853058|NCT03108521|536934959|FG001|Overall Study|Adverse Event|0|||
148853059|NCT00875485|536937082|FG000|Challenge Dose Epoch|Pregnancy|1|||
148853060|NCT00875485|536937083|FG001|Challenge Dose Epoch|Pregnancy|0|||
148853061|NCT01271010|536937084|FG000|Overall Study|Reason not specified|11|||
148853062|NCT01271010|536937084|FG000|Overall Study|Start of new CLL therapy|1|||
148853063|NCT01271010|536937084|FG000|Overall Study|Protocol Violation|1|||
148853064|NCT01271010|536937084|FG000|Overall Study|Death|2|||
148853065|NCT01271010|536937084|FG000|Overall Study|Progression and relapse of disease|1|||
148853066|NCT01271010|536937084|FG000|Overall Study|Withdrawal by Subject|18|||
148853067|NCT01271010|536937084|FG000|Overall Study|Disease progression|27|||
148853068|NCT01631747|536937085|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
148853069|NCT01631747|536937086|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
148853070|NCT01631747|536937085|FG000|Live Birth|Pregnancy Termination|1|||
148853071|NCT01631747|536937086|FG001|Live Birth|Pregnancy Termination|0|||
148853072|NCT01631747|536937085|FG000|Live Birth|MIscarriage|2|||
148853073|NCT01631747|536937086|FG001|Live Birth|MIscarriage|0|||
148853074|NCT01631747|536937085|FG000|Live Birth|Stillbirth|1|||
148853075|NCT01631747|536937086|FG001|Live Birth|Stillbirth|1|||
148853076|NCT01631747|536937085|FG000|One Year Infant Outcomes|Patient Refused|13|||
148853077|NCT01631747|536937086|FG001|One Year Infant Outcomes|Patient Refused|9|||
148853078|NCT02109432|536937087|FG000|Overall Study|Withdrawal by Subject|1|||
148853079|NCT01691014|536937088|FG000|Overall Study|Premature Termination|1|||
148853080|NCT01691014|536937089|FG001|Overall Study|Premature Termination|6|||
148853081|NCT01691014|536937090|FG002|Overall Study|Premature Termination|0|||
148853082|NCT01691014|536937091|FG003|Overall Study|Premature Termination|3|||
148853083|NCT01691014|536937088|FG000|Overall Study|Other|0|||
148853084|NCT01691014|536937089|FG001|Overall Study|Other|0|||
148853085|NCT01691014|536937090|FG002|Overall Study|Other|2|||
148853086|NCT01691014|536937091|FG003|Overall Study|Other|0|||
148853087|NCT01691014|536937088|FG000|Overall Study|Withdrawal by Subject|0|||
148853088|NCT01691014|536937089|FG001|Overall Study|Withdrawal by Subject|1|||
148853089|NCT01691014|536937090|FG002|Overall Study|Withdrawal by Subject|1|||
148853090|NCT01691014|536937091|FG003|Overall Study|Withdrawal by Subject|1|||
148853091|NCT01691014|536937088|FG000|Overall Study|Adverse Event|0|||
148853092|NCT01691014|536937089|FG001|Overall Study|Adverse Event|5|||
148853093|NCT01691014|536937090|FG002|Overall Study|Adverse Event|1|||
148853094|NCT01691014|536937091|FG003|Overall Study|Adverse Event|1|||
148853095|NCT01691014|536937088|FG000|Overall Study|Lack of Efficacy|2|||
148853096|NCT01691014|536937089|FG001|Overall Study|Lack of Efficacy|3|||
148853097|NCT01691014|536937090|FG002|Overall Study|Lack of Efficacy|7|||
148853098|NCT01691014|536937091|FG003|Overall Study|Lack of Efficacy|0|||
148853099|NCT03372551|536937092|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
148853100|NCT03372551|536937093|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
148853101|NCT05897242|536937094|FG000|Overall Study|Lost to Follow-up|6|||
148853102|NCT05897242|536937095|FG001|Overall Study|Lost to Follow-up|1|||
148853103|NCT05897242|536937094|FG000|Overall Study|Incomplete|1|||
148853104|NCT05897242|536937095|FG001|Overall Study|Incomplete|0|||
148853105|NCT05897242|536937094|FG000|Overall Study|Withdrawal by Subject|1|||
148853106|NCT05897242|536937095|FG001|Overall Study|Withdrawal by Subject|0|||
148853107|NCT00809835|536937096|FG000|Overall Study|Lost to Follow-up|7|||
148853108|NCT00809835|536937097|FG001|Overall Study|Lost to Follow-up|6|||
148853109|NCT00809835|536937098|FG002|Overall Study|Lost to Follow-up|10|||
148853110|NCT00809835|536937099|FG003|Overall Study|Lost to Follow-up|2|||
148853111|NCT00809835|536937096|FG000|Overall Study|Withdrawal by Subject|1|||
148853112|NCT00809835|536937097|FG001|Overall Study|Withdrawal by Subject|1|||
148853113|NCT00809835|536937098|FG002|Overall Study|Withdrawal by Subject|1|||
148853114|NCT00809835|536937099|FG003|Overall Study|Withdrawal by Subject|0|||
148853115|NCT01696968|536937100|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
148853116|NCT01696968|536937101|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
148853117|NCT01696968|536937100|FG000|Overall Study|Died Before Randomization|3|||
148853118|NCT01696968|536937101|FG001|Overall Study|Died Before Randomization|8|||
148853119|NCT01696968|536937100|FG000|Overall Study|Died Before ASU (Control)|278|||
148853120|NCT01696968|536937101|FG001|Overall Study|Died Before ASU (Control)|0|||
148853121|NCT01696968|536937100|FG000|Overall Study|Refused ASU (Control)|920|||
148853122|NCT01696968|536937101|FG001|Overall Study|Refused ASU (Control)|0|||
148853123|NCT01696968|536937100|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
148853124|NCT01696968|536937101|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
148853125|NCT03727646|536937102|FG000|Overall Study|Adverse Event|1|||
148853126|NCT03727646|536937103|FG001|Overall Study|Adverse Event|0|||
148853127|NCT04753658|536937106|FG000|Overall Study|Progressive disease|7|||
148853128|NCT04753658|536937106|FG000|Overall Study|Other|7|||
148853129|NCT04753658|536937106|FG000|Overall Study|Adverse Event|1|||
148853130|NCT05659719|536937107|FG000|Overall Study|At sponsor's request|0|||
148853131|NCT05659719|536937108|FG001|Overall Study|At sponsor's request|0|||
148853132|NCT05659719|536937109|FG002|Overall Study|At sponsor's request|0|||
148853133|NCT05659719|536937110|FG003|Overall Study|At sponsor's request|95|||
148853134|NCT05659719|536937107|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
148853135|NCT05659719|536937108|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
148853136|NCT05659719|536937109|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
148853137|NCT05659719|536937110|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
148853138|NCT05659719|536937107|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
148853139|NCT05659719|536937108|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
148853140|NCT05659719|536937109|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
148853141|NCT05659719|536937110|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
148853142|NCT05659719|536937107|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
148853143|NCT05659719|536937108|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
148853144|NCT05659719|536937109|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
148853145|NCT05659719|536937110|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
148853146|NCT05659719|536937107|FG000|Overall Study|Lost to Follow-up|0|||
148853147|NCT05659719|536937108|FG001|Overall Study|Lost to Follow-up|0|||
148853148|NCT05659719|536937109|FG002|Overall Study|Lost to Follow-up|0|||
148853149|NCT05659719|536937110|FG003|Overall Study|Lost to Follow-up|2|||
148853150|NCT05659719|536937107|FG000|Overall Study|Moved to another observational study|0|||
148853151|NCT05659719|536937108|FG001|Overall Study|Moved to another observational study|0|||
148853152|NCT05659719|536937109|FG002|Overall Study|Moved to another observational study|0|||
148853153|NCT05659719|536937110|FG003|Overall Study|Moved to another observational study|1|||
148853154|NCT05659719|536937107|FG000|Overall Study|The child was enrolled in an interventional study|0|||
148853155|NCT05659719|536937108|FG001|Overall Study|The child was enrolled in an interventional study|0|||
148853156|NCT05659719|536937109|FG002|Overall Study|The child was enrolled in an interventional study|0|||
148853157|NCT05659719|536937110|FG003|Overall Study|The child was enrolled in an interventional study|55|||
148853158|NCT05659719|536937107|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
148853159|NCT05659719|536937108|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
148853160|NCT05659719|536937109|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
148853161|NCT05659719|536937110|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
148853162|NCT05659719|536937107|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
148853163|NCT05659719|536937108|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
148853164|NCT05659719|536937109|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
148853165|NCT05659719|536937110|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
148853166|NCT05924165|536937117|FG000|Overall Study|Physician Decision|2|||
148853167|NCT05924165|536937118|FG001|Overall Study|Physician Decision|3|||
148853168|NCT01681186|536937119|FG000|Washout Period From Second Intervention|Adverse Event|0|||
148853169|NCT01681186|536937120|FG001|Washout Period From Second Intervention|Adverse Event|0|||
148853170|NCT01681186|536937121|FG002|Washout Period From Second Intervention|Adverse Event|0|||
148853171|NCT01681186|536937122|FG003|Washout Period From Second Intervention|Adverse Event|0|||
148853172|NCT01681186|536937123|FG004|Washout Period From Second Intervention|Adverse Event|0|||
148853173|NCT01681186|536937124|FG005|Washout Period From Second Intervention|Adverse Event|0|||
148853174|NCT01681186|536937125|FG006|Washout Period From Second Intervention|Adverse Event|1|||
148853175|NCT01681186|536937126|FG007|Washout Period From Second Intervention|Adverse Event|0|||
148853176|NCT01681186|536937119|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
148853177|NCT01681186|536937120|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
149030308|NCT00561574|537587995|FG000|Overall Study|Adverse Event|21|||
149030309|NCT00561574|537587996|FG001|Overall Study|Adverse Event|24|||
148889451|NCT02888106|537074411|FG005|Overall Study|Lost to Follow-up|1|||
148853178|NCT01681186|536937121|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
148853179|NCT01681186|536937122|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
148853180|NCT01681186|536937123|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
148853181|NCT01681186|536937124|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
148853182|NCT01681186|536937125|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
148853183|NCT01681186|536937126|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
148853184|NCT01681186|536937119|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853185|NCT01681186|536937120|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853186|NCT01681186|536937121|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853187|NCT01681186|536937122|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853188|NCT01681186|536937123|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853189|NCT01681186|536937124|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853190|NCT01681186|536937125|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
148853191|NCT01681186|536937126|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
148853192|NCT01681186|536937119|FG000|Fourth Intervention|Protocol Violation|0|||
148853193|NCT01681186|536937120|FG001|Fourth Intervention|Protocol Violation|0|||
148853194|NCT01681186|536937121|FG002|Fourth Intervention|Protocol Violation|0|||
148853195|NCT01681186|536937122|FG003|Fourth Intervention|Protocol Violation|0|||
148853196|NCT01681186|536937123|FG004|Fourth Intervention|Protocol Violation|0|||
148853197|NCT01681186|536937124|FG005|Fourth Intervention|Protocol Violation|0|||
148853198|NCT01681186|536937125|FG006|Fourth Intervention|Protocol Violation|0|||
148853199|NCT01681186|536937126|FG007|Fourth Intervention|Protocol Violation|1|||
148853200|NCT05160415|536937127|FG000|Overall Study|Withdrawal by Subject|3|||
148853201|NCT02582814|536937134|FG000|Overall Study|Study-specific withdrawal criteria|1|||
148853202|NCT02582814|536937135|FG001|Overall Study|Study-specific withdrawal criteria|0|||
148853203|NCT02582814|536937134|FG000|Overall Study|Withdrawal by Subject|4|||
148853204|NCT02582814|536937135|FG001|Overall Study|Withdrawal by Subject|3|||
148853205|NCT02582814|536937134|FG000|Overall Study|Adverse Event|4|||
148853206|NCT02582814|536937135|FG001|Overall Study|Adverse Event|4|||
148853207|NCT03530995|536937142|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
148853208|NCT03530995|536937143|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
148853209|NCT03530995|536937142|FG000|Part 1 Period 3|Protocol Violation|1|||
148853210|NCT03530995|536937143|FG001|Part 1 Period 3|Protocol Violation|0|||
148853211|NCT03530995|536937142|FG000|Part 1 Period 4|Physician Decision|1|||
148853212|NCT03530995|536937143|FG001|Part 1 Period 4|Physician Decision|0|||
148853213|NCT03530995|536937142|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
148853214|NCT03530995|536937143|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
148853215|NCT04308239|536937145|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
148853216|NCT04308239|536937146|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
148853217|NCT04308239|536937145|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
148853218|NCT04308239|536937146|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
148853219|NCT04308239|536937145|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
148853220|NCT04308239|536937146|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
148853221|NCT04308239|536937145|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
148853222|NCT04308239|536937146|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
148853223|NCT04848220|536937151|FG000|Overall Study|Unable to proceed to study procedure|0|||
148853224|NCT04848220|536937152|FG001|Overall Study|Unable to proceed to study procedure|1|||
148853225|NCT04848220|536937153|FG002|Overall Study|Unable to proceed to study procedure|0|||
148853226|NCT04848220|536937151|FG000|Overall Study|Fractional flow not significant|0|||
148853227|NCT04848220|536937152|FG001|Overall Study|Fractional flow not significant|1|||
148853228|NCT04848220|536937153|FG002|Overall Study|Fractional flow not significant|0|||
148853229|NCT02557100|536937164|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
148853230|NCT02557100|536937165|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
148853231|NCT02557100|536937166|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
148853232|NCT02557100|536937164|FG000|Single Blind Treatment Period|Death|0|||
148853233|NCT02557100|536937165|FG001|Single Blind Treatment Period|Death|1|||
148853234|NCT02557100|536937166|FG002|Single Blind Treatment Period|Death|0|||
148853235|NCT02557100|536937164|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
148853236|NCT02557100|536937165|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
148853237|NCT02557100|536937166|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
148853238|NCT02557100|536937164|FG000|Single Blind Treatment Period|Adverse Event|0|||
148853239|NCT02557100|536937165|FG001|Single Blind Treatment Period|Adverse Event|1|||
148853240|NCT02557100|536937166|FG002|Single Blind Treatment Period|Adverse Event|0|||
148853241|NCT02557100|536937164|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
148853242|NCT02557100|536937165|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
148853243|NCT02557100|536937166|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
148853244|NCT02557100|536937164|FG000|Cumulative Abatacept Period|Other Reasons|0|||
148853245|NCT02557100|536937165|FG001|Cumulative Abatacept Period|Other Reasons|0|||
148853246|NCT02557100|536937166|FG002|Cumulative Abatacept Period|Other Reasons|1|||
148853247|NCT02557100|536937164|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
148853248|NCT02557100|536937165|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
148853249|NCT02557100|536937166|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
148853250|NCT02557100|536937164|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
148853251|NCT02557100|536937165|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
148853252|NCT02557100|536937166|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
148853253|NCT00510718|536937167|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
148853254|NCT00510718|536937168|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
148853255|NCT00510718|536937167|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
148853256|NCT00510718|536937168|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
148853257|NCT00510718|536937167|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
148853258|NCT00510718|536937168|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
148853259|NCT00510718|536937167|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
148853260|NCT00510718|536937168|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
148853261|NCT00510718|536937167|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
148853262|NCT00510718|536937168|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
148853263|NCT00510718|536937167|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
148853264|NCT00510718|536937168|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
148853265|NCT05791565|536937176|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
148853266|NCT05791565|536937177|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
148853267|NCT02388165|536937178|FG000|Overall Study|Study terminated by sponsor|5|||
148853268|NCT02388165|536937179|FG001|Overall Study|Study terminated by sponsor|5|||
148853269|NCT02388165|536937178|FG000|Overall Study|Other|11|||
148853270|NCT02388165|536937179|FG001|Overall Study|Other|13|||
148853271|NCT02388165|536937178|FG000|Overall Study|No longer meet eligibility criteria|40|||
148853272|NCT02388165|536937179|FG001|Overall Study|No longer meet eligibility criteria|43|||
148853273|NCT02388165|536937178|FG000|Overall Study|Withdrawal of consent|31|||
148853274|NCT02388165|536937179|FG001|Overall Study|Withdrawal of consent|32|||
148853275|NCT02388165|536937178|FG000|Overall Study|Lost to Follow-up|19|||
148853276|NCT02388165|536937179|FG001|Overall Study|Lost to Follow-up|20|||
148853277|NCT02388165|536937178|FG000|Overall Study|Death|13|||
148853278|NCT02388165|536937179|FG001|Overall Study|Death|10|||
148853279|NCT02388165|536937178|FG000|Overall Study|Adverse Event|3|||
148853280|NCT02388165|536937179|FG001|Overall Study|Adverse Event|5|||
148853281|NCT02388165|536937178|FG000|Overall Study|Did not meet entrance criteria|5|||
148853282|NCT02388165|536937179|FG001|Overall Study|Did not meet entrance criteria|2|||
148853283|NCT00705250|536937180|FG000|Overall Study|Withdrawal by Subject|1|||
148853284|NCT00705250|536937180|FG000|Overall Study|Patient died in car accident|1|||
148853285|NCT01406938|536937181|FG000|Induction Period|Subject/guardian decision|6|||
148853286|NCT01406938|536937182|FG001|Induction Period|Subject/guardian decision|8|||
148853287|NCT01406938|536937183|FG002|Induction Period|Subject/guardian decision|0|||
148853288|NCT01406938|536937184|FG003|Induction Period|Subject/guardian decision|0|||
148853289|NCT01406938|536937185|FG004|Induction Period|Subject/guardian decision|0|||
148853290|NCT01406938|536937186|FG005|Induction Period|Subject/guardian decision|0|||
148853291|NCT01406938|536937181|FG000|Induction Period|Protocol deviation|1|||
148853292|NCT01406938|536937182|FG001|Induction Period|Protocol deviation|0|||
148853293|NCT01406938|536937183|FG002|Induction Period|Protocol deviation|0|||
148853294|NCT01406938|536937184|FG003|Induction Period|Protocol deviation|0|||
148853295|NCT01406938|536937185|FG004|Induction Period|Protocol deviation|0|||
148853296|NCT01406938|536937186|FG005|Induction Period|Protocol deviation|0|||
148853297|NCT01406938|536937181|FG000|Induction Period|Adverse Event|8|||
148853298|NCT01406938|536937182|FG001|Induction Period|Adverse Event|9|||
148853299|NCT01406938|536937183|FG002|Induction Period|Adverse Event|0|||
148853300|NCT01406938|536937184|FG003|Induction Period|Adverse Event|0|||
148853301|NCT01406938|536937185|FG004|Induction Period|Adverse Event|0|||
148853302|NCT01406938|536937186|FG005|Induction Period|Adverse Event|0|||
148853303|NCT01406938|536937181|FG000|Induction Period|Lack of Efficacy|1|||
148986792|NCT00968669|537430553|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
148986793|NCT00968669|537430550|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
148986794|NCT00968669|537430551|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
148986795|NCT00968669|537430552|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
148986796|NCT00968669|537430553|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
148853304|NCT01406938|536937182|FG001|Induction Period|Lack of Efficacy|0|||
148853305|NCT01406938|536937183|FG002|Induction Period|Lack of Efficacy|0|||
148853306|NCT01406938|536937184|FG003|Induction Period|Lack of Efficacy|0|||
148853307|NCT01406938|536937185|FG004|Induction Period|Lack of Efficacy|0|||
148853308|NCT01406938|536937186|FG005|Induction Period|Lack of Efficacy|0|||
148853309|NCT01406938|536937181|FG000|Induction Period|Lost to Follow-up|2|||
148853310|NCT01406938|536937182|FG001|Induction Period|Lost to Follow-up|3|||
148853311|NCT01406938|536937183|FG002|Induction Period|Lost to Follow-up|0|||
148853312|NCT01406938|536937184|FG003|Induction Period|Lost to Follow-up|0|||
148853313|NCT01406938|536937185|FG004|Induction Period|Lost to Follow-up|0|||
148853314|NCT01406938|536937186|FG005|Induction Period|Lost to Follow-up|0|||
148853315|NCT01406938|536937181|FG000|Maintenance Period|Adverse Event|0|||
148853316|NCT01406938|536937182|FG001|Maintenance Period|Adverse Event|0|||
148853317|NCT01406938|536937183|FG002|Maintenance Period|Adverse Event|2|||
148853318|NCT01406938|536937184|FG003|Maintenance Period|Adverse Event|8|||
148853319|NCT01406938|536937185|FG004|Maintenance Period|Adverse Event|4|||
148853320|NCT01406938|536937186|FG005|Maintenance Period|Adverse Event|2|||
148853321|NCT01406938|536937181|FG000|Maintenance Period|Death|0|||
148853322|NCT01406938|536937182|FG001|Maintenance Period|Death|0|||
148853323|NCT01406938|536937183|FG002|Maintenance Period|Death|0|||
148853324|NCT01406938|536937184|FG003|Maintenance Period|Death|0|||
148853325|NCT01406938|536937185|FG004|Maintenance Period|Death|1|||
148853326|NCT01406938|536937186|FG005|Maintenance Period|Death|0|||
148853327|NCT01406938|536937181|FG000|Maintenance Period|Subject/guardian decision|0|||
148853328|NCT01406938|536937182|FG001|Maintenance Period|Subject/guardian decision|0|||
148853329|NCT01406938|536937183|FG002|Maintenance Period|Subject/guardian decision|11|||
148853330|NCT01406938|536937184|FG003|Maintenance Period|Subject/guardian decision|7|||
148853331|NCT01406938|536937185|FG004|Maintenance Period|Subject/guardian decision|10|||
148853332|NCT01406938|536937186|FG005|Maintenance Period|Subject/guardian decision|7|||
148853333|NCT01406938|536937181|FG000|Maintenance Period|Protocol Violation|0|||
148853334|NCT01406938|536937182|FG001|Maintenance Period|Protocol Violation|0|||
148853335|NCT01406938|536937183|FG002|Maintenance Period|Protocol Violation|2|||
148853336|NCT01406938|536937184|FG003|Maintenance Period|Protocol Violation|2|||
148853337|NCT01406938|536937185|FG004|Maintenance Period|Protocol Violation|2|||
148853338|NCT01406938|536937186|FG005|Maintenance Period|Protocol Violation|2|||
148853339|NCT01406938|536937181|FG000|Maintenance Period|Pregnancy|0|||
148853340|NCT01406938|536937182|FG001|Maintenance Period|Pregnancy|0|||
148853341|NCT01406938|536937183|FG002|Maintenance Period|Pregnancy|0|||
148853342|NCT01406938|536937184|FG003|Maintenance Period|Pregnancy|0|||
148853343|NCT01406938|536937185|FG004|Maintenance Period|Pregnancy|1|||
148853344|NCT01406938|536937186|FG005|Maintenance Period|Pregnancy|0|||
148853345|NCT01406938|536937181|FG000|Maintenance Period|Lost to Follow-up|0|||
148853346|NCT01406938|536937182|FG001|Maintenance Period|Lost to Follow-up|0|||
148853347|NCT01406938|536937183|FG002|Maintenance Period|Lost to Follow-up|0|||
148853348|NCT01406938|536937184|FG003|Maintenance Period|Lost to Follow-up|0|||
148853349|NCT01406938|536937185|FG004|Maintenance Period|Lost to Follow-up|4|||
148853350|NCT01406938|536937186|FG005|Maintenance Period|Lost to Follow-up|0|||
148853351|NCT01406938|536937181|FG000|Maintenance Period|Lack of Efficacy|0|||
148853352|NCT01406938|536937182|FG001|Maintenance Period|Lack of Efficacy|0|||
148853353|NCT01406938|536937183|FG002|Maintenance Period|Lack of Efficacy|2|||
148853354|NCT01406938|536937184|FG003|Maintenance Period|Lack of Efficacy|1|||
148853355|NCT01406938|536937185|FG004|Maintenance Period|Lack of Efficacy|3|||
148853356|NCT01406938|536937186|FG005|Maintenance Period|Lack of Efficacy|5|||
148853357|NCT01406938|536937181|FG000|Follow up|Lack of Efficacy|3|||
148853358|NCT01406938|536937182|FG001|Follow up|Lack of Efficacy|2|||
148853359|NCT01406938|536937183|FG002|Follow up|Lack of Efficacy|1|||
148853360|NCT01406938|536937184|FG003|Follow up|Lack of Efficacy|0|||
148853361|NCT01406938|536937185|FG004|Follow up|Lack of Efficacy|0|||
148853362|NCT01406938|536937186|FG005|Follow up|Lack of Efficacy|0|||
148853363|NCT01406938|536937181|FG000|Follow up|Patient/guardian decision|4|||
148853364|NCT01406938|536937182|FG001|Follow up|Patient/guardian decision|2|||
148853365|NCT01406938|536937183|FG002|Follow up|Patient/guardian decision|4|||
148853366|NCT01406938|536937184|FG003|Follow up|Patient/guardian decision|2|||
148853367|NCT01406938|536937185|FG004|Follow up|Patient/guardian decision|4|||
148853368|NCT01406938|536937186|FG005|Follow up|Patient/guardian decision|1|||
148853369|NCT01406938|536937181|FG000|Follow up|Protocol Violation|0|||
148853370|NCT01406938|536937182|FG001|Follow up|Protocol Violation|0|||
148853371|NCT01406938|536937183|FG002|Follow up|Protocol Violation|1|||
149030310|NCT00561574|537587995|FG000|Overall Study|Lack of Efficacy|11|||
149030311|NCT00561574|537587996|FG001|Overall Study|Lack of Efficacy|21|||
149030312|NCT00561574|537587995|FG000|Overall Study|Withdrawal by Subject|4|||
149030313|NCT00561574|537587996|FG001|Overall Study|Withdrawal by Subject|4|||
148853372|NCT01406938|536937184|FG003|Follow up|Protocol Violation|0|||
148853373|NCT01406938|536937185|FG004|Follow up|Protocol Violation|0|||
148853374|NCT01406938|536937186|FG005|Follow up|Protocol Violation|0|||
148853375|NCT01406938|536937181|FG000|Follow up|Physician Decision|0|||
148853376|NCT01406938|536937182|FG001|Follow up|Physician Decision|0|||
148853377|NCT01406938|536937183|FG002|Follow up|Physician Decision|2|||
148853378|NCT01406938|536937184|FG003|Follow up|Physician Decision|0|||
148853379|NCT01406938|536937185|FG004|Follow up|Physician Decision|3|||
148853380|NCT01406938|536937186|FG005|Follow up|Physician Decision|1|||
148853381|NCT01406938|536937181|FG000|Follow up|Lost to Follow-up|1|||
148853382|NCT01406938|536937182|FG001|Follow up|Lost to Follow-up|1|||
148853383|NCT01406938|536937183|FG002|Follow up|Lost to Follow-up|0|||
148853384|NCT01406938|536937184|FG003|Follow up|Lost to Follow-up|1|||
148853385|NCT01406938|536937185|FG004|Follow up|Lost to Follow-up|2|||
148853386|NCT01406938|536937186|FG005|Follow up|Lost to Follow-up|1|||
148853387|NCT01576146|536937191|FG000|Extension Period 1|Adverse Event|2|||
148853388|NCT01576146|536937191|FG000|Extension Period 1|Death|2|||
148853389|NCT01576146|536937191|FG000|Extension Period 1|Physician Decision|2|||
148853390|NCT01576146|536937191|FG000|Extension Period 1|Withdrawal by Subject|1|||
148853391|NCT01576146|536937191|FG000|Extension Period 1|Lost to Follow-up|1|||
148853392|NCT01576146|536937191|FG000|Extension Period 1|Parathyroidectomy|1|||
148853393|NCT01576146|536937191|FG000|Extension Period 1|Renal Transplant|1|||
148853394|NCT01576146|536937191|FG000|Extension Period 2|Sponsor Decision|13|||
148853395|NCT01576146|536937191|FG000|Extension Period 2|Death|1|||
148853396|NCT01576146|536937191|FG000|Extension Period 2|Adverse Event|1|||
148853397|NCT01576146|536937191|FG000|Extension Period 2|Renal Transplant|1|||
148853398|NCT01576146|536937191|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
148853399|NCT00316225|536937196|FG000|Overall Study|Adverse Event|2|||
148853400|NCT00316225|536937196|FG000|Overall Study|Physician Decision|3|||
148853401|NCT00316225|536937196|FG000|Overall Study|Progressive Disease|15|||
148853402|NCT00316225|536937196|FG000|Overall Study|Withdrawal by Subject|3|||
148853403|NCT00316225|536937196|FG000|Overall Study|Death|2|||
148853404|NCT01814878|536937197|FG000|Overall Study|Adverse Event|16|||
148853405|NCT01814878|536937198|FG001|Overall Study|Adverse Event|5|||
148853406|NCT01814878|536937197|FG000|Overall Study|Withdrawal by Subject|20|||
148853407|NCT01814878|536937198|FG001|Overall Study|Withdrawal by Subject|16|||
148853408|NCT01814878|536937197|FG000|Overall Study|Protocol Violation|5|||
148853409|NCT01814878|536937198|FG001|Overall Study|Protocol Violation|5|||
148853410|NCT01814878|536937197|FG000|Overall Study|Physician Decision|3|||
148853411|NCT01814878|536937198|FG001|Overall Study|Physician Decision|1|||
148853412|NCT01814878|536937197|FG000|Overall Study|Screening failure (drop-out)|0|||
148853413|NCT01814878|536937198|FG001|Overall Study|Screening failure (drop-out)|3|||
148853414|NCT01814878|536937197|FG000|Overall Study|Other|2|||
148853415|NCT01814878|536937198|FG001|Overall Study|Other|0|||
148853416|NCT00878254|536937203|FG000|Overall Study|Physician Decision|1|||
148853417|NCT00878254|536937203|FG000|Overall Study|Death|1|||
148853418|NCT00878254|536937203|FG000|Overall Study|Withdrawal by Subject|1|||
148853419|NCT00194077|536937207|FG000|Overall Study|Lack of Efficacy|22|||
148853420|NCT00194077|536937208|FG001|Overall Study|Lack of Efficacy|29|||
148853421|NCT00194077|536937207|FG000|Overall Study|Study nonadherence|1|||
148853422|NCT00194077|536937208|FG001|Overall Study|Study nonadherence|0|||
148853423|NCT00194077|536937207|FG000|Overall Study|Withdrawal by Subject|1|||
148853424|NCT00194077|536937208|FG001|Overall Study|Withdrawal by Subject|1|||
148853425|NCT03470194|536937211|FG000|Overall Study|Lost to Follow-up|11|||
148853426|NCT03470194|536937212|FG001|Overall Study|Lost to Follow-up|17|||
148853427|NCT01268046|536937213|FG000|Overall Study|Withdrawal by Subject|1|||
148853428|NCT01268046|536937214|FG001|Overall Study|Withdrawal by Subject|0|||
148853429|NCT01268046|536937215|FG002|Overall Study|Withdrawal by Subject|0|||
148853430|NCT01268046|536937216|FG003|Overall Study|Withdrawal by Subject|1|||
148853431|NCT01268046|536937213|FG000|Overall Study|Lost to Follow-up|0|||
148853432|NCT01268046|536937214|FG001|Overall Study|Lost to Follow-up|0|||
148853433|NCT01268046|536937215|FG002|Overall Study|Lost to Follow-up|1|||
148853434|NCT01268046|536937216|FG003|Overall Study|Lost to Follow-up|0|||
148853435|NCT01450696|536937218|FG000|Overall Study|Never Treated|1|||
148853436|NCT01450696|536937219|FG001|Overall Study|Never Treated|1|||
148853437|NCT01450696|536937218|FG000|Overall Study|Death|77|||
148853438|NCT01450696|536937219|FG001|Overall Study|Death|84|||
148853439|NCT01450696|536937218|FG000|Overall Study|Lost to Follow-up|3|||
148853440|NCT01450696|536937219|FG001|Overall Study|Lost to Follow-up|3|||
148853441|NCT01450696|536937218|FG000|Overall Study|Non-Compliance|1|||
148853442|NCT01450696|536937219|FG001|Overall Study|Non-Compliance|0|||
148853443|NCT01450696|536937218|FG000|Overall Study|Withdrawal by Subject|13|||
148853444|NCT01450696|536937219|FG001|Overall Study|Withdrawal by Subject|2|||
148853445|NCT01450696|536937218|FG000|Overall Study|Study Terminated by Sponsor|53|||
148853446|NCT01450696|536937219|FG001|Overall Study|Study Terminated by Sponsor|58|||
148853447|NCT05319600|536937223|FG000|Overall Study|Withdrawal by Subject|1|||
148853448|NCT05319600|536937224|FG001|Overall Study|Withdrawal by Subject|0|||
148853449|NCT05319600|536937223|FG000|Overall Study|Lost to Follow-up|0|||
148853450|NCT05319600|536937224|FG001|Overall Study|Lost to Follow-up|4|||
148853451|NCT00582712|536937225|FG000|Overall Study|Adverse Event|1|||
148853452|NCT00582712|536937225|FG000|Overall Study|Lack of Efficacy|1|||
148853453|NCT00582712|536937225|FG000|Overall Study|Withdrawal by Subject|1|||
148853454|NCT00582712|536937225|FG000|Overall Study|Complicating disease requiring treatment|1|||
148853455|NCT05141175|536937226|FG000|Overall Study|Withdrawal by Subject|1|||
148853456|NCT01813058|536937233|FG000|Overall Study|Withdrawal by Subject|5|||
148853457|NCT01813058|536937234|FG001|Overall Study|Withdrawal by Subject|4|||
148853458|NCT03585764|536937235|FG000|Overall Study|Death|3|||
148853459|NCT03585764|536937236|FG001|Overall Study|Death|2|||
148853460|NCT03585764|536937237|FG002|Overall Study|Death|3|||
148853461|NCT03585764|536937238|FG003|Overall Study|Death|0|||
148853462|NCT03585764|536937235|FG000|Overall Study|Lost to Follow-up|0|||
148853463|NCT03585764|536937236|FG001|Overall Study|Lost to Follow-up|1|||
148853464|NCT03585764|536937237|FG002|Overall Study|Lost to Follow-up|0|||
148853465|NCT03585764|536937238|FG003|Overall Study|Lost to Follow-up|0|||
148853466|NCT03585764|536937235|FG000|Overall Study|Physician Decision|0|||
148853467|NCT03585764|536937236|FG001|Overall Study|Physician Decision|0|||
148853468|NCT03585764|536937237|FG002|Overall Study|Physician Decision|2|||
148853469|NCT03585764|536937238|FG003|Overall Study|Physician Decision|0|||
148853470|NCT01581021|536937239|FG000|Overall Study|Lost to Follow-up|4|||
148853471|NCT01581021|536937240|FG001|Overall Study|Lost to Follow-up|6|||
148853472|NCT01581021|536937239|FG000|Overall Study|More than 2 hooks in thoracic|3|||
148853473|NCT01581021|536937240|FG001|Overall Study|More than 2 hooks in thoracic|0|||
148853474|NCT01581021|536937239|FG000|Overall Study|Neuromuscular|2|||
148853475|NCT01581021|536937240|FG001|Overall Study|Neuromuscular|1|||
148853476|NCT01581021|536937239|FG000|Overall Study|Not Randomized|1|||
148853477|NCT01581021|536937240|FG001|Overall Study|Not Randomized|2|||
148853478|NCT01581021|536937239|FG000|Overall Study|Lenke 6 Classification|0|||
148853479|NCT01581021|536937240|FG001|Overall Study|Lenke 6 Classification|1|||
148853480|NCT01581021|536937239|FG000|Overall Study|Lack of Efficacy|0|||
148853481|NCT01581021|536937240|FG001|Overall Study|Lack of Efficacy|1|||
148853482|NCT00923351|536937241|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
148853483|NCT00923351|536937242|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
148853484|NCT00923351|536937243|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
148853485|NCT01262560|536937257|FG000|Overall Study|Protocol Violation|0|||
148853486|NCT01262560|536937258|FG001|Overall Study|Protocol Violation|1|||
148853487|NCT01262560|536937259|FG002|Overall Study|Protocol Violation|2|||
148853488|NCT04295759|536937262|FG000|Overall Study|Lack of Efficacy|9|||
148853489|NCT04295759|536937262|FG000|Overall Study|Death|1|||
148853490|NCT04295759|536937262|FG000|Overall Study|Withdrawal by Subject|2|||
148853491|NCT04295759|536937262|FG000|Overall Study|Deemed ineligible|1|||
148853492|NCT00465972|536937265|FG000|Overall Study|Withdrawal by Subject|2|||
148853493|NCT00465972|536937266|FG001|Overall Study|Withdrawal by Subject|1|||
148853494|NCT00349349|536937267|FG000|Overall Study|Adverse Event|5|||
148853495|NCT00349349|536937268|FG001|Overall Study|Adverse Event|6|||
148853496|NCT00349349|536937269|FG002|Overall Study|Adverse Event|2|||
148853497|NCT00349349|536937267|FG000|Overall Study|Withdrawal by Subject|5|||
148853498|NCT00349349|536937268|FG001|Overall Study|Withdrawal by Subject|2|||
148853499|NCT00349349|536937269|FG002|Overall Study|Withdrawal by Subject|1|||
148853500|NCT00349349|536937267|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
148853501|NCT00349349|536937268|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
148853502|NCT00349349|536937269|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
148853503|NCT00349349|536937267|FG000|Overall Study|Death|13|||
148853504|NCT00349349|536937268|FG001|Overall Study|Death|10|||
148853505|NCT00349349|536937269|FG002|Overall Study|Death|1|||
148853506|NCT00349349|536937267|FG000|Overall Study|Other Treatment Selected|2|||
148853507|NCT00349349|536937268|FG001|Overall Study|Other Treatment Selected|0|||
148853508|NCT00349349|536937269|FG002|Overall Study|Other Treatment Selected|0|||
148853509|NCT00349349|536937267|FG000|Overall Study|Participant Reduced General Condition|0|||
148853510|NCT00349349|536937268|FG001|Overall Study|Participant Reduced General Condition|1|||
148853511|NCT00349349|536937269|FG002|Overall Study|Participant Reduced General Condition|0|||
148853512|NCT00349349|536937267|FG000|Overall Study|Physician Decision|1|||
148853513|NCT00349349|536937268|FG001|Overall Study|Physician Decision|2|||
148853514|NCT00349349|536937269|FG002|Overall Study|Physician Decision|1|||
148853515|NCT00349349|536937267|FG000|Overall Study|No Response|0|||
148853516|NCT00349349|536937268|FG001|Overall Study|No Response|3|||
148853517|NCT00349349|536937269|FG002|Overall Study|No Response|0|||
148853518|NCT00349349|536937267|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
148853519|NCT00349349|536937268|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
148853520|NCT00349349|536937269|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
148853521|NCT01108731|536937271|FG000|Overall Study|Withdrawal by Subject|1|||
148853522|NCT01108731|536937272|FG001|Overall Study|Withdrawal by Subject|1|||
148853523|NCT01108731|536937271|FG000|Overall Study|Adverse Event|3|||
148853524|NCT01108731|536937272|FG001|Overall Study|Adverse Event|3|||
148853525|NCT00851890|536937273|FG000|Overall Study|Lost to Follow-up|0|||
148853526|NCT00851890|536937274|FG001|Overall Study|Lost to Follow-up|1|||
148853527|NCT00851890|536937275|FG002|Overall Study|Lost to Follow-up|0|||
148853528|NCT00851890|536937276|FG003|Overall Study|Lost to Follow-up|1|||
148853529|NCT01170273|536937283|FG000|Overall Study|Lost to Follow-up|6|||
148853530|NCT01170273|536937284|FG001|Overall Study|Lost to Follow-up|8|||
148853531|NCT01170273|536937283|FG000|Overall Study|Protocol Violation|1|||
148853532|NCT01170273|536937284|FG001|Overall Study|Protocol Violation|0|||
148853533|NCT01170273|536937283|FG000|Overall Study|Death|1|||
148853534|NCT01170273|536937284|FG001|Overall Study|Death|0|||
148853535|NCT01170273|536937283|FG000|Overall Study|Adverse Event|0|||
148853536|NCT01170273|536937284|FG001|Overall Study|Adverse Event|1|||
148853537|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
148853538|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
148853539|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
148853540|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
148853541|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
148853542|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
148853543|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
148853544|NCT01673854|536937285|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
148853545|NCT01673854|536937285|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
148853546|NCT01673854|536937285|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
148853547|NCT01673854|536937285|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
148853548|NCT01673854|536937285|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
148853549|NCT02316353|536937286|FG000|Overall Study|Pregnancy|1|||
148853550|NCT02316353|536937287|FG001|Overall Study|Pregnancy|3|||
148853551|NCT02316353|536937286|FG000|Overall Study|Adverse Event|1|||
148853552|NCT02316353|536937287|FG001|Overall Study|Adverse Event|3|||
148853553|NCT02316353|536937286|FG000|Overall Study|Withdrawal by Subject|6|||
148853554|NCT02316353|536937287|FG001|Overall Study|Withdrawal by Subject|2|||
148853555|NCT00375674|536937288|FG000|Overall Study|Other|26|||
148853556|NCT00375674|536937289|FG001|Overall Study|Other|18|||
148853557|NCT00375674|536937288|FG000|Overall Study|Death|67|||
148853558|NCT00375674|536937289|FG001|Overall Study|Death|76|||
148853559|NCT00375674|536937288|FG000|Overall Study|Participants refused further follow-up|31|||
148853560|NCT00375674|536937289|FG001|Overall Study|Participants refused further follow-up|30|||
148853561|NCT00375674|536937288|FG000|Overall Study|Lost to Follow-up|17|||
148853562|NCT00375674|536937289|FG001|Overall Study|Lost to Follow-up|15|||
148853563|NCT00375674|536937288|FG000|Overall Study|Enrolled but not treated|3|||
148853564|NCT00375674|536937289|FG001|Overall Study|Enrolled but not treated|2|||
148853565|NCT01545934|536938670|FG000|Overall Study|Withdrawal by Subject|4|||
148853566|NCT01545934|536938671|FG001|Overall Study|Withdrawal by Subject|3|||
148853567|NCT01545934|536938670|FG000|Overall Study|Lost to Follow-up|1|||
148853568|NCT01545934|536938671|FG001|Overall Study|Lost to Follow-up|0|||
148853569|NCT03654404|536938672|FG000|Overall Study|Death|1|||
148853570|NCT03654404|536938672|FG000|Overall Study|Lost to Follow-up|2|||
148853571|NCT03654404|536938672|FG000|Overall Study|Withdrawal by Subject|5|||
148853572|NCT03299881|536938673|FG000|Overall Study|Study Termination|17|||
148853573|NCT03299881|536938674|FG001|Overall Study|Study Termination|13|||
148853574|NCT01474772|536938675|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
148853575|NCT01474772|536938676|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
148853576|NCT01474772|536938675|FG000|Period 1|AE not Related to Study Drug|1|||
148853577|NCT01474772|536938676|FG001|Period 1|AE not Related to Study Drug|0|||
148853578|NCT01474772|536938675|FG000|Period 1|Withdrawal by Subject|3|||
148853579|NCT01474772|536938676|FG001|Period 1|Withdrawal by Subject|1|||
148853580|NCT01474772|536938675|FG000|Period 1|Lost to Follow-up|1|||
148853581|NCT01474772|536938676|FG001|Period 1|Lost to Follow-up|0|||
148853582|NCT01474772|536938675|FG000|Period 1|Reason not Specified|1|||
148853583|NCT01474772|536938676|FG001|Period 1|Reason not Specified|1|||
148853584|NCT01474772|536938675|FG000|Washout|AE not Related to Study Drug|2|||
148853585|NCT01474772|536938676|FG001|Washout|AE not Related to Study Drug|0|||
148853586|NCT01474772|536938675|FG000|Washout|Withdrawal by Subject|1|||
148853587|NCT01474772|536938676|FG001|Washout|Withdrawal by Subject|0|||
148853588|NCT01474772|536938675|FG000|Washout|Lost to Follow-up|0|||
148853589|NCT01474772|536938676|FG001|Washout|Lost to Follow-up|1|||
148853590|NCT01474772|536938675|FG000|Washout|Reason not Specified|0|||
148853591|NCT01474772|536938676|FG001|Washout|Reason not Specified|1|||
148853592|NCT01474772|536938675|FG000|Period 2|Death|0|||
148853593|NCT01474772|536938676|FG001|Period 2|Death|1|||
148853594|NCT01474772|536938675|FG000|Period 2|AE Related to Study Drug|0|||
148853595|NCT01474772|536938676|FG001|Period 2|AE Related to Study Drug|1|||
148853596|NCT01474772|536938675|FG000|Period 2|AE not Related to Study Drug|4|||
148853597|NCT01474772|536938676|FG001|Period 2|AE not Related to Study Drug|1|||
148853598|NCT01474772|536938675|FG000|Period 2|Lack of Efficacy|1|||
148853599|NCT01474772|536938676|FG001|Period 2|Lack of Efficacy|0|||
148853600|NCT01474772|536938675|FG000|Period 2|Withdrawal by Subject|3|||
148853601|NCT01474772|536938676|FG001|Period 2|Withdrawal by Subject|4|||
148986797|NCT00968669|537430550|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
148986798|NCT00968669|537430551|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
148986799|NCT00968669|537430552|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
148986800|NCT00968669|537430553|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
148986801|NCT00968669|537430550|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
148986802|NCT00968669|537430551|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
148986803|NCT00968669|537430552|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
148986804|NCT00968669|537430553|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
148986805|NCT00968669|537430550|FG000|Overall Study|EARLY WITHDRAWAL|0|||
148853602|NCT01474772|536938675|FG000|Period 2|Lost to Follow-up|1|||
148853603|NCT01474772|536938676|FG001|Period 2|Lost to Follow-up|1|||
148853604|NCT01474772|536938675|FG000|Period 2|Reason not Specified|0|||
148853605|NCT01474772|536938676|FG001|Period 2|Reason not Specified|2|||
148853606|NCT01474772|536938675|FG000|Follow-up|AE not Related to Study Drug|0|||
148853607|NCT01474772|536938676|FG001|Follow-up|AE not Related to Study Drug|1|||
148853608|NCT03195660|536938677|FG000|Overall Study|The study was terminated|2|||
148853609|NCT03367403|536938678|FG000|Overall Study|Adverse Event|20|||
148853610|NCT03367403|536938679|FG001|Overall Study|Adverse Event|6|||
148853611|NCT03367403|536938680|FG002|Overall Study|Adverse Event|2|||
148853612|NCT03367403|536938678|FG000|Overall Study|Withdrawal by Subject|12|||
148853613|NCT03367403|536938679|FG001|Overall Study|Withdrawal by Subject|13|||
148853614|NCT03367403|536938680|FG002|Overall Study|Withdrawal by Subject|1|||
148853615|NCT03367403|536938678|FG000|Overall Study|Death|1|||
148853616|NCT03367403|536938679|FG001|Overall Study|Death|2|||
148853617|NCT03367403|536938680|FG002|Overall Study|Death|0|||
148853618|NCT03367403|536938678|FG000|Overall Study|Physician Decision|0|||
148853619|NCT03367403|536938679|FG001|Overall Study|Physician Decision|1|||
148853620|NCT03367403|536938680|FG002|Overall Study|Physician Decision|0|||
148853621|NCT03367403|536938678|FG000|Overall Study|Protocol Violation|1|||
148853622|NCT03367403|536938679|FG001|Overall Study|Protocol Violation|1|||
148853623|NCT03367403|536938680|FG002|Overall Study|Protocol Violation|0|||
148853624|NCT03367403|536938678|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
148853625|NCT03367403|536938679|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
148853626|NCT03367403|536938680|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
148853627|NCT03367403|536938678|FG000|Overall Study|COVID-19|3|||
148853628|NCT03367403|536938679|FG001|Overall Study|COVID-19|6|||
148853629|NCT03367403|536938680|FG002|Overall Study|COVID-19|0|||
148853630|NCT03367403|536938678|FG000|Overall Study|Abuse of Alcohol Intake|0|||
148853631|NCT03367403|536938679|FG001|Overall Study|Abuse of Alcohol Intake|1|||
148853632|NCT03367403|536938680|FG002|Overall Study|Abuse of Alcohol Intake|0|||
148853633|NCT03367403|536938678|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
148853634|NCT03367403|536938679|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
148853635|NCT03367403|536938680|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
148853636|NCT01822899|536938681|FG000|Overall Study|Adverse Event|6|||
148853637|NCT01822899|536938682|FG001|Overall Study|Adverse Event|5|||
148853638|NCT01822899|536938681|FG000|Overall Study|Lack of Efficacy|6|||
148853639|NCT01822899|536938682|FG001|Overall Study|Lack of Efficacy|3|||
148853640|NCT01822899|536938681|FG000|Overall Study|Protocol Violation|6|||
148853641|NCT01822899|536938682|FG001|Overall Study|Protocol Violation|3|||
148853642|NCT01822899|536938681|FG000|Overall Study|Lost to Follow-up|1|||
148853643|NCT01822899|536938682|FG001|Overall Study|Lost to Follow-up|0|||
148853644|NCT01822899|536938681|FG000|Overall Study|Withdrawal by Subject|5|||
148853645|NCT01822899|536938682|FG001|Overall Study|Withdrawal by Subject|7|||
148853646|NCT00759876|536938683|FG000|Overall Study|Sponsor terminated study early|36|||
148853647|NCT02314156|536938684|FG000|Overall Study|Adverse Event|1|||
148853648|NCT02314156|536938685|FG001|Overall Study|Adverse Event|0|||
148853649|NCT02314156|536938684|FG000|Overall Study|Withdrawal by Subject|1|||
148853650|NCT02314156|536938685|FG001|Overall Study|Withdrawal by Subject|0|||
148853651|NCT02846389|536938686|FG000|Overall Study|Withdrawal by Subject|1|||
148853652|NCT02846389|536938687|FG001|Overall Study|Withdrawal by Subject|1|||
148853653|NCT02321319|536938689|FG000|Overall Study|Product discontinued|5|||
148853654|NCT02249091|536938690|FG000|Overall Study|Lack of Efficacy|8|||
148853655|NCT02249091|536938691|FG001|Overall Study|Lack of Efficacy|3|||
148853656|NCT02249091|536938690|FG000|Overall Study|Physician Decision|4|||
148853657|NCT02249091|536938691|FG001|Overall Study|Physician Decision|1|||
148853658|NCT02249091|536938690|FG000|Overall Study|Withdrawal by Subject|2|||
148853659|NCT02249091|536938691|FG001|Overall Study|Withdrawal by Subject|2|||
148853660|NCT02249091|536938690|FG000|Overall Study|Death|3|||
148853661|NCT02249091|536938691|FG001|Overall Study|Death|4|||
148853662|NCT02249091|536938690|FG000|Overall Study|Adverse Event|1|||
148853663|NCT02249091|536938691|FG001|Overall Study|Adverse Event|0|||
148853664|NCT02249091|536938690|FG000|Overall Study|Stable disease with following SCT|0|||
148853665|NCT02249091|536938691|FG001|Overall Study|Stable disease with following SCT|1|||
148853666|NCT02249091|536938690|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
148853667|NCT02249091|536938691|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
148853668|NCT02249091|536938690|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
148853669|NCT02249091|536938691|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
148853670|NCT02249091|536938690|FG000|Overall Study|Refractory AML|1|||
148853671|NCT02249091|536938691|FG001|Overall Study|Refractory AML|1|||
148853672|NCT05059301|536938692|FG000|Overall Study|Adverse Event|0|||
148853673|NCT05059301|536938693|FG001|Overall Study|Adverse Event|2|||
148853674|NCT05059301|536938694|FG002|Overall Study|Adverse Event|2|||
148853675|NCT05059301|536938692|FG000|Overall Study|Lost to Follow-up|2|||
148853676|NCT05059301|536938693|FG001|Overall Study|Lost to Follow-up|3|||
148853677|NCT05059301|536938694|FG002|Overall Study|Lost to Follow-up|3|||
148853678|NCT00853242|536938695|FG000|Overall Study|Adverse Event|0|||
148853679|NCT00853242|536938696|FG001|Overall Study|Adverse Event|1|||
148853680|NCT00853242|536938697|FG002|Overall Study|Adverse Event|1|||
148853681|NCT00853242|536938698|FG003|Overall Study|Adverse Event|0|||
148853682|NCT00853242|536938699|FG004|Overall Study|Adverse Event|3|||
148853683|NCT00853242|536938700|FG005|Overall Study|Adverse Event|1|||
148853684|NCT00853242|536938701|FG006|Overall Study|Adverse Event|1|||
148853685|NCT00853242|536938695|FG000|Overall Study|Noncompliant|0|||
148986806|NCT00968669|537430551|FG001|Overall Study|EARLY WITHDRAWAL|1|||
148853686|NCT00853242|536938696|FG001|Overall Study|Noncompliant|0|||
148853687|NCT00853242|536938697|FG002|Overall Study|Noncompliant|0|||
148853688|NCT00853242|536938698|FG003|Overall Study|Noncompliant|0|||
148853689|NCT00853242|536938699|FG004|Overall Study|Noncompliant|1|||
148853690|NCT00853242|536938700|FG005|Overall Study|Noncompliant|0|||
148853691|NCT00853242|536938701|FG006|Overall Study|Noncompliant|0|||
148853692|NCT00853242|536938695|FG000|Overall Study|Withdrawal by Subject|1|||
148853693|NCT00853242|536938696|FG001|Overall Study|Withdrawal by Subject|2|||
148853694|NCT00853242|536938697|FG002|Overall Study|Withdrawal by Subject|0|||
148853695|NCT00853242|536938698|FG003|Overall Study|Withdrawal by Subject|4|||
148853696|NCT00853242|536938699|FG004|Overall Study|Withdrawal by Subject|0|||
148853697|NCT00853242|536938700|FG005|Overall Study|Withdrawal by Subject|0|||
148853698|NCT00853242|536938701|FG006|Overall Study|Withdrawal by Subject|2|||
148853699|NCT00853242|536938695|FG000|Overall Study|Other|2|||
148853700|NCT00853242|536938696|FG001|Overall Study|Other|0|||
148853701|NCT00853242|536938697|FG002|Overall Study|Other|2|||
148853702|NCT00853242|536938698|FG003|Overall Study|Other|0|||
148853703|NCT00853242|536938699|FG004|Overall Study|Other|0|||
148853704|NCT00853242|536938700|FG005|Overall Study|Other|1|||
148853705|NCT00853242|536938701|FG006|Overall Study|Other|2|||
148853706|NCT05730335|536938704|FG000|Overall Study|Lost to Follow-up|8|||
148853707|NCT05730335|536938704|FG000|Overall Study|Withdrawal by Subject|6|||
148853708|NCT00923975|536938714|FG000|Overall Study|Did not meet inclusion criteria|1|||
148853709|NCT01005316|536938717|FG000|Overall Study|Adverse Event|0|||
148853710|NCT01005316|536938718|FG001|Overall Study|Adverse Event|0|||
148853711|NCT01005316|536938719|FG002|Overall Study|Adverse Event|0|||
148853712|NCT01005316|536938720|FG003|Overall Study|Adverse Event|1|||
148853713|NCT01005316|536938717|FG000|Overall Study|Death|20|||
148853714|NCT01005316|536938718|FG001|Overall Study|Death|5|||
148853715|NCT01005316|536938719|FG002|Overall Study|Death|1|||
148853716|NCT01005316|536938720|FG003|Overall Study|Death|15|||
148853717|NCT01005316|536938717|FG000|Overall Study|Study Termination|5|||
148853718|NCT01005316|536938718|FG001|Overall Study|Study Termination|63|||
148853719|NCT01005316|536938719|FG002|Overall Study|Study Termination|9|||
148853720|NCT01005316|536938720|FG003|Overall Study|Study Termination|85|||
148853721|NCT01005316|536938717|FG000|Overall Study|Lost to Follow-up|1|||
148853722|NCT01005316|536938718|FG001|Overall Study|Lost to Follow-up|3|||
148853723|NCT01005316|536938719|FG002|Overall Study|Lost to Follow-up|0|||
148853724|NCT01005316|536938720|FG003|Overall Study|Lost to Follow-up|2|||
148853725|NCT01005316|536938717|FG000|Overall Study|Physician Decision|6|||
148853726|NCT01005316|536938718|FG001|Overall Study|Physician Decision|0|||
148853727|NCT01005316|536938719|FG002|Overall Study|Physician Decision|0|||
148853728|NCT01005316|536938720|FG003|Overall Study|Physician Decision|0|||
148853729|NCT01005316|536938717|FG000|Overall Study|Sponsor Decision|6|||
148853730|NCT01005316|536938718|FG001|Overall Study|Sponsor Decision|3|||
148853731|NCT01005316|536938719|FG002|Overall Study|Sponsor Decision|0|||
148853732|NCT01005316|536938720|FG003|Overall Study|Sponsor Decision|0|||
148853733|NCT01005316|536938717|FG000|Overall Study|Withdrawal by Subject|1|||
148853734|NCT01005316|536938718|FG001|Overall Study|Withdrawal by Subject|1|||
148853735|NCT01005316|536938719|FG002|Overall Study|Withdrawal by Subject|0|||
148853736|NCT01005316|536938720|FG003|Overall Study|Withdrawal by Subject|2|||
148853737|NCT01005316|536938717|FG000|Overall Study|Consented to Another Study|2|||
148853738|NCT01005316|536938718|FG001|Overall Study|Consented to Another Study|0|||
148853739|NCT01005316|536938719|FG002|Overall Study|Consented to Another Study|0|||
148853740|NCT01005316|536938720|FG003|Overall Study|Consented to Another Study|0|||
148853741|NCT01005316|536938717|FG000|Overall Study|Delisted|8|||
148853742|NCT01005316|536938718|FG001|Overall Study|Delisted|0|||
148853743|NCT01005316|536938719|FG002|Overall Study|Delisted|0|||
148853744|NCT01005316|536938720|FG003|Overall Study|Delisted|0|||
148853745|NCT01005316|536938717|FG000|Overall Study|Transferred Care|1|||
148853746|NCT01005316|536938718|FG001|Overall Study|Transferred Care|0|||
148853747|NCT01005316|536938719|FG002|Overall Study|Transferred Care|1|||
148853748|NCT01005316|536938720|FG003|Overall Study|Transferred Care|3|||
148853749|NCT01005316|536938717|FG000|Overall Study|Retransplanted|0|||
148853750|NCT01005316|536938718|FG001|Overall Study|Retransplanted|1|||
148853751|NCT01005316|536938719|FG002|Overall Study|Retransplanted|0|||
148853752|NCT01005316|536938720|FG003|Overall Study|Retransplanted|0|||
148853753|NCT02516098|536938723|FG000|Period 1|Protocol Violation|1|||
148853754|NCT02516098|536938724|FG001|Period 1|Protocol Violation|0|||
148853755|NCT02516098|536938723|FG000|Washout After Period 1|Adverse Event|0|||
148853756|NCT02516098|536938724|FG001|Washout After Period 1|Adverse Event|1|||
148853757|NCT02516098|536938723|FG000|Period 2|Withdrawal by Subject|0|||
148853758|NCT02516098|536938724|FG001|Period 2|Withdrawal by Subject|1|||
148853759|NCT01734395|536938725|FG000|Overall Study|Other|65|||
148853760|NCT01734395|536938725|FG000|Overall Study|Lost to Follow-up|287|||
148853761|NCT01734395|536938725|FG000|Overall Study|Lack of Efficacy|5|||
148853762|NCT01734395|536938725|FG000|Overall Study|Adverse Event|40|||
148853763|NCT01734395|536938725|FG000|Overall Study|Withdrawal by Subject|10|||
148853764|NCT01734395|536938725|FG000|Overall Study|Missing the reasons for not completed|3|||
148853765|NCT04026009|536938728|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148853766|NCT04026009|536938729|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148853767|NCT04026009|536938730|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
148853768|NCT04026009|536938731|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
148853769|NCT04026009|536938732|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
148853770|NCT04026009|536938728|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
148853771|NCT04026009|536938729|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
148853772|NCT04026009|536938730|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
148853773|NCT04026009|536938731|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
148853774|NCT04026009|536938732|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
148853775|NCT03748706|536938733|FG000|Overall Study|Lost to Follow-up|1|||
148853776|NCT02300558|536938737|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
148853777|NCT02300558|536938737|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
148853778|NCT02300558|536938737|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
148853779|NCT02300558|536938737|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
148853780|NCT01471028|536938738|FG000|VTI-208|Adverse Event|39|||
148853781|NCT01471028|536938739|FG001|VTI-208|Adverse Event|41|||
148853782|NCT01471028|536938738|FG000|VTI-208|Withdrawal by Subject|0|||
148853783|NCT01471028|536938739|FG001|VTI-208|Withdrawal by Subject|2|||
148853784|NCT01471028|536938738|FG000|VTI-208|Lost to Follow-up|1|||
148853785|NCT01471028|536938739|FG001|VTI-208|Lost to Follow-up|1|||
148853786|NCT01471028|536938738|FG000|VTI-208E|Death|7|||
148853787|NCT01471028|536938739|FG001|VTI-208E|Death|10|||
148853788|NCT01471028|536938738|FG000|VTI-208E|Withdrawal by Subject|1|||
148853789|NCT01471028|536938739|FG001|VTI-208E|Withdrawal by Subject|0|||
148853790|NCT01471028|536938738|FG000|VTI-208E|Lost to Follow-up|0|||
148853791|NCT01471028|536938739|FG001|VTI-208E|Lost to Follow-up|2|||
148853792|NCT00695955|536938740|FG000|Cohort 1|Adverse Event|26|||
148853793|NCT00695955|536938740|FG000|Cohort 1|Protocol Violation|2|||
148853794|NCT00695955|536938740|FG000|Cohort 1|Lost to Follow-up|30|||
148853795|NCT00695955|536938740|FG000|Cohort 1|Withdrawal by Subject|25|||
148853796|NCT00695955|536938740|FG000|Cohort 1|Lack of Efficacy|3|||
148853797|NCT00695955|536938740|FG000|Cohort 1|Other|16|||
148853798|NCT00695955|536938740|FG000|Cohort 2|Adverse Event|24|||
148853799|NCT00695955|536938740|FG000|Cohort 2|Protocol Violation|5|||
148853800|NCT00695955|536938740|FG000|Cohort 2|Lost to Follow-up|38|||
148853801|NCT00695955|536938740|FG000|Cohort 2|Withdrawal by Subject|28|||
148853802|NCT00695955|536938740|FG000|Cohort 2|Lack of Efficacy|4|||
148853803|NCT00695955|536938740|FG000|Cohort 2|Other|5|||
148853804|NCT01177553|536938743|FG000|Overall Study|babies not yet 6 months of age|1|||
148853805|NCT01177553|536938744|FG001|Overall Study|babies not yet 6 months of age|0|||
148853806|NCT02957747|536938745|FG000|Overall Study|Withdrawal by Subject|0|||
148853807|NCT02957747|536938746|FG001|Overall Study|Withdrawal by Subject|3|||
148853808|NCT02957747|536938745|FG000|Overall Study|Lost to Follow-up|10|||
148853809|NCT02957747|536938746|FG001|Overall Study|Lost to Follow-up|5|||
148853810|NCT00610857|536938748|FG000|Overall Study|Not evaluable for response|2|||
148853811|NCT04826094|536938749|FG000|Overall Study|Lost to Follow-up|2|||
148853812|NCT04826094|536938750|FG001|Overall Study|Lost to Follow-up|1|||
148853813|NCT04826094|536938751|FG002|Overall Study|Lost to Follow-up|0|||
148853814|NCT04826094|536938752|FG003|Overall Study|Lost to Follow-up|0|||
148853815|NCT04826094|536938753|FG004|Overall Study|Lost to Follow-up|1|||
148853816|NCT04826094|536938754|FG005|Overall Study|Lost to Follow-up|3|||
148853817|NCT04826094|536938755|FG006|Overall Study|Lost to Follow-up|1|||
148853818|NCT04826094|536938756|FG007|Overall Study|Lost to Follow-up|1|||
148853819|NCT04826094|536938749|FG000|Overall Study|Participant withdrew consent|1|||
148853820|NCT04826094|536938750|FG001|Overall Study|Participant withdrew consent|0|||
148853821|NCT04826094|536938751|FG002|Overall Study|Participant withdrew consent|0|||
148853822|NCT04826094|536938752|FG003|Overall Study|Participant withdrew consent|1|||
148853823|NCT04826094|536938753|FG004|Overall Study|Participant withdrew consent|1|||
148853824|NCT04826094|536938754|FG005|Overall Study|Participant withdrew consent|1|||
148853825|NCT04826094|536938755|FG006|Overall Study|Participant withdrew consent|0|||
148853826|NCT04826094|536938756|FG007|Overall Study|Participant withdrew consent|1|||
148853827|NCT04826094|536938749|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
148853828|NCT04826094|536938750|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
148853829|NCT04826094|536938751|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
148853830|NCT04826094|536938752|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
148986807|NCT00968669|537430552|FG002|Overall Study|EARLY WITHDRAWAL|0|||
148853831|NCT04826094|536938753|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
148853832|NCT04826094|536938754|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
148853833|NCT04826094|536938755|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
148853834|NCT04826094|536938756|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
148853835|NCT04826094|536938749|FG000|Overall Study|Withdrawn by Investigator|0|||
148853836|NCT04826094|536938750|FG001|Overall Study|Withdrawn by Investigator|0|||
148853837|NCT04826094|536938751|FG002|Overall Study|Withdrawn by Investigator|0|||
148853838|NCT04826094|536938752|FG003|Overall Study|Withdrawn by Investigator|0|||
148853839|NCT04826094|536938753|FG004|Overall Study|Withdrawn by Investigator|0|||
148986808|NCT00968669|537430553|FG003|Overall Study|EARLY WITHDRAWAL|0|||
148853840|NCT04826094|536938754|FG005|Overall Study|Withdrawn by Investigator|1|||
148853841|NCT04826094|536938755|FG006|Overall Study|Withdrawn by Investigator|0|||
148853842|NCT04826094|536938756|FG007|Overall Study|Withdrawn by Investigator|1|||
148853843|NCT04826094|536938749|FG000|Overall Study|Other: Moved from area|1|||
148853844|NCT04826094|536938750|FG001|Overall Study|Other: Moved from area|1|||
148853845|NCT04826094|536938751|FG002|Overall Study|Other: Moved from area|1|||
148853846|NCT04826094|536938752|FG003|Overall Study|Other: Moved from area|0|||
148853847|NCT04826094|536938753|FG004|Overall Study|Other: Moved from area|0|||
148853848|NCT04826094|536938754|FG005|Overall Study|Other: Moved from area|0|||
148853849|NCT04826094|536938755|FG006|Overall Study|Other: Moved from area|0|||
148853850|NCT04826094|536938756|FG007|Overall Study|Other: Moved from area|0|||
148853851|NCT04826094|536938749|FG000|Overall Study|Other: Declined|0|||
148853852|NCT04826094|536938750|FG001|Overall Study|Other: Declined|0|||
148853853|NCT04826094|536938751|FG002|Overall Study|Other: Declined|0|||
148853854|NCT04826094|536938752|FG003|Overall Study|Other: Declined|0|||
148853855|NCT04826094|536938753|FG004|Overall Study|Other: Declined|1|||
148853856|NCT04826094|536938754|FG005|Overall Study|Other: Declined|0|||
148853857|NCT04826094|536938755|FG006|Overall Study|Other: Declined|0|||
148853858|NCT04826094|536938756|FG007|Overall Study|Other: Declined|0|||
148853859|NCT04826094|536938749|FG000|Overall Study|Other: Vaccine not administered|0|||
148853860|NCT04826094|536938750|FG001|Overall Study|Other: Vaccine not administered|0|||
148853861|NCT04826094|536938751|FG002|Overall Study|Other: Vaccine not administered|1|||
148853862|NCT04826094|536938752|FG003|Overall Study|Other: Vaccine not administered|0|||
148853863|NCT04826094|536938753|FG004|Overall Study|Other: Vaccine not administered|0|||
148853864|NCT04826094|536938754|FG005|Overall Study|Other: Vaccine not administered|1|||
148853865|NCT04826094|536938755|FG006|Overall Study|Other: Vaccine not administered|1|||
148853866|NCT04826094|536938756|FG007|Overall Study|Other: Vaccine not administered|3|||
148853867|NCT02151903|536938757|FG000|Overall Study|Withdrawal by Subject|1|||
148853868|NCT02151903|536938758|FG001|Overall Study|Withdrawal by Subject|0|||
148853869|NCT02151903|536938757|FG000|Overall Study|Progressive disease|2|||
148853870|NCT02151903|536938758|FG001|Overall Study|Progressive disease|1|||
148853871|NCT02466425|536938762|FG000|Overall Study|Adverse Event|3|||
148853872|NCT02466425|536938763|FG001|Overall Study|Adverse Event|11|||
148853873|NCT02466425|536938762|FG000|Overall Study|Lack of Efficacy|4|||
148853874|NCT02466425|536938763|FG001|Overall Study|Lack of Efficacy|1|||
148853875|NCT02466425|536938762|FG000|Overall Study|Lost to Follow-up|3|||
148853876|NCT02466425|536938763|FG001|Overall Study|Lost to Follow-up|0|||
148853877|NCT02466425|536938762|FG000|Overall Study|Protocol Violation|1|||
148853878|NCT02466425|536938763|FG001|Overall Study|Protocol Violation|0|||
148853879|NCT02466425|536938762|FG000|Overall Study|Withdrawal by Subject|0|||
148853880|NCT02466425|536938763|FG001|Overall Study|Withdrawal by Subject|1|||
148853881|NCT02466425|536938762|FG000|Overall Study|Other|1|||
148853882|NCT02466425|536938763|FG001|Overall Study|Other|3|||
148853883|NCT02466425|536938762|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
148853884|NCT02466425|536938763|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
148853885|NCT01721486|536938774|FG000|Overall Study|Protocol Violation|1|||
148853886|NCT01721486|536938775|FG001|Overall Study|Protocol Violation|0|||
148853887|NCT01721486|536938774|FG000|Overall Study|Physician Decision|0|||
148853888|NCT01721486|536938775|FG001|Overall Study|Physician Decision|1|||
148853889|NCT01917929|536938776|FG000|Overall Study|Death|8|||
148853890|NCT01917929|536938776|FG000|Overall Study|Lost to Follow-up|19|||
148853891|NCT01917929|536938776|FG000|Overall Study|Withdrawal by Subject|33|||
148853892|NCT01917929|536938776|FG000|Overall Study|Adverse Event|6|||
148853893|NCT01917929|536938776|FG000|Overall Study|Investigative Site Terminated|35|||
148853894|NCT01917929|536938776|FG000|Overall Study|Censored because study device not implanted|6|||
148853895|NCT01917929|536938776|FG000|Overall Study|Censored because surgery not performed|3|||
148853896|NCT01917929|536938776|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
148853897|NCT01917929|536938776|FG000|Overall Study|Sponsor terminated study|175|||
148853898|NCT00673231|536938777|FG000|Overall Study|Withdrawal by Subject|14|||
148853899|NCT00673231|536938778|FG001|Overall Study|Withdrawal by Subject|10|||
148853900|NCT00673231|536938779|FG002|Overall Study|Withdrawal by Subject|8|||
148853901|NCT00673231|536938780|FG003|Overall Study|Withdrawal by Subject|6|||
148853902|NCT00673231|536938777|FG000|Overall Study|Adverse Event|6|||
148853903|NCT00673231|536938778|FG001|Overall Study|Adverse Event|5|||
148853904|NCT00673231|536938779|FG002|Overall Study|Adverse Event|9|||
148853905|NCT00673231|536938780|FG003|Overall Study|Adverse Event|6|||
148853906|NCT00673231|536938777|FG000|Overall Study|Lost to Follow-up|1|||
148853907|NCT00673231|536938778|FG001|Overall Study|Lost to Follow-up|2|||
148853908|NCT00673231|536938779|FG002|Overall Study|Lost to Follow-up|1|||
148853909|NCT00673231|536938780|FG003|Overall Study|Lost to Follow-up|2|||
148853910|NCT00673231|536938777|FG000|Overall Study|Death|0|||
148853911|NCT00673231|536938778|FG001|Overall Study|Death|0|||
148853912|NCT00673231|536938779|FG002|Overall Study|Death|1|||
148853913|NCT00673231|536938780|FG003|Overall Study|Death|0|||
148853914|NCT00673231|536938777|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
148853915|NCT00673231|536938778|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
148853916|NCT00673231|536938779|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
148853917|NCT00673231|536938780|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
148853918|NCT03594747|536938781|FG000|Overall Study|Death|78|||
148853919|NCT03594747|536938782|FG001|Overall Study|Death|86|||
148853920|NCT03594747|536938783|FG002|Overall Study|Death|87|||
148853921|NCT03594747|536938781|FG000|Overall Study|Withdrawal by Subject|5|||
148853922|NCT03594747|536938782|FG001|Overall Study|Withdrawal by Subject|2|||
148853923|NCT03594747|536938783|FG002|Overall Study|Withdrawal by Subject|11|||
148853924|NCT03594747|536938781|FG000|Overall Study|Lost to Follow-up|4|||
148853925|NCT03594747|536938782|FG001|Overall Study|Lost to Follow-up|1|||
148853926|NCT03594747|536938783|FG002|Overall Study|Lost to Follow-up|1|||
148853927|NCT03594747|536938781|FG000|Overall Study|Physician Decision|0|||
148853928|NCT03594747|536938782|FG001|Overall Study|Physician Decision|1|||
148853929|NCT03594747|536938783|FG002|Overall Study|Physician Decision|0|||
148853930|NCT03594747|536938781|FG000|Overall Study|Sponsor decision|23|||
148853931|NCT03594747|536938782|FG001|Overall Study|Sponsor decision|17|||
148853932|NCT03594747|536938783|FG002|Overall Study|Sponsor decision|16|||
148853933|NCT03594747|536938781|FG000|Overall Study|Did not meet inclusion criteria|0|||
148853934|NCT03594747|536938782|FG001|Overall Study|Did not meet inclusion criteria|0|||
148853935|NCT03594747|536938783|FG002|Overall Study|Did not meet inclusion criteria|1|||
148853936|NCT03594747|536938781|FG000|Overall Study|Transfer to long term extension study|10|||
148853937|NCT03594747|536938782|FG001|Overall Study|Transfer to long term extension study|12|||
148853938|NCT03594747|536938783|FG002|Overall Study|Transfer to long term extension study|5|||
148853939|NCT03028415|536938784|FG000|Overall Study|Lost to Follow-up|6|||
148853940|NCT03028415|536938785|FG001|Overall Study|Lost to Follow-up|3|||
148853941|NCT03028415|536938784|FG000|Overall Study|Withdrawal by Subject|1|||
148853942|NCT03028415|536938785|FG001|Overall Study|Withdrawal by Subject|0|||
148853943|NCT03028415|536938784|FG000|Overall Study|Discontinued due to COVID-19|1|||
148853944|NCT03028415|536938785|FG001|Overall Study|Discontinued due to COVID-19|0|||
148853945|NCT02907216|536938786|FG000|Overall Study|No benefit to be obtained by continuing|0|||
148853946|NCT02907216|536938787|FG001|Overall Study|No benefit to be obtained by continuing|1|||
148853947|NCT02907216|536938786|FG000|Overall Study|Withdrawal by Subject|1|||
148853948|NCT02907216|536938787|FG001|Overall Study|Withdrawal by Subject|0|||
148853949|NCT02095873|536938789|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
148853950|NCT02095873|536938790|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
148853951|NCT02095873|536938789|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
148853952|NCT02095873|536938790|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
148853953|NCT02095873|536938789|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
148853954|NCT02095873|536938790|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
148853955|NCT00792740|536938791|FG000|Overall Study|Disease Worsening|3|||
148853956|NCT00792740|536938792|FG001|Overall Study|Disease Worsening|2|||
148853957|NCT00792740|536938791|FG000|Overall Study|Personal Reason|1|||
148853958|NCT00792740|536938792|FG001|Overall Study|Personal Reason|0|||
148853959|NCT00792740|536938791|FG000|Overall Study|Adverse Event|1|||
148853960|NCT00792740|536938792|FG001|Overall Study|Adverse Event|3|||
148853961|NCT00792740|536938791|FG000|Overall Study|Patient's withdrawal of consent|0|||
148853962|NCT00792740|536938792|FG001|Overall Study|Patient's withdrawal of consent|1|||
148853963|NCT00792740|536938791|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
148853964|NCT00792740|536938792|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
148853965|NCT00792740|536938791|FG000|Overall Study|Other reasons|0|||
148853966|NCT00792740|536938792|FG001|Overall Study|Other reasons|1|||
148853967|NCT02485639|536938797|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
148853968|NCT02485639|536938797|FG000|Overall Study|Early termination|4|||
148853969|NCT02485639|536938797|FG000|Overall Study|Withdrawal by Subject|4|||
148853970|NCT02016716|536938798|FG000|Overall Study|Withdrawal by Subject|5|||
148853971|NCT02016716|536938799|FG001|Overall Study|Withdrawal by Subject|5|||
148853972|NCT02016716|536938800|FG002|Overall Study|Withdrawal by Subject|5|||
148853973|NCT02016716|536938798|FG000|Overall Study|Protocol-specified Criteria|0|||
148853974|NCT02016716|536938799|FG001|Overall Study|Protocol-specified Criteria|1|||
148853975|NCT02016716|536938800|FG002|Overall Study|Protocol-specified Criteria|0|||
148853976|NCT02016716|536938798|FG000|Overall Study|Lost to Follow-up|1|||
148853977|NCT02016716|536938799|FG001|Overall Study|Lost to Follow-up|2|||
148853978|NCT02016716|536938800|FG002|Overall Study|Lost to Follow-up|1|||
148853979|NCT00107900|536938803|FG000|Overall Study|Adverse Event|3|||
148853980|NCT00107900|536938804|FG001|Overall Study|Adverse Event|2|||
148853981|NCT00107900|536938805|FG002|Overall Study|Adverse Event|10|||
148853982|NCT00107900|536938806|FG003|Overall Study|Adverse Event|3|||
148853983|NCT00107900|536938807|FG004|Overall Study|Adverse Event|5|||
148853984|NCT00107900|536938808|FG005|Overall Study|Adverse Event|3|||
148853985|NCT00107900|536938803|FG000|Overall Study|Death|0|||
148853986|NCT00107900|536938804|FG001|Overall Study|Death|0|||
148853987|NCT00107900|536938805|FG002|Overall Study|Death|0|||
148853988|NCT00107900|536938806|FG003|Overall Study|Death|0|||
148853989|NCT00107900|536938807|FG004|Overall Study|Death|1|||
148853990|NCT00107900|536938808|FG005|Overall Study|Death|0|||
148853991|NCT00107900|536938803|FG000|Overall Study|Lost to Follow-up|4|||
148853992|NCT00107900|536938804|FG001|Overall Study|Lost to Follow-up|1|||
148853993|NCT00107900|536938805|FG002|Overall Study|Lost to Follow-up|3|||
148853994|NCT00107900|536938806|FG003|Overall Study|Lost to Follow-up|2|||
148853995|NCT00107900|536938807|FG004|Overall Study|Lost to Follow-up|5|||
148853996|NCT00107900|536938808|FG005|Overall Study|Lost to Follow-up|5|||
148853997|NCT00107900|536938803|FG000|Overall Study|Protocol Violation|1|||
148853998|NCT00107900|536938804|FG001|Overall Study|Protocol Violation|0|||
148853999|NCT00107900|536938805|FG002|Overall Study|Protocol Violation|5|||
148854000|NCT00107900|536938806|FG003|Overall Study|Protocol Violation|5|||
148854001|NCT00107900|536938807|FG004|Overall Study|Protocol Violation|7|||
148854002|NCT00107900|536938808|FG005|Overall Study|Protocol Violation|0|||
148854003|NCT00107900|536938803|FG000|Overall Study|Withdrawal by Subject|1|||
148854004|NCT00107900|536938804|FG001|Overall Study|Withdrawal by Subject|0|||
148854005|NCT00107900|536938805|FG002|Overall Study|Withdrawal by Subject|5|||
148854006|NCT00107900|536938806|FG003|Overall Study|Withdrawal by Subject|0|||
148854007|NCT00107900|536938807|FG004|Overall Study|Withdrawal by Subject|1|||
148854008|NCT00107900|536938808|FG005|Overall Study|Withdrawal by Subject|1|||
148854009|NCT00107900|536938803|FG000|Overall Study|Administrative Reasons|1|||
148854010|NCT00107900|536938804|FG001|Overall Study|Administrative Reasons|0|||
148854011|NCT00107900|536938805|FG002|Overall Study|Administrative Reasons|2|||
148854012|NCT00107900|536938806|FG003|Overall Study|Administrative Reasons|2|||
148854013|NCT00107900|536938807|FG004|Overall Study|Administrative Reasons|2|||
148854014|NCT00107900|536938808|FG005|Overall Study|Administrative Reasons|0|||
148854015|NCT00394251|536941264|FG000|Overall Study|Adverse Event|7|||
148854016|NCT00394251|536941265|FG001|Overall Study|Adverse Event|5|||
148854017|NCT00394251|536941264|FG000|Overall Study|Unacceptable Toxicity|20|||
148854018|NCT00394251|536941265|FG001|Overall Study|Unacceptable Toxicity|18|||
148854019|NCT00394251|536941264|FG000|Overall Study|Physician Decision|1|||
148854020|NCT00394251|536941265|FG001|Overall Study|Physician Decision|1|||
148854021|NCT00394251|536941264|FG000|Overall Study|Protocol Violation|0|||
148854022|NCT00394251|536941265|FG001|Overall Study|Protocol Violation|1|||
148854023|NCT00394251|536941264|FG000|Overall Study|Withdrawal by Subject|7|||
148854024|NCT00394251|536941265|FG001|Overall Study|Withdrawal by Subject|11|||
148854025|NCT00394251|536941264|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
148854026|NCT00394251|536941265|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
148854027|NCT04644276|536941266|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
148854028|NCT04644276|536941267|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
148854029|NCT04644276|536941268|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
148854030|NCT01667224|536941269|FG000|Overall Study|Withdrawal by Subject|3|||
148854031|NCT01667224|536941270|FG001|Overall Study|Withdrawal by Subject|1|||
148854032|NCT01667224|536941269|FG000|Overall Study|Protocol Violation|1|||
148854033|NCT01667224|536941270|FG001|Overall Study|Protocol Violation|1|||
148854034|NCT01811485|536941271|FG000|Overall Study|Adverse Event|1|||
148854035|NCT01811485|536941272|FG001|Overall Study|Adverse Event|3|||
148854036|NCT01811485|536941273|FG002|Overall Study|Adverse Event|2|||
148854037|NCT01811485|536941271|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148854038|NCT01811485|536941272|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148854039|NCT01811485|536941273|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
148854040|NCT01811485|536941271|FG000|Overall Study|Administrative problems|1|||
148854041|NCT01811485|536941272|FG001|Overall Study|Administrative problems|0|||
148854042|NCT01811485|536941273|FG002|Overall Study|Administrative problems|0|||
148854043|NCT01811485|536941271|FG000|Overall Study|Protocol Deviation|0|||
148854044|NCT01811485|536941272|FG001|Overall Study|Protocol Deviation|1|||
148854045|NCT01811485|536941273|FG002|Overall Study|Protocol Deviation|0|||
148854046|NCT03764631|536941274|FG000|Overall Study|Personal Reasons|3|||
148854047|NCT03764631|536941275|FG001|Overall Study|Personal Reasons|2|||
148854048|NCT03764631|536941274|FG000|Overall Study|Switching Therapy|3|||
148854049|NCT03764631|536941275|FG001|Overall Study|Switching Therapy|3|||
148854050|NCT03764631|536941274|FG000|Overall Study|Adverse Event|0|||
148854051|NCT03764631|536941275|FG001|Overall Study|Adverse Event|1|||
148854052|NCT03764631|536941274|FG000|Overall Study|Lost to Follow-up|33|||
148854053|NCT03764631|536941275|FG001|Overall Study|Lost to Follow-up|41|||
148854054|NCT03764631|536941274|FG000|Overall Study|No data as study site was closed|2|||
148854055|NCT03764631|536941275|FG001|Overall Study|No data as study site was closed|6|||
148854056|NCT03275246|536941278|FG000|Overall Study|Protocol Violation|5|||
148854057|NCT03275246|536941278|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
148854058|NCT02570152|536941279|FG000|Overall Study|Protocol Violation|2|||
148854059|NCT02570152|536941279|FG000|Overall Study|Migrated/moved from study area|13|||
148854060|NCT03497975|536941281|FG000|Overall Study|Withdrew Consent|34|||
148854061|NCT03497975|536941282|FG001|Overall Study|Withdrew Consent|35|||
148854062|NCT03497975|536941281|FG000|Overall Study|Lost to Follow-up|7|||
148854063|NCT03497975|536941282|FG001|Overall Study|Lost to Follow-up|7|||
148854064|NCT03497975|536941281|FG000|Overall Study|Physician Decision|4|||
148854065|NCT03497975|536941282|FG001|Overall Study|Physician Decision|5|||
148854066|NCT03497975|536941281|FG000|Overall Study|Discontinued|42|||
148854067|NCT03497975|536941282|FG001|Overall Study|Discontinued|39|||
148854068|NCT03497975|536941281|FG000|Overall Study|Reason Not Specified|15|||
148854069|NCT03497975|536941282|FG001|Overall Study|Reason Not Specified|14|||
148854070|NCT01296711|536941283|FG000|Overall Study|Adverse Event|3|||
148854071|NCT01296711|536941284|FG001|Overall Study|Adverse Event|1|||
148854072|NCT01296711|536941285|FG002|Overall Study|Adverse Event|4|||
148854073|NCT01296711|536941286|FG003|Overall Study|Adverse Event|3|||
148854074|NCT01296711|536941287|FG004|Overall Study|Adverse Event|1|||
148854075|NCT01296711|536941288|FG005|Overall Study|Adverse Event|6|||
148854076|NCT01296711|536941289|FG006|Overall Study|Adverse Event|11|||
148854077|NCT01296711|536941290|FG007|Overall Study|Adverse Event|3|||
148854078|NCT01296711|536941283|FG000|Overall Study|Lack of Efficacy|1|||
148854079|NCT01296711|536941284|FG001|Overall Study|Lack of Efficacy|4|||
148854080|NCT01296711|536941285|FG002|Overall Study|Lack of Efficacy|1|||
148854081|NCT01296711|536941286|FG003|Overall Study|Lack of Efficacy|1|||
148854082|NCT01296711|536941287|FG004|Overall Study|Lack of Efficacy|1|||
148854083|NCT01296711|536941288|FG005|Overall Study|Lack of Efficacy|0|||
148854084|NCT01296711|536941289|FG006|Overall Study|Lack of Efficacy|2|||
148854085|NCT01296711|536941290|FG007|Overall Study|Lack of Efficacy|3|||
148854086|NCT01296711|536941283|FG000|Overall Study|Lost to Follow-up|0|||
148854087|NCT01296711|536941284|FG001|Overall Study|Lost to Follow-up|0|||
148854088|NCT01296711|536941285|FG002|Overall Study|Lost to Follow-up|1|||
148854089|NCT01296711|536941286|FG003|Overall Study|Lost to Follow-up|1|||
148854090|NCT01296711|536941287|FG004|Overall Study|Lost to Follow-up|2|||
148854091|NCT01296711|536941288|FG005|Overall Study|Lost to Follow-up|0|||
148854092|NCT01296711|536941289|FG006|Overall Study|Lost to Follow-up|4|||
148854093|NCT01296711|536941290|FG007|Overall Study|Lost to Follow-up|2|||
148854094|NCT01296711|536941283|FG000|Overall Study|Protocol Violation|0|||
148854095|NCT01296711|536941284|FG001|Overall Study|Protocol Violation|0|||
148854096|NCT01296711|536941285|FG002|Overall Study|Protocol Violation|0|||
148854097|NCT01296711|536941286|FG003|Overall Study|Protocol Violation|1|||
148854098|NCT01296711|536941287|FG004|Overall Study|Protocol Violation|1|||
148854099|NCT01296711|536941288|FG005|Overall Study|Protocol Violation|0|||
148854100|NCT01296711|536941289|FG006|Overall Study|Protocol Violation|0|||
148854101|NCT01296711|536941290|FG007|Overall Study|Protocol Violation|0|||
148854102|NCT01296711|536941283|FG000|Overall Study|Withdrawal by Subject|4|||
148854103|NCT01296711|536941284|FG001|Overall Study|Withdrawal by Subject|2|||
148854104|NCT01296711|536941285|FG002|Overall Study|Withdrawal by Subject|2|||
148854105|NCT01296711|536941286|FG003|Overall Study|Withdrawal by Subject|1|||
148854106|NCT01296711|536941287|FG004|Overall Study|Withdrawal by Subject|1|||
148854107|NCT01296711|536941288|FG005|Overall Study|Withdrawal by Subject|1|||
148854108|NCT01296711|536941289|FG006|Overall Study|Withdrawal by Subject|2|||
148854109|NCT01296711|536941290|FG007|Overall Study|Withdrawal by Subject|1|||
148854110|NCT01296711|536941283|FG000|Overall Study|Study termination|8|||
148854111|NCT01296711|536941284|FG001|Overall Study|Study termination|1|||
148854112|NCT01296711|536941285|FG002|Overall Study|Study termination|5|||
148854113|NCT01296711|536941286|FG003|Overall Study|Study termination|4|||
148854114|NCT01296711|536941287|FG004|Overall Study|Study termination|4|||
148854115|NCT01296711|536941288|FG005|Overall Study|Study termination|4|||
148854116|NCT01296711|536941289|FG006|Overall Study|Study termination|8|||
148854117|NCT01296711|536941290|FG007|Overall Study|Study termination|10|||
148854118|NCT01296711|536941283|FG000|Overall Study|Continued elevated liver enzymes|0|||
148854119|NCT01296711|536941284|FG001|Overall Study|Continued elevated liver enzymes|0|||
148854120|NCT01296711|536941285|FG002|Overall Study|Continued elevated liver enzymes|0|||
148854121|NCT01296711|536941286|FG003|Overall Study|Continued elevated liver enzymes|1|||
148854122|NCT01296711|536941287|FG004|Overall Study|Continued elevated liver enzymes|0|||
148854123|NCT01296711|536941288|FG005|Overall Study|Continued elevated liver enzymes|0|||
148854124|NCT01296711|536941289|FG006|Overall Study|Continued elevated liver enzymes|0|||
148854125|NCT01296711|536941290|FG007|Overall Study|Continued elevated liver enzymes|0|||
148854126|NCT01296711|536941283|FG000|Overall Study|Methotrexate discontinued|0|||
148854127|NCT01296711|536941284|FG001|Overall Study|Methotrexate discontinued|0|||
148854128|NCT01296711|536941285|FG002|Overall Study|Methotrexate discontinued|0|||
148854129|NCT01296711|536941286|FG003|Overall Study|Methotrexate discontinued|1|||
148854130|NCT01296711|536941287|FG004|Overall Study|Methotrexate discontinued|0|||
148854131|NCT01296711|536941288|FG005|Overall Study|Methotrexate discontinued|0|||
149030314|NCT00561574|537587995|FG000|Overall Study|Reason Unrelated to Trial|6|||
149030315|NCT00561574|537587996|FG001|Overall Study|Reason Unrelated to Trial|2|||
148854132|NCT01296711|536941289|FG006|Overall Study|Methotrexate discontinued|0|||
148854133|NCT01296711|536941290|FG007|Overall Study|Methotrexate discontinued|0|||
148854134|NCT01296711|536941283|FG000|Overall Study|Investigator discretion|0|||
148854135|NCT01296711|536941284|FG001|Overall Study|Investigator discretion|0|||
148854136|NCT01296711|536941285|FG002|Overall Study|Investigator discretion|0|||
148854137|NCT01296711|536941286|FG003|Overall Study|Investigator discretion|0|||
148854138|NCT01296711|536941287|FG004|Overall Study|Investigator discretion|0|||
148854139|NCT01296711|536941288|FG005|Overall Study|Investigator discretion|0|||
148854140|NCT01296711|536941289|FG006|Overall Study|Investigator discretion|1|||
148854141|NCT01296711|536941290|FG007|Overall Study|Investigator discretion|0|||
148854142|NCT01296711|536941283|FG000|Overall Study|Other|0|||
148854143|NCT01296711|536941284|FG001|Overall Study|Other|0|||
148854144|NCT01296711|536941285|FG002|Overall Study|Other|0|||
148854145|NCT01296711|536941286|FG003|Overall Study|Other|0|||
148854146|NCT01296711|536941287|FG004|Overall Study|Other|0|||
148854147|NCT01296711|536941288|FG005|Overall Study|Other|0|||
148854148|NCT01296711|536941289|FG006|Overall Study|Other|1|||
148854149|NCT01296711|536941290|FG007|Overall Study|Other|0|||
148854150|NCT01296711|536941283|FG000|Overall Study|Required restricted steroid injections|0|||
148854151|NCT01296711|536941284|FG001|Overall Study|Required restricted steroid injections|0|||
148854152|NCT01296711|536941285|FG002|Overall Study|Required restricted steroid injections|0|||
148854153|NCT01296711|536941286|FG003|Overall Study|Required restricted steroid injections|0|||
148854154|NCT01296711|536941287|FG004|Overall Study|Required restricted steroid injections|0|||
148854155|NCT01296711|536941288|FG005|Overall Study|Required restricted steroid injections|0|||
148854156|NCT01296711|536941289|FG006|Overall Study|Required restricted steroid injections|1|||
148854157|NCT01296711|536941290|FG007|Overall Study|Required restricted steroid injections|0|||
148854158|NCT01296711|536941283|FG000|Overall Study|Ongoing missed appointments|0|||
148854159|NCT01296711|536941284|FG001|Overall Study|Ongoing missed appointments|0|||
148854160|NCT01296711|536941285|FG002|Overall Study|Ongoing missed appointments|0|||
148854161|NCT01296711|536941286|FG003|Overall Study|Ongoing missed appointments|0|||
148854162|NCT01296711|536941287|FG004|Overall Study|Ongoing missed appointments|0|||
148854163|NCT01296711|536941288|FG005|Overall Study|Ongoing missed appointments|0|||
148854164|NCT01296711|536941289|FG006|Overall Study|Ongoing missed appointments|1|||
148854165|NCT01296711|536941290|FG007|Overall Study|Ongoing missed appointments|0|||
148854166|NCT01296711|536941283|FG000|Overall Study|Failure to comply with visits|0|||
148854167|NCT01296711|536941284|FG001|Overall Study|Failure to comply with visits|0|||
148854168|NCT01296711|536941285|FG002|Overall Study|Failure to comply with visits|0|||
148854169|NCT01296711|536941286|FG003|Overall Study|Failure to comply with visits|0|||
148854170|NCT01296711|536941287|FG004|Overall Study|Failure to comply with visits|0|||
148854171|NCT01296711|536941288|FG005|Overall Study|Failure to comply with visits|0|||
148854172|NCT01296711|536941289|FG006|Overall Study|Failure to comply with visits|0|||
148854173|NCT01296711|536941290|FG007|Overall Study|Failure to comply with visits|1|||
148854174|NCT01296711|536941283|FG000|Overall Study|Patient decision due to transport|0|||
148854175|NCT01296711|536941284|FG001|Overall Study|Patient decision due to transport|0|||
148854176|NCT01296711|536941285|FG002|Overall Study|Patient decision due to transport|0|||
148854177|NCT01296711|536941286|FG003|Overall Study|Patient decision due to transport|0|||
148854178|NCT01296711|536941287|FG004|Overall Study|Patient decision due to transport|0|||
148854179|NCT01296711|536941288|FG005|Overall Study|Patient decision due to transport|0|||
148854180|NCT01296711|536941289|FG006|Overall Study|Patient decision due to transport|0|||
148854181|NCT01296711|536941290|FG007|Overall Study|Patient decision due to transport|1|||
148854182|NCT00632827|536941291|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
148854183|NCT00632827|536941291|FG000|Overall Study|Death|2|||
148854184|NCT00632827|536941291|FG000|Overall Study|Adverse Event|5|||
148854185|NCT00632827|536941291|FG000|Overall Study|Lost to Follow-up|1|||
148854186|NCT01035463|536941292|FG000|Overall Study|Adverse Event|0|||
148854187|NCT01035463|536941293|FG001|Overall Study|Adverse Event|0|||
148854188|NCT01035463|536941294|FG002|Overall Study|Adverse Event|4|||
148854189|NCT01035463|536941295|FG003|Overall Study|Adverse Event|1|||
148854190|NCT01035463|536941296|FG004|Overall Study|Adverse Event|5|||
148854191|NCT01035463|536941297|FG005|Overall Study|Adverse Event|7|||
148854192|NCT01035463|536941292|FG000|Overall Study|Withdrawal by Subject|0|||
148854193|NCT01035463|536941293|FG001|Overall Study|Withdrawal by Subject|2|||
148854194|NCT01035463|536941294|FG002|Overall Study|Withdrawal by Subject|1|||
148854195|NCT01035463|536941295|FG003|Overall Study|Withdrawal by Subject|0|||
148854196|NCT01035463|536941296|FG004|Overall Study|Withdrawal by Subject|1|||
148854197|NCT01035463|536941297|FG005|Overall Study|Withdrawal by Subject|4|||
148854198|NCT01035463|536941292|FG000|Overall Study|Disease progression|0|||
148854199|NCT01035463|536941293|FG001|Overall Study|Disease progression|0|||
148854200|NCT01035463|536941294|FG002|Overall Study|Disease progression|0|||
148854201|NCT01035463|536941295|FG003|Overall Study|Disease progression|0|||
148854202|NCT01035463|536941296|FG004|Overall Study|Disease progression|0|||
148854203|NCT01035463|536941297|FG005|Overall Study|Disease progression|3|||
148854204|NCT01035463|536941292|FG000|Overall Study|Other Malignancy|0|||
148854205|NCT01035463|536941293|FG001|Overall Study|Other Malignancy|0|||
148986809|NCT00968669|537430550|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
148986810|NCT00968669|537430551|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
148986811|NCT00968669|537430552|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
148986812|NCT00968669|537430553|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
148986813|NCT00968669|537430550|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
148854206|NCT01035463|536941294|FG002|Overall Study|Other Malignancy|0|||
148854207|NCT01035463|536941295|FG003|Overall Study|Other Malignancy|0|||
148854208|NCT01035463|536941296|FG004|Overall Study|Other Malignancy|0|||
148854209|NCT01035463|536941297|FG005|Overall Study|Other Malignancy|2|||
148854210|NCT01035463|536941292|FG000|Overall Study|Other|0|||
148854211|NCT01035463|536941293|FG001|Overall Study|Other|0|||
148854212|NCT01035463|536941294|FG002|Overall Study|Other|0|||
148854213|NCT01035463|536941295|FG003|Overall Study|Other|1|||
148986814|NCT00968669|537430551|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
148854214|NCT01035463|536941296|FG004|Overall Study|Other|0|||
148854215|NCT01035463|536941297|FG005|Overall Study|Other|2|||
148854216|NCT01092780|536941300|FG000|Washout Period 1|Adverse Event|0|||
148854217|NCT01092780|536941301|FG001|Washout Period 1|Adverse Event|1|||
148854218|NCT01092780|536941302|FG002|Washout Period 1|Adverse Event|0|||
148854219|NCT01092780|536941303|FG003|Washout Period 1|Adverse Event|0|||
148854220|NCT01092780|536941300|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
148854221|NCT01092780|536941301|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
148854222|NCT01092780|536941302|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
148854223|NCT01092780|536941303|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
148854224|NCT01092780|536941300|FG000|Washout Period 2|Adverse Event|0|||
148854225|NCT01092780|536941301|FG001|Washout Period 2|Adverse Event|1|||
148854226|NCT01092780|536941302|FG002|Washout Period 2|Adverse Event|1|||
148854227|NCT01092780|536941303|FG003|Washout Period 2|Adverse Event|0|||
148854228|NCT01257230|536941304|FG000|Overall Study|Not Treated|0|||
148854229|NCT01257230|536941305|FG001|Overall Study|Not Treated|0|||
148854230|NCT01257230|536941306|FG002|Overall Study|Not Treated|1|||
148854231|NCT01257230|536941304|FG000|Overall Study|Adverse Event|2|||
148854232|NCT01257230|536941305|FG001|Overall Study|Adverse Event|0|||
148854233|NCT01257230|536941306|FG002|Overall Study|Adverse Event|0|||
148854234|NCT01257230|536941304|FG000|Overall Study|Lack of Efficacy|0|||
148854235|NCT01257230|536941305|FG001|Overall Study|Lack of Efficacy|1|||
148854236|NCT01257230|536941306|FG002|Overall Study|Lack of Efficacy|0|||
148854237|NCT01257230|536941304|FG000|Overall Study|Protocol Violation|3|||
148854238|NCT01257230|536941305|FG001|Overall Study|Protocol Violation|0|||
148854239|NCT01257230|536941306|FG002|Overall Study|Protocol Violation|1|||
148854240|NCT01257230|536941304|FG000|Overall Study|Withdrawal by Subject|0|||
148854241|NCT01257230|536941305|FG001|Overall Study|Withdrawal by Subject|4|||
148854242|NCT01257230|536941306|FG002|Overall Study|Withdrawal by Subject|1|||
148854243|NCT01257230|536941304|FG000|Overall Study|Other reason not defined above|1|||
148854244|NCT01257230|536941305|FG001|Overall Study|Other reason not defined above|5|||
148854245|NCT01257230|536941306|FG002|Overall Study|Other reason not defined above|3|||
148854246|NCT01126268|536941310|FG000|Overall Study|Adverse Event|1|||
148854247|NCT01205061|536941311|FG000|Overall Study|Adverse Event|4|||
148854248|NCT01205061|536941311|FG000|Overall Study|Withdrawal by Subject|11|||
148854249|NCT01205061|536941311|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
148854250|NCT01205061|536941311|FG000|Overall Study|Lost to Follow-up|9|||
148854251|NCT01205061|536941311|FG000|Overall Study|Other|1|||
148854252|NCT00765037|536941312|FG000|Overall Study|Lost to Follow-up|5|||
148854253|NCT00765037|536941312|FG000|Overall Study|Adverse Event|1|||
148854254|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
148854255|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
148854256|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
148854257|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
148854258|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
148854259|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
148854260|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
148854261|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
148854262|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
148854263|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
148854264|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
148854265|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
148854266|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
148854267|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
148854268|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
148854269|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
148854270|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
148854271|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854272|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148986815|NCT00968669|537430552|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
148986816|NCT00968669|537430553|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
148986817|NCT00968669|537430550|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
148986818|NCT00968669|537430551|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
148986819|NCT00968669|537430552|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
148986820|NCT00968669|537430553|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
148986821|NCT00968669|537430550|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
148986822|NCT00968669|537430551|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
148986823|NCT00968669|537430552|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
148986824|NCT00968669|537430553|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
148986825|NCT00968669|537430550|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
148854273|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854274|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854275|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854276|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854277|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854278|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854279|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854280|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854281|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854282|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854283|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
148854284|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
148854285|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
148854286|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
148854287|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
148854288|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
148854289|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
148854290|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
148854291|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
148854292|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
148854293|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
148854294|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
148854295|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
148854296|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
148854297|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
148854298|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
148854299|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
148854300|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
148854301|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
148854302|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
148854303|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
148854304|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
148854305|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
148854306|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
148854307|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
148854308|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
148854309|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
148854310|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
148854311|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
148854312|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
148854313|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
148854314|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
148854315|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
148854316|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
148854317|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
148854318|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854319|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854320|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854321|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854322|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854323|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854324|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854325|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854326|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149030316|NCT00561574|537587995|FG000|Overall Study|Lost to Follow-up|1|||
149030317|NCT00561574|537587996|FG001|Overall Study|Lost to Follow-up|0|||
149030318|NCT00561574|537587995|FG000|Overall Study|Other|5|||
149030319|NCT00561574|537587996|FG001|Overall Study|Other|7|||
149030320|NCT00630864|537588002|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
149030321|NCT00630864|537588002|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
149030322|NCT05460663|537588005|FG000|Overall Study|Withdrawal by Subject|2|||
149030323|NCT05460663|537588006|FG001|Overall Study|Withdrawal by Subject|5|||
148854327|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854328|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
148854329|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
148854330|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
148854331|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
148854332|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
148854333|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854334|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854335|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854336|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149030324|NCT01645111|537589579|FG000|Overall Study|Did not require Clevidipine|15|||
148854337|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854338|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854339|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
149030325|NCT04057196|537589580|FG000|Overall Study|Withdrawal by Subject|3|||
148854340|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854341|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854342|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854343|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
148854344|NCT03831191|536941313|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854345|NCT03831191|536941314|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854346|NCT03831191|536941315|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854347|NCT03831191|536941316|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
148854348|NCT03831191|536941317|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854349|NCT03831191|536941318|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854350|NCT03831191|536941319|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854351|NCT03831191|536941320|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854352|NCT03831191|536941321|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854353|NCT03831191|536941322|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854354|NCT03831191|536941323|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854355|NCT03831191|536941324|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854356|NCT03831191|536941325|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854357|NCT03831191|536941326|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854358|NCT03831191|536941327|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
148854359|NCT03831191|536941313|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
148854360|NCT03831191|536941314|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
148854361|NCT03831191|536941315|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
148854362|NCT03831191|536941316|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
148854363|NCT03831191|536941317|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
148854364|NCT03831191|536941318|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
148854365|NCT03831191|536941319|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
148854366|NCT03831191|536941320|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
148854367|NCT03831191|536941321|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
148854368|NCT03831191|536941322|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
148854369|NCT03831191|536941323|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
148854370|NCT03831191|536941324|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
148854371|NCT03831191|536941325|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
148854372|NCT03831191|536941326|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
148854373|NCT03831191|536941327|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
148854374|NCT03831191|536941313|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854375|NCT03831191|536941314|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854376|NCT03831191|536941315|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854377|NCT03831191|536941316|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854378|NCT03831191|536941317|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854379|NCT03831191|536941318|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854380|NCT03831191|536941319|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854381|NCT03831191|536941320|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854382|NCT03831191|536941321|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854383|NCT03831191|536941322|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854384|NCT03831191|536941323|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854385|NCT03831191|536941324|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854386|NCT03831191|536941325|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854387|NCT03831191|536941326|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148854388|NCT03831191|536941327|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
148854389|NCT03831191|536941313|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854390|NCT03831191|536941314|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854391|NCT03831191|536941315|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854392|NCT03831191|536941316|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854393|NCT03831191|536941317|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854394|NCT03831191|536941318|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854395|NCT03831191|536941319|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854396|NCT03831191|536941320|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854397|NCT03831191|536941321|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854398|NCT03831191|536941322|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854399|NCT03831191|536941323|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854400|NCT03831191|536941324|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854401|NCT03831191|536941325|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854402|NCT03831191|536941326|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148854403|NCT03831191|536941327|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
148854404|NCT03070171|536941330|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
148854405|NCT03070171|536941331|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
148854406|NCT03070171|536941330|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
148889452|NCT02888106|537074406|FG000|Overall Study|Adverse Event|2|||
148854407|NCT03070171|536941331|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
148854408|NCT01626118|536941334|FG000|Overall Study|Lack of Efficacy|1|||
148854409|NCT01626118|536941335|FG001|Overall Study|Lack of Efficacy|0|||
148854410|NCT01626118|536941336|FG002|Overall Study|Lack of Efficacy|1|||
148854411|NCT01626118|536941337|FG003|Overall Study|Lack of Efficacy|3|||
148854412|NCT01626118|536941334|FG000|Overall Study|Lost to Follow-up|1|||
148854413|NCT01626118|536941335|FG001|Overall Study|Lost to Follow-up|0|||
148854414|NCT01626118|536941336|FG002|Overall Study|Lost to Follow-up|0|||
148854415|NCT01626118|536941337|FG003|Overall Study|Lost to Follow-up|0|||
148854416|NCT01626118|536941334|FG000|Overall Study|Adverse Event|0|||
148854417|NCT01626118|536941335|FG001|Overall Study|Adverse Event|1|||
148854418|NCT01626118|536941336|FG002|Overall Study|Adverse Event|1|||
148854419|NCT01626118|536941337|FG003|Overall Study|Adverse Event|0|||
148854420|NCT01626118|536941334|FG000|Overall Study|Investigator Decision|0|||
148854421|NCT01626118|536941335|FG001|Overall Study|Investigator Decision|1|||
148854422|NCT01626118|536941336|FG002|Overall Study|Investigator Decision|0|||
148854423|NCT01626118|536941337|FG003|Overall Study|Investigator Decision|0|||
148854424|NCT00888329|536941338|FG000|Overall Study|Physician Decision|6|||
148854425|NCT00888329|536941339|FG001|Overall Study|Physician Decision|9|||
148854426|NCT00002540|536941340|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
148854427|NCT00002540|536941341|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
148854428|NCT00002540|536941340|FG000|Overall Study|Died Before Randomization|2|||
148854429|NCT00002540|536941341|FG001|Overall Study|Died Before Randomization|6|||
148854430|NCT00002540|536941340|FG000|Overall Study|Died Before ASU (Control)|202|||
148854431|NCT00002540|536941341|FG001|Overall Study|Died Before ASU (Control)|0|||
148854432|NCT00002540|536941340|FG000|Overall Study|Refused ASU (Control)|597|||
148854433|NCT00002540|536941341|FG001|Overall Study|Refused ASU (Control)|0|||
148854434|NCT00002540|536941340|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
148854435|NCT00002540|536941341|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
148854436|NCT03490292|536941342|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
148854437|NCT03490292|536941343|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
148854438|NCT03490292|536941342|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
148854439|NCT03490292|536941343|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
148854440|NCT03490292|536941342|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
148854441|NCT03490292|536941343|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
148854442|NCT03490292|536941342|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
148854443|NCT03490292|536941343|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
148854444|NCT03490292|536941342|FG000|1 Year Follow Up Post Last Dose|Death|1|||
148854445|NCT03490292|536941343|FG001|1 Year Follow Up Post Last Dose|Death|1|||
148854446|NCT00778375|536941344|FG000|Overall Study|Ineligible|3|||
148854447|NCT01421303|536941345|FG000|Overall Study|Lost to Follow-up|13|||
148854448|NCT01421303|536941345|FG000|Overall Study|Non compliance with study procedure|1|||
148854449|NCT01421303|536941345|FG000|Overall Study|Other|7|||
148854450|NCT01421303|536941345|FG000|Overall Study|Withdrawal by Subject|1|||
148854451|NCT06003777|536941346|FG000|Period 1|Adverse Event|0|||
148854452|NCT06003777|536941347|FG001|Period 1|Adverse Event|0|||
148854453|NCT06003777|536941348|FG002|Period 1|Adverse Event|1|||
148854454|NCT06003777|536941349|FG003|Period 1|Adverse Event|0|||
148854455|NCT06003777|536941350|FG004|Period 1|Adverse Event|0|||
148854456|NCT06003777|536941351|FG005|Period 1|Adverse Event|0|||
148854457|NCT06003777|536941352|FG006|Period 1|Adverse Event|0|||
148854458|NCT06003777|536941353|FG007|Period 1|Adverse Event|0|||
148854459|NCT06003777|536941354|FG008|Period 1|Adverse Event|0|||
148854460|NCT06003777|536941355|FG009|Period 1|Adverse Event|0|||
148854461|NCT06003777|536941356|FG010|Period 1|Adverse Event|0|||
148854462|NCT06003777|536941357|FG011|Period 1|Adverse Event|0|||
149030326|NCT04057196|537589580|FG000|Overall Study|Death|3|||
149030327|NCT02466516|537589581|FG000|Overall Study|Adverse Event|1|||
149030328|NCT02466516|537589582|FG001|Overall Study|Adverse Event|1|||
148854463|NCT06003777|536941346|FG000|Period 1|Withdrawal by Subject|0|||
148854464|NCT06003777|536941347|FG001|Period 1|Withdrawal by Subject|0|||
148854465|NCT06003777|536941348|FG002|Period 1|Withdrawal by Subject|0|||
148854466|NCT06003777|536941349|FG003|Period 1|Withdrawal by Subject|0|||
148854467|NCT06003777|536941350|FG004|Period 1|Withdrawal by Subject|1|||
148854468|NCT06003777|536941351|FG005|Period 1|Withdrawal by Subject|0|||
148854469|NCT06003777|536941352|FG006|Period 1|Withdrawal by Subject|0|||
149030329|NCT02466516|537589583|FG002|Overall Study|Adverse Event|0|||
149030330|NCT02466516|537589584|FG003|Overall Study|Adverse Event|0|||
149030331|NCT02466516|537589585|FG004|Overall Study|Adverse Event|0|||
149030332|NCT02466516|537589581|FG000|Overall Study|Withdrew Consent|1|||
149030333|NCT02466516|537589582|FG001|Overall Study|Withdrew Consent|0|||
148854470|NCT06003777|536941353|FG007|Period 1|Withdrawal by Subject|0|||
148854471|NCT06003777|536941354|FG008|Period 1|Withdrawal by Subject|0|||
148854472|NCT06003777|536941355|FG009|Period 1|Withdrawal by Subject|0|||
148854473|NCT06003777|536941356|FG010|Period 1|Withdrawal by Subject|0|||
148854474|NCT06003777|536941357|FG011|Period 1|Withdrawal by Subject|0|||
149030334|NCT02466516|537589583|FG002|Overall Study|Withdrew Consent|0|||
149030335|NCT02466516|537589584|FG003|Overall Study|Withdrew Consent|0|||
148854475|NCT06003777|536941346|FG000|Period 2|Withdrawal by Subject|0|||
148854476|NCT06003777|536941347|FG001|Period 2|Withdrawal by Subject|0|||
148854477|NCT06003777|536941348|FG002|Period 2|Withdrawal by Subject|0|||
148854478|NCT06003777|536941349|FG003|Period 2|Withdrawal by Subject|0|||
148854479|NCT06003777|536941350|FG004|Period 2|Withdrawal by Subject|0|||
148854480|NCT06003777|536941351|FG005|Period 2|Withdrawal by Subject|0|||
148854481|NCT06003777|536941352|FG006|Period 2|Withdrawal by Subject|0|||
148854482|NCT06003777|536941353|FG007|Period 2|Withdrawal by Subject|0|||
148854483|NCT06003777|536941354|FG008|Period 2|Withdrawal by Subject|1|||
148854484|NCT06003777|536941355|FG009|Period 2|Withdrawal by Subject|0|||
148854485|NCT06003777|536941356|FG010|Period 2|Withdrawal by Subject|0|||
148854486|NCT06003777|536941357|FG011|Period 2|Withdrawal by Subject|0|||
148854487|NCT06003777|536941346|FG000|Period 3|Adverse Event|0|||
148854488|NCT06003777|536941347|FG001|Period 3|Adverse Event|0|||
148854489|NCT06003777|536941348|FG002|Period 3|Adverse Event|0|||
148854490|NCT06003777|536941349|FG003|Period 3|Adverse Event|0|||
148854491|NCT06003777|536941350|FG004|Period 3|Adverse Event|0|||
148854492|NCT06003777|536941351|FG005|Period 3|Adverse Event|0|||
148854493|NCT06003777|536941352|FG006|Period 3|Adverse Event|1|||
148854494|NCT06003777|536941353|FG007|Period 3|Adverse Event|0|||
148854495|NCT06003777|536941354|FG008|Period 3|Adverse Event|0|||
148854496|NCT06003777|536941355|FG009|Period 3|Adverse Event|0|||
148854497|NCT06003777|536941356|FG010|Period 3|Adverse Event|0|||
148854498|NCT06003777|536941357|FG011|Period 3|Adverse Event|0|||
148854499|NCT06003777|536941346|FG000|Period 4|No longer met eligibility criteria|0|||
148854500|NCT06003777|536941347|FG001|Period 4|No longer met eligibility criteria|0|||
148854501|NCT06003777|536941348|FG002|Period 4|No longer met eligibility criteria|1|||
148854502|NCT06003777|536941349|FG003|Period 4|No longer met eligibility criteria|0|||
148854503|NCT06003777|536941350|FG004|Period 4|No longer met eligibility criteria|0|||
148854504|NCT06003777|536941351|FG005|Period 4|No longer met eligibility criteria|0|||
148854505|NCT06003777|536941352|FG006|Period 4|No longer met eligibility criteria|0|||
148854506|NCT06003777|536941353|FG007|Period 4|No longer met eligibility criteria|0|||
148854507|NCT06003777|536941354|FG008|Period 4|No longer met eligibility criteria|0|||
148854508|NCT06003777|536941355|FG009|Period 4|No longer met eligibility criteria|0|||
148854509|NCT06003777|536941356|FG010|Period 4|No longer met eligibility criteria|0|||
148854510|NCT06003777|536941357|FG011|Period 4|No longer met eligibility criteria|0|||
148854511|NCT06003777|536941346|FG000|Period 4|Withdrawal by Subject|0|||
148854512|NCT06003777|536941347|FG001|Period 4|Withdrawal by Subject|1|||
148854513|NCT06003777|536941348|FG002|Period 4|Withdrawal by Subject|0|||
148854514|NCT06003777|536941349|FG003|Period 4|Withdrawal by Subject|0|||
148854515|NCT06003777|536941350|FG004|Period 4|Withdrawal by Subject|0|||
148854516|NCT06003777|536941351|FG005|Period 4|Withdrawal by Subject|0|||
148854517|NCT06003777|536941352|FG006|Period 4|Withdrawal by Subject|0|||
148854518|NCT06003777|536941353|FG007|Period 4|Withdrawal by Subject|0|||
148854519|NCT06003777|536941354|FG008|Period 4|Withdrawal by Subject|0|||
148854520|NCT06003777|536941355|FG009|Period 4|Withdrawal by Subject|0|||
148854521|NCT06003777|536941356|FG010|Period 4|Withdrawal by Subject|0|||
148854522|NCT06003777|536941357|FG011|Period 4|Withdrawal by Subject|0|||
148854523|NCT01901289|536941358|FG000|Overall Study|Death|32|||
148854524|NCT01901289|536941358|FG000|Overall Study|Lost to Follow-up|16|||
148854525|NCT01901289|536941358|FG000|Overall Study|Withdrawal by Subject|35|||
148854526|NCT01901289|536941358|FG000|Overall Study|Other type of endpoint met|2|||
148854527|NCT00054327|536941359|FG000|Overall Study|Engraftment failure|1|||
148854528|NCT00054327|536941360|FG001|Overall Study|Engraftment failure|0|||
148854529|NCT00054327|536941361|FG002|Overall Study|Engraftment failure|0|||
148854530|NCT00054327|536941362|FG003|Overall Study|Engraftment failure|0|||
148854531|NCT00054327|536941363|FG004|Overall Study|Engraftment failure|0|||
148854532|NCT00054327|536941364|FG005|Overall Study|Engraftment failure|0|||
148854533|NCT01606176|536941371|FG000|Overall Study|Adverse Event|2|||
148854534|NCT01606176|536941372|FG001|Overall Study|Adverse Event|3|||
148854535|NCT01606176|536941371|FG000|Overall Study|Disease progression|1|||
148854536|NCT01606176|536941372|FG001|Overall Study|Disease progression|0|||
148854537|NCT01606176|536941371|FG000|Overall Study|Withdrawal by Subject|1|||
148854538|NCT01606176|536941372|FG001|Overall Study|Withdrawal by Subject|0|||
148854539|NCT00361231|536941374|FG000|Overall Study|Physician Decision|3|||
148854540|NCT00361231|536941374|FG000|Overall Study|Symptomatic deterioration|5|||
148854541|NCT00361231|536941374|FG000|Overall Study|Radiographic disease progression|16|||
148854542|NCT00361231|536941374|FG000|Overall Study|Withdrawal by Subject|4|||
148854543|NCT00361231|536941374|FG000|Overall Study|Adverse Event|6|||
148854544|NCT01814397|536941377|FG000|Overall Study|Adverse Event|7|||
148854545|NCT01814397|536941377|FG000|Overall Study|Withdrawal by Subject|7|||
148854546|NCT01732510|536941378|FG000|Overall Study|Adverse Event|0|||
148854547|NCT01732510|536941379|FG001|Overall Study|Adverse Event|1|||
148854548|NCT01732510|536941380|FG002|Overall Study|Adverse Event|1|||
148854549|NCT01732510|536941381|FG003|Overall Study|Adverse Event|0|||
148854550|NCT01732510|536941382|FG004|Overall Study|Adverse Event|0|||
148854551|NCT01732510|536941383|FG005|Overall Study|Adverse Event|0|||
148854552|NCT01732510|536941384|FG006|Overall Study|Adverse Event|1|||
148854553|NCT01732510|536941378|FG000|Overall Study|Protocol Violation|0|||
148854554|NCT01732510|536941379|FG001|Overall Study|Protocol Violation|0|||
148854555|NCT01732510|536941380|FG002|Overall Study|Protocol Violation|0|||
148854556|NCT01732510|536941381|FG003|Overall Study|Protocol Violation|1|||
148854557|NCT01732510|536941382|FG004|Overall Study|Protocol Violation|0|||
148854558|NCT01732510|536941383|FG005|Overall Study|Protocol Violation|0|||
148854559|NCT01732510|536941384|FG006|Overall Study|Protocol Violation|0|||
148854560|NCT01732510|536941378|FG000|Overall Study|Withdrawal by Subject|1|||
148854561|NCT01732510|536941379|FG001|Overall Study|Withdrawal by Subject|3|||
148854562|NCT01732510|536941380|FG002|Overall Study|Withdrawal by Subject|2|||
148854563|NCT01732510|536941381|FG003|Overall Study|Withdrawal by Subject|1|||
148854564|NCT01732510|536941382|FG004|Overall Study|Withdrawal by Subject|5|||
148854565|NCT01732510|536941383|FG005|Overall Study|Withdrawal by Subject|0|||
148854566|NCT01732510|536941384|FG006|Overall Study|Withdrawal by Subject|1|||
148854567|NCT01732510|536941378|FG000|Overall Study|Lost to Follow-up|0|||
148854568|NCT01732510|536941379|FG001|Overall Study|Lost to Follow-up|0|||
148854569|NCT01732510|536941380|FG002|Overall Study|Lost to Follow-up|1|||
148854570|NCT01732510|536941381|FG003|Overall Study|Lost to Follow-up|1|||
148854571|NCT01732510|536941382|FG004|Overall Study|Lost to Follow-up|0|||
148854572|NCT01732510|536941383|FG005|Overall Study|Lost to Follow-up|1|||
148854573|NCT01732510|536941384|FG006|Overall Study|Lost to Follow-up|0|||
148854574|NCT01732510|536941378|FG000|Overall Study|Physician Decision|0|||
148854575|NCT01732510|536941379|FG001|Overall Study|Physician Decision|1|||
148854576|NCT01732510|536941380|FG002|Overall Study|Physician Decision|0|||
148854577|NCT01732510|536941381|FG003|Overall Study|Physician Decision|0|||
148854578|NCT01732510|536941382|FG004|Overall Study|Physician Decision|0|||
148854579|NCT01732510|536941383|FG005|Overall Study|Physician Decision|0|||
148854580|NCT01732510|536941384|FG006|Overall Study|Physician Decision|0|||
148854581|NCT01732510|536941378|FG000|Overall Study|Pregnancy|0|||
148854582|NCT01732510|536941379|FG001|Overall Study|Pregnancy|0|||
148854583|NCT01732510|536941380|FG002|Overall Study|Pregnancy|0|||
148854584|NCT01732510|536941381|FG003|Overall Study|Pregnancy|1|||
148854585|NCT01732510|536941382|FG004|Overall Study|Pregnancy|0|||
148854586|NCT01732510|536941383|FG005|Overall Study|Pregnancy|0|||
148854587|NCT01732510|536941384|FG006|Overall Study|Pregnancy|0|||
148854588|NCT01732510|536941378|FG000|Overall Study|Study Terminated By Sponsor|0|||
148854589|NCT01732510|536941379|FG001|Overall Study|Study Terminated By Sponsor|0|||
148854590|NCT01732510|536941380|FG002|Overall Study|Study Terminated By Sponsor|0|||
148854591|NCT01732510|536941381|FG003|Overall Study|Study Terminated By Sponsor|1|||
148854592|NCT01732510|536941382|FG004|Overall Study|Study Terminated By Sponsor|0|||
148854593|NCT01732510|536941383|FG005|Overall Study|Study Terminated By Sponsor|12|||
148854594|NCT01732510|536941384|FG006|Overall Study|Study Terminated By Sponsor|6|||
148854595|NCT00244933|536941385|FG000|Overall Study|Not response evaluable|2|||
148854596|NCT04731298|536941388|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
148854597|NCT04731298|536941389|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
148854598|NCT01208961|536941390|FG000|High-Fat Period III|Protocol Violation|1|||
148854599|NCT01208961|536941391|FG001|High-Fat Period III|Protocol Violation|0|||
148854600|NCT03403361|536941392|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
148854601|NCT03213938|536941393|FG000|Overall Study|Lost to Follow-up|4|||
148854602|NCT03213938|536941394|FG001|Overall Study|Lost to Follow-up|3|||
148854603|NCT03213938|536941393|FG000|Overall Study|Lack of Efficacy|1|||
148854604|NCT03213938|536941394|FG001|Overall Study|Lack of Efficacy|0|||
148854605|NCT03213938|536941393|FG000|Overall Study|Decline to participate|5|||
148854606|NCT03213938|536941394|FG001|Overall Study|Decline to participate|4|||
148854607|NCT03213938|536941393|FG000|Overall Study|Without reason|4|||
149030336|NCT02466516|537589585|FG004|Overall Study|Withdrew Consent|0|||
149030337|NCT02466516|537589581|FG000|Overall Study|Lost to Follow-up|2|||
149030338|NCT02466516|537589582|FG001|Overall Study|Lost to Follow-up|0|||
148854608|NCT03213938|536941394|FG001|Overall Study|Without reason|5|||
148854609|NCT02487654|536941396|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
148854610|NCT02487654|536941397|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
148854611|NCT02487654|536941396|FG000|Overall Study|Withdrawal by Subject|3|||
148854612|NCT02487654|536941397|FG001|Overall Study|Withdrawal by Subject|7|||
148854613|NCT04238481|536941398|FG000|Overall Study|Miscellaneous|0|||
148854614|NCT04238481|536941399|FG001|Overall Study|Miscellaneous|1|||
148854615|NCT04238481|536941400|FG002|Overall Study|Miscellaneous|0|||
149030339|NCT02466516|537589583|FG002|Overall Study|Lost to Follow-up|1|||
149030340|NCT02466516|537589584|FG003|Overall Study|Lost to Follow-up|0|||
149030341|NCT02466516|537589585|FG004|Overall Study|Lost to Follow-up|0|||
148854616|NCT04238481|536941401|FG003|Overall Study|Miscellaneous|0|||
148854617|NCT02152371|536941402|FG000|Overall Study|Adverse Event|6|||
148854618|NCT02152371|536941403|FG001|Overall Study|Adverse Event|2|||
148854619|NCT02152371|536941402|FG000|Overall Study|Withdrawal by Subject|3|||
148854620|NCT02152371|536941403|FG001|Overall Study|Withdrawal by Subject|7|||
148854621|NCT02152371|536941402|FG000|Overall Study|Protocol Violation|2|||
148854622|NCT02152371|536941403|FG001|Overall Study|Protocol Violation|3|||
148854623|NCT02152371|536941402|FG000|Overall Study|Lost to Follow-up|1|||
148854624|NCT02152371|536941403|FG001|Overall Study|Lost to Follow-up|0|||
148854625|NCT02152371|536941402|FG000|Overall Study|Lack of Efficacy|0|||
149030342|NCT03712930|537589586|FG000|Overall Study|Death|7|||
148854626|NCT02152371|536941403|FG001|Overall Study|Lack of Efficacy|1|||
148854627|NCT02152371|536941402|FG000|Overall Study|Physician Decision|0|||
148854628|NCT02152371|536941403|FG001|Overall Study|Physician Decision|2|||
148854629|NCT02152371|536941402|FG000|Overall Study|Reason Not Given|0|||
148854630|NCT02152371|536941403|FG001|Overall Study|Reason Not Given|1|||
148854631|NCT00350870|536941404|FG000|Overall Study|Withdrawal by Subject|21|||
148854632|NCT00350870|536941405|FG001|Overall Study|Withdrawal by Subject|17|||
148854633|NCT00350870|536941406|FG002|Overall Study|Withdrawal by Subject|15|||
148854634|NCT00350870|536941407|FG003|Overall Study|Withdrawal by Subject|14|||
148854635|NCT00350870|536941404|FG000|Overall Study|Physician Decision|1|||
148854636|NCT00350870|536941405|FG001|Overall Study|Physician Decision|0|||
148854637|NCT00350870|536941406|FG002|Overall Study|Physician Decision|1|||
148854638|NCT00350870|536941407|FG003|Overall Study|Physician Decision|1|||
148854639|NCT00349921|536941408|FG000|First Spinal Injection|Physician Decision|1|||
148854640|NCT00349921|536941409|FG001|First Spinal Injection|Physician Decision|0|||
148854641|NCT00349921|536941410|FG002|First Spinal Injection|Physician Decision|0|||
148854642|NCT00349921|536941411|FG003|First Spinal Injection|Physician Decision|0|||
148854643|NCT00349921|536941408|FG000|First Spinal Injection|Adverse Event|0|||
148854644|NCT00349921|536941409|FG001|First Spinal Injection|Adverse Event|0|||
148854645|NCT00349921|536941410|FG002|First Spinal Injection|Adverse Event|1|||
148854646|NCT00349921|536941411|FG003|First Spinal Injection|Adverse Event|0|||
148854647|NCT01932372|536941412|FG000|Overall Study|Not meeting eligibility criteria|33|||
148854648|NCT01932372|536941413|FG001|Overall Study|Not meeting eligibility criteria|179|||
148854649|NCT05285644|536941418|FG000|Overall Study|Adverse Event|3|||
148854650|NCT05285644|536941419|FG001|Overall Study|Adverse Event|3|||
148854651|NCT05285644|536941418|FG000|Overall Study|Withdrawal of Consent|2|||
148854652|NCT05285644|536941419|FG001|Overall Study|Withdrawal of Consent|5|||
148854653|NCT05285644|536941418|FG000|Overall Study|Noncompliance|0|||
148854654|NCT05285644|536941419|FG001|Overall Study|Noncompliance|4|||
148854655|NCT05285644|536941418|FG000|Overall Study|Lost to Follow-up|4|||
148854656|NCT05285644|536941419|FG001|Overall Study|Lost to Follow-up|6|||
148854657|NCT05285644|536941418|FG000|Overall Study|Disallowed Concurrent Medication|1|||
148854658|NCT05285644|536941419|FG001|Overall Study|Disallowed Concurrent Medication|1|||
148854659|NCT05285644|536941418|FG000|Overall Study|Investigator Decision|2|||
148854660|NCT05285644|536941419|FG001|Overall Study|Investigator Decision|0|||
148854661|NCT05285644|536941418|FG000|Overall Study|Protocol Deviation|1|||
148854662|NCT05285644|536941419|FG001|Overall Study|Protocol Deviation|0|||
148854663|NCT05285644|536941418|FG000|Overall Study|As specified in the Clinical Study Report|7|||
148854664|NCT05285644|536941419|FG001|Overall Study|As specified in the Clinical Study Report|3|||
148854665|NCT04382586|536941423|FG000|Overall Study|Death|3|||
148854666|NCT04382586|536941424|FG001|Overall Study|Death|4|||
148854667|NCT04382586|536941423|FG000|Overall Study|Lost to Follow-up|11|||
148854668|NCT04382586|536941424|FG001|Overall Study|Lost to Follow-up|8|||
148854669|NCT04382586|536941423|FG000|Overall Study|Withdrawal by Subject|3|||
148854670|NCT04382586|536941424|FG001|Overall Study|Withdrawal by Subject|1|||
148854671|NCT04382586|536941423|FG000|Overall Study|Physician Decision|0|||
148854672|NCT04382586|536941424|FG001|Overall Study|Physician Decision|3|||
148854673|NCT02265536|536941426|FG000|Overall Study|Adverse Event|1|||
148854674|NCT02265536|536941427|FG001|Overall Study|Adverse Event|0|||
148854675|NCT02265536|536941428|FG002|Overall Study|Adverse Event|0|||
148854676|NCT02265536|536941429|FG003|Overall Study|Adverse Event|0|||
148854677|NCT02265536|536941430|FG004|Overall Study|Adverse Event|1|||
148854678|NCT02265536|536941431|FG005|Overall Study|Adverse Event|0|||
148854679|NCT02265536|536941426|FG000|Overall Study|Physician Decision|0|||
148854680|NCT02265536|536941427|FG001|Overall Study|Physician Decision|0|||
148854681|NCT02265536|536941428|FG002|Overall Study|Physician Decision|0|||
148854682|NCT02265536|536941429|FG003|Overall Study|Physician Decision|0|||
148854683|NCT02265536|536941430|FG004|Overall Study|Physician Decision|2|||
148854684|NCT02265536|536941431|FG005|Overall Study|Physician Decision|0|||
148854685|NCT02265536|536941426|FG000|Overall Study|Withdrawal by Subject|0|||
148854686|NCT02265536|536941427|FG001|Overall Study|Withdrawal by Subject|3|||
148854687|NCT02265536|536941428|FG002|Overall Study|Withdrawal by Subject|0|||
148854688|NCT02265536|536941429|FG003|Overall Study|Withdrawal by Subject|0|||
148854689|NCT02265536|536941430|FG004|Overall Study|Withdrawal by Subject|0|||
148854690|NCT02265536|536941431|FG005|Overall Study|Withdrawal by Subject|0|||
148854691|NCT02470585|536941434|FG000|Overall Study|Death|224|||
148854692|NCT02470585|536941435|FG001|Overall Study|Death|227|||
148854693|NCT02470585|536941436|FG002|Overall Study|Death|199|||
148854694|NCT02470585|536941434|FG000|Overall Study|Withdrew consent|21|||
148854695|NCT02470585|536941435|FG001|Overall Study|Withdrew consent|22|||
148854696|NCT02470585|536941436|FG002|Overall Study|Withdrew consent|31|||
148854697|NCT02470585|536941434|FG000|Overall Study|Lost to Follow-up|8|||
148854698|NCT02470585|536941435|FG001|Overall Study|Lost to Follow-up|15|||
148854699|NCT02470585|536941436|FG002|Overall Study|Lost to Follow-up|13|||
148854700|NCT02470585|536941434|FG000|Overall Study|Sponsor discontinued study|117|||
148854701|NCT02470585|536941435|FG001|Overall Study|Sponsor discontinued study|110|||
148854702|NCT02470585|536941436|FG002|Overall Study|Sponsor discontinued study|122|||
148854703|NCT02470585|536941434|FG000|Overall Study|Other, not specified|5|||
148854704|NCT02470585|536941435|FG001|Overall Study|Other, not specified|7|||
148854705|NCT02470585|536941436|FG002|Overall Study|Other, not specified|14|||
148854706|NCT02470585|536941434|FG000|Overall Study|Missing due to site non-compliance|0|||
148854707|NCT02470585|536941435|FG001|Overall Study|Missing due to site non-compliance|2|||
148854708|NCT02470585|536941436|FG002|Overall Study|Missing due to site non-compliance|3|||
148854709|NCT00079391|536941437|FG000|Overall Study|Withdrawal by Subject|1|||
148854710|NCT02524275|536941438|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
148854711|NCT03763656|536941441|FG000|Overall Study|Physician Decision|1|||
148854712|NCT03763656|536941441|FG000|Overall Study|Protocol Violation|1|||
148854713|NCT03763656|536941441|FG000|Overall Study|Withdrawal by Subject|7|||
148854714|NCT03479541|536941442|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
148854715|NCT03479541|536941443|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
148854716|NCT03479541|536941444|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
148854717|NCT03479541|536941445|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
148854718|NCT03479541|536941442|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
148854719|NCT03479541|536941443|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
148854720|NCT03479541|536941444|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
148854721|NCT03479541|536941445|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
148854722|NCT03479541|536941442|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
148854723|NCT03479541|536941443|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
148854724|NCT03479541|536941444|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
148854725|NCT03479541|536941445|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
148854726|NCT03479541|536941442|FG000|Home Monitoring|Lost to Follow-up|0|||
148854727|NCT03479541|536941443|FG001|Home Monitoring|Lost to Follow-up|0|||
148854728|NCT03479541|536941444|FG002|Home Monitoring|Lost to Follow-up|8|||
148854729|NCT03479541|536941445|FG003|Home Monitoring|Lost to Follow-up|12|||
148854730|NCT03479541|536941442|FG000|Home Monitoring|Withdrawal by Subject|0|||
148854731|NCT03479541|536941443|FG001|Home Monitoring|Withdrawal by Subject|0|||
148854732|NCT03479541|536941444|FG002|Home Monitoring|Withdrawal by Subject|17|||
148854733|NCT03479541|536941445|FG003|Home Monitoring|Withdrawal by Subject|30|||
148854734|NCT03479541|536941442|FG000|Home Monitoring|Early Termination - PI Decision|0|||
148854735|NCT03479541|536941443|FG001|Home Monitoring|Early Termination - PI Decision|0|||
148854736|NCT03479541|536941444|FG002|Home Monitoring|Early Termination - PI Decision|4|||
148854737|NCT03479541|536941445|FG003|Home Monitoring|Early Termination - PI Decision|6|||
148854738|NCT02147197|536941449|FG000|Overall Study|Adverse Event|1|||
148854739|NCT02147197|536941450|FG001|Overall Study|Adverse Event|0|||
148854740|NCT02147197|536941451|FG002|Overall Study|Adverse Event|0|||
148854741|NCT02147197|536941449|FG000|Overall Study|Withdrawal of Consent|4|||
148854742|NCT02147197|536941450|FG001|Overall Study|Withdrawal of Consent|3|||
148854743|NCT02147197|536941451|FG002|Overall Study|Withdrawal of Consent|2|||
148854744|NCT02147197|536941449|FG000|Overall Study|Lost to Follow-up|2|||
148854745|NCT02147197|536941450|FG001|Overall Study|Lost to Follow-up|3|||
148854746|NCT02147197|536941451|FG002|Overall Study|Lost to Follow-up|1|||
148854747|NCT02147197|536941449|FG000|Overall Study|Protocol Violation|1|||
148854748|NCT02147197|536941450|FG001|Overall Study|Protocol Violation|0|||
148854749|NCT02147197|536941451|FG002|Overall Study|Protocol Violation|3|||
148854750|NCT02147197|536941449|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148854751|NCT02147197|536941450|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148854752|NCT02147197|536941451|FG002|Overall Study|Other Miscellaneous Reasons|3|||
148854753|NCT00511433|536943386|FG000|Overall Study|Adverse Event|5|||
148854754|NCT00511433|536943387|FG001|Overall Study|Adverse Event|0|||
148854755|NCT00511433|536943386|FG000|Overall Study|Other Reason|1|||
148854756|NCT00511433|536943387|FG001|Overall Study|Other Reason|1|||
148854757|NCT00197145|536943388|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
148854758|NCT00197145|536943389|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
148854759|NCT00197145|536943388|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
148854760|NCT00197145|536943389|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
148854761|NCT00197145|536943388|FG000|Period 1: Randomized Treatment Phase|Other|2|||
148854762|NCT00197145|536943389|FG001|Period 1: Randomized Treatment Phase|Other|2|||
148854763|NCT00197145|536943388|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
148854764|NCT00197145|536943389|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
148854765|NCT00197145|536943388|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
148854766|NCT00197145|536943389|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
148854767|NCT00197145|536943388|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
148854768|NCT00197145|536943389|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
148854769|NCT00197145|536943388|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
148854770|NCT00197145|536943389|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
148854771|NCT00197145|536943388|FG000|Period 2 : Open Label Phase|Other|1|||
148854772|NCT00197145|536943389|FG001|Period 2 : Open Label Phase|Other|0|||
148854773|NCT01380535|536943390|FG000|Overall Study|Adverse Event|3|||
148854774|NCT01380535|536943391|FG001|Overall Study|Adverse Event|3|||
148854775|NCT01380535|536943390|FG000|Overall Study|Death|3|||
148854776|NCT01380535|536943391|FG001|Overall Study|Death|0|||
148854777|NCT01380535|536943390|FG000|Overall Study|Study site closed|0|||
148854778|NCT01380535|536943391|FG001|Overall Study|Study site closed|5|||
148854779|NCT01380535|536943390|FG000|Overall Study|Withdrawal by Subject|1|||
148854780|NCT01380535|536943391|FG001|Overall Study|Withdrawal by Subject|2|||
148854781|NCT01380535|536943390|FG000|Overall Study|Protocol Violation|0|||
148854782|NCT01380535|536943391|FG001|Overall Study|Protocol Violation|2|||
148854783|NCT01380535|536943390|FG000|Overall Study|Lack of Efficacy|0|||
148854784|NCT01380535|536943391|FG001|Overall Study|Lack of Efficacy|3|||
148854785|NCT02370537|536943392|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
148854786|NCT02370537|536943393|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
148854787|NCT02370537|536943394|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
148854788|NCT02370537|536943392|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
148854789|NCT02370537|536943393|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
148854790|NCT02370537|536943394|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
148854791|NCT02370537|536943392|FG000|Part B|Not randomised to receive treatment|1|||
148854792|NCT02370537|536943393|FG001|Part B|Not randomised to receive treatment|2|||
148854793|NCT02370537|536943394|FG002|Part B|Not randomised to receive treatment|259|||
148854794|NCT02370537|536943392|FG000|Part B|Withdrawal by Subject|0|||
148854795|NCT02370537|536943393|FG001|Part B|Withdrawal by Subject|1|||
148854796|NCT02370537|536943394|FG002|Part B|Withdrawal by Subject|0|||
148854797|NCT03100539|536943403|FG000|Overall Study|Lost to Follow-up|60|||
148854798|NCT03100539|536943404|FG001|Overall Study|Lost to Follow-up|54|||
148854799|NCT03100539|536943405|FG002|Overall Study|Lost to Follow-up|17|||
148854800|NCT03100539|536943403|FG000|Overall Study|Uncollected|8|||
148854801|NCT03100539|536943404|FG001|Overall Study|Uncollected|8|||
148854802|NCT03100539|536943405|FG002|Overall Study|Uncollected|0|||
148854803|NCT03100539|536943403|FG000|Overall Study|Ally Health|0|||
148854804|NCT03100539|536943404|FG001|Overall Study|Ally Health|0|||
148854805|NCT03100539|536943405|FG002|Overall Study|Ally Health|3|||
148854806|NCT03100539|536943403|FG000|Overall Study|Disinterest|0|||
148854807|NCT03100539|536943404|FG001|Overall Study|Disinterest|0|||
148854808|NCT03100539|536943405|FG002|Overall Study|Disinterest|22|||
148854809|NCT03100539|536943403|FG000|Overall Study|Veteran Health|0|||
148854810|NCT03100539|536943404|FG001|Overall Study|Veteran Health|0|||
148854811|NCT03100539|536943405|FG002|Overall Study|Veteran Health|8|||
148854812|NCT03100539|536943403|FG000|Overall Study|Moved|0|||
148854813|NCT03100539|536943404|FG001|Overall Study|Moved|0|||
148854814|NCT03100539|536943405|FG002|Overall Study|Moved|1|||
148854815|NCT03100539|536943403|FG000|Overall Study|Scheduling Conflicts|0|||
148854816|NCT03100539|536943404|FG001|Overall Study|Scheduling Conflicts|0|||
148854817|NCT03100539|536943405|FG002|Overall Study|Scheduling Conflicts|12|||
148854818|NCT00882583|536943406|FG000|Overall Study|Physician Decision|1|||
148854819|NCT00882583|536943407|FG001|Overall Study|Physician Decision|0|||
148854820|NCT00882583|536943406|FG000|Overall Study|Adverse Event|0|||
148854821|NCT00882583|536943407|FG001|Overall Study|Adverse Event|1|||
148854822|NCT02596958|536943408|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
148854823|NCT02596958|536943408|FG000|Overall Study|Cancer Progression|441|||
148854824|NCT02596958|536943408|FG000|Overall Study|Death From Cancer|112|||
148854825|NCT02596958|536943408|FG000|Overall Study|Death From Other Cause|33|||
148854826|NCT02596958|536943408|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
148854827|NCT02596958|536943408|FG000|Overall Study|Administrative Reasons/Other|231|||
148854828|NCT02596958|536943408|FG000|Overall Study|Lost to Follow-up|33|||
148854829|NCT02596958|536943408|FG000|Overall Study|Missing|32|||
148854830|NCT02596958|536943408|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
148854831|NCT03596047|536943409|FG000|Overall Study|Withdrawal by Subject|7|||
148854832|NCT03596047|536943410|FG001|Overall Study|Withdrawal by Subject|4|||
148854833|NCT03596047|536943409|FG000|Overall Study|Lost to Follow-up|0|||
148854834|NCT03596047|536943410|FG001|Overall Study|Lost to Follow-up|2|||
148854835|NCT02242435|536943415|FG000|Overall Study|Lost to Follow-up|3|||
148854836|NCT02242435|536943416|FG001|Overall Study|Lost to Follow-up|4|||
148854837|NCT02242435|536943415|FG000|Overall Study|Adverse Event|3|||
148854838|NCT02242435|536943416|FG001|Overall Study|Adverse Event|2|||
148854839|NCT02242435|536943415|FG000|Overall Study|Withdrawal by Subject|13|||
148854840|NCT02242435|536943416|FG001|Overall Study|Withdrawal by Subject|8|||
148854841|NCT02242435|536943415|FG000|Overall Study|Death|0|||
148854842|NCT02242435|536943416|FG001|Overall Study|Death|1|||
148854843|NCT02242435|536943415|FG000|Overall Study|Protocol Violation|1|||
148854844|NCT02242435|536943416|FG001|Overall Study|Protocol Violation|0|||
148854845|NCT02242435|536943415|FG000|Overall Study|Physician Decision|0|||
148854846|NCT02242435|536943416|FG001|Overall Study|Physician Decision|1|||
148854847|NCT01110330|536943419|FG000|Overall Study|Adverse Event|0|||
148854848|NCT01110330|536943420|FG001|Overall Study|Adverse Event|4|||
148854849|NCT01110330|536943421|FG002|Overall Study|Adverse Event|3|||
148854850|NCT01110330|536943419|FG000|Overall Study|Lack of Efficacy|3|||
148854851|NCT01110330|536943420|FG001|Overall Study|Lack of Efficacy|1|||
148854852|NCT01110330|536943421|FG002|Overall Study|Lack of Efficacy|1|||
148854853|NCT01110330|536943419|FG000|Overall Study|Lost to Follow-up|9|||
148854854|NCT01110330|536943420|FG001|Overall Study|Lost to Follow-up|10|||
148854855|NCT01110330|536943421|FG002|Overall Study|Lost to Follow-up|15|||
148854856|NCT01110330|536943419|FG000|Overall Study|Physician Decision|0|||
148854857|NCT01110330|536943420|FG001|Overall Study|Physician Decision|1|||
148854858|NCT01110330|536943421|FG002|Overall Study|Physician Decision|0|||
148854859|NCT01110330|536943419|FG000|Overall Study|Protocol Violation|2|||
148854860|NCT01110330|536943420|FG001|Overall Study|Protocol Violation|0|||
148854861|NCT01110330|536943421|FG002|Overall Study|Protocol Violation|4|||
148854862|NCT01110330|536943419|FG000|Overall Study|Withdrawal by Subject|0|||
148854863|NCT01110330|536943420|FG001|Overall Study|Withdrawal by Subject|6|||
148854864|NCT01110330|536943421|FG002|Overall Study|Withdrawal by Subject|2|||
148854865|NCT01110330|536943419|FG000|Overall Study|Other|1|||
148854866|NCT01110330|536943420|FG001|Overall Study|Other|1|||
148854867|NCT01110330|536943421|FG002|Overall Study|Other|1|||
148854868|NCT02759107|536943426|FG000|Overall Study|Adverse Event|0|||
148854869|NCT02759107|536943427|FG001|Overall Study|Adverse Event|0|||
148854870|NCT02759107|536943428|FG002|Overall Study|Adverse Event|0|||
148854871|NCT02759107|536943429|FG003|Overall Study|Adverse Event|0|||
148854872|NCT02759107|536943430|FG004|Overall Study|Adverse Event|0|||
148854873|NCT02759107|536943431|FG005|Overall Study|Adverse Event|0|||
148854874|NCT02759107|536943432|FG006|Overall Study|Adverse Event|0|||
148854875|NCT02759107|536943433|FG007|Overall Study|Adverse Event|0|||
148854876|NCT02759107|536943434|FG008|Overall Study|Adverse Event|0|||
148854877|NCT02759107|536943435|FG009|Overall Study|Adverse Event|0|||
148854878|NCT02759107|536943436|FG010|Overall Study|Adverse Event|0|||
148854879|NCT02759107|536943437|FG011|Overall Study|Adverse Event|0|||
148854880|NCT02759107|536943438|FG012|Overall Study|Adverse Event|2|||
148854881|NCT02759107|536943439|FG013|Overall Study|Adverse Event|0|||
148854882|NCT02759107|536943440|FG014|Overall Study|Adverse Event|0|||
148854883|NCT02759107|536943441|FG015|Overall Study|Adverse Event|1|||
148854884|NCT02759107|536943442|FG016|Overall Study|Adverse Event|0|||
148854885|NCT02759107|536943443|FG017|Overall Study|Adverse Event|2|||
148854886|NCT02759107|536943426|FG000|Overall Study|Scheduling Conflict|0|||
148854887|NCT02759107|536943427|FG001|Overall Study|Scheduling Conflict|0|||
148854888|NCT02759107|536943428|FG002|Overall Study|Scheduling Conflict|0|||
148854889|NCT02759107|536943429|FG003|Overall Study|Scheduling Conflict|0|||
148854890|NCT02759107|536943430|FG004|Overall Study|Scheduling Conflict|0|||
148854891|NCT02759107|536943431|FG005|Overall Study|Scheduling Conflict|0|||
148854892|NCT02759107|536943432|FG006|Overall Study|Scheduling Conflict|0|||
148854893|NCT02759107|536943433|FG007|Overall Study|Scheduling Conflict|0|||
148854894|NCT02759107|536943434|FG008|Overall Study|Scheduling Conflict|0|||
148854895|NCT02759107|536943435|FG009|Overall Study|Scheduling Conflict|1|||
148854896|NCT02759107|536943436|FG010|Overall Study|Scheduling Conflict|0|||
148854897|NCT02759107|536943437|FG011|Overall Study|Scheduling Conflict|0|||
148854898|NCT02759107|536943438|FG012|Overall Study|Scheduling Conflict|0|||
148854899|NCT02759107|536943439|FG013|Overall Study|Scheduling Conflict|0|||
148854900|NCT02759107|536943440|FG014|Overall Study|Scheduling Conflict|0|||
148854901|NCT02759107|536943441|FG015|Overall Study|Scheduling Conflict|0|||
148854902|NCT02759107|536943442|FG016|Overall Study|Scheduling Conflict|0|||
148854903|NCT02759107|536943443|FG017|Overall Study|Scheduling Conflict|0|||
148854904|NCT02513485|536943452|FG000|Overall Study|Adverse Event|1|||
148854905|NCT02513485|536943453|FG001|Overall Study|Adverse Event|0|||
148854906|NCT00420004|536943463|FG000|Overall Study|Adverse Event|4|||
148854907|NCT00420004|536943464|FG001|Overall Study|Adverse Event|1|||
148854908|NCT00420004|536943465|FG002|Overall Study|Adverse Event|1|||
148854909|NCT00420004|536943463|FG000|Overall Study|Lack of Efficacy|5|||
148854910|NCT00420004|536943464|FG001|Overall Study|Lack of Efficacy|4|||
148854911|NCT00420004|536943465|FG002|Overall Study|Lack of Efficacy|1|||
148854912|NCT00420004|536943463|FG000|Overall Study|Lost to Follow-up|31|||
148854913|NCT00420004|536943464|FG001|Overall Study|Lost to Follow-up|12|||
148854914|NCT00420004|536943465|FG002|Overall Study|Lost to Follow-up|10|||
148854915|NCT00420004|536943463|FG000|Overall Study|Entry Criteria Not Met|0|||
148854916|NCT00420004|536943464|FG001|Overall Study|Entry Criteria Not Met|1|||
148854917|NCT00420004|536943465|FG002|Overall Study|Entry Criteria Not Met|0|||
148854918|NCT00420004|536943463|FG000|Overall Study|Physician Decision|14|||
148854919|NCT00420004|536943464|FG001|Overall Study|Physician Decision|4|||
148854920|NCT00420004|536943465|FG002|Overall Study|Physician Decision|2|||
148854921|NCT00420004|536943463|FG000|Overall Study|Protocol Violation|5|||
148854922|NCT00420004|536943464|FG001|Overall Study|Protocol Violation|4|||
148854923|NCT00420004|536943465|FG002|Overall Study|Protocol Violation|3|||
148854924|NCT00420004|536943463|FG000|Overall Study|Withdrawal by Subject|67|||
148854925|NCT00420004|536943464|FG001|Overall Study|Withdrawal by Subject|42|||
148854926|NCT00420004|536943465|FG002|Overall Study|Withdrawal by Subject|14|||
148854927|NCT00420004|536943463|FG000|Overall Study|Sponsor Decision|3|||
148854928|NCT00420004|536943464|FG001|Overall Study|Sponsor Decision|3|||
148854929|NCT00420004|536943465|FG002|Overall Study|Sponsor Decision|1|||
148854930|NCT03350035|536943468|FG000|Overall Study|Lack of Efficacy|2|||
148854931|NCT03350035|536943469|FG001|Overall Study|Lack of Efficacy|0|||
148854932|NCT03350035|536943470|FG002|Overall Study|Lack of Efficacy|0|||
148854933|NCT03350035|536943468|FG000|Overall Study|Subject discharged to hospice|0|||
148854934|NCT03350035|536943469|FG001|Overall Study|Subject discharged to hospice|0|||
148854935|NCT03350035|536943470|FG002|Overall Study|Subject discharged to hospice|1|||
148854936|NCT04115748|536943471|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
148854937|NCT04115748|536943472|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
148854938|NCT04115748|536943473|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
148854939|NCT04115748|536943474|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
148854940|NCT04115748|536943475|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
148854941|NCT04115748|536943476|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
148854942|NCT04115748|536943477|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
148854943|NCT04115748|536943478|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
148854944|NCT04115748|536943479|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
148854945|NCT04115748|536943480|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
148854946|NCT04115748|536943471|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854947|NCT04115748|536943472|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854948|NCT04115748|536943473|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854949|NCT04115748|536943474|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
148854950|NCT04115748|536943475|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854951|NCT04115748|536943476|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854952|NCT04115748|536943477|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854953|NCT04115748|536943478|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854954|NCT04115748|536943479|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854955|NCT04115748|536943480|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
148854956|NCT04115748|536943471|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
148854957|NCT04115748|536943472|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
148854958|NCT04115748|536943473|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
148854959|NCT04115748|536943474|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
148854960|NCT04115748|536943475|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
148854961|NCT04115748|536943476|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
148854962|NCT04115748|536943477|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
148854963|NCT04115748|536943478|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
148854964|NCT04115748|536943479|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
148854965|NCT04115748|536943480|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
148854966|NCT04115748|536943471|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854967|NCT04115748|536943472|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854968|NCT04115748|536943473|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854969|NCT04115748|536943474|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854970|NCT04115748|536943475|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854971|NCT04115748|536943476|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854972|NCT04115748|536943477|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854973|NCT04115748|536943478|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854974|NCT04115748|536943479|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
148854975|NCT04115748|536943480|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
148854976|NCT00713349|536943481|FG000|Overall Study|Protocol Violation|1|||
148854977|NCT01200407|536943482|FG000|Overall Study|Lost to Follow-up|56|||
148854978|NCT01200407|536943482|FG000|Overall Study|Adverse Event|3|||
148854979|NCT01200407|536943482|FG000|Overall Study|Withdrawal by Subject|4|||
148854980|NCT01200407|536943482|FG000|Overall Study|Other|19|||
148854981|NCT02974855|536943483|FG000|Overall Study|Adverse Event|0|||
148854982|NCT02974855|536943484|FG001|Overall Study|Adverse Event|1|||
148854983|NCT02974855|536943485|FG002|Overall Study|Adverse Event|0|||
148854984|NCT02974855|536943486|FG003|Overall Study|Adverse Event|1|||
148854985|NCT00633074|536943487|FG000|Overall Study|Adverse Event|1|||
148854986|NCT00633074|536943488|FG001|Overall Study|Adverse Event|0|||
148854987|NCT02752633|536943490|FG000|Overall Study|Withdrawal by Subject|1|||
148854988|NCT01843673|536943491|FG000|Overall Study|Lack of Efficacy|2|||
148854989|NCT01843673|536943491|FG000|Overall Study|Withdrawal by Subject|4|||
148854990|NCT00433966|536943494|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
148854991|NCT00433966|536943495|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
148854992|NCT00433966|536943496|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
148854993|NCT00433966|536943497|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
148854994|NCT00433966|536943494|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
148854995|NCT00433966|536943495|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
148854996|NCT00433966|536943496|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
148854997|NCT00433966|536943497|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
148854998|NCT00433966|536943494|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
148854999|NCT00433966|536943495|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
148855000|NCT00433966|536943496|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
148855001|NCT00433966|536943497|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
148986826|NCT00968669|537430551|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
148855002|NCT00433966|536943494|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
148855003|NCT00433966|536943495|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
148855004|NCT00433966|536943496|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
148855005|NCT00433966|536943497|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
148855006|NCT00433966|536943494|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
148855007|NCT00433966|536943495|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
148855008|NCT00433966|536943496|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
148855009|NCT00433966|536943497|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
148855010|NCT01988662|536943504|FG000|Overall Study|Subject/guardian decision|1|||
148855011|NCT01988662|536943505|FG001|Overall Study|Subject/guardian decision|1|||
148855012|NCT01988662|536943504|FG000|Overall Study|Adverse Event|3|||
148855013|NCT01988662|536943505|FG001|Overall Study|Adverse Event|1|||
148855014|NCT03425006|536943506|FG000|Overall Study|Withdrawal by Subject|1|||
148855015|NCT03425006|536943506|FG000|Overall Study|Physician Decision|1|||
148855016|NCT03425006|536943506|FG000|Overall Study|Death|1|||
148855017|NCT01864148|536943517|FG000|Overall Study|Other|2|||
148855018|NCT01864148|536943518|FG001|Overall Study|Other|1|||
148855019|NCT01864148|536943519|FG002|Overall Study|Other|1|||
148855020|NCT01864148|536943520|FG003|Overall Study|Other|3|||
148855021|NCT01864148|536943521|FG004|Overall Study|Other|1|||
148855022|NCT01864148|536943517|FG000|Overall Study|Death|0|||
148855023|NCT01864148|536943518|FG001|Overall Study|Death|0|||
148855024|NCT01864148|536943519|FG002|Overall Study|Death|0|||
148855025|NCT01864148|536943520|FG003|Overall Study|Death|1|||
148855026|NCT01864148|536943521|FG004|Overall Study|Death|0|||
148855027|NCT01864148|536943517|FG000|Overall Study|Investigator Decision|5|||
148855028|NCT01864148|536943518|FG001|Overall Study|Investigator Decision|0|||
148855029|NCT01864148|536943519|FG002|Overall Study|Investigator Decision|0|||
148855030|NCT01864148|536943520|FG003|Overall Study|Investigator Decision|4|||
148855031|NCT01864148|536943521|FG004|Overall Study|Investigator Decision|6|||
148855032|NCT01864148|536943517|FG000|Overall Study|Withdrawal by Subject|9|||
148855033|NCT01864148|536943518|FG001|Overall Study|Withdrawal by Subject|2|||
148855034|NCT01864148|536943519|FG002|Overall Study|Withdrawal by Subject|6|||
148855035|NCT01864148|536943520|FG003|Overall Study|Withdrawal by Subject|8|||
148855036|NCT01864148|536943521|FG004|Overall Study|Withdrawal by Subject|8|||
148855037|NCT01864148|536943517|FG000|Overall Study|Lost to Follow-up|0|||
148855038|NCT01864148|536943518|FG001|Overall Study|Lost to Follow-up|0|||
148855039|NCT01864148|536943519|FG002|Overall Study|Lost to Follow-up|0|||
148855040|NCT01864148|536943520|FG003|Overall Study|Lost to Follow-up|2|||
148855041|NCT01864148|536943521|FG004|Overall Study|Lost to Follow-up|1|||
148855042|NCT01864148|536943517|FG000|Overall Study|Adverse Event|4|||
148855043|NCT01864148|536943518|FG001|Overall Study|Adverse Event|2|||
148855044|NCT01864148|536943519|FG002|Overall Study|Adverse Event|4|||
148855045|NCT01864148|536943520|FG003|Overall Study|Adverse Event|7|||
148855046|NCT01864148|536943521|FG004|Overall Study|Adverse Event|7|||
148855047|NCT01864148|536943517|FG000|Overall Study|Not Dosed|0|||
148855048|NCT01864148|536943518|FG001|Overall Study|Not Dosed|0|||
148855049|NCT01864148|536943519|FG002|Overall Study|Not Dosed|0|||
148855050|NCT01864148|536943520|FG003|Overall Study|Not Dosed|1|||
148855051|NCT01864148|536943521|FG004|Overall Study|Not Dosed|0|||
148855052|NCT01500252|536943522|FG000|Overall Study|Death|4|||
148855053|NCT01500252|536943523|FG001|Overall Study|Death|2|||
148855054|NCT01500252|536943522|FG000|Overall Study|Lost to Follow-up|5|||
148855055|NCT01500252|536943523|FG001|Overall Study|Lost to Follow-up|4|||
148855056|NCT00904670|536943524|FG000|Open Label Phase|Withdrawal by Subject|2|||
148855057|NCT00904670|536943525|FG001|Open Label Phase|Withdrawal by Subject|0|||
148855058|NCT00904670|536943524|FG000|Open Label Phase|Adverse Event|2|||
148855059|NCT00904670|536943525|FG001|Open Label Phase|Adverse Event|0|||
148855060|NCT00904670|536943524|FG000|Open Label Phase|Lack of Efficacy|1|||
148855061|NCT00904670|536943525|FG001|Open Label Phase|Lack of Efficacy|0|||
148855062|NCT00904670|536943524|FG000|Open Label Phase|Lost to Follow-up|1|||
148855063|NCT00904670|536943525|FG001|Open Label Phase|Lost to Follow-up|0|||
148855064|NCT02120300|536943528|FG000|Overall Study|Enrolled but Never Treated|2|||
148855065|NCT02120300|536943529|FG001|Overall Study|Enrolled but Never Treated|0|||
148855066|NCT02120300|536943530|FG002|Overall Study|Enrolled but Never Treated|0|||
148855067|NCT02120300|536943531|FG003|Overall Study|Enrolled but Never Treated|0|||
148855068|NCT02120300|536943528|FG000|Overall Study|Lack of Efficacy|0|||
148855069|NCT02120300|536943529|FG001|Overall Study|Lack of Efficacy|0|||
148855070|NCT02120300|536943530|FG002|Overall Study|Lack of Efficacy|0|||
148855071|NCT02120300|536943531|FG003|Overall Study|Lack of Efficacy|1|||
148855072|NCT02120300|536943528|FG000|Overall Study|Lost to Follow-up|1|||
148855073|NCT02120300|536943529|FG001|Overall Study|Lost to Follow-up|0|||
148855074|NCT02120300|536943530|FG002|Overall Study|Lost to Follow-up|0|||
148855075|NCT02120300|536943531|FG003|Overall Study|Lost to Follow-up|0|||
148855076|NCT00613327|536943537|FG000|Overall Study|Adverse Event|38|||
148855077|NCT00613327|536943537|FG000|Overall Study|Lost to Follow-up|8|||
148855078|NCT00613327|536943537|FG000|Overall Study|Withdrawal by Subject|6|||
148855079|NCT00613327|536943537|FG000|Overall Study|Protocol Violation|2|||
148855080|NCT00613327|536943537|FG000|Overall Study|Other|47|||
148855081|NCT00344318|536943538|FG000|Overall Study|Adverse Event|0|||
148855082|NCT00344318|536943539|FG001|Overall Study|Adverse Event|3|||
148855083|NCT00344318|536943540|FG002|Overall Study|Adverse Event|0|||
148855084|NCT00344318|536943541|FG003|Overall Study|Adverse Event|1|||
148855085|NCT00344318|536943538|FG000|Overall Study|Withdrawal by Subject|2|||
148855086|NCT00344318|536943539|FG001|Overall Study|Withdrawal by Subject|2|||
148855087|NCT00344318|536943540|FG002|Overall Study|Withdrawal by Subject|0|||
148855088|NCT00344318|536943541|FG003|Overall Study|Withdrawal by Subject|2|||
148855089|NCT00344318|536943538|FG000|Overall Study|Lost to Follow-up|2|||
148855090|NCT00344318|536943539|FG001|Overall Study|Lost to Follow-up|0|||
148855091|NCT00344318|536943540|FG002|Overall Study|Lost to Follow-up|1|||
148855092|NCT00344318|536943541|FG003|Overall Study|Lost to Follow-up|0|||
148855093|NCT02791516|536943544|FG000|Overall Study|Withdrawal by Subject|1|||
148855094|NCT02791516|536943545|FG001|Overall Study|Withdrawal by Subject|1|||
148855095|NCT01439971|536943546|FG000|Overall Study|Required number in cohort dosed|0|||
148855096|NCT01439971|536943547|FG001|Overall Study|Required number in cohort dosed|1|||
148855097|NCT01439971|536943548|FG002|Overall Study|Required number in cohort dosed|2|||
148855098|NCT01439971|536943549|FG003|Overall Study|Required number in cohort dosed|0|||
148855099|NCT01439971|536943550|FG004|Overall Study|Required number in cohort dosed|1|||
148855100|NCT02628600|536943551|FG000|Overall Study|Death|2|||
148855101|NCT02628600|536943552|FG001|Overall Study|Death|1|||
148855102|NCT02628600|536943551|FG000|Overall Study|Adverse Event|3|||
148855103|NCT02628600|536943552|FG001|Overall Study|Adverse Event|20|||
148855104|NCT02628600|536943551|FG000|Overall Study|Protocol Violation|0|||
148855105|NCT02628600|536943552|FG001|Overall Study|Protocol Violation|1|||
148855106|NCT02628600|536943551|FG000|Overall Study|Lack of Efficacy|2|||
148855107|NCT02628600|536943552|FG001|Overall Study|Lack of Efficacy|0|||
148855108|NCT02628600|536943551|FG000|Overall Study|Withdrawal by Subject|13|||
148855109|NCT02628600|536943552|FG001|Overall Study|Withdrawal by Subject|8|||
148855110|NCT02628600|536943551|FG000|Overall Study|Lost to Follow-up|1|||
148855111|NCT02628600|536943552|FG001|Overall Study|Lost to Follow-up|0|||
148855112|NCT02628600|536943551|FG000|Overall Study|Physician Decision|2|||
148855113|NCT02628600|536943552|FG001|Overall Study|Physician Decision|2|||
148855114|NCT02628600|536943551|FG000|Overall Study|Other not specified|1|||
148855115|NCT02628600|536943552|FG001|Overall Study|Other not specified|0|||
148855116|NCT00583752|536943553|FG000|Overall Study|Lost to Follow-up|5|||
148855117|NCT00583752|536943554|FG001|Overall Study|Lost to Follow-up|5|||
148855118|NCT01700959|536943555|FG000|Overall Study|Adverse Event|0|||
148855119|NCT01700959|536943556|FG001|Overall Study|Adverse Event|1|||
148855120|NCT01700959|536943557|FG002|Overall Study|Adverse Event|1|||
148855121|NCT01700959|536943558|FG003|Overall Study|Adverse Event|2|||
148855122|NCT01700959|536943559|FG004|Overall Study|Adverse Event|0|||
148855123|NCT01700959|536943560|FG005|Overall Study|Adverse Event|2|||
148855124|NCT01700959|536943555|FG000|Overall Study|Withdrawal by Subject|15|||
148855125|NCT01700959|536943556|FG001|Overall Study|Withdrawal by Subject|9|||
148855126|NCT01700959|536943557|FG002|Overall Study|Withdrawal by Subject|12|||
148855127|NCT01700959|536943558|FG003|Overall Study|Withdrawal by Subject|11|||
148855128|NCT01700959|536943559|FG004|Overall Study|Withdrawal by Subject|8|||
148855129|NCT01700959|536943560|FG005|Overall Study|Withdrawal by Subject|12|||
148855130|NCT01700959|536943555|FG000|Overall Study|Ineligible|2|||
148855131|NCT01700959|536943556|FG001|Overall Study|Ineligible|1|||
148855132|NCT01700959|536943557|FG002|Overall Study|Ineligible|2|||
148855133|NCT01700959|536943558|FG003|Overall Study|Ineligible|0|||
148986827|NCT00968669|537430552|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
148986828|NCT00968669|537430553|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
148986829|NCT00968669|537430550|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
148986830|NCT00968669|537430551|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
148986831|NCT00968669|537430552|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
148986832|NCT00968669|537430553|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
148986833|NCT00968669|537430550|FG000|Overall Study|SPONSOR DECISION|0|||
148986834|NCT00968669|537430551|FG001|Overall Study|SPONSOR DECISION|1|||
148986835|NCT00968669|537430552|FG002|Overall Study|SPONSOR DECISION|0|||
148986836|NCT00968669|537430553|FG003|Overall Study|SPONSOR DECISION|0|||
148986837|NCT00968669|537430550|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
148986838|NCT00968669|537430551|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
148986839|NCT00968669|537430552|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
148855134|NCT01700959|536943559|FG004|Overall Study|Ineligible|0|||
148855135|NCT01700959|536943560|FG005|Overall Study|Ineligible|1|||
148855136|NCT01700959|536943555|FG000|Overall Study|Noncompliant|9|||
148855137|NCT01700959|536943556|FG001|Overall Study|Noncompliant|9|||
148855138|NCT01700959|536943557|FG002|Overall Study|Noncompliant|17|||
148855139|NCT01700959|536943558|FG003|Overall Study|Noncompliant|18|||
149030343|NCT03712930|537589586|FG000|Overall Study|Physician Decision|1|||
148855140|NCT01700959|536943559|FG004|Overall Study|Noncompliant|15|||
148855141|NCT01700959|536943560|FG005|Overall Study|Noncompliant|9|||
148855142|NCT01700959|536943555|FG000|Overall Study|Side effects|1|||
148855143|NCT01700959|536943556|FG001|Overall Study|Side effects|4|||
148855144|NCT01700959|536943557|FG002|Overall Study|Side effects|8|||
149030344|NCT03712930|537589586|FG000|Overall Study|Study Terminated by Sponsor|3|||
149030345|NCT03712930|537589586|FG000|Overall Study|Progressive Disease|2|||
149030346|NCT01118377|537589587|FG000|Overall Study|Did Not Receive Study Medication|1|||
149030347|NCT01118377|537589587|FG000|Overall Study|Death|38|||
149030348|NCT01118377|537589587|FG000|Overall Study|Failure to Return|3|||
149030349|NCT00739102|537589592|FG000|Overall Study|Death|5|||
149030350|NCT00739102|537589592|FG000|Overall Study|Withdrawal by Subject|10|||
149030351|NCT01062126|537589593|FG000|Overall Study|Death|209|||
149030352|NCT01062126|537589593|FG000|Overall Study|All Withdrawals|324|||
149030353|NCT00646451|537589594|FG000|Overall Study|Adverse Event|3|||
149030354|NCT00646451|537589595|FG001|Overall Study|Adverse Event|0|||
149030355|NCT00646451|537589594|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
149030356|NCT00646451|537589595|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
149030357|NCT01117480|537589605|FG000|Overall Study|Protocol Violation|8|||
149030358|NCT01117480|537589605|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
149030359|NCT03721016|537589606|FG000|Overall Study|Adverse Event|0|||
148986840|NCT00968669|537430553|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
148986841|NCT00968669|537430550|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
148986842|NCT00968669|537430551|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
148986843|NCT00968669|537430552|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
148986844|NCT00968669|537430553|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
148986845|NCT00968669|537430550|FG000|Overall Study|SUBJECT INCARCERATED|0|||
148986846|NCT00968669|537430551|FG001|Overall Study|SUBJECT INCARCERATED|1|||
148986847|NCT00968669|537430552|FG002|Overall Study|SUBJECT INCARCERATED|0|||
148986848|NCT00968669|537430553|FG003|Overall Study|SUBJECT INCARCERATED|0|||
148986849|NCT00968669|537430550|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
148986850|NCT00968669|537430551|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
148986851|NCT00968669|537430552|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
148986852|NCT00968669|537430553|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
148986853|NCT00968669|537430550|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
148986854|NCT00968669|537430551|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
148986855|NCT00968669|537430552|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
148986856|NCT00968669|537430553|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
148986857|NCT01953926|537430557|FG000|Overall Study|Withdrawal by Subject|23|||
148986858|NCT01953926|537430558|FG001|Overall Study|Withdrawal by Subject|3|||
148986859|NCT01953926|537430559|FG002|Overall Study|Withdrawal by Subject|3|||
148986860|NCT01953926|537430560|FG003|Overall Study|Withdrawal by Subject|5|||
148986861|NCT01953926|537430561|FG004|Overall Study|Withdrawal by Subject|6|||
148986862|NCT01953926|537430562|FG005|Overall Study|Withdrawal by Subject|0|||
148986863|NCT01953926|537430563|FG006|Overall Study|Withdrawal by Subject|1|||
148986864|NCT01953926|537430557|FG000|Overall Study|Physician Decision|1|||
148986865|NCT01953926|537430558|FG001|Overall Study|Physician Decision|0|||
148986866|NCT01953926|537430559|FG002|Overall Study|Physician Decision|0|||
148986867|NCT01953926|537430560|FG003|Overall Study|Physician Decision|0|||
148986868|NCT01953926|537430561|FG004|Overall Study|Physician Decision|2|||
148986869|NCT01953926|537430562|FG005|Overall Study|Physician Decision|0|||
148986870|NCT01953926|537430563|FG006|Overall Study|Physician Decision|0|||
148986871|NCT01953926|537430557|FG000|Overall Study|Lost to Follow-up|18|||
148986872|NCT01953926|537430558|FG001|Overall Study|Lost to Follow-up|3|||
148986873|NCT01953926|537430559|FG002|Overall Study|Lost to Follow-up|0|||
148986874|NCT01953926|537430560|FG003|Overall Study|Lost to Follow-up|5|||
148986875|NCT01953926|537430561|FG004|Overall Study|Lost to Follow-up|3|||
148986876|NCT01953926|537430562|FG005|Overall Study|Lost to Follow-up|0|||
148986877|NCT01953926|537430563|FG006|Overall Study|Lost to Follow-up|0|||
148986878|NCT01953926|537430557|FG000|Overall Study|Protocol Violation|1|||
148986879|NCT01953926|537430558|FG001|Overall Study|Protocol Violation|0|||
148986880|NCT01953926|537430559|FG002|Overall Study|Protocol Violation|0|||
149030360|NCT03721016|537589607|FG001|Overall Study|Adverse Event|1|||
148986881|NCT01953926|537430560|FG003|Overall Study|Protocol Violation|0|||
148986882|NCT01953926|537430561|FG004|Overall Study|Protocol Violation|0|||
148986883|NCT01953926|537430562|FG005|Overall Study|Protocol Violation|0|||
148986884|NCT01953926|537430563|FG006|Overall Study|Protocol Violation|0|||
148986885|NCT01953926|537430557|FG000|Overall Study|Other, Disease progression|2|||
148986886|NCT01953926|537430558|FG001|Overall Study|Other, Disease progression|1|||
148986887|NCT01953926|537430559|FG002|Overall Study|Other, Disease progression|0|||
148986888|NCT01953926|537430560|FG003|Overall Study|Other, Disease progression|0|||
148986889|NCT01953926|537430561|FG004|Overall Study|Other, Disease progression|1|||
148986890|NCT01953926|537430562|FG005|Overall Study|Other, Disease progression|0|||
149030361|NCT03721016|537589608|FG002|Overall Study|Adverse Event|1|||
149030362|NCT03721016|537589606|FG000|Overall Study|Withdrawal by Subject|8|||
148986891|NCT01953926|537430563|FG006|Overall Study|Other, Disease progression|0|||
148986892|NCT01953926|537430557|FG000|Overall Study|Discontinuation of study by sponsor|41|||
148986893|NCT01953926|537430558|FG001|Overall Study|Discontinuation of study by sponsor|7|||
149030363|NCT03721016|537589607|FG001|Overall Study|Withdrawal by Subject|16|||
149030364|NCT03721016|537589608|FG002|Overall Study|Withdrawal by Subject|13|||
148855145|NCT01700959|536943558|FG003|Overall Study|Side effects|4|||
148986894|NCT01953926|537430559|FG002|Overall Study|Discontinuation of study by sponsor|5|||
148986895|NCT01953926|537430560|FG003|Overall Study|Discontinuation of study by sponsor|12|||
148986896|NCT01953926|537430561|FG004|Overall Study|Discontinuation of study by sponsor|46|||
148986897|NCT01953926|537430562|FG005|Overall Study|Discontinuation of study by sponsor|5|||
148986898|NCT01953926|537430563|FG006|Overall Study|Discontinuation of study by sponsor|6|||
148986899|NCT01953926|537430557|FG000|Overall Study|Not Treated|1|||
148986900|NCT01953926|537430558|FG001|Overall Study|Not Treated|0|||
148986901|NCT01953926|537430559|FG002|Overall Study|Not Treated|1|||
148986902|NCT01953926|537430560|FG003|Overall Study|Not Treated|0|||
148986903|NCT01953926|537430561|FG004|Overall Study|Not Treated|0|||
148986904|NCT01953926|537430562|FG005|Overall Study|Not Treated|0|||
148986905|NCT01953926|537430563|FG006|Overall Study|Not Treated|0|||
148986906|NCT01949480|537430567|FG000|Overall Study|Physician Decision|5|||
148986907|NCT01949480|537430568|FG001|Overall Study|Physician Decision|8|||
148986908|NCT00144339|537430569|FG000|Overall Study|Adverse Event|746|||
148986909|NCT00144339|537430570|FG001|Overall Study|Adverse Event|627|||
148986910|NCT00144339|537430569|FG000|Overall Study|Protocol Violation|75|||
148986911|NCT00144339|537430570|FG001|Overall Study|Protocol Violation|48|||
148986912|NCT00144339|537430569|FG000|Overall Study|Withdrawal by Subject|403|||
148986913|NCT00144339|537430570|FG001|Overall Study|Withdrawal by Subject|300|||
148986914|NCT00144339|537430569|FG000|Overall Study|Lost to Follow-up|76|||
148986915|NCT00144339|537430570|FG001|Overall Study|Lost to Follow-up|64|||
148986916|NCT00144339|537430569|FG000|Overall Study|Other|58|||
148986917|NCT00144339|537430570|FG001|Overall Study|Other|60|||
148986918|NCT01618838|537430571|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
148986919|NCT01587651|537430572|FG000|Overall Study|Adverse Event|0|||
148986920|NCT01587651|537430573|FG001|Overall Study|Adverse Event|1|||
148986921|NCT01587651|537430574|FG002|Overall Study|Adverse Event|0|||
148986922|NCT01587651|537430572|FG000|Overall Study|Protocol Violation|0|||
148986923|NCT01587651|537430573|FG001|Overall Study|Protocol Violation|1|||
148986924|NCT01587651|537430574|FG002|Overall Study|Protocol Violation|1|||
148986925|NCT01587651|537430572|FG000|Overall Study|Withdrawal by Subject|0|||
148986926|NCT01587651|537430573|FG001|Overall Study|Withdrawal by Subject|1|||
148986927|NCT01587651|537430574|FG002|Overall Study|Withdrawal by Subject|0|||
148986928|NCT02308033|537430575|FG000|Overall Study|Normal Gram stain at Baseline|13|||
148986929|NCT02308033|537430576|FG001|Overall Study|Normal Gram stain at Baseline|10|||
148986930|NCT02308033|537430575|FG000|Overall Study|Positive for STD at Baseline|7|||
148986931|NCT02308033|537430576|FG001|Overall Study|Positive for STD at Baseline|4|||
148986932|NCT02308033|537430575|FG000|Overall Study|Lost to Follow-up|6|||
148986933|NCT02308033|537430576|FG001|Overall Study|Lost to Follow-up|5|||
148986934|NCT03325712|537430577|FG000|Overall Study|Protocol Violation|0|||
148986935|NCT03325712|537430578|FG001|Overall Study|Protocol Violation|0|||
148986936|NCT03325712|537430579|FG002|Overall Study|Protocol Violation|0|||
148986937|NCT03325712|537430580|FG003|Overall Study|Protocol Violation|0|||
148986938|NCT03325712|537430581|FG004|Overall Study|Protocol Violation|1|||
148986939|NCT03325712|537430582|FG005|Overall Study|Protocol Violation|0|||
148986940|NCT03325712|537430583|FG006|Overall Study|Protocol Violation|0|||
148986941|NCT03325712|537430584|FG007|Overall Study|Protocol Violation|0|||
148986942|NCT03325712|537430577|FG000|Overall Study|Adverse Event|0|||
148986943|NCT03325712|537430578|FG001|Overall Study|Adverse Event|0|||
148986944|NCT03325712|537430579|FG002|Overall Study|Adverse Event|0|||
148986945|NCT03325712|537430580|FG003|Overall Study|Adverse Event|0|||
148986946|NCT03325712|537430581|FG004|Overall Study|Adverse Event|1|||
148986947|NCT03325712|537430582|FG005|Overall Study|Adverse Event|0|||
148986948|NCT03325712|537430583|FG006|Overall Study|Adverse Event|0|||
148986949|NCT03325712|537430584|FG007|Overall Study|Adverse Event|0|||
148986950|NCT01178853|537430585|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
148986951|NCT01178853|537430586|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
148986952|NCT01178853|537430585|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
148986953|NCT01178853|537430586|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
148986954|NCT01178853|537430585|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
148986955|NCT01178853|537430586|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
148986956|NCT01178853|537430585|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
148986957|NCT01178853|537430586|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
148986958|NCT01178853|537430585|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
149030365|NCT03721016|537589606|FG000|Overall Study|Lost to Follow-up|4|||
148986959|NCT01178853|537430586|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
149030366|NCT03721016|537589607|FG001|Overall Study|Lost to Follow-up|6|||
148986960|NCT00839072|537430587|FG000|First Intervention Period|Withdrawal by Subject|1|||
148855146|NCT01700959|536943559|FG004|Overall Study|Side effects|4|||
148986961|NCT00839072|537430588|FG001|First Intervention Period|Withdrawal by Subject|0|||
148986962|NCT00839072|537430587|FG000|First Intervention Period|Adverse Event|1|||
148986963|NCT00839072|537430588|FG001|First Intervention Period|Adverse Event|1|||
148986964|NCT00839072|537430587|FG000|Second Intervention Period|Withdrawal by Subject|1|||
148986965|NCT00839072|537430588|FG001|Second Intervention Period|Withdrawal by Subject|0|||
148986966|NCT01297062|537430589|FG000|Overall Study|Adverse Event|2|||
148986967|NCT01297062|537430590|FG001|Overall Study|Adverse Event|0|||
149030367|NCT03721016|537589608|FG002|Overall Study|Lost to Follow-up|5|||
149030368|NCT03721016|537589606|FG000|Overall Study|Physician Decision|0|||
149030369|NCT03721016|537589607|FG001|Overall Study|Physician Decision|1|||
149030370|NCT03721016|537589608|FG002|Overall Study|Physician Decision|2|||
149030371|NCT03721016|537589606|FG000|Overall Study|Protocol Violation|0|||
149030372|NCT03721016|537589607|FG001|Overall Study|Protocol Violation|1|||
149030373|NCT03721016|537589608|FG002|Overall Study|Protocol Violation|0|||
149030374|NCT03721016|537589606|FG000|Overall Study|Site terminated by sponsor|3|||
149030375|NCT03721016|537589607|FG001|Overall Study|Site terminated by sponsor|7|||
149030376|NCT03721016|537589608|FG002|Overall Study|Site terminated by sponsor|6|||
149030377|NCT03721016|537589606|FG000|Overall Study|Subject exited early due to COVID-19|1|||
149030378|NCT03721016|537589607|FG001|Overall Study|Subject exited early due to COVID-19|0|||
149030379|NCT03721016|537589608|FG002|Overall Study|Subject exited early due to COVID-19|0|||
149030380|NCT01149681|537589612|FG000|Overall Study|Withdrawal by Subject|7|||
149030381|NCT01149681|537589612|FG000|Overall Study|Progressive disease|1|||
149030382|NCT01149681|537589612|FG000|Overall Study|Physician Decision|2|||
149030383|NCT01149681|537589612|FG000|Overall Study|adverse events nonrelated study drug|2|||
149030384|NCT02232178|537589613|FG000|Overall Study|Lost to Follow-up|0|||
149030385|NCT02232178|537589614|FG001|Overall Study|Lost to Follow-up|1|||
149030386|NCT02232178|537589615|FG002|Overall Study|Lost to Follow-up|0|||
149030387|NCT02232178|537589613|FG000|Overall Study|ineligibility|0|||
149030388|NCT02232178|537589614|FG001|Overall Study|ineligibility|0|||
149030389|NCT02232178|537589615|FG002|Overall Study|ineligibility|1|||
149030390|NCT02232178|537589613|FG000|Overall Study|surgical complication|1|||
149030391|NCT02232178|537589614|FG001|Overall Study|surgical complication|0|||
149030392|NCT02232178|537589615|FG002|Overall Study|surgical complication|0|||
149030393|NCT00817635|537589616|FG000|Overall Study|Adverse Event|1|||
149030394|NCT00817635|537589617|FG001|Overall Study|Adverse Event|0|||
149030395|NCT00817635|537589618|FG002|Overall Study|Adverse Event|0|||
149030396|NCT00817635|537589619|FG003|Overall Study|Adverse Event|1|||
149030397|NCT00817635|537589620|FG004|Overall Study|Adverse Event|1|||
149030398|NCT00817635|537589616|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
149030399|NCT00817635|537589617|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
149030400|NCT00817635|537589618|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
149030401|NCT00817635|537589619|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
149030402|NCT00817635|537589620|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
149030403|NCT00817635|537589616|FG000|Overall Study|Withdrawal by Subject|2|||
149030404|NCT00817635|537589617|FG001|Overall Study|Withdrawal by Subject|1|||
149030405|NCT00817635|537589618|FG002|Overall Study|Withdrawal by Subject|0|||
149030406|NCT00817635|537589619|FG003|Overall Study|Withdrawal by Subject|1|||
149030407|NCT00817635|537589620|FG004|Overall Study|Withdrawal by Subject|2|||
149030408|NCT00817635|537589616|FG000|Overall Study|Lost to Follow-up|0|||
149030409|NCT00817635|537589617|FG001|Overall Study|Lost to Follow-up|1|||
149030410|NCT00817635|537589618|FG002|Overall Study|Lost to Follow-up|0|||
148855147|NCT01700959|536943560|FG005|Overall Study|Side effects|1|||
148855148|NCT00830375|536943561|FG000|Overall Study|Lost to Follow-up|1|||
148855149|NCT03724981|536946223|FG000|First Device|Protocol Violation|1|||
148855150|NCT03724981|536946224|FG001|First Device|Protocol Violation|1|||
148855151|NCT02640625|536946225|FG000|Overall Study|Adverse Event|1|||
148855152|NCT00306293|536946229|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
148855153|NCT00306293|536946230|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
148855154|NCT00306293|536946229|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
148855155|NCT00306293|536946230|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
148855156|NCT00306293|536946229|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
148855157|NCT00306293|536946230|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
148855158|NCT00306293|536946229|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
148855159|NCT00306293|536946230|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
148855160|NCT00306293|536946229|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
148855161|NCT00306293|536946230|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
148855162|NCT00306293|536946229|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
148855163|NCT00306293|536946230|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
148855164|NCT00306293|536946229|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
148855165|NCT00306293|536946230|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
148855166|NCT00306293|536946229|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
148855167|NCT00306293|536946230|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
148855168|NCT00185380|536946231|FG000|Overall Study|Adverse Event|41|||
148855169|NCT00185380|536946232|FG001|Overall Study|Adverse Event|43|||
148855170|NCT00185380|536946233|FG002|Overall Study|Adverse Event|48|||
148855171|NCT00185380|536946231|FG000|Overall Study|Lost to Follow-up|0|||
149030411|NCT00817635|537589619|FG003|Overall Study|Lost to Follow-up|1|||
149030412|NCT00817635|537589620|FG004|Overall Study|Lost to Follow-up|0|||
149030413|NCT00817635|537589616|FG000|Overall Study|Administrative Problems|0|||
149030414|NCT00817635|537589617|FG001|Overall Study|Administrative Problems|0|||
149030415|NCT00817635|537589618|FG002|Overall Study|Administrative Problems|0|||
149030416|NCT00817635|537589619|FG003|Overall Study|Administrative Problems|0|||
148855172|NCT00185380|536946232|FG001|Overall Study|Lost to Follow-up|4|||
148855173|NCT00185380|536946233|FG002|Overall Study|Lost to Follow-up|3|||
148855174|NCT00185380|536946231|FG000|Overall Study|Pregnancy|1|||
148855175|NCT00185380|536946232|FG001|Overall Study|Pregnancy|4|||
148855176|NCT00185380|536946233|FG002|Overall Study|Pregnancy|0|||
148855177|NCT00185380|536946231|FG000|Overall Study|Protocol Violation|2|||
148855178|NCT00185380|536946232|FG001|Overall Study|Protocol Violation|2|||
148855179|NCT00185380|536946233|FG002|Overall Study|Protocol Violation|1|||
148855180|NCT00185380|536946231|FG000|Overall Study|Withdrawal by Subject|1|||
148855181|NCT00185380|536946232|FG001|Overall Study|Withdrawal by Subject|2|||
148855182|NCT00185380|536946233|FG002|Overall Study|Withdrawal by Subject|0|||
148855183|NCT00185380|536946231|FG000|Overall Study|Failed insertion|1|||
148855184|NCT00185380|536946232|FG001|Overall Study|Failed insertion|1|||
148855185|NCT00185380|536946233|FG002|Overall Study|Failed insertion|2|||
148855186|NCT00185380|536946231|FG000|Overall Study|Planned pregnancy|9|||
148855187|NCT00185380|536946232|FG001|Overall Study|Planned pregnancy|12|||
148855188|NCT00185380|536946233|FG002|Overall Study|Planned pregnancy|12|||
148855189|NCT00185380|536946231|FG000|Overall Study|No need for contraception|3|||
148855190|NCT00185380|536946232|FG001|Overall Study|No need for contraception|3|||
148855191|NCT00185380|536946233|FG002|Overall Study|No need for contraception|3|||
148855192|NCT00185380|536946231|FG000|Overall Study|Could not attend visits|2|||
148855193|NCT00185380|536946232|FG001|Overall Study|Could not attend visits|0|||
148855194|NCT00185380|536946233|FG002|Overall Study|Could not attend visits|4|||
148855195|NCT00185380|536946231|FG000|Overall Study|personal reason|6|||
148855196|NCT00185380|536946232|FG001|Overall Study|personal reason|1|||
148855197|NCT00185380|536946233|FG002|Overall Study|personal reason|1|||
148855198|NCT02589665|536946235|FG000|Induction Period|Did not receive drug|0|||
148855199|NCT02589665|536946236|FG001|Induction Period|Did not receive drug|0|||
148855200|NCT02589665|536946237|FG002|Induction Period|Did not receive drug|0|||
148855201|NCT02589665|536946238|FG003|Induction Period|Did not receive drug|1|||
148855202|NCT02589665|536946239|FG004|Induction Period|Did not receive drug|0|||
149030417|NCT00817635|537589620|FG004|Overall Study|Administrative Problems|1|||
149030418|NCT00817635|537589616|FG000|Overall Study|Protocol Violation|5|||
149030419|NCT00817635|537589617|FG001|Overall Study|Protocol Violation|1|||
149030420|NCT00817635|537589618|FG002|Overall Study|Protocol Violation|3|||
149030421|NCT00817635|537589619|FG003|Overall Study|Protocol Violation|2|||
149030422|NCT00817635|537589620|FG004|Overall Study|Protocol Violation|3|||
149030423|NCT01167426|537589621|FG000|Overall Study|Lost to Follow-up|6|||
149030424|NCT01167426|537589621|FG000|Overall Study|Protocol Violation|1|||
148855203|NCT02589665|536946240|FG005|Induction Period|Did not receive drug|0|||
148855204|NCT02589665|536946241|FG006|Induction Period|Did not receive drug|0|||
148855205|NCT02589665|536946242|FG007|Induction Period|Did not receive drug|0|||
148855206|NCT02589665|536946243|FG008|Induction Period|Did not receive drug|0|||
148855207|NCT02589665|536946244|FG009|Induction Period|Did not receive drug|0|||
148855208|NCT02589665|536946235|FG000|Induction Period|Adverse Event|3|||
148855209|NCT02589665|536946236|FG001|Induction Period|Adverse Event|0|||
148986968|NCT01297062|537430591|FG002|Overall Study|Adverse Event|1|||
148986969|NCT01297062|537430592|FG003|Overall Study|Adverse Event|0|||
148986970|NCT01297062|537430593|FG004|Overall Study|Adverse Event|0|||
148986971|NCT01297062|537430594|FG005|Overall Study|Adverse Event|0|||
148986972|NCT01297062|537430595|FG006|Overall Study|Adverse Event|0|||
148986973|NCT01297062|537430589|FG000|Overall Study|Physician Decision|1|||
148986974|NCT01297062|537430590|FG001|Overall Study|Physician Decision|0|||
148986975|NCT01297062|537430591|FG002|Overall Study|Physician Decision|1|||
148986976|NCT01297062|537430592|FG003|Overall Study|Physician Decision|0|||
148986977|NCT01297062|537430593|FG004|Overall Study|Physician Decision|0|||
148986978|NCT01297062|537430594|FG005|Overall Study|Physician Decision|0|||
148986979|NCT01297062|537430595|FG006|Overall Study|Physician Decision|6|||
148986980|NCT01297062|537430589|FG000|Overall Study|Protocol Violation|0|||
148986981|NCT01297062|537430590|FG001|Overall Study|Protocol Violation|0|||
148986982|NCT01297062|537430591|FG002|Overall Study|Protocol Violation|0|||
148986983|NCT01297062|537430592|FG003|Overall Study|Protocol Violation|0|||
148986984|NCT01297062|537430593|FG004|Overall Study|Protocol Violation|1|||
148986985|NCT01297062|537430594|FG005|Overall Study|Protocol Violation|0|||
148986986|NCT01297062|537430595|FG006|Overall Study|Protocol Violation|0|||
148986987|NCT01297062|537430589|FG000|Overall Study|Subject Decision|1|||
148986988|NCT01297062|537430590|FG001|Overall Study|Subject Decision|1|||
148986989|NCT01297062|537430591|FG002|Overall Study|Subject Decision|0|||
148986990|NCT01297062|537430592|FG003|Overall Study|Subject Decision|1|||
148986991|NCT01297062|537430593|FG004|Overall Study|Subject Decision|1|||
148986992|NCT01297062|537430594|FG005|Overall Study|Subject Decision|1|||
148986993|NCT01297062|537430595|FG006|Overall Study|Subject Decision|2|||
148986994|NCT01682837|537430596|FG000|Baseline|Withdrawal by Subject|5|||
148986995|NCT04782323|537430597|FG000|Overall Study|Death|1|||
148986996|NCT04782323|537430598|FG001|Overall Study|Death|0|||
148986997|NCT04782323|537430599|FG002|Overall Study|Death|0|||
148986998|NCT04782323|537430600|FG003|Overall Study|Death|0|||
148986999|NCT04782323|537430601|FG004|Overall Study|Death|1|||
148987000|NCT04782323|537430602|FG005|Overall Study|Death|1|||
148987001|NCT04782323|537430603|FG006|Overall Study|Death|1|||
149030425|NCT01167426|537589621|FG000|Overall Study|Withdrawal by Subject|2|||
148855210|NCT02589665|536946237|FG002|Induction Period|Adverse Event|2|||
148855211|NCT02589665|536946238|FG003|Induction Period|Adverse Event|2|||
148855212|NCT02589665|536946239|FG004|Induction Period|Adverse Event|0|||
148855213|NCT02589665|536946240|FG005|Induction Period|Adverse Event|0|||
148855214|NCT02589665|536946241|FG006|Induction Period|Adverse Event|0|||
148855215|NCT02589665|536946242|FG007|Induction Period|Adverse Event|0|||
148855216|NCT02589665|536946243|FG008|Induction Period|Adverse Event|0|||
148855217|NCT02589665|536946244|FG009|Induction Period|Adverse Event|0|||
148855218|NCT02589665|536946235|FG000|Induction Period|Withdrawal by Subject|0|||
148855219|NCT02589665|536946236|FG001|Induction Period|Withdrawal by Subject|1|||
148855220|NCT02589665|536946237|FG002|Induction Period|Withdrawal by Subject|0|||
148855221|NCT02589665|536946238|FG003|Induction Period|Withdrawal by Subject|1|||
148855222|NCT02589665|536946239|FG004|Induction Period|Withdrawal by Subject|0|||
148855223|NCT02589665|536946240|FG005|Induction Period|Withdrawal by Subject|0|||
148855224|NCT02589665|536946241|FG006|Induction Period|Withdrawal by Subject|0|||
148855225|NCT02589665|536946242|FG007|Induction Period|Withdrawal by Subject|0|||
148855226|NCT02589665|536946243|FG008|Induction Period|Withdrawal by Subject|0|||
148855227|NCT02589665|536946244|FG009|Induction Period|Withdrawal by Subject|0|||
148855228|NCT02589665|536946235|FG000|Induction Period|Protocol Violation|0|||
148855229|NCT02589665|536946236|FG001|Induction Period|Protocol Violation|1|||
148855230|NCT02589665|536946237|FG002|Induction Period|Protocol Violation|0|||
148855231|NCT02589665|536946238|FG003|Induction Period|Protocol Violation|0|||
148855232|NCT02589665|536946239|FG004|Induction Period|Protocol Violation|0|||
148855233|NCT02589665|536946240|FG005|Induction Period|Protocol Violation|0|||
148855234|NCT02589665|536946241|FG006|Induction Period|Protocol Violation|0|||
148855235|NCT02589665|536946242|FG007|Induction Period|Protocol Violation|0|||
148855236|NCT02589665|536946243|FG008|Induction Period|Protocol Violation|0|||
148855237|NCT02589665|536946244|FG009|Induction Period|Protocol Violation|0|||
148855238|NCT02589665|536946235|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855239|NCT02589665|536946236|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855240|NCT02589665|536946237|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855241|NCT02589665|536946238|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855242|NCT02589665|536946239|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
148855243|NCT02589665|536946240|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
148855244|NCT02589665|536946241|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
148855245|NCT02589665|536946242|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855246|NCT02589665|536946243|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855247|NCT02589665|536946244|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855248|NCT02589665|536946235|FG000|Maintenance Period|Withdrawal by Subject|0|||
148855249|NCT02589665|536946236|FG001|Maintenance Period|Withdrawal by Subject|0|||
148855250|NCT02589665|536946237|FG002|Maintenance Period|Withdrawal by Subject|0|||
148855251|NCT02589665|536946238|FG003|Maintenance Period|Withdrawal by Subject|0|||
148855252|NCT02589665|536946239|FG004|Maintenance Period|Withdrawal by Subject|4|||
148855253|NCT02589665|536946240|FG005|Maintenance Period|Withdrawal by Subject|2|||
148855254|NCT02589665|536946241|FG006|Maintenance Period|Withdrawal by Subject|4|||
148855255|NCT02589665|536946242|FG007|Maintenance Period|Withdrawal by Subject|0|||
148855256|NCT02589665|536946243|FG008|Maintenance Period|Withdrawal by Subject|0|||
148855257|NCT02589665|536946244|FG009|Maintenance Period|Withdrawal by Subject|0|||
148855258|NCT02589665|536946235|FG000|Maintenance Period|Lack of Efficacy|0|||
148855259|NCT02589665|536946236|FG001|Maintenance Period|Lack of Efficacy|0|||
148855260|NCT02589665|536946237|FG002|Maintenance Period|Lack of Efficacy|0|||
148855261|NCT02589665|536946238|FG003|Maintenance Period|Lack of Efficacy|0|||
148855262|NCT02589665|536946239|FG004|Maintenance Period|Lack of Efficacy|2|||
148855263|NCT02589665|536946240|FG005|Maintenance Period|Lack of Efficacy|1|||
149030426|NCT01167426|537589621|FG000|Overall Study|Sponsor Decision|1|||
148855264|NCT02589665|536946241|FG006|Maintenance Period|Lack of Efficacy|0|||
148855265|NCT02589665|536946242|FG007|Maintenance Period|Lack of Efficacy|0|||
148855266|NCT02589665|536946243|FG008|Maintenance Period|Lack of Efficacy|0|||
148855267|NCT02589665|536946244|FG009|Maintenance Period|Lack of Efficacy|0|||
148855268|NCT02589665|536946235|FG000|Maintenance Period|Adverse Event|0|||
148855269|NCT02589665|536946236|FG001|Maintenance Period|Adverse Event|0|||
148855270|NCT02589665|536946237|FG002|Maintenance Period|Adverse Event|0|||
148855271|NCT02589665|536946238|FG003|Maintenance Period|Adverse Event|0|||
148855272|NCT02589665|536946239|FG004|Maintenance Period|Adverse Event|0|||
148855273|NCT02589665|536946240|FG005|Maintenance Period|Adverse Event|0|||
148855274|NCT02589665|536946241|FG006|Maintenance Period|Adverse Event|2|||
148855275|NCT02589665|536946242|FG007|Maintenance Period|Adverse Event|0|||
148855276|NCT02589665|536946243|FG008|Maintenance Period|Adverse Event|0|||
148855277|NCT02589665|536946244|FG009|Maintenance Period|Adverse Event|0|||
148855278|NCT02589665|536946235|FG000|Maintenance Period|Lost to Follow-up|0|||
148855279|NCT02589665|536946236|FG001|Maintenance Period|Lost to Follow-up|0|||
148855280|NCT02589665|536946237|FG002|Maintenance Period|Lost to Follow-up|0|||
148855281|NCT02589665|536946238|FG003|Maintenance Period|Lost to Follow-up|0|||
148855282|NCT02589665|536946239|FG004|Maintenance Period|Lost to Follow-up|0|||
148855283|NCT02589665|536946240|FG005|Maintenance Period|Lost to Follow-up|1|||
148855284|NCT02589665|536946241|FG006|Maintenance Period|Lost to Follow-up|0|||
148855285|NCT02589665|536946242|FG007|Maintenance Period|Lost to Follow-up|0|||
148855286|NCT02589665|536946243|FG008|Maintenance Period|Lost to Follow-up|0|||
148855287|NCT02589665|536946244|FG009|Maintenance Period|Lost to Follow-up|0|||
148855288|NCT02589665|536946235|FG000|Maintenance Period|Physician Decision|0|||
148855289|NCT02589665|536946236|FG001|Maintenance Period|Physician Decision|0|||
148855290|NCT02589665|536946237|FG002|Maintenance Period|Physician Decision|0|||
148855291|NCT02589665|536946238|FG003|Maintenance Period|Physician Decision|0|||
148855292|NCT02589665|536946239|FG004|Maintenance Period|Physician Decision|0|||
148855293|NCT02589665|536946240|FG005|Maintenance Period|Physician Decision|1|||
148855294|NCT02589665|536946241|FG006|Maintenance Period|Physician Decision|0|||
148855295|NCT02589665|536946242|FG007|Maintenance Period|Physician Decision|0|||
148855296|NCT02589665|536946243|FG008|Maintenance Period|Physician Decision|0|||
148855297|NCT02589665|536946244|FG009|Maintenance Period|Physician Decision|0|||
148855298|NCT02589665|536946235|FG000|Maintenance Period|Reason Not Collected|0|||
148855299|NCT02589665|536946236|FG001|Maintenance Period|Reason Not Collected|0|||
148855300|NCT02589665|536946237|FG002|Maintenance Period|Reason Not Collected|0|||
148855301|NCT02589665|536946238|FG003|Maintenance Period|Reason Not Collected|0|||
148855302|NCT02589665|536946239|FG004|Maintenance Period|Reason Not Collected|0|||
148855303|NCT02589665|536946240|FG005|Maintenance Period|Reason Not Collected|1|||
148855304|NCT02589665|536946241|FG006|Maintenance Period|Reason Not Collected|1|||
148855305|NCT02589665|536946242|FG007|Maintenance Period|Reason Not Collected|0|||
148855306|NCT02589665|536946243|FG008|Maintenance Period|Reason Not Collected|0|||
148855307|NCT02589665|536946244|FG009|Maintenance Period|Reason Not Collected|0|||
148855308|NCT02589665|536946235|FG000|Induction Extension Period|Adverse Event|0|||
148855309|NCT02589665|536946236|FG001|Induction Extension Period|Adverse Event|0|||
148855310|NCT02589665|536946237|FG002|Induction Extension Period|Adverse Event|0|||
148855311|NCT02589665|536946238|FG003|Induction Extension Period|Adverse Event|0|||
148855312|NCT02589665|536946239|FG004|Induction Extension Period|Adverse Event|0|||
148855313|NCT02589665|536946240|FG005|Induction Extension Period|Adverse Event|0|||
148855314|NCT02589665|536946241|FG006|Induction Extension Period|Adverse Event|0|||
148855315|NCT02589665|536946242|FG007|Induction Extension Period|Adverse Event|0|||
148855316|NCT02589665|536946243|FG008|Induction Extension Period|Adverse Event|4|||
148855317|NCT02589665|536946244|FG009|Induction Extension Period|Adverse Event|0|||
148855318|NCT02589665|536946235|FG000|Induction Extension Period|Lack of Efficacy|0|||
148855319|NCT02589665|536946236|FG001|Induction Extension Period|Lack of Efficacy|0|||
148855320|NCT02589665|536946237|FG002|Induction Extension Period|Lack of Efficacy|0|||
148855321|NCT02589665|536946238|FG003|Induction Extension Period|Lack of Efficacy|0|||
148855322|NCT02589665|536946239|FG004|Induction Extension Period|Lack of Efficacy|0|||
148855323|NCT02589665|536946240|FG005|Induction Extension Period|Lack of Efficacy|0|||
148855324|NCT02589665|536946241|FG006|Induction Extension Period|Lack of Efficacy|0|||
148855325|NCT02589665|536946242|FG007|Induction Extension Period|Lack of Efficacy|0|||
148855326|NCT02589665|536946243|FG008|Induction Extension Period|Lack of Efficacy|3|||
148855327|NCT02589665|536946244|FG009|Induction Extension Period|Lack of Efficacy|0|||
148855328|NCT02589665|536946235|FG000|Induction Extension Period|Withdrawal by Subject|0|||
148855329|NCT02589665|536946236|FG001|Induction Extension Period|Withdrawal by Subject|0|||
148855330|NCT02589665|536946237|FG002|Induction Extension Period|Withdrawal by Subject|0|||
148855331|NCT02589665|536946238|FG003|Induction Extension Period|Withdrawal by Subject|0|||
148855332|NCT02589665|536946239|FG004|Induction Extension Period|Withdrawal by Subject|0|||
148855333|NCT02589665|536946240|FG005|Induction Extension Period|Withdrawal by Subject|0|||
148855334|NCT02589665|536946241|FG006|Induction Extension Period|Withdrawal by Subject|0|||
148855335|NCT02589665|536946242|FG007|Induction Extension Period|Withdrawal by Subject|2|||
148855336|NCT02589665|536946243|FG008|Induction Extension Period|Withdrawal by Subject|3|||
148855337|NCT02589665|536946244|FG009|Induction Extension Period|Withdrawal by Subject|0|||
148855338|NCT02589665|536946235|FG000|Induction Extension Period|Physician Decision|0|||
148855339|NCT02589665|536946236|FG001|Induction Extension Period|Physician Decision|0|||
148855340|NCT02589665|536946237|FG002|Induction Extension Period|Physician Decision|0|||
148855341|NCT02589665|536946238|FG003|Induction Extension Period|Physician Decision|0|||
148855342|NCT02589665|536946239|FG004|Induction Extension Period|Physician Decision|0|||
148855343|NCT02589665|536946240|FG005|Induction Extension Period|Physician Decision|0|||
148855344|NCT02589665|536946241|FG006|Induction Extension Period|Physician Decision|0|||
148855345|NCT02589665|536946242|FG007|Induction Extension Period|Physician Decision|0|||
148855346|NCT02589665|536946243|FG008|Induction Extension Period|Physician Decision|1|||
148855347|NCT02589665|536946244|FG009|Induction Extension Period|Physician Decision|0|||
148855348|NCT02589665|536946235|FG000|Induction Extension Period|Reason Not Collected|0|||
148855349|NCT02589665|536946236|FG001|Induction Extension Period|Reason Not Collected|0|||
148855350|NCT02589665|536946237|FG002|Induction Extension Period|Reason Not Collected|0|||
148855351|NCT02589665|536946238|FG003|Induction Extension Period|Reason Not Collected|0|||
148855352|NCT02589665|536946239|FG004|Induction Extension Period|Reason Not Collected|0|||
148855353|NCT02589665|536946240|FG005|Induction Extension Period|Reason Not Collected|0|||
148889453|NCT02888106|537074407|FG001|Overall Study|Adverse Event|0|||
148855354|NCT02589665|536946241|FG006|Induction Extension Period|Reason Not Collected|0|||
148855355|NCT02589665|536946242|FG007|Induction Extension Period|Reason Not Collected|0|||
148855356|NCT02589665|536946243|FG008|Induction Extension Period|Reason Not Collected|1|||
148855357|NCT02589665|536946244|FG009|Induction Extension Period|Reason Not Collected|0|||
148855358|NCT02589665|536946235|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855359|NCT02589665|536946236|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855360|NCT02589665|536946237|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855361|NCT02589665|536946238|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855362|NCT02589665|536946239|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855363|NCT02589665|536946240|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855364|NCT02589665|536946241|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855365|NCT02589665|536946242|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855366|NCT02589665|536946243|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
148855367|NCT02589665|536946244|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
148855368|NCT02589665|536946235|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
148855369|NCT02589665|536946236|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
148855370|NCT02589665|536946237|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
148855371|NCT02589665|536946238|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
148855372|NCT02589665|536946239|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
148855373|NCT02589665|536946240|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
148855374|NCT02589665|536946241|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
148855375|NCT02589665|536946242|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
148855376|NCT02589665|536946243|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
148855377|NCT02589665|536946244|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
148855378|NCT02589665|536946235|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
148855379|NCT02589665|536946236|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
148855380|NCT02589665|536946237|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
148855381|NCT02589665|536946238|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
148855382|NCT02589665|536946239|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
148855383|NCT02589665|536946240|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
148855384|NCT02589665|536946241|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
148855385|NCT02589665|536946242|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
148855386|NCT02589665|536946243|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
148855387|NCT02589665|536946244|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
148855388|NCT02589665|536946235|FG000|Maintenance Extension Period|Adverse Event|0|||
148855389|NCT02589665|536946236|FG001|Maintenance Extension Period|Adverse Event|0|||
148855390|NCT02589665|536946237|FG002|Maintenance Extension Period|Adverse Event|0|||
148855391|NCT02589665|536946238|FG003|Maintenance Extension Period|Adverse Event|0|||
148855392|NCT02589665|536946239|FG004|Maintenance Extension Period|Adverse Event|0|||
148855393|NCT02589665|536946240|FG005|Maintenance Extension Period|Adverse Event|0|||
148855394|NCT02589665|536946241|FG006|Maintenance Extension Period|Adverse Event|0|||
148855395|NCT02589665|536946242|FG007|Maintenance Extension Period|Adverse Event|0|||
148855396|NCT02589665|536946243|FG008|Maintenance Extension Period|Adverse Event|0|||
148855397|NCT02589665|536946244|FG009|Maintenance Extension Period|Adverse Event|2|||
148855398|NCT02589665|536946235|FG000|Maintenance Extension Period|Non-responder|0|||
148855399|NCT02589665|536946236|FG001|Maintenance Extension Period|Non-responder|0|||
148855400|NCT02589665|536946237|FG002|Maintenance Extension Period|Non-responder|0|||
148855401|NCT02589665|536946238|FG003|Maintenance Extension Period|Non-responder|0|||
148855402|NCT02589665|536946239|FG004|Maintenance Extension Period|Non-responder|0|||
148855403|NCT02589665|536946240|FG005|Maintenance Extension Period|Non-responder|0|||
148855404|NCT02589665|536946241|FG006|Maintenance Extension Period|Non-responder|0|||
148855405|NCT02589665|536946242|FG007|Maintenance Extension Period|Non-responder|0|||
148855406|NCT02589665|536946243|FG008|Maintenance Extension Period|Non-responder|0|||
148855407|NCT02589665|536946244|FG009|Maintenance Extension Period|Non-responder|1|||
148855408|NCT00978380|536946247|FG000|Overall Study|Protocol Violation|2|||
148855409|NCT00978380|536946247|FG000|Overall Study|Withdrawal criteria|9|||
148855410|NCT00978380|536946247|FG000|Overall Study|Unclassified|8|||
148855411|NCT02199314|536946248|FG000|Overall Study|Withdrawal by Subject|6|||
148855412|NCT02199314|536946248|FG000|Overall Study|Physician Decision|10|||
148855413|NCT00176488|536946249|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
148855414|NCT00327015|536946250|FG000|Overall Study|Lack of Efficacy|18|||
148855415|NCT00327015|536946251|FG001|Overall Study|Lack of Efficacy|18|||
149030427|NCT04176458|537589623|FG000|Overall Study|Covid 19|4|||
149030428|NCT02131324|537589624|FG000|Overall Study|Withdrawal by Subject|1|||
149030429|NCT02131324|537589625|FG001|Overall Study|Withdrawal by Subject|2|||
148855416|NCT00327015|536946252|FG002|Overall Study|Lack of Efficacy|35|||
149030430|NCT02131324|537589624|FG000|Overall Study|Lost to Follow-up|1|||
149030431|NCT02131324|537589625|FG001|Overall Study|Lost to Follow-up|1|||
149030432|NCT00891618|537589626|FG000|Overall Study|Withdrawal by Subject|1|||
148855417|NCT00327015|536946253|FG003|Overall Study|Lack of Efficacy|29|||
148855418|NCT00327015|536946250|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
148855419|NCT00327015|536946251|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
148855420|NCT00327015|536946252|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
148855421|NCT00327015|536946253|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
148855422|NCT00327015|536946250|FG000|Overall Study|Lost to Follow-up|22|||
148855423|NCT00327015|536946251|FG001|Overall Study|Lost to Follow-up|23|||
148855424|NCT00327015|536946252|FG002|Overall Study|Lost to Follow-up|29|||
148855425|NCT00327015|536946253|FG003|Overall Study|Lost to Follow-up|22|||
148855426|NCT00327015|536946250|FG000|Overall Study|Adverse Event|14|||
148855427|NCT00327015|536946251|FG001|Overall Study|Adverse Event|10|||
148855428|NCT00327015|536946252|FG002|Overall Study|Adverse Event|14|||
148855429|NCT00327015|536946253|FG003|Overall Study|Adverse Event|14|||
148855430|NCT00327015|536946250|FG000|Overall Study|Subject no longer meets study criteria|4|||
148855431|NCT00327015|536946251|FG001|Overall Study|Subject no longer meets study criteria|2|||
148855432|NCT00327015|536946252|FG002|Overall Study|Subject no longer meets study criteria|8|||
148855433|NCT00327015|536946253|FG003|Overall Study|Subject no longer meets study criteria|7|||
148855434|NCT00327015|536946250|FG000|Overall Study|Poor/Noncompliance|11|||
148855435|NCT00327015|536946251|FG001|Overall Study|Poor/Noncompliance|8|||
148855436|NCT00327015|536946252|FG002|Overall Study|Poor/Noncompliance|4|||
148855437|NCT00327015|536946253|FG003|Overall Study|Poor/Noncompliance|5|||
148855438|NCT00327015|536946250|FG000|Overall Study|Physician Decision|0|||
149030433|NCT04523181|537589628|FG000|Overall Study|Withdrawal by Subject|4|||
149030434|NCT04523181|537589629|FG001|Overall Study|Withdrawal by Subject|5|||
149030435|NCT04523181|537589628|FG000|Overall Study|Lost to Follow-up|2|||
149030436|NCT04523181|537589629|FG001|Overall Study|Lost to Follow-up|3|||
149030437|NCT04523181|537589628|FG000|Overall Study|Physician Decision|1|||
149030438|NCT04523181|537589629|FG001|Overall Study|Physician Decision|0|||
149030439|NCT04523181|537589628|FG000|Overall Study|Transferred to external facility.|1|||
149030440|NCT04523181|537589629|FG001|Overall Study|Transferred to external facility.|1|||
149030441|NCT01268566|537589636|FG000|Overall Study|Lost to Follow-up|1|||
149030442|NCT01268566|537589636|FG000|Overall Study|Withdrawal by Subject|12|||
149030443|NCT01268566|537589636|FG000|Overall Study|Death|30|||
149030444|NCT04305912|537589638|FG000|First Intervention|COVID-19 Suspension|2|||
149030445|NCT04305912|537589639|FG001|First Intervention|COVID-19 Suspension|0|||
149030446|NCT04305912|537589638|FG000|First Intervention|Withdrawal by Subject|0|||
149030447|NCT04305912|537589639|FG001|First Intervention|Withdrawal by Subject|1|||
149030448|NCT04305912|537589638|FG000|Second Intervention|Adverse Event|0|||
148855439|NCT00327015|536946251|FG001|Overall Study|Physician Decision|1|||
148855440|NCT00327015|536946252|FG002|Overall Study|Physician Decision|3|||
148855441|NCT00327015|536946253|FG003|Overall Study|Physician Decision|2|||
148987002|NCT04782323|537430604|FG007|Overall Study|Death|0|||
148987003|NCT04782323|537430597|FG000|Overall Study|Withdrawal by Subject|0|||
148987004|NCT04782323|537430598|FG001|Overall Study|Withdrawal by Subject|0|||
148987005|NCT04782323|537430599|FG002|Overall Study|Withdrawal by Subject|1|||
148987006|NCT04782323|537430600|FG003|Overall Study|Withdrawal by Subject|0|||
148987007|NCT04782323|537430601|FG004|Overall Study|Withdrawal by Subject|0|||
148987008|NCT04782323|537430602|FG005|Overall Study|Withdrawal by Subject|1|||
148987009|NCT04782323|537430603|FG006|Overall Study|Withdrawal by Subject|0|||
148987010|NCT04782323|537430604|FG007|Overall Study|Withdrawal by Subject|1|||
148987011|NCT04782323|537430597|FG000|Overall Study|Lost to Follow-up|0|||
148987012|NCT04782323|537430598|FG001|Overall Study|Lost to Follow-up|1|||
148987013|NCT04782323|537430599|FG002|Overall Study|Lost to Follow-up|1|||
148987014|NCT04782323|537430600|FG003|Overall Study|Lost to Follow-up|0|||
148987015|NCT04782323|537430601|FG004|Overall Study|Lost to Follow-up|0|||
148987016|NCT04782323|537430602|FG005|Overall Study|Lost to Follow-up|1|||
149030449|NCT04305912|537589639|FG001|Second Intervention|Adverse Event|1|||
149030450|NCT01649427|537589644|FG000|Overall Study|Adverse Event|1|||
149030451|NCT01649427|537589645|FG001|Overall Study|Adverse Event|1|||
149030452|NCT01649427|537589644|FG000|Overall Study|Withdrawal by Subject|8|||
149030453|NCT01649427|537589645|FG001|Overall Study|Withdrawal by Subject|7|||
149030454|NCT01649427|537589644|FG000|Overall Study|Lost to Follow-up|0|||
149030455|NCT01649427|537589645|FG001|Overall Study|Lost to Follow-up|1|||
149030456|NCT01649427|537589644|FG000|Overall Study|Graft loss|0|||
149030457|NCT01649427|537589645|FG001|Overall Study|Graft loss|1|||
148987017|NCT04782323|537430603|FG006|Overall Study|Lost to Follow-up|1|||
149030458|NCT01649427|537589644|FG000|Overall Study|Surgical problems during nephrectomy|2|||
148987018|NCT04782323|537430604|FG007|Overall Study|Lost to Follow-up|2|||
148855442|NCT00327015|536946250|FG000|Overall Study|Death|1|||
148987019|NCT04782323|537430597|FG000|Overall Study|randomization in error|1|||
148987020|NCT04782323|537430598|FG001|Overall Study|randomization in error|0|||
148855443|NCT00327015|536946251|FG001|Overall Study|Death|2|||
148855444|NCT00327015|536946252|FG002|Overall Study|Death|2|||
148987021|NCT04782323|537430599|FG002|Overall Study|randomization in error|0|||
149030459|NCT01649427|537589645|FG001|Overall Study|Surgical problems during nephrectomy|2|||
149030460|NCT02138916|537589646|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
149030461|NCT02138916|537589647|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
148987022|NCT04782323|537430600|FG003|Overall Study|randomization in error|0|||
148987023|NCT04782323|537430601|FG004|Overall Study|randomization in error|0|||
148987024|NCT04782323|537430602|FG005|Overall Study|randomization in error|0|||
148987025|NCT04782323|537430603|FG006|Overall Study|randomization in error|0|||
148987026|NCT04782323|537430604|FG007|Overall Study|randomization in error|0|||
148987027|NCT04369469|537430605|FG000|Overall Study|Lost to Follow-up|2|||
148987028|NCT04369469|537430606|FG001|Overall Study|Lost to Follow-up|4|||
148987029|NCT04369469|537430605|FG000|Overall Study|Physician Decision|2|||
148987030|NCT04369469|537430606|FG001|Overall Study|Physician Decision|1|||
148987031|NCT04369469|537430605|FG000|Overall Study|Withdrawal by Subject|2|||
148987032|NCT04369469|537430606|FG001|Overall Study|Withdrawal by Subject|3|||
148987033|NCT04369469|537430605|FG000|Overall Study|Adverse Event|1|||
148987034|NCT04369469|537430606|FG001|Overall Study|Adverse Event|0|||
148987035|NCT04369469|537430605|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
148987036|NCT04369469|537430606|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
148987037|NCT04369469|537430605|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
148987038|NCT04369469|537430606|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
148987039|NCT04369469|537430605|FG000|Overall Study|Unable to Provide Consent|0|||
148987040|NCT04369469|537430606|FG001|Overall Study|Unable to Provide Consent|1|||
148987041|NCT01165281|537430607|FG000|Overall Study|Adverse Event|12|||
148987042|NCT01165281|537430608|FG001|Overall Study|Adverse Event|14|||
148987043|NCT01165281|537430607|FG000|Overall Study|Death|3|||
148987044|NCT01165281|537430608|FG001|Overall Study|Death|4|||
148987045|NCT01165281|537430607|FG000|Overall Study|Lack of Efficacy|4|||
149030462|NCT02138916|537589648|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
149030463|NCT02138916|537589646|FG000|Overall Study|Death|14|||
149030464|NCT02138916|537589647|FG001|Overall Study|Death|11|||
149030465|NCT02138916|537589648|FG002|Overall Study|Death|12|||
149030466|NCT02138916|537589646|FG000|Overall Study|Withdrawal by Subject|27|||
149030467|NCT02138916|537589647|FG001|Overall Study|Withdrawal by Subject|31|||
149030468|NCT02138916|537589648|FG002|Overall Study|Withdrawal by Subject|32|||
149030469|NCT02138916|537589646|FG000|Overall Study|Study specific withdrawal criteria|0|||
149030470|NCT02138916|537589647|FG001|Overall Study|Study specific withdrawal criteria|0|||
149030471|NCT02138916|537589648|FG002|Overall Study|Study specific withdrawal criteria|1|||
149030472|NCT02138916|537589646|FG000|Overall Study|incorrect enrolment|1|||
149030473|NCT02138916|537589647|FG001|Overall Study|incorrect enrolment|1|||
149030474|NCT02138916|537589648|FG002|Overall Study|incorrect enrolment|0|||
149030475|NCT02138916|537589646|FG000|Overall Study|Severe non-compliance|1|||
149030476|NCT02138916|537589647|FG001|Overall Study|Severe non-compliance|2|||
149030477|NCT02138916|537589648|FG002|Overall Study|Severe non-compliance|1|||
149030478|NCT02138916|537589646|FG000|Overall Study|Lost to Follow-up|4|||
149030479|NCT02138916|537589647|FG001|Overall Study|Lost to Follow-up|2|||
149030480|NCT02138916|537589648|FG002|Overall Study|Lost to Follow-up|3|||
149030481|NCT02138916|537589646|FG000|Overall Study|Adverse Event|4|||
149030482|NCT02138916|537589647|FG001|Overall Study|Adverse Event|4|||
149030483|NCT02138916|537589648|FG002|Overall Study|Adverse Event|3|||
149030484|NCT01348087|537589649|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
149030485|NCT01348087|537589649|FG000|Overall Study|Administrative problems|79|||
149030486|NCT01348087|537589649|FG000|Overall Study|protocol deviation|1|||
149030487|NCT01348087|537589649|FG000|Overall Study|Lost to Follow-up|1|||
149030488|NCT01348087|537589649|FG000|Overall Study|Subject withdrew consent|7|||
149030489|NCT01348087|537589649|FG000|Overall Study|Adverse Event|25|||
149030490|NCT00117988|537589654|FG000|Overall Study|Death|3|||
149030491|NCT00117988|537589654|FG000|Overall Study|Adverse Event|1|||
149030492|NCT02482233|537589661|FG000|Overall Study|Lost to Follow-up|1|||
149030493|NCT02482233|537589662|FG001|Overall Study|Lost to Follow-up|1|||
149030494|NCT04888585|537589663|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
149030495|NCT04888585|537589664|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
149030496|NCT04888585|537589665|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
149030497|NCT04888585|537589666|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
149030498|NCT04888585|537589667|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
149030499|NCT04888585|537589668|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
149030500|NCT04888585|537589669|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
149030501|NCT04888585|537589670|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
149030502|NCT04888585|537589671|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
149030503|NCT04888585|537589672|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
148855445|NCT00327015|536946253|FG003|Overall Study|Death|3|||
148987046|NCT01165281|537430608|FG001|Overall Study|Lack of Efficacy|1|||
148987047|NCT01165281|537430607|FG000|Overall Study|Lost to Follow-up|0|||
148987048|NCT01165281|537430608|FG001|Overall Study|Lost to Follow-up|1|||
148987049|NCT01165281|537430607|FG000|Overall Study|Physician Decision|8|||
148987050|NCT01165281|537430608|FG001|Overall Study|Physician Decision|1|||
148987051|NCT01165281|537430607|FG000|Overall Study|Protocol Violation|6|||
148987052|NCT01165281|537430608|FG001|Overall Study|Protocol Violation|5|||
148987053|NCT01165281|537430607|FG000|Overall Study|Withdrawal by Subject|8|||
149030504|NCT04888585|537589673|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
148987054|NCT01165281|537430608|FG001|Overall Study|Withdrawal by Subject|7|||
148987055|NCT01165281|537430607|FG000|Overall Study|Noncompliance with Study Drug|1|||
148987056|NCT01165281|537430608|FG001|Overall Study|Noncompliance with Study Drug|4|||
148987057|NCT01165281|537430607|FG000|Overall Study|Progressive Disease|10|||
148987058|NCT01165281|537430608|FG001|Overall Study|Progressive Disease|14|||
148987059|NCT01165281|537430607|FG000|Overall Study|Other|6|||
148987060|NCT01165281|537430608|FG001|Overall Study|Other|0|||
148987061|NCT02863991|537430609|FG000|Overall Study|Death|0|||
148987062|NCT02863991|537430610|FG001|Overall Study|Death|3|||
148987063|NCT02863991|537430609|FG000|Overall Study|Lack of Efficacy|0|||
148987064|NCT02863991|537430610|FG001|Overall Study|Lack of Efficacy|1|||
148987065|NCT02863991|537430609|FG000|Overall Study|Study Terminated|2|||
148987066|NCT02863991|537430610|FG001|Overall Study|Study Terminated|8|||
148987067|NCT00364858|537430611|FG000|Overall Study|Adverse Event|1|||
148987068|NCT00364858|537430612|FG001|Overall Study|Adverse Event|5|||
148987069|NCT00364858|537430611|FG000|Overall Study|Withdrawal by Subject|1|||
148987070|NCT00364858|537430612|FG001|Overall Study|Withdrawal by Subject|1|||
148987071|NCT00364858|537430611|FG000|Overall Study|Pregnancy|1|||
148987072|NCT00364858|537430612|FG001|Overall Study|Pregnancy|1|||
148987073|NCT00364858|537430611|FG000|Overall Study|Clinical failure|2|||
148987074|NCT00364858|537430612|FG001|Overall Study|Clinical failure|13|||
148987075|NCT00364858|537430611|FG000|Overall Study|Discontinuation at baseline|1|||
148987076|NCT00364858|537430612|FG001|Overall Study|Discontinuation at baseline|0|||
148987077|NCT00364858|537430611|FG000|Overall Study|Non-compliant|1|||
148987078|NCT00364858|537430612|FG001|Overall Study|Non-compliant|0|||
148987079|NCT00364858|537430611|FG000|Overall Study|Return to Q2 regimen|0|||
148987080|NCT00364858|537430612|FG001|Overall Study|Return to Q2 regimen|1|||
148987081|NCT00364858|537430611|FG000|Overall Study|Clinical baseline issue|0|||
148987082|NCT00364858|537430612|FG001|Overall Study|Clinical baseline issue|1|||
148987083|NCT01307501|537430613|FG000|Overall Study|Treatment Failure|1|||
148987084|NCT01307501|537430613|FG000|Overall Study|Death|20|||
148987085|NCT01307501|537430613|FG000|Overall Study|Lost to Follow-up|1|||
148987086|NCT01307501|537430613|FG000|Overall Study|Starting Hospice|1|||
148987087|NCT02053350|537432360|FG000|Overall Study|Withdrawal by Subject|1|||
148987088|NCT02053350|537432360|FG000|Overall Study|Adverse Event|4|||
148987089|NCT01747772|537432361|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
148987090|NCT02244944|537432362|FG000|Overall Study|Withdrawal by Subject|1|||
148987091|NCT02244944|537432362|FG000|Overall Study|Study Terminated|1|||
148987092|NCT01928719|537432365|FG000|Overall Study|Lost to Follow-up|26|||
148987093|NCT01928719|537432366|FG001|Overall Study|Lost to Follow-up|11|||
148987094|NCT01928719|537432365|FG000|Overall Study|Withdrawal by Subject|22|||
148987095|NCT01928719|537432366|FG001|Overall Study|Withdrawal by Subject|7|||
148987096|NCT01928719|537432365|FG000|Overall Study|Protocol Violation|3|||
148987097|NCT01928719|537432366|FG001|Overall Study|Protocol Violation|1|||
148987098|NCT01928719|537432365|FG000|Overall Study|Adverse Event|1|||
148987099|NCT01928719|537432366|FG001|Overall Study|Adverse Event|0|||
148987100|NCT02099838|537432367|FG000|Overall Study|Death|1|||
148987101|NCT02099838|537432368|FG001|Overall Study|Death|0|||
148987102|NCT02099838|537432367|FG000|Overall Study|Lost to Follow-up|3|||
148987103|NCT02099838|537432368|FG001|Overall Study|Lost to Follow-up|1|||
148987104|NCT02099838|537432367|FG000|Overall Study|Withdrawal by Subject|0|||
148987105|NCT02099838|537432368|FG001|Overall Study|Withdrawal by Subject|1|||
148987106|NCT01227889|537432369|FG000|Randomized Phase (RP)|Adverse Event|13|||
148987107|NCT01227889|537432370|FG001|Randomized Phase (RP)|Adverse Event|0|||
148987108|NCT01227889|537432369|FG000|Randomized Phase (RP)|Physician Decision|13|||
148987109|NCT01227889|537432370|FG001|Randomized Phase (RP)|Physician Decision|5|||
148987110|NCT01227889|537432369|FG000|Randomized Phase (RP)|Progressive Disease|135|||
148987111|NCT01227889|537432370|FG001|Randomized Phase (RP)|Progressive Disease|52|||
148987112|NCT01227889|537432369|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
148987113|NCT01227889|537432370|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
148987114|NCT01227889|537432369|FG000|Randomized Phase (RP)|Missing|1|||
148987115|NCT01227889|537432370|FG001|Randomized Phase (RP)|Missing|3|||
148987116|NCT01227889|537432369|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
148987117|NCT01227889|537432370|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
148987118|NCT01227889|537432369|FG000|Crossover Phase|Adverse Event|0|||
148987119|NCT01227889|537432370|FG001|Crossover Phase|Adverse Event|1|||
148987120|NCT01227889|537432369|FG000|Crossover Phase|Physician Decision|0|||
148987121|NCT01227889|537432370|FG001|Crossover Phase|Physician Decision|3|||
148987122|NCT01227889|537432369|FG000|Crossover Phase|Progressive Disease|0|||
148987123|NCT01227889|537432370|FG001|Crossover Phase|Progressive Disease|31|||
148987124|NCT01227889|537432369|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
148987125|NCT01227889|537432370|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
148987126|NCT01227889|537432369|FG000|Crossover Phase|Withdrawal by Subject|0|||
148987127|NCT01227889|537432370|FG001|Crossover Phase|Withdrawal by Subject|1|||
148987128|NCT04121962|537432371|FG000|Overall Study|Lost to Follow-up|42|||
148987129|NCT04121962|537432372|FG001|Overall Study|Lost to Follow-up|39|||
148987130|NCT00774787|537432373|FG000|Overall Study|Lost to Follow-up|1|||
148987131|NCT02019719|537432374|FG000|Overall Study|Adverse Event|1|||
148987132|NCT02019719|537432375|FG001|Overall Study|Adverse Event|0|||
148987133|NCT02019719|537432376|FG002|Overall Study|Adverse Event|0|||
148987134|NCT02019719|537432377|FG003|Overall Study|Adverse Event|1|||
148987135|NCT02019719|537432378|FG004|Overall Study|Adverse Event|1|||
148987136|NCT02019719|537432374|FG000|Overall Study|Protocol Violation|1|||
148987137|NCT02019719|537432375|FG001|Overall Study|Protocol Violation|1|||
148987138|NCT02019719|537432376|FG002|Overall Study|Protocol Violation|0|||
148987139|NCT02019719|537432377|FG003|Overall Study|Protocol Violation|0|||
148987140|NCT02019719|537432378|FG004|Overall Study|Protocol Violation|0|||
148987141|NCT02019719|537432374|FG000|Overall Study|Protocol defined stopping criteria|2|||
148987142|NCT02019719|537432375|FG001|Overall Study|Protocol defined stopping criteria|0|||
148987143|NCT02019719|537432376|FG002|Overall Study|Protocol defined stopping criteria|0|||
148987144|NCT02019719|537432377|FG003|Overall Study|Protocol defined stopping criteria|1|||
148987145|NCT02019719|537432378|FG004|Overall Study|Protocol defined stopping criteria|1|||
148987146|NCT02019719|537432374|FG000|Overall Study|Physician Decision|2|||
148987147|NCT02019719|537432375|FG001|Overall Study|Physician Decision|0|||
148987148|NCT02019719|537432376|FG002|Overall Study|Physician Decision|0|||
148987149|NCT02019719|537432377|FG003|Overall Study|Physician Decision|0|||
148987150|NCT02019719|537432378|FG004|Overall Study|Physician Decision|0|||
148987151|NCT04535037|537432379|FG000|Overall Study|Protocol Violation|1|||
148987152|NCT04535037|537432380|FG001|Overall Study|Protocol Violation|0|||
148987153|NCT04535037|537432379|FG000|Overall Study|Withdrawal by Subject|8|||
148987154|NCT04535037|537432380|FG001|Overall Study|Withdrawal by Subject|9|||
148987155|NCT04535037|537432379|FG000|Overall Study|Migrated / moved from the study area|1|||
148987156|NCT04535037|537432380|FG001|Overall Study|Migrated / moved from the study area|4|||
148987157|NCT04535037|537432379|FG000|Overall Study|Other|2|||
148987158|NCT04535037|537432380|FG001|Overall Study|Other|5|||
148987159|NCT02731131|537432382|FG000|Overall Study|Psychiatric Disorder|0|||
148987160|NCT02731131|537432383|FG001|Overall Study|Psychiatric Disorder|1|||
148987161|NCT02731131|537432382|FG000|Overall Study|Refused Therapy|0|||
148987162|NCT02731131|537432383|FG001|Overall Study|Refused Therapy|1|||
148987163|NCT02348216|537432388|FG000|Overall Study|Death|5|||
148987164|NCT02348216|537432389|FG001|Overall Study|Death|53|||
148987165|NCT02348216|537432390|FG002|Overall Study|Death|11|||
148987166|NCT02348216|537432391|FG003|Overall Study|Death|20|||
148987167|NCT02348216|537432392|FG004|Overall Study|Death|16|||
148987168|NCT02348216|537432393|FG005|Overall Study|Death|32|||
148987169|NCT02348216|537432394|FG006|Overall Study|Death|17|||
148987170|NCT02348216|537432388|FG000|Overall Study|Full consent withdrawal|0|||
148987171|NCT02348216|537432389|FG001|Overall Study|Full consent withdrawal|0|||
148987172|NCT02348216|537432390|FG002|Overall Study|Full consent withdrawal|0|||
148987173|NCT02348216|537432391|FG003|Overall Study|Full consent withdrawal|1|||
148987174|NCT02348216|537432392|FG004|Overall Study|Full consent withdrawal|3|||
148987175|NCT02348216|537432393|FG005|Overall Study|Full consent withdrawal|0|||
148987176|NCT02348216|537432394|FG006|Overall Study|Full consent withdrawal|3|||
148987177|NCT02348216|537432388|FG000|Overall Study|Lost to Follow-up|0|||
148987178|NCT02348216|537432389|FG001|Overall Study|Lost to Follow-up|5|||
148987179|NCT02348216|537432390|FG002|Overall Study|Lost to Follow-up|2|||
148987180|NCT02348216|537432391|FG003|Overall Study|Lost to Follow-up|0|||
148987181|NCT02348216|537432392|FG004|Overall Study|Lost to Follow-up|1|||
148987182|NCT02348216|537432393|FG005|Overall Study|Lost to Follow-up|1|||
148987183|NCT02348216|537432394|FG006|Overall Study|Lost to Follow-up|1|||
148987184|NCT02348216|537432388|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
148987185|NCT02348216|537432389|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
148987186|NCT02348216|537432390|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
148987187|NCT02348216|537432391|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
148987188|NCT02348216|537432392|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
148987189|NCT02348216|537432393|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
148987190|NCT02348216|537432394|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
148987191|NCT02348216|537432388|FG000|Overall Study|Reason not specified|2|||
148987192|NCT02348216|537432389|FG001|Overall Study|Reason not specified|19|||
148987193|NCT02348216|537432390|FG002|Overall Study|Reason not specified|11|||
148987194|NCT02348216|537432391|FG003|Overall Study|Reason not specified|17|||
148987195|NCT02348216|537432392|FG004|Overall Study|Reason not specified|21|||
148987196|NCT02348216|537432393|FG005|Overall Study|Reason not specified|17|||
148987197|NCT02348216|537432394|FG006|Overall Study|Reason not specified|19|||
148987198|NCT01055639|537432395|FG000|Overall Study|Adverse Event|0|||
148987199|NCT01055639|537432396|FG001|Overall Study|Adverse Event|1|||
148987200|NCT01055639|537432395|FG000|Overall Study|Lack of Efficacy|0|||
148987201|NCT01055639|537432396|FG001|Overall Study|Lack of Efficacy|1|||
148987202|NCT01055639|537432395|FG000|Overall Study|Lost to Follow-up|8|||
148987203|NCT01055639|537432396|FG001|Overall Study|Lost to Follow-up|11|||
148987204|NCT01055639|537432395|FG000|Overall Study|Protocol Violation|5|||
148987205|NCT01055639|537432396|FG001|Overall Study|Protocol Violation|5|||
148987206|NCT01055639|537432395|FG000|Overall Study|Withdrawal by Subject|8|||
148987207|NCT01055639|537432396|FG001|Overall Study|Withdrawal by Subject|11|||
148855446|NCT00327015|536946250|FG000|Overall Study|Pregnancy|0|||
148855447|NCT00327015|536946251|FG001|Overall Study|Pregnancy|2|||
148855448|NCT00327015|536946252|FG002|Overall Study|Pregnancy|1|||
148855449|NCT00327015|536946253|FG003|Overall Study|Pregnancy|1|||
148855450|NCT00327015|536946250|FG000|Overall Study|Administrative Reason by Sponsor|1|||
148855451|NCT00327015|536946251|FG001|Overall Study|Administrative Reason by Sponsor|2|||
148855452|NCT00327015|536946252|FG002|Overall Study|Administrative Reason by Sponsor|2|||
148855453|NCT00327015|536946253|FG003|Overall Study|Administrative Reason by Sponsor|1|||
148855454|NCT02650804|536946254|FG000|Overall Study|Adverse Event|3|||
148855455|NCT02650804|536946255|FG001|Overall Study|Adverse Event|2|||
148855456|NCT02650804|536946254|FG000|Overall Study|Death|1|||
148855457|NCT02650804|536946255|FG001|Overall Study|Death|2|||
148855458|NCT02650804|536946254|FG000|Overall Study|Progressive Disease|7|||
148855459|NCT02650804|536946255|FG001|Overall Study|Progressive Disease|10|||
148855460|NCT02650804|536946254|FG000|Overall Study|Physician Decision|0|||
148855461|NCT02650804|536946255|FG001|Overall Study|Physician Decision|2|||
148855462|NCT02650804|536946254|FG000|Overall Study|Withdrawal by Subject|1|||
148855463|NCT02650804|536946255|FG001|Overall Study|Withdrawal by Subject|4|||
148855464|NCT02650804|536946254|FG000|Overall Study|Symptomatic deterioration|5|||
148855465|NCT02650804|536946255|FG001|Overall Study|Symptomatic deterioration|7|||
148855466|NCT02650804|536946254|FG000|Overall Study|Protocol Violation|0|||
148855467|NCT02650804|536946255|FG001|Overall Study|Protocol Violation|1|||
148855468|NCT01159171|536946256|FG000|Overall Study|Adverse Event|11|||
148855469|NCT01159171|536946256|FG000|Overall Study|Progression of Disease|28|||
148855470|NCT01159171|536946256|FG000|Overall Study|Protocol Violation|1|||
148855471|NCT01159171|536946256|FG000|Overall Study|Need for Surgery|5|||
148855472|NCT01159171|536946256|FG000|Overall Study|Medical Decision|4|||
148855473|NCT01159171|536946256|FG000|Overall Study|Death|1|||
148855474|NCT01892436|536946259|FG000|Overall Study|Withdrawal by Subject|8|||
148855475|NCT01892436|536946260|FG001|Overall Study|Withdrawal by Subject|15|||
148855476|NCT01892436|536946261|FG002|Overall Study|Withdrawal by Subject|4|||
148855477|NCT01892436|536946262|FG003|Overall Study|Withdrawal by Subject|4|||
148855478|NCT01892436|536946259|FG000|Overall Study|Death|1|||
148855479|NCT01892436|536946260|FG001|Overall Study|Death|1|||
148855480|NCT01892436|536946261|FG002|Overall Study|Death|0|||
148855481|NCT01892436|536946262|FG003|Overall Study|Death|0|||
148855482|NCT01892436|536946259|FG000|Overall Study|Physician Decision|2|||
148855483|NCT01892436|536946260|FG001|Overall Study|Physician Decision|1|||
148855484|NCT01892436|536946261|FG002|Overall Study|Physician Decision|0|||
148855485|NCT01892436|536946262|FG003|Overall Study|Physician Decision|1|||
148855486|NCT01892436|536946259|FG000|Overall Study|Pregnancy|0|||
148855487|NCT01892436|536946260|FG001|Overall Study|Pregnancy|2|||
148855488|NCT01892436|536946261|FG002|Overall Study|Pregnancy|1|||
148855489|NCT01892436|536946262|FG003|Overall Study|Pregnancy|0|||
148855490|NCT01892436|536946259|FG000|Overall Study|Technical problems|2|||
148855491|NCT01892436|536946260|FG001|Overall Study|Technical problems|1|||
148855492|NCT01892436|536946261|FG002|Overall Study|Technical problems|1|||
148855493|NCT01892436|536946262|FG003|Overall Study|Technical problems|1|||
148855494|NCT01892436|536946259|FG000|Overall Study|Lack of Efficacy|1|||
148855495|NCT01892436|536946260|FG001|Overall Study|Lack of Efficacy|2|||
148855496|NCT01892436|536946261|FG002|Overall Study|Lack of Efficacy|2|||
148855497|NCT01892436|536946262|FG003|Overall Study|Lack of Efficacy|2|||
148855498|NCT01892436|536946259|FG000|Overall Study|Lost to Follow-up|1|||
148855499|NCT01892436|536946260|FG001|Overall Study|Lost to Follow-up|1|||
148855500|NCT01892436|536946261|FG002|Overall Study|Lost to Follow-up|1|||
148855501|NCT01892436|536946262|FG003|Overall Study|Lost to Follow-up|3|||
148855502|NCT01892436|536946259|FG000|Overall Study|non-compliance with treatment|1|||
148855503|NCT01892436|536946260|FG001|Overall Study|non-compliance with treatment|0|||
148855504|NCT01892436|536946261|FG002|Overall Study|non-compliance with treatment|0|||
148855505|NCT01892436|536946262|FG003|Overall Study|non-compliance with treatment|0|||
148987208|NCT00765245|537432397|FG000|Overall Study|disease progression|3|||
148987209|NCT00765245|537432398|FG001|Overall Study|disease progression|2|||
148987210|NCT00765245|537432397|FG000|Overall Study|Withdrawal by Subject|3|||
148987211|NCT00765245|537432398|FG001|Overall Study|Withdrawal by Subject|0|||
148855506|NCT01892436|536946259|FG000|Overall Study|Adverse Event|7|||
148855507|NCT01892436|536946260|FG001|Overall Study|Adverse Event|6|||
148855508|NCT01892436|536946261|FG002|Overall Study|Adverse Event|2|||
148855509|NCT01892436|536946262|FG003|Overall Study|Adverse Event|3|||
148855510|NCT02923830|536946266|FG000|Overall Study|Physician Decision|13|||
148855511|NCT02923830|536946267|FG001|Overall Study|Physician Decision|15|||
148855512|NCT00837265|536946268|FG000|Pilot Phase|Withdrawal by Subject|0|||
148855513|NCT00837265|536946269|FG001|Pilot Phase|Withdrawal by Subject|2|||
148855514|NCT00837265|536946270|FG002|Pilot Phase|Withdrawal by Subject|3|||
148987212|NCT00765245|537432397|FG000|Overall Study|Adverse Event|5|||
148855515|NCT00837265|536946271|FG003|Pilot Phase|Withdrawal by Subject|2|||
148855516|NCT00837265|536946272|FG004|Pilot Phase|Withdrawal by Subject|0|||
148855517|NCT00837265|536946273|FG005|Pilot Phase|Withdrawal by Subject|0|||
148855518|NCT00837265|536946274|FG006|Pilot Phase|Withdrawal by Subject|0|||
148855519|NCT00837265|536946268|FG000|Pilot Phase|Decision of the investigator|2|||
148855520|NCT00837265|536946269|FG001|Pilot Phase|Decision of the investigator|1|||
148987213|NCT00765245|537432398|FG001|Overall Study|Adverse Event|0|||
148987214|NCT00765245|537432397|FG000|Overall Study|Physician Decision|1|||
148987215|NCT00765245|537432398|FG001|Overall Study|Physician Decision|0|||
148987216|NCT00765245|537432397|FG000|Overall Study|Death|1|||
148987217|NCT00765245|537432398|FG001|Overall Study|Death|0|||
148987218|NCT01197950|537432400|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
148987219|NCT01197950|537432401|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
148987220|NCT01197950|537432402|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
148987221|NCT02553330|537432403|FG000|Overall Study|Study Terminated by Sponsor|2|||
148987222|NCT02553330|537432404|FG001|Overall Study|Study Terminated by Sponsor|13|||
148987223|NCT02553330|537432405|FG002|Overall Study|Study Terminated by Sponsor|12|||
148987224|NCT02553330|537432403|FG000|Overall Study|Withdrawal by Subject|3|||
148987225|NCT02553330|537432404|FG001|Overall Study|Withdrawal by Subject|19|||
148987226|NCT02553330|537432405|FG002|Overall Study|Withdrawal by Subject|21|||
148987227|NCT02553330|537432403|FG000|Overall Study|Other|0|||
148987228|NCT02553330|537432404|FG001|Overall Study|Other|1|||
148987229|NCT02553330|537432405|FG002|Overall Study|Other|0|||
148987230|NCT02553330|537432403|FG000|Overall Study|Non compliance to study treatment|0|||
148987231|NCT02553330|537432404|FG001|Overall Study|Non compliance to study treatment|1|||
148987232|NCT02553330|537432405|FG002|Overall Study|Non compliance to study treatment|0|||
148987233|NCT02553330|537432403|FG000|Overall Study|Adverse Event|0|||
148987234|NCT02553330|537432404|FG001|Overall Study|Adverse Event|1|||
148987235|NCT02553330|537432405|FG002|Overall Study|Adverse Event|0|||
148987236|NCT02553330|537432403|FG000|Overall Study|Lost to Follow-up|0|||
148987237|NCT02553330|537432404|FG001|Overall Study|Lost to Follow-up|4|||
148987238|NCT02553330|537432405|FG002|Overall Study|Lost to Follow-up|4|||
148987239|NCT02896855|537432406|FG000|Overall Study|Death|50|||
148987240|NCT02896855|537432407|FG001|Overall Study|Death|40|||
148987241|NCT02896855|537432406|FG000|Overall Study|Lost to Follow-up|15|||
148987242|NCT02896855|537432407|FG001|Overall Study|Lost to Follow-up|9|||
148987243|NCT02896855|537432406|FG000|Overall Study|Withdrawal by Subject|7|||
148987244|NCT02896855|537432407|FG001|Overall Study|Withdrawal by Subject|4|||
148987245|NCT01205685|537432408|FG000|Overall Study|Disease Progression|10|||
148987246|NCT01205685|537432408|FG000|Overall Study|Withdrawal by Subject|1|||
148987247|NCT02169674|537432409|FG000|Overall Study|Withdrawal by Subject|2|||
148987248|NCT02169674|537432410|FG001|Overall Study|Withdrawal by Subject|1|||
148987249|NCT02169674|537432409|FG000|Overall Study|Seroprotected|30|||
148987250|NCT02169674|537432410|FG001|Overall Study|Seroprotected|76|||
148987251|NCT02169674|537432409|FG000|Overall Study|Lost to Follow-up|0|||
148987252|NCT02169674|537432410|FG001|Overall Study|Lost to Follow-up|1|||
148987253|NCT00346034|537432411|FG000|Overall Study|Adverse Event|34|||
148987254|NCT00346034|537432411|FG000|Overall Study|Lack of Efficacy|8|||
148987255|NCT00346034|537432411|FG000|Overall Study|Withdrawal by Subject|13|||
148987256|NCT00346034|537432411|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
148987257|NCT00346034|537432411|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
148987258|NCT04000165|537432412|FG000|Overall Study|Physician Decision|1|||
148987259|NCT04000165|537432412|FG000|Overall Study|Withdrawal by Subject|1|||
148987260|NCT00941603|537432416|FG000|Overall Study|Adverse Event|10|||
148987261|NCT00941603|537432417|FG001|Overall Study|Adverse Event|15|||
148987262|NCT00941603|537432418|FG002|Overall Study|Adverse Event|5|||
148987263|NCT00941603|537432419|FG003|Overall Study|Adverse Event|1|||
148987264|NCT00941603|537432420|FG004|Overall Study|Adverse Event|4|||
148987265|NCT00941603|537432421|FG005|Overall Study|Adverse Event|0|||
148987266|NCT00941603|537432416|FG000|Overall Study|Lost to Follow-up|0|||
148987267|NCT00941603|537432417|FG001|Overall Study|Lost to Follow-up|0|||
148987268|NCT00941603|537432418|FG002|Overall Study|Lost to Follow-up|0|||
148987269|NCT00941603|537432419|FG003|Overall Study|Lost to Follow-up|1|||
148987270|NCT00941603|537432420|FG004|Overall Study|Lost to Follow-up|0|||
148987271|NCT00941603|537432421|FG005|Overall Study|Lost to Follow-up|2|||
148987272|NCT00941603|537432416|FG000|Overall Study|Withdrawal by Subject|0|||
148987273|NCT00941603|537432417|FG001|Overall Study|Withdrawal by Subject|0|||
148987274|NCT00941603|537432418|FG002|Overall Study|Withdrawal by Subject|0|||
148987275|NCT00941603|537432419|FG003|Overall Study|Withdrawal by Subject|2|||
148987276|NCT00941603|537432420|FG004|Overall Study|Withdrawal by Subject|0|||
148987277|NCT00941603|537432421|FG005|Overall Study|Withdrawal by Subject|1|||
148987278|NCT00941603|537432416|FG000|Overall Study|Protocol Violation|0|||
148987279|NCT00941603|537432417|FG001|Overall Study|Protocol Violation|1|||
148987280|NCT00941603|537432418|FG002|Overall Study|Protocol Violation|0|||
148987281|NCT00941603|537432419|FG003|Overall Study|Protocol Violation|0|||
148987282|NCT00941603|537432420|FG004|Overall Study|Protocol Violation|0|||
148987283|NCT00941603|537432421|FG005|Overall Study|Protocol Violation|0|||
148777759|NCT00455520|536660393|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
148987284|NCT00941603|537432416|FG000|Overall Study|Did not meet protocol eligibility|1|||
148987285|NCT00941603|537432417|FG001|Overall Study|Did not meet protocol eligibility|0|||
148987286|NCT00941603|537432418|FG002|Overall Study|Did not meet protocol eligibility|0|||
148987287|NCT00941603|537432419|FG003|Overall Study|Did not meet protocol eligibility|0|||
148855521|NCT00837265|536946270|FG002|Pilot Phase|Decision of the investigator|0|||
148855522|NCT00837265|536946271|FG003|Pilot Phase|Decision of the investigator|0|||
148855523|NCT00837265|536946272|FG004|Pilot Phase|Decision of the investigator|0|||
148855524|NCT00837265|536946273|FG005|Pilot Phase|Decision of the investigator|0|||
148855525|NCT00837265|536946274|FG006|Pilot Phase|Decision of the investigator|0|||
148855526|NCT00837265|536946268|FG000|Pilot Phase|Adverse Event|1|||
148855527|NCT00837265|536946269|FG001|Pilot Phase|Adverse Event|0|||
148855528|NCT00837265|536946270|FG002|Pilot Phase|Adverse Event|0|||
148855529|NCT00837265|536946271|FG003|Pilot Phase|Adverse Event|0|||
148855530|NCT00837265|536946272|FG004|Pilot Phase|Adverse Event|0|||
148855531|NCT00837265|536946273|FG005|Pilot Phase|Adverse Event|0|||
148855532|NCT00837265|536946274|FG006|Pilot Phase|Adverse Event|0|||
148855533|NCT00837265|536946268|FG000|Pilot Phase|Disease progression|0|||
148855534|NCT00837265|536946269|FG001|Pilot Phase|Disease progression|0|||
148855535|NCT00837265|536946270|FG002|Pilot Phase|Disease progression|0|||
148855536|NCT00837265|536946271|FG003|Pilot Phase|Disease progression|1|||
148855537|NCT00837265|536946272|FG004|Pilot Phase|Disease progression|0|||
148855538|NCT00837265|536946273|FG005|Pilot Phase|Disease progression|0|||
148855539|NCT00837265|536946274|FG006|Pilot Phase|Disease progression|0|||
148855540|NCT00837265|536946268|FG000|Pilot Phase|Participant left the city|0|||
148855541|NCT00837265|536946269|FG001|Pilot Phase|Participant left the city|0|||
148855542|NCT00837265|536946270|FG002|Pilot Phase|Participant left the city|0|||
148855543|NCT00837265|536946271|FG003|Pilot Phase|Participant left the city|1|||
148855544|NCT00837265|536946272|FG004|Pilot Phase|Participant left the city|0|||
148855545|NCT00837265|536946273|FG005|Pilot Phase|Participant left the city|0|||
148855546|NCT00837265|536946274|FG006|Pilot Phase|Participant left the city|0|||
148855547|NCT00837265|536946268|FG000|Main Phase|Withdrawal by Subject|0|||
148855548|NCT00837265|536946269|FG001|Main Phase|Withdrawal by Subject|0|||
148855549|NCT00837265|536946270|FG002|Main Phase|Withdrawal by Subject|0|||
148855550|NCT00837265|536946271|FG003|Main Phase|Withdrawal by Subject|0|||
148855551|NCT00837265|536946272|FG004|Main Phase|Withdrawal by Subject|4|||
148855552|NCT00837265|536946273|FG005|Main Phase|Withdrawal by Subject|2|||
148855553|NCT00837265|536946274|FG006|Main Phase|Withdrawal by Subject|1|||
148855554|NCT00837265|536946268|FG000|Main Phase|Decision of the investigator|0|||
148855555|NCT00837265|536946269|FG001|Main Phase|Decision of the investigator|0|||
148855556|NCT00837265|536946270|FG002|Main Phase|Decision of the investigator|0|||
148855557|NCT00837265|536946271|FG003|Main Phase|Decision of the investigator|0|||
148855558|NCT00837265|536946272|FG004|Main Phase|Decision of the investigator|0|||
148855559|NCT00837265|536946273|FG005|Main Phase|Decision of the investigator|2|||
148855560|NCT00837265|536946274|FG006|Main Phase|Decision of the investigator|1|||
148855561|NCT00837265|536946268|FG000|Main Phase|Adverse Event|0|||
148855562|NCT00837265|536946269|FG001|Main Phase|Adverse Event|0|||
148855563|NCT00837265|536946270|FG002|Main Phase|Adverse Event|0|||
148855564|NCT00837265|536946271|FG003|Main Phase|Adverse Event|0|||
148855565|NCT00837265|536946272|FG004|Main Phase|Adverse Event|0|||
148855566|NCT00837265|536946273|FG005|Main Phase|Adverse Event|1|||
148855567|NCT00837265|536946274|FG006|Main Phase|Adverse Event|0|||
148855568|NCT00837265|536946268|FG000|Main Phase|Death|0|||
148855569|NCT00837265|536946269|FG001|Main Phase|Death|0|||
148855570|NCT00837265|536946270|FG002|Main Phase|Death|0|||
148855571|NCT00837265|536946271|FG003|Main Phase|Death|0|||
148855572|NCT00837265|536946272|FG004|Main Phase|Death|2|||
148855573|NCT00837265|536946273|FG005|Main Phase|Death|0|||
148855574|NCT00837265|536946274|FG006|Main Phase|Death|1|||
148855575|NCT00837265|536946268|FG000|Main Phase|Lost to Follow-up|0|||
148855576|NCT00837265|536946269|FG001|Main Phase|Lost to Follow-up|0|||
148855577|NCT00837265|536946270|FG002|Main Phase|Lost to Follow-up|0|||
148855578|NCT00837265|536946271|FG003|Main Phase|Lost to Follow-up|0|||
148855579|NCT00837265|536946272|FG004|Main Phase|Lost to Follow-up|1|||
148855580|NCT00837265|536946273|FG005|Main Phase|Lost to Follow-up|0|||
148855581|NCT00837265|536946274|FG006|Main Phase|Lost to Follow-up|0|||
148855582|NCT00837265|536946268|FG000|Main Phase|Principal investigator resignation|0|||
148855583|NCT00837265|536946269|FG001|Main Phase|Principal investigator resignation|0|||
148855584|NCT00837265|536946270|FG002|Main Phase|Principal investigator resignation|0|||
148855585|NCT00837265|536946271|FG003|Main Phase|Principal investigator resignation|0|||
148855586|NCT00837265|536946272|FG004|Main Phase|Principal investigator resignation|2|||
148987288|NCT00941603|537432420|FG004|Overall Study|Did not meet protocol eligibility|0|||
148987289|NCT00941603|537432421|FG005|Overall Study|Did not meet protocol eligibility|0|||
148987290|NCT02079805|537432422|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
148987291|NCT02079805|537432423|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
148855587|NCT00837265|536946273|FG005|Main Phase|Principal investigator resignation|0|||
148855588|NCT00837265|536946274|FG006|Main Phase|Principal investigator resignation|0|||
148855589|NCT00837265|536946268|FG000|Main Phase|Participant's personal reason|0|||
148855590|NCT00837265|536946269|FG001|Main Phase|Participant's personal reason|0|||
148855591|NCT00837265|536946270|FG002|Main Phase|Participant's personal reason|0|||
148855592|NCT00837265|536946271|FG003|Main Phase|Participant's personal reason|0|||
148855593|NCT00837265|536946272|FG004|Main Phase|Participant's personal reason|1|||
148855594|NCT00837265|536946273|FG005|Main Phase|Participant's personal reason|0|||
148855595|NCT00837265|536946274|FG006|Main Phase|Participant's personal reason|0|||
149030505|NCT04888585|537589663|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030506|NCT04888585|537589664|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
149030507|NCT04888585|537589665|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
149030508|NCT04888585|537589666|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
149030509|NCT04888585|537589667|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
149030510|NCT04888585|537589668|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030511|NCT04888585|537589669|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030512|NCT04888585|537589670|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030513|NCT04888585|537589671|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030514|NCT04888585|537589672|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030515|NCT04888585|537589673|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
149030516|NCT04888585|537589663|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030517|NCT04888585|537589664|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030518|NCT04888585|537589665|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
149030519|NCT04888585|537589666|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030520|NCT04888585|537589667|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
149030521|NCT04888585|537589668|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030522|NCT04888585|537589669|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030523|NCT04888585|537589670|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030524|NCT04888585|537589671|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030525|NCT04888585|537589672|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
148777760|NCT00455520|536660394|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
148987292|NCT02079805|537432422|FG000|Overall Study|Voluntary Withdrawal|0|||
148987293|NCT02079805|537432423|FG001|Overall Study|Voluntary Withdrawal|1|||
148987294|NCT01753193|537432424|FG000|Overall Study|Withdrawal by Subject|23|||
148987295|NCT01753193|537432424|FG000|Overall Study|Lost to Follow-up|6|||
148987296|NCT01753193|537432424|FG000|Overall Study|Death|1|||
148987297|NCT01753193|537432424|FG000|Overall Study|Other|16|||
148987298|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
148987299|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
148987300|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
148987301|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
148987302|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
148987303|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
148987304|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
148987305|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
148987306|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
148987307|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
148987308|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
148777761|NCT00986986|536660398|FG000|Overall Study|Lost to Follow-up|0|||
148777762|NCT00986986|536660399|FG001|Overall Study|Lost to Follow-up|1|||
148777763|NCT03235115|536660400|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
148777764|NCT03235115|536660401|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
148777765|NCT03235115|536660402|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
148777766|NCT03235115|536660403|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
148777767|NCT03235115|536660404|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
148777768|NCT03235115|536660405|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
148777769|NCT00435487|536660406|FG000|Overall Study|Death|3|||
148777770|NCT00435487|536660407|FG001|Overall Study|Death|4|||
148777771|NCT00435487|536660406|FG000|Overall Study|Adverse Event|0|||
148777772|NCT00435487|536660407|FG001|Overall Study|Adverse Event|3|||
148777773|NCT00435487|536660406|FG000|Overall Study|Lost to Follow-up|2|||
148777774|NCT00435487|536660407|FG001|Overall Study|Lost to Follow-up|2|||
148777775|NCT00435487|536660406|FG000|Overall Study|Other|5|||
148777776|NCT00435487|536660407|FG001|Overall Study|Other|2|||
148777777|NCT00435487|536660406|FG000|Overall Study|Withdrawal by Subject|2|||
148777778|NCT00435487|536660407|FG001|Overall Study|Withdrawal by Subject|1|||
148777779|NCT00435487|536660406|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
148777780|NCT00435487|536660407|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
148777781|NCT00435487|536660406|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
148777782|NCT00435487|536660407|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
148777783|NCT00835679|536660408|FG000|Overall Study|Withdrawal by Subject|1|||
148777784|NCT00835679|536660409|FG001|Overall Study|Withdrawal by Subject|0|||
148777785|NCT00835679|536660410|FG002|Overall Study|Withdrawal by Subject|0|||
148777786|NCT00835679|536660411|FG003|Overall Study|Withdrawal by Subject|0|||
148777787|NCT00955968|536660416|FG000|Overall Study|Death|2|||
148777788|NCT00955968|536660417|FG001|Overall Study|Death|4|||
148777789|NCT00955968|536660416|FG000|Overall Study|Withdrawal by Subject|35|||
148777790|NCT00955968|536660417|FG001|Overall Study|Withdrawal by Subject|31|||
148987309|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
148987310|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
148987311|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
148987312|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
148987313|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
148987314|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
148987315|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
148987316|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
148987317|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
148987318|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
148987319|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
148987320|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
148987321|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
148987322|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
148987323|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
148987324|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
148987325|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
148987326|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
148987327|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
148987328|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
148987329|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
148987330|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
148987331|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
148987332|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
148987333|NCT00383435|537432425|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
148987334|NCT00383435|537432426|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
148987335|NCT00383435|537432427|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
148987336|NCT00383435|537432428|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
148987337|NCT00383435|537432429|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
148987338|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
148987339|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
148987340|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
148987341|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
148987342|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
148987343|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
148987344|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
148987345|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
148987346|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
148987347|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
148987348|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
148987349|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
148987350|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
148987351|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
148987352|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
148987353|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
148987354|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
148987355|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
148987356|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
148987357|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
148987358|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
148987359|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
148987360|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
148987361|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
148987362|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
148987363|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
148987364|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
148987365|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
148987366|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
148987367|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
148987368|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
148855596|NCT01751906|536946276|FG000|Overall Study|Lost to Follow-up|151|||
148855597|NCT01751906|536946277|FG001|Overall Study|Lost to Follow-up|68|||
148855598|NCT01751906|536946276|FG000|Overall Study|Withdrawal by Subject|22|||
148987369|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
148987370|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
148987371|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
148987372|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
148987373|NCT00383435|537432425|FG000|26-Week Treatment Safety Extension|Administrative|1|||
148987374|NCT00383435|537432426|FG001|26-Week Treatment Safety Extension|Administrative|1|||
148987375|NCT00383435|537432427|FG002|26-Week Treatment Safety Extension|Administrative|0|||
148987376|NCT00383435|537432428|FG003|26-Week Treatment Safety Extension|Administrative|1|||
148987377|NCT00383435|537432429|FG004|26-Week Treatment Safety Extension|Administrative|0|||
148987378|NCT00583557|537432430|FG000|Overall Study|Withdrawal by Subject|18|||
148987379|NCT00583557|537432430|FG000|Overall Study|Adverse Event|9|||
148987380|NCT00583557|537432430|FG000|Overall Study|Lack of Efficacy|31|||
148987381|NCT00583557|537432430|FG000|Overall Study|Lack of Compliance|5|||
148987382|NCT00583557|537432430|FG000|Overall Study|Other|5|||
148987383|NCT00583557|537432430|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
148987384|NCT02347761|537432431|FG000|All Collected|Death|1|||
148987385|NCT02347761|537432432|FG001|All Collected|Death|0|||
148987386|NCT02347761|537432433|FG002|All Collected|Death|0|||
148987387|NCT02347761|537432431|FG000|All Collected|Lost to Follow-up|3|||
148987388|NCT02347761|537432432|FG001|All Collected|Lost to Follow-up|2|||
148987389|NCT02347761|537432433|FG002|All Collected|Lost to Follow-up|3|||
148987390|NCT02347761|537432431|FG000|All Collected|Withdrawal by Subject|11|||
148987391|NCT02347761|537432432|FG001|All Collected|Withdrawal by Subject|11|||
148987392|NCT02347761|537432433|FG002|All Collected|Withdrawal by Subject|22|||
148987393|NCT02347761|537432431|FG000|All Collected|invetigator disretion|2|||
148987394|NCT02347761|537432432|FG001|All Collected|invetigator disretion|0|||
148987395|NCT02347761|537432433|FG002|All Collected|invetigator disretion|0|||
148987396|NCT02347761|537432431|FG000|All Collected|instillation site pain|0|||
148987397|NCT02347761|537432432|FG001|All Collected|instillation site pain|0|||
148987398|NCT02347761|537432433|FG002|All Collected|instillation site pain|1|||
148987399|NCT02347761|537432431|FG000|All Collected|exacerbation of COPD|0|||
148987400|NCT02347761|537432432|FG001|All Collected|exacerbation of COPD|0|||
148987401|NCT02347761|537432433|FG002|All Collected|exacerbation of COPD|1|||
148987402|NCT02347761|537432431|FG000|All Collected|moved/travel|0|||
148987403|NCT02347761|537432432|FG001|All Collected|moved/travel|1|||
148987404|NCT02347761|537432433|FG002|All Collected|moved/travel|0|||
148987405|NCT02347761|537432431|FG000|On Study Treatment|Lack of Efficacy|2|||
148987406|NCT02347761|537432432|FG001|On Study Treatment|Lack of Efficacy|3|||
148987407|NCT02347761|537432433|FG002|On Study Treatment|Lack of Efficacy|4|||
148987408|NCT02347761|537432431|FG000|On Study Treatment|non-compliance with study medication|0|||
148987409|NCT02347761|537432432|FG001|On Study Treatment|non-compliance with study medication|0|||
148987410|NCT02347761|537432433|FG002|On Study Treatment|non-compliance with study medication|2|||
148987411|NCT02347761|537432431|FG000|On Study Treatment|Withdrawal by Subject|7|||
148987412|NCT02347761|537432432|FG001|On Study Treatment|Withdrawal by Subject|3|||
148987413|NCT02347761|537432433|FG002|On Study Treatment|Withdrawal by Subject|5|||
148987414|NCT02347761|537432431|FG000|On Study Treatment|move/travel|2|||
148987415|NCT02347761|537432432|FG001|On Study Treatment|move/travel|6|||
148987416|NCT02347761|537432433|FG002|On Study Treatment|move/travel|5|||
148987417|NCT02347761|537432431|FG000|On Study Treatment|dissastisfaction with device|2|||
148987418|NCT02347761|537432432|FG001|On Study Treatment|dissastisfaction with device|1|||
148987419|NCT02347761|537432433|FG002|On Study Treatment|dissastisfaction with device|4|||
148987420|NCT02347761|537432431|FG000|On Study Treatment|Lost to Follow-up|2|||
148987421|NCT02347761|537432432|FG001|On Study Treatment|Lost to Follow-up|1|||
148987422|NCT02347761|537432433|FG002|On Study Treatment|Lost to Follow-up|1|||
148987423|NCT02347761|537432431|FG000|On Study Treatment|investigator discretion|2|||
148987424|NCT02347761|537432432|FG001|On Study Treatment|investigator discretion|0|||
148987425|NCT02347761|537432433|FG002|On Study Treatment|investigator discretion|0|||
148987426|NCT02347761|537432431|FG000|On Study Treatment|durg not working|0|||
148987427|NCT02347761|537432432|FG001|On Study Treatment|durg not working|1|||
148987428|NCT02347761|537432433|FG002|On Study Treatment|durg not working|1|||
148987429|NCT02347761|537432431|FG000|On Study Treatment|Adverse Event|10|||
148987430|NCT02347761|537432432|FG001|On Study Treatment|Adverse Event|8|||
148987431|NCT02347761|537432433|FG002|On Study Treatment|Adverse Event|20|||
148987432|NCT02682264|537432434|FG000|Overall Study|Withdrawal by Subject|56|||
148987433|NCT02682264|537432435|FG001|Overall Study|Withdrawal by Subject|45|||
148987434|NCT02682264|537432434|FG000|Overall Study|Lost to Follow-up|49|||
148987435|NCT02682264|537432435|FG001|Overall Study|Lost to Follow-up|41|||
148987436|NCT02682264|537432434|FG000|Overall Study|Lack of Efficacy|14|||
148987437|NCT02682264|537432435|FG001|Overall Study|Lack of Efficacy|16|||
148987438|NCT02682264|537432434|FG000|Overall Study|Withdrawal by Parent|6|||
148987439|NCT02682264|537432435|FG001|Overall Study|Withdrawal by Parent|7|||
148987440|NCT02682264|537432434|FG000|Overall Study|Adverse Event|9|||
148987441|NCT02682264|537432435|FG001|Overall Study|Adverse Event|0|||
148987442|NCT02682264|537432434|FG000|Overall Study|Noncompliance with study drug|1|||
148987443|NCT02682264|537432435|FG001|Overall Study|Noncompliance with study drug|4|||
148987444|NCT02682264|537432434|FG000|Overall Study|Pregnancy|1|||
148987445|NCT02682264|537432435|FG001|Overall Study|Pregnancy|2|||
148987446|NCT02682264|537432434|FG000|Overall Study|Recovery|1|||
148987447|NCT02682264|537432435|FG001|Overall Study|Recovery|2|||
148987448|NCT02682264|537432434|FG000|Overall Study|Progressive Disease|1|||
148987449|NCT02682264|537432435|FG001|Overall Study|Progressive Disease|0|||
148987450|NCT02682264|537432434|FG000|Overall Study|Technical Problems|0|||
148987451|NCT02682264|537432435|FG001|Overall Study|Technical Problems|1|||
148987452|NCT02682264|537432434|FG000|Overall Study|Moved abroad and unable to continue|0|||
148987453|NCT02682264|537432435|FG001|Overall Study|Moved abroad and unable to continue|3|||
148987454|NCT02682264|537432434|FG000|Overall Study|Stopped test article application|0|||
148987455|NCT02682264|537432435|FG001|Overall Study|Stopped test article application|1|||
148987456|NCT00874029|537432436|FG000|Overall Study|Withdrawal by Subject|10|||
148987457|NCT00874029|537432436|FG000|Overall Study|Pregnancy|4|||
148987458|NCT00874029|537432436|FG000|Overall Study|Physician Decision|1|||
148987459|NCT00874029|537432436|FG000|Overall Study|Adverse Event|1|||
148987460|NCT00874029|537432436|FG000|Overall Study|Lost to Follow-up|5|||
148987461|NCT04798586|537432444|FG000|Overall Study|Death|2|||
148987462|NCT00288587|537432454|FG000|Overall Study|Death|4|||
148987463|NCT00288587|537432455|FG001|Overall Study|Death|4|||
148987464|NCT00288587|537432454|FG000|Overall Study|Transplant|0|||
148987465|NCT00288587|537432455|FG001|Overall Study|Transplant|3|||
148987466|NCT00288587|537432454|FG000|Overall Study|Adverse Event|0|||
148987467|NCT00288587|537432455|FG001|Overall Study|Adverse Event|1|||
148987468|NCT00288587|537432454|FG000|Overall Study|Physician Decision|0|||
148987469|NCT00288587|537432455|FG001|Overall Study|Physician Decision|2|||
148987470|NCT00288587|537432454|FG000|Overall Study|Severe Aortic Stenosis|1|||
148987471|NCT00288587|537432455|FG001|Overall Study|Severe Aortic Stenosis|0|||
148987472|NCT01434602|537432456|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
148987473|NCT01434602|537432457|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
148987474|NCT01434602|537432458|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
148987475|NCT01434602|537432459|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
148987476|NCT01434602|537432460|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
148855599|NCT01751906|536946277|FG001|Overall Study|Withdrawal by Subject|18|||
148855600|NCT01751906|536946276|FG000|Overall Study|Physician Decision|5|||
148855601|NCT01751906|536946277|FG001|Overall Study|Physician Decision|2|||
148855602|NCT01751906|536946276|FG000|Overall Study|Death|84|||
148855603|NCT01751906|536946277|FG001|Overall Study|Death|43|||
148855604|NCT01751906|536946276|FG000|Overall Study|Denied on premises for follow-up by law|1|||
148855605|NCT01751906|536946277|FG001|Overall Study|Denied on premises for follow-up by law|0|||
148855606|NCT00733291|536946278|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
148855607|NCT00733291|536946279|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
148855608|NCT00733291|536946280|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
148855609|NCT00733291|536946281|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
148855610|NCT01089413|536946290|FG000|Overall Study|Lost to Follow-up|1|||
148855611|NCT01089413|536946290|FG000|Overall Study|Progressive Disease|93|||
148855612|NCT01089413|536946290|FG000|Overall Study|Participant Withdrew Consent|1|||
148855613|NCT01089413|536946290|FG000|Overall Study|Unacceptable Toxicity|12|||
148855614|NCT01089413|536946290|FG000|Overall Study|Death|10|||
148855615|NCT01089413|536946290|FG000|Overall Study|Metastasectomy|13|||
148855616|NCT01089413|536946290|FG000|Overall Study|Other|71|||
148855617|NCT00470093|536946294|FG000|Overall Study|Adverse Event|2|||
148855618|NCT01610557|536946295|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
148855619|NCT01610557|536946296|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
148855620|NCT01610557|536946297|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
148855621|NCT01610557|536946298|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
148987477|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
148987478|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
148987479|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
148987480|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
148987481|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
148987482|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
148987483|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
148987484|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
149005491|NCT03217747|537497896|FG004|Overall Study|Removal of sole target lesion|0|||
148855622|NCT01610557|536946299|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
148855623|NCT01610557|536946295|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
148855624|NCT01610557|536946296|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
148855625|NCT01610557|536946297|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
148855626|NCT01610557|536946298|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
148855627|NCT01610557|536946299|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
148855628|NCT03931382|536946309|FG000|Overall Study|Equipment malfunction|2|||
148855629|NCT03931382|536946310|FG001|Overall Study|Equipment malfunction|0|||
148855630|NCT03931382|536946311|FG002|Overall Study|Equipment malfunction|2|||
148855631|NCT03931382|536946309|FG000|Overall Study|Withdrawal by Subject|0|||
148855632|NCT03931382|536946310|FG001|Overall Study|Withdrawal by Subject|1|||
148855633|NCT03931382|536946311|FG002|Overall Study|Withdrawal by Subject|0|||
148855634|NCT01106651|536946317|FG000|Overall Study|Adverse Event|17|||
148855635|NCT01106651|536946318|FG001|Overall Study|Adverse Event|9|||
148855636|NCT01106651|536946319|FG002|Overall Study|Adverse Event|23|||
148855637|NCT01106651|536946317|FG000|Overall Study|Lost to Follow-up|8|||
148855638|NCT01106651|536946318|FG001|Overall Study|Lost to Follow-up|2|||
148855639|NCT01106651|536946319|FG002|Overall Study|Lost to Follow-up|6|||
148855640|NCT01106651|536946317|FG000|Overall Study|Physician Decision|4|||
148855641|NCT01106651|536946318|FG001|Overall Study|Physician Decision|3|||
148855642|NCT01106651|536946319|FG002|Overall Study|Physician Decision|1|||
148855643|NCT01106651|536946317|FG000|Overall Study|Protocol Violation|1|||
148855644|NCT01106651|536946318|FG001|Overall Study|Protocol Violation|2|||
148855645|NCT01106651|536946319|FG002|Overall Study|Protocol Violation|1|||
148855646|NCT01106651|536946317|FG000|Overall Study|Withdrawal by Subject|14|||
148855647|NCT01106651|536946318|FG001|Overall Study|Withdrawal by Subject|7|||
148855648|NCT01106651|536946319|FG002|Overall Study|Withdrawal by Subject|4|||
148855649|NCT01106651|536946317|FG000|Overall Study|Noncompliance with study drug|1|||
148855650|NCT01106651|536946318|FG001|Overall Study|Noncompliance with study drug|0|||
148855651|NCT01106651|536946319|FG002|Overall Study|Noncompliance with study drug|2|||
148855652|NCT01106651|536946317|FG000|Overall Study|Other|34|||
148855653|NCT01106651|536946318|FG001|Overall Study|Other|31|||
148855654|NCT01106651|536946319|FG002|Overall Study|Other|21|||
148855655|NCT01106651|536946317|FG000|Overall Study|Death|0|||
148855656|NCT01106651|536946318|FG001|Overall Study|Death|3|||
148855657|NCT01106651|536946319|FG002|Overall Study|Death|0|||
148855658|NCT04154605|536946322|FG000|Overall Study|Procedure Canceled|1|||
148855659|NCT04154605|536946323|FG001|Overall Study|Procedure Canceled|1|||
148855660|NCT04154605|536946322|FG000|Overall Study|Missed follow up|1|||
148855661|NCT04154605|536946323|FG001|Overall Study|Missed follow up|1|||
148855662|NCT04154605|536946322|FG000|Overall Study|Withdrawal by Subject|1|||
148855663|NCT04154605|536946323|FG001|Overall Study|Withdrawal by Subject|0|||
148855664|NCT00675441|536946324|FG000|Overall Study|Withdrawal by Subject|2|||
148855665|NCT00675441|536946324|FG000|Overall Study|Death|1|||
148855666|NCT00700882|536946327|FG000|Overall Study|Never received treatment|6|||
148855667|NCT00700882|536946327|FG000|Overall Study|Ineligible|2|||
148855668|NCT00700882|536946327|FG000|Overall Study|No KIT mutation|51|||
148855669|NCT01832493|536946328|FG000|Overall Study|Physician Decision|2|||
148855670|NCT01832493|536946328|FG000|Overall Study|Protocol Violation|4|||
148855671|NCT01832493|536946328|FG000|Overall Study|Unable to place LV lead|2|||
148855672|NCT00290771|536946331|FG000|Overall Study|Disease progression|95|||
148855673|NCT00290771|536946332|FG001|Overall Study|Disease progression|73|||
148855674|NCT00290771|536946331|FG000|Overall Study|Death|11|||
148855675|NCT00290771|536946332|FG001|Overall Study|Death|10|||
148855676|NCT00290771|536946331|FG000|Overall Study|Adverse Event|12|||
148855677|NCT00290771|536946332|FG001|Overall Study|Adverse Event|6|||
148855678|NCT00290771|536946331|FG000|Overall Study|Withdrawal by Subject|5|||
148855679|NCT00290771|536946332|FG001|Overall Study|Withdrawal by Subject|6|||
148855680|NCT00290771|536946331|FG000|Overall Study|Administrative problems|2|||
148855681|NCT00290771|536946332|FG001|Overall Study|Administrative problems|1|||
148855682|NCT00290771|536946331|FG000|Overall Study|Protocol Violation|2|||
148855683|NCT00290771|536946332|FG001|Overall Study|Protocol Violation|0|||
148855684|NCT00290771|536946331|FG000|Overall Study|Lost to Follow-up|0|||
148855685|NCT00290771|536946332|FG001|Overall Study|Lost to Follow-up|1|||
148855686|NCT00313144|536946333|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
148855687|NCT00313144|536946333|FG000|Overall Study|Death|7|||
148855688|NCT00313144|536946333|FG000|Overall Study|Lost to Follow-up|5|||
148855689|NCT00313144|536946333|FG000|Overall Study|Withdrawal by Subject|4|||
148855690|NCT00313144|536946333|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
148855691|NCT00313144|536946333|FG000|Overall Study|Physician Decision|4|||
148855692|NCT00313144|536946333|FG000|Overall Study|Adverse event - transient|5|||
148855693|NCT00313144|536946333|FG000|Overall Study|Liver transplant|1|||
148987485|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
148855694|NCT00313144|536946333|FG000|Overall Study|Insurance (homecare provider) change|1|||
148855695|NCT00313144|536946333|FG000|Overall Study|Change to different product|1|||
148855696|NCT00313144|536946333|FG000|Overall Study|Due to termination of the study|66|||
148855697|NCT04154293|536946335|FG000|Overall Study|Withdrawal by Subject|2|||
148855698|NCT04154293|536946336|FG001|Overall Study|Withdrawal by Subject|3|||
148855699|NCT04154293|536946337|FG002|Overall Study|Withdrawal by Subject|1|||
148855700|NCT04154293|536946335|FG000|Overall Study|Physician Decision|0|||
148855701|NCT04154293|536946336|FG001|Overall Study|Physician Decision|0|||
148855702|NCT04154293|536946337|FG002|Overall Study|Physician Decision|1|||
148855703|NCT03703817|536946339|FG000|Overall Study|Not meeting eligibility criteria|7|||
148855704|NCT03703817|536946340|FG001|Overall Study|Not meeting eligibility criteria|4|||
148855705|NCT00656058|536946343|FG000|Overall Study|Withdrawal by Subject|2|||
148855706|NCT00656058|536946343|FG000|Overall Study|Withdrawal by Subject|4|||
148855707|NCT00404755|536946346|FG000|Phase I (Bupropion)|Adverse Event|3|||
148855708|NCT00404755|536946346|FG000|Phase I (Bupropion)|Other|1|||
148855709|NCT00404755|536946346|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
148855710|NCT05145322|536946349|FG000|Overall Study|Lost to Follow-up|4|||
148855711|NCT05145322|536946350|FG001|Overall Study|Lost to Follow-up|5|||
148855712|NCT06359028|536946351|FG000|Overall Study|Adverse Event|1|||
148855713|NCT06359028|536946352|FG001|Overall Study|Adverse Event|0|||
148855714|NCT06359028|536946351|FG000|Overall Study|Withdrawal by Subject|1|||
148855715|NCT06359028|536946352|FG001|Overall Study|Withdrawal by Subject|0|||
148855716|NCT04700540|536946353|FG000|Overall Study|Withdrawal by Subject|12|||
148855717|NCT04700540|536946354|FG001|Overall Study|Withdrawal by Subject|8|||
148855718|NCT04700540|536946353|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
148855719|NCT04700540|536946354|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
148855720|NCT03194568|536946355|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
148855721|NCT02952313|536946356|FG000|Primary Endpoint|Lost to Follow-up|4|||
148855722|NCT02952313|536946356|FG000|Primary Endpoint|Withdrawal by Subject|1|||
148855723|NCT02952313|536946356|FG000|Primary Endpoint|Lack of Efficacy|1|||
148855724|NCT02952313|536946356|FG000|Primary Endpoint|Missed visit|1|||
148855725|NCT02952313|536946356|FG000|Long-term Follow-up|Lost to Follow-up|12|||
148855726|NCT02952313|536946356|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
148855727|NCT02952313|536946356|FG000|Long-term Follow-up|Lack of Efficacy|6|||
148855728|NCT02952313|536946356|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
148855729|NCT02952313|536946356|FG000|Long-term Follow-up|Physician Decision|1|||
148855730|NCT02952313|536946356|FG000|Long-term Follow-up|Death|1|||
148855731|NCT00920387|536946363|FG000|Stage 1|Adverse Event|1|||
148855732|NCT00920387|536946364|FG001|Stage 1|Adverse Event|0|||
148855733|NCT00920387|536946365|FG002|Stage 1|Adverse Event|0|||
148855734|NCT02241733|536946376|FG000|Overall Study|Lost to Follow-up|9|||
148855735|NCT02241733|536946377|FG001|Overall Study|Lost to Follow-up|4|||
148855736|NCT02241733|536946376|FG000|Overall Study|Physician Decision|6|||
148855737|NCT02241733|536946377|FG001|Overall Study|Physician Decision|2|||
148855738|NCT02241733|536946376|FG000|Overall Study|Withdrawal by Subject|0|||
148855739|NCT02241733|536946377|FG001|Overall Study|Withdrawal by Subject|2|||
148855740|NCT02241733|536946376|FG000|Overall Study|Death|0|||
148855741|NCT02241733|536946377|FG001|Overall Study|Death|2|||
148855742|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
148855743|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
148855744|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
148855745|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
148855746|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
148855747|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
148855748|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
148855749|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
148855750|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
148987486|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
148987487|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
148987488|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
148987489|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
148987490|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
148987491|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
148987492|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
148987493|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
148855751|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
148855752|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
148855753|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
148855754|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
148855755|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
148855756|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
148855757|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
148855758|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
148855759|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
148855760|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
148855761|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
148855762|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
148855763|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
148855764|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
148855765|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
148855766|NCT01866111|536946378|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
148855767|NCT01866111|536946379|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
148855768|NCT01866111|536946380|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
148855769|NCT01866111|536946381|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
148855770|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
148855771|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
148855772|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
148855773|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
148855774|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
148855775|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
148855776|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
148855777|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
148855778|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
148855779|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
148855780|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
148855781|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
148855782|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
148855783|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
148855784|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
148855785|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
148855786|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Death|1|||
148855787|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Death|1|||
148855788|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Death|3|||
148855789|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Death|2|||
148855790|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
148855791|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
148855792|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
148855793|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
148855794|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
148855795|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
148855796|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
148855797|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
148855798|NCT01866111|536946378|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
148855799|NCT01866111|536946379|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
148855800|NCT01866111|536946380|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
148855801|NCT01866111|536946381|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
148855802|NCT03802630|536946382|FG000|Overall Study|Study terminated by sponsor|130|||
148855803|NCT03802630|536946383|FG001|Overall Study|Study terminated by sponsor|134|||
148855804|NCT03802630|536946382|FG000|Overall Study|Subject decision|16|||
148855805|NCT03802630|536946383|FG001|Overall Study|Subject decision|9|||
148855806|NCT03802630|536946382|FG000|Overall Study|Adverse Event|3|||
148855807|NCT03802630|536946383|FG001|Overall Study|Adverse Event|1|||
148855808|NCT03802630|536946382|FG000|Overall Study|Lost to Follow-up|2|||
148855809|NCT03802630|536946383|FG001|Overall Study|Lost to Follow-up|2|||
148855810|NCT03802630|536946382|FG000|Overall Study|Physician Decision|2|||
148855811|NCT03802630|536946383|FG001|Overall Study|Physician Decision|0|||
148855812|NCT03802630|536946382|FG000|Overall Study|Death|0|||
148855813|NCT03802630|536946383|FG001|Overall Study|Death|2|||
148855814|NCT00157196|536946384|FG000|Overall Study|Ongoing at data cut-off|9|||
148855815|NCT01252186|536946385|FG000|Overall Study|Adverse Event|9|||
148855816|NCT01252186|536946386|FG001|Overall Study|Adverse Event|6|||
148855817|NCT01252186|536946387|FG002|Overall Study|Adverse Event|8|||
148855818|NCT01252186|536946385|FG000|Overall Study|Withdrawal by Subject|2|||
148855819|NCT01252186|536946386|FG001|Overall Study|Withdrawal by Subject|5|||
148855820|NCT01252186|536946387|FG002|Overall Study|Withdrawal by Subject|2|||
148855821|NCT01252186|536946385|FG000|Overall Study|Physician Decision|0|||
148855822|NCT01252186|536946386|FG001|Overall Study|Physician Decision|0|||
148855823|NCT01252186|536946387|FG002|Overall Study|Physician Decision|1|||
148855824|NCT01252186|536946385|FG000|Overall Study|Non-compliance|0|||
148855825|NCT01252186|536946386|FG001|Overall Study|Non-compliance|3|||
148855826|NCT01252186|536946387|FG002|Overall Study|Non-compliance|4|||
148855827|NCT01252186|536946385|FG000|Overall Study|Protocol Violation|0|||
148855828|NCT01252186|536946386|FG001|Overall Study|Protocol Violation|0|||
148855829|NCT01252186|536946387|FG002|Overall Study|Protocol Violation|1|||
148855830|NCT01252186|536946385|FG000|Overall Study|Pregnancy|2|||
148855831|NCT01252186|536946386|FG001|Overall Study|Pregnancy|2|||
148855832|NCT01252186|536946387|FG002|Overall Study|Pregnancy|0|||
148855833|NCT01252186|536946385|FG000|Overall Study|Sponsor Request|2|||
148855834|NCT01252186|536946386|FG001|Overall Study|Sponsor Request|1|||
148855835|NCT01252186|536946387|FG002|Overall Study|Sponsor Request|0|||
148855836|NCT01252186|536946385|FG000|Overall Study|Lost to Follow-up|10|||
148855837|NCT01252186|536946386|FG001|Overall Study|Lost to Follow-up|10|||
148855838|NCT01252186|536946387|FG002|Overall Study|Lost to Follow-up|11|||
148855839|NCT01252186|536946385|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
148987494|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
148987495|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
148987496|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
148987497|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
148987498|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
148987499|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
148987500|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
148987501|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
148987502|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
148987503|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
148987504|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
148987505|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
148987506|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
148987507|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
148987508|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
148987509|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
148987510|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
148987511|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
148987512|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
148987513|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
148987514|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
148987515|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
148987516|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
148987517|NCT01434602|537432456|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
148987518|NCT01434602|537432457|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
148987519|NCT01434602|537432458|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
148987520|NCT01434602|537432459|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
148987521|NCT01434602|537432460|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
148987522|NCT01764945|537432466|FG000|Overall Study|Adverse Event|0|||
148987523|NCT01764945|537432467|FG001|Overall Study|Adverse Event|1|||
148987524|NCT01764945|537432468|FG002|Overall Study|Adverse Event|0|||
148987525|NCT01764945|537432469|FG003|Overall Study|Adverse Event|0|||
148987526|NCT01764945|537432470|FG004|Overall Study|Adverse Event|0|||
148987527|NCT01764945|537432471|FG005|Overall Study|Adverse Event|0|||
148987528|NCT01764945|537432472|FG006|Overall Study|Adverse Event|1|||
148987529|NCT01764945|537432473|FG007|Overall Study|Adverse Event|0|||
148987530|NCT05077267|537432475|FG000|Treatment Period|Lost to Follow-up|0|||
148987531|NCT05077267|537432476|FG001|Treatment Period|Lost to Follow-up|1|||
148987532|NCT05077267|537432477|FG002|Treatment Period|Lost to Follow-up|0|||
148987533|NCT05077267|537432475|FG000|Treatment Period|Withdrawal by Subject|0|||
148987534|NCT05077267|537432476|FG001|Treatment Period|Withdrawal by Subject|1|||
148987535|NCT05077267|537432477|FG002|Treatment Period|Withdrawal by Subject|0|||
148987536|NCT05077267|537432475|FG000|Follow-up Period|Lost to Follow-up|0|||
148987537|NCT05077267|537432476|FG001|Follow-up Period|Lost to Follow-up|5|||
148987538|NCT05077267|537432477|FG002|Follow-up Period|Lost to Follow-up|7|||
148987539|NCT05077267|537432475|FG000|Follow-up Period|Withdrawal by Subject|0|||
148987540|NCT05077267|537432476|FG001|Follow-up Period|Withdrawal by Subject|2|||
148987541|NCT05077267|537432477|FG002|Follow-up Period|Withdrawal by Subject|5|||
148987542|NCT05077267|537432475|FG000|Follow-up Period|Study terminated by sponsor|0|||
148855840|NCT01252186|536946386|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
148855841|NCT01252186|536946387|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
148855842|NCT04283994|536946394|FG000|Overall Study|Death|11|||
148855843|NCT04283994|536946395|FG001|Overall Study|Death|20|||
148987543|NCT05077267|537432476|FG001|Follow-up Period|Study terminated by sponsor|27|||
148987544|NCT05077267|537432477|FG002|Follow-up Period|Study terminated by sponsor|23|||
148987545|NCT05077267|537432475|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
148987546|NCT05077267|537432476|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
148855844|NCT04283994|536946396|FG002|Overall Study|Death|11|||
148855845|NCT04283994|536946397|FG003|Overall Study|Death|0|||
148855846|NCT04283994|536946398|FG004|Overall Study|Death|0|||
148855847|NCT04283994|536946399|FG005|Overall Study|Death|0|||
148855848|NCT04283994|536946400|FG006|Overall Study|Death|0|||
148855849|NCT04283994|536946394|FG000|Overall Study|Withdrawal by Subject|16|||
148855850|NCT04283994|536946395|FG001|Overall Study|Withdrawal by Subject|4|||
148855851|NCT04283994|536946396|FG002|Overall Study|Withdrawal by Subject|6|||
148855852|NCT04283994|536946397|FG003|Overall Study|Withdrawal by Subject|1|||
148855853|NCT04283994|536946398|FG004|Overall Study|Withdrawal by Subject|0|||
148855854|NCT04283994|536946399|FG005|Overall Study|Withdrawal by Subject|1|||
148855855|NCT04283994|536946400|FG006|Overall Study|Withdrawal by Subject|0|||
148855856|NCT01331837|536946401|FG000|Overall Study|Death|30|||
148855857|NCT01331837|536946402|FG001|Overall Study|Death|34|||
148855858|NCT01331837|536946401|FG000|Overall Study|Lost to Follow-up|3|||
148855859|NCT01331837|536946402|FG001|Overall Study|Lost to Follow-up|1|||
148855860|NCT01331837|536946401|FG000|Overall Study|Info not recorded|10|||
148855861|NCT01331837|536946402|FG001|Overall Study|Info not recorded|16|||
148855862|NCT01331837|536946401|FG000|Overall Study|Withdrawal by Subject|13|||
148855863|NCT01331837|536946402|FG001|Overall Study|Withdrawal by Subject|16|||
148855864|NCT02791191|536947888|FG000|Overall Study|Adverse Event|2|||
148855865|NCT02791191|536947889|FG001|Overall Study|Adverse Event|4|||
148855866|NCT02791191|536947890|FG002|Overall Study|Adverse Event|5|||
148855867|NCT02791191|536947888|FG000|Overall Study|Lack of Efficacy|0|||
148855868|NCT02791191|536947889|FG001|Overall Study|Lack of Efficacy|1|||
148855869|NCT02791191|536947890|FG002|Overall Study|Lack of Efficacy|0|||
148855870|NCT02791191|536947888|FG000|Overall Study|Study Drug Non-Compliance|0|||
148855871|NCT02791191|536947889|FG001|Overall Study|Study Drug Non-Compliance|2|||
148855872|NCT02791191|536947890|FG002|Overall Study|Study Drug Non-Compliance|0|||
148855873|NCT02791191|536947888|FG000|Overall Study|Site Closed by Sponsor|1|||
148855874|NCT02791191|536947889|FG001|Overall Study|Site Closed by Sponsor|1|||
148855875|NCT02791191|536947890|FG002|Overall Study|Site Closed by Sponsor|3|||
148855876|NCT02791191|536947888|FG000|Overall Study|Progressive Disease|1|||
148855877|NCT02791191|536947889|FG001|Overall Study|Progressive Disease|0|||
148855878|NCT02791191|536947890|FG002|Overall Study|Progressive Disease|0|||
148855879|NCT02791191|536947888|FG000|Overall Study|Study Terminated by Sponsor|29|||
148855880|NCT02791191|536947889|FG001|Overall Study|Study Terminated by Sponsor|101|||
148855881|NCT02791191|536947890|FG002|Overall Study|Study Terminated by Sponsor|109|||
148855882|NCT02791191|536947888|FG000|Overall Study|Withdrawal by Subject|3|||
148855883|NCT02791191|536947889|FG001|Overall Study|Withdrawal by Subject|1|||
148855884|NCT02791191|536947890|FG002|Overall Study|Withdrawal by Subject|3|||
148855885|NCT02791191|536947888|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
148855886|NCT02791191|536947889|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
148855887|NCT02791191|536947890|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
148855888|NCT02578680|536947894|FG000|Overall Study|Death|329|||
148855889|NCT02578680|536947895|FG001|Overall Study|Death|181|||
148855890|NCT02578680|536947894|FG000|Overall Study|Lost to Follow-up|3|||
148855891|NCT02578680|536947895|FG001|Overall Study|Lost to Follow-up|1|||
148855892|NCT02578680|536947894|FG000|Overall Study|Physician Decision|0|||
148855893|NCT02578680|536947895|FG001|Overall Study|Physician Decision|1|||
148855894|NCT02578680|536947894|FG000|Overall Study|Protocol Violation|1|||
148855895|NCT02578680|536947895|FG001|Overall Study|Protocol Violation|1|||
148855896|NCT02578680|536947894|FG000|Overall Study|Sponsor Decision|64|||
148855897|NCT02578680|536947895|FG001|Overall Study|Sponsor Decision|13|||
148855898|NCT02578680|536947894|FG000|Overall Study|Withdrawal by Subject|13|||
148855899|NCT02578680|536947895|FG001|Overall Study|Withdrawal by Subject|9|||
148855900|NCT02290691|536947896|FG000|Overall Study|Noncompliance|0|||
148855901|NCT02290691|536947897|FG001|Overall Study|Noncompliance|1|||
148855902|NCT02290691|536947896|FG000|Overall Study|Withdrawal by Subject|1|||
148855903|NCT02290691|536947897|FG001|Overall Study|Withdrawal by Subject|1|||
148855904|NCT02290691|536947896|FG000|Overall Study|Lost to Follow-up|7|||
148855905|NCT02290691|536947897|FG001|Overall Study|Lost to Follow-up|7|||
148855906|NCT03215758|536947902|FG000|Overall Study|Technical Problems|1|||
148855907|NCT03215758|536947903|FG001|Overall Study|Technical Problems|0|||
148855908|NCT03215758|536947902|FG000|Overall Study|Protocol deviation|0|||
148855909|NCT03215758|536947903|FG001|Overall Study|Protocol deviation|1|||
148855910|NCT03215758|536947902|FG000|Overall Study|Physician Decision|0|||
148855911|NCT03215758|536947903|FG001|Overall Study|Physician Decision|1|||
148855912|NCT03215758|536947902|FG000|Overall Study|Death|0|||
148855913|NCT03215758|536947903|FG001|Overall Study|Death|1|||
148855914|NCT03215758|536947902|FG000|Overall Study|Adverse Event|1|||
148855915|NCT03215758|536947903|FG001|Overall Study|Adverse Event|2|||
148855916|NCT03215758|536947902|FG000|Overall Study|Subject/Guardian Decision|3|||
148855917|NCT03215758|536947903|FG001|Overall Study|Subject/Guardian Decision|3|||
148855918|NCT01289353|536947904|FG000|Overall Study|Lost to Follow-up|2|||
148855919|NCT01549886|536947905|FG000|Overall Study|Sponsor's decision|2|||
148855920|NCT01549886|536947906|FG001|Overall Study|Sponsor's decision|3|||
148855921|NCT00473668|536947907|FG000|Overall Study|Withdrawal by Subject|0|||
148855922|NCT00473668|536947908|FG001|Overall Study|Withdrawal by Subject|2|||
148855923|NCT00473668|536947909|FG002|Overall Study|Withdrawal by Subject|0|||
148855924|NCT00473668|536947907|FG000|Overall Study|Migrated/moved from study area|3|||
148855925|NCT00473668|536947908|FG001|Overall Study|Migrated/moved from study area|2|||
148855926|NCT00473668|536947909|FG002|Overall Study|Migrated/moved from study area|0|||
148855927|NCT00473668|536947907|FG000|Overall Study|Lost to Follow-up|0|||
148987547|NCT05077267|537432477|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
148987548|NCT05077267|537432475|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
148987549|NCT05077267|537432476|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
148987550|NCT05077267|537432477|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
148987551|NCT01136291|537432486|FG000|Overall Study|Lost to Follow-up|1|||
148987552|NCT01136291|537432487|FG001|Overall Study|Lost to Follow-up|1|||
148987553|NCT03165045|537432492|FG000|Visit 1|No registration after visit 1|9|||
148987554|NCT03165045|537432492|FG000|Visit 1|No treatment documented|10|||
148987555|NCT03165045|537432492|FG000|Visit 1|No visit 1|10|||
148987556|NCT03165045|537432492|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
148987557|NCT03165045|537432492|FG000|Visit 2|No available total CCQ score at all|29|||
148987558|NCT03165045|537432492|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
148987559|NCT01827904|537432493|FG000|Main Study|Withdrawal by Subject|1|||
148987560|NCT01827904|537432494|FG001|Main Study|Withdrawal by Subject|0|||
148987561|NCT01827904|537432495|FG002|Main Study|Withdrawal by Subject|0|||
148987562|NCT01827904|537432493|FG000|Main Study|Adverse Event|1|||
148987563|NCT01827904|537432494|FG001|Main Study|Adverse Event|0|||
148987564|NCT01827904|537432495|FG002|Main Study|Adverse Event|0|||
148987565|NCT01827904|537432493|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
148987566|NCT01827904|537432494|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
148987567|NCT01827904|537432495|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
148987568|NCT01827904|537432493|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
148987569|NCT01827904|537432494|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
148987570|NCT01827904|537432495|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
148987571|NCT01827904|537432493|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
148987572|NCT01827904|537432494|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
148987573|NCT01827904|537432495|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
148987574|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
148987575|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
148987576|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
148987577|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
149030526|NCT04888585|537589673|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
149030527|NCT04888585|537589663|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030528|NCT04888585|537589664|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030529|NCT04888585|537589665|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030530|NCT04888585|537589666|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030531|NCT04888585|537589667|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030532|NCT04888585|537589668|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030533|NCT04888585|537589669|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030534|NCT04888585|537589670|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
149030535|NCT04888585|537589671|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030536|NCT04888585|537589672|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
149030537|NCT04888585|537589673|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
149030538|NCT04888585|537589663|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
149030539|NCT04888585|537589664|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
149030540|NCT04888585|537589665|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
149030541|NCT04888585|537589666|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
149030542|NCT04888585|537589667|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
149030543|NCT04888585|537589668|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
149030544|NCT04888585|537589669|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
149030545|NCT04888585|537589670|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
149030546|NCT04888585|537589671|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
149030547|NCT04888585|537589672|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
149030548|NCT04888585|537589673|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
149030549|NCT04888585|537589663|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
149030550|NCT04888585|537589664|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
149030551|NCT04888585|537589665|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
149030552|NCT04888585|537589666|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
149030553|NCT04888585|537589667|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
149030554|NCT04888585|537589668|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
149030555|NCT04888585|537589669|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
149030556|NCT04888585|537589670|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
149030557|NCT04888585|537589671|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
148987578|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
148777791|NCT00955968|536660416|FG000|Overall Study|Lost to Follow-up|45|||
148777792|NCT00955968|536660417|FG001|Overall Study|Lost to Follow-up|39|||
148987579|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
148987580|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
148987581|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
148987582|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
148987583|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
148987584|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
148987585|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
148987586|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Physician Decision|1|||
148987587|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Physician Decision|0|||
148987588|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Physician Decision|0|||
148987589|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
148987590|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
148987591|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
148987592|NCT01827904|537432493|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
148987593|NCT01827904|537432494|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
148987594|NCT01827904|537432495|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
148987595|NCT00142909|537432501|FG000|Randomization|Various Reasons|7|||
148987596|NCT00142909|537432502|FG001|Randomization|Various Reasons|10|||
148987597|NCT00142909|537432501|FG000|Medications Begin|Protocol Violation|2|||
148987598|NCT00142909|537432502|FG001|Medications Begin|Protocol Violation|0|||
148987599|NCT00142909|537432501|FG000|Medications Begin|Withdrawal by Subject|5|||
148987600|NCT00142909|537432502|FG001|Medications Begin|Withdrawal by Subject|3|||
148987601|NCT00142909|537432501|FG000|Medications Begin|Withdrawal by Subject|2|||
148987602|NCT00142909|537432502|FG001|Medications Begin|Withdrawal by Subject|0|||
148987603|NCT01870843|537432506|FG000|Overall Study|Adverse Event|10|||
148987604|NCT01870843|537432506|FG000|Overall Study|Lost to Follow-up|24|||
148987605|NCT01870843|537432506|FG000|Overall Study|Death|1|||
148987606|NCT01870843|537432506|FG000|Overall Study|Withdrawal by Subject|18|||
148987607|NCT02265237|537432507|FG000|As Treated (Overall Study)|Adverse Event|1|||
148987608|NCT02265237|537432508|FG001|As Treated (Overall Study)|Adverse Event|1|||
148987609|NCT02265237|537432509|FG002|As Treated (Overall Study)|Adverse Event|0|||
148987610|NCT02265237|537432510|FG003|As Treated (Overall Study)|Adverse Event|0|||
148987611|NCT02265237|537432507|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
148987612|NCT02265237|537432508|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
148987613|NCT02265237|537432509|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
148987614|NCT02265237|537432510|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
148987615|NCT02265237|537432507|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
148987616|NCT02265237|537432508|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
148987617|NCT02265237|537432509|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
148987618|NCT02265237|537432510|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
148987619|NCT02265237|537432507|FG000|As Treated (Overall Study)|Other|2|||
148987620|NCT02265237|537432508|FG001|As Treated (Overall Study)|Other|0|||
148987621|NCT02265237|537432509|FG002|As Treated (Overall Study)|Other|3|||
148987622|NCT02265237|537432510|FG003|As Treated (Overall Study)|Other|1|||
148987623|NCT03550313|537432512|FG000|Overall Study|Adverse Event|0|||
148855928|NCT00473668|536947908|FG001|Overall Study|Lost to Follow-up|4|||
148855929|NCT00473668|536947909|FG002|Overall Study|Lost to Follow-up|6|||
148855930|NCT00473668|536947907|FG000|Overall Study|Other|2|||
148855931|NCT00473668|536947908|FG001|Overall Study|Other|3|||
148855932|NCT00473668|536947909|FG002|Overall Study|Other|4|||
148855933|NCT02039219|536947910|FG000|Treatment|Withdrawal by Subject|1|||
148855934|NCT02039219|536947911|FG001|Treatment|Withdrawal by Subject|0|||
148855935|NCT02039219|536947910|FG000|Treatment|Adverse Event|0|||
148855936|NCT02039219|536947911|FG001|Treatment|Adverse Event|1|||
148855937|NCT02039219|536947910|FG000|Treatment|Physician Decision|1|||
148855938|NCT02039219|536947911|FG001|Treatment|Physician Decision|0|||
148855939|NCT02039219|536947910|FG000|Treatment|Lost to Follow-up|0|||
148855940|NCT02039219|536947911|FG001|Treatment|Lost to Follow-up|1|||
148855941|NCT02039219|536947910|FG000|Treatment|Protocol Violation|1|||
148855942|NCT02039219|536947911|FG001|Treatment|Protocol Violation|0|||
148855943|NCT02039219|536947910|FG000|Treatment|Death|1|||
148855944|NCT02039219|536947911|FG001|Treatment|Death|0|||
148987624|NCT03550313|537432513|FG001|Overall Study|Adverse Event|1|||
148987625|NCT03550313|537432514|FG002|Overall Study|Adverse Event|0|||
148987626|NCT03550313|537432512|FG000|Overall Study|Lost to Follow-up|5|||
149030558|NCT04888585|537589672|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
148855945|NCT02039219|536947910|FG000|Follow up|Adverse Event|0|||
148987627|NCT03550313|537432513|FG001|Overall Study|Lost to Follow-up|7|||
148987628|NCT03550313|537432514|FG002|Overall Study|Lost to Follow-up|12|||
148987629|NCT03550313|537432512|FG000|Overall Study|Study terminated by sponsor|44|||
148987630|NCT03550313|537432513|FG001|Overall Study|Study terminated by sponsor|37|||
148987631|NCT03550313|537432514|FG002|Overall Study|Study terminated by sponsor|48|||
148987632|NCT03550313|537432512|FG000|Overall Study|No longer met eligibility criteria|3|||
148855946|NCT02039219|536947911|FG001|Follow up|Adverse Event|1|||
148855947|NCT02226562|536947912|FG000|Overall Study|Lost to Follow-up|0|||
148855948|NCT02226562|536947913|FG001|Overall Study|Lost to Follow-up|1|||
148987633|NCT03550313|537432513|FG001|Overall Study|No longer met eligibility criteria|5|||
148987634|NCT03550313|537432514|FG002|Overall Study|No longer met eligibility criteria|6|||
148987635|NCT03550313|537432512|FG000|Overall Study|Withdrawal by parent/guardian|20|||
148987636|NCT03550313|537432513|FG001|Overall Study|Withdrawal by parent/guardian|18|||
148987637|NCT03550313|537432514|FG002|Overall Study|Withdrawal by parent/guardian|26|||
148987638|NCT03550313|537432512|FG000|Overall Study|Other|4|||
148987639|NCT03550313|537432513|FG001|Overall Study|Other|2|||
148987640|NCT03550313|537432514|FG002|Overall Study|Other|2|||
148987641|NCT03550313|537432512|FG000|Overall Study|Randomized but not vaccinated|3|||
148987642|NCT03550313|537432513|FG001|Overall Study|Randomized but not vaccinated|23|||
148987643|NCT03550313|537432514|FG002|Overall Study|Randomized but not vaccinated|2|||
148987644|NCT03550313|537432512|FG000|Overall Study|Sites terminated due to quality issues|18|||
148987645|NCT03550313|537432513|FG001|Overall Study|Sites terminated due to quality issues|17|||
148987646|NCT03550313|537432514|FG002|Overall Study|Sites terminated due to quality issues|18|||
148987647|NCT00363766|537432519|FG000|Overall Study|Progressive Disease|15|||
148987648|NCT00363766|537432520|FG001|Overall Study|Progressive Disease|9|||
148987649|NCT00363766|537432519|FG000|Overall Study|Adverse Event|10|||
148987650|NCT00363766|537432520|FG001|Overall Study|Adverse Event|2|||
148987651|NCT00363766|537432519|FG000|Overall Study|Disease Related Death|1|||
148987652|NCT00363766|537432520|FG001|Overall Study|Disease Related Death|3|||
148987653|NCT00363766|537432519|FG000|Overall Study|Not Disease Related Death|3|||
148987654|NCT00363766|537432520|FG001|Overall Study|Not Disease Related Death|4|||
148987655|NCT00363766|537432519|FG000|Overall Study|Withdrawal by Subject|2|||
148987656|NCT00363766|537432520|FG001|Overall Study|Withdrawal by Subject|0|||
148987657|NCT00363766|537432519|FG000|Overall Study|Physician Decision|1|||
148987658|NCT00363766|537432520|FG001|Overall Study|Physician Decision|2|||
148987659|NCT00558285|537432521|FG000|Overall Study|Adverse Event|1|||
148987660|NCT00558285|537432522|FG001|Overall Study|Adverse Event|1|||
148987661|NCT00558285|537432523|FG002|Overall Study|Adverse Event|4|||
148987662|NCT00558285|537432524|FG003|Overall Study|Adverse Event|1|||
148987663|NCT00558285|537432525|FG004|Overall Study|Adverse Event|2|||
148987664|NCT00558285|537432521|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148987665|NCT00558285|537432522|FG001|Overall Study|Abnormal test procedure result(s)|0|||
148987666|NCT00558285|537432523|FG002|Overall Study|Abnormal test procedure result(s)|0|||
148987667|NCT00558285|537432524|FG003|Overall Study|Abnormal test procedure result(s)|0|||
148987668|NCT00558285|537432525|FG004|Overall Study|Abnormal test procedure result(s)|0|||
148987669|NCT00558285|537432521|FG000|Overall Study|Subject withdrew consent|2|||
148987670|NCT00558285|537432522|FG001|Overall Study|Subject withdrew consent|0|||
148987671|NCT00558285|537432523|FG002|Overall Study|Subject withdrew consent|1|||
148987672|NCT00558285|537432524|FG003|Overall Study|Subject withdrew consent|1|||
148987673|NCT00558285|537432525|FG004|Overall Study|Subject withdrew consent|1|||
148987674|NCT00558285|537432521|FG000|Overall Study|Lost to Follow-up|1|||
148987675|NCT00558285|537432522|FG001|Overall Study|Lost to Follow-up|1|||
148987676|NCT00558285|537432523|FG002|Overall Study|Lost to Follow-up|0|||
148987677|NCT00558285|537432524|FG003|Overall Study|Lost to Follow-up|0|||
148987678|NCT00558285|537432525|FG004|Overall Study|Lost to Follow-up|0|||
148987679|NCT00558285|537432521|FG000|Overall Study|Administrative problems|0|||
148987680|NCT00558285|537432522|FG001|Overall Study|Administrative problems|0|||
148987681|NCT00558285|537432523|FG002|Overall Study|Administrative problems|0|||
148987682|NCT00558285|537432524|FG003|Overall Study|Administrative problems|1|||
148987683|NCT00558285|537432525|FG004|Overall Study|Administrative problems|1|||
148987684|NCT00558285|537432521|FG000|Overall Study|Protocol deviation|1|||
148987685|NCT00558285|537432522|FG001|Overall Study|Protocol deviation|1|||
148987686|NCT00558285|537432523|FG002|Overall Study|Protocol deviation|0|||
148987687|NCT00558285|537432524|FG003|Overall Study|Protocol deviation|1|||
148987688|NCT00558285|537432525|FG004|Overall Study|Protocol deviation|0|||
148987689|NCT02345512|537432532|FG000|Overall Study|Adverse Event|1|||
148987690|NCT02345512|537432532|FG000|Overall Study|Withdrawal by Subject|1|||
148987691|NCT01660906|537432533|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
148987692|NCT03478891|537432536|FG000|Overall Study|Enrolled, but product never administered|0|||
149030559|NCT04888585|537589673|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
149030560|NCT04888585|537589663|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
148987693|NCT03478891|537432537|FG001|Overall Study|Enrolled, but product never administered|0|||
148987694|NCT03478891|537432538|FG002|Overall Study|Enrolled, but product never administered|1|||
148987695|NCT03478891|537432536|FG000|Overall Study|Moved from area|0|||
148987696|NCT03478891|537432537|FG001|Overall Study|Moved from area|0|||
148987697|NCT03478891|537432538|FG002|Overall Study|Moved from area|1|||
148987698|NCT03478891|537432536|FG000|Overall Study|Lost to Follow-up|1|||
148987699|NCT03478891|537432537|FG001|Overall Study|Lost to Follow-up|0|||
148987700|NCT03478891|537432538|FG002|Overall Study|Lost to Follow-up|1|||
148987701|NCT03823651|537432539|FG000|Overall Study|Death|5|||
148777793|NCT00955968|536660416|FG000|Overall Study|Site closed|55|||
148987702|NCT03823651|537432540|FG001|Overall Study|Death|0|||
148987703|NCT03823651|537432539|FG000|Overall Study|Physician Decision|1|||
148987704|NCT03823651|537432540|FG001|Overall Study|Physician Decision|0|||
148987705|NCT03823651|537432539|FG000|Overall Study|Caregiver to patient who died|0|||
148987706|NCT03823651|537432540|FG001|Overall Study|Caregiver to patient who died|5|||
148987707|NCT03823651|537432539|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
148987708|NCT03823651|537432540|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
148987709|NCT01850004|537432541|FG000|Overall Study|Poor/Non-compliance|1|||
148987710|NCT01850004|537432541|FG000|Overall Study|Participant Withdrew Consent|9|||
148987711|NCT01850004|537432541|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
148987712|NCT01850004|537432541|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
148987713|NCT01850004|537432541|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
148987714|NCT01850004|537432541|FG000|Overall Study|Other Reasons|2|||
148987715|NCT01850004|537432541|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
148987716|NCT01850004|537432541|FG000|Overall Study|Maximum Clinical Benefit|4|||
148987717|NCT04827576|537434294|FG000|Overall Study|Death|5|||
148987718|NCT04827576|537434295|FG001|Overall Study|Death|17|||
148987719|NCT04827576|537434296|FG002|Overall Study|Death|17|||
148987720|NCT04827576|537434297|FG003|Overall Study|Death|32|||
148987721|NCT04827576|537434294|FG000|Overall Study|Study Terminated by Sponsor|2|||
148987722|NCT04827576|537434295|FG001|Overall Study|Study Terminated by Sponsor|9|||
148987723|NCT04827576|537434296|FG002|Overall Study|Study Terminated by Sponsor|7|||
148987724|NCT04827576|537434297|FG003|Overall Study|Study Terminated by Sponsor|5|||
148987725|NCT04827576|537434294|FG000|Overall Study|Investigator's Discretion|1|||
148987726|NCT04827576|537434295|FG001|Overall Study|Investigator's Discretion|0|||
148987727|NCT04827576|537434296|FG002|Overall Study|Investigator's Discretion|2|||
148987728|NCT04827576|537434297|FG003|Overall Study|Investigator's Discretion|5|||
148987729|NCT04827576|537434294|FG000|Overall Study|Withdrew Consent|0|||
148987730|NCT04827576|537434295|FG001|Overall Study|Withdrew Consent|3|||
148987731|NCT04827576|537434296|FG002|Overall Study|Withdrew Consent|0|||
148987732|NCT04827576|537434297|FG003|Overall Study|Withdrew Consent|0|||
148987733|NCT04827576|537434294|FG000|Overall Study|Lost to Follow-up|1|||
148987734|NCT04827576|537434295|FG001|Overall Study|Lost to Follow-up|0|||
148987735|NCT04827576|537434296|FG002|Overall Study|Lost to Follow-up|0|||
148987736|NCT04827576|537434297|FG003|Overall Study|Lost to Follow-up|0|||
148987737|NCT04745169|537434298|FG000|Overall Study|Kidney transplantation|1|||
148987738|NCT04745169|537434298|FG000|Overall Study|Participant health problems|3|||
148987739|NCT04745169|537434298|FG000|Overall Study|Physician Decision|2|||
148987740|NCT00724282|537434302|FG000|Overall Study|Withdrawal by Subject|3|||
148987741|NCT00724282|537434302|FG000|Overall Study|Physician Decision|1|||
148987742|NCT03586648|537434305|FG000|Period 1|Withdrawal by Subject|0|||
148987743|NCT03586648|537434306|FG001|Period 1|Withdrawal by Subject|1|||
148987744|NCT03586648|537434305|FG000|Period 1|Lost to Follow-up|1|||
148987745|NCT03586648|537434306|FG001|Period 1|Lost to Follow-up|1|||
148987746|NCT03586648|537434305|FG000|Period 1|Adverse Event|1|||
148987747|NCT03586648|537434306|FG001|Period 1|Adverse Event|0|||
148987748|NCT03586648|537434305|FG000|Period 1|Study related symptoms or complaints|2|||
148987749|NCT03586648|537434306|FG001|Period 1|Study related symptoms or complaints|1|||
148987750|NCT03586648|537434305|FG000|Period 1|Physician Decision|0|||
148987751|NCT03586648|537434306|FG001|Period 1|Physician Decision|1|||
148987752|NCT03586648|537434305|FG000|Period 2|Adverse Event|1|||
148987753|NCT03586648|537434306|FG001|Period 2|Adverse Event|0|||
148987754|NCT02367911|537434311|FG000|Overall Study|Withdrawal by Subject|3|||
148987755|NCT02367911|537434312|FG001|Overall Study|Withdrawal by Subject|2|||
148987756|NCT02367911|537434311|FG000|Overall Study|Lost to Follow-up|2|||
149030561|NCT04888585|537589664|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
149030562|NCT04888585|537589665|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
149030563|NCT04888585|537589666|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
148987757|NCT02367911|537434312|FG001|Overall Study|Lost to Follow-up|2|||
148987758|NCT00263666|537434313|FG000|Overall Study|Adverse Event|6|||
148987759|NCT00263666|537434314|FG001|Overall Study|Adverse Event|8|||
148987760|NCT00263666|537434313|FG000|Overall Study|Lost to Follow-up|1|||
148987761|NCT00263666|537434314|FG001|Overall Study|Lost to Follow-up|2|||
148987762|NCT00263666|537434313|FG000|Overall Study|Withdrawal by Subject|0|||
148987763|NCT00263666|537434314|FG001|Overall Study|Withdrawal by Subject|1|||
148987764|NCT00896168|537434315|FG000|Overall Study|Adverse Event|4|||
148987765|NCT00896168|537434316|FG001|Overall Study|Adverse Event|7|||
148987766|NCT00896168|537434315|FG000|Overall Study|Treatment failure|8|||
148987767|NCT00896168|537434316|FG001|Overall Study|Treatment failure|10|||
148777794|NCT00955968|536660417|FG001|Overall Study|Site closed|52|||
148987768|NCT00896168|537434315|FG000|Overall Study|Lost to Follow-up|1|||
148987769|NCT00896168|537434316|FG001|Overall Study|Lost to Follow-up|1|||
148987770|NCT00896168|537434315|FG000|Overall Study|Other|1|||
148987771|NCT00896168|537434316|FG001|Overall Study|Other|1|||
148987772|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
148987773|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
148987774|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
148987775|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
148987776|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
148987777|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
149030564|NCT04888585|537589667|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
148987778|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
148987779|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
148987780|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
148987781|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
148987782|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
148987783|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
148987784|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
148987785|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
148987786|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
148987787|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
148987788|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
148987789|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
148987790|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
148987791|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
148987792|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
148987793|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
148987794|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
148987795|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
148987796|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987797|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987798|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987799|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987800|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987801|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987802|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987803|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987804|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987805|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987806|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987807|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987808|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987809|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987810|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987811|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
148987812|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987813|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987814|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
148987815|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
148987816|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
148987817|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987818|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987819|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987820|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987821|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987822|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987823|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987824|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987825|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987826|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987827|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987828|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987829|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987830|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987831|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
148987832|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
148987833|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
148987834|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
148987835|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
148987836|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
148987837|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
148987838|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
148987839|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
148987840|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
148987841|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
148987842|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
148987843|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
148987844|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
148987845|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
148987846|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
148987847|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
148987848|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
148987849|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
148987850|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
148987851|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
148987852|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
148987853|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987854|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987855|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987856|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987857|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987858|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987859|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987860|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987861|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987862|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987863|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987864|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987865|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987866|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987867|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987868|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987869|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987870|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987871|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
148987872|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
148987873|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
148987874|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987875|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
148987876|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
148987877|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987878|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987879|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987880|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987881|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987882|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987883|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987884|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987885|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987886|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987887|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987888|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987889|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987890|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987891|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
148987892|NCT01490632|537434317|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987893|NCT01490632|537434318|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987894|NCT01490632|537434319|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987895|NCT01490632|537434320|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987896|NCT01490632|537434321|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
148987897|NCT01490632|537434322|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987898|NCT01490632|537434323|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987899|NCT01490632|537434324|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987900|NCT01490632|537434325|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987901|NCT01490632|537434326|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987902|NCT01490632|537434327|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987903|NCT01490632|537434328|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987904|NCT01490632|537434329|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987905|NCT01490632|537434330|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987906|NCT01490632|537434331|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987907|NCT01490632|537434332|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987908|NCT01490632|537434333|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
149030565|NCT04888585|537589668|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
149030566|NCT04888585|537589669|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
148987909|NCT01490632|537434334|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987910|NCT01490632|537434335|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987911|NCT01490632|537434336|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
148987912|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987913|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987914|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987915|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987916|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987917|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
148987918|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
148987919|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987920|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987921|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
148987922|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
148987923|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
148987924|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987925|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987926|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987927|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987928|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987929|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987930|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987931|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
148987932|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987933|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987934|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987935|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987936|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987937|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987938|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
148987939|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987940|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
148987941|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
148987942|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
148987943|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987944|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987945|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987946|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987947|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987948|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987949|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987950|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987951|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
148987952|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987953|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987954|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987955|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987956|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987957|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987958|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
148987959|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987960|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987961|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
148987962|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987963|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987964|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987965|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987966|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987967|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987968|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987969|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148855949|NCT04569136|536947914|FG000|Overall Study|Lost to Follow-up|2|||
148855950|NCT04569136|536947915|FG001|Overall Study|Lost to Follow-up|0|||
148855951|NCT04569136|536947916|FG002|Overall Study|Lost to Follow-up|1|||
148855952|NCT01466660|536947922|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
148855953|NCT01466660|536947923|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
148987970|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987971|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
148987972|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987973|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987974|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987975|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987976|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987977|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987978|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
148987979|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987980|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987981|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987982|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987983|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987984|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987985|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987986|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987987|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987988|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987989|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987990|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987991|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
148987992|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148987993|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148987994|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148987995|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148987996|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148987997|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
148987998|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148987999|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988000|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988001|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988002|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988003|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988004|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988005|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988006|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988007|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988008|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988009|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988010|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988011|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
148988012|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988013|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988014|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988015|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988016|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148855954|NCT01466660|536947922|FG000|Overall Study|Worsening of underlying cancer disease|5|||
148855955|NCT01466660|536947923|FG001|Overall Study|Worsening of underlying cancer disease|2|||
148855956|NCT01466660|536947922|FG000|Overall Study|Other adverse event|19|||
148855957|NCT01466660|536947923|FG001|Overall Study|Other adverse event|18|||
148988017|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988018|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
148988019|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988020|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
148988021|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988022|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
148988023|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
148988024|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988025|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988026|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988027|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988028|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988029|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988030|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148988031|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
148855958|NCT01466660|536947922|FG000|Overall Study|Protocol Violation|2|||
148855959|NCT01466660|536947923|FG001|Overall Study|Protocol Violation|1|||
148855960|NCT01466660|536947922|FG000|Overall Study|Refused continuation of trial medication|4|||
148855961|NCT01466660|536947923|FG001|Overall Study|Refused continuation of trial medication|3|||
148855962|NCT01466660|536947922|FG000|Overall Study|Other reason not defined above|10|||
148855963|NCT01466660|536947923|FG001|Overall Study|Other reason not defined above|8|||
149030567|NCT04888585|537589670|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
148855964|NCT03576066|536947924|FG000|Overall Study|Noncompliance with study drug|0|||
148855965|NCT03576066|536947925|FG001|Overall Study|Noncompliance with study drug|1|||
148855966|NCT00129701|536947926|FG000|Overall Study|Withdrawal by Subject|33|||
148855967|NCT02750345|536947927|FG000|Intervention 1|Adverse Event|0|||
148855968|NCT02750345|536947928|FG001|Intervention 1|Adverse Event|0|||
148855969|NCT02750345|536947929|FG002|Intervention 1|Adverse Event|0|||
148855970|NCT02750345|536947930|FG003|Intervention 1|Adverse Event|0|||
148855971|NCT02750345|536947931|FG004|Intervention 1|Adverse Event|1|||
148855972|NCT02750345|536947932|FG005|Intervention 1|Adverse Event|0|||
148855973|NCT00006164|536947933|FG000|Overall Study|Withdrew or lost to follow-up|70|||
148855974|NCT00006164|536947934|FG001|Overall Study|Withdrew or lost to follow-up|81|||
148855975|NCT00223808|536947935|FG000|Overall Study|<5 hrs therapy before discharge|3|||
148855976|NCT00223808|536947936|FG001|Overall Study|<5 hrs therapy before discharge|5|||
148855977|NCT00223808|536947937|FG002|Overall Study|<5 hrs therapy before discharge|5|||
148855978|NCT00365105|536947940|FG000|Overall Study|Protocol Violation|5|||
148855979|NCT00365105|536947941|FG001|Overall Study|Protocol Violation|8|||
148855980|NCT00191724|536947942|FG000|Overall Study|Adverse Event|0|||
148855981|NCT00191724|536947943|FG001|Overall Study|Adverse Event|0|||
148855982|NCT00191724|536947944|FG002|Overall Study|Adverse Event|1|||
148855983|NCT00191724|536947945|FG003|Overall Study|Adverse Event|0|||
148855984|NCT00191724|536947946|FG004|Overall Study|Adverse Event|0|||
148855985|NCT00191724|536947942|FG000|Overall Study|Lost to Follow-up|1|||
148855986|NCT00191724|536947943|FG001|Overall Study|Lost to Follow-up|1|||
148855987|NCT00191724|536947944|FG002|Overall Study|Lost to Follow-up|0|||
148855988|NCT00191724|536947945|FG003|Overall Study|Lost to Follow-up|2|||
148855989|NCT00191724|536947946|FG004|Overall Study|Lost to Follow-up|3|||
148855990|NCT00191724|536947942|FG000|Overall Study|Withdrawal by Subject|0|||
148855991|NCT00191724|536947943|FG001|Overall Study|Withdrawal by Subject|0|||
148855992|NCT00191724|536947944|FG002|Overall Study|Withdrawal by Subject|0|||
148855993|NCT00191724|536947945|FG003|Overall Study|Withdrawal by Subject|1|||
148855994|NCT00191724|536947946|FG004|Overall Study|Withdrawal by Subject|0|||
148855995|NCT00608023|536947947|FG000|Overall Study|Withdrawal by Subject|8|||
148855996|NCT00608023|536947948|FG001|Overall Study|Withdrawal by Subject|10|||
148855997|NCT00608023|536947949|FG002|Overall Study|Withdrawal by Subject|7|||
148855998|NCT00608023|536947947|FG000|Overall Study|Adverse Event|1|||
148855999|NCT00608023|536947948|FG001|Overall Study|Adverse Event|4|||
148856000|NCT00608023|536947949|FG002|Overall Study|Adverse Event|5|||
148856001|NCT00608023|536947947|FG000|Overall Study|Lost to Follow-up|2|||
148856002|NCT00608023|536947948|FG001|Overall Study|Lost to Follow-up|2|||
148856003|NCT00608023|536947949|FG002|Overall Study|Lost to Follow-up|1|||
148856004|NCT00608023|536947947|FG000|Overall Study|Protocol Violation|1|||
148856005|NCT00608023|536947948|FG001|Overall Study|Protocol Violation|3|||
148856006|NCT00608023|536947949|FG002|Overall Study|Protocol Violation|1|||
148856007|NCT00608023|536947947|FG000|Overall Study|Unknown reason|0|||
148856008|NCT00608023|536947948|FG001|Overall Study|Unknown reason|3|||
148856009|NCT00608023|536947949|FG002|Overall Study|Unknown reason|0|||
148856010|NCT06422364|536947950|FG000|Overall Study|Withdrawn due to study closure|0|||
148856011|NCT06422364|536947951|FG001|Overall Study|Withdrawn due to study closure|2|||
148856012|NCT03458910|536947953|FG000|Overall Study|Withdrawal by Subject|7|||
148856013|NCT03458910|536947954|FG001|Overall Study|Withdrawal by Subject|8|||
148856014|NCT03458910|536947955|FG002|Overall Study|Withdrawal by Subject|6|||
148856015|NCT03458910|536947956|FG003|Overall Study|Withdrawal by Subject|4|||
148856016|NCT03458910|536947953|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
148856017|NCT03458910|536947954|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
148856018|NCT03458910|536947955|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
148856019|NCT03458910|536947956|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
148856020|NCT06004895|536947957|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
148856021|NCT06004895|536947957|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
148856022|NCT00152477|536947959|FG000|Chemotherapy Period|Adverse Event|9|||
148856023|NCT00152477|536947960|FG001|Chemotherapy Period|Adverse Event|4|||
148856024|NCT00152477|536947961|FG002|Chemotherapy Period|Adverse Event|5|||
149030568|NCT04888585|537589671|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
148856025|NCT00152477|536947959|FG000|Chemotherapy Period|Death|1|||
148856026|NCT00152477|536947960|FG001|Chemotherapy Period|Death|3|||
148856027|NCT00152477|536947961|FG002|Chemotherapy Period|Death|3|||
148856028|NCT00152477|536947959|FG000|Chemotherapy Period|Lack of Efficacy|4|||
148856029|NCT00152477|536947960|FG001|Chemotherapy Period|Lack of Efficacy|5|||
148856030|NCT00152477|536947961|FG002|Chemotherapy Period|Lack of Efficacy|6|||
148856031|NCT00152477|536947959|FG000|Chemotherapy Period|Lost to Follow-up|1|||
148856032|NCT00152477|536947960|FG001|Chemotherapy Period|Lost to Follow-up|0|||
148856033|NCT00152477|536947961|FG002|Chemotherapy Period|Lost to Follow-up|1|||
148856034|NCT00152477|536947959|FG000|Chemotherapy Period|Protocol Violation|1|||
148856035|NCT00152477|536947960|FG001|Chemotherapy Period|Protocol Violation|1|||
148856036|NCT00152477|536947961|FG002|Chemotherapy Period|Protocol Violation|0|||
148856037|NCT00152477|536947959|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
148856038|NCT00152477|536947960|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
148856039|NCT00152477|536947961|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
148856040|NCT00152477|536947959|FG000|Chemotherapy Period|Progression of Disease|6|||
148856041|NCT00152477|536947960|FG001|Chemotherapy Period|Progression of Disease|8|||
148856042|NCT00152477|536947961|FG002|Chemotherapy Period|Progression of Disease|4|||
148856043|NCT00152477|536947959|FG000|Chemotherapy Period|Investigator decision|0|||
148856044|NCT00152477|536947960|FG001|Chemotherapy Period|Investigator decision|0|||
148856045|NCT00152477|536947961|FG002|Chemotherapy Period|Investigator decision|1|||
148856046|NCT00152477|536947959|FG000|Chemotherapy Period|Patient condition worsened|1|||
148856047|NCT00152477|536947960|FG001|Chemotherapy Period|Patient condition worsened|0|||
148856048|NCT00152477|536947961|FG002|Chemotherapy Period|Patient condition worsened|0|||
148856049|NCT00152477|536947959|FG000|Monotherapy Period|Adverse Event|1|||
148856050|NCT00152477|536947960|FG001|Monotherapy Period|Adverse Event|0|||
148856051|NCT00152477|536947961|FG002|Monotherapy Period|Adverse Event|5|||
148856052|NCT00152477|536947959|FG000|Monotherapy Period|Death|2|||
148856053|NCT00152477|536947960|FG001|Monotherapy Period|Death|0|||
148856054|NCT00152477|536947961|FG002|Monotherapy Period|Death|1|||
148856055|NCT00152477|536947959|FG000|Monotherapy Period|Lack of Efficacy|7|||
148856056|NCT00152477|536947960|FG001|Monotherapy Period|Lack of Efficacy|16|||
148856057|NCT00152477|536947961|FG002|Monotherapy Period|Lack of Efficacy|10|||
148856058|NCT00152477|536947959|FG000|Monotherapy Period|Protocol Violation|0|||
148856059|NCT00152477|536947960|FG001|Monotherapy Period|Protocol Violation|1|||
148856060|NCT00152477|536947961|FG002|Monotherapy Period|Protocol Violation|0|||
148856061|NCT00152477|536947959|FG000|Monotherapy Period|Withdrawal by Subject|0|||
148856062|NCT00152477|536947960|FG001|Monotherapy Period|Withdrawal by Subject|0|||
148988032|NCT01490632|537434317|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148777795|NCT05020899|536660419|FG000|8 Week Follow-up|Lost to Follow-up|3|||
148777796|NCT05020899|536660420|FG001|8 Week Follow-up|Lost to Follow-up|6|||
148777797|NCT05020899|536660419|FG000|12 Week Follow-up|Lost to Follow-up|1|||
148777798|NCT05020899|536660420|FG001|12 Week Follow-up|Lost to Follow-up|0|||
148777799|NCT05020899|536660419|FG000|12 Week Follow-up|Death|0|||
148777800|NCT05020899|536660420|FG001|12 Week Follow-up|Death|1|||
148777801|NCT01068626|536660423|FG000|Overall Study|Adverse Event|3|||
148777802|NCT01068626|536660424|FG001|Overall Study|Adverse Event|0|||
148777803|NCT01068626|536660423|FG000|Overall Study|Withdrawal by Subject|0|||
148777804|NCT01068626|536660424|FG001|Overall Study|Withdrawal by Subject|2|||
148777805|NCT01785849|536660425|FG000|Overall Study|Death|7|||
148777806|NCT01785849|536660426|FG001|Overall Study|Death|9|||
148777807|NCT01785849|536660425|FG000|Overall Study|Protocol Specified Criteria|29|||
148777808|NCT01785849|536660426|FG001|Overall Study|Protocol Specified Criteria|1|||
148777809|NCT01785849|536660425|FG000|Overall Study|Withdrawal by Subject|15|||
148777810|NCT01785849|536660426|FG001|Overall Study|Withdrawal by Subject|12|||
148777811|NCT01785849|536660425|FG000|Overall Study|Sponsor Decision|0|||
148777812|NCT01785849|536660426|FG001|Overall Study|Sponsor Decision|1|||
148777813|NCT01785849|536660425|FG000|Overall Study|Lost to Follow-up|10|||
148777814|NCT01785849|536660426|FG001|Overall Study|Lost to Follow-up|11|||
148777815|NCT01940900|536660427|FG000|Overall Study|Physician Decision|4|||
148777816|NCT01940900|536660428|FG001|Overall Study|Physician Decision|0|||
148777817|NCT01940900|536660427|FG000|Overall Study|Adverse Event|10|||
148777818|NCT01940900|536660428|FG001|Overall Study|Adverse Event|15|||
148777819|NCT01940900|536660427|FG000|Overall Study|Withdrawal by Subject|11|||
148777820|NCT01940900|536660428|FG001|Overall Study|Withdrawal by Subject|15|||
148777821|NCT01940900|536660427|FG000|Overall Study|Lost to Follow-up|1|||
148777822|NCT01940900|536660428|FG001|Overall Study|Lost to Follow-up|0|||
148777823|NCT01940900|536660427|FG000|Overall Study|Sponsor Decision|1|||
148777824|NCT01940900|536660428|FG001|Overall Study|Sponsor Decision|0|||
148777825|NCT01940900|536660427|FG000|Overall Study|subject non-compliance|1|||
148777826|NCT01940900|536660428|FG001|Overall Study|subject non-compliance|1|||
148777827|NCT01940900|536660427|FG000|Overall Study|other|1|||
148777828|NCT01940900|536660428|FG001|Overall Study|other|0|||
148777829|NCT00742508|536660431|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
148777830|NCT00742508|536660432|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
148777831|NCT00742508|536660431|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
148777832|NCT00742508|536660432|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
148777833|NCT00742508|536660431|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
148856063|NCT00152477|536947961|FG002|Monotherapy Period|Withdrawal by Subject|4|||
148856064|NCT00152477|536947959|FG000|Monotherapy Period|Progression of Disease|5|||
148856065|NCT00152477|536947960|FG001|Monotherapy Period|Progression of Disease|11|||
148856066|NCT00152477|536947961|FG002|Monotherapy Period|Progression of Disease|12|||
148856067|NCT00152477|536947959|FG000|Monotherapy Period|Patient decision|0|||
148988033|NCT01490632|537434318|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988034|NCT01490632|537434319|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988035|NCT01490632|537434320|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988036|NCT01490632|537434321|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988037|NCT01490632|537434322|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
148988038|NCT01490632|537434323|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
148988039|NCT01490632|537434324|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
148988040|NCT01490632|537434325|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
148988041|NCT01490632|537434326|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
148988042|NCT01490632|537434327|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
148988043|NCT01490632|537434328|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
148988044|NCT01490632|537434329|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988045|NCT01490632|537434330|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988046|NCT01490632|537434331|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988047|NCT01490632|537434332|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988048|NCT01490632|537434333|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988049|NCT01490632|537434334|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988050|NCT01490632|537434335|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988051|NCT01490632|537434336|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
148988052|NCT01490632|537434317|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988053|NCT01490632|537434318|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988054|NCT01490632|537434319|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988055|NCT01490632|537434320|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988056|NCT01490632|537434321|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988057|NCT01490632|537434322|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988058|NCT01490632|537434323|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988059|NCT01490632|537434324|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988060|NCT01490632|537434325|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988061|NCT01490632|537434326|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988062|NCT01490632|537434327|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988063|NCT01490632|537434328|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988064|NCT01490632|537434329|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988065|NCT01490632|537434330|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988066|NCT01490632|537434331|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
148988067|NCT01490632|537434332|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
148988068|NCT01490632|537434333|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988069|NCT01490632|537434334|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988070|NCT01490632|537434335|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988071|NCT01490632|537434336|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
148988072|NCT01490632|537434317|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988073|NCT01490632|537434318|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988074|NCT01490632|537434319|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988075|NCT01490632|537434320|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988076|NCT01490632|537434321|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988077|NCT01490632|537434322|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148856068|NCT00152477|536947960|FG001|Monotherapy Period|Patient decision|1|||
148856069|NCT00152477|536947961|FG002|Monotherapy Period|Patient decision|1|||
148856070|NCT00152477|536947959|FG000|Monotherapy Period|Study personel decision|0|||
148856071|NCT00152477|536947960|FG001|Monotherapy Period|Study personel decision|0|||
148856072|NCT00152477|536947961|FG002|Monotherapy Period|Study personel decision|1|||
148856073|NCT00425698|536947962|FG000|Overall Study|Adverse Event|3|||
148856074|NCT00425698|536947963|FG001|Overall Study|Adverse Event|1|||
148856075|NCT00425698|536947962|FG000|Overall Study|Withdrawal by Subject|0|||
148856076|NCT00425698|536947963|FG001|Overall Study|Withdrawal by Subject|1|||
148856077|NCT01328535|536947964|FG000|Overall Study|Ineligible|1|||
148856078|NCT03655054|536947967|FG000|Overall Study|Lost to Follow-up|1|||
148856079|NCT01054560|536947970|FG000|Overall Study|Death|10|||
148988078|NCT01490632|537434323|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988079|NCT01490632|537434324|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988080|NCT01490632|537434325|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988081|NCT01490632|537434326|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
149030569|NCT04888585|537589672|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
148856080|NCT01054560|536947971|FG001|Overall Study|Death|21|||
148856081|NCT01054560|536947970|FG000|Overall Study|Lost to Follow-up|2|||
148856082|NCT01054560|536947971|FG001|Overall Study|Lost to Follow-up|5|||
148856083|NCT01054560|536947970|FG000|Overall Study|Withdrawal by Subject|0|||
148856084|NCT01054560|536947971|FG001|Overall Study|Withdrawal by Subject|2|||
148856085|NCT01054560|536947970|FG000|Overall Study|Physician Decision|1|||
148856086|NCT01054560|536947971|FG001|Overall Study|Physician Decision|0|||
148856087|NCT03768089|536947976|FG000|Part A|Lost to Follow-up|0|||
148856088|NCT03768089|536947977|FG001|Part A|Lost to Follow-up|0|||
148856089|NCT03768089|536947978|FG002|Part A|Lost to Follow-up|0|||
148856090|NCT03768089|536947979|FG003|Part A|Lost to Follow-up|0|||
148856091|NCT03768089|536947980|FG004|Part A|Lost to Follow-up|1|||
148856092|NCT03768089|536947981|FG005|Part A|Lost to Follow-up|0|||
148856093|NCT03768089|536947982|FG006|Part A|Lost to Follow-up|0|||
148856094|NCT03768089|536947983|FG007|Part A|Lost to Follow-up|0|||
148856095|NCT03768089|536947984|FG008|Part A|Lost to Follow-up|0|||
148856096|NCT03768089|536947985|FG009|Part A|Lost to Follow-up|0|||
148856097|NCT03768089|536947986|FG010|Part A|Lost to Follow-up|0|||
148856098|NCT03768089|536947987|FG011|Part A|Lost to Follow-up|0|||
148856099|NCT03768089|536947988|FG012|Part A|Lost to Follow-up|0|||
148856100|NCT03768089|536947989|FG013|Part A|Lost to Follow-up|0|||
148856101|NCT03768089|536947990|FG014|Part A|Lost to Follow-up|0|||
148856102|NCT03768089|536947991|FG015|Part A|Lost to Follow-up|0|||
148988082|NCT01490632|537434327|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988083|NCT01490632|537434328|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988084|NCT01490632|537434329|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988085|NCT01490632|537434330|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
148988086|NCT01490632|537434331|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988087|NCT01490632|537434332|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988088|NCT01490632|537434333|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988089|NCT01490632|537434334|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988090|NCT01490632|537434335|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988091|NCT01490632|537434336|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
148988092|NCT01490632|537434317|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988093|NCT01490632|537434318|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988094|NCT01490632|537434319|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988095|NCT01490632|537434320|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988096|NCT01490632|537434321|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988097|NCT01490632|537434322|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988098|NCT01490632|537434323|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988099|NCT01490632|537434324|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988100|NCT01490632|537434325|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988101|NCT01490632|537434326|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988102|NCT01490632|537434327|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988103|NCT01490632|537434328|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988104|NCT01490632|537434329|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988105|NCT01490632|537434330|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988106|NCT01490632|537434331|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
148988107|NCT01490632|537434332|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
148988108|NCT01490632|537434333|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988109|NCT01490632|537434334|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988110|NCT01490632|537434335|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988111|NCT01490632|537434336|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
148988112|NCT01490632|537434317|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988113|NCT01490632|537434318|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988114|NCT01490632|537434319|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988115|NCT01490632|537434320|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988116|NCT01490632|537434321|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988117|NCT01490632|537434322|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988118|NCT01490632|537434323|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988119|NCT01490632|537434324|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
149005492|NCT03217747|537497897|FG005|Overall Study|Removal of sole target lesion|0|||
149005493|NCT03217747|537497898|FG006|Overall Study|Removal of sole target lesion|0|||
148856103|NCT03768089|536947992|FG016|Part A|Lost to Follow-up|0|||
148856104|NCT03768089|536947993|FG017|Part A|Lost to Follow-up|0|||
148856105|NCT03768089|536947976|FG000|Part C|Randomized, Never Dosed|0|||
148856106|NCT03768089|536947977|FG001|Part C|Randomized, Never Dosed|0|||
148856107|NCT03768089|536947978|FG002|Part C|Randomized, Never Dosed|0|||
148856108|NCT03768089|536947979|FG003|Part C|Randomized, Never Dosed|0|||
148856109|NCT03768089|536947980|FG004|Part C|Randomized, Never Dosed|0|||
148856110|NCT03768089|536947981|FG005|Part C|Randomized, Never Dosed|0|||
148856111|NCT03768089|536947982|FG006|Part C|Randomized, Never Dosed|0|||
148856112|NCT03768089|536947983|FG007|Part C|Randomized, Never Dosed|0|||
148856113|NCT03768089|536947984|FG008|Part C|Randomized, Never Dosed|0|||
148988120|NCT01490632|537434325|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988121|NCT01490632|537434326|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988122|NCT01490632|537434327|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988123|NCT01490632|537434328|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988124|NCT01490632|537434329|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
148988125|NCT01490632|537434330|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
148988126|NCT01490632|537434331|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
148988127|NCT01490632|537434332|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
148988128|NCT01490632|537434333|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988129|NCT01490632|537434334|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988130|NCT01490632|537434335|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988131|NCT01490632|537434336|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
148988132|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
148988133|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
148988134|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
148988135|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
148988136|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
148988137|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
148856114|NCT03768089|536947985|FG009|Part C|Randomized, Never Dosed|0|||
148856115|NCT03768089|536947986|FG010|Part C|Randomized, Never Dosed|0|||
148856116|NCT03768089|536947987|FG011|Part C|Randomized, Never Dosed|0|||
148856117|NCT03768089|536947988|FG012|Part C|Randomized, Never Dosed|0|||
148856118|NCT03768089|536947989|FG013|Part C|Randomized, Never Dosed|0|||
148856119|NCT03768089|536947990|FG014|Part C|Randomized, Never Dosed|1|||
148856120|NCT03768089|536947991|FG015|Part C|Randomized, Never Dosed|0|||
148856121|NCT03768089|536947992|FG016|Part C|Randomized, Never Dosed|0|||
148856122|NCT03768089|536947993|FG017|Part C|Randomized, Never Dosed|0|||
148856123|NCT02135029|536947994|FG000|Overall Study|Adverse Event|2|||
148856124|NCT02135029|536947995|FG001|Overall Study|Adverse Event|2|||
148856125|NCT02135029|536947996|FG002|Overall Study|Adverse Event|2|||
148856126|NCT02135029|536947994|FG000|Overall Study|Lost to Follow-up|0|||
148856127|NCT02135029|536947995|FG001|Overall Study|Lost to Follow-up|1|||
148856128|NCT02135029|536947996|FG002|Overall Study|Lost to Follow-up|0|||
148856129|NCT02135029|536947994|FG000|Overall Study|Withdrawal by Subject|2|||
148856130|NCT02135029|536947995|FG001|Overall Study|Withdrawal by Subject|0|||
148856131|NCT02135029|536947996|FG002|Overall Study|Withdrawal by Subject|1|||
148856132|NCT02135029|536947994|FG000|Overall Study|Other|0|||
148856133|NCT02135029|536947995|FG001|Overall Study|Other|1|||
148856134|NCT02135029|536947996|FG002|Overall Study|Other|0|||
148856135|NCT02135029|536947994|FG000|Overall Study|Death|0|||
148856136|NCT02135029|536947995|FG001|Overall Study|Death|1|||
148856137|NCT02135029|536947996|FG002|Overall Study|Death|0|||
148856138|NCT00712725|536947997|FG000|Overall Study|Adverse Event|1|||
148856139|NCT00712725|536947998|FG001|Overall Study|Adverse Event|0|||
148856140|NCT00712725|536947999|FG002|Overall Study|Adverse Event|0|||
148856141|NCT00712725|536948000|FG003|Overall Study|Adverse Event|1|||
148856142|NCT00712725|536948001|FG004|Overall Study|Adverse Event|0|||
148856143|NCT00712725|536948002|FG005|Overall Study|Adverse Event|0|||
148856144|NCT00712725|536948003|FG006|Overall Study|Adverse Event|0|||
148856145|NCT00712725|536948004|FG007|Overall Study|Adverse Event|0|||
148856146|NCT00712725|536947997|FG000|Overall Study|Lost to Follow-up|3|||
148856147|NCT00712725|536947998|FG001|Overall Study|Lost to Follow-up|2|||
148856148|NCT00712725|536947999|FG002|Overall Study|Lost to Follow-up|1|||
148856149|NCT00712725|536948000|FG003|Overall Study|Lost to Follow-up|1|||
148856150|NCT00712725|536948001|FG004|Overall Study|Lost to Follow-up|2|||
148856151|NCT00712725|536948002|FG005|Overall Study|Lost to Follow-up|2|||
148856152|NCT00712725|536948003|FG006|Overall Study|Lost to Follow-up|3|||
148856153|NCT00712725|536948004|FG007|Overall Study|Lost to Follow-up|1|||
148856154|NCT00712725|536947997|FG000|Overall Study|Physician Decision|2|||
148856155|NCT00712725|536947998|FG001|Overall Study|Physician Decision|0|||
148856156|NCT00712725|536947999|FG002|Overall Study|Physician Decision|0|||
148856157|NCT00712725|536948000|FG003|Overall Study|Physician Decision|0|||
149030570|NCT04888585|537589673|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
148856158|NCT00712725|536948001|FG004|Overall Study|Physician Decision|1|||
148856159|NCT00712725|536948002|FG005|Overall Study|Physician Decision|0|||
148856160|NCT00712725|536948003|FG006|Overall Study|Physician Decision|2|||
148856161|NCT00712725|536948004|FG007|Overall Study|Physician Decision|0|||
148856162|NCT00712725|536947997|FG000|Overall Study|Pregnancy|0|||
148856163|NCT00712725|536947998|FG001|Overall Study|Pregnancy|1|||
148856164|NCT00712725|536947999|FG002|Overall Study|Pregnancy|0|||
148856165|NCT00712725|536948000|FG003|Overall Study|Pregnancy|0|||
148856166|NCT00712725|536948001|FG004|Overall Study|Pregnancy|1|||
148856167|NCT00712725|536948002|FG005|Overall Study|Pregnancy|0|||
148856168|NCT00712725|536948003|FG006|Overall Study|Pregnancy|2|||
148856169|NCT00712725|536948004|FG007|Overall Study|Pregnancy|0|||
148988138|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
148988139|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
148988140|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
148988141|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
148988142|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
148988143|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
148988144|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
148988145|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
148988146|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
148988147|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
148988148|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
148988149|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
148988150|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
148988151|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
148988152|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Death|0|||
148988153|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Death|0|||
148988154|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Death|0|||
148988155|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Death|0|||
148988156|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Death|0|||
148988157|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Death|0|||
148988158|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Death|0|||
148988159|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Death|0|||
148988160|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Death|0|||
148988161|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Death|0|||
148988162|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Death|0|||
148988163|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Death|0|||
148988164|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Death|0|||
148988165|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Death|0|||
148988166|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Death|0|||
148988167|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Death|0|||
148988168|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Death|0|||
148988169|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Death|0|||
148988170|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Death|1|||
148988171|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Death|0|||
148988172|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988173|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988174|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988175|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988176|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988177|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988178|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988179|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988180|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988181|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988182|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988183|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988184|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988185|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988186|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988187|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988188|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
148988189|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
148988190|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
148988191|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
148988192|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988193|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988194|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988195|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988196|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988197|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988198|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988199|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988200|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988201|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148856170|NCT00712725|536947997|FG000|Overall Study|Protocol Violation|2|||
148988202|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988203|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988204|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988205|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988206|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988207|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988208|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988209|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988210|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
148988211|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
148988212|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
148988213|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
148988214|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
148988215|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
148988216|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
148988217|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
148988218|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
148988219|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
148988220|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
148988221|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
148988222|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
148988223|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
148988224|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
148988225|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
148988226|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
148988227|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
148988228|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
148988229|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
148988230|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
148988231|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
148988232|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
148988233|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
148988234|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
148988235|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
148988236|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
148988237|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
148988238|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
148988239|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
148988240|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
148988241|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
148988242|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
148988243|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
148988244|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
148988245|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
148988246|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
148988247|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
148988248|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
148988249|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
148988250|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
148988251|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
148988252|NCT01490632|537434317|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988253|NCT01490632|537434318|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988254|NCT01490632|537434319|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988255|NCT01490632|537434320|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988256|NCT01490632|537434321|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988257|NCT01490632|537434322|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988258|NCT01490632|537434323|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988259|NCT01490632|537434324|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988260|NCT01490632|537434325|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988261|NCT01490632|537434326|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988262|NCT01490632|537434327|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988263|NCT01490632|537434328|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988264|NCT01490632|537434329|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988265|NCT01490632|537434330|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988266|NCT01490632|537434331|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988267|NCT01490632|537434332|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988268|NCT01490632|537434333|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
148988269|NCT01490632|537434334|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
148988270|NCT01490632|537434335|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
148988271|NCT01490632|537434336|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
148988272|NCT05732454|537434337|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
148988273|NCT05732454|537434338|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
148988274|NCT05732454|537434337|FG000|Part 1: DB Period|Adverse Event|1|||
148988275|NCT05732454|537434338|FG001|Part 1: DB Period|Adverse Event|0|||
148988276|NCT05732454|537434337|FG000|Part 1: DB Period|Lost to Follow-up|1|||
148988277|NCT05732454|537434338|FG001|Part 1: DB Period|Lost to Follow-up|0|||
148988278|NCT05732454|537434337|FG000|Part 1: DB Period|Protocol Violation|0|||
148988279|NCT05732454|537434338|FG001|Part 1: DB Period|Protocol Violation|1|||
148777834|NCT00742508|536660432|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
148988280|NCT05732454|537434337|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
148988281|NCT05732454|537434338|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
148988282|NCT05732454|537434337|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
148988283|NCT05732454|537434338|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
148988284|NCT05732454|537434337|FG000|Part 1: OLE Period|Adverse Event|0|||
148856171|NCT00712725|536947998|FG001|Overall Study|Protocol Violation|0|||
148856172|NCT00712725|536947999|FG002|Overall Study|Protocol Violation|1|||
148856173|NCT00712725|536948000|FG003|Overall Study|Protocol Violation|3|||
148856174|NCT00712725|536948001|FG004|Overall Study|Protocol Violation|2|||
148856175|NCT00712725|536948002|FG005|Overall Study|Protocol Violation|0|||
148856176|NCT00712725|536948003|FG006|Overall Study|Protocol Violation|1|||
148856177|NCT00712725|536948004|FG007|Overall Study|Protocol Violation|1|||
148856178|NCT00712725|536947997|FG000|Overall Study|Withdrawal by Subject|2|||
148856179|NCT00712725|536947998|FG001|Overall Study|Withdrawal by Subject|1|||
148856180|NCT00712725|536947999|FG002|Overall Study|Withdrawal by Subject|1|||
148856181|NCT00712725|536948000|FG003|Overall Study|Withdrawal by Subject|2|||
148856182|NCT00712725|536948001|FG004|Overall Study|Withdrawal by Subject|1|||
148856183|NCT00712725|536948002|FG005|Overall Study|Withdrawal by Subject|1|||
148856184|NCT00712725|536948003|FG006|Overall Study|Withdrawal by Subject|1|||
148856185|NCT00712725|536948004|FG007|Overall Study|Withdrawal by Subject|2|||
148856186|NCT00712725|536947997|FG000|Overall Study|Lack of Qualifying Event|16|||
148856187|NCT00712725|536947998|FG001|Overall Study|Lack of Qualifying Event|2|||
148856188|NCT00712725|536947999|FG002|Overall Study|Lack of Qualifying Event|6|||
148856189|NCT00712725|536948000|FG003|Overall Study|Lack of Qualifying Event|8|||
148856190|NCT00712725|536948001|FG004|Overall Study|Lack of Qualifying Event|11|||
148856191|NCT00712725|536948002|FG005|Overall Study|Lack of Qualifying Event|13|||
148856192|NCT00712725|536948003|FG006|Overall Study|Lack of Qualifying Event|11|||
148856193|NCT00712725|536948004|FG007|Overall Study|Lack of Qualifying Event|6|||
148856194|NCT00712725|536947997|FG000|Overall Study|Protocol Specified Criteria|3|||
148856195|NCT00712725|536947998|FG001|Overall Study|Protocol Specified Criteria|0|||
148856196|NCT00712725|536947999|FG002|Overall Study|Protocol Specified Criteria|1|||
148856197|NCT00712725|536948000|FG003|Overall Study|Protocol Specified Criteria|2|||
148856198|NCT00712725|536948001|FG004|Overall Study|Protocol Specified Criteria|1|||
148856199|NCT00712725|536948002|FG005|Overall Study|Protocol Specified Criteria|0|||
148856200|NCT00712725|536948003|FG006|Overall Study|Protocol Specified Criteria|2|||
148856201|NCT00712725|536948004|FG007|Overall Study|Protocol Specified Criteria|1|||
148856202|NCT03466099|536948005|FG000|Overall Study|Adverse Event|1|||
148856203|NCT03466099|536948006|FG001|Overall Study|Adverse Event|1|||
148856204|NCT03466099|536948007|FG002|Overall Study|Adverse Event|1|||
148856205|NCT03466099|536948005|FG000|Overall Study|Withdrawal by Subject|2|||
148856206|NCT03466099|536948006|FG001|Overall Study|Withdrawal by Subject|3|||
148856207|NCT03466099|536948007|FG002|Overall Study|Withdrawal by Subject|1|||
148856208|NCT03466099|536948005|FG000|Overall Study|Use of rescue medication|8|||
148856209|NCT03466099|536948006|FG001|Overall Study|Use of rescue medication|9|||
148856210|NCT03466099|536948007|FG002|Overall Study|Use of rescue medication|13|||
148856211|NCT03466099|536948005|FG000|Overall Study|Rescued without meeting criteria|4|||
148856212|NCT03466099|536948006|FG001|Overall Study|Rescued without meeting criteria|1|||
148856213|NCT03466099|536948007|FG002|Overall Study|Rescued without meeting criteria|1|||
148856214|NCT03466099|536948005|FG000|Overall Study|Subject compliance|2|||
148856215|NCT03466099|536948006|FG001|Overall Study|Subject compliance|0|||
148856216|NCT03466099|536948007|FG002|Overall Study|Subject compliance|0|||
148856217|NCT03466099|536948005|FG000|Overall Study|Worsening disease|0|||
148856218|NCT03466099|536948006|FG001|Overall Study|Worsening disease|0|||
148856219|NCT03466099|536948007|FG002|Overall Study|Worsening disease|1|||
148856220|NCT03525600|536948012|FG000|Overall Study|Adverse Event|9|||
148856221|NCT03525600|536948013|FG001|Overall Study|Adverse Event|6|||
148856222|NCT03525600|536948014|FG002|Overall Study|Adverse Event|5|||
148856223|NCT03525600|536948015|FG003|Overall Study|Adverse Event|3|||
148856224|NCT03525600|536948012|FG000|Overall Study|Lost to Follow-up|2|||
148856225|NCT03525600|536948013|FG001|Overall Study|Lost to Follow-up|4|||
148988285|NCT05732454|537434338|FG001|Part 1: OLE Period|Adverse Event|1|||
148988286|NCT05732454|537434337|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
148988287|NCT05732454|537434338|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
148988288|NCT01153633|537434339|FG000|Overall Study|Protocol Violation|1|||
148988289|NCT01153633|537434340|FG001|Overall Study|Protocol Violation|1|||
148856226|NCT03525600|536948014|FG002|Overall Study|Lost to Follow-up|4|||
148856227|NCT03525600|536948015|FG003|Overall Study|Lost to Follow-up|0|||
148856228|NCT03525600|536948012|FG000|Overall Study|Physician Decision|1|||
148856229|NCT03525600|536948013|FG001|Overall Study|Physician Decision|0|||
148856230|NCT03525600|536948014|FG002|Overall Study|Physician Decision|2|||
148856231|NCT03525600|536948015|FG003|Overall Study|Physician Decision|0|||
148856232|NCT03525600|536948012|FG000|Overall Study|Consent withdrawal|36|||
148856233|NCT03525600|536948013|FG001|Overall Study|Consent withdrawal|20|||
148856234|NCT03525600|536948014|FG002|Overall Study|Consent withdrawal|6|||
148856235|NCT03525600|536948015|FG003|Overall Study|Consent withdrawal|13|||
148988290|NCT01153633|537434339|FG000|Overall Study|Therapeutic failure|3|||
148856236|NCT03525600|536948012|FG000|Overall Study|Death|7|||
148856237|NCT03525600|536948013|FG001|Overall Study|Death|6|||
148988291|NCT01153633|537434340|FG001|Overall Study|Therapeutic failure|3|||
148988292|NCT00384085|537434341|FG000|Overall Study|Adverse Event|5|||
148988293|NCT00384085|537434342|FG001|Overall Study|Adverse Event|5|||
148988294|NCT00384085|537434343|FG002|Overall Study|Adverse Event|4|||
148988295|NCT00384085|537434341|FG000|Overall Study|Lack of Efficacy|0|||
148988296|NCT00384085|537434342|FG001|Overall Study|Lack of Efficacy|3|||
148988297|NCT00384085|537434343|FG002|Overall Study|Lack of Efficacy|2|||
148988298|NCT00384085|537434341|FG000|Overall Study|No longer Requires Study Treatment|1|||
148988299|NCT00384085|537434342|FG001|Overall Study|No longer Requires Study Treatment|0|||
148988300|NCT00384085|537434343|FG002|Overall Study|No longer Requires Study Treatment|1|||
148988301|NCT00384085|537434341|FG000|Overall Study|Protocol Violation|2|||
148988302|NCT00384085|537434342|FG001|Overall Study|Protocol Violation|2|||
148988303|NCT00384085|537434343|FG002|Overall Study|Protocol Violation|2|||
148988304|NCT00384085|537434341|FG000|Overall Study|Lost to Follow-up|9|||
148988305|NCT00384085|537434342|FG001|Overall Study|Lost to Follow-up|9|||
148988306|NCT00384085|537434343|FG002|Overall Study|Lost to Follow-up|10|||
148988307|NCT00384085|537434341|FG000|Overall Study|Progressive Disease|0|||
148988308|NCT00384085|537434342|FG001|Overall Study|Progressive Disease|1|||
148988309|NCT00384085|537434343|FG002|Overall Study|Progressive Disease|0|||
148988310|NCT00384085|537434341|FG000|Overall Study|Withdrawal by Subject|14|||
148988311|NCT00384085|537434342|FG001|Overall Study|Withdrawal by Subject|19|||
148988312|NCT00384085|537434343|FG002|Overall Study|Withdrawal by Subject|29|||
148988313|NCT00384085|537434341|FG000|Overall Study|Patient non-compliant|4|||
148988314|NCT00384085|537434342|FG001|Overall Study|Patient non-compliant|4|||
148988315|NCT00384085|537434343|FG002|Overall Study|Patient non-compliant|5|||
148988316|NCT00384085|537434341|FG000|Overall Study|Physician Decision|1|||
148988317|NCT00384085|537434342|FG001|Overall Study|Physician Decision|0|||
148988318|NCT00384085|537434343|FG002|Overall Study|Physician Decision|0|||
148988319|NCT00384085|537434341|FG000|Overall Study|Loss of site personnel|1|||
148988320|NCT00384085|537434342|FG001|Overall Study|Loss of site personnel|0|||
148988321|NCT00384085|537434343|FG002|Overall Study|Loss of site personnel|1|||
148988322|NCT00384085|537434341|FG000|Overall Study|Sponsor decision|1|||
148988323|NCT00384085|537434342|FG001|Overall Study|Sponsor decision|2|||
148988324|NCT00384085|537434343|FG002|Overall Study|Sponsor decision|1|||
148988325|NCT00384085|537434341|FG000|Overall Study|Patient moved|1|||
148988326|NCT00384085|537434342|FG001|Overall Study|Patient moved|0|||
148988327|NCT00384085|537434343|FG002|Overall Study|Patient moved|1|||
148988328|NCT00384085|537434341|FG000|Overall Study|Patient required surgery|0|||
148988329|NCT00384085|537434342|FG001|Overall Study|Patient required surgery|1|||
148988330|NCT00384085|537434343|FG002|Overall Study|Patient required surgery|0|||
148988331|NCT00838110|537434346|FG000|Overall Study|Death|0|||
148988332|NCT00838110|537434347|FG001|Overall Study|Death|0|||
148988333|NCT00838110|537434348|FG002|Overall Study|Death|1|||
148988334|NCT00838110|537434349|FG003|Overall Study|Death|2|||
148988335|NCT00838110|537434346|FG000|Overall Study|Adverse Event|11|||
148988336|NCT00838110|537434347|FG001|Overall Study|Adverse Event|10|||
148988337|NCT00838110|537434348|FG002|Overall Study|Adverse Event|8|||
148988338|NCT00838110|537434349|FG003|Overall Study|Adverse Event|7|||
148988339|NCT00838110|537434346|FG000|Overall Study|Withdrawal by Subject|5|||
148988340|NCT00838110|537434347|FG001|Overall Study|Withdrawal by Subject|6|||
148988341|NCT00838110|537434348|FG002|Overall Study|Withdrawal by Subject|3|||
148988342|NCT00838110|537434349|FG003|Overall Study|Withdrawal by Subject|4|||
148988343|NCT00838110|537434346|FG000|Overall Study|Other|3|||
148988344|NCT00838110|537434347|FG001|Overall Study|Other|3|||
148988345|NCT00838110|537434348|FG002|Overall Study|Other|3|||
148988346|NCT00838110|537434349|FG003|Overall Study|Other|2|||
148988347|NCT00838110|537434346|FG000|Overall Study|Protocol Violation|0|||
148988348|NCT00838110|537434347|FG001|Overall Study|Protocol Violation|2|||
148988349|NCT00838110|537434348|FG002|Overall Study|Protocol Violation|1|||
148988350|NCT00838110|537434349|FG003|Overall Study|Protocol Violation|1|||
148988351|NCT00838110|537434346|FG000|Overall Study|Lost to Follow-up|3|||
148988352|NCT00838110|537434347|FG001|Overall Study|Lost to Follow-up|0|||
148988353|NCT00838110|537434348|FG002|Overall Study|Lost to Follow-up|0|||
148988354|NCT00838110|537434349|FG003|Overall Study|Lost to Follow-up|0|||
148988355|NCT00838110|537434346|FG000|Overall Study|Did not meet eligibility criteria|0|||
148988356|NCT00838110|537434347|FG001|Overall Study|Did not meet eligibility criteria|0|||
148988357|NCT00838110|537434348|FG002|Overall Study|Did not meet eligibility criteria|1|||
148988358|NCT00838110|537434349|FG003|Overall Study|Did not meet eligibility criteria|2|||
148988359|NCT00838110|537434346|FG000|Overall Study|Randomized but not treated|0|||
148988360|NCT00838110|537434347|FG001|Overall Study|Randomized but not treated|1|||
148988361|NCT00838110|537434348|FG002|Overall Study|Randomized but not treated|0|||
148988362|NCT00838110|537434349|FG003|Overall Study|Randomized but not treated|0|||
148988363|NCT00352365|537434350|FG000|Induction Therapy|Adverse Event|7|||
148988364|NCT00352365|537434350|FG000|Induction Therapy|Progression/Relapse|8|||
148988365|NCT00352365|537434350|FG000|Induction Therapy|Death|7|||
148988366|NCT00352365|537434350|FG000|Induction Therapy|Not protocol specified|1|||
148988367|NCT00352365|537434350|FG000|Induction Therapy|Not eligible|3|||
148988368|NCT00352365|537434350|FG000|Induction Therapy|Death before starting protocol therapy|1|||
148988369|NCT00352365|537434350|FG000|Maintenance Therapy|Progression/Relapse|3|||
148988370|NCT00352365|537434350|FG000|Maintenance Therapy|Death|2|||
148988371|NCT00352365|537434350|FG000|Maintenance Therapy|Not protocol specified|3|||
148988372|NCT00352365|537434350|FG000|Maintenance Therapy|Not eligible|4|||
148988373|NCT01262651|537434351|FG000|Overall Study|Adverse Event|40|||
148988374|NCT01262651|537434352|FG001|Overall Study|Adverse Event|35|||
148988375|NCT01262651|537434351|FG000|Overall Study|Withdrawal by Subject|15|||
148988376|NCT01262651|537434352|FG001|Overall Study|Withdrawal by Subject|11|||
148988377|NCT01262651|537434351|FG000|Overall Study|Withdrawal by Investigator|2|||
148988378|NCT01262651|537434352|FG001|Overall Study|Withdrawal by Investigator|2|||
148988379|NCT01262651|537434351|FG000|Overall Study|Met Withdrawal Criteria|1|||
148988380|NCT01262651|537434352|FG001|Overall Study|Met Withdrawal Criteria|0|||
148988381|NCT02811861|537434353|FG000|Overall Study|Radiological Disease Progression|123|||
148988382|NCT02811861|537434354|FG001|Overall Study|Radiological Disease Progression|97|||
148988383|NCT02811861|537434355|FG002|Overall Study|Radiological Disease Progression|174|||
148988384|NCT02811861|537434353|FG000|Overall Study|Clinical Disease Progression|20|||
148988385|NCT02811861|537434354|FG001|Overall Study|Clinical Disease Progression|19|||
148988386|NCT02811861|537434355|FG002|Overall Study|Clinical Disease Progression|22|||
148988387|NCT02811861|537434353|FG000|Overall Study|Adverse Event|63|||
148988388|NCT02811861|537434354|FG001|Overall Study|Adverse Event|60|||
148988389|NCT02811861|537434355|FG002|Overall Study|Adverse Event|41|||
148988390|NCT02811861|537434353|FG000|Overall Study|Lost to Follow-up|0|||
148988391|NCT02811861|537434354|FG001|Overall Study|Lost to Follow-up|0|||
148988392|NCT02811861|537434355|FG002|Overall Study|Lost to Follow-up|1|||
148988393|NCT02811861|537434353|FG000|Overall Study|Subject Choice|29|||
148988394|NCT02811861|537434354|FG001|Overall Study|Subject Choice|17|||
148988395|NCT02811861|537434355|FG002|Overall Study|Subject Choice|23|||
148988396|NCT02811861|537434353|FG000|Overall Study|Withdrawal by Subject|4|||
148988397|NCT02811861|537434354|FG001|Overall Study|Withdrawal by Subject|4|||
148988398|NCT02811861|537434355|FG002|Overall Study|Withdrawal by Subject|9|||
148988399|NCT02811861|537434353|FG000|Overall Study|Other|4|||
148988400|NCT02811861|537434354|FG001|Overall Study|Other|13|||
148988401|NCT02811861|537434355|FG002|Overall Study|Other|3|||
148988402|NCT02811861|537434353|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
148988403|NCT02811861|537434354|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
148988404|NCT02811861|537434355|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
148988405|NCT02811861|537434353|FG000|Overall Study|Randomized but not treated|2|||
148988406|NCT02811861|537434354|FG001|Overall Study|Randomized but not treated|3|||
148988407|NCT02811861|537434355|FG002|Overall Study|Randomized but not treated|17|||
148988408|NCT04743908|537434356|FG000|Overall Study|Death|1|||
148988409|NCT04743908|537434357|FG001|Overall Study|Death|0|||
148988410|NCT04743908|537434356|FG000|Overall Study|Lost to Follow-up|181|||
148988411|NCT04743908|537434357|FG001|Overall Study|Lost to Follow-up|180|||
148988412|NCT04743908|537434356|FG000|Overall Study|Withdrawal by Subject|1|||
148988413|NCT04743908|537434357|FG001|Overall Study|Withdrawal by Subject|2|||
148988414|NCT04969783|537434361|FG000|Overall Study|Lost to Follow-up|2|||
148988415|NCT04969783|537434362|FG001|Overall Study|Lost to Follow-up|0|||
148988416|NCT04969783|537434361|FG000|Overall Study|Withdrawal by Subject|4|||
148988417|NCT04969783|537434362|FG001|Overall Study|Withdrawal by Subject|0|||
148988418|NCT04969783|537434361|FG000|Overall Study|Physician Decision|6|||
148988419|NCT04969783|537434362|FG001|Overall Study|Physician Decision|0|||
148988420|NCT00512135|537434363|FG000|Overall Study|Not Treated|5|||
148988421|NCT00512135|537434363|FG000|Overall Study|Lack of Efficacy|2|||
148988422|NCT00512135|537434363|FG000|Overall Study|Adverse Event|6|||
148988423|NCT00512135|537434363|FG000|Overall Study|Withdrawal by Subject|22|||
148988424|NCT00512135|537434363|FG000|Overall Study|Lost to Follow-up|27|||
148988425|NCT00512135|537434363|FG000|Overall Study|Other|22|||
148988426|NCT03422250|537434364|FG000|Intervention|Adverse Event|0|||
148988427|NCT03422250|537434365|FG001|Intervention|Adverse Event|1|||
148988428|NCT03422250|537434366|FG002|Intervention|Adverse Event|0|||
148988429|NCT03422250|537434367|FG003|Intervention|Adverse Event|1|||
148988430|NCT03422250|537434364|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
148988431|NCT03422250|537434365|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
148988432|NCT03422250|537434366|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
148988433|NCT03422250|537434367|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
148988434|NCT03422250|537434364|FG000|Follow-up|Withdrawal by Subject|0|||
148988435|NCT03422250|537434365|FG001|Follow-up|Withdrawal by Subject|0|||
148988436|NCT03422250|537434366|FG002|Follow-up|Withdrawal by Subject|0|||
148988437|NCT03422250|537434367|FG003|Follow-up|Withdrawal by Subject|1|||
148988438|NCT03422250|537434364|FG000|Follow-up|Adverse Event|0|||
148988439|NCT03422250|537434365|FG001|Follow-up|Adverse Event|0|||
148988440|NCT03422250|537434366|FG002|Follow-up|Adverse Event|0|||
148988441|NCT03422250|537434367|FG003|Follow-up|Adverse Event|1|||
148988442|NCT00377819|537434370|FG000|Overall Study|Adverse Event|2|||
148988443|NCT00377819|537434371|FG001|Overall Study|Adverse Event|3|||
148988444|NCT00377819|537434370|FG000|Overall Study|Withdrawal by Subject|10|||
148988445|NCT00377819|537434371|FG001|Overall Study|Withdrawal by Subject|4|||
148988446|NCT00377819|537434370|FG000|Overall Study|Death|0|||
148988447|NCT00377819|537434371|FG001|Overall Study|Death|1|||
148856238|NCT03525600|536948014|FG002|Overall Study|Death|4|||
148856239|NCT03525600|536948015|FG003|Overall Study|Death|3|||
148889454|NCT02888106|537074408|FG002|Overall Study|Adverse Event|0|||
148889455|NCT02888106|537074409|FG003|Overall Study|Adverse Event|0|||
148889456|NCT02888106|537074410|FG004|Overall Study|Adverse Event|0|||
148889457|NCT02888106|537074411|FG005|Overall Study|Adverse Event|0|||
148889458|NCT02888106|537074406|FG000|Overall Study|Withdrawal of consent|0|||
148889459|NCT02888106|537074407|FG001|Overall Study|Withdrawal of consent|0|||
148889460|NCT02888106|537074408|FG002|Overall Study|Withdrawal of consent|0|||
148889461|NCT02888106|537074409|FG003|Overall Study|Withdrawal of consent|0|||
148889462|NCT02888106|537074410|FG004|Overall Study|Withdrawal of consent|1|||
148889463|NCT02888106|537074411|FG005|Overall Study|Withdrawal of consent|0|||
148889464|NCT02888106|537074406|FG000|Overall Study|Pregnancy|1|||
148889465|NCT02888106|537074407|FG001|Overall Study|Pregnancy|0|||
148889466|NCT02888106|537074408|FG002|Overall Study|Pregnancy|0|||
148889467|NCT02888106|537074409|FG003|Overall Study|Pregnancy|0|||
148889468|NCT02888106|537074410|FG004|Overall Study|Pregnancy|0|||
148889469|NCT02888106|537074411|FG005|Overall Study|Pregnancy|0|||
148889470|NCT00430716|537074416|FG000|Double Blind Phase|Death|1|||
148889471|NCT00430716|537074417|FG001|Double Blind Phase|Death|0|||
148889472|NCT00430716|537074418|FG002|Double Blind Phase|Death|0|||
148889473|NCT00430716|537074416|FG000|Double Blind Phase|No longer willing to participate|2|||
148889474|NCT00430716|537074417|FG001|Double Blind Phase|No longer willing to participate|1|||
148889475|NCT00430716|537074418|FG002|Double Blind Phase|No longer willing to participate|1|||
148889476|NCT00430716|537074416|FG000|Double Blind Phase|Other|0|||
148889477|NCT00430716|537074417|FG001|Double Blind Phase|Other|2|||
148889478|NCT00430716|537074418|FG002|Double Blind Phase|Other|0|||
148889479|NCT00430716|537074416|FG000|Double Blind Phase|Study terminated by sponsor|1|||
148889480|NCT00430716|537074417|FG001|Double Blind Phase|Study terminated by sponsor|1|||
148889481|NCT00430716|537074418|FG002|Double Blind Phase|Study terminated by sponsor|2|||
148889482|NCT00430716|537074416|FG000|Double Blind Phase|Adverse Event|1|||
148889483|NCT00430716|537074417|FG001|Double Blind Phase|Adverse Event|1|||
148889484|NCT00430716|537074418|FG002|Double Blind Phase|Adverse Event|3|||
148889485|NCT00430716|537074416|FG000|Double Blind Phase|Not treated|1|||
148889486|NCT00430716|537074417|FG001|Double Blind Phase|Not treated|0|||
148889487|NCT00430716|537074418|FG002|Double Blind Phase|Not treated|0|||
148889488|NCT00430716|537074416|FG000|Open Label Phase|Lost to Follow-up|1|||
148889489|NCT00430716|537074417|FG001|Open Label Phase|Lost to Follow-up|0|||
148889490|NCT00430716|537074418|FG002|Open Label Phase|Lost to Follow-up|1|||
148889491|NCT00430716|537074416|FG000|Open Label Phase|No longer willing to participate|0|||
148889492|NCT00430716|537074417|FG001|Open Label Phase|No longer willing to participate|1|||
148889493|NCT00430716|537074418|FG002|Open Label Phase|No longer willing to participate|1|||
148889494|NCT00430716|537074416|FG000|Open Label Phase|Other|3|||
148889495|NCT00430716|537074417|FG001|Open Label Phase|Other|1|||
148889496|NCT00430716|537074418|FG002|Open Label Phase|Other|1|||
148889497|NCT00430716|537074416|FG000|Open Label Phase|Protocol Violation|1|||
148889498|NCT00430716|537074417|FG001|Open Label Phase|Protocol Violation|0|||
148889499|NCT00430716|537074418|FG002|Open Label Phase|Protocol Violation|0|||
148889500|NCT00430716|537074416|FG000|Open Label Phase|Study terminated by sponsor|4|||
148889501|NCT00430716|537074417|FG001|Open Label Phase|Study terminated by sponsor|5|||
148889502|NCT00430716|537074418|FG002|Open Label Phase|Study terminated by sponsor|4|||
148889503|NCT02021565|537074422|FG000|Baseline Through Intervention|Death|0|||
148889504|NCT02021565|537074423|FG001|Baseline Through Intervention|Death|1|||
148889505|NCT02021565|537074422|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
148889506|NCT02021565|537074423|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
148889507|NCT02021565|537074422|FG000|Baseline Through Intervention|Protocol Violation|0|||
148889508|NCT02021565|537074423|FG001|Baseline Through Intervention|Protocol Violation|7|||
148889509|NCT02021565|537074422|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
148889510|NCT02021565|537074423|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
148889511|NCT02021565|537074422|FG000|3-month Follow-up|Death|3|||
148889512|NCT02021565|537074423|FG001|3-month Follow-up|Death|0|||
148889513|NCT02021565|537074422|FG000|3-month Follow-up|Withdrawal by Subject|4|||
148889514|NCT02021565|537074423|FG001|3-month Follow-up|Withdrawal by Subject|0|||
148889515|NCT02021565|537074422|FG000|3-month Follow-up|Protocol Violation|3|||
148889516|NCT02021565|537074423|FG001|3-month Follow-up|Protocol Violation|2|||
148889517|NCT01188772|537074426|FG000|Overall Study|Randomized but Not Treated|0|||
148889518|NCT01188772|537074427|FG001|Overall Study|Randomized but Not Treated|1|||
148889519|NCT01188772|537074428|FG002|Overall Study|Randomized but Not Treated|0|||
148889520|NCT01188772|537074429|FG003|Overall Study|Randomized but Not Treated|0|||
148889521|NCT01188772|537074426|FG000|Overall Study|Adverse Event|0|||
148889522|NCT01188772|537074427|FG001|Overall Study|Adverse Event|1|||
148889523|NCT01188772|537074428|FG002|Overall Study|Adverse Event|2|||
148889524|NCT01188772|537074429|FG003|Overall Study|Adverse Event|0|||
148889525|NCT01188772|537074426|FG000|Overall Study|Lost to Follow-up|4|||
148889526|NCT01188772|537074427|FG001|Overall Study|Lost to Follow-up|1|||
148856240|NCT03525600|536948012|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
148856241|NCT03525600|536948013|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
148988448|NCT00377819|537434370|FG000|Overall Study|Lost to Follow-up|0|||
148988449|NCT00377819|537434371|FG001|Overall Study|Lost to Follow-up|1|||
148988450|NCT00377819|537434370|FG000|Overall Study|Protocol Violation|1|||
148988451|NCT00377819|537434371|FG001|Overall Study|Protocol Violation|1|||
148988452|NCT00467870|537434378|FG000|Overall Study|Adverse Event|13|||
148988453|NCT00467870|537434379|FG001|Overall Study|Adverse Event|9|||
148988454|NCT00467870|537434380|FG002|Overall Study|Adverse Event|1|||
148988455|NCT00467870|537434381|FG003|Overall Study|Adverse Event|15|||
148988456|NCT00467870|537434382|FG004|Overall Study|Adverse Event|15|||
148988457|NCT00467870|537434383|FG005|Overall Study|Adverse Event|1|||
148988458|NCT00467870|537434378|FG000|Overall Study|Protocol Violation|2|||
148988459|NCT00467870|537434379|FG001|Overall Study|Protocol Violation|1|||
148988460|NCT00467870|537434380|FG002|Overall Study|Protocol Violation|1|||
148988461|NCT00467870|537434381|FG003|Overall Study|Protocol Violation|2|||
148988462|NCT00467870|537434382|FG004|Overall Study|Protocol Violation|0|||
148988463|NCT00467870|537434383|FG005|Overall Study|Protocol Violation|0|||
148988464|NCT00467870|537434378|FG000|Overall Study|Withdrawal by Subject|14|||
148988465|NCT00467870|537434379|FG001|Overall Study|Withdrawal by Subject|21|||
148988466|NCT00467870|537434380|FG002|Overall Study|Withdrawal by Subject|0|||
148988467|NCT00467870|537434381|FG003|Overall Study|Withdrawal by Subject|9|||
148988468|NCT00467870|537434382|FG004|Overall Study|Withdrawal by Subject|10|||
148988469|NCT00467870|537434383|FG005|Overall Study|Withdrawal by Subject|1|||
148988470|NCT00467870|537434378|FG000|Overall Study|Lost to Follow-up|5|||
148988471|NCT00467870|537434379|FG001|Overall Study|Lost to Follow-up|3|||
148988472|NCT00467870|537434380|FG002|Overall Study|Lost to Follow-up|1|||
148988473|NCT00467870|537434381|FG003|Overall Study|Lost to Follow-up|1|||
148988474|NCT00467870|537434382|FG004|Overall Study|Lost to Follow-up|3|||
148988475|NCT00467870|537434383|FG005|Overall Study|Lost to Follow-up|0|||
148988476|NCT00467870|537434378|FG000|Overall Study|Subject Non-compliance|3|||
148988477|NCT00467870|537434379|FG001|Overall Study|Subject Non-compliance|4|||
148988478|NCT00467870|537434380|FG002|Overall Study|Subject Non-compliance|0|||
148988479|NCT00467870|537434381|FG003|Overall Study|Subject Non-compliance|1|||
148856242|NCT03525600|536948014|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
148856243|NCT03525600|536948015|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
148988480|NCT00467870|537434382|FG004|Overall Study|Subject Non-compliance|5|||
148988481|NCT00467870|537434383|FG005|Overall Study|Subject Non-compliance|0|||
148988482|NCT00467870|537434378|FG000|Overall Study|Other/Unknown|8|||
148988483|NCT00467870|537434379|FG001|Overall Study|Other/Unknown|5|||
148988484|NCT00467870|537434380|FG002|Overall Study|Other/Unknown|1|||
148988485|NCT00467870|537434381|FG003|Overall Study|Other/Unknown|5|||
148988486|NCT00467870|537434382|FG004|Overall Study|Other/Unknown|4|||
148988487|NCT00467870|537434383|FG005|Overall Study|Other/Unknown|0|||
148988488|NCT01917526|537434384|FG000|Overall Study|Protocol Violation|1|||
148988489|NCT01917526|537434385|FG001|Overall Study|Protocol Violation|1|||
148988490|NCT02261363|537434386|FG000|Overall Study|Lost to Follow-up|21|||
148988491|NCT01517802|537434387|FG000|Overall Study|Death|1|||
148988492|NCT03268811|537434393|FG000|Overall Study|Adverse Event|0|||
148988493|NCT03268811|537434394|FG001|Overall Study|Adverse Event|1|||
148988494|NCT02031276|537434395|FG000|Period 1 Double-blind IV|Adverse Event|6|||
148988495|NCT02031276|537434396|FG001|Period 1 Double-blind IV|Adverse Event|5|||
148988496|NCT02031276|537434397|FG002|Period 1 Double-blind IV|Adverse Event|1|||
148988497|NCT02031276|537434395|FG000|Period 1 Double-blind IV|Other|0|||
148988498|NCT02031276|537434396|FG001|Period 1 Double-blind IV|Other|1|||
148988499|NCT02031276|537434397|FG002|Period 1 Double-blind IV|Other|0|||
148988500|NCT02031276|537434395|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
148856244|NCT03525600|536948012|FG000|Overall Study|Other|0|||
148856245|NCT03525600|536948013|FG001|Overall Study|Other|1|||
148856246|NCT03525600|536948014|FG002|Overall Study|Other|0|||
148988501|NCT02031276|537434396|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
148988502|NCT02031276|537434397|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
148988503|NCT02031276|537434395|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
148988504|NCT02031276|537434396|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
148988505|NCT02031276|537434397|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
149030571|NCT04888585|537589663|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
148856247|NCT03525600|536948015|FG003|Overall Study|Other|0|||
148988506|NCT02031276|537434395|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
148988507|NCT02031276|537434396|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
148988508|NCT02031276|537434397|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
148988509|NCT02031276|537434395|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
148988510|NCT02031276|537434396|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
148988511|NCT02031276|537434397|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
148988512|NCT02031276|537434395|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
148988513|NCT02031276|537434396|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
148988514|NCT02031276|537434397|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
148988515|NCT02031276|537434395|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
148988516|NCT02031276|537434396|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
148988517|NCT02031276|537434397|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
148988518|NCT02031276|537434395|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
148988519|NCT02031276|537434396|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
148988520|NCT02031276|537434397|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
148988521|NCT01148810|537434398|FG000|Overall Study|Adverse Event|0|||
148988522|NCT01148810|537434399|FG001|Overall Study|Adverse Event|2|||
148988523|NCT01148810|537434398|FG000|Overall Study|Lack of Efficacy|0|||
148988524|NCT01148810|537434399|FG001|Overall Study|Lack of Efficacy|1|||
148988525|NCT01148810|537434398|FG000|Overall Study|Withdrawal by Subject|0|||
148988526|NCT01148810|537434399|FG001|Overall Study|Withdrawal by Subject|2|||
148988527|NCT01148810|537434398|FG000|Overall Study|Protocol Violation|1|||
148988528|NCT01148810|537434399|FG001|Overall Study|Protocol Violation|0|||
148988529|NCT02417246|537434407|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
148988530|NCT02417246|537434408|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
148988531|NCT02417246|537434407|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
148988532|NCT02417246|537434408|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
148988533|NCT02417246|537434407|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
148988534|NCT02417246|537434408|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
148988535|NCT02417246|537434407|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
148988536|NCT02417246|537434408|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
148988537|NCT04408469|537434412|FG000|Overall Study|Lost to Follow-up|6|||
148988538|NCT04408469|537434413|FG001|Overall Study|Lost to Follow-up|9|||
148988539|NCT04408469|537434412|FG000|Overall Study|Withdrawal by Subject|6|||
148988540|NCT04408469|537434413|FG001|Overall Study|Withdrawal by Subject|1|||
148988541|NCT04408469|537434412|FG000|Overall Study|Dismissal due to ineligibility|0|||
148988542|NCT04408469|537434413|FG001|Overall Study|Dismissal due to ineligibility|1|||
148988543|NCT04321460|537434414|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
148988544|NCT04321460|537434415|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
148988545|NCT01308749|537434416|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
148988546|NCT01308749|537434417|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
148988547|NCT01308749|537434416|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
148988548|NCT01308749|537434417|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
148988549|NCT01308749|537434416|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
148988550|NCT01308749|537434417|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
148988551|NCT03058679|537434422|FG000|Baseline to Week 6|Lost to Follow-up|3|||
148988552|NCT03058679|537434423|FG001|Baseline to Week 6|Lost to Follow-up|2|||
148988553|NCT03058679|537434422|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
148988554|NCT03058679|537434423|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
148988555|NCT03058679|537434422|FG000|Baseline to Week 6|Adverse Event|6|||
148988556|NCT03058679|537434423|FG001|Baseline to Week 6|Adverse Event|6|||
148988557|NCT03058679|537434422|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
148988558|NCT03058679|537434423|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
148988559|NCT03058679|537434422|FG000|Baseline to Week 6|Difficulty following the diet|0|||
148988560|NCT03058679|537434423|FG001|Baseline to Week 6|Difficulty following the diet|2|||
148988561|NCT03058679|537434422|FG000|Baseline to Week 6|Physician Decision|1|||
148988562|NCT03058679|537434423|FG001|Baseline to Week 6|Physician Decision|0|||
148988563|NCT03058679|537434422|FG000|Week 6 to Week 12|Change in medication|5|||
148988564|NCT03058679|537434423|FG001|Week 6 to Week 12|Change in medication|7|||
148988565|NCT03058679|537434422|FG000|Week 6 to Week 12|Adverse Event|4|||
148988566|NCT03058679|537434423|FG001|Week 6 to Week 12|Adverse Event|3|||
148988567|NCT03058679|537434422|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
148988568|NCT03058679|537434423|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
148988569|NCT03058679|537434422|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
148988570|NCT03058679|537434423|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
148988571|NCT00574080|537434424|FG000|Overall Study|Death|10|||
148988572|NCT00574080|537434425|FG001|Overall Study|Death|10|||
148988573|NCT00784810|537434430|FG000|Overall Study|Adverse Event|32|||
148988574|NCT00784810|537434431|FG001|Overall Study|Adverse Event|20|||
148988575|NCT00784810|537434430|FG000|Overall Study|Lack of Efficacy|14|||
148988576|NCT00784810|537434431|FG001|Overall Study|Lack of Efficacy|11|||
148988577|NCT00784810|537434430|FG000|Overall Study|Withdrawal by Subject|11|||
148988578|NCT00784810|537434431|FG001|Overall Study|Withdrawal by Subject|9|||
148988579|NCT00784810|537434430|FG000|Overall Study|Administrative|5|||
148988580|NCT00784810|537434431|FG001|Overall Study|Administrative|8|||
148988581|NCT00784810|537434430|FG000|Overall Study|Lost to Follow-up|1|||
148988582|NCT00784810|537434431|FG001|Overall Study|Lost to Follow-up|1|||
148988583|NCT04137380|537434432|FG000|Overall Study|Physician Decision|0|||
148988584|NCT04137380|537434433|FG001|Overall Study|Physician Decision|0|||
148988585|NCT04137380|537434434|FG002|Overall Study|Physician Decision|0|||
148988586|NCT04137380|537434435|FG003|Overall Study|Physician Decision|1|||
148988587|NCT04137380|537434436|FG004|Overall Study|Physician Decision|0|||
148988588|NCT04137380|537434437|FG005|Overall Study|Physician Decision|0|||
148988589|NCT04137380|537434438|FG006|Overall Study|Physician Decision|0|||
148988590|NCT03434119|537434439|FG000|Overall Study|Randomized but not treated|1|||
148988591|NCT03434119|537434440|FG001|Overall Study|Randomized but not treated|0|||
148988592|NCT03434119|537434439|FG000|Overall Study|Adverse Event|1|||
148988593|NCT03434119|537434440|FG001|Overall Study|Adverse Event|0|||
148988594|NCT03434119|537434439|FG000|Overall Study|Poor Compliance to Protocol|0|||
148988595|NCT03434119|537434440|FG001|Overall Study|Poor Compliance to Protocol|1|||
148988596|NCT03434119|537434439|FG000|Overall Study|Study Terminated by Sponsor|91|||
148988597|NCT03434119|537434440|FG001|Overall Study|Study Terminated by Sponsor|102|||
148988598|NCT03434119|537434439|FG000|Overall Study|Withdrawal by Subject|7|||
148988599|NCT03434119|537434440|FG001|Overall Study|Withdrawal by Subject|5|||
148988600|NCT03434119|537434439|FG000|Overall Study|Other than specified|7|||
148988601|NCT03434119|537434440|FG001|Overall Study|Other than specified|5|||
148988602|NCT02844946|537434442|FG000|Overall Study|Lost to Follow-up|7|||
148988603|NCT02844946|537434443|FG001|Overall Study|Lost to Follow-up|0|||
148988604|NCT06027216|537434444|FG000|Overall Study|Did not qualify|8|||
148988605|NCT05348681|537434448|FG000|Overall Study|Study terminated by Sponsor|8|||
148988606|NCT05348681|537434449|FG001|Overall Study|Study terminated by Sponsor|3|||
148988607|NCT05348681|537434448|FG000|Overall Study|Withdrawal by Subject|1|||
148988608|NCT05348681|537434449|FG001|Overall Study|Withdrawal by Subject|1|||
148988609|NCT05348681|537434448|FG000|Overall Study|Lost to Follow-up|1|||
148988610|NCT05348681|537434449|FG001|Overall Study|Lost to Follow-up|1|||
148988611|NCT05348681|537434448|FG000|Overall Study|Adverse Event|1|||
148988612|NCT05348681|537434449|FG001|Overall Study|Adverse Event|0|||
148988613|NCT05348681|537434448|FG000|Overall Study|Other|2|||
148988614|NCT05348681|537434449|FG001|Overall Study|Other|1|||
148988615|NCT03646513|537434450|FG000|Overall Study|Premature study termination|4|||
148988616|NCT00782340|537434451|FG000|Open Label Titration|Adverse Event|12|||
148988617|NCT00782340|537434452|FG001|Open Label Titration|Adverse Event|0|||
148988618|NCT00782340|537434453|FG002|Open Label Titration|Adverse Event|0|||
148988619|NCT00782340|537434451|FG000|Open Label Titration|Treatment failure|50|||
148988620|NCT00782340|537434452|FG001|Open Label Titration|Treatment failure|0|||
148988621|NCT00782340|537434453|FG002|Open Label Titration|Treatment failure|0|||
148988622|NCT00782340|537434451|FG000|Open Label Titration|Protocol Violation|5|||
148988623|NCT00782340|537434452|FG001|Open Label Titration|Protocol Violation|0|||
148988624|NCT00782340|537434453|FG002|Open Label Titration|Protocol Violation|0|||
148988625|NCT00782340|537434451|FG000|Open Label Titration|Withdrawal by Subject|5|||
148988626|NCT00782340|537434452|FG001|Open Label Titration|Withdrawal by Subject|0|||
148988627|NCT00782340|537434453|FG002|Open Label Titration|Withdrawal by Subject|0|||
148988628|NCT00782340|537434451|FG000|Open Label Titration|Enrollment capped|16|||
148988629|NCT00782340|537434452|FG001|Open Label Titration|Enrollment capped|0|||
148988630|NCT00782340|537434453|FG002|Open Label Titration|Enrollment capped|0|||
148988631|NCT00782340|537434451|FG000|Open Label Titration|Did not meet responder criteria|2|||
148988632|NCT00782340|537434452|FG001|Open Label Titration|Did not meet responder criteria|0|||
148988633|NCT00782340|537434453|FG002|Open Label Titration|Did not meet responder criteria|0|||
148988634|NCT00782340|537434451|FG000|Open Label Titration|Lost to Follow-up|5|||
148988635|NCT00782340|537434452|FG001|Open Label Titration|Lost to Follow-up|0|||
148988636|NCT00782340|537434453|FG002|Open Label Titration|Lost to Follow-up|0|||
148988637|NCT00782340|537434451|FG000|Open Label Titration|Randomized in error|6|||
148988638|NCT00782340|537434452|FG001|Open Label Titration|Randomized in error|0|||
148988639|NCT00782340|537434453|FG002|Open Label Titration|Randomized in error|0|||
148988640|NCT01040130|537434454|FG000|Overall Study|Adverse Event|1|||
148988641|NCT01040130|537434455|FG001|Overall Study|Adverse Event|1|||
148988642|NCT01040130|537434456|FG002|Overall Study|Adverse Event|0|||
148988643|NCT01040130|537434457|FG003|Overall Study|Adverse Event|5|||
148988644|NCT01040130|537434458|FG004|Overall Study|Adverse Event|0|||
148988645|NCT01040130|537434459|FG005|Overall Study|Adverse Event|3|||
148988646|NCT01040130|537434454|FG000|Overall Study|Protocol Violation|0|||
148988647|NCT01040130|537434455|FG001|Overall Study|Protocol Violation|0|||
148988648|NCT01040130|537434456|FG002|Overall Study|Protocol Violation|2|||
148988649|NCT01040130|537434457|FG003|Overall Study|Protocol Violation|0|||
148988650|NCT01040130|537434458|FG004|Overall Study|Protocol Violation|0|||
148988651|NCT01040130|537434459|FG005|Overall Study|Protocol Violation|0|||
148988652|NCT01040130|537434454|FG000|Overall Study|Withdrawal by Subject|0|||
148988653|NCT01040130|537434455|FG001|Overall Study|Withdrawal by Subject|2|||
148988654|NCT01040130|537434456|FG002|Overall Study|Withdrawal by Subject|0|||
148988655|NCT01040130|537434457|FG003|Overall Study|Withdrawal by Subject|0|||
148988656|NCT01040130|537434458|FG004|Overall Study|Withdrawal by Subject|0|||
148988657|NCT01040130|537434459|FG005|Overall Study|Withdrawal by Subject|1|||
148988658|NCT01040130|537434454|FG000|Overall Study|Other reasons not listed above|2|||
148988659|NCT01040130|537434455|FG001|Overall Study|Other reasons not listed above|0|||
148988660|NCT01040130|537434456|FG002|Overall Study|Other reasons not listed above|0|||
148988661|NCT01040130|537434457|FG003|Overall Study|Other reasons not listed above|0|||
148988662|NCT01040130|537434458|FG004|Overall Study|Other reasons not listed above|0|||
148988663|NCT01040130|537434459|FG005|Overall Study|Other reasons not listed above|0|||
148988664|NCT00968617|537434463|FG000|Overall Study|Study terminated by sponsor|6|||
148988665|NCT04433767|537434464|FG000|Overall Study|Adverse Event|1|||
148988666|NCT02720484|537434468|FG000|Treatment on Study|Adverse Event|1|||
148988667|NCT02720484|537434468|FG000|Treatment on Study|Withdrawal by Subject|1|||
148988668|NCT02720484|537434468|FG000|Treatment on Study|Progressive Disease|4|||
148988669|NCT02720484|537434468|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
148988670|NCT02720484|537434468|FG000|Follow Up for 2 Years|Death|3|||
148988671|NCT02720484|537434468|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
148988672|NCT05070897|537434472|FG000|Overall Study|Protocol Violation|123|||
148988673|NCT05070897|537434473|FG001|Overall Study|Protocol Violation|68|||
148988674|NCT01617629|537434474|FG000|Overall Study|Death|2|||
148988675|NCT01617629|537434474|FG000|Overall Study|Investigator's Clinical Judgement|1|||
148988676|NCT01617629|537434474|FG000|Overall Study|Reason Not Specified|1|||
148988677|NCT01617629|537434474|FG000|Overall Study|Participant Withdrew Consent|2|||
148988678|NCT02715765|537434475|FG000|Overall Study|Study Termination|3|||
148988679|NCT02715765|537434476|FG001|Overall Study|Study Termination|0|||
148988680|NCT02715765|537434477|FG002|Overall Study|Study Termination|0|||
148988681|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
148988682|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
148988683|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
148988684|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
148988685|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
148988686|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
148988687|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
148988688|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
148988689|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
148988690|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
148988691|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
148988692|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
148988693|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
148988694|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
148988695|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
148988696|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
148988697|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
148988698|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
148988699|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
148988700|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
148988701|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
148988702|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
148988703|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
148988704|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
148988705|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
148988706|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
148988707|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
148988708|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
148988709|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
148988710|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
148988711|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
148988712|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
148988713|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
148988714|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
148988715|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
148988716|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
148988717|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
148988718|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
148988719|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
148988720|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
148988721|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
148988722|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
148988723|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
149030572|NCT04888585|537589664|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
149030573|NCT04888585|537589665|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
148988724|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
148988725|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
149030574|NCT04888585|537589666|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
148988726|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
148988727|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
148988728|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
148988729|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
148988730|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
148988731|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
148988732|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
148988733|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
148988734|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
148988735|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
148988736|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
148988737|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
148988738|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
148988739|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
148988740|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
148988741|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
148988742|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
148988743|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
148988744|NCT01884350|537434478|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
148988745|NCT01884350|537434479|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
148988746|NCT01884350|537434480|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
148988747|NCT05350449|537434485|FG000|Overall Study|Withdrawal by Subject|4|||
148988748|NCT05350449|537434486|FG001|Overall Study|Withdrawal by Subject|8|||
148988749|NCT04295564|537436167|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
148988750|NCT04295564|537436168|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
148988751|NCT04537923|537436169|FG000|Overall Study|Adverse Event|2|||
148988752|NCT04537923|537436170|FG001|Overall Study|Adverse Event|1|||
148988753|NCT04537923|537436171|FG002|Overall Study|Adverse Event|2|||
148988754|NCT04537923|537436172|FG003|Overall Study|Adverse Event|4|||
148988755|NCT04537923|537436169|FG000|Overall Study|Death|3|||
148988756|NCT04537923|537436170|FG001|Overall Study|Death|3|||
148988757|NCT04537923|537436171|FG002|Overall Study|Death|1|||
148988758|NCT04537923|537436172|FG003|Overall Study|Death|11|||
148988759|NCT04537923|537436169|FG000|Overall Study|Lost to Follow-up|1|||
148988760|NCT04537923|537436170|FG001|Overall Study|Lost to Follow-up|2|||
148988761|NCT04537923|537436171|FG002|Overall Study|Lost to Follow-up|1|||
148988762|NCT04537923|537436172|FG003|Overall Study|Lost to Follow-up|6|||
148988763|NCT04537923|537436169|FG000|Overall Study|Physician Decision|1|||
148988764|NCT04537923|537436170|FG001|Overall Study|Physician Decision|0|||
148988765|NCT04537923|537436171|FG002|Overall Study|Physician Decision|2|||
148988766|NCT04537923|537436172|FG003|Overall Study|Physician Decision|5|||
148988767|NCT04537923|537436169|FG000|Overall Study|Pregnancy|1|||
148988768|NCT04537923|537436170|FG001|Overall Study|Pregnancy|0|||
148988769|NCT04537923|537436171|FG002|Overall Study|Pregnancy|0|||
148988770|NCT04537923|537436172|FG003|Overall Study|Pregnancy|0|||
148988771|NCT04537923|537436169|FG000|Overall Study|Withdrawal by Subject|4|||
148988772|NCT04537923|537436170|FG001|Overall Study|Withdrawal by Subject|4|||
148988773|NCT04537923|537436171|FG002|Overall Study|Withdrawal by Subject|4|||
148988774|NCT04537923|537436172|FG003|Overall Study|Withdrawal by Subject|58|||
148988775|NCT04537923|537436169|FG000|Overall Study|Missed study visits|2|||
148988776|NCT04537923|537436170|FG001|Overall Study|Missed study visits|0|||
148988777|NCT04537923|537436171|FG002|Overall Study|Missed study visits|0|||
148988778|NCT04537923|537436172|FG003|Overall Study|Missed study visits|3|||
148988779|NCT04537923|537436169|FG000|Overall Study|Sponsor's decision|0|||
148988780|NCT04537923|537436170|FG001|Overall Study|Sponsor's decision|0|||
148988781|NCT04537923|537436171|FG002|Overall Study|Sponsor's decision|1|||
148988782|NCT04537923|537436172|FG003|Overall Study|Sponsor's decision|1|||
148988783|NCT04537923|537436169|FG000|Overall Study|Safety reasons|1|||
148856248|NCT01923363|536948018|FG000|Overall Study|Protocol Violation|1|||
148856249|NCT05129449|536948021|FG000|Overall Study|Protocol Violation|1|||
148988784|NCT04537923|537436170|FG001|Overall Study|Safety reasons|0|||
148988785|NCT04537923|537436171|FG002|Overall Study|Safety reasons|0|||
148988786|NCT04537923|537436172|FG003|Overall Study|Safety reasons|0|||
148988787|NCT01261611|537436173|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
148988788|NCT01261611|537436174|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
148988789|NCT01261611|537436175|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
148988790|NCT01261611|537436173|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
148988791|NCT01261611|537436174|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
148988792|NCT01261611|537436175|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
148988793|NCT01261611|537436173|FG000|Treatment Cycle 1|Adverse Event|0|||
148988794|NCT01261611|537436174|FG001|Treatment Cycle 1|Adverse Event|1|||
148988795|NCT01261611|537436175|FG002|Treatment Cycle 1|Adverse Event|0|||
149030575|NCT04888585|537589667|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
149030576|NCT04888585|537589668|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
149030577|NCT04888585|537589669|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
149030578|NCT04888585|537589670|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
149030579|NCT04888585|537589671|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
149030580|NCT04888585|537589672|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
149030581|NCT04888585|537589673|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
149030582|NCT03822351|537589674|FG000|Overall Study|Death|27|||
149030583|NCT03822351|537589675|FG001|Overall Study|Death|23|||
149030584|NCT03822351|537589676|FG002|Overall Study|Death|24|||
149030585|NCT03822351|537589674|FG000|Overall Study|Lost to Follow-up|6|||
149030586|NCT03822351|537589675|FG001|Overall Study|Lost to Follow-up|2|||
149030587|NCT03822351|537589676|FG002|Overall Study|Lost to Follow-up|1|||
149030588|NCT03822351|537589674|FG000|Overall Study|Withdrawal by Subject|10|||
149030589|NCT03822351|537589675|FG001|Overall Study|Withdrawal by Subject|4|||
149030590|NCT03822351|537589676|FG002|Overall Study|Withdrawal by Subject|6|||
148856250|NCT02901054|536948025|FG000|Overall Study|Physician Decision|1|||
148856251|NCT02901054|536948025|FG000|Overall Study|Withdrawal by Subject|3|||
148856252|NCT00616018|536948026|FG000|Overall Study|Protocol Violation|3|||
148856253|NCT01818258|536948027|FG000|Overall Study|Death|3|||
148856254|NCT01818258|536948028|FG001|Overall Study|Death|0|||
148856255|NCT01818258|536948027|FG000|Overall Study|Withdrawal by Subject|0|||
148856256|NCT01818258|536948028|FG001|Overall Study|Withdrawal by Subject|1|||
148856257|NCT01818258|536948027|FG000|Overall Study|Lost to Follow-up|0|||
148856258|NCT01818258|536948028|FG001|Overall Study|Lost to Follow-up|1|||
148856259|NCT01818258|536948027|FG000|Overall Study|Unable to Travel to Clinic|0|||
148856260|NCT01818258|536948028|FG001|Overall Study|Unable to Travel to Clinic|1|||
148856261|NCT02099344|536948029|FG000|Overall Study|Physician Decision|1|||
148856262|NCT02099344|536948030|FG001|Overall Study|Physician Decision|0|||
148856263|NCT03515551|536948033|FG000|Overall Study|Death|4|||
148856264|NCT03515551|536948034|FG001|Overall Study|Death|1|||
148856265|NCT03515551|536948035|FG002|Overall Study|Death|2|||
148856266|NCT03515551|536948036|FG003|Overall Study|Death|2|||
148856267|NCT03515551|536948037|FG004|Overall Study|Death|2|||
148856268|NCT03515551|536948038|FG005|Overall Study|Death|4|||
148856269|NCT03515551|536948039|FG006|Overall Study|Death|1|||
148856270|NCT03515551|536948033|FG000|Overall Study|Lost to Follow-up|0|||
148856271|NCT03515551|536948034|FG001|Overall Study|Lost to Follow-up|0|||
148856272|NCT03515551|536948035|FG002|Overall Study|Lost to Follow-up|1|||
148856273|NCT03515551|536948036|FG003|Overall Study|Lost to Follow-up|0|||
148856274|NCT03515551|536948037|FG004|Overall Study|Lost to Follow-up|0|||
148856275|NCT03515551|536948038|FG005|Overall Study|Lost to Follow-up|0|||
148856276|NCT03515551|536948039|FG006|Overall Study|Lost to Follow-up|0|||
148856277|NCT03515551|536948033|FG000|Overall Study|Withdrawal by Subject|0|||
148856278|NCT03515551|536948034|FG001|Overall Study|Withdrawal by Subject|1|||
148856279|NCT03515551|536948035|FG002|Overall Study|Withdrawal by Subject|0|||
148856280|NCT03515551|536948036|FG003|Overall Study|Withdrawal by Subject|0|||
148856281|NCT03515551|536948037|FG004|Overall Study|Withdrawal by Subject|0|||
148856282|NCT03515551|536948038|FG005|Overall Study|Withdrawal by Subject|0|||
148856283|NCT03515551|536948039|FG006|Overall Study|Withdrawal by Subject|1|||
148856284|NCT03515551|536948033|FG000|Overall Study|Study ended by sponsor|0|||
148856285|NCT03515551|536948034|FG001|Overall Study|Study ended by sponsor|0|||
148856286|NCT03515551|536948035|FG002|Overall Study|Study ended by sponsor|2|||
148856287|NCT03515551|536948036|FG003|Overall Study|Study ended by sponsor|1|||
148856288|NCT03515551|536948037|FG004|Overall Study|Study ended by sponsor|3|||
148856289|NCT03515551|536948038|FG005|Overall Study|Study ended by sponsor|0|||
148856290|NCT03515551|536948039|FG006|Overall Study|Study ended by sponsor|3|||
148856291|NCT03515551|536948033|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
148856292|NCT03515551|536948034|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
148856293|NCT03515551|536948035|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
148856294|NCT03515551|536948036|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
148856295|NCT03515551|536948037|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
148856296|NCT03515551|536948038|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
148856297|NCT03515551|536948039|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
148856298|NCT01221623|536948040|FG000|Overall Study|Withdrawal by Subject|19|||
149030591|NCT03822351|537589674|FG000|Overall Study|Progressive Disease|2|||
149030592|NCT03822351|537589675|FG001|Overall Study|Progressive Disease|1|||
149030593|NCT03822351|537589676|FG002|Overall Study|Progressive Disease|0|||
148856299|NCT01221623|536948041|FG001|Overall Study|Withdrawal by Subject|8|||
148856300|NCT01221623|536948040|FG000|Overall Study|Lost to Follow-up|7|||
148856301|NCT01221623|536948041|FG001|Overall Study|Lost to Follow-up|1|||
148856302|NCT01221623|536948040|FG000|Overall Study|Adverse Event|6|||
148856303|NCT01221623|536948041|FG001|Overall Study|Adverse Event|3|||
148856304|NCT01221623|536948040|FG000|Overall Study|Death|1|||
148856305|NCT01221623|536948041|FG001|Overall Study|Death|0|||
148856306|NCT01221623|536948040|FG000|Overall Study|Other|5|||
148856307|NCT01221623|536948041|FG001|Overall Study|Other|2|||
148988796|NCT01261611|537436173|FG000|Treatment Cycle 1|Protocol Violation|0|||
148988797|NCT01261611|537436174|FG001|Treatment Cycle 1|Protocol Violation|0|||
148988798|NCT01261611|537436175|FG002|Treatment Cycle 1|Protocol Violation|2|||
148988799|NCT01261611|537436173|FG000|Treatment Cycle 2|Completed study|4|||
148988800|NCT01261611|537436174|FG001|Treatment Cycle 2|Completed study|0|||
148988801|NCT01261611|537436175|FG002|Treatment Cycle 2|Completed study|0|||
148988802|NCT01261611|537436173|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
148988803|NCT01261611|537436174|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
148988804|NCT01261611|537436175|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
148988805|NCT01261611|537436173|FG000|Treatment Cycle 2|Adverse Event|1|||
148988806|NCT01261611|537436174|FG001|Treatment Cycle 2|Adverse Event|0|||
148988807|NCT01261611|537436175|FG002|Treatment Cycle 2|Adverse Event|0|||
148988808|NCT01261611|537436173|FG000|Treatment Cycle 2|Protocol Violation|2|||
148988809|NCT01261611|537436174|FG001|Treatment Cycle 2|Protocol Violation|0|||
148988810|NCT01261611|537436175|FG002|Treatment Cycle 2|Protocol Violation|0|||
148988811|NCT01261611|537436173|FG000|Treatment Cycle 2|Not otherwise specified|2|||
148988812|NCT01261611|537436174|FG001|Treatment Cycle 2|Not otherwise specified|0|||
148988813|NCT01261611|537436175|FG002|Treatment Cycle 2|Not otherwise specified|0|||
148988814|NCT01261611|537436173|FG000|Treatment Cycle 3|Completed study|24|||
148988815|NCT01261611|537436174|FG001|Treatment Cycle 3|Completed study|0|||
148988816|NCT01261611|537436175|FG002|Treatment Cycle 3|Completed study|0|||
148988817|NCT01261611|537436173|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
148988818|NCT01261611|537436174|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
148988819|NCT01261611|537436175|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
148988820|NCT01261611|537436173|FG000|Treatment Cycle 3|Adverse Event|1|||
148988821|NCT01261611|537436174|FG001|Treatment Cycle 3|Adverse Event|0|||
148988822|NCT01261611|537436175|FG002|Treatment Cycle 3|Adverse Event|0|||
148988823|NCT01261611|537436173|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
148988824|NCT01261611|537436174|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
148988825|NCT01261611|537436175|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
148988826|NCT01261611|537436173|FG000|Treatment Cycle 4|Completed study|87|||
148988827|NCT01261611|537436174|FG001|Treatment Cycle 4|Completed study|0|||
148988828|NCT01261611|537436175|FG002|Treatment Cycle 4|Completed study|0|||
148988829|NCT01261611|537436173|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
148988830|NCT01261611|537436174|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
148988831|NCT01261611|537436175|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
148988832|NCT01261611|537436173|FG000|Treatment Cycle 4|Adverse Event|1|||
148988833|NCT01261611|537436174|FG001|Treatment Cycle 4|Adverse Event|0|||
148988834|NCT01261611|537436175|FG002|Treatment Cycle 4|Adverse Event|0|||
148988835|NCT01261611|537436173|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
148988836|NCT01261611|537436174|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
148988837|NCT01261611|537436175|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
148988838|NCT01261611|537436173|FG000|Treatment Cycle 4|Not otherwise specified|3|||
148988839|NCT01261611|537436174|FG001|Treatment Cycle 4|Not otherwise specified|0|||
148988840|NCT01261611|537436175|FG002|Treatment Cycle 4|Not otherwise specified|0|||
148988841|NCT01261611|537436173|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
148988842|NCT01261611|537436174|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
148988843|NCT01261611|537436175|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
148988844|NCT01261611|537436173|FG000|Treatment Cycle 5|Adverse Event|1|||
148988845|NCT01261611|537436174|FG001|Treatment Cycle 5|Adverse Event|0|||
148988846|NCT01261611|537436175|FG002|Treatment Cycle 5|Adverse Event|0|||
148988847|NCT01261611|537436173|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
148988848|NCT01261611|537436174|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
148988849|NCT01261611|537436175|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
148988850|NCT02527798|537436176|FG000|Overall Study|Physician Decision|1|||
148988851|NCT02527798|537436177|FG001|Overall Study|Physician Decision|0|||
148988852|NCT02527798|537436178|FG002|Overall Study|Physician Decision|1|||
148856308|NCT00790868|536949537|FG000|Overall Study|Withdrawal by Subject|4|||
148856309|NCT00790868|536949538|FG001|Overall Study|Withdrawal by Subject|5|||
148856310|NCT00790868|536949537|FG000|Overall Study|Lost to Follow-up|2|||
148856311|NCT00790868|536949538|FG001|Overall Study|Lost to Follow-up|12|||
148856312|NCT01579565|536949539|FG000|Randomized|Adverse Event|1|||
148988853|NCT02527798|537436179|FG003|Overall Study|Physician Decision|1|||
148988854|NCT02527798|537436180|FG004|Overall Study|Physician Decision|0|||
148988855|NCT02527798|537436181|FG005|Overall Study|Physician Decision|0|||
148988856|NCT02527798|537436176|FG000|Overall Study|Death|0|||
148988857|NCT02527798|537436177|FG001|Overall Study|Death|0|||
148856313|NCT01579565|536949540|FG001|Randomized|Adverse Event|3|||
148988858|NCT02527798|537436178|FG002|Overall Study|Death|1|||
148988859|NCT02527798|537436179|FG003|Overall Study|Death|0|||
148988860|NCT02527798|537436180|FG004|Overall Study|Death|0|||
148988861|NCT02527798|537436181|FG005|Overall Study|Death|0|||
148988862|NCT02527798|537436176|FG000|Overall Study|Withdrawal by Subject|0|||
148988863|NCT02527798|537436177|FG001|Overall Study|Withdrawal by Subject|1|||
148988864|NCT02527798|537436178|FG002|Overall Study|Withdrawal by Subject|2|||
148988865|NCT02527798|537436179|FG003|Overall Study|Withdrawal by Subject|0|||
148988866|NCT02527798|537436180|FG004|Overall Study|Withdrawal by Subject|0|||
148988867|NCT02527798|537436181|FG005|Overall Study|Withdrawal by Subject|0|||
148988868|NCT02527798|537436176|FG000|Overall Study|Reason undisclosed|1|||
148856314|NCT01579565|536949539|FG000|Randomized|Withdrawal by Subject|3|||
148856315|NCT01579565|536949540|FG001|Randomized|Withdrawal by Subject|0|||
148856316|NCT01579565|536949539|FG000|Randomized|inadequate preoperative pupil dilation|0|||
148856317|NCT01579565|536949540|FG001|Randomized|inadequate preoperative pupil dilation|1|||
148856318|NCT01579565|536949539|FG000|Randomized|prohibited preoperative eating|1|||
148856319|NCT01579565|536949540|FG001|Randomized|prohibited preoperative eating|0|||
148856320|NCT01579565|536949539|FG000|Randomized|prohibited preoperative medication|0|||
148856321|NCT01579565|536949540|FG001|Randomized|prohibited preoperative medication|1|||
148856322|NCT01579565|536949539|FG000|Treated|Physician Decision|0|||
148856323|NCT01579565|536949540|FG001|Treated|Physician Decision|1|||
148856324|NCT01579565|536949539|FG000|Treated|Lost to Follow-up|2|||
148856325|NCT01579565|536949540|FG001|Treated|Lost to Follow-up|1|||
148856326|NCT01579565|536949539|FG000|Treated|declined to return for final visit|0|||
148856327|NCT01579565|536949540|FG001|Treated|declined to return for final visit|1|||
148856328|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Adverse Event|76|||
148856329|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Adverse Event|0|||
148856330|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Adverse Event|0|||
148856331|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Death|3|||
148856332|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Death|0|||
148856333|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Death|0|||
148856334|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
148856335|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
148856336|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
148856337|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Physician Decision|9|||
148856338|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Physician Decision|0|||
148856339|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Physician Decision|0|||
148856340|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
148856341|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
148856342|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
148856343|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Disease progression|45|||
148856344|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Disease progression|0|||
148856345|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Disease progression|0|||
148856346|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
148856347|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
148856348|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
148856349|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
148856350|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
148856351|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
148856352|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
148856353|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
148856354|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
148856355|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
148856356|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
148856357|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
148856358|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
149030594|NCT03822351|537589674|FG000|Overall Study|Not Treated|1|||
149030595|NCT03822351|537589675|FG001|Overall Study|Not Treated|1|||
149030596|NCT03822351|537589676|FG002|Overall Study|Not Treated|1|||
149030597|NCT02081391|537589685|FG000|12-hour Treatment|Withdrawal by Subject|3|||
149030598|NCT02081391|537589686|FG001|12-hour Treatment|Withdrawal by Subject|2|||
149030599|NCT02081391|537589687|FG002|12-hour Treatment|Withdrawal by Subject|0|||
149030600|NCT02081391|537589688|FG003|12-hour Treatment|Withdrawal by Subject|0|||
149030601|NCT02081391|537589685|FG000|12-hour Treatment|Physician Decision|4|||
148856359|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
148856360|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
148856361|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
148856362|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
148856363|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
148856364|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
148856365|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
148856366|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
148856367|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
148856368|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
148856369|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
148856370|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
148856371|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
149030602|NCT02081391|537589686|FG001|12-hour Treatment|Physician Decision|1|||
149030603|NCT02081391|537589687|FG002|12-hour Treatment|Physician Decision|0|||
149030604|NCT02081391|537589688|FG003|12-hour Treatment|Physician Decision|0|||
149030605|NCT02081391|537589685|FG000|12-hour Treatment|Lack of Efficacy|3|||
148988869|NCT02527798|537436177|FG001|Overall Study|Reason undisclosed|0|||
148988870|NCT02527798|537436178|FG002|Overall Study|Reason undisclosed|1|||
148988871|NCT02527798|537436179|FG003|Overall Study|Reason undisclosed|0|||
148988872|NCT02527798|537436180|FG004|Overall Study|Reason undisclosed|0|||
148988873|NCT02527798|537436181|FG005|Overall Study|Reason undisclosed|0|||
148988874|NCT02527798|537436176|FG000|Overall Study|Did not receive intervention|1|||
148988875|NCT02527798|537436177|FG001|Overall Study|Did not receive intervention|1|||
148988876|NCT02527798|537436178|FG002|Overall Study|Did not receive intervention|0|||
148988877|NCT02527798|537436179|FG003|Overall Study|Did not receive intervention|0|||
148988878|NCT02527798|537436180|FG004|Overall Study|Did not receive intervention|0|||
148988879|NCT02527798|537436181|FG005|Overall Study|Did not receive intervention|0|||
148988880|NCT01808690|537436183|FG000|Overall Study|Withdrawal by Subject|1|||
148988881|NCT01808690|537436184|FG001|Overall Study|Withdrawal by Subject|2|||
148988882|NCT02395120|537436185|FG000|Overall Study|Missed follow-up dental exam|57|||
148988883|NCT02395120|537436186|FG001|Overall Study|Missed follow-up dental exam|62|||
148988884|NCT02395120|537436187|FG002|Overall Study|Missed follow-up dental exam|6|||
148988885|NCT02395120|537436188|FG003|Overall Study|Missed follow-up dental exam|6|||
148988886|NCT02395120|537436189|FG004|Overall Study|Missed follow-up dental exam|51|||
148988887|NCT00377234|537436190|FG000|Overall Study|Adverse Event|14|||
148988888|NCT00377234|537436191|FG001|Overall Study|Adverse Event|17|||
148988889|NCT00377234|537436190|FG000|Overall Study|Withdrawal by Subject|11|||
148988890|NCT00377234|537436191|FG001|Overall Study|Withdrawal by Subject|9|||
148856372|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
148856373|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Promotor request|1|||
148856374|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Promotor request|0|||
148856375|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Promotor request|0|||
148856376|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
148856377|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
148856378|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
148856379|NCT01461928|536949543|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
148856380|NCT01461928|536949544|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
148856381|NCT01461928|536949545|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
148856382|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Death|3|||
148856383|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Death|0|||
148856384|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Death|0|||
148856385|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
148856386|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
148856387|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
148856388|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
148856389|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
148988891|NCT00377234|537436190|FG000|Overall Study|Lost to Follow-up|4|||
148988892|NCT00377234|537436191|FG001|Overall Study|Lost to Follow-up|2|||
148988893|NCT00377234|537436190|FG000|Overall Study|Administrative|2|||
148988894|NCT00377234|537436191|FG001|Overall Study|Administrative|1|||
148988895|NCT00377234|537436190|FG000|Overall Study|Not assigned|3|||
148988896|NCT00377234|537436191|FG001|Overall Study|Not assigned|2|||
148988897|NCT01159691|537436193|FG000|Overall Study|Lost to Follow-up|2|||
148988898|NCT01159691|537436193|FG000|Overall Study|Unknown reasons|1|||
148988899|NCT01159691|537436193|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
148988900|NCT01159691|537436193|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
148988901|NCT01159691|537436193|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
148988902|NCT01159691|537436193|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
148988903|NCT01159691|537436193|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
148988904|NCT01159691|537436193|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
148988905|NCT03725982|537436197|FG000|First Intervention|Withdrawal by Subject|0|||
148988906|NCT03725982|537436198|FG001|First Intervention|Withdrawal by Subject|1|||
148988907|NCT03725982|537436197|FG000|First Intervention|Physician Decision|1|||
148988908|NCT03725982|537436198|FG001|First Intervention|Physician Decision|1|||
148988909|NCT01944631|537436200|FG000|Overall Study|Adverse Event|1|||
148988910|NCT01944631|537436201|FG001|Overall Study|Adverse Event|0|||
148988911|NCT01944631|537436200|FG000|Overall Study|Lost to Follow-up|3|||
148988912|NCT01944631|537436201|FG001|Overall Study|Lost to Follow-up|1|||
148988913|NCT01944631|537436200|FG000|Overall Study|Withdrawal by Subject|0|||
148988914|NCT01944631|537436201|FG001|Overall Study|Withdrawal by Subject|1|||
148988915|NCT01003899|537436202|FG000|Overall Study|Other Adverse Event|8|||
148856390|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
148856391|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Diseases progression|91|||
148856392|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Diseases progression|0|||
148988916|NCT01003899|537436202|FG000|Overall Study|Not entered|4|||
148988917|NCT01003899|537436202|FG000|Overall Study|Not treated|1|||
148988918|NCT01003899|537436202|FG000|Overall Study|Progressive disease|34|||
148988919|NCT02489500|537436203|FG000|Overall Study|Death|1|||
148988920|NCT02489500|537436204|FG001|Overall Study|Death|1|||
148988921|NCT00599326|537436207|FG000|Overall Study|Lost to Follow-up|1|||
148856393|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Diseases progression|0|||
148856394|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Adverse Event|70|||
148856395|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Adverse Event|0|||
148856396|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Adverse Event|0|||
148856397|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Physician Decision|9|||
148856398|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Physician Decision|0|||
148856399|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Physician Decision|0|||
148856400|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
149030606|NCT02081391|537589686|FG001|12-hour Treatment|Lack of Efficacy|0|||
149030607|NCT02081391|537589687|FG002|12-hour Treatment|Lack of Efficacy|0|||
149030608|NCT02081391|537589688|FG003|12-hour Treatment|Lack of Efficacy|0|||
149030609|NCT02081391|537589685|FG000|12-hour Treatment|Adverse Event|4|||
149030610|NCT02081391|537589686|FG001|12-hour Treatment|Adverse Event|2|||
149030611|NCT02081391|537589687|FG002|12-hour Treatment|Adverse Event|0|||
149030612|NCT02081391|537589688|FG003|12-hour Treatment|Adverse Event|0|||
148856401|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
148856402|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
148856403|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
148856404|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
148856405|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
148856406|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
148856407|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
148856408|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
148856409|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Not compliant|1|||
148856410|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Not compliant|0|||
148856411|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Not compliant|0|||
148856412|NCT01461928|536949543|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
148856413|NCT01461928|536949544|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
148856414|NCT01461928|536949545|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
148856415|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Adverse Event|0|||
148856416|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Adverse Event|2|||
148856417|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Adverse Event|0|||
148856418|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Death|0|||
148856419|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Death|10|||
148856420|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Death|8|||
148856421|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Physician Decision|0|||
148856422|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Physician Decision|0|||
148856423|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Physician Decision|4|||
148856424|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
148856425|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
148856426|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
148856427|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Moved to another town|0|||
148856428|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Moved to another town|1|||
148856429|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Moved to another town|0|||
149030613|NCT02081391|537589685|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
149030614|NCT02081391|537589686|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
149030615|NCT02081391|537589687|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
149030616|NCT02081391|537589688|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
148856430|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Disease progression|0|||
148856431|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Disease progression|0|||
148856432|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Disease progression|3|||
148856433|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
148856434|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
148856435|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
148856436|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
148856437|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
148856438|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
148856439|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
148856440|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
148856441|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
148856442|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
148856443|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
148856444|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
148856445|NCT01461928|536949543|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
148856446|NCT01461928|536949544|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
148856447|NCT01461928|536949545|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
148856448|NCT02526524|536949547|FG000|Overall Study|Withdrawal by Subject|3|||
148856449|NCT02526524|536949548|FG001|Overall Study|Withdrawal by Subject|3|||
149030617|NCT02081391|537589685|FG000|12-hour Treatment|Further reasons|2|||
148988922|NCT00599326|537436207|FG000|Overall Study|Noncompliant|1|||
148988923|NCT00779246|537436212|FG000|Overall Study|Missing sufficient data for analysis|33|||
148988924|NCT00779246|537436213|FG001|Overall Study|Missing sufficient data for analysis|53|||
148988925|NCT03579459|537436214|FG000|Overall Study|Adverse Event|7|||
148988926|NCT03579459|537436215|FG001|Overall Study|Adverse Event|6|||
148988927|NCT03579459|537436216|FG002|Overall Study|Adverse Event|2|||
148988928|NCT03579459|537436217|FG003|Overall Study|Adverse Event|6|||
148988929|NCT03579459|537436214|FG000|Overall Study|Death|1|||
148988930|NCT03579459|537436215|FG001|Overall Study|Death|0|||
148988931|NCT03579459|537436216|FG002|Overall Study|Death|1|||
148988932|NCT03579459|537436217|FG003|Overall Study|Death|2|||
148988933|NCT03579459|537436214|FG000|Overall Study|Lost to Follow-up|6|||
148988934|NCT03579459|537436215|FG001|Overall Study|Lost to Follow-up|2|||
148988935|NCT03579459|537436216|FG002|Overall Study|Lost to Follow-up|4|||
148988936|NCT03579459|537436217|FG003|Overall Study|Lost to Follow-up|1|||
148988937|NCT03579459|537436214|FG000|Overall Study|Physician Decision|0|||
148988938|NCT03579459|537436215|FG001|Overall Study|Physician Decision|1|||
148988939|NCT03579459|537436216|FG002|Overall Study|Physician Decision|0|||
148988940|NCT03579459|537436217|FG003|Overall Study|Physician Decision|1|||
148988941|NCT03579459|537436214|FG000|Overall Study|Protocol Violation|1|||
148988942|NCT03579459|537436215|FG001|Overall Study|Protocol Violation|2|||
148988943|NCT03579459|537436216|FG002|Overall Study|Protocol Violation|3|||
148988944|NCT03579459|537436217|FG003|Overall Study|Protocol Violation|5|||
148988945|NCT03579459|537436214|FG000|Overall Study|Withdrawal by Subject|12|||
148988946|NCT03579459|537436215|FG001|Overall Study|Withdrawal by Subject|8|||
148988947|NCT03579459|537436216|FG002|Overall Study|Withdrawal by Subject|11|||
148988948|NCT03579459|537436217|FG003|Overall Study|Withdrawal by Subject|8|||
148988949|NCT03579459|537436214|FG000|Overall Study|Medication error without associated adverse event|2|||
148988950|NCT03579459|537436215|FG001|Overall Study|Medication error without associated adverse event|1|||
148988951|NCT03579459|537436216|FG002|Overall Study|Medication error without associated adverse event|1|||
148988952|NCT03579459|537436217|FG003|Overall Study|Medication error without associated adverse event|0|||
148988953|NCT03579459|537436214|FG000|Overall Study|Other|0|||
148988954|NCT03579459|537436215|FG001|Overall Study|Other|1|||
148988955|NCT03579459|537436216|FG002|Overall Study|Other|1|||
148988956|NCT03579459|537436217|FG003|Overall Study|Other|0|||
148988957|NCT03579459|537436214|FG000|Overall Study|Randomized not vaccinated|0|||
148988958|NCT03579459|537436215|FG001|Overall Study|Randomized not vaccinated|2|||
148988959|NCT03579459|537436216|FG002|Overall Study|Randomized not vaccinated|0|||
148988960|NCT03579459|537436217|FG003|Overall Study|Randomized not vaccinated|1|||
148988961|NCT00148343|537436220|FG000|Overall Study|Withdrawal by Subject|12|||
148988962|NCT00148343|537436221|FG001|Overall Study|Withdrawal by Subject|7|||
148988963|NCT00148343|537436220|FG000|Overall Study|Physician Decision|3|||
148988964|NCT00148343|537436221|FG001|Overall Study|Physician Decision|4|||
148988965|NCT02806986|537436222|FG000|Treatment Stage 1|Adverse Event|1|||
148988966|NCT02806986|537436222|FG000|Treatment Stage 2|Adverse Event|3|||
148988967|NCT02806986|537436222|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
148988968|NCT00407537|537436223|FG000|Overall Study|Death|5|||
148988969|NCT00407537|537436224|FG001|Overall Study|Death|2|||
148988970|NCT00407537|537436223|FG000|Overall Study|Adverse Event|36|||
148988971|NCT00407537|537436224|FG001|Overall Study|Adverse Event|0|||
148988972|NCT00407537|537436223|FG000|Overall Study|Lost to Follow-up|12|||
148988973|NCT00407537|537436224|FG001|Overall Study|Lost to Follow-up|19|||
148988974|NCT00407537|537436223|FG000|Overall Study|Other|6|||
148988975|NCT00407537|537436224|FG001|Overall Study|Other|7|||
148988976|NCT00407537|537436223|FG000|Overall Study|Withdrawal by Subject|34|||
148988977|NCT00407537|537436224|FG001|Overall Study|Withdrawal by Subject|16|||
148988978|NCT01380327|537436225|FG000|Overall Study|Lost to Follow-up|0|||
148988979|NCT01380327|537436226|FG001|Overall Study|Lost to Follow-up|1|||
148988980|NCT01380327|537436227|FG002|Overall Study|Lost to Follow-up|1|||
148988981|NCT01380327|537436225|FG000|Overall Study|Protocol Violation|3|||
148988982|NCT01380327|537436226|FG001|Overall Study|Protocol Violation|2|||
148988983|NCT01380327|537436227|FG002|Overall Study|Protocol Violation|3|||
148988984|NCT01380327|537436225|FG000|Overall Study|Withdrawal by Subject|0|||
148988985|NCT01380327|537436226|FG001|Overall Study|Withdrawal by Subject|0|||
148988986|NCT01380327|537436227|FG002|Overall Study|Withdrawal by Subject|1|||
148856450|NCT02526524|536949549|FG002|Overall Study|Withdrawal by Subject|6|||
148988987|NCT01380327|537436225|FG000|Overall Study|Housing situation precluded ability to k|0|||
148988988|NCT01380327|537436226|FG001|Overall Study|Housing situation precluded ability to k|0|||
148988989|NCT01380327|537436227|FG002|Overall Study|Housing situation precluded ability to k|1|||
148856451|NCT02526524|536949550|FG003|Overall Study|Withdrawal by Subject|1|||
148988990|NCT01380327|537436225|FG000|Overall Study|Questionable onset of epilepsy|0|||
148988991|NCT01380327|537436226|FG001|Overall Study|Questionable onset of epilepsy|0|||
148988992|NCT01380327|537436227|FG002|Overall Study|Questionable onset of epilepsy|1|||
148988993|NCT05046795|537436228|FG000|Overall Study|Adverse Event|13|||
148988994|NCT05046795|537436229|FG001|Overall Study|Adverse Event|15|||
148856452|NCT02526524|536949551|FG004|Overall Study|Withdrawal by Subject|9|||
148988995|NCT05046795|537436228|FG000|Overall Study|Withdrawal by Subject|4|||
148988996|NCT05046795|537436229|FG001|Overall Study|Withdrawal by Subject|7|||
148856453|NCT02526524|536949552|FG005|Overall Study|Withdrawal by Subject|5|||
148856454|NCT02526524|536949547|FG000|Overall Study|Adverse Event|3|||
148856455|NCT02526524|536949548|FG001|Overall Study|Adverse Event|2|||
148856456|NCT02526524|536949549|FG002|Overall Study|Adverse Event|4|||
148856457|NCT02526524|536949550|FG003|Overall Study|Adverse Event|2|||
148856458|NCT02526524|536949551|FG004|Overall Study|Adverse Event|6|||
148856459|NCT02526524|536949552|FG005|Overall Study|Adverse Event|8|||
148856460|NCT02526524|536949547|FG000|Overall Study|Lost to Follow-up|2|||
148856461|NCT02526524|536949548|FG001|Overall Study|Lost to Follow-up|3|||
148856462|NCT02526524|536949549|FG002|Overall Study|Lost to Follow-up|8|||
148856463|NCT02526524|536949550|FG003|Overall Study|Lost to Follow-up|1|||
148856464|NCT02526524|536949551|FG004|Overall Study|Lost to Follow-up|2|||
148856465|NCT02526524|536949552|FG005|Overall Study|Lost to Follow-up|5|||
148856466|NCT02526524|536949547|FG000|Overall Study|Protocol Violation|3|||
148856467|NCT02526524|536949548|FG001|Overall Study|Protocol Violation|1|||
148856468|NCT02526524|536949549|FG002|Overall Study|Protocol Violation|5|||
148856469|NCT02526524|536949550|FG003|Overall Study|Protocol Violation|3|||
148856470|NCT02526524|536949551|FG004|Overall Study|Protocol Violation|4|||
148856471|NCT02526524|536949552|FG005|Overall Study|Protocol Violation|3|||
148856472|NCT02526524|536949547|FG000|Overall Study|Loss of Glucose Control|0|||
148856473|NCT02526524|536949548|FG001|Overall Study|Loss of Glucose Control|0|||
148856474|NCT02526524|536949549|FG002|Overall Study|Loss of Glucose Control|3|||
148856475|NCT02526524|536949550|FG003|Overall Study|Loss of Glucose Control|0|||
148856476|NCT02526524|536949551|FG004|Overall Study|Loss of Glucose Control|2|||
148856477|NCT02526524|536949552|FG005|Overall Study|Loss of Glucose Control|0|||
148856478|NCT02526524|536949547|FG000|Overall Study|Physician Decision|0|||
148856479|NCT02526524|536949548|FG001|Overall Study|Physician Decision|0|||
148856480|NCT02526524|536949549|FG002|Overall Study|Physician Decision|0|||
148856481|NCT02526524|536949550|FG003|Overall Study|Physician Decision|0|||
148856482|NCT02526524|536949551|FG004|Overall Study|Physician Decision|1|||
148856483|NCT02526524|536949552|FG005|Overall Study|Physician Decision|0|||
148856484|NCT02526524|536949547|FG000|Overall Study|Sponsor Decision|1|||
148856485|NCT02526524|536949548|FG001|Overall Study|Sponsor Decision|0|||
148856486|NCT02526524|536949549|FG002|Overall Study|Sponsor Decision|0|||
148856487|NCT02526524|536949550|FG003|Overall Study|Sponsor Decision|0|||
148856488|NCT02526524|536949551|FG004|Overall Study|Sponsor Decision|0|||
148856489|NCT02526524|536949552|FG005|Overall Study|Sponsor Decision|0|||
148856490|NCT00664560|536949558|FG000|Overall Study|Adverse Event|19|||
148856491|NCT00664560|536949559|FG001|Overall Study|Adverse Event|16|||
148856492|NCT00664560|536949560|FG002|Overall Study|Adverse Event|7|||
148856493|NCT00664560|536949558|FG000|Overall Study|Withdrawal by Subject|9|||
148856494|NCT00664560|536949559|FG001|Overall Study|Withdrawal by Subject|13|||
148856495|NCT00664560|536949560|FG002|Overall Study|Withdrawal by Subject|7|||
148856496|NCT00664560|536949558|FG000|Overall Study|Lost to Follow-up|0|||
148856497|NCT00664560|536949559|FG001|Overall Study|Lost to Follow-up|2|||
148856498|NCT00664560|536949560|FG002|Overall Study|Lost to Follow-up|0|||
148856499|NCT00664560|536949558|FG000|Overall Study|Other|11|||
148856500|NCT00664560|536949559|FG001|Overall Study|Other|4|||
148856501|NCT00664560|536949560|FG002|Overall Study|Other|5|||
148856502|NCT02456636|536949561|FG000|Overall Study|Death|0|||
148856503|NCT02456636|536949562|FG001|Overall Study|Death|3|||
148856504|NCT02456636|536949563|FG002|Overall Study|Death|0|||
148856505|NCT02456636|536949561|FG000|Overall Study|Pregnancy|1|||
148988997|NCT05046795|537436228|FG000|Overall Study|Physician Decision|1|||
148988998|NCT05046795|537436229|FG001|Overall Study|Physician Decision|2|||
148988999|NCT05046795|537436228|FG000|Overall Study|Protocol Violation|1|||
148989000|NCT05046795|537436229|FG001|Overall Study|Protocol Violation|2|||
148989001|NCT05046795|537436228|FG000|Overall Study|Death|1|||
148989002|NCT05046795|537436229|FG001|Overall Study|Death|0|||
148989003|NCT05046795|537436228|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
148989004|NCT05046795|537436229|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
148989005|NCT01127178|537436230|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
148989006|NCT01127178|537436231|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
148989007|NCT01127178|537436230|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
148856506|NCT02456636|536949562|FG001|Overall Study|Pregnancy|3|||
148856507|NCT02456636|536949563|FG002|Overall Study|Pregnancy|5|||
148856508|NCT02456636|536949561|FG000|Overall Study|Physician Decision|4|||
148856509|NCT02456636|536949562|FG001|Overall Study|Physician Decision|5|||
148856510|NCT02456636|536949563|FG002|Overall Study|Physician Decision|4|||
148856511|NCT02456636|536949561|FG000|Overall Study|Withdrawal by Subject|13|||
148989008|NCT01127178|537436231|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
148989009|NCT01127178|537436230|FG000|Dose Escalation: Treatment Phase|Other|2|||
148989010|NCT01127178|537436231|FG001|Dose Escalation: Treatment Phase|Other|0|||
148989011|NCT01127178|537436230|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
148856512|NCT02456636|536949562|FG001|Overall Study|Withdrawal by Subject|14|||
148856513|NCT02456636|536949563|FG002|Overall Study|Withdrawal by Subject|16|||
148856514|NCT02456636|536949561|FG000|Overall Study|Lost to Follow-up|50|||
148856515|NCT02456636|536949562|FG001|Overall Study|Lost to Follow-up|44|||
148856516|NCT02456636|536949563|FG002|Overall Study|Lost to Follow-up|50|||
148989012|NCT01127178|537436231|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
148989013|NCT01127178|537436230|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
148989014|NCT01127178|537436231|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
148989015|NCT01127178|537436230|FG000|Dose Escalation: Extension Phase|Other|1|||
148989016|NCT01127178|537436231|FG001|Dose Escalation: Extension Phase|Other|0|||
148989017|NCT00413413|537436232|FG000|Single-Blind|Adverse Event|0|||
148989018|NCT00413413|537436233|FG001|Single-Blind|Adverse Event|9|||
148989019|NCT00413413|537436234|FG002|Single-Blind|Adverse Event|0|||
148989020|NCT00413413|537436232|FG000|Single-Blind|Lack of Efficacy|0|||
148989021|NCT00413413|537436233|FG001|Single-Blind|Lack of Efficacy|5|||
148989022|NCT00413413|537436234|FG002|Single-Blind|Lack of Efficacy|0|||
148989023|NCT00413413|537436232|FG000|Single-Blind|Subject no longer requires study drug|0|||
148989024|NCT00413413|537436233|FG001|Single-Blind|Subject no longer requires study drug|151|||
148989025|NCT00413413|537436234|FG002|Single-Blind|Subject no longer requires study drug|0|||
148989026|NCT00413413|537436232|FG000|Single-Blind|Protocol Violation|0|||
148989027|NCT00413413|537436233|FG001|Single-Blind|Protocol Violation|16|||
148989028|NCT00413413|537436234|FG002|Single-Blind|Protocol Violation|0|||
148989029|NCT00413413|537436232|FG000|Single-Blind|Withdrawal by Subject|0|||
148989030|NCT00413413|537436233|FG001|Single-Blind|Withdrawal by Subject|27|||
148989031|NCT00413413|537436234|FG002|Single-Blind|Withdrawal by Subject|0|||
148989032|NCT00413413|537436232|FG000|Single-Blind|Lost to Follow-up|0|||
148989033|NCT00413413|537436233|FG001|Single-Blind|Lost to Follow-up|8|||
148989034|NCT00413413|537436234|FG002|Single-Blind|Lost to Follow-up|0|||
148989035|NCT00413413|537436232|FG000|Double-Blind|Adverse Event|6|||
148989036|NCT00413413|537436233|FG001|Double-Blind|Adverse Event|0|||
148989037|NCT00413413|537436234|FG002|Double-Blind|Adverse Event|5|||
148989038|NCT00413413|537436232|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
148989039|NCT00413413|537436233|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
148989040|NCT00413413|537436234|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
148989041|NCT00413413|537436232|FG000|Double-Blind|Protocol deviation|1|||
148989042|NCT00413413|537436233|FG001|Double-Blind|Protocol deviation|2|||
148989043|NCT00413413|537436234|FG002|Double-Blind|Protocol deviation|1|||
148989044|NCT00413413|537436232|FG000|Double-Blind|Subject withdrew consent|4|||
148989045|NCT00413413|537436233|FG001|Double-Blind|Subject withdrew consent|6|||
148989046|NCT00413413|537436234|FG002|Double-Blind|Subject withdrew consent|9|||
148989047|NCT00413413|537436232|FG000|Double-Blind|Lost to Follow-up|3|||
148989048|NCT00413413|537436233|FG001|Double-Blind|Lost to Follow-up|4|||
148989049|NCT00413413|537436234|FG002|Double-Blind|Lost to Follow-up|2|||
148989050|NCT00096135|537436244|FG000|Overall Study|Physician Decision|20|||
148989051|NCT00096135|537436245|FG001|Overall Study|Physician Decision|4|||
148989052|NCT00096135|537436244|FG000|Overall Study|Refusal of further protocol therapy|4|||
148989053|NCT00096135|537436245|FG001|Overall Study|Refusal of further protocol therapy|1|||
148989054|NCT00096135|537436244|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
148989055|NCT00096135|537436245|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
148989056|NCT00096135|537436244|FG000|Overall Study|Other, specify|15|||
148989057|NCT00096135|537436245|FG001|Overall Study|Other, specify|3|||
148989058|NCT00096135|537436244|FG000|Overall Study|Ineligible|2|||
148989059|NCT00096135|537436245|FG001|Overall Study|Ineligible|0|||
148989060|NCT02365467|537436246|FG000|Overall Study|Death|3|||
148989061|NCT02043782|537436247|FG000|Period 1|Adverse Event|0|||
148989062|NCT02043782|537436248|FG001|Period 1|Adverse Event|0|||
148989063|NCT02043782|537436249|FG002|Period 1|Adverse Event|1|||
148989064|NCT02043782|537436250|FG003|Period 1|Adverse Event|0|||
148989065|NCT02043782|537436251|FG004|Period 1|Adverse Event|0|||
148989066|NCT02043782|537436252|FG005|Period 1|Adverse Event|0|||
148989067|NCT00709722|537436253|FG000|Overall Study|Adverse Event|1|||
148989068|NCT01306162|537436254|FG000|Period 1|Adverse Event|0|||
148989069|NCT01306162|537436255|FG001|Period 1|Adverse Event|0|||
148989070|NCT01306162|537436256|FG002|Period 1|Adverse Event|0|||
148989071|NCT01306162|537436257|FG003|Period 1|Adverse Event|1|||
148989072|NCT01306162|537436254|FG000|Washout 1|Non-compliance to protocol|0|||
148989073|NCT01306162|537436255|FG001|Washout 1|Non-compliance to protocol|1|||
148989074|NCT01306162|537436256|FG002|Washout 1|Non-compliance to protocol|0|||
148989075|NCT01306162|537436257|FG003|Washout 1|Non-compliance to protocol|0|||
148989076|NCT02952924|537436263|FG000|Overall Study|Protocol Violation|0|||
148989077|NCT02952924|537436264|FG001|Overall Study|Protocol Violation|0|||
148989078|NCT02952924|537436265|FG002|Overall Study|Protocol Violation|0|||
148989079|NCT02952924|537436266|FG003|Overall Study|Protocol Violation|0|||
148989080|NCT02952924|537436267|FG004|Overall Study|Protocol Violation|0|||
148989081|NCT02952924|537436268|FG005|Overall Study|Protocol Violation|0|||
148989082|NCT02952924|537436269|FG006|Overall Study|Protocol Violation|0|||
148989083|NCT02952924|537436270|FG007|Overall Study|Protocol Violation|0|||
148989084|NCT02952924|537436271|FG008|Overall Study|Protocol Violation|0|||
148989085|NCT02952924|537436272|FG009|Overall Study|Protocol Violation|0|||
148989086|NCT02952924|537436273|FG010|Overall Study|Protocol Violation|0|||
148989087|NCT02952924|537436274|FG011|Overall Study|Protocol Violation|0|||
148989088|NCT02952924|537436275|FG012|Overall Study|Protocol Violation|0|||
148989089|NCT02952924|537436276|FG013|Overall Study|Protocol Violation|0|||
148856517|NCT02379221|536949566|FG000|Overall Study|Lost to Follow-up|1|||
148856518|NCT02019108|536949567|FG000|Overall Study|Lost to Follow-up|5|||
148856519|NCT02019108|536949568|FG001|Overall Study|Lost to Follow-up|7|||
148856520|NCT05260073|536949576|FG000|Overall Study|Physician Decision|1|||
148856521|NCT05260073|536949576|FG000|Overall Study|Withdrawal by Subject|6|||
148856522|NCT05260073|536949576|FG000|Overall Study|Lost to Follow-up|14|||
148856523|NCT04484649|536949577|FG000|Overall Study|Lost to Follow-up|2|||
148856524|NCT04484649|536949578|FG001|Overall Study|Lost to Follow-up|1|||
148856525|NCT04484649|536949577|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
148856526|NCT04484649|536949578|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
148856527|NCT01463696|536949586|FG000|Overall Study|Adverse Event|0|||
148856528|NCT01463696|536949587|FG001|Overall Study|Adverse Event|1|||
148856529|NCT01463696|536949588|FG002|Overall Study|Adverse Event|0|||
148856530|NCT01463696|536949589|FG003|Overall Study|Adverse Event|2|||
148856531|NCT01463696|536949590|FG004|Overall Study|Adverse Event|0|||
148856532|NCT01463696|536949591|FG005|Overall Study|Adverse Event|1|||
148856533|NCT01463696|536949592|FG006|Overall Study|Adverse Event|3|||
148856534|NCT01463696|536949593|FG007|Overall Study|Adverse Event|2|||
148856535|NCT01463696|536949586|FG000|Overall Study|Lost to Follow-up|0|||
148856536|NCT01463696|536949587|FG001|Overall Study|Lost to Follow-up|0|||
148856537|NCT01463696|536949588|FG002|Overall Study|Lost to Follow-up|1|||
148856538|NCT01463696|536949589|FG003|Overall Study|Lost to Follow-up|0|||
148856539|NCT01463696|536949590|FG004|Overall Study|Lost to Follow-up|0|||
148856540|NCT01463696|536949591|FG005|Overall Study|Lost to Follow-up|0|||
148856541|NCT01463696|536949592|FG006|Overall Study|Lost to Follow-up|0|||
148856542|NCT01463696|536949593|FG007|Overall Study|Lost to Follow-up|0|||
148856543|NCT01463696|536949586|FG000|Overall Study|Progressive Disease|0|||
148856544|NCT01463696|536949587|FG001|Overall Study|Progressive Disease|1|||
148856545|NCT01463696|536949588|FG002|Overall Study|Progressive Disease|0|||
148856546|NCT01463696|536949589|FG003|Overall Study|Progressive Disease|1|||
148856547|NCT01463696|536949590|FG004|Overall Study|Progressive Disease|0|||
148856548|NCT01463696|536949591|FG005|Overall Study|Progressive Disease|1|||
148856549|NCT01463696|536949592|FG006|Overall Study|Progressive Disease|4|||
148856550|NCT01463696|536949593|FG007|Overall Study|Progressive Disease|2|||
148856551|NCT01463696|536949586|FG000|Overall Study|Withdrawal by Subject|0|||
148856552|NCT01463696|536949587|FG001|Overall Study|Withdrawal by Subject|0|||
148856553|NCT01463696|536949588|FG002|Overall Study|Withdrawal by Subject|0|||
148856554|NCT01463696|536949589|FG003|Overall Study|Withdrawal by Subject|1|||
148856555|NCT01463696|536949590|FG004|Overall Study|Withdrawal by Subject|1|||
148856556|NCT01463696|536949591|FG005|Overall Study|Withdrawal by Subject|1|||
148856557|NCT01463696|536949592|FG006|Overall Study|Withdrawal by Subject|2|||
148856558|NCT01463696|536949593|FG007|Overall Study|Withdrawal by Subject|0|||
148856559|NCT01463696|536949586|FG000|Overall Study|Not Treated|0|||
148856560|NCT01463696|536949587|FG001|Overall Study|Not Treated|0|||
148856561|NCT01463696|536949588|FG002|Overall Study|Not Treated|0|||
148856562|NCT01463696|536949589|FG003|Overall Study|Not Treated|0|||
148856563|NCT01463696|536949590|FG004|Overall Study|Not Treated|0|||
148856564|NCT01463696|536949591|FG005|Overall Study|Not Treated|0|||
148856565|NCT01463696|536949592|FG006|Overall Study|Not Treated|1|||
148856566|NCT01463696|536949593|FG007|Overall Study|Not Treated|0|||
148856567|NCT00967694|536949599|FG000|Overall Study|Withdrawal by Subject|6|||
148856568|NCT03905265|536949611|FG000|Overall Study|Withdrawal by Subject|1|||
148856569|NCT03905265|536949612|FG001|Overall Study|Withdrawal by Subject|1|||
148856570|NCT03905265|536949613|FG002|Overall Study|Withdrawal by Subject|0|||
148856571|NCT03905265|536949614|FG003|Overall Study|Withdrawal by Subject|0|||
148856572|NCT00960011|536949615|FG000|Overall Study|Death|5|||
148856573|NCT00960011|536949616|FG001|Overall Study|Death|0|||
148856574|NCT00960011|536949615|FG000|Overall Study|Lost to Follow-up|6|||
148856575|NCT00960011|536949616|FG001|Overall Study|Lost to Follow-up|2|||
148856576|NCT04417218|536949617|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
148856577|NCT04417218|536949618|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
148856578|NCT00758264|536949619|FG000|Active Phase|Withdrawal by Subject|0|||
148856579|NCT00758264|536949620|FG001|Active Phase|Withdrawal by Subject|0|||
148856580|NCT00758264|536949621|FG002|Active Phase|Withdrawal by Subject|1|||
148856581|NCT00758264|536949619|FG000|Active Phase|Lost to Follow-up|1|||
148856582|NCT00758264|536949620|FG001|Active Phase|Lost to Follow-up|0|||
148989090|NCT02952924|537436277|FG014|Overall Study|Protocol Violation|0|||
148989091|NCT02952924|537436278|FG015|Overall Study|Protocol Violation|0|||
148989092|NCT02952924|537436279|FG016|Overall Study|Protocol Violation|0|||
148989093|NCT02952924|537436280|FG017|Overall Study|Protocol Violation|0|||
148989094|NCT02952924|537436281|FG018|Overall Study|Protocol Violation|0|||
148856583|NCT00758264|536949621|FG002|Active Phase|Lost to Follow-up|0|||
148856584|NCT00758264|536949619|FG000|Active Phase|Other|0|||
148856585|NCT00758264|536949620|FG001|Active Phase|Other|0|||
148856586|NCT00758264|536949621|FG002|Active Phase|Other|4|||
148856587|NCT00889603|536949622|FG000|Overall Study|Adverse Event|7|||
148856588|NCT00889603|536949622|FG000|Overall Study|Death|3|||
148856589|NCT00889603|536949622|FG000|Overall Study|Lost to Follow-up|19|||
148856590|NCT00889603|536949622|FG000|Overall Study|No longer willing to participant in stud|4|||
148989095|NCT02952924|537436282|FG019|Overall Study|Protocol Violation|1|||
148989096|NCT02952924|537436283|FG020|Overall Study|Protocol Violation|0|||
148989097|NCT02952924|537436284|FG021|Overall Study|Protocol Violation|0|||
148989098|NCT02952924|537436263|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
148989099|NCT02952924|537436264|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
148989100|NCT02952924|537436265|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
148989101|NCT02952924|537436266|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
148989102|NCT02952924|537436267|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
148989103|NCT02952924|537436268|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
148989104|NCT02952924|537436269|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
148989105|NCT02952924|537436270|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
148989106|NCT02952924|537436271|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
148989107|NCT02952924|537436272|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
148989108|NCT02952924|537436273|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
148989109|NCT02952924|537436274|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
148989110|NCT02952924|537436275|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
148989111|NCT02952924|537436276|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
148989112|NCT02952924|537436277|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
148989113|NCT02952924|537436278|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
148989114|NCT02952924|537436279|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
148989115|NCT02952924|537436280|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
148989116|NCT02952924|537436281|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
148989117|NCT02952924|537436282|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
148989118|NCT02952924|537436283|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
148989119|NCT02952924|537436284|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
148989120|NCT02952924|537436263|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989121|NCT02952924|537436264|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989122|NCT02952924|537436265|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989123|NCT02952924|537436266|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989124|NCT02952924|537436267|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989125|NCT02952924|537436268|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989126|NCT02952924|537436269|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989127|NCT02952924|537436270|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989128|NCT02952924|537436271|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989129|NCT02952924|537436272|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989130|NCT02952924|537436273|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989131|NCT02952924|537436274|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989132|NCT02952924|537436275|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989133|NCT02952924|537436276|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989134|NCT02952924|537436277|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989135|NCT02952924|537436278|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989136|NCT02952924|537436279|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989137|NCT02952924|537436280|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989138|NCT02952924|537436281|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989139|NCT02952924|537436282|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989140|NCT02952924|537436283|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
148989141|NCT02952924|537436284|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
148989142|NCT02952924|537436263|FG000|Overall Study|Noncompliance with study drug|0|||
148989143|NCT02952924|537436264|FG001|Overall Study|Noncompliance with study drug|0|||
148989144|NCT02952924|537436265|FG002|Overall Study|Noncompliance with study drug|0|||
148989145|NCT02952924|537436266|FG003|Overall Study|Noncompliance with study drug|0|||
148989146|NCT02952924|537436267|FG004|Overall Study|Noncompliance with study drug|0|||
148989147|NCT02952924|537436268|FG005|Overall Study|Noncompliance with study drug|0|||
148989148|NCT02952924|537436269|FG006|Overall Study|Noncompliance with study drug|0|||
148989149|NCT02952924|537436270|FG007|Overall Study|Noncompliance with study drug|0|||
148989150|NCT02952924|537436271|FG008|Overall Study|Noncompliance with study drug|0|||
148989151|NCT02952924|537436272|FG009|Overall Study|Noncompliance with study drug|0|||
148989152|NCT02952924|537436273|FG010|Overall Study|Noncompliance with study drug|0|||
148989153|NCT02952924|537436274|FG011|Overall Study|Noncompliance with study drug|0|||
148989154|NCT02952924|537436275|FG012|Overall Study|Noncompliance with study drug|0|||
148989155|NCT02952924|537436276|FG013|Overall Study|Noncompliance with study drug|0|||
148989156|NCT02952924|537436277|FG014|Overall Study|Noncompliance with study drug|0|||
148989157|NCT02952924|537436278|FG015|Overall Study|Noncompliance with study drug|0|||
148989158|NCT02952924|537436279|FG016|Overall Study|Noncompliance with study drug|0|||
149030618|NCT02081391|537589686|FG001|12-hour Treatment|Further reasons|1|||
148856591|NCT00889603|536949622|FG000|Overall Study|Other|4|||
148856592|NCT03718884|536949627|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
148856593|NCT03718884|536949628|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
148856594|NCT03718884|536949627|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
148856595|NCT03718884|536949628|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
148856596|NCT02839720|536949630|FG000|Overall Study|Adverse Event|2|||
148856597|NCT02839720|536949630|FG000|Overall Study|Non-compliance|2|||
148856598|NCT02839720|536949630|FG000|Overall Study|Intercurrent Illness|1|||
148856599|NCT02839720|536949630|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
148856600|NCT05248997|536949633|FG000|Overall Study|Lost to Follow-up|1|||
148856601|NCT05248997|536949634|FG001|Overall Study|Lost to Follow-up|1|||
148856602|NCT05248997|536949633|FG000|Overall Study|Randomized but not treated|32|||
148856603|NCT05248997|536949634|FG001|Overall Study|Randomized but not treated|25|||
148856604|NCT01453205|536949635|FG000|Overall Study|Lost to Follow-up|3|||
148856605|NCT01453205|536949636|FG001|Overall Study|Lost to Follow-up|0|||
148856606|NCT01453205|536949637|FG002|Overall Study|Lost to Follow-up|1|||
148856607|NCT01453205|536949635|FG000|Overall Study|Withdrawal by Subject|8|||
148856608|NCT01453205|536949636|FG001|Overall Study|Withdrawal by Subject|3|||
148856609|NCT01453205|536949637|FG002|Overall Study|Withdrawal by Subject|0|||
148856610|NCT01453205|536949635|FG000|Overall Study|Death|24|||
148856611|NCT01453205|536949636|FG001|Overall Study|Death|22|||
148856612|NCT01453205|536949637|FG002|Overall Study|Death|18|||
148856613|NCT01453205|536949635|FG000|Overall Study|Other|45|||
148856614|NCT01453205|536949636|FG001|Overall Study|Other|27|||
148856615|NCT01453205|536949637|FG002|Overall Study|Other|35|||
148856616|NCT05593913|536949638|FG000|Overall Study|Insufficient image quality|39|||
148856617|NCT02602275|536949639|FG000|Day 1|Physician Decision|0|||
148856618|NCT02602275|536949640|FG001|Day 1|Physician Decision|1|||
148856619|NCT04113018|536949647|FG000|Overall Study|Death|2|||
148856620|NCT04113018|536949647|FG000|Overall Study|Lost to Follow-up|1|||
148856621|NCT04113018|536949647|FG000|Overall Study|Still On Study (on study treatment)|24|||
148856622|NCT04113018|536949647|FG000|Overall Study|Still On Study (in follow up)|12|||
148856623|NCT05005013|536949648|FG000|Overall Study|Withdrawal by Subject|5|||
148856624|NCT05005013|536949649|FG001|Overall Study|Withdrawal by Subject|1|||
148856625|NCT05005013|536949648|FG000|Overall Study|Lost to Follow-up|3|||
148856626|NCT05005013|536949649|FG001|Overall Study|Lost to Follow-up|1|||
148856627|NCT05005013|536949648|FG000|Overall Study|Ineligibility|1|||
148856628|NCT05005013|536949649|FG001|Overall Study|Ineligibility|1|||
148856629|NCT02059499|536949650|FG000|Upto Week 20|Lost to Follow-up|2|||
148856630|NCT02059499|536949651|FG001|Upto Week 20|Lost to Follow-up|6|||
148856631|NCT02059499|536949652|FG002|Upto Week 20|Lost to Follow-up|0|||
148856632|NCT02059499|536949650|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
148856633|NCT02059499|536949651|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
148856634|NCT02059499|536949652|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
148856635|NCT02059499|536949650|FG000|Upto Week 20|Withdrawal by Subject|1|||
148856636|NCT02059499|536949651|FG001|Upto Week 20|Withdrawal by Subject|1|||
148856637|NCT02059499|536949652|FG002|Upto Week 20|Withdrawal by Subject|0|||
148856638|NCT02059499|536949650|FG000|Upto Week 20|No treatment per protocol criteria|0|||
148856639|NCT02059499|536949651|FG001|Upto Week 20|No treatment per protocol criteria|0|||
148856640|NCT02059499|536949652|FG002|Upto Week 20|No treatment per protocol criteria|5|||
148856641|NCT02059499|536949650|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
148856642|NCT02059499|536949651|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
148856643|NCT02059499|536949652|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
148856644|NCT02059499|536949650|FG000|Post-week 20|Lost to Follow-up|0|||
148856645|NCT02059499|536949651|FG001|Post-week 20|Lost to Follow-up|2|||
148856646|NCT02059499|536949652|FG002|Post-week 20|Lost to Follow-up|0|||
148856647|NCT02059499|536949650|FG000|Post-week 20|Withdrawal by Subject|0|||
148856648|NCT02059499|536949651|FG001|Post-week 20|Withdrawal by Subject|1|||
148856649|NCT02059499|536949652|FG002|Post-week 20|Withdrawal by Subject|0|||
148856650|NCT02059499|536949650|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
148856651|NCT02059499|536949651|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
148989159|NCT02952924|537436280|FG017|Overall Study|Noncompliance with study drug|0|||
148989160|NCT02952924|537436281|FG018|Overall Study|Noncompliance with study drug|0|||
148989161|NCT02952924|537436282|FG019|Overall Study|Noncompliance with study drug|0|||
148989162|NCT02952924|537436283|FG020|Overall Study|Noncompliance with study drug|0|||
148989163|NCT02952924|537436284|FG021|Overall Study|Noncompliance with study drug|1|||
148856652|NCT02059499|536949652|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
148856653|NCT04210245|536949653|FG000|Overall Study|Adverse Event|0|||
148856654|NCT04210245|536949654|FG001|Overall Study|Adverse Event|3|||
148989164|NCT01226745|537436285|FG000|Overall Study|Did not complete schedule of assessments|8|||
148856655|NCT04210245|536949655|FG002|Overall Study|Adverse Event|6|||
148856656|NCT04210245|536949656|FG003|Overall Study|Adverse Event|0|||
148856657|NCT04210245|536949653|FG000|Overall Study|Withdrawal by Subject|0|||
148856658|NCT04210245|536949654|FG001|Overall Study|Withdrawal by Subject|1|||
148856659|NCT04210245|536949655|FG002|Overall Study|Withdrawal by Subject|4|||
148856660|NCT04210245|536949656|FG003|Overall Study|Withdrawal by Subject|4|||
148989165|NCT01226745|537436286|FG001|Overall Study|Did not complete schedule of assessments|3|||
148989166|NCT01226745|537436287|FG002|Overall Study|Did not complete schedule of assessments|6|||
148989167|NCT01226745|537436288|FG003|Overall Study|Did not complete schedule of assessments|0|||
148989168|NCT01226745|537436289|FG004|Overall Study|Did not complete schedule of assessments|0|||
148989169|NCT01226745|537436290|FG005|Overall Study|Did not complete schedule of assessments|1|||
148989170|NCT01226745|537436285|FG000|Overall Study|Lost to Follow-up|2|||
148989171|NCT01226745|537436286|FG001|Overall Study|Lost to Follow-up|6|||
148989172|NCT01226745|537436287|FG002|Overall Study|Lost to Follow-up|6|||
148989173|NCT01226745|537436288|FG003|Overall Study|Lost to Follow-up|1|||
148989174|NCT01226745|537436289|FG004|Overall Study|Lost to Follow-up|1|||
148989175|NCT01226745|537436290|FG005|Overall Study|Lost to Follow-up|2|||
148989176|NCT01226745|537436285|FG000|Overall Study|Death|1|||
148989177|NCT01226745|537436286|FG001|Overall Study|Death|0|||
148989178|NCT01226745|537436287|FG002|Overall Study|Death|0|||
148989179|NCT01226745|537436288|FG003|Overall Study|Death|0|||
148989180|NCT01226745|537436289|FG004|Overall Study|Death|0|||
148989181|NCT01226745|537436290|FG005|Overall Study|Death|1|||
148989182|NCT01226745|537436285|FG000|Overall Study|Other|6|||
148989183|NCT01226745|537436286|FG001|Overall Study|Other|7|||
148989184|NCT01226745|537436287|FG002|Overall Study|Other|8|||
148989185|NCT01226745|537436288|FG003|Overall Study|Other|4|||
148989186|NCT01226745|537436289|FG004|Overall Study|Other|3|||
148989187|NCT01226745|537436290|FG005|Overall Study|Other|1|||
148989188|NCT01435577|537436291|FG000|Overall Study|Adverse Event|10|||
148989189|NCT01435577|537436292|FG001|Overall Study|Adverse Event|0|||
148989190|NCT01435577|537436291|FG000|Overall Study|Lack of Efficacy|7|||
148989191|NCT01435577|537436292|FG001|Overall Study|Lack of Efficacy|51|||
148989192|NCT01435577|537436291|FG000|Overall Study|Alternative treatment started|0|||
148989193|NCT01435577|537436292|FG001|Overall Study|Alternative treatment started|1|||
148989194|NCT00759109|537436294|FG000|Overall Study|Adverse Event|17|||
148989195|NCT00759109|537436295|FG001|Overall Study|Adverse Event|12|||
148989196|NCT00759109|537436294|FG000|Overall Study|Inability to comply|1|||
148989197|NCT00759109|537436295|FG001|Overall Study|Inability to comply|1|||
148989198|NCT00759109|537436294|FG000|Overall Study|Withdrawal by Subject|9|||
148989199|NCT00759109|537436295|FG001|Overall Study|Withdrawal by Subject|5|||
148989200|NCT00759109|537436294|FG000|Overall Study|Death|4|||
148989201|NCT00759109|537436295|FG001|Overall Study|Death|3|||
148989202|NCT00759109|537436294|FG000|Overall Study|Lost to Follow-up|4|||
148989203|NCT00759109|537436295|FG001|Overall Study|Lost to Follow-up|6|||
148989204|NCT00759109|537436294|FG000|Overall Study|Started new therapy|2|||
148989205|NCT00759109|537436295|FG001|Overall Study|Started new therapy|6|||
148989206|NCT00759109|537436294|FG000|Overall Study|HCV RNA negative|1|||
148989207|NCT00759109|537436295|FG001|Overall Study|HCV RNA negative|0|||
148989208|NCT00759109|537436294|FG000|Overall Study|Participant moved to a different city|0|||
148989209|NCT00759109|537436295|FG001|Overall Study|Participant moved to a different city|1|||
148989210|NCT00759109|537436294|FG000|Overall Study|Participant had a liver transplant|0|||
148989211|NCT00759109|537436295|FG001|Overall Study|Participant had a liver transplant|1|||
148989212|NCT00759109|537436294|FG000|Overall Study|Lost during study|1|||
148989213|NCT00759109|537436295|FG001|Overall Study|Lost during study|0|||
148989214|NCT01660763|537436298|FG000|Overall Study|Lack of Efficacy|45|||
148989215|NCT01660763|537436299|FG001|Overall Study|Lack of Efficacy|50|||
148989216|NCT01660763|537436298|FG000|Overall Study|Adverse Event|22|||
148989217|NCT01660763|537436299|FG001|Overall Study|Adverse Event|7|||
148989218|NCT01660763|537436298|FG000|Overall Study|Protocol Violation|1|||
148989219|NCT01660763|537436299|FG001|Overall Study|Protocol Violation|0|||
148989220|NCT01660763|537436298|FG000|Overall Study|Withdrawal by Subject|4|||
148989221|NCT01660763|537436299|FG001|Overall Study|Withdrawal by Subject|0|||
148989222|NCT01660763|537436298|FG000|Overall Study|Patient ready for early discharge|28|||
148989223|NCT01660763|537436299|FG001|Overall Study|Patient ready for early discharge|4|||
148989224|NCT01910519|537436300|FG000|Overall Study|Withdrawal by Subject|2|||
148989225|NCT01910519|537436301|FG001|Overall Study|Withdrawal by Subject|0|||
148989226|NCT01910519|537436300|FG000|Overall Study|Adverse Event|2|||
148989227|NCT01910519|537436301|FG001|Overall Study|Adverse Event|0|||
148989228|NCT04266028|537436302|FG000|Overall Study|Adverse Event|0|||
148989229|NCT04266028|537436303|FG001|Overall Study|Adverse Event|0|||
148989230|NCT04266028|537436304|FG002|Overall Study|Adverse Event|1|||
148989231|NCT04266028|537436305|FG003|Overall Study|Adverse Event|0|||
148989232|NCT04266028|537436306|FG004|Overall Study|Adverse Event|1|||
148989233|NCT04266028|537436307|FG005|Overall Study|Adverse Event|0|||
148989234|NCT04266028|537436308|FG006|Overall Study|Adverse Event|2|||
148989235|NCT04266028|537436309|FG007|Overall Study|Adverse Event|0|||
148989236|NCT04266028|537436302|FG000|Overall Study|temporary halt of the study|0|||
148989237|NCT04266028|537436303|FG001|Overall Study|temporary halt of the study|0|||
148989238|NCT04266028|537436304|FG002|Overall Study|temporary halt of the study|0|||
148989239|NCT04266028|537436305|FG003|Overall Study|temporary halt of the study|0|||
148989240|NCT04266028|537436306|FG004|Overall Study|temporary halt of the study|0|||
148989241|NCT04266028|537436307|FG005|Overall Study|temporary halt of the study|0|||
148856661|NCT04210245|536949653|FG000|Overall Study|Lost to Follow-up|0|||
148989242|NCT04266028|537436308|FG006|Overall Study|temporary halt of the study|2|||
148856662|NCT04210245|536949654|FG001|Overall Study|Lost to Follow-up|1|||
148856663|NCT04210245|536949655|FG002|Overall Study|Lost to Follow-up|1|||
148856664|NCT04210245|536949656|FG003|Overall Study|Lost to Follow-up|1|||
148989243|NCT04266028|537436309|FG007|Overall Study|temporary halt of the study|1|||
148989244|NCT04266028|537436302|FG000|Overall Study|Onset of birch pollen season|0|||
148989245|NCT04266028|537436303|FG001|Overall Study|Onset of birch pollen season|0|||
148989246|NCT04266028|537436304|FG002|Overall Study|Onset of birch pollen season|0|||
148989247|NCT04266028|537436305|FG003|Overall Study|Onset of birch pollen season|0|||
148989248|NCT04266028|537436306|FG004|Overall Study|Onset of birch pollen season|1|||
148989249|NCT04266028|537436307|FG005|Overall Study|Onset of birch pollen season|0|||
148989250|NCT04266028|537436308|FG006|Overall Study|Onset of birch pollen season|0|||
148989251|NCT04266028|537436309|FG007|Overall Study|Onset of birch pollen season|0|||
148989252|NCT00380068|537436311|FG000|Overall Study|Adverse Event|40|||
148989253|NCT00380068|537436311|FG000|Overall Study|Withdrawal by Subject|10|||
148989254|NCT00380068|537436311|FG000|Overall Study|Not compliant|6|||
148989255|NCT00380068|537436311|FG000|Overall Study|Lost to Follow-up|1|||
148989256|NCT00380068|537436311|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
148989257|NCT00380068|537436311|FG000|Overall Study|Lung transplant|3|||
148989258|NCT00380068|537436311|FG000|Overall Study|Physician Decision|2|||
148989259|NCT00380068|537436311|FG000|Overall Study|Partipant moved away|1|||
148989260|NCT00380068|537436311|FG000|Overall Study|Lack of Efficacy|5|||
148989261|NCT01458574|537436312|FG000|Overall Study|Adverse Event|5|||
148989262|NCT01458574|537436313|FG001|Overall Study|Adverse Event|9|||
148989263|NCT01458574|537436314|FG002|Overall Study|Adverse Event|7|||
148989264|NCT01458574|537436312|FG000|Overall Study|Lack of Efficacy|70|||
148989265|NCT01458574|537436313|FG001|Overall Study|Lack of Efficacy|53|||
148989266|NCT01458574|537436314|FG002|Overall Study|Lack of Efficacy|132|||
148989267|NCT01458574|537436312|FG000|Overall Study|Lost to Follow-up|3|||
148989268|NCT01458574|537436313|FG001|Overall Study|Lost to Follow-up|2|||
148989269|NCT01458574|537436314|FG002|Overall Study|Lost to Follow-up|1|||
148989270|NCT01458574|537436312|FG000|Overall Study|Pregnancy|1|||
148989271|NCT01458574|537436313|FG001|Overall Study|Pregnancy|1|||
148989272|NCT01458574|537436314|FG002|Overall Study|Pregnancy|0|||
148989273|NCT01458574|537436312|FG000|Overall Study|Protocol Violation|0|||
148989274|NCT01458574|537436313|FG001|Overall Study|Protocol Violation|1|||
148989275|NCT01458574|537436314|FG002|Overall Study|Protocol Violation|0|||
148989276|NCT01458574|537436312|FG000|Overall Study|Withdrawal by Subject|6|||
148989277|NCT01458574|537436313|FG001|Overall Study|Withdrawal by Subject|3|||
148989278|NCT01458574|537436314|FG002|Overall Study|Withdrawal by Subject|5|||
148989279|NCT01458574|537436312|FG000|Overall Study|Other|2|||
148989280|NCT01458574|537436313|FG001|Overall Study|Other|1|||
148989281|NCT01458574|537436314|FG002|Overall Study|Other|0|||
148989282|NCT01458574|537436312|FG000|Overall Study|Randomized but not treated|0|||
148989283|NCT01458574|537436313|FG001|Overall Study|Randomized but not treated|1|||
148989284|NCT01458574|537436314|FG002|Overall Study|Randomized but not treated|0|||
148989285|NCT02125786|537436315|FG000|Overall Study|Still in Follow-up|3|||
148989286|NCT02125786|537436315|FG000|Overall Study|Screen Failure|2|||
148989287|NCT02125786|537436315|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
148989288|NCT02125786|537436315|FG000|Overall Study|Progressive Disease|44|||
148989289|NCT02125786|537436315|FG000|Overall Study|Death|8|||
148989290|NCT04964089|537436318|FG000|Overall Study|Adverse Event|8|||
148989291|NCT04964089|537436319|FG001|Overall Study|Adverse Event|6|||
148989292|NCT04964089|537436318|FG000|Overall Study|Non-compliance with study schedule|1|||
148856665|NCT04210245|536949653|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
148889225|NCT02831764|537074362|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
148889226|NCT02831764|537074363|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
148889227|NCT02831764|537074364|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
148889228|NCT02831764|537074365|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
148889229|NCT02831764|537074366|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
148889230|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
148889231|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
148889232|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
148889233|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
148889234|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
148889235|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
148889236|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
148889237|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
148889238|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
148889239|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
148889240|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
148889241|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
148889527|NCT01188772|537074428|FG002|Overall Study|Lost to Follow-up|1|||
148856666|NCT04210245|536949654|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
148856667|NCT04210245|536949655|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
148856668|NCT04210245|536949656|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
148856669|NCT06099223|536949657|FG000|Overall Study|Preoperative surveys missed|0|||
148856670|NCT06099223|536949658|FG001|Overall Study|Preoperative surveys missed|1|||
148856671|NCT01202188|536949660|FG000|Overall Study|Protocol deviation|14|||
148856672|NCT01202188|536949661|FG001|Overall Study|Protocol deviation|8|||
148856673|NCT01202188|536949662|FG002|Overall Study|Protocol deviation|12|||
148856674|NCT01202188|536949663|FG003|Overall Study|Protocol deviation|10|||
148856675|NCT01202188|536949664|FG004|Overall Study|Protocol deviation|11|||
148856676|NCT01202188|536949660|FG000|Overall Study|Subject withdrew consent|12|||
148856677|NCT01202188|536949661|FG001|Overall Study|Subject withdrew consent|13|||
148856678|NCT01202188|536949662|FG002|Overall Study|Subject withdrew consent|22|||
148856679|NCT01202188|536949663|FG003|Overall Study|Subject withdrew consent|11|||
148856680|NCT01202188|536949664|FG004|Overall Study|Subject withdrew consent|13|||
148856681|NCT01202188|536949660|FG000|Overall Study|Adverse Event|5|||
148856682|NCT01202188|536949661|FG001|Overall Study|Adverse Event|23|||
148856683|NCT01202188|536949662|FG002|Overall Study|Adverse Event|13|||
148856684|NCT01202188|536949663|FG003|Overall Study|Adverse Event|10|||
148856685|NCT01202188|536949664|FG004|Overall Study|Adverse Event|10|||
148856686|NCT01202188|536949660|FG000|Overall Study|Administrative problems|3|||
148856687|NCT01202188|536949661|FG001|Overall Study|Administrative problems|2|||
148856688|NCT01202188|536949662|FG002|Overall Study|Administrative problems|1|||
148856689|NCT01202188|536949663|FG003|Overall Study|Administrative problems|1|||
148856690|NCT01202188|536949664|FG004|Overall Study|Administrative problems|2|||
148856691|NCT01202188|536949660|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
148856692|NCT01202188|536949661|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
148856693|NCT01202188|536949662|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
148856694|NCT01202188|536949663|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
148856695|NCT01202188|536949664|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
148856696|NCT01202188|536949660|FG000|Overall Study|Lost to Follow-up|1|||
148856697|NCT01202188|536949661|FG001|Overall Study|Lost to Follow-up|1|||
148856698|NCT01202188|536949662|FG002|Overall Study|Lost to Follow-up|0|||
148856699|NCT01202188|536949663|FG003|Overall Study|Lost to Follow-up|4|||
148856700|NCT01202188|536949664|FG004|Overall Study|Lost to Follow-up|1|||
148856701|NCT01202188|536949660|FG000|Overall Study|Death|1|||
148856702|NCT01202188|536949661|FG001|Overall Study|Death|1|||
148856703|NCT01202188|536949662|FG002|Overall Study|Death|1|||
148856704|NCT01202188|536949663|FG003|Overall Study|Death|1|||
148856705|NCT01202188|536949664|FG004|Overall Study|Death|0|||
148856706|NCT01202188|536949660|FG000|Overall Study|Abnormal test procedure result (s)|0|||
148856707|NCT01202188|536949661|FG001|Overall Study|Abnormal test procedure result (s)|0|||
148856708|NCT01202188|536949662|FG002|Overall Study|Abnormal test procedure result (s)|2|||
148856709|NCT01202188|536949663|FG003|Overall Study|Abnormal test procedure result (s)|0|||
148856710|NCT01202188|536949664|FG004|Overall Study|Abnormal test procedure result (s)|0|||
148856711|NCT00661726|536949665|FG000|Overall Study|Adverse Event|1|||
148856712|NCT00780143|536949666|FG000|Overall Study|Progressive disease|1|||
148856713|NCT00780143|536949666|FG000|Overall Study|Toxicity|1|||
148856714|NCT00780143|536949666|FG000|Overall Study|Adverse Event|1|||
148856715|NCT02644096|536949667|FG000|Overall Study|Withdrawal by Subject|28|||
148856716|NCT02644096|536949668|FG001|Overall Study|Withdrawal by Subject|25|||
148856717|NCT01457014|536949669|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
148856718|NCT01457014|536949670|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
148856719|NCT01457014|536949671|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
148856720|NCT01457014|536949672|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
148856721|NCT01457014|536949669|FG000|First Night|Withdrawal by Subject|3|||
148856722|NCT01457014|536949670|FG001|First Night|Withdrawal by Subject|0|||
148856723|NCT01457014|536949671|FG002|First Night|Withdrawal by Subject|0|||
148856724|NCT01457014|536949672|FG003|First Night|Withdrawal by Subject|0|||
148856725|NCT02461290|536949673|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
148856726|NCT02461290|536949673|FG000|Overall Study|Lost to Follow-up|3|||
148856727|NCT00322452|536949674|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148856728|NCT00322452|536949675|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
148989293|NCT04964089|537436319|FG001|Overall Study|Non-compliance with study schedule|0|||
148989294|NCT04964089|537436318|FG000|Overall Study|Withdrawal by Subject|6|||
148989295|NCT04964089|537436319|FG001|Overall Study|Withdrawal by Subject|5|||
148989296|NCT04964089|537436318|FG000|Overall Study|Lost to Follow-up|1|||
148989297|NCT04964089|537436319|FG001|Overall Study|Lost to Follow-up|1|||
148989298|NCT04964089|537436318|FG000|Overall Study|Progressive disease|4|||
148989299|NCT04964089|537436319|FG001|Overall Study|Progressive disease|0|||
148989300|NCT04964089|537436318|FG000|Overall Study|Physician Decision|1|||
148989301|NCT04964089|537436319|FG001|Overall Study|Physician Decision|0|||
148989302|NCT04964089|537436318|FG000|Overall Study|Participant did not want to continue study treatment|1|||
148989303|NCT04964089|537436319|FG001|Overall Study|Participant did not want to continue study treatment|0|||
148856729|NCT00322452|536949674|FG000|Overall Study|Lost to Follow-up|5|||
148856730|NCT00322452|536949675|FG001|Overall Study|Lost to Follow-up|2|||
148856731|NCT00322452|536949674|FG000|Overall Study|Withdrawal by Subject|19|||
148856732|NCT00322452|536949675|FG001|Overall Study|Withdrawal by Subject|46|||
148856733|NCT00322452|536949674|FG000|Overall Study|Death|223|||
148856734|NCT00322452|536949675|FG001|Overall Study|Death|227|||
148856735|NCT00526656|536949676|FG000|Overall Study|Death|1|||
148856736|NCT00526656|536949676|FG000|Overall Study|Refused surgery|1|||
148856737|NCT04091581|536949677|FG000|Overall Study|Lost to Follow-up|0|||
148856738|NCT04091581|536949678|FG001|Overall Study|Lost to Follow-up|1|||
148856739|NCT03319953|536949679|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
148856740|NCT03319953|536949680|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
148856741|NCT03319953|536949681|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
148856742|NCT03319953|536949682|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
148856743|NCT03319953|536949679|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
148856744|NCT03319953|536949680|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
148856745|NCT03319953|536949681|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
148856746|NCT03319953|536949682|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
148856747|NCT02438384|536949683|FG000|Overall Study|Lost to Follow-up|8|||
148856748|NCT02438384|536949684|FG001|Overall Study|Lost to Follow-up|6|||
148856749|NCT02438384|536949685|FG002|Overall Study|Lost to Follow-up|4|||
148856750|NCT01795495|536949687|FG000|Overall Study|Protocol Violation|1|||
148856751|NCT01795495|536949688|FG001|Overall Study|Protocol Violation|0|||
148856752|NCT01795495|536949689|FG002|Overall Study|Protocol Violation|1|||
148856753|NCT01795495|536949687|FG000|Overall Study|Physician Decision|0|||
148856754|NCT01795495|536949688|FG001|Overall Study|Physician Decision|0|||
148856755|NCT01795495|536949689|FG002|Overall Study|Physician Decision|1|||
148856756|NCT03315793|536949690|FG000|Overall Study|Adverse Event|4|||
148856757|NCT03315793|536949691|FG001|Overall Study|Adverse Event|2|||
148856758|NCT03315793|536949690|FG000|Overall Study|Protocol Deviation|1|||
148856759|NCT03315793|536949691|FG001|Overall Study|Protocol Deviation|0|||
148856760|NCT03315793|536949690|FG000|Overall Study|Difficult for regular visit|0|||
148856761|NCT03315793|536949691|FG001|Overall Study|Difficult for regular visit|1|||
148856762|NCT04027049|536949692|FG000|Overall Study|Withdrawn by family|1|||
148856763|NCT04027049|536949693|FG001|Overall Study|Withdrawn by family|0|||
148856764|NCT04027049|536949692|FG000|Overall Study|Participant safety|1|||
148856765|NCT04027049|536949693|FG001|Overall Study|Participant safety|0|||
148856766|NCT02867813|536951679|FG000|Overall Study|Withdrawal by Subject|57|||
148856767|NCT02867813|536951680|FG001|Overall Study|Withdrawal by Subject|56|||
148856768|NCT02867813|536951679|FG000|Overall Study|Decision by Sponsor|7|||
148856769|NCT02867813|536951680|FG001|Overall Study|Decision by Sponsor|7|||
148856770|NCT02867813|536951679|FG000|Overall Study|Lost to Follow-up|91|||
148856771|NCT02867813|536951680|FG001|Overall Study|Lost to Follow-up|78|||
148856772|NCT02867813|536951679|FG000|Overall Study|Missing|2|||
148856773|NCT02867813|536951680|FG001|Overall Study|Missing|1|||
148856774|NCT02867813|536951679|FG000|Overall Study|Death|294|||
148856775|NCT02867813|536951680|FG001|Overall Study|Death|268|||
148856776|NCT02013206|536951684|FG000|Overall Study|Progressive disease (PD)|14|||
148856777|NCT02013206|536951685|FG001|Overall Study|Progressive disease (PD)|17|||
148856778|NCT02013206|536951684|FG000|Overall Study|Symptomatic deterioration|3|||
148856779|NCT02013206|536951685|FG001|Overall Study|Symptomatic deterioration|1|||
148856780|NCT02013206|536951684|FG000|Overall Study|Adverse Event|1|||
148856781|NCT02013206|536951685|FG001|Overall Study|Adverse Event|0|||
148856782|NCT02013206|536951684|FG000|Overall Study|Patient refusal|2|||
148856783|NCT02013206|536951685|FG001|Overall Study|Patient refusal|0|||
148856784|NCT02013206|536951684|FG000|Overall Study|Patient non-compliance|1|||
148856785|NCT02013206|536951685|FG001|Overall Study|Patient non-compliance|0|||
148856786|NCT02013206|536951684|FG000|Overall Study|Death|1|||
148856787|NCT02013206|536951685|FG001|Overall Study|Death|2|||
148856788|NCT02013206|536951684|FG000|Overall Study|Other reasons off treatment|5|||
148989304|NCT04964089|537436318|FG000|Overall Study|Participant moved to different state|1|||
148989305|NCT04964089|537436319|FG001|Overall Study|Participant moved to different state|0|||
148989306|NCT04964089|537436318|FG000|Overall Study|Participant decided to discontinue|0|||
148989307|NCT04964089|537436319|FG001|Overall Study|Participant decided to discontinue|1|||
148989308|NCT01365494|537436320|FG000|Overall Study|Adverse Event|1|||
148856789|NCT02013206|536951685|FG001|Overall Study|Other reasons off treatment|2|||
148856790|NCT01952665|536951686|FG000|Overall Study|Physician Decision|3|||
148989309|NCT01365494|537436321|FG001|Overall Study|Adverse Event|0|||
148989310|NCT01365494|537436320|FG000|Overall Study|Withdrawal by Subject|0|||
148856791|NCT01952665|536951687|FG001|Overall Study|Physician Decision|2|||
148856792|NCT01952665|536951686|FG000|Overall Study|Lost to Follow-up|1|||
148856793|NCT01952665|536951687|FG001|Overall Study|Lost to Follow-up|2|||
148856794|NCT01952665|536951686|FG000|Overall Study|Adverse Event|2|||
148856795|NCT01952665|536951687|FG001|Overall Study|Adverse Event|1|||
148856796|NCT01952665|536951686|FG000|Overall Study|Protocol Violation|0|||
148856797|NCT01952665|536951687|FG001|Overall Study|Protocol Violation|1|||
148856798|NCT01537081|536951688|FG000|Overall Study|Adverse Event|5|||
148856799|NCT01537081|536951689|FG001|Overall Study|Adverse Event|2|||
148989311|NCT01365494|537436321|FG001|Overall Study|Withdrawal by Subject|1|||
148989312|NCT01365494|537436320|FG000|Overall Study|Lost to Follow-up|1|||
148989313|NCT01365494|537436321|FG001|Overall Study|Lost to Follow-up|2|||
148989314|NCT01664078|537436324|FG000|Overall Study|Death|9|||
148989315|NCT01664078|537436324|FG000|Overall Study|Withdrawal by Subject|4|||
148989316|NCT01664078|537436324|FG000|Overall Study|Lost to Follow-up|2|||
148989317|NCT01664078|537436324|FG000|Overall Study|missed 5 year visit|1|||
148989318|NCT01664078|537436324|FG000|Overall Study|Other|53|||
148989319|NCT03351049|537436325|FG000|Overall Study|Withdrawal|26|||
148989320|NCT03351049|537436326|FG001|Overall Study|Withdrawal|22|||
148989321|NCT03832946|537436333|FG000|Overall Study|Adverse Event|3|||
148989322|NCT03832946|537436334|FG001|Overall Study|Adverse Event|1|||
148989323|NCT03832946|537436333|FG000|Overall Study|Lost to Follow-up|1|||
148989324|NCT03832946|537436334|FG001|Overall Study|Lost to Follow-up|0|||
148989325|NCT03832946|537436333|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
148989326|NCT03832946|537436334|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
148989327|NCT03832946|537436333|FG000|Overall Study|Lack of Efficacy|1|||
148989328|NCT03832946|537436334|FG001|Overall Study|Lack of Efficacy|0|||
148989329|NCT03832946|537436333|FG000|Overall Study|Withdrawal by Subject|12|||
148989330|NCT03832946|537436334|FG001|Overall Study|Withdrawal by Subject|9|||
148989331|NCT02838017|537436336|FG000|Overall Study|Lost to Follow-up|14|||
148989332|NCT02838017|537436337|FG001|Overall Study|Lost to Follow-up|11|||
148989333|NCT01692197|537436338|FG000|Overall Study|Failed Screening|3|||
148989334|NCT02120924|537436339|FG000|Overall Study|Lack of Efficacy|1|||
148989335|NCT02120924|537436340|FG001|Overall Study|Lack of Efficacy|2|||
148989336|NCT02120924|537436341|FG002|Overall Study|Lack of Efficacy|3|||
148989337|NCT02120924|537436339|FG000|Overall Study|Adverse Event|0|||
148989338|NCT02120924|537436340|FG001|Overall Study|Adverse Event|1|||
148989339|NCT02120924|537436341|FG002|Overall Study|Adverse Event|3|||
148989340|NCT02120924|537436339|FG000|Overall Study|Withdrawal by Subject|16|||
148989341|NCT02120924|537436340|FG001|Overall Study|Withdrawal by Subject|20|||
148989342|NCT02120924|537436341|FG002|Overall Study|Withdrawal by Subject|8|||
148989343|NCT02120924|537436339|FG000|Overall Study|Lost to Follow-up|14|||
148989344|NCT02120924|537436340|FG001|Overall Study|Lost to Follow-up|14|||
148989345|NCT02120924|537436341|FG002|Overall Study|Lost to Follow-up|11|||
148989346|NCT02120924|537436339|FG000|Overall Study|Pregnancy|2|||
148989347|NCT02120924|537436340|FG001|Overall Study|Pregnancy|0|||
148989348|NCT02120924|537436341|FG002|Overall Study|Pregnancy|0|||
148989349|NCT02120924|537436339|FG000|Overall Study|Protocol Violation|3|||
148989350|NCT02120924|537436340|FG001|Overall Study|Protocol Violation|7|||
148989351|NCT02120924|537436341|FG002|Overall Study|Protocol Violation|2|||
148989352|NCT02120924|537436339|FG000|Overall Study|Physician Decision|0|||
148989353|NCT02120924|537436340|FG001|Overall Study|Physician Decision|1|||
148989354|NCT02120924|537436341|FG002|Overall Study|Physician Decision|1|||
148989355|NCT02120924|537436339|FG000|Overall Study|Death|1|||
148989356|NCT02120924|537436340|FG001|Overall Study|Death|0|||
148989357|NCT02120924|537436341|FG002|Overall Study|Death|0|||
148989358|NCT02120924|537436339|FG000|Overall Study|Compliance with IP|5|||
148989359|NCT02120924|537436340|FG001|Overall Study|Compliance with IP|1|||
148989360|NCT02120924|537436341|FG002|Overall Study|Compliance with IP|1|||
148989361|NCT03588572|537436344|FG000|Visitation 1|Lack of Efficacy|1|||
148989362|NCT03588572|537436345|FG001|Visitation 1|Lack of Efficacy|1|||
148989363|NCT03588572|537436344|FG000|Visitation 2|Lost to Follow-up|1|||
148989364|NCT03588572|537436345|FG001|Visitation 2|Lost to Follow-up|1|||
148989365|NCT03588572|537436344|FG000|Visitation 2|Lack of Efficacy|0|||
148989366|NCT03588572|537436345|FG001|Visitation 2|Lack of Efficacy|1|||
148989367|NCT03588572|537436344|FG000|Visitation 2|Withdrawal by Subject|1|||
148989368|NCT03588572|537436345|FG001|Visitation 2|Withdrawal by Subject|0|||
148989369|NCT03588572|537436344|FG000|Visitation 3|Lost to Follow-up|1|||
148989370|NCT03588572|537436345|FG001|Visitation 3|Lost to Follow-up|1|||
148989371|NCT03588572|537436344|FG000|Visitation 3|Physician Decision|1|||
148989372|NCT03588572|537436345|FG001|Visitation 3|Physician Decision|1|||
148989373|NCT03588572|537436344|FG000|Visitation 3|Withdrawal by Subject|1|||
149030619|NCT02081391|537589687|FG002|12-hour Treatment|Further reasons|0|||
149030620|NCT02081391|537589688|FG003|12-hour Treatment|Further reasons|0|||
148989374|NCT03588572|537436345|FG001|Visitation 3|Withdrawal by Subject|0|||
148989375|NCT02526693|537438320|FG000|Overall Study|Physician Decision|3|||
148989376|NCT02526693|537438321|FG001|Overall Study|Physician Decision|1|||
148989377|NCT01585103|537438323|FG000|Overall Study|Unable to swallow Cytosponge|6|||
148989378|NCT01349569|537438324|FG000|Overall Study|Lack of Efficacy|4|||
148989379|NCT03581305|537438325|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
148989380|NCT03581305|537438326|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
148989381|NCT03581305|537438325|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
148989382|NCT03581305|537438326|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
148989383|NCT03581305|537438325|FG000|Serotonergic Study|Withdrawal by Subject|5|||
148989384|NCT03581305|537438326|FG001|Serotonergic Study|Withdrawal by Subject|1|||
148989385|NCT01798927|537438327|FG000|Overall Study|Withdrawal by Subject|1|||
148989386|NCT00626522|537438328|FG000|Overall Study|Protocol Violation|0|||
148989387|NCT00626522|537438329|FG001|Overall Study|Protocol Violation|0|||
148989388|NCT00626522|537438330|FG002|Overall Study|Protocol Violation|0|||
148856800|NCT01537081|536951690|FG002|Overall Study|Adverse Event|2|||
148856801|NCT01537081|536951688|FG000|Overall Study|Lack of Efficacy|2|||
148856802|NCT01537081|536951689|FG001|Overall Study|Lack of Efficacy|1|||
148856803|NCT01537081|536951690|FG002|Overall Study|Lack of Efficacy|0|||
148856804|NCT01537081|536951688|FG000|Overall Study|Lost to Follow-up|17|||
148856805|NCT01537081|536951689|FG001|Overall Study|Lost to Follow-up|15|||
148856806|NCT01537081|536951690|FG002|Overall Study|Lost to Follow-up|9|||
148856807|NCT01537081|536951688|FG000|Overall Study|Protocol Violation|3|||
148856808|NCT01537081|536951689|FG001|Overall Study|Protocol Violation|2|||
148856809|NCT01537081|536951690|FG002|Overall Study|Protocol Violation|2|||
148856810|NCT01537081|536951688|FG000|Overall Study|Withdrawal by Subject|6|||
148856811|NCT01537081|536951689|FG001|Overall Study|Withdrawal by Subject|11|||
148856812|NCT01537081|536951690|FG002|Overall Study|Withdrawal by Subject|3|||
148856813|NCT01537081|536951688|FG000|Overall Study|Physician Decision|5|||
148856814|NCT01537081|536951689|FG001|Overall Study|Physician Decision|6|||
148856815|NCT01537081|536951690|FG002|Overall Study|Physician Decision|0|||
148856816|NCT01537081|536951688|FG000|Overall Study|Sponsor decision|0|||
148856817|NCT01537081|536951689|FG001|Overall Study|Sponsor decision|1|||
148856818|NCT01537081|536951690|FG002|Overall Study|Sponsor decision|0|||
148856819|NCT01537081|536951688|FG000|Overall Study|Assigned but never dosed|1|||
148856820|NCT01537081|536951689|FG001|Overall Study|Assigned but never dosed|0|||
148856821|NCT01537081|536951690|FG002|Overall Study|Assigned but never dosed|0|||
148856822|NCT01463111|536951693|FG000|Overall Study|Withdrawal by Subject|2|||
148856823|NCT01463111|536951693|FG000|Overall Study|Lost to Follow-up|5|||
148856824|NCT01463111|536951693|FG000|Overall Study|Physician Decision|2|||
148856825|NCT01559259|536951704|FG000|Overall Study|Withdrawal by Subject|0|||
148856826|NCT01559259|536951705|FG001|Overall Study|Withdrawal by Subject|0|||
148856827|NCT01559259|536951706|FG002|Overall Study|Withdrawal by Subject|0|||
148856828|NCT01559259|536951707|FG003|Overall Study|Withdrawal by Subject|1|||
148856829|NCT01559259|536951708|FG004|Overall Study|Withdrawal by Subject|0|||
148856830|NCT01559259|536951704|FG000|Overall Study|Adverse Event|0|||
148856831|NCT01559259|536951705|FG001|Overall Study|Adverse Event|1|||
148856832|NCT01559259|536951706|FG002|Overall Study|Adverse Event|1|||
148856833|NCT01559259|536951707|FG003|Overall Study|Adverse Event|0|||
148856834|NCT01559259|536951708|FG004|Overall Study|Adverse Event|0|||
148856835|NCT01995669|536951709|FG000|Overall Study|Progression|2|||
148856836|NCT01995669|536951710|FG001|Overall Study|Progression|1|||
148856837|NCT01995669|536951711|FG002|Overall Study|Progression|1|||
148856838|NCT01995669|536951712|FG003|Overall Study|Progression|13|||
148856839|NCT01995669|536951709|FG000|Overall Study|Adverse Event|0|||
148856840|NCT01995669|536951710|FG001|Overall Study|Adverse Event|0|||
148856841|NCT01995669|536951711|FG002|Overall Study|Adverse Event|0|||
148856842|NCT01995669|536951712|FG003|Overall Study|Adverse Event|3|||
148856843|NCT01995669|536951709|FG000|Overall Study|Death|0|||
148856844|NCT01995669|536951710|FG001|Overall Study|Death|0|||
148856845|NCT01995669|536951711|FG002|Overall Study|Death|0|||
148989389|NCT00626522|537438331|FG003|Overall Study|Protocol Violation|0|||
148989390|NCT00626522|537438332|FG004|Overall Study|Protocol Violation|1|||
148989391|NCT00626522|537438333|FG005|Overall Study|Protocol Violation|0|||
148989392|NCT00626522|537438328|FG000|Overall Study|Adverse Event|2|||
148989393|NCT00626522|537438329|FG001|Overall Study|Adverse Event|1|||
148989394|NCT00626522|537438330|FG002|Overall Study|Adverse Event|2|||
148989395|NCT00626522|537438331|FG003|Overall Study|Adverse Event|0|||
148989396|NCT00626522|537438332|FG004|Overall Study|Adverse Event|1|||
148989397|NCT00626522|537438333|FG005|Overall Study|Adverse Event|1|||
148989398|NCT00626522|537438328|FG000|Overall Study|Withdrawal by Subject|2|||
148989399|NCT00626522|537438329|FG001|Overall Study|Withdrawal by Subject|5|||
148989400|NCT00626522|537438330|FG002|Overall Study|Withdrawal by Subject|5|||
148989401|NCT00626522|537438331|FG003|Overall Study|Withdrawal by Subject|0|||
148989402|NCT00626522|537438332|FG004|Overall Study|Withdrawal by Subject|4|||
148989403|NCT00626522|537438333|FG005|Overall Study|Withdrawal by Subject|1|||
148989404|NCT00626522|537438328|FG000|Overall Study|COPD exacerbation|0|||
148989405|NCT00626522|537438329|FG001|Overall Study|COPD exacerbation|0|||
148989406|NCT00626522|537438330|FG002|Overall Study|COPD exacerbation|0|||
148989407|NCT00626522|537438331|FG003|Overall Study|COPD exacerbation|1|||
148989408|NCT00626522|537438332|FG004|Overall Study|COPD exacerbation|1|||
148856846|NCT01995669|536951712|FG003|Overall Study|Death|6|||
148856847|NCT01995669|536951709|FG000|Overall Study|Withdrawal by Subject|0|||
148856848|NCT01995669|536951710|FG001|Overall Study|Withdrawal by Subject|0|||
148856849|NCT01995669|536951711|FG002|Overall Study|Withdrawal by Subject|0|||
148856850|NCT01995669|536951712|FG003|Overall Study|Withdrawal by Subject|6|||
148856851|NCT01995669|536951709|FG000|Overall Study|Insurance Expired|0|||
148856852|NCT01995669|536951710|FG001|Overall Study|Insurance Expired|0|||
148856853|NCT01995669|536951711|FG002|Overall Study|Insurance Expired|0|||
148856854|NCT01995669|536951712|FG003|Overall Study|Insurance Expired|1|||
148856855|NCT05425732|536951713|FG000|Overall Study|Death|4|||
148856856|NCT05425732|536951714|FG001|Overall Study|Death|2|||
148856857|NCT05425732|536951715|FG002|Overall Study|Death|0|||
148856858|NCT05425732|536951716|FG003|Overall Study|Death|0|||
148856859|NCT05425732|536951713|FG000|Overall Study|Lost to Follow-up|10|||
148856860|NCT05425732|536951714|FG001|Overall Study|Lost to Follow-up|15|||
148856861|NCT05425732|536951715|FG002|Overall Study|Lost to Follow-up|5|||
148856862|NCT05425732|536951716|FG003|Overall Study|Lost to Follow-up|3|||
148856863|NCT05425732|536951713|FG000|Overall Study|Physician Decision|0|||
148856864|NCT05425732|536951714|FG001|Overall Study|Physician Decision|2|||
148856865|NCT05425732|536951715|FG002|Overall Study|Physician Decision|0|||
148856866|NCT05425732|536951716|FG003|Overall Study|Physician Decision|0|||
148856867|NCT05425732|536951713|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
148856868|NCT05425732|536951714|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
148856869|NCT05425732|536951715|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148856870|NCT05425732|536951716|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
148856871|NCT05425732|536951713|FG000|Overall Study|Withdrawal by Subject|4|||
148856872|NCT05425732|536951714|FG001|Overall Study|Withdrawal by Subject|8|||
148856873|NCT05425732|536951715|FG002|Overall Study|Withdrawal by Subject|1|||
148856874|NCT05425732|536951716|FG003|Overall Study|Withdrawal by Subject|1|||
148856875|NCT05425732|536951713|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
148856876|NCT05425732|536951714|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
148856877|NCT05425732|536951715|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
148856878|NCT05425732|536951716|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
148856879|NCT02688088|536951719|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
148856880|NCT02688088|536951720|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
148856881|NCT02688088|536951721|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
148856882|NCT02688088|536951722|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
148856883|NCT02688088|536951723|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
148856884|NCT02688088|536951719|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
148856885|NCT02688088|536951720|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
148856886|NCT02688088|536951721|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
148856887|NCT02688088|536951722|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
148856888|NCT02688088|536951723|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
148889528|NCT01188772|537074429|FG003|Overall Study|Lost to Follow-up|1|||
148889529|NCT01188772|537074426|FG000|Overall Study|Non-responder|0|||
148889530|NCT01188772|537074427|FG001|Overall Study|Non-responder|0|||
148889531|NCT01188772|537074428|FG002|Overall Study|Non-responder|3|||
148889532|NCT01188772|537074429|FG003|Overall Study|Non-responder|0|||
148889533|NCT01188772|537074426|FG000|Overall Study|Physician Decision|0|||
148889534|NCT01188772|537074427|FG001|Overall Study|Physician Decision|0|||
148889535|NCT01188772|537074428|FG002|Overall Study|Physician Decision|1|||
148889536|NCT01188772|537074429|FG003|Overall Study|Physician Decision|0|||
148889537|NCT01188772|537074426|FG000|Overall Study|Terminated by Sponsor|0|||
148889538|NCT01188772|537074427|FG001|Overall Study|Terminated by Sponsor|0|||
148889539|NCT01188772|537074428|FG002|Overall Study|Terminated by Sponsor|1|||
148889540|NCT01188772|537074429|FG003|Overall Study|Terminated by Sponsor|0|||
148889541|NCT01188772|537074426|FG000|Overall Study|Treatment Failure|0|||
148889542|NCT01188772|537074427|FG001|Overall Study|Treatment Failure|0|||
148889543|NCT01188772|537074428|FG002|Overall Study|Treatment Failure|1|||
148889544|NCT01188772|537074429|FG003|Overall Study|Treatment Failure|0|||
148889545|NCT01188772|537074426|FG000|Overall Study|Virologic Failure|1|||
148889546|NCT01188772|537074427|FG001|Overall Study|Virologic Failure|0|||
148889547|NCT01188772|537074428|FG002|Overall Study|Virologic Failure|0|||
148889548|NCT01188772|537074429|FG003|Overall Study|Virologic Failure|0|||
148889549|NCT01188772|537074426|FG000|Overall Study|Withdrawal by Subject|0|||
148889550|NCT01188772|537074427|FG001|Overall Study|Withdrawal by Subject|0|||
148889551|NCT01188772|537074428|FG002|Overall Study|Withdrawal by Subject|2|||
148889552|NCT01188772|537074429|FG003|Overall Study|Withdrawal by Subject|0|||
148889553|NCT01433172|537074430|FG000|Overall Study|Withdrawal by Subject|0|||
148889554|NCT01433172|537074431|FG001|Overall Study|Withdrawal by Subject|1|||
148889555|NCT01433172|537074432|FG002|Overall Study|Withdrawal by Subject|0|||
148889556|NCT01433172|537074430|FG000|Overall Study|Disease Progression|0|||
148889557|NCT01433172|537074431|FG001|Overall Study|Disease Progression|0|||
148889558|NCT01433172|537074432|FG002|Overall Study|Disease Progression|1|||
148889559|NCT01433172|537074430|FG000|Overall Study|Death|0|||
148889560|NCT01433172|537074431|FG001|Overall Study|Death|2|||
148889561|NCT01433172|537074432|FG002|Overall Study|Death|0|||
148889562|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
148889563|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
148889564|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
148889565|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
148889566|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
148889567|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
148889568|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Death|7|||
148889569|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Death|5|||
148889570|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Death|6|||
148856889|NCT02688088|536951719|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
148856890|NCT02688088|536951720|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
148856891|NCT02688088|536951721|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
148856892|NCT02688088|536951722|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
148856893|NCT02688088|536951723|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
148856894|NCT02688088|536951719|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
148856895|NCT02688088|536951720|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
148856896|NCT02688088|536951721|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
148856897|NCT02688088|536951722|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
148856898|NCT02688088|536951723|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
148856899|NCT02688088|536951719|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
148856900|NCT02688088|536951720|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
148856901|NCT02688088|536951721|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
148856902|NCT02688088|536951722|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
148856903|NCT02688088|536951723|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
148856904|NCT02688088|536951719|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
148989409|NCT00626522|537438333|FG005|Overall Study|COPD exacerbation|0|||
148989410|NCT00626522|537438328|FG000|Overall Study|Lost to Follow-up|0|||
148989411|NCT00626522|537438329|FG001|Overall Study|Lost to Follow-up|1|||
148989412|NCT00626522|537438330|FG002|Overall Study|Lost to Follow-up|0|||
148989413|NCT00626522|537438331|FG003|Overall Study|Lost to Follow-up|0|||
148989414|NCT00626522|537438332|FG004|Overall Study|Lost to Follow-up|0|||
148989415|NCT00626522|537438333|FG005|Overall Study|Lost to Follow-up|0|||
148989416|NCT00626522|537438328|FG000|Overall Study|Inconsistent reason reported|1|||
148989417|NCT00626522|537438329|FG001|Overall Study|Inconsistent reason reported|0|||
148989418|NCT00626522|537438330|FG002|Overall Study|Inconsistent reason reported|0|||
148989419|NCT00626522|537438331|FG003|Overall Study|Inconsistent reason reported|0|||
148989420|NCT00626522|537438332|FG004|Overall Study|Inconsistent reason reported|0|||
148989421|NCT00626522|537438333|FG005|Overall Study|Inconsistent reason reported|0|||
148989422|NCT00626522|537438328|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
148989423|NCT00626522|537438329|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
148989424|NCT00626522|537438330|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
148989425|NCT00626522|537438331|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
148989426|NCT00626522|537438332|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
148989427|NCT00626522|537438333|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
148989428|NCT03822533|537438339|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
148989429|NCT03822533|537438340|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
148989430|NCT03822533|537438339|FG000|3 Month Follow-up|Lost to Follow-up|2|||
148989431|NCT03822533|537438340|FG001|3 Month Follow-up|Lost to Follow-up|2|||
148989432|NCT03822533|537438339|FG000|6 Month Follow-up|Lost to Follow-up|3|||
148989433|NCT03822533|537438340|FG001|6 Month Follow-up|Lost to Follow-up|0|||
148989434|NCT03822533|537438339|FG000|12 Month Follow-up|Lost to Follow-up|2|||
148856905|NCT02688088|536951720|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
148856906|NCT02688088|536951721|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
148856907|NCT02688088|536951722|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
148856908|NCT02688088|536951723|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
148856909|NCT02688088|536951719|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
148856910|NCT02688088|536951720|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
148856911|NCT02688088|536951721|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
148856912|NCT02688088|536951722|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
148856913|NCT02688088|536951723|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
148856914|NCT02688088|536951719|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
148856915|NCT02688088|536951720|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
148856916|NCT02688088|536951721|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
148856917|NCT02688088|536951722|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
148856918|NCT02688088|536951723|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
148856919|NCT02688088|536951719|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
148856920|NCT02688088|536951720|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
148856921|NCT02688088|536951721|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
148856922|NCT02688088|536951722|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
149030621|NCT02081391|537589685|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
149030622|NCT02081391|537589686|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
148856923|NCT02688088|536951723|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
148989435|NCT03822533|537438340|FG001|12 Month Follow-up|Lost to Follow-up|3|||
148989436|NCT03822533|537438339|FG000|12 Month Follow-up|Pregnancy|0|||
148989437|NCT03822533|537438340|FG001|12 Month Follow-up|Pregnancy|1|||
149030623|NCT02081391|537589687|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
149030624|NCT02081391|537589688|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
148989438|NCT03822533|537438339|FG000|12 Month Follow-up|Surgery|2|||
148989439|NCT03822533|537438340|FG001|12 Month Follow-up|Surgery|0|||
148989440|NCT03822533|537438339|FG000|12 Month Follow-up|Wrong address|1|||
148989441|NCT03822533|537438340|FG001|12 Month Follow-up|Wrong address|0|||
148989442|NCT03822533|537438339|FG000|12 Month Follow-up|No symptoms|1|||
148989443|NCT03822533|537438340|FG001|12 Month Follow-up|No symptoms|0|||
148989444|NCT03822533|537438339|FG000|12 Month Follow-up|Changed primary care center|0|||
148989445|NCT03822533|537438340|FG001|12 Month Follow-up|Changed primary care center|1|||
148989446|NCT02863926|537438341|FG000|Overall Study|Physician Decision|1|||
148989447|NCT02863926|537438342|FG001|Overall Study|Physician Decision|0|||
148989448|NCT02863926|537438341|FG000|Overall Study|Lost to Follow-up|1|||
148989449|NCT02863926|537438342|FG001|Overall Study|Lost to Follow-up|1|||
148989450|NCT03489304|537438343|FG000|Overall Study|Lost to Follow-up|4|||
148989451|NCT02239679|537438344|FG000|Overall Study|Lost to Follow-up|1|||
148989452|NCT02239679|537438345|FG001|Overall Study|Lost to Follow-up|0|||
148989453|NCT02239679|537438346|FG002|Overall Study|Lost to Follow-up|0|||
148989454|NCT02239679|537438344|FG000|Overall Study|Withdrawal by Subject|2|||
148989455|NCT02239679|537438345|FG001|Overall Study|Withdrawal by Subject|3|||
148989456|NCT02239679|537438346|FG002|Overall Study|Withdrawal by Subject|1|||
148989457|NCT02605954|537438348|FG000|Overall Study|Adverse Event|5|||
148989458|NCT02605954|537438349|FG001|Overall Study|Adverse Event|1|||
148989459|NCT02605954|537438348|FG000|Overall Study|Investigator's Discretion|1|||
148989460|NCT02605954|537438349|FG001|Overall Study|Investigator's Discretion|0|||
148989461|NCT02605954|537438348|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148989462|NCT02605954|537438349|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148989463|NCT02605954|537438348|FG000|Overall Study|Withdrew Consent|2|||
148989464|NCT02605954|537438349|FG001|Overall Study|Withdrew Consent|2|||
148989465|NCT02605954|537438348|FG000|Overall Study|Lost to Follow-up|3|||
148989466|NCT02605954|537438349|FG001|Overall Study|Lost to Follow-up|0|||
148989467|NCT02605954|537438348|FG000|Overall Study|Randomized but not treated|0|||
148989468|NCT02605954|537438349|FG001|Overall Study|Randomized but not treated|1|||
148989469|NCT02301143|537438350|FG000|Induction Period|Enrolled But Not Treated|1|||
148989470|NCT02301143|537438351|FG001|Induction Period|Enrolled But Not Treated|0|||
148989471|NCT02301143|537438350|FG000|Induction Period|Death|1|||
148989472|NCT02301143|537438351|FG001|Induction Period|Death|0|||
148989473|NCT02301143|537438350|FG000|Induction Period|Adverse Event|22|||
148989474|NCT02301143|537438351|FG001|Induction Period|Adverse Event|0|||
148989475|NCT02301143|537438350|FG000|Induction Period|Progressive Disease|8|||
148989476|NCT02301143|537438351|FG001|Induction Period|Progressive Disease|0|||
148989477|NCT02301143|537438350|FG000|Induction Period|Withdrawal by Subject|3|||
148989478|NCT02301143|537438351|FG001|Induction Period|Withdrawal by Subject|0|||
148989479|NCT02301143|537438350|FG000|Induction Period|Noncompliance with Study Drug|1|||
148989480|NCT02301143|537438351|FG001|Induction Period|Noncompliance with Study Drug|0|||
148989481|NCT02301143|537438350|FG000|Induction Period|Physician Decision|4|||
148989482|NCT02301143|537438351|FG001|Induction Period|Physician Decision|0|||
148989483|NCT02301143|537438350|FG000|Induction Period|Symptomatic Deterioration|2|||
148989484|NCT02301143|537438351|FG001|Induction Period|Symptomatic Deterioration|0|||
148989485|NCT02301143|537438350|FG000|Induction Period|Protocol Violation|2|||
148989486|NCT02301143|537438351|FG001|Induction Period|Protocol Violation|0|||
148989487|NCT02301143|537438350|FG000|Induction Period|Other|1|||
148989488|NCT02301143|537438351|FG001|Induction Period|Other|0|||
148989489|NCT02301143|537438350|FG000|Investigator's Choice|Adverse Event|0|||
148989490|NCT02301143|537438351|FG001|Investigator's Choice|Adverse Event|3|||
148989491|NCT02301143|537438350|FG000|Investigator's Choice|Progressive Disease|0|||
148989492|NCT02301143|537438351|FG001|Investigator's Choice|Progressive Disease|3|||
148989493|NCT02301143|537438350|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
148989494|NCT02301143|537438351|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
148989495|NCT02301143|537438350|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
148989496|NCT02301143|537438351|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
148989497|NCT02301143|537438350|FG000|Investigator's Choice|Other|0|||
148989498|NCT02301143|537438351|FG001|Investigator's Choice|Other|1|||
148989499|NCT02301143|537438350|FG000|Investigator's Choice|Unresectable Surgery|0|||
148989500|NCT02301143|537438351|FG001|Investigator's Choice|Unresectable Surgery|1|||
148989501|NCT04726709|537438355|FG000|Overall Study|Withdrawal by Subject|2|||
148989502|NCT04726709|537438356|FG001|Overall Study|Withdrawal by Subject|2|||
148989503|NCT03073603|537438358|FG000|Overall Study|Noncompliance|3|||
149030625|NCT02081391|537589685|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
149030626|NCT02081391|537589686|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
149030627|NCT02081391|537589687|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
149030628|NCT02081391|537589688|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
149030629|NCT02081391|537589685|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
149030630|NCT02081391|537589686|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
148989504|NCT03073603|537438359|FG001|Overall Study|Noncompliance|1|||
148989505|NCT03073603|537438358|FG000|Overall Study|Adverse Event|5|||
148989506|NCT03073603|537438359|FG001|Overall Study|Adverse Event|3|||
148989507|NCT03073603|537438358|FG000|Overall Study|Physician Decision|1|||
148989508|NCT03073603|537438359|FG001|Overall Study|Physician Decision|2|||
148989509|NCT03073603|537438358|FG000|Overall Study|Required treatment not allowed by protocol|1|||
148989510|NCT03073603|537438359|FG001|Overall Study|Required treatment not allowed by protocol|0|||
148989511|NCT03073603|537438358|FG000|Overall Study|Financial or insurance-related|8|||
148989512|NCT03073603|537438359|FG001|Overall Study|Financial or insurance-related|0|||
148989513|NCT03073603|537438358|FG000|Overall Study|Withdrawal by Subject|0|||
148989514|NCT03073603|537438359|FG001|Overall Study|Withdrawal by Subject|1|||
148989515|NCT03073603|537438358|FG000|Overall Study|Discontinued DMT|4|||
148989516|NCT03073603|537438359|FG001|Overall Study|Discontinued DMT|0|||
148989517|NCT03073603|537438358|FG000|Overall Study|Restarted DMT|0|||
148989518|NCT03073603|537438359|FG001|Overall Study|Restarted DMT|1|||
148989519|NCT00823719|537438362|FG000|Overall Study|Adverse Event|1|||
148989520|NCT00823719|537438363|FG001|Overall Study|Adverse Event|2|||
148989521|NCT00823719|537438362|FG000|Overall Study|Physician Decision|1|||
148989522|NCT00823719|537438363|FG001|Overall Study|Physician Decision|4|||
148989523|NCT00823719|537438362|FG000|Overall Study|Withdrawal by Subject|0|||
148989524|NCT00823719|537438363|FG001|Overall Study|Withdrawal by Subject|1|||
148989525|NCT00823719|537438362|FG000|Overall Study|Disease Progression|4|||
148989526|NCT00823719|537438363|FG001|Overall Study|Disease Progression|4|||
148989527|NCT04757649|537438365|FG000|Overall Study|Withdrawal by Subject|1|||
148989528|NCT04757649|537438365|FG000|Overall Study|Adverse Event|1|||
148989529|NCT01286779|537438366|FG000|Overall Study|Withdrawal by Subject|9|||
148989530|NCT01286779|537438366|FG000|Overall Study|Protocol Violation|5|||
148989531|NCT01286779|537438366|FG000|Overall Study|Physician Decision|2|||
148989532|NCT01286779|537438366|FG000|Overall Study|Participant had scheduled surgery|1|||
148989533|NCT01286779|537438366|FG000|Overall Study|Participant moved to another country|1|||
148989534|NCT01286779|537438366|FG000|Overall Study|Discontinued by sponsor|1|||
148989535|NCT04827212|537438371|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
148989536|NCT04827212|537438372|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
148989537|NCT04827212|537438371|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
148989538|NCT04827212|537438372|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
148989539|NCT02862106|537438373|FG000|Overall Study|Adverse Event|4|||
148989540|NCT02862106|537438374|FG001|Overall Study|Adverse Event|0|||
148989541|NCT02862106|537438373|FG000|Overall Study|Protocol Violation|16|||
148989542|NCT02862106|537438374|FG001|Overall Study|Protocol Violation|1|||
148989543|NCT02862106|537438373|FG000|Overall Study|Lost to Follow-up|15|||
148989544|NCT02862106|537438374|FG001|Overall Study|Lost to Follow-up|5|||
148989545|NCT02862106|537438373|FG000|Overall Study|Withdrawal by Subject|2|||
148989546|NCT02862106|537438374|FG001|Overall Study|Withdrawal by Subject|0|||
148989547|NCT02862106|537438373|FG000|Overall Study|Subjects moved to other city|1|||
148989548|NCT02862106|537438374|FG001|Overall Study|Subjects moved to other city|0|||
148989549|NCT00563784|537438377|FG000|Overall Study|Withdrawal by Subject|2|||
148989550|NCT00563784|537438377|FG000|Overall Study|Screen Failures|20|||
148989551|NCT04360824|537438378|FG000|Overall Study|Withdrawal by Subject|2|||
148989552|NCT04360824|537438379|FG001|Overall Study|Withdrawal by Subject|1|||
148989553|NCT04360824|537438378|FG000|Overall Study|Did not receive assigned treatment|1|||
148989554|NCT04360824|537438379|FG001|Overall Study|Did not receive assigned treatment|3|||
148989555|NCT00304070|537438380|FG000|Overall Study|Death|0|||
148989556|NCT00304070|537438381|FG001|Overall Study|Death|0|||
148989557|NCT00304070|537438382|FG002|Overall Study|Death|3|||
148989558|NCT00304070|537438380|FG000|Overall Study|Lost to Follow-up|0|||
148989559|NCT00304070|537438381|FG001|Overall Study|Lost to Follow-up|0|||
148989560|NCT00304070|537438382|FG002|Overall Study|Lost to Follow-up|1|||
148989561|NCT00304070|537438380|FG000|Overall Study|Physician Decision|0|||
148989562|NCT00304070|537438381|FG001|Overall Study|Physician Decision|0|||
148989563|NCT00304070|537438382|FG002|Overall Study|Physician Decision|3|||
148989564|NCT00304070|537438380|FG000|Overall Study|Withdrawal by Subject|0|||
148989565|NCT00304070|537438381|FG001|Overall Study|Withdrawal by Subject|0|||
148989566|NCT00304070|537438382|FG002|Overall Study|Withdrawal by Subject|1|||
148989567|NCT00304070|537438380|FG000|Overall Study|Progressive Disease|3|||
148989568|NCT00304070|537438381|FG001|Overall Study|Progressive Disease|7|||
148989569|NCT00304070|537438382|FG002|Overall Study|Progressive Disease|4|||
148989570|NCT00320216|537438383|FG000|Overall Study|Adverse Event|0|||
149030631|NCT02081391|537589687|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
149030632|NCT02081391|537589688|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
148989571|NCT00320216|537438384|FG001|Overall Study|Adverse Event|6|||
148989572|NCT00320216|537438385|FG002|Overall Study|Adverse Event|0|||
148989573|NCT00320216|537438386|FG003|Overall Study|Adverse Event|2|||
148989574|NCT00320216|537438387|FG004|Overall Study|Adverse Event|2|||
148989575|NCT00320216|537438383|FG000|Overall Study|Lack of Efficacy|6|||
148989576|NCT00320216|537438384|FG001|Overall Study|Lack of Efficacy|2|||
148989577|NCT00320216|537438385|FG002|Overall Study|Lack of Efficacy|1|||
148989578|NCT00320216|537438386|FG003|Overall Study|Lack of Efficacy|0|||
148989579|NCT00320216|537438387|FG004|Overall Study|Lack of Efficacy|1|||
148989580|NCT00320216|537438383|FG000|Overall Study|Lost to Follow-up|3|||
148989581|NCT00320216|537438384|FG001|Overall Study|Lost to Follow-up|0|||
148989582|NCT00320216|537438385|FG002|Overall Study|Lost to Follow-up|0|||
148989583|NCT00320216|537438386|FG003|Overall Study|Lost to Follow-up|0|||
148989584|NCT00320216|537438387|FG004|Overall Study|Lost to Follow-up|0|||
148989585|NCT00320216|537438383|FG000|Overall Study|Other|7|||
148989586|NCT00320216|537438384|FG001|Overall Study|Other|2|||
148989587|NCT00320216|537438385|FG002|Overall Study|Other|5|||
148989588|NCT00320216|537438386|FG003|Overall Study|Other|1|||
148989589|NCT00320216|537438387|FG004|Overall Study|Other|3|||
148989590|NCT00377676|537438388|FG000|Overall Study|Adverse Event|498|||
148989591|NCT00377676|537438389|FG001|Overall Study|Adverse Event|107|||
148989592|NCT00377676|537438388|FG000|Overall Study|Protocol Violation|33|||
148989593|NCT00377676|537438389|FG001|Overall Study|Protocol Violation|27|||
148989594|NCT00377676|537438388|FG000|Overall Study|Death|5|||
148989595|NCT00377676|537438389|FG001|Overall Study|Death|2|||
148989596|NCT00377676|537438388|FG000|Overall Study|Withdrawal by Subject|187|||
148989597|NCT00377676|537438389|FG001|Overall Study|Withdrawal by Subject|72|||
148989598|NCT00377676|537438388|FG000|Overall Study|Lost to Follow-up|120|||
148989599|NCT00377676|537438389|FG001|Overall Study|Lost to Follow-up|56|||
148989600|NCT00377676|537438388|FG000|Overall Study|Other|118|||
148989601|NCT00377676|537438389|FG001|Overall Study|Other|58|||
148989602|NCT02528214|537438397|FG000|Overall Study|Protocol Violation|0|||
148989603|NCT02528214|537438398|FG001|Overall Study|Protocol Violation|1|||
148989604|NCT02528214|537438397|FG000|Overall Study|Adverse Event|0|||
148989605|NCT02528214|537438398|FG001|Overall Study|Adverse Event|1|||
148989606|NCT02528214|537438397|FG000|Overall Study|Other than specified above|0|||
148989607|NCT02528214|537438398|FG001|Overall Study|Other than specified above|1|||
148989608|NCT02384759|537438399|FG000|Overall Study|Patients not treated|3|||
148989609|NCT02384759|537438400|FG001|Overall Study|Patients not treated|2|||
148989610|NCT01605617|537438401|FG000|First Intervention|Adverse Event|0|||
148989611|NCT01605617|537438402|FG001|First Intervention|Adverse Event|1|||
148989612|NCT01605617|537438401|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
148989613|NCT01605617|537438402|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
148989614|NCT02014116|537438404|FG000|Overall Study|Progressive Disease|3|||
148989615|NCT02014116|537438405|FG001|Overall Study|Progressive Disease|4|||
148989616|NCT02014116|537438406|FG002|Overall Study|Progressive Disease|2|||
148989617|NCT02014116|537438407|FG003|Overall Study|Progressive Disease|6|||
148989618|NCT02014116|537438408|FG004|Overall Study|Progressive Disease|1|||
148989619|NCT02014116|537438409|FG005|Overall Study|Progressive Disease|13|||
148856924|NCT01801436|536951725|FG000|Overall Study|Withdrawal by Subject|3|||
148856925|NCT01801436|536951725|FG000|Overall Study|Adverse Event|2|||
148856926|NCT01801436|536951725|FG000|Overall Study|Progressive disease|4|||
148856927|NCT02447250|536951728|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
148856928|NCT02447250|536951728|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
148856929|NCT02447250|536951728|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
148856930|NCT03632993|536951729|FG000|Overall Study|Withdrawal by Subject|1|||
148856931|NCT03632993|536951730|FG001|Overall Study|Withdrawal by Subject|0|||
148856932|NCT03632993|536951731|FG002|Overall Study|Withdrawal by Subject|0|||
148856933|NCT03632993|536951732|FG003|Overall Study|Withdrawal by Subject|0|||
148856934|NCT03632993|536951733|FG004|Overall Study|Withdrawal by Subject|0|||
148856935|NCT03632993|536951734|FG005|Overall Study|Withdrawal by Subject|0|||
148856936|NCT03632993|536951735|FG006|Overall Study|Withdrawal by Subject|0|||
148856937|NCT03632993|536951736|FG007|Overall Study|Withdrawal by Subject|0|||
148856938|NCT03632993|536951737|FG008|Overall Study|Withdrawal by Subject|0|||
148856939|NCT03632993|536951738|FG009|Overall Study|Withdrawal by Subject|1|||
148856940|NCT03632993|536951729|FG000|Overall Study|Protocol Non-compliance|0|||
148856941|NCT03632993|536951730|FG001|Overall Study|Protocol Non-compliance|1|||
148856942|NCT03632993|536951731|FG002|Overall Study|Protocol Non-compliance|0|||
148856943|NCT03632993|536951732|FG003|Overall Study|Protocol Non-compliance|0|||
148856944|NCT03632993|536951733|FG004|Overall Study|Protocol Non-compliance|0|||
148856945|NCT03632993|536951734|FG005|Overall Study|Protocol Non-compliance|0|||
148856946|NCT03632993|536951735|FG006|Overall Study|Protocol Non-compliance|0|||
148856947|NCT03632993|536951736|FG007|Overall Study|Protocol Non-compliance|0|||
148856948|NCT03632993|536951737|FG008|Overall Study|Protocol Non-compliance|0|||
148856949|NCT03632993|536951738|FG009|Overall Study|Protocol Non-compliance|0|||
148856950|NCT03632993|536951729|FG000|Overall Study|Lost to Follow-up|0|||
148856951|NCT03632993|536951730|FG001|Overall Study|Lost to Follow-up|0|||
148856952|NCT03632993|536951731|FG002|Overall Study|Lost to Follow-up|0|||
148856953|NCT03632993|536951732|FG003|Overall Study|Lost to Follow-up|0|||
148856954|NCT03632993|536951733|FG004|Overall Study|Lost to Follow-up|0|||
148856955|NCT03632993|536951734|FG005|Overall Study|Lost to Follow-up|1|||
148989620|NCT02014116|537438410|FG006|Overall Study|Progressive Disease|1|||
148989621|NCT02014116|537438411|FG007|Overall Study|Progressive Disease|3|||
148989622|NCT02014116|537438412|FG008|Overall Study|Progressive Disease|7|||
148989623|NCT02014116|537438404|FG000|Overall Study|Adverse Event|0|||
148989624|NCT02014116|537438405|FG001|Overall Study|Adverse Event|0|||
148989625|NCT02014116|537438406|FG002|Overall Study|Adverse Event|0|||
148989626|NCT02014116|537438407|FG003|Overall Study|Adverse Event|0|||
148989627|NCT02014116|537438408|FG004|Overall Study|Adverse Event|1|||
148989628|NCT02014116|537438409|FG005|Overall Study|Adverse Event|0|||
148989629|NCT02014116|537438410|FG006|Overall Study|Adverse Event|0|||
148856956|NCT03632993|536951735|FG006|Overall Study|Lost to Follow-up|0|||
148989630|NCT02014116|537438411|FG007|Overall Study|Adverse Event|1|||
148989631|NCT02014116|537438412|FG008|Overall Study|Adverse Event|0|||
148989632|NCT02014116|537438404|FG000|Overall Study|Lost to Follow-up|0|||
148989633|NCT02014116|537438405|FG001|Overall Study|Lost to Follow-up|0|||
148989634|NCT02014116|537438406|FG002|Overall Study|Lost to Follow-up|0|||
148989635|NCT02014116|537438407|FG003|Overall Study|Lost to Follow-up|0|||
148989636|NCT02014116|537438408|FG004|Overall Study|Lost to Follow-up|0|||
148989637|NCT02014116|537438409|FG005|Overall Study|Lost to Follow-up|1|||
148989638|NCT02014116|537438410|FG006|Overall Study|Lost to Follow-up|0|||
148989639|NCT02014116|537438411|FG007|Overall Study|Lost to Follow-up|0|||
148989640|NCT02014116|537438412|FG008|Overall Study|Lost to Follow-up|1|||
148989641|NCT02014116|537438404|FG000|Overall Study|Death|0|||
148989642|NCT02014116|537438405|FG001|Overall Study|Death|0|||
148989643|NCT02014116|537438406|FG002|Overall Study|Death|0|||
148989644|NCT02014116|537438407|FG003|Overall Study|Death|0|||
148989645|NCT02014116|537438408|FG004|Overall Study|Death|0|||
148989646|NCT02014116|537438409|FG005|Overall Study|Death|0|||
148989647|NCT02014116|537438410|FG006|Overall Study|Death|0|||
148989648|NCT02014116|537438411|FG007|Overall Study|Death|1|||
148989649|NCT02014116|537438412|FG008|Overall Study|Death|1|||
148989650|NCT02014116|537438404|FG000|Overall Study|Withdrawal by Subject|0|||
148989651|NCT02014116|537438405|FG001|Overall Study|Withdrawal by Subject|0|||
148989652|NCT02014116|537438406|FG002|Overall Study|Withdrawal by Subject|1|||
148989653|NCT02014116|537438407|FG003|Overall Study|Withdrawal by Subject|1|||
148989654|NCT02014116|537438408|FG004|Overall Study|Withdrawal by Subject|0|||
148989655|NCT02014116|537438409|FG005|Overall Study|Withdrawal by Subject|1|||
148989656|NCT02014116|537438410|FG006|Overall Study|Withdrawal by Subject|0|||
148989657|NCT02014116|537438411|FG007|Overall Study|Withdrawal by Subject|0|||
148989658|NCT02014116|537438412|FG008|Overall Study|Withdrawal by Subject|0|||
148989659|NCT02014116|537438404|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
148989660|NCT02014116|537438405|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
148989661|NCT02014116|537438406|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
148989662|NCT02014116|537438407|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
148989663|NCT02014116|537438408|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
148989664|NCT02014116|537438409|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
148989665|NCT02014116|537438410|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
148989666|NCT02014116|537438411|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
148989667|NCT02014116|537438412|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
148989668|NCT02014116|537438404|FG000|Overall Study|Physician Decision|0|||
148989669|NCT02014116|537438405|FG001|Overall Study|Physician Decision|0|||
148989670|NCT02014116|537438406|FG002|Overall Study|Physician Decision|0|||
148989671|NCT02014116|537438407|FG003|Overall Study|Physician Decision|0|||
148989672|NCT02014116|537438408|FG004|Overall Study|Physician Decision|0|||
148989673|NCT02014116|537438409|FG005|Overall Study|Physician Decision|0|||
148989674|NCT02014116|537438410|FG006|Overall Study|Physician Decision|0|||
148989675|NCT02014116|537438411|FG007|Overall Study|Physician Decision|0|||
148989676|NCT02014116|537438412|FG008|Overall Study|Physician Decision|1|||
148989677|NCT00121238|537438413|FG000|Overall Study|disease progression before intervention|1|||
148989678|NCT00121238|537438413|FG000|Overall Study|Protocol Violation|2|||
148989679|NCT03043664|537438414|FG000|Overall Study|Lost to Follow-up|1|||
148989680|NCT01540851|537438415|FG000|Overall Study|Lost to Follow-up|14|||
148989681|NCT01540851|537438416|FG001|Overall Study|Lost to Follow-up|15|||
148989682|NCT01540851|537438415|FG000|Overall Study|Withdrawal by Subject|7|||
148989683|NCT01540851|537438416|FG001|Overall Study|Withdrawal by Subject|3|||
148989684|NCT00325468|537438417|FG000|Overall Study|Adverse Event|1|||
148989685|NCT00325468|537438418|FG001|Overall Study|Adverse Event|1|||
148989686|NCT00325468|537438419|FG002|Overall Study|Adverse Event|0|||
148989687|NCT00325468|537438420|FG003|Overall Study|Adverse Event|5|||
148989688|NCT00325468|537438421|FG004|Overall Study|Adverse Event|1|||
148989689|NCT00325468|537438417|FG000|Overall Study|Death|2|||
148989690|NCT00325468|537438418|FG001|Overall Study|Death|0|||
148989691|NCT00325468|537438419|FG002|Overall Study|Death|2|||
148856957|NCT03632993|536951736|FG007|Overall Study|Lost to Follow-up|1|||
148856958|NCT03632993|536951737|FG008|Overall Study|Lost to Follow-up|0|||
148856959|NCT03632993|536951738|FG009|Overall Study|Lost to Follow-up|0|||
148856960|NCT03632993|536951729|FG000|Overall Study|Adverse Event|0|||
148989692|NCT00325468|537438420|FG003|Overall Study|Death|4|||
148856961|NCT03632993|536951730|FG001|Overall Study|Adverse Event|0|||
148856962|NCT03632993|536951731|FG002|Overall Study|Adverse Event|0|||
148989693|NCT00325468|537438421|FG004|Overall Study|Death|0|||
148989694|NCT00325468|537438417|FG000|Overall Study|Lost to Follow-up|0|||
148989695|NCT00325468|537438418|FG001|Overall Study|Lost to Follow-up|0|||
148989696|NCT00325468|537438419|FG002|Overall Study|Lost to Follow-up|1|||
148989697|NCT00325468|537438420|FG003|Overall Study|Lost to Follow-up|2|||
148989698|NCT00325468|537438421|FG004|Overall Study|Lost to Follow-up|2|||
148989699|NCT00325468|537438417|FG000|Overall Study|Physician Decision|1|||
148989700|NCT00325468|537438418|FG001|Overall Study|Physician Decision|1|||
148989701|NCT00325468|537438419|FG002|Overall Study|Physician Decision|0|||
148989702|NCT00325468|537438420|FG003|Overall Study|Physician Decision|1|||
149030633|NCT02081391|537589685|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
149030634|NCT02081391|537589686|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
149030635|NCT02081391|537589687|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
149030636|NCT02081391|537589688|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
149030637|NCT02081391|537589685|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
149030638|NCT02081391|537589686|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
149030639|NCT02081391|537589687|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
149030640|NCT02081391|537589688|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
149030641|NCT02081391|537589685|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
149030642|NCT02081391|537589686|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
149030643|NCT02081391|537589687|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
149030644|NCT02081391|537589688|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
149030645|NCT01458275|537589689|FG000|Overall Study|Adverse Event|3|||
149030646|NCT01458275|537589690|FG001|Overall Study|Adverse Event|4|||
149030647|NCT01458275|537589691|FG002|Overall Study|Adverse Event|1|||
149030648|NCT01458275|537589689|FG000|Overall Study|Lost to Follow-up|3|||
149030649|NCT01458275|537589690|FG001|Overall Study|Lost to Follow-up|2|||
149030650|NCT01458275|537589691|FG002|Overall Study|Lost to Follow-up|5|||
149030651|NCT01458275|537589689|FG000|Overall Study|Protocol Violation|5|||
149030652|NCT01458275|537589690|FG001|Overall Study|Protocol Violation|5|||
149030653|NCT01458275|537589691|FG002|Overall Study|Protocol Violation|2|||
148856963|NCT03632993|536951732|FG003|Overall Study|Adverse Event|0|||
148856964|NCT03632993|536951733|FG004|Overall Study|Adverse Event|0|||
148856965|NCT03632993|536951734|FG005|Overall Study|Adverse Event|1|||
148856966|NCT03632993|536951735|FG006|Overall Study|Adverse Event|0|||
148856967|NCT03632993|536951736|FG007|Overall Study|Adverse Event|1|||
148856968|NCT03632993|536951737|FG008|Overall Study|Adverse Event|0|||
148856969|NCT03632993|536951738|FG009|Overall Study|Adverse Event|0|||
148989703|NCT00325468|537438421|FG004|Overall Study|Physician Decision|0|||
148989704|NCT00325468|537438417|FG000|Overall Study|Withdrawal by Subject|3|||
148989705|NCT00325468|537438418|FG001|Overall Study|Withdrawal by Subject|1|||
148989706|NCT00325468|537438419|FG002|Overall Study|Withdrawal by Subject|0|||
148989707|NCT00325468|537438420|FG003|Overall Study|Withdrawal by Subject|14|||
148989708|NCT00325468|537438421|FG004|Overall Study|Withdrawal by Subject|4|||
148989709|NCT00325468|537438417|FG000|Overall Study|site closure etc|4|||
148989710|NCT00325468|537438418|FG001|Overall Study|site closure etc|2|||
148989711|NCT00325468|537438419|FG002|Overall Study|site closure etc|1|||
148989712|NCT00325468|537438420|FG003|Overall Study|site closure etc|8|||
148989713|NCT00325468|537438421|FG004|Overall Study|site closure etc|1|||
148989714|NCT03593655|537438422|FG000|First Product Use Period|Withdrawal by Subject|1|||
148989715|NCT03593655|537438423|FG001|First Product Use Period|Withdrawal by Subject|1|||
148989716|NCT03593655|537438422|FG000|First Product Use Period|Lost to Follow-up|1|||
148989717|NCT03593655|537438423|FG001|First Product Use Period|Lost to Follow-up|3|||
148989718|NCT03593655|537438422|FG000|Second Product Use Period|Withdrawal by Subject|1|||
148989719|NCT03593655|537438423|FG001|Second Product Use Period|Withdrawal by Subject|1|||
148989720|NCT03593655|537438422|FG000|Second Product Use Period|Lost to Follow-up|1|||
148989721|NCT03593655|537438423|FG001|Second Product Use Period|Lost to Follow-up|0|||
148989722|NCT03593655|537438422|FG000|Third Product Use Period|Lost to Follow-up|1|||
148989723|NCT03593655|537438423|FG001|Third Product Use Period|Lost to Follow-up|2|||
148989724|NCT03593655|537438422|FG000|Third Product Use Period|Physician Decision|0|||
148989725|NCT03593655|537438423|FG001|Third Product Use Period|Physician Decision|1|||
148989726|NCT03593655|537438422|FG000|Third Product Use Period|Withdrawal by Subject|0|||
148989727|NCT03593655|537438423|FG001|Third Product Use Period|Withdrawal by Subject|1|||
148989728|NCT03732209|537438424|FG000|Overall Study|Lost to Follow-up|4|||
148989729|NCT03732209|537438425|FG001|Overall Study|Lost to Follow-up|4|||
148989730|NCT03732209|537438424|FG000|Overall Study|Withdrawal by Subject|8|||
148989731|NCT03732209|537438425|FG001|Overall Study|Withdrawal by Subject|9|||
148989732|NCT00093145|537438432|FG000|Overall Study|Unacceptable Toxicity Only|2|||
148989733|NCT00093145|537438432|FG000|Overall Study|Physician Decision|5|||
148989734|NCT00093145|537438432|FG000|Overall Study|Withdrawal by Subject|9|||
148989735|NCT00093145|537438432|FG000|Overall Study|Other|1|||
148989736|NCT01310036|537438433|FG000|Overall Study|Administrative/other|10|||
149030654|NCT01458275|537589689|FG000|Overall Study|Withdrawal by Subject|3|||
149030655|NCT01458275|537589690|FG001|Overall Study|Withdrawal by Subject|2|||
149030656|NCT01458275|537589691|FG002|Overall Study|Withdrawal by Subject|1|||
149030657|NCT00813488|537589692|FG000|Titration Period 1|Adverse Event|6|||
149030658|NCT00813488|537589693|FG001|Titration Period 1|Adverse Event|1|||
149030659|NCT00813488|537589692|FG000|Titration Period 1|Lack of Efficacy|9|||
148856970|NCT01082874|536951747|FG000|Overall Study|Lost to Follow-up|10|||
148989737|NCT01310036|537438433|FG000|Overall Study|Withdrew Consent|11|||
148989738|NCT01310036|537438433|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
149030660|NCT00813488|537589693|FG001|Titration Period 1|Lack of Efficacy|7|||
148856971|NCT01082874|536951748|FG001|Overall Study|Lost to Follow-up|10|||
148856972|NCT01082874|536951749|FG002|Overall Study|Lost to Follow-up|6|||
148989739|NCT01310036|537438433|FG000|Overall Study|Progression of Disease|164|||
148989740|NCT01310036|537438433|FG000|Overall Study|Death|1|||
148989741|NCT01310036|537438433|FG000|Overall Study|Adverse event or intercurrent illness|12|||
148989742|NCT00553267|537438434|FG000|Overall Study|Adverse Event|8|||
148989743|NCT00553267|537438435|FG001|Overall Study|Adverse Event|10|||
148989744|NCT00553267|537438436|FG002|Overall Study|Adverse Event|5|||
148989745|NCT00553267|537438434|FG000|Overall Study|Non compliant with protocol|3|||
148989746|NCT00553267|537438435|FG001|Overall Study|Non compliant with protocol|3|||
148989747|NCT00553267|537438436|FG002|Overall Study|Non compliant with protocol|2|||
148989748|NCT00553267|537438434|FG000|Overall Study|Lost to Follow-up|0|||
148989749|NCT00553267|537438435|FG001|Overall Study|Lost to Follow-up|0|||
148989750|NCT00553267|537438436|FG002|Overall Study|Lost to Follow-up|1|||
148989751|NCT00553267|537438434|FG000|Overall Study|Consent withdrawn|2|||
148989752|NCT00553267|537438435|FG001|Overall Study|Consent withdrawn|3|||
148989753|NCT00553267|537438436|FG002|Overall Study|Consent withdrawn|1|||
148989754|NCT00553267|537438434|FG000|Overall Study|Specified category|1|||
148989755|NCT00553267|537438435|FG001|Overall Study|Specified category|2|||
148989756|NCT00553267|537438436|FG002|Overall Study|Specified category|1|||
148989757|NCT04389840|537438437|FG000|Overall Study|Adverse Event|0|||
148989758|NCT04389840|537438438|FG001|Overall Study|Adverse Event|0|||
148989759|NCT04389840|537438439|FG002|Overall Study|Adverse Event|0|||
148989760|NCT04389840|537438440|FG003|Overall Study|Adverse Event|1|||
148989761|NCT04389840|537438441|FG004|Overall Study|Adverse Event|0|||
148989762|NCT04389840|537438442|FG005|Overall Study|Adverse Event|0|||
148989763|NCT04389840|537438437|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
148989764|NCT04389840|537438438|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
148989765|NCT04389840|537438439|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
148989766|NCT04389840|537438440|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
148989767|NCT04389840|537438441|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
148989768|NCT04389840|537438442|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
148989769|NCT04389840|537438437|FG000|Overall Study|Death|0|||
148989770|NCT04389840|537438438|FG001|Overall Study|Death|1|||
148989771|NCT04389840|537438439|FG002|Overall Study|Death|0|||
148989772|NCT04389840|537438440|FG003|Overall Study|Death|0|||
148989773|NCT04389840|537438441|FG004|Overall Study|Death|0|||
148989774|NCT04389840|537438442|FG005|Overall Study|Death|0|||
148989775|NCT04667117|537438443|FG000|Investigational Period|Lost to Follow-up|0|||
148989776|NCT04667117|537438444|FG001|Investigational Period|Lost to Follow-up|0|||
148989777|NCT04667117|537438445|FG002|Investigational Period|Lost to Follow-up|1|||
148989778|NCT04667117|537438443|FG000|Investigational Period|Protocol Deviation|0|||
148989779|NCT04667117|537438444|FG001|Investigational Period|Protocol Deviation|1|||
148989780|NCT04667117|537438445|FG002|Investigational Period|Protocol Deviation|0|||
148989781|NCT04667117|537438443|FG000|Extension Period|Lost to Follow-up|1|||
148989782|NCT04667117|537438444|FG001|Extension Period|Lost to Follow-up|0|||
148989783|NCT04667117|537438445|FG002|Extension Period|Lost to Follow-up|0|||
148989784|NCT03359096|537438446|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
148989785|NCT03359096|537438447|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
148989786|NCT03359096|537438446|FG000|First Intervention (4 Weeks)|Death|1|||
148989787|NCT03359096|537438447|FG001|First Intervention (4 Weeks)|Death|0|||
148989788|NCT03359096|537438446|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
148989789|NCT03359096|537438447|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
148989790|NCT02232893|537438449|FG000|Overall Study|Withdrawal by Subject|4|||
148989791|NCT02232893|537438450|FG001|Overall Study|Withdrawal by Subject|1|||
148989792|NCT02232893|537438449|FG000|Overall Study|Adverse Event|0|||
148989793|NCT02232893|537438450|FG001|Overall Study|Adverse Event|1|||
148989794|NCT02232893|537438449|FG000|Overall Study|Sponsor request early termination|0|||
148989795|NCT02232893|537438450|FG001|Overall Study|Sponsor request early termination|1|||
148989796|NCT02232893|537438449|FG000|Overall Study|Developed exclusion criteria|0|||
148989797|NCT02232893|537438450|FG001|Overall Study|Developed exclusion criteria|1|||
148989798|NCT02232893|537438449|FG000|Overall Study|Other|0|||
148989799|NCT02232893|537438450|FG001|Overall Study|Other|3|||
148989800|NCT01090453|537438453|FG000|Overall Study|Withdrawal by Subject|1|||
148989801|NCT01090453|537438454|FG001|Overall Study|Withdrawal by Subject|2|||
148989802|NCT01090453|537438453|FG000|Overall Study|Lost to Follow-up|7|||
148989803|NCT01090453|537438454|FG001|Overall Study|Lost to Follow-up|7|||
148989804|NCT01090453|537438453|FG000|Overall Study|Non serious AEs|1|||
148856973|NCT01082874|536951750|FG003|Overall Study|Lost to Follow-up|10|||
148989805|NCT01090453|537438454|FG001|Overall Study|Non serious AEs|0|||
148989806|NCT01090453|537438453|FG000|Overall Study|Protocol Violation|2|||
148989807|NCT01090453|537438454|FG001|Overall Study|Protocol Violation|0|||
148989808|NCT01090453|537438453|FG000|Overall Study|Other|2|||
148989809|NCT01090453|537438454|FG001|Overall Study|Other|4|||
148989810|NCT01090453|537438453|FG000|Overall Study|Eligibility Criteria|0|||
148989811|NCT01090453|537438454|FG001|Overall Study|Eligibility Criteria|1|||
148989812|NCT00522275|537438455|FG000|Overall Study|Adverse Event|35|||
148989813|NCT00522275|537438455|FG000|Overall Study|Lack of Efficacy|80|||
148989814|NCT00522275|537438455|FG000|Overall Study|Subject withdrew consent|16|||
148989815|NCT00522275|537438455|FG000|Overall Study|Protocol deviation|1|||
148989816|NCT00522275|537438455|FG000|Overall Study|Unsatisfactory compliance|11|||
148989817|NCT00522275|537438455|FG000|Overall Study|Lost to Follow-up|8|||
148989818|NCT00522275|537438455|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
148989819|NCT00522275|537438455|FG000|Overall Study|Other: Subject is pregnant|2|||
148856974|NCT01082874|536951747|FG000|Overall Study|Withdrawal by Subject|1|||
148856975|NCT01082874|536951748|FG001|Overall Study|Withdrawal by Subject|2|||
148989820|NCT00522275|537438455|FG000|Overall Study|Other: Subject relocated|2|||
148989821|NCT00522275|537438455|FG000|Overall Study|Other: Subject arrested|1|||
148989822|NCT00522275|537438455|FG000|Overall Study|Other: Site / clinic closed|4|||
148989823|NCT00522275|537438455|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
148989824|NCT00522275|537438455|FG000|Overall Study|Other: Sponsor request|2|||
148989825|NCT00522275|537438455|FG000|Overall Study|Other: Subject ran out of medication|1|||
148989826|NCT00522275|537438455|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
148989827|NCT03867734|537438457|FG000|Overall Study|Lost to Follow-up|2|||
148989828|NCT03965052|537438458|FG000|Overall Study|Protocol Violation|1|||
148989829|NCT03965052|537438459|FG001|Overall Study|Protocol Violation|0|||
148989830|NCT03832192|537438465|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
148989831|NCT03832192|537438466|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
148989832|NCT02663128|537438467|FG000|Period 2|Physician Decision|0|||
148989833|NCT02663128|537438468|FG001|Period 2|Physician Decision|0|||
148989834|NCT02663128|537438469|FG002|Period 2|Physician Decision|0|||
148989835|NCT02663128|537438470|FG003|Period 2|Physician Decision|0|||
148989836|NCT02663128|537438471|FG004|Period 2|Physician Decision|1|||
148989837|NCT02663128|537438472|FG005|Period 2|Physician Decision|0|||
148989838|NCT01663636|537438475|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
148989839|NCT01663636|537438476|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
148989840|NCT02663817|537438477|FG000|Overall Study|Screen failure|2|||
148989841|NCT01308580|537438479|FG000|Overall Study|Lost to Follow-up|12|||
148989842|NCT01308580|537438480|FG001|Overall Study|Lost to Follow-up|7|||
148989843|NCT02535065|537438481|FG000|Overall Study|Death|13|||
148989844|NCT02535065|537438481|FG000|Overall Study|Lost to Follow-up|1|||
148989845|NCT02535065|537438481|FG000|Overall Study|Withdrawal by Subject|6|||
148989846|NCT03712917|537438482|FG000|Overall Study|Pregnancy|0|||
148989847|NCT03712917|537438483|FG001|Overall Study|Pregnancy|0|||
148989848|NCT03712917|537438484|FG002|Overall Study|Pregnancy|1|||
148989849|NCT03712917|537438482|FG000|Overall Study|Adverse Event|0|||
148989850|NCT03712917|537438483|FG001|Overall Study|Adverse Event|4|||
148989851|NCT03712917|537438484|FG002|Overall Study|Adverse Event|3|||
148989852|NCT03712917|537438482|FG000|Overall Study|Lost to Follow-up|9|||
148989853|NCT03712917|537438483|FG001|Overall Study|Lost to Follow-up|4|||
148989854|NCT03712917|537438484|FG002|Overall Study|Lost to Follow-up|5|||
148989855|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
148989856|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
148989857|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
148989858|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
148989859|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
148989860|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
148989861|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
148989862|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
148856976|NCT01082874|536951749|FG002|Overall Study|Withdrawal by Subject|5|||
148856977|NCT01082874|536951750|FG003|Overall Study|Withdrawal by Subject|3|||
148856978|NCT00939029|536951757|FG000|Overall Study|Withdrawal by Subject|3|||
148856979|NCT00939029|536951758|FG001|Overall Study|Withdrawal by Subject|7|||
148856980|NCT00939029|536951757|FG000|Overall Study|Lost to Follow-up|3|||
148856981|NCT00939029|536951758|FG001|Overall Study|Lost to Follow-up|4|||
148856982|NCT00939029|536951757|FG000|Overall Study|Adverse Event|0|||
148856983|NCT00939029|536951758|FG001|Overall Study|Adverse Event|1|||
148856984|NCT01535599|536951759|FG000|Overall Study|Adverse Event|6|||
148856985|NCT01535599|536951760|FG001|Overall Study|Adverse Event|15|||
148856986|NCT01535599|536951759|FG000|Overall Study|Lost to Follow-up|3|||
148989863|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
149030661|NCT00813488|537589692|FG000|Titration Period 1|Withdrawal by Subject|2|||
148856987|NCT01535599|536951760|FG001|Overall Study|Lost to Follow-up|4|||
148856988|NCT01535599|536951759|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
148989864|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
148989865|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
148989866|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
148989867|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
148989868|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
148989869|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
148989870|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
149030662|NCT00813488|537589693|FG001|Titration Period 1|Withdrawal by Subject|2|||
148856989|NCT01535599|536951760|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
148989871|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
148989872|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
148989873|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
148989874|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
148989875|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
148989876|NCT01781572|537438485|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
148989877|NCT01781572|537438486|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
148989878|NCT01781572|537438487|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
148989879|NCT01781572|537438485|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
148989880|NCT01781572|537438486|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
148989881|NCT01781572|537438487|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
148989882|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
148989883|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
148989884|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
148989885|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
148989886|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
148989887|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
148989888|NCT01781572|537438485|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
148989889|NCT01781572|537438486|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
148989890|NCT01781572|537438487|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
148989891|NCT01781572|537438485|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
148989892|NCT01781572|537438486|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
148989893|NCT01781572|537438487|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
148989894|NCT01781572|537438485|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
148989895|NCT01781572|537438486|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
148989896|NCT01781572|537438487|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
148989897|NCT01781572|537438485|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
148989898|NCT01781572|537438486|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
148989899|NCT01781572|537438487|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
148989900|NCT01781572|537438485|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
148989901|NCT01781572|537438486|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
148989902|NCT01781572|537438487|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
148989903|NCT01781572|537438485|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
148989904|NCT01781572|537438486|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
148989905|NCT01781572|537438487|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
148989906|NCT01781572|537438485|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
148989907|NCT01781572|537438486|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
148989908|NCT01781572|537438487|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
148989909|NCT01438541|537438488|FG000|Overall Study|Physician Decision|1|||
148989910|NCT01438541|537438488|FG000|Overall Study|Withdrawal by Subject|1|||
148989911|NCT01438541|537438488|FG000|Overall Study|discharge from the hospital|5|||
148989912|NCT02091167|537438489|FG000|Overall Study|Lost to Follow-up|0|||
148989913|NCT02091167|537438490|FG001|Overall Study|Lost to Follow-up|2|||
148989914|NCT03096782|537438491|FG000|Overall Study|Death|1|||
148989915|NCT03096782|537438491|FG000|Overall Study|Participant Relapsed|1|||
148989916|NCT00791765|537440542|FG000|Weeks 1 to 12|Adverse Event|0|||
148989917|NCT00791765|537440543|FG001|Weeks 1 to 12|Adverse Event|1|||
148989918|NCT00791765|537440542|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
148989919|NCT00791765|537440543|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
148989920|NCT00791765|537440542|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
148989921|NCT00791765|537440543|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
148989922|NCT00791765|537440542|FG000|Weeks 1 to 12|Physician Decision|1|||
148989923|NCT00791765|537440543|FG001|Weeks 1 to 12|Physician Decision|0|||
148989924|NCT00791765|537440542|FG000|Weeks 1 to 12|Disease progression|3|||
148989925|NCT00791765|537440543|FG001|Weeks 1 to 12|Disease progression|0|||
148989926|NCT00791765|537440542|FG000|Weeks 1 to 12|Ineligibility determined|0|||
148989927|NCT00791765|537440543|FG001|Weeks 1 to 12|Ineligibility determined|3|||
148989928|NCT00791765|537440542|FG000|Weeks 13 to 24|Protocol deviation|2|||
148989929|NCT00791765|537440543|FG001|Weeks 13 to 24|Protocol deviation|0|||
148989930|NCT00791765|537440542|FG000|Weeks 13 to 24|Adverse Event|0|||
148989931|NCT00791765|537440543|FG001|Weeks 13 to 24|Adverse Event|3|||
148989932|NCT00791765|537440542|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
148989933|NCT00791765|537440543|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
148989934|NCT00791765|537440542|FG000|Weeks 13 to 24|Disease progression|0|||
148989935|NCT00791765|537440543|FG001|Weeks 13 to 24|Disease progression|1|||
148856990|NCT01535599|536951759|FG000|Overall Study|Treatment Failure|33|||
148856991|NCT01535599|536951760|FG001|Overall Study|Treatment Failure|66|||
148856992|NCT01535599|536951759|FG000|Overall Study|BL Culture + for Group A Strep|0|||
148989936|NCT00791765|537440542|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
148989937|NCT00791765|537440543|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
148989938|NCT00791765|537440542|FG000|Weeks 13 to 24|Other|0|||
148989939|NCT00791765|537440543|FG001|Weeks 13 to 24|Other|1|||
148989940|NCT00924287|537440545|FG000|Overall Study|Death|1|||
148989941|NCT01625897|537440548|FG000|Overall Study|Adverse Event|27|||
148989942|NCT01625897|537440549|FG001|Overall Study|Adverse Event|10|||
148989943|NCT01625897|537440548|FG000|Overall Study|Physician Decision|0|||
148989944|NCT01625897|537440549|FG001|Overall Study|Physician Decision|1|||
148989945|NCT01625897|537440548|FG000|Overall Study|Withdrawal by Subject|25|||
148989946|NCT01625897|537440549|FG001|Overall Study|Withdrawal by Subject|3|||
148989947|NCT00156065|537440550|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
148989948|NCT00156065|537440551|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
148989949|NCT00156065|537440552|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
148989950|NCT00156065|537440550|FG000|Overall Study|Adverse Event|8|||
148989951|NCT00156065|537440551|FG001|Overall Study|Adverse Event|11|||
148989952|NCT00156065|537440552|FG002|Overall Study|Adverse Event|4|||
148989953|NCT00156065|537440550|FG000|Overall Study|Lack of Efficacy|2|||
148989954|NCT00156065|537440551|FG001|Overall Study|Lack of Efficacy|9|||
148989955|NCT00156065|537440552|FG002|Overall Study|Lack of Efficacy|3|||
148989956|NCT00156065|537440550|FG000|Overall Study|Withdrawal by Subject|13|||
148989957|NCT00156065|537440551|FG001|Overall Study|Withdrawal by Subject|26|||
148989958|NCT00156065|537440552|FG002|Overall Study|Withdrawal by Subject|16|||
148989959|NCT00156065|537440550|FG000|Overall Study|Lost to Follow-up|5|||
148989960|NCT00156065|537440551|FG001|Overall Study|Lost to Follow-up|7|||
148989961|NCT00156065|537440552|FG002|Overall Study|Lost to Follow-up|1|||
148989962|NCT00156065|537440550|FG000|Overall Study|Other|2|||
148989963|NCT00156065|537440551|FG001|Overall Study|Other|9|||
148989964|NCT00156065|537440552|FG002|Overall Study|Other|3|||
148989965|NCT02891187|537440553|FG000|Overall Study|Lost to Follow-up|1|||
148989966|NCT02891187|537440554|FG001|Overall Study|Lost to Follow-up|2|||
148989967|NCT04546581|537440555|FG000|Overall Study|Adverse Event|9|||
148989968|NCT04546581|537440556|FG001|Overall Study|Adverse Event|3|||
148989969|NCT04546581|537440555|FG000|Overall Study|Physician Decision|0|||
148989970|NCT04546581|537440556|FG001|Overall Study|Physician Decision|1|||
148989971|NCT04546581|537440555|FG000|Overall Study|Protocol Violation|1|||
148989972|NCT04546581|537440556|FG001|Overall Study|Protocol Violation|2|||
148989973|NCT04546581|537440555|FG000|Overall Study|Withdrawal by Subject|3|||
148989974|NCT04546581|537440556|FG001|Overall Study|Withdrawal by Subject|7|||
148989975|NCT01275625|537440557|FG000|Overall Study|Death|1|||
148989976|NCT01275625|537440557|FG000|Overall Study|Lack of Efficacy|2|||
148989977|NCT01275625|537440557|FG000|Overall Study|Lost to Follow-up|1|||
148989978|NCT01275625|537440557|FG000|Overall Study|Withdrawal by Subject|3|||
148989979|NCT01275625|537440557|FG000|Overall Study|Protocol Violation|1|||
148989980|NCT01275625|537440557|FG000|Overall Study|Adverse Event|4|||
148989981|NCT01275625|537440557|FG000|Overall Study|Other|1|||
148989982|NCT00328510|537440561|FG000|Overall Study|Gag disorder, could not use frame|4|||
148989983|NCT00328510|537440562|FG001|Overall Study|Gag disorder, could not use frame|0|||
148989984|NCT00328510|537440561|FG000|Overall Study|Dentition problems, could not use frame|1|||
148989985|NCT00328510|537440562|FG001|Overall Study|Dentition problems, could not use frame|0|||
148989986|NCT00328510|537440561|FG000|Overall Study|Withdrawal by Subject|4|||
148989987|NCT00328510|537440562|FG001|Overall Study|Withdrawal by Subject|2|||
148989988|NCT00328510|537440561|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
148989989|NCT00328510|537440562|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
148989990|NCT00328510|537440561|FG000|Overall Study|Treatment changed to a single fraction|1|||
148989991|NCT00328510|537440562|FG001|Overall Study|Treatment changed to a single fraction|1|||
148989992|NCT01412944|537440564|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
148989993|NCT01412944|537440565|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
148989994|NCT01412944|537440566|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
148989995|NCT01412944|537440567|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
148989996|NCT01412944|537440568|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
148989997|NCT01412944|537440569|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
148989998|NCT01412944|537440564|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
148989999|NCT01412944|537440565|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
148990000|NCT01412944|537440566|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
148990001|NCT01412944|537440567|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
148990002|NCT01412944|537440568|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
148990003|NCT01412944|537440569|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
148856993|NCT01535599|536951760|FG001|Overall Study|BL Culture + for Group A Strep|1|||
148856994|NCT01535599|536951759|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
148856995|NCT01535599|536951760|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
148856996|NCT01535599|536951759|FG000|Overall Study|Randomized in Error|2|||
148990004|NCT01412944|537440564|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
148990005|NCT01412944|537440565|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
148990006|NCT01412944|537440566|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
148990007|NCT01412944|537440567|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
148990008|NCT01412944|537440568|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
148990009|NCT01412944|537440569|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
148856997|NCT01535599|536951760|FG001|Overall Study|Randomized in Error|4|||
148990010|NCT01412944|537440564|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
148990011|NCT01412944|537440565|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
148990012|NCT01412944|537440566|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
148990013|NCT01412944|537440567|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
148990014|NCT01412944|537440568|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
148990015|NCT01412944|537440569|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
148990016|NCT01412944|537440564|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
148990017|NCT01412944|537440565|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
148990018|NCT01412944|537440566|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
148990019|NCT01412944|537440567|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
148990020|NCT01412944|537440568|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
148990021|NCT01412944|537440569|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
148990022|NCT01412944|537440564|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
148990023|NCT01412944|537440565|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
148990024|NCT01412944|537440566|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
148990025|NCT01412944|537440567|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
148990026|NCT01412944|537440568|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
148990027|NCT01412944|537440569|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
148990028|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990029|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990030|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
148990031|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
148990032|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
148990033|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990034|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Adverse Event|0|||
148990035|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Adverse Event|0|||
148990036|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Adverse Event|0|||
148990037|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Adverse Event|0|||
148990038|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Adverse Event|1|||
148990039|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Adverse Event|0|||
148990040|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
148990041|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
148990042|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
148990043|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
148990044|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
148990045|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
148990046|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990047|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990048|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990049|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990050|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990051|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
148990052|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990053|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990054|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990055|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990056|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
148990057|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990058|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
148990059|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
148990060|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990061|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990062|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990063|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
148990064|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
148990065|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
148990066|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
148990067|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
148990068|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
148990069|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
148990070|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
149030663|NCT00813488|537589692|FG000|Titration Period 1|Protocol Violation|4|||
149030664|NCT00813488|537589693|FG001|Titration Period 1|Protocol Violation|3|||
148990071|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
148990072|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990073|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990074|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990075|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
148990076|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990077|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
148990078|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990079|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990080|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990081|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
148990082|NCT01412944|537440564|FG000|Entire: IV + Maintenance|Adverse Event|0|||
148990083|NCT01412944|537440565|FG001|Entire: IV + Maintenance|Adverse Event|1|||
148990084|NCT01412944|537440566|FG002|Entire: IV + Maintenance|Adverse Event|0|||
148990085|NCT01412944|537440567|FG003|Entire: IV + Maintenance|Adverse Event|0|||
148990086|NCT01412944|537440568|FG004|Entire: IV + Maintenance|Adverse Event|0|||
148990087|NCT01412944|537440569|FG005|Entire: IV + Maintenance|Adverse Event|0|||
148990088|NCT01990950|537440570|FG000|Overall Study|Death|3|||
148990089|NCT01990950|537440570|FG000|Overall Study|Lost to Follow-up|2|||
148990090|NCT01990950|537440570|FG000|Overall Study|Withdrawal by Subject|6|||
148990091|NCT02349295|537440571|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
148990092|NCT02349295|537440572|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
148990093|NCT02349295|537440573|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
148990094|NCT02349295|537440574|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990095|NCT02349295|537440575|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990096|NCT02349295|537440576|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990097|NCT02349295|537440577|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990098|NCT02349295|537440578|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990099|NCT02349295|537440579|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990100|NCT02349295|537440580|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990101|NCT02349295|537440581|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990102|NCT02349295|537440582|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
149030665|NCT00813488|537589692|FG000|Titration Period 1|Non-compliance to study medication|4|||
149030666|NCT00813488|537589693|FG001|Titration Period 1|Non-compliance to study medication|1|||
148856998|NCT01535599|536951759|FG000|Overall Study|Did not use product|1|||
148856999|NCT01535599|536951760|FG001|Overall Study|Did not use product|0|||
148857000|NCT01535599|536951759|FG000|Overall Study|Other|1|||
148857001|NCT01535599|536951760|FG001|Overall Study|Other|0|||
148857002|NCT01535599|536951759|FG000|Overall Study|Stopped medication|0|||
148857003|NCT01535599|536951760|FG001|Overall Study|Stopped medication|1|||
148857004|NCT01535599|536951759|FG000|Overall Study|Noncompliance|0|||
148857005|NCT01535599|536951760|FG001|Overall Study|Noncompliance|1|||
148857006|NCT03305419|536951765|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857007|NCT03305419|536951766|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
148857008|NCT03305419|536951767|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857009|NCT03305419|536951768|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857010|NCT03305419|536951769|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857011|NCT03305419|536951770|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857012|NCT03305419|536951771|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857013|NCT03305419|536951772|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
148857014|NCT03305419|536951765|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
148857015|NCT03305419|536951766|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857016|NCT03305419|536951767|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857017|NCT03305419|536951768|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857018|NCT03305419|536951769|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857019|NCT03305419|536951770|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857020|NCT03305419|536951771|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857021|NCT03305419|536951772|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
148857022|NCT03305419|536951765|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
148857023|NCT03305419|536951766|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857024|NCT03305419|536951767|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857025|NCT03305419|536951768|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857026|NCT03305419|536951769|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857027|NCT03305419|536951770|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857028|NCT03305419|536951771|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857029|NCT03305419|536951772|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
148857030|NCT03305419|536951765|FG000|Part B (14 Days)|Adverse Event|0|||
148857031|NCT03305419|536951766|FG001|Part B (14 Days)|Adverse Event|0|||
148857032|NCT03305419|536951767|FG002|Part B (14 Days)|Adverse Event|0|||
148857033|NCT03305419|536951768|FG003|Part B (14 Days)|Adverse Event|0|||
148857034|NCT03305419|536951769|FG004|Part B (14 Days)|Adverse Event|1|||
148990103|NCT02349295|537440583|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990104|NCT02349295|537440584|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
148990105|NCT02349295|537440571|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
148857035|NCT03305419|536951770|FG005|Part B (14 Days)|Adverse Event|2|||
148990106|NCT02349295|537440572|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
149030667|NCT00813488|537589692|FG000|Titration Period 1|Non-compliance to study procedures|2|||
148857036|NCT03305419|536951771|FG006|Part B (14 Days)|Adverse Event|4|||
148857037|NCT03305419|536951772|FG007|Part B (14 Days)|Adverse Event|0|||
148857038|NCT03305419|536951765|FG000|Part B (14 Days)|Physician Decision|0|||
148990107|NCT02349295|537440573|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
148990108|NCT02349295|537440574|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990109|NCT02349295|537440575|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990110|NCT02349295|537440576|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990111|NCT02349295|537440577|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990112|NCT02349295|537440578|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990113|NCT02349295|537440579|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990114|NCT02349295|537440580|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990115|NCT02349295|537440581|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990116|NCT02349295|537440582|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990117|NCT02349295|537440583|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990118|NCT02349295|537440584|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
148990119|NCT02349295|537440571|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
148990120|NCT02349295|537440572|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
148990121|NCT02349295|537440573|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
148990122|NCT02349295|537440574|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990123|NCT02349295|537440575|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990124|NCT02349295|537440576|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990125|NCT02349295|537440577|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990126|NCT02349295|537440578|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990127|NCT02349295|537440579|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990128|NCT02349295|537440580|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990129|NCT02349295|537440581|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990130|NCT02349295|537440582|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990131|NCT02349295|537440583|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990132|NCT02349295|537440584|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
148990133|NCT02349295|537440571|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
148990134|NCT02349295|537440572|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
148990135|NCT02349295|537440573|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
148990136|NCT02349295|537440574|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990137|NCT02349295|537440575|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990138|NCT02349295|537440576|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990139|NCT02349295|537440577|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990140|NCT02349295|537440578|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990141|NCT02349295|537440579|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990142|NCT02349295|537440580|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990143|NCT02349295|537440581|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990144|NCT02349295|537440582|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990145|NCT02349295|537440583|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990146|NCT02349295|537440584|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
148990147|NCT02349295|537440571|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990148|NCT02349295|537440572|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
148990149|NCT02349295|537440573|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
148990150|NCT02349295|537440574|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990151|NCT02349295|537440575|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990152|NCT02349295|537440576|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990153|NCT02349295|537440577|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990154|NCT02349295|537440578|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990155|NCT02349295|537440579|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990156|NCT02349295|537440580|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990157|NCT02349295|537440581|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990158|NCT02349295|537440582|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990159|NCT02349295|537440583|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990160|NCT02349295|537440584|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
148990161|NCT02349295|537440571|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
148990162|NCT02349295|537440572|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
148990163|NCT02349295|537440573|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
148990164|NCT02349295|537440574|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
148990165|NCT02349295|537440575|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
148990166|NCT02349295|537440576|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
148990167|NCT02349295|537440577|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
148990168|NCT02349295|537440578|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
148990169|NCT02349295|537440579|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
148990170|NCT02349295|537440580|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
148990171|NCT02349295|537440581|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
148990172|NCT02349295|537440582|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
148990173|NCT02349295|537440583|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
148990174|NCT02349295|537440584|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
148990175|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990176|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990177|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990178|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990179|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990180|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990181|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990182|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
148990183|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
148990184|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
148990185|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
148990186|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990187|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990188|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
148990189|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990190|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990191|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990192|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990193|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990194|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990195|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990196|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
148990197|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
148990198|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
148990199|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
148990200|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990201|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990202|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
148990203|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990204|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990205|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990206|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990207|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990208|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990209|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990210|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
148990211|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990212|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
148990213|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990214|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990215|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990216|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
148990217|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
148990218|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
148990219|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
148990220|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
148990221|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
148990222|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
148990223|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
148990224|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
148990225|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
148990226|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
148990227|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
148990228|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
148990229|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
148990230|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
148990231|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990232|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990233|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990234|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990235|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990236|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990237|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990238|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
149030668|NCT00813488|537589693|FG001|Titration Period 1|Non-compliance to study procedures|2|||
148857039|NCT03305419|536951766|FG001|Part B (14 Days)|Physician Decision|0|||
148857040|NCT03305419|536951767|FG002|Part B (14 Days)|Physician Decision|0|||
148857041|NCT03305419|536951768|FG003|Part B (14 Days)|Physician Decision|0|||
148857042|NCT03305419|536951769|FG004|Part B (14 Days)|Physician Decision|2|||
148857043|NCT03305419|536951770|FG005|Part B (14 Days)|Physician Decision|8|||
148857044|NCT03305419|536951771|FG006|Part B (14 Days)|Physician Decision|1|||
148857045|NCT03305419|536951772|FG007|Part B (14 Days)|Physician Decision|0|||
148857046|NCT00075946|536951773|FG000|Overall Study|Path ineligible: undetermined histology|0|||
148857047|NCT00075946|536951774|FG001|Overall Study|Path ineligible: undetermined histology|0|||
148857048|NCT00075946|536951775|FG002|Overall Study|Path ineligible: undetermined histology|0|||
148857049|NCT00075946|536951776|FG003|Overall Study|Path ineligible: undetermined histology|0|||
148857050|NCT00075946|536951777|FG004|Overall Study|Path ineligible: undetermined histology|6|||
148857051|NCT00075946|536951773|FG000|Overall Study|Did not achieve response after induction|0|||
148857052|NCT00075946|536951774|FG001|Overall Study|Did not achieve response after induction|0|||
148857053|NCT00075946|536951775|FG002|Overall Study|Did not achieve response after induction|0|||
148857054|NCT00075946|536951776|FG003|Overall Study|Did not achieve response after induction|0|||
148857055|NCT00075946|536951777|FG004|Overall Study|Did not achieve response after induction|182|||
148857056|NCT00075946|536951773|FG000|Overall Study|Incorrectly randomized (no response)|5|||
148857057|NCT00075946|536951774|FG001|Overall Study|Incorrectly randomized (no response)|5|||
148857058|NCT00075946|536951775|FG002|Overall Study|Incorrectly randomized (no response)|5|||
148857059|NCT00075946|536951776|FG003|Overall Study|Incorrectly randomized (no response)|1|||
148857060|NCT00075946|536951777|FG004|Overall Study|Incorrectly randomized (no response)|0|||
148857061|NCT00075946|536951773|FG000|Overall Study|Adverse Event|2|||
148857062|NCT00075946|536951774|FG001|Overall Study|Adverse Event|10|||
148857063|NCT00075946|536951775|FG002|Overall Study|Adverse Event|0|||
148857064|NCT00075946|536951776|FG003|Overall Study|Adverse Event|2|||
148857065|NCT00075946|536951777|FG004|Overall Study|Adverse Event|0|||
148857066|NCT00075946|536951773|FG000|Overall Study|Death|0|||
148857067|NCT00075946|536951774|FG001|Overall Study|Death|1|||
148857068|NCT00075946|536951775|FG002|Overall Study|Death|0|||
148857069|NCT00075946|536951776|FG003|Overall Study|Death|0|||
148857070|NCT00075946|536951777|FG004|Overall Study|Death|0|||
148857071|NCT00075946|536951773|FG000|Overall Study|Withdrawal by Subject|23|||
148857072|NCT00075946|536951774|FG001|Overall Study|Withdrawal by Subject|58|||
148857073|NCT00075946|536951775|FG002|Overall Study|Withdrawal by Subject|4|||
148857074|NCT00075946|536951776|FG003|Overall Study|Withdrawal by Subject|9|||
148857075|NCT00075946|536951777|FG004|Overall Study|Withdrawal by Subject|0|||
148857076|NCT00075946|536951773|FG000|Overall Study|Alternative therapy|16|||
148857077|NCT00075946|536951774|FG001|Overall Study|Alternative therapy|2|||
148857078|NCT00075946|536951775|FG002|Overall Study|Alternative therapy|5|||
148857079|NCT00075946|536951776|FG003|Overall Study|Alternative therapy|0|||
148857080|NCT00075946|536951777|FG004|Overall Study|Alternative therapy|0|||
148857081|NCT00075946|536951773|FG000|Overall Study|Other complicating disease|7|||
148857082|NCT00075946|536951774|FG001|Overall Study|Other complicating disease|13|||
148857083|NCT00075946|536951775|FG002|Overall Study|Other complicating disease|1|||
148857084|NCT00075946|536951776|FG003|Overall Study|Other complicating disease|4|||
148857085|NCT00075946|536951777|FG004|Overall Study|Other complicating disease|0|||
148857086|NCT00075946|536951773|FG000|Overall Study|No response to retreatment|23|||
148857087|NCT00075946|536951774|FG001|Overall Study|No response to retreatment|0|||
148857088|NCT00075946|536951775|FG002|Overall Study|No response to retreatment|2|||
148857089|NCT00075946|536951776|FG003|Overall Study|No response to retreatment|0|||
148857090|NCT00075946|536951777|FG004|Overall Study|No response to retreatment|0|||
148857091|NCT00075946|536951773|FG000|Overall Study|Time to progression less than 6 months|15|||
148857092|NCT00075946|536951774|FG001|Overall Study|Time to progression less than 6 months|30|||
148857093|NCT00075946|536951775|FG002|Overall Study|Time to progression less than 6 months|8|||
148857094|NCT00075946|536951776|FG003|Overall Study|Time to progression less than 6 months|3|||
148857095|NCT00075946|536951777|FG004|Overall Study|Time to progression less than 6 months|0|||
148857096|NCT00075946|536951773|FG000|Overall Study|Other|57|||
148857097|NCT00075946|536951774|FG001|Overall Study|Other|32|||
148857098|NCT00075946|536951775|FG002|Overall Study|Other|3|||
148857099|NCT00075946|536951776|FG003|Overall Study|Other|11|||
148990239|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
148990240|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
148990241|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
148857100|NCT00075946|536951777|FG004|Overall Study|Other|0|||
148990242|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148857101|NCT02210689|536951778|FG000|Overall Study|Withdrawal by Subject|7|||
148857102|NCT02210689|536951779|FG001|Overall Study|Withdrawal by Subject|4|||
148857103|NCT02210689|536951780|FG002|Overall Study|Withdrawal by Subject|2|||
148857104|NCT02210689|536951778|FG000|Overall Study|Adverse Event|0|||
148857105|NCT02210689|536951779|FG001|Overall Study|Adverse Event|1|||
148857106|NCT02210689|536951780|FG002|Overall Study|Adverse Event|0|||
148857107|NCT02210689|536951778|FG000|Overall Study|Protocol Violation|1|||
148857108|NCT02210689|536951779|FG001|Overall Study|Protocol Violation|0|||
148990243|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990244|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
148990245|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990246|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990247|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990248|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990249|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990250|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990251|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990252|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
148990253|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
148990254|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990255|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990256|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990257|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990258|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
148990259|NCT02349295|537440571|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990260|NCT02349295|537440572|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990261|NCT02349295|537440573|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990262|NCT02349295|537440574|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990263|NCT02349295|537440575|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990264|NCT02349295|537440576|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990265|NCT02349295|537440577|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990266|NCT02349295|537440578|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
148990267|NCT02349295|537440579|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
148990268|NCT02349295|537440580|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990269|NCT02349295|537440581|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990270|NCT02349295|537440582|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990271|NCT02349295|537440583|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990272|NCT02349295|537440584|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
148990273|NCT02349295|537440571|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990274|NCT02349295|537440572|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990275|NCT02349295|537440573|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990276|NCT02349295|537440574|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990277|NCT02349295|537440575|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990278|NCT02349295|537440576|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990279|NCT02349295|537440577|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990280|NCT02349295|537440578|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990281|NCT02349295|537440579|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990282|NCT02349295|537440580|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990283|NCT02349295|537440581|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
148990284|NCT02349295|537440582|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
148990285|NCT02349295|537440583|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
148990286|NCT02349295|537440584|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
148990287|NCT02349295|537440571|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990288|NCT02349295|537440572|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990289|NCT02349295|537440573|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990290|NCT02349295|537440574|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990291|NCT02349295|537440575|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990292|NCT02349295|537440576|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990293|NCT02349295|537440577|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990294|NCT02349295|537440578|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990295|NCT02349295|537440579|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990296|NCT02349295|537440580|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990297|NCT02349295|537440581|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990298|NCT02349295|537440582|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
148990299|NCT02349295|537440583|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
148990300|NCT02349295|537440584|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
148990301|NCT02349295|537440571|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990302|NCT02349295|537440572|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
149030669|NCT00813488|537589692|FG000|Titration Period 1|Technical Difficulties|0|||
149030670|NCT00813488|537589693|FG001|Titration Period 1|Technical Difficulties|1|||
149030671|NCT00813488|537589692|FG000|Titration Period 2|Adverse Event|2|||
148857109|NCT02210689|536951780|FG002|Overall Study|Protocol Violation|0|||
148857110|NCT02210689|536951778|FG000|Overall Study|Lost to Follow-up|11|||
148857111|NCT02210689|536951779|FG001|Overall Study|Lost to Follow-up|9|||
148857112|NCT02210689|536951780|FG002|Overall Study|Lost to Follow-up|5|||
148857113|NCT02210689|536951778|FG000|Overall Study|Pregnancy|0|||
148857114|NCT02210689|536951779|FG001|Overall Study|Pregnancy|1|||
148857115|NCT02210689|536951780|FG002|Overall Study|Pregnancy|0|||
148857116|NCT02210689|536951778|FG000|Overall Study|Lack of Efficacy|0|||
148857117|NCT02210689|536951779|FG001|Overall Study|Lack of Efficacy|1|||
148857118|NCT02210689|536951780|FG002|Overall Study|Lack of Efficacy|5|||
148857119|NCT02210689|536951778|FG000|Overall Study|Prohibited medication|2|||
148857120|NCT02210689|536951779|FG001|Overall Study|Prohibited medication|8|||
148857121|NCT02210689|536951780|FG002|Overall Study|Prohibited medication|1|||
148857122|NCT02210689|536951778|FG000|Overall Study|Negative Nugent score at baseline|6|||
148857123|NCT02210689|536951779|FG001|Overall Study|Negative Nugent score at baseline|2|||
148857124|NCT02210689|536951780|FG002|Overall Study|Negative Nugent score at baseline|2|||
148857125|NCT02210689|536951778|FG000|Overall Study|Other|25|||
148857126|NCT02210689|536951779|FG001|Overall Study|Other|21|||
148857127|NCT02210689|536951780|FG002|Overall Study|Other|8|||
148857128|NCT02231892|536951781|FG000|Overall Study|Lost to Follow-up|1|||
148857129|NCT02231892|536951782|FG001|Overall Study|Lost to Follow-up|0|||
148857130|NCT02231892|536951783|FG002|Overall Study|Lost to Follow-up|3|||
148857131|NCT02231892|536951781|FG000|Overall Study|Withdrawal by Subject|4|||
148857132|NCT02231892|536951782|FG001|Overall Study|Withdrawal by Subject|3|||
148857133|NCT02231892|536951783|FG002|Overall Study|Withdrawal by Subject|15|||
148857134|NCT02231892|536951781|FG000|Overall Study|Physician Decision|0|||
148857135|NCT02231892|536951782|FG001|Overall Study|Physician Decision|2|||
148857136|NCT02231892|536951783|FG002|Overall Study|Physician Decision|4|||
148857137|NCT02231892|536951781|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
148857138|NCT02231892|536951782|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
148857139|NCT02231892|536951783|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
148857140|NCT02231892|536951781|FG000|Overall Study|Participant motor threshold was >83%|0|||
148857141|NCT02231892|536951782|FG001|Overall Study|Participant motor threshold was >83%|0|||
148857142|NCT02231892|536951783|FG002|Overall Study|Participant motor threshold was >83%|9|||
148857143|NCT02231892|536951781|FG000|Overall Study|Could not find motor threshold|2|||
148857144|NCT02231892|536951782|FG001|Overall Study|Could not find motor threshold|0|||
148857145|NCT02231892|536951783|FG002|Overall Study|Could not find motor threshold|1|||
148857146|NCT02231892|536951781|FG000|Overall Study|Could not find reliable motor hotspot|0|||
148857147|NCT02231892|536951782|FG001|Overall Study|Could not find reliable motor hotspot|0|||
148857148|NCT02231892|536951783|FG002|Overall Study|Could not find reliable motor hotspot|1|||
148857149|NCT03832322|536951784|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
148857150|NCT03832322|536951785|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
148857151|NCT02186652|536951794|FG000|Overall Study|Lost to Follow-up|2|||
148857152|NCT02186652|536951795|FG001|Overall Study|Lost to Follow-up|0|||
148857153|NCT05427539|536951798|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
148857154|NCT05427539|536951799|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
148857155|NCT05427539|536951798|FG000|Period 1|Withdrawal by Subject|1|||
148857156|NCT05427539|536951799|FG001|Period 1|Withdrawal by Subject|0|||
148857157|NCT02247011|536951802|FG000|Overall Study|Poor quality of radiological results|125|||
148857158|NCT04470908|536951808|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
148857159|NCT01974206|536951809|FG000|Overall Study|Did Not Take Study Drug|0|||
148857160|NCT01974206|536951810|FG001|Overall Study|Did Not Take Study Drug|1|||
148857161|NCT01974206|536951809|FG000|Overall Study|Physician Decision|1|||
148857162|NCT01974206|536951810|FG001|Overall Study|Physician Decision|0|||
148857163|NCT01974206|536951809|FG000|Overall Study|Withdrawal by Subject|3|||
148857164|NCT01974206|536951810|FG001|Overall Study|Withdrawal by Subject|0|||
148857165|NCT01974206|536951809|FG000|Overall Study|Lost to Follow-up|1|||
148857166|NCT01974206|536951810|FG001|Overall Study|Lost to Follow-up|0|||
148857167|NCT01974206|536951809|FG000|Overall Study|Death|1|||
148857168|NCT01974206|536951810|FG001|Overall Study|Death|0|||
148990303|NCT02349295|537440573|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148857169|NCT02248649|536951813|FG000|Overall Study|Death|7|||
148857170|NCT02248649|536951814|FG001|Overall Study|Death|11|||
148857171|NCT02248649|536951813|FG000|Overall Study|Lost to Follow-up|14|||
148857172|NCT02248649|536951814|FG001|Overall Study|Lost to Follow-up|10|||
148857173|NCT01802580|536951815|FG000|Overall Study|Physician Decision|1|||
148857174|NCT01802580|536951816|FG001|Overall Study|Physician Decision|0|||
148857175|NCT01802580|536951815|FG000|Overall Study|Protocol Violation|2|||
148857176|NCT01802580|536951816|FG001|Overall Study|Protocol Violation|0|||
148857177|NCT01802580|536951815|FG000|Overall Study|Withdrawal by Subject|5|||
148990304|NCT02349295|537440574|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148857178|NCT01802580|536951816|FG001|Overall Study|Withdrawal by Subject|6|||
148857179|NCT01802580|536951815|FG000|Overall Study|Other|1|||
148857180|NCT01802580|536951816|FG001|Overall Study|Other|3|||
148857181|NCT01802580|536951815|FG000|Overall Study|Lack of Efficacy|0|||
148857182|NCT01802580|536951816|FG001|Overall Study|Lack of Efficacy|2|||
148990305|NCT02349295|537440575|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990306|NCT02349295|537440576|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990307|NCT02349295|537440577|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990308|NCT02349295|537440578|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990309|NCT02349295|537440579|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990310|NCT02349295|537440580|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990311|NCT02349295|537440581|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990312|NCT02349295|537440582|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
148990313|NCT02349295|537440583|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
148990314|NCT02349295|537440584|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
148990315|NCT02349295|537440571|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990316|NCT02349295|537440572|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990317|NCT02349295|537440573|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990318|NCT02349295|537440574|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990319|NCT02349295|537440575|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990320|NCT02349295|537440576|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990321|NCT02349295|537440577|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990322|NCT02349295|537440578|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990323|NCT02349295|537440579|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990324|NCT02349295|537440580|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990325|NCT02349295|537440581|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990326|NCT02349295|537440582|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
148990327|NCT02349295|537440583|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990328|NCT02349295|537440584|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
148990329|NCT02349295|537440571|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990330|NCT02349295|537440572|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990331|NCT02349295|537440573|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990332|NCT02349295|537440574|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990333|NCT02349295|537440575|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990334|NCT02349295|537440576|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990335|NCT02349295|537440577|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990336|NCT02349295|537440578|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990337|NCT02349295|537440579|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990338|NCT02349295|537440580|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990339|NCT02349295|537440581|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990340|NCT02349295|537440582|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
148990341|NCT02349295|537440583|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990342|NCT02349295|537440584|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
148990343|NCT06111742|537440588|FG000|Overall Study|Did not receive intervention|1|||
148990344|NCT06111742|537440589|FG001|Overall Study|Did not receive intervention|0|||
148990345|NCT06111742|537440590|FG002|Overall Study|Did not receive intervention|0|||
148990346|NCT06111742|537440588|FG000|Overall Study|Withdrawal by Subject|2|||
148990347|NCT06111742|537440589|FG001|Overall Study|Withdrawal by Subject|0|||
148990348|NCT06111742|537440590|FG002|Overall Study|Withdrawal by Subject|0|||
148990349|NCT01914926|537440591|FG000|Overall Study|Adverse Event|1|||
148990350|NCT01914926|537440592|FG001|Overall Study|Adverse Event|0|||
148990351|NCT01914926|537440591|FG000|Overall Study|uncooperative, agitated and removed|0|||
148990352|NCT01914926|537440592|FG001|Overall Study|uncooperative, agitated and removed|1|||
148990353|NCT03214367|537440593|FG000|Lead-in Period|Withdrawal by Subject|50|||
148990354|NCT03214367|537440594|FG001|Lead-in Period|Withdrawal by Subject|0|||
148990355|NCT03214367|537440595|FG002|Lead-in Period|Withdrawal by Subject|0|||
148990356|NCT03214367|537440596|FG003|Lead-in Period|Withdrawal by Subject|0|||
148990357|NCT03214367|537440597|FG004|Lead-in Period|Withdrawal by Subject|2|||
148990358|NCT03214367|537440598|FG005|Lead-in Period|Withdrawal by Subject|0|||
148990359|NCT03214367|537440599|FG006|Lead-in Period|Withdrawal by Subject|0|||
148990360|NCT03214367|537440600|FG007|Lead-in Period|Withdrawal by Subject|0|||
148990361|NCT03214367|537440593|FG000|Lead-in Period|Adverse Event|3|||
148990362|NCT03214367|537440594|FG001|Lead-in Period|Adverse Event|0|||
148990363|NCT03214367|537440595|FG002|Lead-in Period|Adverse Event|0|||
148990364|NCT03214367|537440596|FG003|Lead-in Period|Adverse Event|0|||
148990365|NCT03214367|537440597|FG004|Lead-in Period|Adverse Event|0|||
148990366|NCT03214367|537440598|FG005|Lead-in Period|Adverse Event|0|||
148990367|NCT03214367|537440599|FG006|Lead-in Period|Adverse Event|0|||
148990368|NCT03214367|537440600|FG007|Lead-in Period|Adverse Event|0|||
148990369|NCT03214367|537440593|FG000|Lead-in Period|Lost to Follow-up|12|||
148990370|NCT03214367|537440594|FG001|Lead-in Period|Lost to Follow-up|0|||
148990371|NCT03214367|537440595|FG002|Lead-in Period|Lost to Follow-up|0|||
148990372|NCT03214367|537440596|FG003|Lead-in Period|Lost to Follow-up|0|||
148990373|NCT03214367|537440597|FG004|Lead-in Period|Lost to Follow-up|0|||
148990374|NCT03214367|537440598|FG005|Lead-in Period|Lost to Follow-up|0|||
148990375|NCT03214367|537440599|FG006|Lead-in Period|Lost to Follow-up|0|||
148990376|NCT03214367|537440600|FG007|Lead-in Period|Lost to Follow-up|0|||
148990377|NCT03214367|537440593|FG000|Lead-in Period|Sponsor Decision|11|||
148990378|NCT03214367|537440594|FG001|Lead-in Period|Sponsor Decision|0|||
148990379|NCT03214367|537440595|FG002|Lead-in Period|Sponsor Decision|0|||
148990380|NCT03214367|537440596|FG003|Lead-in Period|Sponsor Decision|0|||
148990381|NCT03214367|537440597|FG004|Lead-in Period|Sponsor Decision|0|||
148990382|NCT03214367|537440598|FG005|Lead-in Period|Sponsor Decision|0|||
148990383|NCT03214367|537440599|FG006|Lead-in Period|Sponsor Decision|0|||
148990384|NCT03214367|537440600|FG007|Lead-in Period|Sponsor Decision|0|||
148990385|NCT03214367|537440593|FG000|Lead-in Period|Physician Decision|12|||
148990386|NCT03214367|537440594|FG001|Lead-in Period|Physician Decision|0|||
148990387|NCT03214367|537440595|FG002|Lead-in Period|Physician Decision|0|||
148990388|NCT03214367|537440596|FG003|Lead-in Period|Physician Decision|0|||
148990389|NCT03214367|537440597|FG004|Lead-in Period|Physician Decision|0|||
148857183|NCT03255967|536951817|FG000|Overall Study|Adverse Event|26|||
148857184|NCT03255967|536951818|FG001|Overall Study|Adverse Event|30|||
148857185|NCT03255967|536951817|FG000|Overall Study|Withdrawal by Subject|6|||
148857186|NCT03255967|536951818|FG001|Overall Study|Withdrawal by Subject|6|||
148857187|NCT03255967|536951817|FG000|Overall Study|Schedule conflict|6|||
148857188|NCT03255967|536951818|FG001|Overall Study|Schedule conflict|4|||
148857189|NCT03255967|536951817|FG000|Overall Study|POA did not sign consent form|2|||
148857190|NCT03255967|536951818|FG001|Overall Study|POA did not sign consent form|0|||
148857191|NCT00778258|536951826|FG000|Overall Study|Adverse Event|1|||
148857192|NCT00778258|536951827|FG001|Overall Study|Adverse Event|0|||
148857193|NCT00778258|536951828|FG002|Overall Study|Adverse Event|0|||
148857194|NCT00778258|536951829|FG003|Overall Study|Adverse Event|0|||
148857195|NCT00778258|536951830|FG004|Overall Study|Adverse Event|0|||
148857196|NCT00778258|536951831|FG005|Overall Study|Adverse Event|1|||
148857197|NCT00778258|536951832|FG006|Overall Study|Adverse Event|0|||
148857198|NCT00778258|536951833|FG007|Overall Study|Adverse Event|0|||
148857199|NCT00778258|536951834|FG008|Overall Study|Adverse Event|0|||
148857200|NCT00778258|536951826|FG000|Overall Study|Lost to Follow-up|0|||
148857201|NCT00778258|536951827|FG001|Overall Study|Lost to Follow-up|0|||
148857202|NCT00778258|536951828|FG002|Overall Study|Lost to Follow-up|2|||
148857203|NCT00778258|536951829|FG003|Overall Study|Lost to Follow-up|0|||
148857204|NCT00778258|536951830|FG004|Overall Study|Lost to Follow-up|0|||
148857205|NCT00778258|536951831|FG005|Overall Study|Lost to Follow-up|3|||
148857206|NCT00778258|536951832|FG006|Overall Study|Lost to Follow-up|2|||
148857207|NCT00778258|536951833|FG007|Overall Study|Lost to Follow-up|2|||
148857208|NCT00778258|536951834|FG008|Overall Study|Lost to Follow-up|0|||
148857209|NCT00778258|536951826|FG000|Overall Study|Withdrawal by Subject|6|||
148857210|NCT00778258|536951827|FG001|Overall Study|Withdrawal by Subject|2|||
148857211|NCT00778258|536951828|FG002|Overall Study|Withdrawal by Subject|8|||
148857212|NCT00778258|536951829|FG003|Overall Study|Withdrawal by Subject|2|||
148857213|NCT00778258|536951830|FG004|Overall Study|Withdrawal by Subject|0|||
148857214|NCT00778258|536951831|FG005|Overall Study|Withdrawal by Subject|6|||
148857215|NCT00778258|536951832|FG006|Overall Study|Withdrawal by Subject|12|||
148857216|NCT00778258|536951833|FG007|Overall Study|Withdrawal by Subject|12|||
148857217|NCT00778258|536951834|FG008|Overall Study|Withdrawal by Subject|4|||
148857218|NCT00778258|536951826|FG000|Overall Study|New Contraindication|0|||
148857219|NCT00778258|536951827|FG001|Overall Study|New Contraindication|0|||
148857220|NCT00778258|536951828|FG002|Overall Study|New Contraindication|0|||
148857221|NCT00778258|536951829|FG003|Overall Study|New Contraindication|0|||
148857222|NCT00778258|536951830|FG004|Overall Study|New Contraindication|0|||
148857223|NCT00778258|536951831|FG005|Overall Study|New Contraindication|0|||
148857224|NCT00778258|536951832|FG006|Overall Study|New Contraindication|0|||
148990390|NCT03214367|537440598|FG005|Lead-in Period|Physician Decision|0|||
148990391|NCT03214367|537440599|FG006|Lead-in Period|Physician Decision|0|||
148990392|NCT03214367|537440600|FG007|Lead-in Period|Physician Decision|0|||
148857225|NCT00778258|536951833|FG007|Overall Study|New Contraindication|1|||
148857226|NCT00778258|536951834|FG008|Overall Study|New Contraindication|0|||
148857227|NCT00778258|536951826|FG000|Overall Study|Non-compliance|0|||
148857228|NCT00778258|536951827|FG001|Overall Study|Non-compliance|0|||
148857229|NCT00778258|536951828|FG002|Overall Study|Non-compliance|0|||
148857230|NCT00778258|536951829|FG003|Overall Study|Non-compliance|1|||
148857231|NCT00778258|536951830|FG004|Overall Study|Non-compliance|0|||
148857232|NCT00778258|536951831|FG005|Overall Study|Non-compliance|0|||
148857233|NCT00778258|536951832|FG006|Overall Study|Non-compliance|0|||
148990393|NCT03214367|537440593|FG000|Lead-in Period|Protocol Violation|5|||
148990394|NCT03214367|537440594|FG001|Lead-in Period|Protocol Violation|0|||
148990395|NCT03214367|537440595|FG002|Lead-in Period|Protocol Violation|0|||
148857234|NCT00778258|536951833|FG007|Overall Study|Non-compliance|0|||
148857235|NCT00778258|536951834|FG008|Overall Study|Non-compliance|0|||
148857236|NCT00778258|536951826|FG000|Overall Study|Other|0|||
148857237|NCT00778258|536951827|FG001|Overall Study|Other|0|||
148857238|NCT00778258|536951828|FG002|Overall Study|Other|0|||
148857239|NCT00778258|536951829|FG003|Overall Study|Other|0|||
148990396|NCT03214367|537440596|FG003|Lead-in Period|Protocol Violation|0|||
148990397|NCT03214367|537440597|FG004|Lead-in Period|Protocol Violation|0|||
148990398|NCT03214367|537440598|FG005|Lead-in Period|Protocol Violation|0|||
148990399|NCT03214367|537440599|FG006|Lead-in Period|Protocol Violation|0|||
148990400|NCT03214367|537440600|FG007|Lead-in Period|Protocol Violation|0|||
148990401|NCT03214367|537440593|FG000|Lead-in Period|Treatment Interruption|1|||
148990402|NCT03214367|537440594|FG001|Lead-in Period|Treatment Interruption|0|||
148990403|NCT03214367|537440595|FG002|Lead-in Period|Treatment Interruption|0|||
148990404|NCT03214367|537440596|FG003|Lead-in Period|Treatment Interruption|0|||
148990405|NCT03214367|537440597|FG004|Lead-in Period|Treatment Interruption|0|||
148990406|NCT03214367|537440598|FG005|Lead-in Period|Treatment Interruption|0|||
148990407|NCT03214367|537440599|FG006|Lead-in Period|Treatment Interruption|0|||
148990408|NCT03214367|537440600|FG007|Lead-in Period|Treatment Interruption|0|||
148990409|NCT03214367|537440593|FG000|Treatment Period|Adverse Event|0|||
148990410|NCT03214367|537440594|FG001|Treatment Period|Adverse Event|1|||
148990411|NCT03214367|537440595|FG002|Treatment Period|Adverse Event|4|||
148990412|NCT03214367|537440596|FG003|Treatment Period|Adverse Event|2|||
148990413|NCT03214367|537440597|FG004|Treatment Period|Adverse Event|0|||
148990414|NCT03214367|537440598|FG005|Treatment Period|Adverse Event|0|||
148990415|NCT03214367|537440599|FG006|Treatment Period|Adverse Event|0|||
148990416|NCT03214367|537440600|FG007|Treatment Period|Adverse Event|0|||
148990417|NCT03214367|537440593|FG000|Treatment Period|Death|0|||
148990418|NCT03214367|537440594|FG001|Treatment Period|Death|1|||
148990419|NCT03214367|537440595|FG002|Treatment Period|Death|1|||
148990420|NCT03214367|537440596|FG003|Treatment Period|Death|1|||
148990421|NCT03214367|537440597|FG004|Treatment Period|Death|0|||
148990422|NCT03214367|537440598|FG005|Treatment Period|Death|0|||
148990423|NCT03214367|537440599|FG006|Treatment Period|Death|0|||
148990424|NCT03214367|537440600|FG007|Treatment Period|Death|0|||
148990425|NCT03214367|537440593|FG000|Treatment Period|Lost to Follow-up|0|||
148990426|NCT03214367|537440594|FG001|Treatment Period|Lost to Follow-up|5|||
148990427|NCT03214367|537440595|FG002|Treatment Period|Lost to Follow-up|3|||
148990428|NCT03214367|537440596|FG003|Treatment Period|Lost to Follow-up|2|||
148990429|NCT03214367|537440597|FG004|Treatment Period|Lost to Follow-up|0|||
148990430|NCT03214367|537440598|FG005|Treatment Period|Lost to Follow-up|2|||
148990431|NCT03214367|537440599|FG006|Treatment Period|Lost to Follow-up|1|||
148990432|NCT03214367|537440600|FG007|Treatment Period|Lost to Follow-up|0|||
148990433|NCT03214367|537440593|FG000|Treatment Period|Sponsor Decision|0|||
148990434|NCT03214367|537440594|FG001|Treatment Period|Sponsor Decision|3|||
148990435|NCT03214367|537440595|FG002|Treatment Period|Sponsor Decision|0|||
148990436|NCT03214367|537440596|FG003|Treatment Period|Sponsor Decision|0|||
148990437|NCT03214367|537440597|FG004|Treatment Period|Sponsor Decision|0|||
148990438|NCT03214367|537440598|FG005|Treatment Period|Sponsor Decision|0|||
148990439|NCT03214367|537440599|FG006|Treatment Period|Sponsor Decision|0|||
148990440|NCT03214367|537440600|FG007|Treatment Period|Sponsor Decision|0|||
148990441|NCT03214367|537440593|FG000|Treatment Period|Physician Decision|0|||
148990442|NCT03214367|537440594|FG001|Treatment Period|Physician Decision|1|||
148990443|NCT03214367|537440595|FG002|Treatment Period|Physician Decision|2|||
148990444|NCT03214367|537440596|FG003|Treatment Period|Physician Decision|0|||
148990445|NCT03214367|537440597|FG004|Treatment Period|Physician Decision|0|||
148990446|NCT03214367|537440598|FG005|Treatment Period|Physician Decision|0|||
148990447|NCT03214367|537440599|FG006|Treatment Period|Physician Decision|0|||
148990448|NCT03214367|537440600|FG007|Treatment Period|Physician Decision|0|||
148990449|NCT03214367|537440593|FG000|Treatment Period|Protocol Violation|0|||
148990450|NCT03214367|537440594|FG001|Treatment Period|Protocol Violation|3|||
148990451|NCT03214367|537440595|FG002|Treatment Period|Protocol Violation|0|||
148990452|NCT03214367|537440596|FG003|Treatment Period|Protocol Violation|0|||
148990453|NCT03214367|537440597|FG004|Treatment Period|Protocol Violation|0|||
148990454|NCT03214367|537440598|FG005|Treatment Period|Protocol Violation|0|||
148990455|NCT03214367|537440599|FG006|Treatment Period|Protocol Violation|0|||
148990456|NCT03214367|537440600|FG007|Treatment Period|Protocol Violation|0|||
148990457|NCT03214367|537440593|FG000|Treatment Period|Withdrawal by Subject|0|||
148990458|NCT03214367|537440594|FG001|Treatment Period|Withdrawal by Subject|20|||
148990459|NCT03214367|537440595|FG002|Treatment Period|Withdrawal by Subject|23|||
148990460|NCT03214367|537440596|FG003|Treatment Period|Withdrawal by Subject|14|||
148990461|NCT03214367|537440597|FG004|Treatment Period|Withdrawal by Subject|0|||
148990462|NCT03214367|537440598|FG005|Treatment Period|Withdrawal by Subject|1|||
148990463|NCT03214367|537440599|FG006|Treatment Period|Withdrawal by Subject|1|||
148990464|NCT03214367|537440600|FG007|Treatment Period|Withdrawal by Subject|1|||
148990465|NCT03508843|537440601|FG000|Overall Study|Withdrawal by Subject|1|||
148990466|NCT03508843|537440601|FG000|Overall Study|technical difficulties|2|||
148990467|NCT04717596|537440602|FG000|Overall Study|Withdrawal by Subject|4|||
148990468|NCT03555396|537440603|FG000|Overall Study|Death|3|||
148990469|NCT03555396|537440604|FG001|Overall Study|Death|1|||
148990470|NCT03555396|537440603|FG000|Overall Study|Lost to Follow-up|0|||
148990471|NCT03555396|537440604|FG001|Overall Study|Lost to Follow-up|2|||
148990472|NCT02536508|537440605|FG000|Overall Study|Withdrawal by Subject|18|||
148990473|NCT02536508|537440606|FG001|Overall Study|Withdrawal by Subject|13|||
148990474|NCT02536508|537440607|FG002|Overall Study|Withdrawal by Subject|7|||
148990475|NCT02536508|537440605|FG000|Overall Study|Adverse Event|14|||
148990476|NCT02536508|537440606|FG001|Overall Study|Adverse Event|13|||
148990477|NCT02536508|537440607|FG002|Overall Study|Adverse Event|6|||
148990478|NCT02536508|537440605|FG000|Overall Study|Lost to Follow-up|12|||
148990479|NCT02536508|537440606|FG001|Overall Study|Lost to Follow-up|4|||
148990480|NCT02536508|537440607|FG002|Overall Study|Lost to Follow-up|0|||
148990481|NCT02536508|537440605|FG000|Overall Study|Lack of Efficacy|3|||
148990482|NCT02536508|537440606|FG001|Overall Study|Lack of Efficacy|5|||
148990483|NCT02536508|537440607|FG002|Overall Study|Lack of Efficacy|4|||
148990484|NCT02536508|537440605|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
148990485|NCT02536508|537440606|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
148990486|NCT02536508|537440607|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
148990487|NCT02536508|537440605|FG000|Overall Study|Physician Decision|0|||
148990488|NCT02536508|537440606|FG001|Overall Study|Physician Decision|4|||
148990489|NCT02536508|537440607|FG002|Overall Study|Physician Decision|2|||
148990490|NCT02536508|537440605|FG000|Overall Study|Major Protocol Deviation|2|||
148990491|NCT02536508|537440606|FG001|Overall Study|Major Protocol Deviation|2|||
148990492|NCT02536508|537440607|FG002|Overall Study|Major Protocol Deviation|2|||
148990493|NCT02536508|537440605|FG000|Overall Study|Administrative Reasons|0|||
148990494|NCT02536508|537440606|FG001|Overall Study|Administrative Reasons|1|||
148990495|NCT02536508|537440607|FG002|Overall Study|Administrative Reasons|0|||
148990496|NCT03305016|537440613|FG000|Overall Study|Withdrawal by Subject|2|||
148990497|NCT04969250|537440614|FG000|Overall Study|Protocol Violation|0|||
148990498|NCT04969250|537440615|FG001|Overall Study|Protocol Violation|2|||
148990499|NCT04969250|537440616|FG002|Overall Study|Protocol Violation|3|||
148990500|NCT04969250|537440617|FG003|Overall Study|Protocol Violation|8|||
148990501|NCT04969250|537440614|FG000|Overall Study|Withdrawal by Subject|0|||
148990502|NCT04969250|537440615|FG001|Overall Study|Withdrawal by Subject|1|||
148990503|NCT04969250|537440616|FG002|Overall Study|Withdrawal by Subject|0|||
148990504|NCT04969250|537440617|FG003|Overall Study|Withdrawal by Subject|0|||
148990505|NCT02119416|537440618|FG000|Overall Study|Protocol Violation|1|||
148990506|NCT02119416|537440619|FG001|Overall Study|Protocol Violation|1|||
148990507|NCT02119416|537440620|FG002|Overall Study|Protocol Violation|1|||
148990508|NCT02119416|537440618|FG000|Overall Study|wrong pubertal stage|1|||
148990509|NCT02119416|537440619|FG001|Overall Study|wrong pubertal stage|0|||
148990510|NCT02119416|537440620|FG002|Overall Study|wrong pubertal stage|1|||
148990511|NCT02278328|537440621|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
148990512|NCT02278328|537440622|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
148990513|NCT02278328|537440623|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
148990514|NCT02278328|537440621|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
148990515|NCT02278328|537440622|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
148990516|NCT02278328|537440623|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
148990517|NCT02278328|537440621|FG000|Neuropsych Screening|incomplete consent|0|||
148990518|NCT02278328|537440622|FG001|Neuropsych Screening|incomplete consent|0|||
148990519|NCT02278328|537440623|FG002|Neuropsych Screening|incomplete consent|2|||
148990520|NCT00130533|537440624|FG000|Overall Study|Withdrawal by Subject|33|||
148990521|NCT00130533|537440625|FG001|Overall Study|Withdrawal by Subject|6|||
148990522|NCT00130533|537440624|FG000|Overall Study|Adverse Event|34|||
148990523|NCT00130533|537440625|FG001|Overall Study|Adverse Event|1|||
148990524|NCT00130533|537440624|FG000|Overall Study|Disease relapse|9|||
148990525|NCT00130533|537440625|FG001|Overall Study|Disease relapse|13|||
148990526|NCT00130533|537440624|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
148990527|NCT00130533|537440625|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
148990528|NCT00130533|537440624|FG000|Overall Study|Death|4|||
148990529|NCT00130533|537440625|FG001|Overall Study|Death|2|||
148990530|NCT00130533|537440624|FG000|Overall Study|Protocol Violation|5|||
148990531|NCT00130533|537440625|FG001|Overall Study|Protocol Violation|1|||
148990532|NCT00130533|537440624|FG000|Overall Study|Lost to Follow-up|1|||
148990533|NCT00130533|537440625|FG001|Overall Study|Lost to Follow-up|1|||
148990534|NCT00130533|537440624|FG000|Overall Study|Sponsor´s decision|2|||
148990535|NCT00130533|537440625|FG001|Overall Study|Sponsor´s decision|0|||
148990536|NCT00130533|537440624|FG000|Overall Study|Second Primary Malignancy|0|||
148990537|NCT00130533|537440625|FG001|Overall Study|Second Primary Malignancy|1|||
148990538|NCT00130533|537440624|FG000|Overall Study|Other|12|||
148990539|NCT00130533|537440625|FG001|Overall Study|Other|5|||
148990540|NCT03927950|537440632|FG000|Overall Study|Adverse Event|9|||
148990541|NCT03263429|537440633|FG000|Overall Study|Withdrawal by Subject|0|||
148990542|NCT03263429|537440634|FG001|Overall Study|Withdrawal by Subject|1|||
148990543|NCT03263429|537440635|FG002|Overall Study|Withdrawal by Subject|0|||
148990544|NCT03263429|537440633|FG000|Overall Study|Follow-Up Period Completed|0|||
148990545|NCT03263429|537440634|FG001|Overall Study|Follow-Up Period Completed|2|||
148990546|NCT03263429|537440635|FG002|Overall Study|Follow-Up Period Completed|0|||
148990547|NCT03263429|537440633|FG000|Overall Study|Death|3|||
148990548|NCT03263429|537440634|FG001|Overall Study|Death|5|||
148990549|NCT03263429|537440635|FG002|Overall Study|Death|16|||
148990550|NCT03263429|537440633|FG000|Overall Study|Participant unable to return|0|||
148990551|NCT03263429|537440634|FG001|Overall Study|Participant unable to return|0|||
148990552|NCT03263429|537440635|FG002|Overall Study|Participant unable to return|1|||
148990553|NCT03263429|537440633|FG000|Overall Study|Study Closed|0|||
148990554|NCT03263429|537440634|FG001|Overall Study|Study Closed|0|||
148990555|NCT03263429|537440635|FG002|Overall Study|Study Closed|1|||
148990556|NCT00833989|537440636|FG000|Overall Study|Physician Decision|0|||
148990557|NCT00833989|537440637|FG001|Overall Study|Physician Decision|0|||
148990558|NCT00833989|537440638|FG002|Overall Study|Physician Decision|0|||
148990559|NCT00833989|537440639|FG003|Overall Study|Physician Decision|1|||
148990560|NCT00833989|537440636|FG000|Overall Study|Withdrawal by Subject|3|||
148990561|NCT00833989|537440637|FG001|Overall Study|Withdrawal by Subject|0|||
148990562|NCT00833989|537440638|FG002|Overall Study|Withdrawal by Subject|1|||
148990563|NCT00833989|537440639|FG003|Overall Study|Withdrawal by Subject|1|||
148990564|NCT04287920|537440640|FG000|Overall Study|Lost to Follow-up|1|||
148990565|NCT04287920|537440641|FG001|Overall Study|Lost to Follow-up|1|||
148990566|NCT04287920|537440640|FG000|Overall Study|Withdrawal by Subject|0|||
148990567|NCT04287920|537440641|FG001|Overall Study|Withdrawal by Subject|3|||
148990568|NCT02310750|537440642|FG000|HP Period 1|Lost to Follow-up|0|||
148990569|NCT02310750|537440643|FG001|HP Period 1|Lost to Follow-up|0|||
148990570|NCT02310750|537440644|FG002|HP Period 1|Lost to Follow-up|0|||
148990571|NCT02310750|537440645|FG003|HP Period 1|Lost to Follow-up|0|||
148990572|NCT02310750|537440646|FG004|HP Period 1|Lost to Follow-up|0|||
148990573|NCT02310750|537440647|FG005|HP Period 1|Lost to Follow-up|0|||
148990574|NCT02310750|537440648|FG006|HP Period 1|Lost to Follow-up|1|||
148990575|NCT02310750|537440649|FG007|HP Period 1|Lost to Follow-up|0|||
148990576|NCT02310750|537440650|FG008|HP Period 1|Lost to Follow-up|0|||
148990577|NCT02310750|537440651|FG009|HP Period 1|Lost to Follow-up|0|||
148990578|NCT02310750|537440652|FG010|HP Period 1|Lost to Follow-up|0|||
148990579|NCT02310750|537440653|FG011|HP Period 1|Lost to Follow-up|0|||
148990580|NCT02310750|537440654|FG012|HP Period 1|Lost to Follow-up|0|||
148990581|NCT02310750|537440655|FG013|HP Period 1|Lost to Follow-up|0|||
148990582|NCT02310750|537440656|FG014|HP Period 1|Lost to Follow-up|0|||
148990583|NCT02310750|537440657|FG015|HP Period 1|Lost to Follow-up|0|||
148990584|NCT02310750|537440642|FG000|HP Period 1|Withdrawal by Subject|1|||
148990585|NCT02310750|537440643|FG001|HP Period 1|Withdrawal by Subject|0|||
148990586|NCT02310750|537440644|FG002|HP Period 1|Withdrawal by Subject|0|||
148990587|NCT02310750|537440645|FG003|HP Period 1|Withdrawal by Subject|1|||
148990588|NCT02310750|537440646|FG004|HP Period 1|Withdrawal by Subject|0|||
148990589|NCT02310750|537440647|FG005|HP Period 1|Withdrawal by Subject|0|||
148990590|NCT02310750|537440648|FG006|HP Period 1|Withdrawal by Subject|0|||
148990591|NCT02310750|537440649|FG007|HP Period 1|Withdrawal by Subject|0|||
148990592|NCT02310750|537440650|FG008|HP Period 1|Withdrawal by Subject|0|||
148990593|NCT02310750|537440651|FG009|HP Period 1|Withdrawal by Subject|0|||
148990594|NCT02310750|537440652|FG010|HP Period 1|Withdrawal by Subject|0|||
148990595|NCT02310750|537440653|FG011|HP Period 1|Withdrawal by Subject|0|||
148990596|NCT02310750|537440654|FG012|HP Period 1|Withdrawal by Subject|0|||
148990597|NCT02310750|537440655|FG013|HP Period 1|Withdrawal by Subject|0|||
148990598|NCT02310750|537440656|FG014|HP Period 1|Withdrawal by Subject|0|||
148990599|NCT02310750|537440657|FG015|HP Period 1|Withdrawal by Subject|0|||
148990600|NCT02310750|537440642|FG000|HP Washout 1|Lost to Follow-up|0|||
148990601|NCT02310750|537440643|FG001|HP Washout 1|Lost to Follow-up|0|||
148990602|NCT02310750|537440644|FG002|HP Washout 1|Lost to Follow-up|1|||
148990603|NCT02310750|537440645|FG003|HP Washout 1|Lost to Follow-up|1|||
148990604|NCT02310750|537440646|FG004|HP Washout 1|Lost to Follow-up|2|||
148990605|NCT02310750|537440647|FG005|HP Washout 1|Lost to Follow-up|2|||
148990606|NCT02310750|537440648|FG006|HP Washout 1|Lost to Follow-up|3|||
148990607|NCT02310750|537440649|FG007|HP Washout 1|Lost to Follow-up|0|||
148990608|NCT02310750|537440650|FG008|HP Washout 1|Lost to Follow-up|0|||
148990609|NCT02310750|537440651|FG009|HP Washout 1|Lost to Follow-up|0|||
148990610|NCT02310750|537440652|FG010|HP Washout 1|Lost to Follow-up|0|||
148990611|NCT02310750|537440653|FG011|HP Washout 1|Lost to Follow-up|0|||
148990612|NCT02310750|537440654|FG012|HP Washout 1|Lost to Follow-up|0|||
148990613|NCT02310750|537440655|FG013|HP Washout 1|Lost to Follow-up|0|||
148990614|NCT02310750|537440656|FG014|HP Washout 1|Lost to Follow-up|0|||
148990615|NCT02310750|537440657|FG015|HP Washout 1|Lost to Follow-up|0|||
148990616|NCT02310750|537440642|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990617|NCT02310750|537440643|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990618|NCT02310750|537440644|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990619|NCT02310750|537440645|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
148990620|NCT02310750|537440646|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990621|NCT02310750|537440647|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
148990622|NCT02310750|537440648|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990623|NCT02310750|537440649|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990624|NCT02310750|537440650|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
148990625|NCT02310750|537440651|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
148990626|NCT02310750|537440652|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990627|NCT02310750|537440653|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990628|NCT02310750|537440654|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990629|NCT02310750|537440655|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148990630|NCT02310750|537440656|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148857240|NCT00778258|536951830|FG004|Overall Study|Other|0|||
148857241|NCT00778258|536951831|FG005|Overall Study|Other|0|||
148857242|NCT00778258|536951832|FG006|Overall Study|Other|1|||
148857243|NCT00778258|536951833|FG007|Overall Study|Other|0|||
148857244|NCT00778258|536951834|FG008|Overall Study|Other|0|||
148857245|NCT04621240|536951838|FG000|Overall Study|Withdrawal by Subject|36|||
148857246|NCT00487942|536951841|FG000|Overall Study|Adverse Event|1|||
148857247|NCT00487942|536951842|FG001|Overall Study|Adverse Event|1|||
148857248|NCT00487942|536951843|FG002|Overall Study|Adverse Event|1|||
148857249|NCT00487942|536951844|FG003|Overall Study|Adverse Event|1|||
148857250|NCT00487942|536951841|FG000|Overall Study|Lost to Follow-up|1|||
148857251|NCT00487942|536951842|FG001|Overall Study|Lost to Follow-up|0|||
148857252|NCT00487942|536951843|FG002|Overall Study|Lost to Follow-up|0|||
148857253|NCT00487942|536951844|FG003|Overall Study|Lost to Follow-up|1|||
148857254|NCT00487942|536951841|FG000|Overall Study|Protocol Violation|1|||
148857255|NCT00487942|536951842|FG001|Overall Study|Protocol Violation|1|||
148857256|NCT00487942|536951843|FG002|Overall Study|Protocol Violation|0|||
148857257|NCT00487942|536951844|FG003|Overall Study|Protocol Violation|0|||
148857258|NCT00487942|536951841|FG000|Overall Study|Withdrawal by Subject|0|||
148857259|NCT00487942|536951842|FG001|Overall Study|Withdrawal by Subject|1|||
148857260|NCT00487942|536951843|FG002|Overall Study|Withdrawal by Subject|2|||
148857261|NCT00487942|536951844|FG003|Overall Study|Withdrawal by Subject|0|||
148857262|NCT00211757|536951845|FG000|Overall Study|Withdrawal by Subject|1|||
148857263|NCT00211757|536951846|FG001|Overall Study|Withdrawal by Subject|1|||
148857264|NCT00211757|536951845|FG000|Overall Study|Lack of Efficacy|0|||
148857265|NCT00211757|536951846|FG001|Overall Study|Lack of Efficacy|1|||
148857266|NCT02650128|536951852|FG000|Overall Study|Death|2|||
148857267|NCT01740089|536953122|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
148857268|NCT01740089|536953123|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
148857269|NCT01740089|536953124|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
148857270|NCT01740089|536953122|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
148857271|NCT01740089|536953123|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
148857272|NCT01740089|536953124|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
148857273|NCT01740089|536953122|FG000|After 12 Weeks|Lack of Efficacy|3|||
148857274|NCT01740089|536953123|FG001|After 12 Weeks|Lack of Efficacy|1|||
148857275|NCT01740089|536953124|FG002|After 12 Weeks|Lack of Efficacy|4|||
148857276|NCT01740089|536953122|FG000|After 12 Weeks|Adverse Event|2|||
148857277|NCT01740089|536953123|FG001|After 12 Weeks|Adverse Event|0|||
148857278|NCT01740089|536953124|FG002|After 12 Weeks|Adverse Event|5|||
148857279|NCT01740089|536953122|FG000|After 12 Weeks|Protocol Violation|1|||
148857280|NCT01740089|536953123|FG001|After 12 Weeks|Protocol Violation|1|||
148857281|NCT01740089|536953124|FG002|After 12 Weeks|Protocol Violation|1|||
148857282|NCT01740089|536953122|FG000|After 12 Weeks|Withdrawal by Subject|1|||
148857283|NCT01740089|536953123|FG001|After 12 Weeks|Withdrawal by Subject|1|||
148857284|NCT01740089|536953124|FG002|After 12 Weeks|Withdrawal by Subject|1|||
148857285|NCT01448824|536953127|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857286|NCT01448824|536953128|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857287|NCT01448824|536953129|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857288|NCT01448824|536953130|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857289|NCT01448824|536953131|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857290|NCT01448824|536953132|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857291|NCT01448824|536953133|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
148857292|NCT01448824|536953134|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
148857293|NCT01448824|536953127|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
148857294|NCT01448824|536953128|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
148857295|NCT01448824|536953129|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
148857296|NCT01448824|536953130|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
148857297|NCT01448824|536953131|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
148857298|NCT01448824|536953132|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
148857299|NCT01448824|536953133|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
148857300|NCT01448824|536953134|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
148857301|NCT01448824|536953127|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857302|NCT01448824|536953128|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857303|NCT01448824|536953129|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857304|NCT01448824|536953130|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857305|NCT01448824|536953131|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857306|NCT01448824|536953132|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
148857307|NCT01448824|536953133|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857308|NCT01448824|536953134|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
148857309|NCT01448824|536953127|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
148990631|NCT02310750|537440657|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
148857310|NCT01448824|536953128|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
148857311|NCT01448824|536953129|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
148857312|NCT01448824|536953130|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
148857313|NCT01448824|536953131|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
148857314|NCT01448824|536953132|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
148857315|NCT01448824|536953133|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
148857316|NCT01448824|536953134|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
148857317|NCT01448824|536953127|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857318|NCT01448824|536953128|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857319|NCT01448824|536953129|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857320|NCT01448824|536953130|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857321|NCT01448824|536953131|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857322|NCT01448824|536953132|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857323|NCT01448824|536953133|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
148857324|NCT01448824|536953134|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
148857325|NCT01448824|536953127|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857326|NCT01448824|536953128|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857327|NCT01448824|536953129|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857328|NCT01448824|536953130|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857329|NCT01448824|536953131|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857330|NCT01448824|536953132|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857331|NCT01448824|536953133|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
148857332|NCT01448824|536953134|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
148857333|NCT01448824|536953127|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857334|NCT01448824|536953128|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857335|NCT01448824|536953129|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857336|NCT01448824|536953130|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857337|NCT01448824|536953131|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857338|NCT01448824|536953132|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857339|NCT01448824|536953133|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
148857340|NCT01448824|536953134|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
148857341|NCT01448824|536953127|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857342|NCT01448824|536953128|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857343|NCT01448824|536953129|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857344|NCT01448824|536953130|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857345|NCT01448824|536953131|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857346|NCT01448824|536953132|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857347|NCT01448824|536953133|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
148857348|NCT01448824|536953134|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
148857349|NCT00218634|536953136|FG000|Overall Study|Lost to Follow-up|8|||
148857350|NCT00218634|536953137|FG001|Overall Study|Lost to Follow-up|15|||
148857351|NCT00734604|536953138|FG000|Overall Study|Adverse Event|0|||
148857352|NCT00734604|536953139|FG001|Overall Study|Adverse Event|2|||
148857353|NCT00734604|536953140|FG002|Overall Study|Adverse Event|0|||
148857354|NCT00734604|536953141|FG003|Overall Study|Adverse Event|2|||
148857355|NCT00734604|536953142|FG004|Overall Study|Adverse Event|1|||
148857356|NCT00734604|536953143|FG005|Overall Study|Adverse Event|1|||
148857357|NCT00734604|536953138|FG000|Overall Study|Serious Adverse Event|1|||
148857358|NCT00734604|536953139|FG001|Overall Study|Serious Adverse Event|0|||
148857359|NCT00734604|536953140|FG002|Overall Study|Serious Adverse Event|1|||
148857360|NCT00734604|536953141|FG003|Overall Study|Serious Adverse Event|2|||
148857361|NCT00734604|536953142|FG004|Overall Study|Serious Adverse Event|0|||
148857362|NCT00734604|536953143|FG005|Overall Study|Serious Adverse Event|1|||
148857363|NCT00734604|536953138|FG000|Overall Study|Lost to Follow-up|1|||
148857364|NCT00734604|536953139|FG001|Overall Study|Lost to Follow-up|2|||
148857365|NCT00734604|536953140|FG002|Overall Study|Lost to Follow-up|2|||
148857366|NCT00734604|536953141|FG003|Overall Study|Lost to Follow-up|4|||
148857367|NCT00734604|536953142|FG004|Overall Study|Lost to Follow-up|2|||
148857368|NCT00734604|536953143|FG005|Overall Study|Lost to Follow-up|3|||
148857369|NCT00734604|536953138|FG000|Overall Study|Physician Decision|0|||
148857370|NCT00734604|536953139|FG001|Overall Study|Physician Decision|1|||
148857371|NCT00734604|536953140|FG002|Overall Study|Physician Decision|1|||
148857372|NCT00734604|536953141|FG003|Overall Study|Physician Decision|0|||
148857373|NCT00734604|536953142|FG004|Overall Study|Physician Decision|0|||
148857374|NCT00734604|536953143|FG005|Overall Study|Physician Decision|0|||
148857375|NCT00734604|536953138|FG000|Overall Study|Protocol Violation|0|||
149030672|NCT00813488|537589693|FG001|Titration Period 2|Adverse Event|3|||
148857376|NCT00734604|536953139|FG001|Overall Study|Protocol Violation|2|||
148857377|NCT00734604|536953140|FG002|Overall Study|Protocol Violation|0|||
148857378|NCT00734604|536953141|FG003|Overall Study|Protocol Violation|0|||
148857379|NCT00734604|536953142|FG004|Overall Study|Protocol Violation|1|||
148857380|NCT00734604|536953143|FG005|Overall Study|Protocol Violation|0|||
148857381|NCT00734604|536953138|FG000|Overall Study|Sponsor Decision|1|||
148857382|NCT00734604|536953139|FG001|Overall Study|Sponsor Decision|2|||
148990632|NCT02310750|537440642|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990633|NCT02310750|537440643|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990634|NCT02310750|537440644|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990635|NCT02310750|537440645|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990636|NCT02310750|537440646|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990637|NCT02310750|537440647|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990638|NCT02310750|537440648|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990639|NCT02310750|537440649|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990640|NCT02310750|537440650|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990641|NCT02310750|537440651|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
148990642|NCT02310750|537440652|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990643|NCT02310750|537440653|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990644|NCT02310750|537440654|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990645|NCT02310750|537440655|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990646|NCT02310750|537440656|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990647|NCT02310750|537440657|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
148990648|NCT02310750|537440642|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990649|NCT02310750|537440643|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990650|NCT02310750|537440644|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990651|NCT02310750|537440645|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990652|NCT02310750|537440646|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990653|NCT02310750|537440647|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990654|NCT02310750|537440648|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990655|NCT02310750|537440649|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
148990656|NCT02310750|537440650|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
148990657|NCT02310750|537440651|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
148990658|NCT02310750|537440652|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990659|NCT02310750|537440653|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990660|NCT02310750|537440654|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990661|NCT02310750|537440655|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990662|NCT02310750|537440656|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990663|NCT02310750|537440657|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
148990664|NCT02310750|537440642|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990665|NCT02310750|537440643|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990666|NCT02310750|537440644|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990667|NCT02310750|537440645|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990668|NCT02310750|537440646|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990669|NCT02310750|537440647|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990670|NCT02310750|537440648|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990671|NCT02310750|537440649|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
148990672|NCT02310750|537440650|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
148990673|NCT02310750|537440651|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990674|NCT02310750|537440652|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990675|NCT02310750|537440653|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990676|NCT02310750|537440654|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990677|NCT02310750|537440655|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990678|NCT02310750|537440656|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990679|NCT02310750|537440657|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
148990680|NCT02310750|537440642|FG000|HP Washout 2|Lost to Follow-up|0|||
148990681|NCT02310750|537440643|FG001|HP Washout 2|Lost to Follow-up|0|||
148990682|NCT02310750|537440644|FG002|HP Washout 2|Lost to Follow-up|0|||
148990683|NCT02310750|537440645|FG003|HP Washout 2|Lost to Follow-up|0|||
148990684|NCT02310750|537440646|FG004|HP Washout 2|Lost to Follow-up|1|||
148990685|NCT02310750|537440647|FG005|HP Washout 2|Lost to Follow-up|0|||
148990686|NCT02310750|537440648|FG006|HP Washout 2|Lost to Follow-up|7|||
148990687|NCT02310750|537440649|FG007|HP Washout 2|Lost to Follow-up|0|||
148990688|NCT02310750|537440650|FG008|HP Washout 2|Lost to Follow-up|0|||
148990689|NCT02310750|537440651|FG009|HP Washout 2|Lost to Follow-up|0|||
148990690|NCT02310750|537440652|FG010|HP Washout 2|Lost to Follow-up|0|||
148990691|NCT02310750|537440653|FG011|HP Washout 2|Lost to Follow-up|0|||
148990692|NCT02310750|537440654|FG012|HP Washout 2|Lost to Follow-up|0|||
148990693|NCT02310750|537440655|FG013|HP Washout 2|Lost to Follow-up|0|||
148990694|NCT02310750|537440656|FG014|HP Washout 2|Lost to Follow-up|0|||
148990695|NCT02310750|537440657|FG015|HP Washout 2|Lost to Follow-up|0|||
148990696|NCT01934218|537440661|FG000|Double-blind Phase|Adverse Event|8|||
148990697|NCT01934218|537440662|FG001|Double-blind Phase|Adverse Event|8|||
148990698|NCT01934218|537440661|FG000|Double-blind Phase|Lack of Efficacy|6|||
148990699|NCT01934218|537440662|FG001|Double-blind Phase|Lack of Efficacy|7|||
148990700|NCT01934218|537440661|FG000|Double-blind Phase|Lost to Follow-up|7|||
148857383|NCT00734604|536953140|FG002|Overall Study|Sponsor Decision|1|||
148857384|NCT00734604|536953141|FG003|Overall Study|Sponsor Decision|0|||
148857385|NCT00734604|536953142|FG004|Overall Study|Sponsor Decision|2|||
148857386|NCT00734604|536953143|FG005|Overall Study|Sponsor Decision|0|||
148857387|NCT00734604|536953138|FG000|Overall Study|Withdrawal by Subject|0|||
148857388|NCT00734604|536953139|FG001|Overall Study|Withdrawal by Subject|2|||
148857389|NCT00734604|536953140|FG002|Overall Study|Withdrawal by Subject|0|||
148857390|NCT00734604|536953141|FG003|Overall Study|Withdrawal by Subject|1|||
148857391|NCT00734604|536953142|FG004|Overall Study|Withdrawal by Subject|2|||
148857392|NCT00734604|536953143|FG005|Overall Study|Withdrawal by Subject|1|||
148857393|NCT00734604|536953138|FG000|Overall Study|Lack of Efficacy|0|||
148857394|NCT00734604|536953139|FG001|Overall Study|Lack of Efficacy|1|||
148857395|NCT00734604|536953140|FG002|Overall Study|Lack of Efficacy|1|||
148857396|NCT00734604|536953141|FG003|Overall Study|Lack of Efficacy|0|||
148857397|NCT00734604|536953142|FG004|Overall Study|Lack of Efficacy|0|||
148857398|NCT00734604|536953143|FG005|Overall Study|Lack of Efficacy|0|||
148857399|NCT01044745|536953144|FG000|Overall Study|Ineiligible|2|||
148857400|NCT00591149|536953147|FG000|Overall Study|Adverse Event|4|||
148857401|NCT00591149|536953147|FG000|Overall Study|Withdrawal by Subject|1|||
148857402|NCT00539513|536953148|FG000|Overall Study|Withdrawal by Subject|2|||
148857403|NCT00539513|536953149|FG001|Overall Study|Withdrawal by Subject|1|||
148857404|NCT00539513|536953148|FG000|Overall Study|Lost to Follow-up|0|||
148990701|NCT01934218|537440662|FG001|Double-blind Phase|Lost to Follow-up|14|||
149030673|NCT00813488|537589692|FG000|Titration Period 2|Lack of Efficacy|8|||
149030674|NCT00813488|537589693|FG001|Titration Period 2|Lack of Efficacy|4|||
149030675|NCT00813488|537589692|FG000|Titration Period 2|Protocol Violation|3|||
149030676|NCT00813488|537589693|FG001|Titration Period 2|Protocol Violation|2|||
149030677|NCT00813488|537589692|FG000|Titration Period 2|Lost to Follow-up|1|||
148990702|NCT01934218|537440661|FG000|Double-blind Phase|Physician Decision|1|||
148990703|NCT01934218|537440662|FG001|Double-blind Phase|Physician Decision|2|||
148990704|NCT01934218|537440661|FG000|Double-blind Phase|Protocol Violation|4|||
148990705|NCT01934218|537440662|FG001|Double-blind Phase|Protocol Violation|0|||
148990706|NCT01934218|537440661|FG000|Double-blind Phase|Withdrawal by Subject|16|||
148990707|NCT01934218|537440662|FG001|Double-blind Phase|Withdrawal by Subject|13|||
148990708|NCT01934218|537440661|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
148990709|NCT01934218|537440662|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
148990710|NCT01934218|537440661|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
148990711|NCT01934218|537440662|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
148990712|NCT01934218|537440661|FG000|Open-Label Phase|Adverse Event|2|||
148990713|NCT01934218|537440662|FG001|Open-Label Phase|Adverse Event|4|||
148990714|NCT01934218|537440661|FG000|Open-Label Phase|Lack of Efficacy|1|||
148990715|NCT01934218|537440662|FG001|Open-Label Phase|Lack of Efficacy|4|||
148990716|NCT01934218|537440661|FG000|Open-Label Phase|Lost to Follow-up|4|||
148990717|NCT01934218|537440662|FG001|Open-Label Phase|Lost to Follow-up|2|||
148990718|NCT01934218|537440661|FG000|Open-Label Phase|Physician Decision|1|||
148990719|NCT01934218|537440662|FG001|Open-Label Phase|Physician Decision|0|||
148990720|NCT01934218|537440661|FG000|Open-Label Phase|Protocol Violation|1|||
148990721|NCT01934218|537440662|FG001|Open-Label Phase|Protocol Violation|0|||
148990722|NCT01934218|537440661|FG000|Open-Label Phase|Withdrawal by Subject|13|||
148990723|NCT01934218|537440662|FG001|Open-Label Phase|Withdrawal by Subject|11|||
148990724|NCT01934218|537440661|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
148990725|NCT01934218|537440662|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
148857405|NCT00539513|536953149|FG001|Overall Study|Lost to Follow-up|1|||
148857406|NCT03002818|536953150|FG000|Overall Study|Decision of the investigator|1|||
148990726|NCT01934218|537440661|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
148990727|NCT01934218|537440662|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
148990728|NCT03538626|537440663|FG000|Overall Study|Withdrawal by Subject|0|||
148990729|NCT03538626|537440664|FG001|Overall Study|Withdrawal by Subject|1|||
148990730|NCT03538626|537440665|FG002|Overall Study|Withdrawal by Subject|0|||
148990731|NCT03538626|537440666|FG003|Overall Study|Withdrawal by Subject|0|||
148857407|NCT01328041|536953154|FG000|Overall Study|Adverse Event|7|||
148857408|NCT01328041|536953154|FG000|Overall Study|Lack of Efficacy|27|||
148857409|NCT01328041|536953154|FG000|Overall Study|Protocol Violation|7|||
148990732|NCT03538626|537440667|FG004|Overall Study|Withdrawal by Subject|0|||
148990733|NCT03538626|537440668|FG005|Overall Study|Withdrawal by Subject|0|||
148990734|NCT03538626|537440669|FG006|Overall Study|Withdrawal by Subject|0|||
148990735|NCT03538626|537440670|FG007|Overall Study|Withdrawal by Subject|0|||
148990736|NCT03538626|537440663|FG000|Overall Study|Lost to Follow-up|0|||
149030678|NCT00813488|537589693|FG001|Titration Period 2|Lost to Follow-up|0|||
148857410|NCT01328041|536953154|FG000|Overall Study|Lost to Follow-up|7|||
148990737|NCT03538626|537440664|FG001|Overall Study|Lost to Follow-up|0|||
148857411|NCT01328041|536953154|FG000|Overall Study|Physician Decision|2|||
148857412|NCT01328041|536953154|FG000|Overall Study|Withdrawal by Subject|7|||
148857413|NCT00711113|536953155|FG000|Overall Study|Lost to Follow-up|9|||
148990738|NCT03538626|537440665|FG002|Overall Study|Lost to Follow-up|0|||
148990739|NCT03538626|537440666|FG003|Overall Study|Lost to Follow-up|0|||
148990740|NCT03538626|537440667|FG004|Overall Study|Lost to Follow-up|0|||
148990741|NCT03538626|537440668|FG005|Overall Study|Lost to Follow-up|0|||
148990742|NCT03538626|537440669|FG006|Overall Study|Lost to Follow-up|1|||
148990743|NCT03538626|537440670|FG007|Overall Study|Lost to Follow-up|0|||
148990744|NCT02911948|537440676|FG000|Overall Study|Protocol Violation|0|||
148990745|NCT02911948|537440677|FG001|Overall Study|Protocol Violation|1|||
148990746|NCT02911948|537440676|FG000|Overall Study|Withdrawal by Subject|0|||
148990747|NCT02911948|537440677|FG001|Overall Study|Withdrawal by Subject|2|||
148990748|NCT02911948|537440676|FG000|Overall Study|Lack of Efficacy|0|||
148857414|NCT00711113|536953155|FG000|Overall Study|Implant lost|2|||
148857415|NCT01606787|536953158|FG000|Overall Study|Withdrawal by Subject|4|||
148990749|NCT02911948|537440677|FG001|Overall Study|Lack of Efficacy|1|||
148990750|NCT02911948|537440676|FG000|Overall Study|Unclassified|0|||
148990751|NCT02911948|537440677|FG001|Overall Study|Unclassified|3|||
148990752|NCT04323436|537440678|FG000|Overall Study|Adverse Event|7|||
148990753|NCT04323436|537440679|FG001|Overall Study|Adverse Event|0|||
148990754|NCT04323436|537440680|FG002|Overall Study|Adverse Event|0|||
148990755|NCT04323436|537440678|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
148990756|NCT04323436|537440679|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
148990757|NCT04323436|537440680|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
148990758|NCT04323436|537440678|FG000|Overall Study|Death|1|||
148857416|NCT01606787|536953159|FG001|Overall Study|Withdrawal by Subject|5|||
148857417|NCT01606787|536953158|FG000|Overall Study|Surgery canceled|0|||
148857418|NCT01606787|536953159|FG001|Overall Study|Surgery canceled|2|||
148857419|NCT05312632|536953160|FG000|Overall Study|Adverse Event|12|||
148857420|NCT05312632|536953160|FG000|Overall Study|Withdrawal by Subject|10|||
148857421|NCT05312632|536953160|FG000|Overall Study|Lack of Efficacy|4|||
148857422|NCT05312632|536953160|FG000|Overall Study|Non-compliance with study procedures|9|||
148857423|NCT05312632|536953160|FG000|Overall Study|Other|4|||
148857424|NCT00519376|536953164|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857425|NCT00519376|536953165|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857426|NCT00519376|536953166|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857427|NCT00519376|536953167|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857428|NCT00519376|536953168|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857429|NCT00519376|536953169|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857430|NCT00519376|536953170|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857431|NCT00519376|536953171|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857432|NCT00519376|536953172|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857433|NCT00519376|536953173|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857434|NCT00519376|536953174|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857435|NCT00519376|536953175|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857436|NCT00519376|536953176|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
148857437|NCT00519376|536953177|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857438|NCT00519376|536953178|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857439|NCT00519376|536953179|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
148857440|NCT00519376|536953164|FG000|Treatment Period 4|Lost to Follow-up|0|||
148857441|NCT00519376|536953165|FG001|Treatment Period 4|Lost to Follow-up|0|||
148857442|NCT00519376|536953166|FG002|Treatment Period 4|Lost to Follow-up|1|||
148857443|NCT00519376|536953167|FG003|Treatment Period 4|Lost to Follow-up|0|||
148857444|NCT00519376|536953168|FG004|Treatment Period 4|Lost to Follow-up|0|||
148857445|NCT00519376|536953169|FG005|Treatment Period 4|Lost to Follow-up|0|||
148857446|NCT00519376|536953170|FG006|Treatment Period 4|Lost to Follow-up|0|||
148857447|NCT00519376|536953171|FG007|Treatment Period 4|Lost to Follow-up|0|||
148990759|NCT04323436|537440679|FG001|Overall Study|Death|0|||
148990760|NCT04323436|537440680|FG002|Overall Study|Death|0|||
148990761|NCT04323436|537440678|FG000|Overall Study|Physician Decision|2|||
148990762|NCT04323436|537440679|FG001|Overall Study|Physician Decision|0|||
148990763|NCT04323436|537440680|FG002|Overall Study|Physician Decision|0|||
148990764|NCT04323436|537440678|FG000|Overall Study|Progressive disease|10|||
148990765|NCT04323436|537440679|FG001|Overall Study|Progressive disease|0|||
148990766|NCT04323436|537440680|FG002|Overall Study|Progressive disease|0|||
149030679|NCT00813488|537589692|FG000|Titration Period 2|Non-compliance with study procedures|2|||
148857448|NCT00519376|536953172|FG008|Treatment Period 4|Lost to Follow-up|0|||
148857449|NCT00519376|536953173|FG009|Treatment Period 4|Lost to Follow-up|0|||
148857450|NCT00519376|536953174|FG010|Treatment Period 4|Lost to Follow-up|0|||
148857451|NCT00519376|536953175|FG011|Treatment Period 4|Lost to Follow-up|0|||
148857452|NCT00519376|536953176|FG012|Treatment Period 4|Lost to Follow-up|0|||
148857453|NCT00519376|536953177|FG013|Treatment Period 4|Lost to Follow-up|0|||
148857454|NCT00519376|536953178|FG014|Treatment Period 4|Lost to Follow-up|0|||
148990767|NCT04323436|537440678|FG000|Overall Study|Subject decision|3|||
148990768|NCT04323436|537440679|FG001|Overall Study|Subject decision|0|||
148990769|NCT04323436|537440680|FG002|Overall Study|Subject decision|0|||
148990770|NCT03021187|537440681|FG000|Overall Study|Death|0|||
148990771|NCT03021187|537440682|FG001|Overall Study|Death|0|||
148990772|NCT03021187|537440683|FG002|Overall Study|Death|3|||
148990773|NCT03021187|537440684|FG003|Overall Study|Death|0|||
148990774|NCT03021187|537440681|FG000|Overall Study|Withdrawal by Subject|0|||
148990775|NCT03021187|537440682|FG001|Overall Study|Withdrawal by Subject|6|||
148990776|NCT03021187|537440683|FG002|Overall Study|Withdrawal by Subject|2|||
148990777|NCT03021187|537440684|FG003|Overall Study|Withdrawal by Subject|5|||
148990778|NCT03021187|537440681|FG000|Overall Study|Lost to Follow-up|10|||
148990779|NCT03021187|537440682|FG001|Overall Study|Lost to Follow-up|3|||
148990780|NCT03021187|537440683|FG002|Overall Study|Lost to Follow-up|1|||
148990781|NCT03021187|537440684|FG003|Overall Study|Lost to Follow-up|4|||
148990782|NCT03394924|537440685|FG000|Overall Study|Adverse Event|0|||
148990783|NCT03394924|537440686|FG001|Overall Study|Adverse Event|5|||
148990784|NCT03394924|537440687|FG002|Overall Study|Adverse Event|0|||
148990785|NCT03394924|537440685|FG000|Overall Study|Withdrawal by Subject|2|||
148990786|NCT03394924|537440686|FG001|Overall Study|Withdrawal by Subject|0|||
148990787|NCT03394924|537440687|FG002|Overall Study|Withdrawal by Subject|0|||
148990788|NCT03394924|537440685|FG000|Overall Study|Lost to Follow-up|0|||
148990789|NCT03394924|537440686|FG001|Overall Study|Lost to Follow-up|1|||
148990790|NCT03394924|537440687|FG002|Overall Study|Lost to Follow-up|0|||
148990791|NCT03394924|537440685|FG000|Overall Study|Did not meet all inclusion criteria|1|||
148990792|NCT03394924|537440686|FG001|Overall Study|Did not meet all inclusion criteria|0|||
148990793|NCT03394924|537440687|FG002|Overall Study|Did not meet all inclusion criteria|0|||
148990794|NCT02005471|537440697|FG000|Main Study|Adverse Event|0|||
148990795|NCT02005471|537440698|FG001|Main Study|Adverse Event|1|||
148990796|NCT02005471|537440699|FG002|Main Study|Adverse Event|0|||
148990797|NCT02005471|537440700|FG003|Main Study|Adverse Event|0|||
148990798|NCT02005471|537440697|FG000|Main Study|Death|83|||
148990799|NCT02005471|537440698|FG001|Main Study|Death|52|||
148990800|NCT02005471|537440699|FG002|Main Study|Death|0|||
148990801|NCT02005471|537440700|FG003|Main Study|Death|0|||
148990802|NCT02005471|537440697|FG000|Main Study|Lost to Follow-up|4|||
148990803|NCT02005471|537440698|FG001|Main Study|Lost to Follow-up|5|||
148990804|NCT02005471|537440699|FG002|Main Study|Lost to Follow-up|0|||
148990805|NCT02005471|537440700|FG003|Main Study|Lost to Follow-up|0|||
148990806|NCT02005471|537440697|FG000|Main Study|Physician Decision|3|||
148990807|NCT02005471|537440698|FG001|Main Study|Physician Decision|1|||
148990808|NCT02005471|537440699|FG002|Main Study|Physician Decision|0|||
148990809|NCT02005471|537440700|FG003|Main Study|Physician Decision|0|||
148990810|NCT02005471|537440697|FG000|Main Study|Withdrawal by Subject|26|||
148990811|NCT02005471|537440698|FG001|Main Study|Withdrawal by Subject|11|||
148990812|NCT02005471|537440699|FG002|Main Study|Withdrawal by Subject|0|||
148990813|NCT02005471|537440700|FG003|Main Study|Withdrawal by Subject|0|||
148990814|NCT02005471|537440697|FG000|Main Study|Reason not Specified|0|||
148990815|NCT02005471|537440698|FG001|Main Study|Reason not Specified|6|||
148990816|NCT02005471|537440699|FG002|Main Study|Reason not Specified|0|||
148990817|NCT02005471|537440700|FG003|Main Study|Reason not Specified|0|||
148990818|NCT02005471|537440697|FG000|Main Study|Randomized but not Dosed|8|||
148990819|NCT02005471|537440698|FG001|Main Study|Randomized but not Dosed|0|||
148990820|NCT02005471|537440699|FG002|Main Study|Randomized but not Dosed|0|||
148990821|NCT02005471|537440700|FG003|Main Study|Randomized but not Dosed|0|||
148990822|NCT02005471|537440697|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
148990823|NCT02005471|537440698|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
148990824|NCT02005471|537440699|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
148990825|NCT02005471|537440700|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
148990826|NCT02005471|537440697|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
148990827|NCT02005471|537440698|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
148990828|NCT02005471|537440699|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
148990829|NCT02005471|537440700|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
148990830|NCT02005471|537440697|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
148990831|NCT02005471|537440698|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
148990832|NCT02005471|537440699|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
148990833|NCT02005471|537440700|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
148990834|NCT00627705|537440702|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
148990835|NCT00627705|537440703|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
149030680|NCT00813488|537589693|FG001|Titration Period 2|Non-compliance with study procedures|1|||
148990836|NCT00627705|537440702|FG000|Overall Study|Adverse Event|1|||
148990837|NCT00627705|537440703|FG001|Overall Study|Adverse Event|0|||
148990838|NCT00627705|537440702|FG000|Overall Study|Withdrawal by Subject|0|||
148990839|NCT00627705|537440703|FG001|Overall Study|Withdrawal by Subject|2|||
148990840|NCT00627705|537440702|FG000|Overall Study|Lost to Follow-up|0|||
148990841|NCT00627705|537440703|FG001|Overall Study|Lost to Follow-up|1|||
148990842|NCT02730819|537440704|FG000|Overall Study|Lost to Follow-up|9|||
148990843|NCT02121847|537440705|FG000|Overall Study|Administrative Reasons|1|||
148990844|NCT02121847|537440705|FG000|Overall Study|Adverse Event|2|||
148990845|NCT01410448|537440711|FG000|Overall Study|No conversion to everolimus|0|||
148990846|NCT01410448|537440712|FG001|Overall Study|No conversion to everolimus|24|||
148990847|NCT01410448|537440711|FG000|Overall Study|Graft loss|4|||
148990848|NCT01410448|537440712|FG001|Overall Study|Graft loss|1|||
148990849|NCT01410448|537440711|FG000|Overall Study|Administrative issues|2|||
148990850|NCT01410448|537440712|FG001|Overall Study|Administrative issues|1|||
148990851|NCT01410448|537440711|FG000|Overall Study|Lost to Follow-up|1|||
148990852|NCT01410448|537440712|FG001|Overall Study|Lost to Follow-up|0|||
148990853|NCT01410448|537440711|FG000|Overall Study|Withdrawal by Subject|3|||
148990854|NCT01410448|537440712|FG001|Overall Study|Withdrawal by Subject|2|||
148990855|NCT01410448|537440711|FG000|Overall Study|Protocol Violation|0|||
148990856|NCT01410448|537440712|FG001|Overall Study|Protocol Violation|4|||
148990857|NCT01410448|537440711|FG000|Overall Study|Death|2|||
148990858|NCT01410448|537440712|FG001|Overall Study|Death|3|||
148990859|NCT03156023|537440715|FG000|Overall Study|Withdrawal by Subject|1|||
148990860|NCT03156023|537440716|FG001|Overall Study|Withdrawal by Subject|0|||
148990861|NCT03156023|537440717|FG002|Overall Study|Withdrawal by Subject|2|||
148990862|NCT03156023|537440718|FG003|Overall Study|Withdrawal by Subject|1|||
148990863|NCT03156023|537440719|FG004|Overall Study|Withdrawal by Subject|1|||
148990864|NCT03156023|537440715|FG000|Overall Study|Lost to Follow-up|0|||
148990865|NCT03156023|537440716|FG001|Overall Study|Lost to Follow-up|0|||
148990866|NCT03156023|537440717|FG002|Overall Study|Lost to Follow-up|0|||
148990867|NCT03156023|537440718|FG003|Overall Study|Lost to Follow-up|0|||
148990868|NCT03156023|537440719|FG004|Overall Study|Lost to Follow-up|1|||
148857455|NCT00519376|536953179|FG015|Treatment Period 4|Lost to Follow-up|0|||
148857456|NCT01231321|536953184|FG000|Overall Study|Adverse Event|3|||
148857457|NCT01231321|536953184|FG000|Overall Study|Lack of Efficacy|2|||
148857458|NCT00489736|536953185|FG000|Overall Study|Lack of Efficacy|53|||
148857459|NCT00489736|536953186|FG001|Overall Study|Lack of Efficacy|14|||
148857460|NCT00489736|536953185|FG000|Overall Study|Adverse Event|32|||
148857461|NCT00489736|536953186|FG001|Overall Study|Adverse Event|45|||
148857462|NCT00489736|536953185|FG000|Overall Study|Poor compliance|6|||
148857463|NCT00489736|536953186|FG001|Overall Study|Poor compliance|2|||
148857464|NCT00489736|536953185|FG000|Overall Study|Not coded/ Not pre-specified|5|||
148857465|NCT00489736|536953186|FG001|Overall Study|Not coded/ Not pre-specified|8|||
148857466|NCT04021524|536953187|FG000|Overall Study|Change in surgical intervention|0|||
148857467|NCT04021524|536953188|FG001|Overall Study|Change in surgical intervention|1|||
148857468|NCT05275010|536953189|FG000|Overall Study|Reason Not Specified|4|||
148857469|NCT05275010|536953190|FG001|Overall Study|Reason Not Specified|1|||
148857470|NCT05275010|536953189|FG000|Overall Study|Withdrawal by Subject|1|||
148857471|NCT05275010|536953190|FG001|Overall Study|Withdrawal by Subject|0|||
148857472|NCT05275010|536953189|FG000|Overall Study|Lost to Follow-up|0|||
148857473|NCT05275010|536953190|FG001|Overall Study|Lost to Follow-up|1|||
148857474|NCT03883165|536953195|FG000|Overall Study|Withdrawal by Subject|4|||
148857475|NCT03883165|536953196|FG001|Overall Study|Withdrawal by Subject|3|||
148857476|NCT00245050|536953198|FG000|Overall Study|Adverse Event|3|||
148857477|NCT00245050|536953199|FG001|Overall Study|Adverse Event|2|||
148857478|NCT00730041|536953202|FG000|Overall Study|Lost to Follow-up|0|||
148857479|NCT00730041|536953203|FG001|Overall Study|Lost to Follow-up|2|||
148857480|NCT02301546|536953204|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
148857481|NCT02301546|536953205|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
148857482|NCT02301546|536953204|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
148857483|NCT02301546|536953205|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
148857484|NCT02301546|536953204|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
148857485|NCT02301546|536953205|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
148857486|NCT02301546|536953204|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
148857487|NCT02301546|536953205|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
148857488|NCT02301546|536953204|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
148857489|NCT02301546|536953205|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
148857490|NCT02301546|536953204|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
148857491|NCT02301546|536953205|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
148857492|NCT02301546|536953204|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
148990869|NCT00932893|537440720|FG000|Overall Study|Death|115|||
148857493|NCT02301546|536953205|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
148857494|NCT05526781|536953208|FG000|Overall Study|Lost to Follow-up|1|||
148857495|NCT02743949|536953211|FG000|Overall Study|Adverse Event|0|||
148857496|NCT02743949|536953212|FG001|Overall Study|Adverse Event|0|||
148857497|NCT02743949|536953213|FG002|Overall Study|Adverse Event|2|||
148857498|NCT02743949|536953211|FG000|Overall Study|Significant Protocol Deviation|2|||
148857499|NCT02743949|536953212|FG001|Overall Study|Significant Protocol Deviation|0|||
148857500|NCT02743949|536953213|FG002|Overall Study|Significant Protocol Deviation|1|||
148857501|NCT02743949|536953211|FG000|Overall Study|Voluntary Withdrawal|2|||
148990870|NCT00932893|537440721|FG001|Overall Study|Death|24|||
148990871|NCT00932893|537440720|FG000|Overall Study|Lost to Follow-up|8|||
148990872|NCT00932893|537440721|FG001|Overall Study|Lost to Follow-up|0|||
148990873|NCT00932893|537440720|FG000|Overall Study|Withdrawal by Subject|5|||
148990874|NCT00932893|537440721|FG001|Overall Study|Withdrawal by Subject|2|||
148990875|NCT00932893|537440720|FG000|Overall Study|Other|5|||
148990876|NCT00932893|537440721|FG001|Overall Study|Other|144|||
148990877|NCT01432366|537443176|FG000|Overall Study|Non-Responder|7|||
148990878|NCT01432366|537443176|FG000|Overall Study|Adverse Event|8|||
148990879|NCT01432366|537443176|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
148990880|NCT01432366|537443176|FG000|Overall Study|Pregnancy|1|||
148990881|NCT01432366|537443176|FG000|Overall Study|Lost to Follow-up|13|||
148990882|NCT01432366|537443176|FG000|Overall Study|Lack of Efficacy|1|||
148990883|NCT01432366|537443176|FG000|Overall Study|Site Closed|20|||
148990884|NCT01432366|537443176|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
148990885|NCT01432366|537443176|FG000|Overall Study|Other|14|||
148990886|NCT02062632|537443177|FG000|Overall Study|No treatment data|1|||
148990887|NCT00773968|537443179|FG000|Overall Study|Adverse Event|2|||
148990888|NCT00773968|537443179|FG000|Overall Study|Death|1|||
148990889|NCT00773968|537443179|FG000|Overall Study|Failure to Return|2|||
148990890|NCT00773968|537443179|FG000|Overall Study|Lack of Efficacy|3|||
148990891|NCT00773968|537443179|FG000|Overall Study|Protocol Violation|1|||
148990892|NCT00773968|537443179|FG000|Overall Study|Withdrawal by Subject|11|||
148990893|NCT00773968|537443179|FG000|Overall Study|Screen Failure|17|||
148990894|NCT00773968|537443179|FG000|Overall Study|Other|8|||
148990895|NCT04579757|537443187|FG000|Overall Study|Adverse Event|0|||
148990896|NCT04579757|537443188|FG001|Overall Study|Adverse Event|0|||
148990897|NCT04579757|537443189|FG002|Overall Study|Adverse Event|0|||
148990898|NCT04579757|537443190|FG003|Overall Study|Adverse Event|2|||
148990899|NCT04579757|537443191|FG004|Overall Study|Adverse Event|1|||
148990900|NCT04579757|537443192|FG005|Overall Study|Adverse Event|1|||
148990901|NCT04579757|537443193|FG006|Overall Study|Adverse Event|0|||
148990902|NCT04579757|537443194|FG007|Overall Study|Adverse Event|0|||
148990903|NCT04579757|537443195|FG008|Overall Study|Adverse Event|0|||
148990904|NCT04579757|537443187|FG000|Overall Study|Death|4|||
148990905|NCT04579757|537443188|FG001|Overall Study|Death|1|||
148990906|NCT04579757|537443189|FG002|Overall Study|Death|14|||
148990907|NCT04579757|537443190|FG003|Overall Study|Death|3|||
148990908|NCT04579757|537443191|FG004|Overall Study|Death|2|||
148990909|NCT04579757|537443192|FG005|Overall Study|Death|7|||
148990910|NCT04579757|537443193|FG006|Overall Study|Death|0|||
148990911|NCT04579757|537443194|FG007|Overall Study|Death|1|||
148990912|NCT04579757|537443195|FG008|Overall Study|Death|3|||
148990913|NCT04579757|537443187|FG000|Overall Study|Physician Decision|0|||
148990914|NCT04579757|537443188|FG001|Overall Study|Physician Decision|0|||
148990915|NCT04579757|537443189|FG002|Overall Study|Physician Decision|0|||
148990916|NCT04579757|537443190|FG003|Overall Study|Physician Decision|2|||
148990917|NCT04579757|537443191|FG004|Overall Study|Physician Decision|1|||
148990918|NCT04579757|537443192|FG005|Overall Study|Physician Decision|1|||
148990919|NCT04579757|537443193|FG006|Overall Study|Physician Decision|1|||
148990920|NCT04579757|537443194|FG007|Overall Study|Physician Decision|0|||
148990921|NCT04579757|537443195|FG008|Overall Study|Physician Decision|0|||
148990922|NCT04579757|537443187|FG000|Overall Study|Study Terminated By Sponsor|0|||
148990923|NCT04579757|537443188|FG001|Overall Study|Study Terminated By Sponsor|0|||
148990924|NCT04579757|537443189|FG002|Overall Study|Study Terminated By Sponsor|0|||
148990925|NCT04579757|537443190|FG003|Overall Study|Study Terminated By Sponsor|0|||
148990926|NCT04579757|537443191|FG004|Overall Study|Study Terminated By Sponsor|2|||
148990927|NCT04579757|537443192|FG005|Overall Study|Study Terminated By Sponsor|0|||
148990928|NCT04579757|537443193|FG006|Overall Study|Study Terminated By Sponsor|0|||
149030681|NCT00813488|537589692|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
148990929|NCT04579757|537443194|FG007|Overall Study|Study Terminated By Sponsor|2|||
148990930|NCT04579757|537443195|FG008|Overall Study|Study Terminated By Sponsor|0|||
148990931|NCT04579757|537443187|FG000|Overall Study|Withdrawal by Subject|1|||
148990932|NCT04579757|537443188|FG001|Overall Study|Withdrawal by Subject|1|||
148990933|NCT04579757|537443189|FG002|Overall Study|Withdrawal by Subject|0|||
149030682|NCT00813488|537589693|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
149030683|NCT00813488|537589692|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
148990934|NCT04579757|537443190|FG003|Overall Study|Withdrawal by Subject|0|||
148990935|NCT04579757|537443191|FG004|Overall Study|Withdrawal by Subject|2|||
148990936|NCT04579757|537443192|FG005|Overall Study|Withdrawal by Subject|1|||
149030684|NCT00813488|537589693|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
148990937|NCT04579757|537443193|FG006|Overall Study|Withdrawal by Subject|0|||
149030685|NCT00813488|537589692|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
148990938|NCT04579757|537443194|FG007|Overall Study|Withdrawal by Subject|3|||
148990939|NCT04579757|537443195|FG008|Overall Study|Withdrawal by Subject|0|||
148990940|NCT04579757|537443187|FG000|Overall Study|Radiological or Clinical PD|1|||
148990941|NCT04579757|537443188|FG001|Overall Study|Radiological or Clinical PD|4|||
148990942|NCT04579757|537443189|FG002|Overall Study|Radiological or Clinical PD|1|||
148990943|NCT04579757|537443190|FG003|Overall Study|Radiological or Clinical PD|3|||
148990944|NCT04579757|537443191|FG004|Overall Study|Radiological or Clinical PD|9|||
148990945|NCT04579757|537443192|FG005|Overall Study|Radiological or Clinical PD|4|||
148990946|NCT04579757|537443193|FG006|Overall Study|Radiological or Clinical PD|2|||
148990947|NCT04579757|537443194|FG007|Overall Study|Radiological or Clinical PD|2|||
148990948|NCT04579757|537443195|FG008|Overall Study|Radiological or Clinical PD|0|||
148990949|NCT04579757|537443187|FG000|Overall Study|Start of New Therapy|0|||
148990950|NCT04579757|537443188|FG001|Overall Study|Start of New Therapy|0|||
148990951|NCT04579757|537443189|FG002|Overall Study|Start of New Therapy|0|||
148990952|NCT04579757|537443190|FG003|Overall Study|Start of New Therapy|0|||
148990953|NCT04579757|537443191|FG004|Overall Study|Start of New Therapy|2|||
148990954|NCT04579757|537443192|FG005|Overall Study|Start of New Therapy|1|||
148990955|NCT04579757|537443193|FG006|Overall Study|Start of New Therapy|0|||
148990956|NCT04579757|537443194|FG007|Overall Study|Start of New Therapy|0|||
148990957|NCT04579757|537443195|FG008|Overall Study|Start of New Therapy|0|||
148990958|NCT02008890|537443196|FG000|Period 1|Withdrawal by Subject|7|||
148990959|NCT02008890|537443197|FG001|Period 1|Withdrawal by Subject|7|||
148990960|NCT02008890|537443198|FG002|Period 1|Withdrawal by Subject|5|||
148990961|NCT02008890|537443199|FG003|Period 1|Withdrawal by Subject|0|||
148990962|NCT02008890|537443200|FG004|Period 1|Withdrawal by Subject|0|||
148990963|NCT02008890|537443196|FG000|Period 1|Pregnancy|1|||
148990964|NCT02008890|537443197|FG001|Period 1|Pregnancy|0|||
148990965|NCT02008890|537443198|FG002|Period 1|Pregnancy|0|||
148990966|NCT02008890|537443199|FG003|Period 1|Pregnancy|0|||
148990967|NCT02008890|537443200|FG004|Period 1|Pregnancy|0|||
148990968|NCT02008890|537443196|FG000|Period 1|Physician Decision|1|||
148990969|NCT02008890|537443197|FG001|Period 1|Physician Decision|0|||
148990970|NCT02008890|537443198|FG002|Period 1|Physician Decision|1|||
148990971|NCT02008890|537443199|FG003|Period 1|Physician Decision|0|||
148990972|NCT02008890|537443200|FG004|Period 1|Physician Decision|0|||
148990973|NCT02008890|537443196|FG000|Period 1|Adverse Event|6|||
148990974|NCT02008890|537443197|FG001|Period 1|Adverse Event|8|||
148990975|NCT02008890|537443198|FG002|Period 1|Adverse Event|6|||
148990976|NCT02008890|537443199|FG003|Period 1|Adverse Event|0|||
148990977|NCT02008890|537443200|FG004|Period 1|Adverse Event|0|||
148990978|NCT02008890|537443196|FG000|Period 2|Adverse Event|12|||
148990979|NCT02008890|537443197|FG001|Period 2|Adverse Event|7|||
148990980|NCT02008890|537443198|FG002|Period 2|Adverse Event|0|||
148990981|NCT02008890|537443199|FG003|Period 2|Adverse Event|5|||
148990982|NCT02008890|537443200|FG004|Period 2|Adverse Event|5|||
148990983|NCT02008890|537443196|FG000|Period 2|Withdrawal by Subject|11|||
148990984|NCT02008890|537443197|FG001|Period 2|Withdrawal by Subject|8|||
148990985|NCT02008890|537443198|FG002|Period 2|Withdrawal by Subject|0|||
148990986|NCT02008890|537443199|FG003|Period 2|Withdrawal by Subject|7|||
148990987|NCT02008890|537443200|FG004|Period 2|Withdrawal by Subject|2|||
148990988|NCT02008890|537443196|FG000|Period 2|Physician Decision|4|||
148990989|NCT02008890|537443197|FG001|Period 2|Physician Decision|0|||
148990990|NCT02008890|537443198|FG002|Period 2|Physician Decision|0|||
148990991|NCT02008890|537443199|FG003|Period 2|Physician Decision|2|||
148990992|NCT02008890|537443200|FG004|Period 2|Physician Decision|1|||
148990993|NCT02008890|537443196|FG000|Period 2|Lost to Follow-up|0|||
148990994|NCT02008890|537443197|FG001|Period 2|Lost to Follow-up|0|||
148990995|NCT02008890|537443198|FG002|Period 2|Lost to Follow-up|1|||
148990996|NCT02008890|537443199|FG003|Period 2|Lost to Follow-up|0|||
148990997|NCT02008890|537443200|FG004|Period 2|Lost to Follow-up|0|||
148990998|NCT02008890|537443196|FG000|Extension Period|Withdrawal by Subject|3|||
148990999|NCT02008890|537443197|FG001|Extension Period|Withdrawal by Subject|2|||
148991000|NCT02008890|537443198|FG002|Extension Period|Withdrawal by Subject|0|||
148991001|NCT02008890|537443199|FG003|Extension Period|Withdrawal by Subject|4|||
148991002|NCT02008890|537443200|FG004|Extension Period|Withdrawal by Subject|2|||
148991003|NCT02008890|537443196|FG000|Extension Period|Lost to Follow-up|1|||
148991004|NCT02008890|537443197|FG001|Extension Period|Lost to Follow-up|0|||
148991005|NCT02008890|537443198|FG002|Extension Period|Lost to Follow-up|0|||
148991006|NCT02008890|537443199|FG003|Extension Period|Lost to Follow-up|0|||
148991007|NCT02008890|537443200|FG004|Extension Period|Lost to Follow-up|0|||
148991008|NCT02008890|537443196|FG000|Extension Period|Adverse Event|1|||
148857502|NCT02743949|536953212|FG001|Overall Study|Voluntary Withdrawal|1|||
148857503|NCT02743949|536953213|FG002|Overall Study|Voluntary Withdrawal|0|||
148991009|NCT02008890|537443197|FG001|Extension Period|Adverse Event|3|||
148991010|NCT02008890|537443198|FG002|Extension Period|Adverse Event|0|||
148857504|NCT02928029|536953224|FG000|Overall Study|Withdrawal by Subject|0|||
148991011|NCT02008890|537443199|FG003|Extension Period|Adverse Event|0|||
148991012|NCT02008890|537443200|FG004|Extension Period|Adverse Event|2|||
148991013|NCT02332720|537443201|FG000|Part A and Part B|Lost to Follow-up|1|||
148857505|NCT02928029|536953225|FG001|Overall Study|Withdrawal by Subject|1|||
148857506|NCT02928029|536953224|FG000|Overall Study|Radiological progression|1|||
148991014|NCT02332720|537443202|FG001|Part A and Part B|Lost to Follow-up|0|||
148991015|NCT02332720|537443203|FG002|Part A and Part B|Lost to Follow-up|0|||
148991016|NCT02332720|537443204|FG003|Part A and Part B|Lost to Follow-up|0|||
148991017|NCT02332720|537443205|FG004|Part A and Part B|Lost to Follow-up|0|||
148991018|NCT02332720|537443206|FG005|Part A and Part B|Lost to Follow-up|2|||
148991019|NCT02332720|537443207|FG006|Part A and Part B|Lost to Follow-up|1|||
148991020|NCT02332720|537443208|FG007|Part A and Part B|Lost to Follow-up|1|||
148991021|NCT02332720|537443209|FG008|Part A and Part B|Lost to Follow-up|0|||
148991022|NCT02332720|537443210|FG009|Part A and Part B|Lost to Follow-up|0|||
148991023|NCT02332720|537443211|FG010|Part A and Part B|Lost to Follow-up|0|||
148857507|NCT02928029|536953225|FG001|Overall Study|Radiological progression|0|||
148857508|NCT02928029|536953224|FG000|Overall Study|Clinical progression|1|||
148857509|NCT02928029|536953225|FG001|Overall Study|Clinical progression|2|||
148857510|NCT02928029|536953224|FG000|Overall Study|AE not related to clinical progression|1|||
148857511|NCT02928029|536953225|FG001|Overall Study|AE not related to clinical progression|1|||
148857512|NCT01639339|536953236|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
148857513|NCT01639339|536953237|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
148857514|NCT01639339|536953236|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
148857515|NCT01639339|536953237|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
148857516|NCT01639339|536953236|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
148857517|NCT01639339|536953237|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
148857518|NCT01639339|536953236|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
148857519|NCT01639339|536953237|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
148857520|NCT01639339|536953236|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
148857521|NCT01639339|536953237|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
148857522|NCT01639339|536953236|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
148857523|NCT01639339|536953237|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
148857524|NCT01639339|536953236|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
148857525|NCT01639339|536953237|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
148857526|NCT01639339|536953236|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
148857527|NCT01639339|536953237|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
148857528|NCT01639339|536953236|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
148857529|NCT01639339|536953237|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
148857530|NCT01639339|536953236|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
148857531|NCT01639339|536953237|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
148857532|NCT02649218|536953238|FG000|Overall Study|Adverse Event|8|||
148857533|NCT02649218|536953238|FG000|Overall Study|Lack of Efficacy|8|||
148857534|NCT02649218|536953238|FG000|Overall Study|Pregnancy|3|||
148857535|NCT02649218|536953238|FG000|Overall Study|Protocol Violation|3|||
148857536|NCT02649218|536953238|FG000|Overall Study|Physician Decision|1|||
148857537|NCT02649218|536953238|FG000|Overall Study|Withdrawal by Subject|2|||
148857538|NCT00367744|536953239|FG000|Overall Study|Lost to Follow-up|4|||
148857539|NCT00367744|536953240|FG001|Overall Study|Lost to Follow-up|5|||
148857540|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
148857541|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148857542|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148857543|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148857544|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148857545|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
148857546|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
148857547|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
148857548|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148857549|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148857550|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148857551|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
148857552|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
148857553|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
148857554|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
148857555|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
148857556|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
148857557|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
148857558|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
148857559|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
148857560|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148857561|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148857562|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148857563|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
148857564|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
148857565|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
148857566|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
148857567|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
148857568|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
148857569|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
148857570|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
148857571|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
148889242|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
148991024|NCT02332720|537443212|FG011|Part A and Part B|Lost to Follow-up|0|||
148991025|NCT02332720|537443213|FG012|Part A and Part B|Lost to Follow-up|0|||
148991026|NCT02332720|537443214|FG013|Part A and Part B|Lost to Follow-up|0|||
148991027|NCT02332720|537443215|FG014|Part A and Part B|Lost to Follow-up|0|||
148991028|NCT02332720|537443216|FG015|Part A and Part B|Lost to Follow-up|1|||
148991029|NCT02332720|537443217|FG016|Part A and Part B|Lost to Follow-up|0|||
148991030|NCT02332720|537443218|FG017|Part A and Part B|Lost to Follow-up|0|||
148991031|NCT02332720|537443219|FG018|Part A and Part B|Lost to Follow-up|0|||
148991032|NCT02332720|537443220|FG019|Part A and Part B|Lost to Follow-up|0|||
148991033|NCT02332720|537443221|FG020|Part A and Part B|Lost to Follow-up|0|||
148991034|NCT02332720|537443222|FG021|Part A and Part B|Lost to Follow-up|0|||
148991035|NCT02332720|537443223|FG022|Part A and Part B|Lost to Follow-up|0|||
148991036|NCT02332720|537443201|FG000|Part A and Part B|Adverse Event|0|||
148991037|NCT02332720|537443202|FG001|Part A and Part B|Adverse Event|0|||
148991038|NCT02332720|537443203|FG002|Part A and Part B|Adverse Event|0|||
148991039|NCT02332720|537443204|FG003|Part A and Part B|Adverse Event|0|||
148991040|NCT02332720|537443205|FG004|Part A and Part B|Adverse Event|0|||
148991041|NCT02332720|537443206|FG005|Part A and Part B|Adverse Event|0|||
148991042|NCT02332720|537443207|FG006|Part A and Part B|Adverse Event|0|||
148991043|NCT02332720|537443208|FG007|Part A and Part B|Adverse Event|0|||
148991044|NCT02332720|537443209|FG008|Part A and Part B|Adverse Event|0|||
148991045|NCT02332720|537443210|FG009|Part A and Part B|Adverse Event|0|||
148991046|NCT02332720|537443211|FG010|Part A and Part B|Adverse Event|0|||
148991047|NCT02332720|537443212|FG011|Part A and Part B|Adverse Event|0|||
148991048|NCT02332720|537443213|FG012|Part A and Part B|Adverse Event|0|||
148991049|NCT02332720|537443214|FG013|Part A and Part B|Adverse Event|0|||
148991050|NCT02332720|537443215|FG014|Part A and Part B|Adverse Event|0|||
148991051|NCT02332720|537443216|FG015|Part A and Part B|Adverse Event|0|||
148991052|NCT02332720|537443217|FG016|Part A and Part B|Adverse Event|0|||
148991053|NCT02332720|537443218|FG017|Part A and Part B|Adverse Event|1|||
148991054|NCT02332720|537443219|FG018|Part A and Part B|Adverse Event|0|||
148991055|NCT02332720|537443220|FG019|Part A and Part B|Adverse Event|0|||
148991056|NCT02332720|537443221|FG020|Part A and Part B|Adverse Event|0|||
148991057|NCT02332720|537443222|FG021|Part A and Part B|Adverse Event|0|||
148991058|NCT02332720|537443223|FG022|Part A and Part B|Adverse Event|0|||
148991059|NCT02332720|537443201|FG000|Part A and Part B|Physician Decision|0|||
148991060|NCT02332720|537443202|FG001|Part A and Part B|Physician Decision|0|||
148991061|NCT02332720|537443203|FG002|Part A and Part B|Physician Decision|0|||
148991062|NCT02332720|537443204|FG003|Part A and Part B|Physician Decision|0|||
148991063|NCT02332720|537443205|FG004|Part A and Part B|Physician Decision|0|||
148991064|NCT02332720|537443206|FG005|Part A and Part B|Physician Decision|0|||
148991065|NCT02332720|537443207|FG006|Part A and Part B|Physician Decision|0|||
148991066|NCT02332720|537443208|FG007|Part A and Part B|Physician Decision|0|||
148991067|NCT02332720|537443209|FG008|Part A and Part B|Physician Decision|0|||
148991068|NCT02332720|537443210|FG009|Part A and Part B|Physician Decision|0|||
148991069|NCT02332720|537443211|FG010|Part A and Part B|Physician Decision|0|||
148991070|NCT02332720|537443212|FG011|Part A and Part B|Physician Decision|0|||
148991071|NCT02332720|537443213|FG012|Part A and Part B|Physician Decision|0|||
148991072|NCT02332720|537443214|FG013|Part A and Part B|Physician Decision|0|||
148991073|NCT02332720|537443215|FG014|Part A and Part B|Physician Decision|0|||
148991074|NCT02332720|537443216|FG015|Part A and Part B|Physician Decision|0|||
148991075|NCT02332720|537443217|FG016|Part A and Part B|Physician Decision|0|||
148991076|NCT02332720|537443218|FG017|Part A and Part B|Physician Decision|0|||
148991077|NCT02332720|537443219|FG018|Part A and Part B|Physician Decision|1|||
148991078|NCT02332720|537443220|FG019|Part A and Part B|Physician Decision|0|||
148991079|NCT02332720|537443221|FG020|Part A and Part B|Physician Decision|0|||
148991080|NCT02332720|537443222|FG021|Part A and Part B|Physician Decision|0|||
148991081|NCT02332720|537443223|FG022|Part A and Part B|Physician Decision|0|||
148991082|NCT02332720|537443201|FG000|Part A and Part B|Withdrawal by Subject|0|||
148991083|NCT02332720|537443202|FG001|Part A and Part B|Withdrawal by Subject|0|||
148991084|NCT02332720|537443203|FG002|Part A and Part B|Withdrawal by Subject|0|||
148991085|NCT02332720|537443204|FG003|Part A and Part B|Withdrawal by Subject|0|||
148991086|NCT02332720|537443205|FG004|Part A and Part B|Withdrawal by Subject|0|||
148991087|NCT02332720|537443206|FG005|Part A and Part B|Withdrawal by Subject|1|||
148991088|NCT02332720|537443207|FG006|Part A and Part B|Withdrawal by Subject|0|||
148991089|NCT02332720|537443208|FG007|Part A and Part B|Withdrawal by Subject|0|||
148991090|NCT02332720|537443209|FG008|Part A and Part B|Withdrawal by Subject|0|||
148991091|NCT02332720|537443210|FG009|Part A and Part B|Withdrawal by Subject|0|||
148991092|NCT02332720|537443211|FG010|Part A and Part B|Withdrawal by Subject|0|||
148991093|NCT02332720|537443212|FG011|Part A and Part B|Withdrawal by Subject|0|||
148991094|NCT02332720|537443213|FG012|Part A and Part B|Withdrawal by Subject|0|||
148991095|NCT02332720|537443214|FG013|Part A and Part B|Withdrawal by Subject|0|||
148991096|NCT02332720|537443215|FG014|Part A and Part B|Withdrawal by Subject|0|||
148991097|NCT02332720|537443216|FG015|Part A and Part B|Withdrawal by Subject|0|||
148991098|NCT02332720|537443217|FG016|Part A and Part B|Withdrawal by Subject|0|||
148991099|NCT02332720|537443218|FG017|Part A and Part B|Withdrawal by Subject|0|||
148991100|NCT02332720|537443219|FG018|Part A and Part B|Withdrawal by Subject|0|||
148857572|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
148857573|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
148857574|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
148857575|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
148857576|NCT03989349|536953250|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
148857577|NCT03989349|536953251|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
148857578|NCT03989349|536953252|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
148857579|NCT03989349|536953253|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
148857580|NCT03989349|536953254|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
148857581|NCT03989349|536953255|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
148857582|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
148857583|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
148857584|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
148857585|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
148857586|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
148857587|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
148857588|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
148857589|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
148857590|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
148857591|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
148857592|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
148857593|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
148857594|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
148857595|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
148857596|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
148857597|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
148857598|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
148857599|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
148857600|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148857601|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148857602|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
148857603|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148857604|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
148857605|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
148857606|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
148857607|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
148857608|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
148857609|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
148857610|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
148857611|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
148857612|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
148857613|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
148857614|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
148857615|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
148857616|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
148857617|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
148857618|NCT03989349|536953250|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
148857619|NCT03989349|536953251|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
148857620|NCT03989349|536953252|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
148857621|NCT03989349|536953253|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
148857622|NCT03989349|536953254|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
148857623|NCT03989349|536953255|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
148857624|NCT02438683|536953258|FG000|Overall Study|Adverse Event|1|||
148857625|NCT02438683|536953259|FG001|Overall Study|Adverse Event|0|||
148857626|NCT02438683|536953260|FG002|Overall Study|Adverse Event|0|||
148857627|NCT02438683|536953261|FG003|Overall Study|Adverse Event|0|||
148857628|NCT02438683|536953262|FG004|Overall Study|Adverse Event|0|||
148991101|NCT02332720|537443220|FG019|Part A and Part B|Withdrawal by Subject|1|||
148991102|NCT02332720|537443221|FG020|Part A and Part B|Withdrawal by Subject|0|||
148991103|NCT02332720|537443222|FG021|Part A and Part B|Withdrawal by Subject|0|||
148991104|NCT02332720|537443223|FG022|Part A and Part B|Withdrawal by Subject|0|||
148991105|NCT02207816|537443224|FG000|Overall Study|Serious Adverse Event|0|||
148991106|NCT02207816|537443225|FG001|Overall Study|Serious Adverse Event|5|||
148991107|NCT02207816|537443226|FG002|Overall Study|Serious Adverse Event|2|||
148857629|NCT02438683|536953263|FG005|Overall Study|Adverse Event|0|||
148857630|NCT01846299|536953268|FG000|Overall Study|Physician Decision|4|||
148857631|NCT01846299|536953269|FG001|Overall Study|Physician Decision|2|||
148857632|NCT01846299|536953268|FG000|Overall Study|Protocol deviation|1|||
148857633|NCT01846299|536953269|FG001|Overall Study|Protocol deviation|0|||
148857634|NCT01846299|536953268|FG000|Overall Study|Death|1|||
148857635|NCT01846299|536953269|FG001|Overall Study|Death|2|||
148857636|NCT01846299|536953268|FG000|Overall Study|Lost to Follow-up|3|||
148857637|NCT01846299|536953269|FG001|Overall Study|Lost to Follow-up|0|||
148857638|NCT01846299|536953268|FG000|Overall Study|Withdrawal by Subject|1|||
148857639|NCT01846299|536953269|FG001|Overall Study|Withdrawal by Subject|6|||
148857640|NCT01846299|536953268|FG000|Overall Study|Adverse Event|2|||
148857641|NCT01846299|536953269|FG001|Overall Study|Adverse Event|0|||
148857642|NCT00082368|536953270|FG000|Overall Study|Not treated-pt had poor IV access|1|||
148857643|NCT03559517|536953271|FG000|Overall Study|Withdrawal by Subject|1|||
148857644|NCT03559517|536953272|FG001|Overall Study|Withdrawal by Subject|0|||
148857645|NCT03559517|536953273|FG002|Overall Study|Withdrawal by Subject|0|||
148857646|NCT01330628|536953274|FG000|Overall Study|Death|2|||
148857647|NCT01330628|536953275|FG001|Overall Study|Death|3|||
148857648|NCT01330628|536953274|FG000|Overall Study|Lost to Follow-up|5|||
148857649|NCT01330628|536953275|FG001|Overall Study|Lost to Follow-up|6|||
148857650|NCT01330628|536953274|FG000|Overall Study|Adverse Event|44|||
148857651|NCT01330628|536953275|FG001|Overall Study|Adverse Event|25|||
148857652|NCT01330628|536953274|FG000|Overall Study|Withdrawn|18|||
148857653|NCT01330628|536953275|FG001|Overall Study|Withdrawn|6|||
148857654|NCT01330628|536953274|FG000|Overall Study|Didn't receive study treatment|1|||
148857655|NCT01330628|536953275|FG001|Overall Study|Didn't receive study treatment|0|||
148857656|NCT03285958|536955891|FG000|Overall Study|Lost to Follow-up|1|||
148857657|NCT03285958|536955892|FG001|Overall Study|Lost to Follow-up|1|||
148857658|NCT03285958|536955891|FG000|Overall Study|Withdrawal by Subject|1|||
148857659|NCT03285958|536955892|FG001|Overall Study|Withdrawal by Subject|0|||
148857660|NCT03285958|536955891|FG000|Overall Study|Not able to attend required orientation|3|||
148857661|NCT03285958|536955892|FG001|Overall Study|Not able to attend required orientation|0|||
148857662|NCT03116828|536955893|FG000|Overall Study|Adverse Event|1|||
148857663|NCT03116828|536955894|FG001|Overall Study|Adverse Event|10|||
148857664|NCT03116828|536955893|FG000|Overall Study|Withdrawal by Subject|4|||
148857665|NCT03116828|536955894|FG001|Overall Study|Withdrawal by Subject|8|||
148857666|NCT03116828|536955893|FG000|Overall Study|OTHER|3|||
148857667|NCT03116828|536955894|FG001|Overall Study|OTHER|3|||
148857668|NCT05243745|536955895|FG000|Overall Study|Withdrawal by Subject|0|||
148857669|NCT05243745|536955896|FG001|Overall Study|Withdrawal by Subject|0|||
148857670|NCT05243745|536955897|FG002|Overall Study|Withdrawal by Subject|0|||
148857671|NCT05243745|536955898|FG003|Overall Study|Withdrawal by Subject|1|||
148857672|NCT05243745|536955895|FG000|Overall Study|Unable to Attend Visit 6|0|||
148857673|NCT05243745|536955896|FG001|Overall Study|Unable to Attend Visit 6|0|||
148857674|NCT05243745|536955897|FG002|Overall Study|Unable to Attend Visit 6|1|||
148857675|NCT05243745|536955898|FG003|Overall Study|Unable to Attend Visit 6|0|||
148857676|NCT02998203|536955899|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
148857677|NCT02998203|536955900|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
148857678|NCT02998203|536955899|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
148857679|NCT02998203|536955900|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
148857680|NCT04187144|536955911|FG000|Overall Study|Lost to Follow-up|12|||
148857681|NCT04187144|536955912|FG001|Overall Study|Lost to Follow-up|11|||
148857682|NCT04187144|536955911|FG000|Overall Study|Withdrawal by Subject|20|||
148857683|NCT04187144|536955912|FG001|Overall Study|Withdrawal by Subject|18|||
148857684|NCT04187144|536955911|FG000|Overall Study|Adverse Event|19|||
148857685|NCT04187144|536955912|FG001|Overall Study|Adverse Event|4|||
148857686|NCT04187144|536955911|FG000|Overall Study|Physician Decision|5|||
148857687|NCT04187144|536955912|FG001|Overall Study|Physician Decision|3|||
148857688|NCT04187144|536955911|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
148857689|NCT04187144|536955912|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
148857690|NCT04187144|536955911|FG000|Overall Study|Protocol Deviation|1|||
148857691|NCT04187144|536955912|FG001|Overall Study|Protocol Deviation|4|||
148857692|NCT02264665|536955913|FG000|Overall Study|Other|0|||
148857693|NCT02264665|536955914|FG001|Overall Study|Other|0|||
148857694|NCT02264665|536955915|FG002|Overall Study|Other|3|||
148857695|NCT02264665|536955916|FG003|Overall Study|Other|0|||
148857696|NCT02264665|536955917|FG004|Overall Study|Other|0|||
148857697|NCT02264665|536955918|FG005|Overall Study|Other|0|||
148857698|NCT02264665|536955919|FG006|Overall Study|Other|0|||
148857699|NCT02264665|536955913|FG000|Overall Study|Death|9|||
148857700|NCT02264665|536955914|FG001|Overall Study|Death|8|||
148857701|NCT02264665|536955915|FG002|Overall Study|Death|13|||
148857702|NCT02264665|536955916|FG003|Overall Study|Death|5|||
148857703|NCT02264665|536955917|FG004|Overall Study|Death|0|||
148857704|NCT02264665|536955918|FG005|Overall Study|Death|0|||
148857705|NCT02264665|536955919|FG006|Overall Study|Death|1|||
148857706|NCT02264665|536955913|FG000|Overall Study|Lost to Follow-up|1|||
148857707|NCT02264665|536955914|FG001|Overall Study|Lost to Follow-up|0|||
148991108|NCT02207816|537443224|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
148991109|NCT02207816|537443225|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
148991110|NCT02207816|537443226|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
148991111|NCT02207816|537443224|FG000|Overall Study|Withdrawal by Subject|4|||
148991112|NCT02207816|537443225|FG001|Overall Study|Withdrawal by Subject|9|||
148991113|NCT02207816|537443226|FG002|Overall Study|Withdrawal by Subject|7|||
148991114|NCT02207816|537443224|FG000|Overall Study|Migrated/Moved From Study Area|41|||
148991115|NCT02207816|537443225|FG001|Overall Study|Migrated/Moved From Study Area|60|||
148991116|NCT02207816|537443226|FG002|Overall Study|Migrated/Moved From Study Area|51|||
148991117|NCT02207816|537443224|FG000|Overall Study|Lost to Follow-up|3|||
148991118|NCT02207816|537443225|FG001|Overall Study|Lost to Follow-up|9|||
148991119|NCT02207816|537443226|FG002|Overall Study|Lost to Follow-up|1|||
148991120|NCT02207816|537443224|FG000|Overall Study|Other|1|||
148991121|NCT02207816|537443225|FG001|Overall Study|Other|2|||
148991122|NCT02207816|537443226|FG002|Overall Study|Other|4|||
148991123|NCT02473952|537443233|FG000|Overall Study|Adverse Event|2|||
148991124|NCT02473952|537443234|FG001|Overall Study|Adverse Event|2|||
148991125|NCT02473952|537443233|FG000|Overall Study|Withdrawal by Subject|0|||
148991126|NCT02473952|537443234|FG001|Overall Study|Withdrawal by Subject|6|||
148991127|NCT00237744|537443238|FG000|Overall Study|Withdrawal by Subject|3|||
148991128|NCT00237744|537443239|FG001|Overall Study|Withdrawal by Subject|1|||
148991129|NCT00237744|537443240|FG002|Overall Study|Withdrawal by Subject|0|||
148991130|NCT04955639|537443241|FG000|Overall Study|Withdrawal by Subject|2|||
148991131|NCT04955639|537443242|FG001|Overall Study|Withdrawal by Subject|2|||
148991132|NCT04955639|537443241|FG000|Overall Study|Week 26 survey not completed|2|||
148991133|NCT04955639|537443242|FG001|Overall Study|Week 26 survey not completed|2|||
148991134|NCT01369342|537443243|FG000|Overall Study|Withdrawal by Subject|7|||
148991135|NCT01369342|537443244|FG001|Overall Study|Withdrawal by Subject|7|||
148991136|NCT01369342|537443245|FG002|Overall Study|Withdrawal by Subject|2|||
148991137|NCT01369342|537443243|FG000|Overall Study|Lost to Follow-up|5|||
148991138|NCT01369342|537443244|FG001|Overall Study|Lost to Follow-up|2|||
148991139|NCT01369342|537443245|FG002|Overall Study|Lost to Follow-up|1|||
148991140|NCT01369342|537443243|FG000|Overall Study|Not Treated|1|||
148991141|NCT01369342|537443244|FG001|Overall Study|Not Treated|0|||
148991142|NCT01369342|537443245|FG002|Overall Study|Not Treated|0|||
148991143|NCT03204279|537443249|FG000|Overall Study|Withdrawal by Subject|0|||
148991144|NCT03204279|537443250|FG001|Overall Study|Withdrawal by Subject|1|||
148991145|NCT01064739|537443251|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
148991146|NCT04258020|537443254|FG000|Overall Study|Withdrawal by Subject|1|||
148991147|NCT04258020|537443255|FG001|Overall Study|Withdrawal by Subject|0|||
148991148|NCT02097472|537443256|FG000|Received Vaccination 2|Adverse Event|0|||
148991149|NCT02097472|537443257|FG001|Received Vaccination 2|Adverse Event|0|||
148991150|NCT02097472|537443258|FG002|Received Vaccination 2|Adverse Event|0|||
148991151|NCT02097472|537443259|FG003|Received Vaccination 2|Adverse Event|0|||
148991152|NCT02097472|537443260|FG004|Received Vaccination 2|Adverse Event|0|||
148991153|NCT02097472|537443261|FG005|Received Vaccination 2|Adverse Event|0|||
148991154|NCT02097472|537443262|FG006|Received Vaccination 2|Adverse Event|1|||
148991155|NCT02097472|537443263|FG007|Received Vaccination 2|Adverse Event|0|||
148991156|NCT04004611|537443264|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991157|NCT04004611|537443265|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991158|NCT04004611|537443266|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991159|NCT04004611|537443267|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991160|NCT04004611|537443268|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991161|NCT04004611|537443269|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991162|NCT04004611|537443270|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991163|NCT04004611|537443271|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
148991164|NCT04004611|537443272|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
148991165|NCT04004611|537443264|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
148991166|NCT04004611|537443265|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
148991167|NCT04004611|537443266|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
148991168|NCT04004611|537443267|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
148991169|NCT04004611|537443268|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
148991170|NCT04004611|537443269|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
148857708|NCT02264665|536955915|FG002|Overall Study|Lost to Follow-up|2|||
148991171|NCT04004611|537443270|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
148857709|NCT02264665|536955916|FG003|Overall Study|Lost to Follow-up|1|||
148857710|NCT02264665|536955917|FG004|Overall Study|Lost to Follow-up|0|||
148857711|NCT02264665|536955918|FG005|Overall Study|Lost to Follow-up|0|||
148991172|NCT04004611|537443271|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
148991173|NCT04004611|537443272|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
148991174|NCT04004611|537443264|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991175|NCT04004611|537443265|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
149030686|NCT00813488|537589693|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
149030687|NCT00813488|537589692|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
148857712|NCT02264665|536955919|FG006|Overall Study|Lost to Follow-up|0|||
148857713|NCT02264665|536955913|FG000|Overall Study|Participant decision|0|||
148857714|NCT02264665|536955914|FG001|Overall Study|Participant decision|0|||
148857715|NCT02264665|536955915|FG002|Overall Study|Participant decision|0|||
148857716|NCT02264665|536955916|FG003|Overall Study|Participant decision|1|||
148857717|NCT02264665|536955917|FG004|Overall Study|Participant decision|0|||
148857718|NCT02264665|536955918|FG005|Overall Study|Participant decision|0|||
148857719|NCT02264665|536955919|FG006|Overall Study|Participant decision|0|||
148857720|NCT02264665|536955913|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
148857721|NCT02264665|536955914|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
148857722|NCT02264665|536955915|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
148857723|NCT02264665|536955916|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
148857724|NCT02264665|536955917|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
148857725|NCT02264665|536955918|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
148857726|NCT02264665|536955919|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
148857727|NCT02264665|536955913|FG000|Overall Study|Data Missing|0|||
148857728|NCT02264665|536955914|FG001|Overall Study|Data Missing|0|||
148857729|NCT02264665|536955915|FG002|Overall Study|Data Missing|1|||
148857730|NCT02264665|536955916|FG003|Overall Study|Data Missing|0|||
148857731|NCT02264665|536955917|FG004|Overall Study|Data Missing|0|||
148857732|NCT02264665|536955918|FG005|Overall Study|Data Missing|0|||
148857733|NCT02264665|536955919|FG006|Overall Study|Data Missing|0|||
148857734|NCT00789581|536955920|FG000|AC Therapy|Adverse Event|2|||
148857735|NCT00789581|536955921|FG001|AC Therapy|Adverse Event|3|||
148857736|NCT00789581|536955920|FG000|AC Therapy|Withdrawal by Subject|4|||
148857737|NCT00789581|536955921|FG001|AC Therapy|Withdrawal by Subject|7|||
148857738|NCT00789581|536955920|FG000|AC Therapy|Disease recurrence|3|||
148857739|NCT00789581|536955921|FG001|AC Therapy|Disease recurrence|1|||
148857740|NCT00789581|536955920|FG000|AC Therapy|Intercurrent Illness|1|||
148857741|NCT00789581|536955921|FG001|AC Therapy|Intercurrent Illness|0|||
148857742|NCT00789581|536955920|FG000|AC Therapy|Never Treated|1|||
148857743|NCT00789581|536955921|FG001|AC Therapy|Never Treated|4|||
148857744|NCT00789581|536955920|FG000|AC Therapy|Other|0|||
148857745|NCT00789581|536955921|FG001|AC Therapy|Other|2|||
148857746|NCT00789581|536955920|FG000|Adjuvant Therapy|Never treated|2|||
148857747|NCT00789581|536955921|FG001|Adjuvant Therapy|Never treated|2|||
148857748|NCT00789581|536955920|FG000|Adjuvant Therapy|Adverse Event|20|||
148857749|NCT00789581|536955921|FG001|Adjuvant Therapy|Adverse Event|44|||
148857750|NCT00789581|536955920|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
148857751|NCT00789581|536955921|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
148857752|NCT00789581|536955920|FG000|Adjuvant Therapy|Disease recurrence|2|||
148857753|NCT00789581|536955921|FG001|Adjuvant Therapy|Disease recurrence|1|||
148857754|NCT00789581|536955920|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
148857755|NCT00789581|536955921|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
148857756|NCT00789581|536955920|FG000|Adjuvant Therapy|Protocol Violation|1|||
148857757|NCT00789581|536955921|FG001|Adjuvant Therapy|Protocol Violation|1|||
148857758|NCT00789581|536955920|FG000|Adjuvant Therapy|Other|0|||
148857759|NCT00789581|536955921|FG001|Adjuvant Therapy|Other|1|||
148857760|NCT03812185|536955925|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
148857761|NCT01681069|536955926|FG000|Overall Study|Withdrawal by Subject|4|||
148857762|NCT01681069|536955927|FG001|Overall Study|Withdrawal by Subject|5|||
148857763|NCT01681069|536955926|FG000|Overall Study|Protocol Violation|1|||
148857764|NCT01681069|536955927|FG001|Overall Study|Protocol Violation|1|||
148857765|NCT01681069|536955926|FG000|Overall Study|Adverse Event|0|||
148857766|NCT01681069|536955927|FG001|Overall Study|Adverse Event|1|||
148857767|NCT04085458|536955928|FG000|Overall Study|Other|1|||
148857768|NCT04085458|536955928|FG000|Overall Study|Withdrawal by Subject|2|||
148857769|NCT04085458|536955928|FG000|Overall Study|Adverse Event|2|||
148857770|NCT01921218|536955929|FG000|Overall Study|Death|2|||
148857771|NCT01921218|536955930|FG001|Overall Study|Death|1|||
148857772|NCT01921218|536955929|FG000|Overall Study|Withdrawal by Subject|0|||
148857773|NCT01921218|536955930|FG001|Overall Study|Withdrawal by Subject|2|||
148857774|NCT01921218|536955929|FG000|Overall Study|Kidney transplant|1|||
148857775|NCT01921218|536955930|FG001|Overall Study|Kidney transplant|1|||
148857776|NCT03389555|536955931|FG000|Overall Study|Protocol Violation|1|||
148857777|NCT03389555|536955932|FG001|Overall Study|Protocol Violation|3|||
148857778|NCT03389555|536955931|FG000|Overall Study|Death|1|||
148857779|NCT03389555|536955932|FG001|Overall Study|Death|0|||
148857780|NCT01885208|536955933|FG000|Overall Study|Unclassified|32|||
148857781|NCT01885208|536955934|FG001|Overall Study|Unclassified|38|||
148857782|NCT00920218|536955935|FG000|Overall Study|Serious Adverse Event|2|||
148857783|NCT00920218|536955936|FG001|Overall Study|Serious Adverse Event|0|||
148857784|NCT00920218|536955937|FG002|Overall Study|Serious Adverse Event|2|||
148857785|NCT00920218|536955938|FG003|Overall Study|Serious Adverse Event|1|||
148857786|NCT00920218|536955935|FG000|Overall Study|Withdrawal by Subject|0|||
148857787|NCT00920218|536955936|FG001|Overall Study|Withdrawal by Subject|3|||
148857788|NCT00920218|536955937|FG002|Overall Study|Withdrawal by Subject|2|||
148991176|NCT04004611|537443266|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991177|NCT04004611|537443267|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991178|NCT04004611|537443268|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
148991179|NCT04004611|537443269|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991180|NCT04004611|537443270|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991181|NCT04004611|537443271|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991182|NCT04004611|537443272|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
148991183|NCT04004611|537443264|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
148991184|NCT04004611|537443265|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
148991185|NCT04004611|537443266|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
148991186|NCT04004611|537443267|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
148991187|NCT04004611|537443268|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
148991188|NCT04004611|537443269|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
148991189|NCT04004611|537443270|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
148991190|NCT04004611|537443271|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
148991191|NCT04004611|537443272|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
148991192|NCT04004611|537443264|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
148991193|NCT04004611|537443265|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991194|NCT04004611|537443266|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
148991195|NCT04004611|537443267|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991196|NCT04004611|537443268|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991197|NCT04004611|537443269|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991198|NCT04004611|537443270|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991199|NCT04004611|537443271|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991200|NCT04004611|537443272|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
148991201|NCT04004611|537443264|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991202|NCT04004611|537443265|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
148991203|NCT04004611|537443266|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991204|NCT04004611|537443267|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991205|NCT04004611|537443268|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991206|NCT04004611|537443269|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991207|NCT04004611|537443270|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991208|NCT04004611|537443271|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991209|NCT04004611|537443272|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
148991210|NCT03834779|537443278|FG000|Overall Study|Death|1|||
148991211|NCT03834779|537443279|FG001|Overall Study|Death|2|||
148991212|NCT03834779|537443278|FG000|Overall Study|Lost to Follow-up|6|||
148991213|NCT03834779|537443279|FG001|Overall Study|Lost to Follow-up|4|||
148991214|NCT01059565|537443284|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
148991215|NCT01059565|537443285|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
148991216|NCT01059565|537443284|FG000|24-Week Randomized Phase|Adverse Event|5|||
148991217|NCT01059565|537443285|FG001|24-Week Randomized Phase|Adverse Event|0|||
148991218|NCT01059565|537443284|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
148991219|NCT01059565|537443285|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
148991220|NCT01059565|537443284|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
148991221|NCT01059565|537443285|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
148991222|NCT01059565|537443284|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
148991223|NCT01059565|537443285|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
148991224|NCT01059565|537443284|FG000|24-Week Open-Label Phase|Adverse Event|2|||
148991225|NCT01059565|537443285|FG001|24-Week Open-Label Phase|Adverse Event|0|||
148991226|NCT01059565|537443284|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
148991227|NCT01059565|537443285|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
148991228|NCT01059565|537443284|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
148991229|NCT01059565|537443285|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
148991230|NCT01059565|537443284|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
148991231|NCT01059565|537443285|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
148991232|NCT01059565|537443284|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
148991233|NCT01059565|537443285|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
148991234|NCT01059565|537443284|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
148857789|NCT00920218|536955938|FG003|Overall Study|Withdrawal by Subject|0|||
148857790|NCT00920218|536955935|FG000|Overall Study|Migrated/moved from study area|0|||
148857791|NCT00920218|536955936|FG001|Overall Study|Migrated/moved from study area|0|||
148857792|NCT00920218|536955937|FG002|Overall Study|Migrated/moved from study area|1|||
148857793|NCT00920218|536955938|FG003|Overall Study|Migrated/moved from study area|0|||
148857794|NCT00920218|536955935|FG000|Overall Study|Lost to Follow-up|0|||
148857795|NCT00920218|536955936|FG001|Overall Study|Lost to Follow-up|1|||
148991235|NCT01059565|537443285|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
148991236|NCT02864082|537443286|FG000|Overall Study|Adverse Event|1|||
148991237|NCT02864082|537443287|FG001|Overall Study|Adverse Event|1|||
148991238|NCT02864082|537443286|FG000|Overall Study|Lost to Follow-up|0|||
148991239|NCT02864082|537443287|FG001|Overall Study|Lost to Follow-up|1|||
148991240|NCT02864082|537443286|FG000|Overall Study|Withdrawal by Subject|2|||
148991241|NCT02864082|537443287|FG001|Overall Study|Withdrawal by Subject|2|||
148991242|NCT04139317|537443288|FG000|Overall Study|Adverse Event|10|||
148991243|NCT04139317|537443289|FG001|Overall Study|Adverse Event|2|||
148991244|NCT04139317|537443288|FG000|Overall Study|Death|6|||
148991245|NCT04139317|537443289|FG001|Overall Study|Death|4|||
148991246|NCT04139317|537443288|FG000|Overall Study|Lost to Follow-up|1|||
148991247|NCT04139317|537443289|FG001|Overall Study|Lost to Follow-up|0|||
148991248|NCT04139317|537443288|FG000|Overall Study|Physician Decision|3|||
148991249|NCT04139317|537443289|FG001|Overall Study|Physician Decision|1|||
148991250|NCT04139317|537443288|FG000|Overall Study|Progressive Disease|19|||
148991251|NCT04139317|537443289|FG001|Overall Study|Progressive Disease|9|||
148991252|NCT04139317|537443288|FG000|Overall Study|Subject Decision|2|||
148991253|NCT04139317|537443289|FG001|Overall Study|Subject Decision|2|||
148991254|NCT03621696|537443290|FG000|Overall Study|Not eligible|0|||
148991255|NCT03621696|537443291|FG001|Overall Study|Not eligible|0|||
148991256|NCT03621696|537443292|FG002|Overall Study|Not eligible|0|||
148991257|NCT03621696|537443293|FG003|Overall Study|Not eligible|5|||
148991258|NCT03621696|537443290|FG000|Overall Study|Withdrawal by Subject|1|||
148991259|NCT03621696|537443291|FG001|Overall Study|Withdrawal by Subject|1|||
148991260|NCT03621696|537443292|FG002|Overall Study|Withdrawal by Subject|1|||
148991261|NCT03621696|537443293|FG003|Overall Study|Withdrawal by Subject|0|||
148991262|NCT03621696|537443290|FG000|Overall Study|Physician Decision|0|||
148991263|NCT03621696|537443291|FG001|Overall Study|Physician Decision|0|||
148991264|NCT03621696|537443292|FG002|Overall Study|Physician Decision|1|||
148991265|NCT03621696|537443293|FG003|Overall Study|Physician Decision|0|||
148991266|NCT01618864|537443296|FG000|Overall Study|Withdrawal by Subject|2|||
148991267|NCT01618864|537443296|FG000|Overall Study|Lost to Follow-up|2|||
148991268|NCT05177770|537443297|FG000|Overall Study|Death|4|||
148991269|NCT05177770|537443297|FG000|Overall Study|Withdrawal by Subject|1|||
148991270|NCT05177770|537443297|FG000|Overall Study|Adverse Event prior to dosing|1|||
148991271|NCT01109992|537443298|FG000|Overall Study|Withdrawal by Subject|0|||
148991272|NCT01109992|537443299|FG001|Overall Study|Withdrawal by Subject|1|||
148991273|NCT01109992|537443298|FG000|Overall Study|Movement during rest scan.|0|||
148991274|NCT01109992|537443299|FG001|Overall Study|Movement during rest scan.|1|||
148991275|NCT00690755|537443300|FG000|Overall Study|Physician Decision|2|||
148857796|NCT00920218|536955937|FG002|Overall Study|Lost to Follow-up|0|||
148857797|NCT00920218|536955938|FG003|Overall Study|Lost to Follow-up|3|||
148857798|NCT00920218|536955935|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
148857799|NCT00920218|536955936|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
148857800|NCT00920218|536955937|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
148857801|NCT00920218|536955938|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
148857802|NCT00920218|536955935|FG000|Overall Study|Other|0|||
148857803|NCT00920218|536955936|FG001|Overall Study|Other|0|||
148857804|NCT00920218|536955937|FG002|Overall Study|Other|1|||
148857805|NCT00920218|536955938|FG003|Overall Study|Other|0|||
148857806|NCT00873041|536955939|FG000|Core Study|Adverse Event|2|||
148857807|NCT00873041|536955940|FG001|Core Study|Adverse Event|3|||
148857808|NCT00873041|536955941|FG002|Core Study|Adverse Event|1|||
148857809|NCT00873041|536955939|FG000|Core Study|Withdrawal by Subject|1|||
148857810|NCT00873041|536955940|FG001|Core Study|Withdrawal by Subject|2|||
148857811|NCT00873041|536955941|FG002|Core Study|Withdrawal by Subject|2|||
148857812|NCT00873041|536955939|FG000|Core Study|Lost to Follow-up|3|||
148857813|NCT00873041|536955940|FG001|Core Study|Lost to Follow-up|1|||
148857814|NCT00873041|536955941|FG002|Core Study|Lost to Follow-up|0|||
148857815|NCT00873041|536955939|FG000|Core Study|Abnormal laboratory value|0|||
148857816|NCT00873041|536955940|FG001|Core Study|Abnormal laboratory value|0|||
148857817|NCT00873041|536955941|FG002|Core Study|Abnormal laboratory value|1|||
148857818|NCT00873041|536955939|FG000|Core Study|Protocol deviation|1|||
148857819|NCT00873041|536955940|FG001|Core Study|Protocol deviation|0|||
148857820|NCT00873041|536955941|FG002|Core Study|Protocol deviation|1|||
148857821|NCT00873041|536955939|FG000|Extension Study|Adverse Event|1|||
148857822|NCT00873041|536955940|FG001|Extension Study|Adverse Event|0|||
148857823|NCT00873041|536955941|FG002|Extension Study|Adverse Event|1|||
148857824|NCT00873041|536955939|FG000|Extension Study|Administrative reasons|0|||
148857825|NCT00873041|536955940|FG001|Extension Study|Administrative reasons|0|||
148991276|NCT00690755|537443301|FG001|Overall Study|Physician Decision|0|||
148991277|NCT00690755|537443302|FG002|Overall Study|Physician Decision|46|||
148991278|NCT00690755|537443303|FG003|Overall Study|Physician Decision|5|||
148991279|NCT00690755|537443304|FG004|Overall Study|Physician Decision|0|||
148991280|NCT00690755|537443305|FG005|Overall Study|Physician Decision|4|||
148991281|NCT00690755|537443306|FG006|Overall Study|Physician Decision|0|||
148991282|NCT00214136|537443309|FG000|Overall Study|Death|5|||
148991283|NCT03585244|537443312|FG000|Overall Study|Withdrawal by Subject|15|||
148991284|NCT02105948|537443313|FG000|Overall Study|Adverse Event|10|||
148991285|NCT02105948|537443314|FG001|Overall Study|Adverse Event|7|||
148857826|NCT00873041|536955941|FG002|Extension Study|Administrative reasons|1|||
148857827|NCT00313313|536955942|FG000|Overall Study|Lack of Efficacy|14|||
148857828|NCT00313313|536955943|FG001|Overall Study|Lack of Efficacy|9|||
148857829|NCT00313313|536955944|FG002|Overall Study|Lack of Efficacy|20|||
148857830|NCT00313313|536955942|FG000|Overall Study|Withdrawal of consent by subject|18|||
148857831|NCT00313313|536955943|FG001|Overall Study|Withdrawal of consent by subject|17|||
148857832|NCT00313313|536955944|FG002|Overall Study|Withdrawal of consent by subject|31|||
148857833|NCT00313313|536955942|FG000|Overall Study|Lost to Follow-up|10|||
148857834|NCT00313313|536955943|FG001|Overall Study|Lost to Follow-up|7|||
148857835|NCT00313313|536955944|FG002|Overall Study|Lost to Follow-up|9|||
148857836|NCT00313313|536955942|FG000|Overall Study|Adverse Event|15|||
148857837|NCT00313313|536955943|FG001|Overall Study|Adverse Event|16|||
148857838|NCT00313313|536955944|FG002|Overall Study|Adverse Event|12|||
148857839|NCT00313313|536955942|FG000|Overall Study|Physician Decision|2|||
148857840|NCT00313313|536955943|FG001|Overall Study|Physician Decision|6|||
148857841|NCT00313313|536955944|FG002|Overall Study|Physician Decision|4|||
148857842|NCT00313313|536955942|FG000|Overall Study|Poor/Noncompliance|3|||
148857843|NCT00313313|536955943|FG001|Overall Study|Poor/Noncompliance|6|||
148857844|NCT00313313|536955944|FG002|Overall Study|Poor/Noncompliance|2|||
148857845|NCT00313313|536955942|FG000|Overall Study|Pregnancy|1|||
148857846|NCT00313313|536955943|FG001|Overall Study|Pregnancy|2|||
148857847|NCT00313313|536955944|FG002|Overall Study|Pregnancy|0|||
148857848|NCT00313313|536955942|FG000|Overall Study|Death|0|||
148857849|NCT00313313|536955943|FG001|Overall Study|Death|0|||
148857850|NCT00313313|536955944|FG002|Overall Study|Death|2|||
148857851|NCT00313313|536955942|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
148857852|NCT00313313|536955943|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
148857853|NCT00313313|536955944|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
148857854|NCT00368836|536955947|FG000|Phase II|Screen Failure|1|||
148857855|NCT00368836|536955947|FG000|Phase II|Withdrawal by Subject|1|||
148857856|NCT00368836|536955947|FG000|Phase II|unable to collect blood and/or breath|17|||
148857857|NCT00368836|536955947|FG000|Phase II|Protocol Violation|2|||
148857858|NCT01345591|536955952|FG000|Overall Study|Lost to Follow-up|1|||
148857859|NCT00090142|536955953|FG000|Treatment Period I|Lost to Follow-up|1|||
148857860|NCT00090142|536955954|FG001|Treatment Period I|Lost to Follow-up|2|||
148857861|NCT00090142|536955953|FG000|Treatment Period I|Protocol Violation|2|||
148857862|NCT00090142|536955954|FG001|Treatment Period I|Protocol Violation|0|||
148857863|NCT00090142|536955953|FG000|Treatment Period I|Withdrawal by Subject|2|||
148857864|NCT00090142|536955954|FG001|Treatment Period I|Withdrawal by Subject|0|||
148857865|NCT00090142|536955953|FG000|Treatment Period I|Other|0|||
148857866|NCT00090142|536955954|FG001|Treatment Period I|Other|1|||
148857867|NCT00090142|536955953|FG000|Treatment Period II|Other|1|||
148857868|NCT00090142|536955954|FG001|Treatment Period II|Other|0|||
148857869|NCT02442310|536955955|FG000|Overall Study|Adverse Event|2|||
148857870|NCT02442310|536955955|FG000|Overall Study|Withdrawal by Subject|1|||
148857871|NCT01126437|536955956|FG000|Overall Study|Not treated|11|||
148857872|NCT01126437|536955957|FG001|Overall Study|Not treated|18|||
148857873|NCT01126437|536955958|FG002|Overall Study|Not treated|19|||
148857874|NCT01126437|536955956|FG000|Overall Study|Sites with data irregularities/fraud|6|||
148857875|NCT01126437|536955957|FG001|Overall Study|Sites with data irregularities/fraud|6|||
148857876|NCT01126437|536955958|FG002|Overall Study|Sites with data irregularities/fraud|7|||
148857877|NCT01126437|536955956|FG000|Overall Study|Adverse Event|602|||
148857878|NCT01126437|536955957|FG001|Overall Study|Adverse Event|606|||
148857879|NCT01126437|536955958|FG002|Overall Study|Adverse Event|635|||
148857880|NCT01126437|536955956|FG000|Overall Study|Lack of Efficacy|65|||
148857881|NCT01126437|536955957|FG001|Overall Study|Lack of Efficacy|60|||
148857882|NCT01126437|536955958|FG002|Overall Study|Lack of Efficacy|59|||
148857883|NCT01126437|536955956|FG000|Overall Study|Protocol Violation|64|||
148857884|NCT01126437|536955957|FG001|Overall Study|Protocol Violation|66|||
148857885|NCT01126437|536955958|FG002|Overall Study|Protocol Violation|41|||
148857886|NCT01126437|536955956|FG000|Overall Study|Lost to Follow-up|52|||
148857887|NCT01126437|536955957|FG001|Overall Study|Lost to Follow-up|63|||
148857888|NCT01126437|536955958|FG002|Overall Study|Lost to Follow-up|55|||
148857889|NCT01126437|536955956|FG000|Overall Study|Withdrawal by Subject|331|||
148857890|NCT01126437|536955957|FG001|Overall Study|Withdrawal by Subject|335|||
148857891|NCT01126437|536955958|FG002|Overall Study|Withdrawal by Subject|319|||
148857892|NCT01126437|536955956|FG000|Overall Study|Other reason not specified|210|||
148857893|NCT01126437|536955957|FG001|Overall Study|Other reason not specified|176|||
148857894|NCT01126437|536955958|FG002|Overall Study|Other reason not specified|178|||
148857895|NCT00006046|536955964|FG000|Overall Study|Adverse Event|3|||
148857896|NCT00006046|536955965|FG001|Overall Study|Adverse Event|0|||
148857897|NCT00006046|536955966|FG002|Overall Study|Adverse Event|0|||
148857898|NCT00006046|536955967|FG003|Overall Study|Adverse Event|0|||
148857899|NCT00006046|536955968|FG004|Overall Study|Adverse Event|0|||
148857900|NCT00006046|536955964|FG000|Overall Study|Disease Progression|2|||
148857901|NCT00006046|536955965|FG001|Overall Study|Disease Progression|0|||
148857902|NCT00006046|536955966|FG002|Overall Study|Disease Progression|0|||
148857903|NCT00006046|536955967|FG003|Overall Study|Disease Progression|0|||
148857904|NCT00006046|536955968|FG004|Overall Study|Disease Progression|0|||
148991286|NCT02105948|537443315|FG002|Overall Study|Adverse Event|11|||
148991287|NCT02105948|537443316|FG003|Overall Study|Adverse Event|11|||
148991288|NCT02105948|537443313|FG000|Overall Study|Lack of Efficacy|0|||
148991289|NCT02105948|537443314|FG001|Overall Study|Lack of Efficacy|1|||
148991290|NCT02105948|537443315|FG002|Overall Study|Lack of Efficacy|3|||
148991291|NCT02105948|537443316|FG003|Overall Study|Lack of Efficacy|2|||
148991292|NCT02105948|537443313|FG000|Overall Study|Lost to Follow-up|0|||
148991293|NCT02105948|537443314|FG001|Overall Study|Lost to Follow-up|0|||
148991294|NCT02105948|537443315|FG002|Overall Study|Lost to Follow-up|2|||
148991295|NCT02105948|537443316|FG003|Overall Study|Lost to Follow-up|1|||
148991296|NCT02105948|537443313|FG000|Overall Study|Physician Decision|2|||
148991297|NCT02105948|537443314|FG001|Overall Study|Physician Decision|2|||
148991298|NCT02105948|537443315|FG002|Overall Study|Physician Decision|2|||
148991299|NCT02105948|537443316|FG003|Overall Study|Physician Decision|2|||
148991300|NCT02105948|537443313|FG000|Overall Study|Withdrawal by Subject|15|||
148991301|NCT02105948|537443314|FG001|Overall Study|Withdrawal by Subject|10|||
148991302|NCT02105948|537443315|FG002|Overall Study|Withdrawal by Subject|10|||
148991303|NCT02105948|537443316|FG003|Overall Study|Withdrawal by Subject|11|||
148991304|NCT03273946|537443321|FG000|Overall Study|Withdrawal by Subject|5|||
148991305|NCT03273946|537443321|FG000|Overall Study|Unwillingness of the guardian|1|||
148991306|NCT03273946|537443321|FG000|Overall Study|Participant refused to use the drug|2|||
148991307|NCT03273946|537443321|FG000|Overall Study|Participant relative refused to use drug|1|||
148991308|NCT01220557|537443323|FG000|Overall Study|Lost to Follow-up|5|||
148991309|NCT01220557|537443324|FG001|Overall Study|Lost to Follow-up|3|||
148991310|NCT01220557|537443323|FG000|Overall Study|attended less than 6 lessons|1|||
148991311|NCT01220557|537443324|FG001|Overall Study|attended less than 6 lessons|2|||
148991312|NCT00718718|537443325|FG000|Prior to Week 12|Adverse Event|0|||
148991313|NCT00718718|537443326|FG001|Prior to Week 12|Adverse Event|0|||
148991314|NCT00718718|537443327|FG002|Prior to Week 12|Adverse Event|0|||
148991315|NCT00718718|537443328|FG003|Prior to Week 12|Adverse Event|0|||
148991316|NCT00718718|537443329|FG004|Prior to Week 12|Adverse Event|0|||
148991317|NCT00718718|537443330|FG005|Prior to Week 12|Adverse Event|0|||
148991318|NCT00718718|537443331|FG006|Prior to Week 12|Adverse Event|0|||
148991319|NCT00718718|537443332|FG007|Prior to Week 12|Adverse Event|1|||
148991320|NCT00718718|537443333|FG008|Prior to Week 12|Adverse Event|1|||
148991321|NCT00718718|537443334|FG009|Prior to Week 12|Adverse Event|0|||
148991322|NCT00718718|537443325|FG000|Prior to Week 12|Withdrawal by Subject|0|||
148991323|NCT00718718|537443326|FG001|Prior to Week 12|Withdrawal by Subject|0|||
148991324|NCT00718718|537443327|FG002|Prior to Week 12|Withdrawal by Subject|0|||
148991325|NCT00718718|537443328|FG003|Prior to Week 12|Withdrawal by Subject|0|||
148991326|NCT00718718|537443329|FG004|Prior to Week 12|Withdrawal by Subject|3|||
148991327|NCT00718718|537443330|FG005|Prior to Week 12|Withdrawal by Subject|0|||
148991328|NCT00718718|537443331|FG006|Prior to Week 12|Withdrawal by Subject|1|||
148991329|NCT00718718|537443332|FG007|Prior to Week 12|Withdrawal by Subject|1|||
148991330|NCT00718718|537443333|FG008|Prior to Week 12|Withdrawal by Subject|1|||
148991331|NCT00718718|537443334|FG009|Prior to Week 12|Withdrawal by Subject|0|||
148991332|NCT00718718|537443325|FG000|Prior to Week 12|Other|1|||
148991333|NCT00718718|537443326|FG001|Prior to Week 12|Other|0|||
148991334|NCT00718718|537443327|FG002|Prior to Week 12|Other|1|||
148991335|NCT00718718|537443328|FG003|Prior to Week 12|Other|0|||
148991336|NCT00718718|537443329|FG004|Prior to Week 12|Other|0|||
148991337|NCT00718718|537443330|FG005|Prior to Week 12|Other|0|||
148991338|NCT00718718|537443331|FG006|Prior to Week 12|Other|0|||
148991339|NCT00718718|537443332|FG007|Prior to Week 12|Other|0|||
148991340|NCT00718718|537443333|FG008|Prior to Week 12|Other|0|||
148991341|NCT00718718|537443334|FG009|Prior to Week 12|Other|0|||
148991342|NCT00718718|537443325|FG000|Week 12 to End of Study|Adverse Event|0|||
148991343|NCT00718718|537443326|FG001|Week 12 to End of Study|Adverse Event|0|||
148991344|NCT00718718|537443327|FG002|Week 12 to End of Study|Adverse Event|0|||
148991345|NCT00718718|537443328|FG003|Week 12 to End of Study|Adverse Event|0|||
148991346|NCT00718718|537443329|FG004|Week 12 to End of Study|Adverse Event|0|||
148991347|NCT00718718|537443330|FG005|Week 12 to End of Study|Adverse Event|0|||
148991348|NCT00718718|537443331|FG006|Week 12 to End of Study|Adverse Event|0|||
148991349|NCT00718718|537443332|FG007|Week 12 to End of Study|Adverse Event|1|||
148991350|NCT00718718|537443333|FG008|Week 12 to End of Study|Adverse Event|0|||
148991351|NCT00718718|537443334|FG009|Week 12 to End of Study|Adverse Event|0|||
148991352|NCT00718718|537443325|FG000|Week 12 to End of Study|Death|0|||
148991353|NCT00718718|537443326|FG001|Week 12 to End of Study|Death|0|||
148991354|NCT00718718|537443327|FG002|Week 12 to End of Study|Death|0|||
148991355|NCT00718718|537443328|FG003|Week 12 to End of Study|Death|0|||
148991356|NCT00718718|537443329|FG004|Week 12 to End of Study|Death|0|||
148991357|NCT00718718|537443330|FG005|Week 12 to End of Study|Death|1|||
148991358|NCT00718718|537443331|FG006|Week 12 to End of Study|Death|0|||
148991359|NCT00718718|537443332|FG007|Week 12 to End of Study|Death|0|||
148991360|NCT00718718|537443333|FG008|Week 12 to End of Study|Death|0|||
148991361|NCT00718718|537443334|FG009|Week 12 to End of Study|Death|0|||
148991362|NCT00718718|537443325|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
148991363|NCT00718718|537443326|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
148991364|NCT00718718|537443327|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
148991365|NCT00718718|537443328|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
148991366|NCT00718718|537443329|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
148991367|NCT00718718|537443330|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
148991368|NCT00718718|537443331|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
148991369|NCT00718718|537443332|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
148991370|NCT00718718|537443333|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
148991371|NCT00718718|537443334|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
148991372|NCT00718718|537443325|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
148991373|NCT00718718|537443326|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
148991374|NCT00718718|537443327|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
148991375|NCT00718718|537443328|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
149030688|NCT00813488|537589693|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
149030689|NCT00813488|537589692|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
149030690|NCT00813488|537589693|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
149030691|NCT00813488|537589692|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
149030692|NCT00813488|537589693|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
149030693|NCT00813488|537589692|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
148857905|NCT00596154|536955969|FG000|Overall Study|Not Evaluable|2|||
148857906|NCT01846663|536955974|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
148857907|NCT01846663|536955975|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
148857908|NCT01846663|536955974|FG000|Overall Study|Withdrawal by Subject|1|||
148857909|NCT01846663|536955975|FG001|Overall Study|Withdrawal by Subject|0|||
148857910|NCT01846663|536955974|FG000|Overall Study|Adverse Event|1|||
148857911|NCT01846663|536955975|FG001|Overall Study|Adverse Event|2|||
148857912|NCT00585546|536955983|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
148857913|NCT00585546|536955983|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
148857914|NCT02851797|536955984|FG000|Overall Study|Withdrawal by Subject|4|||
148857915|NCT02851797|536955985|FG001|Overall Study|Withdrawal by Subject|2|||
148857916|NCT02851797|536955984|FG000|Overall Study|Adverse Event|3|||
148857917|NCT02851797|536955985|FG001|Overall Study|Adverse Event|0|||
148857918|NCT03077438|536955986|FG000|Overall Study|Protocol Violation|3|||
148857919|NCT03077438|536955987|FG001|Overall Study|Protocol Violation|5|||
148857920|NCT03077438|536955986|FG000|Overall Study|Withdrawal by Subject|3|||
148857921|NCT03077438|536955987|FG001|Overall Study|Withdrawal by Subject|6|||
148857922|NCT03077438|536955986|FG000|Overall Study|Lost to Follow-up|6|||
148857923|NCT03077438|536955987|FG001|Overall Study|Lost to Follow-up|3|||
148857924|NCT00813865|536955988|FG000|Overall Study|Failure to Respond|3|||
148857925|NCT00813865|536955988|FG000|Overall Study|Lost to Follow-up|3|||
148857926|NCT00813865|536955988|FG000|Overall Study|Withdrawal by Subject|1|||
148857927|NCT03888235|536956000|FG000|Overall Study|Lost to Follow-up|1|||
148857928|NCT03888235|536956001|FG001|Overall Study|Lost to Follow-up|1|||
148857929|NCT03888235|536956002|FG002|Overall Study|Lost to Follow-up|0|||
148857930|NCT00676520|536956003|FG000|Overall Study|Withdrawal by Subject|163|||
148857931|NCT00676520|536956003|FG000|Overall Study|Lost to Follow-up|162|||
148857932|NCT00676520|536956003|FG000|Overall Study|Death|159|||
148857933|NCT00676520|536956003|FG000|Overall Study|Physician Decision|20|||
148857934|NCT00676520|536956003|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
148857935|NCT00676520|536956003|FG000|Overall Study|Other Reason|18|||
148857936|NCT01425359|536956004|FG000|Overall Study|Randomized but Not Treated|2|||
148857937|NCT01425359|536956005|FG001|Overall Study|Randomized but Not Treated|3|||
148857938|NCT01425359|536956004|FG000|Overall Study|Adverse Event|9|||
148857939|NCT01425359|536956005|FG001|Overall Study|Adverse Event|8|||
148857940|NCT01425359|536956004|FG000|Overall Study|Revascularization|0|||
148857941|NCT01425359|536956005|FG001|Overall Study|Revascularization|1|||
148857942|NCT01425359|536956004|FG000|Overall Study|Death|0|||
148991376|NCT00718718|537443329|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
149030694|NCT00813488|537589693|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
148857943|NCT01425359|536956005|FG001|Overall Study|Death|1|||
148857944|NCT01425359|536956004|FG000|Overall Study|Unsatisfactory Response|1|||
148857945|NCT01425359|536956005|FG001|Overall Study|Unsatisfactory Response|0|||
148857946|NCT01425359|536956004|FG000|Overall Study|Protocol Violation|1|||
148857947|NCT01425359|536956005|FG001|Overall Study|Protocol Violation|2|||
148857948|NCT01425359|536956004|FG000|Overall Study|Subject Withdrew Consent|1|||
148857949|NCT01425359|536956005|FG001|Overall Study|Subject Withdrew Consent|2|||
148857950|NCT01425359|536956004|FG000|Overall Study|Investigator's Discretion|2|||
148991377|NCT00718718|537443330|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
149030695|NCT00813488|537589692|FG000|Double-blind Treatment Period 2|Other|1|||
148857951|NCT01425359|536956005|FG001|Overall Study|Investigator's Discretion|0|||
148857952|NCT01425359|536956004|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
148857953|NCT01425359|536956005|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
148857954|NCT00744978|536956010|FG000|Period 1|Lost to Follow-up|1|||
148857955|NCT00744978|536956011|FG001|Period 1|Lost to Follow-up|0|||
148857956|NCT00744978|536956010|FG000|Period 1|Withdrawal by Subject|0|||
148857957|NCT00744978|536956011|FG001|Period 1|Withdrawal by Subject|2|||
148857958|NCT00744978|536956010|FG000|Period 1|Other|0|||
148857959|NCT00744978|536956011|FG001|Period 1|Other|2|||
148991378|NCT00718718|537443331|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
148991379|NCT00718718|537443332|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
148991380|NCT00718718|537443333|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
148991381|NCT00718718|537443334|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
148991382|NCT00718718|537443325|FG000|Week 12 to End of Study|Other|0|||
148991383|NCT00718718|537443326|FG001|Week 12 to End of Study|Other|1|||
148991384|NCT00718718|537443327|FG002|Week 12 to End of Study|Other|0|||
148991385|NCT00718718|537443328|FG003|Week 12 to End of Study|Other|1|||
148991386|NCT00718718|537443329|FG004|Week 12 to End of Study|Other|0|||
148991387|NCT00718718|537443330|FG005|Week 12 to End of Study|Other|0|||
148991388|NCT00718718|537443331|FG006|Week 12 to End of Study|Other|1|||
148991389|NCT00718718|537443332|FG007|Week 12 to End of Study|Other|0|||
148991390|NCT00718718|537443333|FG008|Week 12 to End of Study|Other|0|||
148991391|NCT00718718|537443334|FG009|Week 12 to End of Study|Other|0|||
148991392|NCT02276482|537443337|FG000|Overall Study|Adverse Event|1|||
148991393|NCT02276482|537443338|FG001|Overall Study|Adverse Event|0|||
148991394|NCT02276482|537443337|FG000|Overall Study|Withdrawal by Subject|1|||
148991395|NCT02276482|537443338|FG001|Overall Study|Withdrawal by Subject|0|||
148991396|NCT02276482|537443337|FG000|Overall Study|Gram-negative infection|1|||
148991397|NCT02276482|537443338|FG001|Overall Study|Gram-negative infection|0|||
148991398|NCT02276482|537443337|FG000|Overall Study|Reason not specified|0|||
148991399|NCT02276482|537443338|FG001|Overall Study|Reason not specified|1|||
148991400|NCT03277313|537443339|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
148991401|NCT03277313|537443340|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
148991402|NCT03277313|537443339|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
148991403|NCT03277313|537443340|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
148991404|NCT03277313|537443339|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
148991405|NCT03277313|537443340|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
148991406|NCT03277313|537443339|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
148991407|NCT03277313|537443340|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
148991408|NCT03277313|537443339|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
148991409|NCT03277313|537443340|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
148991410|NCT00253864|537443345|FG000|Overall Study|Lost to Follow-up|5|||
148991411|NCT00253864|537443346|FG001|Overall Study|Lost to Follow-up|8|||
148857960|NCT00744978|536956010|FG000|Period 1|Adverse Event|4|||
148857961|NCT00744978|536956011|FG001|Period 1|Adverse Event|0|||
148857962|NCT00744978|536956010|FG000|Period 1|Randomized but not Treated|1|||
148857963|NCT00744978|536956011|FG001|Period 1|Randomized but not Treated|1|||
148857964|NCT00744978|536956010|FG000|Period 2|Adverse Event|0|||
148857965|NCT00744978|536956011|FG001|Period 2|Adverse Event|1|||
148857966|NCT00866047|536956012|FG000|Treatment Period|Progressive disease|13|||
148857967|NCT00866047|536956012|FG000|Treatment Period|Adverse Event|16|||
148857968|NCT00866047|536956012|FG000|Treatment Period|Physician Decision|14|||
148857969|NCT00866047|536956012|FG000|Treatment Period|Withdrawal by Subject|5|||
148857970|NCT00866047|536956012|FG000|Follow-up Period|Lost to Follow-up|5|||
148857971|NCT03773133|536956013|FG000|Overall Study|Screen Failure|8|||
148857972|NCT00503776|536956014|FG000|Overall Study|Withdrawal by Subject|1|||
148857973|NCT00503776|536956015|FG001|Overall Study|Withdrawal by Subject|0|||
148857974|NCT00503776|536956016|FG002|Overall Study|Withdrawal by Subject|1|||
148857975|NCT00503776|536956017|FG003|Overall Study|Withdrawal by Subject|1|||
148991412|NCT00360529|537443350|FG000|Overall Study|Adverse Event|10|||
148991413|NCT00360529|537443351|FG001|Overall Study|Adverse Event|23|||
148991414|NCT00360529|537443352|FG002|Overall Study|Adverse Event|33|||
148991415|NCT00360529|537443350|FG000|Overall Study|Protocol Violation|3|||
148991416|NCT00360529|537443351|FG001|Overall Study|Protocol Violation|3|||
148991417|NCT00360529|537443352|FG002|Overall Study|Protocol Violation|11|||
148991418|NCT00360529|537443350|FG000|Overall Study|Lost to Follow-up|14|||
148991419|NCT00360529|537443351|FG001|Overall Study|Lost to Follow-up|10|||
148991420|NCT00360529|537443352|FG002|Overall Study|Lost to Follow-up|13|||
148991421|NCT00360529|537443350|FG000|Overall Study|Withdrawal by Subject|22|||
148991422|NCT00360529|537443351|FG001|Overall Study|Withdrawal by Subject|14|||
148991423|NCT00360529|537443352|FG002|Overall Study|Withdrawal by Subject|18|||
148991424|NCT00360529|537443350|FG000|Overall Study|Lack of Efficacy|8|||
148991425|NCT00360529|537443351|FG001|Overall Study|Lack of Efficacy|6|||
148991426|NCT00360529|537443352|FG002|Overall Study|Lack of Efficacy|5|||
148991427|NCT00360529|537443350|FG000|Overall Study|Reason discontinued not explained above|4|||
148991428|NCT00360529|537443351|FG001|Overall Study|Reason discontinued not explained above|9|||
148857976|NCT00503776|536956014|FG000|Overall Study|Physician Decision|0|||
148991429|NCT00360529|537443352|FG002|Overall Study|Reason discontinued not explained above|11|||
148991430|NCT00110617|537443356|FG000|Overall Study|Adverse Event|2|||
148857977|NCT00503776|536956015|FG001|Overall Study|Physician Decision|0|||
148857978|NCT00503776|536956016|FG002|Overall Study|Physician Decision|1|||
148857979|NCT00503776|536956017|FG003|Overall Study|Physician Decision|1|||
148857980|NCT00223977|536956020|FG000|Overall Study|Adverse Event|7|||
148991431|NCT00110617|537443357|FG001|Overall Study|Adverse Event|4|||
148991432|NCT00110617|537443356|FG000|Overall Study|Abnormal Laboratory Value|4|||
148991433|NCT00110617|537443357|FG001|Overall Study|Abnormal Laboratory Value|2|||
148991434|NCT00110617|537443356|FG000|Overall Study|Lack of Efficacy|1|||
148991435|NCT00110617|537443357|FG001|Overall Study|Lack of Efficacy|0|||
148991436|NCT00110617|537443356|FG000|Overall Study|Patient no longer requires study drug|1|||
148991437|NCT00110617|537443357|FG001|Overall Study|Patient no longer requires study drug|0|||
148991438|NCT00110617|537443356|FG000|Overall Study|Protocol Violation|5|||
148991439|NCT00110617|537443357|FG001|Overall Study|Protocol Violation|0|||
148991440|NCT00110617|537443356|FG000|Overall Study|Withdrawal by Subject|10|||
148991441|NCT00110617|537443357|FG001|Overall Study|Withdrawal by Subject|4|||
148991442|NCT00110617|537443356|FG000|Overall Study|Lost to Follow-up|9|||
148991443|NCT00110617|537443357|FG001|Overall Study|Lost to Follow-up|1|||
148991444|NCT00110617|537443356|FG000|Overall Study|Administrative problems|6|||
148991445|NCT00110617|537443357|FG001|Overall Study|Administrative problems|5|||
148991446|NCT00110617|537443356|FG000|Overall Study|Death|1|||
148991447|NCT00110617|537443357|FG001|Overall Study|Death|1|||
148991448|NCT00110617|537443356|FG000|Overall Study|Did not receive study drug|0|||
148991449|NCT00110617|537443357|FG001|Overall Study|Did not receive study drug|12|||
148991450|NCT01218438|537443360|FG000|Epoch 1|Physician Decision|2|||
148991451|NCT01218438|537443360|FG000|Epoch 1|Adverse Event|1|||
148991452|NCT01218438|537443360|FG000|Epoch 3|Withdrawal by Subject|3|||
148991453|NCT01218438|537443360|FG000|Epoch 3|Adverse Event|1|||
148991454|NCT01218438|537443360|FG000|Epoch 4|Physician Decision|1|||
148991455|NCT01218438|537443360|FG000|Epoch 4|Withdrawal by Subject|2|||
148991456|NCT00045110|537443361|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
148991457|NCT00045110|537443362|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
148991458|NCT00045110|537443363|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
148991459|NCT00045110|537443361|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
148991460|NCT00045110|537443362|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
148991461|NCT00045110|537443363|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
148991462|NCT00045110|537443361|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
148991463|NCT00045110|537443362|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
148991464|NCT00045110|537443363|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
148991465|NCT03662750|537443368|FG000|Overall Study|Withdrawal by Subject|1|||
148991466|NCT05819749|537443371|FG000|Overall Study|Lost to Follow-up|1|||
148991467|NCT01983293|537445666|FG000|Overall Study|Withdrawal by Subject|29|||
148857981|NCT00223977|536956021|FG001|Overall Study|Adverse Event|10|||
148857982|NCT00223977|536956022|FG002|Overall Study|Adverse Event|0|||
148857983|NCT00223977|536956020|FG000|Overall Study|Protocol Violation|0|||
148857984|NCT00223977|536956021|FG001|Overall Study|Protocol Violation|0|||
148857985|NCT00223977|536956022|FG002|Overall Study|Protocol Violation|1|||
148857986|NCT00223977|536956020|FG000|Overall Study|Withdrawal by Subject|1|||
148857987|NCT00223977|536956021|FG001|Overall Study|Withdrawal by Subject|1|||
148857988|NCT00223977|536956022|FG002|Overall Study|Withdrawal by Subject|2|||
148991468|NCT01983293|537445667|FG001|Overall Study|Withdrawal by Subject|15|||
148991469|NCT01983293|537445666|FG000|Overall Study|Missing 12-month visit|3|||
148991470|NCT01983293|537445667|FG001|Overall Study|Missing 12-month visit|3|||
148991471|NCT01983293|537445666|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
148991472|NCT01983293|537445667|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
148991473|NCT03147248|537445669|FG000|Overall Study|Adverse Event|0|||
148991474|NCT03147248|537445670|FG001|Overall Study|Adverse Event|2|||
148991475|NCT03147248|537445671|FG002|Overall Study|Adverse Event|2|||
148991476|NCT03147248|537445672|FG003|Overall Study|Adverse Event|2|||
148991477|NCT03147248|537445673|FG004|Overall Study|Adverse Event|6|||
148991478|NCT03147248|537445674|FG005|Overall Study|Adverse Event|11|||
148991479|NCT03147248|537445669|FG000|Overall Study|Disease progression|1|||
148991480|NCT03147248|537445670|FG001|Overall Study|Disease progression|0|||
148857989|NCT00223977|536956020|FG000|Overall Study|Other|1|||
148991481|NCT03147248|537445671|FG002|Overall Study|Disease progression|0|||
148991482|NCT03147248|537445672|FG003|Overall Study|Disease progression|0|||
148991483|NCT03147248|537445673|FG004|Overall Study|Disease progression|0|||
148991484|NCT03147248|537445674|FG005|Overall Study|Disease progression|2|||
148991485|NCT03147248|537445669|FG000|Overall Study|Withdrawal by Subject|0|||
148991486|NCT03147248|537445670|FG001|Overall Study|Withdrawal by Subject|0|||
148991487|NCT03147248|537445671|FG002|Overall Study|Withdrawal by Subject|0|||
148857990|NCT00223977|536956021|FG001|Overall Study|Other|0|||
148857991|NCT00223977|536956022|FG002|Overall Study|Other|0|||
148857992|NCT03276026|536956025|FG000|Overall Study|Protocol Violation|1|||
148857993|NCT03276026|536956026|FG001|Overall Study|Protocol Violation|0|||
148857994|NCT03650803|536956028|FG000|Overall Study|Lost to Follow-up|6|||
148857995|NCT01534260|536956029|FG000|Overall Study|Adverse Event|1|||
148991488|NCT03147248|537445672|FG003|Overall Study|Withdrawal by Subject|0|||
148991489|NCT03147248|537445673|FG004|Overall Study|Withdrawal by Subject|12|||
148991490|NCT03147248|537445674|FG005|Overall Study|Withdrawal by Subject|9|||
148991491|NCT03147248|537445669|FG000|Overall Study|Protocol Violation|0|||
148991492|NCT03147248|537445670|FG001|Overall Study|Protocol Violation|0|||
148991493|NCT03147248|537445671|FG002|Overall Study|Protocol Violation|0|||
148857996|NCT01534260|536956030|FG001|Overall Study|Adverse Event|8|||
148857997|NCT01534260|536956029|FG000|Overall Study|Death|2|||
148857998|NCT01534260|536956030|FG001|Overall Study|Death|0|||
148857999|NCT01534260|536956029|FG000|Overall Study|Lack of Efficacy|1|||
148858000|NCT01534260|536956030|FG001|Overall Study|Lack of Efficacy|1|||
148858001|NCT01534260|536956029|FG000|Overall Study|Withdrawal by Subject|1|||
148858002|NCT01534260|536956030|FG001|Overall Study|Withdrawal by Subject|3|||
148858003|NCT01534260|536956029|FG000|Overall Study|Disease Progression|8|||
148858004|NCT01534260|536956030|FG001|Overall Study|Disease Progression|6|||
148858005|NCT01534260|536956029|FG000|Overall Study|Physician Decision|3|||
148858006|NCT01534260|536956030|FG001|Overall Study|Physician Decision|1|||
148858007|NCT01534260|536956029|FG000|Overall Study|No treatment, per protocol|0|||
148858008|NCT01534260|536956030|FG001|Overall Study|No treatment, per protocol|1|||
148858009|NCT02359045|536956031|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
148858010|NCT02359045|536956032|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
148858011|NCT02359045|536956031|FG000|Overall Study|Lost to Follow-up|1|||
148858012|NCT02359045|536956032|FG001|Overall Study|Lost to Follow-up|1|||
148858013|NCT02359045|536956031|FG000|Overall Study|Adverse Event|0|||
148858014|NCT02359045|536956032|FG001|Overall Study|Adverse Event|1|||
148858015|NCT00503581|536956033|FG000|Overall Study|Study closed|3|||
148858016|NCT00503581|536956034|FG001|Overall Study|Study closed|4|||
148858017|NCT00503581|536956035|FG002|Overall Study|Study closed|2|||
148858018|NCT04376684|536956036|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
148858019|NCT04376684|536956037|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
148858020|NCT04376684|536956038|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
148858021|NCT04376684|536956039|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
148858022|NCT04376684|536956036|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
148858023|NCT04376684|536956037|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
148858024|NCT04376684|536956038|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
148858025|NCT04376684|536956039|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
148858026|NCT04376684|536956036|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
148858027|NCT04376684|536956037|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
148858028|NCT04376684|536956038|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
148858029|NCT04376684|536956039|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
148858030|NCT04376684|536956036|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
148858031|NCT04376684|536956037|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
148858032|NCT04376684|536956038|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
148858033|NCT04376684|536956039|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
148858034|NCT04376684|536956036|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
148858035|NCT04376684|536956037|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
148858036|NCT04376684|536956038|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
148858037|NCT04376684|536956039|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
148858038|NCT04376684|536956036|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
148858039|NCT04376684|536956037|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
148858040|NCT04376684|536956038|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
148858041|NCT04376684|536956039|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
148858042|NCT04376684|536956036|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
148858043|NCT04376684|536956037|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
148858044|NCT04376684|536956038|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
148858045|NCT04376684|536956039|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
148858046|NCT01666119|536956040|FG000|Overall Study|Adverse Event|6|||
148858047|NCT01666119|536956040|FG000|Overall Study|Withdrawal by Subject|16|||
148858048|NCT01666119|536956040|FG000|Overall Study|Lost to Follow-up|7|||
148858049|NCT01666119|536956040|FG000|Overall Study|non compliance with study medication, pa|18|||
148858050|NCT01666119|536956040|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
148858051|NCT01301066|536956047|FG000|Overall Study|Lost to Follow-up|5|||
148858052|NCT01301066|536956048|FG001|Overall Study|Lost to Follow-up|11|||
148858053|NCT01301066|536956047|FG000|Overall Study|Protocol Violation|8|||
148858054|NCT01301066|536956048|FG001|Overall Study|Protocol Violation|7|||
148858055|NCT01301066|536956047|FG000|Overall Study|Withdrawal by Subject|4|||
148858056|NCT01301066|536956048|FG001|Overall Study|Withdrawal by Subject|9|||
148858057|NCT01301066|536956047|FG000|Overall Study|Adverse Event|6|||
148858058|NCT01301066|536956048|FG001|Overall Study|Adverse Event|6|||
148858059|NCT01301066|536956047|FG000|Overall Study|Sponsor Decision|2|||
148858060|NCT01301066|536956048|FG001|Overall Study|Sponsor Decision|1|||
148858061|NCT01301066|536956047|FG000|Overall Study|Physician Decision|0|||
148858062|NCT01301066|536956048|FG001|Overall Study|Physician Decision|1|||
148858063|NCT01301066|536956047|FG000|Overall Study|Other|2|||
148858064|NCT01301066|536956048|FG001|Overall Study|Other|0|||
148858065|NCT02979093|536956059|FG000|First Scan Session|Scanning data problems|1|||
148858066|NCT02979093|536956060|FG001|First Scan Session|Scanning data problems|2|||
148858067|NCT02979093|536956061|FG002|First Scan Session|Scanning data problems|2|||
148858068|NCT02979093|536956062|FG003|First Scan Session|Scanning data problems|0|||
148858069|NCT02979093|536956059|FG000|Second Scan Session|Scanning data problems|3|||
148858070|NCT02979093|536956060|FG001|Second Scan Session|Scanning data problems|0|||
148858071|NCT02979093|536956061|FG002|Second Scan Session|Scanning data problems|1|||
148858072|NCT02979093|536956062|FG003|Second Scan Session|Scanning data problems|3|||
148858073|NCT06107803|536956063|FG000|Overall Study|Adverse Event|1|||
148991494|NCT03147248|537445672|FG003|Overall Study|Protocol Violation|0|||
148991495|NCT03147248|537445673|FG004|Overall Study|Protocol Violation|2|||
148991496|NCT03147248|537445674|FG005|Overall Study|Protocol Violation|0|||
148991497|NCT03147248|537445669|FG000|Overall Study|Lost to Follow-up|0|||
148991498|NCT03147248|537445670|FG001|Overall Study|Lost to Follow-up|0|||
148991499|NCT03147248|537445671|FG002|Overall Study|Lost to Follow-up|0|||
148991500|NCT03147248|537445672|FG003|Overall Study|Lost to Follow-up|0|||
148991501|NCT03147248|537445673|FG004|Overall Study|Lost to Follow-up|2|||
148991502|NCT03147248|537445674|FG005|Overall Study|Lost to Follow-up|0|||
148991503|NCT03147248|537445669|FG000|Overall Study|Pregnancy|0|||
148991504|NCT03147248|537445670|FG001|Overall Study|Pregnancy|0|||
148991505|NCT03147248|537445671|FG002|Overall Study|Pregnancy|0|||
148991506|NCT03147248|537445672|FG003|Overall Study|Pregnancy|0|||
148991507|NCT03147248|537445673|FG004|Overall Study|Pregnancy|1|||
148991508|NCT03147248|537445674|FG005|Overall Study|Pregnancy|0|||
148991509|NCT03147248|537445669|FG000|Overall Study|Death|0|||
148991510|NCT03147248|537445670|FG001|Overall Study|Death|0|||
148991511|NCT03147248|537445671|FG002|Overall Study|Death|0|||
148991512|NCT03147248|537445672|FG003|Overall Study|Death|0|||
148991513|NCT03147248|537445673|FG004|Overall Study|Death|0|||
148991514|NCT03147248|537445674|FG005|Overall Study|Death|4|||
148991515|NCT03147248|537445669|FG000|Overall Study|Physician Decision|0|||
148991516|NCT03147248|537445670|FG001|Overall Study|Physician Decision|0|||
148991517|NCT03147248|537445671|FG002|Overall Study|Physician Decision|0|||
148991518|NCT03147248|537445672|FG003|Overall Study|Physician Decision|0|||
148991519|NCT03147248|537445673|FG004|Overall Study|Physician Decision|2|||
148991520|NCT03147248|537445674|FG005|Overall Study|Physician Decision|4|||
148991521|NCT03147248|537445669|FG000|Overall Study|Prolonged Dosing Interval|0|||
148991522|NCT03147248|537445670|FG001|Overall Study|Prolonged Dosing Interval|0|||
148991523|NCT03147248|537445671|FG002|Overall Study|Prolonged Dosing Interval|0|||
148991524|NCT03147248|537445672|FG003|Overall Study|Prolonged Dosing Interval|0|||
148991525|NCT03147248|537445673|FG004|Overall Study|Prolonged Dosing Interval|1|||
148991526|NCT03147248|537445674|FG005|Overall Study|Prolonged Dosing Interval|1|||
148991527|NCT03750552|537445675|FG000|Overall Study|Adverse Event|5|||
148991528|NCT03750552|537445676|FG001|Overall Study|Adverse Event|1|||
148991529|NCT03750552|537445675|FG000|Overall Study|Withdrawal by Subject|1|||
148991530|NCT03750552|537445676|FG001|Overall Study|Withdrawal by Subject|1|||
148991531|NCT03750552|537445675|FG000|Overall Study|Other|2|||
148991532|NCT03750552|537445676|FG001|Overall Study|Other|0|||
148991533|NCT02522494|537445680|FG000|Overall Study|Lost to Follow-up|6|||
148991534|NCT02522494|537445681|FG001|Overall Study|Lost to Follow-up|2|||
148991535|NCT02522494|537445680|FG000|Overall Study|Withdrawal by Subject|1|||
148991536|NCT02522494|537445681|FG001|Overall Study|Withdrawal by Subject|0|||
148991537|NCT02522494|537445680|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
148991538|NCT02522494|537445681|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
148991539|NCT02522494|537445680|FG000|Overall Study|Participant did not watch the video|1|||
148991540|NCT02522494|537445681|FG001|Overall Study|Participant did not watch the video|0|||
148991541|NCT02522494|537445680|FG000|Overall Study|Death|0|||
148991542|NCT02522494|537445681|FG001|Overall Study|Death|1|||
148991543|NCT03240588|537445682|FG000|Overall Study|Death|3|||
148991544|NCT03240588|537445683|FG001|Overall Study|Death|0|||
148991545|NCT03240588|537445684|FG002|Overall Study|Death|0|||
148991546|NCT03240588|537445682|FG000|Overall Study|Adverse Event|5|||
148991547|NCT03240588|537445683|FG001|Overall Study|Adverse Event|4|||
148991548|NCT03240588|537445684|FG002|Overall Study|Adverse Event|0|||
148991549|NCT03240588|537445682|FG000|Overall Study|Lost to Follow-up|9|||
148991550|NCT03240588|537445683|FG001|Overall Study|Lost to Follow-up|4|||
148991551|NCT03240588|537445684|FG002|Overall Study|Lost to Follow-up|0|||
148991552|NCT03240588|537445682|FG000|Overall Study|Physician Decision|3|||
148991553|NCT03240588|537445683|FG001|Overall Study|Physician Decision|2|||
148991554|NCT03240588|537445684|FG002|Overall Study|Physician Decision|0|||
148991555|NCT03240588|537445682|FG000|Overall Study|Did not meet eligibility criteria|0|||
148991556|NCT03240588|537445683|FG001|Overall Study|Did not meet eligibility criteria|6|||
148858074|NCT06107803|536956063|FG000|Overall Study|Withdrawal by Subject|2|||
148991557|NCT03240588|537445684|FG002|Overall Study|Did not meet eligibility criteria|0|||
148991558|NCT03240588|537445682|FG000|Overall Study|No longer meets protocol criteria|12|||
148858075|NCT06107803|536956063|FG000|Overall Study|Protocol Violation|1|||
148991559|NCT03240588|537445683|FG001|Overall Study|No longer meets protocol criteria|7|||
148991560|NCT03240588|537445684|FG002|Overall Study|No longer meets protocol criteria|0|||
148991561|NCT03240588|537445682|FG000|Overall Study|Withdrawal by Subject|60|||
148991562|NCT03240588|537445683|FG001|Overall Study|Withdrawal by Subject|52|||
148991563|NCT03240588|537445684|FG002|Overall Study|Withdrawal by Subject|7|||
148991564|NCT03240588|537445682|FG000|Overall Study|Other, additional details not available.|0|||
148991565|NCT03240588|537445683|FG001|Overall Study|Other, additional details not available.|12|||
148858076|NCT05596734|536956064|FG000|Substudy A|Withdrawal by Subject|1|||
148991566|NCT03240588|537445684|FG002|Overall Study|Other, additional details not available.|1|||
149005494|NCT03217747|537497899|FG007|Overall Study|Removal of sole target lesion|0|||
149005495|NCT03217747|537497900|FG008|Overall Study|Removal of sole target lesion|0|||
148858077|NCT05596734|536956065|FG001|Substudy A|Withdrawal by Subject|0|||
148858078|NCT05596734|536956066|FG002|Substudy A|Withdrawal by Subject|0|||
148858079|NCT05596734|536956067|FG003|Substudy A|Withdrawal by Subject|0|||
148858080|NCT05596734|536956068|FG004|Substudy A|Withdrawal by Subject|0|||
148858081|NCT05596734|536956069|FG005|Substudy A|Withdrawal by Subject|0|||
148858082|NCT05596734|536956070|FG006|Substudy A|Withdrawal by Subject|1|||
148858083|NCT05596734|536956071|FG007|Substudy A|Withdrawal by Subject|0|||
148858084|NCT05596734|536956072|FG008|Substudy A|Withdrawal by Subject|0|||
148858085|NCT05596734|536956073|FG009|Substudy A|Withdrawal by Subject|0|||
148858086|NCT05596734|536956074|FG010|Substudy A|Withdrawal by Subject|0|||
148858087|NCT05596734|536956075|FG011|Substudy A|Withdrawal by Subject|0|||
148858088|NCT05596734|536956076|FG012|Substudy A|Withdrawal by Subject|0|||
148858089|NCT05596734|536956077|FG013|Substudy A|Withdrawal by Subject|0|||
148858090|NCT05596734|536956078|FG014|Substudy A|Withdrawal by Subject|0|||
148858091|NCT05596734|536956079|FG015|Substudy A|Withdrawal by Subject|0|||
148858092|NCT05596734|536956080|FG016|Substudy A|Withdrawal by Subject|0|||
148858093|NCT05596734|536956081|FG017|Substudy A|Withdrawal by Subject|0|||
148858094|NCT05596734|536956082|FG018|Substudy A|Withdrawal by Subject|0|||
148858095|NCT05596734|536956083|FG019|Substudy A|Withdrawal by Subject|0|||
148858096|NCT05596734|536956084|FG020|Substudy A|Withdrawal by Subject|0|||
148858097|NCT05596734|536956085|FG021|Substudy A|Withdrawal by Subject|0|||
148858098|NCT05596734|536956086|FG022|Substudy A|Withdrawal by Subject|0|||
148858099|NCT05596734|536956087|FG023|Substudy A|Withdrawal by Subject|0|||
148858100|NCT05596734|536956064|FG000|Substudy A|Lost to Follow-up|1|||
148858101|NCT05596734|536956065|FG001|Substudy A|Lost to Follow-up|0|||
148858102|NCT05596734|536956066|FG002|Substudy A|Lost to Follow-up|1|||
148858103|NCT05596734|536956067|FG003|Substudy A|Lost to Follow-up|0|||
148858104|NCT05596734|536956068|FG004|Substudy A|Lost to Follow-up|0|||
148858105|NCT05596734|536956069|FG005|Substudy A|Lost to Follow-up|0|||
148858106|NCT05596734|536956070|FG006|Substudy A|Lost to Follow-up|0|||
148858107|NCT05596734|536956071|FG007|Substudy A|Lost to Follow-up|0|||
148858108|NCT05596734|536956072|FG008|Substudy A|Lost to Follow-up|0|||
148858109|NCT05596734|536956073|FG009|Substudy A|Lost to Follow-up|0|||
148858110|NCT05596734|536956074|FG010|Substudy A|Lost to Follow-up|0|||
148858111|NCT05596734|536956075|FG011|Substudy A|Lost to Follow-up|0|||
148858112|NCT05596734|536956076|FG012|Substudy A|Lost to Follow-up|0|||
148858113|NCT05596734|536956077|FG013|Substudy A|Lost to Follow-up|0|||
148858114|NCT05596734|536956078|FG014|Substudy A|Lost to Follow-up|0|||
148858115|NCT05596734|536956079|FG015|Substudy A|Lost to Follow-up|0|||
148858116|NCT05596734|536956080|FG016|Substudy A|Lost to Follow-up|0|||
148858117|NCT05596734|536956081|FG017|Substudy A|Lost to Follow-up|0|||
148858118|NCT05596734|536956082|FG018|Substudy A|Lost to Follow-up|0|||
148858119|NCT05596734|536956083|FG019|Substudy A|Lost to Follow-up|0|||
148858120|NCT05596734|536956084|FG020|Substudy A|Lost to Follow-up|0|||
148858121|NCT05596734|536956085|FG021|Substudy A|Lost to Follow-up|0|||
148858122|NCT05596734|536956086|FG022|Substudy A|Lost to Follow-up|0|||
148858123|NCT05596734|536956087|FG023|Substudy A|Lost to Follow-up|0|||
148858124|NCT05596734|536956064|FG000|Substudy B|Withdrawal by Subject|0|||
148858125|NCT05596734|536956065|FG001|Substudy B|Withdrawal by Subject|0|||
148858126|NCT05596734|536956066|FG002|Substudy B|Withdrawal by Subject|0|||
148858127|NCT05596734|536956067|FG003|Substudy B|Withdrawal by Subject|0|||
148858128|NCT05596734|536956068|FG004|Substudy B|Withdrawal by Subject|0|||
148858129|NCT05596734|536956069|FG005|Substudy B|Withdrawal by Subject|0|||
148858130|NCT05596734|536956070|FG006|Substudy B|Withdrawal by Subject|0|||
149030696|NCT00813488|537589693|FG001|Double-blind Treatment Period 2|Other|0|||
148858131|NCT05596734|536956071|FG007|Substudy B|Withdrawal by Subject|0|||
148858132|NCT05596734|536956072|FG008|Substudy B|Withdrawal by Subject|0|||
148858133|NCT05596734|536956073|FG009|Substudy B|Withdrawal by Subject|0|||
148858134|NCT05596734|536956074|FG010|Substudy B|Withdrawal by Subject|0|||
148858135|NCT05596734|536956075|FG011|Substudy B|Withdrawal by Subject|0|||
148858136|NCT05596734|536956076|FG012|Substudy B|Withdrawal by Subject|1|||
148858137|NCT05596734|536956077|FG013|Substudy B|Withdrawal by Subject|0|||
148858138|NCT05596734|536956078|FG014|Substudy B|Withdrawal by Subject|1|||
148858139|NCT05596734|536956079|FG015|Substudy B|Withdrawal by Subject|2|||
148858140|NCT05596734|536956080|FG016|Substudy B|Withdrawal by Subject|2|||
148858141|NCT05596734|536956081|FG017|Substudy B|Withdrawal by Subject|1|||
148858142|NCT05596734|536956082|FG018|Substudy B|Withdrawal by Subject|2|||
148858143|NCT05596734|536956083|FG019|Substudy B|Withdrawal by Subject|0|||
148858144|NCT05596734|536956084|FG020|Substudy B|Withdrawal by Subject|0|||
148858145|NCT05596734|536956085|FG021|Substudy B|Withdrawal by Subject|0|||
148858146|NCT05596734|536956086|FG022|Substudy B|Withdrawal by Subject|0|||
148858147|NCT05596734|536956087|FG023|Substudy B|Withdrawal by Subject|1|||
148858148|NCT05596734|536956064|FG000|Substudy B|Physician Decision|0|||
148858149|NCT05596734|536956065|FG001|Substudy B|Physician Decision|0|||
148858150|NCT05596734|536956066|FG002|Substudy B|Physician Decision|0|||
148858151|NCT05596734|536956067|FG003|Substudy B|Physician Decision|0|||
148858152|NCT05596734|536956068|FG004|Substudy B|Physician Decision|0|||
148858153|NCT05596734|536956069|FG005|Substudy B|Physician Decision|0|||
148858154|NCT05596734|536956070|FG006|Substudy B|Physician Decision|0|||
148858155|NCT05596734|536956071|FG007|Substudy B|Physician Decision|0|||
148858156|NCT05596734|536956072|FG008|Substudy B|Physician Decision|0|||
148991567|NCT03240588|537445682|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
148991568|NCT03240588|537445683|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
148991569|NCT03240588|537445684|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
148991570|NCT03240588|537445682|FG000|Overall Study|Closure of study|55|||
148991571|NCT03240588|537445683|FG001|Overall Study|Closure of study|3|||
148991572|NCT03240588|537445684|FG002|Overall Study|Closure of study|0|||
148991573|NCT03240588|537445682|FG000|Overall Study|Subject non-compliance|23|||
148991574|NCT03240588|537445683|FG001|Overall Study|Subject non-compliance|2|||
148991575|NCT03240588|537445684|FG002|Overall Study|Subject non-compliance|1|||
148991576|NCT03240588|537445682|FG000|Overall Study|Device Deficiency|1|||
148991577|NCT03240588|537445683|FG001|Overall Study|Device Deficiency|0|||
148991578|NCT03240588|537445684|FG002|Overall Study|Device Deficiency|0|||
148858157|NCT05596734|536956073|FG009|Substudy B|Physician Decision|0|||
148858158|NCT05596734|536956074|FG010|Substudy B|Physician Decision|0|||
148858159|NCT05596734|536956075|FG011|Substudy B|Physician Decision|0|||
148858160|NCT05596734|536956076|FG012|Substudy B|Physician Decision|0|||
148858161|NCT05596734|536956077|FG013|Substudy B|Physician Decision|0|||
148858162|NCT05596734|536956078|FG014|Substudy B|Physician Decision|0|||
148858163|NCT05596734|536956079|FG015|Substudy B|Physician Decision|1|||
148858164|NCT05596734|536956080|FG016|Substudy B|Physician Decision|0|||
148858165|NCT05596734|536956081|FG017|Substudy B|Physician Decision|0|||
148858166|NCT05596734|536956082|FG018|Substudy B|Physician Decision|0|||
148858167|NCT05596734|536956083|FG019|Substudy B|Physician Decision|0|||
148858168|NCT05596734|536956084|FG020|Substudy B|Physician Decision|0|||
148858169|NCT05596734|536956085|FG021|Substudy B|Physician Decision|0|||
148858170|NCT05596734|536956086|FG022|Substudy B|Physician Decision|0|||
148858171|NCT05596734|536956087|FG023|Substudy B|Physician Decision|0|||
148858172|NCT05596734|536956064|FG000|Substudy B|Lost to Follow-up|0|||
148858173|NCT05596734|536956065|FG001|Substudy B|Lost to Follow-up|0|||
148858174|NCT05596734|536956066|FG002|Substudy B|Lost to Follow-up|0|||
148858175|NCT05596734|536956067|FG003|Substudy B|Lost to Follow-up|0|||
148858176|NCT05596734|536956068|FG004|Substudy B|Lost to Follow-up|0|||
148858177|NCT05596734|536956069|FG005|Substudy B|Lost to Follow-up|0|||
148858178|NCT05596734|536956070|FG006|Substudy B|Lost to Follow-up|0|||
148858179|NCT05596734|536956071|FG007|Substudy B|Lost to Follow-up|0|||
148858180|NCT05596734|536956072|FG008|Substudy B|Lost to Follow-up|0|||
148858181|NCT05596734|536956073|FG009|Substudy B|Lost to Follow-up|0|||
148858182|NCT05596734|536956074|FG010|Substudy B|Lost to Follow-up|0|||
148858183|NCT05596734|536956075|FG011|Substudy B|Lost to Follow-up|0|||
148858184|NCT05596734|536956076|FG012|Substudy B|Lost to Follow-up|1|||
148858185|NCT05596734|536956077|FG013|Substudy B|Lost to Follow-up|0|||
148991579|NCT03240588|537445682|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
148991580|NCT03240588|537445683|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
148991581|NCT03240588|537445684|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
148991582|NCT02091726|537445686|FG000|Overall Study|Lost to Follow-up|6|||
148991583|NCT02047045|537445690|FG000|Baseline|Withdrawal by Subject|3|||
148991584|NCT02047045|537445691|FG001|Baseline|Withdrawal by Subject|2|||
148991585|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
148858186|NCT05596734|536956078|FG014|Substudy B|Lost to Follow-up|1|||
148858187|NCT05596734|536956079|FG015|Substudy B|Lost to Follow-up|1|||
148858188|NCT05596734|536956080|FG016|Substudy B|Lost to Follow-up|0|||
148858189|NCT05596734|536956081|FG017|Substudy B|Lost to Follow-up|0|||
148858190|NCT05596734|536956082|FG018|Substudy B|Lost to Follow-up|0|||
148858191|NCT05596734|536956083|FG019|Substudy B|Lost to Follow-up|0|||
148858192|NCT05596734|536956084|FG020|Substudy B|Lost to Follow-up|0|||
148858193|NCT05596734|536956085|FG021|Substudy B|Lost to Follow-up|0|||
148858194|NCT05596734|536956086|FG022|Substudy B|Lost to Follow-up|0|||
148858195|NCT05596734|536956087|FG023|Substudy B|Lost to Follow-up|0|||
148858196|NCT03219034|536956090|FG000|Overall Study|Lost to Follow-up|9|||
148858197|NCT03219034|536956091|FG001|Overall Study|Lost to Follow-up|13|||
148991586|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
148991587|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
148991588|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
148991589|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
148991590|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
148858198|NCT03219034|536956090|FG000|Overall Study|Additional dental work needed|1|||
148858199|NCT03219034|536956091|FG001|Overall Study|Additional dental work needed|0|||
148858200|NCT03219034|536956090|FG000|Overall Study|UPPP Surgery|1|||
148858201|NCT03219034|536956091|FG001|Overall Study|UPPP Surgery|0|||
148858202|NCT03219034|536956090|FG000|Overall Study|Dental sensitivity|0|||
148858203|NCT03219034|536956091|FG001|Overall Study|Dental sensitivity|1|||
148858204|NCT03219034|536956090|FG000|Overall Study|Death in family|0|||
148858205|NCT03219034|536956091|FG001|Overall Study|Death in family|1|||
148858206|NCT02136680|536956095|FG000|Overall Study|No Longer Interested|1|||
148858207|NCT02136680|536956096|FG001|Overall Study|No Longer Interested|1|||
148991591|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
148991592|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
148991593|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
148991594|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
148991595|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
148991596|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
148991597|NCT02047045|537445690|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
148991598|NCT02047045|537445691|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
148991599|NCT02047045|537445690|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
148991600|NCT02047045|537445691|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
148991601|NCT04066114|537445692|FG000|Overall Study|Adverse Event|1|||
148991602|NCT04066114|537445693|FG001|Overall Study|Adverse Event|0|||
148991603|NCT04066114|537445694|FG002|Overall Study|Adverse Event|0|||
148991604|NCT04066114|537445692|FG000|Overall Study|Withdrawal by Subject|1|||
148991605|NCT04066114|537445693|FG001|Overall Study|Withdrawal by Subject|0|||
148991606|NCT04066114|537445694|FG002|Overall Study|Withdrawal by Subject|0|||
148991607|NCT04066114|537445692|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
148991608|NCT04066114|537445693|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
148991609|NCT04066114|537445694|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
148991610|NCT00856856|537445696|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
148991611|NCT00856856|537445696|FG000|4-year Clinical Follow-up|Missed visit|1|||
148991612|NCT00434057|537445699|FG000|Overall Study|Withdrawal by Subject|1|||
148991613|NCT00455195|537445702|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
148991614|NCT00455195|537445703|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
148991615|NCT00455195|537445702|FG000|Double-blind Study AGLU02704|Death|1|||
148991616|NCT00455195|537445703|FG001|Double-blind Study AGLU02704|Death|0|||
148991617|NCT00455195|537445702|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
148991618|NCT00455195|537445703|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
148991619|NCT00455195|537445702|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
148991620|NCT00455195|537445703|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
148991621|NCT02117570|537445706|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
148991622|NCT02117570|537445707|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
148991623|NCT02117570|537445708|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
148991624|NCT02117570|537445706|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
148991625|NCT02117570|537445707|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
148991626|NCT02117570|537445708|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
148991627|NCT02117570|537445706|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
148991628|NCT02117570|537445707|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
148991629|NCT02117570|537445708|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
148991630|NCT02117570|537445706|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
148991631|NCT02117570|537445707|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
148991632|NCT02117570|537445708|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
148991633|NCT02117570|537445706|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
148991634|NCT02117570|537445707|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
148991635|NCT02117570|537445708|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
148991636|NCT02117570|537445706|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
148991637|NCT02117570|537445707|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
148991638|NCT02117570|537445708|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
148991639|NCT02117570|537445706|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
148991640|NCT02117570|537445707|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
148991641|NCT02117570|537445708|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
148991642|NCT02148250|537445709|FG000|Screening|Withdrawal by Subject|5|||
148991643|NCT02148250|537445710|FG001|Screening|Withdrawal by Subject|0|||
148991644|NCT00922428|537445711|FG000|Overall Study|retrospective/extremely implausible data|2|||
148991645|NCT00922428|537445711|FG000|Overall Study|no medication use or questionable use|13|||
148991646|NCT03701555|537445723|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
148991647|NCT03701555|537445724|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
148991648|NCT03701555|537445725|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
148991649|NCT03701555|537445726|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
148991650|NCT03701555|537445727|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
148991651|NCT03701555|537445728|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
148991652|NCT03701555|537445729|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
148991653|NCT03701555|537445730|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
148991654|NCT03701555|537445731|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
148991655|NCT03701555|537445732|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
148991656|NCT03701555|537445733|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
148991657|NCT03701555|537445734|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
148991658|NCT03701555|537445735|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
149030697|NCT00813488|537589692|FG000|Open-label Extension|Adverse Event|1|||
149030698|NCT00813488|537589693|FG001|Open-label Extension|Adverse Event|2|||
148991659|NCT03701555|537445736|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
148991660|NCT03701555|537445737|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
148991661|NCT03701555|537445738|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
148991662|NCT03701555|537445739|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
148991663|NCT03701555|537445740|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
148991664|NCT03701555|537445741|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
148991665|NCT03701555|537445742|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
148991666|NCT03701555|537445743|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
148991667|NCT03701555|537445744|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
148991668|NCT03701555|537445745|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
148991669|NCT03701555|537445746|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
148991670|NCT03701555|537445747|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
148991671|NCT03701555|537445748|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
148991672|NCT03701555|537445749|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
148991673|NCT03701555|537445750|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
148991674|NCT03701555|537445751|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
148991675|NCT03701555|537445752|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
148991676|NCT03701555|537445753|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
148991677|NCT03701555|537445754|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
148991678|NCT03701555|537445755|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
148991679|NCT03701555|537445756|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
148991680|NCT03701555|537445757|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
148991681|NCT03701555|537445758|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
148991682|NCT03701555|537445723|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
148991683|NCT03701555|537445724|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
148991684|NCT03701555|537445725|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
148991685|NCT03701555|537445726|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
148991686|NCT03701555|537445727|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
148991687|NCT03701555|537445728|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
148991688|NCT03701555|537445729|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
148991689|NCT03701555|537445730|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
148991690|NCT03701555|537445731|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
148991691|NCT03701555|537445732|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
148991692|NCT03701555|537445733|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
148991693|NCT03701555|537445734|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
148991694|NCT03701555|537445735|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
148991695|NCT03701555|537445736|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
148991696|NCT03701555|537445737|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
148991697|NCT03701555|537445738|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
148991698|NCT03701555|537445739|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
148991699|NCT03701555|537445740|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
148991700|NCT03701555|537445741|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
148991701|NCT03701555|537445742|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
148991702|NCT03701555|537445743|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
148991703|NCT03701555|537445744|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
148991704|NCT03701555|537445745|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
148991705|NCT03701555|537445746|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
148991706|NCT03701555|537445747|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
148991707|NCT03701555|537445748|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
148991708|NCT03701555|537445749|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
148991709|NCT03701555|537445750|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
148991710|NCT03701555|537445751|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
148991711|NCT03701555|537445752|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
148991712|NCT03701555|537445753|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
148991713|NCT03701555|537445754|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
148991714|NCT03701555|537445755|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
148991715|NCT03701555|537445756|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
148991716|NCT03701555|537445757|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
148991717|NCT03701555|537445758|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
148991718|NCT03701555|537445723|FG000|Part 2 (Day 1)|Other|0|||
148991719|NCT03701555|537445724|FG001|Part 2 (Day 1)|Other|0|||
148991720|NCT03701555|537445725|FG002|Part 2 (Day 1)|Other|0|||
148991721|NCT03701555|537445726|FG003|Part 2 (Day 1)|Other|0|||
148991722|NCT03701555|537445727|FG004|Part 2 (Day 1)|Other|0|||
148991723|NCT03701555|537445728|FG005|Part 2 (Day 1)|Other|0|||
148991724|NCT03701555|537445729|FG006|Part 2 (Day 1)|Other|0|||
148991725|NCT03701555|537445730|FG007|Part 2 (Day 1)|Other|0|||
148991726|NCT03701555|537445731|FG008|Part 2 (Day 1)|Other|0|||
148991727|NCT03701555|537445732|FG009|Part 2 (Day 1)|Other|0|||
148991728|NCT03701555|537445733|FG010|Part 2 (Day 1)|Other|3|||
148991729|NCT03701555|537445734|FG011|Part 2 (Day 1)|Other|1|||
148991730|NCT03701555|537445735|FG012|Part 2 (Day 1)|Other|0|||
148991731|NCT03701555|537445736|FG013|Part 2 (Day 1)|Other|1|||
148991732|NCT03701555|537445737|FG014|Part 2 (Day 1)|Other|0|||
148991733|NCT03701555|537445738|FG015|Part 2 (Day 1)|Other|2|||
148991734|NCT03701555|537445739|FG016|Part 2 (Day 1)|Other|2|||
148991735|NCT03701555|537445740|FG017|Part 2 (Day 1)|Other|0|||
148991736|NCT03701555|537445741|FG018|Part 2 (Day 1)|Other|0|||
148991737|NCT03701555|537445742|FG019|Part 2 (Day 1)|Other|0|||
148991738|NCT03701555|537445743|FG020|Part 2 (Day 1)|Other|0|||
148858208|NCT02136680|536956095|FG000|Overall Study|No longer receiving care at clinic|3|||
148858209|NCT02136680|536956096|FG001|Overall Study|No longer receiving care at clinic|5|||
148858210|NCT02136680|536956095|FG000|Overall Study|Moved away|5|||
148858211|NCT02136680|536956096|FG001|Overall Study|Moved away|4|||
148858212|NCT02136680|536956095|FG000|Overall Study|Unable to schedule|17|||
148858213|NCT02136680|536956096|FG001|Overall Study|Unable to schedule|16|||
148858214|NCT02136680|536956095|FG000|Overall Study|Study ended before interview due|6|||
148858215|NCT02136680|536956096|FG001|Overall Study|Study ended before interview due|3|||
148858216|NCT00983515|536957834|FG000|Ritonavir Alone|liver panel out of range|6|||
148858217|NCT00983515|536957834|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
148858218|NCT01468207|536957835|FG000|Treatment Period 1|Adverse Event|1|||
148858219|NCT01468207|536957836|FG001|Treatment Period 1|Adverse Event|0|||
148858220|NCT01468207|536957837|FG002|Treatment Period 1|Adverse Event|0|||
148858221|NCT01468207|536957838|FG003|Treatment Period 1|Adverse Event|0|||
148858222|NCT01468207|536957839|FG004|Treatment Period 1|Adverse Event|0|||
148858223|NCT01468207|536957840|FG005|Treatment Period 1|Adverse Event|0|||
148858224|NCT01468207|536957835|FG000|Treatment Period 1|Protocol Violation|1|||
148858225|NCT01468207|536957836|FG001|Treatment Period 1|Protocol Violation|1|||
148858226|NCT01468207|536957837|FG002|Treatment Period 1|Protocol Violation|0|||
148858227|NCT01468207|536957838|FG003|Treatment Period 1|Protocol Violation|0|||
148858228|NCT01468207|536957839|FG004|Treatment Period 1|Protocol Violation|0|||
148858229|NCT01468207|536957840|FG005|Treatment Period 1|Protocol Violation|0|||
148858230|NCT01468207|536957835|FG000|Treatment Period 1|Withdrawal by Subject|5|||
148858231|NCT01468207|536957836|FG001|Treatment Period 1|Withdrawal by Subject|4|||
148858232|NCT01468207|536957837|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148858233|NCT01468207|536957838|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148858234|NCT01468207|536957839|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148858235|NCT01468207|536957840|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148858236|NCT01468207|536957835|FG000|Treatment Period 1|Lost to Follow-up|2|||
148858237|NCT01468207|536957836|FG001|Treatment Period 1|Lost to Follow-up|1|||
148858238|NCT01468207|536957837|FG002|Treatment Period 1|Lost to Follow-up|0|||
148858239|NCT01468207|536957838|FG003|Treatment Period 1|Lost to Follow-up|0|||
148858240|NCT01468207|536957839|FG004|Treatment Period 1|Lost to Follow-up|0|||
148858241|NCT01468207|536957840|FG005|Treatment Period 1|Lost to Follow-up|0|||
148858242|NCT01468207|536957835|FG000|Treatment Period 1|Other|0|||
148858243|NCT01468207|536957836|FG001|Treatment Period 1|Other|2|||
148858244|NCT01468207|536957837|FG002|Treatment Period 1|Other|0|||
148858245|NCT01468207|536957838|FG003|Treatment Period 1|Other|0|||
148858246|NCT01468207|536957839|FG004|Treatment Period 1|Other|0|||
148858247|NCT01468207|536957840|FG005|Treatment Period 1|Other|0|||
148858248|NCT01468207|536957835|FG000|Treatment Period 2|Adverse Event|0|||
148858249|NCT01468207|536957836|FG001|Treatment Period 2|Adverse Event|0|||
148858250|NCT01468207|536957837|FG002|Treatment Period 2|Adverse Event|6|||
148858251|NCT01468207|536957838|FG003|Treatment Period 2|Adverse Event|1|||
148858252|NCT01468207|536957839|FG004|Treatment Period 2|Adverse Event|2|||
148858253|NCT01468207|536957840|FG005|Treatment Period 2|Adverse Event|1|||
148858254|NCT01468207|536957835|FG000|Treatment Period 2|Lack of Efficacy|0|||
148858255|NCT01468207|536957836|FG001|Treatment Period 2|Lack of Efficacy|0|||
148858256|NCT01468207|536957837|FG002|Treatment Period 2|Lack of Efficacy|1|||
148858257|NCT01468207|536957838|FG003|Treatment Period 2|Lack of Efficacy|1|||
148858258|NCT01468207|536957839|FG004|Treatment Period 2|Lack of Efficacy|0|||
148858259|NCT01468207|536957840|FG005|Treatment Period 2|Lack of Efficacy|2|||
148858260|NCT01468207|536957835|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148858261|NCT01468207|536957836|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148858262|NCT01468207|536957837|FG002|Treatment Period 2|Withdrawal by Subject|5|||
148858263|NCT01468207|536957838|FG003|Treatment Period 2|Withdrawal by Subject|0|||
148858264|NCT01468207|536957839|FG004|Treatment Period 2|Withdrawal by Subject|0|||
148858265|NCT01468207|536957840|FG005|Treatment Period 2|Withdrawal by Subject|2|||
148858266|NCT01468207|536957835|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
148858267|NCT01468207|536957836|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
148991739|NCT03701555|537445744|FG021|Part 2 (Day 1)|Other|0|||
148991740|NCT03701555|537445745|FG022|Part 2 (Day 1)|Other|0|||
148858268|NCT01468207|536957837|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
148858269|NCT01468207|536957838|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
148858270|NCT01468207|536957839|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
148858271|NCT01468207|536957840|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
148858272|NCT01468207|536957835|FG000|Treatment Period 2|Lost to Follow-up|0|||
148858273|NCT01468207|536957836|FG001|Treatment Period 2|Lost to Follow-up|0|||
148858274|NCT01468207|536957837|FG002|Treatment Period 2|Lost to Follow-up|5|||
148858275|NCT01468207|536957838|FG003|Treatment Period 2|Lost to Follow-up|1|||
148858276|NCT01468207|536957839|FG004|Treatment Period 2|Lost to Follow-up|0|||
148858277|NCT01468207|536957840|FG005|Treatment Period 2|Lost to Follow-up|0|||
148858278|NCT01468207|536957835|FG000|Treatment Period 2|Other|0|||
148858279|NCT01468207|536957836|FG001|Treatment Period 2|Other|0|||
148858280|NCT01468207|536957837|FG002|Treatment Period 2|Other|5|||
148858281|NCT01468207|536957838|FG003|Treatment Period 2|Other|1|||
148991741|NCT03701555|537445746|FG023|Part 2 (Day 1)|Other|0|||
148858282|NCT01468207|536957839|FG004|Treatment Period 2|Other|1|||
148858283|NCT01468207|536957840|FG005|Treatment Period 2|Other|2|||
148858284|NCT04225676|536957847|FG000|Overall Study|Physician Decision|1|||
148991742|NCT03701555|537445747|FG024|Part 2 (Day 1)|Other|0|||
148991743|NCT03701555|537445748|FG025|Part 2 (Day 1)|Other|0|||
148991744|NCT03701555|537445749|FG026|Part 2 (Day 1)|Other|0|||
148991745|NCT03701555|537445750|FG027|Part 2 (Day 1)|Other|0|||
148991746|NCT03701555|537445751|FG028|Part 2 (Day 1)|Other|0|||
148991747|NCT03701555|537445752|FG029|Part 2 (Day 1)|Other|0|||
148991748|NCT03701555|537445753|FG030|Part 2 (Day 1)|Other|0|||
148991749|NCT03701555|537445754|FG031|Part 2 (Day 1)|Other|0|||
148991750|NCT03701555|537445755|FG032|Part 2 (Day 1)|Other|0|||
148991751|NCT03701555|537445756|FG033|Part 2 (Day 1)|Other|0|||
148991752|NCT03701555|537445757|FG034|Part 2 (Day 1)|Other|0|||
148991753|NCT03701555|537445758|FG035|Part 2 (Day 1)|Other|0|||
148991754|NCT03701555|537445723|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
148991755|NCT03701555|537445724|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
148991756|NCT03701555|537445725|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
148991757|NCT03701555|537445726|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
148991758|NCT03701555|537445727|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
148991759|NCT03701555|537445728|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
148991760|NCT03701555|537445729|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
148991761|NCT03701555|537445730|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
148991762|NCT03701555|537445731|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
148991763|NCT03701555|537445732|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
148991764|NCT03701555|537445733|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
148991765|NCT03701555|537445734|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
148991766|NCT03701555|537445735|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
148991767|NCT03701555|537445736|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
148991768|NCT03701555|537445737|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
148991769|NCT03701555|537445738|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
148991770|NCT03701555|537445739|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
148991771|NCT03701555|537445740|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
148991772|NCT03701555|537445741|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
148991773|NCT03701555|537445742|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
148991774|NCT03701555|537445743|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
148991775|NCT03701555|537445744|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
148991776|NCT03701555|537445745|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
148991777|NCT03701555|537445746|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
148991778|NCT03701555|537445747|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
148991779|NCT03701555|537445748|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
148991780|NCT03701555|537445749|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
148991781|NCT03701555|537445750|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
148991782|NCT03701555|537445751|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
148991783|NCT03701555|537445752|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
148991784|NCT03701555|537445753|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
148991785|NCT03701555|537445754|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
148991786|NCT03701555|537445755|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
148991787|NCT03701555|537445756|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
148991788|NCT03701555|537445757|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
148991789|NCT03701555|537445758|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
148991790|NCT03701555|537445723|FG000|Part 3 (Day 1)|Subject Decision|0|||
148991791|NCT03701555|537445724|FG001|Part 3 (Day 1)|Subject Decision|0|||
148991792|NCT03701555|537445725|FG002|Part 3 (Day 1)|Subject Decision|0|||
148991793|NCT03701555|537445726|FG003|Part 3 (Day 1)|Subject Decision|0|||
148991794|NCT03701555|537445727|FG004|Part 3 (Day 1)|Subject Decision|0|||
148991795|NCT03701555|537445728|FG005|Part 3 (Day 1)|Subject Decision|0|||
148991796|NCT03701555|537445729|FG006|Part 3 (Day 1)|Subject Decision|0|||
148991797|NCT03701555|537445730|FG007|Part 3 (Day 1)|Subject Decision|0|||
148991798|NCT03701555|537445731|FG008|Part 3 (Day 1)|Subject Decision|0|||
148991799|NCT03701555|537445732|FG009|Part 3 (Day 1)|Subject Decision|0|||
148991800|NCT03701555|537445733|FG010|Part 3 (Day 1)|Subject Decision|0|||
148991801|NCT03701555|537445734|FG011|Part 3 (Day 1)|Subject Decision|0|||
148991802|NCT03701555|537445735|FG012|Part 3 (Day 1)|Subject Decision|0|||
148991803|NCT03701555|537445736|FG013|Part 3 (Day 1)|Subject Decision|0|||
148858285|NCT04225676|536957847|FG000|Overall Study|Lack of Efficacy|1|||
148858286|NCT04225676|536957847|FG000|Overall Study|Study terminated by sponsor|3|||
148858287|NCT02449889|536957855|FG000|Overall Study|Adverse Event|1|||
148991804|NCT03701555|537445737|FG014|Part 3 (Day 1)|Subject Decision|0|||
148991805|NCT03701555|537445738|FG015|Part 3 (Day 1)|Subject Decision|0|||
148991806|NCT03701555|537445739|FG016|Part 3 (Day 1)|Subject Decision|0|||
148991807|NCT03701555|537445740|FG017|Part 3 (Day 1)|Subject Decision|0|||
148991808|NCT03701555|537445741|FG018|Part 3 (Day 1)|Subject Decision|0|||
148991809|NCT03701555|537445742|FG019|Part 3 (Day 1)|Subject Decision|0|||
148858288|NCT02449889|536957856|FG001|Overall Study|Adverse Event|2|||
148991810|NCT03701555|537445743|FG020|Part 3 (Day 1)|Subject Decision|0|||
148991811|NCT03701555|537445744|FG021|Part 3 (Day 1)|Subject Decision|0|||
148991812|NCT03701555|537445745|FG022|Part 3 (Day 1)|Subject Decision|0|||
149030699|NCT00813488|537589692|FG000|Open-label Extension|Lack of Efficacy|3|||
148991813|NCT03701555|537445746|FG023|Part 3 (Day 1)|Subject Decision|0|||
148991814|NCT03701555|537445747|FG024|Part 3 (Day 1)|Subject Decision|0|||
148991815|NCT03701555|537445748|FG025|Part 3 (Day 1)|Subject Decision|0|||
148991816|NCT03701555|537445749|FG026|Part 3 (Day 1)|Subject Decision|1|||
148991817|NCT03701555|537445750|FG027|Part 3 (Day 1)|Subject Decision|0|||
148991818|NCT03701555|537445751|FG028|Part 3 (Day 1)|Subject Decision|0|||
148991819|NCT03701555|537445752|FG029|Part 3 (Day 1)|Subject Decision|0|||
148991820|NCT03701555|537445753|FG030|Part 3 (Day 1)|Subject Decision|0|||
148991821|NCT03701555|537445754|FG031|Part 3 (Day 1)|Subject Decision|2|||
148991822|NCT03701555|537445755|FG032|Part 3 (Day 1)|Subject Decision|1|||
148991823|NCT03701555|537445756|FG033|Part 3 (Day 1)|Subject Decision|1|||
148991824|NCT03701555|537445757|FG034|Part 3 (Day 1)|Subject Decision|0|||
148991825|NCT03701555|537445758|FG035|Part 3 (Day 1)|Subject Decision|0|||
148991826|NCT03701555|537445723|FG000|Part 3 (Day 1)|Other|0|||
148991827|NCT03701555|537445724|FG001|Part 3 (Day 1)|Other|0|||
148991828|NCT03701555|537445725|FG002|Part 3 (Day 1)|Other|0|||
148991829|NCT03701555|537445726|FG003|Part 3 (Day 1)|Other|0|||
148991830|NCT03701555|537445727|FG004|Part 3 (Day 1)|Other|0|||
148991831|NCT03701555|537445728|FG005|Part 3 (Day 1)|Other|0|||
148991832|NCT03701555|537445729|FG006|Part 3 (Day 1)|Other|0|||
148991833|NCT03701555|537445730|FG007|Part 3 (Day 1)|Other|0|||
148991834|NCT03701555|537445731|FG008|Part 3 (Day 1)|Other|0|||
148991835|NCT03701555|537445732|FG009|Part 3 (Day 1)|Other|0|||
148991836|NCT03701555|537445733|FG010|Part 3 (Day 1)|Other|0|||
148991837|NCT03701555|537445734|FG011|Part 3 (Day 1)|Other|0|||
148991838|NCT03701555|537445735|FG012|Part 3 (Day 1)|Other|0|||
148991839|NCT03701555|537445736|FG013|Part 3 (Day 1)|Other|0|||
148991840|NCT03701555|537445737|FG014|Part 3 (Day 1)|Other|0|||
148991841|NCT03701555|537445738|FG015|Part 3 (Day 1)|Other|0|||
148991842|NCT03701555|537445739|FG016|Part 3 (Day 1)|Other|0|||
148991843|NCT03701555|537445740|FG017|Part 3 (Day 1)|Other|0|||
148991844|NCT03701555|537445741|FG018|Part 3 (Day 1)|Other|0|||
148991845|NCT03701555|537445742|FG019|Part 3 (Day 1)|Other|0|||
148991846|NCT03701555|537445743|FG020|Part 3 (Day 1)|Other|0|||
148991847|NCT03701555|537445744|FG021|Part 3 (Day 1)|Other|0|||
148991848|NCT03701555|537445745|FG022|Part 3 (Day 1)|Other|0|||
148991849|NCT03701555|537445746|FG023|Part 3 (Day 1)|Other|0|||
148991850|NCT03701555|537445747|FG024|Part 3 (Day 1)|Other|1|||
148991851|NCT03701555|537445748|FG025|Part 3 (Day 1)|Other|1|||
148991852|NCT03701555|537445749|FG026|Part 3 (Day 1)|Other|0|||
148991853|NCT03701555|537445750|FG027|Part 3 (Day 1)|Other|0|||
148991854|NCT03701555|537445751|FG028|Part 3 (Day 1)|Other|0|||
148991855|NCT03701555|537445752|FG029|Part 3 (Day 1)|Other|1|||
148991856|NCT03701555|537445753|FG030|Part 3 (Day 1)|Other|1|||
148991857|NCT03701555|537445754|FG031|Part 3 (Day 1)|Other|0|||
148991858|NCT03701555|537445755|FG032|Part 3 (Day 1)|Other|1|||
148991859|NCT03701555|537445756|FG033|Part 3 (Day 1)|Other|1|||
148991860|NCT03701555|537445757|FG034|Part 3 (Day 1)|Other|0|||
148991861|NCT03701555|537445758|FG035|Part 3 (Day 1)|Other|0|||
148991862|NCT02508311|537445764|FG000|Overall Study|Withdrawal by Subject|1|||
148991863|NCT02508311|537445765|FG001|Overall Study|Withdrawal by Subject|0|||
148991864|NCT02370602|537445766|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
148991865|NCT02370602|537445767|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
148991866|NCT02370602|537445768|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
148991867|NCT02370602|537445769|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
148991868|NCT02370602|537445770|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
148991869|NCT02370602|537445771|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
148991870|NCT03349710|537445772|FG000|Treatment Period|Death|0|||
148858289|NCT02449889|536957857|FG002|Overall Study|Adverse Event|0|||
148991871|NCT03349710|537445773|FG001|Treatment Period|Death|0|||
148991872|NCT03349710|537445774|FG002|Treatment Period|Death|1|||
148858290|NCT02449889|536957855|FG000|Overall Study|Protocol Violation|0|||
148858291|NCT02449889|536957856|FG001|Overall Study|Protocol Violation|4|||
148991873|NCT03349710|537445775|FG003|Treatment Period|Death|0|||
148858292|NCT02449889|536957857|FG002|Overall Study|Protocol Violation|1|||
148991874|NCT03349710|537445772|FG000|Treatment Period|Disease Progression|0|||
148991875|NCT03349710|537445773|FG001|Treatment Period|Disease Progression|2|||
148991876|NCT03349710|537445774|FG002|Treatment Period|Disease Progression|0|||
148991877|NCT03349710|537445775|FG003|Treatment Period|Disease Progression|1|||
148991878|NCT03349710|537445772|FG000|Treatment Period|Study Drug Toxicity|1|||
148858293|NCT01973387|536957858|FG000|Overall Study|Adverse Event|14|||
148991879|NCT03349710|537445773|FG001|Treatment Period|Study Drug Toxicity|0|||
148991880|NCT03349710|537445774|FG002|Treatment Period|Study Drug Toxicity|1|||
148991881|NCT03349710|537445775|FG003|Treatment Period|Study Drug Toxicity|1|||
148991882|NCT03349710|537445772|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
148991883|NCT03349710|537445773|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
148991884|NCT03349710|537445774|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
148991885|NCT03349710|537445775|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
148991886|NCT03349710|537445772|FG000|Treatment Period|admin reason by sponsor|0|||
148991887|NCT03349710|537445773|FG001|Treatment Period|admin reason by sponsor|7|||
148991888|NCT03349710|537445774|FG002|Treatment Period|admin reason by sponsor|0|||
148858294|NCT01973387|536957859|FG001|Overall Study|Adverse Event|4|||
148858295|NCT01973387|536957858|FG000|Overall Study|Withdrawal by Subject|7|||
148858296|NCT01973387|536957859|FG001|Overall Study|Withdrawal by Subject|4|||
148858297|NCT01973387|536957858|FG000|Overall Study|Study terminated by sponsor|63|||
148858298|NCT01973387|536957859|FG001|Overall Study|Study terminated by sponsor|0|||
148858299|NCT01973387|536957858|FG000|Overall Study|Progressive disease or relapse|16|||
148858300|NCT01973387|536957859|FG001|Overall Study|Progressive disease or relapse|5|||
148858301|NCT01973387|536957858|FG000|Overall Study|Death|4|||
148858302|NCT01973387|536957859|FG001|Overall Study|Death|3|||
148858303|NCT01973387|536957858|FG000|Overall Study|Randomized, not treated|2|||
148858304|NCT01973387|536957859|FG001|Overall Study|Randomized, not treated|2|||
148858305|NCT01498575|536957860|FG000|Overall Sample|Withdrawal by Subject|60|||
148858306|NCT01498575|536957861|FG001|Overall Sample|Withdrawal by Subject|14|||
148858307|NCT01498575|536957860|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
148858308|NCT01498575|536957861|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
148858309|NCT01498575|536957860|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
148858310|NCT01498575|536957861|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
148858311|NCT03176472|536957869|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
148858312|NCT03176472|536957870|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
148858313|NCT03176472|536957869|FG000|Double Blind Treatment Period|Adverse Event|0|||
148858314|NCT03176472|536957870|FG001|Double Blind Treatment Period|Adverse Event|5|||
148858315|NCT03176472|536957869|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
148858316|NCT03176472|536957870|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
148858317|NCT03176472|536957869|FG000|Double Blind Treatment Period|Physician Decision|0|||
148858318|NCT03176472|536957870|FG001|Double Blind Treatment Period|Physician Decision|1|||
148858319|NCT03176472|536957869|FG000|Double Blind Treatment Period|Protocol Violation|1|||
148858320|NCT03176472|536957870|FG001|Double Blind Treatment Period|Protocol Violation|0|||
148858321|NCT03176472|536957869|FG000|Double Blind Treatment Period|Not Provided|1|||
148858322|NCT03176472|536957870|FG001|Double Blind Treatment Period|Not Provided|0|||
148858323|NCT03176472|536957869|FG000|Open Label Extension|Withdrawal by Subject|3|||
148858324|NCT03176472|536957870|FG001|Open Label Extension|Withdrawal by Subject|4|||
148858325|NCT03176472|536957869|FG000|Open Label Extension|Adverse Event|2|||
148858326|NCT03176472|536957870|FG001|Open Label Extension|Adverse Event|4|||
148858327|NCT03176472|536957869|FG000|Open Label Extension|Lost to Follow-up|1|||
148858328|NCT03176472|536957870|FG001|Open Label Extension|Lost to Follow-up|2|||
148858329|NCT03176472|536957869|FG000|Open Label Extension|Protocol Violation|0|||
148858330|NCT03176472|536957870|FG001|Open Label Extension|Protocol Violation|1|||
148858331|NCT03176472|536957869|FG000|Open Label Extension|Not Provided|2|||
148858332|NCT03176472|536957870|FG001|Open Label Extension|Not Provided|1|||
148858333|NCT03272828|536957871|FG000|Overall Study|Lost to Follow-up|7|||
148858334|NCT03272828|536957872|FG001|Overall Study|Lost to Follow-up|7|||
148858335|NCT03272828|536957871|FG000|Overall Study|Withdrawal by Subject|2|||
148858336|NCT03272828|536957872|FG001|Overall Study|Withdrawal by Subject|0|||
148858337|NCT03272828|536957871|FG000|Overall Study|Deceased|1|||
148858338|NCT03272828|536957872|FG001|Overall Study|Deceased|1|||
148858339|NCT03272828|536957871|FG000|Overall Study|Failed implant|1|||
148858340|NCT03272828|536957872|FG001|Overall Study|Failed implant|2|||
148858341|NCT00847665|536957873|FG000|Overall Study|Withdrawal by Subject|1|||
148858342|NCT00847665|536957874|FG001|Overall Study|Withdrawal by Subject|0|||
148858343|NCT00624585|536957885|FG000|Overall Study|Death|3|||
148858344|NCT00624585|536957885|FG000|Overall Study|Disease Progression|6|||
148858345|NCT00624585|536957885|FG000|Overall Study|Adverse Event|3|||
148858346|NCT04295681|536957886|FG000|Overall Study|Eligibility error|1|||
148858347|NCT04295681|536957887|FG001|Overall Study|Eligibility error|3|||
148991889|NCT03349710|537445775|FG003|Treatment Period|admin reason by sponsor|19|||
148991890|NCT03349710|537445772|FG000|Treatment Period|Other Reason|2|||
148991891|NCT03349710|537445773|FG001|Treatment Period|Other Reason|0|||
148858348|NCT04154345|536957888|FG000|Overall Study|Covid-19 pandemic|4|||
148858349|NCT04686084|536957893|FG000|Overall Study|Lost to Follow-up|1|||
148858350|NCT03172325|536957898|FG000|Overall Study|Adverse Event|2|||
148858351|NCT03172325|536957899|FG001|Overall Study|Adverse Event|3|||
148858352|NCT03172325|536957898|FG000|Overall Study|Positive PPD|1|||
148858353|NCT03172325|536957899|FG001|Overall Study|Positive PPD|0|||
148858354|NCT03172325|536957898|FG000|Overall Study|Poor Compliance|1|||
148858355|NCT03172325|536957899|FG001|Overall Study|Poor Compliance|1|||
148858356|NCT03622112|536957902|FG000|Overall Study|Withdrawal by Subject|6|||
148858357|NCT03622112|536957903|FG001|Overall Study|Withdrawal by Subject|2|||
148858358|NCT03622112|536957904|FG002|Overall Study|Withdrawal by Subject|4|||
148858359|NCT03622112|536957905|FG003|Overall Study|Withdrawal by Subject|2|||
148858360|NCT03622112|536957906|FG004|Overall Study|Withdrawal by Subject|1|||
148858361|NCT03622112|536957907|FG005|Overall Study|Withdrawal by Subject|2|||
148858362|NCT03622112|536957908|FG006|Overall Study|Withdrawal by Subject|2|||
148858363|NCT03622112|536957902|FG000|Overall Study|Death|0|||
148858364|NCT03622112|536957903|FG001|Overall Study|Death|0|||
148858365|NCT03622112|536957904|FG002|Overall Study|Death|0|||
148858366|NCT03622112|536957905|FG003|Overall Study|Death|1|||
148991892|NCT03349710|537445774|FG002|Treatment Period|Other Reason|2|||
148991893|NCT03349710|537445775|FG003|Treatment Period|Other Reason|1|||
148991894|NCT03349710|537445772|FG000|Treatment Period|completed|6|||
148991895|NCT03349710|537445773|FG001|Treatment Period|completed|0|||
148991896|NCT03349710|537445774|FG002|Treatment Period|completed|18|||
148991897|NCT03349710|537445775|FG003|Treatment Period|completed|1|||
148991898|NCT03349710|537445772|FG000|Treatment Period|participant request to discontinue|0|||
148991899|NCT03349710|537445773|FG001|Treatment Period|participant request to discontinue|0|||
148991900|NCT03349710|537445774|FG002|Treatment Period|participant request to discontinue|4|||
148991901|NCT03349710|537445775|FG003|Treatment Period|participant request to discontinue|0|||
148991902|NCT03349710|537445772|FG000|Treatment Period|participant withdrew consent|1|||
148991903|NCT03349710|537445773|FG001|Treatment Period|participant withdrew consent|0|||
148991904|NCT03349710|537445774|FG002|Treatment Period|participant withdrew consent|0|||
148991905|NCT03349710|537445775|FG003|Treatment Period|participant withdrew consent|0|||
148991906|NCT04447404|537445780|FG000|Overall Study|Death|2|||
148991907|NCT04447404|537445781|FG001|Overall Study|Death|0|||
148991908|NCT04723576|537445782|FG000|Overall Study|Withdrawal by Subject|2133|||
148991909|NCT04723576|537445783|FG001|Overall Study|Withdrawal by Subject|3234|||
148991910|NCT00454051|537445784|FG000|Overall Study|Adverse Event|1|||
148991911|NCT00454051|537445785|FG001|Overall Study|Adverse Event|2|||
148991912|NCT00454051|537445784|FG000|Overall Study|Withdrawal by Subject|1|||
148991913|NCT00454051|537445785|FG001|Overall Study|Withdrawal by Subject|0|||
148991914|NCT00454051|537445784|FG000|Overall Study|Protocol Violation|1|||
148991915|NCT00454051|537445785|FG001|Overall Study|Protocol Violation|1|||
148991916|NCT01571362|537445786|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
148991917|NCT01571362|537445787|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
148991918|NCT01571362|537445788|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
148991919|NCT01571362|537445786|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
148991920|NCT01571362|537445787|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
148991921|NCT01571362|537445788|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
148991922|NCT01571362|537445786|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
148991923|NCT01571362|537445787|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
148991924|NCT01571362|537445788|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
148991925|NCT01571362|537445786|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
148991926|NCT01571362|537445787|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
148991927|NCT01571362|537445788|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
148991928|NCT01571362|537445786|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
148991929|NCT01571362|537445787|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
148991930|NCT01571362|537445788|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
148991931|NCT01571362|537445786|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
148991932|NCT01571362|537445787|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
148991933|NCT01571362|537445788|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
148991934|NCT01571362|537445786|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148991935|NCT01571362|537445787|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
148991936|NCT01571362|537445788|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
148991937|NCT01571362|537445786|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
148991938|NCT01571362|537445787|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
148991939|NCT01571362|537445788|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
148991940|NCT01571362|537445786|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148991941|NCT01571362|537445787|FG001|Double-Blind Treatment Period|Adverse Event|9|||
148991942|NCT01571362|537445788|FG002|Double-Blind Treatment Period|Adverse Event|14|||
148991943|NCT01571362|537445786|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
148991944|NCT01571362|537445787|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
148991945|NCT01571362|537445788|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
148991946|NCT01571362|537445786|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
148991947|NCT01571362|537445787|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
148991948|NCT01571362|537445788|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
148991949|NCT01571362|537445786|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
148991950|NCT01571362|537445787|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
148991951|NCT01571362|537445788|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
148991952|NCT03966157|537445789|FG000|Overall Study|Physician Decision|1|||
148991953|NCT03966157|537445790|FG001|Overall Study|Physician Decision|0|||
148991954|NCT01519206|537445791|FG000|Overall Study|Lost to Follow-up|3|||
148991955|NCT01519206|537445791|FG000|Overall Study|Missed Visit|2|||
148991956|NCT01491854|537445792|FG000|Overall Study|mainly due to premature termination|93|||
148991957|NCT01491854|537445792|FG000|Overall Study|Death|1|||
148991958|NCT01491854|537445792|FG000|Overall Study|Withdrawal by Subject|3|||
148991959|NCT01491854|537445792|FG000|Overall Study|Lost to Follow-up|33|||
148991960|NCT01026974|537445793|FG000|Overall Study|Withdrawal by Subject|0|||
148991961|NCT01026974|537445794|FG001|Overall Study|Withdrawal by Subject|1|||
148991962|NCT01026974|537445795|FG002|Overall Study|Withdrawal by Subject|7|||
148991963|NCT01026974|537445796|FG003|Overall Study|Withdrawal by Subject|2|||
148991964|NCT01026974|537445793|FG000|Overall Study|Lost to Follow-up|1|||
148991965|NCT01026974|537445794|FG001|Overall Study|Lost to Follow-up|1|||
148991966|NCT01026974|537445795|FG002|Overall Study|Lost to Follow-up|4|||
148991967|NCT01026974|537445796|FG003|Overall Study|Lost to Follow-up|0|||
148991968|NCT01026974|537445793|FG000|Overall Study|Adverse Event|0|||
148991969|NCT01026974|537445794|FG001|Overall Study|Adverse Event|0|||
148991970|NCT01026974|537445795|FG002|Overall Study|Adverse Event|0|||
148991971|NCT01026974|537445796|FG003|Overall Study|Adverse Event|1|||
148991972|NCT01026974|537445793|FG000|Overall Study|Inappropriate enrollment|0|||
148991973|NCT01026974|537445794|FG001|Overall Study|Inappropriate enrollment|0|||
148991974|NCT01026974|537445795|FG002|Overall Study|Inappropriate enrollment|1|||
148991975|NCT01026974|537445796|FG003|Overall Study|Inappropriate enrollment|0|||
148991976|NCT02199028|537445803|FG000|Week 1|Adverse Event|1|||
148991977|NCT02199028|537445804|FG001|Week 1|Adverse Event|0|||
148991978|NCT02199028|537445803|FG000|Week 3|Adverse Event|1|||
148991979|NCT02199028|537445804|FG001|Week 3|Adverse Event|0|||
148991980|NCT01881126|537445807|FG000|Overall Study|Non-compliance|1|||
148991981|NCT01881126|537445808|FG001|Overall Study|Non-compliance|1|||
148991982|NCT01881126|537445807|FG000|Overall Study|Adverse Event|0|||
148991983|NCT01881126|537445808|FG001|Overall Study|Adverse Event|1|||
148991984|NCT04072159|537445809|FG000|Overall Study|Lost to Follow-up|6|||
148991985|NCT04072159|537445810|FG001|Overall Study|Lost to Follow-up|6|||
148991986|NCT04072159|537445809|FG000|Overall Study|Withdrawal by Subject|2|||
148991987|NCT04072159|537445810|FG001|Overall Study|Withdrawal by Subject|0|||
148991988|NCT00695669|537445813|FG000|Overall Study|Adverse Event|0|||
148991989|NCT00695669|537445814|FG001|Overall Study|Adverse Event|0|||
148991990|NCT00695669|537445815|FG002|Overall Study|Adverse Event|2|||
148991991|NCT00695669|537445816|FG003|Overall Study|Adverse Event|0|||
148991992|NCT00695669|537445813|FG000|Overall Study|Lost to Follow-up|4|||
148991993|NCT00695669|537445814|FG001|Overall Study|Lost to Follow-up|4|||
148991994|NCT00695669|537445815|FG002|Overall Study|Lost to Follow-up|1|||
148991995|NCT00695669|537445816|FG003|Overall Study|Lost to Follow-up|4|||
148991996|NCT05045625|537445817|FG000|Overall Study|Lost to Follow-up|3|||
148991997|NCT00047879|537445819|FG000|Overall Study|Progressive disease|4|||
148991998|NCT00047879|537445820|FG001|Overall Study|Progressive disease|3|||
148991999|NCT01196975|537445822|FG000|Overall Study|Adverse Event|2|||
148992000|NCT01196975|537445823|FG001|Overall Study|Adverse Event|2|||
148992001|NCT01196975|537445824|FG002|Overall Study|Adverse Event|0|||
148992002|NCT01196975|537445825|FG003|Overall Study|Adverse Event|0|||
148992003|NCT01196975|537445826|FG004|Overall Study|Adverse Event|2|||
148992004|NCT01196975|537445822|FG000|Overall Study|Withdrawal by Subject|2|||
148992005|NCT01196975|537445823|FG001|Overall Study|Withdrawal by Subject|1|||
148992006|NCT01196975|537445824|FG002|Overall Study|Withdrawal by Subject|0|||
148992007|NCT01196975|537445825|FG003|Overall Study|Withdrawal by Subject|1|||
148992008|NCT01196975|537445826|FG004|Overall Study|Withdrawal by Subject|0|||
148992009|NCT01196975|537445822|FG000|Overall Study|Lost to Follow-up|11|||
148992010|NCT01196975|537445823|FG001|Overall Study|Lost to Follow-up|6|||
148992011|NCT01196975|537445824|FG002|Overall Study|Lost to Follow-up|5|||
148992012|NCT01196975|537445825|FG003|Overall Study|Lost to Follow-up|5|||
148992013|NCT01196975|537445826|FG004|Overall Study|Lost to Follow-up|11|||
148992014|NCT03738150|537445827|FG000|Base Study|Withdrawal by Subject|1|||
148992015|NCT03738150|537445827|FG000|Extension Study|Withdrawal by Subject|1|||
148992016|NCT04558346|537445842|FG000|Overall Study|Withdrawal by Subject|2|||
148992017|NCT04558346|537445843|FG001|Overall Study|Withdrawal by Subject|0|||
148992018|NCT04558346|537445842|FG000|Overall Study|Lost to Follow-up|0|||
148992019|NCT04558346|537445843|FG001|Overall Study|Lost to Follow-up|1|||
148992020|NCT04558346|537445842|FG000|Overall Study|Adverse Event|0|||
148992021|NCT04558346|537445843|FG001|Overall Study|Adverse Event|1|||
148992022|NCT01462344|537445844|FG000|Overall Study|Withdrawal by Subject|245|||
148992023|NCT01462344|537445845|FG001|Overall Study|Withdrawal by Subject|226|||
148992024|NCT01462344|537445844|FG000|Overall Study|Adverse Event|24|||
148992025|NCT01462344|537445845|FG001|Overall Study|Adverse Event|23|||
148992026|NCT01462344|537445844|FG000|Overall Study|Asthma Exacerbation|34|||
148858367|NCT03622112|536957906|FG004|Overall Study|Death|0|||
148992027|NCT01462344|537445845|FG001|Overall Study|Asthma Exacerbation|35|||
148858368|NCT03622112|536957907|FG005|Overall Study|Death|0|||
148992028|NCT01462344|537445844|FG000|Overall Study|Lack of Efficacy|5|||
148992029|NCT01462344|537445845|FG001|Overall Study|Lack of Efficacy|6|||
148992030|NCT01462344|537445844|FG000|Overall Study|Protocol Violation|68|||
148858369|NCT03622112|536957908|FG006|Overall Study|Death|0|||
148992031|NCT01462344|537445845|FG001|Overall Study|Protocol Violation|53|||
148992032|NCT01462344|537445844|FG000|Overall Study|Lost to Follow-up|7|||
148992033|NCT01462344|537445845|FG001|Overall Study|Lost to Follow-up|7|||
149030700|NCT00813488|537589693|FG001|Open-label Extension|Lack of Efficacy|0|||
148992034|NCT03086447|537445848|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
148992035|NCT03086447|537445849|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
148992036|NCT03086447|537445848|FG000|Overall Study|Lost Lens|2|||
148992037|NCT03086447|537445849|FG001|Overall Study|Lost Lens|5|||
148992038|NCT03086447|537445848|FG000|Overall Study|Product quality complaint|0|||
148992039|NCT03086447|537445849|FG001|Overall Study|Product quality complaint|1|||
148992040|NCT03086447|537445848|FG000|Overall Study|Lens Damage|1|||
148992041|NCT03086447|537445849|FG001|Overall Study|Lens Damage|6|||
148992042|NCT03086447|537445848|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
148992043|NCT03086447|537445849|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
148992044|NCT03086447|537445848|FG000|Overall Study|Test Article No Longer Available|1|||
148992045|NCT03086447|537445849|FG001|Overall Study|Test Article No Longer Available|0|||
148992046|NCT03086447|537445848|FG000|Overall Study|Protocol Violation|2|||
148992047|NCT03086447|537445849|FG001|Overall Study|Protocol Violation|4|||
148992048|NCT03086447|537445848|FG000|Overall Study|Lost to Follow-up|0|||
148992049|NCT03086447|537445849|FG001|Overall Study|Lost to Follow-up|1|||
148992050|NCT03086447|537445848|FG000|Overall Study|Adverse Event|3|||
148992051|NCT03086447|537445849|FG001|Overall Study|Adverse Event|0|||
148992052|NCT03086447|537445848|FG000|Overall Study|Lens Discomfort|2|||
148992053|NCT03086447|537445849|FG001|Overall Study|Lens Discomfort|1|||
148992054|NCT00809757|537445851|FG000|Overall Study|Adverse Event|2|||
148992055|NCT00809757|537445852|FG001|Overall Study|Adverse Event|3|||
148992056|NCT00809757|537445853|FG002|Overall Study|Adverse Event|3|||
148992057|NCT00809757|537445851|FG000|Overall Study|Lost to Follow-up|0|||
148992058|NCT00809757|537445852|FG001|Overall Study|Lost to Follow-up|0|||
148992059|NCT00809757|537445853|FG002|Overall Study|Lost to Follow-up|1|||
148992060|NCT00809757|537445851|FG000|Overall Study|Protocol Violation|1|||
148992061|NCT00809757|537445852|FG001|Overall Study|Protocol Violation|1|||
148992062|NCT00809757|537445853|FG002|Overall Study|Protocol Violation|1|||
148992063|NCT00809757|537445851|FG000|Overall Study|Withdrawal by Subject|2|||
148992064|NCT00809757|537445852|FG001|Overall Study|Withdrawal by Subject|1|||
148992065|NCT00809757|537445853|FG002|Overall Study|Withdrawal by Subject|3|||
148992066|NCT00809757|537445851|FG000|Overall Study|Subject Uncooperative|1|||
148992067|NCT00809757|537445852|FG001|Overall Study|Subject Uncooperative|0|||
148992068|NCT00809757|537445853|FG002|Overall Study|Subject Uncooperative|2|||
148992069|NCT00809757|537445851|FG000|Overall Study|Noncompliance with Medication|0|||
148992070|NCT00809757|537445852|FG001|Overall Study|Noncompliance with Medication|0|||
148992071|NCT00809757|537445853|FG002|Overall Study|Noncompliance with Medication|1|||
148992072|NCT00659334|537445854|FG000|Overall Study|Screen Failure|8|||
148992073|NCT00659334|537445855|FG001|Overall Study|Screen Failure|5|||
148992074|NCT00659334|537445856|FG002|Overall Study|Screen Failure|0|||
148992075|NCT00659334|537445857|FG003|Overall Study|Screen Failure|0|||
148992076|NCT00659334|537445858|FG004|Overall Study|Screen Failure|0|||
148992077|NCT00659334|537445859|FG005|Overall Study|Screen Failure|0|||
148992078|NCT00659334|537445860|FG006|Overall Study|Screen Failure|1|||
148992079|NCT01174342|537445861|FG000|Overall Study|Conversion to cesarean section|4|||
148992080|NCT00722761|537445862|FG000|Overall Study|Lost to Follow-up|1|||
148992081|NCT00722761|537445863|FG001|Overall Study|Lost to Follow-up|4|||
148992082|NCT00722761|537445862|FG000|Overall Study|Withdrawal by Subject|5|||
148992083|NCT00722761|537445863|FG001|Overall Study|Withdrawal by Subject|2|||
148992084|NCT02075593|537445864|FG000|Overall Study|Withdrawal by Subject|1|||
148992085|NCT02010060|537445867|FG000|Overall Study|Lost to Follow-up|1|||
148992086|NCT02010060|537445868|FG001|Overall Study|Lost to Follow-up|2|||
148992087|NCT02010060|537445869|FG002|Overall Study|Lost to Follow-up|2|||
148992088|NCT02010060|537445867|FG000|Overall Study|Injury|0|||
148992089|NCT02010060|537445868|FG001|Overall Study|Injury|1|||
148992090|NCT02010060|537445869|FG002|Overall Study|Injury|0|||
148992091|NCT04414696|537445870|FG000|3-month Follow up|Withdrawal by Subject|1|||
148858370|NCT03622112|536957902|FG000|Overall Study|Lost to Follow-up|1|||
148858371|NCT03622112|536957903|FG001|Overall Study|Lost to Follow-up|1|||
148858372|NCT03622112|536957904|FG002|Overall Study|Lost to Follow-up|0|||
148858373|NCT03622112|536957905|FG003|Overall Study|Lost to Follow-up|0|||
148858374|NCT03622112|536957906|FG004|Overall Study|Lost to Follow-up|0|||
148858375|NCT03622112|536957907|FG005|Overall Study|Lost to Follow-up|0|||
148858376|NCT03622112|536957908|FG006|Overall Study|Lost to Follow-up|0|||
148858377|NCT03622112|536957902|FG000|Overall Study|Study-specific withdrawal criteria|10|||
148858378|NCT03622112|536957903|FG001|Overall Study|Study-specific withdrawal criteria|8|||
148992092|NCT04414696|537445871|FG001|3-month Follow up|Withdrawal by Subject|0|||
148992093|NCT04414696|537445870|FG000|3-month Follow up|Lost to Follow-up|22|||
148858379|NCT03622112|536957904|FG002|Overall Study|Study-specific withdrawal criteria|7|||
148858380|NCT03622112|536957905|FG003|Overall Study|Study-specific withdrawal criteria|6|||
148992094|NCT04414696|537445871|FG001|3-month Follow up|Lost to Follow-up|23|||
148992095|NCT04414696|537445870|FG000|6-month Follow up|Withdrawal by Subject|1|||
148992096|NCT04414696|537445871|FG001|6-month Follow up|Withdrawal by Subject|2|||
148992097|NCT04414696|537445870|FG000|6-month Follow up|Lost to Follow-up|5|||
148858381|NCT03622112|536957906|FG004|Overall Study|Study-specific withdrawal criteria|4|||
148992098|NCT04414696|537445871|FG001|6-month Follow up|Lost to Follow-up|2|||
148992099|NCT00660010|537445872|FG000|Overall Study|Withdrawal by Subject|2|||
148992100|NCT00660010|537445872|FG000|Overall Study|Lost to Follow-up|3|||
148992101|NCT00660010|537445872|FG000|Overall Study|Adverse Event|1|||
148992102|NCT00660010|537445872|FG000|Overall Study|Noncompliance with visit schedule|3|||
148992103|NCT03069482|537448330|FG000|Overall Study|Lost to Follow-up|0|||
148858382|NCT03622112|536957907|FG005|Overall Study|Study-specific withdrawal criteria|18|||
148858383|NCT03622112|536957908|FG006|Overall Study|Study-specific withdrawal criteria|4|||
148858384|NCT03622112|536957902|FG000|Overall Study|Protocol Violation|2|||
148858385|NCT03622112|536957903|FG001|Overall Study|Protocol Violation|0|||
148858386|NCT03622112|536957904|FG002|Overall Study|Protocol Violation|1|||
148858387|NCT03622112|536957905|FG003|Overall Study|Protocol Violation|1|||
148858388|NCT03622112|536957906|FG004|Overall Study|Protocol Violation|0|||
148858389|NCT03622112|536957907|FG005|Overall Study|Protocol Violation|0|||
148858390|NCT03622112|536957908|FG006|Overall Study|Protocol Violation|0|||
148858391|NCT03622112|536957902|FG000|Overall Study|Adverse Event|6|||
148858392|NCT03622112|536957903|FG001|Overall Study|Adverse Event|8|||
148858393|NCT03622112|536957904|FG002|Overall Study|Adverse Event|4|||
148858394|NCT03622112|536957905|FG003|Overall Study|Adverse Event|11|||
148858395|NCT03622112|536957906|FG004|Overall Study|Adverse Event|4|||
148858396|NCT03622112|536957907|FG005|Overall Study|Adverse Event|20|||
148858397|NCT03622112|536957908|FG006|Overall Study|Adverse Event|2|||
148858398|NCT03622112|536957902|FG000|Overall Study|Reason not specified|0|||
148858399|NCT03622112|536957903|FG001|Overall Study|Reason not specified|1|||
148858400|NCT03622112|536957904|FG002|Overall Study|Reason not specified|0|||
148858401|NCT03622112|536957905|FG003|Overall Study|Reason not specified|1|||
148858402|NCT03622112|536957906|FG004|Overall Study|Reason not specified|1|||
148858403|NCT03622112|536957907|FG005|Overall Study|Reason not specified|2|||
148858404|NCT03622112|536957908|FG006|Overall Study|Reason not specified|1|||
148858405|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
148858406|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
148858407|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
148858408|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
148858409|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
148858410|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
148858411|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
148858412|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
148858413|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
148858414|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
148858415|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Other|1|||
148858416|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Other|1|||
148858417|NCT02075047|536957913|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
148858418|NCT02075047|536957914|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
148858419|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
148858420|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
148858421|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
148858422|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
148858423|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
148858424|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
148858425|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
148858426|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
148858427|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
148858428|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
148858429|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Other|1|||
148858430|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Other|2|||
148858431|NCT02075047|536957913|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
148858432|NCT02075047|536957914|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
148858433|NCT00590824|536957915|FG000|Overall Study|Disease could not be resected|0|||
148858434|NCT00590824|536957916|FG001|Overall Study|Disease could not be resected|2|||
148858435|NCT00590824|536957917|FG002|Overall Study|Disease could not be resected|1|||
148858436|NCT00590824|536957918|FG003|Overall Study|Disease could not be resected|0|||
148858437|NCT00590824|536957915|FG000|Overall Study|Adverse Event|0|||
148858438|NCT00590824|536957916|FG001|Overall Study|Adverse Event|0|||
148858439|NCT00590824|536957917|FG002|Overall Study|Adverse Event|0|||
148858440|NCT00590824|536957918|FG003|Overall Study|Adverse Event|1|||
148858441|NCT01229254|536957924|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
148858442|NCT01229254|536957925|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
148858443|NCT01229254|536957926|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
148858444|NCT01229254|536957924|FG000|Overall Study|Adverse Event|4|||
148858445|NCT01229254|536957925|FG001|Overall Study|Adverse Event|5|||
148858446|NCT01229254|536957926|FG002|Overall Study|Adverse Event|3|||
148858447|NCT01229254|536957924|FG000|Overall Study|Lost to Follow-up|3|||
148858448|NCT01229254|536957925|FG001|Overall Study|Lost to Follow-up|0|||
148858449|NCT01229254|536957926|FG002|Overall Study|Lost to Follow-up|1|||
148858450|NCT01229254|536957924|FG000|Overall Study|Physician Decision|0|||
148858451|NCT01229254|536957925|FG001|Overall Study|Physician Decision|3|||
148858452|NCT01229254|536957926|FG002|Overall Study|Physician Decision|0|||
148992104|NCT03069482|537448331|FG001|Overall Study|Lost to Follow-up|1|||
148992105|NCT03069482|537448330|FG000|Overall Study|Physician Decision|1|||
148992106|NCT03069482|537448331|FG001|Overall Study|Physician Decision|0|||
148858453|NCT01229254|536957924|FG000|Overall Study|Protocol Violation|4|||
148858454|NCT01229254|536957925|FG001|Overall Study|Protocol Violation|6|||
148858455|NCT01229254|536957926|FG002|Overall Study|Protocol Violation|5|||
148858456|NCT01229254|536957924|FG000|Overall Study|Withdrawal by Subject|1|||
148858457|NCT01229254|536957925|FG001|Overall Study|Withdrawal by Subject|0|||
148858458|NCT01229254|536957926|FG002|Overall Study|Withdrawal by Subject|1|||
148858459|NCT01229254|536957924|FG000|Overall Study|Non-compliance with Study Drug|0|||
148858460|NCT01229254|536957925|FG001|Overall Study|Non-compliance with Study Drug|1|||
148858461|NCT01229254|536957926|FG002|Overall Study|Non-compliance with Study Drug|1|||
148858462|NCT01694121|536957928|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
148858463|NCT01694121|536957929|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
148858464|NCT02778555|536957936|FG000|Overall Study|Withdrawal by Subject|55|||
148858465|NCT02778555|536957937|FG001|Overall Study|Withdrawal by Subject|32|||
148858466|NCT02778555|536957938|FG002|Overall Study|Withdrawal by Subject|107|||
148858467|NCT02379988|536957939|FG000|Overall Study|Not eligible|1|||
148858468|NCT00107315|536957940|FG000|Overall Study|Disease Progression|9|||
148858469|NCT00107315|536957940|FG000|Overall Study|Adverse Event|4|||
148858470|NCT00107315|536957940|FG000|Overall Study|Withdrawal by Subject|2|||
148858471|NCT03359785|536957941|FG000|Overall Study|Protocol Violation|0|||
148858472|NCT03359785|536957942|FG001|Overall Study|Protocol Violation|1|||
148858473|NCT03359785|536957943|FG002|Overall Study|Protocol Violation|0|||
148858474|NCT03359785|536957944|FG003|Overall Study|Protocol Violation|0|||
148858475|NCT03359785|536957941|FG000|Overall Study|Early study termination due to study pause|0|||
148858476|NCT03359785|536957942|FG001|Overall Study|Early study termination due to study pause|0|||
148858477|NCT03359785|536957943|FG002|Overall Study|Early study termination due to study pause|2|||
148858478|NCT03359785|536957944|FG003|Overall Study|Early study termination due to study pause|0|||
148858479|NCT03359785|536957941|FG000|Overall Study|Withdrawal by Subject|2|||
148858480|NCT03359785|536957942|FG001|Overall Study|Withdrawal by Subject|2|||
148858481|NCT03359785|536957943|FG002|Overall Study|Withdrawal by Subject|0|||
148858482|NCT03359785|536957944|FG003|Overall Study|Withdrawal by Subject|0|||
148858483|NCT01895543|536957945|FG000|Overall Study|Withdrawal by Subject|43|||
148858484|NCT01895543|536957945|FG000|Overall Study|Lost to Follow-up|25|||
148858485|NCT01895543|536957945|FG000|Overall Study|Adverse Event|28|||
148858486|NCT01895543|536957945|FG000|Overall Study|Subject's substantial non-compliance|6|||
148858487|NCT01895543|536957945|FG000|Overall Study|Protocol Violation|1|||
148858488|NCT01895543|536957945|FG000|Overall Study|Physician Decision|2|||
148858489|NCT01895543|536957945|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
148858490|NCT04659174|536957951|FG000|Overall Study|Sponsor decision to discontinue study|0|||
148858491|NCT04659174|536957952|FG001|Overall Study|Sponsor decision to discontinue study|2|||
148858492|NCT04659174|536957951|FG000|Overall Study|Lost to Follow-up|9|||
148858493|NCT04659174|536957952|FG001|Overall Study|Lost to Follow-up|11|||
148858494|NCT04659174|536957951|FG000|Overall Study|Adverse Event|8|||
148858495|NCT04659174|536957952|FG001|Overall Study|Adverse Event|5|||
148858496|NCT04659174|536957951|FG000|Overall Study|Withdrawal by Subject|17|||
148858497|NCT04659174|536957952|FG001|Overall Study|Withdrawal by Subject|33|||
148858498|NCT04659174|536957951|FG000|Overall Study|Progressive disease|0|||
148858499|NCT04659174|536957952|FG001|Overall Study|Progressive disease|2|||
148858500|NCT04659174|536957951|FG000|Overall Study|Other reasons|0|||
148858501|NCT04659174|536957952|FG001|Overall Study|Other reasons|2|||
148858502|NCT04659174|536957951|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
148858503|NCT04659174|536957952|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
148858504|NCT04659174|536957951|FG000|Overall Study|Alcohol or illegal drug use|0|||
148858505|NCT04659174|536957952|FG001|Overall Study|Alcohol or illegal drug use|3|||
148858506|NCT04659174|536957951|FG000|Overall Study|Violation of entry criteria|1|||
148858507|NCT04659174|536957952|FG001|Overall Study|Violation of entry criteria|0|||
148858508|NCT04659174|536957951|FG000|Overall Study|Death|0|||
148858509|NCT04659174|536957952|FG001|Overall Study|Death|1|||
148858510|NCT04934800|536957953|FG000|Overall Study|Other|1|||
148858511|NCT04934800|536957953|FG000|Overall Study|Withdrawal by Subject|5|||
148858512|NCT04934800|536957953|FG000|Overall Study|Lack of Efficacy|1|||
148858513|NCT04934800|536957953|FG000|Overall Study|Adverse Event|9|||
148858514|NCT04934800|536957953|FG000|Overall Study|Lost to Follow-up|5|||
148858515|NCT04934800|536957953|FG000|Overall Study|Enrolled but not treated|1|||
148858516|NCT00516906|536957954|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
148858517|NCT00516906|536957955|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
148858518|NCT02684058|536957959|FG000|Treatment Period|Progressive disease|4|||
148858519|NCT02684058|536957960|FG001|Treatment Period|Progressive disease|10|||
148858520|NCT02684058|536957961|FG002|Treatment Period|Progressive disease|19|||
148858521|NCT02684058|536957959|FG000|Treatment Period|Adverse Event|3|||
148858522|NCT02684058|536957960|FG001|Treatment Period|Adverse Event|8|||
148858523|NCT02684058|536957961|FG002|Treatment Period|Adverse Event|1|||
148858524|NCT02684058|536957959|FG000|Treatment Period|Physician Decision|5|||
148858525|NCT02684058|536957960|FG001|Treatment Period|Physician Decision|1|||
148858526|NCT02684058|536957961|FG002|Treatment Period|Physician Decision|2|||
148858527|NCT02684058|536957959|FG000|Treatment Period|New therapy for study indication|1|||
148992107|NCT05912400|537448337|FG000|Overall Study|Lost to Follow-up|1|||
148992108|NCT05912400|537448338|FG001|Overall Study|Lost to Follow-up|0|||
148992109|NCT05912400|537448337|FG000|Overall Study|Physician Decision|6|||
148992110|NCT05912400|537448338|FG001|Overall Study|Physician Decision|0|||
148992111|NCT05912400|537448337|FG000|Overall Study|Withdrawal by Subject|1|||
148992112|NCT05912400|537448338|FG001|Overall Study|Withdrawal by Subject|0|||
148992113|NCT01843192|537448341|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
148992114|NCT01843192|537448342|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
148992115|NCT01843192|537448343|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
148992116|NCT02181803|537448344|FG000|Overall Study|Withdrawal by Subject|0|||
148992117|NCT02181803|537448345|FG001|Overall Study|Withdrawal by Subject|2|||
148992118|NCT02181803|537448346|FG002|Overall Study|Withdrawal by Subject|0|||
148992119|NCT02181803|537448347|FG003|Overall Study|Withdrawal by Subject|0|||
148992120|NCT02181803|537448348|FG004|Overall Study|Withdrawal by Subject|0|||
148992121|NCT02181803|537448349|FG005|Overall Study|Withdrawal by Subject|0|||
148992122|NCT02181803|537448350|FG006|Overall Study|Withdrawal by Subject|0|||
148992123|NCT02181803|537448351|FG007|Overall Study|Withdrawal by Subject|0|||
148992124|NCT02181803|537448352|FG008|Overall Study|Withdrawal by Subject|0|||
148992125|NCT02181803|537448344|FG000|Overall Study|Physician Decision|0|||
148992126|NCT02181803|537448345|FG001|Overall Study|Physician Decision|0|||
148992127|NCT02181803|537448346|FG002|Overall Study|Physician Decision|0|||
148992128|NCT02181803|537448347|FG003|Overall Study|Physician Decision|1|||
148992129|NCT02181803|537448348|FG004|Overall Study|Physician Decision|0|||
148992130|NCT02181803|537448349|FG005|Overall Study|Physician Decision|0|||
148992131|NCT02181803|537448350|FG006|Overall Study|Physician Decision|0|||
148992132|NCT02181803|537448351|FG007|Overall Study|Physician Decision|1|||
148992133|NCT02181803|537448352|FG008|Overall Study|Physician Decision|0|||
148992134|NCT02181803|537448344|FG000|Overall Study|Adverse Event|0|||
148992135|NCT02181803|537448345|FG001|Overall Study|Adverse Event|2|||
148992136|NCT02181803|537448346|FG002|Overall Study|Adverse Event|0|||
148992137|NCT02181803|537448347|FG003|Overall Study|Adverse Event|1|||
148992138|NCT02181803|537448348|FG004|Overall Study|Adverse Event|0|||
148992139|NCT02181803|537448349|FG005|Overall Study|Adverse Event|0|||
148992140|NCT02181803|537448350|FG006|Overall Study|Adverse Event|1|||
148992141|NCT02181803|537448351|FG007|Overall Study|Adverse Event|0|||
148992142|NCT02181803|537448352|FG008|Overall Study|Adverse Event|0|||
148992143|NCT01259713|537448357|FG000|Overall Study|Adverse Event|54|||
148992144|NCT01259713|537448358|FG001|Overall Study|Adverse Event|23|||
148992145|NCT01259713|537448357|FG000|Overall Study|Death Not Related to IFI|8|||
148992146|NCT01259713|537448358|FG001|Overall Study|Death Not Related to IFI|1|||
148992147|NCT01259713|537448357|FG000|Overall Study|Investigators Discretion|14|||
148992148|NCT01259713|537448358|FG001|Overall Study|Investigators Discretion|6|||
148992149|NCT01259713|537448357|FG000|Overall Study|Lack of Efficacy|2|||
148992150|NCT01259713|537448358|FG001|Overall Study|Lack of Efficacy|0|||
148992151|NCT01259713|537448357|FG000|Overall Study|Protocol Violation|5|||
148992152|NCT01259713|537448358|FG001|Overall Study|Protocol Violation|4|||
148992153|NCT01259713|537448357|FG000|Overall Study|Subject Withdrew Consent|12|||
148992154|NCT01259713|537448358|FG001|Overall Study|Subject Withdrew Consent|7|||
148992155|NCT02388724|537448359|FG000|Overall Study|Reason not Specified|0|||
148992156|NCT02388724|537448360|FG001|Overall Study|Reason not Specified|1|||
148992157|NCT02388724|537448359|FG000|Overall Study|Major Protocol Deviation|3|||
148992158|NCT02388724|537448360|FG001|Overall Study|Major Protocol Deviation|3|||
148992159|NCT02388724|537448359|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
148992160|NCT02388724|537448360|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
148858528|NCT02684058|536957960|FG001|Treatment Period|New therapy for study indication|0|||
148992161|NCT02388724|537448359|FG000|Overall Study|Voluntary Withdrawal|6|||
148992162|NCT02388724|537448360|FG001|Overall Study|Voluntary Withdrawal|5|||
148992163|NCT02388724|537448359|FG000|Overall Study|Randomized but not Treated|0|||
148992164|NCT02388724|537448360|FG001|Overall Study|Randomized but not Treated|2|||
148992165|NCT03461003|537448361|FG000|Overall Study|Lost to Follow-up|2|||
148992166|NCT03461003|537448362|FG001|Overall Study|Lost to Follow-up|2|||
148992167|NCT03461003|537448361|FG000|Overall Study|Withdrawal by Subject|3|||
148992168|NCT03461003|537448362|FG001|Overall Study|Withdrawal by Subject|1|||
148992169|NCT00620750|537448365|FG000|Overall Study|Lost to Follow-up|25|||
148992170|NCT00765843|537448367|FG000|Overall Study|Lost to Follow-up|1|||
148992171|NCT00765843|537448368|FG001|Overall Study|Lost to Follow-up|3|||
148992172|NCT00765843|537448369|FG002|Overall Study|Lost to Follow-up|2|||
148992173|NCT00765843|537448367|FG000|Overall Study|did not return to receive intervention|0|||
148858529|NCT02684058|536957961|FG002|Treatment Period|New therapy for study indication|0|||
148992174|NCT00765843|537448368|FG001|Overall Study|did not return to receive intervention|1|||
148992175|NCT00765843|537448369|FG002|Overall Study|did not return to receive intervention|0|||
148992176|NCT00765843|537448367|FG000|Overall Study|Adverse Event|0|||
148992177|NCT00765843|537448368|FG001|Overall Study|Adverse Event|0|||
148992178|NCT00765843|537448369|FG002|Overall Study|Adverse Event|1|||
148992179|NCT02564523|537448370|FG000|Overall Study|Withdrawal by Subject|3|||
148992180|NCT02564523|537448371|FG001|Overall Study|Withdrawal by Subject|0|||
148992181|NCT02564523|537448372|FG002|Overall Study|Withdrawal by Subject|1|||
148992182|NCT02564523|537448373|FG003|Overall Study|Withdrawal by Subject|0|||
148992183|NCT02564523|537448374|FG004|Overall Study|Withdrawal by Subject|1|||
148992184|NCT02564523|537448375|FG005|Overall Study|Withdrawal by Subject|0|||
148992185|NCT02564523|537448376|FG006|Overall Study|Withdrawal by Subject|1|||
148992186|NCT02564523|537448377|FG007|Overall Study|Withdrawal by Subject|0|||
148992187|NCT02564523|537448378|FG008|Overall Study|Withdrawal by Subject|0|||
148992188|NCT02564523|537448379|FG009|Overall Study|Withdrawal by Subject|0|||
148992189|NCT02564523|537448380|FG010|Overall Study|Withdrawal by Subject|1|||
148992190|NCT02564523|537448381|FG011|Overall Study|Withdrawal by Subject|0|||
148992191|NCT02564523|537448382|FG012|Overall Study|Withdrawal by Subject|1|||
148992192|NCT02564523|537448383|FG013|Overall Study|Withdrawal by Subject|0|||
148992193|NCT02564523|537448384|FG014|Overall Study|Withdrawal by Subject|0|||
148992194|NCT02564523|537448385|FG015|Overall Study|Withdrawal by Subject|0|||
148992195|NCT02564523|537448386|FG016|Overall Study|Withdrawal by Subject|0|||
148992196|NCT02564523|537448387|FG017|Overall Study|Withdrawal by Subject|0|||
148992197|NCT02564523|537448370|FG000|Overall Study|Adverse Event|0|||
148992198|NCT02564523|537448371|FG001|Overall Study|Adverse Event|0|||
148992199|NCT02564523|537448372|FG002|Overall Study|Adverse Event|0|||
148992200|NCT02564523|537448373|FG003|Overall Study|Adverse Event|0|||
148992201|NCT02564523|537448374|FG004|Overall Study|Adverse Event|0|||
148992202|NCT02564523|537448375|FG005|Overall Study|Adverse Event|0|||
148992203|NCT02564523|537448376|FG006|Overall Study|Adverse Event|0|||
148992204|NCT02564523|537448377|FG007|Overall Study|Adverse Event|0|||
148992205|NCT02564523|537448378|FG008|Overall Study|Adverse Event|0|||
148992206|NCT02564523|537448379|FG009|Overall Study|Adverse Event|0|||
148992207|NCT02564523|537448380|FG010|Overall Study|Adverse Event|0|||
148992208|NCT02564523|537448381|FG011|Overall Study|Adverse Event|0|||
148992209|NCT02564523|537448382|FG012|Overall Study|Adverse Event|0|||
148992210|NCT02564523|537448383|FG013|Overall Study|Adverse Event|0|||
148992211|NCT02564523|537448384|FG014|Overall Study|Adverse Event|0|||
148992212|NCT02564523|537448385|FG015|Overall Study|Adverse Event|0|||
148992213|NCT02564523|537448386|FG016|Overall Study|Adverse Event|0|||
148992214|NCT02564523|537448387|FG017|Overall Study|Adverse Event|1|||
148992215|NCT02564523|537448370|FG000|Overall Study|Death|0|||
148992216|NCT02564523|537448371|FG001|Overall Study|Death|0|||
148992217|NCT02564523|537448372|FG002|Overall Study|Death|0|||
148992218|NCT02564523|537448373|FG003|Overall Study|Death|0|||
148992219|NCT02564523|537448374|FG004|Overall Study|Death|0|||
148992220|NCT02564523|537448375|FG005|Overall Study|Death|0|||
148992221|NCT02564523|537448376|FG006|Overall Study|Death|1|||
148992222|NCT02564523|537448377|FG007|Overall Study|Death|0|||
148992223|NCT02564523|537448378|FG008|Overall Study|Death|0|||
148992224|NCT02564523|537448379|FG009|Overall Study|Death|0|||
148858530|NCT02684058|536957959|FG000|Treatment Period|Protocol deviation|0|||
148858531|NCT02684058|536957960|FG001|Treatment Period|Protocol deviation|1|||
148858532|NCT02684058|536957961|FG002|Treatment Period|Protocol deviation|0|||
148858533|NCT02684058|536957959|FG000|Treatment Period|Subject/guardian decision|4|||
148858534|NCT02684058|536957960|FG001|Treatment Period|Subject/guardian decision|3|||
148858535|NCT02684058|536957961|FG002|Treatment Period|Subject/guardian decision|0|||
148858536|NCT02684058|536957959|FG000|Treatment Period|Death|0|||
148858537|NCT02684058|536957960|FG001|Treatment Period|Death|0|||
148858538|NCT02684058|536957961|FG002|Treatment Period|Death|2|||
148858539|NCT02684058|536957959|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
148858540|NCT02684058|536957960|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
148858541|NCT02684058|536957961|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
148858542|NCT02684058|536957959|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
148858543|NCT02684058|536957960|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
148858544|NCT02684058|536957961|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
148858545|NCT02684058|536957959|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
148858546|NCT02684058|536957960|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
148858547|NCT02684058|536957961|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
148858548|NCT02684058|536957959|FG000|Post-treatment Efficacy Follow-up|Death|0|||
148858549|NCT02684058|536957960|FG001|Post-treatment Efficacy Follow-up|Death|0|||
148858550|NCT02684058|536957961|FG002|Post-treatment Efficacy Follow-up|Death|3|||
148858551|NCT02684058|536957959|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
148858552|NCT02684058|536957960|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
148992225|NCT02564523|537448380|FG010|Overall Study|Death|1|||
148858553|NCT02684058|536957961|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
148858554|NCT02684058|536957959|FG000|Post-treatment Survival Follow-up|Death|0|||
148992226|NCT02564523|537448381|FG011|Overall Study|Death|0|||
148992227|NCT02564523|537448382|FG012|Overall Study|Death|0|||
148992228|NCT02564523|537448383|FG013|Overall Study|Death|0|||
148992229|NCT02564523|537448384|FG014|Overall Study|Death|0|||
148992230|NCT02564523|537448385|FG015|Overall Study|Death|0|||
148992231|NCT02564523|537448386|FG016|Overall Study|Death|0|||
148992232|NCT02564523|537448387|FG017|Overall Study|Death|0|||
148858555|NCT02684058|536957960|FG001|Post-treatment Survival Follow-up|Death|0|||
148858556|NCT02684058|536957961|FG002|Post-treatment Survival Follow-up|Death|7|||
148858557|NCT02684058|536957959|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
148858558|NCT02684058|536957960|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
148858559|NCT02684058|536957961|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
148858560|NCT02684058|536957959|FG000|Crossover Treatment Period|Progressive disease|0|||
148858561|NCT02684058|536957960|FG001|Crossover Treatment Period|Progressive disease|1|||
148858562|NCT02684058|536957961|FG002|Crossover Treatment Period|Progressive disease|0|||
148858563|NCT01327053|536957962|FG000|Overall Study|Adverse Event|23|||
148858564|NCT01327053|536957963|FG001|Overall Study|Adverse Event|57|||
148858565|NCT01327053|536957962|FG000|Overall Study|Patient/guardian decision|11|||
148858566|NCT01327053|536957963|FG001|Overall Study|Patient/guardian decision|35|||
148858567|NCT01327053|536957962|FG000|Overall Study|Physician Decision|10|||
148858568|NCT01327053|536957963|FG001|Overall Study|Physician Decision|14|||
148858569|NCT01327053|536957962|FG000|Overall Study|Death|1|||
149030701|NCT00813488|537589692|FG000|Open-label Extension|Withdrawal by Subject|0|||
149030702|NCT00813488|537589693|FG001|Open-label Extension|Withdrawal by Subject|2|||
148858570|NCT01327053|536957963|FG001|Overall Study|Death|5|||
148858571|NCT01327053|536957962|FG000|Overall Study|Lost to Follow-up|2|||
148858572|NCT01327053|536957963|FG001|Overall Study|Lost to Follow-up|4|||
148858573|NCT01327053|536957962|FG000|Overall Study|Non-compliance with study treatment|0|||
148858574|NCT01327053|536957963|FG001|Overall Study|Non-compliance with study treatment|5|||
148858575|NCT01327053|536957962|FG000|Overall Study|Study terminated by Sponsor|1|||
148858576|NCT01327053|536957963|FG001|Overall Study|Study terminated by Sponsor|3|||
148858577|NCT01327053|536957962|FG000|Overall Study|Progressive disease|31|||
148858578|NCT01327053|536957963|FG001|Overall Study|Progressive disease|26|||
148858579|NCT01327053|536957962|FG000|Overall Study|Protocol Violation|0|||
148858580|NCT01327053|536957963|FG001|Overall Study|Protocol Violation|1|||
148858581|NCT01327053|536957962|FG000|Overall Study|Untreated|0|||
148858582|NCT01327053|536957963|FG001|Overall Study|Untreated|1|||
148858583|NCT00721578|536957968|FG000|Overall Study|Death|1|||
148858584|NCT00721578|536957969|FG001|Overall Study|Death|1|||
148858585|NCT00721578|536957968|FG000|Overall Study|Withdrawal by Subject|1|||
148858586|NCT00721578|536957969|FG001|Overall Study|Withdrawal by Subject|1|||
148858587|NCT05151445|536957978|FG000|Overall Study|Withdrawal by Subject|3|||
148858588|NCT02825420|536957983|FG000|Overall Study|Death|30|||
148858589|NCT02825420|536957984|FG001|Overall Study|Death|12|||
148858590|NCT02825420|536957983|FG000|Overall Study|Progressive disease|6|||
148858591|NCT02825420|536957984|FG001|Overall Study|Progressive disease|1|||
148858592|NCT02825420|536957983|FG000|Overall Study|Lost to Follow-up|2|||
148858593|NCT02825420|536957984|FG001|Overall Study|Lost to Follow-up|2|||
148858594|NCT02825420|536957983|FG000|Overall Study|Withdrawal by Subject|1|||
148858595|NCT02825420|536957984|FG001|Overall Study|Withdrawal by Subject|1|||
148858596|NCT02825420|536957983|FG000|Overall Study|Protocol amendment not signed|1|||
148858597|NCT02825420|536957984|FG001|Overall Study|Protocol amendment not signed|1|||
148858598|NCT02825420|536957983|FG000|Overall Study|Physician Decision|1|||
148858599|NCT02825420|536957984|FG001|Overall Study|Physician Decision|0|||
148858600|NCT02825420|536957983|FG000|Overall Study|Did not receive PLD|2|||
148858601|NCT02825420|536957984|FG001|Overall Study|Did not receive PLD|0|||
148858602|NCT01967823|536959807|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
148858603|NCT00413894|536959808|FG000|Overall Study|Withdrawal by Subject|10|||
148858604|NCT00413894|536959808|FG000|Overall Study|Administrative Reasons|1|||
148858605|NCT00413894|536959808|FG000|Overall Study|Hb <10 grams/deciliter|12|||
148858606|NCT00413894|536959808|FG000|Overall Study|Adverse Event|28|||
148858607|NCT00413894|536959808|FG000|Overall Study|Protocol Violation|11|||
148858608|NCT00413894|536959808|FG000|Overall Study|Other|18|||
148858609|NCT05289271|536959809|FG000|Overall Study|Mistakenly allocated, untreated|1|||
148858610|NCT05289271|536959810|FG001|Overall Study|Mistakenly allocated, untreated|0|||
148858611|NCT01739933|536959819|FG000|Overall Study|Death|89|||
148858612|NCT01739933|536959820|FG001|Overall Study|Death|86|||
148858613|NCT01739933|536959819|FG000|Overall Study|Withdrawal by Subject|10|||
148858614|NCT01739933|536959820|FG001|Overall Study|Withdrawal by Subject|8|||
149030703|NCT00813488|537589692|FG000|Open-label Extension|Protocol Violation|1|||
148858615|NCT01739933|536959819|FG000|Overall Study|Lost to Follow-up|3|||
148858616|NCT01739933|536959820|FG001|Overall Study|Lost to Follow-up|10|||
148858617|NCT01739933|536959819|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
148858618|NCT01739933|536959820|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
148858619|NCT03356977|536959821|FG000|Overall Study|Lost to Follow-up|3|||
148858620|NCT03356977|536959821|FG000|Overall Study|Withdrawal by parent/guardian|2|||
148858621|NCT03224507|536959823|FG000|Overall Study|Death|3|||
148858622|NCT03224507|536959824|FG001|Overall Study|Death|0|||
148858623|NCT03224507|536959823|FG000|Overall Study|Lack of Efficacy|6|||
148858624|NCT03224507|536959824|FG001|Overall Study|Lack of Efficacy|0|||
148858625|NCT03224507|536959823|FG000|Overall Study|Withdrawal by Subject|6|||
148858626|NCT03224507|536959824|FG001|Overall Study|Withdrawal by Subject|0|||
148858627|NCT01032291|536959825|FG000|Safety Lead-in|Adverse Event|1|||
148858628|NCT01032291|536959826|FG001|Safety Lead-in|Adverse Event|0|||
148858629|NCT01032291|536959827|FG002|Safety Lead-in|Adverse Event|0|||
148858630|NCT01032291|536959825|FG000|Safety Lead-in|Death|1|||
148858631|NCT01032291|536959826|FG001|Safety Lead-in|Death|0|||
148858632|NCT01032291|536959827|FG002|Safety Lead-in|Death|0|||
148858633|NCT01032291|536959825|FG000|Proof of Concept|Adverse Event|0|||
148858634|NCT01032291|536959826|FG001|Proof of Concept|Adverse Event|5|||
148858635|NCT01032291|536959827|FG002|Proof of Concept|Adverse Event|1|||
148858636|NCT01032291|536959825|FG000|Proof of Concept|Death|0|||
148858637|NCT01032291|536959826|FG001|Proof of Concept|Death|1|||
148858638|NCT01032291|536959827|FG002|Proof of Concept|Death|2|||
148858639|NCT01032291|536959825|FG000|Proof of Concept|Lack of Efficacy|0|||
148858640|NCT01032291|536959826|FG001|Proof of Concept|Lack of Efficacy|1|||
148858641|NCT01032291|536959827|FG002|Proof of Concept|Lack of Efficacy|0|||
148858642|NCT01032291|536959825|FG000|Proof of Concept|Never Received Study Drug|0|||
148858643|NCT01032291|536959826|FG001|Proof of Concept|Never Received Study Drug|1|||
148858644|NCT01032291|536959827|FG002|Proof of Concept|Never Received Study Drug|0|||
148858645|NCT03327220|536959828|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
148858646|NCT03327220|536959829|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
148858647|NCT03327220|536959828|FG000|Overall Study|Investigator Decision|2|||
148858648|NCT03327220|536959829|FG001|Overall Study|Investigator Decision|0|||
148858649|NCT03327220|536959828|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
148858650|NCT03327220|536959829|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
148858651|NCT03327220|536959828|FG000|Overall Study|Fungal infection|1|||
148858652|NCT03327220|536959829|FG001|Overall Study|Fungal infection|0|||
148858653|NCT03327220|536959828|FG000|Overall Study|Discharged to Rehabilitation|0|||
148858654|NCT03327220|536959829|FG001|Overall Study|Discharged to Rehabilitation|1|||
148858655|NCT03327220|536959828|FG000|Overall Study|Missing|1|||
148858656|NCT03327220|536959829|FG001|Overall Study|Missing|0|||
148858657|NCT00693017|536959830|FG000|Overall Study|Sponsor Decision|2|||
148858658|NCT00693017|536959831|FG001|Overall Study|Sponsor Decision|1|||
148858659|NCT00693017|536959830|FG000|Overall Study|Death|0|||
148858660|NCT00693017|536959831|FG001|Overall Study|Death|1|||
148858661|NCT00688324|536959833|FG000|Overall Study|Withdrawal by Subject|2|||
148858662|NCT00688324|536959833|FG000|Overall Study|Physician Decision|5|||
148858663|NCT00688324|536959833|FG000|Overall Study|Lost to Follow-up|1|||
148858664|NCT01972308|536959836|FG000|Overall Study|Withdrawal by Subject|0|||
148858665|NCT01972308|536959837|FG001|Overall Study|Withdrawal by Subject|1|||
148858666|NCT01972308|536959836|FG000|Overall Study|Lost to Follow-up|4|||
148858667|NCT01972308|536959837|FG001|Overall Study|Lost to Follow-up|6|||
148858668|NCT01972308|536959836|FG000|Overall Study|Death|4|||
148858669|NCT01972308|536959837|FG001|Overall Study|Death|1|||
148858670|NCT01562314|536959838|FG000|Overall Study|Adverse Event|10|||
148858671|NCT01562314|536959839|FG001|Overall Study|Adverse Event|5|||
148858672|NCT01562314|536959838|FG000|Overall Study|Met Withdrawal Criteria|3|||
148858673|NCT01562314|536959839|FG001|Overall Study|Met Withdrawal Criteria|2|||
148858674|NCT01562314|536959838|FG000|Overall Study|Withdrawal by Subject|0|||
148858675|NCT01562314|536959839|FG001|Overall Study|Withdrawal by Subject|1|||
148858676|NCT02256384|536959848|FG000|Overall Study|Withdrawal by Subject|12|||
148858677|NCT02256384|536959848|FG000|Overall Study|Equipment not capturing data|2|||
148858678|NCT01779856|536959849|FG000|Overall Study|Withdrawal by Subject|15|||
148858679|NCT01779856|536959849|FG000|Overall Study|Death|3|||
148858680|NCT01779856|536959849|FG000|Overall Study|Physician Decision|1|||
148858681|NCT01779856|536959849|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
148858682|NCT01779856|536959849|FG000|Overall Study|Delays in scheduling implant|1|||
148858683|NCT01779856|536959849|FG000|Overall Study|Subject ineligible for Implant|2|||
148858684|NCT00666588|536959852|FG000|Overall Study|ineligible|2|||
148858685|NCT00666588|536959853|FG001|Overall Study|ineligible|0|||
148858686|NCT00666588|536959854|FG002|Overall Study|ineligible|0|||
148858687|NCT00666588|536959855|FG003|Overall Study|ineligible|2|||
148858688|NCT00666588|536959852|FG000|Overall Study|inevaluable|2|||
148992233|NCT02564523|537448370|FG000|Overall Study|Lost to Follow-up|2|||
148858689|NCT00666588|536959853|FG001|Overall Study|inevaluable|0|||
148858690|NCT00666588|536959854|FG002|Overall Study|inevaluable|0|||
148858691|NCT00666588|536959855|FG003|Overall Study|inevaluable|0|||
148858692|NCT04043234|536959856|FG000|Overall Study|Lost to Follow-up|1|||
148858693|NCT04043234|536959856|FG000|Overall Study|Withdrawal by Subject|1|||
148858694|NCT01165320|536959858|FG000|Overall Study|Clinical adverse experience|2|||
148858695|NCT01165320|536959859|FG001|Overall Study|Clinical adverse experience|1|||
148858696|NCT01165320|536959860|FG002|Overall Study|Clinical adverse experience|0|||
148858697|NCT01165320|536959858|FG000|Overall Study|Laboratory adverse experience|1|||
148858698|NCT01165320|536959859|FG001|Overall Study|Laboratory adverse experience|0|||
148858699|NCT01165320|536959860|FG002|Overall Study|Laboratory adverse experience|0|||
148858700|NCT01165320|536959858|FG000|Overall Study|Lack of Efficacy|0|||
148858701|NCT01165320|536959859|FG001|Overall Study|Lack of Efficacy|2|||
148858702|NCT01165320|536959860|FG002|Overall Study|Lack of Efficacy|0|||
148858703|NCT01165320|536959858|FG000|Overall Study|Reason unknown|0|||
148858704|NCT01165320|536959859|FG001|Overall Study|Reason unknown|1|||
148858705|NCT01165320|536959860|FG002|Overall Study|Reason unknown|0|||
148992234|NCT02564523|537448371|FG001|Overall Study|Lost to Follow-up|1|||
148858706|NCT00385944|536959861|FG000|1st Maintenance Dose Period|Physician Decision|1|||
148858707|NCT00385944|536959862|FG001|1st Maintenance Dose Period|Physician Decision|0|||
148858708|NCT00385944|536959863|FG002|1st Maintenance Dose Period|Physician Decision|0|||
148858709|NCT00385944|536959861|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
148858710|NCT00385944|536959862|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
148858711|NCT00385944|536959863|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
148858712|NCT00385944|536959861|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
148858713|NCT00385944|536959862|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
148858714|NCT00385944|536959863|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
148858715|NCT00385944|536959861|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
148858716|NCT00385944|536959862|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
148858717|NCT00385944|536959863|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
148992235|NCT02564523|537448372|FG002|Overall Study|Lost to Follow-up|4|||
148992236|NCT02564523|537448373|FG003|Overall Study|Lost to Follow-up|0|||
148992237|NCT02564523|537448374|FG004|Overall Study|Lost to Follow-up|1|||
148992238|NCT02564523|537448375|FG005|Overall Study|Lost to Follow-up|0|||
148992239|NCT02564523|537448376|FG006|Overall Study|Lost to Follow-up|1|||
148992240|NCT02564523|537448377|FG007|Overall Study|Lost to Follow-up|0|||
148992241|NCT02564523|537448378|FG008|Overall Study|Lost to Follow-up|0|||
148992242|NCT02564523|537448379|FG009|Overall Study|Lost to Follow-up|0|||
148992243|NCT02564523|537448380|FG010|Overall Study|Lost to Follow-up|0|||
148992244|NCT02564523|537448381|FG011|Overall Study|Lost to Follow-up|1|||
148992245|NCT02564523|537448382|FG012|Overall Study|Lost to Follow-up|1|||
148992246|NCT02564523|537448383|FG013|Overall Study|Lost to Follow-up|0|||
148992247|NCT02564523|537448384|FG014|Overall Study|Lost to Follow-up|0|||
148992248|NCT02564523|537448385|FG015|Overall Study|Lost to Follow-up|0|||
148992249|NCT02564523|537448386|FG016|Overall Study|Lost to Follow-up|0|||
148992250|NCT02564523|537448387|FG017|Overall Study|Lost to Follow-up|0|||
148992251|NCT02564523|537448370|FG000|Overall Study|Physician Decision|0|||
148992252|NCT02564523|537448371|FG001|Overall Study|Physician Decision|0|||
148992253|NCT02564523|537448372|FG002|Overall Study|Physician Decision|0|||
148992254|NCT02564523|537448373|FG003|Overall Study|Physician Decision|0|||
148992255|NCT02564523|537448374|FG004|Overall Study|Physician Decision|1|||
148992256|NCT02564523|537448375|FG005|Overall Study|Physician Decision|0|||
148992257|NCT02564523|537448376|FG006|Overall Study|Physician Decision|0|||
148992258|NCT02564523|537448377|FG007|Overall Study|Physician Decision|0|||
148992259|NCT02564523|537448378|FG008|Overall Study|Physician Decision|0|||
148992260|NCT02564523|537448379|FG009|Overall Study|Physician Decision|0|||
148992261|NCT02564523|537448380|FG010|Overall Study|Physician Decision|1|||
148992262|NCT02564523|537448381|FG011|Overall Study|Physician Decision|0|||
148992263|NCT02564523|537448382|FG012|Overall Study|Physician Decision|0|||
148992264|NCT02564523|537448383|FG013|Overall Study|Physician Decision|0|||
148992265|NCT02564523|537448384|FG014|Overall Study|Physician Decision|0|||
148992266|NCT02564523|537448385|FG015|Overall Study|Physician Decision|0|||
148992267|NCT02564523|537448386|FG016|Overall Study|Physician Decision|0|||
148992268|NCT02564523|537448387|FG017|Overall Study|Physician Decision|0|||
148992269|NCT02564523|537448370|FG000|Overall Study|Protocol Violation|2|||
148992270|NCT02564523|537448371|FG001|Overall Study|Protocol Violation|2|||
148992271|NCT02564523|537448372|FG002|Overall Study|Protocol Violation|5|||
148992272|NCT02564523|537448373|FG003|Overall Study|Protocol Violation|0|||
148992273|NCT02564523|537448374|FG004|Overall Study|Protocol Violation|1|||
148992274|NCT02564523|537448375|FG005|Overall Study|Protocol Violation|0|||
148992275|NCT02564523|537448376|FG006|Overall Study|Protocol Violation|0|||
148992276|NCT02564523|537448377|FG007|Overall Study|Protocol Violation|0|||
148992277|NCT02564523|537448378|FG008|Overall Study|Protocol Violation|0|||
148992278|NCT02564523|537448379|FG009|Overall Study|Protocol Violation|0|||
148992279|NCT02564523|537448380|FG010|Overall Study|Protocol Violation|0|||
148992280|NCT02564523|537448381|FG011|Overall Study|Protocol Violation|0|||
148992281|NCT02564523|537448382|FG012|Overall Study|Protocol Violation|0|||
148992282|NCT02564523|537448383|FG013|Overall Study|Protocol Violation|0|||
148992283|NCT02564523|537448384|FG014|Overall Study|Protocol Violation|0|||
148992284|NCT02564523|537448385|FG015|Overall Study|Protocol Violation|0|||
148858718|NCT01155466|536959864|FG000|Overall Study|Adverse Event|13|||
148858719|NCT01155466|536959865|FG001|Overall Study|Adverse Event|15|||
148992285|NCT02564523|537448386|FG016|Overall Study|Protocol Violation|0|||
148992286|NCT02564523|537448387|FG017|Overall Study|Protocol Violation|0|||
148992287|NCT02564523|537448370|FG000|Overall Study|Other|3|||
148992288|NCT02564523|537448371|FG001|Overall Study|Other|0|||
148992289|NCT02564523|537448372|FG002|Overall Study|Other|0|||
148992290|NCT02564523|537448373|FG003|Overall Study|Other|1|||
148992291|NCT02564523|537448374|FG004|Overall Study|Other|0|||
148858720|NCT01155466|536959866|FG002|Overall Study|Adverse Event|6|||
148858721|NCT01155466|536959867|FG003|Overall Study|Adverse Event|17|||
148992292|NCT02564523|537448375|FG005|Overall Study|Other|0|||
148992293|NCT02564523|537448376|FG006|Overall Study|Other|0|||
148992294|NCT02564523|537448377|FG007|Overall Study|Other|0|||
148992295|NCT02564523|537448378|FG008|Overall Study|Other|0|||
148992296|NCT02564523|537448379|FG009|Overall Study|Other|0|||
148992297|NCT02564523|537448380|FG010|Overall Study|Other|0|||
148992298|NCT02564523|537448381|FG011|Overall Study|Other|0|||
148858722|NCT01155466|536959868|FG004|Overall Study|Adverse Event|18|||
148858723|NCT01155466|536959864|FG000|Overall Study|Lost to Follow-up|0|||
148858724|NCT01155466|536959865|FG001|Overall Study|Lost to Follow-up|0|||
148858725|NCT01155466|536959866|FG002|Overall Study|Lost to Follow-up|0|||
148858726|NCT01155466|536959867|FG003|Overall Study|Lost to Follow-up|0|||
148858727|NCT01155466|536959868|FG004|Overall Study|Lost to Follow-up|2|||
148858728|NCT01155466|536959864|FG000|Overall Study|Withdrawal by Subject|7|||
148858729|NCT01155466|536959865|FG001|Overall Study|Withdrawal by Subject|5|||
148858730|NCT01155466|536959866|FG002|Overall Study|Withdrawal by Subject|9|||
148858731|NCT01155466|536959867|FG003|Overall Study|Withdrawal by Subject|4|||
148858732|NCT01155466|536959868|FG004|Overall Study|Withdrawal by Subject|4|||
148858733|NCT01155466|536959864|FG000|Overall Study|Protocol Violation|0|||
148858734|NCT01155466|536959865|FG001|Overall Study|Protocol Violation|0|||
148858735|NCT01155466|536959866|FG002|Overall Study|Protocol Violation|2|||
148858736|NCT01155466|536959867|FG003|Overall Study|Protocol Violation|0|||
148858737|NCT01155466|536959868|FG004|Overall Study|Protocol Violation|1|||
148858738|NCT01155466|536959864|FG000|Overall Study|Administrative|0|||
148858739|NCT01155466|536959865|FG001|Overall Study|Administrative|3|||
148858740|NCT01155466|536959866|FG002|Overall Study|Administrative|0|||
148858741|NCT01155466|536959867|FG003|Overall Study|Administrative|0|||
148858742|NCT01155466|536959868|FG004|Overall Study|Administrative|0|||
148858743|NCT01155466|536959864|FG000|Overall Study|Randomized not treated|2|||
148858744|NCT01155466|536959865|FG001|Overall Study|Randomized not treated|2|||
148858745|NCT01155466|536959866|FG002|Overall Study|Randomized not treated|3|||
148858746|NCT01155466|536959867|FG003|Overall Study|Randomized not treated|0|||
148858747|NCT01155466|536959868|FG004|Overall Study|Randomized not treated|2|||
148858748|NCT01778049|536959870|FG000|Open Label Treatment Period|Adverse Event|5|||
148858749|NCT01778049|536959871|FG001|Open Label Treatment Period|Adverse Event|15|||
148858750|NCT01778049|536959872|FG002|Open Label Treatment Period|Adverse Event|0|||
148858751|NCT01778049|536959873|FG003|Open Label Treatment Period|Adverse Event|0|||
148858752|NCT01778049|536959874|FG004|Open Label Treatment Period|Adverse Event|0|||
148858753|NCT01778049|536959875|FG005|Open Label Treatment Period|Adverse Event|0|||
148858754|NCT01778049|536959870|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
148858755|NCT01778049|536959871|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
148858756|NCT01778049|536959872|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
148858757|NCT01778049|536959873|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
148858758|NCT01778049|536959874|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
148858759|NCT01778049|536959875|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
148858760|NCT01778049|536959870|FG000|Open Label Treatment Period|Protocol Violation|5|||
148858761|NCT01778049|536959871|FG001|Open Label Treatment Period|Protocol Violation|5|||
148858762|NCT01778049|536959872|FG002|Open Label Treatment Period|Protocol Violation|0|||
148858763|NCT01778049|536959873|FG003|Open Label Treatment Period|Protocol Violation|0|||
148858764|NCT01778049|536959874|FG004|Open Label Treatment Period|Protocol Violation|0|||
148858765|NCT01778049|536959875|FG005|Open Label Treatment Period|Protocol Violation|0|||
148858766|NCT01778049|536959870|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
148858767|NCT01778049|536959871|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
148858768|NCT01778049|536959872|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
148858769|NCT01778049|536959873|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
148858770|NCT01778049|536959874|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
148858771|NCT01778049|536959875|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
148858772|NCT01778049|536959870|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
148858773|NCT01778049|536959871|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
148858774|NCT01778049|536959872|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
148858775|NCT01778049|536959873|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
148858776|NCT01778049|536959874|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
148858777|NCT01778049|536959875|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
148858778|NCT01778049|536959870|FG000|Open Label Treatment Period|Not treated|2|||
148858779|NCT01778049|536959871|FG001|Open Label Treatment Period|Not treated|1|||
148858780|NCT01778049|536959872|FG002|Open Label Treatment Period|Not treated|0|||
148858781|NCT01778049|536959873|FG003|Open Label Treatment Period|Not treated|0|||
148858782|NCT01778049|536959874|FG004|Open Label Treatment Period|Not treated|0|||
148858783|NCT01778049|536959875|FG005|Open Label Treatment Period|Not treated|0|||
148858784|NCT01778049|536959870|FG000|Open Label Treatment Period|Other reason not defined above|77|||
148858785|NCT01778049|536959871|FG001|Open Label Treatment Period|Other reason not defined above|94|||
148858786|NCT01778049|536959872|FG002|Open Label Treatment Period|Other reason not defined above|0|||
148858787|NCT01778049|536959873|FG003|Open Label Treatment Period|Other reason not defined above|0|||
148992299|NCT02564523|537448382|FG012|Overall Study|Other|0|||
148992300|NCT02564523|537448383|FG013|Overall Study|Other|0|||
148992301|NCT02564523|537448384|FG014|Overall Study|Other|0|||
148992302|NCT02564523|537448385|FG015|Overall Study|Other|0|||
148992303|NCT02564523|537448386|FG016|Overall Study|Other|0|||
148992304|NCT02564523|537448387|FG017|Overall Study|Other|0|||
148992305|NCT00448539|537448388|FG000|Overall Study|Medication non-compliance|4|||
148992306|NCT00448539|537448389|FG001|Overall Study|Medication non-compliance|1|||
148992307|NCT00448539|537448388|FG000|Overall Study|Protocol Violation|1|||
148992308|NCT00448539|537448389|FG001|Overall Study|Protocol Violation|0|||
148992309|NCT00448539|537448388|FG000|Overall Study|Request of the investigator or sponsor|67|||
148992310|NCT00448539|537448389|FG001|Overall Study|Request of the investigator or sponsor|54|||
148992311|NCT00448539|537448388|FG000|Overall Study|Withdrawal by Subject|20|||
148992312|NCT00448539|537448389|FG001|Overall Study|Withdrawal by Subject|24|||
148992313|NCT00448539|537448388|FG000|Overall Study|Diary non-compliance|1|||
148992314|NCT00448539|537448389|FG001|Overall Study|Diary non-compliance|0|||
148992315|NCT00448539|537448388|FG000|Overall Study|Adverse Event|9|||
148992316|NCT00448539|537448389|FG001|Overall Study|Adverse Event|26|||
148992317|NCT00448539|537448388|FG000|Overall Study|Lack of Efficacy|27|||
148992318|NCT00448539|537448389|FG001|Overall Study|Lack of Efficacy|40|||
148992319|NCT00448539|537448388|FG000|Overall Study|Miscellaneous|2|||
148992320|NCT00448539|537448389|FG001|Overall Study|Miscellaneous|1|||
148992321|NCT00448539|537448388|FG000|Overall Study|Change of meds|2|||
148992322|NCT00448539|537448389|FG001|Overall Study|Change of meds|3|||
148992323|NCT00448539|537448388|FG000|Overall Study|Lost to Follow-up|1|||
148992324|NCT00448539|537448389|FG001|Overall Study|Lost to Follow-up|3|||
148992325|NCT04862143|537448390|FG000|Overall Study|Adverse Event|1|||
148992326|NCT04862143|537448390|FG000|Overall Study|Study terminated by sponsor|1|||
148992327|NCT02103439|537448391|FG000|Overall Study|Adverse Event|0|||
148992328|NCT02103439|537448392|FG001|Overall Study|Adverse Event|2|||
148992329|NCT02103439|537448391|FG000|Overall Study|Withdrawal by Subject|3|||
148992330|NCT02103439|537448392|FG001|Overall Study|Withdrawal by Subject|1|||
148992331|NCT00695903|537448393|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
148992332|NCT00695903|537448394|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
148992333|NCT00695903|537448393|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
148992334|NCT00695903|537448394|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
148992335|NCT00695903|537448393|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
148992336|NCT00695903|537448394|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
148992337|NCT00695903|537448393|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
148992338|NCT00695903|537448394|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
148992339|NCT00695903|537448393|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
148992340|NCT00695903|537448394|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
148992341|NCT00695903|537448393|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
148992342|NCT00695903|537448394|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
148992343|NCT00695903|537448393|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
148992344|NCT00695903|537448394|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
148992345|NCT00695903|537448393|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
148992346|NCT00695903|537448394|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
148992347|NCT00695903|537448393|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
148992348|NCT00695903|537448394|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
148992349|NCT02696317|537448395|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
148992350|NCT02696317|537448396|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
148992351|NCT02696317|537448395|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
148992352|NCT02696317|537448396|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
148992353|NCT01343368|537448397|FG000|Overall Study|Death|1|||
148992354|NCT01343368|537448398|FG001|Overall Study|Death|0|||
148992355|NCT01343368|537448397|FG000|Overall Study|Lost to Follow-up|1|||
148992356|NCT01343368|537448398|FG001|Overall Study|Lost to Follow-up|0|||
148992357|NCT01296568|537448402|FG000|Continued Access Phase|Lost to Follow-up|1|||
148992358|NCT01296568|537448402|FG000|Continued Access Phase|Withdrawal by Subject|1|||
148992359|NCT01296568|537448402|FG000|Continued Access Phase|Disease Progression|1|||
148992360|NCT00321854|537448403|FG000|Overall Study|Adverse Event|41|||
148992361|NCT00321854|537448404|FG001|Overall Study|Adverse Event|43|||
148992362|NCT00321854|537448403|FG000|Overall Study|Lack of Efficacy|9|||
148992363|NCT00321854|537448404|FG001|Overall Study|Lack of Efficacy|14|||
148992364|NCT00321854|537448403|FG000|Overall Study|Protocol Violation|6|||
148992365|NCT00321854|537448404|FG001|Overall Study|Protocol Violation|5|||
148992366|NCT00321854|537448403|FG000|Overall Study|Lost to Follow-up|0|||
148992367|NCT00321854|537448404|FG001|Overall Study|Lost to Follow-up|2|||
148992368|NCT00321854|537448403|FG000|Overall Study|Withdrawal by Subject|6|||
148992369|NCT00321854|537448404|FG001|Overall Study|Withdrawal by Subject|17|||
148992370|NCT00321854|537448403|FG000|Overall Study|Other|1|||
149030704|NCT00813488|537589693|FG001|Open-label Extension|Protocol Violation|2|||
149030705|NCT00813488|537589692|FG000|Open-label Extension|Non-compliance study medication|4|||
148992371|NCT00321854|537448404|FG001|Overall Study|Other|1|||
148992372|NCT01816594|537448405|FG000|Overall Study|Local Progress|0|||
148992373|NCT01816594|537448406|FG001|Overall Study|Local Progress|2|||
148992374|NCT01816594|537448405|FG000|Overall Study|Adverse Event|9|||
148992375|NCT01816594|537448406|FG001|Overall Study|Adverse Event|0|||
148992376|NCT01816594|537448405|FG000|Overall Study|Withdrawal by Subject|1|||
148992377|NCT01816594|537448406|FG001|Overall Study|Withdrawal by Subject|0|||
148992378|NCT01816594|537448405|FG000|Overall Study|Physician Decision|1|||
148992379|NCT01816594|537448406|FG001|Overall Study|Physician Decision|0|||
148992380|NCT00413153|537448407|FG000|Overall Study|Withdrawal by Subject|1|||
148992381|NCT00413153|537448408|FG001|Overall Study|Withdrawal by Subject|1|||
148992382|NCT00413153|537448407|FG000|Overall Study|Adverse Event|1|||
148992383|NCT00413153|537448408|FG001|Overall Study|Adverse Event|0|||
148992384|NCT03117738|537448409|FG000|Overall Study|Withdrawal by Subject|3|||
148992385|NCT03117738|537448410|FG001|Overall Study|Withdrawal by Subject|1|||
148992386|NCT03117738|537448409|FG000|Overall Study|Lost to Follow-up|1|||
148992387|NCT03117738|537448410|FG001|Overall Study|Lost to Follow-up|4|||
148992388|NCT01669629|537448411|FG000|Period 1|protocol deviation|1|||
148992389|NCT01669629|537448412|FG001|Period 1|protocol deviation|2|||
148992390|NCT01221597|537448413|FG000|Overall Study|Adverse Event|4|||
148992391|NCT01221597|537448414|FG001|Overall Study|Adverse Event|1|||
148992392|NCT01221597|537448413|FG000|Overall Study|Withdrawal by Subject|20|||
148992393|NCT01221597|537448414|FG001|Overall Study|Withdrawal by Subject|6|||
148992394|NCT01221597|537448413|FG000|Overall Study|Lost to Follow-up|6|||
148992395|NCT01221597|537448414|FG001|Overall Study|Lost to Follow-up|5|||
148992396|NCT01221597|537448413|FG000|Overall Study|Protocol Violation|1|||
148992397|NCT01221597|537448414|FG001|Overall Study|Protocol Violation|0|||
148992398|NCT01221597|537448413|FG000|Overall Study|Other|3|||
148992399|NCT01221597|537448414|FG001|Overall Study|Other|4|||
148992400|NCT01221597|537448413|FG000|Overall Study|Death|2|||
148992401|NCT01221597|537448414|FG001|Overall Study|Death|0|||
148992402|NCT04420689|537448416|FG000|Overall Study|COVID-19 related hospitalization|0|||
148992403|NCT04420689|537448417|FG001|Overall Study|COVID-19 related hospitalization|0|||
148992404|NCT04420689|537448418|FG002|Overall Study|COVID-19 related hospitalization|0|||
148992405|NCT04420689|537448419|FG003|Overall Study|COVID-19 related hospitalization|0|||
148992406|NCT04420689|537448420|FG004|Overall Study|COVID-19 related hospitalization|1|||
148992407|NCT04420689|537448421|FG005|Overall Study|COVID-19 related hospitalization|0|||
148992408|NCT04420689|537448422|FG006|Overall Study|COVID-19 related hospitalization|0|||
148992409|NCT04420689|537448416|FG000|Overall Study|Physician Decision|0|||
148992410|NCT04420689|537448417|FG001|Overall Study|Physician Decision|0|||
148992411|NCT04420689|537448418|FG002|Overall Study|Physician Decision|0|||
148992412|NCT04420689|537448419|FG003|Overall Study|Physician Decision|0|||
148992413|NCT04420689|537448420|FG004|Overall Study|Physician Decision|0|||
148992414|NCT04420689|537448421|FG005|Overall Study|Physician Decision|1|||
148992415|NCT04420689|537448422|FG006|Overall Study|Physician Decision|0|||
148992416|NCT01292928|537448428|FG000|Overall Study|Death|8|||
148992417|NCT01292928|537448428|FG000|Overall Study|Withdrawal by Subject|8|||
148992418|NCT01292928|537448428|FG000|Overall Study|Lost to Follow-up|6|||
148992419|NCT01292928|537448428|FG000|Overall Study|Physician Decision|2|||
148992420|NCT04530448|537448432|FG000|Overall Study|Physician Decision|3|||
148992421|NCT04530448|537448433|FG001|Overall Study|Physician Decision|0|||
148992422|NCT03280121|537448438|FG000|Overall Study|Physician Decision|1|||
148992423|NCT03280121|537448438|FG000|Overall Study|Lost to Follow-up|1|||
148992424|NCT03280121|537448438|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
148992425|NCT03638141|537448451|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
148992426|NCT03996473|537448452|FG000|Treatment Assignment|Withdrawal by Subject|1|||
148992427|NCT03996473|537448452|FG000|Treatment Assignment|Progressive disease|6|||
148992428|NCT03996473|537448452|FG000|Treatment Assignment|Study drug never administered|1|||
148992429|NCT03996473|537448452|FG000|Active Follow-up|Death|1|||
148992430|NCT03996473|537448452|FG000|Long-term Follow-up|Death|5|||
148992431|NCT03759873|537448453|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
148992432|NCT03759873|537448454|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
148992433|NCT03759873|537448455|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
148992434|NCT03759873|537448456|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
148992435|NCT03759873|537448453|FG000|Overall Study|Moved outside eligible area|0|||
148992436|NCT03759873|537448454|FG001|Overall Study|Moved outside eligible area|2|||
148992437|NCT03759873|537448455|FG002|Overall Study|Moved outside eligible area|0|||
148992438|NCT03759873|537448456|FG003|Overall Study|Moved outside eligible area|0|||
148992439|NCT03759873|537448453|FG000|Overall Study|Withdrawal by Subject|0|||
148992440|NCT03759873|537448454|FG001|Overall Study|Withdrawal by Subject|0|||
148992441|NCT03759873|537448455|FG002|Overall Study|Withdrawal by Subject|1|||
148992442|NCT03759873|537448456|FG003|Overall Study|Withdrawal by Subject|0|||
148992443|NCT03579563|537448459|FG000|Overall Study|Lost to Follow-up|0|||
148992444|NCT03579563|537448460|FG001|Overall Study|Lost to Follow-up|0|||
148992445|NCT03579563|537448461|FG002|Overall Study|Lost to Follow-up|0|||
148992446|NCT03579563|537448462|FG003|Overall Study|Lost to Follow-up|0|||
148992447|NCT03579563|537448463|FG004|Overall Study|Lost to Follow-up|1|||
148992448|NCT03579563|537448464|FG005|Overall Study|Lost to Follow-up|0|||
148858788|NCT01778049|536959874|FG004|Open Label Treatment Period|Other reason not defined above|0|||
148992449|NCT03579563|537448459|FG000|Overall Study|Lack of Efficacy|1|||
148992450|NCT03579563|537448460|FG001|Overall Study|Lack of Efficacy|1|||
148992451|NCT03579563|537448461|FG002|Overall Study|Lack of Efficacy|4|||
148992452|NCT03579563|537448462|FG003|Overall Study|Lack of Efficacy|1|||
148992453|NCT03579563|537448463|FG004|Overall Study|Lack of Efficacy|2|||
148992454|NCT03579563|537448464|FG005|Overall Study|Lack of Efficacy|3|||
148992455|NCT03579563|537448459|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
148992456|NCT03579563|537448460|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
148992457|NCT03579563|537448461|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
148992458|NCT03579563|537448462|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
148992459|NCT03579563|537448463|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
148992460|NCT03579563|537448464|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
148992461|NCT03579563|537448459|FG000|Overall Study|Time/distance concern|0|||
148992462|NCT03579563|537448460|FG001|Overall Study|Time/distance concern|0|||
148992463|NCT03579563|537448461|FG002|Overall Study|Time/distance concern|1|||
148992464|NCT03579563|537448462|FG003|Overall Study|Time/distance concern|0|||
148992465|NCT03579563|537448463|FG004|Overall Study|Time/distance concern|0|||
148992466|NCT03579563|537448464|FG005|Overall Study|Time/distance concern|1|||
148992467|NCT03579563|537448459|FG000|Overall Study|COVID shutdown|2|||
148992468|NCT03579563|537448460|FG001|Overall Study|COVID shutdown|3|||
148992469|NCT03579563|537448461|FG002|Overall Study|COVID shutdown|4|||
148992470|NCT03579563|537448462|FG003|Overall Study|COVID shutdown|3|||
148992471|NCT03579563|537448463|FG004|Overall Study|COVID shutdown|1|||
148992472|NCT03579563|537448464|FG005|Overall Study|COVID shutdown|2|||
148992473|NCT03579563|537448459|FG000|Overall Study|Protocol administration error|1|||
148992474|NCT03579563|537448460|FG001|Overall Study|Protocol administration error|0|||
148992475|NCT03579563|537448461|FG002|Overall Study|Protocol administration error|1|||
148992476|NCT03579563|537448462|FG003|Overall Study|Protocol administration error|0|||
148992477|NCT03579563|537448463|FG004|Overall Study|Protocol administration error|1|||
148992478|NCT03579563|537448464|FG005|Overall Study|Protocol administration error|5|||
148992479|NCT04349553|537448468|FG000|Overall Study|Withdrawal by Subject|1|||
148992480|NCT04349553|537448469|FG001|Overall Study|Withdrawal by Subject|0|||
148992481|NCT04349553|537448470|FG002|Overall Study|Withdrawal by Subject|1|||
148992482|NCT04349553|537448471|FG003|Overall Study|Withdrawal by Subject|0|||
148992483|NCT03526250|537448472|FG000|Overall Study|Adverse Event|4|||
148992484|NCT03526250|537448472|FG000|Overall Study|Progressive Disease|16|||
148992485|NCT03526250|537448472|FG000|Overall Study|No Treatment|3|||
148992486|NCT04420221|537448473|FG000|Overall Study|Withdrawal by Subject|0|||
148992487|NCT04420221|537448474|FG001|Overall Study|Withdrawal by Subject|0|||
148992488|NCT04420221|537448475|FG002|Overall Study|Withdrawal by Subject|0|||
148992489|NCT04420221|537448476|FG003|Overall Study|Withdrawal by Subject|0|||
148992490|NCT04420221|537448477|FG004|Overall Study|Withdrawal by Subject|0|||
148992491|NCT04420221|537448478|FG005|Overall Study|Withdrawal by Subject|20|||
148992492|NCT04420221|537448479|FG006|Overall Study|Withdrawal by Subject|5|||
148992493|NCT04420221|537448473|FG000|Overall Study|Other|0|||
148992494|NCT04420221|537448474|FG001|Overall Study|Other|0|||
148992495|NCT04420221|537448475|FG002|Overall Study|Other|0|||
148992496|NCT04420221|537448476|FG003|Overall Study|Other|0|||
148992497|NCT04420221|537448477|FG004|Overall Study|Other|0|||
148992498|NCT04420221|537448478|FG005|Overall Study|Other|1|||
148992499|NCT04420221|537448479|FG006|Overall Study|Other|1|||
148992500|NCT04420221|537448473|FG000|Overall Study|Lost to Follow-up|0|||
148992501|NCT04420221|537448474|FG001|Overall Study|Lost to Follow-up|0|||
148992502|NCT04420221|537448475|FG002|Overall Study|Lost to Follow-up|0|||
148992503|NCT04420221|537448476|FG003|Overall Study|Lost to Follow-up|0|||
148992504|NCT04420221|537448477|FG004|Overall Study|Lost to Follow-up|0|||
148992505|NCT04420221|537448478|FG005|Overall Study|Lost to Follow-up|3|||
148992506|NCT04420221|537448479|FG006|Overall Study|Lost to Follow-up|2|||
148992507|NCT04420221|537448473|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
148992508|NCT04420221|537448474|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
148992509|NCT04420221|537448475|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
148992510|NCT04420221|537448476|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
148992511|NCT04420221|537448477|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
148992512|NCT04420221|537448478|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
148992513|NCT04420221|537448479|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
148992514|NCT02219932|537448482|FG000|Overall Study|Other|5|||
148992515|NCT02219932|537448483|FG001|Overall Study|Other|11|||
148992516|NCT02219932|537448482|FG000|Overall Study|Death|1|||
148992517|NCT02219932|537448483|FG001|Overall Study|Death|1|||
148992518|NCT02219932|537448482|FG000|Overall Study|Investigator Decision|0|||
148992519|NCT02219932|537448483|FG001|Overall Study|Investigator Decision|1|||
148992520|NCT02219932|537448482|FG000|Overall Study|Consent Withdrawn|11|||
148992521|NCT02219932|537448483|FG001|Overall Study|Consent Withdrawn|7|||
148992522|NCT02219932|537448482|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
148992523|NCT02219932|537448483|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
148992524|NCT02219932|537448482|FG000|Overall Study|Protocol Violation|10|||
148992525|NCT02219932|537448483|FG001|Overall Study|Protocol Violation|6|||
148992526|NCT02219932|537448482|FG000|Overall Study|Pregnancy|1|||
148992527|NCT02219932|537448483|FG001|Overall Study|Pregnancy|0|||
148992528|NCT02219932|537448482|FG000|Overall Study|Lost to Follow-up|4|||
148992529|NCT02219932|537448483|FG001|Overall Study|Lost to Follow-up|2|||
148992530|NCT02219932|537448482|FG000|Overall Study|Adverse Event|23|||
148992531|NCT02219932|537448483|FG001|Overall Study|Adverse Event|21|||
148992532|NCT00511004|537448484|FG000|Overall Study|Lost to Follow-up|0|||
148992533|NCT00511004|537448485|FG001|Overall Study|Lost to Follow-up|0|||
148992534|NCT00511004|537448486|FG002|Overall Study|Lost to Follow-up|4|||
148992535|NCT00990652|537448487|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
148992536|NCT00990652|537448487|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
148992537|NCT02384954|537448497|FG000|Phase 1|Progressive Disease|2|||
148992538|NCT02384954|537448498|FG001|Phase 1|Progressive Disease|0|||
148992539|NCT02384954|537448499|FG002|Phase 1|Progressive Disease|1|||
148992540|NCT02384954|537448500|FG003|Phase 1|Progressive Disease|1|||
148992541|NCT02384954|537448501|FG004|Phase 1|Progressive Disease|0|||
148992542|NCT02384954|537448502|FG005|Phase 1|Progressive Disease|0|||
148992543|NCT02384954|537448503|FG006|Phase 1|Progressive Disease|0|||
148992544|NCT02384954|537448504|FG007|Phase 1|Progressive Disease|0|||
148992545|NCT02384954|537448505|FG008|Phase 1|Progressive Disease|0|||
148992546|NCT02384954|537448497|FG000|Phase 1|Adverse Event|0|||
148992547|NCT02384954|537448498|FG001|Phase 1|Adverse Event|0|||
148992548|NCT02384954|537448499|FG002|Phase 1|Adverse Event|1|||
148992549|NCT02384954|537448500|FG003|Phase 1|Adverse Event|0|||
148992550|NCT02384954|537448501|FG004|Phase 1|Adverse Event|0|||
148992551|NCT02384954|537448502|FG005|Phase 1|Adverse Event|0|||
148992552|NCT02384954|537448503|FG006|Phase 1|Adverse Event|0|||
148992553|NCT02384954|537448504|FG007|Phase 1|Adverse Event|0|||
148992554|NCT02384954|537448505|FG008|Phase 1|Adverse Event|0|||
148992555|NCT02384954|537448497|FG000|Phase 2|Progressive Disease|0|||
148992556|NCT02384954|537448498|FG001|Phase 2|Progressive Disease|0|||
148992557|NCT02384954|537448499|FG002|Phase 2|Progressive Disease|0|||
148992558|NCT02384954|537448500|FG003|Phase 2|Progressive Disease|0|||
148992559|NCT02384954|537448501|FG004|Phase 2|Progressive Disease|0|||
148992560|NCT02384954|537448502|FG005|Phase 2|Progressive Disease|0|||
148992561|NCT02384954|537448503|FG006|Phase 2|Progressive Disease|0|||
148992562|NCT02384954|537448504|FG007|Phase 2|Progressive Disease|1|||
148858789|NCT01778049|536959875|FG005|Open Label Treatment Period|Other reason not defined above|0|||
148858790|NCT01778049|536959870|FG000|Double Blind Treatment Period|Adverse Event|0|||
148858791|NCT01778049|536959871|FG001|Double Blind Treatment Period|Adverse Event|0|||
148858792|NCT01778049|536959872|FG002|Double Blind Treatment Period|Adverse Event|4|||
148858793|NCT01778049|536959873|FG003|Double Blind Treatment Period|Adverse Event|5|||
148858794|NCT01778049|536959874|FG004|Double Blind Treatment Period|Adverse Event|3|||
148858795|NCT01778049|536959875|FG005|Double Blind Treatment Period|Adverse Event|2|||
148858796|NCT01778049|536959870|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
148858797|NCT01778049|536959871|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
148858798|NCT01778049|536959872|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
148858799|NCT01778049|536959873|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
148858800|NCT01778049|536959874|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
148858801|NCT01778049|536959875|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
148858802|NCT01778049|536959870|FG000|Double Blind Treatment Period|Protocol Violation|0|||
148858803|NCT01778049|536959871|FG001|Double Blind Treatment Period|Protocol Violation|0|||
148858804|NCT01778049|536959872|FG002|Double Blind Treatment Period|Protocol Violation|2|||
148858805|NCT01778049|536959873|FG003|Double Blind Treatment Period|Protocol Violation|0|||
148858806|NCT01778049|536959874|FG004|Double Blind Treatment Period|Protocol Violation|0|||
148858807|NCT01778049|536959875|FG005|Double Blind Treatment Period|Protocol Violation|0|||
148858808|NCT01778049|536959870|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
148858809|NCT01778049|536959871|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
148858810|NCT01778049|536959872|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
148858811|NCT01778049|536959873|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
148858812|NCT01778049|536959874|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
148858813|NCT01778049|536959875|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
148858814|NCT01778049|536959870|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
148858815|NCT01778049|536959871|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
148858816|NCT01778049|536959872|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
148858817|NCT01778049|536959873|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
148858818|NCT01778049|536959874|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
148858819|NCT01778049|536959875|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
148858820|NCT01778049|536959870|FG000|Double Blind Treatment Period|Not treated|0|||
148858821|NCT01778049|536959871|FG001|Double Blind Treatment Period|Not treated|0|||
148992563|NCT02384954|537448505|FG008|Phase 2|Progressive Disease|2|||
148992564|NCT02384954|537448497|FG000|Phase 2|Adverse Event|0|||
148858822|NCT01778049|536959872|FG002|Double Blind Treatment Period|Not treated|0|||
148992565|NCT02384954|537448498|FG001|Phase 2|Adverse Event|0|||
148992566|NCT02384954|537448499|FG002|Phase 2|Adverse Event|0|||
148992567|NCT02384954|537448500|FG003|Phase 2|Adverse Event|0|||
148992568|NCT02384954|537448501|FG004|Phase 2|Adverse Event|0|||
148858823|NCT01778049|536959873|FG003|Double Blind Treatment Period|Not treated|2|||
148992569|NCT02384954|537448502|FG005|Phase 2|Adverse Event|0|||
148992570|NCT02384954|537448503|FG006|Phase 2|Adverse Event|0|||
148992571|NCT02384954|537448504|FG007|Phase 2|Adverse Event|1|||
148992572|NCT02384954|537448505|FG008|Phase 2|Adverse Event|1|||
148858824|NCT01778049|536959874|FG004|Double Blind Treatment Period|Not treated|2|||
148858825|NCT01778049|536959875|FG005|Double Blind Treatment Period|Not treated|0|||
148858826|NCT01778049|536959870|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
148858827|NCT01778049|536959871|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
148858828|NCT01778049|536959872|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
148858829|NCT01778049|536959873|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
148858830|NCT01778049|536959874|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
148858831|NCT01778049|536959875|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
148858832|NCT00515294|536959876|FG000|Overall Study|Lost to Follow-up|3|||
148858833|NCT00515294|536959877|FG001|Overall Study|Lost to Follow-up|2|||
148858834|NCT00515294|536959878|FG002|Overall Study|Lost to Follow-up|3|||
148858835|NCT00515294|536959879|FG003|Overall Study|Lost to Follow-up|1|||
148858836|NCT00515294|536959876|FG000|Overall Study|Driver simulator problems|1|||
148858837|NCT00515294|536959877|FG001|Overall Study|Driver simulator problems|1|||
148858838|NCT00515294|536959878|FG002|Overall Study|Driver simulator problems|1|||
148858839|NCT00515294|536959879|FG003|Overall Study|Driver simulator problems|3|||
148858840|NCT00515294|536959876|FG000|Overall Study|Caffeine amount inaccurate|5|||
148858841|NCT00515294|536959877|FG001|Overall Study|Caffeine amount inaccurate|0|||
148858842|NCT00515294|536959878|FG002|Overall Study|Caffeine amount inaccurate|7|||
148858843|NCT00515294|536959879|FG003|Overall Study|Caffeine amount inaccurate|0|||
148858844|NCT03770728|536959884|FG000|Overall Study|Adverse Event|1|||
148858845|NCT03770728|536959885|FG001|Overall Study|Adverse Event|0|||
148858846|NCT03770728|536959886|FG002|Overall Study|Adverse Event|1|||
148858847|NCT03770728|536959887|FG003|Overall Study|Adverse Event|0|||
148858848|NCT03770728|536959884|FG000|Overall Study|Poor compliance to protocol|0|||
148858849|NCT03770728|536959885|FG001|Overall Study|Poor compliance to protocol|0|||
148858850|NCT03770728|536959886|FG002|Overall Study|Poor compliance to protocol|1|||
148858851|NCT03770728|536959887|FG003|Overall Study|Poor compliance to protocol|0|||
148858852|NCT03770728|536959884|FG000|Overall Study|Withdrawal by Subject|13|||
148858853|NCT03770728|536959885|FG001|Overall Study|Withdrawal by Subject|8|||
148858854|NCT03770728|536959886|FG002|Overall Study|Withdrawal by Subject|9|||
148858855|NCT03770728|536959887|FG003|Overall Study|Withdrawal by Subject|13|||
148858856|NCT03770728|536959884|FG000|Overall Study|Other than specified|24|||
148858857|NCT03770728|536959885|FG001|Overall Study|Other than specified|23|||
148858858|NCT03770728|536959886|FG002|Overall Study|Other than specified|21|||
148858859|NCT03770728|536959887|FG003|Overall Study|Other than specified|22|||
148858860|NCT02509039|536959893|FG000|Overall Study|Adverse Event|0|||
148858861|NCT02509039|536959894|FG001|Overall Study|Adverse Event|1|||
148858862|NCT02509039|536959895|FG002|Overall Study|Adverse Event|1|||
148858863|NCT02509039|536959896|FG003|Overall Study|Adverse Event|1|||
148858864|NCT02509039|536959893|FG000|Overall Study|Withdrawal by Subject|0|||
148858865|NCT02509039|536959894|FG001|Overall Study|Withdrawal by Subject|0|||
148858866|NCT02509039|536959895|FG002|Overall Study|Withdrawal by Subject|1|||
148858867|NCT02509039|536959896|FG003|Overall Study|Withdrawal by Subject|0|||
148858868|NCT02509039|536959893|FG000|Overall Study|Progressive disease|2|||
148858869|NCT02509039|536959894|FG001|Overall Study|Progressive disease|2|||
148858870|NCT02509039|536959895|FG002|Overall Study|Progressive disease|1|||
148858871|NCT02509039|536959896|FG003|Overall Study|Progressive disease|5|||
148858872|NCT02509039|536959893|FG000|Overall Study|Study terminated by Sponsor|1|||
148858873|NCT02509039|536959894|FG001|Overall Study|Study terminated by Sponsor|0|||
148858874|NCT02509039|536959895|FG002|Overall Study|Study terminated by Sponsor|0|||
148858875|NCT02509039|536959896|FG003|Overall Study|Study terminated by Sponsor|0|||
148858876|NCT03943550|536959899|FG000|Overall Study|Adverse Event|0|||
148858877|NCT03943550|536959900|FG001|Overall Study|Adverse Event|0|||
148858878|NCT03943550|536959901|FG002|Overall Study|Adverse Event|1|||
148858879|NCT03943550|536959899|FG000|Overall Study|Lost to Follow-up|0|||
148858880|NCT03943550|536959900|FG001|Overall Study|Lost to Follow-up|0|||
148858881|NCT03943550|536959901|FG002|Overall Study|Lost to Follow-up|1|||
148858882|NCT03943550|536959899|FG000|Overall Study|Progressive Disease|0|||
148858883|NCT03943550|536959900|FG001|Overall Study|Progressive Disease|0|||
148858884|NCT03943550|536959901|FG002|Overall Study|Progressive Disease|2|||
148858885|NCT03943550|536959899|FG000|Overall Study|Participant Moved Out of the Country|0|||
148858886|NCT03943550|536959900|FG001|Overall Study|Participant Moved Out of the Country|1|||
148858887|NCT03943550|536959901|FG002|Overall Study|Participant Moved Out of the Country|0|||
148858888|NCT00557310|536959902|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
148858889|NCT00557310|536959902|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
148858890|NCT00557310|536959902|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
148858891|NCT00557310|536959902|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
148858892|NCT00557310|536959902|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
148858893|NCT00557310|536959902|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
148858894|NCT01271712|536959908|FG000|Double Blind Treatment|Death|2|||
148858895|NCT01271712|536959909|FG001|Double Blind Treatment|Death|0|||
148858896|NCT01271712|536959908|FG000|Double Blind Treatment|Lack of Efficacy|1|||
148858897|NCT01271712|536959909|FG001|Double Blind Treatment|Lack of Efficacy|0|||
148858898|NCT01271712|536959908|FG000|Double Blind Treatment|Adverse Event|9|||
148992573|NCT02384954|537448497|FG000|Phase 2|Failure to meet continuation criteria|0|||
148992574|NCT02384954|537448498|FG001|Phase 2|Failure to meet continuation criteria|0|||
148992575|NCT02384954|537448499|FG002|Phase 2|Failure to meet continuation criteria|0|||
148992576|NCT02384954|537448500|FG003|Phase 2|Failure to meet continuation criteria|0|||
148992577|NCT02384954|537448501|FG004|Phase 2|Failure to meet continuation criteria|0|||
148992578|NCT02384954|537448502|FG005|Phase 2|Failure to meet continuation criteria|0|||
148992579|NCT02384954|537448503|FG006|Phase 2|Failure to meet continuation criteria|0|||
148992580|NCT02384954|537448504|FG007|Phase 2|Failure to meet continuation criteria|1|||
148992581|NCT02384954|537448505|FG008|Phase 2|Failure to meet continuation criteria|0|||
148992582|NCT02372396|537448506|FG000|Overall Study|Lost to Follow-up|7|||
148992583|NCT02372396|537448507|FG001|Overall Study|Lost to Follow-up|9|||
148992584|NCT01272934|537448509|FG000|Overall Study|Adverse Event|0|||
148992585|NCT01272934|537448510|FG001|Overall Study|Adverse Event|1|||
148992586|NCT01272934|537448509|FG000|Overall Study|Abnormal Laboratory Value|0|||
148992587|NCT01272934|537448510|FG001|Overall Study|Abnormal Laboratory Value|1|||
148992588|NCT04313634|537448511|FG000|Overall Study|Adverse Event|2|||
148992589|NCT04313634|537448512|FG001|Overall Study|Adverse Event|2|||
148992590|NCT04313634|537448513|FG002|Overall Study|Adverse Event|0|||
148992591|NCT04313634|537448511|FG000|Overall Study|Withdrawal by Subject|1|||
148992592|NCT04313634|537448512|FG001|Overall Study|Withdrawal by Subject|0|||
148992593|NCT04313634|537448513|FG002|Overall Study|Withdrawal by Subject|1|||
148992594|NCT04313634|537448511|FG000|Overall Study|Protocol Violation|0|||
148992595|NCT04313634|537448512|FG001|Overall Study|Protocol Violation|0|||
148992596|NCT04313634|537448513|FG002|Overall Study|Protocol Violation|1|||
148992597|NCT03595904|537448522|FG000|Overall Study|Protocol Violation|3|||
148992598|NCT03595904|537448523|FG001|Overall Study|Protocol Violation|1|||
148992599|NCT03595904|537448522|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
148992600|NCT03595904|537448523|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
148992601|NCT03595904|537448522|FG000|Overall Study|Insurance complications|1|||
148992602|NCT03595904|537448523|FG001|Overall Study|Insurance complications|0|||
148992603|NCT03595904|537448522|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
148992604|NCT03595904|537448523|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
148992605|NCT01581281|537448524|FG000|Overall Study|Early Study Closure|15|||
148992606|NCT01581281|537448525|FG001|Overall Study|Early Study Closure|6|||
148992607|NCT01581281|537448526|FG002|Overall Study|Early Study Closure|12|||
148992608|NCT01358526|537448527|FG000|Open-label Titration Period|Adverse Event|95|||
148992609|NCT01358526|537448528|FG001|Open-label Titration Period|Adverse Event|0|||
148992610|NCT01358526|537448529|FG002|Open-label Titration Period|Adverse Event|0|||
148992611|NCT01358526|537448527|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
148992612|NCT01358526|537448528|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
148992613|NCT01358526|537448529|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
148992614|NCT01358526|537448527|FG000|Open-label Titration Period|Lost to Follow-up|25|||
148992615|NCT01358526|537448528|FG001|Open-label Titration Period|Lost to Follow-up|0|||
148992616|NCT01358526|537448529|FG002|Open-label Titration Period|Lost to Follow-up|0|||
148992617|NCT01358526|537448527|FG000|Open-label Titration Period|Lack of Efficacy|107|||
148992618|NCT01358526|537448528|FG001|Open-label Titration Period|Lack of Efficacy|0|||
148992619|NCT01358526|537448529|FG002|Open-label Titration Period|Lack of Efficacy|0|||
148992620|NCT01358526|537448527|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
148992621|NCT01358526|537448528|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
148992622|NCT01358526|537448529|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
148992623|NCT01358526|537448527|FG000|Open-label Titration Period|Administrative|8|||
148992624|NCT01358526|537448528|FG001|Open-label Titration Period|Administrative|0|||
148992625|NCT01358526|537448529|FG002|Open-label Titration Period|Administrative|0|||
148992626|NCT01358526|537448527|FG000|Open-label Titration Period|Did not qualify|178|||
148992627|NCT01358526|537448528|FG001|Open-label Titration Period|Did not qualify|0|||
148992628|NCT01358526|537448529|FG002|Open-label Titration Period|Did not qualify|0|||
148992629|NCT01358526|537448527|FG000|Double-blind Phase|Adverse Event|0|||
148992630|NCT01358526|537448528|FG001|Double-blind Phase|Adverse Event|24|||
148858899|NCT01271712|536959909|FG001|Double Blind Treatment|Adverse Event|4|||
148858900|NCT01271712|536959908|FG000|Double Blind Treatment|Progressive disease|23|||
148858901|NCT01271712|536959909|FG001|Double Blind Treatment|Progressive disease|3|||
148858902|NCT01271712|536959908|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
148858903|NCT01271712|536959909|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
148992631|NCT01358526|537448529|FG002|Double-blind Phase|Adverse Event|23|||
148992632|NCT01358526|537448527|FG000|Double-blind Phase|Withdrawal by Subject|0|||
148992633|NCT01358526|537448528|FG001|Double-blind Phase|Withdrawal by Subject|10|||
148992634|NCT01358526|537448529|FG002|Double-blind Phase|Withdrawal by Subject|8|||
148992635|NCT01358526|537448527|FG000|Double-blind Phase|Lost to Follow-up|0|||
148992636|NCT01358526|537448528|FG001|Double-blind Phase|Lost to Follow-up|4|||
148992637|NCT01358526|537448529|FG002|Double-blind Phase|Lost to Follow-up|1|||
148992638|NCT01358526|537448527|FG000|Double-blind Phase|Lack of Efficacy|0|||
148858904|NCT01271712|536959908|FG000|Double Blind Treatment|Non compliance with study drug|2|||
148858905|NCT01271712|536959909|FG001|Double Blind Treatment|Non compliance with study drug|0|||
148858906|NCT01271712|536959908|FG000|Double Blind Treatment|receive no study drug|1|||
148858907|NCT01271712|536959909|FG001|Double Blind Treatment|receive no study drug|0|||
148858908|NCT01271712|536959908|FG000|Open Label Treatment|Death|6|||
148858909|NCT01271712|536959909|FG001|Open Label Treatment|Death|5|||
148858910|NCT01271712|536959908|FG000|Open Label Treatment|Withdrawal by Subject|6|||
148858911|NCT01271712|536959909|FG001|Open Label Treatment|Withdrawal by Subject|11|||
148858912|NCT01271712|536959908|FG000|Open Label Treatment|Physician Decision|2|||
148858913|NCT01271712|536959909|FG001|Open Label Treatment|Physician Decision|0|||
148858914|NCT01271712|536959908|FG000|Open Label Treatment|Adverse Event|14|||
148858915|NCT01271712|536959909|FG001|Open Label Treatment|Adverse Event|8|||
148858916|NCT01271712|536959908|FG000|Open Label Treatment|Progressive disease|59|||
148858917|NCT01271712|536959909|FG001|Open Label Treatment|Progressive disease|32|||
148858918|NCT01271712|536959908|FG000|Open Label Treatment|transferred to rollover study|1|||
148858919|NCT01271712|536959909|FG001|Open Label Treatment|transferred to rollover study|0|||
148858920|NCT01271712|536959908|FG000|Open Label Treatment|Non-compliance with study drug|1|||
148858921|NCT01271712|536959909|FG001|Open Label Treatment|Non-compliance with study drug|0|||
148858922|NCT01271712|536959908|FG000|Open Label Treatment|Protocol Violation|0|||
148858923|NCT01271712|536959909|FG001|Open Label Treatment|Protocol Violation|1|||
148858924|NCT01271712|536959908|FG000|Open Label Treatment|Switching to other therapy|2|||
148858925|NCT01271712|536959909|FG001|Open Label Treatment|Switching to other therapy|1|||
148858926|NCT01271712|536959908|FG000|Safety Follow-up|Death|11|||
148858927|NCT01271712|536959909|FG001|Safety Follow-up|Death|7|||
148858928|NCT01271712|536959908|FG000|Safety Follow-up|Withdrawal by Subject|4|||
148858929|NCT01271712|536959909|FG001|Safety Follow-up|Withdrawal by Subject|2|||
148858930|NCT01271712|536959908|FG000|Safety Follow-up|Protocol Violation|1|||
148858931|NCT01271712|536959909|FG001|Safety Follow-up|Protocol Violation|1|||
148858932|NCT01271712|536959908|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
148858933|NCT01271712|536959909|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
148858934|NCT01271712|536959908|FG000|Safety Follow-up|No follow-up|1|||
148858935|NCT01271712|536959909|FG001|Safety Follow-up|No follow-up|1|||
148858936|NCT01271712|536959908|FG000|Safety Follow-up|Progressive disease|1|||
148858937|NCT01271712|536959909|FG001|Safety Follow-up|Progressive disease|0|||
148858938|NCT01271712|536959908|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
148858939|NCT01271712|536959909|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
148858940|NCT00096226|536959910|FG000|Overall Study|Ineligible|2|||
148858941|NCT00096226|536959910|FG000|Overall Study|Protocol treatment not started|1|||
148858942|NCT04262882|536959911|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
148858943|NCT04262882|536959912|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
148858944|NCT04262882|536959911|FG000|Overall Study|Lost to Follow-up|1|||
148858945|NCT04262882|536959912|FG001|Overall Study|Lost to Follow-up|0|||
148858946|NCT03099174|536959913|FG000|Overall Study|Withdrawal by Subject|0|||
148858947|NCT03099174|536959914|FG001|Overall Study|Withdrawal by Subject|0|||
148858948|NCT03099174|536959915|FG002|Overall Study|Withdrawal by Subject|1|||
148858949|NCT03099174|536959916|FG003|Overall Study|Withdrawal by Subject|0|||
148858950|NCT03099174|536959917|FG004|Overall Study|Withdrawal by Subject|2|||
148858951|NCT03099174|536959918|FG005|Overall Study|Withdrawal by Subject|2|||
148858952|NCT03099174|536959919|FG006|Overall Study|Withdrawal by Subject|1|||
148858953|NCT03099174|536959920|FG007|Overall Study|Withdrawal by Subject|4|||
148858954|NCT03099174|536959913|FG000|Overall Study|Adverse Event|0|||
148858955|NCT03099174|536959914|FG001|Overall Study|Adverse Event|1|||
148858956|NCT03099174|536959915|FG002|Overall Study|Adverse Event|1|||
148858957|NCT03099174|536959916|FG003|Overall Study|Adverse Event|2|||
148858958|NCT03099174|536959917|FG004|Overall Study|Adverse Event|5|||
148858959|NCT03099174|536959918|FG005|Overall Study|Adverse Event|3|||
148858960|NCT03099174|536959919|FG006|Overall Study|Adverse Event|6|||
148858961|NCT03099174|536959920|FG007|Overall Study|Adverse Event|4|||
148858962|NCT03099174|536959913|FG000|Overall Study|Other than listed|6|||
148858963|NCT03099174|536959914|FG001|Overall Study|Other than listed|6|||
148858964|NCT03099174|536959915|FG002|Overall Study|Other than listed|5|||
148858965|NCT03099174|536959916|FG003|Overall Study|Other than listed|6|||
148858966|NCT03099174|536959917|FG004|Overall Study|Other than listed|19|||
148858967|NCT03099174|536959918|FG005|Overall Study|Other than listed|10|||
148858968|NCT03099174|536959919|FG006|Overall Study|Other than listed|26|||
148858969|NCT03099174|536959920|FG007|Overall Study|Other than listed|23|||
148858970|NCT04730635|536959921|FG000|Overall Study|Lost to Follow-up|1|||
148858971|NCT04730635|536959922|FG001|Overall Study|Lost to Follow-up|0|||
148858972|NCT04730635|536959921|FG000|Overall Study|Withdrawal by Subject|0|||
148858973|NCT04730635|536959922|FG001|Overall Study|Withdrawal by Subject|1|||
148858974|NCT03070223|536959923|FG000|Overall Study|Lost to Follow-up|34|||
148858975|NCT03070223|536959924|FG001|Overall Study|Lost to Follow-up|27|||
148858976|NCT03070223|536959923|FG000|Overall Study|Withdrawal by Subject|12|||
148858977|NCT03070223|536959924|FG001|Overall Study|Withdrawal by Subject|22|||
148858978|NCT03070223|536959923|FG000|Overall Study|Protocol Violation|0|||
148858979|NCT03070223|536959924|FG001|Overall Study|Protocol Violation|1|||
148858980|NCT02118766|536959930|FG000|Overall Study|Adverse Event|7|||
148858981|NCT02118766|536959931|FG001|Overall Study|Adverse Event|2|||
148858982|NCT02118766|536959930|FG000|Overall Study|Withdrawal by Subject|3|||
148858983|NCT02118766|536959931|FG001|Overall Study|Withdrawal by Subject|6|||
148858984|NCT02118766|536959930|FG000|Overall Study|Lost to Follow-up|5|||
148858985|NCT02118766|536959931|FG001|Overall Study|Lost to Follow-up|4|||
148858986|NCT02118766|536959930|FG000|Overall Study|Withdrawal by parent/guardian|12|||
148992639|NCT01358526|537448528|FG001|Double-blind Phase|Lack of Efficacy|31|||
148992640|NCT01358526|537448529|FG002|Double-blind Phase|Lack of Efficacy|73|||
148992641|NCT01358526|537448527|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
148992642|NCT01358526|537448528|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
148992643|NCT01358526|537448529|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
148992644|NCT01358526|537448527|FG000|Double-blind Phase|Administrative|0|||
148992645|NCT01358526|537448528|FG001|Double-blind Phase|Administrative|6|||
148992646|NCT01358526|537448529|FG002|Double-blind Phase|Administrative|10|||
148992647|NCT01962974|537448530|FG000|Overall Study|Study termination|7|||
148992648|NCT04764396|537448531|FG000|Overall Study|Physician Decision|1|||
148992649|NCT04764396|537448532|FG001|Overall Study|Physician Decision|0|||
148992650|NCT03230916|537448533|FG000|Overall Study|Withdrawal by Subject|0|||
148992651|NCT03230916|537448534|FG001|Overall Study|Withdrawal by Subject|0|||
148992652|NCT03230916|537448535|FG002|Overall Study|Withdrawal by Subject|0|||
148992653|NCT03230916|537448536|FG003|Overall Study|Withdrawal by Subject|0|||
148992654|NCT03230916|537448537|FG004|Overall Study|Withdrawal by Subject|0|||
148992655|NCT03230916|537448538|FG005|Overall Study|Withdrawal by Subject|1|||
148992656|NCT03230916|537448539|FG006|Overall Study|Withdrawal by Subject|0|||
148992657|NCT03230916|537448540|FG007|Overall Study|Withdrawal by Subject|0|||
148992658|NCT03230916|537448541|FG008|Overall Study|Withdrawal by Subject|0|||
148992659|NCT03230916|537448542|FG009|Overall Study|Withdrawal by Subject|0|||
148992660|NCT03230916|537448543|FG010|Overall Study|Withdrawal by Subject|0|||
148992661|NCT01128413|537448545|FG000|Overall Study|Withdrawal by Subject|1|||
148992662|NCT01128413|537448546|FG001|Overall Study|Withdrawal by Subject|0|||
148992663|NCT01128413|537448545|FG000|Overall Study|NICOM Monitor Problems|2|||
148992664|NCT01128413|537448546|FG001|Overall Study|NICOM Monitor Problems|1|||
148992665|NCT01128413|537448545|FG000|Overall Study|Pt made DNR|1|||
148992666|NCT01128413|537448546|FG001|Overall Study|Pt made DNR|0|||
148992667|NCT01218646|537448549|FG000|Overall Study|Adverse Event|0|||
148992668|NCT01218646|537448550|FG001|Overall Study|Adverse Event|0|||
148992669|NCT01218646|537448551|FG002|Overall Study|Adverse Event|1|||
149030706|NCT00813488|537589693|FG001|Open-label Extension|Non-compliance study medication|0|||
149030707|NCT00813488|537589692|FG000|Open-label Extension|Non-compliance study procedures|2|||
148858987|NCT02118766|536959931|FG001|Overall Study|Withdrawal by parent/guardian|18|||
148858988|NCT02118766|536959930|FG000|Overall Study|Other|3|||
148858989|NCT02118766|536959931|FG001|Overall Study|Other|1|||
148858990|NCT05032690|536959932|FG000|Period 1|Adverse Event|0|||
148858991|NCT05032690|536959933|FG001|Period 1|Adverse Event|1|||
148858992|NCT05032690|536959934|FG002|Period 1|Adverse Event|0|||
148858993|NCT05032690|536959935|FG003|Period 1|Adverse Event|0|||
148858994|NCT05032690|536959932|FG000|Period 1|Withdrawal by Subject|1|||
148858995|NCT05032690|536959933|FG001|Period 1|Withdrawal by Subject|0|||
148858996|NCT05032690|536959934|FG002|Period 1|Withdrawal by Subject|0|||
148858997|NCT05032690|536959935|FG003|Period 1|Withdrawal by Subject|0|||
148858998|NCT05032690|536959932|FG000|Period 1|No longer meets eligibility criteria|0|||
148858999|NCT05032690|536959933|FG001|Period 1|No longer meets eligibility criteria|1|||
148859000|NCT05032690|536959934|FG002|Period 1|No longer meets eligibility criteria|0|||
148859001|NCT05032690|536959935|FG003|Period 1|No longer meets eligibility criteria|0|||
148859002|NCT05032690|536959932|FG000|Period 2|Adverse Event|1|||
148859003|NCT05032690|536959933|FG001|Period 2|Adverse Event|0|||
148859004|NCT05032690|536959934|FG002|Period 2|Adverse Event|0|||
148859005|NCT05032690|536959935|FG003|Period 2|Adverse Event|0|||
148859006|NCT05032690|536959932|FG000|Period 2|Withdrawal by Subject|0|||
148859007|NCT05032690|536959933|FG001|Period 2|Withdrawal by Subject|1|||
148859008|NCT05032690|536959934|FG002|Period 2|Withdrawal by Subject|0|||
148992670|NCT01218646|537448552|FG003|Overall Study|Adverse Event|0|||
149030708|NCT00813488|537589693|FG001|Open-label Extension|Non-compliance study procedures|1|||
148859009|NCT05032690|536959935|FG003|Period 2|Withdrawal by Subject|0|||
148859010|NCT05032690|536959932|FG000|Period 2|No longer meets eligibility criteria|0|||
148859011|NCT05032690|536959933|FG001|Period 2|No longer meets eligibility criteria|1|||
148859012|NCT05032690|536959934|FG002|Period 2|No longer meets eligibility criteria|0|||
148859013|NCT05032690|536959935|FG003|Period 2|No longer meets eligibility criteria|0|||
148859014|NCT05032690|536959932|FG000|Period 3|Adverse Event|0|||
148992671|NCT01218646|537448549|FG000|Overall Study|Lost to Follow-up|1|||
148992672|NCT01218646|537448550|FG001|Overall Study|Lost to Follow-up|0|||
148992673|NCT01218646|537448551|FG002|Overall Study|Lost to Follow-up|0|||
148992674|NCT01218646|537448552|FG003|Overall Study|Lost to Follow-up|0|||
148992675|NCT01218646|537448549|FG000|Overall Study|Protocol Violation|0|||
148859015|NCT05032690|536959933|FG001|Period 3|Adverse Event|1|||
148859016|NCT05032690|536959934|FG002|Period 3|Adverse Event|0|||
148859017|NCT05032690|536959935|FG003|Period 3|Adverse Event|0|||
148992676|NCT01218646|537448550|FG001|Overall Study|Protocol Violation|0|||
148992677|NCT01218646|537448551|FG002|Overall Study|Protocol Violation|1|||
148992678|NCT01218646|537448552|FG003|Overall Study|Protocol Violation|1|||
148992679|NCT02693665|537448553|FG000|Overall Study|Death|3|||
148992680|NCT02693665|537448554|FG001|Overall Study|Death|2|||
148992681|NCT02693665|537448553|FG000|Overall Study|Lost to Follow-up|7|||
148992682|NCT02693665|537448554|FG001|Overall Study|Lost to Follow-up|3|||
148992683|NCT02693665|537448553|FG000|Overall Study|Protocol Violation|1|||
148992684|NCT02693665|537448554|FG001|Overall Study|Protocol Violation|0|||
148992685|NCT02693665|537448553|FG000|Overall Study|Withdrawal by Subject|2|||
148992686|NCT02693665|537448554|FG001|Overall Study|Withdrawal by Subject|0|||
148992687|NCT02693665|537448553|FG000|Overall Study|patient wanted to leave it behind|1|||
148992688|NCT02693665|537448554|FG001|Overall Study|patient wanted to leave it behind|0|||
148992689|NCT02693665|537448553|FG000|Overall Study|anxiety|1|||
148992690|NCT02693665|537448554|FG001|Overall Study|anxiety|0|||
148992691|NCT02693665|537448553|FG000|Overall Study|family issues|1|||
148992692|NCT02693665|537448554|FG001|Overall Study|family issues|0|||
148992693|NCT02693665|537448553|FG000|Overall Study|no reason given|1|||
148992694|NCT02693665|537448554|FG001|Overall Study|no reason given|0|||
148992695|NCT00726752|537448555|FG000|Overall Study|Lack of Efficacy|6|||
148992696|NCT00844857|537451164|FG000|Overall Study|Adverse Event|24|||
148992697|NCT00844857|537451165|FG001|Overall Study|Adverse Event|5|||
148992698|NCT00844857|537451164|FG000|Overall Study|Sponsor Decision|1|||
148992699|NCT00844857|537451165|FG001|Overall Study|Sponsor Decision|1|||
148992700|NCT00844857|537451164|FG000|Overall Study|Physician Decision|2|||
148992701|NCT00844857|537451165|FG001|Overall Study|Physician Decision|0|||
148992702|NCT00844857|537451164|FG000|Overall Study|Parent/Caregiver Decision|6|||
148992703|NCT00844857|537451165|FG001|Overall Study|Parent/Caregiver Decision|2|||
148992704|NCT00844857|537451164|FG000|Overall Study|Withdrawal by Subject|8|||
148992705|NCT00844857|537451165|FG001|Overall Study|Withdrawal by Subject|7|||
148992706|NCT00844857|537451164|FG000|Overall Study|Protocol Violation|6|||
148992707|NCT00844857|537451165|FG001|Overall Study|Protocol Violation|0|||
148992708|NCT00844857|537451164|FG000|Overall Study|Lack of Efficacy|5|||
148992709|NCT00844857|537451165|FG001|Overall Study|Lack of Efficacy|5|||
148992710|NCT00844857|537451164|FG000|Overall Study|Clinical Relapse|0|||
148992711|NCT00844857|537451165|FG001|Overall Study|Clinical Relapse|1|||
148992712|NCT00844857|537451164|FG000|Overall Study|Entry Criteria Not Met|0|||
148992713|NCT00844857|537451165|FG001|Overall Study|Entry Criteria Not Met|1|||
148992714|NCT00844857|537451164|FG000|Overall Study|Lost to Follow-up|2|||
148992715|NCT00844857|537451165|FG001|Overall Study|Lost to Follow-up|3|||
148992716|NCT00844857|537451164|FG000|Overall Study|Did Not Take Study Drug|3|||
148992717|NCT00844857|537451165|FG001|Overall Study|Did Not Take Study Drug|1|||
148992718|NCT00844857|537451164|FG000|Overall Study|Good Clinical Practice Violations|21|||
148992719|NCT00844857|537451165|FG001|Overall Study|Good Clinical Practice Violations|11|||
148992720|NCT00570674|537451166|FG000|Overall Study|Withdrawal by Subject|0|||
148992721|NCT00570674|537451167|FG001|Overall Study|Withdrawal by Subject|0|||
148992722|NCT00570674|537451168|FG002|Overall Study|Withdrawal by Subject|1|||
148992723|NCT00570674|537451169|FG003|Overall Study|Withdrawal by Subject|0|||
148992724|NCT00570674|537451170|FG004|Overall Study|Withdrawal by Subject|0|||
148992725|NCT00570674|537451171|FG005|Overall Study|Withdrawal by Subject|0|||
148992726|NCT00570674|537451172|FG006|Overall Study|Withdrawal by Subject|0|||
148992727|NCT01877408|537451173|FG000|Overall Study|Lost to Follow-up|0|||
148992728|NCT01877408|537451174|FG001|Overall Study|Lost to Follow-up|2|||
148992729|NCT02621931|537451175|FG000|Overall Study|Death|0|||
148992730|NCT02621931|537451176|FG001|Overall Study|Death|1|||
148992731|NCT02621931|537451177|FG002|Overall Study|Death|0|||
148992732|NCT02621931|537451175|FG000|Overall Study|Adverse Event|8|||
148992733|NCT02621931|537451176|FG001|Overall Study|Adverse Event|5|||
148992734|NCT02621931|537451177|FG002|Overall Study|Adverse Event|7|||
148992735|NCT02621931|537451175|FG000|Overall Study|Withdrawal by Subject|12|||
149030709|NCT00813488|537589692|FG000|Open-label Extension|Other|1|||
149030710|NCT00813488|537589693|FG001|Open-label Extension|Other|0|||
149030711|NCT01559090|537589694|FG000|Stage I|Withdrawal by Subject|2|||
148992736|NCT02621931|537451176|FG001|Overall Study|Withdrawal by Subject|10|||
148859018|NCT01638013|536959936|FG000|Overall Study|Adverse Event|36|||
148992737|NCT02621931|537451177|FG002|Overall Study|Withdrawal by Subject|11|||
148992738|NCT02621931|537451175|FG000|Overall Study|Protocol Violation|2|||
148992739|NCT02621931|537451176|FG001|Overall Study|Protocol Violation|2|||
148992740|NCT02621931|537451177|FG002|Overall Study|Protocol Violation|2|||
148992741|NCT02621931|537451175|FG000|Overall Study|Pregnancy|2|||
148992742|NCT02621931|537451176|FG001|Overall Study|Pregnancy|0|||
148992743|NCT02621931|537451177|FG002|Overall Study|Pregnancy|0|||
148992744|NCT02621931|537451175|FG000|Overall Study|Noncompliance to study procedures|0|||
148992745|NCT02621931|537451176|FG001|Overall Study|Noncompliance to study procedures|1|||
148992746|NCT02621931|537451177|FG002|Overall Study|Noncompliance to study procedures|2|||
148992747|NCT02621931|537451175|FG000|Overall Study|Lost to Follow-up|8|||
148992748|NCT02621931|537451176|FG001|Overall Study|Lost to Follow-up|7|||
148992749|NCT02621931|537451177|FG002|Overall Study|Lost to Follow-up|10|||
149030712|NCT01559090|537589695|FG001|Stage I|Withdrawal by Subject|2|||
148992750|NCT02621931|537451175|FG000|Overall Study|Lack of Efficacy|0|||
148992751|NCT02621931|537451176|FG001|Overall Study|Lack of Efficacy|0|||
148992752|NCT02621931|537451177|FG002|Overall Study|Lack of Efficacy|1|||
148992753|NCT02621931|537451175|FG000|Overall Study|Other|1|||
148992754|NCT02621931|537451176|FG001|Overall Study|Other|1|||
148992755|NCT02621931|537451177|FG002|Overall Study|Other|3|||
148992756|NCT00920426|537451178|FG000|ITZ111451|Adverse Event|1|||
148992757|NCT00920426|537451179|FG001|ITZ111451|Adverse Event|0|||
148992758|NCT00920426|537451180|FG002|ITZ111451|Adverse Event|0|||
148992759|NCT00920426|537451181|FG003|ITZ111451|Adverse Event|0|||
148992760|NCT01292603|537451182|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
148992761|NCT01292603|537451183|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
148992762|NCT01292603|537451184|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
148992763|NCT01292603|537451185|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
148992764|NCT01292603|537451186|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
148992765|NCT01292603|537451187|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
148992766|NCT01292603|537451182|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
148992767|NCT01292603|537451183|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
148992768|NCT01292603|537451184|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
148992769|NCT01292603|537451185|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
148992770|NCT01292603|537451186|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
148992771|NCT01292603|537451187|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
148992772|NCT01292603|537451182|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
148992773|NCT01292603|537451183|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
148992774|NCT01292603|537451184|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
148992775|NCT01292603|537451185|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
148992776|NCT01292603|537451186|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
148992777|NCT01292603|537451187|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
148992778|NCT01292603|537451182|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
148992779|NCT01292603|537451183|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
148992780|NCT01292603|537451184|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
148992781|NCT01292603|537451185|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
148992782|NCT01292603|537451186|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
148992783|NCT01292603|537451187|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
148992784|NCT01292603|537451182|FG000|Part 1: Regular Follow-Up Period|Death|3|||
148992785|NCT01292603|537451183|FG001|Part 1: Regular Follow-Up Period|Death|1|||
148992786|NCT01292603|537451184|FG002|Part 1: Regular Follow-Up Period|Death|3|||
148992787|NCT01292603|537451185|FG003|Part 1: Regular Follow-Up Period|Death|1|||
148992788|NCT01292603|537451186|FG004|Part 1: Regular Follow-Up Period|Death|0|||
148992789|NCT01292603|537451187|FG005|Part 1: Regular Follow-Up Period|Death|0|||
148992790|NCT01292603|537451182|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
148992791|NCT01292603|537451183|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
148992792|NCT01292603|537451184|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
148992793|NCT01292603|537451185|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
148992794|NCT01292603|537451186|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
148992795|NCT01292603|537451187|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
148992796|NCT01292603|537451182|FG000|Part 2: Dose Confirmation Period|Death|0|||
148992797|NCT01292603|537451183|FG001|Part 2: Dose Confirmation Period|Death|0|||
148992798|NCT01292603|537451184|FG002|Part 2: Dose Confirmation Period|Death|0|||
148992799|NCT01292603|537451185|FG003|Part 2: Dose Confirmation Period|Death|0|||
148992800|NCT01292603|537451186|FG004|Part 2: Dose Confirmation Period|Death|1|||
148992801|NCT01292603|537451187|FG005|Part 2: Dose Confirmation Period|Death|0|||
148992802|NCT01292603|537451182|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
148992803|NCT01292603|537451183|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
148992804|NCT01292603|537451184|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
148992805|NCT01292603|537451185|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
148992806|NCT01292603|537451186|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
148992807|NCT01292603|537451187|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
148992808|NCT01292603|537451182|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
148992809|NCT01292603|537451183|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
148992810|NCT01292603|537451184|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
148992811|NCT01292603|537451185|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
148992812|NCT01292603|537451186|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
148992813|NCT01292603|537451187|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
148992814|NCT01292603|537451182|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
148992815|NCT01292603|537451183|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
148992816|NCT01292603|537451184|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
148992817|NCT01292603|537451185|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
148992818|NCT01292603|537451186|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
149030713|NCT01559090|537589696|FG002|Stage I|Withdrawal by Subject|3|||
149030714|NCT01559090|537589694|FG000|Stage II|Withdrawal by Subject|1|||
148992819|NCT01292603|537451187|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
148992820|NCT01292603|537451182|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
148992821|NCT01292603|537451183|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
148992822|NCT01292603|537451184|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
148992823|NCT01292603|537451185|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
148992824|NCT01292603|537451186|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
148992825|NCT01292603|537451187|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
148992826|NCT01292603|537451182|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
148992827|NCT01292603|537451183|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
148992828|NCT01292603|537451184|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
148992829|NCT01292603|537451185|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
148992830|NCT01292603|537451186|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
148992831|NCT01292603|537451187|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
148992832|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Death|0|||
148992833|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Death|0|||
148992834|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Death|0|||
148992835|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Death|0|||
148992836|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Death|6|||
148992837|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Death|3|||
148992838|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
148992839|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
148992840|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
148992841|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
148992842|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
148992843|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
148992844|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
148992845|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
148992846|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
148992847|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
148992848|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
148992849|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
148992850|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
148992851|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
148992852|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
148992853|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
148992854|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
148992855|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
148992856|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
148992857|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
148992858|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
148992859|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
148992860|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
148992861|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
148992862|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
148992863|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
148992864|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
148992865|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
148992866|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
148992867|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
148992868|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
148992869|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
148992870|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
148992871|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
148992872|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
148992873|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
148859019|NCT01638013|536959937|FG001|Overall Study|Adverse Event|29|||
148859020|NCT01638013|536959938|FG002|Overall Study|Adverse Event|48|||
149030715|NCT01559090|537589695|FG001|Stage II|Withdrawal by Subject|0|||
148859021|NCT01638013|536959936|FG000|Overall Study|Lack of Efficacy|39|||
148992874|NCT01292603|537451182|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
148992875|NCT01292603|537451183|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
148992876|NCT01292603|537451184|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
148992877|NCT01292603|537451185|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
148992878|NCT01292603|537451186|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
148992879|NCT01292603|537451187|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
148992880|NCT01292603|537451182|FG000|Overall Survival Status|Death|3|||
148992881|NCT01292603|537451183|FG001|Overall Survival Status|Death|1|||
148992882|NCT01292603|537451184|FG002|Overall Survival Status|Death|3|||
149030716|NCT01559090|537589696|FG002|Stage II|Withdrawal by Subject|0|||
148992883|NCT01292603|537451185|FG003|Overall Survival Status|Death|1|||
148992884|NCT01292603|537451186|FG004|Overall Survival Status|Death|16|||
148859022|NCT01638013|536959937|FG001|Overall Study|Lack of Efficacy|11|||
148992885|NCT01292603|537451187|FG005|Overall Survival Status|Death|10|||
148992886|NCT03870763|537451190|FG000|Overall Study|Study terminated by sponsor|0|||
148992887|NCT03870763|537451191|FG001|Overall Study|Study terminated by sponsor|2|||
148992888|NCT03870763|537451192|FG002|Overall Study|Study terminated by sponsor|0|||
148992889|NCT03870763|537451190|FG000|Overall Study|Withdrawal by Subject|0|||
148992890|NCT03870763|537451191|FG001|Overall Study|Withdrawal by Subject|1|||
148992891|NCT03870763|537451192|FG002|Overall Study|Withdrawal by Subject|0|||
148992892|NCT03870763|537451190|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
148992893|NCT03870763|537451191|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
148992894|NCT03870763|537451192|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
148992895|NCT01912612|537451201|FG000|Overall Study|Adverse Event|4|||
148992896|NCT01912612|537451202|FG001|Overall Study|Adverse Event|0|||
148992897|NCT01912612|537451203|FG002|Overall Study|Adverse Event|0|||
148992898|NCT01912612|537451201|FG000|Overall Study|Withdrew consent|1|||
148992899|NCT01912612|537451202|FG001|Overall Study|Withdrew consent|0|||
148992900|NCT01912612|537451203|FG002|Overall Study|Withdrew consent|0|||
148992901|NCT01912612|537451201|FG000|Overall Study|Study design change|0|||
148992902|NCT01912612|537451202|FG001|Overall Study|Study design change|0|||
148992903|NCT01912612|537451203|FG002|Overall Study|Study design change|3|||
148992904|NCT01588184|537451204|FG000|Overall Study|Death|1|||
148992905|NCT01588184|537451205|FG001|Overall Study|Death|0|||
148992906|NCT01588184|537451206|FG002|Overall Study|Death|0|||
148992907|NCT01588184|537451207|FG003|Overall Study|Death|1|||
148992908|NCT01588184|537451208|FG004|Overall Study|Death|1|||
148992909|NCT01588184|537451209|FG005|Overall Study|Death|1|||
148992910|NCT01588184|537451204|FG000|Overall Study|Withdrawal by Subject|2|||
148992911|NCT01588184|537451205|FG001|Overall Study|Withdrawal by Subject|4|||
148992912|NCT01588184|537451206|FG002|Overall Study|Withdrawal by Subject|0|||
148992913|NCT01588184|537451207|FG003|Overall Study|Withdrawal by Subject|1|||
148992914|NCT01588184|537451208|FG004|Overall Study|Withdrawal by Subject|0|||
148992915|NCT01588184|537451209|FG005|Overall Study|Withdrawal by Subject|0|||
148992916|NCT01588184|537451204|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
148992917|NCT01588184|537451205|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
148992918|NCT01588184|537451206|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
148992919|NCT01588184|537451207|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
148992920|NCT01588184|537451208|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
148992921|NCT01588184|537451209|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
148992922|NCT01588184|537451204|FG000|Overall Study|multiple reasons|0|||
148992923|NCT01588184|537451205|FG001|Overall Study|multiple reasons|3|||
148992924|NCT01588184|537451206|FG002|Overall Study|multiple reasons|0|||
148992925|NCT01588184|537451207|FG003|Overall Study|multiple reasons|1|||
148992926|NCT01588184|537451208|FG004|Overall Study|multiple reasons|0|||
148992927|NCT01588184|537451209|FG005|Overall Study|multiple reasons|0|||
148992928|NCT00907153|537451210|FG000|Overall Study|Lost to Follow-up|1|||
148992929|NCT00907153|537451211|FG001|Overall Study|Lost to Follow-up|1|||
148992930|NCT00907153|537451210|FG000|Overall Study|Withdrawal by Subject|1|||
148992931|NCT00907153|537451211|FG001|Overall Study|Withdrawal by Subject|3|||
148992932|NCT02120027|537451214|FG000|Overall Study|Adverse Event|4|||
148992933|NCT02120027|537451215|FG001|Overall Study|Adverse Event|5|||
148992934|NCT02120027|537451214|FG000|Overall Study|Lack of Efficacy|3|||
148992935|NCT02120027|537451215|FG001|Overall Study|Lack of Efficacy|5|||
148992936|NCT02120027|537451214|FG000|Overall Study|Lost to Follow-up|5|||
148992937|NCT02120027|537451215|FG001|Overall Study|Lost to Follow-up|13|||
148992938|NCT02120027|537451214|FG000|Overall Study|Other|4|||
148992939|NCT02120027|537451215|FG001|Overall Study|Other|0|||
148992940|NCT02120027|537451214|FG000|Overall Study|Physician Decision|4|||
148992941|NCT02120027|537451215|FG001|Overall Study|Physician Decision|3|||
148992942|NCT02120027|537451214|FG000|Overall Study|Protocol Violation|18|||
148992943|NCT02120027|537451215|FG001|Overall Study|Protocol Violation|21|||
148992944|NCT02120027|537451214|FG000|Overall Study|Study terminated by Sponsor|45|||
148992945|NCT02120027|537451215|FG001|Overall Study|Study terminated by Sponsor|47|||
148992946|NCT02120027|537451214|FG000|Overall Study|Withdrawal by Subject|33|||
148992947|NCT02120027|537451215|FG001|Overall Study|Withdrawal by Subject|25|||
148992948|NCT03393000|537451216|FG000|Overall Study|Death|11|||
148992949|NCT03393000|537451216|FG000|Overall Study|Withdrawal by Subject|2|||
148992950|NCT03393000|537451216|FG000|Overall Study|Physician Decision|1|||
148992951|NCT01773070|537451217|FG000|Overall Study|Withdrawal by Subject|24|||
148992952|NCT01773070|537451217|FG000|Overall Study|Lost to Follow-up|39|||
148992953|NCT01773070|537451217|FG000|Overall Study|Other|15|||
148992954|NCT01773070|537451217|FG000|Overall Study|Death (unrelated to study procedures)|3|||
148992955|NCT01471054|537451218|FG000|Overall Study|Study terminated prematurely|4|||
148992956|NCT01471054|537451219|FG001|Overall Study|Study terminated prematurely|0|||
148992957|NCT01559844|537451220|FG000|Overall Study|Consent Withdrawn|7|||
148992958|NCT01559844|537451220|FG000|Overall Study|Death|5|||
148992959|NCT01559844|537451220|FG000|Overall Study|Efficacy Failure|10|||
148992960|NCT01559844|537451220|FG000|Overall Study|No Longer A Transplant Candidate|3|||
148992961|NCT00951041|537451221|FG000|Overall Study|Withdrawal by Subject|1|||
149030717|NCT03677375|537589697|FG000|Overall Study|Incomplete procedure|8|||
148859023|NCT01638013|536959938|FG002|Overall Study|Lack of Efficacy|14|||
148859024|NCT01638013|536959936|FG000|Overall Study|Protocol Violation|10|||
148859025|NCT01638013|536959937|FG001|Overall Study|Protocol Violation|7|||
148859026|NCT01638013|536959938|FG002|Overall Study|Protocol Violation|11|||
148859027|NCT01638013|536959936|FG000|Overall Study|Met discontinuation criteria|4|||
148859028|NCT01638013|536959937|FG001|Overall Study|Met discontinuation criteria|0|||
148859029|NCT01638013|536959938|FG002|Overall Study|Met discontinuation criteria|7|||
148859030|NCT01638013|536959936|FG000|Overall Study|Subject Lost to Follow up|1|||
148859031|NCT01638013|536959937|FG001|Overall Study|Subject Lost to Follow up|0|||
148859032|NCT01638013|536959938|FG002|Overall Study|Subject Lost to Follow up|1|||
148859033|NCT01638013|536959936|FG000|Overall Study|Miscellaneous|25|||
148859034|NCT01638013|536959937|FG001|Overall Study|Miscellaneous|19|||
148859035|NCT01638013|536959938|FG002|Overall Study|Miscellaneous|23|||
148859036|NCT01638013|536959936|FG000|Overall Study|Withdrawal of Consent|16|||
148859037|NCT01638013|536959937|FG001|Overall Study|Withdrawal of Consent|12|||
148859038|NCT01638013|536959938|FG002|Overall Study|Withdrawal of Consent|16|||
148859039|NCT01638013|536959936|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
148859040|NCT01638013|536959937|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
148859041|NCT01638013|536959938|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
148859042|NCT02298179|536959939|FG000|Overall Study|Lost to Follow-up|0|||
148859043|NCT02298179|536959940|FG001|Overall Study|Lost to Follow-up|0|||
148859044|NCT02298179|536959941|FG002|Overall Study|Lost to Follow-up|1|||
148859045|NCT02298179|536959942|FG003|Overall Study|Lost to Follow-up|0|||
148859046|NCT02298179|536959943|FG004|Overall Study|Lost to Follow-up|0|||
148859047|NCT02298179|536959944|FG005|Overall Study|Lost to Follow-up|0|||
148859048|NCT02298179|536959945|FG006|Overall Study|Lost to Follow-up|0|||
148859049|NCT02298179|536959946|FG007|Overall Study|Lost to Follow-up|1|||
148859050|NCT02298179|536959947|FG008|Overall Study|Lost to Follow-up|0|||
148859051|NCT02298179|536959948|FG009|Overall Study|Lost to Follow-up|0|||
148859052|NCT02298179|536959949|FG010|Overall Study|Lost to Follow-up|0|||
148859053|NCT02298179|536959950|FG011|Overall Study|Lost to Follow-up|0|||
148859054|NCT00068250|536959953|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
148859055|NCT00068250|536959954|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
148859056|NCT00068250|536959955|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
148859057|NCT00068250|536959956|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
148859058|NCT02226198|536961500|FG000|Lead-in Phase|Protocol Violation|1|||
148859059|NCT02226198|536961501|FG001|Lead-in Phase|Protocol Violation|0|||
148859060|NCT02226198|536961502|FG002|Lead-in Phase|Protocol Violation|0|||
148859061|NCT02226198|536961500|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
148859062|NCT02226198|536961501|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
148859063|NCT02226198|536961502|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
148859064|NCT01440517|536961506|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
148859065|NCT01288612|536961507|FG000|Overall Study|Unable to contact|11|||
148859066|NCT01288612|536961508|FG001|Overall Study|Unable to contact|16|||
148859067|NCT01288612|536961509|FG002|Overall Study|Unable to contact|20|||
148859068|NCT01288612|536961507|FG000|Overall Study|Declined|78|||
148859069|NCT01288612|536961508|FG001|Overall Study|Declined|63|||
148859070|NCT01288612|536961509|FG002|Overall Study|Declined|62|||
148859071|NCT01288612|536961507|FG000|Overall Study|Unable to intubate|0|||
148859072|NCT01288612|536961508|FG001|Overall Study|Unable to intubate|3|||
148859073|NCT01288612|536961509|FG002|Overall Study|Unable to intubate|0|||
148859074|NCT00871923|536961510|FG000|Overall Study|Death|1|||
148859075|NCT00871923|536961510|FG000|Overall Study|Withdrawal by Subject|1|||
148859076|NCT01263015|536961515|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
148859077|NCT01263015|536961516|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
148859078|NCT01263015|536961515|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
148859079|NCT01263015|536961516|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
148859080|NCT01263015|536961515|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
148859081|NCT01263015|536961516|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
148859082|NCT01263015|536961515|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
148859083|NCT01263015|536961516|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
148859084|NCT01263015|536961515|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
148859085|NCT01263015|536961516|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
148859086|NCT01263015|536961515|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
148859087|NCT01263015|536961516|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
148859088|NCT01263015|536961515|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
148859089|NCT01263015|536961516|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
148859090|NCT01263015|536961515|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
148859091|NCT01263015|536961516|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
148859092|NCT01263015|536961515|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
148859093|NCT01263015|536961516|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
148859094|NCT01263015|536961515|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
148992962|NCT00951041|537451222|FG001|Overall Study|Withdrawal by Subject|1|||
148992963|NCT00951041|537451221|FG000|Overall Study|Lost to Follow-up|1|||
148992964|NCT00951041|537451222|FG001|Overall Study|Lost to Follow-up|0|||
148992965|NCT00951041|537451221|FG000|Overall Study|Other|3|||
148992966|NCT00951041|537451222|FG001|Overall Study|Other|0|||
148992967|NCT01217073|537451224|FG000|Base Period|Adverse Event|1|||
148992968|NCT01217073|537451225|FG001|Base Period|Adverse Event|0|||
148992969|NCT01217073|537451226|FG002|Base Period|Adverse Event|1|||
148992970|NCT01217073|537451227|FG003|Base Period|Adverse Event|0|||
148992971|NCT01217073|537451228|FG004|Base Period|Adverse Event|4|||
148992972|NCT01217073|537451229|FG005|Base Period|Adverse Event|1|||
148992973|NCT01217073|537451230|FG006|Base Period|Adverse Event|0|||
148992974|NCT01217073|537451231|FG007|Base Period|Adverse Event|0|||
148992975|NCT01217073|537451224|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
148992976|NCT01217073|537451225|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148992977|NCT01217073|537451226|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148859095|NCT01263015|536961516|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
148859096|NCT01263015|536961515|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
148859097|NCT01263015|536961516|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
148859098|NCT01263015|536961515|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
148859099|NCT01263015|536961516|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
148859100|NCT05599451|536961517|FG000|Overall Study|Not randomized|11|||
148859101|NCT05599451|536961518|FG001|Overall Study|Not randomized|0|||
148859102|NCT05599451|536961519|FG002|Overall Study|Not randomized|0|||
148859103|NCT05599451|536961520|FG003|Overall Study|Not randomized|0|||
148859104|NCT05599451|536961521|FG004|Overall Study|Not randomized|0|||
148859105|NCT05599451|536961517|FG000|Overall Study|Physician Decision|0|||
148859106|NCT05599451|536961518|FG001|Overall Study|Physician Decision|0|||
148859107|NCT05599451|536961519|FG002|Overall Study|Physician Decision|0|||
148859108|NCT05599451|536961520|FG003|Overall Study|Physician Decision|1|||
148859109|NCT05599451|536961521|FG004|Overall Study|Physician Decision|0|||
148859110|NCT02723006|536961522|FG000|Overall Study|Withdrawal by Subject|0|||
148859111|NCT02723006|536961523|FG001|Overall Study|Withdrawal by Subject|1|||
148859112|NCT02723006|536961524|FG002|Overall Study|Withdrawal by Subject|1|||
148859113|NCT02723006|536961522|FG000|Overall Study|Study Terminated by Sponsor|1|||
148859114|NCT02723006|536961523|FG001|Overall Study|Study Terminated by Sponsor|6|||
148859115|NCT02723006|536961524|FG002|Overall Study|Study Terminated by Sponsor|6|||
148859116|NCT00303446|536961525|FG000|Overall Study|Withdrawal by Subject|2|||
148859117|NCT00303446|536961526|FG001|Overall Study|Withdrawal by Subject|2|||
148859118|NCT00303446|536961525|FG000|Overall Study|Death|0|||
148859119|NCT00303446|536961526|FG001|Overall Study|Death|1|||
148859120|NCT00303446|536961525|FG000|Overall Study|Physician Decision|0|||
148859121|NCT00303446|536961526|FG001|Overall Study|Physician Decision|1|||
148859122|NCT04258995|536961527|FG000|Overall Study|Lost to Follow-up|1|||
148859123|NCT04258995|536961528|FG001|Overall Study|Lost to Follow-up|1|||
148859124|NCT03842969|536961530|FG000|Overall Study|Participant declined follow-up visit|0|||
148859125|NCT03842969|536961531|FG001|Overall Study|Participant declined follow-up visit|1|||
148859126|NCT03842969|536961532|FG002|Overall Study|Participant declined follow-up visit|0|||
148859127|NCT03842969|536961530|FG000|Overall Study|Sponsor's decision|12|||
148859128|NCT03842969|536961531|FG001|Overall Study|Sponsor's decision|99|||
148859129|NCT03842969|536961532|FG002|Overall Study|Sponsor's decision|61|||
148859130|NCT03842969|536961530|FG000|Overall Study|Pregnancy|0|||
148859131|NCT03842969|536961531|FG001|Overall Study|Pregnancy|0|||
148859132|NCT03842969|536961532|FG002|Overall Study|Pregnancy|1|||
148859133|NCT03842969|536961530|FG000|Overall Study|Death|1|||
148859134|NCT03842969|536961531|FG001|Overall Study|Death|0|||
148859135|NCT03842969|536961532|FG002|Overall Study|Death|1|||
148859136|NCT03842969|536961530|FG000|Overall Study|Withdrawal by Subject|3|||
148992978|NCT01217073|537451227|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148992979|NCT01217073|537451228|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148992980|NCT01217073|537451229|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148992981|NCT01217073|537451230|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148992982|NCT01217073|537451231|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
148859137|NCT03842969|536961531|FG001|Overall Study|Withdrawal by Subject|30|||
148859138|NCT03842969|536961532|FG002|Overall Study|Withdrawal by Subject|18|||
148859139|NCT03842969|536961530|FG000|Overall Study|Protocol Violation|1|||
148859140|NCT03842969|536961531|FG001|Overall Study|Protocol Violation|1|||
148859141|NCT03842969|536961532|FG002|Overall Study|Protocol Violation|0|||
148859142|NCT03842969|536961530|FG000|Overall Study|Physician Decision|0|||
148992983|NCT01217073|537451224|FG000|Base Period|Excluded medication|0|||
148992984|NCT01217073|537451225|FG001|Base Period|Excluded medication|0|||
148992985|NCT01217073|537451226|FG002|Base Period|Excluded medication|0|||
148992986|NCT01217073|537451227|FG003|Base Period|Excluded medication|0|||
148859143|NCT03842969|536961531|FG001|Overall Study|Physician Decision|3|||
148859144|NCT03842969|536961532|FG002|Overall Study|Physician Decision|0|||
148859145|NCT03842969|536961530|FG000|Overall Study|Lost to Follow-up|0|||
148859146|NCT03842969|536961531|FG001|Overall Study|Lost to Follow-up|2|||
148859147|NCT03842969|536961532|FG002|Overall Study|Lost to Follow-up|0|||
148992987|NCT01217073|537451228|FG004|Base Period|Excluded medication|1|||
148992988|NCT01217073|537451229|FG005|Base Period|Excluded medication|0|||
148992989|NCT01217073|537451230|FG006|Base Period|Excluded medication|0|||
148992990|NCT01217073|537451231|FG007|Base Period|Excluded medication|0|||
148992991|NCT01217073|537451224|FG000|Base Period|Lack of Efficacy|0|||
148992992|NCT01217073|537451225|FG001|Base Period|Lack of Efficacy|0|||
148992993|NCT01217073|537451226|FG002|Base Period|Lack of Efficacy|0|||
148992994|NCT01217073|537451227|FG003|Base Period|Lack of Efficacy|0|||
148992995|NCT01217073|537451228|FG004|Base Period|Lack of Efficacy|0|||
148992996|NCT01217073|537451229|FG005|Base Period|Lack of Efficacy|1|||
148992997|NCT01217073|537451230|FG006|Base Period|Lack of Efficacy|0|||
148992998|NCT01217073|537451231|FG007|Base Period|Lack of Efficacy|0|||
148992999|NCT01217073|537451224|FG000|Base Period|Lost to Follow-up|0|||
148993000|NCT01217073|537451225|FG001|Base Period|Lost to Follow-up|0|||
148993001|NCT01217073|537451226|FG002|Base Period|Lost to Follow-up|1|||
148993002|NCT01217073|537451227|FG003|Base Period|Lost to Follow-up|1|||
148993003|NCT01217073|537451228|FG004|Base Period|Lost to Follow-up|3|||
148993004|NCT01217073|537451229|FG005|Base Period|Lost to Follow-up|0|||
148993005|NCT01217073|537451230|FG006|Base Period|Lost to Follow-up|0|||
148993006|NCT01217073|537451231|FG007|Base Period|Lost to Follow-up|0|||
148993007|NCT01217073|537451224|FG000|Base Period|Physician Decision|0|||
148993008|NCT01217073|537451225|FG001|Base Period|Physician Decision|0|||
148993009|NCT01217073|537451226|FG002|Base Period|Physician Decision|0|||
148993010|NCT01217073|537451227|FG003|Base Period|Physician Decision|0|||
148993011|NCT01217073|537451228|FG004|Base Period|Physician Decision|1|||
148993012|NCT01217073|537451229|FG005|Base Period|Physician Decision|0|||
148993013|NCT01217073|537451230|FG006|Base Period|Physician Decision|0|||
148993014|NCT01217073|537451231|FG007|Base Period|Physician Decision|0|||
148993015|NCT01217073|537451224|FG000|Base Period|Protocol Violation|1|||
148993016|NCT01217073|537451225|FG001|Base Period|Protocol Violation|0|||
148993017|NCT01217073|537451226|FG002|Base Period|Protocol Violation|0|||
148993018|NCT01217073|537451227|FG003|Base Period|Protocol Violation|0|||
148993019|NCT01217073|537451228|FG004|Base Period|Protocol Violation|1|||
148993020|NCT01217073|537451229|FG005|Base Period|Protocol Violation|2|||
148993021|NCT01217073|537451230|FG006|Base Period|Protocol Violation|0|||
148993022|NCT01217073|537451231|FG007|Base Period|Protocol Violation|0|||
148993023|NCT01217073|537451224|FG000|Base Period|Withdrawal by Subject|4|||
148993024|NCT01217073|537451225|FG001|Base Period|Withdrawal by Subject|5|||
148993025|NCT01217073|537451226|FG002|Base Period|Withdrawal by Subject|5|||
148993026|NCT01217073|537451227|FG003|Base Period|Withdrawal by Subject|1|||
148993027|NCT01217073|537451228|FG004|Base Period|Withdrawal by Subject|5|||
148993028|NCT01217073|537451229|FG005|Base Period|Withdrawal by Subject|5|||
148993029|NCT01217073|537451230|FG006|Base Period|Withdrawal by Subject|0|||
148993030|NCT01217073|537451231|FG007|Base Period|Withdrawal by Subject|0|||
148993031|NCT01217073|537451224|FG000|Extension Period|Adverse Event|0|||
148993032|NCT01217073|537451225|FG001|Extension Period|Adverse Event|0|||
148993033|NCT01217073|537451226|FG002|Extension Period|Adverse Event|0|||
148993034|NCT01217073|537451227|FG003|Extension Period|Adverse Event|0|||
148993035|NCT01217073|537451228|FG004|Extension Period|Adverse Event|0|||
148993036|NCT01217073|537451229|FG005|Extension Period|Adverse Event|0|||
148993037|NCT01217073|537451230|FG006|Extension Period|Adverse Event|19|||
148993038|NCT01217073|537451231|FG007|Extension Period|Adverse Event|5|||
148993039|NCT01217073|537451224|FG000|Extension Period|ALT/AST|0|||
148993040|NCT01217073|537451225|FG001|Extension Period|ALT/AST|0|||
148993041|NCT01217073|537451226|FG002|Extension Period|ALT/AST|0|||
148993042|NCT01217073|537451227|FG003|Extension Period|ALT/AST|0|||
148993043|NCT01217073|537451228|FG004|Extension Period|ALT/AST|0|||
148993044|NCT01217073|537451229|FG005|Extension Period|ALT/AST|0|||
148993045|NCT01217073|537451230|FG006|Extension Period|ALT/AST|2|||
148993046|NCT01217073|537451231|FG007|Extension Period|ALT/AST|0|||
148993047|NCT01217073|537451224|FG000|Extension Period|Contraindication to study medication|0|||
148993048|NCT01217073|537451225|FG001|Extension Period|Contraindication to study medication|0|||
148993049|NCT01217073|537451226|FG002|Extension Period|Contraindication to study medication|0|||
148993050|NCT01217073|537451227|FG003|Extension Period|Contraindication to study medication|0|||
148993051|NCT01217073|537451228|FG004|Extension Period|Contraindication to study medication|0|||
148993052|NCT01217073|537451229|FG005|Extension Period|Contraindication to study medication|0|||
148993053|NCT01217073|537451230|FG006|Extension Period|Contraindication to study medication|1|||
148993054|NCT01217073|537451231|FG007|Extension Period|Contraindication to study medication|0|||
148993055|NCT01217073|537451224|FG000|Extension Period|Creatinine/eGFR|0|||
148993056|NCT01217073|537451225|FG001|Extension Period|Creatinine/eGFR|0|||
148993057|NCT01217073|537451226|FG002|Extension Period|Creatinine/eGFR|0|||
148993058|NCT01217073|537451227|FG003|Extension Period|Creatinine/eGFR|0|||
148993059|NCT01217073|537451228|FG004|Extension Period|Creatinine/eGFR|0|||
148993060|NCT01217073|537451229|FG005|Extension Period|Creatinine/eGFR|0|||
148993061|NCT01217073|537451230|FG006|Extension Period|Creatinine/eGFR|11|||
148993062|NCT01217073|537451231|FG007|Extension Period|Creatinine/eGFR|1|||
148993063|NCT01217073|537451224|FG000|Extension Period|Death|0|||
148993064|NCT01217073|537451225|FG001|Extension Period|Death|0|||
148993065|NCT01217073|537451226|FG002|Extension Period|Death|0|||
148993066|NCT01217073|537451227|FG003|Extension Period|Death|0|||
148993067|NCT01217073|537451228|FG004|Extension Period|Death|0|||
148993068|NCT01217073|537451229|FG005|Extension Period|Death|0|||
148993069|NCT01217073|537451230|FG006|Extension Period|Death|1|||
148993070|NCT01217073|537451231|FG007|Extension Period|Death|0|||
148859148|NCT03842969|536961530|FG000|Overall Study|Adverse Event|0|||
148859149|NCT03842969|536961531|FG001|Overall Study|Adverse Event|2|||
148859150|NCT03842969|536961532|FG002|Overall Study|Adverse Event|0|||
148859151|NCT01962987|536961535|FG000|Overall Study|Adverse Event|4|||
148859152|NCT01962987|536961536|FG001|Overall Study|Adverse Event|4|||
148859153|NCT01962987|536961537|FG002|Overall Study|Adverse Event|0|||
148859154|NCT01962987|536961535|FG000|Overall Study|Lost to Follow-up|0|||
148859155|NCT01962987|536961536|FG001|Overall Study|Lost to Follow-up|0|||
148859156|NCT01962987|536961537|FG002|Overall Study|Lost to Follow-up|1|||
148859157|NCT01962987|536961535|FG000|Overall Study|Non compliance with dosing requirements|4|||
148859158|NCT01962987|536961536|FG001|Overall Study|Non compliance with dosing requirements|2|||
148859159|NCT01962987|536961537|FG002|Overall Study|Non compliance with dosing requirements|0|||
148859160|NCT01962987|536961535|FG000|Overall Study|Miscellaneous|1|||
148859161|NCT01962987|536961536|FG001|Overall Study|Miscellaneous|9|||
148859162|NCT01962987|536961537|FG002|Overall Study|Miscellaneous|2|||
148859163|NCT01962987|536961535|FG000|Overall Study|Restricted medication|5|||
148859164|NCT01962987|536961536|FG001|Overall Study|Restricted medication|1|||
148859165|NCT01962987|536961537|FG002|Overall Study|Restricted medication|1|||
148859166|NCT01962987|536961535|FG000|Overall Study|Serious Adverse Event|1|||
148859167|NCT01962987|536961536|FG001|Overall Study|Serious Adverse Event|0|||
148859168|NCT01962987|536961537|FG002|Overall Study|Serious Adverse Event|0|||
148859169|NCT01962987|536961535|FG000|Overall Study|Withdrawal by Subject|11|||
148859170|NCT01962987|536961536|FG001|Overall Study|Withdrawal by Subject|10|||
148859171|NCT01962987|536961537|FG002|Overall Study|Withdrawal by Subject|6|||
148859172|NCT01962987|536961535|FG000|Overall Study|Randomized in Error|4|||
148859173|NCT01962987|536961536|FG001|Overall Study|Randomized in Error|2|||
148859174|NCT01962987|536961537|FG002|Overall Study|Randomized in Error|2|||
148859175|NCT01942161|536961541|FG000|Overall Study|Adverse Event|1|||
148859176|NCT01942161|536961542|FG001|Overall Study|Adverse Event|2|||
148859177|NCT01942161|536961543|FG002|Overall Study|Adverse Event|5|||
148859178|NCT01942161|536961541|FG000|Overall Study|Physician Decision|3|||
148859179|NCT01942161|536961542|FG001|Overall Study|Physician Decision|1|||
148859180|NCT01942161|536961543|FG002|Overall Study|Physician Decision|0|||
148859181|NCT01942161|536961541|FG000|Overall Study|Protocol Violation|1|||
148859182|NCT01942161|536961542|FG001|Overall Study|Protocol Violation|0|||
148859183|NCT01942161|536961543|FG002|Overall Study|Protocol Violation|0|||
148859184|NCT01942161|536961541|FG000|Overall Study|Withdrawal by Subject|3|||
148859185|NCT01942161|536961542|FG001|Overall Study|Withdrawal by Subject|3|||
148859186|NCT01942161|536961543|FG002|Overall Study|Withdrawal by Subject|1|||
148859187|NCT01257568|536961544|FG000|Overall Study|Lost to Follow-up|2|||
148859188|NCT01257568|536961544|FG000|Overall Study|Withdrawal by Subject|6|||
148859189|NCT01257568|536961544|FG000|Overall Study|Terminated|1|||
148859190|NCT01257568|536961544|FG000|Overall Study|Component Revision|24|||
148859191|NCT03392883|536961546|FG000|Overall Study|Lost to Follow-up|122|||
148859192|NCT03392883|536961547|FG001|Overall Study|Lost to Follow-up|13|||
148859193|NCT03392883|536961548|FG002|Overall Study|Lost to Follow-up|9|||
148859194|NCT03392883|536961546|FG000|Overall Study|Death|4|||
148859195|NCT03392883|536961547|FG001|Overall Study|Death|0|||
148859196|NCT03392883|536961548|FG002|Overall Study|Death|0|||
148859197|NCT03392883|536961546|FG000|Overall Study|Lack of Efficacy|29|||
148859198|NCT03392883|536961547|FG001|Overall Study|Lack of Efficacy|0|||
148859199|NCT03392883|536961548|FG002|Overall Study|Lack of Efficacy|0|||
148859200|NCT03392883|536961546|FG000|Overall Study|Withdrawal by Subject|180|||
148993071|NCT01217073|537451224|FG000|Extension Period|Excluded medication|0|||
148993072|NCT01217073|537451225|FG001|Extension Period|Excluded medication|0|||
148993073|NCT01217073|537451226|FG002|Extension Period|Excluded medication|0|||
148993074|NCT01217073|537451227|FG003|Extension Period|Excluded medication|0|||
148859201|NCT03392883|536961547|FG001|Overall Study|Withdrawal by Subject|0|||
148859202|NCT03392883|536961548|FG002|Overall Study|Withdrawal by Subject|0|||
148859203|NCT03392883|536961546|FG000|Overall Study|Adverse Event|1|||
148859204|NCT03392883|536961547|FG001|Overall Study|Adverse Event|0|||
148859205|NCT03392883|536961548|FG002|Overall Study|Adverse Event|0|||
148859206|NCT00908115|536961557|FG000|Overall Study|Other|14|||
148859207|NCT01728077|536961559|FG000|Overall Study|Lack of Efficacy|3|||
148859208|NCT01728077|536961560|FG001|Overall Study|Lack of Efficacy|1|||
148859209|NCT01728077|536961559|FG000|Overall Study|Lost to Follow-up|1|||
148859210|NCT01728077|536961560|FG001|Overall Study|Lost to Follow-up|0|||
148859211|NCT01728077|536961559|FG000|Overall Study|Subject choice|2|||
148859212|NCT01728077|536961560|FG001|Overall Study|Subject choice|3|||
148859213|NCT01728077|536961559|FG000|Overall Study|Death|0|||
148859214|NCT01728077|536961560|FG001|Overall Study|Death|1|||
148859215|NCT01728077|536961559|FG000|Overall Study|Patient moving|1|||
148859216|NCT01728077|536961560|FG001|Overall Study|Patient moving|0|||
148859217|NCT01728077|536961559|FG000|Overall Study|Non compliance|1|||
148993075|NCT01217073|537451228|FG004|Extension Period|Excluded medication|0|||
148993076|NCT01217073|537451229|FG005|Extension Period|Excluded medication|0|||
148859218|NCT01728077|536961560|FG001|Overall Study|Non compliance|0|||
148859219|NCT00378599|536961563|FG000|Overall Study|Adverse Event|38|||
148859220|NCT00378599|536961563|FG000|Overall Study|Protocol Violation|2|||
148859221|NCT00378599|536961563|FG000|Overall Study|Treatment failure|7|||
148859222|NCT00378599|536961563|FG000|Overall Study|Withdrawal by Subject|5|||
148859223|NCT00416715|536961564|FG000|Overall Study|Not evaluable for joint aches|7|||
148859224|NCT00416715|536961564|FG000|Overall Study|Vitamin D levels not evaluable|8|||
148859225|NCT01007435|536961567|FG000|Overall Study|Adverse Event|16|||
148859226|NCT01007435|536961568|FG001|Overall Study|Adverse Event|25|||
148859227|NCT01007435|536961569|FG002|Overall Study|Adverse Event|47|||
148859228|NCT01007435|536961570|FG003|Overall Study|Adverse Event|31|||
148859229|NCT01007435|536961567|FG000|Overall Study|Death|2|||
148859230|NCT01007435|536961568|FG001|Overall Study|Death|4|||
148859231|NCT01007435|536961569|FG002|Overall Study|Death|2|||
148859232|NCT01007435|536961570|FG003|Overall Study|Death|1|||
148859233|NCT01007435|536961567|FG000|Overall Study|Insufficient Therapeutic Response|21|||
148859234|NCT01007435|536961568|FG001|Overall Study|Insufficient Therapeutic Response|7|||
148859235|NCT01007435|536961569|FG002|Overall Study|Insufficient Therapeutic Response|2|||
148859236|NCT01007435|536961570|FG003|Overall Study|Insufficient Therapeutic Response|9|||
148859237|NCT01007435|536961567|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
148859238|NCT01007435|536961568|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
148859239|NCT01007435|536961569|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
148859240|NCT01007435|536961570|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
148859241|NCT01007435|536961567|FG000|Overall Study|Other Protocol Violation|2|||
148859242|NCT01007435|536961568|FG001|Overall Study|Other Protocol Violation|0|||
148859243|NCT01007435|536961569|FG002|Overall Study|Other Protocol Violation|1|||
148859244|NCT01007435|536961570|FG003|Overall Study|Other Protocol Violation|0|||
148859245|NCT01007435|536961567|FG000|Overall Study|Refused Treatment|13|||
148859246|NCT01007435|536961568|FG001|Overall Study|Refused Treatment|13|||
148859247|NCT01007435|536961569|FG002|Overall Study|Refused Treatment|5|||
148859248|NCT01007435|536961570|FG003|Overall Study|Refused Treatment|8|||
148859249|NCT01007435|536961567|FG000|Overall Study|Failure to Return|5|||
148859250|NCT01007435|536961568|FG001|Overall Study|Failure to Return|4|||
148859251|NCT01007435|536961569|FG002|Overall Study|Failure to Return|3|||
148859252|NCT01007435|536961570|FG003|Overall Study|Failure to Return|6|||
148859253|NCT01007435|536961567|FG000|Overall Study|Reason not Specified|1|||
148859254|NCT01007435|536961568|FG001|Overall Study|Reason not Specified|1|||
148859255|NCT01007435|536961569|FG002|Overall Study|Reason not Specified|2|||
148859256|NCT01007435|536961570|FG003|Overall Study|Reason not Specified|1|||
148859257|NCT00347438|536961571|FG000|Overall Study|Withdrawal by Subject|1|||
148859258|NCT00347438|536961571|FG000|Overall Study|Physician Decision|1|||
148859259|NCT02545517|536961572|FG000|Overall Study|Death|2|||
148859260|NCT02545517|536961573|FG001|Overall Study|Death|2|||
148859261|NCT02545517|536961574|FG002|Overall Study|Death|1|||
148859262|NCT02545517|536961572|FG000|Overall Study|Lost to Follow-up|14|||
148859263|NCT02545517|536961573|FG001|Overall Study|Lost to Follow-up|13|||
148859264|NCT02545517|536961574|FG002|Overall Study|Lost to Follow-up|17|||
148859265|NCT02545517|536961572|FG000|Overall Study|Protocol Violation|0|||
148859266|NCT02545517|536961573|FG001|Overall Study|Protocol Violation|1|||
148859267|NCT02545517|536961574|FG002|Overall Study|Protocol Violation|1|||
148859268|NCT02545517|536961572|FG000|Overall Study|Withdrawal by Subject|5|||
148859269|NCT02545517|536961573|FG001|Overall Study|Withdrawal by Subject|8|||
148859270|NCT02545517|536961574|FG002|Overall Study|Withdrawal by Subject|9|||
148859271|NCT02545517|536961572|FG000|Overall Study|Administrative reason|5|||
148859272|NCT02545517|536961573|FG001|Overall Study|Administrative reason|6|||
148859273|NCT02545517|536961574|FG002|Overall Study|Administrative reason|10|||
148859274|NCT02545517|536961572|FG000|Overall Study|Other|2|||
148859275|NCT02545517|536961573|FG001|Overall Study|Other|4|||
148859276|NCT02545517|536961574|FG002|Overall Study|Other|3|||
148859277|NCT01529515|536961575|FG000|TRANSITION PHASE|Adverse Event|16|||
148859278|NCT01529515|536961576|FG001|TRANSITION PHASE|Adverse Event|0|||
148859279|NCT01529515|536961577|FG002|TRANSITION PHASE|Adverse Event|0|||
148859280|NCT01529515|536961578|FG003|TRANSITION PHASE|Adverse Event|0|||
148859281|NCT01529515|536961575|FG000|TRANSITION PHASE|Death|1|||
148859282|NCT01529515|536961576|FG001|TRANSITION PHASE|Death|0|||
148859283|NCT01529515|536961577|FG002|TRANSITION PHASE|Death|0|||
148859284|NCT01529515|536961578|FG003|TRANSITION PHASE|Death|0|||
148859285|NCT01529515|536961575|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
148859286|NCT01529515|536961576|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
148859287|NCT01529515|536961577|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
148859288|NCT01529515|536961578|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
148859289|NCT01529515|536961575|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
148859290|NCT01529515|536961576|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
148859291|NCT01529515|536961577|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
148859292|NCT01529515|536961578|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
148859293|NCT01529515|536961575|FG000|TRANSITION PHASE|Protocol Violation|4|||
148859294|NCT01529515|536961576|FG001|TRANSITION PHASE|Protocol Violation|0|||
148859295|NCT01529515|536961577|FG002|TRANSITION PHASE|Protocol Violation|0|||
149030718|NCT03677375|537589697|FG000|Overall Study|Adverse Event|3|||
148859296|NCT01529515|536961578|FG003|TRANSITION PHASE|Protocol Violation|0|||
148859297|NCT01529515|536961575|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
148859298|NCT01529515|536961576|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
148859299|NCT01529515|536961577|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
148859300|NCT01529515|536961578|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
148859301|NCT01529515|536961575|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
148859302|NCT01529515|536961576|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
148859303|NCT01529515|536961577|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
148859304|NCT01529515|536961578|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
148859305|NCT01529515|536961575|FG000|TRANSITION PHASE|Other|9|||
148859306|NCT01529515|536961576|FG001|TRANSITION PHASE|Other|0|||
148859307|NCT01529515|536961577|FG002|TRANSITION PHASE|Other|0|||
148859308|NCT01529515|536961578|FG003|TRANSITION PHASE|Other|0|||
148859309|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Adverse Event|0|||
148859310|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Adverse Event|10|||
148859311|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Adverse Event|0|||
148859312|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Adverse Event|0|||
148859313|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
148859314|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
148859315|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
148859316|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
148859317|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
148859318|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
148859319|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
148859320|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
148859321|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
148859322|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
148859323|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
148859324|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
148859325|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
148859326|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
148859327|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
148859328|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
148859329|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
148859330|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
148859331|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
148859332|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
148859333|NCT01529515|536961575|FG000|MAINTENANCE PHASE|Other|0|||
148859334|NCT01529515|536961576|FG001|MAINTENANCE PHASE|Other|10|||
148859335|NCT01529515|536961577|FG002|MAINTENANCE PHASE|Other|0|||
148859336|NCT01529515|536961578|FG003|MAINTENANCE PHASE|Other|0|||
148859337|NCT01529515|536961575|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
148859338|NCT01529515|536961576|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
148859339|NCT01529515|536961577|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
148859340|NCT01529515|536961578|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
148859341|NCT01529515|536961575|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
148859342|NCT01529515|536961576|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
148859343|NCT01529515|536961577|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
148859344|NCT01529515|536961578|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
148859345|NCT01529515|536961575|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
148859346|NCT01529515|536961576|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
148859347|NCT01529515|536961577|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
148859348|NCT01529515|536961578|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
148859349|NCT01529515|536961575|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
148859350|NCT01529515|536961576|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
148859351|NCT01529515|536961577|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
148859352|NCT01529515|536961578|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
148859353|NCT01529515|536961575|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
148859354|NCT01529515|536961576|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
148859355|NCT01529515|536961577|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
148859356|NCT01529515|536961578|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
148859357|NCT01529515|536961575|FG000|DOUBLE BLIND PHASE|Other|0|||
148859358|NCT01529515|536961576|FG001|DOUBLE BLIND PHASE|Other|0|||
148859359|NCT01529515|536961577|FG002|DOUBLE BLIND PHASE|Other|9|||
148859360|NCT01529515|536961578|FG003|DOUBLE BLIND PHASE|Other|2|||
148859361|NCT03334851|536961580|FG000|Overall Study|Other|0|||
148859362|NCT03334851|536961581|FG001|Overall Study|Other|0|||
148859363|NCT03334851|536961582|FG002|Overall Study|Other|0|||
148859364|NCT03334851|536961583|FG003|Overall Study|Other|0|||
149030719|NCT03677375|537589697|FG000|Overall Study|Physician Decision|1|||
148859365|NCT03334851|536961584|FG004|Overall Study|Other|0|||
148859366|NCT03334851|536961585|FG005|Overall Study|Other|0|||
148859367|NCT03334851|536961586|FG006|Overall Study|Other|0|||
148859368|NCT03334851|536961587|FG007|Overall Study|Other|1|||
148859369|NCT03334851|536961588|FG008|Overall Study|Other|0|||
148859370|NCT03334851|536961589|FG009|Overall Study|Other|0|||
148859371|NCT03334851|536961590|FG010|Overall Study|Other|0|||
148859372|NCT03334851|536961591|FG011|Overall Study|Other|0|||
148859373|NCT03334851|536961592|FG012|Overall Study|Other|0|||
148859374|NCT03334851|536961580|FG000|Overall Study|Adverse Event|0|||
148859375|NCT03334851|536961581|FG001|Overall Study|Adverse Event|0|||
148859376|NCT03334851|536961582|FG002|Overall Study|Adverse Event|0|||
148859377|NCT03334851|536961583|FG003|Overall Study|Adverse Event|0|||
148859378|NCT03334851|536961584|FG004|Overall Study|Adverse Event|0|||
148859379|NCT03334851|536961585|FG005|Overall Study|Adverse Event|0|||
148859380|NCT03334851|536961586|FG006|Overall Study|Adverse Event|0|||
148859381|NCT03334851|536961587|FG007|Overall Study|Adverse Event|1|||
148859382|NCT03334851|536961588|FG008|Overall Study|Adverse Event|0|||
148859383|NCT03334851|536961589|FG009|Overall Study|Adverse Event|0|||
148859384|NCT03334851|536961590|FG010|Overall Study|Adverse Event|0|||
148859385|NCT03334851|536961591|FG011|Overall Study|Adverse Event|0|||
148859386|NCT03334851|536961592|FG012|Overall Study|Adverse Event|0|||
148859387|NCT03334851|536961580|FG000|Overall Study|Withdrawal by Subject|0|||
148859388|NCT03334851|536961581|FG001|Overall Study|Withdrawal by Subject|0|||
148859389|NCT03334851|536961582|FG002|Overall Study|Withdrawal by Subject|0|||
148859390|NCT03334851|536961583|FG003|Overall Study|Withdrawal by Subject|0|||
148859391|NCT03334851|536961584|FG004|Overall Study|Withdrawal by Subject|0|||
148859392|NCT03334851|536961585|FG005|Overall Study|Withdrawal by Subject|0|||
148859393|NCT03334851|536961586|FG006|Overall Study|Withdrawal by Subject|0|||
148859394|NCT03334851|536961587|FG007|Overall Study|Withdrawal by Subject|0|||
148859395|NCT03334851|536961588|FG008|Overall Study|Withdrawal by Subject|0|||
148859396|NCT03334851|536961589|FG009|Overall Study|Withdrawal by Subject|0|||
148859397|NCT03334851|536961590|FG010|Overall Study|Withdrawal by Subject|1|||
148859398|NCT03334851|536961591|FG011|Overall Study|Withdrawal by Subject|0|||
148859399|NCT03334851|536961592|FG012|Overall Study|Withdrawal by Subject|1|||
148859400|NCT03334851|536961580|FG000|Overall Study|Lost to Follow-up|0|||
148859401|NCT03334851|536961581|FG001|Overall Study|Lost to Follow-up|0|||
148859402|NCT03334851|536961582|FG002|Overall Study|Lost to Follow-up|0|||
148859403|NCT03334851|536961583|FG003|Overall Study|Lost to Follow-up|0|||
148859404|NCT03334851|536961584|FG004|Overall Study|Lost to Follow-up|0|||
148859405|NCT03334851|536961585|FG005|Overall Study|Lost to Follow-up|0|||
148859406|NCT03334851|536961586|FG006|Overall Study|Lost to Follow-up|0|||
148859407|NCT03334851|536961587|FG007|Overall Study|Lost to Follow-up|0|||
148859408|NCT03334851|536961588|FG008|Overall Study|Lost to Follow-up|0|||
148859409|NCT03334851|536961589|FG009|Overall Study|Lost to Follow-up|0|||
148859410|NCT03334851|536961590|FG010|Overall Study|Lost to Follow-up|2|||
148859411|NCT03334851|536961591|FG011|Overall Study|Lost to Follow-up|1|||
148859412|NCT03334851|536961592|FG012|Overall Study|Lost to Follow-up|0|||
148859413|NCT00523705|536961593|FG000|Overall Study|No time for study.|0|||
148859414|NCT00523705|536961594|FG001|Overall Study|No time for study.|1|||
148859415|NCT01691885|536961595|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
148859416|NCT01691885|536961596|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
148859417|NCT01691885|536961595|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
148859418|NCT01691885|536961596|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
148859419|NCT00642369|536961598|FG000|Overall Study|Adverse Event|2|||
148859420|NCT00642369|536961599|FG001|Overall Study|Adverse Event|3|||
148859421|NCT00642369|536961598|FG000|Overall Study|Withdrawal by Subject|1|||
148859422|NCT00642369|536961599|FG001|Overall Study|Withdrawal by Subject|0|||
148859423|NCT00642369|536961598|FG000|Overall Study|misdiagnosis|0|||
148859424|NCT00642369|536961599|FG001|Overall Study|misdiagnosis|1|||
148859425|NCT00642369|536961598|FG000|Overall Study|Lack of Efficacy|2|||
148859426|NCT00642369|536961599|FG001|Overall Study|Lack of Efficacy|2|||
148859427|NCT01190475|536961600|FG000|Overall Study|Withdrawal by Subject|0|||
148859428|NCT01190475|536961601|FG001|Overall Study|Withdrawal by Subject|0|||
148859429|NCT01190475|536961602|FG002|Overall Study|Withdrawal by Subject|1|||
148993077|NCT01217073|537451230|FG006|Extension Period|Excluded medication|2|||
148993078|NCT01217073|537451231|FG007|Extension Period|Excluded medication|0|||
148993079|NCT01217073|537451224|FG000|Extension Period|Lack of Efficacy|0|||
148993080|NCT01217073|537451225|FG001|Extension Period|Lack of Efficacy|0|||
148993081|NCT01217073|537451226|FG002|Extension Period|Lack of Efficacy|0|||
148993082|NCT01217073|537451227|FG003|Extension Period|Lack of Efficacy|0|||
148859430|NCT00543803|536961603|FG000|Overall Study|Adverse Event|14|||
148859431|NCT00543803|536961603|FG000|Overall Study|Lack of Efficacy|22|||
148859432|NCT00543803|536961603|FG000|Overall Study|Lost to Follow-up|20|||
148859433|NCT00543803|536961603|FG000|Overall Study|Other|86|||
148859434|NCT03575065|536961605|FG000|Overall Study|Death|31|||
148859435|NCT03575065|536961606|FG001|Overall Study|Death|12|||
148859436|NCT03575065|536961605|FG000|Overall Study|Sponsor's Decision|28|||
148859437|NCT03575065|536961606|FG001|Overall Study|Sponsor's Decision|13|||
148859438|NCT03575065|536961605|FG000|Overall Study|Withdrawal by Subject|2|||
148859439|NCT03575065|536961606|FG001|Overall Study|Withdrawal by Subject|1|||
148859440|NCT03575065|536961605|FG000|Overall Study|Lost to Follow-up|1|||
148859441|NCT03575065|536961606|FG001|Overall Study|Lost to Follow-up|0|||
148859442|NCT02680041|536961611|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
148859443|NCT02680041|536961611|FG000|Overall Study|Lost to Follow-up|2|||
148859444|NCT00521599|536961612|FG000|Overall Study|Adverse Event|5|||
148993083|NCT01217073|537451228|FG004|Extension Period|Lack of Efficacy|0|||
148993084|NCT01217073|537451229|FG005|Extension Period|Lack of Efficacy|0|||
148859445|NCT00521599|536961613|FG001|Overall Study|Adverse Event|7|||
148859446|NCT00521599|536961614|FG002|Overall Study|Adverse Event|6|||
148859447|NCT00521599|536961612|FG000|Overall Study|Treatment Failure|8|||
148859448|NCT00521599|536961613|FG001|Overall Study|Treatment Failure|9|||
148859449|NCT00521599|536961614|FG002|Overall Study|Treatment Failure|22|||
148859450|NCT00521599|536961612|FG000|Overall Study|Lost to Follow-up|2|||
148859451|NCT00521599|536961613|FG001|Overall Study|Lost to Follow-up|1|||
148859452|NCT00521599|536961614|FG002|Overall Study|Lost to Follow-up|2|||
148859453|NCT00521599|536961612|FG000|Overall Study|Withdrawal by Subject|3|||
148859454|NCT00521599|536961613|FG001|Overall Study|Withdrawal by Subject|5|||
148859455|NCT00521599|536961614|FG002|Overall Study|Withdrawal by Subject|1|||
148859456|NCT00521599|536961612|FG000|Overall Study|Withdrawal by subject treatment related|3|||
148859457|NCT00521599|536961613|FG001|Overall Study|Withdrawal by subject treatment related|1|||
148859458|NCT00521599|536961614|FG002|Overall Study|Withdrawal by subject treatment related|2|||
148859459|NCT00521599|536961612|FG000|Overall Study|Protocol Violation|2|||
148859460|NCT00521599|536961613|FG001|Overall Study|Protocol Violation|4|||
148859461|NCT00521599|536961614|FG002|Overall Study|Protocol Violation|2|||
148859462|NCT00521599|536961612|FG000|Overall Study|Did not meet protocol eligibility|2|||
148859463|NCT00521599|536961613|FG001|Overall Study|Did not meet protocol eligibility|2|||
148859464|NCT00521599|536961614|FG002|Overall Study|Did not meet protocol eligibility|1|||
148859465|NCT01610713|536961615|FG000|Overall Study|Adverse Event|3|||
148859466|NCT01610713|536961616|FG001|Overall Study|Adverse Event|0|||
148859467|NCT01610713|536961615|FG000|Overall Study|Lack of Efficacy|1|||
148859468|NCT01610713|536961616|FG001|Overall Study|Lack of Efficacy|0|||
148859469|NCT01610713|536961615|FG000|Overall Study|low mood and poor motivation|1|||
148859470|NCT01610713|536961616|FG001|Overall Study|low mood and poor motivation|0|||
148859471|NCT01610713|536961615|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
148859472|NCT01610713|536961616|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
148859473|NCT01610713|536961615|FG000|Overall Study|Lost to Follow-up|0|||
148859474|NCT01610713|536961616|FG001|Overall Study|Lost to Follow-up|1|||
148859475|NCT01774097|536961619|FG000|Overall Study|Withdrawal by Subject|1|||
148859476|NCT01774097|536961620|FG001|Overall Study|Withdrawal by Subject|1|||
148859477|NCT01774097|536961619|FG000|Overall Study|Adverse Event|1|||
148859478|NCT01774097|536961620|FG001|Overall Study|Adverse Event|1|||
148859479|NCT01703208|536961621|FG000|Overall Study|Death|61|||
148859480|NCT01703208|536961622|FG001|Overall Study|Death|48|||
148859481|NCT01703208|536961621|FG000|Overall Study|Lack of Efficacy|1|||
148859482|NCT01703208|536961622|FG001|Overall Study|Lack of Efficacy|2|||
148859483|NCT01703208|536961621|FG000|Overall Study|Lost to Follow-up|68|||
148859484|NCT01703208|536961622|FG001|Overall Study|Lost to Follow-up|62|||
148859485|NCT01703208|536961621|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148859486|NCT01703208|536961622|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148859487|NCT01703208|536961621|FG000|Overall Study|Excluded Medication|1|||
148859488|NCT01703208|536961622|FG001|Overall Study|Excluded Medication|2|||
148859489|NCT01703208|536961621|FG000|Overall Study|Site Discontinued Study Participation|23|||
148859490|NCT01703208|536961622|FG001|Overall Study|Site Discontinued Study Participation|27|||
148859491|NCT01703208|536961621|FG000|Overall Study|Physician Decision|11|||
148859492|NCT01703208|536961622|FG001|Overall Study|Physician Decision|13|||
148859493|NCT01703208|536961621|FG000|Overall Study|Progressive disease|2|||
148859494|NCT01703208|536961622|FG001|Overall Study|Progressive disease|2|||
148859495|NCT01703208|536961621|FG000|Overall Study|Protocol Violation|1|||
148859496|NCT01703208|536961622|FG001|Overall Study|Protocol Violation|1|||
148859497|NCT01703208|536961621|FG000|Overall Study|Study Terminated by Sponsor|1710|||
148859498|NCT01703208|536961622|FG001|Overall Study|Study Terminated by Sponsor|1716|||
148859499|NCT01703208|536961621|FG000|Overall Study|Withdrawal by Subject|205|||
148859500|NCT01703208|536961622|FG001|Overall Study|Withdrawal by Subject|209|||
148859501|NCT01703208|536961621|FG000|Overall Study|Adverse Event|14|||
148859502|NCT01703208|536961622|FG001|Overall Study|Adverse Event|19|||
148859503|NCT01703208|536961621|FG000|Overall Study|Technical Problems|0|||
148859504|NCT01703208|536961622|FG001|Overall Study|Technical Problems|1|||
148859505|NCT01703208|536961621|FG000|Overall Study|Protocol Deviation|2|||
148859506|NCT01703208|536961622|FG001|Overall Study|Protocol Deviation|0|||
148859507|NCT04003207|536961624|FG000|Overall Study|Protocol Violation|1|||
148859508|NCT00443053|536961627|FG000|Overall Study|Adverse Event|2|||
148859509|NCT00443053|536961628|FG001|Overall Study|Adverse Event|1|||
148859510|NCT00443053|536961627|FG000|Overall Study|Withdrawal by Subject|9|||
148859511|NCT00443053|536961628|FG001|Overall Study|Withdrawal by Subject|18|||
148859512|NCT00443053|536961627|FG000|Overall Study|Lost to Follow-up|4|||
148859513|NCT00443053|536961628|FG001|Overall Study|Lost to Follow-up|5|||
148859514|NCT00443053|536961627|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
148859515|NCT00443053|536961628|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
148859516|NCT00443053|536961627|FG000|Overall Study|Noncompliance|2|||
148859517|NCT00443053|536961628|FG001|Overall Study|Noncompliance|1|||
148993085|NCT01217073|537451230|FG006|Extension Period|Lack of Efficacy|3|||
148859518|NCT00443053|536961627|FG000|Overall Study|Other|3|||
148859519|NCT00443053|536961628|FG001|Overall Study|Other|4|||
148859520|NCT00443053|536961627|FG000|Overall Study|Physician Decision|0|||
148993086|NCT01217073|537451231|FG007|Extension Period|Lack of Efficacy|0|||
148859521|NCT00443053|536961628|FG001|Overall Study|Physician Decision|4|||
148859522|NCT00541866|536961629|FG000|Overall Study|Adverse Event|3|||
148859523|NCT00541866|536961630|FG001|Overall Study|Adverse Event|0|||
148859524|NCT00541866|536961631|FG002|Overall Study|Adverse Event|0|||
148859525|NCT00541866|536961632|FG003|Overall Study|Adverse Event|0|||
148859526|NCT00541866|536961633|FG004|Overall Study|Adverse Event|0|||
148859527|NCT00541866|536961629|FG000|Overall Study|Death|1|||
148859528|NCT00541866|536961630|FG001|Overall Study|Death|0|||
148859529|NCT00541866|536961631|FG002|Overall Study|Death|0|||
148859530|NCT00541866|536961632|FG003|Overall Study|Death|0|||
148859531|NCT00541866|536961633|FG004|Overall Study|Death|0|||
148859532|NCT00541866|536961629|FG000|Overall Study|Lack of Efficacy|19|||
148859533|NCT00541866|536961630|FG001|Overall Study|Lack of Efficacy|15|||
148859534|NCT00541866|536961631|FG002|Overall Study|Lack of Efficacy|10|||
148859535|NCT00541866|536961632|FG003|Overall Study|Lack of Efficacy|12|||
148859536|NCT00541866|536961633|FG004|Overall Study|Lack of Efficacy|14|||
148859537|NCT00541866|536961629|FG000|Overall Study|Not Reported or Other|11|||
148859538|NCT00541866|536961630|FG001|Overall Study|Not Reported or Other|3|||
148859539|NCT00541866|536961631|FG002|Overall Study|Not Reported or Other|3|||
148859540|NCT00541866|536961632|FG003|Overall Study|Not Reported or Other|3|||
148859541|NCT00541866|536961633|FG004|Overall Study|Not Reported or Other|1|||
148859542|NCT00541866|536961629|FG000|Overall Study|Physician Decision|0|||
148859543|NCT00541866|536961630|FG001|Overall Study|Physician Decision|0|||
148859544|NCT00541866|536961631|FG002|Overall Study|Physician Decision|2|||
148859545|NCT00541866|536961632|FG003|Overall Study|Physician Decision|1|||
148859546|NCT00541866|536961633|FG004|Overall Study|Physician Decision|0|||
148859547|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
148859548|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
148859549|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
148859550|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
148859551|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
148859552|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
148859553|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
148859554|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
148859555|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
148859556|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
148859557|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
148859558|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
148859559|NCT01632241|536961634|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
148859560|NCT01632241|536961635|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
148859561|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
148859562|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
148859563|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
148859564|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
148859565|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
148859566|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
148859567|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
148859568|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
148859569|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
148859570|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
148859571|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
148859572|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
148859573|NCT01632241|536961634|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
148859574|NCT01632241|536961635|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
148859575|NCT05463744|536961636|FG000|Treatment Period|Withdrawal by Subject|19|||
148859576|NCT05463744|536961637|FG001|Treatment Period|Withdrawal by Subject|16|||
148859577|NCT05463744|536961636|FG000|Treatment Period|Adverse Event|4|||
148859578|NCT05463744|536961637|FG001|Treatment Period|Adverse Event|4|||
148859579|NCT05463744|536961636|FG000|Treatment Period|Pregnancy|0|||
148859580|NCT05463744|536961637|FG001|Treatment Period|Pregnancy|3|||
148859581|NCT05463744|536961636|FG000|Treatment Period|Lost to Follow-up|1|||
148859582|NCT05463744|536961637|FG001|Treatment Period|Lost to Follow-up|3|||
148859583|NCT05463744|536961636|FG000|Treatment Period|Inadvertent enrollment|2|||
148859584|NCT05463744|536961637|FG001|Treatment Period|Inadvertent enrollment|1|||
148859585|NCT05463744|536961636|FG000|Treatment Period|Death|0|||
148859586|NCT05463744|536961637|FG001|Treatment Period|Death|1|||
148859587|NCT05463744|536961636|FG000|Treatment Period|Non-compliance with Study Drug|1|||
148859588|NCT05463744|536961637|FG001|Treatment Period|Non-compliance with Study Drug|0|||
148859589|NCT05463744|536961636|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
148859590|NCT05463744|536961637|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
148859591|NCT05463744|536961636|FG000|Treatment Period|Physician Decision|0|||
148859592|NCT05463744|536961637|FG001|Treatment Period|Physician Decision|1|||
148859593|NCT05463744|536961636|FG000|Follow-Up Period|Withdrawal by Subject|3|||
148859594|NCT05463744|536961637|FG001|Follow-Up Period|Withdrawal by Subject|1|||
148859595|NCT05463744|536961636|FG000|Follow-Up Period|Lost to Follow-up|1|||
148859596|NCT05463744|536961637|FG001|Follow-Up Period|Lost to Follow-up|1|||
148859597|NCT01357161|536961638|FG000|Part 1 (Open Label Run-in)|Death|5|||
148859598|NCT01357161|536961639|FG001|Part 1 (Open Label Run-in)|Death|0|||
148859599|NCT01357161|536961640|FG002|Part 1 (Open Label Run-in)|Death|0|||
148859600|NCT01357161|536961638|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
148859601|NCT01357161|536961639|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
148859602|NCT01357161|536961640|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
148859603|NCT01357161|536961638|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
148859604|NCT01357161|536961639|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
148859605|NCT01357161|536961640|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
148859606|NCT01357161|536961638|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
148859607|NCT01357161|536961639|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
148859608|NCT01357161|536961640|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
148859609|NCT01357161|536961638|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
148859610|NCT01357161|536961639|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
148859611|NCT01357161|536961640|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
148859612|NCT01357161|536961638|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
148859613|NCT01357161|536961639|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
148859614|NCT01357161|536961640|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
148859615|NCT01357161|536961638|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
148859616|NCT01357161|536961639|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
148859617|NCT01357161|536961640|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
148859618|NCT01357161|536961638|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
148859619|NCT01357161|536961639|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
148859620|NCT01357161|536961640|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
148859621|NCT01357161|536961638|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
148859622|NCT01357161|536961639|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
148859623|NCT01357161|536961640|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
148859624|NCT01357161|536961638|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
148859625|NCT01357161|536961639|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
148859626|NCT01357161|536961640|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
148859627|NCT01357161|536961638|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
148993087|NCT01217073|537451224|FG000|Extension Period|Lost to Follow-up|0|||
148993088|NCT01217073|537451225|FG001|Extension Period|Lost to Follow-up|0|||
148993089|NCT01217073|537451226|FG002|Extension Period|Lost to Follow-up|0|||
148993090|NCT01217073|537451227|FG003|Extension Period|Lost to Follow-up|0|||
148993091|NCT01217073|537451228|FG004|Extension Period|Lost to Follow-up|0|||
148993092|NCT01217073|537451229|FG005|Extension Period|Lost to Follow-up|0|||
148993093|NCT01217073|537451230|FG006|Extension Period|Lost to Follow-up|9|||
148993094|NCT01217073|537451231|FG007|Extension Period|Lost to Follow-up|1|||
148993095|NCT01217073|537451224|FG000|Extension Period|Non-compliance with study drug|0|||
148993096|NCT01217073|537451225|FG001|Extension Period|Non-compliance with study drug|0|||
148993097|NCT01217073|537451226|FG002|Extension Period|Non-compliance with study drug|0|||
148993098|NCT01217073|537451227|FG003|Extension Period|Non-compliance with study drug|0|||
148993099|NCT01217073|537451228|FG004|Extension Period|Non-compliance with study drug|0|||
148993100|NCT01217073|537451229|FG005|Extension Period|Non-compliance with study drug|0|||
148993101|NCT01217073|537451230|FG006|Extension Period|Non-compliance with study drug|0|||
148993102|NCT01217073|537451231|FG007|Extension Period|Non-compliance with study drug|1|||
148993103|NCT01217073|537451224|FG000|Extension Period|Physician Decision|0|||
148993104|NCT01217073|537451225|FG001|Extension Period|Physician Decision|0|||
148993105|NCT01217073|537451226|FG002|Extension Period|Physician Decision|0|||
148993106|NCT01217073|537451227|FG003|Extension Period|Physician Decision|0|||
148993107|NCT01217073|537451228|FG004|Extension Period|Physician Decision|0|||
148993108|NCT01217073|537451229|FG005|Extension Period|Physician Decision|0|||
148993109|NCT01217073|537451230|FG006|Extension Period|Physician Decision|4|||
149030720|NCT01729871|537589700|FG000|Overall Study|Adverse Event|7|||
149030721|NCT01729871|537589701|FG001|Overall Study|Adverse Event|7|||
148859628|NCT01357161|536961639|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
148859629|NCT01357161|536961640|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
148859630|NCT01824823|536961641|FG000|Overall Study|Lack of Efficacy|1|||
148859631|NCT01824823|536961642|FG001|Overall Study|Lack of Efficacy|1|||
148859632|NCT01824823|536961641|FG000|Overall Study|Off-treatment reason not submitted|1|||
148859633|NCT01824823|536961642|FG001|Overall Study|Off-treatment reason not submitted|0|||
148993110|NCT01217073|537451231|FG007|Extension Period|Physician Decision|1|||
148993111|NCT01217073|537451224|FG000|Extension Period|Protocol Violation|0|||
149030722|NCT01729871|537589700|FG000|Overall Study|Death|0|||
149030723|NCT01729871|537589701|FG001|Overall Study|Death|1|||
148859634|NCT00840060|536964092|FG000|Overall Study|Withdrawal by Subject|1|||
148993112|NCT01217073|537451225|FG001|Extension Period|Protocol Violation|0|||
148993113|NCT01217073|537451226|FG002|Extension Period|Protocol Violation|0|||
148993114|NCT01217073|537451227|FG003|Extension Period|Protocol Violation|0|||
148993115|NCT01217073|537451228|FG004|Extension Period|Protocol Violation|0|||
148859635|NCT00840060|536964093|FG001|Overall Study|Withdrawal by Subject|0|||
148859636|NCT00840060|536964092|FG000|Overall Study|Change in emotional/behavioral status|0|||
148859637|NCT00840060|536964093|FG001|Overall Study|Change in emotional/behavioral status|1|||
148859638|NCT00445939|536964094|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
148859639|NCT00445939|536964095|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
148859640|NCT00445939|536964096|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
148859641|NCT00445939|536964097|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
149030724|NCT01729871|537589700|FG000|Overall Study|Lack of Efficacy|0|||
148859642|NCT00445939|536964094|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
148859643|NCT00445939|536964095|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
148859644|NCT00445939|536964096|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
148859645|NCT00445939|536964097|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
148859646|NCT02576535|536964111|FG000|Overall Study|Withdrawal by Subject|2|||
148859647|NCT03555981|536964113|FG000|Overall Study|Lost to Follow-up|0|||
148859648|NCT03555981|536964114|FG001|Overall Study|Lost to Follow-up|2|||
148859649|NCT00354107|536964115|FG000|Overall Study|Adverse Event|2|||
148859650|NCT00354107|536964115|FG000|Overall Study|Physician Decision|2|||
148859651|NCT00354107|536964115|FG000|Overall Study|Withdrawal by Subject|1|||
148859652|NCT04035564|536964116|FG000|Overall Study|Protocol Violation|1|||
148859653|NCT04035564|536964117|FG001|Overall Study|Protocol Violation|2|||
148859654|NCT04035564|536964116|FG000|Overall Study|No laboratory available|2|||
148859655|NCT04035564|536964117|FG001|Overall Study|No laboratory available|2|||
148859656|NCT04035564|536964116|FG000|Overall Study|Guardian declined consent|1|||
148859657|NCT04035564|536964117|FG001|Overall Study|Guardian declined consent|2|||
148859658|NCT00996281|536964121|FG000|Overall Study|Adverse Event|75|||
148859659|NCT00996281|536964122|FG001|Overall Study|Adverse Event|37|||
148859660|NCT00996281|536964121|FG000|Overall Study|Major Protocol Deviation|6|||
148859661|NCT00996281|536964122|FG001|Overall Study|Major Protocol Deviation|7|||
148859662|NCT00996281|536964121|FG000|Overall Study|Lost to Follow-up|14|||
148859663|NCT00996281|536964122|FG001|Overall Study|Lost to Follow-up|16|||
148859664|NCT00996281|536964121|FG000|Overall Study|Withdrawal by Subject|31|||
148859665|NCT00996281|536964122|FG001|Overall Study|Withdrawal by Subject|20|||
148859666|NCT00996281|536964121|FG000|Overall Study|Lack of Efficacy|0|||
148859667|NCT00996281|536964122|FG001|Overall Study|Lack of Efficacy|2|||
148859668|NCT00996281|536964121|FG000|Overall Study|Other|5|||
149030725|NCT01729871|537589701|FG001|Overall Study|Lack of Efficacy|1|||
149030726|NCT01729871|537589700|FG000|Overall Study|Physician Decision|0|||
149030727|NCT01729871|537589701|FG001|Overall Study|Physician Decision|2|||
149030728|NCT01729871|537589700|FG000|Overall Study|Protocol Violation|1|||
149030729|NCT01729871|537589701|FG001|Overall Study|Protocol Violation|0|||
149030730|NCT01729871|537589700|FG000|Overall Study|Withdrawal by Subject|0|||
148859669|NCT00996281|536964122|FG001|Overall Study|Other|7|||
148859670|NCT03505788|536964125|FG000|Overall Study|Lost to Follow-up|2|||
148859671|NCT03505788|536964126|FG001|Overall Study|Lost to Follow-up|1|||
148859672|NCT03505788|536964125|FG000|Overall Study|Withdrawal by Subject|1|||
148859673|NCT03505788|536964126|FG001|Overall Study|Withdrawal by Subject|3|||
148859674|NCT03505788|536964125|FG000|Overall Study|Physician Decision|0|||
148859675|NCT03505788|536964126|FG001|Overall Study|Physician Decision|1|||
148859676|NCT02323126|536964127|FG000|Overall Study|Patient / guardian decision|0|||
148859677|NCT02323126|536964128|FG001|Overall Study|Patient / guardian decision|1|||
148993116|NCT01217073|537451229|FG005|Extension Period|Protocol Violation|0|||
148993117|NCT01217073|537451230|FG006|Extension Period|Protocol Violation|2|||
148993118|NCT01217073|537451231|FG007|Extension Period|Protocol Violation|1|||
148993119|NCT01217073|537451224|FG000|Extension Period|Site discontinued study participation|0|||
148993120|NCT01217073|537451225|FG001|Extension Period|Site discontinued study participation|0|||
148993121|NCT01217073|537451226|FG002|Extension Period|Site discontinued study participation|0|||
148993122|NCT01217073|537451227|FG003|Extension Period|Site discontinued study participation|0|||
148859678|NCT02323126|536964129|FG002|Overall Study|Patient / guardian decision|2|||
148859679|NCT02323126|536964127|FG000|Overall Study|Progressive disease|14|||
148859680|NCT02323126|536964128|FG001|Overall Study|Progressive disease|8|||
148859681|NCT02323126|536964129|FG002|Overall Study|Progressive disease|14|||
148859682|NCT02323126|536964127|FG000|Overall Study|Physician Decision|0|||
148859683|NCT02323126|536964128|FG001|Overall Study|Physician Decision|1|||
148859684|NCT02323126|536964129|FG002|Overall Study|Physician Decision|3|||
148859685|NCT02323126|536964127|FG000|Overall Study|Death|1|||
148859686|NCT02323126|536964128|FG001|Overall Study|Death|1|||
148859687|NCT02323126|536964129|FG002|Overall Study|Death|4|||
148993123|NCT01217073|537451228|FG004|Extension Period|Site discontinued study participation|0|||
148993124|NCT01217073|537451229|FG005|Extension Period|Site discontinued study participation|0|||
148993125|NCT01217073|537451230|FG006|Extension Period|Site discontinued study participation|7|||
148993126|NCT01217073|537451231|FG007|Extension Period|Site discontinued study participation|2|||
148859688|NCT02323126|536964127|FG000|Overall Study|Adverse Event|3|||
148859689|NCT02323126|536964128|FG001|Overall Study|Adverse Event|5|||
148859690|NCT02323126|536964129|FG002|Overall Study|Adverse Event|7|||
148859691|NCT03333252|536964130|FG000|Overall Study|Adverse Event|10|||
148859692|NCT03333252|536964131|FG001|Overall Study|Adverse Event|6|||
149030731|NCT01729871|537589701|FG001|Overall Study|Withdrawal by Subject|3|||
148859693|NCT03333252|536964132|FG002|Overall Study|Adverse Event|5|||
148859694|NCT03333252|536964133|FG003|Overall Study|Adverse Event|2|||
148859695|NCT03333252|536964130|FG000|Overall Study|Death|1|||
148859696|NCT03333252|536964131|FG001|Overall Study|Death|3|||
148859697|NCT03333252|536964132|FG002|Overall Study|Death|0|||
148859698|NCT03333252|536964133|FG003|Overall Study|Death|0|||
148859699|NCT03333252|536964130|FG000|Overall Study|Lack of Efficacy|8|||
148859700|NCT03333252|536964131|FG001|Overall Study|Lack of Efficacy|4|||
148859701|NCT03333252|536964132|FG002|Overall Study|Lack of Efficacy|0|||
148859702|NCT03333252|536964133|FG003|Overall Study|Lack of Efficacy|7|||
148859703|NCT03333252|536964130|FG000|Overall Study|Lost to Follow-up|0|||
148859704|NCT03333252|536964131|FG001|Overall Study|Lost to Follow-up|5|||
148859705|NCT03333252|536964132|FG002|Overall Study|Lost to Follow-up|9|||
148859706|NCT03333252|536964133|FG003|Overall Study|Lost to Follow-up|3|||
148859707|NCT03333252|536964130|FG000|Overall Study|Withdrawal by Subject|14|||
148859708|NCT03333252|536964131|FG001|Overall Study|Withdrawal by Subject|24|||
148859709|NCT03333252|536964132|FG002|Overall Study|Withdrawal by Subject|11|||
148859710|NCT03333252|536964133|FG003|Overall Study|Withdrawal by Subject|17|||
148859711|NCT00113399|536964134|FG000|Overall Study|Death|1|||
148859712|NCT00113399|536964135|FG001|Overall Study|Death|1|||
148859713|NCT00113399|536964134|FG000|Overall Study|Withdrawal by Subject|1|||
148859714|NCT00113399|536964135|FG001|Overall Study|Withdrawal by Subject|2|||
148859715|NCT00113399|536964134|FG000|Overall Study|Complete Response|0|||
148859716|NCT00113399|536964135|FG001|Overall Study|Complete Response|1|||
148859717|NCT00113399|536964134|FG000|Overall Study|Other|0|||
148859718|NCT00113399|536964135|FG001|Overall Study|Other|1|||
148859719|NCT00396136|536964136|FG000|Overall Study|Death|43|||
148859720|NCT00396136|536964136|FG000|Overall Study|Withdrawal by Subject|59|||
148859721|NCT00396136|536964136|FG000|Overall Study|Lost to Follow-up|15|||
148859722|NCT00396136|536964136|FG000|Overall Study|Study device explanted|8|||
148859723|NCT03960580|536964137|FG000|Overall Study|Adverse Event|2|||
148859724|NCT03960580|536964138|FG001|Overall Study|Adverse Event|1|||
148859725|NCT03960580|536964139|FG002|Overall Study|Adverse Event|1|||
148859726|NCT03960580|536964137|FG000|Overall Study|Lost to Follow-up|1|||
148859727|NCT03960580|536964138|FG001|Overall Study|Lost to Follow-up|0|||
148859728|NCT03960580|536964139|FG002|Overall Study|Lost to Follow-up|0|||
148859729|NCT03960580|536964137|FG000|Overall Study|Lack of Efficacy|2|||
148859730|NCT03960580|536964138|FG001|Overall Study|Lack of Efficacy|1|||
148859731|NCT03960580|536964139|FG002|Overall Study|Lack of Efficacy|0|||
148859732|NCT03960580|536964137|FG000|Overall Study|Protocol Violation|0|||
148859733|NCT03960580|536964138|FG001|Overall Study|Protocol Violation|0|||
148859734|NCT03960580|536964139|FG002|Overall Study|Protocol Violation|1|||
148859735|NCT03960580|536964137|FG000|Overall Study|Withdrawal by Subject|1|||
148859736|NCT03960580|536964138|FG001|Overall Study|Withdrawal by Subject|1|||
148859737|NCT03960580|536964139|FG002|Overall Study|Withdrawal by Subject|1|||
148859738|NCT03960580|536964137|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
148859739|NCT03960580|536964138|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
148859740|NCT03960580|536964139|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
148859741|NCT00791479|536964147|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
148859742|NCT00791479|536964148|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
148859743|NCT00791479|536964149|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
148859744|NCT00791479|536964150|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
148859745|NCT00791479|536964151|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
148859746|NCT00791479|536964152|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
148859747|NCT00791479|536964147|FG000|Overall Study|Adverse Event|0|||
148859748|NCT00791479|536964148|FG001|Overall Study|Adverse Event|1|||
148859749|NCT00791479|536964149|FG002|Overall Study|Adverse Event|0|||
148859750|NCT00791479|536964150|FG003|Overall Study|Adverse Event|2|||
148859751|NCT00791479|536964151|FG004|Overall Study|Adverse Event|0|||
148859752|NCT00791479|536964152|FG005|Overall Study|Adverse Event|1|||
148859753|NCT00791479|536964147|FG000|Overall Study|Lost to Follow-up|0|||
148859754|NCT00791479|536964148|FG001|Overall Study|Lost to Follow-up|1|||
148859755|NCT00791479|536964149|FG002|Overall Study|Lost to Follow-up|0|||
148859756|NCT00791479|536964150|FG003|Overall Study|Lost to Follow-up|0|||
148859757|NCT00791479|536964151|FG004|Overall Study|Lost to Follow-up|0|||
148859758|NCT00791479|536964152|FG005|Overall Study|Lost to Follow-up|1|||
148859759|NCT00791479|536964147|FG000|Overall Study|Protocol Violation|2|||
148859760|NCT00791479|536964148|FG001|Overall Study|Protocol Violation|1|||
148859761|NCT00791479|536964149|FG002|Overall Study|Protocol Violation|0|||
148859762|NCT00791479|536964150|FG003|Overall Study|Protocol Violation|1|||
148859763|NCT00791479|536964151|FG004|Overall Study|Protocol Violation|0|||
148859764|NCT00791479|536964152|FG005|Overall Study|Protocol Violation|0|||
148859765|NCT00791479|536964147|FG000|Overall Study|Withdrawal by Subject|0|||
148859766|NCT00791479|536964148|FG001|Overall Study|Withdrawal by Subject|0|||
148859767|NCT00791479|536964149|FG002|Overall Study|Withdrawal by Subject|0|||
148859768|NCT00791479|536964150|FG003|Overall Study|Withdrawal by Subject|1|||
148859769|NCT00791479|536964151|FG004|Overall Study|Withdrawal by Subject|0|||
148859770|NCT00791479|536964152|FG005|Overall Study|Withdrawal by Subject|1|||
148859771|NCT00934947|536964155|FG000|Overall Study|Adverse Event|0|||
148859772|NCT00934947|536964156|FG001|Overall Study|Adverse Event|2|||
148859773|NCT03447314|536964158|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
148859774|NCT03447314|536964159|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
148859775|NCT03447314|536964160|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
148859776|NCT03447314|536964161|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
148859777|NCT03447314|536964162|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
148859778|NCT03447314|536964163|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
148859779|NCT03447314|536964164|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
148859780|NCT03447314|536964165|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859781|NCT03447314|536964166|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859782|NCT03447314|536964167|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859783|NCT03447314|536964168|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
148859784|NCT03447314|536964169|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
148859785|NCT03447314|536964170|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859786|NCT03447314|536964171|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859787|NCT03447314|536964172|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859788|NCT03447314|536964173|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859789|NCT03447314|536964174|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859790|NCT03447314|536964175|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
148859791|NCT03447314|536964158|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
148859792|NCT03447314|536964159|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859793|NCT03447314|536964160|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
148859794|NCT03447314|536964161|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859795|NCT03447314|536964162|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859796|NCT03447314|536964163|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
148859797|NCT03447314|536964164|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
148859798|NCT03447314|536964165|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859799|NCT03447314|536964166|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859800|NCT03447314|536964167|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859801|NCT03447314|536964168|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859802|NCT03447314|536964169|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859803|NCT03447314|536964170|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859804|NCT03447314|536964171|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859805|NCT03447314|536964172|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859806|NCT03447314|536964173|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859807|NCT03447314|536964174|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859808|NCT03447314|536964175|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
148859809|NCT03447314|536964158|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859810|NCT03447314|536964159|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859811|NCT03447314|536964160|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
148859812|NCT03447314|536964161|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859813|NCT03447314|536964162|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859814|NCT03447314|536964163|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859815|NCT03447314|536964164|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859816|NCT03447314|536964165|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859817|NCT03447314|536964166|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859818|NCT03447314|536964167|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859819|NCT03447314|536964168|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859820|NCT03447314|536964169|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859821|NCT03447314|536964170|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859822|NCT03447314|536964171|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859823|NCT03447314|536964172|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859824|NCT03447314|536964173|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859825|NCT03447314|536964174|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859826|NCT03447314|536964175|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
148859827|NCT03447314|536964158|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859828|NCT03447314|536964159|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859829|NCT03447314|536964160|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
148859830|NCT03447314|536964161|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859831|NCT03447314|536964162|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859832|NCT03447314|536964163|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859833|NCT03447314|536964164|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859834|NCT03447314|536964165|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859835|NCT03447314|536964166|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859836|NCT03447314|536964167|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859837|NCT03447314|536964168|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859838|NCT03447314|536964169|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859839|NCT03447314|536964170|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859840|NCT03447314|536964171|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859841|NCT03447314|536964172|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859842|NCT03447314|536964173|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859843|NCT03447314|536964174|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859844|NCT03447314|536964175|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
148859845|NCT03447314|536964158|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859846|NCT03447314|536964159|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859847|NCT03447314|536964160|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859848|NCT03447314|536964161|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859849|NCT03447314|536964162|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859850|NCT03447314|536964163|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859851|NCT03447314|536964164|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859852|NCT03447314|536964165|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859853|NCT03447314|536964166|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859854|NCT03447314|536964167|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859855|NCT03447314|536964168|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
148859856|NCT03447314|536964169|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859857|NCT03447314|536964170|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859858|NCT03447314|536964171|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859859|NCT03447314|536964172|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859860|NCT03447314|536964173|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859861|NCT03447314|536964174|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859862|NCT03447314|536964175|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
148859863|NCT03447314|536964158|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859864|NCT03447314|536964159|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859865|NCT03447314|536964160|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859866|NCT03447314|536964161|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
148859867|NCT03447314|536964162|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859868|NCT03447314|536964163|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
148859869|NCT03447314|536964164|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859870|NCT03447314|536964165|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
149030732|NCT01729871|537589700|FG000|Overall Study|Other|4|||
148777835|NCT00742508|536660431|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
148777836|NCT00742508|536660432|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
148777837|NCT00742508|536660431|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
148777838|NCT00742508|536660432|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
148777839|NCT02431806|536660433|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
148777840|NCT02431806|536660434|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
148777841|NCT02431806|536660435|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
148777842|NCT02431806|536660436|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
148777843|NCT02431806|536660433|FG000|Double-blind Treatment Period|Adverse Event|4|||
148777844|NCT02431806|536660434|FG001|Double-blind Treatment Period|Adverse Event|7|||
148777845|NCT02431806|536660435|FG002|Double-blind Treatment Period|Adverse Event|11|||
148777846|NCT02431806|536660436|FG003|Double-blind Treatment Period|Adverse Event|7|||
148777847|NCT02431806|536660433|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
148777848|NCT02431806|536660434|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
148777849|NCT02431806|536660435|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
148777850|NCT02431806|536660436|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
148777851|NCT02431806|536660433|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
148777852|NCT02431806|536660434|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
148777853|NCT02431806|536660435|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
148777854|NCT02431806|536660436|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
148777855|NCT02431806|536660433|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
148777856|NCT02431806|536660434|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
148777857|NCT02431806|536660435|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
148859871|NCT03447314|536964166|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859872|NCT03447314|536964167|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859873|NCT03447314|536964168|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859874|NCT03447314|536964169|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859875|NCT03447314|536964170|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859876|NCT03447314|536964171|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859877|NCT03447314|536964172|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859878|NCT03447314|536964173|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148993127|NCT01217073|537451224|FG000|Extension Period|Withdrawal by Subject|0|||
148993128|NCT01217073|537451225|FG001|Extension Period|Withdrawal by Subject|0|||
148993129|NCT01217073|537451226|FG002|Extension Period|Withdrawal by Subject|0|||
148993130|NCT01217073|537451227|FG003|Extension Period|Withdrawal by Subject|0|||
148993131|NCT01217073|537451228|FG004|Extension Period|Withdrawal by Subject|0|||
148993132|NCT01217073|537451229|FG005|Extension Period|Withdrawal by Subject|0|||
148993133|NCT01217073|537451230|FG006|Extension Period|Withdrawal by Subject|30|||
148993134|NCT01217073|537451231|FG007|Extension Period|Withdrawal by Subject|8|||
148993135|NCT04477187|537451232|FG000|Overall Study|Lost to Follow-up|2|||
148993136|NCT02460991|537451233|FG000|Overall Study|Withdrawal by Subject|0|||
148993137|NCT02460991|537451234|FG001|Overall Study|Withdrawal by Subject|2|||
148993138|NCT03905655|537451237|FG000|Overall Study|Adverse Event|1|||
148993139|NCT03905655|537451238|FG001|Overall Study|Adverse Event|0|||
148993140|NCT03905655|537451239|FG002|Overall Study|Adverse Event|1|||
148993141|NCT03905655|537451240|FG003|Overall Study|Adverse Event|1|||
148993142|NCT02566031|537451241|FG000|Overall Study|Patient/guardian decision|14|||
148993143|NCT02566031|537451242|FG001|Overall Study|Patient/guardian decision|7|||
148993144|NCT02566031|537451241|FG000|Overall Study|Protocol deviation|2|||
148993145|NCT02566031|537451242|FG001|Overall Study|Protocol deviation|3|||
148859879|NCT03447314|536964174|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859880|NCT03447314|536964175|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
148859881|NCT01920568|536964176|FG000|Overall Study|Adverse Event|27|||
148859882|NCT01920568|536964177|FG001|Overall Study|Adverse Event|8|||
148859883|NCT01920568|536964176|FG000|Overall Study|Protocol Violation|5|||
148859884|NCT01920568|536964177|FG001|Overall Study|Protocol Violation|3|||
148859885|NCT01920568|536964176|FG000|Overall Study|Lost to Follow-up|2|||
148859886|NCT01920568|536964177|FG001|Overall Study|Lost to Follow-up|2|||
148859887|NCT01920568|536964176|FG000|Overall Study|Physician Decision|13|||
148859888|NCT01920568|536964177|FG001|Overall Study|Physician Decision|4|||
148859889|NCT01920568|536964176|FG000|Overall Study|Withdrawal by Subject|79|||
148859890|NCT01920568|536964177|FG001|Overall Study|Withdrawal by Subject|55|||
148859891|NCT01920568|536964176|FG000|Overall Study|Death due to disease progression|25|||
148859892|NCT01920568|536964177|FG001|Overall Study|Death due to disease progression|12|||
148859893|NCT00252694|536964178|FG000|Overall Study|Withdrawal by Subject|83|||
148859894|NCT00252694|536964179|FG001|Overall Study|Withdrawal by Subject|91|||
148859895|NCT00252694|536964178|FG000|Overall Study|Death|36|||
148859896|NCT00252694|536964179|FG001|Overall Study|Death|34|||
148859897|NCT00252694|536964178|FG000|Overall Study|Mostly Lost to Follow Up|8|||
148859898|NCT00252694|536964179|FG001|Overall Study|Mostly Lost to Follow Up|13|||
148859899|NCT00252694|536964178|FG000|Overall Study|Patient Moving|17|||
148859900|NCT00252694|536964179|FG001|Overall Study|Patient Moving|16|||
148859901|NCT00468676|536964182|FG000|Overall Study|Lost to Follow-up|14|||
148859902|NCT00468676|536964183|FG001|Overall Study|Lost to Follow-up|11|||
148859903|NCT00468676|536964182|FG000|Overall Study|Death|2|||
148859904|NCT00468676|536964183|FG001|Overall Study|Death|1|||
148859905|NCT04173260|536964185|FG000|Overall Study|Early termination|4|||
148859906|NCT02308163|536964186|FG000|Overall Study|Not fulfill eligible criteria|1|||
148859907|NCT02308163|536964187|FG001|Overall Study|Not fulfill eligible criteria|2|||
148859908|NCT02308163|536964188|FG002|Overall Study|Not fulfill eligible criteria|0|||
148859909|NCT02308163|536964189|FG003|Overall Study|Not fulfill eligible criteria|1|||
148859910|NCT02308163|536964190|FG004|Overall Study|Not fulfill eligible criteria|1|||
148993146|NCT02566031|537451241|FG000|Overall Study|Adverse Event|3|||
148993147|NCT02566031|537451242|FG001|Overall Study|Adverse Event|1|||
148993148|NCT02566031|537451241|FG000|Overall Study|Lost to Follow-up|1|||
148993149|NCT02566031|537451242|FG001|Overall Study|Lost to Follow-up|1|||
148993150|NCT02277106|537451243|FG000|Stage 2|Adverse Event|0|||
148859911|NCT02308163|536964186|FG000|Overall Study|Adverse Event|9|||
148993151|NCT02277106|537451244|FG001|Stage 2|Adverse Event|0|||
148993152|NCT02277106|537451245|FG002|Stage 2|Adverse Event|1|||
148993153|NCT03031938|537451246|FG000|Overall Study|Death|1|||
148993154|NCT03031938|537451247|FG001|Overall Study|Death|0|||
148993155|NCT02479412|537451248|FG000|Overall Study|Adverse Event|0|||
148859912|NCT02308163|536964187|FG001|Overall Study|Adverse Event|5|||
148859913|NCT02308163|536964188|FG002|Overall Study|Adverse Event|2|||
148993156|NCT02479412|537451249|FG001|Overall Study|Adverse Event|0|||
148993157|NCT02479412|537451250|FG002|Overall Study|Adverse Event|1|||
148993158|NCT02479412|537451251|FG003|Overall Study|Adverse Event|0|||
148993159|NCT02479412|537451252|FG004|Overall Study|Adverse Event|0|||
148859914|NCT02308163|536964189|FG003|Overall Study|Adverse Event|2|||
148859915|NCT02308163|536964190|FG004|Overall Study|Adverse Event|11|||
148859916|NCT02308163|536964186|FG000|Overall Study|Lack of Efficacy|11|||
148859917|NCT02308163|536964187|FG001|Overall Study|Lack of Efficacy|3|||
148859918|NCT02308163|536964188|FG002|Overall Study|Lack of Efficacy|8|||
148859919|NCT02308163|536964189|FG003|Overall Study|Lack of Efficacy|4|||
148859920|NCT02308163|536964190|FG004|Overall Study|Lack of Efficacy|6|||
148859921|NCT02308163|536964186|FG000|Overall Study|Withdrawal of consent|2|||
148859922|NCT02308163|536964187|FG001|Overall Study|Withdrawal of consent|3|||
148859923|NCT02308163|536964188|FG002|Overall Study|Withdrawal of consent|0|||
148859924|NCT02308163|536964189|FG003|Overall Study|Withdrawal of consent|2|||
148859925|NCT02308163|536964190|FG004|Overall Study|Withdrawal of consent|6|||
148859926|NCT02308163|536964186|FG000|Overall Study|Protocol Violation|3|||
148859927|NCT02308163|536964187|FG001|Overall Study|Protocol Violation|3|||
148859928|NCT02308163|536964188|FG002|Overall Study|Protocol Violation|3|||
148859929|NCT02308163|536964189|FG003|Overall Study|Protocol Violation|2|||
148859930|NCT02308163|536964190|FG004|Overall Study|Protocol Violation|5|||
148859931|NCT02308163|536964186|FG000|Overall Study|Lab data met discontinuation criteria|3|||
148859932|NCT02308163|536964187|FG001|Overall Study|Lab data met discontinuation criteria|0|||
148859933|NCT02308163|536964188|FG002|Overall Study|Lab data met discontinuation criteria|0|||
148859934|NCT02308163|536964189|FG003|Overall Study|Lab data met discontinuation criteria|2|||
148859935|NCT02308163|536964190|FG004|Overall Study|Lab data met discontinuation criteria|0|||
148859936|NCT02308163|536964186|FG000|Overall Study|Miscellaneous|2|||
148859937|NCT02308163|536964187|FG001|Overall Study|Miscellaneous|2|||
148859938|NCT02308163|536964188|FG002|Overall Study|Miscellaneous|1|||
148859939|NCT02308163|536964189|FG003|Overall Study|Miscellaneous|0|||
148859940|NCT02308163|536964190|FG004|Overall Study|Miscellaneous|5|||
148859941|NCT03941964|536964195|FG000|Overall Study|Adverse Event|1|||
148859942|NCT03941964|536964196|FG001|Overall Study|Adverse Event|8|||
148859943|NCT03941964|536964195|FG000|Overall Study|Progressive disease|7|||
148859944|NCT03941964|536964196|FG001|Overall Study|Progressive disease|3|||
148859945|NCT03941964|536964195|FG000|Overall Study|Lack of Efficacy|0|||
148859946|NCT03941964|536964196|FG001|Overall Study|Lack of Efficacy|1|||
148859947|NCT03941964|536964195|FG000|Overall Study|Death|3|||
148859948|NCT03941964|536964196|FG001|Overall Study|Death|1|||
148859949|NCT03941964|536964195|FG000|Overall Study|Withdrew consent|1|||
148859950|NCT03941964|536964196|FG001|Overall Study|Withdrew consent|3|||
148859951|NCT03941964|536964195|FG000|Overall Study|Physician Decision|9|||
148859952|NCT03941964|536964196|FG001|Overall Study|Physician Decision|2|||
148859953|NCT03941964|536964195|FG000|Overall Study|Other, not specified|2|||
148859954|NCT03941964|536964196|FG001|Overall Study|Other, not specified|1|||
148859955|NCT00118846|536964198|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
148859956|NCT00118846|536964199|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
148859957|NCT00118846|536964198|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
148859958|NCT00118846|536964199|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
148859959|NCT00118846|536964198|FG000|Overall Study|Physician Decision|1|||
148859960|NCT00118846|536964199|FG001|Overall Study|Physician Decision|0|||
148859961|NCT00118846|536964198|FG000|Overall Study|Medical condition|2|||
148859962|NCT00118846|536964199|FG001|Overall Study|Medical condition|2|||
148859963|NCT00118846|536964198|FG000|Overall Study|Lost to Follow-up|0|||
148859964|NCT00118846|536964199|FG001|Overall Study|Lost to Follow-up|2|||
148859965|NCT00118846|536964198|FG000|Overall Study|Personal reason|4|||
148859966|NCT00118846|536964199|FG001|Overall Study|Personal reason|5|||
148859967|NCT00522418|536964201|FG000|Overall Study|Local IRB Consent Violation|5|||
148859968|NCT00522418|536964202|FG001|Overall Study|Local IRB Consent Violation|5|||
148859969|NCT00522418|536964201|FG000|Overall Study|Early Study Termination|46|||
148859970|NCT00522418|536964202|FG001|Overall Study|Early Study Termination|47|||
148859971|NCT00522418|536964201|FG000|Overall Study|Noncompliance|2|||
148859972|NCT00522418|536964202|FG001|Overall Study|Noncompliance|2|||
148859973|NCT00522418|536964201|FG000|Overall Study|Reason Not Specified|3|||
148859974|NCT00522418|536964202|FG001|Overall Study|Reason Not Specified|1|||
148859975|NCT00522418|536964201|FG000|Overall Study|Consent Withdraw|1|||
148859976|NCT00522418|536964202|FG001|Overall Study|Consent Withdraw|2|||
148859977|NCT00522418|536964201|FG000|Overall Study|Lack of Efficacy|0|||
148859978|NCT00522418|536964202|FG001|Overall Study|Lack of Efficacy|1|||
148859979|NCT01574157|536964203|FG000|Overall Study|Withdrawal by Subject|4|||
148859980|NCT01574157|536964204|FG001|Overall Study|Withdrawal by Subject|5|||
148859981|NCT01574157|536964203|FG000|Overall Study|Lost to Follow-up|0|||
148859982|NCT01574157|536964204|FG001|Overall Study|Lost to Follow-up|3|||
148859983|NCT00578877|536964207|FG000|Overall Study|Lost to Follow-up|8|||
148859984|NCT00578877|536964208|FG001|Overall Study|Lost to Follow-up|10|||
148859985|NCT00578877|536964207|FG000|Overall Study|early discontinue|61|||
148859986|NCT00578877|536964208|FG001|Overall Study|early discontinue|101|||
148859987|NCT00578877|536964207|FG000|Overall Study|did not provide follow-up data|12|||
148859988|NCT00578877|536964208|FG001|Overall Study|did not provide follow-up data|17|||
148859989|NCT01944098|536964213|FG000|Overall Study|Physician Decision|1|||
148859990|NCT01944098|536964214|FG001|Overall Study|Physician Decision|0|||
148993160|NCT02479412|537451253|FG005|Overall Study|Adverse Event|0|||
148859991|NCT04669262|536964215|FG000|Overall Study|Withdrawal by Subject|0|||
148859992|NCT04669262|536964216|FG001|Overall Study|Withdrawal by Subject|0|||
148859993|NCT04669262|536964217|FG002|Overall Study|Withdrawal by Subject|0|||
148859994|NCT04669262|536964218|FG003|Overall Study|Withdrawal by Subject|1|||
148859995|NCT04669262|536964215|FG000|Overall Study|Randomized but Not Treated|0|||
148859996|NCT04669262|536964216|FG001|Overall Study|Randomized but Not Treated|1|||
148859997|NCT04669262|536964217|FG002|Overall Study|Randomized but Not Treated|0|||
148859998|NCT04669262|536964218|FG003|Overall Study|Randomized but Not Treated|0|||
148859999|NCT03349645|536964219|FG000|Overall Study|Sponsor Terminated Study|75|||
148860000|NCT03349645|536964219|FG000|Overall Study|Withdrawal by Subject|4|||
148860001|NCT03349645|536964219|FG000|Overall Study|Protocol Violation|1|||
148860002|NCT03349645|536964219|FG000|Overall Study|Other|2|||
148860003|NCT01939002|536964231|FG000|Overall Study|Adverse Event|13|||
148860004|NCT01939002|536964232|FG001|Overall Study|Adverse Event|13|||
148860005|NCT01939002|536964231|FG000|Overall Study|Withdrawal by Subject|5|||
148860006|NCT01939002|536964232|FG001|Overall Study|Withdrawal by Subject|3|||
148860007|NCT01939002|536964231|FG000|Overall Study|Other|1|||
148860008|NCT01939002|536964232|FG001|Overall Study|Other|2|||
148860009|NCT02910401|536964235|FG000|Overall Study|Study closure Study closure|0|||
148860010|NCT02910401|536964236|FG001|Overall Study|Study closure Study closure|0|||
148860011|NCT02910401|536964237|FG002|Overall Study|Study closure Study closure|2|||
148860012|NCT02910401|536964235|FG000|Overall Study|Physician Decision|1|||
148860013|NCT02910401|536964236|FG001|Overall Study|Physician Decision|0|||
148860014|NCT02910401|536964237|FG002|Overall Study|Physician Decision|0|||
148860015|NCT00098748|536964240|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
148860016|NCT00098748|536964241|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
148860017|NCT00098748|536964242|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
148860018|NCT00098748|536964240|FG000|Received Study Treatment|Death|2|||
148860019|NCT00098748|536964241|FG001|Received Study Treatment|Death|1|||
148860020|NCT00098748|536964242|FG002|Received Study Treatment|Death|2|||
148860021|NCT00098748|536964240|FG000|Received Study Treatment|Adverse Event|1|||
148860022|NCT00098748|536964241|FG001|Received Study Treatment|Adverse Event|2|||
148860023|NCT00098748|536964242|FG002|Received Study Treatment|Adverse Event|5|||
148860024|NCT00098748|536964240|FG000|Received Study Treatment|Lack of Efficacy|40|||
148860025|NCT00098748|536964241|FG001|Received Study Treatment|Lack of Efficacy|27|||
148860026|NCT00098748|536964242|FG002|Received Study Treatment|Lack of Efficacy|27|||
148860027|NCT00098748|536964240|FG000|Received Study Treatment|Other|2|||
148860028|NCT00098748|536964241|FG001|Received Study Treatment|Other|2|||
148860029|NCT00098748|536964242|FG002|Received Study Treatment|Other|6|||
148860030|NCT00098748|536964240|FG000|Received Study Treatment|Subject defaulted|3|||
148860031|NCT00098748|536964241|FG001|Received Study Treatment|Subject defaulted|4|||
148860032|NCT00098748|536964242|FG002|Received Study Treatment|Subject defaulted|4|||
148860033|NCT00098748|536964240|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
148860034|NCT00098748|536964241|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
148860035|NCT00098748|536964242|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
148860036|NCT00098748|536964240|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
148860037|NCT00098748|536964241|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
148860038|NCT00098748|536964242|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
148860039|NCT00098748|536964240|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
148860040|NCT00098748|536964241|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
148860041|NCT00098748|536964242|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
148860042|NCT00098748|536964240|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
148860043|NCT00098748|536964241|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
148860044|NCT00098748|536964242|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
148860045|NCT00098748|536964240|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
148860046|NCT00098748|536964241|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
148860047|NCT00098748|536964242|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
148860048|NCT01774253|536964243|FG000|Overall Study|Lack of Efficacy|4|||
148860049|NCT01774253|536964243|FG000|Overall Study|Physician Decision|2|||
148860050|NCT01774253|536964243|FG000|Overall Study|Withdrawal by Subject|2|||
148860051|NCT01774253|536964243|FG000|Overall Study|Death|1|||
148860052|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
148860053|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
148860054|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Death|0|||
148860055|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Death|0|||
148860056|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
148860057|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
148860058|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
148860059|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
148860060|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
148860061|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
148860062|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
148860063|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
148860064|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
148860065|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
148860066|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
148860067|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
148860068|NCT00433160|536964244|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
148860069|NCT00433160|536964245|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
148860070|NCT00433160|536964244|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
148860071|NCT00433160|536964245|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
148860072|NCT00433160|536964244|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
148860073|NCT00433160|536964245|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
148860074|NCT00433160|536964244|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
148860075|NCT00433160|536964245|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
148860076|NCT00433160|536964244|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
148860077|NCT00433160|536964245|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
148860078|NCT00433160|536964244|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
148860079|NCT00433160|536964245|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
148860080|NCT00433160|536964244|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
148860081|NCT00433160|536964245|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
148860082|NCT00433160|536964244|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
148860083|NCT00433160|536964245|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
148860084|NCT02240368|536964249|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
148860085|NCT02240368|536964250|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
148860086|NCT02240368|536964251|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
148860087|NCT02240368|536964249|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
148860088|NCT02240368|536964250|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
148860089|NCT02240368|536964251|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
148860090|NCT00871117|536964257|FG000|Overall Study|Lost to Follow-up|5|||
148860091|NCT00871117|536964258|FG001|Overall Study|Lost to Follow-up|6|||
148860092|NCT00871117|536964257|FG000|Overall Study|Other|0|||
148860093|NCT00871117|536964258|FG001|Overall Study|Other|4|||
148860094|NCT03222973|536964259|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
148860095|NCT03222973|536964260|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
148860096|NCT03222973|536964261|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
148860097|NCT03222973|536964262|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
148860098|NCT03222973|536964259|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
148860099|NCT03222973|536964260|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
148860100|NCT03222973|536964261|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
148860101|NCT03222973|536964262|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
148860102|NCT03222973|536964259|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
148860103|NCT03222973|536964260|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
148860104|NCT03222973|536964261|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
148860105|NCT03222973|536964262|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
148860106|NCT03222973|536964259|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
148860107|NCT03222973|536964260|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
148860108|NCT03222973|536964261|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
148860109|NCT03222973|536964262|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
148860110|NCT03222973|536964259|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
148860111|NCT03222973|536964260|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
148860112|NCT03222973|536964261|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
148860113|NCT03222973|536964262|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
148860114|NCT03222973|536964259|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
148860115|NCT03222973|536964260|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
148860116|NCT03222973|536964261|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
148860117|NCT03222973|536964262|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
148860118|NCT03222973|536964259|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
148860119|NCT03222973|536964260|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
148860120|NCT03222973|536964261|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
148860121|NCT03222973|536964262|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
148860122|NCT03222973|536964259|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
148860123|NCT03222973|536964260|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
148860124|NCT03222973|536964261|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
148860125|NCT03222973|536964262|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
148860126|NCT03222973|536964259|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
148860127|NCT03222973|536964260|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
148860128|NCT03222973|536964261|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
148860129|NCT03222973|536964262|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
148860130|NCT03222973|536964259|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
148860131|NCT03222973|536964260|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
148860132|NCT03222973|536964261|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
148860133|NCT03222973|536964262|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
148860134|NCT03222973|536964259|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
148860135|NCT03222973|536964260|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
148860136|NCT03222973|536964261|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
148860137|NCT03222973|536964262|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
148860138|NCT03222973|536964259|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
148860139|NCT03222973|536964260|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
148860140|NCT03222973|536964261|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
148860141|NCT03222973|536964262|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
148860142|NCT02080481|536964263|FG000|Overall Study|Never received a block.|1|||
148860143|NCT02080481|536964264|FG001|Overall Study|Never received a block.|0|||
148860144|NCT03095027|536965630|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
148860145|NCT03095027|536965631|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
148860146|NCT00316693|536965632|FG000|Overall Study|Adverse Event|6|||
148860147|NCT00316693|536965633|FG001|Overall Study|Adverse Event|1|||
148860148|NCT00316693|536965632|FG000|Overall Study|Protocol Violation|1|||
148860149|NCT00316693|536965633|FG001|Overall Study|Protocol Violation|0|||
148860150|NCT00316693|536965632|FG000|Overall Study|Withdrawal by Subject|6|||
148860151|NCT00316693|536965633|FG001|Overall Study|Withdrawal by Subject|6|||
148860152|NCT00316693|536965632|FG000|Overall Study|Lost to Follow-up|26|||
148860153|NCT00316693|536965633|FG001|Overall Study|Lost to Follow-up|34|||
148860154|NCT00316693|536965632|FG000|Overall Study|Other|38|||
148860155|NCT00316693|536965633|FG001|Overall Study|Other|44|||
148860156|NCT02982018|536965634|FG000|Overall Study|Incorrect Lens Dispensed|1|||
148860157|NCT02982018|536965635|FG001|Overall Study|Incorrect Lens Dispensed|0|||
148860158|NCT02982018|536965634|FG000|Overall Study|Protocol Violation|1|||
148860159|NCT02982018|536965635|FG001|Overall Study|Protocol Violation|1|||
148860160|NCT02982018|536965634|FG000|Overall Study|Adverse Event|1|||
148860161|NCT02982018|536965635|FG001|Overall Study|Adverse Event|1|||
148860162|NCT02982018|536965634|FG000|Overall Study|Lens Discomfort|2|||
148860163|NCT02982018|536965635|FG001|Overall Study|Lens Discomfort|0|||
148860164|NCT02982018|536965634|FG000|Overall Study|Withdrawal by Subject|0|||
148860165|NCT02982018|536965635|FG001|Overall Study|Withdrawal by Subject|1|||
148860166|NCT03245736|536965636|FG000|Overall Study|Adverse Event|1|||
148860167|NCT03245736|536965636|FG000|Overall Study|Progressive Disease|4|||
148860168|NCT00132691|536965638|FG000|Overall Study|Lost to Follow-up|5|||
148860169|NCT00132691|536965639|FG001|Overall Study|Lost to Follow-up|8|||
148860170|NCT00132691|536965638|FG000|Overall Study|Missed 2-year visit|4|||
148860171|NCT00132691|536965639|FG001|Overall Study|Missed 2-year visit|4|||
148860172|NCT00132691|536965638|FG000|Overall Study|Death|2|||
148860173|NCT00132691|536965639|FG001|Overall Study|Death|0|||
148860174|NCT04098367|536965640|FG000|Overall Study|Adverse Event|0|||
148860175|NCT04098367|536965641|FG001|Overall Study|Adverse Event|0|||
148860176|NCT04098367|536965642|FG002|Overall Study|Adverse Event|1|||
148860177|NCT04098367|536965640|FG000|Overall Study|Lost to Follow-up|1|||
148860178|NCT04098367|536965641|FG001|Overall Study|Lost to Follow-up|5|||
148860179|NCT04098367|536965642|FG002|Overall Study|Lost to Follow-up|2|||
148860180|NCT04098367|536965640|FG000|Overall Study|Withdrawal by Subject|0|||
148860181|NCT04098367|536965641|FG001|Overall Study|Withdrawal by Subject|0|||
148860182|NCT04098367|536965642|FG002|Overall Study|Withdrawal by Subject|1|||
148860183|NCT04098367|536965640|FG000|Overall Study|Sick . Could not attend visit|1|||
148860184|NCT04098367|536965641|FG001|Overall Study|Sick . Could not attend visit|0|||
148860185|NCT04098367|536965642|FG002|Overall Study|Sick . Could not attend visit|0|||
148860186|NCT02251717|536965643|FG000|Overall Study|Adverse Event|0|||
148860187|NCT02251717|536965644|FG001|Overall Study|Adverse Event|1|||
148860188|NCT02251717|536965643|FG000|Overall Study|Withdrew Consent|1|||
148860189|NCT02251717|536965644|FG001|Overall Study|Withdrew Consent|0|||
148860190|NCT00919867|536965647|FG000|First Intervention|Withdrawal by Subject|0|||
148860191|NCT00919867|536965648|FG001|First Intervention|Withdrawal by Subject|0|||
148860192|NCT00919867|536965649|FG002|First Intervention|Withdrawal by Subject|1|||
148860193|NCT00919867|536965650|FG003|First Intervention|Withdrawal by Subject|0|||
148860194|NCT00919867|536965651|FG004|First Intervention|Withdrawal by Subject|0|||
148860195|NCT00919867|536965652|FG005|First Intervention|Withdrawal by Subject|0|||
148860196|NCT00919867|536965647|FG000|First Intervention|Physician Decision|0|||
148860197|NCT00919867|536965648|FG001|First Intervention|Physician Decision|0|||
148860198|NCT00919867|536965649|FG002|First Intervention|Physician Decision|0|||
148860199|NCT00919867|536965650|FG003|First Intervention|Physician Decision|0|||
148860200|NCT00919867|536965651|FG004|First Intervention|Physician Decision|0|||
148860201|NCT00919867|536965652|FG005|First Intervention|Physician Decision|1|||
148860202|NCT00322023|536965657|FG000|Overall Study|various|0|||
148860203|NCT00322023|536965658|FG001|Overall Study|various|2|||
148860204|NCT00322023|536965659|FG002|Overall Study|various|6|||
148860205|NCT03920293|536965660|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
148860206|NCT03920293|536965661|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
148860207|NCT03920293|536965660|FG000|Randomized-Controlled Period|Physician Decision|1|||
148860208|NCT03920293|536965661|FG001|Randomized-Controlled Period|Physician Decision|2|||
148860209|NCT03920293|536965660|FG000|Randomized-Controlled Period|Adverse Event|0|||
148860210|NCT03920293|536965661|FG001|Randomized-Controlled Period|Adverse Event|2|||
148860211|NCT03920293|536965660|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
148860212|NCT03920293|536965661|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
148860213|NCT03920293|536965660|FG000|Randomized-Controlled Period|Death|2|||
148860214|NCT03920293|536965661|FG001|Randomized-Controlled Period|Death|0|||
148860215|NCT03920293|536965660|FG000|Randomized-Controlled Period|Protocol Violation|1|||
148860216|NCT03920293|536965661|FG001|Randomized-Controlled Period|Protocol Violation|0|||
148860217|NCT03920293|536965660|FG000|Randomized-Controlled Period|Noncompliance|1|||
148860218|NCT03920293|536965661|FG001|Randomized-Controlled Period|Noncompliance|0|||
148860219|NCT03920293|536965660|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
148860220|NCT03920293|536965661|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
148860221|NCT03920293|536965660|FG000|Open- Label Extension Period|Death|3|||
148860222|NCT03920293|536965661|FG001|Open- Label Extension Period|Death|3|||
148860223|NCT03920293|536965660|FG000|Open- Label Extension Period|Physician Decision|5|||
148860224|NCT03920293|536965661|FG001|Open- Label Extension Period|Physician Decision|3|||
148860225|NCT03920293|536965660|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
148860226|NCT03920293|536965661|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
148860227|NCT03361189|536965666|FG000|Overall Study|Received heart transplant|1|||
148860228|NCT03361189|536965667|FG001|Overall Study|Received heart transplant|0|||
148860229|NCT03361189|536965666|FG000|Overall Study|Pacemake replacement|0|||
148860230|NCT03361189|536965667|FG001|Overall Study|Pacemake replacement|1|||
148860231|NCT03344549|536965668|FG000|Overall Study|Withdrawal by Subject|3|||
148860232|NCT03344549|536965669|FG001|Overall Study|Withdrawal by Subject|2|||
148860233|NCT03344549|536965668|FG000|Overall Study|Dialysis|2|||
148860234|NCT03344549|536965669|FG001|Overall Study|Dialysis|0|||
148860235|NCT03344549|536965668|FG000|Overall Study|Cancer|1|||
148860236|NCT03344549|536965669|FG001|Overall Study|Cancer|0|||
148860237|NCT03344549|536965668|FG000|Overall Study|Lack of electronic device|1|||
148860238|NCT03344549|536965669|FG001|Overall Study|Lack of electronic device|0|||
148860239|NCT03344549|536965668|FG000|Overall Study|Transportation difficulty|0|||
148860240|NCT03344549|536965669|FG001|Overall Study|Transportation difficulty|13|||
148860241|NCT01685801|536965675|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
148860242|NCT01685801|536965676|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
148993161|NCT02479412|537451254|FG006|Overall Study|Adverse Event|0|||
148993162|NCT02479412|537451255|FG007|Overall Study|Adverse Event|0|||
148993163|NCT02479412|537451256|FG008|Overall Study|Adverse Event|0|||
148993164|NCT02479412|537451248|FG000|Overall Study|Study-specific withdrawal criteria|0|||
148993165|NCT02479412|537451249|FG001|Overall Study|Study-specific withdrawal criteria|0|||
148993166|NCT02479412|537451250|FG002|Overall Study|Study-specific withdrawal criteria|1|||
148993167|NCT02479412|537451251|FG003|Overall Study|Study-specific withdrawal criteria|1|||
148993168|NCT02479412|537451252|FG004|Overall Study|Study-specific withdrawal criteria|0|||
148993169|NCT02479412|537451253|FG005|Overall Study|Study-specific withdrawal criteria|0|||
148993170|NCT02479412|537451254|FG006|Overall Study|Study-specific withdrawal criteria|0|||
148993171|NCT02479412|537451255|FG007|Overall Study|Study-specific withdrawal criteria|1|||
148860243|NCT01685801|536965677|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
148860244|NCT01685801|536965678|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
148860245|NCT01685801|536965675|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
148860246|NCT01685801|536965676|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
148860247|NCT01685801|536965677|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
148860248|NCT01685801|536965678|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
148860249|NCT03350256|536965679|FG000|Overall Study|Inclusion/exclusion violation|4|||
148860250|NCT03350256|536965679|FG000|Overall Study|Recommended for other therapies|2|||
148860251|NCT03350256|536965679|FG000|Overall Study|Protocol Violation|3|||
148860252|NCT03350256|536965679|FG000|Overall Study|Non compliance|2|||
148860253|NCT03350256|536965679|FG000|Overall Study|Denial by insurance|1|||
148860254|NCT03350256|536965679|FG000|Overall Study|Adverse Event|2|||
148860255|NCT03350256|536965679|FG000|Overall Study|Trial failure|12|||
148860256|NCT03350256|536965679|FG000|Overall Study|Did not proceed to permanent implant|3|||
148860257|NCT03350256|536965679|FG000|Overall Study|Withdrawal by Subject|3|||
148860258|NCT03350256|536965679|FG000|Overall Study|Subject moving out of state|1|||
148860259|NCT03350256|536965679|FG000|Overall Study|Lost to Follow-up|1|||
148860260|NCT03350256|536965679|FG000|Overall Study|Lack of Efficacy|2|||
148860261|NCT00543296|536965682|FG000|Overall Study|Physician Decision|7|||
148860262|NCT04600076|536965685|FG000|Overall Study|Lost to Follow-up|3|||
148860263|NCT03664674|536965687|FG000|Overall Study|Adverse Event|1|||
148860264|NCT03664674|536965688|FG001|Overall Study|Adverse Event|1|||
148993172|NCT02479412|537451256|FG008|Overall Study|Study-specific withdrawal criteria|1|||
148993173|NCT02479412|537451248|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
148860265|NCT03664674|536965687|FG000|Overall Study|Physician Decision|0|||
148860266|NCT03664674|536965688|FG001|Overall Study|Physician Decision|1|||
148860267|NCT03664674|536965687|FG000|Overall Study|Withdrawal by Subject|2|||
148860268|NCT03664674|536965688|FG001|Overall Study|Withdrawal by Subject|0|||
148860269|NCT01342965|536965689|FG000|Overall Study|Death|58|||
148860270|NCT01342965|536965690|FG001|Overall Study|Death|57|||
148860271|NCT01342965|536965689|FG000|Overall Study|Lost to Follow-up|5|||
148860272|NCT01342965|536965690|FG001|Overall Study|Lost to Follow-up|3|||
148860273|NCT01342965|536965689|FG000|Overall Study|Other Reasons- Unspecified|44|||
148860274|NCT01342965|536965690|FG001|Overall Study|Other Reasons- Unspecified|38|||
148860275|NCT01342965|536965689|FG000|Overall Study|Withdrawal by Subject|2|||
148860276|NCT01342965|536965690|FG001|Overall Study|Withdrawal by Subject|9|||
148860277|NCT01170598|536965691|FG000|Overall Study|Withdrawal by Subject|1|||
148860278|NCT01170598|536965691|FG000|Overall Study|Death|3|||
148860279|NCT01170598|536965691|FG000|Overall Study|Lost to Follow-up|1|||
148860280|NCT01170598|536965691|FG000|Overall Study|Refused|1|||
148860281|NCT03022097|536965696|FG000|Overall Study|Adverse Event|3|||
148860282|NCT03022097|536965697|FG001|Overall Study|Adverse Event|4|||
148860283|NCT03022097|536965698|FG002|Overall Study|Adverse Event|1|||
148860284|NCT03022097|536965699|FG003|Overall Study|Adverse Event|3|||
148860285|NCT03022097|536965696|FG000|Overall Study|Progressive Disease|2|||
148860286|NCT03022097|536965697|FG001|Overall Study|Progressive Disease|0|||
148860287|NCT03022097|536965698|FG002|Overall Study|Progressive Disease|5|||
148860288|NCT03022097|536965699|FG003|Overall Study|Progressive Disease|2|||
148860289|NCT03022097|536965696|FG000|Overall Study|Lack of Efficacy|0|||
148860290|NCT03022097|536965697|FG001|Overall Study|Lack of Efficacy|0|||
148860291|NCT03022097|536965698|FG002|Overall Study|Lack of Efficacy|3|||
148860292|NCT03022097|536965699|FG003|Overall Study|Lack of Efficacy|3|||
148860293|NCT03022097|536965696|FG000|Overall Study|Protocol Violation|1|||
148860294|NCT03022097|536965697|FG001|Overall Study|Protocol Violation|0|||
148860295|NCT03022097|536965698|FG002|Overall Study|Protocol Violation|1|||
148860296|NCT03022097|536965699|FG003|Overall Study|Protocol Violation|0|||
148860297|NCT03022097|536965696|FG000|Overall Study|Withdrawal by Subject|11|||
148860298|NCT03022097|536965697|FG001|Overall Study|Withdrawal by Subject|13|||
148860299|NCT03022097|536965698|FG002|Overall Study|Withdrawal by Subject|15|||
148860300|NCT03022097|536965699|FG003|Overall Study|Withdrawal by Subject|21|||
148860301|NCT03022097|536965696|FG000|Overall Study|Lost to Follow-up|0|||
148860302|NCT03022097|536965697|FG001|Overall Study|Lost to Follow-up|0|||
148860303|NCT03022097|536965698|FG002|Overall Study|Lost to Follow-up|1|||
148860304|NCT03022097|536965699|FG003|Overall Study|Lost to Follow-up|1|||
148860305|NCT03022097|536965696|FG000|Overall Study|Other|4|||
148860306|NCT03022097|536965697|FG001|Overall Study|Other|1|||
148860307|NCT03022097|536965698|FG002|Overall Study|Other|6|||
148860308|NCT03022097|536965699|FG003|Overall Study|Other|4|||
148860309|NCT03022097|536965696|FG000|Overall Study|Due to COVID-19 pandemic|0|||
148860310|NCT03022097|536965697|FG001|Overall Study|Due to COVID-19 pandemic|1|||
148860311|NCT03022097|536965698|FG002|Overall Study|Due to COVID-19 pandemic|0|||
148860312|NCT03022097|536965699|FG003|Overall Study|Due to COVID-19 pandemic|0|||
148860313|NCT01451931|536965700|FG000|Overall Study|Lost to Follow-up|17|||
148860314|NCT01451931|536965701|FG001|Overall Study|Lost to Follow-up|36|||
148860315|NCT01451931|536965702|FG002|Overall Study|Lost to Follow-up|21|||
148860316|NCT01451931|536965700|FG000|Overall Study|Withdrawal by Subject|16|||
148860317|NCT01451931|536965701|FG001|Overall Study|Withdrawal by Subject|22|||
148860318|NCT01451931|536965702|FG002|Overall Study|Withdrawal by Subject|22|||
148860319|NCT02780856|536965709|FG000|Overall Study|Lost to Follow-up|1|||
148860320|NCT03894969|536965717|FG000|Overall Study|Adverse Event|0|||
148860321|NCT03894969|536965718|FG001|Overall Study|Adverse Event|2|||
148860322|NCT03894969|536965719|FG002|Overall Study|Adverse Event|0|||
148860323|NCT03894969|536965720|FG003|Overall Study|Adverse Event|1|||
148860324|NCT03894969|536965721|FG004|Overall Study|Adverse Event|2|||
148860325|NCT03894969|536965717|FG000|Overall Study|Lost to Follow-up|3|||
148860326|NCT03894969|536965718|FG001|Overall Study|Lost to Follow-up|1|||
148860327|NCT03894969|536965719|FG002|Overall Study|Lost to Follow-up|1|||
148860328|NCT03894969|536965720|FG003|Overall Study|Lost to Follow-up|0|||
148860329|NCT03894969|536965721|FG004|Overall Study|Lost to Follow-up|0|||
148860330|NCT03894969|536965717|FG000|Overall Study|Withdrawal by Subject|2|||
148860331|NCT03894969|536965718|FG001|Overall Study|Withdrawal by Subject|1|||
148860332|NCT03894969|536965719|FG002|Overall Study|Withdrawal by Subject|3|||
148860333|NCT03894969|536965720|FG003|Overall Study|Withdrawal by Subject|4|||
148860334|NCT03894969|536965721|FG004|Overall Study|Withdrawal by Subject|8|||
148860335|NCT03894969|536965717|FG000|Overall Study|Other|0|||
148860336|NCT03894969|536965718|FG001|Overall Study|Other|0|||
148860337|NCT03894969|536965719|FG002|Overall Study|Other|0|||
148860338|NCT03894969|536965720|FG003|Overall Study|Other|0|||
148860339|NCT03894969|536965721|FG004|Overall Study|Other|3|||
148860340|NCT03894969|536965717|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
148860341|NCT03894969|536965718|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
148860342|NCT03894969|536965719|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
148860343|NCT03894969|536965720|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
148860344|NCT03894969|536965721|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
148860345|NCT03894969|536965717|FG000|Overall Study|Solicited Adverse Event|0|||
148860346|NCT03894969|536965718|FG001|Overall Study|Solicited Adverse Event|1|||
148860347|NCT03894969|536965719|FG002|Overall Study|Solicited Adverse Event|0|||
148860348|NCT03894969|536965720|FG003|Overall Study|Solicited Adverse Event|0|||
148860349|NCT03894969|536965721|FG004|Overall Study|Solicited Adverse Event|0|||
148860350|NCT02378298|536965724|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
148860351|NCT02378298|536965725|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
148860352|NCT02378298|536965726|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
148860353|NCT02378298|536965724|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
148860354|NCT02378298|536965725|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
148860355|NCT02378298|536965726|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
148860356|NCT02378298|536965724|FG000|Surveillance (19-68 Weeks)|Death|1|||
148860357|NCT02378298|536965725|FG001|Surveillance (19-68 Weeks)|Death|0|||
148860358|NCT02378298|536965726|FG002|Surveillance (19-68 Weeks)|Death|0|||
148860359|NCT01904149|536965730|FG000|Overall Study|Adverse Event|3|||
148860360|NCT01904149|536965731|FG001|Overall Study|Adverse Event|4|||
148860361|NCT01904149|536965732|FG002|Overall Study|Adverse Event|0|||
148860362|NCT01904149|536965733|FG003|Overall Study|Adverse Event|1|||
148860363|NCT01904149|536965734|FG004|Overall Study|Adverse Event|1|||
148860364|NCT01904149|536965735|FG005|Overall Study|Adverse Event|2|||
148860365|NCT01904149|536965730|FG000|Overall Study|Lack of Efficacy|0|||
148860366|NCT01904149|536965731|FG001|Overall Study|Lack of Efficacy|3|||
148860367|NCT01904149|536965732|FG002|Overall Study|Lack of Efficacy|1|||
148860368|NCT01904149|536965733|FG003|Overall Study|Lack of Efficacy|3|||
148860369|NCT01904149|536965734|FG004|Overall Study|Lack of Efficacy|3|||
148860370|NCT01904149|536965735|FG005|Overall Study|Lack of Efficacy|1|||
148860371|NCT01904149|536965730|FG000|Overall Study|Withdrawal by Subject|1|||
148860372|NCT01904149|536965731|FG001|Overall Study|Withdrawal by Subject|3|||
148860373|NCT01904149|536965732|FG002|Overall Study|Withdrawal by Subject|1|||
148860374|NCT01904149|536965733|FG003|Overall Study|Withdrawal by Subject|0|||
148860375|NCT01904149|536965734|FG004|Overall Study|Withdrawal by Subject|1|||
148860376|NCT01904149|536965735|FG005|Overall Study|Withdrawal by Subject|0|||
148860377|NCT01904149|536965730|FG000|Overall Study|Protocol Violation|0|||
148860378|NCT01904149|536965731|FG001|Overall Study|Protocol Violation|1|||
148860379|NCT01904149|536965732|FG002|Overall Study|Protocol Violation|0|||
148860380|NCT01904149|536965733|FG003|Overall Study|Protocol Violation|0|||
148860381|NCT01904149|536965734|FG004|Overall Study|Protocol Violation|0|||
148860382|NCT01904149|536965735|FG005|Overall Study|Protocol Violation|0|||
148860383|NCT01904149|536965730|FG000|Overall Study|non compliance with study drug|1|||
148860384|NCT01904149|536965731|FG001|Overall Study|non compliance with study drug|0|||
148860385|NCT01904149|536965732|FG002|Overall Study|non compliance with study drug|0|||
148860386|NCT01904149|536965733|FG003|Overall Study|non compliance with study drug|0|||
148860387|NCT01904149|536965734|FG004|Overall Study|non compliance with study drug|0|||
148860388|NCT01904149|536965735|FG005|Overall Study|non compliance with study drug|0|||
148860389|NCT00350272|536965736|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
148860390|NCT00350272|536965737|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
148860391|NCT00350272|536965736|FG000|Blinded 12-Week Treatment|Death|1|||
148860392|NCT00350272|536965737|FG001|Blinded 12-Week Treatment|Death|0|||
148860393|NCT00350272|536965736|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
148860394|NCT00350272|536965737|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
148860395|NCT00350272|536965736|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
148860396|NCT00350272|536965737|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
148860397|NCT00350272|536965736|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
148860398|NCT00350272|536965737|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
148860399|NCT00350272|536965736|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
148860400|NCT00350272|536965737|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
148860401|NCT00350272|536965736|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
148860402|NCT00350272|536965737|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
148860403|NCT00350272|536965736|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
148860404|NCT00350272|536965737|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
148860405|NCT00350272|536965736|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
148860406|NCT00350272|536965737|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
148860407|NCT00350272|536965736|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
148860408|NCT00350272|536965737|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
148860409|NCT00350272|536965736|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
148860410|NCT00350272|536965737|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
148860411|NCT02323204|536965743|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
148860412|NCT02323204|536965744|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
148860413|NCT02323204|536965745|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
148860414|NCT02323204|536965746|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
148860415|NCT02323204|536965743|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
148860416|NCT02323204|536965744|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
148860417|NCT02323204|536965745|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
148860418|NCT02323204|536965746|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
148860419|NCT02323204|536965743|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
148860420|NCT02323204|536965744|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
148777858|NCT02431806|536660436|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
148777859|NCT02431806|536660433|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
148777860|NCT02431806|536660434|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
148777861|NCT02431806|536660435|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
148777862|NCT02431806|536660436|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
148777863|NCT02431806|536660433|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
148777864|NCT02431806|536660434|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
148777865|NCT02431806|536660435|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
148777866|NCT02431806|536660436|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
148777867|NCT04972968|536660440|FG000|Overall Study|Adverse Event|3|||
148777868|NCT04972968|536660441|FG001|Overall Study|Adverse Event|1|||
148777869|NCT04972968|536660442|FG002|Overall Study|Adverse Event|1|||
148777870|NCT04972968|536660443|FG003|Overall Study|Adverse Event|7|||
148777871|NCT04972968|536660440|FG000|Overall Study|Lack of Efficacy|2|||
148777872|NCT04972968|536660441|FG001|Overall Study|Lack of Efficacy|1|||
148777873|NCT04972968|536660442|FG002|Overall Study|Lack of Efficacy|0|||
148777874|NCT04972968|536660443|FG003|Overall Study|Lack of Efficacy|0|||
148777875|NCT04972968|536660440|FG000|Overall Study|Withdrawal by Subject|7|||
148777876|NCT04972968|536660441|FG001|Overall Study|Withdrawal by Subject|4|||
148777877|NCT04972968|536660442|FG002|Overall Study|Withdrawal by Subject|3|||
148777878|NCT04972968|536660443|FG003|Overall Study|Withdrawal by Subject|2|||
148777879|NCT04972968|536660440|FG000|Overall Study|Study Terminated by Sponsor|25|||
148777880|NCT04972968|536660441|FG001|Overall Study|Study Terminated by Sponsor|28|||
148777881|NCT04972968|536660442|FG002|Overall Study|Study Terminated by Sponsor|32|||
148777882|NCT04972968|536660443|FG003|Overall Study|Study Terminated by Sponsor|27|||
148777883|NCT04972968|536660440|FG000|Overall Study|Other|1|||
148777884|NCT04972968|536660441|FG001|Overall Study|Other|0|||
148777885|NCT04972968|536660442|FG002|Overall Study|Other|1|||
148777886|NCT04972968|536660443|FG003|Overall Study|Other|1|||
148777887|NCT01698879|536660444|FG000|Overall Study|Withdrawal by Subject|1|||
148777888|NCT01698879|536660445|FG001|Overall Study|Withdrawal by Subject|0|||
148777889|NCT01698879|536660446|FG002|Overall Study|Withdrawal by Subject|0|||
148777890|NCT00191282|536660447|FG000|Overall Study|Adverse Event|5|||
148777891|NCT00191282|536660448|FG001|Overall Study|Adverse Event|6|||
148777892|NCT00191282|536660447|FG000|Overall Study|Death|51|||
148777893|NCT00191282|536660448|FG001|Overall Study|Death|51|||
148777894|NCT00191282|536660447|FG000|Overall Study|Lack of Efficacy|11|||
148777895|NCT00191282|536660448|FG001|Overall Study|Lack of Efficacy|6|||
148777896|NCT00191282|536660447|FG000|Overall Study|Noncompliance|14|||
148777897|NCT00191282|536660448|FG001|Overall Study|Noncompliance|17|||
148777898|NCT00191282|536660447|FG000|Overall Study|Patient moved|11|||
148777899|NCT00191282|536660448|FG001|Overall Study|Patient moved|14|||
148777900|NCT00191282|536660447|FG000|Overall Study|Withdrawal by Subject|59|||
148777901|NCT00191282|536660448|FG001|Overall Study|Withdrawal by Subject|44|||
148777902|NCT00191282|536660447|FG000|Overall Study|Physician Decision|18|||
148777903|NCT00191282|536660448|FG001|Overall Study|Physician Decision|15|||
148777904|NCT00191282|536660447|FG000|Overall Study|Protocol entry criteria not met|14|||
148777905|NCT00191282|536660448|FG001|Overall Study|Protocol entry criteria not met|9|||
148777906|NCT00191282|536660447|FG000|Overall Study|Protocol Violation|9|||
148777907|NCT00191282|536660448|FG001|Overall Study|Protocol Violation|12|||
148777908|NCT00191282|536660447|FG000|Overall Study|Severity of outcome|2|||
148777909|NCT00191282|536660448|FG001|Overall Study|Severity of outcome|5|||
148777910|NCT00191282|536660447|FG000|Overall Study|Sponsor's decision|2|||
148777911|NCT00191282|536660448|FG001|Overall Study|Sponsor's decision|2|||
148777912|NCT00191282|536660447|FG000|Overall Study|Lost to Follow-up|24|||
148777913|NCT00191282|536660448|FG001|Overall Study|Lost to Follow-up|31|||
148777914|NCT04756154|536660451|FG000|Overall Study|Did not meet treatment day baseline|30|||
148777915|NCT04756154|536660452|FG001|Overall Study|Did not meet treatment day baseline|28|||
148777916|NCT04756154|536660453|FG002|Overall Study|Did not meet treatment day baseline|7|||
148777917|NCT04756154|536660451|FG000|Overall Study|Did not return for final sample collection|1|||
148777918|NCT04756154|536660452|FG001|Overall Study|Did not return for final sample collection|1|||
148777919|NCT04756154|536660453|FG002|Overall Study|Did not return for final sample collection|0|||
148777920|NCT03589976|536660454|FG000|Overall Study|Death|5|||
148777921|NCT03589976|536660455|FG001|Overall Study|Death|1|||
148777922|NCT03589976|536660454|FG000|Overall Study|Adverse Event|5|||
148777923|NCT03589976|536660455|FG001|Overall Study|Adverse Event|1|||
148777924|NCT03589976|536660454|FG000|Overall Study|Withdrawal by Subject|4|||
148777925|NCT03589976|536660455|FG001|Overall Study|Withdrawal by Subject|1|||
148777926|NCT03589976|536660454|FG000|Overall Study|Lost to Follow-up|1|||
148777927|NCT03589976|536660455|FG001|Overall Study|Lost to Follow-up|0|||
148777928|NCT03589976|536660454|FG000|Overall Study|Other|4|||
148777929|NCT03589976|536660455|FG001|Overall Study|Other|3|||
148777930|NCT02089334|536660458|FG000|Overall Study|Withdrawal by Subject|0|||
148777931|NCT02089334|536660459|FG001|Overall Study|Withdrawal by Subject|0|||
148777932|NCT02089334|536660460|FG002|Overall Study|Withdrawal by Subject|0|||
148777933|NCT02089334|536660461|FG003|Overall Study|Withdrawal by Subject|2|||
148860421|NCT02323204|536965745|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
148860422|NCT02323204|536965746|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
148860423|NCT02323204|536965743|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
148860424|NCT02323204|536965744|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
148860425|NCT02323204|536965745|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
148860426|NCT02323204|536965746|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
148860427|NCT02323204|536965743|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
148860428|NCT02323204|536965744|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
148860429|NCT02323204|536965745|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
148860430|NCT02323204|536965746|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
148860431|NCT02323204|536965743|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
148860432|NCT02323204|536965744|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
148860433|NCT02323204|536965745|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
148860434|NCT02323204|536965746|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
148860435|NCT02323204|536965743|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
148860436|NCT02323204|536965744|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
148860437|NCT02323204|536965745|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
148860438|NCT02323204|536965746|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
148860439|NCT02323204|536965743|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
148860440|NCT02323204|536965744|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
148860441|NCT02323204|536965745|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
148860442|NCT02323204|536965746|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
148860443|NCT02323204|536965743|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
148860444|NCT02323204|536965744|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
148860445|NCT02323204|536965745|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
148860446|NCT02323204|536965746|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
148860447|NCT04508751|536965751|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
148860448|NCT04508751|536965752|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
148860449|NCT04508751|536965753|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
148860450|NCT02752958|536965754|FG000|Overall Study|Adverse Event|3|||
148860451|NCT02752958|536965754|FG000|Overall Study|Lost to Follow-up|1|||
148860452|NCT02752958|536965754|FG000|Overall Study|Protocol Violation|1|||
148860453|NCT02752958|536965754|FG000|Overall Study|Withdrawal by Subject|2|||
148860454|NCT02752958|536965754|FG000|Overall Study|Other (Reason not specified)|2|||
148860455|NCT03023826|536965755|FG000|Period 1|Withdrawal by Subject|0|||
148860456|NCT03023826|536965756|FG001|Period 1|Withdrawal by Subject|0|||
148860457|NCT03023826|536965757|FG002|Period 1|Withdrawal by Subject|0|||
148860458|NCT03023826|536965758|FG003|Period 1|Withdrawal by Subject|0|||
148860459|NCT03023826|536965759|FG004|Period 1|Withdrawal by Subject|1|||
148860460|NCT03023826|536965760|FG005|Period 1|Withdrawal by Subject|0|||
148860461|NCT00717522|536965761|FG000|Overall Study|Disease Progression|5|||
148860462|NCT00717522|536965761|FG000|Overall Study|Adverse Event|1|||
148860463|NCT00717522|536965761|FG000|Overall Study|Death|1|||
148860464|NCT00072293|536965762|FG000|Overall Study|Lost to Follow-up|1|||
148860465|NCT00072293|536965763|FG001|Overall Study|Lost to Follow-up|1|||
148860466|NCT00072293|536965762|FG000|Overall Study|Withdrawal by Subject|0|||
148860467|NCT00072293|536965763|FG001|Overall Study|Withdrawal by Subject|1|||
148860468|NCT01444027|536965770|FG000|Overall Study|Withdrawal by Subject|4|||
148860469|NCT01444027|536965771|FG001|Overall Study|Withdrawal by Subject|10|||
148860470|NCT01444027|536965772|FG002|Overall Study|Withdrawal by Subject|24|||
148860471|NCT01444027|536965770|FG000|Overall Study|Lost to Follow-up|26|||
148860472|NCT01444027|536965771|FG001|Overall Study|Lost to Follow-up|20|||
148860473|NCT01444027|536965772|FG002|Overall Study|Lost to Follow-up|14|||
148860474|NCT03551665|536965774|FG000|Overall Study|Lost to Follow-up|11|||
148860475|NCT03551665|536965775|FG001|Overall Study|Lost to Follow-up|2|||
148993174|NCT02479412|537451249|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
148860476|NCT00496483|536967396|FG000|Overall Study|Not dosed|9|||
148860477|NCT00496483|536967396|FG000|Overall Study|Adverse Event|2|||
148860478|NCT00496483|536967396|FG000|Overall Study|Lack of Efficacy|1|||
148860479|NCT00428220|536967397|FG000|Overall Study|Participant died|8|||
148860480|NCT00428220|536967397|FG000|Overall Study|Global deterioration of health status|7|||
148860481|NCT00428220|536967397|FG000|Overall Study|Lost to Follow-up|4|||
148860482|NCT00428220|536967397|FG000|Overall Study|Objective progression or relapse|123|||
148860483|NCT00428220|536967397|FG000|Overall Study|Participant refused continued treatment|7|||
148860484|NCT00428220|536967397|FG000|Overall Study|Adverse Event|51|||
148860485|NCT00428220|536967397|FG000|Overall Study|Other|23|||
148860486|NCT00642174|536967404|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
148860487|NCT00642174|536967405|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
148860488|NCT00896363|536967406|FG000|Overall Study|Adverse Event|3|||
148860489|NCT00896363|536967407|FG001|Overall Study|Adverse Event|4|||
148860490|NCT00896363|536967408|FG002|Overall Study|Adverse Event|2|||
148860491|NCT00896363|536967406|FG000|Overall Study|Lack of Efficacy|0|||
148860492|NCT00896363|536967407|FG001|Overall Study|Lack of Efficacy|2|||
148860493|NCT00896363|536967408|FG002|Overall Study|Lack of Efficacy|1|||
148860494|NCT00896363|536967406|FG000|Overall Study|Withdrawal by Subject|3|||
148860495|NCT00896363|536967407|FG001|Overall Study|Withdrawal by Subject|5|||
148860496|NCT00896363|536967408|FG002|Overall Study|Withdrawal by Subject|5|||
148860497|NCT01730339|536967409|FG000|Overall Study|Withdrawal by Subject|3|||
148860498|NCT01730339|536967410|FG001|Overall Study|Withdrawal by Subject|2|||
148860499|NCT01730339|536967409|FG000|Overall Study|Lost to Follow-up|1|||
148860500|NCT01730339|536967410|FG001|Overall Study|Lost to Follow-up|1|||
148860501|NCT01730339|536967409|FG000|Overall Study|Un-specified|1|||
148860502|NCT01730339|536967410|FG001|Overall Study|Un-specified|0|||
148860503|NCT01145352|536967413|FG000|Overall Study|Found to have been registered twice|6|||
148860504|NCT01145352|536967413|FG000|Overall Study|Treated before marketing approval|4|||
148860505|NCT01145352|536967413|FG000|Overall Study|Syringe formulation was used|1|||
148860506|NCT04143217|536967414|FG000|Overall Study|Withdrawal by Subject|42|||
148860507|NCT04143217|536967414|FG000|Overall Study|Adverse Event|29|||
148860508|NCT04143217|536967414|FG000|Overall Study|Lost to Follow-up|29|||
148860509|NCT04143217|536967414|FG000|Overall Study|Lack of Efficacy|15|||
148860510|NCT04143217|536967414|FG000|Overall Study|Physician Decision|1|||
148860511|NCT04143217|536967414|FG000|Overall Study|Non-Compliance With Study Drug|6|||
148860512|NCT04143217|536967414|FG000|Overall Study|Other, Multiple Categories|11|||
148860513|NCT00496197|536967415|FG000|Overall Study|Discontinued study due to death|43|||
148860514|NCT00496197|536967415|FG000|Overall Study|Adverse Event|13|||
148860515|NCT00496197|536967415|FG000|Overall Study|Does not meet entrance criteria|5|||
148860516|NCT00496197|536967415|FG000|Overall Study|Insufficient clinical response|3|||
148860517|NCT00496197|536967415|FG000|Overall Study|Insufficient bacteriological response|10|||
148860518|NCT00496197|536967415|FG000|Overall Study|Lost to Follow-up|11|||
148860519|NCT00496197|536967415|FG000|Overall Study|Withdrawal by Subject|11|||
148860520|NCT00496197|536967415|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
148860521|NCT00496197|536967415|FG000|Overall Study|Other|14|||
148860522|NCT00496197|536967415|FG000|Overall Study|Protocol Violation|8|||
148860523|NCT04431713|536967416|FG000|Overall Study|Withdrawal by Subject|2|||
148860524|NCT04431713|536967417|FG001|Overall Study|Withdrawal by Subject|0|||
148860525|NCT04431713|536967416|FG000|Overall Study|Death|2|||
148860526|NCT04431713|536967417|FG001|Overall Study|Death|2|||
148860527|NCT01655381|536967418|FG000|Overall Study|Investigator Decision|1|||
148860528|NCT01655381|536967418|FG000|Overall Study|Moved to Another City|1|||
148860529|NCT01655381|536967418|FG000|Overall Study|Insufficient Treatment Response|1|||
148860530|NCT04049266|536967421|FG000|Overall Study|Adverse Event|16|||
148860531|NCT04049266|536967422|FG001|Overall Study|Adverse Event|9|||
148860532|NCT04049266|536967421|FG000|Overall Study|Non-compliance with study drug|0|||
148860533|NCT04049266|536967422|FG001|Overall Study|Non-compliance with study drug|3|||
148860534|NCT04049266|536967421|FG000|Overall Study|Withdrawal by Subject|6|||
148860535|NCT04049266|536967422|FG001|Overall Study|Withdrawal by Subject|10|||
148860536|NCT04049266|536967421|FG000|Overall Study|Lost to Follow-up|2|||
148860537|NCT04049266|536967422|FG001|Overall Study|Lost to Follow-up|2|||
148860538|NCT04049266|536967421|FG000|Overall Study|Progressive disease|11|||
148860539|NCT04049266|536967422|FG001|Overall Study|Progressive disease|2|||
148860540|NCT04049266|536967421|FG000|Overall Study|Physician Decision|1|||
148860541|NCT04049266|536967422|FG001|Overall Study|Physician Decision|0|||
148860542|NCT04049266|536967421|FG000|Overall Study|Patient moved out of state|1|||
148860543|NCT04049266|536967422|FG001|Overall Study|Patient moved out of state|0|||
148860544|NCT02174523|536967423|FG000|Overall Study|Withdrawal by Subject|1|||
148860545|NCT02174523|536967424|FG001|Overall Study|Withdrawal by Subject|0|||
148860546|NCT00856206|536967425|FG000|Overall Study|Protocol Violation|6|||
148860547|NCT00856206|536967426|FG001|Overall Study|Protocol Violation|18|||
148860548|NCT00856206|536967425|FG000|Overall Study|Adverse Event|10|||
148860549|NCT00856206|536967426|FG001|Overall Study|Adverse Event|46|||
148860550|NCT00856206|536967425|FG000|Overall Study|Lack of Efficacy|1|||
148860551|NCT00856206|536967426|FG001|Overall Study|Lack of Efficacy|2|||
148860552|NCT00856206|536967425|FG000|Overall Study|Withdrawal by Subject|15|||
148860553|NCT00856206|536967426|FG001|Overall Study|Withdrawal by Subject|36|||
148860554|NCT00856206|536967425|FG000|Overall Study|Lost to Follow-up|13|||
148860555|NCT00856206|536967426|FG001|Overall Study|Lost to Follow-up|39|||
148860556|NCT00856206|536967425|FG000|Overall Study|Death|2|||
148860557|NCT00856206|536967426|FG001|Overall Study|Death|2|||
148860558|NCT00856206|536967425|FG000|Overall Study|Decision by the Sponsor|4|||
148860559|NCT00856206|536967426|FG001|Overall Study|Decision by the Sponsor|8|||
148860560|NCT00856206|536967425|FG000|Overall Study|Other than specified above|3|||
148860561|NCT00856206|536967426|FG001|Overall Study|Other than specified above|10|||
148860562|NCT04584346|536967440|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
148860563|NCT04584346|536967441|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
148860564|NCT03640052|536967442|FG000|Overall Study|Lost to Follow-up|0|||
148860565|NCT03640052|536967443|FG001|Overall Study|Lost to Follow-up|1|||
148860566|NCT03640052|536967444|FG002|Overall Study|Lost to Follow-up|0|||
148860567|NCT03640052|536967445|FG003|Overall Study|Lost to Follow-up|0|||
148860568|NCT03640052|536967446|FG004|Overall Study|Lost to Follow-up|0|||
148860569|NCT05479097|536967447|FG000|Overall Study|Withdrawal by Subject|2|||
148860570|NCT03006458|536967448|FG000|First Intervention|Unsatisfied Vision|0|||
148860571|NCT03006458|536967449|FG001|First Intervention|Unsatisfied Vision|3|||
148860572|NCT01468233|536967450|FG000|Treatment Period 1|Adverse Event|5|||
148860573|NCT01468233|536967451|FG001|Treatment Period 1|Adverse Event|3|||
148860574|NCT01468233|536967452|FG002|Treatment Period 1|Adverse Event|0|||
148860575|NCT01468233|536967453|FG003|Treatment Period 1|Adverse Event|0|||
148860576|NCT01468233|536967454|FG004|Treatment Period 1|Adverse Event|0|||
148860577|NCT01468233|536967455|FG005|Treatment Period 1|Adverse Event|0|||
148860578|NCT01468233|536967450|FG000|Treatment Period 1|Withdrawal by Subject|3|||
148860579|NCT01468233|536967451|FG001|Treatment Period 1|Withdrawal by Subject|4|||
148860580|NCT01468233|536967452|FG002|Treatment Period 1|Withdrawal by Subject|0|||
148860581|NCT01468233|536967453|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148860582|NCT01468233|536967454|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148860583|NCT01468233|536967455|FG005|Treatment Period 1|Withdrawal by Subject|0|||
148860584|NCT01468233|536967450|FG000|Treatment Period 1|Lost to Follow-up|3|||
148860585|NCT01468233|536967451|FG001|Treatment Period 1|Lost to Follow-up|0|||
148860586|NCT01468233|536967452|FG002|Treatment Period 1|Lost to Follow-up|0|||
148860587|NCT01468233|536967453|FG003|Treatment Period 1|Lost to Follow-up|0|||
148860588|NCT01468233|536967454|FG004|Treatment Period 1|Lost to Follow-up|0|||
148860589|NCT01468233|536967455|FG005|Treatment Period 1|Lost to Follow-up|0|||
148860590|NCT01468233|536967450|FG000|Treatment Period 1|Other|1|||
148860591|NCT01468233|536967451|FG001|Treatment Period 1|Other|1|||
148860592|NCT01468233|536967452|FG002|Treatment Period 1|Other|0|||
148860593|NCT01468233|536967453|FG003|Treatment Period 1|Other|0|||
148860594|NCT01468233|536967454|FG004|Treatment Period 1|Other|0|||
148860595|NCT01468233|536967455|FG005|Treatment Period 1|Other|0|||
148860596|NCT01468233|536967450|FG000|Treatment Period 2|Adverse Event|0|||
148860597|NCT01468233|536967451|FG001|Treatment Period 2|Adverse Event|0|||
148860598|NCT01468233|536967452|FG002|Treatment Period 2|Adverse Event|3|||
148860599|NCT01468233|536967453|FG003|Treatment Period 2|Adverse Event|0|||
148860600|NCT01468233|536967454|FG004|Treatment Period 2|Adverse Event|2|||
148860601|NCT01468233|536967455|FG005|Treatment Period 2|Adverse Event|1|||
148860602|NCT01468233|536967450|FG000|Treatment Period 2|Lack of Efficacy|0|||
148860603|NCT01468233|536967451|FG001|Treatment Period 2|Lack of Efficacy|0|||
148860604|NCT01468233|536967452|FG002|Treatment Period 2|Lack of Efficacy|9|||
148860605|NCT01468233|536967453|FG003|Treatment Period 2|Lack of Efficacy|2|||
148860606|NCT01468233|536967454|FG004|Treatment Period 2|Lack of Efficacy|0|||
148860607|NCT01468233|536967455|FG005|Treatment Period 2|Lack of Efficacy|1|||
148860608|NCT01468233|536967450|FG000|Treatment Period 2|Withdrawal by Subject|0|||
148860609|NCT01468233|536967451|FG001|Treatment Period 2|Withdrawal by Subject|0|||
148860610|NCT01468233|536967452|FG002|Treatment Period 2|Withdrawal by Subject|9|||
148860611|NCT01468233|536967453|FG003|Treatment Period 2|Withdrawal by Subject|1|||
148860612|NCT01468233|536967454|FG004|Treatment Period 2|Withdrawal by Subject|1|||
148860613|NCT01468233|536967455|FG005|Treatment Period 2|Withdrawal by Subject|1|||
148860614|NCT01468233|536967450|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
148860615|NCT01468233|536967451|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
148860616|NCT01468233|536967452|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
148860617|NCT01468233|536967453|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
148860618|NCT01468233|536967454|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
148860619|NCT01468233|536967455|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
148860620|NCT01468233|536967450|FG000|Treatment Period 2|Lost to Follow-up|0|||
148860621|NCT01468233|536967451|FG001|Treatment Period 2|Lost to Follow-up|0|||
148860622|NCT01468233|536967452|FG002|Treatment Period 2|Lost to Follow-up|3|||
148860623|NCT01468233|536967453|FG003|Treatment Period 2|Lost to Follow-up|0|||
148860624|NCT01468233|536967454|FG004|Treatment Period 2|Lost to Follow-up|2|||
148860625|NCT01468233|536967455|FG005|Treatment Period 2|Lost to Follow-up|0|||
148860626|NCT01468233|536967450|FG000|Treatment Period 2|Other|0|||
148860627|NCT01468233|536967451|FG001|Treatment Period 2|Other|0|||
148860628|NCT01468233|536967452|FG002|Treatment Period 2|Other|3|||
148860629|NCT01468233|536967453|FG003|Treatment Period 2|Other|0|||
148860630|NCT01468233|536967454|FG004|Treatment Period 2|Other|1|||
148860631|NCT01468233|536967455|FG005|Treatment Period 2|Other|0|||
148860632|NCT00457821|536967459|FG000|Part 2|Withdrawal by Subject|0|||
148860633|NCT00457821|536967460|FG001|Part 2|Withdrawal by Subject|0|||
148860634|NCT00457821|536967461|FG002|Part 2|Withdrawal by Subject|0|||
148860635|NCT00457821|536967462|FG003|Part 2|Withdrawal by Subject|0|||
148860636|NCT00457821|536967463|FG004|Part 2|Withdrawal by Subject|0|||
148860637|NCT00457821|536967464|FG005|Part 2|Withdrawal by Subject|0|||
149030733|NCT01729871|537589701|FG001|Overall Study|Other|9|||
148860638|NCT00457821|536967465|FG006|Part 2|Withdrawal by Subject|0|||
148860639|NCT00457821|536967466|FG007|Part 2|Withdrawal by Subject|1|||
148860640|NCT02437409|536967469|FG000|Overall Study|Withdrawal by Subject|3|||
148860641|NCT02437409|536967469|FG000|Overall Study|Screening failure|12|||
148860642|NCT03549871|536967480|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
148860643|NCT03549871|536967481|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
148860644|NCT03549871|536967480|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
148860645|NCT03549871|536967481|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
148860646|NCT03549871|536967480|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
148860647|NCT03549871|536967481|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
148860648|NCT03549871|536967480|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
148860649|NCT03549871|536967481|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
148860650|NCT03549871|536967480|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
148860651|NCT03549871|536967481|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
148860652|NCT03549871|536967480|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
148860653|NCT03549871|536967481|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
148860654|NCT03549871|536967480|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
148860655|NCT03549871|536967481|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
148860656|NCT03549871|536967480|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
148860657|NCT03549871|536967481|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
148860658|NCT03549871|536967480|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
148860659|NCT03549871|536967481|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
148860660|NCT03549871|536967480|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
148860661|NCT03549871|536967481|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
148860662|NCT03549871|536967480|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
148860663|NCT03549871|536967481|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
148860664|NCT00737568|536967482|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
148860665|NCT00737568|536967483|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
148860666|NCT00737568|536967482|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
148860667|NCT00737568|536967483|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
148860668|NCT00737568|536967482|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
148860669|NCT00737568|536967483|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
148860670|NCT00737568|536967482|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
148860671|NCT00737568|536967483|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
148860672|NCT00737568|536967482|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
148860673|NCT00737568|536967483|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
148860674|NCT00737568|536967482|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
148860675|NCT00737568|536967483|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
148860676|NCT00737568|536967482|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
148860677|NCT00737568|536967483|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
148860678|NCT00737568|536967482|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
148860679|NCT00737568|536967483|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
148860680|NCT00737568|536967482|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
148860681|NCT00737568|536967483|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
148860682|NCT01133626|536967484|FG000|Overall Study|Adverse Event|0|||
148860683|NCT01133626|536967485|FG001|Overall Study|Adverse Event|1|||
148860684|NCT01133626|536967486|FG002|Overall Study|Adverse Event|0|||
148860685|NCT01133626|536967484|FG000|Overall Study|Withdrawal by Subject|1|||
148860686|NCT01133626|536967485|FG001|Overall Study|Withdrawal by Subject|2|||
148860687|NCT01133626|536967486|FG002|Overall Study|Withdrawal by Subject|2|||
148860688|NCT01133626|536967484|FG000|Overall Study|Other|0|||
148860689|NCT01133626|536967485|FG001|Overall Study|Other|2|||
148860690|NCT01133626|536967486|FG002|Overall Study|Other|0|||
148860691|NCT00855933|536967487|FG000|Overall Study|Withdrawal by Subject|0|||
148860692|NCT00855933|536967488|FG001|Overall Study|Withdrawal by Subject|1|||
148860693|NCT00951080|536967489|FG000|Overall Study|Adverse Event|3|||
148860694|NCT00951080|536967490|FG001|Overall Study|Adverse Event|3|||
148860695|NCT00951080|536967489|FG000|Overall Study|Lost to Follow-up|0|||
148860696|NCT00951080|536967490|FG001|Overall Study|Lost to Follow-up|1|||
148860697|NCT00951080|536967489|FG000|Overall Study|Physician Decision|4|||
148860698|NCT00951080|536967490|FG001|Overall Study|Physician Decision|1|||
148860699|NCT00951080|536967489|FG000|Overall Study|Other|19|||
148860700|NCT00951080|536967490|FG001|Overall Study|Other|22|||
148860701|NCT01960998|536967491|FG000|Overall Study|Lost to Follow-up|3|||
148860702|NCT01960998|536967492|FG001|Overall Study|Lost to Follow-up|7|||
148860703|NCT01960998|536967491|FG000|Overall Study|Death|0|||
148860704|NCT01960998|536967492|FG001|Overall Study|Death|1|||
148860705|NCT01960998|536967491|FG000|Overall Study|Withdrawal by Subject|8|||
148860706|NCT01960998|536967492|FG001|Overall Study|Withdrawal by Subject|2|||
148860707|NCT01960998|536967491|FG000|Overall Study|lost computer access|0|||
148860708|NCT01960998|536967492|FG001|Overall Study|lost computer access|1|||
148860709|NCT00835640|536967496|FG000|Second Intervention|Protocol Violation|1|||
148860710|NCT00835640|536967497|FG001|Second Intervention|Protocol Violation|0|||
148860711|NCT00812006|536967498|FG000|Overall Study|Lost to Follow-up|0|||
148860712|NCT00812006|536967499|FG001|Overall Study|Lost to Follow-up|0|||
148860713|NCT00812006|536967500|FG002|Overall Study|Lost to Follow-up|2|||
148860714|NCT00812006|536967498|FG000|Overall Study|Physician Decision|0|||
148860715|NCT00812006|536967499|FG001|Overall Study|Physician Decision|0|||
148860716|NCT00812006|536967500|FG002|Overall Study|Physician Decision|1|||
148860717|NCT00812006|536967498|FG000|Overall Study|Withdrawal by Subject|2|||
148860718|NCT00812006|536967499|FG001|Overall Study|Withdrawal by Subject|1|||
148860719|NCT00812006|536967500|FG002|Overall Study|Withdrawal by Subject|1|||
148860720|NCT00812006|536967498|FG000|Overall Study|Lack of Qualifying Event|4|||
148860721|NCT00812006|536967499|FG001|Overall Study|Lack of Qualifying Event|2|||
148860722|NCT00812006|536967500|FG002|Overall Study|Lack of Qualifying Event|2|||
148860723|NCT00235391|536967502|FG000|Overall Study|Adverse Event|4|||
148860724|NCT00235391|536967503|FG001|Overall Study|Adverse Event|5|||
148860725|NCT00235391|536967504|FG002|Overall Study|Adverse Event|10|||
148860726|NCT00235391|536967505|FG003|Overall Study|Adverse Event|72|||
148860727|NCT00235391|536967506|FG004|Overall Study|Adverse Event|5|||
148860728|NCT00235391|536967507|FG005|Overall Study|Adverse Event|2|||
148860729|NCT00235391|536967502|FG000|Overall Study|Abnormal laboratory value(s)|3|||
148860730|NCT00235391|536967503|FG001|Overall Study|Abnormal laboratory value(s)|5|||
148860731|NCT00235391|536967504|FG002|Overall Study|Abnormal laboratory value(s)|4|||
148860732|NCT00235391|536967505|FG003|Overall Study|Abnormal laboratory value(s)|27|||
148860733|NCT00235391|536967506|FG004|Overall Study|Abnormal laboratory value(s)|1|||
148860734|NCT00235391|536967507|FG005|Overall Study|Abnormal laboratory value(s)|2|||
148860735|NCT00235391|536967502|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
148860736|NCT00235391|536967503|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
148860737|NCT00235391|536967504|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
148860738|NCT00235391|536967505|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
148860739|NCT00235391|536967506|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
148860740|NCT00235391|536967507|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
148860741|NCT00235391|536967502|FG000|Overall Study|Condition no longer requires treatment|3|||
148860742|NCT00235391|536967503|FG001|Overall Study|Condition no longer requires treatment|0|||
148860743|NCT00235391|536967504|FG002|Overall Study|Condition no longer requires treatment|0|||
148860744|NCT00235391|536967505|FG003|Overall Study|Condition no longer requires treatment|11|||
148860745|NCT00235391|536967506|FG004|Overall Study|Condition no longer requires treatment|1|||
148860746|NCT00235391|536967507|FG005|Overall Study|Condition no longer requires treatment|0|||
148860747|NCT00235391|536967502|FG000|Overall Study|Protocol deviation|0|||
148860748|NCT00235391|536967503|FG001|Overall Study|Protocol deviation|0|||
148860749|NCT00235391|536967504|FG002|Overall Study|Protocol deviation|1|||
148860750|NCT00235391|536967505|FG003|Overall Study|Protocol deviation|11|||
148860751|NCT00235391|536967506|FG004|Overall Study|Protocol deviation|0|||
148860752|NCT00235391|536967507|FG005|Overall Study|Protocol deviation|0|||
148860753|NCT00235391|536967502|FG000|Overall Study|Withdrawal by Subject|2|||
148860754|NCT00235391|536967503|FG001|Overall Study|Withdrawal by Subject|3|||
148860755|NCT00235391|536967504|FG002|Overall Study|Withdrawal by Subject|3|||
148860756|NCT00235391|536967505|FG003|Overall Study|Withdrawal by Subject|61|||
148860757|NCT00235391|536967506|FG004|Overall Study|Withdrawal by Subject|5|||
148860758|NCT00235391|536967507|FG005|Overall Study|Withdrawal by Subject|0|||
148860759|NCT00235391|536967502|FG000|Overall Study|Lost to Follow-up|0|||
148860760|NCT00235391|536967503|FG001|Overall Study|Lost to Follow-up|3|||
148860761|NCT00235391|536967504|FG002|Overall Study|Lost to Follow-up|3|||
148860762|NCT00235391|536967505|FG003|Overall Study|Lost to Follow-up|16|||
148860763|NCT00235391|536967506|FG004|Overall Study|Lost to Follow-up|0|||
148860764|NCT00235391|536967507|FG005|Overall Study|Lost to Follow-up|0|||
148860765|NCT00235391|536967502|FG000|Overall Study|Administrative problems|0|||
148860766|NCT00235391|536967503|FG001|Overall Study|Administrative problems|0|||
148860767|NCT00235391|536967504|FG002|Overall Study|Administrative problems|0|||
148860768|NCT00235391|536967505|FG003|Overall Study|Administrative problems|1|||
148860769|NCT00235391|536967506|FG004|Overall Study|Administrative problems|0|||
148860770|NCT00235391|536967507|FG005|Overall Study|Administrative problems|0|||
148860771|NCT00235391|536967502|FG000|Overall Study|Death|0|||
148860772|NCT00235391|536967503|FG001|Overall Study|Death|0|||
148860773|NCT00235391|536967504|FG002|Overall Study|Death|1|||
148860774|NCT00235391|536967505|FG003|Overall Study|Death|4|||
148860775|NCT00235391|536967506|FG004|Overall Study|Death|0|||
148860776|NCT00235391|536967507|FG005|Overall Study|Death|0|||
148993175|NCT02479412|537451250|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
148993176|NCT02479412|537451251|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
148993177|NCT02479412|537451252|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
148860777|NCT03761394|536967508|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
148860778|NCT03761394|536967509|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
148860779|NCT03761394|536967510|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
148860780|NCT03761394|536967511|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
148860781|NCT03761394|536967508|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
148860782|NCT03761394|536967509|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
148860783|NCT03761394|536967510|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
148860784|NCT03761394|536967511|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
149030734|NCT03971357|537589702|FG000|Overall Study|Lack of Efficacy|0|||
149030735|NCT03971357|537589703|FG001|Overall Study|Lack of Efficacy|1|||
149030736|NCT01143077|537589704|FG000|Overall Study|Lack of Efficacy|0|||
149030737|NCT01143077|537589705|FG001|Overall Study|Lack of Efficacy|2|||
149030738|NCT01143077|537589706|FG002|Overall Study|Lack of Efficacy|1|||
149030739|NCT01143077|537589704|FG000|Overall Study|Adverse Event|5|||
149030740|NCT01143077|537589705|FG001|Overall Study|Adverse Event|6|||
149030741|NCT01143077|537589706|FG002|Overall Study|Adverse Event|5|||
149030742|NCT01143077|537589704|FG000|Overall Study|Lost to Follow-up|2|||
149030743|NCT01143077|537589705|FG001|Overall Study|Lost to Follow-up|3|||
149030744|NCT01143077|537589706|FG002|Overall Study|Lost to Follow-up|4|||
149030745|NCT01143077|537589704|FG000|Overall Study|Protocol Violation|2|||
148860785|NCT03761394|536967508|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
148860786|NCT03761394|536967509|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
148860787|NCT03761394|536967510|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
148860788|NCT03761394|536967511|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
148860789|NCT03761394|536967508|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
148860790|NCT03761394|536967509|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
148860791|NCT03761394|536967510|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
148860792|NCT03761394|536967511|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
148860793|NCT02927925|536967516|FG000|Overall Study|Death|16|||
148860794|NCT02927925|536967516|FG000|Overall Study|Physician Decision|1|||
148860795|NCT02927925|536967516|FG000|Overall Study|Withdrawal by Subject|11|||
148860796|NCT02927925|536967516|FG000|Overall Study|Other|3|||
148860797|NCT02927925|536967516|FG000|Overall Study|Disease progression at clinical cutoff|1|||
148860798|NCT01080768|536967517|FG000|Overall Study|Protocol Deviation|2|||
148860799|NCT01080768|536967518|FG001|Overall Study|Protocol Deviation|1|||
148860800|NCT00580034|536967519|FG000|Overall Study|Toxicity|10|||
148860801|NCT00580034|536967520|FG001|Overall Study|Toxicity|0|||
148860802|NCT00772369|536967522|FG000|Overall Study|Did not return record release form|1|||
148860803|NCT00916058|536967523|FG000|Phase 1|Screen Failure|0|||
148860804|NCT00916058|536967524|FG001|Phase 1|Screen Failure|0|||
148860805|NCT00916058|536967525|FG002|Phase 1|Screen Failure|0|||
148860806|NCT00916058|536967526|FG003|Phase 1|Screen Failure|0|||
148860807|NCT00916058|536967527|FG004|Phase 1|Screen Failure|0|||
148860808|NCT00916058|536967528|FG005|Phase 1|Screen Failure|1|||
148860809|NCT00916058|536967529|FG006|Phase 1|Screen Failure|0|||
148993178|NCT02479412|537451253|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
148993179|NCT02479412|537451254|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
148993180|NCT02479412|537451255|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
148993181|NCT02479412|537451256|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
148993182|NCT02732938|537451258|FG000|Overall Study|Death|0|||
148993183|NCT02732938|537451259|FG001|Overall Study|Death|11|||
148993184|NCT02732938|537451260|FG002|Overall Study|Death|0|||
148993185|NCT02732938|537451258|FG000|Overall Study|Randomized but did not receive treatment|0|||
148993186|NCT02732938|537451259|FG001|Overall Study|Randomized but did not receive treatment|1|||
148993187|NCT02732938|537451260|FG002|Overall Study|Randomized but did not receive treatment|0|||
148993188|NCT02732938|537451258|FG000|Overall Study|Refused further follow-up|1|||
148993189|NCT02732938|537451259|FG001|Overall Study|Refused further follow-up|0|||
148993190|NCT02732938|537451260|FG002|Overall Study|Refused further follow-up|0|||
148993191|NCT02732938|537451258|FG000|Overall Study|Study terminated by sponsor|3|||
148993192|NCT02732938|537451259|FG001|Overall Study|Study terminated by sponsor|6|||
148993193|NCT02732938|537451260|FG002|Overall Study|Study terminated by sponsor|0|||
148993194|NCT01613248|537451261|FG000|Overall Study|Adverse Event|0|||
148993195|NCT01613248|537451262|FG001|Overall Study|Adverse Event|0|||
148993196|NCT01613248|537451263|FG002|Overall Study|Adverse Event|0|||
148993197|NCT01613248|537451264|FG003|Overall Study|Adverse Event|1|||
148993198|NCT01613248|537451265|FG004|Overall Study|Adverse Event|0|||
148993199|NCT01613248|537451266|FG005|Overall Study|Adverse Event|0|||
148993200|NCT01613248|537451261|FG000|Overall Study|Withdrawal by Subject|3|||
148993201|NCT01613248|537451262|FG001|Overall Study|Withdrawal by Subject|2|||
148993202|NCT01613248|537451263|FG002|Overall Study|Withdrawal by Subject|2|||
148993203|NCT01613248|537451264|FG003|Overall Study|Withdrawal by Subject|5|||
148993204|NCT01613248|537451265|FG004|Overall Study|Withdrawal by Subject|0|||
148860810|NCT00916058|536967523|FG000|Phase 2|Screen Failure|0|||
148860811|NCT00916058|536967524|FG001|Phase 2|Screen Failure|0|||
148860812|NCT00916058|536967525|FG002|Phase 2|Screen Failure|0|||
148860813|NCT00916058|536967526|FG003|Phase 2|Screen Failure|0|||
148993205|NCT01613248|537451266|FG005|Overall Study|Withdrawal by Subject|1|||
148993206|NCT01613248|537451261|FG000|Overall Study|Lost to Follow-up|5|||
148993207|NCT01613248|537451262|FG001|Overall Study|Lost to Follow-up|7|||
148993208|NCT01613248|537451263|FG002|Overall Study|Lost to Follow-up|4|||
149030746|NCT01143077|537589705|FG001|Overall Study|Protocol Violation|0|||
149030747|NCT01143077|537589706|FG002|Overall Study|Protocol Violation|0|||
148993209|NCT01613248|537451264|FG003|Overall Study|Lost to Follow-up|8|||
148993210|NCT01613248|537451265|FG004|Overall Study|Lost to Follow-up|4|||
149030748|NCT01143077|537589704|FG000|Overall Study|Withdrawal by Subject|4|||
148860814|NCT00916058|536967527|FG004|Phase 2|Screen Failure|0|||
148860815|NCT00916058|536967528|FG005|Phase 2|Screen Failure|0|||
148860816|NCT00916058|536967529|FG006|Phase 2|Screen Failure|3|||
148860817|NCT03385265|536967531|FG000|Overall Study|Withdrawal by Subject|5|||
148860818|NCT03385265|536967532|FG001|Overall Study|Withdrawal by Subject|2|||
148860819|NCT03385265|536967533|FG002|Overall Study|Withdrawal by Subject|5|||
148860820|NCT03385265|536967534|FG003|Overall Study|Withdrawal by Subject|2|||
148860821|NCT02439450|536967536|FG000|Overall Study|Adverse Event|4|||
148860822|NCT02439450|536967537|FG001|Overall Study|Adverse Event|1|||
148860823|NCT02439450|536967538|FG002|Overall Study|Adverse Event|0|||
148860824|NCT02439450|536967539|FG003|Overall Study|Adverse Event|0|||
148860825|NCT02439450|536967536|FG000|Overall Study|Withdrawal by Subject|1|||
148860826|NCT02439450|536967537|FG001|Overall Study|Withdrawal by Subject|2|||
148860827|NCT02439450|536967538|FG002|Overall Study|Withdrawal by Subject|0|||
148860828|NCT02439450|536967539|FG003|Overall Study|Withdrawal by Subject|0|||
148860829|NCT02439450|536967536|FG000|Overall Study|Death|3|||
148860830|NCT02439450|536967537|FG001|Overall Study|Death|0|||
148860831|NCT02439450|536967538|FG002|Overall Study|Death|0|||
148860832|NCT02439450|536967539|FG003|Overall Study|Death|1|||
148860833|NCT02439450|536967536|FG000|Overall Study|Progressive Disease|18|||
148860834|NCT02439450|536967537|FG001|Overall Study|Progressive Disease|41|||
148860835|NCT02439450|536967538|FG002|Overall Study|Progressive Disease|2|||
148860836|NCT02439450|536967539|FG003|Overall Study|Progressive Disease|3|||
148860837|NCT01170065|536967556|FG000|Overall Study|Adverse Event|17|||
148860838|NCT01170065|536967557|FG001|Overall Study|Adverse Event|50|||
148860839|NCT01170065|536967558|FG002|Overall Study|Adverse Event|10|||
148860840|NCT01170065|536967556|FG000|Overall Study|Lost to Follow-up|1|||
148860841|NCT01170065|536967557|FG001|Overall Study|Lost to Follow-up|4|||
148860842|NCT01170065|536967558|FG002|Overall Study|Lost to Follow-up|1|||
148860843|NCT01170065|536967556|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
148860844|NCT01170065|536967557|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
148860845|NCT01170065|536967558|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
148860846|NCT01170065|536967556|FG000|Overall Study|Reason other than specified|3|||
148860847|NCT01170065|536967557|FG001|Overall Study|Reason other than specified|8|||
148860848|NCT01170065|536967558|FG002|Overall Study|Reason other than specified|3|||
148860849|NCT01170065|536967556|FG000|Overall Study|Ongoing after planned observation time|5|||
148860850|NCT01170065|536967557|FG001|Overall Study|Ongoing after planned observation time|26|||
148860851|NCT01170065|536967558|FG002|Overall Study|Ongoing after planned observation time|10|||
148860852|NCT01071200|536967563|FG000|Overall Study|Lack of ovarian response|1|||
148860853|NCT01071200|536967564|FG001|Overall Study|Lack of ovarian response|1|||
148860854|NCT01071200|536967563|FG000|Overall Study|No fertilization|4|||
148860855|NCT01071200|536967564|FG001|Overall Study|No fertilization|0|||
148860856|NCT01071200|536967563|FG000|Overall Study|No oocytes retrieved|1|||
148860857|NCT01071200|536967564|FG001|Overall Study|No oocytes retrieved|1|||
148860858|NCT01071200|536967563|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
148860859|NCT01071200|536967564|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
148860860|NCT01071200|536967563|FG000|Overall Study|No viable embryos|0|||
148860861|NCT01071200|536967564|FG001|Overall Study|No viable embryos|1|||
148860862|NCT02434354|536967565|FG000|Overall Study|screen fail|3|||
148860863|NCT03730961|536967566|FG000|Overall Study|Adverse Event|0|||
148860864|NCT03730961|536967567|FG001|Overall Study|Adverse Event|1|||
148860865|NCT00853125|536967570|FG000|Overall Study|Study participant's donor was CMV +|1|||
148860866|NCT01646645|536967572|FG000|Overall Study|No Treated|1|||
148860867|NCT01646645|536967572|FG000|Overall Study|Inevaluable Donor|29|||
148860868|NCT00884039|536967573|FG000|Overall Study|Withdrawal by Subject|0|||
148860869|NCT00884039|536967574|FG001|Overall Study|Withdrawal by Subject|1|||
148860870|NCT00884039|536967573|FG000|Overall Study|Lack of Efficacy|2|||
148860871|NCT00884039|536967574|FG001|Overall Study|Lack of Efficacy|0|||
148860872|NCT04209114|536967575|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
148860873|NCT04209114|536967576|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
148860874|NCT04209114|536967577|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
148860875|NCT04209114|536967575|FG000|Pre-Treatment Phase|Other reasons|0|||
148860876|NCT04209114|536967576|FG001|Pre-Treatment Phase|Other reasons|0|||
148860877|NCT04209114|536967577|FG002|Pre-Treatment Phase|Other reasons|1|||
148860878|NCT04209114|536967575|FG000|Pre-Treatment Phase|Death|0|||
148860879|NCT04209114|536967576|FG001|Pre-Treatment Phase|Death|0|||
148860880|NCT04209114|536967577|FG002|Pre-Treatment Phase|Death|1|||
148860881|NCT04209114|536967575|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
148860882|NCT04209114|536967576|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
148860883|NCT04209114|536967577|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
148860884|NCT04209114|536967575|FG000|Treatment Phase|Other reasons|5|||
148860885|NCT04209114|536967576|FG001|Treatment Phase|Other reasons|3|||
148860886|NCT04209114|536967577|FG002|Treatment Phase|Other reasons|0|||
148860887|NCT04209114|536967575|FG000|Treatment Phase|Lost to Follow-up|1|||
148860888|NCT04209114|536967576|FG001|Treatment Phase|Lost to Follow-up|0|||
148860889|NCT04209114|536967577|FG002|Treatment Phase|Lost to Follow-up|0|||
148860890|NCT04209114|536967575|FG000|Treatment Phase|Participant withdrew consent|1|||
148860891|NCT04209114|536967576|FG001|Treatment Phase|Participant withdrew consent|0|||
148993211|NCT01613248|537451266|FG005|Overall Study|Lost to Follow-up|2|||
148860892|NCT04209114|536967577|FG002|Treatment Phase|Participant withdrew consent|0|||
148860893|NCT04209114|536967575|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
148860894|NCT04209114|536967576|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
148860895|NCT04209114|536967577|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
148860896|NCT04209114|536967575|FG000|Treatment Phase|Death|4|||
148860897|NCT04209114|536967576|FG001|Treatment Phase|Death|1|||
148860898|NCT04209114|536967577|FG002|Treatment Phase|Death|0|||
148860899|NCT04209114|536967575|FG000|Treatment Phase|Study drug toxicity|4|||
148860900|NCT04209114|536967576|FG001|Treatment Phase|Study drug toxicity|6|||
148860901|NCT04209114|536967577|FG002|Treatment Phase|Study drug toxicity|0|||
148860902|NCT04209114|536967575|FG000|Treatment Phase|Disease progression|6|||
148860903|NCT04209114|536967576|FG001|Treatment Phase|Disease progression|9|||
148860904|NCT04209114|536967577|FG002|Treatment Phase|Disease progression|0|||
148860905|NCT00405964|536967581|FG000|Overall Study|Treatment Failure|17|||
148860906|NCT00405964|536967582|FG001|Overall Study|Treatment Failure|45|||
148860907|NCT00405964|536967581|FG000|Overall Study|Adverse Event|7|||
148860908|NCT00405964|536967582|FG001|Overall Study|Adverse Event|16|||
148860909|NCT00405964|536967581|FG000|Overall Study|Lost to Follow-up|5|||
148860910|NCT00405964|536967582|FG001|Overall Study|Lost to Follow-up|5|||
148860911|NCT00405964|536967581|FG000|Overall Study|Withdrawal by Subject|19|||
148860912|NCT00405964|536967582|FG001|Overall Study|Withdrawal by Subject|23|||
148860913|NCT00405964|536967581|FG000|Overall Study|Protocol Violation|11|||
148860914|NCT00405964|536967582|FG001|Overall Study|Protocol Violation|6|||
148860915|NCT01896271|536967584|FG000|Overall Study|Physician Decision|10|||
148860916|NCT01514240|536969310|FG000|Overall Study|Adverse Event|4|||
148860917|NCT01514240|536969311|FG001|Overall Study|Adverse Event|4|||
148860918|NCT01514240|536969310|FG000|Overall Study|Subject Decision|2|||
148860919|NCT01514240|536969311|FG001|Overall Study|Subject Decision|7|||
148860920|NCT00509093|536969312|FG000|Overall Study|Adverse Event|10|||
148860921|NCT00509093|536969312|FG000|Overall Study|Disease Progression|9|||
148860922|NCT00509093|536969312|FG000|Overall Study|Transformed into MDS|1|||
148860923|NCT00509093|536969312|FG000|Overall Study|Withdrawal by Subject|3|||
148860924|NCT00509093|536969312|FG000|Overall Study|Physician Decision|1|||
148860925|NCT01103063|536969313|FG000|Overall Study|Adverse Event|3|||
148860926|NCT01103063|536969314|FG001|Overall Study|Adverse Event|1|||
148860927|NCT01103063|536969313|FG000|Overall Study|Lost to Follow-up|68|||
148860928|NCT01103063|536969314|FG001|Overall Study|Lost to Follow-up|51|||
148860929|NCT01103063|536969313|FG000|Overall Study|Withdrawal by Subject|60|||
148860930|NCT01103063|536969314|FG001|Overall Study|Withdrawal by Subject|15|||
148860931|NCT01103063|536969313|FG000|Overall Study|Other|16|||
148860932|NCT01103063|536969314|FG001|Overall Study|Other|11|||
148860933|NCT01103063|536969313|FG000|Overall Study|Protocol Violation|1|||
148860934|NCT01103063|536969314|FG001|Overall Study|Protocol Violation|0|||
148860935|NCT01103063|536969313|FG000|Overall Study|Study terminated by Sponsor|326|||
148860936|NCT01103063|536969314|FG001|Overall Study|Study terminated by Sponsor|342|||
148860937|NCT01103063|536969313|FG000|Overall Study|Death|3|||
148860938|NCT01103063|536969314|FG001|Overall Study|Death|1|||
148860939|NCT05320393|536969315|FG000|Overall Study|Withdrawal by Subject|1|||
148860940|NCT05320393|536969316|FG001|Overall Study|Withdrawal by Subject|0|||
148860941|NCT05320393|536969317|FG002|Overall Study|Withdrawal by Subject|2|||
148860942|NCT05320393|536969315|FG000|Overall Study|Lost to Follow-up|1|||
148860943|NCT05320393|536969316|FG001|Overall Study|Lost to Follow-up|2|||
148860944|NCT05320393|536969317|FG002|Overall Study|Lost to Follow-up|1|||
148860945|NCT05320393|536969315|FG000|Overall Study|Moved; too much driving|0|||
148860946|NCT05320393|536969316|FG001|Overall Study|Moved; too much driving|0|||
148860947|NCT05320393|536969317|FG002|Overall Study|Moved; too much driving|2|||
148993212|NCT01613248|537451261|FG000|Overall Study|Study Terminated by Sponsor|4|||
148993213|NCT01613248|537451262|FG001|Overall Study|Study Terminated by Sponsor|6|||
148993214|NCT01613248|537451263|FG002|Overall Study|Study Terminated by Sponsor|8|||
148860948|NCT05320393|536969315|FG000|Overall Study|Did not receive treatment|0|||
148860949|NCT05320393|536969316|FG001|Overall Study|Did not receive treatment|0|||
148860950|NCT05320393|536969317|FG002|Overall Study|Did not receive treatment|1|||
148860951|NCT03283098|536969318|FG000|Overall Study|Withdrawal by Subject|0|||
148860952|NCT03283098|536969319|FG001|Overall Study|Withdrawal by Subject|1|||
148860953|NCT00798317|536969320|FG000|Overall Study|Physician Decision|0|||
148860954|NCT00798317|536969321|FG001|Overall Study|Physician Decision|1|||
148860955|NCT00798317|536969320|FG000|Overall Study|Withdrawal by Subject|5|||
148860956|NCT00798317|536969321|FG001|Overall Study|Withdrawal by Subject|4|||
148860957|NCT00798317|536969320|FG000|Overall Study|Lost to Follow-up|2|||
148860958|NCT00798317|536969321|FG001|Overall Study|Lost to Follow-up|2|||
148860959|NCT00798317|536969320|FG000|Overall Study|Adverse Event|2|||
148993215|NCT01613248|537451264|FG003|Overall Study|Study Terminated by Sponsor|8|||
148860960|NCT00798317|536969321|FG001|Overall Study|Adverse Event|0|||
148860961|NCT00798317|536969320|FG000|Overall Study|Death|1|||
148860962|NCT00798317|536969321|FG001|Overall Study|Death|0|||
148860963|NCT01069861|536969323|FG000|Overall Study|Death|1|||
148860964|NCT01069861|536969323|FG000|Overall Study|Adverse Event|1|||
148860965|NCT01069861|536969323|FG000|Overall Study|Did not meet entrance criteria|1|||
148860966|NCT00149994|536969324|FG000|Overall Study|Administrative problems:|1|||
148860967|NCT00149994|536969325|FG001|Overall Study|Administrative problems:|0|||
148860968|NCT00149994|536969324|FG000|Overall Study|Protocol Violation|0|||
148860969|NCT00149994|536969325|FG001|Overall Study|Protocol Violation|1|||
148860970|NCT03405935|536969327|FG000|Overall Study|Adverse Event|3|||
148860971|NCT03405935|536969327|FG000|Overall Study|Death|2|||
148860972|NCT03405935|536969327|FG000|Overall Study|Withdrawal by Subject|1|||
148860973|NCT03405935|536969327|FG000|Overall Study|Lost to Follow-up|2|||
148860974|NCT04979897|536969328|FG000|Overall Study|Death|1|||
148860975|NCT04979897|536969329|FG001|Overall Study|Death|8|||
148860976|NCT04979897|536969328|FG000|Overall Study|Lost to Follow-up|111|||
148860977|NCT04979897|536969329|FG001|Overall Study|Lost to Follow-up|56|||
148860978|NCT04979897|536969328|FG000|Overall Study|Withdrawal by Subject|7|||
148860979|NCT04979897|536969329|FG001|Overall Study|Withdrawal by Subject|2|||
148860980|NCT04195438|536969330|FG000|Overall Study|Withdrawal by Subject|1|||
148860981|NCT00613925|536969336|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
148860982|NCT00613925|536969337|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
148860983|NCT03136497|536969338|FG000|Overall Study|Screen Failure|1|||
148860984|NCT03136497|536969339|FG001|Overall Study|Screen Failure|0|||
148860985|NCT03136497|536969340|FG002|Overall Study|Screen Failure|0|||
148860986|NCT02781792|536969343|FG000|Overall Study|Adverse Event|1|||
148860987|NCT02781792|536969344|FG001|Overall Study|Adverse Event|2|||
148860988|NCT02781792|536969343|FG000|Overall Study|Withdrawal by Subject|3|||
148860989|NCT02781792|536969344|FG001|Overall Study|Withdrawal by Subject|1|||
148993216|NCT01613248|537451265|FG004|Overall Study|Study Terminated by Sponsor|9|||
148993217|NCT01613248|537451266|FG005|Overall Study|Study Terminated by Sponsor|11|||
148993218|NCT01613248|537451261|FG000|Overall Study|Physician Decision|8|||
148993219|NCT01613248|537451262|FG001|Overall Study|Physician Decision|8|||
148993220|NCT01613248|537451263|FG002|Overall Study|Physician Decision|9|||
148993221|NCT01613248|537451264|FG003|Overall Study|Physician Decision|4|||
148993222|NCT01613248|537451265|FG004|Overall Study|Physician Decision|7|||
148993223|NCT01613248|537451266|FG005|Overall Study|Physician Decision|6|||
148993224|NCT01613248|537451261|FG000|Overall Study|Lack of Qualifying Event|9|||
148993225|NCT01613248|537451262|FG001|Overall Study|Lack of Qualifying Event|11|||
148993226|NCT01613248|537451263|FG002|Overall Study|Lack of Qualifying Event|10|||
148993227|NCT01613248|537451264|FG003|Overall Study|Lack of Qualifying Event|11|||
148993228|NCT01613248|537451265|FG004|Overall Study|Lack of Qualifying Event|15|||
148993229|NCT01613248|537451266|FG005|Overall Study|Lack of Qualifying Event|18|||
148993230|NCT01613248|537451261|FG000|Overall Study|Pregnancy|0|||
148993231|NCT01613248|537451262|FG001|Overall Study|Pregnancy|0|||
148993232|NCT01613248|537451263|FG002|Overall Study|Pregnancy|0|||
148993233|NCT01613248|537451264|FG003|Overall Study|Pregnancy|1|||
148993234|NCT01613248|537451265|FG004|Overall Study|Pregnancy|0|||
148993235|NCT01613248|537451266|FG005|Overall Study|Pregnancy|0|||
148993236|NCT06116591|537451276|FG000|Overall Study|No longer met eligibility criteria|0|||
148993237|NCT06116591|537451277|FG001|Overall Study|No longer met eligibility criteria|1|||
148993238|NCT06116591|537451276|FG000|Overall Study|Other: Change in life situation|0|||
148993239|NCT06116591|537451277|FG001|Overall Study|Other: Change in life situation|1|||
148993240|NCT05585307|537451278|FG000|Overall Study|Lost to Follow-up|0|||
148993241|NCT05585307|537451279|FG001|Overall Study|Lost to Follow-up|0|||
148993242|NCT05585307|537451280|FG002|Overall Study|Lost to Follow-up|0|||
148993243|NCT05585307|537451281|FG003|Overall Study|Lost to Follow-up|0|||
148993244|NCT05585307|537451282|FG004|Overall Study|Lost to Follow-up|0|||
148993245|NCT05585307|537451283|FG005|Overall Study|Lost to Follow-up|0|||
148993246|NCT05585307|537451284|FG006|Overall Study|Lost to Follow-up|1|||
148993247|NCT05585307|537451285|FG007|Overall Study|Lost to Follow-up|0|||
148993248|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
148993249|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
148993250|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
148993251|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
148993252|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
148993253|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
148993254|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
148993255|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
148860990|NCT02781792|536969343|FG000|Overall Study|Lack of Efficacy|1|||
148860991|NCT02781792|536969344|FG001|Overall Study|Lack of Efficacy|1|||
148993256|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
148993257|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
148993258|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
148993259|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
148993260|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
148993261|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
148860992|NCT02781792|536969343|FG000|Overall Study|Hospice|0|||
148860993|NCT02781792|536969344|FG001|Overall Study|Hospice|1|||
148860994|NCT02891681|536969347|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
148860995|NCT02891681|536969348|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
149030749|NCT01143077|537589705|FG001|Overall Study|Withdrawal by Subject|3|||
149030750|NCT01143077|537589706|FG002|Overall Study|Withdrawal by Subject|3|||
149030751|NCT01143077|537589704|FG000|Overall Study|Non-compliance with study drug|0|||
149030752|NCT01143077|537589705|FG001|Overall Study|Non-compliance with study drug|1|||
148860996|NCT02891681|536969349|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
148860997|NCT02891681|536969347|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
148860998|NCT02891681|536969348|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
148860999|NCT02891681|536969349|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
148861000|NCT02891681|536969347|FG000|Overall Study|Taken off study after first imaging appointment|1|||
148861001|NCT02891681|536969348|FG001|Overall Study|Taken off study after first imaging appointment|0|||
148861002|NCT02891681|536969349|FG002|Overall Study|Taken off study after first imaging appointment|0|||
148861003|NCT00794365|536969350|FG000|Overall Study|Lost to Follow-up|38|||
148861004|NCT00794365|536969350|FG000|Overall Study|Other|17|||
148861005|NCT00794365|536969350|FG000|Overall Study|Poor Compliance|11|||
148861006|NCT00794365|536969350|FG000|Overall Study|Adverse Event|10|||
148861007|NCT00794365|536969350|FG000|Overall Study|Lack of Efficacy|3|||
148861008|NCT03538444|536969351|FG000|Overall Study|opioid withdrawal|1|||
148861009|NCT03538444|536969352|FG001|Overall Study|opioid withdrawal|0|||
148861010|NCT01779869|536969357|FG000|Overall Study|Physician Decision|2|||
148861011|NCT00957944|536969362|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
148861012|NCT00957944|536969363|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
148861013|NCT01482169|536969365|FG000|Overall Study|Physician Decision|2|||
148861014|NCT01369680|536969373|FG000|Overall Study|Lost to Follow-up|0|||
148861015|NCT01369680|536969374|FG001|Overall Study|Lost to Follow-up|0|||
148861016|NCT01369680|536969375|FG002|Overall Study|Lost to Follow-up|1|||
148861017|NCT01369680|536969376|FG003|Overall Study|Lost to Follow-up|2|||
148861018|NCT00759356|536969380|FG000|Overall Study|Adverse Event|0|||
148861019|NCT00759356|536969381|FG001|Overall Study|Adverse Event|1|||
148861020|NCT00759356|536969380|FG000|Overall Study|Withdrawal by Subject|0|||
148861021|NCT00759356|536969381|FG001|Overall Study|Withdrawal by Subject|2|||
148861022|NCT00759356|536969380|FG000|Overall Study|Subject was unable to return|1|||
148861023|NCT00759356|536969381|FG001|Overall Study|Subject was unable to return|0|||
148861024|NCT02851407|536969382|FG000|Overall Study|Withdrawal by parent/guardian|2|||
148861025|NCT02851407|536969383|FG001|Overall Study|Withdrawal by parent/guardian|7|||
148861026|NCT02851407|536969382|FG000|Overall Study|Protocol deviation|0|||
148861027|NCT02851407|536969383|FG001|Overall Study|Protocol deviation|1|||
148861028|NCT02851407|536969382|FG000|Overall Study|Transferred to another hospital to continue|1|||
148861029|NCT02851407|536969383|FG001|Overall Study|Transferred to another hospital to continue|0|||
148861030|NCT02851407|536969382|FG000|Overall Study|Other Death|30|||
148861031|NCT02851407|536969383|FG001|Overall Study|Other Death|20|||
148861032|NCT02851407|536969382|FG000|Overall Study|Adverse event, serious fatal|6|||
148861033|NCT02851407|536969383|FG001|Overall Study|Adverse event, serious fatal|8|||
148861034|NCT02851407|536969382|FG000|Overall Study|Consent withdrawn by participant|5|||
148861035|NCT02851407|536969383|FG001|Overall Study|Consent withdrawn by participant|3|||
148861036|NCT02851407|536969382|FG000|Overall Study|Screen failure|2|||
148861037|NCT02851407|536969383|FG001|Overall Study|Screen failure|1|||
148861038|NCT02851407|536969382|FG000|Overall Study|Disease relapse|9|||
148861039|NCT02851407|536969383|FG001|Overall Study|Disease relapse|6|||
148861040|NCT02851407|536969382|FG000|Overall Study|Physician Decision|7|||
148861041|NCT02851407|536969383|FG001|Overall Study|Physician Decision|6|||
149030753|NCT01143077|537589706|FG002|Overall Study|Non-compliance with study drug|1|||
148861042|NCT02851407|536969382|FG000|Overall Study|Transferred to hospital closer to home|0|||
148861043|NCT02851407|536969383|FG001|Overall Study|Transferred to hospital closer to home|1|||
148861044|NCT02851407|536969382|FG000|Overall Study|Enrolled in an investigational study|0|||
148861045|NCT02851407|536969383|FG001|Overall Study|Enrolled in an investigational study|1|||
148861046|NCT02851407|536969382|FG000|Overall Study|Early recovery|1|||
148861047|NCT02851407|536969383|FG001|Overall Study|Early recovery|0|||
148861048|NCT02851407|536969382|FG000|Overall Study|Adverse event, non-fatal|7|||
148861049|NCT02851407|536969383|FG001|Overall Study|Adverse event, non-fatal|5|||
148861050|NCT02851407|536969382|FG000|Overall Study|Lost to Follow-up|0|||
148861051|NCT02851407|536969383|FG001|Overall Study|Lost to Follow-up|2|||
148861052|NCT01713283|536969384|FG000|Overall Study|Lack of Efficacy|10|||
148861053|NCT01713283|536969385|FG001|Overall Study|Lack of Efficacy|2|||
148861054|NCT01713283|536969384|FG000|Overall Study|Lost to Follow-up|1|||
148861055|NCT01713283|536969385|FG001|Overall Study|Lost to Follow-up|1|||
148861056|NCT02585830|536969386|FG000|Overall Study|Withdrawal by Subject|3|||
148861057|NCT03054350|536969394|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
148861058|NCT03054350|536969395|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
148861059|NCT03054350|536969396|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
148861060|NCT03054350|536969397|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
148861061|NCT03054350|536969398|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
149030754|NCT01143077|537589704|FG000|Overall Study|Administrative|1|||
148861062|NCT03054350|536969399|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
148861063|NCT03054350|536969394|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
148861064|NCT03054350|536969395|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
148861065|NCT03054350|536969396|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
148861066|NCT03054350|536969397|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
148861067|NCT03054350|536969398|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
148861068|NCT03054350|536969399|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
148861069|NCT03054350|536969394|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
148861070|NCT03054350|536969395|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
148861071|NCT03054350|536969396|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
148861072|NCT03054350|536969397|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
148861073|NCT03054350|536969398|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
148861074|NCT03054350|536969399|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
148861075|NCT03054350|536969394|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
148861076|NCT03054350|536969395|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
148861077|NCT03054350|536969396|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
148861078|NCT03054350|536969397|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
148861079|NCT03054350|536969398|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
148861080|NCT03054350|536969399|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
148861081|NCT03510468|536969401|FG000|Overall Study|Lost to Follow-up|1|||
148861082|NCT03510468|536969401|FG000|Overall Study|Adverse Event|5|||
148861083|NCT03510468|536969401|FG000|Overall Study|Physician Decision|1|||
148861084|NCT03510468|536969401|FG000|Overall Study|non-compliant with treatment|2|||
148861085|NCT03510468|536969401|FG000|Overall Study|Missed visit|1|||
148861086|NCT03372460|536969402|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
148861087|NCT03372460|536969403|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
148861088|NCT02499900|536969404|FG000|Core Study Period|Other|1|||
148861089|NCT02499900|536969405|FG001|Core Study Period|Other|4|||
148861090|NCT02499900|536969404|FG000|Core Study Period|Lost to Follow-up|1|||
148861091|NCT02499900|536969405|FG001|Core Study Period|Lost to Follow-up|2|||
148861092|NCT02499900|536969404|FG000|Core Study Period|Per sponsor request|0|||
148861093|NCT02499900|536969405|FG001|Core Study Period|Per sponsor request|1|||
148861094|NCT02499900|536969404|FG000|Core Study Period|Pregnancy|1|||
148861095|NCT02499900|536969405|FG001|Core Study Period|Pregnancy|0|||
148861096|NCT02499900|536969404|FG000|Core Study Period|Protocol Violation|3|||
148861097|NCT02499900|536969405|FG001|Core Study Period|Protocol Violation|0|||
148861098|NCT02499900|536969404|FG000|Core Study Period|Withdrawal by Subject|11|||
148861099|NCT02499900|536969405|FG001|Core Study Period|Withdrawal by Subject|10|||
148861100|NCT02499900|536969404|FG000|Core Study Period|Adverse Event|18|||
148861101|NCT02499900|536969405|FG001|Core Study Period|Adverse Event|14|||
148861102|NCT02499900|536969404|FG000|Core Study Period|Death|0|||
148861103|NCT02499900|536969405|FG001|Core Study Period|Death|1|||
148861104|NCT02499900|536969404|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
148861105|NCT02499900|536969405|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
148861106|NCT02499900|536969404|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
148861107|NCT02499900|536969405|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
148861108|NCT02499900|536969404|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
148861109|NCT02499900|536969405|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
148993262|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
148993263|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
148993264|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
148993265|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
148993266|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
148861110|NCT02499900|536969404|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
148861111|NCT02499900|536969405|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
148861112|NCT02499900|536969404|FG000|Extension Study Period|Adverse Event|2|||
148861113|NCT02499900|536969405|FG001|Extension Study Period|Adverse Event|4|||
148861114|NCT02499900|536969404|FG000|Extension Study Period|Withdrawal by Subject|5|||
148861115|NCT02499900|536969405|FG001|Extension Study Period|Withdrawal by Subject|2|||
148861116|NCT02499900|536969404|FG000|Extension Study Period|Physician Decision|2|||
148861117|NCT02499900|536969405|FG001|Extension Study Period|Physician Decision|5|||
148861118|NCT02499900|536969404|FG000|Extension Study Period|Pregnancy|1|||
148861119|NCT02499900|536969405|FG001|Extension Study Period|Pregnancy|2|||
148993267|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
148993268|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
148993269|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
148993270|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
148993271|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
148861120|NCT02499900|536969404|FG000|Extension Study Period|Lost to Follow-up|2|||
148861121|NCT02499900|536969405|FG001|Extension Study Period|Lost to Follow-up|5|||
148861122|NCT02499900|536969404|FG000|Extension Study Period|Other|0|||
148861123|NCT02499900|536969405|FG001|Extension Study Period|Other|2|||
149030755|NCT01143077|537589705|FG001|Overall Study|Administrative|0|||
149030756|NCT01143077|537589706|FG002|Overall Study|Administrative|0|||
149030757|NCT01143077|537589704|FG000|Overall Study|Principal Investigator Decision|2|||
149030758|NCT01143077|537589705|FG001|Overall Study|Principal Investigator Decision|0|||
149030759|NCT01143077|537589706|FG002|Overall Study|Principal Investigator Decision|1|||
149030760|NCT01555762|537589707|FG000|Overall Study|No information on Bevacizumab intake|11|||
149030761|NCT01555762|537589707|FG000|Overall Study|Missing start date of infusion|8|||
149030762|NCT01555762|537589707|FG000|Overall Study|75 years old or more ticked No|1|||
149030763|NCT01555762|537589707|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
149030764|NCT01555762|537589707|FG000|Overall Study|Death linked to progression of disease|165|||
148861124|NCT01920893|536969410|FG000|Overall Study|Adverse Event|5|||
148861125|NCT01920893|536969411|FG001|Overall Study|Adverse Event|2|||
148861126|NCT01920893|536969410|FG000|Overall Study|Lack of Efficacy|2|||
148861127|NCT01920893|536969411|FG001|Overall Study|Lack of Efficacy|0|||
148861128|NCT03576755|536969412|FG000|Overall Study|Withdrawal by Subject|1|||
148861129|NCT03576755|536969413|FG001|Overall Study|Withdrawal by Subject|0|||
148861130|NCT03576755|536969414|FG002|Overall Study|Withdrawal by Subject|0|||
148861131|NCT03576755|536969415|FG003|Overall Study|Withdrawal by Subject|0|||
148861132|NCT01767493|536969416|FG000|Overall Study|screen failures|3|||
148861133|NCT02046226|536969417|FG000|Overall Study|Lost to Follow-up|7|||
148861134|NCT01095653|536969418|FG000|Overall Study|Lack of Efficacy|3|||
148861135|NCT01095653|536969419|FG001|Overall Study|Lack of Efficacy|0|||
148861136|NCT01095653|536969420|FG002|Overall Study|Lack of Efficacy|0|||
148861137|NCT01095653|536969418|FG000|Overall Study|Adverse Event|1|||
148861138|NCT01095653|536969419|FG001|Overall Study|Adverse Event|4|||
148861139|NCT01095653|536969420|FG002|Overall Study|Adverse Event|4|||
148861140|NCT01095653|536969418|FG000|Overall Study|Lost to Follow-up|1|||
148861141|NCT01095653|536969419|FG001|Overall Study|Lost to Follow-up|0|||
148861142|NCT01095653|536969420|FG002|Overall Study|Lost to Follow-up|4|||
148861143|NCT01095653|536969418|FG000|Overall Study|Withdrawal by Subject|4|||
148861144|NCT01095653|536969419|FG001|Overall Study|Withdrawal by Subject|5|||
148861145|NCT01095653|536969420|FG002|Overall Study|Withdrawal by Subject|3|||
148861146|NCT01095653|536969418|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
148861147|NCT01095653|536969419|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
148861148|NCT01095653|536969420|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
148861149|NCT00171925|536969421|FG000|Overall Study|Adverse Event|10|||
148861150|NCT00171925|536969422|FG001|Overall Study|Adverse Event|6|||
148861151|NCT00171925|536969421|FG000|Overall Study|Protocol Violation|1|||
148861152|NCT00171925|536969422|FG001|Overall Study|Protocol Violation|1|||
148861153|NCT00171925|536969421|FG000|Overall Study|Withdrawal by Subject|6|||
148861154|NCT00171925|536969422|FG001|Overall Study|Withdrawal by Subject|9|||
148861155|NCT00171925|536969421|FG000|Overall Study|Lost to Follow-up|2|||
148861156|NCT00171925|536969422|FG001|Overall Study|Lost to Follow-up|2|||
148861157|NCT00171925|536969421|FG000|Overall Study|Administrative problems|10|||
148861158|NCT00171925|536969422|FG001|Overall Study|Administrative problems|11|||
148861159|NCT00171925|536969421|FG000|Overall Study|Death|1|||
148993272|NCT01715805|537451286|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
148993273|NCT01715805|537451287|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
148993274|NCT01715805|537451288|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
148993275|NCT01715805|537451289|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
148993276|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
148993277|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
148993278|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
148993279|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
148993280|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
148993281|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
148993282|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
148993283|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
148993284|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
148993285|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
148993286|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
148861160|NCT00171925|536969422|FG001|Overall Study|Death|2|||
148861161|NCT03746600|536969423|FG000|Overall Study|Withdrawal by Subject|3|||
148861162|NCT03746600|536969424|FG001|Overall Study|Withdrawal by Subject|3|||
148861163|NCT03746600|536969423|FG000|Overall Study|dismissed from study|1|||
148861164|NCT03746600|536969424|FG001|Overall Study|dismissed from study|0|||
148993287|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
148993288|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
148861165|NCT03746600|536969423|FG000|Overall Study|Lost to Follow-up|1|||
148861166|NCT03746600|536969424|FG001|Overall Study|Lost to Follow-up|0|||
148861167|NCT00681564|536969427|FG000|Overall Study|Lost to Follow-up|6|||
148861168|NCT00681564|536969428|FG001|Overall Study|Lost to Follow-up|6|||
148861169|NCT00681564|536969427|FG000|Overall Study|Withdrawal by Subject|0|||
148861170|NCT00681564|536969428|FG001|Overall Study|Withdrawal by Subject|1|||
148861171|NCT00681564|536969427|FG000|Overall Study|Death|0|||
148861172|NCT00681564|536969428|FG001|Overall Study|Death|1|||
148861173|NCT02826421|536969429|FG000|Overall Study|Adverse Event|1|||
148861174|NCT02826421|536969430|FG001|Overall Study|Adverse Event|0|||
148861175|NCT02826421|536969431|FG002|Overall Study|Adverse Event|0|||
148861176|NCT02826421|536969432|FG003|Overall Study|Adverse Event|1|||
148861177|NCT02826421|536969429|FG000|Overall Study|Withdrawal by Subject|1|||
148861178|NCT02826421|536969430|FG001|Overall Study|Withdrawal by Subject|3|||
148861179|NCT02826421|536969431|FG002|Overall Study|Withdrawal by Subject|1|||
148861180|NCT02826421|536969432|FG003|Overall Study|Withdrawal by Subject|1|||
148861181|NCT02826421|536969429|FG000|Overall Study|Reason not given|1|||
148861182|NCT02826421|536969430|FG001|Overall Study|Reason not given|0|||
148861183|NCT02826421|536969431|FG002|Overall Study|Reason not given|1|||
148861184|NCT02826421|536969432|FG003|Overall Study|Reason not given|0|||
148861185|NCT02210221|536969435|FG000|Overall Study|Lack of Efficacy|7|||
148861186|NCT02210221|536969435|FG000|Overall Study|Withdrawal by Subject|43|||
148861187|NCT02981407|536969438|FG000|Overall Study|Withdrawal by Subject|2|||
148861188|NCT02981407|536969439|FG001|Overall Study|Withdrawal by Subject|0|||
148861189|NCT01300819|536969442|FG000|Overall Study|Adverse Event|9|||
148861190|NCT01300819|536969443|FG001|Overall Study|Adverse Event|27|||
148861191|NCT01300819|536969442|FG000|Overall Study|Lack of Efficacy|2|||
148861192|NCT01300819|536969443|FG001|Overall Study|Lack of Efficacy|1|||
148861193|NCT01300819|536969442|FG000|Overall Study|Withdrawal by Subject|10|||
148861194|NCT01300819|536969443|FG001|Overall Study|Withdrawal by Subject|12|||
148861195|NCT01300819|536969442|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
148861196|NCT01300819|536969443|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
148861197|NCT01300819|536969442|FG000|Overall Study|Refusal to down titrate study drug|0|||
148861198|NCT01300819|536969443|FG001|Overall Study|Refusal to down titrate study drug|1|||
148861199|NCT01300819|536969442|FG000|Overall Study|Administrative reason|0|||
148861200|NCT01300819|536969443|FG001|Overall Study|Administrative reason|1|||
148861201|NCT01300819|536969442|FG000|Overall Study|Safety follow up not done by mistake|0|||
148861202|NCT01300819|536969443|FG001|Overall Study|Safety follow up not done by mistake|1|||
148861203|NCT01300819|536969442|FG000|Overall Study|Follow up call was not done|1|||
148861204|NCT01300819|536969443|FG001|Overall Study|Follow up call was not done|0|||
148861205|NCT02818036|536969447|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
148861206|NCT02818036|536969448|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
148861207|NCT02818036|536969447|FG000|Overall Study|Withdrawal by Subject|1|||
148861208|NCT02818036|536969448|FG001|Overall Study|Withdrawal by Subject|0|||
148861209|NCT01319721|536969457|FG000|Overall Study|Lost to Follow-up|1|||
148861210|NCT01319721|536969458|FG001|Overall Study|Lost to Follow-up|6|||
148861211|NCT00468845|536969459|FG000|Overall Study|Adverse Event|9|||
148861212|NCT00468845|536969460|FG001|Overall Study|Adverse Event|14|||
148861213|NCT00468845|536969461|FG002|Overall Study|Adverse Event|11|||
148861214|NCT00468845|536969459|FG000|Overall Study|Lost to Follow-up|2|||
148861215|NCT00468845|536969460|FG001|Overall Study|Lost to Follow-up|1|||
148861216|NCT00468845|536969461|FG002|Overall Study|Lost to Follow-up|2|||
148861217|NCT00468845|536969459|FG000|Overall Study|Other|4|||
148861218|NCT00468845|536969460|FG001|Overall Study|Other|9|||
148861219|NCT00468845|536969461|FG002|Overall Study|Other|5|||
148861220|NCT00468845|536969459|FG000|Overall Study|No longer willing to participate|5|||
148861221|NCT00468845|536969460|FG001|Overall Study|No longer willing to participate|6|||
148861222|NCT00468845|536969461|FG002|Overall Study|No longer willing to participate|10|||
148861223|NCT00468845|536969459|FG000|Overall Study|Randomized, not treated|1|||
148861224|NCT00468845|536969460|FG001|Overall Study|Randomized, not treated|4|||
148861225|NCT00468845|536969461|FG002|Overall Study|Randomized, not treated|2|||
148861226|NCT03966885|536972126|FG000|Overall Study|Death|1|||
148861227|NCT03966885|536972127|FG001|Overall Study|Death|0|||
148861228|NCT03966885|536972126|FG000|Overall Study|Lost to Follow-up|1|||
148861229|NCT03966885|536972127|FG001|Overall Study|Lost to Follow-up|2|||
148861230|NCT03966885|536972126|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
148861231|NCT03966885|536972127|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
148861232|NCT03966885|536972126|FG000|Overall Study|Moved from study area.|0|||
148861233|NCT03966885|536972127|FG001|Overall Study|Moved from study area.|2|||
148861234|NCT00549900|536972128|FG000|Overall Study|Adverse Event|1|||
148861235|NCT03187834|536972130|FG000|Overall Study|Lost to Follow-up|0|||
148861236|NCT03187834|536972131|FG001|Overall Study|Lost to Follow-up|1|||
148861237|NCT03187834|536972132|FG002|Overall Study|Lost to Follow-up|2|||
148861238|NCT03187834|536972133|FG003|Overall Study|Lost to Follow-up|2|||
148861239|NCT03187834|536972130|FG000|Overall Study|Had invalid anthropometric measurements|5|||
148861240|NCT03187834|536972131|FG001|Overall Study|Had invalid anthropometric measurements|3|||
148861241|NCT03187834|536972132|FG002|Overall Study|Had invalid anthropometric measurements|4|||
148861242|NCT03187834|536972133|FG003|Overall Study|Had invalid anthropometric measurements|2|||
148861243|NCT02210832|536972134|FG000|Overall Study|Pregnancy termination .|3|||
148861244|NCT02210832|536972135|FG001|Overall Study|Pregnancy termination .|4|||
148861245|NCT02210832|536972136|FG002|Overall Study|Pregnancy termination .|1|||
148861246|NCT02210832|536972134|FG000|Overall Study|Lost to Follow-up|26|||
148861247|NCT02210832|536972135|FG001|Overall Study|Lost to Follow-up|32|||
148861248|NCT02210832|536972136|FG002|Overall Study|Lost to Follow-up|17|||
148861249|NCT02754141|536972141|FG000|Overall Study|Disease progression|11|||
148861250|NCT02754141|536972142|FG001|Overall Study|Disease progression|7|||
148861251|NCT02754141|536972143|FG002|Overall Study|Disease progression|8|||
148861252|NCT02754141|536972144|FG003|Overall Study|Disease progression|5|||
148861253|NCT02754141|536972145|FG004|Overall Study|Disease progression|7|||
148861254|NCT02754141|536972146|FG005|Overall Study|Disease progression|7|||
148861255|NCT02754141|536972147|FG006|Overall Study|Disease progression|7|||
148861256|NCT02754141|536972148|FG007|Overall Study|Disease progression|6|||
148861257|NCT02754141|536972149|FG008|Overall Study|Disease progression|11|||
148861258|NCT02754141|536972150|FG009|Overall Study|Disease progression|16|||
148861259|NCT02754141|536972151|FG010|Overall Study|Disease progression|18|||
148861260|NCT02754141|536972152|FG011|Overall Study|Disease progression|13|||
148861261|NCT02754141|536972153|FG012|Overall Study|Disease progression|10|||
148861262|NCT02754141|536972154|FG013|Overall Study|Disease progression|12|||
148861263|NCT02754141|536972155|FG014|Overall Study|Disease progression|12|||
148861264|NCT02754141|536972156|FG015|Overall Study|Disease progression|14|||
148861265|NCT02754141|536972157|FG016|Overall Study|Disease progression|0|||
148861266|NCT02754141|536972158|FG017|Overall Study|Disease progression|1|||
148861267|NCT02754141|536972141|FG000|Overall Study|Study drug toxicity|1|||
148861268|NCT02754141|536972142|FG001|Overall Study|Study drug toxicity|1|||
148861269|NCT02754141|536972143|FG002|Overall Study|Study drug toxicity|0|||
148861270|NCT02754141|536972144|FG003|Overall Study|Study drug toxicity|0|||
148861271|NCT02754141|536972145|FG004|Overall Study|Study drug toxicity|0|||
148861272|NCT02754141|536972146|FG005|Overall Study|Study drug toxicity|0|||
148861273|NCT02754141|536972147|FG006|Overall Study|Study drug toxicity|0|||
148861274|NCT02754141|536972148|FG007|Overall Study|Study drug toxicity|0|||
148861275|NCT02754141|536972149|FG008|Overall Study|Study drug toxicity|0|||
148861276|NCT02754141|536972150|FG009|Overall Study|Study drug toxicity|0|||
148861277|NCT02754141|536972151|FG010|Overall Study|Study drug toxicity|2|||
148861278|NCT02754141|536972152|FG011|Overall Study|Study drug toxicity|1|||
148861279|NCT02754141|536972153|FG012|Overall Study|Study drug toxicity|1|||
148861280|NCT02754141|536972154|FG013|Overall Study|Study drug toxicity|0|||
148861281|NCT02754141|536972155|FG014|Overall Study|Study drug toxicity|0|||
148861282|NCT02754141|536972156|FG015|Overall Study|Study drug toxicity|0|||
148861283|NCT02754141|536972157|FG016|Overall Study|Study drug toxicity|0|||
148861284|NCT02754141|536972158|FG017|Overall Study|Study drug toxicity|0|||
148861285|NCT02754141|536972141|FG000|Overall Study|AE unrelated to study drug|1|||
148861286|NCT02754141|536972142|FG001|Overall Study|AE unrelated to study drug|1|||
148861287|NCT02754141|536972143|FG002|Overall Study|AE unrelated to study drug|0|||
148861288|NCT02754141|536972144|FG003|Overall Study|AE unrelated to study drug|1|||
148861289|NCT02754141|536972145|FG004|Overall Study|AE unrelated to study drug|3|||
148861290|NCT02754141|536972146|FG005|Overall Study|AE unrelated to study drug|2|||
148861291|NCT02754141|536972147|FG006|Overall Study|AE unrelated to study drug|1|||
148861292|NCT02754141|536972148|FG007|Overall Study|AE unrelated to study drug|0|||
148861293|NCT02754141|536972149|FG008|Overall Study|AE unrelated to study drug|0|||
148861294|NCT02754141|536972150|FG009|Overall Study|AE unrelated to study drug|0|||
148861295|NCT02754141|536972151|FG010|Overall Study|AE unrelated to study drug|0|||
148861296|NCT02754141|536972152|FG011|Overall Study|AE unrelated to study drug|0|||
148861297|NCT02754141|536972153|FG012|Overall Study|AE unrelated to study drug|0|||
148861298|NCT02754141|536972154|FG013|Overall Study|AE unrelated to study drug|0|||
148861299|NCT02754141|536972155|FG014|Overall Study|AE unrelated to study drug|0|||
148861300|NCT02754141|536972156|FG015|Overall Study|AE unrelated to study drug|0|||
148861301|NCT02754141|536972157|FG016|Overall Study|AE unrelated to study drug|0|||
148861302|NCT02754141|536972158|FG017|Overall Study|AE unrelated to study drug|0|||
148861303|NCT02754141|536972141|FG000|Overall Study|Request to discontinue|0|||
148993289|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
148993290|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
148861304|NCT02754141|536972142|FG001|Overall Study|Request to discontinue|0|||
148861305|NCT02754141|536972143|FG002|Overall Study|Request to discontinue|0|||
148861306|NCT02754141|536972144|FG003|Overall Study|Request to discontinue|0|||
148861307|NCT02754141|536972145|FG004|Overall Study|Request to discontinue|0|||
148993291|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
148861308|NCT02754141|536972146|FG005|Overall Study|Request to discontinue|0|||
148861309|NCT02754141|536972147|FG006|Overall Study|Request to discontinue|0|||
148861310|NCT02754141|536972148|FG007|Overall Study|Request to discontinue|0|||
148861311|NCT02754141|536972149|FG008|Overall Study|Request to discontinue|1|||
148861312|NCT02754141|536972150|FG009|Overall Study|Request to discontinue|0|||
148861313|NCT02754141|536972151|FG010|Overall Study|Request to discontinue|0|||
148993292|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
148861314|NCT02754141|536972152|FG011|Overall Study|Request to discontinue|0|||
148861315|NCT02754141|536972153|FG012|Overall Study|Request to discontinue|0|||
148861316|NCT02754141|536972154|FG013|Overall Study|Request to discontinue|1|||
148861317|NCT02754141|536972155|FG014|Overall Study|Request to discontinue|1|||
148861318|NCT02754141|536972156|FG015|Overall Study|Request to discontinue|0|||
148861319|NCT02754141|536972157|FG016|Overall Study|Request to discontinue|0|||
148861320|NCT02754141|536972158|FG017|Overall Study|Request to discontinue|0|||
148861321|NCT02754141|536972141|FG000|Overall Study|Withdrew consent|0|||
148861322|NCT02754141|536972142|FG001|Overall Study|Withdrew consent|0|||
148861323|NCT02754141|536972143|FG002|Overall Study|Withdrew consent|0|||
148861324|NCT02754141|536972144|FG003|Overall Study|Withdrew consent|0|||
148861325|NCT02754141|536972145|FG004|Overall Study|Withdrew consent|0|||
148861326|NCT02754141|536972146|FG005|Overall Study|Withdrew consent|0|||
148861327|NCT02754141|536972147|FG006|Overall Study|Withdrew consent|0|||
148861328|NCT02754141|536972148|FG007|Overall Study|Withdrew consent|0|||
148861329|NCT02754141|536972149|FG008|Overall Study|Withdrew consent|0|||
148861330|NCT02754141|536972150|FG009|Overall Study|Withdrew consent|1|||
148861331|NCT02754141|536972151|FG010|Overall Study|Withdrew consent|0|||
148861332|NCT02754141|536972152|FG011|Overall Study|Withdrew consent|0|||
148861333|NCT02754141|536972153|FG012|Overall Study|Withdrew consent|0|||
148861334|NCT02754141|536972154|FG013|Overall Study|Withdrew consent|0|||
148861335|NCT02754141|536972155|FG014|Overall Study|Withdrew consent|0|||
148861336|NCT02754141|536972156|FG015|Overall Study|Withdrew consent|0|||
148861337|NCT02754141|536972157|FG016|Overall Study|Withdrew consent|0|||
148861338|NCT02754141|536972158|FG017|Overall Study|Withdrew consent|0|||
148861339|NCT02754141|536972141|FG000|Overall Study|Maximum clinical benefit|0|||
148861340|NCT02754141|536972142|FG001|Overall Study|Maximum clinical benefit|0|||
148861341|NCT02754141|536972143|FG002|Overall Study|Maximum clinical benefit|0|||
148861342|NCT02754141|536972144|FG003|Overall Study|Maximum clinical benefit|1|||
148861343|NCT02754141|536972145|FG004|Overall Study|Maximum clinical benefit|0|||
148861344|NCT02754141|536972146|FG005|Overall Study|Maximum clinical benefit|0|||
148861345|NCT02754141|536972147|FG006|Overall Study|Maximum clinical benefit|0|||
148861346|NCT02754141|536972148|FG007|Overall Study|Maximum clinical benefit|0|||
148861347|NCT02754141|536972149|FG008|Overall Study|Maximum clinical benefit|0|||
148861348|NCT02754141|536972150|FG009|Overall Study|Maximum clinical benefit|0|||
148861349|NCT02754141|536972151|FG010|Overall Study|Maximum clinical benefit|0|||
148861350|NCT02754141|536972152|FG011|Overall Study|Maximum clinical benefit|0|||
148861351|NCT02754141|536972153|FG012|Overall Study|Maximum clinical benefit|0|||
148861352|NCT02754141|536972154|FG013|Overall Study|Maximum clinical benefit|0|||
148861353|NCT02754141|536972155|FG014|Overall Study|Maximum clinical benefit|0|||
148861354|NCT02754141|536972156|FG015|Overall Study|Maximum clinical benefit|0|||
148861355|NCT02754141|536972157|FG016|Overall Study|Maximum clinical benefit|0|||
148861356|NCT02754141|536972158|FG017|Overall Study|Maximum clinical benefit|0|||
148861357|NCT02754141|536972141|FG000|Overall Study|No longer meets study criteria|0|||
148861358|NCT02754141|536972142|FG001|Overall Study|No longer meets study criteria|0|||
148861359|NCT02754141|536972143|FG002|Overall Study|No longer meets study criteria|0|||
148861360|NCT02754141|536972144|FG003|Overall Study|No longer meets study criteria|1|||
148861361|NCT02754141|536972145|FG004|Overall Study|No longer meets study criteria|0|||
148861362|NCT02754141|536972146|FG005|Overall Study|No longer meets study criteria|0|||
148861363|NCT02754141|536972147|FG006|Overall Study|No longer meets study criteria|0|||
148861364|NCT02754141|536972148|FG007|Overall Study|No longer meets study criteria|0|||
148861365|NCT02754141|536972149|FG008|Overall Study|No longer meets study criteria|0|||
148861366|NCT02754141|536972150|FG009|Overall Study|No longer meets study criteria|0|||
148861367|NCT02754141|536972151|FG010|Overall Study|No longer meets study criteria|0|||
148861368|NCT02754141|536972152|FG011|Overall Study|No longer meets study criteria|0|||
148861369|NCT02754141|536972153|FG012|Overall Study|No longer meets study criteria|0|||
148861370|NCT02754141|536972154|FG013|Overall Study|No longer meets study criteria|0|||
148861371|NCT02754141|536972155|FG014|Overall Study|No longer meets study criteria|0|||
148861372|NCT02754141|536972156|FG015|Overall Study|No longer meets study criteria|0|||
148861373|NCT02754141|536972157|FG016|Overall Study|No longer meets study criteria|0|||
148861374|NCT02754141|536972158|FG017|Overall Study|No longer meets study criteria|0|||
148861375|NCT02754141|536972141|FG000|Overall Study|Other reasons|0|||
148861376|NCT02754141|536972142|FG001|Overall Study|Other reasons|0|||
148861377|NCT02754141|536972143|FG002|Overall Study|Other reasons|0|||
148861378|NCT02754141|536972144|FG003|Overall Study|Other reasons|0|||
148861379|NCT02754141|536972145|FG004|Overall Study|Other reasons|0|||
148861380|NCT02754141|536972146|FG005|Overall Study|Other reasons|0|||
148861381|NCT02754141|536972147|FG006|Overall Study|Other reasons|0|||
148861382|NCT02754141|536972148|FG007|Overall Study|Other reasons|1|||
148861383|NCT02754141|536972149|FG008|Overall Study|Other reasons|0|||
148861384|NCT02754141|536972150|FG009|Overall Study|Other reasons|0|||
148861385|NCT02754141|536972151|FG010|Overall Study|Other reasons|0|||
148861386|NCT02754141|536972152|FG011|Overall Study|Other reasons|0|||
148861387|NCT02754141|536972153|FG012|Overall Study|Other reasons|2|||
148861388|NCT02754141|536972154|FG013|Overall Study|Other reasons|0|||
148861389|NCT02754141|536972155|FG014|Overall Study|Other reasons|0|||
148861390|NCT02754141|536972156|FG015|Overall Study|Other reasons|0|||
148861391|NCT02754141|536972157|FG016|Overall Study|Other reasons|0|||
148861392|NCT02754141|536972158|FG017|Overall Study|Other reasons|0|||
148861393|NCT02754141|536972141|FG000|Overall Study|Completed treatment as per protocol|0|||
148861394|NCT02754141|536972142|FG001|Overall Study|Completed treatment as per protocol|1|||
148861395|NCT02754141|536972143|FG002|Overall Study|Completed treatment as per protocol|0|||
148861396|NCT02754141|536972144|FG003|Overall Study|Completed treatment as per protocol|0|||
148861397|NCT02754141|536972145|FG004|Overall Study|Completed treatment as per protocol|0|||
148861398|NCT02754141|536972146|FG005|Overall Study|Completed treatment as per protocol|0|||
148861399|NCT02754141|536972147|FG006|Overall Study|Completed treatment as per protocol|0|||
148861400|NCT02754141|536972148|FG007|Overall Study|Completed treatment as per protocol|0|||
148861401|NCT02754141|536972149|FG008|Overall Study|Completed treatment as per protocol|0|||
148861402|NCT02754141|536972150|FG009|Overall Study|Completed treatment as per protocol|0|||
148861403|NCT02754141|536972151|FG010|Overall Study|Completed treatment as per protocol|0|||
148861404|NCT02754141|536972152|FG011|Overall Study|Completed treatment as per protocol|0|||
148861405|NCT02754141|536972153|FG012|Overall Study|Completed treatment as per protocol|1|||
148861406|NCT02754141|536972154|FG013|Overall Study|Completed treatment as per protocol|0|||
148861407|NCT02754141|536972155|FG014|Overall Study|Completed treatment as per protocol|0|||
148861408|NCT02754141|536972156|FG015|Overall Study|Completed treatment as per protocol|0|||
148861409|NCT02754141|536972157|FG016|Overall Study|Completed treatment as per protocol|0|||
148861410|NCT02754141|536972158|FG017|Overall Study|Completed treatment as per protocol|0|||
148861411|NCT02754141|536972141|FG000|Overall Study|Not completing monotherapy|0|||
148861412|NCT02754141|536972142|FG001|Overall Study|Not completing monotherapy|0|||
148861413|NCT02754141|536972143|FG002|Overall Study|Not completing monotherapy|0|||
148861414|NCT02754141|536972144|FG003|Overall Study|Not completing monotherapy|0|||
148861415|NCT02754141|536972145|FG004|Overall Study|Not completing monotherapy|0|||
148861416|NCT02754141|536972146|FG005|Overall Study|Not completing monotherapy|0|||
148861417|NCT02754141|536972147|FG006|Overall Study|Not completing monotherapy|0|||
148861418|NCT02754141|536972148|FG007|Overall Study|Not completing monotherapy|0|||
148861419|NCT02754141|536972149|FG008|Overall Study|Not completing monotherapy|0|||
148861420|NCT02754141|536972150|FG009|Overall Study|Not completing monotherapy|0|||
148861421|NCT02754141|536972151|FG010|Overall Study|Not completing monotherapy|0|||
148861422|NCT02754141|536972152|FG011|Overall Study|Not completing monotherapy|0|||
148861423|NCT02754141|536972153|FG012|Overall Study|Not completing monotherapy|0|||
148861424|NCT02754141|536972154|FG013|Overall Study|Not completing monotherapy|1|||
148861425|NCT02754141|536972155|FG014|Overall Study|Not completing monotherapy|0|||
148861426|NCT02754141|536972156|FG015|Overall Study|Not completing monotherapy|0|||
148861427|NCT02754141|536972157|FG016|Overall Study|Not completing monotherapy|0|||
148861428|NCT02754141|536972158|FG017|Overall Study|Not completing monotherapy|0|||
148861429|NCT01187446|536972159|FG000|Overall Study|Patient started non-protocol therapy|0|||
148861430|NCT01187446|536972160|FG001|Overall Study|Patient started non-protocol therapy|1|||
148861431|NCT00823212|536972165|FG000|Overall Study|Death|8|||
148861432|NCT00823212|536972166|FG001|Overall Study|Death|10|||
148861433|NCT00823212|536972165|FG000|Overall Study|Withdrawal by Subject|6|||
148861434|NCT00823212|536972166|FG001|Overall Study|Withdrawal by Subject|1|||
148861435|NCT00823212|536972165|FG000|Overall Study|Incarcerated|0|||
148861436|NCT00823212|536972166|FG001|Overall Study|Incarcerated|1|||
148861437|NCT00823212|536972165|FG000|Overall Study|Missed 12-month visit|21|||
148861438|NCT00823212|536972166|FG001|Overall Study|Missed 12-month visit|21|||
148861439|NCT01344538|536972167|FG000|Overall Study|Adverse Event|1|||
148861440|NCT01344538|536972168|FG001|Overall Study|Adverse Event|1|||
148861441|NCT01344538|536972167|FG000|Overall Study|Lost to Follow-up|1|||
148861442|NCT01344538|536972168|FG001|Overall Study|Lost to Follow-up|0|||
148861443|NCT02324205|536972171|FG000|Overall Study|Withdrawal by Subject|37|||
148861444|NCT01224821|536972184|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
148861445|NCT01224821|536972184|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
148861446|NCT01224821|536972184|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
148861447|NCT01224821|536972184|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
148993293|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
148993294|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
148993295|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
148993296|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
148993297|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
148993298|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
148993299|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
148993300|NCT01715805|537451286|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
148861448|NCT01224821|536972184|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
148861449|NCT01224821|536972184|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
148861450|NCT01224821|536972184|FG000|Long-Term Follow-Up|Death|2|||
148861451|NCT01224821|536972184|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
148861452|NCT00683917|536972185|FG000|Overall Study|Study prematurely terminated|10|||
148861453|NCT04422561|536972189|FG000|Overall Study|Lost to Follow-up|25|||
148861454|NCT04422561|536972190|FG001|Overall Study|Lost to Follow-up|11|||
148861455|NCT00623545|536972191|FG000|Overall Study|Adverse Event|6|||
148861456|NCT00623545|536972191|FG000|Overall Study|Withdrawal by Subject|4|||
148861457|NCT04239222|536972192|FG000|Baseline|Withdrawal by Subject|0|||
148861458|NCT04239222|536972193|FG001|Baseline|Withdrawal by Subject|0|||
148861459|NCT04239222|536972194|FG002|Baseline|Withdrawal by Subject|1|||
148861460|NCT04239222|536972195|FG003|Baseline|Withdrawal by Subject|1|||
148861461|NCT04239222|536972192|FG000|First Foot Assignment|Withdrawal by Subject|0|||
148861462|NCT04239222|536972193|FG001|First Foot Assignment|Withdrawal by Subject|0|||
148861463|NCT04239222|536972194|FG002|First Foot Assignment|Withdrawal by Subject|1|||
148861464|NCT04239222|536972195|FG003|First Foot Assignment|Withdrawal by Subject|0|||
148861465|NCT04239222|536972192|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
148861466|NCT04239222|536972193|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
148861467|NCT04239222|536972194|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
148861468|NCT04239222|536972195|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
148861469|NCT02685748|536972201|FG000|Overall Study|Withdrawal by Subject|3|||
148861470|NCT02685748|536972202|FG001|Overall Study|Withdrawal by Subject|2|||
148861471|NCT00937404|536972206|FG000|Overall Study|Protocol Violation|1|||
148861472|NCT00937404|536972206|FG000|Overall Study|Withdrawal by Subject|1|||
148861473|NCT00230282|536972208|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
148861474|NCT00230282|536972208|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
148861475|NCT00230282|536972208|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
148861476|NCT00230282|536972208|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
148861477|NCT01691105|536972210|FG000|1 Month Follow-up|Lost to Follow-up|41|||
148861478|NCT01691105|536972211|FG001|1 Month Follow-up|Lost to Follow-up|38|||
148861479|NCT01691105|536972210|FG000|1 Month Follow-up|Death|2|||
148861480|NCT01691105|536972211|FG001|1 Month Follow-up|Death|3|||
148861481|NCT01691105|536972210|FG000|6 Month Follow-up|Lost to Follow-up|39|||
148861482|NCT01691105|536972211|FG001|6 Month Follow-up|Lost to Follow-up|58|||
148861483|NCT01691105|536972210|FG000|6 Month Follow-up|Death|13|||
148861484|NCT01691105|536972211|FG001|6 Month Follow-up|Death|13|||
148861485|NCT01691105|536972210|FG000|12 Month Follow-up|Lost to Follow-up|50|||
148861486|NCT01691105|536972211|FG001|12 Month Follow-up|Lost to Follow-up|71|||
148861487|NCT01691105|536972210|FG000|12 Month Follow-up|Death|22|||
148861488|NCT01691105|536972211|FG001|12 Month Follow-up|Death|30|||
148861489|NCT01691105|536972210|FG000|12 Month Biochemical Verification|Death|22|||
148861490|NCT01691105|536972211|FG001|12 Month Biochemical Verification|Death|30|||
148861491|NCT01691105|536972210|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
148861492|NCT01691105|536972211|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
148861493|NCT01691105|536972210|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
148861494|NCT01691105|536972211|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
148861495|NCT00445848|536972212|FG000|Overall Study|Adverse Event|14|||
148861496|NCT00445848|536972212|FG000|Overall Study|Withdrawal by Subject|4|||
148861497|NCT00445848|536972212|FG000|Overall Study|Progression|62|||
148861498|NCT00445848|536972212|FG000|Overall Study|Other-Not protocol specified|5|||
148861499|NCT00790647|536972215|FG000|Overall Study|Adverse Event|1|||
148861500|NCT01777542|536972218|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
148861501|NCT01777542|536972219|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
148861502|NCT00027378|536972220|FG000|Overall Study|Physician Decision|0|||
148861503|NCT00027378|536972221|FG001|Overall Study|Physician Decision|3|||
148861504|NCT02701777|536972223|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
148861505|NCT02701777|536972224|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
148861506|NCT02701777|536972225|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
148861507|NCT02701777|536972226|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
148861508|NCT02701777|536972223|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
148861509|NCT02701777|536972224|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
148861510|NCT02701777|536972225|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
148861511|NCT02701777|536972226|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
148861512|NCT00585221|536972227|FG000|Overall Study|Protocol Violation|8|||
148861513|NCT03263923|536972228|FG000|Overall Study|Withdrawal by Subject|10|||
148861514|NCT03263923|536972229|FG001|Overall Study|Withdrawal by Subject|8|||
148861515|NCT03263923|536972228|FG000|Overall Study|Lost to Follow-up|15|||
148861516|NCT03263923|536972229|FG001|Overall Study|Lost to Follow-up|13|||
148861517|NCT01323270|536972230|FG000|Overall Study|Withdrawal by Subject|19|||
148861518|NCT01323270|536972231|FG001|Overall Study|Withdrawal by Subject|10|||
148861519|NCT01323270|536972230|FG000|Overall Study|Protocol Violation|9|||
148861520|NCT01323270|536972231|FG001|Overall Study|Protocol Violation|7|||
148861521|NCT01323270|536972230|FG000|Overall Study|Lost to Follow-up|4|||
148861522|NCT01323270|536972231|FG001|Overall Study|Lost to Follow-up|6|||
148861523|NCT01323270|536972230|FG000|Overall Study|Adverse Event|8|||
148861524|NCT01323270|536972231|FG001|Overall Study|Adverse Event|0|||
148861525|NCT01323270|536972230|FG000|Overall Study|Other|0|||
148861526|NCT01323270|536972231|FG001|Overall Study|Other|3|||
148861527|NCT01323270|536972230|FG000|Overall Study|Physician Decision|0|||
148861528|NCT01323270|536972231|FG001|Overall Study|Physician Decision|2|||
148861529|NCT01323270|536972230|FG000|Overall Study|Not eligible|1|||
148861530|NCT01323270|536972231|FG001|Overall Study|Not eligible|1|||
148861531|NCT01323270|536972230|FG000|Overall Study|Death|1|||
148861532|NCT01323270|536972231|FG001|Overall Study|Death|0|||
148861533|NCT01323270|536972230|FG000|Overall Study|Randomized, but not vaccinated|1|||
148861534|NCT01323270|536972231|FG001|Overall Study|Randomized, but not vaccinated|0|||
148861535|NCT02229214|536972242|FG000|Overall Study|Adverse Event|2|||
148861536|NCT02229214|536972243|FG001|Overall Study|Adverse Event|0|||
148861537|NCT02229214|536972242|FG000|Overall Study|Withdrawal by Subject|4|||
148861538|NCT02229214|536972243|FG001|Overall Study|Withdrawal by Subject|0|||
148861539|NCT00246025|536972244|FG000|Overall Study|Adverse Event|7|||
148861540|NCT00246025|536972245|FG001|Overall Study|Adverse Event|9|||
148861541|NCT00246025|536972246|FG002|Overall Study|Adverse Event|9|||
148861542|NCT00246025|536972247|FG003|Overall Study|Adverse Event|10|||
148861543|NCT00246025|536972244|FG000|Overall Study|Withdrawal by Subject|3|||
148861544|NCT00246025|536972245|FG001|Overall Study|Withdrawal by Subject|0|||
148861545|NCT00246025|536972246|FG002|Overall Study|Withdrawal by Subject|1|||
148861546|NCT00246025|536972247|FG003|Overall Study|Withdrawal by Subject|2|||
148861547|NCT00246025|536972244|FG000|Overall Study|unsuitable medical history was found|0|||
148861548|NCT00246025|536972245|FG001|Overall Study|unsuitable medical history was found|0|||
148861549|NCT00246025|536972246|FG002|Overall Study|unsuitable medical history was found|0|||
148861550|NCT00246025|536972247|FG003|Overall Study|unsuitable medical history was found|1|||
148861551|NCT01643850|536972250|FG000|Overall Study|Withdrawal by Subject|0|||
148861552|NCT01643850|536972251|FG001|Overall Study|Withdrawal by Subject|0|||
148861553|NCT01643850|536972252|FG002|Overall Study|Withdrawal by Subject|0|||
148861554|NCT01643850|536972253|FG003|Overall Study|Withdrawal by Subject|0|||
148861555|NCT01643850|536972254|FG004|Overall Study|Withdrawal by Subject|1|||
148861556|NCT01643850|536972255|FG005|Overall Study|Withdrawal by Subject|0|||
148861557|NCT01643850|536972256|FG006|Overall Study|Withdrawal by Subject|0|||
148861558|NCT01643850|536972257|FG007|Overall Study|Withdrawal by Subject|0|||
148861559|NCT01643850|536972258|FG008|Overall Study|Withdrawal by Subject|0|||
148861560|NCT01643850|536972250|FG000|Overall Study|Lost to Follow-up|0|||
148861561|NCT01643850|536972251|FG001|Overall Study|Lost to Follow-up|0|||
148861562|NCT01643850|536972252|FG002|Overall Study|Lost to Follow-up|0|||
148861563|NCT01643850|536972253|FG003|Overall Study|Lost to Follow-up|0|||
148861564|NCT01643850|536972254|FG004|Overall Study|Lost to Follow-up|0|||
148861565|NCT01643850|536972255|FG005|Overall Study|Lost to Follow-up|0|||
148861566|NCT01643850|536972256|FG006|Overall Study|Lost to Follow-up|1|||
148861567|NCT01643850|536972257|FG007|Overall Study|Lost to Follow-up|0|||
148861568|NCT01643850|536972258|FG008|Overall Study|Lost to Follow-up|1|||
148861569|NCT01643850|536972250|FG000|Overall Study|Adverse Event|0|||
148861570|NCT01643850|536972251|FG001|Overall Study|Adverse Event|0|||
148861571|NCT01643850|536972252|FG002|Overall Study|Adverse Event|0|||
148861572|NCT01643850|536972253|FG003|Overall Study|Adverse Event|0|||
148861573|NCT01643850|536972254|FG004|Overall Study|Adverse Event|1|||
148861574|NCT01643850|536972255|FG005|Overall Study|Adverse Event|0|||
148861575|NCT01643850|536972256|FG006|Overall Study|Adverse Event|0|||
148861576|NCT01643850|536972257|FG007|Overall Study|Adverse Event|0|||
148861577|NCT01643850|536972258|FG008|Overall Study|Adverse Event|0|||
148861578|NCT01643850|536972250|FG000|Overall Study|Administrative Problems|0|||
148861579|NCT01643850|536972251|FG001|Overall Study|Administrative Problems|0|||
148861580|NCT01643850|536972252|FG002|Overall Study|Administrative Problems|1|||
148861581|NCT01643850|536972253|FG003|Overall Study|Administrative Problems|0|||
148861582|NCT01643850|536972254|FG004|Overall Study|Administrative Problems|1|||
148861583|NCT01643850|536972255|FG005|Overall Study|Administrative Problems|0|||
148861584|NCT01643850|536972256|FG006|Overall Study|Administrative Problems|0|||
148861585|NCT01643850|536972257|FG007|Overall Study|Administrative Problems|0|||
148861586|NCT01643850|536972258|FG008|Overall Study|Administrative Problems|0|||
148861587|NCT00931723|536972259|FG000|Overall Study|Withdrawal by Subject|11|||
148861588|NCT00931723|536972260|FG001|Overall Study|Withdrawal by Subject|13|||
148861589|NCT00931723|536972259|FG000|Overall Study|Adverse Event|6|||
148861590|NCT00931723|536972260|FG001|Overall Study|Adverse Event|13|||
148861591|NCT00931723|536972259|FG000|Overall Study|Lithium found in blood|0|||
148861592|NCT00931723|536972260|FG001|Overall Study|Lithium found in blood|1|||
148861593|NCT00931723|536972259|FG000|Overall Study|Condition under investigation worsened|1|||
148861594|NCT00931723|536972260|FG001|Overall Study|Condition under investigation worsened|2|||
148861595|NCT00931723|536972259|FG000|Overall Study|Lost to Follow-up|1|||
148861596|NCT00931723|536972260|FG001|Overall Study|Lost to Follow-up|2|||
148861597|NCT00931723|536972259|FG000|Overall Study|Study-specific discontinuation criteria|1|||
148861598|NCT00931723|536972260|FG001|Overall Study|Study-specific discontinuation criteria|1|||
148861599|NCT00931723|536972259|FG000|Overall Study|Severe non-compliance to protocol|2|||
148861600|NCT00931723|536972260|FG001|Overall Study|Severe non-compliance to protocol|0|||
148993301|NCT01715805|537451287|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
148861601|NCT00931723|536972259|FG000|Overall Study|Safety reasons|0|||
148861602|NCT00931723|536972260|FG001|Overall Study|Safety reasons|1|||
148861603|NCT00931723|536972259|FG000|Overall Study|Took prohibited concomitant medication|0|||
148861604|NCT00931723|536972260|FG001|Overall Study|Took prohibited concomitant medication|1|||
148861605|NCT00931723|536972259|FG000|Overall Study|Lack or insufficient theraputic response|2|||
148861606|NCT00931723|536972260|FG001|Overall Study|Lack or insufficient theraputic response|5|||
148861607|NCT00931723|536972259|FG000|Overall Study|Sponsor decision|1|||
148861608|NCT00931723|536972260|FG001|Overall Study|Sponsor decision|0|||
148861609|NCT00931723|536972259|FG000|Overall Study|Late hospital discharge|1|||
148861610|NCT00931723|536972260|FG001|Overall Study|Late hospital discharge|0|||
148861611|NCT00075725|536972261|FG000|Overall Study|Adverse Event|6|||
148861612|NCT00075725|536972262|FG001|Overall Study|Adverse Event|6|||
148861613|NCT00075725|536972263|FG002|Overall Study|Adverse Event|20|||
148861614|NCT00075725|536972264|FG003|Overall Study|Adverse Event|8|||
148861615|NCT00075725|536972265|FG004|Overall Study|Adverse Event|4|||
148861616|NCT00075725|536972266|FG005|Overall Study|Adverse Event|38|||
148861617|NCT00075725|536972267|FG006|Overall Study|Adverse Event|3|||
148861618|NCT00075725|536972268|FG007|Overall Study|Adverse Event|51|||
148861619|NCT00075725|536972269|FG008|Overall Study|Adverse Event|15|||
148861620|NCT00075725|536972270|FG009|Overall Study|Adverse Event|4|||
148861621|NCT00075725|536972271|FG010|Overall Study|Adverse Event|2|||
148861622|NCT00075725|536972272|FG011|Overall Study|Adverse Event|2|||
148861623|NCT00075725|536972261|FG000|Overall Study|Death|3|||
148861624|NCT00075725|536972262|FG001|Overall Study|Death|5|||
148861625|NCT00075725|536972263|FG002|Overall Study|Death|10|||
148861626|NCT00075725|536972264|FG003|Overall Study|Death|2|||
148861627|NCT00075725|536972265|FG004|Overall Study|Death|3|||
148861628|NCT00075725|536972266|FG005|Overall Study|Death|25|||
148861629|NCT00075725|536972267|FG006|Overall Study|Death|4|||
148861630|NCT00075725|536972268|FG007|Overall Study|Death|22|||
148861631|NCT00075725|536972269|FG008|Overall Study|Death|14|||
148861632|NCT00075725|536972270|FG009|Overall Study|Death|4|||
148861633|NCT00075725|536972271|FG010|Overall Study|Death|3|||
148861634|NCT00075725|536972272|FG011|Overall Study|Death|0|||
148861635|NCT00075725|536972261|FG000|Overall Study|Lost to Follow-up|1|||
148861636|NCT00075725|536972262|FG001|Overall Study|Lost to Follow-up|1|||
148861637|NCT00075725|536972263|FG002|Overall Study|Lost to Follow-up|4|||
148861638|NCT00075725|536972264|FG003|Overall Study|Lost to Follow-up|1|||
148861639|NCT00075725|536972265|FG004|Overall Study|Lost to Follow-up|0|||
148861640|NCT00075725|536972266|FG005|Overall Study|Lost to Follow-up|13|||
148861641|NCT00075725|536972267|FG006|Overall Study|Lost to Follow-up|2|||
148861642|NCT00075725|536972268|FG007|Overall Study|Lost to Follow-up|4|||
148861643|NCT00075725|536972269|FG008|Overall Study|Lost to Follow-up|1|||
148861644|NCT00075725|536972270|FG009|Overall Study|Lost to Follow-up|0|||
148861645|NCT00075725|536972271|FG010|Overall Study|Lost to Follow-up|0|||
148861646|NCT00075725|536972272|FG011|Overall Study|Lost to Follow-up|0|||
148861647|NCT00075725|536972261|FG000|Overall Study|Physician Decision|2|||
148861648|NCT00075725|536972262|FG001|Overall Study|Physician Decision|6|||
148861649|NCT00075725|536972263|FG002|Overall Study|Physician Decision|5|||
148861650|NCT00075725|536972264|FG003|Overall Study|Physician Decision|8|||
148861651|NCT00075725|536972265|FG004|Overall Study|Physician Decision|4|||
148861652|NCT00075725|536972266|FG005|Overall Study|Physician Decision|19|||
148861653|NCT00075725|536972267|FG006|Overall Study|Physician Decision|3|||
148861654|NCT00075725|536972268|FG007|Overall Study|Physician Decision|17|||
148861655|NCT00075725|536972269|FG008|Overall Study|Physician Decision|5|||
148861656|NCT00075725|536972270|FG009|Overall Study|Physician Decision|0|||
148861657|NCT00075725|536972271|FG010|Overall Study|Physician Decision|1|||
148861658|NCT00075725|536972272|FG011|Overall Study|Physician Decision|0|||
148861659|NCT00075725|536972261|FG000|Overall Study|Pregnancy|0|||
148861660|NCT00075725|536972262|FG001|Overall Study|Pregnancy|0|||
148861661|NCT00075725|536972263|FG002|Overall Study|Pregnancy|0|||
148861662|NCT00075725|536972264|FG003|Overall Study|Pregnancy|0|||
148861663|NCT00075725|536972265|FG004|Overall Study|Pregnancy|0|||
148861664|NCT00075725|536972266|FG005|Overall Study|Pregnancy|1|||
148861665|NCT00075725|536972267|FG006|Overall Study|Pregnancy|0|||
148861666|NCT00075725|536972268|FG007|Overall Study|Pregnancy|1|||
148861667|NCT00075725|536972269|FG008|Overall Study|Pregnancy|0|||
148861668|NCT00075725|536972270|FG009|Overall Study|Pregnancy|0|||
148861669|NCT00075725|536972271|FG010|Overall Study|Pregnancy|0|||
148861670|NCT00075725|536972272|FG011|Overall Study|Pregnancy|0|||
148861671|NCT00075725|536972261|FG000|Overall Study|Protocol Violation|1|||
148861672|NCT00075725|536972262|FG001|Overall Study|Protocol Violation|1|||
148861673|NCT00075725|536972263|FG002|Overall Study|Protocol Violation|0|||
148861674|NCT00075725|536972264|FG003|Overall Study|Protocol Violation|3|||
148861675|NCT00075725|536972265|FG004|Overall Study|Protocol Violation|3|||
148861676|NCT00075725|536972266|FG005|Overall Study|Protocol Violation|2|||
148861677|NCT00075725|536972267|FG006|Overall Study|Protocol Violation|1|||
148861678|NCT00075725|536972268|FG007|Overall Study|Protocol Violation|2|||
148861679|NCT00075725|536972269|FG008|Overall Study|Protocol Violation|3|||
149005496|NCT03217747|537497901|FG009|Overall Study|Removal of sole target lesion|0|||
148861680|NCT00075725|536972270|FG009|Overall Study|Protocol Violation|0|||
148861681|NCT00075725|536972271|FG010|Overall Study|Protocol Violation|0|||
148861682|NCT00075725|536972272|FG011|Overall Study|Protocol Violation|1|||
148861683|NCT00075725|536972261|FG000|Overall Study|Withdrawal by Subject|12|||
149030765|NCT01555762|537589707|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
149030766|NCT01555762|537589707|FG000|Overall Study|Investigator's decision|10|||
148993302|NCT01715805|537451288|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
148993303|NCT01715805|537451289|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
148993304|NCT02647359|537451290|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
149030767|NCT01555762|537589707|FG000|Overall Study|Participant not wishing to continue|5|||
149030768|NCT01555762|537589707|FG000|Overall Study|Missing data|1|||
149030769|NCT01555762|537589707|FG000|Overall Study|Death linked to an adverse event|14|||
149030770|NCT01333514|537589708|FG000|Overall Study|Withdrawal by Subject|1|||
149030771|NCT01333514|537589709|FG001|Overall Study|Withdrawal by Subject|0|||
149030772|NCT00819910|537589710|FG000|Overall Study|Adverse Event|0|||
149030773|NCT00819910|537589711|FG001|Overall Study|Adverse Event|0|||
148993305|NCT02647359|537451291|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
148993306|NCT02647359|537451290|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
148993307|NCT02647359|537451291|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
148993308|NCT02647359|537451290|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
148993309|NCT02647359|537451291|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
148993310|NCT02647359|537451290|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
148993311|NCT02647359|537451291|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
148993312|NCT02647359|537451290|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
149030774|NCT00819910|537589712|FG002|Overall Study|Adverse Event|2|||
149030775|NCT00819910|537589713|FG003|Overall Study|Adverse Event|1|||
149030776|NCT00819910|537589710|FG000|Overall Study|Withdrawal by Subject|1|||
149030777|NCT00819910|537589711|FG001|Overall Study|Withdrawal by Subject|1|||
149030778|NCT00819910|537589712|FG002|Overall Study|Withdrawal by Subject|1|||
148777934|NCT02089334|536660458|FG000|Overall Study|Adverse Event|0|||
148777935|NCT02089334|536660459|FG001|Overall Study|Adverse Event|0|||
148777936|NCT02089334|536660460|FG002|Overall Study|Adverse Event|0|||
148777937|NCT02089334|536660461|FG003|Overall Study|Adverse Event|2|||
148777938|NCT02089334|536660458|FG000|Overall Study|Progressive disease|0|||
148777939|NCT02089334|536660459|FG001|Overall Study|Progressive disease|0|||
148777940|NCT02089334|536660460|FG002|Overall Study|Progressive disease|0|||
148777941|NCT02089334|536660461|FG003|Overall Study|Progressive disease|2|||
148777942|NCT02089334|536660458|FG000|Overall Study|Physician Decision|0|||
148777943|NCT02089334|536660459|FG001|Overall Study|Physician Decision|0|||
148777944|NCT02089334|536660460|FG002|Overall Study|Physician Decision|1|||
148777945|NCT02089334|536660461|FG003|Overall Study|Physician Decision|1|||
148777946|NCT04778059|536660462|FG000|Overall Study|Death|2|||
148777947|NCT04778059|536660463|FG001|Overall Study|Death|2|||
148777948|NCT04778059|536660464|FG002|Overall Study|Death|1|||
148777949|NCT04778059|536660465|FG003|Overall Study|Death|1|||
148777950|NCT04778059|536660466|FG004|Overall Study|Death|1|||
148777951|NCT04778059|536660462|FG000|Overall Study|Lost to Follow-up|0|||
148777952|NCT04778059|536660463|FG001|Overall Study|Lost to Follow-up|0|||
148777953|NCT04778059|536660464|FG002|Overall Study|Lost to Follow-up|0|||
148777954|NCT04778059|536660465|FG003|Overall Study|Lost to Follow-up|0|||
148777955|NCT04778059|536660466|FG004|Overall Study|Lost to Follow-up|1|||
148777956|NCT04778059|536660462|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
148777957|NCT04778059|536660463|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
148777958|NCT04778059|536660464|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
148777959|NCT04778059|536660465|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
148777960|NCT04778059|536660466|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
148777961|NCT02832375|536660467|FG000|Overall Study|Lost to Follow-up|1|||
148777962|NCT02832375|536660468|FG001|Overall Study|Lost to Follow-up|0|||
148777963|NCT02832375|536660467|FG000|Overall Study|Withdrawal of Consent|1|||
148777964|NCT02832375|536660468|FG001|Overall Study|Withdrawal of Consent|0|||
148777965|NCT00084318|536660474|FG000|Overall Study|Withdrawal by Subject|5|||
148777966|NCT00084318|536660475|FG001|Overall Study|Withdrawal by Subject|2|||
148777967|NCT00084318|536660474|FG000|Overall Study|Protocol Violation|15|||
148777968|NCT00084318|536660475|FG001|Overall Study|Protocol Violation|11|||
148777969|NCT00084318|536660474|FG000|Overall Study|No protocol treatment|2|||
148777970|NCT00084318|536660475|FG001|Overall Study|No protocol treatment|0|||
148777971|NCT03430895|536660476|FG000|Overall Study|Not Treated|2|||
148777972|NCT01645891|536660484|FG000|Overall Study|Adverse Event|6|||
148777973|NCT01645891|536660485|FG001|Overall Study|Adverse Event|10|||
148777974|NCT01645891|536660484|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
148777975|NCT01645891|536660485|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
148777976|NCT01645891|536660484|FG000|Overall Study|Withdrawal by Subject|3|||
148777977|NCT01645891|536660485|FG001|Overall Study|Withdrawal by Subject|3|||
148777978|NCT01645891|536660484|FG000|Overall Study|Protocol Violation|4|||
148777979|NCT01645891|536660485|FG001|Overall Study|Protocol Violation|0|||
148777980|NCT01645891|536660484|FG000|Overall Study|Lost to Follow-up|4|||
148777981|NCT01645891|536660485|FG001|Overall Study|Lost to Follow-up|1|||
148777982|NCT01645891|536660484|FG000|Overall Study|Death|0|||
148777983|NCT01645891|536660485|FG001|Overall Study|Death|2|||
148861684|NCT00075725|536972262|FG001|Overall Study|Withdrawal by Subject|3|||
148861685|NCT00075725|536972263|FG002|Overall Study|Withdrawal by Subject|6|||
148861686|NCT00075725|536972264|FG003|Overall Study|Withdrawal by Subject|10|||
148861687|NCT00075725|536972265|FG004|Overall Study|Withdrawal by Subject|6|||
148861688|NCT00075725|536972266|FG005|Overall Study|Withdrawal by Subject|27|||
148861689|NCT00075725|536972267|FG006|Overall Study|Withdrawal by Subject|7|||
148861690|NCT00075725|536972268|FG007|Overall Study|Withdrawal by Subject|31|||
148861691|NCT00075725|536972269|FG008|Overall Study|Withdrawal by Subject|10|||
148861692|NCT00075725|536972270|FG009|Overall Study|Withdrawal by Subject|2|||
148861693|NCT00075725|536972271|FG010|Overall Study|Withdrawal by Subject|0|||
148861694|NCT00075725|536972272|FG011|Overall Study|Withdrawal by Subject|0|||
148861695|NCT00075725|536972261|FG000|Overall Study|Disease Progression, all other reasons|17|||
148861696|NCT00075725|536972262|FG001|Overall Study|Disease Progression, all other reasons|5|||
148861697|NCT00075725|536972263|FG002|Overall Study|Disease Progression, all other reasons|33|||
148861698|NCT00075725|536972264|FG003|Overall Study|Disease Progression, all other reasons|6|||
148861699|NCT00075725|536972265|FG004|Overall Study|Disease Progression, all other reasons|21|||
148861700|NCT00075725|536972266|FG005|Overall Study|Disease Progression, all other reasons|59|||
148861701|NCT00075725|536972267|FG006|Overall Study|Disease Progression, all other reasons|20|||
148861702|NCT00075725|536972268|FG007|Overall Study|Disease Progression, all other reasons|46|||
148861703|NCT00075725|536972269|FG008|Overall Study|Disease Progression, all other reasons|21|||
148861704|NCT00075725|536972270|FG009|Overall Study|Disease Progression, all other reasons|4|||
148861705|NCT00075725|536972271|FG010|Overall Study|Disease Progression, all other reasons|0|||
148861706|NCT00075725|536972272|FG011|Overall Study|Disease Progression, all other reasons|5|||
148861707|NCT00075725|536972261|FG000|Overall Study|Patient off treatment|0|||
148861708|NCT00075725|536972262|FG001|Overall Study|Patient off treatment|0|||
148861709|NCT00075725|536972263|FG002|Overall Study|Patient off treatment|1|||
148861710|NCT00075725|536972264|FG003|Overall Study|Patient off treatment|2|||
148861711|NCT00075725|536972265|FG004|Overall Study|Patient off treatment|1|||
148861712|NCT00075725|536972266|FG005|Overall Study|Patient off treatment|0|||
148861713|NCT00075725|536972267|FG006|Overall Study|Patient off treatment|0|||
148861714|NCT00075725|536972268|FG007|Overall Study|Patient off treatment|2|||
148861715|NCT00075725|536972269|FG008|Overall Study|Patient off treatment|1|||
148861716|NCT00075725|536972270|FG009|Overall Study|Patient off treatment|0|||
148861717|NCT00075725|536972271|FG010|Overall Study|Patient off treatment|0|||
148861718|NCT00075725|536972272|FG011|Overall Study|Patient off treatment|0|||
148861719|NCT00075725|536972261|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
148861720|NCT00075725|536972262|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
148861721|NCT00075725|536972263|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
148861722|NCT00075725|536972264|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
148861723|NCT00075725|536972265|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
148861724|NCT00075725|536972266|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
148861725|NCT00075725|536972267|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
148861726|NCT00075725|536972268|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
148861727|NCT00075725|536972269|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
148861728|NCT00075725|536972270|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
148861729|NCT00075725|536972271|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
148861730|NCT00075725|536972272|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
148861731|NCT00075725|536972261|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
148861732|NCT00075725|536972262|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
148861733|NCT00075725|536972263|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
148861734|NCT00075725|536972264|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
148861735|NCT00075725|536972265|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
148861736|NCT00075725|536972266|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
148861737|NCT00075725|536972267|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
148861738|NCT00075725|536972268|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
148861739|NCT00075725|536972269|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
148861740|NCT00075725|536972270|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
148861741|NCT00075725|536972271|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
148861742|NCT00075725|536972272|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
148861743|NCT00075725|536972261|FG000|Overall Study|Pt non compliant with therapy|2|||
148861744|NCT00075725|536972262|FG001|Overall Study|Pt non compliant with therapy|1|||
148861745|NCT00075725|536972263|FG002|Overall Study|Pt non compliant with therapy|1|||
148861746|NCT00075725|536972264|FG003|Overall Study|Pt non compliant with therapy|0|||
148861747|NCT00075725|536972265|FG004|Overall Study|Pt non compliant with therapy|2|||
148861748|NCT00075725|536972266|FG005|Overall Study|Pt non compliant with therapy|14|||
148861749|NCT00075725|536972267|FG006|Overall Study|Pt non compliant with therapy|2|||
148861750|NCT00075725|536972268|FG007|Overall Study|Pt non compliant with therapy|5|||
148861751|NCT00075725|536972269|FG008|Overall Study|Pt non compliant with therapy|3|||
148861752|NCT00075725|536972270|FG009|Overall Study|Pt non compliant with therapy|0|||
148861753|NCT00075725|536972271|FG010|Overall Study|Pt non compliant with therapy|0|||
148861754|NCT00075725|536972272|FG011|Overall Study|Pt non compliant with therapy|0|||
148861755|NCT00075725|536972261|FG000|Overall Study|Pt age out of range for treatment|0|||
148861756|NCT00075725|536972262|FG001|Overall Study|Pt age out of range for treatment|1|||
148861757|NCT00075725|536972263|FG002|Overall Study|Pt age out of range for treatment|0|||
148861758|NCT00075725|536972264|FG003|Overall Study|Pt age out of range for treatment|0|||
148861759|NCT00075725|536972265|FG004|Overall Study|Pt age out of range for treatment|0|||
148861760|NCT00075725|536972266|FG005|Overall Study|Pt age out of range for treatment|1|||
148861761|NCT00075725|536972267|FG006|Overall Study|Pt age out of range for treatment|0|||
148861762|NCT00075725|536972268|FG007|Overall Study|Pt age out of range for treatment|1|||
148861763|NCT00075725|536972269|FG008|Overall Study|Pt age out of range for treatment|0|||
148861764|NCT00075725|536972270|FG009|Overall Study|Pt age out of range for treatment|0|||
148861765|NCT00075725|536972271|FG010|Overall Study|Pt age out of range for treatment|0|||
148861766|NCT00075725|536972272|FG011|Overall Study|Pt age out of range for treatment|0|||
148861767|NCT00075725|536972261|FG000|Overall Study|Insurance issues|0|||
148861768|NCT00075725|536972262|FG001|Overall Study|Insurance issues|1|||
148861769|NCT00075725|536972263|FG002|Overall Study|Insurance issues|0|||
148861770|NCT00075725|536972264|FG003|Overall Study|Insurance issues|1|||
148861771|NCT00075725|536972265|FG004|Overall Study|Insurance issues|1|||
148861772|NCT00075725|536972266|FG005|Overall Study|Insurance issues|1|||
148861773|NCT00075725|536972267|FG006|Overall Study|Insurance issues|0|||
148861774|NCT00075725|536972268|FG007|Overall Study|Insurance issues|1|||
148861775|NCT00075725|536972269|FG008|Overall Study|Insurance issues|0|||
148861776|NCT00075725|536972270|FG009|Overall Study|Insurance issues|0|||
148861777|NCT00075725|536972271|FG010|Overall Study|Insurance issues|0|||
148861778|NCT00075725|536972272|FG011|Overall Study|Insurance issues|0|||
148861779|NCT00075725|536972261|FG000|Overall Study|MRD positive after extended ind|0|||
148861780|NCT00075725|536972262|FG001|Overall Study|MRD positive after extended ind|1|||
148861781|NCT00075725|536972263|FG002|Overall Study|MRD positive after extended ind|1|||
148861782|NCT00075725|536972264|FG003|Overall Study|MRD positive after extended ind|0|||
148861783|NCT00075725|536972265|FG004|Overall Study|MRD positive after extended ind|1|||
148861784|NCT00075725|536972266|FG005|Overall Study|MRD positive after extended ind|2|||
148861785|NCT00075725|536972267|FG006|Overall Study|MRD positive after extended ind|0|||
148861786|NCT00075725|536972268|FG007|Overall Study|MRD positive after extended ind|1|||
148861787|NCT00075725|536972269|FG008|Overall Study|MRD positive after extended ind|0|||
148861788|NCT00075725|536972270|FG009|Overall Study|MRD positive after extended ind|0|||
148861789|NCT00075725|536972271|FG010|Overall Study|MRD positive after extended ind|0|||
148861790|NCT00075725|536972272|FG011|Overall Study|MRD positive after extended ind|0|||
148861791|NCT00075725|536972261|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
148861792|NCT00075725|536972262|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
148861793|NCT00075725|536972263|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
148861794|NCT00075725|536972264|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
148861795|NCT00075725|536972265|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
148861796|NCT00075725|536972266|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
148861797|NCT00075725|536972267|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
148861798|NCT00075725|536972268|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
148861799|NCT00075725|536972269|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
148861800|NCT00075725|536972270|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
148861801|NCT00075725|536972271|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
148861802|NCT00075725|536972272|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
148861803|NCT00075725|536972261|FG000|Overall Study|Inevaluable|1|||
148861804|NCT00075725|536972262|FG001|Overall Study|Inevaluable|1|||
148861805|NCT00075725|536972263|FG002|Overall Study|Inevaluable|4|||
148861806|NCT00075725|536972264|FG003|Overall Study|Inevaluable|2|||
148861807|NCT00075725|536972265|FG004|Overall Study|Inevaluable|2|||
148861808|NCT00075725|536972266|FG005|Overall Study|Inevaluable|9|||
148861809|NCT00075725|536972267|FG006|Overall Study|Inevaluable|1|||
148861810|NCT00075725|536972268|FG007|Overall Study|Inevaluable|11|||
148861811|NCT00075725|536972269|FG008|Overall Study|Inevaluable|2|||
148993313|NCT02647359|537451291|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
148861812|NCT00075725|536972270|FG009|Overall Study|Inevaluable|0|||
148861813|NCT00075725|536972271|FG010|Overall Study|Inevaluable|1|||
148861814|NCT00075725|536972272|FG011|Overall Study|Inevaluable|0|||
148861815|NCT00075725|536972261|FG000|Overall Study|Other|4|||
148861816|NCT00075725|536972262|FG001|Overall Study|Other|2|||
148861817|NCT00075725|536972263|FG002|Overall Study|Other|1|||
148861818|NCT00075725|536972264|FG003|Overall Study|Other|1|||
148861819|NCT00075725|536972265|FG004|Overall Study|Other|1|||
148861820|NCT00075725|536972266|FG005|Overall Study|Other|4|||
148861821|NCT00075725|536972267|FG006|Overall Study|Other|2|||
148861822|NCT00075725|536972268|FG007|Overall Study|Other|9|||
148861823|NCT00075725|536972269|FG008|Overall Study|Other|2|||
148861824|NCT00075725|536972270|FG009|Overall Study|Other|1|||
148993314|NCT02647359|537451290|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
148993315|NCT02647359|537451291|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
148861825|NCT00075725|536972271|FG010|Overall Study|Other|0|||
148861826|NCT00075725|536972272|FG011|Overall Study|Other|3|||
148861827|NCT00075725|536972261|FG000|Overall Study|Pt trying to find a BM donor|0|||
148861828|NCT00075725|536972262|FG001|Overall Study|Pt trying to find a BM donor|1|||
148861829|NCT00075725|536972263|FG002|Overall Study|Pt trying to find a BM donor|0|||
148861830|NCT00075725|536972264|FG003|Overall Study|Pt trying to find a BM donor|0|||
148861831|NCT00075725|536972265|FG004|Overall Study|Pt trying to find a BM donor|0|||
148861832|NCT00075725|536972266|FG005|Overall Study|Pt trying to find a BM donor|0|||
148861833|NCT00075725|536972267|FG006|Overall Study|Pt trying to find a BM donor|0|||
148861834|NCT00075725|536972268|FG007|Overall Study|Pt trying to find a BM donor|0|||
148861835|NCT00075725|536972269|FG008|Overall Study|Pt trying to find a BM donor|0|||
148861836|NCT00075725|536972270|FG009|Overall Study|Pt trying to find a BM donor|0|||
148861837|NCT00075725|536972271|FG010|Overall Study|Pt trying to find a BM donor|0|||
148861838|NCT00075725|536972272|FG011|Overall Study|Pt trying to find a BM donor|0|||
148861839|NCT00075725|536972261|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
148861840|NCT00075725|536972262|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
148861841|NCT00075725|536972263|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
148861842|NCT00075725|536972264|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
148861843|NCT00075725|536972265|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
148861844|NCT00075725|536972266|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
148861845|NCT00075725|536972267|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
148861846|NCT00075725|536972268|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
148861847|NCT00075725|536972269|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
148861848|NCT00075725|536972270|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
148861849|NCT00075725|536972271|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
148861850|NCT00075725|536972272|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
148861851|NCT00075725|536972261|FG000|Overall Study|Unsuccessful institutional transfer|0|||
148861852|NCT00075725|536972262|FG001|Overall Study|Unsuccessful institutional transfer|0|||
148861853|NCT00075725|536972263|FG002|Overall Study|Unsuccessful institutional transfer|2|||
148861854|NCT00075725|536972264|FG003|Overall Study|Unsuccessful institutional transfer|0|||
148861855|NCT00075725|536972265|FG004|Overall Study|Unsuccessful institutional transfer|0|||
148861856|NCT00075725|536972266|FG005|Overall Study|Unsuccessful institutional transfer|0|||
148861857|NCT00075725|536972267|FG006|Overall Study|Unsuccessful institutional transfer|0|||
148861858|NCT00075725|536972268|FG007|Overall Study|Unsuccessful institutional transfer|0|||
148861859|NCT00075725|536972269|FG008|Overall Study|Unsuccessful institutional transfer|0|||
148861860|NCT00075725|536972270|FG009|Overall Study|Unsuccessful institutional transfer|1|||
148861861|NCT00075725|536972271|FG010|Overall Study|Unsuccessful institutional transfer|0|||
148861862|NCT00075725|536972272|FG011|Overall Study|Unsuccessful institutional transfer|0|||
148861863|NCT00075725|536972261|FG000|Overall Study|specimen(s) not submitted|0|||
148861864|NCT00075725|536972262|FG001|Overall Study|specimen(s) not submitted|0|||
148861865|NCT00075725|536972263|FG002|Overall Study|specimen(s) not submitted|2|||
148861866|NCT00075725|536972264|FG003|Overall Study|specimen(s) not submitted|0|||
148861867|NCT00075725|536972265|FG004|Overall Study|specimen(s) not submitted|0|||
148861868|NCT00075725|536972266|FG005|Overall Study|specimen(s) not submitted|0|||
148861869|NCT00075725|536972267|FG006|Overall Study|specimen(s) not submitted|0|||
148861870|NCT00075725|536972268|FG007|Overall Study|specimen(s) not submitted|0|||
148861871|NCT00075725|536972269|FG008|Overall Study|specimen(s) not submitted|0|||
148861872|NCT00075725|536972270|FG009|Overall Study|specimen(s) not submitted|0|||
148861873|NCT00075725|536972271|FG010|Overall Study|specimen(s) not submitted|0|||
148861874|NCT00075725|536972272|FG011|Overall Study|specimen(s) not submitted|0|||
148861875|NCT00075725|536972261|FG000|Overall Study|Pt went to transplant|0|||
148861876|NCT00075725|536972262|FG001|Overall Study|Pt went to transplant|0|||
148861877|NCT00075725|536972263|FG002|Overall Study|Pt went to transplant|0|||
148861878|NCT00075725|536972264|FG003|Overall Study|Pt went to transplant|1|||
148861879|NCT00075725|536972265|FG004|Overall Study|Pt went to transplant|0|||
148861880|NCT00075725|536972266|FG005|Overall Study|Pt went to transplant|1|||
148861881|NCT00075725|536972267|FG006|Overall Study|Pt went to transplant|0|||
148861882|NCT00075725|536972268|FG007|Overall Study|Pt went to transplant|0|||
148861883|NCT00075725|536972269|FG008|Overall Study|Pt went to transplant|0|||
148861884|NCT00075725|536972270|FG009|Overall Study|Pt went to transplant|0|||
148861885|NCT00075725|536972271|FG010|Overall Study|Pt went to transplant|0|||
148861886|NCT00075725|536972272|FG011|Overall Study|Pt went to transplant|0|||
148861887|NCT00075725|536972261|FG000|Overall Study|Pt received additional steroids|0|||
148861888|NCT00075725|536972262|FG001|Overall Study|Pt received additional steroids|0|||
148861889|NCT00075725|536972263|FG002|Overall Study|Pt received additional steroids|0|||
148861890|NCT00075725|536972264|FG003|Overall Study|Pt received additional steroids|1|||
148861891|NCT00075725|536972265|FG004|Overall Study|Pt received additional steroids|0|||
148861892|NCT00075725|536972266|FG005|Overall Study|Pt received additional steroids|0|||
148861893|NCT00075725|536972267|FG006|Overall Study|Pt received additional steroids|0|||
148861894|NCT00075725|536972268|FG007|Overall Study|Pt received additional steroids|0|||
149030779|NCT00819910|537589713|FG003|Overall Study|Withdrawal by Subject|0|||
148861895|NCT00075725|536972269|FG008|Overall Study|Pt received additional steroids|0|||
148861896|NCT00075725|536972270|FG009|Overall Study|Pt received additional steroids|0|||
148861897|NCT00075725|536972271|FG010|Overall Study|Pt received additional steroids|0|||
149030780|NCT00819910|537589710|FG000|Overall Study|Lost to Follow-up|1|||
149030781|NCT00819910|537589711|FG001|Overall Study|Lost to Follow-up|0|||
149030782|NCT00819910|537589712|FG002|Overall Study|Lost to Follow-up|0|||
149030783|NCT00819910|537589713|FG003|Overall Study|Lost to Follow-up|0|||
149030784|NCT00836810|537589716|FG000|Overall Study|New diagnosis|1|||
149030785|NCT00836810|537589717|FG001|Overall Study|New diagnosis|0|||
149030786|NCT00871429|537589719|FG000|Overall Study|Lost to Follow-up|6|||
149030787|NCT00871429|537589719|FG000|Overall Study|Withdrawal by Subject|17|||
149030788|NCT00871429|537589719|FG000|Overall Study|Questionnaire not completed|1|||
149030789|NCT03102242|537589720|FG000|Overall Study|Adverse Event|2|||
149030790|NCT02931396|537589721|FG000|Overall Study|Lost to Follow-up|3|||
149030791|NCT02931396|537589722|FG001|Overall Study|Lost to Follow-up|0|||
149030792|NCT02931396|537589721|FG000|Overall Study|Withdrawal by Subject|2|||
149030793|NCT02931396|537589722|FG001|Overall Study|Withdrawal by Subject|0|||
149030794|NCT05273801|537589723|FG000|Overall Study|Physician Decision|1|||
149030795|NCT03784963|537591562|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
149030796|NCT03784963|537591563|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
149030797|NCT03784963|537591564|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
149030798|NCT03784963|537591565|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
149030799|NCT01510912|537591566|FG000|Overall Study|Adverse Event|99|||
149030800|NCT01510912|537591566|FG000|Overall Study|Lack of Efficacy|12|||
149030801|NCT01510912|537591566|FG000|Overall Study|Non-compliance with trial drug|23|||
149030802|NCT01510912|537591566|FG000|Overall Study|Withdrawal by Subject|49|||
149030803|NCT01510912|537591566|FG000|Overall Study|Physician Decision|1|||
149030804|NCT01510912|537591566|FG000|Overall Study|Protocol Violation|27|||
149030805|NCT01510912|537591566|FG000|Overall Study|Lost to Follow-up|26|||
149030806|NCT01510912|537591566|FG000|Overall Study|Other, including joint replacement|5|||
149030807|NCT00349908|537591567|FG000|Overall Study|Withdrawal by Subject|0|||
149030808|NCT00349908|537591568|FG001|Overall Study|Withdrawal by Subject|4|||
149030809|NCT00109967|537591571|FG000|Overall Study|Cancel Prior to Treatment|2|||
149030810|NCT00109967|537591572|FG001|Overall Study|Cancel Prior to Treatment|0|||
149030811|NCT00109967|537591571|FG000|Overall Study|Adverse Event|12|||
149030812|NCT00109967|537591572|FG001|Overall Study|Adverse Event|1|||
149030813|NCT00109967|537591571|FG000|Overall Study|Withdrawal by Subject|5|||
149030814|NCT00109967|537591572|FG001|Overall Study|Withdrawal by Subject|0|||
149030815|NCT00109967|537591571|FG000|Overall Study|Physician Decision|1|||
149030816|NCT00109967|537591572|FG001|Overall Study|Physician Decision|3|||
149030817|NCT00109967|537591571|FG000|Overall Study|Death|0|||
149030818|NCT00109967|537591572|FG001|Overall Study|Death|2|||
149030819|NCT01063036|537591575|FG000|Participants Treated With Study Drug|Adverse Event|1|||
149030820|NCT01063036|537591575|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
149030821|NCT01063036|537591575|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
149030822|NCT01063036|537591575|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
149030823|NCT01063036|537591575|FG000|Participants Treated With Study Drug|Pregnancy|1|||
149030824|NCT01063036|537591575|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
149030825|NCT01063036|537591575|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
149030826|NCT01063036|537591575|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
149030827|NCT01977612|537591576|FG000|Overall Study|Lost to Follow-up|1|||
149030828|NCT01977612|537591577|FG001|Overall Study|Lost to Follow-up|1|||
149030829|NCT02715258|537591578|FG000|Overall Study|Withdrawal by Subject|6|||
149030830|NCT02715258|537591579|FG001|Overall Study|Withdrawal by Subject|1|||
149030831|NCT02715258|537591578|FG000|Overall Study|Lost to Follow-up|7|||
149030832|NCT02715258|537591579|FG001|Overall Study|Lost to Follow-up|1|||
149030833|NCT02715258|537591578|FG000|Overall Study|Terminated by Sponsor|0|||
149030834|NCT02715258|537591579|FG001|Overall Study|Terminated by Sponsor|1|||
149030835|NCT02715258|537591578|FG000|Overall Study|Death|0|||
149030836|NCT02715258|537591579|FG001|Overall Study|Death|1|||
149030837|NCT02715258|537591578|FG000|Overall Study|Subject non-compliant|1|||
149030838|NCT02715258|537591579|FG001|Overall Study|Subject non-compliant|1|||
149030839|NCT02715258|537591578|FG000|Overall Study|GCP violation|2|||
149030840|NCT02715258|537591579|FG001|Overall Study|GCP violation|1|||
149030841|NCT02955069|537591581|FG000|Overall Study|Adverse Event|7|||
149030842|NCT02955069|537591582|FG001|Overall Study|Adverse Event|2|||
149030843|NCT02955069|537591581|FG000|Overall Study|Death|7|||
149030844|NCT02955069|537591582|FG001|Overall Study|Death|3|||
148861898|NCT00075725|536972272|FG011|Overall Study|Pt received additional steroids|0|||
148861899|NCT00075725|536972261|FG000|Overall Study|Pt relocated|0|||
149030845|NCT02955069|537591581|FG000|Overall Study|Physician Decision|10|||
149030846|NCT02955069|537591582|FG001|Overall Study|Physician Decision|2|||
149030847|NCT02955069|537591581|FG000|Overall Study|Progressive disease|64|||
149030848|NCT02955069|537591582|FG001|Overall Study|Progressive disease|13|||
149030849|NCT02955069|537591581|FG000|Overall Study|Study terminated by sponsor|4|||
149030850|NCT02955069|537591582|FG001|Overall Study|Study terminated by sponsor|0|||
149030851|NCT02955069|537591581|FG000|Overall Study|Subject/Guardian decision|3|||
148861900|NCT00075725|536972262|FG001|Overall Study|Pt relocated|0|||
148861901|NCT00075725|536972263|FG002|Overall Study|Pt relocated|0|||
148861902|NCT00075725|536972264|FG003|Overall Study|Pt relocated|2|||
148861903|NCT00075725|536972265|FG004|Overall Study|Pt relocated|0|||
148861904|NCT00075725|536972266|FG005|Overall Study|Pt relocated|1|||
148861905|NCT00075725|536972267|FG006|Overall Study|Pt relocated|1|||
148861906|NCT00075725|536972268|FG007|Overall Study|Pt relocated|2|||
148861907|NCT00075725|536972269|FG008|Overall Study|Pt relocated|1|||
148861908|NCT00075725|536972270|FG009|Overall Study|Pt relocated|0|||
148861909|NCT00075725|536972271|FG010|Overall Study|Pt relocated|0|||
148861910|NCT00075725|536972272|FG011|Overall Study|Pt relocated|0|||
148861911|NCT00075725|536972261|FG000|Overall Study|Institution Terminated|0|||
148861912|NCT00075725|536972262|FG001|Overall Study|Institution Terminated|0|||
148861913|NCT00075725|536972263|FG002|Overall Study|Institution Terminated|0|||
148861914|NCT00075725|536972264|FG003|Overall Study|Institution Terminated|0|||
148861915|NCT00075725|536972265|FG004|Overall Study|Institution Terminated|1|||
148861916|NCT00075725|536972266|FG005|Overall Study|Institution Terminated|0|||
148861917|NCT00075725|536972267|FG006|Overall Study|Institution Terminated|0|||
148861918|NCT00075725|536972268|FG007|Overall Study|Institution Terminated|3|||
148861919|NCT00075725|536972269|FG008|Overall Study|Institution Terminated|0|||
148861920|NCT00075725|536972270|FG009|Overall Study|Institution Terminated|0|||
148861921|NCT00075725|536972271|FG010|Overall Study|Institution Terminated|0|||
148861922|NCT00075725|536972272|FG011|Overall Study|Institution Terminated|0|||
148861923|NCT00075725|536972261|FG000|Overall Study|Study Closure|1|||
148861924|NCT00075725|536972262|FG001|Overall Study|Study Closure|0|||
148861925|NCT00075725|536972263|FG002|Overall Study|Study Closure|0|||
148861926|NCT00075725|536972264|FG003|Overall Study|Study Closure|0|||
148861927|NCT00075725|536972265|FG004|Overall Study|Study Closure|1|||
148861928|NCT00075725|536972266|FG005|Overall Study|Study Closure|3|||
148861929|NCT00075725|536972267|FG006|Overall Study|Study Closure|0|||
149030852|NCT02955069|537591582|FG001|Overall Study|Subject/Guardian decision|1|||
148861930|NCT00075725|536972268|FG007|Overall Study|Study Closure|1|||
148861931|NCT00075725|536972269|FG008|Overall Study|Study Closure|0|||
148861932|NCT00075725|536972270|FG009|Overall Study|Study Closure|0|||
148861933|NCT00075725|536972271|FG010|Overall Study|Study Closure|0|||
148861934|NCT00075725|536972272|FG011|Overall Study|Study Closure|0|||
148861935|NCT00075725|536972261|FG000|Overall Study|Other complications|0|||
148861936|NCT00075725|536972262|FG001|Overall Study|Other complications|0|||
148861937|NCT00075725|536972263|FG002|Overall Study|Other complications|0|||
148861938|NCT00075725|536972264|FG003|Overall Study|Other complications|0|||
148861939|NCT00075725|536972265|FG004|Overall Study|Other complications|0|||
148861940|NCT00075725|536972266|FG005|Overall Study|Other complications|1|||
148861941|NCT00075725|536972267|FG006|Overall Study|Other complications|0|||
148861942|NCT00075725|536972268|FG007|Overall Study|Other complications|0|||
148861943|NCT00075725|536972269|FG008|Overall Study|Other complications|0|||
148861944|NCT00075725|536972270|FG009|Overall Study|Other complications|0|||
148861945|NCT00075725|536972271|FG010|Overall Study|Other complications|0|||
148861946|NCT00075725|536972272|FG011|Overall Study|Other complications|0|||
148861947|NCT00075725|536972261|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
148861948|NCT00075725|536972262|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
148861949|NCT00075725|536972263|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
148861950|NCT00075725|536972264|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
148861951|NCT00075725|536972265|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
148861952|NCT00075725|536972266|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
148861953|NCT00075725|536972267|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
148861954|NCT00075725|536972268|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
148861955|NCT00075725|536972269|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
148861956|NCT00075725|536972270|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
148861957|NCT00075725|536972271|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
148861958|NCT00075725|536972272|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
148861959|NCT00075725|536972261|FG000|Overall Study|Pt incarcerated|0|||
148861960|NCT00075725|536972262|FG001|Overall Study|Pt incarcerated|0|||
148861961|NCT00075725|536972263|FG002|Overall Study|Pt incarcerated|0|||
148861962|NCT00075725|536972264|FG003|Overall Study|Pt incarcerated|0|||
148861963|NCT00075725|536972265|FG004|Overall Study|Pt incarcerated|0|||
148861964|NCT00075725|536972266|FG005|Overall Study|Pt incarcerated|0|||
148861965|NCT00075725|536972267|FG006|Overall Study|Pt incarcerated|0|||
148861966|NCT00075725|536972268|FG007|Overall Study|Pt incarcerated|1|||
148861967|NCT00075725|536972269|FG008|Overall Study|Pt incarcerated|0|||
148861968|NCT00075725|536972270|FG009|Overall Study|Pt incarcerated|0|||
148861969|NCT00075725|536972271|FG010|Overall Study|Pt incarcerated|0|||
148861970|NCT00075725|536972272|FG011|Overall Study|Pt incarcerated|0|||
148861971|NCT03242772|536972273|FG000|Overall Study|Lost to Follow-up|2|||
148861972|NCT03242772|536972274|FG001|Overall Study|Lost to Follow-up|0|||
148861973|NCT03242772|536972273|FG000|Overall Study|Physician Decision|0|||
148861974|NCT03242772|536972274|FG001|Overall Study|Physician Decision|1|||
148861975|NCT03242772|536972273|FG000|Overall Study|Withdrawal by Subject|1|||
148861976|NCT03242772|536972274|FG001|Overall Study|Withdrawal by Subject|0|||
148861977|NCT02437305|536972276|FG000|Overall Study|Lost to Follow-up|18|||
148861978|NCT02437305|536972277|FG001|Overall Study|Lost to Follow-up|12|||
148861979|NCT01560637|536972278|FG000|Overall Study|Adverse Event|63|||
148861980|NCT01560637|536972278|FG000|Overall Study|Death|69|||
148861981|NCT01560637|536972278|FG000|Overall Study|Lost to Follow-up|8|||
148861982|NCT01560637|536972278|FG000|Overall Study|Protocol Violation|8|||
148861983|NCT01560637|536972278|FG000|Overall Study|Withdrawal by Subject|24|||
148861984|NCT01560637|536972278|FG000|Overall Study|Progressive Disease|20|||
148861985|NCT01560637|536972278|FG000|Overall Study|Other Reason Not Specified|6|||
148861986|NCT03220581|536972279|FG000|Overall Study|Withdrawal by Subject|0|||
148861987|NCT03220581|536972280|FG001|Overall Study|Withdrawal by Subject|1|||
148861988|NCT03220581|536972279|FG000|Overall Study|Lost to Follow-up|3|||
148861989|NCT03220581|536972280|FG001|Overall Study|Lost to Follow-up|6|||
148861990|NCT01185964|536972282|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
148861991|NCT01185964|536972283|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
148861992|NCT01185964|536972284|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
148861993|NCT01185964|536972285|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
148861994|NCT01185964|536972282|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
148861995|NCT01185964|536972283|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
148861996|NCT01185964|536972284|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
148861997|NCT01185964|536972285|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
148861998|NCT01185964|536972282|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
148861999|NCT01185964|536972283|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
148862000|NCT01185964|536972284|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
148862001|NCT01185964|536972285|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
148862002|NCT01185964|536972282|FG000|Phase 1b and Phase 2|Adverse Event|1|||
148862003|NCT01185964|536972283|FG001|Phase 1b and Phase 2|Adverse Event|0|||
148862004|NCT01185964|536972284|FG002|Phase 1b and Phase 2|Adverse Event|2|||
148862005|NCT01185964|536972285|FG003|Phase 1b and Phase 2|Adverse Event|0|||
148862006|NCT01185964|536972282|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
148862007|NCT01185964|536972283|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
148862008|NCT01185964|536972284|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
148862009|NCT01185964|536972285|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
148862010|NCT01185964|536972282|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
148862011|NCT01185964|536972283|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
148862012|NCT01185964|536972284|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
148862013|NCT01185964|536972285|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
148862014|NCT01185964|536972282|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
148862015|NCT01185964|536972283|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
148862016|NCT01185964|536972284|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
148862017|NCT01185964|536972285|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
148862018|NCT01185964|536972282|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
148862019|NCT01185964|536972283|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
148862020|NCT01185964|536972284|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
148862021|NCT01185964|536972285|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
148862022|NCT04465877|536972286|FG000|Overall Study|Noncompliant with study requirements|0|||
148862023|NCT04465877|536972287|FG001|Overall Study|Noncompliant with study requirements|0|||
148862024|NCT04465877|536972288|FG002|Overall Study|Noncompliant with study requirements|1|||
148993316|NCT04642638|537451292|FG000|Overall Study|Withdrawal by Subject|23|||
148993317|NCT04642638|537451293|FG001|Overall Study|Withdrawal by Subject|29|||
148993318|NCT04642638|537451294|FG002|Overall Study|Withdrawal by Subject|9|||
148993319|NCT04642638|537451295|FG003|Overall Study|Withdrawal by Subject|7|||
148993320|NCT04642638|537451296|FG004|Overall Study|Withdrawal by Subject|61|||
148993321|NCT04642638|537451297|FG005|Overall Study|Withdrawal by Subject|27|||
148993322|NCT04642638|537451292|FG000|Overall Study|Lost to Follow-up|17|||
148993323|NCT04642638|537451293|FG001|Overall Study|Lost to Follow-up|18|||
148993324|NCT04642638|537451294|FG002|Overall Study|Lost to Follow-up|5|||
148993325|NCT04642638|537451295|FG003|Overall Study|Lost to Follow-up|5|||
148993326|NCT04642638|537451296|FG004|Overall Study|Lost to Follow-up|6|||
148993327|NCT04642638|537451297|FG005|Overall Study|Lost to Follow-up|3|||
148993328|NCT04642638|537451292|FG000|Overall Study|Adverse Event|0|||
148993329|NCT04642638|537451293|FG001|Overall Study|Adverse Event|0|||
148993330|NCT04642638|537451294|FG002|Overall Study|Adverse Event|1|||
148993331|NCT04642638|537451295|FG003|Overall Study|Adverse Event|0|||
148993332|NCT04642638|537451296|FG004|Overall Study|Adverse Event|10|||
148993333|NCT04642638|537451297|FG005|Overall Study|Adverse Event|3|||
148993334|NCT04642638|537451292|FG000|Overall Study|Reason Not Specified|1|||
148993335|NCT04642638|537451293|FG001|Overall Study|Reason Not Specified|4|||
148993336|NCT04642638|537451294|FG002|Overall Study|Reason Not Specified|0|||
148993337|NCT04642638|537451295|FG003|Overall Study|Reason Not Specified|0|||
149030853|NCT00943605|537591583|FG000|Overall Study|Study termination|30|||
148993338|NCT04642638|537451296|FG004|Overall Study|Reason Not Specified|38|||
148993339|NCT04642638|537451297|FG005|Overall Study|Reason Not Specified|16|||
148993340|NCT04642638|537451292|FG000|Overall Study|Physician Decision|0|||
148993341|NCT04642638|537451293|FG001|Overall Study|Physician Decision|0|||
148993342|NCT04642638|537451294|FG002|Overall Study|Physician Decision|0|||
148993343|NCT04642638|537451295|FG003|Overall Study|Physician Decision|0|||
148993344|NCT04642638|537451296|FG004|Overall Study|Physician Decision|2|||
148993345|NCT04642638|537451297|FG005|Overall Study|Physician Decision|1|||
148993346|NCT04642638|537451292|FG000|Overall Study|Protocol Deviation|0|||
148993347|NCT04642638|537451293|FG001|Overall Study|Protocol Deviation|0|||
148993348|NCT04642638|537451294|FG002|Overall Study|Protocol Deviation|0|||
148993349|NCT04642638|537451295|FG003|Overall Study|Protocol Deviation|0|||
148993350|NCT04642638|537451296|FG004|Overall Study|Protocol Deviation|1|||
148993351|NCT04642638|537451297|FG005|Overall Study|Protocol Deviation|3|||
148993352|NCT04642638|537451292|FG000|Overall Study|Study Terminated|0|||
148993353|NCT04642638|537451293|FG001|Overall Study|Study Terminated|0|||
148993354|NCT04642638|537451294|FG002|Overall Study|Study Terminated|0|||
148993355|NCT04642638|537451295|FG003|Overall Study|Study Terminated|0|||
148993356|NCT04642638|537451296|FG004|Overall Study|Study Terminated|484|||
148993357|NCT04642638|537451297|FG005|Overall Study|Study Terminated|250|||
148993358|NCT04642638|537451292|FG000|Overall Study|Pregnancy|0|||
148993359|NCT04642638|537451293|FG001|Overall Study|Pregnancy|0|||
148993360|NCT04642638|537451294|FG002|Overall Study|Pregnancy|0|||
148993361|NCT04642638|537451295|FG003|Overall Study|Pregnancy|0|||
148993362|NCT04642638|537451296|FG004|Overall Study|Pregnancy|1|||
148993363|NCT04642638|537451297|FG005|Overall Study|Pregnancy|0|||
148993364|NCT01672801|537451304|FG000|Overall Study|Screen Failure|0|||
148993365|NCT01672801|537451305|FG001|Overall Study|Screen Failure|1|||
148993366|NCT06476366|537451306|FG000|Overall Study|Lost to Follow-up|1|||
148993367|NCT06476366|537451307|FG001|Overall Study|Lost to Follow-up|3|||
148993368|NCT06476366|537451306|FG000|Overall Study|Adverse Event|1|||
148993369|NCT06476366|537451307|FG001|Overall Study|Adverse Event|0|||
148993370|NCT03449030|537451323|FG000|Overall Study|Withdrawal by Subject|0|||
148993371|NCT03449030|537451324|FG001|Overall Study|Withdrawal by Subject|0|||
148993372|NCT03449030|537451325|FG002|Overall Study|Withdrawal by Subject|0|||
148993373|NCT03449030|537451326|FG003|Overall Study|Withdrawal by Subject|1|||
148993374|NCT03449030|537451327|FG004|Overall Study|Withdrawal by Subject|1|||
148993375|NCT03449030|537451328|FG005|Overall Study|Withdrawal by Subject|1|||
148993376|NCT03449030|537451329|FG006|Overall Study|Withdrawal by Subject|1|||
148993377|NCT03449030|537451330|FG007|Overall Study|Withdrawal by Subject|2|||
148993378|NCT03449030|537451331|FG008|Overall Study|Withdrawal by Subject|0|||
148993379|NCT03449030|537451332|FG009|Overall Study|Withdrawal by Subject|0|||
148993380|NCT03449030|537451323|FG000|Overall Study|Symptomatic Deterioration|0|||
148993381|NCT03449030|537451324|FG001|Overall Study|Symptomatic Deterioration|1|||
148993382|NCT03449030|537451325|FG002|Overall Study|Symptomatic Deterioration|0|||
148993383|NCT03449030|537451326|FG003|Overall Study|Symptomatic Deterioration|0|||
148993384|NCT03449030|537451327|FG004|Overall Study|Symptomatic Deterioration|0|||
148993385|NCT03449030|537451328|FG005|Overall Study|Symptomatic Deterioration|1|||
148993386|NCT03449030|537451329|FG006|Overall Study|Symptomatic Deterioration|1|||
148993387|NCT03449030|537451330|FG007|Overall Study|Symptomatic Deterioration|0|||
148993388|NCT03449030|537451331|FG008|Overall Study|Symptomatic Deterioration|2|||
148993389|NCT03449030|537451332|FG009|Overall Study|Symptomatic Deterioration|0|||
148777984|NCT00138073|536660486|FG000|Overall Study|lack of resources|55|||
148777985|NCT03026530|536660487|FG000|Overall Study|Lost to Follow-up|19|||
148777986|NCT03026530|536660488|FG001|Overall Study|Lost to Follow-up|24|||
148777987|NCT03026530|536660487|FG000|Overall Study|Protocol Violation|2|||
148777988|NCT03026530|536660488|FG001|Overall Study|Protocol Violation|5|||
148777989|NCT03301740|536660489|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
148777990|NCT03301740|536660490|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
148777991|NCT03301740|536660489|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
148777992|NCT03301740|536660490|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
148777993|NCT01173055|536660491|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
148777994|NCT01173055|536660492|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
148777995|NCT01173055|536660491|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
148777996|NCT01173055|536660492|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
148777997|NCT04814368|536660493|FG000|Overall Study|Study Terminated by Sponsor|0|||
148777998|NCT04814368|536660494|FG001|Overall Study|Study Terminated by Sponsor|3|||
148777999|NCT04814368|536660495|FG002|Overall Study|Study Terminated by Sponsor|0|||
148778000|NCT04814368|536660496|FG003|Overall Study|Study Terminated by Sponsor|2|||
148778001|NCT04814368|536660493|FG000|Overall Study|Subject Decision|1|||
148778002|NCT04814368|536660494|FG001|Overall Study|Subject Decision|2|||
148778003|NCT04814368|536660495|FG002|Overall Study|Subject Decision|0|||
148778004|NCT04814368|536660496|FG003|Overall Study|Subject Decision|0|||
148778005|NCT04216589|536660498|FG000|Overall Study|Withdrawal by Subject|2|||
148778006|NCT04216589|536660498|FG000|Overall Study|Protocol Violation|1|||
148778007|NCT04216589|536660498|FG000|Overall Study|Incarceration|1|||
148778008|NCT03721835|536660499|FG000|Overall Study|Participant not able to return|1|||
148862025|NCT04465877|536972289|FG003|Overall Study|Noncompliant with study requirements|0|||
148862026|NCT03440918|536972295|FG000|Overall Study|Protocol Violation|0|||
148862027|NCT03440918|536972296|FG001|Overall Study|Protocol Violation|16|||
148993390|NCT03449030|537451323|FG000|Overall Study|Progressive Disease|1|||
148993391|NCT03449030|537451324|FG001|Overall Study|Progressive Disease|0|||
148993392|NCT03449030|537451325|FG002|Overall Study|Progressive Disease|1|||
148993393|NCT03449030|537451326|FG003|Overall Study|Progressive Disease|4|||
148862028|NCT01396265|536972308|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
148862029|NCT03444766|536972309|FG000|Overall Study|Other Reasons|2|||
148862030|NCT03444766|536972309|FG000|Overall Study|Participant Withdrew Consent|5|||
148862031|NCT03444766|536972309|FG000|Overall Study|Lost to Follow-up|2|||
148862032|NCT03444766|536972309|FG000|Overall Study|Death|2|||
148862033|NCT03444766|536972309|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
148862034|NCT03444766|536972309|FG000|Overall Study|Disease Progression|49|||
148862035|NCT04346108|536972310|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
148862036|NCT04346108|536972311|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
148862037|NCT04346108|536972312|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
148862038|NCT04346108|536972310|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
148862039|NCT04346108|536972311|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
148862040|NCT04346108|536972312|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
148862041|NCT01081301|536972313|FG000|Overall Study|Bereaved|3|||
148862042|NCT01081301|536972313|FG000|Overall Study|Too busy|5|||
148862043|NCT01081301|536972313|FG000|Overall Study|Patient too ill|2|||
148862044|NCT01081301|536972313|FG000|Overall Study|Lost to Follow-up|4|||
148862045|NCT00724854|536972314|FG000|Overall Study|Lack of Efficacy|187|||
148862046|NCT00724854|536972315|FG001|Overall Study|Lack of Efficacy|13|||
148862047|NCT00724854|536972314|FG000|Overall Study|Lost to Follow-up|87|||
148862048|NCT00724854|536972315|FG001|Overall Study|Lost to Follow-up|10|||
148862049|NCT00724854|536972314|FG000|Overall Study|Adverse Event|62|||
148862050|NCT00724854|536972315|FG001|Overall Study|Adverse Event|4|||
148862051|NCT00724854|536972314|FG000|Overall Study|Other|42|||
148862052|NCT00724854|536972315|FG001|Overall Study|Other|3|||
148862053|NCT00724854|536972314|FG000|Overall Study|Death|11|||
148862054|NCT00724854|536972315|FG001|Overall Study|Death|0|||
148862055|NCT00724854|536972314|FG000|Overall Study|Change of treatment|7|||
148862056|NCT00724854|536972315|FG001|Overall Study|Change of treatment|0|||
148862057|NCT00724854|536972314|FG000|Overall Study|Withdrawal by Subject|5|||
148862058|NCT00724854|536972315|FG001|Overall Study|Withdrawal by Subject|0|||
148862059|NCT00724854|536972314|FG000|Overall Study|Adverse event + lack of efficacy|2|||
148862060|NCT00724854|536972315|FG001|Overall Study|Adverse event + lack of efficacy|1|||
148862061|NCT02374814|536972318|FG000|Overall Study|Lost to Follow-up|1|||
148862062|NCT02374814|536972319|FG001|Overall Study|Lost to Follow-up|1|||
148862063|NCT02374814|536972320|FG002|Overall Study|Lost to Follow-up|0|||
148862064|NCT02374814|536972321|FG003|Overall Study|Lost to Follow-up|1|||
148862065|NCT02374814|536972322|FG004|Overall Study|Lost to Follow-up|0|||
148862066|NCT02374814|536972323|FG005|Overall Study|Lost to Follow-up|0|||
148862067|NCT02374814|536972318|FG000|Overall Study|Withdrawal by Subject|0|||
148862068|NCT02374814|536972319|FG001|Overall Study|Withdrawal by Subject|0|||
148862069|NCT02374814|536972320|FG002|Overall Study|Withdrawal by Subject|1|||
148862070|NCT02374814|536972321|FG003|Overall Study|Withdrawal by Subject|1|||
148862071|NCT02374814|536972322|FG004|Overall Study|Withdrawal by Subject|0|||
148862072|NCT02374814|536972323|FG005|Overall Study|Withdrawal by Subject|0|||
148862073|NCT02182440|536972324|FG000|Overall Study|Adverse Event|0|||
148862074|NCT02182440|536972325|FG001|Overall Study|Adverse Event|1|||
148862075|NCT02182440|536972326|FG002|Overall Study|Adverse Event|0|||
148862076|NCT02182440|536972327|FG003|Overall Study|Adverse Event|0|||
148862077|NCT02182440|536972324|FG000|Overall Study|Death|31|||
148862078|NCT02182440|536972325|FG001|Overall Study|Death|8|||
148993394|NCT03449030|537451327|FG004|Overall Study|Progressive Disease|5|||
148993395|NCT03449030|537451328|FG005|Overall Study|Progressive Disease|3|||
148993396|NCT03449030|537451329|FG006|Overall Study|Progressive Disease|0|||
148862079|NCT02182440|536972326|FG002|Overall Study|Death|5|||
148862080|NCT02182440|536972327|FG003|Overall Study|Death|16|||
148862081|NCT02182440|536972324|FG000|Overall Study|Protocol Violation|0|||
148862082|NCT02182440|536972325|FG001|Overall Study|Protocol Violation|1|||
148993397|NCT03449030|537451330|FG007|Overall Study|Progressive Disease|1|||
148862083|NCT02182440|536972326|FG002|Overall Study|Protocol Violation|0|||
148862084|NCT02182440|536972327|FG003|Overall Study|Protocol Violation|0|||
148862085|NCT02182440|536972324|FG000|Overall Study|Physician Decision|1|||
148862086|NCT02182440|536972325|FG001|Overall Study|Physician Decision|0|||
148862087|NCT02182440|536972326|FG002|Overall Study|Physician Decision|0|||
148862088|NCT02182440|536972327|FG003|Overall Study|Physician Decision|0|||
148862089|NCT02182440|536972324|FG000|Overall Study|Withdrawal by Subject|1|||
148862090|NCT02182440|536972325|FG001|Overall Study|Withdrawal by Subject|1|||
148862091|NCT02182440|536972326|FG002|Overall Study|Withdrawal by Subject|3|||
148862092|NCT02182440|536972327|FG003|Overall Study|Withdrawal by Subject|4|||
148993398|NCT03449030|537451331|FG008|Overall Study|Progressive Disease|1|||
148993399|NCT03449030|537451332|FG009|Overall Study|Progressive Disease|1|||
148862093|NCT02182440|536972324|FG000|Overall Study|different, e.g adm other hospital|12|||
148862094|NCT02182440|536972325|FG001|Overall Study|different, e.g adm other hospital|3|||
148862095|NCT02182440|536972326|FG002|Overall Study|different, e.g adm other hospital|3|||
148862096|NCT02182440|536972327|FG003|Overall Study|different, e.g adm other hospital|10|||
148862097|NCT01799239|536972328|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
148862098|NCT01799239|536972329|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
148862099|NCT01799239|536972328|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
148862100|NCT01799239|536972329|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
148862101|NCT01799239|536972328|FG000|Period 1 (7 Days)|Protocol Violation|0|||
148862102|NCT01799239|536972329|FG001|Period 1 (7 Days)|Protocol Violation|1|||
148862103|NCT01799239|536972328|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
148862104|NCT01799239|536972329|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
148862105|NCT01799239|536972328|FG000|Period 2 (7 Days)|Protocol Violation|1|||
148862106|NCT01799239|536972329|FG001|Period 2 (7 Days)|Protocol Violation|0|||
148862107|NCT03754582|536972330|FG000|Treatment Phase|Adverse Event|0|||
148862108|NCT03754582|536972331|FG001|Treatment Phase|Adverse Event|1|||
148862109|NCT03754582|536972332|FG002|Treatment Phase|Adverse Event|0|||
148862110|NCT03754582|536972330|FG000|Follow-up Phase|Other|0|||
148862111|NCT03754582|536972331|FG001|Follow-up Phase|Other|0|||
148862112|NCT03754582|536972332|FG002|Follow-up Phase|Other|1|||
148862113|NCT01561755|536972335|FG000|Overall Study|Lost to Follow-up|0|||
148862114|NCT01561755|536972336|FG001|Overall Study|Lost to Follow-up|1|||
148862115|NCT02680574|536972337|FG000|Overall Study|Death|137|||
148862116|NCT02680574|536972338|FG001|Overall Study|Death|137|||
148862117|NCT02680574|536972337|FG000|Overall Study|Withdrawal by Subject|17|||
148862118|NCT02680574|536972338|FG001|Overall Study|Withdrawal by Subject|9|||
148862119|NCT02680574|536972337|FG000|Overall Study|Lost to Follow-up|4|||
148862120|NCT02680574|536972338|FG001|Overall Study|Lost to Follow-up|6|||
148862121|NCT01166958|536972339|FG000|Overall Study|Withdrawal by Subject|1|||
148862122|NCT01166958|536972340|FG001|Overall Study|Withdrawal by Subject|0|||
148862123|NCT01286987|536972341|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
148862124|NCT01286987|536972342|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
148862125|NCT01286987|536972343|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
148862126|NCT01286987|536972344|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
148862127|NCT01286987|536972345|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
148862128|NCT01286987|536972346|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
148862129|NCT01286987|536972347|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
148862130|NCT01286987|536972348|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
148862131|NCT01286987|536972349|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
148862132|NCT01286987|536972350|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
148862133|NCT01286987|536972351|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
148862134|NCT01286987|536972352|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
148862135|NCT01286987|536972353|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
148862136|NCT01286987|536972354|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
148862137|NCT01286987|536972355|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
148862138|NCT01286987|536972341|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
148862139|NCT01286987|536972342|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
148862140|NCT01286987|536972343|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
148862141|NCT01286987|536972344|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
148862142|NCT01286987|536972345|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
148862143|NCT01286987|536972346|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
148862144|NCT01286987|536972347|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
148862145|NCT01286987|536972348|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
148862146|NCT01286987|536972349|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
148862147|NCT01286987|536972350|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
148862148|NCT01286987|536972351|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
148862149|NCT01286987|536972352|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
148862150|NCT01286987|536972353|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
148862151|NCT01286987|536972354|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
148862152|NCT01286987|536972355|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
148862153|NCT01286987|536972341|FG000|Part 1: Dose Escalation|Physician Decision|0|||
148862154|NCT01286987|536972342|FG001|Part 1: Dose Escalation|Physician Decision|0|||
148862155|NCT01286987|536972343|FG002|Part 1: Dose Escalation|Physician Decision|0|||
148862156|NCT01286987|536972344|FG003|Part 1: Dose Escalation|Physician Decision|0|||
148862157|NCT01286987|536972345|FG004|Part 1: Dose Escalation|Physician Decision|1|||
148862158|NCT01286987|536972346|FG005|Part 1: Dose Escalation|Physician Decision|0|||
148862159|NCT01286987|536972347|FG006|Part 1: Dose Escalation|Physician Decision|0|||
148862160|NCT01286987|536972348|FG007|Part 1: Dose Escalation|Physician Decision|0|||
148862161|NCT01286987|536972349|FG008|Part 1: Dose Escalation|Physician Decision|0|||
148862162|NCT01286987|536972350|FG009|Part 1: Dose Escalation|Physician Decision|0|||
148862163|NCT01286987|536972351|FG010|Part 1: Dose Escalation|Physician Decision|0|||
148862164|NCT01286987|536972352|FG011|Part 1: Dose Escalation|Physician Decision|0|||
148862165|NCT01286987|536972353|FG012|Part 1: Dose Escalation|Physician Decision|0|||
148862166|NCT01286987|536972354|FG013|Part 1: Dose Escalation|Physician Decision|0|||
148862167|NCT01286987|536972355|FG014|Part 1: Dose Escalation|Physician Decision|0|||
148862168|NCT01286987|536972341|FG000|Part 2: Dose Expansion|Death|0|||
148862169|NCT01286987|536972342|FG001|Part 2: Dose Expansion|Death|0|||
148862170|NCT01286987|536972343|FG002|Part 2: Dose Expansion|Death|0|||
148862171|NCT01286987|536972344|FG003|Part 2: Dose Expansion|Death|0|||
148862172|NCT01286987|536972345|FG004|Part 2: Dose Expansion|Death|0|||
148862173|NCT01286987|536972346|FG005|Part 2: Dose Expansion|Death|0|||
148862174|NCT01286987|536972347|FG006|Part 2: Dose Expansion|Death|0|||
148862175|NCT01286987|536972348|FG007|Part 2: Dose Expansion|Death|0|||
148862176|NCT01286987|536972349|FG008|Part 2: Dose Expansion|Death|0|||
148862177|NCT01286987|536972350|FG009|Part 2: Dose Expansion|Death|0|||
148862178|NCT01286987|536972351|FG010|Part 2: Dose Expansion|Death|0|||
148862179|NCT01286987|536972352|FG011|Part 2: Dose Expansion|Death|0|||
148862180|NCT01286987|536972353|FG012|Part 2: Dose Expansion|Death|1|||
148862181|NCT01286987|536972354|FG013|Part 2: Dose Expansion|Death|1|||
148862182|NCT01286987|536972355|FG014|Part 2: Dose Expansion|Death|0|||
148862183|NCT01286987|536972341|FG000|Part 2: Dose Expansion|Physician Decision|0|||
148862184|NCT01286987|536972342|FG001|Part 2: Dose Expansion|Physician Decision|0|||
148862185|NCT01286987|536972343|FG002|Part 2: Dose Expansion|Physician Decision|0|||
148862186|NCT01286987|536972344|FG003|Part 2: Dose Expansion|Physician Decision|0|||
148862187|NCT01286987|536972345|FG004|Part 2: Dose Expansion|Physician Decision|0|||
148862188|NCT01286987|536972346|FG005|Part 2: Dose Expansion|Physician Decision|0|||
148862189|NCT01286987|536972347|FG006|Part 2: Dose Expansion|Physician Decision|0|||
148862190|NCT01286987|536972348|FG007|Part 2: Dose Expansion|Physician Decision|0|||
148862191|NCT01286987|536972349|FG008|Part 2: Dose Expansion|Physician Decision|0|||
148862192|NCT01286987|536972350|FG009|Part 2: Dose Expansion|Physician Decision|0|||
148862193|NCT01286987|536972351|FG010|Part 2: Dose Expansion|Physician Decision|1|||
148862194|NCT01286987|536972352|FG011|Part 2: Dose Expansion|Physician Decision|1|||
148862195|NCT01286987|536972353|FG012|Part 2: Dose Expansion|Physician Decision|0|||
148862196|NCT01286987|536972354|FG013|Part 2: Dose Expansion|Physician Decision|1|||
148862197|NCT01286987|536972355|FG014|Part 2: Dose Expansion|Physician Decision|0|||
148862198|NCT01286987|536972341|FG000|Part 2: Dose Expansion|Other|0|||
148862199|NCT01286987|536972342|FG001|Part 2: Dose Expansion|Other|0|||
148862200|NCT01286987|536972343|FG002|Part 2: Dose Expansion|Other|0|||
148862201|NCT01286987|536972344|FG003|Part 2: Dose Expansion|Other|0|||
148862202|NCT01286987|536972345|FG004|Part 2: Dose Expansion|Other|0|||
148862203|NCT01286987|536972346|FG005|Part 2: Dose Expansion|Other|0|||
148862204|NCT01286987|536972347|FG006|Part 2: Dose Expansion|Other|0|||
148862205|NCT01286987|536972348|FG007|Part 2: Dose Expansion|Other|0|||
148862206|NCT01286987|536972349|FG008|Part 2: Dose Expansion|Other|0|||
148862207|NCT01286987|536972350|FG009|Part 2: Dose Expansion|Other|0|||
148862208|NCT01286987|536972351|FG010|Part 2: Dose Expansion|Other|0|||
148862209|NCT01286987|536972352|FG011|Part 2: Dose Expansion|Other|0|||
148862210|NCT01286987|536972353|FG012|Part 2: Dose Expansion|Other|0|||
148862211|NCT01286987|536972354|FG013|Part 2: Dose Expansion|Other|1|||
148862212|NCT01286987|536972355|FG014|Part 2: Dose Expansion|Other|0|||
148862213|NCT01286987|536972341|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
148862214|NCT01286987|536972342|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
148862215|NCT01286987|536972343|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
148862216|NCT01286987|536972344|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
148862217|NCT01286987|536972345|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
148862218|NCT01286987|536972346|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
148862219|NCT01286987|536972347|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
148862220|NCT01286987|536972348|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
148862221|NCT01286987|536972349|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
148862222|NCT01286987|536972350|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
148862223|NCT01286987|536972351|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
148862224|NCT01286987|536972352|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
148862225|NCT01286987|536972353|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
148862226|NCT01286987|536972354|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
148862227|NCT01286987|536972355|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
148862228|NCT01286987|536972341|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
148862229|NCT01286987|536972342|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
148862230|NCT01286987|536972343|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
148862231|NCT01286987|536972344|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
148862232|NCT01286987|536972345|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
148862233|NCT01286987|536972346|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
148862234|NCT01286987|536972347|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
148862235|NCT01286987|536972348|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
148862236|NCT01286987|536972349|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
148862237|NCT01286987|536972350|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
148862238|NCT01286987|536972351|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
148862239|NCT01286987|536972352|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
148862240|NCT01286987|536972353|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
148993400|NCT03449030|537451323|FG000|Overall Study|Adverse Event|0|||
148993401|NCT03449030|537451324|FG001|Overall Study|Adverse Event|0|||
148993402|NCT03449030|537451325|FG002|Overall Study|Adverse Event|0|||
148993403|NCT03449030|537451326|FG003|Overall Study|Adverse Event|0|||
148993404|NCT03449030|537451327|FG004|Overall Study|Adverse Event|0|||
148993405|NCT03449030|537451328|FG005|Overall Study|Adverse Event|2|||
148993406|NCT03449030|537451329|FG006|Overall Study|Adverse Event|0|||
148993407|NCT03449030|537451330|FG007|Overall Study|Adverse Event|0|||
148993408|NCT03449030|537451331|FG008|Overall Study|Adverse Event|0|||
148993409|NCT03449030|537451332|FG009|Overall Study|Adverse Event|0|||
148993410|NCT03449030|537451323|FG000|Overall Study|Death|0|||
148993411|NCT03449030|537451324|FG001|Overall Study|Death|0|||
148993412|NCT03449030|537451325|FG002|Overall Study|Death|0|||
148993413|NCT03449030|537451326|FG003|Overall Study|Death|0|||
148993414|NCT03449030|537451327|FG004|Overall Study|Death|1|||
148993415|NCT03449030|537451328|FG005|Overall Study|Death|0|||
148778009|NCT03721835|536660499|FG000|Overall Study|Lost to Follow-up|1|||
148778010|NCT03721835|536660499|FG000|Overall Study|Revision of the components of the study device|2|||
148778011|NCT03721835|536660499|FG000|Overall Study|Sponsor terminated study|6|||
148778012|NCT03721835|536660499|FG000|Overall Study|Death|1|||
148778013|NCT03721835|536660499|FG000|Overall Study|Sponsor decision|1|||
148778014|NCT01306045|536660504|FG000|Met General Eligibility Criteria|Screen failures|193|||
148778015|NCT01306045|536660505|FG001|Met General Eligibility Criteria|Screen failures|11|||
148778016|NCT01306045|536660506|FG002|Met General Eligibility Criteria|Screen failures|8|||
148778017|NCT04676412|536661865|FG000|Overall Study|Death|28|||
148778018|NCT04676412|536661866|FG001|Overall Study|Death|31|||
148778019|NCT04676412|536661865|FG000|Overall Study|Lost to Follow-up|1|||
148778020|NCT04676412|536661866|FG001|Overall Study|Lost to Follow-up|2|||
148778021|NCT04676412|536661865|FG000|Overall Study|Sponsor Decision|20|||
148778022|NCT04676412|536661866|FG001|Overall Study|Sponsor Decision|23|||
148778023|NCT04676412|536661865|FG000|Overall Study|Withdrawal by Subject|0|||
148778024|NCT04676412|536661866|FG001|Overall Study|Withdrawal by Subject|2|||
148778025|NCT04550832|536661867|FG000|Overall Study|Adverse Event|0|||
148778026|NCT04550832|536661868|FG001|Overall Study|Adverse Event|0|||
148778027|NCT04550832|536661869|FG002|Overall Study|Adverse Event|2|||
148778028|NCT04550832|536661870|FG003|Overall Study|Adverse Event|0|||
148778029|NCT04550832|536661871|FG004|Overall Study|Adverse Event|1|||
148778030|NCT04823130|536661872|FG000|Overall Study|Withdrawal by Subject|2|||
148778031|NCT04823130|536661873|FG001|Overall Study|Withdrawal by Subject|3|||
148778032|NCT04823130|536661872|FG000|Overall Study|Failure to meet inclusion criteria|6|||
148778033|NCT04823130|536661873|FG001|Overall Study|Failure to meet inclusion criteria|4|||
148778034|NCT04823130|536661872|FG000|Overall Study|Other-unspecified|1|||
148778035|NCT04823130|536661873|FG001|Overall Study|Other-unspecified|0|||
148778036|NCT03315455|536661875|FG000|Overall Study|Ongoing in the Study|13|||
148778037|NCT03315455|536661876|FG001|Overall Study|Ongoing in the Study|24|||
148778038|NCT03315455|536661877|FG002|Overall Study|Ongoing in the Study|17|||
148778039|NCT03315455|536661878|FG003|Overall Study|Ongoing in the Study|15|||
148778040|NCT03315455|536661875|FG000|Overall Study|Withdrawal by Subject|0|||
148778041|NCT03315455|536661876|FG001|Overall Study|Withdrawal by Subject|1|||
148778042|NCT03315455|536661877|FG002|Overall Study|Withdrawal by Subject|0|||
148778043|NCT03315455|536661878|FG003|Overall Study|Withdrawal by Subject|0|||
148778044|NCT04439357|536661879|FG000|Overall Study|Disease Progression|4|||
148778045|NCT01458951|536661887|FG000|Overall Study|Other|1|||
148778046|NCT01458951|536661888|FG001|Overall Study|Other|0|||
148778047|NCT01458951|536661889|FG002|Overall Study|Other|0|||
148778048|NCT01458951|536661887|FG000|Overall Study|Protocol Violation|5|||
148778049|NCT01458951|536661888|FG001|Overall Study|Protocol Violation|1|||
148778050|NCT01458951|536661889|FG002|Overall Study|Protocol Violation|0|||
148778051|NCT01458951|536661887|FG000|Overall Study|Withdrawal by Subject|2|||
148778052|NCT01458951|536661888|FG001|Overall Study|Withdrawal by Subject|0|||
148778053|NCT01458951|536661889|FG002|Overall Study|Withdrawal by Subject|2|||
148778054|NCT01458951|536661887|FG000|Overall Study|Adverse Event|7|||
148778055|NCT01458951|536661888|FG001|Overall Study|Adverse Event|0|||
148778056|NCT01458951|536661889|FG002|Overall Study|Adverse Event|2|||
148778057|NCT01458951|536661887|FG000|Overall Study|Insufficient Clinical Response|17|||
148778058|NCT01458951|536661888|FG001|Overall Study|Insufficient Clinical Response|0|||
148778059|NCT01458951|536661889|FG002|Overall Study|Insufficient Clinical Response|11|||
148778060|NCT04392167|536661894|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
148778061|NCT01573767|536661895|FG000|Overall Study|Adverse Event|0|||
148778062|NCT01573767|536661896|FG001|Overall Study|Adverse Event|1|||
148778063|NCT01573767|536661897|FG002|Overall Study|Adverse Event|0|||
148778064|NCT01573767|536661898|FG003|Overall Study|Adverse Event|1|||
148778065|NCT01573767|536661895|FG000|Overall Study|Lack of Efficacy|18|||
148778066|NCT01573767|536661896|FG001|Overall Study|Lack of Efficacy|15|||
148778067|NCT01573767|536661897|FG002|Overall Study|Lack of Efficacy|12|||
148778068|NCT01573767|536661898|FG003|Overall Study|Lack of Efficacy|17|||
148778069|NCT01573767|536661895|FG000|Overall Study|Protocol Violation|3|||
148862241|NCT01286987|536972354|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
148862242|NCT01286987|536972355|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
148862243|NCT01286987|536972341|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862244|NCT01286987|536972342|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862245|NCT01286987|536972343|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862246|NCT01286987|536972344|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862247|NCT01286987|536972345|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862248|NCT01286987|536972346|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862249|NCT01286987|536972347|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862250|NCT01286987|536972348|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862251|NCT01286987|536972349|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862252|NCT01286987|536972350|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862253|NCT01286987|536972351|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
148862254|NCT01286987|536972352|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862255|NCT01286987|536972353|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862256|NCT01286987|536972354|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862257|NCT01286987|536972355|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148862258|NCT00461305|536972363|FG000|Treatment|Adverse Event|26|||
148862259|NCT00461305|536972364|FG001|Treatment|Adverse Event|3|||
148862260|NCT00461305|536972363|FG000|Treatment|Lost to Follow-up|4|||
148862261|NCT00461305|536972364|FG001|Treatment|Lost to Follow-up|2|||
148862262|NCT00461305|536972363|FG000|Treatment|Protocol Violation|13|||
148862263|NCT00461305|536972364|FG001|Treatment|Protocol Violation|2|||
148862264|NCT00461305|536972363|FG000|Treatment|Withdrawal by Subject|48|||
148862265|NCT00461305|536972364|FG001|Treatment|Withdrawal by Subject|2|||
148862266|NCT00461305|536972363|FG000|Treatment|Never dispensed|5|||
148862267|NCT00461305|536972364|FG001|Treatment|Never dispensed|0|||
148862268|NCT00461305|536972363|FG000|Treatment|Study drug not taken|1|||
148862269|NCT00461305|536972364|FG001|Treatment|Study drug not taken|0|||
148862270|NCT00461305|536972363|FG000|Treatment|Partially missing diary|2|||
148862271|NCT00461305|536972364|FG001|Treatment|Partially missing diary|0|||
148862272|NCT00461305|536972363|FG000|Treatment|Other (missing drug etc)|2|||
148862273|NCT00461305|536972364|FG001|Treatment|Other (missing drug etc)|0|||
148862274|NCT00461305|536972363|FG000|Continued Treatment|Adverse Event|26|||
148862275|NCT00461305|536972364|FG001|Continued Treatment|Adverse Event|0|||
148862276|NCT00461305|536972363|FG000|Continued Treatment|Lost to Follow-up|4|||
148862277|NCT00461305|536972364|FG001|Continued Treatment|Lost to Follow-up|0|||
148862278|NCT00461305|536972363|FG000|Continued Treatment|Protocol Violation|13|||
148862279|NCT00461305|536972364|FG001|Continued Treatment|Protocol Violation|0|||
148862280|NCT00461305|536972363|FG000|Continued Treatment|Withdrawal by Subject|48|||
148862281|NCT00461305|536972364|FG001|Continued Treatment|Withdrawal by Subject|0|||
148862282|NCT00461305|536972363|FG000|Continued Treatment|Partially missing diary|2|||
148862283|NCT00461305|536972364|FG001|Continued Treatment|Partially missing diary|0|||
148862284|NCT00461305|536972363|FG000|Continued Treatment|Other (missing drug etc)|2|||
148862285|NCT00461305|536972364|FG001|Continued Treatment|Other (missing drug etc)|0|||
148862286|NCT00953680|536972368|FG000|Period 1|Withdrawal by Subject|0|||
148862287|NCT00953680|536972369|FG001|Period 1|Withdrawal by Subject|1|||
148862288|NCT03710876|536974181|FG000|Overall Study|Death|0|||
148862289|NCT03710876|536974182|FG001|Overall Study|Death|2|||
148862290|NCT03710876|536974181|FG000|Overall Study|Withdrawal by Subject|0|||
148862291|NCT03710876|536974182|FG001|Overall Study|Withdrawal by Subject|2|||
148862292|NCT02838901|536974183|FG000|Overall Study|Withdrawal by Subject|1|||
148862293|NCT02838901|536974184|FG001|Overall Study|Withdrawal by Subject|1|||
148862294|NCT02838901|536974183|FG000|Overall Study|Lost to Follow-up|1|||
148862295|NCT02838901|536974184|FG001|Overall Study|Lost to Follow-up|1|||
148862296|NCT01007123|536974185|FG000|Overall Study|Adverse Event|3|||
148862297|NCT01007123|536974186|FG001|Overall Study|Adverse Event|4|||
148862298|NCT01007123|536974187|FG002|Overall Study|Adverse Event|7|||
148862299|NCT01007123|536974188|FG003|Overall Study|Adverse Event|1|||
148862300|NCT01007123|536974185|FG000|Overall Study|Lack of Efficacy|1|||
148862301|NCT01007123|536974186|FG001|Overall Study|Lack of Efficacy|0|||
148862302|NCT01007123|536974187|FG002|Overall Study|Lack of Efficacy|1|||
148862303|NCT01007123|536974188|FG003|Overall Study|Lack of Efficacy|4|||
148862304|NCT01007123|536974185|FG000|Overall Study|Protocol Violation|1|||
148862305|NCT01007123|536974186|FG001|Overall Study|Protocol Violation|1|||
148862306|NCT01007123|536974187|FG002|Overall Study|Protocol Violation|2|||
149030854|NCT00943605|537591584|FG001|Overall Study|Study termination|30|||
148862307|NCT01007123|536974188|FG003|Overall Study|Protocol Violation|1|||
148862308|NCT01007123|536974185|FG000|Overall Study|Withdrawal by Subject|1|||
148862309|NCT01007123|536974186|FG001|Overall Study|Withdrawal by Subject|0|||
148862310|NCT01007123|536974187|FG002|Overall Study|Withdrawal by Subject|1|||
148862311|NCT01007123|536974188|FG003|Overall Study|Withdrawal by Subject|0|||
148862312|NCT01007123|536974185|FG000|Overall Study|Lost to Follow-up|0|||
148862313|NCT01007123|536974186|FG001|Overall Study|Lost to Follow-up|1|||
148862314|NCT01007123|536974187|FG002|Overall Study|Lost to Follow-up|0|||
148862315|NCT01007123|536974188|FG003|Overall Study|Lost to Follow-up|0|||
148862316|NCT00320255|536974189|FG000|Overall Study|Lack of Efficacy|1|||
148862317|NCT00320255|536974190|FG001|Overall Study|Lack of Efficacy|0|||
148862318|NCT00320255|536974191|FG002|Overall Study|Lack of Efficacy|0|||
148862319|NCT00320255|536974192|FG003|Overall Study|Lack of Efficacy|0|||
148862320|NCT00320255|536974193|FG004|Overall Study|Lack of Efficacy|0|||
148862321|NCT00320255|536974194|FG005|Overall Study|Lack of Efficacy|0|||
148862322|NCT00320255|536974189|FG000|Overall Study|Adverse Event|5|||
148862323|NCT00320255|536974190|FG001|Overall Study|Adverse Event|2|||
148862324|NCT00320255|536974191|FG002|Overall Study|Adverse Event|3|||
148862325|NCT00320255|536974192|FG003|Overall Study|Adverse Event|2|||
148862326|NCT00320255|536974193|FG004|Overall Study|Adverse Event|0|||
148862327|NCT00320255|536974194|FG005|Overall Study|Adverse Event|0|||
148862328|NCT00320255|536974189|FG000|Overall Study|Withdrawal by Subject|1|||
148862329|NCT00320255|536974190|FG001|Overall Study|Withdrawal by Subject|2|||
148862330|NCT00320255|536974191|FG002|Overall Study|Withdrawal by Subject|2|||
148862331|NCT00320255|536974192|FG003|Overall Study|Withdrawal by Subject|4|||
148862332|NCT00320255|536974193|FG004|Overall Study|Withdrawal by Subject|0|||
148862333|NCT00320255|536974194|FG005|Overall Study|Withdrawal by Subject|0|||
148862334|NCT00320255|536974189|FG000|Overall Study|Poor compliance/noncompliance|1|||
148862335|NCT00320255|536974190|FG001|Overall Study|Poor compliance/noncompliance|1|||
148862336|NCT00320255|536974191|FG002|Overall Study|Poor compliance/noncompliance|0|||
148862337|NCT00320255|536974192|FG003|Overall Study|Poor compliance/noncompliance|1|||
148862338|NCT00320255|536974193|FG004|Overall Study|Poor compliance/noncompliance|0|||
148862339|NCT00320255|536974194|FG005|Overall Study|Poor compliance/noncompliance|0|||
148862340|NCT00320255|536974189|FG000|Overall Study|No longer meets study criteria|0|||
148862341|NCT00320255|536974190|FG001|Overall Study|No longer meets study criteria|0|||
148862342|NCT00320255|536974191|FG002|Overall Study|No longer meets study criteria|0|||
148862343|NCT00320255|536974192|FG003|Overall Study|No longer meets study criteria|1|||
148862344|NCT00320255|536974193|FG004|Overall Study|No longer meets study criteria|0|||
148862345|NCT00320255|536974194|FG005|Overall Study|No longer meets study criteria|0|||
148862346|NCT00320255|536974189|FG000|Overall Study|Other|3|||
148862347|NCT00320255|536974190|FG001|Overall Study|Other|2|||
148862348|NCT00320255|536974191|FG002|Overall Study|Other|1|||
148862349|NCT00320255|536974192|FG003|Overall Study|Other|0|||
148862350|NCT00320255|536974193|FG004|Overall Study|Other|0|||
148862351|NCT00320255|536974194|FG005|Overall Study|Other|0|||
148862352|NCT00090233|536974198|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
148862353|NCT00090233|536974199|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
148862354|NCT00090233|536974198|FG000|Overall Study|Adverse Event|214|||
148862355|NCT00090233|536974199|FG001|Overall Study|Adverse Event|198|||
148862356|NCT00090233|536974198|FG000|Overall Study|Lost to Follow-up|68|||
148862357|NCT00090233|536974199|FG001|Overall Study|Lost to Follow-up|95|||
148862358|NCT00090233|536974198|FG000|Overall Study|Protocol Violation|960|||
148862359|NCT00090233|536974199|FG001|Overall Study|Protocol Violation|1022|||
148862360|NCT00090233|536974198|FG000|Overall Study|Withdrawal by Subject|182|||
148862361|NCT00090233|536974199|FG001|Overall Study|Withdrawal by Subject|211|||
148862362|NCT00090233|536974198|FG000|Overall Study|Moved|203|||
148862363|NCT00090233|536974199|FG001|Overall Study|Moved|189|||
148862364|NCT00090233|536974198|FG000|Overall Study|Other|1211|||
148862365|NCT00090233|536974199|FG001|Overall Study|Other|1160|||
148862366|NCT00090233|536974198|FG000|Overall Study|Data not available at data cut-off point|1552|||
148862367|NCT00090233|536974199|FG001|Overall Study|Data not available at data cut-off point|1563|||
148862368|NCT04863248|536974200|FG000|Overall Study|Sponsor Terminated|4|||
148862369|NCT04863248|536974201|FG001|Overall Study|Sponsor Terminated|1|||
148862370|NCT04863248|536974200|FG000|Overall Study|Death|0|||
148862371|NCT04863248|536974201|FG001|Overall Study|Death|1|||
148862372|NCT04863248|536974200|FG000|Overall Study|Withdrawal by Subject|0|||
148862373|NCT04863248|536974201|FG001|Overall Study|Withdrawal by Subject|1|||
148862374|NCT04706273|536974204|FG000|Overall Study|Withdrawal by Subject|27|||
148862375|NCT04706273|536974204|FG000|Overall Study|Physician Decision|1|||
148862376|NCT04706273|536974204|FG000|Overall Study|Lost to Follow-up|42|||
148862377|NCT04706273|536974204|FG000|Overall Study|Death|85|||
148862378|NCT04706273|536974204|FG000|Overall Study|Amputation that removes study device|2|||
148862379|NCT04706273|536974204|FG000|Overall Study|Surgical bypass|3|||
148862380|NCT04706273|536974204|FG000|Overall Study|Changing hospital|23|||
148862381|NCT04706273|536974204|FG000|Overall Study|Unable to attend hospital|2|||
148993416|NCT03449030|537451329|FG006|Overall Study|Death|0|||
148862382|NCT00869050|536974205|FG000|Overall Study|Screen Failure|3|||
148993417|NCT03449030|537451330|FG007|Overall Study|Death|0|||
148862383|NCT03199053|536974208|FG000|ST Period|Withdrawal by Subject|2|||
148862384|NCT03199053|536974209|FG001|ST Period|Withdrawal by Subject|4|||
148862385|NCT03199053|536974210|FG002|ST Period|Withdrawal by Subject|6|||
148862386|NCT03199053|536974208|FG000|ST Period|Withdrawal by parent/guardian|1|||
148862387|NCT03199053|536974209|FG001|ST Period|Withdrawal by parent/guardian|1|||
148862388|NCT03199053|536974210|FG002|ST Period|Withdrawal by parent/guardian|1|||
148862389|NCT03199053|536974208|FG000|ST Period|Lost to Follow-up|2|||
148862390|NCT03199053|536974209|FG001|ST Period|Lost to Follow-up|0|||
148862391|NCT03199053|536974210|FG002|ST Period|Lost to Follow-up|1|||
148862392|NCT03199053|536974208|FG000|LT Period|Withdrawal by Subject|1|||
148862393|NCT03199053|536974209|FG001|LT Period|Withdrawal by Subject|3|||
148862394|NCT03199053|536974210|FG002|LT Period|Withdrawal by Subject|3|||
148862395|NCT03199053|536974208|FG000|LT Period|Withdrawal by parent/guardian|0|||
148862396|NCT03199053|536974209|FG001|LT Period|Withdrawal by parent/guardian|0|||
148862397|NCT03199053|536974210|FG002|LT Period|Withdrawal by parent/guardian|1|||
148862398|NCT03199053|536974208|FG000|LT Period|Lost to Follow-up|0|||
148862399|NCT03199053|536974209|FG001|LT Period|Lost to Follow-up|1|||
148862400|NCT03199053|536974210|FG002|LT Period|Lost to Follow-up|1|||
148862401|NCT03199053|536974208|FG000|LT Period|Miscellaneous|0|||
148862402|NCT03199053|536974209|FG001|LT Period|Miscellaneous|0|||
148862403|NCT03199053|536974210|FG002|LT Period|Miscellaneous|2|||
148862404|NCT03199053|536974208|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
148862405|NCT03199053|536974209|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
148862406|NCT03199053|536974210|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
148862407|NCT03199053|536974208|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
148862408|NCT03199053|536974209|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
148862409|NCT03199053|536974210|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
148862410|NCT03199053|536974208|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
148862411|NCT03199053|536974209|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
148862412|NCT03199053|536974210|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
148862413|NCT03199053|536974208|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
148862414|NCT03199053|536974209|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
148862415|NCT03199053|536974210|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
148862416|NCT03298984|536974211|FG000|Overall Study|Physician Decision|1|||
148862417|NCT03298984|536974212|FG001|Overall Study|Physician Decision|0|||
148862418|NCT03298984|536974213|FG002|Overall Study|Physician Decision|0|||
148862419|NCT03298984|536974214|FG003|Overall Study|Physician Decision|6|||
148862420|NCT03298984|536974211|FG000|Overall Study|Lack of Efficacy|0|||
148862421|NCT03298984|536974212|FG001|Overall Study|Lack of Efficacy|1|||
148862422|NCT03298984|536974213|FG002|Overall Study|Lack of Efficacy|1|||
148862423|NCT03298984|536974214|FG003|Overall Study|Lack of Efficacy|4|||
148862424|NCT03298984|536974211|FG000|Overall Study|Relapsed disease (following remission)|0|||
148862425|NCT03298984|536974212|FG001|Overall Study|Relapsed disease (following remission)|0|||
148862426|NCT03298984|536974213|FG002|Overall Study|Relapsed disease (following remission)|1|||
148862427|NCT03298984|536974214|FG003|Overall Study|Relapsed disease (following remission)|1|||
148862428|NCT03298984|536974211|FG000|Overall Study|Adverse Event|0|||
148862429|NCT03298984|536974212|FG001|Overall Study|Adverse Event|0|||
148862430|NCT03298984|536974213|FG002|Overall Study|Adverse Event|0|||
148862431|NCT03298984|536974214|FG003|Overall Study|Adverse Event|1|||
148862432|NCT03298984|536974211|FG000|Overall Study|Death|0|||
148862433|NCT03298984|536974212|FG001|Overall Study|Death|0|||
148862434|NCT03298984|536974213|FG002|Overall Study|Death|0|||
148862435|NCT03298984|536974214|FG003|Overall Study|Death|2|||
148862436|NCT03298984|536974211|FG000|Overall Study|Insurance Company Decision|0|||
148862437|NCT03298984|536974212|FG001|Overall Study|Insurance Company Decision|0|||
148862438|NCT03298984|536974213|FG002|Overall Study|Insurance Company Decision|0|||
148862439|NCT03298984|536974214|FG003|Overall Study|Insurance Company Decision|1|||
148862440|NCT02403635|536974217|FG000|Overall Study|Not eligible|9|||
148862441|NCT02509052|536974221|FG000|Overall Study|Non compliance|0|||
148862442|NCT02509052|536974222|FG001|Overall Study|Non compliance|0|||
148862443|NCT02509052|536974223|FG002|Overall Study|Non compliance|1|||
148862444|NCT02098369|536974225|FG000|Overall Study|Withdrawal by Subject|1|||
148862445|NCT02098369|536974226|FG001|Overall Study|Withdrawal by Subject|5|||
148862446|NCT02098369|536974227|FG002|Overall Study|Withdrawal by Subject|0|||
148862447|NCT02098369|536974225|FG000|Overall Study|Lost to Follow-up|5|||
148862448|NCT02098369|536974226|FG001|Overall Study|Lost to Follow-up|1|||
148862449|NCT02098369|536974227|FG002|Overall Study|Lost to Follow-up|3|||
148862450|NCT02098369|536974225|FG000|Overall Study|Death|1|||
148862451|NCT02098369|536974226|FG001|Overall Study|Death|1|||
148862452|NCT02098369|536974227|FG002|Overall Study|Death|1|||
148862453|NCT02098369|536974225|FG000|Overall Study|Other|0|||
148862454|NCT02098369|536974226|FG001|Overall Study|Other|2|||
148862455|NCT02098369|536974227|FG002|Overall Study|Other|1|||
148862456|NCT03362931|536974228|FG000|Overall Study|Adverse Event|1|||
148862457|NCT03362931|536974228|FG000|Overall Study|Death|2|||
148862458|NCT03300024|536974229|FG000|Overall Study|Physician Decision|4|||
148862459|NCT03300024|536974230|FG001|Overall Study|Physician Decision|6|||
148862460|NCT03305081|536974231|FG000|Overall Study|Lost to Follow-up|10|||
148862461|NCT03305081|536974232|FG001|Overall Study|Lost to Follow-up|15|||
148862462|NCT00570037|536974233|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
148862463|NCT00570037|536974234|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
148862464|NCT00554619|536974235|FG000|Overall Study|Adverse Event|1|||
148993418|NCT03449030|537451331|FG008|Overall Study|Death|0|||
148993419|NCT03449030|537451332|FG009|Overall Study|Death|0|||
148862465|NCT00554619|536974235|FG000|Overall Study|Physician Decision|1|||
148993420|NCT00700401|537451342|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
148993421|NCT00700401|537451342|FG000|Overall Study|Adverse Event|5|||
148862466|NCT00554619|536974235|FG000|Overall Study|Liver Function Test Abnormality|1|||
148862467|NCT01571284|536974236|FG000|Overall Study|Participant's decision|84|||
148862468|NCT01571284|536974236|FG000|Overall Study|Lost to Follow-up|3|||
148862469|NCT01571284|536974236|FG000|Overall Study|Enrolled but not treated|2|||
148862470|NCT01571284|536974236|FG000|Overall Study|Other than specified above|80|||
148862471|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Death|1|||
148862472|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Death|1|||
148862473|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Death|0|||
148862474|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Death|0|||
148862475|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Death|1|||
148862476|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Death|0|||
148862477|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Death|0|||
148862478|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Death|0|||
148862479|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Death|0|||
148862480|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Death|0|||
148862481|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
148862482|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
148862483|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
148862484|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
148862485|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
148862486|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
148862487|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
148862488|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
148862489|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
148862490|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
148862491|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862492|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862493|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862494|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862495|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
148862496|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862497|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862498|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862499|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862500|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
148862501|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
148862502|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862503|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862504|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862505|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862506|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862507|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862508|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862509|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862510|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
148862511|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
148862512|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862513|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862514|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
148862515|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
148862516|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862517|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862518|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862519|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862520|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
148862521|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
148862522|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862523|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862524|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
148862525|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862526|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862527|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862528|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
149030855|NCT04148937|537591585|FG000|Overall Study|Withdrawal by Subject|0|||
149030856|NCT04148937|537591586|FG001|Overall Study|Withdrawal by Subject|0|||
149030857|NCT04148937|537591587|FG002|Overall Study|Withdrawal by Subject|0|||
149030858|NCT04148937|537591588|FG003|Overall Study|Withdrawal by Subject|1|||
148862529|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862530|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
148862531|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
148862532|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
149030859|NCT04148937|537591589|FG004|Overall Study|Withdrawal by Subject|0|||
148862533|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
148862534|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
148862535|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
148862536|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
148862537|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
148862538|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
148862539|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
148862540|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
148862541|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
148862542|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
148862543|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
148862544|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862545|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
148862546|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862547|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862548|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862549|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862550|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862551|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
148862552|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862553|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862554|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
148862555|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
148862556|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862557|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862558|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862559|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862560|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
148862561|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862562|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862563|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862564|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862565|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862566|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862567|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862568|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862569|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862570|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862571|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862572|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862573|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
148862574|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148993422|NCT00700401|537451342|FG000|Overall Study|Refused Treatment|2|||
148993423|NCT00700401|537451342|FG000|Overall Study|Lost to Follow-up|1|||
148993424|NCT00700401|537451342|FG000|Overall Study|Treatment never started|1|||
148993425|NCT00700401|537451342|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
148993426|NCT00700401|537451342|FG000|Overall Study|Withdrawal by Subject|2|||
148993427|NCT00295750|537451346|FG000|Overall Study|Adverse Event|19|||
148993428|NCT00295750|537451347|FG001|Overall Study|Adverse Event|15|||
148993429|NCT00295750|537451348|FG002|Overall Study|Adverse Event|12|||
148993430|NCT00295750|537451346|FG000|Overall Study|Lack of Efficacy|1|||
148993431|NCT00295750|537451347|FG001|Overall Study|Lack of Efficacy|1|||
148993432|NCT00295750|537451348|FG002|Overall Study|Lack of Efficacy|0|||
148993433|NCT00295750|537451346|FG000|Overall Study|Lost to Follow-up|1|||
148993434|NCT00295750|537451347|FG001|Overall Study|Lost to Follow-up|4|||
148993435|NCT00295750|537451348|FG002|Overall Study|Lost to Follow-up|1|||
148862575|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
148862576|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862577|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862578|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862579|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862580|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862581|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
148862582|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
148862583|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
148862584|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
148862585|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
148862586|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
148862587|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
148862588|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
148862589|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
148862590|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
148862591|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862592|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862593|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862594|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
148862595|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
148862596|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862597|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862598|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862599|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862600|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862601|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
148862602|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862603|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
148862604|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
148862605|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
148862606|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862607|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862608|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862609|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862610|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862611|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
148862612|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862613|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862614|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862615|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
148862616|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862617|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862618|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862619|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862620|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
148862621|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862622|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862623|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862624|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862625|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
148862626|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862627|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862628|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862629|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862630|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862631|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862632|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
148862633|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862634|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862635|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
148862636|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862637|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862638|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862639|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862640|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
148862641|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
148862642|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862643|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862644|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862645|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
148862646|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862647|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862648|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862649|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862650|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
148862651|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
148862652|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862653|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
148862654|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862655|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
148862656|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862657|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862658|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862659|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862660|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
148862661|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Other|5|||
148862662|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Other|1|||
148862663|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Other|0|||
148862664|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Other|3|||
148862665|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Other|0|||
148862666|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Other|0|||
148862667|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Other|0|||
148862668|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Other|0|||
148862669|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Other|0|||
148862670|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Other|0|||
148862671|NCT03352557|536974237|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862672|NCT03352557|536974238|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862673|NCT03352557|536974239|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862674|NCT03352557|536974240|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862675|NCT03352557|536974241|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
148862676|NCT03352557|536974242|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862677|NCT03352557|536974243|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862678|NCT03352557|536974244|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862679|NCT03352557|536974245|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862680|NCT03352557|536974246|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
148862681|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Death|0|||
148862682|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Death|0|||
148862683|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Death|0|||
148862684|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Death|0|||
148862685|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Death|0|||
148862686|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Death|1|||
148862687|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Death|0|||
148862688|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Death|1|||
148862689|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Death|1|||
148862690|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Death|1|||
148862691|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862692|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862693|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862694|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862695|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862696|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
149030860|NCT04148937|537591590|FG005|Overall Study|Withdrawal by Subject|1|||
148862697|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862698|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862699|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862700|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
148862701|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862702|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862703|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862704|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862705|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862706|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862707|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862708|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862709|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
148862710|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
148862711|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
148862712|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
148862713|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
148862714|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
148862715|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
148862716|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
148862717|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
148862718|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
148862719|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
148862720|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
148862721|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862722|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862723|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862724|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862725|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862726|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
148862727|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
148862728|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
148862729|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
148862730|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
148862731|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862732|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862733|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862734|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862735|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862736|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862737|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862738|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862739|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
148862740|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
148862741|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
148862742|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
148862743|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
148862744|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
148862745|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
148862746|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
148862747|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
148862748|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
148993436|NCT00295750|537451346|FG000|Overall Study|Taking prohibited therapy|2|||
148993437|NCT00295750|537451347|FG001|Overall Study|Taking prohibited therapy|3|||
148993438|NCT00295750|537451348|FG002|Overall Study|Taking prohibited therapy|2|||
148993439|NCT00295750|537451346|FG000|Overall Study|Administrative errors|2|||
148993440|NCT00295750|537451347|FG001|Overall Study|Administrative errors|4|||
148993441|NCT00295750|537451348|FG002|Overall Study|Administrative errors|5|||
148862749|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
148862750|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
148862751|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862752|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862753|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862754|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862755|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862756|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862757|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862758|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
148862759|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
148862760|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
148862761|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862762|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862763|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862764|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862765|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862766|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862767|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862768|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
148862769|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862770|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
148862771|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862772|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862773|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862774|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862775|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862776|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862777|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862778|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
148862779|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862780|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
148862781|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862782|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862783|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862784|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862785|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862786|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862787|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862788|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
148862789|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
148862790|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
148862791|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862792|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862793|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862794|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862795|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862796|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
148862797|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862798|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148993442|NCT00295750|537451346|FG000|Overall Study|Trial drug errors|1|||
148993443|NCT00295750|537451347|FG001|Overall Study|Trial drug errors|1|||
148993444|NCT00295750|537451348|FG002|Overall Study|Trial drug errors|0|||
148993445|NCT00295750|537451346|FG000|Overall Study|Disease progression|2|||
148993446|NCT00295750|537451347|FG001|Overall Study|Disease progression|1|||
148993447|NCT00295750|537451348|FG002|Overall Study|Disease progression|0|||
149030861|NCT04148937|537591591|FG006|Overall Study|Withdrawal by Subject|1|||
149030862|NCT04148937|537591592|FG007|Overall Study|Withdrawal by Subject|0|||
149030863|NCT04148937|537591585|FG000|Overall Study|Lost to Follow-up|0|||
149030864|NCT04148937|537591586|FG001|Overall Study|Lost to Follow-up|0|||
149030865|NCT04148937|537591587|FG002|Overall Study|Lost to Follow-up|1|||
149030866|NCT04148937|537591588|FG003|Overall Study|Lost to Follow-up|0|||
149030867|NCT04148937|537591589|FG004|Overall Study|Lost to Follow-up|0|||
149030868|NCT04148937|537591590|FG005|Overall Study|Lost to Follow-up|2|||
149030869|NCT04148937|537591591|FG006|Overall Study|Lost to Follow-up|0|||
149030870|NCT04148937|537591592|FG007|Overall Study|Lost to Follow-up|0|||
149030871|NCT00918957|537591594|FG000|Overall Study|Adverse Event|2|||
149030872|NCT00918957|537591595|FG001|Overall Study|Adverse Event|0|||
149030873|NCT00918957|537591594|FG000|Overall Study|Withdrawal by Subject|1|||
149030874|NCT00918957|537591595|FG001|Overall Study|Withdrawal by Subject|0|||
149030875|NCT03107611|537591596|FG000|Overall Study|Adverse Event|1|||
149030876|NCT03107611|537591597|FG001|Overall Study|Adverse Event|0|||
149030877|NCT03107611|537591598|FG002|Overall Study|Adverse Event|2|||
149030878|NCT03107611|537591596|FG000|Overall Study|Lost to Follow-up|3|||
149030879|NCT03107611|537591597|FG001|Overall Study|Lost to Follow-up|3|||
149030880|NCT03107611|537591598|FG002|Overall Study|Lost to Follow-up|3|||
149030881|NCT03107611|537591596|FG000|Overall Study|Protocol Violation|0|||
149030882|NCT03107611|537591597|FG001|Overall Study|Protocol Violation|0|||
149030883|NCT03107611|537591598|FG002|Overall Study|Protocol Violation|1|||
149030884|NCT03107611|537591596|FG000|Overall Study|Withdrawal by Subject|1|||
149030885|NCT03107611|537591597|FG001|Overall Study|Withdrawal by Subject|0|||
149030886|NCT03107611|537591598|FG002|Overall Study|Withdrawal by Subject|1|||
148862799|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
148993448|NCT00295750|537451346|FG000|Overall Study|Personal reasons|0|||
148993449|NCT00295750|537451347|FG001|Overall Study|Personal reasons|1|||
148993450|NCT00295750|537451348|FG002|Overall Study|Personal reasons|0|||
148993451|NCT00295750|537451346|FG000|Overall Study|Randomized but never received trial drug|4|||
148993452|NCT00295750|537451347|FG001|Overall Study|Randomized but never received trial drug|3|||
148993453|NCT00295750|537451348|FG002|Overall Study|Randomized but never received trial drug|3|||
148993454|NCT00295750|537451346|FG000|Overall Study|Withdrawal by Subject|9|||
148993455|NCT00295750|537451347|FG001|Overall Study|Withdrawal by Subject|4|||
148993456|NCT00295750|537451348|FG002|Overall Study|Withdrawal by Subject|7|||
148993457|NCT00295750|537451346|FG000|Overall Study|Protocol Violation|2|||
148993458|NCT00295750|537451347|FG001|Overall Study|Protocol Violation|4|||
148993459|NCT00295750|537451348|FG002|Overall Study|Protocol Violation|2|||
148993460|NCT01650259|537451349|FG000|Overall Study|Improvement|105|||
148993461|NCT01650259|537451350|FG001|Overall Study|Improvement|0|||
148993462|NCT01650259|537451349|FG000|Overall Study|Adverse Event|127|||
148993463|NCT01650259|537451350|FG001|Overall Study|Adverse Event|0|||
148993464|NCT01650259|537451349|FG000|Overall Study|Lack of Efficacy|143|||
148993465|NCT01650259|537451350|FG001|Overall Study|Lack of Efficacy|0|||
148993466|NCT01650259|537451349|FG000|Overall Study|Lost to Follow-up|435|||
148993467|NCT01650259|537451350|FG001|Overall Study|Lost to Follow-up|0|||
148993468|NCT01650259|537451349|FG000|Overall Study|Patients had no visit after entry|70|||
148993469|NCT01650259|537451350|FG001|Overall Study|Patients had no visit after entry|0|||
148993470|NCT01650259|537451349|FG000|Overall Study|CRF not collected|98|||
148993471|NCT01650259|537451350|FG001|Overall Study|CRF not collected|82|||
148993472|NCT01650259|537451349|FG000|Overall Study|Not treated|1|||
148993473|NCT01650259|537451350|FG001|Overall Study|Not treated|7|||
148993474|NCT01650259|537451349|FG000|Overall Study|Other than listed|64|||
148993475|NCT01650259|537451350|FG001|Overall Study|Other than listed|146|||
148993476|NCT00355082|537451356|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
148993477|NCT00355082|537451357|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
148993478|NCT00355082|537451358|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
148993479|NCT00355082|537451356|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
148993480|NCT00355082|537451357|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
148993481|NCT00355082|537451358|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
148993482|NCT00355082|537451356|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
149030887|NCT03107611|537591596|FG000|Overall Study|Worsening signs/symptoms|2|||
149030888|NCT03107611|537591597|FG001|Overall Study|Worsening signs/symptoms|1|||
149030889|NCT03107611|537591598|FG002|Overall Study|Worsening signs/symptoms|2|||
149030890|NCT01720446|537591601|FG000|Overall Study|Lost to Follow-up|12|||
148993483|NCT00355082|537451357|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
148993484|NCT00355082|537451358|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
148993485|NCT00355082|537451356|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
148993486|NCT00355082|537451357|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
148993487|NCT00355082|537451358|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
148993488|NCT00355082|537451356|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
148993489|NCT00355082|537451357|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
149030891|NCT01720446|537591602|FG001|Overall Study|Lost to Follow-up|6|||
149030892|NCT01720446|537591603|FG002|Overall Study|Lost to Follow-up|16|||
149030893|NCT01720446|537591604|FG003|Overall Study|Lost to Follow-up|16|||
149030894|NCT01720446|537591601|FG000|Overall Study|Withdrawal by Subject|2|||
149030895|NCT01720446|537591602|FG001|Overall Study|Withdrawal by Subject|5|||
149030896|NCT01720446|537591603|FG002|Overall Study|Withdrawal by Subject|4|||
149030897|NCT01720446|537591604|FG003|Overall Study|Withdrawal by Subject|4|||
148862800|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
148862801|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862802|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862803|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862804|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862805|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862806|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862807|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862808|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862809|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
148862810|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
148862811|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862812|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862813|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862814|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862815|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862816|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862817|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862818|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
148862819|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
148862820|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
148862821|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862822|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862823|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862824|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862825|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862826|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862827|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862828|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
148862829|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
148862830|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
148862831|NCT03352557|536974237|FG000|LTE Period: Week 80 to Week 173|Other|0|||
148862832|NCT03352557|536974238|FG001|LTE Period: Week 80 to Week 173|Other|0|||
148862833|NCT03352557|536974239|FG002|LTE Period: Week 80 to Week 173|Other|0|||
148862834|NCT03352557|536974240|FG003|LTE Period: Week 80 to Week 173|Other|0|||
148862835|NCT03352557|536974241|FG004|LTE Period: Week 80 to Week 173|Other|0|||
148862836|NCT03352557|536974242|FG005|LTE Period: Week 80 to Week 173|Other|0|||
148862837|NCT03352557|536974243|FG006|LTE Period: Week 80 to Week 173|Other|0|||
148862838|NCT03352557|536974244|FG007|LTE Period: Week 80 to Week 173|Other|1|||
148862839|NCT03352557|536974245|FG008|LTE Period: Week 80 to Week 173|Other|0|||
148862840|NCT03352557|536974246|FG009|LTE Period: Week 80 to Week 173|Other|0|||
148862841|NCT04677660|536974247|FG000|Overall Study|Lost to Follow-up|0|||
148862842|NCT04677660|536974248|FG001|Overall Study|Lost to Follow-up|2|||
148862843|NCT04677660|536974247|FG000|Overall Study|Withdrawal by Subject|0|||
148862844|NCT04677660|536974248|FG001|Overall Study|Withdrawal by Subject|1|||
148862845|NCT04677660|536974247|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
148862846|NCT04677660|536974248|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
148862847|NCT04065074|536974249|FG000|Overall Study|Adverse Event|1|||
148862848|NCT04065074|536974249|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
148862849|NCT01218100|536974250|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
148862850|NCT01218100|536974251|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
148862851|NCT01218100|536974252|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
148862852|NCT01218100|536974253|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
148862853|NCT01218100|536974250|FG000|Overall Study|Adverse Event|4|||
148862854|NCT01218100|536974251|FG001|Overall Study|Adverse Event|6|||
148862855|NCT01218100|536974252|FG002|Overall Study|Adverse Event|6|||
148862856|NCT01218100|536974253|FG003|Overall Study|Adverse Event|7|||
148862857|NCT01218100|536974250|FG000|Overall Study|Lack of Efficacy|9|||
148862858|NCT01218100|536974251|FG001|Overall Study|Lack of Efficacy|6|||
148862859|NCT01218100|536974252|FG002|Overall Study|Lack of Efficacy|5|||
148862860|NCT01218100|536974253|FG003|Overall Study|Lack of Efficacy|12|||
148862861|NCT01218100|536974250|FG000|Overall Study|Protocol Violation|0|||
148862862|NCT01218100|536974251|FG001|Overall Study|Protocol Violation|0|||
148862863|NCT01218100|536974252|FG002|Overall Study|Protocol Violation|1|||
148862864|NCT01218100|536974253|FG003|Overall Study|Protocol Violation|1|||
148862865|NCT01218100|536974250|FG000|Overall Study|Withdrawal by Subject|5|||
149030898|NCT01020838|537591605|FG000|Overall Study|Death|90|||
149030899|NCT01020838|537591605|FG000|Overall Study|Adverse Event|1|||
148993490|NCT00355082|537451358|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
148993491|NCT00355082|537451356|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
148993492|NCT00355082|537451357|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
148993493|NCT00355082|537451358|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
148993494|NCT00355082|537451356|FG000|Continuation Phase|Adverse Event|2|||
148993495|NCT00355082|537451357|FG001|Continuation Phase|Adverse Event|0|||
148993496|NCT00355082|537451358|FG002|Continuation Phase|Adverse Event|1|||
148993497|NCT00355082|537451356|FG000|Continuation Phase|Lost to Follow-up|2|||
148993498|NCT00355082|537451357|FG001|Continuation Phase|Lost to Follow-up|0|||
148993499|NCT00355082|537451358|FG002|Continuation Phase|Lost to Follow-up|1|||
148993500|NCT00355082|537451356|FG000|Continuation Phase|Protocol Violation|1|||
148993501|NCT00355082|537451357|FG001|Continuation Phase|Protocol Violation|0|||
148993502|NCT00355082|537451358|FG002|Continuation Phase|Protocol Violation|1|||
148993503|NCT00355082|537451356|FG000|Continuation Phase|Withdrawal by Subject|4|||
148993504|NCT00355082|537451357|FG001|Continuation Phase|Withdrawal by Subject|0|||
148993505|NCT00355082|537451358|FG002|Continuation Phase|Withdrawal by Subject|0|||
148862866|NCT01218100|536974251|FG001|Overall Study|Withdrawal by Subject|2|||
148862867|NCT01218100|536974252|FG002|Overall Study|Withdrawal by Subject|6|||
148862868|NCT01218100|536974253|FG003|Overall Study|Withdrawal by Subject|7|||
148862869|NCT01218100|536974250|FG000|Overall Study|Lost to Follow-up|3|||
148862870|NCT01218100|536974251|FG001|Overall Study|Lost to Follow-up|8|||
148862871|NCT01218100|536974252|FG002|Overall Study|Lost to Follow-up|2|||
148862872|NCT01218100|536974253|FG003|Overall Study|Lost to Follow-up|1|||
148862873|NCT01218100|536974250|FG000|Overall Study|Other Reason|2|||
148862874|NCT01218100|536974251|FG001|Overall Study|Other Reason|2|||
148862875|NCT01218100|536974252|FG002|Overall Study|Other Reason|6|||
148862876|NCT01218100|536974253|FG003|Overall Study|Other Reason|4|||
148862877|NCT01118520|536974256|FG000|Overall Study|AAA repair|9|||
148862878|NCT01118520|536974257|FG001|Overall Study|AAA repair|7|||
148862879|NCT01118520|536974258|FG002|Overall Study|AAA repair|9|||
148862880|NCT01118520|536974256|FG000|Overall Study|Adverse Event|3|||
148862881|NCT01118520|536974257|FG001|Overall Study|Adverse Event|3|||
148862882|NCT01118520|536974258|FG002|Overall Study|Adverse Event|3|||
148862883|NCT01118520|536974256|FG000|Overall Study|Withdrawal by Subject|8|||
148862884|NCT01118520|536974257|FG001|Overall Study|Withdrawal by Subject|13|||
148862885|NCT01118520|536974258|FG002|Overall Study|Withdrawal by Subject|8|||
148862886|NCT01089023|536974261|FG000|Overall Study|Lost to Follow-up|3|||
148862887|NCT01089023|536974261|FG000|Overall Study|Adverse Event|1|||
148862888|NCT01089023|536974261|FG000|Overall Study|Withdrawal by Subject|1|||
148862889|NCT01089023|536974261|FG000|Overall Study|Protocol Violation|1|||
148862890|NCT01089023|536974261|FG000|Overall Study|Lack of Efficacy|1|||
148862891|NCT03883113|536974265|FG000|Overall Study|Physician Decision|4|||
148862892|NCT03883113|536974266|FG001|Overall Study|Physician Decision|2|||
148862893|NCT03883113|536974265|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
148862894|NCT03883113|536974266|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
148862895|NCT03883113|536974265|FG000|Overall Study|Pregnancy|1|||
148862896|NCT03883113|536974266|FG001|Overall Study|Pregnancy|0|||
148862897|NCT03883113|536974265|FG000|Overall Study|Adverse Event|0|||
148862898|NCT03883113|536974266|FG001|Overall Study|Adverse Event|1|||
148862899|NCT03883113|536974265|FG000|Overall Study|Withdrawal by Subject|1|||
148862900|NCT03883113|536974266|FG001|Overall Study|Withdrawal by Subject|2|||
148862901|NCT03883113|536974265|FG000|Overall Study|Lost to Follow-up|1|||
148862902|NCT03883113|536974266|FG001|Overall Study|Lost to Follow-up|0|||
148862903|NCT04962230|536974267|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
148862904|NCT04962230|536974267|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
148862905|NCT01598753|536974268|FG000|Overall Study|Adverse Event|1|||
148862906|NCT01598753|536974269|FG001|Overall Study|Adverse Event|9|||
148862907|NCT01598753|536974270|FG002|Overall Study|Adverse Event|1|||
148862908|NCT01598753|536974271|FG003|Overall Study|Adverse Event|7|||
148862909|NCT01598753|536974268|FG000|Overall Study|Lost to Follow-up|4|||
148993506|NCT00355082|537451356|FG000|Continuation Phase|Lack of Efficacy|5|||
148862910|NCT01598753|536974269|FG001|Overall Study|Lost to Follow-up|3|||
148993507|NCT00355082|537451357|FG001|Continuation Phase|Lack of Efficacy|0|||
148993508|NCT00355082|537451358|FG002|Continuation Phase|Lack of Efficacy|0|||
148993509|NCT00355082|537451356|FG000|Continuation Phase|Site Closed by Sponsor|8|||
148993510|NCT00355082|537451357|FG001|Continuation Phase|Site Closed by Sponsor|0|||
148862911|NCT01598753|536974270|FG002|Overall Study|Lost to Follow-up|7|||
148862912|NCT01598753|536974271|FG003|Overall Study|Lost to Follow-up|5|||
148862913|NCT01598753|536974268|FG000|Overall Study|Physician Decision|0|||
148862914|NCT01598753|536974269|FG001|Overall Study|Physician Decision|1|||
148862915|NCT01598753|536974270|FG002|Overall Study|Physician Decision|0|||
148862916|NCT01598753|536974271|FG003|Overall Study|Physician Decision|2|||
148862917|NCT01598753|536974268|FG000|Overall Study|Withdrawal by Subject|7|||
148862918|NCT01598753|536974269|FG001|Overall Study|Withdrawal by Subject|2|||
148862919|NCT01598753|536974270|FG002|Overall Study|Withdrawal by Subject|0|||
148862920|NCT01598753|536974271|FG003|Overall Study|Withdrawal by Subject|1|||
148862921|NCT02275117|536974272|FG000|Overall Study|Adverse Event|0|||
148862922|NCT02275117|536974273|FG001|Overall Study|Adverse Event|0|||
148862923|NCT02275117|536974274|FG002|Overall Study|Adverse Event|0|||
148862924|NCT02275117|536974275|FG003|Overall Study|Adverse Event|0|||
148862925|NCT02275117|536974276|FG004|Overall Study|Adverse Event|1|||
148862926|NCT02275117|536974272|FG000|Overall Study|Lack of Efficacy|6|||
148862927|NCT02275117|536974273|FG001|Overall Study|Lack of Efficacy|7|||
148862928|NCT02275117|536974274|FG002|Overall Study|Lack of Efficacy|5|||
148862929|NCT02275117|536974275|FG003|Overall Study|Lack of Efficacy|2|||
148862930|NCT02275117|536974276|FG004|Overall Study|Lack of Efficacy|10|||
148862931|NCT02275117|536974272|FG000|Overall Study|Lost to Follow-up|11|||
148862932|NCT02275117|536974273|FG001|Overall Study|Lost to Follow-up|16|||
148862933|NCT02275117|536974274|FG002|Overall Study|Lost to Follow-up|15|||
148862934|NCT02275117|536974275|FG003|Overall Study|Lost to Follow-up|16|||
148862935|NCT02275117|536974276|FG004|Overall Study|Lost to Follow-up|8|||
148862936|NCT02275117|536974272|FG000|Overall Study|Physician Decision|0|||
148862937|NCT02275117|536974273|FG001|Overall Study|Physician Decision|1|||
148862938|NCT02275117|536974274|FG002|Overall Study|Physician Decision|1|||
148862939|NCT02275117|536974275|FG003|Overall Study|Physician Decision|0|||
148862940|NCT02275117|536974276|FG004|Overall Study|Physician Decision|1|||
148862941|NCT02275117|536974272|FG000|Overall Study|Protocol Violation|1|||
148862942|NCT02275117|536974273|FG001|Overall Study|Protocol Violation|0|||
148862943|NCT02275117|536974274|FG002|Overall Study|Protocol Violation|1|||
148862944|NCT02275117|536974275|FG003|Overall Study|Protocol Violation|1|||
148862945|NCT02275117|536974276|FG004|Overall Study|Protocol Violation|0|||
148862946|NCT02275117|536974272|FG000|Overall Study|Withdrawal by Subject|6|||
148862947|NCT02275117|536974273|FG001|Overall Study|Withdrawal by Subject|4|||
148862948|NCT02275117|536974274|FG002|Overall Study|Withdrawal by Subject|7|||
148862949|NCT02275117|536974275|FG003|Overall Study|Withdrawal by Subject|3|||
148862950|NCT02275117|536974276|FG004|Overall Study|Withdrawal by Subject|3|||
148862951|NCT02275117|536974272|FG000|Overall Study|Terminated by Sponsor|4|||
148862952|NCT02275117|536974273|FG001|Overall Study|Terminated by Sponsor|4|||
148862953|NCT02275117|536974274|FG002|Overall Study|Terminated by Sponsor|4|||
148862954|NCT02275117|536974275|FG003|Overall Study|Terminated by Sponsor|6|||
148862955|NCT02275117|536974276|FG004|Overall Study|Terminated by Sponsor|4|||
148862956|NCT02275117|536974272|FG000|Overall Study|Worsening of Study Indication|0|||
148862957|NCT02275117|536974273|FG001|Overall Study|Worsening of Study Indication|1|||
148862958|NCT02275117|536974274|FG002|Overall Study|Worsening of Study Indication|2|||
148862959|NCT02275117|536974275|FG003|Overall Study|Worsening of Study Indication|0|||
148862960|NCT02275117|536974276|FG004|Overall Study|Worsening of Study Indication|0|||
148862961|NCT02275117|536974272|FG000|Overall Study|Study Burden|5|||
148862962|NCT02275117|536974273|FG001|Overall Study|Study Burden|4|||
148862963|NCT02275117|536974274|FG002|Overall Study|Study Burden|7|||
148862964|NCT02275117|536974275|FG003|Overall Study|Study Burden|5|||
148862965|NCT02275117|536974276|FG004|Overall Study|Study Burden|7|||
148862966|NCT02275117|536974272|FG000|Overall Study|Other|1|||
148862967|NCT02275117|536974273|FG001|Overall Study|Other|0|||
148862968|NCT02275117|536974274|FG002|Overall Study|Other|0|||
148862969|NCT02275117|536974275|FG003|Overall Study|Other|0|||
148862970|NCT02275117|536974276|FG004|Overall Study|Other|2|||
148862971|NCT02014480|536974279|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
148862972|NCT02014480|536974280|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
148862973|NCT02014480|536974281|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
148862974|NCT02014480|536974282|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
148862975|NCT02014480|536974283|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
148862976|NCT02014480|536974284|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
148862977|NCT02014480|536974279|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148862978|NCT02014480|536974280|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148862979|NCT02014480|536974281|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148862980|NCT02014480|536974282|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
148862981|NCT02014480|536974283|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
148862982|NCT02014480|536974284|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148862983|NCT02014480|536974279|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148862984|NCT02014480|536974280|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148862985|NCT02014480|536974281|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
148862986|NCT02014480|536974282|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148862987|NCT02014480|536974283|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148862988|NCT02014480|536974284|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
148862989|NCT02014480|536974279|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
148862990|NCT02014480|536974280|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
148862991|NCT02014480|536974281|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
148862992|NCT02014480|536974282|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
148862993|NCT02014480|536974283|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148862994|NCT02014480|536974284|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
148862995|NCT02014480|536974279|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148862996|NCT02014480|536974280|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
148862997|NCT02014480|536974281|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148993511|NCT00355082|537451358|FG002|Continuation Phase|Site Closed by Sponsor|0|||
148993512|NCT00355082|537451356|FG000|Continuation Phase|Scheduling Error|1|||
148993513|NCT00355082|537451357|FG001|Continuation Phase|Scheduling Error|0|||
148993514|NCT00355082|537451358|FG002|Continuation Phase|Scheduling Error|0|||
148993515|NCT00355082|537451356|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
148993516|NCT00355082|537451357|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
148993517|NCT00355082|537451358|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
148993518|NCT00724971|537451368|FG000|Overall Study|Adverse Event|5|||
148993519|NCT00724971|537451368|FG000|Overall Study|Withdrawal by Subject|1|||
148993520|NCT01003249|537451369|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148993521|NCT01003249|537451370|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
148993522|NCT01003249|537451369|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
148993523|NCT01003249|537451370|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
148993524|NCT01003249|537451369|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
148993525|NCT01003249|537451370|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148993526|NCT01003249|537451369|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
148993527|NCT01003249|537451370|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
148993528|NCT02132611|537451375|FG000|Overall Study|Death|2|||
148993529|NCT02298192|537451376|FG000|Overall Study|Unclassified|3|||
148993530|NCT02298192|537451377|FG001|Overall Study|Unclassified|2|||
148993531|NCT02298192|537451376|FG000|Overall Study|Withdrawal criteria|2|||
148993532|NCT02298192|537451377|FG001|Overall Study|Withdrawal criteria|0|||
148993533|NCT02298192|537451376|FG000|Overall Study|Withdrawal by Subject|6|||
148993534|NCT02298192|537451377|FG001|Overall Study|Withdrawal by Subject|1|||
148993535|NCT02298192|537451376|FG000|Overall Study|Lost to Follow-up|2|||
148993536|NCT02298192|537451377|FG001|Overall Study|Lost to Follow-up|1|||
148993537|NCT02298192|537451376|FG000|Overall Study|Adverse Event|6|||
148993538|NCT02298192|537451377|FG001|Overall Study|Adverse Event|2|||
148993539|NCT04657211|537451381|FG000|Overall Study|Withdrawal by Subject|21|||
148993540|NCT04657211|537451381|FG000|Overall Study|Lost to Follow-up|113|||
148993541|NCT04657211|537451381|FG000|Overall Study|Death|47|||
148993542|NCT04657211|537451381|FG000|Overall Study|Transfer to another institution|21|||
148993543|NCT04657211|537451381|FG000|Overall Study|Other|29|||
148993544|NCT06167031|537451382|FG000|Overall Study|Lost to Follow-up|5|||
148993545|NCT06167031|537451383|FG001|Overall Study|Lost to Follow-up|1|||
148993546|NCT02979639|537452997|FG000|Overall Study|Withdrawal based on medical judgement|1|||
148993547|NCT02979639|537452997|FG000|Overall Study|Lost to Follow-up|8|||
148993548|NCT02979639|537452997|FG000|Overall Study|Withdrawal by Subject|3|||
148993549|NCT02979639|537452997|FG000|Overall Study|Adverse Event|2|||
148993550|NCT00319098|537453011|FG000|Overall Study|Serious adverse event|3|||
148993551|NCT00319098|537453012|FG001|Overall Study|Serious adverse event|0|||
148993552|NCT00319098|537453011|FG000|Overall Study|Adverse Event|20|||
148993553|NCT00319098|537453012|FG001|Overall Study|Adverse Event|1|||
148993554|NCT00319098|537453011|FG000|Overall Study|Withdrawal by Subject|37|||
148993555|NCT00319098|537453012|FG001|Overall Study|Withdrawal by Subject|8|||
148993556|NCT00319098|537453011|FG000|Overall Study|Migrated/moved from study area|2|||
148993557|NCT00319098|537453012|FG001|Overall Study|Migrated/moved from study area|1|||
148993558|NCT00319098|537453011|FG000|Overall Study|Lost to Follow-up|37|||
148993559|NCT00319098|537453012|FG001|Overall Study|Lost to Follow-up|13|||
148993560|NCT00319098|537453011|FG000|Overall Study|Others|33|||
148993561|NCT00319098|537453012|FG001|Overall Study|Others|8|||
148993562|NCT00319098|537453011|FG000|Overall Study|Protocol Violation|3|||
148993563|NCT00319098|537453012|FG001|Overall Study|Protocol Violation|1|||
148993564|NCT00965523|537453013|FG000|Study 221|Progressive Disease|4|||
148993565|NCT00965523|537453013|FG000|Study 221|Physician Decision|3|||
148993566|NCT00965523|537453013|FG000|Study 224|Progressive Disease|5|||
148993567|NCT00965523|537453013|FG000|Study 224|Physician Decision|1|||
148993568|NCT02415400|537453014|FG000|Overall Study|Adverse Event|0|||
148993569|NCT02415400|537453015|FG001|Overall Study|Adverse Event|1|||
148993570|NCT02415400|537453016|FG002|Overall Study|Adverse Event|1|||
148993571|NCT02415400|537453017|FG003|Overall Study|Adverse Event|2|||
148993572|NCT02415400|537453014|FG000|Overall Study|Participant request to stop therapy|4|||
148993573|NCT02415400|537453015|FG001|Overall Study|Participant request to stop therapy|3|||
148993574|NCT02415400|537453016|FG002|Overall Study|Participant request to stop therapy|8|||
148993575|NCT02415400|537453017|FG003|Overall Study|Participant request to stop therapy|6|||
148993576|NCT02415400|537453014|FG000|Overall Study|Participant withdrew consent|14|||
148993577|NCT02415400|537453015|FG001|Overall Study|Participant withdrew consent|12|||
148993578|NCT02415400|537453016|FG002|Overall Study|Participant withdrew consent|30|||
148993579|NCT02415400|537453017|FG003|Overall Study|Participant withdrew consent|21|||
148993580|NCT02415400|537453014|FG000|Overall Study|Death|39|||
148993581|NCT02415400|537453015|FG001|Overall Study|Death|41|||
148993582|NCT02415400|537453016|FG002|Overall Study|Death|35|||
148993583|NCT02415400|537453017|FG003|Overall Study|Death|42|||
148993584|NCT02415400|537453014|FG000|Overall Study|Lost to Follow-up|3|||
148993585|NCT02415400|537453015|FG001|Overall Study|Lost to Follow-up|3|||
148993586|NCT02415400|537453016|FG002|Overall Study|Lost to Follow-up|2|||
148993587|NCT02415400|537453017|FG003|Overall Study|Lost to Follow-up|5|||
148862998|NCT02014480|536974282|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148862999|NCT02014480|536974283|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148863000|NCT02014480|536974284|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
148863001|NCT02014480|536974279|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
148863002|NCT02014480|536974280|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
148863003|NCT02014480|536974281|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
148863004|NCT02014480|536974282|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
148863005|NCT02014480|536974283|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
148863006|NCT02014480|536974284|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
148863007|NCT02014480|536974279|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148863008|NCT02014480|536974280|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148863009|NCT02014480|536974281|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148863010|NCT02014480|536974282|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148863011|NCT02014480|536974283|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
148863012|NCT02014480|536974284|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
148863013|NCT01865812|536974285|FG000|Primary Treatment Phase|Adverse Event|2|||
148863014|NCT01865812|536974286|FG001|Primary Treatment Phase|Adverse Event|0|||
148863015|NCT01865812|536974285|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
148863016|NCT01865812|536974286|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
148863017|NCT01865812|536974285|FG000|Long-term Safety Extension Phase|Pruritus|0|||
148863018|NCT01865812|536974286|FG001|Long-term Safety Extension Phase|Pruritus|3|||
148863019|NCT01865812|536974285|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
148863020|NCT01865812|536974286|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
148863021|NCT01865812|536974285|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
148863022|NCT01865812|536974286|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
148863023|NCT01338610|536974287|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
148863024|NCT01338610|536974288|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
148863025|NCT01338610|536974289|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
148863026|NCT01338610|536974287|FG000|Overall Study|Protocol Violation|1|||
148863027|NCT01338610|536974288|FG001|Overall Study|Protocol Violation|0|||
148863028|NCT01338610|536974289|FG002|Overall Study|Protocol Violation|1|||
148863029|NCT01338610|536974287|FG000|Overall Study|Adverse Event|3|||
148863030|NCT01338610|536974288|FG001|Overall Study|Adverse Event|0|||
148863031|NCT01338610|536974289|FG002|Overall Study|Adverse Event|0|||
148863032|NCT02692040|536974290|FG000|Overall Study|Protocol Violation|0|||
148863033|NCT02692040|536974291|FG001|Overall Study|Protocol Violation|0|||
148863034|NCT02692040|536974292|FG002|Overall Study|Protocol Violation|0|||
148863035|NCT02692040|536974293|FG003|Overall Study|Protocol Violation|0|||
148863036|NCT02692040|536974294|FG004|Overall Study|Protocol Violation|0|||
148863037|NCT02692040|536974295|FG005|Overall Study|Protocol Violation|0|||
148863038|NCT02692040|536974296|FG006|Overall Study|Protocol Violation|0|||
148863039|NCT02692040|536974297|FG007|Overall Study|Protocol Violation|0|||
148863040|NCT02692040|536974298|FG008|Overall Study|Protocol Violation|0|||
148863041|NCT02692040|536974299|FG009|Overall Study|Protocol Violation|0|||
148863042|NCT02692040|536974300|FG010|Overall Study|Protocol Violation|0|||
148863043|NCT02692040|536974301|FG011|Overall Study|Protocol Violation|0|||
148863044|NCT02692040|536974302|FG012|Overall Study|Protocol Violation|1|||
148863045|NCT02692040|536974303|FG013|Overall Study|Protocol Violation|0|||
148863046|NCT02692040|536974304|FG014|Overall Study|Protocol Violation|0|||
148863047|NCT02692040|536974305|FG015|Overall Study|Protocol Violation|0|||
148863048|NCT02692040|536974306|FG016|Overall Study|Protocol Violation|0|||
148863049|NCT02692040|536974290|FG000|Overall Study|Adverse Event|0|||
148863050|NCT02692040|536974291|FG001|Overall Study|Adverse Event|0|||
148863051|NCT02692040|536974292|FG002|Overall Study|Adverse Event|0|||
148863052|NCT02692040|536974293|FG003|Overall Study|Adverse Event|0|||
148863053|NCT02692040|536974294|FG004|Overall Study|Adverse Event|0|||
148863054|NCT02692040|536974295|FG005|Overall Study|Adverse Event|0|||
148863055|NCT02692040|536974296|FG006|Overall Study|Adverse Event|0|||
148863056|NCT02692040|536974297|FG007|Overall Study|Adverse Event|0|||
148863057|NCT02692040|536974298|FG008|Overall Study|Adverse Event|0|||
148863058|NCT02692040|536974299|FG009|Overall Study|Adverse Event|0|||
148863059|NCT02692040|536974300|FG010|Overall Study|Adverse Event|0|||
148863060|NCT02692040|536974301|FG011|Overall Study|Adverse Event|0|||
148863061|NCT02692040|536974302|FG012|Overall Study|Adverse Event|0|||
148863062|NCT02692040|536974303|FG013|Overall Study|Adverse Event|3|||
148863063|NCT02692040|536974304|FG014|Overall Study|Adverse Event|1|||
148863064|NCT02692040|536974305|FG015|Overall Study|Adverse Event|1|||
148863065|NCT02692040|536974306|FG016|Overall Study|Adverse Event|0|||
148863066|NCT00435162|536974310|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
148863067|NCT00435162|536974311|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
148863068|NCT00435162|536974312|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
148863069|NCT00435162|536974313|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
148863070|NCT00435162|536974314|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
148863071|NCT00435162|536974315|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
148863072|NCT01819129|536974316|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
148863073|NCT01819129|536974317|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
148863074|NCT01819129|536974316|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
148863075|NCT01819129|536974317|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
148863076|NCT01819129|536974316|FG000|Overall Study|Other, Subject moved out of the country|0|||
148863077|NCT01819129|536974317|FG001|Overall Study|Other, Subject moved out of the country|1|||
148863078|NCT01819129|536974316|FG000|Overall Study|Withdrawal by Subject|15|||
148863079|NCT01819129|536974317|FG001|Overall Study|Withdrawal by Subject|15|||
148863080|NCT01819129|536974316|FG000|Overall Study|Lost to Follow-up|5|||
148863081|NCT01819129|536974317|FG001|Overall Study|Lost to Follow-up|2|||
148863082|NCT01819129|536974316|FG000|Overall Study|Lack of Efficacy|0|||
148863083|NCT01819129|536974317|FG001|Overall Study|Lack of Efficacy|1|||
148863084|NCT01819129|536974316|FG000|Overall Study|Adverse Event|1|||
148863085|NCT01819129|536974317|FG001|Overall Study|Adverse Event|4|||
148863086|NCT01819129|536974316|FG000|Overall Study|Death|1|||
148863087|NCT01819129|536974317|FG001|Overall Study|Death|1|||
148863088|NCT01819129|536974316|FG000|Overall Study|Withdrawal Criteria|20|||
148863089|NCT01819129|536974317|FG001|Overall Study|Withdrawal Criteria|15|||
148863090|NCT00054691|536974323|FG000|Overall Study|Unmeasurable Disease|2|||
148863091|NCT00054691|536974323|FG000|Overall Study|Noncompliant|1|||
148863092|NCT02836873|536974330|FG000|Overall Study|Protocol Violation|0|||
148863093|NCT02836873|536974331|FG001|Overall Study|Protocol Violation|1|||
148863094|NCT02836873|536974330|FG000|Overall Study|Adverse Event|1|||
148863095|NCT02836873|536974331|FG001|Overall Study|Adverse Event|4|||
148863096|NCT02836873|536974330|FG000|Overall Study|Withdrawal by Subject|2|||
148863097|NCT02836873|536974331|FG001|Overall Study|Withdrawal by Subject|2|||
148863098|NCT02836873|536974330|FG000|Overall Study|Lost to Follow-up|1|||
148863099|NCT02836873|536974331|FG001|Overall Study|Lost to Follow-up|3|||
148863100|NCT02836873|536974330|FG000|Overall Study|Physician Decision|0|||
148863101|NCT02836873|536974331|FG001|Overall Study|Physician Decision|1|||
148863102|NCT02836873|536974330|FG000|Overall Study|Other|1|||
148863103|NCT02836873|536974331|FG001|Overall Study|Other|0|||
148863104|NCT02142283|536974332|FG000|Overall Study|Death|20|||
148863105|NCT02142283|536974333|FG001|Overall Study|Death|18|||
148863106|NCT02142283|536974332|FG000|Overall Study|Withdrawal by Subject|1|||
148863107|NCT02142283|536974333|FG001|Overall Study|Withdrawal by Subject|3|||
148863108|NCT02185014|536974336|FG000|Overall Study|Adverse Event|18|||
148863109|NCT02185014|536974336|FG000|Overall Study|Withdrew Consent|8|||
148863110|NCT02185014|536974336|FG000|Overall Study|Lost to Follow-up|4|||
148863111|NCT02185014|536974336|FG000|Overall Study|Lack of Efficacy|14|||
148863112|NCT02185014|536974336|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
148863113|NCT02185014|536974336|FG000|Overall Study|Subject Noncompliance|1|||
148863114|NCT02185014|536974336|FG000|Overall Study|Other|4|||
148863115|NCT03093974|536974337|FG000|Overall Study|Withdrawal by Subject|32|||
148863116|NCT03093974|536974338|FG001|Overall Study|Withdrawal by Subject|27|||
148863117|NCT03093974|536974337|FG000|Overall Study|Adverse Event|17|||
148863118|NCT03093974|536974338|FG001|Overall Study|Adverse Event|24|||
148863119|NCT03093974|536974337|FG000|Overall Study|Death|0|||
148863120|NCT03093974|536974338|FG001|Overall Study|Death|1|||
148863121|NCT03093974|536974337|FG000|Overall Study|Non-Compliance with Study Drug|1|||
148863122|NCT03093974|536974338|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148863123|NCT03093974|536974337|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
148863124|NCT03093974|536974338|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
148863125|NCT03093974|536974337|FG000|Overall Study|Lost to Follow-up|0|||
148863126|NCT03093974|536974338|FG001|Overall Study|Lost to Follow-up|1|||
148863127|NCT03093974|536974337|FG000|Overall Study|Other|1|||
148863128|NCT03093974|536974338|FG001|Overall Study|Other|2|||
148863129|NCT02141490|536974339|FG000|Overall Study|Screening failures|4|||
148863130|NCT02141490|536974340|FG001|Overall Study|Screening failures|0|||
148863131|NCT02141490|536974341|FG002|Overall Study|Screening failures|0|||
148863132|NCT02387164|536974342|FG000|Overall Study|Lost to Follow-up|2|||
148863133|NCT02387164|536974343|FG001|Overall Study|Lost to Follow-up|0|||
148863134|NCT02387164|536974342|FG000|Overall Study|Diagnosed|1|||
148863135|NCT02387164|536974343|FG001|Overall Study|Diagnosed|2|||
148863136|NCT00033540|536974346|FG000|Overall Study|Adverse Event|14|||
148863137|NCT00033540|536974346|FG000|Overall Study|Death|1|||
148863138|NCT00033540|536974346|FG000|Overall Study|Progression|26|||
148863139|NCT00033540|536974346|FG000|Overall Study|Withdrawal by Subject|6|||
148863140|NCT00033540|536974346|FG000|Overall Study|Other|5|||
148863141|NCT00033540|536974346|FG000|Overall Study|Ineligible|3|||
148993588|NCT02415400|537453014|FG000|Overall Study|Poor/Non-Compliance|0|||
148863142|NCT00033540|536974346|FG000|Overall Study|Never received treatment|2|||
148863143|NCT01253265|536974349|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
148863144|NCT01253265|536974350|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
148863145|NCT01253265|536974351|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
148863146|NCT01253265|536974352|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
148863147|NCT01253265|536974353|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
148863148|NCT01253265|536974349|FG000|Overall Study|Withdrawal by Subject|0|||
148863149|NCT01253265|536974350|FG001|Overall Study|Withdrawal by Subject|0|||
148863150|NCT01253265|536974351|FG002|Overall Study|Withdrawal by Subject|0|||
148863151|NCT01253265|536974352|FG003|Overall Study|Withdrawal by Subject|0|||
148863152|NCT01253265|536974353|FG004|Overall Study|Withdrawal by Subject|1|||
148863153|NCT03271047|536974354|FG000|Phase 1b: Dose Finding Period|Death|8|||
148863154|NCT03271047|536974355|FG001|Phase 1b: Dose Finding Period|Death|8|||
148863155|NCT03271047|536974356|FG002|Phase 1b: Dose Finding Period|Death|0|||
148863156|NCT03271047|536974357|FG003|Phase 1b: Dose Finding Period|Death|0|||
148863157|NCT03271047|536974354|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
148863158|NCT03271047|536974355|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
148863159|NCT03271047|536974356|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
148863160|NCT03271047|536974357|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
148863161|NCT03271047|536974354|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
148863162|NCT03271047|536974355|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
148863163|NCT03271047|536974356|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
148863164|NCT03271047|536974357|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
148863165|NCT03271047|536974354|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
148863166|NCT03271047|536974355|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
148863167|NCT03271047|536974356|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
148863168|NCT03271047|536974357|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
148863169|NCT03271047|536974354|FG000|Randomized Phase 2 Period|Other|0|||
148863170|NCT03271047|536974355|FG001|Randomized Phase 2 Period|Other|0|||
148863171|NCT03271047|536974356|FG002|Randomized Phase 2 Period|Other|0|||
148863172|NCT03271047|536974357|FG003|Randomized Phase 2 Period|Other|1|||
148863173|NCT03271047|536974354|FG000|Randomized Phase 2 Period|Death|0|||
148863174|NCT03271047|536974355|FG001|Randomized Phase 2 Period|Death|0|||
148863175|NCT03271047|536974356|FG002|Randomized Phase 2 Period|Death|20|||
148863176|NCT03271047|536974357|FG003|Randomized Phase 2 Period|Death|21|||
148863177|NCT03271047|536974354|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
148863178|NCT03271047|536974355|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
148863179|NCT03271047|536974356|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
148863180|NCT03271047|536974357|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
148863181|NCT03271047|536974354|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
148863182|NCT03271047|536974355|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
148863183|NCT03271047|536974356|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
148863184|NCT03271047|536974357|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
148863185|NCT03271047|536974354|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
148863186|NCT03271047|536974355|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
148863187|NCT03271047|536974356|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
148863188|NCT03271047|536974357|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
148863189|NCT00434759|536974359|FG000|Overall Study|Lack of Efficacy|5|||
148863190|NCT00434759|536974360|FG001|Overall Study|Lack of Efficacy|4|||
148863191|NCT00434759|536974359|FG000|Overall Study|Withdrawal by Subject|17|||
148863192|NCT00434759|536974360|FG001|Overall Study|Withdrawal by Subject|1|||
148863193|NCT00434759|536974359|FG000|Overall Study|family affairs|2|||
148863194|NCT00434759|536974360|FG001|Overall Study|family affairs|0|||
148863195|NCT00495521|536974361|FG000|Overall Study|Physician Decision|0|||
148863196|NCT00495521|536974362|FG001|Overall Study|Physician Decision|1|||
148863197|NCT02410824|536974363|FG000|First Intervention (One Week)|Headache|0|||
148863198|NCT02410824|536974364|FG001|First Intervention (One Week)|Headache|1|||
148863199|NCT00392808|536974365|FG000|Overall Study|Lost to Follow-up|3|||
148863200|NCT00392808|536974366|FG001|Overall Study|Lost to Follow-up|2|||
148863201|NCT00392808|536974367|FG002|Overall Study|Lost to Follow-up|1|||
148863202|NCT00392808|536974368|FG003|Overall Study|Lost to Follow-up|2|||
148863203|NCT00392808|536974365|FG000|Overall Study|Unable to withdraw blood|3|||
148863204|NCT00392808|536974366|FG001|Overall Study|Unable to withdraw blood|1|||
148863205|NCT00392808|536974367|FG002|Overall Study|Unable to withdraw blood|1|||
148863206|NCT00392808|536974368|FG003|Overall Study|Unable to withdraw blood|2|||
148863207|NCT02649855|536974369|FG000|Overall Study|Refused further treatment|2|||
148863208|NCT02649855|536974370|FG001|Overall Study|Refused further treatment|1|||
148863209|NCT02649855|536974371|FG002|Overall Study|Refused further treatment|1|||
148863210|NCT02649855|536974369|FG000|Overall Study|Withdrew consent|0|||
148863211|NCT02649855|536974370|FG001|Overall Study|Withdrew consent|1|||
148993589|NCT02415400|537453015|FG001|Overall Study|Poor/Non-Compliance|1|||
148863212|NCT02649855|536974371|FG002|Overall Study|Withdrew consent|0|||
148863213|NCT02649855|536974369|FG000|Overall Study|Switched to alternative treatment|0|||
148993590|NCT02415400|537453016|FG002|Overall Study|Poor/Non-Compliance|3|||
148863214|NCT02649855|536974370|FG001|Overall Study|Switched to alternative treatment|1|||
148863215|NCT02649855|536974371|FG002|Overall Study|Switched to alternative treatment|1|||
148863216|NCT02649855|536974369|FG000|Overall Study|Principal investigator discretion|0|||
148863217|NCT02649855|536974370|FG001|Overall Study|Principal investigator discretion|1|||
148863218|NCT02649855|536974371|FG002|Overall Study|Principal investigator discretion|1|||
148863219|NCT02649855|536974369|FG000|Overall Study|No treatment, per protocol|1|||
148993591|NCT02415400|537453017|FG003|Overall Study|Poor/Non-Compliance|4|||
148993592|NCT02415400|537453014|FG000|Overall Study|Participant no longer meets criteria|2|||
148993593|NCT02415400|537453015|FG001|Overall Study|Participant no longer meets criteria|0|||
148993594|NCT02415400|537453016|FG002|Overall Study|Participant no longer meets criteria|0|||
148993595|NCT02415400|537453017|FG003|Overall Study|Participant no longer meets criteria|1|||
148993596|NCT02415400|537453014|FG000|Overall Study|Participant doesn't answer phone|1|||
148993597|NCT02415400|537453015|FG001|Overall Study|Participant doesn't answer phone|0|||
148993598|NCT02415400|537453016|FG002|Overall Study|Participant doesn't answer phone|0|||
148993599|NCT02415400|537453017|FG003|Overall Study|Participant doesn't answer phone|0|||
148993600|NCT02415400|537453014|FG000|Overall Study|Participant wanted home visits|1|||
148993601|NCT02415400|537453015|FG001|Overall Study|Participant wanted home visits|0|||
148993602|NCT02415400|537453016|FG002|Overall Study|Participant wanted home visits|0|||
148993603|NCT02415400|537453017|FG003|Overall Study|Participant wanted home visits|0|||
148993604|NCT02415400|537453014|FG000|Overall Study|Randomized in error|2|||
148993605|NCT02415400|537453015|FG001|Overall Study|Randomized in error|0|||
148993606|NCT02415400|537453016|FG002|Overall Study|Randomized in error|0|||
148993607|NCT02415400|537453017|FG003|Overall Study|Randomized in error|0|||
148993608|NCT02415400|537453014|FG000|Overall Study|No study drug on site|0|||
148993609|NCT02415400|537453015|FG001|Overall Study|No study drug on site|1|||
148993610|NCT02415400|537453016|FG002|Overall Study|No study drug on site|0|||
148993611|NCT02415400|537453017|FG003|Overall Study|No study drug on site|0|||
148993612|NCT02415400|537453014|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
148993613|NCT02415400|537453015|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
148993614|NCT02415400|537453016|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
148993615|NCT02415400|537453017|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
148993616|NCT02415400|537453014|FG000|Overall Study|Coagulation values cannot be set|0|||
148993617|NCT02415400|537453015|FG001|Overall Study|Coagulation values cannot be set|0|||
148993618|NCT02415400|537453016|FG002|Overall Study|Coagulation values cannot be set|1|||
148993619|NCT02415400|537453017|FG003|Overall Study|Coagulation values cannot be set|0|||
148993620|NCT02415400|537453014|FG000|Overall Study|State regulations prevent participation|0|||
148993621|NCT02415400|537453015|FG001|Overall Study|State regulations prevent participation|0|||
148993622|NCT02415400|537453016|FG002|Overall Study|State regulations prevent participation|1|||
148993623|NCT02415400|537453017|FG003|Overall Study|State regulations prevent participation|0|||
148993624|NCT02415400|537453014|FG000|Overall Study|Poor treatment monitoring|0|||
148993625|NCT02415400|537453015|FG001|Overall Study|Poor treatment monitoring|0|||
148993626|NCT02415400|537453016|FG002|Overall Study|Poor treatment monitoring|1|||
148993627|NCT02415400|537453017|FG003|Overall Study|Poor treatment monitoring|0|||
148993628|NCT02415400|537453014|FG000|Overall Study|Participant in jail|0|||
148993629|NCT02415400|537453015|FG001|Overall Study|Participant in jail|0|||
148993630|NCT02415400|537453016|FG002|Overall Study|Participant in jail|1|||
148993631|NCT02415400|537453017|FG003|Overall Study|Participant in jail|0|||
148993632|NCT02415400|537453014|FG000|Overall Study|Investigator decision|0|||
148993633|NCT02415400|537453015|FG001|Overall Study|Investigator decision|0|||
148993634|NCT02415400|537453016|FG002|Overall Study|Investigator decision|1|||
148993635|NCT02415400|537453017|FG003|Overall Study|Investigator decision|1|||
148993636|NCT02415400|537453014|FG000|Overall Study|Site closure; participant won't transfer|0|||
148993637|NCT02415400|537453015|FG001|Overall Study|Site closure; participant won't transfer|0|||
148993638|NCT02415400|537453016|FG002|Overall Study|Site closure; participant won't transfer|0|||
148993639|NCT02415400|537453017|FG003|Overall Study|Site closure; participant won't transfer|1|||
148993640|NCT02270450|537453018|FG000|Overall Study|Refusal unrelated to adverse event|3|||
148993641|NCT02270450|537453019|FG001|Overall Study|Refusal unrelated to adverse event|1|||
148993642|NCT02270450|537453020|FG002|Overall Study|Refusal unrelated to adverse event|5|||
148993643|NCT02270450|537453021|FG003|Overall Study|Refusal unrelated to adverse event|14|||
148993644|NCT02270450|537453018|FG000|Overall Study|Progression/relapse|1|||
148993645|NCT02270450|537453019|FG001|Overall Study|Progression/relapse|2|||
148993646|NCT02270450|537453020|FG002|Overall Study|Progression/relapse|4|||
148993647|NCT02270450|537453021|FG003|Overall Study|Progression/relapse|9|||
148993648|NCT02270450|537453018|FG000|Overall Study|Death|19|||
148993649|NCT02270450|537453019|FG001|Overall Study|Death|19|||
148993650|NCT02270450|537453020|FG002|Overall Study|Death|31|||
148993651|NCT02270450|537453021|FG003|Overall Study|Death|59|||
148993652|NCT02363738|537453022|FG000|Overall Study|Adverse Event|5|||
148993653|NCT02363738|537453023|FG001|Overall Study|Adverse Event|2|||
148993654|NCT02363738|537453022|FG000|Overall Study|Lack of Efficacy|1|||
148993655|NCT02363738|537453023|FG001|Overall Study|Lack of Efficacy|2|||
148993656|NCT02363738|537453022|FG000|Overall Study|Lost to Follow-up|2|||
148993657|NCT02363738|537453023|FG001|Overall Study|Lost to Follow-up|1|||
148993658|NCT02187991|537453027|FG000|Overall Study|Adverse Event|13|||
148993659|NCT02187991|537453028|FG001|Overall Study|Adverse Event|14|||
148993660|NCT02187991|537453029|FG002|Overall Study|Adverse Event|3|||
148993661|NCT02187991|537453030|FG003|Overall Study|Adverse Event|2|||
148993662|NCT02187991|537453027|FG000|Overall Study|Withdrawal by Subject|9|||
148993663|NCT02187991|537453028|FG001|Overall Study|Withdrawal by Subject|6|||
148993664|NCT02187991|537453029|FG002|Overall Study|Withdrawal by Subject|3|||
148993665|NCT02187991|537453030|FG003|Overall Study|Withdrawal by Subject|2|||
149030900|NCT01020838|537591605|FG000|Overall Study|Withdrawal by Subject|9|||
149030901|NCT01020838|537591605|FG000|Overall Study|Lost to Follow-up|6|||
149030902|NCT01020838|537591605|FG000|Overall Study|Most common: Study ended by sponsor|77|||
149030903|NCT01956669|537591606|FG000|Overall Study|Disease Progression|12|||
149030904|NCT01956669|537591607|FG001|Overall Study|Disease Progression|7|||
148863220|NCT02649855|536974370|FG001|Overall Study|No treatment, per protocol|0|||
148863221|NCT02649855|536974371|FG002|Overall Study|No treatment, per protocol|0|||
148863222|NCT02649855|536974369|FG000|Overall Study|Initiate new treatment|1|||
148863223|NCT02649855|536974370|FG001|Overall Study|Initiate new treatment|0|||
148863224|NCT02649855|536974371|FG002|Overall Study|Initiate new treatment|0|||
148863225|NCT01038713|536974372|FG000|Overall Study|Patient to hospice|1|||
148863226|NCT01038713|536974373|FG001|Overall Study|Patient to hospice|1|||
148863227|NCT01038713|536974374|FG002|Overall Study|Patient to hospice|1|||
148863228|NCT01038713|536974372|FG000|Overall Study|Lost to Follow-up|3|||
148863229|NCT01038713|536974373|FG001|Overall Study|Lost to Follow-up|0|||
148863230|NCT01038713|536974374|FG002|Overall Study|Lost to Follow-up|0|||
148863231|NCT01038713|536974372|FG000|Overall Study|Neuroendocrine Tumor|0|||
148863232|NCT01038713|536974373|FG001|Overall Study|Neuroendocrine Tumor|1|||
148863233|NCT01038713|536974374|FG002|Overall Study|Neuroendocrine Tumor|0|||
148863234|NCT01038713|536974372|FG000|Overall Study|died from PEP|0|||
148863235|NCT01038713|536974373|FG001|Overall Study|died from PEP|1|||
148863236|NCT01038713|536974374|FG002|Overall Study|died from PEP|0|||
148863237|NCT01038713|536974372|FG000|Overall Study|Autoimmune Pancreatitis|1|||
148863238|NCT01038713|536974373|FG001|Overall Study|Autoimmune Pancreatitis|0|||
148863239|NCT01038713|536974374|FG002|Overall Study|Autoimmune Pancreatitis|0|||
148863240|NCT03777917|536974375|FG000|Overall Study|Withdrawal by Subject|1|||
148863241|NCT03777917|536974376|FG001|Overall Study|Withdrawal by Subject|0|||
148863242|NCT03777917|536974375|FG000|Overall Study|Physician Decision|1|||
148863243|NCT03777917|536974376|FG001|Overall Study|Physician Decision|0|||
148863244|NCT03777917|536974375|FG000|Overall Study|Lost to Follow-up|6|||
148863245|NCT03777917|536974376|FG001|Overall Study|Lost to Follow-up|2|||
148863246|NCT03777917|536974375|FG000|Overall Study|Other|1|||
148863247|NCT03777917|536974376|FG001|Overall Study|Other|0|||
148863248|NCT00432744|536974377|FG000|Months 0-6|Withdrawal by Subject|4|||
148863249|NCT00432744|536974378|FG001|Months 0-6|Withdrawal by Subject|4|||
148863250|NCT00432744|536974377|FG000|Months 0-6|Too disabled to score|1|||
148863251|NCT00432744|536974378|FG001|Months 0-6|Too disabled to score|0|||
148863252|NCT00432744|536974377|FG000|Months 7 - 12|Withdrawal by Subject|1|||
148863253|NCT00432744|536974378|FG001|Months 7 - 12|Withdrawal by Subject|0|||
148863254|NCT00432744|536974377|FG000|Months 7 - 12|Too disabled to score|0|||
148863255|NCT00432744|536974378|FG001|Months 7 - 12|Too disabled to score|1|||
148863256|NCT02653495|536974379|FG000|Overall Study|Lost to Follow-up|2|||
148863257|NCT02653495|536974380|FG001|Overall Study|Lost to Follow-up|0|||
148863258|NCT02653495|536974379|FG000|Overall Study|Screening Failure|10|||
148863259|NCT02653495|536974380|FG001|Overall Study|Screening Failure|0|||
148863260|NCT04030247|536976357|FG000|Overall Study|Withdrawal by Subject|4|||
148863261|NCT04030247|536976357|FG000|Overall Study|Lost to Follow-up|13|||
148863262|NCT03559699|536976358|FG000|Overall Study|Withdrawal by Subject|6|||
148863263|NCT03559699|536976358|FG000|Overall Study|Lost to Follow-up|1|||
148863264|NCT00031460|536976359|FG000|Overall Study|Lost to Follow-up|0|||
148863265|NCT00031460|536976360|FG001|Overall Study|Lost to Follow-up|1|||
148863266|NCT00031460|536976359|FG000|Overall Study|Withdrawal by Subject|1|||
148863267|NCT00031460|536976360|FG001|Overall Study|Withdrawal by Subject|1|||
148863268|NCT00031460|536976359|FG000|Overall Study|Non-Compliant|1|||
148863269|NCT00031460|536976360|FG001|Overall Study|Non-Compliant|1|||
148863270|NCT00031460|536976359|FG000|Overall Study|Death|0|||
148863271|NCT00031460|536976360|FG001|Overall Study|Death|1|||
148863272|NCT00031460|536976359|FG000|Overall Study|Reactivation of Disease|5|||
148863273|NCT00031460|536976360|FG001|Overall Study|Reactivation of Disease|9|||
148863274|NCT00031460|536976359|FG000|Overall Study|Disruption of blinded drug supply|2|||
148863275|NCT00031460|536976360|FG001|Overall Study|Disruption of blinded drug supply|0|||
148863276|NCT00031460|536976359|FG000|Overall Study|Confirmed unevaluable|0|||
148863277|NCT00031460|536976360|FG001|Overall Study|Confirmed unevaluable|1|||
148863278|NCT01930890|536976364|FG000|Overall Study|Study Termination|14|||
148863279|NCT01930890|536976365|FG001|Overall Study|Study Termination|28|||
148863280|NCT01930890|536976366|FG002|Overall Study|Study Termination|13|||
148863281|NCT01930890|536976367|FG003|Overall Study|Study Termination|25|||
148863282|NCT01930890|536976364|FG000|Overall Study|Death|0|||
148863283|NCT01930890|536976365|FG001|Overall Study|Death|0|||
148863284|NCT01930890|536976366|FG002|Overall Study|Death|0|||
148863285|NCT01930890|536976367|FG003|Overall Study|Death|1|||
148863286|NCT01930890|536976364|FG000|Overall Study|Investigator Decision|0|||
148863287|NCT01930890|536976365|FG001|Overall Study|Investigator Decision|1|||
148863288|NCT01930890|536976366|FG002|Overall Study|Investigator Decision|0|||
148863289|NCT01930890|536976367|FG003|Overall Study|Investigator Decision|0|||
148863290|NCT01930890|536976364|FG000|Overall Study|Consent Withdrawn|0|||
148863291|NCT01930890|536976365|FG001|Overall Study|Consent Withdrawn|3|||
149030905|NCT01956669|537591608|FG002|Overall Study|Disease Progression|7|||
149030906|NCT01956669|537591609|FG003|Overall Study|Disease Progression|8|||
148863292|NCT01930890|536976366|FG002|Overall Study|Consent Withdrawn|0|||
148863293|NCT01930890|536976367|FG003|Overall Study|Consent Withdrawn|1|||
148863294|NCT01930890|536976364|FG000|Overall Study|Adverse Event|0|||
148863295|NCT01930890|536976365|FG001|Overall Study|Adverse Event|1|||
148863296|NCT01930890|536976366|FG002|Overall Study|Adverse Event|0|||
148863297|NCT01930890|536976367|FG003|Overall Study|Adverse Event|0|||
148863298|NCT01278407|536976368|FG000|Confirmatory Phase|Adverse Event|5|||
148863299|NCT01278407|536976369|FG001|Confirmatory Phase|Adverse Event|10|||
148863300|NCT01278407|536976370|FG002|Confirmatory Phase|Adverse Event|1|||
148863301|NCT01278407|536976371|FG003|Confirmatory Phase|Adverse Event|0|||
148863302|NCT01278407|536976372|FG004|Confirmatory Phase|Adverse Event|0|||
148863303|NCT01278407|536976368|FG000|Confirmatory Phase|Participant's Choice|3|||
148863304|NCT01278407|536976369|FG001|Confirmatory Phase|Participant's Choice|5|||
148863305|NCT01278407|536976370|FG002|Confirmatory Phase|Participant's Choice|3|||
148863306|NCT01278407|536976371|FG003|Confirmatory Phase|Participant's Choice|0|||
148863307|NCT01278407|536976372|FG004|Confirmatory Phase|Participant's Choice|0|||
148863308|NCT01278407|536976368|FG000|Confirmatory Phase|Other|1|||
148863309|NCT01278407|536976369|FG001|Confirmatory Phase|Other|1|||
148863310|NCT01278407|536976370|FG002|Confirmatory Phase|Other|2|||
148863311|NCT01278407|536976371|FG003|Confirmatory Phase|Other|0|||
148863312|NCT01278407|536976372|FG004|Confirmatory Phase|Other|0|||
148863313|NCT01278407|536976368|FG000|Extension Phase|Adverse Event|0|||
148863314|NCT01278407|536976369|FG001|Extension Phase|Adverse Event|0|||
148863315|NCT01278407|536976370|FG002|Extension Phase|Adverse Event|0|||
148863316|NCT01278407|536976371|FG003|Extension Phase|Adverse Event|7|||
148863317|NCT01278407|536976372|FG004|Extension Phase|Adverse Event|16|||
148863318|NCT01278407|536976368|FG000|Extension Phase|Participant's Choice|0|||
148863319|NCT01278407|536976369|FG001|Extension Phase|Participant's Choice|0|||
148863320|NCT01278407|536976370|FG002|Extension Phase|Participant's Choice|0|||
148863321|NCT01278407|536976371|FG003|Extension Phase|Participant's Choice|4|||
148863322|NCT01278407|536976372|FG004|Extension Phase|Participant's Choice|11|||
148863323|NCT01278407|536976368|FG000|Extension Phase|Other|0|||
148863324|NCT01278407|536976369|FG001|Extension Phase|Other|0|||
148863325|NCT01278407|536976370|FG002|Extension Phase|Other|0|||
148863326|NCT01278407|536976371|FG003|Extension Phase|Other|1|||
148863327|NCT01278407|536976372|FG004|Extension Phase|Other|3|||
148863328|NCT02534935|536976373|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
148863329|NCT02534935|536976374|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
148863330|NCT02534935|536976375|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
148863331|NCT02534935|536976373|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
148863332|NCT02534935|536976374|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
148863333|NCT02534935|536976375|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
148863334|NCT02534935|536976373|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
148863335|NCT02534935|536976374|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
148863336|NCT02534935|536976375|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
148863337|NCT02534935|536976373|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
148863338|NCT02534935|536976374|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
148863339|NCT02534935|536976375|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
148863340|NCT02534935|536976373|FG000|Stage 1: 24 Months|Adverse Event|0|||
148863341|NCT02534935|536976374|FG001|Stage 1: 24 Months|Adverse Event|2|||
148863342|NCT02534935|536976375|FG002|Stage 1: 24 Months|Adverse Event|0|||
148863343|NCT02534935|536976373|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
148863344|NCT02534935|536976374|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
148863345|NCT02534935|536976375|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
148863346|NCT02534935|536976373|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
148863347|NCT02534935|536976374|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
148863348|NCT02534935|536976375|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
148863349|NCT01596335|536976376|FG000|Overall Study|exacerbation of primary disease|5|||
148863350|NCT01596335|536976377|FG001|Overall Study|exacerbation of primary disease|9|||
148863351|NCT01460719|536976378|FG000|Overall Study|Adverse Event|1|||
148863352|NCT01460719|536976378|FG000|Overall Study|Withdrawal by Subject|1|||
148863353|NCT01176565|536976385|FG000|Overall Study|Lost to Follow-up|12|||
148863354|NCT01176565|536976386|FG001|Overall Study|Lost to Follow-up|16|||
148863355|NCT01176565|536976385|FG000|Overall Study|Withdrawal by Subject|7|||
148863356|NCT01176565|536976386|FG001|Overall Study|Withdrawal by Subject|1|||
148863357|NCT01176565|536976385|FG000|Overall Study|Not Analyzed (any other reason)|1|||
148863358|NCT01176565|536976386|FG001|Overall Study|Not Analyzed (any other reason)|2|||
148863359|NCT03602885|536976388|FG000|Overall Study|Lost to Follow-up|3|||
148863360|NCT03602885|536976389|FG001|Overall Study|Lost to Follow-up|0|||
148863361|NCT02536300|536976399|FG000|Overall Study|Investigator's Discretion|17|||
148863362|NCT02536300|536976400|FG001|Overall Study|Investigator's Discretion|11|||
148863363|NCT02536300|536976401|FG002|Overall Study|Investigator's Discretion|2|||
148863364|NCT02536300|536976399|FG000|Overall Study|Progressive Disease|11|||
148863365|NCT02536300|536976400|FG001|Overall Study|Progressive Disease|7|||
148863366|NCT02536300|536976401|FG002|Overall Study|Progressive Disease|6|||
148863367|NCT02536300|536976399|FG000|Overall Study|Study Terminated by Sponsor|6|||
148993666|NCT02187991|537453027|FG000|Overall Study|Physician Decision|4|||
148993667|NCT02187991|537453028|FG001|Overall Study|Physician Decision|4|||
148993668|NCT02187991|537453029|FG002|Overall Study|Physician Decision|0|||
148993669|NCT02187991|537453030|FG003|Overall Study|Physician Decision|2|||
148993670|NCT02187991|537453027|FG000|Overall Study|Other, unrelated complication|7|||
148993671|NCT02187991|537453028|FG001|Overall Study|Other, unrelated complication|1|||
148993672|NCT02187991|537453029|FG002|Overall Study|Other, unrelated complication|1|||
148993673|NCT02187991|537453030|FG003|Overall Study|Other, unrelated complication|2|||
148993674|NCT02187991|537453027|FG000|Overall Study|Death|1|||
148993675|NCT02187991|537453028|FG001|Overall Study|Death|3|||
148993676|NCT02187991|537453029|FG002|Overall Study|Death|0|||
148993677|NCT02187991|537453030|FG003|Overall Study|Death|0|||
148993678|NCT01392560|537453031|FG000|Overall Study|Adverse Event|2|||
148993679|NCT01392560|537453031|FG000|Overall Study|not entered|8|||
148993680|NCT01392560|537453031|FG000|Overall Study|discontinued during placebo run-in|2|||
148993681|NCT01939028|537453032|FG000|Overall Study|Withdrawal by Subject|5|||
148993682|NCT01939028|537453032|FG000|Overall Study|Physician Decision|7|||
148993683|NCT02081846|537453035|FG000|Overall Study|Withdrawal by Subject|1|||
148993684|NCT02081846|537453036|FG001|Overall Study|Withdrawal by Subject|0|||
148993685|NCT02081846|537453035|FG000|Overall Study|invalid consent|1|||
148993686|NCT02081846|537453036|FG001|Overall Study|invalid consent|0|||
148993687|NCT03282227|537453037|FG000|Overall Study|Exposure Goals Achieved|60|||
148993688|NCT03282227|537453037|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
148993689|NCT03282227|537453037|FG000|Overall Study|Adverse Event|15|||
148993690|NCT03282227|537453037|FG000|Overall Study|Lost to Follow-up|21|||
148993691|NCT03282227|537453037|FG000|Overall Study|Withdrawal by Subject|20|||
148993692|NCT03282227|537453037|FG000|Overall Study|Lack of Efficacy|12|||
148993693|NCT03282227|537453037|FG000|Overall Study|Sponsor decision|3|||
148993694|NCT03282227|537453037|FG000|Overall Study|Physician Decision|2|||
148993695|NCT03282227|537453037|FG000|Overall Study|Pregnancy|2|||
148993696|NCT03282227|537453037|FG000|Overall Study|Other|1|||
148993697|NCT00322348|537453038|FG000|Overall Study|Adverse Event|0|||
148993698|NCT00322348|537453039|FG001|Overall Study|Adverse Event|1|||
148993699|NCT00322348|537453038|FG000|Overall Study|Withdrawal by Subject|1|||
148993700|NCT00322348|537453039|FG001|Overall Study|Withdrawal by Subject|4|||
148993701|NCT00322348|537453038|FG000|Overall Study|Lost to Follow-up|1|||
148993702|NCT00322348|537453039|FG001|Overall Study|Lost to Follow-up|0|||
148993703|NCT00322348|537453038|FG000|Overall Study|Death|0|||
148993704|NCT00322348|537453039|FG001|Overall Study|Death|2|||
148993705|NCT00322348|537453038|FG000|Overall Study|Disease Progression|30|||
148993706|NCT00322348|537453039|FG001|Overall Study|Disease Progression|25|||
148993707|NCT00322348|537453038|FG000|Overall Study|Reasons not specified|5|||
148993708|NCT00322348|537453039|FG001|Overall Study|Reasons not specified|1|||
148993709|NCT00989287|537453044|FG000|Overall Study|Adverse Event|1|||
148993710|NCT00989287|537453045|FG001|Overall Study|Adverse Event|0|||
148993711|NCT00989287|537453044|FG000|Overall Study|Lost to Follow-up|0|||
148993712|NCT00989287|537453045|FG001|Overall Study|Lost to Follow-up|1|||
148993713|NCT01857531|537453059|FG000|Overall Study|Withdrawal by Subject|4|||
148993714|NCT02576067|537453060|FG000|Overall Study|Death|0|||
148993715|NCT02576067|537453061|FG001|Overall Study|Death|1|||
148993716|NCT02576067|537453060|FG000|Overall Study|Lack of Efficacy|1|||
148993717|NCT02576067|537453061|FG001|Overall Study|Lack of Efficacy|0|||
148993718|NCT02576067|537453060|FG000|Overall Study|Lost to Follow-up|11|||
148993719|NCT02576067|537453061|FG001|Overall Study|Lost to Follow-up|0|||
148993720|NCT02576067|537453060|FG000|Overall Study|Withdrawal by Subject|11|||
148993721|NCT02576067|537453061|FG001|Overall Study|Withdrawal by Subject|2|||
148993722|NCT02576067|537453060|FG000|Overall Study|study closure of main CIRT trial)|0|||
148993723|NCT02576067|537453061|FG001|Overall Study|study closure of main CIRT trial)|8|||
148993724|NCT02576067|537453060|FG000|Overall Study|not randomized, failed run-in|7|||
148993725|NCT02576067|537453061|FG001|Overall Study|not randomized, failed run-in|0|||
148993726|NCT02576067|537453060|FG000|Overall Study|screen failure/ re-enrolled|0|||
148993727|NCT02576067|537453061|FG001|Overall Study|screen failure/ re-enrolled|25|||
148993728|NCT02576067|537453060|FG000|Overall Study|Physician Decision|4|||
148863368|NCT02536300|536976400|FG001|Overall Study|Study Terminated by Sponsor|4|||
148863369|NCT02536300|536976401|FG002|Overall Study|Study Terminated by Sponsor|7|||
148993729|NCT02576067|537453061|FG001|Overall Study|Physician Decision|0|||
148993730|NCT03570619|537453064|FG000|Overall Study|Adverse Event|2|||
148993731|NCT03570619|537453065|FG001|Overall Study|Adverse Event|0|||
148993732|NCT03570619|537453066|FG002|Overall Study|Adverse Event|1|||
148863370|NCT02536300|536976399|FG000|Overall Study|Death|7|||
148993733|NCT03570619|537453064|FG000|Overall Study|new diagnosis of new malignancy|1|||
148993734|NCT03570619|537453065|FG001|Overall Study|new diagnosis of new malignancy|0|||
148993735|NCT03570619|537453066|FG002|Overall Study|new diagnosis of new malignancy|0|||
148993736|NCT03570619|537453064|FG000|Overall Study|Physician Decision|1|||
148993737|NCT03570619|537453065|FG001|Overall Study|Physician Decision|1|||
148993738|NCT03570619|537453066|FG002|Overall Study|Physician Decision|0|||
148993739|NCT03570619|537453064|FG000|Overall Study|Withdrawal by Subject|0|||
148993740|NCT03570619|537453065|FG001|Overall Study|Withdrawal by Subject|2|||
149030907|NCT01956669|537591610|FG004|Overall Study|Disease Progression|4|||
148993741|NCT03570619|537453066|FG002|Overall Study|Withdrawal by Subject|0|||
148993742|NCT01808313|537453067|FG000|Overall Study|Adverse Event|5|||
148993743|NCT01808313|537453067|FG000|Overall Study|Protocol Violation|2|||
148993744|NCT01808313|537453067|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
148993745|NCT01808313|537453067|FG000|Overall Study|Lost to Follow-up|1|||
148993746|NCT01808313|537453067|FG000|Overall Study|Physician Decision|1|||
148993747|NCT04656847|537453070|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
148993748|NCT03301051|537453071|FG000|Overall Study|Adverse Event|0|||
148993749|NCT03301051|537453072|FG001|Overall Study|Adverse Event|4|||
148993750|NCT03301051|537453071|FG000|Overall Study|Withdrawal by Subject|59|||
148993751|NCT03301051|537453072|FG001|Overall Study|Withdrawal by Subject|65|||
148993752|NCT03301051|537453071|FG000|Overall Study|Lost to Follow-up|263|||
148993753|NCT03301051|537453072|FG001|Overall Study|Lost to Follow-up|282|||
148993754|NCT03301051|537453071|FG000|Overall Study|Protocol Violation|1|||
148993755|NCT03301051|537453072|FG001|Overall Study|Protocol Violation|3|||
148993756|NCT03301051|537453071|FG000|Overall Study|Physician Decision|1|||
148993757|NCT03301051|537453072|FG001|Overall Study|Physician Decision|3|||
148993758|NCT03301051|537453071|FG000|Overall Study|Death|1|||
148993759|NCT03301051|537453072|FG001|Overall Study|Death|1|||
148993760|NCT03301051|537453071|FG000|Overall Study|Miscellaneous|8|||
148993761|NCT03301051|537453072|FG001|Overall Study|Miscellaneous|4|||
148993762|NCT03301051|537453071|FG000|Overall Study|Randomized, not vaccinated|13|||
148993763|NCT03301051|537453072|FG001|Overall Study|Randomized, not vaccinated|10|||
148993764|NCT00622167|537453073|FG000|Overall Study|Did not meet angiographic criteria|20|||
148993765|NCT02820623|537453074|FG000|Overall Study|Withdrawal by Subject|1|||
148993766|NCT02820623|537453075|FG001|Overall Study|Withdrawal by Subject|3|||
148993767|NCT02820623|537453076|FG002|Overall Study|Withdrawal by Subject|3|||
148993768|NCT02820623|537453074|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
148993769|NCT02820623|537453075|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
148993770|NCT02820623|537453076|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
148993771|NCT02820623|537453074|FG000|Overall Study|Therapist unable to enroll clients|1|||
148993772|NCT02820623|537453075|FG001|Overall Study|Therapist unable to enroll clients|1|||
148778070|NCT01573767|536661896|FG001|Overall Study|Protocol Violation|1|||
148778071|NCT01573767|536661897|FG002|Overall Study|Protocol Violation|1|||
148778072|NCT01573767|536661898|FG003|Overall Study|Protocol Violation|3|||
148778073|NCT01573767|536661895|FG000|Overall Study|Lost to Follow-up|0|||
148778074|NCT01573767|536661896|FG001|Overall Study|Lost to Follow-up|1|||
148778075|NCT01573767|536661897|FG002|Overall Study|Lost to Follow-up|1|||
148778076|NCT01573767|536661898|FG003|Overall Study|Lost to Follow-up|1|||
148778077|NCT01573767|536661895|FG000|Overall Study|Physician Decision|1|||
148778078|NCT01573767|536661896|FG001|Overall Study|Physician Decision|2|||
148778079|NCT01573767|536661897|FG002|Overall Study|Physician Decision|0|||
148778080|NCT01573767|536661898|FG003|Overall Study|Physician Decision|2|||
148778081|NCT01573767|536661895|FG000|Overall Study|Withdrawal by Subject|0|||
148778082|NCT01573767|536661896|FG001|Overall Study|Withdrawal by Subject|1|||
148778083|NCT01573767|536661897|FG002|Overall Study|Withdrawal by Subject|0|||
148778084|NCT01573767|536661898|FG003|Overall Study|Withdrawal by Subject|0|||
148778085|NCT01371877|536661899|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
148778086|NCT01371877|536661900|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
148778087|NCT05932225|536661901|FG000|Overall Study|Lost to Follow-up|0|||
148778088|NCT05932225|536661902|FG001|Overall Study|Lost to Follow-up|1|||
148778089|NCT05932225|536661903|FG002|Overall Study|Lost to Follow-up|0|||
148778090|NCT05932225|536661901|FG000|Overall Study|Withdrawal by Subject|1|||
148778091|NCT05932225|536661902|FG001|Overall Study|Withdrawal by Subject|0|||
148778092|NCT05932225|536661903|FG002|Overall Study|Withdrawal by Subject|0|||
148863371|NCT02536300|536976400|FG001|Overall Study|Death|0|||
148863372|NCT02536300|536976401|FG002|Overall Study|Death|5|||
148863373|NCT02536300|536976399|FG000|Overall Study|Withdrew Consent|4|||
148863374|NCT02536300|536976400|FG001|Overall Study|Withdrew Consent|2|||
148863375|NCT02536300|536976401|FG002|Overall Study|Withdrew Consent|0|||
148863376|NCT02536300|536976399|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
148863377|NCT02536300|536976400|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
148863378|NCT02536300|536976401|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
148863379|NCT02536300|536976399|FG000|Overall Study|Enrolled but Never Treated|0|||
148778093|NCT05932225|536661901|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
148778094|NCT05932225|536661902|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
148778095|NCT05932225|536661903|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
148778096|NCT01027897|536661904|FG000|Overall Study|Protocol Violation|1|||
148778097|NCT01027897|536661904|FG000|Overall Study|Withdrawal by Subject|1|||
148863380|NCT02536300|536976400|FG001|Overall Study|Enrolled but Never Treated|0|||
148993773|NCT02820623|537453076|FG002|Overall Study|Therapist unable to enroll clients|3|||
148993774|NCT02820623|537453074|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
148993775|NCT02820623|537453075|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
148993776|NCT02820623|537453076|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
148778098|NCT02667626|536661905|FG000|Overall Study|Withdrawal by Subject|0|||
148993777|NCT00435370|537453079|FG000|Overall Study|Adverse Event|8|||
148993778|NCT00435370|537453080|FG001|Overall Study|Adverse Event|8|||
148993779|NCT00435370|537453079|FG000|Overall Study|Withdrawal by Subject|10|||
148993780|NCT00435370|537453080|FG001|Overall Study|Withdrawal by Subject|10|||
148993781|NCT00435370|537453079|FG000|Overall Study|Antipsychotic medication changed|4|||
148993782|NCT00435370|537453080|FG001|Overall Study|Antipsychotic medication changed|2|||
148993783|NCT01965834|537453082|FG000|Overall Study|Lack of Efficacy|4|||
148993784|NCT03943095|537453085|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
148993785|NCT03943095|537453086|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
148993786|NCT03943095|537453085|FG000|Overall Study|Withdrawal by Subject|1|||
148993787|NCT03943095|537453086|FG001|Overall Study|Withdrawal by Subject|0|||
148993788|NCT03387852|537453087|FG000|Overall Study|Adverse event (AE)|3|||
148993789|NCT03387852|537453088|FG001|Overall Study|Adverse event (AE)|0|||
148993790|NCT03387852|537453089|FG002|Overall Study|Adverse event (AE)|2|||
148993791|NCT03387852|537453090|FG003|Overall Study|Adverse event (AE)|0|||
148993792|NCT03387852|537453087|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
148993793|NCT03387852|537453088|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
148993794|NCT03387852|537453089|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
148993795|NCT03387852|537453090|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
148993796|NCT03387852|537453087|FG000|Overall Study|Withdrawal by participant|1|||
148993797|NCT03387852|537453088|FG001|Overall Study|Withdrawal by participant|1|||
148993798|NCT03387852|537453089|FG002|Overall Study|Withdrawal by participant|3|||
148993799|NCT03387852|537453090|FG003|Overall Study|Withdrawal by participant|2|||
148993800|NCT03387852|537453087|FG000|Overall Study|Other- Unspecified|1|||
148993801|NCT03387852|537453088|FG001|Overall Study|Other- Unspecified|1|||
148993802|NCT03387852|537453089|FG002|Overall Study|Other- Unspecified|2|||
148993803|NCT03387852|537453090|FG003|Overall Study|Other- Unspecified|1|||
148993804|NCT03387852|537453087|FG000|Overall Study|Poor compliance to protocol|0|||
148993805|NCT03387852|537453088|FG001|Overall Study|Poor compliance to protocol|0|||
148993806|NCT03387852|537453089|FG002|Overall Study|Poor compliance to protocol|0|||
148993807|NCT03387852|537453090|FG003|Overall Study|Poor compliance to protocol|1|||
148993808|NCT03387852|537453087|FG000|Overall Study|Randomized and not treated|0|||
148993809|NCT03387852|537453088|FG001|Overall Study|Randomized and not treated|0|||
148993810|NCT03387852|537453089|FG002|Overall Study|Randomized and not treated|0|||
148993811|NCT03387852|537453090|FG003|Overall Study|Randomized and not treated|1|||
148993812|NCT02194621|537453098|FG000|Overall Study|6 withdrew prior to randomization|2|||
148993813|NCT02194621|537453099|FG001|Overall Study|6 withdrew prior to randomization|2|||
148993814|NCT02194621|537453100|FG002|Overall Study|6 withdrew prior to randomization|2|||
148993815|NCT02194621|537453098|FG000|Overall Study|Withdrawal by Subject|4|||
148993816|NCT02194621|537453099|FG001|Overall Study|Withdrawal by Subject|4|||
148993817|NCT02194621|537453100|FG002|Overall Study|Withdrawal by Subject|7|||
148993818|NCT02493127|537453101|FG000|Overall Study|Lost to Follow-up|1|||
148993819|NCT02493127|537453102|FG001|Overall Study|Lost to Follow-up|1|||
148993820|NCT02763384|537453103|FG000|Overall Study|Physician Decision|1|||
148993821|NCT02763384|537453103|FG000|Overall Study|Rapid decline - went on hospice|1|||
148993822|NCT00714168|537453104|FG000|Overall Study|Pregnancy|5|||
148993823|NCT00714168|537453105|FG001|Overall Study|Pregnancy|4|||
148993824|NCT00714168|537453104|FG000|Overall Study|Lost to Follow-up|32|||
148993825|NCT00714168|537453105|FG001|Overall Study|Lost to Follow-up|50|||
148993826|NCT00714168|537453104|FG000|Overall Study|Relocation|4|||
148993827|NCT00714168|537453105|FG001|Overall Study|Relocation|3|||
148993828|NCT00714168|537453104|FG000|Overall Study|Non-study medical condition|3|||
148993829|NCT00714168|537453105|FG001|Overall Study|Non-study medical condition|2|||
148993830|NCT04988308|537453107|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
148993831|NCT04988308|537453108|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
148993832|NCT04988308|537453109|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
148993833|NCT04988308|537453110|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
148993834|NCT04988308|537453111|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
148993835|NCT04988308|537453112|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
148778099|NCT02667626|536661906|FG001|Overall Study|Withdrawal by Subject|1|||
148778100|NCT00473824|536661907|FG000|Overall Study|Virologic Breakthrough|1|||
148778101|NCT00473824|536661908|FG001|Overall Study|Virologic Breakthrough|0|||
148993836|NCT04988308|537453107|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
148993837|NCT04988308|537453108|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
148993838|NCT04988308|537453109|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
148993839|NCT04988308|537453110|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
148993840|NCT04988308|537453111|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
148993841|NCT04988308|537453112|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
148993842|NCT04988308|537453107|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
148993843|NCT04988308|537453108|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
148993844|NCT04988308|537453109|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
148993845|NCT04988308|537453110|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
148993846|NCT04988308|537453111|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
148993847|NCT04988308|537453112|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
148993848|NCT04988308|537453107|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
148993849|NCT04988308|537453108|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
148993850|NCT04988308|537453109|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
148993851|NCT04988308|537453110|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
148993852|NCT04988308|537453111|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
148993853|NCT04988308|537453112|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
148993854|NCT04988308|537453107|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
148993855|NCT04988308|537453108|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
148993856|NCT04988308|537453109|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
148993857|NCT04988308|537453110|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
148993858|NCT04988308|537453111|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
148993859|NCT04988308|537453112|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
148993860|NCT04988308|537453107|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
148993861|NCT04988308|537453108|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
148993862|NCT04988308|537453109|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
148993863|NCT04988308|537453110|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
148993864|NCT04988308|537453111|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
148993865|NCT04988308|537453112|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
148993866|NCT04988308|537453107|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
148993867|NCT04988308|537453108|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
148993868|NCT04988308|537453109|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
148993869|NCT04988308|537453110|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
148993870|NCT04988308|537453111|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
148993871|NCT04988308|537453112|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
148993872|NCT04988308|537453107|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148993873|NCT04988308|537453108|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148993874|NCT04988308|537453109|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
148993875|NCT04988308|537453110|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
148993876|NCT04988308|537453111|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
148993877|NCT04988308|537453112|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
148993878|NCT04988308|537453107|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
148993879|NCT04988308|537453108|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
148993880|NCT04988308|537453109|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
148993881|NCT04988308|537453110|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
148993882|NCT04988308|537453111|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
148993883|NCT04988308|537453112|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
148993884|NCT02096900|537453117|FG000|Overall Study|Did not receive medication|3|||
148993885|NCT02096900|537453118|FG001|Overall Study|Did not receive medication|1|||
148993886|NCT02096900|537453117|FG000|Overall Study|Surgery cancelled- medication received|1|||
148993887|NCT02096900|537453118|FG001|Overall Study|Surgery cancelled- medication received|1|||
148993888|NCT03034577|537453126|FG000|Overall Study|Withdrawal by Subject|6|||
148993889|NCT03034577|537453127|FG001|Overall Study|Withdrawal by Subject|9|||
148993890|NCT03034577|537453126|FG000|Overall Study|Lost to Follow-up|25|||
148993891|NCT03034577|537453127|FG001|Overall Study|Lost to Follow-up|26|||
148993892|NCT04177758|537453130|FG000|Overall Study|Lost to Follow-up|19|||
148993893|NCT04177758|537453131|FG001|Overall Study|Lost to Follow-up|11|||
148993894|NCT00808808|537453135|FG000|Overall Study|Vaccinated; survey not completed|131|||
148993895|NCT00808808|537453136|FG001|Overall Study|Vaccinated; survey not completed|169|||
148993896|NCT00808808|537453137|FG002|Overall Study|Vaccinated; survey not completed|302|||
148993897|NCT00808808|537453135|FG000|Overall Study|Employee was not vaccinated.|2686|||
148993898|NCT00808808|537453136|FG001|Overall Study|Employee was not vaccinated.|2268|||
148993899|NCT00808808|537453137|FG002|Overall Study|Employee was not vaccinated.|2255|||
148993900|NCT02352948|537453141|FG000|Overall Study|Death|47|||
148993901|NCT02352948|537453142|FG001|Overall Study|Death|48|||
148993902|NCT02352948|537453143|FG002|Overall Study|Death|114|||
148993903|NCT02352948|537453144|FG003|Overall Study|Death|74|||
148993904|NCT02352948|537453145|FG004|Overall Study|Death|77|||
148993905|NCT02352948|537453146|FG005|Overall Study|Death|44|||
148993906|NCT02352948|537453141|FG000|Overall Study|Lost to Follow-up|1|||
148993907|NCT02352948|537453142|FG001|Overall Study|Lost to Follow-up|0|||
148993908|NCT02352948|537453143|FG002|Overall Study|Lost to Follow-up|2|||
148993909|NCT02352948|537453144|FG003|Overall Study|Lost to Follow-up|1|||
148993910|NCT02352948|537453145|FG004|Overall Study|Lost to Follow-up|2|||
148993911|NCT02352948|537453146|FG005|Overall Study|Lost to Follow-up|1|||
148993912|NCT02352948|537453141|FG000|Overall Study|Withdrawal by Subject|1|||
148993913|NCT02352948|537453142|FG001|Overall Study|Withdrawal by Subject|10|||
148993914|NCT02352948|537453143|FG002|Overall Study|Withdrawal by Subject|11|||
148993915|NCT02352948|537453144|FG003|Overall Study|Withdrawal by Subject|23|||
148863381|NCT02536300|536976401|FG002|Overall Study|Enrolled but Never Treated|1|||
148863382|NCT02536300|536976399|FG000|Overall Study|Non-compliance With Study Drug|1|||
148863383|NCT02536300|536976400|FG001|Overall Study|Non-compliance With Study Drug|0|||
148863384|NCT02536300|536976401|FG002|Overall Study|Non-compliance With Study Drug|0|||
148863385|NCT02536300|536976399|FG000|Overall Study|Protocol Violation|0|||
148863386|NCT02536300|536976400|FG001|Overall Study|Protocol Violation|1|||
148863387|NCT02536300|536976401|FG002|Overall Study|Protocol Violation|0|||
148863388|NCT00330928|536976407|FG000|Overall Study|Lost to Follow-up|6|||
148863389|NCT00330928|536976407|FG000|Overall Study|Physician Decision|9|||
148863390|NCT00330928|536976407|FG000|Overall Study|Death|1|||
148863391|NCT00330928|536976407|FG000|Overall Study|IVUS could not be performed.|1|||
148863392|NCT05605691|536976408|FG000|Overall Study|Lost to Follow-up|1|||
148863393|NCT02279719|536976409|FG000|Overall Study|Patients randomized but never treated|0|||
148863394|NCT02279719|536976410|FG001|Overall Study|Patients randomized but never treated|0|||
148863395|NCT02279719|536976411|FG002|Overall Study|Patients randomized but never treated|0|||
148863396|NCT02279719|536976412|FG003|Overall Study|Patients randomized but never treated|0|||
148863397|NCT02279719|536976413|FG004|Overall Study|Patients randomized but never treated|3|||
148863398|NCT02279719|536976414|FG005|Overall Study|Patients randomized but never treated|0|||
148863399|NCT02279719|536976415|FG006|Overall Study|Patients randomized but never treated|3|||
148863400|NCT03541187|536976418|FG000|Overall Study|Lost to Follow-up|2|||
148863401|NCT03541187|536976419|FG001|Overall Study|Lost to Follow-up|6|||
148863402|NCT03541187|536976418|FG000|Overall Study|Pregnancy|0|||
148863403|NCT03541187|536976419|FG001|Overall Study|Pregnancy|1|||
148863404|NCT03541187|536976418|FG000|Overall Study|Withdrawal by Subject|6|||
148863405|NCT03541187|536976419|FG001|Overall Study|Withdrawal by Subject|2|||
148863406|NCT03541187|536976418|FG000|Overall Study|Moved out of town|1|||
148863407|NCT03541187|536976419|FG001|Overall Study|Moved out of town|0|||
148863408|NCT03541187|536976418|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
148863409|NCT03541187|536976419|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
148863410|NCT03541187|536976418|FG000|Overall Study|Did not meet randomization criteria|1|||
148863411|NCT03541187|536976419|FG001|Overall Study|Did not meet randomization criteria|1|||
148863412|NCT03541187|536976418|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
148863413|NCT03541187|536976419|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
148863414|NCT03541187|536976418|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
148863415|NCT03541187|536976419|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
148863416|NCT00294645|536976424|FG000|Overall Study|Death|10|||
148863417|NCT00294645|536976425|FG001|Overall Study|Death|18|||
148863418|NCT00294645|536976424|FG000|Overall Study|Lost to Follow-up|1|||
148863419|NCT00294645|536976425|FG001|Overall Study|Lost to Follow-up|10|||
148863420|NCT00294645|536976424|FG000|Overall Study|Withdrawal by Subject|18|||
148863421|NCT00294645|536976425|FG001|Overall Study|Withdrawal by Subject|34|||
148863422|NCT00294645|536976424|FG000|Overall Study|Physician Decision|15|||
148863423|NCT00294645|536976425|FG001|Overall Study|Physician Decision|20|||
148863424|NCT00294645|536976424|FG000|Overall Study|Other|4|||
148863425|NCT00294645|536976425|FG001|Overall Study|Other|10|||
148863426|NCT02419131|536976428|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
148863427|NCT02419131|536976429|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
148863428|NCT02419131|536976430|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
148863429|NCT02419131|536976428|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
148863430|NCT02419131|536976429|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
148863431|NCT02419131|536976430|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
148863432|NCT03958656|536976431|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
148863433|NCT03958656|536976432|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
148863434|NCT03958656|536976433|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
148863435|NCT03958656|536976434|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
148863436|NCT03958656|536976431|FG000|Overall Study|No longer meets eligibility criteria|0|||
148863437|NCT03958656|536976432|FG001|Overall Study|No longer meets eligibility criteria|0|||
148863438|NCT03958656|536976433|FG002|Overall Study|No longer meets eligibility criteria|1|||
148863439|NCT03958656|536976434|FG003|Overall Study|No longer meets eligibility criteria|0|||
148863440|NCT03958656|536976431|FG000|Overall Study|Started anti-cancer treatment|0|||
148863441|NCT03958656|536976432|FG001|Overall Study|Started anti-cancer treatment|0|||
148863442|NCT03958656|536976433|FG002|Overall Study|Started anti-cancer treatment|1|||
148863443|NCT03958656|536976434|FG003|Overall Study|Started anti-cancer treatment|0|||
148863444|NCT03158012|536976439|FG000|Overall Study|Withdrawal by Subject|0|||
148863445|NCT03158012|536976440|FG001|Overall Study|Withdrawal by Subject|1|||
148863446|NCT01852825|536976441|FG000|Overall Study|Withdrawal by Subject|2|||
148863447|NCT01852825|536976442|FG001|Overall Study|Withdrawal by Subject|0|||
148863448|NCT01852825|536976443|FG002|Overall Study|Withdrawal by Subject|0|||
148863449|NCT02446418|536976447|FG000|Overall Study|Adverse Event|4|||
148863450|NCT02446418|536976448|FG001|Overall Study|Adverse Event|8|||
148863451|NCT02446418|536976447|FG000|Overall Study|Physician Decision|5|||
148993916|NCT02352948|537453145|FG004|Overall Study|Withdrawal by Subject|9|||
148993917|NCT02352948|537453146|FG005|Overall Study|Withdrawal by Subject|4|||
148993918|NCT02352948|537453141|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
148993919|NCT02352948|537453142|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
148993920|NCT02352948|537453143|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
148993921|NCT02352948|537453144|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
148993922|NCT02352948|537453145|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
148993923|NCT02352948|537453146|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
148993924|NCT02352948|537453141|FG000|Overall Study|Other|0|||
148993925|NCT02352948|537453142|FG001|Overall Study|Other|0|||
148993926|NCT02352948|537453143|FG002|Overall Study|Other|2|||
148993927|NCT02352948|537453144|FG003|Overall Study|Other|0|||
148993928|NCT02352948|537453145|FG004|Overall Study|Other|0|||
148993929|NCT02352948|537453146|FG005|Overall Study|Other|0|||
148993930|NCT00679939|537453147|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
148993931|NCT00679939|537453148|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
148993932|NCT00679939|537453147|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
148993933|NCT00679939|537453148|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
148993934|NCT00679939|537453147|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
148993935|NCT00679939|537453148|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
148993936|NCT00679939|537453147|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
148993937|NCT00679939|537453148|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
148993938|NCT00679939|537453147|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
148993939|NCT00679939|537453148|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
148993940|NCT00679939|537453147|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
148993941|NCT00679939|537453148|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
148993942|NCT00679939|537453147|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
148993943|NCT00679939|537453148|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
148993944|NCT00679939|537453147|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
148993945|NCT00679939|537453148|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
148993946|NCT00679939|537453147|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
148993947|NCT00679939|537453148|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
148993948|NCT00679939|537453147|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
148993949|NCT00679939|537453148|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
148993950|NCT02653482|537453150|FG000|Overall Study|Death|1|||
148993951|NCT02653482|537453151|FG001|Overall Study|Death|1|||
148993952|NCT06273774|537453153|FG000|Overall Study|Participant was out of state.|0|||
148993953|NCT06273774|537453154|FG001|Overall Study|Participant was out of state.|0|||
148993954|NCT06273774|537453155|FG002|Overall Study|Participant was out of state.|0|||
148993955|NCT06273774|537453156|FG003|Overall Study|Participant was out of state.|0|||
148993956|NCT06273774|537453157|FG004|Overall Study|Participant was out of state.|0|||
148993957|NCT06273774|537453158|FG005|Overall Study|Participant was out of state.|1|||
148993958|NCT06273774|537453153|FG000|Overall Study|Lost to Follow-up|0|||
148993959|NCT06273774|537453154|FG001|Overall Study|Lost to Follow-up|0|||
148993960|NCT06273774|537453155|FG002|Overall Study|Lost to Follow-up|0|||
148993961|NCT06273774|537453156|FG003|Overall Study|Lost to Follow-up|0|||
148993962|NCT06273774|537453157|FG004|Overall Study|Lost to Follow-up|1|||
148993963|NCT06273774|537453158|FG005|Overall Study|Lost to Follow-up|0|||
148993964|NCT02985866|537455355|FG000|Overall Study|Poor CGM data|1|||
148993965|NCT02985866|537455356|FG001|Overall Study|Poor CGM data|1|||
148993966|NCT01949311|537455357|FG000|Overall Study|Lost to Follow-up|73|||
148993967|NCT01949311|537455357|FG000|Overall Study|Terminated by Sponsor|708|||
148993968|NCT01949311|537455357|FG000|Overall Study|Withdrawal by Subject|375|||
148993969|NCT01949311|537455357|FG000|Overall Study|Lack of Efficacy|50|||
148993970|NCT01949311|537455357|FG000|Overall Study|Protocol Deviation|34|||
148993971|NCT01949311|537455357|FG000|Overall Study|Pregnancy|20|||
148993972|NCT01949311|537455357|FG000|Overall Study|Physician Decision|9|||
148993973|NCT01949311|537455357|FG000|Overall Study|Other|4|||
148993974|NCT01949311|537455357|FG000|Overall Study|Adverse Event|107|||
148993975|NCT02338154|537455358|FG000|Overall Study|Death|46|||
148993976|NCT02338154|537455358|FG000|Overall Study|Valve Implant Failure|17|||
148863452|NCT02446418|536976448|FG001|Overall Study|Physician Decision|1|||
148863453|NCT02446418|536976447|FG000|Overall Study|Withdrawal by Subject|3|||
148863454|NCT02446418|536976448|FG001|Overall Study|Withdrawal by Subject|3|||
148993977|NCT02338154|537455358|FG000|Overall Study|Valve Explant|11|||
148993978|NCT02338154|537455358|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
148993979|NCT02338154|537455358|FG000|Overall Study|Lost to Follow-up|8|||
148993980|NCT02338154|537455358|FG000|Overall Study|Other Reason|3|||
148993981|NCT02338154|537455358|FG000|Overall Study|Patients Without Exit Form|47|||
148863455|NCT02446418|536976447|FG000|Overall Study|Lost to Follow-up|2|||
148863456|NCT02446418|536976448|FG001|Overall Study|Lost to Follow-up|2|||
148993982|NCT02338154|537455358|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
148993983|NCT04279314|537455361|FG000|Overall Study|Adverse Event|55|||
148993984|NCT04279314|537455361|FG000|Overall Study|Withdrawal by Subject|5|||
148993985|NCT04279314|537455361|FG000|Overall Study|Lack of Efficacy|5|||
148863457|NCT02446418|536976447|FG000|Overall Study|Protocol Violation|1|||
148863458|NCT02446418|536976448|FG001|Overall Study|Protocol Violation|2|||
148863459|NCT02446418|536976447|FG000|Overall Study|Lack of Efficacy|2|||
148863460|NCT02446418|536976448|FG001|Overall Study|Lack of Efficacy|0|||
148863461|NCT02446418|536976447|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
148863462|NCT02446418|536976448|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
148863463|NCT03421743|536976453|FG000|Overall Study|Lack of Efficacy|1|||
148863464|NCT03421743|536976454|FG001|Overall Study|Lack of Efficacy|0|||
148863465|NCT03421743|536976453|FG000|Overall Study|Adverse Event|2|||
148863466|NCT03421743|536976454|FG001|Overall Study|Adverse Event|1|||
148863467|NCT03421743|536976453|FG000|Overall Study|Withdrawal by Subject|0|||
148863468|NCT03421743|536976454|FG001|Overall Study|Withdrawal by Subject|1|||
148863469|NCT00694096|536976455|FG000|Overall Study|Withdrawal by Subject|5|||
148863470|NCT02914548|536976465|FG000|Overall Study|Adverse Event|15|||
148863471|NCT02914548|536976466|FG001|Overall Study|Adverse Event|7|||
148863472|NCT02914548|536976467|FG002|Overall Study|Adverse Event|15|||
148863473|NCT02914548|536976465|FG000|Overall Study|Physician Decision|2|||
148863474|NCT02914548|536976466|FG001|Overall Study|Physician Decision|2|||
148863475|NCT02914548|536976467|FG002|Overall Study|Physician Decision|0|||
148863476|NCT02914548|536976465|FG000|Overall Study|Protocol Violation|1|||
148863477|NCT02914548|536976466|FG001|Overall Study|Protocol Violation|0|||
148863478|NCT02914548|536976467|FG002|Overall Study|Protocol Violation|0|||
148863479|NCT02914548|536976465|FG000|Overall Study|Withdrawal by Subject|3|||
148863480|NCT02914548|536976466|FG001|Overall Study|Withdrawal by Subject|4|||
148863481|NCT02914548|536976467|FG002|Overall Study|Withdrawal by Subject|4|||
148863482|NCT02914548|536976465|FG000|Overall Study|>40% of body surface area|0|||
148863483|NCT02914548|536976466|FG001|Overall Study|>40% of body surface area|1|||
148863484|NCT02914548|536976467|FG002|Overall Study|>40% of body surface area|1|||
148863485|NCT00977938|536976473|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
148863486|NCT00977938|536976474|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
148863487|NCT00977938|536976475|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
148863488|NCT00977938|536976476|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
148863489|NCT00977938|536976473|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
148863490|NCT00977938|536976474|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
148863491|NCT00977938|536976475|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
148863492|NCT00977938|536976476|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
148863493|NCT00977938|536976473|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
148863494|NCT00977938|536976474|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
148863495|NCT00977938|536976475|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
148863496|NCT00977938|536976476|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
148863497|NCT00977938|536976473|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
148863498|NCT00977938|536976474|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
148863499|NCT00977938|536976475|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
148863500|NCT00977938|536976476|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
148863501|NCT00977938|536976473|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
148863502|NCT00977938|536976474|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
148863503|NCT00977938|536976475|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
148863504|NCT00977938|536976476|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
148863505|NCT00977938|536976473|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
148863506|NCT00977938|536976474|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
148863507|NCT00977938|536976475|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
148863508|NCT00977938|536976476|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
148863509|NCT00747344|536976482|FG000|Controlled Period|Adverse Event|3|||
148863510|NCT00747344|536976483|FG001|Controlled Period|Adverse Event|0|||
148863511|NCT00747344|536976484|FG002|Controlled Period|Adverse Event|0|||
148863512|NCT00747344|536976485|FG003|Controlled Period|Adverse Event|0|||
148863513|NCT00747344|536976482|FG000|Controlled Period|Lack of Efficacy|2|||
148863514|NCT00747344|536976483|FG001|Controlled Period|Lack of Efficacy|1|||
148863515|NCT00747344|536976484|FG002|Controlled Period|Lack of Efficacy|0|||
148863516|NCT00747344|536976485|FG003|Controlled Period|Lack of Efficacy|0|||
148863517|NCT00747344|536976482|FG000|Controlled Period|Other|0|||
148993986|NCT04279314|537455361|FG000|Overall Study|Protocol Violation|3|||
148863518|NCT00747344|536976483|FG001|Controlled Period|Other|3|||
148863519|NCT00747344|536976484|FG002|Controlled Period|Other|0|||
148863520|NCT00747344|536976485|FG003|Controlled Period|Other|0|||
148863521|NCT00747344|536976482|FG000|After Controlled Period|Adverse Event|0|||
148863522|NCT00747344|536976483|FG001|After Controlled Period|Adverse Event|0|||
148863523|NCT00747344|536976484|FG002|After Controlled Period|Adverse Event|0|||
148863524|NCT00747344|536976485|FG003|After Controlled Period|Adverse Event|1|||
148863525|NCT01484834|536976486|FG000|Overall Study|Lost to Follow-up|5|||
148863526|NCT01484834|536976487|FG001|Overall Study|Lost to Follow-up|8|||
148863527|NCT01484834|536976488|FG002|Overall Study|Lost to Follow-up|1|||
148863528|NCT01484834|536976489|FG003|Overall Study|Lost to Follow-up|4|||
148993987|NCT04279314|537455361|FG000|Overall Study|Other (not COVID-19 related)|2|||
148863529|NCT02460783|536976490|FG000|Overall Study|Withdrawal by Subject|1|||
148863530|NCT02460783|536976491|FG001|Overall Study|Withdrawal by Subject|3|||
148863531|NCT02460783|536976490|FG000|Overall Study|Lost to Follow-up|1|||
148863532|NCT02460783|536976491|FG001|Overall Study|Lost to Follow-up|1|||
148863533|NCT01371643|536976497|FG000|Overall Study|Withdrawal by Subject|3|||
148863534|NCT01371643|536976498|FG001|Overall Study|Withdrawal by Subject|0|||
148863535|NCT02214225|536976503|FG000|Overall Study|Lost to Follow-up|46|||
148863536|NCT02214225|536976504|FG001|Overall Study|Lost to Follow-up|18|||
148863537|NCT02214225|536976505|FG002|Overall Study|Lost to Follow-up|18|||
148863538|NCT02214225|536976503|FG000|Overall Study|Withdrawal by Subject|2|||
148863539|NCT02214225|536976504|FG001|Overall Study|Withdrawal by Subject|0|||
148863540|NCT02214225|536976505|FG002|Overall Study|Withdrawal by Subject|2|||
148863541|NCT02214225|536976503|FG000|Overall Study|Death|5|||
148863542|NCT02214225|536976504|FG001|Overall Study|Death|0|||
148863543|NCT02214225|536976505|FG002|Overall Study|Death|1|||
148863544|NCT02214225|536976503|FG000|Overall Study|randomized in error, not vaccinated|2|||
148863545|NCT02214225|536976504|FG001|Overall Study|randomized in error, not vaccinated|1|||
148863546|NCT02214225|536976505|FG002|Overall Study|randomized in error, not vaccinated|1|||
148863547|NCT03987932|536976506|FG000|Overall Study|Lost to Follow-up|2|||
148863548|NCT03987932|536976507|FG001|Overall Study|Lost to Follow-up|1|||
148863549|NCT03987932|536976508|FG002|Overall Study|Lost to Follow-up|1|||
148863550|NCT03987932|536976506|FG000|Overall Study|Non-study related elective surgery|0|||
148863551|NCT03987932|536976507|FG001|Overall Study|Non-study related elective surgery|0|||
148863552|NCT03987932|536976508|FG002|Overall Study|Non-study related elective surgery|1|||
148863553|NCT01605227|536976512|FG000|Overall Study|Did not receive study treatment|2|||
148863554|NCT01605227|536976513|FG001|Overall Study|Did not receive study treatment|3|||
148863555|NCT01605227|536976512|FG000|Overall Study|Adverse Event|228|||
148863556|NCT01605227|536976513|FG001|Overall Study|Adverse Event|42|||
148863557|NCT01605227|536976512|FG000|Overall Study|Progressive Disease|132|||
148863558|NCT01605227|536976513|FG001|Overall Study|Progressive Disease|128|||
148863559|NCT01605227|536976512|FG000|Overall Study|Clinical Deterioration|227|||
148863560|NCT01605227|536976513|FG001|Overall Study|Clinical Deterioration|133|||
148863561|NCT01605227|536976512|FG000|Overall Study|Lost to Follow-up|1|||
148863562|NCT01605227|536976513|FG001|Overall Study|Lost to Follow-up|0|||
148863563|NCT01605227|536976512|FG000|Overall Study|Protocol Violation|1|||
148863564|NCT01605227|536976513|FG001|Overall Study|Protocol Violation|0|||
148863565|NCT01605227|536976512|FG000|Overall Study|Physician Decision|9|||
148863566|NCT01605227|536976513|FG001|Overall Study|Physician Decision|7|||
148863567|NCT01605227|536976512|FG000|Overall Study|Withdrawal by Subject|18|||
148863568|NCT01605227|536976513|FG001|Overall Study|Withdrawal by Subject|14|||
148863569|NCT01605227|536976512|FG000|Overall Study|Sponsor Decision|2|||
148863570|NCT01605227|536976513|FG001|Overall Study|Sponsor Decision|0|||
148863571|NCT01605227|536976512|FG000|Overall Study|Started New Therapy|1|||
148863572|NCT01605227|536976513|FG001|Overall Study|Started New Therapy|0|||
148863573|NCT01605227|536976512|FG000|Overall Study|Subject Decision|0|||
148863574|NCT01605227|536976513|FG001|Overall Study|Subject Decision|1|||
148863575|NCT01605227|536976512|FG000|Overall Study|Dose Held >6 weeks|0|||
148863576|NCT01605227|536976513|FG001|Overall Study|Dose Held >6 weeks|1|||
148863577|NCT00624819|536976515|FG000|Follow-up Period: Year 4|Parents decision|0|||
148863578|NCT00624819|536976516|FG001|Follow-up Period: Year 4|Parents decision|0|||
148863579|NCT00624819|536976517|FG002|Follow-up Period: Year 4|Parents decision|1|||
148863580|NCT00624819|536976518|FG003|Follow-up Period: Year 4|Parents decision|0|||
148863581|NCT00624819|536976515|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
148863582|NCT00624819|536976516|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
148863583|NCT00624819|536976517|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
148863584|NCT00624819|536976518|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
148863585|NCT02847858|536976519|FG000|Overall Study|Lost to Follow-up|401|||
148863586|NCT02847858|536976520|FG001|Overall Study|Lost to Follow-up|269|||
148863587|NCT05291936|536976523|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
148863588|NCT05291936|536976524|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
148863589|NCT05291936|536976523|FG000|Period 1|Withdrew Consent during study|1|||
148863590|NCT05291936|536976524|FG001|Period 1|Withdrew Consent during study|0|||
148863591|NCT05291936|536976523|FG000|Period 2|Adverse Event|0|||
148863592|NCT05291936|536976524|FG001|Period 2|Adverse Event|1|||
148863593|NCT05291936|536976523|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
148863594|NCT05291936|536976524|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148863595|NCT02436408|536976525|FG000|Overall Study|Death|1|||
148863596|NCT02782325|536976526|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
148863597|NCT02782325|536976527|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
148863598|NCT02782325|536976528|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
148863599|NCT02782325|536976526|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
148863600|NCT02782325|536976527|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
148863601|NCT02782325|536976528|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
148863602|NCT01287221|536976529|FG000|Overall Study|Lack of Perceived Benefit|1|||
148863603|NCT01287221|536976530|FG001|Overall Study|Lack of Perceived Benefit|1|||
148863604|NCT01287221|536976529|FG000|Overall Study|Adverse Event|3|||
148993988|NCT03166618|537455366|FG000|Overall Study|Study was Terminated|0|||
148993989|NCT03166618|537455367|FG001|Overall Study|Study was Terminated|1|||
148993990|NCT03137303|537455369|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
148993991|NCT03137303|537455370|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
148993992|NCT03137303|537455369|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
148993993|NCT03137303|537455370|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
148993994|NCT03137303|537455369|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
148993995|NCT03137303|537455370|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
148993996|NCT03137303|537455369|FG000|T3: 9-month Follow-up|Death|1|||
148993997|NCT03137303|537455370|FG001|T3: 9-month Follow-up|Death|0|||
148993998|NCT03137303|537455369|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
148993999|NCT03137303|537455370|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
148994000|NCT03137303|537455369|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
148994001|NCT03137303|537455370|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
148994002|NCT03137303|537455369|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
148994003|NCT03137303|537455370|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
148994004|NCT03561090|537455371|FG000|Overall Study|Adverse Event|11|||
148994005|NCT03561090|537455372|FG001|Overall Study|Adverse Event|7|||
148994006|NCT03561090|537455371|FG000|Overall Study|Non-Compliance With Study Drug|2|||
148994007|NCT03561090|537455372|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148994008|NCT03561090|537455371|FG000|Overall Study|Protocol Violation|2|||
148994009|NCT03561090|537455372|FG001|Overall Study|Protocol Violation|2|||
148994010|NCT03561090|537455371|FG000|Overall Study|Withdrawal by Subject|7|||
148994011|NCT03561090|537455372|FG001|Overall Study|Withdrawal by Subject|7|||
148994012|NCT03561090|537455371|FG000|Overall Study|Lost to Follow-up|7|||
148994013|NCT03561090|537455372|FG001|Overall Study|Lost to Follow-up|2|||
148994014|NCT03561090|537455371|FG000|Overall Study|Study Terminated by Sponsor|10|||
148994015|NCT03561090|537455372|FG001|Overall Study|Study Terminated by Sponsor|15|||
148994016|NCT03561090|537455371|FG000|Overall Study|Randomized by Mistake|1|||
148994017|NCT03561090|537455372|FG001|Overall Study|Randomized by Mistake|1|||
148994018|NCT03561090|537455371|FG000|Overall Study|Other Not Specified|0|||
148994019|NCT03561090|537455372|FG001|Overall Study|Other Not Specified|2|||
148994020|NCT04402866|537455390|FG000|Overall Study|Discontinued Prior to Treatment|0|||
148994021|NCT04402866|537455391|FG001|Overall Study|Discontinued Prior to Treatment|0|||
148994022|NCT04402866|537455392|FG002|Overall Study|Discontinued Prior to Treatment|0|||
148994023|NCT04402866|537455393|FG003|Overall Study|Discontinued Prior to Treatment|0|||
148994024|NCT04402866|537455394|FG004|Overall Study|Discontinued Prior to Treatment|2|||
148994025|NCT04402866|537455395|FG005|Overall Study|Discontinued Prior to Treatment|3|||
148994026|NCT04402866|537455390|FG000|Overall Study|Adverse Event|2|||
148994027|NCT04402866|537455391|FG001|Overall Study|Adverse Event|1|||
148994028|NCT04402866|537455392|FG002|Overall Study|Adverse Event|0|||
148994029|NCT04402866|537455393|FG003|Overall Study|Adverse Event|0|||
148994030|NCT04402866|537455394|FG004|Overall Study|Adverse Event|13|||
148994031|NCT04402866|537455395|FG005|Overall Study|Adverse Event|8|||
148994032|NCT04402866|537455390|FG000|Overall Study|Miscellaneous|0|||
148994033|NCT04402866|537455391|FG001|Overall Study|Miscellaneous|0|||
148994034|NCT04402866|537455392|FG002|Overall Study|Miscellaneous|1|||
148994035|NCT04402866|537455393|FG003|Overall Study|Miscellaneous|0|||
148994036|NCT04402866|537455394|FG004|Overall Study|Miscellaneous|0|||
148994037|NCT04402866|537455395|FG005|Overall Study|Miscellaneous|0|||
148994038|NCT04402866|537455390|FG000|Overall Study|Lost to Follow-up|0|||
148994039|NCT04402866|537455391|FG001|Overall Study|Lost to Follow-up|0|||
148994040|NCT04402866|537455392|FG002|Overall Study|Lost to Follow-up|0|||
148994041|NCT04402866|537455393|FG003|Overall Study|Lost to Follow-up|0|||
148994042|NCT04402866|537455394|FG004|Overall Study|Lost to Follow-up|0|||
148994043|NCT04402866|537455395|FG005|Overall Study|Lost to Follow-up|1|||
148994044|NCT04402866|537455390|FG000|Overall Study|Withdrawal by Subject|0|||
148994045|NCT04402866|537455391|FG001|Overall Study|Withdrawal by Subject|0|||
148994046|NCT04402866|537455392|FG002|Overall Study|Withdrawal by Subject|0|||
148994047|NCT04402866|537455393|FG003|Overall Study|Withdrawal by Subject|0|||
148994048|NCT04402866|537455394|FG004|Overall Study|Withdrawal by Subject|0|||
148994049|NCT04402866|537455395|FG005|Overall Study|Withdrawal by Subject|2|||
148994050|NCT03667053|537455396|FG000|Overall Study|Withdrawal by Subject|1|||
148994051|NCT03667053|537455397|FG001|Overall Study|Withdrawal by Subject|0|||
148994052|NCT03667053|537455398|FG002|Overall Study|Withdrawal by Subject|0|||
148994053|NCT00515502|537455399|FG000|Treatment Period 1|Adverse Event|0|||
148994054|NCT00515502|537455400|FG001|Treatment Period 1|Adverse Event|0|||
148994055|NCT00515502|537455401|FG002|Treatment Period 1|Adverse Event|0|||
148994056|NCT00515502|537455402|FG003|Treatment Period 1|Adverse Event|0|||
148994057|NCT00515502|537455403|FG004|Treatment Period 1|Adverse Event|0|||
148994058|NCT00515502|537455404|FG005|Treatment Period 1|Adverse Event|0|||
148994059|NCT00515502|537455405|FG006|Treatment Period 1|Adverse Event|1|||
149030908|NCT01956669|537591611|FG005|Overall Study|Disease Progression|3|||
148994060|NCT00515502|537455406|FG007|Treatment Period 1|Adverse Event|0|||
148994061|NCT00515502|537455407|FG008|Treatment Period 1|Adverse Event|1|||
148994062|NCT00515502|537455408|FG009|Treatment Period 1|Adverse Event|0|||
148994063|NCT00515502|537455409|FG010|Treatment Period 1|Adverse Event|0|||
148994064|NCT00515502|537455410|FG011|Treatment Period 1|Adverse Event|1|||
148994065|NCT00515502|537455399|FG000|Treatment Period 2|Adverse Event|0|||
148994066|NCT00515502|537455400|FG001|Treatment Period 2|Adverse Event|1|||
148994067|NCT00515502|537455401|FG002|Treatment Period 2|Adverse Event|0|||
148994068|NCT00515502|537455402|FG003|Treatment Period 2|Adverse Event|0|||
148994069|NCT00515502|537455403|FG004|Treatment Period 2|Adverse Event|0|||
148994070|NCT00515502|537455404|FG005|Treatment Period 2|Adverse Event|0|||
148994071|NCT00515502|537455405|FG006|Treatment Period 2|Adverse Event|0|||
148994072|NCT00515502|537455406|FG007|Treatment Period 2|Adverse Event|0|||
148994073|NCT00515502|537455407|FG008|Treatment Period 2|Adverse Event|0|||
148994074|NCT00515502|537455408|FG009|Treatment Period 2|Adverse Event|0|||
148994075|NCT00515502|537455409|FG010|Treatment Period 2|Adverse Event|0|||
148994076|NCT00515502|537455410|FG011|Treatment Period 2|Adverse Event|0|||
148994077|NCT03647501|537455411|FG000|Overall Study|Lost to Follow-up|1|||
148994078|NCT03647501|537455412|FG001|Overall Study|Lost to Follow-up|1|||
148994079|NCT03647501|537455411|FG000|Overall Study|Withdrawal by Subject|0|||
148994080|NCT03647501|537455412|FG001|Overall Study|Withdrawal by Subject|1|||
148994081|NCT04307004|537455413|FG000|Randomization 1|Withdrawal by Subject|25|||
148994082|NCT04307004|537455414|FG001|Randomization 1|Withdrawal by Subject|26|||
148994083|NCT04307004|537455415|FG002|Randomization 1|Withdrawal by Subject|0|||
148994084|NCT04307004|537455416|FG003|Randomization 1|Withdrawal by Subject|0|||
148994085|NCT04307004|537455413|FG000|Randomization 2|Withdrawal by Subject|0|||
148994086|NCT04307004|537455414|FG001|Randomization 2|Withdrawal by Subject|0|||
148994087|NCT04307004|537455415|FG002|Randomization 2|Withdrawal by Subject|28|||
148994088|NCT04307004|537455416|FG003|Randomization 2|Withdrawal by Subject|23|||
148994089|NCT05545072|537455417|FG000|Overall Study|Lost to Follow-up|1|||
148994090|NCT05545072|537455418|FG001|Overall Study|Lost to Follow-up|0|||
148994091|NCT05545072|537455417|FG000|Overall Study|Study ended prematurely due to funding|2|||
148994092|NCT05545072|537455418|FG001|Overall Study|Study ended prematurely due to funding|2|||
148994093|NCT02395042|537455419|FG000|Treatment 1 Period|Adverse Event|1|||
148994094|NCT02395042|537455420|FG001|Treatment 1 Period|Adverse Event|3|||
148994095|NCT02395042|537455421|FG002|Treatment 1 Period|Adverse Event|1|||
148994096|NCT02395042|537455419|FG000|Treatment 1 Period|Lack of Efficacy|1|||
148994097|NCT02395042|537455420|FG001|Treatment 1 Period|Lack of Efficacy|1|||
148994098|NCT02395042|537455421|FG002|Treatment 1 Period|Lack of Efficacy|0|||
148994099|NCT02395042|537455419|FG000|Treatment 1 Period|Lost to Follow-up|1|||
148994100|NCT02395042|537455420|FG001|Treatment 1 Period|Lost to Follow-up|0|||
148994101|NCT02395042|537455421|FG002|Treatment 1 Period|Lost to Follow-up|0|||
148994102|NCT02395042|537455419|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
148994103|NCT02395042|537455420|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
148994104|NCT02395042|537455421|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
148994105|NCT02395042|537455419|FG000|Treatment 2 Period|Lack of Efficacy|1|||
148994106|NCT02395042|537455420|FG001|Treatment 2 Period|Lack of Efficacy|1|||
148994107|NCT02395042|537455421|FG002|Treatment 2 Period|Lack of Efficacy|0|||
148994108|NCT01324271|537455422|FG000|Overall Study|Lost to Follow-up|3|||
148994109|NCT01324271|537455423|FG001|Overall Study|Lost to Follow-up|0|||
148994110|NCT01324271|537455422|FG000|Overall Study|Physician Decision|1|||
148994111|NCT01324271|537455423|FG001|Overall Study|Physician Decision|0|||
148994112|NCT02807558|537455424|FG000|Overall Study|Consent withdrawn by participant|4|||
148994113|NCT02807558|537455425|FG001|Overall Study|Consent withdrawn by participant|0|||
148994114|NCT02807558|537455426|FG002|Overall Study|Consent withdrawn by participant|4|||
148994115|NCT02807558|537455427|FG003|Overall Study|Consent withdrawn by participant|2|||
148994116|NCT02807558|537455428|FG004|Overall Study|Consent withdrawn by participant|1|||
148994117|NCT02807558|537455429|FG005|Overall Study|Consent withdrawn by participant|0|||
148994118|NCT02807558|537455424|FG000|Overall Study|Non-compliance with Study Drug|0|||
148994119|NCT02807558|537455425|FG001|Overall Study|Non-compliance with Study Drug|0|||
148994120|NCT02807558|537455426|FG002|Overall Study|Non-compliance with Study Drug|1|||
148994121|NCT02807558|537455427|FG003|Overall Study|Non-compliance with Study Drug|0|||
148994122|NCT02807558|537455428|FG004|Overall Study|Non-compliance with Study Drug|0|||
148994123|NCT02807558|537455429|FG005|Overall Study|Non-compliance with Study Drug|0|||
148994124|NCT02807558|537455424|FG000|Overall Study|Adverse Event|0|||
149030909|NCT01956669|537591612|FG006|Overall Study|Disease Progression|5|||
149030910|NCT01956669|537591606|FG000|Overall Study|Adverse Event|0|||
149030911|NCT01956669|537591607|FG001|Overall Study|Adverse Event|2|||
149030912|NCT01956669|537591608|FG002|Overall Study|Adverse Event|2|||
148994125|NCT02807558|537455425|FG001|Overall Study|Adverse Event|0|||
148994126|NCT02807558|537455426|FG002|Overall Study|Adverse Event|9|||
148994127|NCT02807558|537455427|FG003|Overall Study|Adverse Event|0|||
148994128|NCT02807558|537455428|FG004|Overall Study|Adverse Event|0|||
148994129|NCT02807558|537455429|FG005|Overall Study|Adverse Event|0|||
148994130|NCT02807558|537455424|FG000|Overall Study|Death|23|||
148994131|NCT02807558|537455425|FG001|Overall Study|Death|2|||
148994132|NCT02807558|537455426|FG002|Overall Study|Death|3|||
149030913|NCT01956669|537591609|FG003|Overall Study|Adverse Event|1|||
148994133|NCT02807558|537455427|FG003|Overall Study|Death|43|||
148994134|NCT02807558|537455428|FG004|Overall Study|Death|24|||
149030914|NCT01956669|537591610|FG004|Overall Study|Adverse Event|0|||
148994135|NCT02807558|537455429|FG005|Overall Study|Death|15|||
148994136|NCT02807558|537455424|FG000|Overall Study|Progressive Disease|0|||
148994137|NCT02807558|537455425|FG001|Overall Study|Progressive Disease|0|||
148994138|NCT02807558|537455426|FG002|Overall Study|Progressive Disease|1|||
148994139|NCT02807558|537455427|FG003|Overall Study|Progressive Disease|0|||
148994140|NCT02807558|537455428|FG004|Overall Study|Progressive Disease|0|||
148994141|NCT02807558|537455429|FG005|Overall Study|Progressive Disease|0|||
148994142|NCT02807558|537455424|FG000|Overall Study|Other than specified|1|||
148994143|NCT02807558|537455425|FG001|Overall Study|Other than specified|0|||
148994144|NCT02807558|537455426|FG002|Overall Study|Other than specified|2|||
148994145|NCT02807558|537455427|FG003|Overall Study|Other than specified|0|||
148994146|NCT02807558|537455428|FG004|Overall Study|Other than specified|1|||
148994147|NCT02807558|537455429|FG005|Overall Study|Other than specified|1|||
148994148|NCT02807558|537455424|FG000|Overall Study|Lack of Efficacy|0|||
148994149|NCT02807558|537455425|FG001|Overall Study|Lack of Efficacy|0|||
148994150|NCT02807558|537455426|FG002|Overall Study|Lack of Efficacy|9|||
148994151|NCT02807558|537455427|FG003|Overall Study|Lack of Efficacy|0|||
148994152|NCT02807558|537455428|FG004|Overall Study|Lack of Efficacy|0|||
148994153|NCT02807558|537455429|FG005|Overall Study|Lack of Efficacy|0|||
148994154|NCT01972841|537455430|FG000|Overall Study|Randomized but Never Received Treatment|2|||
148994155|NCT01972841|537455431|FG001|Overall Study|Randomized but Never Received Treatment|5|||
148994156|NCT01972841|537455432|FG002|Overall Study|Randomized but Never Received Treatment|4|||
148994157|NCT01972841|537455433|FG003|Overall Study|Randomized but Never Received Treatment|2|||
148994158|NCT01972841|537455434|FG004|Overall Study|Randomized but Never Received Treatment|6|||
148994159|NCT01972841|537455435|FG005|Overall Study|Randomized but Never Received Treatment|13|||
148994160|NCT01972841|537455430|FG000|Overall Study|Adverse Event|13|||
148994161|NCT01972841|537455431|FG001|Overall Study|Adverse Event|8|||
148994162|NCT01972841|537455432|FG002|Overall Study|Adverse Event|12|||
148994163|NCT01972841|537455433|FG003|Overall Study|Adverse Event|9|||
148994164|NCT01972841|537455434|FG004|Overall Study|Adverse Event|21|||
148994165|NCT01972841|537455435|FG005|Overall Study|Adverse Event|26|||
148994166|NCT01972841|537455430|FG000|Overall Study|Lack of Efficacy|1|||
148994167|NCT01972841|537455431|FG001|Overall Study|Lack of Efficacy|0|||
148994168|NCT01972841|537455432|FG002|Overall Study|Lack of Efficacy|0|||
148994169|NCT01972841|537455433|FG003|Overall Study|Lack of Efficacy|2|||
148994170|NCT01972841|537455434|FG004|Overall Study|Lack of Efficacy|4|||
148994171|NCT01972841|537455435|FG005|Overall Study|Lack of Efficacy|1|||
148994172|NCT01972841|537455430|FG000|Overall Study|Lost to Follow-up|4|||
148994173|NCT01972841|537455431|FG001|Overall Study|Lost to Follow-up|2|||
148994174|NCT01972841|537455432|FG002|Overall Study|Lost to Follow-up|4|||
148994175|NCT01972841|537455433|FG003|Overall Study|Lost to Follow-up|2|||
148994176|NCT01972841|537455434|FG004|Overall Study|Lost to Follow-up|9|||
148994177|NCT01972841|537455435|FG005|Overall Study|Lost to Follow-up|3|||
148994178|NCT01972841|537455430|FG000|Overall Study|Protocol Violation|2|||
148994179|NCT01972841|537455431|FG001|Overall Study|Protocol Violation|2|||
148994180|NCT01972841|537455432|FG002|Overall Study|Protocol Violation|3|||
148994181|NCT01972841|537455433|FG003|Overall Study|Protocol Violation|5|||
148994182|NCT01972841|537455434|FG004|Overall Study|Protocol Violation|9|||
148994183|NCT01972841|537455435|FG005|Overall Study|Protocol Violation|4|||
148994184|NCT01972841|537455430|FG000|Overall Study|Withdrawal by participants|21|||
148994185|NCT01972841|537455431|FG001|Overall Study|Withdrawal by participants|27|||
148994186|NCT01972841|537455432|FG002|Overall Study|Withdrawal by participants|23|||
148994187|NCT01972841|537455433|FG003|Overall Study|Withdrawal by participants|16|||
148994188|NCT01972841|537455434|FG004|Overall Study|Withdrawal by participants|33|||
148994189|NCT01972841|537455435|FG005|Overall Study|Withdrawal by participants|34|||
148994190|NCT01972841|537455430|FG000|Overall Study|Miscellaneous|0|||
148994191|NCT01972841|537455431|FG001|Overall Study|Miscellaneous|0|||
148994192|NCT01972841|537455432|FG002|Overall Study|Miscellaneous|4|||
148994193|NCT01972841|537455433|FG003|Overall Study|Miscellaneous|1|||
148994194|NCT01972841|537455434|FG004|Overall Study|Miscellaneous|0|||
148994195|NCT01972841|537455435|FG005|Overall Study|Miscellaneous|4|||
148863605|NCT01287221|536976530|FG001|Overall Study|Adverse Event|3|||
148863606|NCT01287221|536976529|FG000|Overall Study|Withdrawal by Subject|0|||
148863607|NCT01287221|536976530|FG001|Overall Study|Withdrawal by Subject|1|||
148863608|NCT00930969|536976531|FG000|Overall Study|Death|5|||
148863609|NCT00930969|536976531|FG000|Overall Study|Lost to Follow-up|1|||
148863610|NCT00930969|536976531|FG000|Overall Study|Physician Decision|13|||
148994196|NCT01972841|537455430|FG000|Overall Study|Did not have end of treatment page|0|||
148994197|NCT01972841|537455431|FG001|Overall Study|Did not have end of treatment page|0|||
148994198|NCT01972841|537455432|FG002|Overall Study|Did not have end of treatment page|0|||
148994199|NCT01972841|537455433|FG003|Overall Study|Did not have end of treatment page|0|||
148994200|NCT01972841|537455434|FG004|Overall Study|Did not have end of treatment page|1|||
148994201|NCT01972841|537455435|FG005|Overall Study|Did not have end of treatment page|0|||
148994202|NCT01869491|537455438|FG000|Overall Study|Adverse Event|3|||
148994203|NCT01869491|537455439|FG001|Overall Study|Adverse Event|5|||
148994204|NCT01869491|537455438|FG000|Overall Study|Lack of Efficacy|0|||
148994205|NCT01869491|537455439|FG001|Overall Study|Lack of Efficacy|3|||
148863611|NCT00930969|536976531|FG000|Overall Study|Withdrawal by Subject|19|||
148994206|NCT01869491|537455438|FG000|Overall Study|Withdrawal by Subject|6|||
148994207|NCT01869491|537455439|FG001|Overall Study|Withdrawal by Subject|7|||
148994208|NCT01869491|537455438|FG000|Overall Study|Lost to Follow-up|11|||
148994209|NCT01869491|537455439|FG001|Overall Study|Lost to Follow-up|9|||
148994210|NCT01869491|537455438|FG000|Overall Study|No further need of investigational product|1|||
148994211|NCT01869491|537455439|FG001|Overall Study|No further need of investigational product|0|||
148994212|NCT01362140|537455440|FG000|Overall Study|Noncompliance|1|||
148994213|NCT01362140|537455441|FG001|Overall Study|Noncompliance|0|||
148994214|NCT01362140|537455440|FG000|Overall Study|Adverse Event|2|||
148994215|NCT01362140|537455441|FG001|Overall Study|Adverse Event|2|||
148994216|NCT01362140|537455440|FG000|Overall Study|Withdrawal by Subject|3|||
148994217|NCT01362140|537455441|FG001|Overall Study|Withdrawal by Subject|3|||
148994218|NCT01362140|537455440|FG000|Overall Study|Administrative Decision|0|||
148994219|NCT01362140|537455441|FG001|Overall Study|Administrative Decision|1|||
148994220|NCT01362140|537455440|FG000|Overall Study|Death|2|||
148994221|NCT01362140|537455441|FG001|Overall Study|Death|1|||
148994222|NCT01362140|537455440|FG000|Overall Study|Other|1|||
148994223|NCT01362140|537455441|FG001|Overall Study|Other|1|||
148994224|NCT01362140|537455440|FG000|Overall Study|Protocol-specified Criteria|1|||
148994225|NCT01362140|537455441|FG001|Overall Study|Protocol-specified Criteria|2|||
148863612|NCT00657150|536976532|FG000|Overall Study|Adverse Event|19|||
148863613|NCT00657150|536976533|FG001|Overall Study|Adverse Event|10|||
148863614|NCT00657150|536976532|FG000|Overall Study|Non-compliant with protocol|5|||
148863615|NCT00657150|536976533|FG001|Overall Study|Non-compliant with protocol|9|||
148863616|NCT00657150|536976532|FG000|Overall Study|Lost to Follow-up|2|||
148863617|NCT00657150|536976533|FG001|Overall Study|Lost to Follow-up|0|||
148863618|NCT00657150|536976532|FG000|Overall Study|Withdrawal by Subject|51|||
148863619|NCT00657150|536976533|FG001|Overall Study|Withdrawal by Subject|36|||
148863620|NCT00657150|536976532|FG000|Overall Study|Other|38|||
148863621|NCT00657150|536976533|FG001|Overall Study|Other|38|||
148863622|NCT00657150|536976532|FG000|Treatment|Adverse Event|60|||
148863623|NCT00657150|536976533|FG001|Treatment|Adverse Event|53|||
148863624|NCT00657150|536976532|FG000|Treatment|Non-compliant with protocol|10|||
148863625|NCT00657150|536976533|FG001|Treatment|Non-compliant with protocol|9|||
148863626|NCT00657150|536976532|FG000|Treatment|Lost to Follow-up|1|||
148863627|NCT00657150|536976533|FG001|Treatment|Lost to Follow-up|0|||
148863628|NCT00657150|536976532|FG000|Treatment|Withdrawal by Subject|23|||
148863629|NCT00657150|536976533|FG001|Treatment|Withdrawal by Subject|20|||
148863630|NCT00657150|536976532|FG000|Treatment|Other|13|||
148863631|NCT00657150|536976533|FG001|Treatment|Other|15|||
148863632|NCT02966795|536976534|FG000|Overall Study|Patient Left the Country|0|||
148863633|NCT02966795|536976535|FG001|Overall Study|Patient Left the Country|1|||
148863634|NCT01416441|536976536|FG000|Overall Study|Lost to Follow-up|5|||
148863635|NCT01416441|536976536|FG000|Overall Study|Adverse Event|6|||
148863636|NCT01416441|536976536|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
148863637|NCT01416441|536976536|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
148863638|NCT01416441|536976536|FG000|Overall Study|Investigator Withdrew Subject|2|||
148863639|NCT01416441|536976536|FG000|Overall Study|Subject Withdrew Consent|12|||
148863640|NCT01416441|536976536|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
148863641|NCT00526110|536976545|FG000|Overall Study|Adverse Event|2|||
148863642|NCT00526110|536976546|FG001|Overall Study|Adverse Event|9|||
148863643|NCT00526110|536976545|FG000|Overall Study|Disease Progression|0|||
148863644|NCT00526110|536976546|FG001|Overall Study|Disease Progression|19|||
148863645|NCT00526110|536976545|FG000|Overall Study|Maximal Response|0|||
148863646|NCT00526110|536976546|FG001|Overall Study|Maximal Response|6|||
148863647|NCT00526110|536976545|FG000|Overall Study|Withdrawal by Subject|0|||
148863648|NCT00526110|536976546|FG001|Overall Study|Withdrawal by Subject|2|||
148863649|NCT00526110|536976545|FG000|Overall Study|Poor Tolerance|0|||
148863650|NCT00526110|536976546|FG001|Overall Study|Poor Tolerance|5|||
148863651|NCT01400243|536976547|FG000|Overall Study|Protocol Violation|8|||
148994226|NCT01362140|537455440|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
148994227|NCT01362140|537455441|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
148994228|NCT01910129|537455442|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
148994229|NCT01910129|537455443|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
148994230|NCT01910129|537455444|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
148994231|NCT01910129|537455442|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
148863652|NCT01400243|536976548|FG001|Overall Study|Protocol Violation|11|||
148863653|NCT02278614|536976551|FG000|Overall Study|Withdrawal by Subject|3|||
148863654|NCT02278614|536976552|FG001|Overall Study|Withdrawal by Subject|5|||
148863655|NCT02278614|536976551|FG000|Overall Study|Adverse Event|1|||
148863656|NCT02278614|536976552|FG001|Overall Study|Adverse Event|0|||
148863657|NCT02278614|536976551|FG000|Overall Study|left eye was not eligible|1|||
148994232|NCT01910129|537455443|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
148994233|NCT01910129|537455444|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
148863658|NCT02278614|536976552|FG001|Overall Study|left eye was not eligible|0|||
148863659|NCT03762616|536976554|FG000|Overall Study|Protocol Violation|2|||
148863660|NCT01309269|536978998|FG000|Overall Study|Adverse Event|56|||
148863661|NCT01309269|536978998|FG000|Overall Study|Withdrawal by Subject|25|||
148863662|NCT01309269|536978998|FG000|Overall Study|Lack of Acceptance|15|||
148863663|NCT01309269|536978998|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
148863664|NCT01309269|536978998|FG000|Overall Study|Kidney Transplant|25|||
148863665|NCT01309269|536978998|FG000|Overall Study|Administrative Problems|141|||
148863666|NCT01309269|536978998|FG000|Overall Study|Other|256|||
148863667|NCT01309269|536978998|FG000|Overall Study|Other|1|||
148863668|NCT01309269|536978998|FG000|Overall Study|Study Completion Data Not Recorded|95|||
148863669|NCT01309269|536978998|FG000|Overall Study|Enrolled but not Treated|107|||
148863670|NCT05013424|536979015|FG000|Overall Study|Lost to Follow-up|1|||
148863671|NCT05013424|536979016|FG001|Overall Study|Lost to Follow-up|1|||
148863672|NCT05013424|536979017|FG002|Overall Study|Lost to Follow-up|1|||
148863673|NCT05013424|536979015|FG000|Overall Study|Withdrawal by Subject|0|||
148863674|NCT05013424|536979016|FG001|Overall Study|Withdrawal by Subject|1|||
148863675|NCT05013424|536979017|FG002|Overall Study|Withdrawal by Subject|0|||
148863676|NCT02285114|536979019|FG000|Main Phase|Investigator's Discretion|0|||
148863677|NCT02285114|536979020|FG001|Main Phase|Investigator's Discretion|2|||
148863678|NCT02285114|536979021|FG002|Main Phase|Investigator's Discretion|0|||
148863679|NCT02285114|536979022|FG003|Main Phase|Investigator's Discretion|0|||
148863680|NCT02285114|536979023|FG004|Main Phase|Investigator's Discretion|0|||
148863681|NCT02285114|536979024|FG005|Main Phase|Investigator's Discretion|0|||
148863682|NCT02285114|536979019|FG000|Main Phase|Enrolled but Never Treated|1|||
148863683|NCT02285114|536979020|FG001|Main Phase|Enrolled but Never Treated|0|||
148863684|NCT02285114|536979021|FG002|Main Phase|Enrolled but Never Treated|0|||
148863685|NCT02285114|536979022|FG003|Main Phase|Enrolled but Never Treated|0|||
148863686|NCT02285114|536979023|FG004|Main Phase|Enrolled but Never Treated|0|||
148863687|NCT02285114|536979024|FG005|Main Phase|Enrolled but Never Treated|0|||
148863688|NCT02285114|536979019|FG000|Main Phase|Withdrew Consent|0|||
148863689|NCT02285114|536979020|FG001|Main Phase|Withdrew Consent|0|||
148863690|NCT02285114|536979021|FG002|Main Phase|Withdrew Consent|1|||
148863691|NCT02285114|536979022|FG003|Main Phase|Withdrew Consent|0|||
148863692|NCT02285114|536979023|FG004|Main Phase|Withdrew Consent|0|||
148863693|NCT02285114|536979024|FG005|Main Phase|Withdrew Consent|0|||
148863694|NCT02285114|536979019|FG000|Extension Phase|Investigator's Discretion|0|||
148863695|NCT02285114|536979020|FG001|Extension Phase|Investigator's Discretion|0|||
148863696|NCT02285114|536979021|FG002|Extension Phase|Investigator's Discretion|0|||
148863697|NCT02285114|536979022|FG003|Extension Phase|Investigator's Discretion|14|||
148863698|NCT02285114|536979023|FG004|Extension Phase|Investigator's Discretion|1|||
148863699|NCT02285114|536979024|FG005|Extension Phase|Investigator's Discretion|0|||
148863700|NCT02285114|536979019|FG000|Extension Phase|Lost to Follow-up|0|||
148863701|NCT02285114|536979020|FG001|Extension Phase|Lost to Follow-up|0|||
148863702|NCT02285114|536979021|FG002|Extension Phase|Lost to Follow-up|0|||
148863703|NCT02285114|536979022|FG003|Extension Phase|Lost to Follow-up|1|||
148863704|NCT02285114|536979023|FG004|Extension Phase|Lost to Follow-up|1|||
148863705|NCT02285114|536979024|FG005|Extension Phase|Lost to Follow-up|0|||
148863706|NCT02285114|536979019|FG000|Extension Phase|Non-compliance with Study Drug|0|||
148863707|NCT02285114|536979020|FG001|Extension Phase|Non-compliance with Study Drug|0|||
148863708|NCT02285114|536979021|FG002|Extension Phase|Non-compliance with Study Drug|0|||
148863709|NCT02285114|536979022|FG003|Extension Phase|Non-compliance with Study Drug|2|||
148863710|NCT02285114|536979023|FG004|Extension Phase|Non-compliance with Study Drug|0|||
148863711|NCT02285114|536979024|FG005|Extension Phase|Non-compliance with Study Drug|0|||
148863712|NCT02285114|536979019|FG000|Extension Phase|Pregnancy|0|||
148863713|NCT02285114|536979020|FG001|Extension Phase|Pregnancy|0|||
148863714|NCT02285114|536979021|FG002|Extension Phase|Pregnancy|0|||
148863715|NCT02285114|536979022|FG003|Extension Phase|Pregnancy|1|||
148863716|NCT02285114|536979023|FG004|Extension Phase|Pregnancy|0|||
148863717|NCT02285114|536979024|FG005|Extension Phase|Pregnancy|0|||
148863718|NCT03383783|536979025|FG000|Overall Study|Withdrawal by Subject|2|||
148863719|NCT01156389|536979026|FG000|Overall Study|Elevated liver enzymes|4|||
148863720|NCT01156389|536979027|FG001|Overall Study|Elevated liver enzymes|0|||
148863721|NCT01156389|536979026|FG000|Overall Study|Vomiting|0|||
148863722|NCT01156389|536979027|FG001|Overall Study|Vomiting|1|||
148863723|NCT00350623|536979031|FG000|Overall Study|Lost to Follow-up|8|||
148863724|NCT00350623|536979032|FG001|Overall Study|Lost to Follow-up|3|||
148863725|NCT00350623|536979033|FG002|Overall Study|Lost to Follow-up|4|||
148863726|NCT00350623|536979031|FG000|Overall Study|Withdrawal by Subject|0|||
148863727|NCT00350623|536979032|FG001|Overall Study|Withdrawal by Subject|1|||
148863728|NCT00350623|536979033|FG002|Overall Study|Withdrawal by Subject|1|||
148863729|NCT00350623|536979031|FG000|Overall Study|patient traveling outside the country|0|||
148863730|NCT00350623|536979032|FG001|Overall Study|patient traveling outside the country|0|||
148863731|NCT00350623|536979033|FG002|Overall Study|patient traveling outside the country|1|||
148863732|NCT04126564|536979034|FG000|Overall Study|Withdrawal by Subject|0|||
148863733|NCT04126564|536979035|FG001|Overall Study|Withdrawal by Subject|2|||
148863734|NCT04126564|536979034|FG000|Overall Study|Lost to Follow-up|0|||
148863735|NCT04126564|536979035|FG001|Overall Study|Lost to Follow-up|1|||
148863736|NCT02233738|536979037|FG000|Overall Study|Lost to Follow-up|5|||
148863737|NCT02233738|536979038|FG001|Overall Study|Lost to Follow-up|12|||
148863738|NCT02233738|536979037|FG000|Overall Study|Death|0|||
148863739|NCT02233738|536979038|FG001|Overall Study|Death|1|||
148994234|NCT02491671|537455446|FG000|Overall Study|Adverse Event|6|||
148994235|NCT02491671|537455447|FG001|Overall Study|Adverse Event|8|||
148994236|NCT02491671|537455446|FG000|Overall Study|Death|0|||
148994237|NCT02491671|537455447|FG001|Overall Study|Death|2|||
148994238|NCT02491671|537455446|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
148994239|NCT02491671|537455447|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
148994240|NCT00535730|537455448|FG000|Overall Study|Adverse Event|1|||
148994241|NCT00535730|537455449|FG001|Overall Study|Adverse Event|1|||
148994242|NCT00535730|537455448|FG000|Overall Study|Lost to Follow-up|0|||
148994243|NCT00535730|537455449|FG001|Overall Study|Lost to Follow-up|1|||
148994244|NCT00535730|537455448|FG000|Overall Study|Physician Decision|0|||
148994245|NCT00535730|537455449|FG001|Overall Study|Physician Decision|1|||
148994246|NCT00535730|537455448|FG000|Overall Study|Protocol Violation|1|||
148994247|NCT00535730|537455449|FG001|Overall Study|Protocol Violation|0|||
148994248|NCT00535730|537455448|FG000|Overall Study|Withdrawal by Subject|0|||
148994249|NCT00535730|537455449|FG001|Overall Study|Withdrawal by Subject|4|||
148994250|NCT00936858|537455450|FG000|Overall Study|Death|3|||
148994251|NCT00936858|537455450|FG000|Overall Study|Progression|29|||
148994252|NCT00936858|537455450|FG000|Overall Study|Withdrawal by Subject|5|||
148994253|NCT00936858|537455450|FG000|Overall Study|Adverse Event|1|||
148994254|NCT00936858|537455450|FG000|Overall Study|Physician Decision|7|||
148994255|NCT00936858|537455450|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
148994256|NCT00936858|537455450|FG000|Overall Study|Lost to Follow-up|1|||
148994257|NCT00584727|537455458|FG000|First Intervention|Discontinuation|0|||
148994258|NCT00584727|537455459|FG001|First Intervention|Discontinuation|0|||
148994259|NCT00584727|537455460|FG002|First Intervention|Discontinuation|1|||
148994260|NCT00584727|537455461|FG003|First Intervention|Discontinuation|0|||
148994261|NCT00584727|537455462|FG004|First Intervention|Discontinuation|0|||
148994262|NCT00584727|537455463|FG005|First Intervention|Discontinuation|0|||
148994263|NCT00584727|537455458|FG000|Third Intervention|Protocol Violation|0|||
148994264|NCT00584727|537455459|FG001|Third Intervention|Protocol Violation|0|||
148994265|NCT00584727|537455460|FG002|Third Intervention|Protocol Violation|1|||
148994266|NCT00584727|537455461|FG003|Third Intervention|Protocol Violation|0|||
148994267|NCT00584727|537455462|FG004|Third Intervention|Protocol Violation|4|||
148994268|NCT00584727|537455463|FG005|Third Intervention|Protocol Violation|2|||
148994269|NCT00729833|537455466|FG000|Overall Study|Death|5|||
148994270|NCT00729833|537455467|FG001|Overall Study|Death|1|||
148994271|NCT00729833|537455468|FG002|Overall Study|Death|3|||
148994272|NCT00729833|537455469|FG003|Overall Study|Death|5|||
148994273|NCT00729833|537455466|FG000|Overall Study|Study Terminated by Sponsor|0|||
148994274|NCT00729833|537455467|FG001|Overall Study|Study Terminated by Sponsor|0|||
148994275|NCT00729833|537455468|FG002|Overall Study|Study Terminated by Sponsor|1|||
148778102|NCT00473824|536661907|FG000|Overall Study|Adverse Event|1|||
148778103|NCT00473824|536661908|FG001|Overall Study|Adverse Event|0|||
148778104|NCT00473824|536661907|FG000|Overall Study|Death|1|||
148778105|NCT00473824|536661908|FG001|Overall Study|Death|0|||
148778106|NCT00473824|536661907|FG000|Overall Study|Lost to Follow-up|1|||
148778107|NCT00473824|536661908|FG001|Overall Study|Lost to Follow-up|0|||
148778108|NCT00473824|536661907|FG000|Overall Study|Withdrawal by physician|1|||
148778109|NCT00473824|536661908|FG001|Overall Study|Withdrawal by physician|0|||
148778110|NCT02560623|536661909|FG000|Overall Study|Unable to swallow sponge|0|||
148778111|NCT02560623|536661910|FG001|Overall Study|Unable to swallow sponge|1|||
148778112|NCT02560623|536661911|FG002|Overall Study|Unable to swallow sponge|0|||
148778113|NCT02560623|536661912|FG003|Overall Study|Unable to swallow sponge|0|||
148778114|NCT02560623|536661909|FG000|Overall Study|Intervention prior to sponge administration|0|||
148778115|NCT02560623|536661910|FG001|Overall Study|Intervention prior to sponge administration|1|||
148778116|NCT02560623|536661911|FG002|Overall Study|Intervention prior to sponge administration|0|||
148778117|NCT02560623|536661912|FG003|Overall Study|Intervention prior to sponge administration|0|||
148778118|NCT00723190|536661921|FG000|Overall Study|Withdrawal by Subject|45|||
148778119|NCT00723190|536661921|FG000|Overall Study|Lost to Follow-up|37|||
148778120|NCT00723190|536661921|FG000|Overall Study|Adverse Event|18|||
148778121|NCT00723190|536661921|FG000|Overall Study|Lack of Efficacy|16|||
148778122|NCT00723190|536661921|FG000|Overall Study|Protocol Violation|15|||
148778123|NCT00723190|536661921|FG000|Overall Study|Other-Premature Discontinuation|9|||
148778124|NCT00723190|536661921|FG000|Overall Study|Other-Not included in safety population|2|||
148778125|NCT00454818|536661922|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
148778126|NCT00454818|536661923|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
148778127|NCT00454818|536661924|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
148778128|NCT00454818|536661925|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
148778129|NCT00454818|536661926|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
148778130|NCT00454818|536661922|FG000|Phase I: Open-label Dose-escalation|Death|0|||
148778131|NCT00454818|536661923|FG001|Phase I: Open-label Dose-escalation|Death|1|||
148778132|NCT00454818|536661924|FG002|Phase I: Open-label Dose-escalation|Death|0|||
148778133|NCT00454818|536661925|FG003|Phase I: Open-label Dose-escalation|Death|0|||
148863740|NCT02233738|536979037|FG000|Overall Study|Withdrawal by Subject|0|||
148863741|NCT02233738|536979038|FG001|Overall Study|Withdrawal by Subject|1|||
148863742|NCT02233738|536979037|FG000|Overall Study|Did not return after Baseline|3|||
148863743|NCT02233738|536979038|FG001|Overall Study|Did not return after Baseline|2|||
148863744|NCT00096174|536979042|FG000|Overall Study|Lack of Efficacy|9|||
148863745|NCT00096174|536979042|FG000|Overall Study|Adverse Event|15|||
148863746|NCT00096174|536979042|FG000|Overall Study|Death|6|||
148863747|NCT00096174|536979042|FG000|Overall Study|Withdrawal by Subject|15|||
148863748|NCT00096174|536979042|FG000|Overall Study|Not started protocol therapy|3|||
148863749|NCT00096174|536979042|FG000|Overall Study|Ineligible|6|||
148863750|NCT00096174|536979042|FG000|Overall Study|other reason|8|||
148863751|NCT03028480|536979043|FG000|Overall Study|No revisit after the first prescription date|2|||
148863752|NCT03028480|536979043|FG000|Overall Study|Did not use the drug|1|||
148863753|NCT03028480|536979043|FG000|Overall Study|Violation of the enrollment deadline|10|||
148863754|NCT03028480|536979043|FG000|Overall Study|Case report forms were not collected|21|||
148863755|NCT01030874|536979044|FG000|Overall Study|Withdrawal by Subject|1|||
148863756|NCT01030874|536979045|FG001|Overall Study|Withdrawal by Subject|0|||
148863757|NCT01030874|536979044|FG000|Overall Study|Discharged in first 2 weeks|17|||
148863758|NCT01030874|536979045|FG001|Overall Study|Discharged in first 2 weeks|16|||
148863759|NCT03554772|536979051|FG000|Overall Study|Lost to Follow-up|0|||
148863760|NCT03554772|536979052|FG001|Overall Study|Lost to Follow-up|0|||
148863761|NCT03554772|536979053|FG002|Overall Study|Lost to Follow-up|0|||
148863762|NCT03554772|536979054|FG003|Overall Study|Lost to Follow-up|2|||
148863763|NCT01133405|536979059|FG000|Period 1|Withdrawal by Subject|0|||
148863764|NCT01133405|536979060|FG001|Period 1|Withdrawal by Subject|1|||
148863765|NCT01133405|536979061|FG002|Period 1|Withdrawal by Subject|0|||
148863766|NCT01133405|536979062|FG003|Period 1|Withdrawal by Subject|1|||
148863767|NCT01133405|536979063|FG004|Period 1|Withdrawal by Subject|0|||
148863768|NCT01133405|536979064|FG005|Period 1|Withdrawal by Subject|1|||
148863769|NCT01133405|536979065|FG006|Period 1|Withdrawal by Subject|0|||
148863770|NCT01133405|536979066|FG007|Period 1|Withdrawal by Subject|0|||
148863771|NCT01133405|536979067|FG008|Period 1|Withdrawal by Subject|0|||
148863772|NCT01133405|536979068|FG009|Period 1|Withdrawal by Subject|0|||
148863773|NCT01133405|536979059|FG000|Period 1|Physician Decision|0|||
148863774|NCT01133405|536979060|FG001|Period 1|Physician Decision|0|||
148863775|NCT01133405|536979061|FG002|Period 1|Physician Decision|0|||
148863776|NCT01133405|536979062|FG003|Period 1|Physician Decision|1|||
148863777|NCT01133405|536979063|FG004|Period 1|Physician Decision|0|||
148863778|NCT01133405|536979064|FG005|Period 1|Physician Decision|0|||
148863779|NCT01133405|536979065|FG006|Period 1|Physician Decision|0|||
148863780|NCT01133405|536979066|FG007|Period 1|Physician Decision|0|||
148863781|NCT01133405|536979067|FG008|Period 1|Physician Decision|0|||
148863782|NCT01133405|536979068|FG009|Period 1|Physician Decision|0|||
148863783|NCT01133405|536979059|FG000|Period 1|Discontinued after randomization|1|||
148863784|NCT01133405|536979060|FG001|Period 1|Discontinued after randomization|0|||
148863785|NCT01133405|536979061|FG002|Period 1|Discontinued after randomization|0|||
148863786|NCT01133405|536979062|FG003|Period 1|Discontinued after randomization|0|||
148863787|NCT01133405|536979063|FG004|Period 1|Discontinued after randomization|0|||
148863788|NCT01133405|536979064|FG005|Period 1|Discontinued after randomization|0|||
148863789|NCT01133405|536979065|FG006|Period 1|Discontinued after randomization|1|||
148863790|NCT01133405|536979066|FG007|Period 1|Discontinued after randomization|0|||
148863791|NCT01133405|536979067|FG008|Period 1|Discontinued after randomization|0|||
148863792|NCT01133405|536979068|FG009|Period 1|Discontinued after randomization|0|||
148863793|NCT01133405|536979059|FG000|Period 1|Received drug only in period 2|0|||
148863794|NCT01133405|536979060|FG001|Period 1|Received drug only in period 2|1|||
148863795|NCT01133405|536979061|FG002|Period 1|Received drug only in period 2|0|||
148863796|NCT01133405|536979062|FG003|Period 1|Received drug only in period 2|2|||
148863797|NCT01133405|536979063|FG004|Period 1|Received drug only in period 2|0|||
148863798|NCT01133405|536979064|FG005|Period 1|Received drug only in period 2|1|||
148863799|NCT01133405|536979065|FG006|Period 1|Received drug only in period 2|0|||
148863800|NCT01133405|536979066|FG007|Period 1|Received drug only in period 2|0|||
148863801|NCT01133405|536979067|FG008|Period 1|Received drug only in period 2|0|||
148994276|NCT00729833|537455469|FG003|Overall Study|Study Terminated by Sponsor|0|||
148994277|NCT00729833|537455466|FG000|Overall Study|Lost to Follow-up|1|||
148994278|NCT00729833|537455467|FG001|Overall Study|Lost to Follow-up|0|||
148994279|NCT00729833|537455468|FG002|Overall Study|Lost to Follow-up|0|||
148863802|NCT01133405|536979068|FG009|Period 1|Received drug only in period 2|0|||
148863803|NCT01133405|536979059|FG000|Period 1|Received drug only in period 3|0|||
148863804|NCT01133405|536979060|FG001|Period 1|Received drug only in period 3|1|||
148863805|NCT01133405|536979061|FG002|Period 1|Received drug only in period 3|1|||
148863806|NCT01133405|536979062|FG003|Period 1|Received drug only in period 3|0|||
148863807|NCT01133405|536979063|FG004|Period 1|Received drug only in period 3|0|||
148863808|NCT01133405|536979064|FG005|Period 1|Received drug only in period 3|0|||
148863809|NCT01133405|536979065|FG006|Period 1|Received drug only in period 3|0|||
148863810|NCT01133405|536979066|FG007|Period 1|Received drug only in period 3|0|||
148994280|NCT00729833|537455469|FG003|Overall Study|Lost to Follow-up|0|||
148863811|NCT01133405|536979067|FG008|Period 1|Received drug only in period 3|0|||
148994281|NCT00729833|537455466|FG000|Overall Study|Withdrawal by Subject|3|||
148994282|NCT00729833|537455467|FG001|Overall Study|Withdrawal by Subject|1|||
148994283|NCT00729833|537455468|FG002|Overall Study|Withdrawal by Subject|3|||
148994284|NCT00729833|537455469|FG003|Overall Study|Withdrawal by Subject|0|||
148994285|NCT00729833|537455466|FG000|Overall Study|Unspecified Reasons|11|||
148994286|NCT00729833|537455467|FG001|Overall Study|Unspecified Reasons|5|||
148994287|NCT00729833|537455468|FG002|Overall Study|Unspecified Reasons|5|||
148994288|NCT00729833|537455469|FG003|Overall Study|Unspecified Reasons|1|||
148994289|NCT00092131|537455470|FG000|Treatment Period I|Adverse Event|1|||
148994290|NCT00092131|537455471|FG001|Treatment Period I|Adverse Event|0|||
148994291|NCT00092131|537455470|FG000|Treatment Period II|Adverse Event|0|||
148994292|NCT00092131|537455471|FG001|Treatment Period II|Adverse Event|1|||
148994293|NCT02341417|537455472|FG000|Overall Study|Withdrawal by Subject|0|||
148994294|NCT02341417|537455473|FG001|Overall Study|Withdrawal by Subject|2|||
148994295|NCT02341417|537455474|FG002|Overall Study|Withdrawal by Subject|0|||
148994296|NCT02341417|537455472|FG000|Overall Study|Decision by sponsor|2|||
148994297|NCT02341417|537455473|FG001|Overall Study|Decision by sponsor|0|||
148994298|NCT02341417|537455474|FG002|Overall Study|Decision by sponsor|0|||
148994299|NCT02341417|537455472|FG000|Overall Study|Death|0|||
148994300|NCT02341417|537455473|FG001|Overall Study|Death|0|||
148994301|NCT02341417|537455474|FG002|Overall Study|Death|1|||
148994302|NCT04773587|537455475|FG000|Overall Study|Lost to Follow-up|11|||
148994303|NCT04773587|537455476|FG001|Overall Study|Lost to Follow-up|3|||
148994304|NCT04773587|537455475|FG000|Overall Study|Adverse Event|6|||
148994305|NCT04773587|537455476|FG001|Overall Study|Adverse Event|3|||
148994306|NCT04773587|537455475|FG000|Overall Study|Lack of Efficacy|5|||
148994307|NCT04773587|537455476|FG001|Overall Study|Lack of Efficacy|2|||
148994308|NCT04773587|537455475|FG000|Overall Study|Withdrawal by Subject|4|||
148994309|NCT04773587|537455476|FG001|Overall Study|Withdrawal by Subject|5|||
148994310|NCT04773587|537455475|FG000|Overall Study|Noncompliance|1|||
148994311|NCT04773587|537455476|FG001|Overall Study|Noncompliance|0|||
148994312|NCT04773587|537455475|FG000|Overall Study|Protocol Violation|1|||
148994313|NCT04773587|537455476|FG001|Overall Study|Protocol Violation|0|||
148994314|NCT04773587|537455475|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
148994315|NCT04773587|537455476|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
148994316|NCT02372409|537455477|FG000|Overall Study|Lost to Follow-up|1|||
148994317|NCT02372409|537455478|FG001|Overall Study|Lost to Follow-up|0|||
148994318|NCT02372409|537455477|FG000|Overall Study|Disease progression|1|||
148994319|NCT02372409|537455478|FG001|Overall Study|Disease progression|1|||
148994320|NCT01954017|537455490|FG000|Overall Study|Adverse Event|0|||
148994321|NCT01954017|537455491|FG001|Overall Study|Adverse Event|0|||
148994322|NCT01954017|537455492|FG002|Overall Study|Adverse Event|1|||
148994323|NCT01954017|537455490|FG000|Overall Study|Death|2|||
148994324|NCT01954017|537455491|FG001|Overall Study|Death|1|||
148994325|NCT01954017|537455492|FG002|Overall Study|Death|1|||
148994326|NCT01954017|537455490|FG000|Overall Study|Withdrawal by Subject|0|||
148994327|NCT01954017|537455491|FG001|Overall Study|Withdrawal by Subject|1|||
148994328|NCT01954017|537455492|FG002|Overall Study|Withdrawal by Subject|0|||
148994329|NCT01954017|537455490|FG000|Overall Study|Protocol Violation|0|||
148994330|NCT01954017|537455491|FG001|Overall Study|Protocol Violation|3|||
148994331|NCT01954017|537455492|FG002|Overall Study|Protocol Violation|2|||
148994332|NCT01954017|537455490|FG000|Overall Study|Necrotizing enterocolitis|1|||
148994333|NCT01954017|537455491|FG001|Overall Study|Necrotizing enterocolitis|0|||
148994334|NCT01954017|537455492|FG002|Overall Study|Necrotizing enterocolitis|1|||
148994335|NCT01954017|537455490|FG000|Overall Study|Enteral intake stopped >7 days|0|||
148994336|NCT01954017|537455491|FG001|Overall Study|Enteral intake stopped >7 days|1|||
148994337|NCT01954017|537455492|FG002|Overall Study|Enteral intake stopped >7 days|1|||
148994338|NCT01954017|537455490|FG000|Overall Study|All other reasons|2|||
148994339|NCT01954017|537455491|FG001|Overall Study|All other reasons|2|||
148994340|NCT01954017|537455492|FG002|Overall Study|All other reasons|7|||
148994341|NCT04598152|537455493|FG000|Overall Study|Lost to Follow-up|0|||
148994342|NCT04598152|537455494|FG001|Overall Study|Lost to Follow-up|1|||
148994343|NCT03346759|537455495|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
148994344|NCT03346759|537455496|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
148994345|NCT03346759|537455495|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
148994346|NCT03346759|537455496|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
148994347|NCT03346759|537455495|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
148994348|NCT03346759|537455496|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
148994349|NCT03674177|537455497|FG000|Overall Study|Lost to Follow-up|2|||
148994350|NCT03674177|537455498|FG001|Overall Study|Lost to Follow-up|1|||
148994351|NCT03674177|537455499|FG002|Overall Study|Lost to Follow-up|0|||
148994352|NCT03674177|537455500|FG003|Overall Study|Lost to Follow-up|2|||
148994353|NCT02625623|537455501|FG000|Overall Study|Participants randomized but not treated|9|||
148994354|NCT02625623|537455502|FG001|Overall Study|Participants randomized but not treated|1|||
148994355|NCT00744653|537455503|FG000|Overall Study|antineoplastic treatment|11|||
148994356|NCT00744653|537455503|FG000|Overall Study|Death|1|||
148994357|NCT00744653|537455503|FG000|Overall Study|Lost to Follow-up|1|||
148863812|NCT01133405|536979068|FG009|Period 1|Received drug only in period 3|0|||
148863813|NCT01133405|536979059|FG000|Period 2|Adverse Event|0|||
148863814|NCT01133405|536979060|FG001|Period 2|Adverse Event|0|||
148863815|NCT01133405|536979061|FG002|Period 2|Adverse Event|1|||
148863816|NCT01133405|536979062|FG003|Period 2|Adverse Event|0|||
148863817|NCT01133405|536979063|FG004|Period 2|Adverse Event|0|||
148863818|NCT01133405|536979064|FG005|Period 2|Adverse Event|0|||
148863819|NCT01133405|536979065|FG006|Period 2|Adverse Event|0|||
148863820|NCT01133405|536979066|FG007|Period 2|Adverse Event|0|||
148863821|NCT01133405|536979067|FG008|Period 2|Adverse Event|0|||
148863822|NCT01133405|536979068|FG009|Period 2|Adverse Event|0|||
148863823|NCT01133405|536979059|FG000|Period 2|Withdrawal by Subject|0|||
148863824|NCT01133405|536979060|FG001|Period 2|Withdrawal by Subject|0|||
148863825|NCT01133405|536979061|FG002|Period 2|Withdrawal by Subject|0|||
148863826|NCT01133405|536979062|FG003|Period 2|Withdrawal by Subject|1|||
148863827|NCT01133405|536979063|FG004|Period 2|Withdrawal by Subject|0|||
148863828|NCT01133405|536979064|FG005|Period 2|Withdrawal by Subject|1|||
148863829|NCT01133405|536979065|FG006|Period 2|Withdrawal by Subject|0|||
148863830|NCT01133405|536979066|FG007|Period 2|Withdrawal by Subject|0|||
148863831|NCT01133405|536979067|FG008|Period 2|Withdrawal by Subject|0|||
148863832|NCT01133405|536979068|FG009|Period 2|Withdrawal by Subject|0|||
148863833|NCT01133405|536979059|FG000|Period 2|Entry Criteria Not Met|0|||
148863834|NCT01133405|536979060|FG001|Period 2|Entry Criteria Not Met|1|||
148863835|NCT01133405|536979061|FG002|Period 2|Entry Criteria Not Met|0|||
148863836|NCT01133405|536979062|FG003|Period 2|Entry Criteria Not Met|0|||
148863837|NCT01133405|536979063|FG004|Period 2|Entry Criteria Not Met|0|||
148863838|NCT01133405|536979064|FG005|Period 2|Entry Criteria Not Met|0|||
148863839|NCT01133405|536979065|FG006|Period 2|Entry Criteria Not Met|0|||
148863840|NCT01133405|536979066|FG007|Period 2|Entry Criteria Not Met|0|||
148863841|NCT01133405|536979067|FG008|Period 2|Entry Criteria Not Met|0|||
148863842|NCT01133405|536979068|FG009|Period 2|Entry Criteria Not Met|0|||
148863843|NCT01133405|536979059|FG000|Period 2|Physician Decision|0|||
148863844|NCT01133405|536979060|FG001|Period 2|Physician Decision|0|||
148863845|NCT01133405|536979061|FG002|Period 2|Physician Decision|0|||
148863846|NCT01133405|536979062|FG003|Period 2|Physician Decision|0|||
148863847|NCT01133405|536979063|FG004|Period 2|Physician Decision|0|||
148863848|NCT01133405|536979064|FG005|Period 2|Physician Decision|1|||
148863849|NCT01133405|536979065|FG006|Period 2|Physician Decision|0|||
148863850|NCT01133405|536979066|FG007|Period 2|Physician Decision|0|||
148863851|NCT01133405|536979067|FG008|Period 2|Physician Decision|0|||
148863852|NCT01133405|536979068|FG009|Period 2|Physician Decision|0|||
148863853|NCT01238835|536979077|FG000|Overall Study|Death|124|||
148863854|NCT01238835|536979077|FG000|Overall Study|Withdrawal by Subject|9|||
148863855|NCT01238835|536979077|FG000|Overall Study|Lost to Follow-up|1|||
148863856|NCT01238835|536979077|FG000|Overall Study|Site early discontinuation|2|||
148863857|NCT00907803|536979079|FG000|Overall Study|Withdrawal of consent - long commute|1|||
148863858|NCT00907803|536979080|FG001|Overall Study|Withdrawal of consent - long commute|0|||
148863859|NCT00907803|536979081|FG002|Overall Study|Withdrawal of consent - long commute|0|||
148863860|NCT00907803|536979079|FG000|Overall Study|Adverse Event|2|||
148863861|NCT00907803|536979080|FG001|Overall Study|Adverse Event|0|||
148863862|NCT00907803|536979081|FG002|Overall Study|Adverse Event|0|||
148863863|NCT00907803|536979079|FG000|Overall Study|Withdrawal by Subject|0|||
148863864|NCT00907803|536979080|FG001|Overall Study|Withdrawal by Subject|1|||
148863865|NCT00907803|536979081|FG002|Overall Study|Withdrawal by Subject|0|||
148863866|NCT00907803|536979079|FG000|Overall Study|Lost to Follow-up|0|||
148863867|NCT00907803|536979080|FG001|Overall Study|Lost to Follow-up|1|||
148863868|NCT00907803|536979081|FG002|Overall Study|Lost to Follow-up|0|||
148863869|NCT00907803|536979079|FG000|Overall Study|Protocol Violation|0|||
148863870|NCT00907803|536979080|FG001|Overall Study|Protocol Violation|1|||
148863871|NCT00907803|536979081|FG002|Overall Study|Protocol Violation|0|||
148863872|NCT04612842|536979082|FG000|Overall Study|Lost to Follow-up|20|||
148863873|NCT04612842|536979083|FG001|Overall Study|Lost to Follow-up|11|||
148863874|NCT04612842|536979082|FG000|Overall Study|Withdrawal by Subject|26|||
148863875|NCT04612842|536979083|FG001|Overall Study|Withdrawal by Subject|15|||
148863876|NCT04612842|536979082|FG000|Overall Study|Death|2|||
148863877|NCT04612842|536979083|FG001|Overall Study|Death|2|||
148863878|NCT05426031|536979084|FG000|Overall Study|Circulatory Arrest|3|||
148863879|NCT05426031|536979085|FG001|Overall Study|Circulatory Arrest|2|||
148863880|NCT03060512|536979086|FG000|Overall Study|Adverse Event|4|||
148863881|NCT03060512|536979087|FG001|Overall Study|Adverse Event|6|||
148863882|NCT03060512|536979086|FG000|Overall Study|Lost to Follow-up|1|||
148863883|NCT03060512|536979087|FG001|Overall Study|Lost to Follow-up|1|||
148863884|NCT03060512|536979086|FG000|Overall Study|Withdrawal by Subject|1|||
148863885|NCT03060512|536979087|FG001|Overall Study|Withdrawal by Subject|0|||
148863886|NCT03060512|536979086|FG000|Overall Study|Non-compliance with study medication|1|||
148863887|NCT03060512|536979087|FG001|Overall Study|Non-compliance with study medication|2|||
148863888|NCT00089986|536979088|FG000|Overall Study|Adverse Event|6|||
148863889|NCT00089986|536979089|FG001|Overall Study|Adverse Event|9|||
148863890|NCT00089986|536979090|FG002|Overall Study|Adverse Event|6|||
148863891|NCT00089986|536979088|FG000|Overall Study|Lost to Follow-up|3|||
148994358|NCT00744653|537455503|FG000|Overall Study|Physician Decision|3|||
148994359|NCT03826667|537455504|FG000|Overall Study|Protocol deviation|21|||
148994360|NCT01453595|537455509|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
148994361|NCT01453595|537455510|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
148994362|NCT01453595|537455511|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
148994363|NCT03077724|537455516|FG000|Overall Study|Lost to Follow-up|5|||
148994364|NCT03077724|537455517|FG001|Overall Study|Lost to Follow-up|1|||
148994365|NCT03077724|537455516|FG000|Overall Study|Withdrawal by Subject|3|||
148994366|NCT03077724|537455517|FG001|Overall Study|Withdrawal by Subject|1|||
148994367|NCT02269670|537455518|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
148994368|NCT02313428|537455519|FG000|Overall Study|Lost to Follow-up|1|||
148994369|NCT02313428|537455520|FG001|Overall Study|Lost to Follow-up|1|||
148994370|NCT05374421|537455521|FG000|Overall Study|Withdrawal by Subject|3|||
148994371|NCT05374421|537455522|FG001|Overall Study|Withdrawal by Subject|4|||
148994372|NCT04370054|537455525|FG000|Treatment Phase|Lost to Follow-up|1|||
148994373|NCT04370054|537455525|FG000|Treatment Phase|Withdrawal by Subject|1|||
148994374|NCT04370054|537455525|FG000|Follow-Up Phase|Ongoing|75|||
148994375|NCT01962493|537455527|FG000|Overall Study|Adverse Event|1|||
148994376|NCT01962493|537455528|FG001|Overall Study|Adverse Event|2|||
148994377|NCT01962493|537455527|FG000|Overall Study|Protocol Violation|0|||
148994378|NCT01962493|537455528|FG001|Overall Study|Protocol Violation|1|||
148994379|NCT01962493|537455527|FG000|Overall Study|Withdrawal by Subject|4|||
148994380|NCT01962493|537455528|FG001|Overall Study|Withdrawal by Subject|2|||
148994381|NCT00003508|537457324|FG000|Overall Study|Not evaluable|5|||
148994382|NCT00593567|537457325|FG000|Overall Study|Adverse Event|2|||
148994383|NCT00593567|537457326|FG001|Overall Study|Adverse Event|0|||
148994384|NCT00593567|537457325|FG000|Overall Study|Physician Decision|2|||
148994385|NCT00593567|537457326|FG001|Overall Study|Physician Decision|0|||
148994386|NCT00593567|537457325|FG000|Overall Study|Protocol Violation|13|||
148994387|NCT00593567|537457326|FG001|Overall Study|Protocol Violation|7|||
148994388|NCT00593567|537457325|FG000|Overall Study|Lack of Efficacy|2|||
148994389|NCT00593567|537457326|FG001|Overall Study|Lack of Efficacy|1|||
148994390|NCT00593567|537457325|FG000|Overall Study|Withdrawal by Subject|1|||
148994391|NCT00593567|537457326|FG001|Overall Study|Withdrawal by Subject|2|||
148994392|NCT00785291|537457327|FG000|Overall Study|Never began treatment|8|||
148994393|NCT00785291|537457328|FG001|Overall Study|Never began treatment|4|||
148994394|NCT00785291|537457329|FG002|Overall Study|Never began treatment|4|||
148994395|NCT00785291|537457327|FG000|Overall Study|Adverse Event|39|||
148994396|NCT00785291|537457328|FG001|Overall Study|Adverse Event|70|||
148994397|NCT00785291|537457329|FG002|Overall Study|Adverse Event|56|||
148994398|NCT00785291|537457327|FG000|Overall Study|Death|7|||
148994399|NCT00785291|537457328|FG001|Overall Study|Death|4|||
148863892|NCT00089986|536979089|FG001|Overall Study|Lost to Follow-up|1|||
148863893|NCT00089986|536979090|FG002|Overall Study|Lost to Follow-up|1|||
148863894|NCT00089986|536979088|FG000|Overall Study|Protocol Violation|0|||
148863895|NCT00089986|536979089|FG001|Overall Study|Protocol Violation|1|||
148863896|NCT00089986|536979090|FG002|Overall Study|Protocol Violation|0|||
148863897|NCT00089986|536979088|FG000|Overall Study|Patient transferred to another hospital|2|||
148863898|NCT00089986|536979089|FG001|Overall Study|Patient transferred to another hospital|1|||
148863899|NCT00089986|536979090|FG002|Overall Study|Patient transferred to another hospital|0|||
148863900|NCT00089986|536979088|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
148863901|NCT00089986|536979089|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
148863902|NCT00089986|536979090|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
148863903|NCT00089986|536979088|FG000|Overall Study|Hemohlobin stopping rule|0|||
148863904|NCT00089986|536979089|FG001|Overall Study|Hemohlobin stopping rule|1|||
148863905|NCT00089986|536979090|FG002|Overall Study|Hemohlobin stopping rule|0|||
148863906|NCT00089986|536979088|FG000|Overall Study|Investigator decision to withdrew|0|||
148863907|NCT00089986|536979089|FG001|Overall Study|Investigator decision to withdrew|1|||
148863908|NCT00089986|536979090|FG002|Overall Study|Investigator decision to withdrew|0|||
148863909|NCT00089986|536979088|FG000|Overall Study|Enrollment in another study|0|||
148863910|NCT00089986|536979089|FG001|Overall Study|Enrollment in another study|1|||
148863911|NCT00089986|536979090|FG002|Overall Study|Enrollment in another study|0|||
148863912|NCT00089986|536979088|FG000|Overall Study|Family decision|0|||
148863913|NCT00089986|536979089|FG001|Overall Study|Family decision|1|||
148863914|NCT00089986|536979090|FG002|Overall Study|Family decision|0|||
148863915|NCT00089986|536979088|FG000|Overall Study|Do not resuscitate (DNR)|0|||
148994400|NCT00785291|537457329|FG002|Overall Study|Death|3|||
148994401|NCT00785291|537457327|FG000|Overall Study|Withdrawal by Subject|35|||
148994402|NCT00785291|537457328|FG001|Overall Study|Withdrawal by Subject|36|||
148994403|NCT00785291|537457329|FG002|Overall Study|Withdrawal by Subject|17|||
148994404|NCT00785291|537457327|FG000|Overall Study|Alternative Therapy|12|||
148994405|NCT00785291|537457328|FG001|Overall Study|Alternative Therapy|6|||
148994406|NCT00785291|537457329|FG002|Overall Study|Alternative Therapy|7|||
148994407|NCT00785291|537457327|FG000|Overall Study|Complicating illness|6|||
148994408|NCT00785291|537457328|FG001|Overall Study|Complicating illness|4|||
148994409|NCT00785291|537457329|FG002|Overall Study|Complicating illness|4|||
148994410|NCT00785291|537457327|FG000|Overall Study|Other Medical Reasons|29|||
148994411|NCT00785291|537457328|FG001|Overall Study|Other Medical Reasons|25|||
148994412|NCT00785291|537457329|FG002|Overall Study|Other Medical Reasons|15|||
148994413|NCT02057874|537457331|FG000|Overall Study|participant did not return for scan|1|||
148994414|NCT01738984|537457334|FG000|Overall Study|Pregnancy|4|||
148994415|NCT01738984|537457335|FG001|Overall Study|Pregnancy|0|||
148994416|NCT01738984|537457334|FG000|Overall Study|Withdrawal by Subject|1|||
148994417|NCT01738984|537457335|FG001|Overall Study|Withdrawal by Subject|0|||
148994418|NCT01738984|537457334|FG000|Overall Study|Lost to Follow-up|59|||
148994419|NCT01738984|537457335|FG001|Overall Study|Lost to Follow-up|39|||
148994420|NCT03912259|537457338|FG000|Overall Study|Adverse Event (AE)|2|||
148994421|NCT03912259|537457339|FG001|Overall Study|Adverse Event (AE)|4|||
148994422|NCT03912259|537457338|FG000|Overall Study|Lack of Efficacy|4|||
148994423|NCT03912259|537457339|FG001|Overall Study|Lack of Efficacy|1|||
148994424|NCT03912259|537457338|FG000|Overall Study|Withdrawal by Subject|11|||
148994425|NCT03912259|537457339|FG001|Overall Study|Withdrawal by Subject|1|||
148994426|NCT00360308|537457340|FG000|Overall Study|Adverse Event|15|||
148994427|NCT00360308|537457341|FG001|Overall Study|Adverse Event|14|||
148994428|NCT00360308|537457342|FG002|Overall Study|Adverse Event|25|||
148994429|NCT00360308|537457340|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
148994430|NCT00360308|537457341|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
148994431|NCT00360308|537457342|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
148994432|NCT00360308|537457340|FG000|Overall Study|Protocol Violation|2|||
148994433|NCT00360308|537457341|FG001|Overall Study|Protocol Violation|1|||
148994434|NCT00360308|537457342|FG002|Overall Study|Protocol Violation|2|||
148994435|NCT00360308|537457340|FG000|Overall Study|Withdrawal by Subject|11|||
148994436|NCT00360308|537457341|FG001|Overall Study|Withdrawal by Subject|7|||
148994437|NCT00360308|537457342|FG002|Overall Study|Withdrawal by Subject|14|||
148994438|NCT00360308|537457340|FG000|Overall Study|Lack of Efficacy|3|||
148994439|NCT00360308|537457341|FG001|Overall Study|Lack of Efficacy|0|||
148994440|NCT00360308|537457342|FG002|Overall Study|Lack of Efficacy|2|||
148994441|NCT00360308|537457340|FG000|Overall Study|Other|2|||
148994442|NCT00360308|537457341|FG001|Overall Study|Other|1|||
148994443|NCT00360308|537457342|FG002|Overall Study|Other|1|||
148994444|NCT00360308|537457340|FG000|Overall Study|Study termination by sponsor|43|||
148994445|NCT00360308|537457341|FG001|Overall Study|Study termination by sponsor|55|||
148994446|NCT00360308|537457342|FG002|Overall Study|Study termination by sponsor|44|||
148994447|NCT04786444|537457343|FG000|Overall Study|Withdrawal by Subject|4|||
148994448|NCT04786444|537457344|FG001|Overall Study|Withdrawal by Subject|7|||
148994449|NCT04786444|537457345|FG002|Overall Study|Withdrawal by Subject|2|||
148994450|NCT04786444|537457343|FG000|Overall Study|Lost to Follow-up|11|||
148994451|NCT04786444|537457344|FG001|Overall Study|Lost to Follow-up|9|||
148994452|NCT04786444|537457345|FG002|Overall Study|Lost to Follow-up|10|||
148994453|NCT04786444|537457343|FG000|Overall Study|Subject would like to become pregnant|0|||
148994454|NCT04786444|537457344|FG001|Overall Study|Subject would like to become pregnant|1|||
148863916|NCT00089986|536979089|FG001|Overall Study|Do not resuscitate (DNR)|0|||
148863917|NCT00089986|536979090|FG002|Overall Study|Do not resuscitate (DNR)|1|||
148863918|NCT00089986|536979088|FG000|Overall Study|Withdrawal by Subject|3|||
148863919|NCT00089986|536979089|FG001|Overall Study|Withdrawal by Subject|6|||
148863920|NCT00089986|536979090|FG002|Overall Study|Withdrawal by Subject|2|||
148863921|NCT03946124|536979091|FG000|Overall Study|Withdrawal by Subject|19|||
148863922|NCT00241631|536979092|FG000|Run in (2 Weeks)|Physician Decision|3|||
148863923|NCT00241631|536979093|FG001|Run in (2 Weeks)|Physician Decision|3|||
148863924|NCT00241631|536979092|FG000|Phase 1 (4 Weeks)|sore throat|1|||
148863925|NCT00241631|536979093|FG001|Phase 1 (4 Weeks)|sore throat|0|||
148863926|NCT00241631|536979092|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
148863927|NCT00241631|536979093|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
148994455|NCT04786444|537457345|FG002|Overall Study|Subject would like to become pregnant|0|||
148994456|NCT01925950|537457346|FG000|Part 2|Withdrawal by Subject|1|||
148994457|NCT01925950|537457347|FG001|Part 2|Withdrawal by Subject|0|||
148994458|NCT01433354|537457354|FG000|Overall Study|Adverse Event|6|||
148994459|NCT01433354|537457354|FG000|Overall Study|Lost to Follow-up|1|||
148994460|NCT01433354|537457354|FG000|Overall Study|Administrative problems|90|||
148863928|NCT00241631|536979092|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
148994461|NCT01433354|537457354|FG000|Overall Study|Protocol Violation|2|||
148994462|NCT01433354|537457354|FG000|Overall Study|Lack of Efficacy|17|||
148994463|NCT01433354|537457354|FG000|Overall Study|Subject Withdrew Consent|3|||
148994464|NCT02015676|537457363|FG000|Overall Study|Adverse Event|2|||
148863929|NCT00241631|536979093|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
148863930|NCT00241631|536979092|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
148994465|NCT02015676|537457364|FG001|Overall Study|Adverse Event|18|||
148994466|NCT02015676|537457365|FG002|Overall Study|Adverse Event|0|||
148994467|NCT02015676|537457363|FG000|Overall Study|Lack of Efficacy|2|||
148994468|NCT02015676|537457364|FG001|Overall Study|Lack of Efficacy|4|||
148994469|NCT02015676|537457365|FG002|Overall Study|Lack of Efficacy|0|||
148994470|NCT02015676|537457363|FG000|Overall Study|Protocol Violation|1|||
148994471|NCT02015676|537457364|FG001|Overall Study|Protocol Violation|0|||
148994472|NCT02015676|537457365|FG002|Overall Study|Protocol Violation|0|||
148994473|NCT02015676|537457363|FG000|Overall Study|Withdrawal by Subject|1|||
148863931|NCT00241631|536979093|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
148863932|NCT00413920|536979097|FG000|Overall Study|Adverse Event|9|||
148863933|NCT00413920|536979098|FG001|Overall Study|Adverse Event|11|||
148863934|NCT00413920|536979097|FG000|Overall Study|Lack of Efficacy|11|||
148863935|NCT00413920|536979098|FG001|Overall Study|Lack of Efficacy|9|||
148863936|NCT00413920|536979097|FG000|Overall Study|Death|3|||
148863937|NCT00413920|536979098|FG001|Overall Study|Death|5|||
148863938|NCT00413920|536979097|FG000|Overall Study|Graft Loss|5|||
148863939|NCT00413920|536979098|FG001|Overall Study|Graft Loss|3|||
148863940|NCT03831880|536979099|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
148863941|NCT03831880|536979100|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
148863942|NCT03831880|536979099|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
148863943|NCT03831880|536979100|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
148863944|NCT02788201|536979101|FG000|Overall Study|Death|1|||
148863945|NCT02788201|536979102|FG001|Overall Study|Death|1|||
148863946|NCT02788201|536979103|FG002|Overall Study|Death|1|||
148863947|NCT02788201|536979104|FG003|Overall Study|Death|1|||
148863948|NCT02788201|536979105|FG004|Overall Study|Death|0|||
148863949|NCT02788201|536979106|FG005|Overall Study|Death|1|||
148863950|NCT02788201|536979101|FG000|Overall Study|Ineligible|0|||
148863951|NCT02788201|536979102|FG001|Overall Study|Ineligible|0|||
148863952|NCT02788201|536979103|FG002|Overall Study|Ineligible|0|||
148863953|NCT02788201|536979104|FG003|Overall Study|Ineligible|0|||
148863954|NCT02788201|536979105|FG004|Overall Study|Ineligible|0|||
148863955|NCT02788201|536979106|FG005|Overall Study|Ineligible|1|||
148863956|NCT02788201|536979101|FG000|Overall Study|Withdrawal by Subject|0|||
148863957|NCT02788201|536979102|FG001|Overall Study|Withdrawal by Subject|0|||
148863958|NCT02788201|536979103|FG002|Overall Study|Withdrawal by Subject|0|||
148863959|NCT02788201|536979104|FG003|Overall Study|Withdrawal by Subject|0|||
148863960|NCT02788201|536979105|FG004|Overall Study|Withdrawal by Subject|0|||
148863961|NCT02788201|536979106|FG005|Overall Study|Withdrawal by Subject|1|||
148863962|NCT01457950|536979109|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
148863963|NCT01457950|536979110|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
148863964|NCT01457950|536979111|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
148863965|NCT01457950|536979112|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
148863966|NCT01457950|536979109|FG000|Double-Blind Phase|Protocol Violation|2|||
148863967|NCT01457950|536979110|FG001|Double-Blind Phase|Protocol Violation|1|||
148863968|NCT01457950|536979111|FG002|Double-Blind Phase|Protocol Violation|0|||
148863969|NCT01457950|536979112|FG003|Double-Blind Phase|Protocol Violation|0|||
148863970|NCT01457950|536979109|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
148863971|NCT01457950|536979110|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
148863972|NCT01457950|536979111|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
148863973|NCT01457950|536979112|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
148863974|NCT01457950|536979109|FG000|Open-Label Phase|Adverse Event|0|||
148863975|NCT01457950|536979110|FG001|Open-Label Phase|Adverse Event|0|||
148863976|NCT01457950|536979111|FG002|Open-Label Phase|Adverse Event|0|||
148863977|NCT01457950|536979112|FG003|Open-Label Phase|Adverse Event|1|||
148863978|NCT01457950|536979109|FG000|Open-Label Phase|Protocol Violation|0|||
148863979|NCT01457950|536979110|FG001|Open-Label Phase|Protocol Violation|0|||
148863980|NCT01457950|536979111|FG002|Open-Label Phase|Protocol Violation|0|||
148863981|NCT01457950|536979112|FG003|Open-Label Phase|Protocol Violation|1|||
148863982|NCT01457950|536979109|FG000|Open-Label Phase|Withdrawal by Subject|0|||
148863983|NCT01457950|536979110|FG001|Open-Label Phase|Withdrawal by Subject|0|||
148863984|NCT01457950|536979111|FG002|Open-Label Phase|Withdrawal by Subject|2|||
148863985|NCT01457950|536979112|FG003|Open-Label Phase|Withdrawal by Subject|0|||
148863986|NCT01765426|536979113|FG000|Overall Study|Lost to Follow-up|0|||
148863987|NCT01765426|536979114|FG001|Overall Study|Lost to Follow-up|1|||
148863988|NCT01765426|536979115|FG002|Overall Study|Lost to Follow-up|0|||
148863989|NCT01765426|536979116|FG003|Overall Study|Lost to Follow-up|0|||
148863990|NCT01166373|536979117|FG000|Overall Study|Lost to Follow-up|3|||
148863991|NCT01166373|536979118|FG001|Overall Study|Lost to Follow-up|2|||
148863992|NCT01166373|536979119|FG002|Overall Study|Lost to Follow-up|2|||
148863993|NCT01166373|536979120|FG003|Overall Study|Lost to Follow-up|2|||
148863994|NCT01166373|536979117|FG000|Overall Study|Withdrawal by Subject|1|||
148863995|NCT01166373|536979118|FG001|Overall Study|Withdrawal by Subject|2|||
148863996|NCT01166373|536979119|FG002|Overall Study|Withdrawal by Subject|2|||
148863997|NCT01166373|536979120|FG003|Overall Study|Withdrawal by Subject|3|||
148863998|NCT01166373|536979117|FG000|Overall Study|Physician Decision|1|||
148863999|NCT01166373|536979118|FG001|Overall Study|Physician Decision|0|||
148864000|NCT01166373|536979119|FG002|Overall Study|Physician Decision|0|||
148864001|NCT01166373|536979120|FG003|Overall Study|Physician Decision|0|||
148864002|NCT01510184|536979121|FG000|Overall Study|Sponsor discretion|28|||
148994474|NCT02015676|537457364|FG001|Overall Study|Withdrawal by Subject|7|||
148864003|NCT01510184|536979122|FG001|Overall Study|Sponsor discretion|28|||
148864004|NCT01510184|536979121|FG000|Overall Study|Death|1|||
148864005|NCT01510184|536979122|FG001|Overall Study|Death|2|||
148864006|NCT01510184|536979121|FG000|Overall Study|Withdrawal by Subject|1|||
148864007|NCT01510184|536979122|FG001|Overall Study|Withdrawal by Subject|4|||
148864008|NCT01510184|536979121|FG000|Overall Study|Other|0|||
148994475|NCT02015676|537457365|FG002|Overall Study|Withdrawal by Subject|1|||
148994476|NCT02015676|537457363|FG000|Overall Study|Administrative reasons|0|||
148994477|NCT02015676|537457364|FG001|Overall Study|Administrative reasons|3|||
148994478|NCT02015676|537457365|FG002|Overall Study|Administrative reasons|1|||
148994479|NCT02015676|537457363|FG000|Overall Study|Death|0|||
148994480|NCT02015676|537457364|FG001|Overall Study|Death|1|||
148994481|NCT02015676|537457365|FG002|Overall Study|Death|0|||
148994482|NCT02015676|537457363|FG000|Overall Study|Disease progression|3|||
148994483|NCT02015676|537457364|FG001|Overall Study|Disease progression|1|||
148994484|NCT02015676|537457365|FG002|Overall Study|Disease progression|1|||
148994485|NCT04794803|537457366|FG000|Overall Study|Death|1|||
148994486|NCT04794803|537457367|FG001|Overall Study|Death|3|||
148994487|NCT04794803|537457366|FG000|Overall Study|Lost to Follow-up|2|||
148994488|NCT04794803|537457367|FG001|Overall Study|Lost to Follow-up|2|||
148994489|NCT04794803|537457366|FG000|Overall Study|Withdrawal by Subject|1|||
148994490|NCT04794803|537457367|FG001|Overall Study|Withdrawal by Subject|0|||
148994491|NCT04794803|537457366|FG000|Overall Study|Physician Decision|1|||
148994492|NCT04794803|537457367|FG001|Overall Study|Physician Decision|1|||
148994493|NCT04794803|537457366|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
148994494|NCT04794803|537457367|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
148994495|NCT04794803|537457366|FG000|Overall Study|Refused to continue the treatment|1|||
148994496|NCT04794803|537457367|FG001|Overall Study|Refused to continue the treatment|0|||
148994497|NCT04794803|537457366|FG000|Overall Study|Patient admitted to ICU|0|||
148994498|NCT04794803|537457367|FG001|Overall Study|Patient admitted to ICU|1|||
148994499|NCT01618162|537457369|FG000|Overall Study|Protocol Violation|13|||
148994500|NCT01618162|537457370|FG001|Overall Study|Protocol Violation|10|||
148994501|NCT01618162|537457369|FG000|Overall Study|Adverse Event|9|||
148994502|NCT01618162|537457370|FG001|Overall Study|Adverse Event|2|||
148994503|NCT01618162|537457369|FG000|Overall Study|Withdrawal Criteria|2|||
148994504|NCT01618162|537457370|FG001|Overall Study|Withdrawal Criteria|10|||
148994505|NCT01618162|537457369|FG000|Overall Study|Unclassified|14|||
148994506|NCT01618162|537457370|FG001|Overall Study|Unclassified|13|||
148994507|NCT00476476|537457371|FG000|Overall Study|Adverse Event|2|||
148994508|NCT00476476|537457372|FG001|Overall Study|Adverse Event|7|||
148994509|NCT00476476|537457371|FG000|Overall Study|Progressive Disease|0|||
148994510|NCT00476476|537457372|FG001|Overall Study|Progressive Disease|17|||
148994511|NCT00971048|537457380|FG000|Overall Study|Protocol Violation|1|||
148994512|NCT00971048|537457381|FG001|Overall Study|Protocol Violation|2|||
148994513|NCT00971048|537457382|FG002|Overall Study|Protocol Violation|0|||
148994514|NCT00971048|537457383|FG003|Overall Study|Protocol Violation|1|||
148994515|NCT00971048|537457380|FG000|Overall Study|Adverse Event|0|||
148994516|NCT00971048|537457381|FG001|Overall Study|Adverse Event|0|||
148994517|NCT00971048|537457382|FG002|Overall Study|Adverse Event|1|||
148994518|NCT00971048|537457383|FG003|Overall Study|Adverse Event|0|||
148994519|NCT00971048|537457380|FG000|Overall Study|Physician Decision|0|||
148994520|NCT00971048|537457381|FG001|Overall Study|Physician Decision|0|||
148994521|NCT00971048|537457382|FG002|Overall Study|Physician Decision|0|||
148994522|NCT00971048|537457383|FG003|Overall Study|Physician Decision|1|||
148994523|NCT03321396|537457384|FG000|Overall Study|Physician Decision|1|||
148994524|NCT01654549|537457389|FG000|Overall Study|H.pylori eradication not successful|0|||
148994525|NCT01654549|537457390|FG001|Overall Study|H.pylori eradication not successful|1|||
148994526|NCT00937924|537457391|FG000|Overall Study|Lost to Follow-up|44|||
148994527|NCT00937924|537457392|FG001|Overall Study|Lost to Follow-up|44|||
148994528|NCT00937924|537457393|FG002|Overall Study|Lost to Follow-up|41|||
148994529|NCT02633137|537457412|FG000|Overall Study|Adverse Event|1|||
148994530|NCT02633137|537457412|FG000|Overall Study|Lack of Efficacy|2|||
148994531|NCT02633137|537457412|FG000|Overall Study|Withdrawal by Subject|1|||
148994532|NCT03152526|537457413|FG000|Overall Study|Withdrawal by Subject|0|||
148994533|NCT03152526|537457414|FG001|Overall Study|Withdrawal by Subject|1|||
148994534|NCT01270347|537457418|FG000|Core Phase|Adverse Event|1|||
148994535|NCT01270347|537457419|FG001|Core Phase|Adverse Event|6|||
148994536|NCT01270347|537457418|FG000|Core Phase|Withdrawal by Subject|1|||
148994537|NCT01270347|537457419|FG001|Core Phase|Withdrawal by Subject|2|||
148994538|NCT01270347|537457418|FG000|Core Phase|Lost to Follow-up|0|||
148994539|NCT01270347|537457419|FG001|Core Phase|Lost to Follow-up|1|||
148994540|NCT01270347|537457418|FG000|Core Phase|Miscellaneous|8|||
148994541|NCT01270347|537457419|FG001|Core Phase|Miscellaneous|14|||
148994542|NCT01270347|537457418|FG000|Extension Phase|Adverse Event|1|||
148994543|NCT01270347|537457419|FG001|Extension Phase|Adverse Event|3|||
148994544|NCT01270347|537457418|FG000|Extension Phase|Withdrawal by Subject|3|||
148994545|NCT01270347|537457419|FG001|Extension Phase|Withdrawal by Subject|4|||
148994546|NCT01270347|537457418|FG000|Extension Phase|Miscellaneous|2|||
148994547|NCT01270347|537457419|FG001|Extension Phase|Miscellaneous|2|||
148994548|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
148994549|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
148994550|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
148994551|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
148994552|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
148994553|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
148994554|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
148994555|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
148994556|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
148994557|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
148994558|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
148994559|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
148994560|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
148994561|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
148994562|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
148994563|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
148994564|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
148994565|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
148994566|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
148994567|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
148994568|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
148994569|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
148994570|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
148994571|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
148994572|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
148994573|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
148994574|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
148994575|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
148994576|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
148994577|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
148994578|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
148994579|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
148994580|NCT04818346|537457420|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
148994581|NCT04818346|537457421|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
148994582|NCT04818346|537457422|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
148994583|NCT04818346|537457423|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
148994584|NCT04818346|537457420|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
148994585|NCT04818346|537457421|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
148994586|NCT04818346|537457422|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
148994587|NCT04818346|537457423|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
148994588|NCT04818346|537457420|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
148994589|NCT04818346|537457421|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
148994590|NCT04818346|537457422|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
148994591|NCT04818346|537457423|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
148994592|NCT04818346|537457420|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
148994593|NCT04818346|537457421|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
148994594|NCT04818346|537457422|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
148994595|NCT04818346|537457423|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
148994596|NCT04818346|537457420|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
148994597|NCT04818346|537457421|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
148994598|NCT04818346|537457422|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
148994599|NCT04818346|537457423|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
148994600|NCT04818346|537457420|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
148994601|NCT04818346|537457421|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
148994602|NCT04818346|537457422|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
148994603|NCT04818346|537457423|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
148994604|NCT04818346|537457420|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
148994605|NCT04818346|537457421|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
148994606|NCT04818346|537457422|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
148994607|NCT04818346|537457423|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
148994608|NCT05553808|537457424|FG000|Overall Study|Death|25|||
148994609|NCT05553808|537457425|FG001|Overall Study|Death|62|||
148994610|NCT05553808|537457424|FG000|Overall Study|Site Closed|6|||
148994611|NCT05553808|537457425|FG001|Overall Study|Site Closed|6|||
148994612|NCT05553808|537457424|FG000|Overall Study|Lost to Follow-up|1|||
148994613|NCT05553808|537457425|FG001|Overall Study|Lost to Follow-up|0|||
149030915|NCT01956669|537591611|FG005|Overall Study|Adverse Event|0|||
148864009|NCT01510184|536979122|FG001|Overall Study|Other|1|||
148864010|NCT02310230|536979123|FG000|Overall Study|Physician Decision|1|||
148864011|NCT02310230|536979124|FG001|Overall Study|Physician Decision|3|||
148864012|NCT02310230|536979123|FG000|Overall Study|monitor baseline taken after induction|2|||
148864013|NCT02310230|536979124|FG001|Overall Study|monitor baseline taken after induction|7|||
148864014|NCT02310230|536979123|FG000|Overall Study|Poor signal quality|5|||
148864015|NCT02310230|536979124|FG001|Overall Study|Poor signal quality|8|||
148864016|NCT02310230|536979123|FG000|Overall Study|Case cancelled|1|||
148864017|NCT02310230|536979124|FG001|Overall Study|Case cancelled|0|||
148864018|NCT03593681|536979125|FG000|Overall Study|Inadequate sample collected|12|||
148864019|NCT03593681|536979125|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
148864020|NCT03593681|536979125|FG000|Overall Study|Protocol Violation|3|||
148864021|NCT03593681|536979125|FG000|Overall Study|Withdrawal by Subject|3|||
148864022|NCT03593681|536979125|FG000|Overall Study|Procedure not attempted|3|||
148864023|NCT03593681|536979125|FG000|Overall Study|Adverse Event|2|||
148864024|NCT03593681|536979125|FG000|Overall Study|Physician Decision|1|||
148864025|NCT02078102|536979126|FG000|Overall Study|Adverse Event|1|||
148864026|NCT02078102|536979127|FG001|Overall Study|Adverse Event|0|||
148864027|NCT02078102|536979126|FG000|Overall Study|Withdrawal by Subject|1|||
148864028|NCT02078102|536979127|FG001|Overall Study|Withdrawal by Subject|0|||
148864029|NCT02078102|536979126|FG000|Overall Study|Physician Decision|0|||
148864030|NCT02078102|536979127|FG001|Overall Study|Physician Decision|1|||
148864031|NCT00541099|536979129|FG000|Overall Study|Ineligible|3|||
148864032|NCT00066469|536979131|FG000|Overall Study|Death|3|||
148864033|NCT00066469|536979131|FG000|Overall Study|Lack of Efficacy|9|||
148864034|NCT00066469|536979131|FG000|Overall Study|Lost to Follow-up|1|||
148864035|NCT00066469|536979131|FG000|Overall Study|Physician Decision|1|||
148864036|NCT00066469|536979131|FG000|Overall Study|Withdrawal by Subject|1|||
148864037|NCT00066469|536979131|FG000|Overall Study|ineligible|1|||
148864038|NCT00711802|536979132|FG000|Overall Study|Not treated (no further detail)|2|||
148864039|NCT00711802|536979133|FG001|Overall Study|Not treated (no further detail)|1|||
148864040|NCT00711802|536979134|FG002|Overall Study|Not treated (no further detail)|2|||
148864041|NCT00711802|536979135|FG003|Overall Study|Not treated (no further detail)|0|||
148864042|NCT00711802|536979136|FG004|Overall Study|Not treated (no further detail)|2|||
148864043|NCT00711802|536979137|FG005|Overall Study|Not treated (no further detail)|0|||
148864044|NCT00711802|536979138|FG006|Overall Study|Not treated (no further detail)|0|||
148864045|NCT00711802|536979139|FG007|Overall Study|Not treated (no further detail)|0|||
148864046|NCT00711802|536979132|FG000|Overall Study|Adverse Event|0|||
148864047|NCT00711802|536979133|FG001|Overall Study|Adverse Event|0|||
148864048|NCT00711802|536979134|FG002|Overall Study|Adverse Event|0|||
148864049|NCT00711802|536979135|FG003|Overall Study|Adverse Event|0|||
148864050|NCT00711802|536979136|FG004|Overall Study|Adverse Event|1|||
148864051|NCT00711802|536979137|FG005|Overall Study|Adverse Event|1|||
148864052|NCT00711802|536979138|FG006|Overall Study|Adverse Event|0|||
148864053|NCT00711802|536979139|FG007|Overall Study|Adverse Event|0|||
148864054|NCT00711802|536979132|FG000|Overall Study|Microbiological failure|0|||
148864055|NCT00711802|536979133|FG001|Overall Study|Microbiological failure|1|||
148864056|NCT00711802|536979134|FG002|Overall Study|Microbiological failure|0|||
148864057|NCT00711802|536979135|FG003|Overall Study|Microbiological failure|0|||
148864058|NCT00711802|536979136|FG004|Overall Study|Microbiological failure|0|||
148864059|NCT00711802|536979137|FG005|Overall Study|Microbiological failure|1|||
148864060|NCT00711802|536979138|FG006|Overall Study|Microbiological failure|0|||
148864061|NCT00711802|536979139|FG007|Overall Study|Microbiological failure|0|||
148864062|NCT00711802|536979132|FG000|Overall Study|Protocol Violation|0|||
148864063|NCT00711802|536979133|FG001|Overall Study|Protocol Violation|0|||
148864064|NCT00711802|536979134|FG002|Overall Study|Protocol Violation|0|||
148864065|NCT00711802|536979135|FG003|Overall Study|Protocol Violation|1|||
148864066|NCT00711802|536979136|FG004|Overall Study|Protocol Violation|0|||
148864067|NCT00711802|536979137|FG005|Overall Study|Protocol Violation|0|||
148864068|NCT00711802|536979138|FG006|Overall Study|Protocol Violation|0|||
148864069|NCT00711802|536979139|FG007|Overall Study|Protocol Violation|0|||
148864070|NCT00711802|536979132|FG000|Overall Study|Physician Decision|0|||
148864071|NCT00711802|536979133|FG001|Overall Study|Physician Decision|2|||
148864072|NCT00711802|536979134|FG002|Overall Study|Physician Decision|0|||
148864073|NCT00711802|536979135|FG003|Overall Study|Physician Decision|0|||
148864074|NCT00711802|536979136|FG004|Overall Study|Physician Decision|0|||
148864075|NCT00711802|536979137|FG005|Overall Study|Physician Decision|0|||
148864076|NCT00711802|536979138|FG006|Overall Study|Physician Decision|0|||
148864077|NCT00711802|536979139|FG007|Overall Study|Physician Decision|0|||
149030916|NCT01956669|537591612|FG006|Overall Study|Adverse Event|0|||
148864078|NCT00711802|536979132|FG000|Overall Study|Withdrawal by Subject|0|||
148864079|NCT00711802|536979133|FG001|Overall Study|Withdrawal by Subject|1|||
148864080|NCT00711802|536979134|FG002|Overall Study|Withdrawal by Subject|0|||
148864081|NCT00711802|536979135|FG003|Overall Study|Withdrawal by Subject|1|||
148864082|NCT00711802|536979136|FG004|Overall Study|Withdrawal by Subject|0|||
148864083|NCT00711802|536979137|FG005|Overall Study|Withdrawal by Subject|0|||
148864084|NCT00711802|536979138|FG006|Overall Study|Withdrawal by Subject|0|||
148864085|NCT00711802|536979139|FG007|Overall Study|Withdrawal by Subject|0|||
148994614|NCT05553808|537457424|FG000|Overall Study|Withdrawal by Subject|3|||
148994615|NCT05553808|537457425|FG001|Overall Study|Withdrawal by Subject|2|||
148994616|NCT02273141|537457426|FG000|Overall Study|Adverse Event|0|||
148994617|NCT02273141|537457427|FG001|Overall Study|Adverse Event|1|||
148994618|NCT02273141|537457426|FG000|Overall Study|Lost to Follow-up|1|||
148994619|NCT02273141|537457427|FG001|Overall Study|Lost to Follow-up|3|||
148994620|NCT02273141|537457426|FG000|Overall Study|Withdrawal by Subject|10|||
148994621|NCT02273141|537457427|FG001|Overall Study|Withdrawal by Subject|15|||
148994622|NCT02273141|537457426|FG000|Overall Study|Various|6|||
148994623|NCT02273141|537457427|FG001|Overall Study|Various|6|||
148994624|NCT00492284|537457428|FG000|Overall Study|Adverse Event|0|||
148994625|NCT00492284|537457429|FG001|Overall Study|Adverse Event|1|||
148994626|NCT00492284|537457430|FG002|Overall Study|Adverse Event|1|||
148994627|NCT00492284|537457431|FG003|Overall Study|Adverse Event|2|||
148994628|NCT00492284|537457428|FG000|Overall Study|Lost to Follow-up|0|||
148994629|NCT00492284|537457429|FG001|Overall Study|Lost to Follow-up|0|||
148994630|NCT00492284|537457430|FG002|Overall Study|Lost to Follow-up|3|||
148994631|NCT00492284|537457431|FG003|Overall Study|Lost to Follow-up|1|||
148994632|NCT00492284|537457428|FG000|Overall Study|Death|0|||
148994633|NCT00492284|537457429|FG001|Overall Study|Death|3|||
148994634|NCT00492284|537457430|FG002|Overall Study|Death|2|||
148994635|NCT00492284|537457431|FG003|Overall Study|Death|5|||
148994636|NCT00492284|537457428|FG000|Overall Study|Withdrawal by Subject|1|||
148994637|NCT00492284|537457429|FG001|Overall Study|Withdrawal by Subject|0|||
148994638|NCT00492284|537457430|FG002|Overall Study|Withdrawal by Subject|0|||
148994639|NCT00492284|537457431|FG003|Overall Study|Withdrawal by Subject|2|||
148994640|NCT02734212|537457432|FG000|Overall Study|Lost to Follow-up|5|||
148994641|NCT02734212|537457433|FG001|Overall Study|Lost to Follow-up|10|||
148994642|NCT04313881|537457434|FG000|Overall Study|Death|138|||
148994643|NCT04313881|537457435|FG001|Overall Study|Death|126|||
148994644|NCT04313881|537457434|FG000|Overall Study|Study terminated by sponsor|108|||
148994645|NCT04313881|537457435|FG001|Overall Study|Study terminated by sponsor|129|||
148994646|NCT04313881|537457434|FG000|Overall Study|Consent withdrawn|19|||
148994647|NCT04313881|537457435|FG001|Overall Study|Consent withdrawn|15|||
148994648|NCT04313881|537457434|FG000|Overall Study|Reason not Specified|3|||
148994649|NCT04313881|537457435|FG001|Overall Study|Reason not Specified|1|||
148994650|NCT00727272|537457436|FG000|Washout Period A|Adverse Event|0|||
148994651|NCT00727272|537457437|FG001|Washout Period A|Adverse Event|0|||
148994652|NCT00727272|537457438|FG002|Washout Period A|Adverse Event|1|||
148994653|NCT00727272|537457436|FG000|Washout Period B|Withdrawal by Subject|0|||
148994654|NCT00727272|537457437|FG001|Washout Period B|Withdrawal by Subject|0|||
148994655|NCT00727272|537457438|FG002|Washout Period B|Withdrawal by Subject|1|||
148994656|NCT00651664|537457439|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
148994657|NCT00651664|537457440|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
148994658|NCT00651664|537457441|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
148994659|NCT00651664|537457442|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
148994660|NCT00651664|537457443|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
148994661|NCT00651664|537457444|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
148994662|NCT00651664|537457445|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
148994663|NCT00651664|537457446|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
148994664|NCT00651664|537457447|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
148994665|NCT00651664|537457448|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
148994666|NCT00651664|537457439|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
148994667|NCT00651664|537457440|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
148994668|NCT00651664|537457441|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
148994669|NCT00651664|537457442|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
148994670|NCT00651664|537457443|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
148994671|NCT00651664|537457444|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
148994672|NCT00651664|537457445|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
148994673|NCT00651664|537457446|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
148994674|NCT00651664|537457447|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
148994675|NCT00651664|537457448|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
148994676|NCT00651664|537457439|FG000|Overall Study|Progressive Disease|3|||
148994677|NCT00651664|537457440|FG001|Overall Study|Progressive Disease|3|||
148994678|NCT00651664|537457441|FG002|Overall Study|Progressive Disease|3|||
148994679|NCT00651664|537457442|FG003|Overall Study|Progressive Disease|12|||
148994680|NCT00651664|537457443|FG004|Overall Study|Progressive Disease|4|||
148994681|NCT00651664|537457444|FG005|Overall Study|Progressive Disease|1|||
148994682|NCT00651664|537457445|FG006|Overall Study|Progressive Disease|3|||
148994683|NCT00651664|537457446|FG007|Overall Study|Progressive Disease|6|||
148994684|NCT00651664|537457447|FG008|Overall Study|Progressive Disease|5|||
148994685|NCT00651664|537457448|FG009|Overall Study|Progressive Disease|5|||
148994686|NCT00651664|537457439|FG000|Overall Study|Patient Declined Further Treatment|0|||
148994687|NCT00651664|537457440|FG001|Overall Study|Patient Declined Further Treatment|0|||
148994688|NCT00651664|537457441|FG002|Overall Study|Patient Declined Further Treatment|0|||
148994689|NCT00651664|537457442|FG003|Overall Study|Patient Declined Further Treatment|1|||
148994690|NCT00651664|537457443|FG004|Overall Study|Patient Declined Further Treatment|1|||
148994691|NCT00651664|537457444|FG005|Overall Study|Patient Declined Further Treatment|1|||
148994692|NCT00651664|537457445|FG006|Overall Study|Patient Declined Further Treatment|0|||
148994693|NCT00651664|537457446|FG007|Overall Study|Patient Declined Further Treatment|0|||
148994694|NCT00651664|537457447|FG008|Overall Study|Patient Declined Further Treatment|0|||
148994695|NCT00651664|537457448|FG009|Overall Study|Patient Declined Further Treatment|1|||
148994696|NCT00651664|537457439|FG000|Overall Study|Symptomatic Deterioration|0|||
148994697|NCT00651664|537457440|FG001|Overall Study|Symptomatic Deterioration|0|||
148994698|NCT00651664|537457441|FG002|Overall Study|Symptomatic Deterioration|0|||
148994699|NCT00651664|537457442|FG003|Overall Study|Symptomatic Deterioration|1|||
148994700|NCT00651664|537457443|FG004|Overall Study|Symptomatic Deterioration|0|||
148994701|NCT00651664|537457444|FG005|Overall Study|Symptomatic Deterioration|0|||
148994702|NCT00651664|537457445|FG006|Overall Study|Symptomatic Deterioration|1|||
148994703|NCT00651664|537457446|FG007|Overall Study|Symptomatic Deterioration|0|||
148994704|NCT00651664|537457447|FG008|Overall Study|Symptomatic Deterioration|1|||
148994705|NCT00651664|537457448|FG009|Overall Study|Symptomatic Deterioration|0|||
148994706|NCT00651664|537457439|FG000|Overall Study|Reason not Specified|0|||
148994707|NCT00651664|537457440|FG001|Overall Study|Reason not Specified|0|||
148994708|NCT00651664|537457441|FG002|Overall Study|Reason not Specified|0|||
148994709|NCT00651664|537457442|FG003|Overall Study|Reason not Specified|0|||
148994710|NCT00651664|537457443|FG004|Overall Study|Reason not Specified|0|||
148994711|NCT00651664|537457444|FG005|Overall Study|Reason not Specified|0|||
148994712|NCT00651664|537457445|FG006|Overall Study|Reason not Specified|1|||
148994713|NCT00651664|537457446|FG007|Overall Study|Reason not Specified|0|||
148994714|NCT00651664|537457447|FG008|Overall Study|Reason not Specified|0|||
148994715|NCT00651664|537457448|FG009|Overall Study|Reason not Specified|0|||
148994716|NCT00688636|537457449|FG000|Overall Study|Adverse Event|2|||
148994717|NCT00688636|537457450|FG001|Overall Study|Adverse Event|1|||
148994718|NCT01572727|537457451|FG000|Overall Study|Adverse Event|43|||
148994719|NCT01572727|537457452|FG001|Overall Study|Adverse Event|15|||
148994720|NCT01572727|537457451|FG000|Overall Study|Lost to Follow-up|1|||
148994721|NCT01572727|537457452|FG001|Overall Study|Lost to Follow-up|1|||
148994722|NCT01572727|537457451|FG000|Overall Study|Physician Decision|23|||
148994723|NCT01572727|537457452|FG001|Overall Study|Physician Decision|9|||
148994724|NCT01572727|537457451|FG000|Overall Study|Progressive disease|59|||
148994725|NCT01572727|537457452|FG001|Overall Study|Progressive disease|82|||
148994726|NCT01572727|537457451|FG000|Overall Study|Protocol Violation|0|||
148994727|NCT01572727|537457452|FG001|Overall Study|Protocol Violation|1|||
148994728|NCT01572727|537457451|FG000|Overall Study|Study terminated by sponsor|61|||
148994729|NCT01572727|537457452|FG001|Overall Study|Study terminated by sponsor|83|||
148994730|NCT01572727|537457451|FG000|Overall Study|Parent/guardian decision|14|||
148994731|NCT01572727|537457452|FG001|Overall Study|Parent/guardian decision|9|||
148994732|NCT01572727|537457451|FG000|Overall Study|Death|2|||
148994733|NCT01572727|537457452|FG001|Overall Study|Death|2|||
148994734|NCT01572727|537457451|FG000|Overall Study|Untreated|4|||
148994735|NCT01572727|537457452|FG001|Overall Study|Untreated|7|||
148994736|NCT04053764|537457453|FG000|Overall Study|Withdrawal by Subject|6|||
148994737|NCT04053764|537457454|FG001|Overall Study|Withdrawal by Subject|2|||
149030917|NCT01956669|537591606|FG000|Overall Study|Physician Decision|0|||
148864086|NCT00711802|536979132|FG000|Overall Study|Lost to Follow-up|0|||
148864087|NCT00711802|536979133|FG001|Overall Study|Lost to Follow-up|0|||
148864088|NCT00711802|536979134|FG002|Overall Study|Lost to Follow-up|3|||
148864089|NCT00711802|536979135|FG003|Overall Study|Lost to Follow-up|1|||
148864090|NCT00711802|536979136|FG004|Overall Study|Lost to Follow-up|10|||
148864091|NCT00711802|536979137|FG005|Overall Study|Lost to Follow-up|6|||
148864092|NCT00711802|536979138|FG006|Overall Study|Lost to Follow-up|4|||
148864093|NCT00711802|536979139|FG007|Overall Study|Lost to Follow-up|2|||
148864094|NCT00711802|536979132|FG000|Overall Study|Reason not reported|0|||
148864095|NCT00711802|536979133|FG001|Overall Study|Reason not reported|1|||
148864096|NCT00711802|536979134|FG002|Overall Study|Reason not reported|1|||
148864097|NCT00711802|536979135|FG003|Overall Study|Reason not reported|0|||
148864098|NCT00711802|536979136|FG004|Overall Study|Reason not reported|1|||
148864099|NCT00711802|536979137|FG005|Overall Study|Reason not reported|0|||
148864100|NCT00711802|536979138|FG006|Overall Study|Reason not reported|1|||
148864101|NCT00711802|536979139|FG007|Overall Study|Reason not reported|0|||
148864102|NCT02084238|536979144|FG000|Overall Study|Lost to Follow-up|2|||
148864103|NCT01154283|536979145|FG000|0-6 Weeks|Withdrawal by Subject|7|||
148994738|NCT04053764|537457453|FG000|Overall Study|Physician Decision|2|||
148994739|NCT04053764|537457454|FG001|Overall Study|Physician Decision|1|||
148994740|NCT04053764|537457453|FG000|Overall Study|Adverse Event|1|||
148994741|NCT04053764|537457454|FG001|Overall Study|Adverse Event|0|||
148864104|NCT01154283|536979146|FG001|0-6 Weeks|Withdrawal by Subject|2|||
148994742|NCT04053764|537457453|FG000|Overall Study|Pregnancy|1|||
148994743|NCT04053764|537457454|FG001|Overall Study|Pregnancy|0|||
148994744|NCT04732286|537457455|FG000|Overall Study|Progressive Disease|2|||
148994745|NCT04732286|537457455|FG000|Overall Study|Physician Decision|1|||
148994746|NCT04732286|537457455|FG000|Overall Study|Study Terminated by Sponsor|31|||
148994747|NCT04732286|537457455|FG000|Overall Study|Withdrawal by Subject|10|||
148994748|NCT04732286|537457455|FG000|Overall Study|Non-compliance With Study Drug|1|||
148864105|NCT01154283|536979145|FG000|0-6 Weeks|Death|0|||
148864106|NCT01154283|536979146|FG001|0-6 Weeks|Death|1|||
148994749|NCT04732286|537457455|FG000|Overall Study|Lost to Follow-up|4|||
148994750|NCT04732286|537457455|FG000|Overall Study|Death|51|||
148994751|NCT01474681|537457456|FG000|Overall Study|Death|0|||
148994752|NCT01474681|537457457|FG001|Overall Study|Death|3|||
148994753|NCT01474681|537457458|FG002|Overall Study|Death|2|||
148994754|NCT01474681|537457459|FG003|Overall Study|Death|6|||
148994755|NCT02195986|537457462|FG000|Overall Study|Adverse Event|3|||
148994756|NCT02195986|537457463|FG001|Overall Study|Adverse Event|0|||
148994757|NCT02195986|537457464|FG002|Overall Study|Adverse Event|0|||
148994758|NCT02195986|537457462|FG000|Overall Study|Withdrawal by Subject|0|||
148994759|NCT02195986|537457463|FG001|Overall Study|Withdrawal by Subject|3|||
148994760|NCT02195986|537457464|FG002|Overall Study|Withdrawal by Subject|0|||
148994761|NCT02195986|537457462|FG000|Overall Study|Family Emergency|0|||
148994762|NCT02195986|537457463|FG001|Overall Study|Family Emergency|0|||
148994763|NCT02195986|537457464|FG002|Overall Study|Family Emergency|1|||
148994764|NCT02195986|537457462|FG000|Overall Study|Protocol Violation|0|||
148994765|NCT02195986|537457463|FG001|Overall Study|Protocol Violation|1|||
148994766|NCT02195986|537457464|FG002|Overall Study|Protocol Violation|1|||
148994767|NCT02195986|537457462|FG000|Overall Study|Non-compliance|0|||
148994768|NCT02195986|537457463|FG001|Overall Study|Non-compliance|1|||
148994769|NCT02195986|537457464|FG002|Overall Study|Non-compliance|0|||
148994770|NCT02834780|537457467|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
148994771|NCT02834780|537457468|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
148994772|NCT02834780|537457469|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
148994773|NCT02834780|537457470|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
148994774|NCT02834780|537457471|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
148994775|NCT02834780|537457472|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
148994776|NCT02834780|537457473|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
148994777|NCT02834780|537457474|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
148994778|NCT02834780|537457475|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
148994779|NCT02834780|537457476|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
148994780|NCT02834780|537457477|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
148994781|NCT02834780|537457478|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
148994782|NCT02834780|537457479|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
148994783|NCT02834780|537457467|FG000|Overall Study|Withdrawal by Subject|0|||
148994784|NCT02834780|537457468|FG001|Overall Study|Withdrawal by Subject|0|||
148994785|NCT02834780|537457469|FG002|Overall Study|Withdrawal by Subject|1|||
148994786|NCT02834780|537457470|FG003|Overall Study|Withdrawal by Subject|0|||
148994787|NCT02834780|537457471|FG004|Overall Study|Withdrawal by Subject|0|||
148994788|NCT02834780|537457472|FG005|Overall Study|Withdrawal by Subject|0|||
148994789|NCT02834780|537457473|FG006|Overall Study|Withdrawal by Subject|0|||
148994790|NCT02834780|537457474|FG007|Overall Study|Withdrawal by Subject|0|||
148994791|NCT02834780|537457475|FG008|Overall Study|Withdrawal by Subject|0|||
148994792|NCT02834780|537457476|FG009|Overall Study|Withdrawal by Subject|0|||
148994793|NCT02834780|537457477|FG010|Overall Study|Withdrawal by Subject|1|||
148994794|NCT02834780|537457478|FG011|Overall Study|Withdrawal by Subject|0|||
148994795|NCT02834780|537457479|FG012|Overall Study|Withdrawal by Subject|0|||
148994796|NCT02834780|537457467|FG000|Overall Study|Adverse Event|0|||
148994797|NCT02834780|537457468|FG001|Overall Study|Adverse Event|0|||
148994798|NCT02834780|537457469|FG002|Overall Study|Adverse Event|0|||
148994799|NCT02834780|537457470|FG003|Overall Study|Adverse Event|0|||
148994800|NCT02834780|537457471|FG004|Overall Study|Adverse Event|1|||
148994801|NCT02834780|537457472|FG005|Overall Study|Adverse Event|0|||
148994802|NCT02834780|537457473|FG006|Overall Study|Adverse Event|1|||
148994803|NCT02834780|537457474|FG007|Overall Study|Adverse Event|1|||
148994804|NCT02834780|537457475|FG008|Overall Study|Adverse Event|0|||
148994805|NCT02834780|537457476|FG009|Overall Study|Adverse Event|2|||
148994806|NCT02834780|537457477|FG010|Overall Study|Adverse Event|0|||
148994807|NCT02834780|537457478|FG011|Overall Study|Adverse Event|3|||
148994808|NCT02834780|537457479|FG012|Overall Study|Adverse Event|2|||
148994809|NCT02834780|537457467|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
148864107|NCT01154283|536979145|FG000|7-12 Weeks|Death|1|||
148994810|NCT02834780|537457468|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
148994811|NCT02834780|537457469|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
148994812|NCT02834780|537457470|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
148994813|NCT02834780|537457471|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
148994814|NCT02834780|537457472|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
148994815|NCT02834780|537457473|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
148994816|NCT02834780|537457474|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
148994817|NCT02834780|537457475|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
148994818|NCT02834780|537457476|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
148864108|NCT01154283|536979146|FG001|7-12 Weeks|Death|0|||
148864109|NCT01154283|536979145|FG000|7-12 Weeks|Withdrawal by Subject|0|||
148864110|NCT01154283|536979146|FG001|7-12 Weeks|Withdrawal by Subject|1|||
148864111|NCT00042432|536979147|FG000|Overall Study|Adverse Event|4|||
148864112|NCT00042432|536979148|FG001|Overall Study|Adverse Event|1|||
148864113|NCT00042432|536979147|FG000|Overall Study|Withdrawal by Subject|1|||
148864114|NCT00042432|536979148|FG001|Overall Study|Withdrawal by Subject|3|||
148864115|NCT00042432|536979147|FG000|Overall Study|Death|0|||
148864116|NCT00042432|536979148|FG001|Overall Study|Death|2|||
148864117|NCT00042432|536979147|FG000|Overall Study|Ineligibility determined|1|||
148864118|NCT00042432|536979148|FG001|Overall Study|Ineligibility determined|0|||
148864119|NCT00042432|536979147|FG000|Overall Study|Initiation of maintenance dialysis|1|||
148864120|NCT00042432|536979148|FG001|Overall Study|Initiation of maintenance dialysis|1|||
148864121|NCT00042432|536979147|FG000|Overall Study|Other|2|||
148864122|NCT00042432|536979148|FG001|Overall Study|Other|0|||
148864123|NCT00320372|536979149|FG000|Overall Study|Physician Decision|4|||
148864124|NCT00320372|536979150|FG001|Overall Study|Physician Decision|7|||
148864125|NCT00320372|536979149|FG000|Overall Study|Death|7|||
148864126|NCT00320372|536979150|FG001|Overall Study|Death|8|||
148864127|NCT00320372|536979149|FG000|Overall Study|Withdrawal by Subject|55|||
148864128|NCT00320372|536979150|FG001|Overall Study|Withdrawal by Subject|37|||
148864129|NCT00320372|536979149|FG000|Overall Study|Non-Compliance|40|||
148864130|NCT00320372|536979150|FG001|Overall Study|Non-Compliance|39|||
148864131|NCT00320372|536979149|FG000|Overall Study|Did not Meet (I/E)|3|||
148864132|NCT00320372|536979150|FG001|Overall Study|Did not Meet (I/E)|1|||
148864133|NCT00320372|536979149|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
148864134|NCT00320372|536979150|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
148864135|NCT01853072|536979151|FG000|Overall Study|Adverse event prior to treatment|0|||
148864136|NCT01853072|536979152|FG001|Overall Study|Adverse event prior to treatment|1|||
148864137|NCT01853072|536979151|FG000|Overall Study|Adverse Event|0|||
148864138|NCT01853072|536979152|FG001|Overall Study|Adverse Event|3|||
148864139|NCT01853072|536979151|FG000|Overall Study|Death|1|||
148864140|NCT01853072|536979152|FG001|Overall Study|Death|4|||
148864141|NCT01853072|536979151|FG000|Overall Study|Lost to Follow-up|0|||
148864142|NCT01853072|536979152|FG001|Overall Study|Lost to Follow-up|3|||
148864143|NCT01853072|536979151|FG000|Overall Study|Non-compliance with study drug|0|||
148864144|NCT01853072|536979152|FG001|Overall Study|Non-compliance with study drug|1|||
148864145|NCT01853072|536979151|FG000|Overall Study|Physician Decision|1|||
148864146|NCT01853072|536979152|FG001|Overall Study|Physician Decision|1|||
148864147|NCT01853072|536979151|FG000|Overall Study|Withdrawal by Subject|1|||
148864148|NCT01853072|536979152|FG001|Overall Study|Withdrawal by Subject|2|||
148864149|NCT01853072|536979151|FG000|Overall Study|Reason not specified|9|||
148864150|NCT01853072|536979152|FG001|Overall Study|Reason not specified|6|||
148864151|NCT02761694|536979158|FG000|Overall Study|Lack of Efficacy|0|||
148864152|NCT02761694|536979159|FG001|Overall Study|Lack of Efficacy|0|||
148864153|NCT02761694|536979160|FG002|Overall Study|Lack of Efficacy|0|||
148864154|NCT02761694|536979161|FG003|Overall Study|Lack of Efficacy|0|||
148864155|NCT02761694|536979162|FG004|Overall Study|Lack of Efficacy|0|||
148864156|NCT02761694|536979163|FG005|Overall Study|Lack of Efficacy|0|||
148864157|NCT02761694|536979164|FG006|Overall Study|Lack of Efficacy|6|||
148864158|NCT02761694|536979165|FG007|Overall Study|Lack of Efficacy|0|||
148864159|NCT02761694|536979166|FG008|Overall Study|Lack of Efficacy|0|||
148864160|NCT02761694|536979167|FG009|Overall Study|Lack of Efficacy|1|||
148864161|NCT02761694|536979168|FG010|Overall Study|Lack of Efficacy|1|||
148864162|NCT02761694|536979169|FG011|Overall Study|Lack of Efficacy|4|||
148864163|NCT02761694|536979158|FG000|Overall Study|Death|0|||
148864164|NCT02761694|536979159|FG001|Overall Study|Death|0|||
148864165|NCT02761694|536979160|FG002|Overall Study|Death|0|||
148864166|NCT02761694|536979161|FG003|Overall Study|Death|0|||
148864167|NCT02761694|536979162|FG004|Overall Study|Death|0|||
148864168|NCT02761694|536979163|FG005|Overall Study|Death|0|||
148864169|NCT02761694|536979164|FG006|Overall Study|Death|2|||
148864170|NCT02761694|536979165|FG007|Overall Study|Death|0|||
148864171|NCT02761694|536979166|FG008|Overall Study|Death|2|||
148864172|NCT02761694|536979167|FG009|Overall Study|Death|2|||
148864173|NCT02761694|536979168|FG010|Overall Study|Death|1|||
148864174|NCT02761694|536979169|FG011|Overall Study|Death|0|||
148864175|NCT02761694|536979158|FG000|Overall Study|Physician Decision|0|||
148864176|NCT02761694|536979159|FG001|Overall Study|Physician Decision|0|||
148864177|NCT02761694|536979160|FG002|Overall Study|Physician Decision|0|||
148864178|NCT02761694|536979161|FG003|Overall Study|Physician Decision|0|||
148864179|NCT02761694|536979162|FG004|Overall Study|Physician Decision|0|||
148864180|NCT02761694|536979163|FG005|Overall Study|Physician Decision|0|||
148864181|NCT02761694|536979164|FG006|Overall Study|Physician Decision|1|||
148864182|NCT02761694|536979165|FG007|Overall Study|Physician Decision|0|||
148864183|NCT02761694|536979166|FG008|Overall Study|Physician Decision|0|||
148864184|NCT02761694|536979167|FG009|Overall Study|Physician Decision|0|||
148864185|NCT02761694|536979168|FG010|Overall Study|Physician Decision|0|||
148864186|NCT02761694|536979169|FG011|Overall Study|Physician Decision|0|||
148864187|NCT02761694|536979158|FG000|Overall Study|Withdrawal by Subject|0|||
148864188|NCT02761694|536979159|FG001|Overall Study|Withdrawal by Subject|0|||
148994819|NCT02834780|537457477|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
148994820|NCT02834780|537457478|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
148994821|NCT02834780|537457479|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
148994822|NCT02834780|537457467|FG000|Overall Study|Other|1|||
148994823|NCT02834780|537457468|FG001|Overall Study|Other|0|||
148994824|NCT02834780|537457469|FG002|Overall Study|Other|1|||
148994825|NCT02834780|537457470|FG003|Overall Study|Other|2|||
148994826|NCT02834780|537457471|FG004|Overall Study|Other|0|||
148994827|NCT02834780|537457472|FG005|Overall Study|Other|0|||
148994828|NCT02834780|537457473|FG006|Overall Study|Other|0|||
148994829|NCT02834780|537457474|FG007|Overall Study|Other|0|||
148994830|NCT02834780|537457475|FG008|Overall Study|Other|0|||
148994831|NCT02834780|537457476|FG009|Overall Study|Other|0|||
148994832|NCT02834780|537457477|FG010|Overall Study|Other|0|||
148994833|NCT02834780|537457478|FG011|Overall Study|Other|0|||
148994834|NCT02834780|537457479|FG012|Overall Study|Other|1|||
148994835|NCT03150056|537457480|FG000|Overall Study|Withdrawal by Subject|0|||
148994836|NCT03150056|537457481|FG001|Overall Study|Withdrawal by Subject|0|||
148994837|NCT03150056|537457482|FG002|Overall Study|Withdrawal by Subject|0|||
148994838|NCT03150056|537457483|FG003|Overall Study|Withdrawal by Subject|0|||
148994839|NCT03150056|537457484|FG004|Overall Study|Withdrawal by Subject|0|||
148994840|NCT03150056|537457485|FG005|Overall Study|Withdrawal by Subject|2|||
148994841|NCT03150056|537457480|FG000|Overall Study|Study terminated by Sponsor|1|||
148994842|NCT03150056|537457481|FG001|Overall Study|Study terminated by Sponsor|3|||
148994843|NCT03150056|537457482|FG002|Overall Study|Study terminated by Sponsor|1|||
148994844|NCT03150056|537457483|FG003|Overall Study|Study terminated by Sponsor|1|||
148994845|NCT03150056|537457484|FG004|Overall Study|Study terminated by Sponsor|5|||
148994846|NCT03150056|537457485|FG005|Overall Study|Study terminated by Sponsor|6|||
148994847|NCT03150056|537457480|FG000|Overall Study|Death|9|||
148994848|NCT03150056|537457481|FG001|Overall Study|Death|2|||
148994849|NCT03150056|537457482|FG002|Overall Study|Death|2|||
148994850|NCT03150056|537457483|FG003|Overall Study|Death|7|||
148994851|NCT03150056|537457484|FG004|Overall Study|Death|8|||
148994852|NCT03150056|537457485|FG005|Overall Study|Death|10|||
148994853|NCT02251990|537457495|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
148994854|NCT02251990|537457496|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
148994855|NCT02251990|537457495|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
148994856|NCT02251990|537457496|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
148994857|NCT02251990|537457495|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
148994858|NCT02251990|537457496|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
148994859|NCT02251990|537457495|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
148994860|NCT02251990|537457496|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
148994861|NCT02251990|537457495|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
148994862|NCT02251990|537457496|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
148994863|NCT02251990|537457495|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
148994864|NCT02251990|537457496|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
148994865|NCT03265600|537457497|FG000|Overall Study|Lost to Follow-up|17|||
148994866|NCT03265600|537457498|FG001|Overall Study|Lost to Follow-up|5|||
148994867|NCT03265600|537457497|FG000|Overall Study|Withdrawal by Subject|4|||
148994868|NCT03265600|537457498|FG001|Overall Study|Withdrawal by Subject|2|||
148994869|NCT03265600|537457497|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
148994870|NCT03265600|537457498|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
148994871|NCT02293538|537457499|FG000|Overall Study|Adverse Event|0|||
148994872|NCT02293538|537457500|FG001|Overall Study|Adverse Event|1|||
148864189|NCT02761694|536979160|FG002|Overall Study|Withdrawal by Subject|0|||
148994873|NCT02293538|537457499|FG000|Overall Study|Lost to Follow-up|1|||
148994874|NCT02293538|537457500|FG001|Overall Study|Lost to Follow-up|0|||
148994875|NCT02293538|537457499|FG000|Overall Study|Withdrawal by Subject|0|||
148994876|NCT02293538|537457500|FG001|Overall Study|Withdrawal by Subject|1|||
148994877|NCT00710424|537457503|FG000|Overall Study|Adverse Event|30|||
148994878|NCT00710424|537457504|FG001|Overall Study|Adverse Event|12|||
148994879|NCT00710424|537457503|FG000|Overall Study|Lack of Efficacy|4|||
148864190|NCT02761694|536979161|FG003|Overall Study|Withdrawal by Subject|1|||
148994880|NCT00710424|537457504|FG001|Overall Study|Lack of Efficacy|5|||
148994881|NCT00710424|537457503|FG000|Overall Study|Withdrawal by Subject|5|||
148994882|NCT00710424|537457504|FG001|Overall Study|Withdrawal by Subject|3|||
148994883|NCT00710424|537457503|FG000|Overall Study|Lost to Follow-up|0|||
148994884|NCT00710424|537457504|FG001|Overall Study|Lost to Follow-up|1|||
148994885|NCT00710424|537457503|FG000|Overall Study|Refused medication, no side effects|1|||
148994886|NCT00710424|537457504|FG001|Overall Study|Refused medication, no side effects|0|||
148994887|NCT00710424|537457503|FG000|Overall Study|Non-compliance with stable analgesia|1|||
148994888|NCT00710424|537457504|FG001|Overall Study|Non-compliance with stable analgesia|0|||
148994889|NCT00710424|537457503|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
148994890|NCT00710424|537457504|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
148994891|NCT00710424|537457503|FG000|Overall Study|Subject thought medication changed|1|||
148994892|NCT00710424|537457504|FG001|Overall Study|Subject thought medication changed|0|||
148994893|NCT00710424|537457503|FG000|Overall Study|Ceased treatment due to travel|1|||
148994894|NCT00710424|537457504|FG001|Overall Study|Ceased treatment due to travel|0|||
148994895|NCT00710424|537457503|FG000|Overall Study|Subject preferred paracetamol|0|||
148994896|NCT00710424|537457504|FG001|Overall Study|Subject preferred paracetamol|1|||
148994897|NCT00710424|537457503|FG000|Overall Study|Felt good so stopped treatment|0|||
148994898|NCT00710424|537457504|FG001|Overall Study|Felt good so stopped treatment|1|||
148994899|NCT02160314|537459422|FG000|Overall Study|Adverse Event|0|||
148994900|NCT02160314|537459423|FG001|Overall Study|Adverse Event|6|||
148994901|NCT02160314|537459422|FG000|Overall Study|Protocol Violation|0|||
148994902|NCT02160314|537459423|FG001|Overall Study|Protocol Violation|4|||
148994903|NCT02160314|537459422|FG000|Overall Study|Withdrawal by Subject|1|||
148994904|NCT02160314|537459423|FG001|Overall Study|Withdrawal by Subject|2|||
148994905|NCT02160314|537459422|FG000|Overall Study|Lost to Follow-up|0|||
148994906|NCT02160314|537459423|FG001|Overall Study|Lost to Follow-up|1|||
148994907|NCT00590902|537459429|FG000|Overall Study|Death|1|||
148994908|NCT02119260|537459430|FG000|Overall Study|Adverse Event|1|||
148994909|NCT02119260|537459431|FG001|Overall Study|Adverse Event|0|||
148994910|NCT02119260|537459432|FG002|Overall Study|Adverse Event|0|||
148994911|NCT02119260|537459433|FG003|Overall Study|Adverse Event|0|||
148994912|NCT02119260|537459434|FG004|Overall Study|Adverse Event|0|||
148994913|NCT02119260|537459435|FG005|Overall Study|Adverse Event|0|||
148994914|NCT02119260|537459436|FG006|Overall Study|Adverse Event|0|||
148994915|NCT02119260|537459430|FG000|Overall Study|Withdrew consent|0|||
148994916|NCT02119260|537459431|FG001|Overall Study|Withdrew consent|1|||
148994917|NCT02119260|537459432|FG002|Overall Study|Withdrew consent|1|||
148994918|NCT02119260|537459433|FG003|Overall Study|Withdrew consent|0|||
148994919|NCT02119260|537459434|FG004|Overall Study|Withdrew consent|0|||
148994920|NCT02119260|537459435|FG005|Overall Study|Withdrew consent|0|||
148994921|NCT02119260|537459436|FG006|Overall Study|Withdrew consent|0|||
148994922|NCT01986881|537459437|FG000|Overall Study|Death|228|||
148994923|NCT01986881|537459438|FG001|Overall Study|Death|233|||
148994924|NCT01986881|537459439|FG002|Overall Study|Death|247|||
148994925|NCT01986881|537459437|FG000|Overall Study|Lost to Follow-up|51|||
148994926|NCT01986881|537459438|FG001|Overall Study|Lost to Follow-up|44|||
148994927|NCT01986881|537459439|FG002|Overall Study|Lost to Follow-up|55|||
148994928|NCT01986881|537459437|FG000|Overall Study|Physician Decision|7|||
148994929|NCT01986881|537459438|FG001|Overall Study|Physician Decision|4|||
148994930|NCT01986881|537459439|FG002|Overall Study|Physician Decision|6|||
148994931|NCT01986881|537459437|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
148994932|NCT01986881|537459438|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
148994933|NCT01986881|537459439|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
148994934|NCT01986881|537459437|FG000|Overall Study|Withdrawal by Subject|41|||
148994935|NCT01986881|537459438|FG001|Overall Study|Withdrawal by Subject|60|||
148994936|NCT01986881|537459439|FG002|Overall Study|Withdrawal by Subject|45|||
148994937|NCT01986881|537459437|FG000|Overall Study|Subject Moved|0|||
148994938|NCT01986881|537459438|FG001|Overall Study|Subject Moved|1|||
148994939|NCT01986881|537459439|FG002|Overall Study|Subject Moved|0|||
148994940|NCT01986881|537459437|FG000|Overall Study|Other|1|||
148994941|NCT01986881|537459438|FG001|Overall Study|Other|2|||
148994942|NCT01986881|537459439|FG002|Overall Study|Other|2|||
148994943|NCT00955357|537459440|FG000|Titration Phase|Adverse Event|9|||
148994944|NCT00955357|537459441|FG001|Titration Phase|Adverse Event|46|||
148994945|NCT00955357|537459440|FG000|Titration Phase|Lack of Efficacy|0|||
148994946|NCT00955357|537459441|FG001|Titration Phase|Lack of Efficacy|2|||
148994947|NCT00955357|537459440|FG000|Titration Phase|Protocol Violation|3|||
148994948|NCT00955357|537459441|FG001|Titration Phase|Protocol Violation|7|||
148994949|NCT00955357|537459440|FG000|Titration Phase|Lost to Follow-up|1|||
148994950|NCT00955357|537459441|FG001|Titration Phase|Lost to Follow-up|3|||
148994951|NCT00955357|537459440|FG000|Titration Phase|Withdrawal by Subject|3|||
148994952|NCT00955357|537459441|FG001|Titration Phase|Withdrawal by Subject|5|||
148994953|NCT00955357|537459440|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
148994954|NCT00955357|537459441|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
148994955|NCT00955357|537459440|FG000|Titration Phase|Study medication not tolerated|0|||
148994956|NCT00955357|537459441|FG001|Titration Phase|Study medication not tolerated|1|||
148864191|NCT02761694|536979162|FG004|Overall Study|Withdrawal by Subject|0|||
148864192|NCT02761694|536979163|FG005|Overall Study|Withdrawal by Subject|0|||
148994957|NCT00955357|537459440|FG000|Titration Phase|Non compliance to study procedures|0|||
148994958|NCT00955357|537459441|FG001|Titration Phase|Non compliance to study procedures|1|||
148994959|NCT00955357|537459440|FG000|Maintenance Phase|Adverse Event|3|||
148994960|NCT00955357|537459441|FG001|Maintenance Phase|Adverse Event|23|||
148994961|NCT00955357|537459440|FG000|Maintenance Phase|Lack of Efficacy|0|||
148994962|NCT00955357|537459441|FG001|Maintenance Phase|Lack of Efficacy|4|||
148994963|NCT00955357|537459440|FG000|Maintenance Phase|Protocol Violation|2|||
148994964|NCT00955357|537459441|FG001|Maintenance Phase|Protocol Violation|6|||
148994965|NCT00955357|537459440|FG000|Maintenance Phase|Lost to Follow-up|2|||
148994966|NCT00955357|537459441|FG001|Maintenance Phase|Lost to Follow-up|7|||
148994967|NCT00955357|537459440|FG000|Maintenance Phase|Withdrawal by Subject|4|||
148994968|NCT00955357|537459441|FG001|Maintenance Phase|Withdrawal by Subject|4|||
148994969|NCT00955357|537459440|FG000|Maintenance Phase|Patient moving out of area|0|||
148994970|NCT00955357|537459441|FG001|Maintenance Phase|Patient moving out of area|1|||
148994971|NCT00955357|537459440|FG000|Maintenance Phase|Non compliance to study procedures|1|||
148994972|NCT00955357|537459441|FG001|Maintenance Phase|Non compliance to study procedures|0|||
148994973|NCT01258608|537459442|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
148994974|NCT01258608|537459443|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
148864193|NCT02761694|536979164|FG006|Overall Study|Withdrawal by Subject|4|||
148864194|NCT02761694|536979165|FG007|Overall Study|Withdrawal by Subject|0|||
148864195|NCT02761694|536979166|FG008|Overall Study|Withdrawal by Subject|2|||
148864196|NCT02761694|536979167|FG009|Overall Study|Withdrawal by Subject|1|||
148864197|NCT02761694|536979168|FG010|Overall Study|Withdrawal by Subject|0|||
148864198|NCT02761694|536979169|FG011|Overall Study|Withdrawal by Subject|0|||
148864199|NCT02761694|536979158|FG000|Overall Study|Lost to Follow-up|0|||
148864200|NCT02761694|536979159|FG001|Overall Study|Lost to Follow-up|0|||
148864201|NCT02761694|536979160|FG002|Overall Study|Lost to Follow-up|0|||
148864202|NCT02761694|536979161|FG003|Overall Study|Lost to Follow-up|0|||
148864203|NCT02761694|536979162|FG004|Overall Study|Lost to Follow-up|0|||
148864204|NCT02761694|536979163|FG005|Overall Study|Lost to Follow-up|0|||
148864205|NCT02761694|536979164|FG006|Overall Study|Lost to Follow-up|1|||
148864206|NCT02761694|536979165|FG007|Overall Study|Lost to Follow-up|0|||
148864207|NCT02761694|536979166|FG008|Overall Study|Lost to Follow-up|0|||
148864208|NCT02761694|536979167|FG009|Overall Study|Lost to Follow-up|0|||
148864209|NCT02761694|536979168|FG010|Overall Study|Lost to Follow-up|0|||
148864210|NCT02761694|536979169|FG011|Overall Study|Lost to Follow-up|1|||
148864211|NCT02761694|536979158|FG000|Overall Study|Adverse Event|0|||
148864212|NCT02761694|536979159|FG001|Overall Study|Adverse Event|0|||
148864213|NCT02761694|536979160|FG002|Overall Study|Adverse Event|0|||
148864214|NCT02761694|536979161|FG003|Overall Study|Adverse Event|0|||
148864215|NCT02761694|536979162|FG004|Overall Study|Adverse Event|0|||
148864216|NCT02761694|536979163|FG005|Overall Study|Adverse Event|0|||
148864217|NCT02761694|536979164|FG006|Overall Study|Adverse Event|1|||
148864218|NCT02761694|536979165|FG007|Overall Study|Adverse Event|0|||
148864219|NCT02761694|536979166|FG008|Overall Study|Adverse Event|1|||
148864220|NCT02761694|536979167|FG009|Overall Study|Adverse Event|0|||
148864221|NCT02761694|536979168|FG010|Overall Study|Adverse Event|0|||
148864222|NCT02761694|536979169|FG011|Overall Study|Adverse Event|1|||
148864223|NCT02761694|536979158|FG000|Overall Study|Other|4|||
148864224|NCT02761694|536979159|FG001|Overall Study|Other|4|||
148864225|NCT02761694|536979160|FG002|Overall Study|Other|1|||
148864226|NCT02761694|536979161|FG003|Overall Study|Other|2|||
148864227|NCT02761694|536979162|FG004|Overall Study|Other|3|||
148864228|NCT02761694|536979163|FG005|Overall Study|Other|3|||
148864229|NCT02761694|536979164|FG006|Overall Study|Other|18|||
148864230|NCT02761694|536979165|FG007|Overall Study|Other|8|||
148864231|NCT02761694|536979166|FG008|Overall Study|Other|0|||
148864232|NCT02761694|536979167|FG009|Overall Study|Other|1|||
148864233|NCT02761694|536979168|FG010|Overall Study|Other|1|||
148864234|NCT02761694|536979169|FG011|Overall Study|Other|0|||
148864235|NCT00787930|536979174|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
148864236|NCT02395055|536979175|FG000|Overall Study|Withdrawal by Subject|7|||
148864237|NCT02395055|536979176|FG001|Overall Study|Withdrawal by Subject|3|||
148864238|NCT02513823|536979177|FG000|Overall Study|Lost to Follow-up|4|||
148864239|NCT02513823|536979177|FG000|Overall Study|Physician Decision|1|||
148864240|NCT01294462|536979179|FG000|Overall Study|Lost to Follow-up|1|||
148864241|NCT01294462|536979180|FG001|Overall Study|Lost to Follow-up|0|||
148864242|NCT01294462|536979179|FG000|Overall Study|Withdrawal by Subject|65|||
148864243|NCT01294462|536979180|FG001|Overall Study|Withdrawal by Subject|63|||
148864244|NCT02743780|536979181|FG000|Part 3 (7 Days)|Adverse Event|0|||
148864245|NCT02743780|536979182|FG001|Part 3 (7 Days)|Adverse Event|0|||
148864246|NCT02743780|536979183|FG002|Part 3 (7 Days)|Adverse Event|1|||
148864247|NCT02743780|536979184|FG003|Part 3 (7 Days)|Adverse Event|0|||
148864248|NCT02743780|536979185|FG004|Part 3 (7 Days)|Adverse Event|0|||
148864249|NCT01460407|536979186|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
148864250|NCT01460407|536979187|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
148864251|NCT04070326|536979188|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
148864252|NCT04070326|536979189|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
148864253|NCT02193087|536979194|FG000|Overall Study|Adverse Event|2|||
148864254|NCT02193087|536979195|FG001|Overall Study|Adverse Event|0|||
148864255|NCT02193087|536979196|FG002|Overall Study|Adverse Event|0|||
148864256|NCT02193087|536979197|FG003|Overall Study|Adverse Event|11|||
148994975|NCT01258608|537459442|FG000|Overall Study|Clinical progression|1|||
148994976|NCT01258608|537459443|FG001|Overall Study|Clinical progression|0|||
148864257|NCT02193087|536979194|FG000|Overall Study|Lost to Follow-up|14|||
148864258|NCT02193087|536979195|FG001|Overall Study|Lost to Follow-up|6|||
148864259|NCT02193087|536979196|FG002|Overall Study|Lost to Follow-up|4|||
148864260|NCT02193087|536979197|FG003|Overall Study|Lost to Follow-up|37|||
148864261|NCT02193087|536979194|FG000|Overall Study|Protocol Violation|2|||
148864262|NCT02193087|536979195|FG001|Overall Study|Protocol Violation|0|||
148864263|NCT02193087|536979196|FG002|Overall Study|Protocol Violation|1|||
148994977|NCT01258608|537459442|FG000|Overall Study|Sponsor decision|0|||
148994978|NCT01258608|537459443|FG001|Overall Study|Sponsor decision|1|||
148994979|NCT01258608|537459442|FG000|Overall Study|Physician Decision|6|||
148994980|NCT01258608|537459443|FG001|Overall Study|Physician Decision|1|||
148994981|NCT01258608|537459442|FG000|Overall Study|Lost to Follow-up|0|||
148994982|NCT01258608|537459443|FG001|Overall Study|Lost to Follow-up|1|||
148994983|NCT01258608|537459442|FG000|Overall Study|Lack of compliance|1|||
148994984|NCT01258608|537459443|FG001|Overall Study|Lack of compliance|0|||
148994985|NCT01258608|537459442|FG000|Overall Study|Lack of Efficacy|0|||
148994986|NCT01258608|537459443|FG001|Overall Study|Lack of Efficacy|1|||
148994987|NCT01258608|537459442|FG000|Overall Study|Adverse Event|6|||
148994988|NCT01258608|537459443|FG001|Overall Study|Adverse Event|10|||
148994989|NCT01258608|537459442|FG000|Overall Study|Withdrawal by Subject|6|||
148994990|NCT01258608|537459443|FG001|Overall Study|Withdrawal by Subject|5|||
148994991|NCT04205630|537459444|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
148994992|NCT04205630|537459444|FG000|Overall Study|Disease clinical progression|7|||
148994993|NCT04205630|537459444|FG000|Overall Study|Withdrawal by Subject|2|||
148994994|NCT04205630|537459444|FG000|Overall Study|Adverse Event|17|||
148994995|NCT04205630|537459444|FG000|Overall Study|Other|1|||
148994996|NCT02943408|537459450|FG000|Overall Study|Lost to Follow-up|7|||
148994997|NCT02943408|537459451|FG001|Overall Study|Lost to Follow-up|1|||
148994998|NCT02943408|537459450|FG000|Overall Study|Withdrawal by Subject|0|||
148994999|NCT02943408|537459451|FG001|Overall Study|Withdrawal by Subject|1|||
148995000|NCT01621126|537459454|FG000|Overall Study|Physician Decision|6|||
148995001|NCT00886340|537459455|FG000|Overall Study|Withdrawal by Subject|0|||
148995002|NCT00886340|537459456|FG001|Overall Study|Withdrawal by Subject|7|||
148995003|NCT03224182|537459457|FG000|Overall Study|Study Drug Not Instilled|6|||
148995004|NCT03224182|537459458|FG001|Overall Study|Study Drug Not Instilled|1|||
148995005|NCT03224182|537459457|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
148995006|NCT03224182|537459458|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
148995007|NCT03224182|537459457|FG000|Overall Study|Withdrew of Consent|4|||
148995008|NCT03224182|537459458|FG001|Overall Study|Withdrew of Consent|2|||
148995009|NCT03224182|537459457|FG000|Overall Study|Investigator Decision|3|||
148995010|NCT03224182|537459458|FG001|Overall Study|Investigator Decision|1|||
148995011|NCT03224182|537459457|FG000|Overall Study|Sponsor Decision|26|||
148995012|NCT03224182|537459458|FG001|Overall Study|Sponsor Decision|12|||
148995013|NCT03224182|537459457|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
148995014|NCT03224182|537459458|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
148995015|NCT03224182|537459457|FG000|Overall Study|Lost to Follow-up|1|||
148995016|NCT03224182|537459458|FG001|Overall Study|Lost to Follow-up|0|||
148995017|NCT03224182|537459457|FG000|Overall Study|Participant Had Recurrence|11|||
148995018|NCT03224182|537459458|FG001|Overall Study|Participant Had Recurrence|5|||
148995019|NCT03224182|537459457|FG000|Overall Study|Death|0|||
148995020|NCT03224182|537459458|FG001|Overall Study|Death|1|||
148995021|NCT03224182|537459457|FG000|Overall Study|Reason not Specified|3|||
148995022|NCT03224182|537459458|FG001|Overall Study|Reason not Specified|3|||
148995023|NCT03224182|537459457|FG000|Overall Study|Other|1|||
148995024|NCT03224182|537459458|FG001|Overall Study|Other|0|||
148995025|NCT02481310|537459459|FG000|Follow up|Still in follow up|0|||
148995026|NCT02481310|537459460|FG001|Follow up|Still in follow up|3|||
148995027|NCT02481310|537459461|FG002|Follow up|Still in follow up|0|||
148995028|NCT02925455|537459466|FG000|Overall Study|Withdrawal by Subject|2|||
148995029|NCT02925455|537459467|FG001|Overall Study|Withdrawal by Subject|0|||
148995030|NCT00686166|537459468|FG000|Overall Study|Adverse Event|7|||
148995031|NCT00686166|537459468|FG000|Overall Study|Withdrawal by Subject|1|||
148995032|NCT00686166|537459468|FG000|Overall Study|Progression/Relapse|1|||
148995033|NCT00686166|537459468|FG000|Overall Study|Death|1|||
148995034|NCT00686166|537459468|FG000|Overall Study|Not Protocol Specified|1|||
148995035|NCT00686166|537459468|FG000|Overall Study|Ineligible|5|||
148995036|NCT00686166|537459468|FG000|Overall Study|Did not begin protocol therapy|4|||
148995037|NCT01514448|537459469|FG000|Overall Study|Death|7|||
148995038|NCT01514448|537459470|FG001|Overall Study|Death|8|||
148995039|NCT01514448|537459469|FG000|Overall Study|Withdrawal by Subject|2|||
148995040|NCT01514448|537459470|FG001|Overall Study|Withdrawal by Subject|0|||
148995041|NCT01514448|537459469|FG000|Overall Study|Lost to Follow-up|2|||
148864264|NCT02193087|536979197|FG003|Overall Study|Protocol Violation|2|||
148995042|NCT01514448|537459470|FG001|Overall Study|Lost to Follow-up|0|||
148995043|NCT01514448|537459469|FG000|Overall Study|New Cancer Therapy|1|||
148995044|NCT01514448|537459470|FG001|Overall Study|New Cancer Therapy|0|||
148995045|NCT02314624|537459471|FG000|Overall Study|No participating patient|16|||
148995046|NCT02314624|537459472|FG001|Overall Study|No participating patient|13|||
148995047|NCT02314624|537459471|FG000|Overall Study|Participant withdrew|7|||
148995048|NCT02314624|537459472|FG001|Overall Study|Participant withdrew|2|||
148995049|NCT02314624|537459471|FG000|Overall Study|Lost to Follow-up|2|||
148995050|NCT02314624|537459472|FG001|Overall Study|Lost to Follow-up|5|||
148995051|NCT02314624|537459471|FG000|Overall Study|Dropped/Excluded by PI|6|||
148995052|NCT02314624|537459472|FG001|Overall Study|Dropped/Excluded by PI|6|||
148864265|NCT02193087|536979194|FG000|Overall Study|Withdrawal by Subject|10|||
148864266|NCT02193087|536979195|FG001|Overall Study|Withdrawal by Subject|3|||
148864267|NCT02193087|536979196|FG002|Overall Study|Withdrawal by Subject|1|||
148864268|NCT02193087|536979197|FG003|Overall Study|Withdrawal by Subject|19|||
148864269|NCT02193087|536979194|FG000|Overall Study|Other Reason Not Specified|7|||
148864270|NCT02193087|536979195|FG001|Overall Study|Other Reason Not Specified|2|||
148864271|NCT02193087|536979196|FG002|Overall Study|Other Reason Not Specified|1|||
148864272|NCT02193087|536979197|FG003|Overall Study|Other Reason Not Specified|9|||
148864273|NCT02193087|536979194|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
148864274|NCT02193087|536979195|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
148864275|NCT02193087|536979196|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
148864276|NCT02193087|536979197|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
148864277|NCT02279498|536979198|FG000|Overall Study|Adverse Event|3|||
148864278|NCT02279498|536979199|FG001|Overall Study|Adverse Event|0|||
148864279|NCT02279498|536979198|FG000|Overall Study|Lack of Efficacy|4|||
148864280|NCT02279498|536979199|FG001|Overall Study|Lack of Efficacy|0|||
148864281|NCT02279498|536979198|FG000|Overall Study|Lost to Follow-up|0|||
148864282|NCT02279498|536979199|FG001|Overall Study|Lost to Follow-up|1|||
148864283|NCT02279498|536979198|FG000|Overall Study|Withdrawal by Subject|9|||
148864284|NCT02279498|536979199|FG001|Overall Study|Withdrawal by Subject|2|||
148864285|NCT02279498|536979198|FG000|Overall Study|Undefined|2|||
148864286|NCT02279498|536979199|FG001|Overall Study|Undefined|1|||
148864287|NCT00737711|536979200|FG000|Overall Study|Adverse Event|2|||
148864288|NCT00737711|536979200|FG000|Overall Study|Death|8|||
148864289|NCT00737711|536979200|FG000|Overall Study|Failure to return|4|||
148864290|NCT00737711|536979200|FG000|Overall Study|Protocol Violation|1|||
148864291|NCT00737711|536979200|FG000|Overall Study|Withdrawal by Subject|5|||
148864292|NCT00737711|536979200|FG000|Overall Study|Blood transfusion|6|||
148864293|NCT00737711|536979200|FG000|Overall Study|Other|5|||
148864294|NCT00624780|536979201|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
148864295|NCT00624780|536979202|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
148864296|NCT00624780|536979203|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
148864297|NCT00624780|536979204|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
148864298|NCT00624780|536979205|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
148864299|NCT00624780|536979206|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
148864300|NCT00624780|536979201|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
148864301|NCT00624780|536979202|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
148864302|NCT00624780|536979203|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
148864303|NCT00624780|536979204|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
148864304|NCT00624780|536979205|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
148864305|NCT00624780|536979206|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
148864306|NCT00624780|536979201|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
148864307|NCT00624780|536979202|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
148864308|NCT00624780|536979203|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
148864309|NCT00624780|536979204|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
148864310|NCT00624780|536979205|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
148864311|NCT00624780|536979206|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
148864312|NCT00624780|536979201|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
148864313|NCT00624780|536979202|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
148864314|NCT00624780|536979203|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
148864315|NCT00624780|536979204|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
148864316|NCT00624780|536979205|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
148864317|NCT00624780|536979206|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
148864318|NCT00624780|536979201|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
148864319|NCT00624780|536979202|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
148864320|NCT00624780|536979203|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
148864321|NCT00624780|536979204|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
148864322|NCT00624780|536979205|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
148864323|NCT00624780|536979206|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
148864324|NCT00624780|536979201|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
148864325|NCT00624780|536979202|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
148864326|NCT00624780|536979203|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
148995053|NCT00725452|537459476|FG000|Overall Study|Adverse Event|3|||
148995054|NCT00725452|537459476|FG000|Overall Study|Lack of Efficacy|2|||
148995055|NCT00725452|537459476|FG000|Overall Study|Reason not specified|1|||
148864327|NCT00624780|536979204|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
148864328|NCT00624780|536979205|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
148864329|NCT00624780|536979206|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
148864330|NCT00624780|536979201|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
148864331|NCT00624780|536979202|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
148864332|NCT00624780|536979203|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
148864333|NCT00624780|536979204|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
148995056|NCT00725452|537459476|FG000|Overall Study|Physician Decision|1|||
148995057|NCT00725452|537459476|FG000|Overall Study|Withdrawal by Subject|3|||
148995058|NCT00725452|537459476|FG000|Overall Study|Lost to Follow-up|1|||
148995059|NCT02163733|537459477|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
148995060|NCT02163733|537459478|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
148995061|NCT02163733|537459479|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
148995062|NCT02163733|537459477|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
148995063|NCT02163733|537459478|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
148995064|NCT02163733|537459479|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
148995065|NCT02723864|537459480|FG000|Overall Study|Refused further treatment|1|||
148995066|NCT02723864|537459481|FG001|Overall Study|Refused further treatment|0|||
148995067|NCT02723864|537459482|FG002|Overall Study|Refused further treatment|0|||
148995068|NCT02723864|537459483|FG003|Overall Study|Refused further treatment|0|||
148995069|NCT02723864|537459484|FG004|Overall Study|Refused further treatment|1|||
148995070|NCT02723864|537459485|FG005|Overall Study|Refused further treatment|2|||
148995071|NCT02723864|537459486|FG006|Overall Study|Refused further treatment|0|||
148995072|NCT02723864|537459480|FG000|Overall Study|Exceed treatment hold time|0|||
148995073|NCT02723864|537459481|FG001|Overall Study|Exceed treatment hold time|1|||
148995074|NCT02723864|537459482|FG002|Overall Study|Exceed treatment hold time|0|||
148995075|NCT02723864|537459483|FG003|Overall Study|Exceed treatment hold time|0|||
148995076|NCT02723864|537459484|FG004|Overall Study|Exceed treatment hold time|0|||
148995077|NCT02723864|537459485|FG005|Overall Study|Exceed treatment hold time|0|||
148995078|NCT02723864|537459486|FG006|Overall Study|Exceed treatment hold time|0|||
148995079|NCT02723864|537459480|FG000|Overall Study|Clinical progression|0|||
148995080|NCT02723864|537459481|FG001|Overall Study|Clinical progression|0|||
148995081|NCT02723864|537459482|FG002|Overall Study|Clinical progression|1|||
148995082|NCT02723864|537459483|FG003|Overall Study|Clinical progression|0|||
148995083|NCT02723864|537459484|FG004|Overall Study|Clinical progression|0|||
148995084|NCT02723864|537459485|FG005|Overall Study|Clinical progression|3|||
148995085|NCT02723864|537459486|FG006|Overall Study|Clinical progression|1|||
148995086|NCT02723864|537459480|FG000|Overall Study|Physician Decision|0|||
148995087|NCT02723864|537459481|FG001|Overall Study|Physician Decision|0|||
148995088|NCT02723864|537459482|FG002|Overall Study|Physician Decision|0|||
148995089|NCT02723864|537459483|FG003|Overall Study|Physician Decision|0|||
148995090|NCT02723864|537459484|FG004|Overall Study|Physician Decision|0|||
148995091|NCT02723864|537459485|FG005|Overall Study|Physician Decision|0|||
148995092|NCT02723864|537459486|FG006|Overall Study|Physician Decision|1|||
148995093|NCT02723864|537459480|FG000|Overall Study|Changes in patient condition|0|||
148995094|NCT02723864|537459481|FG001|Overall Study|Changes in patient condition|0|||
148995095|NCT02723864|537459482|FG002|Overall Study|Changes in patient condition|0|||
148995096|NCT02723864|537459483|FG003|Overall Study|Changes in patient condition|0|||
148995097|NCT02723864|537459484|FG004|Overall Study|Changes in patient condition|0|||
148995098|NCT02723864|537459485|FG005|Overall Study|Changes in patient condition|1|||
148995099|NCT02723864|537459486|FG006|Overall Study|Changes in patient condition|0|||
148995100|NCT02723864|537459480|FG000|Overall Study|Patient choice|0|||
148995101|NCT02723864|537459481|FG001|Overall Study|Patient choice|0|||
148995102|NCT02723864|537459482|FG002|Overall Study|Patient choice|0|||
148995103|NCT02723864|537459483|FG003|Overall Study|Patient choice|0|||
148995104|NCT02723864|537459484|FG004|Overall Study|Patient choice|0|||
148995105|NCT02723864|537459485|FG005|Overall Study|Patient choice|1|||
148995106|NCT02723864|537459486|FG006|Overall Study|Patient choice|0|||
148995107|NCT02723864|537459480|FG000|Overall Study|Adverse Event|0|||
148995108|NCT02723864|537459481|FG001|Overall Study|Adverse Event|0|||
148995109|NCT02723864|537459482|FG002|Overall Study|Adverse Event|0|||
148995110|NCT02723864|537459483|FG003|Overall Study|Adverse Event|0|||
148995111|NCT02723864|537459484|FG004|Overall Study|Adverse Event|0|||
148995112|NCT02723864|537459485|FG005|Overall Study|Adverse Event|1|||
148995113|NCT02723864|537459486|FG006|Overall Study|Adverse Event|0|||
148995114|NCT02723864|537459480|FG000|Overall Study|Started new treatment|0|||
148995115|NCT02723864|537459481|FG001|Overall Study|Started new treatment|0|||
148995116|NCT02723864|537459482|FG002|Overall Study|Started new treatment|0|||
148995117|NCT02723864|537459483|FG003|Overall Study|Started new treatment|0|||
148995118|NCT02723864|537459484|FG004|Overall Study|Started new treatment|0|||
148995119|NCT02723864|537459485|FG005|Overall Study|Started new treatment|1|||
148995120|NCT02723864|537459486|FG006|Overall Study|Started new treatment|0|||
148995121|NCT02723864|537459480|FG000|Overall Study|Switched to alternative treatment|0|||
148995122|NCT02723864|537459481|FG001|Overall Study|Switched to alternative treatment|0|||
148995123|NCT02723864|537459482|FG002|Overall Study|Switched to alternative treatment|0|||
148995124|NCT02723864|537459483|FG003|Overall Study|Switched to alternative treatment|0|||
148995125|NCT02723864|537459484|FG004|Overall Study|Switched to alternative treatment|0|||
149030918|NCT01956669|537591607|FG001|Overall Study|Physician Decision|2|||
148995126|NCT02723864|537459485|FG005|Overall Study|Switched to alternative treatment|1|||
148995127|NCT02723864|537459486|FG006|Overall Study|Switched to alternative treatment|0|||
148995128|NCT02723864|537459480|FG000|Overall Study|Late determination of ineligibility|0|||
148995129|NCT02723864|537459481|FG001|Overall Study|Late determination of ineligibility|0|||
148995130|NCT02723864|537459482|FG002|Overall Study|Late determination of ineligibility|0|||
148995131|NCT02723864|537459483|FG003|Overall Study|Late determination of ineligibility|0|||
148995132|NCT02723864|537459484|FG004|Overall Study|Late determination of ineligibility|0|||
148995133|NCT02723864|537459485|FG005|Overall Study|Late determination of ineligibility|1|||
148995134|NCT02723864|537459486|FG006|Overall Study|Late determination of ineligibility|0|||
148995135|NCT00713648|537459489|FG000|Overall Study|Adverse Event|1|||
148995136|NCT00713648|537459489|FG000|Overall Study|Unclassified|2|||
148995137|NCT00713648|537459489|FG000|Overall Study|According to Protocol|2|||
148995138|NCT00713648|537459489|FG000|Overall Study|Development of antibodies|3|||
148995139|NCT00082173|537459490|FG000|Overall Study|Withdrawal by Subject|3|||
148995140|NCT00082173|537459491|FG001|Overall Study|Withdrawal by Subject|5|||
148995141|NCT00082173|537459490|FG000|Overall Study|Lost to Follow-up|1|||
148995142|NCT00082173|537459491|FG001|Overall Study|Lost to Follow-up|0|||
148995143|NCT00082173|537459490|FG000|Overall Study|Adverse Event|1|||
148995144|NCT00082173|537459491|FG001|Overall Study|Adverse Event|0|||
148995145|NCT00082173|537459490|FG000|Overall Study|Culture negative or resistant at baselin|5|||
148995146|NCT00082173|537459491|FG001|Overall Study|Culture negative or resistant at baselin|6|||
148995147|NCT01733732|537459492|FG000|Overall Study|Adverse Event|1|||
148995148|NCT01733732|537459493|FG001|Overall Study|Adverse Event|0|||
148995149|NCT01733732|537459492|FG000|Overall Study|Did not attend all study visits|1|||
148995150|NCT01733732|537459493|FG001|Overall Study|Did not attend all study visits|0|||
148995151|NCT00746590|537459494|FG000|Overall Study|Death|1|||
148995152|NCT00464815|537459497|FG000|Overall Study|Withdrawal by Subject|6|||
148995153|NCT00464815|537459498|FG001|Overall Study|Withdrawal by Subject|3|||
148995154|NCT02633800|537459501|FG000|Overall Study|Death|3|||
148995155|NCT02633800|537459502|FG001|Overall Study|Death|3|||
148995156|NCT02633800|537459501|FG000|Overall Study|Reason not provided|1|||
148995157|NCT02633800|537459502|FG001|Overall Study|Reason not provided|0|||
148995158|NCT02633800|537459501|FG000|Overall Study|Radiologic(al) progression|23|||
148995159|NCT02633800|537459502|FG001|Overall Study|Radiologic(al) progression|23|||
148995160|NCT02633800|537459501|FG000|Overall Study|Clinical progression|3|||
148995161|NCT02633800|537459502|FG001|Overall Study|Clinical progression|6|||
148995162|NCT02633800|537459501|FG000|Overall Study|Study terminated by sponsor|6|||
148995163|NCT02633800|537459502|FG001|Overall Study|Study terminated by sponsor|5|||
148995164|NCT02633800|537459501|FG000|Overall Study|Adverse event, non-fatal|7|||
148995165|NCT02633800|537459502|FG001|Overall Study|Adverse event, non-fatal|2|||
148995166|NCT02633800|537459501|FG000|Overall Study|Withdrawal by Subject|0|||
148995167|NCT02633800|537459502|FG001|Overall Study|Withdrawal by Subject|3|||
148995168|NCT02633800|537459501|FG000|Overall Study|Patient Request|1|||
148995169|NCT02633800|537459502|FG001|Overall Study|Patient Request|1|||
148995170|NCT00254982|537459507|FG000|Overall Study|Other|2|||
148995171|NCT00254982|537459508|FG001|Overall Study|Other|1|||
148995172|NCT00254982|537459507|FG000|Overall Study|Lack of Efficacy|5|||
148995173|NCT00254982|537459508|FG001|Overall Study|Lack of Efficacy|3|||
148995174|NCT00254982|537459507|FG000|Overall Study|Lost to Follow-up|5|||
148995175|NCT00254982|537459508|FG001|Overall Study|Lost to Follow-up|3|||
148995176|NCT00254982|537459507|FG000|Overall Study|Adverse Event|18|||
148995177|NCT00254982|537459508|FG001|Overall Study|Adverse Event|16|||
148995178|NCT00254982|537459507|FG000|Overall Study|Withdrawal by Subject|1|||
148995179|NCT00254982|537459508|FG001|Overall Study|Withdrawal by Subject|1|||
148995180|NCT00254982|537459507|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
148995181|NCT00254982|537459508|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
148995182|NCT00254982|537459507|FG000|Overall Study|Protocol deviation|1|||
148995183|NCT00254982|537459508|FG001|Overall Study|Protocol deviation|1|||
148995184|NCT00254982|537459507|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
148995185|NCT00254982|537459508|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
148995186|NCT00254982|537459507|FG000|Overall Study|Malignancy|0|||
148995187|NCT00254982|537459508|FG001|Overall Study|Malignancy|2|||
148995188|NCT00254982|537459507|FG000|Overall Study|Opportunistic infection|1|||
148995189|NCT00254982|537459508|FG001|Overall Study|Opportunistic infection|0|||
148995190|NCT00254982|537459507|FG000|Overall Study|Abnormal liver function tests|2|||
148995191|NCT00254982|537459508|FG001|Overall Study|Abnormal liver function tests|1|||
148995192|NCT04969198|537459512|FG000|Overall Study|Withdrawal by Subject|20|||
148995193|NCT04969198|537459512|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
148995194|NCT04969198|537459512|FG000|Overall Study|Lost to Follow-up|20|||
148995195|NCT04391023|537459513|FG000|Overall Study|Withdrawal by Subject|2|||
148995196|NCT04391023|537459514|FG001|Overall Study|Withdrawal by Subject|2|||
148995197|NCT04009291|537459515|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
148995198|NCT04009291|537459516|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
148995199|NCT04009291|537459517|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
148995200|NCT04009291|537459518|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
148995201|NCT04009291|537459519|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
148995202|NCT04009291|537459515|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
148995203|NCT04009291|537459516|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
148995204|NCT04009291|537459517|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
148995205|NCT04009291|537459518|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
148995206|NCT04009291|537459519|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
148995207|NCT02085408|537459520|FG000|Step 1: Induction|Disease Progression|19|||
148995208|NCT02085408|537459521|FG001|Step 1: Induction|Disease Progression|19|||
148995209|NCT02085408|537459520|FG000|Step 1: Induction|Adverse Event|18|||
148995210|NCT02085408|537459521|FG001|Step 1: Induction|Adverse Event|17|||
148995211|NCT02085408|537459520|FG000|Step 1: Induction|Death|33|||
148995212|NCT02085408|537459521|FG001|Step 1: Induction|Death|30|||
148995213|NCT02085408|537459520|FG000|Step 1: Induction|Withdrawal by Subject|16|||
148995214|NCT02085408|537459521|FG001|Step 1: Induction|Withdrawal by Subject|8|||
148995215|NCT02085408|537459520|FG000|Step 1: Induction|Alternative Therapy|15|||
148995216|NCT02085408|537459521|FG001|Step 1: Induction|Alternative Therapy|19|||
148995217|NCT02085408|537459520|FG000|Step 1: Induction|Complicating Disease|2|||
148995218|NCT02085408|537459521|FG001|Step 1: Induction|Complicating Disease|3|||
148995219|NCT02085408|537459520|FG000|Step 1: Induction|Other|27|||
148995220|NCT02085408|537459521|FG001|Step 1: Induction|Other|39|||
148995221|NCT02085408|537459520|FG000|Step 1: Induction|Never started treatment|6|||
148995222|NCT02085408|537459521|FG001|Step 1: Induction|Never started treatment|4|||
148995223|NCT02085408|537459520|FG000|Step 2: Consolidation|Disease Progression|5|||
148995224|NCT02085408|537459521|FG001|Step 2: Consolidation|Disease Progression|20|||
148995225|NCT02085408|537459520|FG000|Step 2: Consolidation|Adverse Event|9|||
148995226|NCT02085408|537459521|FG001|Step 2: Consolidation|Adverse Event|8|||
148995227|NCT02085408|537459520|FG000|Step 2: Consolidation|Death|4|||
148995228|NCT02085408|537459521|FG001|Step 2: Consolidation|Death|3|||
148995229|NCT02085408|537459520|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
148995230|NCT02085408|537459521|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
148995231|NCT02085408|537459520|FG000|Step 2: Consolidation|Alternative Therapy|9|||
148995232|NCT02085408|537459521|FG001|Step 2: Consolidation|Alternative Therapy|3|||
148995233|NCT02085408|537459520|FG000|Step 2: Consolidation|Complicating Disease|0|||
148995234|NCT02085408|537459521|FG001|Step 2: Consolidation|Complicating Disease|2|||
148995235|NCT02085408|537459520|FG000|Step 2: Consolidation|Other|6|||
148995236|NCT02085408|537459521|FG001|Step 2: Consolidation|Other|6|||
148995237|NCT02085408|537459520|FG000|Step 2: Consolidation|Never started treatment|4|||
148995238|NCT02085408|537459521|FG001|Step 2: Consolidation|Never started treatment|3|||
148995239|NCT02085408|537459520|FG000|Step 3: Maintenance|Disease Progression|13|||
148995240|NCT02085408|537459521|FG001|Step 3: Maintenance|Disease Progression|11|||
148995241|NCT02085408|537459520|FG000|Step 3: Maintenance|Adverse Event|2|||
148995242|NCT02085408|537459521|FG001|Step 3: Maintenance|Adverse Event|4|||
148995243|NCT02085408|537459520|FG000|Step 3: Maintenance|Death|1|||
148995244|NCT02085408|537459521|FG001|Step 3: Maintenance|Death|2|||
148995245|NCT02085408|537459520|FG000|Step 3: Maintenance|Alternative Therapy|1|||
148995246|NCT02085408|537459521|FG001|Step 3: Maintenance|Alternative Therapy|1|||
148995247|NCT02085408|537459520|FG000|Step 3: Maintenance|Complicating Disease|0|||
148995248|NCT02085408|537459521|FG001|Step 3: Maintenance|Complicating Disease|1|||
148995249|NCT02085408|537459520|FG000|Step 3: Maintenance|Other|3|||
148995250|NCT02085408|537459521|FG001|Step 3: Maintenance|Other|2|||
148995251|NCT02085408|537459520|FG000|Step 3: Maintenance|Never started treatment|5|||
148995252|NCT02085408|537459521|FG001|Step 3: Maintenance|Never started treatment|1|||
148995253|NCT02189798|537459522|FG000|Extended Use Phase|Withdrawal by Subject|0|||
148995254|NCT02189798|537459523|FG001|Extended Use Phase|Withdrawal by Subject|4|||
148995255|NCT02189798|537459522|FG000|Extended Use Phase|Physician Decision|1|||
148995256|NCT02189798|537459523|FG001|Extended Use Phase|Physician Decision|0|||
148995257|NCT02189798|537459522|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
148995258|NCT02189798|537459523|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
148995259|NCT02189798|537459522|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
148995260|NCT02189798|537459523|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
148995261|NCT02189798|537459522|FG000|Extended Use Phase|Travel Issues|2|||
148995262|NCT02189798|537459523|FG001|Extended Use Phase|Travel Issues|1|||
148995263|NCT02189798|537459522|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
148995264|NCT02189798|537459523|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
148995265|NCT01556438|537459528|FG000|Overall Study|Adverse Event|4|||
148995266|NCT01556438|537459529|FG001|Overall Study|Adverse Event|2|||
148995267|NCT01556438|537459528|FG000|Overall Study|Sponsor Decision|0|||
148995268|NCT01556438|537459529|FG001|Overall Study|Sponsor Decision|2|||
148995269|NCT01556438|537459528|FG000|Overall Study|Progressive Disease|0|||
148995270|NCT01556438|537459529|FG001|Overall Study|Progressive Disease|6|||
148995271|NCT01556438|537459528|FG000|Overall Study|Death|0|||
148995272|NCT01556438|537459529|FG001|Overall Study|Death|1|||
148995273|NCT00529399|537459530|FG000|Overall Study|Lost to Follow-up|1|||
148995274|NCT00529399|537459531|FG001|Overall Study|Lost to Follow-up|0|||
148995275|NCT00529399|537459532|FG002|Overall Study|Lost to Follow-up|1|||
148995276|NCT00529399|537459530|FG000|Overall Study|Withdrawal by Subject|1|||
148995277|NCT00529399|537459531|FG001|Overall Study|Withdrawal by Subject|0|||
148995278|NCT00529399|537459532|FG002|Overall Study|Withdrawal by Subject|1|||
148995279|NCT00529399|537459530|FG000|Overall Study|Non-compliant|0|||
148995280|NCT00529399|537459531|FG001|Overall Study|Non-compliant|1|||
148995281|NCT00529399|537459532|FG002|Overall Study|Non-compliant|0|||
148995282|NCT03695172|537459533|FG000|Overall Study|Withdrawal by Subject|1|||
148995283|NCT03695172|537459534|FG001|Overall Study|Withdrawal by Subject|1|||
148995284|NCT03695172|537459535|FG002|Overall Study|Withdrawal by Subject|0|||
148995285|NCT01483924|537459554|FG000|Overall Study|Withdrawal by Subject|2|||
148995286|NCT01483924|537459555|FG001|Overall Study|Withdrawal by Subject|0|||
148864334|NCT00624780|536979205|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
148864335|NCT00624780|536979206|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
148864336|NCT00624780|536979201|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
148864337|NCT00624780|536979202|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
148864338|NCT00624780|536979203|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
148864339|NCT00624780|536979204|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
148864340|NCT00624780|536979205|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
148864341|NCT00624780|536979206|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
148864342|NCT00624780|536979201|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
148864343|NCT00624780|536979202|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
148864344|NCT00624780|536979203|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
148864345|NCT00624780|536979204|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
148864346|NCT00624780|536979205|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
148864347|NCT00624780|536979206|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
148864348|NCT00624780|536979201|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
148864349|NCT00624780|536979202|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
148864350|NCT00624780|536979203|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
148864351|NCT00624780|536979204|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
148864352|NCT00624780|536979205|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
148864353|NCT00624780|536979206|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
148864354|NCT00624780|536979201|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
148864355|NCT00624780|536979202|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
148864356|NCT00624780|536979203|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
148864357|NCT00624780|536979204|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
148864358|NCT00624780|536979205|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
148864359|NCT00624780|536979206|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
148864360|NCT00624780|536979201|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
148864361|NCT00624780|536979202|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
148864362|NCT00624780|536979203|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
148864363|NCT00624780|536979204|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
148864364|NCT00624780|536979205|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
148864365|NCT00624780|536979206|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
148864366|NCT00624780|536979201|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
148864367|NCT00624780|536979202|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
148864368|NCT00624780|536979203|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
148864369|NCT00624780|536979204|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
148864370|NCT00624780|536979205|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
148864371|NCT00624780|536979206|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
148864372|NCT00624780|536979201|FG000|Follow-up (Week 26)|Death|0|||
148864373|NCT00624780|536979202|FG001|Follow-up (Week 26)|Death|0|||
148864374|NCT00624780|536979203|FG002|Follow-up (Week 26)|Death|1|||
148864375|NCT00624780|536979204|FG003|Follow-up (Week 26)|Death|0|||
148864376|NCT00624780|536979205|FG004|Follow-up (Week 26)|Death|0|||
148864377|NCT00624780|536979206|FG005|Follow-up (Week 26)|Death|0|||
148864378|NCT00624780|536979201|FG000|Follow-up (Week 26)|Adverse Event|0|||
148864379|NCT00624780|536979202|FG001|Follow-up (Week 26)|Adverse Event|0|||
148864380|NCT00624780|536979203|FG002|Follow-up (Week 26)|Adverse Event|0|||
148864381|NCT00624780|536979204|FG003|Follow-up (Week 26)|Adverse Event|0|||
148864382|NCT00624780|536979205|FG004|Follow-up (Week 26)|Adverse Event|1|||
148864383|NCT00624780|536979206|FG005|Follow-up (Week 26)|Adverse Event|0|||
148864384|NCT00624780|536979201|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
148864385|NCT00624780|536979202|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
148864386|NCT00624780|536979203|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
148864387|NCT00624780|536979204|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
148864388|NCT00624780|536979205|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
148864389|NCT00624780|536979206|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
148995287|NCT01483924|537459556|FG002|Overall Study|Withdrawal by Subject|0|||
148995288|NCT01483924|537459557|FG003|Overall Study|Withdrawal by Subject|1|||
148995289|NCT01483924|537459558|FG004|Overall Study|Withdrawal by Subject|1|||
148995290|NCT01483924|537459554|FG000|Overall Study|Adverse Event|0|||
148864390|NCT00624780|536979201|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
148864391|NCT00624780|536979202|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
148864392|NCT00624780|536979203|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
148995291|NCT01483924|537459555|FG001|Overall Study|Adverse Event|0|||
148995292|NCT01483924|537459556|FG002|Overall Study|Adverse Event|1|||
148995293|NCT01483924|537459557|FG003|Overall Study|Adverse Event|1|||
148995294|NCT01483924|537459558|FG004|Overall Study|Adverse Event|0|||
148995295|NCT01483924|537459554|FG000|Overall Study|Non-compliance|0|||
148995296|NCT01483924|537459555|FG001|Overall Study|Non-compliance|0|||
148995297|NCT01483924|537459556|FG002|Overall Study|Non-compliance|0|||
148995298|NCT01483924|537459557|FG003|Overall Study|Non-compliance|1|||
148995299|NCT01483924|537459558|FG004|Overall Study|Non-compliance|1|||
148995300|NCT01483924|537459554|FG000|Overall Study|Sponsor concern over ECG result|0|||
148995301|NCT01483924|537459555|FG001|Overall Study|Sponsor concern over ECG result|0|||
148995302|NCT01483924|537459556|FG002|Overall Study|Sponsor concern over ECG result|0|||
148995303|NCT01483924|537459557|FG003|Overall Study|Sponsor concern over ECG result|1|||
148995304|NCT01483924|537459558|FG004|Overall Study|Sponsor concern over ECG result|0|||
148995305|NCT00003298|537459559|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
148995306|NCT00003298|537459559|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
148995307|NCT00003298|537459559|FG000|Surgery|Unresectable at surgery|3|||
148995308|NCT00003298|537459559|FG000|Surgery|Progression before surgery|2|||
148995309|NCT00003298|537459559|FG000|Surgery|Unevaluable and off study|2|||
148995310|NCT00003298|537459559|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
148995311|NCT00003298|537459559|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
148995312|NCT00003298|537459559|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
148995313|NCT00003298|537459559|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
148995314|NCT00003298|537459559|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
148995315|NCT00003298|537459559|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
148995316|NCT00003298|537459559|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
148995317|NCT00003298|537459559|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
148995318|NCT00003298|537459559|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
148995319|NCT00003298|537459559|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
148995320|NCT00335322|537459560|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
148995321|NCT00335322|537459561|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
148995322|NCT00335322|537459562|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
148995323|NCT04330638|537459567|FG000|Overall Study|Adverse Event|9|||
148995324|NCT04330638|537459568|FG001|Overall Study|Adverse Event|10|||
148995325|NCT04330638|537459569|FG002|Overall Study|Adverse Event|15|||
148995326|NCT04330638|537459570|FG003|Overall Study|Adverse Event|6|||
148995327|NCT04330638|537459571|FG004|Overall Study|Adverse Event|10|||
148995328|NCT04330638|537459572|FG005|Overall Study|Adverse Event|5|||
148995329|NCT04330638|537459567|FG000|Overall Study|Other|2|||
148995330|NCT04330638|537459568|FG001|Overall Study|Other|2|||
148995331|NCT04330638|537459569|FG002|Overall Study|Other|5|||
148995332|NCT04330638|537459570|FG003|Overall Study|Other|1|||
148995333|NCT04330638|537459571|FG004|Overall Study|Other|3|||
148995334|NCT04330638|537459572|FG005|Overall Study|Other|2|||
148995335|NCT04330638|537459567|FG000|Overall Study|Withdrawal by Subject|4|||
148995336|NCT04330638|537459568|FG001|Overall Study|Withdrawal by Subject|0|||
148995337|NCT04330638|537459569|FG002|Overall Study|Withdrawal by Subject|0|||
148995338|NCT04330638|537459570|FG003|Overall Study|Withdrawal by Subject|0|||
148995339|NCT04330638|537459571|FG004|Overall Study|Withdrawal by Subject|0|||
148995340|NCT04330638|537459572|FG005|Overall Study|Withdrawal by Subject|0|||
148995341|NCT04330638|537459567|FG000|Overall Study|Lost to Follow-up|3|||
148995342|NCT04330638|537459568|FG001|Overall Study|Lost to Follow-up|2|||
148995343|NCT04330638|537459569|FG002|Overall Study|Lost to Follow-up|3|||
148995344|NCT04330638|537459570|FG003|Overall Study|Lost to Follow-up|2|||
148995345|NCT04330638|537459571|FG004|Overall Study|Lost to Follow-up|3|||
148995346|NCT04330638|537459572|FG005|Overall Study|Lost to Follow-up|0|||
148995347|NCT01041638|537459574|FG000|Overall Study|Adverse Event|4|||
148995348|NCT01041638|537459574|FG000|Overall Study|Death|1|||
148995349|NCT01041638|537459574|FG000|Overall Study|Lack of Efficacy|7|||
148995350|NCT01041638|537459574|FG000|Overall Study|Physician Decision|4|||
148995351|NCT01041638|537459574|FG000|Overall Study|Withdrawal by Subject|11|||
148995352|NCT03152552|537459575|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
148995353|NCT03152552|537459576|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
148864393|NCT00624780|536979204|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
148864394|NCT00624780|536979205|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
148864395|NCT00624780|536979206|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
148864396|NCT00624780|536979201|FG000|Follow-up (Week 26)|Other|1|||
148864397|NCT00624780|536979202|FG001|Follow-up (Week 26)|Other|1|||
148995354|NCT03152552|537459577|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
148995355|NCT03152552|537459578|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
148995356|NCT03152552|537459579|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
148995357|NCT03152552|537459575|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
148995358|NCT03152552|537459576|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
148995359|NCT03152552|537459577|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
148995360|NCT03152552|537459578|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
148995361|NCT03152552|537459579|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
148995362|NCT03152552|537459575|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
149030919|NCT01956669|537591608|FG002|Overall Study|Physician Decision|0|||
148864398|NCT00624780|536979203|FG002|Follow-up (Week 26)|Other|0|||
148864399|NCT00624780|536979204|FG003|Follow-up (Week 26)|Other|0|||
148864400|NCT00624780|536979205|FG004|Follow-up (Week 26)|Other|0|||
148864401|NCT00624780|536979206|FG005|Follow-up (Week 26)|Other|0|||
148864402|NCT04068519|536979207|FG000|Dose Verification|Death|15|||
148864403|NCT04068519|536979207|FG000|Dose Verification|Withdrawal by Subject|1|||
148864404|NCT04068519|536979207|FG000|Pharmacokinetic Sub-study|Death|35|||
148864405|NCT04068519|536979207|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
148864406|NCT04068519|536979207|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
148864407|NCT04068519|536979207|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
148864408|NCT04068519|536979207|FG000|Indication Expansion|Death|152|||
148864409|NCT04068519|536979207|FG000|Indication Expansion|Withdrawal by Subject|10|||
148864410|NCT04068519|536979207|FG000|Indication Expansion|Lost to Follow-up|7|||
148864411|NCT00969761|536979208|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
148864412|NCT00969761|536979209|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864413|NCT00969761|536979210|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864414|NCT00969761|536979211|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
148864415|NCT00969761|536979212|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864416|NCT00969761|536979213|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864417|NCT00969761|536979214|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864418|NCT00969761|536979215|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864419|NCT00969761|536979216|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
148864420|NCT00969761|536979217|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
148864421|NCT00969761|536979218|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864422|NCT00969761|536979219|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
148864423|NCT00969761|536979208|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864424|NCT00969761|536979209|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864425|NCT00969761|536979210|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
148864426|NCT00969761|536979211|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864427|NCT00969761|536979212|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864428|NCT00969761|536979213|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864429|NCT00969761|536979214|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864430|NCT00969761|536979215|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864431|NCT00969761|536979216|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864432|NCT00969761|536979217|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864433|NCT00969761|536979218|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864434|NCT00969761|536979219|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
148864435|NCT00969761|536979208|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864436|NCT00969761|536979209|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864437|NCT00969761|536979210|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
148864438|NCT00969761|536979211|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864439|NCT00969761|536979212|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864440|NCT00969761|536979213|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864441|NCT00969761|536979214|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864442|NCT00969761|536979215|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864443|NCT00969761|536979216|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864444|NCT00969761|536979217|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864445|NCT00969761|536979218|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864446|NCT00969761|536979219|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
148864447|NCT00969761|536979208|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864448|NCT00969761|536979209|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864449|NCT00969761|536979210|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864450|NCT00969761|536979211|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864451|NCT00969761|536979212|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864452|NCT00969761|536979213|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864453|NCT00969761|536979214|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864454|NCT00969761|536979215|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864455|NCT00969761|536979216|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
148864456|NCT00969761|536979217|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864457|NCT00969761|536979218|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864458|NCT00969761|536979219|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
148864459|NCT00969761|536979208|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
148864460|NCT00969761|536979209|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
148864461|NCT00969761|536979210|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
148864462|NCT00969761|536979211|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
148995363|NCT03152552|537459576|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
148995364|NCT03152552|537459577|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
148995365|NCT03152552|537459578|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
148995366|NCT03152552|537459579|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
148995367|NCT03152552|537459575|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148995368|NCT03152552|537459576|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148995369|NCT03152552|537459577|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
148995370|NCT03152552|537459578|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148995371|NCT03152552|537459579|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
148995372|NCT03152552|537459575|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
148995373|NCT03152552|537459576|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
148995374|NCT03152552|537459577|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
148995375|NCT03152552|537459578|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
148995376|NCT03152552|537459579|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
148995377|NCT03152552|537459575|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
148995378|NCT03152552|537459576|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
148995379|NCT03152552|537459577|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
148995380|NCT03152552|537459578|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
148995381|NCT03152552|537459579|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
148995382|NCT03152552|537459575|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
148995383|NCT03152552|537459576|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
148995384|NCT03152552|537459577|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
148995385|NCT03152552|537459578|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
148995386|NCT03152552|537459579|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
148995387|NCT04084314|537459582|FG000|Overall Study|Subject/guardian decision|91|||
148995388|NCT04084314|537459582|FG000|Overall Study|Adverse Event|24|||
148995389|NCT04084314|537459582|FG000|Overall Study|Lost to Follow-up|19|||
148995390|NCT04084314|537459582|FG000|Overall Study|New therapy for study indication|9|||
148995391|NCT04084314|537459582|FG000|Overall Study|Pregnancy|9|||
148995392|NCT04084314|537459582|FG000|Overall Study|Withdrawal of informed consent|8|||
148995393|NCT04084314|537459582|FG000|Overall Study|Physician Decision|4|||
148995394|NCT04084314|537459582|FG000|Overall Study|Protocol Deviation|3|||
148995395|NCT03336619|537459583|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
148995396|NCT03336619|537459584|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
148995397|NCT03336619|537459583|FG000|Overall Study|Withdrawal by Subject|17|||
148995398|NCT03336619|537459584|FG001|Overall Study|Withdrawal by Subject|16|||
148995399|NCT03336619|537459583|FG000|Overall Study|Adverse Event|2|||
148995400|NCT03336619|537459584|FG001|Overall Study|Adverse Event|5|||
148995401|NCT03336619|537459583|FG000|Overall Study|Physician Decision|3|||
148995402|NCT03336619|537459584|FG001|Overall Study|Physician Decision|0|||
148995403|NCT01300546|537459585|FG000|Overall Study|Withdrawal by Subject|1|||
148995404|NCT01300546|537459586|FG001|Overall Study|Withdrawal by Subject|0|||
148995405|NCT01300546|537459585|FG000|Overall Study|Lost to Follow-up|0|||
148995406|NCT01300546|537459586|FG001|Overall Study|Lost to Follow-up|2|||
148995407|NCT01300546|537459585|FG000|Overall Study|Lack of Efficacy|0|||
148995408|NCT01300546|537459586|FG001|Overall Study|Lack of Efficacy|3|||
148995409|NCT01300546|537459585|FG000|Overall Study|Adverse Event|0|||
148995410|NCT01300546|537459586|FG001|Overall Study|Adverse Event|1|||
148995411|NCT01864564|537459595|FG000|Overall Study|Lost to Follow-up|17|||
148995412|NCT01864564|537459596|FG001|Overall Study|Lost to Follow-up|23|||
148995413|NCT01864564|537459595|FG000|Overall Study|Withdrawal by Subject|20|||
148995414|NCT01864564|537459596|FG001|Overall Study|Withdrawal by Subject|11|||
148995415|NCT01864564|537459595|FG000|Overall Study|Protocol Violation|0|||
148995416|NCT01864564|537459596|FG001|Overall Study|Protocol Violation|27|||
148995417|NCT01864564|537459595|FG000|Overall Study|not reported|0|||
148995418|NCT01864564|537459596|FG001|Overall Study|not reported|34|||
148995419|NCT03576768|537460941|FG000|Overall Study|Lost to Follow-up|3|||
148995420|NCT03576768|537460942|FG001|Overall Study|Lost to Follow-up|3|||
148995421|NCT03576768|537460943|FG002|Overall Study|Lost to Follow-up|0|||
148995422|NCT03576768|537460944|FG003|Overall Study|Lost to Follow-up|0|||
148995423|NCT01549613|537460956|FG000|Overall Study|Lost to Follow-up|11|||
148995424|NCT01549613|537460957|FG001|Overall Study|Lost to Follow-up|11|||
148995425|NCT02216123|537460958|FG000|Overall Study|Lost to Follow-up|4|||
148995426|NCT02216123|537460959|FG001|Overall Study|Lost to Follow-up|2|||
148995427|NCT02216123|537460958|FG000|Overall Study|Withdrawal by Subject|2|||
148995428|NCT02216123|537460959|FG001|Overall Study|Withdrawal by Subject|0|||
148995429|NCT02131272|537460960|FG000|Overall Study|Withdrawal by parent|0|||
148995430|NCT02131272|537460961|FG001|Overall Study|Withdrawal by parent|1|||
148995431|NCT02131272|537460960|FG000|Overall Study|Withdrawal by Subject|0|||
148995432|NCT02131272|537460961|FG001|Overall Study|Withdrawal by Subject|1|||
148995433|NCT02131272|537460960|FG000|Overall Study|Withdrawal Criteria|1|||
148995434|NCT02131272|537460961|FG001|Overall Study|Withdrawal Criteria|0|||
148995435|NCT00381940|537460962|FG000|Overall Study|Lack of Efficacy|3|||
148995436|NCT00381940|537460962|FG000|Overall Study|Protocol Violation|1|||
148995437|NCT00381940|537460962|FG000|Overall Study|Ineligible|1|||
148864463|NCT00969761|536979212|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
148864464|NCT00969761|536979213|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
148864465|NCT00969761|536979214|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
148864466|NCT00969761|536979215|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
148864467|NCT00969761|536979216|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
148864468|NCT00969761|536979217|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
148864469|NCT00969761|536979218|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
148864470|NCT00969761|536979219|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
148864471|NCT00969761|536979208|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864472|NCT00969761|536979209|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864473|NCT00969761|536979210|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864474|NCT00969761|536979211|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
148864475|NCT00969761|536979212|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
148864476|NCT00969761|536979213|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864477|NCT00969761|536979214|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864478|NCT00969761|536979215|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864479|NCT00969761|536979216|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
148864480|NCT00969761|536979217|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864481|NCT00969761|536979218|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864482|NCT00969761|536979219|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
148864483|NCT03081858|536981181|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
148864484|NCT03081858|536981182|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
148864485|NCT03081858|536981183|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
148864486|NCT03081858|536981184|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
148864487|NCT03959982|536981189|FG000|Overall Study|Withdrawal by Subject|1|||
148864488|NCT03959982|536981190|FG001|Overall Study|Withdrawal by Subject|0|||
148864489|NCT03959982|536981189|FG000|Overall Study|Physician Decision|2|||
148864490|NCT03959982|536981190|FG001|Overall Study|Physician Decision|0|||
148864491|NCT03959982|536981189|FG000|Overall Study|Lost to Follow-up|1|||
148864492|NCT03959982|536981190|FG001|Overall Study|Lost to Follow-up|0|||
148864493|NCT00262847|536981191|FG000|Overall Study|Disease Progression|309|||
148864494|NCT00262847|536981192|FG001|Overall Study|Disease Progression|274|||
148864495|NCT00262847|536981193|FG002|Overall Study|Disease Progression|195|||
148864496|NCT00262847|536981191|FG000|Overall Study|Patient Refusal|41|||
148864497|NCT00262847|536981192|FG001|Overall Study|Patient Refusal|52|||
148864498|NCT00262847|536981193|FG002|Overall Study|Patient Refusal|47|||
148864499|NCT00262847|536981191|FG000|Overall Study|Adverse Event|74|||
148864500|NCT00262847|536981192|FG001|Overall Study|Adverse Event|88|||
148864501|NCT00262847|536981193|FG002|Overall Study|Adverse Event|108|||
148864502|NCT00262847|536981191|FG000|Overall Study|Death|8|||
148864503|NCT00262847|536981192|FG001|Overall Study|Death|8|||
148864504|NCT00262847|536981193|FG002|Overall Study|Death|11|||
148864505|NCT00262847|536981191|FG000|Overall Study|Concomitant disease|3|||
148864506|NCT00262847|536981192|FG001|Overall Study|Concomitant disease|2|||
148864507|NCT00262847|536981193|FG002|Overall Study|Concomitant disease|4|||
148864508|NCT00262847|536981191|FG000|Overall Study|Other Reasons|79|||
148864509|NCT00262847|536981192|FG001|Overall Study|Other Reasons|88|||
148864510|NCT00262847|536981193|FG002|Overall Study|Other Reasons|27|||
148864511|NCT00262847|536981191|FG000|Overall Study|Did not receive study treatment|4|||
148864512|NCT00262847|536981192|FG001|Overall Study|Did not receive study treatment|1|||
148864513|NCT00262847|536981193|FG002|Overall Study|Did not receive study treatment|4|||
148864514|NCT00387647|536981194|FG000|Overall Study|Death|18|||
148864515|NCT00758589|536981195|FG000|Overall Study|Adverse Event|3|||
148864516|NCT00758589|536981196|FG001|Overall Study|Adverse Event|2|||
148864517|NCT00758589|536981197|FG002|Overall Study|Adverse Event|5|||
148864518|NCT00758589|536981198|FG003|Overall Study|Adverse Event|4|||
148864519|NCT00758589|536981195|FG000|Overall Study|Withdrawal by Subject|0|||
148864520|NCT00758589|536981196|FG001|Overall Study|Withdrawal by Subject|1|||
148864521|NCT00758589|536981197|FG002|Overall Study|Withdrawal by Subject|1|||
148864522|NCT00758589|536981198|FG003|Overall Study|Withdrawal by Subject|1|||
148864523|NCT00758589|536981195|FG000|Overall Study|Palm stopped to work|0|||
148864524|NCT00758589|536981196|FG001|Overall Study|Palm stopped to work|0|||
148864525|NCT00758589|536981197|FG002|Overall Study|Palm stopped to work|0|||
148864526|NCT00758589|536981198|FG003|Overall Study|Palm stopped to work|1|||
148864527|NCT02032407|536981199|FG000|Overall Study|Lost to Follow-up|2|||
148864528|NCT02032407|536981199|FG000|Overall Study|Pregnancy|1|||
148864529|NCT02032407|536981199|FG000|Overall Study|Other Miscellaneous Reasons|2|||
148864530|NCT04411420|536981200|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
148864531|NCT04411420|536981201|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
148864532|NCT04411420|536981200|FG000|Survey Subset|Lost to Follow-up|134|||
148995438|NCT03162224|537460963|FG000|Overall Study|Death|4|||
148995439|NCT03162224|537460964|FG001|Overall Study|Death|5|||
148995440|NCT03162224|537460965|FG002|Overall Study|Death|8|||
148995441|NCT03162224|537460963|FG000|Overall Study|Withdrawal by Subject|1|||
148995442|NCT03162224|537460964|FG001|Overall Study|Withdrawal by Subject|0|||
148995443|NCT03162224|537460965|FG002|Overall Study|Withdrawal by Subject|1|||
148995444|NCT03162224|537460963|FG000|Overall Study|Lost to Follow-up|0|||
148995445|NCT03162224|537460964|FG001|Overall Study|Lost to Follow-up|1|||
148995446|NCT03162224|537460965|FG002|Overall Study|Lost to Follow-up|0|||
148995447|NCT03162224|537460963|FG000|Overall Study|Other|6|||
148995448|NCT03162224|537460964|FG001|Overall Study|Other|2|||
148995449|NCT03162224|537460965|FG002|Overall Study|Other|1|||
148995450|NCT05159622|537460966|FG000|Overall Study|Lost to Follow-up|4|||
148995451|NCT05159622|537460967|FG001|Overall Study|Lost to Follow-up|5|||
148995452|NCT04162769|537460968|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
148995453|NCT04162769|537460969|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
148995454|NCT04162769|537460970|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
148995455|NCT04162769|537460971|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
148995456|NCT04162769|537460968|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
148995457|NCT04162769|537460969|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
148995458|NCT04162769|537460970|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
148995459|NCT04162769|537460971|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
148995460|NCT04162769|537460968|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
148995461|NCT04162769|537460969|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
148995462|NCT04162769|537460970|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
148995463|NCT04162769|537460971|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
148995464|NCT04162769|537460968|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
148995465|NCT04162769|537460969|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
148995466|NCT04162769|537460970|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
148995467|NCT04162769|537460971|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
148995468|NCT04162769|537460968|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
148995469|NCT04162769|537460969|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
148995470|NCT04162769|537460970|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
148995471|NCT04162769|537460971|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
148995472|NCT04162769|537460968|FG000|Double-blind Treatment (12-Week)|Other|0|||
148995473|NCT04162769|537460969|FG001|Double-blind Treatment (12-Week)|Other|1|||
148995474|NCT04162769|537460970|FG002|Double-blind Treatment (12-Week)|Other|1|||
148995475|NCT04162769|537460971|FG003|Double-blind Treatment (12-Week)|Other|0|||
148995476|NCT04162769|537460968|FG000|OLE Period (52-Week)|Adverse Event|0|||
148995477|NCT04162769|537460969|FG001|OLE Period (52-Week)|Adverse Event|0|||
148995478|NCT04162769|537460970|FG002|OLE Period (52-Week)|Adverse Event|0|||
148995479|NCT04162769|537460971|FG003|OLE Period (52-Week)|Adverse Event|5|||
148995480|NCT04162769|537460968|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
148995481|NCT04162769|537460969|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
148995482|NCT04162769|537460970|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
148995483|NCT04162769|537460971|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
148995484|NCT04162769|537460968|FG000|OLE Period (52-Week)|Physician Decision|0|||
148995485|NCT04162769|537460969|FG001|OLE Period (52-Week)|Physician Decision|0|||
148995486|NCT04162769|537460970|FG002|OLE Period (52-Week)|Physician Decision|0|||
148995487|NCT04162769|537460971|FG003|OLE Period (52-Week)|Physician Decision|1|||
148995488|NCT04162769|537460968|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
148995489|NCT04162769|537460969|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
148995490|NCT04162769|537460970|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
148995491|NCT04162769|537460971|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
148995492|NCT04162769|537460968|FG000|OLE Period (52-Week)|Protocol deviation|0|||
148995493|NCT04162769|537460969|FG001|OLE Period (52-Week)|Protocol deviation|0|||
148995494|NCT04162769|537460970|FG002|OLE Period (52-Week)|Protocol deviation|0|||
148995495|NCT04162769|537460971|FG003|OLE Period (52-Week)|Protocol deviation|2|||
148995496|NCT03643952|537460972|FG000|Overall Study|Lack of Efficacy|1|||
148995497|NCT01358968|537460973|FG000|Period 2|Adverse Event|0|||
148995498|NCT01358968|537460974|FG001|Period 2|Adverse Event|1|||
148995499|NCT01358968|537460975|FG002|Period 2|Adverse Event|0|||
148995500|NCT01358968|537460976|FG003|Period 2|Adverse Event|0|||
148995501|NCT01358968|537460973|FG000|Continued Access Phase|Progression of Disease|0|||
148995502|NCT01358968|537460974|FG001|Continued Access Phase|Progression of Disease|0|||
148995503|NCT01358968|537460975|FG002|Continued Access Phase|Progression of Disease|8|||
148995504|NCT01358968|537460976|FG003|Continued Access Phase|Progression of Disease|4|||
148995505|NCT01358968|537460973|FG000|Continued Access Phase|Protocol Violation|0|||
148995506|NCT01358968|537460974|FG001|Continued Access Phase|Protocol Violation|0|||
148995507|NCT01358968|537460975|FG002|Continued Access Phase|Protocol Violation|0|||
148864533|NCT04411420|536981201|FG001|Survey Subset|Lost to Follow-up|120|||
148864534|NCT03899064|536981204|FG000|Overall Study|Lost to Follow-up|1|||
148995508|NCT01358968|537460976|FG003|Continued Access Phase|Protocol Violation|2|||
148995509|NCT01358968|537460973|FG000|Continued Access Phase|Withdrawal by Subject|0|||
148995510|NCT01358968|537460974|FG001|Continued Access Phase|Withdrawal by Subject|0|||
149030920|NCT01956669|537591609|FG003|Overall Study|Physician Decision|0|||
148995511|NCT01358968|537460975|FG002|Continued Access Phase|Withdrawal by Subject|3|||
148995512|NCT01358968|537460976|FG003|Continued Access Phase|Withdrawal by Subject|0|||
148995513|NCT01358968|537460973|FG000|Continued Access Phase|Death|0|||
148995514|NCT01358968|537460974|FG001|Continued Access Phase|Death|0|||
148995515|NCT01358968|537460975|FG002|Continued Access Phase|Death|1|||
148995516|NCT01358968|537460976|FG003|Continued Access Phase|Death|1|||
148995517|NCT00487162|537460979|FG000|Overall Study|Adverse Event|0|||
148995518|NCT00487162|537460980|FG001|Overall Study|Adverse Event|1|||
148995519|NCT00487162|537460979|FG000|Overall Study|Physician Decision|0|||
148995520|NCT00487162|537460980|FG001|Overall Study|Physician Decision|1|||
148995521|NCT00487162|537460979|FG000|Overall Study|Withdrawal by Subject|2|||
148995522|NCT00487162|537460980|FG001|Overall Study|Withdrawal by Subject|3|||
148995523|NCT00815295|537460981|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
148995524|NCT00815295|537460982|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
148995525|NCT00815295|537460983|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
148995526|NCT02794285|537460984|FG000|Overall Study|Adverse Event|11|||
148995527|NCT02794285|537460985|FG001|Overall Study|Adverse Event|4|||
148995528|NCT02794285|537460986|FG002|Overall Study|Adverse Event|5|||
148995529|NCT02794285|537460987|FG003|Overall Study|Adverse Event|8|||
148995530|NCT02794285|537460984|FG000|Overall Study|Condition Under Investigation Improved|1|||
148995531|NCT02794285|537460985|FG001|Overall Study|Condition Under Investigation Improved|0|||
148995532|NCT02794285|537460986|FG002|Overall Study|Condition Under Investigation Improved|0|||
148995533|NCT02794285|537460987|FG003|Overall Study|Condition Under Investigation Improved|0|||
148995534|NCT02794285|537460984|FG000|Overall Study|Condition Under Investigation Worsened|0|||
148995535|NCT02794285|537460985|FG001|Overall Study|Condition Under Investigation Worsened|2|||
148995536|NCT02794285|537460986|FG002|Overall Study|Condition Under Investigation Worsened|1|||
148995537|NCT02794285|537460987|FG003|Overall Study|Condition Under Investigation Worsened|0|||
148995538|NCT02794285|537460984|FG000|Overall Study|Death|2|||
148995539|NCT02794285|537460985|FG001|Overall Study|Death|1|||
148995540|NCT02794285|537460986|FG002|Overall Study|Death|2|||
148995541|NCT02794285|537460987|FG003|Overall Study|Death|0|||
148995542|NCT02794285|537460984|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
148995543|NCT02794285|537460985|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
148995544|NCT02794285|537460986|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
148995545|NCT02794285|537460987|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
148995546|NCT02794285|537460984|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
148995547|NCT02794285|537460985|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
148995548|NCT02794285|537460986|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
148995549|NCT02794285|537460987|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
148995550|NCT02794285|537460984|FG000|Overall Study|Lack of Efficacy|10|||
148995551|NCT02794285|537460985|FG001|Overall Study|Lack of Efficacy|6|||
148995552|NCT02794285|537460986|FG002|Overall Study|Lack of Efficacy|3|||
148995553|NCT02794285|537460987|FG003|Overall Study|Lack of Efficacy|3|||
148995554|NCT02794285|537460984|FG000|Overall Study|Lost to Follow-up|5|||
148995555|NCT02794285|537460985|FG001|Overall Study|Lost to Follow-up|6|||
148995556|NCT02794285|537460986|FG002|Overall Study|Lost to Follow-up|3|||
148995557|NCT02794285|537460987|FG003|Overall Study|Lost to Follow-up|1|||
148995558|NCT02794285|537460984|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
148995559|NCT02794285|537460985|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
148995560|NCT02794285|537460986|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
148995561|NCT02794285|537460987|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
148995562|NCT02794285|537460984|FG000|Overall Study|Withdrawal by Subject|38|||
148995563|NCT02794285|537460985|FG001|Overall Study|Withdrawal by Subject|29|||
148995564|NCT02794285|537460986|FG002|Overall Study|Withdrawal by Subject|20|||
148995565|NCT02794285|537460987|FG003|Overall Study|Withdrawal by Subject|12|||
148995566|NCT02794285|537460984|FG000|Overall Study|Missing|1|||
148995567|NCT02794285|537460985|FG001|Overall Study|Missing|0|||
148995568|NCT02794285|537460986|FG002|Overall Study|Missing|0|||
148995569|NCT02794285|537460987|FG003|Overall Study|Missing|0|||
148995570|NCT02794285|537460984|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
148995571|NCT02794285|537460985|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
148995572|NCT02794285|537460986|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
148995573|NCT02794285|537460987|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
148995574|NCT02794285|537460984|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
148864535|NCT03899064|536981204|FG000|Overall Study|Protocol Violation|2|||
148864536|NCT03899064|536981204|FG000|Overall Study|Withdrawal by Subject|2|||
148995575|NCT02794285|537460985|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
148995576|NCT02794285|537460986|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
148995577|NCT02794285|537460987|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
148995578|NCT04052204|537460988|FG000|Overall Study|Death|1|||
148995579|NCT04052204|537460989|FG001|Overall Study|Death|0|||
148995580|NCT04052204|537460990|FG002|Overall Study|Death|0|||
148995581|NCT04052204|537460988|FG000|Overall Study|Progressive disease|1|||
148995582|NCT04052204|537460989|FG001|Overall Study|Progressive disease|0|||
148995583|NCT04052204|537460990|FG002|Overall Study|Progressive disease|0|||
148995584|NCT04052204|537460988|FG000|Overall Study|Other|1|||
148995585|NCT04052204|537460989|FG001|Overall Study|Other|0|||
148995586|NCT04052204|537460990|FG002|Overall Study|Other|0|||
148995587|NCT04124926|537461006|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
148995588|NCT04124926|537461007|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
148995589|NCT04124926|537461008|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
148995590|NCT04124926|537461009|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
148995591|NCT04124926|537461010|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
148995592|NCT04124926|537461006|FG000|Healing Phase|Protocol Violation|0|||
148995593|NCT04124926|537461007|FG001|Healing Phase|Protocol Violation|1|||
148995594|NCT04124926|537461008|FG002|Healing Phase|Protocol Violation|0|||
148995595|NCT04124926|537461009|FG003|Healing Phase|Protocol Violation|0|||
148995596|NCT04124926|537461010|FG004|Healing Phase|Protocol Violation|0|||
148995597|NCT04124926|537461006|FG000|Healing Phase|Lost to Follow-up|5|||
148995598|NCT04124926|537461007|FG001|Healing Phase|Lost to Follow-up|4|||
148995599|NCT04124926|537461008|FG002|Healing Phase|Lost to Follow-up|0|||
148995600|NCT04124926|537461009|FG003|Healing Phase|Lost to Follow-up|0|||
148995601|NCT04124926|537461010|FG004|Healing Phase|Lost to Follow-up|0|||
148995602|NCT04124926|537461006|FG000|Healing Phase|Voluntary Withdrawal|10|||
148995603|NCT04124926|537461007|FG001|Healing Phase|Voluntary Withdrawal|7|||
148995604|NCT04124926|537461008|FG002|Healing Phase|Voluntary Withdrawal|0|||
148995605|NCT04124926|537461009|FG003|Healing Phase|Voluntary Withdrawal|0|||
148995606|NCT04124926|537461010|FG004|Healing Phase|Voluntary Withdrawal|0|||
148995607|NCT04124926|537461006|FG000|Healing Phase|Withdrawal of Consent|5|||
148995608|NCT04124926|537461007|FG001|Healing Phase|Withdrawal of Consent|3|||
148995609|NCT04124926|537461008|FG002|Healing Phase|Withdrawal of Consent|0|||
148995610|NCT04124926|537461009|FG003|Healing Phase|Withdrawal of Consent|0|||
148995611|NCT04124926|537461010|FG004|Healing Phase|Withdrawal of Consent|0|||
148995612|NCT04124926|537461006|FG000|Healing Phase|Miscellaneous|8|||
148995613|NCT04124926|537461007|FG001|Healing Phase|Miscellaneous|7|||
148995614|NCT04124926|537461008|FG002|Healing Phase|Miscellaneous|0|||
148995615|NCT04124926|537461009|FG003|Healing Phase|Miscellaneous|0|||
148995616|NCT04124926|537461010|FG004|Healing Phase|Miscellaneous|0|||
148995617|NCT04124926|537461006|FG000|Healing Phase|Randomized but not Treated|0|||
148995618|NCT04124926|537461007|FG001|Healing Phase|Randomized but not Treated|3|||
148995619|NCT04124926|537461008|FG002|Healing Phase|Randomized but not Treated|0|||
148995620|NCT04124926|537461009|FG003|Healing Phase|Randomized but not Treated|0|||
148995621|NCT04124926|537461010|FG004|Healing Phase|Randomized but not Treated|0|||
148995622|NCT04124926|537461006|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
148995623|NCT04124926|537461007|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
148995624|NCT04124926|537461008|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
148995625|NCT04124926|537461009|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
148995626|NCT04124926|537461010|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
148995627|NCT04124926|537461006|FG000|Maintenance Phase|Protocol Violation|0|||
148995628|NCT04124926|537461007|FG001|Maintenance Phase|Protocol Violation|0|||
148995629|NCT04124926|537461008|FG002|Maintenance Phase|Protocol Violation|3|||
148995630|NCT04124926|537461009|FG003|Maintenance Phase|Protocol Violation|0|||
148995631|NCT04124926|537461010|FG004|Maintenance Phase|Protocol Violation|0|||
148995632|NCT04124926|537461006|FG000|Maintenance Phase|Lost to Follow-up|0|||
148995633|NCT04124926|537461007|FG001|Maintenance Phase|Lost to Follow-up|0|||
148995634|NCT04124926|537461008|FG002|Maintenance Phase|Lost to Follow-up|7|||
148995635|NCT04124926|537461009|FG003|Maintenance Phase|Lost to Follow-up|8|||
148995636|NCT04124926|537461010|FG004|Maintenance Phase|Lost to Follow-up|9|||
148995637|NCT04124926|537461006|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
148995638|NCT04124926|537461007|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
148995639|NCT04124926|537461008|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
148995640|NCT04124926|537461009|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
148995641|NCT04124926|537461010|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
148995642|NCT04124926|537461006|FG000|Maintenance Phase|Pregnancy|0|||
148995643|NCT04124926|537461007|FG001|Maintenance Phase|Pregnancy|0|||
148995644|NCT04124926|537461008|FG002|Maintenance Phase|Pregnancy|0|||
148995645|NCT04124926|537461009|FG003|Maintenance Phase|Pregnancy|1|||
148995646|NCT04124926|537461010|FG004|Maintenance Phase|Pregnancy|0|||
148995647|NCT04124926|537461006|FG000|Maintenance Phase|Lack of Efficacy|0|||
148995648|NCT04124926|537461007|FG001|Maintenance Phase|Lack of Efficacy|0|||
148995649|NCT04124926|537461008|FG002|Maintenance Phase|Lack of Efficacy|0|||
148995650|NCT04124926|537461009|FG003|Maintenance Phase|Lack of Efficacy|0|||
148995651|NCT04124926|537461010|FG004|Maintenance Phase|Lack of Efficacy|1|||
148995652|NCT04124926|537461006|FG000|Maintenance Phase|Withdrawal of Consent|0|||
148995653|NCT04124926|537461007|FG001|Maintenance Phase|Withdrawal of Consent|0|||
148995654|NCT04124926|537461008|FG002|Maintenance Phase|Withdrawal of Consent|5|||
148995655|NCT04124926|537461009|FG003|Maintenance Phase|Withdrawal of Consent|5|||
148995656|NCT04124926|537461010|FG004|Maintenance Phase|Withdrawal of Consent|5|||
148864537|NCT03899064|536981204|FG000|Overall Study|Other|2|||
148995657|NCT04124926|537461006|FG000|Maintenance Phase|Miscellaneous|0|||
148995658|NCT04124926|537461007|FG001|Maintenance Phase|Miscellaneous|0|||
148995659|NCT04124926|537461008|FG002|Maintenance Phase|Miscellaneous|1|||
148995660|NCT04124926|537461009|FG003|Maintenance Phase|Miscellaneous|2|||
148995661|NCT04124926|537461010|FG004|Maintenance Phase|Miscellaneous|4|||
148995662|NCT04124926|537461006|FG000|Maintenance Phase|Randomized but not Treated|0|||
148995663|NCT04124926|537461007|FG001|Maintenance Phase|Randomized but not Treated|0|||
148995664|NCT04124926|537461008|FG002|Maintenance Phase|Randomized but not Treated|2|||
148995665|NCT04124926|537461009|FG003|Maintenance Phase|Randomized but not Treated|2|||
148995666|NCT04124926|537461010|FG004|Maintenance Phase|Randomized but not Treated|0|||
148995667|NCT02013622|537461016|FG000|Overall Study|Lost to Follow-up|10|||
148995668|NCT02013622|537461016|FG000|Overall Study|Adverse Event|3|||
148995669|NCT02013622|537461016|FG000|Overall Study|Met Withdrawal Criteria|3|||
148995670|NCT02013622|537461016|FG000|Overall Study|Withdrawal by Subject|6|||
148995671|NCT02013622|537461016|FG000|Overall Study|Protocol Deviation|1|||
148995672|NCT02013622|537461016|FG000|Overall Study|Lack of Efficacy|1|||
148995673|NCT03644186|537461019|FG000|Overall Study|Withdrawal by Subject|1|||
148995674|NCT03644186|537461020|FG001|Overall Study|Withdrawal by Subject|1|||
148995675|NCT02701985|537461023|FG000|Overall Study|Withdrawal by Subject|1|||
148995676|NCT02701985|537461024|FG001|Overall Study|Withdrawal by Subject|1|||
148995677|NCT02701985|537461023|FG000|Overall Study|Lost to Follow-up|1|||
148995678|NCT02701985|537461024|FG001|Overall Study|Lost to Follow-up|0|||
148995679|NCT02701985|537461023|FG000|Overall Study|Death|1|||
148995680|NCT02701985|537461024|FG001|Overall Study|Death|0|||
148995681|NCT02701985|537461023|FG000|Overall Study|Adverse Event|0|||
148995682|NCT02701985|537461024|FG001|Overall Study|Adverse Event|5|||
148995683|NCT01506193|537461028|FG000|Overall Study|Protocol Violation|1|||
148995684|NCT01506193|537461029|FG001|Overall Study|Protocol Violation|0|||
148995685|NCT01506193|537461030|FG002|Overall Study|Protocol Violation|1|||
148995686|NCT01506193|537461028|FG000|Overall Study|Migrated/moved from study area|0|||
148995687|NCT01506193|537461029|FG001|Overall Study|Migrated/moved from study area|0|||
148995688|NCT01506193|537461030|FG002|Overall Study|Migrated/moved from study area|1|||
148995689|NCT01506193|537461028|FG000|Overall Study|Adverse event, non-fatal|0|||
148995690|NCT01506193|537461029|FG001|Overall Study|Adverse event, non-fatal|0|||
148995691|NCT01506193|537461030|FG002|Overall Study|Adverse event, non-fatal|1|||
148995692|NCT01506193|537461028|FG000|Overall Study|Withdrawal by Subject|5|||
148995693|NCT01506193|537461029|FG001|Overall Study|Withdrawal by Subject|1|||
148995694|NCT01506193|537461030|FG002|Overall Study|Withdrawal by Subject|8|||
148995695|NCT01506193|537461028|FG000|Overall Study|Lost to Follow-up|8|||
148995696|NCT01506193|537461029|FG001|Overall Study|Lost to Follow-up|3|||
148995697|NCT01506193|537461030|FG002|Overall Study|Lost to Follow-up|3|||
148995698|NCT01388816|537461031|FG000|Overall Study|Adverse Event|0|||
148995699|NCT01388816|537461032|FG001|Overall Study|Adverse Event|2|||
148995700|NCT01388816|537461033|FG002|Overall Study|Adverse Event|0|||
148995701|NCT01388816|537461034|FG003|Overall Study|Adverse Event|0|||
148995702|NCT01388816|537461031|FG000|Overall Study|Lost to Follow-up|0|||
148995703|NCT01388816|537461032|FG001|Overall Study|Lost to Follow-up|1|||
148995704|NCT01388816|537461033|FG002|Overall Study|Lost to Follow-up|0|||
148995705|NCT01388816|537461034|FG003|Overall Study|Lost to Follow-up|0|||
148995706|NCT01388816|537461031|FG000|Overall Study|Withdrawal by Subject|2|||
148995707|NCT01388816|537461032|FG001|Overall Study|Withdrawal by Subject|1|||
148995708|NCT01388816|537461033|FG002|Overall Study|Withdrawal by Subject|1|||
148995709|NCT01388816|537461034|FG003|Overall Study|Withdrawal by Subject|0|||
148995710|NCT01388816|537461031|FG000|Overall Study|Protocol Violation|0|||
148995711|NCT01388816|537461032|FG001|Overall Study|Protocol Violation|0|||
148995712|NCT01388816|537461033|FG002|Overall Study|Protocol Violation|2|||
148995713|NCT01388816|537461034|FG003|Overall Study|Protocol Violation|0|||
148995714|NCT00743366|537461035|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
148995715|NCT00743366|537461036|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
148995716|NCT03206203|537461037|FG000|Treatment|Death|38|||
148995717|NCT03206203|537461038|FG001|Treatment|Death|26|||
148995718|NCT03206203|537461039|FG002|Treatment|Death|0|||
148995719|NCT03206203|537461037|FG000|Treatment|Withdrawal by Subject|1|||
148995720|NCT03206203|537461038|FG001|Treatment|Withdrawal by Subject|0|||
148995721|NCT03206203|537461039|FG002|Treatment|Withdrawal by Subject|0|||
148995722|NCT03206203|537461037|FG000|Treatment|Lost to Follow-up|4|||
148995723|NCT03206203|537461038|FG001|Treatment|Lost to Follow-up|0|||
148995724|NCT03206203|537461039|FG002|Treatment|Lost to Follow-up|0|||
148995725|NCT03206203|537461037|FG000|Treatment|N/A in Follow-Up|8|||
148995726|NCT03206203|537461038|FG001|Treatment|N/A in Follow-Up|1|||
148995727|NCT03206203|537461039|FG002|Treatment|N/A in Follow-Up|0|||
148995728|NCT03206203|537461037|FG000|Treatment|Disease progression|0|||
148778134|NCT00454818|536661926|FG004|Phase I: Open-label Dose-escalation|Death|0|||
148995729|NCT03206203|537461038|FG001|Treatment|Disease progression|1|||
148995730|NCT03206203|537461039|FG002|Treatment|Disease progression|0|||
148995731|NCT03206203|537461037|FG000|Treatment|Refused follow-up|0|||
148995732|NCT03206203|537461038|FG001|Treatment|Refused follow-up|1|||
148995733|NCT03206203|537461039|FG002|Treatment|Refused follow-up|0|||
148995734|NCT03206203|537461037|FG000|Treatment|Cross over to Arm 1|0|||
148995735|NCT03206203|537461038|FG001|Treatment|Cross over to Arm 1|19|||
148995736|NCT03206203|537461039|FG002|Treatment|Cross over to Arm 1|0|||
148995737|NCT03206203|537461037|FG000|Optional Cross-Over|Death|0|||
148995738|NCT03206203|537461038|FG001|Optional Cross-Over|Death|0|||
148995739|NCT03206203|537461039|FG002|Optional Cross-Over|Death|14|||
148995740|NCT03206203|537461037|FG000|Optional Cross-Over|Refused follow-up|0|||
148995741|NCT03206203|537461038|FG001|Optional Cross-Over|Refused follow-up|0|||
148995742|NCT03206203|537461039|FG002|Optional Cross-Over|Refused follow-up|2|||
148995743|NCT03998618|537461040|FG000|Overall Study|Death|7|||
148995744|NCT03998618|537461041|FG001|Overall Study|Death|11|||
148995745|NCT03998618|537461040|FG000|Overall Study|hospice enrollment|3|||
148995746|NCT03998618|537461041|FG001|Overall Study|hospice enrollment|3|||
148995747|NCT03998618|537461040|FG000|Overall Study|Not feeling well/health problems|3|||
148995748|NCT03998618|537461041|FG001|Overall Study|Not feeling well/health problems|5|||
148995749|NCT03998618|537461040|FG000|Overall Study|Lost to Follow-up|6|||
148995750|NCT03998618|537461041|FG001|Overall Study|Lost to Follow-up|6|||
148995751|NCT03998618|537461040|FG000|Overall Study|Withdrawal by Subject|0|||
148995752|NCT03998618|537461041|FG001|Overall Study|Withdrawal by Subject|4|||
148995753|NCT02308748|537461049|FG000|Period 1|Withdrawal by Subject|0|||
148995754|NCT02308748|537461050|FG001|Period 1|Withdrawal by Subject|0|||
148995755|NCT02308748|537461051|FG002|Period 1|Withdrawal by Subject|1|||
148995756|NCT02308748|537461052|FG003|Period 1|Withdrawal by Subject|0|||
148995757|NCT02308748|537461053|FG004|Period 1|Withdrawal by Subject|0|||
148995758|NCT02308748|537461054|FG005|Period 1|Withdrawal by Subject|0|||
148995759|NCT02308748|537461055|FG006|Period 1|Withdrawal by Subject|0|||
148995760|NCT02308748|537461056|FG007|Period 1|Withdrawal by Subject|0|||
148995761|NCT02308748|537461057|FG008|Period 1|Withdrawal by Subject|0|||
148995762|NCT02308748|537461058|FG009|Period 1|Withdrawal by Subject|0|||
148995763|NCT02308748|537461049|FG000|Period 2|Adverse Event|0|||
148995764|NCT02308748|537461050|FG001|Period 2|Adverse Event|0|||
148995765|NCT02308748|537461051|FG002|Period 2|Adverse Event|0|||
148995766|NCT02308748|537461052|FG003|Period 2|Adverse Event|0|||
148995767|NCT02308748|537461053|FG004|Period 2|Adverse Event|0|||
148995768|NCT02308748|537461054|FG005|Period 2|Adverse Event|0|||
148995769|NCT02308748|537461055|FG006|Period 2|Adverse Event|0|||
148995770|NCT02308748|537461056|FG007|Period 2|Adverse Event|1|||
148995771|NCT02308748|537461057|FG008|Period 2|Adverse Event|0|||
149030921|NCT01956669|537591610|FG004|Overall Study|Physician Decision|0|||
149030922|NCT01956669|537591611|FG005|Overall Study|Physician Decision|1|||
148864538|NCT00471887|536981210|FG000|Overall Study|Adverse Event|9|||
148864539|NCT05438602|536981211|FG000|Treatment (15 Days)|Adverse Event|2|||
148864540|NCT05438602|536981212|FG001|Treatment (15 Days)|Adverse Event|1|||
148864541|NCT05438602|536981213|FG002|Treatment (15 Days)|Adverse Event|3|||
148864542|NCT05438602|536981211|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
148864543|NCT05438602|536981212|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
148864544|NCT05438602|536981213|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
148864545|NCT05438602|536981211|FG000|Treatment (15 Days)|Other|0|||
148864546|NCT05438602|536981212|FG001|Treatment (15 Days)|Other|0|||
148864547|NCT05438602|536981213|FG002|Treatment (15 Days)|Other|1|||
148864548|NCT05438602|536981211|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
148864549|NCT05438602|536981212|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
148864550|NCT05438602|536981213|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
148864551|NCT05438602|536981211|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
148864552|NCT05438602|536981212|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
148864553|NCT05438602|536981213|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
148864554|NCT05438602|536981211|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
148864555|NCT05438602|536981212|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
148864556|NCT05438602|536981213|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
148864557|NCT05438602|536981211|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
148864558|NCT05438602|536981212|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
148864559|NCT05438602|536981213|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
148864560|NCT05438602|536981211|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
148864561|NCT05438602|536981212|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
148864562|NCT05438602|536981213|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
148864563|NCT05438602|536981211|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
148864564|NCT05438602|536981212|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
148995772|NCT02308748|537461058|FG009|Period 2|Adverse Event|0|||
148995773|NCT02308748|537461049|FG000|Period 3|Protocol Violation|0|||
148995774|NCT02308748|537461050|FG001|Period 3|Protocol Violation|0|||
148995775|NCT02308748|537461051|FG002|Period 3|Protocol Violation|0|||
148995776|NCT02308748|537461052|FG003|Period 3|Protocol Violation|0|||
148864565|NCT05438602|536981213|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
148864566|NCT05438602|536981211|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
148995777|NCT02308748|537461053|FG004|Period 3|Protocol Violation|0|||
148864567|NCT05438602|536981212|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
148864568|NCT05438602|536981213|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
148995778|NCT02308748|537461054|FG005|Period 3|Protocol Violation|0|||
148995779|NCT02308748|537461055|FG006|Period 3|Protocol Violation|0|||
148995780|NCT02308748|537461056|FG007|Period 3|Protocol Violation|0|||
149030923|NCT01956669|537591612|FG006|Overall Study|Physician Decision|0|||
148995781|NCT02308748|537461057|FG008|Period 3|Protocol Violation|0|||
148995782|NCT02308748|537461058|FG009|Period 3|Protocol Violation|1|||
148995783|NCT02308748|537461049|FG000|Period 5|Adverse Event|1|||
148995784|NCT02308748|537461050|FG001|Period 5|Adverse Event|0|||
148995785|NCT02308748|537461051|FG002|Period 5|Adverse Event|0|||
148995786|NCT02308748|537461052|FG003|Period 5|Adverse Event|0|||
148995787|NCT02308748|537461053|FG004|Period 5|Adverse Event|0|||
148995788|NCT02308748|537461054|FG005|Period 5|Adverse Event|0|||
148995789|NCT02308748|537461055|FG006|Period 5|Adverse Event|0|||
148995790|NCT02308748|537461056|FG007|Period 5|Adverse Event|0|||
148995791|NCT02308748|537461057|FG008|Period 5|Adverse Event|1|||
148995792|NCT02308748|537461058|FG009|Period 5|Adverse Event|0|||
148995793|NCT01988779|537461062|FG000|Overall Study|Withdrawal by Subject|2|||
148995794|NCT01988779|537461063|FG001|Overall Study|Withdrawal by Subject|2|||
148995795|NCT01988779|537461062|FG000|Overall Study|Protocol Violation|1|||
148995796|NCT01988779|537461063|FG001|Overall Study|Protocol Violation|0|||
148995797|NCT00377403|537461064|FG000|Overall Study|Unable to contact for telephone intervie|4|||
148995798|NCT00377403|537461065|FG001|Overall Study|Unable to contact for telephone intervie|7|||
148995799|NCT00417079|537461067|FG000|Overall Study|Disease progression|267|||
148995800|NCT00417079|537461068|FG001|Overall Study|Disease progression|180|||
148995801|NCT00417079|537461067|FG000|Overall Study|Adverse Event|32|||
148995802|NCT00417079|537461068|FG001|Overall Study|Adverse Event|67|||
148995803|NCT00417079|537461067|FG000|Overall Study|Non-compliance to protocol|0|||
148995804|NCT00417079|537461068|FG001|Overall Study|Non-compliance to protocol|1|||
148995805|NCT00417079|537461067|FG000|Overall Study|Lost to Follow-up|2|||
148995806|NCT00417079|537461068|FG001|Overall Study|Lost to Follow-up|0|||
148864569|NCT02091284|536981214|FG000|Overall Study|Withdrawal by Subject|2|||
148864570|NCT02091284|536981215|FG001|Overall Study|Withdrawal by Subject|1|||
148864571|NCT02091284|536981214|FG000|Overall Study|unreliable data|1|||
148864572|NCT02091284|536981215|FG001|Overall Study|unreliable data|0|||
148864573|NCT04524455|536981220|FG000|Overall Study|Death|3|||
148995807|NCT00417079|537461067|FG000|Overall Study|Withdrawal by Subject|17|||
148995808|NCT00417079|537461068|FG001|Overall Study|Withdrawal by Subject|8|||
148995809|NCT00417079|537461067|FG000|Overall Study|Not treated|6|||
148995810|NCT00417079|537461068|FG001|Overall Study|Not treated|7|||
148995811|NCT00417079|537461067|FG000|Overall Study|Screened failure|2|||
148995812|NCT00417079|537461068|FG001|Overall Study|Screened failure|1|||
148995813|NCT00417079|537461067|FG000|Overall Study|Investigator's decision|1|||
148995814|NCT00417079|537461068|FG001|Overall Study|Investigator's decision|4|||
148995815|NCT00417079|537461067|FG000|Overall Study|Non-confirmed Disease progression|1|||
148995816|NCT00417079|537461068|FG001|Overall Study|Non-confirmed Disease progression|1|||
148995817|NCT00417079|537461067|FG000|Overall Study|Clinical deterioration|1|||
148995818|NCT00417079|537461068|FG001|Overall Study|Clinical deterioration|0|||
148864574|NCT04524455|536981221|FG001|Overall Study|Death|3|||
148864575|NCT04524455|536981220|FG000|Overall Study|Decision by Sponsor|0|||
148864576|NCT04524455|536981221|FG001|Overall Study|Decision by Sponsor|2|||
148864577|NCT04524455|536981220|FG000|Overall Study|Withdrawal of Consent From Study|1|||
148864578|NCT04524455|536981221|FG001|Overall Study|Withdrawal of Consent From Study|0|||
148864579|NCT04524455|536981220|FG000|Overall Study|Lost to Follow-up|0|||
148864580|NCT04524455|536981221|FG001|Overall Study|Lost to Follow-up|1|||
148995819|NCT00417079|537461067|FG000|Overall Study|Screening error|2|||
148995820|NCT00417079|537461068|FG001|Overall Study|Screening error|1|||
148995821|NCT00417079|537461067|FG000|Overall Study|Withdrawal by subject's family|0|||
148995822|NCT00417079|537461068|FG001|Overall Study|Withdrawal by subject's family|1|||
148995823|NCT00417079|537461067|FG000|Overall Study|Patient unable to come to the clinic|0|||
148995824|NCT00417079|537461068|FG001|Overall Study|Patient unable to come to the clinic|1|||
148995825|NCT00417079|537461067|FG000|Overall Study|abnormal liver function tests|0|||
148995826|NCT00417079|537461068|FG001|Overall Study|abnormal liver function tests|1|||
148995827|NCT01687257|537461070|FG000|Overall Study|Efficacy Failure|6|||
148995828|NCT01687257|537461071|FG001|Overall Study|Efficacy Failure|0|||
148995829|NCT01687257|537461072|FG002|Overall Study|Efficacy Failure|5|||
148995830|NCT01687257|537461070|FG000|Overall Study|Subject Withdrew Consent|1|||
148995831|NCT01687257|537461071|FG001|Overall Study|Subject Withdrew Consent|1|||
148995832|NCT01687257|537461072|FG002|Overall Study|Subject Withdrew Consent|1|||
149030924|NCT01956669|537591606|FG000|Overall Study|Withdrawal by Subject|0|||
149030925|NCT01956669|537591607|FG001|Overall Study|Withdrawal by Subject|0|||
148995833|NCT01687257|537461070|FG000|Overall Study|Adverse Event|1|||
148995834|NCT01687257|537461071|FG001|Overall Study|Adverse Event|0|||
148995835|NCT01687257|537461072|FG002|Overall Study|Adverse Event|0|||
148995836|NCT01687257|537461070|FG000|Overall Study|Investigator's Discretion|0|||
148995837|NCT01687257|537461071|FG001|Overall Study|Investigator's Discretion|3|||
149030926|NCT01956669|537591608|FG002|Overall Study|Withdrawal by Subject|1|||
148864581|NCT00076336|536981224|FG000|Overall Study|Death|13|||
148995838|NCT01687257|537461072|FG002|Overall Study|Investigator's Discretion|0|||
148995839|NCT00983073|537461074|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
149030927|NCT01956669|537591609|FG003|Overall Study|Withdrawal by Subject|1|||
148864582|NCT00076336|536981225|FG001|Overall Study|Death|17|||
148864583|NCT00076336|536981224|FG000|Overall Study|Adverse Event|4|||
148864584|NCT00076336|536981225|FG001|Overall Study|Adverse Event|4|||
148864585|NCT00076336|536981224|FG000|Overall Study|Lost to Follow-up|4|||
148864586|NCT00076336|536981225|FG001|Overall Study|Lost to Follow-up|4|||
148864587|NCT00076336|536981224|FG000|Overall Study|Non-Compliance|2|||
148864588|NCT00076336|536981225|FG001|Overall Study|Non-Compliance|0|||
148864589|NCT00076336|536981224|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
148864590|NCT00076336|536981225|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
148864591|NCT00076336|536981224|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
148864592|NCT00076336|536981225|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
148864593|NCT00076336|536981224|FG000|Overall Study|Liver Transplantation|3|||
148864594|NCT00076336|536981225|FG001|Overall Study|Liver Transplantation|3|||
148864595|NCT00076336|536981224|FG000|Overall Study|Virologic Breakthrough|14|||
148864596|NCT00076336|536981225|FG001|Overall Study|Virologic Breakthrough|16|||
148864597|NCT00076336|536981224|FG000|Overall Study|Treatment failure|4|||
148864598|NCT00076336|536981225|FG001|Overall Study|Treatment failure|5|||
148864599|NCT00098722|536981229|FG000|Double Blind Phase|Adverse Event|7|||
148864600|NCT00098722|536981230|FG001|Double Blind Phase|Adverse Event|7|||
148864601|NCT00098722|536981231|FG002|Double Blind Phase|Adverse Event|3|||
148864602|NCT00098722|536981232|FG003|Double Blind Phase|Adverse Event|0|||
148864603|NCT00098722|536981233|FG004|Double Blind Phase|Adverse Event|0|||
148864604|NCT00098722|536981234|FG005|Double Blind Phase|Adverse Event|0|||
148864605|NCT00098722|536981235|FG006|Double Blind Phase|Adverse Event|0|||
148864606|NCT00098722|536981229|FG000|Double Blind Phase|Death|2|||
148864607|NCT00098722|536981230|FG001|Double Blind Phase|Death|5|||
148864608|NCT00098722|536981231|FG002|Double Blind Phase|Death|0|||
148864609|NCT00098722|536981232|FG003|Double Blind Phase|Death|0|||
148864610|NCT00098722|536981233|FG004|Double Blind Phase|Death|0|||
148864611|NCT00098722|536981234|FG005|Double Blind Phase|Death|0|||
148864612|NCT00098722|536981235|FG006|Double Blind Phase|Death|0|||
148864613|NCT00098722|536981229|FG000|Double Blind Phase|Lack of Efficacy|21|||
148864614|NCT00098722|536981230|FG001|Double Blind Phase|Lack of Efficacy|23|||
148864615|NCT00098722|536981231|FG002|Double Blind Phase|Lack of Efficacy|15|||
148864616|NCT00098722|536981232|FG003|Double Blind Phase|Lack of Efficacy|0|||
148864617|NCT00098722|536981233|FG004|Double Blind Phase|Lack of Efficacy|0|||
148864618|NCT00098722|536981234|FG005|Double Blind Phase|Lack of Efficacy|0|||
148864619|NCT00098722|536981235|FG006|Double Blind Phase|Lack of Efficacy|0|||
148864620|NCT00098722|536981229|FG000|Double Blind Phase|Participant defaulted|16|||
148864621|NCT00098722|536981230|FG001|Double Blind Phase|Participant defaulted|11|||
148864622|NCT00098722|536981231|FG002|Double Blind Phase|Participant defaulted|9|||
148864623|NCT00098722|536981232|FG003|Double Blind Phase|Participant defaulted|0|||
148864624|NCT00098722|536981233|FG004|Double Blind Phase|Participant defaulted|0|||
148864625|NCT00098722|536981234|FG005|Double Blind Phase|Participant defaulted|0|||
148864626|NCT00098722|536981235|FG006|Double Blind Phase|Participant defaulted|0|||
148864627|NCT00098722|536981229|FG000|Double Blind Phase|Pregnancy|1|||
148864628|NCT00098722|536981230|FG001|Double Blind Phase|Pregnancy|0|||
148864629|NCT00098722|536981231|FG002|Double Blind Phase|Pregnancy|0|||
148864630|NCT00098722|536981232|FG003|Double Blind Phase|Pregnancy|0|||
148864631|NCT00098722|536981233|FG004|Double Blind Phase|Pregnancy|0|||
148864632|NCT00098722|536981234|FG005|Double Blind Phase|Pregnancy|0|||
148864633|NCT00098722|536981235|FG006|Double Blind Phase|Pregnancy|0|||
148864634|NCT00098722|536981229|FG000|Double Blind Phase|Randomized, not treated|4|||
148864635|NCT00098722|536981230|FG001|Double Blind Phase|Randomized, not treated|3|||
148864636|NCT00098722|536981231|FG002|Double Blind Phase|Randomized, not treated|3|||
148864637|NCT00098722|536981232|FG003|Double Blind Phase|Randomized, not treated|0|||
148864638|NCT00098722|536981233|FG004|Double Blind Phase|Randomized, not treated|0|||
148864639|NCT00098722|536981234|FG005|Double Blind Phase|Randomized, not treated|0|||
148864640|NCT00098722|536981235|FG006|Double Blind Phase|Randomized, not treated|0|||
148864641|NCT00098722|536981229|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
148864642|NCT00098722|536981230|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
148864643|NCT00098722|536981231|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
148864644|NCT00098722|536981232|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
148864645|NCT00098722|536981233|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
148864646|NCT00098722|536981234|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
148864647|NCT00098722|536981235|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
148864648|NCT00098722|536981229|FG000|Double Blind Phase|Other|7|||
148864649|NCT00098722|536981230|FG001|Double Blind Phase|Other|8|||
148864650|NCT00098722|536981231|FG002|Double Blind Phase|Other|7|||
148864651|NCT00098722|536981232|FG003|Double Blind Phase|Other|0|||
148864652|NCT00098722|536981233|FG004|Double Blind Phase|Other|0|||
148864653|NCT00098722|536981234|FG005|Double Blind Phase|Other|0|||
148864654|NCT00098722|536981235|FG006|Double Blind Phase|Other|0|||
148864655|NCT00098722|536981229|FG000|Open Label Phase|Adverse Event|0|||
148864656|NCT00098722|536981230|FG001|Open Label Phase|Adverse Event|0|||
148864657|NCT00098722|536981231|FG002|Open Label Phase|Adverse Event|0|||
148864658|NCT00098722|536981232|FG003|Open Label Phase|Adverse Event|5|||
148864659|NCT00098722|536981233|FG004|Open Label Phase|Adverse Event|0|||
148864660|NCT00098722|536981234|FG005|Open Label Phase|Adverse Event|0|||
148864661|NCT00098722|536981235|FG006|Open Label Phase|Adverse Event|0|||
148995840|NCT00983073|537461074|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
148995841|NCT00983073|537461074|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
148995842|NCT00983073|537461074|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
148995843|NCT00983073|537461074|FG000|Titration and Optimal Dose Period|Other reason|4|||
148995844|NCT00983073|537461074|FG000|Maintenance Period|Adverse Event|5|||
148995845|NCT00983073|537461074|FG000|Maintenance Period|Withdrawal by Subject|2|||
148995846|NCT00983073|537461074|FG000|Maintenance Period|Lack of Efficacy|2|||
148995847|NCT00983073|537461074|FG000|Maintenance Period|Other Reason|7|||
148864662|NCT00098722|536981229|FG000|Open Label Phase|Death|0|||
148995848|NCT00234065|537461075|FG000|Overall Study|Adverse Event|268|||
148995849|NCT00234065|537461076|FG001|Overall Study|Adverse Event|166|||
148995850|NCT00234065|537461075|FG000|Overall Study|Withdrawal by Subject|73|||
148995851|NCT00234065|537461076|FG001|Overall Study|Withdrawal by Subject|56|||
148995852|NCT00234065|537461075|FG000|Overall Study|Physician Decision|23|||
148995853|NCT00234065|537461076|FG001|Overall Study|Physician Decision|22|||
148995854|NCT00234065|537461075|FG000|Overall Study|Not Classified|111|||
148995855|NCT00234065|537461076|FG001|Overall Study|Not Classified|112|||
148995856|NCT05557942|537461077|FG000|Overall Study|Death|0|||
148995857|NCT05557942|537461078|FG001|Overall Study|Death|0|||
148995858|NCT05557942|537461079|FG002|Overall Study|Death|0|||
148995859|NCT05557942|537461080|FG003|Overall Study|Death|2|||
148995860|NCT05557942|537461081|FG004|Overall Study|Death|1|||
148995861|NCT05557942|537461082|FG005|Overall Study|Death|1|||
148995862|NCT05557942|537461077|FG000|Overall Study|Physician Decision|1|||
148995863|NCT05557942|537461078|FG001|Overall Study|Physician Decision|1|||
148995864|NCT05557942|537461079|FG002|Overall Study|Physician Decision|2|||
148995865|NCT05557942|537461080|FG003|Overall Study|Physician Decision|3|||
148995866|NCT05557942|537461081|FG004|Overall Study|Physician Decision|0|||
148995867|NCT05557942|537461082|FG005|Overall Study|Physician Decision|2|||
148995868|NCT05557942|537461077|FG000|Overall Study|Study terminated by sponsor|17|||
148995869|NCT05557942|537461078|FG001|Overall Study|Study terminated by sponsor|17|||
148995870|NCT05557942|537461079|FG002|Overall Study|Study terminated by sponsor|14|||
148995871|NCT05557942|537461080|FG003|Overall Study|Study terminated by sponsor|40|||
148995872|NCT05557942|537461081|FG004|Overall Study|Study terminated by sponsor|45|||
148995873|NCT05557942|537461082|FG005|Overall Study|Study terminated by sponsor|37|||
148995874|NCT05557942|537461077|FG000|Overall Study|Protocol Violation|0|||
148995875|NCT05557942|537461078|FG001|Overall Study|Protocol Violation|0|||
148995876|NCT05557942|537461079|FG002|Overall Study|Protocol Violation|0|||
148995877|NCT05557942|537461080|FG003|Overall Study|Protocol Violation|0|||
148995878|NCT05557942|537461081|FG004|Overall Study|Protocol Violation|0|||
148995879|NCT05557942|537461082|FG005|Overall Study|Protocol Violation|1|||
148995880|NCT05557942|537461077|FG000|Overall Study|Withdrawal by Subject|0|||
148995881|NCT05557942|537461078|FG001|Overall Study|Withdrawal by Subject|0|||
148995882|NCT05557942|537461079|FG002|Overall Study|Withdrawal by Subject|0|||
148995883|NCT05557942|537461080|FG003|Overall Study|Withdrawal by Subject|0|||
148995884|NCT05557942|537461081|FG004|Overall Study|Withdrawal by Subject|2|||
148995885|NCT05557942|537461082|FG005|Overall Study|Withdrawal by Subject|0|||
148995886|NCT03776136|537461083|FG000|Overall Study|Death|85|||
148995887|NCT03776136|537461083|FG000|Overall Study|Withdrawal by Subject|3|||
148995888|NCT03776136|537461083|FG000|Overall Study|Sponsor Decision|15|||
148995889|NCT05245864|537461090|FG000|Overall Study|Withdrawal by Subject|1|||
148995890|NCT05245864|537461091|FG001|Overall Study|Withdrawal by Subject|1|||
148995891|NCT00643916|537462964|FG000|Overall Study|Protocol Violation|0|||
148864663|NCT00098722|536981230|FG001|Open Label Phase|Death|0|||
148995892|NCT00643916|537462965|FG001|Overall Study|Protocol Violation|1|||
148995893|NCT00643916|537462966|FG002|Overall Study|Protocol Violation|1|||
148995894|NCT00643916|537462967|FG003|Overall Study|Protocol Violation|1|||
148995895|NCT00643916|537462968|FG004|Overall Study|Protocol Violation|0|||
148995896|NCT00643916|537462969|FG005|Overall Study|Protocol Violation|0|||
148995897|NCT00643916|537462964|FG000|Overall Study|Lost to Follow-up|0|||
148995898|NCT00643916|537462965|FG001|Overall Study|Lost to Follow-up|1|||
148995899|NCT00643916|537462966|FG002|Overall Study|Lost to Follow-up|0|||
148995900|NCT00643916|537462967|FG003|Overall Study|Lost to Follow-up|0|||
148995901|NCT00643916|537462968|FG004|Overall Study|Lost to Follow-up|0|||
148995902|NCT00643916|537462969|FG005|Overall Study|Lost to Follow-up|0|||
148995903|NCT00643916|537462964|FG000|Overall Study|Withdrawal by Subject|2|||
148995904|NCT00643916|537462965|FG001|Overall Study|Withdrawal by Subject|2|||
148995905|NCT00643916|537462966|FG002|Overall Study|Withdrawal by Subject|2|||
148995906|NCT00643916|537462967|FG003|Overall Study|Withdrawal by Subject|1|||
148995907|NCT00643916|537462968|FG004|Overall Study|Withdrawal by Subject|0|||
148995908|NCT00643916|537462969|FG005|Overall Study|Withdrawal by Subject|1|||
148995909|NCT00643916|537462964|FG000|Overall Study|Not Vaccinated|2|||
148995910|NCT00643916|537462965|FG001|Overall Study|Not Vaccinated|2|||
148995911|NCT00643916|537462966|FG002|Overall Study|Not Vaccinated|3|||
148995912|NCT00643916|537462967|FG003|Overall Study|Not Vaccinated|0|||
148995913|NCT00643916|537462968|FG004|Overall Study|Not Vaccinated|2|||
148995914|NCT00643916|537462969|FG005|Overall Study|Not Vaccinated|0|||
148995915|NCT00677833|537462972|FG000|Overall Study|Withdrawal by Subject|4|||
148864664|NCT00098722|536981231|FG002|Open Label Phase|Death|0|||
148864665|NCT00098722|536981232|FG003|Open Label Phase|Death|2|||
148864666|NCT00098722|536981233|FG004|Open Label Phase|Death|0|||
148864667|NCT00098722|536981234|FG005|Open Label Phase|Death|0|||
148864668|NCT00098722|536981235|FG006|Open Label Phase|Death|0|||
148864669|NCT00098722|536981229|FG000|Open Label Phase|Lack of Efficacy|0|||
148864670|NCT00098722|536981230|FG001|Open Label Phase|Lack of Efficacy|0|||
148864671|NCT00098722|536981231|FG002|Open Label Phase|Lack of Efficacy|0|||
148864672|NCT00098722|536981232|FG003|Open Label Phase|Lack of Efficacy|8|||
148864673|NCT00098722|536981233|FG004|Open Label Phase|Lack of Efficacy|0|||
148864674|NCT00098722|536981234|FG005|Open Label Phase|Lack of Efficacy|0|||
148864675|NCT00098722|536981235|FG006|Open Label Phase|Lack of Efficacy|0|||
148864676|NCT00098722|536981229|FG000|Open Label Phase|Pregnancy|0|||
148864677|NCT00098722|536981230|FG001|Open Label Phase|Pregnancy|0|||
148864678|NCT00098722|536981231|FG002|Open Label Phase|Pregnancy|0|||
148864679|NCT00098722|536981232|FG003|Open Label Phase|Pregnancy|1|||
148864680|NCT00098722|536981233|FG004|Open Label Phase|Pregnancy|0|||
148864681|NCT00098722|536981234|FG005|Open Label Phase|Pregnancy|0|||
148864682|NCT00098722|536981235|FG006|Open Label Phase|Pregnancy|0|||
148864683|NCT00098722|536981229|FG000|Open Label Phase|Participant defaulted|0|||
148864684|NCT00098722|536981230|FG001|Open Label Phase|Participant defaulted|0|||
148864685|NCT00098722|536981231|FG002|Open Label Phase|Participant defaulted|0|||
148864686|NCT00098722|536981232|FG003|Open Label Phase|Participant defaulted|18|||
148864687|NCT00098722|536981233|FG004|Open Label Phase|Participant defaulted|0|||
148864688|NCT00098722|536981234|FG005|Open Label Phase|Participant defaulted|0|||
148864689|NCT00098722|536981235|FG006|Open Label Phase|Participant defaulted|0|||
148864690|NCT00098722|536981229|FG000|Open Label Phase|Ongoing at cut-off date|0|||
148864691|NCT00098722|536981230|FG001|Open Label Phase|Ongoing at cut-off date|0|||
148864692|NCT00098722|536981231|FG002|Open Label Phase|Ongoing at cut-off date|0|||
148864693|NCT00098722|536981232|FG003|Open Label Phase|Ongoing at cut-off date|220|||
148864694|NCT00098722|536981233|FG004|Open Label Phase|Ongoing at cut-off date|50|||
148864695|NCT00098722|536981234|FG005|Open Label Phase|Ongoing at cut-off date|0|||
148864696|NCT00098722|536981235|FG006|Open Label Phase|Ongoing at cut-off date|0|||
148864697|NCT00098722|536981229|FG000|Open Label Phase|Other|0|||
148864698|NCT00098722|536981230|FG001|Open Label Phase|Other|0|||
148864699|NCT00098722|536981231|FG002|Open Label Phase|Other|0|||
148864700|NCT00098722|536981232|FG003|Open Label Phase|Other|18|||
148864701|NCT00098722|536981233|FG004|Open Label Phase|Other|0|||
148864702|NCT00098722|536981234|FG005|Open Label Phase|Other|0|||
148864703|NCT00098722|536981235|FG006|Open Label Phase|Other|0|||
148864704|NCT00098722|536981229|FG000|Observation Phase|Death|0|||
148864705|NCT00098722|536981230|FG001|Observation Phase|Death|0|||
148864706|NCT00098722|536981231|FG002|Observation Phase|Death|0|||
148864707|NCT00098722|536981232|FG003|Observation Phase|Death|0|||
148864708|NCT00098722|536981233|FG004|Observation Phase|Death|0|||
148864709|NCT00098722|536981234|FG005|Observation Phase|Death|5|||
148864710|NCT00098722|536981235|FG006|Observation Phase|Death|3|||
148864711|NCT00098722|536981229|FG000|Observation Phase|Lack of Efficacy|0|||
148864712|NCT00098722|536981230|FG001|Observation Phase|Lack of Efficacy|0|||
148864713|NCT00098722|536981231|FG002|Observation Phase|Lack of Efficacy|0|||
148864714|NCT00098722|536981232|FG003|Observation Phase|Lack of Efficacy|0|||
148864715|NCT00098722|536981233|FG004|Observation Phase|Lack of Efficacy|0|||
148864716|NCT00098722|536981234|FG005|Observation Phase|Lack of Efficacy|2|||
148864717|NCT00098722|536981235|FG006|Observation Phase|Lack of Efficacy|0|||
148864718|NCT00098722|536981229|FG000|Observation Phase|Participant defaulted|0|||
148864719|NCT00098722|536981230|FG001|Observation Phase|Participant defaulted|0|||
148864720|NCT00098722|536981231|FG002|Observation Phase|Participant defaulted|0|||
148864721|NCT00098722|536981232|FG003|Observation Phase|Participant defaulted|0|||
148864722|NCT00098722|536981233|FG004|Observation Phase|Participant defaulted|0|||
148864723|NCT00098722|536981234|FG005|Observation Phase|Participant defaulted|17|||
148864724|NCT00098722|536981235|FG006|Observation Phase|Participant defaulted|4|||
148864725|NCT00098722|536981229|FG000|Observation Phase|Other|0|||
148864726|NCT00098722|536981230|FG001|Observation Phase|Other|0|||
148864727|NCT00098722|536981231|FG002|Observation Phase|Other|0|||
148864728|NCT00098722|536981232|FG003|Observation Phase|Other|0|||
148864729|NCT00098722|536981233|FG004|Observation Phase|Other|0|||
148864730|NCT00098722|536981234|FG005|Observation Phase|Other|21|||
148864731|NCT00098722|536981235|FG006|Observation Phase|Other|10|||
148864732|NCT02351349|536981241|FG000|Overall Study|Withdrawal by Subject|2|||
148864733|NCT02351349|536981242|FG001|Overall Study|Withdrawal by Subject|3|||
148864734|NCT01703117|536981243|FG000|Overall Study|Adverse Event|4|||
148864735|NCT01703117|536981244|FG001|Overall Study|Adverse Event|3|||
148864736|NCT01703117|536981243|FG000|Overall Study|Withdrawal by Subject|0|||
148864737|NCT01703117|536981244|FG001|Overall Study|Withdrawal by Subject|1|||
148864738|NCT01340937|536981246|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
148864739|NCT01340937|536981247|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
148864740|NCT01340937|536981248|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
148864741|NCT01340937|536981249|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
148864742|NCT01340937|536981246|FG000|Period 1: Infant Series|Adverse Event|0|||
148864743|NCT01340937|536981247|FG001|Period 1: Infant Series|Adverse Event|1|||
148995916|NCT00677833|537462973|FG001|Overall Study|Withdrawal by Subject|0|||
148995917|NCT00677833|537462974|FG002|Overall Study|Withdrawal by Subject|1|||
148995918|NCT00677833|537462975|FG003|Overall Study|Withdrawal by Subject|3|||
148995919|NCT00677833|537462972|FG000|Overall Study|Lost to Follow-up|0|||
148995920|NCT00677833|537462973|FG001|Overall Study|Lost to Follow-up|0|||
148995921|NCT00677833|537462974|FG002|Overall Study|Lost to Follow-up|1|||
148995922|NCT00677833|537462975|FG003|Overall Study|Lost to Follow-up|0|||
148995923|NCT02606279|537462976|FG000|Overall Study|Lost to Follow-up|0|||
148995924|NCT02606279|537462977|FG001|Overall Study|Lost to Follow-up|1|||
148995925|NCT03252587|537462978|FG000|Overall Study|Adverse Event|3|||
148995926|NCT03252587|537462979|FG001|Overall Study|Adverse Event|8|||
148995927|NCT03252587|537462980|FG002|Overall Study|Adverse Event|6|||
148995928|NCT03252587|537462981|FG003|Overall Study|Adverse Event|12|||
148995929|NCT03252587|537462978|FG000|Overall Study|Lack of Efficacy|7|||
148995930|NCT03252587|537462979|FG001|Overall Study|Lack of Efficacy|2|||
148995931|NCT03252587|537462980|FG002|Overall Study|Lack of Efficacy|2|||
148995932|NCT03252587|537462981|FG003|Overall Study|Lack of Efficacy|4|||
148995933|NCT03252587|537462978|FG000|Overall Study|Lost to Follow-up|2|||
148995934|NCT03252587|537462979|FG001|Overall Study|Lost to Follow-up|0|||
148995935|NCT03252587|537462980|FG002|Overall Study|Lost to Follow-up|0|||
148995936|NCT03252587|537462981|FG003|Overall Study|Lost to Follow-up|2|||
148995937|NCT03252587|537462978|FG000|Overall Study|Pregnancy|2|||
148995938|NCT03252587|537462979|FG001|Overall Study|Pregnancy|1|||
148995939|NCT03252587|537462980|FG002|Overall Study|Pregnancy|0|||
148995940|NCT03252587|537462981|FG003|Overall Study|Pregnancy|1|||
148995941|NCT03252587|537462978|FG000|Overall Study|Withdrawal by Subject|8|||
148995942|NCT03252587|537462979|FG001|Overall Study|Withdrawal by Subject|4|||
148995943|NCT03252587|537462980|FG002|Overall Study|Withdrawal by Subject|4|||
148995944|NCT03252587|537462981|FG003|Overall Study|Withdrawal by Subject|4|||
148995945|NCT03252587|537462978|FG000|Overall Study|Other Reasons|2|||
148995946|NCT03252587|537462979|FG001|Overall Study|Other Reasons|5|||
148995947|NCT03252587|537462980|FG002|Overall Study|Other Reasons|5|||
148995948|NCT03252587|537462981|FG003|Overall Study|Other Reasons|4|||
148995949|NCT05130970|537462985|FG000|Overall Study|Adverse Event|1|||
148995950|NCT05130970|537462986|FG001|Overall Study|Adverse Event|1|||
148995951|NCT05130970|537462985|FG000|Overall Study|Death|0|||
148995952|NCT05130970|537462986|FG001|Overall Study|Death|1|||
148995953|NCT05130970|537462985|FG000|Overall Study|Lost to Follow-up|0|||
148995954|NCT05130970|537462986|FG001|Overall Study|Lost to Follow-up|1|||
148995955|NCT05130970|537462985|FG000|Overall Study|Physician Decision|0|||
148995956|NCT05130970|537462986|FG001|Overall Study|Physician Decision|1|||
148995957|NCT05130970|537462985|FG000|Overall Study|Withdrawal by Subject|1|||
148995958|NCT05130970|537462986|FG001|Overall Study|Withdrawal by Subject|1|||
148995959|NCT01640808|537462987|FG000|Overall Study|Unable to continue dynamic CT|14|||
148995960|NCT01640808|537462988|FG001|Overall Study|Unable to continue dynamic CT|4|||
148995961|NCT01640808|537462987|FG000|Overall Study|Withdrawal by Subject|12|||
148995962|NCT01640808|537462988|FG001|Overall Study|Withdrawal by Subject|4|||
148995963|NCT01640808|537462987|FG000|Overall Study|Lost to Follow-up|4|||
148995964|NCT01640808|537462988|FG001|Overall Study|Lost to Follow-up|0|||
148995965|NCT01640808|537462987|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
148995966|NCT01640808|537462988|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
148995967|NCT01640808|537462987|FG000|Overall Study|Administration of anticancer drugs|2|||
148995968|NCT01640808|537462988|FG001|Overall Study|Administration of anticancer drugs|1|||
148995969|NCT01640808|537462987|FG000|Overall Study|Physician Decision|19|||
148995970|NCT01640808|537462988|FG001|Overall Study|Physician Decision|5|||
148995971|NCT01640808|537462987|FG000|Overall Study|Randomized but not treated|4|||
148995972|NCT01640808|537462988|FG001|Overall Study|Randomized but not treated|2|||
148995973|NCT03896035|537462989|FG000|Overall Study|Lost to Follow-up|2|||
148995974|NCT03896035|537462990|FG001|Overall Study|Lost to Follow-up|6|||
148995975|NCT03896035|537462989|FG000|Overall Study|Withdrawal by Subject|0|||
148995976|NCT03896035|537462990|FG001|Overall Study|Withdrawal by Subject|1|||
148995977|NCT03896035|537462989|FG000|Overall Study|Health/family health issues during COVID|0|||
148995978|NCT03896035|537462990|FG001|Overall Study|Health/family health issues during COVID|4|||
148995979|NCT00675766|537462991|FG000|Overall Study|Lost to Follow-up|6|||
148995980|NCT00675766|537462992|FG001|Overall Study|Lost to Follow-up|5|||
148864744|NCT01340937|536981248|FG002|Period 1: Infant Series|Adverse Event|4|||
148864745|NCT01340937|536981249|FG003|Period 1: Infant Series|Adverse Event|0|||
148995981|NCT00675766|537462993|FG002|Overall Study|Lost to Follow-up|21|||
148995982|NCT00675766|537462994|FG003|Overall Study|Lost to Follow-up|26|||
148995983|NCT01749982|537462995|FG000|Overall Study|Physician Decision|0|||
148995984|NCT01749982|537462996|FG001|Overall Study|Physician Decision|0|||
148995985|NCT01749982|537462997|FG002|Overall Study|Physician Decision|0|||
148995986|NCT01749982|537462998|FG003|Overall Study|Physician Decision|1|||
148995987|NCT01749982|537462995|FG000|Overall Study|Lost to Follow-up|0|||
148995988|NCT01749982|537462996|FG001|Overall Study|Lost to Follow-up|0|||
148995989|NCT01749982|537462997|FG002|Overall Study|Lost to Follow-up|0|||
148995990|NCT01749982|537462998|FG003|Overall Study|Lost to Follow-up|1|||
148995991|NCT01749982|537462995|FG000|Overall Study|Withdrawal by Subject|0|||
148995992|NCT01749982|537462996|FG001|Overall Study|Withdrawal by Subject|0|||
149030928|NCT01956669|537591610|FG004|Overall Study|Withdrawal by Subject|0|||
149030929|NCT01956669|537591611|FG005|Overall Study|Withdrawal by Subject|0|||
149030930|NCT01956669|537591612|FG006|Overall Study|Withdrawal by Subject|1|||
149030931|NCT01908634|537591613|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
149030932|NCT01908634|537591613|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
149030933|NCT00464672|537591615|FG000|Overall Study|withdrawal of consent|0|||
149030934|NCT00464672|537591616|FG001|Overall Study|withdrawal of consent|0|||
149030935|NCT00464672|537591617|FG002|Overall Study|withdrawal of consent|0|||
149030936|NCT00464672|537591618|FG003|Overall Study|withdrawal of consent|1|||
149030937|NCT00464672|537591619|FG004|Overall Study|withdrawal of consent|9|||
149030938|NCT00464672|537591620|FG005|Overall Study|withdrawal of consent|4|||
149030939|NCT00464672|537591615|FG000|Overall Study|Lost to Follow-up|25|||
149030940|NCT00464672|537591616|FG001|Overall Study|Lost to Follow-up|10|||
149030941|NCT00464672|537591617|FG002|Overall Study|Lost to Follow-up|0|||
149030942|NCT00464672|537591618|FG003|Overall Study|Lost to Follow-up|0|||
149030943|NCT00464672|537591619|FG004|Overall Study|Lost to Follow-up|1|||
149030944|NCT00464672|537591620|FG005|Overall Study|Lost to Follow-up|0|||
149030945|NCT00601640|537591621|FG000|Overall Study|Withdrawal by Subject|3|||
149030946|NCT00601640|537591622|FG001|Overall Study|Withdrawal by Subject|0|||
149030947|NCT00601640|537591623|FG002|Overall Study|Withdrawal by Subject|7|||
149030948|NCT00601640|537591621|FG000|Overall Study|Death|1|||
149030949|NCT00601640|537591622|FG001|Overall Study|Death|0|||
149030950|NCT00601640|537591623|FG002|Overall Study|Death|0|||
149030951|NCT00601640|537591621|FG000|Overall Study|Adverse Event|0|||
149030952|NCT00601640|537591622|FG001|Overall Study|Adverse Event|4|||
149030953|NCT00601640|537591623|FG002|Overall Study|Adverse Event|2|||
149030954|NCT00601640|537591621|FG000|Overall Study|intercurrent illness|1|||
149030955|NCT00601640|537591622|FG001|Overall Study|intercurrent illness|0|||
149030956|NCT00601640|537591623|FG002|Overall Study|intercurrent illness|0|||
149030957|NCT00601640|537591621|FG000|Overall Study|change in eligibility status|0|||
149030958|NCT00601640|537591622|FG001|Overall Study|change in eligibility status|1|||
149030959|NCT00601640|537591623|FG002|Overall Study|change in eligibility status|1|||
149030960|NCT01710514|537591624|FG000|Overall Study|Adverse Event|6|||
149030961|NCT01710514|537591625|FG001|Overall Study|Adverse Event|7|||
149030962|NCT01710514|537591624|FG000|Overall Study|Withdrawal by Subject|1|||
149030963|NCT01710514|537591625|FG001|Overall Study|Withdrawal by Subject|0|||
149030964|NCT00544440|537591634|FG000|Overall Study|Other|1|||
149030965|NCT00544440|537591634|FG000|Overall Study|Adverse Event|1|||
149030966|NCT00544440|537591634|FG000|Overall Study|Withdrawal by Subject|2|||
149030967|NCT00544440|537591634|FG000|Overall Study|Subject Non-compliance|1|||
149030968|NCT00544440|537591634|FG000|Overall Study|Progressive Disease|47|||
149030969|NCT00544440|537591634|FG000|Overall Study|Other|5|||
149030970|NCT02107014|537591636|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
149030971|NCT03586167|537591637|FG000|Overall Study|Other|1|||
149030972|NCT03586167|537591638|FG001|Overall Study|Other|0|||
149030973|NCT00591838|537591639|FG000|Overall Study|Withdrawal by Subject|0|||
149030974|NCT00591838|537591640|FG001|Overall Study|Withdrawal by Subject|0|||
149030975|NCT00591838|537591641|FG002|Overall Study|Withdrawal by Subject|0|||
149030976|NCT00591838|537591642|FG003|Overall Study|Withdrawal by Subject|1|||
149030977|NCT00591838|537591643|FG004|Overall Study|Withdrawal by Subject|0|||
149030978|NCT03761784|537591644|FG000|Overall Study|Adverse Event|4|||
148995993|NCT01749982|537462997|FG002|Overall Study|Withdrawal by Subject|0|||
148995994|NCT01749982|537462998|FG003|Overall Study|Withdrawal by Subject|1|||
148995995|NCT01922076|537462999|FG000|Overall Study|Adverse Event|0|||
148995996|NCT01922076|537463000|FG001|Overall Study|Adverse Event|0|||
148995997|NCT01922076|537463001|FG002|Overall Study|Adverse Event|0|||
148995998|NCT01922076|537463002|FG003|Overall Study|Adverse Event|0|||
148995999|NCT01922076|537463003|FG004|Overall Study|Adverse Event|1|||
148996000|NCT01922076|537463004|FG005|Overall Study|Adverse Event|0|||
148996001|NCT01922076|537463005|FG006|Overall Study|Adverse Event|0|||
148996002|NCT01922076|537462999|FG000|Overall Study|Physician Decision|0|||
148996003|NCT01922076|537463000|FG001|Overall Study|Physician Decision|0|||
149030979|NCT03761784|537591645|FG001|Overall Study|Adverse Event|0|||
149030980|NCT03761784|537591644|FG000|Overall Study|Lost to Follow-up|10|||
149030981|NCT03761784|537591645|FG001|Overall Study|Lost to Follow-up|7|||
149030982|NCT03761784|537591644|FG000|Overall Study|Pregnancy|1|||
148996004|NCT01922076|537463001|FG002|Overall Study|Physician Decision|1|||
149030983|NCT03761784|537591645|FG001|Overall Study|Pregnancy|0|||
149030984|NCT03761784|537591644|FG000|Overall Study|Protocol Violation|2|||
148996005|NCT01922076|537463002|FG003|Overall Study|Physician Decision|0|||
149030985|NCT03761784|537591645|FG001|Overall Study|Protocol Violation|0|||
149030986|NCT03761784|537591644|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
149030987|NCT03761784|537591645|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
148996006|NCT01922076|537463003|FG004|Overall Study|Physician Decision|0|||
149030988|NCT03761784|537591644|FG000|Overall Study|Withdrawal by Subject|9|||
149030989|NCT03761784|537591645|FG001|Overall Study|Withdrawal by Subject|4|||
149030990|NCT03761784|537591644|FG000|Overall Study|Physician Decision|1|||
149030991|NCT03761784|537591645|FG001|Overall Study|Physician Decision|0|||
148996007|NCT01922076|537463004|FG005|Overall Study|Physician Decision|0|||
148996008|NCT01922076|537463005|FG006|Overall Study|Physician Decision|0|||
148996009|NCT01922076|537462999|FG000|Overall Study|Withdrawal by Subject|0|||
148996010|NCT01922076|537463000|FG001|Overall Study|Withdrawal by Subject|0|||
148996011|NCT01922076|537463001|FG002|Overall Study|Withdrawal by Subject|0|||
148996012|NCT01922076|537463002|FG003|Overall Study|Withdrawal by Subject|1|||
148996013|NCT01922076|537463003|FG004|Overall Study|Withdrawal by Subject|0|||
148996014|NCT01922076|537463004|FG005|Overall Study|Withdrawal by Subject|1|||
148996015|NCT01922076|537463005|FG006|Overall Study|Withdrawal by Subject|1|||
148996016|NCT01022762|537463006|FG000|Overall Study|Adverse Event|3|||
148996017|NCT01022762|537463007|FG001|Overall Study|Adverse Event|1|||
148996018|NCT01022762|537463006|FG000|Overall Study|Lack of Efficacy|0|||
148996019|NCT01022762|537463007|FG001|Overall Study|Lack of Efficacy|1|||
148996020|NCT01022762|537463006|FG000|Overall Study|Protocol Violation|7|||
148996021|NCT01022762|537463007|FG001|Overall Study|Protocol Violation|6|||
148996022|NCT01022762|537463006|FG000|Overall Study|Unclassified|12|||
148996023|NCT01022762|537463007|FG001|Overall Study|Unclassified|20|||
148996024|NCT00827918|537463008|FG000|Overall Study|Adverse Event|4|||
148996025|NCT00827918|537463009|FG001|Overall Study|Adverse Event|0|||
148996026|NCT00827918|537463010|FG002|Overall Study|Adverse Event|0|||
148996027|NCT00827918|537463008|FG000|Overall Study|Lack of Efficacy|16|||
148996028|NCT00827918|537463009|FG001|Overall Study|Lack of Efficacy|4|||
148996029|NCT00827918|537463010|FG002|Overall Study|Lack of Efficacy|15|||
148996030|NCT00827918|537463008|FG000|Overall Study|Physician Decision|1|||
148996031|NCT00827918|537463009|FG001|Overall Study|Physician Decision|0|||
148996032|NCT00827918|537463010|FG002|Overall Study|Physician Decision|0|||
148996033|NCT00827918|537463008|FG000|Overall Study|Pregnancy|0|||
148996034|NCT00827918|537463009|FG001|Overall Study|Pregnancy|1|||
148996035|NCT00827918|537463010|FG002|Overall Study|Pregnancy|0|||
148996036|NCT00827918|537463008|FG000|Overall Study|Progressive Disease|1|||
148996037|NCT00827918|537463009|FG001|Overall Study|Progressive Disease|1|||
148996038|NCT00827918|537463010|FG002|Overall Study|Progressive Disease|0|||
148996039|NCT00827918|537463008|FG000|Overall Study|Protocol Violation|0|||
148996040|NCT00827918|537463009|FG001|Overall Study|Protocol Violation|1|||
148996041|NCT00827918|537463010|FG002|Overall Study|Protocol Violation|0|||
148996042|NCT00827918|537463008|FG000|Overall Study|Withdrawal by Subject|6|||
148996043|NCT00827918|537463009|FG001|Overall Study|Withdrawal by Subject|2|||
148996044|NCT00827918|537463010|FG002|Overall Study|Withdrawal by Subject|6|||
148996045|NCT00802074|537463011|FG000|Overall Study|Adverse Event|1|||
148996046|NCT00802074|537463012|FG001|Overall Study|Adverse Event|1|||
148996047|NCT00802074|537463013|FG002|Overall Study|Adverse Event|1|||
148996048|NCT00802074|537463014|FG003|Overall Study|Adverse Event|0|||
148996049|NCT00802074|537463015|FG004|Overall Study|Adverse Event|0|||
148996050|NCT00802074|537463016|FG005|Overall Study|Adverse Event|0|||
148996051|NCT00802074|537463011|FG000|Overall Study|Withdrawal by Subject|1|||
148996052|NCT00802074|537463012|FG001|Overall Study|Withdrawal by Subject|0|||
148996053|NCT00802074|537463013|FG002|Overall Study|Withdrawal by Subject|0|||
148996054|NCT00802074|537463014|FG003|Overall Study|Withdrawal by Subject|0|||
148996055|NCT00802074|537463015|FG004|Overall Study|Withdrawal by Subject|0|||
148996056|NCT00802074|537463016|FG005|Overall Study|Withdrawal by Subject|0|||
148996057|NCT03743038|537463019|FG000|Overall Study|Physician Decision|1|||
148996058|NCT01565707|537463020|FG000|Overall Study|Adverse Event|1|||
148996059|NCT01565707|537463021|FG001|Overall Study|Adverse Event|6|||
148996060|NCT01565707|537463022|FG002|Overall Study|Adverse Event|2|||
148996061|NCT01565707|537463023|FG003|Overall Study|Adverse Event|1|||
148996062|NCT01565707|537463020|FG000|Overall Study|Lost to Follow-up|1|||
148996063|NCT01565707|537463021|FG001|Overall Study|Lost to Follow-up|0|||
148996064|NCT01565707|537463022|FG002|Overall Study|Lost to Follow-up|0|||
149030992|NCT03761784|537591644|FG000|Overall Study|Other Than Specified|1|||
149030993|NCT03761784|537591645|FG001|Overall Study|Other Than Specified|0|||
149030994|NCT00586339|537591646|FG000|Overall Study|Withdrawal by Subject|1|||
149030995|NCT00586339|537591647|FG001|Overall Study|Withdrawal by Subject|3|||
149030996|NCT00586339|537591648|FG002|Overall Study|Withdrawal by Subject|1|||
149030997|NCT00586339|537591646|FG000|Overall Study|Migrated/moved from study area|3|||
149030998|NCT00586339|537591647|FG001|Overall Study|Migrated/moved from study area|2|||
148996065|NCT01565707|537463023|FG003|Overall Study|Lost to Follow-up|0|||
148996066|NCT01565707|537463020|FG000|Overall Study|Protocol Violation|1|||
148996067|NCT01565707|537463021|FG001|Overall Study|Protocol Violation|0|||
148996068|NCT01565707|537463022|FG002|Overall Study|Protocol Violation|0|||
148996069|NCT01565707|537463023|FG003|Overall Study|Protocol Violation|1|||
148864746|NCT01340937|536981246|FG000|Period 1: Infant Series|Death|2|||
148996070|NCT01565707|537463020|FG000|Overall Study|Withdrawal by Subject|3|||
148996071|NCT01565707|537463021|FG001|Overall Study|Withdrawal by Subject|1|||
148996072|NCT01565707|537463022|FG002|Overall Study|Withdrawal by Subject|1|||
148996073|NCT01565707|537463023|FG003|Overall Study|Withdrawal by Subject|1|||
148996074|NCT01565707|537463020|FG000|Overall Study|Randomized but not evaluable|2|||
148996075|NCT01565707|537463021|FG001|Overall Study|Randomized but not evaluable|0|||
148996076|NCT01565707|537463022|FG002|Overall Study|Randomized but not evaluable|0|||
148996077|NCT01565707|537463023|FG003|Overall Study|Randomized but not evaluable|0|||
148996078|NCT01565707|537463020|FG000|Overall Study|Miscellaneous|1|||
148996079|NCT01565707|537463021|FG001|Overall Study|Miscellaneous|1|||
148996080|NCT01565707|537463022|FG002|Overall Study|Miscellaneous|0|||
148996081|NCT01565707|537463023|FG003|Overall Study|Miscellaneous|2|||
148996082|NCT05207813|537463024|FG000|Overall Study|Lost to Follow-up|2|||
148996083|NCT00617344|537463026|FG000|Overall Study|Serious adverse event|1|||
148996084|NCT00617344|537463027|FG001|Overall Study|Serious adverse event|0|||
148996085|NCT00617344|537463028|FG002|Overall Study|Serious adverse event|0|||
148996086|NCT00617344|537463026|FG000|Overall Study|Other Adverse Event|1|||
148996087|NCT00617344|537463027|FG001|Overall Study|Other Adverse Event|1|||
148996088|NCT00617344|537463028|FG002|Overall Study|Other Adverse Event|0|||
148996089|NCT00617344|537463026|FG000|Overall Study|Protocol Violation|10|||
148996090|NCT00617344|537463027|FG001|Overall Study|Protocol Violation|8|||
148996091|NCT00617344|537463028|FG002|Overall Study|Protocol Violation|5|||
148996092|NCT00617344|537463026|FG000|Overall Study|Lost to Follow-up|5|||
148996093|NCT00617344|537463027|FG001|Overall Study|Lost to Follow-up|4|||
148996094|NCT00617344|537463028|FG002|Overall Study|Lost to Follow-up|1|||
148996095|NCT00617344|537463026|FG000|Overall Study|Withdrawal by Subject|8|||
148996096|NCT00617344|537463027|FG001|Overall Study|Withdrawal by Subject|9|||
148996097|NCT00617344|537463028|FG002|Overall Study|Withdrawal by Subject|2|||
148996098|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
148996099|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
148996100|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
148996101|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
148996102|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
148996103|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
148996104|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
148996105|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
148996106|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
148996107|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
148996108|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
148996109|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
148996110|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
148996111|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
148996112|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
148996113|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
148996114|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
148996115|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
148996116|NCT00833638|537463029|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
148996117|NCT00833638|537463030|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
148996118|NCT00833638|537463031|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
148996119|NCT00833638|537463029|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
148996120|NCT00833638|537463030|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
148996121|NCT00833638|537463031|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
148996122|NCT00833638|537463029|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
148996123|NCT00833638|537463030|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
148996124|NCT00833638|537463031|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
148996125|NCT00490646|537463032|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
149030999|NCT00586339|537591648|FG002|Overall Study|Migrated/moved from study area|4|||
149031000|NCT00586339|537591646|FG000|Overall Study|Lost to Follow-up|3|||
148864747|NCT01340937|536981247|FG001|Period 1: Infant Series|Death|0|||
148864748|NCT01340937|536981248|FG002|Period 1: Infant Series|Death|2|||
148864749|NCT01340937|536981249|FG003|Period 1: Infant Series|Death|0|||
148864750|NCT01340937|536981246|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
148864751|NCT01340937|536981247|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
148864752|NCT01340937|536981248|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
148864753|NCT01340937|536981249|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
148864754|NCT01340937|536981246|FG000|Period 1: Infant Series|Physician Decision|2|||
148864755|NCT01340937|536981247|FG001|Period 1: Infant Series|Physician Decision|3|||
148864756|NCT01340937|536981248|FG002|Period 1: Infant Series|Physician Decision|1|||
148864757|NCT01340937|536981249|FG003|Period 1: Infant Series|Physician Decision|0|||
148864758|NCT01340937|536981246|FG000|Period 1: Infant Series|Protocol Violation|1|||
148864759|NCT01340937|536981247|FG001|Period 1: Infant Series|Protocol Violation|4|||
148996126|NCT00490646|537463033|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
148996127|NCT00490646|537463032|FG000|Overall Study|Never Treated (had an adverse event)|1|||
148996128|NCT00490646|537463033|FG001|Overall Study|Never Treated (had an adverse event)|0|||
148996129|NCT00490646|537463032|FG000|Overall Study|Never Treated (withdrew consent)|0|||
148996130|NCT00490646|537463033|FG001|Overall Study|Never Treated (withdrew consent)|1|||
149031001|NCT00586339|537591647|FG001|Overall Study|Lost to Follow-up|2|||
148864760|NCT01340937|536981248|FG002|Period 1: Infant Series|Protocol Violation|4|||
148864761|NCT01340937|536981249|FG003|Period 1: Infant Series|Protocol Violation|3|||
148864762|NCT01340937|536981246|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
148864763|NCT01340937|536981247|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
148996131|NCT01178086|537463034|FG000|Overall Study|Participant refusal|7|||
148996132|NCT01178086|537463034|FG000|Overall Study|Physician Decision|44|||
148996133|NCT01178086|537463034|FG000|Overall Study|Switch to other CLL therapy|113|||
148996134|NCT01178086|537463034|FG000|Overall Study|Death|59|||
148996135|NCT01178086|537463034|FG000|Overall Study|Other unspecified|89|||
148996136|NCT01178086|537463034|FG000|Overall Study|Excluded from EAS|20|||
148996137|NCT02137369|537463035|FG000|Overall Study|Withdrawal by Subject|3|||
148996138|NCT02137369|537463036|FG001|Overall Study|Withdrawal by Subject|2|||
148996139|NCT02137369|537463035|FG000|Overall Study|Adverse Event|2|||
148996140|NCT02137369|537463036|FG001|Overall Study|Adverse Event|0|||
148996141|NCT02137369|537463035|FG000|Overall Study|Lost to Follow-up|1|||
148996142|NCT02137369|537463036|FG001|Overall Study|Lost to Follow-up|0|||
148996143|NCT02137369|537463035|FG000|Overall Study|Moved away|2|||
148996144|NCT02137369|537463036|FG001|Overall Study|Moved away|0|||
148996145|NCT01400503|537463038|FG000|Overall Study|Withdrawal by Subject|1|||
148996146|NCT01400503|537463038|FG000|Overall Study|Study Terminated by Sponsor|58|||
148996147|NCT01400503|537463038|FG000|Overall Study|Other|1|||
148996148|NCT01669122|537463041|FG000|Period I|Lost to Follow-up|1|||
148996149|NCT01669122|537463041|FG000|Washout Period II|Protocol Violation|2|||
148996150|NCT02962908|537463044|FG000|Overall Study|Lost to Follow-up|0|||
148996151|NCT02962908|537463045|FG001|Overall Study|Lost to Follow-up|3|||
148996152|NCT02962908|537463046|FG002|Overall Study|Lost to Follow-up|0|||
148996153|NCT02962908|537463047|FG003|Overall Study|Lost to Follow-up|1|||
148996154|NCT02962908|537463044|FG000|Overall Study|Withdrawal by Subject|0|||
148996155|NCT02962908|537463045|FG001|Overall Study|Withdrawal by Subject|3|||
148996156|NCT02962908|537463046|FG002|Overall Study|Withdrawal by Subject|0|||
148996157|NCT02962908|537463047|FG003|Overall Study|Withdrawal by Subject|2|||
148996158|NCT02962908|537463044|FG000|Overall Study|Protocol Violation|0|||
148996159|NCT02962908|537463045|FG001|Overall Study|Protocol Violation|1|||
148996160|NCT02962908|537463046|FG002|Overall Study|Protocol Violation|0|||
148996161|NCT02962908|537463047|FG003|Overall Study|Protocol Violation|0|||
148996162|NCT02962908|537463044|FG000|Overall Study|Physician Decision|0|||
148996163|NCT02962908|537463045|FG001|Overall Study|Physician Decision|1|||
148996164|NCT02962908|537463046|FG002|Overall Study|Physician Decision|0|||
148996165|NCT02962908|537463047|FG003|Overall Study|Physician Decision|0|||
148996166|NCT03762473|537463048|FG000|Overall Study|Death|1|||
148996167|NCT03762473|537463049|FG001|Overall Study|Death|0|||
148996168|NCT03543254|537463050|FG000|Overall Study|Lost to Follow-up|1|||
148996169|NCT02077166|537463051|FG000|Overall Study|Death|6|||
148996170|NCT02077166|537463052|FG001|Overall Study|Death|7|||
148996171|NCT02077166|537463053|FG002|Overall Study|Death|5|||
148996172|NCT02077166|537463054|FG003|Overall Study|Death|6|||
148996173|NCT02077166|537463055|FG004|Overall Study|Death|4|||
148996174|NCT02077166|537463056|FG005|Overall Study|Death|32|||
148996175|NCT02077166|537463057|FG006|Overall Study|Death|22|||
148864764|NCT01340937|536981248|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
148864765|NCT01340937|536981249|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
148864766|NCT01340937|536981246|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
148864767|NCT01340937|536981247|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
148864768|NCT01340937|536981248|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
148864769|NCT01340937|536981249|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
148864770|NCT01340937|536981246|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
148864771|NCT01340937|536981247|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
148864772|NCT01340937|536981248|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
148864773|NCT01340937|536981249|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
148864774|NCT01340937|536981246|FG000|Period 2: Interim Period|Adverse Event|1|||
148864775|NCT01340937|536981247|FG001|Period 2: Interim Period|Adverse Event|0|||
148864776|NCT01340937|536981248|FG002|Period 2: Interim Period|Adverse Event|1|||
148864777|NCT01340937|536981249|FG003|Period 2: Interim Period|Adverse Event|0|||
148864778|NCT01340937|536981246|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
148864779|NCT01340937|536981247|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
148864780|NCT01340937|536981248|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
148864781|NCT01340937|536981249|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
148864782|NCT01340937|536981246|FG000|Period 2: Interim Period|Physician Decision|0|||
148864783|NCT01340937|536981247|FG001|Period 2: Interim Period|Physician Decision|1|||
149031002|NCT00586339|537591648|FG002|Overall Study|Lost to Follow-up|1|||
148996176|NCT02077166|537463051|FG000|Overall Study|Study Closure by Sponsor|3|||
148996177|NCT02077166|537463052|FG001|Overall Study|Study Closure by Sponsor|0|||
148996178|NCT02077166|537463053|FG002|Overall Study|Study Closure by Sponsor|2|||
148996179|NCT02077166|537463054|FG003|Overall Study|Study Closure by Sponsor|2|||
148996180|NCT02077166|537463055|FG004|Overall Study|Study Closure by Sponsor|2|||
148996181|NCT02077166|537463056|FG005|Overall Study|Study Closure by Sponsor|12|||
148996182|NCT02077166|537463057|FG006|Overall Study|Study Closure by Sponsor|4|||
148996183|NCT02077166|537463051|FG000|Overall Study|Lost to Follow-up|0|||
148864784|NCT01340937|536981248|FG002|Period 2: Interim Period|Physician Decision|1|||
148864785|NCT01340937|536981249|FG003|Period 2: Interim Period|Physician Decision|0|||
148864786|NCT01340937|536981246|FG000|Period 2: Interim Period|Protocol Violation|5|||
148864787|NCT01340937|536981247|FG001|Period 2: Interim Period|Protocol Violation|3|||
148864788|NCT01340937|536981248|FG002|Period 2: Interim Period|Protocol Violation|6|||
148864789|NCT01340937|536981249|FG003|Period 2: Interim Period|Protocol Violation|3|||
148864790|NCT01340937|536981246|FG000|Period 2: Interim Period|Technical problems|4|||
148864791|NCT01340937|536981247|FG001|Period 2: Interim Period|Technical problems|4|||
148864792|NCT01340937|536981248|FG002|Period 2: Interim Period|Technical problems|6|||
148864793|NCT01340937|536981249|FG003|Period 2: Interim Period|Technical problems|3|||
148864794|NCT01340937|536981246|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
148864795|NCT01340937|536981247|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
148864796|NCT01340937|536981248|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
148864797|NCT01340937|536981249|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
148864798|NCT01340937|536981246|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
148864799|NCT01340937|536981247|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
148996184|NCT02077166|537463052|FG001|Overall Study|Lost to Follow-up|0|||
148996185|NCT02077166|537463053|FG002|Overall Study|Lost to Follow-up|0|||
148778135|NCT00454818|536661922|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
148778136|NCT00454818|536661923|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
148778137|NCT00454818|536661924|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
148778138|NCT00454818|536661925|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
148778139|NCT00454818|536661926|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
148778140|NCT00454818|536661922|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
148778141|NCT00454818|536661923|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
148778142|NCT00454818|536661924|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
148778143|NCT00454818|536661925|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
148778144|NCT00454818|536661926|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
148778145|NCT00454818|536661922|FG000|Phase 2: Randomized Double-blind|Death|0|||
148778146|NCT00454818|536661923|FG001|Phase 2: Randomized Double-blind|Death|1|||
148778147|NCT00454818|536661924|FG002|Phase 2: Randomized Double-blind|Death|0|||
148778148|NCT00454818|536661925|FG003|Phase 2: Randomized Double-blind|Death|0|||
148778149|NCT00454818|536661926|FG004|Phase 2: Randomized Double-blind|Death|1|||
148778150|NCT00454818|536661922|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
148778151|NCT00454818|536661923|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
148778152|NCT00454818|536661924|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
148778153|NCT00454818|536661925|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
148778154|NCT00454818|536661926|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
148778155|NCT00454818|536661922|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
148778156|NCT00454818|536661923|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
148778157|NCT00454818|536661924|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
148778158|NCT00454818|536661925|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
148778159|NCT00454818|536661926|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
148778160|NCT03181503|536661927|FG000|Overall Study|Adverse Event|2|||
148778161|NCT03181503|536661928|FG001|Overall Study|Adverse Event|2|||
148778162|NCT03181503|536661927|FG000|Overall Study|Protocol Violation|1|||
148778163|NCT03181503|536661928|FG001|Overall Study|Protocol Violation|0|||
148996186|NCT02077166|537463054|FG003|Overall Study|Lost to Follow-up|0|||
148996187|NCT02077166|537463055|FG004|Overall Study|Lost to Follow-up|0|||
148996188|NCT02077166|537463056|FG005|Overall Study|Lost to Follow-up|1|||
148996189|NCT02077166|537463057|FG006|Overall Study|Lost to Follow-up|0|||
148996190|NCT02077166|537463051|FG000|Overall Study|Withdrawal by Subject|3|||
148996191|NCT02077166|537463052|FG001|Overall Study|Withdrawal by Subject|0|||
148996192|NCT02077166|537463053|FG002|Overall Study|Withdrawal by Subject|1|||
148996193|NCT02077166|537463054|FG003|Overall Study|Withdrawal by Subject|1|||
148996194|NCT02077166|537463055|FG004|Overall Study|Withdrawal by Subject|1|||
148996195|NCT02077166|537463056|FG005|Overall Study|Withdrawal by Subject|3|||
148996196|NCT02077166|537463057|FG006|Overall Study|Withdrawal by Subject|0|||
148996197|NCT02077166|537463051|FG000|Overall Study|Other, Not Specified|0|||
148996198|NCT02077166|537463052|FG001|Overall Study|Other, Not Specified|0|||
148996199|NCT02077166|537463053|FG002|Overall Study|Other, Not Specified|1|||
148996200|NCT02077166|537463054|FG003|Overall Study|Other, Not Specified|0|||
148996201|NCT02077166|537463055|FG004|Overall Study|Other, Not Specified|1|||
148996202|NCT02077166|537463056|FG005|Overall Study|Other, Not Specified|7|||
148996203|NCT02077166|537463057|FG006|Overall Study|Other, Not Specified|8|||
148996204|NCT01261338|537463058|FG000|Overall Study|Withdrawal by Subject|3|||
148996205|NCT01261338|537463059|FG001|Overall Study|Withdrawal by Subject|2|||
148996206|NCT03519854|537463060|FG000|Overall Study|Technical Error|0|||
148864800|NCT01340937|536981248|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
148864801|NCT01340937|536981249|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
148864802|NCT01340937|536981246|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
148864803|NCT01340937|536981247|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
148864804|NCT01340937|536981248|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
148864805|NCT01340937|536981249|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
148864806|NCT01340937|536981246|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
148864807|NCT01340937|536981247|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
148864808|NCT01340937|536981248|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
148864809|NCT01340937|536981249|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
148864810|NCT00440310|536981250|FG000|Overall Study|Lost to Follow-up|4|||
148864811|NCT00440310|536981251|FG001|Overall Study|Lost to Follow-up|5|||
148864812|NCT00440310|536981250|FG000|Overall Study|Protocol Violation|0|||
148864813|NCT00440310|536981251|FG001|Overall Study|Protocol Violation|1|||
148864814|NCT00440310|536981250|FG000|Overall Study|Withdrawal by Subject|15|||
148864815|NCT00440310|536981251|FG001|Overall Study|Withdrawal by Subject|14|||
148864816|NCT00440310|536981250|FG000|Overall Study|No Reply at EOS|7|||
148864817|NCT00440310|536981251|FG001|Overall Study|No Reply at EOS|7|||
148864818|NCT00440310|536981250|FG000|Overall Study|Other|1|||
148864819|NCT00440310|536981251|FG001|Overall Study|Other|0|||
148864820|NCT00440310|536981250|FG000|Overall Study|Status Unknown|1|||
148864821|NCT00440310|536981251|FG001|Overall Study|Status Unknown|3|||
148864822|NCT02119156|536981252|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
148864823|NCT02119156|536981253|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
148864824|NCT02119156|536981254|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
148864825|NCT02119156|536981252|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
148864826|NCT02119156|536981253|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
148864827|NCT02119156|536981254|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
148864828|NCT02119156|536981252|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
148864829|NCT02119156|536981253|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
148864830|NCT02119156|536981254|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
148864831|NCT02119156|536981252|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
148864832|NCT02119156|536981253|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
148864833|NCT02119156|536981254|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
148864834|NCT02119156|536981252|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
148864835|NCT02119156|536981253|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
148864836|NCT02119156|536981254|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
148864837|NCT02469415|536981255|FG000|Overall Study|Withdrawal by Subject|1|||
148864838|NCT02469415|536981255|FG000|Overall Study|Investigational agent placed on hold|2|||
148864839|NCT01998893|536981265|FG000|Overall Study|Adverse Event|2|||
148864840|NCT01998893|536981265|FG000|Overall Study|Death|1|||
148864841|NCT01998893|536981265|FG000|Overall Study|Lost to Follow-up|8|||
148864842|NCT01998893|536981265|FG000|Overall Study|Physician Decision|2|||
148864843|NCT01998893|536981265|FG000|Overall Study|Protocol Violation|2|||
148864844|NCT01998893|536981265|FG000|Overall Study|Withdrawal by Subject|1|||
148864845|NCT01998893|536981265|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
148864846|NCT05136898|536981266|FG000|Overall Study|Adverse Event|2|||
148864847|NCT00867087|536981267|FG000|Overall Study|Other|1|||
148864848|NCT00867087|536981267|FG000|Overall Study|Withdrawal by Subject|4|||
148864849|NCT00867087|536981267|FG000|Overall Study|Death|37|||
148864850|NCT02334683|536981276|FG000|First 12 Week Period|Lost to Follow-up|1|||
148864851|NCT02334683|536981277|FG001|First 12 Week Period|Lost to Follow-up|0|||
148864852|NCT02334683|536981276|FG000|Second 12 Week Period|Adverse Event|0|||
148864853|NCT02334683|536981277|FG001|Second 12 Week Period|Adverse Event|1|||
148864854|NCT01891344|536981278|FG000|Overall Study|Ongoing|6|||
148864855|NCT01891344|536981279|FG001|Overall Study|Ongoing|2|||
148996207|NCT03519854|537463061|FG001|Overall Study|Technical Error|0|||
148996208|NCT03519854|537463062|FG002|Overall Study|Technical Error|1|||
148996209|NCT03519854|537463063|FG003|Overall Study|Technical Error|0|||
148996210|NCT03519854|537463064|FG004|Overall Study|Technical Error|0|||
148996211|NCT03519854|537463065|FG005|Overall Study|Technical Error|0|||
148996212|NCT03519854|537463066|FG006|Overall Study|Technical Error|0|||
148996213|NCT03519854|537463067|FG007|Overall Study|Technical Error|0|||
148996214|NCT03519854|537463068|FG008|Overall Study|Technical Error|0|||
148996215|NCT03519854|537463069|FG009|Overall Study|Technical Error|0|||
148996216|NCT03519854|537463070|FG010|Overall Study|Technical Error|0|||
148996217|NCT03519854|537463071|FG011|Overall Study|Technical Error|0|||
149031003|NCT04163458|537591651|FG000|Overall Study|Protocol Deviation|7|||
148864856|NCT01891344|536981280|FG002|Overall Study|Ongoing|0|||
148864857|NCT01891344|536981281|FG003|Overall Study|Ongoing|1|||
148864858|NCT01891344|536981282|FG004|Overall Study|Ongoing|4|||
148864859|NCT01891344|536981283|FG005|Overall Study|Ongoing|1|||
148864860|NCT01891344|536981284|FG006|Overall Study|Ongoing|0|||
148996218|NCT03519854|537463072|FG012|Overall Study|Technical Error|0|||
148996219|NCT03519854|537463073|FG013|Overall Study|Technical Error|0|||
148996220|NCT03519854|537463074|FG014|Overall Study|Technical Error|0|||
148864861|NCT01891344|536981285|FG007|Overall Study|Ongoing|0|||
148864862|NCT02969590|536981286|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
148996221|NCT03519854|537463075|FG015|Overall Study|Technical Error|0|||
148996222|NCT03519854|537463076|FG016|Overall Study|Technical Error|0|||
148996223|NCT03519854|537463077|FG017|Overall Study|Technical Error|0|||
148996224|NCT00126438|537463078|FG000|Overall Study|Withdrawal due to adverse event|1|||
148996225|NCT00126438|537463079|FG001|Overall Study|Withdrawal due to adverse event|0|||
148996226|NCT00126438|537463078|FG000|Overall Study|Lost to Follow-up|22|||
148996227|NCT00126438|537463079|FG001|Overall Study|Lost to Follow-up|0|||
148996228|NCT00126438|537463078|FG000|Overall Study|Protocol Violation|8|||
148996229|NCT00126438|537463079|FG001|Overall Study|Protocol Violation|8|||
148996230|NCT00126438|537463078|FG000|Overall Study|Withdrawal by Subject|3|||
148996231|NCT00126438|537463079|FG001|Overall Study|Withdrawal by Subject|2|||
148996232|NCT05132699|537463083|FG000|Overall Study|Withdrawal by Subject|3|||
148996233|NCT05132699|537463084|FG001|Overall Study|Withdrawal by Subject|0|||
148996234|NCT02899728|537463085|FG000|Overall Study|Withdrawal by Subject|1|||
148996235|NCT02899728|537463086|FG001|Overall Study|Withdrawal by Subject|1|||
148996236|NCT02626780|537463090|FG000|Overall Study|Withdrawal by Subject|3|||
148996237|NCT04304833|537463091|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
148996238|NCT04304833|537463092|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
148996239|NCT01951625|537463093|FG000|Treatment Period|Protocol Violation|2|||
148996240|NCT01951625|537463094|FG001|Treatment Period|Protocol Violation|0|||
148996241|NCT01951625|537463095|FG002|Treatment Period|Protocol Violation|1|||
148996242|NCT01951625|537463096|FG003|Treatment Period|Protocol Violation|3|||
148996243|NCT01951625|537463097|FG004|Treatment Period|Protocol Violation|2|||
148996244|NCT01951625|537463093|FG000|Treatment Period|Physician Decision|0|||
148996245|NCT01951625|537463094|FG001|Treatment Period|Physician Decision|0|||
148996246|NCT01951625|537463095|FG002|Treatment Period|Physician Decision|0|||
148996247|NCT01951625|537463096|FG003|Treatment Period|Physician Decision|0|||
148996248|NCT01951625|537463097|FG004|Treatment Period|Physician Decision|1|||
148996249|NCT01951625|537463093|FG000|Treatment Period|Protocol driven decision point|0|||
148996250|NCT01951625|537463094|FG001|Treatment Period|Protocol driven decision point|5|||
148996251|NCT01951625|537463095|FG002|Treatment Period|Protocol driven decision point|0|||
148996252|NCT01951625|537463096|FG003|Treatment Period|Protocol driven decision point|2|||
148996253|NCT01951625|537463097|FG004|Treatment Period|Protocol driven decision point|1|||
148996254|NCT01951625|537463093|FG000|Treatment Period|Non compliance with study drug|1|||
148996255|NCT01951625|537463094|FG001|Treatment Period|Non compliance with study drug|2|||
148996256|NCT01951625|537463095|FG002|Treatment Period|Non compliance with study drug|2|||
148996257|NCT01951625|537463096|FG003|Treatment Period|Non compliance with study drug|0|||
148996258|NCT01951625|537463097|FG004|Treatment Period|Non compliance with study drug|0|||
148996259|NCT01951625|537463093|FG000|Treatment Period|Death|3|||
148996260|NCT01951625|537463094|FG001|Treatment Period|Death|2|||
148996261|NCT01951625|537463095|FG002|Treatment Period|Death|2|||
148996262|NCT01951625|537463096|FG003|Treatment Period|Death|1|||
148996263|NCT01951625|537463097|FG004|Treatment Period|Death|2|||
148996264|NCT01951625|537463093|FG000|Treatment Period|Adverse Event|7|||
148996265|NCT01951625|537463094|FG001|Treatment Period|Adverse Event|10|||
148996266|NCT01951625|537463095|FG002|Treatment Period|Adverse Event|9|||
148996267|NCT01951625|537463096|FG003|Treatment Period|Adverse Event|8|||
148996268|NCT01951625|537463097|FG004|Treatment Period|Adverse Event|8|||
148996269|NCT01951625|537463093|FG000|Treatment Period|Withdrawal by Subject|5|||
148996270|NCT01951625|537463094|FG001|Treatment Period|Withdrawal by Subject|2|||
148996271|NCT01951625|537463095|FG002|Treatment Period|Withdrawal by Subject|1|||
148996272|NCT01951625|537463096|FG003|Treatment Period|Withdrawal by Subject|7|||
148996273|NCT01951625|537463097|FG004|Treatment Period|Withdrawal by Subject|3|||
148996274|NCT01951625|537463093|FG000|Treatment Period|Lost to Follow-up|1|||
148996275|NCT01951625|537463094|FG001|Treatment Period|Lost to Follow-up|0|||
148996276|NCT01951625|537463095|FG002|Treatment Period|Lost to Follow-up|0|||
148996277|NCT01951625|537463096|FG003|Treatment Period|Lost to Follow-up|1|||
148996278|NCT01951625|537463097|FG004|Treatment Period|Lost to Follow-up|0|||
148996279|NCT01951625|537463093|FG000|Follow Up Period|Non-compliance with study drug|1|||
148864863|NCT02969590|536981287|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
148864864|NCT02969590|536981288|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
148864865|NCT01414205|536981289|FG000|Overall Study|Death|5|||
148864866|NCT01414205|536981290|FG001|Overall Study|Death|1|||
148996280|NCT01951625|537463094|FG001|Follow Up Period|Non-compliance with study drug|0|||
148996281|NCT01951625|537463095|FG002|Follow Up Period|Non-compliance with study drug|0|||
148996282|NCT01951625|537463096|FG003|Follow Up Period|Non-compliance with study drug|0|||
148996283|NCT01951625|537463097|FG004|Follow Up Period|Non-compliance with study drug|0|||
148996284|NCT01951625|537463093|FG000|Follow Up Period|Death|1|||
148996285|NCT01951625|537463094|FG001|Follow Up Period|Death|3|||
148996286|NCT01951625|537463095|FG002|Follow Up Period|Death|2|||
148996287|NCT01951625|537463096|FG003|Follow Up Period|Death|2|||
148996288|NCT01951625|537463097|FG004|Follow Up Period|Death|1|||
148864867|NCT01414205|536981289|FG000|Overall Study|Lost to Follow-up|1|||
148864868|NCT01414205|536981290|FG001|Overall Study|Lost to Follow-up|4|||
148864869|NCT01414205|536981289|FG000|Overall Study|Physician Decision|0|||
148864870|NCT01414205|536981290|FG001|Overall Study|Physician Decision|1|||
148864871|NCT01414205|536981289|FG000|Overall Study|Randomized but not Treated|1|||
148864872|NCT01414205|536981290|FG001|Overall Study|Randomized but not Treated|1|||
148864873|NCT02498067|536981291|FG000|Overall Study|Lost to Follow-up|22|||
148864874|NCT02498067|536981291|FG000|Overall Study|Did not meet inclusion criteria|11|||
148864875|NCT04662073|536981297|FG000|Overall Study|Withdrawal by Subject|1|||
148864876|NCT04662073|536981298|FG001|Overall Study|Withdrawal by Subject|0|||
148864877|NCT02961790|536981299|FG000|Overall Study|Canceled|4|||
148864878|NCT02961790|536981300|FG001|Overall Study|Canceled|5|||
148864879|NCT02961790|536981301|FG002|Overall Study|Canceled|1|||
148864880|NCT02961790|536981302|FG003|Overall Study|Canceled|4|||
148864881|NCT02961790|536981299|FG000|Overall Study|without baseline data|4|||
148864882|NCT02961790|536981300|FG001|Overall Study|without baseline data|0|||
148864883|NCT02961790|536981301|FG002|Overall Study|without baseline data|1|||
148864884|NCT02961790|536981302|FG003|Overall Study|without baseline data|0|||
148864885|NCT02961790|536981299|FG000|Overall Study|without post baseline data|7|||
148864886|NCT02961790|536981300|FG001|Overall Study|without post baseline data|6|||
148864887|NCT02961790|536981301|FG002|Overall Study|without post baseline data|4|||
148864888|NCT02961790|536981302|FG003|Overall Study|without post baseline data|1|||
148864889|NCT02594098|536981305|FG000|Overall Study|Lack of Efficacy|17|||
148864890|NCT02594098|536981306|FG001|Overall Study|Lack of Efficacy|6|||
148864891|NCT02594098|536981305|FG000|Overall Study|Withdrawal by Subject|1|||
148864892|NCT02594098|536981306|FG001|Overall Study|Withdrawal by Subject|3|||
148864893|NCT02594098|536981305|FG000|Overall Study|Terminated participation|6|||
148864894|NCT02594098|536981306|FG001|Overall Study|Terminated participation|2|||
148864895|NCT02594098|536981305|FG000|Overall Study|Seek alternative treatment|2|||
148864896|NCT02594098|536981306|FG001|Overall Study|Seek alternative treatment|1|||
148864897|NCT02594098|536981305|FG000|Overall Study|Other|0|||
148864898|NCT02594098|536981306|FG001|Overall Study|Other|1|||
148864899|NCT02370641|536981310|FG000|Overall Study|dropped study|4|||
148864900|NCT02370641|536981311|FG001|Overall Study|dropped study|2|||
148864901|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
148864902|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
148864903|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
148864904|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
148864905|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
148864906|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
148864907|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
148864908|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
148864909|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
148864910|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
148864911|NCT03906656|536981314|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
148864912|NCT03906656|536981315|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
148864913|NCT03906656|536981314|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
148864914|NCT03906656|536981315|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
148864915|NCT03906656|536981314|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
148864916|NCT03906656|536981315|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
148864917|NCT03906656|536981314|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
148864918|NCT03906656|536981315|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
148864919|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
148864920|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
148864921|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
148864922|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
148864923|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
148864924|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
148864925|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
148864926|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
149031004|NCT04163458|537591652|FG001|Overall Study|Protocol Deviation|13|||
149031005|NCT04163458|537591651|FG000|Overall Study|Adverse Event|5|||
149031006|NCT04163458|537591652|FG001|Overall Study|Adverse Event|8|||
148864927|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
148864928|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
148864929|NCT03906656|536981314|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
148864930|NCT03906656|536981315|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
148864931|NCT03906656|536981314|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
148864932|NCT03906656|536981315|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
148864933|NCT03906656|536981314|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
148864934|NCT03906656|536981315|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
148864935|NCT03906656|536981314|FG000|Home Use 2 (3 Months)|Death|2|||
148864936|NCT03906656|536981315|FG001|Home Use 2 (3 Months)|Death|0|||
148996289|NCT01951625|537463093|FG000|Follow Up Period|Logistical difficulties|1|||
148996290|NCT01951625|537463094|FG001|Follow Up Period|Logistical difficulties|2|||
148996291|NCT01951625|537463095|FG002|Follow Up Period|Logistical difficulties|0|||
148996292|NCT01951625|537463096|FG003|Follow Up Period|Logistical difficulties|0|||
148996293|NCT01951625|537463097|FG004|Follow Up Period|Logistical difficulties|0|||
148996294|NCT01951625|537463093|FG000|Follow Up Period|Adverse Event|0|||
148996295|NCT01951625|537463094|FG001|Follow Up Period|Adverse Event|3|||
148996296|NCT01951625|537463095|FG002|Follow Up Period|Adverse Event|2|||
148996297|NCT01951625|537463096|FG003|Follow Up Period|Adverse Event|3|||
148996298|NCT01951625|537463097|FG004|Follow Up Period|Adverse Event|5|||
148996299|NCT01951625|537463093|FG000|Follow Up Period|Withdrawal by Subject|4|||
148996300|NCT01951625|537463094|FG001|Follow Up Period|Withdrawal by Subject|1|||
148996301|NCT01951625|537463095|FG002|Follow Up Period|Withdrawal by Subject|0|||
148996302|NCT01951625|537463096|FG003|Follow Up Period|Withdrawal by Subject|5|||
148996303|NCT01951625|537463097|FG004|Follow Up Period|Withdrawal by Subject|3|||
148996304|NCT01951625|537463093|FG000|Follow Up Period|Lost to Follow-up|1|||
148996305|NCT01951625|537463094|FG001|Follow Up Period|Lost to Follow-up|0|||
148996306|NCT01951625|537463095|FG002|Follow Up Period|Lost to Follow-up|0|||
148996307|NCT01951625|537463096|FG003|Follow Up Period|Lost to Follow-up|1|||
148996308|NCT01951625|537463097|FG004|Follow Up Period|Lost to Follow-up|1|||
148996309|NCT00613951|537463100|FG000|Overall Study|Adverse Event|1|||
148996310|NCT00613951|537463101|FG001|Overall Study|Adverse Event|0|||
148996311|NCT00613951|537463102|FG002|Overall Study|Adverse Event|1|||
148996312|NCT00613951|537463100|FG000|Overall Study|Lack of Efficacy|0|||
148996313|NCT00613951|537463101|FG001|Overall Study|Lack of Efficacy|1|||
148996314|NCT00613951|537463102|FG002|Overall Study|Lack of Efficacy|1|||
148996315|NCT00613951|537463100|FG000|Overall Study|Protocol Violation|1|||
148996316|NCT00613951|537463101|FG001|Overall Study|Protocol Violation|1|||
148996317|NCT00613951|537463102|FG002|Overall Study|Protocol Violation|1|||
148996318|NCT00613951|537463100|FG000|Overall Study|Unclassified|5|||
148996319|NCT00613951|537463101|FG001|Overall Study|Unclassified|3|||
148996320|NCT00613951|537463102|FG002|Overall Study|Unclassified|2|||
148996321|NCT00655980|537463104|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
148996322|NCT00655980|537463105|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
148996323|NCT00655980|537463106|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
148996324|NCT05540522|537463108|FG000|Overall Study|Adverse Event|1|||
148996325|NCT05540522|537463109|FG001|Overall Study|Adverse Event|0|||
148996326|NCT05540522|537463110|FG002|Overall Study|Adverse Event|2|||
148996327|NCT05540522|537463111|FG003|Overall Study|Adverse Event|5|||
148996328|NCT05540522|537463108|FG000|Overall Study|Lost to Follow-up|487|||
148996329|NCT05540522|537463109|FG001|Overall Study|Lost to Follow-up|427|||
148996330|NCT05540522|537463110|FG002|Overall Study|Lost to Follow-up|146|||
148996331|NCT05540522|537463111|FG003|Overall Study|Lost to Follow-up|166|||
148996332|NCT05540522|537463108|FG000|Overall Study|Physician Decision|11|||
148996333|NCT05540522|537463109|FG001|Overall Study|Physician Decision|19|||
148996334|NCT05540522|537463110|FG002|Overall Study|Physician Decision|8|||
148996335|NCT05540522|537463111|FG003|Overall Study|Physician Decision|13|||
148996336|NCT05540522|537463108|FG000|Overall Study|Pregnancy|1|||
148996337|NCT05540522|537463109|FG001|Overall Study|Pregnancy|0|||
148996338|NCT05540522|537463110|FG002|Overall Study|Pregnancy|0|||
148996339|NCT05540522|537463111|FG003|Overall Study|Pregnancy|0|||
148996340|NCT05540522|537463108|FG000|Overall Study|Protocol Violation|3|||
148996341|NCT05540522|537463109|FG001|Overall Study|Protocol Violation|1|||
148996342|NCT05540522|537463110|FG002|Overall Study|Protocol Violation|9|||
148996343|NCT05540522|537463111|FG003|Overall Study|Protocol Violation|7|||
148996344|NCT05540522|537463108|FG000|Overall Study|Withdrawal by Subject|168|||
148996345|NCT05540522|537463109|FG001|Overall Study|Withdrawal by Subject|134|||
148996346|NCT05540522|537463110|FG002|Overall Study|Withdrawal by Subject|331|||
148864937|NCT03906656|536981314|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
148996347|NCT05540522|537463111|FG003|Overall Study|Withdrawal by Subject|322|||
148996348|NCT05540522|537463108|FG000|Overall Study|Death|7|||
148996349|NCT05540522|537463109|FG001|Overall Study|Death|9|||
148996350|NCT05540522|537463110|FG002|Overall Study|Death|49|||
148996351|NCT05540522|537463111|FG003|Overall Study|Death|46|||
148996352|NCT05540522|537463108|FG000|Overall Study|Not vaccinated|34|||
148996353|NCT05540522|537463109|FG001|Overall Study|Not vaccinated|53|||
148996354|NCT05540522|537463110|FG002|Overall Study|Not vaccinated|57|||
148996355|NCT05540522|537463111|FG003|Overall Study|Not vaccinated|50|||
148996356|NCT05540522|537463108|FG000|Overall Study|No longer meets eligibility criteria|0|||
148996357|NCT05540522|537463109|FG001|Overall Study|No longer meets eligibility criteria|0|||
148996358|NCT05540522|537463110|FG002|Overall Study|No longer meets eligibility criteria|3|||
148996359|NCT05540522|537463111|FG003|Overall Study|No longer meets eligibility criteria|2|||
148996360|NCT05540522|537463108|FG000|Overall Study|Other (Unspecified)|8|||
148996361|NCT05540522|537463109|FG001|Overall Study|Other (Unspecified)|10|||
148996362|NCT05540522|537463110|FG002|Overall Study|Other (Unspecified)|4|||
148996363|NCT05540522|537463111|FG003|Overall Study|Other (Unspecified)|2|||
148996364|NCT03754803|537463114|FG000|Overall Study|Withdrawal by Subject|2|||
148996365|NCT04348604|537463117|FG000|Week 8|Withdrawal by Subject|1|||
148864938|NCT03906656|536981315|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
148864939|NCT03906656|536981314|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
148864940|NCT03906656|536981315|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
148864941|NCT01036529|536981316|FG000|Overall Study|Adverse Event|0|||
148864942|NCT01036529|536981317|FG001|Overall Study|Adverse Event|1|||
148864943|NCT01036529|536981316|FG000|Overall Study|Lost to Follow-up|0|||
148864944|NCT01036529|536981317|FG001|Overall Study|Lost to Follow-up|1|||
148864945|NCT01036529|536981316|FG000|Overall Study|Physician Decision|1|||
148864946|NCT01036529|536981317|FG001|Overall Study|Physician Decision|0|||
148864947|NCT01036529|536981316|FG000|Overall Study|Withdrawal by Subject|1|||
148864948|NCT01036529|536981317|FG001|Overall Study|Withdrawal by Subject|1|||
148864949|NCT01036529|536981316|FG000|Overall Study|Sponsor study termination|11|||
148864950|NCT01036529|536981317|FG001|Overall Study|Sponsor study termination|12|||
148864951|NCT00581828|536981319|FG000|Overall Study|Protocol Violation|1|||
148864952|NCT02370095|536981320|FG000|Overall Study|Withdrawal by Subject|0|||
148864953|NCT02370095|536981321|FG001|Overall Study|Withdrawal by Subject|1|||
148996366|NCT04348604|537463118|FG001|Week 8|Withdrawal by Subject|1|||
148996367|NCT04348604|537463117|FG000|Week 8|Lost to Follow-up|1|||
148996368|NCT04348604|537463118|FG001|Week 8|Lost to Follow-up|2|||
148996369|NCT04348604|537463117|FG000|Week 8|Suspended|0|||
148996370|NCT04348604|537463118|FG001|Week 8|Suspended|1|||
148996371|NCT04348604|537463117|FG000|Week 12|Lost to Follow-up|1|||
148996372|NCT04348604|537463118|FG001|Week 12|Lost to Follow-up|2|||
148996373|NCT04348604|537463117|FG000|Week 12|Withdrawal by Subject|1|||
148996374|NCT04348604|537463118|FG001|Week 12|Withdrawal by Subject|0|||
148996375|NCT04348604|537463117|FG000|Week 24|Lost to Follow-up|2|||
148996376|NCT04348604|537463118|FG001|Week 24|Lost to Follow-up|1|||
148996377|NCT02097108|537463119|FG000|Overall Study|Adverse Event|1|||
148996378|NCT02097108|537463119|FG000|Overall Study|patient was abroad for 6 months|1|||
148996379|NCT00127608|537463122|FG000|Overall Study|VZV DNA negative|1|||
148996380|NCT01329029|537463125|FG000|Overall Study|Withdrawal by Subject|117|||
148996381|NCT01329029|537463126|FG001|Overall Study|Withdrawal by Subject|87|||
148996382|NCT01329029|537463125|FG000|Overall Study|Adverse Event|82|||
148996383|NCT01329029|537463126|FG001|Overall Study|Adverse Event|29|||
148996384|NCT01329029|537463125|FG000|Overall Study|Death|16|||
148996385|NCT01329029|537463126|FG001|Overall Study|Death|19|||
148996386|NCT01329029|537463125|FG000|Overall Study|Other|14|||
148996387|NCT01329029|537463126|FG001|Overall Study|Other|20|||
148996388|NCT01329029|537463125|FG000|Overall Study|COPD Exacerbation|11|||
148996389|NCT01329029|537463126|FG001|Overall Study|COPD Exacerbation|18|||
148996390|NCT01329029|537463125|FG000|Overall Study|Physician Decision|16|||
148996391|NCT01329029|537463126|FG001|Overall Study|Physician Decision|13|||
148996392|NCT01329029|537463125|FG000|Overall Study|Lost to Follow-up|8|||
148996393|NCT01329029|537463126|FG001|Overall Study|Lost to Follow-up|5|||
148996394|NCT01329029|537463125|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
148996395|NCT01329029|537463126|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
148996396|NCT00680407|537463135|FG000|Overall Study|Lost to Follow-up|3|||
148996397|NCT00680407|537463136|FG001|Overall Study|Lost to Follow-up|3|||
148996398|NCT00680407|537463137|FG002|Overall Study|Lost to Follow-up|1|||
148996399|NCT00680407|537463135|FG000|Overall Study|Withdrawal by Subject|5|||
148996400|NCT00680407|537463136|FG001|Overall Study|Withdrawal by Subject|2|||
148996401|NCT00680407|537463137|FG002|Overall Study|Withdrawal by Subject|2|||
148996402|NCT00447057|537465243|FG000|Overall Study|Adverse Event|4|||
148996403|NCT00447057|537465244|FG001|Overall Study|Adverse Event|10|||
148996404|NCT00447057|537465245|FG002|Overall Study|Adverse Event|0|||
148996405|NCT00447057|537465246|FG003|Overall Study|Adverse Event|3|||
148996406|NCT00447057|537465243|FG000|Overall Study|Death due to study disease|6|||
148996407|NCT00447057|537465244|FG001|Overall Study|Death due to study disease|4|||
148996408|NCT00447057|537465245|FG002|Overall Study|Death due to study disease|1|||
148996409|NCT00447057|537465246|FG003|Overall Study|Death due to study disease|1|||
148996410|NCT00447057|537465243|FG000|Overall Study|Lost to Follow-up|0|||
148996411|NCT00447057|537465244|FG001|Overall Study|Lost to Follow-up|1|||
148996412|NCT00447057|537465245|FG002|Overall Study|Lost to Follow-up|0|||
148996413|NCT00447057|537465246|FG003|Overall Study|Lost to Follow-up|0|||
148996414|NCT00447057|537465243|FG000|Overall Study|Entry criteria not met|1|||
148996415|NCT00447057|537465244|FG001|Overall Study|Entry criteria not met|1|||
148996416|NCT00447057|537465245|FG002|Overall Study|Entry criteria not met|0|||
148864954|NCT01129882|536981322|FG000|Overall Study|Adverse Event|39|||
148996417|NCT00447057|537465246|FG003|Overall Study|Entry criteria not met|0|||
148996418|NCT00447057|537465243|FG000|Overall Study|Protocol Violation|0|||
149031007|NCT04163458|537591651|FG000|Overall Study|Due to COVID-19 pandemic|4|||
148996419|NCT00447057|537465244|FG001|Overall Study|Protocol Violation|1|||
148996420|NCT00447057|537465245|FG002|Overall Study|Protocol Violation|0|||
148996421|NCT00447057|537465246|FG003|Overall Study|Protocol Violation|0|||
148996422|NCT00447057|537465243|FG000|Overall Study|Withdrawal by Subject|4|||
148996423|NCT00447057|537465244|FG001|Overall Study|Withdrawal by Subject|5|||
148996424|NCT00447057|537465245|FG002|Overall Study|Withdrawal by Subject|1|||
148996425|NCT00447057|537465246|FG003|Overall Study|Withdrawal by Subject|1|||
148996426|NCT00447057|537465243|FG000|Overall Study|Physician Decision|9|||
148864955|NCT01129882|536981322|FG000|Overall Study|Death|6|||
148864956|NCT01129882|536981322|FG000|Overall Study|Lack of Efficacy|5|||
148864957|NCT01129882|536981322|FG000|Overall Study|Lost to Follow-up|13|||
148864958|NCT01129882|536981322|FG000|Overall Study|Physician Decision|27|||
148864959|NCT01129882|536981322|FG000|Overall Study|Protocol Deviation|3|||
148864960|NCT01129882|536981322|FG000|Overall Study|Withdrawal Criteria Met|19|||
148864961|NCT01129882|536981322|FG000|Overall Study|Trial Termination by Sponsor|6|||
148864962|NCT01129882|536981322|FG000|Overall Study|Withdrawal by Subject|160|||
148864963|NCT02130986|536981323|FG000|Overall Study|Withdrawal by Subject|4|||
148864964|NCT02130986|536981324|FG001|Overall Study|Withdrawal by Subject|4|||
148864965|NCT02130986|536981323|FG000|Overall Study|Lost to Follow-up|151|||
148864966|NCT02130986|536981324|FG001|Overall Study|Lost to Follow-up|160|||
148864967|NCT02305849|536981325|FG000|Overall Study|Adverse Event|10|||
148864968|NCT02305849|536981326|FG001|Overall Study|Adverse Event|12|||
148864969|NCT02305849|536981327|FG002|Overall Study|Adverse Event|7|||
148864970|NCT02305849|536981328|FG003|Overall Study|Adverse Event|3|||
148864971|NCT02305849|536981325|FG000|Overall Study|Lack of Efficacy|10|||
148864972|NCT02305849|536981326|FG001|Overall Study|Lack of Efficacy|6|||
148864973|NCT02305849|536981327|FG002|Overall Study|Lack of Efficacy|3|||
148864974|NCT02305849|536981328|FG003|Overall Study|Lack of Efficacy|9|||
148864975|NCT02305849|536981325|FG000|Overall Study|Withdrawal by Subject|2|||
148864976|NCT02305849|536981326|FG001|Overall Study|Withdrawal by Subject|2|||
148864977|NCT02305849|536981327|FG002|Overall Study|Withdrawal by Subject|1|||
148864978|NCT02305849|536981328|FG003|Overall Study|Withdrawal by Subject|4|||
148864979|NCT02305849|536981325|FG000|Overall Study|Lost to Follow-up|0|||
148864980|NCT02305849|536981326|FG001|Overall Study|Lost to Follow-up|2|||
148864981|NCT02305849|536981327|FG002|Overall Study|Lost to Follow-up|0|||
148864982|NCT02305849|536981328|FG003|Overall Study|Lost to Follow-up|0|||
148864983|NCT02305849|536981325|FG000|Overall Study|Protocol Violation|3|||
148864984|NCT02305849|536981326|FG001|Overall Study|Protocol Violation|2|||
148864985|NCT02305849|536981327|FG002|Overall Study|Protocol Violation|1|||
148864986|NCT02305849|536981328|FG003|Overall Study|Protocol Violation|1|||
148864987|NCT02305849|536981325|FG000|Overall Study|Lab data met discontinuation criteria|0|||
148864988|NCT02305849|536981326|FG001|Overall Study|Lab data met discontinuation criteria|1|||
148864989|NCT02305849|536981327|FG002|Overall Study|Lab data met discontinuation criteria|2|||
148864990|NCT02305849|536981328|FG003|Overall Study|Lab data met discontinuation criteria|1|||
148864991|NCT02305849|536981325|FG000|Overall Study|Miscellaneous|1|||
148864992|NCT02305849|536981326|FG001|Overall Study|Miscellaneous|2|||
148864993|NCT02305849|536981327|FG002|Overall Study|Miscellaneous|4|||
148864994|NCT02305849|536981328|FG003|Overall Study|Miscellaneous|1|||
148864995|NCT02305849|536981325|FG000|Overall Study|Not fulfill eligibility criteria|1|||
148864996|NCT02305849|536981326|FG001|Overall Study|Not fulfill eligibility criteria|1|||
148864997|NCT02305849|536981327|FG002|Overall Study|Not fulfill eligibility criteria|0|||
148864998|NCT02305849|536981328|FG003|Overall Study|Not fulfill eligibility criteria|0|||
148864999|NCT00475865|536981339|FG000|Overall Study|Adverse Event|0|||
148865000|NCT00475865|536981340|FG001|Overall Study|Adverse Event|3|||
148865001|NCT00475865|536981341|FG002|Overall Study|Adverse Event|4|||
148865002|NCT00475865|536981339|FG000|Overall Study|Lack of Efficacy|1|||
148865003|NCT00475865|536981340|FG001|Overall Study|Lack of Efficacy|0|||
148865004|NCT00475865|536981341|FG002|Overall Study|Lack of Efficacy|0|||
148865005|NCT00475865|536981339|FG000|Overall Study|Progressive disease|0|||
148865006|NCT00475865|536981340|FG001|Overall Study|Progressive disease|1|||
148865007|NCT00475865|536981341|FG002|Overall Study|Progressive disease|2|||
148865008|NCT00475865|536981339|FG000|Overall Study|Participant did not wish to continue|1|||
148865009|NCT00475865|536981340|FG001|Overall Study|Participant did not wish to continue|0|||
148865010|NCT00475865|536981341|FG002|Overall Study|Participant did not wish to continue|0|||
148865011|NCT00475865|536981339|FG000|Overall Study|Other than above|0|||
148865012|NCT00475865|536981340|FG001|Overall Study|Other than above|1|||
148865013|NCT00475865|536981341|FG002|Overall Study|Other than above|0|||
148865014|NCT04316741|536981342|FG000|Baseline Enrollment|Lost to Follow-up|1|||
148865015|NCT04316741|536981343|FG001|Baseline Enrollment|Lost to Follow-up|1|||
148865016|NCT04316741|536981342|FG000|Immediate Post-Test|Lost to Follow-up|5|||
148865017|NCT04316741|536981343|FG001|Immediate Post-Test|Lost to Follow-up|1|||
148865018|NCT04316741|536981342|FG000|1-month Post-test|Lost to Follow-up|7|||
148865019|NCT04316741|536981343|FG001|1-month Post-test|Lost to Follow-up|2|||
148865020|NCT04316741|536981342|FG000|3-month Follow-up|Lost to Follow-up|10|||
148865021|NCT04316741|536981343|FG001|3-month Follow-up|Lost to Follow-up|2|||
148865022|NCT02726880|536981344|FG000|Overall Study|Withdrawal by Subject|2|||
148865023|NCT02726880|536981345|FG001|Overall Study|Withdrawal by Subject|0|||
148865024|NCT02726880|536981344|FG000|Overall Study|Lost to Follow-up|1|||
148865025|NCT02726880|536981345|FG001|Overall Study|Lost to Follow-up|3|||
148865026|NCT04599166|536982909|FG000|Overall Study|Technological failure connecting to study app|80|||
148865027|NCT01974752|536982910|FG000|Overall Study|Death|33|||
148865028|NCT01974752|536982911|FG001|Overall Study|Death|11|||
148865029|NCT01974752|536982910|FG000|Overall Study|Lost to Follow-up|2|||
148865030|NCT01974752|536982911|FG001|Overall Study|Lost to Follow-up|0|||
148865031|NCT01974752|536982910|FG000|Overall Study|Withdrawal by Subject|2|||
148996427|NCT00447057|537465244|FG001|Overall Study|Physician Decision|6|||
148996428|NCT00447057|537465245|FG002|Overall Study|Physician Decision|3|||
148996429|NCT00447057|537465246|FG003|Overall Study|Physician Decision|1|||
148996430|NCT00447057|537465243|FG000|Overall Study|Sponsor decision|1|||
148996431|NCT00447057|537465244|FG001|Overall Study|Sponsor decision|1|||
148996432|NCT00447057|537465245|FG002|Overall Study|Sponsor decision|0|||
148996433|NCT00447057|537465246|FG003|Overall Study|Sponsor decision|0|||
148996434|NCT00447057|537465243|FG000|Overall Study|Progressive disease|58|||
148996435|NCT00447057|537465244|FG001|Overall Study|Progressive disease|43|||
148996436|NCT00447057|537465245|FG002|Overall Study|Progressive disease|13|||
148996437|NCT00447057|537465246|FG003|Overall Study|Progressive disease|18|||
148996438|NCT00447057|537465243|FG000|Overall Study|Death due to adverse event|0|||
148996439|NCT00447057|537465244|FG001|Overall Study|Death due to adverse event|0|||
148996440|NCT00447057|537465245|FG002|Overall Study|Death due to adverse event|1|||
148996441|NCT00447057|537465246|FG003|Overall Study|Death due to adverse event|2|||
148996442|NCT00447057|537465243|FG000|Overall Study|Death, study drug related|0|||
148996443|NCT00447057|537465244|FG001|Overall Study|Death, study drug related|1|||
148996444|NCT00447057|537465245|FG002|Overall Study|Death, study drug related|0|||
148996445|NCT00447057|537465246|FG003|Overall Study|Death, study drug related|0|||
148996446|NCT00440531|537465247|FG000|Overall Study|Adverse Event|1|||
148996447|NCT00440531|537465248|FG001|Overall Study|Adverse Event|0|||
148996448|NCT00440531|537465249|FG002|Overall Study|Adverse Event|2|||
148996449|NCT00440531|537465247|FG000|Overall Study|Withdrawal by Subject|2|||
148996450|NCT00440531|537465248|FG001|Overall Study|Withdrawal by Subject|0|||
148996451|NCT00440531|537465249|FG002|Overall Study|Withdrawal by Subject|0|||
148996452|NCT00440531|537465247|FG000|Overall Study|Protocol Violation|1|||
148996453|NCT00440531|537465248|FG001|Overall Study|Protocol Violation|2|||
148996454|NCT00440531|537465249|FG002|Overall Study|Protocol Violation|0|||
148996455|NCT00440531|537465247|FG000|Overall Study|Lost to Follow-up|4|||
148996456|NCT00440531|537465248|FG001|Overall Study|Lost to Follow-up|3|||
148996457|NCT00440531|537465249|FG002|Overall Study|Lost to Follow-up|5|||
148996458|NCT00440531|537465247|FG000|Overall Study|see pre-assignment details|2|||
148996459|NCT00440531|537465248|FG001|Overall Study|see pre-assignment details|0|||
148996460|NCT00440531|537465249|FG002|Overall Study|see pre-assignment details|0|||
148996461|NCT02184611|537465256|FG000|Overall Study|Lack of Efficacy|11|||
148996462|NCT02184611|537465257|FG001|Overall Study|Lack of Efficacy|15|||
148996463|NCT02184611|537465256|FG000|Overall Study|Withdrawal by Subject|5|||
148996464|NCT02184611|537465257|FG001|Overall Study|Withdrawal by Subject|6|||
148996465|NCT02184611|537465256|FG000|Overall Study|Adverse Event|4|||
148996466|NCT02184611|537465257|FG001|Overall Study|Adverse Event|5|||
148996467|NCT02184611|537465256|FG000|Overall Study|Protocol Violation|1|||
148996468|NCT02184611|537465257|FG001|Overall Study|Protocol Violation|1|||
148996469|NCT02184611|537465256|FG000|Overall Study|Protocol defined stopping criteria|0|||
148996470|NCT02184611|537465257|FG001|Overall Study|Protocol defined stopping criteria|1|||
148996471|NCT00160680|537465258|FG000|Overall Study|Adverse Event|0|||
148996472|NCT00160680|537465259|FG001|Overall Study|Adverse Event|1|||
148996473|NCT00160680|537465258|FG000|Overall Study|Lack of Efficacy|2|||
148996474|NCT00160680|537465259|FG001|Overall Study|Lack of Efficacy|1|||
148996475|NCT00160680|537465258|FG000|Overall Study|Lost to Follow-up|3|||
148996476|NCT00160680|537465259|FG001|Overall Study|Lost to Follow-up|2|||
148996477|NCT00160680|537465258|FG000|Overall Study|Withdrawal by Subject|4|||
148996478|NCT00160680|537465259|FG001|Overall Study|Withdrawal by Subject|9|||
148996479|NCT04493216|537465260|FG000|Overall Study|Study terminated by sponsor|30|||
148996480|NCT04493216|537465261|FG001|Overall Study|Study terminated by sponsor|33|||
148996481|NCT04493216|537465262|FG002|Overall Study|Study terminated by sponsor|28|||
148996482|NCT04493216|537465263|FG003|Overall Study|Study terminated by sponsor|27|||
148996483|NCT04493216|537465260|FG000|Overall Study|Withdrawal by Subject|2|||
148996484|NCT04493216|537465261|FG001|Overall Study|Withdrawal by Subject|1|||
148996485|NCT04493216|537465262|FG002|Overall Study|Withdrawal by Subject|1|||
148996486|NCT04493216|537465263|FG003|Overall Study|Withdrawal by Subject|2|||
148996487|NCT04493216|537465260|FG000|Overall Study|Protocol Violation|1|||
148996488|NCT04493216|537465261|FG001|Overall Study|Protocol Violation|2|||
148996489|NCT04493216|537465262|FG002|Overall Study|Protocol Violation|0|||
148996490|NCT04493216|537465263|FG003|Overall Study|Protocol Violation|2|||
148996491|NCT04493216|537465260|FG000|Overall Study|Physician Decision|0|||
148996492|NCT04493216|537465261|FG001|Overall Study|Physician Decision|0|||
148996493|NCT04493216|537465262|FG002|Overall Study|Physician Decision|1|||
148996494|NCT04493216|537465263|FG003|Overall Study|Physician Decision|0|||
148996495|NCT04493216|537465260|FG000|Overall Study|Lost to Follow-up|2|||
148996496|NCT04493216|537465261|FG001|Overall Study|Lost to Follow-up|1|||
148996497|NCT04493216|537465262|FG002|Overall Study|Lost to Follow-up|0|||
148996498|NCT04493216|537465263|FG003|Overall Study|Lost to Follow-up|1|||
148996499|NCT04493216|537465260|FG000|Overall Study|Adverse Event|1|||
148996500|NCT04493216|537465261|FG001|Overall Study|Adverse Event|4|||
148996501|NCT04493216|537465262|FG002|Overall Study|Adverse Event|5|||
148996502|NCT04493216|537465263|FG003|Overall Study|Adverse Event|2|||
148996503|NCT04493216|537465260|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
148996504|NCT04493216|537465261|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
148996505|NCT04493216|537465262|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
148996506|NCT04493216|537465263|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
148996507|NCT00985725|537465266|FG000|Overall Study|Adverse Event|4|||
148996508|NCT00985725|537465267|FG001|Overall Study|Adverse Event|1|||
148996509|NCT00985725|537465266|FG000|Overall Study|Protocol Violation|1|||
148996510|NCT00985725|537465267|FG001|Overall Study|Protocol Violation|3|||
148996511|NCT00985725|537465266|FG000|Overall Study|Withdrawal by Subject|4|||
148996512|NCT00985725|537465267|FG001|Overall Study|Withdrawal by Subject|4|||
148996513|NCT00985725|537465266|FG000|Overall Study|Lost to Follow-up|1|||
148996514|NCT00985725|537465267|FG001|Overall Study|Lost to Follow-up|1|||
148996515|NCT00985725|537465266|FG000|Overall Study|Lack of Efficacy|0|||
148996516|NCT00985725|537465267|FG001|Overall Study|Lack of Efficacy|1|||
148996517|NCT00985725|537465266|FG000|Overall Study|Non-compliance|1|||
148996518|NCT00985725|537465267|FG001|Overall Study|Non-compliance|2|||
148996519|NCT00985725|537465266|FG000|Overall Study|Out-of-window visits|0|||
148996520|NCT00985725|537465267|FG001|Overall Study|Out-of-window visits|1|||
148996521|NCT03151005|537465273|FG000|Overall Study|Lost to Follow-up|5|||
148996522|NCT03151005|537465274|FG001|Overall Study|Lost to Follow-up|5|||
148996523|NCT03318523|537465279|FG000|PC Period: Up to Year 1|Adverse Event|1|||
148996524|NCT03318523|537465280|FG001|PC Period: Up to Year 1|Adverse Event|0|||
148996525|NCT03318523|537465281|FG002|PC Period: Up to Year 1|Adverse Event|2|||
148996526|NCT03318523|537465282|FG003|PC Period: Up to Year 1|Adverse Event|0|||
148996527|NCT03318523|537465283|FG004|PC Period: Up to Year 1|Adverse Event|0|||
148996528|NCT03318523|537465284|FG005|PC Period: Up to Year 1|Adverse Event|0|||
148996529|NCT03318523|537465285|FG006|PC Period: Up to Year 1|Adverse Event|0|||
148996530|NCT03318523|537465286|FG007|PC Period: Up to Year 1|Adverse Event|0|||
148996531|NCT03318523|537465287|FG008|PC Period: Up to Year 1|Adverse Event|0|||
148996532|NCT03318523|537465288|FG009|PC Period: Up to Year 1|Adverse Event|0|||
148996533|NCT03318523|537465279|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
148996534|NCT03318523|537465280|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
148996535|NCT03318523|537465281|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996536|NCT03318523|537465282|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
148996537|NCT03318523|537465283|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996538|NCT03318523|537465284|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996539|NCT03318523|537465285|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996540|NCT03318523|537465286|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996541|NCT03318523|537465287|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996542|NCT03318523|537465288|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
148996543|NCT03318523|537465279|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996544|NCT03318523|537465280|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996545|NCT03318523|537465281|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996546|NCT03318523|537465282|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996547|NCT03318523|537465283|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
148996548|NCT03318523|537465284|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996549|NCT03318523|537465285|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996550|NCT03318523|537465286|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
148996551|NCT03318523|537465287|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
148996552|NCT03318523|537465288|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
148996553|NCT03318523|537465279|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
148996554|NCT03318523|537465280|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
148996555|NCT03318523|537465281|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
148996556|NCT03318523|537465282|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
148996557|NCT03318523|537465283|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
148996558|NCT03318523|537465284|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
148996559|NCT03318523|537465285|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
148996560|NCT03318523|537465286|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
148996561|NCT03318523|537465287|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
148996562|NCT03318523|537465288|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
148996563|NCT03318523|537465279|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996564|NCT03318523|537465280|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996565|NCT03318523|537465281|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996566|NCT03318523|537465282|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996567|NCT03318523|537465283|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996568|NCT03318523|537465284|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
148996569|NCT03318523|537465285|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996570|NCT03318523|537465286|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996571|NCT03318523|537465287|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996572|NCT03318523|537465288|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
148996573|NCT03318523|537465279|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996574|NCT03318523|537465280|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996575|NCT03318523|537465281|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996576|NCT03318523|537465282|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996577|NCT03318523|537465283|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996578|NCT03318523|537465284|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996579|NCT03318523|537465285|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996580|NCT03318523|537465286|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996581|NCT03318523|537465287|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
148996582|NCT03318523|537465288|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
148996583|NCT03318523|537465279|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
148996584|NCT03318523|537465280|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
148996585|NCT03318523|537465281|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
148996586|NCT03318523|537465282|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
148996587|NCT03318523|537465283|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
148996588|NCT03318523|537465284|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
148996589|NCT03318523|537465285|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
148996590|NCT03318523|537465286|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
148996591|NCT03318523|537465287|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
148996592|NCT03318523|537465288|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
148996593|NCT03318523|537465279|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996594|NCT03318523|537465280|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996595|NCT03318523|537465281|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996596|NCT03318523|537465282|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996597|NCT03318523|537465283|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
148996598|NCT03318523|537465284|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996599|NCT03318523|537465285|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996600|NCT03318523|537465286|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
148996601|NCT03318523|537465287|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
148996602|NCT03318523|537465288|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
148996603|NCT03232983|537465291|FG000|Period 1|Physician Decision|0|||
148865032|NCT01974752|536982911|FG001|Overall Study|Withdrawal by Subject|3|||
148865033|NCT01974752|536982910|FG000|Overall Study|Other Eligibility Criteria|0|||
148865034|NCT01974752|536982911|FG001|Overall Study|Other Eligibility Criteria|1|||
148865035|NCT02435680|536982912|FG000|Overall Study|Physician Decision|3|||
148865036|NCT02435680|536982913|FG001|Overall Study|Physician Decision|0|||
148865037|NCT02435680|536982914|FG002|Overall Study|Physician Decision|0|||
148865038|NCT02435680|536982912|FG000|Overall Study|subject / guardian decision|0|||
148865039|NCT02435680|536982913|FG001|Overall Study|subject / guardian decision|3|||
148865040|NCT02435680|536982914|FG002|Overall Study|subject / guardian decision|2|||
148865041|NCT02435680|536982912|FG000|Overall Study|Adverse Event|8|||
148865042|NCT02435680|536982913|FG001|Overall Study|Adverse Event|3|||
148865043|NCT02435680|536982914|FG002|Overall Study|Adverse Event|2|||
148865044|NCT02435680|536982912|FG000|Overall Study|progressive disease|10|||
148865045|NCT02435680|536982913|FG001|Overall Study|progressive disease|7|||
148865046|NCT02435680|536982914|FG002|Overall Study|progressive disease|11|||
148865047|NCT02435680|536982912|FG000|Overall Study|not treated|0|||
148865048|NCT02435680|536982913|FG001|Overall Study|not treated|0|||
148996604|NCT03232983|537465292|FG001|Period 1|Physician Decision|0|||
148996605|NCT03232983|537465293|FG002|Period 1|Physician Decision|1|||
148778164|NCT03181503|536661927|FG000|Overall Study|Withdrawal by Subject|3|||
148778165|NCT03181503|536661928|FG001|Overall Study|Withdrawal by Subject|0|||
148778166|NCT03181503|536661927|FG000|Overall Study|Lost to Follow-up|1|||
148778167|NCT03181503|536661928|FG001|Overall Study|Lost to Follow-up|1|||
148778168|NCT01892085|536661929|FG000|Overall Study|Death|4|||
148778169|NCT01892085|536661930|FG001|Overall Study|Death|1|||
148778170|NCT01892085|536661931|FG002|Overall Study|Death|3|||
148778171|NCT01892085|536661929|FG000|Overall Study|Withdrawal by Subject|2|||
148778172|NCT01892085|536661930|FG001|Overall Study|Withdrawal by Subject|0|||
148778173|NCT01892085|536661931|FG002|Overall Study|Withdrawal by Subject|2|||
148778174|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
148778175|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
148778176|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
148778177|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
148778178|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|Death|1|||
148778179|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|Death|1|||
148778180|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
148778181|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
148778182|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
148778183|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
148778184|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
148778185|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
148778186|NCT00033657|536661933|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
148865049|NCT02435680|536982914|FG002|Overall Study|not treated|1|||
148865050|NCT03276052|536982918|FG000|Overall Study|Withdrawal by Subject|5|||
148865051|NCT03276052|536982918|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
148865052|NCT03784846|536982919|FG000|Pre-COVID Study|Lost to Follow-up|3|||
148865053|NCT03784846|536982920|FG001|Pre-COVID Study|Lost to Follow-up|3|||
148865054|NCT03784846|536982921|FG002|Pre-COVID Study|Lost to Follow-up|2|||
148865055|NCT03784846|536982919|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
148865056|NCT03784846|536982920|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
148865057|NCT03784846|536982921|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
148865058|NCT03784846|536982919|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
148865059|NCT03784846|536982920|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
148865060|NCT03784846|536982921|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
148865061|NCT03784846|536982919|FG000|Post-COVID Study|Lost to Follow-up|3|||
148865062|NCT03784846|536982920|FG001|Post-COVID Study|Lost to Follow-up|5|||
148865063|NCT03784846|536982921|FG002|Post-COVID Study|Lost to Follow-up|1|||
148865064|NCT03784846|536982919|FG000|Post-COVID Study|Withdrawal by Subject|1|||
148865065|NCT03784846|536982920|FG001|Post-COVID Study|Withdrawal by Subject|2|||
148865066|NCT03784846|536982921|FG002|Post-COVID Study|Withdrawal by Subject|0|||
148865067|NCT01062841|536982927|FG000|Overall Study|Indwelling Device Removed|41|||
148865068|NCT01062841|536982928|FG001|Overall Study|Indwelling Device Removed|48|||
148865069|NCT01062841|536982927|FG000|Overall Study|Death|3|||
148865070|NCT01062841|536982928|FG001|Overall Study|Death|5|||
148865071|NCT01062841|536982927|FG000|Overall Study|Withdrawal by Subject|2|||
148865072|NCT01062841|536982928|FG001|Overall Study|Withdrawal by Subject|0|||
148865073|NCT01062841|536982927|FG000|Overall Study|Withdrawal by Study|3|||
148865074|NCT01062841|536982928|FG001|Overall Study|Withdrawal by Study|0|||
148865075|NCT02046174|536982929|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
148865076|NCT02046174|536982930|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
148865077|NCT00186537|536982934|FG000|Overall Study|Withdrawal by Subject|4|||
148865078|NCT00186537|536982935|FG001|Overall Study|Withdrawal by Subject|0|||
148865079|NCT00186537|536982936|FG002|Overall Study|Withdrawal by Subject|3|||
148865080|NCT00186537|536982934|FG000|Overall Study|ALT > 1.5 x ULN|3|||
148865081|NCT00186537|536982935|FG001|Overall Study|ALT > 1.5 x ULN|0|||
148865082|NCT00186537|536982936|FG002|Overall Study|ALT > 1.5 x ULN|0|||
148865083|NCT01143051|536982937|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
148865084|NCT01143051|536982938|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
148865085|NCT01143051|536982939|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
148865086|NCT01143051|536982940|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
148865087|NCT01143051|536982941|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
148865088|NCT01143051|536982942|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
148865089|NCT01143051|536982937|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
148865090|NCT01143051|536982938|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
148865091|NCT01143051|536982939|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
148865092|NCT01143051|536982940|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
148865093|NCT01143051|536982941|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
148865094|NCT01143051|536982942|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
148865095|NCT01874275|536982947|FG000|Overall Study|Lost to Follow-up|1|||
148865096|NCT01874275|536982948|FG001|Overall Study|Lost to Follow-up|0|||
148865097|NCT03351114|536982949|FG000|Overall Study|Withdrawal by Subject|1|||
148865098|NCT02231762|536982952|FG000|Combination Phase|Adverse Event|10|||
148865099|NCT02231762|536982953|FG001|Combination Phase|Adverse Event|0|||
148865100|NCT02231762|536982954|FG002|Combination Phase|Adverse Event|0|||
148865101|NCT02231762|536982955|FG003|Combination Phase|Adverse Event|0|||
148865102|NCT02231762|536982952|FG000|Combination Phase|Withdrawal by Subject|2|||
148865103|NCT02231762|536982953|FG001|Combination Phase|Withdrawal by Subject|0|||
148865104|NCT02231762|536982954|FG002|Combination Phase|Withdrawal by Subject|0|||
148865105|NCT02231762|536982955|FG003|Combination Phase|Withdrawal by Subject|0|||
148865106|NCT02231762|536982952|FG000|Combination Phase|Disease Progression|6|||
148865107|NCT02231762|536982953|FG001|Combination Phase|Disease Progression|0|||
148865108|NCT02231762|536982954|FG002|Combination Phase|Disease Progression|0|||
148865109|NCT02231762|536982955|FG003|Combination Phase|Disease Progression|0|||
148865110|NCT02231762|536982952|FG000|Combination Phase|Did not meet inclusion criteria|1|||
148865111|NCT02231762|536982953|FG001|Combination Phase|Did not meet inclusion criteria|0|||
148865112|NCT02231762|536982954|FG002|Combination Phase|Did not meet inclusion criteria|0|||
148865113|NCT02231762|536982955|FG003|Combination Phase|Did not meet inclusion criteria|0|||
148865114|NCT02231762|536982952|FG000|Combination Phase|Protocol Violation|1|||
148865115|NCT02231762|536982953|FG001|Combination Phase|Protocol Violation|0|||
148865116|NCT02231762|536982954|FG002|Combination Phase|Protocol Violation|0|||
148865117|NCT02231762|536982955|FG003|Combination Phase|Protocol Violation|0|||
148865118|NCT02231762|536982952|FG000|Maintenance Phase|Disease progression|0|||
148865119|NCT02231762|536982953|FG001|Maintenance Phase|Disease progression|3|||
148865120|NCT02231762|536982954|FG002|Maintenance Phase|Disease progression|4|||
148865121|NCT02231762|536982955|FG003|Maintenance Phase|Disease progression|3|||
148865122|NCT02231762|536982952|FG000|Maintenance Phase|Adverse Event|0|||
148865123|NCT02231762|536982953|FG001|Maintenance Phase|Adverse Event|0|||
148865124|NCT02231762|536982954|FG002|Maintenance Phase|Adverse Event|1|||
148865125|NCT02231762|536982955|FG003|Maintenance Phase|Adverse Event|2|||
148865126|NCT00989235|536982960|FG000|Overall Study|Death|0|||
148865127|NCT00989235|536982961|FG001|Overall Study|Death|1|||
148865128|NCT00989235|536982960|FG000|Overall Study|Adverse Event|0|||
148865129|NCT00989235|536982961|FG001|Overall Study|Adverse Event|1|||
148865130|NCT00989235|536982960|FG000|Overall Study|Lack of Efficacy|1|||
148865131|NCT00989235|536982961|FG001|Overall Study|Lack of Efficacy|0|||
148865132|NCT00989235|536982960|FG000|Overall Study|Withdrawal of Consent|1|||
148865133|NCT00989235|536982961|FG001|Overall Study|Withdrawal of Consent|1|||
148865134|NCT00989235|536982960|FG000|Overall Study|Desire to Become Pregnant|1|||
148865135|NCT00989235|536982961|FG001|Overall Study|Desire to Become Pregnant|0|||
148865136|NCT00989235|536982960|FG000|Overall Study|Randomized by Mistake|0|||
148865137|NCT00989235|536982961|FG001|Overall Study|Randomized by Mistake|2|||
148865138|NCT00989235|536982960|FG000|Overall Study|Lost to Follow-up|0|||
148865139|NCT00989235|536982961|FG001|Overall Study|Lost to Follow-up|1|||
148865140|NCT03249935|536982962|FG000|Overall Study|Discharged from facility early|36|||
148865141|NCT03249935|536982962|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
148865142|NCT03249935|536982962|FG000|Overall Study|Protocol Violation|5|||
148865143|NCT01669421|536982965|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
148865144|NCT01669421|536982965|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
148865145|NCT01149486|536982966|FG000|First Intervention|Adverse Event|0|||
148865146|NCT01149486|536982967|FG001|First Intervention|Adverse Event|1|||
148865147|NCT02813668|536982972|FG000|Overall Study|Death|4|||
148865148|NCT02813668|536982972|FG000|Overall Study|Lost to Follow-up|509|||
148865149|NCT02813668|536982972|FG000|Overall Study|Withdrawal by Subject|148|||
148865150|NCT02813668|536982972|FG000|Overall Study|No longer at worksite|85|||
148865151|NCT02813668|536982972|FG000|Overall Study|Medical reasons not related to the study|4|||
148865152|NCT01135914|536982975|FG000|Overall Study|Withdrawal by Subject|1|||
148865153|NCT01135914|536982976|FG001|Overall Study|Withdrawal by Subject|3|||
148865154|NCT01135914|536982977|FG002|Overall Study|Withdrawal by Subject|6|||
148865155|NCT01135914|536982975|FG000|Overall Study|Lost to Follow-up|1|||
148865156|NCT01135914|536982976|FG001|Overall Study|Lost to Follow-up|0|||
148865157|NCT01135914|536982977|FG002|Overall Study|Lost to Follow-up|1|||
148865158|NCT01135914|536982975|FG000|Overall Study|Protocol Violation|0|||
148865159|NCT01135914|536982976|FG001|Overall Study|Protocol Violation|0|||
148865160|NCT01135914|536982977|FG002|Overall Study|Protocol Violation|3|||
148865161|NCT01135914|536982975|FG000|Overall Study|Lack of Efficacy|2|||
148865162|NCT01135914|536982976|FG001|Overall Study|Lack of Efficacy|1|||
148865163|NCT01135914|536982977|FG002|Overall Study|Lack of Efficacy|10|||
148865164|NCT01135914|536982975|FG000|Overall Study|Adverse Event|0|||
148865165|NCT01135914|536982976|FG001|Overall Study|Adverse Event|1|||
148865166|NCT01135914|536982977|FG002|Overall Study|Adverse Event|2|||
148865167|NCT02133664|536982982|FG000|Overall Study|Lost to Follow-up|2|||
148865168|NCT02133664|536982983|FG001|Overall Study|Lost to Follow-up|1|||
148865169|NCT02133664|536982982|FG000|Overall Study|Adverse Event|3|||
148865170|NCT02133664|536982983|FG001|Overall Study|Adverse Event|6|||
148865171|NCT03366103|536982984|FG000|Overall Study|Disease Progression|3|||
148865172|NCT03366103|536982985|FG001|Overall Study|Disease Progression|1|||
148865173|NCT03366103|536982986|FG002|Overall Study|Disease Progression|0|||
148865174|NCT03366103|536982984|FG000|Overall Study|Adverse Event|0|||
148865175|NCT03366103|536982985|FG001|Overall Study|Adverse Event|1|||
148865176|NCT03366103|536982986|FG002|Overall Study|Adverse Event|0|||
148865177|NCT01667562|536982993|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
148865178|NCT01667562|536982994|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
148865179|NCT01667562|536982993|FG000|Erlotinib Phase|Lost to Follow-up|0|||
148865180|NCT01667562|536982994|FG001|Erlotinib Phase|Lost to Follow-up|1|||
148865181|NCT01667562|536982993|FG000|Erlotinib Phase|Adverse Event|0|||
148865182|NCT01667562|536982994|FG001|Erlotinib Phase|Adverse Event|1|||
148865183|NCT01667562|536982993|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
148865184|NCT01667562|536982994|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
148865185|NCT00355342|536982995|FG000|Overall Study|Adverse Event|13|||
148865186|NCT00355342|536982996|FG001|Overall Study|Adverse Event|15|||
148865187|NCT00355342|536982995|FG000|Overall Study|Lost to Follow-up|4|||
148865188|NCT00355342|536982996|FG001|Overall Study|Lost to Follow-up|2|||
148865189|NCT00355342|536982995|FG000|Overall Study|Withdrawal by Subject|14|||
148865190|NCT00355342|536982996|FG001|Overall Study|Withdrawal by Subject|11|||
148865191|NCT00355342|536982995|FG000|Overall Study|Sponsor terminated study|2|||
148865192|NCT00355342|536982996|FG001|Overall Study|Sponsor terminated study|2|||
148865193|NCT00355342|536982995|FG000|Overall Study|Overcompliant-PI discretion|1|||
148865194|NCT00355342|536982996|FG001|Overall Study|Overcompliant-PI discretion|0|||
148865195|NCT00355342|536982995|FG000|Overall Study|Use of prohibited medication|1|||
148865196|NCT00355342|536982996|FG001|Overall Study|Use of prohibited medication|0|||
148865197|NCT00355342|536982995|FG000|Overall Study|COPD exacerbation|1|||
148865198|NCT00355342|536982996|FG001|Overall Study|COPD exacerbation|1|||
148865199|NCT00355342|536982995|FG000|Overall Study|Dispensed wrong study drug kit|1|||
148865200|NCT00355342|536982996|FG001|Overall Study|Dispensed wrong study drug kit|0|||
148865201|NCT00355342|536982995|FG000|Overall Study|Non-compliance with Dexa scans|1|||
148996606|NCT03232983|537465294|FG003|Period 1|Physician Decision|0|||
148996607|NCT03232983|537465291|FG000|Washout Period 2|Physician Decision|0|||
148996608|NCT03232983|537465292|FG001|Washout Period 2|Physician Decision|0|||
148996609|NCT03232983|537465293|FG002|Washout Period 2|Physician Decision|1|||
148996610|NCT03232983|537465294|FG003|Washout Period 2|Physician Decision|0|||
148996611|NCT03232983|537465291|FG000|Washout Period 2|Withdrawal by Subject|0|||
148996612|NCT03232983|537465292|FG001|Washout Period 2|Withdrawal by Subject|0|||
148996613|NCT03232983|537465293|FG002|Washout Period 2|Withdrawal by Subject|0|||
148996614|NCT03232983|537465294|FG003|Washout Period 2|Withdrawal by Subject|1|||
148996615|NCT03232983|537465291|FG000|Period 4|Withdrawal by Subject|1|||
148996616|NCT03232983|537465292|FG001|Period 4|Withdrawal by Subject|0|||
148996617|NCT03232983|537465293|FG002|Period 4|Withdrawal by Subject|0|||
148996618|NCT03232983|537465294|FG003|Period 4|Withdrawal by Subject|0|||
148996619|NCT01615328|537465295|FG000|Overall Study|Lost to Follow-up|3|||
148996620|NCT01615328|537465296|FG001|Overall Study|Lost to Follow-up|5|||
148996621|NCT00863655|537465297|FG000|Overall Study|Protocol Violation|4|||
148996622|NCT00863655|537465298|FG001|Overall Study|Protocol Violation|0|||
148996623|NCT00863655|537465297|FG000|Overall Study|Adverse Event|52|||
148996624|NCT00863655|537465298|FG001|Overall Study|Adverse Event|8|||
148996625|NCT00863655|537465297|FG000|Overall Study|Withdrawal by Subject|47|||
148996626|NCT00863655|537465298|FG001|Overall Study|Withdrawal by Subject|7|||
148996627|NCT00863655|537465297|FG000|Overall Study|Administrative problems|1|||
148996628|NCT00863655|537465298|FG001|Overall Study|Administrative problems|0|||
148996629|NCT00863655|537465297|FG000|Overall Study|Death|7|||
148996630|NCT00863655|537465298|FG001|Overall Study|Death|1|||
148996631|NCT00863655|537465297|FG000|Overall Study|New cancer therapy|5|||
148996632|NCT00863655|537465298|FG001|Overall Study|New cancer therapy|1|||
148996633|NCT00863655|537465297|FG000|Overall Study|Disease progression|364|||
148996634|NCT00863655|537465298|FG001|Overall Study|Disease progression|221|||
148996635|NCT00863655|537465297|FG000|Overall Study|Treatment completed as per protocol|5|||
148996636|NCT00863655|537465298|FG001|Overall Study|Treatment completed as per protocol|1|||
148996637|NCT02261493|537465299|FG000|Overall Study|Noncompliance|0|||
148996638|NCT02261493|537465300|FG001|Overall Study|Noncompliance|0|||
148996639|NCT02261493|537465301|FG002|Overall Study|Noncompliance|2|||
148996640|NCT02261493|537465299|FG000|Overall Study|Physician Decision|0|||
148996641|NCT02261493|537465300|FG001|Overall Study|Physician Decision|1|||
148996642|NCT02261493|537465301|FG002|Overall Study|Physician Decision|0|||
148996643|NCT02261493|537465299|FG000|Overall Study|Undisclosed alcohol abuse|0|||
148996644|NCT02261493|537465300|FG001|Overall Study|Undisclosed alcohol abuse|1|||
148996645|NCT02261493|537465301|FG002|Overall Study|Undisclosed alcohol abuse|0|||
148996646|NCT02261493|537465299|FG000|Overall Study|Protocol Violation|1|||
148996647|NCT02261493|537465300|FG001|Overall Study|Protocol Violation|0|||
148996648|NCT02261493|537465301|FG002|Overall Study|Protocol Violation|0|||
148996649|NCT02261493|537465299|FG000|Overall Study|Personal Reasons|14|||
148996650|NCT02261493|537465300|FG001|Overall Study|Personal Reasons|14|||
148996651|NCT02261493|537465301|FG002|Overall Study|Personal Reasons|16|||
148996652|NCT02261493|537465299|FG000|Overall Study|Lost to Follow-up|14|||
148996653|NCT02261493|537465300|FG001|Overall Study|Lost to Follow-up|27|||
148996654|NCT02261493|537465301|FG002|Overall Study|Lost to Follow-up|8|||
148996655|NCT02261493|537465299|FG000|Overall Study|Pregnancy|1|||
148996656|NCT02261493|537465300|FG001|Overall Study|Pregnancy|2|||
148996657|NCT02261493|537465301|FG002|Overall Study|Pregnancy|0|||
148996658|NCT02261493|537465299|FG000|Overall Study|Lack of Efficacy|0|||
148996659|NCT02261493|537465300|FG001|Overall Study|Lack of Efficacy|1|||
148996660|NCT02261493|537465301|FG002|Overall Study|Lack of Efficacy|0|||
148996661|NCT02261493|537465299|FG000|Overall Study|Adverse Event|0|||
148996662|NCT02261493|537465300|FG001|Overall Study|Adverse Event|1|||
148996663|NCT02261493|537465301|FG002|Overall Study|Adverse Event|0|||
148996664|NCT01597050|537465302|FG000|Overall Study|Withdrawal by Subject|1|||
148996665|NCT01597050|537465303|FG001|Overall Study|Withdrawal by Subject|0|||
148996666|NCT00483184|537465304|FG000|Overall Study|Withdrawal by Subject|2|||
148996667|NCT00483184|537465305|FG001|Overall Study|Withdrawal by Subject|2|||
148996668|NCT00483184|537465306|FG002|Overall Study|Withdrawal by Subject|0|||
148996669|NCT00483184|537465304|FG000|Overall Study|Lost to Follow-up|1|||
148996670|NCT00483184|537465305|FG001|Overall Study|Lost to Follow-up|0|||
148996671|NCT00483184|537465306|FG002|Overall Study|Lost to Follow-up|0|||
148996672|NCT00483184|537465304|FG000|Overall Study|Adverse Event|1|||
148996673|NCT00483184|537465305|FG001|Overall Study|Adverse Event|2|||
148996674|NCT00483184|537465306|FG002|Overall Study|Adverse Event|2|||
148996675|NCT00483184|537465304|FG000|Overall Study|Protocol Violation|1|||
148996676|NCT00483184|537465305|FG001|Overall Study|Protocol Violation|0|||
148996677|NCT00483184|537465306|FG002|Overall Study|Protocol Violation|1|||
148996678|NCT02065336|537465310|FG000|Extension Phase|Study Terminated by Sponsor|0|||
148996679|NCT02065336|537465311|FG001|Extension Phase|Study Terminated by Sponsor|0|||
148996680|NCT02065336|537465312|FG002|Extension Phase|Study Terminated by Sponsor|0|||
148996681|NCT02065336|537465313|FG003|Extension Phase|Study Terminated by Sponsor|0|||
148996682|NCT02065336|537465314|FG004|Extension Phase|Study Terminated by Sponsor|0|||
148996683|NCT02065336|537465315|FG005|Extension Phase|Study Terminated by Sponsor|0|||
148996684|NCT02065336|537465316|FG006|Extension Phase|Study Terminated by Sponsor|0|||
148996685|NCT02065336|537465317|FG007|Extension Phase|Study Terminated by Sponsor|0|||
148996686|NCT02065336|537465318|FG008|Extension Phase|Study Terminated by Sponsor|2|||
148996687|NCT02065336|537465319|FG009|Extension Phase|Study Terminated by Sponsor|8|||
148996688|NCT02192502|537465322|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
148996689|NCT02192502|537465323|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
148996690|NCT02192502|537465322|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
148996691|NCT02192502|537465323|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
148996692|NCT02192502|537465322|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
148996693|NCT02192502|537465323|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
148996694|NCT01381692|537465324|FG000|Overall Study|Adverse Event|1|||
148996695|NCT01381692|537465325|FG001|Overall Study|Adverse Event|0|||
148996696|NCT01381692|537465326|FG002|Overall Study|Adverse Event|0|||
148996697|NCT01381692|537465327|FG003|Overall Study|Adverse Event|0|||
148996698|NCT01381692|537465328|FG004|Overall Study|Adverse Event|0|||
148996699|NCT01381692|537465329|FG005|Overall Study|Adverse Event|0|||
148996700|NCT04575467|537465330|FG000|Overall Study|Adverse Event|0|||
148996701|NCT04575467|537465331|FG001|Overall Study|Adverse Event|1|||
148996702|NCT04575467|537465332|FG002|Overall Study|Adverse Event|0|||
148996703|NCT04575467|537465333|FG003|Overall Study|Adverse Event|0|||
148996704|NCT01994954|537465334|FG000|Overall Study|Death|1|||
148996705|NCT01994954|537465335|FG001|Overall Study|Death|0|||
148996706|NCT01994954|537465334|FG000|Overall Study|Withdrawal by Subject|9|||
148996707|NCT01994954|537465335|FG001|Overall Study|Withdrawal by Subject|14|||
148996708|NCT01994954|537465334|FG000|Overall Study|Physician Decision|2|||
148996709|NCT01994954|537465335|FG001|Overall Study|Physician Decision|2|||
148996710|NCT01994954|537465334|FG000|Overall Study|Lost to Follow-up|8|||
148996711|NCT01994954|537465335|FG001|Overall Study|Lost to Follow-up|10|||
148996712|NCT01994954|537465334|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
148996713|NCT01994954|537465335|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
148996714|NCT00449176|537465336|FG000|Overall Study|Withdrawal by Subject|39|||
148996715|NCT00449176|537465337|FG001|Overall Study|Withdrawal by Subject|43|||
148996716|NCT00449176|537465338|FG002|Overall Study|Withdrawal by Subject|59|||
148996717|NCT00449176|537465336|FG000|Overall Study|Lost to Follow-up|13|||
148996718|NCT00449176|537465337|FG001|Overall Study|Lost to Follow-up|8|||
148996719|NCT00449176|537465338|FG002|Overall Study|Lost to Follow-up|12|||
148996720|NCT00449176|537465336|FG000|Overall Study|Adverse Event|51|||
148996721|NCT00449176|537465337|FG001|Overall Study|Adverse Event|107|||
148996722|NCT00449176|537465338|FG002|Overall Study|Adverse Event|15|||
148996723|NCT00449176|537465336|FG000|Overall Study|Lack of Efficacy|13|||
148996724|NCT00449176|537465337|FG001|Overall Study|Lack of Efficacy|7|||
148996725|NCT00449176|537465338|FG002|Overall Study|Lack of Efficacy|50|||
148996726|NCT00449176|537465336|FG000|Overall Study|Study drug non-compliant|14|||
148996727|NCT00449176|537465337|FG001|Overall Study|Study drug non-compliant|11|||
148996728|NCT00449176|537465338|FG002|Overall Study|Study drug non-compliant|11|||
148996729|NCT00449176|537465336|FG000|Overall Study|all other|22|||
148996730|NCT00449176|537465337|FG001|Overall Study|all other|19|||
148996731|NCT00449176|537465338|FG002|Overall Study|all other|20|||
148996732|NCT02576678|537465339|FG000|Overall Study|Adverse Event|0|||
148996733|NCT02576678|537465340|FG001|Overall Study|Adverse Event|0|||
148996734|NCT02576678|537465341|FG002|Overall Study|Adverse Event|2|||
148996735|NCT02576678|537465339|FG000|Overall Study|Withdrawal by Subject|3|||
148996736|NCT02576678|537465340|FG001|Overall Study|Withdrawal by Subject|1|||
148996737|NCT02576678|537465341|FG002|Overall Study|Withdrawal by Subject|2|||
148996738|NCT02576678|537465339|FG000|Overall Study|Lost to Follow-up|0|||
148996739|NCT02576678|537465340|FG001|Overall Study|Lost to Follow-up|0|||
148996740|NCT02576678|537465341|FG002|Overall Study|Lost to Follow-up|1|||
148996741|NCT02576678|537465339|FG000|Overall Study|Miscellaneous|2|||
148996742|NCT02576678|537465340|FG001|Overall Study|Miscellaneous|0|||
148996743|NCT02576678|537465341|FG002|Overall Study|Miscellaneous|0|||
148996744|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
148996745|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
148996746|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|disease progression|58|||
148996747|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|disease progression|47|||
148996748|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|Death|3|||
148996749|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|Death|6|||
148996750|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
148996751|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
148996752|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
148996753|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
148996754|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
148996755|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
148996756|NCT02472964|537465342|FG000|Part 1 (up to Week 24)|Other|2|||
148996757|NCT02472964|537465343|FG001|Part 1 (up to Week 24)|Other|1|||
148996758|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
148996759|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
148996760|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
148865202|NCT00355342|536982996|FG001|Overall Study|Non-compliance with Dexa scans|0|||
148865203|NCT00355342|536982995|FG000|Overall Study|Withdrawal by participant and physician|1|||
148865204|NCT00355342|536982996|FG001|Overall Study|Withdrawal by participant and physician|0|||
148865205|NCT00355342|536982995|FG000|Overall Study|Participant relocated|0|||
148865206|NCT00355342|536982996|FG001|Overall Study|Participant relocated|1|||
148865207|NCT00355342|536982995|FG000|Overall Study|Participant discontinued study drug|0|||
148865208|NCT00355342|536982996|FG001|Overall Study|Participant discontinued study drug|1|||
148865209|NCT00355342|536982995|FG000|Overall Study|Study management|0|||
148865210|NCT00355342|536982996|FG001|Overall Study|Study management|1|||
148865211|NCT00355342|536982995|FG000|Overall Study|Protocol Violation|0|||
148865212|NCT00355342|536982996|FG001|Overall Study|Protocol Violation|1|||
148865213|NCT00355342|536982995|FG000|Overall Study|Use of protocol excluded medication|0|||
148865214|NCT00355342|536982996|FG001|Overall Study|Use of protocol excluded medication|1|||
148865215|NCT00536874|536982997|FG000|Overall Study|Adverse Event|1|||
148865216|NCT00536874|536982997|FG000|Overall Study|Death|2|||
148865217|NCT00536874|536982997|FG000|Overall Study|Withdrawal by Subject|1|||
148865218|NCT00391391|536982999|FG000|Overall Study|Adverse Event|0|||
148865219|NCT00391391|536983000|FG001|Overall Study|Adverse Event|0|||
148865220|NCT00391391|536983001|FG002|Overall Study|Adverse Event|0|||
148865221|NCT00391391|536983002|FG003|Overall Study|Adverse Event|1|||
148865222|NCT00391391|536982999|FG000|Overall Study|Lost to Follow-up|1|||
148865223|NCT00391391|536983000|FG001|Overall Study|Lost to Follow-up|3|||
148865224|NCT00391391|536983001|FG002|Overall Study|Lost to Follow-up|7|||
148865225|NCT00391391|536983002|FG003|Overall Study|Lost to Follow-up|4|||
148865226|NCT00391391|536982999|FG000|Overall Study|Protocol Violation|2|||
148865227|NCT00391391|536983000|FG001|Overall Study|Protocol Violation|3|||
148865228|NCT00391391|536983001|FG002|Overall Study|Protocol Violation|6|||
148865229|NCT00391391|536983002|FG003|Overall Study|Protocol Violation|7|||
148865230|NCT00391391|536982999|FG000|Overall Study|Withdrawal by Subject|6|||
148865231|NCT00391391|536983000|FG001|Overall Study|Withdrawal by Subject|4|||
148865232|NCT00391391|536983001|FG002|Overall Study|Withdrawal by Subject|10|||
148865233|NCT00391391|536983002|FG003|Overall Study|Withdrawal by Subject|7|||
148865234|NCT00693472|536983003|FG000|Part 1|Adverse Event|1|||
148865235|NCT00693472|536983004|FG001|Part 1|Adverse Event|1|||
148865236|NCT00693472|536983005|FG002|Part 1|Adverse Event|0|||
148865237|NCT00693472|536983006|FG003|Part 1|Adverse Event|0|||
148865238|NCT00693472|536983003|FG000|Part 1|Lost to Follow-up|0|||
148865239|NCT00693472|536983004|FG001|Part 1|Lost to Follow-up|1|||
148865240|NCT00693472|536983005|FG002|Part 1|Lost to Follow-up|0|||
148865241|NCT00693472|536983006|FG003|Part 1|Lost to Follow-up|0|||
148865242|NCT00693472|536983003|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
148865243|NCT00693472|536983004|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
148865244|NCT00693472|536983005|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
148865245|NCT00693472|536983006|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
148865246|NCT00693472|536983003|FG000|Part 2|Adverse Event|0|||
148865247|NCT00693472|536983004|FG001|Part 2|Adverse Event|0|||
148865248|NCT00693472|536983005|FG002|Part 2|Adverse Event|1|||
148865249|NCT00693472|536983006|FG003|Part 2|Adverse Event|0|||
148865250|NCT00693472|536983003|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
148865251|NCT00693472|536983004|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
148865252|NCT00693472|536983005|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
148865253|NCT00693472|536983006|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
148865254|NCT04342689|536983009|FG000|Overall Study|Withdrawal by Subject|32|||
148865255|NCT04342689|536983010|FG001|Overall Study|Withdrawal by Subject|33|||
148865256|NCT04342689|536983009|FG000|Overall Study|Lost to Follow-up|10|||
148865257|NCT04342689|536983010|FG001|Overall Study|Lost to Follow-up|12|||
148865258|NCT00844805|536983013|FG000|Treatment Phase|Adverse Event|5|||
148865259|NCT00844805|536983014|FG001|Treatment Phase|Adverse Event|1|||
148865260|NCT00844805|536983015|FG002|Treatment Phase|Adverse Event|0|||
148865261|NCT00844805|536983016|FG003|Treatment Phase|Adverse Event|0|||
148865262|NCT00844805|536983013|FG000|Treatment Phase|Withdrawal by Subject|3|||
148865263|NCT00844805|536983014|FG001|Treatment Phase|Withdrawal by Subject|4|||
148865264|NCT00844805|536983015|FG002|Treatment Phase|Withdrawal by Subject|0|||
148865265|NCT00844805|536983016|FG003|Treatment Phase|Withdrawal by Subject|0|||
148865266|NCT00844805|536983013|FG000|Treatment Phase|Noncompliance With Protocol|1|||
148865267|NCT00844805|536983014|FG001|Treatment Phase|Noncompliance With Protocol|0|||
148865268|NCT00844805|536983015|FG002|Treatment Phase|Noncompliance With Protocol|0|||
149031008|NCT04163458|537591652|FG001|Overall Study|Due to COVID-19 pandemic|2|||
148865269|NCT00844805|536983016|FG003|Treatment Phase|Noncompliance With Protocol|0|||
148865270|NCT00844805|536983013|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
148865271|NCT00844805|536983014|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
148865272|NCT00844805|536983015|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
148865273|NCT00844805|536983016|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
148865274|NCT00844805|536983013|FG000|Follow-Up Phase|Adverse Event|0|||
148865275|NCT00844805|536983014|FG001|Follow-Up Phase|Adverse Event|0|||
148865276|NCT00844805|536983015|FG002|Follow-Up Phase|Adverse Event|1|||
148865277|NCT00844805|536983016|FG003|Follow-Up Phase|Adverse Event|0|||
148996761|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
148996762|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Death|0|||
148996763|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Death|1|||
148996764|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
148996765|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
148996766|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
148996767|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
148996768|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
148996769|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
148996770|NCT02472964|537465342|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
148996771|NCT02472964|537465343|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
148996772|NCT01454583|537465346|FG000|1st Year|Lost to Follow-up|1057|||
148996773|NCT01454583|537465347|FG001|1st Year|Lost to Follow-up|318|||
148996774|NCT01454583|537465348|FG002|1st Year|Lost to Follow-up|180|||
148996775|NCT01454583|537465346|FG000|2nd Year|Lost to Follow-up|3965|||
148996776|NCT01454583|537465347|FG001|2nd Year|Lost to Follow-up|1049|||
148996777|NCT01454583|537465348|FG002|2nd Year|Lost to Follow-up|737|||
148996778|NCT01454583|537465346|FG000|3rd Year|Lost to Follow-up|1959|||
148996779|NCT01454583|537465347|FG001|3rd Year|Lost to Follow-up|512|||
148996780|NCT01454583|537465348|FG002|3rd Year|Lost to Follow-up|297|||
148996781|NCT01967732|537465351|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
148996782|NCT01967732|537465352|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
148996783|NCT01967732|537465353|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
148996784|NCT01967732|537465354|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
148996785|NCT01967732|537465351|FG000|First Intervention (Day 1)|Poor venous access|0|||
148996786|NCT01967732|537465352|FG001|First Intervention (Day 1)|Poor venous access|1|||
148996787|NCT01967732|537465353|FG002|First Intervention (Day 1)|Poor venous access|0|||
148996788|NCT01967732|537465354|FG003|First Intervention (Day 1)|Poor venous access|0|||
148996789|NCT00113568|537465362|FG000|Overall Study|Adverse Event|97|||
148996790|NCT00113568|537465362|FG000|Overall Study|Death|1|||
148996791|NCT00113568|537465362|FG000|Overall Study|Lack of Efficacy|30|||
148996792|NCT00113568|537465362|FG000|Overall Study|Lost to Follow-up|156|||
148996793|NCT00113568|537465362|FG000|Overall Study|Protocol Violation|32|||
148996794|NCT00113568|537465362|FG000|Overall Study|Withdrawal by Subject|117|||
148996795|NCT00113568|537465362|FG000|Overall Study|Other|112|||
148996796|NCT01018394|537465365|FG000|Overall Study|Withdrawal by Subject|5|||
148996797|NCT01018394|537465366|FG001|Overall Study|Withdrawal by Subject|5|||
148996798|NCT01018394|537465365|FG000|Overall Study|Lost to Follow-up|4|||
148996799|NCT01018394|537465366|FG001|Overall Study|Lost to Follow-up|3|||
148996800|NCT03792126|537465367|FG000|Overall Study|Adverse Event|1|||
148996801|NCT03792126|537465368|FG001|Overall Study|Adverse Event|2|||
148996802|NCT03792126|537465367|FG000|Overall Study|Death|0|||
148996803|NCT03792126|537465368|FG001|Overall Study|Death|1|||
148996804|NCT03792126|537465367|FG000|Overall Study|Lost to Follow-up|1|||
148996805|NCT03792126|537465368|FG001|Overall Study|Lost to Follow-up|0|||
148996806|NCT03792126|537465367|FG000|Overall Study|Withdrawal by Subject|0|||
148996807|NCT03792126|537465368|FG001|Overall Study|Withdrawal by Subject|1|||
148996808|NCT03792126|537465367|FG000|Overall Study|COVID-19 Restrictions|1|||
148996809|NCT03792126|537465368|FG001|Overall Study|COVID-19 Restrictions|3|||
148996810|NCT03792126|537465367|FG000|Overall Study|Symptoms resolved|0|||
148996811|NCT03792126|537465368|FG001|Overall Study|Symptoms resolved|3|||
148996812|NCT00683644|537465369|FG000|Overall Study|Withdrawal by Subject|4|||
148996813|NCT00683644|537465370|FG001|Overall Study|Withdrawal by Subject|2|||
148996814|NCT00683644|537465369|FG000|Overall Study|Lost to Follow-up|1|||
148996815|NCT00683644|537465370|FG001|Overall Study|Lost to Follow-up|4|||
148996816|NCT00683644|537465369|FG000|Overall Study|Adverse Event|1|||
148996817|NCT00683644|537465370|FG001|Overall Study|Adverse Event|2|||
148996818|NCT00683644|537465369|FG000|Overall Study|Low copper, other health problems,|7|||
148996819|NCT00683644|537465370|FG001|Overall Study|Low copper, other health problems,|6|||
148996820|NCT04322682|537465371|FG000|Overall Study|Withdrawal by Subject|33|||
148996821|NCT04322682|537465372|FG001|Overall Study|Withdrawal by Subject|47|||
148996822|NCT04322682|537465371|FG000|Overall Study|Death|5|||
148996823|NCT04322682|537465372|FG001|Overall Study|Death|9|||
148996824|NCT04322682|537465371|FG000|Overall Study|Lost to Follow-up|4|||
148996825|NCT04322682|537465372|FG001|Overall Study|Lost to Follow-up|8|||
148996826|NCT04322682|537465371|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
148996827|NCT04322682|537465372|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
148996828|NCT04123067|537465374|FG000|Overall Study|Lost to Follow-up|0|||
148996829|NCT04123067|537465375|FG001|Overall Study|Lost to Follow-up|1|||
148996830|NCT02238379|537465376|FG000|Overall Study|Lost to Follow-up|1|||
148996831|NCT02238379|537465377|FG001|Overall Study|Lost to Follow-up|0|||
148996832|NCT00441090|537465378|FG000|Overall Study|Adverse Event|0|||
148996833|NCT00441090|537465379|FG001|Overall Study|Adverse Event|1|||
148996834|NCT00441090|537465380|FG002|Overall Study|Adverse Event|1|||
148996835|NCT00441090|537465381|FG003|Overall Study|Adverse Event|0|||
148996836|NCT00441090|537465382|FG004|Overall Study|Adverse Event|0|||
148996837|NCT00441090|537465378|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
148996838|NCT00441090|537465379|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
148996839|NCT00441090|537465380|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
148996840|NCT00441090|537465381|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
148996841|NCT00441090|537465382|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
148996842|NCT00441090|537465378|FG000|Overall Study|Withdrawal by Subject|1|||
148996843|NCT00441090|537465379|FG001|Overall Study|Withdrawal by Subject|0|||
148996844|NCT00441090|537465380|FG002|Overall Study|Withdrawal by Subject|1|||
148996845|NCT00441090|537465381|FG003|Overall Study|Withdrawal by Subject|0|||
148996846|NCT00441090|537465382|FG004|Overall Study|Withdrawal by Subject|0|||
148996847|NCT00441090|537465378|FG000|Overall Study|Lack of Efficacy|1|||
148996848|NCT00441090|537465379|FG001|Overall Study|Lack of Efficacy|0|||
148996849|NCT00441090|537465380|FG002|Overall Study|Lack of Efficacy|0|||
148996850|NCT00441090|537465381|FG003|Overall Study|Lack of Efficacy|0|||
148996851|NCT00441090|537465382|FG004|Overall Study|Lack of Efficacy|0|||
148996852|NCT01441102|537465383|FG000|Overall Study|Adverse Event|1|||
148996853|NCT01441102|537465383|FG000|Overall Study|Withdrawal by Subject|2|||
148996854|NCT03085485|537465384|FG000|Overall Study|Death|1|||
148996855|NCT03085485|537465385|FG001|Overall Study|Death|0|||
148996856|NCT03085485|537465384|FG000|Overall Study|Lost to Follow-up|1|||
148996857|NCT03085485|537465385|FG001|Overall Study|Lost to Follow-up|0|||
148996858|NCT00605280|537465386|FG000|Year 1|Protocol Violation|0|||
148996859|NCT00605280|537465387|FG001|Year 1|Protocol Violation|0|||
148996860|NCT00605280|537465388|FG002|Year 1|Protocol Violation|0|||
148996861|NCT00605280|537465389|FG003|Year 1|Protocol Violation|1|||
148996862|NCT00605280|537465386|FG000|Year 1|Adverse Event|3|||
148996863|NCT00605280|537465387|FG001|Year 1|Adverse Event|1|||
148996864|NCT00605280|537465388|FG002|Year 1|Adverse Event|1|||
148865278|NCT00844805|536983013|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
148865279|NCT00844805|536983014|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
148865280|NCT00844805|536983015|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
148865281|NCT00844805|536983016|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
148996865|NCT00605280|537465389|FG003|Year 1|Adverse Event|5|||
148996866|NCT00605280|537465386|FG000|Year 1|Physician Decision|7|||
148996867|NCT00605280|537465387|FG001|Year 1|Physician Decision|4|||
148996868|NCT00605280|537465388|FG002|Year 1|Physician Decision|0|||
148996869|NCT00605280|537465389|FG003|Year 1|Physician Decision|6|||
148996870|NCT00605280|537465386|FG000|Year 1|Withdrawal by Subject|2|||
148996871|NCT00605280|537465387|FG001|Year 1|Withdrawal by Subject|4|||
148996872|NCT00605280|537465388|FG002|Year 1|Withdrawal by Subject|0|||
148996873|NCT00605280|537465389|FG003|Year 1|Withdrawal by Subject|4|||
148996874|NCT00605280|537465386|FG000|Year 1|Other|2|||
148996875|NCT00605280|537465387|FG001|Year 1|Other|1|||
148996876|NCT00605280|537465388|FG002|Year 1|Other|0|||
148996877|NCT00605280|537465389|FG003|Year 1|Other|1|||
148996878|NCT00605280|537465386|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
148996879|NCT00605280|537465387|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
148996880|NCT00605280|537465388|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
148996881|NCT00605280|537465389|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
148996882|NCT00605280|537465386|FG000|Year 2|Adverse Event|4|||
148996883|NCT00605280|537465387|FG001|Year 2|Adverse Event|0|||
148996884|NCT00605280|537465388|FG002|Year 2|Adverse Event|2|||
148996885|NCT00605280|537465389|FG003|Year 2|Adverse Event|4|||
148996886|NCT00605280|537465386|FG000|Year 2|Physician Decision|11|||
148996887|NCT00605280|537465387|FG001|Year 2|Physician Decision|6|||
148996888|NCT00605280|537465388|FG002|Year 2|Physician Decision|4|||
148996889|NCT00605280|537465389|FG003|Year 2|Physician Decision|11|||
148996890|NCT00605280|537465386|FG000|Year 2|Withdrawal by Subject|4|||
148996891|NCT00605280|537465387|FG001|Year 2|Withdrawal by Subject|0|||
148996892|NCT00605280|537465388|FG002|Year 2|Withdrawal by Subject|0|||
148996893|NCT00605280|537465389|FG003|Year 2|Withdrawal by Subject|4|||
148996894|NCT00605280|537465386|FG000|Year 2|Other|1|||
148996895|NCT00605280|537465387|FG001|Year 2|Other|0|||
148996896|NCT00605280|537465388|FG002|Year 2|Other|0|||
148996897|NCT00605280|537465389|FG003|Year 2|Other|1|||
148996898|NCT00605280|537465386|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
148778187|NCT00033657|536661934|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
148996899|NCT00605280|537465387|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
148778188|NCT00033657|536661933|FG000|Surgical Resection|not complete resection|0|||
148778189|NCT00033657|536661934|FG001|Surgical Resection|not complete resection|3|||
148778190|NCT00033657|536661933|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
148778191|NCT00033657|536661934|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
148778192|NCT00033657|536661933|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
148778193|NCT00033657|536661934|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
148778194|NCT00033657|536661933|FG000|Adjuvant Chemotherapy|Death|2|||
148778195|NCT00033657|536661934|FG001|Adjuvant Chemotherapy|Death|1|||
148778196|NCT00033657|536661933|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
148996900|NCT00605280|537465388|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
148996901|NCT00605280|537465389|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
148996902|NCT00605280|537465386|FG000|Year 3 Extension|Adverse Event|2|||
148996903|NCT00605280|537465387|FG001|Year 3 Extension|Adverse Event|0|||
148996904|NCT00605280|537465388|FG002|Year 3 Extension|Adverse Event|0|||
148996905|NCT00605280|537465389|FG003|Year 3 Extension|Adverse Event|2|||
148996906|NCT00605280|537465386|FG000|Year 3 Extension|Physician Decision|0|||
148996907|NCT00605280|537465387|FG001|Year 3 Extension|Physician Decision|0|||
148996908|NCT00605280|537465388|FG002|Year 3 Extension|Physician Decision|0|||
148996909|NCT00605280|537465389|FG003|Year 3 Extension|Physician Decision|2|||
148996910|NCT00605280|537465386|FG000|Year 3 Extension|Withdrawal by Subject|2|||
148996911|NCT00605280|537465387|FG001|Year 3 Extension|Withdrawal by Subject|0|||
148996912|NCT00605280|537465388|FG002|Year 3 Extension|Withdrawal by Subject|0|||
148996913|NCT00605280|537465389|FG003|Year 3 Extension|Withdrawal by Subject|5|||
148996914|NCT00605280|537465386|FG000|Year 3 Extension|Other|2|||
148996915|NCT00605280|537465387|FG001|Year 3 Extension|Other|0|||
148996916|NCT00605280|537465388|FG002|Year 3 Extension|Other|0|||
148996917|NCT00605280|537465389|FG003|Year 3 Extension|Other|0|||
148996918|NCT00605280|537465386|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
148996919|NCT00605280|537465387|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
148996920|NCT00605280|537465388|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
148996921|NCT00605280|537465389|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
148996922|NCT01302119|537465390|FG000|Overall Study|Withdrawal by Subject|30|||
148996923|NCT01302119|537465391|FG001|Overall Study|Withdrawal by Subject|20|||
148996924|NCT01302119|537465390|FG000|Overall Study|Lost to Follow-up|10|||
148996925|NCT01302119|537465391|FG001|Overall Study|Lost to Follow-up|4|||
148996926|NCT01302119|537465390|FG000|Overall Study|Adverse Event|2|||
148996927|NCT01302119|537465391|FG001|Overall Study|Adverse Event|1|||
148996928|NCT01302119|537465390|FG000|Overall Study|Non-compliance|4|||
148996929|NCT01302119|537465391|FG001|Overall Study|Non-compliance|2|||
148996930|NCT01302119|537465390|FG000|Overall Study|Non-specific|4|||
148996931|NCT01302119|537465391|FG001|Overall Study|Non-specific|1|||
148996932|NCT01775904|537465395|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
148996933|NCT01775904|537465395|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
148996934|NCT00518115|537465396|FG000|Overall Study|Adverse Event|6|||
148996935|NCT00518115|537465397|FG001|Overall Study|Adverse Event|1|||
148996936|NCT00518115|537465398|FG002|Overall Study|Adverse Event|5|||
148996937|NCT00518115|537465399|FG003|Overall Study|Adverse Event|6|||
148996938|NCT00518115|537465400|FG004|Overall Study|Adverse Event|5|||
148996939|NCT00518115|537465401|FG005|Overall Study|Adverse Event|5|||
148996940|NCT00518115|537465402|FG006|Overall Study|Adverse Event|5|||
148996941|NCT00518115|537465403|FG007|Overall Study|Adverse Event|10|||
148996942|NCT00518115|537465404|FG008|Overall Study|Adverse Event|2|||
148996943|NCT00518115|537465405|FG009|Overall Study|Adverse Event|9|||
148996944|NCT00518115|537465396|FG000|Overall Study|Lost to Follow-up|0|||
148996945|NCT00518115|537465397|FG001|Overall Study|Lost to Follow-up|0|||
148996946|NCT00518115|537465398|FG002|Overall Study|Lost to Follow-up|2|||
148996947|NCT00518115|537465399|FG003|Overall Study|Lost to Follow-up|3|||
148996948|NCT00518115|537465400|FG004|Overall Study|Lost to Follow-up|1|||
148996949|NCT00518115|537465401|FG005|Overall Study|Lost to Follow-up|3|||
148996950|NCT00518115|537465402|FG006|Overall Study|Lost to Follow-up|0|||
148996951|NCT00518115|537465403|FG007|Overall Study|Lost to Follow-up|1|||
148996952|NCT00518115|537465404|FG008|Overall Study|Lost to Follow-up|1|||
148996953|NCT00518115|537465405|FG009|Overall Study|Lost to Follow-up|1|||
148996954|NCT00518115|537465396|FG000|Overall Study|Protocol Violation|1|||
148996955|NCT00518115|537465397|FG001|Overall Study|Protocol Violation|3|||
148996956|NCT00518115|537465398|FG002|Overall Study|Protocol Violation|1|||
148996957|NCT00518115|537465399|FG003|Overall Study|Protocol Violation|0|||
148996958|NCT00518115|537465400|FG004|Overall Study|Protocol Violation|0|||
148996959|NCT00518115|537465401|FG005|Overall Study|Protocol Violation|0|||
148996960|NCT00518115|537465402|FG006|Overall Study|Protocol Violation|0|||
148996961|NCT00518115|537465403|FG007|Overall Study|Protocol Violation|0|||
148996962|NCT00518115|537465404|FG008|Overall Study|Protocol Violation|0|||
148996963|NCT00518115|537465405|FG009|Overall Study|Protocol Violation|0|||
148996964|NCT00518115|537465396|FG000|Overall Study|Withdrawal by Subject|1|||
148996965|NCT00518115|537465397|FG001|Overall Study|Withdrawal by Subject|1|||
148996966|NCT00518115|537465398|FG002|Overall Study|Withdrawal by Subject|5|||
148996967|NCT00518115|537465399|FG003|Overall Study|Withdrawal by Subject|0|||
149031009|NCT04163458|537591651|FG000|Overall Study|Participant withdrew consent|2|||
148996968|NCT00518115|537465400|FG004|Overall Study|Withdrawal by Subject|2|||
148996969|NCT00518115|537465401|FG005|Overall Study|Withdrawal by Subject|1|||
148996970|NCT00518115|537465402|FG006|Overall Study|Withdrawal by Subject|0|||
148996971|NCT00518115|537465403|FG007|Overall Study|Withdrawal by Subject|2|||
148996972|NCT00518115|537465404|FG008|Overall Study|Withdrawal by Subject|1|||
148996973|NCT00518115|537465405|FG009|Overall Study|Withdrawal by Subject|3|||
148996974|NCT00518115|537465396|FG000|Overall Study|Lack of Efficacy|1|||
148996975|NCT00518115|537465397|FG001|Overall Study|Lack of Efficacy|0|||
148996976|NCT00518115|537465398|FG002|Overall Study|Lack of Efficacy|1|||
148996977|NCT00518115|537465399|FG003|Overall Study|Lack of Efficacy|1|||
148996978|NCT00518115|537465400|FG004|Overall Study|Lack of Efficacy|0|||
148996979|NCT00518115|537465401|FG005|Overall Study|Lack of Efficacy|0|||
148996980|NCT00518115|537465402|FG006|Overall Study|Lack of Efficacy|0|||
149031010|NCT04163458|537591652|FG001|Overall Study|Participant withdrew consent|3|||
149031011|NCT04163458|537591651|FG000|Overall Study|Randomization failure|2|||
149031012|NCT04163458|537591652|FG001|Overall Study|Randomization failure|2|||
149031013|NCT04163458|537591651|FG000|Overall Study|Other|4|||
149031014|NCT04163458|537591652|FG001|Overall Study|Other|2|||
149031015|NCT01981850|537591654|FG000|Main Phase Stage 1|Death|2|||
149031016|NCT01981850|537591655|FG001|Main Phase Stage 1|Death|0|||
149031017|NCT01981850|537591656|FG002|Main Phase Stage 1|Death|0|||
149031018|NCT01981850|537591657|FG003|Main Phase Stage 1|Death|0|||
148865282|NCT00844805|536983013|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
148865283|NCT00844805|536983014|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
148865284|NCT00844805|536983015|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
148865285|NCT00844805|536983016|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
148865286|NCT00844805|536983013|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
148865287|NCT00844805|536983014|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
148865288|NCT00844805|536983015|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
148865289|NCT00844805|536983016|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
148865290|NCT00844805|536983013|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
148865291|NCT00844805|536983014|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
148865292|NCT00844805|536983015|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
148865293|NCT00844805|536983016|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
148865294|NCT01367704|536983017|FG000|Overall Study|Lost to Follow-up|47|||
148865295|NCT01367704|536983018|FG001|Overall Study|Lost to Follow-up|161|||
148865296|NCT04096820|536983019|FG000|Overall Study|Did not return for intervention|2|||
148865297|NCT04096820|536983019|FG000|Overall Study|Death|1|||
148865298|NCT00787202|536983020|FG000|Overall Study|Adverse Event|3|||
148865299|NCT00787202|536983021|FG001|Overall Study|Adverse Event|2|||
148865300|NCT00787202|536983022|FG002|Overall Study|Adverse Event|0|||
148865301|NCT00787202|536983023|FG003|Overall Study|Adverse Event|0|||
148865302|NCT00787202|536983024|FG004|Overall Study|Adverse Event|2|||
148865303|NCT00787202|536983020|FG000|Overall Study|Lack of Efficacy|5|||
148865304|NCT00787202|536983021|FG001|Overall Study|Lack of Efficacy|6|||
148865305|NCT00787202|536983022|FG002|Overall Study|Lack of Efficacy|5|||
148865306|NCT00787202|536983023|FG003|Overall Study|Lack of Efficacy|2|||
148865307|NCT00787202|536983024|FG004|Overall Study|Lack of Efficacy|1|||
148865308|NCT00787202|536983020|FG000|Overall Study|Lost to Follow-up|1|||
148865309|NCT00787202|536983021|FG001|Overall Study|Lost to Follow-up|0|||
148865310|NCT00787202|536983022|FG002|Overall Study|Lost to Follow-up|0|||
148865311|NCT00787202|536983023|FG003|Overall Study|Lost to Follow-up|0|||
148865312|NCT00787202|536983024|FG004|Overall Study|Lost to Follow-up|0|||
148865313|NCT00787202|536983020|FG000|Overall Study|Withdrawal by Subject|2|||
148865314|NCT00787202|536983021|FG001|Overall Study|Withdrawal by Subject|2|||
148865315|NCT00787202|536983022|FG002|Overall Study|Withdrawal by Subject|2|||
148865316|NCT00787202|536983023|FG003|Overall Study|Withdrawal by Subject|0|||
148865317|NCT00787202|536983024|FG004|Overall Study|Withdrawal by Subject|0|||
148865318|NCT00787202|536983020|FG000|Overall Study|Protocol Violation|2|||
148865319|NCT00787202|536983021|FG001|Overall Study|Protocol Violation|1|||
148865320|NCT00787202|536983022|FG002|Overall Study|Protocol Violation|0|||
148865321|NCT00787202|536983023|FG003|Overall Study|Protocol Violation|0|||
148865322|NCT00787202|536983024|FG004|Overall Study|Protocol Violation|1|||
148865323|NCT00787202|536983020|FG000|Overall Study|Randomized, not treated|1|||
148865324|NCT00787202|536983021|FG001|Overall Study|Randomized, not treated|0|||
148865325|NCT00787202|536983022|FG002|Overall Study|Randomized, not treated|0|||
148865326|NCT00787202|536983023|FG003|Overall Study|Randomized, not treated|0|||
148865327|NCT00787202|536983024|FG004|Overall Study|Randomized, not treated|0|||
148865328|NCT01510145|536983025|FG000|Overall Study|Adverse Event|6|||
148865329|NCT01510145|536983025|FG000|Overall Study|Lost to Follow-up|5|||
148865330|NCT01510145|536983025|FG000|Overall Study|Withdrawal by Subject|6|||
148865331|NCT01510145|536983025|FG000|Overall Study|Relative reported subject withdrew|1|||
148865332|NCT01360398|536983027|FG000|Overall Study|Withdrawal by Subject|14|||
148865333|NCT01360398|536983027|FG000|Overall Study|Other|7|||
148865334|NCT01360398|536983027|FG000|Overall Study|Migrated/moved from study area|1|||
148865335|NCT01453946|536983028|FG000|Overall Study|Did not receive drug for the taper phase|1|||
148865336|NCT01453946|536983028|FG000|Overall Study|Protocol Violation|2|||
148865337|NCT01453946|536983028|FG000|Overall Study|Lack of Efficacy|3|||
148865338|NCT01453946|536983028|FG000|Overall Study|Adverse Event|3|||
148865339|NCT00846040|536983029|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
148865340|NCT00846040|536983030|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
148865341|NCT00846040|536983031|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
148865342|NCT00846040|536983029|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
148865343|NCT00846040|536983030|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
148865344|NCT00846040|536983031|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
148865345|NCT03158272|536983035|FG000|Overall Study|Disease progression|3|||
148865346|NCT03158272|536983036|FG001|Overall Study|Disease progression|3|||
148865347|NCT03158272|536983037|FG002|Overall Study|Disease progression|4|||
148865348|NCT03158272|536983038|FG003|Overall Study|Disease progression|6|||
148865349|NCT03158272|536983035|FG000|Overall Study|Death|0|||
149031019|NCT01981850|537591658|FG004|Main Phase Stage 1|Death|0|||
149031020|NCT01981850|537591659|FG005|Main Phase Stage 1|Death|0|||
149031021|NCT01981850|537591660|FG006|Main Phase Stage 1|Death|0|||
149031022|NCT01981850|537591661|FG007|Main Phase Stage 1|Death|0|||
149031023|NCT01981850|537591662|FG008|Main Phase Stage 1|Death|0|||
149031024|NCT01981850|537591663|FG009|Main Phase Stage 1|Death|0|||
149031025|NCT01981850|537591654|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
149031026|NCT01981850|537591655|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031027|NCT01981850|537591656|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031028|NCT01981850|537591657|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031029|NCT01981850|537591658|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031030|NCT01981850|537591659|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031031|NCT01981850|537591660|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031032|NCT01981850|537591661|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031033|NCT01981850|537591662|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031034|NCT01981850|537591663|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
149031035|NCT01981850|537591654|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
149031036|NCT01981850|537591655|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
149031037|NCT01981850|537591656|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
149031038|NCT01981850|537591657|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
149031039|NCT01981850|537591658|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
149031040|NCT01981850|537591659|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
149031041|NCT01981850|537591660|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
149031042|NCT01981850|537591661|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
149031043|NCT01981850|537591662|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
149031044|NCT01981850|537591663|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
149031045|NCT01981850|537591654|FG000|Main Phase Stage 1|Various reasons|0|||
149031046|NCT01981850|537591655|FG001|Main Phase Stage 1|Various reasons|0|||
149031047|NCT01981850|537591656|FG002|Main Phase Stage 1|Various reasons|2|||
149031048|NCT01981850|537591657|FG003|Main Phase Stage 1|Various reasons|0|||
149031049|NCT01981850|537591658|FG004|Main Phase Stage 1|Various reasons|0|||
149031050|NCT01981850|537591659|FG005|Main Phase Stage 1|Various reasons|0|||
149031051|NCT01981850|537591660|FG006|Main Phase Stage 1|Various reasons|0|||
149031052|NCT01981850|537591661|FG007|Main Phase Stage 1|Various reasons|0|||
149031053|NCT01981850|537591662|FG008|Main Phase Stage 1|Various reasons|0|||
149031054|NCT01981850|537591663|FG009|Main Phase Stage 1|Various reasons|0|||
149031055|NCT01981850|537591654|FG000|Main Phase Stage 2|Adverse Event|0|||
149031056|NCT01981850|537591655|FG001|Main Phase Stage 2|Adverse Event|0|||
149031057|NCT01981850|537591656|FG002|Main Phase Stage 2|Adverse Event|0|||
149031058|NCT01981850|537591657|FG003|Main Phase Stage 2|Adverse Event|0|||
149031059|NCT01981850|537591658|FG004|Main Phase Stage 2|Adverse Event|6|||
149031060|NCT01981850|537591659|FG005|Main Phase Stage 2|Adverse Event|5|||
149031061|NCT01981850|537591660|FG006|Main Phase Stage 2|Adverse Event|7|||
149031062|NCT01981850|537591661|FG007|Main Phase Stage 2|Adverse Event|0|||
149031063|NCT01981850|537591662|FG008|Main Phase Stage 2|Adverse Event|0|||
149031064|NCT01981850|537591663|FG009|Main Phase Stage 2|Adverse Event|0|||
149031065|NCT01981850|537591654|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031066|NCT01981850|537591655|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031067|NCT01981850|537591656|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031068|NCT01981850|537591657|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031069|NCT01981850|537591658|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
149031070|NCT01981850|537591659|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
149031071|NCT01981850|537591660|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
149031072|NCT01981850|537591661|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031073|NCT01981850|537591662|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031074|NCT01981850|537591663|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
149031075|NCT01981850|537591654|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
149031076|NCT01981850|537591655|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
149031077|NCT01981850|537591656|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
148996981|NCT00518115|537465403|FG007|Overall Study|Lack of Efficacy|1|||
148996982|NCT00518115|537465404|FG008|Overall Study|Lack of Efficacy|0|||
148996983|NCT00518115|537465405|FG009|Overall Study|Lack of Efficacy|0|||
148996984|NCT00518115|537465396|FG000|Overall Study|Non-Compliance|1|||
148996985|NCT00518115|537465397|FG001|Overall Study|Non-Compliance|0|||
148996986|NCT00518115|537465398|FG002|Overall Study|Non-Compliance|1|||
148996987|NCT00518115|537465399|FG003|Overall Study|Non-Compliance|0|||
148996988|NCT00518115|537465400|FG004|Overall Study|Non-Compliance|1|||
148996989|NCT00518115|537465401|FG005|Overall Study|Non-Compliance|1|||
149031078|NCT01981850|537591657|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
149031079|NCT01981850|537591658|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
149031080|NCT01981850|537591659|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
148996990|NCT00518115|537465402|FG006|Overall Study|Non-Compliance|1|||
148996991|NCT00518115|537465403|FG007|Overall Study|Non-Compliance|1|||
148996992|NCT00518115|537465404|FG008|Overall Study|Non-Compliance|0|||
149031081|NCT01981850|537591660|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
149031082|NCT01981850|537591661|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
148996993|NCT00518115|537465405|FG009|Overall Study|Non-Compliance|1|||
148996994|NCT00518115|537465396|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
148996995|NCT00518115|537465397|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
148996996|NCT00518115|537465398|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148996997|NCT00518115|537465399|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148996998|NCT00518115|537465400|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148996999|NCT00518115|537465401|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
148997000|NCT00518115|537465402|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148997001|NCT00518115|537465403|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148997002|NCT00518115|537465404|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148997003|NCT00518115|537465405|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
148997004|NCT00518115|537465396|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
148997005|NCT00518115|537465397|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997006|NCT00518115|537465398|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997007|NCT00518115|537465399|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997008|NCT00518115|537465400|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997009|NCT00518115|537465401|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997010|NCT00518115|537465402|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997011|NCT00518115|537465403|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997012|NCT00518115|537465404|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997013|NCT00518115|537465405|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
148997014|NCT00518115|537465396|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997015|NCT00518115|537465397|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997016|NCT00518115|537465398|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
148997017|NCT00518115|537465399|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997018|NCT00518115|537465400|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997019|NCT00518115|537465401|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997020|NCT00518115|537465402|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997021|NCT00518115|537465403|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997022|NCT00518115|537465404|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
148997023|NCT00518115|537465405|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
148997024|NCT00518115|537465396|FG000|Overall Study|Wrong Monotherapy Administered|0|||
148997025|NCT00518115|537465397|FG001|Overall Study|Wrong Monotherapy Administered|0|||
148997026|NCT00518115|537465398|FG002|Overall Study|Wrong Monotherapy Administered|1|||
148997027|NCT00518115|537465399|FG003|Overall Study|Wrong Monotherapy Administered|0|||
148997028|NCT00518115|537465400|FG004|Overall Study|Wrong Monotherapy Administered|0|||
148997029|NCT00518115|537465401|FG005|Overall Study|Wrong Monotherapy Administered|0|||
148997030|NCT00518115|537465402|FG006|Overall Study|Wrong Monotherapy Administered|1|||
148997031|NCT00518115|537465403|FG007|Overall Study|Wrong Monotherapy Administered|0|||
148997032|NCT00518115|537465404|FG008|Overall Study|Wrong Monotherapy Administered|0|||
148997033|NCT00518115|537465405|FG009|Overall Study|Wrong Monotherapy Administered|0|||
148997034|NCT00518115|537465396|FG000|Overall Study|Violation of Exclusion Criteria|0|||
148997035|NCT00518115|537465397|FG001|Overall Study|Violation of Exclusion Criteria|0|||
148997036|NCT00518115|537465398|FG002|Overall Study|Violation of Exclusion Criteria|0|||
148997037|NCT00518115|537465399|FG003|Overall Study|Violation of Exclusion Criteria|1|||
148997038|NCT00518115|537465400|FG004|Overall Study|Violation of Exclusion Criteria|0|||
148997039|NCT00518115|537465401|FG005|Overall Study|Violation of Exclusion Criteria|0|||
148997040|NCT00518115|537465402|FG006|Overall Study|Violation of Exclusion Criteria|1|||
148997041|NCT00518115|537465403|FG007|Overall Study|Violation of Exclusion Criteria|0|||
148997042|NCT00518115|537465404|FG008|Overall Study|Violation of Exclusion Criteria|0|||
148997043|NCT00518115|537465405|FG009|Overall Study|Violation of Exclusion Criteria|0|||
148997044|NCT00518115|537465396|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
148997045|NCT00518115|537465397|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
148997046|NCT00518115|537465398|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
148997047|NCT00518115|537465399|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
148997048|NCT00518115|537465400|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
148997049|NCT00518115|537465401|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
148997050|NCT00518115|537465402|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
148997051|NCT00518115|537465403|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
148997052|NCT00518115|537465404|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
148997053|NCT00518115|537465405|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
148997054|NCT00518115|537465396|FG000|Overall Study|Withdrew Consent|0|||
148997055|NCT00518115|537465397|FG001|Overall Study|Withdrew Consent|0|||
148997056|NCT00518115|537465398|FG002|Overall Study|Withdrew Consent|0|||
148997057|NCT00518115|537465399|FG003|Overall Study|Withdrew Consent|0|||
148997058|NCT00518115|537465400|FG004|Overall Study|Withdrew Consent|0|||
148997059|NCT00518115|537465401|FG005|Overall Study|Withdrew Consent|1|||
148997060|NCT00518115|537465402|FG006|Overall Study|Withdrew Consent|0|||
148997061|NCT00518115|537465403|FG007|Overall Study|Withdrew Consent|0|||
148997062|NCT00518115|537465404|FG008|Overall Study|Withdrew Consent|0|||
148997063|NCT00518115|537465405|FG009|Overall Study|Withdrew Consent|0|||
148997064|NCT00518115|537465396|FG000|Overall Study|Moved Out of State|0|||
148997065|NCT00518115|537465397|FG001|Overall Study|Moved Out of State|0|||
148997066|NCT00518115|537465398|FG002|Overall Study|Moved Out of State|0|||
148997067|NCT00518115|537465399|FG003|Overall Study|Moved Out of State|0|||
148997068|NCT00518115|537465400|FG004|Overall Study|Moved Out of State|0|||
148997069|NCT00518115|537465401|FG005|Overall Study|Moved Out of State|0|||
148997070|NCT00518115|537465402|FG006|Overall Study|Moved Out of State|0|||
148997071|NCT00518115|537465403|FG007|Overall Study|Moved Out of State|0|||
148997072|NCT00518115|537465404|FG008|Overall Study|Moved Out of State|0|||
148997073|NCT00518115|537465405|FG009|Overall Study|Moved Out of State|1|||
148997074|NCT04891419|537465406|FG000|Overall Study|Withdrawal by Subject|4|||
148997075|NCT04891419|537465407|FG001|Overall Study|Withdrawal by Subject|0|||
148997076|NCT04891419|537465406|FG000|Overall Study|Lost to Follow-up|1|||
148997077|NCT04891419|537465407|FG001|Overall Study|Lost to Follow-up|3|||
148997078|NCT00127101|537465411|FG000|Base Protocol|Adverse Event|0|||
148997079|NCT00127101|537465412|FG001|Base Protocol|Adverse Event|2|||
148997080|NCT00127101|537465413|FG002|Base Protocol|Adverse Event|1|||
148997081|NCT00127101|537465414|FG003|Base Protocol|Adverse Event|0|||
148997082|NCT00127101|537465415|FG004|Base Protocol|Adverse Event|0|||
148997083|NCT00127101|537465416|FG005|Base Protocol|Adverse Event|0|||
148997084|NCT00127101|537465411|FG000|Base Protocol|Lack of Efficacy|1|||
148997085|NCT00127101|537465412|FG001|Base Protocol|Lack of Efficacy|0|||
148997086|NCT00127101|537465413|FG002|Base Protocol|Lack of Efficacy|0|||
148997087|NCT00127101|537465414|FG003|Base Protocol|Lack of Efficacy|0|||
148997088|NCT00127101|537465415|FG004|Base Protocol|Lack of Efficacy|2|||
148997089|NCT00127101|537465416|FG005|Base Protocol|Lack of Efficacy|0|||
148997090|NCT00127101|537465411|FG000|Base Protocol|Withdrawal by Subject|1|||
148997091|NCT00127101|537465412|FG001|Base Protocol|Withdrawal by Subject|2|||
148997092|NCT00127101|537465413|FG002|Base Protocol|Withdrawal by Subject|1|||
148997093|NCT00127101|537465414|FG003|Base Protocol|Withdrawal by Subject|0|||
148997094|NCT00127101|537465415|FG004|Base Protocol|Withdrawal by Subject|0|||
148997095|NCT00127101|537465416|FG005|Base Protocol|Withdrawal by Subject|1|||
148997096|NCT00127101|537465411|FG000|Continuation Phase|Adverse Event|0|||
148997097|NCT00127101|537465412|FG001|Continuation Phase|Adverse Event|0|||
148997098|NCT00127101|537465413|FG002|Continuation Phase|Adverse Event|0|||
148997099|NCT00127101|537465414|FG003|Continuation Phase|Adverse Event|0|||
148997100|NCT00127101|537465415|FG004|Continuation Phase|Adverse Event|1|||
148997101|NCT00127101|537465416|FG005|Continuation Phase|Adverse Event|1|||
148997102|NCT00127101|537465411|FG000|Continuation Phase|Lack of Efficacy|0|||
148997103|NCT00127101|537465412|FG001|Continuation Phase|Lack of Efficacy|0|||
148997104|NCT00127101|537465413|FG002|Continuation Phase|Lack of Efficacy|0|||
148997105|NCT00127101|537465414|FG003|Continuation Phase|Lack of Efficacy|0|||
148997106|NCT00127101|537465415|FG004|Continuation Phase|Lack of Efficacy|0|||
148997107|NCT00127101|537465416|FG005|Continuation Phase|Lack of Efficacy|1|||
148997108|NCT00127101|537465411|FG000|Continuation Phase|Withdrawal by Subject|0|||
148997109|NCT00127101|537465412|FG001|Continuation Phase|Withdrawal by Subject|0|||
148997110|NCT00127101|537465413|FG002|Continuation Phase|Withdrawal by Subject|1|||
148997111|NCT00127101|537465414|FG003|Continuation Phase|Withdrawal by Subject|0|||
148997112|NCT00127101|537465415|FG004|Continuation Phase|Withdrawal by Subject|2|||
148997113|NCT00127101|537465416|FG005|Continuation Phase|Withdrawal by Subject|1|||
148997114|NCT00843167|537465417|FG000|Treatment Period|Adverse Event|1|||
148997115|NCT00843167|537465418|FG001|Treatment Period|Adverse Event|5|||
148997116|NCT00843167|537465417|FG000|Treatment Period|Withdrawal by Subject|2|||
148997117|NCT00843167|537465418|FG001|Treatment Period|Withdrawal by Subject|3|||
148997118|NCT01662310|537465419|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
148997119|NCT01662310|537465420|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
148997120|NCT01662310|537465421|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
148997121|NCT01662310|537465422|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
148997122|NCT01662310|537465423|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
148997123|NCT01662310|537465419|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
148865350|NCT03158272|536983036|FG001|Overall Study|Death|0|||
148865351|NCT03158272|536983037|FG002|Overall Study|Death|1|||
148865352|NCT03158272|536983038|FG003|Overall Study|Death|0|||
148865353|NCT03158272|536983035|FG000|Overall Study|Other reasons|0|||
148865354|NCT03158272|536983036|FG001|Overall Study|Other reasons|0|||
148997124|NCT01662310|537465420|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
148865355|NCT03158272|536983037|FG002|Overall Study|Other reasons|1|||
148865356|NCT03158272|536983038|FG003|Overall Study|Other reasons|0|||
148997125|NCT01662310|537465421|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
148997126|NCT01662310|537465422|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
148997127|NCT01662310|537465423|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
148997128|NCT01662310|537465419|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
148997129|NCT01662310|537465420|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
148997130|NCT01662310|537465421|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
148997131|NCT01662310|537465422|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
148997132|NCT01662310|537465423|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
148997133|NCT01662310|537465419|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
148997134|NCT01662310|537465420|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
148997135|NCT01662310|537465421|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
148997136|NCT01662310|537465422|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
148997137|NCT01662310|537465423|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
148997138|NCT01662310|537465419|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
148997139|NCT01662310|537465420|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
148997140|NCT01662310|537465421|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
148997141|NCT01662310|537465422|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
148997142|NCT01662310|537465423|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
148997143|NCT01662310|537465419|FG000|Run-In or Stabilization Phase|Other|1|||
148997144|NCT01662310|537465420|FG001|Run-In or Stabilization Phase|Other|0|||
148997145|NCT01662310|537465421|FG002|Run-In or Stabilization Phase|Other|0|||
148997146|NCT01662310|537465422|FG003|Run-In or Stabilization Phase|Other|0|||
148997147|NCT01662310|537465423|FG004|Run-In or Stabilization Phase|Other|0|||
148997148|NCT01662310|537465419|FG000|Double-Blind Phase|Adverse Event|0|||
148997149|NCT01662310|537465420|FG001|Double-Blind Phase|Adverse Event|0|||
148997150|NCT01662310|537465421|FG002|Double-Blind Phase|Adverse Event|1|||
148997151|NCT01662310|537465422|FG003|Double-Blind Phase|Adverse Event|0|||
148997152|NCT01662310|537465423|FG004|Double-Blind Phase|Adverse Event|0|||
148997153|NCT01662310|537465419|FG000|Double-Blind Phase|Lost to Follow-up|0|||
148997154|NCT01662310|537465420|FG001|Double-Blind Phase|Lost to Follow-up|3|||
148997155|NCT01662310|537465421|FG002|Double-Blind Phase|Lost to Follow-up|0|||
148997156|NCT01662310|537465422|FG003|Double-Blind Phase|Lost to Follow-up|0|||
148997157|NCT01662310|537465423|FG004|Double-Blind Phase|Lost to Follow-up|0|||
148997158|NCT01662310|537465419|FG000|Double-Blind Phase|Pregnancy|0|||
148997159|NCT01662310|537465420|FG001|Double-Blind Phase|Pregnancy|2|||
148997160|NCT01662310|537465421|FG002|Double-Blind Phase|Pregnancy|0|||
148997161|NCT01662310|537465422|FG003|Double-Blind Phase|Pregnancy|0|||
148997162|NCT01662310|537465423|FG004|Double-Blind Phase|Pregnancy|0|||
148997163|NCT01662310|537465419|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
148997164|NCT01662310|537465420|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
148997165|NCT01662310|537465421|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
148997166|NCT01662310|537465422|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
148997167|NCT01662310|537465423|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
148997168|NCT01662310|537465419|FG000|Double-Blind Phase|Other|0|||
148997169|NCT01662310|537465420|FG001|Double-Blind Phase|Other|0|||
148997170|NCT01662310|537465421|FG002|Double-Blind Phase|Other|1|||
148997171|NCT01662310|537465422|FG003|Double-Blind Phase|Other|0|||
148997172|NCT01662310|537465423|FG004|Double-Blind Phase|Other|0|||
148997173|NCT01662310|537465419|FG000|Double-Blind Phase|Randomized but not treated|0|||
148997174|NCT01662310|537465420|FG001|Double-Blind Phase|Randomized but not treated|1|||
148997175|NCT01662310|537465421|FG002|Double-Blind Phase|Randomized but not treated|0|||
148997176|NCT01662310|537465422|FG003|Double-Blind Phase|Randomized but not treated|0|||
148997177|NCT01662310|537465423|FG004|Double-Blind Phase|Randomized but not treated|0|||
148997178|NCT01662310|537465419|FG000|Open-Label Extension Phase|Adverse Event|0|||
148997179|NCT01662310|537465420|FG001|Open-Label Extension Phase|Adverse Event|0|||
148997180|NCT01662310|537465421|FG002|Open-Label Extension Phase|Adverse Event|0|||
148997181|NCT01662310|537465422|FG003|Open-Label Extension Phase|Adverse Event|3|||
148997182|NCT01662310|537465423|FG004|Open-Label Extension Phase|Adverse Event|0|||
148997183|NCT01662310|537465419|FG000|Open-Label Extension Phase|Death|0|||
148997184|NCT01662310|537465420|FG001|Open-Label Extension Phase|Death|0|||
148997185|NCT01662310|537465421|FG002|Open-Label Extension Phase|Death|0|||
148997186|NCT01662310|537465422|FG003|Open-Label Extension Phase|Death|1|||
148997187|NCT01662310|537465423|FG004|Open-Label Extension Phase|Death|0|||
148997188|NCT01662310|537465419|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
148997189|NCT01662310|537465420|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
148997190|NCT01662310|537465421|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
148997191|NCT01662310|537465422|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
148997192|NCT01662310|537465423|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
148997193|NCT01662310|537465419|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
148997194|NCT01662310|537465420|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
148997195|NCT01662310|537465421|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
148997196|NCT01662310|537465422|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
148997197|NCT01662310|537465423|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
148997198|NCT01662310|537465419|FG000|Open-Label Extension Phase|Pregnancy|0|||
148997199|NCT01662310|537465420|FG001|Open-Label Extension Phase|Pregnancy|0|||
148997200|NCT01662310|537465421|FG002|Open-Label Extension Phase|Pregnancy|0|||
148997201|NCT01662310|537465422|FG003|Open-Label Extension Phase|Pregnancy|1|||
148997202|NCT01662310|537465423|FG004|Open-Label Extension Phase|Pregnancy|0|||
148997203|NCT01662310|537465419|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
148997204|NCT01662310|537465420|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
149031083|NCT01981850|537591662|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
149031084|NCT01981850|537591663|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
148865357|NCT03158272|536983035|FG000|Overall Study|Adverse event unrelated to the drug|0|||
148865358|NCT03158272|536983036|FG001|Overall Study|Adverse event unrelated to the drug|1|||
148865359|NCT03158272|536983037|FG002|Overall Study|Adverse event unrelated to the drug|0|||
148865360|NCT03158272|536983038|FG003|Overall Study|Adverse event unrelated to the drug|0|||
148865361|NCT01822535|536983039|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
148865362|NCT01822535|536983040|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
148865363|NCT01822535|536983039|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
148865364|NCT01822535|536983040|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
148865365|NCT01822535|536983039|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
148865366|NCT01822535|536983040|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
148865367|NCT03697993|536983041|FG000|Overall Study|Became Ineligible after Enrollment|1|||
148865368|NCT03697993|536983042|FG001|Overall Study|Became Ineligible after Enrollment|3|||
148865369|NCT03697993|536983041|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
148865370|NCT03697993|536983042|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
148865371|NCT03697993|536983041|FG000|Overall Study|Lost to Follow-up|3|||
148865372|NCT03697993|536983042|FG001|Overall Study|Lost to Follow-up|0|||
148865373|NCT03697993|536983041|FG000|Overall Study|Physician Decision|4|||
148865374|NCT03697993|536983042|FG001|Overall Study|Physician Decision|0|||
148865375|NCT03697993|536983041|FG000|Overall Study|Initial Urine Culture Negative|0|||
148865376|NCT03697993|536983042|FG001|Overall Study|Initial Urine Culture Negative|1|||
148865377|NCT01048866|536983045|FG000|Overall Study|Adverse Event|1|||
148865378|NCT01048866|536983046|FG001|Overall Study|Adverse Event|0|||
148865379|NCT01048866|536983045|FG000|Overall Study|Protocol Violation|1|||
148865380|NCT01048866|536983046|FG001|Overall Study|Protocol Violation|0|||
148865381|NCT01048866|536983045|FG000|Overall Study|Physician Decision|1|||
148865382|NCT01048866|536983046|FG001|Overall Study|Physician Decision|0|||
148865383|NCT01048866|536983045|FG000|Overall Study|Withdrawal by Subject|0|||
148865384|NCT01048866|536983046|FG001|Overall Study|Withdrawal by Subject|2|||
148865385|NCT01048866|536983045|FG000|Overall Study|Lost to Follow-up|0|||
148865386|NCT01048866|536983046|FG001|Overall Study|Lost to Follow-up|2|||
148865387|NCT01048866|536983045|FG000|Overall Study|Other|1|||
148865388|NCT01048866|536983046|FG001|Overall Study|Other|1|||
148865389|NCT03582813|536983047|FG000|Overall Study|Lost to Follow-up|18|||
148865390|NCT03582813|536983048|FG001|Overall Study|Lost to Follow-up|21|||
148865391|NCT03582813|536983047|FG000|Overall Study|Withdrawal by Subject|1|||
148865392|NCT03582813|536983048|FG001|Overall Study|Withdrawal by Subject|0|||
148865393|NCT02230683|536983052|FG000|Overall Study|Adverse Event|1|||
148889243|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
148889244|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
148889245|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
148889246|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
148889247|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
148889248|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
148889249|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
148889250|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
148889251|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
148889252|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
148889253|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
148889254|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
148889255|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
148889256|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
148889257|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
148889258|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
148889259|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
148889260|NCT02831764|537074362|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
148889261|NCT02831764|537074363|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
148889262|NCT02831764|537074364|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
148889263|NCT02831764|537074365|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
148889264|NCT02831764|537074366|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
148889265|NCT02831764|537074362|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
148889266|NCT02831764|537074363|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
148889267|NCT02831764|537074364|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
148889268|NCT02831764|537074365|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
148889269|NCT02831764|537074366|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
148889270|NCT02831764|537074362|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
148889271|NCT02831764|537074363|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
148889272|NCT02831764|537074364|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
148889273|NCT02831764|537074365|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
148865394|NCT02191605|536984517|FG000|Overall Study|Lost to Follow-up|9|||
148865395|NCT02191605|536984518|FG001|Overall Study|Lost to Follow-up|4|||
148865396|NCT02191605|536984519|FG002|Overall Study|Lost to Follow-up|7|||
148865397|NCT02191605|536984520|FG003|Overall Study|Lost to Follow-up|3|||
148997205|NCT01662310|537465421|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
148997206|NCT01662310|537465422|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
148997207|NCT01662310|537465423|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
148997208|NCT04302350|537465424|FG000|Overall Study|Physician Decision|1|||
148997209|NCT04302350|537465425|FG001|Overall Study|Physician Decision|1|||
148997210|NCT04302350|537465426|FG002|Overall Study|Physician Decision|2|||
148997211|NCT04302350|537465424|FG000|Overall Study|Lack of Efficacy|1|||
148997212|NCT04302350|537465425|FG001|Overall Study|Lack of Efficacy|1|||
148997213|NCT04302350|537465426|FG002|Overall Study|Lack of Efficacy|4|||
148997214|NCT04302350|537465424|FG000|Overall Study|Adverse Event|0|||
148997215|NCT04302350|537465425|FG001|Overall Study|Adverse Event|1|||
148997216|NCT04302350|537465426|FG002|Overall Study|Adverse Event|2|||
148997217|NCT01212770|537465427|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
148997218|NCT01212770|537465428|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
148997219|NCT01212770|537465429|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
148997220|NCT01212770|537465430|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
148997221|NCT01212770|537465431|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
148997222|NCT01212770|537465432|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
148997223|NCT01212770|537465433|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
148997224|NCT01212770|537465434|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
148997225|NCT01212770|537465435|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
148997226|NCT01212770|537465427|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
148997227|NCT01212770|537465428|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
148997228|NCT01212770|537465429|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
148997229|NCT01212770|537465430|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
148997230|NCT01212770|537465431|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
148997231|NCT01212770|537465432|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
148997232|NCT01212770|537465433|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
148997233|NCT01212770|537465434|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
148997234|NCT01212770|537465435|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
148997235|NCT01212770|537465427|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
148997236|NCT01212770|537465428|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
148997237|NCT01212770|537465429|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
148997238|NCT01212770|537465430|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
148997239|NCT01212770|537465431|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
148997240|NCT01212770|537465432|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
148997241|NCT01212770|537465433|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
148997242|NCT01212770|537465434|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
148997243|NCT01212770|537465435|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
148997244|NCT01212770|537465427|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
148997245|NCT01212770|537465428|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997246|NCT01212770|537465429|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
148997247|NCT01212770|537465430|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997248|NCT01212770|537465431|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997249|NCT01212770|537465432|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997250|NCT01212770|537465433|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997251|NCT01212770|537465434|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997252|NCT01212770|537465435|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
148997253|NCT01212770|537465427|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997254|NCT01212770|537465428|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997255|NCT01212770|537465429|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
148997256|NCT01212770|537465430|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997257|NCT01212770|537465431|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997258|NCT01212770|537465432|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997259|NCT01212770|537465433|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148865398|NCT02191605|536984521|FG004|Overall Study|Lost to Follow-up|4|||
148865399|NCT05275582|536984522|FG000|Overall Study|Lost to Follow-up|1|||
148997260|NCT01212770|537465434|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997261|NCT01212770|537465435|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
148997262|NCT01212770|537465427|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
148865400|NCT05275582|536984523|FG001|Overall Study|Lost to Follow-up|0|||
148865401|NCT05275582|536984522|FG000|Overall Study|Withdrawal by Subject|0|||
148865402|NCT05275582|536984523|FG001|Overall Study|Withdrawal by Subject|2|||
148865403|NCT05275582|536984522|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
148997263|NCT01212770|537465428|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
148997264|NCT01212770|537465429|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
148997265|NCT01212770|537465430|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
148997266|NCT01212770|537465431|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
148997267|NCT01212770|537465432|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
148997268|NCT01212770|537465433|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
148997269|NCT01212770|537465434|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
148997270|NCT01212770|537465435|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
148997271|NCT01212770|537465427|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
148997272|NCT01212770|537465428|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
148997273|NCT01212770|537465429|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
148997274|NCT01212770|537465430|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
148997275|NCT01212770|537465431|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
148997276|NCT01212770|537465432|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
148997277|NCT01212770|537465433|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
148997278|NCT01212770|537465434|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
148997279|NCT01212770|537465435|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
148997280|NCT01212770|537465427|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
148997281|NCT01212770|537465428|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
148997282|NCT01212770|537465429|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
148997283|NCT01212770|537465430|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
148997284|NCT01212770|537465431|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
148997285|NCT01212770|537465432|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
148997286|NCT01212770|537465433|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
148997287|NCT01212770|537465434|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
148997288|NCT01212770|537465435|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
148997289|NCT01212770|537465427|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
148997290|NCT01212770|537465428|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
148997291|NCT01212770|537465429|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
148997292|NCT01212770|537465430|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
148997293|NCT01212770|537465431|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
148997294|NCT01212770|537465432|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
148997295|NCT01212770|537465433|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
148997296|NCT01212770|537465434|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
148997297|NCT01212770|537465435|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
148997298|NCT01212770|537465427|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997299|NCT01212770|537465428|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997300|NCT01212770|537465429|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
148997301|NCT01212770|537465430|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997302|NCT01212770|537465431|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997303|NCT01212770|537465432|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997304|NCT01212770|537465433|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997305|NCT01212770|537465434|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997306|NCT01212770|537465435|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
148997307|NCT01212770|537465427|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997308|NCT01212770|537465428|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997309|NCT01212770|537465429|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997310|NCT01212770|537465430|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
148997311|NCT01212770|537465431|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997312|NCT01212770|537465432|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997313|NCT01212770|537465433|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997314|NCT01212770|537465434|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997315|NCT01212770|537465435|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
148997316|NCT01212770|537465427|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997317|NCT01212770|537465428|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997318|NCT01212770|537465429|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
148997319|NCT01212770|537465430|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
148997320|NCT01212770|537465431|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997321|NCT01212770|537465432|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997322|NCT01212770|537465433|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997323|NCT01212770|537465434|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997324|NCT01212770|537465435|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
148997325|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
148997326|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
148997327|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
148997328|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
148997329|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
148997330|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
148997331|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
148997332|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
148997333|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
148997334|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
148997335|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
148997336|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
148997337|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
148997338|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
148997339|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
148997340|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
148997341|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
148997342|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
148997343|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997344|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
148997345|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997346|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997347|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997348|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997349|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997350|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997351|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
148997352|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
148997353|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
148997354|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
148997355|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
148997356|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
148997357|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
148997358|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
148997359|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
148997360|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
148997361|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
148997362|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
148997363|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
148997364|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
148997365|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
148997366|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
148997367|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
148997368|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
148997369|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
148997370|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
148997371|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
148997372|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
148997373|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
148997374|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
148997375|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
148997376|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
148997377|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
148997378|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
148997379|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
148997380|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
148997381|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
148997382|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
148997383|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
148997384|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
148997385|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
148997386|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
148997387|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
148997388|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
148997389|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
148997390|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
148997391|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
148997392|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
148997393|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
148997394|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
148997395|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
148865404|NCT05275582|536984523|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
148865405|NCT05275582|536984522|FG000|Overall Study|Death|1|||
148865406|NCT05275582|536984523|FG001|Overall Study|Death|0|||
148865407|NCT05275582|536984522|FG000|Overall Study|Protocol Violation|1|||
148865408|NCT05275582|536984523|FG001|Overall Study|Protocol Violation|0|||
148865409|NCT01266317|536984526|FG000|Overall Study|Withdrawal by Subject|2|||
148865410|NCT01610596|536984527|FG000|Overall Study|Lost to Follow-up|0|||
148865411|NCT01610596|536984528|FG001|Overall Study|Lost to Follow-up|1|||
148865412|NCT01519674|536984529|FG000|Overall Study|Adverse Event|3|||
148865413|NCT01519674|536984530|FG001|Overall Study|Adverse Event|3|||
148865414|NCT01519674|536984531|FG002|Overall Study|Adverse Event|0|||
148865415|NCT01519674|536984529|FG000|Overall Study|Lack of Efficacy|1|||
148865416|NCT01519674|536984530|FG001|Overall Study|Lack of Efficacy|1|||
148865417|NCT01519674|536984531|FG002|Overall Study|Lack of Efficacy|1|||
148865418|NCT01519674|536984529|FG000|Overall Study|Protocol Violation|0|||
148865419|NCT01519674|536984530|FG001|Overall Study|Protocol Violation|3|||
148865420|NCT01519674|536984531|FG002|Overall Study|Protocol Violation|1|||
148865421|NCT01519674|536984529|FG000|Overall Study|Withdrawal Criteria|7|||
148865422|NCT01519674|536984530|FG001|Overall Study|Withdrawal Criteria|2|||
148865423|NCT01519674|536984531|FG002|Overall Study|Withdrawal Criteria|7|||
148865424|NCT01519674|536984529|FG000|Overall Study|Unsclassified|10|||
148865425|NCT01519674|536984530|FG001|Overall Study|Unsclassified|4|||
148865426|NCT01519674|536984531|FG002|Overall Study|Unsclassified|3|||
148865427|NCT00799591|536984540|FG000|Overall Study|De-escalation of doses|20|||
148865428|NCT00799591|536984540|FG000|Overall Study|Death|14|||
148865429|NCT00799591|536984540|FG000|Overall Study|Technical failure|12|||
148865430|NCT00799591|536984540|FG000|Overall Study|Resistant germ|11|||
148865431|NCT00799591|536984540|FG000|Overall Study|New infection|4|||
148865432|NCT00799591|536984540|FG000|Overall Study|Resistance germ and technical failure|2|||
148865433|NCT00799591|536984540|FG000|Overall Study|Persistance of fever undetermined origin|1|||
148865434|NCT00799591|536984540|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
148865435|NCT00799591|536984540|FG000|Overall Study|Infectious origin not probable|1|||
148865436|NCT02317809|536984541|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
148865437|NCT02317809|536984542|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
148865438|NCT02317809|536984541|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
148865439|NCT02317809|536984542|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
148865440|NCT00953524|536984543|FG000|Overall Study|Adverse Event|2|||
148865441|NCT00953524|536984544|FG001|Overall Study|Adverse Event|0|||
148865442|NCT00953524|536984545|FG002|Overall Study|Adverse Event|1|||
148865443|NCT00953524|536984546|FG003|Overall Study|Adverse Event|2|||
148865444|NCT00953524|536984543|FG000|Overall Study|Protocol Violation|18|||
148865445|NCT00953524|536984544|FG001|Overall Study|Protocol Violation|10|||
148865446|NCT00953524|536984545|FG002|Overall Study|Protocol Violation|11|||
148865447|NCT00953524|536984546|FG003|Overall Study|Protocol Violation|6|||
148865448|NCT00953524|536984543|FG000|Overall Study|Lost to Follow-up|0|||
148865449|NCT00953524|536984544|FG001|Overall Study|Lost to Follow-up|1|||
148865450|NCT00953524|536984545|FG002|Overall Study|Lost to Follow-up|1|||
148865451|NCT00953524|536984546|FG003|Overall Study|Lost to Follow-up|0|||
148865452|NCT00953524|536984543|FG000|Overall Study|Withdrawal by Subject|2|||
148865453|NCT00953524|536984544|FG001|Overall Study|Withdrawal by Subject|4|||
148865454|NCT00953524|536984545|FG002|Overall Study|Withdrawal by Subject|1|||
148865455|NCT00953524|536984546|FG003|Overall Study|Withdrawal by Subject|0|||
148865456|NCT01994863|536984549|FG000|Period 1|Adverse Event|4|||
148865457|NCT01994863|536984550|FG001|Period 1|Adverse Event|0|||
148865458|NCT01994863|536984549|FG000|Period 1|Withdrawal by Subject|1|||
148865459|NCT01994863|536984550|FG001|Period 1|Withdrawal by Subject|0|||
148865460|NCT01994863|536984549|FG000|Period 1|Trial stopped by sponsor|1|||
148865461|NCT01994863|536984550|FG001|Period 1|Trial stopped by sponsor|3|||
148865462|NCT01994863|536984549|FG000|Period 1|Lack of Efficacy|1|||
148865463|NCT01994863|536984550|FG001|Period 1|Lack of Efficacy|0|||
148865464|NCT01994863|536984549|FG000|Period 2|Adverse Event|0|||
148865465|NCT01994863|536984550|FG001|Period 2|Adverse Event|1|||
149031085|NCT01981850|537591654|FG000|Main Phase Stage 2|Various reasons|0|||
148865466|NCT01994863|536984549|FG000|Period 2|Lack of Efficacy|0|||
148865467|NCT01994863|536984550|FG001|Period 2|Lack of Efficacy|2|||
148865468|NCT01994863|536984549|FG000|Period 2|Withdrawal by Subject|1|||
148865469|NCT01994863|536984550|FG001|Period 2|Withdrawal by Subject|1|||
148865470|NCT03294135|536984552|FG000|Overall Study|Serious Adverse Event|1|||
148865471|NCT03294135|536984553|FG001|Overall Study|Serious Adverse Event|0|||
148865472|NCT03294135|536984554|FG002|Overall Study|Serious Adverse Event|0|||
148865473|NCT03294135|536984552|FG000|Overall Study|Lost to Follow-up|1|||
148865474|NCT03294135|536984553|FG001|Overall Study|Lost to Follow-up|0|||
148865475|NCT03294135|536984554|FG002|Overall Study|Lost to Follow-up|1|||
148865476|NCT03294135|536984552|FG000|Overall Study|Withdrawal by Subject|0|||
148865477|NCT03294135|536984553|FG001|Overall Study|Withdrawal by Subject|0|||
148865478|NCT03294135|536984554|FG002|Overall Study|Withdrawal by Subject|1|||
148865479|NCT03294135|536984552|FG000|Overall Study|Other|2|||
148865480|NCT03294135|536984553|FG001|Overall Study|Other|0|||
148997396|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
148997397|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
148997398|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
148997399|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
148997400|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
148997401|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
148997402|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
148997403|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
148997404|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
148997405|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
148997406|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997407|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
148997408|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997409|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997410|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997411|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997412|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997413|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997414|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
148997415|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997416|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997417|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997418|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997419|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997420|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997421|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997422|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
148997423|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
148997424|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
148997425|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
148997426|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
148997427|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
148997428|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
148997429|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
148997430|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
148997431|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
148997432|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
148997433|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
148997434|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
148997435|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
148997436|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
148997437|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
148997438|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
148997439|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
148997440|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
148997441|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
148997442|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
148997443|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
148997444|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
148997445|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
148997446|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
148997447|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
148997448|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
148997449|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
148997450|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
148997451|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
148997452|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
148997453|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
148997454|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
148997455|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
148997456|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
148997457|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
148997458|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
148997459|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
148997460|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997461|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
148997462|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
148865481|NCT03294135|536984554|FG002|Overall Study|Other|0|||
148865482|NCT02763254|536984555|FG000|Overall Study|Adverse Event|1|||
148865483|NCT00598078|536984558|FG000|Period 2 (Day 2)|Adverse Event|1|||
148865484|NCT00598078|536984559|FG001|Period 2 (Day 2)|Adverse Event|0|||
148865485|NCT02120365|536984562|FG000|Overall Study|Withdrawal by Subject|0|||
148865486|NCT02120365|536984563|FG001|Overall Study|Withdrawal by Subject|0|||
148865487|NCT02120365|536984564|FG002|Overall Study|Withdrawal by Subject|2|||
148865488|NCT02120365|536984565|FG003|Overall Study|Withdrawal by Subject|4|||
148865489|NCT02120365|536984566|FG004|Overall Study|Withdrawal by Subject|0|||
148865490|NCT02120365|536984567|FG005|Overall Study|Withdrawal by Subject|2|||
148865491|NCT00343915|536984568|FG000|Primary Study|Withdrawal by Subject|1|||
148865492|NCT00343915|536984569|FG001|Primary Study|Withdrawal by Subject|0|||
148865493|NCT00343915|536984568|FG000|Primary Study|Lost to Follow-up|2|||
148865494|NCT00343915|536984569|FG001|Primary Study|Lost to Follow-up|3|||
148865495|NCT00343915|536984568|FG000|Primary Study|Other|1|||
149031086|NCT01981850|537591655|FG001|Main Phase Stage 2|Various reasons|0|||
149031087|NCT01981850|537591656|FG002|Main Phase Stage 2|Various reasons|0|||
149031088|NCT01981850|537591657|FG003|Main Phase Stage 2|Various reasons|0|||
149031089|NCT01981850|537591658|FG004|Main Phase Stage 2|Various reasons|2|||
149031090|NCT01981850|537591659|FG005|Main Phase Stage 2|Various reasons|0|||
149031091|NCT01981850|537591660|FG006|Main Phase Stage 2|Various reasons|1|||
149031092|NCT01981850|537591661|FG007|Main Phase Stage 2|Various reasons|0|||
149031093|NCT01981850|537591662|FG008|Main Phase Stage 2|Various reasons|0|||
149031094|NCT01981850|537591663|FG009|Main Phase Stage 2|Various reasons|0|||
149031095|NCT01981850|537591654|FG000|Main Phase Stage 2|Progressive Disease|0|||
149031096|NCT01981850|537591655|FG001|Main Phase Stage 2|Progressive Disease|0|||
149031097|NCT01981850|537591656|FG002|Main Phase Stage 2|Progressive Disease|0|||
149031098|NCT01981850|537591657|FG003|Main Phase Stage 2|Progressive Disease|0|||
149031099|NCT01981850|537591658|FG004|Main Phase Stage 2|Progressive Disease|0|||
149031100|NCT01981850|537591659|FG005|Main Phase Stage 2|Progressive Disease|6|||
149031101|NCT01981850|537591660|FG006|Main Phase Stage 2|Progressive Disease|6|||
149031102|NCT01981850|537591661|FG007|Main Phase Stage 2|Progressive Disease|0|||
148865496|NCT00343915|536984569|FG001|Primary Study|Other|0|||
148997463|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997464|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997465|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997466|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997467|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997468|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
148997469|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997470|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997471|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
148997472|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997473|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997474|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997475|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997476|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997477|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
148997478|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997479|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
148997480|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997481|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997482|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997483|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997484|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997485|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
148997486|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
148997487|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
148997488|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
148997489|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
148997490|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
148997491|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
148997492|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
148997493|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
148865497|NCT01719003|536984577|FG000|Overall Study|Non compliant with protocol|1|||
148997494|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
149031103|NCT01981850|537591662|FG008|Main Phase Stage 2|Progressive Disease|0|||
148865498|NCT01719003|536984578|FG001|Overall Study|Non compliant with protocol|1|||
148865499|NCT01719003|536984579|FG002|Overall Study|Non compliant with protocol|0|||
148865500|NCT01719003|536984580|FG003|Overall Study|Non compliant with protocol|1|||
148865501|NCT01719003|536984581|FG004|Overall Study|Non compliant with protocol|2|||
148865502|NCT01719003|536984582|FG005|Overall Study|Non compliant with protocol|1|||
148865503|NCT01719003|536984583|FG006|Overall Study|Non compliant with protocol|2|||
148997495|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
148997496|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997497|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997498|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
148997499|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997500|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997501|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997502|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997503|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997504|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
148997505|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997506|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997507|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
148997508|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997509|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997510|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997511|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997512|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
148997513|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
148997514|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997515|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997516|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
148997517|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997518|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997519|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997520|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997521|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997522|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
148997523|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
148997524|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
148997525|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
148997526|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
148997527|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
148997528|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
148997529|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
148997530|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
148997531|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
148997532|NCT01212770|537465427|FG000|Long-term Safety Phase (Year 5)|Death|0|||
148997533|NCT01212770|537465428|FG001|Long-term Safety Phase (Year 5)|Death|0|||
148997534|NCT01212770|537465429|FG002|Long-term Safety Phase (Year 5)|Death|0|||
148997535|NCT01212770|537465430|FG003|Long-term Safety Phase (Year 5)|Death|0|||
148997536|NCT01212770|537465431|FG004|Long-term Safety Phase (Year 5)|Death|0|||
148997537|NCT01212770|537465432|FG005|Long-term Safety Phase (Year 5)|Death|0|||
148997538|NCT01212770|537465433|FG006|Long-term Safety Phase (Year 5)|Death|0|||
148997539|NCT01212770|537465434|FG007|Long-term Safety Phase (Year 5)|Death|1|||
148997540|NCT01212770|537465435|FG008|Long-term Safety Phase (Year 5)|Death|0|||
148997541|NCT00829387|537465438|FG000|Overall Study|Withdrawal by Subject|2|||
148997542|NCT00829387|537465439|FG001|Overall Study|Withdrawal by Subject|3|||
148997543|NCT00829387|537465438|FG000|Overall Study|Disqualified by PI|1|||
148997544|NCT00829387|537465439|FG001|Overall Study|Disqualified by PI|0|||
148997545|NCT00707031|537465447|FG000|Overall Study|Adverse Event|45|||
148997546|NCT00707031|537465448|FG001|Overall Study|Adverse Event|45|||
148997547|NCT00707031|537465447|FG000|Overall Study|Lack of Efficacy|19|||
148997548|NCT00707031|537465448|FG001|Overall Study|Lack of Efficacy|6|||
148997549|NCT00707031|537465447|FG000|Overall Study|Lost to Follow-up|2|||
148997550|NCT00707031|537465448|FG001|Overall Study|Lost to Follow-up|1|||
148997551|NCT00707031|537465447|FG000|Overall Study|Protocol Violation|1|||
148997552|NCT00707031|537465448|FG001|Overall Study|Protocol Violation|0|||
148997553|NCT00707031|537465447|FG000|Overall Study|Withdrawal by Subject|7|||
148997554|NCT00707031|537465448|FG001|Overall Study|Withdrawal by Subject|8|||
148997555|NCT00707031|537465447|FG000|Overall Study|Poor Compliance to Protocol|7|||
148997556|NCT00707031|537465448|FG001|Overall Study|Poor Compliance to Protocol|13|||
148997557|NCT00707031|537465447|FG000|Overall Study|Familial or Personal Reasons|12|||
148997558|NCT00707031|537465448|FG001|Overall Study|Familial or Personal Reasons|15|||
148997559|NCT00707031|537465447|FG000|Overall Study|Serious Noncompliance|2|||
148997560|NCT00707031|537465448|FG001|Overall Study|Serious Noncompliance|3|||
148997561|NCT00707031|537465447|FG000|Overall Study|Sponsor Decision|9|||
148997562|NCT00707031|537465448|FG001|Overall Study|Sponsor Decision|8|||
148997563|NCT02747238|537465449|FG000|Overall Study|Lack of Efficacy|0|||
148997564|NCT02747238|537465450|FG001|Overall Study|Lack of Efficacy|1|||
148997565|NCT02747238|537465449|FG000|Overall Study|Data lost|3|||
148997566|NCT02747238|537465450|FG001|Overall Study|Data lost|5|||
148997567|NCT00541450|537465451|FG000|Phase A|Adverse Event|3|||
148997568|NCT00541450|537465452|FG001|Phase A|Adverse Event|0|||
148997569|NCT00541450|537465451|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
148997570|NCT00541450|537465452|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
148997571|NCT00541450|537465451|FG000|Phase A|Hyperglycemia|0|||
148997572|NCT00541450|537465452|FG001|Phase A|Hyperglycemia|1|||
148997573|NCT00541450|537465451|FG000|Phase A|Lost to Follow-up|6|||
148997574|NCT00541450|537465452|FG001|Phase A|Lost to Follow-up|4|||
148997575|NCT00541450|537465451|FG000|Phase A|Physician Decision|2|||
148997576|NCT00541450|537465452|FG001|Phase A|Physician Decision|0|||
148997577|NCT00541450|537465451|FG000|Phase A|Protocol Violation|2|||
148997578|NCT00541450|537465452|FG001|Phase A|Protocol Violation|3|||
148997579|NCT00541450|537465451|FG000|Phase A|Withdrawal by Subject|7|||
148997580|NCT00541450|537465452|FG001|Phase A|Withdrawal by Subject|7|||
148997581|NCT00541450|537465451|FG000|Phase B|Adverse Event|6|||
148997582|NCT00541450|537465452|FG001|Phase B|Adverse Event|6|||
148997583|NCT00541450|537465451|FG000|Phase B|Hyperglycemia|10|||
148997584|NCT00541450|537465452|FG001|Phase B|Hyperglycemia|9|||
148997585|NCT00541450|537465451|FG000|Phase B|Lost to Follow-up|6|||
148997586|NCT00541450|537465452|FG001|Phase B|Lost to Follow-up|4|||
148997587|NCT00541450|537465451|FG000|Phase B|Physician Decision|4|||
148997588|NCT00541450|537465452|FG001|Phase B|Physician Decision|2|||
148997589|NCT00541450|537465451|FG000|Phase B|Pregnancy|0|||
148997590|NCT00541450|537465452|FG001|Phase B|Pregnancy|1|||
148997591|NCT00541450|537465451|FG000|Phase B|Protocol Violation|3|||
148997592|NCT00541450|537465452|FG001|Phase B|Protocol Violation|3|||
148997593|NCT00541450|537465451|FG000|Phase B|Withdrawal by Subject|8|||
148997594|NCT00541450|537465452|FG001|Phase B|Withdrawal by Subject|6|||
148997595|NCT02858895|537465453|FG000|Overall Study|Disease progression|31|||
148997596|NCT02858895|537465453|FG000|Overall Study|Death|2|||
148997597|NCT02858895|537465453|FG000|Overall Study|Adverse Event|1|||
148997598|NCT02858895|537465453|FG000|Overall Study|Withdrawal by Subject|3|||
148997599|NCT02858895|537465453|FG000|Overall Study|hospice,|1|||
148997600|NCT02858895|537465453|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
148997601|NCT05338333|537465454|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
148997602|NCT05338333|537465455|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
148997603|NCT01475136|537465456|FG000|Overall Study|Sponsor Decision|0|||
148997604|NCT01475136|537465457|FG001|Overall Study|Sponsor Decision|1|||
148997605|NCT01475136|537465458|FG002|Overall Study|Sponsor Decision|0|||
148997606|NCT01475136|537465459|FG003|Overall Study|Sponsor Decision|0|||
148997607|NCT01475136|537465456|FG000|Overall Study|Entry Criteria Not Met|0|||
148997608|NCT01475136|537465457|FG001|Overall Study|Entry Criteria Not Met|2|||
148997609|NCT01475136|537465458|FG002|Overall Study|Entry Criteria Not Met|3|||
148997610|NCT01475136|537465459|FG003|Overall Study|Entry Criteria Not Met|1|||
148997611|NCT01475136|537465456|FG000|Overall Study|Withdrawal by Subject|0|||
148997612|NCT01475136|537465457|FG001|Overall Study|Withdrawal by Subject|0|||
148997613|NCT01475136|537465458|FG002|Overall Study|Withdrawal by Subject|0|||
148997614|NCT01475136|537465459|FG003|Overall Study|Withdrawal by Subject|2|||
148997615|NCT01475136|537465456|FG000|Overall Study|Adverse Event|1|||
148997616|NCT01475136|537465457|FG001|Overall Study|Adverse Event|0|||
148997617|NCT01475136|537465458|FG002|Overall Study|Adverse Event|0|||
148997618|NCT01475136|537465459|FG003|Overall Study|Adverse Event|1|||
148997619|NCT01475136|537465456|FG000|Overall Study|Death|0|||
148997620|NCT01475136|537465457|FG001|Overall Study|Death|0|||
148997621|NCT01475136|537465458|FG002|Overall Study|Death|0|||
148997622|NCT01475136|537465459|FG003|Overall Study|Death|1|||
148997623|NCT00506493|537465467|FG000|Overall Study|Death|6|||
148997624|NCT00506493|537465467|FG000|Overall Study|Withdrawal by Subject|5|||
148997625|NCT01323530|537467557|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
148997626|NCT01323530|537467558|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148997627|NCT01323530|537467559|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148997628|NCT01323530|537467560|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148997629|NCT01323530|537467561|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148997630|NCT01323530|537467562|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
148997631|NCT01323530|537467563|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
148997632|NCT01323530|537467557|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
148997633|NCT01323530|537467558|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
148997634|NCT01323530|537467559|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
148997635|NCT01323530|537467560|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
148997636|NCT01323530|537467561|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
148997637|NCT01323530|537467562|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
148997638|NCT01323530|537467563|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
148997639|NCT01323530|537467557|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
148997640|NCT01323530|537467558|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
148997641|NCT01323530|537467559|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
148997642|NCT01323530|537467560|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
148997643|NCT01323530|537467561|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
148997644|NCT01323530|537467562|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
148865504|NCT01719003|536984584|FG007|Overall Study|Non compliant with protocol|3|||
148865505|NCT01719003|536984585|FG008|Overall Study|Non compliant with protocol|0|||
148865506|NCT01719003|536984577|FG000|Overall Study|Adverse Event|6|||
148865507|NCT01719003|536984578|FG001|Overall Study|Adverse Event|5|||
148865508|NCT01719003|536984579|FG002|Overall Study|Adverse Event|4|||
148865509|NCT01719003|536984580|FG003|Overall Study|Adverse Event|3|||
148865510|NCT01719003|536984581|FG004|Overall Study|Adverse Event|4|||
148865511|NCT01719003|536984582|FG005|Overall Study|Adverse Event|3|||
148865512|NCT01719003|536984583|FG006|Overall Study|Adverse Event|6|||
148865513|NCT01719003|536984584|FG007|Overall Study|Adverse Event|5|||
148865514|NCT01719003|536984585|FG008|Overall Study|Adverse Event|0|||
148865515|NCT01719003|536984577|FG000|Overall Study|Lost to Follow-up|0|||
148865516|NCT01719003|536984578|FG001|Overall Study|Lost to Follow-up|6|||
148865517|NCT01719003|536984579|FG002|Overall Study|Lost to Follow-up|7|||
148865518|NCT01719003|536984580|FG003|Overall Study|Lost to Follow-up|2|||
148865519|NCT01719003|536984581|FG004|Overall Study|Lost to Follow-up|3|||
148865520|NCT01719003|536984582|FG005|Overall Study|Lost to Follow-up|4|||
148865521|NCT01719003|536984583|FG006|Overall Study|Lost to Follow-up|3|||
148865522|NCT01719003|536984584|FG007|Overall Study|Lost to Follow-up|2|||
148865523|NCT01719003|536984585|FG008|Overall Study|Lost to Follow-up|2|||
148865524|NCT01719003|536984577|FG000|Overall Study|Refusal to continue, not due to AE|2|||
148865525|NCT01719003|536984578|FG001|Overall Study|Refusal to continue, not due to AE|5|||
148865526|NCT01719003|536984579|FG002|Overall Study|Refusal to continue, not due to AE|4|||
148865527|NCT01719003|536984580|FG003|Overall Study|Refusal to continue, not due to AE|4|||
148865528|NCT01719003|536984581|FG004|Overall Study|Refusal to continue, not due to AE|4|||
148865529|NCT01719003|536984582|FG005|Overall Study|Refusal to continue, not due to AE|3|||
148865530|NCT01719003|536984583|FG006|Overall Study|Refusal to continue, not due to AE|8|||
148865531|NCT01719003|536984584|FG007|Overall Study|Refusal to continue, not due to AE|7|||
148865532|NCT01719003|536984585|FG008|Overall Study|Refusal to continue, not due to AE|1|||
148865533|NCT01719003|536984577|FG000|Overall Study|Reason other than those specified|0|||
148865534|NCT01719003|536984578|FG001|Overall Study|Reason other than those specified|0|||
148865535|NCT01719003|536984579|FG002|Overall Study|Reason other than those specified|2|||
148865536|NCT01719003|536984580|FG003|Overall Study|Reason other than those specified|3|||
148865537|NCT01719003|536984581|FG004|Overall Study|Reason other than those specified|4|||
148865538|NCT01719003|536984582|FG005|Overall Study|Reason other than those specified|1|||
148865539|NCT01719003|536984583|FG006|Overall Study|Reason other than those specified|0|||
148865540|NCT01719003|536984584|FG007|Overall Study|Reason other than those specified|3|||
148865541|NCT01719003|536984585|FG008|Overall Study|Reason other than those specified|1|||
148865542|NCT01719003|536984577|FG000|Overall Study|Lack of Efficacy|0|||
148865543|NCT01719003|536984578|FG001|Overall Study|Lack of Efficacy|0|||
148865544|NCT01719003|536984579|FG002|Overall Study|Lack of Efficacy|0|||
148865545|NCT01719003|536984580|FG003|Overall Study|Lack of Efficacy|0|||
148865546|NCT01719003|536984581|FG004|Overall Study|Lack of Efficacy|0|||
148865547|NCT01719003|536984582|FG005|Overall Study|Lack of Efficacy|0|||
148865548|NCT01719003|536984583|FG006|Overall Study|Lack of Efficacy|1|||
148865549|NCT01719003|536984584|FG007|Overall Study|Lack of Efficacy|0|||
148865550|NCT01719003|536984585|FG008|Overall Study|Lack of Efficacy|0|||
148865551|NCT00882908|536984587|FG000|Overall Study|Adverse Event|0|||
148865552|NCT00882908|536984588|FG001|Overall Study|Adverse Event|0|||
148865553|NCT00882908|536984589|FG002|Overall Study|Adverse Event|1|||
148865554|NCT00882908|536984590|FG003|Overall Study|Adverse Event|0|||
148865555|NCT00882908|536984591|FG004|Overall Study|Adverse Event|1|||
148865556|NCT00882908|536984587|FG000|Overall Study|Lost to Follow-up|3|||
148865557|NCT00882908|536984588|FG001|Overall Study|Lost to Follow-up|5|||
148865558|NCT00882908|536984589|FG002|Overall Study|Lost to Follow-up|3|||
148865559|NCT00882908|536984590|FG003|Overall Study|Lost to Follow-up|1|||
148865560|NCT00882908|536984591|FG004|Overall Study|Lost to Follow-up|2|||
148865561|NCT00882908|536984587|FG000|Overall Study|Protocol Violation|0|||
148865562|NCT00882908|536984588|FG001|Overall Study|Protocol Violation|1|||
148997645|NCT01323530|537467563|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
148997646|NCT01323530|537467557|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
148997647|NCT01323530|537467558|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
148997648|NCT01323530|537467559|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
148997649|NCT01323530|537467560|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
148865563|NCT00882908|536984589|FG002|Overall Study|Protocol Violation|0|||
148865564|NCT00882908|536984590|FG003|Overall Study|Protocol Violation|0|||
148865565|NCT00882908|536984591|FG004|Overall Study|Protocol Violation|0|||
148865566|NCT00882908|536984587|FG000|Overall Study|Withdrawal by Subject|0|||
148865567|NCT00882908|536984588|FG001|Overall Study|Withdrawal by Subject|0|||
148865568|NCT00882908|536984589|FG002|Overall Study|Withdrawal by Subject|3|||
148865569|NCT00882908|536984590|FG003|Overall Study|Withdrawal by Subject|5|||
148865570|NCT00882908|536984591|FG004|Overall Study|Withdrawal by Subject|2|||
148865571|NCT00882908|536984587|FG000|Overall Study|Subject reached a virologic endpoint|0|||
148865572|NCT00882908|536984588|FG001|Overall Study|Subject reached a virologic endpoint|0|||
148865573|NCT00882908|536984589|FG002|Overall Study|Subject reached a virologic endpoint|0|||
148997650|NCT01323530|537467561|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
148865574|NCT00882908|536984590|FG003|Overall Study|Subject reached a virologic endpoint|0|||
148865575|NCT00882908|536984591|FG004|Overall Study|Subject reached a virologic endpoint|1|||
148865576|NCT00882908|536984587|FG000|Overall Study|Study terminated in error|0|||
148865577|NCT00882908|536984588|FG001|Overall Study|Study terminated in error|0|||
148865578|NCT00882908|536984589|FG002|Overall Study|Study terminated in error|0|||
148865579|NCT00882908|536984590|FG003|Overall Study|Study terminated in error|1|||
148865580|NCT00882908|536984591|FG004|Overall Study|Study terminated in error|0|||
148865581|NCT01344629|536984592|FG000|Crossover Period 2|Withdrawal by Subject|0|||
148865582|NCT01344629|536984593|FG001|Crossover Period 2|Withdrawal by Subject|1|||
148865583|NCT05590000|536984597|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
148865584|NCT00762996|536984598|FG000|Period One|Protocol Violation|0|||
148865585|NCT00762996|536984599|FG001|Period One|Protocol Violation|0|||
148865586|NCT00762996|536984600|FG002|Period One|Protocol Violation|1|||
148865587|NCT00762996|536984601|FG003|Period One|Protocol Violation|0|||
148865588|NCT00762996|536984598|FG000|Period One|ineligible|0|||
148865589|NCT00762996|536984599|FG001|Period One|ineligible|0|||
148865590|NCT00762996|536984600|FG002|Period One|ineligible|1|||
148865591|NCT00762996|536984601|FG003|Period One|ineligible|1|||
148865592|NCT00762996|536984598|FG000|Period One|Adverse Event|0|||
148865593|NCT00762996|536984599|FG001|Period One|Adverse Event|0|||
148865594|NCT00762996|536984600|FG002|Period One|Adverse Event|1|||
148865595|NCT00762996|536984601|FG003|Period One|Adverse Event|0|||
148865596|NCT00762996|536984598|FG000|Period One|Withdrawal by Subject|0|||
148865597|NCT00762996|536984599|FG001|Period One|Withdrawal by Subject|0|||
148865598|NCT00762996|536984600|FG002|Period One|Withdrawal by Subject|1|||
148865599|NCT00762996|536984601|FG003|Period One|Withdrawal by Subject|0|||
148865600|NCT02689076|536984603|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
148865601|NCT02689076|536984604|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
148865602|NCT02689076|536984605|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
148865603|NCT02689076|536984603|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
148865604|NCT02689076|536984604|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
148865605|NCT02689076|536984605|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
148865606|NCT02689076|536984603|FG000|Overall Study|Did not have an HIE match|2|||
148865607|NCT02689076|536984604|FG001|Overall Study|Did not have an HIE match|0|||
148865608|NCT02689076|536984605|FG002|Overall Study|Did not have an HIE match|0|||
148865609|NCT02689076|536984603|FG000|Overall Study|Death during non-VA encounter|2|||
148865610|NCT02689076|536984604|FG001|Overall Study|Death during non-VA encounter|5|||
148865611|NCT02689076|536984605|FG002|Overall Study|Death during non-VA encounter|0|||
148865612|NCT02689076|536984603|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
148865613|NCT02689076|536984604|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
148865614|NCT02689076|536984605|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
148865615|NCT02689076|536984603|FG000|Overall Study|Participant no longer active in VA system|1|||
148865616|NCT02689076|536984604|FG001|Overall Study|Participant no longer active in VA system|0|||
148865617|NCT02689076|536984605|FG002|Overall Study|Participant no longer active in VA system|0|||
148865618|NCT02689076|536984603|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
148865619|NCT02689076|536984604|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
148865620|NCT02689076|536984605|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
148865621|NCT02266875|536984609|FG000|Overall Study|Withdrawal by Subject|9|||
148865622|NCT02266875|536984610|FG001|Overall Study|Withdrawal by Subject|0|||
148865623|NCT02266875|536984609|FG000|Overall Study|Lost to Follow-up|2|||
148865624|NCT02266875|536984610|FG001|Overall Study|Lost to Follow-up|0|||
148865625|NCT04063787|536984616|FG000|Overall Study|Inadequate Doppler data|4|||
148865626|NCT04063787|536984616|FG000|Overall Study|Lost to Follow-up|2|||
148865627|NCT04063787|536984616|FG000|Overall Study|Death|3|||
148865628|NCT01816906|536984617|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
148865629|NCT01816906|536984618|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
148865630|NCT01816906|536984617|FG000|Six Months|Lost to Follow-up|14|||
148865631|NCT01816906|536984618|FG001|Six Months|Lost to Follow-up|16|||
148865632|NCT01816906|536984617|FG000|12 Months|Adverse Event|2|||
148865633|NCT01816906|536984618|FG001|12 Months|Adverse Event|2|||
148997651|NCT01323530|537467562|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
148997652|NCT01323530|537467563|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
148997653|NCT01323530|537467557|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
148865634|NCT01816906|536984617|FG000|12 Months|Death|0|||
148865635|NCT01816906|536984618|FG001|12 Months|Death|2|||
148865636|NCT01816906|536984617|FG000|12 Months|Lost to Follow-up|2|||
148997654|NCT01323530|537467558|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
148997655|NCT01323530|537467559|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
148997656|NCT01323530|537467560|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
148865637|NCT01816906|536984618|FG001|12 Months|Lost to Follow-up|1|||
148997657|NCT01323530|537467561|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
148997658|NCT01323530|537467562|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
148997659|NCT01323530|537467563|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
148997660|NCT01323530|537467557|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
148997661|NCT01323530|537467558|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
148997662|NCT01323530|537467559|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
148997663|NCT01323530|537467560|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
148997664|NCT01323530|537467561|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
148997665|NCT01323530|537467562|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
148997666|NCT01323530|537467563|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
148997667|NCT01323530|537467557|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
148997668|NCT01323530|537467558|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
148997669|NCT01323530|537467559|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
148997670|NCT01323530|537467560|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
148997671|NCT01323530|537467561|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
148997672|NCT01323530|537467562|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
148997673|NCT01323530|537467563|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
148997674|NCT01323530|537467557|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
148997675|NCT01323530|537467558|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
148997676|NCT01323530|537467559|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
148997677|NCT01323530|537467560|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
148997678|NCT01323530|537467561|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
148997679|NCT01323530|537467562|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
148997680|NCT01323530|537467563|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
148997681|NCT04918784|537467564|FG000|Overall Study|Amputation - no longer eligible|1|||
148997682|NCT04918784|537467565|FG001|Overall Study|Amputation - no longer eligible|2|||
148997683|NCT04918784|537467564|FG000|Overall Study|Death|1|||
148997684|NCT04918784|537467565|FG001|Overall Study|Death|0|||
148997685|NCT04918784|537467564|FG000|Overall Study|patient non-compliance|3|||
148997686|NCT04918784|537467565|FG001|Overall Study|patient non-compliance|1|||
148997687|NCT04918784|537467564|FG000|Overall Study|Adverse Event|1|||
148997688|NCT04918784|537467565|FG001|Overall Study|Adverse Event|0|||
148997689|NCT01712009|537467566|FG000|Overall Study|Withdrawal by Subject|24|||
148997690|NCT01712009|537467567|FG001|Overall Study|Withdrawal by Subject|15|||
148997691|NCT01712009|537467568|FG002|Overall Study|Withdrawal by Subject|8|||
148997692|NCT01712009|537467566|FG000|Overall Study|Lost to Follow-up|2|||
148997693|NCT01712009|537467567|FG001|Overall Study|Lost to Follow-up|0|||
148997694|NCT01712009|537467568|FG002|Overall Study|Lost to Follow-up|1|||
148997695|NCT01712009|537467566|FG000|Overall Study|Decision by Sponsor|12|||
148997696|NCT01712009|537467567|FG001|Overall Study|Decision by Sponsor|14|||
148997697|NCT01712009|537467568|FG002|Overall Study|Decision by Sponsor|12|||
148997698|NCT04050865|537467572|FG000|Overall Study|Adverse Event|1|||
148997699|NCT04050865|537467573|FG001|Overall Study|Adverse Event|0|||
148997700|NCT04050865|537467572|FG000|Overall Study|no insert|1|||
148997701|NCT04050865|537467573|FG001|Overall Study|no insert|0|||
148997702|NCT04050865|537467572|FG000|Overall Study|Only 1 insert|2|||
148997703|NCT04050865|537467573|FG001|Overall Study|Only 1 insert|3|||
148997704|NCT04050865|537467572|FG000|Overall Study|Physician Decision|0|||
148997705|NCT04050865|537467573|FG001|Overall Study|Physician Decision|1|||
148997706|NCT04050865|537467572|FG000|Overall Study|Withdrawal by Subject|0|||
148997707|NCT04050865|537467573|FG001|Overall Study|Withdrawal by Subject|1|||
148997708|NCT00857207|537467575|FG000|Overall Study|Withdrawal by Subject|13|||
148997709|NCT00857207|537467576|FG001|Overall Study|Withdrawal by Subject|0|||
148997710|NCT00857207|537467575|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
148997711|NCT00857207|537467576|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
148997712|NCT00857207|537467575|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
148997713|NCT00857207|537467576|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
148997714|NCT02030015|537467577|FG000|Overall Study|Withdrawal by Subject|3|||
148997715|NCT02030015|537467577|FG000|Overall Study|Death|13|||
148997716|NCT01332227|537467579|FG000|Overall Study|Adverse Event|4|||
148997717|NCT01332227|537467580|FG001|Overall Study|Adverse Event|1|||
148997718|NCT01332227|537467579|FG000|Overall Study|Withdrawal by Subject|5|||
148997719|NCT01332227|537467580|FG001|Overall Study|Withdrawal by Subject|1|||
148997720|NCT01332227|537467579|FG000|Overall Study|Lost to Follow-up|2|||
148997721|NCT01332227|537467580|FG001|Overall Study|Lost to Follow-up|0|||
148997722|NCT01332227|537467579|FG000|Overall Study|Lack of Efficacy|3|||
148997723|NCT01332227|537467580|FG001|Overall Study|Lack of Efficacy|1|||
148997724|NCT01332227|537467579|FG000|Overall Study|Poor compliance/noncompliance|1|||
148997725|NCT01332227|537467580|FG001|Overall Study|Poor compliance/noncompliance|1|||
148997726|NCT01332227|537467579|FG000|Overall Study|Patient moved from area|1|||
148997727|NCT01332227|537467580|FG001|Overall Study|Patient moved from area|0|||
148997728|NCT01332227|537467579|FG000|Overall Study|Patient began prohibited medication|0|||
148997729|NCT01332227|537467580|FG001|Overall Study|Patient began prohibited medication|1|||
148997730|NCT00514943|537467581|FG000|Stage 1|Progressive disease|4|||
148997731|NCT00514943|537467582|FG001|Stage 1|Progressive disease|8|||
148997732|NCT00514943|537467581|FG000|Stage 1|Other Adverse Event|16|||
148997733|NCT00514943|537467582|FG001|Stage 1|Other Adverse Event|6|||
148997734|NCT00514943|537467581|FG000|Stage 1|Not treated|1|||
148997735|NCT00514943|537467582|FG001|Stage 1|Not treated|2|||
148997736|NCT00514943|537467581|FG000|Stage 1|Patient refused to continue study meds|8|||
148997737|NCT00514943|537467582|FG001|Stage 1|Patient refused to continue study meds|3|||
148997738|NCT00514943|537467581|FG000|Stage 1|Other than stated above|1|||
148997739|NCT00514943|537467582|FG001|Stage 1|Other than stated above|7|||
148997740|NCT00514943|537467581|FG000|Stage 2|Progressive disease|27|||
148997741|NCT00514943|537467582|FG001|Stage 2|Progressive disease|24|||
148997742|NCT00514943|537467581|FG000|Stage 2|Other Adverse Event|3|||
148997743|NCT00514943|537467582|FG001|Stage 2|Other Adverse Event|10|||
148997744|NCT00514943|537467581|FG000|Stage 2|Patient refused to continue study meds|2|||
148997745|NCT00514943|537467582|FG001|Stage 2|Patient refused to continue study meds|0|||
148997746|NCT00514943|537467581|FG000|Stage 2|Other than stated above|0|||
148997747|NCT00514943|537467582|FG001|Stage 2|Other than stated above|2|||
148997748|NCT03751631|537467587|FG000|Overall Study|Withdrawal by Subject|0|||
148997749|NCT03751631|537467588|FG001|Overall Study|Withdrawal by Subject|0|||
148997750|NCT03751631|537467589|FG002|Overall Study|Withdrawal by Subject|1|||
148997751|NCT03751631|537467590|FG003|Overall Study|Withdrawal by Subject|1|||
148997752|NCT03751631|537467591|FG004|Overall Study|Withdrawal by Subject|0|||
148997753|NCT03751631|537467592|FG005|Overall Study|Withdrawal by Subject|0|||
148997754|NCT02822222|537467596|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
148997755|NCT02822222|537467597|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
148997756|NCT00428090|537467598|FG000|Overall Study|Adverse Event|10|||
148997757|NCT00428090|537467599|FG001|Overall Study|Adverse Event|8|||
148997758|NCT00428090|537467600|FG002|Overall Study|Adverse Event|10|||
148997759|NCT00428090|537467601|FG003|Overall Study|Adverse Event|11|||
148997760|NCT00428090|537467598|FG000|Overall Study|Lost to Follow-up|3|||
148997761|NCT00428090|537467599|FG001|Overall Study|Lost to Follow-up|6|||
148997762|NCT00428090|537467600|FG002|Overall Study|Lost to Follow-up|1|||
148997763|NCT00428090|537467601|FG003|Overall Study|Lost to Follow-up|4|||
148997764|NCT00428090|537467598|FG000|Overall Study|Protocol Violation|3|||
148997765|NCT00428090|537467599|FG001|Overall Study|Protocol Violation|1|||
148997766|NCT00428090|537467600|FG002|Overall Study|Protocol Violation|3|||
148997767|NCT00428090|537467601|FG003|Overall Study|Protocol Violation|3|||
148997768|NCT00428090|537467598|FG000|Overall Study|Withdrawal by Subject|10|||
148997769|NCT00428090|537467599|FG001|Overall Study|Withdrawal by Subject|12|||
148997770|NCT00428090|537467600|FG002|Overall Study|Withdrawal by Subject|15|||
148997771|NCT00428090|537467601|FG003|Overall Study|Withdrawal by Subject|5|||
148997772|NCT00428090|537467598|FG000|Overall Study|Sponsor terminated study|0|||
148997773|NCT00428090|537467599|FG001|Overall Study|Sponsor terminated study|1|||
148997774|NCT00428090|537467600|FG002|Overall Study|Sponsor terminated study|0|||
148997775|NCT00428090|537467601|FG003|Overall Study|Sponsor terminated study|0|||
148997776|NCT00428090|537467598|FG000|Overall Study|Non-compliance|4|||
148997777|NCT00428090|537467599|FG001|Overall Study|Non-compliance|0|||
148997778|NCT00428090|537467600|FG002|Overall Study|Non-compliance|1|||
148997779|NCT00428090|537467601|FG003|Overall Study|Non-compliance|3|||
148997780|NCT00428090|537467598|FG000|Overall Study|Par. did not returned to visit|1|||
148997781|NCT00428090|537467599|FG001|Overall Study|Par. did not returned to visit|0|||
148997782|NCT00428090|537467600|FG002|Overall Study|Par. did not returned to visit|0|||
149031104|NCT01981850|537591663|FG009|Main Phase Stage 2|Progressive Disease|0|||
148865638|NCT01527383|536984619|FG000|Overall Study|Adverse Event|5|||
148865639|NCT01527383|536984620|FG001|Overall Study|Adverse Event|0|||
148997783|NCT00428090|537467601|FG003|Overall Study|Par. did not returned to visit|1|||
148997784|NCT00428090|537467598|FG000|Overall Study|Follow-Up visit not possible|1|||
148997785|NCT00428090|537467599|FG001|Overall Study|Follow-Up visit not possible|0|||
148997786|NCT00428090|537467600|FG002|Overall Study|Follow-Up visit not possible|0|||
148997787|NCT00428090|537467601|FG003|Overall Study|Follow-Up visit not possible|0|||
148997788|NCT00428090|537467598|FG000|Overall Study|Prohibited medication used for SAE|1|||
148997789|NCT00428090|537467599|FG001|Overall Study|Prohibited medication used for SAE|0|||
148865640|NCT01527383|536984619|FG000|Overall Study|Lost to Follow-up|3|||
148865641|NCT01527383|536984620|FG001|Overall Study|Lost to Follow-up|0|||
148997790|NCT00428090|537467600|FG002|Overall Study|Prohibited medication used for SAE|0|||
148997791|NCT00428090|537467601|FG003|Overall Study|Prohibited medication used for SAE|0|||
148997792|NCT00428090|537467598|FG000|Overall Study|Death of par.|1|||
148997793|NCT00428090|537467599|FG001|Overall Study|Death of par.|0|||
148997794|NCT00428090|537467600|FG002|Overall Study|Death of par.|1|||
148997795|NCT00428090|537467601|FG003|Overall Study|Death of par.|0|||
148997796|NCT00428090|537467598|FG000|Overall Study|Visit 7 exceed the visit window|0|||
148997797|NCT00428090|537467599|FG001|Overall Study|Visit 7 exceed the visit window|1|||
148865642|NCT01527383|536984619|FG000|Overall Study|Physician Decision|2|||
149031105|NCT01981850|537591654|FG000|Open Label Extension (OLE)|Adverse Event|0|||
148865643|NCT01527383|536984620|FG001|Overall Study|Physician Decision|0|||
148865644|NCT01527383|536984619|FG000|Overall Study|Pregnancy|1|||
148865645|NCT01527383|536984620|FG001|Overall Study|Pregnancy|0|||
148865646|NCT01527383|536984619|FG000|Overall Study|Protocol Violation|1|||
148865647|NCT01527383|536984620|FG001|Overall Study|Protocol Violation|0|||
148865648|NCT01527383|536984619|FG000|Overall Study|Screen failure|1|||
148865649|NCT01527383|536984620|FG001|Overall Study|Screen failure|0|||
148865650|NCT01527383|536984619|FG000|Overall Study|Participant moved|0|||
148865651|NCT01527383|536984620|FG001|Overall Study|Participant moved|1|||
148865652|NCT01527383|536984619|FG000|Overall Study|Withdrawal by Subject|2|||
148865653|NCT01527383|536984620|FG001|Overall Study|Withdrawal by Subject|3|||
148865654|NCT00746733|536984621|FG000|Second Intervention|Adverse Event|1|||
148865655|NCT00746733|536984622|FG001|Second Intervention|Adverse Event|0|||
148865656|NCT00746733|536984621|FG000|Third Intervention|Withdrawal by Subject|1|||
148865657|NCT00746733|536984622|FG001|Third Intervention|Withdrawal by Subject|1|||
148865658|NCT00849875|536984623|FG000|Overall Study|Death|28|||
148865659|NCT00849875|536984623|FG000|Overall Study|Ongoing (unknown completion status)|11|||
148865660|NCT00849875|536984623|FG000|Overall Study|Others|6|||
148865661|NCT00849875|536984623|FG000|Overall Study|Lost to Follow-up|2|||
148865662|NCT03412604|536984624|FG000|Overall Study|Withdrawal by Subject|1|||
148865663|NCT00993499|536984636|FG000|Run-in Period (8 Days)|Adverse Event|0|||
148865664|NCT00993499|536984637|FG001|Run-in Period (8 Days)|Adverse Event|1|||
148865665|NCT00993499|536984638|FG002|Run-in Period (8 Days)|Adverse Event|0|||
148865666|NCT00993499|536984639|FG003|Run-in Period (8 Days)|Adverse Event|0|||
148865667|NCT00993499|536984640|FG004|Run-in Period (8 Days)|Adverse Event|0|||
148865668|NCT00993499|536984641|FG005|Run-in Period (8 Days)|Adverse Event|0|||
148865669|NCT00993499|536984636|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
148865670|NCT00993499|536984637|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
148865671|NCT00993499|536984638|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
148865672|NCT00993499|536984639|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
148865673|NCT00993499|536984640|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
148865674|NCT00993499|536984641|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
148865675|NCT00993499|536984636|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
148865676|NCT00993499|536984637|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
148865677|NCT00993499|536984638|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
148865678|NCT00993499|536984639|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
148865679|NCT00993499|536984640|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
148865680|NCT00993499|536984641|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
148865681|NCT00993499|536984636|FG000|Run-in Period (8 Days)|Progressive disease|0|||
148865682|NCT00993499|536984637|FG001|Run-in Period (8 Days)|Progressive disease|1|||
148865683|NCT00993499|536984638|FG002|Run-in Period (8 Days)|Progressive disease|1|||
148865684|NCT00993499|536984639|FG003|Run-in Period (8 Days)|Progressive disease|0|||
148865685|NCT00993499|536984640|FG004|Run-in Period (8 Days)|Progressive disease|0|||
148865686|NCT00993499|536984641|FG005|Run-in Period (8 Days)|Progressive disease|0|||
148865687|NCT00993499|536984636|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
148865688|NCT00993499|536984637|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
148865689|NCT00993499|536984638|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
148865690|NCT00993499|536984639|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
148865691|NCT00993499|536984640|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
148865692|NCT00993499|536984641|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
148865693|NCT00993499|536984636|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
148865694|NCT00993499|536984637|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
148865695|NCT00993499|536984638|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
148865696|NCT00993499|536984639|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
148865697|NCT00993499|536984640|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
148865698|NCT00993499|536984641|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
148865699|NCT00993499|536984636|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
148997798|NCT00428090|537467600|FG002|Overall Study|Visit 7 exceed the visit window|0|||
148997799|NCT00428090|537467601|FG003|Overall Study|Visit 7 exceed the visit window|0|||
148997800|NCT00428090|537467598|FG000|Overall Study|Medical monitor terminated par.|0|||
148997801|NCT00428090|537467599|FG001|Overall Study|Medical monitor terminated par.|1|||
148997802|NCT00428090|537467600|FG002|Overall Study|Medical monitor terminated par.|0|||
148997803|NCT00428090|537467601|FG003|Overall Study|Medical monitor terminated par.|0|||
148865700|NCT00993499|536984637|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
148865701|NCT00993499|536984638|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
148865702|NCT00993499|536984639|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
148865703|NCT00993499|536984640|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
148865704|NCT00993499|536984641|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
148865705|NCT00993499|536984636|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
148997804|NCT00428090|537467598|FG000|Overall Study|Mental status of par. was|0|||
148865706|NCT00993499|536984637|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
148865707|NCT00993499|536984638|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
148865708|NCT00993499|536984639|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
148865709|NCT00993499|536984640|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
148865710|NCT00993499|536984641|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
148865711|NCT00993499|536984636|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
148865712|NCT00993499|536984637|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
148865713|NCT00993499|536984638|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
148865714|NCT00993499|536984639|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
148865715|NCT00993499|536984640|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
148865716|NCT00993499|536984641|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
148865717|NCT00993499|536984636|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
148865718|NCT00993499|536984637|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
148865719|NCT00993499|536984638|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
148865720|NCT00993499|536984639|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
148865721|NCT00993499|536984640|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
148865722|NCT00993499|536984641|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
148865723|NCT00993499|536984636|FG000|Discontinued After Starting Course 3|DLT|1|||
148865724|NCT00993499|536984637|FG001|Discontinued After Starting Course 3|DLT|0|||
148865725|NCT00993499|536984638|FG002|Discontinued After Starting Course 3|DLT|2|||
148865726|NCT00993499|536984639|FG003|Discontinued After Starting Course 3|DLT|1|||
148865727|NCT00993499|536984640|FG004|Discontinued After Starting Course 3|DLT|0|||
148865728|NCT00993499|536984641|FG005|Discontinued After Starting Course 3|DLT|0|||
148865729|NCT00993499|536984636|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
148865730|NCT00993499|536984637|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
148865731|NCT00993499|536984638|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
148865732|NCT00993499|536984639|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
148865733|NCT00993499|536984640|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
148865734|NCT00993499|536984641|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
148865735|NCT01945775|536984642|FG000|Overall Study|Death|214|||
148865736|NCT01945775|536984643|FG001|Overall Study|Death|98|||
148865737|NCT01945775|536984642|FG000|Overall Study|Lost to Follow-up|12|||
148865738|NCT01945775|536984643|FG001|Overall Study|Lost to Follow-up|7|||
148865739|NCT01945775|536984642|FG000|Overall Study|Withdrawal by Subject|11|||
148865740|NCT01945775|536984643|FG001|Overall Study|Withdrawal by Subject|21|||
148865741|NCT01945775|536984642|FG000|Overall Study|Other|50|||
148865742|NCT01945775|536984643|FG001|Overall Study|Other|18|||
148865743|NCT02876328|536984644|FG000|Overall Study|Death|2|||
148865744|NCT02876328|536984645|FG001|Overall Study|Death|1|||
148865745|NCT02876328|536984646|FG002|Overall Study|Death|3|||
148865746|NCT02876328|536984647|FG003|Overall Study|Death|0|||
148865747|NCT02876328|536984648|FG004|Overall Study|Death|0|||
148865748|NCT02876328|536984649|FG005|Overall Study|Death|0|||
148865749|NCT02876328|536984650|FG006|Overall Study|Death|1|||
148865750|NCT02876328|536984651|FG007|Overall Study|Death|3|||
148865751|NCT02876328|536984652|FG008|Overall Study|Death|0|||
148865752|NCT02876328|536984653|FG009|Overall Study|Death|1|||
148865753|NCT02876328|536984654|FG010|Overall Study|Death|1|||
148865754|NCT02876328|536984655|FG011|Overall Study|Death|0|||
148865755|NCT02876328|536984656|FG012|Overall Study|Death|0|||
148865756|NCT02876328|536984657|FG013|Overall Study|Death|0|||
148865757|NCT02876328|536984658|FG014|Overall Study|Death|0|||
148865758|NCT02876328|536984659|FG015|Overall Study|Death|0|||
148865759|NCT02876328|536984660|FG016|Overall Study|Death|1|||
148865760|NCT02876328|536984661|FG017|Overall Study|Death|1|||
148865761|NCT02876328|536984662|FG018|Overall Study|Death|0|||
148865762|NCT02876328|536984663|FG019|Overall Study|Death|0|||
148865763|NCT02876328|536984664|FG020|Overall Study|Death|0|||
148865764|NCT02876328|536984665|FG021|Overall Study|Death|1|||
148997805|NCT00428090|537467599|FG001|Overall Study|Mental status of par. was|1|||
148997806|NCT00428090|537467600|FG002|Overall Study|Mental status of par. was|0|||
148997807|NCT00428090|537467601|FG003|Overall Study|Mental status of par. was|0|||
148997808|NCT00428090|537467598|FG000|Overall Study|Worsening of AD|0|||
148865765|NCT02876328|536984666|FG022|Overall Study|Death|0|||
148865766|NCT02876328|536984667|FG023|Overall Study|Death|0|||
148865767|NCT02876328|536984644|FG000|Overall Study|Withdrawal by Subject|0|||
148865768|NCT02876328|536984645|FG001|Overall Study|Withdrawal by Subject|2|||
148865769|NCT02876328|536984646|FG002|Overall Study|Withdrawal by Subject|3|||
148865770|NCT02876328|536984647|FG003|Overall Study|Withdrawal by Subject|3|||
148865771|NCT02876328|536984648|FG004|Overall Study|Withdrawal by Subject|0|||
148865772|NCT02876328|536984649|FG005|Overall Study|Withdrawal by Subject|1|||
148865773|NCT02876328|536984650|FG006|Overall Study|Withdrawal by Subject|0|||
148865774|NCT02876328|536984651|FG007|Overall Study|Withdrawal by Subject|1|||
148865775|NCT02876328|536984652|FG008|Overall Study|Withdrawal by Subject|1|||
148865776|NCT02876328|536984653|FG009|Overall Study|Withdrawal by Subject|2|||
148997809|NCT00428090|537467599|FG001|Overall Study|Worsening of AD|0|||
148997810|NCT00428090|537467600|FG002|Overall Study|Worsening of AD|1|||
148865777|NCT02876328|536984654|FG010|Overall Study|Withdrawal by Subject|0|||
148865778|NCT02876328|536984655|FG011|Overall Study|Withdrawal by Subject|0|||
148865779|NCT02876328|536984656|FG012|Overall Study|Withdrawal by Subject|0|||
148865780|NCT02876328|536984657|FG013|Overall Study|Withdrawal by Subject|0|||
148865781|NCT02876328|536984658|FG014|Overall Study|Withdrawal by Subject|0|||
148865782|NCT02876328|536984659|FG015|Overall Study|Withdrawal by Subject|0|||
148865783|NCT02876328|536984660|FG016|Overall Study|Withdrawal by Subject|1|||
148865784|NCT02876328|536984661|FG017|Overall Study|Withdrawal by Subject|3|||
148865785|NCT02876328|536984662|FG018|Overall Study|Withdrawal by Subject|0|||
148865786|NCT02876328|536984663|FG019|Overall Study|Withdrawal by Subject|0|||
148865787|NCT02876328|536984664|FG020|Overall Study|Withdrawal by Subject|1|||
148865788|NCT02876328|536984665|FG021|Overall Study|Withdrawal by Subject|0|||
148865789|NCT02876328|536984666|FG022|Overall Study|Withdrawal by Subject|0|||
148865790|NCT02876328|536984667|FG023|Overall Study|Withdrawal by Subject|0|||
148865791|NCT02876328|536984644|FG000|Overall Study|Missed 12 Month Visit|15|||
148865792|NCT02876328|536984645|FG001|Overall Study|Missed 12 Month Visit|10|||
148865793|NCT02876328|536984646|FG002|Overall Study|Missed 12 Month Visit|11|||
148865794|NCT02876328|536984647|FG003|Overall Study|Missed 12 Month Visit|6|||
148865795|NCT02876328|536984648|FG004|Overall Study|Missed 12 Month Visit|10|||
148865796|NCT02876328|536984649|FG005|Overall Study|Missed 12 Month Visit|14|||
148865797|NCT02876328|536984650|FG006|Overall Study|Missed 12 Month Visit|3|||
148865798|NCT02876328|536984651|FG007|Overall Study|Missed 12 Month Visit|8|||
148865799|NCT02876328|536984652|FG008|Overall Study|Missed 12 Month Visit|9|||
148865800|NCT02876328|536984653|FG009|Overall Study|Missed 12 Month Visit|5|||
148865801|NCT02876328|536984654|FG010|Overall Study|Missed 12 Month Visit|4|||
148865802|NCT02876328|536984655|FG011|Overall Study|Missed 12 Month Visit|1|||
148865803|NCT02876328|536984656|FG012|Overall Study|Missed 12 Month Visit|5|||
148865804|NCT02876328|536984657|FG013|Overall Study|Missed 12 Month Visit|4|||
148865805|NCT02876328|536984658|FG014|Overall Study|Missed 12 Month Visit|4|||
148865806|NCT02876328|536984659|FG015|Overall Study|Missed 12 Month Visit|4|||
148865807|NCT02876328|536984660|FG016|Overall Study|Missed 12 Month Visit|3|||
148865808|NCT02876328|536984661|FG017|Overall Study|Missed 12 Month Visit|6|||
148865809|NCT02876328|536984662|FG018|Overall Study|Missed 12 Month Visit|2|||
148865810|NCT02876328|536984663|FG019|Overall Study|Missed 12 Month Visit|2|||
148865811|NCT02876328|536984664|FG020|Overall Study|Missed 12 Month Visit|11|||
148865812|NCT02876328|536984665|FG021|Overall Study|Missed 12 Month Visit|7|||
148865813|NCT02876328|536984666|FG022|Overall Study|Missed 12 Month Visit|1|||
148865814|NCT02876328|536984667|FG023|Overall Study|Missed 12 Month Visit|0|||
148865815|NCT03515941|536984674|FG000|Overall Study|Adverse Event|1|||
148865816|NCT03515941|536984675|FG001|Overall Study|Adverse Event|0|||
148865817|NCT00276094|536984678|FG000|Overall Study|Adverse Event|15|||
148865818|NCT00276094|536984679|FG001|Overall Study|Adverse Event|13|||
148865819|NCT00276094|536984680|FG002|Overall Study|Adverse Event|11|||
148865820|NCT00276094|536984678|FG000|Overall Study|Withdrawal by Subject|14|||
148865821|NCT00276094|536984679|FG001|Overall Study|Withdrawal by Subject|14|||
148865822|NCT00276094|536984680|FG002|Overall Study|Withdrawal by Subject|12|||
148865823|NCT00276094|536984678|FG000|Overall Study|Protocol Violation|16|||
148865824|NCT00276094|536984679|FG001|Overall Study|Protocol Violation|7|||
148865825|NCT00276094|536984680|FG002|Overall Study|Protocol Violation|10|||
148865826|NCT00276094|536984678|FG000|Overall Study|Lost to Follow-up|8|||
148865827|NCT00276094|536984679|FG001|Overall Study|Lost to Follow-up|6|||
148865828|NCT00276094|536984680|FG002|Overall Study|Lost to Follow-up|4|||
148865829|NCT00276094|536984678|FG000|Overall Study|Other-Subject moved out of country|1|||
148865830|NCT00276094|536984679|FG001|Overall Study|Other-Subject moved out of country|0|||
148865831|NCT00276094|536984680|FG002|Overall Study|Other-Subject moved out of country|0|||
148865832|NCT00276094|536984678|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
148865833|NCT00276094|536984679|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
148865834|NCT00276094|536984680|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
148997811|NCT00428090|537467601|FG003|Overall Study|Worsening of AD|0|||
148997812|NCT00428090|537467598|FG000|Overall Study|Excluded for concerning QTc value|0|||
148997813|NCT00428090|537467599|FG001|Overall Study|Excluded for concerning QTc value|0|||
148997814|NCT00428090|537467600|FG002|Overall Study|Excluded for concerning QTc value|1|||
148997815|NCT00428090|537467601|FG003|Overall Study|Excluded for concerning QTc value|0|||
148997816|NCT00428090|537467598|FG000|Overall Study|Insufficient AD documentation|0|||
148865835|NCT00276094|536984678|FG000|Overall Study|Other-Lack of efficacy|1|||
148865836|NCT00276094|536984679|FG001|Overall Study|Other-Lack of efficacy|0|||
148865837|NCT00276094|536984680|FG002|Overall Study|Other-Lack of efficacy|0|||
148865838|NCT00276094|536984678|FG000|Overall Study|Other-Refused follow-up visit|1|||
148865839|NCT00276094|536984679|FG001|Overall Study|Other-Refused follow-up visit|0|||
148865840|NCT00276094|536984680|FG002|Overall Study|Other-Refused follow-up visit|0|||
148865841|NCT00276094|536984678|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
148865842|NCT00276094|536984679|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
148997817|NCT00428090|537467599|FG001|Overall Study|Insufficient AD documentation|0|||
148865843|NCT00276094|536984680|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
148865844|NCT00276094|536984678|FG000|Overall Study|Other-Relocation|0|||
148865845|NCT00276094|536984679|FG001|Overall Study|Other-Relocation|1|||
148865846|NCT00276094|536984680|FG002|Overall Study|Other-Relocation|0|||
148865847|NCT00276094|536984678|FG000|Overall Study|Other-Study medication lost|0|||
148865848|NCT00276094|536984679|FG001|Overall Study|Other-Study medication lost|0|||
148865849|NCT00276094|536984680|FG002|Overall Study|Other-Study medication lost|1|||
148865850|NCT02759315|536984681|FG000|Overall Study|Adverse Event|0|||
148865851|NCT02759315|536984682|FG001|Overall Study|Adverse Event|0|||
148865852|NCT02759315|536984683|FG002|Overall Study|Adverse Event|0|||
148865853|NCT02759315|536984684|FG003|Overall Study|Adverse Event|1|||
148865854|NCT02759315|536984685|FG004|Overall Study|Adverse Event|0|||
148865855|NCT02759315|536984681|FG000|Overall Study|Death|0|||
148865856|NCT02759315|536984682|FG001|Overall Study|Death|0|||
148865857|NCT02759315|536984683|FG002|Overall Study|Death|1|||
148865858|NCT02759315|536984684|FG003|Overall Study|Death|0|||
148865859|NCT02759315|536984685|FG004|Overall Study|Death|0|||
148865860|NCT02759315|536984681|FG000|Overall Study|Lost to Follow-up|2|||
148865861|NCT02759315|536984682|FG001|Overall Study|Lost to Follow-up|0|||
148865862|NCT02759315|536984683|FG002|Overall Study|Lost to Follow-up|4|||
148865863|NCT02759315|536984684|FG003|Overall Study|Lost to Follow-up|0|||
148865864|NCT02759315|536984685|FG004|Overall Study|Lost to Follow-up|0|||
148865865|NCT02759315|536984681|FG000|Overall Study|Protocol Violation|0|||
148865866|NCT02759315|536984682|FG001|Overall Study|Protocol Violation|1|||
148865867|NCT02759315|536984683|FG002|Overall Study|Protocol Violation|0|||
148865868|NCT02759315|536984684|FG003|Overall Study|Protocol Violation|0|||
148865869|NCT02759315|536984685|FG004|Overall Study|Protocol Violation|0|||
148865870|NCT02759315|536984681|FG000|Overall Study|Study terminated prior to completion|2|||
148865871|NCT02759315|536984682|FG001|Overall Study|Study terminated prior to completion|0|||
148865872|NCT02759315|536984683|FG002|Overall Study|Study terminated prior to completion|5|||
148865873|NCT02759315|536984684|FG003|Overall Study|Study terminated prior to completion|0|||
148865874|NCT02759315|536984685|FG004|Overall Study|Study terminated prior to completion|1|||
148997818|NCT00428090|537467600|FG002|Overall Study|Insufficient AD documentation|1|||
148997819|NCT00428090|537467601|FG003|Overall Study|Insufficient AD documentation|0|||
148997820|NCT00428090|537467598|FG000|Overall Study|High MMSE scores|0|||
148997821|NCT00428090|537467599|FG001|Overall Study|High MMSE scores|0|||
148997822|NCT00428090|537467600|FG002|Overall Study|High MMSE scores|1|||
148997823|NCT00428090|537467601|FG003|Overall Study|High MMSE scores|0|||
148997824|NCT00428090|537467598|FG000|Overall Study|Deterioration of cognitive status|0|||
148997825|NCT00428090|537467599|FG001|Overall Study|Deterioration of cognitive status|0|||
148997826|NCT00428090|537467600|FG002|Overall Study|Deterioration of cognitive status|1|||
148997827|NCT00428090|537467601|FG003|Overall Study|Deterioration of cognitive status|0|||
148997828|NCT00428090|537467598|FG000|Overall Study|Serious adverse event|0|||
148997829|NCT00428090|537467599|FG001|Overall Study|Serious adverse event|0|||
148997830|NCT00428090|537467600|FG002|Overall Study|Serious adverse event|1|||
148997831|NCT00428090|537467601|FG003|Overall Study|Serious adverse event|0|||
148997832|NCT00428090|537467598|FG000|Overall Study|Excluded for heart insufficiency|0|||
148997833|NCT00428090|537467599|FG001|Overall Study|Excluded for heart insufficiency|0|||
148997834|NCT00428090|537467600|FG002|Overall Study|Excluded for heart insufficiency|1|||
148997835|NCT00428090|537467601|FG003|Overall Study|Excluded for heart insufficiency|0|||
148997836|NCT00428090|537467598|FG000|Overall Study|Raised Creatinine Value|0|||
148997837|NCT00428090|537467599|FG001|Overall Study|Raised Creatinine Value|0|||
148997838|NCT00428090|537467600|FG002|Overall Study|Raised Creatinine Value|0|||
148997839|NCT00428090|537467601|FG003|Overall Study|Raised Creatinine Value|1|||
148997840|NCT02690974|537467605|FG000|Overall Study|Adverse Event|16|||
148997841|NCT02690974|537467605|FG000|Overall Study|Death|9|||
148997842|NCT02690974|537467605|FG000|Overall Study|Subject/guardian decision|4|||
148997843|NCT02690974|537467605|FG000|Overall Study|Lost to Follow-up|3|||
148997844|NCT02690974|537467605|FG000|Overall Study|Withdrawal of Informed Consent|3|||
148997845|NCT02690974|537467605|FG000|Overall Study|Physician Decision|2|||
148997846|NCT02690974|537467605|FG000|Overall Study|Non-compliance with study treatment|1|||
148997847|NCT02690974|537467605|FG000|Overall Study|Protocol-defined stopping criteria|1|||
148997848|NCT02690974|537467605|FG000|Overall Study|Protocol Deviation|1|||
148997849|NCT02548455|537467609|FG000|Overall Study|Withdrawal by Subject|27|||
148997850|NCT02548455|537467609|FG000|Overall Study|Death|26|||
148997851|NCT02548455|537467609|FG000|Overall Study|Lost to Follow-up|14|||
148997852|NCT02548455|537467609|FG000|Overall Study|Visit not completed|173|||
148997853|NCT00530855|537467610|FG000|Overall Study|Lack of Efficacy|20|||
148997854|NCT00530855|537467610|FG000|Overall Study|Withdrawal by Subject|30|||
148997855|NCT00530855|537467610|FG000|Overall Study|Fatal Serious AE|3|||
148865875|NCT01406015|536984688|FG000|Overall Study|Withdrawal by Subject|3|||
148865876|NCT01406015|536984689|FG001|Overall Study|Withdrawal by Subject|3|||
148865877|NCT00787137|536984690|FG000|Overall Study|Study Termination|0|||
148865878|NCT00787137|536984691|FG001|Overall Study|Study Termination|0|||
148865879|NCT00787137|536984692|FG002|Overall Study|Study Termination|1|||
148865880|NCT00554099|536984696|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
148865881|NCT00554099|536984697|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
148997856|NCT00530855|537467610|FG000|Overall Study|Non Fatal Serious AE|7|||
148997857|NCT00530855|537467610|FG000|Overall Study|Non Fatal Non Serious AE|12|||
148997858|NCT00530855|537467610|FG000|Overall Study|Protocol Violation|3|||
148997859|NCT00530855|537467610|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
148997860|NCT00530855|537467610|FG000|Overall Study|Lost to Follow-up|9|||
148997861|NCT00530855|537467610|FG000|Overall Study|Other reason for premature termination|17|||
148997862|NCT01627327|537467611|FG000|Overall Study|Adverse Event|6|||
148997863|NCT01627327|537467612|FG001|Overall Study|Adverse Event|12|||
148997864|NCT01627327|537467611|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
148997865|NCT01627327|537467612|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
148997866|NCT01627327|537467611|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
148997867|NCT01627327|537467612|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
148997868|NCT01627327|537467611|FG000|Overall Study|Protocol Violation|4|||
148997869|NCT01627327|537467612|FG001|Overall Study|Protocol Violation|10|||
148997870|NCT01627327|537467611|FG000|Overall Study|Lost to Follow-up|1|||
148997871|NCT01627327|537467612|FG001|Overall Study|Lost to Follow-up|3|||
148997872|NCT01627327|537467611|FG000|Overall Study|Physician Decision|1|||
148997873|NCT01627327|537467612|FG001|Overall Study|Physician Decision|0|||
148997874|NCT01627327|537467611|FG000|Overall Study|Withdrawal by Subject|3|||
148997875|NCT01627327|537467612|FG001|Overall Study|Withdrawal by Subject|3|||
148997876|NCT01137474|537467616|FG000|Overall Study|Adverse Event|3|||
148997877|NCT01137474|537467617|FG001|Overall Study|Adverse Event|5|||
148997878|NCT01137474|537467618|FG002|Overall Study|Adverse Event|1|||
148997879|NCT01137474|537467619|FG003|Overall Study|Adverse Event|3|||
148997880|NCT01137474|537467616|FG000|Overall Study|Withdrawal by Subject|7|||
148997881|NCT01137474|537467617|FG001|Overall Study|Withdrawal by Subject|2|||
148997882|NCT01137474|537467618|FG002|Overall Study|Withdrawal by Subject|6|||
148997883|NCT01137474|537467619|FG003|Overall Study|Withdrawal by Subject|9|||
148997884|NCT01137474|537467616|FG000|Overall Study|No longer met study criteria|6|||
148997885|NCT01137474|537467617|FG001|Overall Study|No longer met study criteria|1|||
148997886|NCT01137474|537467618|FG002|Overall Study|No longer met study criteria|0|||
148997887|NCT01137474|537467619|FG003|Overall Study|No longer met study criteria|5|||
148997888|NCT01137474|537467616|FG000|Overall Study|Lost to Follow-up|5|||
148997889|NCT01137474|537467617|FG001|Overall Study|Lost to Follow-up|1|||
148997890|NCT01137474|537467618|FG002|Overall Study|Lost to Follow-up|0|||
148997891|NCT01137474|537467619|FG003|Overall Study|Lost to Follow-up|2|||
148997892|NCT01137474|537467616|FG000|Overall Study|Lack of Efficacy|0|||
148997893|NCT01137474|537467617|FG001|Overall Study|Lack of Efficacy|0|||
148997894|NCT01137474|537467618|FG002|Overall Study|Lack of Efficacy|0|||
148997895|NCT01137474|537467619|FG003|Overall Study|Lack of Efficacy|2|||
148997896|NCT01137474|537467616|FG000|Overall Study|Other|3|||
148997897|NCT01137474|537467617|FG001|Overall Study|Other|1|||
148997898|NCT01137474|537467618|FG002|Overall Study|Other|0|||
148997899|NCT01137474|537467619|FG003|Overall Study|Other|0|||
148997900|NCT01137474|537467616|FG000|Overall Study|Pregnancy|0|||
148997901|NCT01137474|537467617|FG001|Overall Study|Pregnancy|1|||
148997902|NCT01137474|537467618|FG002|Overall Study|Pregnancy|0|||
148997903|NCT01137474|537467619|FG003|Overall Study|Pregnancy|0|||
148997904|NCT01137474|537467616|FG000|Overall Study|Administrative reason by sponsor|0|||
148997905|NCT01137474|537467617|FG001|Overall Study|Administrative reason by sponsor|1|||
148997906|NCT01137474|537467618|FG002|Overall Study|Administrative reason by sponsor|0|||
148997907|NCT01137474|537467619|FG003|Overall Study|Administrative reason by sponsor|0|||
148997908|NCT00868439|537467627|FG000|Overall Study|Adverse Event|4|||
148997909|NCT00868439|537467628|FG001|Overall Study|Adverse Event|3|||
148997910|NCT00868439|537467627|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
148997911|NCT00868439|537467628|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
148997912|NCT00868439|537467627|FG000|Overall Study|Death|0|||
148997913|NCT00868439|537467628|FG001|Overall Study|Death|1|||
148997914|NCT00868439|537467627|FG000|Overall Study|Protocol Violation|1|||
148997915|NCT00868439|537467628|FG001|Overall Study|Protocol Violation|1|||
148997916|NCT00868439|537467627|FG000|Overall Study|Physician Decision|1|||
148997917|NCT00868439|537467628|FG001|Overall Study|Physician Decision|0|||
148997918|NCT00868439|537467627|FG000|Overall Study|Withdrawal by Subject|0|||
148997919|NCT00868439|537467628|FG001|Overall Study|Withdrawal by Subject|1|||
148997920|NCT00423176|537467631|FG000|Overall Study|Adverse Event|4|||
148997921|NCT00423176|537467632|FG001|Overall Study|Adverse Event|6|||
148997922|NCT00423176|537467631|FG000|Overall Study|Treatment Failure|1|||
148997923|NCT00423176|537467632|FG001|Overall Study|Treatment Failure|6|||
148997924|NCT00423176|537467631|FG000|Overall Study|Lost to Follow-up|4|||
148997925|NCT00423176|537467632|FG001|Overall Study|Lost to Follow-up|7|||
148997926|NCT00423176|537467631|FG000|Overall Study|Withdrawal by Subject|4|||
148997927|NCT00423176|537467632|FG001|Overall Study|Withdrawal by Subject|3|||
148997928|NCT00423176|537467631|FG000|Overall Study|Protocol Violation|1|||
148997929|NCT00423176|537467632|FG001|Overall Study|Protocol Violation|3|||
148997930|NCT00423176|537467631|FG000|Overall Study|Did not meet protocol eligibility|2|||
148997931|NCT00423176|537467632|FG001|Overall Study|Did not meet protocol eligibility|4|||
148997932|NCT00224874|537467635|FG000|Overall Study|Withdrawal by Subject|0|||
148997933|NCT00224874|537467636|FG001|Overall Study|Withdrawal by Subject|0|||
148997934|NCT00224874|537467637|FG002|Overall Study|Withdrawal by Subject|1|||
148997935|NCT00224874|537467638|FG003|Overall Study|Withdrawal by Subject|0|||
148997936|NCT00911534|537467639|FG000|Overall Study|Adverse Event|4|||
148997937|NCT00911534|537467640|FG001|Overall Study|Adverse Event|4|||
148997938|NCT00911534|537467639|FG000|Overall Study|Lost to Follow-up|2|||
148997939|NCT00911534|537467640|FG001|Overall Study|Lost to Follow-up|4|||
148997940|NCT00911534|537467639|FG000|Overall Study|Withdrawal by Subject|2|||
148997941|NCT00911534|537467640|FG001|Overall Study|Withdrawal by Subject|1|||
148997942|NCT00911534|537467639|FG000|Overall Study|Lack of Efficacy|4|||
148997943|NCT00911534|537467640|FG001|Overall Study|Lack of Efficacy|1|||
148997944|NCT00911534|537467639|FG000|Overall Study|Withdrawal of consent|1|||
148997945|NCT00911534|537467640|FG001|Overall Study|Withdrawal of consent|4|||
148997946|NCT00911534|537467639|FG000|Overall Study|Other|2|||
148997947|NCT00911534|537467640|FG001|Overall Study|Other|2|||
148997948|NCT05072080|537467641|FG000|Overall Study|Death|0|||
148997949|NCT05072080|537467642|FG001|Overall Study|Death|0|||
148997950|NCT05072080|537467643|FG002|Overall Study|Death|1|||
148997951|NCT05072080|537467644|FG003|Overall Study|Death|0|||
148997952|NCT05072080|537467641|FG000|Overall Study|Lost to Follow-up|65|||
148997953|NCT05072080|537467642|FG001|Overall Study|Lost to Follow-up|70|||
148997954|NCT05072080|537467643|FG002|Overall Study|Lost to Follow-up|58|||
148997955|NCT05072080|537467644|FG003|Overall Study|Lost to Follow-up|23|||
148997956|NCT05072080|537467641|FG000|Overall Study|Physician Decision|2|||
148997957|NCT05072080|537467642|FG001|Overall Study|Physician Decision|1|||
148997958|NCT05072080|537467643|FG002|Overall Study|Physician Decision|1|||
148997959|NCT05072080|537467644|FG003|Overall Study|Physician Decision|0|||
148997960|NCT05072080|537467641|FG000|Overall Study|Withdrawal by Subject|45|||
148997961|NCT05072080|537467642|FG001|Overall Study|Withdrawal by Subject|30|||
148997962|NCT05072080|537467643|FG002|Overall Study|Withdrawal by Subject|27|||
148997963|NCT05072080|537467644|FG003|Overall Study|Withdrawal by Subject|7|||
148997964|NCT05072080|537467641|FG000|Overall Study|Sponsor Decision|0|||
148997965|NCT05072080|537467642|FG001|Overall Study|Sponsor Decision|1|||
148997966|NCT05072080|537467643|FG002|Overall Study|Sponsor Decision|0|||
148997967|NCT05072080|537467644|FG003|Overall Study|Sponsor Decision|0|||
148997968|NCT05072080|537467641|FG000|Overall Study|Subject moved|1|||
148997969|NCT05072080|537467642|FG001|Overall Study|Subject moved|3|||
148997970|NCT05072080|537467643|FG002|Overall Study|Subject moved|5|||
148997971|NCT05072080|537467644|FG003|Overall Study|Subject moved|2|||
148997972|NCT05072080|537467641|FG000|Overall Study|Withdrawal by parent|0|||
148997973|NCT05072080|537467642|FG001|Overall Study|Withdrawal by parent|0|||
148997974|NCT05072080|537467643|FG002|Overall Study|Withdrawal by parent|1|||
148997975|NCT05072080|537467644|FG003|Overall Study|Withdrawal by parent|0|||
148997976|NCT05072080|537467641|FG000|Overall Study|Subject was deployed|0|||
148997977|NCT05072080|537467642|FG001|Overall Study|Subject was deployed|1|||
148997978|NCT05072080|537467643|FG002|Overall Study|Subject was deployed|0|||
148997979|NCT05072080|537467644|FG003|Overall Study|Subject was deployed|0|||
148997980|NCT05072080|537467641|FG000|Overall Study|Subject left site without receiving dose|0|||
148997981|NCT05072080|537467642|FG001|Overall Study|Subject left site without receiving dose|1|||
148997982|NCT05072080|537467643|FG002|Overall Study|Subject left site without receiving dose|0|||
148997983|NCT05072080|537467644|FG003|Overall Study|Subject left site without receiving dose|0|||
148997984|NCT05072080|537467641|FG000|Overall Study|Subject incarcerated|0|||
148997985|NCT05072080|537467642|FG001|Overall Study|Subject incarcerated|1|||
148997986|NCT05072080|537467643|FG002|Overall Study|Subject incarcerated|0|||
148997987|NCT05072080|537467644|FG003|Overall Study|Subject incarcerated|1|||
148997988|NCT05072080|537467641|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
148997989|NCT05072080|537467642|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
148997990|NCT05072080|537467643|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
148997991|NCT05072080|537467644|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
148997992|NCT05072080|537467641|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
148997993|NCT05072080|537467642|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
148997994|NCT05072080|537467643|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
148997995|NCT05072080|537467644|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
148997996|NCT04867369|537467645|FG000|Overall Study|Withdrawal by Subject|1|||
148997997|NCT04867369|537467646|FG001|Overall Study|Withdrawal by Subject|0|||
148997998|NCT05554237|537467647|FG000|Part 2 (7 Days)|Adverse Event|0|||
148997999|NCT05554237|537467648|FG001|Part 2 (7 Days)|Adverse Event|0|||
148998000|NCT05554237|537467649|FG002|Part 2 (7 Days)|Adverse Event|0|||
148998001|NCT05554237|537467650|FG003|Part 2 (7 Days)|Adverse Event|0|||
148998002|NCT05554237|537467651|FG004|Part 2 (7 Days)|Adverse Event|2|||
148998003|NCT05554237|537467652|FG005|Part 2 (7 Days)|Adverse Event|0|||
148998004|NCT05554237|537467653|FG006|Part 2 (7 Days)|Adverse Event|0|||
148998005|NCT05554237|537467654|FG007|Part 2 (7 Days)|Adverse Event|0|||
148998006|NCT05554237|537467655|FG008|Part 2 (7 Days)|Adverse Event|0|||
148998007|NCT05554237|537467656|FG009|Part 2 (7 Days)|Adverse Event|1|||
148998008|NCT05554237|537467657|FG010|Part 2 (7 Days)|Adverse Event|0|||
148998009|NCT05554237|537467658|FG011|Part 2 (7 Days)|Adverse Event|0|||
148998010|NCT05554237|537467659|FG012|Part 2 (7 Days)|Adverse Event|1|||
148998011|NCT05554237|537467660|FG013|Part 2 (7 Days)|Adverse Event|0|||
148998012|NCT02477111|537467661|FG000|Overall Study|Death|28|||
148998013|NCT02477111|537467661|FG000|Overall Study|Withdrawal by Subject|19|||
148998014|NCT02477111|537467661|FG000|Overall Study|Lost to Follow-up|4|||
148998015|NCT01328574|537467665|FG000|Overall Study|Refused further treatment|1|||
148998016|NCT01152580|537467668|FG000|Overall Study|Withdrawal by Subject|0|||
148998017|NCT01152580|537467669|FG001|Overall Study|Withdrawal by Subject|1|||
148998018|NCT02275065|537467679|FG000|Overall Study|Randomized but not treated|1|||
148998019|NCT02275065|537467680|FG001|Overall Study|Randomized but not treated|0|||
148998020|NCT02275065|537467681|FG002|Overall Study|Randomized but not treated|1|||
148998021|NCT02275065|537467682|FG003|Overall Study|Randomized but not treated|1|||
148998022|NCT02275065|537467683|FG004|Overall Study|Randomized but not treated|0|||
148998023|NCT01569438|537467692|FG000|Overall Study|Lack of Efficacy|1|||
148998024|NCT01569438|537467693|FG001|Overall Study|Lack of Efficacy|2|||
148998025|NCT01569438|537467692|FG000|Overall Study|Withdrawal by Subject|0|||
148998026|NCT01569438|537467693|FG001|Overall Study|Withdrawal by Subject|3|||
148998027|NCT01569438|537467692|FG000|Overall Study|Adverse Event|2|||
148998028|NCT01569438|537467693|FG001|Overall Study|Adverse Event|15|||
148998029|NCT01569438|537467692|FG000|Overall Study|Protocol Violation|2|||
148998030|NCT01569438|537467693|FG001|Overall Study|Protocol Violation|0|||
148998031|NCT01569438|537467692|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
148998032|NCT01569438|537467693|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
148998033|NCT01569438|537467692|FG000|Overall Study|Sponsor/Physician decision|1|||
148998034|NCT01569438|537467693|FG001|Overall Study|Sponsor/Physician decision|1|||
148998035|NCT01569438|537467692|FG000|Overall Study|Unable to adhere to study schedule|0|||
148998036|NCT01569438|537467693|FG001|Overall Study|Unable to adhere to study schedule|1|||
148998037|NCT01207102|537467694|FG000|Overall Study|Withdrawal by Subject|5|||
148998038|NCT01207102|537467694|FG000|Overall Study|Adverse Event|2|||
148998039|NCT01207102|537467694|FG000|Overall Study|progression|2|||
148998040|NCT01207102|537467694|FG000|Overall Study|Withdrawal by Treating Physician|1|||
148998041|NCT00736645|537467696|FG000|Overall Study|Adverse Event|0|||
148998042|NCT00736645|537467697|FG001|Overall Study|Adverse Event|2|||
148998043|NCT00736645|537467698|FG002|Overall Study|Adverse Event|0|||
148998044|NCT00736645|537467699|FG003|Overall Study|Adverse Event|0|||
148998045|NCT04403698|537467700|FG000|Overall Study|Adverse Event|1|||
148998046|NCT04403698|537467701|FG001|Overall Study|Adverse Event|1|||
148998047|NCT04403698|537467700|FG000|Overall Study|Lost to Follow-up|1|||
148998048|NCT04403698|537467701|FG001|Overall Study|Lost to Follow-up|0|||
148998049|NCT04403698|537467700|FG000|Overall Study|Protocol Violation|0|||
148998050|NCT04403698|537467701|FG001|Overall Study|Protocol Violation|1|||
148998051|NCT00977665|537467702|FG000|Overall Study|Withdrawal by Subject|1|||
148998052|NCT00977665|537467703|FG001|Overall Study|Withdrawal by Subject|3|||
148998053|NCT00977665|537467702|FG000|Overall Study|Physician Decision|2|||
148998054|NCT00977665|537467703|FG001|Overall Study|Physician Decision|1|||
148998055|NCT00977665|537467702|FG000|Overall Study|Sponsor requested withdrawal|0|||
148998056|NCT00977665|537467703|FG001|Overall Study|Sponsor requested withdrawal|1|||
148998057|NCT00977665|537467702|FG000|Overall Study|Lost to Follow-up|1|||
148998058|NCT00977665|537467703|FG001|Overall Study|Lost to Follow-up|0|||
148998059|NCT00977665|537467702|FG000|Overall Study|Death|3|||
148998060|NCT00977665|537467703|FG001|Overall Study|Death|2|||
148998061|NCT00977665|537467702|FG000|Overall Study|Adverse Event|14|||
148998062|NCT00977665|537467703|FG001|Overall Study|Adverse Event|7|||
148998063|NCT00977665|537467702|FG000|Overall Study|Treatment failure|0|||
148998064|NCT00977665|537467703|FG001|Overall Study|Treatment failure|1|||
148998065|NCT01330433|537467704|FG000|Overall Study|Death|1|||
148998066|NCT01330433|537467705|FG001|Overall Study|Death|3|||
148998067|NCT01330433|537467704|FG000|Overall Study|Lost to Follow-up|1|||
148998068|NCT01330433|537467705|FG001|Overall Study|Lost to Follow-up|0|||
148998069|NCT04899349|537467713|FG000|Overall Study|Study terminated by Sponsor|2|||
148998070|NCT04899349|537467714|FG001|Overall Study|Study terminated by Sponsor|0|||
148998071|NCT03240692|537467715|FG000|Overall Study|Physician Decision|1|||
148998072|NCT03240692|537467715|FG000|Overall Study|Withdrawal by Subject|1|||
148998073|NCT02300220|537467716|FG000|Overall Study|Lost to Follow-up|1|||
148998074|NCT02300220|537467717|FG001|Overall Study|Lost to Follow-up|2|||
148998075|NCT02300220|537467716|FG000|Overall Study|Death|1|||
148998076|NCT02300220|537467717|FG001|Overall Study|Death|1|||
148998077|NCT02300220|537467716|FG000|Overall Study|Adverse Event|1|||
148998078|NCT02300220|537467717|FG001|Overall Study|Adverse Event|1|||
148998079|NCT02300220|537467716|FG000|Overall Study|Protocol Violation|1|||
148998080|NCT02300220|537467717|FG001|Overall Study|Protocol Violation|0|||
148998081|NCT02300220|537467716|FG000|Overall Study|Withdrawal by Subject|0|||
148998082|NCT02300220|537467717|FG001|Overall Study|Withdrawal by Subject|2|||
148998083|NCT02300220|537467716|FG000|Overall Study|Did not tolerate IMP|0|||
148998084|NCT02300220|537467717|FG001|Overall Study|Did not tolerate IMP|1|||
148998085|NCT02291614|537467718|FG000|Overall Study|Lost to Follow-up|0|||
148998086|NCT02291614|537467719|FG001|Overall Study|Lost to Follow-up|0|||
148998087|NCT02291614|537467720|FG002|Overall Study|Lost to Follow-up|0|||
148998088|NCT02291614|537467721|FG003|Overall Study|Lost to Follow-up|0|||
148998089|NCT02291614|537467722|FG004|Overall Study|Lost to Follow-up|0|||
148865882|NCT00554099|536984698|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
148865883|NCT00554099|536984696|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
148865884|NCT00554099|536984697|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
148865885|NCT00554099|536984698|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
148865886|NCT00554099|536984696|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
148865887|NCT00554099|536984697|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
148865888|NCT00554099|536984698|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
148865889|NCT00554099|536984696|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
148865890|NCT00554099|536984697|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
148865891|NCT00554099|536984698|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
148998090|NCT02291614|537467723|FG005|Overall Study|Lost to Follow-up|0|||
148998091|NCT02291614|537467724|FG006|Overall Study|Lost to Follow-up|0|||
148998092|NCT02291614|537467725|FG007|Overall Study|Lost to Follow-up|1|||
148998093|NCT02291614|537467726|FG008|Overall Study|Lost to Follow-up|0|||
148865892|NCT00554099|536984696|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
148865893|NCT00554099|536984697|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
148865894|NCT00554099|536984698|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
148865895|NCT00554099|536984696|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
148865896|NCT00554099|536984697|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
148865897|NCT00554099|536984698|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
148865898|NCT00554099|536984696|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
148865899|NCT00554099|536984697|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
148865900|NCT00554099|536984698|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
148865901|NCT00554099|536984696|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
148865902|NCT00554099|536984697|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
148865903|NCT00554099|536984698|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
148865904|NCT00554099|536984696|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
148865905|NCT00554099|536984697|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
148865906|NCT00554099|536984698|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
148865907|NCT02075632|536984699|FG000|Overall Study|Adverse Event|1|||
148865908|NCT02075632|536984700|FG001|Overall Study|Adverse Event|1|||
148865909|NCT02075632|536984699|FG000|Overall Study|Lost to Follow-up|0|||
148865910|NCT02075632|536984700|FG001|Overall Study|Lost to Follow-up|3|||
148865911|NCT02075632|536984699|FG000|Overall Study|Withdrawal by Subject|0|||
148865912|NCT02075632|536984700|FG001|Overall Study|Withdrawal by Subject|1|||
148865913|NCT03464422|536984704|FG000|Overall Study|Lost to Follow-up|2|||
148865914|NCT03464422|536984704|FG000|Overall Study|Withdrawal by Subject|2|||
148865915|NCT02312219|536984710|FG000|Overall Study|Withdrawal by Subject|1|||
148865916|NCT02312219|536984711|FG001|Overall Study|Withdrawal by Subject|2|||
148865917|NCT02312219|536984710|FG000|Overall Study|could not schedule imaging in time|0|||
148865918|NCT02312219|536984711|FG001|Overall Study|could not schedule imaging in time|2|||
148865919|NCT02312219|536984710|FG000|Overall Study|Other|0|||
148865920|NCT02312219|536984711|FG001|Overall Study|Other|1|||
148865921|NCT02312219|536984710|FG000|Overall Study|Not randomized. Ineligible|0|||
148865922|NCT02312219|536984711|FG001|Overall Study|Not randomized. Ineligible|1|||
148865923|NCT01591863|536984714|FG000|Overall Study|Adverse Event|3|||
148865924|NCT01591863|536984714|FG000|Overall Study|Withdrawal by Subject|1|||
148865925|NCT01591863|536984714|FG000|Overall Study|recurrence|9|||
148865926|NCT01591863|536984714|FG000|Overall Study|Lack of Efficacy|1|||
148865927|NCT02366767|536984717|FG000|Overall Study|left for home after 1 day at camp|1|||
148865928|NCT02366767|536984718|FG001|Overall Study|left for home after 1 day at camp|0|||
148865929|NCT02558400|536984719|FG000|Overall Study|Adverse Event|47|||
148865930|NCT02558400|536984720|FG001|Overall Study|Adverse Event|53|||
148865931|NCT02558400|536984721|FG002|Overall Study|Adverse Event|4|||
148865932|NCT02558400|536984719|FG000|Overall Study|Withdrawal by Subject|13|||
148865933|NCT02558400|536984720|FG001|Overall Study|Withdrawal by Subject|9|||
148865934|NCT02558400|536984721|FG002|Overall Study|Withdrawal by Subject|8|||
148865935|NCT02558400|536984719|FG000|Overall Study|Non-Compliant|0|||
148865936|NCT02558400|536984720|FG001|Overall Study|Non-Compliant|1|||
148865937|NCT02558400|536984721|FG002|Overall Study|Non-Compliant|3|||
148865938|NCT02558400|536984719|FG000|Overall Study|Lost to Follow-up|5|||
148865939|NCT02558400|536984720|FG001|Overall Study|Lost to Follow-up|5|||
148865940|NCT02558400|536984721|FG002|Overall Study|Lost to Follow-up|4|||
148865941|NCT02558400|536984719|FG000|Overall Study|Lack of Efficacy|0|||
148998094|NCT02291614|537467727|FG009|Overall Study|Lost to Follow-up|0|||
148998095|NCT02291614|537467728|FG010|Overall Study|Lost to Follow-up|0|||
148998096|NCT02291614|537467718|FG000|Overall Study|Withdrawal by Subject|0|||
148865942|NCT02558400|536984720|FG001|Overall Study|Lack of Efficacy|13|||
148865943|NCT02558400|536984721|FG002|Overall Study|Lack of Efficacy|1|||
148865944|NCT02558400|536984719|FG000|Overall Study|Disallowed Concurrent Medication|6|||
148865945|NCT02558400|536984720|FG001|Overall Study|Disallowed Concurrent Medication|7|||
148865946|NCT02558400|536984721|FG002|Overall Study|Disallowed Concurrent Medication|5|||
148865947|NCT02558400|536984719|FG000|Overall Study|Physician Decision|2|||
148865948|NCT02558400|536984720|FG001|Overall Study|Physician Decision|2|||
148998097|NCT02291614|537467719|FG001|Overall Study|Withdrawal by Subject|1|||
148998098|NCT02291614|537467720|FG002|Overall Study|Withdrawal by Subject|0|||
148998099|NCT02291614|537467721|FG003|Overall Study|Withdrawal by Subject|0|||
148998100|NCT02291614|537467722|FG004|Overall Study|Withdrawal by Subject|0|||
148998101|NCT02291614|537467723|FG005|Overall Study|Withdrawal by Subject|0|||
148998102|NCT02291614|537467724|FG006|Overall Study|Withdrawal by Subject|0|||
148998103|NCT02291614|537467725|FG007|Overall Study|Withdrawal by Subject|0|||
148998104|NCT02291614|537467726|FG008|Overall Study|Withdrawal by Subject|0|||
148998105|NCT02291614|537467727|FG009|Overall Study|Withdrawal by Subject|2|||
148998106|NCT02291614|537467728|FG010|Overall Study|Withdrawal by Subject|2|||
148998107|NCT02291614|537467718|FG000|Overall Study|Decision by sponsor|0|||
148998108|NCT02291614|537467719|FG001|Overall Study|Decision by sponsor|0|||
148998109|NCT02291614|537467720|FG002|Overall Study|Decision by sponsor|0|||
148998110|NCT02291614|537467721|FG003|Overall Study|Decision by sponsor|1|||
148998111|NCT02291614|537467722|FG004|Overall Study|Decision by sponsor|0|||
148998112|NCT02291614|537467723|FG005|Overall Study|Decision by sponsor|0|||
148998113|NCT02291614|537467724|FG006|Overall Study|Decision by sponsor|0|||
148998114|NCT02291614|537467725|FG007|Overall Study|Decision by sponsor|0|||
148998115|NCT02291614|537467726|FG008|Overall Study|Decision by sponsor|0|||
148998116|NCT02291614|537467727|FG009|Overall Study|Decision by sponsor|0|||
148998117|NCT02291614|537467728|FG010|Overall Study|Decision by sponsor|0|||
148998118|NCT02291614|537467718|FG000|Overall Study|Death|0|||
148998119|NCT02291614|537467719|FG001|Overall Study|Death|0|||
148998120|NCT02291614|537467720|FG002|Overall Study|Death|1|||
148998121|NCT02291614|537467721|FG003|Overall Study|Death|0|||
148998122|NCT02291614|537467722|FG004|Overall Study|Death|1|||
148998123|NCT02291614|537467723|FG005|Overall Study|Death|1|||
148998124|NCT02291614|537467724|FG006|Overall Study|Death|1|||
148998125|NCT02291614|537467725|FG007|Overall Study|Death|0|||
148998126|NCT02291614|537467726|FG008|Overall Study|Death|0|||
148998127|NCT02291614|537467727|FG009|Overall Study|Death|0|||
148998128|NCT02291614|537467728|FG010|Overall Study|Death|0|||
148998129|NCT02432105|537467732|FG000|Overall Study|Lost to Follow-up|1|||
148998130|NCT02432105|537467733|FG001|Overall Study|Lost to Follow-up|1|||
148998131|NCT02432105|537467734|FG002|Overall Study|Lost to Follow-up|0|||
148998132|NCT02432105|537467732|FG000|Overall Study|Withdrawal by Subject|1|||
148998133|NCT02432105|537467733|FG001|Overall Study|Withdrawal by Subject|0|||
148998134|NCT02432105|537467734|FG002|Overall Study|Withdrawal by Subject|1|||
148998135|NCT02432105|537467732|FG000|Overall Study|Culture positive for yeast|0|||
148998136|NCT02432105|537467733|FG001|Overall Study|Culture positive for yeast|1|||
148998137|NCT02432105|537467734|FG002|Overall Study|Culture positive for yeast|0|||
148998138|NCT02432105|537467732|FG000|Overall Study|Randomized in error|0|||
148998139|NCT02432105|537467733|FG001|Overall Study|Randomized in error|0|||
148998140|NCT02432105|537467734|FG002|Overall Study|Randomized in error|2|||
148998141|NCT02012491|537467739|FG000|Overall Study|Lost to Follow-up|1|||
148998142|NCT02012491|537467740|FG001|Overall Study|Lost to Follow-up|0|||
148998143|NCT02012491|537467739|FG000|Overall Study|Protocol Violation|0|||
148998144|NCT02012491|537467740|FG001|Overall Study|Protocol Violation|1|||
148998145|NCT02012491|537467739|FG000|Overall Study|Withdrawal by Subject|1|||
148998146|NCT02012491|537467740|FG001|Overall Study|Withdrawal by Subject|0|||
148998147|NCT05608629|537467751|FG000|Overall Study|Lost to Follow-up|2|||
148998148|NCT03969719|537467752|FG000|Overall Study|Other reasons not specified|1|||
148998149|NCT03969719|537467753|FG001|Overall Study|Other reasons not specified|1|||
148998150|NCT03969719|537467754|FG002|Overall Study|Other reasons not specified|3|||
148998151|NCT03969719|537467752|FG000|Overall Study|Withdrawal by Subject|2|||
148998152|NCT03969719|537467753|FG001|Overall Study|Withdrawal by Subject|3|||
148998153|NCT03969719|537467754|FG002|Overall Study|Withdrawal by Subject|2|||
148998154|NCT03969719|537467752|FG000|Overall Study|Protocol Violation|1|||
148998155|NCT03969719|537467753|FG001|Overall Study|Protocol Violation|2|||
148998156|NCT03969719|537467754|FG002|Overall Study|Protocol Violation|0|||
148998157|NCT03969719|537467752|FG000|Overall Study|Adverse Event|0|||
148998158|NCT03969719|537467753|FG001|Overall Study|Adverse Event|2|||
148998159|NCT03969719|537467754|FG002|Overall Study|Adverse Event|0|||
148998160|NCT03969719|537467752|FG000|Overall Study|Lost to Follow-up|0|||
148998161|NCT03969719|537467753|FG001|Overall Study|Lost to Follow-up|1|||
148998162|NCT03969719|537467754|FG002|Overall Study|Lost to Follow-up|0|||
148998163|NCT02130193|537467755|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
148998164|NCT02130193|537467756|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
148998165|NCT02130193|537467757|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
148998166|NCT02130193|537467755|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
148998167|NCT02130193|537467756|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
148998168|NCT02130193|537467757|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
148998169|NCT02130193|537467755|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
148998170|NCT02130193|537467756|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
148998171|NCT02130193|537467757|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
148998172|NCT02130193|537467755|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
148998173|NCT02130193|537467756|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
148998174|NCT02130193|537467757|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
148998175|NCT01266642|537467758|FG000|Overall Study|Protocol Violation|0|||
148998176|NCT01266642|537467759|FG001|Overall Study|Protocol Violation|1|||
148998177|NCT01266850|537469581|FG000|Overall Study|Lost to Follow-up|19|||
148998178|NCT01266850|537469582|FG001|Overall Study|Lost to Follow-up|19|||
148998179|NCT01266850|537469583|FG002|Overall Study|Lost to Follow-up|13|||
148998180|NCT01266850|537469584|FG003|Overall Study|Lost to Follow-up|13|||
148998181|NCT01266850|537469585|FG004|Overall Study|Lost to Follow-up|12|||
148998182|NCT01266850|537469581|FG000|Overall Study|Withdrawal by Subject|8|||
148998183|NCT01266850|537469582|FG001|Overall Study|Withdrawal by Subject|9|||
148998184|NCT01266850|537469583|FG002|Overall Study|Withdrawal by Subject|6|||
148998185|NCT01266850|537469584|FG003|Overall Study|Withdrawal by Subject|9|||
148998186|NCT01266850|537469585|FG004|Overall Study|Withdrawal by Subject|12|||
148998187|NCT01266850|537469581|FG000|Overall Study|Physician Decision|3|||
148998188|NCT01266850|537469582|FG001|Overall Study|Physician Decision|6|||
148998189|NCT01266850|537469583|FG002|Overall Study|Physician Decision|4|||
148998190|NCT01266850|537469584|FG003|Overall Study|Physician Decision|4|||
148998191|NCT01266850|537469585|FG004|Overall Study|Physician Decision|3|||
148998192|NCT01266850|537469581|FG000|Overall Study|Protocol Violation|0|||
148998193|NCT01266850|537469582|FG001|Overall Study|Protocol Violation|1|||
148998194|NCT01266850|537469583|FG002|Overall Study|Protocol Violation|0|||
148998195|NCT01266850|537469584|FG003|Overall Study|Protocol Violation|1|||
148998196|NCT01266850|537469585|FG004|Overall Study|Protocol Violation|2|||
148998197|NCT01266850|537469581|FG000|Overall Study|Adverse Event|0|||
148998198|NCT01266850|537469582|FG001|Overall Study|Adverse Event|0|||
148998199|NCT01266850|537469583|FG002|Overall Study|Adverse Event|0|||
148998200|NCT01266850|537469584|FG003|Overall Study|Adverse Event|0|||
148998201|NCT01266850|537469585|FG004|Overall Study|Adverse Event|1|||
148998202|NCT01266850|537469581|FG000|Overall Study|Site Closure|0|||
148998203|NCT01266850|537469582|FG001|Overall Study|Site Closure|1|||
148998204|NCT01266850|537469583|FG002|Overall Study|Site Closure|1|||
148998205|NCT01266850|537469584|FG003|Overall Study|Site Closure|1|||
148998206|NCT01266850|537469585|FG004|Overall Study|Site Closure|0|||
148998207|NCT04128293|537469587|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
148998208|NCT04128293|537469588|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
148998209|NCT04128293|537469589|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
148998210|NCT04128293|537469590|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
148998211|NCT02035332|537469591|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
148998212|NCT00833560|537469597|FG000|Overall Study|Toxicity|13|||
148998213|NCT00833560|537469597|FG000|Overall Study|Adverse Event|11|||
148998214|NCT00833560|537469597|FG000|Overall Study|Protocol Violation|6|||
148998215|NCT00833560|537469597|FG000|Overall Study|Lack of Efficacy|4|||
148998216|NCT00833560|537469597|FG000|Overall Study|Death|2|||
148998217|NCT00833560|537469597|FG000|Overall Study|Pregression of other disease|1|||
148998218|NCT00833560|537469597|FG000|Overall Study|Other|5|||
148998219|NCT00499031|537469598|FG000|Overall Study|Improper pre-protocol treatment|1|||
148998220|NCT00499031|537469598|FG000|Overall Study|Required test not done|1|||
148998221|NCT00499031|537469598|FG000|Overall Study|Never treated|1|||
148998222|NCT03382782|537469603|FG000|Cohort 1|Withdrawal by Subject|11|||
148998223|NCT03382782|537469604|FG001|Cohort 1|Withdrawal by Subject|5|||
148998224|NCT03382782|537469605|FG002|Cohort 1|Withdrawal by Subject|0|||
148998225|NCT03382782|537469603|FG000|Cohort 2|Withdrawal by Subject|1|||
148998226|NCT03382782|537469604|FG001|Cohort 2|Withdrawal by Subject|1|||
148998227|NCT03382782|537469605|FG002|Cohort 2|Withdrawal by Subject|0|||
148998228|NCT03382782|537469603|FG000|Cohort 3|Withdrawal by Subject|1|||
148998229|NCT03382782|537469604|FG001|Cohort 3|Withdrawal by Subject|2|||
148998230|NCT03382782|537469605|FG002|Cohort 3|Withdrawal by Subject|0|||
148998231|NCT03409666|537469610|FG000|Overall Study|Physician Decision|0|||
148998232|NCT03409666|537469611|FG001|Overall Study|Physician Decision|1|||
148998233|NCT03409666|537469610|FG000|Overall Study|Protocol Violation|0|||
148998234|NCT03409666|537469611|FG001|Overall Study|Protocol Violation|3|||
148998235|NCT01791725|537469612|FG000|Overall Study|Withdrawal by Subject|0|||
148998236|NCT01791725|537469613|FG001|Overall Study|Withdrawal by Subject|1|||
148998237|NCT01791725|537469614|FG002|Overall Study|Withdrawal by Subject|0|||
148998238|NCT00512148|537469615|FG000|Primay Study Period|Withdrawal by Subject|1|||
148998239|NCT01666951|537469622|FG000|Overall Study|Not dosed|1|||
148998240|NCT01666951|537469623|FG001|Overall Study|Not dosed|1|||
148998241|NCT02366910|537469624|FG000|Overall Study|Withdrawal by Subject|2|||
148998242|NCT02366910|537469624|FG000|Overall Study|Screen Failure|3|||
148998243|NCT02623322|537469625|FG000|Overall Study|Lost to Follow-up|2|||
148998244|NCT02623322|537469626|FG001|Overall Study|Lost to Follow-up|1|||
148998245|NCT02623322|537469627|FG002|Overall Study|Lost to Follow-up|0|||
148998246|NCT03284788|537469628|FG000|Overall Study|Withdrawal by Subject|2|||
148998247|NCT03563716|537469629|FG000|Overall Study|Death|20|||
148998248|NCT03563716|537469630|FG001|Overall Study|Death|14|||
148998249|NCT03563716|537469629|FG000|Overall Study|Withdrawal by Subject|3|||
148998250|NCT03563716|537469630|FG001|Overall Study|Withdrawal by Subject|3|||
148998251|NCT03563716|537469629|FG000|Overall Study|Still on Study|45|||
148998252|NCT03563716|537469630|FG001|Overall Study|Still on Study|50|||
148998253|NCT02583425|537469631|FG000|Screening|Did not meet entry criteria|12|||
148998254|NCT02583425|537469631|FG000|Baseline|Did not meet continued criteria|5|||
148998255|NCT02583425|537469631|FG000|Treatment Period|Adverse Event|1|||
148998256|NCT02157779|537469636|FG000|Overall Study|Logistical|9|||
148998257|NCT02157779|537469637|FG001|Overall Study|Logistical|3|||
148998258|NCT02157779|537469636|FG000|Overall Study|Stopped attending, reason unknown|11|||
148998259|NCT02157779|537469637|FG001|Overall Study|Stopped attending, reason unknown|7|||
148998260|NCT02157779|537469636|FG000|Overall Study|No response to outreach after Baseline|1|||
148998261|NCT02157779|537469637|FG001|Overall Study|No response to outreach after Baseline|1|||
148998262|NCT02157779|537469636|FG000|Overall Study|Moved|1|||
148998263|NCT02157779|537469637|FG001|Overall Study|Moved|0|||
148998264|NCT02157779|537469636|FG000|Overall Study|Medical|1|||
148998265|NCT02157779|537469637|FG001|Overall Study|Medical|0|||
148998266|NCT02157779|537469636|FG000|Overall Study|Legal issue|1|||
148998267|NCT02157779|537469637|FG001|Overall Study|Legal issue|0|||
148998268|NCT01292876|537469639|FG000|Overall Study|Physician Decision|4|||
148998269|NCT04528069|537469642|FG000|Overall Study|Adverse Event|1|||
148998270|NCT04528069|537469642|FG000|Overall Study|Lost to Follow-up|1|||
148998271|NCT04528069|537469642|FG000|Overall Study|Patient Unable to Come|1|||
148998272|NCT04528069|537469642|FG000|Overall Study|Patient Unable to Attend|1|||
148998273|NCT02525874|537469643|FG000|Overall Study|Other|1|||
148998274|NCT02525874|537469643|FG000|Overall Study|Investigator Decision|1|||
148998275|NCT02525874|537469643|FG000|Overall Study|Consent withdrawn|22|||
148998276|NCT02525874|537469643|FG000|Overall Study|Non-compliance with study drug|3|||
148998277|NCT02525874|537469643|FG000|Overall Study|Adverse Event|17|||
148998278|NCT02525874|537469643|FG000|Overall Study|Lost to Follow-up|7|||
148998279|NCT02525874|537469643|FG000|Overall Study|Disease progression, defined by protocol|2|||
148998280|NCT02525874|537469643|FG000|Overall Study|Disease relapse|4|||
148998281|NCT02525874|537469643|FG000|Overall Study|Alternative Treatment for MS|2|||
148998282|NCT02525874|537469643|FG000|Overall Study|New lesions in Brain|1|||
148998283|NCT01814371|537469644|FG000|Overall Study|Lost to Follow-up|30|||
148998284|NCT01814371|537469645|FG001|Overall Study|Lost to Follow-up|27|||
148998285|NCT01692782|537469646|FG000|Overall Study|Adverse Event|12|||
148998286|NCT01692782|537469647|FG001|Overall Study|Adverse Event|32|||
148998287|NCT01692782|537469648|FG002|Overall Study|Adverse Event|2|||
148998288|NCT01692782|537469646|FG000|Overall Study|Lack of Efficacy|1|||
148998289|NCT01692782|537469647|FG001|Overall Study|Lack of Efficacy|2|||
148998290|NCT01692782|537469648|FG002|Overall Study|Lack of Efficacy|0|||
148998291|NCT01692782|537469646|FG000|Overall Study|Lost to Follow-up|2|||
148998292|NCT01692782|537469647|FG001|Overall Study|Lost to Follow-up|7|||
148998293|NCT01692782|537469648|FG002|Overall Study|Lost to Follow-up|1|||
148998294|NCT01692782|537469646|FG000|Overall Study|Pregnancy|1|||
148998295|NCT01692782|537469647|FG001|Overall Study|Pregnancy|0|||
148998296|NCT01692782|537469648|FG002|Overall Study|Pregnancy|0|||
148998297|NCT01692782|537469646|FG000|Overall Study|Protocol Violation|1|||
148998298|NCT01692782|537469647|FG001|Overall Study|Protocol Violation|0|||
148998299|NCT01692782|537469648|FG002|Overall Study|Protocol Violation|2|||
148998300|NCT01692782|537469646|FG000|Overall Study|Non-complance with study drug|0|||
148998301|NCT01692782|537469647|FG001|Overall Study|Non-complance with study drug|4|||
148998302|NCT01692782|537469648|FG002|Overall Study|Non-complance with study drug|1|||
148998303|NCT01692782|537469646|FG000|Overall Study|Non-compliant with study visits|0|||
148998304|NCT01692782|537469647|FG001|Overall Study|Non-compliant with study visits|0|||
148998305|NCT01692782|537469648|FG002|Overall Study|Non-compliant with study visits|1|||
148998306|NCT01692782|537469646|FG000|Overall Study|SAE not related to study drug|0|||
148998307|NCT01692782|537469647|FG001|Overall Study|SAE not related to study drug|1|||
148998308|NCT01692782|537469648|FG002|Overall Study|SAE not related to study drug|0|||
148998309|NCT01692782|537469646|FG000|Overall Study|Withdrawal by Subject|3|||
148998310|NCT01692782|537469647|FG001|Overall Study|Withdrawal by Subject|10|||
148998311|NCT01692782|537469648|FG002|Overall Study|Withdrawal by Subject|3|||
148998312|NCT03945188|537469652|FG000|Overall Study|Protocol Violation|1|||
148998313|NCT03945188|537469653|FG001|Overall Study|Protocol Violation|0|||
148998314|NCT03945188|537469652|FG000|Overall Study|Disease worsening|79|||
148998315|NCT03945188|537469653|FG001|Overall Study|Disease worsening|73|||
148998316|NCT03945188|537469652|FG000|Overall Study|Physician Decision|2|||
148998317|NCT03945188|537469653|FG001|Overall Study|Physician Decision|2|||
148998318|NCT03945188|537469652|FG000|Overall Study|Lack of Efficacy|7|||
148998319|NCT03945188|537469653|FG001|Overall Study|Lack of Efficacy|4|||
148998320|NCT03945188|537469652|FG000|Overall Study|Pregnancy|2|||
148998321|NCT03945188|537469653|FG001|Overall Study|Pregnancy|0|||
148998322|NCT03945188|537469652|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
148998323|NCT03945188|537469653|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
148998324|NCT03945188|537469652|FG000|Overall Study|Adverse Event|10|||
148998325|NCT03945188|537469653|FG001|Overall Study|Adverse Event|5|||
148998326|NCT03945188|537469652|FG000|Overall Study|Other|2|||
148998327|NCT03945188|537469653|FG001|Overall Study|Other|2|||
148998328|NCT03945188|537469652|FG000|Overall Study|Lost to Follow-up|1|||
148998329|NCT03945188|537469653|FG001|Overall Study|Lost to Follow-up|2|||
148998330|NCT00338884|537469663|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
148998331|NCT00338884|537469663|FG000|Overall Study|Adverse Event|14|||
148998332|NCT00338884|537469663|FG000|Overall Study|Death|8|||
148865949|NCT02558400|536984721|FG002|Overall Study|Physician Decision|0|||
148865950|NCT02558400|536984719|FG000|Overall Study|Protocol Violation|6|||
148865951|NCT02558400|536984720|FG001|Overall Study|Protocol Violation|3|||
148865952|NCT02558400|536984721|FG002|Overall Study|Protocol Violation|8|||
148865953|NCT02558400|536984719|FG000|Overall Study|Death|0|||
148865954|NCT02558400|536984720|FG001|Overall Study|Death|1|||
148865955|NCT02558400|536984721|FG002|Overall Study|Death|0|||
148865956|NCT02558400|536984719|FG000|Overall Study|Ineligible for the study|0|||
148865957|NCT02558400|536984720|FG001|Overall Study|Ineligible for the study|2|||
148865958|NCT02558400|536984721|FG002|Overall Study|Ineligible for the study|0|||
148865959|NCT00456599|536984722|FG000|Overall Study|Non-compliance|1|||
148865960|NCT00456599|536984722|FG000|Overall Study|Withdrawal by Subject|2|||
148865961|NCT00734071|536987184|FG000|Overall Study|Adverse Event|4|||
148865962|NCT00734071|536987185|FG001|Overall Study|Adverse Event|3|||
148865963|NCT00734071|536987184|FG000|Overall Study|Lack of Efficacy|3|||
148865964|NCT00734071|536987185|FG001|Overall Study|Lack of Efficacy|1|||
148865965|NCT00734071|536987184|FG000|Overall Study|Noncompliance|2|||
148865966|NCT00734071|536987185|FG001|Overall Study|Noncompliance|2|||
148865967|NCT00734071|536987184|FG000|Overall Study|Protocol Deviations|3|||
148865968|NCT00734071|536987185|FG001|Overall Study|Protocol Deviations|4|||
148865969|NCT00734071|536987184|FG000|Overall Study|Voluntary Withdrawal|9|||
148865970|NCT00734071|536987185|FG001|Overall Study|Voluntary Withdrawal|7|||
148865971|NCT00734071|536987184|FG000|Overall Study|Lost to Follow-up|16|||
148865972|NCT00734071|536987185|FG001|Overall Study|Lost to Follow-up|8|||
148865973|NCT00734071|536987184|FG000|Overall Study|Other|1|||
148865974|NCT00734071|536987185|FG001|Overall Study|Other|2|||
148865975|NCT00240110|536987189|FG000|Overall Study|Lost to Follow-up|6|||
148865976|NCT00240110|536987190|FG001|Overall Study|Lost to Follow-up|7|||
148865977|NCT00583791|536987191|FG000|Overall Study|Other|67|||
148865978|NCT00583791|536987191|FG000|Overall Study|Death|6|||
148865979|NCT00203021|536987192|FG000|Overall Study|Death|4|||
148865980|NCT00203021|536987193|FG001|Overall Study|Death|1|||
148865981|NCT00203021|536987192|FG000|Overall Study|Adverse Event|10|||
148865982|NCT00203021|536987193|FG001|Overall Study|Adverse Event|5|||
148865983|NCT00203021|536987192|FG000|Overall Study|Withdrawal by Subject|45|||
148865984|NCT00203021|536987193|FG001|Overall Study|Withdrawal by Subject|48|||
148865985|NCT00203021|536987192|FG000|Overall Study|Lost to Follow-up|9|||
148865986|NCT00203021|536987193|FG001|Overall Study|Lost to Follow-up|7|||
148865987|NCT00203021|536987192|FG000|Overall Study|Other than specified|11|||
148865988|NCT00203021|536987193|FG001|Overall Study|Other than specified|16|||
148865989|NCT02080260|536987195|FG000|Overall Study|Death|18|||
148865990|NCT02080260|536987195|FG000|Overall Study|Withdrawal by Subject|1|||
148865991|NCT03204890|536987200|FG000|Overall Study|Withdrawal by Subject|1|||
148865992|NCT03769311|536987201|FG000|Overall Study|Withdrawal by Subject|1|||
148865993|NCT02853435|536987202|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
148865994|NCT02853435|536987203|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
148865995|NCT02853435|536987204|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
148865996|NCT02853435|536987205|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
148865997|NCT02853435|536987206|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
148865998|NCT02853435|536987207|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
148865999|NCT03747120|536987208|FG000|Overall Study|treatment related toxicity|3|||
148866000|NCT03747120|536987209|FG001|Overall Study|treatment related toxicity|0|||
148866001|NCT03747120|536987210|FG002|Overall Study|treatment related toxicity|0|||
148866002|NCT03747120|536987208|FG000|Overall Study|Withdrawal by Subject|0|||
148866003|NCT03747120|536987209|FG001|Overall Study|Withdrawal by Subject|1|||
148866004|NCT03747120|536987210|FG002|Overall Study|Withdrawal by Subject|2|||
148866005|NCT03627065|536987211|FG000|Overall Study|Study Terminated by sponsor|1|||
148866006|NCT03627065|536987211|FG000|Overall Study|Withdrawal by Subject|2|||
148866007|NCT00996801|536987218|FG000|Overall Study|Adverse Event|6|||
148866008|NCT00996801|536987219|FG001|Overall Study|Adverse Event|4|||
148866009|NCT00996801|536987220|FG002|Overall Study|Adverse Event|12|||
148866010|NCT00996801|536987221|FG003|Overall Study|Adverse Event|17|||
148998333|NCT00338884|537469663|FG000|Overall Study|Other|4|||
148998334|NCT00338884|537469663|FG000|Overall Study|Global Deterioration of Health Status|3|||
148998335|NCT00338884|537469663|FG000|Overall Study|Withdrawal by Subject|3|||
148866011|NCT00996801|536987222|FG004|Overall Study|Adverse Event|31|||
148866012|NCT00996801|536987223|FG005|Overall Study|Adverse Event|3|||
148866013|NCT00996801|536987218|FG000|Overall Study|Lack of Efficacy|3|||
148866014|NCT00996801|536987219|FG001|Overall Study|Lack of Efficacy|0|||
148866015|NCT00996801|536987220|FG002|Overall Study|Lack of Efficacy|1|||
148866016|NCT00996801|536987221|FG003|Overall Study|Lack of Efficacy|3|||
148866017|NCT00996801|536987222|FG004|Overall Study|Lack of Efficacy|0|||
148998336|NCT00338884|537469663|FG000|Overall Study|Lost to Follow-up|1|||
148866018|NCT00996801|536987223|FG005|Overall Study|Lack of Efficacy|1|||
148866019|NCT00996801|536987218|FG000|Overall Study|Lost to Follow-up|0|||
148866020|NCT00996801|536987219|FG001|Overall Study|Lost to Follow-up|0|||
148866021|NCT00996801|536987220|FG002|Overall Study|Lost to Follow-up|0|||
148866022|NCT00996801|536987221|FG003|Overall Study|Lost to Follow-up|3|||
148998337|NCT00338884|537469663|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
148998338|NCT02355002|537469664|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
148998339|NCT02355002|537469665|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
148998340|NCT02355002|537469664|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
148998341|NCT02355002|537469665|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
148998342|NCT02355002|537469664|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
148998343|NCT02355002|537469665|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
148998344|NCT02355002|537469664|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
148998345|NCT02355002|537469665|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
148998346|NCT02355002|537469664|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
148998347|NCT02355002|537469665|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
148998348|NCT02355002|537469664|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
148998349|NCT02355002|537469665|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
148998350|NCT02355002|537469664|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
148998351|NCT02355002|537469665|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
148998352|NCT04575051|537469671|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
148998353|NCT04575051|537469672|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
148998354|NCT04575051|537469673|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
148998355|NCT04575051|537469674|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
148998356|NCT04575051|537469675|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
148998357|NCT04575051|537469671|FG000|Time Period 1|Missing follow up|1|||
148998358|NCT04575051|537469672|FG001|Time Period 1|Missing follow up|3|||
148998359|NCT04575051|537469673|FG002|Time Period 1|Missing follow up|1|||
148998360|NCT04575051|537469674|FG003|Time Period 1|Missing follow up|3|||
148998361|NCT04575051|537469675|FG004|Time Period 1|Missing follow up|2|||
148998362|NCT04575051|537469671|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
148998363|NCT04575051|537469672|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
148998364|NCT04575051|537469673|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
148998365|NCT04575051|537469674|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
148998366|NCT04575051|537469675|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
148998367|NCT04575051|537469671|FG000|Time Period 2|Missing follow up|1|||
148998368|NCT04575051|537469672|FG001|Time Period 2|Missing follow up|8|||
148998369|NCT04575051|537469673|FG002|Time Period 2|Missing follow up|7|||
148998370|NCT04575051|537469674|FG003|Time Period 2|Missing follow up|0|||
148998371|NCT04575051|537469675|FG004|Time Period 2|Missing follow up|1|||
148998372|NCT04575051|537469671|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
148998373|NCT04575051|537469672|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
149031106|NCT01981850|537591655|FG001|Open Label Extension (OLE)|Adverse Event|0|||
149031107|NCT01981850|537591656|FG002|Open Label Extension (OLE)|Adverse Event|0|||
149031108|NCT01981850|537591657|FG003|Open Label Extension (OLE)|Adverse Event|0|||
149031109|NCT01981850|537591658|FG004|Open Label Extension (OLE)|Adverse Event|0|||
149031110|NCT01981850|537591659|FG005|Open Label Extension (OLE)|Adverse Event|0|||
149031111|NCT01981850|537591660|FG006|Open Label Extension (OLE)|Adverse Event|0|||
149031112|NCT01981850|537591661|FG007|Open Label Extension (OLE)|Adverse Event|2|||
148998374|NCT04575051|537469673|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
148998375|NCT04575051|537469674|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
148998376|NCT04575051|537469675|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
148998377|NCT04575051|537469671|FG000|Time Period 3|Missing follow up|8|||
148998378|NCT04575051|537469672|FG001|Time Period 3|Missing follow up|6|||
148998379|NCT04575051|537469673|FG002|Time Period 3|Missing follow up|4|||
148998380|NCT04575051|537469674|FG003|Time Period 3|Missing follow up|3|||
148998381|NCT04575051|537469675|FG004|Time Period 3|Missing follow up|0|||
148998382|NCT04575051|537469671|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
149031113|NCT01981850|537591662|FG008|Open Label Extension (OLE)|Adverse Event|1|||
149031114|NCT01981850|537591663|FG009|Open Label Extension (OLE)|Adverse Event|8|||
148866023|NCT00996801|536987222|FG004|Overall Study|Lost to Follow-up|3|||
148866024|NCT00996801|536987223|FG005|Overall Study|Lost to Follow-up|2|||
148866025|NCT00996801|536987218|FG000|Overall Study|Physician Decision|0|||
148866026|NCT00996801|536987219|FG001|Overall Study|Physician Decision|0|||
148866027|NCT00996801|536987220|FG002|Overall Study|Physician Decision|0|||
148998383|NCT04575051|537469672|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
148998384|NCT04575051|537469673|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
148998385|NCT04575051|537469674|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
148998386|NCT04575051|537469675|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
149031115|NCT01981850|537591654|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
148866028|NCT00996801|536987221|FG003|Overall Study|Physician Decision|1|||
148998387|NCT04575051|537469671|FG000|Time Period 4|Missing follow up|17|||
148998388|NCT04575051|537469672|FG001|Time Period 4|Missing follow up|3|||
148998389|NCT04575051|537469673|FG002|Time Period 4|Missing follow up|4|||
148998390|NCT04575051|537469674|FG003|Time Period 4|Missing follow up|2|||
148998391|NCT04575051|537469675|FG004|Time Period 4|Missing follow up|1|||
148998392|NCT04575051|537469671|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
148998393|NCT04575051|537469672|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
148998394|NCT04575051|537469673|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
148998395|NCT04575051|537469674|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
148998396|NCT04575051|537469675|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
148998397|NCT04575051|537469671|FG000|Time Period 5|Missing follow up|11|||
148998398|NCT04575051|537469672|FG001|Time Period 5|Missing follow up|8|||
148998399|NCT04575051|537469673|FG002|Time Period 5|Missing follow up|12|||
148998400|NCT04575051|537469674|FG003|Time Period 5|Missing follow up|3|||
148998401|NCT04575051|537469675|FG004|Time Period 5|Missing follow up|11|||
148998402|NCT02677116|537469681|FG000|Overall Study|Adverse Event|0|||
148998403|NCT02677116|537469682|FG001|Overall Study|Adverse Event|1|||
148998404|NCT02677116|537469683|FG002|Overall Study|Adverse Event|0|||
148998405|NCT02677116|537469684|FG003|Overall Study|Adverse Event|0|||
148998406|NCT02677116|537469685|FG004|Overall Study|Adverse Event|0|||
148998407|NCT02677116|537469686|FG005|Overall Study|Adverse Event|1|||
148998408|NCT02677116|537469687|FG006|Overall Study|Adverse Event|1|||
148998409|NCT02677116|537469688|FG007|Overall Study|Adverse Event|0|||
148998410|NCT02677116|537469689|FG008|Overall Study|Adverse Event|0|||
148998411|NCT02677116|537469681|FG000|Overall Study|Physician Decision|0|||
148998412|NCT02677116|537469682|FG001|Overall Study|Physician Decision|2|||
148998413|NCT02677116|537469683|FG002|Overall Study|Physician Decision|3|||
148998414|NCT02677116|537469684|FG003|Overall Study|Physician Decision|2|||
148998415|NCT02677116|537469685|FG004|Overall Study|Physician Decision|1|||
148998416|NCT02677116|537469686|FG005|Overall Study|Physician Decision|3|||
148998417|NCT02677116|537469687|FG006|Overall Study|Physician Decision|1|||
148998418|NCT02677116|537469688|FG007|Overall Study|Physician Decision|1|||
148998419|NCT02677116|537469689|FG008|Overall Study|Physician Decision|2|||
148998420|NCT02677116|537469681|FG000|Overall Study|Withdrawal by parent or guardian|2|||
148998421|NCT02677116|537469682|FG001|Overall Study|Withdrawal by parent or guardian|1|||
148998422|NCT02677116|537469683|FG002|Overall Study|Withdrawal by parent or guardian|0|||
148998423|NCT02677116|537469684|FG003|Overall Study|Withdrawal by parent or guardian|1|||
148998424|NCT02677116|537469685|FG004|Overall Study|Withdrawal by parent or guardian|0|||
148998425|NCT02677116|537469686|FG005|Overall Study|Withdrawal by parent or guardian|0|||
148998426|NCT02677116|537469687|FG006|Overall Study|Withdrawal by parent or guardian|2|||
148998427|NCT02677116|537469688|FG007|Overall Study|Withdrawal by parent or guardian|1|||
148998428|NCT02677116|537469689|FG008|Overall Study|Withdrawal by parent or guardian|0|||
148998429|NCT02677116|537469681|FG000|Overall Study|Withdrawal by Subject|1|||
148998430|NCT02677116|537469682|FG001|Overall Study|Withdrawal by Subject|0|||
148998431|NCT02677116|537469683|FG002|Overall Study|Withdrawal by Subject|0|||
148998432|NCT02677116|537469684|FG003|Overall Study|Withdrawal by Subject|0|||
148998433|NCT02677116|537469685|FG004|Overall Study|Withdrawal by Subject|0|||
148998434|NCT02677116|537469686|FG005|Overall Study|Withdrawal by Subject|0|||
148998435|NCT02677116|537469687|FG006|Overall Study|Withdrawal by Subject|0|||
148998436|NCT02677116|537469688|FG007|Overall Study|Withdrawal by Subject|0|||
148998437|NCT02677116|537469689|FG008|Overall Study|Withdrawal by Subject|0|||
148998438|NCT03182868|537469690|FG000|Overall Study|Protocol Violation|3|||
148998439|NCT03182868|537469691|FG001|Overall Study|Protocol Violation|0|||
148998440|NCT03182868|537469692|FG002|Overall Study|Protocol Violation|4|||
148998441|NCT03182868|537469693|FG003|Overall Study|Protocol Violation|1|||
148998442|NCT03182868|537469694|FG004|Overall Study|Protocol Violation|8|||
148998443|NCT03342638|537469695|FG000|Overall Study|Withdrawal by Subject|1|||
148998444|NCT03342638|537469696|FG001|Overall Study|Withdrawal by Subject|0|||
148998445|NCT03342638|537469695|FG000|Overall Study|Physician Decision|0|||
148998446|NCT03342638|537469696|FG001|Overall Study|Physician Decision|1|||
148998447|NCT01292239|537469697|FG000|Overall Study|Other|1|||
148998448|NCT01292239|537469698|FG001|Overall Study|Other|1|||
149031116|NCT01981850|537591655|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
148998449|NCT01292239|537469697|FG000|Overall Study|Withdrawal by Subject|3|||
148998450|NCT01292239|537469698|FG001|Overall Study|Withdrawal by Subject|6|||
148998451|NCT03213158|537469699|FG000|Overall Study|Withdrawal by Subject|1|||
148998452|NCT03213158|537469699|FG000|Overall Study|Physician Decision|2|||
148998453|NCT03649230|537469700|FG000|Overall Study|Adverse Event|12|||
148998454|NCT03649230|537469700|FG000|Overall Study|Death|8|||
148998455|NCT03649230|537469700|FG000|Overall Study|Withdrawal by Subject|6|||
148998456|NCT03649230|537469700|FG000|Overall Study|Physician Decision|5|||
148998457|NCT03649230|537469700|FG000|Overall Study|Disease progression|5|||
148998458|NCT03649230|537469700|FG000|Overall Study|Switched to non-HEC|5|||
148998459|NCT03649230|537469700|FG000|Overall Study|Chemotherapy discontinued|4|||
148998460|NCT03649230|537469700|FG000|Overall Study|Received only 3 HEC cycles|4|||
148998461|NCT03649230|537469700|FG000|Overall Study|Screen Failure|3|||
148998462|NCT03649230|537469700|FG000|Overall Study|Patient stopped treatment|2|||
148998463|NCT03649230|537469700|FG000|Overall Study|Protocol Violation|1|||
148998464|NCT03649230|537469700|FG000|Overall Study|Non-compliance|1|||
148998465|NCT03649230|537469700|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
148998466|NCT01693068|537469704|FG000|Randomization Period|On-study|2|||
148998467|NCT01693068|537469705|FG001|Randomization Period|On-study|5|||
148998468|NCT01693068|537469706|FG002|Randomization Period|On-study|0|||
148998469|NCT01693068|537469704|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
149031117|NCT01981850|537591656|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
148998470|NCT01693068|537469705|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
148998471|NCT01693068|537469706|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
148998472|NCT00295022|537469709|FG000|Overall Study|Adverse Event|1|||
148998473|NCT00295022|537469710|FG001|Overall Study|Adverse Event|1|||
148998474|NCT00295022|537469711|FG002|Overall Study|Adverse Event|2|||
148998475|NCT00295022|537469709|FG000|Overall Study|Lost to Follow-up|0|||
148998476|NCT00295022|537469710|FG001|Overall Study|Lost to Follow-up|0|||
148998477|NCT00295022|537469711|FG002|Overall Study|Lost to Follow-up|1|||
148998478|NCT00295022|537469709|FG000|Overall Study|Withdrawal by Subject|0|||
148998479|NCT00295022|537469710|FG001|Overall Study|Withdrawal by Subject|0|||
148998480|NCT00295022|537469711|FG002|Overall Study|Withdrawal by Subject|2|||
148998481|NCT00734630|537469713|FG000|Overall Study|Lack of Efficacy|4|||
148998482|NCT00734630|537469714|FG001|Overall Study|Lack of Efficacy|4|||
148998483|NCT00734630|537469713|FG000|Overall Study|Withdrawal by Subject|7|||
148998484|NCT00734630|537469714|FG001|Overall Study|Withdrawal by Subject|9|||
148998485|NCT00734630|537469713|FG000|Overall Study|Lost to Follow-up|13|||
148998486|NCT00734630|537469714|FG001|Overall Study|Lost to Follow-up|7|||
148998487|NCT00734630|537469713|FG000|Overall Study|Protocol Violation|0|||
148998488|NCT00734630|537469714|FG001|Overall Study|Protocol Violation|3|||
148998489|NCT00734630|537469713|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
148998490|NCT00734630|537469714|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
148998491|NCT00734630|537469713|FG000|Overall Study|Adverse Event|3|||
148998492|NCT00734630|537469714|FG001|Overall Study|Adverse Event|6|||
148998493|NCT00734630|537469713|FG000|Overall Study|Randomized in Error|0|||
148998494|NCT00734630|537469714|FG001|Overall Study|Randomized in Error|1|||
148998495|NCT00734630|537469713|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
148998496|NCT00734630|537469714|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
148998497|NCT00734630|537469713|FG000|Overall Study|Poor Compliance|1|||
148998498|NCT00734630|537469714|FG001|Overall Study|Poor Compliance|1|||
148998499|NCT01239030|537469715|FG000|Double Blind|Adverse Event|0|||
148998500|NCT01239030|537469716|FG001|Double Blind|Adverse Event|1|||
148998501|NCT01239030|537469717|FG002|Double Blind|Adverse Event|0|||
148998502|NCT01239030|537469718|FG003|Double Blind|Adverse Event|2|||
148998503|NCT01239030|537469719|FG004|Double Blind|Adverse Event|0|||
148998504|NCT01239030|537469715|FG000|Double Blind|Withdrawal by Subject|0|||
148998505|NCT01239030|537469716|FG001|Double Blind|Withdrawal by Subject|1|||
148998506|NCT01239030|537469717|FG002|Double Blind|Withdrawal by Subject|1|||
148998507|NCT01239030|537469718|FG003|Double Blind|Withdrawal by Subject|0|||
148998508|NCT01239030|537469719|FG004|Double Blind|Withdrawal by Subject|1|||
148998509|NCT01239030|537469715|FG000|Double Blind|Lost to Follow-up|1|||
148998510|NCT01239030|537469716|FG001|Double Blind|Lost to Follow-up|1|||
148998511|NCT01239030|537469717|FG002|Double Blind|Lost to Follow-up|0|||
148998512|NCT01239030|537469718|FG003|Double Blind|Lost to Follow-up|0|||
148998513|NCT01239030|537469719|FG004|Double Blind|Lost to Follow-up|0|||
148998514|NCT01239030|537469715|FG000|Double Blind|Physician Decision|0|||
148998515|NCT01239030|537469716|FG001|Double Blind|Physician Decision|1|||
148998516|NCT01239030|537469717|FG002|Double Blind|Physician Decision|0|||
148998517|NCT01239030|537469718|FG003|Double Blind|Physician Decision|0|||
148998518|NCT01239030|537469719|FG004|Double Blind|Physician Decision|0|||
148998519|NCT01239030|537469715|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
148998520|NCT01239030|537469716|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
148998521|NCT01239030|537469717|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
148998522|NCT01239030|537469718|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
148998523|NCT01239030|537469719|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
148998524|NCT01239030|537469715|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
149031118|NCT01981850|537591657|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
148998525|NCT01239030|537469716|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
148998526|NCT01239030|537469717|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
148998527|NCT01239030|537469718|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
148998528|NCT01239030|537469719|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
148998529|NCT01239030|537469715|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
148998530|NCT01239030|537469716|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
148998531|NCT01239030|537469717|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
148998532|NCT01239030|537469718|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
148998533|NCT01239030|537469719|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
149031119|NCT01981850|537591658|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
148998534|NCT01239030|537469715|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
148998535|NCT01239030|537469716|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
148998536|NCT01239030|537469717|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
148998537|NCT01239030|537469718|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
148998538|NCT01239030|537469719|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
148998539|NCT01830127|537469723|FG000|Overall Study|Adverse Event|1|||
148998540|NCT01830127|537469724|FG001|Overall Study|Adverse Event|6|||
148998541|NCT01830127|537469723|FG000|Overall Study|Lack of Efficacy|3|||
148998542|NCT01830127|537469724|FG001|Overall Study|Lack of Efficacy|0|||
148998543|NCT01830127|537469723|FG000|Overall Study|Withdrawal by Subject|1|||
148998544|NCT01830127|537469724|FG001|Overall Study|Withdrawal by Subject|1|||
148998545|NCT01830127|537469723|FG000|Overall Study|Other reason not defined above|0|||
148998546|NCT01830127|537469724|FG001|Overall Study|Other reason not defined above|2|||
148998547|NCT01302847|537469728|FG000|Overall Study|Death|0|||
148998548|NCT01302847|537469729|FG001|Overall Study|Death|1|||
148998549|NCT01302847|537469730|FG002|Overall Study|Death|0|||
148998550|NCT01302847|537469731|FG003|Overall Study|Death|0|||
148998551|NCT01302847|537469732|FG004|Overall Study|Death|0|||
148998552|NCT01302847|537469733|FG005|Overall Study|Death|1|||
148998553|NCT01302847|537469734|FG006|Overall Study|Death|1|||
148998554|NCT01302847|537469735|FG007|Overall Study|Death|0|||
148998555|NCT01302847|537469728|FG000|Overall Study|Pregnancy|2|||
148998556|NCT01302847|537469729|FG001|Overall Study|Pregnancy|0|||
148998557|NCT01302847|537469730|FG002|Overall Study|Pregnancy|0|||
148998558|NCT01302847|537469731|FG003|Overall Study|Pregnancy|0|||
148998559|NCT01302847|537469732|FG004|Overall Study|Pregnancy|0|||
148998560|NCT01302847|537469733|FG005|Overall Study|Pregnancy|0|||
148998561|NCT01302847|537469734|FG006|Overall Study|Pregnancy|0|||
148998562|NCT01302847|537469735|FG007|Overall Study|Pregnancy|0|||
148998563|NCT01302847|537469728|FG000|Overall Study|Virologic failure|0|||
148998564|NCT01302847|537469729|FG001|Overall Study|Virologic failure|2|||
148998565|NCT01302847|537469730|FG002|Overall Study|Virologic failure|0|||
148998566|NCT01302847|537469731|FG003|Overall Study|Virologic failure|2|||
148998567|NCT01302847|537469732|FG004|Overall Study|Virologic failure|1|||
148998568|NCT01302847|537469733|FG005|Overall Study|Virologic failure|3|||
148998569|NCT01302847|537469734|FG006|Overall Study|Virologic failure|1|||
148998570|NCT01302847|537469735|FG007|Overall Study|Virologic failure|2|||
148998571|NCT01302847|537469728|FG000|Overall Study|Severe debilitation, unable to continue|0|||
148998572|NCT01302847|537469729|FG001|Overall Study|Severe debilitation, unable to continue|0|||
148998573|NCT01302847|537469730|FG002|Overall Study|Severe debilitation, unable to continue|0|||
148998574|NCT01302847|537469731|FG003|Overall Study|Severe debilitation, unable to continue|0|||
148998575|NCT01302847|537469732|FG004|Overall Study|Severe debilitation, unable to continue|0|||
148998576|NCT01302847|537469733|FG005|Overall Study|Severe debilitation, unable to continue|1|||
148998577|NCT01302847|537469734|FG006|Overall Study|Severe debilitation, unable to continue|1|||
148998578|NCT01302847|537469735|FG007|Overall Study|Severe debilitation, unable to continue|0|||
148998579|NCT01302847|537469728|FG000|Overall Study|Not able to get to clinic|1|||
148998580|NCT01302847|537469729|FG001|Overall Study|Not able to get to clinic|1|||
148998581|NCT01302847|537469730|FG002|Overall Study|Not able to get to clinic|0|||
148998582|NCT01302847|537469731|FG003|Overall Study|Not able to get to clinic|0|||
148998583|NCT01302847|537469732|FG004|Overall Study|Not able to get to clinic|0|||
148998584|NCT01302847|537469733|FG005|Overall Study|Not able to get to clinic|0|||
148998585|NCT01302847|537469734|FG006|Overall Study|Not able to get to clinic|0|||
148998586|NCT01302847|537469735|FG007|Overall Study|Not able to get to clinic|0|||
148998587|NCT01302847|537469728|FG000|Overall Study|Site closing|2|||
148998588|NCT01302847|537469729|FG001|Overall Study|Site closing|2|||
148998589|NCT01302847|537469730|FG002|Overall Study|Site closing|0|||
148998590|NCT01302847|537469731|FG003|Overall Study|Site closing|0|||
148998591|NCT01302847|537469732|FG004|Overall Study|Site closing|0|||
148998592|NCT01302847|537469733|FG005|Overall Study|Site closing|0|||
148998593|NCT01302847|537469734|FG006|Overall Study|Site closing|0|||
148998594|NCT01302847|537469735|FG007|Overall Study|Site closing|0|||
148998595|NCT01302847|537469728|FG000|Overall Study|Withdrawal by Subject|1|||
148998596|NCT01302847|537469729|FG001|Overall Study|Withdrawal by Subject|0|||
148998597|NCT01302847|537469730|FG002|Overall Study|Withdrawal by Subject|0|||
148998598|NCT01302847|537469731|FG003|Overall Study|Withdrawal by Subject|0|||
148998599|NCT01302847|537469732|FG004|Overall Study|Withdrawal by Subject|1|||
148998600|NCT01302847|537469733|FG005|Overall Study|Withdrawal by Subject|0|||
148998601|NCT01302847|537469734|FG006|Overall Study|Withdrawal by Subject|0|||
148998602|NCT01302847|537469735|FG007|Overall Study|Withdrawal by Subject|1|||
148998603|NCT01302847|537469728|FG000|Overall Study|Not willing to adhere to requirements|5|||
148998604|NCT01302847|537469729|FG001|Overall Study|Not willing to adhere to requirements|0|||
148998605|NCT01302847|537469730|FG002|Overall Study|Not willing to adhere to requirements|1|||
148998606|NCT01302847|537469731|FG003|Overall Study|Not willing to adhere to requirements|0|||
148998607|NCT01302847|537469732|FG004|Overall Study|Not willing to adhere to requirements|0|||
148998608|NCT01302847|537469733|FG005|Overall Study|Not willing to adhere to requirements|0|||
148998609|NCT01302847|537469734|FG006|Overall Study|Not willing to adhere to requirements|0|||
148998610|NCT01302847|537469735|FG007|Overall Study|Not willing to adhere to requirements|2|||
148998611|NCT01302847|537469728|FG000|Overall Study|Site unable to contact participant|2|||
148998612|NCT01302847|537469729|FG001|Overall Study|Site unable to contact participant|1|||
148998613|NCT01302847|537469730|FG002|Overall Study|Site unable to contact participant|0|||
148998614|NCT01302847|537469731|FG003|Overall Study|Site unable to contact participant|0|||
148998615|NCT01302847|537469732|FG004|Overall Study|Site unable to contact participant|0|||
148998616|NCT01302847|537469733|FG005|Overall Study|Site unable to contact participant|0|||
148998617|NCT01302847|537469734|FG006|Overall Study|Site unable to contact participant|2|||
148998618|NCT01302847|537469735|FG007|Overall Study|Site unable to contact participant|0|||
148998619|NCT01371851|537469736|FG000|Overall Study|Lost to Follow-up|5|||
148998620|NCT01371851|537469737|FG001|Overall Study|Lost to Follow-up|8|||
148998621|NCT01371851|537469736|FG000|Overall Study|was arrested and put in jail|0|||
148998622|NCT01371851|537469737|FG001|Overall Study|was arrested and put in jail|1|||
148998623|NCT01371851|537469736|FG000|Overall Study|non study related adverse event|1|||
148998624|NCT01371851|537469737|FG001|Overall Study|non study related adverse event|0|||
148998625|NCT01371851|537469736|FG000|Overall Study|Blood Pressure outside study parameters|2|||
148998626|NCT01371851|537469737|FG001|Overall Study|Blood Pressure outside study parameters|0|||
148998627|NCT00450411|537469738|FG000|Overall Study|Protocol Violation|6|||
148998628|NCT00450411|537469738|FG000|Overall Study|No protocol treatment|2|||
148998629|NCT00941330|537469741|FG000|Overall Study|Other|1|||
148998630|NCT00941330|537469742|FG001|Overall Study|Other|0|||
148998631|NCT00941330|537469741|FG000|Overall Study|Physician Decision|0|||
148998632|NCT00941330|537469742|FG001|Overall Study|Physician Decision|2|||
148998633|NCT01194570|537471419|FG000|Overall Study|Adverse Event|22|||
148998634|NCT01194570|537471420|FG001|Overall Study|Adverse Event|40|||
148998635|NCT01194570|537471419|FG000|Overall Study|Death|6|||
148998636|NCT01194570|537471420|FG001|Overall Study|Death|20|||
148998637|NCT01194570|537471419|FG000|Overall Study|Lack of Efficacy|32|||
148998638|NCT01194570|537471420|FG001|Overall Study|Lack of Efficacy|33|||
148998639|NCT01194570|537471419|FG000|Overall Study|Lost to Follow-up|4|||
148998640|NCT01194570|537471420|FG001|Overall Study|Lost to Follow-up|15|||
148998641|NCT01194570|537471419|FG000|Overall Study|Non-Compliance|2|||
148998642|NCT01194570|537471420|FG001|Overall Study|Non-Compliance|2|||
148998643|NCT01194570|537471419|FG000|Overall Study|Non-Compliance With Study Drug|2|||
148998644|NCT01194570|537471420|FG001|Overall Study|Non-Compliance With Study Drug|2|||
148998645|NCT01194570|537471419|FG000|Overall Study|Other|18|||
148998646|NCT01194570|537471420|FG001|Overall Study|Other|47|||
148998647|NCT01194570|537471419|FG000|Overall Study|Physician Decision|10|||
148998648|NCT01194570|537471420|FG001|Overall Study|Physician Decision|25|||
148998649|NCT01194570|537471419|FG000|Overall Study|Protocol Violation|1|||
148998650|NCT01194570|537471420|FG001|Overall Study|Protocol Violation|2|||
148998651|NCT01194570|537471419|FG000|Overall Study|Study Terminated By Sponsor|0|||
148998652|NCT01194570|537471420|FG001|Overall Study|Study Terminated By Sponsor|1|||
148998653|NCT01194570|537471419|FG000|Overall Study|Withdrawal by Subject|57|||
148998654|NCT01194570|537471420|FG001|Overall Study|Withdrawal by Subject|82|||
148998655|NCT01194570|537471419|FG000|Overall Study|Pregnancy|1|||
148998656|NCT01194570|537471420|FG001|Overall Study|Pregnancy|1|||
148998657|NCT00289887|537471428|FG000|Overall Study|Adverse Event|3|||
148998658|NCT00289887|537471429|FG001|Overall Study|Adverse Event|3|||
148998659|NCT00289887|537471428|FG000|Overall Study|Lack of Efficacy|3|||
148998660|NCT00289887|537471429|FG001|Overall Study|Lack of Efficacy|11|||
148998661|NCT00289887|537471428|FG000|Overall Study|Lost to Follow-up|3|||
148998662|NCT00289887|537471429|FG001|Overall Study|Lost to Follow-up|3|||
148998663|NCT00289887|537471428|FG000|Overall Study|Protocol Violation|3|||
148998664|NCT00289887|537471429|FG001|Overall Study|Protocol Violation|1|||
148998665|NCT00289887|537471428|FG000|Overall Study|Withdrawal by Subject|3|||
148998666|NCT00289887|537471429|FG001|Overall Study|Withdrawal by Subject|8|||
148998667|NCT00289887|537471428|FG000|Overall Study|Other|7|||
148998668|NCT00289887|537471429|FG001|Overall Study|Other|3|||
148998669|NCT03014674|537471430|FG000|Overall Study|Withdrawal by Subject|1|||
148998670|NCT03014674|537471431|FG001|Overall Study|Withdrawal by Subject|0|||
148998671|NCT03014674|537471432|FG002|Overall Study|Withdrawal by Subject|0|||
148998672|NCT04605978|537471436|FG000|Overall Study|Adverse Event|2|||
148998673|NCT04605978|537471437|FG001|Overall Study|Adverse Event|1|||
148998674|NCT04605978|537471436|FG000|Overall Study|Withdrawal nonmedical reason|1|||
148998675|NCT04605978|537471437|FG001|Overall Study|Withdrawal nonmedical reason|1|||
148998676|NCT03813238|537471438|FG000|Overall Study|Adverse Event|0|||
148998677|NCT03813238|537471439|FG001|Overall Study|Adverse Event|6|||
148998678|NCT03813238|537471438|FG000|Overall Study|Withdrawal by parent/guardian|0|||
148998679|NCT03813238|537471439|FG001|Overall Study|Withdrawal by parent/guardian|2|||
148998680|NCT03813238|537471438|FG000|Overall Study|Lost to Follow-up|0|||
148998681|NCT03813238|537471439|FG001|Overall Study|Lost to Follow-up|1|||
148998682|NCT03813238|537471438|FG000|Overall Study|Other than specified|1|||
148998683|NCT03813238|537471439|FG001|Overall Study|Other than specified|2|||
148998684|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
148998685|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
148998686|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
148866029|NCT00996801|536987222|FG004|Overall Study|Physician Decision|0|||
148866030|NCT00996801|536987223|FG005|Overall Study|Physician Decision|0|||
148866031|NCT00996801|536987218|FG000|Overall Study|Progressive Disease|0|||
148866032|NCT00996801|536987219|FG001|Overall Study|Progressive Disease|1|||
148866033|NCT00996801|536987220|FG002|Overall Study|Progressive Disease|0|||
148866034|NCT00996801|536987221|FG003|Overall Study|Progressive Disease|0|||
148866035|NCT00996801|536987222|FG004|Overall Study|Progressive Disease|0|||
148866036|NCT00996801|536987223|FG005|Overall Study|Progressive Disease|0|||
148866037|NCT00996801|536987218|FG000|Overall Study|Protocol Violation|3|||
148866038|NCT00996801|536987219|FG001|Overall Study|Protocol Violation|4|||
148866039|NCT00996801|536987220|FG002|Overall Study|Protocol Violation|1|||
148866040|NCT00996801|536987221|FG003|Overall Study|Protocol Violation|2|||
148866041|NCT00996801|536987222|FG004|Overall Study|Protocol Violation|3|||
148866042|NCT00996801|536987223|FG005|Overall Study|Protocol Violation|4|||
148866043|NCT00996801|536987218|FG000|Overall Study|Study Terminated by Sponsor|0|||
148866044|NCT00996801|536987219|FG001|Overall Study|Study Terminated by Sponsor|1|||
148866045|NCT00996801|536987220|FG002|Overall Study|Study Terminated by Sponsor|0|||
148866046|NCT00996801|536987221|FG003|Overall Study|Study Terminated by Sponsor|0|||
148866047|NCT00996801|536987222|FG004|Overall Study|Study Terminated by Sponsor|46|||
148866048|NCT00996801|536987223|FG005|Overall Study|Study Terminated by Sponsor|0|||
148866049|NCT00996801|536987218|FG000|Overall Study|Withdrawal by Subject|8|||
148866050|NCT00996801|536987219|FG001|Overall Study|Withdrawal by Subject|6|||
148866051|NCT00996801|536987220|FG002|Overall Study|Withdrawal by Subject|9|||
148866052|NCT00996801|536987221|FG003|Overall Study|Withdrawal by Subject|5|||
148866053|NCT00996801|536987222|FG004|Overall Study|Withdrawal by Subject|5|||
148866054|NCT00996801|536987223|FG005|Overall Study|Withdrawal by Subject|9|||
148866055|NCT01688739|536987224|FG000|Overall Study|Administrative Decision|1|||
148866056|NCT01688739|536987225|FG001|Overall Study|Administrative Decision|0|||
148866057|NCT01688739|536987226|FG002|Overall Study|Administrative Decision|0|||
148866058|NCT01688739|536987227|FG003|Overall Study|Administrative Decision|0|||
148866059|NCT01688739|536987228|FG004|Overall Study|Administrative Decision|0|||
148866060|NCT01688739|536987229|FG005|Overall Study|Administrative Decision|0|||
148866061|NCT01688739|536987230|FG006|Overall Study|Administrative Decision|0|||
148866062|NCT01688739|536987231|FG007|Overall Study|Administrative Decision|0|||
148866063|NCT01688739|536987232|FG008|Overall Study|Administrative Decision|0|||
148866064|NCT01688739|536987233|FG009|Overall Study|Administrative Decision|0|||
148866065|NCT00289198|536987234|FG000|Overall Study|Adverse Event|0|||
148866066|NCT00289198|536987235|FG001|Overall Study|Adverse Event|2|||
148866067|NCT00289198|536987234|FG000|Overall Study|Protocol Violation|2|||
148866068|NCT00289198|536987235|FG001|Overall Study|Protocol Violation|1|||
148866069|NCT00289198|536987234|FG000|Overall Study|Withdrawal by Subject|4|||
148866070|NCT00289198|536987235|FG001|Overall Study|Withdrawal by Subject|1|||
148866071|NCT00289198|536987234|FG000|Overall Study|Lack of Efficacy|2|||
148866072|NCT00289198|536987235|FG001|Overall Study|Lack of Efficacy|0|||
148866073|NCT00289198|536987234|FG000|Overall Study|Other: Low compliance|0|||
148866074|NCT00289198|536987235|FG001|Overall Study|Other: Low compliance|1|||
148866075|NCT00289198|536987234|FG000|Overall Study|Other: Physician's decision|0|||
148866076|NCT00289198|536987235|FG001|Overall Study|Other: Physician's decision|1|||
148866077|NCT00289198|536987234|FG000|Overall Study|Other: Unable to attend on schedule|2|||
148866078|NCT00289198|536987235|FG001|Overall Study|Other: Unable to attend on schedule|1|||
148866079|NCT00289198|536987234|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
148866080|NCT00289198|536987235|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
148866081|NCT00289198|536987234|FG000|Overall Study|Other: Impossible to come on visit|0|||
148866082|NCT00289198|536987235|FG001|Overall Study|Other: Impossible to come on visit|1|||
148866083|NCT03369431|536987237|FG000|Overall Study|Lost to Follow-up|1|||
148866084|NCT03369431|536987238|FG001|Overall Study|Lost to Follow-up|3|||
148866085|NCT03369431|536987237|FG000|Overall Study|Withdrawal by Subject|2|||
148866086|NCT03369431|536987238|FG001|Overall Study|Withdrawal by Subject|3|||
148866087|NCT03369431|536987237|FG000|Overall Study|Protocol Violation|1|||
148866088|NCT03369431|536987238|FG001|Overall Study|Protocol Violation|1|||
148866089|NCT01062061|536987239|FG000|Overall Study|Enrolled more than once|2|||
148866090|NCT01062061|536987239|FG000|Overall Study|Investigated before study start|13|||
148866091|NCT01062061|536987239|FG000|Overall Study|Outside chief indications|10|||
148866092|NCT01062061|536987239|FG000|Overall Study|Failed to meet inclusion criteria|2|||
148866093|NCT00524589|536987240|FG000|Overall Study|Withdrawal by Subject|2|||
148866094|NCT00524589|536987240|FG000|Overall Study|Disease Progression|16|||
148866095|NCT00490776|536987241|FG000|Overall Study|Withdrawal by Subject|1|||
148866096|NCT00490776|536987241|FG000|Overall Study|Administrative Problems|1|||
148866097|NCT00490776|536987241|FG000|Overall Study|Death|1|||
148866098|NCT00490776|536987241|FG000|Overall Study|New Cancer Therapy|1|||
148866099|NCT00490776|536987241|FG000|Overall Study|Disease Progression|5|||
148866100|NCT00046930|536987242|FG000|Overall Study|Ineligible|12|||
148866101|NCT00046930|536987243|FG001|Overall Study|Ineligible|4|||
148866102|NCT01657760|536987244|FG000|Overall Study|Withdrawal by Subject|0|||
148866103|NCT01657760|536987245|FG001|Overall Study|Withdrawal by Subject|0|||
148866104|NCT01657760|536987246|FG002|Overall Study|Withdrawal by Subject|0|||
148866105|NCT01657760|536987247|FG003|Overall Study|Withdrawal by Subject|1|||
148998687|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
148998688|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
148998689|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
148998690|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
148998691|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
148998692|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
148998693|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
148998694|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
148998695|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
148998696|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Death|6|||
148998697|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Death|3|||
148998698|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Death|0|||
148998699|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Death|1|||
148998700|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Death|1|||
148998701|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Death|0|||
148998702|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
148998703|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
148998704|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
148998705|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
148998706|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
148998707|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
148998708|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
148998709|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
148998710|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
148998711|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
148998712|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
148998713|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
148998714|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
148998715|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
148998716|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
148998717|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
148998718|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
148998719|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
148998720|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
148998721|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
148998722|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
148998723|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
148998724|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
148998725|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
148998726|NCT03104699|537471440|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
148998727|NCT03104699|537471441|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
148998728|NCT03104699|537471442|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
148998729|NCT03104699|537471443|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
148998730|NCT03104699|537471444|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
148998731|NCT03104699|537471445|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
148998732|NCT03104699|537471440|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148998733|NCT03104699|537471441|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148998734|NCT03104699|537471442|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148998735|NCT03104699|537471443|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148998736|NCT03104699|537471444|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
148998737|NCT03104699|537471445|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
148998738|NCT03104699|537471440|FG000|Phase 2: Dose Expansion|Death|0|||
148998739|NCT03104699|537471441|FG001|Phase 2: Dose Expansion|Death|0|||
148998740|NCT03104699|537471442|FG002|Phase 2: Dose Expansion|Death|0|||
148998741|NCT03104699|537471443|FG003|Phase 2: Dose Expansion|Death|0|||
148998742|NCT03104699|537471444|FG004|Phase 2: Dose Expansion|Death|0|||
148998743|NCT03104699|537471445|FG005|Phase 2: Dose Expansion|Death|107|||
148998744|NCT03104699|537471440|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
148998745|NCT03104699|537471441|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
148998746|NCT03104699|537471442|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
148998747|NCT03104699|537471443|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
148998748|NCT03104699|537471444|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
148998749|NCT03104699|537471445|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
148998750|NCT03104699|537471440|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
148998751|NCT03104699|537471441|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
148998752|NCT03104699|537471442|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
148866106|NCT01657760|536987244|FG000|Overall Study|Physician Decision|1|||
148866107|NCT01657760|536987245|FG001|Overall Study|Physician Decision|1|||
148998753|NCT03104699|537471443|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
148998754|NCT03104699|537471444|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
149031120|NCT01981850|537591659|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
149031121|NCT01981850|537591660|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
149031122|NCT01981850|537591661|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
149031123|NCT01981850|537591662|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
149031124|NCT01981850|537591663|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
149031125|NCT01981850|537591654|FG000|Open Label Extension (OLE)|Various reasons|0|||
149031126|NCT01981850|537591655|FG001|Open Label Extension (OLE)|Various reasons|0|||
149031127|NCT01981850|537591656|FG002|Open Label Extension (OLE)|Various reasons|0|||
149031128|NCT01981850|537591657|FG003|Open Label Extension (OLE)|Various reasons|0|||
149031129|NCT01981850|537591658|FG004|Open Label Extension (OLE)|Various reasons|0|||
149031130|NCT01981850|537591659|FG005|Open Label Extension (OLE)|Various reasons|0|||
149031131|NCT01981850|537591660|FG006|Open Label Extension (OLE)|Various reasons|0|||
149031132|NCT01981850|537591661|FG007|Open Label Extension (OLE)|Various reasons|3|||
149031133|NCT01981850|537591662|FG008|Open Label Extension (OLE)|Various reasons|1|||
149031134|NCT01981850|537591663|FG009|Open Label Extension (OLE)|Various reasons|3|||
149031135|NCT01981850|537591654|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
149031136|NCT01981850|537591655|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
149031137|NCT01981850|537591656|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
149031138|NCT01981850|537591657|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
149031139|NCT01981850|537591658|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
149031140|NCT01981850|537591659|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
149031141|NCT01981850|537591660|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
149031142|NCT01981850|537591661|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
149031143|NCT01981850|537591662|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
149031144|NCT01981850|537591663|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
149031145|NCT01981850|537591654|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031146|NCT01981850|537591655|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031147|NCT01981850|537591656|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031148|NCT01981850|537591657|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031149|NCT01981850|537591658|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031150|NCT01981850|537591659|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031151|NCT01981850|537591660|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031152|NCT01981850|537591661|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031153|NCT01981850|537591662|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
149031154|NCT01981850|537591663|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
149031155|NCT01981850|537591654|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031156|NCT01981850|537591655|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031157|NCT01981850|537591656|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031158|NCT01981850|537591657|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031159|NCT01981850|537591658|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031160|NCT01981850|537591659|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031161|NCT01981850|537591660|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031162|NCT01981850|537591661|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031163|NCT01981850|537591662|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
149031164|NCT01981850|537591663|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
149031165|NCT01467700|537591664|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
149031166|NCT01467700|537591665|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
149031167|NCT01467700|537591666|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
149031168|NCT01467700|537591667|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
149031169|NCT01467700|537591664|FG000|Overall Study|Major Protocol Deviation|3|||
149031170|NCT01467700|537591665|FG001|Overall Study|Major Protocol Deviation|3|||
149031171|NCT01467700|537591666|FG002|Overall Study|Major Protocol Deviation|2|||
149031172|NCT01467700|537591667|FG003|Overall Study|Major Protocol Deviation|3|||
149031173|NCT01467700|537591664|FG000|Overall Study|Lost to Follow-up|6|||
148866108|NCT01657760|536987246|FG002|Overall Study|Physician Decision|1|||
149031174|NCT01467700|537591665|FG001|Overall Study|Lost to Follow-up|5|||
149031175|NCT01467700|537591666|FG002|Overall Study|Lost to Follow-up|2|||
148866109|NCT01657760|536987247|FG003|Overall Study|Physician Decision|2|||
148866110|NCT01113580|536987254|FG000|Overall Study|Protocol Violation|1|||
148866111|NCT01113580|536987255|FG001|Overall Study|Protocol Violation|0|||
148866112|NCT03684304|536987263|FG000|Overall Study|Lost to Follow-up|19|||
148866113|NCT03684304|536987264|FG001|Overall Study|Lost to Follow-up|17|||
148866114|NCT00765882|536987265|FG000|Overall Study|Adverse Event|10|||
149031176|NCT01467700|537591667|FG003|Overall Study|Lost to Follow-up|3|||
149031177|NCT01467700|537591664|FG000|Overall Study|Voluntary Withdrawal|5|||
149031178|NCT01467700|537591665|FG001|Overall Study|Voluntary Withdrawal|7|||
149031179|NCT01467700|537591666|FG002|Overall Study|Voluntary Withdrawal|6|||
149031180|NCT01467700|537591667|FG003|Overall Study|Voluntary Withdrawal|2|||
149031181|NCT01467700|537591664|FG000|Overall Study|Study Termination|6|||
149031182|NCT01467700|537591665|FG001|Overall Study|Study Termination|5|||
149031183|NCT01467700|537591666|FG002|Overall Study|Study Termination|10|||
149031184|NCT01467700|537591667|FG003|Overall Study|Study Termination|7|||
148866115|NCT00765882|536987266|FG001|Overall Study|Adverse Event|21|||
148866116|NCT00765882|536987267|FG002|Overall Study|Adverse Event|20|||
148866117|NCT00765882|536987265|FG000|Overall Study|Lack of Efficacy|4|||
148866118|NCT00765882|536987266|FG001|Overall Study|Lack of Efficacy|0|||
148866119|NCT00765882|536987267|FG002|Overall Study|Lack of Efficacy|1|||
148866120|NCT00765882|536987265|FG000|Overall Study|Protocol Violation|4|||
148866121|NCT00765882|536987266|FG001|Overall Study|Protocol Violation|3|||
148866122|NCT00765882|536987267|FG002|Overall Study|Protocol Violation|1|||
148866123|NCT00765882|536987265|FG000|Overall Study|Withdrawal by Subject|2|||
148866124|NCT00765882|536987266|FG001|Overall Study|Withdrawal by Subject|6|||
148866125|NCT00765882|536987267|FG002|Overall Study|Withdrawal by Subject|6|||
148866126|NCT00765882|536987265|FG000|Overall Study|Lost to Follow-up|1|||
148866127|NCT00765882|536987266|FG001|Overall Study|Lost to Follow-up|9|||
148866128|NCT00765882|536987267|FG002|Overall Study|Lost to Follow-up|6|||
148866129|NCT00765882|536987265|FG000|Overall Study|Other Reason|3|||
148866130|NCT00765882|536987266|FG001|Overall Study|Other Reason|1|||
148866131|NCT00765882|536987267|FG002|Overall Study|Other Reason|2|||
148866132|NCT01665430|536987268|FG000|Overall Study|Adverse Event|1|||
148866133|NCT01665430|536987268|FG000|Overall Study|Withdrawal by Subject|6|||
148866134|NCT01665430|536987268|FG000|Overall Study|Other Unspecified|2|||
148866135|NCT01866423|536987269|FG000|Overall Study|Lack of Efficacy|3|||
148866136|NCT01866423|536987269|FG000|Overall Study|Sponsor Decision|1|||
148866137|NCT01813721|536987270|FG000|Overall Study|Ineligibility determined|63|||
148866138|NCT01813721|536987270|FG000|Overall Study|Withdrawal by Subject|1|||
148866139|NCT01479595|536987271|FG000|Overall Study|Protocol deviation|0|||
148866140|NCT01479595|536987272|FG001|Overall Study|Protocol deviation|1|||
148866141|NCT01479595|536987271|FG000|Overall Study|Adverse Event|2|||
148866142|NCT01479595|536987272|FG001|Overall Study|Adverse Event|1|||
148866143|NCT02699450|536987273|FG000|Overall Study|Death|2|||
148866144|NCT02699450|536987274|FG001|Overall Study|Death|1|||
148866145|NCT02699450|536987275|FG002|Overall Study|Death|2|||
148866146|NCT02699450|536987273|FG000|Overall Study|Met Criteria for Study Exit|0|||
148866147|NCT02699450|536987274|FG001|Overall Study|Met Criteria for Study Exit|0|||
148866148|NCT02699450|536987275|FG002|Overall Study|Met Criteria for Study Exit|1|||
148866149|NCT02699450|536987273|FG000|Overall Study|Protocol Violation|4|||
148866150|NCT02699450|536987274|FG001|Overall Study|Protocol Violation|3|||
148866151|NCT02699450|536987275|FG002|Overall Study|Protocol Violation|5|||
148866152|NCT02699450|536987273|FG000|Overall Study|Lost to Follow-up|3|||
148866153|NCT02699450|536987274|FG001|Overall Study|Lost to Follow-up|0|||
148866154|NCT02699450|536987275|FG002|Overall Study|Lost to Follow-up|5|||
148866155|NCT02699450|536987273|FG000|Overall Study|Physician Decision|2|||
148866156|NCT02699450|536987274|FG001|Overall Study|Physician Decision|0|||
148866157|NCT02699450|536987275|FG002|Overall Study|Physician Decision|0|||
148866158|NCT02699450|536987273|FG000|Overall Study|Withdrawal by Subject|3|||
148866159|NCT02699450|536987274|FG001|Overall Study|Withdrawal by Subject|1|||
148866160|NCT02699450|536987275|FG002|Overall Study|Withdrawal by Subject|2|||
148866161|NCT02699450|536987273|FG000|Overall Study|Adverse Event|1|||
148866162|NCT02699450|536987274|FG001|Overall Study|Adverse Event|0|||
148866163|NCT02699450|536987275|FG002|Overall Study|Adverse Event|0|||
148866164|NCT00810901|536987276|FG000|Overall Study|Lost to Follow-up|88|||
148866165|NCT00810901|536987277|FG001|Overall Study|Lost to Follow-up|58|||
148866166|NCT01009346|536987278|FG000|Overall Study|Adverse Event|4|||
148866167|NCT03283150|536987281|FG000|Overall Study|Withdrawal by Subject|6|||
148998755|NCT03104699|537471445|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
148998756|NCT03104699|537471440|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148998757|NCT03104699|537471441|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148998758|NCT03104699|537471442|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148998759|NCT03104699|537471443|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148998760|NCT03104699|537471444|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
148998761|NCT03104699|537471445|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
148998762|NCT03104699|537471440|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
148998763|NCT03104699|537471441|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
148998764|NCT03104699|537471442|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
148998765|NCT03104699|537471443|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
148998766|NCT03104699|537471444|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
148998767|NCT03104699|537471445|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
148998768|NCT01690130|537471446|FG000|Overall Study|Subject have cancelled visit.|1|||
148998769|NCT01690130|537471447|FG001|Overall Study|Subject have cancelled visit.|0|||
149031185|NCT01467700|537591664|FG000|Overall Study|Pregnancy|0|||
148866168|NCT03283150|536987282|FG001|Overall Study|Withdrawal by Subject|0|||
148866169|NCT03283150|536987283|FG002|Overall Study|Withdrawal by Subject|0|||
148866170|NCT00900146|536987284|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
148866171|NCT00900146|536987285|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
148866172|NCT00900146|536987286|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
148866173|NCT00900146|536987287|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
148866174|NCT00900146|536987288|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
148866175|NCT00900146|536987284|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
149031186|NCT01467700|537591665|FG001|Overall Study|Pregnancy|1|||
149031187|NCT01467700|537591666|FG002|Overall Study|Pregnancy|1|||
149031188|NCT01467700|537591667|FG003|Overall Study|Pregnancy|0|||
149031189|NCT01467700|537591664|FG000|Overall Study|Lack of Efficacy|2|||
149031190|NCT01467700|537591665|FG001|Overall Study|Lack of Efficacy|0|||
149031191|NCT01467700|537591666|FG002|Overall Study|Lack of Efficacy|2|||
149031192|NCT01467700|537591667|FG003|Overall Study|Lack of Efficacy|1|||
149031193|NCT01467700|537591664|FG000|Overall Study|Reason not Specified|1|||
149031194|NCT01467700|537591665|FG001|Overall Study|Reason not Specified|3|||
149031195|NCT01467700|537591666|FG002|Overall Study|Reason not Specified|2|||
149031196|NCT01467700|537591667|FG003|Overall Study|Reason not Specified|8|||
149031197|NCT03523962|537591668|FG000|Closed Fractures|Death|86|||
149031198|NCT03523962|537591669|FG001|Closed Fractures|Death|71|||
149031199|NCT03523962|537591670|FG002|Closed Fractures|Death|0|||
149031200|NCT03523962|537591671|FG003|Closed Fractures|Death|0|||
149031201|NCT03523962|537591668|FG000|Closed Fractures|Lost to Follow-up|62|||
149031202|NCT03523962|537591669|FG001|Closed Fractures|Lost to Follow-up|36|||
149031203|NCT03523962|537591670|FG002|Closed Fractures|Lost to Follow-up|0|||
149031204|NCT03523962|537591671|FG003|Closed Fractures|Lost to Follow-up|0|||
149031205|NCT03523962|537591668|FG000|Closed Fractures|Withdrawal by Subject|19|||
149031206|NCT03523962|537591669|FG001|Closed Fractures|Withdrawal by Subject|29|||
149031207|NCT03523962|537591670|FG002|Closed Fractures|Withdrawal by Subject|0|||
149031208|NCT03523962|537591671|FG003|Closed Fractures|Withdrawal by Subject|0|||
149031209|NCT03523962|537591668|FG000|Closed Fractures|Incarceration|1|||
149031210|NCT03523962|537591669|FG001|Closed Fractures|Incarceration|4|||
149031211|NCT03523962|537591670|FG002|Closed Fractures|Incarceration|0|||
149031212|NCT03523962|537591671|FG003|Closed Fractures|Incarceration|0|||
149031213|NCT03523962|537591668|FG000|Open Fractures|Death|0|||
149031214|NCT03523962|537591669|FG001|Open Fractures|Death|0|||
149031215|NCT03523962|537591670|FG002|Open Fractures|Death|11|||
149031216|NCT03523962|537591671|FG003|Open Fractures|Death|6|||
149031217|NCT03523962|537591668|FG000|Open Fractures|Lost to Follow-up|0|||
149031218|NCT03523962|537591669|FG001|Open Fractures|Lost to Follow-up|0|||
149031219|NCT03523962|537591670|FG002|Open Fractures|Lost to Follow-up|15|||
149031220|NCT03523962|537591671|FG003|Open Fractures|Lost to Follow-up|8|||
149031221|NCT03523962|537591668|FG000|Open Fractures|Withdrawal by Subject|0|||
149031222|NCT03523962|537591669|FG001|Open Fractures|Withdrawal by Subject|0|||
149031223|NCT03523962|537591670|FG002|Open Fractures|Withdrawal by Subject|6|||
149031224|NCT03523962|537591671|FG003|Open Fractures|Withdrawal by Subject|2|||
149031225|NCT03523962|537591668|FG000|Open Fractures|Incarceration|0|||
149031226|NCT03523962|537591669|FG001|Open Fractures|Incarceration|0|||
149031227|NCT03523962|537591670|FG002|Open Fractures|Incarceration|1|||
149031228|NCT03523962|537591671|FG003|Open Fractures|Incarceration|0|||
149031229|NCT01081145|537591681|FG000|Open-Label Phase|Lack of Efficacy|56|||
149031230|NCT01081145|537591682|FG001|Open-Label Phase|Lack of Efficacy|0|||
149031231|NCT01081145|537591681|FG000|Open-Label Phase|Response criteria not met|46|||
149031232|NCT01081145|537591682|FG001|Open-Label Phase|Response criteria not met|0|||
149031233|NCT01081145|537591681|FG000|Open-Label Phase|Adverse Event|42|||
149031234|NCT01081145|537591682|FG001|Open-Label Phase|Adverse Event|0|||
149031235|NCT01081145|537591681|FG000|Open-Label Phase|Withdrawal by Subject|41|||
149031236|NCT01081145|537591682|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149031237|NCT01081145|537591681|FG000|Open-Label Phase|Other|12|||
149031238|NCT01081145|537591682|FG001|Open-Label Phase|Other|0|||
149031239|NCT01081145|537591681|FG000|Open-Label Phase|Lost to Follow-up|11|||
149031240|NCT01081145|537591682|FG001|Open-Label Phase|Lost to Follow-up|0|||
149031241|NCT01081145|537591681|FG000|Open-Label Phase|Protocol Violation|4|||
149031242|NCT01081145|537591682|FG001|Open-Label Phase|Protocol Violation|0|||
149031243|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
149031244|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
149031245|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
149031246|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
148866176|NCT00900146|536987285|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
148866177|NCT00900146|536987286|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
149031247|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
149031248|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
149031249|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
149031250|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
149031251|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
149031252|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
149031253|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
149031254|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
149031255|NCT01081145|537591681|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
149031256|NCT01081145|537591682|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
149031257|NCT00121199|537591684|FG000|Overall Study|Adverse Event|11|||
149031258|NCT00121199|537591684|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
149031259|NCT00121199|537591684|FG000|Overall Study|Progression/Relapse|1|||
149031260|NCT00121199|537591684|FG000|Overall Study|Death|3|||
149031261|NCT00121199|537591684|FG000|Overall Study|Other - Not Protocol Specified|3|||
149031262|NCT00121199|537591684|FG000|Overall Study|Ineligible|9|||
149031263|NCT03168438|537591685|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
149031264|NCT03168438|537591686|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
149031265|NCT04109118|537591689|FG000|Overall Study|Lost to Follow-up|3|||
149031266|NCT03235349|537591692|FG000|Overall Study|Adverse Event|1|||
149031267|NCT03235349|537591692|FG000|Overall Study|Other|1|||
149031268|NCT03394027|537591693|FG000|Overall Study|Ineligible|3|||
149031269|NCT03394027|537591694|FG001|Overall Study|Ineligible|1|||
149031270|NCT03394027|537591695|FG002|Overall Study|Ineligible|3|||
149031271|NCT03394027|537591693|FG000|Overall Study|Participant declined to participate before treatment started|0|||
149031272|NCT03394027|537591694|FG001|Overall Study|Participant declined to participate before treatment started|0|||
149031273|NCT03394027|537591695|FG002|Overall Study|Participant declined to participate before treatment started|1|||
149031274|NCT01018511|537591699|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
149031275|NCT01018511|537591700|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
149031276|NCT01018511|537591701|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
149031277|NCT01018511|537591702|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
149031278|NCT01018511|537591699|FG000|Overall Study|Adverse Event|5|||
149031279|NCT01018511|537591700|FG001|Overall Study|Adverse Event|9|||
149031280|NCT01018511|537591701|FG002|Overall Study|Adverse Event|13|||
149031281|NCT01018511|537591702|FG003|Overall Study|Adverse Event|10|||
149031282|NCT01018511|537591699|FG000|Overall Study|Lack of Efficacy|4|||
149031283|NCT01018511|537591700|FG001|Overall Study|Lack of Efficacy|1|||
149031284|NCT01018511|537591701|FG002|Overall Study|Lack of Efficacy|1|||
149031285|NCT01018511|537591702|FG003|Overall Study|Lack of Efficacy|2|||
149031286|NCT01018511|537591699|FG000|Overall Study|Withdrawal by Subject|6|||
149031287|NCT01018511|537591700|FG001|Overall Study|Withdrawal by Subject|5|||
149031288|NCT01018511|537591701|FG002|Overall Study|Withdrawal by Subject|11|||
149031289|NCT01018511|537591702|FG003|Overall Study|Withdrawal by Subject|9|||
149031290|NCT01018511|537591699|FG000|Overall Study|Lost to Follow-up|0|||
149031291|NCT01018511|537591700|FG001|Overall Study|Lost to Follow-up|0|||
149031292|NCT01018511|537591701|FG002|Overall Study|Lost to Follow-up|1|||
149031293|NCT01018511|537591702|FG003|Overall Study|Lost to Follow-up|0|||
149031294|NCT01018511|537591699|FG000|Overall Study|Protocol Violation|5|||
149031295|NCT01018511|537591700|FG001|Overall Study|Protocol Violation|8|||
149031296|NCT01018511|537591701|FG002|Overall Study|Protocol Violation|7|||
148866178|NCT00900146|536987287|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
148866179|NCT00900146|536987288|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
148866180|NCT00900146|536987284|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
148866181|NCT00900146|536987285|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
148866182|NCT00900146|536987286|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
148866183|NCT00900146|536987287|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
148866184|NCT00900146|536987288|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
148866185|NCT00900146|536987284|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
148866186|NCT00900146|536987285|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
148866187|NCT00900146|536987286|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
148866188|NCT00900146|536987287|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
148866189|NCT00900146|536987288|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
148866190|NCT00900146|536987284|FG000|Intermediate: Period III|Lost to Follow-up|2|||
148866191|NCT00900146|536987285|FG001|Intermediate: Period III|Lost to Follow-up|0|||
148866192|NCT00900146|536987286|FG002|Intermediate: Period III|Lost to Follow-up|0|||
148866193|NCT00900146|536987287|FG003|Intermediate: Period III|Lost to Follow-up|0|||
148866194|NCT00900146|536987288|FG004|Intermediate: Period III|Lost to Follow-up|1|||
148866195|NCT00900146|536987284|FG000|Intermediate: Period III|Administrative problems|85|||
148866196|NCT00900146|536987285|FG001|Intermediate: Period III|Administrative problems|92|||
148866197|NCT00900146|536987286|FG002|Intermediate: Period III|Administrative problems|84|||
148866198|NCT00900146|536987287|FG003|Intermediate: Period III|Administrative problems|90|||
148866199|NCT00900146|536987288|FG004|Intermediate: Period III|Administrative problems|163|||
148866200|NCT00700102|536987289|FG000|Overall Study|Died|394|||
148866201|NCT00700102|536987290|FG001|Overall Study|Died|385|||
148866202|NCT00700102|536987289|FG000|Overall Study|Lost to Follow-up|8|||
148866203|NCT00700102|536987290|FG001|Overall Study|Lost to Follow-up|10|||
148866204|NCT02525939|536987295|FG000|Overall Study|Lost to Follow-up|27|||
148866205|NCT02525939|536987296|FG001|Overall Study|Lost to Follow-up|24|||
148866206|NCT02525939|536987295|FG000|Overall Study|Physician Decision|0|||
149031297|NCT01018511|537591702|FG003|Overall Study|Protocol Violation|9|||
149031298|NCT01018511|537591699|FG000|Overall Study|Miscellaneous|0|||
149031299|NCT01018511|537591700|FG001|Overall Study|Miscellaneous|2|||
149031300|NCT01018511|537591701|FG002|Overall Study|Miscellaneous|0|||
149031301|NCT01018511|537591702|FG003|Overall Study|Miscellaneous|0|||
149031302|NCT02926937|537591704|FG000|Overall Study|Adverse Event|0|||
149031303|NCT02926937|537591705|FG001|Overall Study|Adverse Event|1|||
149031304|NCT02926937|537591706|FG002|Overall Study|Adverse Event|1|||
148866207|NCT02525939|536987296|FG001|Overall Study|Physician Decision|1|||
148998770|NCT01644734|537471448|FG000|Overall Study|Adverse Event|4|||
148998771|NCT01644734|537471448|FG000|Overall Study|Lost to Follow-up|17|||
148998772|NCT01644734|537471448|FG000|Overall Study|Reasons other than stated above|7|||
148998773|NCT01644734|537471448|FG000|Overall Study|Missing documentation|238|||
148998774|NCT02462876|537471449|FG000|Overall Study|Death|3|||
148998775|NCT02462876|537471449|FG000|Overall Study|Lost to Follow-up|7|||
148998776|NCT02462876|537471449|FG000|Overall Study|Surgical Bypass|9|||
148998777|NCT02462876|537471449|FG000|Overall Study|Amputation Above the Metatarsals|1|||
148998778|NCT02462876|537471449|FG000|Overall Study|36 months follow-up visit missed|1|||
148998779|NCT02462876|537471449|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
148998780|NCT02462876|537471449|FG000|Overall Study|Patient did not come back to the vascular department|1|||
148998781|NCT02462876|537471449|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
148998782|NCT02462876|537471449|FG000|Overall Study|Patient refused to come back|1|||
148998783|NCT02462876|537471449|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
148998784|NCT02462876|537471449|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
148998785|NCT01786512|537471450|FG000|Overall Study|Lost to Follow-up|0|||
148998786|NCT01786512|537471451|FG001|Overall Study|Lost to Follow-up|0|||
148998787|NCT01786512|537471452|FG002|Overall Study|Lost to Follow-up|0|||
148998788|NCT01786512|537471453|FG003|Overall Study|Lost to Follow-up|0|||
148998789|NCT01786512|537471454|FG004|Overall Study|Lost to Follow-up|0|||
148998790|NCT01786512|537471455|FG005|Overall Study|Lost to Follow-up|0|||
148998791|NCT01786512|537471456|FG006|Overall Study|Lost to Follow-up|0|||
148998792|NCT01786512|537471457|FG007|Overall Study|Lost to Follow-up|0|||
148998793|NCT01786512|537471458|FG008|Overall Study|Lost to Follow-up|0|||
148998794|NCT01786512|537471459|FG009|Overall Study|Lost to Follow-up|1|||
148998795|NCT01786512|537471460|FG010|Overall Study|Lost to Follow-up|0|||
148998796|NCT01786512|537471450|FG000|Overall Study|Decision by sponsor|0|||
148998797|NCT01786512|537471451|FG001|Overall Study|Decision by sponsor|0|||
148998798|NCT01786512|537471452|FG002|Overall Study|Decision by sponsor|0|||
148998799|NCT01786512|537471453|FG003|Overall Study|Decision by sponsor|0|||
148998800|NCT01786512|537471454|FG004|Overall Study|Decision by sponsor|0|||
148998801|NCT01786512|537471455|FG005|Overall Study|Decision by sponsor|0|||
148998802|NCT01786512|537471456|FG006|Overall Study|Decision by sponsor|0|||
148998803|NCT01786512|537471457|FG007|Overall Study|Decision by sponsor|0|||
148998804|NCT01786512|537471458|FG008|Overall Study|Decision by sponsor|0|||
148998805|NCT01786512|537471459|FG009|Overall Study|Decision by sponsor|0|||
148998806|NCT01786512|537471460|FG010|Overall Study|Decision by sponsor|2|||
148998807|NCT01786512|537471450|FG000|Overall Study|Withdrawal by Subject|0|||
148998808|NCT01786512|537471451|FG001|Overall Study|Withdrawal by Subject|1|||
148998809|NCT01786512|537471452|FG002|Overall Study|Withdrawal by Subject|0|||
148998810|NCT01786512|537471453|FG003|Overall Study|Withdrawal by Subject|0|||
148998811|NCT01786512|537471454|FG004|Overall Study|Withdrawal by Subject|0|||
148998812|NCT01786512|537471455|FG005|Overall Study|Withdrawal by Subject|0|||
148998813|NCT01786512|537471456|FG006|Overall Study|Withdrawal by Subject|1|||
148998814|NCT01786512|537471457|FG007|Overall Study|Withdrawal by Subject|0|||
148998815|NCT01786512|537471458|FG008|Overall Study|Withdrawal by Subject|0|||
148998816|NCT01786512|537471459|FG009|Overall Study|Withdrawal by Subject|3|||
148998817|NCT01786512|537471460|FG010|Overall Study|Withdrawal by Subject|7|||
148998818|NCT01786512|537471450|FG000|Overall Study|Death|0|||
148998819|NCT01786512|537471451|FG001|Overall Study|Death|0|||
148998820|NCT01786512|537471452|FG002|Overall Study|Death|0|||
148998821|NCT01786512|537471453|FG003|Overall Study|Death|0|||
148998822|NCT01786512|537471454|FG004|Overall Study|Death|0|||
148998823|NCT01786512|537471455|FG005|Overall Study|Death|0|||
148998824|NCT01786512|537471456|FG006|Overall Study|Death|0|||
148998825|NCT01786512|537471457|FG007|Overall Study|Death|0|||
148998826|NCT01786512|537471458|FG008|Overall Study|Death|4|||
148998827|NCT01786512|537471459|FG009|Overall Study|Death|1|||
148998828|NCT01786512|537471460|FG010|Overall Study|Death|3|||
148998829|NCT00605293|537471461|FG000|Overall Study|Death|2|||
148998830|NCT00605293|537471462|FG001|Overall Study|Death|1|||
148998831|NCT00605293|537471461|FG000|Overall Study|Insufficient Therapeutic Response|2|||
148998832|NCT00605293|537471462|FG001|Overall Study|Insufficient Therapeutic Response|0|||
148998833|NCT00605293|537471461|FG000|Overall Study|Adverse Event|1|||
148998834|NCT00605293|537471462|FG001|Overall Study|Adverse Event|0|||
148998835|NCT00605293|537471461|FG000|Overall Study|Holidays Dialysis Out|1|||
148998836|NCT00605293|537471462|FG001|Overall Study|Holidays Dialysis Out|0|||
148998837|NCT00605293|537471461|FG000|Overall Study|Blood Transfusion|7|||
148998838|NCT00605293|537471462|FG001|Overall Study|Blood Transfusion|1|||
148998839|NCT00605293|537471461|FG000|Overall Study|Renal Transplantation|3|||
148998840|NCT00605293|537471462|FG001|Overall Study|Renal Transplantation|1|||
148998841|NCT00605293|537471461|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
148998842|NCT00605293|537471462|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
148998843|NCT00605293|537471461|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
148998844|NCT00605293|537471462|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
148998845|NCT00605293|537471461|FG000|Overall Study|Principal Investigator Decision|0|||
149031305|NCT02926937|537591704|FG000|Overall Study|Poor Compliance to Protocol|1|||
149031306|NCT02926937|537591705|FG001|Overall Study|Poor Compliance to Protocol|0|||
149031307|NCT02926937|537591706|FG002|Overall Study|Poor Compliance to Protocol|0|||
149031308|NCT02926937|537591704|FG000|Overall Study|Lost to Follow-up|4|||
149031309|NCT02926937|537591705|FG001|Overall Study|Lost to Follow-up|5|||
149031310|NCT02926937|537591706|FG002|Overall Study|Lost to Follow-up|0|||
149031311|NCT02926937|537591704|FG000|Overall Study|At the Participant's own Request|11|||
149031312|NCT02926937|537591705|FG001|Overall Study|At the Participant's own Request|5|||
149031313|NCT02926937|537591706|FG002|Overall Study|At the Participant's own Request|8|||
149031314|NCT02926937|537591704|FG000|Overall Study|Reason not Specified|3|||
149031315|NCT02926937|537591705|FG001|Overall Study|Reason not Specified|4|||
149031316|NCT02926937|537591706|FG002|Overall Study|Reason not Specified|2|||
149031317|NCT01137292|537591708|FG000|Overall Study|Death|30|||
149031318|NCT01137292|537591708|FG000|Overall Study|Adverse Event|3|||
149031319|NCT01137292|537591708|FG000|Overall Study|Lack of Efficacy|13|||
149031320|NCT01137292|537591708|FG000|Overall Study|Lost to Follow-up|1|||
149031321|NCT01137292|537591708|FG000|Overall Study|Other|7|||
149031322|NCT01311713|537591709|FG000|Overall Study|Death|0|||
149031323|NCT01311713|537591710|FG001|Overall Study|Death|0|||
149031324|NCT01311713|537591711|FG002|Overall Study|Death|1|||
149031325|NCT01311713|537591712|FG003|Overall Study|Death|1|||
149031326|NCT01311713|537591713|FG004|Overall Study|Death|0|||
149031327|NCT01311713|537591714|FG005|Overall Study|Death|1|||
149031328|NCT01311713|537591715|FG006|Overall Study|Death|0|||
149031329|NCT01311713|537591709|FG000|Overall Study|Adverse Event|0|||
149031330|NCT01311713|537591710|FG001|Overall Study|Adverse Event|1|||
149031331|NCT01311713|537591711|FG002|Overall Study|Adverse Event|0|||
149031332|NCT01311713|537591712|FG003|Overall Study|Adverse Event|2|||
149031333|NCT01311713|537591713|FG004|Overall Study|Adverse Event|0|||
149031334|NCT01311713|537591714|FG005|Overall Study|Adverse Event|0|||
149031335|NCT01311713|537591715|FG006|Overall Study|Adverse Event|2|||
149031336|NCT01311713|537591709|FG000|Overall Study|Withdrawal by Subject|0|||
149031337|NCT01311713|537591710|FG001|Overall Study|Withdrawal by Subject|1|||
149031338|NCT01311713|537591711|FG002|Overall Study|Withdrawal by Subject|1|||
149031339|NCT01311713|537591712|FG003|Overall Study|Withdrawal by Subject|0|||
149031340|NCT01311713|537591713|FG004|Overall Study|Withdrawal by Subject|0|||
149031341|NCT01311713|537591714|FG005|Overall Study|Withdrawal by Subject|1|||
149031342|NCT01311713|537591715|FG006|Overall Study|Withdrawal by Subject|2|||
149031343|NCT01311713|537591709|FG000|Overall Study|Disease progression|3|||
149031344|NCT01311713|537591710|FG001|Overall Study|Disease progression|4|||
149031345|NCT01311713|537591711|FG002|Overall Study|Disease progression|3|||
149031346|NCT01311713|537591712|FG003|Overall Study|Disease progression|2|||
149031347|NCT01311713|537591713|FG004|Overall Study|Disease progression|4|||
149031348|NCT01311713|537591714|FG005|Overall Study|Disease progression|4|||
149031349|NCT01311713|537591715|FG006|Overall Study|Disease progression|5|||
149031350|NCT01311713|537591709|FG000|Overall Study|Lost to Follow-up|0|||
149031351|NCT01311713|537591710|FG001|Overall Study|Lost to Follow-up|0|||
149031352|NCT01311713|537591711|FG002|Overall Study|Lost to Follow-up|1|||
149031353|NCT01311713|537591712|FG003|Overall Study|Lost to Follow-up|0|||
149031354|NCT01311713|537591713|FG004|Overall Study|Lost to Follow-up|0|||
149031355|NCT01311713|537591714|FG005|Overall Study|Lost to Follow-up|0|||
149031356|NCT01311713|537591715|FG006|Overall Study|Lost to Follow-up|0|||
149031357|NCT01311713|537591709|FG000|Overall Study|Stopped taking study medication|0|||
149031358|NCT01311713|537591710|FG001|Overall Study|Stopped taking study medication|0|||
149031359|NCT01311713|537591711|FG002|Overall Study|Stopped taking study medication|0|||
149031360|NCT01311713|537591712|FG003|Overall Study|Stopped taking study medication|1|||
149031361|NCT01311713|537591713|FG004|Overall Study|Stopped taking study medication|1|||
149031362|NCT01311713|537591714|FG005|Overall Study|Stopped taking study medication|0|||
149031363|NCT01311713|537591715|FG006|Overall Study|Stopped taking study medication|0|||
148866208|NCT02525939|536987295|FG000|Overall Study|Withdrawal by Subject|24|||
148866209|NCT02525939|536987296|FG001|Overall Study|Withdrawal by Subject|39|||
149031364|NCT01311713|537591709|FG000|Overall Study|Enrolled but not treated|0|||
149031365|NCT01311713|537591710|FG001|Overall Study|Enrolled but not treated|0|||
149031366|NCT01311713|537591711|FG002|Overall Study|Enrolled but not treated|1|||
149031367|NCT01311713|537591712|FG003|Overall Study|Enrolled but not treated|0|||
149031368|NCT01311713|537591713|FG004|Overall Study|Enrolled but not treated|0|||
149031369|NCT01311713|537591714|FG005|Overall Study|Enrolled but not treated|0|||
149031370|NCT01311713|537591715|FG006|Overall Study|Enrolled but not treated|0|||
149031371|NCT01311713|537591709|FG000|Overall Study|Other than specified|0|||
149031372|NCT01311713|537591710|FG001|Overall Study|Other than specified|1|||
149031373|NCT01311713|537591711|FG002|Overall Study|Other than specified|2|||
149031374|NCT01311713|537591712|FG003|Overall Study|Other than specified|0|||
149031375|NCT01311713|537591713|FG004|Overall Study|Other than specified|0|||
149031376|NCT01311713|537591714|FG005|Overall Study|Other than specified|0|||
149031377|NCT01311713|537591715|FG006|Overall Study|Other than specified|0|||
149031378|NCT01772719|537591716|FG000|Overall Study|Withdrawal by Subject|3|||
149031379|NCT01772719|537591716|FG000|Overall Study|Adverse Event|2|||
149031380|NCT01772719|537591716|FG000|Overall Study|Protocol Violation|1|||
148998846|NCT00605293|537471462|FG001|Overall Study|Principal Investigator Decision|1|||
148998847|NCT02450331|537471463|FG000|Overall Study|Death|162|||
148998848|NCT02450331|537471464|FG001|Overall Study|Death|171|||
148998849|NCT02450331|537471463|FG000|Overall Study|Lost to Follow-up|14|||
148998850|NCT02450331|537471464|FG001|Overall Study|Lost to Follow-up|12|||
148998851|NCT02450331|537471463|FG000|Overall Study|Withdrawal by Subject|55|||
148998852|NCT02450331|537471464|FG001|Overall Study|Withdrawal by Subject|44|||
148998853|NCT02450331|537471463|FG000|Overall Study|Non-specified other|1|||
148998854|NCT02450331|537471464|FG001|Overall Study|Non-specified other|1|||
148998855|NCT03581981|537471465|FG000|Overall Study|Withdrawal by Subject|12|||
148998856|NCT03581981|537471466|FG001|Overall Study|Withdrawal by Subject|13|||
148998857|NCT03581981|537471465|FG000|Overall Study|Physician Decision|1|||
148998858|NCT03581981|537471466|FG001|Overall Study|Physician Decision|2|||
148998859|NCT03581981|537471465|FG000|Overall Study|Lost to Follow-up|0|||
148998860|NCT03581981|537471466|FG001|Overall Study|Lost to Follow-up|4|||
148998861|NCT02080871|537471467|FG000|Overall Study|Death|1|||
148998862|NCT02080871|537471467|FG000|Overall Study|Lost to Follow-up|1|||
148998863|NCT00234052|537471468|FG000|Treatment|Withdrawal by Subject|3|||
148998864|NCT00234052|537471468|FG000|Treatment|Adverse Event|5|||
148998865|NCT00234052|537471468|FG000|Treatment|Death|2|||
148998866|NCT00234052|537471468|FG000|Treatment|Progressive Disease|11|||
148998867|NCT00234052|537471468|FG000|Follow-up for 5 Years|Death|41|||
148998868|NCT00234052|537471468|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
148998869|NCT00234052|537471468|FG000|Follow-up for 5 Years|Other|7|||
148998870|NCT01410474|537471469|FG000|Overall Study|Withdrawal by Subject|0|||
148998871|NCT01410474|537471470|FG001|Overall Study|Withdrawal by Subject|1|||
148998872|NCT02428296|537471471|FG000|Overall Study|Adverse Event|7|||
148998873|NCT02428296|537471471|FG000|Overall Study|Withdrawal by Subject|2|||
148998874|NCT00828984|537471473|FG000|Overall Study|Adverse Event|2|||
148998875|NCT00828984|537471474|FG001|Overall Study|Adverse Event|3|||
148998876|NCT00828984|537471475|FG002|Overall Study|Adverse Event|0|||
148998877|NCT00828984|537471473|FG000|Overall Study|Lost to Follow-up|5|||
148998878|NCT00828984|537471474|FG001|Overall Study|Lost to Follow-up|3|||
148998879|NCT00828984|537471475|FG002|Overall Study|Lost to Follow-up|1|||
148998880|NCT00828984|537471473|FG000|Overall Study|Withdrawal by Subject|4|||
148998881|NCT00828984|537471474|FG001|Overall Study|Withdrawal by Subject|4|||
148998882|NCT00828984|537471475|FG002|Overall Study|Withdrawal by Subject|4|||
148998883|NCT00828984|537471473|FG000|Overall Study|Ineligable|1|||
148998884|NCT00828984|537471474|FG001|Overall Study|Ineligable|2|||
148998885|NCT00828984|537471475|FG002|Overall Study|Ineligable|0|||
148998886|NCT00828984|537471473|FG000|Overall Study|Medical Contraindication|0|||
148998887|NCT00828984|537471474|FG001|Overall Study|Medical Contraindication|1|||
148998888|NCT00828984|537471475|FG002|Overall Study|Medical Contraindication|0|||
148998889|NCT00828984|537471473|FG000|Overall Study|Noncompliant|1|||
148998890|NCT00828984|537471474|FG001|Overall Study|Noncompliant|2|||
148998891|NCT00828984|537471475|FG002|Overall Study|Noncompliant|3|||
148998892|NCT00828984|537471473|FG000|Overall Study|ConMed|1|||
148998893|NCT00828984|537471474|FG001|Overall Study|ConMed|1|||
148998894|NCT00828984|537471475|FG002|Overall Study|ConMed|1|||
148998895|NCT00420199|537471479|FG000|Overall Study|Participant no longer met study criteria|1|||
148998896|NCT00420199|537471480|FG001|Overall Study|Participant no longer met study criteria|0|||
148998897|NCT02123108|537471485|FG000|Overall Study|Death|2|||
148998898|NCT02123108|537471486|FG001|Overall Study|Death|3|||
148998899|NCT00716092|537471487|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
148998900|NCT00716092|537471488|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
148998901|NCT00716092|537471489|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
148998902|NCT02219048|537471490|FG000|Overall Study|Adverse Event|2|||
148998903|NCT02219048|537471491|FG001|Overall Study|Adverse Event|5|||
148998904|NCT02219048|537471490|FG000|Overall Study|No longer meets eligibility criteria|1|||
148998905|NCT02219048|537471491|FG001|Overall Study|No longer meets eligibility criteria|0|||
148998906|NCT02219048|537471490|FG000|Overall Study|Study terminated by sponsor|16|||
148998907|NCT02219048|537471491|FG001|Overall Study|Study terminated by sponsor|15|||
148998908|NCT02219048|537471490|FG000|Overall Study|Withdrawal by Subject|2|||
148998909|NCT02219048|537471491|FG001|Overall Study|Withdrawal by Subject|0|||
148998910|NCT02219048|537471490|FG000|Overall Study|Other|0|||
148998911|NCT02219048|537471491|FG001|Overall Study|Other|1|||
148998912|NCT02436330|537471492|FG000|Cohort 1|Lost to Follow-up|5|||
148998913|NCT02436330|537471493|FG001|Cohort 1|Lost to Follow-up|2|||
148998914|NCT02436330|537471492|FG000|Cohort 1|Withdrawal by Subject|0|||
148998915|NCT02436330|537471493|FG001|Cohort 1|Withdrawal by Subject|1|||
148998916|NCT02436330|537471492|FG000|Cohort 2|Lost to Follow-up|2|||
148998917|NCT02436330|537471493|FG001|Cohort 2|Lost to Follow-up|0|||
148998918|NCT02436330|537471492|FG000|Cohort 2|Withdrawal by Subject|2|||
148998919|NCT02436330|537471493|FG001|Cohort 2|Withdrawal by Subject|3|||
148998920|NCT02436330|537471492|FG000|Cohort 3|Lost to Follow-up|1|||
148998921|NCT02436330|537471493|FG001|Cohort 3|Lost to Follow-up|0|||
148998922|NCT02436330|537471492|FG000|Cohort 3|Withdrawal by Subject|4|||
148998923|NCT02436330|537471493|FG001|Cohort 3|Withdrawal by Subject|0|||
148998924|NCT02436330|537471492|FG000|Cohort 4|Lost to Follow-up|1|||
148998925|NCT02436330|537471493|FG001|Cohort 4|Lost to Follow-up|0|||
148998926|NCT02436330|537471492|FG000|Cohort 4|Withdrawal by Subject|1|||
148998927|NCT02436330|537471493|FG001|Cohort 4|Withdrawal by Subject|0|||
148998928|NCT02436330|537471492|FG000|Cohort 5|Lost to Follow-up|3|||
148998929|NCT02436330|537471493|FG001|Cohort 5|Lost to Follow-up|2|||
148998930|NCT02436330|537471492|FG000|Cohort 5|Withdrawal by Subject|3|||
148998931|NCT02436330|537471493|FG001|Cohort 5|Withdrawal by Subject|2|||
148998932|NCT02436330|537471492|FG000|Cohort 6|Lost to Follow-up|2|||
148998933|NCT02436330|537471493|FG001|Cohort 6|Lost to Follow-up|0|||
148998934|NCT02436330|537471492|FG000|Cohort 6|Withdrawal by Subject|1|||
148998935|NCT02436330|537471493|FG001|Cohort 6|Withdrawal by Subject|1|||
148998936|NCT02054806|537471494|FG000|Overall Study|Sponsor Decision|31|||
148998937|NCT02054806|537471494|FG000|Overall Study|Withdrawal by Subject|43|||
148998938|NCT02054806|537471494|FG000|Overall Study|Protocol Violation|2|||
148998939|NCT02054806|537471494|FG000|Overall Study|Lost to Follow-up|10|||
148998940|NCT02054806|537471494|FG000|Overall Study|Death|391|||
148998941|NCT01132326|537471495|FG000|Overall Study|Lack of Efficacy|25|||
148998942|NCT01132326|537471495|FG000|Overall Study|Adverse Event|37|||
148998943|NCT01132326|537471495|FG000|Overall Study|Protocol Violation|1|||
148998944|NCT01132326|537471495|FG000|Overall Study|Lost to Follow-up|16|||
148998945|NCT01132326|537471495|FG000|Overall Study|Withdrawal by Subject|40|||
148998946|NCT01132326|537471495|FG000|Overall Study|Physician Decision|10|||
148998947|NCT01132326|537471495|FG000|Overall Study|Study Termination|80|||
148998948|NCT01132326|537471495|FG000|Overall Study|Declining Health|1|||
148998949|NCT01132326|537471495|FG000|Overall Study|Pregnancy|1|||
148998950|NCT01132326|537471495|FG000|Overall Study|Caregiver Withdrew Consent|1|||
148998951|NCT01132326|537471495|FG000|Overall Study|Death|5|||
148998952|NCT01132326|537471495|FG000|Overall Study|Subject Unable to Come To Visits|1|||
148998953|NCT00781391|537471496|FG000|Overall Study|never received study drug|24|||
148998954|NCT00781391|537471497|FG001|Overall Study|never received study drug|23|||
148998955|NCT00781391|537471498|FG002|Overall Study|never received study drug|32|||
148998956|NCT00781391|537471496|FG000|Overall Study|Protocol Violation|19|||
148998957|NCT00781391|537471497|FG001|Overall Study|Protocol Violation|17|||
148998958|NCT00781391|537471498|FG002|Overall Study|Protocol Violation|20|||
148998959|NCT00781391|537471496|FG000|Overall Study|Death|789|||
148998960|NCT00781391|537471497|FG001|Overall Study|Death|730|||
148998961|NCT00781391|537471498|FG002|Overall Study|Death|706|||
148998962|NCT00781391|537471496|FG000|Overall Study|Withdrawal by Subject|47|||
148998963|NCT00781391|537471497|FG001|Overall Study|Withdrawal by Subject|37|||
148998964|NCT00781391|537471498|FG002|Overall Study|Withdrawal by Subject|25|||
148998965|NCT00781391|537471496|FG000|Overall Study|Lost to Follow-up|0|||
148998966|NCT00781391|537471497|FG001|Overall Study|Lost to Follow-up|0|||
148998967|NCT00781391|537471498|FG002|Overall Study|Lost to Follow-up|1|||
148998968|NCT04535947|537471507|FG000|Overall Study|Adverse Event|1|||
148998969|NCT04535947|537471508|FG001|Overall Study|Adverse Event|4|||
148998970|NCT04535947|537471507|FG000|Overall Study|Other reasons not specified|2|||
148998971|NCT04535947|537471508|FG001|Overall Study|Other reasons not specified|0|||
148998972|NCT04535947|537471507|FG000|Overall Study|Withdrawal by Subject|1|||
148998973|NCT04535947|537471508|FG001|Overall Study|Withdrawal by Subject|1|||
148998974|NCT03205371|537471518|FG000|Overall Study|Withdrawal by Subject|4|||
148998975|NCT03205371|537471519|FG001|Overall Study|Withdrawal by Subject|1|||
148998976|NCT03205371|537471520|FG002|Overall Study|Withdrawal by Subject|0|||
148998977|NCT03205371|537471521|FG003|Overall Study|Withdrawal by Subject|0|||
148998978|NCT03205371|537471522|FG004|Overall Study|Withdrawal by Subject|0|||
148998979|NCT03205371|537471523|FG005|Overall Study|Withdrawal by Subject|0|||
148998980|NCT03205371|537471524|FG006|Overall Study|Withdrawal by Subject|4|||
148998981|NCT03205371|537471525|FG007|Overall Study|Withdrawal by Subject|0|||
148998982|NCT03205371|537471526|FG008|Overall Study|Withdrawal by Subject|2|||
148998983|NCT03205371|537471527|FG009|Overall Study|Withdrawal by Subject|0|||
148998984|NCT03205371|537471528|FG010|Overall Study|Withdrawal by Subject|0|||
148998985|NCT03205371|537471529|FG011|Overall Study|Withdrawal by Subject|1|||
148998986|NCT03205371|537471518|FG000|Overall Study|Lost to Follow-up|0|||
148998987|NCT03205371|537471519|FG001|Overall Study|Lost to Follow-up|0|||
148998988|NCT03205371|537471520|FG002|Overall Study|Lost to Follow-up|0|||
148998989|NCT03205371|537471521|FG003|Overall Study|Lost to Follow-up|0|||
148998990|NCT03205371|537471522|FG004|Overall Study|Lost to Follow-up|0|||
148998991|NCT03205371|537471523|FG005|Overall Study|Lost to Follow-up|0|||
148998992|NCT03205371|537471524|FG006|Overall Study|Lost to Follow-up|5|||
148998993|NCT03205371|537471525|FG007|Overall Study|Lost to Follow-up|2|||
148998994|NCT03205371|537471526|FG008|Overall Study|Lost to Follow-up|3|||
148998995|NCT03205371|537471527|FG009|Overall Study|Lost to Follow-up|0|||
148998996|NCT03205371|537471528|FG010|Overall Study|Lost to Follow-up|0|||
148998997|NCT03205371|537471529|FG011|Overall Study|Lost to Follow-up|0|||
148998998|NCT03205371|537471518|FG000|Overall Study|Protocol Violation|0|||
148998999|NCT03205371|537471519|FG001|Overall Study|Protocol Violation|0|||
148999000|NCT03205371|537471520|FG002|Overall Study|Protocol Violation|0|||
148999001|NCT03205371|537471521|FG003|Overall Study|Protocol Violation|0|||
148999002|NCT03205371|537471522|FG004|Overall Study|Protocol Violation|0|||
148999003|NCT03205371|537471523|FG005|Overall Study|Protocol Violation|0|||
148999004|NCT03205371|537471524|FG006|Overall Study|Protocol Violation|1|||
148866210|NCT02525939|536987295|FG000|Overall Study|Death|180|||
148866211|NCT02525939|536987296|FG001|Overall Study|Death|179|||
148866212|NCT01028716|536987297|FG000|Overall Study|Physician Decision|1|||
148866213|NCT01635764|536987298|FG000|Overall Study|Adverse Event|46|||
148866214|NCT01635764|536987298|FG000|Overall Study|Lack of Efficacy|76|||
148866215|NCT01635764|536987298|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
148866216|NCT01635764|536987298|FG000|Overall Study|Protocol Deviation|1|||
148866217|NCT01635764|536987298|FG000|Overall Study|Withdrew Consent|67|||
148866218|NCT01635764|536987298|FG000|Overall Study|Lost to Follow-up|53|||
148866219|NCT01635764|536987298|FG000|Overall Study|Other|28|||
148866220|NCT01628367|536987299|FG000|Overall Study|Adverse Event|1|||
148866221|NCT01628367|536987300|FG001|Overall Study|Adverse Event|0|||
148866222|NCT03353922|536987303|FG000|Overall Study|Withdrawal by Subject|1|||
148866223|NCT03353922|536987304|FG001|Overall Study|Withdrawal by Subject|0|||
148866224|NCT03353922|536987305|FG002|Overall Study|Withdrawal by Subject|1|||
148866225|NCT03353922|536987306|FG003|Overall Study|Withdrawal by Subject|1|||
148866226|NCT03353922|536987307|FG004|Overall Study|Withdrawal by Subject|0|||
148866227|NCT03353922|536987308|FG005|Overall Study|Withdrawal by Subject|0|||
148866228|NCT03353922|536987303|FG000|Overall Study|Adverse Event|0|||
148866229|NCT03353922|536987304|FG001|Overall Study|Adverse Event|1|||
148866230|NCT03353922|536987305|FG002|Overall Study|Adverse Event|0|||
148866231|NCT03353922|536987306|FG003|Overall Study|Adverse Event|0|||
148866232|NCT03353922|536987307|FG004|Overall Study|Adverse Event|0|||
148866233|NCT03353922|536987308|FG005|Overall Study|Adverse Event|0|||
148866234|NCT00740714|536987309|FG000|Overall Study|Withdrawal by Subject|17|||
148866235|NCT00740714|536987310|FG001|Overall Study|Withdrawal by Subject|19|||
148866236|NCT00740714|536987311|FG002|Overall Study|Withdrawal by Subject|29|||
148866237|NCT03688555|536987312|FG000|Treatment Period|Adverse Event|0|||
148866238|NCT03688555|536987313|FG001|Treatment Period|Adverse Event|0|||
148866239|NCT03688555|536987314|FG002|Treatment Period|Adverse Event|1|||
148866240|NCT00886119|536987319|FG000|Period 1|Did not meet inclusion criteria|1|||
148866241|NCT00886119|536987320|FG001|Period 1|Did not meet inclusion criteria|0|||
148866242|NCT00394901|536987321|FG000|Baseline Phase|Protocol Violation|0|||
148866243|NCT00394901|536987322|FG001|Baseline Phase|Protocol Violation|0|||
148866244|NCT00394901|536987323|FG002|Baseline Phase|Protocol Violation|1|||
148866245|NCT00394901|536987324|FG003|Baseline Phase|Protocol Violation|0|||
148866246|NCT00394901|536987321|FG000|Double-blind Phase|Adverse Event|5|||
148866247|NCT00394901|536987322|FG001|Double-blind Phase|Adverse Event|7|||
148866248|NCT00394901|536987323|FG002|Double-blind Phase|Adverse Event|16|||
148866249|NCT00394901|536987324|FG003|Double-blind Phase|Adverse Event|20|||
148866250|NCT00394901|536987321|FG000|Double-blind Phase|Lack of Efficacy|6|||
148866251|NCT00394901|536987322|FG001|Double-blind Phase|Lack of Efficacy|4|||
148866252|NCT00394901|536987323|FG002|Double-blind Phase|Lack of Efficacy|1|||
148866253|NCT00394901|536987324|FG003|Double-blind Phase|Lack of Efficacy|3|||
148866254|NCT00394901|536987321|FG000|Double-blind Phase|Withdrawal by Subject|2|||
148866255|NCT00394901|536987322|FG001|Double-blind Phase|Withdrawal by Subject|0|||
148866256|NCT00394901|536987323|FG002|Double-blind Phase|Withdrawal by Subject|0|||
148866257|NCT00394901|536987324|FG003|Double-blind Phase|Withdrawal by Subject|0|||
148866258|NCT00394901|536987321|FG000|Double-blind Phase|Lost to Follow-up|0|||
148866259|NCT00394901|536987322|FG001|Double-blind Phase|Lost to Follow-up|0|||
148866260|NCT00394901|536987323|FG002|Double-blind Phase|Lost to Follow-up|0|||
148866261|NCT00394901|536987324|FG003|Double-blind Phase|Lost to Follow-up|1|||
148866262|NCT00394901|536987321|FG000|Double-blind Phase|Protocol Violation|0|||
148866263|NCT00394901|536987322|FG001|Double-blind Phase|Protocol Violation|0|||
148866264|NCT00394901|536987323|FG002|Double-blind Phase|Protocol Violation|0|||
148866265|NCT00394901|536987324|FG003|Double-blind Phase|Protocol Violation|1|||
148866266|NCT00394901|536987321|FG000|Double-blind Phase|Death|1|||
148866267|NCT00394901|536987322|FG001|Double-blind Phase|Death|0|||
148866268|NCT00394901|536987323|FG002|Double-blind Phase|Death|0|||
148866269|NCT00394901|536987324|FG003|Double-blind Phase|Death|0|||
148866270|NCT00394901|536987321|FG000|Double-blind Phase|Subject's Personal Reason|1|||
148999005|NCT03205371|537471525|FG007|Overall Study|Protocol Violation|0|||
148999006|NCT03205371|537471526|FG008|Overall Study|Protocol Violation|0|||
148999007|NCT03205371|537471527|FG009|Overall Study|Protocol Violation|0|||
148999008|NCT03205371|537471528|FG010|Overall Study|Protocol Violation|0|||
148999009|NCT03205371|537471529|FG011|Overall Study|Protocol Violation|0|||
148866271|NCT00394901|536987322|FG001|Double-blind Phase|Subject's Personal Reason|0|||
148866272|NCT00394901|536987323|FG002|Double-blind Phase|Subject's Personal Reason|0|||
148866273|NCT00394901|536987324|FG003|Double-blind Phase|Subject's Personal Reason|1|||
148866274|NCT00394901|536987321|FG000|Double-blind Phase|Lack of Compliance|0|||
148866275|NCT00394901|536987322|FG001|Double-blind Phase|Lack of Compliance|3|||
148866276|NCT00394901|536987323|FG002|Double-blind Phase|Lack of Compliance|0|||
148866277|NCT00394901|536987324|FG003|Double-blind Phase|Lack of Compliance|0|||
148866278|NCT00394901|536987321|FG000|Double-blind Phase|Entry into another study was found|0|||
148866279|NCT00394901|536987322|FG001|Double-blind Phase|Entry into another study was found|0|||
148866280|NCT00394901|536987323|FG002|Double-blind Phase|Entry into another study was found|1|||
148866281|NCT00394901|536987324|FG003|Double-blind Phase|Entry into another study was found|0|||
148999010|NCT03205371|537471518|FG000|Overall Study|Adverse Event|0|||
148999011|NCT03205371|537471519|FG001|Overall Study|Adverse Event|0|||
148999012|NCT03205371|537471520|FG002|Overall Study|Adverse Event|0|||
148999013|NCT03205371|537471521|FG003|Overall Study|Adverse Event|0|||
148999014|NCT03205371|537471522|FG004|Overall Study|Adverse Event|0|||
148999015|NCT03205371|537471523|FG005|Overall Study|Adverse Event|0|||
148999016|NCT03205371|537471524|FG006|Overall Study|Adverse Event|0|||
148999017|NCT03205371|537471525|FG007|Overall Study|Adverse Event|1|||
148999018|NCT03205371|537471526|FG008|Overall Study|Adverse Event|0|||
148999019|NCT03205371|537471527|FG009|Overall Study|Adverse Event|0|||
148999020|NCT03205371|537471528|FG010|Overall Study|Adverse Event|0|||
148999021|NCT03205371|537471529|FG011|Overall Study|Adverse Event|0|||
148999022|NCT03492281|537471531|FG000|Overall Study|Withdrawal by Subject|21|||
148999023|NCT03492281|537471532|FG001|Overall Study|Withdrawal by Subject|14|||
148999024|NCT03492281|537471533|FG002|Overall Study|Withdrawal by Subject|13|||
148999025|NCT03492281|537471531|FG000|Overall Study|Lost to Follow-up|14|||
148999026|NCT03492281|537471532|FG001|Overall Study|Lost to Follow-up|15|||
148999027|NCT03492281|537471533|FG002|Overall Study|Lost to Follow-up|10|||
148999028|NCT03492281|537471531|FG000|Overall Study|Adverse Event|6|||
148999029|NCT03492281|537471532|FG001|Overall Study|Adverse Event|8|||
148999030|NCT03492281|537471533|FG002|Overall Study|Adverse Event|13|||
148999031|NCT03492281|537471531|FG000|Overall Study|Lack of Efficacy|3|||
148999032|NCT03492281|537471532|FG001|Overall Study|Lack of Efficacy|0|||
148999033|NCT03492281|537471533|FG002|Overall Study|Lack of Efficacy|1|||
148999034|NCT03492281|537471531|FG000|Overall Study|Physician Decision|1|||
148999035|NCT03492281|537471532|FG001|Overall Study|Physician Decision|0|||
148999036|NCT03492281|537471533|FG002|Overall Study|Physician Decision|3|||
148999037|NCT03492281|537471531|FG000|Overall Study|Protocol Violation|0|||
148999038|NCT03492281|537471532|FG001|Overall Study|Protocol Violation|2|||
148999039|NCT03492281|537471533|FG002|Overall Study|Protocol Violation|1|||
148999040|NCT03492281|537471531|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
148999041|NCT03492281|537471532|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
148999042|NCT03492281|537471533|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
148999043|NCT03492281|537471531|FG000|Overall Study|Death|0|||
148999044|NCT03492281|537471532|FG001|Overall Study|Death|0|||
148999045|NCT03492281|537471533|FG002|Overall Study|Death|1|||
148999046|NCT03492281|537471531|FG000|Overall Study|Captured as Other in Database|8|||
148999047|NCT03492281|537471532|FG001|Overall Study|Captured as Other in Database|6|||
148999048|NCT03492281|537471533|FG002|Overall Study|Captured as Other in Database|3|||
148999049|NCT03624504|537471534|FG000|Overall Study|Unsuccessful Implant|1|||
148999050|NCT02363946|537471536|FG000|Overall Study|Lost to Follow-up|0|||
148999051|NCT02363946|537471537|FG001|Overall Study|Lost to Follow-up|0|||
148999052|NCT02363946|537471538|FG002|Overall Study|Lost to Follow-up|0|||
148999053|NCT02363946|537471539|FG003|Overall Study|Lost to Follow-up|0|||
148999054|NCT02363946|537471540|FG004|Overall Study|Lost to Follow-up|0|||
148999055|NCT02363946|537471541|FG005|Overall Study|Lost to Follow-up|0|||
148999056|NCT02363946|537471542|FG006|Overall Study|Lost to Follow-up|0|||
148999057|NCT02363946|537471543|FG007|Overall Study|Lost to Follow-up|1|||
148999058|NCT02363946|537471544|FG008|Overall Study|Lost to Follow-up|0|||
148999059|NCT02363946|537471545|FG009|Overall Study|Lost to Follow-up|0|||
148999060|NCT02363946|537471546|FG010|Overall Study|Lost to Follow-up|0|||
148999061|NCT02363946|537471547|FG011|Overall Study|Lost to Follow-up|0|||
148999062|NCT02363946|537471548|FG012|Overall Study|Lost to Follow-up|0|||
148999063|NCT00765388|537471549|FG000|Period 1|Lack of Efficacy|1|||
148999064|NCT00765388|537471550|FG001|Period 1|Lack of Efficacy|2|||
148999065|NCT00765388|537471549|FG000|Period 1|Lost to Follow-up|0|||
148999066|NCT00765388|537471550|FG001|Period 1|Lost to Follow-up|1|||
148999067|NCT00765388|537471549|FG000|Period 1|Herpes Zoster|0|||
148999068|NCT00765388|537471550|FG001|Period 1|Herpes Zoster|1|||
148999069|NCT00765388|537471549|FG000|Period 1|Hip operation|0|||
148999070|NCT00765388|537471550|FG001|Period 1|Hip operation|1|||
148999071|NCT03923933|537471554|FG000|Overall Study|Lost to Follow-up|1|||
148999072|NCT03923933|537471555|FG001|Overall Study|Lost to Follow-up|0|||
148999073|NCT03923933|537471554|FG000|Overall Study|Withdrawal by Subject|0|||
148999074|NCT03923933|537471555|FG001|Overall Study|Withdrawal by Subject|1|||
148999075|NCT00587964|537471556|FG000|Overall Study|Withdrawal by Subject|1|||
148999076|NCT00587964|537471556|FG000|Overall Study|Lost to Follow-up|1|||
148999077|NCT00587964|537471556|FG000|Overall Study|Patient found to be ineligible|1|||
148999078|NCT00587964|537471556|FG000|Overall Study|Patient did not receive intervention|5|||
148999079|NCT00587964|537471556|FG000|Overall Study|Progression of Disease|4|||
148999080|NCT03645759|537471562|FG000|Overall Study|Lost to Follow-up|3|||
148999081|NCT03645759|537471563|FG001|Overall Study|Lost to Follow-up|2|||
148999082|NCT00818753|537471564|FG000|Overall Study|Protocol Violation|1|||
148999083|NCT00818753|537471565|FG001|Overall Study|Protocol Violation|0|||
148999084|NCT00818753|537471566|FG002|Overall Study|Protocol Violation|0|||
148999085|NCT00818753|537471564|FG000|Overall Study|Other reason (not specified)|0|||
148999086|NCT00818753|537471565|FG001|Overall Study|Other reason (not specified)|0|||
148999087|NCT00818753|537471566|FG002|Overall Study|Other reason (not specified)|1|||
148999088|NCT00818753|537471564|FG000|Overall Study|Randomised and not treated|2|||
148999089|NCT00818753|537471565|FG001|Overall Study|Randomised and not treated|0|||
149031381|NCT01772719|537591716|FG000|Overall Study|Lost to Follow-up|1|||
149031382|NCT00477412|537591723|FG000|Overall Study|Death|0|||
149031383|NCT00477412|537591724|FG001|Overall Study|Death|0|||
149031384|NCT00477412|537591725|FG002|Overall Study|Death|0|||
149031385|NCT00477412|537591726|FG003|Overall Study|Death|4|||
149031386|NCT00477412|537591723|FG000|Overall Study|Lost to Follow-up|0|||
149031387|NCT00477412|537591724|FG001|Overall Study|Lost to Follow-up|0|||
149031388|NCT00477412|537591725|FG002|Overall Study|Lost to Follow-up|0|||
149031389|NCT00477412|537591726|FG003|Overall Study|Lost to Follow-up|1|||
149031390|NCT00477412|537591723|FG000|Overall Study|Withdrawal by Subject|0|||
149031391|NCT00477412|537591724|FG001|Overall Study|Withdrawal by Subject|0|||
149031392|NCT00477412|537591725|FG002|Overall Study|Withdrawal by Subject|0|||
149031393|NCT00477412|537591726|FG003|Overall Study|Withdrawal by Subject|2|||
149031394|NCT00477412|537591723|FG000|Overall Study|Second Malignancy|0|||
149031395|NCT00477412|537591724|FG001|Overall Study|Second Malignancy|0|||
149031396|NCT00477412|537591725|FG002|Overall Study|Second Malignancy|0|||
149031397|NCT00477412|537591726|FG003|Overall Study|Second Malignancy|1|||
149031398|NCT00477412|537591723|FG000|Overall Study|Adverse Event|1|||
149031399|NCT00477412|537591724|FG001|Overall Study|Adverse Event|0|||
149031400|NCT00477412|537591725|FG002|Overall Study|Adverse Event|1|||
149031401|NCT00477412|537591726|FG003|Overall Study|Adverse Event|0|||
149031402|NCT04257058|537593546|FG000|Overall Study|Lost to Follow-up|31|||
149031403|NCT03227757|537593547|FG000|Overall Study|Death|25|||
149031404|NCT03227757|537593547|FG000|Overall Study|Withdrawal|10|||
149031405|NCT03227757|537593547|FG000|Overall Study|Missed visits|1|||
149031406|NCT03227757|537593547|FG000|Overall Study|Lost to Follow-up|2|||
149031407|NCT01144468|537593549|FG000|Overall Study|Lost to Follow-up|4|||
149031408|NCT01144468|537593550|FG001|Overall Study|Lost to Follow-up|7|||
149031409|NCT01144468|537593549|FG000|Overall Study|Adverse Event|3|||
149031410|NCT01144468|537593550|FG001|Overall Study|Adverse Event|2|||
149031411|NCT01144468|537593549|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
149031412|NCT01144468|537593550|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
149031413|NCT02960659|537593551|FG000|Overall Study|Withdrawal by Subject|1|||
149031414|NCT02960659|537593552|FG001|Overall Study|Withdrawal by Subject|0|||
149031415|NCT02960659|537593551|FG000|Overall Study|Poor compliance|0|||
149031416|NCT02960659|537593552|FG001|Overall Study|Poor compliance|1|||
149031417|NCT04199728|537593556|FG000|Overall Study|Adverse Event|1|||
149031418|NCT04199728|537593557|FG001|Overall Study|Adverse Event|0|||
149031419|NCT04199728|537593556|FG000|Overall Study|Withdrawal by Subject|8|||
149031420|NCT04199728|537593557|FG001|Overall Study|Withdrawal by Subject|3|||
149031421|NCT04199728|537593556|FG000|Overall Study|Screen fail after consent|0|||
149031422|NCT04199728|537593557|FG001|Overall Study|Screen fail after consent|1|||
149031423|NCT04199728|537593556|FG000|Overall Study|Early withdraw criteria met|0|||
149031424|NCT04199728|537593557|FG001|Overall Study|Early withdraw criteria met|1|||
149031425|NCT04199728|537593556|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
149031426|NCT04199728|537593557|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
149031427|NCT03068468|537593558|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
149031428|NCT03068468|537593559|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
149031429|NCT03068468|537593560|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
149031430|NCT03068468|537593561|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
149031431|NCT03068468|537593558|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
149031432|NCT03068468|537593559|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
149031433|NCT03068468|537593560|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
149031434|NCT03068468|537593561|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
149031435|NCT03068468|537593558|FG000|Placebo-Controlled Period|Adverse Event|16|||
149031436|NCT03068468|537593559|FG001|Placebo-Controlled Period|Adverse Event|21|||
149031437|NCT03068468|537593560|FG002|Placebo-Controlled Period|Adverse Event|0|||
149031438|NCT03068468|537593561|FG003|Placebo-Controlled Period|Adverse Event|0|||
149031439|NCT03068468|537593558|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
148866282|NCT00394901|536987321|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
148866283|NCT00394901|536987322|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
148866284|NCT00394901|536987323|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
148866285|NCT00394901|536987324|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
148866286|NCT03002623|536987325|FG000|Overall Study|Lost to Follow-up|1|||
148866287|NCT03002623|536987326|FG001|Overall Study|Lost to Follow-up|0|||
149031440|NCT03068468|537593559|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
149031441|NCT03068468|537593560|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
149031442|NCT03068468|537593561|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
149031443|NCT03068468|537593558|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
149031444|NCT03068468|537593559|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
149031445|NCT03068468|537593560|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149031446|NCT03068468|537593561|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149031447|NCT03068468|537593558|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
148866288|NCT03002623|536987325|FG000|Overall Study|Physician Decision|1|||
149031448|NCT03068468|537593559|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
148999090|NCT00818753|537471566|FG002|Overall Study|Randomised and not treated|0|||
148999091|NCT01389973|537471567|FG000|Overall Study|Lost to Follow-up|1|||
148999092|NCT01389973|537471567|FG000|Overall Study|Trial Stopped by Sponsor|9|||
148999093|NCT01389973|537471567|FG000|Overall Study|Other|10|||
148999094|NCT00725296|537471568|FG000|Overall Study|Adverse Event|11|||
148999095|NCT00725296|537471568|FG000|Overall Study|Lack of Efficacy|7|||
148999096|NCT00725296|537471568|FG000|Overall Study|Withdrawal by Subject|3|||
148999097|NCT00725296|537471568|FG000|Overall Study|Non-Compliance|2|||
148999098|NCT00725296|537471568|FG000|Overall Study|Lost to Follow-up|1|||
148999099|NCT00725296|537471568|FG000|Overall Study|Other|38|||
148999100|NCT02693743|537471569|FG000|Overall Study|Physician Decision|1|||
148999101|NCT02693743|537471570|FG001|Overall Study|Physician Decision|0|||
148999102|NCT03360942|537471571|FG000|Overall Study|Device explanted|2|||
148999103|NCT03360942|537471571|FG000|Overall Study|Study closure|1|||
148999104|NCT03360942|537471571|FG000|Overall Study|Withdrawal by Subject|2|||
148999105|NCT02459574|537471577|FG000|Overall Study|Withdrawal by Subject|6|||
148999106|NCT02459574|537471578|FG001|Overall Study|Withdrawal by Subject|6|||
148999107|NCT02459574|537471579|FG002|Overall Study|Withdrawal by Subject|2|||
148999108|NCT02459574|537471577|FG000|Overall Study|Lost to Follow-up|1|||
148999109|NCT02459574|537471578|FG001|Overall Study|Lost to Follow-up|1|||
148999110|NCT02459574|537471579|FG002|Overall Study|Lost to Follow-up|0|||
148999111|NCT02459574|537471577|FG000|Overall Study|Death|0|||
148999112|NCT02459574|537471578|FG001|Overall Study|Death|1|||
148999113|NCT02459574|537471579|FG002|Overall Study|Death|0|||
148999114|NCT01377480|537473923|FG000|Overall Study|Protocol Violation|0|||
148999115|NCT01377480|537473924|FG001|Overall Study|Protocol Violation|0|||
148999116|NCT01377480|537473925|FG002|Overall Study|Protocol Violation|0|||
148999117|NCT01377480|537473926|FG003|Overall Study|Protocol Violation|4|||
148999118|NCT01377480|537473923|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
148999119|NCT01377480|537473924|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
148999120|NCT01377480|537473925|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
148999121|NCT01377480|537473926|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
148999122|NCT01377480|537473923|FG000|Overall Study|Withdrawal by Subject|0|||
148999123|NCT01377480|537473924|FG001|Overall Study|Withdrawal by Subject|0|||
148999124|NCT01377480|537473925|FG002|Overall Study|Withdrawal by Subject|1|||
148999125|NCT01377480|537473926|FG003|Overall Study|Withdrawal by Subject|0|||
148999126|NCT01377480|537473923|FG000|Overall Study|Serious adverse event|0|||
148999127|NCT01377480|537473924|FG001|Overall Study|Serious adverse event|0|||
148999128|NCT01377480|537473925|FG002|Overall Study|Serious adverse event|1|||
148999129|NCT01377480|537473926|FG003|Overall Study|Serious adverse event|1|||
148999130|NCT01377480|537473923|FG000|Overall Study|Other|0|||
148999131|NCT01377480|537473924|FG001|Overall Study|Other|0|||
148999132|NCT01377480|537473925|FG002|Overall Study|Other|7|||
148999133|NCT01377480|537473926|FG003|Overall Study|Other|6|||
148999134|NCT01111123|537473930|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
148999135|NCT01111123|537473931|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
148999136|NCT01111123|537473930|FG000|Maintenance Phase|Lost to Follow-up|0|||
148999137|NCT01111123|537473931|FG001|Maintenance Phase|Lost to Follow-up|2|||
148999138|NCT01735201|537473932|FG000|Overall Study|Adverse Event|1|||
148999139|NCT01735201|537473933|FG001|Overall Study|Adverse Event|1|||
148999140|NCT01735201|537473934|FG002|Overall Study|Adverse Event|0|||
148999141|NCT01735201|537473935|FG003|Overall Study|Adverse Event|1|||
148999142|NCT01735201|537473936|FG004|Overall Study|Adverse Event|1|||
148999143|NCT01735201|537473937|FG005|Overall Study|Adverse Event|3|||
148999144|NCT01735201|537473938|FG006|Overall Study|Adverse Event|2|||
148999145|NCT01735201|537473939|FG007|Overall Study|Adverse Event|1|||
148999146|NCT01735201|537473932|FG000|Overall Study|Personal Reasons|1|||
148999147|NCT01735201|537473933|FG001|Overall Study|Personal Reasons|0|||
148999148|NCT01735201|537473934|FG002|Overall Study|Personal Reasons|0|||
148999149|NCT01735201|537473935|FG003|Overall Study|Personal Reasons|0|||
148999150|NCT01735201|537473936|FG004|Overall Study|Personal Reasons|0|||
148999151|NCT01735201|537473937|FG005|Overall Study|Personal Reasons|0|||
148999152|NCT01735201|537473938|FG006|Overall Study|Personal Reasons|0|||
148999153|NCT01735201|537473939|FG007|Overall Study|Personal Reasons|0|||
148999154|NCT01735201|537473932|FG000|Overall Study|Protocol Violation|1|||
148999155|NCT01735201|537473933|FG001|Overall Study|Protocol Violation|0|||
148999156|NCT01735201|537473934|FG002|Overall Study|Protocol Violation|0|||
148999157|NCT01735201|537473935|FG003|Overall Study|Protocol Violation|0|||
148999158|NCT01735201|537473936|FG004|Overall Study|Protocol Violation|0|||
148866289|NCT03002623|536987326|FG001|Overall Study|Physician Decision|1|||
148999159|NCT01735201|537473937|FG005|Overall Study|Protocol Violation|0|||
148999160|NCT01735201|537473938|FG006|Overall Study|Protocol Violation|0|||
148999161|NCT01735201|537473939|FG007|Overall Study|Protocol Violation|0|||
148999162|NCT01735201|537473932|FG000|Overall Study|Other Miscellaneous Reasons|0|||
148999163|NCT01735201|537473933|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148999164|NCT01735201|537473934|FG002|Overall Study|Other Miscellaneous Reasons|0|||
148999165|NCT01735201|537473935|FG003|Overall Study|Other Miscellaneous Reasons|1|||
148999166|NCT01735201|537473936|FG004|Overall Study|Other Miscellaneous Reasons|0|||
148999167|NCT01735201|537473937|FG005|Overall Study|Other Miscellaneous Reasons|2|||
148999168|NCT01735201|537473938|FG006|Overall Study|Other Miscellaneous Reasons|1|||
148999169|NCT01735201|537473939|FG007|Overall Study|Other Miscellaneous Reasons|1|||
148999170|NCT01203930|537473944|FG000|Overall Study|Disease Progression|0|||
148999171|NCT01203930|537473945|FG001|Overall Study|Disease Progression|4|||
148999172|NCT01203930|537473944|FG000|Overall Study|Death|3|||
148999173|NCT01203930|537473945|FG001|Overall Study|Death|1|||
148999174|NCT01203930|537473944|FG000|Overall Study|Withdrew Consent|1|||
148999175|NCT01203930|537473945|FG001|Overall Study|Withdrew Consent|10|||
148999176|NCT01203930|537473944|FG000|Overall Study|Investigator Request|0|||
148999177|NCT01203930|537473945|FG001|Overall Study|Investigator Request|8|||
148999178|NCT01203930|537473944|FG000|Overall Study|Study Terminated by Sponsor|0|||
148999179|NCT01203930|537473945|FG001|Overall Study|Study Terminated by Sponsor|12|||
148999180|NCT01203930|537473944|FG000|Overall Study|Poor tolerance of study drug|0|||
148999181|NCT01203930|537473945|FG001|Overall Study|Poor tolerance of study drug|1|||
148999182|NCT01203930|537473944|FG000|Overall Study|Adverse Event|17|||
148999183|NCT01203930|537473945|FG001|Overall Study|Adverse Event|5|||
148999184|NCT00002558|537473954|FG000|Overall Study|Withdrawal by Subject|0|||
148999185|NCT00002558|537473955|FG001|Overall Study|Withdrawal by Subject|1|||
148999186|NCT01260350|537473956|FG000|Overall Study|Lack of Efficacy|0|||
148999187|NCT01260350|537473957|FG001|Overall Study|Lack of Efficacy|0|||
148999188|NCT01260350|537473958|FG002|Overall Study|Lack of Efficacy|0|||
148999189|NCT01260350|537473959|FG003|Overall Study|Lack of Efficacy|0|||
148999190|NCT01260350|537473960|FG004|Overall Study|Lack of Efficacy|0|||
148999191|NCT01260350|537473961|FG005|Overall Study|Lack of Efficacy|0|||
148999192|NCT01260350|537473962|FG006|Overall Study|Lack of Efficacy|0|||
148999193|NCT01260350|537473963|FG007|Overall Study|Lack of Efficacy|0|||
148999194|NCT01260350|537473964|FG008|Overall Study|Lack of Efficacy|0|||
148999195|NCT01260350|537473965|FG009|Overall Study|Lack of Efficacy|0|||
148999196|NCT01260350|537473966|FG010|Overall Study|Lack of Efficacy|0|||
148999197|NCT01260350|537473967|FG011|Overall Study|Lack of Efficacy|0|||
148999198|NCT01260350|537473968|FG012|Overall Study|Lack of Efficacy|0|||
148999199|NCT01260350|537473969|FG013|Overall Study|Lack of Efficacy|0|||
148999200|NCT01260350|537473970|FG014|Overall Study|Lack of Efficacy|0|||
148999201|NCT01260350|537473971|FG015|Overall Study|Lack of Efficacy|0|||
148999202|NCT01260350|537473972|FG016|Overall Study|Lack of Efficacy|0|||
148999203|NCT01260350|537473973|FG017|Overall Study|Lack of Efficacy|1|||
148999204|NCT01260350|537473974|FG018|Overall Study|Lack of Efficacy|0|||
148999205|NCT01260350|537473975|FG019|Overall Study|Lack of Efficacy|0|||
148999206|NCT01260350|537473976|FG020|Overall Study|Lack of Efficacy|3|||
148999207|NCT01260350|537473977|FG021|Overall Study|Lack of Efficacy|0|||
148999208|NCT01260350|537473956|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999209|NCT01260350|537473957|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999210|NCT01260350|537473958|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999211|NCT01260350|537473959|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999212|NCT01260350|537473960|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999213|NCT01260350|537473961|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999214|NCT01260350|537473962|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999215|NCT01260350|537473963|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999216|NCT01260350|537473964|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
148999217|NCT01260350|537473965|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999218|NCT01260350|537473966|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999219|NCT01260350|537473967|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999220|NCT01260350|537473968|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999221|NCT01260350|537473969|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999222|NCT01260350|537473970|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999223|NCT01260350|537473971|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999224|NCT01260350|537473972|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999225|NCT01260350|537473973|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999226|NCT01260350|537473974|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999227|NCT01260350|537473975|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999228|NCT01260350|537473976|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999229|NCT01260350|537473977|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
148999230|NCT00558428|537473980|FG000|Overall Study|Adverse Event|6|||
148999231|NCT00558428|537473981|FG001|Overall Study|Adverse Event|22|||
148999232|NCT00558428|537473982|FG002|Overall Study|Adverse Event|3|||
148999233|NCT00558428|537473983|FG003|Overall Study|Adverse Event|4|||
148999234|NCT00558428|537473980|FG000|Overall Study|Lost to Follow-up|0|||
148999235|NCT00558428|537473981|FG001|Overall Study|Lost to Follow-up|1|||
148999236|NCT00558428|537473982|FG002|Overall Study|Lost to Follow-up|0|||
148999237|NCT00558428|537473983|FG003|Overall Study|Lost to Follow-up|0|||
148999238|NCT00558428|537473980|FG000|Overall Study|Lack of Efficacy|0|||
148999239|NCT00558428|537473981|FG001|Overall Study|Lack of Efficacy|0|||
148999240|NCT00558428|537473982|FG002|Overall Study|Lack of Efficacy|1|||
148999241|NCT00558428|537473983|FG003|Overall Study|Lack of Efficacy|2|||
148999242|NCT00558428|537473980|FG000|Overall Study|Non compliant with protocol|1|||
148999243|NCT00558428|537473981|FG001|Overall Study|Non compliant with protocol|0|||
148999244|NCT00558428|537473982|FG002|Overall Study|Non compliant with protocol|0|||
148999245|NCT00558428|537473983|FG003|Overall Study|Non compliant with protocol|3|||
148999246|NCT00558428|537473980|FG000|Overall Study|Consent withdrawn|2|||
148999247|NCT00558428|537473981|FG001|Overall Study|Consent withdrawn|1|||
148999248|NCT00558428|537473982|FG002|Overall Study|Consent withdrawn|0|||
148999249|NCT00558428|537473983|FG003|Overall Study|Consent withdrawn|1|||
148999250|NCT00558428|537473980|FG000|Overall Study|Other|3|||
148999251|NCT00558428|537473981|FG001|Overall Study|Other|0|||
148999252|NCT00558428|537473982|FG002|Overall Study|Other|0|||
148999253|NCT00558428|537473983|FG003|Overall Study|Other|1|||
148999254|NCT00626028|537473984|FG000|Overall Study|Adverse Event|1|||
148999255|NCT00626028|537473985|FG001|Overall Study|Adverse Event|1|||
148999256|NCT00626028|537473984|FG000|Overall Study|Device Failure|0|||
148999257|NCT00626028|537473985|FG001|Overall Study|Device Failure|1|||
148999258|NCT00626028|537473984|FG000|Overall Study|Physician Decision|2|||
148999259|NCT00626028|537473985|FG001|Overall Study|Physician Decision|1|||
148999260|NCT00626028|537473984|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
148999261|NCT00626028|537473985|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
148999262|NCT05224050|537473986|FG000|Overall Study|Withdrawal by Subject|9|||
148999263|NCT05224050|537473986|FG000|Overall Study|Lost to Follow-up|3|||
148999264|NCT04385368|537473987|FG000|Overall Study|Death|5|||
148999265|NCT04385368|537473988|FG001|Overall Study|Death|5|||
148999266|NCT04385368|537473987|FG000|Overall Study|Physician Decision|3|||
148999267|NCT04385368|537473988|FG001|Overall Study|Physician Decision|0|||
148999268|NCT04385368|537473987|FG000|Overall Study|Withdrawal by Subject|4|||
148999269|NCT04385368|537473988|FG001|Overall Study|Withdrawal by Subject|3|||
148999270|NCT00677235|537473989|FG000|Overall Study|Withdrawal by Subject|1|||
148999271|NCT00677235|537473990|FG001|Overall Study|Withdrawal by Subject|1|||
148999272|NCT00677235|537473989|FG000|Overall Study|Lost to Follow-up|2|||
148999273|NCT00677235|537473990|FG001|Overall Study|Lost to Follow-up|1|||
148999274|NCT00677235|537473989|FG000|Overall Study|Death|37|||
148999275|NCT00677235|537473990|FG001|Overall Study|Death|36|||
148999276|NCT00677235|537473989|FG000|Overall Study|Adverse Experience|1|||
148999277|NCT00677235|537473990|FG001|Overall Study|Adverse Experience|0|||
148999278|NCT00952367|537473991|FG000|Overall Study|Withdrawal by Subject|2|||
148999279|NCT00952367|537473991|FG000|Overall Study|Noncoordination|1|||
148999280|NCT00952367|537473991|FG000|Overall Study|Protocol Violation|3|||
148999281|NCT02230956|537473992|FG000|Overall Study|Adverse Event|1|||
148999282|NCT02230956|537473993|FG001|Overall Study|Adverse Event|1|||
148999283|NCT02230956|537473994|FG002|Overall Study|Adverse Event|0|||
148999284|NCT02230956|537473992|FG000|Overall Study|Lack of Efficacy|1|||
148999285|NCT02230956|537473993|FG001|Overall Study|Lack of Efficacy|1|||
148999286|NCT02230956|537473994|FG002|Overall Study|Lack of Efficacy|1|||
148999287|NCT02230956|537473992|FG000|Overall Study|Lost to Follow-up|1|||
148999288|NCT02230956|537473993|FG001|Overall Study|Lost to Follow-up|1|||
148999289|NCT02230956|537473994|FG002|Overall Study|Lost to Follow-up|2|||
148999290|NCT02230956|537473992|FG000|Overall Study|Personal Reasons|2|||
148999291|NCT02230956|537473993|FG001|Overall Study|Personal Reasons|1|||
148999292|NCT02230956|537473994|FG002|Overall Study|Personal Reasons|1|||
148999293|NCT02230956|537473992|FG000|Overall Study|Protocol Violation|0|||
148999294|NCT02230956|537473993|FG001|Overall Study|Protocol Violation|1|||
148999295|NCT02230956|537473994|FG002|Overall Study|Protocol Violation|1|||
148999296|NCT02230956|537473992|FG000|Overall Study|Other Miscellaneous Reason|0|||
148999297|NCT02230956|537473993|FG001|Overall Study|Other Miscellaneous Reason|1|||
148999298|NCT02230956|537473994|FG002|Overall Study|Other Miscellaneous Reason|2|||
148999299|NCT04918147|537474005|FG000|Overall Study|Disease flare as defined in protocol|0|||
148999300|NCT04918147|537474006|FG001|Overall Study|Disease flare as defined in protocol|2|||
148999301|NCT03574597|537474008|FG000|Overall Study|Withdrawal by Subject|67|||
148999302|NCT03574597|537474009|FG001|Overall Study|Withdrawal by Subject|96|||
148999303|NCT03574597|537474008|FG000|Overall Study|Lost to Follow-up|192|||
148999304|NCT03574597|537474009|FG001|Overall Study|Lost to Follow-up|188|||
148999305|NCT02355743|537474010|FG000|Overall Study|Withdrawal by Subject|1|||
148999306|NCT02355743|537474010|FG000|Overall Study|Lost to Follow-up|1|||
148999307|NCT04212091|537474011|FG000|Overall Study|Lost to Follow-up|0|||
148999308|NCT04212091|537474012|FG001|Overall Study|Lost to Follow-up|0|||
148999309|NCT04212091|537474013|FG002|Overall Study|Lost to Follow-up|0|||
148999310|NCT04212091|537474014|FG003|Overall Study|Lost to Follow-up|0|||
148999311|NCT04212091|537474015|FG004|Overall Study|Lost to Follow-up|1|||
148999312|NCT04212091|537474016|FG005|Overall Study|Lost to Follow-up|1|||
148999313|NCT04212091|537474011|FG000|Overall Study|Participant unable to adhere to visit|0|||
148999314|NCT04212091|537474012|FG001|Overall Study|Participant unable to adhere to visit|0|||
148999315|NCT04212091|537474013|FG002|Overall Study|Participant unable to adhere to visit|0|||
148999316|NCT04212091|537474014|FG003|Overall Study|Participant unable to adhere to visit|0|||
148999317|NCT04212091|537474015|FG004|Overall Study|Participant unable to adhere to visit|1|||
148999318|NCT04212091|537474016|FG005|Overall Study|Participant unable to adhere to visit|0|||
148999319|NCT02712905|537474017|FG000|Monotherapy|Death|2|||
148999320|NCT02712905|537474018|FG001|Monotherapy|Death|5|||
148999321|NCT02712905|537474019|FG002|Monotherapy|Death|0|||
148999322|NCT02712905|537474020|FG003|Monotherapy|Death|3|||
148999323|NCT02712905|537474021|FG004|Monotherapy|Death|15|||
148999324|NCT02712905|537474022|FG005|Monotherapy|Death|1|||
148866290|NCT02256267|536987327|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
148866291|NCT02256267|536987327|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
148999325|NCT02712905|537474023|FG006|Monotherapy|Death|3|||
148999326|NCT02712905|537474024|FG007|Monotherapy|Death|3|||
148999327|NCT02712905|537474025|FG008|Monotherapy|Death|0|||
148999328|NCT02712905|537474026|FG009|Monotherapy|Death|27|||
148999329|NCT02712905|537474027|FG010|Monotherapy|Death|2|||
148999330|NCT02712905|537474028|FG011|Monotherapy|Death|5|||
148999331|NCT02712905|537474029|FG012|Monotherapy|Death|0|||
148999332|NCT02712905|537474030|FG013|Monotherapy|Death|0|||
148999333|NCT02712905|537474031|FG014|Monotherapy|Death|0|||
148999334|NCT02712905|537474032|FG015|Monotherapy|Death|0|||
148999335|NCT02712905|537474033|FG016|Monotherapy|Death|0|||
148999336|NCT02712905|537474034|FG017|Monotherapy|Death|0|||
148999337|NCT02712905|537474017|FG000|Monotherapy|Lost to Follow-up|0|||
148999338|NCT02712905|537474018|FG001|Monotherapy|Lost to Follow-up|1|||
148999339|NCT02712905|537474019|FG002|Monotherapy|Lost to Follow-up|0|||
148999340|NCT02712905|537474020|FG003|Monotherapy|Lost to Follow-up|1|||
148999341|NCT02712905|537474021|FG004|Monotherapy|Lost to Follow-up|0|||
148999342|NCT02712905|537474022|FG005|Monotherapy|Lost to Follow-up|0|||
148999343|NCT02712905|537474023|FG006|Monotherapy|Lost to Follow-up|0|||
148999344|NCT02712905|537474024|FG007|Monotherapy|Lost to Follow-up|0|||
148999345|NCT02712905|537474025|FG008|Monotherapy|Lost to Follow-up|0|||
148999346|NCT02712905|537474026|FG009|Monotherapy|Lost to Follow-up|2|||
148999347|NCT02712905|537474027|FG010|Monotherapy|Lost to Follow-up|0|||
148999348|NCT02712905|537474028|FG011|Monotherapy|Lost to Follow-up|0|||
148999349|NCT02712905|537474029|FG012|Monotherapy|Lost to Follow-up|0|||
148999350|NCT02712905|537474030|FG013|Monotherapy|Lost to Follow-up|0|||
148999351|NCT02712905|537474031|FG014|Monotherapy|Lost to Follow-up|0|||
148999352|NCT02712905|537474032|FG015|Monotherapy|Lost to Follow-up|0|||
148999353|NCT02712905|537474033|FG016|Monotherapy|Lost to Follow-up|0|||
148999354|NCT02712905|537474034|FG017|Monotherapy|Lost to Follow-up|0|||
148999355|NCT02712905|537474017|FG000|Monotherapy|Physician Decision|1|||
148999356|NCT02712905|537474018|FG001|Monotherapy|Physician Decision|0|||
148999357|NCT02712905|537474019|FG002|Monotherapy|Physician Decision|0|||
148999358|NCT02712905|537474020|FG003|Monotherapy|Physician Decision|1|||
148999359|NCT02712905|537474021|FG004|Monotherapy|Physician Decision|0|||
148999360|NCT02712905|537474022|FG005|Monotherapy|Physician Decision|0|||
148999361|NCT02712905|537474023|FG006|Monotherapy|Physician Decision|0|||
148999362|NCT02712905|537474024|FG007|Monotherapy|Physician Decision|0|||
148999363|NCT02712905|537474025|FG008|Monotherapy|Physician Decision|0|||
148999364|NCT02712905|537474026|FG009|Monotherapy|Physician Decision|1|||
148999365|NCT02712905|537474027|FG010|Monotherapy|Physician Decision|0|||
148999366|NCT02712905|537474028|FG011|Monotherapy|Physician Decision|0|||
148999367|NCT02712905|537474029|FG012|Monotherapy|Physician Decision|0|||
148999368|NCT02712905|537474030|FG013|Monotherapy|Physician Decision|0|||
148999369|NCT02712905|537474031|FG014|Monotherapy|Physician Decision|0|||
148999370|NCT02712905|537474032|FG015|Monotherapy|Physician Decision|0|||
148999371|NCT02712905|537474033|FG016|Monotherapy|Physician Decision|0|||
148999372|NCT02712905|537474034|FG017|Monotherapy|Physician Decision|0|||
148999373|NCT02712905|537474017|FG000|Monotherapy|Study Terminated by Sponsor|0|||
148999374|NCT02712905|537474018|FG001|Monotherapy|Study Terminated by Sponsor|0|||
148999375|NCT02712905|537474019|FG002|Monotherapy|Study Terminated by Sponsor|0|||
148999376|NCT02712905|537474020|FG003|Monotherapy|Study Terminated by Sponsor|0|||
148999377|NCT02712905|537474021|FG004|Monotherapy|Study Terminated by Sponsor|1|||
148999378|NCT02712905|537474022|FG005|Monotherapy|Study Terminated by Sponsor|0|||
148999379|NCT02712905|537474023|FG006|Monotherapy|Study Terminated by Sponsor|0|||
148999380|NCT02712905|537474024|FG007|Monotherapy|Study Terminated by Sponsor|0|||
148999381|NCT02712905|537474025|FG008|Monotherapy|Study Terminated by Sponsor|0|||
148999382|NCT02712905|537474026|FG009|Monotherapy|Study Terminated by Sponsor|2|||
148999383|NCT02712905|537474027|FG010|Monotherapy|Study Terminated by Sponsor|0|||
148999384|NCT02712905|537474028|FG011|Monotherapy|Study Terminated by Sponsor|0|||
148999385|NCT02712905|537474029|FG012|Monotherapy|Study Terminated by Sponsor|0|||
148999386|NCT02712905|537474030|FG013|Monotherapy|Study Terminated by Sponsor|0|||
148999387|NCT02712905|537474031|FG014|Monotherapy|Study Terminated by Sponsor|0|||
148999388|NCT02712905|537474032|FG015|Monotherapy|Study Terminated by Sponsor|0|||
148999389|NCT02712905|537474033|FG016|Monotherapy|Study Terminated by Sponsor|0|||
148999390|NCT02712905|537474034|FG017|Monotherapy|Study Terminated by Sponsor|0|||
148999391|NCT02712905|537474017|FG000|Monotherapy|Withdrawal by Subject|0|||
148999392|NCT02712905|537474018|FG001|Monotherapy|Withdrawal by Subject|0|||
148999393|NCT02712905|537474019|FG002|Monotherapy|Withdrawal by Subject|1|||
148999394|NCT02712905|537474020|FG003|Monotherapy|Withdrawal by Subject|0|||
148999395|NCT02712905|537474021|FG004|Monotherapy|Withdrawal by Subject|2|||
148999396|NCT02712905|537474022|FG005|Monotherapy|Withdrawal by Subject|0|||
148999397|NCT02712905|537474023|FG006|Monotherapy|Withdrawal by Subject|0|||
148999398|NCT02712905|537474024|FG007|Monotherapy|Withdrawal by Subject|0|||
148999399|NCT02712905|537474025|FG008|Monotherapy|Withdrawal by Subject|0|||
148999400|NCT02712905|537474026|FG009|Monotherapy|Withdrawal by Subject|4|||
148999401|NCT02712905|537474027|FG010|Monotherapy|Withdrawal by Subject|1|||
148999402|NCT02712905|537474028|FG011|Monotherapy|Withdrawal by Subject|2|||
148999403|NCT02712905|537474029|FG012|Monotherapy|Withdrawal by Subject|0|||
148999404|NCT02712905|537474030|FG013|Monotherapy|Withdrawal by Subject|0|||
148999405|NCT02712905|537474031|FG014|Monotherapy|Withdrawal by Subject|0|||
148999406|NCT02712905|537474032|FG015|Monotherapy|Withdrawal by Subject|0|||
148999407|NCT02712905|537474033|FG016|Monotherapy|Withdrawal by Subject|0|||
148999408|NCT02712905|537474034|FG017|Monotherapy|Withdrawal by Subject|0|||
148999409|NCT02712905|537474017|FG000|Monotherapy|Started New Cancer Drug|0|||
148999410|NCT02712905|537474018|FG001|Monotherapy|Started New Cancer Drug|0|||
148999411|NCT02712905|537474019|FG002|Monotherapy|Started New Cancer Drug|0|||
148999412|NCT02712905|537474020|FG003|Monotherapy|Started New Cancer Drug|0|||
148999413|NCT02712905|537474021|FG004|Monotherapy|Started New Cancer Drug|0|||
148999414|NCT02712905|537474022|FG005|Monotherapy|Started New Cancer Drug|1|||
148999415|NCT02712905|537474023|FG006|Monotherapy|Started New Cancer Drug|0|||
148999416|NCT02712905|537474024|FG007|Monotherapy|Started New Cancer Drug|0|||
148999417|NCT02712905|537474025|FG008|Monotherapy|Started New Cancer Drug|0|||
148999418|NCT02712905|537474026|FG009|Monotherapy|Started New Cancer Drug|0|||
148999419|NCT02712905|537474027|FG010|Monotherapy|Started New Cancer Drug|0|||
148999420|NCT02712905|537474028|FG011|Monotherapy|Started New Cancer Drug|0|||
148999421|NCT02712905|537474029|FG012|Monotherapy|Started New Cancer Drug|0|||
148999422|NCT02712905|537474030|FG013|Monotherapy|Started New Cancer Drug|0|||
148999423|NCT02712905|537474031|FG014|Monotherapy|Started New Cancer Drug|0|||
148999424|NCT02712905|537474032|FG015|Monotherapy|Started New Cancer Drug|0|||
148999425|NCT02712905|537474033|FG016|Monotherapy|Started New Cancer Drug|0|||
148999426|NCT02712905|537474034|FG017|Monotherapy|Started New Cancer Drug|0|||
148999427|NCT02712905|537474017|FG000|Monotherapy|Adverse Event|0|||
148999428|NCT02712905|537474018|FG001|Monotherapy|Adverse Event|0|||
148999429|NCT02712905|537474019|FG002|Monotherapy|Adverse Event|0|||
148999430|NCT02712905|537474020|FG003|Monotherapy|Adverse Event|0|||
148999431|NCT02712905|537474021|FG004|Monotherapy|Adverse Event|0|||
148999432|NCT02712905|537474022|FG005|Monotherapy|Adverse Event|0|||
148999433|NCT02712905|537474023|FG006|Monotherapy|Adverse Event|0|||
148999434|NCT02712905|537474024|FG007|Monotherapy|Adverse Event|0|||
148999435|NCT02712905|537474025|FG008|Monotherapy|Adverse Event|1|||
148999436|NCT02712905|537474026|FG009|Monotherapy|Adverse Event|0|||
148999437|NCT02712905|537474027|FG010|Monotherapy|Adverse Event|0|||
148999438|NCT02712905|537474028|FG011|Monotherapy|Adverse Event|0|||
148999439|NCT02712905|537474029|FG012|Monotherapy|Adverse Event|0|||
148999440|NCT02712905|537474030|FG013|Monotherapy|Adverse Event|0|||
148999441|NCT02712905|537474031|FG014|Monotherapy|Adverse Event|0|||
148999442|NCT02712905|537474032|FG015|Monotherapy|Adverse Event|0|||
148999443|NCT02712905|537474033|FG016|Monotherapy|Adverse Event|0|||
148999444|NCT02712905|537474034|FG017|Monotherapy|Adverse Event|0|||
148999445|NCT02712905|537474017|FG000|Combination Therapy|Death|0|||
148999446|NCT02712905|537474018|FG001|Combination Therapy|Death|0|||
148999447|NCT02712905|537474019|FG002|Combination Therapy|Death|0|||
148999448|NCT02712905|537474020|FG003|Combination Therapy|Death|0|||
148999449|NCT02712905|537474021|FG004|Combination Therapy|Death|0|||
148999450|NCT02712905|537474022|FG005|Combination Therapy|Death|0|||
148999451|NCT02712905|537474023|FG006|Combination Therapy|Death|0|||
148999452|NCT02712905|537474024|FG007|Combination Therapy|Death|0|||
148999453|NCT02712905|537474025|FG008|Combination Therapy|Death|0|||
148999454|NCT02712905|537474026|FG009|Combination Therapy|Death|0|||
148999455|NCT02712905|537474027|FG010|Combination Therapy|Death|0|||
148999456|NCT02712905|537474028|FG011|Combination Therapy|Death|0|||
148999457|NCT02712905|537474029|FG012|Combination Therapy|Death|5|||
148999458|NCT02712905|537474030|FG013|Combination Therapy|Death|6|||
148999459|NCT02712905|537474031|FG014|Combination Therapy|Death|1|||
148999460|NCT02712905|537474032|FG015|Combination Therapy|Death|3|||
148999461|NCT02712905|537474033|FG016|Combination Therapy|Death|1|||
148999462|NCT02712905|537474034|FG017|Combination Therapy|Death|3|||
148999463|NCT02712905|537474017|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
148999464|NCT02712905|537474018|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
148999465|NCT02712905|537474019|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
148999466|NCT02712905|537474020|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
148999467|NCT02712905|537474021|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
148999468|NCT02712905|537474022|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
148999469|NCT02712905|537474023|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
148999470|NCT02712905|537474024|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
148999471|NCT02712905|537474025|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
148999472|NCT02712905|537474026|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
148999473|NCT02712905|537474027|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
148999474|NCT02712905|537474028|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
148999475|NCT02712905|537474029|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
148999476|NCT02712905|537474030|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
148999477|NCT02712905|537474031|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
148999478|NCT02712905|537474032|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
148999479|NCT02712905|537474033|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
148999480|NCT02712905|537474034|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
148999481|NCT02712905|537474017|FG000|Combination Therapy|Withdrawal by Subject|0|||
148999482|NCT02712905|537474018|FG001|Combination Therapy|Withdrawal by Subject|0|||
148999483|NCT02712905|537474019|FG002|Combination Therapy|Withdrawal by Subject|0|||
149031449|NCT03068468|537593560|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
149031450|NCT03068468|537593561|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
149031451|NCT03068468|537593558|FG000|Placebo-Controlled Period|Death|0|||
149031452|NCT03068468|537593559|FG001|Placebo-Controlled Period|Death|1|||
149031453|NCT03068468|537593560|FG002|Placebo-Controlled Period|Death|0|||
149031454|NCT03068468|537593561|FG003|Placebo-Controlled Period|Death|0|||
149031455|NCT03068468|537593558|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
149031456|NCT03068468|537593559|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
149031457|NCT03068468|537593560|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
149031458|NCT03068468|537593561|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
149031459|NCT03068468|537593558|FG000|Open-Label Extension Period|Adverse Event|0|||
149031460|NCT03068468|537593559|FG001|Open-Label Extension Period|Adverse Event|0|||
149031461|NCT03068468|537593560|FG002|Open-Label Extension Period|Adverse Event|13|||
149031462|NCT03068468|537593561|FG003|Open-Label Extension Period|Adverse Event|17|||
149031463|NCT03068468|537593558|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
149031464|NCT03068468|537593559|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
149031465|NCT03068468|537593560|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
149031466|NCT03068468|537593561|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
149031467|NCT03068468|537593558|FG000|Open-Label Extension Period|Death|0|||
149031468|NCT03068468|537593559|FG001|Open-Label Extension Period|Death|0|||
149031469|NCT03068468|537593560|FG002|Open-Label Extension Period|Death|0|||
149031470|NCT03068468|537593561|FG003|Open-Label Extension Period|Death|1|||
149031471|NCT03068468|537593558|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
149031472|NCT03068468|537593559|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
149031473|NCT03068468|537593560|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
148999484|NCT02712905|537474020|FG003|Combination Therapy|Withdrawal by Subject|0|||
148999485|NCT02712905|537474021|FG004|Combination Therapy|Withdrawal by Subject|0|||
148999486|NCT02712905|537474022|FG005|Combination Therapy|Withdrawal by Subject|0|||
148999487|NCT02712905|537474023|FG006|Combination Therapy|Withdrawal by Subject|0|||
148999488|NCT02712905|537474024|FG007|Combination Therapy|Withdrawal by Subject|0|||
148999489|NCT02712905|537474025|FG008|Combination Therapy|Withdrawal by Subject|0|||
148999490|NCT02712905|537474026|FG009|Combination Therapy|Withdrawal by Subject|0|||
148999491|NCT02712905|537474027|FG010|Combination Therapy|Withdrawal by Subject|0|||
148999492|NCT02712905|537474028|FG011|Combination Therapy|Withdrawal by Subject|0|||
148999493|NCT02712905|537474029|FG012|Combination Therapy|Withdrawal by Subject|0|||
148999494|NCT02712905|537474030|FG013|Combination Therapy|Withdrawal by Subject|0|||
148999495|NCT02712905|537474031|FG014|Combination Therapy|Withdrawal by Subject|0|||
148999496|NCT02712905|537474032|FG015|Combination Therapy|Withdrawal by Subject|1|||
148999497|NCT02712905|537474033|FG016|Combination Therapy|Withdrawal by Subject|0|||
148999498|NCT02712905|537474034|FG017|Combination Therapy|Withdrawal by Subject|2|||
148999499|NCT02712905|537474017|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999500|NCT02712905|537474018|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999501|NCT02712905|537474019|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999502|NCT02712905|537474020|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999503|NCT02712905|537474021|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999504|NCT02712905|537474022|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999505|NCT02712905|537474023|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999506|NCT02712905|537474024|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999507|NCT02712905|537474025|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999508|NCT02712905|537474026|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999509|NCT02712905|537474027|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999510|NCT02712905|537474028|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999511|NCT02712905|537474029|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999512|NCT02712905|537474030|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999513|NCT02712905|537474031|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
149031474|NCT03068468|537593561|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
149031475|NCT03068468|537593558|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
149031476|NCT03068468|537593559|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
149031477|NCT03068468|537593560|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
149031478|NCT03068468|537593561|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
149031479|NCT03068468|537593558|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
149031480|NCT03068468|537593559|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
149031481|NCT03068468|537593560|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
148999514|NCT02712905|537474032|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
149031482|NCT03068468|537593561|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
148999515|NCT02712905|537474033|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999516|NCT02712905|537474034|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
148999517|NCT03721965|537474035|FG000|Overall Study|Death|1|||
148999518|NCT03721965|537474035|FG000|Overall Study|Study Terminated by Sponsor|1|||
148999519|NCT02862457|537474036|FG000|Overall Study|Death|1|||
148999520|NCT02862457|537474037|FG001|Overall Study|Death|3|||
148999521|NCT02862457|537474038|FG002|Overall Study|Death|2|||
148999522|NCT02862457|537474039|FG003|Overall Study|Death|3|||
148999523|NCT02862457|537474040|FG004|Overall Study|Death|0|||
148999524|NCT02862457|537474041|FG005|Overall Study|Death|2|||
148999525|NCT02862457|537474042|FG006|Overall Study|Death|1|||
148999526|NCT02862457|537474036|FG000|Overall Study|Lost to Follow-up|1|||
148999527|NCT02862457|537474037|FG001|Overall Study|Lost to Follow-up|0|||
148999528|NCT02862457|537474038|FG002|Overall Study|Lost to Follow-up|0|||
148999529|NCT02862457|537474039|FG003|Overall Study|Lost to Follow-up|1|||
148999530|NCT02862457|537474040|FG004|Overall Study|Lost to Follow-up|0|||
148999531|NCT02862457|537474041|FG005|Overall Study|Lost to Follow-up|0|||
148999532|NCT02862457|537474042|FG006|Overall Study|Lost to Follow-up|0|||
148999533|NCT02862457|537474036|FG000|Overall Study|Withdrawal by Subject|0|||
148999534|NCT02862457|537474037|FG001|Overall Study|Withdrawal by Subject|0|||
148999535|NCT02862457|537474038|FG002|Overall Study|Withdrawal by Subject|1|||
148999536|NCT02862457|537474039|FG003|Overall Study|Withdrawal by Subject|0|||
148999537|NCT02862457|537474040|FG004|Overall Study|Withdrawal by Subject|0|||
148999538|NCT02862457|537474041|FG005|Overall Study|Withdrawal by Subject|1|||
148999539|NCT02862457|537474042|FG006|Overall Study|Withdrawal by Subject|0|||
148999540|NCT04085328|537474043|FG000|Overall Study|Witihdrew Consent|16|||
148999541|NCT04085328|537474044|FG001|Overall Study|Witihdrew Consent|16|||
148999542|NCT04085328|537474043|FG000|Overall Study|Adverse Event|8|||
148999543|NCT04085328|537474044|FG001|Overall Study|Adverse Event|7|||
148999544|NCT04085328|537474043|FG000|Overall Study|Lost to Follow-up|7|||
148999545|NCT04085328|537474044|FG001|Overall Study|Lost to Follow-up|2|||
148999546|NCT04085328|537474043|FG000|Overall Study|Physician Decision|0|||
148999547|NCT04085328|537474044|FG001|Overall Study|Physician Decision|1|||
148999548|NCT04085328|537474043|FG000|Overall Study|Pregnancy|0|||
148999549|NCT04085328|537474044|FG001|Overall Study|Pregnancy|1|||
148999550|NCT04085328|537474043|FG000|Overall Study|Reasons Related to COVID-19|5|||
148999551|NCT04085328|537474044|FG001|Overall Study|Reasons Related to COVID-19|8|||
148999552|NCT04085328|537474043|FG000|Overall Study|Did not meet inclusion criteria|1|||
148999553|NCT04085328|537474044|FG001|Overall Study|Did not meet inclusion criteria|1|||
148999554|NCT04085328|537474043|FG000|Overall Study|Early termination|1|||
148999555|NCT04085328|537474044|FG001|Overall Study|Early termination|0|||
148999556|NCT00951483|537474047|FG000|Overall Study|Physician Decision|4|||
148999557|NCT00951483|537474048|FG001|Overall Study|Physician Decision|0|||
148999558|NCT00951483|537474047|FG000|Overall Study|Withdrawal by Subject|15|||
148999559|NCT00951483|537474048|FG001|Overall Study|Withdrawal by Subject|0|||
148999560|NCT03565887|537474049|FG000|Overall Study|Adverse Event|1|||
148999561|NCT03565887|537474050|FG001|Overall Study|Adverse Event|0|||
148999562|NCT03565887|537474049|FG000|Overall Study|Withdrawal by Subject|0|||
148999563|NCT03565887|537474050|FG001|Overall Study|Withdrawal by Subject|2|||
148999564|NCT03364751|537474051|FG000|Overall Study|Withdrawal by Subject|1|||
148999565|NCT03364751|537474052|FG001|Overall Study|Withdrawal by Subject|0|||
148999566|NCT03364751|537474053|FG002|Overall Study|Withdrawal by Subject|0|||
148999567|NCT03364751|537474054|FG003|Overall Study|Withdrawal by Subject|0|||
148999568|NCT03364751|537474051|FG000|Overall Study|Lost to Follow-up|0|||
148999569|NCT03364751|537474052|FG001|Overall Study|Lost to Follow-up|1|||
149031483|NCT03068468|537593558|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
148999570|NCT03364751|537474053|FG002|Overall Study|Lost to Follow-up|0|||
148999571|NCT03364751|537474054|FG003|Overall Study|Lost to Follow-up|0|||
148999572|NCT02975973|537474055|FG000|Overall Study|Adverse Event|1|||
148999573|NCT02975973|537474056|FG001|Overall Study|Adverse Event|1|||
148999574|NCT02975973|537474057|FG002|Overall Study|Adverse Event|1|||
148999575|NCT02975973|537474058|FG003|Overall Study|Adverse Event|0|||
148999576|NCT03804710|537474060|FG000|Overall Study|Adverse Event|0|||
148999577|NCT03804710|537474061|FG001|Overall Study|Adverse Event|3|||
148999578|NCT03804710|537474060|FG000|Overall Study|Withdrawal by Subject|2|||
148999579|NCT03804710|537474061|FG001|Overall Study|Withdrawal by Subject|1|||
148999580|NCT03804710|537474060|FG000|Overall Study|Other|0|||
148999581|NCT03804710|537474061|FG001|Overall Study|Other|1|||
148999582|NCT04542018|537474062|FG000|Overall Study|Withdrawal by Subject|0|||
148999583|NCT04542018|537474063|FG001|Overall Study|Withdrawal by Subject|0|||
148999584|NCT04542018|537474064|FG002|Overall Study|Withdrawal by Subject|4|||
148999585|NCT04542018|537474062|FG000|Overall Study|Protocol Violation|0|||
148999586|NCT04542018|537474063|FG001|Overall Study|Protocol Violation|0|||
148999587|NCT04542018|537474064|FG002|Overall Study|Protocol Violation|2|||
148999588|NCT03583554|537474065|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
148999589|NCT03583554|537474066|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
148999590|NCT03583554|537474067|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
148866292|NCT01352741|536987330|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
148866293|NCT01352741|536987331|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
148866294|NCT01352741|536987330|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
148866295|NCT01352741|536987331|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
148866296|NCT01352741|536987330|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
148866297|NCT01352741|536987331|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
148866298|NCT01352741|536987330|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
148866299|NCT01352741|536987331|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
148999591|NCT03178266|537474068|FG000|Overall Study|Death|0|||
148999592|NCT03178266|537474069|FG001|Overall Study|Death|1|||
148999593|NCT03178266|537474068|FG000|Overall Study|Disont. Early|0|||
148999594|NCT03178266|537474069|FG001|Overall Study|Disont. Early|1|||
148999595|NCT03178266|537474068|FG000|Overall Study|Withdrawal by Subject|0|||
148999596|NCT03178266|537474069|FG001|Overall Study|Withdrawal by Subject|2|||
148999597|NCT00689221|537474078|FG000|Overall Study|Ongoing at cut-off date|39|||
148999598|NCT00689221|537474079|FG001|Overall Study|Ongoing at cut-off date|36|||
148999599|NCT01812655|537474080|FG000|Overall Study|Protocol Violation|1|||
148999600|NCT01812655|537474081|FG001|Overall Study|Protocol Violation|1|||
148999601|NCT01812655|537474082|FG002|Overall Study|Protocol Violation|0|||
148999602|NCT00262821|537474084|FG000|Overall Study|Ineligible - wrong stage|0|||
148999603|NCT00262821|537474085|FG001|Overall Study|Ineligible - wrong stage|3|||
148999604|NCT00262821|537474084|FG000|Overall Study|Ineligible - wrong cell type|2|||
148999605|NCT00262821|537474085|FG001|Overall Study|Ineligible - wrong cell type|2|||
148999606|NCT00262821|537474084|FG000|Overall Study|Ineligible - wrong primary|0|||
148999607|NCT00262821|537474085|FG001|Overall Study|Ineligible - wrong primary|1|||
148999608|NCT00262821|537474084|FG000|Overall Study|Ineligible - inadequate pathology|1|||
148999609|NCT00262821|537474085|FG001|Overall Study|Ineligible - inadequate pathology|3|||
148999610|NCT00262821|537474084|FG000|Overall Study|Ineligible - elevated creatinine|0|||
148999611|NCT00262821|537474085|FG001|Overall Study|Ineligible - elevated creatinine|2|||
148999612|NCT00262821|537474084|FG000|Overall Study|Ineligible - required test not done|1|||
148999613|NCT00262821|537474085|FG001|Overall Study|Ineligible - required test not done|4|||
148999614|NCT00262821|537474084|FG000|Overall Study|Inevaluable - inadequate data|0|||
148999615|NCT00262821|537474085|FG001|Overall Study|Inevaluable - inadequate data|4|||
148999616|NCT04435665|537474086|FG000|Overall Study|Lost to Follow-up|0|||
148999617|NCT04435665|537474087|FG001|Overall Study|Lost to Follow-up|0|||
148999618|NCT04435665|537474088|FG002|Overall Study|Lost to Follow-up|0|||
148999619|NCT04435665|537474089|FG003|Overall Study|Lost to Follow-up|1|||
148999620|NCT02454101|537474090|FG000|Overall Study|Adverse Event|2|||
148999621|NCT02454101|537474091|FG001|Overall Study|Adverse Event|3|||
148999622|NCT02454101|537474090|FG000|Overall Study|Lost to Follow-up|3|||
148999623|NCT02454101|537474091|FG001|Overall Study|Lost to Follow-up|4|||
148999624|NCT00419263|537474092|FG000|Overall Study|Lost to Follow-up|2|||
148999625|NCT00419263|537474093|FG001|Overall Study|Lost to Follow-up|1|||
148999626|NCT00419263|537474094|FG002|Overall Study|Lost to Follow-up|1|||
148999627|NCT00419263|537474092|FG000|Overall Study|Randomized in Error, Not Treated|1|||
148999628|NCT00419263|537474093|FG001|Overall Study|Randomized in Error, Not Treated|1|||
148999629|NCT00419263|537474094|FG002|Overall Study|Randomized in Error, Not Treated|0|||
148999630|NCT00419263|537474092|FG000|Overall Study|Adverse Event|0|||
148999631|NCT00419263|537474093|FG001|Overall Study|Adverse Event|0|||
148999632|NCT00419263|537474094|FG002|Overall Study|Adverse Event|1|||
148999633|NCT00419263|537474092|FG000|Overall Study|Withdrawal by Subject|0|||
148999634|NCT00419263|537474093|FG001|Overall Study|Withdrawal by Subject|0|||
148999635|NCT00419263|537474094|FG002|Overall Study|Withdrawal by Subject|1|||
148999636|NCT02342886|537474095|FG000|Overall Study|Treatment non-compliance|1|||
148999637|NCT02342886|537474096|FG001|Overall Study|Treatment non-compliance|0|||
148999638|NCT02342886|537474097|FG002|Overall Study|Treatment non-compliance|0|||
148999639|NCT02342886|537474098|FG003|Overall Study|Treatment non-compliance|1|||
148999640|NCT02342886|537474099|FG004|Overall Study|Treatment non-compliance|0|||
148999641|NCT02342886|537474095|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
148999642|NCT02342886|537474096|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
148999643|NCT02342886|537474097|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
148999644|NCT02342886|537474098|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
148999645|NCT02342886|537474099|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
148999646|NCT02342886|537474095|FG000|Overall Study|Adverse event/specific toxicity|4|||
148999647|NCT02342886|537474096|FG001|Overall Study|Adverse event/specific toxicity|3|||
148999648|NCT02342886|537474097|FG002|Overall Study|Adverse event/specific toxicity|11|||
148999649|NCT02342886|537474098|FG003|Overall Study|Adverse event/specific toxicity|2|||
148999650|NCT02342886|537474099|FG004|Overall Study|Adverse event/specific toxicity|1|||
149031484|NCT03068468|537593559|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
148999651|NCT02342886|537474095|FG000|Overall Study|Lost to Follow-up|1|||
148999652|NCT02342886|537474096|FG001|Overall Study|Lost to Follow-up|0|||
148999653|NCT02342886|537474097|FG002|Overall Study|Lost to Follow-up|0|||
148999654|NCT02342886|537474098|FG003|Overall Study|Lost to Follow-up|0|||
148999655|NCT02342886|537474099|FG004|Overall Study|Lost to Follow-up|0|||
148999656|NCT02342886|537474095|FG000|Overall Study|Death|1|||
148999657|NCT02342886|537474096|FG001|Overall Study|Death|2|||
148999658|NCT02342886|537474097|FG002|Overall Study|Death|1|||
148999659|NCT02342886|537474098|FG003|Overall Study|Death|0|||
148999660|NCT02342886|537474099|FG004|Overall Study|Death|1|||
148999661|NCT02342886|537474095|FG000|Overall Study|Withdrawal by Subject|0|||
148999662|NCT02342886|537474096|FG001|Overall Study|Withdrawal by Subject|1|||
148999663|NCT02342886|537474097|FG002|Overall Study|Withdrawal by Subject|0|||
148999664|NCT02342886|537474098|FG003|Overall Study|Withdrawal by Subject|1|||
148999665|NCT02342886|537474099|FG004|Overall Study|Withdrawal by Subject|0|||
148999666|NCT02342886|537474095|FG000|Overall Study|Investigator/sponsor decision|0|||
148999667|NCT02342886|537474096|FG001|Overall Study|Investigator/sponsor decision|2|||
148999668|NCT02342886|537474097|FG002|Overall Study|Investigator/sponsor decision|0|||
148999669|NCT02342886|537474098|FG003|Overall Study|Investigator/sponsor decision|3|||
148999670|NCT02342886|537474099|FG004|Overall Study|Investigator/sponsor decision|1|||
148999671|NCT02342886|537474095|FG000|Overall Study|Pregnancy|0|||
148999672|NCT02342886|537474096|FG001|Overall Study|Pregnancy|0|||
148999673|NCT02342886|537474097|FG002|Overall Study|Pregnancy|2|||
148999674|NCT02342886|537474098|FG003|Overall Study|Pregnancy|0|||
148999675|NCT02342886|537474099|FG004|Overall Study|Pregnancy|0|||
148999676|NCT02342886|537474095|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
148999677|NCT02342886|537474096|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
148999678|NCT02342886|537474097|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
148999679|NCT02342886|537474098|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
148999680|NCT02342886|537474099|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
148999681|NCT02342886|537474095|FG000|Overall Study|Protocol Violation|0|||
148999682|NCT02342886|537474096|FG001|Overall Study|Protocol Violation|0|||
148999683|NCT02342886|537474097|FG002|Overall Study|Protocol Violation|0|||
148999684|NCT02342886|537474098|FG003|Overall Study|Protocol Violation|2|||
148999685|NCT02342886|537474099|FG004|Overall Study|Protocol Violation|0|||
148999686|NCT01328080|537474100|FG000|Overall Study|Lost to Follow-up|5|||
148999687|NCT00765674|537474101|FG000|Overall Study|Adverse Event|7|||
148999688|NCT00765674|537474102|FG001|Overall Study|Adverse Event|2|||
148999689|NCT00765674|537474103|FG002|Overall Study|Adverse Event|8|||
148999690|NCT00765674|537474104|FG003|Overall Study|Adverse Event|11|||
148999691|NCT00765674|537474101|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
148999692|NCT00765674|537474102|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
148999693|NCT00765674|537474103|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
148999694|NCT00765674|537474104|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
148999695|NCT00765674|537474101|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
148999696|NCT00765674|537474102|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
148999697|NCT00765674|537474103|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
148999698|NCT00765674|537474104|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
148999699|NCT00765674|537474101|FG000|Overall Study|Lack of Efficacy|2|||
148999700|NCT00765674|537474102|FG001|Overall Study|Lack of Efficacy|3|||
148999701|NCT00765674|537474103|FG002|Overall Study|Lack of Efficacy|1|||
148999702|NCT00765674|537474104|FG003|Overall Study|Lack of Efficacy|2|||
148999703|NCT00765674|537474101|FG000|Overall Study|Protocol Violation|2|||
148999704|NCT00765674|537474102|FG001|Overall Study|Protocol Violation|0|||
148999705|NCT00765674|537474103|FG002|Overall Study|Protocol Violation|1|||
148999706|NCT00765674|537474104|FG003|Overall Study|Protocol Violation|0|||
148999707|NCT00765674|537474101|FG000|Overall Study|Withdrawal by Subject|5|||
148999708|NCT00765674|537474102|FG001|Overall Study|Withdrawal by Subject|7|||
148999709|NCT00765674|537474103|FG002|Overall Study|Withdrawal by Subject|3|||
148999710|NCT00765674|537474104|FG003|Overall Study|Withdrawal by Subject|8|||
148999711|NCT00765674|537474101|FG000|Overall Study|Lost to Follow-up|4|||
148999712|NCT00765674|537474102|FG001|Overall Study|Lost to Follow-up|6|||
148999713|NCT00765674|537474103|FG002|Overall Study|Lost to Follow-up|2|||
148999714|NCT00765674|537474104|FG003|Overall Study|Lost to Follow-up|1|||
148999715|NCT00765674|537474101|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
148999716|NCT00765674|537474102|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
148999717|NCT00765674|537474103|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
148999718|NCT00765674|537474104|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
148999719|NCT01813474|537474105|FG000|Overall Study|Withdrawal by Subject|0|||
148999720|NCT01813474|537474106|FG001|Overall Study|Withdrawal by Subject|0|||
148999721|NCT01813474|537474107|FG002|Overall Study|Withdrawal by Subject|1|||
148999722|NCT01813474|537474105|FG000|Overall Study|Adverse Event|1|||
148999723|NCT01813474|537474106|FG001|Overall Study|Adverse Event|1|||
148999724|NCT01813474|537474107|FG002|Overall Study|Adverse Event|0|||
148999725|NCT01813474|537474105|FG000|Overall Study|Lack of Efficacy|2|||
148999726|NCT01813474|537474106|FG001|Overall Study|Lack of Efficacy|6|||
148999727|NCT01813474|537474107|FG002|Overall Study|Lack of Efficacy|9|||
148999728|NCT01813474|537474105|FG000|Overall Study|Death|0|||
148999729|NCT01813474|537474106|FG001|Overall Study|Death|0|||
148999730|NCT01813474|537474107|FG002|Overall Study|Death|1|||
148999731|NCT03015402|537474113|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
148999732|NCT03015402|537474114|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
148999733|NCT03015402|537474113|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
148999734|NCT03015402|537474114|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
148999735|NCT00316082|537474115|FG000|Overall Study|Lack of Efficacy|2|||
148999736|NCT00316082|537474116|FG001|Overall Study|Lack of Efficacy|3|||
148999737|NCT00316082|537474117|FG002|Overall Study|Lack of Efficacy|3|||
148999738|NCT00316082|537474118|FG003|Overall Study|Lack of Efficacy|4|||
148999739|NCT00316082|537474119|FG004|Overall Study|Lack of Efficacy|6|||
148999740|NCT00316082|537474115|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
148999741|NCT00316082|537474116|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
148999742|NCT00316082|537474117|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
148999743|NCT00316082|537474118|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
148999744|NCT00316082|537474119|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
148999745|NCT00316082|537474115|FG000|Overall Study|Lost to Follow-up|7|||
148999746|NCT00316082|537474116|FG001|Overall Study|Lost to Follow-up|6|||
148999747|NCT00316082|537474117|FG002|Overall Study|Lost to Follow-up|7|||
148999748|NCT00316082|537474118|FG003|Overall Study|Lost to Follow-up|8|||
148999749|NCT00316082|537474119|FG004|Overall Study|Lost to Follow-up|6|||
148999750|NCT00316082|537474115|FG000|Overall Study|Poor/noncompliance|6|||
148999751|NCT00316082|537474116|FG001|Overall Study|Poor/noncompliance|1|||
148999752|NCT00316082|537474117|FG002|Overall Study|Poor/noncompliance|4|||
148999753|NCT00316082|537474118|FG003|Overall Study|Poor/noncompliance|1|||
148999754|NCT00316082|537474119|FG004|Overall Study|Poor/noncompliance|4|||
148999755|NCT00316082|537474115|FG000|Overall Study|Adverse Event|4|||
148999756|NCT00316082|537474116|FG001|Overall Study|Adverse Event|2|||
148999757|NCT00316082|537474117|FG002|Overall Study|Adverse Event|5|||
148999758|NCT00316082|537474118|FG003|Overall Study|Adverse Event|1|||
148999759|NCT00316082|537474119|FG004|Overall Study|Adverse Event|3|||
148999760|NCT00316082|537474115|FG000|Overall Study|Subject no longer meets study criteria|3|||
148999761|NCT00316082|537474116|FG001|Overall Study|Subject no longer meets study criteria|1|||
148999762|NCT00316082|537474117|FG002|Overall Study|Subject no longer meets study criteria|2|||
148999763|NCT00316082|537474118|FG003|Overall Study|Subject no longer meets study criteria|2|||
148999764|NCT00316082|537474119|FG004|Overall Study|Subject no longer meets study criteria|1|||
148999765|NCT00316082|537474115|FG000|Overall Study|Physician Decision|1|||
148999766|NCT00316082|537474116|FG001|Overall Study|Physician Decision|1|||
148999767|NCT00316082|537474117|FG002|Overall Study|Physician Decision|2|||
148999768|NCT00316082|537474118|FG003|Overall Study|Physician Decision|1|||
148999769|NCT00316082|537474119|FG004|Overall Study|Physician Decision|1|||
148999770|NCT00316082|537474115|FG000|Overall Study|Death|0|||
148999771|NCT00316082|537474116|FG001|Overall Study|Death|0|||
148999772|NCT00316082|537474117|FG002|Overall Study|Death|1|||
148999773|NCT00316082|537474118|FG003|Overall Study|Death|0|||
148999774|NCT00316082|537474119|FG004|Overall Study|Death|0|||
148999775|NCT00316082|537474115|FG000|Overall Study|Administrative reason by sponsor|0|||
148999776|NCT00316082|537474116|FG001|Overall Study|Administrative reason by sponsor|0|||
148999777|NCT00316082|537474117|FG002|Overall Study|Administrative reason by sponsor|1|||
148999778|NCT00316082|537474118|FG003|Overall Study|Administrative reason by sponsor|0|||
148999779|NCT00316082|537474119|FG004|Overall Study|Administrative reason by sponsor|0|||
148999780|NCT00528775|537474122|FG000|Overall Study|Other not specified|1|||
148999781|NCT00540124|537474123|FG000|Overall Study|Adverse Event|0|||
148999782|NCT00540124|537474124|FG001|Overall Study|Adverse Event|2|||
148999783|NCT00540124|537474125|FG002|Overall Study|Adverse Event|1|||
148999784|NCT00540124|537474123|FG000|Overall Study|Entry Criteria Not Met|2|||
148999785|NCT00540124|537474124|FG001|Overall Study|Entry Criteria Not Met|0|||
148999786|NCT00540124|537474125|FG002|Overall Study|Entry Criteria Not Met|0|||
148999787|NCT00540124|537474123|FG000|Overall Study|Lack of Efficacy|1|||
148999788|NCT00540124|537474124|FG001|Overall Study|Lack of Efficacy|0|||
148999789|NCT00540124|537474125|FG002|Overall Study|Lack of Efficacy|0|||
148999790|NCT00540124|537474123|FG000|Overall Study|Withdrawal by Subject|1|||
148999791|NCT00540124|537474124|FG001|Overall Study|Withdrawal by Subject|1|||
148999792|NCT00540124|537474125|FG002|Overall Study|Withdrawal by Subject|0|||
148999793|NCT00344461|537474126|FG000|Overall Study|Adverse Event|6|||
148999794|NCT00344461|537474126|FG000|Overall Study|Death|1|||
148999795|NCT00344461|537474126|FG000|Overall Study|Lack of Efficacy|2|||
148999796|NCT00344461|537474126|FG000|Overall Study|Lost to Follow-up|2|||
148999797|NCT00344461|537474126|FG000|Overall Study|Physician Decision|2|||
148999798|NCT00344461|537474126|FG000|Overall Study|Protocol Violation|6|||
148999799|NCT00344461|537474126|FG000|Overall Study|Withdrawal by Subject|2|||
148999800|NCT00671931|537474129|FG000|Overall Study|Physician Decision|1|||
148999801|NCT00671931|537474130|FG001|Overall Study|Physician Decision|0|||
148999802|NCT00671931|537474131|FG002|Overall Study|Physician Decision|0|||
148999803|NCT00671931|537474132|FG003|Overall Study|Physician Decision|2|||
148999804|NCT00671931|537474133|FG004|Overall Study|Physician Decision|1|||
148999805|NCT00951275|537474134|FG000|Overall Study|Administrative Reason|1|||
148999806|NCT00951275|537474134|FG000|Overall Study|Adverse Event|7|||
148999807|NCT00951275|537474134|FG000|Overall Study|Withdrawal by Subject|4|||
148999808|NCT00951275|537474134|FG000|Overall Study|Protocol Violation|1|||
148999809|NCT00251745|537474136|FG000|Overall Study|Adverse Event|7|||
148866300|NCT01352741|536987330|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
148866301|NCT01352741|536987331|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
148866302|NCT01352741|536987330|FG000|Open-label Tapentadol Titration Period|Other|4|||
148866303|NCT01352741|536987331|FG001|Open-label Tapentadol Titration Period|Other|0|||
148866304|NCT01352741|536987330|FG000|Double-blind Comparative Period|Protocol Violation|2|||
148866305|NCT01352741|536987331|FG001|Double-blind Comparative Period|Protocol Violation|0|||
148866306|NCT01352741|536987330|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
148866307|NCT01352741|536987331|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
148866308|NCT01352741|536987330|FG000|Double-blind Comparative Period|Adverse Event|16|||
148866309|NCT01352741|536987331|FG001|Double-blind Comparative Period|Adverse Event|17|||
148866310|NCT01352741|536987330|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
148866311|NCT01352741|536987331|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
148866312|NCT01352741|536987330|FG000|Double-blind Comparative Period|Death|0|||
148866313|NCT01352741|536987331|FG001|Double-blind Comparative Period|Death|1|||
148866314|NCT01352741|536987330|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
148866315|NCT01352741|536987331|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
148866316|NCT01352741|536987330|FG000|Double-blind Comparative Period|Other|1|||
148866317|NCT01352741|536987331|FG001|Double-blind Comparative Period|Other|2|||
148866318|NCT01352741|536987330|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
148866319|NCT01352741|536987331|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
148866320|NCT01352741|536987330|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
148866321|NCT01352741|536987331|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
148866322|NCT01352741|536987330|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
148866323|NCT01352741|536987331|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
148866324|NCT01352741|536987330|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
148866325|NCT01352741|536987331|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
148866326|NCT00259298|536987332|FG000|Overall Study|Withdrawal by Subject|1|||
148866327|NCT00259298|536987332|FG000|Overall Study|Physician Decision|2|||
148866328|NCT00645528|536987333|FG000|Overall Study|Did not show up for Visit 2|7|||
148866329|NCT03618628|536987334|FG000|Overall Study|Death|1|||
148866330|NCT03618628|536987334|FG000|Overall Study|Lost to Follow-up|1|||
148866331|NCT01969500|536987335|FG000|Overall Study|Death|0|||
148866332|NCT01969500|536987336|FG001|Overall Study|Death|1|||
148866333|NCT01969500|536987335|FG000|Overall Study|extended hospitalization|1|||
148866334|NCT01969500|536987336|FG001|Overall Study|extended hospitalization|1|||
148866335|NCT01741532|536987337|FG000|Overall Study|Adverse Event|4|||
148866336|NCT01741532|536987338|FG001|Overall Study|Adverse Event|0|||
148866337|NCT01741532|536987337|FG000|Overall Study|Withdrawal by Subject|1|||
148866338|NCT01741532|536987338|FG001|Overall Study|Withdrawal by Subject|1|||
148866339|NCT01741532|536987337|FG000|Overall Study|Protocol Violation|0|||
148866340|NCT01741532|536987338|FG001|Overall Study|Protocol Violation|1|||
148866341|NCT01741532|536987337|FG000|Overall Study|Worsening of the disease|3|||
148866342|NCT01741532|536987338|FG001|Overall Study|Worsening of the disease|1|||
148866343|NCT01741532|536987337|FG000|Overall Study|Sponsor decision|1|||
148866344|NCT01741532|536987338|FG001|Overall Study|Sponsor decision|0|||
148866345|NCT01741532|536987337|FG000|Overall Study|Medical event|1|||
148866346|NCT01741532|536987338|FG001|Overall Study|Medical event|0|||
148866347|NCT02463032|536987339|FG000|Overall Study|Lack of Efficacy|61|||
148866348|NCT02463032|536987340|FG001|Overall Study|Lack of Efficacy|50|||
148866349|NCT02463032|536987339|FG000|Overall Study|Death|8|||
148866350|NCT02463032|536987340|FG001|Overall Study|Death|8|||
148866351|NCT02463032|536987339|FG000|Overall Study|Adverse Event|2|||
148866352|NCT02463032|536987340|FG001|Overall Study|Adverse Event|6|||
148866353|NCT00613080|536987341|FG000|Overall Study|Ineligible / no protocol treatment|11|||
148866354|NCT00612508|536987342|FG000|Overall Study|Withdrawal by Subject|3|||
148866355|NCT00612508|536987343|FG001|Overall Study|Withdrawal by Subject|4|||
148866356|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
148866357|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
148866358|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
148866359|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
148866360|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
148866361|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
148866362|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
148866363|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
148866364|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
148866365|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
148866366|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
148866367|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
148866368|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
148866369|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
149031485|NCT03068468|537593560|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
148866370|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
148866371|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
148866372|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
148866373|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
148866374|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
148866375|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
148866376|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
148866377|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
148866378|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
148866379|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
148866380|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
148866381|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
148999810|NCT00251745|537474137|FG001|Overall Study|Adverse Event|9|||
148999811|NCT00251745|537474138|FG002|Overall Study|Adverse Event|11|||
148999812|NCT00251745|537474136|FG000|Overall Study|Lost to Follow-up|4|||
148999813|NCT00251745|537474137|FG001|Overall Study|Lost to Follow-up|2|||
148999814|NCT00251745|537474138|FG002|Overall Study|Lost to Follow-up|5|||
148999815|NCT00251745|537474136|FG000|Overall Study|Withdrawal by Subject|13|||
148999816|NCT00251745|537474137|FG001|Overall Study|Withdrawal by Subject|7|||
148999817|NCT00251745|537474138|FG002|Overall Study|Withdrawal by Subject|3|||
148999818|NCT00251745|537474136|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
148999819|NCT00251745|537474137|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
148999820|NCT00251745|537474138|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
148999821|NCT00251745|537474136|FG000|Overall Study|Lack of Efficacy|3|||
148999822|NCT00251745|537474137|FG001|Overall Study|Lack of Efficacy|0|||
148999823|NCT00251745|537474138|FG002|Overall Study|Lack of Efficacy|0|||
148999824|NCT00251745|537474136|FG000|Overall Study|Noncompliant|0|||
148999825|NCT00251745|537474137|FG001|Overall Study|Noncompliant|2|||
148999826|NCT00251745|537474138|FG002|Overall Study|Noncompliant|2|||
148999827|NCT00251745|537474136|FG000|Overall Study|Pregnancy|0|||
148999828|NCT00251745|537474137|FG001|Overall Study|Pregnancy|1|||
148999829|NCT00251745|537474138|FG002|Overall Study|Pregnancy|0|||
148999830|NCT00251745|537474136|FG000|Overall Study|Per Subject Request|0|||
148999831|NCT00251745|537474137|FG001|Overall Study|Per Subject Request|0|||
148999832|NCT00251745|537474138|FG002|Overall Study|Per Subject Request|1|||
148999833|NCT00251745|537474136|FG000|Overall Study|Per Investigator Request|1|||
148999834|NCT00251745|537474137|FG001|Overall Study|Per Investigator Request|0|||
148999835|NCT00251745|537474138|FG002|Overall Study|Per Investigator Request|0|||
148999836|NCT04508699|537474143|FG000|Overall Study|Lack of Efficacy|2|||
148999837|NCT04508699|537474144|FG001|Overall Study|Lack of Efficacy|15|||
148999838|NCT04508699|537474143|FG000|Overall Study|Withdrawal by Subject|0|||
148999839|NCT04508699|537474144|FG001|Overall Study|Withdrawal by Subject|2|||
148999840|NCT04866017|537474145|FG000|Overall Study|Study Terminated by Sponsor|13|||
148999841|NCT04866017|537474146|FG001|Overall Study|Study Terminated by Sponsor|14|||
148999842|NCT04866017|537474147|FG002|Overall Study|Study Terminated by Sponsor|13|||
148999843|NCT04866017|537474145|FG000|Overall Study|Death|8|||
148999844|NCT04866017|537474146|FG001|Overall Study|Death|4|||
148999845|NCT04866017|537474147|FG002|Overall Study|Death|8|||
148999846|NCT04866017|537474145|FG000|Overall Study|Withdrawal by Subject|1|||
148999847|NCT04866017|537474146|FG001|Overall Study|Withdrawal by Subject|0|||
148999848|NCT04866017|537474147|FG002|Overall Study|Withdrawal by Subject|1|||
148999849|NCT04866017|537474145|FG000|Overall Study|Physician Decision|0|||
148999850|NCT04866017|537474146|FG001|Overall Study|Physician Decision|1|||
148999851|NCT04866017|537474147|FG002|Overall Study|Physician Decision|0|||
148999852|NCT03355326|537474148|FG000|Overall Study|Protocol Violation|3|||
148999853|NCT03355326|537474149|FG001|Overall Study|Protocol Violation|3|||
148999854|NCT03040713|537475538|FG000|Overall Study|Positive amyloid scan|3|||
148999855|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
148999856|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
148999857|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
148999858|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
148999859|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
148999860|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
148999861|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
148999862|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
148999863|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Other|18|||
148999864|NCT02565914|537475539|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
148999865|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
148999866|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Other|1|||
148999867|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
148999868|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
148999869|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
148999870|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
149031486|NCT03068468|537593561|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
149031487|NCT03068468|537593558|FG000|Open-Label Extension Period|Reason not Specified|0|||
149031488|NCT03068468|537593559|FG001|Open-Label Extension Period|Reason not Specified|0|||
149031489|NCT03068468|537593560|FG002|Open-Label Extension Period|Reason not Specified|1|||
149031490|NCT03068468|537593561|FG003|Open-Label Extension Period|Reason not Specified|4|||
149031491|NCT03895034|537593563|FG000|Overall Study|Lost to Follow-up|2|||
149031492|NCT03181958|537593564|FG000|Overall Study|Lost to Follow-up|17|||
149031493|NCT03181958|537593565|FG001|Overall Study|Lost to Follow-up|21|||
149031494|NCT03181958|537593566|FG002|Overall Study|Lost to Follow-up|15|||
149031495|NCT02030028|537593567|FG000|Overall Study|Withdrawal by Subject|4|||
149031496|NCT02030028|537593567|FG000|Overall Study|lack of transportation|1|||
149031497|NCT00661778|537593568|FG000|Overall Study|Disease Progression|23|||
149031498|NCT00661778|537593568|FG000|Overall Study|Adverse Event|18|||
149031499|NCT00661778|537593568|FG000|Overall Study|Reason not Specified|6|||
149031500|NCT00661778|537593568|FG000|Overall Study|Protocol Violation|2|||
149031501|NCT00661778|537593568|FG000|Overall Study|Withdrawal of Consent|1|||
149031502|NCT01249092|537593578|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
149031503|NCT01249092|537593578|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
149031504|NCT00151996|537593581|FG000|Overall Study|Adverse Event|3|||
149031505|NCT00151996|537593582|FG001|Overall Study|Adverse Event|2|||
149031506|NCT00151996|537593581|FG000|Overall Study|Withdrawal by Subject|1|||
149031507|NCT00151996|537593582|FG001|Overall Study|Withdrawal by Subject|1|||
149031508|NCT00151996|537593581|FG000|Overall Study|Protocol Violation|1|||
149031509|NCT00151996|537593582|FG001|Overall Study|Protocol Violation|2|||
149031510|NCT00151996|537593581|FG000|Overall Study|Sponsor's decision|0|||
149031511|NCT00151996|537593582|FG001|Overall Study|Sponsor's decision|2|||
149031512|NCT02001623|537593587|FG000|Overall Study|Disease Progression|2|||
149031513|NCT02001623|537593588|FG001|Overall Study|Disease Progression|2|||
149031514|NCT02001623|537593589|FG002|Overall Study|Disease Progression|3|||
149031515|NCT02001623|537593590|FG003|Overall Study|Disease Progression|2|||
149031516|NCT02001623|537593591|FG004|Overall Study|Disease Progression|3|||
149031517|NCT02001623|537593592|FG005|Overall Study|Disease Progression|2|||
149031518|NCT02001623|537593593|FG006|Overall Study|Disease Progression|3|||
149031519|NCT02001623|537593594|FG007|Overall Study|Disease Progression|3|||
149031520|NCT02001623|537593595|FG008|Overall Study|Disease Progression|7|||
149031521|NCT02001623|537593596|FG009|Overall Study|Disease Progression|40|||
149031522|NCT02001623|537593597|FG010|Overall Study|Disease Progression|5|||
149031523|NCT02001623|537593598|FG011|Overall Study|Disease Progression|9|||
149031524|NCT02001623|537593599|FG012|Overall Study|Disease Progression|9|||
149031525|NCT02001623|537593600|FG013|Overall Study|Disease Progression|20|||
149031526|NCT02001623|537593601|FG014|Overall Study|Disease Progression|9|||
149031527|NCT02001623|537593587|FG000|Overall Study|Physician Decision|0|||
149031528|NCT02001623|537593588|FG001|Overall Study|Physician Decision|0|||
149031529|NCT02001623|537593589|FG002|Overall Study|Physician Decision|0|||
149031530|NCT02001623|537593590|FG003|Overall Study|Physician Decision|0|||
149031531|NCT02001623|537593591|FG004|Overall Study|Physician Decision|0|||
149031532|NCT02001623|537593592|FG005|Overall Study|Physician Decision|0|||
149031533|NCT02001623|537593593|FG006|Overall Study|Physician Decision|0|||
149031534|NCT02001623|537593594|FG007|Overall Study|Physician Decision|0|||
149031535|NCT02001623|537593595|FG008|Overall Study|Physician Decision|3|||
149031536|NCT02001623|537593596|FG009|Overall Study|Physician Decision|2|||
149031537|NCT02001623|537593597|FG010|Overall Study|Physician Decision|3|||
149031538|NCT02001623|537593598|FG011|Overall Study|Physician Decision|3|||
149031539|NCT02001623|537593599|FG012|Overall Study|Physician Decision|1|||
149031540|NCT02001623|537593600|FG013|Overall Study|Physician Decision|2|||
149031541|NCT02001623|537593601|FG014|Overall Study|Physician Decision|1|||
149031542|NCT02001623|537593587|FG000|Overall Study|Death|0|||
149031543|NCT02001623|537593588|FG001|Overall Study|Death|1|||
149031544|NCT02001623|537593589|FG002|Overall Study|Death|0|||
149031545|NCT02001623|537593590|FG003|Overall Study|Death|0|||
149031546|NCT02001623|537593591|FG004|Overall Study|Death|0|||
149031547|NCT02001623|537593592|FG005|Overall Study|Death|0|||
149031548|NCT02001623|537593593|FG006|Overall Study|Death|0|||
149031549|NCT02001623|537593594|FG007|Overall Study|Death|0|||
149031550|NCT02001623|537593595|FG008|Overall Study|Death|0|||
149031551|NCT02001623|537593596|FG009|Overall Study|Death|0|||
149031552|NCT02001623|537593597|FG010|Overall Study|Death|0|||
149031553|NCT02001623|537593598|FG011|Overall Study|Death|0|||
149031554|NCT02001623|537593599|FG012|Overall Study|Death|0|||
149031555|NCT02001623|537593600|FG013|Overall Study|Death|0|||
149031556|NCT02001623|537593601|FG014|Overall Study|Death|0|||
149031557|NCT02001623|537593587|FG000|Overall Study|Adverse Event|0|||
149031558|NCT02001623|537593588|FG001|Overall Study|Adverse Event|0|||
149031559|NCT02001623|537593589|FG002|Overall Study|Adverse Event|0|||
149031560|NCT02001623|537593590|FG003|Overall Study|Adverse Event|0|||
149031561|NCT02001623|537593591|FG004|Overall Study|Adverse Event|0|||
149031562|NCT02001623|537593592|FG005|Overall Study|Adverse Event|1|||
149031563|NCT02001623|537593593|FG006|Overall Study|Adverse Event|0|||
149031564|NCT02001623|537593594|FG007|Overall Study|Adverse Event|3|||
149031565|NCT02001623|537593595|FG008|Overall Study|Adverse Event|4|||
149031566|NCT02001623|537593596|FG009|Overall Study|Adverse Event|6|||
149031567|NCT02001623|537593597|FG010|Overall Study|Adverse Event|4|||
149031568|NCT02001623|537593598|FG011|Overall Study|Adverse Event|0|||
149031569|NCT02001623|537593599|FG012|Overall Study|Adverse Event|3|||
149031570|NCT02001623|537593600|FG013|Overall Study|Adverse Event|5|||
149031571|NCT02001623|537593601|FG014|Overall Study|Adverse Event|6|||
149031572|NCT02001623|537593587|FG000|Overall Study|Other - Miscellaneous|0|||
149031573|NCT02001623|537593588|FG001|Overall Study|Other - Miscellaneous|0|||
149031574|NCT02001623|537593589|FG002|Overall Study|Other - Miscellaneous|0|||
149031575|NCT02001623|537593590|FG003|Overall Study|Other - Miscellaneous|0|||
149031576|NCT02001623|537593591|FG004|Overall Study|Other - Miscellaneous|0|||
149031577|NCT02001623|537593592|FG005|Overall Study|Other - Miscellaneous|0|||
149031578|NCT02001623|537593593|FG006|Overall Study|Other - Miscellaneous|0|||
149031579|NCT02001623|537593594|FG007|Overall Study|Other - Miscellaneous|0|||
149031580|NCT02001623|537593595|FG008|Overall Study|Other - Miscellaneous|0|||
149031581|NCT02001623|537593596|FG009|Overall Study|Other - Miscellaneous|1|||
149031582|NCT02001623|537593597|FG010|Overall Study|Other - Miscellaneous|0|||
149031583|NCT02001623|537593598|FG011|Overall Study|Other - Miscellaneous|0|||
149031584|NCT02001623|537593599|FG012|Overall Study|Other - Miscellaneous|0|||
149031585|NCT02001623|537593600|FG013|Overall Study|Other - Miscellaneous|1|||
149031586|NCT02001623|537593601|FG014|Overall Study|Other - Miscellaneous|0|||
149031587|NCT02001623|537593587|FG000|Overall Study|Withdrawal by Subject|1|||
149031588|NCT02001623|537593588|FG001|Overall Study|Withdrawal by Subject|0|||
149031589|NCT02001623|537593589|FG002|Overall Study|Withdrawal by Subject|0|||
149031590|NCT02001623|537593590|FG003|Overall Study|Withdrawal by Subject|0|||
149031591|NCT02001623|537593591|FG004|Overall Study|Withdrawal by Subject|0|||
149031592|NCT02001623|537593592|FG005|Overall Study|Withdrawal by Subject|0|||
149031593|NCT02001623|537593593|FG006|Overall Study|Withdrawal by Subject|0|||
149031594|NCT02001623|537593594|FG007|Overall Study|Withdrawal by Subject|0|||
149031595|NCT02001623|537593595|FG008|Overall Study|Withdrawal by Subject|1|||
149031596|NCT02001623|537593596|FG009|Overall Study|Withdrawal by Subject|3|||
149031597|NCT02001623|537593597|FG010|Overall Study|Withdrawal by Subject|2|||
149031598|NCT02001623|537593598|FG011|Overall Study|Withdrawal by Subject|2|||
149031599|NCT02001623|537593599|FG012|Overall Study|Withdrawal by Subject|1|||
149031600|NCT02001623|537593600|FG013|Overall Study|Withdrawal by Subject|5|||
149031601|NCT02001623|537593601|FG014|Overall Study|Withdrawal by Subject|2|||
149031602|NCT02001623|537593587|FG000|Overall Study|Lost to Follow-up|0|||
149031603|NCT02001623|537593588|FG001|Overall Study|Lost to Follow-up|0|||
149031604|NCT02001623|537593589|FG002|Overall Study|Lost to Follow-up|0|||
149031605|NCT02001623|537593590|FG003|Overall Study|Lost to Follow-up|0|||
149031606|NCT02001623|537593591|FG004|Overall Study|Lost to Follow-up|0|||
149031607|NCT02001623|537593592|FG005|Overall Study|Lost to Follow-up|0|||
149031608|NCT02001623|537593593|FG006|Overall Study|Lost to Follow-up|0|||
149031609|NCT02001623|537593594|FG007|Overall Study|Lost to Follow-up|0|||
149031610|NCT02001623|537593595|FG008|Overall Study|Lost to Follow-up|0|||
149031611|NCT02001623|537593596|FG009|Overall Study|Lost to Follow-up|1|||
149031612|NCT02001623|537593597|FG010|Overall Study|Lost to Follow-up|0|||
149031613|NCT02001623|537593598|FG011|Overall Study|Lost to Follow-up|0|||
149031614|NCT02001623|537593599|FG012|Overall Study|Lost to Follow-up|0|||
149031615|NCT02001623|537593600|FG013|Overall Study|Lost to Follow-up|0|||
149031616|NCT02001623|537593601|FG014|Overall Study|Lost to Follow-up|0|||
149031617|NCT02001623|537593587|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
149031618|NCT02001623|537593588|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
149031619|NCT02001623|537593589|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
149031620|NCT02001623|537593590|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
149031621|NCT02001623|537593591|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
149031622|NCT02001623|537593592|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
149031623|NCT02001623|537593593|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
149031624|NCT02001623|537593594|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
149031625|NCT02001623|537593595|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
149031626|NCT02001623|537593596|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
149031627|NCT02001623|537593597|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
149031628|NCT02001623|537593598|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
149031629|NCT02001623|537593599|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
149031630|NCT02001623|537593600|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
149031631|NCT02001623|537593601|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
149031632|NCT02001623|537593587|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
149031633|NCT02001623|537593588|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
149031634|NCT02001623|537593589|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
149031635|NCT02001623|537593590|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
149031636|NCT02001623|537593591|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
149031637|NCT02001623|537593592|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
149031638|NCT02001623|537593593|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
149031639|NCT02001623|537593594|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
149031640|NCT02001623|537593595|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
149031641|NCT02001623|537593596|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
149031642|NCT02001623|537593597|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
149031643|NCT02001623|537593598|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
149031644|NCT02001623|537593599|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
149031645|NCT02001623|537593600|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
149031646|NCT02001623|537593601|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
149031647|NCT01072357|537593608|FG000|Overall Study|Lost to Follow-up|0|||
149031648|NCT01072357|537593609|FG001|Overall Study|Lost to Follow-up|1|||
149031649|NCT01570751|537593610|FG000|Period A (16 Weeks)|Protocol Violation|1|||
149031650|NCT01570751|537593611|FG001|Period A (16 Weeks)|Protocol Violation|1|||
149031651|NCT01570751|537593610|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
149031652|NCT01570751|537593611|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
149031653|NCT01570751|537593610|FG000|Period A (16 Weeks)|Unclassified|2|||
149031654|NCT01570751|537593611|FG001|Period A (16 Weeks)|Unclassified|3|||
149031655|NCT01570751|537593610|FG000|Period B (16 Weeks)|Adverse Event|1|||
149031656|NCT01570751|537593611|FG001|Period B (16 Weeks)|Adverse Event|0|||
149031657|NCT01570751|537593610|FG000|Period B (16 Weeks)|Protocol Violation|0|||
149031658|NCT01570751|537593611|FG001|Period B (16 Weeks)|Protocol Violation|1|||
149031659|NCT01876511|537593612|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
149031660|NCT01876511|537593613|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
149031661|NCT01876511|537593614|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
149031662|NCT01876511|537593612|FG000|Overall Study|Death (unrelated)|3|||
149031663|NCT01876511|537593613|FG001|Overall Study|Death (unrelated)|0|||
149031664|NCT01876511|537593614|FG002|Overall Study|Death (unrelated)|2|||
149031665|NCT01876511|537593612|FG000|Overall Study|Drug-related Toxicity|5|||
149031666|NCT01876511|537593613|FG001|Overall Study|Drug-related Toxicity|1|||
149031667|NCT01876511|537593614|FG002|Overall Study|Drug-related Toxicity|6|||
149031668|NCT01876511|537593612|FG000|Overall Study|Patient Decision|3|||
149031669|NCT01876511|537593613|FG001|Overall Study|Patient Decision|0|||
148866382|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
148999871|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
148999872|NCT02565914|537475539|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
148999873|NCT02565914|537475539|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
148999874|NCT02565914|537475539|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
148999875|NCT02565914|537475539|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
148999876|NCT02565914|537475539|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
148999877|NCT02565914|537475539|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
148999878|NCT02565914|537475539|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
148999879|NCT04465357|537475544|FG000|Overall Study|Adverse Event|2|||
148999880|NCT04465357|537475544|FG000|Overall Study|Lack of Efficacy|1|||
148999881|NCT04465357|537475544|FG000|Overall Study|Lost to Follow-up|2|||
148999882|NCT04465357|537475544|FG000|Overall Study|Withdrawal by Subject|6|||
148999883|NCT04465357|537475544|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
148999884|NCT02570126|537475549|FG000|Overall Study|Lost to Follow-up|2|||
148999885|NCT02570126|537475550|FG001|Overall Study|Lost to Follow-up|0|||
148999886|NCT02570126|537475549|FG000|Overall Study|Unable To Arrange Visit 3|1|||
148999887|NCT02570126|537475550|FG001|Overall Study|Unable To Arrange Visit 3|0|||
148999888|NCT02570126|537475549|FG000|Overall Study|Violation Of Procedures GSK|0|||
148999889|NCT02570126|537475550|FG001|Overall Study|Violation Of Procedures GSK|1|||
148999890|NCT02570126|537475549|FG000|Overall Study|Protocol Violation|0|||
148999891|NCT02570126|537475550|FG001|Overall Study|Protocol Violation|1|||
148999892|NCT02570126|537475549|FG000|Overall Study|Withdrawal by Subject|3|||
148999893|NCT02570126|537475550|FG001|Overall Study|Withdrawal by Subject|7|||
148999894|NCT04683926|537475558|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
148999895|NCT04683926|537475559|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
148999896|NCT04683926|537475560|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
148999897|NCT04683926|537475561|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
148999898|NCT01040260|537475562|FG000|Overall Study|Withdrawal by Subject|12|||
148999899|NCT01040260|537475563|FG001|Overall Study|Withdrawal by Subject|6|||
148999900|NCT01040260|537475562|FG000|Overall Study|Lost to Follow-up|3|||
148999901|NCT01040260|537475563|FG001|Overall Study|Lost to Follow-up|5|||
148999902|NCT01970982|537475566|FG000|Overall Study|Withdrawal by Subject|0|||
148999903|NCT01970982|537475567|FG001|Overall Study|Withdrawal by Subject|0|||
148999904|NCT01970982|537475568|FG002|Overall Study|Withdrawal by Subject|2|||
148999905|NCT04555096|537475571|FG000|Overall Study|Death|4|||
148999906|NCT04555096|537475572|FG001|Overall Study|Death|4|||
148999907|NCT04555096|537475571|FG000|Overall Study|Withdrawal by Subject|1|||
148999908|NCT04555096|537475572|FG001|Overall Study|Withdrawal by Subject|0|||
148999909|NCT04555096|537475571|FG000|Overall Study|Other|0|||
148999910|NCT04555096|537475572|FG001|Overall Study|Other|1|||
149031670|NCT01876511|537593614|FG002|Overall Study|Patient Decision|6|||
149031671|NCT01876511|537593612|FG000|Overall Study|Physician Decision|1|||
149031672|NCT01876511|537593613|FG001|Overall Study|Physician Decision|0|||
149031673|NCT01876511|537593614|FG002|Overall Study|Physician Decision|1|||
149031674|NCT05419557|537593620|FG000|Overall Study|Lost to Follow-up|11|||
149031675|NCT05419557|537593621|FG001|Overall Study|Lost to Follow-up|4|||
149031676|NCT01196988|537593622|FG000|Overall Study|Adverse Event|1|||
149031677|NCT01196988|537593623|FG001|Overall Study|Adverse Event|2|||
148866383|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
148866384|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
148866385|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
148866386|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
148866387|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
148866388|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
148866389|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
148866390|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
148866391|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
148866392|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
148866393|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
148866394|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
148999911|NCT02835339|537475575|FG000|Overall Study|Did not receive allocated intervention|13|||
148999912|NCT02835339|537475576|FG001|Overall Study|Did not receive allocated intervention|16|||
148999913|NCT03923959|537475577|FG000|Overall Study|Death|16|||
148999914|NCT03923959|537475578|FG001|Overall Study|Death|12|||
148999915|NCT03923959|537475577|FG000|Overall Study|Lost to Follow-up|56|||
148999916|NCT03923959|537475578|FG001|Overall Study|Lost to Follow-up|56|||
148999917|NCT03923959|537475577|FG000|Overall Study|Withdrawal by Subject|1|||
148999918|NCT03923959|537475578|FG001|Overall Study|Withdrawal by Subject|1|||
148999919|NCT03923959|537475577|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
148999920|NCT03923959|537475578|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
148999921|NCT03575325|537475579|FG000|Overall Study|Death|1|||
148999922|NCT05711641|537475580|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
148999923|NCT05711641|537475581|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
148999924|NCT05711641|537475580|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
148999925|NCT05711641|537475581|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
148999926|NCT04040751|537475592|FG000|Overall Study|Withdrawal by Subject|2|||
148999927|NCT04040751|537475593|FG001|Overall Study|Withdrawal by Subject|0|||
148999928|NCT04040751|537475594|FG002|Overall Study|Withdrawal by Subject|2|||
148999929|NCT04040751|537475595|FG003|Overall Study|Withdrawal by Subject|0|||
148999930|NCT01596582|537475599|FG000|Overall Study|Deemed ineligible after study visit|3|||
148999931|NCT01596582|537475600|FG001|Overall Study|Deemed ineligible after study visit|6|||
148999932|NCT01596582|537475599|FG000|Overall Study|Missing all outcome data|1|||
148999933|NCT01596582|537475600|FG001|Overall Study|Missing all outcome data|1|||
148999934|NCT01428076|537475601|FG000|Overall Study|Adverse Event|0|||
148999935|NCT01428076|537475602|FG001|Overall Study|Adverse Event|1|||
148999936|NCT00862134|537475606|FG000|Overall Study|Death|1|||
148999937|NCT00862134|537475607|FG001|Overall Study|Death|0|||
148999938|NCT00862134|537475606|FG000|Overall Study|Physician Decision|0|||
148999939|NCT00862134|537475607|FG001|Overall Study|Physician Decision|1|||
148999940|NCT00862134|537475606|FG000|Overall Study|Withdrawal by Subject|1|||
148999941|NCT00862134|537475607|FG001|Overall Study|Withdrawal by Subject|2|||
148999942|NCT00862134|537475606|FG000|Overall Study|Sponsor terminated study|5|||
148999943|NCT00862134|537475607|FG001|Overall Study|Sponsor terminated study|7|||
148999944|NCT00862134|537475606|FG000|Overall Study|Adverse Event|2|||
148999945|NCT00862134|537475607|FG001|Overall Study|Adverse Event|2|||
148999946|NCT00862134|537475606|FG000|Overall Study|Withdrew prior to dosing|2|||
148999947|NCT00862134|537475607|FG001|Overall Study|Withdrew prior to dosing|0|||
148999948|NCT02191267|537475608|FG000|Overall Study|Withdrawal by Subject|1|||
148999949|NCT02191267|537475609|FG001|Overall Study|Withdrawal by Subject|0|||
148999950|NCT02191267|537475610|FG002|Overall Study|Withdrawal by Subject|0|||
148999951|NCT02216773|537475611|FG000|Overall Study|Disease progression|4|||
148999952|NCT02216773|537475612|FG001|Overall Study|Disease progression|2|||
148999953|NCT02216773|537475611|FG000|Overall Study|Insufficient FLRV|4|||
148999954|NCT02216773|537475612|FG001|Overall Study|Insufficient FLRV|0|||
148999955|NCT02216773|537475611|FG000|Overall Study|Abandoned|4|||
148999956|NCT02216773|537475612|FG001|Overall Study|Abandoned|3|||
148999957|NCT01995461|537475613|FG000|Overall Study|Death|1|||
148999958|NCT01995461|537475613|FG000|Overall Study|Lost to Follow-up|2|||
148999959|NCT01995461|537475613|FG000|Overall Study|Withdrawal by Subject|2|||
148999960|NCT01777854|537475622|FG000|Overall Study|Physician Decision|3|||
148999961|NCT01777854|537475623|FG001|Overall Study|Physician Decision|3|||
148999962|NCT03311373|537475627|FG000|Overall Study|Adverse Event|1|||
148999963|NCT03311373|537475627|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
148999964|NCT03311373|537475627|FG000|Overall Study|Lost to Follow-up|1|||
148999965|NCT03311373|537475627|FG000|Overall Study|Physician Decision|1|||
148999966|NCT03311373|537475627|FG000|Overall Study|Withdrawal by Subject|3|||
148999967|NCT01939548|537475628|FG000|Overall Study|Non compliance|0|||
148999968|NCT01939548|537475629|FG001|Overall Study|Non compliance|2|||
148999969|NCT01939548|537475630|FG002|Overall Study|Non compliance|0|||
148999970|NCT01939548|537475628|FG000|Overall Study|Study Terminated by Sponsor|17|||
149031678|NCT01196988|537593624|FG002|Overall Study|Adverse Event|0|||
149031679|NCT01196988|537593625|FG003|Overall Study|Adverse Event|0|||
149031680|NCT01196988|537593622|FG000|Overall Study|Withdrawal by Subject|5|||
149031681|NCT01196988|537593623|FG001|Overall Study|Withdrawal by Subject|1|||
149031682|NCT01196988|537593624|FG002|Overall Study|Withdrawal by Subject|4|||
149031683|NCT01196988|537593625|FG003|Overall Study|Withdrawal by Subject|0|||
149031684|NCT01196988|537593622|FG000|Overall Study|Lost to Follow-up|16|||
149031685|NCT01196988|537593623|FG001|Overall Study|Lost to Follow-up|29|||
149031686|NCT01196988|537593624|FG002|Overall Study|Lost to Follow-up|21|||
149031687|NCT01196988|537593625|FG003|Overall Study|Lost to Follow-up|1|||
149031688|NCT01196988|537593622|FG000|Overall Study|Other|2|||
149031689|NCT01196988|537593623|FG001|Overall Study|Other|0|||
149031690|NCT01196988|537593624|FG002|Overall Study|Other|0|||
149031691|NCT01196988|537593625|FG003|Overall Study|Other|0|||
149031692|NCT04304534|537593627|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
149031693|NCT04304534|537593628|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
149031694|NCT04304534|537593629|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
149031695|NCT04304534|537593630|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
149031696|NCT04304534|537593627|FG000|Overall Study|Non-Compliance with study drug|0|||
149031697|NCT04304534|537593628|FG001|Overall Study|Non-Compliance with study drug|1|||
149031698|NCT04304534|537593629|FG002|Overall Study|Non-Compliance with study drug|1|||
149031699|NCT04304534|537593630|FG003|Overall Study|Non-Compliance with study drug|1|||
149031700|NCT04304534|537593627|FG000|Overall Study|Lost to Follow-up|0|||
149031701|NCT04304534|537593628|FG001|Overall Study|Lost to Follow-up|1|||
149031702|NCT04304534|537593629|FG002|Overall Study|Lost to Follow-up|2|||
149031703|NCT04304534|537593630|FG003|Overall Study|Lost to Follow-up|3|||
149031704|NCT04304534|537593627|FG000|Overall Study|Unspecific|4|||
149031705|NCT04304534|537593628|FG001|Overall Study|Unspecific|2|||
149031706|NCT04304534|537593629|FG002|Overall Study|Unspecific|2|||
149031707|NCT04304534|537593630|FG003|Overall Study|Unspecific|2|||
149031708|NCT04304534|537593627|FG000|Overall Study|Technical Problems|2|||
149031709|NCT04304534|537593628|FG001|Overall Study|Technical Problems|2|||
149031710|NCT04304534|537593629|FG002|Overall Study|Technical Problems|3|||
149031711|NCT04304534|537593630|FG003|Overall Study|Technical Problems|4|||
149031712|NCT04304534|537593627|FG000|Overall Study|Death|7|||
149031713|NCT04304534|537593628|FG001|Overall Study|Death|2|||
149031714|NCT04304534|537593629|FG002|Overall Study|Death|4|||
149031715|NCT04304534|537593630|FG003|Overall Study|Death|3|||
149031716|NCT04304534|537593627|FG000|Overall Study|Withdrawal by Subject|7|||
149031717|NCT04304534|537593628|FG001|Overall Study|Withdrawal by Subject|2|||
149031718|NCT04304534|537593629|FG002|Overall Study|Withdrawal by Subject|7|||
149031719|NCT04304534|537593630|FG003|Overall Study|Withdrawal by Subject|4|||
149031720|NCT04304534|537593627|FG000|Overall Study|Physician Decision|4|||
149031721|NCT04304534|537593628|FG001|Overall Study|Physician Decision|9|||
149031722|NCT04304534|537593629|FG002|Overall Study|Physician Decision|9|||
149031723|NCT04304534|537593630|FG003|Overall Study|Physician Decision|5|||
149031724|NCT04304534|537593627|FG000|Overall Study|Subject Decision|34|||
149031725|NCT04304534|537593628|FG001|Overall Study|Subject Decision|25|||
149031726|NCT04304534|537593629|FG002|Overall Study|Subject Decision|25|||
149031727|NCT04304534|537593630|FG003|Overall Study|Subject Decision|26|||
149031728|NCT04304534|537593627|FG000|Overall Study|Adverse Event|35|||
149031729|NCT04304534|537593628|FG001|Overall Study|Adverse Event|40|||
149031730|NCT04304534|537593629|FG002|Overall Study|Adverse Event|39|||
149031731|NCT04304534|537593630|FG003|Overall Study|Adverse Event|44|||
149031732|NCT04012853|537593631|FG000|Overall Study|Withdrawal by Subject|1|||
149031733|NCT04012853|537593632|FG001|Overall Study|Withdrawal by Subject|1|||
149031734|NCT04012853|537593631|FG000|Overall Study|Protocol Violation|1|||
149031735|NCT04012853|537593632|FG001|Overall Study|Protocol Violation|0|||
149031736|NCT04012853|537593631|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
149031737|NCT04012853|537593632|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
149031738|NCT01695317|537593633|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
149031739|NCT01695317|537593634|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
149031740|NCT01695317|537593633|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
149031741|NCT01695317|537593634|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
149031742|NCT03055767|537593635|FG000|Open-Label Period|Lost to Follow-up|0|||
149031743|NCT03055767|537593636|FG001|Open-Label Period|Lost to Follow-up|0|||
149031744|NCT03055767|537593637|FG002|Open-Label Period|Lost to Follow-up|2|||
149031745|NCT03055767|537593638|FG003|Open-Label Period|Lost to Follow-up|0|||
149031746|NCT03055767|537593635|FG000|Open-Label Period|Withdrawal by Subject|0|||
149031747|NCT03055767|537593636|FG001|Open-Label Period|Withdrawal by Subject|0|||
149031748|NCT03055767|537593637|FG002|Open-Label Period|Withdrawal by Subject|0|||
149031749|NCT03055767|537593638|FG003|Open-Label Period|Withdrawal by Subject|1|||
149031750|NCT02759731|537593641|FG000|Overall Study|Did not complete treatment.|8|||
149031751|NCT01466881|537593643|FG000|Overall Study|Ineligible|5|||
149031752|NCT01466881|537593643|FG000|Overall Study|Adverse Event|6|||
149031753|NCT01466881|537593643|FG000|Overall Study|Progression/relapse|20|||
149031754|NCT01466881|537593643|FG000|Overall Study|Death|4|||
149031755|NCT01466881|537593643|FG000|Overall Study|Other reason not protocol specified|5|||
148866395|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
148866396|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
148866397|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
148866398|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
148866399|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
148866400|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
148866401|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
148866402|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
148866403|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
148866404|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
148866405|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
148866406|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
148866407|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
148866408|NCT02008357|536987344|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
148866409|NCT02008357|536987345|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
148866410|NCT02008357|536987344|FG000|Open-label Extension Period|Adverse Event|8|||
148866411|NCT02008357|536987345|FG001|Open-label Extension Period|Adverse Event|7|||
148866412|NCT02008357|536987344|FG000|Open-label Extension Period|Death|7|||
148866413|NCT02008357|536987345|FG001|Open-label Extension Period|Death|4|||
148866414|NCT02008357|536987344|FG000|Open-label Extension Period|Lack of Efficacy|9|||
148866415|NCT02008357|536987345|FG001|Open-label Extension Period|Lack of Efficacy|5|||
148866416|NCT02008357|536987344|FG000|Open-label Extension Period|Lost to Follow-up|2|||
148866417|NCT02008357|536987345|FG001|Open-label Extension Period|Lost to Follow-up|2|||
148866418|NCT02008357|536987344|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
148866419|NCT02008357|536987345|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
148866420|NCT02008357|536987344|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
148866421|NCT02008357|536987345|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
148866422|NCT02008357|536987344|FG000|Open-label Extension Period|Safety Risk|2|||
148866423|NCT02008357|536987345|FG001|Open-label Extension Period|Safety Risk|1|||
148866424|NCT02008357|536987344|FG000|Open-label Extension Period|Non-Compliance|0|||
148866425|NCT02008357|536987345|FG001|Open-label Extension Period|Non-Compliance|1|||
148866426|NCT02008357|536987344|FG000|Open-label Extension Period|Investigator Recommendation|0|||
148866427|NCT02008357|536987345|FG001|Open-label Extension Period|Investigator Recommendation|1|||
148866428|NCT02008357|536987344|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
148866429|NCT02008357|536987345|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
148866430|NCT02008357|536987344|FG000|Open-label Extension Period|Coordinating Center Request|2|||
148866431|NCT02008357|536987345|FG001|Open-label Extension Period|Coordinating Center Request|4|||
148866432|NCT02008357|536987344|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
148866433|NCT02008357|536987345|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
148866434|NCT02008357|536987344|FG000|Open-label Extension Period|Study Ended|20|||
148866435|NCT02008357|536987345|FG001|Open-label Extension Period|Study Ended|25|||
148866436|NCT02008357|536987344|FG000|Open-label Extension Period|Personal Reasons|0|||
148866437|NCT02008357|536987345|FG001|Open-label Extension Period|Personal Reasons|1|||
148866438|NCT02008357|536987344|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
148866439|NCT02008357|536987345|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
148866440|NCT02008357|536987344|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
148866441|NCT02008357|536987345|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
148866442|NCT02008357|536987344|FG000|Open-label Extension Period|Other|2|||
148866443|NCT02008357|536987345|FG001|Open-label Extension Period|Other|0|||
148866444|NCT01442064|536987346|FG000|Overall Study|Adverse Event|2|||
148866445|NCT01442064|536987347|FG001|Overall Study|Adverse Event|2|||
148866446|NCT01442064|536987348|FG002|Overall Study|Adverse Event|2|||
148866447|NCT01442064|536987349|FG003|Overall Study|Adverse Event|1|||
148866448|NCT01442064|536987350|FG004|Overall Study|Adverse Event|2|||
148866449|NCT01442064|536987351|FG005|Overall Study|Adverse Event|0|||
148866450|NCT01442064|536987346|FG000|Overall Study|Death|0|||
149031756|NCT00606580|537593644|FG000|Overall Study|Lost to Follow-up|1|||
149031757|NCT00606580|537593645|FG001|Overall Study|Lost to Follow-up|1|||
149031758|NCT00606580|537593646|FG002|Overall Study|Lost to Follow-up|4|||
149031759|NCT00606580|537593644|FG000|Overall Study|Clinical failures|1|||
149031760|NCT00606580|537593645|FG001|Overall Study|Clinical failures|0|||
148866451|NCT01442064|536987347|FG001|Overall Study|Death|1|||
148866452|NCT01442064|536987348|FG002|Overall Study|Death|3|||
148866453|NCT01442064|536987349|FG003|Overall Study|Death|3|||
148866454|NCT01442064|536987350|FG004|Overall Study|Death|1|||
148866455|NCT01442064|536987351|FG005|Overall Study|Death|3|||
149031761|NCT00606580|537593646|FG002|Overall Study|Clinical failures|12|||
149031762|NCT00606580|537593644|FG000|Overall Study|Withdrawal by investigator|0|||
148866456|NCT01442064|536987346|FG000|Overall Study|Lost to Follow-up|5|||
148866457|NCT01442064|536987347|FG001|Overall Study|Lost to Follow-up|5|||
148866458|NCT01442064|536987348|FG002|Overall Study|Lost to Follow-up|1|||
148866459|NCT01442064|536987349|FG003|Overall Study|Lost to Follow-up|1|||
148866460|NCT01442064|536987350|FG004|Overall Study|Lost to Follow-up|3|||
148866461|NCT01442064|536987351|FG005|Overall Study|Lost to Follow-up|3|||
148866462|NCT01442064|536987346|FG000|Overall Study|Physician Decision|1|||
148866463|NCT01442064|536987347|FG001|Overall Study|Physician Decision|1|||
148866464|NCT01442064|536987348|FG002|Overall Study|Physician Decision|2|||
148866465|NCT01442064|536987349|FG003|Overall Study|Physician Decision|3|||
148866466|NCT01442064|536987350|FG004|Overall Study|Physician Decision|3|||
148866467|NCT01442064|536987351|FG005|Overall Study|Physician Decision|1|||
148866468|NCT01442064|536987346|FG000|Overall Study|Withdrawal by Subject|6|||
148866469|NCT01442064|536987347|FG001|Overall Study|Withdrawal by Subject|3|||
148866470|NCT01442064|536987348|FG002|Overall Study|Withdrawal by Subject|2|||
148866471|NCT01442064|536987349|FG003|Overall Study|Withdrawal by Subject|2|||
148866472|NCT01442064|536987350|FG004|Overall Study|Withdrawal by Subject|2|||
148866473|NCT01442064|536987351|FG005|Overall Study|Withdrawal by Subject|1|||
148866474|NCT01442064|536987346|FG000|Overall Study|Sponsor decision|82|||
148866475|NCT01442064|536987347|FG001|Overall Study|Sponsor decision|88|||
148866476|NCT01442064|536987348|FG002|Overall Study|Sponsor decision|92|||
148866477|NCT01442064|536987349|FG003|Overall Study|Sponsor decision|88|||
148866478|NCT01442064|536987350|FG004|Overall Study|Sponsor decision|95|||
148866479|NCT01442064|536987351|FG005|Overall Study|Sponsor decision|87|||
148866480|NCT01442064|536987346|FG000|Overall Study|Subject non-compliance|0|||
148866481|NCT01442064|536987347|FG001|Overall Study|Subject non-compliance|0|||
148866482|NCT01442064|536987348|FG002|Overall Study|Subject non-compliance|0|||
148866483|NCT01442064|536987349|FG003|Overall Study|Subject non-compliance|0|||
148866484|NCT01442064|536987350|FG004|Overall Study|Subject non-compliance|0|||
148866485|NCT01442064|536987351|FG005|Overall Study|Subject non-compliance|2|||
148866486|NCT01442064|536987346|FG000|Overall Study|Condition mandated other intervention|1|||
148866487|NCT01442064|536987347|FG001|Overall Study|Condition mandated other intervention|1|||
148866488|NCT01442064|536987348|FG002|Overall Study|Condition mandated other intervention|2|||
148866489|NCT01442064|536987349|FG003|Overall Study|Condition mandated other intervention|0|||
148866490|NCT01442064|536987350|FG004|Overall Study|Condition mandated other intervention|0|||
148866491|NCT01442064|536987351|FG005|Overall Study|Condition mandated other intervention|2|||
148866492|NCT02153346|536987352|FG000|Overall Study|Lost to Follow-up|11|||
148866493|NCT00260065|536987355|FG000|Overall Study|Progressive Disease|22|||
148866494|NCT00260065|536987355|FG000|Overall Study|Adverse Event|17|||
148866495|NCT00260065|536987355|FG000|Overall Study|Death|13|||
148866496|NCT00260065|536987355|FG000|Overall Study|Withdrawal by Subject|13|||
148866497|NCT00260065|536987355|FG000|Overall Study|Physician Decision|19|||
148866498|NCT00260065|536987355|FG000|Overall Study|Not otherwise specified|8|||
148866499|NCT00260065|536987355|FG000|Overall Study|Medication Noncompliance|1|||
148866500|NCT04573881|536987357|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
148866501|NCT00664326|536988891|FG000|Overall Study|Adverse Event|14|||
148866502|NCT00664326|536988891|FG000|Overall Study|Noncompliance with study medication|3|||
148866503|NCT00664326|536988891|FG000|Overall Study|Withdrawal by Subject|1|||
148866504|NCT00664326|536988891|FG000|Overall Study|Physician Decision|1|||
148866505|NCT00664326|536988891|FG000|Overall Study|Other Reasons|3|||
148866506|NCT00664326|536988891|FG000|Overall Study|Death|2|||
148866507|NCT00664326|536988891|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
148866508|NCT03647267|536988894|FG000|Overall Study|Lost to Follow-up|1|||
148866509|NCT03647267|536988895|FG001|Overall Study|Lost to Follow-up|0|||
148866510|NCT05079477|536988896|FG000|Overall Study|Lost to Follow-up|2|||
148866511|NCT05079477|536988897|FG001|Overall Study|Lost to Follow-up|0|||
148866512|NCT05079477|536988896|FG000|Overall Study|Withdrawal by Subject|1|||
148866513|NCT05079477|536988897|FG001|Overall Study|Withdrawal by Subject|0|||
148866514|NCT05079477|536988896|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
148866515|NCT05079477|536988897|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
148866516|NCT05079477|536988896|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
148866517|NCT05079477|536988897|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
148866518|NCT03131596|536988898|FG000|Overall Study|Protocol Violation|3|||
148866519|NCT03131596|536988899|FG001|Overall Study|Protocol Violation|3|||
148866520|NCT03131596|536988898|FG000|Overall Study|Lost to Follow-up|3|||
148866521|NCT03131596|536988899|FG001|Overall Study|Lost to Follow-up|0|||
148866522|NCT03654885|536988900|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
148866523|NCT03654885|536988901|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
148866524|NCT03654885|536988900|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
148866525|NCT03654885|536988901|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
148866526|NCT03654885|536988900|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
148866527|NCT03654885|536988901|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
148866528|NCT03654885|536988900|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
148866529|NCT03654885|536988901|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
148866530|NCT03654885|536988900|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
148866531|NCT03654885|536988901|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
148866532|NCT03654885|536988900|FG000|Overall Study|Adverse Event in Study Eye|3|||
148866533|NCT03654885|536988901|FG001|Overall Study|Adverse Event in Study Eye|0|||
148866534|NCT03654885|536988900|FG000|Overall Study|Consent Withdrawn|1|||
148866535|NCT03654885|536988901|FG001|Overall Study|Consent Withdrawn|0|||
148866536|NCT03654885|536988900|FG000|Overall Study|Death|3|||
148866537|NCT03654885|536988901|FG001|Overall Study|Death|1|||
148866538|NCT03654885|536988900|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
148866539|NCT03654885|536988901|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
148866540|NCT03654885|536988900|FG000|Overall Study|Lost to Follow-up|3|||
148866541|NCT03654885|536988901|FG001|Overall Study|Lost to Follow-up|3|||
148866542|NCT00004445|536988902|FG000|Overall Study|Physician Decision|2|||
148866543|NCT00004445|536988902|FG000|Overall Study|Withdrawal by Subject|1|||
148866544|NCT04912895|536988905|FG000|Overall Study|Unable to provide specimen|2|||
148866545|NCT04912895|536988906|FG001|Overall Study|Unable to provide specimen|0|||
148866546|NCT04912895|536988907|FG002|Overall Study|Unable to provide specimen|0|||
148866547|NCT01145053|536988908|FG000|Overall Study|Adverse Event|22|||
148866548|NCT01145053|536988908|FG000|Overall Study|Lost to Follow-up|28|||
148866549|NCT01145053|536988908|FG000|Overall Study|Withdrawal by Subject|25|||
148866550|NCT01145053|536988908|FG000|Overall Study|Other|18|||
148866551|NCT02088073|536988909|FG000|Acute Phase|Withdrawal by Subject|5|||
148866552|NCT02088073|536988910|FG001|Acute Phase|Withdrawal by Subject|0|||
148866553|NCT02088073|536988911|FG002|Acute Phase|Withdrawal by Subject|0|||
148866554|NCT02088073|536988912|FG003|Acute Phase|Withdrawal by Subject|0|||
148866555|NCT02088073|536988913|FG004|Acute Phase|Withdrawal by Subject|0|||
149031763|NCT00606580|537593645|FG001|Overall Study|Withdrawal by investigator|1|||
149031764|NCT00606580|537593646|FG002|Overall Study|Withdrawal by investigator|6|||
149031765|NCT00606580|537593644|FG000|Overall Study|Withdrawal by Subject|0|||
149031766|NCT00606580|537593645|FG001|Overall Study|Withdrawal by Subject|1|||
149031767|NCT00606580|537593646|FG002|Overall Study|Withdrawal by Subject|0|||
149031768|NCT01101165|537593647|FG000|Period 1|Adverse Event|1|||
149031769|NCT01101165|537593648|FG001|Period 1|Adverse Event|2|||
149031770|NCT01101165|537593647|FG000|Period 1|Withdrawal by Subject|0|||
149031771|NCT01101165|537593648|FG001|Period 1|Withdrawal by Subject|2|||
149031772|NCT01101165|537593647|FG000|Period 1|Positive Drug Screen|0|||
149031773|NCT01101165|537593648|FG001|Period 1|Positive Drug Screen|1|||
149031774|NCT01101165|537593647|FG000|Period 1|Lost to Follow-up|1|||
149031775|NCT01101165|537593648|FG001|Period 1|Lost to Follow-up|0|||
149031776|NCT01101165|537593647|FG000|Period 2|Withdrawal by Subject|3|||
149031777|NCT01101165|537593648|FG001|Period 2|Withdrawal by Subject|1|||
149031778|NCT01101165|537593647|FG000|Period 2|Adverse Event|1|||
149031779|NCT01101165|537593648|FG001|Period 2|Adverse Event|0|||
149031780|NCT04580303|537593649|FG000|Overall Study|Adverse Event|0|||
149031781|NCT04580303|537593650|FG001|Overall Study|Adverse Event|1|||
149031782|NCT04580303|537593651|FG002|Overall Study|Adverse Event|0|||
149031783|NCT04580303|537593652|FG003|Overall Study|Adverse Event|0|||
149031784|NCT04580303|537593649|FG000|Overall Study|Withdrawal by Subject|0|||
149031785|NCT04580303|537593650|FG001|Overall Study|Withdrawal by Subject|0|||
149031786|NCT04580303|537593651|FG002|Overall Study|Withdrawal by Subject|1|||
149031787|NCT04580303|537593652|FG003|Overall Study|Withdrawal by Subject|0|||
149031788|NCT01833065|537593654|FG000|Overall Study|Adverse Event|6|||
149031789|NCT01833065|537593655|FG001|Overall Study|Adverse Event|1|||
149031790|NCT01833065|537593656|FG002|Overall Study|Adverse Event|0|||
149031791|NCT01833065|537593657|FG003|Overall Study|Adverse Event|2|||
149031792|NCT01833065|537593658|FG004|Overall Study|Adverse Event|3|||
149031793|NCT01833065|537593654|FG000|Overall Study|Protocol Violation|1|||
149031794|NCT01833065|537593655|FG001|Overall Study|Protocol Violation|0|||
149031795|NCT01833065|537593656|FG002|Overall Study|Protocol Violation|0|||
149031796|NCT01833065|537593657|FG003|Overall Study|Protocol Violation|0|||
149031797|NCT01833065|537593658|FG004|Overall Study|Protocol Violation|2|||
148866556|NCT02088073|536988909|FG000|Acute Phase|Hyperkalemia|2|||
148866557|NCT02088073|536988910|FG001|Acute Phase|Hyperkalemia|0|||
148866558|NCT02088073|536988911|FG002|Acute Phase|Hyperkalemia|0|||
148866559|NCT02088073|536988912|FG003|Acute Phase|Hyperkalemia|0|||
149031798|NCT01833065|537593654|FG000|Overall Study|Lost to Follow-up|1|||
149031799|NCT01833065|537593655|FG001|Overall Study|Lost to Follow-up|0|||
149031800|NCT01833065|537593656|FG002|Overall Study|Lost to Follow-up|0|||
148866560|NCT02088073|536988913|FG004|Acute Phase|Hyperkalemia|0|||
148866561|NCT02088073|536988909|FG000|Maintanance Phase|Withdrawal by Subject|0|||
149031801|NCT01833065|537593657|FG003|Overall Study|Lost to Follow-up|0|||
149031802|NCT01833065|537593658|FG004|Overall Study|Lost to Follow-up|3|||
149031803|NCT01833065|537593654|FG000|Overall Study|Withdrawal by Subject|6|||
149031804|NCT01833065|537593655|FG001|Overall Study|Withdrawal by Subject|2|||
149031805|NCT01833065|537593656|FG002|Overall Study|Withdrawal by Subject|4|||
148866562|NCT02088073|536988910|FG001|Maintanance Phase|Withdrawal by Subject|2|||
148866563|NCT02088073|536988911|FG002|Maintanance Phase|Withdrawal by Subject|0|||
148866564|NCT02088073|536988912|FG003|Maintanance Phase|Withdrawal by Subject|0|||
148866565|NCT02088073|536988913|FG004|Maintanance Phase|Withdrawal by Subject|0|||
148866566|NCT02088073|536988909|FG000|Maintanance Phase|Adverse Event|0|||
148866567|NCT02088073|536988910|FG001|Maintanance Phase|Adverse Event|0|||
148866568|NCT02088073|536988911|FG002|Maintanance Phase|Adverse Event|3|||
148866569|NCT02088073|536988912|FG003|Maintanance Phase|Adverse Event|0|||
148866570|NCT02088073|536988913|FG004|Maintanance Phase|Adverse Event|1|||
148866571|NCT02088073|536988909|FG000|Maintanance Phase|Physician Decision|0|||
148866572|NCT02088073|536988910|FG001|Maintanance Phase|Physician Decision|0|||
148866573|NCT02088073|536988911|FG002|Maintanance Phase|Physician Decision|0|||
148866574|NCT02088073|536988912|FG003|Maintanance Phase|Physician Decision|0|||
148866575|NCT02088073|536988913|FG004|Maintanance Phase|Physician Decision|1|||
148866576|NCT02088073|536988909|FG000|Maintanance Phase|Sponsor's decision|0|||
148866577|NCT02088073|536988910|FG001|Maintanance Phase|Sponsor's decision|2|||
148866578|NCT02088073|536988911|FG002|Maintanance Phase|Sponsor's decision|0|||
148866579|NCT02088073|536988912|FG003|Maintanance Phase|Sponsor's decision|2|||
148866580|NCT02088073|536988913|FG004|Maintanance Phase|Sponsor's decision|1|||
148866581|NCT02088073|536988909|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
148866582|NCT02088073|536988910|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
148866583|NCT02088073|536988911|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
148866584|NCT02088073|536988912|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
148866585|NCT02088073|536988913|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
148866586|NCT02088073|536988909|FG000|Maintanance Phase|Miscellaneous|0|||
148866587|NCT02088073|536988910|FG001|Maintanance Phase|Miscellaneous|2|||
148866588|NCT02088073|536988911|FG002|Maintanance Phase|Miscellaneous|1|||
148866589|NCT02088073|536988912|FG003|Maintanance Phase|Miscellaneous|2|||
148866590|NCT02088073|536988913|FG004|Maintanance Phase|Miscellaneous|1|||
148866591|NCT02088073|536988909|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
148866592|NCT02088073|536988910|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
148866593|NCT02088073|536988911|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
148866594|NCT02088073|536988912|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
148866595|NCT02088073|536988913|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
148866596|NCT02088073|536988909|FG000|Maintanance Phase|Subject compliance|0|||
148866597|NCT02088073|536988910|FG001|Maintanance Phase|Subject compliance|1|||
148866598|NCT02088073|536988911|FG002|Maintanance Phase|Subject compliance|0|||
148866599|NCT02088073|536988912|FG003|Maintanance Phase|Subject compliance|0|||
148866600|NCT02088073|536988913|FG004|Maintanance Phase|Subject compliance|0|||
148866601|NCT02785458|536988914|FG000|1 Month|Withdrawal by Subject|2|||
148866602|NCT02785458|536988915|FG001|1 Month|Withdrawal by Subject|1|||
148866603|NCT02785458|536988914|FG000|1 Month|Lost to Follow-up|38|||
148866604|NCT02785458|536988915|FG001|1 Month|Lost to Follow-up|31|||
148866605|NCT02785458|536988914|FG000|1 Month|Deemed Ineligible|1|||
148866606|NCT02785458|536988915|FG001|1 Month|Deemed Ineligible|0|||
148866607|NCT02785458|536988914|FG000|1 Month|Completed Evaluation by Baseline|42|||
148866608|NCT02785458|536988915|FG001|1 Month|Completed Evaluation by Baseline|39|||
148866609|NCT02785458|536988914|FG000|1 Month|Partial Interview|0|||
148866610|NCT02785458|536988915|FG001|1 Month|Partial Interview|4|||
148866611|NCT02785458|536988914|FG000|3 Months|Withdrawal by Subject|3|||
148866612|NCT02785458|536988915|FG001|3 Months|Withdrawal by Subject|1|||
148866613|NCT02785458|536988914|FG000|3 Months|Lost to Follow-up|25|||
148866614|NCT02785458|536988915|FG001|3 Months|Lost to Follow-up|21|||
148866615|NCT02785458|536988914|FG000|3 Months|Completed Evaluation at 1 Month|100|||
148866616|NCT02785458|536988915|FG001|3 Months|Completed Evaluation at 1 Month|89|||
148866617|NCT01146652|536988916|FG000|Overall Study|Adverse Event|506|||
148866618|NCT01146652|536988917|FG001|Overall Study|Adverse Event|15|||
148866619|NCT01146652|536988916|FG000|Overall Study|Lack of Efficacy|91|||
148866620|NCT01146652|536988917|FG001|Overall Study|Lack of Efficacy|7|||
148866621|NCT01146652|536988916|FG000|Overall Study|Poor compliance to protocol|38|||
148866622|NCT01146652|536988917|FG001|Overall Study|Poor compliance to protocol|1|||
148866623|NCT01146652|536988916|FG000|Overall Study|Other unspecified reasons|314|||
148866624|NCT01146652|536988917|FG001|Overall Study|Other unspecified reasons|22|||
148866625|NCT01146652|536988916|FG000|Overall Study|Enrolled but not treated|2|||
148866626|NCT01146652|536988917|FG001|Overall Study|Enrolled but not treated|0|||
148866627|NCT00520013|536988918|FG000|Overall Study|Withdrawal by Subject|0|||
148866628|NCT00520013|536988919|FG001|Overall Study|Withdrawal by Subject|0|||
148866629|NCT00520013|536988920|FG002|Overall Study|Withdrawal by Subject|1|||
148866630|NCT00520013|536988918|FG000|Overall Study|Adverse Event|2|||
148999971|NCT01939548|537475629|FG001|Overall Study|Study Terminated by Sponsor|19|||
148999972|NCT01939548|537475630|FG002|Overall Study|Study Terminated by Sponsor|12|||
148866631|NCT00520013|536988919|FG001|Overall Study|Adverse Event|10|||
148866632|NCT00520013|536988920|FG002|Overall Study|Adverse Event|7|||
148866633|NCT00520013|536988918|FG000|Overall Study|Progressive Disease|7|||
148866634|NCT00520013|536988919|FG001|Overall Study|Progressive Disease|3|||
148866635|NCT00520013|536988920|FG002|Overall Study|Progressive Disease|0|||
148866636|NCT00520013|536988918|FG000|Overall Study|Clinical Progression|3|||
148866637|NCT00520013|536988919|FG001|Overall Study|Clinical Progression|1|||
148866638|NCT00520013|536988920|FG002|Overall Study|Clinical Progression|0|||
149031806|NCT01833065|537593657|FG003|Overall Study|Withdrawal by Subject|3|||
149031807|NCT01833065|537593658|FG004|Overall Study|Withdrawal by Subject|11|||
149031808|NCT01833065|537593654|FG000|Overall Study|Subject's substantial non-compliance|0|||
149031809|NCT01833065|537593655|FG001|Overall Study|Subject's substantial non-compliance|1|||
149031810|NCT01833065|537593656|FG002|Overall Study|Subject's substantial non-compliance|0|||
149031811|NCT01833065|537593657|FG003|Overall Study|Subject's substantial non-compliance|0|||
149031812|NCT01833065|537593658|FG004|Overall Study|Subject's substantial non-compliance|0|||
149031813|NCT01833065|537593654|FG000|Overall Study|Trial terminated by sponsor|8|||
149031814|NCT01833065|537593655|FG001|Overall Study|Trial terminated by sponsor|8|||
149031815|NCT01833065|537593656|FG002|Overall Study|Trial terminated by sponsor|7|||
149031816|NCT01833065|537593657|FG003|Overall Study|Trial terminated by sponsor|3|||
149031817|NCT01833065|537593658|FG004|Overall Study|Trial terminated by sponsor|13|||
149031818|NCT01833065|537593654|FG000|Overall Study|Others|2|||
149031819|NCT01833065|537593655|FG001|Overall Study|Others|1|||
149031820|NCT01833065|537593656|FG002|Overall Study|Others|1|||
149031821|NCT01833065|537593657|FG003|Overall Study|Others|1|||
149031822|NCT01833065|537593658|FG004|Overall Study|Others|4|||
149031823|NCT02299635|537593661|FG000|Overall Study|Adverse Event|2|||
149031824|NCT02299635|537593661|FG000|Overall Study|Death|1|||
148866639|NCT00520013|536988918|FG000|Overall Study|Death|0|||
148866640|NCT00520013|536988919|FG001|Overall Study|Death|1|||
148866641|NCT00520013|536988920|FG002|Overall Study|Death|0|||
148866642|NCT00520013|536988918|FG000|Overall Study|Physician Decision|0|||
148866643|NCT00520013|536988919|FG001|Overall Study|Physician Decision|0|||
148866644|NCT00520013|536988920|FG002|Overall Study|Physician Decision|3|||
148866645|NCT02118597|536988921|FG000|Overall Study|Sponsor terminated the study|14|||
148866646|NCT02118597|536988921|FG000|Overall Study|Serious Adverse Event|1|||
148866647|NCT02118597|536988921|FG000|Overall Study|Investigator's decision|1|||
148866648|NCT02590562|536988926|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
148866649|NCT00824005|536988927|FG000|Overall Study|Death|0|||
148866650|NCT00824005|536988928|FG001|Overall Study|Death|1|||
148866651|NCT00824005|536988927|FG000|Overall Study|Lost to Follow-up|0|||
148866652|NCT00824005|536988928|FG001|Overall Study|Lost to Follow-up|1|||
148866653|NCT01146288|536988929|FG000|First Intervention(1 Day)|Adverse Event|0|||
148866654|NCT01146288|536988930|FG001|First Intervention(1 Day)|Adverse Event|1|||
148866655|NCT03532932|536988934|FG000|Overall Study|Protocol Deviation|33|||
148866656|NCT03532932|536988935|FG001|Overall Study|Protocol Deviation|31|||
148866657|NCT03532932|536988934|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
148866658|NCT03532932|536988935|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
148866659|NCT03532932|536988934|FG000|Overall Study|Withdrawal by Subject|2|||
148866660|NCT03532932|536988935|FG001|Overall Study|Withdrawal by Subject|0|||
148866661|NCT03532932|536988934|FG000|Overall Study|Lost to Follow-up|15|||
148866662|NCT03532932|536988935|FG001|Overall Study|Lost to Follow-up|9|||
148866663|NCT03532932|536988934|FG000|Overall Study|Adverse Event|4|||
148866664|NCT03532932|536988935|FG001|Overall Study|Adverse Event|3|||
148866665|NCT03532932|536988934|FG000|Overall Study|Death|0|||
148866666|NCT03532932|536988935|FG001|Overall Study|Death|2|||
148866667|NCT03532932|536988934|FG000|Overall Study|Other|11|||
148866668|NCT03532932|536988935|FG001|Overall Study|Other|16|||
148866669|NCT02255565|536988936|FG000|Overall Study|Withdrawal by Subject|0|||
149031825|NCT02299635|537593661|FG000|Overall Study|Global deterioration of health status|1|||
149031826|NCT02299635|537593661|FG000|Overall Study|Objective progression or relapse|10|||
149031827|NCT02299635|537593661|FG000|Overall Study|Withdrawal by Subject|2|||
149031828|NCT02299635|537593661|FG000|Overall Study|Other|3|||
149031829|NCT00828672|537593662|FG000|Study Treatment|Lost to Follow-up|1|||
149031830|NCT00828672|537593663|FG001|Study Treatment|Lost to Follow-up|0|||
149031831|NCT00828672|537593662|FG000|Study Treatment|Adverse Event|0|||
149031832|NCT00828672|537593663|FG001|Study Treatment|Adverse Event|1|||
149031833|NCT00828672|537593662|FG000|Study Treatment|Complete response, no surgery|1|||
149031834|NCT00828672|537593663|FG001|Study Treatment|Complete response, no surgery|1|||
149031835|NCT00828672|537593662|FG000|Post-surgery (<30 Days)|No central review materials|0|||
149031836|NCT00828672|537593663|FG001|Post-surgery (<30 Days)|No central review materials|1|||
148866670|NCT02255565|536988937|FG001|Overall Study|Withdrawal by Subject|1|||
148866671|NCT02255565|536988938|FG002|Overall Study|Withdrawal by Subject|0|||
148866672|NCT00931801|536988939|FG000|Overall Study|Adverse Event|0|||
148866673|NCT00931801|536988940|FG001|Overall Study|Adverse Event|0|||
149031837|NCT00015457|537593670|FG000|First Intervention|Adverse Event|0|||
149031838|NCT00015457|537593671|FG001|First Intervention|Adverse Event|2|||
149031839|NCT00015457|537593670|FG000|First Intervention|Lack of Efficacy|0|||
149031840|NCT00015457|537593671|FG001|First Intervention|Lack of Efficacy|1|||
148866674|NCT00931801|536988941|FG002|Overall Study|Adverse Event|1|||
148866675|NCT00931801|536988939|FG000|Overall Study|Lost to Follow-up|0|||
149031841|NCT00015457|537593670|FG000|Second Intervention|Withdrawal by Subject|1|||
148866676|NCT00931801|536988940|FG001|Overall Study|Lost to Follow-up|1|||
149031842|NCT00015457|537593671|FG001|Second Intervention|Withdrawal by Subject|0|||
149031843|NCT01456936|537593676|FG000|Overall Study|Other reason|41|||
148866677|NCT00931801|536988941|FG002|Overall Study|Lost to Follow-up|0|||
148866678|NCT00931801|536988939|FG000|Overall Study|Withdrawal by Subject|1|||
148866679|NCT00931801|536988940|FG001|Overall Study|Withdrawal by Subject|0|||
148866680|NCT00931801|536988941|FG002|Overall Study|Withdrawal by Subject|0|||
148866681|NCT00931801|536988939|FG000|Overall Study|Confirmed Virologic Failure|0|||
148866682|NCT00931801|536988940|FG001|Overall Study|Confirmed Virologic Failure|0|||
148866683|NCT00931801|536988941|FG002|Overall Study|Confirmed Virologic Failure|3|||
148866684|NCT01174004|536988942|FG000|Overall Study|Adverse Event|2|||
148866685|NCT01174004|536988943|FG001|Overall Study|Adverse Event|10|||
148866686|NCT01174004|536988942|FG000|Overall Study|Withdrawal by Subject|2|||
148866687|NCT01174004|536988943|FG001|Overall Study|Withdrawal by Subject|3|||
148866688|NCT01174004|536988942|FG000|Overall Study|At Discretion of Sponsor|2|||
148866689|NCT01174004|536988943|FG001|Overall Study|At Discretion of Sponsor|2|||
148866690|NCT01174004|536988942|FG000|Overall Study|Protocol Violation|0|||
148866691|NCT01174004|536988943|FG001|Overall Study|Protocol Violation|1|||
148866692|NCT01174004|536988942|FG000|Overall Study|Physician Decision|1|||
148866693|NCT01174004|536988943|FG001|Overall Study|Physician Decision|0|||
148866694|NCT00933244|536988944|FG000|Overall Study|Withdrawal by Subject|5|||
148866695|NCT00933244|536988945|FG001|Overall Study|Withdrawal by Subject|1|||
148866696|NCT00933244|536988946|FG002|Overall Study|Withdrawal by Subject|3|||
148866697|NCT02956850|536988949|FG000|Overall Study|Withdrawal by Subject|0|||
148866698|NCT02956850|536988950|FG001|Overall Study|Withdrawal by Subject|0|||
148866699|NCT02956850|536988951|FG002|Overall Study|Withdrawal by Subject|0|||
148866700|NCT02956850|536988952|FG003|Overall Study|Withdrawal by Subject|0|||
148866701|NCT02956850|536988953|FG004|Overall Study|Withdrawal by Subject|0|||
148866702|NCT02956850|536988954|FG005|Overall Study|Withdrawal by Subject|0|||
148866703|NCT02956850|536988955|FG006|Overall Study|Withdrawal by Subject|0|||
148866704|NCT02956850|536988956|FG007|Overall Study|Withdrawal by Subject|0|||
148866705|NCT02956850|536988957|FG008|Overall Study|Withdrawal by Subject|0|||
148866706|NCT02956850|536988958|FG009|Overall Study|Withdrawal by Subject|0|||
148866707|NCT02956850|536988959|FG010|Overall Study|Withdrawal by Subject|0|||
148866708|NCT02956850|536988960|FG011|Overall Study|Withdrawal by Subject|0|||
148866709|NCT02956850|536988961|FG012|Overall Study|Withdrawal by Subject|0|||
148866710|NCT02956850|536988962|FG013|Overall Study|Withdrawal by Subject|0|||
148866711|NCT02956850|536988963|FG014|Overall Study|Withdrawal by Subject|0|||
148866712|NCT02956850|536988964|FG015|Overall Study|Withdrawal by Subject|0|||
148866713|NCT02956850|536988965|FG016|Overall Study|Withdrawal by Subject|0|||
148866714|NCT02956850|536988966|FG017|Overall Study|Withdrawal by Subject|1|||
148866715|NCT01920152|536988967|FG000|Overall Study|Withdrawal by Subject|1|||
148866716|NCT01920152|536988968|FG001|Overall Study|Withdrawal by Subject|2|||
148866717|NCT00086502|536988970|FG000|Overall Study|Adverse Event|11|||
148866718|NCT00086502|536988971|FG001|Overall Study|Adverse Event|2|||
148866719|NCT00086502|536988970|FG000|Overall Study|Lack of Efficacy|0|||
148866720|NCT00086502|536988971|FG001|Overall Study|Lack of Efficacy|2|||
148866721|NCT00086502|536988970|FG000|Overall Study|Lost to Follow-up|3|||
148866722|NCT00086502|536988971|FG001|Overall Study|Lost to Follow-up|1|||
148866723|NCT00086502|536988970|FG000|Overall Study|Physician Decision|1|||
148866724|NCT00086502|536988971|FG001|Overall Study|Physician Decision|1|||
148866725|NCT00086502|536988970|FG000|Overall Study|Pregnancy|0|||
148866726|NCT00086502|536988971|FG001|Overall Study|Pregnancy|1|||
148866727|NCT00086502|536988970|FG000|Overall Study|Protocol Violation|3|||
148866728|NCT00086502|536988971|FG001|Overall Study|Protocol Violation|3|||
148866729|NCT00086502|536988970|FG000|Overall Study|Withdrawal by Subject|5|||
148866730|NCT00086502|536988971|FG001|Overall Study|Withdrawal by Subject|6|||
148866731|NCT00086502|536988970|FG000|Overall Study|Patient Moved|1|||
148866732|NCT00086502|536988971|FG001|Overall Study|Patient Moved|1|||
148866733|NCT00086502|536988970|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
148866734|NCT00086502|536988971|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
148866735|NCT00086502|536988970|FG000|Overall Study|Patient Accidentally Unblinded|1|||
148866736|NCT00086502|536988971|FG001|Overall Study|Patient Accidentally Unblinded|0|||
148866737|NCT01304329|536988972|FG000|Third Intervention (3 Days)|Adverse Event|0|||
148866738|NCT01304329|536988973|FG001|Third Intervention (3 Days)|Adverse Event|1|||
148866739|NCT01304329|536988974|FG002|Third Intervention (3 Days)|Adverse Event|0|||
148866740|NCT01304329|536988975|FG003|Third Intervention (3 Days)|Adverse Event|0|||
148866741|NCT01304329|536988976|FG004|Third Intervention (3 Days)|Adverse Event|0|||
148866742|NCT01304329|536988977|FG005|Third Intervention (3 Days)|Adverse Event|0|||
148866743|NCT05545644|536988978|FG000|Overall Study|Lost to Follow-up|4|||
148866744|NCT05545644|536988979|FG001|Overall Study|Lost to Follow-up|3|||
148866745|NCT01995552|536988980|FG000|Overall Study|Protocol Violation|1|||
148866746|NCT01995552|536988980|FG000|Overall Study|Lack of Efficacy|15|||
148866747|NCT01995552|536988980|FG000|Overall Study|Death|1|||
148866748|NCT01515475|536988981|FG000|Overall Study|Lost to Follow-up|20|||
148866749|NCT01515475|536988982|FG001|Overall Study|Lost to Follow-up|15|||
148866750|NCT01515475|536988983|FG002|Overall Study|Lost to Follow-up|12|||
148866751|NCT01515475|536988984|FG003|Overall Study|Lost to Follow-up|12|||
148866752|NCT04957758|536988988|FG000|Overall Study|Adverse Event|1|||
148866753|NCT04957758|536988989|FG001|Overall Study|Adverse Event|0|||
148866754|NCT04957758|536988988|FG000|Overall Study|Lost to Follow-up|0|||
149031844|NCT01456936|537593677|FG001|Overall Study|Other reason|30|||
149031845|NCT01456936|537593678|FG002|Overall Study|Other reason|36|||
149031846|NCT01456936|537593679|FG003|Overall Study|Other reason|33|||
149031847|NCT01456936|537593676|FG000|Overall Study|No longer meets eligibility criteria|4|||
148866755|NCT04957758|536988989|FG001|Overall Study|Lost to Follow-up|2|||
148866756|NCT04957758|536988988|FG000|Overall Study|Withdrawal by Subject|4|||
148866757|NCT04957758|536988989|FG001|Overall Study|Withdrawal by Subject|2|||
148866758|NCT04957758|536988988|FG000|Overall Study|Protocol Violation|0|||
148866759|NCT04957758|536988989|FG001|Overall Study|Protocol Violation|1|||
148866760|NCT01066780|536988994|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
148866761|NCT01066780|536988995|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
148866762|NCT02360293|536988996|FG000|Overall Study|Lost to Follow-up|73|||
148866763|NCT02360293|536988997|FG001|Overall Study|Lost to Follow-up|95|||
148866764|NCT02360293|536988996|FG000|Overall Study|Withdrawal by Subject|2|||
148866765|NCT02360293|536988997|FG001|Overall Study|Withdrawal by Subject|1|||
148866766|NCT02360293|536988996|FG000|Overall Study|Excluded|1|||
148866767|NCT02360293|536988997|FG001|Overall Study|Excluded|0|||
148866768|NCT02226549|536988998|FG000|Overall Study|Randomized but Never Treated|1|||
148866769|NCT02226549|536988999|FG001|Overall Study|Randomized but Never Treated|0|||
148866770|NCT02226549|536988998|FG000|Overall Study|Lost to Follow-up|0|||
148866771|NCT02226549|536988999|FG001|Overall Study|Lost to Follow-up|1|||
148866772|NCT02741570|536989001|FG000|Pre-Treatment Period|Other reasons|0|||
148866773|NCT02741570|536989002|FG001|Pre-Treatment Period|Other reasons|3|||
148866774|NCT02741570|536989001|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
148866775|NCT02741570|536989002|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
148866776|NCT02741570|536989001|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
148866777|NCT02741570|536989002|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
148866778|NCT02741570|536989001|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
148866779|NCT02741570|536989002|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
148866780|NCT02741570|536989001|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
148866781|NCT02741570|536989002|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
148866782|NCT02741570|536989001|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
148866783|NCT02741570|536989002|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
148866784|NCT02741570|536989001|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
148866785|NCT02741570|536989002|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
148866786|NCT02741570|536989001|FG000|Pre-Treatment Period|Death|0|||
148866787|NCT02741570|536989002|FG001|Pre-Treatment Period|Death|1|||
148866788|NCT02741570|536989001|FG000|Pre-Treatment Period|Disease progression|0|||
148866789|NCT02741570|536989002|FG001|Pre-Treatment Period|Disease progression|1|||
148866790|NCT02741570|536989001|FG000|Treatment Period|Other reasons|47|||
148866791|NCT02741570|536989002|FG001|Treatment Period|Other reasons|12|||
148866792|NCT02741570|536989001|FG000|Treatment Period|Poor/non-compliance|0|||
148866793|NCT02741570|536989002|FG001|Treatment Period|Poor/non-compliance|2|||
148866794|NCT02741570|536989001|FG000|Treatment Period|Maximum clinical benefit|4|||
148866795|NCT02741570|536989002|FG001|Treatment Period|Maximum clinical benefit|6|||
148866796|NCT02741570|536989001|FG000|Treatment Period|Lost to Follow-up|1|||
148866797|NCT02741570|536989002|FG001|Treatment Period|Lost to Follow-up|3|||
148866798|NCT02741570|536989001|FG000|Treatment Period|Participant withdrew consent|9|||
148866799|NCT02741570|536989002|FG001|Treatment Period|Participant withdrew consent|13|||
148866800|NCT02741570|536989001|FG000|Treatment Period|Participant request to discontinue treatment|8|||
148866801|NCT02741570|536989002|FG001|Treatment Period|Participant request to discontinue treatment|23|||
148866802|NCT02741570|536989001|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
148866803|NCT02741570|536989002|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
148866804|NCT02741570|536989001|FG000|Treatment Period|Death|9|||
148866805|NCT02741570|536989002|FG001|Treatment Period|Death|7|||
148866806|NCT02741570|536989001|FG000|Treatment Period|Study drug toxicity|55|||
148866807|NCT02741570|536989002|FG001|Treatment Period|Study drug toxicity|47|||
148866808|NCT02741570|536989001|FG000|Treatment Period|Disease progression|294|||
148866809|NCT02741570|536989002|FG001|Treatment Period|Disease progression|301|||
148866810|NCT02741570|536989001|FG000|Treatment Period|Administrative reason by sponsor|0|||
148866811|NCT02741570|536989002|FG001|Treatment Period|Administrative reason by sponsor|1|||
148866812|NCT01498185|536989003|FG000|Overall Study|Adverse Event|0|||
148866813|NCT01498185|536989004|FG001|Overall Study|Adverse Event|0|||
148866814|NCT01498185|536989005|FG002|Overall Study|Adverse Event|0|||
148866815|NCT01498185|536989006|FG003|Overall Study|Adverse Event|1|||
149031848|NCT01456936|537593677|FG001|Overall Study|No longer meets eligibility criteria|8|||
149031849|NCT01456936|537593678|FG002|Overall Study|No longer meets eligibility criteria|6|||
148866816|NCT01498185|536989007|FG004|Overall Study|Adverse Event|0|||
148866817|NCT01498185|536989003|FG000|Overall Study|Withdrawal by Subject|1|||
148866818|NCT01498185|536989004|FG001|Overall Study|Withdrawal by Subject|1|||
148866819|NCT01498185|536989005|FG002|Overall Study|Withdrawal by Subject|0|||
148866820|NCT01498185|536989006|FG003|Overall Study|Withdrawal by Subject|2|||
148866821|NCT01498185|536989007|FG004|Overall Study|Withdrawal by Subject|1|||
148866822|NCT01498185|536989003|FG000|Overall Study|No longer met criteria, etc|0|||
148866823|NCT01498185|536989004|FG001|Overall Study|No longer met criteria, etc|0|||
148866824|NCT01498185|536989005|FG002|Overall Study|No longer met criteria, etc|0|||
148866825|NCT01498185|536989006|FG003|Overall Study|No longer met criteria, etc|0|||
148866826|NCT01498185|536989007|FG004|Overall Study|No longer met criteria, etc|2|||
148866827|NCT00946322|536989008|FG000|Pre-treatment|participant failure to follow up|1|||
148866828|NCT00946322|536989008|FG000|Post-treatment|participant failure to follow up|2|||
148866829|NCT01688921|536989012|FG000|Overall Study|Lost to Follow-up|7|||
148866830|NCT01688921|536989013|FG001|Overall Study|Lost to Follow-up|13|||
148866831|NCT01688921|536989012|FG000|Overall Study|Physician Decision|6|||
148866832|NCT01688921|536989013|FG001|Overall Study|Physician Decision|1|||
148866833|NCT01688921|536989012|FG000|Overall Study|Protocol Violation|0|||
148866834|NCT01688921|536989013|FG001|Overall Study|Protocol Violation|1|||
148866835|NCT01688921|536989012|FG000|Overall Study|informed consent|3|||
148866836|NCT01688921|536989013|FG001|Overall Study|informed consent|0|||
148866837|NCT04384107|536989017|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
148866838|NCT04384107|536989018|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
148866839|NCT04384107|536989017|FG000|Overall Study|Lost to Follow-up|1|||
148866840|NCT04384107|536989018|FG001|Overall Study|Lost to Follow-up|0|||
148866841|NCT01522404|536989019|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
148866842|NCT01522404|536989020|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
148866843|NCT01522404|536989019|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
148866844|NCT01522404|536989020|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
148866845|NCT01522404|536989019|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
148866846|NCT01522404|536989020|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
148866847|NCT00459537|536989021|FG000|Overall Study|Adverse Event|1|||
148866848|NCT00459537|536989022|FG001|Overall Study|Adverse Event|6|||
148866849|NCT00459537|536989021|FG000|Overall Study|Lack of Efficacy|10|||
148866850|NCT00459537|536989022|FG001|Overall Study|Lack of Efficacy|11|||
148866851|NCT00459537|536989021|FG000|Overall Study|Withdrawal by Subject|20|||
148866852|NCT00459537|536989022|FG001|Overall Study|Withdrawal by Subject|26|||
148866853|NCT00459537|536989021|FG000|Overall Study|Lost to Follow-up|27|||
148866854|NCT00459537|536989022|FG001|Overall Study|Lost to Follow-up|30|||
148866855|NCT00459537|536989021|FG000|Overall Study|Administrative problems|3|||
148866856|NCT00459537|536989022|FG001|Overall Study|Administrative problems|0|||
148866857|NCT00459537|536989021|FG000|Overall Study|Protocol Violation|4|||
148866858|NCT00459537|536989022|FG001|Overall Study|Protocol Violation|3|||
148866859|NCT00459537|536989021|FG000|Overall Study|Missing|1|||
148866860|NCT00459537|536989022|FG001|Overall Study|Missing|0|||
148866861|NCT02753127|536990685|FG000|Overall Study|Lost to Follow-up|13|||
148866862|NCT02753127|536990686|FG001|Overall Study|Lost to Follow-up|11|||
148866863|NCT02753127|536990685|FG000|Overall Study|Withdrawal by Subject|37|||
148866864|NCT02753127|536990686|FG001|Overall Study|Withdrawal by Subject|47|||
148866865|NCT02753127|536990685|FG000|Overall Study|Other|3|||
148866866|NCT02753127|536990686|FG001|Overall Study|Other|8|||
148866867|NCT02753127|536990685|FG000|Overall Study|Hospice|0|||
148866868|NCT02753127|536990686|FG001|Overall Study|Hospice|2|||
148866869|NCT00940485|536990687|FG000|Overall Study|HBeAb positive at Baseline|3|||
148866870|NCT00940485|536990688|FG001|Overall Study|HBeAb positive at Baseline|2|||
148866871|NCT00940485|536990687|FG000|Overall Study|Lost to Follow-up|2|||
148866872|NCT00940485|536990688|FG001|Overall Study|Lost to Follow-up|3|||
148866873|NCT00940485|536990687|FG000|Overall Study|Adverse Event|8|||
148866874|NCT00940485|536990688|FG001|Overall Study|Adverse Event|0|||
148866875|NCT00940485|536990687|FG000|Overall Study|Withdrawal by Subject|1|||
148866876|NCT00940485|536990688|FG001|Overall Study|Withdrawal by Subject|1|||
148866877|NCT00940485|536990687|FG000|Overall Study|Others|1|||
148866878|NCT00940485|536990688|FG001|Overall Study|Others|1|||
148866879|NCT06250738|536990691|FG000|Overall Study|Lost to Follow-up|1|||
148866880|NCT02936284|536990692|FG000|Overall Study|Withdrawal by Subject|3|||
148866881|NCT02936284|536990693|FG001|Overall Study|Withdrawal by Subject|1|||
148999973|NCT01939548|537475628|FG000|Overall Study|Insufficient Clinical Response|1|||
148999974|NCT01939548|537475629|FG001|Overall Study|Insufficient Clinical Response|0|||
148999975|NCT01939548|537475630|FG002|Overall Study|Insufficient Clinical Response|0|||
148866882|NCT02936284|536990692|FG000|Overall Study|Lost to Follow-up|7|||
148866883|NCT02936284|536990693|FG001|Overall Study|Lost to Follow-up|8|||
148866884|NCT00293709|536990698|FG000|Overall Study|Other|47|||
148999976|NCT01939548|537475628|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
148866885|NCT02981524|536990700|FG000|Overall Study|Progressive Disease|14|||
148866886|NCT02981524|536990700|FG000|Overall Study|Death (unrelated)|1|||
148866887|NCT02981524|536990700|FG000|Overall Study|Treatment Related Toxicity|1|||
148866888|NCT02981524|536990700|FG000|Overall Study|Withdrawal by Subject|1|||
148866889|NCT02677844|536990702|FG000|Period 3|Withdrawal by Subject|0|||
148866890|NCT02677844|536990703|FG001|Period 3|Withdrawal by Subject|0|||
148866891|NCT02677844|536990704|FG002|Period 3|Withdrawal by Subject|0|||
148866892|NCT02677844|536990705|FG003|Period 3|Withdrawal by Subject|1|||
148866893|NCT02677844|536990706|FG004|Period 3|Withdrawal by Subject|0|||
148866894|NCT02677844|536990707|FG005|Period 3|Withdrawal by Subject|0|||
148866895|NCT02677844|536990708|FG006|Period 3|Withdrawal by Subject|0|||
148866896|NCT03458702|536990709|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
148866897|NCT03458702|536990710|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
148866898|NCT03458702|536990709|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
148866899|NCT03458702|536990710|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
148866900|NCT01697462|536990711|FG000|Overall Study|Disease Progression|1|||
148866901|NCT01697462|536990711|FG000|Overall Study|Adverse Event|6|||
148866902|NCT01697462|536990711|FG000|Overall Study|Lost to Follow-up|21|||
148866903|NCT01697462|536990711|FG000|Overall Study|Withdrawal by Subject|12|||
148866904|NCT01697462|536990711|FG000|Overall Study|Investigator Decision|21|||
148866905|NCT01697462|536990711|FG000|Overall Study|Death|1|||
148866906|NCT01697462|536990711|FG000|Overall Study|Other|10|||
148866907|NCT01697462|536990711|FG000|Overall Study|Missing|5|||
148866908|NCT00168103|536990712|FG000|Overall Study|Withdrawal by Subject|1|||
148866909|NCT00168103|536990713|FG001|Overall Study|Withdrawal by Subject|2|||
148866910|NCT00168103|536990714|FG002|Overall Study|Withdrawal by Subject|1|||
148866911|NCT00168103|536990715|FG003|Overall Study|Withdrawal by Subject|0|||
148866912|NCT00168103|536990712|FG000|Overall Study|Lost to Follow-up|1|||
148866913|NCT00168103|536990713|FG001|Overall Study|Lost to Follow-up|3|||
148866914|NCT00168103|536990714|FG002|Overall Study|Lost to Follow-up|0|||
148866915|NCT00168103|536990715|FG003|Overall Study|Lost to Follow-up|0|||
148866916|NCT00545532|536990716|FG000|Overall Study|Withdrawal by Subject|1|||
148866917|NCT00545532|536990717|FG001|Overall Study|Withdrawal by Subject|3|||
148866918|NCT00545532|536990716|FG000|Overall Study|Lost to Follow-up|5|||
148866919|NCT00545532|536990717|FG001|Overall Study|Lost to Follow-up|6|||
148866920|NCT00545532|536990716|FG000|Overall Study|Death|0|||
148866921|NCT00545532|536990717|FG001|Overall Study|Death|1|||
148866922|NCT03630302|536990718|FG000|Surgery|hardware issue prevented LFP recordings|1|||
148866923|NCT03630302|536990718|FG000|3 Month Visit|Adverse Event|2|||
148866924|NCT03630302|536990718|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
148866925|NCT01133275|536990720|FG000|Overall Study|Withdrawal by Subject|1|||
148866926|NCT01133275|536990720|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
148866927|NCT01143896|536990721|FG000|Overall Study|Did not complete Baseline Interview|5|||
148866928|NCT01143896|536990722|FG001|Overall Study|Did not complete Baseline Interview|4|||
148866929|NCT01143896|536990721|FG000|Overall Study|Lost to Follow-up|18|||
148866930|NCT01143896|536990722|FG001|Overall Study|Lost to Follow-up|13|||
148866931|NCT01143896|536990721|FG000|Overall Study|Withdrawal by Subject|13|||
148866932|NCT01143896|536990722|FG001|Overall Study|Withdrawal by Subject|5|||
148866933|NCT01143896|536990721|FG000|Overall Study|Death|6|||
148866934|NCT01143896|536990722|FG001|Overall Study|Death|3|||
148866935|NCT01318070|536990723|FG000|Overall Study|Adverse Event|1|||
148866936|NCT01318070|536990724|FG001|Overall Study|Adverse Event|1|||
148866937|NCT01318070|536990725|FG002|Overall Study|Adverse Event|5|||
148866938|NCT01318070|536990723|FG000|Overall Study|Withdrawal by Subject|0|||
148866939|NCT01318070|536990724|FG001|Overall Study|Withdrawal by Subject|1|||
148866940|NCT01318070|536990725|FG002|Overall Study|Withdrawal by Subject|1|||
148866941|NCT01318070|536990723|FG000|Overall Study|Lack of Efficacy|0|||
148866942|NCT01318070|536990724|FG001|Overall Study|Lack of Efficacy|0|||
148866943|NCT01318070|536990725|FG002|Overall Study|Lack of Efficacy|1|||
148866944|NCT01318070|536990723|FG000|Overall Study|Principal Investigator Discretion|1|||
148866945|NCT01318070|536990724|FG001|Overall Study|Principal Investigator Discretion|0|||
148866946|NCT01318070|536990725|FG002|Overall Study|Principal Investigator Discretion|0|||
148866947|NCT04375397|536990728|FG000|Overall Study|Death|1|||
148866948|NCT04375397|536990729|FG001|Overall Study|Death|1|||
148866949|NCT04375397|536990728|FG000|Overall Study|Withdrew consent|2|||
148866950|NCT04375397|536990729|FG001|Overall Study|Withdrew consent|0|||
148866951|NCT04375397|536990728|FG000|Overall Study|Lost to Follow-up|6|||
148866952|NCT04375397|536990729|FG001|Overall Study|Lost to Follow-up|4|||
148866953|NCT04375397|536990728|FG000|Overall Study|Other, not specified|0|||
148866954|NCT04375397|536990729|FG001|Overall Study|Other, not specified|1|||
148999977|NCT01939548|537475629|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
148999978|NCT01939548|537475630|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
148999979|NCT01939548|537475628|FG000|Overall Study|Withdrawal by Subject|4|||
148866955|NCT00610441|536990731|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
148866956|NCT00610441|536990732|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
148866957|NCT00610441|536990733|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
148866958|NCT00610441|536990734|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
148866959|NCT00610441|536990731|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
148866960|NCT00610441|536990732|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
148866961|NCT00610441|536990733|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
148999980|NCT01939548|537475629|FG001|Overall Study|Withdrawal by Subject|4|||
148999981|NCT01939548|537475630|FG002|Overall Study|Withdrawal by Subject|1|||
148866962|NCT00610441|536990734|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
148866963|NCT00610441|536990731|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
148866964|NCT00610441|536990732|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
148866965|NCT00610441|536990733|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
148866966|NCT00610441|536990734|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
148866967|NCT00610441|536990731|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
148866968|NCT00610441|536990732|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
148866969|NCT00610441|536990733|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
148866970|NCT00610441|536990734|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
148866971|NCT00610441|536990731|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
148866972|NCT00610441|536990732|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
148866973|NCT00610441|536990733|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
148866974|NCT00610441|536990734|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
148866975|NCT00610441|536990731|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
148866976|NCT00610441|536990732|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
148866977|NCT00610441|536990733|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
148866978|NCT00610441|536990734|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
148866979|NCT00610441|536990731|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
148866980|NCT00610441|536990732|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
148866981|NCT00610441|536990733|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
148866982|NCT00610441|536990734|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
148866983|NCT00610441|536990731|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
148866984|NCT00610441|536990732|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
148866985|NCT00610441|536990733|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
148866986|NCT00610441|536990734|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
149031850|NCT01456936|537593679|FG003|Overall Study|No longer meets eligibility criteria|5|||
149031851|NCT01456936|537593676|FG000|Overall Study|Protocol Violation|4|||
149031852|NCT01456936|537593677|FG001|Overall Study|Protocol Violation|2|||
149031853|NCT01456936|537593678|FG002|Overall Study|Protocol Violation|5|||
149031854|NCT01456936|537593679|FG003|Overall Study|Protocol Violation|5|||
149031855|NCT01456936|537593676|FG000|Overall Study|Pregnancy|1|||
149031856|NCT01456936|537593677|FG001|Overall Study|Pregnancy|0|||
149031857|NCT01456936|537593678|FG002|Overall Study|Pregnancy|0|||
149031858|NCT01456936|537593679|FG003|Overall Study|Pregnancy|1|||
149031859|NCT01456936|537593676|FG000|Overall Study|Insufficient clinical response|4|||
149031860|NCT01456936|537593677|FG001|Overall Study|Insufficient clinical response|4|||
149031861|NCT01456936|537593678|FG002|Overall Study|Insufficient clinical response|14|||
149031862|NCT01456936|537593679|FG003|Overall Study|Insufficient clinical response|13|||
149031863|NCT01456936|537593676|FG000|Overall Study|No longer willing to participate|195|||
149031864|NCT01456936|537593677|FG001|Overall Study|No longer willing to participate|218|||
149031865|NCT01456936|537593678|FG002|Overall Study|No longer willing to participate|224|||
149031866|NCT01456936|537593679|FG003|Overall Study|No longer willing to participate|248|||
149031867|NCT01456936|537593676|FG000|Overall Study|Lost to Follow-up|135|||
149031868|NCT01456936|537593677|FG001|Overall Study|Lost to Follow-up|126|||
149031869|NCT01456936|537593678|FG002|Overall Study|Lost to Follow-up|144|||
149031870|NCT01456936|537593679|FG003|Overall Study|Lost to Follow-up|127|||
149031871|NCT01456936|537593676|FG000|Overall Study|Medication error|0|||
149031872|NCT01456936|537593677|FG001|Overall Study|Medication error|1|||
149031873|NCT01456936|537593678|FG002|Overall Study|Medication error|0|||
149031874|NCT01456936|537593679|FG003|Overall Study|Medication error|1|||
149031875|NCT01456936|537593676|FG000|Overall Study|Adverse event (study drug)|25|||
149031876|NCT01456936|537593677|FG001|Overall Study|Adverse event (study drug)|21|||
149031877|NCT01456936|537593678|FG002|Overall Study|Adverse event (study drug)|26|||
149031878|NCT01456936|537593679|FG003|Overall Study|Adverse event (study drug)|17|||
149031879|NCT01456936|537593676|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
149031880|NCT01456936|537593677|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
149031881|NCT01456936|537593678|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
149031882|NCT01456936|537593679|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
149031883|NCT01456936|537593676|FG000|Overall Study|Death|0|||
149031884|NCT01456936|537593677|FG001|Overall Study|Death|3|||
149031885|NCT01456936|537593678|FG002|Overall Study|Death|1|||
149031886|NCT01456936|537593679|FG003|Overall Study|Death|3|||
149031887|NCT01456936|537593676|FG000|Overall Study|Randomized but not treated|21|||
149031888|NCT01456936|537593677|FG001|Overall Study|Randomized but not treated|28|||
149031889|NCT01456936|537593678|FG002|Overall Study|Randomized but not treated|16|||
149031890|NCT01456936|537593679|FG003|Overall Study|Randomized but not treated|21|||
149031891|NCT03095508|537593680|FG000|Overall Study|Adverse Event|0|||
149031892|NCT03095508|537593681|FG001|Overall Study|Adverse Event|1|||
149031893|NCT02317705|537593682|FG000|Overall Study|Withdrawal by Subject|3|||
149031894|NCT02317705|537593682|FG000|Overall Study|Physician Decision|1|||
149031895|NCT02317705|537593682|FG000|Overall Study|Drug not usable|1|||
149031896|NCT01674569|537593683|FG000|Overall Study|Adverse Event|0|||
149031897|NCT01674569|537593684|FG001|Overall Study|Adverse Event|2|||
149031898|NCT01674569|537593685|FG002|Overall Study|Adverse Event|0|||
149031899|NCT01674569|537593686|FG003|Overall Study|Adverse Event|1|||
149031900|NCT01674569|537593687|FG004|Overall Study|Adverse Event|2|||
149031901|NCT01674569|537593688|FG005|Overall Study|Adverse Event|2|||
149031902|NCT01674569|537593683|FG000|Overall Study|Protocol Violation|0|||
149031903|NCT01674569|537593684|FG001|Overall Study|Protocol Violation|1|||
149031904|NCT01674569|537593685|FG002|Overall Study|Protocol Violation|1|||
148866987|NCT00610441|536990731|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
148866988|NCT00610441|536990732|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
148866989|NCT00610441|536990733|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
148866990|NCT00610441|536990734|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
148866991|NCT01842581|536990740|FG000|Overall Study|Adverse Event|6|||
148866992|NCT01842581|536990741|FG001|Overall Study|Adverse Event|4|||
148866993|NCT01842581|536990740|FG000|Overall Study|HE breakthrough|26|||
148866994|NCT01842581|536990741|FG001|Overall Study|HE breakthrough|13|||
148866995|NCT01842581|536990740|FG000|Overall Study|Liver transplant|2|||
148866996|NCT01842581|536990741|FG001|Overall Study|Liver transplant|0|||
148866997|NCT01842581|536990740|FG000|Overall Study|Lost to Follow-up|2|||
148866998|NCT01842581|536990741|FG001|Overall Study|Lost to Follow-up|5|||
148866999|NCT01842581|536990740|FG000|Overall Study|Withdrawal by Subject|5|||
148867000|NCT01842581|536990741|FG001|Overall Study|Withdrawal by Subject|7|||
148867001|NCT01842581|536990740|FG000|Overall Study|Other than specified|3|||
148867002|NCT01842581|536990741|FG001|Overall Study|Other than specified|1|||
148867003|NCT00334282|536990744|FG000|Overall Study|Lost to Follow-up|11|||
148867004|NCT00334282|536990745|FG001|Overall Study|Lost to Follow-up|5|||
148867005|NCT00334282|536990744|FG000|Overall Study|Withdrawal by Subject|17|||
148867006|NCT00334282|536990745|FG001|Overall Study|Withdrawal by Subject|3|||
148867007|NCT00334282|536990744|FG000|Overall Study|Death|194|||
148867008|NCT00334282|536990745|FG001|Overall Study|Death|100|||
148867009|NCT01420627|536990746|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
148867010|NCT00837876|536990747|FG000|Overall Study|Death|2|||
148867011|NCT00837876|536990747|FG000|Overall Study|Adverse Event|7|||
148867012|NCT00837876|536990747|FG000|Overall Study|Physician Decision|1|||
148867013|NCT00837876|536990747|FG000|Overall Study|Withdrawal by Subject|3|||
148867014|NCT00837876|536990747|FG000|Overall Study|disease progression|24|||
148867015|NCT00707746|536990754|FG000|Treatment Period|Adverse Event|2|||
148867016|NCT00707746|536990755|FG001|Treatment Period|Adverse Event|4|||
148867017|NCT00707746|536990754|FG000|Treatment Period|Ineligibility|0|||
148867018|NCT00707746|536990755|FG001|Treatment Period|Ineligibility|1|||
148867019|NCT01685983|536990756|FG000|Overall Study|Adverse Event|7|||
148867020|NCT01685983|536990756|FG000|Overall Study|Death|1|||
148867021|NCT01685983|536990756|FG000|Overall Study|Withdrawal by Subject|19|||
148867022|NCT01685983|536990756|FG000|Overall Study|Protocol Violation|2|||
148867023|NCT01685983|536990756|FG000|Overall Study|Physician Decision|13|||
148867024|NCT01685983|536990756|FG000|Overall Study|Other|7|||
148867025|NCT01685983|536990756|FG000|Overall Study|Progressive Disease|32|||
148867026|NCT01685983|536990756|FG000|Overall Study|Noncompliance with Study Drug|1|||
148867027|NCT01167907|536990769|FG000|Overall Study|Protocol Violation|1|||
148867028|NCT01167907|536990770|FG001|Overall Study|Protocol Violation|0|||
148867029|NCT01167907|536990769|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
148867030|NCT01167907|536990770|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
148867031|NCT01886690|536990773|FG000|Overall Study|Protocol Violation|0|||
148867032|NCT01886690|536990774|FG001|Overall Study|Protocol Violation|1|||
148867033|NCT01886690|536990773|FG000|Overall Study|Personal Reasons|0|||
148867034|NCT01886690|536990774|FG001|Overall Study|Personal Reasons|1|||
148867035|NCT03077698|536990775|FG000|Progestin Monotherapy|Stable Disease|8|||
148867036|NCT03077698|536990776|FG001|Progestin Monotherapy|Stable Disease|0|||
148867037|NCT03077698|536990775|FG000|Progestin Monotherapy|Adverse Event|1|||
148867038|NCT03077698|536990776|FG001|Progestin Monotherapy|Adverse Event|0|||
148867039|NCT03077698|536990775|FG000|Progestin Monotherapy|Death|1|||
148867040|NCT03077698|536990776|FG001|Progestin Monotherapy|Death|0|||
148867041|NCT03077698|536990775|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
148867042|NCT03077698|536990776|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
148867043|NCT03077698|536990775|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
148867044|NCT03077698|536990776|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
148867045|NCT03077698|536990775|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
148867046|NCT03077698|536990776|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
148867047|NCT03077698|536990775|FG000|Safety Follow Up|Withdrawal by Subject|2|||
148867048|NCT03077698|536990776|FG001|Safety Follow Up|Withdrawal by Subject|1|||
148867049|NCT03077698|536990775|FG000|Safety Follow Up|Transfer of care to hospice|1|||
148867050|NCT03077698|536990776|FG001|Safety Follow Up|Transfer of care to hospice|0|||
148867051|NCT03461406|536990777|FG000|Overall Study|Death|1|||
148867052|NCT03461406|536990778|FG001|Overall Study|Death|2|||
148867053|NCT03461406|536990777|FG000|Overall Study|Consent Withdrawn by Participant|0|||
148867054|NCT03461406|536990778|FG001|Overall Study|Consent Withdrawn by Participant|1|||
148867055|NCT03461406|536990777|FG000|Overall Study|Screen Failure|3|||
148867056|NCT03461406|536990778|FG001|Overall Study|Screen Failure|1|||
148867057|NCT03461406|536990777|FG000|Overall Study|Reason not Specified|1|||
148867058|NCT03461406|536990778|FG001|Overall Study|Reason not Specified|3|||
148867059|NCT03461406|536990777|FG000|Overall Study|Lost to Follow-up|3|||
148867060|NCT03461406|536990778|FG001|Overall Study|Lost to Follow-up|0|||
148867061|NCT01140568|536990779|FG000|Overall Study|disease progression|31|||
148867062|NCT01140568|536990779|FG000|Overall Study|Withdrawal by Subject|1|||
148867063|NCT01140568|536990779|FG000|Overall Study|Screen Fail|4|||
148867064|NCT01873729|536990783|FG000|Overall Study|Withdrawal by Subject|1|||
148867065|NCT03099148|536990784|FG000|Wash-out|scheduling conflict|0|||
148867066|NCT03099148|536990785|FG001|Wash-out|scheduling conflict|1|||
148867067|NCT03099148|536990786|FG002|Wash-out|scheduling conflict|0|||
148867068|NCT03099148|536990787|FG003|Wash-out|scheduling conflict|0|||
148867069|NCT03099148|536990784|FG000|Wash-out|Adverse Event|0|||
148867070|NCT03099148|536990785|FG001|Wash-out|Adverse Event|1|||
148867071|NCT03099148|536990786|FG002|Wash-out|Adverse Event|0|||
148867072|NCT03099148|536990787|FG003|Wash-out|Adverse Event|0|||
148867073|NCT01269385|536990788|FG000|Overall Study|Adverse Event|1|||
148867074|NCT01269385|536990789|FG001|Overall Study|Adverse Event|1|||
148867075|NCT01269385|536990790|FG002|Overall Study|Adverse Event|0|||
148867076|NCT01269385|536990791|FG003|Overall Study|Adverse Event|0|||
148867077|NCT01710527|536990793|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
148867078|NCT01710527|536990794|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
148867079|NCT01827332|536990795|FG000|Overall Study|Lost to Follow-up|2|||
148867080|NCT01827332|536990796|FG001|Overall Study|Lost to Follow-up|1|||
148867081|NCT03352453|536990797|FG000|Overall Study|Miscellaneous Reasons|1|||
148867082|NCT03352453|536990798|FG001|Overall Study|Miscellaneous Reasons|2|||
148867083|NCT03352453|536990797|FG000|Overall Study|Lack of Efficacy|1|||
148867084|NCT03352453|536990798|FG001|Overall Study|Lack of Efficacy|0|||
148867085|NCT03352453|536990797|FG000|Overall Study|Withdrawal by Subject|8|||
148867086|NCT03352453|536990798|FG001|Overall Study|Withdrawal by Subject|14|||
148867087|NCT03352453|536990797|FG000|Overall Study|Study Terminated by Sponsor|2|||
148867088|NCT03352453|536990798|FG001|Overall Study|Study Terminated by Sponsor|1|||
148867089|NCT03352453|536990797|FG000|Overall Study|Protocol Deviation|1|||
148867090|NCT03352453|536990798|FG001|Overall Study|Protocol Deviation|0|||
148867091|NCT03352453|536990797|FG000|Overall Study|Lost to Follow-up|7|||
148867092|NCT03352453|536990798|FG001|Overall Study|Lost to Follow-up|6|||
148867093|NCT03352453|536990797|FG000|Overall Study|Adverse Event|2|||
148867094|NCT03352453|536990798|FG001|Overall Study|Adverse Event|9|||
148867095|NCT01241760|536990799|FG000|Overall Study|Adverse Event|1|||
148999982|NCT01939548|537475628|FG000|Overall Study|Protocol Violation|7|||
148999983|NCT01939548|537475629|FG001|Overall Study|Protocol Violation|6|||
148999984|NCT01939548|537475630|FG002|Overall Study|Protocol Violation|5|||
148999985|NCT01939548|537475628|FG000|Overall Study|Lost to Follow-up|5|||
148999986|NCT01939548|537475629|FG001|Overall Study|Lost to Follow-up|5|||
148999987|NCT01939548|537475630|FG002|Overall Study|Lost to Follow-up|3|||
148999988|NCT01939548|537475628|FG000|Overall Study|Adverse Event|2|||
148999989|NCT01939548|537475629|FG001|Overall Study|Adverse Event|9|||
148999990|NCT01939548|537475630|FG002|Overall Study|Adverse Event|7|||
148999991|NCT01939548|537475628|FG000|Overall Study|Death|0|||
148999992|NCT01939548|537475629|FG001|Overall Study|Death|0|||
148999993|NCT01939548|537475630|FG002|Overall Study|Death|1|||
148999994|NCT01939548|537475628|FG000|Overall Study|Participant dropped|0|||
148999995|NCT01939548|537475629|FG001|Overall Study|Participant dropped|0|||
148999996|NCT01939548|537475630|FG002|Overall Study|Participant dropped|1|||
148999997|NCT01939548|537475628|FG000|Overall Study|Participant unwilling to continue|0|||
148999998|NCT01939548|537475629|FG001|Overall Study|Participant unwilling to continue|1|||
148999999|NCT01939548|537475630|FG002|Overall Study|Participant unwilling to continue|0|||
149000000|NCT01939548|537475628|FG000|Overall Study|Participant withdrew consent|0|||
149000001|NCT01939548|537475629|FG001|Overall Study|Participant withdrew consent|2|||
149000002|NCT01939548|537475630|FG002|Overall Study|Participant withdrew consent|0|||
149000003|NCT01939548|537475628|FG000|Overall Study|Did not complete follow-up|0|||
149000004|NCT01939548|537475629|FG001|Overall Study|Did not complete follow-up|1|||
149000005|NCT01939548|537475630|FG002|Overall Study|Did not complete follow-up|0|||
149000006|NCT02124265|537475631|FG000|Overall Study|Adverse Event|1|||
149000007|NCT00374322|537475642|FG000|Overall Study|Lost to Follow-up|92|||
149000008|NCT00374322|537475643|FG001|Overall Study|Lost to Follow-up|90|||
149000009|NCT00374322|537475642|FG000|Overall Study|Protocol Violation|8|||
149000010|NCT00374322|537475643|FG001|Overall Study|Protocol Violation|3|||
149000011|NCT00374322|537475642|FG000|Overall Study|Withdrawal by Subject|235|||
149000012|NCT00374322|537475643|FG001|Overall Study|Withdrawal by Subject|167|||
149000013|NCT00374322|537475642|FG000|Overall Study|Sponsor Terminated Study|866|||
149000014|NCT00374322|537475643|FG001|Overall Study|Sponsor Terminated Study|990|||
149000015|NCT00374322|537475642|FG000|Overall Study|Physician Decision|36|||
149000016|NCT00374322|537475643|FG001|Overall Study|Physician Decision|32|||
149000017|NCT00374322|537475642|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
149000018|NCT00374322|537475643|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
149000019|NCT00374322|537475642|FG000|Overall Study|Sponsor Decision|2|||
149000020|NCT00374322|537475643|FG001|Overall Study|Sponsor Decision|3|||
149000021|NCT00374322|537475642|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
149000022|NCT00374322|537475643|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
149000023|NCT00374322|537475642|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
149000024|NCT00374322|537475643|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
149000025|NCT00374322|537475642|FG000|Overall Study|Severe Toxicity|1|||
148867096|NCT01241760|536990800|FG001|Overall Study|Adverse Event|0|||
148867097|NCT01241760|536990799|FG000|Overall Study|Lost to Follow-up|18|||
148867098|NCT01241760|536990800|FG001|Overall Study|Lost to Follow-up|22|||
148867099|NCT01241760|536990799|FG000|Overall Study|Withdrawal by Subject|13|||
148867100|NCT01241760|536990800|FG001|Overall Study|Withdrawal by Subject|13|||
148867101|NCT01241760|536990799|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
148867102|NCT01241760|536990800|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
148867103|NCT01241760|536990799|FG000|Overall Study|Other|1|||
148867104|NCT01241760|536990800|FG001|Overall Study|Other|1|||
148867105|NCT02725593|536990801|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
148867106|NCT02725593|536990802|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
148867107|NCT02725593|536990801|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
148867108|NCT02725593|536990802|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
148867109|NCT02725593|536990801|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
148867110|NCT02725593|536990802|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
148867111|NCT02725593|536990801|FG000|Long Term Extension|Withdrawal by Subject|1|||
148867112|NCT02725593|536990802|FG001|Long Term Extension|Withdrawal by Subject|3|||
148867113|NCT00514020|536990803|FG000|Overall Study|Adverse Event|6|||
148867114|NCT00514020|536990803|FG000|Overall Study|Withdrawal by Subject|3|||
148867115|NCT00514020|536990803|FG000|Overall Study|Physician Decision|1|||
148867116|NCT00514020|536990803|FG000|Overall Study|disease progression|9|||
148867117|NCT00514020|536990803|FG000|Overall Study|other complicating disease|2|||
148867118|NCT00514020|536990803|FG000|Overall Study|patient went to radiation treatment|1|||
148867119|NCT00514020|536990803|FG000|Overall Study|"patients moved to the no tx group"|6|||
148867120|NCT00276614|536990814|FG000|Overall Study|Progression of disease under study|3|||
148867121|NCT02644356|536990825|FG000|Overall Study|Withdrawal by Subject|2|||
148867122|NCT02210091|536990827|FG000|Overall Study|Physician Decision|0|||
148867123|NCT02210091|536990828|FG001|Overall Study|Physician Decision|1|||
148867124|NCT02210091|536990827|FG000|Overall Study|Withdrawal by Sponsor|0|||
148867125|NCT02210091|536990828|FG001|Overall Study|Withdrawal by Sponsor|1|||
148867126|NCT01711866|536990832|FG000|Overall Study|Noncompliant|3|||
148867127|NCT01711866|536990832|FG000|Overall Study|Withdrawal by Subject|3|||
148867128|NCT01711866|536990832|FG000|Overall Study|Adverse Event|2|||
148867129|NCT00897390|536990833|FG000|Overall Study|Adverse Event|2|||
148867130|NCT00897390|536990833|FG000|Overall Study|No Longer Met Study Criteria|1|||
148867131|NCT00897390|536990833|FG000|Overall Study|Personal Reasons|1|||
148867132|NCT00897390|536990833|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
148867133|NCT01831817|536990834|FG000|Overall Study|Lost to Follow-up|1|||
148867134|NCT01831817|536990835|FG001|Overall Study|Lost to Follow-up|0|||
148867135|NCT01831817|536990836|FG002|Overall Study|Lost to Follow-up|0|||
148867136|NCT01831817|536990837|FG003|Overall Study|Lost to Follow-up|0|||
148867137|NCT01831817|536990834|FG000|Overall Study|Withdrawl of Consent|3|||
148867138|NCT01831817|536990835|FG001|Overall Study|Withdrawl of Consent|0|||
148867139|NCT01831817|536990836|FG002|Overall Study|Withdrawl of Consent|0|||
148867140|NCT01831817|536990837|FG003|Overall Study|Withdrawl of Consent|0|||
148867141|NCT03159104|536990838|FG000|Overall Study|Violation of inclusion criteria|1|||
148867142|NCT03159104|536990839|FG001|Overall Study|Violation of inclusion criteria|2|||
148867143|NCT00958217|536990840|FG000|Overall Study|Death|2|||
148867144|NCT00958217|536990841|FG001|Overall Study|Death|1|||
148867145|NCT00958217|536990840|FG000|Overall Study|Withdrawal by Subject|4|||
148867146|NCT00958217|536990841|FG001|Overall Study|Withdrawal by Subject|3|||
148867147|NCT00958217|536990840|FG000|Overall Study|Lost to Follow-up|17|||
148867148|NCT00958217|536990841|FG001|Overall Study|Lost to Follow-up|19|||
148867149|NCT00958217|536990840|FG000|Overall Study|Moved out of area|1|||
148867150|NCT00958217|536990841|FG001|Overall Study|Moved out of area|1|||
148867151|NCT00958217|536990840|FG000|Overall Study|Inpatient hospitalization|0|||
148867152|NCT00958217|536990841|FG001|Overall Study|Inpatient hospitalization|1|||
148867153|NCT02198235|536990843|FG000|Overall Study|Lost to Follow-up|3|||
148867154|NCT02198235|536990844|FG001|Overall Study|Lost to Follow-up|2|||
148867155|NCT02198235|536990845|FG002|Overall Study|Lost to Follow-up|2|||
148867156|NCT01999218|536990847|FG000|Overall Study|Hyperglycemia|18|||
148867157|NCT01999218|536990848|FG001|Overall Study|Hyperglycemia|17|||
148867158|NCT01999218|536990849|FG002|Overall Study|Hyperglycemia|17|||
148867159|NCT01999218|536990847|FG000|Overall Study|Lack of Efficacy|1|||
148867160|NCT01999218|536990848|FG001|Overall Study|Lack of Efficacy|0|||
148867161|NCT01999218|536990849|FG002|Overall Study|Lack of Efficacy|1|||
148867162|NCT01999218|536990847|FG000|Overall Study|Lost to Follow-up|22|||
148867163|NCT01999218|536990848|FG001|Overall Study|Lost to Follow-up|17|||
148867164|NCT01999218|536990849|FG002|Overall Study|Lost to Follow-up|18|||
148867165|NCT01999218|536990847|FG000|Overall Study|Non-Compliance With Study Drug|6|||
148867166|NCT01999218|536990848|FG001|Overall Study|Non-Compliance With Study Drug|4|||
148867167|NCT01999218|536990849|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148867168|NCT01999218|536990847|FG000|Overall Study|Physician Decision|1|||
148867169|NCT01999218|536990848|FG001|Overall Study|Physician Decision|4|||
148867170|NCT01999218|536990849|FG002|Overall Study|Physician Decision|6|||
148867171|NCT01999218|536990847|FG000|Overall Study|Protocol Violation|4|||
148867172|NCT01999218|536990848|FG001|Overall Study|Protocol Violation|5|||
148867173|NCT01999218|536990849|FG002|Overall Study|Protocol Violation|4|||
148867174|NCT01999218|536990847|FG000|Overall Study|Screen failure|0|||
148867175|NCT01999218|536990848|FG001|Overall Study|Screen failure|1|||
148867176|NCT01999218|536990849|FG002|Overall Study|Screen failure|0|||
148867177|NCT01999218|536990847|FG000|Overall Study|Study Terminated By Sponsor|7|||
148867178|NCT01999218|536990848|FG001|Overall Study|Study Terminated By Sponsor|5|||
148867179|NCT01999218|536990849|FG002|Overall Study|Study Terminated By Sponsor|12|||
148867180|NCT01999218|536990847|FG000|Overall Study|Participant moves|2|||
148867181|NCT01999218|536990848|FG001|Overall Study|Participant moves|5|||
148867182|NCT01999218|536990849|FG002|Overall Study|Participant moves|3|||
148867183|NCT01999218|536990847|FG000|Overall Study|Withdrawal by Subject|28|||
148867184|NCT01999218|536990848|FG001|Overall Study|Withdrawal by Subject|29|||
148867185|NCT01999218|536990849|FG002|Overall Study|Withdrawal by Subject|34|||
148867186|NCT01999218|536990847|FG000|Overall Study|Creatinine/eGFR|0|||
148867187|NCT01999218|536990848|FG001|Overall Study|Creatinine/eGFR|0|||
148867188|NCT01999218|536990849|FG002|Overall Study|Creatinine/eGFR|1|||
149000026|NCT00374322|537475643|FG001|Overall Study|Severe Toxicity|0|||
149000027|NCT00374322|537475642|FG000|Overall Study|Site Closed|2|||
149000028|NCT00374322|537475643|FG001|Overall Study|Site Closed|2|||
149000029|NCT00374322|537475642|FG000|Overall Study|Participant Changed Physician|1|||
149000030|NCT00374322|537475643|FG001|Overall Study|Participant Changed Physician|0|||
149000031|NCT00374322|537475642|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
149000032|NCT00374322|537475643|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
149000033|NCT00374322|537475642|FG000|Overall Study|Noncompliance with Study Requirements|0|||
149000034|NCT00374322|537475643|FG001|Overall Study|Noncompliance with Study Requirements|1|||
149000035|NCT00374322|537475642|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
149000036|NCT00374322|537475643|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
149000037|NCT00374322|537475642|FG000|Overall Study|Did Not Receive Study Medication|8|||
149000038|NCT00374322|537475643|FG001|Overall Study|Did Not Receive Study Medication|6|||
149000039|NCT01297959|537475646|FG000|Overall Study|Adverse Event|0|||
149000040|NCT01297959|537475647|FG001|Overall Study|Adverse Event|1|||
149000041|NCT01297959|537475646|FG000|Overall Study|Protocol Violation|2|||
149000042|NCT01297959|537475647|FG001|Overall Study|Protocol Violation|1|||
149000043|NCT01297959|537475646|FG000|Overall Study|Withdrawal by Subject|5|||
149000044|NCT01297959|537475647|FG001|Overall Study|Withdrawal by Subject|4|||
149000045|NCT01297959|537475646|FG000|Overall Study|Physician Decision|0|||
149000046|NCT01297959|537475647|FG001|Overall Study|Physician Decision|1|||
149000047|NCT01297959|537475646|FG000|Overall Study|Unrelated medical illness / complication|0|||
149000048|NCT01297959|537475647|FG001|Overall Study|Unrelated medical illness / complication|2|||
149000049|NCT01297959|537475646|FG000|Overall Study|Other|13|||
149000050|NCT01297959|537475647|FG001|Overall Study|Other|7|||
149000051|NCT01667432|537475648|FG000|Overall Study|Premature Study Termination|26|||
149000052|NCT01667432|537475648|FG000|Overall Study|Failure to Return|10|||
149000053|NCT01667432|537475648|FG000|Overall Study|Moved to Another Center|3|||
149000054|NCT01667432|537475648|FG000|Overall Study|Lost to Follow-up|3|||
149000055|NCT01667432|537475648|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
149000056|NCT01667432|537475648|FG000|Overall Study|Insufficient Therapeutic Response|4|||
149000057|NCT01667432|537475648|FG000|Overall Study|Adverse Event|1|||
149000058|NCT01667432|537475648|FG000|Overall Study|Protocol Deviation|2|||
149000059|NCT01667432|537475648|FG000|Overall Study|Principal Investigator Decision|1|||
149000060|NCT01667432|537475648|FG000|Overall Study|Reason Not Specified|2|||
149000061|NCT01667432|537475648|FG000|Overall Study|Missing Information|4|||
149000062|NCT00553696|537475653|FG000|Overall Study|Adverse Event|2|||
149000063|NCT00553696|537475654|FG001|Overall Study|Adverse Event|4|||
149000064|NCT00553696|537475655|FG002|Overall Study|Adverse Event|0|||
149000065|NCT00553696|537475656|FG003|Overall Study|Adverse Event|1|||
149000066|NCT00553696|537475653|FG000|Overall Study|Global deterioration of health status|0|||
149000067|NCT00553696|537475654|FG001|Overall Study|Global deterioration of health status|2|||
149000068|NCT00553696|537475655|FG002|Overall Study|Global deterioration of health status|0|||
149000069|NCT00553696|537475656|FG003|Overall Study|Global deterioration of health status|0|||
149000070|NCT00553696|537475653|FG000|Overall Study|Objective progression or relapse|2|||
149000071|NCT00553696|537475654|FG001|Overall Study|Objective progression or relapse|9|||
149000072|NCT00553696|537475655|FG002|Overall Study|Objective progression or relapse|6|||
149000073|NCT00553696|537475656|FG003|Overall Study|Objective progression or relapse|0|||
149000074|NCT00553696|537475653|FG000|Overall Study|Withdrawal by Subject|0|||
149000075|NCT00553696|537475654|FG001|Overall Study|Withdrawal by Subject|1|||
148867189|NCT01999218|536990847|FG000|Overall Study|Death|7|||
148867190|NCT01999218|536990848|FG001|Overall Study|Death|1|||
149000076|NCT00553696|537475655|FG002|Overall Study|Withdrawal by Subject|0|||
149000077|NCT00553696|537475656|FG003|Overall Study|Withdrawal by Subject|0|||
149000078|NCT00686881|537475657|FG000|Overall Study|Withdrawal by Subject|11|||
149000079|NCT00686881|537475658|FG001|Overall Study|Withdrawal by Subject|18|||
149000080|NCT00686881|537475657|FG000|Overall Study|Lost to Follow-up|0|||
149000081|NCT00686881|537475658|FG001|Overall Study|Lost to Follow-up|1|||
149000082|NCT00686881|537475657|FG000|Overall Study|Treatment-related adverse event|10|||
148867191|NCT01999218|536990849|FG002|Overall Study|Death|2|||
148867192|NCT01999218|536990847|FG000|Overall Study|Excluded Medication|1|||
148867193|NCT01999218|536990848|FG001|Overall Study|Excluded Medication|1|||
148867194|NCT01999218|536990849|FG002|Overall Study|Excluded Medication|2|||
149031905|NCT01674569|537593686|FG003|Overall Study|Protocol Violation|0|||
149031906|NCT01674569|537593687|FG004|Overall Study|Protocol Violation|0|||
148867195|NCT01999218|536990847|FG000|Overall Study|Adverse Event|9|||
148867196|NCT01999218|536990848|FG001|Overall Study|Adverse Event|7|||
148867197|NCT01999218|536990849|FG002|Overall Study|Adverse Event|7|||
148867198|NCT01999218|536990847|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
148867199|NCT01999218|536990848|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
148867200|NCT01999218|536990849|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
148867201|NCT00546260|536990850|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
148867202|NCT00546260|536990851|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
148867203|NCT03780959|536990852|FG000|Part 1|Adverse Event|1|||
148867204|NCT03780959|536990853|FG001|Part 1|Adverse Event|0|||
148867205|NCT03780959|536990854|FG002|Part 1|Adverse Event|0|||
148867206|NCT03780959|536990852|FG000|Part 1|Withdrawal by Subject|1|||
148867207|NCT03780959|536990853|FG001|Part 1|Withdrawal by Subject|0|||
148867208|NCT03780959|536990854|FG002|Part 1|Withdrawal by Subject|0|||
148867209|NCT03780959|536990852|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
148867210|NCT03780959|536990853|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
148867211|NCT03780959|536990854|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
148867212|NCT03780959|536990852|FG000|Part 1|Response Status|2|||
148867213|NCT03780959|536990853|FG001|Part 1|Response Status|0|||
148867214|NCT03780959|536990854|FG002|Part 1|Response Status|0|||
148867215|NCT03780959|536990852|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
148867216|NCT03780959|536990853|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
148867217|NCT03780959|536990854|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
148867218|NCT03780959|536990852|FG000|Part 2|Response Status|0|||
148867219|NCT03780959|536990853|FG001|Part 2|Response Status|18|||
148867220|NCT03780959|536990854|FG002|Part 2|Response Status|6|||
148867221|NCT00528996|536992580|FG000|Overall Study|Other reasons than listing|6|||
148867222|NCT00528996|536992581|FG001|Overall Study|Other reasons than listing|7|||
148867223|NCT00528996|536992582|FG002|Overall Study|Other reasons than listing|14|||
148867224|NCT00528996|536992583|FG003|Overall Study|Other reasons than listing|11|||
148867225|NCT00528996|536992584|FG004|Overall Study|Other reasons than listing|5|||
148867226|NCT00528996|536992580|FG000|Overall Study|Refused continue medication|16|||
148867227|NCT00528996|536992581|FG001|Overall Study|Refused continue medication|0|||
148867228|NCT00528996|536992582|FG002|Overall Study|Refused continue medication|3|||
148867229|NCT00528996|536992583|FG003|Overall Study|Refused continue medication|3|||
148867230|NCT00528996|536992584|FG004|Overall Study|Refused continue medication|6|||
148867231|NCT00528996|536992580|FG000|Overall Study|Lost to Follow-up|2|||
148867232|NCT00528996|536992581|FG001|Overall Study|Lost to Follow-up|0|||
148867233|NCT00528996|536992582|FG002|Overall Study|Lost to Follow-up|4|||
148867234|NCT00528996|536992583|FG003|Overall Study|Lost to Follow-up|1|||
148867235|NCT00528996|536992584|FG004|Overall Study|Lost to Follow-up|3|||
148867236|NCT00528996|536992580|FG000|Overall Study|Protocol Violation|1|||
149031907|NCT01674569|537593688|FG005|Overall Study|Protocol Violation|0|||
149031908|NCT01674569|537593683|FG000|Overall Study|Withdrawal by Subject|0|||
149031909|NCT01674569|537593684|FG001|Overall Study|Withdrawal by Subject|0|||
149031910|NCT01674569|537593685|FG002|Overall Study|Withdrawal by Subject|1|||
149031911|NCT01674569|537593686|FG003|Overall Study|Withdrawal by Subject|0|||
149031912|NCT01674569|537593687|FG004|Overall Study|Withdrawal by Subject|0|||
149031913|NCT01674569|537593688|FG005|Overall Study|Withdrawal by Subject|0|||
149031914|NCT01599325|537593689|FG000|Primary Parent Phase|Adverse Event|5|||
149031915|NCT01599325|537593689|FG000|Primary Parent Phase|Disease Progression|7|||
149031916|NCT01599325|537593689|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
149031917|NCT01599325|537593689|FG000|Primary Parent Phase|Death|13|||
148867237|NCT00528996|536992581|FG001|Overall Study|Protocol Violation|2|||
148867238|NCT00528996|536992582|FG002|Overall Study|Protocol Violation|3|||
148867239|NCT00528996|536992583|FG003|Overall Study|Protocol Violation|3|||
148867240|NCT00528996|536992584|FG004|Overall Study|Protocol Violation|2|||
148867241|NCT00528996|536992580|FG000|Overall Study|Lack of Efficacy|7|||
149031918|NCT01599325|537593689|FG000|Primary Parent Phase|Protocol Violation|1|||
149031919|NCT01599325|537593689|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
149031920|NCT01599325|537593689|FG000|Primary Parent Phase|Other|2|||
149031921|NCT01599325|537593689|FG000|Extension Phase|Study Closure|1|||
148867242|NCT00528996|536992581|FG001|Overall Study|Lack of Efficacy|2|||
148867243|NCT00528996|536992582|FG002|Overall Study|Lack of Efficacy|1|||
148867244|NCT00528996|536992583|FG003|Overall Study|Lack of Efficacy|3|||
148867245|NCT00528996|536992584|FG004|Overall Study|Lack of Efficacy|3|||
148867246|NCT00528996|536992580|FG000|Overall Study|Adverse Event|32|||
148867247|NCT00528996|536992581|FG001|Overall Study|Adverse Event|13|||
148867248|NCT00528996|536992582|FG002|Overall Study|Adverse Event|18|||
148867249|NCT00528996|536992583|FG003|Overall Study|Adverse Event|29|||
148867250|NCT00528996|536992584|FG004|Overall Study|Adverse Event|18|||
149031922|NCT01599325|537593689|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
149031923|NCT01599325|537593689|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
149031924|NCT01599325|537593689|FG000|Extension Phase|Disease Progression|1|||
149031925|NCT01599325|537593689|FG000|Extension Phase|Withdrawal by Subject|8|||
148867251|NCT02831933|536992586|FG000|Overall Study|Physician Decision|11|||
148867252|NCT05065190|536992590|FG000|Overall Study|Other than listed|2|||
148867253|NCT05065190|536992591|FG001|Overall Study|Other than listed|12|||
148867254|NCT05065190|536992590|FG000|Overall Study|Lack of Efficacy|4|||
148867255|NCT05065190|536992591|FG001|Overall Study|Lack of Efficacy|0|||
148867256|NCT05065190|536992590|FG000|Overall Study|Adverse Event|1|||
148867257|NCT05065190|536992591|FG001|Overall Study|Adverse Event|10|||
148867258|NCT02943915|536992592|FG000|Overall Study|Withdrawal by Subject|2|||
148867259|NCT02943915|536992593|FG001|Overall Study|Withdrawal by Subject|1|||
148867260|NCT02943915|536992594|FG002|Overall Study|Withdrawal by Subject|0|||
148867261|NCT02943915|536992595|FG003|Overall Study|Withdrawal by Subject|0|||
148867262|NCT02943915|536992592|FG000|Overall Study|Lost to Follow-up|3|||
148867263|NCT02943915|536992593|FG001|Overall Study|Lost to Follow-up|1|||
148867264|NCT02943915|536992594|FG002|Overall Study|Lost to Follow-up|0|||
148867265|NCT02943915|536992595|FG003|Overall Study|Lost to Follow-up|0|||
148867266|NCT02943915|536992592|FG000|Overall Study|excluded|0|||
148867267|NCT02943915|536992593|FG001|Overall Study|excluded|1|||
148867268|NCT02943915|536992594|FG002|Overall Study|excluded|0|||
148867269|NCT02943915|536992595|FG003|Overall Study|excluded|0|||
148867270|NCT02559414|536992596|FG000|Overall Study|Lost to Follow-up|0|||
148867271|NCT02559414|536992597|FG001|Overall Study|Lost to Follow-up|1|||
148867272|NCT02559414|536992598|FG002|Overall Study|Lost to Follow-up|0|||
148867273|NCT02559414|536992596|FG000|Overall Study|Withdrawal by Subject|1|||
148867274|NCT02559414|536992597|FG001|Overall Study|Withdrawal by Subject|0|||
148867275|NCT02559414|536992598|FG002|Overall Study|Withdrawal by Subject|1|||
148867276|NCT02559414|536992596|FG000|Overall Study|Other|0|||
148867277|NCT02559414|536992597|FG001|Overall Study|Other|1|||
148867278|NCT02559414|536992598|FG002|Overall Study|Other|1|||
148867279|NCT01287195|536992607|FG000|Overall Study|Withdrawal by Subject|2|||
148867280|NCT02068118|536992611|FG000|18-month Comparative Study Period|Death|90|||
148867281|NCT02068118|536992612|FG001|18-month Comparative Study Period|Death|97|||
148867282|NCT02068118|536992611|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
148867283|NCT02068118|536992612|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
148867284|NCT02068118|536992611|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
148867285|NCT02068118|536992612|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
148867286|NCT02068118|536992611|FG000|18-month Comparative Study Period|Heart transplant|9|||
148867287|NCT02068118|536992612|FG001|18-month Comparative Study Period|Heart transplant|15|||
148867288|NCT02068118|536992611|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
148867289|NCT02068118|536992612|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
148867290|NCT02068118|536992611|FG000|18-month Comparative Study Period|Hemiplegia|0|||
148867291|NCT02068118|536992612|FG001|18-month Comparative Study Period|Hemiplegia|1|||
148867292|NCT02068118|536992611|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
148867293|NCT02068118|536992612|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
148867294|NCT02068118|536992611|FG000|18-month Comparative Study Period|Move|0|||
148867295|NCT02068118|536992612|FG001|18-month Comparative Study Period|Move|1|||
148867296|NCT02068118|536992611|FG000|18-month Comparative Study Period|Hearing loss|0|||
148867297|NCT02068118|536992612|FG001|18-month Comparative Study Period|Hearing loss|1|||
148867298|NCT02068118|536992611|FG000|Extension Period|Death|0|||
148867299|NCT02068118|536992612|FG001|Extension Period|Death|2|||
148867300|NCT02068118|536992611|FG000|Extension Period|Withdrawal by Subject|1|||
148867301|NCT02068118|536992612|FG001|Extension Period|Withdrawal by Subject|0|||
148867302|NCT02068118|536992611|FG000|Extension Period|Heart transplant|1|||
148867303|NCT02068118|536992612|FG001|Extension Period|Heart transplant|0|||
148867304|NCT02068118|536992611|FG000|Extension Period|Wrong device use|0|||
148867305|NCT02068118|536992612|FG001|Extension Period|Wrong device use|1|||
148867306|NCT00283868|536992615|FG000|Overall Study|Lost to Follow-up|7|||
148867307|NCT00283868|536992616|FG001|Overall Study|Lost to Follow-up|8|||
148867308|NCT00453973|536992617|FG000|Overall Study|Adverse Event|4|||
148867309|NCT00453973|536992618|FG001|Overall Study|Adverse Event|9|||
148867310|NCT00453973|536992617|FG000|Overall Study|Withdrawal by Subject|7|||
148867311|NCT00453973|536992618|FG001|Overall Study|Withdrawal by Subject|6|||
148867312|NCT00453973|536992617|FG000|Overall Study|PI Decision|0|||
148867313|NCT00453973|536992618|FG001|Overall Study|PI Decision|2|||
148867314|NCT00453973|536992617|FG000|Overall Study|Relocation|1|||
149000083|NCT00686881|537475658|FG001|Overall Study|Treatment-related adverse event|9|||
149000084|NCT00686881|537475657|FG000|Overall Study|Met discontinuation criteria|5|||
149000085|NCT00686881|537475658|FG001|Overall Study|Met discontinuation criteria|0|||
149000086|NCT00686881|537475657|FG000|Overall Study|Onset of malignant tumor|11|||
149000087|NCT00686881|537475658|FG001|Overall Study|Onset of malignant tumor|11|||
148867315|NCT00453973|536992618|FG001|Overall Study|Relocation|0|||
148867316|NCT00453973|536992617|FG000|Overall Study|Renal transplant|1|||
149000088|NCT00686881|537475657|FG000|Overall Study|Lack of Efficacy|4|||
148867317|NCT00453973|536992618|FG001|Overall Study|Renal transplant|1|||
149000089|NCT00686881|537475658|FG001|Overall Study|Lack of Efficacy|3|||
148867318|NCT00453973|536992617|FG000|Overall Study|Site closed by sponsor|3|||
148867319|NCT00453973|536992618|FG001|Overall Study|Site closed by sponsor|0|||
148867320|NCT00453973|536992617|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
148867321|NCT00453973|536992618|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
148867322|NCT01996592|536992619|FG000|Overall Study|no response to text/no diary entry|32|||
148867323|NCT01996592|536992619|FG000|Overall Study|change in surgical date|4|||
148867324|NCT01996592|536992619|FG000|Overall Study|Withdrawal by Subject|5|||
148867325|NCT01996592|536992619|FG000|Overall Study|change in mode of delivery|4|||
148867326|NCT00870194|536992620|FG000|Overall Study|Adverse Event|10|||
148867327|NCT00870194|536992621|FG001|Overall Study|Adverse Event|5|||
148867328|NCT00870194|536992620|FG000|Overall Study|Lack of Efficacy|0|||
148867329|NCT00870194|536992621|FG001|Overall Study|Lack of Efficacy|1|||
148867330|NCT00870194|536992620|FG000|Overall Study|Lost to Follow-up|2|||
148867331|NCT00870194|536992621|FG001|Overall Study|Lost to Follow-up|0|||
148867332|NCT00870194|536992620|FG000|Overall Study|Physician Decision|3|||
148867333|NCT00870194|536992621|FG001|Overall Study|Physician Decision|1|||
148867334|NCT00870194|536992620|FG000|Overall Study|Protocol Violation|3|||
148867335|NCT00870194|536992621|FG001|Overall Study|Protocol Violation|3|||
148867336|NCT00870194|536992620|FG000|Overall Study|Entry Criteria Not Met|1|||
148867337|NCT00870194|536992621|FG001|Overall Study|Entry Criteria Not Met|2|||
148867338|NCT00870194|536992620|FG000|Overall Study|Subject Decision|7|||
148867339|NCT00870194|536992621|FG001|Overall Study|Subject Decision|2|||
148867340|NCT01219933|536992625|FG000|Overall Study|Adverse Event|8|||
148867341|NCT01219933|536992625|FG000|Overall Study|No LDA reached|5|||
148867342|NCT01219933|536992625|FG000|Overall Study|No LDA maintained|7|||
148867343|NCT01219933|536992625|FG000|Overall Study|Lost to Follow-up|3|||
148867344|NCT01219933|536992625|FG000|Overall Study|GC free|1|||
148867345|NCT01219933|536992625|FG000|Overall Study|Withdrawal by Subject|5|||
148867346|NCT01219933|536992625|FG000|Overall Study|Protocol Violation|8|||
148867347|NCT01219933|536992625|FG000|Overall Study|Lack of Efficacy|1|||
148867348|NCT01902888|536992626|FG000|Overall Study|Study Terminated|3|||
148867349|NCT03149003|536992627|FG000|Overall Study|Randomized but not treated|0|||
148867350|NCT03149003|536992628|FG001|Overall Study|Randomized but not treated|1|||
148867351|NCT03149003|536992629|FG002|Overall Study|Randomized but not treated|18|||
148867352|NCT01443130|536992630|FG000|Overall Study|Lost to Follow-up|44|||
148867353|NCT01443130|536992631|FG001|Overall Study|Lost to Follow-up|42|||
148867354|NCT01443130|536992632|FG002|Overall Study|Lost to Follow-up|50|||
148867355|NCT01443130|536992633|FG003|Overall Study|Lost to Follow-up|23|||
148867356|NCT01443130|536992634|FG004|Overall Study|Lost to Follow-up|25|||
148867357|NCT01443130|536992635|FG005|Overall Study|Lost to Follow-up|21|||
148867358|NCT01443130|536992630|FG000|Overall Study|Death|0|||
148867359|NCT01443130|536992631|FG001|Overall Study|Death|1|||
148867360|NCT01443130|536992632|FG002|Overall Study|Death|0|||
148867361|NCT01443130|536992633|FG003|Overall Study|Death|7|||
148867362|NCT01443130|536992634|FG004|Overall Study|Death|10|||
148867363|NCT01443130|536992635|FG005|Overall Study|Death|8|||
148867364|NCT01443130|536992630|FG000|Overall Study|Adverse Event|2|||
148867365|NCT01443130|536992631|FG001|Overall Study|Adverse Event|1|||
148867366|NCT01443130|536992632|FG002|Overall Study|Adverse Event|1|||
148867367|NCT01443130|536992633|FG003|Overall Study|Adverse Event|0|||
148867368|NCT01443130|536992634|FG004|Overall Study|Adverse Event|0|||
148867369|NCT01443130|536992635|FG005|Overall Study|Adverse Event|0|||
148867370|NCT01443130|536992630|FG000|Overall Study|Protocol Violation|2|||
148867371|NCT01443130|536992631|FG001|Overall Study|Protocol Violation|1|||
148867372|NCT01443130|536992632|FG002|Overall Study|Protocol Violation|3|||
148867373|NCT01443130|536992633|FG003|Overall Study|Protocol Violation|2|||
148867374|NCT01443130|536992634|FG004|Overall Study|Protocol Violation|2|||
148867375|NCT01443130|536992635|FG005|Overall Study|Protocol Violation|3|||
148867376|NCT01443130|536992630|FG000|Overall Study|Withdrawal by Subject|15|||
148867377|NCT01443130|536992631|FG001|Overall Study|Withdrawal by Subject|14|||
148867378|NCT01443130|536992632|FG002|Overall Study|Withdrawal by Subject|12|||
148867379|NCT01443130|536992633|FG003|Overall Study|Withdrawal by Subject|7|||
148867380|NCT01443130|536992634|FG004|Overall Study|Withdrawal by Subject|7|||
148867381|NCT01443130|536992635|FG005|Overall Study|Withdrawal by Subject|2|||
148867382|NCT01443130|536992630|FG000|Overall Study|Death of Subject's Infant|5|||
148867383|NCT01443130|536992631|FG001|Overall Study|Death of Subject's Infant|10|||
148867384|NCT01443130|536992632|FG002|Overall Study|Death of Subject's Infant|11|||
148867385|NCT01443130|536992633|FG003|Overall Study|Death of Subject's Infant|0|||
148867386|NCT01443130|536992634|FG004|Overall Study|Death of Subject's Infant|0|||
148867387|NCT01443130|536992635|FG005|Overall Study|Death of Subject's Infant|0|||
148867388|NCT00685373|536992636|FG000|Overall Study|Adverse Event|3|||
148867389|NCT00685373|536992636|FG000|Overall Study|Withdrawal by Subject|5|||
148867390|NCT00685373|536992636|FG000|Overall Study|Lack of Efficacy|3|||
148867391|NCT00685373|536992636|FG000|Overall Study|Condition no longer requires study drug|1|||
148867392|NCT00685373|536992636|FG000|Overall Study|Lost to Follow-up|2|||
148867393|NCT00685373|536992636|FG000|Overall Study|Protocol Violation|1|||
148867394|NCT00582738|536992637|FG000|Overall Study|Administrative Problems|7|||
148867395|NCT00582738|536992638|FG001|Overall Study|Administrative Problems|8|||
148867396|NCT00582738|536992637|FG000|Overall Study|Adverse Event|0|||
148867397|NCT00582738|536992638|FG001|Overall Study|Adverse Event|5|||
148867398|NCT00582738|536992637|FG000|Overall Study|Graft Lost|0|||
148867399|NCT00582738|536992638|FG001|Overall Study|Graft Lost|1|||
148867400|NCT00582738|536992637|FG000|Overall Study|Other|1|||
148867401|NCT00582738|536992638|FG001|Overall Study|Other|0|||
148867402|NCT00582738|536992637|FG000|Overall Study|Protocol Violation|1|||
148867403|NCT00582738|536992638|FG001|Overall Study|Protocol Violation|1|||
148867404|NCT00582738|536992637|FG000|Overall Study|Withdrawal by Subject|0|||
148867405|NCT00582738|536992638|FG001|Overall Study|Withdrawal by Subject|3|||
148867406|NCT02758301|536992639|FG000|Overall Study|Death|12|||
148867407|NCT02758301|536992640|FG001|Overall Study|Death|0|||
148867408|NCT02758301|536992639|FG000|Overall Study|Physician Decision|10|||
148867409|NCT02758301|536992640|FG001|Overall Study|Physician Decision|1|||
148867410|NCT02758301|536992639|FG000|Overall Study|Withdrawal by Subject|5|||
148867411|NCT02758301|536992640|FG001|Overall Study|Withdrawal by Subject|6|||
148867412|NCT02758301|536992639|FG000|Overall Study|Lost to Follow-up|7|||
148867413|NCT02758301|536992640|FG001|Overall Study|Lost to Follow-up|0|||
148867414|NCT02758301|536992639|FG000|Overall Study|Protocol Violation|0|||
148867415|NCT02758301|536992640|FG001|Overall Study|Protocol Violation|1|||
148867416|NCT00364533|536992641|FG000|Overall Study|Adverse Event|8|||
148867417|NCT00364533|536992642|FG001|Overall Study|Adverse Event|7|||
148867418|NCT00364533|536992643|FG002|Overall Study|Adverse Event|15|||
148867419|NCT00364533|536992644|FG003|Overall Study|Adverse Event|5|||
148867420|NCT00364533|536992645|FG004|Overall Study|Adverse Event|2|||
148867421|NCT00364533|536992641|FG000|Overall Study|Withdrawal by Subject|4|||
148867422|NCT00364533|536992642|FG001|Overall Study|Withdrawal by Subject|8|||
148867423|NCT00364533|536992643|FG002|Overall Study|Withdrawal by Subject|6|||
148867424|NCT00364533|536992644|FG003|Overall Study|Withdrawal by Subject|6|||
148867425|NCT00364533|536992645|FG004|Overall Study|Withdrawal by Subject|6|||
148867426|NCT00364533|536992641|FG000|Overall Study|Lack of Efficacy|22|||
148867427|NCT00364533|536992642|FG001|Overall Study|Lack of Efficacy|22|||
148867428|NCT00364533|536992643|FG002|Overall Study|Lack of Efficacy|21|||
148867429|NCT00364533|536992644|FG003|Overall Study|Lack of Efficacy|17|||
148867430|NCT00364533|536992645|FG004|Overall Study|Lack of Efficacy|42|||
148867431|NCT00364533|536992641|FG000|Overall Study|Subject discharged from hospital|4|||
148867432|NCT00364533|536992642|FG001|Overall Study|Subject discharged from hospital|1|||
148867433|NCT00364533|536992643|FG002|Overall Study|Subject discharged from hospital|2|||
148867434|NCT00364533|536992644|FG003|Overall Study|Subject discharged from hospital|3|||
148867435|NCT00364533|536992645|FG004|Overall Study|Subject discharged from hospital|1|||
148867436|NCT00364533|536992641|FG000|Overall Study|Variations in drug compliance|2|||
148867437|NCT00364533|536992642|FG001|Overall Study|Variations in drug compliance|1|||
148867438|NCT00364533|536992643|FG002|Overall Study|Variations in drug compliance|1|||
148867439|NCT00364533|536992644|FG003|Overall Study|Variations in drug compliance|0|||
148867440|NCT00364533|536992645|FG004|Overall Study|Variations in drug compliance|0|||
148867441|NCT00364533|536992641|FG000|Overall Study|Non-compliance|1|||
148867442|NCT00364533|536992642|FG001|Overall Study|Non-compliance|0|||
148867443|NCT00364533|536992643|FG002|Overall Study|Non-compliance|0|||
148867444|NCT00364533|536992644|FG003|Overall Study|Non-compliance|0|||
148867445|NCT00364533|536992645|FG004|Overall Study|Non-compliance|0|||
148867446|NCT00364533|536992641|FG000|Overall Study|Protocol Violation|1|||
148867447|NCT00364533|536992642|FG001|Overall Study|Protocol Violation|1|||
148867448|NCT00364533|536992643|FG002|Overall Study|Protocol Violation|0|||
148867449|NCT00364533|536992644|FG003|Overall Study|Protocol Violation|0|||
148867450|NCT00364533|536992645|FG004|Overall Study|Protocol Violation|0|||
148867451|NCT02642965|536992647|FG000|Overall Study|Lack of Efficacy|4|||
148867452|NCT02642965|536992647|FG000|Overall Study|Physician Decision|9|||
148867453|NCT01011933|536992649|FG000|Overall Study|Wrong cell type|1|||
148867454|NCT01011933|536992649|FG000|Overall Study|Improper pre-protocol Rx|1|||
149000090|NCT00686881|537475657|FG000|Overall Study|Physician Decision|1|||
149000091|NCT00686881|537475658|FG001|Overall Study|Physician Decision|0|||
149000092|NCT00686881|537475657|FG000|Overall Study|Circumstances of site|1|||
149000093|NCT00686881|537475658|FG001|Overall Study|Circumstances of site|1|||
149000094|NCT00686881|537475657|FG000|Overall Study|Did not meet protocol eligibility|1|||
149000095|NCT00686881|537475658|FG001|Overall Study|Did not meet protocol eligibility|0|||
149000096|NCT00686881|537475657|FG000|Overall Study|Irregular visits|1|||
149000097|NCT00686881|537475658|FG001|Overall Study|Irregular visits|0|||
149000098|NCT00686881|537475657|FG000|Overall Study|Study discontinuation|35|||
149000099|NCT00686881|537475658|FG001|Overall Study|Study discontinuation|32|||
149000100|NCT00686881|537475657|FG000|Overall Study|Never received study drug|2|||
149000101|NCT00686881|537475658|FG001|Overall Study|Never received study drug|6|||
149000102|NCT02085252|537475661|FG000|Overall Study|Withdrawal of Consent|1|||
149000103|NCT02085252|537475662|FG001|Overall Study|Withdrawal of Consent|0|||
149000104|NCT02085252|537475661|FG000|Overall Study|Adverse Event|0|||
149000105|NCT02085252|537475662|FG001|Overall Study|Adverse Event|1|||
149000106|NCT02085252|537475661|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
149000107|NCT02085252|537475662|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
149000108|NCT02085252|537475661|FG000|Overall Study|Reason Not Specified|0|||
149000109|NCT02085252|537475662|FG001|Overall Study|Reason Not Specified|1|||
149000110|NCT02085252|537475661|FG000|Overall Study|Reason Unknown|0|||
149000111|NCT02085252|537475662|FG001|Overall Study|Reason Unknown|1|||
148867455|NCT01011933|536992649|FG000|Overall Study|Inadequate pathology|1|||
148867456|NCT01011933|536992649|FG000|Overall Study|Never treated|1|||
148867457|NCT01439074|536992650|FG000|Overall Study|Lost to Follow-up|3|||
148867458|NCT01439074|536992651|FG001|Overall Study|Lost to Follow-up|4|||
148867459|NCT01439074|536992650|FG000|Overall Study|Subject shedding|1|||
148867460|NCT01439074|536992651|FG001|Overall Study|Subject shedding|0|||
148867461|NCT01439074|536992650|FG000|Overall Study|Withdrawal by Subject|1|||
148867462|NCT01439074|536992651|FG001|Overall Study|Withdrawal by Subject|5|||
148867463|NCT01439074|536992650|FG000|Overall Study|Other|4|||
148867464|NCT01439074|536992651|FG001|Overall Study|Other|4|||
148867465|NCT00815191|536992652|FG000|Overall Study|Protocol Violation|1|||
148867466|NCT00815191|536992653|FG001|Overall Study|Protocol Violation|1|||
148867467|NCT02639338|536992654|FG000|Overall Study|Lost to Follow-up|2|||
148867468|NCT02639338|536992655|FG001|Overall Study|Lost to Follow-up|2|||
148867469|NCT02639338|536992654|FG000|Overall Study|Withdrew Consent|1|||
148867470|NCT02639338|536992655|FG001|Overall Study|Withdrew Consent|2|||
148867471|NCT02639338|536992654|FG000|Overall Study|Death|1|||
148867472|NCT02639338|536992655|FG001|Overall Study|Death|0|||
148867473|NCT02639338|536992654|FG000|Overall Study|Randomized but Not Treated|0|||
148867474|NCT02639338|536992655|FG001|Overall Study|Randomized but Not Treated|1|||
148867475|NCT00493636|536992656|FG000|Overall Study|Withdrawal by Subject|1|||
148867476|NCT00493636|536992657|FG001|Overall Study|Withdrawal by Subject|0|||
148867477|NCT00493636|536992656|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
148867478|NCT00493636|536992657|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
148867479|NCT00493636|536992656|FG000|Overall Study|Mis-randomization|1|||
148867480|NCT00493636|536992657|FG001|Overall Study|Mis-randomization|1|||
148867481|NCT02900170|536992661|FG000|Overall Study|Lost to Follow-up|8|||
148867482|NCT01814670|536992662|FG000|Overall Study|Protocol Violation|12|||
148867483|NCT00973102|536992666|FG000|Overall Study|Protocol Violation|1|||
148867484|NCT00973102|536992667|FG001|Overall Study|Protocol Violation|0|||
148867485|NCT00973102|536992666|FG000|Overall Study|Prisoner|0|||
148867486|NCT00973102|536992667|FG001|Overall Study|Prisoner|1|||
148867487|NCT02012686|536992668|FG000|Overall Study|muscle contraction|0|||
148867488|NCT02012686|536992669|FG001|Overall Study|muscle contraction|1|||
148867489|NCT02012686|536992668|FG000|Overall Study|electrocardiography monitoring noise|0|||
148867490|NCT02012686|536992669|FG001|Overall Study|electrocardiography monitoring noise|1|||
148867491|NCT00966719|536992670|FG000|Overall Study|Lost to Follow-up|6|||
148867492|NCT00966719|536992671|FG001|Overall Study|Lost to Follow-up|11|||
148867493|NCT01703065|536992674|FG000|Overall Study|Lack of Efficacy|1|||
148867494|NCT01703065|536992675|FG001|Overall Study|Lack of Efficacy|0|||
148867495|NCT00160199|536992678|FG000|Overall Study|Adverse Event|5|||
148867496|NCT00160199|536992679|FG001|Overall Study|Adverse Event|14|||
148867497|NCT00160199|536992678|FG000|Overall Study|Lack of Efficacy|0|||
148867498|NCT00160199|536992679|FG001|Overall Study|Lack of Efficacy|1|||
148867499|NCT00160199|536992678|FG000|Overall Study|Lost to Follow-up|7|||
148867500|NCT00160199|536992679|FG001|Overall Study|Lost to Follow-up|7|||
148867501|NCT00160199|536992678|FG000|Overall Study|Withdrawal by Subject|4|||
148867502|NCT00160199|536992679|FG001|Overall Study|Withdrawal by Subject|6|||
148867503|NCT00160199|536992678|FG000|Overall Study|Administrative|0|||
148867504|NCT00160199|536992679|FG001|Overall Study|Administrative|1|||
148867505|NCT00160199|536992678|FG000|Overall Study|Protocol Violation|8|||
148867506|NCT00160199|536992679|FG001|Overall Study|Protocol Violation|8|||
148867507|NCT02124772|536992680|FG000|Overall Study|Lack of Efficacy|2|||
148867508|NCT02124772|536992681|FG001|Overall Study|Lack of Efficacy|0|||
148867509|NCT02124772|536992682|FG002|Overall Study|Lack of Efficacy|0|||
148867510|NCT02124772|536992683|FG003|Overall Study|Lack of Efficacy|1|||
148867511|NCT02124772|536992684|FG004|Overall Study|Lack of Efficacy|2|||
148867512|NCT02124772|536992685|FG005|Overall Study|Lack of Efficacy|3|||
148867513|NCT02124772|536992686|FG006|Overall Study|Lack of Efficacy|0|||
148867514|NCT02124772|536992687|FG007|Overall Study|Lack of Efficacy|2|||
148867515|NCT02124772|536992688|FG008|Overall Study|Lack of Efficacy|0|||
148867516|NCT02124772|536992689|FG009|Overall Study|Lack of Efficacy|1|||
148867517|NCT02124772|536992690|FG010|Overall Study|Lack of Efficacy|0|||
148867518|NCT02124772|536992691|FG011|Overall Study|Lack of Efficacy|0|||
148867519|NCT02124772|536992692|FG012|Overall Study|Lack of Efficacy|1|||
148867520|NCT02124772|536992680|FG000|Overall Study|Adverse Event|1|||
148867521|NCT02124772|536992681|FG001|Overall Study|Adverse Event|4|||
148867522|NCT02124772|536992682|FG002|Overall Study|Adverse Event|1|||
148867523|NCT02124772|536992683|FG003|Overall Study|Adverse Event|5|||
148867524|NCT02124772|536992684|FG004|Overall Study|Adverse Event|2|||
148867525|NCT02124772|536992685|FG005|Overall Study|Adverse Event|1|||
148867526|NCT02124772|536992686|FG006|Overall Study|Adverse Event|1|||
148867527|NCT02124772|536992687|FG007|Overall Study|Adverse Event|5|||
148867528|NCT02124772|536992688|FG008|Overall Study|Adverse Event|0|||
148867529|NCT02124772|536992689|FG009|Overall Study|Adverse Event|3|||
148867530|NCT02124772|536992690|FG010|Overall Study|Adverse Event|1|||
148867531|NCT02124772|536992691|FG011|Overall Study|Adverse Event|3|||
148867532|NCT02124772|536992692|FG012|Overall Study|Adverse Event|1|||
148867533|NCT02124772|536992680|FG000|Overall Study|Withdrawal consent|0|||
148867534|NCT02124772|536992681|FG001|Overall Study|Withdrawal consent|1|||
148867535|NCT02124772|536992682|FG002|Overall Study|Withdrawal consent|1|||
148867536|NCT02124772|536992683|FG003|Overall Study|Withdrawal consent|1|||
148867537|NCT02124772|536992684|FG004|Overall Study|Withdrawal consent|0|||
148867538|NCT02124772|536992685|FG005|Overall Study|Withdrawal consent|1|||
148867539|NCT02124772|536992686|FG006|Overall Study|Withdrawal consent|1|||
148867540|NCT02124772|536992687|FG007|Overall Study|Withdrawal consent|0|||
148867541|NCT02124772|536992688|FG008|Overall Study|Withdrawal consent|0|||
148867542|NCT02124772|536992689|FG009|Overall Study|Withdrawal consent|1|||
148867543|NCT02124772|536992690|FG010|Overall Study|Withdrawal consent|0|||
148867544|NCT02124772|536992691|FG011|Overall Study|Withdrawal consent|1|||
148867545|NCT02124772|536992692|FG012|Overall Study|Withdrawal consent|0|||
148867546|NCT02124772|536992680|FG000|Overall Study|Investigator discretion|0|||
148867547|NCT02124772|536992681|FG001|Overall Study|Investigator discretion|2|||
148867548|NCT02124772|536992682|FG002|Overall Study|Investigator discretion|2|||
148867549|NCT02124772|536992683|FG003|Overall Study|Investigator discretion|1|||
148867550|NCT02124772|536992684|FG004|Overall Study|Investigator discretion|1|||
148867551|NCT02124772|536992685|FG005|Overall Study|Investigator discretion|0|||
148867552|NCT02124772|536992686|FG006|Overall Study|Investigator discretion|1|||
148867553|NCT02124772|536992687|FG007|Overall Study|Investigator discretion|0|||
148867554|NCT02124772|536992688|FG008|Overall Study|Investigator discretion|0|||
148867555|NCT02124772|536992689|FG009|Overall Study|Investigator discretion|1|||
148867556|NCT02124772|536992690|FG010|Overall Study|Investigator discretion|0|||
148867557|NCT02124772|536992691|FG011|Overall Study|Investigator discretion|1|||
148867558|NCT02124772|536992692|FG012|Overall Study|Investigator discretion|0|||
148867559|NCT02124772|536992680|FG000|Overall Study|Progressive disease|0|||
148867560|NCT02124772|536992681|FG001|Overall Study|Progressive disease|0|||
148867561|NCT02124772|536992682|FG002|Overall Study|Progressive disease|0|||
148867562|NCT02124772|536992683|FG003|Overall Study|Progressive disease|0|||
148867563|NCT02124772|536992684|FG004|Overall Study|Progressive disease|0|||
148867564|NCT02124772|536992685|FG005|Overall Study|Progressive disease|0|||
148867565|NCT02124772|536992686|FG006|Overall Study|Progressive disease|1|||
148867566|NCT02124772|536992687|FG007|Overall Study|Progressive disease|1|||
148867567|NCT02124772|536992688|FG008|Overall Study|Progressive disease|0|||
148867568|NCT02124772|536992689|FG009|Overall Study|Progressive disease|0|||
148867569|NCT02124772|536992690|FG010|Overall Study|Progressive disease|0|||
148867570|NCT02124772|536992691|FG011|Overall Study|Progressive disease|0|||
148867571|NCT02124772|536992692|FG012|Overall Study|Progressive disease|0|||
148867572|NCT02124772|536992680|FG000|Overall Study|Other|0|||
148867573|NCT02124772|536992681|FG001|Overall Study|Other|7|||
148867574|NCT02124772|536992682|FG002|Overall Study|Other|2|||
148867575|NCT02124772|536992683|FG003|Overall Study|Other|5|||
148867576|NCT02124772|536992684|FG004|Overall Study|Other|4|||
148867577|NCT02124772|536992685|FG005|Overall Study|Other|3|||
148867578|NCT02124772|536992686|FG006|Overall Study|Other|4|||
148867579|NCT02124772|536992687|FG007|Overall Study|Other|1|||
148867580|NCT02124772|536992688|FG008|Overall Study|Other|1|||
148867581|NCT02124772|536992689|FG009|Overall Study|Other|1|||
148867582|NCT02124772|536992690|FG010|Overall Study|Other|1|||
148867583|NCT02124772|536992691|FG011|Overall Study|Other|1|||
148867584|NCT02124772|536992692|FG012|Overall Study|Other|0|||
148867585|NCT02827500|536992693|FG000|Overall Study|Death|7|||
148867586|NCT02827500|536992694|FG001|Overall Study|Death|3|||
148867587|NCT02827500|536992693|FG000|Overall Study|Lost to Follow-up|1|||
148867588|NCT02827500|536992694|FG001|Overall Study|Lost to Follow-up|1|||
148867589|NCT02827500|536992693|FG000|Overall Study|Withdrawal by Subject|3|||
148867590|NCT02827500|536992694|FG001|Overall Study|Withdrawal by Subject|1|||
148867591|NCT02827500|536992693|FG000|Overall Study|Missing primary endpoint data|3|||
148867592|NCT02827500|536992694|FG001|Overall Study|Missing primary endpoint data|1|||
148867593|NCT02827500|536992693|FG000|Overall Study|Other|5|||
148867594|NCT02827500|536992694|FG001|Overall Study|Other|1|||
148867595|NCT03089944|536992697|FG000|Overall Study|Lost to Follow-up|8|||
148867596|NCT03089944|536992697|FG000|Overall Study|Withdrew Consent|2|||
148867597|NCT03089944|536992697|FG000|Overall Study|Adverse Event|1|||
148867598|NCT03089944|536992697|FG000|Overall Study|Other|1|||
149000112|NCT03260868|537475664|FG000|Overall Study|Poor Compliance to Protocol|0|||
149000113|NCT03260868|537475665|FG001|Overall Study|Poor Compliance to Protocol|2|||
148867599|NCT00525824|536992703|FG000|Overall Study|Adverse Event|7|||
148867600|NCT00525824|536992704|FG001|Overall Study|Adverse Event|11|||
148867601|NCT00525824|536992705|FG002|Overall Study|Adverse Event|6|||
148867602|NCT00525824|536992706|FG003|Overall Study|Adverse Event|7|||
148867603|NCT00525824|536992703|FG000|Overall Study|Withdrawal by Subject|5|||
148867604|NCT00525824|536992704|FG001|Overall Study|Withdrawal by Subject|9|||
148867605|NCT00525824|536992705|FG002|Overall Study|Withdrawal by Subject|3|||
148867606|NCT00525824|536992706|FG003|Overall Study|Withdrawal by Subject|4|||
148867607|NCT00525824|536992703|FG000|Overall Study|Lost to Follow-up|4|||
148867608|NCT00525824|536992704|FG001|Overall Study|Lost to Follow-up|2|||
148867609|NCT00525824|536992705|FG002|Overall Study|Lost to Follow-up|4|||
148867610|NCT00525824|536992706|FG003|Overall Study|Lost to Follow-up|0|||
148867611|NCT00525824|536992703|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
148867612|NCT00525824|536992704|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
148867613|NCT00525824|536992705|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
148867614|NCT00525824|536992706|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
148867615|NCT00525824|536992703|FG000|Overall Study|Severe non-compliance|0|||
148867616|NCT00525824|536992704|FG001|Overall Study|Severe non-compliance|1|||
148867617|NCT00525824|536992705|FG002|Overall Study|Severe non-compliance|1|||
148867618|NCT00525824|536992706|FG003|Overall Study|Severe non-compliance|1|||
148867619|NCT00525824|536992703|FG000|Overall Study|Safety reasons|1|||
148867620|NCT00525824|536992704|FG001|Overall Study|Safety reasons|0|||
148867621|NCT00525824|536992705|FG002|Overall Study|Safety reasons|1|||
148867622|NCT00525824|536992706|FG003|Overall Study|Safety reasons|0|||
148867623|NCT00525824|536992703|FG000|Overall Study|Other|1|||
148867624|NCT00525824|536992704|FG001|Overall Study|Other|3|||
148867625|NCT00525824|536992705|FG002|Overall Study|Other|3|||
148867626|NCT00525824|536992706|FG003|Overall Study|Other|1|||
148867627|NCT01490294|536992710|FG000|Overall Study|Prematurely discontinuation|4|||
148867628|NCT01490294|536992711|FG001|Overall Study|Prematurely discontinuation|0|||
148867629|NCT01490294|536992712|FG002|Overall Study|Prematurely discontinuation|1|||
148867630|NCT01490294|536992713|FG003|Overall Study|Prematurely discontinuation|1|||
148867631|NCT01490294|536992710|FG000|Overall Study|Adverse Event|1|||
148867632|NCT01490294|536992711|FG001|Overall Study|Adverse Event|0|||
148867633|NCT01490294|536992712|FG002|Overall Study|Adverse Event|0|||
148867634|NCT01490294|536992713|FG003|Overall Study|Adverse Event|0|||
148867635|NCT01751776|536992716|FG000|Overall Study|Adverse Event|0|||
148867636|NCT01751776|536992717|FG001|Overall Study|Adverse Event|0|||
148867637|NCT01751776|536992718|FG002|Overall Study|Adverse Event|0|||
148867638|NCT01751776|536992719|FG003|Overall Study|Adverse Event|0|||
148867639|NCT01751776|536992720|FG004|Overall Study|Adverse Event|0|||
148867640|NCT01751776|536992721|FG005|Overall Study|Adverse Event|0|||
148867641|NCT01751776|536992722|FG006|Overall Study|Adverse Event|4|||
148867642|NCT01751776|536992723|FG007|Overall Study|Adverse Event|2|||
148867643|NCT01751776|536992716|FG000|Overall Study|Consent withdrawn|0|||
148867644|NCT01751776|536992717|FG001|Overall Study|Consent withdrawn|0|||
148867645|NCT01751776|536992718|FG002|Overall Study|Consent withdrawn|0|||
148867646|NCT01751776|536992719|FG003|Overall Study|Consent withdrawn|0|||
148867647|NCT01751776|536992720|FG004|Overall Study|Consent withdrawn|0|||
148867648|NCT01751776|536992721|FG005|Overall Study|Consent withdrawn|0|||
148867649|NCT01751776|536992722|FG006|Overall Study|Consent withdrawn|0|||
148867650|NCT01751776|536992723|FG007|Overall Study|Consent withdrawn|1|||
148867651|NCT01751776|536992716|FG000|Overall Study|Other reason not specified above|0|||
148867652|NCT01751776|536992717|FG001|Overall Study|Other reason not specified above|0|||
148867653|NCT01751776|536992718|FG002|Overall Study|Other reason not specified above|0|||
148867654|NCT01751776|536992719|FG003|Overall Study|Other reason not specified above|0|||
148867655|NCT01751776|536992720|FG004|Overall Study|Other reason not specified above|0|||
148867656|NCT01751776|536992721|FG005|Overall Study|Other reason not specified above|0|||
148867657|NCT01751776|536992722|FG006|Overall Study|Other reason not specified above|0|||
148867658|NCT01751776|536992723|FG007|Overall Study|Other reason not specified above|1|||
148867659|NCT00160654|536992724|FG000|Overall Study|Adverse Event|14|||
148867660|NCT00160654|536992724|FG000|Overall Study|Lack of Efficacy|4|||
148867661|NCT00160654|536992724|FG000|Overall Study|Lost to Follow-up|2|||
148867662|NCT00160654|536992724|FG000|Overall Study|Intake of expired drug|7|||
148867663|NCT00160654|536992724|FG000|Overall Study|Psychological trauma|1|||
148867664|NCT00160654|536992724|FG000|Overall Study|Sponsor decision|1|||
148867665|NCT00160654|536992724|FG000|Overall Study|Patient met exclusion criteria|1|||
148867666|NCT00160654|536992724|FG000|Overall Study|Patient decision|1|||
148867667|NCT00160654|536992724|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
148867668|NCT00160654|536992724|FG000|Overall Study|Met exclusion criteria|1|||
148867669|NCT04938037|536994230|FG000|Overall Study|Lost to Follow-up|4|||
148867670|NCT04938037|536994231|FG001|Overall Study|Lost to Follow-up|3|||
148867671|NCT05160766|536994235|FG000|Overall Study|Adverse Event|0|||
148867672|NCT05160766|536994236|FG001|Overall Study|Adverse Event|1|||
148867673|NCT05160766|536994237|FG002|Overall Study|Adverse Event|0|||
148867674|NCT05160766|536994238|FG003|Overall Study|Adverse Event|0|||
148867675|NCT05160766|536994235|FG000|Overall Study|COVID-19 infection|0|||
148867676|NCT05160766|536994236|FG001|Overall Study|COVID-19 infection|1|||
148867677|NCT05160766|536994237|FG002|Overall Study|COVID-19 infection|0|||
148867678|NCT05160766|536994238|FG003|Overall Study|COVID-19 infection|0|||
148867679|NCT05160766|536994235|FG000|Overall Study|travel time|1|||
148867680|NCT05160766|536994236|FG001|Overall Study|travel time|0|||
148867681|NCT05160766|536994237|FG002|Overall Study|travel time|0|||
148867682|NCT05160766|536994238|FG003|Overall Study|travel time|1|||
148867683|NCT05160766|536994235|FG000|Overall Study|Withdrawal by Subject|3|||
148867684|NCT05160766|536994236|FG001|Overall Study|Withdrawal by Subject|5|||
148867685|NCT05160766|536994237|FG002|Overall Study|Withdrawal by Subject|4|||
148867686|NCT05160766|536994238|FG003|Overall Study|Withdrawal by Subject|2|||
148867687|NCT05160766|536994235|FG000|Overall Study|Death|0|||
149031926|NCT01878890|537593690|FG000|Overall Study|Protocol Violation|0|||
148867688|NCT05160766|536994236|FG001|Overall Study|Death|0|||
148867689|NCT05160766|536994237|FG002|Overall Study|Death|2|||
148867690|NCT05160766|536994238|FG003|Overall Study|Death|5|||
148867691|NCT05160766|536994235|FG000|Overall Study|Lost to Follow-up|0|||
148867692|NCT05160766|536994236|FG001|Overall Study|Lost to Follow-up|0|||
148867693|NCT05160766|536994237|FG002|Overall Study|Lost to Follow-up|1|||
148867694|NCT05160766|536994238|FG003|Overall Study|Lost to Follow-up|2|||
148867695|NCT05160766|536994235|FG000|Overall Study|No show|0|||
148867696|NCT05160766|536994236|FG001|Overall Study|No show|0|||
148867697|NCT05160766|536994237|FG002|Overall Study|No show|1|||
148867698|NCT05160766|536994238|FG003|Overall Study|No show|1|||
148867699|NCT05160766|536994235|FG000|Overall Study|Physician Decision|0|||
148867700|NCT05160766|536994236|FG001|Overall Study|Physician Decision|0|||
148867701|NCT05160766|536994237|FG002|Overall Study|Physician Decision|0|||
148867702|NCT05160766|536994238|FG003|Overall Study|Physician Decision|1|||
148867703|NCT05160766|536994235|FG000|Overall Study|Protocol Violation|0|||
148867704|NCT05160766|536994236|FG001|Overall Study|Protocol Violation|0|||
148867705|NCT05160766|536994237|FG002|Overall Study|Protocol Violation|1|||
148867706|NCT05160766|536994238|FG003|Overall Study|Protocol Violation|0|||
148867707|NCT02654236|536994239|FG000|Overall Study|Withdrawal by Subject|0|||
148867708|NCT02654236|536994240|FG001|Overall Study|Withdrawal by Subject|0|||
148867709|NCT02654236|536994241|FG002|Overall Study|Withdrawal by Subject|2|||
148867710|NCT01549873|536994242|FG000|Overall Study|Physician Decision|0|||
148867711|NCT01549873|536994243|FG001|Overall Study|Physician Decision|1|||
148867712|NCT02804750|536994247|FG000|Period 1|Adverse Event|0|||
148867713|NCT02804750|536994248|FG001|Period 1|Adverse Event|2|||
148867714|NCT02804750|536994247|FG000|Period 1|Withdrawal by Subject|0|||
148867715|NCT02804750|536994248|FG001|Period 1|Withdrawal by Subject|1|||
148867716|NCT02804750|536994247|FG000|Period 2|Adverse Event|1|||
148867717|NCT02804750|536994248|FG001|Period 2|Adverse Event|0|||
148867718|NCT02804750|536994247|FG000|Period 3|Adverse Event|0|||
148867719|NCT02804750|536994248|FG001|Period 3|Adverse Event|2|||
148867720|NCT02804750|536994247|FG000|Period 4|Adverse Event|0|||
148867721|NCT02804750|536994248|FG001|Period 4|Adverse Event|5|||
148867722|NCT01867086|536994249|FG000|Overall Study|Disease Progression|1|||
148867723|NCT04271475|536994250|FG000|DB Period: Day 1 up to EODBT|Death|1|||
148867724|NCT04271475|536994251|FG001|DB Period: Day 1 up to EODBT|Death|0|||
148867725|NCT04271475|536994252|FG002|DB Period: Day 1 up to EODBT|Death|0|||
148867726|NCT04271475|536994253|FG003|DB Period: Day 1 up to EODBT|Death|0|||
148867727|NCT04271475|536994250|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
148867728|NCT04271475|536994251|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
148867729|NCT04271475|536994252|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
148867730|NCT04271475|536994253|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
148867731|NCT04271475|536994250|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
148867732|NCT04271475|536994251|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
148867733|NCT04271475|536994252|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
148867734|NCT04271475|536994253|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
148867735|NCT04271475|536994250|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
148867736|NCT04271475|536994251|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
148867737|NCT04271475|536994252|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
148867738|NCT04271475|536994253|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
148867739|NCT04271475|536994250|FG000|DB Period: Day 1 up to EODBT|Other|8|||
148867740|NCT04271475|536994251|FG001|DB Period: Day 1 up to EODBT|Other|5|||
148867741|NCT04271475|536994252|FG002|DB Period: Day 1 up to EODBT|Other|0|||
148867742|NCT04271475|536994253|FG003|DB Period: Day 1 up to EODBT|Other|0|||
148867743|NCT04271475|536994250|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
148867744|NCT04271475|536994251|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
148867745|NCT04271475|536994252|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
148867746|NCT04271475|536994253|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
148867747|NCT04271475|536994250|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
148867748|NCT04271475|536994251|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
148867749|NCT04271475|536994252|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
148867750|NCT04271475|536994253|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
148867751|NCT01818284|536994255|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
148867752|NCT01818284|536994256|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
149000114|NCT03260868|537475664|FG000|Overall Study|Study Terminated By Sponsor|2|||
149000115|NCT03260868|537475665|FG001|Overall Study|Study Terminated By Sponsor|1|||
149000116|NCT03260868|537475664|FG000|Overall Study|Other than specified above|1|||
149000117|NCT03260868|537475665|FG001|Overall Study|Other than specified above|0|||
148867753|NCT01818284|536994255|FG000|Overall Study|Death|0|||
148867754|NCT01818284|536994256|FG001|Overall Study|Death|2|||
149000118|NCT02925676|537475666|FG000|Overall Study|Withdrawal by Subject|1|||
148867755|NCT03681678|536994257|FG000|Overall Study|Lost to Follow-up|20|||
148867756|NCT04619004|536994258|FG000|Overall Study|Death|114|||
148867757|NCT04619004|536994259|FG001|Overall Study|Death|28|||
148867758|NCT04619004|536994258|FG000|Overall Study|Lost to Follow-up|1|||
148867759|NCT04619004|536994259|FG001|Overall Study|Lost to Follow-up|1|||
148867760|NCT04619004|536994258|FG000|Overall Study|Withdrawal by Subject|24|||
149000119|NCT00981084|537475667|FG000|Post Intervention (Data Analysis)|poor effort|1|||
148867761|NCT04619004|536994259|FG001|Overall Study|Withdrawal by Subject|7|||
148867762|NCT04619004|536994258|FG000|Overall Study|Other - Not specified|0|||
148867763|NCT04619004|536994259|FG001|Overall Study|Other - Not specified|1|||
148867764|NCT04030962|536994260|FG000|Stage 2|Adverse Event|0|||
148867765|NCT04030962|536994261|FG001|Stage 2|Adverse Event|0|||
148867766|NCT04030962|536994262|FG002|Stage 2|Adverse Event|0|||
148867767|NCT04030962|536994263|FG003|Stage 2|Adverse Event|0|||
148867768|NCT04030962|536994264|FG004|Stage 2|Adverse Event|0|||
148867769|NCT04030962|536994265|FG005|Stage 2|Adverse Event|0|||
148867770|NCT04030962|536994266|FG006|Stage 2|Adverse Event|0|||
148867771|NCT04030962|536994267|FG007|Stage 2|Adverse Event|0|||
148867772|NCT04030962|536994268|FG008|Stage 2|Adverse Event|1|||
148867773|NCT04030962|536994269|FG009|Stage 2|Adverse Event|0|||
148867774|NCT04030962|536994270|FG010|Stage 2|Adverse Event|1|||
148867775|NCT04030962|536994271|FG011|Stage 2|Adverse Event|1|||
148867776|NCT04030962|536994272|FG012|Stage 2|Adverse Event|1|||
148867777|NCT04030962|536994260|FG000|Stage 2|Withdrawal by Subject|0|||
148867778|NCT04030962|536994261|FG001|Stage 2|Withdrawal by Subject|0|||
148867779|NCT04030962|536994262|FG002|Stage 2|Withdrawal by Subject|0|||
148867780|NCT04030962|536994263|FG003|Stage 2|Withdrawal by Subject|0|||
148867781|NCT04030962|536994264|FG004|Stage 2|Withdrawal by Subject|0|||
148867782|NCT04030962|536994265|FG005|Stage 2|Withdrawal by Subject|0|||
148867783|NCT04030962|536994266|FG006|Stage 2|Withdrawal by Subject|0|||
148867784|NCT04030962|536994267|FG007|Stage 2|Withdrawal by Subject|0|||
148867785|NCT04030962|536994268|FG008|Stage 2|Withdrawal by Subject|1|||
148867786|NCT04030962|536994269|FG009|Stage 2|Withdrawal by Subject|0|||
148867787|NCT04030962|536994270|FG010|Stage 2|Withdrawal by Subject|0|||
148867788|NCT04030962|536994271|FG011|Stage 2|Withdrawal by Subject|2|||
148867789|NCT04030962|536994272|FG012|Stage 2|Withdrawal by Subject|1|||
148867790|NCT04030962|536994260|FG000|Stage 2|Lost to Follow-up|0|||
148867791|NCT04030962|536994261|FG001|Stage 2|Lost to Follow-up|0|||
148867792|NCT04030962|536994262|FG002|Stage 2|Lost to Follow-up|0|||
148867793|NCT04030962|536994263|FG003|Stage 2|Lost to Follow-up|0|||
148867794|NCT04030962|536994264|FG004|Stage 2|Lost to Follow-up|0|||
148867795|NCT04030962|536994265|FG005|Stage 2|Lost to Follow-up|0|||
148867796|NCT04030962|536994266|FG006|Stage 2|Lost to Follow-up|0|||
148867797|NCT04030962|536994267|FG007|Stage 2|Lost to Follow-up|0|||
148867798|NCT04030962|536994268|FG008|Stage 2|Lost to Follow-up|1|||
148867799|NCT04030962|536994269|FG009|Stage 2|Lost to Follow-up|0|||
148867800|NCT04030962|536994270|FG010|Stage 2|Lost to Follow-up|0|||
148867801|NCT04030962|536994271|FG011|Stage 2|Lost to Follow-up|0|||
148867802|NCT04030962|536994272|FG012|Stage 2|Lost to Follow-up|0|||
148867803|NCT04030962|536994260|FG000|Stage 2|Technical Problems|0|||
148867804|NCT04030962|536994261|FG001|Stage 2|Technical Problems|0|||
148867805|NCT04030962|536994262|FG002|Stage 2|Technical Problems|0|||
148867806|NCT04030962|536994263|FG003|Stage 2|Technical Problems|0|||
148867807|NCT04030962|536994264|FG004|Stage 2|Technical Problems|0|||
148867808|NCT04030962|536994265|FG005|Stage 2|Technical Problems|0|||
148867809|NCT04030962|536994266|FG006|Stage 2|Technical Problems|0|||
148867810|NCT04030962|536994267|FG007|Stage 2|Technical Problems|0|||
148867811|NCT04030962|536994268|FG008|Stage 2|Technical Problems|0|||
148867812|NCT04030962|536994269|FG009|Stage 2|Technical Problems|0|||
148867813|NCT04030962|536994270|FG010|Stage 2|Technical Problems|0|||
148867814|NCT04030962|536994271|FG011|Stage 2|Technical Problems|1|||
148867815|NCT04030962|536994272|FG012|Stage 2|Technical Problems|0|||
148867816|NCT05288166|536994282|FG000|Overall Study|Adverse Event|1|||
148867817|NCT05288166|536994283|FG001|Overall Study|Adverse Event|0|||
148867818|NCT05288166|536994282|FG000|Overall Study|Lost to Follow-up|2|||
148867819|NCT05288166|536994283|FG001|Overall Study|Lost to Follow-up|0|||
148867820|NCT05288166|536994282|FG000|Overall Study|Physician Decision|0|||
148867821|NCT05288166|536994283|FG001|Overall Study|Physician Decision|2|||
148867822|NCT05288166|536994282|FG000|Overall Study|Screen Failure|1|||
148867823|NCT05288166|536994283|FG001|Overall Study|Screen Failure|1|||
148867824|NCT05288166|536994282|FG000|Overall Study|Withdrawal by Subject|4|||
148867825|NCT05288166|536994283|FG001|Overall Study|Withdrawal by Subject|2|||
148867826|NCT05288166|536994282|FG000|Overall Study|On Study Treatment|408|||
148867827|NCT05288166|536994283|FG001|Overall Study|On Study Treatment|418|||
148867828|NCT01114360|536994284|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
148867829|NCT01114360|536994285|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
148867830|NCT04284813|536994286|FG000|Overall Study|Withdrawal by Subject|1|||
148867831|NCT03106415|536994287|FG000|Phase 1|Withdrawal by Subject|1|||
148867832|NCT03106415|536994288|FG001|Phase 1|Withdrawal by Subject|0|||
148867833|NCT03106415|536994289|FG002|Phase 1|Withdrawal by Subject|0|||
148867834|NCT03106415|536994287|FG000|Phase 1|Adverse Event|1|||
148867835|NCT03106415|536994288|FG001|Phase 1|Adverse Event|1|||
148867836|NCT03106415|536994289|FG002|Phase 1|Adverse Event|0|||
148867837|NCT03106415|536994287|FG000|Phase 1|Protocol Violation|0|||
148867838|NCT03106415|536994288|FG001|Phase 1|Protocol Violation|1|||
148867839|NCT03106415|536994289|FG002|Phase 1|Protocol Violation|0|||
148867840|NCT01804582|536994290|FG000|Overall Study|Lost to Follow-up|47|||
148867841|NCT01804582|536994291|FG001|Overall Study|Lost to Follow-up|56|||
148867842|NCT01804582|536994290|FG000|Overall Study|Physician Decision|2|||
148867843|NCT01804582|536994291|FG001|Overall Study|Physician Decision|0|||
148867844|NCT00159913|536994294|FG000|Overall Study|Adverse Event|1|||
148867845|NCT00159913|536994295|FG001|Overall Study|Adverse Event|0|||
148867846|NCT00159913|536994296|FG002|Overall Study|Adverse Event|1|||
148867847|NCT00159913|536994297|FG003|Overall Study|Adverse Event|0|||
148867848|NCT00159913|536994294|FG000|Overall Study|Withdrawal by Subject|0|||
148867849|NCT00159913|536994295|FG001|Overall Study|Withdrawal by Subject|0|||
148867850|NCT00159913|536994296|FG002|Overall Study|Withdrawal by Subject|0|||
148867851|NCT00159913|536994297|FG003|Overall Study|Withdrawal by Subject|1|||
148867852|NCT00159913|536994294|FG000|Overall Study|Lost to Follow-up|0|||
148867853|NCT00159913|536994295|FG001|Overall Study|Lost to Follow-up|0|||
148867854|NCT00159913|536994296|FG002|Overall Study|Lost to Follow-up|0|||
148867855|NCT00159913|536994297|FG003|Overall Study|Lost to Follow-up|1|||
148867856|NCT00159913|536994294|FG000|Overall Study|Protocol Violation|1|||
148867857|NCT00159913|536994295|FG001|Overall Study|Protocol Violation|0|||
148867858|NCT00159913|536994296|FG002|Overall Study|Protocol Violation|1|||
148867859|NCT00159913|536994297|FG003|Overall Study|Protocol Violation|0|||
148867860|NCT00385723|536994298|FG000|Overall Study|Lost to Follow-up|1|||
148867861|NCT00385723|536994299|FG001|Overall Study|Lost to Follow-up|1|||
148867862|NCT00385723|536994300|FG002|Overall Study|Lost to Follow-up|0|||
148867863|NCT00385723|536994298|FG000|Overall Study|Withdrawal by Subject|1|||
148867864|NCT00385723|536994299|FG001|Overall Study|Withdrawal by Subject|0|||
148867865|NCT00385723|536994300|FG002|Overall Study|Withdrawal by Subject|2|||
148867866|NCT01390779|536994301|FG000|Overall Study|Physician Decision|1|||
148867867|NCT03455829|536994302|FG000|Overall Study|Death|2|||
148867868|NCT03455829|536994303|FG001|Overall Study|Death|3|||
148867869|NCT03455829|536994304|FG002|Overall Study|Death|2|||
148867870|NCT03455829|536994305|FG003|Overall Study|Death|4|||
148867871|NCT03455829|536994306|FG004|Overall Study|Death|2|||
148867872|NCT03455829|536994302|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
148867873|NCT03455829|536994303|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
148867874|NCT03455829|536994304|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
148867875|NCT03455829|536994305|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
148867876|NCT03455829|536994306|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
148867877|NCT03455829|536994302|FG000|Overall Study|Disease progression|0|||
148867878|NCT03455829|536994303|FG001|Overall Study|Disease progression|0|||
148867879|NCT03455829|536994304|FG002|Overall Study|Disease progression|0|||
148867880|NCT03455829|536994305|FG003|Overall Study|Disease progression|1|||
148867881|NCT03455829|536994306|FG004|Overall Study|Disease progression|1|||
148867882|NCT03689712|536994310|FG000|Overall Study|Adverse Event|1|||
148867883|NCT03689712|536994311|FG001|Overall Study|Adverse Event|0|||
148867884|NCT03689712|536994310|FG000|Overall Study|Death|20|||
148867885|NCT03689712|536994311|FG001|Overall Study|Death|10|||
148867886|NCT03689712|536994310|FG000|Overall Study|Lost to Follow-up|6|||
148867887|NCT03689712|536994311|FG001|Overall Study|Lost to Follow-up|6|||
148867888|NCT03689712|536994310|FG000|Overall Study|Other|1|||
148867889|NCT03689712|536994311|FG001|Overall Study|Other|0|||
149000120|NCT00981084|537475668|FG001|Post Intervention (Data Analysis)|poor effort|1|||
149000121|NCT00981084|537475667|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
149000122|NCT00981084|537475668|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
149000123|NCT02291679|537475669|FG000|Overall Study|Adverse Event|2|||
149000124|NCT02291679|537475670|FG001|Overall Study|Adverse Event|12|||
149000125|NCT02291679|537475671|FG002|Overall Study|Adverse Event|19|||
149000126|NCT02291679|537475669|FG000|Overall Study|Protocol Violation|5|||
149000127|NCT02291679|537475670|FG001|Overall Study|Protocol Violation|1|||
149000128|NCT02291679|537475671|FG002|Overall Study|Protocol Violation|7|||
149000129|NCT02291679|537475669|FG000|Overall Study|Withdrew Consent|18|||
149000130|NCT02291679|537475670|FG001|Overall Study|Withdrew Consent|10|||
149000131|NCT02291679|537475671|FG002|Overall Study|Withdrew Consent|15|||
149000132|NCT02291679|537475669|FG000|Overall Study|Lost to Follow-up|12|||
149000133|NCT02291679|537475670|FG001|Overall Study|Lost to Follow-up|10|||
149000134|NCT02291679|537475671|FG002|Overall Study|Lost to Follow-up|9|||
149000135|NCT02291679|537475669|FG000|Overall Study|Insufficient Therapeutic Response|5|||
149000136|NCT02291679|537475670|FG001|Overall Study|Insufficient Therapeutic Response|5|||
149000137|NCT02291679|537475671|FG002|Overall Study|Insufficient Therapeutic Response|7|||
149000138|NCT02291679|537475669|FG000|Overall Study|Other|2|||
149000139|NCT02291679|537475670|FG001|Overall Study|Other|4|||
149000140|NCT02291679|537475671|FG002|Overall Study|Other|2|||
149000141|NCT02048072|537475672|FG000|Overall Study|Adverse Event|3|||
149000142|NCT02048072|537475672|FG000|Overall Study|Lost to Follow-up|1|||
148867890|NCT03689712|536994310|FG000|Overall Study|Patient Non-Compliance|0|||
149000143|NCT01112579|537475673|FG000|Overall Study|Missed Visit|1|||
149000144|NCT01112579|537475674|FG001|Overall Study|Missed Visit|1|||
148867891|NCT03689712|536994311|FG001|Overall Study|Patient Non-Compliance|1|||
148867892|NCT03689712|536994310|FG000|Overall Study|Withdrawal by Subject|20|||
148867893|NCT03689712|536994311|FG001|Overall Study|Withdrawal by Subject|4|||
148867894|NCT03689712|536994310|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
148867895|NCT03689712|536994311|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
149000145|NCT01112579|537475673|FG000|Overall Study|Death|0|||
148867896|NCT03689712|536994310|FG000|Overall Study|Randomized but not Treated|13|||
148867897|NCT03689712|536994311|FG001|Overall Study|Randomized but not Treated|7|||
148867898|NCT03689712|536994310|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
148867899|NCT03689712|536994311|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
148867900|NCT00689793|536994312|FG000|Overall Study|Lost to Follow-up|4|||
148867901|NCT00689793|536994313|FG001|Overall Study|Lost to Follow-up|5|||
148867902|NCT00875056|536994314|FG000|Overall Study|Adverse Event|6|||
148867903|NCT00875056|536994315|FG001|Overall Study|Adverse Event|1|||
148867904|NCT00875056|536994316|FG002|Overall Study|Adverse Event|2|||
148867905|NCT00875056|536994314|FG000|Overall Study|Progressive Disease|14|||
148867906|NCT00875056|536994315|FG001|Overall Study|Progressive Disease|8|||
148867907|NCT00875056|536994316|FG002|Overall Study|Progressive Disease|3|||
148867908|NCT00875056|536994314|FG000|Overall Study|Withdrawal by Subject|3|||
148867909|NCT00875056|536994315|FG001|Overall Study|Withdrawal by Subject|0|||
148867910|NCT00875056|536994316|FG002|Overall Study|Withdrawal by Subject|1|||
148867911|NCT00357656|536994319|FG000|Overall Study|Other, No surgery performed|0|||
148867912|NCT00357656|536994320|FG001|Overall Study|Other, No surgery performed|3|||
148867913|NCT02573246|536994321|FG000|Overall Study|Lost to Follow-up|2|||
148867914|NCT02573246|536994322|FG001|Overall Study|Lost to Follow-up|0|||
148867915|NCT02573246|536994323|FG002|Overall Study|Lost to Follow-up|0|||
148867916|NCT02573246|536994324|FG003|Overall Study|Lost to Follow-up|0|||
148867917|NCT02573246|536994325|FG004|Overall Study|Lost to Follow-up|1|||
148867918|NCT02573246|536994321|FG000|Overall Study|Withdrawal by Subject|0|||
148867919|NCT02573246|536994322|FG001|Overall Study|Withdrawal by Subject|0|||
148867920|NCT02573246|536994323|FG002|Overall Study|Withdrawal by Subject|0|||
148867921|NCT02573246|536994324|FG003|Overall Study|Withdrawal by Subject|0|||
148867922|NCT02573246|536994325|FG004|Overall Study|Withdrawal by Subject|1|||
148867923|NCT02573246|536994321|FG000|Overall Study|Physician Decision|1|||
148867924|NCT02573246|536994322|FG001|Overall Study|Physician Decision|1|||
148867925|NCT02573246|536994323|FG002|Overall Study|Physician Decision|3|||
148867926|NCT02573246|536994324|FG003|Overall Study|Physician Decision|2|||
148867927|NCT02573246|536994325|FG004|Overall Study|Physician Decision|2|||
148867928|NCT02713529|536994328|FG000|Overall Study|Withdrawal by Subject|3|||
148867929|NCT02713529|536994329|FG001|Overall Study|Withdrawal by Subject|1|||
148867930|NCT02713529|536994330|FG002|Overall Study|Withdrawal by Subject|4|||
148867931|NCT02713529|536994331|FG003|Overall Study|Withdrawal by Subject|2|||
148867932|NCT02713529|536994332|FG004|Overall Study|Withdrawal by Subject|0|||
148867933|NCT02713529|536994333|FG005|Overall Study|Withdrawal by Subject|1|||
148867934|NCT02713529|536994334|FG006|Overall Study|Withdrawal by Subject|1|||
148867935|NCT02713529|536994328|FG000|Overall Study|Lost to Follow-up|1|||
148867936|NCT02713529|536994329|FG001|Overall Study|Lost to Follow-up|0|||
148867937|NCT02713529|536994330|FG002|Overall Study|Lost to Follow-up|1|||
148867938|NCT02713529|536994331|FG003|Overall Study|Lost to Follow-up|0|||
148867939|NCT02713529|536994332|FG004|Overall Study|Lost to Follow-up|0|||
148867940|NCT02713529|536994333|FG005|Overall Study|Lost to Follow-up|0|||
148867941|NCT02713529|536994334|FG006|Overall Study|Lost to Follow-up|0|||
148867942|NCT02713529|536994328|FG000|Overall Study|Death|3|||
148867943|NCT02713529|536994329|FG001|Overall Study|Death|3|||
148867944|NCT02713529|536994330|FG002|Overall Study|Death|26|||
148867945|NCT02713529|536994331|FG003|Overall Study|Death|27|||
148867946|NCT02713529|536994332|FG004|Overall Study|Death|3|||
148867947|NCT02713529|536994333|FG005|Overall Study|Death|13|||
148867948|NCT02713529|536994334|FG006|Overall Study|Death|3|||
148867949|NCT01636713|536994335|FG000|Overall Study|Adverse Event|16|||
148867950|NCT01636713|536994336|FG001|Overall Study|Adverse Event|16|||
148867951|NCT01636713|536994337|FG002|Overall Study|Adverse Event|7|||
148867952|NCT01636713|536994335|FG000|Overall Study|Lack of Efficacy|6|||
148867953|NCT01636713|536994336|FG001|Overall Study|Lack of Efficacy|6|||
148867954|NCT01636713|536994337|FG002|Overall Study|Lack of Efficacy|2|||
148867955|NCT01636713|536994335|FG000|Overall Study|Protocol Violation|3|||
148867956|NCT01636713|536994336|FG001|Overall Study|Protocol Violation|0|||
148867957|NCT01636713|536994337|FG002|Overall Study|Protocol Violation|1|||
148867958|NCT01636713|536994335|FG000|Overall Study|Lost to Follow-up|0|||
148867959|NCT01636713|536994336|FG001|Overall Study|Lost to Follow-up|0|||
148867960|NCT01636713|536994337|FG002|Overall Study|Lost to Follow-up|1|||
148867961|NCT01636713|536994335|FG000|Overall Study|Withdrawal by Subject|5|||
148867962|NCT01636713|536994336|FG001|Overall Study|Withdrawal by Subject|4|||
148867963|NCT01636713|536994337|FG002|Overall Study|Withdrawal by Subject|8|||
148867964|NCT01636713|536994335|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
148867965|NCT01636713|536994336|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
148867966|NCT01636713|536994337|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
148867967|NCT03689244|536994338|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
148867968|NCT03689244|536994339|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
148867969|NCT03689244|536994340|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
148867970|NCT03689244|536994341|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
148867971|NCT03689244|536994338|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
148867972|NCT03689244|536994339|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
148867973|NCT03689244|536994340|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
148867974|NCT03689244|536994341|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
148867975|NCT03689244|536994338|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
148867976|NCT03689244|536994339|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
148867977|NCT03689244|536994340|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
148867978|NCT03689244|536994341|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
148867979|NCT03689244|536994338|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
148867980|NCT03689244|536994339|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
148867981|NCT03689244|536994340|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
148867982|NCT03689244|536994341|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
148867983|NCT03689244|536994338|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
148867984|NCT03689244|536994339|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
148867985|NCT03689244|536994340|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
148867986|NCT03689244|536994341|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
148867987|NCT03689244|536994338|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
148867988|NCT03689244|536994339|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
148867989|NCT03689244|536994340|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
148867990|NCT03689244|536994341|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
148867991|NCT03689244|536994338|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
148867992|NCT03689244|536994339|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
148867993|NCT03689244|536994340|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
148867994|NCT03689244|536994341|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
148867995|NCT03689244|536994338|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
148867996|NCT03689244|536994339|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
148867997|NCT03689244|536994340|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
148867998|NCT03689244|536994341|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
148867999|NCT02308488|536994344|FG000|Overall Study|Withdrawal by Subject|2|||
148868000|NCT01541917|536994345|FG000|Overall Study|Lost to Follow-up|2|||
148868001|NCT01541917|536994346|FG001|Overall Study|Lost to Follow-up|2|||
148868002|NCT01541917|536994345|FG000|Overall Study|Withdrawal by Subject|13|||
148868003|NCT01541917|536994346|FG001|Overall Study|Withdrawal by Subject|7|||
148868004|NCT01739803|536994353|FG000|Overall Study|Lost to Follow-up|9|||
148868005|NCT01739803|536994354|FG001|Overall Study|Lost to Follow-up|6|||
148868006|NCT03759041|536994358|FG000|Overall Study|Withdrawal by Subject|4|||
148868007|NCT03759041|536994359|FG001|Overall Study|Withdrawal by Subject|10|||
148868008|NCT03759041|536994360|FG002|Overall Study|Withdrawal by Subject|10|||
148868009|NCT03759041|536994358|FG000|Overall Study|Adverse Event|1|||
148868010|NCT03759041|536994359|FG001|Overall Study|Adverse Event|3|||
148868011|NCT03759041|536994360|FG002|Overall Study|Adverse Event|4|||
148868012|NCT03759041|536994358|FG000|Overall Study|Lack of Efficacy|0|||
148868013|NCT03759041|536994359|FG001|Overall Study|Lack of Efficacy|0|||
148868014|NCT03759041|536994360|FG002|Overall Study|Lack of Efficacy|1|||
148868015|NCT03759041|536994358|FG000|Overall Study|Study Terminated by Sponsor|15|||
148868016|NCT03759041|536994359|FG001|Overall Study|Study Terminated by Sponsor|16|||
148868017|NCT03759041|536994360|FG002|Overall Study|Study Terminated by Sponsor|10|||
148868018|NCT03759041|536994358|FG000|Overall Study|Other reason for discontinuation|0|||
148868019|NCT03759041|536994359|FG001|Overall Study|Other reason for discontinuation|2|||
148868020|NCT03759041|536994360|FG002|Overall Study|Other reason for discontinuation|1|||
148868021|NCT03759041|536994358|FG000|Overall Study|Lost to Follow-up|7|||
148868022|NCT03759041|536994359|FG001|Overall Study|Lost to Follow-up|2|||
148868023|NCT03759041|536994360|FG002|Overall Study|Lost to Follow-up|2|||
148868024|NCT03759041|536994358|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
148868025|NCT03759041|536994359|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
148868026|NCT03759041|536994360|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
148868027|NCT00831701|536994364|FG000|Overall Study|Withdrawal by Subject|2|||
148868028|NCT00831701|536994365|FG001|Overall Study|Withdrawal by Subject|0|||
148868029|NCT00831701|536994364|FG000|Overall Study|Stone expulsion before first medication|2|||
149000146|NCT01112579|537475674|FG001|Overall Study|Death|2|||
149000147|NCT01648270|537475675|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
149000148|NCT00902694|537475676|FG000|Overall Study|Death|1|||
149000149|NCT00902694|537475677|FG001|Overall Study|Death|3|||
149000150|NCT00902694|537475676|FG000|Overall Study|Lost to Follow-up|1|||
149000151|NCT00902694|537475677|FG001|Overall Study|Lost to Follow-up|0|||
148868030|NCT00831701|536994365|FG001|Overall Study|Stone expulsion before first medication|2|||
148868031|NCT00831701|536994364|FG000|Overall Study|Lost to Follow-up|1|||
148868032|NCT00831701|536994365|FG001|Overall Study|Lost to Follow-up|3|||
148868033|NCT02117349|536994366|FG000|Overall Study|Withdrawal by Subject|1|||
148868034|NCT02117349|536994367|FG001|Overall Study|Withdrawal by Subject|0|||
148868035|NCT02117349|536994366|FG000|Overall Study|Lost to Follow-up|1|||
149000152|NCT00902694|537475676|FG000|Overall Study|Censored per protocol|3|||
148868036|NCT02117349|536994367|FG001|Overall Study|Lost to Follow-up|1|||
149000153|NCT00902694|537475677|FG001|Overall Study|Censored per protocol|1|||
148868037|NCT02117349|536994366|FG000|Overall Study|Death|1|||
148868038|NCT02117349|536994367|FG001|Overall Study|Death|0|||
148868039|NCT02242981|536994370|FG000|Overall Study|Withdrawal by Subject|1|||
148868040|NCT01440881|536994371|FG000|Overall Study|Death|0|||
148868041|NCT01440881|536994372|FG001|Overall Study|Death|1|||
148868042|NCT02535416|536994373|FG000|Overall Study|Family bereavement overseas|1|||
148868043|NCT02535416|536994374|FG001|Overall Study|Family bereavement overseas|0|||
148868044|NCT02535416|536994375|FG002|Overall Study|Family bereavement overseas|0|||
148868045|NCT02535416|536994376|FG003|Overall Study|Family bereavement overseas|0|||
148868046|NCT02535416|536994377|FG004|Overall Study|Family bereavement overseas|0|||
148868047|NCT02535416|536994378|FG005|Overall Study|Family bereavement overseas|0|||
148868048|NCT02535416|536994379|FG006|Overall Study|Family bereavement overseas|0|||
148868049|NCT02535416|536994380|FG007|Overall Study|Family bereavement overseas|0|||
148868050|NCT02535416|536994381|FG008|Overall Study|Family bereavement overseas|0|||
148868051|NCT03474081|536994382|FG000|Overall Study|Adverse Event|6|||
148868052|NCT03474081|536994383|FG001|Overall Study|Adverse Event|3|||
148868053|NCT03474081|536994382|FG000|Overall Study|Lost to Follow-up|2|||
148868054|NCT03474081|536994383|FG001|Overall Study|Lost to Follow-up|1|||
148868055|NCT03474081|536994382|FG000|Overall Study|Physician Decision|3|||
148868056|NCT03474081|536994383|FG001|Overall Study|Physician Decision|2|||
148868057|NCT03474081|536994382|FG000|Overall Study|Withdrawal by Subject|5|||
148868058|NCT03474081|536994383|FG001|Overall Study|Withdrawal by Subject|7|||
148868059|NCT03474081|536994382|FG000|Overall Study|Investigator site closed|1|||
148868060|NCT03474081|536994383|FG001|Overall Study|Investigator site closed|0|||
148868061|NCT01977690|536994386|FG000|Overall Study|Withdrawal by Subject|0|||
148868062|NCT01977690|536994387|FG001|Overall Study|Withdrawal by Subject|4|||
148868063|NCT02739321|536994392|FG000|Overall Study|Lack of Efficacy|1|||
148868064|NCT02739321|536994393|FG001|Overall Study|Lack of Efficacy|1|||
148868065|NCT02739321|536994392|FG000|Overall Study|Lost to Follow-up|1|||
148868066|NCT02739321|536994393|FG001|Overall Study|Lost to Follow-up|1|||
148868067|NCT02739321|536994392|FG000|Overall Study|Withdrawal by Subject|1|||
148868068|NCT02739321|536994393|FG001|Overall Study|Withdrawal by Subject|2|||
148868069|NCT02440789|536994396|FG000|Overall Study|Withdrawal by Subject|3|||
148868070|NCT02440789|536994396|FG000|Overall Study|Not willing to adhere to reqs|1|||
148868071|NCT03172130|536995728|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
148868072|NCT03172130|536995729|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
148868073|NCT01350115|536995733|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
148868074|NCT01350115|536995734|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
148868075|NCT01350115|536995733|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
148868076|NCT01350115|536995734|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
148868077|NCT01350115|536995733|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
148868078|NCT01350115|536995734|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
148868079|NCT02769962|536995741|FG000|Overall Study|Physician Decision|0|||
148868080|NCT02769962|536995742|FG001|Overall Study|Physician Decision|0|||
148868081|NCT02769962|536995743|FG002|Overall Study|Physician Decision|0|||
148868082|NCT02769962|536995744|FG003|Overall Study|Physician Decision|0|||
149000154|NCT00902694|537475676|FG000|Overall Study|Pregnancy|1|||
149000155|NCT00902694|537475677|FG001|Overall Study|Pregnancy|1|||
149000156|NCT00902694|537475676|FG000|Overall Study|Incarceration|1|||
149000157|NCT00902694|537475677|FG001|Overall Study|Incarceration|0|||
149000158|NCT04969263|537475678|FG000|Overall Study|Death|1|||
149000159|NCT04969263|537475678|FG000|Overall Study|Lost to Follow-up|2|||
149000160|NCT04969263|537475678|FG000|Overall Study|Withdrawal by Subject|5|||
149000161|NCT04969263|537475678|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
149000162|NCT03456700|537475679|FG000|Overall Study|Withdrawal by Subject|1|||
149000163|NCT04154787|537475680|FG000|Overall Study|Adverse Event|0|||
149000164|NCT04154787|537475681|FG001|Overall Study|Adverse Event|1|||
149000165|NCT04154787|537475682|FG002|Overall Study|Adverse Event|0|||
149000166|NCT04154787|537475680|FG000|Overall Study|Patient Requires Other Treatment|0|||
149000167|NCT04154787|537475681|FG001|Overall Study|Patient Requires Other Treatment|1|||
149000168|NCT04154787|537475682|FG002|Overall Study|Patient Requires Other Treatment|0|||
149000169|NCT04154787|537475680|FG000|Overall Study|Study Terminated By Sponsor|0|||
149000170|NCT04154787|537475681|FG001|Overall Study|Study Terminated By Sponsor|6|||
149000171|NCT04154787|537475682|FG002|Overall Study|Study Terminated By Sponsor|1|||
149000172|NCT04154787|537475680|FG000|Overall Study|Subject Decision|0|||
149000173|NCT04154787|537475681|FG001|Overall Study|Subject Decision|1|||
149000174|NCT04154787|537475682|FG002|Overall Study|Subject Decision|0|||
148868083|NCT02769962|536995745|FG004|Overall Study|Physician Decision|0|||
148868084|NCT02769962|536995746|FG005|Overall Study|Physician Decision|1|||
149000175|NCT04154787|537475680|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
149000176|NCT04154787|537475681|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
149000177|NCT04154787|537475682|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
148868085|NCT02769962|536995747|FG006|Overall Study|Physician Decision|0|||
148868086|NCT02769962|536995748|FG007|Overall Study|Physician Decision|1|||
148868087|NCT02769962|536995741|FG000|Overall Study|Refused further treatment|0|||
148868088|NCT02769962|536995742|FG001|Overall Study|Refused further treatment|0|||
148868089|NCT02769962|536995743|FG002|Overall Study|Refused further treatment|0|||
148868090|NCT02769962|536995744|FG003|Overall Study|Refused further treatment|0|||
148868091|NCT02769962|536995745|FG004|Overall Study|Refused further treatment|0|||
148868092|NCT02769962|536995746|FG005|Overall Study|Refused further treatment|1|||
148868093|NCT02769962|536995747|FG006|Overall Study|Refused further treatment|1|||
148868094|NCT02769962|536995748|FG007|Overall Study|Refused further treatment|0|||
148868095|NCT05565937|536995749|FG000|Overall Study|Adverse Event|0|||
148868096|NCT05565937|536995750|FG001|Overall Study|Adverse Event|1|||
148868097|NCT05565937|536995749|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
148868098|NCT05565937|536995750|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
148868099|NCT05565937|536995749|FG000|Overall Study|Lost to Follow-up|2|||
148868100|NCT05565937|536995750|FG001|Overall Study|Lost to Follow-up|0|||
148868101|NCT05565937|536995749|FG000|Overall Study|Pregnancy|0|||
148868102|NCT05565937|536995750|FG001|Overall Study|Pregnancy|2|||
148868103|NCT05565937|536995749|FG000|Overall Study|Anisometropia|0|||
148868104|NCT05565937|536995750|FG001|Overall Study|Anisometropia|1|||
148868105|NCT04544683|536995751|FG000|Overall Study|Lost to Follow-up|2|||
148868106|NCT04544683|536995751|FG000|Overall Study|Underwent cervical spine surgery|6|||
148868107|NCT02783170|536995752|FG000|Overall Study|Randomized but not Vaccinated|1|||
148868108|NCT02783170|536995753|FG001|Overall Study|Randomized but not Vaccinated|0|||
148868109|NCT00541346|536995754|FG000|Follow-up|Adverse Event|1|||
148868110|NCT03323736|536995755|FG000|Overall Study|Screen Failure|14|||
148868111|NCT03323736|536995756|FG001|Overall Study|Screen Failure|9|||
148868112|NCT03323736|536995757|FG002|Overall Study|Screen Failure|1|||
148868113|NCT03323736|536995755|FG000|Overall Study|Withdrawal Before Treatment|3|||
148868114|NCT03323736|536995756|FG001|Overall Study|Withdrawal Before Treatment|1|||
148868115|NCT03323736|536995757|FG002|Overall Study|Withdrawal Before Treatment|1|||
148868116|NCT03323736|536995755|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
148868117|NCT03323736|536995756|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
148868118|NCT03323736|536995757|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
148868119|NCT01806064|536995758|FG000|Overall Study|Randomized Not Enrolled|0|||
148868120|NCT01806064|536995759|FG001|Overall Study|Randomized Not Enrolled|0|||
148868121|NCT01806064|536995760|FG002|Overall Study|Randomized Not Enrolled|0|||
148868122|NCT01806064|536995761|FG003|Overall Study|Randomized Not Enrolled|1|||
148868123|NCT01806064|536995762|FG004|Overall Study|Randomized Not Enrolled|2|||
148868124|NCT00701805|536995763|FG000|Overall Study|Withdrawal by Subject|3|||
148868125|NCT00701805|536995764|FG001|Overall Study|Withdrawal by Subject|1|||
148868126|NCT00701805|536995765|FG002|Overall Study|Withdrawal by Subject|4|||
148868127|NCT00701805|536995766|FG003|Overall Study|Withdrawal by Subject|3|||
148868128|NCT00701805|536995763|FG000|Overall Study|Adverse Event|0|||
148868129|NCT00701805|536995764|FG001|Overall Study|Adverse Event|1|||
148868130|NCT00701805|536995765|FG002|Overall Study|Adverse Event|1|||
148868131|NCT00701805|536995766|FG003|Overall Study|Adverse Event|0|||
148868132|NCT00701805|536995763|FG000|Overall Study|Missed 7 consecutive doses|0|||
148868133|NCT00701805|536995764|FG001|Overall Study|Missed 7 consecutive doses|1|||
148868134|NCT00701805|536995765|FG002|Overall Study|Missed 7 consecutive doses|0|||
148868135|NCT00701805|536995766|FG003|Overall Study|Missed 7 consecutive doses|0|||
148868136|NCT00701805|536995763|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
148868137|NCT00701805|536995764|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
148868138|NCT00701805|536995765|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
148868139|NCT00701805|536995766|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
148868140|NCT00701805|536995763|FG000|Overall Study|Physician decision, change of therapy|0|||
148868141|NCT00701805|536995764|FG001|Overall Study|Physician decision, change of therapy|0|||
148868142|NCT00701805|536995765|FG002|Overall Study|Physician decision, change of therapy|0|||
148868143|NCT00701805|536995766|FG003|Overall Study|Physician decision, change of therapy|1|||
148868144|NCT00701805|536995763|FG000|Overall Study|Difficult to travel to dialysis site|0|||
148868145|NCT00701805|536995764|FG001|Overall Study|Difficult to travel to dialysis site|0|||
148868146|NCT00701805|536995765|FG002|Overall Study|Difficult to travel to dialysis site|1|||
148868147|NCT00701805|536995766|FG003|Overall Study|Difficult to travel to dialysis site|0|||
148868148|NCT00701805|536995763|FG000|Overall Study|Resumption criteria were not met|0|||
148868149|NCT00701805|536995764|FG001|Overall Study|Resumption criteria were not met|1|||
148868150|NCT00701805|536995765|FG002|Overall Study|Resumption criteria were not met|0|||
148868151|NCT00701805|536995766|FG003|Overall Study|Resumption criteria were not met|0|||
148868152|NCT02797184|536995783|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
148868153|NCT02797184|536995784|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
148868154|NCT04692077|536995785|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
148868155|NCT05149313|536995786|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
148868156|NCT05149313|536995787|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
148868157|NCT05149313|536995788|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
148868158|NCT05149313|536995789|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
148868159|NCT05149313|536995786|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
148868160|NCT05149313|536995787|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
148868161|NCT05149313|536995788|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
148868162|NCT05149313|536995789|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
148868163|NCT05149313|536995786|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
148868164|NCT05149313|536995787|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
148868165|NCT05149313|536995788|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
148868166|NCT05149313|536995789|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
148868167|NCT05149313|536995786|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
148868168|NCT05149313|536995787|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
148868169|NCT05149313|536995788|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
148868170|NCT05149313|536995789|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
148868171|NCT05149313|536995786|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
148868172|NCT05149313|536995787|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
148868173|NCT05149313|536995788|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
148868174|NCT05149313|536995789|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
148868175|NCT05149313|536995786|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
148868176|NCT05149313|536995787|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
148868177|NCT05149313|536995788|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
148868178|NCT05149313|536995789|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
148868179|NCT05149313|536995786|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
148868180|NCT05149313|536995787|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
148868181|NCT05149313|536995788|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
148868182|NCT05149313|536995789|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
148868183|NCT05149313|536995786|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148868184|NCT05149313|536995787|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
148868185|NCT05149313|536995788|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
148868186|NCT05149313|536995789|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
148868187|NCT05149313|536995786|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
148868188|NCT05149313|536995787|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
148868189|NCT05149313|536995788|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
148868190|NCT05149313|536995789|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
148868191|NCT05149313|536995786|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148868192|NCT05149313|536995787|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148868193|NCT05149313|536995788|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
148868194|NCT05149313|536995789|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
148868195|NCT05149313|536995786|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
148868196|NCT05149313|536995787|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
148868197|NCT05149313|536995788|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
148868198|NCT05149313|536995789|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
148868199|NCT03199391|536995794|FG000|Overall Study|Death|1|||
148868200|NCT03199391|536995794|FG000|Overall Study|Lost to Follow-up|3|||
148868201|NCT03199391|536995794|FG000|Overall Study|Adverse Event|2|||
148868202|NCT03199391|536995794|FG000|Overall Study|Withdrawal by Subject|10|||
148868203|NCT03826342|536995804|FG000|Overall Study|Withdrawal by Subject|8|||
148868204|NCT03826342|536995805|FG001|Overall Study|Withdrawal by Subject|1|||
148868205|NCT03826342|536995804|FG000|Overall Study|Lost to Follow-up|7|||
148868206|NCT03826342|536995805|FG001|Overall Study|Lost to Follow-up|7|||
148868207|NCT03826342|536995804|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
148868208|NCT03826342|536995805|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
148868209|NCT02212678|536995812|FG000|Overall Study|Adverse Event|1|||
148868210|NCT02337634|536995813|FG000|Overall Study|Protocol Violation|3|||
148868211|NCT02337634|536995814|FG001|Overall Study|Protocol Violation|1|||
148868212|NCT02337634|536995813|FG000|Overall Study|Lost to Follow-up|1|||
148868213|NCT02337634|536995814|FG001|Overall Study|Lost to Follow-up|0|||
148868226|NCT02046070|536995818|FG000|Overall Study|Progressive Disease|18|||
148868227|NCT02046070|536995819|FG001|Overall Study|Progressive Disease|11|||
148868228|NCT02046070|536995820|FG002|Overall Study|Progressive Disease|40|||
148868229|NCT02046070|536995818|FG000|Overall Study|Adverse Event|8|||
148868230|NCT02046070|536995819|FG001|Overall Study|Adverse Event|10|||
148868231|NCT02046070|536995820|FG002|Overall Study|Adverse Event|17|||
148868232|NCT02046070|536995818|FG000|Overall Study|Withdrawal by Subject|1|||
148868233|NCT02046070|536995819|FG001|Overall Study|Withdrawal by Subject|2|||
148868234|NCT02046070|536995820|FG002|Overall Study|Withdrawal by Subject|6|||
148868235|NCT02046070|536995818|FG000|Overall Study|Study Terminated by Sponsor|1|||
148868236|NCT02046070|536995819|FG001|Overall Study|Study Terminated by Sponsor|1|||
148868237|NCT02046070|536995820|FG002|Overall Study|Study Terminated by Sponsor|1|||
148868238|NCT02046070|536995818|FG000|Overall Study|Reason not Specified|4|||
148868239|NCT02046070|536995819|FG001|Overall Study|Reason not Specified|4|||
148868240|NCT02046070|536995820|FG002|Overall Study|Reason not Specified|6|||
148868241|NCT05601102|536995821|FG000|Overall Study|Death|1|||
148868242|NCT05601102|536995822|FG001|Overall Study|Death|2|||
148868243|NCT05601102|536995821|FG000|Overall Study|Withdrawal by Subject|1|||
148868244|NCT05601102|536995822|FG001|Overall Study|Withdrawal by Subject|1|||
148868245|NCT05601102|536995821|FG000|Overall Study|Lost to Follow-up|0|||
148868246|NCT05601102|536995822|FG001|Overall Study|Lost to Follow-up|2|||
148868247|NCT00353873|536995823|FG000|Overall Study|Protocol Violation|1|||
148868248|NCT00353873|536995824|FG001|Overall Study|Protocol Violation|2|||
148868249|NCT00353873|536995823|FG000|Overall Study|Exacerbation|1|||
148868250|NCT00353873|536995824|FG001|Overall Study|Exacerbation|0|||
148868251|NCT00353873|536995823|FG000|Overall Study|Adverse Event|1|||
148868252|NCT00353873|536995824|FG001|Overall Study|Adverse Event|0|||
148868253|NCT00353873|536995823|FG000|Overall Study|Physician Decision|2|||
148868254|NCT00353873|536995824|FG001|Overall Study|Physician Decision|0|||
148868255|NCT00353873|536995823|FG000|Overall Study|Withdrawal by Subject|1|||
148868256|NCT00353873|536995824|FG001|Overall Study|Withdrawal by Subject|1|||
148868257|NCT03743064|536995825|FG000|Overall Study|Adverse Event|7|||
148868258|NCT03743064|536995826|FG001|Overall Study|Adverse Event|9|||
148868259|NCT03743064|536995825|FG000|Overall Study|Death|25|||
148868260|NCT03743064|536995826|FG001|Overall Study|Death|28|||
148868261|NCT03743064|536995825|FG000|Overall Study|Lost to Follow-up|3|||
148868262|NCT03743064|536995826|FG001|Overall Study|Lost to Follow-up|6|||
148868263|NCT03743064|536995825|FG000|Overall Study|Withdrawal by Subject|28|||
148868264|NCT03743064|536995826|FG001|Overall Study|Withdrawal by Subject|25|||
148868265|NCT03743064|536995825|FG000|Overall Study|Physician Decision|2|||
148868266|NCT03743064|536995826|FG001|Overall Study|Physician Decision|4|||
148868267|NCT03743064|536995825|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
148868268|NCT03743064|536995826|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
148868269|NCT04941807|536995832|FG000|Overall Study|Lost to Follow-up|1|||
148868270|NCT04941807|536995833|FG001|Overall Study|Lost to Follow-up|1|||
148868271|NCT03553498|536995834|FG000|Overall Study|Missing primary outcome|1|||
148868272|NCT03553498|536995835|FG001|Overall Study|Missing primary outcome|2|||
148868273|NCT01100567|536995836|FG000|Overall Study|Withdrawal by Subject|5|||
148868274|NCT01100567|536995837|FG001|Overall Study|Withdrawal by Subject|8|||
148868275|NCT01100567|536995836|FG000|Overall Study|Early Hospital Discharge|6|||
148868276|NCT01100567|536995837|FG001|Overall Study|Early Hospital Discharge|4|||
148868277|NCT01100567|536995836|FG000|Overall Study|Lost to Follow-up|1|||
148868278|NCT01100567|536995837|FG001|Overall Study|Lost to Follow-up|2|||
148868279|NCT01100567|536995836|FG000|Overall Study|Physician Decision|0|||
148868280|NCT01100567|536995837|FG001|Overall Study|Physician Decision|1|||
148868281|NCT01100567|536995836|FG000|Overall Study|Deemed ineligible after consent|0|||
148868282|NCT01100567|536995837|FG001|Overall Study|Deemed ineligible after consent|1|||
148868283|NCT01565564|536995843|FG000|Overall Study|Lost to Follow-up|5|||
148868284|NCT01565564|536995844|FG001|Overall Study|Lost to Follow-up|1|||
148868285|NCT02449018|536995845|FG000|Overall Study|Abnormal laboratory value|0|||
148868286|NCT02449018|536995846|FG001|Overall Study|Abnormal laboratory value|1|||
148868287|NCT02449018|536995845|FG000|Overall Study|Administrative problems|1|||
148868288|NCT02449018|536995846|FG001|Overall Study|Administrative problems|0|||
148868289|NCT02449018|536995845|FG000|Overall Study|Adverse Event|5|||
148868290|NCT02449018|536995846|FG001|Overall Study|Adverse Event|1|||
148868291|NCT02449018|536995845|FG000|Overall Study|Protocol deviation|4|||
148868292|NCT02449018|536995846|FG001|Overall Study|Protocol deviation|0|||
148868293|NCT02449018|536995845|FG000|Overall Study|Patient decision|2|||
148868294|NCT02449018|536995846|FG001|Overall Study|Patient decision|0|||
148868295|NCT03995355|536995847|FG000|Overall Study|Adverse Event|1|||
148868296|NCT03995355|536995848|FG001|Overall Study|Adverse Event|0|||
148868297|NCT03995355|536995847|FG000|Overall Study|Withdrawal by Subject|1|||
148868298|NCT03995355|536995848|FG001|Overall Study|Withdrawal by Subject|0|||
148868299|NCT03995355|536995847|FG000|Overall Study|Scheduling Issues|0|||
148868300|NCT03995355|536995848|FG001|Overall Study|Scheduling Issues|1|||
149000178|NCT03053050|537475683|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
149000179|NCT03053050|537475684|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
149000180|NCT03053050|537475685|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
149000181|NCT03053050|537475686|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
148868301|NCT00094107|536995849|FG000|Overall Study|Lack of Efficacy|23|||
148868302|NCT00094107|536995849|FG000|Overall Study|Death|5|||
149000182|NCT03053050|537475683|FG000|Randomized Phase|Withdrew Consent|16|||
148868303|NCT00094107|536995849|FG000|Overall Study|Adverse Event|3|||
148868304|NCT00094107|536995849|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
148868305|NCT02698371|536995877|FG000|All Participants Flow|Lost to Follow-up|3|||
148868306|NCT02698371|536995877|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
148868307|NCT02698371|536995877|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
148868308|NCT02698371|536995877|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
148868309|NCT02698371|536995877|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
148868310|NCT02698371|536995877|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
148868311|NCT02698371|536995877|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
148868312|NCT02525094|536995878|FG000|Overall Study|Lost to Follow-up|2|||
148868313|NCT02525094|536995879|FG001|Overall Study|Lost to Follow-up|1|||
148868314|NCT02525094|536995878|FG000|Overall Study|Withdrawal by Subject|5|||
148868315|NCT02525094|536995879|FG001|Overall Study|Withdrawal by Subject|6|||
148868316|NCT02525094|536995878|FG000|Overall Study|Not Treated|1|||
148868317|NCT02525094|536995879|FG001|Overall Study|Not Treated|1|||
148868318|NCT00969436|536995881|FG000|Overall Study|Protocol Violation|1|||
148868319|NCT00969436|536995882|FG001|Overall Study|Protocol Violation|3|||
148868320|NCT00969436|536995883|FG002|Overall Study|Protocol Violation|0|||
148868321|NCT00969436|536995881|FG000|Overall Study|Migrated/moved from study area|12|||
148868322|NCT00969436|536995882|FG001|Overall Study|Migrated/moved from study area|10|||
148868323|NCT00969436|536995883|FG002|Overall Study|Migrated/moved from study area|2|||
148868324|NCT00969436|536995881|FG000|Overall Study|Father - serious health problem|0|||
148868325|NCT00969436|536995882|FG001|Overall Study|Father - serious health problem|0|||
148868326|NCT00969436|536995883|FG002|Overall Study|Father - serious health problem|1|||
148868327|NCT00969436|536995881|FG000|Overall Study|Parents personal problem|0|||
148868328|NCT00969436|536995882|FG001|Overall Study|Parents personal problem|0|||
148868329|NCT00969436|536995883|FG002|Overall Study|Parents personal problem|1|||
148868330|NCT00969436|536995881|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
148868331|NCT00969436|536995882|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
148868332|NCT00969436|536995883|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
148868333|NCT00969436|536995881|FG000|Overall Study|Withdrawal by Subject|3|||
148868334|NCT00969436|536995882|FG001|Overall Study|Withdrawal by Subject|0|||
148868335|NCT00969436|536995883|FG002|Overall Study|Withdrawal by Subject|2|||
148868336|NCT00969436|536995881|FG000|Overall Study|Lost to Follow-up|8|||
148868337|NCT00969436|536995882|FG001|Overall Study|Lost to Follow-up|8|||
148868338|NCT00969436|536995883|FG002|Overall Study|Lost to Follow-up|5|||
148868339|NCT02290938|536995888|FG000|Overall Study|Lost to Follow-up|14|||
148868340|NCT02290938|536995889|FG001|Overall Study|Lost to Follow-up|43|||
148868341|NCT01825941|536997100|FG000|Overall Study|Lost to Follow-up|4|||
148868342|NCT01825941|536997101|FG001|Overall Study|Lost to Follow-up|1|||
148868343|NCT03495102|536997102|FG000|Overall Study|Adverse Event|5|||
148868344|NCT03495102|536997103|FG001|Overall Study|Adverse Event|7|||
148868345|NCT03495102|536997104|FG002|Overall Study|Adverse Event|10|||
148868346|NCT03495102|536997102|FG000|Overall Study|Death|3|||
148868347|NCT03495102|536997103|FG001|Overall Study|Death|4|||
148868348|NCT03495102|536997104|FG002|Overall Study|Death|4|||
148868349|NCT03495102|536997102|FG000|Overall Study|Lost to Follow-up|15|||
148868350|NCT03495102|536997103|FG001|Overall Study|Lost to Follow-up|16|||
148868351|NCT03495102|536997104|FG002|Overall Study|Lost to Follow-up|17|||
148868352|NCT03495102|536997102|FG000|Overall Study|Physician Decision|2|||
148868353|NCT03495102|536997103|FG001|Overall Study|Physician Decision|0|||
148868354|NCT03495102|536997104|FG002|Overall Study|Physician Decision|2|||
148868355|NCT03495102|536997102|FG000|Overall Study|Withdrawal by Subject|25|||
148868356|NCT03495102|536997103|FG001|Overall Study|Withdrawal by Subject|36|||
148868357|NCT03495102|536997104|FG002|Overall Study|Withdrawal by Subject|18|||
148868358|NCT03495102|536997102|FG000|Overall Study|Protocol Violation|1|||
148868359|NCT03495102|536997103|FG001|Overall Study|Protocol Violation|1|||
148868360|NCT03495102|536997104|FG002|Overall Study|Protocol Violation|0|||
148868361|NCT03495102|536997102|FG000|Overall Study|Site Closure|3|||
148868362|NCT03495102|536997103|FG001|Overall Study|Site Closure|1|||
148868363|NCT03495102|536997104|FG002|Overall Study|Site Closure|2|||
148868364|NCT03495102|536997102|FG000|Overall Study|Non-compliance|1|||
148868365|NCT03495102|536997103|FG001|Overall Study|Non-compliance|0|||
148868366|NCT03495102|536997104|FG002|Overall Study|Non-compliance|0|||
148868367|NCT03495102|536997102|FG000|Overall Study|Participant Duplicated at Another Site|0|||
148868368|NCT03495102|536997103|FG001|Overall Study|Participant Duplicated at Another Site|0|||
148868369|NCT03495102|536997104|FG002|Overall Study|Participant Duplicated at Another Site|1|||
148868370|NCT03495102|536997102|FG000|Overall Study|Primary Care Physician Recommendation|0|||
148868371|NCT03495102|536997103|FG001|Overall Study|Primary Care Physician Recommendation|1|||
148868372|NCT03495102|536997104|FG002|Overall Study|Primary Care Physician Recommendation|0|||
148868373|NCT03495102|536997102|FG000|Overall Study|Relocated to Another Country|0|||
148868374|NCT03495102|536997103|FG001|Overall Study|Relocated to Another Country|1|||
148868375|NCT03495102|536997104|FG002|Overall Study|Relocated to Another Country|0|||
148868376|NCT03495102|536997102|FG000|Overall Study|Participant was in Rehabilitation|1|||
148868377|NCT03495102|536997103|FG001|Overall Study|Participant was in Rehabilitation|0|||
148868378|NCT03495102|536997104|FG002|Overall Study|Participant was in Rehabilitation|0|||
148868379|NCT01161537|536997105|FG000|Part B|Withdrawal by Subject|2|||
148868380|NCT00151372|536997108|FG000|Overall Study|Death|12|||
148868381|NCT00151372|536997109|FG001|Overall Study|Death|11|||
148868382|NCT00151372|536997108|FG000|Overall Study|Lost to Follow-up|5|||
148868383|NCT00151372|536997109|FG001|Overall Study|Lost to Follow-up|5|||
148868384|NCT00151372|536997108|FG000|Overall Study|Too sick medically to continue|5|||
148868385|NCT00151372|536997109|FG001|Overall Study|Too sick medically to continue|6|||
148868386|NCT00151372|536997108|FG000|Overall Study|Withdrawal by Subject|7|||
148868387|NCT00151372|536997109|FG001|Overall Study|Withdrawal by Subject|7|||
148868388|NCT01286077|536997112|FG000|Overall Study|Adverse Event|2|||
148868389|NCT01286077|536997113|FG001|Overall Study|Adverse Event|0|||
148868390|NCT01286077|536997112|FG000|Overall Study|Death|1|||
148868391|NCT01286077|536997113|FG001|Overall Study|Death|0|||
148868392|NCT01286077|536997112|FG000|Overall Study|Protocol Violation|1|||
148868393|NCT01286077|536997113|FG001|Overall Study|Protocol Violation|1|||
148868394|NCT01286077|536997112|FG000|Overall Study|Withdrawal by Subject|0|||
148868395|NCT01286077|536997113|FG001|Overall Study|Withdrawal by Subject|2|||
148868396|NCT01286077|536997112|FG000|Overall Study|Intercurrent illness|1|||
148868397|NCT01286077|536997113|FG001|Overall Study|Intercurrent illness|0|||
148868398|NCT01286077|536997112|FG000|Overall Study|Non-compliance|1|||
148868399|NCT01286077|536997113|FG001|Overall Study|Non-compliance|0|||
148868400|NCT01286077|536997112|FG000|Overall Study|The subject starts with alternative MMY|0|||
148868401|NCT01286077|536997113|FG001|Overall Study|The subject starts with alternative MMY|3|||
148868402|NCT01286077|536997112|FG000|Overall Study|Patient's decision to stop treatment|3|||
148868403|NCT01286077|536997113|FG001|Overall Study|Patient's decision to stop treatment|0|||
148868404|NCT01286077|536997112|FG000|Overall Study|Progression of disease|0|||
148868405|NCT01286077|536997113|FG001|Overall Study|Progression of disease|1|||
148868406|NCT01286077|536997112|FG000|Overall Study|refill medication not received in time|1|||
148868407|NCT01286077|536997113|FG001|Overall Study|refill medication not received in time|0|||
148868408|NCT01282294|536997116|FG000|Overall Study|Lost to Follow-up|14|||
148868409|NCT01282294|536997116|FG000|Overall Study|Screening failure|1|||
148868410|NCT01282294|536997116|FG000|Overall Study|Adverse Event|1|||
148868411|NCT01282294|536997116|FG000|Overall Study|Patient non-compliance|2|||
148868412|NCT01282294|536997116|FG000|Overall Study|Physician Decision|1|||
148868413|NCT02408523|536997117|FG000|Overall Study|Adverse Event|4|||
148868414|NCT02408523|536997118|FG001|Overall Study|Adverse Event|10|||
148868415|NCT02408523|536997117|FG000|Overall Study|Lack of Efficacy|0|||
148868416|NCT02408523|536997118|FG001|Overall Study|Lack of Efficacy|1|||
148868417|NCT02408523|536997117|FG000|Overall Study|Protocol Violation|1|||
148868418|NCT02408523|536997118|FG001|Overall Study|Protocol Violation|2|||
148868419|NCT02408523|536997117|FG000|Overall Study|Lost to Follow-up|2|||
148868420|NCT02408523|536997118|FG001|Overall Study|Lost to Follow-up|3|||
148868421|NCT02408523|536997117|FG000|Overall Study|Withdrawal by Subject|3|||
148868422|NCT02408523|536997118|FG001|Overall Study|Withdrawal by Subject|1|||
148868423|NCT02408523|536997117|FG000|Overall Study|Sponsor request|1|||
148868424|NCT02408523|536997118|FG001|Overall Study|Sponsor request|0|||
148868425|NCT02408523|536997117|FG000|Overall Study|Did not satisfy extension conditions|0|||
148868426|NCT02408523|536997118|FG001|Overall Study|Did not satisfy extension conditions|1|||
148868427|NCT03007745|536997119|FG000|Overall Study|Sleep test negative for OSA|53|||
148868428|NCT03007745|536997120|FG001|Overall Study|Sleep test negative for OSA|49|||
148868429|NCT03007745|536997119|FG000|Overall Study|Physician Decision|6|||
148868430|NCT03007745|536997120|FG001|Overall Study|Physician Decision|9|||
148868431|NCT03007745|536997119|FG000|Overall Study|Withdrawal by Subject|38|||
148868432|NCT03007745|536997120|FG001|Overall Study|Withdrawal by Subject|16|||
148868433|NCT03007745|536997119|FG000|Overall Study|Lost to Follow-up|19|||
148868434|NCT03007745|536997120|FG001|Overall Study|Lost to Follow-up|25|||
148868435|NCT03007745|536997119|FG000|Overall Study|Unable to login to website|17|||
148868436|NCT03007745|536997120|FG001|Overall Study|Unable to login to website|4|||
148868437|NCT03921554|536997121|FG000|Overall Study|Adverse Event|2|||
148868438|NCT03921554|536997121|FG000|Overall Study|Withdrawal by Subject|1|||
148868439|NCT03921554|536997121|FG000|Overall Study|Death|3|||
148868440|NCT01300351|536997123|FG000|Overall Study|Did not receive treatment|2|||
148868441|NCT01300351|536997124|FG001|Overall Study|Did not receive treatment|0|||
148868442|NCT01300351|536997123|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
148868443|NCT01300351|536997124|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
148868444|NCT01300351|536997123|FG000|Overall Study|Lost to Follow-up|0|||
148868445|NCT01300351|536997124|FG001|Overall Study|Lost to Follow-up|1|||
148868446|NCT01300351|536997123|FG000|Overall Study|Adverse Event|0|||
148868447|NCT01300351|536997124|FG001|Overall Study|Adverse Event|4|||
148868448|NCT01300351|536997123|FG000|Overall Study|Withdrawal by Subject|7|||
148868449|NCT01300351|536997124|FG001|Overall Study|Withdrawal by Subject|10|||
148868450|NCT00431951|536997126|FG000|Overall Study|Inability to follow study procedures|1|||
148868451|NCT00431951|536997127|FG001|Overall Study|Inability to follow study procedures|0|||
148868452|NCT00431951|536997128|FG002|Overall Study|Inability to follow study procedures|1|||
148868453|NCT00431951|536997129|FG003|Overall Study|Inability to follow study procedures|2|||
148868454|NCT00431951|536997126|FG000|Overall Study|Lost to Follow-up|0|||
148868455|NCT00431951|536997127|FG001|Overall Study|Lost to Follow-up|1|||
148868456|NCT00431951|536997128|FG002|Overall Study|Lost to Follow-up|0|||
148868457|NCT00431951|536997129|FG003|Overall Study|Lost to Follow-up|0|||
148868458|NCT00431951|536997126|FG000|Overall Study|Withdrawal by Subject|0|||
148868459|NCT00431951|536997127|FG001|Overall Study|Withdrawal by Subject|1|||
148868460|NCT00431951|536997128|FG002|Overall Study|Withdrawal by Subject|0|||
148868461|NCT00431951|536997129|FG003|Overall Study|Withdrawal by Subject|0|||
148868462|NCT00431951|536997126|FG000|Overall Study|Adverse Event|0|||
148868463|NCT00431951|536997127|FG001|Overall Study|Adverse Event|0|||
148868464|NCT00431951|536997128|FG002|Overall Study|Adverse Event|1|||
148868465|NCT00431951|536997129|FG003|Overall Study|Adverse Event|0|||
148868466|NCT05824936|536997140|FG000|Overall Study|Lost to Follow-up|1|||
148868467|NCT00096018|536997141|FG000|Overall Study|Became Ineligible (not treated)|0|||
148868468|NCT00096018|536997142|FG001|Overall Study|Became Ineligible (not treated)|3|||
148868469|NCT00096018|536997141|FG000|Overall Study|Miscellaneous (not treated)|0|||
148868470|NCT00096018|536997142|FG001|Overall Study|Miscellaneous (not treated)|2|||
148868471|NCT00096018|536997141|FG000|Overall Study|Adverse Event|0|||
148868472|NCT00096018|536997142|FG001|Overall Study|Adverse Event|5|||
148868473|NCT00096018|536997141|FG000|Overall Study|Death|0|||
148868474|NCT00096018|536997142|FG001|Overall Study|Death|1|||
148868475|NCT00096018|536997141|FG000|Overall Study|Withdrawal by Subject|0|||
148868476|NCT00096018|536997142|FG001|Overall Study|Withdrawal by Subject|2|||
148868477|NCT00096018|536997141|FG000|Overall Study|Miscellaneous|2|||
148868478|NCT00096018|536997142|FG001|Overall Study|Miscellaneous|1|||
148868479|NCT00673881|536997143|FG000|Overall Study|Withdrawal by Subject|1|||
148868480|NCT03968159|536997147|FG000|Overall Study|Adverse Event|4|||
148868481|NCT03968159|536997148|FG001|Overall Study|Adverse Event|4|||
148868482|NCT03968159|536997147|FG000|Overall Study|Lost to Follow-up|1|||
148868483|NCT03968159|536997148|FG001|Overall Study|Lost to Follow-up|1|||
148868484|NCT03968159|536997147|FG000|Overall Study|Use of prohibited medication|0|||
148868485|NCT03968159|536997148|FG001|Overall Study|Use of prohibited medication|1|||
148868486|NCT03968159|536997147|FG000|Overall Study|Protocol Violation|2|||
148868487|NCT03968159|536997148|FG001|Overall Study|Protocol Violation|2|||
148868488|NCT03968159|536997147|FG000|Overall Study|Withdrawal by Subject|4|||
148868489|NCT03968159|536997148|FG001|Overall Study|Withdrawal by Subject|6|||
148868490|NCT03968159|536997147|FG000|Overall Study|Lack of Efficacy|0|||
148868491|NCT03968159|536997148|FG001|Overall Study|Lack of Efficacy|1|||
148868492|NCT03968159|536997147|FG000|Overall Study|Not further specified|2|||
148868493|NCT03968159|536997148|FG001|Overall Study|Not further specified|0|||
148868494|NCT01299571|536997151|FG000|Overall Study|Protocol Violation|107|||
148868495|NCT00708734|536997154|FG000|Overall Study|scheduling conflict|2|||
148868496|NCT00708734|536997154|FG000|Overall Study|moved|1|||
148868497|NCT00708734|536997154|FG000|Overall Study|leg injury|1|||
148868498|NCT00708734|536997154|FG000|Overall Study|knee replacement|1|||
148868499|NCT00708734|536997154|FG000|Overall Study|vertigo|1|||
148868500|NCT00708734|536997154|FG000|Overall Study|leg fracture|1|||
148868501|NCT02634606|536997158|FG000|Overall Study|unable to obtain the drug at start|13|||
148868502|NCT05432167|536997163|FG000|Overall Study|Adverse Event|0|||
148868503|NCT05432167|536997164|FG001|Overall Study|Adverse Event|2|||
148868504|NCT05432167|536997165|FG002|Overall Study|Adverse Event|1|||
148868505|NCT05432167|536997163|FG000|Overall Study|Lost to Follow-up|3|||
148868506|NCT05432167|536997164|FG001|Overall Study|Lost to Follow-up|3|||
148868507|NCT05432167|536997165|FG002|Overall Study|Lost to Follow-up|2|||
148868508|NCT05432167|536997163|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
148868509|NCT05432167|536997164|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
148868510|NCT05432167|536997165|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
148868511|NCT05432167|536997163|FG000|Overall Study|Physician Decision|1|||
148868512|NCT05432167|536997164|FG001|Overall Study|Physician Decision|0|||
148868513|NCT05432167|536997165|FG002|Overall Study|Physician Decision|0|||
148868514|NCT05432167|536997163|FG000|Overall Study|Withdrawal by Subject|7|||
148868515|NCT05432167|536997164|FG001|Overall Study|Withdrawal by Subject|4|||
149000183|NCT03053050|537475684|FG001|Randomized Phase|Withdrew Consent|8|||
149000184|NCT03053050|537475685|FG002|Randomized Phase|Withdrew Consent|9|||
149000185|NCT03053050|537475686|FG003|Randomized Phase|Withdrew Consent|0|||
149000186|NCT03053050|537475683|FG000|Randomized Phase|Investigator's Discretion|6|||
148868516|NCT05432167|536997165|FG002|Overall Study|Withdrawal by Subject|11|||
148868517|NCT05432167|536997163|FG000|Overall Study|Other|0|||
148868518|NCT05432167|536997164|FG001|Overall Study|Other|0|||
148868519|NCT05432167|536997165|FG002|Overall Study|Other|1|||
148868520|NCT01267175|536997166|FG000|Overall Study|Withdrawal by Subject|1|||
148868521|NCT01267175|536997166|FG000|Overall Study|Lost to Follow-up|1|||
148868522|NCT00895661|536997167|FG000|Overall Study|Death|1|||
148868523|NCT00895661|536997167|FG000|Overall Study|reason unknown|2|||
148868524|NCT02006069|536997168|FG000|Overall Study|MPP other programming|239|||
148868525|NCT02006069|536997169|FG001|Overall Study|MPP other programming|0|||
148868526|NCT02006069|536997168|FG000|Overall Study|RV only pacing|0|||
149031927|NCT01878890|537593691|FG001|Overall Study|Protocol Violation|1|||
148868527|NCT02006069|536997169|FG001|Overall Study|RV only pacing|3|||
148868528|NCT02553538|536997172|FG000|Overall Study|Could Not Reach by Telephone|133|||
149031928|NCT01878890|537593692|FG002|Overall Study|Protocol Violation|0|||
149031929|NCT01878890|537593693|FG003|Overall Study|Protocol Violation|0|||
149031930|NCT02701361|537593698|FG000|Overall Study|Lost to Follow-up|5|||
149031931|NCT02701361|537593699|FG001|Overall Study|Lost to Follow-up|2|||
149031932|NCT02701361|537593700|FG002|Overall Study|Lost to Follow-up|1|||
149031933|NCT02701361|537593698|FG000|Overall Study|Withdrawal by Subject|4|||
149031934|NCT02701361|537593699|FG001|Overall Study|Withdrawal by Subject|0|||
149031935|NCT02701361|537593700|FG002|Overall Study|Withdrawal by Subject|0|||
149031936|NCT02701361|537593698|FG000|Overall Study|timed out in rehab center|0|||
149031937|NCT02701361|537593699|FG001|Overall Study|timed out in rehab center|1|||
149031938|NCT02701361|537593700|FG002|Overall Study|timed out in rehab center|0|||
149031939|NCT02701361|537593698|FG000|Overall Study|incarceration|0|||
149031940|NCT02701361|537593699|FG001|Overall Study|incarceration|0|||
149031941|NCT02701361|537593700|FG002|Overall Study|incarceration|1|||
149031942|NCT02595398|537593702|FG000|Overall Study|Non-compliance|1|||
149031943|NCT02595398|537593703|FG001|Overall Study|Non-compliance|0|||
149031944|NCT02595398|537593702|FG000|Overall Study|Withdrawal by Subject|2|||
149031945|NCT02595398|537593703|FG001|Overall Study|Withdrawal by Subject|1|||
149031946|NCT02595398|537593702|FG000|Overall Study|Lost to Follow-up|1|||
149031947|NCT02595398|537593703|FG001|Overall Study|Lost to Follow-up|0|||
149031948|NCT03601507|537593704|FG000|Overall Study|Adverse Event|1|||
149031949|NCT01664104|537593705|FG000|Overall Study|Adverse Event|6|||
149031950|NCT01664104|537593705|FG000|Overall Study|Lack of Efficacy|2|||
149031951|NCT01664104|537593705|FG000|Overall Study|Withdrawal by Subject|1|||
149031952|NCT01664104|537593705|FG000|Overall Study|Lost to Follow-up|4|||
149031953|NCT01664104|537593705|FG000|Overall Study|Other|1|||
149031954|NCT01664104|537593705|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
149031955|NCT01331824|537595907|FG000|Overall Study|Adverse Event|2|||
149031956|NCT01331824|537595907|FG000|Overall Study|Death|1|||
149031957|NCT01331824|537595907|FG000|Overall Study|Disease Progression|9|||
149031958|NCT01331824|537595907|FG000|Overall Study|Withdrawal by Subject|1|||
149031959|NCT01091454|537595908|FG000|Overall Study|Ineligible|1|||
149031960|NCT05298111|537595911|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
149031961|NCT05298111|537595912|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
149031962|NCT02380742|537595913|FG000|Overall Study|Withdrawal by Subject|1|||
149031963|NCT02380742|537595914|FG001|Overall Study|Withdrawal by Subject|0|||
149031964|NCT03518112|537595915|FG000|Overall Study|Withdrawal by Subject|1|||
149031965|NCT02263508|537595918|FG000|Overall Study|Withdrawal by Subject|1|||
149031966|NCT02263508|537595919|FG001|Overall Study|Withdrawal by Subject|23|||
149031967|NCT02263508|537595920|FG002|Overall Study|Withdrawal by Subject|17|||
149031968|NCT02263508|537595918|FG000|Overall Study|Sponsor Decision|12|||
149031969|NCT02263508|537595919|FG001|Overall Study|Sponsor Decision|165|||
149031970|NCT02263508|537595920|FG002|Overall Study|Sponsor Decision|182|||
149031971|NCT02263508|537595918|FG000|Overall Study|Lost to Follow-up|2|||
149031972|NCT02263508|537595919|FG001|Overall Study|Lost to Follow-up|7|||
149031973|NCT02263508|537595920|FG002|Overall Study|Lost to Follow-up|7|||
149031974|NCT02263508|537595918|FG000|Overall Study|Death|6|||
149031975|NCT02263508|537595919|FG001|Overall Study|Death|151|||
149031976|NCT02263508|537595920|FG002|Overall Study|Death|140|||
149031977|NCT01280591|537595921|FG000|Overall Study|Withdrawal by Subject|0|||
149031978|NCT01280591|537595922|FG001|Overall Study|Withdrawal by Subject|0|||
149031979|NCT01280591|537595923|FG002|Overall Study|Withdrawal by Subject|0|||
149031980|NCT01280591|537595924|FG003|Overall Study|Withdrawal by Subject|2|||
149031981|NCT01280591|537595921|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
149031982|NCT01280591|537595922|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
149031983|NCT01280591|537595923|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
149031984|NCT01280591|537595924|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
149031985|NCT03357341|537595925|FG000|Overall Study|Withdrawal by Subject|3|||
149031986|NCT03357341|537595926|FG001|Overall Study|Withdrawal by Subject|6|||
149031987|NCT03357341|537595925|FG000|Overall Study|Lost to Follow-up|4|||
149031988|NCT03357341|537595926|FG001|Overall Study|Lost to Follow-up|5|||
149031989|NCT03357341|537595925|FG000|Overall Study|Death|0|||
149031990|NCT03357341|537595926|FG001|Overall Study|Death|1|||
149031991|NCT00930813|537595927|FG000|Overall Study|Death|4|||
149031992|NCT00930813|537595928|FG001|Overall Study|Death|5|||
149031993|NCT00930813|537595927|FG000|Overall Study|Withdrawal by Subject|2|||
149031994|NCT00930813|537595928|FG001|Overall Study|Withdrawal by Subject|5|||
149031995|NCT00930813|537595927|FG000|Overall Study|Lost to Follow-up|2|||
149031996|NCT00930813|537595928|FG001|Overall Study|Lost to Follow-up|4|||
149031997|NCT05790408|537595929|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
149031998|NCT01048788|537595930|FG000|Overall Study|Adverse Event|5|||
149031999|NCT01048788|537595931|FG001|Overall Study|Adverse Event|1|||
149032000|NCT01048788|537595932|FG002|Overall Study|Adverse Event|1|||
149032001|NCT01048788|537595930|FG000|Overall Study|Lack of Efficacy|0|||
149032002|NCT01048788|537595931|FG001|Overall Study|Lack of Efficacy|0|||
149032003|NCT01048788|537595932|FG002|Overall Study|Lack of Efficacy|1|||
149032004|NCT01048788|537595930|FG000|Overall Study|Withdrawal by Subject|0|||
149032005|NCT01048788|537595931|FG001|Overall Study|Withdrawal by Subject|1|||
148868529|NCT02553538|536997173|FG001|Overall Study|Could Not Reach by Telephone|0|||
148868530|NCT02553538|536997172|FG000|Overall Study|Died or Left Network|54|||
148868531|NCT02553538|536997173|FG001|Overall Study|Died or Left Network|56|||
148868532|NCT02276547|536997174|FG000|Overall Study|Death|2|||
148868533|NCT02276547|536997174|FG000|Overall Study|Explant|2|||
148868534|NCT00106691|536997175|FG000|Overall Study|Adverse Event|60|||
148868535|NCT00106691|536997176|FG001|Overall Study|Adverse Event|64|||
148868536|NCT00106691|536997175|FG000|Overall Study|Lost to Follow-up|23|||
148868537|NCT00106691|536997176|FG001|Overall Study|Lost to Follow-up|18|||
148868538|NCT00106691|536997175|FG000|Overall Study|Physician Decision|18|||
148868539|NCT00106691|536997176|FG001|Overall Study|Physician Decision|21|||
148868540|NCT00106691|536997175|FG000|Overall Study|Protocol Violation|13|||
148868541|NCT00106691|536997176|FG001|Overall Study|Protocol Violation|18|||
148868542|NCT00106691|536997175|FG000|Overall Study|Withdrawal by Subject|75|||
148868543|NCT00106691|536997176|FG001|Overall Study|Withdrawal by Subject|70|||
148868544|NCT00106691|536997175|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
148868545|NCT00106691|536997176|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
148868546|NCT00106691|536997175|FG000|Overall Study|QTc>480|3|||
148868547|NCT00106691|536997176|FG001|Overall Study|QTc>480|1|||
148868548|NCT00106691|536997175|FG000|Overall Study|mililtary deployment|2|||
148868549|NCT00106691|536997176|FG001|Overall Study|mililtary deployment|0|||
148868550|NCT00106691|536997175|FG000|Overall Study|Study Site Closing/PI Moved|1|||
148868551|NCT00106691|536997176|FG001|Overall Study|Study Site Closing/PI Moved|2|||
148868552|NCT00106691|536997175|FG000|Overall Study|Cardiologist recommendation|1|||
148868553|NCT00106691|536997176|FG001|Overall Study|Cardiologist recommendation|0|||
148868554|NCT00106691|536997175|FG000|Overall Study|Pt. moved to another state|1|||
148868555|NCT00106691|536997176|FG001|Overall Study|Pt. moved to another state|0|||
148868556|NCT00106691|536997175|FG000|Overall Study|Taking exclusionary avodart|1|||
148868557|NCT00106691|536997176|FG001|Overall Study|Taking exclusionary avodart|0|||
148868558|NCT00106691|536997175|FG000|Overall Study|Not able to discontinue plavix|0|||
148868559|NCT00106691|536997176|FG001|Overall Study|Not able to discontinue plavix|1|||
148868560|NCT01754194|536997177|FG000|Overall Study|Lost to Follow-up|39|||
148868561|NCT01754194|536997178|FG001|Overall Study|Lost to Follow-up|14|||
148868562|NCT01754194|536997177|FG000|Overall Study|Withdrawal by Subject|4|||
148868563|NCT01754194|536997178|FG001|Overall Study|Withdrawal by Subject|5|||
148868564|NCT01754194|536997177|FG000|Overall Study|Other|9|||
148868565|NCT01754194|536997178|FG001|Overall Study|Other|8|||
148868566|NCT00530920|536997179|FG000|Overall Study|Randomized but not treated|0|||
148868567|NCT00530920|536997180|FG001|Overall Study|Randomized but not treated|2|||
148868568|NCT00530920|536997181|FG002|Overall Study|Randomized but not treated|0|||
148868569|NCT00530920|536997179|FG000|Overall Study|Adverse Event|0|||
148868570|NCT00530920|536997180|FG001|Overall Study|Adverse Event|0|||
148868571|NCT00530920|536997181|FG002|Overall Study|Adverse Event|3|||
148868572|NCT00530920|536997179|FG000|Overall Study|Withdrawal by Subject|0|||
148868573|NCT00530920|536997180|FG001|Overall Study|Withdrawal by Subject|0|||
148868574|NCT00530920|536997181|FG002|Overall Study|Withdrawal by Subject|1|||
148868575|NCT00791557|536997182|FG000|Overall Study|Adverse Event|1|||
148868576|NCT02066129|536997184|FG000|Overall Study|Lost to Follow-up|13|||
148868577|NCT02066129|536997185|FG001|Overall Study|Lost to Follow-up|12|||
148868578|NCT02066129|536997184|FG000|Overall Study|Withdrawal by Subject|7|||
148868579|NCT02066129|536997185|FG001|Overall Study|Withdrawal by Subject|10|||
148868580|NCT02066129|536997184|FG000|Overall Study|Lack of Efficacy|8|||
148868581|NCT02066129|536997185|FG001|Overall Study|Lack of Efficacy|10|||
148868582|NCT02066129|536997184|FG000|Overall Study|Physician Decision|1|||
148868583|NCT02066129|536997185|FG001|Overall Study|Physician Decision|1|||
148868584|NCT02392403|536997186|FG000|Overall Study|Adverse Event|1|||
148868585|NCT02392403|536997186|FG000|Overall Study|Death|1|||
148868586|NCT02392403|536997186|FG000|Overall Study|Withdrawal by Subject|1|||
148868587|NCT02322190|536997190|FG000|Overall Study|Death on study|1|||
148868588|NCT02322190|536997191|FG001|Overall Study|Death on study|0|||
148868589|NCT00316888|536997193|FG000|Overall Study|Adverse Event|4|||
148868590|NCT00316888|536997194|FG001|Overall Study|Adverse Event|5|||
148868591|NCT00316888|536997193|FG000|Overall Study|Withdrawal by Subject|2|||
148868592|NCT00316888|536997194|FG001|Overall Study|Withdrawal by Subject|2|||
148868593|NCT00316888|536997193|FG000|Overall Study|Not start protocol therapy|0|||
148868594|NCT00316888|536997194|FG001|Overall Study|Not start protocol therapy|1|||
148868595|NCT01439126|536997198|FG000|Overall Study|Adverse Event|2|||
148868596|NCT01439126|536997199|FG001|Overall Study|Adverse Event|0|||
148868597|NCT01439126|536997198|FG000|Overall Study|Withdrawal by Subject|5|||
148868598|NCT01439126|536997199|FG001|Overall Study|Withdrawal by Subject|21|||
148868599|NCT01439126|536997198|FG000|Overall Study|Protocol Violation|6|||
148868600|NCT01439126|536997199|FG001|Overall Study|Protocol Violation|4|||
148868601|NCT01439126|536997198|FG000|Overall Study|Lost to Follow-up|6|||
148868602|NCT01439126|536997199|FG001|Overall Study|Lost to Follow-up|3|||
148868603|NCT01439126|536997198|FG000|Overall Study|Other-Use of prohibited treatment|0|||
148868604|NCT01439126|536997199|FG001|Overall Study|Other-Use of prohibited treatment|2|||
148868605|NCT01439126|536997198|FG000|Overall Study|Other-Miscellaneous|12|||
148868606|NCT01439126|536997199|FG001|Overall Study|Other-Miscellaneous|12|||
149032006|NCT01048788|537595932|FG002|Overall Study|Withdrawal by Subject|0|||
149032007|NCT01131494|537595933|FG000|Overall Study|Withdrawal by Subject|2|||
149032008|NCT02145182|537595935|FG000|Overall Study|Adverse Event|4|||
149032009|NCT02145182|537595936|FG001|Overall Study|Adverse Event|1|||
149032010|NCT02145182|537595935|FG000|Overall Study|Death|7|||
149032011|NCT02145182|537595936|FG001|Overall Study|Death|7|||
149032012|NCT02145182|537595935|FG000|Overall Study|Lost to Follow-up|2|||
149032013|NCT02145182|537595936|FG001|Overall Study|Lost to Follow-up|2|||
149032014|NCT02145182|537595935|FG000|Overall Study|Pre-transplant Withdrawal|0|||
149032015|NCT02145182|537595936|FG001|Overall Study|Pre-transplant Withdrawal|2|||
149032016|NCT02145182|537595935|FG000|Overall Study|Withdrawal by Subject|5|||
149032017|NCT02145182|537595936|FG001|Overall Study|Withdrawal by Subject|4|||
149032018|NCT00588666|537595937|FG000|Overall Study|Adverse Event|4|||
149032019|NCT01233050|537595938|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
149032020|NCT01233050|537595939|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
149032021|NCT03999554|537595940|FG000|Overall Study|Lost to Follow-up|4|||
149032022|NCT03999554|537595941|FG001|Overall Study|Lost to Follow-up|5|||
149032023|NCT03999554|537595942|FG002|Overall Study|Lost to Follow-up|4|||
149032024|NCT03999554|537595943|FG003|Overall Study|Lost to Follow-up|5|||
149032025|NCT03999554|537595944|FG004|Overall Study|Lost to Follow-up|8|||
149032026|NCT03999554|537595940|FG000|Overall Study|Protocol Violation|0|||
149032027|NCT03999554|537595941|FG001|Overall Study|Protocol Violation|0|||
149032028|NCT03999554|537595942|FG002|Overall Study|Protocol Violation|5|||
149032029|NCT03999554|537595943|FG003|Overall Study|Protocol Violation|0|||
149032030|NCT03999554|537595944|FG004|Overall Study|Protocol Violation|0|||
149032031|NCT03999554|537595940|FG000|Overall Study|Pregnancy|0|||
149032032|NCT03999554|537595941|FG001|Overall Study|Pregnancy|0|||
149032033|NCT03999554|537595942|FG002|Overall Study|Pregnancy|1|||
149032034|NCT03999554|537595943|FG003|Overall Study|Pregnancy|0|||
149032035|NCT03999554|537595944|FG004|Overall Study|Pregnancy|0|||
149032036|NCT03999554|537595940|FG000|Overall Study|Withdrawal by Subject|2|||
149032037|NCT03999554|537595941|FG001|Overall Study|Withdrawal by Subject|2|||
149032038|NCT03999554|537595942|FG002|Overall Study|Withdrawal by Subject|2|||
149032039|NCT03999554|537595943|FG003|Overall Study|Withdrawal by Subject|1|||
149032040|NCT03999554|537595944|FG004|Overall Study|Withdrawal by Subject|1|||
149032041|NCT03999554|537595940|FG000|Overall Study|failure to comply with protocol requirements|0|||
149032042|NCT03999554|537595941|FG001|Overall Study|failure to comply with protocol requirements|0|||
148868607|NCT03242018|536997200|FG000|Overall Study|Adverse Event|7|||
148868608|NCT03242018|536997201|FG001|Overall Study|Adverse Event|7|||
148868609|NCT03242018|536997202|FG002|Overall Study|Adverse Event|6|||
148868610|NCT03242018|536997200|FG000|Overall Study|Lost to Follow-up|2|||
148868611|NCT03242018|536997201|FG001|Overall Study|Lost to Follow-up|2|||
148868612|NCT03242018|536997202|FG002|Overall Study|Lost to Follow-up|2|||
148868613|NCT03242018|536997200|FG000|Overall Study|At the Participant's Own Request|5|||
148868614|NCT03242018|536997201|FG001|Overall Study|At the Participant's Own Request|1|||
148868615|NCT03242018|536997202|FG002|Overall Study|At the Participant's Own Request|4|||
148868616|NCT03242018|536997200|FG000|Overall Study|Reason Not Specified|3|||
148868617|NCT03242018|536997201|FG001|Overall Study|Reason Not Specified|4|||
148868618|NCT03242018|536997202|FG002|Overall Study|Reason Not Specified|1|||
148868619|NCT03242018|536997200|FG000|Overall Study|Study Terminated by Sponsor|1|||
148868620|NCT03242018|536997201|FG001|Overall Study|Study Terminated by Sponsor|0|||
148868621|NCT03242018|536997202|FG002|Overall Study|Study Terminated by Sponsor|1|||
148868622|NCT00687609|536997203|FG000|Overall Study|Physician Decision|1|||
148868623|NCT00687609|536997203|FG000|Overall Study|Withdrawal by Subject|2|||
148868624|NCT02635347|536997204|FG000|Overall Study|Failed screening|20|||
148868625|NCT02635347|536997205|FG001|Overall Study|Failed screening|7|||
148868626|NCT01617447|536997207|FG000|Overall Study|Adverse Event|0|||
148868627|NCT01617447|536997208|FG001|Overall Study|Adverse Event|1|||
148868628|NCT01617447|536997207|FG000|Overall Study|Physician Decision|0|||
148868629|NCT01617447|536997208|FG001|Overall Study|Physician Decision|2|||
148868630|NCT00576472|536997209|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868631|NCT00576472|536997210|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868632|NCT00576472|536997211|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868633|NCT00576472|536997212|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
149032043|NCT03999554|537595942|FG002|Overall Study|failure to comply with protocol requirements|0|||
148868634|NCT00576472|536997213|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868635|NCT00576472|536997214|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868636|NCT00576472|536997215|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868637|NCT00576472|536997216|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
149032044|NCT03999554|537595943|FG003|Overall Study|failure to comply with protocol requirements|1|||
149032045|NCT03999554|537595944|FG004|Overall Study|failure to comply with protocol requirements|0|||
149032046|NCT00703911|537595945|FG000|Overall Study|Death|1|||
149032047|NCT00703911|537595945|FG000|Overall Study|Physician Decision|6|||
149032048|NCT00703911|537595945|FG000|Overall Study|Lost to Follow-up|1|||
149032049|NCT00703911|537595945|FG000|Overall Study|Withdrawal by Subject|2|||
149032050|NCT02082158|537595946|FG000|Overall Study|Withdrawal by Subject|0|||
148868638|NCT00576472|536997217|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868639|NCT00576472|536997218|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868640|NCT00576472|536997219|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868641|NCT00576472|536997220|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868642|NCT00576472|536997221|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868643|NCT00576472|536997222|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868644|NCT00576472|536997223|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
148868645|NCT00576472|536997209|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
148868646|NCT00576472|536997210|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
148868647|NCT00576472|536997211|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
148868648|NCT00576472|536997212|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
148868649|NCT00576472|536997213|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
148868650|NCT00576472|536997214|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
148868651|NCT00576472|536997215|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
148868652|NCT00576472|536997216|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
148868653|NCT00576472|536997217|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
148868654|NCT00576472|536997218|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
148868655|NCT00576472|536997219|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
148868656|NCT00576472|536997220|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
148868657|NCT00576472|536997221|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
148868658|NCT00576472|536997222|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
148868659|NCT00576472|536997223|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
148868660|NCT00576472|536997209|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868661|NCT00576472|536997210|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868662|NCT00576472|536997211|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868663|NCT00576472|536997212|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
148868664|NCT00576472|536997213|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868665|NCT00576472|536997214|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868666|NCT00576472|536997215|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868667|NCT00576472|536997216|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868668|NCT00576472|536997217|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868669|NCT00576472|536997218|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868670|NCT00576472|536997219|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868671|NCT00576472|536997220|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868672|NCT00576472|536997221|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868673|NCT00576472|536997222|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868674|NCT00576472|536997223|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
148868675|NCT00576472|536997209|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
148868676|NCT00576472|536997210|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
148868677|NCT00576472|536997211|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
148868678|NCT00576472|536997212|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
148868679|NCT00576472|536997213|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
148868680|NCT00576472|536997214|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
148868681|NCT00576472|536997215|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
148868682|NCT00576472|536997216|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
148868683|NCT00576472|536997217|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
148868684|NCT00576472|536997218|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
148868685|NCT00576472|536997219|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
148868686|NCT00576472|536997220|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
148868687|NCT00576472|536997221|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
148868688|NCT00576472|536997222|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
149000187|NCT03053050|537475684|FG001|Randomized Phase|Investigator's Discretion|6|||
149000188|NCT03053050|537475685|FG002|Randomized Phase|Investigator's Discretion|3|||
149000189|NCT03053050|537475686|FG003|Randomized Phase|Investigator's Discretion|0|||
149000190|NCT03053050|537475683|FG000|Randomized Phase|Lost to Follow-up|5|||
148868689|NCT00576472|536997223|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
148868690|NCT00576472|536997209|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868691|NCT00576472|536997210|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868692|NCT00576472|536997211|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868693|NCT00576472|536997212|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
148868694|NCT00576472|536997213|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868695|NCT00576472|536997214|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868696|NCT00576472|536997215|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868697|NCT00576472|536997216|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868698|NCT00576472|536997217|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868699|NCT00576472|536997218|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868700|NCT00576472|536997219|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868701|NCT00576472|536997220|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868702|NCT00576472|536997221|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868703|NCT00576472|536997222|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868704|NCT00576472|536997223|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
148868705|NCT00576472|536997209|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868706|NCT00576472|536997210|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868707|NCT00576472|536997211|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868708|NCT00576472|536997212|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868709|NCT00576472|536997213|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868710|NCT00576472|536997214|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868711|NCT00576472|536997215|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
148868712|NCT00576472|536997216|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868713|NCT00576472|536997217|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868714|NCT00576472|536997218|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868715|NCT00576472|536997219|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868716|NCT00576472|536997220|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868717|NCT00576472|536997221|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868718|NCT00576472|536997222|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868719|NCT00576472|536997223|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
148868720|NCT00576472|536997209|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
148868721|NCT00576472|536997210|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
148868722|NCT00576472|536997211|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
148868723|NCT00576472|536997212|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
148868724|NCT00576472|536997213|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
148868725|NCT00576472|536997214|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
148868726|NCT00576472|536997215|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
148868727|NCT00576472|536997216|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
148868728|NCT00576472|536997217|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
148868729|NCT00576472|536997218|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
148868730|NCT00576472|536997219|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
148868731|NCT00576472|536997220|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
148868732|NCT00576472|536997221|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
148868733|NCT00576472|536997222|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
148868734|NCT00576472|536997223|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
148868735|NCT00576472|536997209|FG000|MPH Cross Over Phase|Physician Decision|0|||
148868736|NCT00576472|536997210|FG001|MPH Cross Over Phase|Physician Decision|0|||
148868737|NCT00576472|536997211|FG002|MPH Cross Over Phase|Physician Decision|0|||
148868738|NCT00576472|536997212|FG003|MPH Cross Over Phase|Physician Decision|0|||
148868739|NCT00576472|536997213|FG004|MPH Cross Over Phase|Physician Decision|0|||
148868740|NCT00576472|536997214|FG005|MPH Cross Over Phase|Physician Decision|0|||
148868741|NCT00576472|536997215|FG006|MPH Cross Over Phase|Physician Decision|4|||
148868742|NCT00576472|536997216|FG007|MPH Cross Over Phase|Physician Decision|0|||
148868743|NCT00576472|536997217|FG008|MPH Cross Over Phase|Physician Decision|0|||
148868744|NCT00576472|536997218|FG009|MPH Cross Over Phase|Physician Decision|0|||
148868745|NCT00576472|536997219|FG010|MPH Cross Over Phase|Physician Decision|0|||
148868746|NCT00576472|536997220|FG011|MPH Cross Over Phase|Physician Decision|0|||
148868747|NCT00576472|536997221|FG012|MPH Cross Over Phase|Physician Decision|0|||
148868748|NCT00576472|536997222|FG013|MPH Cross Over Phase|Physician Decision|0|||
148868749|NCT00576472|536997223|FG014|MPH Cross Over Phase|Physician Decision|0|||
148868750|NCT00576472|536997209|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868751|NCT00576472|536997210|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868752|NCT00576472|536997211|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868753|NCT00576472|536997212|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868754|NCT00576472|536997213|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868755|NCT00576472|536997214|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868756|NCT00576472|536997215|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868757|NCT00576472|536997216|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868758|NCT00576472|536997217|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
148868759|NCT00576472|536997218|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868760|NCT00576472|536997219|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
148868761|NCT00576472|536997220|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
148868762|NCT00576472|536997221|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868763|NCT00576472|536997222|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868764|NCT00576472|536997223|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
148868765|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
149032051|NCT02082158|537595947|FG001|Overall Study|Withdrawal by Subject|0|||
148868766|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868767|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868768|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868769|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868770|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868771|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
149032052|NCT02082158|537595948|FG002|Overall Study|Withdrawal by Subject|0|||
149032053|NCT02082158|537595949|FG003|Overall Study|Withdrawal by Subject|0|||
148868772|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868773|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868774|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868775|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868776|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868777|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868778|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
148868779|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
148868780|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
148868781|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
148868782|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
148868783|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
148868784|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
148868785|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
148868786|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
148868787|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
148868788|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
148868789|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
148868790|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
148868791|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
148868792|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
148868793|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
148868794|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
148868795|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
148868796|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
148868797|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
148868798|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
148868799|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
148868800|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
148868801|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
148868802|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
148868803|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
148868804|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
148868805|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
148868806|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
148868807|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
148868808|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
148868809|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
148868810|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Side effects|0|||
148868811|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Side effects|0|||
148868812|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Side effects|0|||
148868813|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Side effects|0|||
148868814|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Side effects|0|||
148868815|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Side effects|0|||
148868816|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Side effects|0|||
148868817|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Side effects|0|||
148868818|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Side effects|0|||
148868819|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Side effects|0|||
148868820|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Side effects|0|||
148868821|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Side effects|0|||
148868822|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Side effects|0|||
148868823|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Side effects|0|||
148868824|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Side effects|8|||
148868825|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868826|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868827|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868828|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868829|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868830|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868831|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868832|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868833|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868834|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868835|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868836|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868837|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868838|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
148868839|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
148868840|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
148868841|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
148868842|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
148868843|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
148868844|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
148868845|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
148868846|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
148868847|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
148868848|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
148868849|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
148868850|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
148868851|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
148868852|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
148868853|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
148868854|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
148868855|NCT00576472|536997209|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868856|NCT00576472|536997210|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868857|NCT00576472|536997211|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868858|NCT00576472|536997212|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868859|NCT00576472|536997213|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868860|NCT00576472|536997214|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868861|NCT00576472|536997215|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868862|NCT00576472|536997216|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868863|NCT00576472|536997217|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868864|NCT00576472|536997218|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868865|NCT00576472|536997219|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868866|NCT00576472|536997220|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868867|NCT00576472|536997221|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868868|NCT00576472|536997222|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
148868869|NCT00576472|536997223|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
148868870|NCT00780273|536997224|FG000|Overall Study|Death|1|||
148868871|NCT00780273|536997224|FG000|Overall Study|Lost to Follow-up|1|||
148868872|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
148868873|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
148868874|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
148868875|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
148868876|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
148868877|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
148868878|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
148868879|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
148868880|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
148868881|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
148868882|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
148868883|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
148868884|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
148868885|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
148868886|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
148868887|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
148868888|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
148868889|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
148868890|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
148868891|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
148868892|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
148868893|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
148868894|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
148868895|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
148868896|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
148868897|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
148868898|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
148868899|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
148868900|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
148868901|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
148868902|NCT00121641|536997225|FG000|24-week Short-term Treatment Period|Other Reason|1|||
148868903|NCT00121641|536997226|FG001|24-week Short-term Treatment Period|Other Reason|0|||
148868904|NCT00121641|536997227|FG002|24-week Short-term Treatment Period|Other Reason|0|||
148868905|NCT00121641|536997228|FG003|24-week Short-term Treatment Period|Other Reason|0|||
148868906|NCT00121641|536997229|FG004|24-week Short-term Treatment Period|Other Reason|0|||
148868907|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
148868908|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
148868909|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
148868910|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
148868911|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
148868912|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
148868913|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
148868914|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
148868915|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
148868916|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
148868917|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
148868918|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
148868919|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
148868920|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
148868921|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
148868922|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
148868923|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
148868924|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
148868925|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
148868926|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
148868927|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
148868928|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
148868929|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
148868930|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
148868931|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
148868932|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
148868933|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
148868934|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
148868935|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
148868936|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
148868937|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
148868938|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
148868939|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
148868940|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
148868941|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
148868942|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
148868943|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
148868944|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
148868945|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
148868946|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
148868947|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Death|0|||
148868948|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Death|0|||
148868949|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Death|0|||
148868950|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Death|1|||
148868951|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Death|0|||
148868952|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Missing|0|||
148868953|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Missing|0|||
148868954|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Missing|1|||
148868955|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Missing|0|||
148868956|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Missing|0|||
148868957|NCT00121641|536997225|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
148868958|NCT00121641|536997226|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
148868959|NCT00121641|536997227|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
148868960|NCT00121641|536997228|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
148868961|NCT00121641|536997229|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
148868962|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
148868963|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
148868964|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
149032054|NCT02082158|537595950|FG004|Overall Study|Withdrawal by Subject|1|||
149032055|NCT02082158|537595951|FG005|Overall Study|Withdrawal by Subject|0|||
149032056|NCT02082158|537595946|FG000|Overall Study|Failed Fit-testing|8|||
149032057|NCT02082158|537595947|FG001|Overall Study|Failed Fit-testing|8|||
149032058|NCT02082158|537595948|FG002|Overall Study|Failed Fit-testing|14|||
149032059|NCT02082158|537595949|FG003|Overall Study|Failed Fit-testing|4|||
149032060|NCT02082158|537595950|FG004|Overall Study|Failed Fit-testing|3|||
148868965|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
148868966|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
148868967|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
148868968|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
148868969|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
148868970|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
148868971|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
148868972|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
148868973|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
148868974|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
148868975|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
148868976|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
148868977|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
148868978|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
148868979|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
148868980|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
148868981|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
148868982|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
148868983|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
148868984|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
148868985|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
148868986|NCT01672866|536997233|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
148868987|NCT01672866|536997234|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
148868988|NCT01672866|536997235|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
148868989|NCT01672866|536997233|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
148868990|NCT01672866|536997234|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
148868991|NCT01672866|536997235|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
148868992|NCT01672866|536997233|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
148868993|NCT01672866|536997234|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
148868994|NCT01672866|536997235|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
148868995|NCT01672866|536997233|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
148868996|NCT01672866|536997234|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
148868997|NCT01672866|536997235|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
148868998|NCT01672866|536997233|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
148868999|NCT01672866|536997234|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
148869000|NCT01672866|536997235|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
148869001|NCT00358436|536998482|FG000|Overall Study|Adverse Event|29|||
148869002|NCT00358436|536998483|FG001|Overall Study|Adverse Event|13|||
148869003|NCT00358436|536998482|FG000|Overall Study|Lack of Efficacy|34|||
148869004|NCT00358436|536998483|FG001|Overall Study|Lack of Efficacy|36|||
148869005|NCT00358436|536998482|FG000|Overall Study|Lost to Follow-up|11|||
148869006|NCT00358436|536998483|FG001|Overall Study|Lost to Follow-up|6|||
148869007|NCT00358436|536998482|FG000|Overall Study|Protocol Violation|8|||
148869008|NCT00358436|536998483|FG001|Overall Study|Protocol Violation|3|||
148869009|NCT00358436|536998482|FG000|Overall Study|Withdrawal by Subject|40|||
148869010|NCT00358436|536998483|FG001|Overall Study|Withdrawal by Subject|17|||
148869011|NCT00358436|536998482|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
148869012|NCT00358436|536998483|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
148869013|NCT00358436|536998482|FG000|Overall Study|COPD exacerbation|22|||
148869014|NCT00358436|536998483|FG001|Overall Study|COPD exacerbation|10|||
148869015|NCT00358436|536998482|FG000|Overall Study|Other|6|||
148869016|NCT00358436|536998483|FG001|Overall Study|Other|1|||
148869017|NCT03938324|536998485|FG000|Overall Study|Lost to Follow-up|42|||
148869018|NCT03938324|536998486|FG001|Overall Study|Lost to Follow-up|21|||
148869019|NCT03938324|536998485|FG000|Overall Study|Withdrawal by Subject|6|||
148869020|NCT03938324|536998486|FG001|Overall Study|Withdrawal by Subject|1|||
148869021|NCT01266590|536998487|FG000|Overall Study|Adverse Event|3|||
148869022|NCT01266590|536998487|FG000|Overall Study|Lost to Follow-up|1|||
148869023|NCT01266590|536998487|FG000|Overall Study|Withdrawal by Subject|1|||
148869024|NCT01266590|536998487|FG000|Overall Study|Physician Decision|1|||
149000191|NCT03053050|537475684|FG001|Randomized Phase|Lost to Follow-up|1|||
149000192|NCT03053050|537475685|FG002|Randomized Phase|Lost to Follow-up|1|||
149000193|NCT03053050|537475686|FG003|Randomized Phase|Lost to Follow-up|0|||
149000194|NCT03053050|537475683|FG000|Randomized Phase|Adverse Event|0|||
149000195|NCT03053050|537475684|FG001|Randomized Phase|Adverse Event|1|||
148869025|NCT02008773|536998492|FG000|Overall Study|Adverse Event|3|||
148869026|NCT02008773|536998493|FG001|Overall Study|Adverse Event|3|||
148869027|NCT02008773|536998494|FG002|Overall Study|Adverse Event|1|||
149000196|NCT03053050|537475685|FG002|Randomized Phase|Adverse Event|0|||
149000197|NCT03053050|537475686|FG003|Randomized Phase|Adverse Event|0|||
148869028|NCT02008773|536998495|FG003|Overall Study|Adverse Event|2|||
148869029|NCT02008773|536998492|FG000|Overall Study|Medication Non-compliance|2|||
148869030|NCT02008773|536998493|FG001|Overall Study|Medication Non-compliance|1|||
149032061|NCT02082158|537595951|FG005|Overall Study|Failed Fit-testing|7|||
148869031|NCT02008773|536998494|FG002|Overall Study|Medication Non-compliance|3|||
148869032|NCT02008773|536998495|FG003|Overall Study|Medication Non-compliance|2|||
148869033|NCT02008773|536998492|FG000|Overall Study|Withdrawal by Subject|8|||
148869034|NCT02008773|536998493|FG001|Overall Study|Withdrawal by Subject|4|||
148869035|NCT02008773|536998494|FG002|Overall Study|Withdrawal by Subject|7|||
148869036|NCT02008773|536998495|FG003|Overall Study|Withdrawal by Subject|6|||
148869037|NCT02008773|536998492|FG000|Overall Study|Lost to Follow-up|0|||
148869038|NCT02008773|536998493|FG001|Overall Study|Lost to Follow-up|1|||
148869039|NCT02008773|536998494|FG002|Overall Study|Lost to Follow-up|3|||
148869040|NCT02008773|536998495|FG003|Overall Study|Lost to Follow-up|2|||
148869041|NCT04732949|536998496|FG000|Overall Study|Withdrawal by Subject|23|||
148869042|NCT04732949|536998497|FG001|Overall Study|Withdrawal by Subject|27|||
148869043|NCT04732949|536998496|FG000|Overall Study|Protocol Violation|0|||
148869044|NCT04732949|536998497|FG001|Overall Study|Protocol Violation|1|||
148869045|NCT04732949|536998496|FG000|Overall Study|Non-compliance|0|||
148869046|NCT04732949|536998497|FG001|Overall Study|Non-compliance|2|||
148869047|NCT04732949|536998496|FG000|Overall Study|Physician Decision|2|||
148869048|NCT04732949|536998497|FG001|Overall Study|Physician Decision|1|||
148869049|NCT04732949|536998496|FG000|Overall Study|Serious adverse event (Fatal)|16|||
148869050|NCT04732949|536998497|FG001|Overall Study|Serious adverse event (Fatal)|18|||
148869051|NCT04732949|536998496|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
148869052|NCT04732949|536998497|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
148869053|NCT04732949|536998496|FG000|Overall Study|Non-serious adverse event|1|||
148869054|NCT04732949|536998497|FG001|Overall Study|Non-serious adverse event|3|||
148869055|NCT04732949|536998496|FG000|Overall Study|Lost to Follow-up|26|||
148869056|NCT04732949|536998497|FG001|Overall Study|Lost to Follow-up|27|||
148869057|NCT04732949|536998496|FG000|Overall Study|Other|6|||
148869058|NCT04732949|536998497|FG001|Overall Study|Other|3|||
148869059|NCT04256512|536998500|FG000|Overall Study|Withdrawal by Subject|1|||
148869060|NCT04435600|536998501|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869061|NCT04435600|536998502|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869062|NCT04435600|536998503|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
148869063|NCT04435600|536998504|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869064|NCT04435600|536998505|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869065|NCT04435600|536998506|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869066|NCT04435600|536998507|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869067|NCT04435600|536998508|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869068|NCT04435600|536998509|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869069|NCT04435600|536998510|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
148869070|NCT04435600|536998501|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869071|NCT04435600|536998502|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869072|NCT04435600|536998503|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869073|NCT04435600|536998504|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869074|NCT04435600|536998505|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869075|NCT04435600|536998506|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869076|NCT04435600|536998507|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869077|NCT04435600|536998508|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869078|NCT04435600|536998509|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
148869079|NCT04435600|536998510|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
148869080|NCT04435600|536998501|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869081|NCT04435600|536998502|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869082|NCT04435600|536998503|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869083|NCT04435600|536998504|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869084|NCT04435600|536998505|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869085|NCT04435600|536998506|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869086|NCT04435600|536998507|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869087|NCT04435600|536998508|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869088|NCT04435600|536998509|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
148869089|NCT04435600|536998510|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
148869090|NCT04435600|536998501|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869091|NCT04435600|536998502|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869092|NCT04435600|536998503|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869093|NCT04435600|536998504|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869094|NCT04435600|536998505|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869095|NCT04435600|536998506|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869096|NCT04435600|536998507|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869097|NCT04435600|536998508|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869098|NCT04435600|536998509|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
148869099|NCT04435600|536998510|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
149000198|NCT03053050|537475683|FG000|Randomized Phase|Randomized but Never Treated|2|||
149000199|NCT03053050|537475684|FG001|Randomized Phase|Randomized but Never Treated|2|||
149032062|NCT00957229|537595952|FG000|Study Start|Adverse Event|0|||
148869100|NCT03344172|536998514|FG000|Overall Study|Received <1 dose of treatment|1|||
148869101|NCT03344172|536998515|FG001|Overall Study|Received <1 dose of treatment|0|||
148869102|NCT02258529|536998522|FG000|Overall Study|Study Terminated by Sponsor|9|||
148869103|NCT02258529|536998522|FG000|Overall Study|Adverse Event|1|||
148869104|NCT00413010|536998523|FG000|Overall Study|Adverse Event|8|||
148869105|NCT00413010|536998524|FG001|Overall Study|Adverse Event|4|||
148869106|NCT00413010|536998523|FG000|Overall Study|Laboratory abnormality|0|||
148869107|NCT00413010|536998524|FG001|Overall Study|Laboratory abnormality|2|||
148869108|NCT00413010|536998523|FG000|Overall Study|Lack of Efficacy|0|||
148869109|NCT00413010|536998524|FG001|Overall Study|Lack of Efficacy|3|||
148869110|NCT00413010|536998523|FG000|Overall Study|Lost to Follow-up|3|||
148869111|NCT00413010|536998524|FG001|Overall Study|Lost to Follow-up|0|||
148869112|NCT00413010|536998523|FG000|Overall Study|Withdrawal by Subject|7|||
148869113|NCT00413010|536998524|FG001|Overall Study|Withdrawal by Subject|2|||
148869114|NCT00413010|536998523|FG000|Overall Study|Due to termination of the study|54|||
148869115|NCT00413010|536998524|FG001|Overall Study|Due to termination of the study|52|||
148869116|NCT00443781|536998525|FG000|Overall Study|Lost to Follow-up|10|||
148869117|NCT00443781|536998525|FG000|Overall Study|Physician Decision|2|||
148869118|NCT00443781|536998525|FG000|Overall Study|Protocol Violation|1|||
148869119|NCT00443781|536998525|FG000|Overall Study|Withdrawal by Subject|6|||
148869120|NCT00443781|536998525|FG000|Overall Study|Unable to comply with study follow up|2|||
148869121|NCT00443781|536998525|FG000|Overall Study|Investigator terminated participation|1|||
148869122|NCT00443781|536998525|FG000|Overall Study|Insurance not covered|2|||
148869123|NCT00443781|536998525|FG000|Overall Study|PD/FAD not done|1|||
148869124|NCT00430937|536998526|FG000|Overall Study|Adverse Event|3|||
148869125|NCT00430937|536998527|FG001|Overall Study|Adverse Event|8|||
148869126|NCT00430937|536998526|FG000|Overall Study|Death|0|||
148869127|NCT00430937|536998527|FG001|Overall Study|Death|1|||
148869128|NCT00430937|536998526|FG000|Overall Study|Lost to Follow-up|6|||
148869129|NCT00430937|536998527|FG001|Overall Study|Lost to Follow-up|6|||
148869130|NCT00430937|536998526|FG000|Overall Study|Withdrawal by Subject|5|||
148869131|NCT00430937|536998527|FG001|Overall Study|Withdrawal by Subject|2|||
148869132|NCT00430937|536998526|FG000|Overall Study|Protocol Violation|3|||
148869133|NCT00430937|536998527|FG001|Overall Study|Protocol Violation|2|||
148869134|NCT00430937|536998526|FG000|Overall Study|Lack of Efficacy|6|||
148869135|NCT00430937|536998527|FG001|Overall Study|Lack of Efficacy|5|||
148869136|NCT00430937|536998526|FG000|Overall Study|Inappropriate enrollment|2|||
148869137|NCT00430937|536998527|FG001|Overall Study|Inappropriate enrollment|1|||
148869138|NCT00430937|536998526|FG000|Overall Study|Administrative reasons|1|||
148869139|NCT00430937|536998527|FG001|Overall Study|Administrative reasons|0|||
148869140|NCT00430937|536998526|FG000|Overall Study|Protocol discontinuation criteria met|1|||
148869141|NCT00430937|536998527|FG001|Overall Study|Protocol discontinuation criteria met|2|||
148869142|NCT00430937|536998526|FG000|Overall Study|Unable to classify|0|||
148869143|NCT00430937|536998527|FG001|Overall Study|Unable to classify|1|||
148869144|NCT01533922|536998528|FG000|Overall Study|Adverse Event|5|||
148869145|NCT01533922|536998529|FG001|Overall Study|Adverse Event|8|||
148869146|NCT01533922|536998530|FG002|Overall Study|Adverse Event|6|||
148869147|NCT01533922|536998531|FG003|Overall Study|Adverse Event|3|||
148869148|NCT01533922|536998532|FG004|Overall Study|Adverse Event|4|||
148869149|NCT01533922|536998528|FG000|Overall Study|Lack of Efficacy|0|||
148869150|NCT01533922|536998529|FG001|Overall Study|Lack of Efficacy|0|||
148869151|NCT01533922|536998530|FG002|Overall Study|Lack of Efficacy|1|||
148869152|NCT01533922|536998531|FG003|Overall Study|Lack of Efficacy|0|||
149000200|NCT03053050|537475685|FG002|Randomized Phase|Randomized but Never Treated|2|||
149000201|NCT03053050|537475686|FG003|Randomized Phase|Randomized but Never Treated|0|||
149000202|NCT03053050|537475683|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
149000203|NCT03053050|537475684|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
149000204|NCT03053050|537475685|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
149000205|NCT03053050|537475686|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
148869153|NCT01533922|536998532|FG004|Overall Study|Lack of Efficacy|0|||
148869154|NCT01533922|536998528|FG000|Overall Study|Protocol Violation|0|||
148869155|NCT01533922|536998529|FG001|Overall Study|Protocol Violation|3|||
148869156|NCT01533922|536998530|FG002|Overall Study|Protocol Violation|0|||
148869157|NCT01533922|536998531|FG003|Overall Study|Protocol Violation|0|||
148869158|NCT01533922|536998532|FG004|Overall Study|Protocol Violation|1|||
148869159|NCT01533922|536998528|FG000|Overall Study|Withdrawal by Subject|3|||
149000206|NCT03053050|537475683|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
148869160|NCT01533922|536998529|FG001|Overall Study|Withdrawal by Subject|1|||
148869161|NCT01533922|536998530|FG002|Overall Study|Withdrawal by Subject|2|||
148869162|NCT01533922|536998531|FG003|Overall Study|Withdrawal by Subject|2|||
148869163|NCT01533922|536998532|FG004|Overall Study|Withdrawal by Subject|1|||
148869164|NCT01533922|536998528|FG000|Overall Study|Other reason not defined above|2|||
148869165|NCT01533922|536998529|FG001|Overall Study|Other reason not defined above|0|||
148869166|NCT01533922|536998530|FG002|Overall Study|Other reason not defined above|1|||
148869167|NCT01533922|536998531|FG003|Overall Study|Other reason not defined above|0|||
148869168|NCT01533922|536998532|FG004|Overall Study|Other reason not defined above|0|||
148869169|NCT02989805|536998534|FG000|Overall Study|invalid consent|6|||
148869170|NCT02989805|536998535|FG001|Overall Study|invalid consent|4|||
148869171|NCT00286221|536998536|FG000|Overall Study|Protocol Violation|2|||
148869172|NCT00286221|536998537|FG001|Overall Study|Protocol Violation|1|||
148869173|NCT00286221|536998538|FG002|Overall Study|Protocol Violation|6|||
148869174|NCT00286221|536998539|FG003|Overall Study|Protocol Violation|4|||
148869175|NCT00286221|536998536|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
148869176|NCT00286221|536998537|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
148869177|NCT00286221|536998538|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
148869178|NCT00286221|536998539|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
148869179|NCT00286221|536998536|FG000|Overall Study|Inability to trigger PCA|2|||
148869180|NCT00286221|536998537|FG001|Overall Study|Inability to trigger PCA|0|||
148869181|NCT00286221|536998538|FG002|Overall Study|Inability to trigger PCA|0|||
148869182|NCT00286221|536998539|FG003|Overall Study|Inability to trigger PCA|0|||
148869183|NCT00286221|536998536|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
148869184|NCT00286221|536998537|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
148869185|NCT00286221|536998538|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
148869186|NCT00286221|536998539|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
148869187|NCT02771626|536998543|FG000|Overall Study|Adverse Event|1|||
148869188|NCT02771626|536998544|FG001|Overall Study|Adverse Event|5|||
148869189|NCT02771626|536998545|FG002|Overall Study|Adverse Event|3|||
148869190|NCT02771626|536998546|FG003|Overall Study|Adverse Event|0|||
148869191|NCT02771626|536998547|FG004|Overall Study|Adverse Event|1|||
148869192|NCT02771626|536998548|FG005|Overall Study|Adverse Event|1|||
148869193|NCT02771626|536998543|FG000|Overall Study|Radiologic Disease Progression|6|||
148869194|NCT02771626|536998544|FG001|Overall Study|Radiologic Disease Progression|13|||
148869195|NCT02771626|536998545|FG002|Overall Study|Radiologic Disease Progression|10|||
148869196|NCT02771626|536998546|FG003|Overall Study|Radiologic Disease Progression|7|||
148869197|NCT02771626|536998547|FG004|Overall Study|Radiologic Disease Progression|28|||
148869198|NCT02771626|536998548|FG005|Overall Study|Radiologic Disease Progression|15|||
148869199|NCT02771626|536998543|FG000|Overall Study|Symptomatic Deterioration|0|||
148869200|NCT02771626|536998544|FG001|Overall Study|Symptomatic Deterioration|4|||
148869201|NCT02771626|536998545|FG002|Overall Study|Symptomatic Deterioration|2|||
148869202|NCT02771626|536998546|FG003|Overall Study|Symptomatic Deterioration|0|||
148869203|NCT02771626|536998547|FG004|Overall Study|Symptomatic Deterioration|5|||
148869204|NCT02771626|536998548|FG005|Overall Study|Symptomatic Deterioration|2|||
148869205|NCT02771626|536998543|FG000|Overall Study|Participant Request|0|||
148869206|NCT02771626|536998544|FG001|Overall Study|Participant Request|1|||
148869207|NCT02771626|536998545|FG002|Overall Study|Participant Request|0|||
148869208|NCT02771626|536998546|FG003|Overall Study|Participant Request|2|||
148869209|NCT02771626|536998547|FG004|Overall Study|Participant Request|0|||
148869210|NCT02771626|536998548|FG005|Overall Study|Participant Request|1|||
148869211|NCT02771626|536998543|FG000|Overall Study|Investigator Decision|0|||
148869212|NCT02771626|536998544|FG001|Overall Study|Investigator Decision|1|||
148869213|NCT02771626|536998545|FG002|Overall Study|Investigator Decision|0|||
148869214|NCT02771626|536998546|FG003|Overall Study|Investigator Decision|0|||
148869215|NCT02771626|536998547|FG004|Overall Study|Investigator Decision|1|||
148869216|NCT02771626|536998548|FG005|Overall Study|Investigator Decision|0|||
148869217|NCT02771626|536998543|FG000|Overall Study|Study Termination by Sponsor|0|||
148869218|NCT02771626|536998544|FG001|Overall Study|Study Termination by Sponsor|2|||
148869219|NCT02771626|536998545|FG002|Overall Study|Study Termination by Sponsor|1|||
148869220|NCT02771626|536998546|FG003|Overall Study|Study Termination by Sponsor|0|||
148869221|NCT02771626|536998547|FG004|Overall Study|Study Termination by Sponsor|1|||
148869222|NCT02771626|536998548|FG005|Overall Study|Study Termination by Sponsor|0|||
148869223|NCT02771626|536998543|FG000|Overall Study|Informed Consent Withdrawn|0|||
148869224|NCT02771626|536998544|FG001|Overall Study|Informed Consent Withdrawn|0|||
148869225|NCT02771626|536998545|FG002|Overall Study|Informed Consent Withdrawn|1|||
148869226|NCT02771626|536998546|FG003|Overall Study|Informed Consent Withdrawn|0|||
148869227|NCT02771626|536998547|FG004|Overall Study|Informed Consent Withdrawn|1|||
148869228|NCT02771626|536998548|FG005|Overall Study|Informed Consent Withdrawn|1|||
149032063|NCT00957229|537595953|FG001|Study Start|Adverse Event|3|||
149032064|NCT00957229|537595952|FG000|Study Start|Disease Progression|1|||
149032065|NCT00957229|537595953|FG001|Study Start|Disease Progression|0|||
148869229|NCT02771626|536998543|FG000|Overall Study|Other, Not Specified|1|||
148869230|NCT02771626|536998544|FG001|Overall Study|Other, Not Specified|0|||
148869231|NCT02771626|536998545|FG002|Overall Study|Other, Not Specified|0|||
148869232|NCT02771626|536998546|FG003|Overall Study|Other, Not Specified|0|||
148869233|NCT02771626|536998547|FG004|Overall Study|Other, Not Specified|0|||
148869234|NCT02771626|536998548|FG005|Overall Study|Other, Not Specified|1|||
148869235|NCT02648217|536998551|FG000|Overall Study|Adverse Event|0|||
148869236|NCT02648217|536998552|FG001|Overall Study|Adverse Event|1|||
148869237|NCT02648217|536998551|FG000|Overall Study|Lost to Follow-up|1|||
148869238|NCT02648217|536998552|FG001|Overall Study|Lost to Follow-up|1|||
148869239|NCT02648217|536998551|FG000|Overall Study|Withdrawal by Subject|4|||
148869240|NCT02648217|536998552|FG001|Overall Study|Withdrawal by Subject|3|||
148869241|NCT02648217|536998551|FG000|Overall Study|Unclassified|5|||
148869242|NCT02648217|536998552|FG001|Overall Study|Unclassified|0|||
148869243|NCT02690649|536998553|FG000|Overall Study|Withdrawal by Subject|1|||
148869244|NCT02690649|536998554|FG001|Overall Study|Withdrawal by Subject|1|||
148869245|NCT02690649|536998553|FG000|Overall Study|Protocol Violation|0|||
148869246|NCT02690649|536998554|FG001|Overall Study|Protocol Violation|3|||
148869247|NCT00907296|536998555|FG000|Overall Study|Ineligibility Determined|1|||
148869248|NCT00907296|536998556|FG001|Overall Study|Ineligibility Determined|0|||
148869249|NCT00907296|536998557|FG002|Overall Study|Ineligibility Determined|0|||
148869250|NCT00907296|536998558|FG003|Overall Study|Ineligibility Determined|1|||
148869251|NCT00907296|536998559|FG004|Overall Study|Ineligibility Determined|0|||
148869252|NCT00907296|536998560|FG005|Overall Study|Ineligibility Determined|0|||
148869253|NCT00907296|536998561|FG006|Overall Study|Ineligibility Determined|0|||
148869254|NCT00907296|536998562|FG007|Overall Study|Ineligibility Determined|1|||
148869255|NCT00907296|536998563|FG008|Overall Study|Ineligibility Determined|0|||
148869256|NCT00907296|536998564|FG009|Overall Study|Ineligibility Determined|0|||
148869257|NCT00907296|536998555|FG000|Overall Study|Protocol Deviation|0|||
148869258|NCT00907296|536998556|FG001|Overall Study|Protocol Deviation|1|||
148869259|NCT00907296|536998557|FG002|Overall Study|Protocol Deviation|0|||
148869260|NCT00907296|536998558|FG003|Overall Study|Protocol Deviation|0|||
148869261|NCT00907296|536998559|FG004|Overall Study|Protocol Deviation|0|||
148869262|NCT00907296|536998560|FG005|Overall Study|Protocol Deviation|0|||
148869263|NCT00907296|536998561|FG006|Overall Study|Protocol Deviation|0|||
148869264|NCT00907296|536998562|FG007|Overall Study|Protocol Deviation|0|||
148869265|NCT00907296|536998563|FG008|Overall Study|Protocol Deviation|0|||
148869266|NCT00907296|536998564|FG009|Overall Study|Protocol Deviation|0|||
148869267|NCT00907296|536998555|FG000|Overall Study|Noncompliance|1|||
148869268|NCT00907296|536998556|FG001|Overall Study|Noncompliance|1|||
148869269|NCT00907296|536998557|FG002|Overall Study|Noncompliance|1|||
148869270|NCT00907296|536998558|FG003|Overall Study|Noncompliance|0|||
148869271|NCT00907296|536998559|FG004|Overall Study|Noncompliance|0|||
148869272|NCT00907296|536998560|FG005|Overall Study|Noncompliance|1|||
148869273|NCT00907296|536998561|FG006|Overall Study|Noncompliance|0|||
148869274|NCT00907296|536998562|FG007|Overall Study|Noncompliance|2|||
148869275|NCT00907296|536998563|FG008|Overall Study|Noncompliance|0|||
148869276|NCT00907296|536998564|FG009|Overall Study|Noncompliance|0|||
148869277|NCT00907296|536998555|FG000|Overall Study|Adverse Event|2|||
148869278|NCT00907296|536998556|FG001|Overall Study|Adverse Event|0|||
148869279|NCT00907296|536998557|FG002|Overall Study|Adverse Event|0|||
148869280|NCT00907296|536998558|FG003|Overall Study|Adverse Event|0|||
148869281|NCT00907296|536998559|FG004|Overall Study|Adverse Event|0|||
148869282|NCT00907296|536998560|FG005|Overall Study|Adverse Event|0|||
148869283|NCT00907296|536998561|FG006|Overall Study|Adverse Event|1|||
148869284|NCT00907296|536998562|FG007|Overall Study|Adverse Event|0|||
148869285|NCT00907296|536998563|FG008|Overall Study|Adverse Event|0|||
148869286|NCT00907296|536998564|FG009|Overall Study|Adverse Event|1|||
148869287|NCT00907296|536998555|FG000|Overall Study|Withdrawal by Subject|7|||
148869288|NCT00907296|536998556|FG001|Overall Study|Withdrawal by Subject|2|||
148869289|NCT00907296|536998557|FG002|Overall Study|Withdrawal by Subject|1|||
148869290|NCT00907296|536998558|FG003|Overall Study|Withdrawal by Subject|1|||
148869291|NCT00907296|536998559|FG004|Overall Study|Withdrawal by Subject|1|||
148869292|NCT00907296|536998560|FG005|Overall Study|Withdrawal by Subject|5|||
148869293|NCT00907296|536998561|FG006|Overall Study|Withdrawal by Subject|3|||
148869294|NCT00907296|536998562|FG007|Overall Study|Withdrawal by Subject|2|||
148869295|NCT00907296|536998563|FG008|Overall Study|Withdrawal by Subject|4|||
149032066|NCT00957229|537595952|FG000|Reallocated to or Continued Vismodegib|Death|1|||
149032067|NCT00957229|537595953|FG001|Reallocated to or Continued Vismodegib|Death|1|||
149032068|NCT00957229|537595952|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
149032069|NCT00957229|537595953|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
149032070|NCT00927823|537595954|FG000|Continuous Dosing Period|Death|0|||
148869296|NCT00907296|536998564|FG009|Overall Study|Withdrawal by Subject|2|||
149032071|NCT00927823|537595955|FG001|Continuous Dosing Period|Death|0|||
148869297|NCT00907296|536998555|FG000|Overall Study|Lost to Follow-up|9|||
148869298|NCT00907296|536998556|FG001|Overall Study|Lost to Follow-up|1|||
148869299|NCT00907296|536998557|FG002|Overall Study|Lost to Follow-up|0|||
148869300|NCT00907296|536998558|FG003|Overall Study|Lost to Follow-up|2|||
148869301|NCT00907296|536998559|FG004|Overall Study|Lost to Follow-up|0|||
148869302|NCT00907296|536998560|FG005|Overall Study|Lost to Follow-up|3|||
148869303|NCT00907296|536998561|FG006|Overall Study|Lost to Follow-up|2|||
148869304|NCT00907296|536998562|FG007|Overall Study|Lost to Follow-up|2|||
148869305|NCT00907296|536998563|FG008|Overall Study|Lost to Follow-up|0|||
148869306|NCT00907296|536998564|FG009|Overall Study|Lost to Follow-up|4|||
148869307|NCT02776033|536998567|FG000|Overall Study|Withdrawal by Subject|0|||
148869308|NCT02776033|536998568|FG001|Overall Study|Withdrawal by Subject|0|||
148869309|NCT02776033|536998569|FG002|Overall Study|Withdrawal by Subject|2|||
148869310|NCT02776033|536998567|FG000|Overall Study|Physician Decision|2|||
148869311|NCT02776033|536998568|FG001|Overall Study|Physician Decision|0|||
148869312|NCT02776033|536998569|FG002|Overall Study|Physician Decision|0|||
148869313|NCT02776033|536998567|FG000|Overall Study|Lost to Follow-up|1|||
148869314|NCT02776033|536998568|FG001|Overall Study|Lost to Follow-up|0|||
148869315|NCT02776033|536998569|FG002|Overall Study|Lost to Follow-up|0|||
148869316|NCT02776033|536998567|FG000|Overall Study|Adverse Event|1|||
148869317|NCT02776033|536998568|FG001|Overall Study|Adverse Event|2|||
148869318|NCT02776033|536998569|FG002|Overall Study|Adverse Event|0|||
148869319|NCT02616393|536998573|FG000|Overall Study|Death|5|||
148869320|NCT02616393|536998574|FG001|Overall Study|Death|12|||
148869321|NCT02616393|536998575|FG002|Overall Study|Death|1|||
148869322|NCT02616393|536998573|FG000|Overall Study|Termination by Sponsor|4|||
148869323|NCT02616393|536998574|FG001|Overall Study|Termination by Sponsor|5|||
148869324|NCT02616393|536998575|FG002|Overall Study|Termination by Sponsor|2|||
148869325|NCT02616393|536998573|FG000|Overall Study|Other|3|||
148869326|NCT02616393|536998574|FG001|Overall Study|Other|0|||
148869327|NCT02616393|536998575|FG002|Overall Study|Other|0|||
148869328|NCT02616393|536998573|FG000|Overall Study|Withdrawal by Subject|1|||
148869329|NCT02616393|536998574|FG001|Overall Study|Withdrawal by Subject|1|||
148869330|NCT02616393|536998575|FG002|Overall Study|Withdrawal by Subject|0|||
148869331|NCT02616393|536998573|FG000|Overall Study|Lost to Follow-up|0|||
148869332|NCT02616393|536998574|FG001|Overall Study|Lost to Follow-up|2|||
148869333|NCT02616393|536998575|FG002|Overall Study|Lost to Follow-up|0|||
148869334|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
148869335|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
148869336|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
148869337|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
148869338|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
148869339|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
148869340|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
148869341|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
148869342|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
148869343|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
148869344|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
148869345|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
148869346|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
148869347|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
148869348|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
148869349|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
148869350|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
148869351|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
148869352|NCT01302054|536998576|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
148869353|NCT01302054|536998577|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
148869354|NCT01302054|536998578|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
148869355|NCT01302054|536998576|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
148869356|NCT01302054|536998577|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
148869357|NCT01302054|536998578|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
148869358|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
148869359|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
148869360|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
148869361|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
148869362|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
148869363|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
148869364|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
148869365|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
149032072|NCT00927823|537595956|FG002|Continuous Dosing Period|Death|6|||
148869366|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
148869367|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
148869368|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
148869369|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
148869370|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
148869371|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
148869372|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
148869373|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
148869374|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
148869375|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
148869376|NCT01302054|536998576|FG000|Double-Blind Treatment Phase|Other|0|||
148869377|NCT01302054|536998577|FG001|Double-Blind Treatment Phase|Other|4|||
148869378|NCT01302054|536998578|FG002|Double-Blind Treatment Phase|Other|9|||
148869379|NCT00857948|536998579|FG000|Overall Study|Withdrawal by Subject|2|||
149032073|NCT00927823|537595957|FG003|Continuous Dosing Period|Death|0|||
148869380|NCT00857948|536998580|FG001|Overall Study|Withdrawal by Subject|0|||
148869381|NCT00857948|536998581|FG002|Overall Study|Withdrawal by Subject|0|||
148869382|NCT00857948|536998582|FG003|Overall Study|Withdrawal by Subject|0|||
148869383|NCT00857948|536998579|FG000|Overall Study|Protocol Violation|1|||
148869384|NCT00857948|536998580|FG001|Overall Study|Protocol Violation|0|||
148869385|NCT00857948|536998581|FG002|Overall Study|Protocol Violation|1|||
148869386|NCT00857948|536998582|FG003|Overall Study|Protocol Violation|0|||
148869387|NCT03757130|536998587|FG000|Overall Study|Lost to Follow-up|0|||
148869388|NCT03757130|536998588|FG001|Overall Study|Lost to Follow-up|0|||
148869389|NCT03757130|536998589|FG002|Overall Study|Lost to Follow-up|0|||
148869390|NCT03757130|536998590|FG003|Overall Study|Lost to Follow-up|1|||
148869391|NCT03757130|536998591|FG004|Overall Study|Lost to Follow-up|0|||
148869392|NCT03757130|536998592|FG005|Overall Study|Lost to Follow-up|0|||
148869393|NCT03757130|536998593|FG006|Overall Study|Lost to Follow-up|0|||
148869394|NCT03757130|536998594|FG007|Overall Study|Lost to Follow-up|1|||
148869395|NCT03757130|536998587|FG000|Overall Study|Withdrawal by Subject|0|||
148869396|NCT03757130|536998588|FG001|Overall Study|Withdrawal by Subject|0|||
148869397|NCT03757130|536998589|FG002|Overall Study|Withdrawal by Subject|0|||
148869398|NCT03757130|536998590|FG003|Overall Study|Withdrawal by Subject|0|||
148869399|NCT03757130|536998591|FG004|Overall Study|Withdrawal by Subject|0|||
148869400|NCT03757130|536998592|FG005|Overall Study|Withdrawal by Subject|0|||
148869401|NCT03757130|536998593|FG006|Overall Study|Withdrawal by Subject|1|||
148869402|NCT03757130|536998594|FG007|Overall Study|Withdrawal by Subject|0|||
148869403|NCT02636946|536998599|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
148869404|NCT02636946|536998600|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
148869405|NCT02636946|536998599|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
148869406|NCT02636946|536998600|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
148869407|NCT02636946|536998599|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
148869408|NCT02636946|536998600|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
148869409|NCT02636946|536998599|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
148869410|NCT02636946|536998600|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
148869411|NCT02636946|536998599|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
148869412|NCT02636946|536998600|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
148869413|NCT02636946|536998599|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
148869414|NCT02636946|536998600|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
148869415|NCT05059977|536998601|FG000|Overall Study|Withdrawal by Subject|0|||
148869416|NCT05059977|536998602|FG001|Overall Study|Withdrawal by Subject|0|||
148869417|NCT05059977|536998603|FG002|Overall Study|Withdrawal by Subject|1|||
148869418|NCT03443427|536998604|FG000|Overall Study|Adverse Event|2|||
148869419|NCT03443427|536998605|FG001|Overall Study|Adverse Event|3|||
148869420|NCT03443427|536998604|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
148869421|NCT03443427|536998605|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
148869422|NCT03443427|536998604|FG000|Overall Study|Other|4|||
148869423|NCT03443427|536998605|FG001|Overall Study|Other|6|||
148869424|NCT00424190|536998615|FG000|Overall Study|Withdrew consent|3|||
148869425|NCT00424190|536998616|FG001|Overall Study|Withdrew consent|4|||
149032074|NCT00927823|537595954|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
149032075|NCT00927823|537595955|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
149032076|NCT00927823|537595956|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
149032077|NCT00927823|537595957|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
149032078|NCT00927823|537595954|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
149032079|NCT00927823|537595955|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
149032080|NCT00927823|537595956|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
149032081|NCT00927823|537595957|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
149032082|NCT00927823|537595954|FG000|Continuous Dosing Period|Other|1|||
149032083|NCT00927823|537595955|FG001|Continuous Dosing Period|Other|2|||
149032084|NCT00927823|537595956|FG002|Continuous Dosing Period|Other|9|||
149032085|NCT00927823|537595957|FG003|Continuous Dosing Period|Other|3|||
149032086|NCT00543725|537595958|FG000|Overall Study|Adverse Event|18|||
149032087|NCT00543725|537595959|FG001|Overall Study|Adverse Event|27|||
149032088|NCT00543725|537595958|FG000|Overall Study|Sponsor's Decision|0|||
149032089|NCT00543725|537595959|FG001|Overall Study|Sponsor's Decision|1|||
149032090|NCT00543725|537595958|FG000|Overall Study|Subject Non-Compliant|4|||
149032091|NCT00543725|537595959|FG001|Overall Study|Subject Non-Compliant|4|||
149032092|NCT00543725|537595958|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
148869426|NCT00424190|536998615|FG000|Overall Study|Death|3|||
148869427|NCT00424190|536998616|FG001|Overall Study|Death|0|||
148869428|NCT00424190|536998615|FG000|Overall Study|Noncompliance|1|||
148869429|NCT00424190|536998616|FG001|Overall Study|Noncompliance|2|||
148869430|NCT00424190|536998615|FG000|Overall Study|Request of sponsor or investigator|0|||
149032093|NCT00543725|537595959|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
149032094|NCT00543725|537595958|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
148869431|NCT00424190|536998616|FG001|Overall Study|Request of sponsor or investigator|2|||
148869432|NCT00424190|536998615|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
148869433|NCT00424190|536998616|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
148869434|NCT00424190|536998615|FG000|Overall Study|Other|15|||
148869435|NCT00424190|536998616|FG001|Overall Study|Other|21|||
148869436|NCT00351273|536998617|FG000|Overall Study|Lost to Follow-up|1|||
148869437|NCT00351273|536998618|FG001|Overall Study|Lost to Follow-up|2|||
148869438|NCT00351273|536998619|FG002|Overall Study|Lost to Follow-up|5|||
148869439|NCT01378429|536998622|FG000|Overall Study|Noncompliance with study drug|1|||
148869440|NCT01378429|536998623|FG001|Overall Study|Noncompliance with study drug|0|||
148869441|NCT00619489|536998624|FG000|Overall Study|Adverse Event|0|||
148869442|NCT00619489|536998625|FG001|Overall Study|Adverse Event|7|||
148869443|NCT00619489|536998624|FG000|Overall Study|Withdrawal by Subject|1|||
148869444|NCT00619489|536998625|FG001|Overall Study|Withdrawal by Subject|1|||
148869445|NCT00619489|536998624|FG000|Overall Study|Lack of Efficacy|0|||
148869446|NCT00619489|536998625|FG001|Overall Study|Lack of Efficacy|11|||
148869447|NCT00619489|536998624|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
148869448|NCT00619489|536998625|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
148869449|NCT02356887|536998626|FG000|Overall Study|poor compliance|2|||
148869450|NCT02273960|536998627|FG000|Short Term Period|Lost to Follow-up|1|||
148869451|NCT02273960|536998628|FG001|Short Term Period|Lost to Follow-up|0|||
148869452|NCT02273960|536998629|FG002|Short Term Period|Lost to Follow-up|0|||
148869453|NCT02273960|536998630|FG003|Short Term Period|Lost to Follow-up|0|||
148869454|NCT02273960|536998627|FG000|Short Term Period|Lack of Efficacy|0|||
148869455|NCT02273960|536998628|FG001|Short Term Period|Lack of Efficacy|0|||
148869456|NCT02273960|536998629|FG002|Short Term Period|Lack of Efficacy|0|||
148869457|NCT02273960|536998630|FG003|Short Term Period|Lack of Efficacy|1|||
148869458|NCT02273960|536998627|FG000|Short Term Period|ST complete, not entering LTE|4|||
148869459|NCT02273960|536998628|FG001|Short Term Period|ST complete, not entering LTE|6|||
148869460|NCT02273960|536998629|FG002|Short Term Period|ST complete, not entering LTE|4|||
148869461|NCT02273960|536998630|FG003|Short Term Period|ST complete, not entering LTE|5|||
148869462|NCT02273960|536998627|FG000|Long Term Extension|Death|0|||
148869463|NCT02273960|536998628|FG001|Long Term Extension|Death|0|||
148869464|NCT02273960|536998629|FG002|Long Term Extension|Death|0|||
148869465|NCT02273960|536998630|FG003|Long Term Extension|Death|1|||
148869466|NCT01789606|536998631|FG000|Overall Study|Participant not Purchased the Product|0|||
148869467|NCT01789606|536998632|FG001|Overall Study|Participant not Purchased the Product|20|||
148869468|NCT01789606|536998631|FG000|Overall Study|Withdrawal by Subject|0|||
148869469|NCT01789606|536998632|FG001|Overall Study|Withdrawal by Subject|1|||
148869470|NCT01789606|536998631|FG000|Overall Study|Ineligible|6|||
148869471|NCT01789606|536998632|FG001|Overall Study|Ineligible|2|||
148869472|NCT01789606|536998631|FG000|Overall Study|Administrative Reasons|17|||
148869473|NCT01789606|536998632|FG001|Overall Study|Administrative Reasons|6|||
148869474|NCT01789606|536998631|FG000|Overall Study|No Study Medication Taken|0|||
148869475|NCT01789606|536998632|FG001|Overall Study|No Study Medication Taken|1|||
148869476|NCT01789606|536998631|FG000|Overall Study|Protocol Violation|0|||
148869477|NCT01789606|536998632|FG001|Overall Study|Protocol Violation|55|||
148869478|NCT01789606|536998631|FG000|Overall Study|Adverse Event|0|||
148869479|NCT01789606|536998632|FG001|Overall Study|Adverse Event|3|||
148869480|NCT01789606|536998631|FG000|Overall Study|Lost to Follow-up|0|||
148869481|NCT01789606|536998632|FG001|Overall Study|Lost to Follow-up|14|||
148869482|NCT01789606|536998631|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
148869483|NCT01789606|536998632|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
148869484|NCT01105377|536998635|FG000|Overall Study|Withdrawal by Subject|0|||
148869485|NCT01105377|536998636|FG001|Overall Study|Withdrawal by Subject|1|||
148869486|NCT04327024|537000479|FG000|Overall Study|Death|1|||
148869487|NCT04327024|537000480|FG001|Overall Study|Death|2|||
148869488|NCT04327024|537000481|FG002|Overall Study|Death|1|||
148869489|NCT04327024|537000479|FG000|Overall Study|Non-compliance with study drug|0|||
148869490|NCT04327024|537000480|FG001|Overall Study|Non-compliance with study drug|1|||
148869491|NCT04327024|537000481|FG002|Overall Study|Non-compliance with study drug|0|||
148869492|NCT04327024|537000479|FG000|Overall Study|Withdrawal by Subject|1|||
148869493|NCT04327024|537000480|FG001|Overall Study|Withdrawal by Subject|1|||
148869494|NCT04327024|537000481|FG002|Overall Study|Withdrawal by Subject|2|||
148869495|NCT02066415|537000482|FG000|Overall Study|Decision by Sponsor|5|||
148869496|NCT02066415|537000483|FG001|Overall Study|Decision by Sponsor|4|||
149000207|NCT03053050|537475684|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
148869497|NCT02066415|537000484|FG002|Overall Study|Decision by Sponsor|2|||
148869498|NCT02066415|537000482|FG000|Overall Study|Withdrawal by Subject|9|||
148869499|NCT02066415|537000483|FG001|Overall Study|Withdrawal by Subject|1|||
148869500|NCT02066415|537000484|FG002|Overall Study|Withdrawal by Subject|4|||
148869501|NCT02066415|537000482|FG000|Overall Study|Lost to Follow-up|7|||
148869502|NCT02066415|537000483|FG001|Overall Study|Lost to Follow-up|2|||
148869503|NCT02066415|537000484|FG002|Overall Study|Lost to Follow-up|2|||
149000208|NCT03053050|537475685|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
148869504|NCT04094584|537000485|FG000|Overall Study|No interest in study|88|||
148869505|NCT04094584|537000485|FG000|Overall Study|Unwilling to undergo screening tests|36|||
149000209|NCT03053050|537475686|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
148869506|NCT04094584|537000485|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
148869507|NCT04094584|537000485|FG000|Overall Study|Opioid use|7|||
148869508|NCT04094584|537000485|FG000|Overall Study|Need for major surgery in study period|4|||
148869509|NCT04094584|537000485|FG000|Overall Study|eligible but declined enrollment|4|||
148869510|NCT04094584|537000485|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
148869511|NCT04094584|537000485|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
148869512|NCT04094584|537000485|FG000|Overall Study|Lost to Follow-up|3|||
148869513|NCT04094584|537000485|FG000|Overall Study|Withdrawal by Subject|2|||
148869514|NCT02713867|537000494|FG000|Randomization|Other Reason|2|||
148869515|NCT02713867|537000495|FG001|Randomization|Other Reason|1|||
148869516|NCT02713867|537000494|FG000|Randomization|Participant Withdrew consent|0|||
148869517|NCT02713867|537000495|FG001|Randomization|Participant Withdrew consent|2|||
148869518|NCT02713867|537000494|FG000|Treatment Period|Other Reasons|22|||
148869519|NCT02713867|537000495|FG001|Treatment Period|Other Reasons|28|||
148869520|NCT02713867|537000494|FG000|Treatment Period|Administrative reason by sponsor|21|||
148869521|NCT02713867|537000495|FG001|Treatment Period|Administrative reason by sponsor|16|||
148869522|NCT02713867|537000494|FG000|Treatment Period|No longer meets study criteria|2|||
148869523|NCT02713867|537000495|FG001|Treatment Period|No longer meets study criteria|1|||
148869524|NCT02713867|537000494|FG000|Treatment Period|Poor/Non Compliance|1|||
148869525|NCT02713867|537000495|FG001|Treatment Period|Poor/Non Compliance|0|||
148869526|NCT02713867|537000494|FG000|Treatment Period|Maximum Clinical Benefit|5|||
148869527|NCT02713867|537000495|FG001|Treatment Period|Maximum Clinical Benefit|6|||
148869528|NCT02713867|537000494|FG000|Treatment Period|Withdrew consent|3|||
148869529|NCT02713867|537000495|FG001|Treatment Period|Withdrew consent|6|||
148869530|NCT02713867|537000494|FG000|Treatment Period|Requested to Discontinue|8|||
148869531|NCT02713867|537000495|FG001|Treatment Period|Requested to Discontinue|8|||
148869532|NCT02713867|537000494|FG000|Treatment Period|AE unrelated to Study Drug|11|||
148869533|NCT02713867|537000495|FG001|Treatment Period|AE unrelated to Study Drug|10|||
148869534|NCT02713867|537000494|FG000|Treatment Period|Death|7|||
148869535|NCT02713867|537000495|FG001|Treatment Period|Death|3|||
148869536|NCT02713867|537000494|FG000|Treatment Period|Study Drug Toxicity|16|||
148869537|NCT02713867|537000495|FG001|Treatment Period|Study Drug Toxicity|19|||
148869538|NCT02713867|537000494|FG000|Treatment Period|Disease Progression|82|||
148869539|NCT02713867|537000495|FG001|Treatment Period|Disease Progression|83|||
148869540|NCT04135859|537000497|FG000|Overall Study|Withdrawal by Subject|1|||
148869541|NCT04135859|537000498|FG001|Overall Study|Withdrawal by Subject|0|||
148869542|NCT04135859|537000497|FG000|Overall Study|Withdrawal due to screening failure|1|||
148869543|NCT04135859|537000498|FG001|Overall Study|Withdrawal due to screening failure|2|||
148869544|NCT04135859|537000497|FG000|Overall Study|Did not complete stress test|3|||
148869545|NCT04135859|537000498|FG001|Overall Study|Did not complete stress test|3|||
148869546|NCT04135859|537000497|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
148869547|NCT04135859|537000498|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
148869548|NCT01600053|537000499|FG000|Overall Study|Adverse Event|2|||
148869549|NCT01600053|537000499|FG000|Overall Study|trial will not meet the interim endpoint|9|||
148869550|NCT02715726|537000500|FG000|Overall Study|Adverse Event|2|||
148869551|NCT02715726|537000501|FG001|Overall Study|Adverse Event|6|||
148869552|NCT02715726|537000500|FG000|Overall Study|Protocol Violation|1|||
148869553|NCT02715726|537000501|FG001|Overall Study|Protocol Violation|0|||
148869554|NCT02715726|537000500|FG000|Overall Study|Death|2|||
148869555|NCT02715726|537000501|FG001|Overall Study|Death|1|||
148869556|NCT02715726|537000500|FG000|Overall Study|Participant moved|1|||
148869557|NCT02715726|537000501|FG001|Overall Study|Participant moved|3|||
148869558|NCT02715726|537000500|FG000|Overall Study|Other than specified above|11|||
148869559|NCT02715726|537000501|FG001|Overall Study|Other than specified above|15|||
148869560|NCT02715726|537000500|FG000|Overall Study|Randomized but not treated|1|||
148869561|NCT02715726|537000501|FG001|Overall Study|Randomized but not treated|2|||
148869562|NCT02445573|537000502|FG000|Overall Study|Withdrawal by Subject|1|||
148869563|NCT02445573|537000503|FG001|Overall Study|Withdrawal by Subject|1|||
148869564|NCT02445573|537000502|FG000|Overall Study|Lost to Follow-up|0|||
148869565|NCT02445573|537000503|FG001|Overall Study|Lost to Follow-up|1|||
148869566|NCT01565941|537000504|FG000|Overall Study|Withdrawn by parent/guardian|3|||
148869567|NCT01565941|537000505|FG001|Overall Study|Withdrawn by parent/guardian|2|||
148869568|NCT01565941|537000504|FG000|Overall Study|Randomized; did not receive intevention|8|||
148869569|NCT01565941|537000505|FG001|Overall Study|Randomized; did not receive intevention|2|||
148869570|NCT03230292|537000506|FG000|Overall Study|Adverse Event|1|||
148869571|NCT03230292|537000506|FG000|Overall Study|Protocol Violation|1|||
148869572|NCT03230292|537000506|FG000|Overall Study|Lost to Follow-up|1|||
148869573|NCT03230292|537000506|FG000|Overall Study|Withdrawal by Subject|3|||
148869574|NCT04047420|537000507|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
148869575|NCT04047420|537000507|FG000|Washout Period|Refused Participation|2|||
148869576|NCT02855944|537000508|FG000|Period 1: Treatment|Ongoing|14|||
148869577|NCT02855944|537000509|FG001|Period 1: Treatment|Ongoing|0|||
148869578|NCT02855944|537000508|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
148869579|NCT02855944|537000509|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
149000210|NCT03053050|537475683|FG000|Open-label Phase|Withdrew Consent|0|||
148869580|NCT02855944|537000508|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
148869581|NCT02855944|537000509|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
148869582|NCT01639755|537000510|FG000|Overall Study|Study Ongoing|15|||
148869583|NCT01639755|537000510|FG000|Overall Study|Patient had device explantation|4|||
148869584|NCT03629912|537000514|FG000|Overall Study|Lost to Follow-up|19|||
148869585|NCT03629912|537000515|FG001|Overall Study|Lost to Follow-up|7|||
148869586|NCT03629912|537000516|FG002|Overall Study|Lost to Follow-up|5|||
148869587|NCT03629912|537000517|FG003|Overall Study|Lost to Follow-up|1|||
148869588|NCT03629912|537000514|FG000|Overall Study|Withdrawal by Subject|6|||
148869589|NCT03629912|537000515|FG001|Overall Study|Withdrawal by Subject|0|||
148869590|NCT03629912|537000516|FG002|Overall Study|Withdrawal by Subject|1|||
148869591|NCT03629912|537000517|FG003|Overall Study|Withdrawal by Subject|2|||
148869592|NCT03629912|537000514|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
148869593|NCT03629912|537000515|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
148869594|NCT03629912|537000516|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
148869595|NCT03629912|537000517|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
148869596|NCT03629912|537000514|FG000|Overall Study|Death|1|||
148869597|NCT03629912|537000515|FG001|Overall Study|Death|0|||
148869598|NCT03629912|537000516|FG002|Overall Study|Death|0|||
148869599|NCT03629912|537000517|FG003|Overall Study|Death|0|||
148869600|NCT02365285|537000520|FG000|Overall Study|Physician Decision|0|||
148869601|NCT02365285|537000521|FG001|Overall Study|Physician Decision|1|||
148869602|NCT02365285|537000522|FG002|Overall Study|Physician Decision|1|||
148869603|NCT02365285|537000523|FG003|Overall Study|Physician Decision|0|||
148869604|NCT02365285|537000520|FG000|Overall Study|Adverse Event|0|||
148869605|NCT02365285|537000521|FG001|Overall Study|Adverse Event|0|||
148869606|NCT02365285|537000522|FG002|Overall Study|Adverse Event|0|||
148869607|NCT02365285|537000523|FG003|Overall Study|Adverse Event|2|||
148869608|NCT03262116|537000524|FG000|Overall Study|Physician Decision|0|||
148869609|NCT03262116|537000525|FG001|Overall Study|Physician Decision|2|||
148869610|NCT03262116|537000526|FG002|Overall Study|Physician Decision|1|||
148869611|NCT03262116|537000527|FG003|Overall Study|Physician Decision|1|||
148869612|NCT03262116|537000528|FG004|Overall Study|Physician Decision|1|||
148869613|NCT03262116|537000529|FG005|Overall Study|Physician Decision|2|||
148869614|NCT02608450|537000531|FG000|Overall Study|Lost to Follow-up|39|||
148869615|NCT02608450|537000532|FG001|Overall Study|Lost to Follow-up|32|||
148869616|NCT02608450|537000531|FG000|Overall Study|Withdrawal by Subject|21|||
148869617|NCT02608450|537000532|FG001|Overall Study|Withdrawal by Subject|15|||
148869618|NCT02608450|537000531|FG000|Overall Study|Adverse Event|3|||
148869619|NCT02608450|537000532|FG001|Overall Study|Adverse Event|6|||
148869620|NCT02608450|537000531|FG000|Overall Study|Withdrawal by parent|2|||
148869621|NCT02608450|537000532|FG001|Overall Study|Withdrawal by parent|3|||
148869622|NCT02608450|537000531|FG000|Overall Study|Lack of Efficacy|0|||
148869623|NCT02608450|537000532|FG001|Overall Study|Lack of Efficacy|3|||
148869624|NCT02608450|537000531|FG000|Overall Study|Noncompliance with study drug|0|||
148869625|NCT02608450|537000532|FG001|Overall Study|Noncompliance with study drug|2|||
148869626|NCT02608450|537000531|FG000|Overall Study|Physician Decision|0|||
148869627|NCT02608450|537000532|FG001|Overall Study|Physician Decision|1|||
148869628|NCT02608450|537000531|FG000|Overall Study|Pregnancy|0|||
148869629|NCT02608450|537000532|FG001|Overall Study|Pregnancy|1|||
148869630|NCT02608450|537000531|FG000|Overall Study|Progressive disease|1|||
148869631|NCT02608450|537000532|FG001|Overall Study|Progressive disease|0|||
148869632|NCT02608450|537000531|FG000|Overall Study|Multiple reasons|0|||
148869633|NCT02608450|537000532|FG001|Overall Study|Multiple reasons|2|||
148869634|NCT00635089|537000535|FG000|Overall Study|Adverse Event|7|||
148869635|NCT00635089|537000535|FG000|Overall Study|Lack of Efficacy|28|||
149032095|NCT00543725|537595959|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
149032096|NCT00543725|537595958|FG000|Overall Study|Protocol Violation|0|||
149032097|NCT00543725|537595959|FG001|Overall Study|Protocol Violation|1|||
148869636|NCT00635089|537000535|FG000|Overall Study|Protocol Deviation|4|||
148869637|NCT00635089|537000535|FG000|Overall Study|Lost to Follow-up|8|||
148869638|NCT00635089|537000535|FG000|Overall Study|Other|31|||
148869639|NCT01283542|537000537|FG000|Main Phase|Acute or progressive vision loss|1|||
148869640|NCT01283542|537000537|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
148869641|NCT01283542|537000537|FG000|Main Phase|abnormal laboratory values|5|||
148869642|NCT01283542|537000537|FG000|Extension Phase|Physician Decision|1|||
148869643|NCT01283542|537000537|FG000|Extension Phase|Adverse Event|1|||
148869644|NCT01283542|537000537|FG000|Extension Phase|Administrative problems|1|||
148869645|NCT04405245|537000538|FG000|Overall Study|Adverse Event|0|||
148869646|NCT04405245|537000539|FG001|Overall Study|Adverse Event|1|||
148869647|NCT04405245|537000540|FG002|Overall Study|Adverse Event|0|||
148869648|NCT02576860|537000543|FG000|Overall Study|Adverse Event|6|||
148869649|NCT02576860|537000544|FG001|Overall Study|Adverse Event|6|||
148869650|NCT02576860|537000543|FG000|Overall Study|Lost to Follow-up|5|||
148869651|NCT02576860|537000544|FG001|Overall Study|Lost to Follow-up|7|||
148869652|NCT02576860|537000543|FG000|Overall Study|Physician Decision|0|||
148869653|NCT02576860|537000544|FG001|Overall Study|Physician Decision|1|||
148869654|NCT02576860|537000543|FG000|Overall Study|Protocol Violation|0|||
148869655|NCT02576860|537000544|FG001|Overall Study|Protocol Violation|2|||
148869656|NCT02576860|537000543|FG000|Overall Study|Withdrawal by Subject|13|||
148869657|NCT02576860|537000544|FG001|Overall Study|Withdrawal by Subject|8|||
148869658|NCT02576860|537000543|FG000|Overall Study|Disallowed medication|1|||
148869659|NCT02576860|537000544|FG001|Overall Study|Disallowed medication|0|||
148869660|NCT02391961|537000545|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
148869661|NCT02391961|537000546|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
148869662|NCT02391961|537000545|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
148869663|NCT02391961|537000546|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
148869664|NCT02391961|537000545|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148869665|NCT02391961|537000546|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
148869666|NCT00477269|537000547|FG000|Core Study|Adverse Event|6|||
148869667|NCT00477269|537000548|FG001|Core Study|Adverse Event|4|||
148869668|NCT00477269|537000549|FG002|Core Study|Adverse Event|0|||
148869669|NCT00477269|537000547|FG000|Core Study|Death|3|||
148869670|NCT00477269|537000548|FG001|Core Study|Death|3|||
148869671|NCT00477269|537000549|FG002|Core Study|Death|0|||
148869672|NCT00477269|537000547|FG000|Core Study|Withdrawn Consent|0|||
148869673|NCT00477269|537000548|FG001|Core Study|Withdrawn Consent|1|||
148869674|NCT00477269|537000549|FG002|Core Study|Withdrawn Consent|0|||
148869675|NCT00477269|537000547|FG000|Open Label Extension|Adverse Event|0|||
148869676|NCT00477269|537000548|FG001|Open Label Extension|Adverse Event|0|||
148869677|NCT00477269|537000549|FG002|Open Label Extension|Adverse Event|4|||
148869678|NCT00477269|537000547|FG000|Open Label Extension|Abnormal laboratory values|0|||
148869679|NCT00477269|537000548|FG001|Open Label Extension|Abnormal laboratory values|0|||
148869680|NCT00477269|537000549|FG002|Open Label Extension|Abnormal laboratory values|1|||
148869681|NCT00477269|537000547|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
148869682|NCT00477269|537000548|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
148869683|NCT00477269|537000549|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
149032098|NCT00543725|537595958|FG000|Overall Study|Withdrawal by Subject|4|||
149032099|NCT00543725|537595959|FG001|Overall Study|Withdrawal by Subject|13|||
149032100|NCT00543725|537595958|FG000|Overall Study|Lost to Follow-up|15|||
149032101|NCT00543725|537595959|FG001|Overall Study|Lost to Follow-up|11|||
149032102|NCT00543725|537595958|FG000|Overall Study|Other|3|||
149032103|NCT00543725|537595959|FG001|Overall Study|Other|3|||
149032104|NCT00906698|537595960|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
149032105|NCT00906698|537595961|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
149032106|NCT00906698|537595962|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
149032107|NCT00906698|537595963|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
149032108|NCT00906698|537595964|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
149032109|NCT00906698|537595965|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
149032110|NCT00906698|537595960|FG000|Overall Study|Adverse Event|0|||
149032111|NCT00906698|537595961|FG001|Overall Study|Adverse Event|0|||
149032112|NCT00906698|537595962|FG002|Overall Study|Adverse Event|2|||
149032113|NCT00906698|537595963|FG003|Overall Study|Adverse Event|0|||
149032114|NCT00906698|537595964|FG004|Overall Study|Adverse Event|4|||
149032115|NCT00906698|537595965|FG005|Overall Study|Adverse Event|1|||
149032116|NCT00906698|537595960|FG000|Overall Study|Disease progression|3|||
149032117|NCT00906698|537595961|FG001|Overall Study|Disease progression|12|||
149032118|NCT00906698|537595962|FG002|Overall Study|Disease progression|4|||
149032119|NCT00906698|537595963|FG003|Overall Study|Disease progression|4|||
149032120|NCT00906698|537595964|FG004|Overall Study|Disease progression|12|||
149032121|NCT00906698|537595965|FG005|Overall Study|Disease progression|4|||
149032122|NCT00906698|537595960|FG000|Overall Study|Withdrawal by Subject|0|||
149032123|NCT00906698|537595961|FG001|Overall Study|Withdrawal by Subject|0|||
149032124|NCT00906698|537595962|FG002|Overall Study|Withdrawal by Subject|0|||
149032125|NCT00906698|537595963|FG003|Overall Study|Withdrawal by Subject|0|||
149032126|NCT00906698|537595964|FG004|Overall Study|Withdrawal by Subject|1|||
149032127|NCT00906698|537595965|FG005|Overall Study|Withdrawal by Subject|0|||
149032128|NCT00906698|537595960|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
149032129|NCT00906698|537595961|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
149032130|NCT00906698|537595962|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
149032131|NCT00906698|537595963|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
149032132|NCT00906698|537595964|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
149032133|NCT00906698|537595965|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
149032134|NCT01250002|537595966|FG000|Overall Study|Change to open surgical procedure|4|||
149032135|NCT01250002|537595967|FG001|Overall Study|Change to open surgical procedure|3|||
148869684|NCT00477269|537000547|FG000|Open Label Extension|Adminiatrative problems|0|||
148869685|NCT00477269|537000548|FG001|Open Label Extension|Adminiatrative problems|0|||
148869686|NCT00477269|537000549|FG002|Open Label Extension|Adminiatrative problems|2|||
149032136|NCT03404843|537595980|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
148869687|NCT00477269|537000547|FG000|Open Label Extension|Death|0|||
148869688|NCT00477269|537000548|FG001|Open Label Extension|Death|0|||
149032137|NCT03404843|537595981|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
149032138|NCT00567164|537595982|FG000|Overall Study|Withdrawal by Subject|171|||
149032139|NCT00567164|537595983|FG001|Overall Study|Withdrawal by Subject|21|||
149000211|NCT03053050|537475684|FG001|Open-label Phase|Withdrew Consent|0|||
149000212|NCT03053050|537475685|FG002|Open-label Phase|Withdrew Consent|0|||
149000213|NCT03053050|537475686|FG003|Open-label Phase|Withdrew Consent|6|||
149000214|NCT03053050|537475683|FG000|Open-label Phase|Investigator's Discretion|0|||
149000215|NCT03053050|537475684|FG001|Open-label Phase|Investigator's Discretion|0|||
149000216|NCT03053050|537475685|FG002|Open-label Phase|Investigator's Discretion|0|||
149000217|NCT03053050|537475686|FG003|Open-label Phase|Investigator's Discretion|4|||
149000218|NCT03703466|537475687|FG000|Overall Study|Death|2|||
149000219|NCT03703466|537475688|FG001|Overall Study|Death|1|||
149000220|NCT03703466|537475689|FG002|Overall Study|Death|0|||
149000221|NCT03703466|537475687|FG000|Overall Study|Withdrawal by Subject|0|||
148778197|NCT00033657|536661934|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
148778198|NCT00033657|536661933|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
148778199|NCT00033657|536661934|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
148778200|NCT00033657|536661933|FG000|Adjuvant Chemotherapy|Other|0|||
148778201|NCT00033657|536661934|FG001|Adjuvant Chemotherapy|Other|2|||
148778202|NCT03448939|536661935|FG000|Overall Study|Adverse Event|5|||
148778203|NCT03448939|536661936|FG001|Overall Study|Adverse Event|1|||
148778204|NCT03448939|536661935|FG000|Overall Study|Lost to Follow-up|6|||
148778205|NCT03448939|536661936|FG001|Overall Study|Lost to Follow-up|6|||
148778206|NCT03448939|536661935|FG000|Overall Study|Pregnancy|1|||
148778207|NCT03448939|536661936|FG001|Overall Study|Pregnancy|1|||
148778208|NCT03448939|536661935|FG000|Overall Study|Withdrawal by Subject|9|||
148778209|NCT03448939|536661936|FG001|Overall Study|Withdrawal by Subject|3|||
148778210|NCT03488225|536661939|FG000|Overall Study|Off Protocol Therapy|2|||
148778211|NCT03488225|536661939|FG000|Overall Study|Stem Cell Transplant|2|||
148778212|NCT02332239|536661940|FG000|Overall Study|Lost to Follow-up|4|||
148778213|NCT02332239|536661941|FG001|Overall Study|Lost to Follow-up|6|||
148778214|NCT01472965|536661942|FG000|Overall Study|Withdrawal by Subject|1|||
148778215|NCT01472965|536661943|FG001|Overall Study|Withdrawal by Subject|0|||
148778216|NCT04631107|536661947|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
148778217|NCT04631107|536661947|FG000|Second Intervention (1 Night)|Adverse Event|1|||
148778218|NCT04631107|536661947|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
148778219|NCT04631107|536661947|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
148778220|NCT00096993|536661954|FG000|Overall Study|Death|1|||
148778221|NCT00096993|536661955|FG001|Overall Study|Death|0|||
148778222|NCT00096993|536661954|FG000|Overall Study|Disease progression|56|||
148778223|NCT00096993|536661955|FG001|Overall Study|Disease progression|53|||
148778224|NCT00096993|536661954|FG000|Overall Study|Adverse Event|2|||
148778225|NCT00096993|536661955|FG001|Overall Study|Adverse Event|8|||
148778226|NCT00096993|536661954|FG000|Overall Study|Subject's decision|3|||
148778227|NCT00096993|536661955|FG001|Overall Study|Subject's decision|1|||
148778228|NCT00096993|536661954|FG000|Overall Study|Physician Decision|2|||
148778229|NCT00096993|536661955|FG001|Overall Study|Physician Decision|1|||
148778230|NCT00096993|536661954|FG000|Overall Study|Non-compliance|0|||
148778231|NCT00096993|536661955|FG001|Overall Study|Non-compliance|1|||
148778232|NCT00096993|536661954|FG000|Overall Study|Other unspecified|1|||
148778233|NCT00096993|536661955|FG001|Overall Study|Other unspecified|1|||
148778234|NCT01440569|536661959|FG000|Main Study|Enrolled but not treated|1|||
148778235|NCT01440569|536661960|FG001|Main Study|Enrolled but not treated|0|||
148778236|NCT01440569|536661959|FG000|Main Study|Adverse Event|9|||
148778237|NCT01440569|536661960|FG001|Main Study|Adverse Event|0|||
148778238|NCT01440569|536661959|FG000|Main Study|Pregnancy|1|||
148778239|NCT01440569|536661960|FG001|Main Study|Pregnancy|0|||
148778240|NCT01440569|536661959|FG000|Main Study|Investigator's Discretion|1|||
148778241|NCT01440569|536661960|FG001|Main Study|Investigator's Discretion|1|||
148778242|NCT01440569|536661959|FG000|Main Study|Withdrew Consent|7|||
148778243|NCT01440569|536661960|FG001|Main Study|Withdrew Consent|1|||
148778244|NCT01440569|536661959|FG000|Main Study|Lost to Follow-up|13|||
148778245|NCT01440569|536661960|FG001|Main Study|Lost to Follow-up|2|||
148778246|NCT01440569|536661959|FG000|Main Study|Subject Non-Compliance|3|||
148778247|NCT01440569|536661960|FG001|Main Study|Subject Non-Compliance|0|||
148778248|NCT01440569|536661959|FG000|Main Study|Protocol Violation|1|||
148778249|NCT01440569|536661960|FG001|Main Study|Protocol Violation|0|||
148778250|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Adverse Event|3|||
148778251|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Adverse Event|0|||
148778252|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Pregnancy|1|||
148778253|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Pregnancy|0|||
148778254|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
148778255|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
148778256|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
148778257|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
148778258|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
148778259|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
148778260|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
148869689|NCT00477269|537000549|FG002|Open Label Extension|Death|4|||
148869690|NCT01792518|537000550|FG000|Overall Study|Adverse Event|3|||
148869691|NCT01792518|537000551|FG001|Overall Study|Adverse Event|4|||
148869692|NCT01792518|537000550|FG000|Overall Study|Protocol Violation|0|||
148869693|NCT01792518|537000551|FG001|Overall Study|Protocol Violation|1|||
148869694|NCT01792518|537000550|FG000|Overall Study|Lost to Follow-up|3|||
148869695|NCT01792518|537000551|FG001|Overall Study|Lost to Follow-up|1|||
148869696|NCT01792518|537000550|FG000|Overall Study|Withdrawal by Subject|2|||
148869697|NCT01792518|537000551|FG001|Overall Study|Withdrawal by Subject|0|||
148869698|NCT01792518|537000550|FG000|Overall Study|Other Reason|0|||
148869699|NCT01792518|537000551|FG001|Overall Study|Other Reason|1|||
148869700|NCT03263780|537000552|FG000|Overall Study|Withdrawal by Subject|3|||
148869701|NCT03263780|537000552|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
148869702|NCT00249613|537000557|FG000|12 Month Follow-up|Death|1|||
148869703|NCT00249613|537000558|FG001|12 Month Follow-up|Death|1|||
148869704|NCT00249613|537000557|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
148869705|NCT00249613|537000558|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
148869706|NCT00249613|537000557|FG000|12 Month Follow-up|Lost to Follow-up|10|||
148869707|NCT00249613|537000558|FG001|12 Month Follow-up|Lost to Follow-up|8|||
148869708|NCT00806442|537000559|FG000|Overall Study|Lost to Follow-up|3|||
148869709|NCT00806442|537000560|FG001|Overall Study|Lost to Follow-up|2|||
148869710|NCT00806442|537000559|FG000|Overall Study|Withdrawal by Subject|1|||
148869711|NCT00806442|537000560|FG001|Overall Study|Withdrawal by Subject|5|||
148869712|NCT01455220|537000571|FG000|Overall Study|screen fail|30|||
148869713|NCT00267150|537000572|FG000|Overall Study|Adverse Event|1|||
148869714|NCT04881747|537000573|FG000|Period 2 Washout|Adverse Event|1|||
148869715|NCT04881747|537000574|FG001|Period 2 Washout|Adverse Event|0|||
148869716|NCT04881747|537000575|FG002|Period 2 Washout|Adverse Event|0|||
148869717|NCT04881747|537000576|FG003|Period 2 Washout|Adverse Event|0|||
148869718|NCT04881747|537000577|FG004|Period 2 Washout|Adverse Event|1|||
148869719|NCT04881747|537000578|FG005|Period 2 Washout|Adverse Event|0|||
148869720|NCT04881747|537000573|FG000|Period 2 Washout|Withdrawal by Subject|1|||
148869721|NCT04881747|537000574|FG001|Period 2 Washout|Withdrawal by Subject|0|||
148869722|NCT04881747|537000575|FG002|Period 2 Washout|Withdrawal by Subject|0|||
148869723|NCT04881747|537000576|FG003|Period 2 Washout|Withdrawal by Subject|1|||
148869724|NCT04881747|537000577|FG004|Period 2 Washout|Withdrawal by Subject|0|||
148869725|NCT04881747|537000578|FG005|Period 2 Washout|Withdrawal by Subject|0|||
148869726|NCT00521222|537000580|FG000|Overall Study|Lost to Follow-up|0|||
148869727|NCT00521222|537000581|FG001|Overall Study|Lost to Follow-up|0|||
148869728|NCT00521222|537000582|FG002|Overall Study|Lost to Follow-up|1|||
148869729|NCT00521222|537000583|FG003|Overall Study|Lost to Follow-up|1|||
148869730|NCT00521222|537000580|FG000|Overall Study|Withdrawal by Subject|0|||
148869731|NCT00521222|537000581|FG001|Overall Study|Withdrawal by Subject|0|||
148869732|NCT00521222|537000582|FG002|Overall Study|Withdrawal by Subject|2|||
148869733|NCT00521222|537000583|FG003|Overall Study|Withdrawal by Subject|0|||
148869734|NCT00521222|537000580|FG000|Overall Study|Physician Decision|0|||
148869735|NCT00521222|537000581|FG001|Overall Study|Physician Decision|1|||
148869736|NCT00521222|537000582|FG002|Overall Study|Physician Decision|0|||
148869737|NCT00521222|537000583|FG003|Overall Study|Physician Decision|1|||
148869738|NCT02544373|537000588|FG000|Overall Study|Lost to Follow-up|5|||
148869739|NCT02544373|537000589|FG001|Overall Study|Lost to Follow-up|3|||
148869740|NCT02544373|537000588|FG000|Overall Study|Withdrawal by Subject|8|||
148869741|NCT02544373|537000589|FG001|Overall Study|Withdrawal by Subject|2|||
148869742|NCT02404649|537000590|FG000|Overall Study|Adverse Event|1|||
148869743|NCT02404649|537000591|FG001|Overall Study|Adverse Event|2|||
149000222|NCT03703466|537475688|FG001|Overall Study|Withdrawal by Subject|3|||
148869744|NCT00162266|537000595|FG000|Double-Blind Period|Adverse Event|5|||
148869745|NCT00162266|537000596|FG001|Double-Blind Period|Adverse Event|9|||
148869746|NCT00162266|537000597|FG002|Double-Blind Period|Adverse Event|11|||
148869747|NCT00162266|537000598|FG003|Double-Blind Period|Adverse Event|0|||
148869748|NCT00162266|537000595|FG000|Double-Blind Period|Death|0|||
148869749|NCT00162266|537000596|FG001|Double-Blind Period|Death|1|||
148869750|NCT00162266|537000597|FG002|Double-Blind Period|Death|0|||
148869751|NCT00162266|537000598|FG003|Double-Blind Period|Death|0|||
148869752|NCT00162266|537000595|FG000|Double-Blind Period|Lost to Follow-up|1|||
148869753|NCT00162266|537000596|FG001|Double-Blind Period|Lost to Follow-up|2|||
148869754|NCT00162266|537000597|FG002|Double-Blind Period|Lost to Follow-up|0|||
148869755|NCT00162266|537000598|FG003|Double-Blind Period|Lost to Follow-up|0|||
148869756|NCT00162266|537000595|FG000|Double-Blind Period|Other Reason|1|||
148869757|NCT00162266|537000596|FG001|Double-Blind Period|Other Reason|0|||
148869758|NCT00162266|537000597|FG002|Double-Blind Period|Other Reason|1|||
148869759|NCT00162266|537000598|FG003|Double-Blind Period|Other Reason|0|||
148869760|NCT00162266|537000595|FG000|Double-Blind Period|Lack of Efficacy|13|||
148869761|NCT00162266|537000596|FG001|Double-Blind Period|Lack of Efficacy|17|||
148869762|NCT00162266|537000597|FG002|Double-Blind Period|Lack of Efficacy|30|||
148869763|NCT00162266|537000598|FG003|Double-Blind Period|Lack of Efficacy|0|||
148869764|NCT00162266|537000595|FG000|Double-Blind Period|Withdrawal by Subject|5|||
148869765|NCT00162266|537000596|FG001|Double-Blind Period|Withdrawal by Subject|2|||
148869766|NCT00162266|537000597|FG002|Double-Blind Period|Withdrawal by Subject|6|||
148869767|NCT00162266|537000598|FG003|Double-Blind Period|Withdrawal by Subject|0|||
148869768|NCT00162266|537000595|FG000|Open-Label Period|Death|0|||
148869769|NCT00162266|537000596|FG001|Open-Label Period|Death|0|||
148869770|NCT00162266|537000597|FG002|Open-Label Period|Death|0|||
148869771|NCT00162266|537000598|FG003|Open-Label Period|Death|7|||
148869772|NCT00162266|537000595|FG000|Open-Label Period|Adverse Event|0|||
148869773|NCT00162266|537000596|FG001|Open-Label Period|Adverse Event|0|||
148869774|NCT00162266|537000597|FG002|Open-Label Period|Adverse Event|0|||
148869775|NCT00162266|537000598|FG003|Open-Label Period|Adverse Event|46|||
148869776|NCT00162266|537000595|FG000|Open-Label Period|Lack of Efficacy|0|||
148869777|NCT00162266|537000596|FG001|Open-Label Period|Lack of Efficacy|0|||
148869778|NCT00162266|537000597|FG002|Open-Label Period|Lack of Efficacy|0|||
148869779|NCT00162266|537000598|FG003|Open-Label Period|Lack of Efficacy|26|||
148869780|NCT00162266|537000595|FG000|Open-Label Period|Lost to Follow-up|0|||
148869781|NCT00162266|537000596|FG001|Open-Label Period|Lost to Follow-up|0|||
148869782|NCT00162266|537000597|FG002|Open-Label Period|Lost to Follow-up|0|||
148869783|NCT00162266|537000598|FG003|Open-Label Period|Lost to Follow-up|3|||
148869784|NCT00162266|537000595|FG000|Open-Label Period|Withdrawal by Subject|0|||
148869785|NCT00162266|537000596|FG001|Open-Label Period|Withdrawal by Subject|0|||
148869786|NCT00162266|537000597|FG002|Open-Label Period|Withdrawal by Subject|0|||
148869787|NCT00162266|537000598|FG003|Open-Label Period|Withdrawal by Subject|31|||
148869788|NCT00162266|537000595|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
148869789|NCT00162266|537000596|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
148869790|NCT00162266|537000597|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
148869791|NCT00162266|537000598|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
148869792|NCT00162266|537000595|FG000|Open-Label Period|Other Reasons|0|||
148869793|NCT00162266|537000596|FG001|Open-Label Period|Other Reasons|0|||
148869794|NCT00162266|537000597|FG002|Open-Label Period|Other Reasons|0|||
148869795|NCT00162266|537000598|FG003|Open-Label Period|Other Reasons|15|||
148869796|NCT04208087|537000599|FG000|Overall Study|Adverse Event|1|||
148869797|NCT04208087|537000600|FG001|Overall Study|Adverse Event|0|||
148869798|NCT04208087|537000601|FG002|Overall Study|Adverse Event|0|||
148869799|NCT04208087|537000602|FG003|Overall Study|Adverse Event|0|||
148869800|NCT04208087|537000603|FG004|Overall Study|Adverse Event|0|||
148869801|NCT04208087|537000599|FG000|Overall Study|Withdrawal by Subject|0|||
148869802|NCT04208087|537000600|FG001|Overall Study|Withdrawal by Subject|0|||
148869803|NCT04208087|537000601|FG002|Overall Study|Withdrawal by Subject|1|||
148869804|NCT04208087|537000602|FG003|Overall Study|Withdrawal by Subject|0|||
148869805|NCT04208087|537000603|FG004|Overall Study|Withdrawal by Subject|0|||
149000223|NCT03703466|537475689|FG002|Overall Study|Withdrawal by Subject|0|||
149000224|NCT03703466|537475687|FG000|Overall Study|Completed < 3 Cycles|2|||
149000225|NCT03703466|537475688|FG001|Overall Study|Completed < 3 Cycles|2|||
149000226|NCT03703466|537475689|FG002|Overall Study|Completed < 3 Cycles|2|||
149000227|NCT01553318|537477631|FG000|Overall Study|Protocol Violation|3|||
149000228|NCT01553318|537477632|FG001|Overall Study|Protocol Violation|2|||
149000229|NCT02178059|537477634|FG000|Washout|Physician Decision|1|||
149000230|NCT02178059|537477635|FG001|Washout|Physician Decision|0|||
149000231|NCT02586025|537477638|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
149000232|NCT02586025|537477639|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
149000233|NCT02586025|537477638|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
149000234|NCT02586025|537477639|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
149000235|NCT02586025|537477638|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
149000236|NCT02586025|537477639|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
149000237|NCT02586025|537477638|FG000|Neoadjuvant Treatment|Death|1|||
149000238|NCT02586025|537477639|FG001|Neoadjuvant Treatment|Death|0|||
149000239|NCT02586025|537477638|FG000|Neoadjuvant Treatment|Adverse Event|1|||
149000240|NCT02586025|537477639|FG001|Neoadjuvant Treatment|Adverse Event|0|||
149000241|NCT02586025|537477638|FG000|Neoadjuvant Treatment|Physician Decision|2|||
149000242|NCT02586025|537477639|FG001|Neoadjuvant Treatment|Physician Decision|1|||
149000243|NCT02586025|537477638|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
149000244|NCT02586025|537477639|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
149000245|NCT02586025|537477638|FG000|Adjuvant Treatment|Recurrent Disease|4|||
149000246|NCT02586025|537477639|FG001|Adjuvant Treatment|Recurrent Disease|5|||
149000247|NCT02586025|537477638|FG000|Adjuvant Treatment|Physician Decision|0|||
149000248|NCT02586025|537477639|FG001|Adjuvant Treatment|Physician Decision|1|||
149000249|NCT02586025|537477638|FG000|Adjuvant Treatment|Pregnancy|1|||
148869806|NCT04208087|537000599|FG000|Overall Study|Other|0|||
149000250|NCT02586025|537477639|FG001|Adjuvant Treatment|Pregnancy|0|||
148869807|NCT04208087|537000600|FG001|Overall Study|Other|0|||
148869808|NCT04208087|537000601|FG002|Overall Study|Other|0|||
148869809|NCT04208087|537000602|FG003|Overall Study|Other|0|||
148869810|NCT04208087|537000603|FG004|Overall Study|Other|1|||
148869811|NCT01839656|537000604|FG000|Overall Study|Withdrawal by Subject|1|||
148869812|NCT01839656|537000605|FG001|Overall Study|Withdrawal by Subject|1|||
148869813|NCT01839656|537000604|FG000|Overall Study|Adverse event, serious fatal|1|||
148869814|NCT01839656|537000605|FG001|Overall Study|Adverse event, serious fatal|4|||
149000251|NCT02586025|537477638|FG000|Treatment-Free Follow-Up|Death|11|||
148869815|NCT01839656|537000604|FG000|Overall Study|Early study closure|0|||
148869816|NCT01839656|537000605|FG001|Overall Study|Early study closure|11|||
148869817|NCT01839656|537000604|FG000|Overall Study|Adverse Event|1|||
149032140|NCT00567164|537595984|FG002|Overall Study|Withdrawal by Subject|17|||
149032141|NCT00567164|537595982|FG000|Overall Study|Protocol Violation|23|||
149032142|NCT00567164|537595983|FG001|Overall Study|Protocol Violation|4|||
149032143|NCT00567164|537595984|FG002|Overall Study|Protocol Violation|2|||
149032144|NCT00567164|537595982|FG000|Overall Study|Adverse Event|92|||
149032145|NCT00567164|537595983|FG001|Overall Study|Adverse Event|13|||
149032146|NCT00567164|537595984|FG002|Overall Study|Adverse Event|9|||
149032147|NCT00567164|537595982|FG000|Overall Study|Death|0|||
149032148|NCT00567164|537595983|FG001|Overall Study|Death|0|||
149032149|NCT00567164|537595984|FG002|Overall Study|Death|1|||
149032150|NCT00567164|537595982|FG000|Overall Study|Lost to Follow-up|202|||
149032151|NCT00567164|537595983|FG001|Overall Study|Lost to Follow-up|23|||
149032152|NCT00567164|537595984|FG002|Overall Study|Lost to Follow-up|21|||
149032153|NCT00567164|537595982|FG000|Overall Study|Pregnancy|20|||
149032154|NCT00567164|537595983|FG001|Overall Study|Pregnancy|4|||
149032155|NCT00567164|537595984|FG002|Overall Study|Pregnancy|6|||
149032156|NCT00567164|537595982|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
149032157|NCT00567164|537595983|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
149032158|NCT00567164|537595984|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
149032159|NCT00567164|537595982|FG000|Overall Study|Missing|1|||
149032160|NCT00567164|537595983|FG001|Overall Study|Missing|0|||
149032161|NCT00567164|537595984|FG002|Overall Study|Missing|0|||
149032162|NCT04044664|537595985|FG000|Stage 1|Adverse Event|3|||
149032163|NCT04044664|537595986|FG001|Stage 1|Adverse Event|3|||
149032164|NCT04044664|537595987|FG002|Stage 1|Adverse Event|1|||
149032165|NCT04044664|537595985|FG000|Stage 1|Lost to Follow-up|3|||
149032166|NCT04044664|537595986|FG001|Stage 1|Lost to Follow-up|2|||
149032167|NCT04044664|537595987|FG002|Stage 1|Lost to Follow-up|2|||
149032168|NCT04044664|537595985|FG000|Stage 1|Withdrawal by Subject|9|||
149032169|NCT04044664|537595986|FG001|Stage 1|Withdrawal by Subject|1|||
149032170|NCT04044664|537595987|FG002|Stage 1|Withdrawal by Subject|0|||
149032171|NCT04044664|537595985|FG000|Stage 1|noncompliance, personal reason|2|||
149032172|NCT04044664|537595986|FG001|Stage 1|noncompliance, personal reason|0|||
149032173|NCT04044664|537595987|FG002|Stage 1|noncompliance, personal reason|0|||
149032174|NCT04044664|537595985|FG000|Stage 1|randomization error|0|||
149032175|NCT04044664|537595986|FG001|Stage 1|randomization error|1|||
149032176|NCT04044664|537595987|FG002|Stage 1|randomization error|0|||
149032177|NCT04044664|537595985|FG000|Stage 2|Adverse Event|2|||
149032178|NCT04044664|537595986|FG001|Stage 2|Adverse Event|0|||
149032179|NCT04044664|537595987|FG002|Stage 2|Adverse Event|0|||
149032180|NCT04044664|537595985|FG000|Stage 2|Lost to Follow-up|3|||
149032181|NCT04044664|537595986|FG001|Stage 2|Lost to Follow-up|2|||
149032182|NCT04044664|537595987|FG002|Stage 2|Lost to Follow-up|1|||
149032183|NCT04044664|537595985|FG000|Stage 2|Withdrawal by Subject|3|||
149032184|NCT04044664|537595986|FG001|Stage 2|Withdrawal by Subject|0|||
149032185|NCT04044664|537595987|FG002|Stage 2|Withdrawal by Subject|0|||
149032186|NCT04044664|537595985|FG000|Stage 2|protocol deviation|1|||
149032187|NCT04044664|537595986|FG001|Stage 2|protocol deviation|0|||
149032188|NCT04044664|537595987|FG002|Stage 2|protocol deviation|0|||
149032189|NCT00001575|537595991|FG000|Overall Study|Screening failures-Ph I portion|22|||
149032190|NCT00001575|537595991|FG000|Overall Study|Withdrawn/deaths|23|||
149032191|NCT00831792|537595994|FG000|Overall Study|Not Eligible|3|||
149032192|NCT00831792|537595994|FG000|Overall Study|Adverse Event|1|||
149032193|NCT00831792|537595994|FG000|Overall Study|Death|1|||
149032194|NCT00831792|537595994|FG000|Overall Study|Lack of Efficacy|1|||
149032195|NCT01744691|537595996|FG000|Overall Study|Progressive Disease|18|||
149032196|NCT01744691|537595996|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
149032197|NCT01744691|537595996|FG000|Overall Study|Withdrawal of consent for treatment|3|||
149032198|NCT01744691|537595996|FG000|Overall Study|Physician Decision|4|||
149032199|NCT04588480|537595998|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
149032200|NCT04588480|537595999|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
149032201|NCT04588480|537596000|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
149032202|NCT04588480|537595998|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
149032203|NCT04588480|537595999|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
149032204|NCT04588480|537596000|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
149032205|NCT01242085|537596001|FG000|Overall Study|Withdrawal by Subject|4|||
149032206|NCT01242085|537596002|FG001|Overall Study|Withdrawal by Subject|2|||
149032207|NCT01242085|537596003|FG002|Overall Study|Withdrawal by Subject|0|||
149032208|NCT01242085|537596001|FG000|Overall Study|medically unable to have surgery|4|||
149032209|NCT01242085|537596002|FG001|Overall Study|medically unable to have surgery|5|||
149032210|NCT01242085|537596003|FG002|Overall Study|medically unable to have surgery|0|||
149032211|NCT01178762|537596004|FG000|Overall Study|Lost to Follow-up|15|||
149032212|NCT02377362|537596005|FG000|Part A Second Treatment|Protocol Violation|0|||
149032213|NCT02377362|537596006|FG001|Part A Second Treatment|Protocol Violation|0|||
148869818|NCT01839656|537000605|FG001|Overall Study|Adverse Event|0|||
149032214|NCT02377362|537596007|FG002|Part A Second Treatment|Protocol Violation|0|||
148869819|NCT02621073|537000615|FG000|Overall Study|Lost to Follow-up|0|||
148869820|NCT02621073|537000616|FG001|Overall Study|Lost to Follow-up|1|||
148869821|NCT02621073|537000615|FG000|Overall Study|Physician Decision|3|||
148869822|NCT02621073|537000616|FG001|Overall Study|Physician Decision|2|||
148869823|NCT01595581|537000617|FG000|Overall Study|Withdrawal by Subject|1|||
148869824|NCT01595581|537000618|FG001|Overall Study|Withdrawal by Subject|0|||
148869825|NCT01012323|537000622|FG000|Overall Study|Investigator Judgment|1|||
148869826|NCT00495755|537000623|FG000|Overall Study|Adverse Event|3|||
148869827|NCT02920957|537000624|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
148869828|NCT02920957|537000625|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
148869829|NCT02920957|537000624|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
148869830|NCT02920957|537000625|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
148869831|NCT02920957|537000624|FG000|First Intervention : 1 Month|Adverse Event|1|||
148869832|NCT02920957|537000625|FG001|First Intervention : 1 Month|Adverse Event|0|||
148869833|NCT02920957|537000624|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
148869834|NCT02920957|537000625|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
148869835|NCT00558272|537000626|FG000|Overall Study|Adverse Event|10|||
148869836|NCT00558272|537000627|FG001|Overall Study|Adverse Event|0|||
148869837|NCT00558272|537000626|FG000|Overall Study|Death|1|||
148869838|NCT00558272|537000627|FG001|Overall Study|Death|0|||
148869839|NCT00558272|537000626|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
148869840|NCT00558272|537000627|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
148869841|NCT00558272|537000626|FG000|Overall Study|AZ study team decision|0|||
148869842|NCT00558272|537000627|FG001|Overall Study|AZ study team decision|1|||
148869843|NCT00558272|537000626|FG000|Overall Study|Incorrectly enrolled|1|||
148869844|NCT00558272|537000627|FG001|Overall Study|Incorrectly enrolled|0|||
148869845|NCT00558272|537000626|FG000|Overall Study|Withdrawal by Subject|0|||
148869846|NCT00558272|537000627|FG001|Overall Study|Withdrawal by Subject|1|||
148869847|NCT02014584|537000631|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
148869848|NCT02014584|537000632|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
148869849|NCT02014584|537000633|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
148869850|NCT02014584|537000634|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
148869851|NCT02014584|537000635|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
148869852|NCT02014584|537000636|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
148869853|NCT02014584|537000631|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
148869854|NCT02014584|537000632|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
148869855|NCT02014584|537000633|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
148869856|NCT02014584|537000634|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
148869857|NCT02014584|537000635|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
148869858|NCT02014584|537000636|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
148869859|NCT02014584|537000631|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
148869860|NCT02014584|537000632|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
148869861|NCT02014584|537000633|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
148869862|NCT02014584|537000634|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
148869863|NCT02014584|537000635|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
148869864|NCT02014584|537000636|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
148869865|NCT02014584|537000631|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
148869866|NCT02014584|537000632|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
148869867|NCT02014584|537000633|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
148869868|NCT02014584|537000634|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
148869869|NCT02014584|537000635|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
148869870|NCT02014584|537000636|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
148869871|NCT02014584|537000631|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
148869872|NCT02014584|537000632|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
148869873|NCT02014584|537000633|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
148869874|NCT02014584|537000634|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
148869875|NCT02014584|537000635|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
148869876|NCT02014584|537000636|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
148869877|NCT00483002|537000637|FG000|Overall Study|Adverse Event|68|||
148869878|NCT00483002|537000637|FG000|Overall Study|Lack of Efficacy|555|||
148869879|NCT00483002|537000637|FG000|Overall Study|Lost to Follow-up|962|||
148869880|NCT00483002|537000637|FG000|Overall Study|Other|2|||
148869881|NCT00483002|537000637|FG000|Overall Study|Other|967|||
148869882|NCT03442296|537000638|FG000|3 Month Follow-up|Death|3|||
148869883|NCT03442296|537000639|FG001|3 Month Follow-up|Death|1|||
148869884|NCT03442296|537000638|FG000|3 Month Follow-up|Lost to Follow-up|1|||
148869885|NCT03442296|537000639|FG001|3 Month Follow-up|Lost to Follow-up|1|||
148869886|NCT03442296|537000638|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
148869887|NCT03442296|537000639|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
148869888|NCT03442296|537000638|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
149032215|NCT02377362|537596008|FG003|Part A Second Treatment|Protocol Violation|0|||
149032216|NCT02377362|537596009|FG004|Part A Second Treatment|Protocol Violation|1|||
148869889|NCT03442296|537000639|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
148869890|NCT03442296|537000638|FG000|12 Month Follow-up|Incomplete measurement|1|||
148869891|NCT03442296|537000639|FG001|12 Month Follow-up|Incomplete measurement|1|||
148869892|NCT03684694|537000640|FG000|Phase 1|Withdrawal by Subject|1|||
148869893|NCT03684694|537000641|FG001|Phase 1|Withdrawal by Subject|0|||
148869894|NCT03684694|537000642|FG002|Phase 1|Withdrawal by Subject|0|||
148869895|NCT03684694|537000643|FG003|Phase 1|Withdrawal by Subject|0|||
148869896|NCT03684694|537000644|FG004|Phase 1|Withdrawal by Subject|0|||
148869897|NCT03684694|537000645|FG005|Phase 1|Withdrawal by Subject|0|||
148869898|NCT03684694|537000640|FG000|Phase 1|Investigator/Sponsor Decision|12|||
148869899|NCT03684694|537000641|FG001|Phase 1|Investigator/Sponsor Decision|2|||
148869900|NCT03684694|537000642|FG002|Phase 1|Investigator/Sponsor Decision|1|||
148869901|NCT03684694|537000643|FG003|Phase 1|Investigator/Sponsor Decision|0|||
148869902|NCT03684694|537000644|FG004|Phase 1|Investigator/Sponsor Decision|0|||
148869903|NCT03684694|537000645|FG005|Phase 1|Investigator/Sponsor Decision|0|||
148869904|NCT03684694|537000640|FG000|Phase 1|Death|24|||
148869905|NCT03684694|537000641|FG001|Phase 1|Death|0|||
148869906|NCT03684694|537000642|FG002|Phase 1|Death|3|||
148869907|NCT03684694|537000643|FG003|Phase 1|Death|0|||
148869908|NCT03684694|537000644|FG004|Phase 1|Death|0|||
148869909|NCT03684694|537000645|FG005|Phase 1|Death|0|||
148869910|NCT03684694|537000640|FG000|Phase 1|Lost to Follow-up|0|||
148869911|NCT03684694|537000641|FG001|Phase 1|Lost to Follow-up|0|||
148869912|NCT03684694|537000642|FG002|Phase 1|Lost to Follow-up|1|||
148869913|NCT03684694|537000643|FG003|Phase 1|Lost to Follow-up|0|||
148869914|NCT03684694|537000644|FG004|Phase 1|Lost to Follow-up|0|||
148869915|NCT03684694|537000645|FG005|Phase 1|Lost to Follow-up|0|||
148869916|NCT03684694|537000640|FG000|Phase 1|Miscellaneous|0|||
148869917|NCT03684694|537000641|FG001|Phase 1|Miscellaneous|1|||
148869918|NCT03684694|537000642|FG002|Phase 1|Miscellaneous|0|||
148869919|NCT03684694|537000643|FG003|Phase 1|Miscellaneous|0|||
148869920|NCT03684694|537000644|FG004|Phase 1|Miscellaneous|0|||
148869921|NCT03684694|537000645|FG005|Phase 1|Miscellaneous|0|||
148869922|NCT03684694|537000640|FG000|Phase 2|Withdrawal by Subject|0|||
148869923|NCT03684694|537000641|FG001|Phase 2|Withdrawal by Subject|0|||
148869924|NCT03684694|537000642|FG002|Phase 2|Withdrawal by Subject|0|||
148869925|NCT03684694|537000643|FG003|Phase 2|Withdrawal by Subject|0|||
148869926|NCT03684694|537000644|FG004|Phase 2|Withdrawal by Subject|0|||
148869927|NCT03684694|537000645|FG005|Phase 2|Withdrawal by Subject|1|||
148869928|NCT03684694|537000640|FG000|Phase 2|Investigator/Sponsor Decision|0|||
148869929|NCT03684694|537000641|FG001|Phase 2|Investigator/Sponsor Decision|0|||
148869930|NCT03684694|537000642|FG002|Phase 2|Investigator/Sponsor Decision|0|||
148869931|NCT03684694|537000643|FG003|Phase 2|Investigator/Sponsor Decision|17|||
148869932|NCT03684694|537000644|FG004|Phase 2|Investigator/Sponsor Decision|16|||
148869933|NCT03684694|537000645|FG005|Phase 2|Investigator/Sponsor Decision|6|||
148869934|NCT03684694|537000640|FG000|Phase 2|Death|0|||
148869935|NCT03684694|537000641|FG001|Phase 2|Death|0|||
148869936|NCT03684694|537000642|FG002|Phase 2|Death|0|||
148869937|NCT03684694|537000643|FG003|Phase 2|Death|28|||
148869938|NCT03684694|537000644|FG004|Phase 2|Death|14|||
148869939|NCT03684694|537000645|FG005|Phase 2|Death|3|||
148869940|NCT03684694|537000640|FG000|Phase 2|Lost to Follow-up|0|||
149032217|NCT02377362|537596010|FG005|Part A Second Treatment|Protocol Violation|0|||
149032218|NCT02377362|537596011|FG006|Part A Second Treatment|Protocol Violation|0|||
149032219|NCT02377362|537596012|FG007|Part A Second Treatment|Protocol Violation|0|||
149032220|NCT02377362|537596013|FG008|Part A Second Treatment|Protocol Violation|0|||
149032221|NCT02377362|537596014|FG009|Part A Second Treatment|Protocol Violation|0|||
148869941|NCT03684694|537000641|FG001|Phase 2|Lost to Follow-up|0|||
148869942|NCT03684694|537000642|FG002|Phase 2|Lost to Follow-up|0|||
148869943|NCT03684694|537000643|FG003|Phase 2|Lost to Follow-up|1|||
148869944|NCT03684694|537000644|FG004|Phase 2|Lost to Follow-up|0|||
149032222|NCT02377362|537596015|FG010|Part A Second Treatment|Protocol Violation|0|||
149032223|NCT02377362|537596016|FG011|Part A Second Treatment|Protocol Violation|0|||
149032224|NCT02377362|537596017|FG012|Part A Second Treatment|Protocol Violation|0|||
149032225|NCT02377362|537596005|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
148869945|NCT03684694|537000645|FG005|Phase 2|Lost to Follow-up|0|||
148869946|NCT03684694|537000640|FG000|Phase 2|Miscellaneous|0|||
148869947|NCT03684694|537000641|FG001|Phase 2|Miscellaneous|0|||
148869948|NCT03684694|537000642|FG002|Phase 2|Miscellaneous|0|||
148869949|NCT03684694|537000643|FG003|Phase 2|Miscellaneous|3|||
148869950|NCT03684694|537000644|FG004|Phase 2|Miscellaneous|0|||
148869951|NCT03684694|537000645|FG005|Phase 2|Miscellaneous|0|||
148869952|NCT05011513|537002235|FG000|Overall Study|Death|0|||
148869953|NCT05011513|537002236|FG001|Overall Study|Death|1|||
148869954|NCT05011513|537002235|FG000|Overall Study|Lost to Follow-up|4|||
148869955|NCT05011513|537002236|FG001|Overall Study|Lost to Follow-up|0|||
148869956|NCT05011513|537002235|FG000|Overall Study|Withdrawal by Subject|18|||
148869957|NCT05011513|537002236|FG001|Overall Study|Withdrawal by Subject|17|||
148869958|NCT05011513|537002235|FG000|Overall Study|Other|4|||
148869959|NCT05011513|537002236|FG001|Overall Study|Other|2|||
148869960|NCT03667690|537002237|FG000|Overall Study|Adverse Event|0|||
148869961|NCT03667690|537002238|FG001|Overall Study|Adverse Event|3|||
148869962|NCT03667690|537002237|FG000|Overall Study|Death|22|||
148869963|NCT03667690|537002238|FG001|Overall Study|Death|21|||
148869964|NCT03667690|537002237|FG000|Overall Study|Lost to Follow-up|4|||
148869965|NCT03667690|537002238|FG001|Overall Study|Lost to Follow-up|5|||
148869966|NCT03667690|537002237|FG000|Overall Study|Withdrawal by Subject|7|||
148869967|NCT03667690|537002238|FG001|Overall Study|Withdrawal by Subject|8|||
148869968|NCT03667690|537002237|FG000|Overall Study|Subject could not return for additional investigational product|1|||
148869969|NCT03667690|537002238|FG001|Overall Study|Subject could not return for additional investigational product|0|||
148869970|NCT03667690|537002237|FG000|Overall Study|Subject discharged to hospice care|2|||
148869971|NCT03667690|537002238|FG001|Overall Study|Subject discharged to hospice care|0|||
148869972|NCT03667690|537002237|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
148869973|NCT03667690|537002238|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
148869974|NCT03667690|537002237|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
148869975|NCT03667690|537002238|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
148869976|NCT03667690|537002237|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
148869977|NCT03667690|537002238|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
148869978|NCT03667690|537002237|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
148869979|NCT03667690|537002238|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
148869980|NCT03667690|537002237|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
148869981|NCT03667690|537002238|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
148869982|NCT00837759|537002241|FG000|Overall Study|Protocol Violation|3|||
148869983|NCT00837759|537002241|FG000|Overall Study|Lost to Follow-up|1|||
148869984|NCT01073930|537002243|FG000|Overall Study|Withdrawal by Subject|3|||
148869985|NCT01073930|537002244|FG001|Overall Study|Withdrawal by Subject|2|||
148869986|NCT01073930|537002243|FG000|Overall Study|Lost to Follow-up|0|||
148869987|NCT01073930|537002244|FG001|Overall Study|Lost to Follow-up|1|||
148869988|NCT01073930|537002243|FG000|Overall Study|Adverse Event|0|||
148869989|NCT01073930|537002244|FG001|Overall Study|Adverse Event|1|||
148869990|NCT01073930|537002243|FG000|Overall Study|Noncompliance with study drug|0|||
148869991|NCT01073930|537002244|FG001|Overall Study|Noncompliance with study drug|1|||
148869992|NCT01073930|537002243|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
148869993|NCT01073930|537002244|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
148869994|NCT01192568|537002245|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
148869995|NCT01192568|537002246|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
148869996|NCT01192568|537002247|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
148869997|NCT01192568|537002248|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
148869998|NCT01192568|537002245|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
148869999|NCT01192568|537002246|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
148870000|NCT01192568|537002247|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
148870001|NCT01192568|537002248|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
148870002|NCT03459365|537002249|FG000|Overall Study|Withdrawal by Subject|6|||
148870003|NCT03459365|537002249|FG000|Overall Study|Protocol Violation|8|||
148870004|NCT00599755|537002250|FG000|Overall Study|Adverse Event|11|||
148870005|NCT00599755|537002250|FG000|Overall Study|Withdrawal by Subject|2|||
148870006|NCT00599755|537002250|FG000|Overall Study|Progression of Disease|3|||
148870007|NCT00599755|537002250|FG000|Overall Study|Other Reason|2|||
148870008|NCT00599755|537002250|FG000|Overall Study|No data available|1|||
148870009|NCT04037254|537002251|FG000|Overall Study|Protocol Violation|1|||
148870010|NCT04037254|537002252|FG001|Overall Study|Protocol Violation|0|||
148870011|NCT04037254|537002253|FG002|Overall Study|Protocol Violation|0|||
148870012|NCT04037254|537002254|FG003|Overall Study|Protocol Violation|0|||
148870013|NCT04037254|537002255|FG004|Overall Study|Protocol Violation|0|||
148870014|NCT04037254|537002251|FG000|Overall Study|Withdrawal by Subject|0|||
148870015|NCT04037254|537002252|FG001|Overall Study|Withdrawal by Subject|0|||
148870016|NCT04037254|537002253|FG002|Overall Study|Withdrawal by Subject|1|||
148870017|NCT04037254|537002254|FG003|Overall Study|Withdrawal by Subject|0|||
148870018|NCT04037254|537002255|FG004|Overall Study|Withdrawal by Subject|0|||
148870019|NCT04037254|537002251|FG000|Overall Study|Delayed or incomplete treatment|0|||
148870020|NCT04037254|537002252|FG001|Overall Study|Delayed or incomplete treatment|2|||
148870021|NCT04037254|537002253|FG002|Overall Study|Delayed or incomplete treatment|1|||
148870022|NCT04037254|537002254|FG003|Overall Study|Delayed or incomplete treatment|0|||
148870023|NCT04037254|537002255|FG004|Overall Study|Delayed or incomplete treatment|0|||
148870024|NCT03320330|537002256|FG000|Overall Study|Lack of Efficacy|5|||
148870025|NCT03320330|537002257|FG001|Overall Study|Lack of Efficacy|5|||
148870026|NCT03320330|537002258|FG002|Overall Study|Lack of Efficacy|14|||
148870027|NCT03320330|537002256|FG000|Overall Study|Physician Decision|1|||
148870028|NCT03320330|537002257|FG001|Overall Study|Physician Decision|0|||
148870029|NCT03320330|537002258|FG002|Overall Study|Physician Decision|0|||
148870030|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
149032226|NCT02377362|537596006|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
148870031|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
148870032|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
148870033|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
148870034|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
148870035|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
148870036|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
148870037|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
148870038|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
148870039|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
148870040|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
148870041|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
148870042|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
148870043|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
148870044|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
148870045|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
148870046|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
149000252|NCT02586025|537477639|FG001|Treatment-Free Follow-Up|Death|11|||
149000253|NCT02586025|537477638|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
149000254|NCT02586025|537477639|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
149000255|NCT02586025|537477638|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
149000256|NCT02586025|537477639|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
149000257|NCT02586025|537477638|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
149000258|NCT02586025|537477639|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
149000259|NCT02586025|537477638|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
149000260|NCT02586025|537477639|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
149000261|NCT00175825|537477640|FG000|Overall Study|Adverse Event|3|||
149000262|NCT00175825|537477641|FG001|Overall Study|Adverse Event|2|||
149000263|NCT00175825|537477642|FG002|Overall Study|Adverse Event|1|||
149000264|NCT00175825|537477643|FG003|Overall Study|Adverse Event|1|||
149000265|NCT00175825|537477640|FG000|Overall Study|Lost to Follow-up|1|||
149000266|NCT00175825|537477641|FG001|Overall Study|Lost to Follow-up|2|||
149000267|NCT00175825|537477642|FG002|Overall Study|Lost to Follow-up|0|||
149000268|NCT00175825|537477643|FG003|Overall Study|Lost to Follow-up|0|||
149000269|NCT00175825|537477640|FG000|Overall Study|Withdrawal by Subject|1|||
149000270|NCT00175825|537477641|FG001|Overall Study|Withdrawal by Subject|0|||
149000271|NCT00175825|537477642|FG002|Overall Study|Withdrawal by Subject|0|||
149000272|NCT00175825|537477643|FG003|Overall Study|Withdrawal by Subject|0|||
149000273|NCT04098406|537477644|FG000|Overall Study|Adverse Event|2|||
149000274|NCT04098406|537477645|FG001|Overall Study|Adverse Event|1|||
149000275|NCT04098406|537477644|FG000|Overall Study|Withdrawal by Subject|1|||
149000276|NCT04098406|537477645|FG001|Overall Study|Withdrawal by Subject|0|||
149000277|NCT03597568|537477646|FG000|Overall Study|Withdrawal by Subject|1|||
149000278|NCT03597568|537477647|FG001|Overall Study|Withdrawal by Subject|1|||
149000279|NCT03597568|537477646|FG000|Overall Study|Unable to analyze vascular data|1|||
149000280|NCT03597568|537477647|FG001|Overall Study|Unable to analyze vascular data|1|||
149000281|NCT00999466|537477650|FG000|Main Part|Withdrawal by Subject|0|||
149000282|NCT00999466|537477651|FG001|Main Part|Withdrawal by Subject|0|||
149000283|NCT00999466|537477652|FG002|Main Part|Withdrawal by Subject|2|||
149000284|NCT00999466|537477650|FG000|Main Part|Adverse Event|0|||
149000285|NCT00999466|537477651|FG001|Main Part|Adverse Event|4|||
149000286|NCT00999466|537477652|FG002|Main Part|Adverse Event|2|||
149000287|NCT01357616|537477653|FG000|Overall Study|Adverse Event|1|||
149000288|NCT01357616|537477654|FG001|Overall Study|Adverse Event|1|||
149000289|NCT01357616|537477653|FG000|Overall Study|Lost to Follow-up|4|||
149000290|NCT01357616|537477654|FG001|Overall Study|Lost to Follow-up|3|||
149000291|NCT01357616|537477653|FG000|Overall Study|Protocol Violation|0|||
149000292|NCT01357616|537477654|FG001|Overall Study|Protocol Violation|2|||
149000293|NCT01357616|537477653|FG000|Overall Study|Inadequate Control of IOP|1|||
149000294|NCT01357616|537477654|FG001|Overall Study|Inadequate Control of IOP|2|||
149000295|NCT01357616|537477653|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
149000296|NCT01357616|537477654|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
149000297|NCT01357616|537477653|FG000|Overall Study|Withdrawal by Subject|1|||
149000298|NCT01357616|537477654|FG001|Overall Study|Withdrawal by Subject|0|||
149000299|NCT03255824|537477656|FG000|Overall Study|Under-sedation|2|||
149000300|NCT03255824|537477657|FG001|Overall Study|Under-sedation|1|||
149000301|NCT02001194|537477659|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
149000302|NCT02001194|537477660|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
149000303|NCT02001194|537477661|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
149000304|NCT02001194|537477662|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
148870047|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
148870048|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
149000305|NCT02001194|537477659|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
149000306|NCT02001194|537477660|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
149000307|NCT02001194|537477661|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
149032227|NCT02377362|537596007|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032228|NCT02377362|537596008|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
149032229|NCT02377362|537596009|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
149032230|NCT02377362|537596010|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
149032231|NCT02377362|537596011|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032232|NCT02377362|537596012|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032233|NCT02377362|537596013|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032234|NCT02377362|537596014|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032235|NCT02377362|537596015|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032236|NCT02377362|537596016|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032237|NCT02377362|537596017|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
149032238|NCT02377362|537596005|FG000|Part B Overall|Protocol Violation|0|||
149032239|NCT02377362|537596006|FG001|Part B Overall|Protocol Violation|0|||
149032240|NCT02377362|537596007|FG002|Part B Overall|Protocol Violation|0|||
149032241|NCT02377362|537596008|FG003|Part B Overall|Protocol Violation|0|||
149032242|NCT02377362|537596009|FG004|Part B Overall|Protocol Violation|0|||
149032243|NCT02377362|537596010|FG005|Part B Overall|Protocol Violation|0|||
149032244|NCT02377362|537596011|FG006|Part B Overall|Protocol Violation|0|||
149032245|NCT02377362|537596012|FG007|Part B Overall|Protocol Violation|0|||
149032246|NCT02377362|537596013|FG008|Part B Overall|Protocol Violation|0|||
149032247|NCT02377362|537596014|FG009|Part B Overall|Protocol Violation|1|||
149032248|NCT02377362|537596015|FG010|Part B Overall|Protocol Violation|0|||
149032249|NCT02377362|537596016|FG011|Part B Overall|Protocol Violation|0|||
149032250|NCT02377362|537596017|FG012|Part B Overall|Protocol Violation|0|||
149032251|NCT02377362|537596005|FG000|Part B Overall|Adverse Event|0|||
149032252|NCT02377362|537596006|FG001|Part B Overall|Adverse Event|0|||
149032253|NCT02377362|537596007|FG002|Part B Overall|Adverse Event|0|||
148870049|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
148870050|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
148870051|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
148870052|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
148870053|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
148870054|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
148870055|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
148870056|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
148870057|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
148870058|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
148870059|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
148870060|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
148870061|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
148870062|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
148870063|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
148870064|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
148870065|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
148870066|NCT02198794|537002259|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
148870067|NCT02198794|537002260|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
148870068|NCT02198794|537002261|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
148870069|NCT02198794|537002262|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
148870070|NCT02198794|537002259|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
148870071|NCT02198794|537002260|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
148870072|NCT02198794|537002261|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
148870073|NCT02198794|537002262|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
148870074|NCT02198794|537002259|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
148870075|NCT02198794|537002260|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
148870076|NCT02198794|537002261|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
148870077|NCT02198794|537002262|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
148870078|NCT02198794|537002259|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
148870079|NCT02198794|537002260|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
148870080|NCT02198794|537002261|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
149032254|NCT02377362|537596008|FG003|Part B Overall|Adverse Event|0|||
148870081|NCT02198794|537002262|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
149032255|NCT02377362|537596009|FG004|Part B Overall|Adverse Event|0|||
149032256|NCT02377362|537596010|FG005|Part B Overall|Adverse Event|0|||
148870082|NCT02198794|537002259|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
149032257|NCT02377362|537596011|FG006|Part B Overall|Adverse Event|1|||
149032258|NCT02377362|537596012|FG007|Part B Overall|Adverse Event|1|||
149032259|NCT02377362|537596013|FG008|Part B Overall|Adverse Event|0|||
149032260|NCT02377362|537596014|FG009|Part B Overall|Adverse Event|0|||
148870083|NCT02198794|537002260|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
149032261|NCT02377362|537596015|FG010|Part B Overall|Adverse Event|0|||
148870084|NCT02198794|537002261|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
148870085|NCT02198794|537002262|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
148870086|NCT02198794|537002259|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
148870087|NCT02198794|537002260|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
148870088|NCT02198794|537002261|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
148870089|NCT02198794|537002262|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
148870090|NCT01306656|537002264|FG000|Overall Study|Lost to Follow-up|1|||
148870091|NCT01306656|537002265|FG001|Overall Study|Lost to Follow-up|0|||
148870092|NCT00477152|537002268|FG000|Overall Study|Parent withdrew consent|2|||
148870093|NCT00477152|537002268|FG000|Overall Study|Adverse Event|1|||
148870094|NCT01023672|537002269|FG000|Overall Study|Worsening disease|2|||
148870095|NCT01023672|537002269|FG000|Overall Study|Death|1|||
148870096|NCT01918332|537002270|FG000|Overall Study|Adverse Event|0|||
148870097|NCT01918332|537002271|FG001|Overall Study|Adverse Event|0|||
148870098|NCT01918332|537002272|FG002|Overall Study|Adverse Event|0|||
148870099|NCT01918332|537002273|FG003|Overall Study|Adverse Event|1|||
148870100|NCT01918332|537002270|FG000|Overall Study|Withdrawal by Subject|2|||
148870101|NCT01918332|537002271|FG001|Overall Study|Withdrawal by Subject|3|||
148870102|NCT01918332|537002272|FG002|Overall Study|Withdrawal by Subject|2|||
148870103|NCT01918332|537002273|FG003|Overall Study|Withdrawal by Subject|3|||
148870104|NCT01918332|537002270|FG000|Overall Study|Protocol Violation|6|||
148870105|NCT01918332|537002271|FG001|Overall Study|Protocol Violation|2|||
148870106|NCT01918332|537002272|FG002|Overall Study|Protocol Violation|6|||
148870107|NCT01918332|537002273|FG003|Overall Study|Protocol Violation|3|||
148870108|NCT01918332|537002270|FG000|Overall Study|lipid result by central lab did not meet|0|||
148870109|NCT01918332|537002271|FG001|Overall Study|lipid result by central lab did not meet|0|||
148870110|NCT01918332|537002272|FG002|Overall Study|lipid result by central lab did not meet|1|||
148870111|NCT01918332|537002273|FG003|Overall Study|lipid result by central lab did not meet|0|||
148870112|NCT02905006|537002274|FG000|Overall Study|Adverse Event|1|||
148870113|NCT02905006|537002275|FG001|Overall Study|Adverse Event|1|||
148870114|NCT02905006|537002276|FG002|Overall Study|Adverse Event|1|||
148870115|NCT02905006|537002277|FG003|Overall Study|Adverse Event|1|||
148870116|NCT02905006|537002278|FG004|Overall Study|Adverse Event|0|||
148870117|NCT02905006|537002279|FG005|Overall Study|Adverse Event|1|||
148870118|NCT02905006|537002274|FG000|Overall Study|Lack of Efficacy|1|||
148870119|NCT02905006|537002275|FG001|Overall Study|Lack of Efficacy|0|||
148870120|NCT02905006|537002276|FG002|Overall Study|Lack of Efficacy|0|||
148870121|NCT02905006|537002277|FG003|Overall Study|Lack of Efficacy|0|||
148870122|NCT02905006|537002278|FG004|Overall Study|Lack of Efficacy|0|||
148870123|NCT02905006|537002279|FG005|Overall Study|Lack of Efficacy|0|||
148870124|NCT02905006|537002274|FG000|Overall Study|Protocol Violation|2|||
148870125|NCT02905006|537002275|FG001|Overall Study|Protocol Violation|0|||
148870126|NCT02905006|537002276|FG002|Overall Study|Protocol Violation|0|||
148870127|NCT02905006|537002277|FG003|Overall Study|Protocol Violation|0|||
148870128|NCT02905006|537002278|FG004|Overall Study|Protocol Violation|0|||
148870129|NCT02905006|537002279|FG005|Overall Study|Protocol Violation|0|||
148870130|NCT02905006|537002274|FG000|Overall Study|Lost to Follow-up|0|||
148870131|NCT02905006|537002275|FG001|Overall Study|Lost to Follow-up|0|||
148870132|NCT02905006|537002276|FG002|Overall Study|Lost to Follow-up|0|||
148870133|NCT02905006|537002277|FG003|Overall Study|Lost to Follow-up|1|||
148870134|NCT02905006|537002278|FG004|Overall Study|Lost to Follow-up|1|||
148870135|NCT02905006|537002279|FG005|Overall Study|Lost to Follow-up|0|||
148870136|NCT02905006|537002274|FG000|Overall Study|Withdrawal by Subject|0|||
148870137|NCT02905006|537002275|FG001|Overall Study|Withdrawal by Subject|0|||
148870138|NCT02905006|537002276|FG002|Overall Study|Withdrawal by Subject|1|||
148870139|NCT02905006|537002277|FG003|Overall Study|Withdrawal by Subject|1|||
148870140|NCT02905006|537002278|FG004|Overall Study|Withdrawal by Subject|0|||
148870141|NCT02905006|537002279|FG005|Overall Study|Withdrawal by Subject|1|||
148870142|NCT02905006|537002274|FG000|Overall Study|Screening exclusion criteria met|1|||
148870143|NCT02905006|537002275|FG001|Overall Study|Screening exclusion criteria met|0|||
148870144|NCT02905006|537002276|FG002|Overall Study|Screening exclusion criteria met|0|||
148870145|NCT02905006|537002277|FG003|Overall Study|Screening exclusion criteria met|0|||
148870146|NCT02905006|537002278|FG004|Overall Study|Screening exclusion criteria met|0|||
148870147|NCT02905006|537002279|FG005|Overall Study|Screening exclusion criteria met|0|||
148870148|NCT02905006|537002274|FG000|Overall Study|Lab withdrawal criterion met|0|||
148870149|NCT02905006|537002275|FG001|Overall Study|Lab withdrawal criterion met|1|||
148870150|NCT02905006|537002276|FG002|Overall Study|Lab withdrawal criterion met|2|||
148870151|NCT02905006|537002277|FG003|Overall Study|Lab withdrawal criterion met|2|||
149000308|NCT02001194|537477662|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
149000309|NCT03432364|537477664|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
148870152|NCT02905006|537002278|FG004|Overall Study|Lab withdrawal criterion met|2|||
148870153|NCT02905006|537002279|FG005|Overall Study|Lab withdrawal criterion met|1|||
148870154|NCT02905006|537002274|FG000|Overall Study|Positive for Tuberculosis|0|||
148870155|NCT02905006|537002275|FG001|Overall Study|Positive for Tuberculosis|1|||
148870156|NCT02905006|537002276|FG002|Overall Study|Positive for Tuberculosis|0|||
148870157|NCT02905006|537002277|FG003|Overall Study|Positive for Tuberculosis|0|||
148870158|NCT02905006|537002278|FG004|Overall Study|Positive for Tuberculosis|0|||
148870159|NCT02905006|537002279|FG005|Overall Study|Positive for Tuberculosis|0|||
148870160|NCT02905006|537002274|FG000|Overall Study|Subject positive for Hep B|0|||
148870161|NCT02905006|537002275|FG001|Overall Study|Subject positive for Hep B|0|||
148870162|NCT02905006|537002276|FG002|Overall Study|Subject positive for Hep B|1|||
148870163|NCT02905006|537002277|FG003|Overall Study|Subject positive for Hep B|0|||
148870164|NCT02905006|537002278|FG004|Overall Study|Subject positive for Hep B|0|||
148870165|NCT02905006|537002279|FG005|Overall Study|Subject positive for Hep B|0|||
148870166|NCT02905006|537002274|FG000|Overall Study|Patient moved abroad|0|||
148870167|NCT02905006|537002275|FG001|Overall Study|Patient moved abroad|0|||
148870168|NCT02905006|537002276|FG002|Overall Study|Patient moved abroad|0|||
148870169|NCT02905006|537002277|FG003|Overall Study|Patient moved abroad|1|||
148870170|NCT02905006|537002278|FG004|Overall Study|Patient moved abroad|0|||
148870171|NCT02905006|537002279|FG005|Overall Study|Patient moved abroad|0|||
148870172|NCT02905006|537002274|FG000|Overall Study|Patient randomized by mistake|0|||
148870173|NCT02905006|537002275|FG001|Overall Study|Patient randomized by mistake|0|||
148870174|NCT02905006|537002276|FG002|Overall Study|Patient randomized by mistake|0|||
148870175|NCT02905006|537002277|FG003|Overall Study|Patient randomized by mistake|0|||
148870176|NCT02905006|537002278|FG004|Overall Study|Patient randomized by mistake|0|||
148870177|NCT02905006|537002279|FG005|Overall Study|Patient randomized by mistake|1|||
148870178|NCT05063539|537002280|FG000|Overall Study|Adverse Event|1|||
148870179|NCT05063539|537002281|FG001|Overall Study|Adverse Event|2|||
148870180|NCT05063539|537002282|FG002|Overall Study|Adverse Event|1|||
148870181|NCT05063539|537002280|FG000|Overall Study|Death|0|||
148870182|NCT05063539|537002281|FG001|Overall Study|Death|1|||
148870183|NCT05063539|537002282|FG002|Overall Study|Death|1|||
148870184|NCT05063539|537002280|FG000|Overall Study|Lost to Follow-up|0|||
148870185|NCT05063539|537002281|FG001|Overall Study|Lost to Follow-up|1|||
148870186|NCT05063539|537002282|FG002|Overall Study|Lost to Follow-up|0|||
148870187|NCT05063539|537002280|FG000|Overall Study|Physician Decision|4|||
148870188|NCT05063539|537002281|FG001|Overall Study|Physician Decision|3|||
148870189|NCT05063539|537002282|FG002|Overall Study|Physician Decision|1|||
148870190|NCT05063539|537002280|FG000|Overall Study|Progressive Disease|0|||
148870191|NCT05063539|537002281|FG001|Overall Study|Progressive Disease|2|||
148870192|NCT05063539|537002282|FG002|Overall Study|Progressive Disease|0|||
148870193|NCT05063539|537002280|FG000|Overall Study|Withdrawal by Subject|17|||
148870194|NCT05063539|537002281|FG001|Overall Study|Withdrawal by Subject|26|||
148870195|NCT05063539|537002282|FG002|Overall Study|Withdrawal by Subject|14|||
148870196|NCT05063539|537002280|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
148870197|NCT05063539|537002281|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
148870198|NCT05063539|537002282|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
148870199|NCT05063539|537002280|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
148870200|NCT05063539|537002281|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
148870201|NCT05063539|537002282|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
148870202|NCT05063539|537002280|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
148870203|NCT05063539|537002281|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
148870204|NCT05063539|537002282|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
148870205|NCT05063539|537002280|FG000|Overall Study|Discontinued due to Common Close Design|0|||
148870206|NCT05063539|537002281|FG001|Overall Study|Discontinued due to Common Close Design|1|||
148870207|NCT05063539|537002282|FG002|Overall Study|Discontinued due to Common Close Design|0|||
148870208|NCT05063539|537002280|FG000|Overall Study|Participant not co-operative|0|||
148870209|NCT05063539|537002281|FG001|Overall Study|Participant not co-operative|1|||
148870210|NCT05063539|537002282|FG002|Overall Study|Participant not co-operative|0|||
148870211|NCT05063539|537002280|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
148870212|NCT05063539|537002281|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
148870213|NCT05063539|537002282|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
148870214|NCT05063539|537002280|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
148870215|NCT05063539|537002281|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
148870216|NCT05063539|537002282|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
148870217|NCT01751139|537002283|FG000|Overall Study|Other|135|||
148870218|NCT01751139|537002283|FG000|Overall Study|Sponsor study termination|1609|||
148870219|NCT01751139|537002283|FG000|Overall Study|Lost to Follow-up|240|||
148870220|NCT01751139|537002283|FG000|Overall Study|Withdrawal by Subject|251|||
148870221|NCT01751139|537002283|FG000|Overall Study|Adverse Event|1|||
148870222|NCT01751139|537002283|FG000|Overall Study|Death|31|||
148870223|NCT04736628|537002284|FG000|Overall Study|Not treated|0|||
148870224|NCT04736628|537002285|FG001|Overall Study|Not treated|0|||
148870225|NCT04736628|537002286|FG002|Overall Study|Not treated|0|||
148870226|NCT04736628|537002287|FG003|Overall Study|Not treated|2|||
148870227|NCT04736628|537002284|FG000|Overall Study|Other reason than listed|1|||
148870228|NCT04736628|537002285|FG001|Overall Study|Other reason than listed|2|||
148870229|NCT04736628|537002286|FG002|Overall Study|Other reason than listed|2|||
148870230|NCT04736628|537002287|FG003|Overall Study|Other reason than listed|3|||
148870231|NCT04736628|537002284|FG000|Overall Study|Protocol deviation|0|||
148870232|NCT04736628|537002285|FG001|Overall Study|Protocol deviation|0|||
148870233|NCT04736628|537002286|FG002|Overall Study|Protocol deviation|0|||
148870234|NCT04736628|537002287|FG003|Overall Study|Protocol deviation|1|||
148870235|NCT04736628|537002284|FG000|Overall Study|Burden of study procedures|1|||
148870236|NCT04736628|537002285|FG001|Overall Study|Burden of study procedures|0|||
148870237|NCT04736628|537002286|FG002|Overall Study|Burden of study procedures|0|||
148870238|NCT04736628|537002287|FG003|Overall Study|Burden of study procedures|1|||
148870239|NCT04736628|537002284|FG000|Overall Study|Change of residence|0|||
148870240|NCT04736628|537002285|FG001|Overall Study|Change of residence|1|||
148870241|NCT04736628|537002286|FG002|Overall Study|Change of residence|0|||
148870242|NCT04736628|537002287|FG003|Overall Study|Change of residence|0|||
148870243|NCT04736628|537002284|FG000|Overall Study|Perceived lack of efficacy|1|||
148870244|NCT04736628|537002285|FG001|Overall Study|Perceived lack of efficacy|0|||
148870245|NCT04736628|537002286|FG002|Overall Study|Perceived lack of efficacy|0|||
148870246|NCT04736628|537002287|FG003|Overall Study|Perceived lack of efficacy|1|||
148870247|NCT04736628|537002284|FG000|Overall Study|Adverse Event|3|||
148870248|NCT04736628|537002285|FG001|Overall Study|Adverse Event|2|||
148870249|NCT04736628|537002286|FG002|Overall Study|Adverse Event|4|||
148870250|NCT04736628|537002287|FG003|Overall Study|Adverse Event|3|||
148870251|NCT02428205|537002290|FG000|Overall Study|Lack of Efficacy|1|||
148870252|NCT02428205|537002291|FG001|Overall Study|Lack of Efficacy|0|||
148870253|NCT02428205|537002290|FG000|Overall Study|Lost to Follow-up|1|||
148870254|NCT02428205|537002291|FG001|Overall Study|Lost to Follow-up|1|||
148870255|NCT02428205|537002290|FG000|Overall Study|Worse behavior|0|||
148870256|NCT02428205|537002291|FG001|Overall Study|Worse behavior|1|||
148870257|NCT00527319|537002292|FG000|Overall Study|Withdrawal by Subject|5|||
148870258|NCT00527319|537002293|FG001|Overall Study|Withdrawal by Subject|0|||
148870259|NCT00527319|537002294|FG002|Overall Study|Withdrawal by Subject|1|||
148870260|NCT00527319|537002292|FG000|Overall Study|Lost to Follow-up|1|||
148870261|NCT00527319|537002293|FG001|Overall Study|Lost to Follow-up|0|||
148870262|NCT00527319|537002294|FG002|Overall Study|Lost to Follow-up|0|||
148870263|NCT00527319|537002292|FG000|Overall Study|Death|0|||
148870264|NCT00527319|537002293|FG001|Overall Study|Death|3|||
148870265|NCT00527319|537002294|FG002|Overall Study|Death|1|||
148870266|NCT00527319|537002292|FG000|Overall Study|Intercurrent Medical Illness|0|||
148870267|NCT00527319|537002293|FG001|Overall Study|Intercurrent Medical Illness|1|||
148870268|NCT00527319|537002294|FG002|Overall Study|Intercurrent Medical Illness|3|||
148870269|NCT00527319|537002292|FG000|Overall Study|Adverse Event|0|||
148870270|NCT00527319|537002293|FG001|Overall Study|Adverse Event|0|||
148870271|NCT00527319|537002294|FG002|Overall Study|Adverse Event|1|||
148870272|NCT00680368|537002296|FG000|Overall Study|not supervised, not eligible|15|||
148870273|NCT00483041|537002297|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
148870274|NCT00483041|537002298|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
148870275|NCT03779503|537002299|FG000|First Intervention|Adverse Event|0|||
148870276|NCT03779503|537002300|FG001|First Intervention|Adverse Event|1|||
148870277|NCT03779503|537002299|FG000|First Intervention|Withdrawal by Subject|1|||
148870278|NCT03779503|537002300|FG001|First Intervention|Withdrawal by Subject|0|||
148870279|NCT00864851|537002301|FG000|Overall Study|Withdrawal by Subject|0|||
148870280|NCT00864851|537002302|FG001|Overall Study|Withdrawal by Subject|1|||
148870281|NCT00864851|537002303|FG002|Overall Study|Withdrawal by Subject|0|||
148870282|NCT00864851|537002301|FG000|Overall Study|Physician Decision|1|||
148870283|NCT00864851|537002302|FG001|Overall Study|Physician Decision|0|||
148870284|NCT00864851|537002303|FG002|Overall Study|Physician Decision|0|||
148870285|NCT00864851|537002301|FG000|Overall Study|Death|1|||
148870286|NCT00864851|537002302|FG001|Overall Study|Death|0|||
148870287|NCT00864851|537002303|FG002|Overall Study|Death|0|||
148870288|NCT00864851|537002301|FG000|Overall Study|Patient uncooperative|1|||
148870289|NCT00864851|537002302|FG001|Overall Study|Patient uncooperative|0|||
149032262|NCT02377362|537596016|FG011|Part B Overall|Adverse Event|0|||
148870290|NCT00864851|537002303|FG002|Overall Study|Patient uncooperative|0|||
148870291|NCT03242252|537002305|FG000|Overall Study|At the Participant's own Request|18|||
148870292|NCT03242252|537002306|FG001|Overall Study|At the Participant's own Request|10|||
148870293|NCT03242252|537002307|FG002|Overall Study|At the Participant's own Request|15|||
148870294|NCT03242252|537002305|FG000|Overall Study|Adverse Event|8|||
148870295|NCT03242252|537002306|FG001|Overall Study|Adverse Event|6|||
148870296|NCT03242252|537002307|FG002|Overall Study|Adverse Event|9|||
148870297|NCT03242252|537002305|FG000|Overall Study|Poor Compliance to Protocol|0|||
148870298|NCT03242252|537002306|FG001|Overall Study|Poor Compliance to Protocol|2|||
148870299|NCT03242252|537002307|FG002|Overall Study|Poor Compliance to Protocol|3|||
148870300|NCT03242252|537002305|FG000|Overall Study|Study Terminated by Sponsor|1|||
148870301|NCT03242252|537002306|FG001|Overall Study|Study Terminated by Sponsor|0|||
148870302|NCT03242252|537002307|FG002|Overall Study|Study Terminated by Sponsor|0|||
149032263|NCT02377362|537596017|FG012|Part B Overall|Adverse Event|0|||
148870303|NCT03242252|537002305|FG000|Overall Study|Reason not Specified|4|||
148870304|NCT03242252|537002306|FG001|Overall Study|Reason not Specified|4|||
148870305|NCT03242252|537002307|FG002|Overall Study|Reason not Specified|1|||
148870306|NCT03242252|537002305|FG000|Overall Study|Lost to Follow-up|5|||
148870307|NCT03242252|537002306|FG001|Overall Study|Lost to Follow-up|1|||
148870308|NCT03242252|537002307|FG002|Overall Study|Lost to Follow-up|4|||
148870309|NCT01116427|537002308|FG000|Core Phase|Adverse Event|0|||
148870310|NCT01116427|537002309|FG001|Core Phase|Adverse Event|1|||
148870311|NCT01116427|537002308|FG000|Core Phase|Lost to Follow-up|1|||
148870312|NCT01116427|537002309|FG001|Core Phase|Lost to Follow-up|0|||
148870313|NCT01116427|537002308|FG000|Core Phase|Withdrawal by Subject|3|||
148870314|NCT01116427|537002309|FG001|Core Phase|Withdrawal by Subject|0|||
148870315|NCT01116427|537002308|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
148870316|NCT01116427|537002309|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
148870317|NCT01116427|537002308|FG000|Extension Phase|Adverse Event|1|||
148870318|NCT01116427|537002309|FG001|Extension Phase|Adverse Event|1|||
148870319|NCT01116427|537002308|FG000|Extension Phase|Lost to Follow-up|2|||
148870320|NCT01116427|537002309|FG001|Extension Phase|Lost to Follow-up|0|||
148870321|NCT01116427|537002308|FG000|Extension Phase|Withdrawal by Subject|5|||
148870322|NCT01116427|537002309|FG001|Extension Phase|Withdrawal by Subject|1|||
148870323|NCT01116427|537002308|FG000|Extension Phase|Not using appropriate birth control|1|||
148870324|NCT01116427|537002309|FG001|Extension Phase|Not using appropriate birth control|0|||
148870325|NCT03344640|537002310|FG000|Overall Study|Adverse Event|1|||
148870326|NCT03344640|537002311|FG001|Overall Study|Adverse Event|0|||
148870327|NCT03344640|537002310|FG000|Overall Study|Physician Decision|1|||
148870328|NCT03344640|537002311|FG001|Overall Study|Physician Decision|1|||
148870329|NCT03344640|537002310|FG000|Overall Study|Withdrawal by Subject|1|||
148870330|NCT03344640|537002311|FG001|Overall Study|Withdrawal by Subject|2|||
148870331|NCT03344640|537002310|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
148870332|NCT03344640|537002311|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
148870333|NCT02358044|537002314|FG000|Overall Study|Adverse Event|0|||
148870334|NCT02358044|537002315|FG001|Overall Study|Adverse Event|1|||
148870335|NCT02358044|537002314|FG000|Overall Study|Lost to Follow-up|2|||
148870336|NCT02358044|537002315|FG001|Overall Study|Lost to Follow-up|1|||
148870337|NCT02358044|537002314|FG000|Overall Study|Physician Decision|0|||
148870338|NCT02358044|537002315|FG001|Overall Study|Physician Decision|1|||
148870339|NCT02358044|537002314|FG000|Overall Study|Withdrawal by Subject|0|||
148870340|NCT02358044|537002315|FG001|Overall Study|Withdrawal by Subject|4|||
148870341|NCT03426631|537002324|FG000|Overall Study|Lost to Follow-up|0|||
148870342|NCT03426631|537002325|FG001|Overall Study|Lost to Follow-up|1|||
148870343|NCT00654004|537002326|FG000|Overall Study|Lost to Follow-up|1|||
148870344|NCT00654004|537002327|FG001|Overall Study|Lost to Follow-up|0|||
148870345|NCT00444067|537002332|FG000|Overall Study|Lost to Follow-up|0|||
148870346|NCT00444067|537002333|FG001|Overall Study|Lost to Follow-up|1|||
148870347|NCT00710385|537002334|FG000|Overall Study|Did not qualify|1|||
148870348|NCT00710385|537002334|FG000|Overall Study|Withdrawal by Subject|1|||
148870349|NCT00710385|537002334|FG000|Overall Study|Undisclosed back pain|1|||
148870350|NCT00710385|537002334|FG000|Overall Study|Physician Decision|1|||
148870351|NCT00710385|537002334|FG000|Overall Study|Undisclosed excessive methadone use|1|||
148870352|NCT01264770|537002335|FG000|Overall Study|Not reported|0|||
148870353|NCT01264770|537002336|FG001|Overall Study|Not reported|0|||
148870354|NCT01264770|537002337|FG002|Overall Study|Not reported|1|||
148870355|NCT01264770|537002338|FG003|Overall Study|Not reported|0|||
148870356|NCT01264770|537002339|FG004|Overall Study|Not reported|0|||
148870357|NCT01264770|537002340|FG005|Overall Study|Not reported|0|||
148870358|NCT01264770|537002335|FG000|Overall Study|e.g., change in circumstances|8|||
148870359|NCT01264770|537002336|FG001|Overall Study|e.g., change in circumstances|3|||
148870360|NCT01264770|537002337|FG002|Overall Study|e.g., change in circumstances|3|||
148870361|NCT01264770|537002338|FG003|Overall Study|e.g., change in circumstances|3|||
148870362|NCT01264770|537002339|FG004|Overall Study|e.g., change in circumstances|4|||
148870363|NCT01264770|537002340|FG005|Overall Study|e.g., change in circumstances|4|||
148870364|NCT01264770|537002335|FG000|Overall Study|Severe non-compliance to protocol|0|||
148870365|NCT01264770|537002336|FG001|Overall Study|Severe non-compliance to protocol|0|||
149000310|NCT00522301|537477665|FG000|Overall Study|Withdrawal by Subject|1|||
149000311|NCT00522301|537477665|FG000|Overall Study|Adverse Event|5|||
149000312|NCT01699022|537477672|FG000|Overall Study|Early discontinuation from the study|3|||
148870366|NCT01264770|537002337|FG002|Overall Study|Severe non-compliance to protocol|1|||
148870367|NCT01264770|537002338|FG003|Overall Study|Severe non-compliance to protocol|1|||
148870368|NCT01264770|537002339|FG004|Overall Study|Severe non-compliance to protocol|0|||
148870369|NCT01264770|537002340|FG005|Overall Study|Severe non-compliance to protocol|0|||
148870370|NCT01264770|537002335|FG000|Overall Study|Lack of therapeutic response|1|||
148870371|NCT01264770|537002336|FG001|Overall Study|Lack of therapeutic response|0|||
148870372|NCT01264770|537002337|FG002|Overall Study|Lack of therapeutic response|2|||
148870373|NCT01264770|537002338|FG003|Overall Study|Lack of therapeutic response|1|||
148870374|NCT01264770|537002339|FG004|Overall Study|Lack of therapeutic response|1|||
148870375|NCT01264770|537002340|FG005|Overall Study|Lack of therapeutic response|0|||
148870376|NCT01264770|537002335|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
148870377|NCT01264770|537002336|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
148870378|NCT01264770|537002337|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
148870379|NCT01264770|537002338|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
148870380|NCT01264770|537002339|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
148870381|NCT01264770|537002340|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
148870382|NCT01264770|537002335|FG000|Overall Study|Lost to Follow-up|0|||
148870383|NCT01264770|537002336|FG001|Overall Study|Lost to Follow-up|0|||
148870384|NCT01264770|537002337|FG002|Overall Study|Lost to Follow-up|1|||
148870385|NCT01264770|537002338|FG003|Overall Study|Lost to Follow-up|1|||
148870386|NCT01264770|537002339|FG004|Overall Study|Lost to Follow-up|0|||
148870387|NCT01264770|537002340|FG005|Overall Study|Lost to Follow-up|0|||
148870388|NCT01264770|537002335|FG000|Overall Study|Adverse Event|7|||
148870389|NCT01264770|537002336|FG001|Overall Study|Adverse Event|7|||
148870390|NCT01264770|537002337|FG002|Overall Study|Adverse Event|8|||
148870391|NCT01264770|537002338|FG003|Overall Study|Adverse Event|0|||
148870392|NCT01264770|537002339|FG004|Overall Study|Adverse Event|2|||
148870393|NCT01264770|537002340|FG005|Overall Study|Adverse Event|1|||
148870394|NCT02241187|537002344|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
148870395|NCT00199888|537002347|FG000|Overall Study|Lost to Follow-up|1|||
148870396|NCT05219669|537002348|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
148870397|NCT05219669|537002349|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
148870398|NCT05219669|537002350|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
148870399|NCT05219669|537002351|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
148870400|NCT05219669|537002352|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
148870401|NCT05219669|537002353|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
148870402|NCT02299076|537002356|FG000|Overall Study|Fraudulent Entries|20|||
148870403|NCT02299076|537002357|FG001|Overall Study|Fraudulent Entries|14|||
148870404|NCT00330668|537002358|FG000|BID Dosing Period|Adverse Event|1|||
148870405|NCT00330668|537002358|FG000|BID Dosing Period|Lost to Follow-up|7|||
148870406|NCT00330668|537002358|FG000|BID Dosing Period|Non-Compliance|5|||
148870407|NCT00330668|537002358|FG000|BID Dosing Period|Withdrawal by Subject|19|||
148870408|NCT00330668|537002358|FG000|BID Dosing Period|Sponsor's decision|1|||
148870409|NCT00330668|537002358|FG000|BID Dosing Period|Other|3|||
148870410|NCT00330668|537002358|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
148870411|NCT00330668|537002358|FG000|QD Dosing Period|Other|1|||
148870412|NCT00330668|537002358|FG000|QD Dosing Period|Withdrawal by Subject|1|||
148870413|NCT00330668|537002358|FG000|QD Dosing Period|Lost to Follow-up|2|||
148870414|NCT00499746|537002359|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
148870415|NCT00499746|537002359|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
148870416|NCT00499746|537002359|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
148870417|NCT00499746|537002359|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
148870418|NCT02228096|537002360|FG000|Overall Study|Study terminated by Sponsor|24|||
148870419|NCT02228096|537002360|FG000|Overall Study|Lack of Efficacy|18|||
148870420|NCT02228096|537002360|FG000|Overall Study|Death|12|||
148870421|NCT02228096|537002360|FG000|Overall Study|Physician Decision|3|||
148870422|NCT02228096|537002360|FG000|Overall Study|Subject/guardian decision|2|||
148870423|NCT02228096|537002360|FG000|Overall Study|New therapy for study indication|1|||
148870424|NCT02228096|537002360|FG000|Overall Study|Enrolled, not infused|11|||
148870425|NCT01969721|537002361|FG000|Overall Study|Adverse Event|3|||
148870426|NCT01969721|537002362|FG001|Overall Study|Adverse Event|8|||
148870427|NCT01969721|537002363|FG002|Overall Study|Adverse Event|3|||
148870428|NCT01969721|537002364|FG003|Overall Study|Adverse Event|2|||
148870429|NCT01969721|537002361|FG000|Overall Study|Lack of Efficacy|0|||
148870430|NCT01969721|537002362|FG001|Overall Study|Lack of Efficacy|0|||
148870431|NCT01969721|537002363|FG002|Overall Study|Lack of Efficacy|1|||
148870432|NCT01969721|537002364|FG003|Overall Study|Lack of Efficacy|0|||
148870433|NCT01969721|537002361|FG000|Overall Study|Non compliant with protocol|1|||
148870434|NCT01969721|537002362|FG001|Overall Study|Non compliant with protocol|1|||
148870435|NCT01969721|537002363|FG002|Overall Study|Non compliant with protocol|0|||
148870436|NCT01969721|537002364|FG003|Overall Study|Non compliant with protocol|2|||
148870437|NCT01969721|537002361|FG000|Overall Study|Other not defined above|0|||
148870438|NCT01969721|537002362|FG001|Overall Study|Other not defined above|2|||
148870439|NCT01969721|537002363|FG002|Overall Study|Other not defined above|0|||
148870440|NCT01969721|537002364|FG003|Overall Study|Other not defined above|0|||
148870441|NCT01969721|537002361|FG000|Overall Study|Discontinued during washout periods.|0|||
149000313|NCT02066402|537477677|FG000|Overall Study|Adverse Event|1|||
148870442|NCT01969721|537002362|FG001|Overall Study|Discontinued during washout periods.|1|||
148870443|NCT01969721|537002363|FG002|Overall Study|Discontinued during washout periods.|1|||
148870444|NCT01969721|537002364|FG003|Overall Study|Discontinued during washout periods.|2|||
148870445|NCT02265796|537002365|FG000|Overall Study|Death|1|||
148870446|NCT02265796|537002366|FG001|Overall Study|Death|0|||
148870447|NCT02265796|537002365|FG000|Overall Study|started on excluded medication|1|||
148870448|NCT02265796|537002366|FG001|Overall Study|started on excluded medication|0|||
148870449|NCT02265796|537002365|FG000|Overall Study|Withdrawal by Subject|1|||
148870450|NCT02265796|537002366|FG001|Overall Study|Withdrawal by Subject|1|||
149000314|NCT02066402|537477678|FG001|Overall Study|Adverse Event|2|||
148870451|NCT00849108|537002368|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
148870452|NCT00849108|537002369|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
148870453|NCT00849108|537002368|FG000|Cohort 2 Efficacy|Adverse Event|0|||
148870454|NCT00849108|537002369|FG001|Cohort 2 Efficacy|Adverse Event|1|||
148870455|NCT00849108|537002368|FG000|Cohort 2 Efficacy|Other|0|||
148870456|NCT00849108|537002369|FG001|Cohort 2 Efficacy|Other|9|||
148870457|NCT01075984|537002372|FG000|Treatment Phase|Adverse Event|0|||
148870458|NCT01075984|537002373|FG001|Treatment Phase|Adverse Event|1|||
148870459|NCT01075984|537002374|FG002|Treatment Phase|Adverse Event|3|||
148870460|NCT01075984|537002375|FG003|Treatment Phase|Adverse Event|7|||
148870461|NCT01075984|537002376|FG004|Treatment Phase|Adverse Event|35|||
148870462|NCT01075984|537002372|FG000|Treatment Phase|Protocol Violation|0|||
148870463|NCT01075984|537002373|FG001|Treatment Phase|Protocol Violation|0|||
148870464|NCT01075984|537002374|FG002|Treatment Phase|Protocol Violation|1|||
148870465|NCT01075984|537002375|FG003|Treatment Phase|Protocol Violation|0|||
148870466|NCT01075984|537002376|FG004|Treatment Phase|Protocol Violation|3|||
148870467|NCT01075984|537002372|FG000|Treatment Phase|Withdrawal by Subject|0|||
148870468|NCT01075984|537002373|FG001|Treatment Phase|Withdrawal by Subject|0|||
148870469|NCT01075984|537002374|FG002|Treatment Phase|Withdrawal by Subject|2|||
148870470|NCT01075984|537002375|FG003|Treatment Phase|Withdrawal by Subject|0|||
148870471|NCT01075984|537002376|FG004|Treatment Phase|Withdrawal by Subject|15|||
148870472|NCT01075984|537002372|FG000|Treatment Phase|Treatment Failure|0|||
148870473|NCT01075984|537002373|FG001|Treatment Phase|Treatment Failure|0|||
148870474|NCT01075984|537002374|FG002|Treatment Phase|Treatment Failure|1|||
148870475|NCT01075984|537002375|FG003|Treatment Phase|Treatment Failure|0|||
148870476|NCT01075984|537002376|FG004|Treatment Phase|Treatment Failure|5|||
148870477|NCT01075984|537002372|FG000|Treatment Phase|Progression of disease|0|||
148870478|NCT01075984|537002373|FG001|Treatment Phase|Progression of disease|0|||
148870479|NCT01075984|537002374|FG002|Treatment Phase|Progression of disease|0|||
148870480|NCT01075984|537002375|FG003|Treatment Phase|Progression of disease|0|||
148870481|NCT01075984|537002376|FG004|Treatment Phase|Progression of disease|2|||
148870482|NCT01075984|537002372|FG000|Follow-up Phase|Protocol Violation|0|||
148870483|NCT01075984|537002373|FG001|Follow-up Phase|Protocol Violation|0|||
148870484|NCT01075984|537002374|FG002|Follow-up Phase|Protocol Violation|1|||
148870485|NCT01075984|537002375|FG003|Follow-up Phase|Protocol Violation|0|||
148870486|NCT01075984|537002376|FG004|Follow-up Phase|Protocol Violation|3|||
148870487|NCT01075984|537002372|FG000|Follow-up Phase|Adverse Event|0|||
148870488|NCT01075984|537002373|FG001|Follow-up Phase|Adverse Event|0|||
148870489|NCT01075984|537002374|FG002|Follow-up Phase|Adverse Event|0|||
148870490|NCT01075984|537002375|FG003|Follow-up Phase|Adverse Event|2|||
148870491|NCT01075984|537002376|FG004|Follow-up Phase|Adverse Event|27|||
148870492|NCT01075984|537002372|FG000|Follow-up Phase|Administrative|0|||
148870493|NCT01075984|537002373|FG001|Follow-up Phase|Administrative|0|||
148870494|NCT01075984|537002374|FG002|Follow-up Phase|Administrative|0|||
148870495|NCT01075984|537002375|FG003|Follow-up Phase|Administrative|0|||
148870496|NCT01075984|537002376|FG004|Follow-up Phase|Administrative|1|||
148870497|NCT01075984|537002372|FG000|Follow-up Phase|Withdrawal by Subject|0|||
148870498|NCT01075984|537002373|FG001|Follow-up Phase|Withdrawal by Subject|0|||
148870499|NCT01075984|537002374|FG002|Follow-up Phase|Withdrawal by Subject|0|||
148870500|NCT01075984|537002375|FG003|Follow-up Phase|Withdrawal by Subject|0|||
148870501|NCT01075984|537002376|FG004|Follow-up Phase|Withdrawal by Subject|10|||
148870502|NCT01075984|537002372|FG000|Follow-up Phase|Progression of disease|0|||
148870503|NCT01075984|537002373|FG001|Follow-up Phase|Progression of disease|0|||
148870504|NCT01075984|537002374|FG002|Follow-up Phase|Progression of disease|0|||
148870505|NCT01075984|537002375|FG003|Follow-up Phase|Progression of disease|0|||
148870506|NCT01075984|537002376|FG004|Follow-up Phase|Progression of disease|2|||
148870507|NCT01075984|537002372|FG000|Follow-up Phase|Treatment failure|0|||
148870508|NCT01075984|537002373|FG001|Follow-up Phase|Treatment failure|0|||
148870509|NCT01075984|537002374|FG002|Follow-up Phase|Treatment failure|0|||
148870510|NCT01075984|537002375|FG003|Follow-up Phase|Treatment failure|0|||
148870511|NCT01075984|537002376|FG004|Follow-up Phase|Treatment failure|4|||
148870512|NCT01597635|537004216|FG000|Part A|Adverse Event|3|||
148870513|NCT01597635|537004217|FG001|Part A|Adverse Event|0|||
148870514|NCT01597635|537004218|FG002|Part A|Adverse Event|0|||
148870515|NCT01597635|537004216|FG000|Part B|Adverse Event|0|||
149000315|NCT02066402|537477677|FG000|Overall Study|Lost to Follow-up|11|||
149000316|NCT02066402|537477678|FG001|Overall Study|Lost to Follow-up|8|||
148870516|NCT01597635|537004217|FG001|Part B|Adverse Event|0|||
148870517|NCT01597635|537004218|FG002|Part B|Adverse Event|1|||
148870518|NCT01597635|537004216|FG000|Part B|Protocol Violation|0|||
148870519|NCT01597635|537004217|FG001|Part B|Protocol Violation|1|||
148870520|NCT01597635|537004218|FG002|Part B|Protocol Violation|0|||
149000317|NCT02066402|537477677|FG000|Overall Study|Withdrawal by Subject|14|||
149000318|NCT02066402|537477678|FG001|Overall Study|Withdrawal by Subject|11|||
148870521|NCT01597635|537004216|FG000|Part B|Protocol-defined stopping criteria|0|||
148870522|NCT01597635|537004217|FG001|Part B|Protocol-defined stopping criteria|4|||
148870523|NCT01597635|537004218|FG002|Part B|Protocol-defined stopping criteria|3|||
148870524|NCT01597635|537004216|FG000|Part B|Withdrawal by Subject|0|||
148870525|NCT01597635|537004217|FG001|Part B|Withdrawal by Subject|1|||
148870526|NCT01597635|537004218|FG002|Part B|Withdrawal by Subject|0|||
148870527|NCT00652951|537004219|FG000|Booster Phase|Adverse event, non-fatal|0|||
148870528|NCT00652951|537004220|FG001|Booster Phase|Adverse event, non-fatal|1|||
148870529|NCT00652951|537004221|FG002|Booster Phase|Adverse event, non-fatal|0|||
148870530|NCT00652951|537004219|FG000|Booster Phase|Other|1|||
148870531|NCT00652951|537004220|FG001|Booster Phase|Other|0|||
148870532|NCT00652951|537004221|FG002|Booster Phase|Other|0|||
148870533|NCT02593825|537004222|FG000|Intervention|Lost to Follow-up|10|||
148870534|NCT02593825|537004223|FG001|Intervention|Lost to Follow-up|12|||
148870535|NCT01022424|537004224|FG000|Overall Study|Adverse Event|1|||
148870536|NCT01022424|537004224|FG000|Overall Study|Physician Decision|1|||
148870537|NCT01022424|537004224|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
148870538|NCT06359080|537004225|FG000|Overall Study|Withdrawal by Subject|3|||
148870539|NCT00720343|537004226|FG000|Overall Study|Lost to Follow-up|1|||
148870540|NCT00720343|537004227|FG001|Overall Study|Lost to Follow-up|0|||
148870541|NCT00720343|537004226|FG000|Overall Study|Protocol Violation|0|||
148870542|NCT00720343|537004227|FG001|Overall Study|Protocol Violation|2|||
148870543|NCT00511134|537004228|FG000|Overall Study|Withdrawal by Subject|0|||
148870544|NCT00511134|537004229|FG001|Overall Study|Withdrawal by Subject|2|||
148870545|NCT01949090|537004230|FG000|Overall Study|Serious Adverse Event|0|||
148870546|NCT01949090|537004231|FG001|Overall Study|Serious Adverse Event|1|||
148870547|NCT01949090|537004232|FG002|Overall Study|Serious Adverse Event|2|||
148870548|NCT01949090|537004233|FG003|Overall Study|Serious Adverse Event|0|||
148870549|NCT01949090|537004234|FG004|Overall Study|Serious Adverse Event|1|||
148870550|NCT01949090|537004230|FG000|Overall Study|Withdrawal by Subject|2|||
148870551|NCT01949090|537004231|FG001|Overall Study|Withdrawal by Subject|0|||
148870552|NCT01949090|537004232|FG002|Overall Study|Withdrawal by Subject|0|||
148870553|NCT01949090|537004233|FG003|Overall Study|Withdrawal by Subject|0|||
148870554|NCT01949090|537004234|FG004|Overall Study|Withdrawal by Subject|1|||
148870555|NCT01949090|537004230|FG000|Overall Study|Protocol non-compliance|0|||
148870556|NCT01949090|537004231|FG001|Overall Study|Protocol non-compliance|0|||
148870557|NCT01949090|537004232|FG002|Overall Study|Protocol non-compliance|0|||
148870558|NCT01949090|537004233|FG003|Overall Study|Protocol non-compliance|0|||
148870559|NCT01949090|537004234|FG004|Overall Study|Protocol non-compliance|1|||
148870560|NCT01949090|537004230|FG000|Overall Study|Lost to Follow-up|2|||
148870561|NCT01949090|537004231|FG001|Overall Study|Lost to Follow-up|1|||
148870562|NCT01949090|537004232|FG002|Overall Study|Lost to Follow-up|0|||
148870563|NCT01949090|537004233|FG003|Overall Study|Lost to Follow-up|1|||
148870564|NCT01949090|537004234|FG004|Overall Study|Lost to Follow-up|1|||
148870565|NCT00707954|537004235|FG000|Overall Study|Physician Decision|0|||
148870566|NCT00707954|537004236|FG001|Overall Study|Physician Decision|0|||
148870567|NCT00707954|537004237|FG002|Overall Study|Physician Decision|0|||
148870568|NCT00707954|537004238|FG003|Overall Study|Physician Decision|0|||
148870569|NCT00707954|537004239|FG004|Overall Study|Physician Decision|1|||
148870570|NCT02017522|537004240|FG000|Overall Study|Withdrawal by Subject|1|||
148870571|NCT05856227|537004241|FG000|Overall Study|Adverse Event|0|||
148870572|NCT05856227|537004242|FG001|Overall Study|Adverse Event|1|||
148870573|NCT05856227|537004241|FG000|Overall Study|Due to Investigator absence|1|||
148870574|NCT05856227|537004242|FG001|Overall Study|Due to Investigator absence|0|||
148870575|NCT05856227|537004241|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
148870576|NCT05856227|537004242|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
148870577|NCT01646203|537004243|FG000|Overall Study|Adverse Event|2|||
148870578|NCT01646203|537004244|FG001|Overall Study|Adverse Event|0|||
148870579|NCT01646203|537004245|FG002|Overall Study|Adverse Event|1|||
148870580|NCT01646203|537004243|FG000|Overall Study|Withdrawal by Subject|0|||
148870581|NCT01646203|537004244|FG001|Overall Study|Withdrawal by Subject|1|||
148870582|NCT01646203|537004245|FG002|Overall Study|Withdrawal by Subject|0|||
148870583|NCT01646203|537004243|FG000|Overall Study|Physician's Decision|0|||
148870584|NCT01646203|537004244|FG001|Overall Study|Physician's Decision|1|||
148870585|NCT01646203|537004245|FG002|Overall Study|Physician's Decision|0|||
148870586|NCT01100528|537004249|FG000|Overall Study|Death|1|||
148870587|NCT01100528|537004249|FG000|Overall Study|Withdrawal by Subject|2|||
148870588|NCT02211313|537004254|FG000|Overall Study|Treatment Failure|5|||
148870589|NCT02211313|537004255|FG001|Overall Study|Treatment Failure|2|||
148870590|NCT02211313|537004254|FG000|Overall Study|No Follow up Questionnaires|1|||
148870591|NCT02211313|537004255|FG001|Overall Study|No Follow up Questionnaires|1|||
148870592|NCT02717130|537004256|FG000|Overall Study|Withdrawal by Subject|1|||
148870593|NCT02717130|537004256|FG000|Overall Study|Adverse Event|1|||
148870594|NCT02717130|537004256|FG000|Overall Study|Physician Decision|1|||
148870595|NCT02717130|537004256|FG000|Overall Study|Study Closure|4|||
148870596|NCT01079936|537004257|FG000|Phase I: MTD|First Remission Status|2|||
148870597|NCT01079936|537004258|FG001|Phase I: MTD|First Remission Status|0|||
148870598|NCT01079936|537004259|FG002|Phase I: MTD|First Remission Status|0|||
148870599|NCT01079936|537004260|FG003|Phase I: MTD|First Remission Status|0|||
148870600|NCT01079936|537004261|FG004|Phase I: MTD|First Remission Status|0|||
148870601|NCT01079936|537004257|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
148870602|NCT01079936|537004258|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
148870603|NCT01079936|537004259|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
148870604|NCT01079936|537004260|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
148870605|NCT01079936|537004261|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
148870606|NCT01079936|537004257|FG000|Phase II|Adverse Event|0|||
148870607|NCT01079936|537004258|FG001|Phase II|Adverse Event|0|||
148870608|NCT01079936|537004259|FG002|Phase II|Adverse Event|1|||
148870609|NCT01079936|537004260|FG003|Phase II|Adverse Event|0|||
148870610|NCT01079936|537004261|FG004|Phase II|Adverse Event|0|||
148870611|NCT01079936|537004257|FG000|Phase II|Insurance Issue|0|||
148870612|NCT01079936|537004258|FG001|Phase II|Insurance Issue|0|||
148870613|NCT01079936|537004259|FG002|Phase II|Insurance Issue|0|||
148870614|NCT01079936|537004260|FG003|Phase II|Insurance Issue|0|||
148870615|NCT01079936|537004261|FG004|Phase II|Insurance Issue|1|||
148870616|NCT00657371|537004262|FG000|Overall Study|Poor bowel preparation|15|||
148870617|NCT00657371|537004262|FG000|Overall Study|Unable to intubate the cecum|5|||
148870618|NCT00657371|537004262|FG000|Overall Study|Protocol Violation|2|||
148870619|NCT00657371|537004262|FG000|Overall Study|Device- related reasons|13|||
148870620|NCT00657371|537004262|FG000|Overall Study|Pre-existing medical condition|4|||
148870621|NCT00652899|537004263|FG000|Overall Study|Death|1|||
148870622|NCT00652899|537004263|FG000|Overall Study|Treating physician decision|1|||
148870623|NCT00551291|537004264|FG000|Overall Study|Physician Decision|1|||
148870624|NCT01943552|537004265|FG000|Overall Study|Adverse Event|3|||
148870625|NCT01943552|537004266|FG001|Overall Study|Adverse Event|2|||
148870626|NCT01943552|537004265|FG000|Overall Study|Withdrawal by Subject|6|||
148870627|NCT01943552|537004266|FG001|Overall Study|Withdrawal by Subject|6|||
148870628|NCT01943552|537004265|FG000|Overall Study|Other Reasons|16|||
148870629|NCT01943552|537004266|FG001|Overall Study|Other Reasons|17|||
148870630|NCT01177969|537004267|FG000|Overall Study|Protocol Violation|2|||
148870631|NCT01177969|537004268|FG001|Overall Study|Protocol Violation|1|||
148870632|NCT01177969|537004267|FG000|Overall Study|Withdrawal by Subject|1|||
148870633|NCT01177969|537004268|FG001|Overall Study|Withdrawal by Subject|2|||
148870634|NCT01475162|537004272|FG000|Overall Study|Physician Decision|1|||
148870635|NCT01475162|537004272|FG000|Overall Study|Death|10|||
148870636|NCT01475162|537004272|FG000|Overall Study|Study closed for safety|3|||
148870637|NCT00490022|537004273|FG000|Overall Study|Adverse Event|0|||
148870638|NCT00490022|537004274|FG001|Overall Study|Adverse Event|2|||
148870639|NCT00490022|537004273|FG000|Overall Study|Withdrawal by Subject|1|||
148870640|NCT00490022|537004274|FG001|Overall Study|Withdrawal by Subject|0|||
148870641|NCT00490022|537004273|FG000|Overall Study|Subject failed to disclose concommitant|0|||
148870642|NCT00490022|537004274|FG001|Overall Study|Subject failed to disclose concommitant|1|||
148870643|NCT01504204|537004275|FG000|Overall Study|Lost to Follow-up|1|||
148870644|NCT01504204|537004276|FG001|Overall Study|Lost to Follow-up|1|||
148870645|NCT00903331|537004277|FG000|Overall Study|Death|4|||
148870646|NCT00903331|537004278|FG001|Overall Study|Death|8|||
148870647|NCT00903331|537004277|FG000|Overall Study|Withdrawal of consent|1|||
148870648|NCT00903331|537004278|FG001|Overall Study|Withdrawal of consent|8|||
148870649|NCT00903331|537004277|FG000|Overall Study|Lung transplant|0|||
148870650|NCT00903331|537004278|FG001|Overall Study|Lung transplant|2|||
148870651|NCT02528357|537004281|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870652|NCT02528357|537004282|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
148870653|NCT02528357|537004283|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870654|NCT02528357|537004284|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870655|NCT02528357|537004285|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870656|NCT02528357|537004286|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870657|NCT02528357|537004287|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870658|NCT02528357|537004288|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870659|NCT02528357|537004289|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870660|NCT02528357|537004290|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870661|NCT02528357|537004291|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870662|NCT02528357|537004292|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870663|NCT02528357|537004293|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870664|NCT02528357|537004294|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
149000319|NCT02066402|537477677|FG000|Overall Study|Progressive disease-clinical progression|0|||
149000320|NCT02066402|537477678|FG001|Overall Study|Progressive disease-clinical progression|1|||
149000321|NCT02066402|537477677|FG000|Overall Study|Protocol driven decision point|0|||
149000322|NCT02066402|537477678|FG001|Overall Study|Protocol driven decision point|1|||
149000323|NCT00152464|537477679|FG000|Overall Study|Adverse Event|3|||
148870665|NCT02528357|537004295|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870666|NCT02528357|537004296|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870667|NCT02528357|537004297|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870668|NCT02528357|537004298|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870669|NCT02528357|537004299|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
148870670|NCT02528357|537004281|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870671|NCT02528357|537004282|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870672|NCT02528357|537004283|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870673|NCT02528357|537004284|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
148870674|NCT02528357|537004285|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870675|NCT02528357|537004286|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
148870676|NCT02528357|537004287|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870677|NCT02528357|537004288|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
148870678|NCT02528357|537004289|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870679|NCT02528357|537004290|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870680|NCT02528357|537004291|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870681|NCT02528357|537004292|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870682|NCT02528357|537004293|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870683|NCT02528357|537004294|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870684|NCT02528357|537004295|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870685|NCT02528357|537004296|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870686|NCT02528357|537004297|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870687|NCT02528357|537004298|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870688|NCT02528357|537004299|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
148870689|NCT02528357|537004281|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870690|NCT02528357|537004282|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870691|NCT02528357|537004283|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
148870692|NCT02528357|537004284|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870693|NCT02528357|537004285|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
148870694|NCT02528357|537004286|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870695|NCT02528357|537004287|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
148870696|NCT02528357|537004288|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
148870697|NCT02528357|537004289|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870698|NCT02528357|537004290|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870699|NCT02528357|537004291|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870700|NCT02528357|537004292|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870701|NCT02528357|537004293|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
149000324|NCT00152464|537477680|FG001|Overall Study|Adverse Event|6|||
149000325|NCT00152464|537477679|FG000|Overall Study|Lost to Follow-up|8|||
149000326|NCT00152464|537477680|FG001|Overall Study|Lost to Follow-up|4|||
149000327|NCT00152464|537477679|FG000|Overall Study|Protocol Violation|3|||
149000328|NCT00152464|537477680|FG001|Overall Study|Protocol Violation|1|||
149000329|NCT00152464|537477679|FG000|Overall Study|Withdrawal by Subject|21|||
149000330|NCT00152464|537477680|FG001|Overall Study|Withdrawal by Subject|22|||
149000331|NCT00152464|537477679|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
149000332|NCT00152464|537477680|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
149000333|NCT00152464|537477679|FG000|Overall Study|Eczema deterioration|0|||
149000334|NCT00152464|537477680|FG001|Overall Study|Eczema deterioration|1|||
149000335|NCT00152464|537477679|FG000|Overall Study|Parent decision|1|||
149000336|NCT00152464|537477680|FG001|Overall Study|Parent decision|1|||
149000337|NCT00152464|537477679|FG000|Overall Study|Investigator decision|1|||
149000338|NCT00152464|537477680|FG001|Overall Study|Investigator decision|0|||
149000339|NCT00152464|537477679|FG000|Overall Study|Lack of Efficacy|1|||
149000340|NCT00152464|537477680|FG001|Overall Study|Lack of Efficacy|0|||
149000341|NCT00152464|537477679|FG000|Overall Study|Eczema poorly controlled|1|||
149000342|NCT00152464|537477680|FG001|Overall Study|Eczema poorly controlled|0|||
149000343|NCT00152464|537477679|FG000|Overall Study|Patient relocated|1|||
149000344|NCT00152464|537477680|FG001|Overall Study|Patient relocated|0|||
149000345|NCT04493931|537477681|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
149000346|NCT04493931|537477682|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
149000347|NCT04493931|537477683|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
149000348|NCT04493931|537477684|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
149000349|NCT04493931|537477685|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
149000350|NCT04493931|537477686|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
149000351|NCT04493931|537477687|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
149000352|NCT04493931|537477681|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
149000353|NCT04493931|537477682|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
149000354|NCT04493931|537477683|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
149000355|NCT04493931|537477684|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
149000356|NCT04493931|537477685|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
149000357|NCT04493931|537477686|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
149000358|NCT04493931|537477687|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
148870702|NCT02528357|537004294|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870703|NCT02528357|537004295|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870704|NCT02528357|537004296|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870705|NCT02528357|537004297|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870706|NCT02528357|537004298|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870707|NCT02528357|537004299|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
148870708|NCT02528357|537004281|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870709|NCT02528357|537004282|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870710|NCT02528357|537004283|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870711|NCT02528357|537004284|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870712|NCT02528357|537004285|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
148870713|NCT02528357|537004286|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870714|NCT02528357|537004287|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870715|NCT02528357|537004288|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870716|NCT02528357|537004289|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870717|NCT02528357|537004290|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870718|NCT02528357|537004291|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870719|NCT02528357|537004292|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870720|NCT02528357|537004293|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870721|NCT02528357|537004294|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148889274|NCT02831764|537074366|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
148889275|NCT02831764|537074362|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
148889276|NCT02831764|537074363|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
148889277|NCT02831764|537074364|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
148889278|NCT02831764|537074365|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
149032264|NCT02377362|537596005|FG000|Part B Overall|Withdrawal by Subject|0|||
148889279|NCT02831764|537074366|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
148889280|NCT02831764|537074362|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
148889281|NCT02831764|537074363|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
148889282|NCT02831764|537074364|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
148889283|NCT02831764|537074365|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
148889284|NCT02831764|537074366|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
148889285|NCT04154943|537074370|FG000|Overall Study|Study Ongoing|68|||
148889286|NCT04154943|537074370|FG000|Overall Study|Lost to Follow-up|1|||
148889287|NCT04154943|537074370|FG000|Overall Study|Decision by the Investigator|1|||
148889288|NCT04154943|537074370|FG000|Overall Study|Death|5|||
148889289|NCT04154943|537074370|FG000|Overall Study|Withdrawal by Subject|4|||
148889290|NCT00101686|537074371|FG000|Overall Study|Progressive Disease|37|||
148889291|NCT00101686|537074372|FG001|Overall Study|Progressive Disease|28|||
148889292|NCT00101686|537074373|FG002|Overall Study|Progressive Disease|37|||
148889293|NCT00101686|537074374|FG003|Overall Study|Progressive Disease|38|||
148889294|NCT00101686|537074375|FG004|Overall Study|Progressive Disease|28|||
148889295|NCT00101686|537074376|FG005|Overall Study|Progressive Disease|25|||
148889296|NCT00101686|537074377|FG006|Overall Study|Progressive Disease|5|||
148889297|NCT00101686|537074378|FG007|Overall Study|Progressive Disease|7|||
148889298|NCT00101686|537074379|FG008|Overall Study|Progressive Disease|10|||
148889299|NCT00101686|537074380|FG009|Overall Study|Progressive Disease|8|||
148889300|NCT00101686|537074371|FG000|Overall Study|initiation other anti-cancer treatment|4|||
148889301|NCT00101686|537074372|FG001|Overall Study|initiation other anti-cancer treatment|3|||
148889302|NCT00101686|537074373|FG002|Overall Study|initiation other anti-cancer treatment|4|||
148889303|NCT00101686|537074374|FG003|Overall Study|initiation other anti-cancer treatment|3|||
148889304|NCT00101686|537074375|FG004|Overall Study|initiation other anti-cancer treatment|1|||
148889305|NCT00101686|537074376|FG005|Overall Study|initiation other anti-cancer treatment|1|||
148889306|NCT00101686|537074377|FG006|Overall Study|initiation other anti-cancer treatment|2|||
148889307|NCT00101686|537074378|FG007|Overall Study|initiation other anti-cancer treatment|2|||
148889308|NCT00101686|537074379|FG008|Overall Study|initiation other anti-cancer treatment|3|||
148889309|NCT00101686|537074380|FG009|Overall Study|initiation other anti-cancer treatment|3|||
148889310|NCT00101686|537074371|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
148889311|NCT00101686|537074372|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
148889312|NCT00101686|537074373|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
148889313|NCT00101686|537074374|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
148870722|NCT02528357|537004295|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870723|NCT02528357|537004296|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870724|NCT02528357|537004297|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870725|NCT02528357|537004298|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870726|NCT02528357|537004299|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870727|NCT02528357|537004281|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870728|NCT02528357|537004282|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870729|NCT02528357|537004283|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870730|NCT02528357|537004284|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870731|NCT02528357|537004285|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870732|NCT02528357|537004286|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870733|NCT02528357|537004287|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870734|NCT02528357|537004288|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870735|NCT02528357|537004289|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870736|NCT02528357|537004290|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870737|NCT02528357|537004291|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870738|NCT02528357|537004292|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870739|NCT02528357|537004293|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870740|NCT02528357|537004294|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
148870741|NCT02528357|537004295|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
148870742|NCT02528357|537004296|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870743|NCT02528357|537004297|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870744|NCT02528357|537004298|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870745|NCT02528357|537004299|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
148870746|NCT02528357|537004281|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870747|NCT02528357|537004282|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870748|NCT02528357|537004283|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870749|NCT02528357|537004284|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870750|NCT02528357|537004285|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870751|NCT02528357|537004286|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870752|NCT02528357|537004287|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870753|NCT02528357|537004288|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870754|NCT02528357|537004289|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870755|NCT02528357|537004290|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870756|NCT02528357|537004291|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870757|NCT02528357|537004292|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870758|NCT02528357|537004293|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870759|NCT02528357|537004294|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
148870760|NCT02528357|537004295|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870761|NCT02528357|537004296|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870762|NCT02528357|537004297|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870763|NCT02528357|537004298|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870764|NCT02528357|537004299|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
148870765|NCT02528357|537004281|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870766|NCT02528357|537004282|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870767|NCT02528357|537004283|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870768|NCT02528357|537004284|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870769|NCT02528357|537004285|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870770|NCT02528357|537004286|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870771|NCT02528357|537004287|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870772|NCT02528357|537004288|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870773|NCT02528357|537004289|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870774|NCT02528357|537004290|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870775|NCT02528357|537004291|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
148870776|NCT02528357|537004292|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870777|NCT02528357|537004293|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
148870778|NCT02528357|537004294|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
148870779|NCT02528357|537004295|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
149000359|NCT04493931|537477681|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
149000360|NCT04493931|537477682|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
148870780|NCT02528357|537004296|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870781|NCT02528357|537004297|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870782|NCT02528357|537004298|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870783|NCT02528357|537004299|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
148870784|NCT02528357|537004281|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870785|NCT02528357|537004282|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870786|NCT02528357|537004283|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870787|NCT02528357|537004284|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870788|NCT02528357|537004285|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870789|NCT02528357|537004286|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870790|NCT02528357|537004287|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870791|NCT02528357|537004288|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870792|NCT02528357|537004289|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
148870793|NCT02528357|537004290|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
148870794|NCT02528357|537004291|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870795|NCT02528357|537004292|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
148870796|NCT02528357|537004293|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
148870797|NCT02528357|537004294|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
148870798|NCT02528357|537004295|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
148870799|NCT02528357|537004296|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870800|NCT02528357|537004297|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870801|NCT02528357|537004298|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870802|NCT02528357|537004299|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870803|NCT02528357|537004281|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870804|NCT02528357|537004282|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870805|NCT02528357|537004283|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870806|NCT02528357|537004284|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870807|NCT02528357|537004285|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870808|NCT02528357|537004286|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870809|NCT02528357|537004287|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870810|NCT02528357|537004288|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870811|NCT02528357|537004289|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870812|NCT02528357|537004290|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870813|NCT02528357|537004291|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870814|NCT02528357|537004292|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870815|NCT02528357|537004293|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870816|NCT02528357|537004294|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870817|NCT02528357|537004295|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870818|NCT02528357|537004296|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870819|NCT02528357|537004297|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
148870820|NCT02528357|537004298|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870821|NCT02528357|537004299|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
148870822|NCT02528357|537004281|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870823|NCT02528357|537004282|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870824|NCT02528357|537004283|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870825|NCT02528357|537004284|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870826|NCT02528357|537004285|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870827|NCT02528357|537004286|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870828|NCT02528357|537004287|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870829|NCT02528357|537004288|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870830|NCT02528357|537004289|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
149000361|NCT04493931|537477683|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
149000362|NCT04493931|537477684|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
149000363|NCT04493931|537477685|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
149000364|NCT04493931|537477686|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
148870831|NCT02528357|537004290|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870832|NCT02528357|537004291|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870833|NCT02528357|537004292|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870834|NCT02528357|537004293|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870835|NCT02528357|537004294|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870836|NCT02528357|537004295|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870837|NCT02528357|537004296|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
148870838|NCT02528357|537004297|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
148870839|NCT02528357|537004298|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
148870840|NCT02528357|537004299|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
148870841|NCT01927055|537004300|FG000|Open-label|Adverse Event|6|||
148870842|NCT01927055|537004301|FG001|Open-label|Adverse Event|0|||
148870843|NCT01927055|537004302|FG002|Open-label|Adverse Event|0|||
148870844|NCT01927055|537004300|FG000|Open-label|Withdrawal by Subject|1|||
148870845|NCT01927055|537004301|FG001|Open-label|Withdrawal by Subject|0|||
148870846|NCT01927055|537004302|FG002|Open-label|Withdrawal by Subject|0|||
148870847|NCT01927055|537004300|FG000|Open-label|Study Stopped|4|||
148870848|NCT01927055|537004301|FG001|Open-label|Study Stopped|0|||
148870849|NCT01927055|537004302|FG002|Open-label|Study Stopped|0|||
148870850|NCT01927055|537004300|FG000|Open-label|Supine Hypertension|4|||
148870851|NCT01927055|537004301|FG001|Open-label|Supine Hypertension|0|||
148870852|NCT01927055|537004302|FG002|Open-label|Supine Hypertension|0|||
148870853|NCT01927055|537004300|FG000|Open-label|Difficulty attending study visits|1|||
148870854|NCT01927055|537004301|FG001|Open-label|Difficulty attending study visits|0|||
148870855|NCT01927055|537004302|FG002|Open-label|Difficulty attending study visits|0|||
148870856|NCT01927055|537004300|FG000|Double-Blind|Adverse Event|0|||
148870857|NCT01927055|537004301|FG001|Double-Blind|Adverse Event|1|||
148870858|NCT01927055|537004302|FG002|Double-Blind|Adverse Event|1|||
148870859|NCT01927055|537004300|FG000|Double-Blind|Protocol Violation|0|||
148870860|NCT01927055|537004301|FG001|Double-Blind|Protocol Violation|0|||
148870861|NCT01927055|537004302|FG002|Double-Blind|Protocol Violation|1|||
148870862|NCT01927055|537004300|FG000|Double-Blind|Withdrawal by Subject|0|||
148870863|NCT01927055|537004301|FG001|Double-Blind|Withdrawal by Subject|2|||
148870864|NCT01927055|537004302|FG002|Double-Blind|Withdrawal by Subject|3|||
148870865|NCT01927055|537004300|FG000|Double-Blind|Study Stopped|0|||
148870866|NCT01927055|537004301|FG001|Double-Blind|Study Stopped|7|||
148870867|NCT01927055|537004302|FG002|Double-Blind|Study Stopped|7|||
148870868|NCT01927055|537004300|FG000|Double-Blind|Supine Hypertension|0|||
148870869|NCT01927055|537004301|FG001|Double-Blind|Supine Hypertension|0|||
148870870|NCT01927055|537004302|FG002|Double-Blind|Supine Hypertension|1|||
148870871|NCT01927055|537004300|FG000|Double-Blind|Extended Vacation|0|||
148870872|NCT01927055|537004301|FG001|Double-Blind|Extended Vacation|1|||
148870873|NCT01927055|537004302|FG002|Double-Blind|Extended Vacation|0|||
148870874|NCT03134183|537004304|FG000|Overall Study|Withdrawal by Subject|1|||
148870875|NCT03134183|537004305|FG001|Overall Study|Withdrawal by Subject|1|||
148870876|NCT00845065|537004307|FG000|Overall Study|Adverse Event|3|||
148870877|NCT00845065|537004308|FG001|Overall Study|Adverse Event|23|||
148870878|NCT00845065|537004307|FG000|Overall Study|Lack of Efficacy|43|||
149032265|NCT02377362|537596006|FG001|Part B Overall|Withdrawal by Subject|0|||
149032266|NCT02377362|537596007|FG002|Part B Overall|Withdrawal by Subject|0|||
149032267|NCT02377362|537596008|FG003|Part B Overall|Withdrawal by Subject|0|||
149032268|NCT02377362|537596009|FG004|Part B Overall|Withdrawal by Subject|0|||
149032269|NCT02377362|537596010|FG005|Part B Overall|Withdrawal by Subject|0|||
149032270|NCT02377362|537596011|FG006|Part B Overall|Withdrawal by Subject|1|||
149032271|NCT02377362|537596012|FG007|Part B Overall|Withdrawal by Subject|0|||
149032272|NCT02377362|537596013|FG008|Part B Overall|Withdrawal by Subject|0|||
148870879|NCT00845065|537004308|FG001|Overall Study|Lack of Efficacy|21|||
148870880|NCT00845065|537004307|FG000|Overall Study|Non-Medical Reasons|1|||
148870881|NCT00845065|537004308|FG001|Overall Study|Non-Medical Reasons|11|||
148870882|NCT01198509|537004309|FG000|Overall Study|Withdrawal by Subject|1|||
148870883|NCT01198509|537004310|FG001|Overall Study|Withdrawal by Subject|0|||
148870884|NCT01198509|537004311|FG002|Overall Study|Withdrawal by Subject|0|||
148870885|NCT01198509|537004312|FG003|Overall Study|Withdrawal by Subject|0|||
148870886|NCT01198509|537004313|FG004|Overall Study|Withdrawal by Subject|0|||
148870887|NCT01198509|537004314|FG005|Overall Study|Withdrawal by Subject|0|||
148870888|NCT01291277|537004330|FG000|Overall Study|Death|2|||
148870889|NCT01291277|537004331|FG001|Overall Study|Death|2|||
148870890|NCT01291277|537004330|FG000|Overall Study|Lost to Follow-up|3|||
148870891|NCT01291277|537004331|FG001|Overall Study|Lost to Follow-up|1|||
148870892|NCT02963701|537004332|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
149032273|NCT02377362|537596014|FG009|Part B Overall|Withdrawal by Subject|0|||
149032274|NCT02377362|537596015|FG010|Part B Overall|Withdrawal by Subject|0|||
149032275|NCT02377362|537596016|FG011|Part B Overall|Withdrawal by Subject|1|||
148870893|NCT02963701|537004333|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
148870894|NCT01345682|537004334|FG000|Overall Study|Progressive disease per RECIST|226|||
148870895|NCT01345682|537004335|FG001|Overall Study|Progressive disease per RECIST|93|||
148870896|NCT01345682|537004334|FG000|Overall Study|Worsening of underlying cancer disease|23|||
148870897|NCT01345682|537004335|FG001|Overall Study|Worsening of underlying cancer disease|12|||
148870898|NCT01345682|537004334|FG000|Overall Study|Adverse Event|51|||
148870899|NCT01345682|537004335|FG001|Overall Study|Adverse Event|41|||
148870900|NCT01345682|537004334|FG000|Overall Study|Non-compliance with protocol|0|||
148870901|NCT01345682|537004335|FG001|Overall Study|Non-compliance with protocol|1|||
148870902|NCT01345682|537004334|FG000|Overall Study|Lost to Follow-up|0|||
148870903|NCT01345682|537004335|FG001|Overall Study|Lost to Follow-up|1|||
148870904|NCT01345682|537004334|FG000|Overall Study|Refused to continue trial medication|16|||
148870905|NCT01345682|537004335|FG001|Overall Study|Refused to continue trial medication|9|||
148870906|NCT01345682|537004334|FG000|Overall Study|Not treated|2|||
148870907|NCT01345682|537004335|FG001|Overall Study|Not treated|1|||
148870908|NCT01345682|537004334|FG000|Overall Study|Reason other than those specified above|4|||
148870909|NCT01345682|537004335|FG001|Overall Study|Reason other than those specified above|3|||
149000365|NCT04493931|537477687|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
149000366|NCT04493931|537477681|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
149000367|NCT04493931|537477682|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
149000368|NCT04493931|537477683|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
149000369|NCT04493931|537477684|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
149000370|NCT04493931|537477685|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
149000371|NCT04493931|537477686|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
149000372|NCT04493931|537477687|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
149000373|NCT03338894|537477688|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
149000374|NCT00266825|537477695|FG000|Completed Follow-Up|Lost to Follow-up|14|||
149000375|NCT00266825|537477696|FG001|Completed Follow-Up|Lost to Follow-up|19|||
149000376|NCT00266825|537477695|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
149000377|NCT00266825|537477696|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
149000378|NCT00430248|537477697|FG000|Overall Study|Adverse Event|49|||
149000379|NCT00430248|537477698|FG001|Overall Study|Adverse Event|61|||
149000380|NCT00430248|537477699|FG002|Overall Study|Adverse Event|64|||
149000381|NCT00430248|537477697|FG000|Overall Study|Protocol Violation|10|||
149000382|NCT00430248|537477698|FG001|Overall Study|Protocol Violation|2|||
149000383|NCT00430248|537477699|FG002|Overall Study|Protocol Violation|4|||
149000384|NCT00430248|537477697|FG000|Overall Study|Personal Reasons|12|||
149000385|NCT00430248|537477698|FG001|Overall Study|Personal Reasons|24|||
149000386|NCT00430248|537477699|FG002|Overall Study|Personal Reasons|9|||
149000387|NCT00430248|537477697|FG000|Overall Study|Lost to Follow-up|28|||
149000388|NCT00430248|537477698|FG001|Overall Study|Lost to Follow-up|33|||
149000389|NCT00430248|537477699|FG002|Overall Study|Lost to Follow-up|28|||
149000390|NCT00430248|537477697|FG000|Overall Study|Therapeutic Failure|1|||
149000391|NCT00430248|537477698|FG001|Overall Study|Therapeutic Failure|1|||
149000392|NCT00430248|537477699|FG002|Overall Study|Therapeutic Failure|1|||
149000393|NCT00430248|537477697|FG000|Overall Study|Withdrawal by Subject|14|||
149000394|NCT00430248|537477698|FG001|Overall Study|Withdrawal by Subject|20|||
149000395|NCT00430248|537477699|FG002|Overall Study|Withdrawal by Subject|16|||
149000396|NCT00430248|537477697|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149000397|NCT00430248|537477698|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
149000398|NCT00430248|537477699|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149000399|NCT00430248|537477697|FG000|Overall Study|Gout Flare|3|||
149000400|NCT00430248|537477698|FG001|Overall Study|Gout Flare|7|||
149000401|NCT00430248|537477699|FG002|Overall Study|Gout Flare|2|||
149000402|NCT00430248|537477697|FG000|Overall Study|Reason Not Specified|8|||
149000403|NCT00430248|537477698|FG001|Overall Study|Reason Not Specified|8|||
149000404|NCT00430248|537477699|FG002|Overall Study|Reason Not Specified|11|||
149000405|NCT00917579|537477700|FG000|Washout >= 2 Weeks|Adverse Event|1|||
149000406|NCT00917579|537477701|FG001|Washout >= 2 Weeks|Adverse Event|0|||
149000407|NCT00917579|537477700|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
149000408|NCT00917579|537477701|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
149000409|NCT00754338|537477702|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
149000410|NCT00754338|537477703|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
149000411|NCT00754338|537477704|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
149000412|NCT00754338|537477705|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
149000413|NCT00754338|537477702|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
149000414|NCT00754338|537477703|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
148870910|NCT00637572|537004336|FG000|Overall Study|Adverse Event|1|||
148870911|NCT00637572|537004337|FG001|Overall Study|Adverse Event|2|||
148870912|NCT00637572|537004336|FG000|Overall Study|Death|0|||
148870913|NCT00637572|537004337|FG001|Overall Study|Death|1|||
148870914|NCT00637572|537004336|FG000|Overall Study|Lost to Follow-up|0|||
148870915|NCT00637572|537004337|FG001|Overall Study|Lost to Follow-up|1|||
148870916|NCT00637572|537004336|FG000|Overall Study|Physician Decision|1|||
148870917|NCT00637572|537004337|FG001|Overall Study|Physician Decision|1|||
148870918|NCT00637572|537004336|FG000|Overall Study|Withdrawal by Subject|0|||
148870919|NCT00637572|537004337|FG001|Overall Study|Withdrawal by Subject|2|||
148870920|NCT00637572|537004336|FG000|Overall Study|Illicit Drug Use|1|||
148870921|NCT00637572|537004337|FG001|Overall Study|Illicit Drug Use|0|||
148870922|NCT00896649|537004338|FG000|Overall Study|Physician Decision|1|||
148870923|NCT00896649|537004338|FG000|Overall Study|Pregnancy|1|||
148870924|NCT00896649|537004338|FG000|Overall Study|missing documentation|1|||
148870925|NCT00896649|537004338|FG000|Overall Study|technical difficulties|2|||
148870926|NCT03180307|537004343|FG000|Overall Study|Lost to Follow-up|2|||
148870927|NCT03180307|537004344|FG001|Overall Study|Lost to Follow-up|0|||
148870928|NCT03180307|537004343|FG000|Overall Study|Death|1|||
148870929|NCT03180307|537004344|FG001|Overall Study|Death|0|||
148870930|NCT03180307|537004343|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
148870931|NCT03180307|537004344|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
148870932|NCT01563172|537004345|FG000|Overall Study|Adverse Event|5|||
148870933|NCT01563172|537004345|FG000|Overall Study|Lost to Follow-up|2|||
148870934|NCT01563172|537004345|FG000|Overall Study|Other (Protocol deviation)|5|||
148870935|NCT01563172|537004345|FG000|Overall Study|Other (Not specified)|1|||
148870936|NCT03652675|537004346|FG000|Overall Study|Lost to Follow-up|4|||
148870937|NCT03652675|537004347|FG001|Overall Study|Lost to Follow-up|4|||
148870938|NCT01638559|537004348|FG000|Overall Study|Lost to Follow-up|1|||
148870939|NCT01638559|537004348|FG000|Overall Study|Withdrawal by Subject|1|||
148870940|NCT01638559|537004348|FG000|Overall Study|Subject declined to travel for biopsy|1|||
148870941|NCT01555125|537004359|FG000|Induction Period|Lost to Follow-up|0|||
148870942|NCT01555125|537004360|FG001|Induction Period|Lost to Follow-up|2|||
148870943|NCT01555125|537004361|FG002|Induction Period|Lost to Follow-up|0|||
148870944|NCT01555125|537004362|FG003|Induction Period|Lost to Follow-up|0|||
148870945|NCT01555125|537004363|FG004|Induction Period|Lost to Follow-up|0|||
148870946|NCT01555125|537004359|FG000|Induction Period|Adverse Event|0|||
148870947|NCT01555125|537004360|FG001|Induction Period|Adverse Event|1|||
148870948|NCT01555125|537004361|FG002|Induction Period|Adverse Event|0|||
148870949|NCT01555125|537004362|FG003|Induction Period|Adverse Event|0|||
148870950|NCT01555125|537004363|FG004|Induction Period|Adverse Event|1|||
148870951|NCT01555125|537004359|FG000|Induction Period|Subject / guardian decision|0|||
148870952|NCT01555125|537004360|FG001|Induction Period|Subject / guardian decision|0|||
148870953|NCT01555125|537004361|FG002|Induction Period|Subject / guardian decision|0|||
148870954|NCT01555125|537004362|FG003|Induction Period|Subject / guardian decision|0|||
148870955|NCT01555125|537004363|FG004|Induction Period|Subject / guardian decision|2|||
148870956|NCT01555125|537004359|FG000|Induction Period|Death|1|||
148870957|NCT01555125|537004360|FG001|Induction Period|Death|0|||
148870958|NCT01555125|537004361|FG002|Induction Period|Death|0|||
148870959|NCT01555125|537004362|FG003|Induction Period|Death|0|||
148870960|NCT01555125|537004363|FG004|Induction Period|Death|0|||
148870961|NCT01555125|537004359|FG000|Maintenance Period|Adverse Event|1|||
148870962|NCT01555125|537004360|FG001|Maintenance Period|Adverse Event|1|||
148870963|NCT01555125|537004361|FG002|Maintenance Period|Adverse Event|0|||
148870964|NCT01555125|537004362|FG003|Maintenance Period|Adverse Event|0|||
148870965|NCT01555125|537004363|FG004|Maintenance Period|Adverse Event|0|||
148870966|NCT01555125|537004359|FG000|Maintenance Period|Subject / guardian decision|1|||
148870967|NCT01555125|537004360|FG001|Maintenance Period|Subject / guardian decision|2|||
148870968|NCT01555125|537004361|FG002|Maintenance Period|Subject / guardian decision|0|||
148870969|NCT01555125|537004362|FG003|Maintenance Period|Subject / guardian decision|0|||
148870970|NCT01555125|537004363|FG004|Maintenance Period|Subject / guardian decision|0|||
148870971|NCT01555125|537004359|FG000|Maintenance Period|Lost to Follow-up|2|||
148870972|NCT01555125|537004360|FG001|Maintenance Period|Lost to Follow-up|0|||
148870973|NCT01555125|537004361|FG002|Maintenance Period|Lost to Follow-up|0|||
148870974|NCT01555125|537004362|FG003|Maintenance Period|Lost to Follow-up|1|||
148870975|NCT01555125|537004363|FG004|Maintenance Period|Lost to Follow-up|0|||
148870976|NCT01555125|537004359|FG000|Maintenance Period|Lack of Efficacy|6|||
148870977|NCT01555125|537004360|FG001|Maintenance Period|Lack of Efficacy|1|||
149000415|NCT00754338|537477704|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
149000416|NCT00754338|537477705|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
148870978|NCT01555125|537004361|FG002|Maintenance Period|Lack of Efficacy|3|||
148870979|NCT01555125|537004362|FG003|Maintenance Period|Lack of Efficacy|0|||
148870980|NCT01555125|537004363|FG004|Maintenance Period|Lack of Efficacy|0|||
148870981|NCT01555125|537004359|FG000|Maintenance Period|Physician Decision|0|||
148870982|NCT01555125|537004360|FG001|Maintenance Period|Physician Decision|0|||
148870983|NCT01555125|537004361|FG002|Maintenance Period|Physician Decision|1|||
148870984|NCT01555125|537004362|FG003|Maintenance Period|Physician Decision|0|||
148870985|NCT01555125|537004363|FG004|Maintenance Period|Physician Decision|0|||
148870986|NCT01555125|537004359|FG000|Maintenance Period|Death|0|||
148870987|NCT01555125|537004360|FG001|Maintenance Period|Death|0|||
148870988|NCT01555125|537004361|FG002|Maintenance Period|Death|0|||
148870989|NCT01555125|537004362|FG003|Maintenance Period|Death|1|||
148870990|NCT01555125|537004363|FG004|Maintenance Period|Death|0|||
148870991|NCT01555125|537004359|FG000|Extension|Adverse Event|1|||
148870992|NCT01555125|537004360|FG001|Extension|Adverse Event|2|||
148870993|NCT01555125|537004361|FG002|Extension|Adverse Event|1|||
148870994|NCT01555125|537004362|FG003|Extension|Adverse Event|1|||
148870995|NCT01555125|537004363|FG004|Extension|Adverse Event|0|||
148870996|NCT01555125|537004359|FG000|Extension|Protocol deviation|1|||
148870997|NCT01555125|537004360|FG001|Extension|Protocol deviation|0|||
148870998|NCT01555125|537004361|FG002|Extension|Protocol deviation|0|||
148870999|NCT01555125|537004362|FG003|Extension|Protocol deviation|0|||
148871000|NCT01555125|537004363|FG004|Extension|Protocol deviation|0|||
148871001|NCT01555125|537004359|FG000|Extension|Lack of Efficacy|7|||
148871002|NCT01555125|537004360|FG001|Extension|Lack of Efficacy|6|||
148871003|NCT01555125|537004361|FG002|Extension|Lack of Efficacy|3|||
148871004|NCT01555125|537004362|FG003|Extension|Lack of Efficacy|0|||
148871005|NCT01555125|537004363|FG004|Extension|Lack of Efficacy|0|||
148871006|NCT01555125|537004359|FG000|Extension|Lost to Follow-up|2|||
148871007|NCT01555125|537004360|FG001|Extension|Lost to Follow-up|1|||
148871008|NCT01555125|537004361|FG002|Extension|Lost to Follow-up|2|||
148871009|NCT01555125|537004362|FG003|Extension|Lost to Follow-up|0|||
148871010|NCT01555125|537004363|FG004|Extension|Lost to Follow-up|0|||
148871011|NCT01555125|537004359|FG000|Extension|Study terminated by sponsor|32|||
148871012|NCT01555125|537004360|FG001|Extension|Study terminated by sponsor|33|||
148871013|NCT01555125|537004361|FG002|Extension|Study terminated by sponsor|16|||
148871014|NCT01555125|537004362|FG003|Extension|Study terminated by sponsor|20|||
148871015|NCT01555125|537004363|FG004|Extension|Study terminated by sponsor|0|||
148871016|NCT01555125|537004359|FG000|Extension|Subject/guardian decision|1|||
148871017|NCT01555125|537004360|FG001|Extension|Subject/guardian decision|9|||
148871018|NCT01555125|537004361|FG002|Extension|Subject/guardian decision|1|||
148871019|NCT01555125|537004362|FG003|Extension|Subject/guardian decision|0|||
148871020|NCT01555125|537004363|FG004|Extension|Subject/guardian decision|0|||
148871021|NCT01555125|537004359|FG000|Extension|Technical Problems|1|||
148871022|NCT01555125|537004360|FG001|Extension|Technical Problems|0|||
148871023|NCT01555125|537004361|FG002|Extension|Technical Problems|0|||
148871024|NCT01555125|537004362|FG003|Extension|Technical Problems|1|||
148871025|NCT01555125|537004363|FG004|Extension|Technical Problems|0|||
148871026|NCT01555125|537004359|FG000|Follow-Up Period|Lost to Follow-up|1|||
148871027|NCT01555125|537004360|FG001|Follow-Up Period|Lost to Follow-up|0|||
148871028|NCT01555125|537004361|FG002|Follow-Up Period|Lost to Follow-up|0|||
148871029|NCT01555125|537004362|FG003|Follow-Up Period|Lost to Follow-up|0|||
148871030|NCT01555125|537004363|FG004|Follow-Up Period|Lost to Follow-up|0|||
148871031|NCT01555125|537004359|FG000|Follow-Up Period|Subject / guardian decision|3|||
148871032|NCT01555125|537004360|FG001|Follow-Up Period|Subject / guardian decision|1|||
148871033|NCT01555125|537004361|FG002|Follow-Up Period|Subject / guardian decision|1|||
148871034|NCT01555125|537004362|FG003|Follow-Up Period|Subject / guardian decision|1|||
148871035|NCT01555125|537004363|FG004|Follow-Up Period|Subject / guardian decision|0|||
148871036|NCT02651220|537004364|FG000|Overall Study|Adverse Event|1|||
148871037|NCT02651220|537004365|FG001|Overall Study|Adverse Event|5|||
148871038|NCT02651220|537004366|FG002|Overall Study|Adverse Event|1|||
148871039|NCT02651220|537004364|FG000|Overall Study|Lost to Follow-up|8|||
148871040|NCT02651220|537004365|FG001|Overall Study|Lost to Follow-up|14|||
148871041|NCT02651220|537004366|FG002|Overall Study|Lost to Follow-up|14|||
148871042|NCT02651220|537004364|FG000|Overall Study|Non-Compliance with Study Drug|4|||
148871043|NCT02651220|537004365|FG001|Overall Study|Non-Compliance with Study Drug|0|||
148871044|NCT02651220|537004366|FG002|Overall Study|Non-Compliance with Study Drug|1|||
148871045|NCT02651220|537004364|FG000|Overall Study|Pregnancy|1|||
148871046|NCT02651220|537004365|FG001|Overall Study|Pregnancy|0|||
148871047|NCT02651220|537004366|FG002|Overall Study|Pregnancy|1|||
148871048|NCT02651220|537004364|FG000|Overall Study|Protocol Violation|0|||
148871049|NCT02651220|537004365|FG001|Overall Study|Protocol Violation|0|||
148871050|NCT02651220|537004366|FG002|Overall Study|Protocol Violation|1|||
148871051|NCT02651220|537004364|FG000|Overall Study|Withdrawal by Subject|5|||
148871052|NCT02651220|537004365|FG001|Overall Study|Withdrawal by Subject|6|||
148871053|NCT02651220|537004366|FG002|Overall Study|Withdrawal by Subject|8|||
148871054|NCT02651220|537004364|FG000|Overall Study|Miscellaneous|4|||
148871055|NCT02651220|537004365|FG001|Overall Study|Miscellaneous|1|||
148871056|NCT02651220|537004366|FG002|Overall Study|Miscellaneous|2|||
148871057|NCT02651220|537004364|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148871058|NCT02651220|537004365|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149000417|NCT00831779|537477708|FG000|Overall Study|Lost to Follow-up|1|||
149000418|NCT00831779|537477709|FG001|Overall Study|Lost to Follow-up|0|||
148871059|NCT02651220|537004366|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
148871060|NCT00447122|537004367|FG000|Overall Study|worsening medical condition -came off|0|||
148871061|NCT00447122|537004368|FG001|Overall Study|worsening medical condition -came off|1|||
148871062|NCT00447122|537004369|FG002|Overall Study|worsening medical condition -came off|0|||
148871063|NCT00447122|537004370|FG003|Overall Study|worsening medical condition -came off|0|||
148871064|NCT01274429|537004372|FG000|Overall Study|Study closed do to lack of funding|5|||
149000419|NCT00831779|537477708|FG000|Overall Study|No longer met criteria|0|||
149032276|NCT02377362|537596017|FG012|Part B Overall|Withdrawal by Subject|0|||
149032277|NCT02430532|537596022|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
149032278|NCT02430532|537596023|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
149032279|NCT02430532|537596022|FG000|Overall Study|Consent Withdrawn|0|||
149032280|NCT02430532|537596023|FG001|Overall Study|Consent Withdrawn|2|||
149032281|NCT02430532|537596022|FG000|Overall Study|Adverse Event|0|||
149032282|NCT02430532|537596023|FG001|Overall Study|Adverse Event|1|||
149032283|NCT01190150|537596024|FG000|First Treatment|Withdrawal by Subject|1|||
149032284|NCT01190150|537596025|FG001|First Treatment|Withdrawal by Subject|0|||
149032285|NCT01190150|537596024|FG000|Washout|Withdrawal by Subject|0|||
149032286|NCT01190150|537596025|FG001|Washout|Withdrawal by Subject|1|||
149032287|NCT01190150|537596024|FG000|Washout|Difficulty in adherence|0|||
149032288|NCT01190150|537596025|FG001|Washout|Difficulty in adherence|1|||
149032289|NCT02750709|537596028|FG000|Treatment Period 1|Adverse Event|0|||
149032290|NCT02750709|537596029|FG001|Treatment Period 1|Adverse Event|0|||
149032291|NCT02750709|537596030|FG002|Treatment Period 1|Adverse Event|0|||
149032292|NCT02750709|537596031|FG003|Treatment Period 1|Adverse Event|0|||
149032293|NCT02750709|537596032|FG004|Treatment Period 1|Adverse Event|0|||
149032294|NCT02750709|537596033|FG005|Treatment Period 1|Adverse Event|1|||
149032295|NCT03256344|537596034|FG000|Overall Study|Death|6|||
149032296|NCT03256344|537596035|FG001|Overall Study|Death|22|||
149032297|NCT03256344|537596034|FG000|Overall Study|Withdrawal by Subject|3|||
149032298|NCT03256344|537596035|FG001|Overall Study|Withdrawal by Subject|3|||
149032299|NCT03256344|537596034|FG000|Overall Study|Sponsor Decision|1|||
149032300|NCT03256344|537596035|FG001|Overall Study|Sponsor Decision|0|||
149032301|NCT00580801|537596043|FG000|Overall Study|Physician Decision|1|||
149032302|NCT00580801|537596044|FG001|Overall Study|Physician Decision|0|||
149032303|NCT00580801|537596045|FG002|Overall Study|Physician Decision|0|||
149032304|NCT00580801|537596043|FG000|Overall Study|Adverse Event|2|||
149032305|NCT00580801|537596044|FG001|Overall Study|Adverse Event|0|||
149032306|NCT00580801|537596045|FG002|Overall Study|Adverse Event|0|||
149032307|NCT00580801|537596043|FG000|Overall Study|Lost to Follow-up|2|||
149032308|NCT00580801|537596044|FG001|Overall Study|Lost to Follow-up|0|||
149032309|NCT00580801|537596045|FG002|Overall Study|Lost to Follow-up|0|||
149032310|NCT00580801|537596043|FG000|Overall Study|Reached a virologic endpoint|0|||
149032311|NCT00580801|537596044|FG001|Overall Study|Reached a virologic endpoint|1|||
149032312|NCT00580801|537596045|FG002|Overall Study|Reached a virologic endpoint|2|||
149032313|NCT00580801|537596043|FG000|Overall Study|Participant non-compliant|0|||
149032314|NCT00580801|537596044|FG001|Overall Study|Participant non-compliant|0|||
149032315|NCT00580801|537596045|FG002|Overall Study|Participant non-compliant|1|||
149032316|NCT00580801|537596043|FG000|Overall Study|Travel|1|||
149032317|NCT00580801|537596044|FG001|Overall Study|Travel|0|||
149032318|NCT00580801|537596045|FG002|Overall Study|Travel|0|||
149032319|NCT00502593|537596046|FG000|Overall Study|Withdrawn unspecified reason|1|||
149032320|NCT00502593|537596047|FG001|Overall Study|Withdrawn unspecified reason|1|||
149032321|NCT00502593|537596048|FG002|Overall Study|Withdrawn unspecified reason|3|||
149032322|NCT00502593|537596049|FG003|Overall Study|Withdrawn unspecified reason|1|||
149032323|NCT00502593|537596050|FG004|Overall Study|Withdrawn unspecified reason|2|||
149032324|NCT00502593|537596051|FG005|Overall Study|Withdrawn unspecified reason|0|||
149032325|NCT00502593|537596052|FG006|Overall Study|Withdrawn unspecified reason|2|||
149032326|NCT00502593|537596053|FG007|Overall Study|Withdrawn unspecified reason|0|||
149032327|NCT00502593|537596054|FG008|Overall Study|Withdrawn unspecified reason|0|||
149032328|NCT00502593|537596055|FG009|Overall Study|Withdrawn unspecified reason|0|||
149032329|NCT00502593|537596056|FG010|Overall Study|Withdrawn unspecified reason|0|||
149032330|NCT00502593|537596057|FG011|Overall Study|Withdrawn unspecified reason|0|||
149032331|NCT00502593|537596046|FG000|Overall Study|Withdrawal by Subject|0|||
149032332|NCT00502593|537596047|FG001|Overall Study|Withdrawal by Subject|0|||
149032333|NCT00502593|537596048|FG002|Overall Study|Withdrawal by Subject|6|||
149032334|NCT00502593|537596049|FG003|Overall Study|Withdrawal by Subject|2|||
149032335|NCT00502593|537596050|FG004|Overall Study|Withdrawal by Subject|2|||
149032336|NCT00502593|537596051|FG005|Overall Study|Withdrawal by Subject|0|||
149032337|NCT00502593|537596052|FG006|Overall Study|Withdrawal by Subject|3|||
149032338|NCT00502593|537596053|FG007|Overall Study|Withdrawal by Subject|0|||
149032339|NCT00502593|537596054|FG008|Overall Study|Withdrawal by Subject|3|||
149032340|NCT00502593|537596055|FG009|Overall Study|Withdrawal by Subject|0|||
149032341|NCT00502593|537596056|FG010|Overall Study|Withdrawal by Subject|1|||
149032342|NCT00502593|537596057|FG011|Overall Study|Withdrawal by Subject|0|||
149032343|NCT00502593|537596046|FG000|Overall Study|Lost to Follow-up|2|||
149032344|NCT00502593|537596047|FG001|Overall Study|Lost to Follow-up|1|||
149032345|NCT00502593|537596048|FG002|Overall Study|Lost to Follow-up|1|||
149032346|NCT00502593|537596049|FG003|Overall Study|Lost to Follow-up|1|||
149032347|NCT00502593|537596050|FG004|Overall Study|Lost to Follow-up|0|||
149032348|NCT00502593|537596051|FG005|Overall Study|Lost to Follow-up|0|||
149032349|NCT00502593|537596052|FG006|Overall Study|Lost to Follow-up|0|||
149032350|NCT00502593|537596053|FG007|Overall Study|Lost to Follow-up|0|||
149032351|NCT00502593|537596054|FG008|Overall Study|Lost to Follow-up|3|||
149032352|NCT00502593|537596055|FG009|Overall Study|Lost to Follow-up|0|||
148871065|NCT01439373|537004378|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
148871066|NCT01439373|537004379|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
148871067|NCT01439373|537004378|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
148871068|NCT01439373|537004379|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
148871069|NCT04046250|537004384|FG000|Overall Study|Death|0|||
148871070|NCT04046250|537004385|FG001|Overall Study|Death|1|||
148871071|NCT04046250|537004384|FG000|Overall Study|Withdrawal by Subject|3|||
148871072|NCT04046250|537004385|FG001|Overall Study|Withdrawal by Subject|3|||
148871073|NCT04576897|537004386|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
148871074|NCT03834220|537004387|FG000|Overall Study|Adverse Event|1|||
148871075|NCT03834220|537004388|FG001|Overall Study|Adverse Event|0|||
148871076|NCT03834220|537004389|FG002|Overall Study|Adverse Event|0|||
148871077|NCT03834220|537004387|FG000|Overall Study|Death|8|||
148871078|NCT03834220|537004388|FG001|Overall Study|Death|1|||
148871079|NCT03834220|537004389|FG002|Overall Study|Death|17|||
148871080|NCT03834220|537004387|FG000|Overall Study|Reason not Specified|9|||
148871081|NCT03834220|537004388|FG001|Overall Study|Reason not Specified|0|||
148871082|NCT03834220|537004389|FG002|Overall Study|Reason not Specified|6|||
148871083|NCT03834220|537004387|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
148871084|NCT03834220|537004388|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
148871085|NCT03834220|537004389|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
148871086|NCT03834220|537004387|FG000|Overall Study|Withdrawal of Consent|2|||
148871087|NCT03834220|537004388|FG001|Overall Study|Withdrawal of Consent|2|||
148871088|NCT03834220|537004389|FG002|Overall Study|Withdrawal of Consent|2|||
148871089|NCT02593318|537004392|FG000|Overall Study|Withdrawal by Subject|1|||
148871090|NCT02593318|537004393|FG001|Overall Study|Withdrawal by Subject|1|||
148871091|NCT01174173|537004395|FG000|Overall Study|drug-drug interaction|1|||
148871092|NCT03268941|537005932|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
148871093|NCT03268941|537005933|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
148871094|NCT03268941|537005934|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
148871095|NCT03268941|537005935|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
148871096|NCT03268941|537005936|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
148871097|NCT03268941|537005937|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
148871098|NCT03268941|537005938|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
148871099|NCT03268941|537005932|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
148871100|NCT03268941|537005933|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
148871101|NCT03268941|537005934|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
148871102|NCT03268941|537005935|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
148871103|NCT03268941|537005936|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
148871104|NCT03268941|537005937|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
148871105|NCT03268941|537005938|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
148871106|NCT03268941|537005932|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
148871107|NCT03268941|537005933|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
148871108|NCT03268941|537005934|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
148871109|NCT03268941|537005935|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
148871110|NCT03268941|537005936|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
148871111|NCT03268941|537005937|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
148871112|NCT03268941|537005938|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
148871113|NCT03268941|537005932|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
148871114|NCT03268941|537005933|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
148871115|NCT03268941|537005934|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
148871116|NCT03268941|537005935|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
148871117|NCT03268941|537005936|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
148871118|NCT03268941|537005937|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
148871119|NCT03268941|537005938|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
148871120|NCT03268941|537005932|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
148871121|NCT03268941|537005933|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
148871122|NCT03268941|537005934|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
148871123|NCT03268941|537005935|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
148871124|NCT03268941|537005936|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
149000420|NCT00831779|537477709|FG001|Overall Study|No longer met criteria|1|||
149000421|NCT04020341|537477710|FG000|Overall Study|Adverse Event|8|||
149000422|NCT04020341|537477711|FG001|Overall Study|Adverse Event|6|||
149000423|NCT04020341|537477710|FG000|Overall Study|Lost to Follow-up|8|||
149000424|NCT04020341|537477711|FG001|Overall Study|Lost to Follow-up|2|||
148871125|NCT03268941|537005937|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
148871126|NCT03268941|537005938|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
148871127|NCT01216683|537005939|FG000|Induction|Never started treatment|0|||
148871128|NCT01216683|537005940|FG001|Induction|Never started treatment|6|||
148871129|NCT01216683|537005941|FG002|Induction|Never started treatment|3|||
148871130|NCT01216683|537005939|FG000|Induction|Lack of Efficacy|4|||
148871131|NCT01216683|537005940|FG001|Induction|Lack of Efficacy|3|||
148871132|NCT01216683|537005941|FG002|Induction|Lack of Efficacy|7|||
148871133|NCT01216683|537005939|FG000|Induction|Adverse Event|0|||
148871134|NCT01216683|537005940|FG001|Induction|Adverse Event|5|||
148871135|NCT01216683|537005941|FG002|Induction|Adverse Event|5|||
148871136|NCT01216683|537005939|FG000|Induction|Death|0|||
148871137|NCT01216683|537005940|FG001|Induction|Death|0|||
148871138|NCT01216683|537005941|FG002|Induction|Death|2|||
148871139|NCT01216683|537005939|FG000|Induction|Withdrawal by Subject|0|||
148871140|NCT01216683|537005940|FG001|Induction|Withdrawal by Subject|4|||
148871141|NCT01216683|537005941|FG002|Induction|Withdrawal by Subject|2|||
148871142|NCT01216683|537005939|FG000|Induction|Other disease|0|||
149032353|NCT00502593|537596056|FG010|Overall Study|Lost to Follow-up|1|||
149032354|NCT00502593|537596057|FG011|Overall Study|Lost to Follow-up|0|||
149032355|NCT00880906|537596059|FG000|Overall Study|Lost to Follow-up|0|||
149032356|NCT00880906|537596060|FG001|Overall Study|Lost to Follow-up|1|||
149032357|NCT00880906|537596059|FG000|Overall Study|Did not meet criteria following patholog|12|||
149032358|NCT00880906|537596060|FG001|Overall Study|Did not meet criteria following patholog|6|||
149032359|NCT01460342|537596063|FG000|Overall Study|Adverse Event|5|||
149032360|NCT01460342|537596064|FG001|Overall Study|Adverse Event|4|||
149032361|NCT01460342|537596063|FG000|Overall Study|Lost to Follow-up|1|||
149032362|NCT01460342|537596064|FG001|Overall Study|Lost to Follow-up|2|||
149032363|NCT01460342|537596063|FG000|Overall Study|Protocol Violation|0|||
149032364|NCT01460342|537596064|FG001|Overall Study|Protocol Violation|1|||
149032365|NCT01460342|537596063|FG000|Overall Study|Withdrawal by Subject|3|||
149032366|NCT01460342|537596064|FG001|Overall Study|Withdrawal by Subject|4|||
149032367|NCT01460342|537596063|FG000|Overall Study|Physician Decision|1|||
149032368|NCT01460342|537596064|FG001|Overall Study|Physician Decision|3|||
149032369|NCT01460342|537596063|FG000|Overall Study|Lack of Efficacy|1|||
149032370|NCT01460342|537596064|FG001|Overall Study|Lack of Efficacy|0|||
149032371|NCT02512042|537596066|FG000|Overall Study|Adverse Event|0|||
149032372|NCT02512042|537596067|FG001|Overall Study|Adverse Event|4|||
149032373|NCT02512042|537596066|FG000|Overall Study|Withdrawal by Subject|6|||
149032374|NCT02512042|537596067|FG001|Overall Study|Withdrawal by Subject|6|||
149032375|NCT02512042|537596066|FG000|Overall Study|Non-compliance with study drug|1|||
149032376|NCT02512042|537596067|FG001|Overall Study|Non-compliance with study drug|2|||
149032377|NCT02512042|537596066|FG000|Overall Study|Lost to Follow-up|5|||
149032378|NCT02512042|537596067|FG001|Overall Study|Lost to Follow-up|2|||
149032379|NCT02512042|537596066|FG000|Overall Study|Other|11|||
149032380|NCT02512042|537596067|FG001|Overall Study|Other|11|||
149032381|NCT03563053|537596072|FG000|Overall Study|Withdrawal by Subject|17|||
149032382|NCT03563053|537596072|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
149032383|NCT03563053|537596072|FG000|Overall Study|Adverse Event|3|||
149032384|NCT03563053|537596072|FG000|Overall Study|Physician Decision|1|||
149032385|NCT03563053|537596072|FG000|Overall Study|study terminated by sponsor|71|||
149032386|NCT00124982|537596073|FG000|Short-term Period|Death|1|||
149032387|NCT00124982|537596074|FG001|Short-term Period|Death|1|||
149032388|NCT00124982|537596075|FG002|Short-term Period|Death|0|||
149032389|NCT00124982|537596073|FG000|Short-term Period|Adverse Event|17|||
149032390|NCT00124982|537596074|FG001|Short-term Period|Adverse Event|22|||
149032391|NCT00124982|537596075|FG002|Short-term Period|Adverse Event|0|||
149032392|NCT00124982|537596073|FG000|Short-term Period|Lack of Efficacy|32|||
149032393|NCT00124982|537596074|FG001|Short-term Period|Lack of Efficacy|73|||
149032394|NCT00124982|537596075|FG002|Short-term Period|Lack of Efficacy|0|||
149032395|NCT00124982|537596073|FG000|Short-term Period|Lost to Follow-up|8|||
149032396|NCT00124982|537596074|FG001|Short-term Period|Lost to Follow-up|5|||
149032397|NCT00124982|537596075|FG002|Short-term Period|Lost to Follow-up|0|||
149032398|NCT00124982|537596073|FG000|Short-term Period|Withdrawal of Consent|7|||
149032399|NCT00124982|537596074|FG001|Short-term Period|Withdrawal of Consent|9|||
149032400|NCT00124982|537596075|FG002|Short-term Period|Withdrawal of Consent|0|||
149032401|NCT00124982|537596073|FG000|Short-term Period|Poor/Non-compliance|3|||
149032402|NCT00124982|537596074|FG001|Short-term Period|Poor/Non-compliance|1|||
149032403|NCT00124982|537596075|FG002|Short-term Period|Poor/Non-compliance|0|||
149032404|NCT00124982|537596073|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
149032405|NCT00124982|537596074|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
149032406|NCT00124982|537596075|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
149032407|NCT00124982|537596073|FG000|Short-term Period|Participant Decision|1|||
149032408|NCT00124982|537596074|FG001|Short-term Period|Participant Decision|0|||
149032409|NCT00124982|537596075|FG002|Short-term Period|Participant Decision|0|||
148871143|NCT01216683|537005940|FG001|Induction|Other disease|1|||
148871144|NCT01216683|537005941|FG002|Induction|Other disease|2|||
149032410|NCT00124982|537596073|FG000|Short-term Period|Participant Chose Own Doctor|0|||
149032411|NCT00124982|537596074|FG001|Short-term Period|Participant Chose Own Doctor|1|||
149032412|NCT00124982|537596075|FG002|Short-term Period|Participant Chose Own Doctor|0|||
149032413|NCT00124982|537596073|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
149032414|NCT00124982|537596074|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
149032415|NCT00124982|537596075|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
149032416|NCT00124982|537596073|FG000|Short-term Period|Participant Had Lymphopenia|1|||
148871145|NCT01216683|537005939|FG000|Continuation|Lack of Efficacy|3|||
149032417|NCT00124982|537596074|FG001|Short-term Period|Participant Had Lymphopenia|0|||
149032418|NCT00124982|537596075|FG002|Short-term Period|Participant Had Lymphopenia|0|||
148871146|NCT01216683|537005940|FG001|Continuation|Lack of Efficacy|2|||
148871147|NCT01216683|537005941|FG002|Continuation|Lack of Efficacy|7|||
148871148|NCT01216683|537005939|FG000|Continuation|Adverse Event|5|||
148871149|NCT01216683|537005940|FG001|Continuation|Adverse Event|3|||
148871150|NCT01216683|537005941|FG002|Continuation|Adverse Event|16|||
148871151|NCT01216683|537005939|FG000|Continuation|Death|1|||
148871152|NCT01216683|537005940|FG001|Continuation|Death|0|||
148871153|NCT01216683|537005941|FG002|Continuation|Death|2|||
148871154|NCT01216683|537005939|FG000|Continuation|Withdrawal by Subject|4|||
148871155|NCT01216683|537005940|FG001|Continuation|Withdrawal by Subject|5|||
148871156|NCT01216683|537005941|FG002|Continuation|Withdrawal by Subject|9|||
148871157|NCT01216683|537005939|FG000|Continuation|Other diseases|0|||
148871158|NCT01216683|537005940|FG001|Continuation|Other diseases|2|||
148871159|NCT01216683|537005941|FG002|Continuation|Other diseases|1|||
148871160|NCT01216683|537005939|FG000|Continuation|Physician Decision|1|||
148871161|NCT01216683|537005940|FG001|Continuation|Physician Decision|0|||
148871162|NCT01216683|537005941|FG002|Continuation|Physician Decision|1|||
148871163|NCT01216683|537005939|FG000|Continuation|Non-compliance|1|||
148871164|NCT01216683|537005940|FG001|Continuation|Non-compliance|0|||
148871165|NCT01216683|537005941|FG002|Continuation|Non-compliance|1|||
148871166|NCT01216683|537005939|FG000|Continuation|Insurance change|0|||
148871167|NCT01216683|537005940|FG001|Continuation|Insurance change|1|||
148871168|NCT01216683|537005941|FG002|Continuation|Insurance change|0|||
148871169|NCT01216683|537005939|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
148871170|NCT01216683|537005940|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
148871171|NCT01216683|537005941|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
148871172|NCT01216683|537005939|FG000|Continuation|Not reported|0|||
148871173|NCT01216683|537005940|FG001|Continuation|Not reported|0|||
148871174|NCT01216683|537005941|FG002|Continuation|Not reported|1|||
148871175|NCT01216683|537005939|FG000|Continuation|Never started treatment|0|||
148871176|NCT01216683|537005940|FG001|Continuation|Never started treatment|1|||
148871177|NCT01216683|537005941|FG002|Continuation|Never started treatment|5|||
148871178|NCT02100969|537005942|FG000|Overall Study|Did not pass screening phase|1|||
148871179|NCT01629953|537005943|FG000|Overall Study|Death|3|||
148871180|NCT01629953|537005944|FG001|Overall Study|Death|1|||
148871181|NCT01629953|537005943|FG000|Overall Study|Lost to Follow-up|10|||
148871182|NCT01629953|537005944|FG001|Overall Study|Lost to Follow-up|14|||
148871183|NCT00344500|537005945|FG000|Overall Study|Adverse Event|6|||
148871184|NCT00344500|537005946|FG001|Overall Study|Adverse Event|2|||
148871185|NCT00344500|537005947|FG002|Overall Study|Adverse Event|0|||
148871186|NCT00344500|537005945|FG000|Overall Study|Lost to Follow-up|5|||
148871187|NCT00344500|537005946|FG001|Overall Study|Lost to Follow-up|13|||
148871188|NCT00344500|537005947|FG002|Overall Study|Lost to Follow-up|1|||
148871189|NCT00344500|537005945|FG000|Overall Study|Withdrawal by Subject|7|||
148871190|NCT00344500|537005946|FG001|Overall Study|Withdrawal by Subject|10|||
148871191|NCT00344500|537005947|FG002|Overall Study|Withdrawal by Subject|0|||
148871192|NCT00344500|537005945|FG000|Overall Study|Protocol Violation|4|||
148871193|NCT00344500|537005946|FG001|Overall Study|Protocol Violation|7|||
148871194|NCT00344500|537005947|FG002|Overall Study|Protocol Violation|1|||
148871195|NCT00344500|537005945|FG000|Overall Study|Not Noted|1|||
148871196|NCT00344500|537005946|FG001|Overall Study|Not Noted|3|||
148871197|NCT00344500|537005947|FG002|Overall Study|Not Noted|0|||
148871198|NCT00417963|537005949|FG000|Overall Study|Lost to Follow-up|3|||
148871199|NCT00417963|537005949|FG000|Overall Study|Withdrawal by Subject|18|||
148871200|NCT00417963|537005949|FG000|Overall Study|Death|17|||
148871201|NCT00417963|537005949|FG000|Overall Study|Study device could not be deployed|3|||
148871202|NCT02504580|537005952|FG000|Overall Study|Other|1|||
148871203|NCT02504580|537005953|FG001|Overall Study|Other|0|||
148871204|NCT02504580|537005954|FG002|Overall Study|Other|0|||
148871205|NCT02504580|537005955|FG003|Overall Study|Other|2|||
148871206|NCT02504580|537005956|FG004|Overall Study|Other|1|||
148871207|NCT02504580|537005957|FG005|Overall Study|Other|1|||
148871208|NCT02504580|537005958|FG006|Overall Study|Other|1|||
149032419|NCT00124982|537596073|FG000|Long-term Period|Death|0|||
149032420|NCT00124982|537596074|FG001|Long-term Period|Death|0|||
149032421|NCT00124982|537596075|FG002|Long-term Period|Death|1|||
149032422|NCT00124982|537596073|FG000|Long-term Period|Adverse Event|0|||
149032423|NCT00124982|537596074|FG001|Long-term Period|Adverse Event|0|||
149032424|NCT00124982|537596075|FG002|Long-term Period|Adverse Event|17|||
149032425|NCT00124982|537596073|FG000|Long-term Period|Lack of Efficacy|0|||
148871209|NCT02504580|537005959|FG007|Overall Study|Other|2|||
148871210|NCT02504580|537005960|FG008|Overall Study|Other|0|||
148871211|NCT02504580|537005961|FG009|Overall Study|Other|0|||
148871212|NCT02504580|537005962|FG010|Overall Study|Other|0|||
148871213|NCT02504580|537005963|FG011|Overall Study|Other|2|||
148871214|NCT02504580|537005952|FG000|Overall Study|Subject refusal to continue|0|||
148871215|NCT02504580|537005953|FG001|Overall Study|Subject refusal to continue|1|||
148871216|NCT02504580|537005954|FG002|Overall Study|Subject refusal to continue|0|||
148871217|NCT02504580|537005955|FG003|Overall Study|Subject refusal to continue|0|||
148871218|NCT02504580|537005956|FG004|Overall Study|Subject refusal to continue|0|||
149032426|NCT00124982|537596074|FG001|Long-term Period|Lack of Efficacy|0|||
148871219|NCT02504580|537005957|FG005|Overall Study|Subject refusal to continue|0|||
148871220|NCT02504580|537005958|FG006|Overall Study|Subject refusal to continue|0|||
148871221|NCT02504580|537005959|FG007|Overall Study|Subject refusal to continue|0|||
148871222|NCT02504580|537005960|FG008|Overall Study|Subject refusal to continue|0|||
148871223|NCT02504580|537005961|FG009|Overall Study|Subject refusal to continue|0|||
148871224|NCT02504580|537005962|FG010|Overall Study|Subject refusal to continue|0|||
148871225|NCT02504580|537005963|FG011|Overall Study|Subject refusal to continue|0|||
148871226|NCT00448747|537005965|FG000|Overall Study|collapsed veins|1|||
148871227|NCT00448747|537005966|FG001|Overall Study|collapsed veins|0|||
148871228|NCT02252965|537005972|FG000|Overall Study|Adverse Event|9|||
148871229|NCT02252965|537005973|FG001|Overall Study|Adverse Event|14|||
148871230|NCT02252965|537005972|FG000|Overall Study|Lost to Follow-up|16|||
148871231|NCT02252965|537005973|FG001|Overall Study|Lost to Follow-up|8|||
148871232|NCT02252965|537005972|FG000|Overall Study|Protocol Violation|4|||
148871233|NCT02252965|537005973|FG001|Overall Study|Protocol Violation|5|||
148871234|NCT02252965|537005972|FG000|Overall Study|Lack of Efficacy|0|||
148871235|NCT02252965|537005973|FG001|Overall Study|Lack of Efficacy|2|||
148871236|NCT02252965|537005972|FG000|Overall Study|Withdrawal by Subject|7|||
148871237|NCT02252965|537005973|FG001|Overall Study|Withdrawal by Subject|9|||
148871238|NCT02252965|537005972|FG000|Overall Study|Other|4|||
148871239|NCT02252965|537005973|FG001|Overall Study|Other|5|||
148871240|NCT02615691|537005976|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
148871241|NCT02615691|537005976|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
148871242|NCT02615691|537005976|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
148871243|NCT02615691|537005976|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
148871244|NCT01276223|537005977|FG000|Overall Study|Adverse Event|7|||
148871245|NCT01276223|537005978|FG001|Overall Study|Adverse Event|4|||
148871246|NCT01276223|537005979|FG002|Overall Study|Adverse Event|1|||
148871247|NCT01276223|537005977|FG000|Overall Study|Lost to Follow-up|0|||
148871248|NCT01276223|537005978|FG001|Overall Study|Lost to Follow-up|0|||
148871249|NCT01276223|537005979|FG002|Overall Study|Lost to Follow-up|1|||
148871250|NCT01276223|537005977|FG000|Overall Study|Other|0|||
148871251|NCT01276223|537005978|FG001|Overall Study|Other|0|||
148871252|NCT01276223|537005979|FG002|Overall Study|Other|1|||
148871253|NCT01276223|537005977|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
148871254|NCT01276223|537005978|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
148871255|NCT01276223|537005979|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
148871256|NCT01276223|537005977|FG000|Overall Study|Protocol Violation|1|||
148871257|NCT01276223|537005978|FG001|Overall Study|Protocol Violation|0|||
148871258|NCT01276223|537005979|FG002|Overall Study|Protocol Violation|0|||
148871259|NCT04279613|537005981|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
149000425|NCT04020341|537477710|FG000|Overall Study|Withdrawal by Subject|16|||
149000426|NCT04020341|537477711|FG001|Overall Study|Withdrawal by Subject|16|||
149000427|NCT04020341|537477710|FG000|Overall Study|Participant not able to swallow the tablet|1|||
149000428|NCT04020341|537477711|FG001|Overall Study|Participant not able to swallow the tablet|0|||
149000429|NCT04020341|537477710|FG000|Overall Study|Physician Decision|0|||
149000430|NCT04020341|537477711|FG001|Overall Study|Physician Decision|2|||
149000431|NCT04020341|537477710|FG000|Overall Study|Protocol Deviation|0|||
149000432|NCT04020341|537477711|FG001|Overall Study|Protocol Deviation|2|||
149000433|NCT05763628|537477712|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
149000434|NCT05763628|537477713|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
149000435|NCT05763628|537477712|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
149000436|NCT05763628|537477713|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
149000437|NCT05763628|537477712|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
149000438|NCT05763628|537477713|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
149000439|NCT04721925|537477717|FG000|2-Month Assessment|Lost to Follow-up|5|||
149000440|NCT04721925|537477718|FG001|2-Month Assessment|Lost to Follow-up|3|||
149000441|NCT04721925|537477717|FG000|4-Month Assessment|Lost to Follow-up|3|||
149000442|NCT04721925|537477718|FG001|4-Month Assessment|Lost to Follow-up|6|||
149000443|NCT01113502|537477722|FG000|Overall Study|Withdrawal by Subject|1|||
149000444|NCT01113502|537477723|FG001|Overall Study|Withdrawal by Subject|0|||
149000445|NCT01113502|537477724|FG002|Overall Study|Withdrawal by Subject|1|||
149000446|NCT01113502|537477725|FG003|Overall Study|Withdrawal by Subject|1|||
149000447|NCT01113502|537477726|FG004|Overall Study|Withdrawal by Subject|0|||
149000448|NCT01113502|537477722|FG000|Overall Study|Adverse Event|0|||
149000449|NCT01113502|537477723|FG001|Overall Study|Adverse Event|0|||
149000450|NCT01113502|537477724|FG002|Overall Study|Adverse Event|3|||
149000451|NCT01113502|537477725|FG003|Overall Study|Adverse Event|2|||
149000452|NCT01113502|537477726|FG004|Overall Study|Adverse Event|0|||
149000453|NCT03002610|537477727|FG000|Overall Study|Withdrawal by Subject|6|||
148871260|NCT04279613|537005982|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
148871261|NCT04279613|537005983|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
148871262|NCT04279613|537005984|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
148871263|NCT04279613|537005985|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
148871264|NCT04279613|537005981|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
148871265|NCT04279613|537005982|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
148871266|NCT04279613|537005983|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
148871267|NCT04279613|537005984|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
148871268|NCT04279613|537005985|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
148871269|NCT04279613|537005981|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
148871270|NCT04279613|537005982|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
148871271|NCT04279613|537005983|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
148871272|NCT04279613|537005984|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
148871273|NCT04279613|537005985|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
148871274|NCT04279613|537005981|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
148871275|NCT04279613|537005982|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
148871276|NCT04279613|537005983|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
148871277|NCT04279613|537005984|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
148871278|NCT04279613|537005985|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
148871279|NCT04279613|537005981|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
148871280|NCT04279613|537005982|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
148871281|NCT04279613|537005983|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
148871282|NCT04279613|537005984|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
148871283|NCT04279613|537005985|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
148871284|NCT02478164|537005986|FG000|Overall Study|Lack of Efficacy|13|||
148871285|NCT02478164|537005986|FG000|Overall Study|Adverse Event|1|||
148871286|NCT02478164|537005986|FG000|Overall Study|Withdrawal by Subject|1|||
148871287|NCT02704689|537005987|FG000|Overall Study|Physician Decision|1|||
148871288|NCT02704689|537005987|FG000|Overall Study|Study device not implanted|2|||
148871289|NCT04051827|537005989|FG000|Overall Study|Death|1|||
148871290|NCT04051827|537005989|FG000|Overall Study|Withdrawal by Subject|4|||
148871291|NCT04051827|537005989|FG000|Overall Study|Progressive disease|16|||
148871292|NCT04051827|537005989|FG000|Overall Study|Physician Decision|1|||
148871293|NCT04051827|537005989|FG000|Overall Study|Other|4|||
148871294|NCT02888743|537005990|FG000|Overall Study|Withdrawal by Subject|1|||
148871295|NCT02888743|537005991|FG001|Overall Study|Withdrawal by Subject|2|||
148871296|NCT02888743|537005992|FG002|Overall Study|Withdrawal by Subject|2|||
148871297|NCT02888743|537005993|FG003|Overall Study|Withdrawal by Subject|0|||
148871298|NCT02888743|537005994|FG004|Overall Study|Withdrawal by Subject|1|||
148871299|NCT02888743|537005990|FG000|Overall Study|Disease progression before treatment|2|||
148871300|NCT02888743|537005991|FG001|Overall Study|Disease progression before treatment|0|||
148871301|NCT02888743|537005992|FG002|Overall Study|Disease progression before treatment|2|||
148871302|NCT02888743|537005993|FG003|Overall Study|Disease progression before treatment|0|||
148871303|NCT02888743|537005994|FG004|Overall Study|Disease progression before treatment|0|||
148871304|NCT02888743|537005990|FG000|Overall Study|Patient ineligible|1|||
148871305|NCT02888743|537005991|FG001|Overall Study|Patient ineligible|2|||
148871306|NCT02888743|537005992|FG002|Overall Study|Patient ineligible|0|||
148871307|NCT02888743|537005993|FG003|Overall Study|Patient ineligible|0|||
148871308|NCT02888743|537005994|FG004|Overall Study|Patient ineligible|0|||
148871309|NCT01424566|537005995|FG000|Single-blind Treatment|Adverse Event|71|||
148871310|NCT01424566|537005996|FG001|Single-blind Treatment|Adverse Event|0|||
148871311|NCT01424566|537005997|FG002|Single-blind Treatment|Adverse Event|0|||
148871312|NCT01424566|537005995|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
148871313|NCT01424566|537005996|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
148871314|NCT01424566|537005997|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
148871315|NCT01424566|537005995|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
148871316|NCT01424566|537005996|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
148871317|NCT01424566|537005997|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
148871318|NCT01424566|537005995|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
148871319|NCT01424566|537005996|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
148871320|NCT01424566|537005997|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
148871321|NCT01424566|537005995|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
148871322|NCT01424566|537005996|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
148871323|NCT01424566|537005997|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
148871324|NCT01424566|537005995|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
149000454|NCT03002610|537477728|FG001|Overall Study|Withdrawal by Subject|25|||
148871325|NCT01424566|537005996|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
148871326|NCT01424566|537005997|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
148871327|NCT01424566|537005995|FG000|Double-blind Treatment|Adverse Event|0|||
148871328|NCT01424566|537005996|FG001|Double-blind Treatment|Adverse Event|21|||
148871329|NCT01424566|537005997|FG002|Double-blind Treatment|Adverse Event|13|||
148871330|NCT01424566|537005995|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
148871331|NCT01424566|537005996|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
148871332|NCT01424566|537005997|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
148871333|NCT01424566|537005995|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
149000455|NCT03002610|537477729|FG002|Overall Study|Withdrawal by Subject|13|||
148871334|NCT01424566|537005996|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
148871335|NCT01424566|537005997|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
148871336|NCT01424566|537005995|FG000|Double-blind Treatment|Lack of Efficacy|0|||
148871337|NCT01424566|537005996|FG001|Double-blind Treatment|Lack of Efficacy|1|||
148871338|NCT01424566|537005997|FG002|Double-blind Treatment|Lack of Efficacy|1|||
148871339|NCT02335424|537006004|FG000|Overall Study|Withdrawal by Subject|19|||
148871340|NCT02335424|537006004|FG000|Overall Study|Adverse Event|25|||
148871341|NCT02335424|537006004|FG000|Overall Study|Death|273|||
148871342|NCT02335424|537006004|FG000|Overall Study|Lost to Follow-up|3|||
148871343|NCT02335424|537006004|FG000|Overall Study|Physician Decision|13|||
148871344|NCT02335424|537006004|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
148871345|NCT02335424|537006004|FG000|Overall Study|Protocol Violation|1|||
148871346|NCT02335424|537006004|FG000|Overall Study|Screen failure|1|||
148871347|NCT02712424|537006005|FG000|Overall Study|Lost to Follow-up|34|||
148871348|NCT02712424|537006006|FG001|Overall Study|Lost to Follow-up|32|||
148871349|NCT02723175|537006007|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
148871350|NCT02723175|537006008|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
148871351|NCT02723175|537006007|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
148871352|NCT02723175|537006008|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
148871353|NCT04109976|537006009|FG000|Overall Study|Withdrawal by Subject|1|||
148871354|NCT04109976|537006010|FG001|Overall Study|Withdrawal by Subject|0|||
148871355|NCT01571453|537006011|FG000|Overall Study|Adverse Event|14|||
148871356|NCT01571453|537006012|FG001|Overall Study|Adverse Event|32|||
148871357|NCT01571453|537006011|FG000|Overall Study|Lack of Efficacy|8|||
148871358|NCT01571453|537006012|FG001|Overall Study|Lack of Efficacy|3|||
148871359|NCT01571453|537006011|FG000|Overall Study|Non-compliance|2|||
148871360|NCT01571453|537006012|FG001|Overall Study|Non-compliance|4|||
148871361|NCT01571453|537006011|FG000|Overall Study|Protocol Violation|1|||
148871362|NCT01571453|537006012|FG001|Overall Study|Protocol Violation|5|||
148871363|NCT01571453|537006011|FG000|Overall Study|Withdrawal of consent|5|||
148871364|NCT01571453|537006012|FG001|Overall Study|Withdrawal of consent|13|||
148871365|NCT01571453|537006011|FG000|Overall Study|Lost to Follow-up|4|||
148871366|NCT01571453|537006012|FG001|Overall Study|Lost to Follow-up|2|||
148871367|NCT01571453|537006011|FG000|Overall Study|Administrative or other reason(s)|4|||
148871368|NCT01571453|537006012|FG001|Overall Study|Administrative or other reason(s)|3|||
148871369|NCT00129961|537006013|FG000|Overall Study|Adverse Event|1|||
148871370|NCT00129961|537006014|FG001|Overall Study|Adverse Event|0|||
148871371|NCT00129961|537006013|FG000|Overall Study|Death|1|||
148871372|NCT00129961|537006014|FG001|Overall Study|Death|1|||
148871373|NCT00129961|537006013|FG000|Overall Study|Withdrawal by Sponsor|14|||
148871374|NCT00129961|537006014|FG001|Overall Study|Withdrawal by Sponsor|20|||
148871375|NCT00129961|537006013|FG000|Overall Study|Physician Decision|1|||
148871376|NCT00129961|537006014|FG001|Overall Study|Physician Decision|0|||
148871377|NCT00129961|537006013|FG000|Overall Study|Withdrawal by Subject|2|||
148871378|NCT00129961|537006014|FG001|Overall Study|Withdrawal by Subject|1|||
148871379|NCT00129961|537006013|FG000|Overall Study|Missing Record|0|||
148871380|NCT00129961|537006014|FG001|Overall Study|Missing Record|1|||
148871381|NCT01985360|537006015|FG000|Overall Study|Withdrawal by Subject|4|||
148871382|NCT01985360|537006016|FG001|Overall Study|Withdrawal by Subject|0|||
148871383|NCT01985360|537006015|FG000|Overall Study|Lost to Follow-up|5|||
148871384|NCT01985360|537006016|FG001|Overall Study|Lost to Follow-up|3|||
148871385|NCT03691779|537006019|FG000|Part B (24 Weeks)|Adverse Event|0|||
148871386|NCT03691779|537006020|FG001|Part B (24 Weeks)|Adverse Event|1|||
148871387|NCT03691779|537006019|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
148871388|NCT03691779|537006020|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
148871389|NCT03869333|537006030|FG000|Overall Study|Lost to Follow-up|1|||
148871390|NCT03869333|537006031|FG001|Overall Study|Lost to Follow-up|0|||
148871391|NCT03869333|537006032|FG002|Overall Study|Lost to Follow-up|0|||
148871392|NCT03869333|537006033|FG003|Overall Study|Lost to Follow-up|0|||
148871393|NCT03869333|537006030|FG000|Overall Study|Pregnancy|1|||
148871394|NCT03869333|537006031|FG001|Overall Study|Pregnancy|0|||
148871395|NCT03869333|537006032|FG002|Overall Study|Pregnancy|0|||
148871396|NCT03869333|537006033|FG003|Overall Study|Pregnancy|0|||
148871397|NCT03869333|537006030|FG000|Overall Study|Physician Decision|0|||
148871398|NCT03869333|537006031|FG001|Overall Study|Physician Decision|1|||
148871399|NCT03869333|537006032|FG002|Overall Study|Physician Decision|0|||
148871400|NCT03869333|537006033|FG003|Overall Study|Physician Decision|0|||
148871401|NCT02598128|537006034|FG000|Period A: Days -7 to -1|Adverse Event|1|||
148871402|NCT02598128|537006035|FG001|Period A: Days -7 to -1|Adverse Event|0|||
148871403|NCT02598128|537006036|FG002|Period A: Days -7 to -1|Adverse Event|0|||
148871404|NCT02598128|537006037|FG003|Period A: Days -7 to -1|Adverse Event|0|||
148871405|NCT01064687|537006038|FG000|Overall Study|Adverse Event|9|||
148871406|NCT01064687|537006039|FG001|Overall Study|Adverse Event|4|||
148871407|NCT01064687|537006040|FG002|Overall Study|Adverse Event|10|||
148871408|NCT01064687|537006041|FG003|Overall Study|Adverse Event|3|||
148871409|NCT01064687|537006038|FG000|Overall Study|Death|1|||
148871410|NCT01064687|537006039|FG001|Overall Study|Death|1|||
148871411|NCT01064687|537006040|FG002|Overall Study|Death|0|||
148871412|NCT01064687|537006041|FG003|Overall Study|Death|0|||
148871413|NCT01064687|537006038|FG000|Overall Study|Entry Criteria Not Met|3|||
148871414|NCT01064687|537006039|FG001|Overall Study|Entry Criteria Not Met|0|||
148871415|NCT01064687|537006040|FG002|Overall Study|Entry Criteria Not Met|0|||
148871416|NCT01064687|537006041|FG003|Overall Study|Entry Criteria Not Met|0|||
148871417|NCT01064687|537006038|FG000|Overall Study|Lack of Efficacy|1|||
148871418|NCT01064687|537006039|FG001|Overall Study|Lack of Efficacy|0|||
148871419|NCT01064687|537006040|FG002|Overall Study|Lack of Efficacy|2|||
148871420|NCT01064687|537006041|FG003|Overall Study|Lack of Efficacy|3|||
148871421|NCT01064687|537006038|FG000|Overall Study|Lost to Follow-up|7|||
148871422|NCT01064687|537006039|FG001|Overall Study|Lost to Follow-up|10|||
148871423|NCT01064687|537006040|FG002|Overall Study|Lost to Follow-up|13|||
148871424|NCT01064687|537006041|FG003|Overall Study|Lost to Follow-up|5|||
148871425|NCT01064687|537006038|FG000|Overall Study|Physician Decision|2|||
148871426|NCT01064687|537006039|FG001|Overall Study|Physician Decision|2|||
148871427|NCT01064687|537006040|FG002|Overall Study|Physician Decision|0|||
148871428|NCT01064687|537006041|FG003|Overall Study|Physician Decision|0|||
148871429|NCT01064687|537006038|FG000|Overall Study|Protocol Violation|1|||
148871430|NCT01064687|537006039|FG001|Overall Study|Protocol Violation|1|||
148871431|NCT01064687|537006040|FG002|Overall Study|Protocol Violation|0|||
148871432|NCT01064687|537006041|FG003|Overall Study|Protocol Violation|1|||
148871433|NCT01064687|537006038|FG000|Overall Study|Sponsor Decision|0|||
148871434|NCT01064687|537006039|FG001|Overall Study|Sponsor Decision|0|||
148871435|NCT01064687|537006040|FG002|Overall Study|Sponsor Decision|3|||
148871436|NCT01064687|537006041|FG003|Overall Study|Sponsor Decision|0|||
148871437|NCT01064687|537006038|FG000|Overall Study|Withdrawal by Subject|9|||
148871438|NCT01064687|537006039|FG001|Overall Study|Withdrawal by Subject|7|||
148871439|NCT01064687|537006040|FG002|Overall Study|Withdrawal by Subject|12|||
148871440|NCT01064687|537006041|FG003|Overall Study|Withdrawal by Subject|5|||
148871441|NCT01064687|537006038|FG000|Overall Study|Treatment Noncompliance|1|||
148871442|NCT01064687|537006039|FG001|Overall Study|Treatment Noncompliance|1|||
148871443|NCT01064687|537006040|FG002|Overall Study|Treatment Noncompliance|1|||
148871444|NCT01064687|537006041|FG003|Overall Study|Treatment Noncompliance|0|||
148871445|NCT02966015|537006042|FG000|Inclusion Visit|did not answer questionnaire|8|||
148871446|NCT02966015|537006043|FG001|Inclusion Visit|did not answer questionnaire|3|||
148871447|NCT02383433|537006045|FG000|Overall Study|Disease progression|2|||
148871448|NCT02477553|537006048|FG000|Overall Study|Screening up-to-date|12|||
148871449|NCT02477553|537006049|FG001|Overall Study|Screening up-to-date|13|||
148871450|NCT02477553|537006048|FG000|Overall Study|No MD visit|1|||
148871451|NCT02477553|537006049|FG001|Overall Study|No MD visit|1|||
148871452|NCT02477553|537006048|FG000|Overall Study|Workup consistent w/CRC|1|||
148871453|NCT02477553|537006049|FG001|Overall Study|Workup consistent w/CRC|1|||
148871454|NCT02477553|537006048|FG000|Overall Study|Technical issues with intervention|2|||
148871455|NCT02477553|537006049|FG001|Overall Study|Technical issues with intervention|0|||
148871456|NCT02477553|537006048|FG000|Overall Study|Elevated risk for CRC|2|||
148871457|NCT02477553|537006049|FG001|Overall Study|Elevated risk for CRC|2|||
148871458|NCT02477553|537006048|FG000|Overall Study|MD advised against screening|1|||
148871459|NCT02477553|537006049|FG001|Overall Study|MD advised against screening|3|||
148871460|NCT02477553|537006048|FG000|Overall Study|patient deceased|1|||
148871461|NCT02477553|537006049|FG001|Overall Study|patient deceased|0|||
148871462|NCT04311463|537006050|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
148871463|NCT04311463|537006051|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
148871464|NCT04311463|537006050|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
148871465|NCT04311463|537006051|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
148871466|NCT04311463|537006050|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
148871467|NCT04311463|537006051|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
148871468|NCT00952614|537006052|FG000|Overall Study|Death|3|||
148871469|NCT00952614|537006052|FG000|Overall Study|Lost to Follow-up|3|||
148871470|NCT00952614|537006052|FG000|Overall Study|other reason|1|||
148871471|NCT04023682|537006054|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
148871472|NCT02745535|537006056|FG000|Overall Study|Death|1|||
149000456|NCT00708916|537477732|FG000|Overall Study|Subject Noncompliance|2|||
149000457|NCT00708916|537477732|FG000|Overall Study|Adverse Event|2|||
149000458|NCT01984684|537477734|FG000|Overall Study|Lost to Follow-up|25|||
149000459|NCT01984684|537477735|FG001|Overall Study|Lost to Follow-up|24|||
149000460|NCT01984684|537477734|FG000|Overall Study|Adverse Event|8|||
149000461|NCT01984684|537477735|FG001|Overall Study|Adverse Event|12|||
149000462|NCT01984684|537477734|FG000|Overall Study|Withdrawal by Subject|9|||
148871473|NCT02745535|537006056|FG000|Overall Study|Adverse Event|3|||
148871474|NCT02745535|537006056|FG000|Overall Study|Lost to Follow-up|2|||
148871475|NCT03480009|537006067|FG000|Overall Study|Lost to Follow-up|4|||
148871476|NCT03480009|537006068|FG001|Overall Study|Lost to Follow-up|5|||
148871477|NCT03480009|537006069|FG002|Overall Study|Lost to Follow-up|4|||
148871478|NCT03480009|537006070|FG003|Overall Study|Lost to Follow-up|0|||
148871479|NCT04268745|537006071|FG000|Overall Study|Lost to Follow-up|2|||
148871480|NCT04268745|537006072|FG001|Overall Study|Lost to Follow-up|3|||
148871481|NCT04268745|537006071|FG000|Overall Study|Withdrawal by Subject|4|||
148871482|NCT04268745|537006072|FG001|Overall Study|Withdrawal by Subject|2|||
148871483|NCT04268745|537006071|FG000|Overall Study|Death in the family|1|||
148871484|NCT04268745|537006072|FG001|Overall Study|Death in the family|0|||
148871485|NCT00527332|537006077|FG000|Overall Study|Protocol Violation|4|||
148871486|NCT00527332|537006078|FG001|Overall Study|Protocol Violation|8|||
148871487|NCT00527332|537006077|FG000|Overall Study|Withdrew consent|5|||
148871488|NCT00527332|537006078|FG001|Overall Study|Withdrew consent|1|||
148871489|NCT02720692|537008023|FG000|Overall Study|Withdrawal by Subject|3|||
148871490|NCT02720692|537008024|FG001|Overall Study|Withdrawal by Subject|0|||
148871491|NCT02720692|537008023|FG000|Overall Study|Physician Decision|1|||
148871492|NCT02720692|537008024|FG001|Overall Study|Physician Decision|0|||
148871493|NCT02720692|537008023|FG000|Overall Study|Lost to Follow-up|8|||
148871494|NCT02720692|537008024|FG001|Overall Study|Lost to Follow-up|3|||
148871495|NCT02720692|537008023|FG000|Overall Study|Subject unable to return for visit|1|||
148871496|NCT02720692|537008024|FG001|Overall Study|Subject unable to return for visit|0|||
148871497|NCT02503501|537008025|FG000|Overall Study|Physician Decision|1|||
148871498|NCT02503501|537008026|FG001|Overall Study|Physician Decision|0|||
148871499|NCT02503501|537008025|FG000|Overall Study|Protocol Violation|0|||
148871500|NCT02503501|537008026|FG001|Overall Study|Protocol Violation|1|||
148871501|NCT02503501|537008025|FG000|Overall Study|Withdrawal by Subject|0|||
148871502|NCT02503501|537008026|FG001|Overall Study|Withdrawal by Subject|2|||
148871503|NCT01740401|537008027|FG000|Overall Study|Progression of disease|6|||
148871504|NCT01740401|537008027|FG000|Overall Study|Adverse Event|2|||
148871505|NCT01740401|537008027|FG000|Overall Study|Did not reach primary endpoint|2|||
148871506|NCT03878758|537008028|FG000|Overall Study|Withdrawal by Subject|1|||
148871507|NCT03878758|537008028|FG000|Overall Study|Protocol defined|2|||
148871508|NCT03878758|537008028|FG000|Overall Study|Improper consent documentation|1|||
148871509|NCT00765063|537008029|FG000|Overall Study|Lack of Efficacy|5|||
148871510|NCT00765063|537008029|FG000|Overall Study|Withdrawal by Subject|1|||
148871511|NCT00765063|537008029|FG000|Overall Study|Other|16|||
148871512|NCT00765063|537008029|FG000|Overall Study|Protocol Violation|6|||
148871513|NCT00765063|537008029|FG000|Overall Study|Adverse Event|4|||
148871514|NCT03614325|537008030|FG000|Overall Study|Withdrawal by Subject|0|||
148871515|NCT03614325|537008031|FG001|Overall Study|Withdrawal by Subject|2|||
148871516|NCT03614325|537008030|FG000|Overall Study|Surgery Cancelled|2|||
148871517|NCT03614325|537008031|FG001|Overall Study|Surgery Cancelled|1|||
148871518|NCT03614325|537008030|FG000|Overall Study|Lost to Follow-up|2|||
148871519|NCT03614325|537008031|FG001|Overall Study|Lost to Follow-up|1|||
148871520|NCT03614325|537008030|FG000|Overall Study|Surgery never scheduled|1|||
148871521|NCT03614325|537008031|FG001|Overall Study|Surgery never scheduled|0|||
148871522|NCT00321464|537008032|FG000|Overall Study|Death|169|||
148871523|NCT00321464|537008033|FG001|Overall Study|Death|174|||
148871524|NCT00321464|537008032|FG000|Overall Study|Disease progression|124|||
148871525|NCT00321464|537008033|FG001|Overall Study|Disease progression|124|||
148871526|NCT00321464|537008032|FG000|Overall Study|Withdrawal by Subject|117|||
148871527|NCT00321464|537008033|FG001|Overall Study|Withdrawal by Subject|118|||
148871528|NCT00321464|537008032|FG000|Overall Study|Participant request|57|||
148871529|NCT00321464|537008033|FG001|Overall Study|Participant request|61|||
148871530|NCT00321464|537008032|FG000|Overall Study|Adverse Event|43|||
148871531|NCT00321464|537008033|FG001|Overall Study|Adverse Event|28|||
148871532|NCT00321464|537008032|FG000|Overall Study|Physician Decision|15|||
148871533|NCT00321464|537008033|FG001|Overall Study|Physician Decision|14|||
148871534|NCT00321464|537008032|FG000|Overall Study|Noncompliance|4|||
148871535|NCT00321464|537008033|FG001|Overall Study|Noncompliance|10|||
148871536|NCT00321464|537008032|FG000|Overall Study|Lost to Follow-up|7|||
148871537|NCT00321464|537008033|FG001|Overall Study|Lost to Follow-up|8|||
148871538|NCT00321464|537008032|FG000|Overall Study|Protocol deviation|0|||
149032427|NCT00124982|537596075|FG002|Long-term Period|Lack of Efficacy|46|||
149032428|NCT00124982|537596073|FG000|Long-term Period|Lost to Follow-up|0|||
149032429|NCT00124982|537596074|FG001|Long-term Period|Lost to Follow-up|0|||
148871539|NCT00321464|537008033|FG001|Overall Study|Protocol deviation|2|||
149032430|NCT00124982|537596075|FG002|Long-term Period|Lost to Follow-up|4|||
149032431|NCT00124982|537596073|FG000|Long-term Period|Withdrawal by Subject|0|||
148871540|NCT00321464|537008032|FG000|Overall Study|Ineligibility determined|2|||
148871541|NCT00321464|537008033|FG001|Overall Study|Ineligibility determined|1|||
148871542|NCT00321464|537008032|FG000|Overall Study|Other|21|||
148871543|NCT00321464|537008033|FG001|Overall Study|Other|18|||
148871544|NCT01673620|537008034|FG000|Overall Study|Adverse Event|1|||
149032432|NCT00124982|537596074|FG001|Long-term Period|Withdrawal by Subject|0|||
148871545|NCT01673620|537008035|FG001|Overall Study|Adverse Event|0|||
148871546|NCT01206582|537008036|FG000|Overall Study|Withdrew prior to study|1|||
148871547|NCT01206582|537008037|FG001|Overall Study|Withdrew prior to study|0|||
148871548|NCT01206582|537008036|FG000|Overall Study|Discontinued intervention before week 8|1|||
148871549|NCT01206582|537008037|FG001|Overall Study|Discontinued intervention before week 8|2|||
148871550|NCT02522325|537008038|FG000|Overall Study|Adverse Event|0|||
148871551|NCT02522325|537008039|FG001|Overall Study|Adverse Event|1|||
148871552|NCT02081599|537008042|FG000|Period 1：Double-blind Period|Adverse Event|3|||
148871553|NCT02081599|537008043|FG001|Period 1：Double-blind Period|Adverse Event|0|||
148871554|NCT02081599|537008042|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
148871555|NCT02081599|537008043|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
148871556|NCT02081599|537008042|FG000|Period 1：Double-blind Period|Physician Decision|1|||
148871557|NCT02081599|537008043|FG001|Period 1：Double-blind Period|Physician Decision|0|||
148871558|NCT02081599|537008042|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
148871559|NCT02081599|537008043|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
148871560|NCT02081599|537008042|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
148871561|NCT02081599|537008043|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
148871562|NCT02081599|537008042|FG000|Period 1：Double-blind Period|stopping criteria|1|||
148871563|NCT02081599|537008043|FG001|Period 1：Double-blind Period|stopping criteria|0|||
148871564|NCT02081599|537008042|FG000|Period 2：Open-label Period|Adverse Event|1|||
148871565|NCT02081599|537008043|FG001|Period 2：Open-label Period|Adverse Event|0|||
148871566|NCT02081599|537008042|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
148871567|NCT02081599|537008043|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
148871568|NCT02081599|537008042|FG000|Period 2：Open-label Period|Physician Decision|1|||
148871569|NCT02081599|537008043|FG001|Period 2：Open-label Period|Physician Decision|0|||
148871570|NCT02081599|537008042|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
148871571|NCT02081599|537008043|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
148871572|NCT00306527|537008049|FG000|Overall Study|Lost to Follow-up|3|||
148871573|NCT00306527|537008050|FG001|Overall Study|Lost to Follow-up|4|||
148871574|NCT00306527|537008051|FG002|Overall Study|Lost to Follow-up|3|||
148871575|NCT00306527|537008052|FG003|Overall Study|Lost to Follow-up|0|||
148871576|NCT00306527|537008049|FG000|Overall Study|Withdrawal by Subject|2|||
148871577|NCT00306527|537008050|FG001|Overall Study|Withdrawal by Subject|3|||
148871578|NCT00306527|537008051|FG002|Overall Study|Withdrawal by Subject|0|||
148871579|NCT00306527|537008052|FG003|Overall Study|Withdrawal by Subject|3|||
148871580|NCT00306527|537008049|FG000|Overall Study|Adverse Event|0|||
148871581|NCT00306527|537008050|FG001|Overall Study|Adverse Event|0|||
148871582|NCT00306527|537008051|FG002|Overall Study|Adverse Event|1|||
148871583|NCT00306527|537008052|FG003|Overall Study|Adverse Event|1|||
148871584|NCT00306527|537008049|FG000|Overall Study|Death|1|||
149032433|NCT00124982|537596075|FG002|Long-term Period|Withdrawal by Subject|16|||
149032434|NCT00124982|537596073|FG000|Long-term Period|Pregnancy|0|||
149032435|NCT00124982|537596074|FG001|Long-term Period|Pregnancy|0|||
149032436|NCT00124982|537596075|FG002|Long-term Period|Pregnancy|1|||
149032437|NCT00124982|537596073|FG000|Long-term Period|Poor/Non-compliance|0|||
149032438|NCT00124982|537596074|FG001|Long-term Period|Poor/Non-compliance|0|||
149032439|NCT00124982|537596075|FG002|Long-term Period|Poor/Non-compliance|2|||
149032440|NCT00124982|537596073|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
149032441|NCT00124982|537596074|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
149032442|NCT00124982|537596075|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
149032443|NCT00124982|537596073|FG000|Long-term Period|Neurologist Recommendation|0|||
149032444|NCT00124982|537596074|FG001|Long-term Period|Neurologist Recommendation|0|||
149032445|NCT00124982|537596075|FG002|Long-term Period|Neurologist Recommendation|1|||
149032446|NCT00482729|537597338|FG000|Overall Study|Adverse Event|29|||
149032447|NCT00482729|537597339|FG001|Overall Study|Adverse Event|33|||
149032448|NCT00482729|537597338|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
149032449|NCT00482729|537597339|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
149032450|NCT00482729|537597338|FG000|Overall Study|Hyperglycemia Criteria|7|||
149032451|NCT00482729|537597339|FG001|Overall Study|Hyperglycemia Criteria|5|||
149032452|NCT00482729|537597338|FG000|Overall Study|Lack of Efficacy|4|||
149032453|NCT00482729|537597339|FG001|Overall Study|Lack of Efficacy|16|||
149032454|NCT00482729|537597338|FG000|Overall Study|Lost to Follow-up|86|||
149032455|NCT00482729|537597339|FG001|Overall Study|Lost to Follow-up|66|||
149032456|NCT00482729|537597338|FG000|Overall Study|Physician Decision|10|||
149032457|NCT00482729|537597339|FG001|Overall Study|Physician Decision|7|||
149032458|NCT00482729|537597338|FG000|Overall Study|Pregnancy|4|||
149032459|NCT00482729|537597339|FG001|Overall Study|Pregnancy|2|||
149032460|NCT00482729|537597338|FG000|Overall Study|Protocol Violation|10|||
149032461|NCT00482729|537597339|FG001|Overall Study|Protocol Violation|18|||
149032462|NCT00482729|537597338|FG000|Overall Study|Withdrawal by Subject|67|||
149032463|NCT00482729|537597339|FG001|Overall Study|Withdrawal by Subject|69|||
148871585|NCT00306527|537008050|FG001|Overall Study|Death|0|||
148871586|NCT00306527|537008051|FG002|Overall Study|Death|1|||
148871587|NCT00306527|537008052|FG003|Overall Study|Death|2|||
148871588|NCT00785980|537008053|FG000|7 Day Washout Period|Protocol Violation|3|||
149032464|NCT03179787|537597343|FG000|Overall Study|Lost to Follow-up|15|||
149032465|NCT03179787|537597343|FG000|Overall Study|Case report failures|2|||
149032466|NCT03179787|537597343|FG000|Overall Study|Treatment not administered|1|||
149032467|NCT00149630|537597350|FG000|Overall Study|Incarceration|2|||
149032468|NCT00149630|537597351|FG001|Overall Study|Incarceration|0|||
149032469|NCT00149630|537597350|FG000|Overall Study|Treatment Programs|4|||
149032470|NCT00149630|537597351|FG001|Overall Study|Treatment Programs|5|||
148871589|NCT00528801|537008054|FG000|Overall Study|Withdrawal by Subject|1|||
148871590|NCT00528801|537008055|FG001|Overall Study|Withdrawal by Subject|1|||
148871591|NCT00528801|537008054|FG000|Overall Study|Protocol Violation|11|||
148871592|NCT00528801|537008055|FG001|Overall Study|Protocol Violation|5|||
149032471|NCT00149630|537597350|FG000|Overall Study|Adverse Event|2|||
148871593|NCT00528801|537008054|FG000|Overall Study|Lost to Follow-up|15|||
148871594|NCT00528801|537008055|FG001|Overall Study|Lost to Follow-up|4|||
148871595|NCT00528801|537008054|FG000|Overall Study|Administrative Reasons|0|||
148871596|NCT00528801|537008055|FG001|Overall Study|Administrative Reasons|1|||
148871597|NCT02207491|537008056|FG000|Overall Study|Adverse Event|20|||
148871598|NCT02207491|537008057|FG001|Overall Study|Adverse Event|4|||
148871599|NCT02207491|537008056|FG000|Overall Study|Withdrawal by Subject|3|||
148871600|NCT02207491|537008057|FG001|Overall Study|Withdrawal by Subject|2|||
148871601|NCT02207491|537008056|FG000|Overall Study|Non-compliant|0|||
148871602|NCT02207491|537008057|FG001|Overall Study|Non-compliant|1|||
148871603|NCT02207491|537008056|FG000|Overall Study|Lost to Follow-up|0|||
148871604|NCT02207491|537008057|FG001|Overall Study|Lost to Follow-up|1|||
148871605|NCT02207491|537008056|FG000|Overall Study|Lack of Efficacy|3|||
148871606|NCT02207491|537008057|FG001|Overall Study|Lack of Efficacy|0|||
148871607|NCT02207491|537008056|FG000|Overall Study|Physician Decision|2|||
148871608|NCT02207491|537008057|FG001|Overall Study|Physician Decision|0|||
148871609|NCT02207491|537008056|FG000|Overall Study|Protocol Violation|3|||
148871610|NCT02207491|537008057|FG001|Overall Study|Protocol Violation|5|||
148871611|NCT00387725|537008058|FG000|Overall Study|Adverse Event|0|||
148871612|NCT00387725|537008059|FG001|Overall Study|Adverse Event|0|||
148871613|NCT00387725|537008060|FG002|Overall Study|Adverse Event|0|||
148871614|NCT00387725|537008061|FG003|Overall Study|Adverse Event|1|||
148871615|NCT00387725|537008058|FG000|Overall Study|Protocol Violation|0|||
148871616|NCT00387725|537008059|FG001|Overall Study|Protocol Violation|1|||
148871617|NCT00387725|537008060|FG002|Overall Study|Protocol Violation|0|||
148871618|NCT00387725|537008061|FG003|Overall Study|Protocol Violation|0|||
148871619|NCT00387725|537008058|FG000|Overall Study|Withdrawal by Subject|1|||
148871620|NCT00387725|537008059|FG001|Overall Study|Withdrawal by Subject|0|||
148871621|NCT00387725|537008060|FG002|Overall Study|Withdrawal by Subject|1|||
148871622|NCT00387725|537008061|FG003|Overall Study|Withdrawal by Subject|0|||
148871623|NCT00387725|537008058|FG000|Overall Study|Parent/legal guardian request|0|||
148871624|NCT00387725|537008059|FG001|Overall Study|Parent/legal guardian request|0|||
148871625|NCT00387725|537008060|FG002|Overall Study|Parent/legal guardian request|1|||
148871626|NCT00387725|537008061|FG003|Overall Study|Parent/legal guardian request|1|||
148871627|NCT02429791|537008062|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
148871628|NCT02429791|537008063|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
148871629|NCT02429791|537008062|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
148871630|NCT02429791|537008063|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
148871631|NCT02429791|537008062|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
148871632|NCT02429791|537008063|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
148871633|NCT02429791|537008062|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
148871634|NCT02429791|537008063|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
148871635|NCT02429791|537008062|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
148871636|NCT02429791|537008063|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
148871637|NCT02429791|537008062|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
148871638|NCT02429791|537008063|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
148871639|NCT02429791|537008062|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
148871640|NCT02429791|537008063|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
148871641|NCT02429791|537008062|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
148871642|NCT02429791|537008063|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
148871643|NCT02429791|537008062|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
148871644|NCT02429791|537008063|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
148871645|NCT02429791|537008062|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
148871646|NCT02429791|537008063|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
148871647|NCT02429791|537008062|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
149032472|NCT00149630|537597351|FG001|Overall Study|Adverse Event|0|||
149032473|NCT00377455|537597354|FG000|Overall Study|Withdrawal by Subject|1|||
149032474|NCT02814643|537597357|FG000|Overall Study|Lost to Follow-up|0|||
149032475|NCT02814643|537597358|FG001|Overall Study|Lost to Follow-up|1|||
149032476|NCT02814643|537597357|FG000|Overall Study|Withdrawal by Subject|1|||
149032477|NCT02814643|537597358|FG001|Overall Study|Withdrawal by Subject|2|||
149032478|NCT01259102|537597360|FG000|Overall Study|Adverse Event|1|||
148871648|NCT02429791|537008063|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
148871649|NCT02429791|537008062|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
148871650|NCT02429791|537008063|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
148871651|NCT02429791|537008062|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
148871652|NCT02429791|537008063|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
148871653|NCT02429791|537008062|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
148871654|NCT02429791|537008063|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
148871655|NCT02429791|537008062|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
148871656|NCT02429791|537008063|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
149032479|NCT01259102|537597361|FG001|Overall Study|Adverse Event|0|||
149032480|NCT01259102|537597362|FG002|Overall Study|Adverse Event|1|||
149032481|NCT01259102|537597363|FG003|Overall Study|Adverse Event|1|||
149032482|NCT01259102|537597364|FG004|Overall Study|Adverse Event|0|||
149032483|NCT01259102|537597360|FG000|Overall Study|Other|0|||
149032484|NCT01259102|537597361|FG001|Overall Study|Other|0|||
149032485|NCT01259102|537597362|FG002|Overall Study|Other|1|||
149032486|NCT01259102|537597363|FG003|Overall Study|Other|1|||
149032487|NCT01259102|537597364|FG004|Overall Study|Other|1|||
149032488|NCT00686517|537597365|FG000|Treatment|Serious Adverse Event|1|||
149032489|NCT00686517|537597366|FG001|Treatment|Serious Adverse Event|2|||
149032490|NCT00686517|537597367|FG002|Treatment|Serious Adverse Event|1|||
149032491|NCT00686517|537597365|FG000|Treatment|Adverse Event|2|||
149032492|NCT00686517|537597366|FG001|Treatment|Adverse Event|0|||
149032493|NCT00686517|537597367|FG002|Treatment|Adverse Event|0|||
149032494|NCT00686517|537597365|FG000|Treatment|Poor Protocol Compliance|1|||
149032495|NCT00686517|537597366|FG001|Treatment|Poor Protocol Compliance|0|||
149032496|NCT00686517|537597367|FG002|Treatment|Poor Protocol Compliance|0|||
149032497|NCT00686517|537597365|FG000|Treatment|Protocol Violation|2|||
149032498|NCT00686517|537597366|FG001|Treatment|Protocol Violation|1|||
149032499|NCT00686517|537597367|FG002|Treatment|Protocol Violation|0|||
149032500|NCT01803646|537597368|FG000|Overall Study|Protocol Violation|1|||
149032501|NCT01803646|537597369|FG001|Overall Study|Protocol Violation|0|||
149032502|NCT01803646|537597368|FG000|Overall Study|Adverse Event|1|||
149032503|NCT01803646|537597369|FG001|Overall Study|Adverse Event|1|||
149032504|NCT01803646|537597368|FG000|Overall Study|Withdrawal by Subject|9|||
149032505|NCT01803646|537597369|FG001|Overall Study|Withdrawal by Subject|6|||
149032506|NCT01803646|537597368|FG000|Overall Study|Randomization error|1|||
149032507|NCT01803646|537597369|FG001|Overall Study|Randomization error|2|||
149032508|NCT01803646|537597368|FG000|Overall Study|Lost to Follow-up|5|||
149032509|NCT01803646|537597369|FG001|Overall Study|Lost to Follow-up|1|||
149032510|NCT00420316|537597374|FG000|Overall Study|Withdrawal by Subject|0|||
149032511|NCT00420316|537597375|FG001|Overall Study|Withdrawal by Subject|1|||
149032512|NCT00420316|537597374|FG000|Overall Study|Lost to Follow-up|12|||
149032513|NCT00420316|537597375|FG001|Overall Study|Lost to Follow-up|8|||
149032514|NCT01281813|537597376|FG000|Overall Study|Adverse Event|0|||
149032515|NCT01281813|537597377|FG001|Overall Study|Adverse Event|0|||
149032516|NCT01281813|537597378|FG002|Overall Study|Adverse Event|10|||
149032517|NCT01281813|537597376|FG000|Overall Study|Lost to Follow-up|0|||
149032518|NCT01281813|537597377|FG001|Overall Study|Lost to Follow-up|0|||
149032519|NCT01281813|537597378|FG002|Overall Study|Lost to Follow-up|31|||
149032520|NCT01281813|537597376|FG000|Overall Study|Withdrawal by Subject|0|||
149032521|NCT01281813|537597377|FG001|Overall Study|Withdrawal by Subject|0|||
149032522|NCT01281813|537597378|FG002|Overall Study|Withdrawal by Subject|13|||
149032523|NCT01281813|537597376|FG000|Overall Study|Subject Non-Compliant|0|||
149032524|NCT01281813|537597377|FG001|Overall Study|Subject Non-Compliant|0|||
149032525|NCT01281813|537597378|FG002|Overall Study|Subject Non-Compliant|6|||
149032526|NCT01281813|537597376|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
149032527|NCT01281813|537597377|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
149032528|NCT01281813|537597378|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
149032529|NCT01281813|537597376|FG000|Overall Study|Sponsor's Decision|4|||
149032530|NCT01281813|537597377|FG001|Overall Study|Sponsor's Decision|3|||
149032531|NCT01281813|537597378|FG002|Overall Study|Sponsor's Decision|7|||
149032532|NCT01281813|537597376|FG000|Overall Study|Switched to Commercially Available Medication|0|||
149032533|NCT01281813|537597377|FG001|Overall Study|Switched to Commercially Available Medication|0|||
149032534|NCT01281813|537597378|FG002|Overall Study|Switched to Commercially Available Medication|26|||
149032535|NCT01281813|537597376|FG000|Overall Study|Other|0|||
149032536|NCT01281813|537597377|FG001|Overall Study|Other|1|||
149032537|NCT01281813|537597378|FG002|Overall Study|Other|39|||
149032538|NCT05257798|537597379|FG000|Follow-up Phase|Lost to Follow-up|1|||
149032539|NCT05257798|537597380|FG001|Follow-up Phase|Lost to Follow-up|0|||
149032540|NCT02274493|537597381|FG000|Overall Study|Withdrawal by Subject|1|||
149032541|NCT01368406|537597382|FG000|Overall Study|Lost to Follow-up|8|||
149032542|NCT01368406|537597383|FG001|Overall Study|Lost to Follow-up|4|||
149032543|NCT01368406|537597382|FG000|Overall Study|Withdrawal by Subject|8|||
149032544|NCT01368406|537597383|FG001|Overall Study|Withdrawal by Subject|4|||
149032545|NCT01368406|537597382|FG000|Overall Study|relapse of the disease|3|||
149032546|NCT01368406|537597383|FG001|Overall Study|relapse of the disease|2|||
149032547|NCT01368406|537597382|FG000|Overall Study|started working|2|||
149032548|NCT01368406|537597383|FG001|Overall Study|started working|3|||
149032549|NCT01313182|537597384|FG000|Overall Study|Protocol Violation|66|||
149032550|NCT01313182|537597385|FG001|Overall Study|Protocol Violation|92|||
149032551|NCT02846415|537597388|FG000|Overall Study|Lost to Follow-up|2|||
149032552|NCT02846415|537597389|FG001|Overall Study|Lost to Follow-up|0|||
149032553|NCT02846415|537597388|FG000|Overall Study|Withdrawal by Subject|1|||
149032554|NCT02846415|537597389|FG001|Overall Study|Withdrawal by Subject|1|||
149032555|NCT02322216|537597392|FG000|Overall Study|Adverse Event|1|||
149032556|NCT02322216|537597393|FG001|Overall Study|Adverse Event|0|||
149032557|NCT02322216|537597392|FG000|Overall Study|Withdrawal by Subject|1|||
149032558|NCT02322216|537597393|FG001|Overall Study|Withdrawal by Subject|4|||
148871657|NCT02429791|537008062|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
148871658|NCT02429791|537008063|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
148871659|NCT02429791|537008062|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
148871660|NCT02429791|537008063|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
148871661|NCT02429791|537008062|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
148871662|NCT02429791|537008063|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
148871663|NCT00007020|537008064|FG000|Overall Study|Death|16|||
148871664|NCT00007020|537008064|FG000|Overall Study|Lost to Follow-up|13|||
148871665|NCT00007020|537008064|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
148871666|NCT00007020|537008064|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
148871667|NCT00007020|537008064|FG000|Overall Study|Pt cared for by outside physician|4|||
148871668|NCT00007020|537008064|FG000|Overall Study|No evidence of treatment|6|||
148871669|NCT00881504|537008065|FG000|Overall Study|Withdrawal by Subject|1|||
148871670|NCT05011058|537008066|FG000|Overall Study|Sponsor Decision|2|||
148871671|NCT05011058|537008067|FG001|Overall Study|Sponsor Decision|0|||
148871672|NCT05011058|537008068|FG002|Overall Study|Sponsor Decision|14|||
148871673|NCT05011058|537008069|FG003|Overall Study|Sponsor Decision|0|||
148871674|NCT05011058|537008070|FG004|Overall Study|Sponsor Decision|0|||
148871675|NCT05011058|537008071|FG005|Overall Study|Sponsor Decision|1|||
148871676|NCT05011058|537008072|FG006|Overall Study|Sponsor Decision|0|||
148871677|NCT05011058|537008073|FG007|Overall Study|Sponsor Decision|5|||
148871678|NCT02596230|537008074|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
148871679|NCT02596230|537008075|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
149032559|NCT01651949|537597394|FG000|Overall Study|Unknown status|4|||
149032560|NCT01651949|537597395|FG001|Overall Study|Unknown status|4|||
149032561|NCT01651949|537597396|FG002|Overall Study|Unknown status|0|||
149032562|NCT01651949|537597394|FG000|Overall Study|Lost to Follow-up|30|||
149032563|NCT01651949|537597395|FG001|Overall Study|Lost to Follow-up|56|||
149032564|NCT01651949|537597396|FG002|Overall Study|Lost to Follow-up|20|||
149032565|NCT01651949|537597394|FG000|Overall Study|Protocol Violation|0|||
149032566|NCT01651949|537597395|FG001|Overall Study|Protocol Violation|2|||
149032567|NCT01651949|537597396|FG002|Overall Study|Protocol Violation|1|||
149032568|NCT01651949|537597394|FG000|Overall Study|Physician Decision|0|||
149032569|NCT01651949|537597395|FG001|Overall Study|Physician Decision|2|||
149032570|NCT01651949|537597396|FG002|Overall Study|Physician Decision|0|||
149032571|NCT01651949|537597394|FG000|Overall Study|Adverse Event|0|||
149032572|NCT01651949|537597395|FG001|Overall Study|Adverse Event|2|||
149032573|NCT01651949|537597396|FG002|Overall Study|Adverse Event|1|||
149032574|NCT01651949|537597394|FG000|Overall Study|Screen failure|2|||
149032575|NCT01651949|537597395|FG001|Overall Study|Screen failure|2|||
149032576|NCT01651949|537597396|FG002|Overall Study|Screen failure|0|||
149032577|NCT01651949|537597394|FG000|Overall Study|Withdrawal by Subject|17|||
149032578|NCT01651949|537597395|FG001|Overall Study|Withdrawal by Subject|18|||
149032579|NCT01651949|537597396|FG002|Overall Study|Withdrawal by Subject|9|||
149032580|NCT00678795|537597397|FG000|Overall Study|Adverse Event|7|||
149032581|NCT00678795|537597398|FG001|Overall Study|Adverse Event|3|||
149032582|NCT00678795|537597397|FG000|Overall Study|Withdrawal by Subject|3|||
149032583|NCT00678795|537597398|FG001|Overall Study|Withdrawal by Subject|0|||
149032584|NCT00678795|537597397|FG000|Overall Study|Protocol Violation|0|||
149032585|NCT00678795|537597398|FG001|Overall Study|Protocol Violation|1|||
149032586|NCT00678795|537597397|FG000|Overall Study|Lost to Follow-up|0|||
149032587|NCT00678795|537597398|FG001|Overall Study|Lost to Follow-up|1|||
149032588|NCT00678795|537597397|FG000|Overall Study|Lack of Efficacy|1|||
149032589|NCT00678795|537597398|FG001|Overall Study|Lack of Efficacy|1|||
149032590|NCT00404079|537597399|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
149032591|NCT00404079|537597400|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
149032592|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Other|4|||
149032593|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Other|0|||
149032594|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
149032595|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
149032596|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
149032597|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
148871680|NCT02596230|537008076|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
148871681|NCT02596230|537008077|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
148871682|NCT02596230|537008078|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
148871683|NCT02596230|537008074|FG000|Objective 2, One Year|Lost to Follow-up|0|||
148871684|NCT02596230|537008075|FG001|Objective 2, One Year|Lost to Follow-up|41|||
149032598|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
149032599|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
149032600|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
149032601|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
149032602|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
149032603|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
149032604|NCT00853827|537597402|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
149032605|NCT00853827|537597403|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
149032606|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
149032607|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
149032608|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
149032609|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
149032610|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
149032611|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
149032612|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
149032613|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
149032614|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
149032615|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
149032616|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
149032617|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
149032618|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
149032619|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
149032620|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
149032621|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
149032622|NCT00853827|537597402|FG000|Double Blind Period (103 Weeks)|Death|1|||
149032623|NCT00853827|537597403|FG001|Double Blind Period (103 Weeks)|Death|6|||
149032624|NCT00290732|537597407|FG000|Overall Study|Inability to instill drug intraductally.|0|||
149032625|NCT00290732|537597408|FG001|Overall Study|Inability to instill drug intraductally.|1|||
149032626|NCT00290732|537597409|FG002|Overall Study|Inability to instill drug intraductally.|1|||
149032627|NCT00290732|537597410|FG003|Overall Study|Inability to instill drug intraductally.|0|||
149032628|NCT00290732|537597411|FG004|Overall Study|Inability to instill drug intraductally.|0|||
149032629|NCT00843193|537597412|FG000|Overall Study|Adverse Event|2|||
149032630|NCT00843193|537597413|FG001|Overall Study|Adverse Event|4|||
149032631|NCT00843193|537597412|FG000|Overall Study|Lack of Efficacy|1|||
149032632|NCT00843193|537597413|FG001|Overall Study|Lack of Efficacy|1|||
149032633|NCT00843193|537597412|FG000|Overall Study|Protocol Violation|1|||
149032634|NCT00843193|537597413|FG001|Overall Study|Protocol Violation|2|||
149032635|NCT00843193|537597412|FG000|Overall Study|Lost to Follow-up|1|||
149032636|NCT00843193|537597413|FG001|Overall Study|Lost to Follow-up|0|||
149032637|NCT00843193|537597412|FG000|Overall Study|Physician Decision|0|||
149032638|NCT00843193|537597413|FG001|Overall Study|Physician Decision|1|||
149032639|NCT00843193|537597412|FG000|Overall Study|Withdrawal by Subject|3|||
149032640|NCT00843193|537597413|FG001|Overall Study|Withdrawal by Subject|3|||
149032641|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
149032642|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
149032643|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
149032644|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
149032645|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
149032646|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
149032647|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
149032648|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
149032649|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
149032650|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
149032651|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
149032652|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
149032653|NCT02057718|537597414|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
149032654|NCT02057718|537597415|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
149032655|NCT02057718|537597414|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
149032656|NCT02057718|537597415|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
149032657|NCT02057718|537597414|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
149032658|NCT02057718|537597415|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
149032659|NCT02057718|537597414|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
149032660|NCT02057718|537597415|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
149032661|NCT02057718|537597414|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
149032662|NCT02057718|537597415|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
149032663|NCT00542386|537597416|FG000|Overall Study|Adverse Event|1|||
149032664|NCT00542386|537597417|FG001|Overall Study|Adverse Event|7|||
149032665|NCT00542386|537597418|FG002|Overall Study|Adverse Event|7|||
149032666|NCT00542386|537597419|FG003|Overall Study|Adverse Event|8|||
149032667|NCT00542386|537597420|FG004|Overall Study|Adverse Event|13|||
149032668|NCT00542386|537597421|FG005|Overall Study|Adverse Event|4|||
149032669|NCT00542386|537597416|FG000|Overall Study|Death|0|||
149032670|NCT00542386|537597417|FG001|Overall Study|Death|0|||
149032671|NCT00542386|537597418|FG002|Overall Study|Death|1|||
149032672|NCT00542386|537597419|FG003|Overall Study|Death|2|||
149000463|NCT01984684|537477735|FG001|Overall Study|Withdrawal by Subject|9|||
149000464|NCT01984684|537477734|FG000|Overall Study|Lack of Efficacy|3|||
149000465|NCT01984684|537477735|FG001|Overall Study|Lack of Efficacy|6|||
149000466|NCT01984684|537477734|FG000|Overall Study|Physician Decision|4|||
149000467|NCT01984684|537477735|FG001|Overall Study|Physician Decision|2|||
149000468|NCT01984684|537477734|FG000|Overall Study|Protocol Violation|4|||
149000469|NCT01984684|537477735|FG001|Overall Study|Protocol Violation|2|||
149000470|NCT01984684|537477734|FG000|Overall Study|Death|0|||
149000471|NCT01984684|537477735|FG001|Overall Study|Death|1|||
149000472|NCT01984684|537477734|FG000|Overall Study|Noncompliance with study drug|2|||
149000473|NCT01984684|537477735|FG001|Overall Study|Noncompliance with study drug|1|||
149000474|NCT01984684|537477734|FG000|Overall Study|Subject incarcerated|1|||
149000475|NCT01984684|537477735|FG001|Overall Study|Subject incarcerated|0|||
149000476|NCT01984684|537477734|FG000|Overall Study|Study drug not available at site|1|||
149000477|NCT01984684|537477735|FG001|Overall Study|Study drug not available at site|1|||
149000478|NCT01984684|537477734|FG000|Overall Study|Subject had inadequate IV access|0|||
149000479|NCT01984684|537477735|FG001|Overall Study|Subject had inadequate IV access|1|||
149000480|NCT01077544|537477739|FG000|Overall Study|New Cancer Therapy|3|||
149000481|NCT01077544|537477740|FG001|Overall Study|New Cancer Therapy|3|||
149000482|NCT01077544|537477739|FG000|Overall Study|Adverse Event|0|||
149000483|NCT01077544|537477740|FG001|Overall Study|Adverse Event|1|||
149000484|NCT01077544|537477739|FG000|Overall Study|Disease Progression|0|||
149000485|NCT01077544|537477740|FG001|Overall Study|Disease Progression|1|||
149000486|NCT01362439|537477741|FG000|Overall Study|Adverse Event|1|||
149000487|NCT01362439|537477741|FG000|Overall Study|Lack of Efficacy|3|||
149000488|NCT01362439|537477741|FG000|Overall Study|Lost to Follow-up|2|||
149000489|NCT01362439|537477741|FG000|Overall Study|Study medication non-compliant|1|||
149000490|NCT01362439|537477741|FG000|Overall Study|Participant who withdrew consent|8|||
149000491|NCT02612311|537477742|FG000|Overall Study|Adverse Event|16|||
149000492|NCT02612311|537477743|FG001|Overall Study|Adverse Event|12|||
149000493|NCT02612311|537477744|FG002|Overall Study|Adverse Event|7|||
149000494|NCT02612311|537477745|FG003|Overall Study|Adverse Event|13|||
149000495|NCT02612311|537477742|FG000|Overall Study|Death|29|||
149000496|NCT02612311|537477743|FG001|Overall Study|Death|10|||
149000497|NCT02612311|537477744|FG002|Overall Study|Death|11|||
149000498|NCT02612311|537477745|FG003|Overall Study|Death|11|||
149000499|NCT02612311|537477742|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
149000500|NCT02612311|537477743|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
149000501|NCT02612311|537477744|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
149000502|NCT02612311|537477745|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
149000503|NCT02612311|537477742|FG000|Overall Study|Investigator's Decision|11|||
149000504|NCT02612311|537477743|FG001|Overall Study|Investigator's Decision|15|||
149000505|NCT02612311|537477744|FG002|Overall Study|Investigator's Decision|6|||
149000506|NCT02612311|537477745|FG003|Overall Study|Investigator's Decision|6|||
149000507|NCT02612311|537477742|FG000|Overall Study|Lack of Efficacy|0|||
149000508|NCT02612311|537477743|FG001|Overall Study|Lack of Efficacy|0|||
149000509|NCT02612311|537477744|FG002|Overall Study|Lack of Efficacy|1|||
149000510|NCT02612311|537477745|FG003|Overall Study|Lack of Efficacy|1|||
149000511|NCT02612311|537477742|FG000|Overall Study|Lost to Follow-up|2|||
149000512|NCT02612311|537477743|FG001|Overall Study|Lost to Follow-up|2|||
149000513|NCT02612311|537477744|FG002|Overall Study|Lost to Follow-up|1|||
149000514|NCT02612311|537477745|FG003|Overall Study|Lost to Follow-up|2|||
149000515|NCT02612311|537477742|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
149000516|NCT02612311|537477743|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
149000517|NCT02612311|537477744|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
149000518|NCT02612311|537477745|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
149000519|NCT02612311|537477742|FG000|Overall Study|Site Terminated by Sponsor|29|||
149000520|NCT02612311|537477743|FG001|Overall Study|Site Terminated by Sponsor|12|||
149000521|NCT02612311|537477744|FG002|Overall Study|Site Terminated by Sponsor|13|||
149000522|NCT02612311|537477745|FG003|Overall Study|Site Terminated by Sponsor|5|||
149000523|NCT02612311|537477742|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
149000524|NCT02612311|537477743|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
149000525|NCT02612311|537477744|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
149000526|NCT02612311|537477745|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
149000527|NCT02612311|537477742|FG000|Overall Study|Reason Not Specified|3|||
149000528|NCT02612311|537477743|FG001|Overall Study|Reason Not Specified|7|||
149000529|NCT02612311|537477744|FG002|Overall Study|Reason Not Specified|4|||
149000530|NCT02612311|537477745|FG003|Overall Study|Reason Not Specified|5|||
149000531|NCT02612311|537477742|FG000|Overall Study|Unknown/Missing|10|||
149000532|NCT02612311|537477743|FG001|Overall Study|Unknown/Missing|13|||
149000533|NCT02612311|537477744|FG002|Overall Study|Unknown/Missing|4|||
149000534|NCT02612311|537477745|FG003|Overall Study|Unknown/Missing|0|||
149000535|NCT02612311|537477742|FG000|Overall Study|Non-Compliance with Study|1|||
149000536|NCT02612311|537477743|FG001|Overall Study|Non-Compliance with Study|0|||
149000537|NCT02612311|537477744|FG002|Overall Study|Non-Compliance with Study|0|||
148871685|NCT02596230|537008076|FG002|Objective 2, One Year|Lost to Follow-up|41|||
148871686|NCT02596230|537008077|FG003|Objective 2, One Year|Lost to Follow-up|32|||
148871687|NCT02596230|537008078|FG004|Objective 2, One Year|Lost to Follow-up|46|||
148871688|NCT02596230|537008074|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
148871689|NCT02596230|537008075|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
148871690|NCT02596230|537008076|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
148871691|NCT02596230|537008077|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
148871692|NCT02596230|537008078|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
148871693|NCT02596230|537008074|FG000|Objective 2, One Year|Adverse drug reaction|0|||
148871694|NCT02596230|537008075|FG001|Objective 2, One Year|Adverse drug reaction|1|||
148871695|NCT02596230|537008076|FG002|Objective 2, One Year|Adverse drug reaction|0|||
148871696|NCT02596230|537008077|FG003|Objective 2, One Year|Adverse drug reaction|0|||
148871697|NCT02596230|537008078|FG004|Objective 2, One Year|Adverse drug reaction|0|||
148871698|NCT02596230|537008074|FG000|Objective 2, One Year|Death|0|||
148871699|NCT02596230|537008075|FG001|Objective 2, One Year|Death|12|||
148871700|NCT02596230|537008076|FG002|Objective 2, One Year|Death|41|||
148871701|NCT02596230|537008077|FG003|Objective 2, One Year|Death|21|||
148871702|NCT02596230|537008078|FG004|Objective 2, One Year|Death|30|||
148871703|NCT02596230|537008074|FG000|Objective 2, One Year|Other|0|||
148871704|NCT02596230|537008075|FG001|Objective 2, One Year|Other|3|||
148871705|NCT02596230|537008076|FG002|Objective 2, One Year|Other|2|||
148871706|NCT02596230|537008077|FG003|Objective 2, One Year|Other|0|||
148871707|NCT02596230|537008078|FG004|Objective 2, One Year|Other|0|||
148871708|NCT01571232|537008079|FG000|Overall Study|Lost to Follow-up|0|||
148871709|NCT01571232|537008080|FG001|Overall Study|Lost to Follow-up|1|||
148871710|NCT01571232|537008079|FG000|Overall Study|Withdrawal by Subject|1|||
148871711|NCT01571232|537008080|FG001|Overall Study|Withdrawal by Subject|0|||
149000538|NCT02612311|537477745|FG003|Overall Study|Non-Compliance with Study|0|||
149000539|NCT04510675|537477748|FG000|Overall Study|Withdrawal by Subject|5|||
149000540|NCT01494584|537477753|FG000|Overall Study|Study Closed/Terminated|1|||
149000541|NCT01499082|537477754|FG000|Overall Study|Randomized but not Treated|0|||
149000542|NCT01499082|537477755|FG001|Overall Study|Randomized but not Treated|1|||
149000543|NCT01499082|537477754|FG000|Overall Study|Adverse Event|12|||
149000544|NCT01499082|537477755|FG001|Overall Study|Adverse Event|16|||
149000545|NCT01499082|537477754|FG000|Overall Study|Lack of Efficacy|1|||
149000546|NCT01499082|537477755|FG001|Overall Study|Lack of Efficacy|1|||
149000547|NCT01499082|537477754|FG000|Overall Study|Protocol Violation|6|||
149000548|NCT01499082|537477755|FG001|Overall Study|Protocol Violation|8|||
149000549|NCT01499082|537477754|FG000|Overall Study|Diverse Reasons|18|||
149000550|NCT01499082|537477755|FG001|Overall Study|Diverse Reasons|14|||
149000551|NCT01499082|537477754|FG000|Overall Study|Site Closure for Noncompliance|5|||
149000552|NCT01499082|537477755|FG001|Overall Study|Site Closure for Noncompliance|2|||
149000553|NCT01499082|537477754|FG000|Overall Study|Hypoglycemia|2|||
149000554|NCT01499082|537477755|FG001|Overall Study|Hypoglycemia|3|||
149000555|NCT01499082|537477754|FG000|Overall Study|Lost to Follow-up|1|||
149000556|NCT01499082|537477755|FG001|Overall Study|Lost to Follow-up|3|||
149000557|NCT00058123|537477764|FG000|Overall Study|Wrong histology|9|||
149000558|NCT00058123|537477764|FG000|Overall Study|Received >3 prior treatments|1|||
149000559|NCT01298999|537477770|FG000|Overall Study|Physician Decision|0|||
149000560|NCT01298999|537477771|FG001|Overall Study|Physician Decision|1|||
149000561|NCT01298999|537477770|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
149000562|NCT01298999|537477771|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
149000563|NCT02151266|537477772|FG000|Overall Study|Lost to Follow-up|1|||
149000564|NCT02151266|537477773|FG001|Overall Study|Lost to Follow-up|4|||
149000565|NCT02151266|537477774|FG002|Overall Study|Lost to Follow-up|1|||
149000566|NCT02151266|537477772|FG000|Overall Study|Did NOT receive intervention|3|||
149000567|NCT02151266|537477773|FG001|Overall Study|Did NOT receive intervention|6|||
149000568|NCT02151266|537477774|FG002|Overall Study|Did NOT receive intervention|2|||
149000569|NCT02151266|537477772|FG000|Overall Study|Not able to exercise|4|||
149000570|NCT02151266|537477773|FG001|Overall Study|Not able to exercise|5|||
149000571|NCT02151266|537477774|FG002|Overall Study|Not able to exercise|4|||
149000572|NCT04839965|537477776|FG000|Overall Study|Death|6|||
149000573|NCT04839965|537477777|FG001|Overall Study|Death|6|||
149000574|NCT04839965|537477776|FG000|Overall Study|Lost to Follow-up|1|||
149000575|NCT04839965|537477777|FG001|Overall Study|Lost to Follow-up|0|||
149000576|NCT02170025|537477778|FG000|Overall Study|Adverse Event|2|||
149000577|NCT02170025|537477779|FG001|Overall Study|Adverse Event|0|||
149000578|NCT01337674|537479290|FG000|Treatment Period 1|Adverse Event|0|||
149000579|NCT01337674|537479291|FG001|Treatment Period 1|Adverse Event|1|||
149000580|NCT01337674|537479292|FG002|Treatment Period 1|Adverse Event|0|||
148871712|NCT00802893|537008081|FG000|Overall Study|study terminated|3|||
149000581|NCT01337674|537479293|FG003|Treatment Period 1|Adverse Event|0|||
149000582|NCT01337674|537479290|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
148871713|NCT00320424|537008082|FG000|Overall Study|Adverse Event|3|||
148871714|NCT00320424|537008082|FG000|Overall Study|Other|3|||
148871715|NCT03316950|537008084|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
149032673|NCT00542386|537597420|FG004|Overall Study|Death|1|||
149032674|NCT00542386|537597421|FG005|Overall Study|Death|2|||
149032675|NCT00542386|537597416|FG000|Overall Study|Lack of Efficacy|32|||
149032676|NCT00542386|537597417|FG001|Overall Study|Lack of Efficacy|12|||
149032677|NCT00542386|537597418|FG002|Overall Study|Lack of Efficacy|10|||
149032678|NCT00542386|537597419|FG003|Overall Study|Lack of Efficacy|13|||
149032679|NCT00542386|537597420|FG004|Overall Study|Lack of Efficacy|7|||
149032680|NCT00542386|537597421|FG005|Overall Study|Lack of Efficacy|31|||
149032681|NCT00542386|537597416|FG000|Overall Study|Physician Decision|1|||
149032682|NCT00542386|537597417|FG001|Overall Study|Physician Decision|0|||
149032683|NCT00542386|537597418|FG002|Overall Study|Physician Decision|0|||
149032684|NCT00542386|537597419|FG003|Overall Study|Physician Decision|1|||
149032685|NCT00542386|537597420|FG004|Overall Study|Physician Decision|0|||
149032686|NCT00542386|537597421|FG005|Overall Study|Physician Decision|0|||
149032687|NCT00542386|537597416|FG000|Overall Study|Protocol Violation|0|||
149032688|NCT00542386|537597417|FG001|Overall Study|Protocol Violation|0|||
149032689|NCT00542386|537597418|FG002|Overall Study|Protocol Violation|1|||
149032690|NCT00542386|537597419|FG003|Overall Study|Protocol Violation|0|||
149032691|NCT00542386|537597420|FG004|Overall Study|Protocol Violation|0|||
148778261|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
148778262|NCT01440569|536661959|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
148778263|NCT01440569|536661960|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
148778264|NCT02584959|536661968|FG000|Period 1|Withdrawn from study|3|||
148778265|NCT02584959|536661969|FG001|Period 1|Withdrawn from study|4|||
148778266|NCT02584959|536661970|FG002|Period 1|Withdrawn from study|0|||
148778267|NCT02584959|536661968|FG000|Period 2|Withdrawn from study|6|||
148778268|NCT02584959|536661969|FG001|Period 2|Withdrawn from study|1|||
148778269|NCT02584959|536661970|FG002|Period 2|Withdrawn from study|2|||
148778270|NCT00204477|536661972|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
148778271|NCT00204477|536661973|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
148778272|NCT00204477|536661972|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
148778273|NCT00204477|536661973|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
148778274|NCT01966068|536661976|FG000|Overall Study|Withdrawal by Subject|57|||
148778275|NCT01966068|536661976|FG000|Overall Study|Lost to Follow-up|81|||
148778276|NCT02889835|536661983|FG000|Overall Study|Lost to Follow-up|13|||
149032692|NCT00542386|537597421|FG005|Overall Study|Protocol Violation|4|||
149032693|NCT00542386|537597416|FG000|Overall Study|Withdrawal by Subject|5|||
149032694|NCT00542386|537597417|FG001|Overall Study|Withdrawal by Subject|8|||
149032695|NCT00542386|537597418|FG002|Overall Study|Withdrawal by Subject|10|||
149032696|NCT00542386|537597419|FG003|Overall Study|Withdrawal by Subject|11|||
149032697|NCT00542386|537597420|FG004|Overall Study|Withdrawal by Subject|15|||
148778277|NCT02889835|536661984|FG001|Overall Study|Lost to Follow-up|13|||
148778278|NCT02889835|536661985|FG002|Overall Study|Lost to Follow-up|13|||
148778279|NCT02889835|536661983|FG000|Overall Study|Withdrawal by Subject|2|||
148778280|NCT02889835|536661984|FG001|Overall Study|Withdrawal by Subject|2|||
148778281|NCT02889835|536661985|FG002|Overall Study|Withdrawal by Subject|2|||
148778282|NCT02889835|536661983|FG000|Overall Study|Protocol Violation|1|||
148778283|NCT02889835|536661984|FG001|Overall Study|Protocol Violation|1|||
148778284|NCT02889835|536661985|FG002|Overall Study|Protocol Violation|1|||
148778285|NCT02889835|536661983|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
148778286|NCT02889835|536661984|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
148778287|NCT02889835|536661985|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
148778288|NCT02889835|536661983|FG000|Overall Study|Death|1|||
148778289|NCT02889835|536661984|FG001|Overall Study|Death|1|||
148778290|NCT02889835|536661985|FG002|Overall Study|Death|1|||
148778291|NCT02987972|536661986|FG000|Overall Study|Adverse Event|1|||
148778292|NCT02987972|536661987|FG001|Overall Study|Adverse Event|1|||
148778293|NCT02987972|536661988|FG002|Overall Study|Adverse Event|0|||
148778294|NCT02987972|536661986|FG000|Overall Study|Death|1|||
149032698|NCT00542386|537597421|FG005|Overall Study|Withdrawal by Subject|7|||
149032699|NCT00542386|537597416|FG000|Overall Study|Other Reasons|4|||
149032700|NCT00542386|537597417|FG001|Overall Study|Other Reasons|1|||
149032701|NCT00542386|537597418|FG002|Overall Study|Other Reasons|4|||
149032702|NCT00542386|537597419|FG003|Overall Study|Other Reasons|3|||
149032703|NCT00542386|537597420|FG004|Overall Study|Other Reasons|4|||
149032704|NCT00542386|537597421|FG005|Overall Study|Other Reasons|2|||
149032705|NCT00608907|537597426|FG000|Overall Study|Adverse Event|6|||
149032706|NCT00608907|537597427|FG001|Overall Study|Adverse Event|0|||
149032707|NCT00608907|537597428|FG002|Overall Study|Adverse Event|1|||
149032708|NCT00608907|537597426|FG000|Overall Study|Death|1|||
149032709|NCT00608907|537597427|FG001|Overall Study|Death|0|||
149032710|NCT00608907|537597428|FG002|Overall Study|Death|0|||
149032711|NCT00608907|537597426|FG000|Overall Study|Withdrawal by Subject|4|||
149032712|NCT00608907|537597427|FG001|Overall Study|Withdrawal by Subject|0|||
148778295|NCT02987972|536661987|FG001|Overall Study|Death|0|||
148778296|NCT02987972|536661988|FG002|Overall Study|Death|0|||
149032713|NCT00608907|537597428|FG002|Overall Study|Withdrawal by Subject|0|||
149032714|NCT00608907|537597426|FG000|Overall Study|Progressive Disease|1|||
149032715|NCT00608907|537597427|FG001|Overall Study|Progressive Disease|0|||
149032716|NCT00608907|537597428|FG002|Overall Study|Progressive Disease|0|||
149032717|NCT01689519|537597429|FG000|Intent to Treat|Death|157|||
149032718|NCT01689519|537597430|FG001|Intent to Treat|Death|167|||
149032719|NCT01689519|537597429|FG000|Intent to Treat|Lost to Follow-up|4|||
149032720|NCT01689519|537597430|FG001|Intent to Treat|Lost to Follow-up|8|||
149032721|NCT01689519|537597429|FG000|Intent to Treat|Other|2|||
149032722|NCT01689519|537597430|FG001|Intent to Treat|Other|4|||
149032723|NCT01689519|537597429|FG000|Intent to Treat|Physician Decision|4|||
149032724|NCT01689519|537597430|FG001|Intent to Treat|Physician Decision|1|||
149032725|NCT01689519|537597429|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
149032726|NCT01689519|537597430|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
149032727|NCT01689519|537597429|FG000|Intent to Treat|Withdrawal by Subject|21|||
149032728|NCT01689519|537597430|FG001|Intent to Treat|Withdrawal by Subject|20|||
149032729|NCT01689519|537597429|FG000|Safety Population|Death|158|||
148778297|NCT02987972|536661986|FG000|Overall Study|Lack of Efficacy|9|||
148778298|NCT02987972|536661987|FG001|Overall Study|Lack of Efficacy|12|||
148778299|NCT02987972|536661988|FG002|Overall Study|Lack of Efficacy|12|||
148778300|NCT02987972|536661986|FG000|Overall Study|Lost to Follow-up|7|||
148778301|NCT02987972|536661987|FG001|Overall Study|Lost to Follow-up|8|||
148778302|NCT02987972|536661988|FG002|Overall Study|Lost to Follow-up|4|||
148778303|NCT02987972|536661986|FG000|Overall Study|Physician Decision|1|||
148778304|NCT02987972|536661987|FG001|Overall Study|Physician Decision|6|||
148778305|NCT02987972|536661988|FG002|Overall Study|Physician Decision|0|||
148778306|NCT02987972|536661986|FG000|Overall Study|Protocol Violation|2|||
148778307|NCT02987972|536661987|FG001|Overall Study|Protocol Violation|1|||
149032730|NCT01689519|537597430|FG001|Safety Population|Death|165|||
149032731|NCT01689519|537597429|FG000|Safety Population|Lost to Follow-up|4|||
149032732|NCT01689519|537597430|FG001|Safety Population|Lost to Follow-up|8|||
149032733|NCT01689519|537597429|FG000|Safety Population|Other|2|||
149032734|NCT01689519|537597430|FG001|Safety Population|Other|4|||
149032735|NCT01689519|537597429|FG000|Safety Population|Physician Decision|4|||
149032736|NCT01689519|537597430|FG001|Safety Population|Physician Decision|1|||
149032737|NCT01689519|537597429|FG000|Safety Population|Study Terminated By Sponsor|60|||
149032738|NCT01689519|537597430|FG001|Safety Population|Study Terminated By Sponsor|47|||
149032739|NCT01689519|537597429|FG000|Safety Population|Withdrawal by Subject|20|||
148778308|NCT02987972|536661988|FG002|Overall Study|Protocol Violation|5|||
148778309|NCT02987972|536661986|FG000|Overall Study|Withdrawal by Subject|22|||
148778310|NCT02987972|536661987|FG001|Overall Study|Withdrawal by Subject|17|||
148778311|NCT02987972|536661988|FG002|Overall Study|Withdrawal by Subject|21|||
148778312|NCT01328548|536661990|FG000|Overall Study|Death|3|||
148778313|NCT01328548|536661991|FG001|Overall Study|Death|0|||
148778314|NCT01328548|536661990|FG000|Overall Study|Protocol Violation|1|||
148778315|NCT01328548|536661991|FG001|Overall Study|Protocol Violation|0|||
148778316|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
148778317|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
148778318|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
148778319|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
148778320|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
148778321|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
148778322|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
148778323|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
148778324|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
148778325|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
148778326|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
148778327|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
149032740|NCT01689519|537597430|FG001|Safety Population|Withdrawal by Subject|20|||
149032741|NCT02982213|537597435|FG000|Overall Study|Did not complete follow up questionnaire|5|||
149032742|NCT02982213|537597436|FG001|Overall Study|Did not complete follow up questionnaire|1|||
148871716|NCT03316950|537008085|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
148871717|NCT03316950|537008086|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
149032743|NCT01549652|537597437|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
149032744|NCT01549652|537597438|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
148871718|NCT03316950|537008087|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
149032745|NCT01549652|537597439|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
149032746|NCT01549652|537597440|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
148778328|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
148778329|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
148778330|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
148778331|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
148778332|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
148778333|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
148778334|NCT02294461|536661992|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
148871719|NCT03316950|537008084|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
148871720|NCT03316950|537008085|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
148871721|NCT03316950|537008086|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
148871722|NCT03316950|537008087|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
148871723|NCT03316950|537008084|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
148871724|NCT03316950|537008085|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
148871725|NCT03316950|537008086|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
148871726|NCT03316950|537008087|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
148871727|NCT00549770|537008088|FG000|Overall Study|Protocol deviation|1|||
148871728|NCT00549770|537008089|FG001|Overall Study|Protocol deviation|1|||
148871729|NCT00549770|537008090|FG002|Overall Study|Protocol deviation|1|||
148871730|NCT00549770|537008091|FG003|Overall Study|Protocol deviation|2|||
148871731|NCT00549770|537008092|FG004|Overall Study|Protocol deviation|2|||
148871732|NCT00549770|537008093|FG005|Overall Study|Protocol deviation|2|||
148871733|NCT00549770|537008094|FG006|Overall Study|Protocol deviation|1|||
148871734|NCT00549770|537008095|FG007|Overall Study|Protocol deviation|2|||
148871735|NCT00549770|537008088|FG000|Overall Study|Administrative problems|0|||
148871736|NCT00549770|537008089|FG001|Overall Study|Administrative problems|1|||
148871737|NCT00549770|537008090|FG002|Overall Study|Administrative problems|0|||
148871738|NCT00549770|537008091|FG003|Overall Study|Administrative problems|0|||
148871739|NCT00549770|537008092|FG004|Overall Study|Administrative problems|0|||
148871740|NCT00549770|537008093|FG005|Overall Study|Administrative problems|0|||
148871741|NCT00549770|537008094|FG006|Overall Study|Administrative problems|0|||
148871742|NCT00549770|537008095|FG007|Overall Study|Administrative problems|1|||
148871743|NCT00549770|537008088|FG000|Overall Study|Lost to Follow-up|0|||
148871744|NCT00549770|537008089|FG001|Overall Study|Lost to Follow-up|0|||
148871745|NCT00549770|537008090|FG002|Overall Study|Lost to Follow-up|2|||
148871746|NCT00549770|537008091|FG003|Overall Study|Lost to Follow-up|2|||
148871747|NCT00549770|537008092|FG004|Overall Study|Lost to Follow-up|3|||
148871748|NCT00549770|537008093|FG005|Overall Study|Lost to Follow-up|2|||
148871749|NCT00549770|537008094|FG006|Overall Study|Lost to Follow-up|0|||
148871750|NCT00549770|537008095|FG007|Overall Study|Lost to Follow-up|0|||
148871751|NCT00549770|537008088|FG000|Overall Study|Withdrawal by Subject|4|||
148871752|NCT00549770|537008089|FG001|Overall Study|Withdrawal by Subject|6|||
148871753|NCT00549770|537008090|FG002|Overall Study|Withdrawal by Subject|4|||
148871754|NCT00549770|537008091|FG003|Overall Study|Withdrawal by Subject|5|||
148871755|NCT00549770|537008092|FG004|Overall Study|Withdrawal by Subject|6|||
148871756|NCT00549770|537008093|FG005|Overall Study|Withdrawal by Subject|6|||
148871757|NCT00549770|537008094|FG006|Overall Study|Withdrawal by Subject|4|||
148871758|NCT00549770|537008095|FG007|Overall Study|Withdrawal by Subject|9|||
148871759|NCT00549770|537008088|FG000|Overall Study|Lack of Efficacy|1|||
148871760|NCT00549770|537008089|FG001|Overall Study|Lack of Efficacy|0|||
148871761|NCT00549770|537008090|FG002|Overall Study|Lack of Efficacy|2|||
148871762|NCT00549770|537008091|FG003|Overall Study|Lack of Efficacy|3|||
148871763|NCT00549770|537008092|FG004|Overall Study|Lack of Efficacy|5|||
148871764|NCT00549770|537008093|FG005|Overall Study|Lack of Efficacy|1|||
148871765|NCT00549770|537008094|FG006|Overall Study|Lack of Efficacy|3|||
148871766|NCT00549770|537008095|FG007|Overall Study|Lack of Efficacy|8|||
148871767|NCT00549770|537008088|FG000|Overall Study|Abnormal test procedure results|0|||
148871768|NCT00549770|537008089|FG001|Overall Study|Abnormal test procedure results|0|||
148871769|NCT00549770|537008090|FG002|Overall Study|Abnormal test procedure results|0|||
148871770|NCT00549770|537008091|FG003|Overall Study|Abnormal test procedure results|2|||
148871771|NCT00549770|537008092|FG004|Overall Study|Abnormal test procedure results|0|||
148871772|NCT00549770|537008093|FG005|Overall Study|Abnormal test procedure results|1|||
148871773|NCT00549770|537008094|FG006|Overall Study|Abnormal test procedure results|1|||
148871774|NCT00549770|537008095|FG007|Overall Study|Abnormal test procedure results|1|||
148871775|NCT00549770|537008088|FG000|Overall Study|Abnormal laboratory values|0|||
148871776|NCT00549770|537008089|FG001|Overall Study|Abnormal laboratory values|0|||
148871777|NCT00549770|537008090|FG002|Overall Study|Abnormal laboratory values|0|||
148871778|NCT00549770|537008091|FG003|Overall Study|Abnormal laboratory values|0|||
148871779|NCT00549770|537008092|FG004|Overall Study|Abnormal laboratory values|0|||
148871780|NCT00549770|537008093|FG005|Overall Study|Abnormal laboratory values|1|||
148871781|NCT00549770|537008094|FG006|Overall Study|Abnormal laboratory values|0|||
148871782|NCT00549770|537008095|FG007|Overall Study|Abnormal laboratory values|0|||
148871783|NCT00549770|537008088|FG000|Overall Study|Adverse Event|1|||
148871784|NCT00549770|537008089|FG001|Overall Study|Adverse Event|3|||
148871785|NCT00549770|537008090|FG002|Overall Study|Adverse Event|1|||
148871786|NCT00549770|537008091|FG003|Overall Study|Adverse Event|2|||
148871787|NCT00549770|537008092|FG004|Overall Study|Adverse Event|1|||
148871788|NCT00549770|537008093|FG005|Overall Study|Adverse Event|0|||
148871789|NCT00549770|537008094|FG006|Overall Study|Adverse Event|5|||
148871790|NCT00549770|537008095|FG007|Overall Study|Adverse Event|4|||
148871791|NCT00548717|537008096|FG000|Overall Study|Death|5|||
148871792|NCT00548717|537008097|FG001|Overall Study|Death|2|||
148871793|NCT00548717|537008096|FG000|Overall Study|Relapse|3|||
148871794|NCT00548717|537008097|FG001|Overall Study|Relapse|0|||
148871795|NCT00548717|537008096|FG000|Overall Study|Alternative treatment for GVHD|1|||
148871796|NCT00548717|537008097|FG001|Overall Study|Alternative treatment for GVHD|0|||
148871797|NCT02809053|537008100|FG000|Overall Study|Death|0|||
149000583|NCT01337674|537479291|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
149000584|NCT01337674|537479292|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
149000585|NCT01337674|537479293|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
149000586|NCT01337674|537479290|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149000587|NCT01337674|537479291|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149000588|NCT01337674|537479292|FG002|Treatment Period 2|Withdrawal by Subject|1|||
149000589|NCT01337674|537479293|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149000590|NCT02543658|537479294|FG000|Overall Study|Lack of Efficacy|0|||
149000591|NCT02543658|537479295|FG001|Overall Study|Lack of Efficacy|4|||
149000592|NCT02293395|537479303|FG000|Overall Study|Lost to Follow-up|1|||
149000593|NCT02293395|537479304|FG001|Overall Study|Lost to Follow-up|0|||
149000594|NCT02293395|537479303|FG000|Overall Study|Withdrawal by Subject|8|||
149000595|NCT02293395|537479304|FG001|Overall Study|Withdrawal by Subject|7|||
149000596|NCT00224770|537479310|FG000|Overall Study|Lost to Follow-up|4|||
149000597|NCT00224770|537479311|FG001|Overall Study|Lost to Follow-up|2|||
149000598|NCT00224770|537479312|FG002|Overall Study|Lost to Follow-up|0|||
149000599|NCT01106430|537479313|FG000|Overall Study|Adverse Event|8|||
149000600|NCT01106430|537479314|FG001|Overall Study|Adverse Event|10|||
149000601|NCT01106430|537479313|FG000|Overall Study|Lack of Efficacy|2|||
149000602|NCT01106430|537479314|FG001|Overall Study|Lack of Efficacy|13|||
149000603|NCT01106430|537479313|FG000|Overall Study|Lost to Follow-up|5|||
149000604|NCT01106430|537479314|FG001|Overall Study|Lost to Follow-up|1|||
149000605|NCT01106430|537479313|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
149000606|NCT01106430|537479314|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
149000607|NCT01106430|537479313|FG000|Overall Study|Moved Out Of State|0|||
149000608|NCT01106430|537479314|FG001|Overall Study|Moved Out Of State|1|||
149000609|NCT01106430|537479313|FG000|Overall Study|Refused To Take Medication|0|||
149000610|NCT01106430|537479314|FG001|Overall Study|Refused To Take Medication|1|||
149000611|NCT01106430|537479313|FG000|Overall Study|Noncompliance|0|||
149000612|NCT01106430|537479314|FG001|Overall Study|Noncompliance|1|||
149000613|NCT01106430|537479313|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
149000614|NCT01106430|537479314|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
149000615|NCT01106430|537479313|FG000|Overall Study|Previous Use Of Marijuana|1|||
149000616|NCT01106430|537479314|FG001|Overall Study|Previous Use Of Marijuana|0|||
149000617|NCT01106430|537479313|FG000|Overall Study|Protocol Violation|7|||
149000618|NCT01106430|537479314|FG001|Overall Study|Protocol Violation|2|||
149000619|NCT01106430|537479313|FG000|Overall Study|Withdrawal by Subject|8|||
149000620|NCT01106430|537479314|FG001|Overall Study|Withdrawal by Subject|4|||
149000621|NCT00437645|537479321|FG000|Overall Study|Adverse Event|15|||
149000622|NCT00437645|537479322|FG001|Overall Study|Adverse Event|84|||
149000623|NCT00437645|537479321|FG000|Overall Study|Withdrawal by Subject|10|||
149000624|NCT00437645|537479322|FG001|Overall Study|Withdrawal by Subject|22|||
149000625|NCT00437645|537479321|FG000|Overall Study|Protocol Violation|3|||
149000626|NCT00437645|537479322|FG001|Overall Study|Protocol Violation|3|||
149000627|NCT00437645|537479321|FG000|Overall Study|Lost to Follow-up|2|||
149000628|NCT00437645|537479322|FG001|Overall Study|Lost to Follow-up|3|||
149000629|NCT00437645|537479321|FG000|Overall Study|Administrative problems|2|||
149000630|NCT00437645|537479322|FG001|Overall Study|Administrative problems|1|||
149000631|NCT00437645|537479321|FG000|Overall Study|Lack of Efficacy|2|||
149000632|NCT00437645|537479322|FG001|Overall Study|Lack of Efficacy|1|||
149000633|NCT00437645|537479321|FG000|Overall Study|Condition no longer requires study drug|1|||
149000634|NCT00437645|537479322|FG001|Overall Study|Condition no longer requires study drug|1|||
149000635|NCT00662857|537479323|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
149000636|NCT00662857|537479324|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
149000637|NCT00662857|537479323|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
149000638|NCT00662857|537479324|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
149000639|NCT00662857|537479323|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
149000640|NCT00662857|537479324|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
149000641|NCT03966053|537479325|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
149000642|NCT00989092|537479326|FG000|Overall Study|Physician Decision|9|||
149000643|NCT00989092|537479327|FG001|Overall Study|Physician Decision|6|||
149000644|NCT00989092|537479326|FG000|Overall Study|Adverse Event|20|||
149000645|NCT00989092|537479327|FG001|Overall Study|Adverse Event|1|||
149000646|NCT00989092|537479326|FG000|Overall Study|Chemotherapy initiated|12|||
149000647|NCT00989092|537479327|FG001|Overall Study|Chemotherapy initiated|4|||
149000648|NCT00989092|537479326|FG000|Overall Study|Withdrawal by Subject|17|||
149000649|NCT00989092|537479327|FG001|Overall Study|Withdrawal by Subject|9|||
149000650|NCT00989092|537479326|FG000|Overall Study|Death|14|||
149000651|NCT00989092|537479327|FG001|Overall Study|Death|2|||
149000652|NCT00989092|537479326|FG000|Overall Study|Ineligibility determined|3|||
149000653|NCT00989092|537479327|FG001|Overall Study|Ineligibility determined|3|||
149000654|NCT00989092|537479326|FG000|Overall Study|Lost to Follow-up|6|||
149000655|NCT00989092|537479327|FG001|Overall Study|Lost to Follow-up|2|||
149000656|NCT00989092|537479326|FG000|Overall Study|Other|3|||
148778335|NCT02294461|536661993|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
148778336|NCT02294461|536661994|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
148778337|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
148778338|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
148778339|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
148778340|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
148778341|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
148778342|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
148778343|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
148778344|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
148778345|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
148778346|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
148778347|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
148778348|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
148778349|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
148778350|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
148778351|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
148778352|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
148778353|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
148778354|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
149032747|NCT01549652|537597437|FG000|Overall Study|Study Drug Titration Failure|5|||
149032748|NCT01549652|537597438|FG001|Overall Study|Study Drug Titration Failure|6|||
149032749|NCT01549652|537597439|FG002|Overall Study|Study Drug Titration Failure|0|||
149032750|NCT01549652|537597440|FG003|Overall Study|Study Drug Titration Failure|0|||
149032751|NCT01549652|537597437|FG000|Overall Study|Withdrawal Effect|0|||
149032752|NCT01549652|537597438|FG001|Overall Study|Withdrawal Effect|2|||
149032753|NCT01549652|537597439|FG002|Overall Study|Withdrawal Effect|0|||
149032754|NCT01549652|537597440|FG003|Overall Study|Withdrawal Effect|0|||
149032755|NCT01549652|537597437|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
149032756|NCT01549652|537597438|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
149032757|NCT01549652|537597439|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
149032758|NCT01549652|537597440|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
148778355|NCT02294461|536661992|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
148778356|NCT02294461|536661993|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
148778357|NCT02294461|536661994|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
148778358|NCT02000882|536663147|FG000|Overall Study|Adverse Event|3|||
148778359|NCT02000882|536663147|FG000|Overall Study|Physician Decision|2|||
148778360|NCT02000882|536663147|FG000|Overall Study|Withdrawal by Subject|1|||
148778361|NCT00549601|536663148|FG000|Randomized|Protocol Violation|0|||
148778362|NCT00549601|536663149|FG001|Randomized|Protocol Violation|0|||
148778363|NCT00549601|536663150|FG002|Randomized|Protocol Violation|1|||
148778364|NCT00549601|536663148|FG000|Randomized|Withdrawal by Subject|0|||
148778365|NCT00549601|536663149|FG001|Randomized|Withdrawal by Subject|1|||
148778366|NCT00549601|536663150|FG002|Randomized|Withdrawal by Subject|1|||
148778367|NCT00549601|536663148|FG000|Received Study Drug|Adverse Event|2|||
148778368|NCT00549601|536663149|FG001|Received Study Drug|Adverse Event|5|||
148778369|NCT00549601|536663150|FG002|Received Study Drug|Adverse Event|1|||
148778370|NCT00549601|536663148|FG000|Received Study Drug|Death|0|||
148778371|NCT00549601|536663149|FG001|Received Study Drug|Death|1|||
148778372|NCT00549601|536663150|FG002|Received Study Drug|Death|0|||
148778373|NCT00549601|536663148|FG000|Received Study Drug|Lost to Follow-up|0|||
148778374|NCT00549601|536663149|FG001|Received Study Drug|Lost to Follow-up|1|||
148778375|NCT00549601|536663150|FG002|Received Study Drug|Lost to Follow-up|1|||
148778376|NCT00549601|536663148|FG000|Received Study Drug|Protocol Violation|3|||
148871798|NCT02809053|537008101|FG001|Overall Study|Death|1|||
148871799|NCT02809053|537008100|FG000|Overall Study|Lost to Follow-up|3|||
148871800|NCT02809053|537008101|FG001|Overall Study|Lost to Follow-up|1|||
148871801|NCT02809053|537008100|FG000|Overall Study|Withdrawal by Subject|2|||
148871802|NCT02809053|537008101|FG001|Overall Study|Withdrawal by Subject|3|||
148871803|NCT02809053|537008100|FG000|Overall Study|Disease Progression|2|||
148871804|NCT02809053|537008101|FG001|Overall Study|Disease Progression|1|||
148871805|NCT00908037|537008104|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871806|NCT00908037|537008105|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871807|NCT00908037|537008106|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148778377|NCT00549601|536663149|FG001|Received Study Drug|Protocol Violation|4|||
148778378|NCT00549601|536663150|FG002|Received Study Drug|Protocol Violation|1|||
148871808|NCT00908037|537008107|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
149032759|NCT01549652|537597437|FG000|Overall Study|Problem with Infusion|1|||
149032760|NCT01549652|537597438|FG001|Overall Study|Problem with Infusion|0|||
149032761|NCT01549652|537597439|FG002|Overall Study|Problem with Infusion|0|||
149032762|NCT01549652|537597440|FG003|Overall Study|Problem with Infusion|0|||
149032763|NCT01549652|537597437|FG000|Overall Study|Titration Non-Compliance|1|||
148871809|NCT00908037|537008108|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
148871810|NCT00908037|537008109|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871811|NCT00908037|537008110|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
148871812|NCT00908037|537008111|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871813|NCT00908037|537008112|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
148871814|NCT00908037|537008113|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871815|NCT00908037|537008114|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871816|NCT00908037|537008115|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
148871817|NCT00908037|537008104|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871818|NCT00908037|537008105|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871819|NCT00908037|537008106|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871820|NCT00908037|537008107|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871821|NCT00908037|537008108|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
149000657|NCT00989092|537479327|FG001|Overall Study|Other|1|||
149000658|NCT00989092|537479326|FG000|Overall Study|Protocol deviation|2|||
149000659|NCT00989092|537479327|FG001|Overall Study|Protocol deviation|0|||
149000660|NCT00989092|537479326|FG000|Overall Study|Erythropoietin therapy initiated|2|||
149000661|NCT00989092|537479327|FG001|Overall Study|Erythropoietin therapy initiated|0|||
149000662|NCT00989092|537479326|FG000|Overall Study|Did not receive study drug|2|||
149000663|NCT00989092|537479327|FG001|Overall Study|Did not receive study drug|0|||
149000664|NCT02832622|537479329|FG000|Overall Study|MPP not programmed|1259|||
149000665|NCT02832622|537479329|FG000|Overall Study|Withdrawal by Subject|123|||
149000666|NCT02832622|537479329|FG000|Overall Study|Death|119|||
149000667|NCT02832622|537479329|FG000|Overall Study|Unsuccessful CRT implant|93|||
149000668|NCT02832622|537479329|FG000|Overall Study|Lost to Follow-up|45|||
149000669|NCT02832622|537479329|FG000|Overall Study|Patient non-compliance|42|||
149000670|NCT02832622|537479329|FG000|Overall Study|Withdrawal by other reasons|25|||
149000671|NCT02832622|537479329|FG000|Overall Study|System explant|24|||
149000672|NCT02832622|537479329|FG000|Overall Study|Physician Decision|6|||
149000673|NCT04586569|537479330|FG000|Overall Study|Withdrawal by Subject|0|||
149000674|NCT04586569|537479331|FG001|Overall Study|Withdrawal by Subject|2|||
149000675|NCT04586569|537479330|FG000|Overall Study|No longer eligible|2|||
149000676|NCT04586569|537479331|FG001|Overall Study|No longer eligible|3|||
149000677|NCT04586569|537479330|FG000|Overall Study|Physician Decision|1|||
149000678|NCT04586569|537479331|FG001|Overall Study|Physician Decision|0|||
149000679|NCT02127372|537479333|FG000|Overall Study|Withdrawal by Subject|1|||
149000680|NCT02127372|537479334|FG001|Overall Study|Withdrawal by Subject|0|||
149000681|NCT02173548|537479335|FG000|Overall Study|Lost to Follow-up|0|||
149000682|NCT02173548|537479336|FG001|Overall Study|Lost to Follow-up|2|||
149000683|NCT02173548|537479335|FG000|Overall Study|Withdrawal by Subject|1|||
149000684|NCT02173548|537479336|FG001|Overall Study|Withdrawal by Subject|0|||
149000685|NCT03548207|537479339|FG000|Overall Study|Death|10|||
149000686|NCT03548207|537479340|FG001|Overall Study|Death|23|||
149000687|NCT03548207|537479341|FG002|Overall Study|Death|3|||
149000688|NCT03548207|537479339|FG000|Overall Study|Lost to Follow-up|0|||
149000689|NCT03548207|537479340|FG001|Overall Study|Lost to Follow-up|2|||
149000690|NCT03548207|537479341|FG002|Overall Study|Lost to Follow-up|0|||
149000691|NCT03548207|537479339|FG000|Overall Study|Withdrawal by Subject|0|||
149000692|NCT03548207|537479340|FG001|Overall Study|Withdrawal by Subject|3|||
149000693|NCT03548207|537479341|FG002|Overall Study|Withdrawal by Subject|0|||
149000694|NCT03548207|537479339|FG000|Overall Study|Sponsor decision|19|||
149000695|NCT03548207|537479340|FG001|Overall Study|Sponsor decision|40|||
149000696|NCT03548207|537479341|FG002|Overall Study|Sponsor decision|6|||
149000697|NCT03548207|537479339|FG000|Overall Study|Randomized but not treated|6|||
149000698|NCT03548207|537479340|FG001|Overall Study|Randomized but not treated|10|||
149000699|NCT03548207|537479341|FG002|Overall Study|Randomized but not treated|4|||
149000700|NCT01756352|537479342|FG000|Overall Study|moved away and lost to followup|1|||
149000701|NCT03822117|537479343|FG000|Overall Study|Death|18|||
149000702|NCT03822117|537479344|FG001|Overall Study|Death|17|||
149000703|NCT03822117|537479345|FG002|Overall Study|Death|12|||
149000704|NCT03822117|537479346|FG003|Overall Study|Death|4|||
149000705|NCT03822117|537479343|FG000|Overall Study|Lost to Follow-up|1|||
149000706|NCT03822117|537479344|FG001|Overall Study|Lost to Follow-up|2|||
149000707|NCT03822117|537479345|FG002|Overall Study|Lost to Follow-up|3|||
149000708|NCT03822117|537479346|FG003|Overall Study|Lost to Follow-up|0|||
149000709|NCT03822117|537479343|FG000|Overall Study|Study Terminated by Sponsor|25|||
149000710|NCT03822117|537479344|FG001|Overall Study|Study Terminated by Sponsor|11|||
149000711|NCT03822117|537479345|FG002|Overall Study|Study Terminated by Sponsor|6|||
149000712|NCT03822117|537479346|FG003|Overall Study|Study Terminated by Sponsor|0|||
149000713|NCT03822117|537479343|FG000|Overall Study|Withdrawal by Subject|4|||
149000714|NCT03822117|537479344|FG001|Overall Study|Withdrawal by Subject|0|||
149000715|NCT03822117|537479345|FG002|Overall Study|Withdrawal by Subject|3|||
149000716|NCT03822117|537479346|FG003|Overall Study|Withdrawal by Subject|0|||
149000717|NCT03822117|537479343|FG000|Overall Study|Disease Progression|1|||
149032764|NCT01549652|537597438|FG001|Overall Study|Titration Non-Compliance|3|||
149032765|NCT01549652|537597439|FG002|Overall Study|Titration Non-Compliance|4|||
149032766|NCT01549652|537597440|FG003|Overall Study|Titration Non-Compliance|5|||
149032767|NCT01549652|537597437|FG000|Overall Study|Titration Side Effects|0|||
149032768|NCT01549652|537597438|FG001|Overall Study|Titration Side Effects|0|||
149032769|NCT01549652|537597439|FG002|Overall Study|Titration Side Effects|6|||
149032770|NCT01549652|537597440|FG003|Overall Study|Titration Side Effects|3|||
149032771|NCT01549652|537597437|FG000|Overall Study|Withdrawal by Subject|0|||
149032772|NCT01549652|537597438|FG001|Overall Study|Withdrawal by Subject|0|||
149032773|NCT01549652|537597439|FG002|Overall Study|Withdrawal by Subject|5|||
149032774|NCT01549652|537597440|FG003|Overall Study|Withdrawal by Subject|3|||
149032775|NCT00559949|537597441|FG000|Overall Study|Progressive Disease during cycle 1|1|||
149032776|NCT00559949|537597441|FG000|Overall Study|Adverse Event|1|||
149032777|NCT00559949|537597441|FG000|Overall Study|Withdrawal by Subject|4|||
149032778|NCT00559949|537597441|FG000|Overall Study|No disease evaluation per protocol|1|||
149032779|NCT00835380|537597449|FG000|Overall Study|Withdrawal by Subject|2|||
149032780|NCT03247543|537597450|FG000|Overall Study|Adverse Event|3|||
149032781|NCT03247543|537597451|FG001|Overall Study|Adverse Event|6|||
149032782|NCT03247543|537597452|FG002|Overall Study|Adverse Event|4|||
149032783|NCT03247543|537597450|FG000|Overall Study|Lost to Follow-up|10|||
149032784|NCT03247543|537597451|FG001|Overall Study|Lost to Follow-up|7|||
149032785|NCT03247543|537597452|FG002|Overall Study|Lost to Follow-up|8|||
149032786|NCT03247543|537597450|FG000|Overall Study|Consent withdrawn by caregiver|2|||
149032787|NCT03247543|537597451|FG001|Overall Study|Consent withdrawn by caregiver|2|||
149032788|NCT03247543|537597452|FG002|Overall Study|Consent withdrawn by caregiver|9|||
149032789|NCT03247543|537597450|FG000|Overall Study|Withdrawal by Subject|0|||
149032790|NCT03247543|537597451|FG001|Overall Study|Withdrawal by Subject|0|||
149032791|NCT03247543|537597452|FG002|Overall Study|Withdrawal by Subject|1|||
149032792|NCT03247543|537597450|FG000|Overall Study|Failure to Follow study procedures|1|||
149032793|NCT03247543|537597451|FG001|Overall Study|Failure to Follow study procedures|3|||
149032794|NCT03247543|537597452|FG002|Overall Study|Failure to Follow study procedures|1|||
149032795|NCT03247543|537597450|FG000|Overall Study|Lack of Efficacy|1|||
149032796|NCT03247543|537597451|FG001|Overall Study|Lack of Efficacy|0|||
149032797|NCT03247543|537597452|FG002|Overall Study|Lack of Efficacy|0|||
149032798|NCT03247543|537597450|FG000|Overall Study|Non-compliance with study visits|0|||
149032799|NCT03247543|537597451|FG001|Overall Study|Non-compliance with study visits|1|||
149032800|NCT03247543|537597452|FG002|Overall Study|Non-compliance with study visits|0|||
149032801|NCT02059980|537597456|FG000|Overall Study|Lost to Follow-up|2|||
149032802|NCT02059980|537597457|FG001|Overall Study|Lost to Follow-up|1|||
149032803|NCT01104415|537597458|FG000|Core Phase|Consent withdrawn by subjects|1|||
149032804|NCT01104415|537597459|FG001|Core Phase|Consent withdrawn by subjects|0|||
149032805|NCT01104415|537597458|FG000|Extension Period|Progressive disease|0|||
149032806|NCT01104415|537597459|FG001|Extension Period|Progressive disease|4|||
149032807|NCT01104415|537597458|FG000|Extension Period|Death|0|||
149032808|NCT01104415|537597459|FG001|Extension Period|Death|1|||
149032809|NCT01104415|537597458|FG000|Extension Period|Physician Decision|0|||
149032810|NCT01104415|537597459|FG001|Extension Period|Physician Decision|1|||
149032811|NCT01104415|537597458|FG000|Extension Period|Transition to Study LX1606.302|0|||
149032812|NCT01104415|537597459|FG001|Extension Period|Transition to Study LX1606.302|4|||
149032813|NCT01104415|537597458|FG000|Extension Period|Heart surgery/feeling miserable|0|||
149032814|NCT01104415|537597459|FG001|Extension Period|Heart surgery/feeling miserable|1|||
149032815|NCT01582945|537597461|FG000|Overall Study|Intolerable side-effects|1|||
149032816|NCT01582945|537597461|FG000|Overall Study|Scheduling conflicts|1|||
149032817|NCT01726023|537597462|FG000|Overall Study|Death|1|||
149032818|NCT01726023|537597463|FG001|Overall Study|Death|1|||
149032819|NCT01726023|537597462|FG000|Overall Study|Lost to Follow-up|5|||
149032820|NCT01726023|537597463|FG001|Overall Study|Lost to Follow-up|10|||
149032821|NCT01726023|537597462|FG000|Overall Study|Other Eligibility criteria|7|||
149032822|NCT01726023|537597463|FG001|Overall Study|Other Eligibility criteria|7|||
149032823|NCT01726023|537597462|FG000|Overall Study|Withdrawal by Subject|16|||
149032824|NCT01726023|537597463|FG001|Overall Study|Withdrawal by Subject|8|||
149032825|NCT04858425|537597464|FG000|Overall Study|Adverse Event|2|||
149032826|NCT04858425|537597465|FG001|Overall Study|Adverse Event|2|||
149032827|NCT04858425|537597464|FG000|Overall Study|Withdrawal by Subject|3|||
149032828|NCT04858425|537597465|FG001|Overall Study|Withdrawal by Subject|1|||
149032829|NCT04858425|537597464|FG000|Overall Study|Lost to Follow-up|4|||
149032830|NCT04858425|537597465|FG001|Overall Study|Lost to Follow-up|2|||
149032831|NCT04858425|537597464|FG000|Overall Study|Lost to Follow-up|1|||
149032832|NCT04858425|537597465|FG001|Overall Study|Lost to Follow-up|0|||
149032833|NCT02824432|537597467|FG000|Overall Study|Major Protocol Deviation|1|||
149032834|NCT02824432|537597468|FG001|Overall Study|Major Protocol Deviation|0|||
149032835|NCT05196737|537597470|FG000|Non-intervention Week|Lost to Follow-up|2|||
149032836|NCT05196737|537597470|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
149032837|NCT05824351|537597471|FG000|Overall Study|Adverse Event|6|||
149032838|NCT00828945|537597472|FG000|Overall Study|Death|4|||
149032839|NCT00828945|537597472|FG000|Overall Study|Participant was missing|1|||
149032840|NCT00828945|537597472|FG000|Overall Study|Other|36|||
149032841|NCT02698241|537597475|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
149032842|NCT02698241|537597475|FG000|Overall Study|Screening not met|7|||
149032843|NCT02698241|537597475|FG000|Overall Study|Withdrawal by Subject|7|||
149032844|NCT02698241|537597475|FG000|Overall Study|Physician Decision|2|||
149032845|NCT02698241|537597475|FG000|Overall Study|Subject underwent system modification|2|||
149032846|NCT02698241|537597475|FG000|Overall Study|Lost to Follow-up|3|||
149032847|NCT02698241|537597475|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
149032848|NCT02698241|537597475|FG000|Overall Study|geographic and licensing issue|1|||
149032849|NCT02698241|537597475|FG000|Overall Study|Death|2|||
149032850|NCT03722446|537597476|FG000|Overall Study|Protocol Violation|15|||
149032851|NCT03722446|537597477|FG001|Overall Study|Protocol Violation|2|||
149032852|NCT01875250|537598920|FG000|Overall Study|Adverse Event|2|||
149032853|NCT01875250|537598921|FG001|Overall Study|Adverse Event|0|||
149032854|NCT03140176|537598927|FG000|Overall Study|Reason missing|23|||
149032855|NCT03140176|537598927|FG000|Overall Study|Death|33|||
149032856|NCT03140176|537598927|FG000|Overall Study|Disease progression|1|||
149032857|NCT03140176|537598927|FG000|Overall Study|Physician Decision|1|||
149032858|NCT03140176|537598927|FG000|Overall Study|Withdrawal by Subject|1|||
149032859|NCT03140176|537598927|FG000|Overall Study|Lost to Follow-up|15|||
149032860|NCT01090024|537598930|FG000|Period 1|Met exclusion criteria|0|||
149032861|NCT01090024|537598931|FG001|Period 1|Met exclusion criteria|0|||
149032862|NCT01090024|537598932|FG002|Period 1|Met exclusion criteria|0|||
149032863|NCT01090024|537598933|FG003|Period 1|Met exclusion criteria|0|||
149032864|NCT01090024|537598934|FG004|Period 1|Met exclusion criteria|0|||
149032865|NCT01090024|537598935|FG005|Period 1|Met exclusion criteria|0|||
149032866|NCT01090024|537598936|FG006|Period 1|Met exclusion criteria|0|||
149032867|NCT01090024|537598937|FG007|Period 1|Met exclusion criteria|0|||
149032868|NCT01090024|537598938|FG008|Period 1|Met exclusion criteria|0|||
149032869|NCT01090024|537598939|FG009|Period 1|Met exclusion criteria|0|||
149032870|NCT01090024|537598940|FG010|Period 1|Met exclusion criteria|0|||
149032871|NCT01090024|537598941|FG011|Period 1|Met exclusion criteria|0|||
149032872|NCT01090024|537598942|FG012|Period 1|Met exclusion criteria|0|||
149032873|NCT01090024|537598943|FG013|Period 1|Met exclusion criteria|0|||
149032874|NCT01090024|537598944|FG014|Period 1|Met exclusion criteria|1|||
149032875|NCT01090024|537598945|FG015|Period 1|Met exclusion criteria|0|||
149032876|NCT01090024|537598946|FG016|Period 1|Met exclusion criteria|0|||
149032877|NCT01090024|537598947|FG017|Period 1|Met exclusion criteria|0|||
149032878|NCT01090024|537598930|FG000|Period 1|Adverse Event|0|||
149032879|NCT01090024|537598931|FG001|Period 1|Adverse Event|0|||
149032880|NCT01090024|537598932|FG002|Period 1|Adverse Event|0|||
149032881|NCT01090024|537598933|FG003|Period 1|Adverse Event|0|||
149032882|NCT01090024|537598934|FG004|Period 1|Adverse Event|0|||
149032883|NCT01090024|537598935|FG005|Period 1|Adverse Event|0|||
149032884|NCT01090024|537598936|FG006|Period 1|Adverse Event|0|||
149032885|NCT01090024|537598937|FG007|Period 1|Adverse Event|0|||
149032886|NCT01090024|537598938|FG008|Period 1|Adverse Event|0|||
149032887|NCT01090024|537598939|FG009|Period 1|Adverse Event|1|||
149032888|NCT01090024|537598940|FG010|Period 1|Adverse Event|0|||
149032889|NCT01090024|537598941|FG011|Period 1|Adverse Event|1|||
149032890|NCT01090024|537598942|FG012|Period 1|Adverse Event|0|||
149032891|NCT01090024|537598943|FG013|Period 1|Adverse Event|0|||
149032892|NCT01090024|537598944|FG014|Period 1|Adverse Event|0|||
149032893|NCT01090024|537598945|FG015|Period 1|Adverse Event|0|||
149032894|NCT01090024|537598946|FG016|Period 1|Adverse Event|0|||
149032895|NCT01090024|537598947|FG017|Period 1|Adverse Event|1|||
149032896|NCT01090024|537598930|FG000|Period 1|Withdrawal by Subject|0|||
149032897|NCT01090024|537598931|FG001|Period 1|Withdrawal by Subject|0|||
149032898|NCT01090024|537598932|FG002|Period 1|Withdrawal by Subject|0|||
149032899|NCT01090024|537598933|FG003|Period 1|Withdrawal by Subject|1|||
149032900|NCT01090024|537598934|FG004|Period 1|Withdrawal by Subject|0|||
149032901|NCT01090024|537598935|FG005|Period 1|Withdrawal by Subject|0|||
149032902|NCT01090024|537598936|FG006|Period 1|Withdrawal by Subject|0|||
149032903|NCT01090024|537598937|FG007|Period 1|Withdrawal by Subject|0|||
149032904|NCT01090024|537598938|FG008|Period 1|Withdrawal by Subject|0|||
149032905|NCT01090024|537598939|FG009|Period 1|Withdrawal by Subject|0|||
149032906|NCT01090024|537598940|FG010|Period 1|Withdrawal by Subject|0|||
149032907|NCT01090024|537598941|FG011|Period 1|Withdrawal by Subject|0|||
149032908|NCT01090024|537598942|FG012|Period 1|Withdrawal by Subject|0|||
149032909|NCT01090024|537598943|FG013|Period 1|Withdrawal by Subject|0|||
149032910|NCT01090024|537598944|FG014|Period 1|Withdrawal by Subject|0|||
149032911|NCT01090024|537598945|FG015|Period 1|Withdrawal by Subject|0|||
149032912|NCT01090024|537598946|FG016|Period 1|Withdrawal by Subject|0|||
149032913|NCT01090024|537598947|FG017|Period 1|Withdrawal by Subject|0|||
149032914|NCT01090024|537598930|FG000|Period 1|Lost to Follow-up|0|||
149032915|NCT01090024|537598931|FG001|Period 1|Lost to Follow-up|1|||
149032916|NCT01090024|537598932|FG002|Period 1|Lost to Follow-up|0|||
149032917|NCT01090024|537598933|FG003|Period 1|Lost to Follow-up|0|||
149032918|NCT01090024|537598934|FG004|Period 1|Lost to Follow-up|0|||
149032919|NCT01090024|537598935|FG005|Period 1|Lost to Follow-up|0|||
149032920|NCT01090024|537598936|FG006|Period 1|Lost to Follow-up|0|||
149032921|NCT01090024|537598937|FG007|Period 1|Lost to Follow-up|0|||
149032922|NCT01090024|537598938|FG008|Period 1|Lost to Follow-up|0|||
149032923|NCT01090024|537598939|FG009|Period 1|Lost to Follow-up|0|||
149032924|NCT01090024|537598940|FG010|Period 1|Lost to Follow-up|0|||
149032925|NCT01090024|537598941|FG011|Period 1|Lost to Follow-up|0|||
149032926|NCT01090024|537598942|FG012|Period 1|Lost to Follow-up|0|||
149032927|NCT01090024|537598943|FG013|Period 1|Lost to Follow-up|0|||
149032928|NCT01090024|537598944|FG014|Period 1|Lost to Follow-up|0|||
149032929|NCT01090024|537598945|FG015|Period 1|Lost to Follow-up|0|||
149032930|NCT01090024|537598946|FG016|Period 1|Lost to Follow-up|0|||
149032931|NCT01090024|537598947|FG017|Period 1|Lost to Follow-up|0|||
149032932|NCT01090024|537598930|FG000|Period 2|Lost to Follow-up|0|||
149032933|NCT01090024|537598931|FG001|Period 2|Lost to Follow-up|0|||
149032934|NCT01090024|537598932|FG002|Period 2|Lost to Follow-up|0|||
149032935|NCT01090024|537598933|FG003|Period 2|Lost to Follow-up|1|||
149032936|NCT01090024|537598934|FG004|Period 2|Lost to Follow-up|0|||
149032937|NCT01090024|537598935|FG005|Period 2|Lost to Follow-up|0|||
149032938|NCT01090024|537598936|FG006|Period 2|Lost to Follow-up|0|||
149032939|NCT01090024|537598937|FG007|Period 2|Lost to Follow-up|0|||
149032940|NCT01090024|537598938|FG008|Period 2|Lost to Follow-up|0|||
149032941|NCT01090024|537598939|FG009|Period 2|Lost to Follow-up|0|||
149032942|NCT01090024|537598940|FG010|Period 2|Lost to Follow-up|0|||
149032943|NCT01090024|537598941|FG011|Period 2|Lost to Follow-up|0|||
149032944|NCT01090024|537598942|FG012|Period 2|Lost to Follow-up|0|||
149032945|NCT01090024|537598943|FG013|Period 2|Lost to Follow-up|0|||
149032946|NCT01090024|537598944|FG014|Period 2|Lost to Follow-up|0|||
149032947|NCT01090024|537598945|FG015|Period 2|Lost to Follow-up|0|||
149032948|NCT01090024|537598946|FG016|Period 2|Lost to Follow-up|0|||
149032949|NCT01090024|537598947|FG017|Period 2|Lost to Follow-up|0|||
149032950|NCT01090024|537598930|FG000|Period 2|Adverse Event|1|||
149032951|NCT01090024|537598931|FG001|Period 2|Adverse Event|0|||
149032952|NCT01090024|537598932|FG002|Period 2|Adverse Event|0|||
149032953|NCT01090024|537598933|FG003|Period 2|Adverse Event|0|||
149032954|NCT01090024|537598934|FG004|Period 2|Adverse Event|0|||
149032955|NCT01090024|537598935|FG005|Period 2|Adverse Event|0|||
149032956|NCT01090024|537598936|FG006|Period 2|Adverse Event|0|||
149032957|NCT01090024|537598937|FG007|Period 2|Adverse Event|0|||
149032958|NCT01090024|537598938|FG008|Period 2|Adverse Event|0|||
149032959|NCT01090024|537598939|FG009|Period 2|Adverse Event|0|||
149032960|NCT01090024|537598940|FG010|Period 2|Adverse Event|0|||
149032961|NCT01090024|537598941|FG011|Period 2|Adverse Event|0|||
149032962|NCT01090024|537598942|FG012|Period 2|Adverse Event|0|||
149032963|NCT01090024|537598943|FG013|Period 2|Adverse Event|0|||
149032964|NCT01090024|537598944|FG014|Period 2|Adverse Event|0|||
149032965|NCT01090024|537598945|FG015|Period 2|Adverse Event|0|||
149032966|NCT01090024|537598946|FG016|Period 2|Adverse Event|0|||
149032967|NCT01090024|537598947|FG017|Period 2|Adverse Event|0|||
149032968|NCT01090024|537598930|FG000|Period 3|Withdrawal by Subject|0|||
149032969|NCT01090024|537598931|FG001|Period 3|Withdrawal by Subject|0|||
149032970|NCT01090024|537598932|FG002|Period 3|Withdrawal by Subject|0|||
149032971|NCT01090024|537598933|FG003|Period 3|Withdrawal by Subject|0|||
149032972|NCT01090024|537598934|FG004|Period 3|Withdrawal by Subject|0|||
149032973|NCT01090024|537598935|FG005|Period 3|Withdrawal by Subject|0|||
149032974|NCT01090024|537598936|FG006|Period 3|Withdrawal by Subject|0|||
149032975|NCT01090024|537598937|FG007|Period 3|Withdrawal by Subject|0|||
149032976|NCT01090024|537598938|FG008|Period 3|Withdrawal by Subject|0|||
149032977|NCT01090024|537598939|FG009|Period 3|Withdrawal by Subject|0|||
149032978|NCT01090024|537598940|FG010|Period 3|Withdrawal by Subject|0|||
149032979|NCT01090024|537598941|FG011|Period 3|Withdrawal by Subject|0|||
149032980|NCT01090024|537598942|FG012|Period 3|Withdrawal by Subject|0|||
149032981|NCT01090024|537598943|FG013|Period 3|Withdrawal by Subject|0|||
149032982|NCT01090024|537598944|FG014|Period 3|Withdrawal by Subject|0|||
149032983|NCT01090024|537598945|FG015|Period 3|Withdrawal by Subject|1|||
149032984|NCT01090024|537598946|FG016|Period 3|Withdrawal by Subject|0|||
148871822|NCT00908037|537008109|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871823|NCT00908037|537008110|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
149032985|NCT01090024|537598947|FG017|Period 3|Withdrawal by Subject|0|||
149032986|NCT01090024|537598930|FG000|Period 3|Protocol Violation|0|||
149032987|NCT01090024|537598931|FG001|Period 3|Protocol Violation|0|||
149032988|NCT01090024|537598932|FG002|Period 3|Protocol Violation|0|||
148871824|NCT00908037|537008111|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871825|NCT00908037|537008112|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
148871826|NCT00908037|537008113|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
149032989|NCT01090024|537598933|FG003|Period 3|Protocol Violation|0|||
149032990|NCT01090024|537598934|FG004|Period 3|Protocol Violation|0|||
149032991|NCT01090024|537598935|FG005|Period 3|Protocol Violation|0|||
149032992|NCT01090024|537598936|FG006|Period 3|Protocol Violation|0|||
149032993|NCT01090024|537598937|FG007|Period 3|Protocol Violation|0|||
149032994|NCT01090024|537598938|FG008|Period 3|Protocol Violation|1|||
149032995|NCT01090024|537598939|FG009|Period 3|Protocol Violation|0|||
149032996|NCT01090024|537598940|FG010|Period 3|Protocol Violation|0|||
149032997|NCT01090024|537598941|FG011|Period 3|Protocol Violation|0|||
149032998|NCT01090024|537598942|FG012|Period 3|Protocol Violation|0|||
149032999|NCT01090024|537598943|FG013|Period 3|Protocol Violation|0|||
149033000|NCT01090024|537598944|FG014|Period 3|Protocol Violation|0|||
149033001|NCT01090024|537598945|FG015|Period 3|Protocol Violation|0|||
149033002|NCT01090024|537598946|FG016|Period 3|Protocol Violation|0|||
149033003|NCT01090024|537598947|FG017|Period 3|Protocol Violation|0|||
149033004|NCT01090024|537598930|FG000|Period 3|Adverse Event|0|||
149033005|NCT01090024|537598931|FG001|Period 3|Adverse Event|0|||
149033006|NCT01090024|537598932|FG002|Period 3|Adverse Event|0|||
149033007|NCT01090024|537598933|FG003|Period 3|Adverse Event|0|||
149033008|NCT01090024|537598934|FG004|Period 3|Adverse Event|0|||
149033009|NCT01090024|537598935|FG005|Period 3|Adverse Event|1|||
149033010|NCT01090024|537598936|FG006|Period 3|Adverse Event|0|||
149033011|NCT01090024|537598937|FG007|Period 3|Adverse Event|0|||
149033012|NCT01090024|537598938|FG008|Period 3|Adverse Event|0|||
149033013|NCT01090024|537598939|FG009|Period 3|Adverse Event|0|||
149033014|NCT01090024|537598940|FG010|Period 3|Adverse Event|0|||
149033015|NCT01090024|537598941|FG011|Period 3|Adverse Event|0|||
149033016|NCT01090024|537598942|FG012|Period 3|Adverse Event|0|||
149033017|NCT01090024|537598943|FG013|Period 3|Adverse Event|0|||
149033018|NCT01090024|537598944|FG014|Period 3|Adverse Event|0|||
149033019|NCT01090024|537598945|FG015|Period 3|Adverse Event|0|||
149033020|NCT01090024|537598946|FG016|Period 3|Adverse Event|0|||
149033021|NCT01090024|537598947|FG017|Period 3|Adverse Event|0|||
149033022|NCT00567879|537598948|FG000|Overall Study|Adverse Event|2|||
149033023|NCT00567879|537598949|FG001|Overall Study|Adverse Event|0|||
149033024|NCT00567879|537598950|FG002|Overall Study|Adverse Event|1|||
149033025|NCT00567879|537598951|FG003|Overall Study|Adverse Event|0|||
149033026|NCT00567879|537598952|FG004|Overall Study|Adverse Event|1|||
149033027|NCT00567879|537598953|FG005|Overall Study|Adverse Event|0|||
149033028|NCT00567879|537598948|FG000|Overall Study|Abnormal test procedure(s)|0|||
149033029|NCT00567879|537598949|FG001|Overall Study|Abnormal test procedure(s)|0|||
149033030|NCT00567879|537598950|FG002|Overall Study|Abnormal test procedure(s)|1|||
149033031|NCT00567879|537598951|FG003|Overall Study|Abnormal test procedure(s)|0|||
149033032|NCT00567879|537598952|FG004|Overall Study|Abnormal test procedure(s)|0|||
149033033|NCT00567879|537598953|FG005|Overall Study|Abnormal test procedure(s)|0|||
149033034|NCT00567879|537598948|FG000|Overall Study|Withdrawal by Subject|0|||
149033035|NCT00567879|537598949|FG001|Overall Study|Withdrawal by Subject|0|||
149033036|NCT00567879|537598950|FG002|Overall Study|Withdrawal by Subject|3|||
149033037|NCT00567879|537598951|FG003|Overall Study|Withdrawal by Subject|1|||
149033038|NCT00567879|537598952|FG004|Overall Study|Withdrawal by Subject|0|||
149033039|NCT00567879|537598953|FG005|Overall Study|Withdrawal by Subject|0|||
149033040|NCT00567879|537598948|FG000|Overall Study|New cancer therapy|0|||
149033041|NCT00567879|537598949|FG001|Overall Study|New cancer therapy|0|||
148778379|NCT00549601|536663148|FG000|Received Study Drug|Withdrawal by Subject|2|||
148778380|NCT00549601|536663149|FG001|Received Study Drug|Withdrawal by Subject|0|||
148778381|NCT00549601|536663150|FG002|Received Study Drug|Withdrawal by Subject|1|||
148778382|NCT00908596|536663154|FG000|Overall Study|Other reasons|46|||
148778383|NCT00908596|536663155|FG001|Overall Study|Other reasons|6|||
148778384|NCT00908596|536663156|FG002|Overall Study|Other reasons|2|||
149033042|NCT00567879|537598950|FG002|Overall Study|New cancer therapy|1|||
149033043|NCT00567879|537598951|FG003|Overall Study|New cancer therapy|0|||
149033044|NCT00567879|537598952|FG004|Overall Study|New cancer therapy|0|||
149033045|NCT00567879|537598953|FG005|Overall Study|New cancer therapy|0|||
148778385|NCT00908596|536663157|FG003|Overall Study|Other reasons|0|||
148778386|NCT00908596|536663154|FG000|Overall Study|Lost to Follow-up|0|||
148778387|NCT00908596|536663155|FG001|Overall Study|Lost to Follow-up|1|||
148778388|NCT00908596|536663156|FG002|Overall Study|Lost to Follow-up|12|||
148778389|NCT00908596|536663157|FG003|Overall Study|Lost to Follow-up|4|||
148778390|NCT00908596|536663154|FG000|Overall Study|Death|0|||
148778391|NCT00908596|536663155|FG001|Overall Study|Death|5|||
148871827|NCT00908037|537008114|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148778392|NCT00908596|536663156|FG002|Overall Study|Death|57|||
148778393|NCT00908596|536663157|FG003|Overall Study|Death|32|||
148778394|NCT00908596|536663154|FG000|Overall Study|Protocol Violation|1|||
148778395|NCT00908596|536663155|FG001|Overall Study|Protocol Violation|0|||
148871828|NCT00908037|537008115|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
148871829|NCT00908037|537008104|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871830|NCT00908037|537008105|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148778396|NCT00908596|536663156|FG002|Overall Study|Protocol Violation|0|||
148778397|NCT00908596|536663157|FG003|Overall Study|Protocol Violation|0|||
148778398|NCT00908596|536663154|FG000|Overall Study|Withdrawal by Subject|0|||
148778399|NCT00908596|536663155|FG001|Overall Study|Withdrawal by Subject|1|||
148778400|NCT00908596|536663156|FG002|Overall Study|Withdrawal by Subject|3|||
148778401|NCT00908596|536663157|FG003|Overall Study|Withdrawal by Subject|1|||
148778402|NCT00224406|536663158|FG000|Overall Study|Re-transplant|0|||
149033046|NCT00567879|537598948|FG000|Overall Study|Disease progression|5|||
149033047|NCT00567879|537598949|FG001|Overall Study|Disease progression|7|||
149033048|NCT00567879|537598950|FG002|Overall Study|Disease progression|15|||
149033049|NCT00567879|537598951|FG003|Overall Study|Disease progression|5|||
149000718|NCT03822117|537479344|FG001|Overall Study|Disease Progression|2|||
149000719|NCT03822117|537479345|FG002|Overall Study|Disease Progression|1|||
149000720|NCT03822117|537479346|FG003|Overall Study|Disease Progression|0|||
149000721|NCT03822117|537479343|FG000|Overall Study|Never Returned to Hospital|0|||
149000722|NCT03822117|537479344|FG001|Overall Study|Never Returned to Hospital|0|||
149000723|NCT03822117|537479345|FG002|Overall Study|Never Returned to Hospital|1|||
149000724|NCT03822117|537479346|FG003|Overall Study|Never Returned to Hospital|0|||
149000725|NCT00415610|537479347|FG000|Overall Study|Death|3|||
149000726|NCT00415610|537479348|FG001|Overall Study|Death|2|||
149000727|NCT00415610|537479349|FG002|Overall Study|Death|5|||
149000728|NCT00337272|537479351|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
149000729|NCT00337272|537479352|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
149000730|NCT00337272|537479351|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
149000731|NCT00337272|537479352|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
149000732|NCT00337272|537479351|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
149000733|NCT00337272|537479352|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
149000734|NCT00337272|537479351|FG000|Treatment Period|Non-compliance|1|||
149000735|NCT00337272|537479352|FG001|Treatment Period|Non-compliance|1|||
149000736|NCT00337272|537479351|FG000|Treatment Period|Withdrawal by Subject|0|||
149000737|NCT00337272|537479352|FG001|Treatment Period|Withdrawal by Subject|1|||
149000738|NCT00337272|537479351|FG000|Withdrawal Period|Non-compliance|0|||
149000739|NCT00337272|537479352|FG001|Withdrawal Period|Non-compliance|1|||
149000740|NCT04539821|537479356|FG000|Overall Study|Withdrawal by Subject|2|||
149000741|NCT04539821|537479356|FG000|Overall Study|continued care with their physician|20|||
149000742|NCT04539821|537479356|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
149000743|NCT01127646|537479359|FG000|Overall Study|Entry Criteria Not Met|1|||
149000744|NCT01127646|537479360|FG001|Overall Study|Entry Criteria Not Met|0|||
149000745|NCT01127646|537479359|FG000|Overall Study|Protocol Violation|0|||
149000746|NCT01127646|537479360|FG001|Overall Study|Protocol Violation|1|||
149000747|NCT03466086|537479361|FG000|Period 1|Sponsor decision due to study timeline|1|||
149000748|NCT03466086|537479362|FG001|Period 1|Sponsor decision due to study timeline|0|||
149000749|NCT03466086|537479361|FG000|Period 1|Withdrawal by Subject|1|||
149000750|NCT03466086|537479362|FG001|Period 1|Withdrawal by Subject|0|||
149000751|NCT01754467|537479363|FG000|Overall Study|Lost to Follow-up|1|||
149000752|NCT01970462|537479364|FG000|Overall Study|Lost to Follow-up|0|||
149000753|NCT01970462|537479365|FG001|Overall Study|Lost to Follow-up|2|||
149000754|NCT03802123|537479366|FG000|Overall Study|Withdrawal by Subject|3|||
149000755|NCT03802123|537479366|FG000|Overall Study|Physician Decision|1|||
149000756|NCT03802123|537479366|FG000|Overall Study|Subject moved to hospice care|1|||
149000757|NCT03802123|537479366|FG000|Overall Study|technician error|1|||
149000758|NCT03802123|537479366|FG000|Overall Study|Death|3|||
149000759|NCT04495179|537479371|FG000|Overall Study|Lost to Follow-up|0|||
149000760|NCT04495179|537479372|FG001|Overall Study|Lost to Follow-up|1|||
149000761|NCT04495179|537479371|FG000|Overall Study|Withdrawal by Subject|2|||
149000762|NCT04495179|537479372|FG001|Overall Study|Withdrawal by Subject|4|||
149000763|NCT04495179|537479371|FG000|Overall Study|Study terminated by sponsor|0|||
149000764|NCT04495179|537479372|FG001|Overall Study|Study terminated by sponsor|18|||
149000765|NCT04495179|537479371|FG000|Overall Study|Death|0|||
149000766|NCT04495179|537479372|FG001|Overall Study|Death|4|||
149000767|NCT04495179|537479371|FG000|Overall Study|Adverse Event|0|||
149000768|NCT04495179|537479372|FG001|Overall Study|Adverse Event|1|||
149000769|NCT00162370|537479373|FG000|Efficacy Population|Lost to Follow-up|51|||
149000770|NCT00569582|537479374|FG000|Overall Study|Withdrawal by Subject|5|||
149000771|NCT00569582|537479374|FG000|Overall Study|Death|2|||
149000772|NCT00569582|537479374|FG000|Overall Study|Adverse Event|7|||
149000773|NCT00569582|537479374|FG000|Overall Study|Subject was too ill to travel.|1|||
149000774|NCT00569582|537479374|FG000|Overall Study|Subject was non-compliant.|1|||
149000775|NCT00810264|537479382|FG000|Overall Study|Lost to Follow-up|191|||
149000776|NCT00810264|537479382|FG000|Overall Study|Withdrawal by subject or physician|721|||
149000777|NCT00810264|537479382|FG000|Overall Study|Death|641|||
149000778|NCT05380947|537479383|FG000|Washout Period 1|Not attend visit|1|||
149000779|NCT05380947|537479384|FG001|Washout Period 1|Not attend visit|0|||
149000780|NCT05380947|537479385|FG002|Washout Period 1|Not attend visit|0|||
149000781|NCT05380947|537479386|FG003|Washout Period 1|Not attend visit|0|||
149000782|NCT05380947|537479383|FG000|Washout Period 2|Adverse Event|1|||
149000783|NCT05380947|537479384|FG001|Washout Period 2|Adverse Event|0|||
149000784|NCT05380947|537479385|FG002|Washout Period 2|Adverse Event|0|||
149000785|NCT05380947|537479386|FG003|Washout Period 2|Adverse Event|0|||
149000786|NCT05380947|537479383|FG000|Washout Period 3|Adverse Event|0|||
149000787|NCT05380947|537479384|FG001|Washout Period 3|Adverse Event|1|||
149000788|NCT05380947|537479385|FG002|Washout Period 3|Adverse Event|0|||
149000789|NCT05380947|537479386|FG003|Washout Period 3|Adverse Event|0|||
149000790|NCT05380947|537479383|FG000|Washout Period 3|Not attend visit|0|||
149000791|NCT05380947|537479384|FG001|Washout Period 3|Not attend visit|1|||
149000792|NCT05380947|537479385|FG002|Washout Period 3|Not attend visit|0|||
149000793|NCT05380947|537479386|FG003|Washout Period 3|Not attend visit|1|||
149000794|NCT01563536|537479387|FG000|Overall Study|Withdrawal by Subject|0|||
149000795|NCT01563536|537479388|FG001|Overall Study|Withdrawal by Subject|2|||
148778403|NCT00224406|536663159|FG001|Overall Study|Re-transplant|2|||
148778404|NCT00224406|536663158|FG000|Overall Study|Death|0|||
148778405|NCT00224406|536663159|FG001|Overall Study|Death|1|||
148778406|NCT00224406|536663158|FG000|Overall Study|Transplant cancelled|0|||
148778407|NCT00224406|536663159|FG001|Overall Study|Transplant cancelled|4|||
148778408|NCT00224406|536663158|FG000|Overall Study|Drug not delivered|2|||
148778409|NCT00224406|536663159|FG001|Overall Study|Drug not delivered|0|||
148778410|NCT00224406|536663158|FG000|Overall Study|Other|4|||
148778411|NCT00224406|536663159|FG001|Overall Study|Other|0|||
148778412|NCT00224406|536663158|FG000|Overall Study|Transplant cancelled|3|||
148778413|NCT00224406|536663159|FG001|Overall Study|Transplant cancelled|0|||
148778414|NCT01556997|536663162|FG000|Overall Study|Adverse Event|10|||
148778415|NCT01556997|536663163|FG001|Overall Study|Adverse Event|12|||
148778416|NCT01556997|536663164|FG002|Overall Study|Adverse Event|12|||
148778417|NCT01556997|536663162|FG000|Overall Study|Lost to Follow-up|6|||
148778418|NCT01556997|536663163|FG001|Overall Study|Lost to Follow-up|6|||
148778419|NCT01556997|536663164|FG002|Overall Study|Lost to Follow-up|4|||
148778420|NCT01556997|536663162|FG000|Overall Study|Physician Decision|1|||
148778421|NCT01556997|536663163|FG001|Overall Study|Physician Decision|1|||
148778422|NCT01556997|536663164|FG002|Overall Study|Physician Decision|1|||
148778423|NCT01556997|536663162|FG000|Overall Study|Withdrawal by Subject|7|||
148778424|NCT01556997|536663163|FG001|Overall Study|Withdrawal by Subject|6|||
148778425|NCT01556997|536663164|FG002|Overall Study|Withdrawal by Subject|8|||
148778426|NCT01556997|536663162|FG000|Overall Study|Other|2|||
148778427|NCT01556997|536663163|FG001|Overall Study|Other|3|||
148778428|NCT01556997|536663164|FG002|Overall Study|Other|7|||
148778429|NCT03309696|536663169|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
148778430|NCT03309696|536663170|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
148778431|NCT03309696|536663171|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
148778432|NCT03309696|536663172|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
148778433|NCT02949908|536663173|FG000|Overall Study|Study termination|2|||
148778434|NCT02607280|536663174|FG000|Overall Study|Adverse Event|4|||
148778435|NCT02607280|536663175|FG001|Overall Study|Adverse Event|0|||
148778436|NCT02607280|536663174|FG000|Overall Study|Decrease in CrCl <15|0|||
148778437|NCT02607280|536663175|FG001|Overall Study|Decrease in CrCl <15|1|||
148778438|NCT00078949|536663176|FG000|Overall Study|No treated|4|||
148778439|NCT00078949|536663177|FG001|Overall Study|No treated|5|||
148778440|NCT00078949|536663178|FG002|Overall Study|No treated|3|||
148778441|NCT00078949|536663179|FG003|Overall Study|No treated|3|||
148778442|NCT01004432|536663180|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
148778443|NCT01004432|536663181|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
148778444|NCT01004432|536663182|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
148778445|NCT01004432|536663183|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
148778446|NCT01004432|536663184|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
148778447|NCT01004432|536663180|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
148778448|NCT01004432|536663181|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
148778449|NCT01004432|536663182|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
148778450|NCT01004432|536663183|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
148778451|NCT01004432|536663184|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
148778452|NCT01004432|536663180|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
148778453|NCT01004432|536663181|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
148778454|NCT01004432|536663182|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
148778455|NCT01004432|536663183|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
148778456|NCT01004432|536663184|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
148778457|NCT01004432|536663180|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
148778458|NCT01004432|536663181|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
148778459|NCT01004432|536663182|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
148778460|NCT01004432|536663183|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
148778461|NCT01004432|536663184|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
148871831|NCT00908037|537008106|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871832|NCT00908037|537008107|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
148871833|NCT00908037|537008108|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871834|NCT00908037|537008109|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871835|NCT00908037|537008110|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
148871836|NCT00908037|537008111|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148778462|NCT01004432|536663180|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
148778463|NCT01004432|536663181|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
148778464|NCT01004432|536663182|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
148778465|NCT01004432|536663183|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
148778466|NCT01004432|536663184|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
148778467|NCT01004432|536663180|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
148778468|NCT01004432|536663181|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
148778469|NCT01004432|536663182|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
148778470|NCT01004432|536663183|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
148778471|NCT01004432|536663184|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
148778472|NCT01004432|536663180|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
148778473|NCT01004432|536663181|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
148778474|NCT01004432|536663182|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
148778475|NCT01004432|536663183|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
148778476|NCT01004432|536663184|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
148778477|NCT01004432|536663180|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
148778478|NCT01004432|536663181|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
148778479|NCT01004432|536663182|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
148778480|NCT01004432|536663183|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
148778481|NCT01004432|536663184|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
148778482|NCT01004432|536663180|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
148778483|NCT01004432|536663181|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
148778484|NCT01004432|536663182|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
148778485|NCT01004432|536663183|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
148778486|NCT01004432|536663184|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
148778487|NCT01004432|536663180|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
148778488|NCT01004432|536663181|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
148778489|NCT01004432|536663182|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
148778490|NCT01004432|536663183|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
148778491|NCT01004432|536663184|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
148778492|NCT01004432|536663180|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
148778493|NCT01004432|536663181|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
148778494|NCT01004432|536663182|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
148778495|NCT01004432|536663183|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
148778496|NCT01004432|536663184|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
148778497|NCT01004432|536663180|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
148778498|NCT01004432|536663181|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
148778499|NCT01004432|536663182|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
148871837|NCT00908037|537008112|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871838|NCT00908037|537008113|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871839|NCT00908037|537008114|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871840|NCT00908037|537008115|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
148871841|NCT00908037|537008104|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871842|NCT00908037|537008105|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871843|NCT00908037|537008106|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871844|NCT00908037|537008107|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871845|NCT00908037|537008108|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871846|NCT00908037|537008109|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871847|NCT00908037|537008110|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871848|NCT00908037|537008111|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871849|NCT00908037|537008112|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871850|NCT00908037|537008113|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871851|NCT00908037|537008114|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
148871852|NCT00908037|537008115|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
148871853|NCT00908037|537008104|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871854|NCT00908037|537008105|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871855|NCT00908037|537008106|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871856|NCT00908037|537008107|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871857|NCT00908037|537008108|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871858|NCT00908037|537008109|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871859|NCT00908037|537008110|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871860|NCT00908037|537008111|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871861|NCT00908037|537008112|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871862|NCT00908037|537008113|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
148871863|NCT00908037|537008114|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
148871864|NCT00908037|537008115|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
148871865|NCT00908037|537008104|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871866|NCT00908037|537008105|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871867|NCT00908037|537008106|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871868|NCT00908037|537008107|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871869|NCT00908037|537008108|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871870|NCT00908037|537008109|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871871|NCT00908037|537008110|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871872|NCT00908037|537008111|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871873|NCT00908037|537008112|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871874|NCT00908037|537008113|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
148871875|NCT00908037|537008114|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871876|NCT00908037|537008115|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
148871877|NCT00908037|537008104|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871878|NCT00908037|537008105|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871879|NCT00908037|537008106|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871880|NCT00908037|537008107|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871881|NCT00908037|537008108|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871882|NCT00908037|537008109|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871883|NCT00908037|537008110|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871884|NCT00908037|537008111|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871885|NCT00908037|537008112|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871886|NCT00908037|537008113|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871887|NCT00908037|537008114|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
148871888|NCT00908037|537008115|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
148871889|NCT00908037|537008104|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871890|NCT00908037|537008105|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871891|NCT00908037|537008106|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871892|NCT00908037|537008107|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871893|NCT00908037|537008108|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871894|NCT00908037|537008109|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871895|NCT00908037|537008110|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871896|NCT00908037|537008111|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871897|NCT00908037|537008112|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871898|NCT00908037|537008113|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
148871899|NCT00908037|537008114|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871900|NCT00908037|537008115|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
148871901|NCT00908037|537008104|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871902|NCT00908037|537008105|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871903|NCT00908037|537008106|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871904|NCT00908037|537008107|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148778500|NCT01004432|536663183|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
148778501|NCT01004432|536663184|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
148778502|NCT01004432|536663180|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
148778503|NCT01004432|536663181|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
148778504|NCT01004432|536663182|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
148778505|NCT01004432|536663183|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
148778506|NCT01004432|536663184|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
148778507|NCT01004432|536663180|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
148778508|NCT01004432|536663181|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
148778509|NCT01004432|536663182|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
148778510|NCT01004432|536663183|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
148778511|NCT01004432|536663184|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
148778512|NCT01004432|536663180|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
148778513|NCT01004432|536663181|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
148778514|NCT01004432|536663182|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
148778515|NCT01004432|536663183|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
148778516|NCT01004432|536663184|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
148778517|NCT00590538|536663185|FG000|Overall Study|Study terminated before completed|2|||
148778518|NCT02309723|536663186|FG000|Overall Study|Withdrawal by Subject|24|||
148778519|NCT02309723|536663187|FG001|Overall Study|Withdrawal by Subject|23|||
148778520|NCT02309723|536663188|FG002|Overall Study|Withdrawal by Subject|24|||
148778521|NCT01125813|536663189|FG000|Overall Study|Death|1|||
148778522|NCT01125813|536663189|FG000|Overall Study|Withdrawal by Subject|1|||
148778523|NCT01125813|536663189|FG000|Overall Study|Screen Failures|4|||
148778524|NCT01143064|536663192|FG000|Overall Study|Death|109|||
148778525|NCT01143064|536663193|FG001|Overall Study|Death|91|||
148871905|NCT00908037|537008108|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871906|NCT00908037|537008109|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
149000796|NCT01563536|537479387|FG000|Overall Study|Lost to Follow-up|1|||
148778526|NCT01143064|536663192|FG000|Overall Study|Adverse Event|0|||
148871907|NCT00908037|537008110|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871908|NCT00908037|537008111|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871909|NCT00908037|537008112|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871910|NCT00908037|537008113|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871911|NCT00908037|537008114|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
148871912|NCT00908037|537008115|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
148871913|NCT02565810|537008116|FG000|Overall Study|Withdrawal by Subject|1|||
148871914|NCT02049138|537008119|FG000|Overall Study|Adverse Event|46|||
148871915|NCT02049138|537008120|FG001|Overall Study|Adverse Event|25|||
148871916|NCT02049138|537008121|FG002|Overall Study|Adverse Event|1|||
148871917|NCT02049138|537008119|FG000|Overall Study|Withdrawal by Subject|57|||
148871918|NCT02049138|537008120|FG001|Overall Study|Withdrawal by Subject|21|||
148871919|NCT02049138|537008121|FG002|Overall Study|Withdrawal by Subject|5|||
148871920|NCT02049138|537008119|FG000|Overall Study|Lost to Follow-up|18|||
148871921|NCT02049138|537008120|FG001|Overall Study|Lost to Follow-up|5|||
148871922|NCT02049138|537008121|FG002|Overall Study|Lost to Follow-up|1|||
148871923|NCT02049138|537008119|FG000|Overall Study|Lack of Efficacy|10|||
148871924|NCT02049138|537008120|FG001|Overall Study|Lack of Efficacy|26|||
148871925|NCT02049138|537008121|FG002|Overall Study|Lack of Efficacy|1|||
148871926|NCT02049138|537008119|FG000|Overall Study|Non-Compliance|15|||
148871927|NCT02049138|537008120|FG001|Overall Study|Non-Compliance|6|||
148871928|NCT02049138|537008121|FG002|Overall Study|Non-Compliance|0|||
148871929|NCT02049138|537008119|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
148871930|NCT02049138|537008120|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
148871931|NCT02049138|537008121|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
148871932|NCT02049138|537008119|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
148871933|NCT02049138|537008120|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
148871934|NCT02049138|537008121|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
148871935|NCT02049138|537008119|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
148871936|NCT02049138|537008120|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
148871937|NCT02049138|537008121|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
148871938|NCT02049138|537008119|FG000|Overall Study|Other|15|||
148871939|NCT02049138|537008120|FG001|Overall Study|Other|13|||
148871940|NCT02049138|537008121|FG002|Overall Study|Other|0|||
148871941|NCT02049138|537008119|FG000|Overall Study|Missing|0|||
148871942|NCT02049138|537008120|FG001|Overall Study|Missing|1|||
148871943|NCT02049138|537008121|FG002|Overall Study|Missing|0|||
148871944|NCT00257660|537008122|FG000|Overall Study|Lack of Efficacy|5|||
148871945|NCT00257660|537008123|FG001|Overall Study|Lack of Efficacy|23|||
148871946|NCT00257660|537008122|FG000|Overall Study|Withdrawal by Subject|2|||
148871947|NCT00257660|537008123|FG001|Overall Study|Withdrawal by Subject|0|||
148871948|NCT00257660|537008122|FG000|Overall Study|Lost to Follow-up|1|||
148871949|NCT00257660|537008123|FG001|Overall Study|Lost to Follow-up|0|||
148871950|NCT00257660|537008122|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
148871951|NCT00257660|537008123|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
148871952|NCT00257660|537008122|FG000|Overall Study|No longer wanted to do blood draws|1|||
148871953|NCT00257660|537008123|FG001|Overall Study|No longer wanted to do blood draws|0|||
148871954|NCT00491608|537008124|FG000|Overall Study|Death|2|||
148871955|NCT00491608|537008124|FG000|Overall Study|Withdrawal by Subject|1|||
148871956|NCT00025155|537008127|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
148871957|NCT00025155|537008127|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
148871958|NCT05086510|537008130|FG000|Overall Study|Lost to Follow-up|0|||
148871959|NCT05086510|537008131|FG001|Overall Study|Lost to Follow-up|2|||
148871960|NCT05086510|537008130|FG000|Overall Study|Death|0|||
148871961|NCT05086510|537008131|FG001|Overall Study|Death|2|||
148871962|NCT00413374|537008132|FG000|Overall Study|Ineligible due to screening criteria.|3|||
148871963|NCT00413374|537008133|FG001|Overall Study|Ineligible due to screening criteria.|0|||
148871964|NCT00413374|537008132|FG000|Overall Study|Adverse Event|1|||
148871965|NCT00413374|537008133|FG001|Overall Study|Adverse Event|0|||
148871966|NCT00413374|537008132|FG000|Overall Study|Lost to Follow-up|1|||
148871967|NCT00413374|537008133|FG001|Overall Study|Lost to Follow-up|0|||
148871968|NCT00413374|537008132|FG000|Overall Study|Surgery|1|||
148871969|NCT00413374|537008133|FG001|Overall Study|Surgery|0|||
148871970|NCT00552760|537008134|FG000|Overall Study|Adverse Event|3|||
148871971|NCT00552760|537008135|FG001|Overall Study|Adverse Event|5|||
148871972|NCT00552760|537008134|FG000|Overall Study|Relapsed- Depressed Event|10|||
148871973|NCT00552760|537008135|FG001|Overall Study|Relapsed- Depressed Event|16|||
148871974|NCT00552760|537008134|FG000|Overall Study|Relapse- Manic Event|3|||
148871975|NCT00552760|537008135|FG001|Overall Study|Relapse- Manic Event|3|||
148871976|NCT00552760|537008134|FG000|Overall Study|Relapsed- Mixed Event|3|||
148871977|NCT00552760|537008135|FG001|Overall Study|Relapsed- Mixed Event|5|||
148871978|NCT00552760|537008134|FG000|Overall Study|Protocol Violation|0|||
148871979|NCT00552760|537008135|FG001|Overall Study|Protocol Violation|1|||
148871980|NCT00552760|537008134|FG000|Overall Study|Lost to Follow-up|1|||
148871981|NCT00552760|537008135|FG001|Overall Study|Lost to Follow-up|1|||
148778527|NCT01143064|536663193|FG001|Overall Study|Adverse Event|1|||
148778528|NCT01143064|536663192|FG000|Overall Study|Withdrawal by Subject|7|||
148778529|NCT01143064|536663193|FG001|Overall Study|Withdrawal by Subject|5|||
148778530|NCT01143064|536663192|FG000|Overall Study|Lost to Follow-up|17|||
148778531|NCT01143064|536663193|FG001|Overall Study|Lost to Follow-up|14|||
148778532|NCT01143064|536663192|FG000|Overall Study|Physician Decision|0|||
148778533|NCT01143064|536663193|FG001|Overall Study|Physician Decision|4|||
148778534|NCT01661933|536663194|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
148778535|NCT01661933|536663194|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
148778536|NCT00150800|536663201|FG000|Overall Study|Adverse Event|89|||
148778537|NCT00150800|536663201|FG000|Overall Study|Death|18|||
148778538|NCT00150800|536663201|FG000|Overall Study|Lack of Efficacy|166|||
148778539|NCT00150800|536663201|FG000|Overall Study|Lost to Follow-up|58|||
148778540|NCT00150800|536663201|FG000|Overall Study|Subject's choice|90|||
148778541|NCT00150800|536663201|FG000|Overall Study|No compliance|18|||
148778542|NCT00150800|536663201|FG000|Overall Study|IP misshandling|1|||
148778543|NCT00150800|536663201|FG000|Overall Study|Site closure|24|||
148778544|NCT00150800|536663201|FG000|Overall Study|Protocol non-adherence|2|||
148778545|NCT00150800|536663201|FG000|Overall Study|Nobody to accompany patient|1|||
148778546|NCT00150800|536663201|FG000|Overall Study|Distance too long for patient|1|||
148778547|NCT00150800|536663201|FG000|Overall Study|Neurosurgery|2|||
148778548|NCT00150800|536663201|FG000|Overall Study|BRV monotherapy|1|||
148778549|NCT00150800|536663201|FG000|Overall Study|Visit refusal|3|||
148778550|NCT00150800|536663201|FG000|Overall Study|Sponsor's request|2|||
148778551|NCT00150800|536663201|FG000|Overall Study|Generalized Epilepsy|1|||
148778552|NCT00150800|536663201|FG000|Overall Study|Moved from area/country|8|||
148778553|NCT00150800|536663201|FG000|Overall Study|PI retiring|2|||
148778554|NCT00150800|536663201|FG000|Overall Study|PI leaving site|2|||
148778555|NCT00150800|536663201|FG000|Overall Study|Patient insurance|1|||
148778556|NCT00150800|536663201|FG000|Overall Study|Surgical intervention|4|||
148778557|NCT00150800|536663201|FG000|Overall Study|Pregnancy planned|1|||
148778558|NCT00150800|536663201|FG000|Overall Study|PI discontinuation request|1|||
148778559|NCT01790828|536663202|FG000|Overall Study|Other|34|||
148778560|NCT01037127|536663206|FG000|Overall Study|Lost to Follow-up|2|||
148778561|NCT01037127|536663207|FG001|Overall Study|Lost to Follow-up|4|||
148778562|NCT01037127|536663206|FG000|Overall Study|Physician Decision|1|||
148778563|NCT01037127|536663207|FG001|Overall Study|Physician Decision|0|||
148778564|NCT01037127|536663206|FG000|Overall Study|Study Closed Terminated|2|||
148778565|NCT01037127|536663207|FG001|Overall Study|Study Closed Terminated|17|||
148778566|NCT02637713|536663211|FG000|Overall Study|Screen Failure|2|||
148778567|NCT02847182|536663212|FG000|Overall Study|Withdrawal by Subject|0|||
148778568|NCT02847182|536663213|FG001|Overall Study|Withdrawal by Subject|1|||
148778569|NCT02345889|536663214|FG000|Overall Study|Inadequate Bowel Prep|17|||
148778570|NCT02345889|536663215|FG001|Overall Study|Inadequate Bowel Prep|16|||
148778571|NCT02345889|536663216|FG002|Overall Study|Inadequate Bowel Prep|18|||
148778572|NCT02345889|536663217|FG003|Overall Study|Inadequate Bowel Prep|14|||
148778573|NCT02345889|536663214|FG000|Overall Study|Polyposis identified during procedure|1|||
148778574|NCT02345889|536663215|FG001|Overall Study|Polyposis identified during procedure|1|||
148778575|NCT02345889|536663216|FG002|Overall Study|Polyposis identified during procedure|0|||
148778576|NCT02345889|536663217|FG003|Overall Study|Polyposis identified during procedure|1|||
148778577|NCT02345889|536663214|FG000|Overall Study|Recognized ineligible post-randomization|1|||
148778578|NCT02345889|536663215|FG001|Overall Study|Recognized ineligible post-randomization|0|||
148778579|NCT02345889|536663216|FG002|Overall Study|Recognized ineligible post-randomization|2|||
148778580|NCT02345889|536663217|FG003|Overall Study|Recognized ineligible post-randomization|1|||
148778581|NCT02345889|536663214|FG000|Overall Study|Ulcerative Colitis identified|1|||
148778582|NCT02345889|536663215|FG001|Overall Study|Ulcerative Colitis identified|0|||
148778583|NCT02345889|536663216|FG002|Overall Study|Ulcerative Colitis identified|0|||
148778584|NCT02345889|536663217|FG003|Overall Study|Ulcerative Colitis identified|0|||
148778585|NCT02345889|536663214|FG000|Overall Study|Cecum not intubated|1|||
148778586|NCT02345889|536663215|FG001|Overall Study|Cecum not intubated|0|||
148778587|NCT02345889|536663216|FG002|Overall Study|Cecum not intubated|0|||
148778588|NCT02345889|536663217|FG003|Overall Study|Cecum not intubated|0|||
148778589|NCT04325698|536663218|FG000|Overall Study|Study Terminated By Sponsor|1|||
148778590|NCT04325698|536663219|FG001|Overall Study|Study Terminated By Sponsor|1|||
148778591|NCT04325698|536663218|FG000|Overall Study|Withdrawal by Subject|0|||
148778592|NCT04325698|536663219|FG001|Overall Study|Withdrawal by Subject|2|||
148778593|NCT00962091|536663220|FG000|Overall Study|Withdrawal by Subject|1|||
148778594|NCT00962091|536663221|FG001|Overall Study|Withdrawal by Subject|2|||
148778595|NCT00962091|536663222|FG002|Overall Study|Withdrawal by Subject|1|||
148778596|NCT00962091|536663223|FG003|Overall Study|Withdrawal by Subject|1|||
148778597|NCT00962091|536663224|FG004|Overall Study|Withdrawal by Subject|0|||
148778598|NCT00962091|536663225|FG005|Overall Study|Withdrawal by Subject|1|||
148778599|NCT00962091|536663226|FG006|Overall Study|Withdrawal by Subject|0|||
148778600|NCT00962091|536663220|FG000|Overall Study|Adverse Event|0|||
148778601|NCT00962091|536663221|FG001|Overall Study|Adverse Event|0|||
148871982|NCT00552760|537008134|FG000|Overall Study|Non-compliance|1|||
148871983|NCT00552760|537008135|FG001|Overall Study|Non-compliance|1|||
148871984|NCT00552760|537008134|FG000|Overall Study|Medical Condition|1|||
148778602|NCT00962091|536663222|FG002|Overall Study|Adverse Event|0|||
148778603|NCT00962091|536663223|FG003|Overall Study|Adverse Event|0|||
148778604|NCT00962091|536663224|FG004|Overall Study|Adverse Event|0|||
148778605|NCT00962091|536663225|FG005|Overall Study|Adverse Event|0|||
148778606|NCT00962091|536663226|FG006|Overall Study|Adverse Event|1|||
148778607|NCT04253782|536663227|FG000|Overall Study|Death|2|||
148778608|NCT04253782|536663228|FG001|Overall Study|Death|0|||
148778609|NCT02326298|536663231|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778610|NCT02326298|536663232|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778611|NCT02326298|536663233|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
148778612|NCT02326298|536663234|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778613|NCT02326298|536663235|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778614|NCT02326298|536663236|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778615|NCT02326298|536663237|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778616|NCT02326298|536663238|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778617|NCT02326298|536663239|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778618|NCT02326298|536663240|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778619|NCT02326298|536663241|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778620|NCT02326298|536663242|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778621|NCT02326298|536663243|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778622|NCT02326298|536663244|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
148778623|NCT02326298|536663231|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
148778624|NCT02326298|536663232|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778625|NCT02326298|536663233|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778626|NCT02326298|536663234|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778627|NCT02326298|536663235|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778628|NCT02326298|536663236|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778629|NCT02326298|536663237|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778630|NCT02326298|536663238|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778631|NCT02326298|536663239|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778632|NCT02326298|536663240|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778633|NCT02326298|536663241|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778634|NCT02326298|536663242|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778635|NCT02326298|536663243|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778636|NCT02326298|536663244|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
148778637|NCT02326298|536663231|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
148778638|NCT02326298|536663232|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
148778639|NCT02326298|536663233|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778640|NCT02326298|536663234|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778641|NCT02326298|536663235|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778642|NCT02326298|536663236|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778643|NCT02326298|536663237|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778644|NCT02326298|536663238|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778645|NCT02326298|536663239|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778646|NCT02326298|536663240|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778647|NCT02326298|536663241|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778648|NCT02326298|536663242|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778649|NCT02326298|536663243|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778650|NCT02326298|536663244|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
148778651|NCT02326298|536663231|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
148778652|NCT02326298|536663232|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
148778653|NCT02326298|536663233|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778654|NCT02326298|536663234|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778655|NCT02326298|536663235|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778656|NCT02326298|536663236|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778657|NCT02326298|536663237|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778658|NCT02326298|536663238|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778659|NCT02326298|536663239|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778660|NCT02326298|536663240|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778661|NCT02326298|536663241|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778662|NCT02326298|536663242|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778663|NCT02326298|536663243|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778664|NCT02326298|536663244|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
148778665|NCT02326298|536663231|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148871985|NCT00552760|537008135|FG001|Overall Study|Medical Condition|1|||
148871986|NCT00552760|537008134|FG000|Overall Study|Withdrawal by Subject|3|||
148871987|NCT00552760|537008135|FG001|Overall Study|Withdrawal by Subject|0|||
148871988|NCT00552760|537008134|FG000|Overall Study|Medication Change|1|||
148871989|NCT00552760|537008135|FG001|Overall Study|Medication Change|0|||
148871990|NCT03022981|537008136|FG000|Overall Study|Adverse Event|0|||
148871991|NCT03022981|537008137|FG001|Overall Study|Adverse Event|1|||
148871992|NCT03022981|537008138|FG002|Overall Study|Adverse Event|0|||
148871993|NCT03022981|537008136|FG000|Overall Study|Investigator's Discretion|0|||
148871994|NCT03022981|537008137|FG001|Overall Study|Investigator's Discretion|1|||
148871995|NCT03022981|537008138|FG002|Overall Study|Investigator's Discretion|2|||
148871996|NCT03022981|537008136|FG000|Overall Study|Lost to Follow-up|6|||
148871997|NCT03022981|537008137|FG001|Overall Study|Lost to Follow-up|2|||
148871998|NCT03022981|537008138|FG002|Overall Study|Lost to Follow-up|1|||
148871999|NCT03022981|537008136|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148872000|NCT03022981|537008137|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148872001|NCT03022981|537008138|FG002|Overall Study|Non-Compliance With Study Drug|2|||
148872002|NCT03022981|537008136|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
148872003|NCT03022981|537008137|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
148872004|NCT03022981|537008138|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
148872005|NCT03615066|537008142|FG000|Main Study|Withdrew Consent|0|||
148872006|NCT03615066|537008143|FG001|Main Study|Withdrew Consent|1|||
148872007|NCT03615066|537008144|FG002|Main Study|Withdrew Consent|1|||
148872008|NCT03615066|537008142|FG000|Main Study|Lost to Follow-up|0|||
148872009|NCT03615066|537008143|FG001|Main Study|Lost to Follow-up|0|||
148872010|NCT03615066|537008144|FG002|Main Study|Lost to Follow-up|1|||
148872011|NCT03615066|537008142|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
148872012|NCT03615066|537008143|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
148872013|NCT03615066|537008144|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
148872014|NCT03615066|537008142|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
148872015|NCT03615066|537008143|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
148872016|NCT03615066|537008144|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
148872017|NCT03615066|537008142|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
148872018|NCT03615066|537008143|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
148872019|NCT03615066|537008144|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
148872020|NCT00924404|537008145|FG000|Overall Study|Lost to Follow-up|6|||
148872021|NCT00924404|537008146|FG001|Overall Study|Lost to Follow-up|4|||
148872022|NCT02437084|537008147|FG000|Overall Study|Withdrawal by Subject|2|||
148872023|NCT02437084|537008147|FG000|Overall Study|Physician Decision|1|||
148872024|NCT01459913|537008150|FG000|Overall Study|Adverse Event|0|||
148872025|NCT01459913|537008151|FG001|Overall Study|Adverse Event|0|||
148872026|NCT01459913|537008152|FG002|Overall Study|Adverse Event|0|||
148872027|NCT01459913|537008153|FG003|Overall Study|Adverse Event|3|||
148872028|NCT01459913|537008150|FG000|Overall Study|Withdrawal by Subject|4|||
148872029|NCT01459913|537008151|FG001|Overall Study|Withdrawal by Subject|0|||
148872030|NCT01459913|537008152|FG002|Overall Study|Withdrawal by Subject|0|||
148872031|NCT01459913|537008153|FG003|Overall Study|Withdrawal by Subject|5|||
148872032|NCT01459913|537008150|FG000|Overall Study|Lost to Follow-up|7|||
148872033|NCT01459913|537008151|FG001|Overall Study|Lost to Follow-up|4|||
148872034|NCT01459913|537008152|FG002|Overall Study|Lost to Follow-up|1|||
148872035|NCT01459913|537008153|FG003|Overall Study|Lost to Follow-up|8|||
148872036|NCT01459913|537008150|FG000|Overall Study|Death|0|||
148872037|NCT01459913|537008151|FG001|Overall Study|Death|0|||
148872038|NCT01459913|537008152|FG002|Overall Study|Death|0|||
148872039|NCT01459913|537008153|FG003|Overall Study|Death|1|||
148872040|NCT01459913|537008150|FG000|Overall Study|Non- Compliance|0|||
148872041|NCT01459913|537008151|FG001|Overall Study|Non- Compliance|0|||
148872042|NCT01459913|537008152|FG002|Overall Study|Non- Compliance|0|||
148872043|NCT01459913|537008153|FG003|Overall Study|Non- Compliance|3|||
148872044|NCT01459913|537008150|FG000|Overall Study|Physician Decision|0|||
148872045|NCT01459913|537008151|FG001|Overall Study|Physician Decision|1|||
148872046|NCT01459913|537008152|FG002|Overall Study|Physician Decision|0|||
148872047|NCT01459913|537008153|FG003|Overall Study|Physician Decision|0|||
148872048|NCT01459913|537008150|FG000|Overall Study|Study Terminated by Sponsor|30|||
148872049|NCT01459913|537008151|FG001|Overall Study|Study Terminated by Sponsor|15|||
148872050|NCT01459913|537008152|FG002|Overall Study|Study Terminated by Sponsor|9|||
148872051|NCT01459913|537008153|FG003|Overall Study|Study Terminated by Sponsor|11|||
148872052|NCT01459913|537008150|FG000|Overall Study|Other|0|||
148872053|NCT01459913|537008151|FG001|Overall Study|Other|0|||
148872054|NCT01459913|537008152|FG002|Overall Study|Other|3|||
148872055|NCT01459913|537008153|FG003|Overall Study|Other|1|||
148872056|NCT01459913|537008150|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
148872057|NCT01459913|537008151|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
148872058|NCT01459913|537008152|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
148872059|NCT01459913|537008153|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
148872060|NCT02177838|537008156|FG000|Overall Study|Withdrawal by Subject|1|||
148872061|NCT02177838|537008156|FG000|Overall Study|Physician Decision|1|||
148872062|NCT02177838|537008156|FG000|Overall Study|Death|1|||
148872063|NCT00737633|537008157|FG000|Overall Study|Study terminated by sponsor|44|||
148872064|NCT00737633|537008158|FG001|Overall Study|Study terminated by sponsor|55|||
148872065|NCT00737633|537008157|FG000|Overall Study|Lost to Follow-up|0|||
148872066|NCT00737633|537008158|FG001|Overall Study|Lost to Follow-up|1|||
148872067|NCT00737633|537008157|FG000|Overall Study|protocol non-compliance|0|||
148872068|NCT00737633|537008158|FG001|Overall Study|protocol non-compliance|1|||
148872069|NCT00377364|537008159|FG000|Overall Study|Lost to Follow-up|1|||
148872070|NCT00377364|537008160|FG001|Overall Study|Lost to Follow-up|0|||
148872071|NCT00377364|537008159|FG000|Overall Study|Withdrawal by Subject|1|||
148872072|NCT00377364|537008160|FG001|Overall Study|Withdrawal by Subject|0|||
148872073|NCT03101085|537008162|FG000|Overall Study|Lost to Follow-up|0|||
148872074|NCT03101085|537008163|FG001|Overall Study|Lost to Follow-up|1|||
148872075|NCT02986854|537008164|FG000|Overall Study|Withdrawal by Subject|0|||
148872076|NCT02986854|537008165|FG001|Overall Study|Withdrawal by Subject|1|||
148872077|NCT02986854|537008166|FG002|Overall Study|Withdrawal by Subject|1|||
148872078|NCT02986854|537008164|FG000|Overall Study|Lost to Follow-up|3|||
148872079|NCT02986854|537008165|FG001|Overall Study|Lost to Follow-up|11|||
148872080|NCT02986854|537008166|FG002|Overall Study|Lost to Follow-up|2|||
148872081|NCT00718770|537008169|FG000|Overall Study|Adverse Event|1|||
148872082|NCT00718770|537008169|FG000|Overall Study|Lack of Efficacy|1|||
148872083|NCT00718770|537008169|FG000|Overall Study|Lack of Efficacy|1|||
148872084|NCT00718770|537008169|FG000|Overall Study|Adverse Event|1|||
148872085|NCT00718770|537008169|FG000|Overall Study|Lack of Efficacy|1|||
148872086|NCT00718770|537008169|FG000|Overall Study|Adverse Event|1|||
148872087|NCT00718770|537008169|FG000|Overall Study|Lack of Efficacy|1|||
148872088|NCT00718770|537008169|FG000|Overall Study|Adverse Event|1|||
148872089|NCT00695864|537008170|FG000|Placebo|Withdrawal by Subject|1|||
148872090|NCT00695864|537008170|FG000|Placebo|Physician Decision|4|||
148872091|NCT01624090|537008174|FG000|Overall Study|DLT, taken off therapy|0|||
148872092|NCT01624090|537008175|FG001|Overall Study|DLT, taken off therapy|1|||
148872093|NCT01624090|537008176|FG002|Overall Study|DLT, taken off therapy|0|||
148872094|NCT01624090|537008177|FG003|Overall Study|DLT, taken off therapy|0|||
148872095|NCT01624090|537008174|FG000|Overall Study|Withdrew prior to treatment|0|||
148872096|NCT01624090|537008175|FG001|Overall Study|Withdrew prior to treatment|1|||
148872097|NCT01624090|537008176|FG002|Overall Study|Withdrew prior to treatment|0|||
148872098|NCT01624090|537008177|FG003|Overall Study|Withdrew prior to treatment|0|||
148872099|NCT01624090|537008174|FG000|Overall Study|Died on study|0|||
148872100|NCT01624090|537008175|FG001|Overall Study|Died on study|0|||
148872101|NCT01624090|537008176|FG002|Overall Study|Died on study|2|||
148872102|NCT01624090|537008177|FG003|Overall Study|Died on study|0|||
148872103|NCT01624090|537008174|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
148872104|NCT01624090|537008175|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
148872105|NCT01624090|537008176|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
148872106|NCT01624090|537008177|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
148872107|NCT01624090|537008174|FG000|Overall Study|Dose escalated|0|||
148872108|NCT01624090|537008175|FG001|Overall Study|Dose escalated|0|||
148872109|NCT01624090|537008176|FG002|Overall Study|Dose escalated|3|||
148872110|NCT01624090|537008177|FG003|Overall Study|Dose escalated|0|||
148872111|NCT00772109|537008178|FG000|Overall Study|Serious adverse event|1|||
148872112|NCT00772109|537008179|FG001|Overall Study|Serious adverse event|0|||
148872113|NCT00772109|537008180|FG002|Overall Study|Serious adverse event|1|||
148872114|NCT00772109|537008181|FG003|Overall Study|Serious adverse event|0|||
148872115|NCT00772109|537008178|FG000|Overall Study|Protocol Violation|5|||
148872116|NCT00772109|537008179|FG001|Overall Study|Protocol Violation|8|||
148872117|NCT00772109|537008180|FG002|Overall Study|Protocol Violation|7|||
148872118|NCT00772109|537008181|FG003|Overall Study|Protocol Violation|6|||
148872119|NCT00772109|537008178|FG000|Overall Study|Lost to Follow-up|7|||
148872120|NCT00772109|537008179|FG001|Overall Study|Lost to Follow-up|3|||
148872121|NCT00772109|537008180|FG002|Overall Study|Lost to Follow-up|5|||
148872122|NCT00772109|537008181|FG003|Overall Study|Lost to Follow-up|9|||
148872123|NCT00772109|537008178|FG000|Overall Study|Withdrawal by Subject|8|||
148872124|NCT00772109|537008179|FG001|Overall Study|Withdrawal by Subject|8|||
148872125|NCT00772109|537008180|FG002|Overall Study|Withdrawal by Subject|6|||
148872126|NCT00772109|537008181|FG003|Overall Study|Withdrawal by Subject|16|||
148872127|NCT01403116|537008182|FG000|Overall Study|Adverse Event|7|||
148872128|NCT01403116|537008183|FG001|Overall Study|Adverse Event|4|||
148872129|NCT01403116|537008182|FG000|Overall Study|Lost to Follow-up|7|||
148872130|NCT01403116|537008183|FG001|Overall Study|Lost to Follow-up|5|||
148872131|NCT01403116|537008182|FG000|Overall Study|Withdrawal by Subject|12|||
148872132|NCT01403116|537008183|FG001|Overall Study|Withdrawal by Subject|15|||
148872133|NCT01403116|537008182|FG000|Overall Study|Non-compliance of study drug|3|||
148872134|NCT01403116|537008183|FG001|Overall Study|Non-compliance of study drug|0|||
148872135|NCT01403116|537008182|FG000|Overall Study|Protocol Violation|0|||
148872136|NCT01403116|537008183|FG001|Overall Study|Protocol Violation|1|||
148872137|NCT01403116|537008182|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
148872138|NCT01403116|537008183|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
148872139|NCT01403116|537008182|FG000|Overall Study|Hct >54%|2|||
148872140|NCT01403116|537008183|FG001|Overall Study|Hct >54%|0|||
148872141|NCT01403116|537008182|FG000|Overall Study|unable to keep appointments|0|||
148872142|NCT01403116|537008183|FG001|Overall Study|unable to keep appointments|2|||
148872143|NCT00752726|537008184|FG000|Overall Study|Lost to Follow-up|2|||
148872144|NCT00752726|537008185|FG001|Overall Study|Lost to Follow-up|1|||
148872145|NCT00752726|537008184|FG000|Overall Study|Adverse Event|3|||
148872146|NCT00752726|537008185|FG001|Overall Study|Adverse Event|0|||
148872147|NCT00752726|537008184|FG000|Overall Study|Withdrawal by Subject|5|||
148872148|NCT00752726|537008185|FG001|Overall Study|Withdrawal by Subject|10|||
148872149|NCT00752726|537008184|FG000|Overall Study|Other Reason|1|||
148872150|NCT00752726|537008185|FG001|Overall Study|Other Reason|2|||
148872151|NCT01895309|537008186|FG000|Overall Study|Adverse Event|13|||
148872152|NCT01895309|537008187|FG001|Overall Study|Adverse Event|17|||
148872153|NCT01895309|537008186|FG000|Overall Study|Protocol Violation|1|||
148872154|NCT01895309|537008187|FG001|Overall Study|Protocol Violation|0|||
148872155|NCT01895309|537008186|FG000|Overall Study|Lack of Efficacy|1|||
148872156|NCT01895309|537008187|FG001|Overall Study|Lack of Efficacy|3|||
148872157|NCT01895309|537008186|FG000|Overall Study|Lost to Follow-up|1|||
148872158|NCT01895309|537008187|FG001|Overall Study|Lost to Follow-up|3|||
148872159|NCT01895309|537008186|FG000|Overall Study|Physician Decision|15|||
148872160|NCT01895309|537008187|FG001|Overall Study|Physician Decision|10|||
148872161|NCT01895309|537008186|FG000|Overall Study|Withdrawal by Subject|9|||
148872162|NCT01895309|537008187|FG001|Overall Study|Withdrawal by Subject|18|||
148872163|NCT00042666|537008188|FG000|Overall Study|Adverse Event|2|||
148872164|NCT00042666|537008188|FG000|Overall Study|Death|4|||
148872165|NCT00042666|537008188|FG000|Overall Study|Protocol Violation|1|||
148872166|NCT00042666|537008188|FG000|Overall Study|Participant/Physician Perception|1|||
148872167|NCT00042666|537008188|FG000|Overall Study|Progressive Disease|41|||
148872168|NCT00042666|537008188|FG000|Overall Study|Other|1|||
148872169|NCT00042666|537008188|FG000|Overall Study|Other|4|||
148872170|NCT04232215|537008189|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
148872171|NCT04232215|537008190|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
148872172|NCT02409342|537008193|FG000|Overall Study|Death|211|||
148872173|NCT02409342|537008194|FG001|Overall Study|Death|201|||
148872174|NCT02409342|537008193|FG000|Overall Study|Withdrawal by Subject|24|||
149000797|NCT01563536|537479388|FG001|Overall Study|Lost to Follow-up|0|||
149000798|NCT00538590|537479397|FG000|Overall Study|Death|1|||
149000799|NCT00538590|537479398|FG001|Overall Study|Death|0|||
149000800|NCT01256567|537479399|FG000|Overall Study|Withdrawal by Subject|1|||
149000801|NCT00567190|537479405|FG000|Overall Study|Death|235|||
149000802|NCT00567190|537479406|FG001|Overall Study|Death|280|||
149000803|NCT00567190|537479405|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
149000804|NCT00567190|537479406|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
149000805|NCT00636610|537479407|FG000|Overall Study|Adverse Event|4|||
149000806|NCT00636610|537479408|FG001|Overall Study|Adverse Event|4|||
149000807|NCT00636610|537479407|FG000|Overall Study|Death|6|||
149000808|NCT00636610|537479408|FG001|Overall Study|Death|3|||
149000809|NCT00636610|537479407|FG000|Overall Study|Physician decision to withdraw patient|15|||
149000810|NCT00636610|537479408|FG001|Overall Study|Physician decision to withdraw patient|9|||
149000811|NCT00636610|537479407|FG000|Overall Study|Subject decision to withdraw|15|||
149000812|NCT00636610|537479408|FG001|Overall Study|Subject decision to withdraw|11|||
149000813|NCT00636610|537479407|FG000|Overall Study|Disease progression - radiographic|41|||
149000814|NCT00636610|537479408|FG001|Overall Study|Disease progression - radiographic|51|||
149000815|NCT00636610|537479407|FG000|Overall Study|Disease progression - clinical|8|||
149000816|NCT00636610|537479408|FG001|Overall Study|Disease progression - clinical|3|||
149000817|NCT00636610|537479407|FG000|Overall Study|Reason for discontinuation not available|3|||
149000818|NCT00636610|537479408|FG001|Overall Study|Reason for discontinuation not available|2|||
149000819|NCT00313820|537479409|FG000|Assigned to Treatment|Other|1|||
149000820|NCT00313820|537479410|FG001|Assigned to Treatment|Other|0|||
149000821|NCT00313820|537479409|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
149000822|NCT00313820|537479410|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
149000823|NCT00313820|537479409|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
149000824|NCT00313820|537479410|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
149000825|NCT00313820|537479409|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
149000826|NCT00313820|537479410|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
149000827|NCT00313820|537479409|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
149000828|NCT00313820|537479410|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
148872175|NCT02409342|537008194|FG001|Overall Study|Withdrawal by Subject|17|||
148872176|NCT02409342|537008193|FG000|Overall Study|Study Terminated By Sponsor|48|||
148872177|NCT02409342|537008194|FG001|Overall Study|Study Terminated By Sponsor|59|||
148872178|NCT02409342|537008193|FG000|Overall Study|Lost to Follow-up|3|||
148872179|NCT02409342|537008194|FG001|Overall Study|Lost to Follow-up|5|||
148872180|NCT02409342|537008193|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
148872181|NCT02409342|537008194|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
148872182|NCT02409342|537008193|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
149000829|NCT00313820|537479409|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
149033050|NCT00567879|537598952|FG004|Overall Study|Disease progression|11|||
148872183|NCT02409342|537008194|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
148872184|NCT02409342|537008193|FG000|Overall Study|Sponsor Decision|1|||
148872185|NCT02409342|537008194|FG001|Overall Study|Sponsor Decision|0|||
148872186|NCT00279812|537008204|FG000|Overall Study|Protocol Violation|1|||
148872187|NCT00279812|537008205|FG001|Overall Study|Protocol Violation|1|||
148872188|NCT00279812|537008206|FG002|Overall Study|Protocol Violation|0|||
148872189|NCT00279812|537008207|FG003|Overall Study|Protocol Violation|0|||
148872190|NCT00279812|537008208|FG004|Overall Study|Protocol Violation|1|||
148872191|NCT00279812|537008209|FG005|Overall Study|Protocol Violation|0|||
148872192|NCT00279812|537008204|FG000|Overall Study|Withdrawal by Subject|0|||
148872193|NCT00279812|537008205|FG001|Overall Study|Withdrawal by Subject|4|||
148872194|NCT00279812|537008206|FG002|Overall Study|Withdrawal by Subject|2|||
148872195|NCT00279812|537008207|FG003|Overall Study|Withdrawal by Subject|0|||
148872196|NCT00279812|537008208|FG004|Overall Study|Withdrawal by Subject|0|||
148872197|NCT00279812|537008209|FG005|Overall Study|Withdrawal by Subject|0|||
148872198|NCT00279812|537008204|FG000|Overall Study|Adverse Event|0|||
148872199|NCT00279812|537008205|FG001|Overall Study|Adverse Event|1|||
148872200|NCT00279812|537008206|FG002|Overall Study|Adverse Event|1|||
148872201|NCT00279812|537008207|FG003|Overall Study|Adverse Event|0|||
148872202|NCT00279812|537008208|FG004|Overall Study|Adverse Event|2|||
148872203|NCT00279812|537008209|FG005|Overall Study|Adverse Event|1|||
148872204|NCT05327361|537008210|FG000|Overall Study|Lost to Follow-up|4|||
148872205|NCT00626405|537008211|FG000|Overall Study|Deemed Ineligible|1|||
148872206|NCT00626405|537008212|FG001|Overall Study|Deemed Ineligible|0|||
148872207|NCT00626405|537008211|FG000|Overall Study|Withdrawal by Subject|0|||
148872208|NCT00626405|537008212|FG001|Overall Study|Withdrawal by Subject|1|||
148872209|NCT02666105|537008213|FG000|Overall Study|Death|1|||
148872210|NCT01264419|537008217|FG000|Overall Study|Lost to Follow-up|3|||
148872211|NCT02100475|537009772|FG000|Overall Study|Unclassified|1|||
148872212|NCT02100475|537009773|FG001|Overall Study|Unclassified|2|||
148872213|NCT02100475|537009772|FG000|Overall Study|Withdrawal criteria|1|||
148872214|NCT02100475|537009773|FG001|Overall Study|Withdrawal criteria|0|||
148872215|NCT02806960|537009775|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
148872216|NCT02806960|537009776|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
148872217|NCT02806960|537009777|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
148872218|NCT02806960|537009778|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
148872219|NCT01769196|537009779|FG000|Overall Study|Adverse Event|24|||
148872220|NCT01769196|537009780|FG001|Overall Study|Adverse Event|20|||
148872221|NCT01769196|537009779|FG000|Overall Study|Death|21|||
148872222|NCT01769196|537009780|FG001|Overall Study|Death|26|||
148872223|NCT01769196|537009779|FG000|Overall Study|Investigator Discretion|7|||
148872224|NCT01769196|537009780|FG001|Overall Study|Investigator Discretion|3|||
148872225|NCT01769196|537009779|FG000|Overall Study|Lack of Efficacy|3|||
148872226|NCT01769196|537009780|FG001|Overall Study|Lack of Efficacy|2|||
148872227|NCT01769196|537009779|FG000|Overall Study|Progressive disease|11|||
148872228|NCT01769196|537009780|FG001|Overall Study|Progressive disease|6|||
148872229|NCT01769196|537009779|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
148872230|NCT01769196|537009780|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
148872231|NCT01769196|537009779|FG000|Overall Study|Protocol Violation|0|||
148872232|NCT01769196|537009780|FG001|Overall Study|Protocol Violation|3|||
148872233|NCT01769196|537009779|FG000|Overall Study|Study terminated by sponsor|160|||
148872234|NCT01769196|537009780|FG001|Overall Study|Study terminated by sponsor|161|||
148872235|NCT01769196|537009779|FG000|Overall Study|Participant never dosed with study drug|1|||
148872236|NCT01769196|537009780|FG001|Overall Study|Participant never dosed with study drug|0|||
148872237|NCT01769196|537009779|FG000|Overall Study|Withdrew consent|36|||
148872238|NCT01769196|537009780|FG001|Overall Study|Withdrew consent|40|||
148872239|NCT00126776|537009786|FG000|Overall Study|follow up complete on all patients|0|||
148872240|NCT00126776|537009787|FG001|Overall Study|follow up complete on all patients|0|||
149000830|NCT00313820|537479410|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
149000831|NCT00522626|537479411|FG000|Overall Study|Lost to Follow-up|7|||
149000832|NCT01169675|537479414|FG000|Overall Study|Progressive disease|13|||
149000833|NCT01169675|537479415|FG001|Overall Study|Progressive disease|2|||
149000834|NCT01169675|537479416|FG002|Overall Study|Progressive disease|5|||
149000835|NCT01169675|537479417|FG003|Overall Study|Progressive disease|15|||
149000836|NCT01169675|537479418|FG004|Overall Study|Progressive disease|1|||
148872241|NCT00527982|537009800|FG000|Overall Study|Physician Decision|1|||
148872242|NCT00527982|537009801|FG001|Overall Study|Physician Decision|0|||
148872243|NCT01939366|537009802|FG000|Overall Study|Adverse Event|8|||
148872244|NCT01939366|537009803|FG001|Overall Study|Adverse Event|17|||
148872245|NCT01939366|537009804|FG002|Overall Study|Adverse Event|30|||
148872246|NCT01939366|537009805|FG003|Overall Study|Adverse Event|8|||
149000837|NCT01169675|537479414|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
148872247|NCT01939366|537009806|FG004|Overall Study|Adverse Event|5|||
148872248|NCT01939366|537009802|FG000|Overall Study|Lack of Efficacy|2|||
148872249|NCT01939366|537009803|FG001|Overall Study|Lack of Efficacy|1|||
148872250|NCT01939366|537009804|FG002|Overall Study|Lack of Efficacy|1|||
148872251|NCT01939366|537009805|FG003|Overall Study|Lack of Efficacy|1|||
148872252|NCT01939366|537009806|FG004|Overall Study|Lack of Efficacy|3|||
148872253|NCT01939366|537009802|FG000|Overall Study|Lost to Follow-up|1|||
148872254|NCT01939366|537009803|FG001|Overall Study|Lost to Follow-up|1|||
148872255|NCT01939366|537009804|FG002|Overall Study|Lost to Follow-up|0|||
148872256|NCT01939366|537009805|FG003|Overall Study|Lost to Follow-up|0|||
148872257|NCT01939366|537009806|FG004|Overall Study|Lost to Follow-up|0|||
148872258|NCT01939366|537009802|FG000|Overall Study|Withdrawal by Subject|1|||
148872259|NCT01939366|537009803|FG001|Overall Study|Withdrawal by Subject|0|||
148872260|NCT01939366|537009804|FG002|Overall Study|Withdrawal by Subject|2|||
148872261|NCT01939366|537009805|FG003|Overall Study|Withdrawal by Subject|2|||
148872262|NCT01939366|537009806|FG004|Overall Study|Withdrawal by Subject|3|||
148872263|NCT01939366|537009802|FG000|Overall Study|Inclusion criteria not met|0|||
148872264|NCT01939366|537009803|FG001|Overall Study|Inclusion criteria not met|1|||
148872265|NCT01939366|537009804|FG002|Overall Study|Inclusion criteria not met|1|||
148872266|NCT01939366|537009805|FG003|Overall Study|Inclusion criteria not met|0|||
148872267|NCT01939366|537009806|FG004|Overall Study|Inclusion criteria not met|1|||
148872268|NCT01939366|537009802|FG000|Overall Study|Other|0|||
148872269|NCT01939366|537009803|FG001|Overall Study|Other|0|||
148872270|NCT01939366|537009804|FG002|Overall Study|Other|2|||
148872271|NCT01939366|537009805|FG003|Overall Study|Other|2|||
148872272|NCT01939366|537009806|FG004|Overall Study|Other|1|||
148872273|NCT01939366|537009802|FG000|Overall Study|Protocol Violation|0|||
148872274|NCT01939366|537009803|FG001|Overall Study|Protocol Violation|0|||
148872275|NCT01939366|537009804|FG002|Overall Study|Protocol Violation|0|||
148872276|NCT01939366|537009805|FG003|Overall Study|Protocol Violation|1|||
148872277|NCT01939366|537009806|FG004|Overall Study|Protocol Violation|0|||
148872278|NCT01939366|537009802|FG000|Overall Study|Sponsor decision|0|||
148872279|NCT01939366|537009803|FG001|Overall Study|Sponsor decision|0|||
148872280|NCT01939366|537009804|FG002|Overall Study|Sponsor decision|0|||
148872281|NCT01939366|537009805|FG003|Overall Study|Sponsor decision|0|||
148872282|NCT01939366|537009806|FG004|Overall Study|Sponsor decision|2|||
148872283|NCT01939366|537009802|FG000|Overall Study|GCP non-compliance at site|2|||
148872284|NCT01939366|537009803|FG001|Overall Study|GCP non-compliance at site|3|||
148872285|NCT01939366|537009804|FG002|Overall Study|GCP non-compliance at site|2|||
148872286|NCT01939366|537009805|FG003|Overall Study|GCP non-compliance at site|3|||
148872287|NCT01939366|537009806|FG004|Overall Study|GCP non-compliance at site|3|||
148872288|NCT04201093|537009812|FG000|Overall Study|Adverse Event|6|||
148872289|NCT04201093|537009813|FG001|Overall Study|Adverse Event|29|||
148872290|NCT04201093|537009814|FG002|Overall Study|Adverse Event|35|||
148872291|NCT04201093|537009812|FG000|Overall Study|Death|2|||
148872292|NCT04201093|537009813|FG001|Overall Study|Death|1|||
148872293|NCT04201093|537009814|FG002|Overall Study|Death|0|||
148872294|NCT04201093|537009812|FG000|Overall Study|Lack of Efficacy|5|||
148872295|NCT04201093|537009813|FG001|Overall Study|Lack of Efficacy|1|||
148872296|NCT04201093|537009814|FG002|Overall Study|Lack of Efficacy|2|||
148872297|NCT04201093|537009812|FG000|Overall Study|Lost to Follow-up|0|||
148872298|NCT04201093|537009813|FG001|Overall Study|Lost to Follow-up|0|||
148872299|NCT04201093|537009814|FG002|Overall Study|Lost to Follow-up|1|||
148872300|NCT04201093|537009812|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
148872301|NCT04201093|537009813|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
148872302|NCT04201093|537009814|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
148872303|NCT04201093|537009812|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
148872304|NCT04201093|537009813|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
148872305|NCT04201093|537009814|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
148872306|NCT04201093|537009812|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
148872307|NCT04201093|537009813|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
148872308|NCT04201093|537009814|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
149000838|NCT01169675|537479415|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149000839|NCT01169675|537479416|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149000840|NCT01169675|537479417|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149000841|NCT01169675|537479418|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
149000842|NCT01169675|537479414|FG000|Overall Study|Adverse Event|5|||
149000843|NCT01169675|537479415|FG001|Overall Study|Adverse Event|1|||
149000844|NCT01169675|537479416|FG002|Overall Study|Adverse Event|2|||
149000845|NCT01169675|537479417|FG003|Overall Study|Adverse Event|0|||
149000846|NCT01169675|537479418|FG004|Overall Study|Adverse Event|0|||
149000847|NCT01169675|537479414|FG000|Overall Study|Withdrawal by Subject|1|||
149000848|NCT01169675|537479415|FG001|Overall Study|Withdrawal by Subject|0|||
149000849|NCT01169675|537479416|FG002|Overall Study|Withdrawal by Subject|0|||
149000850|NCT01169675|537479417|FG003|Overall Study|Withdrawal by Subject|1|||
149000851|NCT01169675|537479418|FG004|Overall Study|Withdrawal by Subject|2|||
148872309|NCT04201093|537009812|FG000|Overall Study|Physician Decision|1|||
148872310|NCT04201093|537009813|FG001|Overall Study|Physician Decision|0|||
148872311|NCT04201093|537009814|FG002|Overall Study|Physician Decision|0|||
148872312|NCT04201093|537009812|FG000|Overall Study|Protocol Deviation|1|||
148872313|NCT04201093|537009813|FG001|Overall Study|Protocol Deviation|0|||
149000852|NCT01169675|537479414|FG000|Overall Study|Other Reason Not Defined Above|0|||
149000853|NCT01169675|537479415|FG001|Overall Study|Other Reason Not Defined Above|0|||
148872314|NCT04201093|537009814|FG002|Overall Study|Protocol Deviation|0|||
148872315|NCT04201093|537009812|FG000|Overall Study|Site Terminated by Sponsor|5|||
148872316|NCT04201093|537009813|FG001|Overall Study|Site Terminated by Sponsor|3|||
148872317|NCT04201093|537009814|FG002|Overall Study|Site Terminated by Sponsor|1|||
148872318|NCT04201093|537009812|FG000|Overall Study|Withdrawal by Subject|7|||
148872319|NCT04201093|537009813|FG001|Overall Study|Withdrawal by Subject|8|||
148872320|NCT04201093|537009814|FG002|Overall Study|Withdrawal by Subject|15|||
148872321|NCT04201093|537009812|FG000|Overall Study|Other|0|||
148872322|NCT04201093|537009813|FG001|Overall Study|Other|1|||
148872323|NCT04201093|537009814|FG002|Overall Study|Other|2|||
148872324|NCT01272869|537009815|FG000|Period 2 (14 Days)|Adverse Event|1|||
148872325|NCT01272869|537009816|FG001|Period 2 (14 Days)|Adverse Event|0|||
148872326|NCT00771615|537009817|FG000|Overall Study|Withdrawal by Subject|0|||
148872327|NCT00771615|537009818|FG001|Overall Study|Withdrawal by Subject|1|||
148872328|NCT00771615|537009819|FG002|Overall Study|Withdrawal by Subject|0|||
148872329|NCT00771615|537009820|FG003|Overall Study|Withdrawal by Subject|0|||
148872330|NCT00771615|537009821|FG004|Overall Study|Withdrawal by Subject|0|||
148872331|NCT00771615|537009822|FG005|Overall Study|Withdrawal by Subject|0|||
148872332|NCT00771615|537009823|FG006|Overall Study|Withdrawal by Subject|0|||
148872333|NCT00771615|537009824|FG007|Overall Study|Withdrawal by Subject|1|||
148872334|NCT00771615|537009825|FG008|Overall Study|Withdrawal by Subject|0|||
148872335|NCT00771615|537009817|FG000|Overall Study|Lost to Follow-up|1|||
148872336|NCT00771615|537009818|FG001|Overall Study|Lost to Follow-up|1|||
148872337|NCT00771615|537009819|FG002|Overall Study|Lost to Follow-up|1|||
148872338|NCT00771615|537009820|FG003|Overall Study|Lost to Follow-up|1|||
148872339|NCT00771615|537009821|FG004|Overall Study|Lost to Follow-up|0|||
148872340|NCT00771615|537009822|FG005|Overall Study|Lost to Follow-up|1|||
148872341|NCT00771615|537009823|FG006|Overall Study|Lost to Follow-up|1|||
148872342|NCT00771615|537009824|FG007|Overall Study|Lost to Follow-up|0|||
148872343|NCT00771615|537009825|FG008|Overall Study|Lost to Follow-up|0|||
148872344|NCT02455076|537009826|FG000|Inpatient|Withdrawal by Subject|1|||
148872345|NCT02455076|537009827|FG001|Inpatient|Withdrawal by Subject|0|||
148872346|NCT02455076|537009828|FG002|Inpatient|Withdrawal by Subject|0|||
148872347|NCT02455076|537009829|FG003|Inpatient|Withdrawal by Subject|0|||
148872348|NCT02455076|537009830|FG004|Inpatient|Withdrawal by Subject|0|||
148872349|NCT02455076|537009826|FG000|Inpatient|Discharged <24 h after admission|0|||
148872350|NCT02455076|537009827|FG001|Inpatient|Discharged <24 h after admission|1|||
148872351|NCT02455076|537009828|FG002|Inpatient|Discharged <24 h after admission|0|||
148872352|NCT02455076|537009829|FG003|Inpatient|Discharged <24 h after admission|0|||
148872353|NCT02455076|537009830|FG004|Inpatient|Discharged <24 h after admission|0|||
148872354|NCT02455076|537009826|FG000|Inpatient|Adverse Event|3|||
148872355|NCT02455076|537009827|FG001|Inpatient|Adverse Event|0|||
148872356|NCT02455076|537009828|FG002|Inpatient|Adverse Event|0|||
148872357|NCT02455076|537009829|FG003|Inpatient|Adverse Event|0|||
148872358|NCT02455076|537009830|FG004|Inpatient|Adverse Event|0|||
148872359|NCT02455076|537009826|FG000|Outpatient|Adverse Event|0|||
148872360|NCT02455076|537009827|FG001|Outpatient|Adverse Event|0|||
148872361|NCT02455076|537009828|FG002|Outpatient|Adverse Event|0|||
148872362|NCT02455076|537009829|FG003|Outpatient|Adverse Event|5|||
148872363|NCT02455076|537009830|FG004|Outpatient|Adverse Event|0|||
148872364|NCT02455076|537009826|FG000|Outpatient|Lost to Follow-up|0|||
148872365|NCT02455076|537009827|FG001|Outpatient|Lost to Follow-up|0|||
148872366|NCT02455076|537009828|FG002|Outpatient|Lost to Follow-up|0|||
148872367|NCT02455076|537009829|FG003|Outpatient|Lost to Follow-up|1|||
148872368|NCT02455076|537009830|FG004|Outpatient|Lost to Follow-up|12|||
148872369|NCT00859937|537009831|FG000|Overall Study|Protocol Violation|1|||
148872370|NCT00859937|537009832|FG001|Overall Study|Protocol Violation|0|||
148872371|NCT03908476|537009833|FG000|Overall Study|Death|3|||
148872372|NCT03908476|537009834|FG001|Overall Study|Death|0|||
148872373|NCT03908476|537009833|FG000|Overall Study|Lost to Follow-up|3|||
148872374|NCT03908476|537009834|FG001|Overall Study|Lost to Follow-up|1|||
148872375|NCT03908476|537009833|FG000|Overall Study|Withdrawal by Subject|7|||
148872376|NCT03908476|537009834|FG001|Overall Study|Withdrawal by Subject|1|||
148872377|NCT03908476|537009833|FG000|Overall Study|Physician Decision|2|||
148872378|NCT03908476|537009834|FG001|Overall Study|Physician Decision|0|||
148872379|NCT03908476|537009833|FG000|Overall Study|System Explanted and not Replaced|4|||
148872380|NCT03908476|537009834|FG001|Overall Study|System Explanted and not Replaced|0|||
148872381|NCT03908476|537009833|FG000|Overall Study|Intrathecal Pump|1|||
148872382|NCT03908476|537009834|FG001|Overall Study|Intrathecal Pump|0|||
148872383|NCT03908476|537009833|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
148872384|NCT03908476|537009834|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
148872385|NCT05194267|537009835|FG000|Overall Study|Withdrawal by Subject|2|||
148872386|NCT03270891|537009836|FG000|Overall Study|Lost to Follow-up|3|||
148872387|NCT03270891|537009837|FG001|Overall Study|Lost to Follow-up|6|||
148872388|NCT03270891|537009838|FG002|Overall Study|Lost to Follow-up|0|||
148872389|NCT03270891|537009836|FG000|Overall Study|Withdrawal by Subject|1|||
148872390|NCT03270891|537009837|FG001|Overall Study|Withdrawal by Subject|0|||
148872391|NCT03270891|537009838|FG002|Overall Study|Withdrawal by Subject|0|||
148889314|NCT00101686|537074375|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
148872392|NCT03270891|537009836|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
148872393|NCT03270891|537009837|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
148778666|NCT02326298|536663232|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778667|NCT02326298|536663233|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
148778668|NCT02326298|536663234|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778669|NCT02326298|536663235|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778670|NCT02326298|536663236|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778671|NCT02326298|536663237|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778672|NCT02326298|536663238|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778673|NCT02326298|536663239|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778674|NCT02326298|536663240|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778675|NCT02326298|536663241|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778676|NCT02326298|536663242|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778677|NCT02326298|536663243|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148872394|NCT03270891|537009838|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
148872395|NCT02540668|537009839|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
148872396|NCT02540668|537009840|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
148778678|NCT02326298|536663244|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
148778679|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778680|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778681|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148872397|NCT05779007|537009841|FG000|Overall Study|not meeting eligibility criteria|3517|||
148872398|NCT05779007|537009842|FG001|Overall Study|not meeting eligibility criteria|2009|||
148778682|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778683|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778684|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148778685|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
148778686|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148778687|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148778688|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
148778689|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778690|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778691|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778692|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
148778693|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778694|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778695|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778696|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778697|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778698|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
148872399|NCT03194438|537009847|FG000|Overall Study|Withdrawal by Subject|2|||
148872400|NCT05147662|537009848|FG000|Overall Study|Withdrawal by parent/guardian|3|||
148872401|NCT05147662|537009848|FG000|Overall Study|Assigned to treatment but never treated|1|||
148872402|NCT00231413|537009851|FG000|Overall Study|Non-serious AE|0|||
148872403|NCT00231413|537009852|FG001|Overall Study|Non-serious AE|0|||
148872404|NCT00231413|537009853|FG002|Overall Study|Non-serious AE|1|||
148872405|NCT00231413|537009854|FG003|Overall Study|Non-serious AE|0|||
148872406|NCT00231413|537009855|FG004|Overall Study|Non-serious AE|0|||
148872407|NCT00231413|537009856|FG005|Overall Study|Non-serious AE|0|||
148872408|NCT00231413|537009857|FG006|Overall Study|Non-serious AE|1|||
148872409|NCT00231413|537009851|FG000|Overall Study|Withdrawal by Subject|3|||
148872410|NCT00231413|537009852|FG001|Overall Study|Withdrawal by Subject|1|||
148872411|NCT00231413|537009853|FG002|Overall Study|Withdrawal by Subject|4|||
148872412|NCT00231413|537009854|FG003|Overall Study|Withdrawal by Subject|2|||
148872413|NCT00231413|537009855|FG004|Overall Study|Withdrawal by Subject|2|||
148872414|NCT00231413|537009856|FG005|Overall Study|Withdrawal by Subject|0|||
148872415|NCT00231413|537009857|FG006|Overall Study|Withdrawal by Subject|3|||
148872416|NCT00231413|537009851|FG000|Overall Study|Migrated/moved from study area|0|||
148872417|NCT00231413|537009852|FG001|Overall Study|Migrated/moved from study area|0|||
148872418|NCT00231413|537009853|FG002|Overall Study|Migrated/moved from study area|1|||
148872419|NCT00231413|537009854|FG003|Overall Study|Migrated/moved from study area|0|||
148872420|NCT00231413|537009855|FG004|Overall Study|Migrated/moved from study area|0|||
148872421|NCT00231413|537009856|FG005|Overall Study|Migrated/moved from study area|1|||
148872422|NCT00231413|537009857|FG006|Overall Study|Migrated/moved from study area|0|||
148778699|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
148778700|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778701|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
148778702|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778703|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778704|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778705|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778706|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
148778707|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778708|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778709|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778710|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778711|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778712|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
148778713|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778714|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778715|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778716|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778717|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778718|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778719|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778720|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
148778721|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778722|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778723|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778724|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778725|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778726|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778727|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
148778728|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778729|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778730|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778731|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778732|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778733|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778734|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
148778735|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778736|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778737|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778738|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778739|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778740|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778741|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778742|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
148778743|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778744|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778745|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778746|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778747|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778748|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
148778749|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778750|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778751|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778752|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778753|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778754|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778755|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
148778756|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
148778757|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778758|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778759|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778760|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778761|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778762|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
148778763|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778764|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778765|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778766|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778767|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778768|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778769|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778770|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
148778771|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778772|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778773|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778774|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778775|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778776|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
148778777|NCT02326298|536663231|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778778|NCT02326298|536663232|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778779|NCT02326298|536663233|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778780|NCT02326298|536663234|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778781|NCT02326298|536663235|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778782|NCT02326298|536663236|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
148778783|NCT02326298|536663237|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778784|NCT02326298|536663238|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778785|NCT02326298|536663239|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778786|NCT02326298|536663240|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778787|NCT02326298|536663241|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778788|NCT02326298|536663242|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778789|NCT02326298|536663243|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778790|NCT02326298|536663244|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
148778791|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
148778792|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
148778793|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
148778794|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
148778795|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
148778796|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
148778797|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
148778798|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
148778799|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
148778800|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
148778801|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
148778802|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
148778803|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
148778804|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
148778805|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778806|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778807|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778808|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778809|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778810|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778811|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778812|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778813|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778814|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778815|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778816|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
148778817|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
148778818|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
148778819|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778820|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778821|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778822|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778823|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148872423|NCT00231413|537009851|FG000|Overall Study|Lost to Follow-up|4|||
148872424|NCT00231413|537009852|FG001|Overall Study|Lost to Follow-up|4|||
148872425|NCT00231413|537009853|FG002|Overall Study|Lost to Follow-up|1|||
148872426|NCT00231413|537009854|FG003|Overall Study|Lost to Follow-up|1|||
148872427|NCT00231413|537009855|FG004|Overall Study|Lost to Follow-up|1|||
148872428|NCT00231413|537009856|FG005|Overall Study|Lost to Follow-up|4|||
148872429|NCT00231413|537009857|FG006|Overall Study|Lost to Follow-up|0|||
148872430|NCT00231413|537009851|FG000|Overall Study|Pregnancy|1|||
148872431|NCT00231413|537009852|FG001|Overall Study|Pregnancy|0|||
148872432|NCT00231413|537009853|FG002|Overall Study|Pregnancy|0|||
148872433|NCT00231413|537009854|FG003|Overall Study|Pregnancy|0|||
148872434|NCT00231413|537009855|FG004|Overall Study|Pregnancy|0|||
148872435|NCT00231413|537009856|FG005|Overall Study|Pregnancy|0|||
148872436|NCT00231413|537009857|FG006|Overall Study|Pregnancy|0|||
148872437|NCT02708485|537009858|FG000|Overall Study|Withdrawal by Subject|3|||
148872438|NCT02708485|537009859|FG001|Overall Study|Withdrawal by Subject|2|||
148872439|NCT01659255|537009860|FG000|Overall Study|Adverse Event|0|||
148872440|NCT01659255|537009861|FG001|Overall Study|Adverse Event|0|||
148872441|NCT01659255|537009862|FG002|Overall Study|Adverse Event|0|||
148872442|NCT01659255|537009863|FG003|Overall Study|Adverse Event|0|||
148872443|NCT01659255|537009864|FG004|Overall Study|Adverse Event|0|||
148872444|NCT01659255|537009865|FG005|Overall Study|Adverse Event|1|||
148872445|NCT01659255|537009866|FG006|Overall Study|Adverse Event|1|||
148872446|NCT01659255|537009867|FG007|Overall Study|Adverse Event|0|||
148872447|NCT01659255|537009868|FG008|Overall Study|Adverse Event|0|||
148872448|NCT01659255|537009869|FG009|Overall Study|Adverse Event|1|||
148872449|NCT01659255|537009870|FG010|Overall Study|Adverse Event|0|||
148872450|NCT01659255|537009871|FG011|Overall Study|Adverse Event|1|||
148872451|NCT01659255|537009872|FG012|Overall Study|Adverse Event|0|||
148872452|NCT01659255|537009873|FG013|Overall Study|Adverse Event|2|||
148872453|NCT01659255|537009874|FG014|Overall Study|Adverse Event|0|||
148872454|NCT01659255|537009875|FG015|Overall Study|Adverse Event|1|||
148778824|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778825|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778826|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778827|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778828|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778829|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778830|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
148778831|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
148778832|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
148778833|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778834|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778835|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778836|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778837|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778838|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778839|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778840|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778841|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778842|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778843|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778844|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778845|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
148778846|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
148778847|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148872455|NCT01659255|537009876|FG016|Overall Study|Adverse Event|0|||
148872456|NCT01659255|537009860|FG000|Overall Study|Death|0|||
148872457|NCT01659255|537009861|FG001|Overall Study|Death|1|||
148872458|NCT01659255|537009862|FG002|Overall Study|Death|0|||
148872459|NCT01659255|537009863|FG003|Overall Study|Death|0|||
148872460|NCT01659255|537009864|FG004|Overall Study|Death|0|||
148872461|NCT01659255|537009865|FG005|Overall Study|Death|0|||
148872462|NCT01659255|537009866|FG006|Overall Study|Death|0|||
148778848|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148872463|NCT01659255|537009867|FG007|Overall Study|Death|1|||
148778849|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148872464|NCT01659255|537009868|FG008|Overall Study|Death|1|||
148872465|NCT01659255|537009869|FG009|Overall Study|Death|0|||
148872466|NCT01659255|537009870|FG010|Overall Study|Death|0|||
148872467|NCT01659255|537009871|FG011|Overall Study|Death|0|||
148872468|NCT01659255|537009872|FG012|Overall Study|Death|1|||
148872469|NCT01659255|537009873|FG013|Overall Study|Death|1|||
148872470|NCT01659255|537009874|FG014|Overall Study|Death|2|||
148872471|NCT01659255|537009875|FG015|Overall Study|Death|1|||
148872472|NCT01659255|537009876|FG016|Overall Study|Death|0|||
148872473|NCT01659255|537009860|FG000|Overall Study|Progressive Disease|2|||
148872474|NCT01659255|537009861|FG001|Overall Study|Progressive Disease|0|||
148872475|NCT01659255|537009862|FG002|Overall Study|Progressive Disease|0|||
148872476|NCT01659255|537009863|FG003|Overall Study|Progressive Disease|0|||
148778850|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778851|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778852|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778853|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778854|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778855|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
149033051|NCT00567879|537598953|FG005|Overall Study|Disease progression|3|||
149033052|NCT01546155|537598955|FG000|Overall Study|could not tolerate long scan duration|3|||
149033053|NCT02930343|537598956|FG000|Overall Study|Lost to Follow-up|9|||
149033054|NCT02930343|537598957|FG001|Overall Study|Lost to Follow-up|7|||
149033055|NCT00486759|537598962|FG000|Treatment|Adverse event/intercurrent illness|86|||
149033056|NCT00486759|537598963|FG001|Treatment|Adverse event/intercurrent illness|39|||
149033057|NCT00486759|537598962|FG000|Treatment|Insufficient therapeutic response|37|||
149033058|NCT00486759|537598963|FG001|Treatment|Insufficient therapeutic response|39|||
149033059|NCT00486759|537598962|FG000|Treatment|Death|17|||
149033060|NCT00486759|537598963|FG001|Treatment|Death|10|||
149033061|NCT00486759|537598962|FG000|Treatment|Withdrew consent|15|||
149033062|NCT00486759|537598963|FG001|Treatment|Withdrew consent|12|||
148778856|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778857|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
148778858|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
148778859|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
148778860|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
148778861|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778862|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778863|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778864|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778865|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778866|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778867|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778868|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778869|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778870|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778871|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
148778872|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
148778873|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
148778874|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
148778875|NCT02326298|536663231|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778876|NCT02326298|536663232|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778877|NCT02326298|536663233|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778878|NCT02326298|536663234|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778879|NCT02326298|536663235|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778880|NCT02326298|536663236|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778881|NCT02326298|536663237|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778882|NCT02326298|536663238|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778883|NCT02326298|536663239|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778884|NCT02326298|536663240|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778885|NCT02326298|536663241|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
148778886|NCT02326298|536663242|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
148778887|NCT02326298|536663243|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
148778888|NCT02326298|536663244|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
148778889|NCT02044874|536663248|FG000|Overall Study|Adverse Event|5|||
148778890|NCT02044874|536663249|FG001|Overall Study|Adverse Event|6|||
148778891|NCT02044874|536663250|FG002|Overall Study|Adverse Event|6|||
148778892|NCT02044874|536663248|FG000|Overall Study|Withdrawal by Subject|8|||
148778893|NCT02044874|536663249|FG001|Overall Study|Withdrawal by Subject|16|||
148778894|NCT02044874|536663250|FG002|Overall Study|Withdrawal by Subject|23|||
148778895|NCT02044874|536663248|FG000|Overall Study|Physician Decision|0|||
148778896|NCT02044874|536663249|FG001|Overall Study|Physician Decision|2|||
148778897|NCT02044874|536663250|FG002|Overall Study|Physician Decision|1|||
148778898|NCT02044874|536663248|FG000|Overall Study|Lost to Follow-up|10|||
148778899|NCT02044874|536663249|FG001|Overall Study|Lost to Follow-up|27|||
148778900|NCT02044874|536663250|FG002|Overall Study|Lost to Follow-up|21|||
148872477|NCT01659255|537009864|FG004|Overall Study|Progressive Disease|0|||
149033063|NCT00486759|537598962|FG000|Treatment|Administrative/reason not specified|17|||
149033064|NCT00486759|537598963|FG001|Treatment|Administrative/reason not specified|21|||
149033065|NCT00486759|537598962|FG000|Treatment|Refused treatment|10|||
149033066|NCT00486759|537598963|FG001|Treatment|Refused treatment|7|||
149033067|NCT00486759|537598962|FG000|Treatment|Violation of selection criteria at entry|3|||
149033068|NCT00486759|537598963|FG001|Treatment|Violation of selection criteria at entry|3|||
149033069|NCT00486759|537598962|FG000|Treatment|Other protocol violation|1|||
149033070|NCT00486759|537598963|FG001|Treatment|Other protocol violation|5|||
149033071|NCT00486759|537598962|FG000|Treatment|Failure to return|1|||
148872478|NCT01659255|537009865|FG005|Overall Study|Progressive Disease|0|||
148872479|NCT01659255|537009866|FG006|Overall Study|Progressive Disease|0|||
148872480|NCT01659255|537009867|FG007|Overall Study|Progressive Disease|1|||
148872481|NCT01659255|537009868|FG008|Overall Study|Progressive Disease|0|||
148872482|NCT01659255|537009869|FG009|Overall Study|Progressive Disease|2|||
148872483|NCT01659255|537009870|FG010|Overall Study|Progressive Disease|2|||
148872484|NCT01659255|537009871|FG011|Overall Study|Progressive Disease|3|||
148872485|NCT01659255|537009872|FG012|Overall Study|Progressive Disease|5|||
148872486|NCT01659255|537009873|FG013|Overall Study|Progressive Disease|13|||
148872487|NCT01659255|537009874|FG014|Overall Study|Progressive Disease|6|||
148872488|NCT01659255|537009875|FG015|Overall Study|Progressive Disease|2|||
148872489|NCT01659255|537009876|FG016|Overall Study|Progressive Disease|3|||
148872490|NCT01659255|537009860|FG000|Overall Study|Withdrew Consent|0|||
148872491|NCT01659255|537009861|FG001|Overall Study|Withdrew Consent|0|||
148872492|NCT01659255|537009862|FG002|Overall Study|Withdrew Consent|0|||
148872493|NCT01659255|537009863|FG003|Overall Study|Withdrew Consent|0|||
148872494|NCT01659255|537009864|FG004|Overall Study|Withdrew Consent|0|||
148872495|NCT01659255|537009865|FG005|Overall Study|Withdrew Consent|0|||
148872496|NCT01659255|537009866|FG006|Overall Study|Withdrew Consent|0|||
148872497|NCT01659255|537009867|FG007|Overall Study|Withdrew Consent|0|||
148872498|NCT01659255|537009868|FG008|Overall Study|Withdrew Consent|0|||
148872499|NCT01659255|537009869|FG009|Overall Study|Withdrew Consent|0|||
148872500|NCT01659255|537009870|FG010|Overall Study|Withdrew Consent|1|||
148872501|NCT01659255|537009871|FG011|Overall Study|Withdrew Consent|0|||
148872502|NCT01659255|537009872|FG012|Overall Study|Withdrew Consent|0|||
148872503|NCT01659255|537009873|FG013|Overall Study|Withdrew Consent|1|||
148872504|NCT01659255|537009874|FG014|Overall Study|Withdrew Consent|0|||
148872505|NCT01659255|537009875|FG015|Overall Study|Withdrew Consent|0|||
148872506|NCT01659255|537009876|FG016|Overall Study|Withdrew Consent|0|||
148872507|NCT01659255|537009860|FG000|Overall Study|Investigator Decision|0|||
148872508|NCT01659255|537009861|FG001|Overall Study|Investigator Decision|0|||
148872509|NCT01659255|537009862|FG002|Overall Study|Investigator Decision|0|||
148872510|NCT01659255|537009863|FG003|Overall Study|Investigator Decision|0|||
148872511|NCT01659255|537009864|FG004|Overall Study|Investigator Decision|0|||
148872512|NCT01659255|537009865|FG005|Overall Study|Investigator Decision|0|||
148872513|NCT01659255|537009866|FG006|Overall Study|Investigator Decision|0|||
148872514|NCT01659255|537009867|FG007|Overall Study|Investigator Decision|0|||
148872515|NCT01659255|537009868|FG008|Overall Study|Investigator Decision|0|||
148872516|NCT01659255|537009869|FG009|Overall Study|Investigator Decision|0|||
148872517|NCT01659255|537009870|FG010|Overall Study|Investigator Decision|0|||
148872518|NCT01659255|537009871|FG011|Overall Study|Investigator Decision|0|||
148872519|NCT01659255|537009872|FG012|Overall Study|Investigator Decision|1|||
148872520|NCT01659255|537009873|FG013|Overall Study|Investigator Decision|1|||
148872521|NCT01659255|537009874|FG014|Overall Study|Investigator Decision|0|||
148872522|NCT01659255|537009875|FG015|Overall Study|Investigator Decision|0|||
148872523|NCT01659255|537009876|FG016|Overall Study|Investigator Decision|0|||
148872524|NCT01659255|537009860|FG000|Overall Study|Sponsor's Decision|0|||
148872525|NCT01659255|537009861|FG001|Overall Study|Sponsor's Decision|0|||
148872526|NCT01659255|537009862|FG002|Overall Study|Sponsor's Decision|0|||
148872527|NCT01659255|537009863|FG003|Overall Study|Sponsor's Decision|0|||
148872528|NCT01659255|537009864|FG004|Overall Study|Sponsor's Decision|0|||
148778901|NCT02044874|536663248|FG000|Overall Study|Sponsor Decision|0|||
148778902|NCT02044874|536663249|FG001|Overall Study|Sponsor Decision|1|||
148778903|NCT02044874|536663250|FG002|Overall Study|Sponsor Decision|1|||
148778904|NCT02044874|536663248|FG000|Overall Study|Other|7|||
148778905|NCT02044874|536663249|FG001|Overall Study|Other|3|||
148778906|NCT02044874|536663250|FG002|Overall Study|Other|8|||
148778907|NCT05072964|536663253|FG000|Overall Study|Withdrawal by Subject|4|||
148778908|NCT05072964|536663253|FG000|Overall Study|Death|1|||
148778909|NCT01047332|536663256|FG000|Overall Study|SEMS Obstruction|11|||
148778910|NCT01047332|536663257|FG001|Overall Study|SEMS Obstruction|20|||
148778911|NCT01047332|536663256|FG000|Overall Study|Died Unobstructed|38|||
148778912|NCT01047332|536663257|FG001|Overall Study|Died Unobstructed|41|||
148778913|NCT01047332|536663256|FG000|Overall Study|Lost to Follow-up|8|||
148778914|NCT01047332|536663257|FG001|Overall Study|Lost to Follow-up|3|||
148778915|NCT03521817|536663262|FG000|Overall Study|Protocol Violation|0|||
148778916|NCT03521817|536663263|FG001|Overall Study|Protocol Violation|1|||
148778917|NCT00778102|536663264|FG000|Overall Study|Adverse Event|8|||
148778918|NCT00778102|536663265|FG001|Overall Study|Adverse Event|5|||
148778919|NCT00778102|536663264|FG000|Overall Study|Death|1|||
148872529|NCT01659255|537009865|FG005|Overall Study|Sponsor's Decision|0|||
148872530|NCT01659255|537009866|FG006|Overall Study|Sponsor's Decision|1|||
148872531|NCT01659255|537009867|FG007|Overall Study|Sponsor's Decision|0|||
148872532|NCT01659255|537009868|FG008|Overall Study|Sponsor's Decision|0|||
148872533|NCT01659255|537009869|FG009|Overall Study|Sponsor's Decision|0|||
148872534|NCT01659255|537009870|FG010|Overall Study|Sponsor's Decision|0|||
148872535|NCT01659255|537009871|FG011|Overall Study|Sponsor's Decision|0|||
148872536|NCT01659255|537009872|FG012|Overall Study|Sponsor's Decision|0|||
148872537|NCT01659255|537009873|FG013|Overall Study|Sponsor's Decision|0|||
148872538|NCT01659255|537009874|FG014|Overall Study|Sponsor's Decision|0|||
148872539|NCT01659255|537009875|FG015|Overall Study|Sponsor's Decision|0|||
148872540|NCT01659255|537009876|FG016|Overall Study|Sponsor's Decision|0|||
148872541|NCT01659255|537009860|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872542|NCT01659255|537009861|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872543|NCT01659255|537009862|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872544|NCT01659255|537009863|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872545|NCT01659255|537009864|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872546|NCT01659255|537009865|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872547|NCT01659255|537009866|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872548|NCT01659255|537009867|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872549|NCT01659255|537009868|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872550|NCT01659255|537009869|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872551|NCT01659255|537009870|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872552|NCT01659255|537009871|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872553|NCT01659255|537009872|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872554|NCT01659255|537009873|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872555|NCT01659255|537009874|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872556|NCT01659255|537009875|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
148872557|NCT01659255|537009876|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
148872558|NCT01659255|537009860|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
148872559|NCT01659255|537009861|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
148872560|NCT01659255|537009862|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
148872561|NCT01659255|537009863|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
148872562|NCT01659255|537009864|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
148872563|NCT01659255|537009865|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
148872564|NCT01659255|537009866|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
148872565|NCT01659255|537009867|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
148872566|NCT01659255|537009868|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
148872567|NCT01659255|537009869|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
148872568|NCT01659255|537009870|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
148872569|NCT01659255|537009871|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
148872570|NCT01659255|537009872|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
148872571|NCT01659255|537009873|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
148872572|NCT01659255|537009874|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
148872573|NCT01659255|537009875|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
148872574|NCT01659255|537009876|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
148872575|NCT03157583|537009877|FG000|Overall Study|Other (did not meet study criteria)|1|||
148872576|NCT02613169|537009886|FG000|Overall Study|Withdrawal by Subject|4|||
148872577|NCT02613169|537009887|FG001|Overall Study|Withdrawal by Subject|1|||
148872578|NCT02613169|537009886|FG000|Overall Study|Lost to Follow-up|0|||
148872579|NCT02613169|537009887|FG001|Overall Study|Lost to Follow-up|5|||
148872580|NCT02613169|537009886|FG000|Overall Study|HIV|0|||
148872581|NCT02613169|537009887|FG001|Overall Study|HIV|2|||
148872582|NCT02613169|537009886|FG000|Overall Study|No TB infection endpoint|14|||
148872583|NCT02613169|537009887|FG001|Overall Study|No TB infection endpoint|9|||
148872584|NCT00084487|537009894|FG000|Overall Study|Death|1|||
148872585|NCT03332160|537009895|FG000|Overall Study|Withdrawal by Subject|1|||
148872586|NCT03332160|537009896|FG001|Overall Study|Withdrawal by Subject|1|||
148872587|NCT03332160|537009895|FG000|Overall Study|Adverse Event|0|||
148872588|NCT03332160|537009896|FG001|Overall Study|Adverse Event|1|||
148872589|NCT03332160|537009895|FG000|Overall Study|Developed Exclusion Criteria|0|||
148872590|NCT03332160|537009896|FG001|Overall Study|Developed Exclusion Criteria|1|||
148872591|NCT03332160|537009895|FG000|Overall Study|Non-adherence to treatment|0|||
148872592|NCT03332160|537009896|FG001|Overall Study|Non-adherence to treatment|2|||
148872593|NCT01561963|537009897|FG000|Overall Study|Adverse Event|1|||
148872594|NCT04598269|537009898|FG000|Overall Study|Adverse Event|0|||
148872595|NCT04598269|537009899|FG001|Overall Study|Adverse Event|3|||
148872596|NCT04598269|537009898|FG000|Overall Study|Withdrawal by Subject|1|||
148872597|NCT04598269|537009899|FG001|Overall Study|Withdrawal by Subject|4|||
148872598|NCT04598269|537009898|FG000|Overall Study|Lost to Follow-up|1|||
148872599|NCT04598269|537009899|FG001|Overall Study|Lost to Follow-up|0|||
148872600|NCT04598269|537009898|FG000|Overall Study|Not Treated|2|||
148872601|NCT04598269|537009899|FG001|Overall Study|Not Treated|0|||
148872602|NCT03040986|537009902|FG000|Overall Study|Hospice|1|||
148778920|NCT00778102|536663265|FG001|Overall Study|Death|1|||
148778921|NCT00778102|536663264|FG000|Overall Study|Lost to Follow-up|1|||
148778922|NCT00778102|536663265|FG001|Overall Study|Lost to Follow-up|0|||
148778923|NCT00778102|536663264|FG000|Overall Study|Violation of Selection Criteria|1|||
148778924|NCT00778102|536663265|FG001|Overall Study|Violation of Selection Criteria|1|||
148872603|NCT03040986|537009903|FG001|Overall Study|Hospice|0|||
148872604|NCT03040986|537009902|FG000|Overall Study|Adverse Event|2|||
148872605|NCT03040986|537009903|FG001|Overall Study|Adverse Event|1|||
148872606|NCT03040986|537009902|FG000|Overall Study|Disease progression on study|3|||
148872607|NCT03040986|537009903|FG001|Overall Study|Disease progression on study|1|||
148872608|NCT02925728|537009908|FG000|Overall Study|Death|3|||
148872609|NCT02925728|537009909|FG001|Overall Study|Death|5|||
148872610|NCT02925728|537009908|FG000|Overall Study|Physician Decision|1|||
148872611|NCT02925728|537009909|FG001|Overall Study|Physician Decision|0|||
148872612|NCT02925728|537009908|FG000|Overall Study|Withdrawal by Subject|1|||
148872613|NCT02925728|537009909|FG001|Overall Study|Withdrawal by Subject|0|||
148872614|NCT02039856|537009910|FG000|Overall Study|Death|5|||
148872615|NCT02039856|537009911|FG001|Overall Study|Death|3|||
148872616|NCT02039856|537009910|FG000|Overall Study|Partial survey completion|61|||
148872617|NCT02039856|537009911|FG001|Overall Study|Partial survey completion|26|||
148778925|NCT00778102|536663264|FG000|Overall Study|Protocol Violation|0|||
148778926|NCT00778102|536663265|FG001|Overall Study|Protocol Violation|1|||
148778927|NCT00778102|536663264|FG000|Overall Study|Refused Treatment|2|||
148778928|NCT00778102|536663265|FG001|Overall Study|Refused Treatment|3|||
148778929|NCT00778102|536663264|FG000|Overall Study|Withdrawal by Subject|1|||
148778930|NCT00778102|536663265|FG001|Overall Study|Withdrawal by Subject|1|||
148778931|NCT00778102|536663264|FG000|Overall Study|Administrative Reason|7|||
148778932|NCT00778102|536663265|FG001|Overall Study|Administrative Reason|10|||
148778933|NCT04506905|536663268|FG000|Overall Study|Lost to Follow-up|1|||
148778934|NCT04506905|536663269|FG001|Overall Study|Lost to Follow-up|0|||
148778935|NCT04506905|536663270|FG002|Overall Study|Lost to Follow-up|0|||
148778936|NCT04506905|536663271|FG003|Overall Study|Lost to Follow-up|1|||
148778937|NCT04506905|536663272|FG004|Overall Study|Lost to Follow-up|0|||
148778938|NCT04506905|536663273|FG005|Overall Study|Lost to Follow-up|0|||
148778939|NCT04506905|536663274|FG006|Overall Study|Lost to Follow-up|0|||
148778940|NCT04506905|536663275|FG007|Overall Study|Lost to Follow-up|0|||
149033072|NCT00486759|537598963|FG001|Treatment|Failure to return|1|||
149033073|NCT00486759|537598962|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
149033074|NCT00486759|537598963|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
149033075|NCT00486759|537598962|FG000|Safety Follow-up|Death|40|||
149033076|NCT00486759|537598963|FG001|Safety Follow-up|Death|29|||
149033077|NCT00486759|537598962|FG000|Safety Follow-up|Withdrew consent|32|||
148778941|NCT04506905|536663276|FG008|Overall Study|Lost to Follow-up|0|||
148778942|NCT04506905|536663268|FG000|Overall Study|Withdrawal by Subject|0|||
148778943|NCT04506905|536663269|FG001|Overall Study|Withdrawal by Subject|0|||
148778944|NCT04506905|536663270|FG002|Overall Study|Withdrawal by Subject|0|||
148778945|NCT04506905|536663271|FG003|Overall Study|Withdrawal by Subject|2|||
148778946|NCT04506905|536663272|FG004|Overall Study|Withdrawal by Subject|0|||
148778947|NCT04506905|536663273|FG005|Overall Study|Withdrawal by Subject|0|||
148778948|NCT04506905|536663274|FG006|Overall Study|Withdrawal by Subject|0|||
148778949|NCT04506905|536663275|FG007|Overall Study|Withdrawal by Subject|0|||
149033078|NCT00486759|537598963|FG001|Safety Follow-up|Withdrew consent|23|||
149033079|NCT00486759|537598962|FG000|Safety Follow-up|Failure to return|9|||
149033080|NCT00486759|537598963|FG001|Safety Follow-up|Failure to return|6|||
149033081|NCT00486759|537598962|FG000|Safety Follow-up|Administrative/not specified|8|||
149033082|NCT00486759|537598963|FG001|Safety Follow-up|Administrative/not specified|6|||
149033083|NCT00486759|537598962|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
149033084|NCT00486759|537598963|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
149033085|NCT00486759|537598962|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
149033086|NCT00486759|537598963|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
148872618|NCT02039856|537009910|FG000|Overall Study|Lost to Follow-up|388|||
148872619|NCT02039856|537009911|FG001|Overall Study|Lost to Follow-up|206|||
148872620|NCT02039856|537009910|FG000|Overall Study|Withdrawal by Subject|1573|||
148872621|NCT02039856|537009911|FG001|Overall Study|Withdrawal by Subject|618|||
148872622|NCT02540291|537009912|FG000|Overall Study|Death|7|||
148872623|NCT02540291|537009913|FG001|Overall Study|Death|7|||
148778950|NCT04506905|536663276|FG008|Overall Study|Withdrawal by Subject|0|||
148778951|NCT00073983|536663277|FG000|Overall Study|not evaluable|1|||
148778952|NCT03976323|536663280|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
148872624|NCT02540291|537009914|FG002|Overall Study|Death|5|||
148872625|NCT02540291|537009915|FG003|Overall Study|Death|7|||
148872626|NCT02540291|537009912|FG000|Overall Study|Lost to Follow-up|0|||
149033087|NCT01729819|537598964|FG000|Overall Study|Adverse Event|2|||
148872627|NCT02540291|537009913|FG001|Overall Study|Lost to Follow-up|0|||
148872628|NCT02540291|537009914|FG002|Overall Study|Lost to Follow-up|1|||
149033088|NCT01729819|537598965|FG001|Overall Study|Adverse Event|4|||
149033089|NCT01729819|537598964|FG000|Overall Study|Lack of Efficacy|1|||
149033090|NCT01729819|537598965|FG001|Overall Study|Lack of Efficacy|0|||
149033091|NCT01729819|537598964|FG000|Overall Study|Lost to Follow-up|2|||
149033092|NCT01729819|537598965|FG001|Overall Study|Lost to Follow-up|0|||
149033093|NCT01729819|537598964|FG000|Overall Study|Other reason|1|||
149033094|NCT01729819|537598965|FG001|Overall Study|Other reason|0|||
149033095|NCT01729819|537598964|FG000|Overall Study|Protocol Violation|0|||
149033096|NCT01729819|537598965|FG001|Overall Study|Protocol Violation|1|||
149033097|NCT01729819|537598964|FG000|Overall Study|Withdrawal by Subject|0|||
149033098|NCT01729819|537598965|FG001|Overall Study|Withdrawal by Subject|2|||
149033099|NCT01025843|537598966|FG000|Washout 4|Withdrawal by Subject|0|||
149033100|NCT01025843|537598967|FG001|Washout 4|Withdrawal by Subject|0|||
149033101|NCT01025843|537598968|FG002|Washout 4|Withdrawal by Subject|1|||
149033102|NCT01025843|537598969|FG003|Washout 4|Withdrawal by Subject|1|||
148872629|NCT02540291|537009915|FG003|Overall Study|Lost to Follow-up|0|||
148872630|NCT02540291|537009912|FG000|Overall Study|Withdrawal Of Consent|0|||
149033103|NCT01025843|537598970|FG004|Washout 4|Withdrawal by Subject|0|||
149033104|NCT01025843|537598971|FG005|Washout 4|Withdrawal by Subject|0|||
149033105|NCT01025843|537598972|FG006|Washout 4|Withdrawal by Subject|0|||
148872631|NCT02540291|537009913|FG001|Overall Study|Withdrawal Of Consent|1|||
148872632|NCT02540291|537009914|FG002|Overall Study|Withdrawal Of Consent|0|||
148872633|NCT02540291|537009915|FG003|Overall Study|Withdrawal Of Consent|0|||
148872634|NCT02540291|537009912|FG000|Overall Study|Study Terminated By Sponsor|1|||
149033106|NCT01025843|537598973|FG007|Washout 4|Withdrawal by Subject|0|||
149033107|NCT01025843|537598974|FG008|Washout 4|Withdrawal by Subject|0|||
149033108|NCT01025843|537598975|FG009|Washout 4|Withdrawal by Subject|0|||
149033109|NCT01649791|537598978|FG000|Overall Study|Disease Progression|2|||
149033110|NCT01649791|537598978|FG000|Overall Study|Adverse Event|1|||
149033111|NCT02987543|537598979|FG000|Overall Study|Ongoing study at data cut off|49|||
149033112|NCT02987543|537598980|FG001|Overall Study|Ongoing study at data cut off|21|||
149033113|NCT02987543|537598981|FG002|Overall Study|Ongoing study at data cut off|19|||
148778953|NCT03976323|536663281|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
148778954|NCT03976323|536663282|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
148778955|NCT03976323|536663280|FG000|Induction Phase|Death|80|||
148778956|NCT03976323|536663281|FG001|Induction Phase|Death|0|||
148778957|NCT03976323|536663282|FG002|Induction Phase|Death|0|||
148778958|NCT03976323|536663280|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
148778959|NCT03976323|536663281|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
148778960|NCT03976323|536663282|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
148778961|NCT03976323|536663280|FG000|Maintenance Phase|Withdrawal by Subject|0|||
148778962|NCT03976323|536663281|FG001|Maintenance Phase|Withdrawal by Subject|9|||
148778963|NCT03976323|536663282|FG002|Maintenance Phase|Withdrawal by Subject|3|||
148872635|NCT02540291|537009913|FG001|Overall Study|Study Terminated By Sponsor|0|||
148872636|NCT02540291|537009914|FG002|Overall Study|Study Terminated By Sponsor|0|||
148872637|NCT02540291|537009915|FG003|Overall Study|Study Terminated By Sponsor|0|||
148872638|NCT02540291|537009912|FG000|Overall Study|Other|0|||
148872639|NCT02540291|537009913|FG001|Overall Study|Other|0|||
148872640|NCT02540291|537009914|FG002|Overall Study|Other|1|||
148872641|NCT02540291|537009915|FG003|Overall Study|Other|0|||
148872642|NCT01879072|537009925|FG000|Overall Study|Withdrawal by Subject|121|||
148872643|NCT01879072|537009925|FG000|Overall Study|Not Transplanted|30|||
148872644|NCT03109184|537012235|FG000|Overall Study|Lost to Follow-up|6|||
148872645|NCT03109184|537012236|FG001|Overall Study|Lost to Follow-up|6|||
148872646|NCT03109184|537012235|FG000|Overall Study|Withdrawal by Subject|1|||
148872647|NCT03109184|537012236|FG001|Overall Study|Withdrawal by Subject|1|||
148872648|NCT01041287|537012238|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
148872649|NCT01041287|537012239|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
148872650|NCT01041287|537012238|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
148872651|NCT01041287|537012239|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
148872652|NCT01209078|537012240|FG000|Overall Study|Adverse Event|5|||
148872653|NCT01209078|537012241|FG001|Overall Study|Adverse Event|0|||
148778964|NCT03976323|536663280|FG000|Maintenance Phase|Physician Decision|0|||
148778965|NCT03976323|536663281|FG001|Maintenance Phase|Physician Decision|0|||
148872654|NCT01209078|537012240|FG000|Overall Study|Lost to Follow-up|4|||
148872655|NCT01209078|537012241|FG001|Overall Study|Lost to Follow-up|0|||
148872656|NCT01209078|537012240|FG000|Overall Study|Physician Decision|5|||
148872657|NCT01209078|537012241|FG001|Overall Study|Physician Decision|2|||
148872658|NCT01209078|537012240|FG000|Overall Study|Withdrawal by Subject|2|||
148872659|NCT01209078|537012241|FG001|Overall Study|Withdrawal by Subject|1|||
149033114|NCT02987543|537598982|FG003|Overall Study|Ongoing study at data cut off|12|||
149033115|NCT02987543|537598979|FG000|Overall Study|Death|88|||
149033116|NCT02987543|537598980|FG001|Overall Study|Death|54|||
149033117|NCT02987543|537598981|FG002|Overall Study|Death|67|||
149033118|NCT02987543|537598982|FG003|Overall Study|Death|28|||
149033119|NCT02987543|537598979|FG000|Overall Study|Lost to Follow-up|3|||
149033120|NCT02987543|537598980|FG001|Overall Study|Lost to Follow-up|0|||
149033121|NCT02987543|537598981|FG002|Overall Study|Lost to Follow-up|1|||
148872660|NCT00924508|537012242|FG000|Overall Study|Withdrawal by Subject|3|||
148872661|NCT00372697|537012243|FG000|Overall Study|Protocol Violation|1|||
148872662|NCT00372697|537012244|FG001|Overall Study|Protocol Violation|1|||
148872663|NCT03221842|537012246|FG000|Period 1 (Open-label)|Adverse Event|4|||
148872664|NCT03221842|537012247|FG001|Period 1 (Open-label)|Adverse Event|0|||
148872665|NCT03221842|537012246|FG000|Period 1 (Open-label)|Physician Decision|2|||
148872666|NCT03221842|537012247|FG001|Period 1 (Open-label)|Physician Decision|0|||
148872667|NCT03221842|537012246|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
148872668|NCT03221842|537012247|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
148872669|NCT03221842|537012246|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
148872670|NCT03221842|537012247|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
148872671|NCT03221842|537012246|FG000|Period 1 (Open-label)|Other|2|||
148872672|NCT03221842|537012247|FG001|Period 1 (Open-label)|Other|0|||
148872673|NCT03221842|537012246|FG000|Period 2 (Randomized, Blinded)|Death|0|||
148872674|NCT03221842|537012247|FG001|Period 2 (Randomized, Blinded)|Death|1|||
148872675|NCT03221842|537012246|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
148872676|NCT03221842|537012247|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
148872677|NCT00704288|537012248|FG000|Overall Treatment Period|Adverse Event|11|||
148872678|NCT00704288|537012249|FG001|Overall Treatment Period|Adverse Event|8|||
148872679|NCT00704288|537012250|FG002|Overall Treatment Period|Adverse Event|22|||
148872680|NCT00704288|537012248|FG000|Overall Treatment Period|Death|0|||
148872681|NCT00704288|537012249|FG001|Overall Treatment Period|Death|0|||
148872682|NCT00704288|537012250|FG002|Overall Treatment Period|Death|1|||
148872683|NCT00704288|537012248|FG000|Overall Treatment Period|Physician Decision|0|||
148872684|NCT00704288|537012249|FG001|Overall Treatment Period|Physician Decision|2|||
148872685|NCT00704288|537012250|FG002|Overall Treatment Period|Physician Decision|0|||
148872686|NCT00704288|537012248|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
148872687|NCT00704288|537012249|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
148872688|NCT00704288|537012250|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
148872689|NCT00704288|537012248|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
148872690|NCT00704288|537012249|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
148872691|NCT00704288|537012250|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
148872692|NCT00704288|537012248|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
148872693|NCT00704288|537012249|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
148872694|NCT00704288|537012250|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
148872695|NCT00704288|537012248|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
148872696|NCT00704288|537012249|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
148872697|NCT00704288|537012250|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
148872698|NCT00704288|537012248|FG000|Overall Treatment Period|Roll-over to another study|1|||
148872699|NCT00704288|537012249|FG001|Overall Treatment Period|Roll-over to another study|0|||
148872700|NCT00704288|537012250|FG002|Overall Treatment Period|Roll-over to another study|4|||
148872701|NCT00704288|537012248|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
148872702|NCT00704288|537012249|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
148872703|NCT00704288|537012250|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
148872704|NCT00704288|537012248|FG000|Extended Post Treatment Follow Up Period|Death|41|||
148872705|NCT00704288|537012249|FG001|Extended Post Treatment Follow Up Period|Death|50|||
148872706|NCT00704288|537012250|FG002|Extended Post Treatment Follow Up Period|Death|93|||
148872707|NCT00704288|537012248|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
148872708|NCT00704288|537012249|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
148872709|NCT00704288|537012250|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
148872710|NCT00704288|537012248|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
148872711|NCT00704288|537012249|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
148872712|NCT00704288|537012250|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
148872713|NCT00704288|537012248|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
148872714|NCT00704288|537012249|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
148872715|NCT00704288|537012250|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
148872716|NCT01055314|537012251|FG000|Overall Study|Adverse Event|7|||
148872717|NCT01055314|537012252|FG001|Overall Study|Adverse Event|4|||
148872718|NCT01055314|537012251|FG000|Overall Study|Death|2|||
148872719|NCT01055314|537012252|FG001|Overall Study|Death|1|||
148778966|NCT03976323|536663282|FG002|Maintenance Phase|Physician Decision|1|||
148778967|NCT03976323|536663280|FG000|Maintenance Phase|Death|0|||
148778968|NCT03976323|536663281|FG001|Maintenance Phase|Death|228|||
148778969|NCT03976323|536663282|FG002|Maintenance Phase|Death|234|||
148778970|NCT03800836|536663284|FG000|Overall Study|Other|2|||
148778971|NCT03800836|536663285|FG001|Overall Study|Other|1|||
148778972|NCT03800836|536663286|FG002|Overall Study|Other|0|||
148778973|NCT03800836|536663287|FG003|Overall Study|Other|2|||
148778974|NCT03800836|536663288|FG004|Overall Study|Other|0|||
148778975|NCT03800836|536663289|FG005|Overall Study|Other|1|||
148872720|NCT01055314|537012251|FG000|Overall Study|Lack of Efficacy|11|||
148872721|NCT01055314|537012252|FG001|Overall Study|Lack of Efficacy|19|||
148872722|NCT01055314|537012251|FG000|Overall Study|Physician Decision|10|||
148872723|NCT01055314|537012252|FG001|Overall Study|Physician Decision|5|||
148872724|NCT01055314|537012251|FG000|Overall Study|Withdrawal by Subject|1|||
148872725|NCT01055314|537012252|FG001|Overall Study|Withdrawal by Subject|0|||
148872726|NCT01055314|537012251|FG000|Overall Study|Ineligible|3|||
148872727|NCT01055314|537012252|FG001|Overall Study|Ineligible|5|||
148872728|NCT01055314|537012251|FG000|Overall Study|Refusal of further protocol therapy|10|||
148872729|NCT01055314|537012252|FG001|Overall Study|Refusal of further protocol therapy|4|||
148872730|NCT01055314|537012251|FG000|Overall Study|No treatment|1|||
148872731|NCT01055314|537012252|FG001|Overall Study|No treatment|0|||
148872732|NCT04680975|537012253|FG000|Overall Study|Adverse Event|3|||
148872733|NCT04680975|537012253|FG000|Overall Study|Death|1|||
148872734|NCT04680975|537012253|FG000|Overall Study|Progressive Disease|1|||
148872735|NCT04680975|537012253|FG000|Overall Study|Withdrawal by Subject|1|||
148872736|NCT03909152|537012254|FG000|Overall Study|Adverse Event|14|||
148872737|NCT03909152|537012255|FG001|Overall Study|Adverse Event|5|||
148872738|NCT03909152|537012256|FG002|Overall Study|Adverse Event|1|||
148872739|NCT03909152|537012257|FG003|Overall Study|Adverse Event|14|||
148872740|NCT04541628|537012260|FG000|Overall Study|Study Terminated|1|||
148872741|NCT04541628|537012261|FG001|Overall Study|Study Terminated|1|||
148872742|NCT04541628|537012262|FG002|Overall Study|Study Terminated|1|||
148872743|NCT01192412|537012267|FG000|Overall Study|Lost to Follow-up|2|||
148872744|NCT01192412|537012268|FG001|Overall Study|Lost to Follow-up|1|||
148872745|NCT01192412|537012267|FG000|Overall Study|Withdrawal by Subject|2|||
148872746|NCT01192412|537012268|FG001|Overall Study|Withdrawal by Subject|1|||
148872747|NCT00151476|537012269|FG000|FAP Identified Subjects|Protocol Violation|0|||
148872748|NCT00151476|537012270|FG001|FAP Identified Subjects|Protocol Violation|1|||
148872749|NCT00151476|537012269|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
148872750|NCT00151476|537012270|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
148872751|NCT00151476|537012269|FG000|FAP Analyzed Subjects|Other study participation|0|||
148872752|NCT00151476|537012270|FG001|FAP Analyzed Subjects|Other study participation|1|||
148872753|NCT04099511|537012275|FG000|Overall Study|Lost to Follow-up|2|||
148872754|NCT04099511|537012276|FG001|Overall Study|Lost to Follow-up|2|||
148872755|NCT04099511|537012275|FG000|Overall Study|Withdrawal by Subject|8|||
148872756|NCT04099511|537012276|FG001|Overall Study|Withdrawal by Subject|4|||
148872757|NCT02868229|537012277|FG000|Overall Study|Adverse Event|1|||
148872758|NCT02868229|537012278|FG001|Overall Study|Adverse Event|0|||
148872759|NCT02868229|537012279|FG002|Overall Study|Adverse Event|0|||
148872760|NCT02868229|537012280|FG003|Overall Study|Adverse Event|1|||
148872761|NCT02868229|537012277|FG000|Overall Study|Death|0|||
148872762|NCT02868229|537012278|FG001|Overall Study|Death|0|||
148872763|NCT02868229|537012279|FG002|Overall Study|Death|1|||
148872764|NCT02868229|537012280|FG003|Overall Study|Death|1|||
148872765|NCT02868229|537012277|FG000|Overall Study|Missed dose|0|||
148872766|NCT02868229|537012278|FG001|Overall Study|Missed dose|0|||
148872767|NCT02868229|537012279|FG002|Overall Study|Missed dose|0|||
148778976|NCT03800836|536663284|FG000|Overall Study|Lost to Follow-up|2|||
148778977|NCT03800836|536663285|FG001|Overall Study|Lost to Follow-up|0|||
148778978|NCT03800836|536663286|FG002|Overall Study|Lost to Follow-up|1|||
148778979|NCT03800836|536663287|FG003|Overall Study|Lost to Follow-up|1|||
148778980|NCT03800836|536663288|FG004|Overall Study|Lost to Follow-up|3|||
148778981|NCT03800836|536663289|FG005|Overall Study|Lost to Follow-up|0|||
148778982|NCT03800836|536663284|FG000|Overall Study|Withdrawal by Subject|1|||
148872768|NCT02868229|537012280|FG003|Overall Study|Missed dose|3|||
148872769|NCT06151288|537012282|FG000|Overall Study|Lost to Follow-up|4|||
148872770|NCT06151288|537012283|FG001|Overall Study|Lost to Follow-up|2|||
148872771|NCT06151288|537012284|FG002|Overall Study|Lost to Follow-up|4|||
148872772|NCT06151288|537012285|FG003|Overall Study|Lost to Follow-up|3|||
148872773|NCT06151288|537012282|FG000|Overall Study|Withdrawal by Subject|4|||
148872774|NCT06151288|537012283|FG001|Overall Study|Withdrawal by Subject|5|||
148872775|NCT06151288|537012284|FG002|Overall Study|Withdrawal by Subject|1|||
148778983|NCT03800836|536663285|FG001|Overall Study|Withdrawal by Subject|0|||
148778984|NCT03800836|536663286|FG002|Overall Study|Withdrawal by Subject|0|||
148872776|NCT06151288|537012285|FG003|Overall Study|Withdrawal by Subject|1|||
148778985|NCT03800836|536663287|FG003|Overall Study|Withdrawal by Subject|0|||
148778986|NCT03800836|536663288|FG004|Overall Study|Withdrawal by Subject|0|||
148872777|NCT01240200|537012287|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
148872778|NCT01240200|537012288|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
148872779|NCT04676867|537012291|FG000|Overall Study|Screen failure|0|||
148872780|NCT04676867|537012292|FG001|Overall Study|Screen failure|0|||
148872781|NCT04676867|537012293|FG002|Overall Study|Screen failure|6|||
148872782|NCT04676867|537012294|FG003|Overall Study|Screen failure|2|||
148872783|NCT04676867|537012291|FG000|Overall Study|Death|0|||
148872784|NCT04676867|537012292|FG001|Overall Study|Death|0|||
148872785|NCT04676867|537012293|FG002|Overall Study|Death|1|||
148872786|NCT04676867|537012294|FG003|Overall Study|Death|0|||
148872787|NCT04676867|537012291|FG000|Overall Study|Withdrawal by Subject|2|||
148872788|NCT04676867|537012292|FG001|Overall Study|Withdrawal by Subject|2|||
148872789|NCT04676867|537012293|FG002|Overall Study|Withdrawal by Subject|4|||
148872790|NCT04676867|537012294|FG003|Overall Study|Withdrawal by Subject|4|||
148872791|NCT04676867|537012291|FG000|Overall Study|Lost to Follow-up|1|||
148872792|NCT04676867|537012292|FG001|Overall Study|Lost to Follow-up|0|||
148872793|NCT04676867|537012293|FG002|Overall Study|Lost to Follow-up|0|||
148872794|NCT04676867|537012294|FG003|Overall Study|Lost to Follow-up|0|||
148872795|NCT01554514|537012299|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
148872796|NCT01554514|537012299|FG000|Overall Study|Physician Decision|1|||
148872797|NCT01423916|537012300|FG000|Overall Study|Adverse Event|5|||
148872798|NCT01423916|537012301|FG001|Overall Study|Adverse Event|9|||
148872799|NCT01423916|537012302|FG002|Overall Study|Adverse Event|2|||
148872800|NCT01423916|537012300|FG000|Overall Study|Met Withdrawal Criteria|1|||
148872801|NCT01423916|537012301|FG001|Overall Study|Met Withdrawal Criteria|1|||
148872802|NCT01423916|537012302|FG002|Overall Study|Met Withdrawal Criteria|1|||
148872803|NCT01423916|537012300|FG000|Overall Study|Physician Decision|1|||
148872804|NCT01423916|537012301|FG001|Overall Study|Physician Decision|0|||
148872805|NCT01423916|537012302|FG002|Overall Study|Physician Decision|1|||
148872806|NCT01423916|537012300|FG000|Overall Study|Withdrawal by Subject|3|||
148872807|NCT01423916|537012301|FG001|Overall Study|Withdrawal by Subject|10|||
148872808|NCT01423916|537012302|FG002|Overall Study|Withdrawal by Subject|3|||
148872809|NCT01423916|537012300|FG000|Overall Study|Protocol Deviation|1|||
148872810|NCT01423916|537012301|FG001|Overall Study|Protocol Deviation|0|||
148872811|NCT01423916|537012302|FG002|Overall Study|Protocol Deviation|0|||
148778987|NCT03800836|536663289|FG005|Overall Study|Withdrawal by Subject|0|||
148778988|NCT03800836|536663284|FG000|Overall Study|Physician Decision|31|||
148778989|NCT03800836|536663285|FG001|Overall Study|Physician Decision|3|||
148778990|NCT03800836|536663286|FG002|Overall Study|Physician Decision|6|||
148778991|NCT03800836|536663287|FG003|Overall Study|Physician Decision|4|||
148778992|NCT03800836|536663288|FG004|Overall Study|Physician Decision|4|||
148778993|NCT03800836|536663289|FG005|Overall Study|Physician Decision|5|||
148778994|NCT03800836|536663284|FG000|Overall Study|Death|34|||
148778995|NCT03800836|536663285|FG001|Overall Study|Death|16|||
148778996|NCT03800836|536663286|FG002|Overall Study|Death|5|||
148778997|NCT03800836|536663287|FG003|Overall Study|Death|5|||
148778998|NCT03800836|536663288|FG004|Overall Study|Death|10|||
148778999|NCT03800836|536663289|FG005|Overall Study|Death|0|||
148779000|NCT03800836|536663284|FG000|Overall Study|Symptomatic Deterioration|1|||
148779001|NCT03800836|536663285|FG001|Overall Study|Symptomatic Deterioration|0|||
148779002|NCT03800836|536663286|FG002|Overall Study|Symptomatic Deterioration|1|||
148779003|NCT03800836|536663287|FG003|Overall Study|Symptomatic Deterioration|0|||
148779004|NCT03800836|536663288|FG004|Overall Study|Symptomatic Deterioration|0|||
148779005|NCT03800836|536663289|FG005|Overall Study|Symptomatic Deterioration|0|||
148779006|NCT01250171|536665894|FG000|Overall Study|Administrative reasons|1|||
148779007|NCT01250171|536665895|FG001|Overall Study|Administrative reasons|0|||
148779008|NCT01250171|536665896|FG002|Overall Study|Administrative reasons|0|||
148779009|NCT00577005|536665899|FG000|Overall Study|Lost to Follow-up|3|||
148779010|NCT00577005|536665900|FG001|Overall Study|Lost to Follow-up|2|||
148779011|NCT00577005|536665899|FG000|Overall Study|Withdrawal by Subject|2|||
148779012|NCT00577005|536665900|FG001|Overall Study|Withdrawal by Subject|1|||
148779013|NCT02453282|536665901|FG000|Overall Study|Death|275|||
148779014|NCT02453282|536665902|FG001|Overall Study|Death|277|||
148779015|NCT02453282|536665903|FG002|Overall Study|Death|296|||
148779016|NCT02453282|536665901|FG000|Overall Study|Lost to Follow-up|1|||
148779017|NCT02453282|536665902|FG001|Overall Study|Lost to Follow-up|0|||
148779018|NCT02453282|536665903|FG002|Overall Study|Lost to Follow-up|2|||
148779019|NCT02453282|536665901|FG000|Overall Study|Withdrawal by Subject|12|||
148779020|NCT02453282|536665902|FG001|Overall Study|Withdrawal by Subject|10|||
148779021|NCT02453282|536665903|FG002|Overall Study|Withdrawal by Subject|11|||
148779022|NCT02453282|536665901|FG000|Overall Study|Participants ongoing at data cut-off|85|||
148779023|NCT02453282|536665902|FG001|Overall Study|Participants ongoing at data cut-off|84|||
148779024|NCT02453282|536665903|FG002|Overall Study|Participants ongoing at data cut-off|62|||
148779025|NCT02453282|536665901|FG000|Overall Study|Other|1|||
148779026|NCT02453282|536665902|FG001|Overall Study|Other|1|||
148779027|NCT02453282|536665903|FG002|Overall Study|Other|1|||
148779028|NCT02327013|536665904|FG000|Overall Study|Adverse Event|4|||
148779029|NCT02327013|536665905|FG001|Overall Study|Adverse Event|4|||
148779030|NCT02327013|536665906|FG002|Overall Study|Adverse Event|3|||
148872812|NCT02294734|537012305|FG000|Overall Study|Adverse Event|5|||
148872813|NCT02294734|537012306|FG001|Overall Study|Adverse Event|5|||
148872814|NCT02294734|537012305|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
148872815|NCT02294734|537012306|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
148872816|NCT02294734|537012305|FG000|Overall Study|Lost to Follow-up|2|||
148779031|NCT02327013|536665907|FG003|Overall Study|Adverse Event|0|||
148872817|NCT02294734|537012306|FG001|Overall Study|Lost to Follow-up|0|||
148779032|NCT02327013|536665908|FG004|Overall Study|Adverse Event|1|||
148779033|NCT02327013|536665904|FG000|Overall Study|Lack of Efficacy|2|||
148872818|NCT02294734|537012305|FG000|Overall Study|Physician Decision|2|||
148872819|NCT02294734|537012306|FG001|Overall Study|Physician Decision|1|||
148779034|NCT02327013|536665905|FG001|Overall Study|Lack of Efficacy|0|||
148779035|NCT02327013|536665906|FG002|Overall Study|Lack of Efficacy|5|||
148779036|NCT02327013|536665907|FG003|Overall Study|Lack of Efficacy|0|||
148779037|NCT02327013|536665908|FG004|Overall Study|Lack of Efficacy|1|||
148779038|NCT02327013|536665904|FG000|Overall Study|Non-compliance with IMP|1|||
148779039|NCT02327013|536665905|FG001|Overall Study|Non-compliance with IMP|2|||
149033122|NCT02987543|537598982|FG003|Overall Study|Lost to Follow-up|0|||
149033123|NCT02987543|537598979|FG000|Overall Study|Screen failure|0|||
149033124|NCT02987543|537598980|FG001|Overall Study|Screen failure|0|||
149033125|NCT02987543|537598981|FG002|Overall Study|Screen failure|0|||
149033126|NCT02987543|537598982|FG003|Overall Study|Screen failure|1|||
149033127|NCT02987543|537598979|FG000|Overall Study|Withdrawal by Subject|21|||
149033128|NCT02987543|537598980|FG001|Overall Study|Withdrawal by Subject|7|||
149033129|NCT02987543|537598981|FG002|Overall Study|Withdrawal by Subject|7|||
149033130|NCT02987543|537598982|FG003|Overall Study|Withdrawal by Subject|6|||
149033131|NCT02987543|537598979|FG000|Overall Study|Study terminated by sponsor|1|||
149033132|NCT02987543|537598980|FG001|Overall Study|Study terminated by sponsor|0|||
149033133|NCT02987543|537598981|FG002|Overall Study|Study terminated by sponsor|0|||
148779040|NCT02327013|536665906|FG002|Overall Study|Non-compliance with IMP|7|||
148779041|NCT02327013|536665907|FG003|Overall Study|Non-compliance with IMP|0|||
148779042|NCT02327013|536665908|FG004|Overall Study|Non-compliance with IMP|0|||
148779043|NCT02327013|536665904|FG000|Overall Study|Withdrawal of Consent|1|||
148779044|NCT02327013|536665905|FG001|Overall Study|Withdrawal of Consent|0|||
148779045|NCT02327013|536665906|FG002|Overall Study|Withdrawal of Consent|3|||
148779046|NCT02327013|536665907|FG003|Overall Study|Withdrawal of Consent|0|||
148779047|NCT02327013|536665908|FG004|Overall Study|Withdrawal of Consent|0|||
148779048|NCT02327013|536665904|FG000|Overall Study|Lost to Follow-up|2|||
148779049|NCT02327013|536665905|FG001|Overall Study|Lost to Follow-up|4|||
148779050|NCT02327013|536665906|FG002|Overall Study|Lost to Follow-up|5|||
148779051|NCT02327013|536665907|FG003|Overall Study|Lost to Follow-up|0|||
148779052|NCT02327013|536665908|FG004|Overall Study|Lost to Follow-up|0|||
148779053|NCT02327013|536665904|FG000|Overall Study|Administrative or other reason(s)|1|||
148779054|NCT02327013|536665905|FG001|Overall Study|Administrative or other reason(s)|5|||
148779055|NCT02327013|536665906|FG002|Overall Study|Administrative or other reason(s)|11|||
148779056|NCT02327013|536665907|FG003|Overall Study|Administrative or other reason(s)|1|||
148779057|NCT02327013|536665908|FG004|Overall Study|Administrative or other reason(s)|1|||
148779058|NCT02327013|536665904|FG000|Overall Study|Protocol Violation|0|||
148779059|NCT02327013|536665905|FG001|Overall Study|Protocol Violation|0|||
148779060|NCT02327013|536665906|FG002|Overall Study|Protocol Violation|3|||
148779061|NCT02327013|536665907|FG003|Overall Study|Protocol Violation|0|||
148779062|NCT02327013|536665908|FG004|Overall Study|Protocol Violation|1|||
148779063|NCT02327013|536665904|FG000|Overall Study|Withdrawal before treatment|2|||
148779064|NCT02327013|536665905|FG001|Overall Study|Withdrawal before treatment|1|||
148779065|NCT02327013|536665906|FG002|Overall Study|Withdrawal before treatment|5|||
148779066|NCT02327013|536665907|FG003|Overall Study|Withdrawal before treatment|0|||
148779067|NCT02327013|536665908|FG004|Overall Study|Withdrawal before treatment|0|||
148779068|NCT02380859|536665911|FG000|Overall Study|Withdrawal by Subject|2|||
148779069|NCT02380859|536665912|FG001|Overall Study|Withdrawal by Subject|0|||
148779070|NCT01565668|536665913|FG000|Overall Study|Death|2|||
148779071|NCT01565668|536665914|FG001|Overall Study|Death|1|||
148779072|NCT01565668|536665913|FG000|Overall Study|Lack of Efficacy|4|||
148779073|NCT01565668|536665914|FG001|Overall Study|Lack of Efficacy|2|||
148779074|NCT01565668|536665913|FG000|Overall Study|Participant went on Hospice Care|1|||
148779075|NCT01565668|536665914|FG001|Overall Study|Participant went on Hospice Care|0|||
148779076|NCT01565668|536665913|FG000|Overall Study|Adverse Event|6|||
148779077|NCT01565668|536665914|FG001|Overall Study|Adverse Event|1|||
148779078|NCT01565668|536665913|FG000|Overall Study|Randomized, but never received drug|0|||
148779079|NCT01565668|536665914|FG001|Overall Study|Randomized, but never received drug|2|||
148779080|NCT01565668|536665913|FG000|Overall Study|Progressive disease|13|||
148779081|NCT01565668|536665914|FG001|Overall Study|Progressive disease|14|||
148779082|NCT01565668|536665913|FG000|Overall Study|Withdrawal by Subject|1|||
148779083|NCT01565668|536665914|FG001|Overall Study|Withdrawal by Subject|3|||
148779084|NCT01565668|536665913|FG000|Overall Study|HSCT Transplant|11|||
148779085|NCT01565668|536665914|FG001|Overall Study|HSCT Transplant|15|||
148779086|NCT04258254|536665915|FG000|Overall Study|Withdrawal by Subject|0|||
148779087|NCT04258254|536665916|FG001|Overall Study|Withdrawal by Subject|1|||
148779088|NCT04258254|536665917|FG002|Overall Study|Withdrawal by Subject|0|||
148779089|NCT02255552|536665918|FG000|Overall Study|Participants enrolled into another study|0|||
148779090|NCT02255552|536665919|FG001|Overall Study|Participants enrolled into another study|11|||
148779091|NCT02255552|536665918|FG000|Overall Study|Withdrawal by Subject|1|||
148779092|NCT02255552|536665919|FG001|Overall Study|Withdrawal by Subject|4|||
148779093|NCT01447446|536665920|FG000|Overall Study|Death|6|||
148779094|NCT01447446|536665921|FG001|Overall Study|Death|3|||
148779095|NCT01447446|536665922|FG002|Overall Study|Death|2|||
148779096|NCT01447446|536665923|FG003|Overall Study|Death|1|||
149033134|NCT02987543|537598982|FG003|Overall Study|Study terminated by sponsor|0|||
149033135|NCT02987543|537598979|FG000|Overall Study|Investigator decision|0|||
148779097|NCT01447446|536665924|FG004|Overall Study|Death|7|||
149033136|NCT02987543|537598980|FG001|Overall Study|Investigator decision|1|||
149033137|NCT02987543|537598981|FG002|Overall Study|Investigator decision|0|||
148779098|NCT01447446|536665925|FG005|Overall Study|Death|0|||
148779099|NCT01447446|536665920|FG000|Overall Study|Adverse Event|3|||
148779100|NCT01447446|536665921|FG001|Overall Study|Adverse Event|0|||
148779101|NCT01447446|536665922|FG002|Overall Study|Adverse Event|1|||
148779102|NCT01447446|536665923|FG003|Overall Study|Adverse Event|0|||
148779103|NCT01447446|536665924|FG004|Overall Study|Adverse Event|2|||
148779104|NCT01447446|536665925|FG005|Overall Study|Adverse Event|0|||
148779105|NCT01447446|536665920|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
148779106|NCT01447446|536665921|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
148779107|NCT01447446|536665922|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
148779108|NCT01447446|536665923|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
148779109|NCT01447446|536665924|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
148779110|NCT01447446|536665925|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
148779111|NCT01447446|536665920|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
148779112|NCT01447446|536665921|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
148779113|NCT01447446|536665922|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
148779114|NCT01447446|536665923|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
148779115|NCT01447446|536665924|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
148779116|NCT01447446|536665925|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
148779117|NCT01447446|536665920|FG000|Overall Study|Administrative/Other|34|||
148779118|NCT01447446|536665921|FG001|Overall Study|Administrative/Other|9|||
148779119|NCT01447446|536665922|FG002|Overall Study|Administrative/Other|10|||
148779120|NCT01447446|536665923|FG003|Overall Study|Administrative/Other|2|||
148779121|NCT01447446|536665924|FG004|Overall Study|Administrative/Other|33|||
148779122|NCT01447446|536665925|FG005|Overall Study|Administrative/Other|4|||
149033138|NCT02987543|537598982|FG003|Overall Study|Investigator decision|0|||
149033139|NCT02987543|537598979|FG000|Overall Study|Disease progression|0|||
149033140|NCT02987543|537598980|FG001|Overall Study|Disease progression|0|||
149033141|NCT02987543|537598981|FG002|Overall Study|Disease progression|0|||
149033142|NCT02987543|537598982|FG003|Overall Study|Disease progression|1|||
149033143|NCT03646669|537598985|FG000|Overall Study|Withdrawal by Subject|5|||
149033144|NCT03646669|537598986|FG001|Overall Study|Withdrawal by Subject|0|||
148779123|NCT01447446|536665920|FG000|Overall Study|SVR12 Assessment|13|||
148779124|NCT01447446|536665921|FG001|Overall Study|SVR12 Assessment|1|||
148779125|NCT01447446|536665922|FG002|Overall Study|SVR12 Assessment|2|||
148779126|NCT01447446|536665923|FG003|Overall Study|SVR12 Assessment|1|||
148779127|NCT01447446|536665924|FG004|Overall Study|SVR12 Assessment|5|||
148779128|NCT01447446|536665925|FG005|Overall Study|SVR12 Assessment|5|||
148779129|NCT01447446|536665920|FG000|Overall Study|New Treatment Started|8|||
149033145|NCT00309452|537598987|FG000|Overall Study|Withdrawal by Subject|3|||
149033146|NCT00309452|537598988|FG001|Overall Study|Withdrawal by Subject|0|||
148872820|NCT02294734|537012305|FG000|Overall Study|Withdrawal by Subject|4|||
148872821|NCT02294734|537012306|FG001|Overall Study|Withdrawal by Subject|2|||
149033147|NCT00771667|537598989|FG000|Induction Phase|Adverse Event|5|||
149033148|NCT00771667|537598990|FG001|Induction Phase|Adverse Event|2|||
149033149|NCT00771667|537598991|FG002|Induction Phase|Adverse Event|4|||
149033150|NCT00771667|537598992|FG003|Induction Phase|Adverse Event|1|||
149033151|NCT00771667|537598993|FG004|Induction Phase|Adverse Event|0|||
149033152|NCT00771667|537598994|FG005|Induction Phase|Adverse Event|0|||
148779130|NCT01447446|536665921|FG001|Overall Study|New Treatment Started|2|||
148779131|NCT01447446|536665922|FG002|Overall Study|New Treatment Started|1|||
148779132|NCT01447446|536665923|FG003|Overall Study|New Treatment Started|0|||
148779133|NCT01447446|536665924|FG004|Overall Study|New Treatment Started|2|||
148779134|NCT01447446|536665925|FG005|Overall Study|New Treatment Started|0|||
148779135|NCT01447446|536665920|FG000|Overall Study|Reason not Specified|1|||
148779136|NCT01447446|536665921|FG001|Overall Study|Reason not Specified|1|||
148779137|NCT01447446|536665922|FG002|Overall Study|Reason not Specified|1|||
148779138|NCT01447446|536665923|FG003|Overall Study|Reason not Specified|1|||
148779139|NCT01447446|536665924|FG004|Overall Study|Reason not Specified|1|||
149033153|NCT00771667|537598995|FG006|Induction Phase|Adverse Event|0|||
149033154|NCT00771667|537598996|FG007|Induction Phase|Adverse Event|0|||
149033155|NCT00771667|537598997|FG008|Induction Phase|Adverse Event|0|||
149033156|NCT00771667|537598998|FG009|Induction Phase|Adverse Event|0|||
149033157|NCT00771667|537598989|FG000|Induction Phase|Lack of Efficacy|9|||
149033158|NCT00771667|537598990|FG001|Induction Phase|Lack of Efficacy|2|||
149033159|NCT00771667|537598991|FG002|Induction Phase|Lack of Efficacy|4|||
148872822|NCT01141478|537012307|FG000|Overall Study|Withdrawal by Subject|1|||
149033160|NCT00771667|537598992|FG003|Induction Phase|Lack of Efficacy|3|||
149033161|NCT00771667|537598993|FG004|Induction Phase|Lack of Efficacy|0|||
149033162|NCT00771667|537598994|FG005|Induction Phase|Lack of Efficacy|0|||
149033163|NCT00771667|537598995|FG006|Induction Phase|Lack of Efficacy|0|||
148779140|NCT01447446|536665925|FG005|Overall Study|Reason not Specified|0|||
149033164|NCT00771667|537598996|FG007|Induction Phase|Lack of Efficacy|0|||
148779141|NCT04829331|536665928|FG000|Overall Study|Lost to Follow-up|1|||
149033165|NCT00771667|537598997|FG008|Induction Phase|Lack of Efficacy|0|||
149033166|NCT00771667|537598998|FG009|Induction Phase|Lack of Efficacy|0|||
149033167|NCT00771667|537598989|FG000|Induction Phase|Lost to Follow-up|1|||
149033168|NCT00771667|537598990|FG001|Induction Phase|Lost to Follow-up|0|||
149033169|NCT00771667|537598991|FG002|Induction Phase|Lost to Follow-up|1|||
149033170|NCT00771667|537598992|FG003|Induction Phase|Lost to Follow-up|0|||
149033171|NCT00771667|537598993|FG004|Induction Phase|Lost to Follow-up|0|||
149033172|NCT00771667|537598994|FG005|Induction Phase|Lost to Follow-up|0|||
149033173|NCT00771667|537598995|FG006|Induction Phase|Lost to Follow-up|0|||
149033174|NCT00771667|537598996|FG007|Induction Phase|Lost to Follow-up|0|||
149033175|NCT00771667|537598997|FG008|Induction Phase|Lost to Follow-up|0|||
149033176|NCT00771667|537598998|FG009|Induction Phase|Lost to Follow-up|0|||
149033177|NCT00771667|537598989|FG000|Induction Phase|Other|4|||
149033178|NCT00771667|537598990|FG001|Induction Phase|Other|6|||
149033179|NCT00771667|537598991|FG002|Induction Phase|Other|3|||
149033180|NCT00771667|537598992|FG003|Induction Phase|Other|4|||
149033181|NCT00771667|537598993|FG004|Induction Phase|Other|0|||
149033182|NCT00771667|537598994|FG005|Induction Phase|Other|0|||
149033183|NCT00771667|537598995|FG006|Induction Phase|Other|0|||
149033184|NCT00771667|537598996|FG007|Induction Phase|Other|0|||
149033185|NCT00771667|537598997|FG008|Induction Phase|Other|0|||
149033186|NCT00771667|537598998|FG009|Induction Phase|Other|0|||
149033187|NCT00771667|537598989|FG000|Maintenance Phase|Adverse Event|0|||
149033188|NCT00771667|537598990|FG001|Maintenance Phase|Adverse Event|0|||
149033189|NCT00771667|537598991|FG002|Maintenance Phase|Adverse Event|0|||
149033190|NCT00771667|537598992|FG003|Maintenance Phase|Adverse Event|0|||
149033191|NCT00771667|537598993|FG004|Maintenance Phase|Adverse Event|1|||
149033192|NCT00771667|537598994|FG005|Maintenance Phase|Adverse Event|3|||
149033193|NCT00771667|537598995|FG006|Maintenance Phase|Adverse Event|5|||
149033194|NCT00771667|537598996|FG007|Maintenance Phase|Adverse Event|1|||
149033195|NCT00771667|537598997|FG008|Maintenance Phase|Adverse Event|8|||
149033196|NCT00771667|537598998|FG009|Maintenance Phase|Adverse Event|7|||
149033197|NCT00771667|537598989|FG000|Maintenance Phase|Lack of Efficacy|0|||
149033198|NCT00771667|537598990|FG001|Maintenance Phase|Lack of Efficacy|0|||
149033199|NCT00771667|537598991|FG002|Maintenance Phase|Lack of Efficacy|0|||
149033200|NCT00771667|537598992|FG003|Maintenance Phase|Lack of Efficacy|0|||
149033201|NCT00771667|537598993|FG004|Maintenance Phase|Lack of Efficacy|1|||
149033202|NCT00771667|537598994|FG005|Maintenance Phase|Lack of Efficacy|3|||
149033203|NCT00771667|537598995|FG006|Maintenance Phase|Lack of Efficacy|3|||
149033204|NCT00771667|537598996|FG007|Maintenance Phase|Lack of Efficacy|2|||
149033205|NCT00771667|537598997|FG008|Maintenance Phase|Lack of Efficacy|11|||
149033206|NCT00771667|537598998|FG009|Maintenance Phase|Lack of Efficacy|7|||
149033207|NCT00771667|537598989|FG000|Maintenance Phase|Other|0|||
149033208|NCT00771667|537598990|FG001|Maintenance Phase|Other|0|||
149033209|NCT00771667|537598991|FG002|Maintenance Phase|Other|0|||
149033210|NCT00771667|537598992|FG003|Maintenance Phase|Other|0|||
149033211|NCT00771667|537598993|FG004|Maintenance Phase|Other|0|||
149033212|NCT00771667|537598994|FG005|Maintenance Phase|Other|1|||
149033213|NCT00771667|537598995|FG006|Maintenance Phase|Other|2|||
149033214|NCT00771667|537598996|FG007|Maintenance Phase|Other|2|||
149033215|NCT00771667|537598997|FG008|Maintenance Phase|Other|3|||
149033216|NCT00771667|537598998|FG009|Maintenance Phase|Other|3|||
149033217|NCT01897233|537598999|FG000|Part B (24 Weeks)|Adverse Event|1|||
149033218|NCT01897233|537598999|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
149033219|NCT01897233|537598999|FG000|Part B (24 Weeks)|Physician Decision|1|||
149033220|NCT01883492|537599005|FG000|Overall Study|Lost to Follow-up|3|||
149033221|NCT01883492|537599006|FG001|Overall Study|Lost to Follow-up|4|||
149033222|NCT01883492|537599005|FG000|Overall Study|Surgery on contra-lateral hip|0|||
149033223|NCT01883492|537599006|FG001|Overall Study|Surgery on contra-lateral hip|1|||
149033224|NCT01883492|537599005|FG000|Overall Study|Poor X-ray quality|7|||
149033225|NCT01883492|537599006|FG001|Overall Study|Poor X-ray quality|4|||
149033226|NCT01883492|537599005|FG000|Overall Study|Withdrawal by Subject|1|||
149033227|NCT01883492|537599006|FG001|Overall Study|Withdrawal by Subject|0|||
149033228|NCT01883492|537599005|FG000|Overall Study|inappropriate implant used|1|||
149033229|NCT01883492|537599006|FG001|Overall Study|inappropriate implant used|1|||
149033230|NCT01883492|537599005|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
148779142|NCT04829331|536665929|FG001|Overall Study|Lost to Follow-up|0|||
148779143|NCT02604550|536665932|FG000|Overall Study|Lost to Follow-up|7|||
149033231|NCT01883492|537599006|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
149033232|NCT03265210|537599007|FG000|Overall Study|Withdrawal by Subject|7|||
149033233|NCT03265210|537599008|FG001|Overall Study|Withdrawal by Subject|9|||
149033234|NCT03265210|537599007|FG000|Overall Study|Lost to Follow-up|2|||
149033235|NCT03265210|537599008|FG001|Overall Study|Lost to Follow-up|0|||
149033236|NCT03265210|537599007|FG000|Overall Study|Physician Decision|2|||
149033237|NCT03265210|537599008|FG001|Overall Study|Physician Decision|0|||
149033238|NCT03265210|537599007|FG000|Overall Study|Adverse Event|1|||
149033239|NCT03265210|537599008|FG001|Overall Study|Adverse Event|0|||
149033240|NCT01693614|537599012|FG000|Overall Study|Adverse Event|7|||
149033241|NCT01693614|537599013|FG001|Overall Study|Adverse Event|11|||
149033242|NCT01693614|537599014|FG002|Overall Study|Adverse Event|5|||
149033243|NCT01693614|537599012|FG000|Overall Study|Disease progression|11|||
149033244|NCT01693614|537599013|FG001|Overall Study|Disease progression|8|||
149033245|NCT01693614|537599014|FG002|Overall Study|Disease progression|7|||
149033246|NCT01693614|537599012|FG000|Overall Study|Protocol Violation|5|||
149033247|NCT01693614|537599013|FG001|Overall Study|Protocol Violation|2|||
149033248|NCT01693614|537599014|FG002|Overall Study|Protocol Violation|1|||
149033249|NCT01693614|537599012|FG000|Overall Study|Death|1|||
149033250|NCT01693614|537599013|FG001|Overall Study|Death|0|||
149033251|NCT01693614|537599014|FG002|Overall Study|Death|0|||
149033252|NCT01693614|537599012|FG000|Overall Study|Physician Decision|1|||
149033253|NCT01693614|537599013|FG001|Overall Study|Physician Decision|1|||
149033254|NCT01693614|537599014|FG002|Overall Study|Physician Decision|4|||
149033255|NCT01693614|537599012|FG000|Overall Study|Withdrawal by subject/guardian|0|||
149033256|NCT01693614|537599013|FG001|Overall Study|Withdrawal by subject/guardian|0|||
149033257|NCT01693614|537599014|FG002|Overall Study|Withdrawal by subject/guardian|2|||
149033258|NCT01693614|537599012|FG000|Overall Study|Withdrawal by Subject|1|||
149033259|NCT01693614|537599013|FG001|Overall Study|Withdrawal by Subject|0|||
149033260|NCT01693614|537599014|FG002|Overall Study|Withdrawal by Subject|5|||
149033261|NCT02281318|537599015|FG000|Overall Study|Adverse Event|2|||
149033262|NCT02281318|537599016|FG001|Overall Study|Adverse Event|2|||
149033263|NCT02281318|537599015|FG000|Overall Study|Lack of Efficacy|2|||
149033264|NCT02281318|537599016|FG001|Overall Study|Lack of Efficacy|0|||
149033265|NCT02281318|537599015|FG000|Overall Study|Lost to Follow-up|2|||
149033266|NCT02281318|537599016|FG001|Overall Study|Lost to Follow-up|1|||
149033267|NCT02281318|537599015|FG000|Overall Study|Physician Decision|2|||
149033268|NCT02281318|537599016|FG001|Overall Study|Physician Decision|0|||
149033269|NCT02281318|537599015|FG000|Overall Study|Withdrawal by Subject|6|||
149033270|NCT02281318|537599016|FG001|Overall Study|Withdrawal by Subject|2|||
149033271|NCT01064817|537599019|FG000|Study Completion|Physician Decision|1|||
149033272|NCT01064817|537599020|FG001|Study Completion|Physician Decision|0|||
149033273|NCT01064817|537599019|FG000|Study Completion|Withdrawal by Subject|1|||
149033274|NCT01064817|537599020|FG001|Study Completion|Withdrawal by Subject|0|||
149033275|NCT00558363|537599021|FG000|Overall Study|Physician Decision|18|||
149033276|NCT00558363|537599022|FG001|Overall Study|Physician Decision|4|||
149033277|NCT00558363|537599021|FG000|Overall Study|Withdrawal by Subject|11|||
149033278|NCT00558363|537599022|FG001|Overall Study|Withdrawal by Subject|4|||
149033279|NCT00558363|537599021|FG000|Overall Study|Adverse Event|5|||
149033280|NCT00558363|537599022|FG001|Overall Study|Adverse Event|5|||
149033281|NCT00558363|537599021|FG000|Overall Study|Lack of Efficacy|2|||
149033282|NCT00558363|537599022|FG001|Overall Study|Lack of Efficacy|2|||
149033283|NCT00558363|537599021|FG000|Overall Study|Protocol Violation|2|||
149033284|NCT00558363|537599022|FG001|Overall Study|Protocol Violation|1|||
149033285|NCT00558363|537599021|FG000|Overall Study|Lost to Follow-up|0|||
149033286|NCT00558363|537599022|FG001|Overall Study|Lost to Follow-up|1|||
149033287|NCT00558363|537599021|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
149033288|NCT00558363|537599022|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
149033289|NCT00558363|537599021|FG000|Overall Study|Randomized in Error|1|||
149033290|NCT00558363|537599022|FG001|Overall Study|Randomized in Error|2|||
149033291|NCT00558363|537599021|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
149033292|NCT00558363|537599022|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
149033293|NCT03102710|537599023|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
149033294|NCT03102710|537599024|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
149033295|NCT03102710|537599025|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
149033296|NCT03102710|537599023|FG000|Overall Study|Technical issues during final MRI scan|0|||
149033297|NCT03102710|537599024|FG001|Overall Study|Technical issues during final MRI scan|1|||
149033298|NCT03102710|537599025|FG002|Overall Study|Technical issues during final MRI scan|0|||
149033299|NCT03102710|537599023|FG000|Overall Study|Nausea during MRI scan|0|||
149033300|NCT03102710|537599024|FG001|Overall Study|Nausea during MRI scan|1|||
149033301|NCT03102710|537599025|FG002|Overall Study|Nausea during MRI scan|0|||
149033302|NCT03102710|537599023|FG000|Overall Study|Subject unable to attend final session|0|||
149033303|NCT03102710|537599024|FG001|Overall Study|Subject unable to attend final session|1|||
149033304|NCT03102710|537599025|FG002|Overall Study|Subject unable to attend final session|0|||
149033305|NCT03383887|537599032|FG000|Overall Study|Lost to Follow-up|0|||
149033306|NCT03383887|537599033|FG001|Overall Study|Lost to Follow-up|1|||
149033307|NCT01806714|537599041|FG000|Overall Study|No functioning phone number|200|||
149033308|NCT01806714|537599042|FG001|Overall Study|No functioning phone number|170|||
149033309|NCT02155829|537599043|FG000|Overall Study|Adverse Event|1|||
149033310|NCT02155829|537599044|FG001|Overall Study|Adverse Event|0|||
149033311|NCT02155829|537599043|FG000|Overall Study|Withdrawal by Subject|3|||
149033312|NCT02155829|537599044|FG001|Overall Study|Withdrawal by Subject|3|||
149033313|NCT02155829|537599043|FG000|Overall Study|Protocol Violation|2|||
149033314|NCT02155829|537599044|FG001|Overall Study|Protocol Violation|0|||
149033315|NCT04107805|537599047|FG000|Overall Study|Adverse Event|0|||
149033316|NCT04107805|537599048|FG001|Overall Study|Adverse Event|0|||
149033317|NCT04107805|537599049|FG002|Overall Study|Adverse Event|0|||
149033318|NCT04107805|537599050|FG003|Overall Study|Adverse Event|1|||
149033319|NCT04107805|537599051|FG004|Overall Study|Adverse Event|0|||
149033320|NCT04107805|537599052|FG005|Overall Study|Adverse Event|1|||
149033321|NCT04107805|537599053|FG006|Overall Study|Adverse Event|0|||
149033322|NCT04107805|537599054|FG007|Overall Study|Adverse Event|0|||
149033323|NCT04107805|537599055|FG008|Overall Study|Adverse Event|1|||
149033324|NCT01253226|537599056|FG000|Overall Study|Adverse Event|0|||
149033325|NCT01253226|537599057|FG001|Overall Study|Adverse Event|0|||
149033326|NCT01253226|537599058|FG002|Overall Study|Adverse Event|1|||
149033327|NCT01253226|537599059|FG003|Overall Study|Adverse Event|0|||
149033328|NCT01253226|537599060|FG004|Overall Study|Adverse Event|0|||
149033329|NCT01253226|537599056|FG000|Overall Study|Death|0|||
149033330|NCT01253226|537599057|FG001|Overall Study|Death|1|||
149033331|NCT01253226|537599058|FG002|Overall Study|Death|0|||
149033332|NCT01253226|537599059|FG003|Overall Study|Death|0|||
149033333|NCT01253226|537599060|FG004|Overall Study|Death|0|||
149033334|NCT01253226|537599056|FG000|Overall Study|Physician Decision|0|||
149033335|NCT01253226|537599057|FG001|Overall Study|Physician Decision|0|||
149033336|NCT01253226|537599058|FG002|Overall Study|Physician Decision|0|||
149033337|NCT01253226|537599059|FG003|Overall Study|Physician Decision|0|||
149033338|NCT01253226|537599060|FG004|Overall Study|Physician Decision|2|||
149033339|NCT01253226|537599056|FG000|Overall Study|Withdrawal by Subject|0|||
148779144|NCT02604550|536665933|FG001|Overall Study|Lost to Follow-up|6|||
148779145|NCT02604550|536665932|FG000|Overall Study|Withdrawal by Subject|0|||
148779146|NCT02604550|536665933|FG001|Overall Study|Withdrawal by Subject|1|||
148779147|NCT02604550|536665932|FG000|Overall Study|Incomplete data using paper journal|18|||
148779148|NCT02604550|536665933|FG001|Overall Study|Incomplete data using paper journal|19|||
148779149|NCT01404208|536665934|FG000|Overall Study|Discontinued|3|||
148779150|NCT01404208|536665935|FG001|Overall Study|Discontinued|0|||
148779151|NCT03747302|536665936|FG000|Overall Study|Withdrawal by Subject|1|||
148779152|NCT03747302|536665937|FG001|Overall Study|Withdrawal by Subject|2|||
148779153|NCT03769675|536665938|FG000|Overall Study|Lost to Follow-up|1|||
148779154|NCT01032070|536665941|FG000|Overall Study|Disease progression|13|||
148779155|NCT01032070|536665942|FG001|Overall Study|Disease progression|8|||
148779156|NCT01032070|536665941|FG000|Overall Study|Medical or ethical reasons|0|||
148779157|NCT01032070|536665942|FG001|Overall Study|Medical or ethical reasons|2|||
148779158|NCT01032070|536665941|FG000|Overall Study|Withdrawal by Subject|0|||
148779159|NCT01032070|536665942|FG001|Overall Study|Withdrawal by Subject|2|||
148779160|NCT02772276|536665943|FG000|Overall Study|Lost to Follow-up|0|||
148779161|NCT02772276|536665944|FG001|Overall Study|Lost to Follow-up|0|||
148779162|NCT02772276|536665945|FG002|Overall Study|Lost to Follow-up|0|||
148779163|NCT02772276|536665946|FG003|Overall Study|Lost to Follow-up|0|||
148779164|NCT02772276|536665947|FG004|Overall Study|Lost to Follow-up|0|||
148779165|NCT02772276|536665948|FG005|Overall Study|Lost to Follow-up|0|||
148779166|NCT02772276|536665949|FG006|Overall Study|Lost to Follow-up|1|||
148779167|NCT02772276|536665950|FG007|Overall Study|Lost to Follow-up|0|||
148779168|NCT02772276|536665951|FG008|Overall Study|Lost to Follow-up|0|||
149033340|NCT01253226|537599057|FG001|Overall Study|Withdrawal by Subject|0|||
149033341|NCT01253226|537599058|FG002|Overall Study|Withdrawal by Subject|0|||
149033342|NCT01253226|537599059|FG003|Overall Study|Withdrawal by Subject|1|||
149033343|NCT01253226|537599060|FG004|Overall Study|Withdrawal by Subject|0|||
149033344|NCT03643211|537599064|FG000|Overall Study|Contract violation/deficiency|12|||
149033345|NCT03643211|537599064|FG000|Overall Study|Invalid registration|3|||
149033346|NCT03643211|537599064|FG000|Overall Study|No treatment information|2|||
149033347|NCT03643211|537599064|FG000|Overall Study|No adverse event information - No revisit|4|||
149033348|NCT04536077|537599065|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
149033349|NCT04536077|537599066|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
149033350|NCT04536077|537599065|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
149033351|NCT04536077|537599066|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
149033352|NCT01155869|537599076|FG000|Overall Study|Lost to Follow-up|3|||
149033353|NCT01155869|537599077|FG001|Overall Study|Lost to Follow-up|1|||
149033354|NCT02908464|537599081|FG000|Overall Study|Withdrawal by Subject|2|||
149033355|NCT02908464|537599082|FG001|Overall Study|Withdrawal by Subject|1|||
149033356|NCT02908464|537599081|FG000|Overall Study|Found ineligible after randomization|0|||
149033357|NCT02908464|537599082|FG001|Overall Study|Found ineligible after randomization|2|||
149033358|NCT02163915|537599085|FG000|Overall Study|Withdrawal by Subject|2|||
149033359|NCT02163915|537599086|FG001|Overall Study|Withdrawal by Subject|0|||
148779169|NCT02772276|536665952|FG009|Overall Study|Lost to Follow-up|0|||
148779170|NCT02772276|536665953|FG010|Overall Study|Lost to Follow-up|0|||
148779171|NCT02772276|536665954|FG011|Overall Study|Lost to Follow-up|0|||
148779172|NCT02772276|536665955|FG012|Overall Study|Lost to Follow-up|0|||
148779173|NCT02772276|536665943|FG000|Overall Study|Withdrew consent|0|||
148779174|NCT02772276|536665944|FG001|Overall Study|Withdrew consent|0|||
148779175|NCT02772276|536665945|FG002|Overall Study|Withdrew consent|0|||
148779176|NCT02772276|536665946|FG003|Overall Study|Withdrew consent|0|||
148779177|NCT02772276|536665947|FG004|Overall Study|Withdrew consent|0|||
148779178|NCT02772276|536665948|FG005|Overall Study|Withdrew consent|0|||
148779179|NCT02772276|536665949|FG006|Overall Study|Withdrew consent|0|||
148779180|NCT02772276|536665950|FG007|Overall Study|Withdrew consent|1|||
148779181|NCT02772276|536665951|FG008|Overall Study|Withdrew consent|0|||
148779182|NCT02772276|536665952|FG009|Overall Study|Withdrew consent|0|||
148779183|NCT02772276|536665953|FG010|Overall Study|Withdrew consent|0|||
148779184|NCT02772276|536665954|FG011|Overall Study|Withdrew consent|0|||
148779185|NCT02772276|536665955|FG012|Overall Study|Withdrew consent|0|||
148779186|NCT00738062|536665956|FG000|Open Label Treatment|Lack of Efficacy|5|||
148779187|NCT00738062|536665957|FG001|Open Label Treatment|Lack of Efficacy|0|||
148779188|NCT00738062|536665958|FG002|Open Label Treatment|Lack of Efficacy|0|||
148779189|NCT00738062|536665956|FG000|Open Label Treatment|Adverse Event|11|||
148779190|NCT00738062|536665957|FG001|Open Label Treatment|Adverse Event|0|||
148779191|NCT00738062|536665958|FG002|Open Label Treatment|Adverse Event|0|||
148779192|NCT00738062|536665956|FG000|Open Label Treatment|Protocol Violation|2|||
148779193|NCT00738062|536665957|FG001|Open Label Treatment|Protocol Violation|0|||
148779194|NCT00738062|536665958|FG002|Open Label Treatment|Protocol Violation|0|||
148779195|NCT00738062|536665956|FG000|Open Label Treatment|Withdrawal by Subject|9|||
148779196|NCT00738062|536665957|FG001|Open Label Treatment|Withdrawal by Subject|0|||
148779197|NCT00738062|536665958|FG002|Open Label Treatment|Withdrawal by Subject|0|||
148779198|NCT00738062|536665956|FG000|Open Label Treatment|Investigator Decision|1|||
148779199|NCT00738062|536665957|FG001|Open Label Treatment|Investigator Decision|0|||
148779200|NCT00738062|536665958|FG002|Open Label Treatment|Investigator Decision|0|||
148779201|NCT00738062|536665956|FG000|Open-Label Extension|Adverse Event|5|||
148779202|NCT00738062|536665957|FG001|Open-Label Extension|Adverse Event|0|||
148779203|NCT00738062|536665958|FG002|Open-Label Extension|Adverse Event|0|||
148779204|NCT00738062|536665956|FG000|Open-Label Extension|Physician Decision|1|||
148779205|NCT00738062|536665957|FG001|Open-Label Extension|Physician Decision|0|||
148779206|NCT00738062|536665958|FG002|Open-Label Extension|Physician Decision|0|||
148779207|NCT00738062|536665956|FG000|Open-Label Extension|Lack of Efficacy|2|||
148779208|NCT00738062|536665957|FG001|Open-Label Extension|Lack of Efficacy|0|||
148779209|NCT00738062|536665958|FG002|Open-Label Extension|Lack of Efficacy|0|||
148779210|NCT00738062|536665956|FG000|Open-Label Extension|Withdrawal by Subject|6|||
148779211|NCT00738062|536665957|FG001|Open-Label Extension|Withdrawal by Subject|0|||
148779212|NCT00738062|536665958|FG002|Open-Label Extension|Withdrawal by Subject|0|||
148779213|NCT00738062|536665956|FG000|Open-Label Extension|Protocol Violation|1|||
148779214|NCT00738062|536665957|FG001|Open-Label Extension|Protocol Violation|0|||
148779215|NCT00738062|536665958|FG002|Open-Label Extension|Protocol Violation|0|||
148779216|NCT00738062|536665956|FG000|Open-Label Extension|Study Terminated|2|||
148779217|NCT00738062|536665957|FG001|Open-Label Extension|Study Terminated|0|||
148779218|NCT00738062|536665958|FG002|Open-Label Extension|Study Terminated|0|||
148779219|NCT02248974|536665961|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
148779220|NCT02248974|536665962|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
148779221|NCT02248974|536665961|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
148779222|NCT02248974|536665962|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
148779223|NCT02248974|536665961|FG000|1-Day Follow-Up|Enrolled in another study|1|||
148779224|NCT02248974|536665962|FG001|1-Day Follow-Up|Enrolled in another study|0|||
148779225|NCT02248974|536665961|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
148779226|NCT02248974|536665962|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
148779227|NCT02248974|536665961|FG000|1-Week Follow-Up|Enrolled in another study|1|||
148779228|NCT02248974|536665962|FG001|1-Week Follow-Up|Enrolled in another study|1|||
148779229|NCT02248974|536665961|FG000|1-Week Follow-Up|Transferred to another facility|1|||
148779230|NCT02248974|536665962|FG001|1-Week Follow-Up|Transferred to another facility|0|||
148779231|NCT02248974|536665961|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
148779232|NCT02248974|536665962|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
148779233|NCT02248974|536665961|FG000|1-Week Follow-Up|Death|1|||
148779234|NCT02248974|536665962|FG001|1-Week Follow-Up|Death|1|||
148779235|NCT02248974|536665961|FG000|1-Week Follow-Up|Excluded because of age|0|||
148779236|NCT02248974|536665962|FG001|1-Week Follow-Up|Excluded because of age|1|||
148779237|NCT02248974|536665961|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
148779238|NCT02248974|536665962|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
149033360|NCT02163915|537599087|FG002|Overall Study|Withdrawal by Subject|2|||
149033361|NCT02163915|537599088|FG003|Overall Study|Withdrawal by Subject|2|||
149033362|NCT02163915|537599089|FG004|Overall Study|Withdrawal by Subject|2|||
149033363|NCT02163915|537599085|FG000|Overall Study|Study termination|1|||
149033364|NCT02163915|537599086|FG001|Overall Study|Study termination|0|||
149033365|NCT02163915|537599087|FG002|Overall Study|Study termination|0|||
149033366|NCT02163915|537599088|FG003|Overall Study|Study termination|0|||
148779239|NCT02248974|536665961|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
148779240|NCT02248974|536665962|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
148779241|NCT02248974|536665961|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
148779242|NCT02248974|536665962|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
148779243|NCT02248974|536665961|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
148779244|NCT02248974|536665962|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
148779245|NCT02248974|536665961|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
148779246|NCT02248974|536665962|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
148779247|NCT00894790|536665963|FG000|Overall Study|Protocol Violation|0|||
149033367|NCT02163915|537599089|FG004|Overall Study|Study termination|2|||
148779248|NCT00894790|536665964|FG001|Overall Study|Protocol Violation|1|||
148779249|NCT00894790|536665963|FG000|Overall Study|Lost to Follow-up|0|||
148779250|NCT00894790|536665964|FG001|Overall Study|Lost to Follow-up|1|||
148779251|NCT00894790|536665963|FG000|Overall Study|Did not meet entrance criteria|1|||
148779252|NCT00894790|536665964|FG001|Overall Study|Did not meet entrance criteria|0|||
148779253|NCT04093492|536665965|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
148779254|NCT04093492|536665966|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
148779255|NCT04093492|536665967|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
148779256|NCT04093492|536665968|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
148779257|NCT04093492|536665965|FG000|25 Weeks Gestational Age (GA)|No response|5|||
148779258|NCT04093492|536665966|FG001|25 Weeks Gestational Age (GA)|No response|5|||
148779259|NCT04093492|536665967|FG002|25 Weeks Gestational Age (GA)|No response|5|||
148779260|NCT04093492|536665968|FG003|25 Weeks Gestational Age (GA)|No response|2|||
148779261|NCT04093492|536665965|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
148779262|NCT04093492|536665966|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
148779263|NCT04093492|536665967|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
148779264|NCT04093492|536665968|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
148779265|NCT04093492|536665965|FG000|30 Weeks GA|Delivered before assessment|1|||
148779266|NCT04093492|536665966|FG001|30 Weeks GA|Delivered before assessment|2|||
148779267|NCT04093492|536665967|FG002|30 Weeks GA|Delivered before assessment|0|||
148779268|NCT04093492|536665968|FG003|30 Weeks GA|Delivered before assessment|0|||
148779269|NCT04093492|536665965|FG000|30 Weeks GA|No response|7|||
148779270|NCT04093492|536665966|FG001|30 Weeks GA|No response|5|||
148779271|NCT04093492|536665967|FG002|30 Weeks GA|No response|5|||
148779272|NCT04093492|536665968|FG003|30 Weeks GA|No response|2|||
148779273|NCT04093492|536665965|FG000|30 Weeks GA|Lost to Follow-up|0|||
148779274|NCT04093492|536665966|FG001|30 Weeks GA|Lost to Follow-up|1|||
148779275|NCT04093492|536665967|FG002|30 Weeks GA|Lost to Follow-up|0|||
148779276|NCT04093492|536665968|FG003|30 Weeks GA|Lost to Follow-up|0|||
148779277|NCT04093492|536665965|FG000|34 Weeks GA|Delivered before assessment|6|||
148779278|NCT04093492|536665966|FG001|34 Weeks GA|Delivered before assessment|3|||
148779279|NCT04093492|536665967|FG002|34 Weeks GA|Delivered before assessment|0|||
148779280|NCT04093492|536665968|FG003|34 Weeks GA|Delivered before assessment|0|||
148779281|NCT04093492|536665965|FG000|34 Weeks GA|No response|0|||
148779282|NCT04093492|536665966|FG001|34 Weeks GA|No response|7|||
148779283|NCT04093492|536665967|FG002|34 Weeks GA|No response|5|||
148779284|NCT04093492|536665968|FG003|34 Weeks GA|No response|3|||
148779285|NCT04093492|536665965|FG000|34 Weeks GA|Lost to Follow-up|0|||
148779286|NCT04093492|536665966|FG001|34 Weeks GA|Lost to Follow-up|1|||
148779287|NCT04093492|536665967|FG002|34 Weeks GA|Lost to Follow-up|0|||
148779288|NCT04093492|536665968|FG003|34 Weeks GA|Lost to Follow-up|0|||
148779289|NCT02945254|536665969|FG000|Overall Study|Lost to Follow-up|1|||
148779290|NCT02945254|536665970|FG001|Overall Study|Lost to Follow-up|0|||
148779291|NCT02945254|536665969|FG000|Overall Study|Withdrawal by Subject|1|||
148779292|NCT02945254|536665970|FG001|Overall Study|Withdrawal by Subject|0|||
148779293|NCT00783224|536665971|FG000|Overall Study|Adverse Event|0|||
148779294|NCT00783224|536665972|FG001|Overall Study|Adverse Event|0|||
148779295|NCT00783224|536665973|FG002|Overall Study|Adverse Event|1|||
148779296|NCT00783224|536665974|FG003|Overall Study|Adverse Event|0|||
148779297|NCT00783224|536665971|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
148779298|NCT00783224|536665972|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
148779299|NCT00783224|536665973|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
148779300|NCT00783224|536665974|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
148779301|NCT00783224|536665971|FG000|Overall Study|Inappropriate as a study subject|0|||
148779302|NCT00783224|536665972|FG001|Overall Study|Inappropriate as a study subject|0|||
148779303|NCT00783224|536665973|FG002|Overall Study|Inappropriate as a study subject|0|||
148779304|NCT00783224|536665974|FG003|Overall Study|Inappropriate as a study subject|1|||
148779305|NCT01711619|536665975|FG000|Overall Study|Early study termination|10|||
148779306|NCT01711619|536665976|FG001|Overall Study|Early study termination|14|||
148779307|NCT01711619|536665975|FG000|Overall Study|Withdrawal by Subject|3|||
148779308|NCT01711619|536665976|FG001|Overall Study|Withdrawal by Subject|7|||
148779309|NCT01711619|536665975|FG000|Overall Study|Protocol Violation|2|||
148779310|NCT01711619|536665976|FG001|Overall Study|Protocol Violation|3|||
148779311|NCT01711619|536665975|FG000|Overall Study|Adverse Event|2|||
148779312|NCT01711619|536665976|FG001|Overall Study|Adverse Event|0|||
148779313|NCT01711619|536665975|FG000|Overall Study|Lost to Follow-up|1|||
148779314|NCT01711619|536665976|FG001|Overall Study|Lost to Follow-up|0|||
148779315|NCT00334802|536665977|FG000|Overall Study|Progressive Disease|2|||
148779316|NCT00334802|536665978|FG001|Overall Study|Progressive Disease|24|||
148779317|NCT00334802|536665977|FG000|Overall Study|Toxicity|1|||
148779318|NCT00334802|536665978|FG001|Overall Study|Toxicity|5|||
148779319|NCT00334802|536665977|FG000|Overall Study|Lack of Efficacy|1|||
148779320|NCT00334802|536665978|FG001|Overall Study|Lack of Efficacy|3|||
148779321|NCT00334802|536665977|FG000|Overall Study|Patient Condition Aggrevated|1|||
148779322|NCT00334802|536665978|FG001|Overall Study|Patient Condition Aggrevated|0|||
148779323|NCT00334802|536665977|FG000|Overall Study|Physician Decision|1|||
148779324|NCT00334802|536665978|FG001|Overall Study|Physician Decision|0|||
148779325|NCT00334802|536665977|FG000|Overall Study|Withdrawal by Subject|0|||
148779326|NCT00334802|536665978|FG001|Overall Study|Withdrawal by Subject|4|||
148779327|NCT00334802|536665977|FG000|Overall Study|Adverse Event|0|||
148779328|NCT00334802|536665978|FG001|Overall Study|Adverse Event|3|||
148779329|NCT00334802|536665977|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
148779330|NCT00334802|536665978|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
148779331|NCT03422159|536665979|FG000|Overall Study|Exclusion due to terminal disease|2|||
148779332|NCT03422159|536665980|FG001|Overall Study|Exclusion due to terminal disease|1|||
148779333|NCT03436199|536665981|FG000|Overall Study|Adverse Event|15|||
148779334|NCT03436199|536665982|FG001|Overall Study|Adverse Event|40|||
148779335|NCT03436199|536665983|FG002|Overall Study|Adverse Event|7|||
148779336|NCT03436199|536665981|FG000|Overall Study|Withdrawal by Subject|4|||
148779337|NCT03436199|536665982|FG001|Overall Study|Withdrawal by Subject|10|||
148779338|NCT03436199|536665983|FG002|Overall Study|Withdrawal by Subject|3|||
148779339|NCT03436199|536665981|FG000|Overall Study|Lost to Follow-up|1|||
148779340|NCT03436199|536665982|FG001|Overall Study|Lost to Follow-up|0|||
148779341|NCT03436199|536665983|FG002|Overall Study|Lost to Follow-up|2|||
148779342|NCT03436199|536665981|FG000|Overall Study|Protocol Violation|1|||
148779343|NCT03436199|536665982|FG001|Overall Study|Protocol Violation|1|||
148779344|NCT03436199|536665983|FG002|Overall Study|Protocol Violation|0|||
148779345|NCT03436199|536665981|FG000|Overall Study|Physician Decision|0|||
148779346|NCT03436199|536665982|FG001|Overall Study|Physician Decision|1|||
148779347|NCT03436199|536665983|FG002|Overall Study|Physician Decision|0|||
148779348|NCT03436199|536665981|FG000|Overall Study|Could not return to clinic|1|||
148779349|NCT03436199|536665982|FG001|Overall Study|Could not return to clinic|0|||
148779350|NCT03436199|536665983|FG002|Overall Study|Could not return to clinic|0|||
148779351|NCT03436199|536665981|FG000|Overall Study|Withdrawn per physician|0|||
148779352|NCT03436199|536665982|FG001|Overall Study|Withdrawn per physician|1|||
148779353|NCT03436199|536665983|FG002|Overall Study|Withdrawn per physician|0|||
148779354|NCT00503997|536665986|FG000|Overall Study|disease progression|1|||
148779355|NCT00503997|536665986|FG000|Overall Study|Adverse Event|5|||
148779356|NCT00503997|536665986|FG000|Overall Study|Death|1|||
148779357|NCT00503997|536665986|FG000|Overall Study|Withdrawal by Subject|1|||
148779358|NCT01195844|536665987|FG000|Overall Study|Fecal sample not collected|40|||
148779359|NCT00087126|536665991|FG000|Overall Study|Ineligible - second primary|1|||
148779360|NCT00087126|536665991|FG000|Overall Study|Never treated|1|||
148779361|NCT01432275|536665992|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
148779362|NCT01432275|536665993|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
148779363|NCT01432275|536665992|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
148779364|NCT01432275|536665993|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
148779365|NCT01432275|536665992|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
148779366|NCT01432275|536665993|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
148779367|NCT01432275|536665992|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
148779368|NCT01432275|536665993|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
148779369|NCT01432275|536665992|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
148779370|NCT01432275|536665993|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
148779371|NCT01432275|536665992|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
148779372|NCT01432275|536665993|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
148779373|NCT01432275|536665992|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
148779374|NCT01432275|536665993|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
148779375|NCT01432275|536665992|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
148779376|NCT01432275|536665993|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
148779377|NCT01432275|536665992|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
148779378|NCT01432275|536665993|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
148779379|NCT01935700|536666000|FG000|Overall Study|Withdrawal by Subject|1|||
148779380|NCT01935700|536666001|FG001|Overall Study|Withdrawal by Subject|0|||
148779381|NCT01935700|536666000|FG000|Overall Study|Physician Decision|4|||
148779382|NCT01935700|536666001|FG001|Overall Study|Physician Decision|0|||
148779383|NCT01935128|536666002|FG000|Overall Study|Death|1|||
148779384|NCT01935128|536666002|FG000|Overall Study|Adverse Event|6|||
148779385|NCT00772005|536666004|FG000|Overall Study|Adverse Event|9|||
148779386|NCT00772005|536666005|FG001|Overall Study|Adverse Event|14|||
148779387|NCT00772005|536666006|FG002|Overall Study|Adverse Event|10|||
148779388|NCT00772005|536666007|FG003|Overall Study|Adverse Event|13|||
148779389|NCT00772005|536666004|FG000|Overall Study|Lack of Efficacy|0|||
148779390|NCT00772005|536666005|FG001|Overall Study|Lack of Efficacy|1|||
148779391|NCT00772005|536666006|FG002|Overall Study|Lack of Efficacy|0|||
148779392|NCT00772005|536666007|FG003|Overall Study|Lack of Efficacy|0|||
148779393|NCT00772005|536666004|FG000|Overall Study|Withdrawal by Subject|3|||
148779394|NCT00772005|536666005|FG001|Overall Study|Withdrawal by Subject|7|||
148779395|NCT00772005|536666006|FG002|Overall Study|Withdrawal by Subject|10|||
148779396|NCT00772005|536666007|FG003|Overall Study|Withdrawal by Subject|2|||
148779397|NCT00772005|536666004|FG000|Overall Study|Protocol Violation|2|||
148779398|NCT00772005|536666005|FG001|Overall Study|Protocol Violation|4|||
148779399|NCT00772005|536666006|FG002|Overall Study|Protocol Violation|1|||
148779400|NCT00772005|536666007|FG003|Overall Study|Protocol Violation|6|||
148779401|NCT00772005|536666004|FG000|Overall Study|Lost to Follow-up|7|||
148779402|NCT00772005|536666005|FG001|Overall Study|Lost to Follow-up|3|||
148779403|NCT00772005|536666006|FG002|Overall Study|Lost to Follow-up|6|||
148779404|NCT00772005|536666007|FG003|Overall Study|Lost to Follow-up|3|||
148779405|NCT00772005|536666004|FG000|Overall Study|Non-compliance with study procedures|1|||
148779406|NCT00772005|536666005|FG001|Overall Study|Non-compliance with study procedures|1|||
148779407|NCT00772005|536666006|FG002|Overall Study|Non-compliance with study procedures|0|||
148779408|NCT00772005|536666007|FG003|Overall Study|Non-compliance with study procedures|1|||
148779409|NCT00772005|536666004|FG000|Overall Study|Non-compliance with drug administration|3|||
148779410|NCT00772005|536666005|FG001|Overall Study|Non-compliance with drug administration|0|||
148779411|NCT00772005|536666006|FG002|Overall Study|Non-compliance with drug administration|1|||
148779412|NCT00772005|536666007|FG003|Overall Study|Non-compliance with drug administration|1|||
149033368|NCT02163915|537599085|FG000|Overall Study|Physician Decision|0|||
149033369|NCT02163915|537599086|FG001|Overall Study|Physician Decision|0|||
148779413|NCT01162122|536666018|FG000|Overall Study|Withdrawal by Subject|52|||
148779414|NCT01162122|536666019|FG001|Overall Study|Withdrawal by Subject|43|||
148779415|NCT01162122|536666018|FG000|Overall Study|Lost to Follow-up|73|||
148779416|NCT01162122|536666019|FG001|Overall Study|Lost to Follow-up|91|||
148779417|NCT01162122|536666018|FG000|Overall Study|Adverse Event|3|||
148779418|NCT01162122|536666019|FG001|Overall Study|Adverse Event|2|||
148779419|NCT01162122|536666018|FG000|Overall Study|Death|51|||
148779420|NCT01162122|536666019|FG001|Overall Study|Death|46|||
148779421|NCT01162122|536666018|FG000|Overall Study|Protocol Violation|2|||
148779422|NCT01162122|536666019|FG001|Overall Study|Protocol Violation|2|||
148779423|NCT01162122|536666018|FG000|Overall Study|Inappropriate enrollment|5|||
148779424|NCT01162122|536666019|FG001|Overall Study|Inappropriate enrollment|4|||
148779425|NCT01162122|536666018|FG000|Overall Study|Administrative reason|1|||
148779426|NCT01162122|536666019|FG001|Overall Study|Administrative reason|1|||
148779427|NCT01162122|536666018|FG000|Overall Study|Unable to classify|3|||
148779428|NCT01162122|536666019|FG001|Overall Study|Unable to classify|7|||
148779429|NCT01162122|536666018|FG000|Overall Study|Missing primary reason|1|||
148779430|NCT01162122|536666019|FG001|Overall Study|Missing primary reason|0|||
148779431|NCT02020512|536666020|FG000|Overall Study|Adverse Event|1|||
148779432|NCT02020512|536666020|FG000|Overall Study|Lost to Follow-up|3|||
148779433|NCT02020512|536666020|FG000|Overall Study|Protocol Violation|4|||
148779434|NCT00483704|536666034|FG000|Randomization|Withdrawal by Subject|19|||
148779435|NCT00483704|536666035|FG001|Randomization|Withdrawal by Subject|28|||
148779436|NCT00483704|536666036|FG002|Randomization|Withdrawal by Subject|18|||
148779437|NCT00483704|536666034|FG000|Randomization|Protocol Violation|14|||
148779438|NCT00483704|536666035|FG001|Randomization|Protocol Violation|25|||
148779439|NCT00483704|536666036|FG002|Randomization|Protocol Violation|22|||
148779440|NCT00483704|536666034|FG000|Randomization|Lost to Follow-up|14|||
148779441|NCT00483704|536666035|FG001|Randomization|Lost to Follow-up|14|||
148779442|NCT00483704|536666036|FG002|Randomization|Lost to Follow-up|19|||
148779443|NCT00483704|536666034|FG000|Randomization|Pregnancy|1|||
148779444|NCT00483704|536666035|FG001|Randomization|Pregnancy|0|||
148779445|NCT00483704|536666036|FG002|Randomization|Pregnancy|0|||
148779446|NCT00483704|536666034|FG000|Randomization|Physician Decision|2|||
148779447|NCT00483704|536666035|FG001|Randomization|Physician Decision|4|||
148779448|NCT00483704|536666036|FG002|Randomization|Physician Decision|0|||
148779449|NCT00483704|536666034|FG000|Randomization|Progressive disease|0|||
148779450|NCT00483704|536666035|FG001|Randomization|Progressive disease|0|||
148779451|NCT00483704|536666036|FG002|Randomization|Progressive disease|1|||
148779452|NCT00483704|536666034|FG000|Randomization|Lack of qualifying migraines|21|||
148779453|NCT00483704|536666035|FG001|Randomization|Lack of qualifying migraines|25|||
148779454|NCT00483704|536666036|FG002|Randomization|Lack of qualifying migraines|31|||
148779455|NCT00483704|536666034|FG000|Treatment|Lack of qualifying migraines|101|||
148779456|NCT00483704|536666035|FG001|Treatment|Lack of qualifying migraines|99|||
148779457|NCT00483704|536666036|FG002|Treatment|Lack of qualifying migraines|116|||
148779458|NCT00483704|536666034|FG000|Treatment|Adverse Event|3|||
148779459|NCT00483704|536666035|FG001|Treatment|Adverse Event|5|||
148779460|NCT00483704|536666036|FG002|Treatment|Adverse Event|4|||
148779461|NCT00483704|536666034|FG000|Treatment|Withdrawal by Subject|16|||
148779462|NCT00483704|536666035|FG001|Treatment|Withdrawal by Subject|12|||
148779463|NCT00483704|536666036|FG002|Treatment|Withdrawal by Subject|21|||
148779464|NCT00483704|536666034|FG000|Treatment|Protocol Violation|6|||
148779465|NCT00483704|536666035|FG001|Treatment|Protocol Violation|3|||
148779466|NCT00483704|536666036|FG002|Treatment|Protocol Violation|5|||
148779467|NCT00483704|536666034|FG000|Treatment|Lost to Follow-up|2|||
148779468|NCT00483704|536666035|FG001|Treatment|Lost to Follow-up|7|||
148779469|NCT00483704|536666036|FG002|Treatment|Lost to Follow-up|5|||
148872823|NCT01141478|537012308|FG001|Overall Study|Withdrawal by Subject|1|||
149033370|NCT02163915|537599087|FG002|Overall Study|Physician Decision|0|||
148779470|NCT00483704|536666034|FG000|Treatment|Lack of Efficacy|1|||
148779471|NCT00483704|536666035|FG001|Treatment|Lack of Efficacy|1|||
148779472|NCT00483704|536666036|FG002|Treatment|Lack of Efficacy|1|||
148779473|NCT00483704|536666034|FG000|Treatment|Pregnancy|0|||
148779474|NCT00483704|536666035|FG001|Treatment|Pregnancy|1|||
148779475|NCT00483704|536666036|FG002|Treatment|Pregnancy|0|||
148779476|NCT00483704|536666034|FG000|Treatment|Physician Decision|0|||
148779477|NCT00483704|536666035|FG001|Treatment|Physician Decision|1|||
148779478|NCT00483704|536666036|FG002|Treatment|Physician Decision|4|||
148779479|NCT00948506|536666037|FG000|Overall Study|Withdrawal by Subject|3|||
148779480|NCT00948506|536666038|FG001|Overall Study|Withdrawal by Subject|1|||
149033371|NCT02163915|537599088|FG003|Overall Study|Physician Decision|1|||
148779481|NCT03912428|536666039|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
148779482|NCT03912428|536666040|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
148779483|NCT03912428|536666041|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
148779484|NCT03912428|536666042|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
148779485|NCT03912428|536666039|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
148779486|NCT03912428|536666040|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
148779487|NCT03912428|536666041|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
148779488|NCT03912428|536666042|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
148779489|NCT03912428|536666039|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
148779490|NCT03912428|536666040|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
148779491|NCT03912428|536666041|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
148779492|NCT03912428|536666042|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
148779493|NCT03233204|536666043|FG000|Overall Study|Adverse Event|1|||
148779494|NCT03233204|536666043|FG000|Overall Study|Death|1|||
148779495|NCT03233204|536666043|FG000|Overall Study|Withdrawal by Subject|1|||
148779496|NCT03233204|536666043|FG000|Overall Study|Progressive Disease|3|||
148779497|NCT00793624|536666044|FG000|Overall Study|Adverse Event|18|||
148779498|NCT00793624|536666045|FG001|Overall Study|Adverse Event|16|||
148779499|NCT00793624|536666046|FG002|Overall Study|Adverse Event|15|||
148779500|NCT00793624|536666047|FG003|Overall Study|Adverse Event|20|||
148779501|NCT00793624|536666044|FG000|Overall Study|Lost to Follow-up|2|||
148779502|NCT00793624|536666045|FG001|Overall Study|Lost to Follow-up|2|||
148779503|NCT00793624|536666046|FG002|Overall Study|Lost to Follow-up|4|||
148779504|NCT00793624|536666047|FG003|Overall Study|Lost to Follow-up|0|||
148779505|NCT00793624|536666044|FG000|Overall Study|Withdrawal by Subject|20|||
148779506|NCT00793624|536666045|FG001|Overall Study|Withdrawal by Subject|9|||
148779507|NCT00793624|536666046|FG002|Overall Study|Withdrawal by Subject|11|||
148779508|NCT00793624|536666047|FG003|Overall Study|Withdrawal by Subject|14|||
148779509|NCT00793624|536666044|FG000|Overall Study|Lack of Efficacy|9|||
148779510|NCT00793624|536666045|FG001|Overall Study|Lack of Efficacy|2|||
148779511|NCT00793624|536666046|FG002|Overall Study|Lack of Efficacy|1|||
148779512|NCT00793624|536666047|FG003|Overall Study|Lack of Efficacy|3|||
148779513|NCT00793624|536666044|FG000|Overall Study|Non compliance with protocol|2|||
148779514|NCT00793624|536666045|FG001|Overall Study|Non compliance with protocol|3|||
148779515|NCT00793624|536666046|FG002|Overall Study|Non compliance with protocol|2|||
148779516|NCT00793624|536666047|FG003|Overall Study|Non compliance with protocol|3|||
148779517|NCT00793624|536666044|FG000|Overall Study|Other reason not described above|6|||
148779518|NCT00793624|536666045|FG001|Overall Study|Other reason not described above|4|||
148779519|NCT00793624|536666046|FG002|Overall Study|Other reason not described above|6|||
148779520|NCT00793624|536666047|FG003|Overall Study|Other reason not described above|3|||
148872824|NCT01581619|537012309|FG000|Overall Study|Withdrawal by Subject|1|||
148872825|NCT01581619|537012309|FG000|Overall Study|Lost to Follow-up|1|||
148872826|NCT00290498|537012310|FG000|Overall Study|Death|2|||
148872827|NCT00290498|537012311|FG001|Overall Study|Death|0|||
148872828|NCT00290498|537012310|FG000|Overall Study|Physician Decision|1|||
148872829|NCT00290498|537012311|FG001|Overall Study|Physician Decision|0|||
148872830|NCT00290498|537012310|FG000|Overall Study|Withdrawal by Subject|1|||
148872831|NCT00290498|537012311|FG001|Overall Study|Withdrawal by Subject|0|||
148872832|NCT00290498|537012310|FG000|Overall Study|Ineligible|3|||
148872833|NCT00290498|537012311|FG001|Overall Study|Ineligible|0|||
148872834|NCT00290498|537012310|FG000|Overall Study|Non-Compliance|1|||
148872835|NCT00290498|537012311|FG001|Overall Study|Non-Compliance|0|||
148872836|NCT02250664|537012314|FG000|Overall Study|Lost to Follow-up|18|||
148872837|NCT02250664|537012315|FG001|Overall Study|Lost to Follow-up|28|||
148872838|NCT02250664|537012316|FG002|Overall Study|Lost to Follow-up|33|||
148872839|NCT02250664|537012314|FG000|Overall Study|Personal Reasons|7|||
148872840|NCT02250664|537012315|FG001|Overall Study|Personal Reasons|8|||
148872841|NCT02250664|537012316|FG002|Overall Study|Personal Reasons|14|||
148872842|NCT02250664|537012314|FG000|Overall Study|Adverse Event|6|||
148872843|NCT02250664|537012315|FG001|Overall Study|Adverse Event|3|||
148872844|NCT02250664|537012316|FG002|Overall Study|Adverse Event|8|||
148872845|NCT02250664|537012314|FG000|Overall Study|Incarcerated|2|||
148872846|NCT02250664|537012315|FG001|Overall Study|Incarcerated|1|||
148872847|NCT02250664|537012316|FG002|Overall Study|Incarcerated|2|||
148872848|NCT02250664|537012314|FG000|Overall Study|Withdrawal by Subject|0|||
148872849|NCT02250664|537012315|FG001|Overall Study|Withdrawal by Subject|1|||
148872850|NCT02250664|537012316|FG002|Overall Study|Withdrawal by Subject|2|||
148872851|NCT02250664|537012314|FG000|Overall Study|Death|0|||
148872852|NCT02250664|537012315|FG001|Overall Study|Death|1|||
148872853|NCT02250664|537012316|FG002|Overall Study|Death|1|||
148872854|NCT02250664|537012314|FG000|Overall Study|Physician Decision|1|||
148872855|NCT02250664|537012315|FG001|Overall Study|Physician Decision|3|||
148872856|NCT02250664|537012316|FG002|Overall Study|Physician Decision|1|||
148872857|NCT02250664|537012314|FG000|Overall Study|Protocol Violation|1|||
148872858|NCT02250664|537012315|FG001|Overall Study|Protocol Violation|0|||
148872859|NCT02250664|537012316|FG002|Overall Study|Protocol Violation|1|||
148872860|NCT02250664|537012314|FG000|Overall Study|Reason unknown|1|||
148872861|NCT02250664|537012315|FG001|Overall Study|Reason unknown|0|||
148872862|NCT02250664|537012316|FG002|Overall Study|Reason unknown|0|||
148872863|NCT03847909|537012317|FG000|Overall Study|Withdrawal by Subject|1|||
148872864|NCT03847909|537012318|FG001|Overall Study|Withdrawal by Subject|1|||
148872865|NCT04268173|537012320|FG000|Overall Study|Lost to Follow-up|75|||
148872866|NCT04268173|537012321|FG001|Overall Study|Lost to Follow-up|108|||
148872867|NCT00869401|537012322|FG000|Overall Study|Withdrawal by Subject|0|||
148872868|NCT00869401|537012323|FG001|Overall Study|Withdrawal by Subject|0|||
148872869|NCT00869401|537012324|FG002|Overall Study|Withdrawal by Subject|0|||
148872870|NCT00869401|537012325|FG003|Overall Study|Withdrawal by Subject|5|||
148872871|NCT00869401|537012326|FG004|Overall Study|Withdrawal by Subject|3|||
148872872|NCT00545103|537012327|FG000|Overall Study|Lack of Efficacy|48|||
148872873|NCT00545103|537012328|FG001|Overall Study|Lack of Efficacy|45|||
148872874|NCT00545103|537012329|FG002|Overall Study|Lack of Efficacy|31|||
148872875|NCT00545103|537012330|FG003|Overall Study|Lack of Efficacy|27|||
148872876|NCT00545103|537012327|FG000|Overall Study|Withdrawal by Subject|6|||
148872877|NCT00545103|537012328|FG001|Overall Study|Withdrawal by Subject|10|||
148872878|NCT00545103|537012329|FG002|Overall Study|Withdrawal by Subject|18|||
148872879|NCT00545103|537012330|FG003|Overall Study|Withdrawal by Subject|22|||
149033372|NCT02163915|537599089|FG004|Overall Study|Physician Decision|0|||
149033373|NCT00603447|537599090|FG000|Overall Study|Adverse Event|0|||
149033374|NCT00603447|537599091|FG001|Overall Study|Adverse Event|1|||
149033375|NCT00603447|537599092|FG002|Overall Study|Adverse Event|1|||
149033376|NCT00603447|537599093|FG003|Overall Study|Adverse Event|2|||
149033377|NCT00603447|537599094|FG004|Overall Study|Adverse Event|1|||
149033378|NCT00603447|537599095|FG005|Overall Study|Adverse Event|2|||
149033379|NCT00603447|537599096|FG006|Overall Study|Adverse Event|10|||
149033380|NCT00603447|537599090|FG000|Overall Study|Other|0|||
149033381|NCT00603447|537599091|FG001|Overall Study|Other|0|||
149033382|NCT00603447|537599092|FG002|Overall Study|Other|1|||
149033383|NCT00603447|537599093|FG003|Overall Study|Other|0|||
149033384|NCT00603447|537599094|FG004|Overall Study|Other|3|||
149033385|NCT00603447|537599095|FG005|Overall Study|Other|0|||
149033386|NCT00603447|537599096|FG006|Overall Study|Other|13|||
149033387|NCT00603447|537599090|FG000|Overall Study|Withdrew Consent|0|||
149033388|NCT00603447|537599091|FG001|Overall Study|Withdrew Consent|2|||
149033389|NCT00603447|537599092|FG002|Overall Study|Withdrew Consent|0|||
149033390|NCT00603447|537599093|FG003|Overall Study|Withdrew Consent|0|||
149033391|NCT00603447|537599094|FG004|Overall Study|Withdrew Consent|1|||
148872880|NCT00545103|537012327|FG000|Overall Study|Adverse Event|11|||
148872881|NCT00545103|537012328|FG001|Overall Study|Adverse Event|12|||
148872882|NCT00545103|537012329|FG002|Overall Study|Adverse Event|17|||
148872883|NCT00545103|537012330|FG003|Overall Study|Adverse Event|10|||
148872884|NCT00545103|537012327|FG000|Overall Study|Lost to Follow-up|4|||
148872885|NCT00545103|537012328|FG001|Overall Study|Lost to Follow-up|6|||
148872886|NCT00545103|537012329|FG002|Overall Study|Lost to Follow-up|3|||
148872887|NCT00545103|537012330|FG003|Overall Study|Lost to Follow-up|4|||
148872888|NCT00545103|537012327|FG000|Overall Study|Protocol Violation|1|||
148872889|NCT00545103|537012328|FG001|Overall Study|Protocol Violation|2|||
148872890|NCT00545103|537012329|FG002|Overall Study|Protocol Violation|3|||
148872891|NCT00545103|537012330|FG003|Overall Study|Protocol Violation|0|||
148872892|NCT00545103|537012327|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
148872893|NCT00545103|537012328|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
148872894|NCT00545103|537012329|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
148872895|NCT00545103|537012330|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
148872896|NCT00545103|537012327|FG000|Overall Study|Difficult to open package|0|||
148872897|NCT00545103|537012328|FG001|Overall Study|Difficult to open package|0|||
148872898|NCT00545103|537012329|FG002|Overall Study|Difficult to open package|0|||
148872899|NCT00545103|537012330|FG003|Overall Study|Difficult to open package|1|||
148872900|NCT00545103|537012327|FG000|Overall Study|Investigational product not taken|1|||
148872901|NCT00545103|537012328|FG001|Overall Study|Investigational product not taken|0|||
148872902|NCT00545103|537012329|FG002|Overall Study|Investigational product not taken|0|||
148872903|NCT00545103|537012330|FG003|Overall Study|Investigational product not taken|1|||
148872904|NCT00545103|537012327|FG000|Overall Study|Wish to start a family|0|||
148872905|NCT00545103|537012328|FG001|Overall Study|Wish to start a family|0|||
148872906|NCT00545103|537012329|FG002|Overall Study|Wish to start a family|0|||
148872907|NCT00545103|537012330|FG003|Overall Study|Wish to start a family|1|||
149033392|NCT00603447|537599095|FG005|Overall Study|Withdrew Consent|0|||
149033393|NCT00603447|537599096|FG006|Overall Study|Withdrew Consent|1|||
149033394|NCT00470626|537600321|FG000|Overall Study|Lost to Follow-up|10|||
148872908|NCT00545103|537012327|FG000|Overall Study|Diverticulitis crisis|0|||
148872909|NCT00545103|537012328|FG001|Overall Study|Diverticulitis crisis|0|||
148872910|NCT00545103|537012329|FG002|Overall Study|Diverticulitis crisis|0|||
148872911|NCT00545103|537012330|FG003|Overall Study|Diverticulitis crisis|1|||
148872912|NCT00545103|537012327|FG000|Overall Study|Personal reasons|1|||
148872913|NCT00545103|537012328|FG001|Overall Study|Personal reasons|0|||
148872914|NCT00545103|537012329|FG002|Overall Study|Personal reasons|0|||
148872915|NCT00545103|537012330|FG003|Overall Study|Personal reasons|0|||
148872916|NCT00545103|537012327|FG000|Overall Study|Subject's decision|1|||
149033395|NCT00470626|537600321|FG000|Overall Study|Withdrawal by Subject|7|||
149033396|NCT00777556|537600322|FG000|Overall Study|Inappropriate self-selection|34|||
149033397|NCT00777556|537600322|FG000|Overall Study|Dispensed but did not use product|12|||
149033398|NCT00777556|537600322|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
149033399|NCT02689349|537600323|FG000|Overall Study|Not implanted|4|||
149033400|NCT02689349|537600324|FG001|Overall Study|Not implanted|0|||
149033401|NCT02689349|537600323|FG000|Overall Study|Withdrawal by Subject|9|||
149033402|NCT02689349|537600324|FG001|Overall Study|Withdrawal by Subject|0|||
149033403|NCT01185522|537600325|FG000|Overall Study|Lack of Efficacy|28|||
149033404|NCT01185522|537600325|FG000|Overall Study|Lost to Follow-up|19|||
148872917|NCT00545103|537012328|FG001|Overall Study|Subject's decision|0|||
148872918|NCT00545103|537012329|FG002|Overall Study|Subject's decision|0|||
148872919|NCT00545103|537012330|FG003|Overall Study|Subject's decision|0|||
148872920|NCT00545103|537012327|FG000|Overall Study|Noncompliance|0|||
148872921|NCT00545103|537012328|FG001|Overall Study|Noncompliance|1|||
148872922|NCT00545103|537012329|FG002|Overall Study|Noncompliance|0|||
149033405|NCT01185522|537600325|FG000|Overall Study|Withdrawal by Subject|10|||
149033406|NCT01185522|537600325|FG000|Overall Study|Poor tolerance|39|||
149033407|NCT01185522|537600325|FG000|Overall Study|Other reasons|12|||
149033408|NCT00364286|537600326|FG000|Overall Study|Withdrawal by Subject|1|||
149033409|NCT00364286|537600326|FG000|Overall Study|Adverse Event|2|||
149033410|NCT01227278|537600329|FG000|Overall Study|Withdrawal by Subject|4|||
149033411|NCT01227278|537600330|FG001|Overall Study|Withdrawal by Subject|4|||
149033412|NCT01227278|537600329|FG000|Overall Study|Death|0|||
149033413|NCT01227278|537600330|FG001|Overall Study|Death|2|||
149033414|NCT01227278|537600329|FG000|Overall Study|Other|1|||
149033415|NCT01227278|537600330|FG001|Overall Study|Other|2|||
149033416|NCT03546907|537600345|FG000|Overall Study|Lack of Efficacy|1|||
149033417|NCT03546907|537600346|FG001|Overall Study|Lack of Efficacy|1|||
149033418|NCT03546907|537600345|FG000|Overall Study|Withdrawal by Subject|8|||
149033419|NCT03546907|537600346|FG001|Overall Study|Withdrawal by Subject|9|||
148872923|NCT00545103|537012330|FG003|Overall Study|Noncompliance|0|||
148872924|NCT00545103|537012327|FG000|Overall Study|Investigator decision|0|||
148872925|NCT00545103|537012328|FG001|Overall Study|Investigator decision|0|||
148872926|NCT00545103|537012329|FG002|Overall Study|Investigator decision|1|||
148872927|NCT00545103|537012330|FG003|Overall Study|Investigator decision|0|||
148872928|NCT00545103|537012327|FG000|Overall Study|Subject moved|0|||
149033420|NCT03546907|537600345|FG000|Overall Study|Adverse events (AEs)|7|||
149033421|NCT03546907|537600346|FG001|Overall Study|Adverse events (AEs)|10|||
149033422|NCT03546907|537600345|FG000|Overall Study|Other-unspecified|1|||
149033423|NCT03546907|537600346|FG001|Overall Study|Other-unspecified|1|||
149033424|NCT00975806|537600347|FG000|Overall Study|Adverse Event|2|||
149033425|NCT00975806|537600348|FG001|Overall Study|Adverse Event|1|||
149033426|NCT00975806|537600349|FG002|Overall Study|Adverse Event|2|||
149033427|NCT00975806|537600347|FG000|Overall Study|Disease Progression|1|||
149033428|NCT00975806|537600348|FG001|Overall Study|Disease Progression|5|||
149033429|NCT00975806|537600349|FG002|Overall Study|Disease Progression|1|||
149033430|NCT00975806|537600347|FG000|Overall Study|Withdrawal by Subject|1|||
149033431|NCT00975806|537600348|FG001|Overall Study|Withdrawal by Subject|0|||
149033432|NCT00975806|537600349|FG002|Overall Study|Withdrawal by Subject|0|||
149033433|NCT00975806|537600347|FG000|Overall Study|Death|0|||
149033434|NCT00975806|537600348|FG001|Overall Study|Death|1|||
149033435|NCT00975806|537600349|FG002|Overall Study|Death|0|||
148872929|NCT00545103|537012328|FG001|Overall Study|Subject moved|1|||
149033436|NCT00975806|537600347|FG000|Overall Study|Physician decision and disease related|1|||
149033437|NCT00975806|537600348|FG001|Overall Study|Physician decision and disease related|0|||
149033438|NCT00975806|537600349|FG002|Overall Study|Physician decision and disease related|1|||
149033439|NCT00246012|537600350|FG000|Overall Study|Adverse Event|0|||
148872930|NCT00545103|537012329|FG002|Overall Study|Subject moved|0|||
148872931|NCT00545103|537012330|FG003|Overall Study|Subject moved|0|||
148872932|NCT00545103|537012327|FG000|Overall Study|Use of prohibited medication|0|||
148872933|NCT00545103|537012328|FG001|Overall Study|Use of prohibited medication|0|||
148872934|NCT00545103|537012329|FG002|Overall Study|Use of prohibited medication|1|||
148872935|NCT00545103|537012330|FG003|Overall Study|Use of prohibited medication|0|||
148872936|NCT00545103|537012327|FG000|Overall Study|Does not want to take study drug anymore|1|||
148872937|NCT00545103|537012328|FG001|Overall Study|Does not want to take study drug anymore|0|||
148872938|NCT00545103|537012329|FG002|Overall Study|Does not want to take study drug anymore|1|||
149033440|NCT00246012|537600351|FG001|Overall Study|Adverse Event|0|||
148872939|NCT00545103|537012330|FG003|Overall Study|Does not want to take study drug anymore|0|||
148872940|NCT00545103|537012327|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
148872941|NCT00545103|537012328|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
148872942|NCT00545103|537012329|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
148872943|NCT00545103|537012330|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
148872944|NCT00545103|537012327|FG000|Overall Study|Death|0|||
148872945|NCT00545103|537012328|FG001|Overall Study|Death|1|||
148872946|NCT00545103|537012329|FG002|Overall Study|Death|0|||
148872947|NCT00545103|537012330|FG003|Overall Study|Death|0|||
148872948|NCT01953913|537012331|FG000|Overall Study|Disease Progression|349|||
148872949|NCT01953913|537012331|FG000|Overall Study|Worsening of underlying cancer|22|||
148872950|NCT01953913|537012331|FG000|Overall Study|Adverse Event|20|||
148872951|NCT01953913|537012331|FG000|Overall Study|Protocol Violation|6|||
148872952|NCT01953913|537012331|FG000|Overall Study|Lost to Follow-up|4|||
148872953|NCT01953913|537012331|FG000|Overall Study|Withdrawal by Subject|32|||
148872954|NCT01953913|537012331|FG000|Overall Study|Other than listed|108|||
148872955|NCT01953913|537012331|FG000|Overall Study|Not Treated|1|||
148872956|NCT05026853|537012332|FG000|Overall Study|Cancelled appointment|1|||
148872957|NCT05026853|537012333|FG001|Overall Study|Cancelled appointment|0|||
148872958|NCT05026853|537012332|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
148872959|NCT05026853|537012333|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
148872960|NCT05026853|537012332|FG000|Overall Study|Did not complete 12-week survey|16|||
148872961|NCT05026853|537012333|FG001|Overall Study|Did not complete 12-week survey|16|||
148872962|NCT03836677|537012334|FG000|Period 1|Adverse Event|0|||
148872963|NCT03836677|537012335|FG001|Period 1|Adverse Event|1|||
148872964|NCT03836677|537012334|FG000|Period 2|Severe non-compliance to protocol|1|||
148872965|NCT03836677|537012335|FG001|Period 2|Severe non-compliance to protocol|0|||
148872966|NCT01353911|537012336|FG000|Overall Study|Lost to Follow-up|2|||
148872967|NCT01353911|537012337|FG001|Overall Study|Lost to Follow-up|6|||
148872968|NCT01353911|537012338|FG002|Overall Study|Lost to Follow-up|4|||
148872969|NCT01353911|537012339|FG003|Overall Study|Lost to Follow-up|0|||
148872970|NCT01353911|537012340|FG004|Overall Study|Lost to Follow-up|4|||
148872971|NCT01353911|537012341|FG005|Overall Study|Lost to Follow-up|4|||
148872972|NCT01353911|537012342|FG006|Overall Study|Lost to Follow-up|3|||
148872973|NCT01353911|537012343|FG007|Overall Study|Lost to Follow-up|6|||
148872974|NCT01353911|537012336|FG000|Overall Study|Withdrawal by Subject|2|||
148872975|NCT01353911|537012337|FG001|Overall Study|Withdrawal by Subject|3|||
148872976|NCT01353911|537012338|FG002|Overall Study|Withdrawal by Subject|4|||
148872977|NCT01353911|537012339|FG003|Overall Study|Withdrawal by Subject|2|||
148872978|NCT01353911|537012340|FG004|Overall Study|Withdrawal by Subject|2|||
148872979|NCT01353911|537012341|FG005|Overall Study|Withdrawal by Subject|3|||
148872980|NCT01353911|537012342|FG006|Overall Study|Withdrawal by Subject|3|||
148872981|NCT01353911|537012343|FG007|Overall Study|Withdrawal by Subject|9|||
148872982|NCT01353911|537012336|FG000|Overall Study|Status Not Recorded|4|||
148872983|NCT01353911|537012337|FG001|Overall Study|Status Not Recorded|0|||
148872984|NCT01353911|537012338|FG002|Overall Study|Status Not Recorded|1|||
148872985|NCT01353911|537012339|FG003|Overall Study|Status Not Recorded|0|||
148872986|NCT01353911|537012340|FG004|Overall Study|Status Not Recorded|0|||
148872987|NCT01353911|537012341|FG005|Overall Study|Status Not Recorded|0|||
148872988|NCT01353911|537012342|FG006|Overall Study|Status Not Recorded|0|||
148872989|NCT01353911|537012343|FG007|Overall Study|Status Not Recorded|0|||
148872990|NCT01732913|537012344|FG000|Overall Study|Study Terminated by Sponsor|105|||
148872991|NCT01732913|537012345|FG001|Overall Study|Study Terminated by Sponsor|55|||
148872992|NCT01732913|537012344|FG000|Overall Study|Withdrawal by Subject|27|||
148872993|NCT01732913|537012345|FG001|Overall Study|Withdrawal by Subject|4|||
148872994|NCT01732913|537012344|FG000|Overall Study|Physician Decision|14|||
148872995|NCT01732913|537012345|FG001|Overall Study|Physician Decision|7|||
148872996|NCT01732913|537012344|FG000|Overall Study|Other|7|||
148872997|NCT01732913|537012345|FG001|Overall Study|Other|1|||
148872998|NCT01732913|537012344|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
148872999|NCT01732913|537012345|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
148873000|NCT03233438|537012346|FG000|Overall Study|Lost to Follow-up|4|||
148873001|NCT03233438|537012347|FG001|Overall Study|Lost to Follow-up|9|||
148873002|NCT03233438|537012346|FG000|Overall Study|Withdrawal by Subject|2|||
148873003|NCT03233438|537012347|FG001|Overall Study|Withdrawal by Subject|1|||
148873004|NCT03233438|537012346|FG000|Overall Study|No recording of dalbavancin|0|||
148873005|NCT03233438|537012347|FG001|Overall Study|No recording of dalbavancin|1|||
148873006|NCT00082381|537012349|FG000|Overall Study|Adverse Event|27|||
148873007|NCT00082381|537012350|FG001|Overall Study|Adverse Event|2|||
148873008|NCT00082381|537012349|FG000|Overall Study|Lost to Follow-up|5|||
148873009|NCT00082381|537012350|FG001|Overall Study|Lost to Follow-up|7|||
149033441|NCT00246012|537600352|FG002|Overall Study|Adverse Event|0|||
149033442|NCT00246012|537600353|FG003|Overall Study|Adverse Event|0|||
149033443|NCT00246012|537600354|FG004|Overall Study|Adverse Event|0|||
149033444|NCT00246012|537600355|FG005|Overall Study|Adverse Event|1|||
149033445|NCT00246012|537600356|FG006|Overall Study|Adverse Event|0|||
149033446|NCT00246012|537600357|FG007|Overall Study|Adverse Event|0|||
149033447|NCT00246012|537600358|FG008|Overall Study|Adverse Event|2|||
149033448|NCT00246012|537600350|FG000|Overall Study|Withdrawal by Subject|0|||
149033449|NCT00246012|537600351|FG001|Overall Study|Withdrawal by Subject|0|||
149033450|NCT00246012|537600352|FG002|Overall Study|Withdrawal by Subject|0|||
149033451|NCT00246012|537600353|FG003|Overall Study|Withdrawal by Subject|0|||
149033452|NCT00246012|537600354|FG004|Overall Study|Withdrawal by Subject|0|||
148873010|NCT00082381|537012349|FG000|Overall Study|Patient Decision|8|||
148873011|NCT00082381|537012350|FG001|Overall Study|Patient Decision|4|||
149033453|NCT00246012|537600355|FG005|Overall Study|Withdrawal by Subject|1|||
149033454|NCT00246012|537600356|FG006|Overall Study|Withdrawal by Subject|0|||
149033455|NCT00246012|537600357|FG007|Overall Study|Withdrawal by Subject|0|||
149033456|NCT00246012|537600358|FG008|Overall Study|Withdrawal by Subject|0|||
148873012|NCT00082381|537012349|FG000|Overall Study|Physician Decision|1|||
148873013|NCT00082381|537012350|FG001|Overall Study|Physician Decision|2|||
148873014|NCT00082381|537012349|FG000|Overall Study|Protocol Violation|10|||
148873015|NCT00082381|537012350|FG001|Overall Study|Protocol Violation|11|||
148873016|NCT00082381|537012349|FG000|Overall Study|Loss of Glucose Control|4|||
148873017|NCT00082381|537012350|FG001|Overall Study|Loss of Glucose Control|0|||
148873018|NCT02925741|537012352|FG000|Overall Study|Withdrawal by Subject|11|||
148873019|NCT02925741|537012353|FG001|Overall Study|Withdrawal by Subject|0|||
148873020|NCT00494507|537012356|FG000|Double-Blind Phase|Adverse Event|2|||
148873021|NCT00494507|537012357|FG001|Double-Blind Phase|Adverse Event|0|||
148873022|NCT00494507|537012358|FG002|Double-Blind Phase|Adverse Event|1|||
148873023|NCT00494507|537012359|FG003|Double-Blind Phase|Adverse Event|0|||
148873024|NCT00494507|537012356|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
148873025|NCT00494507|537012357|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
148873026|NCT00494507|537012358|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
148873027|NCT00494507|537012359|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
148873028|NCT00494507|537012356|FG000|Double-Blind Phase|Subject Non-compliance|0|||
148873029|NCT00494507|537012357|FG001|Double-Blind Phase|Subject Non-compliance|0|||
148873030|NCT00494507|537012358|FG002|Double-Blind Phase|Subject Non-compliance|1|||
148873031|NCT00494507|537012359|FG003|Double-Blind Phase|Subject Non-compliance|0|||
148873032|NCT00494507|537012356|FG000|Double-Blind Phase|Negative DNA test|0|||
148873033|NCT00494507|537012357|FG001|Double-Blind Phase|Negative DNA test|0|||
148873034|NCT00494507|537012358|FG002|Double-Blind Phase|Negative DNA test|0|||
148873035|NCT00494507|537012359|FG003|Double-Blind Phase|Negative DNA test|1|||
148873036|NCT00494507|537012356|FG000|Open-Label Phase|Adverse Event|0|||
148873037|NCT00494507|537012357|FG001|Open-Label Phase|Adverse Event|1|||
148873038|NCT00494507|537012358|FG002|Open-Label Phase|Adverse Event|5|||
148873039|NCT00494507|537012359|FG003|Open-Label Phase|Adverse Event|3|||
148873040|NCT00494507|537012356|FG000|Open-Label Phase|Worsening Disease|0|||
148873041|NCT00494507|537012357|FG001|Open-Label Phase|Worsening Disease|0|||
148873042|NCT00494507|537012358|FG002|Open-Label Phase|Worsening Disease|0|||
149033457|NCT00246012|537600350|FG000|Overall Study|Disease progression|3|||
149033458|NCT00246012|537600351|FG001|Overall Study|Disease progression|1|||
149033459|NCT00246012|537600352|FG002|Overall Study|Disease progression|2|||
149033460|NCT00246012|537600353|FG003|Overall Study|Disease progression|3|||
148873043|NCT00494507|537012359|FG003|Open-Label Phase|Worsening Disease|2|||
148873044|NCT03831945|537012360|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
148873045|NCT03831945|537012361|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
148873046|NCT03831945|537012360|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
148873047|NCT03831945|537012361|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
148873048|NCT03831945|537012360|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
148873049|NCT03831945|537012361|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
148873050|NCT00295932|537012362|FG000|Overall Study|Not Treated|0|||
148873051|NCT00295932|537012363|FG001|Overall Study|Not Treated|0|||
148873052|NCT00295932|537012364|FG002|Overall Study|Not Treated|0|||
149033461|NCT00246012|537600354|FG004|Overall Study|Disease progression|3|||
149033462|NCT00246012|537600355|FG005|Overall Study|Disease progression|25|||
148873053|NCT00295932|537012365|FG003|Overall Study|Not Treated|0|||
148873054|NCT00295932|537012366|FG004|Overall Study|Not Treated|0|||
148873055|NCT00295932|537012367|FG005|Overall Study|Not Treated|0|||
148873056|NCT00295932|537012368|FG006|Overall Study|Not Treated|0|||
148873057|NCT00295932|537012369|FG007|Overall Study|Not Treated|0|||
148873058|NCT00295932|537012370|FG008|Overall Study|Not Treated|0|||
148873059|NCT00295932|537012371|FG009|Overall Study|Not Treated|0|||
148873060|NCT00295932|537012372|FG010|Overall Study|Not Treated|1|||
148873061|NCT00109577|537012373|FG000|Overall Study|Withdrawal by Subject|3|||
148873062|NCT00109577|537012374|FG001|Overall Study|Withdrawal by Subject|3|||
148873063|NCT00587847|537012375|FG000|Overall Study|Lack of Efficacy|5|||
148873064|NCT00587847|537012375|FG000|Overall Study|Adverse Event|2|||
148873065|NCT00343382|537012376|FG000|Overall Study|Adverse Event|2|||
149033463|NCT00246012|537600356|FG006|Overall Study|Disease progression|30|||
149033464|NCT00246012|537600357|FG007|Overall Study|Disease progression|27|||
149033465|NCT00246012|537600358|FG008|Overall Study|Disease progression|26|||
148873066|NCT00343382|537012377|FG001|Overall Study|Adverse Event|10|||
148873067|NCT00343382|537012378|FG002|Overall Study|Adverse Event|7|||
148873068|NCT00343382|537012376|FG000|Overall Study|Withdrawal by Subject|1|||
148873069|NCT00343382|537012377|FG001|Overall Study|Withdrawal by Subject|2|||
148873070|NCT00343382|537012378|FG002|Overall Study|Withdrawal by Subject|6|||
148873071|NCT00343382|537012376|FG000|Overall Study|Other Reason Not Specified|1|||
148873072|NCT00343382|537012377|FG001|Overall Study|Other Reason Not Specified|2|||
148873073|NCT00343382|537012378|FG002|Overall Study|Other Reason Not Specified|4|||
148873074|NCT04032080|537012379|FG000|Overall Study|Death|6|||
148873075|NCT02337725|537012380|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
148873076|NCT02337725|537012381|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
148873077|NCT02337725|537012380|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
148873078|NCT02337725|537012381|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
148873079|NCT02337725|537012380|FG000|Overall Study|Major Protocol Deviation|0|||
149033466|NCT00246012|537600350|FG000|Overall Study|Other|0|||
149033467|NCT00246012|537600351|FG001|Overall Study|Other|0|||
149033468|NCT00246012|537600352|FG002|Overall Study|Other|0|||
149033469|NCT00246012|537600353|FG003|Overall Study|Other|0|||
149033470|NCT00246012|537600354|FG004|Overall Study|Other|0|||
149033471|NCT00246012|537600355|FG005|Overall Study|Other|0|||
149033472|NCT00246012|537600356|FG006|Overall Study|Other|0|||
148873080|NCT02337725|537012381|FG001|Overall Study|Major Protocol Deviation|1|||
148873081|NCT02337725|537012380|FG000|Overall Study|Voluntary Withdrawal|14|||
148873082|NCT02337725|537012381|FG001|Overall Study|Voluntary Withdrawal|3|||
148873083|NCT02337725|537012380|FG000|Overall Study|Lack of Efficacy|4|||
148873084|NCT02337725|537012381|FG001|Overall Study|Lack of Efficacy|0|||
148873085|NCT03517566|537012387|FG000|Overall Study|Adverse Event|5|||
148873086|NCT03517566|537012388|FG001|Overall Study|Adverse Event|2|||
148873087|NCT03517566|537012389|FG002|Overall Study|Adverse Event|2|||
148873088|NCT03517566|537012390|FG003|Overall Study|Adverse Event|8|||
148873089|NCT03517566|537012391|FG004|Overall Study|Adverse Event|7|||
148873090|NCT03517566|537012387|FG000|Overall Study|Lack of Efficacy|3|||
148873091|NCT03517566|537012388|FG001|Overall Study|Lack of Efficacy|2|||
148873092|NCT03517566|537012389|FG002|Overall Study|Lack of Efficacy|1|||
148873093|NCT03517566|537012390|FG003|Overall Study|Lack of Efficacy|1|||
148873094|NCT03517566|537012391|FG004|Overall Study|Lack of Efficacy|4|||
148873095|NCT03517566|537012387|FG000|Overall Study|Lost to Follow-up|3|||
148873096|NCT03517566|537012388|FG001|Overall Study|Lost to Follow-up|1|||
148873097|NCT03517566|537012389|FG002|Overall Study|Lost to Follow-up|1|||
148873098|NCT03517566|537012390|FG003|Overall Study|Lost to Follow-up|1|||
148873099|NCT03517566|537012391|FG004|Overall Study|Lost to Follow-up|0|||
148873100|NCT03517566|537012387|FG000|Overall Study|Physician Decision|1|||
148873101|NCT03517566|537012388|FG001|Overall Study|Physician Decision|1|||
148873102|NCT03517566|537012389|FG002|Overall Study|Physician Decision|0|||
148873103|NCT03517566|537012390|FG003|Overall Study|Physician Decision|1|||
148873104|NCT03517566|537012391|FG004|Overall Study|Physician Decision|0|||
148873105|NCT03517566|537012387|FG000|Overall Study|Pregnancy|0|||
148873106|NCT03517566|537012388|FG001|Overall Study|Pregnancy|1|||
148873107|NCT03517566|537012389|FG002|Overall Study|Pregnancy|0|||
148873108|NCT03517566|537012390|FG003|Overall Study|Pregnancy|0|||
148873109|NCT03517566|537012391|FG004|Overall Study|Pregnancy|0|||
148873110|NCT03517566|537012387|FG000|Overall Study|Protocol Deviation|0|||
148873111|NCT03517566|537012388|FG001|Overall Study|Protocol Deviation|1|||
148873112|NCT03517566|537012389|FG002|Overall Study|Protocol Deviation|0|||
148873113|NCT03517566|537012390|FG003|Overall Study|Protocol Deviation|1|||
148873114|NCT03517566|537012391|FG004|Overall Study|Protocol Deviation|1|||
148873115|NCT03517566|537012387|FG000|Overall Study|Study terminated by Sponsor|11|||
148873116|NCT03517566|537012388|FG001|Overall Study|Study terminated by Sponsor|5|||
148873117|NCT03517566|537012389|FG002|Overall Study|Study terminated by Sponsor|6|||
148873118|NCT03517566|537012390|FG003|Overall Study|Study terminated by Sponsor|14|||
148873119|NCT03517566|537012391|FG004|Overall Study|Study terminated by Sponsor|12|||
148873120|NCT03517566|537012387|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
148873121|NCT03517566|537012388|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
148873122|NCT03517566|537012389|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
148873123|NCT03517566|537012390|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
148873124|NCT03517566|537012391|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
148873125|NCT01183468|537012392|FG000|Overall Study|Lost to Follow-up|2|||
148873126|NCT01183468|537012393|FG001|Overall Study|Lost to Follow-up|1|||
148873127|NCT01183468|537012394|FG002|Overall Study|Lost to Follow-up|0|||
148873128|NCT01183468|537012395|FG003|Overall Study|Lost to Follow-up|0|||
148873129|NCT01183468|537012392|FG000|Overall Study|Physician Decision|1|||
148873130|NCT01183468|537012393|FG001|Overall Study|Physician Decision|0|||
148873131|NCT01183468|537012394|FG002|Overall Study|Physician Decision|0|||
148873132|NCT01183468|537012395|FG003|Overall Study|Physician Decision|0|||
148873133|NCT01183468|537012392|FG000|Overall Study|Withdrawal by Subject|0|||
148873134|NCT01183468|537012393|FG001|Overall Study|Withdrawal by Subject|1|||
148873135|NCT01183468|537012394|FG002|Overall Study|Withdrawal by Subject|0|||
148873136|NCT01183468|537012395|FG003|Overall Study|Withdrawal by Subject|0|||
149033473|NCT00246012|537600357|FG007|Overall Study|Other|1|||
148873137|NCT00454649|537012397|FG000|Overall Study|Lack of Efficacy|2|||
148873138|NCT00454649|537012398|FG001|Overall Study|Lack of Efficacy|2|||
148873139|NCT00454649|537012399|FG002|Overall Study|Lack of Efficacy|10|||
148873140|NCT00454649|537012400|FG003|Overall Study|Lack of Efficacy|3|||
148873141|NCT00454649|537012401|FG004|Overall Study|Lack of Efficacy|0|||
148873142|NCT00454649|537012402|FG005|Overall Study|Lack of Efficacy|4|||
148873143|NCT00454649|537012403|FG006|Overall Study|Lack of Efficacy|5|||
148873144|NCT00454649|537012404|FG007|Overall Study|Lack of Efficacy|13|||
148873145|NCT00454649|537012405|FG008|Overall Study|Lack of Efficacy|10|||
148873146|NCT00454649|537012406|FG009|Overall Study|Lack of Efficacy|2|||
148873147|NCT00454649|537012397|FG000|Overall Study|Adverse Event|0|||
148873148|NCT00454649|537012398|FG001|Overall Study|Adverse Event|1|||
148873149|NCT00454649|537012399|FG002|Overall Study|Adverse Event|3|||
148873150|NCT00454649|537012400|FG003|Overall Study|Adverse Event|0|||
148873151|NCT00454649|537012401|FG004|Overall Study|Adverse Event|1|||
148873152|NCT00454649|537012402|FG005|Overall Study|Adverse Event|2|||
148873153|NCT00454649|537012403|FG006|Overall Study|Adverse Event|3|||
148873154|NCT00454649|537012404|FG007|Overall Study|Adverse Event|4|||
148873155|NCT00454649|537012405|FG008|Overall Study|Adverse Event|6|||
148873156|NCT00454649|537012406|FG009|Overall Study|Adverse Event|2|||
148873157|NCT00454649|537012397|FG000|Overall Study|Lost to Follow-up|0|||
148873158|NCT00454649|537012398|FG001|Overall Study|Lost to Follow-up|0|||
148873159|NCT00454649|537012399|FG002|Overall Study|Lost to Follow-up|1|||
148873160|NCT00454649|537012400|FG003|Overall Study|Lost to Follow-up|0|||
148873161|NCT00454649|537012401|FG004|Overall Study|Lost to Follow-up|0|||
148873162|NCT00454649|537012402|FG005|Overall Study|Lost to Follow-up|0|||
148873163|NCT00454649|537012403|FG006|Overall Study|Lost to Follow-up|1|||
148873164|NCT00454649|537012404|FG007|Overall Study|Lost to Follow-up|0|||
148873165|NCT00454649|537012405|FG008|Overall Study|Lost to Follow-up|0|||
148873166|NCT00454649|537012406|FG009|Overall Study|Lost to Follow-up|0|||
148873167|NCT00454649|537012397|FG000|Overall Study|Other|1|||
148873168|NCT00454649|537012398|FG001|Overall Study|Other|1|||
148873169|NCT00454649|537012399|FG002|Overall Study|Other|5|||
148873170|NCT00454649|537012400|FG003|Overall Study|Other|3|||
148873171|NCT00454649|537012401|FG004|Overall Study|Other|0|||
148873172|NCT00454649|537012402|FG005|Overall Study|Other|0|||
148873173|NCT00454649|537012403|FG006|Overall Study|Other|0|||
148873174|NCT00454649|537012404|FG007|Overall Study|Other|0|||
148873175|NCT00454649|537012405|FG008|Overall Study|Other|3|||
148873176|NCT00454649|537012406|FG009|Overall Study|Other|1|||
148873177|NCT00454649|537012397|FG000|Overall Study|Withdrawal by Subject|0|||
148873178|NCT00454649|537012398|FG001|Overall Study|Withdrawal by Subject|0|||
148873179|NCT00454649|537012399|FG002|Overall Study|Withdrawal by Subject|0|||
148873180|NCT00454649|537012400|FG003|Overall Study|Withdrawal by Subject|0|||
148873181|NCT00454649|537012401|FG004|Overall Study|Withdrawal by Subject|0|||
148873182|NCT00454649|537012402|FG005|Overall Study|Withdrawal by Subject|1|||
148873183|NCT00454649|537012403|FG006|Overall Study|Withdrawal by Subject|0|||
148873184|NCT00454649|537012404|FG007|Overall Study|Withdrawal by Subject|2|||
148873185|NCT00454649|537012405|FG008|Overall Study|Withdrawal by Subject|1|||
148873186|NCT00454649|537012406|FG009|Overall Study|Withdrawal by Subject|0|||
148873187|NCT00086411|537012414|FG000|Overall Study|Lost to Follow-up|11|||
148873188|NCT00086411|537012415|FG001|Overall Study|Lost to Follow-up|11|||
148873189|NCT00086411|537012416|FG002|Overall Study|Lost to Follow-up|13|||
148873190|NCT00086411|537012417|FG003|Overall Study|Lost to Follow-up|12|||
148873191|NCT00410605|537012420|FG000|Overall Study|Adverse Event|12|||
148873192|NCT00410605|537012420|FG000|Overall Study|Physician Decision|3|||
148873193|NCT00410605|537012420|FG000|Overall Study|Withdrawal by Subject|5|||
148873194|NCT00410605|537012420|FG000|Overall Study|Started Non-Protocol Therapy|3|||
148873195|NCT00410605|537012420|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
148873196|NCT00410605|537012420|FG000|Overall Study|Transferred to another Institution|1|||
148873197|NCT01078168|537012421|FG000|Overall Study|Physician Decision|0|||
148873198|NCT01078168|537012422|FG001|Overall Study|Physician Decision|1|||
148873199|NCT00602420|537014174|FG000|Overall Study|Death|1|||
148873200|NCT00602420|537014175|FG001|Overall Study|Death|4|||
148873201|NCT00602420|537014174|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
148873202|NCT00602420|537014175|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
148873203|NCT00602420|537014174|FG000|Overall Study|Withdrawal by Subject|18|||
148873204|NCT00602420|537014175|FG001|Overall Study|Withdrawal by Subject|17|||
148873205|NCT00602420|537014174|FG000|Overall Study|Adverse Event|1|||
148873206|NCT00602420|537014175|FG001|Overall Study|Adverse Event|0|||
148873207|NCT02315560|537014178|FG000|Overall Study|noncompliance by subjects|3|||
148873208|NCT03464019|537014179|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
148873209|NCT03464019|537014180|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
148873210|NCT03464019|537014181|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
148873211|NCT03464019|537014179|FG000|NODE-301 Part 1|Ablation|0|||
148873212|NCT03464019|537014180|FG001|NODE-301 Part 1|Ablation|0|||
148873213|NCT03464019|537014181|FG002|NODE-301 Part 1|Ablation|16|||
148873214|NCT03464019|537014179|FG000|NODE-301 Part 1|Test Dose Failure|0|||
148873215|NCT03464019|537014180|FG001|NODE-301 Part 1|Test Dose Failure|0|||
148873216|NCT03464019|537014181|FG002|NODE-301 Part 1|Test Dose Failure|8|||
148873217|NCT03464019|537014179|FG000|NODE-301 Part 1|Adverse Event|0|||
148873218|NCT03464019|537014180|FG001|NODE-301 Part 1|Adverse Event|0|||
148873219|NCT03464019|537014181|FG002|NODE-301 Part 1|Adverse Event|5|||
148873220|NCT03464019|537014179|FG000|NODE-301 Part 1|Physician Decision|0|||
148873221|NCT03464019|537014180|FG001|NODE-301 Part 1|Physician Decision|0|||
149033474|NCT00246012|537600358|FG008|Overall Study|Other|0|||
149033475|NCT00246012|537600350|FG000|Overall Study|Randomly assigned but not treated|0|||
149033476|NCT00246012|537600351|FG001|Overall Study|Randomly assigned but not treated|0|||
149033477|NCT00246012|537600352|FG002|Overall Study|Randomly assigned but not treated|0|||
149033478|NCT00246012|537600353|FG003|Overall Study|Randomly assigned but not treated|0|||
149033479|NCT00246012|537600354|FG004|Overall Study|Randomly assigned but not treated|0|||
149033480|NCT00246012|537600355|FG005|Overall Study|Randomly assigned but not treated|1|||
149033481|NCT00246012|537600356|FG006|Overall Study|Randomly assigned but not treated|1|||
149033482|NCT00246012|537600357|FG007|Overall Study|Randomly assigned but not treated|0|||
149033483|NCT00246012|537600358|FG008|Overall Study|Randomly assigned but not treated|0|||
149033484|NCT04889664|537600359|FG000|Screen|Lost to Follow-up|1|||
149033485|NCT04889664|537600359|FG000|Screen|Failed to meet screening criteria|1|||
149033486|NCT04889664|537600359|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
149033487|NCT02469064|537600366|FG000|Overall Study|Request not to receive intervention.|1|||
149033488|NCT02469064|537600367|FG001|Overall Study|Request not to receive intervention.|3|||
149033489|NCT01120275|537600371|FG000|Overall Study|Adverse Event|3|||
149033490|NCT01120275|537600371|FG000|Overall Study|Progression|27|||
149033491|NCT01120275|537600371|FG000|Overall Study|Ineligible|3|||
149033492|NCT01120275|537600371|FG000|Overall Study|Withdrawal by Subject|1|||
149033493|NCT01120275|537600371|FG000|Overall Study|Refusal|1|||
149033494|NCT01120275|537600371|FG000|Overall Study|Not specific|1|||
149033495|NCT01191086|537600372|FG000|Overall Study|Adverse Event|20|||
149033496|NCT01191086|537600372|FG000|Overall Study|Lack of Efficacy|10|||
149033497|NCT01191086|537600372|FG000|Overall Study|Lost to Follow-up|4|||
149033498|NCT01191086|537600372|FG000|Overall Study|Physician Decision|2|||
149033499|NCT01191086|537600372|FG000|Overall Study|Withdrawal by Subject|24|||
149033500|NCT01191086|537600372|FG000|Overall Study|Discontinuation criterion met|1|||
149033501|NCT01191086|537600372|FG000|Overall Study|Other|1|||
149033502|NCT00771849|537600373|FG000|Overall Study|Lost to Follow-up|1|||
149033503|NCT00771849|537600374|FG001|Overall Study|Lost to Follow-up|2|||
149033504|NCT00771849|537600373|FG000|Overall Study|Withdrawal by Subject|1|||
149033505|NCT00771849|537600374|FG001|Overall Study|Withdrawal by Subject|1|||
149033506|NCT00771849|537600373|FG000|Overall Study|Not vaccinated|0|||
149033507|NCT00771849|537600374|FG001|Overall Study|Not vaccinated|1|||
149033508|NCT02736799|537600378|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
149033509|NCT02736799|537600379|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
149033510|NCT02736799|537600380|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
149033511|NCT02736799|537600381|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
149033512|NCT01833832|537600382|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
149033513|NCT01156116|537600383|FG000|Overall Study|Withdrawal by Subject|3|||
149033514|NCT01156116|537600384|FG001|Overall Study|Withdrawal by Subject|1|||
149033515|NCT01156116|537600383|FG000|Overall Study|CPAP intolerance|2|||
149033516|NCT01156116|537600384|FG001|Overall Study|CPAP intolerance|0|||
149033517|NCT00197015|537600385|FG000|Overall Study|Adverse Event|3|||
149033518|NCT00197015|537600386|FG001|Overall Study|Adverse Event|0|||
149033519|NCT00197015|537600387|FG002|Overall Study|Adverse Event|1|||
149033520|NCT00197015|537600385|FG000|Overall Study|Protocol Violation|0|||
149033521|NCT00197015|537600386|FG001|Overall Study|Protocol Violation|3|||
149033522|NCT00197015|537600387|FG002|Overall Study|Protocol Violation|3|||
149033523|NCT00197015|537600385|FG000|Overall Study|Withdrawal by Subject|17|||
149033524|NCT00197015|537600386|FG001|Overall Study|Withdrawal by Subject|37|||
149033525|NCT00197015|537600387|FG002|Overall Study|Withdrawal by Subject|34|||
149033526|NCT00197015|537600385|FG000|Overall Study|Lost to Follow-up|28|||
149033527|NCT00197015|537600386|FG001|Overall Study|Lost to Follow-up|46|||
149033528|NCT00197015|537600387|FG002|Overall Study|Lost to Follow-up|37|||
149033529|NCT00197015|537600385|FG000|Overall Study|Other|2|||
149033530|NCT00197015|537600386|FG001|Overall Study|Other|3|||
149033531|NCT00197015|537600387|FG002|Overall Study|Other|2|||
149033532|NCT04511650|537600390|FG000|Overall Study|Lost to Follow-up|1|||
149033533|NCT04511650|537600391|FG001|Overall Study|Lost to Follow-up|0|||
149033534|NCT04511650|537600392|FG002|Overall Study|Lost to Follow-up|0|||
149033535|NCT04511650|537600390|FG000|Overall Study|Withdrawal by Subject|1|||
149033536|NCT04511650|537600391|FG001|Overall Study|Withdrawal by Subject|0|||
149033537|NCT04511650|537600392|FG002|Overall Study|Withdrawal by Subject|0|||
149033538|NCT04511650|537600390|FG000|Overall Study|reason not provided|0|||
149033539|NCT04511650|537600391|FG001|Overall Study|reason not provided|0|||
149033540|NCT04511650|537600392|FG002|Overall Study|reason not provided|1|||
149033541|NCT04511650|537600390|FG000|Overall Study|Death|1|||
148873222|NCT03464019|537014181|FG002|NODE-301 Part 1|Physician Decision|4|||
148873223|NCT03464019|537014179|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
149033542|NCT04511650|537600391|FG001|Overall Study|Death|1|||
149033543|NCT04511650|537600392|FG002|Overall Study|Death|1|||
149033544|NCT00906035|537600396|FG000|Overall Study|Withdrawal by Subject|2|||
149033545|NCT00906035|537600397|FG001|Overall Study|Withdrawal by Subject|3|||
148873224|NCT03464019|537014180|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
148873225|NCT03464019|537014181|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
148873226|NCT03464019|537014179|FG000|NODE-301 Part 1|Protocol Violation|0|||
148873227|NCT03464019|537014180|FG001|NODE-301 Part 1|Protocol Violation|0|||
148873228|NCT03464019|537014181|FG002|NODE-301 Part 1|Protocol Violation|2|||
148873229|NCT03464019|537014179|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
148873230|NCT03464019|537014180|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
148873231|NCT03464019|537014181|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
149000854|NCT01169675|537479416|FG002|Overall Study|Other Reason Not Defined Above|0|||
149000855|NCT01169675|537479417|FG003|Overall Study|Other Reason Not Defined Above|1|||
149000856|NCT01169675|537479418|FG004|Overall Study|Other Reason Not Defined Above|1|||
149000857|NCT02816138|537479421|FG000|Overall Study|Adverse Event|1|||
149000858|NCT02355028|537479422|FG000|Overall Study|Adverse Event|2|||
149000859|NCT02355028|537479423|FG001|Overall Study|Adverse Event|0|||
149000860|NCT02355028|537479422|FG000|Overall Study|Withdrawal by Subject|1|||
149000861|NCT02355028|537479423|FG001|Overall Study|Withdrawal by Subject|1|||
149000862|NCT02355028|537479422|FG000|Overall Study|Deemed ineligible after randomization|8|||
149000863|NCT02355028|537479423|FG001|Overall Study|Deemed ineligible after randomization|4|||
149000864|NCT02276222|537479424|FG000|Overall Study|Adverse Event|62|||
149000865|NCT02276222|537479425|FG001|Overall Study|Adverse Event|11|||
149000866|NCT02276222|537479424|FG000|Overall Study|Death|3|||
149000867|NCT02276222|537479425|FG001|Overall Study|Death|4|||
148873232|NCT03464019|537014179|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
148873233|NCT03464019|537014180|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
148873234|NCT03464019|537014181|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
148873235|NCT03464019|537014179|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
148873236|NCT03464019|537014180|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
148873237|NCT03464019|537014181|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
148873238|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
148873239|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
148873240|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
148873241|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
148873242|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
148873243|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
149000868|NCT02276222|537479424|FG000|Overall Study|Lack of Efficacy|13|||
149000869|NCT02276222|537479425|FG001|Overall Study|Lack of Efficacy|3|||
149000870|NCT02276222|537479424|FG000|Overall Study|Protocol Violation|3|||
149000871|NCT02276222|537479425|FG001|Overall Study|Protocol Violation|2|||
149000872|NCT02276222|537479424|FG000|Overall Study|Withdrawal by Subject|79|||
149000873|NCT02276222|537479425|FG001|Overall Study|Withdrawal by Subject|33|||
149000874|NCT02276222|537479424|FG000|Overall Study|non compliance with study medication|6|||
149000875|NCT02276222|537479425|FG001|Overall Study|non compliance with study medication|2|||
149000876|NCT02276222|537479424|FG000|Overall Study|sponsor decision|0|||
149000877|NCT02276222|537479425|FG001|Overall Study|sponsor decision|3|||
149000878|NCT02276222|537479424|FG000|Overall Study|Lost to Follow-up|15|||
149000879|NCT02276222|537479425|FG001|Overall Study|Lost to Follow-up|5|||
149000880|NCT02276222|537479424|FG000|Overall Study|Physician Decision|2|||
149000881|NCT02276222|537479425|FG001|Overall Study|Physician Decision|1|||
149000882|NCT02276222|537479424|FG000|Overall Study|sheduling conflict|1|||
149000883|NCT02276222|537479425|FG001|Overall Study|sheduling conflict|0|||
149000884|NCT02276222|537479424|FG000|Overall Study|subject withdrew after randomization|1|||
149000885|NCT02276222|537479425|FG001|Overall Study|subject withdrew after randomization|0|||
149000886|NCT04102579|537479426|FG000|Overall Study|Withdrawal by Subject|3|||
149000887|NCT04102579|537479427|FG001|Overall Study|Withdrawal by Subject|4|||
149000888|NCT04102579|537479426|FG000|Overall Study|Lost to Follow-up|0|||
149000889|NCT04102579|537479427|FG001|Overall Study|Lost to Follow-up|1|||
149000890|NCT04102579|537479426|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
149000891|NCT04102579|537479427|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
149000892|NCT04102579|537479426|FG000|Overall Study|Other than Specified|1|||
149000893|NCT04102579|537479427|FG001|Overall Study|Other than Specified|0|||
149000894|NCT04102579|537479426|FG000|Overall Study|Not Dosed with Study Drug|0|||
149000895|NCT04102579|537479427|FG001|Overall Study|Not Dosed with Study Drug|1|||
149000896|NCT05899686|537479428|FG000|Overall Study|Protocol Violation|1|||
149000897|NCT00572195|537479429|FG000|Overall Study|Withdrawal by Subject|50|||
149000898|NCT00572195|537479429|FG000|Overall Study|Death|9|||
149000899|NCT00572195|537479429|FG000|Overall Study|Adverse Event|4|||
149000900|NCT00572195|537479429|FG000|Overall Study|Lost to Follow-up|5|||
149000901|NCT01525602|537479430|FG000|Overall Study|Adverse Event|1|||
149000902|NCT01525602|537479431|FG001|Overall Study|Adverse Event|0|||
149033546|NCT00906035|537600398|FG002|Overall Study|Withdrawal by Subject|0|||
149033547|NCT03058991|537600399|FG000|Overall Study|Lost to Follow-up|17|||
148873244|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
148873245|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
148873246|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
148873247|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
148873248|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
148873249|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
148873250|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
148873251|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
148873252|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
148873253|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
148873254|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
148873255|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
148873256|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
148873257|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
148873258|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
148873259|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
148873260|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
148873261|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
148873262|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
148873263|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
148873264|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
148873265|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
148873266|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
148873267|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
148873268|NCT03464019|537014179|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
148873269|NCT03464019|537014180|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
148873270|NCT03464019|537014181|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
148873271|NCT00767806|537014182|FG000|Overall Study|Adverse Event|30|||
148873272|NCT00767806|537014183|FG001|Overall Study|Adverse Event|11|||
148873273|NCT00767806|537014182|FG000|Overall Study|Withdrawal by Subject|8|||
148873274|NCT00767806|537014183|FG001|Overall Study|Withdrawal by Subject|13|||
148873275|NCT00767806|537014182|FG000|Overall Study|Protocol Violation|6|||
148873276|NCT00767806|537014183|FG001|Overall Study|Protocol Violation|5|||
148873277|NCT00767806|537014182|FG000|Overall Study|Lack of Efficacy|1|||
148873278|NCT00767806|537014183|FG001|Overall Study|Lack of Efficacy|9|||
148873279|NCT00767806|537014182|FG000|Overall Study|Physician Decision|4|||
148873280|NCT00767806|537014183|FG001|Overall Study|Physician Decision|3|||
148873281|NCT00767806|537014182|FG000|Overall Study|Lost to Follow-up|1|||
148873282|NCT00767806|537014183|FG001|Overall Study|Lost to Follow-up|4|||
148873283|NCT00767806|537014182|FG000|Overall Study|Entry Criteria Not Met|1|||
148873284|NCT00767806|537014183|FG001|Overall Study|Entry Criteria Not Met|1|||
148873285|NCT00767806|537014182|FG000|Overall Study|Sponsor Decision|0|||
148873286|NCT00767806|537014183|FG001|Overall Study|Sponsor Decision|1|||
148873287|NCT01815840|537014184|FG000|Overall Study|Missing|1|||
148873288|NCT01815840|537014185|FG001|Overall Study|Missing|0|||
148873289|NCT01815840|537014184|FG000|Overall Study|Withdrew Consent|31|||
148873290|NCT01815840|537014185|FG001|Overall Study|Withdrew Consent|30|||
148873291|NCT01815840|537014184|FG000|Overall Study|Administrative/Other|1|||
148873292|NCT01815840|537014185|FG001|Overall Study|Administrative/Other|3|||
148873293|NCT01815840|537014184|FG000|Overall Study|Adverse Event|10|||
148873294|NCT01815840|537014185|FG001|Overall Study|Adverse Event|16|||
148873295|NCT01815840|537014184|FG000|Overall Study|Death|2|||
148873296|NCT01815840|537014185|FG001|Overall Study|Death|2|||
148873297|NCT01815840|537014184|FG000|Overall Study|Disease progression|3|||
148873298|NCT01815840|537014185|FG001|Overall Study|Disease progression|2|||
148873299|NCT01815840|537014184|FG000|Overall Study|Investigators Decision|2|||
148873300|NCT01815840|537014185|FG001|Overall Study|Investigators Decision|3|||
148873301|NCT01815840|537014184|FG000|Overall Study|Lost to Follow-up|3|||
148873302|NCT01815840|537014185|FG001|Overall Study|Lost to Follow-up|6|||
148873303|NCT01815840|537014184|FG000|Overall Study|Refused Treatment|5|||
148873304|NCT01815840|537014185|FG001|Overall Study|Refused Treatment|1|||
148873305|NCT01815840|537014184|FG000|Overall Study|Sponsor Termination Treatment|1|||
148873306|NCT01815840|537014185|FG001|Overall Study|Sponsor Termination Treatment|0|||
148873307|NCT00568126|537014186|FG000|Overall Study|Adverse Event|3|||
148873308|NCT00568126|537014187|FG001|Overall Study|Adverse Event|0|||
148873309|NCT00568126|537014186|FG000|Overall Study|Withdrawal by Subject|2|||
148873310|NCT00568126|537014187|FG001|Overall Study|Withdrawal by Subject|3|||
148873311|NCT00568126|537014186|FG000|Overall Study|Lost to Follow-up|4|||
148873312|NCT00568126|537014187|FG001|Overall Study|Lost to Follow-up|3|||
148873313|NCT00568126|537014186|FG000|Overall Study|Lack of Efficacy|0|||
148873314|NCT00568126|537014187|FG001|Overall Study|Lack of Efficacy|1|||
148873315|NCT00568126|537014186|FG000|Overall Study|Physician Decision|2|||
148873316|NCT00568126|537014187|FG001|Overall Study|Physician Decision|2|||
148873317|NCT04395690|537014188|FG000|Overall Study|Lost to Follow-up|1|||
148873318|NCT04395690|537014189|FG001|Overall Study|Lost to Follow-up|1|||
148873319|NCT00615030|537014191|FG000|Period I|Administrative problem|0|||
148873320|NCT00615030|537014192|FG001|Period I|Administrative problem|0|||
148873321|NCT00615030|537014193|FG002|Period I|Administrative problem|0|||
148873322|NCT00615030|537014194|FG003|Period I|Administrative problem|0|||
148873323|NCT00615030|537014195|FG004|Period I|Administrative problem|1|||
148873324|NCT00615030|537014196|FG005|Period I|Administrative problem|0|||
148873325|NCT00615030|537014197|FG006|Period I|Administrative problem|0|||
148873326|NCT00615030|537014198|FG007|Period I|Administrative problem|0|||
148873327|NCT00615030|537014199|FG008|Period I|Administrative problem|0|||
148873328|NCT00615030|537014200|FG009|Period I|Administrative problem|0|||
148873329|NCT00615030|537014201|FG010|Period I|Administrative problem|0|||
148873330|NCT00615030|537014202|FG011|Period I|Administrative problem|0|||
148873331|NCT00615030|537014191|FG000|Period I|Protocol deviation|1|||
148873332|NCT00615030|537014192|FG001|Period I|Protocol deviation|0|||
148873333|NCT00615030|537014193|FG002|Period I|Protocol deviation|0|||
148873334|NCT00615030|537014194|FG003|Period I|Protocol deviation|0|||
148873335|NCT00615030|537014195|FG004|Period I|Protocol deviation|0|||
148873336|NCT00615030|537014196|FG005|Period I|Protocol deviation|0|||
148873337|NCT00615030|537014197|FG006|Period I|Protocol deviation|0|||
148873338|NCT00615030|537014198|FG007|Period I|Protocol deviation|0|||
148873339|NCT00615030|537014199|FG008|Period I|Protocol deviation|0|||
148873340|NCT00615030|537014200|FG009|Period I|Protocol deviation|0|||
148873341|NCT00615030|537014201|FG010|Period I|Protocol deviation|0|||
148873342|NCT00615030|537014202|FG011|Period I|Protocol deviation|0|||
148873343|NCT00615030|537014191|FG000|Period I|Subject withdrew consent|0|||
148873344|NCT00615030|537014192|FG001|Period I|Subject withdrew consent|0|||
148873345|NCT00615030|537014193|FG002|Period I|Subject withdrew consent|0|||
148873346|NCT00615030|537014194|FG003|Period I|Subject withdrew consent|0|||
148873347|NCT00615030|537014195|FG004|Period I|Subject withdrew consent|0|||
148873348|NCT00615030|537014196|FG005|Period I|Subject withdrew consent|0|||
148873349|NCT00615030|537014197|FG006|Period I|Subject withdrew consent|0|||
148873350|NCT00615030|537014198|FG007|Period I|Subject withdrew consent|0|||
148873351|NCT00615030|537014199|FG008|Period I|Subject withdrew consent|1|||
148873352|NCT00615030|537014200|FG009|Period I|Subject withdrew consent|0|||
148873353|NCT00615030|537014201|FG010|Period I|Subject withdrew consent|1|||
148873354|NCT00615030|537014202|FG011|Period I|Subject withdrew consent|1|||
148873355|NCT00615030|537014191|FG000|Period I|Abnormal laboratory value(s)|0|||
148873356|NCT00615030|537014192|FG001|Period I|Abnormal laboratory value(s)|0|||
148873357|NCT00615030|537014193|FG002|Period I|Abnormal laboratory value(s)|0|||
148873358|NCT00615030|537014194|FG003|Period I|Abnormal laboratory value(s)|0|||
148873359|NCT00615030|537014195|FG004|Period I|Abnormal laboratory value(s)|0|||
148873360|NCT00615030|537014196|FG005|Period I|Abnormal laboratory value(s)|1|||
148873361|NCT00615030|537014197|FG006|Period I|Abnormal laboratory value(s)|0|||
148873362|NCT00615030|537014198|FG007|Period I|Abnormal laboratory value(s)|0|||
148873363|NCT00615030|537014199|FG008|Period I|Abnormal laboratory value(s)|0|||
148873364|NCT00615030|537014200|FG009|Period I|Abnormal laboratory value(s)|0|||
148873365|NCT00615030|537014201|FG010|Period I|Abnormal laboratory value(s)|0|||
148873366|NCT00615030|537014202|FG011|Period I|Abnormal laboratory value(s)|0|||
148873367|NCT00615030|537014191|FG000|Period II|Adverse Event|0|||
148873368|NCT00615030|537014192|FG001|Period II|Adverse Event|0|||
148873369|NCT00615030|537014193|FG002|Period II|Adverse Event|1|||
148873370|NCT00615030|537014194|FG003|Period II|Adverse Event|0|||
148873371|NCT00615030|537014195|FG004|Period II|Adverse Event|0|||
148873372|NCT00615030|537014196|FG005|Period II|Adverse Event|0|||
148873373|NCT00615030|537014197|FG006|Period II|Adverse Event|0|||
148873374|NCT00615030|537014198|FG007|Period II|Adverse Event|0|||
148873375|NCT00615030|537014199|FG008|Period II|Adverse Event|1|||
148873376|NCT00615030|537014200|FG009|Period II|Adverse Event|0|||
148873377|NCT00615030|537014201|FG010|Period II|Adverse Event|0|||
148873378|NCT00615030|537014202|FG011|Period II|Adverse Event|0|||
148873379|NCT00615030|537014191|FG000|Period II|Subject withdrew consent|0|||
148873380|NCT00615030|537014192|FG001|Period II|Subject withdrew consent|0|||
148873381|NCT00615030|537014193|FG002|Period II|Subject withdrew consent|0|||
148873382|NCT00615030|537014194|FG003|Period II|Subject withdrew consent|1|||
148873383|NCT00615030|537014195|FG004|Period II|Subject withdrew consent|0|||
148873384|NCT00615030|537014196|FG005|Period II|Subject withdrew consent|0|||
148873385|NCT00615030|537014197|FG006|Period II|Subject withdrew consent|1|||
148873386|NCT00615030|537014198|FG007|Period II|Subject withdrew consent|0|||
148873387|NCT00615030|537014199|FG008|Period II|Subject withdrew consent|0|||
148873388|NCT00615030|537014200|FG009|Period II|Subject withdrew consent|0|||
148873389|NCT00615030|537014201|FG010|Period II|Subject withdrew consent|0|||
148873390|NCT00615030|537014202|FG011|Period II|Subject withdrew consent|0|||
148873391|NCT00615030|537014191|FG000|Period III|Administrative problems|1|||
148873392|NCT00615030|537014192|FG001|Period III|Administrative problems|0|||
148873393|NCT00615030|537014193|FG002|Period III|Administrative problems|0|||
148873394|NCT00615030|537014194|FG003|Period III|Administrative problems|1|||
148873395|NCT00615030|537014195|FG004|Period III|Administrative problems|0|||
148873396|NCT00615030|537014196|FG005|Period III|Administrative problems|0|||
148873397|NCT00615030|537014197|FG006|Period III|Administrative problems|0|||
148873398|NCT00615030|537014198|FG007|Period III|Administrative problems|0|||
148873399|NCT00615030|537014199|FG008|Period III|Administrative problems|0|||
148873400|NCT00615030|537014200|FG009|Period III|Administrative problems|0|||
148873401|NCT00615030|537014201|FG010|Period III|Administrative problems|0|||
148873402|NCT00615030|537014202|FG011|Period III|Administrative problems|0|||
148873403|NCT03446456|537014203|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
148873404|NCT03446456|537014204|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
148873405|NCT03446456|537014203|FG000|Overall Study|Lost to Follow-up|1|||
148873406|NCT03446456|537014204|FG001|Overall Study|Lost to Follow-up|3|||
148873407|NCT03446456|537014203|FG000|Overall Study|Participant failed the toxicology test|1|||
148873408|NCT03446456|537014204|FG001|Overall Study|Participant failed the toxicology test|0|||
148873409|NCT03446456|537014203|FG000|Overall Study|Break down of the experimental equipment|1|||
149033548|NCT03058991|537600400|FG001|Overall Study|Lost to Follow-up|12|||
149033549|NCT03058991|537600401|FG002|Overall Study|Lost to Follow-up|12|||
148873410|NCT03446456|537014204|FG001|Overall Study|Break down of the experimental equipment|0|||
149033550|NCT03058991|537600399|FG000|Overall Study|Withdrawal by Subject|1|||
149033551|NCT03058991|537600400|FG001|Overall Study|Withdrawal by Subject|0|||
149033552|NCT03058991|537600401|FG002|Overall Study|Withdrawal by Subject|0|||
149033553|NCT01972152|537600402|FG000|First Treatment Visit|Lost to Follow-up|0|||
149033554|NCT01972152|537600403|FG001|First Treatment Visit|Lost to Follow-up|1|||
149033555|NCT01972152|537600404|FG002|First Treatment Visit|Lost to Follow-up|0|||
149033556|NCT01972152|537600405|FG003|First Treatment Visit|Lost to Follow-up|0|||
149033557|NCT01972152|537600406|FG004|First Treatment Visit|Lost to Follow-up|0|||
149033558|NCT01972152|537600407|FG005|First Treatment Visit|Lost to Follow-up|0|||
149033559|NCT01972152|537600402|FG000|Second Treatment Visit|Protocol Violation|0|||
149033560|NCT01972152|537600403|FG001|Second Treatment Visit|Protocol Violation|1|||
149033561|NCT01972152|537600404|FG002|Second Treatment Visit|Protocol Violation|0|||
149033562|NCT01972152|537600405|FG003|Second Treatment Visit|Protocol Violation|0|||
149033563|NCT01972152|537600406|FG004|Second Treatment Visit|Protocol Violation|0|||
149033564|NCT01972152|537600407|FG005|Second Treatment Visit|Protocol Violation|0|||
149033565|NCT01186848|537600408|FG000|Overall Study|Lost to Follow-up|4|||
149033566|NCT01186848|537600408|FG000|Overall Study|Withdrawal by Subject|2|||
149033567|NCT01186848|537600408|FG000|Overall Study|Adverse Event|2|||
149033568|NCT02596035|537600409|FG000|Overall Study|Disease Progression|64|||
149033569|NCT02596035|537600410|FG001|Overall Study|Disease Progression|32|||
149033570|NCT02596035|537600411|FG002|Overall Study|Disease Progression|1|||
149033571|NCT02596035|537600409|FG000|Overall Study|study drug toxicity|12|||
149033572|NCT02596035|537600410|FG001|Overall Study|study drug toxicity|3|||
149033573|NCT02596035|537600411|FG002|Overall Study|study drug toxicity|0|||
149033574|NCT02596035|537600409|FG000|Overall Study|AE unrelated to study drug|5|||
149033575|NCT02596035|537600410|FG001|Overall Study|AE unrelated to study drug|2|||
149033576|NCT02596035|537600411|FG002|Overall Study|AE unrelated to study drug|0|||
149033577|NCT02596035|537600409|FG000|Overall Study|participant request to discontinue study treatment|2|||
149033578|NCT02596035|537600410|FG001|Overall Study|participant request to discontinue study treatment|0|||
149033579|NCT02596035|537600411|FG002|Overall Study|participant request to discontinue study treatment|0|||
149033580|NCT02596035|537600409|FG000|Overall Study|participant withdrew consent|2|||
149033581|NCT02596035|537600410|FG001|Overall Study|participant withdrew consent|2|||
149033582|NCT02596035|537600411|FG002|Overall Study|participant withdrew consent|0|||
148873411|NCT00308074|537014207|FG000|Overall Study|Withdrawal by Subject|1|||
148873412|NCT03002311|537014208|FG000|Overall Study|Lost to Follow-up|13|||
148873413|NCT03002311|537014209|FG001|Overall Study|Lost to Follow-up|26|||
148873414|NCT03002311|537014208|FG000|Overall Study|Referral provider called to schedule app|3|||
148873415|NCT03002311|537014209|FG001|Overall Study|Referral provider called to schedule app|3|||
148873416|NCT03002311|537014208|FG000|Overall Study|Physician Decision|3|||
148873417|NCT03002311|537014209|FG001|Overall Study|Physician Decision|1|||
148873418|NCT03722524|537014210|FG000|Overall Study|Protocol Violation|86|||
148873419|NCT03722524|537014210|FG000|Overall Study|Adverse Event|7|||
148873420|NCT03722524|537014210|FG000|Overall Study|Lost to Follow-up|1|||
148873421|NCT03722524|537014210|FG000|Overall Study|Reason is not stated|1|||
148873422|NCT03722524|537014210|FG000|Overall Study|Physician Decision|1|||
148873423|NCT03722524|537014210|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
148873424|NCT04369950|537014211|FG000|Overall Study|Protocol Violation|2|||
148873425|NCT04369950|537014212|FG001|Overall Study|Protocol Violation|2|||
148873426|NCT00989963|537014213|FG000|Overall Study|Adverse Event|1|||
148873427|NCT00989963|537014214|FG001|Overall Study|Adverse Event|1|||
148873428|NCT00989963|537014215|FG002|Overall Study|Adverse Event|1|||
148873429|NCT01529034|537014224|FG000|Overall Study|Discontinued prior to study treatment|14|||
148873430|NCT01529034|537014224|FG000|Overall Study|Site closure|62|||
148873431|NCT01529034|537014224|FG000|Overall Study|Study termination|29|||
148873432|NCT01529034|537014224|FG000|Overall Study|Withdrawal by Subject|25|||
148873433|NCT01529034|537014224|FG000|Overall Study|No treated SCs within protocol window|13|||
148873434|NCT01529034|537014224|FG000|Overall Study|Noncompliance|8|||
148873435|NCT01529034|537014224|FG000|Overall Study|Caregiver no longer available|7|||
148873436|NCT01529034|537014224|FG000|Overall Study|Adverse Event|4|||
148873437|NCT01529034|537014224|FG000|Overall Study|Protocol Violation|4|||
148873438|NCT01529034|537014224|FG000|Overall Study|Lack of Efficacy|4|||
148873439|NCT01529034|537014224|FG000|Overall Study|Investigator no longer available|2|||
148873440|NCT01529034|537014224|FG000|Overall Study|Study drug not available|2|||
148873441|NCT04588389|537014225|FG000|Overall Study|Issues with anesthesia during surgery|2|||
148873442|NCT04588389|537014226|FG001|Overall Study|Issues with anesthesia during surgery|0|||
148873443|NCT04588389|537014227|FG002|Overall Study|Issues with anesthesia during surgery|0|||
148873444|NCT00658814|537014228|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
148873445|NCT00658814|537014229|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
148873446|NCT00658814|537014228|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
148873447|NCT00658814|537014229|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
148873448|NCT00658814|537014228|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
148873449|NCT00658814|537014229|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
148873450|NCT00658814|537014228|FG000|Remission Induction Chemotherapy|Death|1|||
148873451|NCT00658814|537014229|FG001|Remission Induction Chemotherapy|Death|4|||
148873452|NCT00658814|537014228|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
148873453|NCT00658814|537014229|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
148873454|NCT00658814|537014228|FG000|Remission Induction Chemotherapy|Not eligible|1|||
148873455|NCT00658814|537014229|FG001|Remission Induction Chemotherapy|Not eligible|2|||
148873456|NCT00658814|537014228|FG000|Consolidation Therapy|Not protocol specified|0|||
148873457|NCT00658814|537014229|FG001|Consolidation Therapy|Not protocol specified|1|||
148873458|NCT00658814|537014228|FG000|Consolidation Therapy|Not eligible|2|||
148873459|NCT00658814|537014229|FG001|Consolidation Therapy|Not eligible|2|||
148873460|NCT00658814|537014228|FG000|Maintenance Therapy|Adverse Event|1|||
148873461|NCT00658814|537014229|FG001|Maintenance Therapy|Adverse Event|1|||
148873462|NCT00658814|537014228|FG000|Maintenance Therapy|Not protocol specified|1|||
148873463|NCT00658814|537014229|FG001|Maintenance Therapy|Not protocol specified|0|||
148873464|NCT00658814|537014228|FG000|Maintenance Therapy|Not eligible|1|||
148873465|NCT00658814|537014229|FG001|Maintenance Therapy|Not eligible|0|||
148873466|NCT01641822|537014230|FG000|Run-in Phase|Noncompliance with study drug|1|||
148873467|NCT01641822|537014231|FG001|Run-in Phase|Noncompliance with study drug|0|||
148873468|NCT01641822|537014232|FG002|Run-in Phase|Noncompliance with study drug|0|||
148873469|NCT01641822|537014230|FG000|Run-in Phase|Adverse Event|3|||
148873470|NCT01641822|537014231|FG001|Run-in Phase|Adverse Event|0|||
148873471|NCT01641822|537014232|FG002|Run-in Phase|Adverse Event|0|||
148873472|NCT01641822|537014230|FG000|Run-in Phase|Withdrew consent|1|||
148873473|NCT01641822|537014231|FG001|Run-in Phase|Withdrew consent|0|||
148873474|NCT01641822|537014232|FG002|Run-in Phase|Withdrew consent|0|||
148873475|NCT01641822|537014230|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
148873476|NCT01641822|537014231|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
148873477|NCT01641822|537014232|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
148873478|NCT01641822|537014230|FG000|Comparative Phase|Noncompliance with study drug|0|||
148873479|NCT01641822|537014231|FG001|Comparative Phase|Noncompliance with study drug|1|||
148873480|NCT01641822|537014232|FG002|Comparative Phase|Noncompliance with study drug|0|||
148873481|NCT01641822|537014230|FG000|Comparative Phase|Investigator's discretion|0|||
148873482|NCT01641822|537014231|FG001|Comparative Phase|Investigator's discretion|0|||
148873483|NCT01641822|537014232|FG002|Comparative Phase|Investigator's discretion|1|||
148873484|NCT01641822|537014230|FG000|Comparative Phase|Pregnancy|0|||
148873485|NCT01641822|537014231|FG001|Comparative Phase|Pregnancy|0|||
148873486|NCT01641822|537014232|FG002|Comparative Phase|Pregnancy|1|||
148873487|NCT01641822|537014230|FG000|Comparative Phase|Adverse event, serious fatal|0|||
148873488|NCT01641822|537014231|FG001|Comparative Phase|Adverse event, serious fatal|1|||
148873489|NCT01641822|537014232|FG002|Comparative Phase|Adverse event, serious fatal|0|||
148873490|NCT01641822|537014230|FG000|Comparative Phase|Withdrew consent|0|||
148873491|NCT01641822|537014231|FG001|Comparative Phase|Withdrew consent|3|||
148873492|NCT01641822|537014232|FG002|Comparative Phase|Withdrew consent|7|||
148873493|NCT01641822|537014230|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
148873494|NCT01641822|537014231|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
148873495|NCT01641822|537014232|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
148873496|NCT00975143|537014239|FG000|Overall Study|Adverse Event|19|||
148873497|NCT00975143|537014240|FG001|Overall Study|Adverse Event|15|||
148873498|NCT00975143|537014239|FG000|Overall Study|Withdrawal by Subject|15|||
148873499|NCT00975143|537014240|FG001|Overall Study|Withdrawal by Subject|15|||
148873500|NCT00975143|537014239|FG000|Overall Study|Lost to Follow-up|20|||
148873501|NCT00975143|537014240|FG001|Overall Study|Lost to Follow-up|16|||
148873502|NCT00975143|537014239|FG000|Overall Study|Non-compliance|5|||
148873503|NCT00975143|537014240|FG001|Overall Study|Non-compliance|8|||
148873504|NCT00975143|537014239|FG000|Overall Study|Physician Decision|1|||
148873505|NCT00975143|537014240|FG001|Overall Study|Physician Decision|2|||
148873506|NCT00975143|537014239|FG000|Overall Study|Details not available|10|||
148873507|NCT00975143|537014240|FG001|Overall Study|Details not available|4|||
148873508|NCT01147900|537014241|FG000|At Year 10|Lost to Follow-up|0|||
148873509|NCT01147900|537014242|FG001|At Year 10|Lost to Follow-up|1|||
148873510|NCT01147900|537014243|FG002|At Year 10|Lost to Follow-up|0|||
148873511|NCT01375608|537014244|FG000|Overall Study|Withdrawal by Subject|2|||
148873512|NCT00581360|537014245|FG000|Overall Study|Withdrawal by Subject|1|||
148873513|NCT03129360|537014246|FG000|Overall Study|Did not meet entry criteria|0|||
148873514|NCT03129360|537014247|FG001|Overall Study|Did not meet entry criteria|2|||
148873515|NCT03129360|537014248|FG002|Overall Study|Did not meet entry criteria|1|||
148873516|NCT03129360|537014246|FG000|Overall Study|Excluded due to motion in scanner|1|||
148873517|NCT03129360|537014247|FG001|Overall Study|Excluded due to motion in scanner|0|||
148873518|NCT03129360|537014248|FG002|Overall Study|Excluded due to motion in scanner|0|||
148873519|NCT03729245|537014249|FG000|Overall Study|Lost to Follow-up|5|||
148873520|NCT03729245|537014250|FG001|Overall Study|Lost to Follow-up|6|||
148873521|NCT03729245|537014249|FG000|Overall Study|Withdrawal by Subject|16|||
148873522|NCT03729245|537014250|FG001|Overall Study|Withdrawal by Subject|19|||
148873523|NCT03729245|537014249|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
148873524|NCT03729245|537014250|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
148873525|NCT00884832|537014251|FG000|Overall Study|Withdrawal by Subject|0|||
148873526|NCT00884832|537014252|FG001|Overall Study|Withdrawal by Subject|1|||
148873527|NCT03322423|537014253|FG000|Period 1|Subject no longer eligible|0|||
148873528|NCT03322423|537014254|FG001|Period 1|Subject no longer eligible|1|||
148873529|NCT03322423|537014253|FG000|Period 1|Withdrawal by Subject|0|||
149033583|NCT02596035|537600409|FG000|Overall Study|Poor/Non Comlpiance|0|||
149033584|NCT02596035|537600410|FG001|Overall Study|Poor/Non Comlpiance|1|||
149033585|NCT02596035|537600411|FG002|Overall Study|Poor/Non Comlpiance|0|||
149033586|NCT02596035|537600409|FG000|Overall Study|participant no longer meets study criteria|1|||
149033587|NCT02596035|537600410|FG001|Overall Study|participant no longer meets study criteria|0|||
149033588|NCT02596035|537600411|FG002|Overall Study|participant no longer meets study criteria|0|||
149033589|NCT02596035|537600409|FG000|Overall Study|other reasons|11|||
149033590|NCT02596035|537600410|FG001|Overall Study|other reasons|4|||
149033591|NCT02596035|537600411|FG002|Overall Study|other reasons|0|||
148873530|NCT03322423|537014254|FG001|Period 1|Withdrawal by Subject|1|||
148873531|NCT03322423|537014253|FG000|Period 1|Incorrect Lens Dispensed|1|||
148873532|NCT03322423|537014254|FG001|Period 1|Incorrect Lens Dispensed|0|||
148873533|NCT03322423|537014253|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
148873534|NCT03322423|537014254|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
148873535|NCT03322423|537014253|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
148873536|NCT03322423|537014254|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
148873537|NCT03322423|537014253|FG000|Period 2|Protocol Violation|1|||
148873538|NCT03322423|537014254|FG001|Period 2|Protocol Violation|0|||
148873539|NCT03322423|537014253|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
148873540|NCT03322423|537014254|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
148873541|NCT02096263|537014255|FG000|Overall Study|Adverse Event|1|||
148873542|NCT02096263|537014256|FG001|Overall Study|Adverse Event|0|||
148873543|NCT02096263|537014257|FG002|Overall Study|Adverse Event|1|||
148873544|NCT02096263|537014255|FG000|Overall Study|Lost to Follow-up|14|||
148873545|NCT02096263|537014256|FG001|Overall Study|Lost to Follow-up|18|||
148873546|NCT02096263|537014257|FG002|Overall Study|Lost to Follow-up|15|||
148873547|NCT02096263|537014255|FG000|Overall Study|Other|7|||
148873548|NCT02096263|537014256|FG001|Overall Study|Other|9|||
148873549|NCT02096263|537014257|FG002|Overall Study|Other|6|||
148873550|NCT02096263|537014255|FG000|Overall Study|Sponsor study termination|0|||
148873551|NCT02096263|537014256|FG001|Overall Study|Sponsor study termination|0|||
148873552|NCT02096263|537014257|FG002|Overall Study|Sponsor study termination|1|||
148873553|NCT02096263|537014255|FG000|Overall Study|Protocol Violation|7|||
148873554|NCT02096263|537014256|FG001|Overall Study|Protocol Violation|2|||
148873555|NCT02096263|537014257|FG002|Overall Study|Protocol Violation|8|||
148873556|NCT02096263|537014255|FG000|Overall Study|Withdrawal by Subject|5|||
148873557|NCT02096263|537014256|FG001|Overall Study|Withdrawal by Subject|7|||
148873558|NCT02096263|537014257|FG002|Overall Study|Withdrawal by Subject|8|||
148873559|NCT04891107|537014258|FG000|Overall Study|Physician Decision|1|||
148873560|NCT04891107|537014258|FG000|Overall Study|Withdrawal by Subject|1|||
148873561|NCT04891107|537014258|FG000|Overall Study|Screen failure after consent|1|||
148873562|NCT00500760|537014265|FG000|Overall Study|Death|32|||
148873563|NCT00500760|537014266|FG001|Overall Study|Death|15|||
148873564|NCT00500760|537014265|FG000|Overall Study|Withdrawal by Subject|5|||
148873565|NCT00500760|537014266|FG001|Overall Study|Withdrawal by Subject|7|||
148873566|NCT00500760|537014265|FG000|Overall Study|Administrative decision|2|||
148873567|NCT00500760|537014266|FG001|Overall Study|Administrative decision|0|||
148873568|NCT00500760|537014265|FG000|Overall Study|Lost to Follow-up|3|||
148873569|NCT00500760|537014266|FG001|Overall Study|Lost to Follow-up|0|||
148873570|NCT00500760|537014265|FG000|Overall Study|Other|1|||
148873571|NCT00500760|537014266|FG001|Overall Study|Other|2|||
148873572|NCT03178669|537014267|FG000|Overall Study|Adverse Event|4|||
148873573|NCT03178669|537014268|FG001|Overall Study|Adverse Event|1|||
148873574|NCT03178669|537014269|FG002|Overall Study|Adverse Event|4|||
148873575|NCT03178669|537014270|FG003|Overall Study|Adverse Event|2|||
148873576|NCT03178669|537014271|FG004|Overall Study|Adverse Event|2|||
148873577|NCT03178669|537014267|FG000|Overall Study|Lack of Efficacy|0|||
148873578|NCT03178669|537014268|FG001|Overall Study|Lack of Efficacy|0|||
148873579|NCT03178669|537014269|FG002|Overall Study|Lack of Efficacy|2|||
148873580|NCT03178669|537014270|FG003|Overall Study|Lack of Efficacy|0|||
148873581|NCT03178669|537014271|FG004|Overall Study|Lack of Efficacy|1|||
148873582|NCT03178669|537014267|FG000|Overall Study|Physician Decision|0|||
148873583|NCT03178669|537014268|FG001|Overall Study|Physician Decision|0|||
148873584|NCT03178669|537014269|FG002|Overall Study|Physician Decision|0|||
148873585|NCT03178669|537014270|FG003|Overall Study|Physician Decision|0|||
148873586|NCT03178669|537014271|FG004|Overall Study|Physician Decision|1|||
148873587|NCT03178669|537014267|FG000|Overall Study|Withdrawal by Subject|1|||
148873588|NCT03178669|537014268|FG001|Overall Study|Withdrawal by Subject|0|||
148873589|NCT03178669|537014269|FG002|Overall Study|Withdrawal by Subject|1|||
148873590|NCT03178669|537014270|FG003|Overall Study|Withdrawal by Subject|1|||
148873591|NCT03178669|537014271|FG004|Overall Study|Withdrawal by Subject|0|||
148873592|NCT03178669|537014267|FG000|Overall Study|Lost to Follow-up|0|||
148873593|NCT03178669|537014268|FG001|Overall Study|Lost to Follow-up|0|||
148873594|NCT03178669|537014269|FG002|Overall Study|Lost to Follow-up|0|||
148873595|NCT03178669|537014270|FG003|Overall Study|Lost to Follow-up|1|||
148873596|NCT03178669|537014271|FG004|Overall Study|Lost to Follow-up|0|||
148873597|NCT01600092|537014272|FG000|Overall Study|Adverse Event|2|||
148873598|NCT01600092|537014273|FG001|Overall Study|Adverse Event|0|||
148873599|NCT01600092|537014272|FG000|Overall Study|Lost to Follow-up|4|||
148873600|NCT01600092|537014273|FG001|Overall Study|Lost to Follow-up|6|||
148873601|NCT01600092|537014272|FG000|Overall Study|Withdrawal by parent/guardian|8|||
148873602|NCT01600092|537014273|FG001|Overall Study|Withdrawal by parent/guardian|6|||
148873603|NCT01600092|537014272|FG000|Overall Study|Physician Decision|1|||
148873604|NCT01600092|537014273|FG001|Overall Study|Physician Decision|1|||
148873605|NCT01600092|537014272|FG000|Overall Study|Randomized but not vaccinated|3|||
148873606|NCT01600092|537014273|FG001|Overall Study|Randomized but not vaccinated|3|||
148873607|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
148873608|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
148873609|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
148873610|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
148873611|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
148873612|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
148873613|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
148873614|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
148873615|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
148873616|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
148873617|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
148873618|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
148873619|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
148873620|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
148873621|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
148873622|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
148873623|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
148873624|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
148873625|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
148873626|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
148873627|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
148873628|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
148873629|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
148873630|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
148873631|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
148873632|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
148873633|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
148873634|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
148873635|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
148873636|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
148873637|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
148873638|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
148873639|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
148873640|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
148873641|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
148873642|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
148873643|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
148873644|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
148873645|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
148873646|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
148873647|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
148873648|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
148873649|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
148873650|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
148873651|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873652|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873653|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
148873654|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873655|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873656|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
148873657|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873658|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873659|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873660|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873661|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
148873662|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
148873663|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873664|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873665|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873666|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873667|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873668|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873669|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873670|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873671|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873672|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
148873673|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873674|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873675|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
148873676|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873677|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873678|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873679|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873680|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873681|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873682|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873683|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
148873684|NCT02914561|537014275|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
148873685|NCT02914561|537014276|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
148873686|NCT02914561|537014277|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
148873687|NCT02914561|537014278|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
148873688|NCT02914561|537014279|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
148873689|NCT02914561|537014280|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
148873690|NCT02914561|537014281|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
148873691|NCT02914561|537014282|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
148873692|NCT02914561|537014283|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
148873693|NCT02914561|537014284|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
148873694|NCT02914561|537014285|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
148873695|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
148873696|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
148873697|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
148873698|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
148873699|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
148873700|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
148873701|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
148873702|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
148873703|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
148873704|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
148873705|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
148873706|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
148873707|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
148873708|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
148873709|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
148873710|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
148873711|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
148873712|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
148873713|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
148873714|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
148873715|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
148873716|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
148873717|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
148873718|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
148873719|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
148873720|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
148873721|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
148873722|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
148873723|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
148873724|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
148873725|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
148873726|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
148873727|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
148873728|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873729|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873730|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873731|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873732|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873733|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873734|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
148873735|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873736|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
148873737|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
148873738|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
148873739|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873740|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873741|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873742|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873743|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873744|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873745|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
148873746|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
148873747|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
148873748|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
148873749|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
148873750|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873751|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873752|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873753|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873754|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873755|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873756|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
148873757|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873758|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
148873759|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873760|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
148873761|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873762|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873763|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873764|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873765|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873766|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873767|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873768|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873769|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
148873770|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873771|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
148873772|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873773|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873774|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873775|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873776|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873777|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873778|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
149000903|NCT01525602|537479432|FG002|Overall Study|Adverse Event|1|||
148873779|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873780|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873781|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873782|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
148873783|NCT02914561|537014275|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873784|NCT02914561|537014276|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873785|NCT02914561|537014277|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873786|NCT02914561|537014278|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873787|NCT02914561|537014279|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873788|NCT02914561|537014280|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873789|NCT02914561|537014281|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873790|NCT02914561|537014282|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
148873791|NCT02914561|537014283|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
148873792|NCT02914561|537014284|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
148873793|NCT02914561|537014285|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
148873794|NCT01300455|537014286|FG000|Washout|Withdrawal by Subject|1|||
148873795|NCT01300455|537014287|FG001|Washout|Withdrawal by Subject|0|||
148873796|NCT00565136|537014288|FG000|Overall Study|Lost to Follow-up|1|||
148873797|NCT00565136|537014288|FG000|Overall Study|Withdrawal by Subject|1|||
148873798|NCT00565136|537014288|FG000|Overall Study|Protocol Violation|1|||
148873799|NCT02438813|537014299|FG000|Overall Study|Patient Decision|59|||
148873800|NCT02438813|537014299|FG000|Overall Study|Patient Lost to Follow-Up|137|||
148873801|NCT02438813|537014299|FG000|Overall Study|Study Ended by Sponsor|80|||
148873802|NCT02438813|537014299|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
148873803|NCT00694304|537014300|FG000|Overall Study|Adverse Event|42|||
148873804|NCT00694304|537014300|FG000|Overall Study|Lack of Efficacy|35|||
148873805|NCT00694304|537014300|FG000|Overall Study|Non-compliance With Study Product|16|||
148873806|NCT00694304|537014300|FG000|Overall Study|Protocol Violation|6|||
148873807|NCT00694304|537014300|FG000|Overall Study|Withdrawal of Consent|61|||
148873808|NCT00694304|537014300|FG000|Overall Study|Lost to Follow-up|15|||
148873809|NCT00694304|537014300|FG000|Overall Study|Administrative or Other Reasons|32|||
148873810|NCT00576576|537014301|FG000|Overall Study|Lost to Follow-up|6|||
148873811|NCT00576576|537014301|FG000|Overall Study|Protocol Violation|1|||
148873812|NCT03135210|537014302|FG000|Overall Study|Death|0|||
148873813|NCT03135210|537014303|FG001|Overall Study|Death|1|||
148873814|NCT01805037|537014311|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
148873815|NCT01805037|537014312|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
148873816|NCT01805037|537014311|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
148873817|NCT01805037|537014312|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
148873818|NCT01805037|537014311|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
148873819|NCT01805037|537014312|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
148873820|NCT01805037|537014311|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
148873821|NCT01805037|537014312|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
148873822|NCT01805037|537014311|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
148873823|NCT01805037|537014312|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
148873824|NCT01805037|537014311|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
148873825|NCT01805037|537014312|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
148873826|NCT01805037|537014311|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
148873827|NCT01805037|537014312|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
148873828|NCT01805037|537014311|FG000|Follow Up (up to 3 Years)|Death|0|||
148873829|NCT01805037|537014312|FG001|Follow Up (up to 3 Years)|Death|2|||
148873830|NCT01805037|537014311|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
148873831|NCT01805037|537014312|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
148873832|NCT01805037|537014311|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
148873833|NCT01805037|537014312|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
148873834|NCT01270256|537014313|FG000|Overall Study|Withdrawal by Subject|1|||
148873835|NCT01270256|537014314|FG001|Overall Study|Withdrawal by Subject|0|||
148873836|NCT02879578|537014315|FG000|Overall Study|Adverse Event|1|||
148873837|NCT02879578|537014316|FG001|Overall Study|Adverse Event|2|||
148873838|NCT02879578|537014317|FG002|Overall Study|Adverse Event|14|||
148873839|NCT02879578|537014315|FG000|Overall Study|Protocol Violation|0|||
148873840|NCT02879578|537014316|FG001|Overall Study|Protocol Violation|1|||
148873841|NCT02879578|537014317|FG002|Overall Study|Protocol Violation|1|||
148873842|NCT02879578|537014315|FG000|Overall Study|Withdrawal by Subject|8|||
148873843|NCT02879578|537014316|FG001|Overall Study|Withdrawal by Subject|6|||
149033592|NCT00509769|537600412|FG000|Overall Study|Progressive disease|77|||
149033593|NCT00509769|537600412|FG000|Overall Study|Adverse Event|4|||
148873844|NCT02879578|537014317|FG002|Overall Study|Withdrawal by Subject|9|||
148873845|NCT02879578|537014315|FG000|Overall Study|Lost to Follow-up|1|||
148873846|NCT02879578|537014316|FG001|Overall Study|Lost to Follow-up|0|||
148873847|NCT02879578|537014317|FG002|Overall Study|Lost to Follow-up|4|||
148873848|NCT02879578|537014315|FG000|Overall Study|Physician Decision|0|||
148873849|NCT02879578|537014316|FG001|Overall Study|Physician Decision|0|||
148873850|NCT02879578|537014317|FG002|Overall Study|Physician Decision|4|||
148873851|NCT04566692|537014318|FG000|Overall Study|Adverse Event|2|||
148873852|NCT04566692|537014319|FG001|Overall Study|Adverse Event|0|||
148873853|NCT04566692|537014318|FG000|Overall Study|Withdrawal by Subject|1|||
148873854|NCT04566692|537014319|FG001|Overall Study|Withdrawal by Subject|1|||
148873855|NCT00671437|537014320|FG000|Overall Study|Progressive disease before C1 week 8|8|||
148873856|NCT00671437|537014320|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
148873857|NCT00671437|537014320|FG000|Overall Study|Adverse Event|3|||
148873858|NCT00671437|537014320|FG000|Overall Study|Ineligible post-hoc|1|||
148873859|NCT03927404|537014321|FG000|Overall Study|Withdrawal by Subject|1|||
148873860|NCT01229449|537014322|FG000|Overall Study|Withdrawal by Subject|0|||
148873861|NCT01229449|537014323|FG001|Overall Study|Withdrawal by Subject|3|||
148873862|NCT01229449|537014324|FG002|Overall Study|Withdrawal by Subject|0|||
148873863|NCT01229449|537014325|FG003|Overall Study|Withdrawal by Subject|1|||
148873864|NCT01229449|537014326|FG004|Overall Study|Withdrawal by Subject|1|||
148873865|NCT01229449|537014322|FG000|Overall Study|Lost to Follow-up|1|||
148873866|NCT01229449|537014323|FG001|Overall Study|Lost to Follow-up|1|||
148873867|NCT01229449|537014324|FG002|Overall Study|Lost to Follow-up|1|||
148873868|NCT01229449|537014325|FG003|Overall Study|Lost to Follow-up|0|||
148873869|NCT01229449|537014326|FG004|Overall Study|Lost to Follow-up|0|||
148873870|NCT01229449|537014322|FG000|Overall Study|Physician Decision|0|||
148873871|NCT01229449|537014323|FG001|Overall Study|Physician Decision|0|||
148873872|NCT01229449|537014324|FG002|Overall Study|Physician Decision|1|||
148873873|NCT01229449|537014325|FG003|Overall Study|Physician Decision|0|||
148873874|NCT01229449|537014326|FG004|Overall Study|Physician Decision|0|||
148873875|NCT03203291|537014327|FG000|Overall Study|Withdrawal by Subject|1|||
148873876|NCT05098509|537014328|FG000|Overall Study|Withdrawal by Subject|0|||
148873877|NCT05098509|537014329|FG001|Overall Study|Withdrawal by Subject|0|||
148873878|NCT05098509|537014330|FG002|Overall Study|Withdrawal by Subject|1|||
148873879|NCT05098509|537014331|FG003|Overall Study|Withdrawal by Subject|0|||
148873880|NCT05098509|537014328|FG000|Overall Study|Early study termination|1|||
148873881|NCT05098509|537014329|FG001|Overall Study|Early study termination|1|||
148873882|NCT05098509|537014330|FG002|Overall Study|Early study termination|1|||
148873883|NCT05098509|537014331|FG003|Overall Study|Early study termination|0|||
148873884|NCT04033068|537014332|FG000|Overall Study|Withdrawal by Subject|0|||
148873885|NCT04033068|537014333|FG001|Overall Study|Withdrawal by Subject|0|||
148873886|NCT04033068|537014334|FG002|Overall Study|Withdrawal by Subject|1|||
148873887|NCT04033068|537014335|FG003|Overall Study|Withdrawal by Subject|0|||
148873888|NCT04033068|537014332|FG000|Overall Study|Lost to Follow-up|0|||
148873889|NCT04033068|537014333|FG001|Overall Study|Lost to Follow-up|1|||
148873890|NCT04033068|537014334|FG002|Overall Study|Lost to Follow-up|0|||
148873891|NCT04033068|537014335|FG003|Overall Study|Lost to Follow-up|0|||
148873892|NCT04033068|537014332|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
148873893|NCT04033068|537014333|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
148873894|NCT04033068|537014334|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
148873895|NCT04033068|537014335|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
148873896|NCT02540265|537014339|FG000|Overall Study|Lost to Follow-up|0|||
148873897|NCT02540265|537014340|FG001|Overall Study|Lost to Follow-up|0|||
148873898|NCT02540265|537014341|FG002|Overall Study|Lost to Follow-up|1|||
148873899|NCT03157037|537014342|FG000|Overall Study|Death|1|||
148873900|NCT02102399|537014343|FG000|Overall Study|Withdrawal by Subject|6|||
148873901|NCT02102399|537014344|FG001|Overall Study|Withdrawal by Subject|4|||
148873902|NCT00324233|537014345|FG000|First Period|unable to insert catheter|1|||
148873903|NCT00324233|537014346|FG001|First Period|unable to insert catheter|0|||
148873904|NCT00324233|537014345|FG000|Second Period|unable to insert catheter|1|||
148873905|NCT00324233|537014346|FG001|Second Period|unable to insert catheter|1|||
148873906|NCT00324233|537014345|FG000|Second Period|Protocol Violation|4|||
148873907|NCT00324233|537014346|FG001|Second Period|Protocol Violation|6|||
148873908|NCT01972789|537014347|FG000|Overall Study|Adverse Event|11|||
148873909|NCT01972789|537014348|FG001|Overall Study|Adverse Event|4|||
148873910|NCT01972789|537014347|FG000|Overall Study|Subject withdrew consent|14|||
148873911|NCT01972789|537014348|FG001|Overall Study|Subject withdrew consent|12|||
148873912|NCT01972789|537014347|FG000|Overall Study|Lost to Follow-up|4|||
148873913|NCT01972789|537014348|FG001|Overall Study|Lost to Follow-up|7|||
148873914|NCT01972789|537014347|FG000|Overall Study|Death|7|||
148873915|NCT01972789|537014348|FG001|Overall Study|Death|5|||
148873916|NCT01972789|537014347|FG000|Overall Study|Protocol deviation|1|||
148873917|NCT01972789|537014348|FG001|Overall Study|Protocol deviation|0|||
148873918|NCT01972789|537014347|FG000|Overall Study|Physician Decision|3|||
148873919|NCT01972789|537014348|FG001|Overall Study|Physician Decision|2|||
148873920|NCT01704456|537014351|FG000|Overall Study|Lost to Follow-up|8|||
148873921|NCT01704456|537014352|FG001|Overall Study|Lost to Follow-up|14|||
148873922|NCT01887353|537014363|FG000|Overall Study|Study stopped early|4|||
148873923|NCT01887353|537014364|FG001|Overall Study|Study stopped early|3|||
148873924|NCT00649428|537016548|FG000|Overall Study|Adverse Event|2|||
148873925|NCT00649428|537016549|FG001|Overall Study|Adverse Event|2|||
148873926|NCT00649428|537016548|FG000|Overall Study|Withdrawal by Subject|6|||
148873927|NCT00649428|537016549|FG001|Overall Study|Withdrawal by Subject|6|||
148873928|NCT00649428|537016548|FG000|Overall Study|Lost to Follow-up|1|||
148873929|NCT00649428|537016549|FG001|Overall Study|Lost to Follow-up|3|||
148873930|NCT00649428|537016548|FG000|Overall Study|Insufficient manufacturing yield|5|||
148873931|NCT00649428|537016549|FG001|Overall Study|Insufficient manufacturing yield|1|||
148873932|NCT00649428|537016548|FG000|Overall Study|Protocol Violation|6|||
148873933|NCT00649428|537016549|FG001|Overall Study|Protocol Violation|2|||
148873934|NCT00649428|537016548|FG000|Overall Study|Physician Decision|0|||
148873935|NCT00649428|537016549|FG001|Overall Study|Physician Decision|1|||
148873936|NCT02008227|537016550|FG000|Overall Study|Lost to Follow-up|7|||
148873937|NCT02008227|537016551|FG001|Overall Study|Lost to Follow-up|9|||
148873938|NCT02008227|537016550|FG000|Overall Study|Death|494|||
148873939|NCT02008227|537016551|FG001|Overall Study|Death|485|||
148873940|NCT02008227|537016550|FG000|Overall Study|Withdrawal by Subject|67|||
148873941|NCT02008227|537016551|FG001|Overall Study|Withdrawal by Subject|36|||
148873942|NCT02008227|537016550|FG000|Overall Study|Study Terminated By Sponsor|44|||
148873943|NCT02008227|537016551|FG001|Overall Study|Study Terminated By Sponsor|83|||
148873944|NCT04599465|537016552|FG000|Overall Study|Physician Decision|1|||
148873945|NCT04599465|537016552|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
148873946|NCT00495625|537016555|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
148873947|NCT02702180|537016557|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
148873948|NCT02702180|537016558|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
148873949|NCT02702180|537016559|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
148873950|NCT02702180|537016557|FG000|Double-blind Treatment Period|Adverse Event|0|||
148873951|NCT02702180|537016558|FG001|Double-blind Treatment Period|Adverse Event|0|||
148873952|NCT02702180|537016559|FG002|Double-blind Treatment Period|Adverse Event|1|||
148873953|NCT02702180|537016557|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
148873954|NCT02702180|537016558|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
148873955|NCT02702180|537016559|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
148873956|NCT02702180|537016557|FG000|Double-blind Treatment Period|Protocol Violation|0|||
148873957|NCT02702180|537016558|FG001|Double-blind Treatment Period|Protocol Violation|0|||
148873958|NCT02702180|537016559|FG002|Double-blind Treatment Period|Protocol Violation|2|||
148873959|NCT02702180|537016557|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
148873960|NCT02702180|537016558|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
148873961|NCT02702180|537016559|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
148873962|NCT02702180|537016557|FG000|Open-label Treatment Period|Withdrawn in error|0|||
148873963|NCT02702180|537016558|FG001|Open-label Treatment Period|Withdrawn in error|0|||
148873964|NCT02702180|537016559|FG002|Open-label Treatment Period|Withdrawn in error|1|||
148873965|NCT00679172|537016563|FG000|Overall Study|Non-compliance|1|||
148873966|NCT00679172|537016564|FG001|Overall Study|Non-compliance|1|||
148873967|NCT00679172|537016565|FG002|Overall Study|Non-compliance|0|||
148873968|NCT00679172|537016566|FG003|Overall Study|Non-compliance|1|||
148873969|NCT00679172|537016567|FG004|Overall Study|Non-compliance|0|||
148873970|NCT00679172|537016563|FG000|Overall Study|Other not specified|0|||
148873971|NCT00679172|537016564|FG001|Overall Study|Other not specified|0|||
148873972|NCT00679172|537016565|FG002|Overall Study|Other not specified|1|||
148873973|NCT00679172|537016566|FG003|Overall Study|Other not specified|0|||
148873974|NCT00679172|537016567|FG004|Overall Study|Other not specified|0|||
148873975|NCT04512976|537016569|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
148873976|NCT04512976|537016570|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
148873977|NCT04512976|537016571|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
148873978|NCT04512976|537016572|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
148873979|NCT04512976|537016573|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
148873980|NCT04512976|537016574|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
148873981|NCT02241343|537016577|FG000|Overall Study|Adverse Event|1|||
148873982|NCT00753454|537016578|FG000|Overall Study|Adverse Event|4|||
148873983|NCT00753454|537016578|FG000|Overall Study|Lack of Efficacy|1|||
148873984|NCT00753454|537016578|FG000|Overall Study|Lost to Follow-up|3|||
148873985|NCT00753454|537016578|FG000|Overall Study|Withdrawal by Subject|5|||
148873986|NCT00753454|537016578|FG000|Overall Study|Investigator Decision|1|||
148873987|NCT03927144|537016579|FG000|Core Phase|Adverse Event|9|||
148873988|NCT03927144|537016580|FG001|Core Phase|Adverse Event|5|||
148873989|NCT03927144|537016579|FG000|Core Phase|Lost to Follow-up|3|||
148873990|NCT03927144|537016580|FG001|Core Phase|Lost to Follow-up|2|||
148873991|NCT03927144|537016579|FG000|Core Phase|New Therapy for Study Indication|0|||
148873992|NCT03927144|537016580|FG001|Core Phase|New Therapy for Study Indication|1|||
148873993|NCT03927144|537016579|FG000|Core Phase|No Longer Clinically Benefiting|4|||
148873994|NCT03927144|537016580|FG001|Core Phase|No Longer Clinically Benefiting|4|||
148873995|NCT03927144|537016579|FG000|Core Phase|Physician Decision|2|||
148873996|NCT03927144|537016580|FG001|Core Phase|Physician Decision|8|||
148873997|NCT03927144|537016579|FG000|Core Phase|Protocol Violation|2|||
148873998|NCT03927144|537016580|FG001|Core Phase|Protocol Violation|2|||
148873999|NCT03927144|537016579|FG000|Core Phase|Withdrawal by Subject|16|||
148874000|NCT03927144|537016580|FG001|Core Phase|Withdrawal by Subject|40|||
148874001|NCT03927144|537016579|FG000|Extension Phase|Adverse Event|2|||
148874002|NCT03927144|537016580|FG001|Extension Phase|Adverse Event|1|||
148874003|NCT03927144|537016579|FG000|Extension Phase|No longer clinically benefiting|4|||
148874004|NCT03927144|537016580|FG001|Extension Phase|No longer clinically benefiting|5|||
148874005|NCT03927144|537016579|FG000|Extension Phase|Pregnancy|1|||
148874006|NCT03927144|537016580|FG001|Extension Phase|Pregnancy|0|||
148874007|NCT03927144|537016579|FG000|Extension Phase|Protocol Violation|0|||
148874008|NCT03927144|537016580|FG001|Extension Phase|Protocol Violation|1|||
148874009|NCT03927144|537016579|FG000|Extension Phase|Withdrawal by Subject|8|||
148874010|NCT03927144|537016580|FG001|Extension Phase|Withdrawal by Subject|3|||
148874011|NCT02702414|537016583|FG000|Overall Study|Death|96|||
148874012|NCT02702414|537016584|FG001|Overall Study|Death|42|||
148874013|NCT02702414|537016583|FG000|Overall Study|Lost to Follow-up|0|||
148874014|NCT02702414|537016584|FG001|Overall Study|Lost to Follow-up|1|||
148874015|NCT02702414|537016583|FG000|Overall Study|Withdrawal by Subject|0|||
148874016|NCT02702414|537016584|FG001|Overall Study|Withdrawal by Subject|1|||
148874017|NCT02702414|537016583|FG000|Overall Study|Protocol Violation|1|||
148874018|NCT02702414|537016584|FG001|Overall Study|Protocol Violation|0|||
148874019|NCT02702414|537016583|FG000|Overall Study|Sponsor Decision|8|||
148874020|NCT02702414|537016584|FG001|Overall Study|Sponsor Decision|7|||
148874021|NCT02271945|537016585|FG000|Overall Study|Death|3|||
148874022|NCT02271945|537016586|FG001|Overall Study|Death|3|||
148874023|NCT02271945|537016585|FG000|Overall Study|Withdrawal by Subject|1|||
148874024|NCT02271945|537016586|FG001|Overall Study|Withdrawal by Subject|1|||
148874025|NCT02271945|537016585|FG000|Overall Study|Other|1|||
148874026|NCT02271945|537016586|FG001|Overall Study|Other|1|||
148874027|NCT02911142|537016590|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
148874028|NCT02911142|537016590|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
148874029|NCT02911142|537016590|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
148874030|NCT02911142|537016590|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
148874031|NCT01178099|537016591|FG000|Overall Study|Physician Decision|0|||
148874032|NCT01178099|537016592|FG001|Overall Study|Physician Decision|1|||
148874033|NCT02473367|537016595|FG000|Wait 1|Withdrawal by Subject|1|||
148874034|NCT02473367|537016595|FG000|Period 4|Lost to Follow-up|1|||
148874035|NCT04816721|537016596|FG000|Overall Study|Withdrawal by Subject|0|||
148874036|NCT04816721|537016597|FG001|Overall Study|Withdrawal by Subject|2|||
148874037|NCT04816721|537016598|FG002|Overall Study|Withdrawal by Subject|0|||
148874038|NCT04816721|537016599|FG003|Overall Study|Withdrawal by Subject|1|||
148874039|NCT04816721|537016600|FG004|Overall Study|Withdrawal by Subject|1|||
148874040|NCT04816721|537016601|FG005|Overall Study|Withdrawal by Subject|0|||
148874041|NCT04816721|537016602|FG006|Overall Study|Withdrawal by Subject|0|||
148874042|NCT04816721|537016603|FG007|Overall Study|Withdrawal by Subject|0|||
148874043|NCT04816721|537016596|FG000|Overall Study|Miscellaneous|0|||
148874044|NCT04816721|537016597|FG001|Overall Study|Miscellaneous|0|||
148874045|NCT04816721|537016598|FG002|Overall Study|Miscellaneous|0|||
148874046|NCT04816721|537016599|FG003|Overall Study|Miscellaneous|0|||
148874047|NCT04816721|537016600|FG004|Overall Study|Miscellaneous|0|||
148874048|NCT04816721|537016601|FG005|Overall Study|Miscellaneous|1|||
148874049|NCT04816721|537016602|FG006|Overall Study|Miscellaneous|0|||
148874050|NCT04816721|537016603|FG007|Overall Study|Miscellaneous|0|||
148874051|NCT04816721|537016596|FG000|Overall Study|Lost to Follow-up|0|||
148874052|NCT04816721|537016597|FG001|Overall Study|Lost to Follow-up|0|||
148874053|NCT04816721|537016598|FG002|Overall Study|Lost to Follow-up|0|||
148874054|NCT04816721|537016599|FG003|Overall Study|Lost to Follow-up|1|||
148874055|NCT04816721|537016600|FG004|Overall Study|Lost to Follow-up|0|||
148874056|NCT04816721|537016601|FG005|Overall Study|Lost to Follow-up|0|||
148874057|NCT04816721|537016602|FG006|Overall Study|Lost to Follow-up|0|||
148874058|NCT04816721|537016603|FG007|Overall Study|Lost to Follow-up|0|||
148874059|NCT01286740|537016618|FG000|Overall Study|Enrolled but not treated|1|||
148874060|NCT01286740|537016618|FG000|Overall Study|Protocol Violation|1|||
148874061|NCT02678923|537016619|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
148874062|NCT02678923|537016620|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
148874063|NCT02678923|537016619|FG000|Overall Study|Withdrawal by Subject|3|||
148874064|NCT02678923|537016620|FG001|Overall Study|Withdrawal by Subject|2|||
148874065|NCT02678923|537016619|FG000|Overall Study|Lost to Follow-up|1|||
148874066|NCT02678923|537016620|FG001|Overall Study|Lost to Follow-up|0|||
148874067|NCT02678923|537016619|FG000|Overall Study|Did Not Return for Study Visits|1|||
148874068|NCT02678923|537016620|FG001|Overall Study|Did Not Return for Study Visits|0|||
148874069|NCT00455143|537016621|FG000|Overall Study|Physician Decision|1|||
148874070|NCT00455143|537016621|FG000|Overall Study|Withdrawal by Subject|1|||
148874071|NCT00455143|537016621|FG000|Overall Study|Staff was not avail to follow patient|2|||
148874072|NCT00455143|537016621|FG000|Overall Study|No longer met Inclusion Criteria|1|||
148874073|NCT00455143|537016621|FG000|Overall Study|Surgical time, staff not available|1|||
148874074|NCT03266172|537016622|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
148874075|NCT03266172|537016623|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
148874076|NCT03266172|537016624|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
148874077|NCT03266172|537016622|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
148874078|NCT03266172|537016623|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
148874079|NCT03266172|537016624|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
148874080|NCT03266172|537016622|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
148874081|NCT03266172|537016623|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
148874082|NCT03266172|537016624|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
148874083|NCT03266172|537016622|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
148874084|NCT03266172|537016623|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
148874085|NCT03266172|537016624|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
148874086|NCT03266172|537016622|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
148874087|NCT03266172|537016623|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
148874088|NCT03266172|537016624|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
148874089|NCT03266172|537016622|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
148874090|NCT03266172|537016623|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
148874091|NCT03266172|537016624|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
148874092|NCT04856904|537016627|FG000|Overall Study|Physician Decision|1|||
148874093|NCT04856904|537016628|FG001|Overall Study|Physician Decision|1|||
148874094|NCT04856904|537016627|FG000|Overall Study|Withdrawal by Subject|13|||
148874095|NCT04856904|537016628|FG001|Overall Study|Withdrawal by Subject|13|||
148874096|NCT04856904|537016627|FG000|Overall Study|Adverse Event|1|||
148874097|NCT04856904|537016628|FG001|Overall Study|Adverse Event|1|||
148874098|NCT04856904|537016627|FG000|Overall Study|Non-compliance with study drug|1|||
148874099|NCT04856904|537016628|FG001|Overall Study|Non-compliance with study drug|1|||
148874100|NCT04856904|537016627|FG000|Overall Study|Lost to Follow-up|4|||
148874101|NCT04856904|537016628|FG001|Overall Study|Lost to Follow-up|4|||
148874102|NCT04856904|537016627|FG000|Overall Study|Withdrawal by Subject|1|||
148874103|NCT04856904|537016628|FG001|Overall Study|Withdrawal by Subject|1|||
148874104|NCT04856904|537016627|FG000|Overall Study|Protocol Violation|1|||
148874105|NCT04856904|537016628|FG001|Overall Study|Protocol Violation|1|||
148874106|NCT00847015|537016629|FG000|Overall Study|Withdrawal by Subject|1|||
148874107|NCT00847015|537016629|FG000|Overall Study|declined any surgery|1|||
148874108|NCT00847015|537016629|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
148874109|NCT00902174|537016630|FG000|Overall Study|Adverse Event|27|||
148874110|NCT00902174|537016631|FG001|Overall Study|Adverse Event|7|||
148874111|NCT00902174|537016630|FG000|Overall Study|Lack of Efficacy|1|||
148874112|NCT00902174|537016631|FG001|Overall Study|Lack of Efficacy|5|||
148874113|NCT00902174|537016630|FG000|Overall Study|Death|2|||
148874114|NCT00902174|537016631|FG001|Overall Study|Death|2|||
148874115|NCT00902174|537016630|FG000|Overall Study|Withdrawal by Subject|2|||
148874116|NCT00902174|537016631|FG001|Overall Study|Withdrawal by Subject|1|||
148874117|NCT00902174|537016630|FG000|Overall Study|Abnormal labs|1|||
148874118|NCT00902174|537016631|FG001|Overall Study|Abnormal labs|1|||
148874119|NCT00902174|537016630|FG000|Overall Study|Protocol Violation|1|||
148874120|NCT00902174|537016631|FG001|Overall Study|Protocol Violation|1|||
148874121|NCT00902174|537016630|FG000|Overall Study|Administration problem|0|||
148874122|NCT00902174|537016631|FG001|Overall Study|Administration problem|1|||
148874123|NCT00454584|537016632|FG000|Controlled Period|Adverse Event|5|||
148874124|NCT00454584|537016633|FG001|Controlled Period|Adverse Event|2|||
148874125|NCT00454584|537016634|FG002|Controlled Period|Adverse Event|1|||
148874126|NCT00454584|537016635|FG003|Controlled Period|Adverse Event|0|||
148874127|NCT00454584|537016636|FG004|Controlled Period|Adverse Event|0|||
148874128|NCT00454584|537016637|FG005|Controlled Period|Adverse Event|0|||
148874129|NCT00454584|537016632|FG000|Controlled Period|Lost to Follow-up|1|||
148874130|NCT00454584|537016633|FG001|Controlled Period|Lost to Follow-up|2|||
149033594|NCT00509769|537600412|FG000|Overall Study|Patient's decision|1|||
149033595|NCT00509769|537600412|FG000|Overall Study|Physician Decision|8|||
149033596|NCT00509769|537600412|FG000|Overall Study|Use of prohibited therapies during study|1|||
149033597|NCT01194258|537600414|FG000|Titration Period|Withdrawal by Subject|6|||
149033598|NCT01194258|537600415|FG001|Titration Period|Withdrawal by Subject|0|||
149033599|NCT01194258|537600416|FG002|Titration Period|Withdrawal by Subject|0|||
148874131|NCT00454584|537016634|FG002|Controlled Period|Lost to Follow-up|2|||
148874132|NCT00454584|537016635|FG003|Controlled Period|Lost to Follow-up|0|||
148874133|NCT00454584|537016636|FG004|Controlled Period|Lost to Follow-up|0|||
148874134|NCT00454584|537016637|FG005|Controlled Period|Lost to Follow-up|0|||
148874135|NCT00454584|537016632|FG000|Controlled Period|Other|5|||
148874136|NCT00454584|537016633|FG001|Controlled Period|Other|4|||
148874137|NCT00454584|537016634|FG002|Controlled Period|Other|2|||
148874138|NCT00454584|537016635|FG003|Controlled Period|Other|0|||
148874139|NCT00454584|537016636|FG004|Controlled Period|Other|0|||
148874140|NCT00454584|537016637|FG005|Controlled Period|Other|0|||
148874141|NCT00454584|537016632|FG000|After Controlled Period|Adverse Event|0|||
148874142|NCT00454584|537016633|FG001|After Controlled Period|Adverse Event|0|||
148874143|NCT00454584|537016634|FG002|After Controlled Period|Adverse Event|0|||
148874144|NCT00454584|537016635|FG003|After Controlled Period|Adverse Event|9|||
148874145|NCT00454584|537016636|FG004|After Controlled Period|Adverse Event|3|||
148874146|NCT00454584|537016637|FG005|After Controlled Period|Adverse Event|9|||
148874147|NCT00454584|537016632|FG000|After Controlled Period|Lack of Efficacy|0|||
148874148|NCT00454584|537016633|FG001|After Controlled Period|Lack of Efficacy|0|||
148874149|NCT00454584|537016634|FG002|After Controlled Period|Lack of Efficacy|0|||
148874150|NCT00454584|537016635|FG003|After Controlled Period|Lack of Efficacy|1|||
148874151|NCT00454584|537016636|FG004|After Controlled Period|Lack of Efficacy|0|||
148874152|NCT00454584|537016637|FG005|After Controlled Period|Lack of Efficacy|0|||
148874153|NCT00454584|537016632|FG000|After Controlled Period|Lost to Follow-up|0|||
148874154|NCT00454584|537016633|FG001|After Controlled Period|Lost to Follow-up|0|||
148874155|NCT00454584|537016634|FG002|After Controlled Period|Lost to Follow-up|0|||
148874156|NCT00454584|537016635|FG003|After Controlled Period|Lost to Follow-up|2|||
148874157|NCT00454584|537016636|FG004|After Controlled Period|Lost to Follow-up|4|||
148874158|NCT00454584|537016637|FG005|After Controlled Period|Lost to Follow-up|6|||
148874159|NCT00454584|537016632|FG000|After Controlled Period|Other|0|||
148874160|NCT00454584|537016633|FG001|After Controlled Period|Other|0|||
148874161|NCT00454584|537016634|FG002|After Controlled Period|Other|0|||
148874162|NCT00454584|537016635|FG003|After Controlled Period|Other|1|||
148874163|NCT00454584|537016636|FG004|After Controlled Period|Other|0|||
148874164|NCT00454584|537016637|FG005|After Controlled Period|Other|0|||
148874165|NCT00454584|537016632|FG000|After Controlled Period|Other|0|||
148874166|NCT00454584|537016633|FG001|After Controlled Period|Other|0|||
148874167|NCT00454584|537016634|FG002|After Controlled Period|Other|0|||
148874168|NCT00454584|537016635|FG003|After Controlled Period|Other|13|||
148874169|NCT00454584|537016636|FG004|After Controlled Period|Other|5|||
148874170|NCT00454584|537016637|FG005|After Controlled Period|Other|17|||
148874171|NCT02760810|537016638|FG000|Overall Study|Protocol Violation|1|||
148874172|NCT02421601|537016639|FG000|Overall Study|Adverse Event|4|||
148874173|NCT02421601|537016639|FG000|Overall Study|Lack of Efficacy|5|||
148874174|NCT02421601|537016639|FG000|Overall Study|Physician Decision|1|||
148874175|NCT02421601|537016639|FG000|Overall Study|Withdrawal by Subject|31|||
148874176|NCT02421601|537016639|FG000|Overall Study|Others|41|||
148874177|NCT01716104|537016640|FG000|Overall Study|Do not meet inclusion criteria|6|||
148874178|NCT01716104|537016641|FG001|Overall Study|Do not meet inclusion criteria|7|||
148874179|NCT02895945|537016642|FG000|Overall Study|Physician Decision|2|||
148874180|NCT02895945|537016643|FG001|Overall Study|Physician Decision|1|||
148874181|NCT03429543|537016648|FG000|Overall Study|Adverse Event|1|||
148874182|NCT03429543|537016649|FG001|Overall Study|Adverse Event|1|||
148874183|NCT03429543|537016650|FG002|Overall Study|Adverse Event|0|||
148874184|NCT03429543|537016651|FG003|Overall Study|Adverse Event|0|||
148874185|NCT03429543|537016652|FG004|Overall Study|Adverse Event|0|||
148874186|NCT03429543|537016653|FG005|Overall Study|Adverse Event|2|||
148874187|NCT03429543|537016654|FG006|Overall Study|Adverse Event|0|||
148874188|NCT03429543|537016648|FG000|Overall Study|Lost to Follow-up|1|||
148874189|NCT03429543|537016649|FG001|Overall Study|Lost to Follow-up|0|||
148874190|NCT03429543|537016650|FG002|Overall Study|Lost to Follow-up|0|||
148874191|NCT03429543|537016651|FG003|Overall Study|Lost to Follow-up|0|||
148874192|NCT03429543|537016652|FG004|Overall Study|Lost to Follow-up|1|||
148874193|NCT03429543|537016653|FG005|Overall Study|Lost to Follow-up|0|||
148874194|NCT03429543|537016654|FG006|Overall Study|Lost to Follow-up|0|||
148874195|NCT03429543|537016648|FG000|Overall Study|Withdrawal by Subject|5|||
148874196|NCT03429543|537016649|FG001|Overall Study|Withdrawal by Subject|0|||
148874197|NCT03429543|537016650|FG002|Overall Study|Withdrawal by Subject|1|||
148874198|NCT03429543|537016651|FG003|Overall Study|Withdrawal by Subject|2|||
148874199|NCT03429543|537016652|FG004|Overall Study|Withdrawal by Subject|6|||
148874200|NCT03429543|537016653|FG005|Overall Study|Withdrawal by Subject|3|||
148874201|NCT03429543|537016654|FG006|Overall Study|Withdrawal by Subject|1|||
148874202|NCT03429543|537016648|FG000|Overall Study|Other reason than listed|0|||
148874203|NCT03429543|537016649|FG001|Overall Study|Other reason than listed|1|||
148874204|NCT03429543|537016650|FG002|Overall Study|Other reason than listed|0|||
148874205|NCT03429543|537016651|FG003|Overall Study|Other reason than listed|0|||
148874206|NCT03429543|537016652|FG004|Overall Study|Other reason than listed|4|||
148874207|NCT03429543|537016653|FG005|Overall Study|Other reason than listed|4|||
148874208|NCT03429543|537016654|FG006|Overall Study|Other reason than listed|0|||
148874209|NCT03429543|537016648|FG000|Overall Study|Not treated|0|||
148874210|NCT03429543|537016649|FG001|Overall Study|Not treated|0|||
148874211|NCT03429543|537016650|FG002|Overall Study|Not treated|0|||
148874212|NCT03429543|537016651|FG003|Overall Study|Not treated|0|||
148874213|NCT03429543|537016652|FG004|Overall Study|Not treated|1|||
148874214|NCT03429543|537016653|FG005|Overall Study|Not treated|0|||
148874215|NCT03429543|537016654|FG006|Overall Study|Not treated|0|||
148874216|NCT01818492|537016655|FG000|Overall Study|Adverse Event|2|||
148874217|NCT01818492|537016655|FG000|Overall Study|Death|3|||
148874218|NCT01818492|537016655|FG000|Overall Study|Withdrawal by Subject|1|||
148874219|NCT01818492|537016655|FG000|Overall Study|Additional therapy when not allowed PP|4|||
148874220|NCT02345330|537016658|FG000|Overall Study|Death|1|||
148874221|NCT02345330|537016658|FG000|Overall Study|Progressive Disease|2|||
148874222|NCT00454181|537016660|FG000|Overall Study|Adverse Event|1|||
148874223|NCT00454181|537016661|FG001|Overall Study|Adverse Event|1|||
148874224|NCT00454181|537016660|FG000|Overall Study|Lost to Follow-up|11|||
148874225|NCT00454181|537016661|FG001|Overall Study|Lost to Follow-up|1|||
148874226|NCT00454181|537016660|FG000|Overall Study|Protocol Violation|1|||
148874227|NCT00454181|537016661|FG001|Overall Study|Protocol Violation|1|||
148874228|NCT00454181|537016660|FG000|Overall Study|Withdrawal by Subject|2|||
148874229|NCT00454181|537016661|FG001|Overall Study|Withdrawal by Subject|0|||
148874230|NCT02976103|537016665|FG000|Overall Study|Withdrawal by Subject|1|||
148874231|NCT02976103|537016666|FG001|Overall Study|Withdrawal by Subject|0|||
148874232|NCT02976103|537016665|FG000|Overall Study|Lost to Follow-up|12|||
148874233|NCT02976103|537016666|FG001|Overall Study|Lost to Follow-up|8|||
148874234|NCT00079677|537016667|FG000|Overall Study|Adverse Event|5|||
148874235|NCT00079677|537016668|FG001|Overall Study|Adverse Event|6|||
148874236|NCT00079677|537016667|FG000|Overall Study|Lack of Efficacy|1|||
148874237|NCT00079677|537016668|FG001|Overall Study|Lack of Efficacy|0|||
148874238|NCT00079677|537016667|FG000|Overall Study|Lost to Follow-up|2|||
148874239|NCT00079677|537016668|FG001|Overall Study|Lost to Follow-up|2|||
148874240|NCT00079677|537016667|FG000|Overall Study|Physician Decision|3|||
148874241|NCT00079677|537016668|FG001|Overall Study|Physician Decision|0|||
148874242|NCT00079677|537016667|FG000|Overall Study|Protocol Violation|2|||
148874243|NCT00079677|537016668|FG001|Overall Study|Protocol Violation|3|||
148874244|NCT00079677|537016667|FG000|Overall Study|Withdrawal by Subject|5|||
148874245|NCT00079677|537016668|FG001|Overall Study|Withdrawal by Subject|3|||
148874246|NCT00079677|537016667|FG000|Overall Study|Miscellaneous|2|||
148874247|NCT00079677|537016668|FG001|Overall Study|Miscellaneous|0|||
148874248|NCT03908970|537016669|FG000|Overall Study|Adverse Event|7|||
148874249|NCT03908970|537016670|FG001|Overall Study|Adverse Event|21|||
148874250|NCT03908970|537016669|FG000|Overall Study|Physician Decision|1|||
148874251|NCT03908970|537016670|FG001|Overall Study|Physician Decision|4|||
148874252|NCT03908970|537016669|FG000|Overall Study|Withdrawal by Subject|9|||
148874253|NCT03908970|537016670|FG001|Overall Study|Withdrawal by Subject|22|||
148874254|NCT00428844|537016671|FG000|Completed Study Drug Treatment|Adverse Event|2|||
148874255|NCT00428844|537016672|FG001|Completed Study Drug Treatment|Adverse Event|4|||
148874256|NCT00428844|537016673|FG002|Completed Study Drug Treatment|Adverse Event|4|||
148874257|NCT00428844|537016671|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
148874258|NCT00428844|537016672|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
148874259|NCT00428844|537016673|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
148874260|NCT00428844|537016671|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
148874261|NCT00428844|537016672|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
148874262|NCT00428844|537016673|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
148874263|NCT00428844|537016671|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
148874264|NCT00428844|537016672|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
148874265|NCT00428844|537016673|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
148874266|NCT00428844|537016671|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
148874267|NCT00428844|537016672|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
148874268|NCT00428844|537016673|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
148874269|NCT00428844|537016671|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
148874270|NCT00428844|537016672|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
148874271|NCT00428844|537016673|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
148874272|NCT00428844|537016671|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
148874273|NCT00428844|537016672|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
148874274|NCT00428844|537016673|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
148874275|NCT00428844|537016671|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
148874276|NCT00428844|537016672|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
148874277|NCT00428844|537016673|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
148874278|NCT00428844|537016671|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
148874279|NCT00428844|537016672|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
148874280|NCT00428844|537016673|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
148874281|NCT00488826|537016676|FG000|Overall Study|Withdrawal by Subject|40|||
148874282|NCT00488826|537016677|FG001|Overall Study|Withdrawal by Subject|35|||
148874283|NCT00488826|537016678|FG002|Overall Study|Withdrawal by Subject|19|||
148874284|NCT00488826|537016676|FG000|Overall Study|Protocol Violation|0|||
148874285|NCT00488826|537016677|FG001|Overall Study|Protocol Violation|0|||
148874286|NCT00488826|537016678|FG002|Overall Study|Protocol Violation|2|||
148874287|NCT00488826|537016676|FG000|Overall Study|Adverse Event|9|||
148874288|NCT00488826|537016677|FG001|Overall Study|Adverse Event|15|||
148874289|NCT00488826|537016678|FG002|Overall Study|Adverse Event|4|||
148874290|NCT00488826|537016676|FG000|Overall Study|Lost to Follow-up|5|||
148874291|NCT00488826|537016677|FG001|Overall Study|Lost to Follow-up|1|||
148874292|NCT00488826|537016678|FG002|Overall Study|Lost to Follow-up|0|||
148874293|NCT00488826|537016676|FG000|Overall Study|Protocol Deviations|2|||
148874294|NCT00488826|537016677|FG001|Overall Study|Protocol Deviations|1|||
148874295|NCT00488826|537016678|FG002|Overall Study|Protocol Deviations|1|||
148874296|NCT04667104|537016685|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
148874297|NCT04667104|537016686|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
148874298|NCT04667104|537016687|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
148874299|NCT03208088|537016689|FG000|Period 2|Withdrawal by Subject|0|||
148874300|NCT03208088|537016690|FG001|Period 2|Withdrawal by Subject|0|||
148874301|NCT03208088|537016691|FG002|Period 2|Withdrawal by Subject|0|||
148874302|NCT03208088|537016692|FG003|Period 2|Withdrawal by Subject|0|||
148874303|NCT03208088|537016693|FG004|Period 2|Withdrawal by Subject|0|||
148874304|NCT03208088|537016694|FG005|Period 2|Withdrawal by Subject|0|||
148874305|NCT03208088|537016695|FG006|Period 2|Withdrawal by Subject|0|||
148874306|NCT03208088|537016696|FG007|Period 2|Withdrawal by Subject|0|||
148874307|NCT03208088|537016697|FG008|Period 2|Withdrawal by Subject|1|||
148874308|NCT03208088|537016698|FG009|Period 2|Withdrawal by Subject|0|||
148874309|NCT03208088|537016689|FG000|Period 3|Unsatisfactory Test Article|0|||
148874310|NCT03208088|537016690|FG001|Period 3|Unsatisfactory Test Article|0|||
148874311|NCT03208088|537016691|FG002|Period 3|Unsatisfactory Test Article|0|||
148874312|NCT03208088|537016692|FG003|Period 3|Unsatisfactory Test Article|1|||
148874313|NCT03208088|537016693|FG004|Period 3|Unsatisfactory Test Article|0|||
148874314|NCT03208088|537016694|FG005|Period 3|Unsatisfactory Test Article|0|||
148874315|NCT03208088|537016695|FG006|Period 3|Unsatisfactory Test Article|0|||
148874316|NCT03208088|537016696|FG007|Period 3|Unsatisfactory Test Article|0|||
148874317|NCT03208088|537016697|FG008|Period 3|Unsatisfactory Test Article|0|||
148874318|NCT03208088|537016698|FG009|Period 3|Unsatisfactory Test Article|0|||
148874319|NCT03208088|537016689|FG000|Period 4|Unsatisfactory Test Article|0|||
148874320|NCT03208088|537016690|FG001|Period 4|Unsatisfactory Test Article|0|||
148874321|NCT03208088|537016691|FG002|Period 4|Unsatisfactory Test Article|0|||
148874322|NCT03208088|537016692|FG003|Period 4|Unsatisfactory Test Article|1|||
148874323|NCT03208088|537016693|FG004|Period 4|Unsatisfactory Test Article|0|||
148874324|NCT03208088|537016694|FG005|Period 4|Unsatisfactory Test Article|0|||
148874325|NCT03208088|537016695|FG006|Period 4|Unsatisfactory Test Article|0|||
148874326|NCT03208088|537016696|FG007|Period 4|Unsatisfactory Test Article|0|||
148874327|NCT03208088|537016697|FG008|Period 4|Unsatisfactory Test Article|0|||
148874328|NCT03208088|537016698|FG009|Period 4|Unsatisfactory Test Article|0|||
148874329|NCT00605345|537016699|FG000|Overall Study|Withdrawal by Subject|1|||
148874330|NCT00605345|537016700|FG001|Overall Study|Withdrawal by Subject|0|||
148874331|NCT00605345|537016699|FG000|Overall Study|Adverse Event|0|||
148874332|NCT00605345|537016700|FG001|Overall Study|Adverse Event|1|||
148874333|NCT00605345|537016699|FG000|Overall Study|Protocol Violation|0|||
148874334|NCT00605345|537016700|FG001|Overall Study|Protocol Violation|2|||
148874335|NCT02126839|537016701|FG000|Overall Study|Adverse Event|0|||
148874336|NCT02126839|537016702|FG001|Overall Study|Adverse Event|1|||
148874337|NCT02126839|537016701|FG000|Overall Study|Withdrawal by Subject|1|||
148874338|NCT02126839|537016702|FG001|Overall Study|Withdrawal by Subject|0|||
148874339|NCT02126839|537016701|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148874340|NCT02126839|537016702|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148874341|NCT02126839|537016701|FG000|Overall Study|Protocol Violation|2|||
148874342|NCT02126839|537016702|FG001|Overall Study|Protocol Violation|3|||
148874343|NCT02126839|537016701|FG000|Overall Study|Sponsor request|0|||
148874344|NCT02126839|537016702|FG001|Overall Study|Sponsor request|1|||
148874345|NCT02126839|537016701|FG000|Overall Study|Lost to Follow-up|1|||
148874346|NCT02126839|537016702|FG001|Overall Study|Lost to Follow-up|4|||
148874347|NCT02126839|537016701|FG000|Overall Study|Other|5|||
148874348|NCT02126839|537016702|FG001|Overall Study|Other|5|||
148874349|NCT00422383|537016703|FG000|Overall Study|Adverse Event|5|||
148874350|NCT00422383|537016704|FG001|Overall Study|Adverse Event|3|||
148874351|NCT00422383|537016705|FG002|Overall Study|Adverse Event|1|||
148874352|NCT00422383|537016706|FG003|Overall Study|Adverse Event|1|||
148874353|NCT00422383|537016707|FG004|Overall Study|Adverse Event|0|||
148874354|NCT00422383|537016703|FG000|Overall Study|Lack of Efficacy|4|||
148874355|NCT00422383|537016704|FG001|Overall Study|Lack of Efficacy|4|||
148874356|NCT00422383|537016705|FG002|Overall Study|Lack of Efficacy|2|||
148874357|NCT00422383|537016706|FG003|Overall Study|Lack of Efficacy|1|||
148874358|NCT00422383|537016707|FG004|Overall Study|Lack of Efficacy|1|||
148874359|NCT00422383|537016703|FG000|Overall Study|Lost to Follow-up|0|||
148874360|NCT00422383|537016704|FG001|Overall Study|Lost to Follow-up|1|||
148874361|NCT00422383|537016705|FG002|Overall Study|Lost to Follow-up|0|||
148874362|NCT00422383|537016706|FG003|Overall Study|Lost to Follow-up|0|||
148874363|NCT00422383|537016707|FG004|Overall Study|Lost to Follow-up|1|||
148874364|NCT00422383|537016703|FG000|Overall Study|Protocol Violation|1|||
148874365|NCT00422383|537016704|FG001|Overall Study|Protocol Violation|1|||
148874366|NCT00422383|537016705|FG002|Overall Study|Protocol Violation|1|||
148874367|NCT00422383|537016706|FG003|Overall Study|Protocol Violation|0|||
148874368|NCT00422383|537016707|FG004|Overall Study|Protocol Violation|0|||
148874369|NCT00422383|537016703|FG000|Overall Study|Withdrawal by Subject|5|||
148874370|NCT00422383|537016704|FG001|Overall Study|Withdrawal by Subject|5|||
148874371|NCT00422383|537016705|FG002|Overall Study|Withdrawal by Subject|0|||
148874372|NCT00422383|537016706|FG003|Overall Study|Withdrawal by Subject|0|||
148874373|NCT00422383|537016707|FG004|Overall Study|Withdrawal by Subject|1|||
148874374|NCT00411632|537016708|FG000|Overall Study|Death|1|||
148874375|NCT01108523|537016709|FG000|Overall Study|Protocol Violation|4|||
148874376|NCT00761527|537016712|FG000|Overall Study|Adverse Event|3|||
148874377|NCT00761527|537016712|FG000|Overall Study|Poor Compliance|8|||
148874378|NCT00761527|537016712|FG000|Overall Study|Lost to Follow-up|9|||
148874379|NCT00761527|537016712|FG000|Overall Study|Unknown reason|2|||
148874380|NCT00742417|537018320|FG000|Randomized|Withdrawal by legal representative|0|||
148874381|NCT00742417|537018321|FG001|Randomized|Withdrawal by legal representative|1|||
148874382|NCT00742417|537018320|FG000|Randomized|Withdrawal by Subject|1|||
148874383|NCT00742417|537018321|FG001|Randomized|Withdrawal by Subject|0|||
148874384|NCT00742417|537018320|FG000|Randomized|Physician Decision|1|||
148874385|NCT00742417|537018321|FG001|Randomized|Physician Decision|0|||
148874386|NCT00742417|537018320|FG000|Intensive Period|Withdrawal by Subject|1|||
148874387|NCT00742417|537018321|FG001|Intensive Period|Withdrawal by Subject|1|||
148874388|NCT00742417|537018320|FG000|Intensive Period|Adverse Event|2|||
148874389|NCT00742417|537018321|FG001|Intensive Period|Adverse Event|0|||
148874390|NCT00965575|537018324|FG000|Overall Study|subject unwillingness to swallow study c|1|||
148874391|NCT00965575|537018325|FG001|Overall Study|subject unwillingness to swallow study c|0|||
148874392|NCT03775512|537018328|FG000|Overall Study|Death|1|||
148874393|NCT03775512|537018329|FG001|Overall Study|Death|1|||
148874394|NCT03775512|537018328|FG000|Overall Study|Withdrawal by Subject|7|||
148874395|NCT03775512|537018329|FG001|Overall Study|Withdrawal by Subject|4|||
148874396|NCT03775512|537018328|FG000|Overall Study|Lost to Follow-up|5|||
148874397|NCT03775512|537018329|FG001|Overall Study|Lost to Follow-up|5|||
148874398|NCT03775512|537018328|FG000|Overall Study|Excluded before Catheter insertion|14|||
148874399|NCT03775512|537018329|FG001|Overall Study|Excluded before Catheter insertion|5|||
148874400|NCT03775512|537018328|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
148874401|NCT03775512|537018329|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
148874402|NCT03775512|537018328|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
148874403|NCT03775512|537018329|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
148874404|NCT02629822|537018330|FG000|Base Study|Lost to Follow-up|2|||
148874405|NCT02629822|537018330|FG000|Base Study|Non-Compliance With Study Drug|1|||
148874406|NCT02629822|537018330|FG000|Extension Study|Adverse Event|1|||
148874407|NCT02629822|537018330|FG000|Extension Study|Lost to Follow-up|1|||
148874408|NCT01912339|537018331|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
148874409|NCT01912339|537018332|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
148874410|NCT01912339|537018333|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
148874411|NCT01912339|537018331|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
148874412|NCT01912339|537018332|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
148874413|NCT01912339|537018333|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
148874414|NCT01912339|537018331|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
148874415|NCT01912339|537018332|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
148874416|NCT01912339|537018333|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
148874417|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
148874418|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
148874419|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
148874420|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
148874421|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
148874422|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
148874423|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
148874424|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
148874425|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
148874426|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
148874427|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
148874428|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
148874429|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
148874430|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
148874431|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
148874432|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
148874433|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
148874434|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
148874435|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
148874436|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
148874437|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
148874438|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
148874439|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
149000904|NCT01525602|537479433|FG003|Overall Study|Adverse Event|1|||
149000905|NCT01525602|537479434|FG004|Overall Study|Adverse Event|3|||
149000906|NCT01525602|537479435|FG005|Overall Study|Adverse Event|3|||
149000907|NCT01525602|537479436|FG006|Overall Study|Adverse Event|0|||
149000908|NCT01525602|537479437|FG007|Overall Study|Adverse Event|1|||
149000909|NCT01525602|537479430|FG000|Overall Study|Disease progression|6|||
149000910|NCT01525602|537479431|FG001|Overall Study|Disease progression|3|||
149000911|NCT01525602|537479432|FG002|Overall Study|Disease progression|2|||
149000912|NCT01525602|537479433|FG003|Overall Study|Disease progression|5|||
149000913|NCT01525602|537479434|FG004|Overall Study|Disease progression|22|||
149000914|NCT01525602|537479435|FG005|Overall Study|Disease progression|2|||
148874440|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
148874441|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
149033600|NCT01194258|537600417|FG003|Titration Period|Withdrawal by Subject|0|||
149033601|NCT01194258|537600418|FG004|Titration Period|Withdrawal by Subject|0|||
149033602|NCT01194258|537600414|FG000|Titration Period|Lost to Follow-up|2|||
149033603|NCT01194258|537600415|FG001|Titration Period|Lost to Follow-up|0|||
149033604|NCT01194258|537600416|FG002|Titration Period|Lost to Follow-up|0|||
149033605|NCT01194258|537600417|FG003|Titration Period|Lost to Follow-up|0|||
149033606|NCT01194258|537600418|FG004|Titration Period|Lost to Follow-up|0|||
149033607|NCT01194258|537600414|FG000|Titration Period|Titration failure|3|||
149033608|NCT01194258|537600415|FG001|Titration Period|Titration failure|0|||
149033609|NCT01194258|537600416|FG002|Titration Period|Titration failure|0|||
149033610|NCT01194258|537600417|FG003|Titration Period|Titration failure|0|||
149033611|NCT01194258|537600418|FG004|Titration Period|Titration failure|0|||
149033612|NCT01194258|537600414|FG000|Period 1 (12 Weeks)|Death|0|||
149033613|NCT01194258|537600415|FG001|Period 1 (12 Weeks)|Death|0|||
149033614|NCT01194258|537600416|FG002|Period 1 (12 Weeks)|Death|0|||
149033615|NCT01194258|537600417|FG003|Period 1 (12 Weeks)|Death|0|||
149033616|NCT01194258|537600418|FG004|Period 1 (12 Weeks)|Death|1|||
149033617|NCT01194258|537600414|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149033618|NCT01194258|537600415|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149033619|NCT01194258|537600416|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149033620|NCT01194258|537600417|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
149033621|NCT01194258|537600418|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
149033622|NCT01194258|537600414|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
148874442|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
148874443|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
148874444|NCT01912339|537018331|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
148874445|NCT01912339|537018332|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
148874446|NCT01912339|537018333|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
148874447|NCT01754493|537018334|FG000|Overall Study|Adverse Event|1|||
148874448|NCT01754493|537018334|FG000|Overall Study|Lost to Follow-up|3|||
148874449|NCT01754493|537018334|FG000|Overall Study|Withdrawal by Subject|1|||
148874450|NCT01754493|537018334|FG000|Overall Study|Moved out of town|1|||
148874451|NCT01754493|537018334|FG000|Overall Study|Scheduling conflict|1|||
148874452|NCT02489942|537018335|FG000|Overall Study|Request by patient|602|||
148874453|NCT02489942|537018335|FG000|Overall Study|Improvement/remission|157|||
148874454|NCT02489942|537018335|FG000|Overall Study|No change/Progressive disease|263|||
149033623|NCT01194258|537600415|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
149033624|NCT01194258|537600416|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
149033625|NCT01194258|537600417|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
149033626|NCT01194258|537600418|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
149033627|NCT01194258|537600414|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149033628|NCT01194258|537600415|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149033629|NCT01194258|537600416|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
149033630|NCT01194258|537600417|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149033631|NCT01194258|537600418|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
149033632|NCT02873754|537600420|FG000|Overall Study|Lost to Follow-up|5|||
149033633|NCT02873754|537600420|FG000|Overall Study|Couldn't complete study procedures|1|||
149033634|NCT04550039|537600421|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
149033635|NCT04550039|537600422|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
149033636|NCT04550039|537600421|FG000|Overall Study|patient self-withdrew from study|0|||
148874455|NCT02489942|537018335|FG000|Overall Study|Adverse Event|522|||
148874456|NCT02489942|537018335|FG000|Overall Study|Other personal reasons|1218|||
148874457|NCT02489942|537018335|FG000|Overall Study|Lost to Follow-up|456|||
148874458|NCT02489942|537018335|FG000|Overall Study|Not continuously investigated|7|||
148874459|NCT02489942|537018335|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
148874460|NCT02489942|537018335|FG000|Overall Study|Multiple registration|1|||
148874461|NCT02489942|537018335|FG000|Overall Study|No patient visit after entry|100|||
148874462|NCT02489942|537018335|FG000|Overall Study|No treatment with Jardiance|2|||
148874463|NCT02489942|537018335|FG000|Overall Study|Patient received Jardiance before registration|1|||
148874464|NCT02489942|537018335|FG000|Overall Study|No CRF collected|86|||
148874465|NCT00858208|537018336|FG000|Overall Study|Adverse Event|3|||
148874466|NCT00858208|537018336|FG000|Overall Study|Lost to Follow-up|26|||
148874467|NCT00858208|537018336|FG000|Overall Study|Participant refused|40|||
148874468|NCT00858208|537018336|FG000|Overall Study|Other|10|||
148874469|NCT01272635|537018337|FG000|Overall Study|Lost to Follow-up|31|||
149033637|NCT04550039|537600422|FG001|Overall Study|patient self-withdrew from study|1|||
149033638|NCT00881335|537600423|FG000|Overall Study|Lost to Follow-up|3|||
148874470|NCT01272635|537018338|FG001|Overall Study|Lost to Follow-up|20|||
148874471|NCT01272635|537018339|FG002|Overall Study|Lost to Follow-up|31|||
148874472|NCT01272635|537018340|FG003|Overall Study|Lost to Follow-up|23|||
148874473|NCT01543776|537018343|FG000|Overall Study|Withdrawal by Subject|2|||
148874474|NCT01543776|537018344|FG001|Overall Study|Withdrawal by Subject|2|||
148874475|NCT02397057|537018345|FG000|Overall Study|Withdrawal by Subject|6|||
148874476|NCT02397057|537018346|FG001|Overall Study|Withdrawal by Subject|7|||
148874477|NCT02397057|537018345|FG000|Overall Study|Lost to Follow-up|4|||
148874478|NCT02397057|537018346|FG001|Overall Study|Lost to Follow-up|3|||
148874479|NCT02397057|537018345|FG000|Overall Study|Death|1|||
148874480|NCT02397057|537018346|FG001|Overall Study|Death|0|||
148874481|NCT02397057|537018345|FG000|Overall Study|Adverse Event|0|||
148874482|NCT02397057|537018346|FG001|Overall Study|Adverse Event|1|||
148874483|NCT02397057|537018345|FG000|Overall Study|Physician Decision|0|||
148874484|NCT02397057|537018346|FG001|Overall Study|Physician Decision|1|||
148874485|NCT02397057|537018345|FG000|Overall Study|Subject did not receive study drug|0|||
148874486|NCT02397057|537018346|FG001|Overall Study|Subject did not receive study drug|1|||
148874487|NCT00434642|537018347|FG000|Blinded Treatment Phase|Adverse Event|12|||
148874488|NCT00434642|537018348|FG001|Blinded Treatment Phase|Adverse Event|58|||
148874489|NCT00434642|537018347|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
148874490|NCT00434642|537018348|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
148874491|NCT00434642|537018347|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
148874492|NCT00434642|537018348|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
148874493|NCT00434642|537018347|FG000|Blinded Treatment Phase|Physician Decision|19|||
148874494|NCT00434642|537018348|FG001|Blinded Treatment Phase|Physician Decision|27|||
148874495|NCT00434642|537018347|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
148874496|NCT00434642|537018348|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
148874497|NCT00434642|537018347|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
148874498|NCT00434642|537018348|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
148874499|NCT00434642|537018347|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
148874500|NCT00434642|537018348|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
148874501|NCT00434642|537018347|FG000|Open-label Treatment Phase|Adverse Event|0|||
148874502|NCT00434642|537018348|FG001|Open-label Treatment Phase|Adverse Event|5|||
148874503|NCT00434642|537018347|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
148874504|NCT00434642|537018348|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
148874505|NCT05249569|537018351|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
148874506|NCT01452919|537018352|FG000|Open-Label Treatment|Adverse Event|5|||
148874507|NCT01452919|537018353|FG001|Open-Label Treatment|Adverse Event|0|||
148874508|NCT01452919|537018354|FG002|Open-Label Treatment|Adverse Event|0|||
148874509|NCT01452919|537018352|FG000|Open-Label Treatment|Lost to Follow-up|4|||
148874510|NCT01452919|537018353|FG001|Open-Label Treatment|Lost to Follow-up|0|||
148874511|NCT01452919|537018354|FG002|Open-Label Treatment|Lost to Follow-up|0|||
148874512|NCT01452919|537018352|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
148874513|NCT01452919|537018353|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
148874514|NCT01452919|537018354|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
148874515|NCT01452919|537018352|FG000|Open-Label Treatment|Protocol Violation|4|||
148874516|NCT01452919|537018353|FG001|Open-Label Treatment|Protocol Violation|0|||
148874517|NCT01452919|537018354|FG002|Open-Label Treatment|Protocol Violation|0|||
148874518|NCT01452919|537018352|FG000|Open-Label Treatment|Sponsor Decision|1|||
148874519|NCT01452919|537018353|FG001|Open-Label Treatment|Sponsor Decision|0|||
148874520|NCT01452919|537018354|FG002|Open-Label Treatment|Sponsor Decision|0|||
148874521|NCT01452919|537018352|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
148874522|NCT01452919|537018353|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
148874523|NCT01452919|537018354|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
148874524|NCT01452919|537018352|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
148874525|NCT01452919|537018353|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
148874526|NCT01452919|537018354|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
148874527|NCT01452919|537018352|FG000|Randomization Treatment|Adverse Event|0|||
148874528|NCT01452919|537018353|FG001|Randomization Treatment|Adverse Event|0|||
148874529|NCT01452919|537018354|FG002|Randomization Treatment|Adverse Event|2|||
148874530|NCT01452919|537018352|FG000|Randomization Treatment|Sponsor Decision|0|||
148874531|NCT01452919|537018353|FG001|Randomization Treatment|Sponsor Decision|1|||
148874532|NCT01452919|537018354|FG002|Randomization Treatment|Sponsor Decision|0|||
148874533|NCT01452919|537018352|FG000|Randomization Treatment|Withdrawal by Subject|0|||
148874534|NCT01452919|537018353|FG001|Randomization Treatment|Withdrawal by Subject|1|||
148874535|NCT01452919|537018354|FG002|Randomization Treatment|Withdrawal by Subject|0|||
148874536|NCT01452919|537018352|FG000|Randomization Treatment|Subject is moving or has moved|0|||
148874537|NCT01452919|537018353|FG001|Randomization Treatment|Subject is moving or has moved|1|||
148874538|NCT01452919|537018354|FG002|Randomization Treatment|Subject is moving or has moved|0|||
148874539|NCT02421588|537018355|FG000|Overall Study|Non-treatment-related AE|8|||
148874540|NCT02421588|537018356|FG001|Overall Study|Non-treatment-related AE|8|||
148874541|NCT02421588|537018355|FG000|Overall Study|Progressive disease|152|||
148874542|NCT02421588|537018356|FG001|Overall Study|Progressive disease|135|||
148874543|NCT02421588|537018355|FG000|Overall Study|Death|11|||
148874544|NCT02421588|537018356|FG001|Overall Study|Death|3|||
148874545|NCT02421588|537018355|FG000|Overall Study|Physician Decision|8|||
148874546|NCT02421588|537018356|FG001|Overall Study|Physician Decision|17|||
149000915|NCT01525602|537479436|FG006|Overall Study|Disease progression|3|||
148874547|NCT02421588|537018355|FG000|Overall Study|Other reason not specified|3|||
148874548|NCT02421588|537018356|FG001|Overall Study|Other reason not specified|1|||
148874549|NCT02421588|537018355|FG000|Overall Study|Symptomatic deterioration|13|||
148874550|NCT02421588|537018356|FG001|Overall Study|Symptomatic deterioration|19|||
148874551|NCT02421588|537018355|FG000|Overall Study|Treatment-related AE|10|||
148874552|NCT02421588|537018356|FG001|Overall Study|Treatment-related AE|14|||
148874553|NCT02421588|537018355|FG000|Overall Study|Withdrawal by Subject|14|||
148874554|NCT02421588|537018356|FG001|Overall Study|Withdrawal by Subject|16|||
148874555|NCT02421588|537018355|FG000|Overall Study|Not treated|2|||
148874556|NCT02421588|537018356|FG001|Overall Study|Not treated|8|||
148874557|NCT01359943|537018357|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
148874558|NCT01359943|537018358|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
148874559|NCT01359943|537018359|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
148874560|NCT01359943|537018357|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
148874561|NCT01359943|537018358|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
148874562|NCT01359943|537018359|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
148874563|NCT01359943|537018357|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
148874564|NCT01359943|537018358|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
148874565|NCT01359943|537018359|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
148874566|NCT01359943|537018357|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
148874567|NCT01359943|537018358|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
148874568|NCT01359943|537018359|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
148874569|NCT01359943|537018357|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
148874570|NCT01359943|537018358|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
148874571|NCT01359943|537018359|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
148874572|NCT01359943|537018357|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
148874573|NCT01359943|537018358|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
148874574|NCT01359943|537018359|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
148874575|NCT01359943|537018357|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
148874576|NCT01359943|537018358|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
148874577|NCT01359943|537018359|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
148874578|NCT01359943|537018357|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
148874579|NCT01359943|537018358|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
148874580|NCT01359943|537018359|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
148874581|NCT01359943|537018357|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
148874582|NCT01359943|537018358|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
148874583|NCT01359943|537018359|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
148874584|NCT01359943|537018357|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
148874585|NCT01359943|537018358|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
148874586|NCT01359943|537018359|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
148874587|NCT01359943|537018357|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
148874588|NCT01359943|537018358|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
148874589|NCT01359943|537018359|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
148874590|NCT01359943|537018357|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
148874591|NCT01359943|537018358|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
148874592|NCT01359943|537018359|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
148874593|NCT01359943|537018357|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
148874594|NCT01359943|537018358|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
148874595|NCT01359943|537018359|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
148874596|NCT01359943|537018357|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
148874597|NCT01359943|537018358|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
148874598|NCT01359943|537018359|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
148874599|NCT01359943|537018357|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
148874600|NCT01359943|537018358|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
148874601|NCT01359943|537018359|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
148874602|NCT01329939|537018372|FG000|Overall Study|Lost to Follow-up|3|||
148874603|NCT01329939|537018373|FG001|Overall Study|Lost to Follow-up|0|||
148874604|NCT01329939|537018374|FG002|Overall Study|Lost to Follow-up|1|||
148874605|NCT01329939|537018375|FG003|Overall Study|Lost to Follow-up|2|||
148874606|NCT01329939|537018372|FG000|Overall Study|Withdrawal by Subject|0|||
148874607|NCT01329939|537018373|FG001|Overall Study|Withdrawal by Subject|1|||
148874608|NCT01329939|537018374|FG002|Overall Study|Withdrawal by Subject|0|||
148874609|NCT01329939|537018375|FG003|Overall Study|Withdrawal by Subject|0|||
148874610|NCT01329939|537018372|FG000|Overall Study|Adverse Event|0|||
148874611|NCT01329939|537018373|FG001|Overall Study|Adverse Event|0|||
148874612|NCT01329939|537018374|FG002|Overall Study|Adverse Event|0|||
148874613|NCT01329939|537018375|FG003|Overall Study|Adverse Event|3|||
148874626|NCT00719680|537018378|FG000|Overall Study|Adverse Event|1|||
148874627|NCT00719680|537018378|FG000|Overall Study|Lost to Follow-up|1|||
148874628|NCT00719680|537018378|FG000|Overall Study|Withdrawal by Subject|3|||
148874629|NCT04071158|537018379|FG000|Overall Study|Lost to Follow-up|1|||
148874630|NCT04071158|537018380|FG001|Overall Study|Lost to Follow-up|2|||
148874631|NCT04071158|537018381|FG002|Overall Study|Lost to Follow-up|3|||
148874632|NCT04071158|537018382|FG003|Overall Study|Lost to Follow-up|3|||
148874633|NCT04071158|537018383|FG004|Overall Study|Lost to Follow-up|5|||
148874634|NCT04071158|537018379|FG000|Overall Study|Randomized but not treated|2|||
148874635|NCT04071158|537018380|FG001|Overall Study|Randomized but not treated|2|||
148874636|NCT04071158|537018381|FG002|Overall Study|Randomized but not treated|0|||
148874637|NCT04071158|537018382|FG003|Overall Study|Randomized but not treated|0|||
148874638|NCT04071158|537018383|FG004|Overall Study|Randomized but not treated|0|||
148874639|NCT05222555|537018387|FG000|Overall Study|Ongoing|2|||
148874640|NCT05222555|537018388|FG001|Overall Study|Ongoing|18|||
148874641|NCT05222555|537018387|FG000|Overall Study|Adverse Event|1|||
148874642|NCT05222555|537018388|FG001|Overall Study|Adverse Event|1|||
148874643|NCT05222555|537018387|FG000|Overall Study|Death|0|||
148874644|NCT05222555|537018388|FG001|Overall Study|Death|6|||
148874645|NCT05222555|537018387|FG000|Overall Study|Withdrawal by Subject|0|||
148874646|NCT05222555|537018388|FG001|Overall Study|Withdrawal by Subject|11|||
148874647|NCT00300365|537018389|FG000|Overall Study|Lost to Follow-up|1|||
148874648|NCT00300365|537018390|FG001|Overall Study|Lost to Follow-up|0|||
148874649|NCT00300365|537018389|FG000|Overall Study|Physician Decision|2|||
148874650|NCT00300365|537018390|FG001|Overall Study|Physician Decision|0|||
148874651|NCT00300365|537018389|FG000|Overall Study|Withdrawal by Subject|1|||
148874652|NCT00300365|537018390|FG001|Overall Study|Withdrawal by Subject|0|||
148874653|NCT00300365|537018389|FG000|Overall Study|Adverse Event|0|||
148874654|NCT00300365|537018390|FG001|Overall Study|Adverse Event|2|||
148874655|NCT01966445|537018393|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
148874656|NCT01966445|537018394|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
148874657|NCT01966445|537018395|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
148874658|NCT01966445|537018396|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
148874659|NCT01966445|537018397|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
148874660|NCT01966445|537018398|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
148874661|NCT01966445|537018399|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
148874662|NCT01966445|537018393|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
148874663|NCT01966445|537018394|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
148874664|NCT01966445|537018395|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
148874665|NCT01966445|537018396|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
148874666|NCT01966445|537018397|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
148874667|NCT01966445|537018398|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
148874668|NCT01966445|537018399|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
148874669|NCT01966445|537018393|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
148874670|NCT01966445|537018394|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
148874671|NCT01966445|537018395|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
148874672|NCT01966445|537018396|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
148874673|NCT01966445|537018397|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
148874674|NCT01966445|537018398|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
148874675|NCT01966445|537018399|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
148874676|NCT01966445|537018393|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
148874677|NCT01966445|537018394|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
148874678|NCT01966445|537018395|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
148874679|NCT01966445|537018396|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
148874680|NCT01966445|537018397|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
148874681|NCT01966445|537018398|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
148874682|NCT01966445|537018399|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
148874683|NCT01966445|537018393|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
148874684|NCT01966445|537018394|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
148874685|NCT01966445|537018395|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
148874686|NCT01966445|537018396|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
148874687|NCT01966445|537018397|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
148874688|NCT01966445|537018398|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
148874689|NCT01966445|537018399|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
148874690|NCT01374178|537018400|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
148874691|NCT01374178|537018401|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
148874692|NCT01374178|537018400|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
148874693|NCT01374178|537018401|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
148874694|NCT01422824|537018404|FG000|Overall Study|Case record form not evaluated|1|||
148874695|NCT01422824|537018404|FG000|Overall Study|Lost to Follow-up|37|||
148874696|NCT00117793|537018405|FG000|Overall Study|Withdrawal by Subject|12|||
148874697|NCT01753401|537018408|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
148874698|NCT01753401|537018409|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
148874699|NCT01753401|537018410|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
148874700|NCT01753401|537018411|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
148874701|NCT01753401|537018408|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
148874702|NCT01753401|537018409|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
148874703|NCT01753401|537018410|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
148874704|NCT01753401|537018411|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
148874705|NCT01753401|537018408|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
148874706|NCT01753401|537018409|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
148874707|NCT01753401|537018410|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
148874708|NCT01753401|537018411|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
148874709|NCT01753401|537018408|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
148874710|NCT01753401|537018409|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
148874711|NCT01753401|537018410|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
148874712|NCT01753401|537018411|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
148874713|NCT01753401|537018408|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
148874714|NCT01753401|537018409|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
148874715|NCT01753401|537018410|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
148874716|NCT01753401|537018411|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
148874717|NCT01753401|537018408|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
148874718|NCT01753401|537018409|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
148874719|NCT01753401|537018410|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
148874720|NCT01753401|537018411|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
148874721|NCT01753401|537018408|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
148874722|NCT01753401|537018409|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
148874723|NCT01753401|537018410|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
148874724|NCT01753401|537018411|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
148874725|NCT00470418|537018412|FG000|Overall Study|Withdrawal by Subject|1|||
148874726|NCT00470418|537018413|FG001|Overall Study|Withdrawal by Subject|0|||
148874727|NCT00599638|537018414|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
148874728|NCT00599638|537018415|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
148874729|NCT00599638|537018416|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
148874730|NCT00599638|537018417|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
148874731|NCT00599638|537018414|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
148874732|NCT00599638|537018415|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
148874733|NCT00599638|537018416|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
148874734|NCT00599638|537018417|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
148874735|NCT00599638|537018414|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
148874736|NCT00599638|537018415|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
148874737|NCT00599638|537018416|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
148874738|NCT00599638|537018417|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
148874739|NCT00599638|537018414|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
148874740|NCT00599638|537018415|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
148874741|NCT00599638|537018416|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
148874742|NCT00599638|537018417|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
148874743|NCT00599638|537018414|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
148874744|NCT00599638|537018415|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
148874745|NCT00599638|537018416|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
148874746|NCT00599638|537018417|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
148874747|NCT00599638|537018414|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
148874748|NCT00599638|537018415|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
148874749|NCT00599638|537018416|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
148874750|NCT00599638|537018417|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
148874751|NCT00599638|537018414|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
148874752|NCT00599638|537018415|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
148874753|NCT00599638|537018416|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
148874754|NCT00599638|537018417|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
148874755|NCT00599638|537018414|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
149000916|NCT01525602|537479437|FG007|Overall Study|Disease progression|3|||
149000917|NCT01525602|537479430|FG000|Overall Study|Clinical progression|2|||
148874756|NCT00599638|537018415|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
148874757|NCT00599638|537018416|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
148874758|NCT00599638|537018417|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
148874759|NCT00599638|537018414|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
148874760|NCT00599638|537018415|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
148874761|NCT00599638|537018416|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
148874762|NCT00599638|537018417|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
148874763|NCT03006887|537018421|FG000|Overall Study|Adverse Event|1|||
148874764|NCT00462748|537018422|FG000|Overall Study|Adverse Event|7|||
148874765|NCT00462748|537018423|FG001|Overall Study|Adverse Event|5|||
148874766|NCT00462748|537018424|FG002|Overall Study|Adverse Event|9|||
148874767|NCT00462748|537018422|FG000|Overall Study|Protocol Violation|0|||
148874768|NCT00462748|537018423|FG001|Overall Study|Protocol Violation|2|||
148874769|NCT00462748|537018424|FG002|Overall Study|Protocol Violation|1|||
148874770|NCT00462748|537018422|FG000|Overall Study|Withdrew consent|3|||
148874771|NCT00462748|537018423|FG001|Overall Study|Withdrew consent|3|||
148874772|NCT00462748|537018424|FG002|Overall Study|Withdrew consent|0|||
148874773|NCT00462748|537018422|FG000|Overall Study|Lost to Follow-up|1|||
148874774|NCT00462748|537018423|FG001|Overall Study|Lost to Follow-up|1|||
148874775|NCT00462748|537018424|FG002|Overall Study|Lost to Follow-up|1|||
148874776|NCT00462748|537018422|FG000|Overall Study|Discontinued after 41 days Rx|1|||
148874777|NCT00462748|537018423|FG001|Overall Study|Discontinued after 41 days Rx|0|||
148874778|NCT00462748|537018424|FG002|Overall Study|Discontinued after 41 days Rx|0|||
148874779|NCT01729208|537018425|FG000|Baseline|Physician Decision|5|||
148874780|NCT01729208|537018426|FG001|Baseline|Physician Decision|4|||
148874781|NCT01729208|537018425|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
148874782|NCT01729208|537018426|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
148874783|NCT01729208|537018425|FG000|12 Months Follow-up|Lost to Follow-up|3|||
148874784|NCT01729208|537018426|FG001|12 Months Follow-up|Lost to Follow-up|3|||
148874785|NCT01729208|537018425|FG000|24 Months Follow-up|Lost to Follow-up|3|||
148874786|NCT01729208|537018426|FG001|24 Months Follow-up|Lost to Follow-up|0|||
148874787|NCT01729208|537018425|FG000|36 Months Follow-up|Physician Decision|1|||
148874788|NCT01729208|537018426|FG001|36 Months Follow-up|Physician Decision|0|||
148874789|NCT01729208|537018425|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
148874790|NCT01729208|537018426|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
148874791|NCT02428413|537018427|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
148874792|NCT02428413|537018428|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
148874793|NCT02428413|537018427|FG000|Overall Study|Protocol Violation|1|||
148874794|NCT02428413|537018428|FG001|Overall Study|Protocol Violation|2|||
148874795|NCT02428413|537018427|FG000|Overall Study|Case Cancelled|2|||
148874796|NCT02428413|537018428|FG001|Overall Study|Case Cancelled|0|||
148874797|NCT02428413|537018427|FG000|Overall Study|Missed Cases|1|||
148874798|NCT02428413|537018428|FG001|Overall Study|Missed Cases|2|||
148874799|NCT02428413|537018427|FG000|Overall Study|Nurse Refusal|1|||
148874800|NCT02428413|537018428|FG001|Overall Study|Nurse Refusal|0|||
148874801|NCT03688100|537018430|FG000|Overall Study|Lost to Follow-up|21|||
148874802|NCT03688100|537018431|FG001|Overall Study|Lost to Follow-up|15|||
148874803|NCT03688100|537018432|FG002|Overall Study|Lost to Follow-up|15|||
148874804|NCT03688100|537018433|FG003|Overall Study|Lost to Follow-up|18|||
148874805|NCT03688100|537018430|FG000|Overall Study|Withdrawal by Subject|19|||
148874806|NCT03688100|537018431|FG001|Overall Study|Withdrawal by Subject|16|||
148874807|NCT03688100|537018432|FG002|Overall Study|Withdrawal by Subject|0|||
148874808|NCT03688100|537018433|FG003|Overall Study|Withdrawal by Subject|0|||
148874809|NCT03688100|537018430|FG000|Overall Study|Death|36|||
148874810|NCT03688100|537018431|FG001|Overall Study|Death|27|||
148874811|NCT03688100|537018432|FG002|Overall Study|Death|0|||
148874812|NCT03688100|537018433|FG003|Overall Study|Death|0|||
148874813|NCT02453555|537018443|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
148874814|NCT02453555|537018444|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
148874815|NCT02453555|537018445|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
148874816|NCT02453555|537018446|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
148874817|NCT02453555|537018447|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
148874818|NCT02453555|537018448|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
148874819|NCT02453555|537018443|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
148874820|NCT02453555|537018444|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
148874821|NCT02453555|537018445|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
148874822|NCT02453555|537018446|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
148874823|NCT02453555|537018447|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
148874824|NCT02453555|537018448|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
148874825|NCT02453555|537018443|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
148874826|NCT02453555|537018444|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
148874827|NCT02453555|537018445|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
148874828|NCT02453555|537018446|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
148874829|NCT02453555|537018447|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
148874830|NCT02453555|537018448|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
148874831|NCT02453555|537018443|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
148874832|NCT02453555|537018444|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
148874833|NCT02453555|537018445|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
148874834|NCT02453555|537018446|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
148874835|NCT02453555|537018447|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
148874836|NCT02453555|537018448|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
148874837|NCT02453555|537018443|FG000|Extension Period|Adverse Event|0|||
148874838|NCT02453555|537018444|FG001|Extension Period|Adverse Event|0|||
148874839|NCT02453555|537018445|FG002|Extension Period|Adverse Event|1|||
148874840|NCT02453555|537018446|FG003|Extension Period|Adverse Event|2|||
148874841|NCT02453555|537018447|FG004|Extension Period|Adverse Event|1|||
148874842|NCT02453555|537018448|FG005|Extension Period|Adverse Event|1|||
148874843|NCT02453555|537018443|FG000|Extension Period|Protocol Violation|0|||
148874844|NCT02453555|537018444|FG001|Extension Period|Protocol Violation|0|||
148874845|NCT02453555|537018445|FG002|Extension Period|Protocol Violation|1|||
148874846|NCT02453555|537018446|FG003|Extension Period|Protocol Violation|0|||
148874847|NCT02453555|537018447|FG004|Extension Period|Protocol Violation|0|||
148874848|NCT02453555|537018448|FG005|Extension Period|Protocol Violation|0|||
148874849|NCT02453555|537018443|FG000|Extension Period|Withdrawal by Subject|0|||
148874850|NCT02453555|537018444|FG001|Extension Period|Withdrawal by Subject|0|||
148874851|NCT02453555|537018445|FG002|Extension Period|Withdrawal by Subject|1|||
148874852|NCT02453555|537018446|FG003|Extension Period|Withdrawal by Subject|0|||
148874853|NCT02453555|537018447|FG004|Extension Period|Withdrawal by Subject|0|||
148874854|NCT02453555|537018448|FG005|Extension Period|Withdrawal by Subject|0|||
148874855|NCT02409719|537018453|FG000|Overall Study|Lost to Follow-up|3|||
148874856|NCT02409719|537018454|FG001|Overall Study|Lost to Follow-up|3|||
148874857|NCT03689855|537018455|FG000|Overall Study|Adverse Event|3|||
148874858|NCT03689855|537018455|FG000|Overall Study|Withdrawal by Subject|1|||
148874859|NCT02479139|537018456|FG000|Overall Study|Lost to Follow-up|2|||
148874860|NCT02479139|537018457|FG001|Overall Study|Lost to Follow-up|4|||
148874861|NCT02479139|537018458|FG002|Overall Study|Lost to Follow-up|4|||
148874862|NCT02479139|537018459|FG003|Overall Study|Lost to Follow-up|2|||
148874863|NCT02479139|537018460|FG004|Overall Study|Lost to Follow-up|3|||
148874864|NCT02479139|537018461|FG005|Overall Study|Lost to Follow-up|5|||
148874865|NCT02479139|537018456|FG000|Overall Study|Withdrew Consent|5|||
148874866|NCT02479139|537018457|FG001|Overall Study|Withdrew Consent|6|||
148874867|NCT02479139|537018458|FG002|Overall Study|Withdrew Consent|1|||
148874868|NCT02479139|537018459|FG003|Overall Study|Withdrew Consent|4|||
148874869|NCT02479139|537018460|FG004|Overall Study|Withdrew Consent|1|||
148874870|NCT02479139|537018461|FG005|Overall Study|Withdrew Consent|1|||
148874871|NCT02479139|537018456|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
148874872|NCT02479139|537018457|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
148874873|NCT02479139|537018458|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
148874874|NCT02479139|537018459|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
148874875|NCT02479139|537018460|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
148874876|NCT02479139|537018461|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
148874877|NCT02479139|537018456|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148874878|NCT02479139|537018457|FG001|Overall Study|Other Miscellaneous Reasons|0|||
148874879|NCT02479139|537018458|FG002|Overall Study|Other Miscellaneous Reasons|1|||
148874880|NCT02479139|537018459|FG003|Overall Study|Other Miscellaneous Reasons|1|||
148874881|NCT02479139|537018460|FG004|Overall Study|Other Miscellaneous Reasons|1|||
148874882|NCT02479139|537018461|FG005|Overall Study|Other Miscellaneous Reasons|0|||
148874883|NCT00764673|537018462|FG000|Overall Study|Death|1|||
148874884|NCT00764673|537018462|FG000|Overall Study|Lost to Follow-up|3|||
148874885|NCT00764673|537018462|FG000|Overall Study|Withdrawal by Subject|6|||
148874886|NCT00764673|537018462|FG000|Overall Study|Revision of Device|2|||
148874887|NCT01438177|537018463|FG000|Overall Study|Withdrawal by Subject|1|||
148874888|NCT01438177|537018463|FG000|Overall Study|Initiation of new therapy|1|||
148874889|NCT01727336|537018464|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
148874890|NCT01727336|537018465|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
148874891|NCT01727336|537018466|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
148874892|NCT01727336|537018467|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
148874893|NCT01727336|537018468|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
148874894|NCT01727336|537018469|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
148874895|NCT01727336|537018464|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
148874896|NCT01727336|537018465|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
148874897|NCT01727336|537018466|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
148874898|NCT01727336|537018467|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
149000918|NCT01525602|537479431|FG001|Overall Study|Clinical progression|0|||
148874899|NCT01727336|537018468|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
148874900|NCT01727336|537018469|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
148874901|NCT01727336|537018464|FG000|Part 2 Blinded|Death|0|||
148874902|NCT01727336|537018465|FG001|Part 2 Blinded|Death|0|||
148874903|NCT01727336|537018466|FG002|Part 2 Blinded|Death|0|||
148874904|NCT01727336|537018467|FG003|Part 2 Blinded|Death|0|||
148874905|NCT01727336|537018468|FG004|Part 2 Blinded|Death|20|||
148874906|NCT01727336|537018469|FG005|Part 2 Blinded|Death|16|||
148874907|NCT01727336|537018464|FG000|Part 2 Blinded|Lack of Efficacy|0|||
148874908|NCT01727336|537018465|FG001|Part 2 Blinded|Lack of Efficacy|0|||
148874909|NCT01727336|537018466|FG002|Part 2 Blinded|Lack of Efficacy|0|||
148874910|NCT01727336|537018467|FG003|Part 2 Blinded|Lack of Efficacy|0|||
148874911|NCT01727336|537018468|FG004|Part 2 Blinded|Lack of Efficacy|42|||
148874912|NCT01727336|537018469|FG005|Part 2 Blinded|Lack of Efficacy|44|||
148874913|NCT01727336|537018464|FG000|Part 2 Blinded|Lost to Follow-up|0|||
148874914|NCT01727336|537018465|FG001|Part 2 Blinded|Lost to Follow-up|0|||
148874915|NCT01727336|537018466|FG002|Part 2 Blinded|Lost to Follow-up|0|||
148874916|NCT01727336|537018467|FG003|Part 2 Blinded|Lost to Follow-up|0|||
148874917|NCT01727336|537018468|FG004|Part 2 Blinded|Lost to Follow-up|0|||
148874918|NCT01727336|537018469|FG005|Part 2 Blinded|Lost to Follow-up|1|||
148874919|NCT01727336|537018464|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
148874920|NCT01727336|537018465|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
148874921|NCT01727336|537018466|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
148874922|NCT01727336|537018467|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
148874923|NCT01727336|537018468|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
148874924|NCT01727336|537018469|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
148874925|NCT01727336|537018464|FG000|Part 2 Blinded|use of prohibited medications|0|||
148874926|NCT01727336|537018465|FG001|Part 2 Blinded|use of prohibited medications|0|||
148874927|NCT01727336|537018466|FG002|Part 2 Blinded|use of prohibited medications|0|||
148874928|NCT01727336|537018467|FG003|Part 2 Blinded|use of prohibited medications|0|||
148874929|NCT01727336|537018468|FG004|Part 2 Blinded|use of prohibited medications|1|||
148874930|NCT01727336|537018469|FG005|Part 2 Blinded|use of prohibited medications|3|||
148874931|NCT00619099|537018472|FG000|Overall Study|Progressive Disease|7|||
148874932|NCT00619099|537018473|FG001|Overall Study|Progressive Disease|5|||
148874933|NCT00619099|537018472|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
148874934|NCT00619099|537018473|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
148874935|NCT00619099|537018472|FG000|Overall Study|Adverse Event|4|||
148874936|NCT00619099|537018473|FG001|Overall Study|Adverse Event|3|||
148874937|NCT00619099|537018472|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
148874938|NCT00619099|537018473|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
148874939|NCT00619099|537018472|FG000|Overall Study|Withdrawal by Subject|10|||
148874940|NCT00619099|537018473|FG001|Overall Study|Withdrawal by Subject|2|||
148874941|NCT00619099|537018472|FG000|Overall Study|Physician Decision|9|||
148874942|NCT00619099|537018473|FG001|Overall Study|Physician Decision|6|||
148874943|NCT00885482|537018474|FG000|Overall Study|Pregnancy|1|||
148874944|NCT00885482|537018474|FG000|Overall Study|Lack of Efficacy|1|||
148874945|NCT00885482|537018474|FG000|Overall Study|Death|1|||
148874946|NCT00885482|537018474|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
148874947|NCT00084656|537018475|FG000|Overall Study|Other reasons|0|||
148874948|NCT00084656|537018476|FG001|Overall Study|Other reasons|12|||
148874949|NCT00084656|537018477|FG002|Overall Study|Other reasons|11|||
148874950|NCT00084656|537018475|FG000|Overall Study|Withdrawal by Subject|15|||
148874951|NCT00084656|537018476|FG001|Overall Study|Withdrawal by Subject|4|||
148874952|NCT00084656|537018477|FG002|Overall Study|Withdrawal by Subject|4|||
148874953|NCT00084656|537018475|FG000|Overall Study|Disease relapse|0|||
148874954|NCT00084656|537018476|FG001|Overall Study|Disease relapse|9|||
148874955|NCT00084656|537018477|FG002|Overall Study|Disease relapse|10|||
148874956|NCT00084656|537018475|FG000|Overall Study|Disease progression|9|||
148874957|NCT00084656|537018476|FG001|Overall Study|Disease progression|0|||
148874958|NCT00084656|537018477|FG002|Overall Study|Disease progression|0|||
148874959|NCT00084656|537018475|FG000|Overall Study|Lost to Follow-up|1|||
148874960|NCT00084656|537018476|FG001|Overall Study|Lost to Follow-up|0|||
148874961|NCT00084656|537018477|FG002|Overall Study|Lost to Follow-up|1|||
148874962|NCT02772978|537018478|FG000|Overall Study|Withdrawal by Subject|1|||
148874963|NCT02772978|537018479|FG001|Overall Study|Withdrawal by Subject|1|||
148874964|NCT00989781|537018480|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
148874965|NCT00989781|537018481|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
148874966|NCT01026220|537018482|FG000|Induction|Death|1|||
148874967|NCT01026220|537018483|FG001|Induction|Death|0|||
148874968|NCT01026220|537018484|FG002|Induction|Death|0|||
148874969|NCT01026220|537018482|FG000|Induction|Lack of Efficacy|2|||
148874970|NCT01026220|537018483|FG001|Induction|Lack of Efficacy|0|||
148874971|NCT01026220|537018484|FG002|Induction|Lack of Efficacy|0|||
148874972|NCT01026220|537018482|FG000|Induction|Physician Decision|12|||
148874973|NCT01026220|537018483|FG001|Induction|Physician Decision|0|||
148874974|NCT01026220|537018484|FG002|Induction|Physician Decision|0|||
148874975|NCT01026220|537018482|FG000|Induction|Withdrawal by Subject|9|||
148874976|NCT01026220|537018483|FG001|Induction|Withdrawal by Subject|0|||
148874977|NCT01026220|537018484|FG002|Induction|Withdrawal by Subject|0|||
148874978|NCT01026220|537018482|FG000|Induction|Ineligible|1|||
148874979|NCT01026220|537018483|FG001|Induction|Ineligible|0|||
148874980|NCT01026220|537018484|FG002|Induction|Ineligible|0|||
148874981|NCT01026220|537018482|FG000|Consolidation Maintenance|Death|0|||
148874982|NCT01026220|537018483|FG001|Consolidation Maintenance|Death|1|||
148874983|NCT01026220|537018484|FG002|Consolidation Maintenance|Death|0|||
148874984|NCT01026220|537018482|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
148874985|NCT01026220|537018483|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
148874986|NCT01026220|537018484|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
148874987|NCT01026220|537018482|FG000|Consolidation Maintenance|Physician Decision|0|||
148874988|NCT01026220|537018483|FG001|Consolidation Maintenance|Physician Decision|2|||
148874989|NCT01026220|537018484|FG002|Consolidation Maintenance|Physician Decision|7|||
148874990|NCT01026220|537018482|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
148874991|NCT01026220|537018483|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
148874992|NCT01026220|537018484|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
148874993|NCT00409344|537018487|FG000|Overall Study|no enrollment|0|||
148874994|NCT00409344|537018488|FG001|Overall Study|no enrollment|0|||
148874995|NCT05096312|537018489|FG000|Overall Study|Lost to Follow-up|2|||
148874996|NCT05096312|537018490|FG001|Overall Study|Lost to Follow-up|4|||
148874997|NCT05096312|537018489|FG000|Overall Study|Adverse Event|1|||
148874998|NCT05096312|537018490|FG001|Overall Study|Adverse Event|0|||
148874999|NCT04349033|537018494|FG000|Overall Study|Lost to Follow-up|3|||
148875000|NCT04349033|537018495|FG001|Overall Study|Lost to Follow-up|1|||
148875001|NCT04349033|537018496|FG002|Overall Study|Lost to Follow-up|1|||
148875002|NCT00498355|537018499|FG000|Overall Study|Lost to Follow-up|1|||
148875003|NCT04583956|537018500|FG000|Overall Study|Death|9|||
148875004|NCT04583956|537018501|FG001|Overall Study|Death|11|||
148875005|NCT04583956|537018500|FG000|Overall Study|Lost to Follow-up|7|||
148875006|NCT04583956|537018501|FG001|Overall Study|Lost to Follow-up|9|||
148875007|NCT04583956|537018500|FG000|Overall Study|Protocol Violation|2|||
148875008|NCT04583956|537018501|FG001|Overall Study|Protocol Violation|0|||
148875009|NCT04583956|537018500|FG000|Overall Study|Withdrawal by Subject|0|||
148875010|NCT04583956|537018501|FG001|Overall Study|Withdrawal by Subject|2|||
148875011|NCT04583956|537018500|FG000|Overall Study|Randomized but not dosed|2|||
148875012|NCT04583956|537018501|FG001|Overall Study|Randomized but not dosed|3|||
148875013|NCT04583956|537018500|FG000|Overall Study|Withdrawal of consent before product administration|1|||
148875014|NCT04583956|537018501|FG001|Overall Study|Withdrawal of consent before product administration|0|||
148875015|NCT04407234|537018502|FG000|Overall Study|Adverse Event|3|||
148875016|NCT04407234|537018503|FG001|Overall Study|Adverse Event|3|||
148875017|NCT03210961|537020519|FG000|Overall Study|Adverse Event|0|||
148875018|NCT03210961|537020520|FG001|Overall Study|Adverse Event|0|||
148875019|NCT03210961|537020521|FG002|Overall Study|Adverse Event|0|||
148875020|NCT03210961|537020522|FG003|Overall Study|Adverse Event|0|||
148875021|NCT03210961|537020523|FG004|Overall Study|Adverse Event|0|||
148875022|NCT03210961|537020524|FG005|Overall Study|Adverse Event|0|||
148875023|NCT03210961|537020525|FG006|Overall Study|Adverse Event|0|||
148875024|NCT03210961|537020526|FG007|Overall Study|Adverse Event|0|||
148875025|NCT03210961|537020527|FG008|Overall Study|Adverse Event|0|||
148875026|NCT03210961|537020528|FG009|Overall Study|Adverse Event|0|||
148875027|NCT03210961|537020529|FG010|Overall Study|Adverse Event|0|||
148875028|NCT03210961|537020530|FG011|Overall Study|Adverse Event|0|||
148875029|NCT03210961|537020531|FG012|Overall Study|Adverse Event|0|||
148875030|NCT03210961|537020532|FG013|Overall Study|Adverse Event|1|||
148875031|NCT03210961|537020533|FG014|Overall Study|Adverse Event|0|||
148875032|NCT03210961|537020519|FG000|Overall Study|Lost to Follow-up|0|||
148875033|NCT03210961|537020520|FG001|Overall Study|Lost to Follow-up|0|||
148875034|NCT03210961|537020521|FG002|Overall Study|Lost to Follow-up|0|||
148875035|NCT03210961|537020522|FG003|Overall Study|Lost to Follow-up|0|||
148875036|NCT03210961|537020523|FG004|Overall Study|Lost to Follow-up|0|||
148875037|NCT03210961|537020524|FG005|Overall Study|Lost to Follow-up|0|||
148875038|NCT03210961|537020525|FG006|Overall Study|Lost to Follow-up|0|||
148875039|NCT03210961|537020526|FG007|Overall Study|Lost to Follow-up|0|||
148875040|NCT03210961|537020527|FG008|Overall Study|Lost to Follow-up|0|||
148875041|NCT03210961|537020528|FG009|Overall Study|Lost to Follow-up|0|||
148875042|NCT03210961|537020529|FG010|Overall Study|Lost to Follow-up|0|||
148875043|NCT03210961|537020530|FG011|Overall Study|Lost to Follow-up|0|||
148875044|NCT03210961|537020531|FG012|Overall Study|Lost to Follow-up|0|||
148875045|NCT03210961|537020532|FG013|Overall Study|Lost to Follow-up|0|||
148875046|NCT03210961|537020533|FG014|Overall Study|Lost to Follow-up|1|||
148875047|NCT03210961|537020519|FG000|Overall Study|Withdrawal by Subject|0|||
148875048|NCT03210961|537020520|FG001|Overall Study|Withdrawal by Subject|0|||
148875049|NCT03210961|537020521|FG002|Overall Study|Withdrawal by Subject|0|||
148875050|NCT03210961|537020522|FG003|Overall Study|Withdrawal by Subject|0|||
148875051|NCT03210961|537020523|FG004|Overall Study|Withdrawal by Subject|0|||
148875052|NCT03210961|537020524|FG005|Overall Study|Withdrawal by Subject|0|||
148875053|NCT03210961|537020525|FG006|Overall Study|Withdrawal by Subject|0|||
148875054|NCT03210961|537020526|FG007|Overall Study|Withdrawal by Subject|0|||
148875055|NCT03210961|537020527|FG008|Overall Study|Withdrawal by Subject|0|||
148875056|NCT03210961|537020528|FG009|Overall Study|Withdrawal by Subject|0|||
148875057|NCT03210961|537020529|FG010|Overall Study|Withdrawal by Subject|0|||
148875058|NCT03210961|537020530|FG011|Overall Study|Withdrawal by Subject|0|||
148875059|NCT03210961|537020531|FG012|Overall Study|Withdrawal by Subject|0|||
148875060|NCT03210961|537020532|FG013|Overall Study|Withdrawal by Subject|0|||
148875061|NCT03210961|537020533|FG014|Overall Study|Withdrawal by Subject|1|||
148875062|NCT03210961|537020519|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875063|NCT03210961|537020520|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875064|NCT03210961|537020521|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875065|NCT03210961|537020522|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875066|NCT03210961|537020523|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875067|NCT03210961|537020524|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875068|NCT03210961|537020525|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875069|NCT03210961|537020526|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875070|NCT03210961|537020527|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875071|NCT03210961|537020528|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875072|NCT03210961|537020529|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875073|NCT03210961|537020530|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875074|NCT03210961|537020531|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875075|NCT03210961|537020532|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
148875076|NCT03210961|537020533|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
148875077|NCT03210961|537020519|FG000|Overall Study|Other|0|||
148875078|NCT03210961|537020520|FG001|Overall Study|Other|0|||
148875079|NCT03210961|537020521|FG002|Overall Study|Other|0|||
148875080|NCT03210961|537020522|FG003|Overall Study|Other|1|||
148875081|NCT03210961|537020523|FG004|Overall Study|Other|0|||
148875082|NCT03210961|537020524|FG005|Overall Study|Other|0|||
148875083|NCT03210961|537020525|FG006|Overall Study|Other|1|||
148875084|NCT03210961|537020526|FG007|Overall Study|Other|0|||
148875085|NCT03210961|537020527|FG008|Overall Study|Other|0|||
148875086|NCT03210961|537020528|FG009|Overall Study|Other|0|||
148875087|NCT03210961|537020529|FG010|Overall Study|Other|1|||
148875088|NCT03210961|537020530|FG011|Overall Study|Other|0|||
148875089|NCT03210961|537020531|FG012|Overall Study|Other|2|||
148875090|NCT03210961|537020532|FG013|Overall Study|Other|2|||
148875091|NCT03210961|537020533|FG014|Overall Study|Other|0|||
148875092|NCT03831100|537020535|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
148875093|NCT03831100|537020536|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
148875094|NCT04566601|537020537|FG000|Overall Study|Other than listed|13|||
148875095|NCT04566601|537020538|FG001|Overall Study|Other than listed|4|||
148875096|NCT04566601|537020539|FG002|Overall Study|Other than listed|2|||
148875097|NCT04566601|537020540|FG003|Overall Study|Other than listed|1|||
148875098|NCT04566601|537020541|FG004|Overall Study|Other than listed|4|||
148875099|NCT04566601|537020537|FG000|Overall Study|Protocol deviation|3|||
148875100|NCT04566601|537020538|FG001|Overall Study|Protocol deviation|0|||
148875101|NCT04566601|537020539|FG002|Overall Study|Protocol deviation|1|||
148875102|NCT04566601|537020540|FG003|Overall Study|Protocol deviation|1|||
148875103|NCT04566601|537020541|FG004|Overall Study|Protocol deviation|1|||
148875104|NCT04566601|537020537|FG000|Overall Study|Technical problems|0|||
148875105|NCT04566601|537020538|FG001|Overall Study|Technical problems|0|||
148875106|NCT04566601|537020539|FG002|Overall Study|Technical problems|1|||
148875107|NCT04566601|537020540|FG003|Overall Study|Technical problems|0|||
148875108|NCT04566601|537020541|FG004|Overall Study|Technical problems|0|||
148875109|NCT04566601|537020537|FG000|Overall Study|No reason available|3|||
148875110|NCT04566601|537020538|FG001|Overall Study|No reason available|2|||
148875111|NCT04566601|537020539|FG002|Overall Study|No reason available|7|||
148875112|NCT04566601|537020540|FG003|Overall Study|No reason available|1|||
148875113|NCT04566601|537020541|FG004|Overall Study|No reason available|5|||
148875114|NCT04566601|537020537|FG000|Overall Study|Burden of study procedures|3|||
148875115|NCT04566601|537020538|FG001|Overall Study|Burden of study procedures|0|||
148875116|NCT04566601|537020539|FG002|Overall Study|Burden of study procedures|0|||
148875117|NCT04566601|537020540|FG003|Overall Study|Burden of study procedures|3|||
148875118|NCT04566601|537020541|FG004|Overall Study|Burden of study procedures|1|||
148875119|NCT04566601|537020537|FG000|Overall Study|Change of residence|2|||
148875120|NCT04566601|537020538|FG001|Overall Study|Change of residence|2|||
148875121|NCT04566601|537020539|FG002|Overall Study|Change of residence|0|||
148875122|NCT04566601|537020540|FG003|Overall Study|Change of residence|1|||
148875123|NCT04566601|537020541|FG004|Overall Study|Change of residence|2|||
148875124|NCT04566601|537020537|FG000|Overall Study|Perceived lack of efficacy|2|||
148875125|NCT04566601|537020538|FG001|Overall Study|Perceived lack of efficacy|0|||
148875126|NCT04566601|537020539|FG002|Overall Study|Perceived lack of efficacy|1|||
148875127|NCT04566601|537020540|FG003|Overall Study|Perceived lack of efficacy|1|||
148875128|NCT04566601|537020541|FG004|Overall Study|Perceived lack of efficacy|2|||
148875129|NCT04566601|537020537|FG000|Overall Study|Adverse Event|7|||
148875130|NCT04566601|537020538|FG001|Overall Study|Adverse Event|4|||
148875131|NCT04566601|537020539|FG002|Overall Study|Adverse Event|6|||
148875132|NCT04566601|537020540|FG003|Overall Study|Adverse Event|5|||
148875133|NCT04566601|537020541|FG004|Overall Study|Adverse Event|12|||
148875134|NCT03047031|537020546|FG000|Overall Study|Other than listed|1|||
148875135|NCT03047031|537020547|FG001|Overall Study|Other than listed|0|||
149033639|NCT00881335|537600424|FG001|Overall Study|Lost to Follow-up|2|||
149033640|NCT00554801|537600426|FG000|Overall Study|left area before completion|5|||
149033641|NCT00554801|537600427|FG001|Overall Study|left area before completion|0|||
149033642|NCT00554801|537600426|FG000|Overall Study|Withdrawal by Subject|14|||
149033643|NCT00554801|537600427|FG001|Overall Study|Withdrawal by Subject|0|||
149033644|NCT00462943|537600430|FG000|Overall Study|Failure to achieve a response|5|||
149033645|NCT00462943|537600431|FG001|Overall Study|Failure to achieve a response|5|||
149033646|NCT00462943|537600432|FG002|Overall Study|Failure to achieve a response|1|||
149033647|NCT00462943|537600430|FG000|Overall Study|Adverse Event|6|||
149033648|NCT00462943|537600431|FG001|Overall Study|Adverse Event|4|||
149033649|NCT00462943|537600432|FG002|Overall Study|Adverse Event|1|||
149033650|NCT00462943|537600430|FG000|Overall Study|Protocol Violation|1|||
149033651|NCT00462943|537600431|FG001|Overall Study|Protocol Violation|0|||
149033652|NCT00462943|537600432|FG002|Overall Study|Protocol Violation|0|||
149033653|NCT00462943|537600430|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
149033654|NCT00462943|537600431|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
149033655|NCT00462943|537600432|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
149033656|NCT00462943|537600430|FG000|Overall Study|Disease Progression|15|||
149033657|NCT00462943|537600431|FG001|Overall Study|Disease Progression|15|||
149033658|NCT00462943|537600432|FG002|Overall Study|Disease Progression|9|||
149033659|NCT00462943|537600430|FG000|Overall Study|Death|5|||
149033660|NCT00462943|537600431|FG001|Overall Study|Death|2|||
149033661|NCT00462943|537600432|FG002|Overall Study|Death|7|||
149033662|NCT00462943|537600430|FG000|Overall Study|Stem Cell Transplant|1|||
149033663|NCT00462943|537600431|FG001|Overall Study|Stem Cell Transplant|1|||
149033664|NCT00462943|537600432|FG002|Overall Study|Stem Cell Transplant|0|||
149033665|NCT00462943|537600430|FG000|Overall Study|Bone Marrow Transplant|1|||
149033666|NCT00462943|537600431|FG001|Overall Study|Bone Marrow Transplant|0|||
149033667|NCT00462943|537600432|FG002|Overall Study|Bone Marrow Transplant|0|||
149033668|NCT00462943|537600430|FG000|Overall Study|Required Lymphocyte Infusion|1|||
149033669|NCT00462943|537600431|FG001|Overall Study|Required Lymphocyte Infusion|0|||
149033670|NCT00462943|537600432|FG002|Overall Study|Required Lymphocyte Infusion|0|||
148875136|NCT03047031|537020548|FG002|Overall Study|Other than listed|0|||
148875137|NCT03047031|537020546|FG000|Overall Study|Lost to Follow-up|4|||
148875138|NCT03047031|537020547|FG001|Overall Study|Lost to Follow-up|0|||
148875139|NCT03047031|537020548|FG002|Overall Study|Lost to Follow-up|0|||
148875140|NCT03047031|537020546|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
148875141|NCT03047031|537020547|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
148875142|NCT03047031|537020548|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
148875143|NCT03047031|537020546|FG000|Overall Study|Adverse Event|1|||
148875144|NCT03047031|537020547|FG001|Overall Study|Adverse Event|0|||
148875145|NCT03047031|537020548|FG002|Overall Study|Adverse Event|0|||
148875146|NCT03047031|537020546|FG000|Overall Study|Withdrawal by Subject|2|||
148875147|NCT03047031|537020547|FG001|Overall Study|Withdrawal by Subject|0|||
148875148|NCT03047031|537020548|FG002|Overall Study|Withdrawal by Subject|0|||
148875149|NCT03047031|537020546|FG000|Overall Study|Change to other medication|2|||
148875150|NCT03047031|537020547|FG001|Overall Study|Change to other medication|0|||
148875151|NCT03047031|537020548|FG002|Overall Study|Change to other medication|0|||
148875152|NCT03047031|537020546|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
148875153|NCT03047031|537020547|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
148875154|NCT03047031|537020548|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
148875155|NCT02814175|537020550|FG000|Part 1|Adverse Event|2|||
148875156|NCT02814175|537020551|FG001|Part 1|Adverse Event|3|||
148875157|NCT02814175|537020552|FG002|Part 1|Adverse Event|0|||
148875158|NCT02814175|537020553|FG003|Part 1|Adverse Event|0|||
148875159|NCT02814175|537020554|FG004|Part 1|Adverse Event|0|||
148875160|NCT02814175|537020555|FG005|Part 1|Adverse Event|0|||
148875161|NCT02814175|537020550|FG000|Part 1|Withdrawal Consent|8|||
148875162|NCT02814175|537020551|FG001|Part 1|Withdrawal Consent|1|||
149033671|NCT00462943|537600430|FG000|Overall Study|Transplant - not specified|1|||
148875163|NCT02814175|537020552|FG002|Part 1|Withdrawal Consent|0|||
148875164|NCT02814175|537020553|FG003|Part 1|Withdrawal Consent|0|||
148875165|NCT02814175|537020554|FG004|Part 1|Withdrawal Consent|0|||
148875166|NCT02814175|537020555|FG005|Part 1|Withdrawal Consent|0|||
149033672|NCT00462943|537600431|FG001|Overall Study|Transplant - not specified|0|||
149033673|NCT00462943|537600432|FG002|Overall Study|Transplant - not specified|1|||
149033674|NCT00462943|537600430|FG000|Overall Study|Physician Decision|1|||
149033675|NCT00462943|537600431|FG001|Overall Study|Physician Decision|0|||
148875167|NCT02814175|537020550|FG000|Part 1|Lost to Follow-up|1|||
148875168|NCT02814175|537020551|FG001|Part 1|Lost to Follow-up|0|||
148875169|NCT02814175|537020552|FG002|Part 1|Lost to Follow-up|0|||
148875170|NCT02814175|537020553|FG003|Part 1|Lost to Follow-up|0|||
148875171|NCT02814175|537020554|FG004|Part 1|Lost to Follow-up|0|||
148875172|NCT02814175|537020555|FG005|Part 1|Lost to Follow-up|0|||
149033676|NCT00462943|537600432|FG002|Overall Study|Physician Decision|0|||
148875173|NCT02814175|537020550|FG000|Part 1|Lack of Efficacy|1|||
148875174|NCT02814175|537020551|FG001|Part 1|Lack of Efficacy|2|||
148875175|NCT02814175|537020552|FG002|Part 1|Lack of Efficacy|0|||
148875176|NCT02814175|537020553|FG003|Part 1|Lack of Efficacy|0|||
148875177|NCT02814175|537020554|FG004|Part 1|Lack of Efficacy|0|||
148875178|NCT02814175|537020555|FG005|Part 1|Lack of Efficacy|0|||
148875179|NCT02814175|537020550|FG000|Part 2|Adverse Event|0|||
148875180|NCT02814175|537020551|FG001|Part 2|Adverse Event|0|||
148875181|NCT02814175|537020552|FG002|Part 2|Adverse Event|0|||
148875182|NCT02814175|537020553|FG003|Part 2|Adverse Event|1|||
148875183|NCT02814175|537020554|FG004|Part 2|Adverse Event|1|||
148875184|NCT02814175|537020555|FG005|Part 2|Adverse Event|2|||
148875185|NCT02814175|537020550|FG000|Part 2|Withdrawal Consent|0|||
148875186|NCT02814175|537020551|FG001|Part 2|Withdrawal Consent|0|||
148875187|NCT02814175|537020552|FG002|Part 2|Withdrawal Consent|0|||
148875188|NCT02814175|537020553|FG003|Part 2|Withdrawal Consent|2|||
148875189|NCT02814175|537020554|FG004|Part 2|Withdrawal Consent|1|||
148875190|NCT02814175|537020555|FG005|Part 2|Withdrawal Consent|1|||
148875191|NCT02814175|537020550|FG000|Part 2|Lost to Follow-up|0|||
148875192|NCT02814175|537020551|FG001|Part 2|Lost to Follow-up|0|||
148875193|NCT02814175|537020552|FG002|Part 2|Lost to Follow-up|0|||
148875194|NCT02814175|537020553|FG003|Part 2|Lost to Follow-up|1|||
148875195|NCT02814175|537020554|FG004|Part 2|Lost to Follow-up|0|||
148875196|NCT02814175|537020555|FG005|Part 2|Lost to Follow-up|0|||
148875197|NCT02814175|537020550|FG000|Part 2|Lack of Efficacy|0|||
148875198|NCT02814175|537020551|FG001|Part 2|Lack of Efficacy|0|||
148875199|NCT02814175|537020552|FG002|Part 2|Lack of Efficacy|0|||
148875200|NCT02814175|537020553|FG003|Part 2|Lack of Efficacy|0|||
148875201|NCT02814175|537020554|FG004|Part 2|Lack of Efficacy|0|||
149033677|NCT00462943|537600430|FG000|Overall Study|Withdrawal by Subject|0|||
149033678|NCT00462943|537600431|FG001|Overall Study|Withdrawal by Subject|1|||
149033679|NCT00462943|537600432|FG002|Overall Study|Withdrawal by Subject|0|||
149033680|NCT01697319|537600434|FG000|Primary Phase|Withdrawal by Subject|1|||
149033681|NCT01697319|537600434|FG000|Extension Phase|Terminated by Sponsor|15|||
149033682|NCT04222959|537600437|FG000|Overall Study|Lost to Follow-up|76|||
149033683|NCT04222959|537600438|FG001|Overall Study|Lost to Follow-up|28|||
149033684|NCT01543685|537600443|FG000|Overall Study|Lack of Efficacy|1|||
149033685|NCT01543685|537600444|FG001|Overall Study|Lack of Efficacy|2|||
149033686|NCT01543685|537600445|FG002|Overall Study|Lack of Efficacy|2|||
149033687|NCT01543685|537600446|FG003|Overall Study|Lack of Efficacy|0|||
149033688|NCT01543685|537600447|FG004|Overall Study|Lack of Efficacy|2|||
149033689|NCT01543685|537600443|FG000|Overall Study|Adverse Event|2|||
148875202|NCT02814175|537020555|FG005|Part 2|Lack of Efficacy|3|||
148875203|NCT01450098|537020556|FG000|Period 3|Protocol Violation|0|||
148875204|NCT01450098|537020557|FG001|Period 3|Protocol Violation|1|||
148875205|NCT01450098|537020556|FG000|Period 3|Withdrawal by Subject|0|||
148875206|NCT01450098|537020557|FG001|Period 3|Withdrawal by Subject|2|||
148875207|NCT03354273|537020561|FG000|Overall Study|Adverse Event|5|||
148875208|NCT03354273|537020561|FG000|Overall Study|Screen Failure|21|||
148875209|NCT03354273|537020561|FG000|Overall Study|Withdrawal by Subject|34|||
148875210|NCT03354273|537020561|FG000|Overall Study|Technical Problems|30|||
148875211|NCT03354273|537020561|FG000|Overall Study|Lost to Follow-up|4|||
148875212|NCT03354273|537020561|FG000|Overall Study|Investigator Decision|3|||
148875213|NCT03354273|537020561|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
148875214|NCT03354273|537020561|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
148875215|NCT03354273|537020561|FG000|Overall Study|COVID-19 Restrictions|9|||
148875216|NCT03354273|537020561|FG000|Overall Study|Other|5|||
148875217|NCT03229109|537020562|FG000|Overall Study|Withdrawal by Subject|0|||
148875218|NCT03229109|537020563|FG001|Overall Study|Withdrawal by Subject|0|||
148875219|NCT03229109|537020564|FG002|Overall Study|Withdrawal by Subject|0|||
149033690|NCT01543685|537600444|FG001|Overall Study|Adverse Event|1|||
148875220|NCT03229109|537020565|FG003|Overall Study|Withdrawal by Subject|1|||
148875221|NCT04207749|537020566|FG000|Overall Study|Lost to Follow-up|0|||
149033691|NCT01543685|537600445|FG002|Overall Study|Adverse Event|0|||
149033692|NCT01543685|537600446|FG003|Overall Study|Adverse Event|0|||
148875222|NCT04207749|537020567|FG001|Overall Study|Lost to Follow-up|2|||
148875223|NCT04207749|537020566|FG000|Overall Study|Protocol Violation|0|||
148875224|NCT04207749|537020567|FG001|Overall Study|Protocol Violation|1|||
148875225|NCT04207749|537020566|FG000|Overall Study|Withdrawal by Subject|3|||
148875226|NCT04207749|537020567|FG001|Overall Study|Withdrawal by Subject|0|||
148875227|NCT04207749|537020566|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
148875228|NCT04207749|537020567|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
148875229|NCT01971008|537020570|FG000|Overall Study|Protocol Violation|2|||
149033693|NCT01543685|537600447|FG004|Overall Study|Adverse Event|2|||
149033694|NCT01838551|537600448|FG000|Overall Study|Adverse Event|16|||
149033695|NCT01838551|537600448|FG000|Overall Study|Death|1|||
148875230|NCT01971008|537020571|FG001|Overall Study|Protocol Violation|1|||
148875231|NCT03416127|537020572|FG000|Overall Study|Withdrawal by Subject|0|||
148875232|NCT03416127|537020573|FG001|Overall Study|Withdrawal by Subject|1|||
148875233|NCT03416127|537020574|FG002|Overall Study|Withdrawal by Subject|1|||
148875234|NCT00705367|537020577|FG000|Long-term Extension Period|Adverse Event|2|||
148875235|NCT00705367|537020578|FG001|Long-term Extension Period|Adverse Event|0|||
148875236|NCT00705367|537020577|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
148875237|NCT00705367|537020578|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
148875238|NCT00705367|537020577|FG000|Long-term Extension Period|Lack of Efficacy|1|||
148875239|NCT00705367|537020578|FG001|Long-term Extension Period|Lack of Efficacy|0|||
148875240|NCT00705367|537020577|FG000|Long-term Extension Period|No longer met study criteria|1|||
148875241|NCT00705367|537020578|FG001|Long-term Extension Period|No longer met study criteria|0|||
148875242|NCT00705367|537020577|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
148875243|NCT00705367|537020578|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
148875244|NCT01959139|537020582|FG000|Phase II|Disease progression|0|||
148875245|NCT01959139|537020583|FG001|Phase II|Disease progression|0|||
148875246|NCT01959139|537020584|FG002|Phase II|Disease progression|26|||
148875247|NCT01959139|537020585|FG003|Phase II|Disease progression|34|||
148875248|NCT01959139|537020582|FG000|Phase II|Adverse Event|0|||
148875249|NCT01959139|537020583|FG001|Phase II|Adverse Event|0|||
148875250|NCT01959139|537020584|FG002|Phase II|Adverse Event|10|||
148875251|NCT01959139|537020585|FG003|Phase II|Adverse Event|11|||
148875252|NCT01959139|537020582|FG000|Phase II|Patient Refusal|0|||
148875253|NCT01959139|537020583|FG001|Phase II|Patient Refusal|0|||
148875254|NCT01959139|537020584|FG002|Phase II|Patient Refusal|5|||
148875255|NCT01959139|537020585|FG003|Phase II|Patient Refusal|4|||
148875256|NCT01959139|537020582|FG000|Phase II|Death|0|||
148875257|NCT01959139|537020583|FG001|Phase II|Death|0|||
148875258|NCT01959139|537020584|FG002|Phase II|Death|3|||
148875259|NCT01959139|537020585|FG003|Phase II|Death|1|||
148875260|NCT01959139|537020582|FG000|Phase II|Other/Unknown|0|||
148875261|NCT01959139|537020583|FG001|Phase II|Other/Unknown|0|||
148875262|NCT01959139|537020584|FG002|Phase II|Other/Unknown|8|||
148875263|NCT01959139|537020585|FG003|Phase II|Other/Unknown|5|||
148875264|NCT01959139|537020582|FG000|Phase II|On treatment|0|||
148875265|NCT01959139|537020583|FG001|Phase II|On treatment|0|||
148875266|NCT01959139|537020584|FG002|Phase II|On treatment|4|||
148875267|NCT01959139|537020585|FG003|Phase II|On treatment|0|||
148875268|NCT03679624|537020586|FG000|Overall Study|Adverse Event|1|||
148875269|NCT03679624|537020587|FG001|Overall Study|Adverse Event|0|||
148875270|NCT00741013|537020588|FG000|Overall Study|Adverse Event|1|||
148875271|NCT00741013|537020589|FG001|Overall Study|Adverse Event|0|||
148875272|NCT00741013|537020590|FG002|Overall Study|Adverse Event|0|||
148875273|NCT00741013|537020588|FG000|Overall Study|Withdrawal by Subject|0|||
148875274|NCT00741013|537020589|FG001|Overall Study|Withdrawal by Subject|0|||
148875275|NCT00741013|537020590|FG002|Overall Study|Withdrawal by Subject|1|||
148875276|NCT00741013|537020588|FG000|Overall Study|Discovered failed screen after enrolled|0|||
148875277|NCT00741013|537020589|FG001|Overall Study|Discovered failed screen after enrolled|2|||
148875278|NCT00741013|537020590|FG002|Overall Study|Discovered failed screen after enrolled|0|||
148875279|NCT00082407|537020591|FG000|Overall Study|Adverse Event|20|||
148875280|NCT00082407|537020592|FG001|Overall Study|Adverse Event|0|||
148875281|NCT00082407|537020591|FG000|Overall Study|Protocol Violation|14|||
148875282|NCT00082407|537020592|FG001|Overall Study|Protocol Violation|12|||
148875283|NCT00082407|537020591|FG000|Overall Study|Patient Decision|13|||
148875284|NCT00082407|537020592|FG001|Overall Study|Patient Decision|6|||
148875285|NCT00082407|537020591|FG000|Overall Study|Physician Decision|5|||
148875286|NCT00082407|537020592|FG001|Overall Study|Physician Decision|3|||
148875287|NCT00082407|537020591|FG000|Overall Study|Loss of Glucose Control|2|||
148875288|NCT00082407|537020592|FG001|Overall Study|Loss of Glucose Control|2|||
148875289|NCT00082407|537020591|FG000|Overall Study|Death|2|||
148875290|NCT00082407|537020592|FG001|Overall Study|Death|1|||
148875291|NCT00082407|537020591|FG000|Overall Study|Lost to Follow-up|0|||
148875292|NCT00082407|537020592|FG001|Overall Study|Lost to Follow-up|3|||
148875293|NCT00567359|537020593|FG000|Overall Study|Withdrawal by Subject|1|||
148875294|NCT02352753|537020594|FG000|6-Month Dosing Period|Decision by sponsor|2|||
148875295|NCT02352753|537020594|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
148875296|NCT02352753|537020594|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
148875297|NCT02352753|537020594|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
148875298|NCT02352753|537020594|FG000|3-Month Dosing Period|Decision by sponsor|14|||
148875299|NCT02352753|537020594|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
148875300|NCT00539305|537020595|FG000|Overall Study|Adverse Event|1|||
148875301|NCT00539305|537020596|FG001|Overall Study|Adverse Event|0|||
148875302|NCT00539305|537020595|FG000|Overall Study|Substance Use|0|||
148875303|NCT00539305|537020596|FG001|Overall Study|Substance Use|1|||
148875304|NCT00539305|537020595|FG000|Overall Study|Withdrawal by Subject|0|||
148875305|NCT00539305|537020596|FG001|Overall Study|Withdrawal by Subject|1|||
148875306|NCT03626545|537020600|FG000|Overall Study|Progressive disease|3|||
148875307|NCT03626545|537020601|FG001|Overall Study|Progressive disease|82|||
148875308|NCT03626545|537020602|FG002|Overall Study|Progressive disease|85|||
148875309|NCT03626545|537020600|FG000|Overall Study|Adverse Event|3|||
148875310|NCT03626545|537020601|FG001|Overall Study|Adverse Event|13|||
148875311|NCT03626545|537020602|FG002|Overall Study|Adverse Event|10|||
148875312|NCT03626545|537020600|FG000|Overall Study|Physician Decision|1|||
148875313|NCT03626545|537020601|FG001|Overall Study|Physician Decision|18|||
148875314|NCT03626545|537020602|FG002|Overall Study|Physician Decision|14|||
148875315|NCT03626545|537020600|FG000|Overall Study|Subject Decision|0|||
148875316|NCT03626545|537020601|FG001|Overall Study|Subject Decision|5|||
148875317|NCT03626545|537020602|FG002|Overall Study|Subject Decision|5|||
148875318|NCT03626545|537020600|FG000|Overall Study|Death|1|||
148875319|NCT03626545|537020601|FG001|Overall Study|Death|1|||
148875320|NCT03626545|537020602|FG002|Overall Study|Death|1|||
148875321|NCT03626545|537020600|FG000|Overall Study|Protocol Deviation|0|||
148875322|NCT03626545|537020601|FG001|Overall Study|Protocol Deviation|1|||
148875323|NCT03626545|537020602|FG002|Overall Study|Protocol Deviation|1|||
148875324|NCT03626545|537020600|FG000|Overall Study|Guardian Decision|0|||
148875325|NCT03626545|537020601|FG001|Overall Study|Guardian Decision|0|||
148875326|NCT03626545|537020602|FG002|Overall Study|Guardian Decision|1|||
148875327|NCT00793325|537020604|FG000|Overall Study|Protocol Violation|18|||
148875328|NCT00793325|537020604|FG000|Overall Study|Lost to Follow-up|1|||
148875329|NCT01440816|537020605|FG000|Overall Study|Disease Progression|0|||
148875330|NCT01440816|537020606|FG001|Overall Study|Disease Progression|9|||
148875331|NCT01440816|537020605|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
148875332|NCT01440816|537020606|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
148875333|NCT03387020|537020607|FG000|Overall Study|Adverse Event|0|||
148875334|NCT03387020|537020608|FG001|Overall Study|Adverse Event|2|||
148875335|NCT03387020|537020609|FG002|Overall Study|Adverse Event|0|||
148875336|NCT03387020|537020607|FG000|Overall Study|Withdrawal by Subject|2|||
148875337|NCT03387020|537020608|FG001|Overall Study|Withdrawal by Subject|0|||
148875338|NCT03387020|537020609|FG002|Overall Study|Withdrawal by Subject|0|||
148875339|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
148875340|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
148875341|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
148875342|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
148875343|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
148875344|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
148875345|NCT01389323|537020618|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
148875346|NCT01389323|537020618|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
148875347|NCT01389323|537020618|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
148875348|NCT01389323|537020618|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
148875349|NCT01389323|537020618|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
148875350|NCT03596450|537020631|FG000|Overall Study|Death|9|||
148875351|NCT03596450|537020632|FG001|Overall Study|Death|9|||
148875352|NCT03596450|537020631|FG000|Overall Study|Protocol Violation|18|||
148875353|NCT03596450|537020632|FG001|Overall Study|Protocol Violation|26|||
148875354|NCT03596450|537020631|FG000|Overall Study|Lost to Follow-up|50|||
148875355|NCT03596450|537020632|FG001|Overall Study|Lost to Follow-up|56|||
148875356|NCT03596450|537020631|FG000|Overall Study|Adverse Event|14|||
148875357|NCT03596450|537020632|FG001|Overall Study|Adverse Event|7|||
148875358|NCT03596450|537020631|FG000|Overall Study|Withdrawal by Subject|38|||
148875359|NCT03596450|537020632|FG001|Overall Study|Withdrawal by Subject|36|||
148875360|NCT03596450|537020631|FG000|Overall Study|Accidentally Randomized|2|||
148875361|NCT03596450|537020632|FG001|Overall Study|Accidentally Randomized|0|||
148875362|NCT03596450|537020631|FG000|Overall Study|Other reasons|48|||
148875363|NCT03596450|537020632|FG001|Overall Study|Other reasons|53|||
148875364|NCT03596450|537020631|FG000|Overall Study|Pregnancy|2|||
148875365|NCT03596450|537020632|FG001|Overall Study|Pregnancy|0|||
148875366|NCT01069705|537020633|FG000|Overall Study|Adverse Event|1|||
148875367|NCT01069705|537020633|FG000|Overall Study|Withdrawal by Subject|2|||
148875368|NCT00915551|537020634|FG000|Overall Study|Withdrawal by Subject|0|||
148875369|NCT00915551|537020635|FG001|Overall Study|Withdrawal by Subject|1|||
148875370|NCT04390841|537020636|FG000|Overall Study|Withdrawal by Subject|2|||
148875371|NCT02999633|537020637|FG000|Overall Study|Adverse Event|2|||
148875372|NCT02999633|537020637|FG000|Overall Study|Progressive disease|12|||
148875373|NCT02607228|537020638|FG000|Overall Study|Progressive Disease|4|||
148875374|NCT02607228|537020639|FG001|Overall Study|Progressive Disease|3|||
148875375|NCT02607228|537020640|FG002|Overall Study|Progressive Disease|1|||
148875376|NCT02607228|537020641|FG003|Overall Study|Progressive Disease|5|||
148875377|NCT02607228|537020642|FG004|Overall Study|Progressive Disease|4|||
148875378|NCT02607228|537020643|FG005|Overall Study|Progressive Disease|3|||
148875379|NCT02607228|537020644|FG006|Overall Study|Progressive Disease|1|||
148875380|NCT02607228|537020638|FG000|Overall Study|Adverse Event|1|||
148875381|NCT02607228|537020639|FG001|Overall Study|Adverse Event|0|||
148875382|NCT02607228|537020640|FG002|Overall Study|Adverse Event|1|||
148875383|NCT02607228|537020641|FG003|Overall Study|Adverse Event|0|||
148875384|NCT02607228|537020642|FG004|Overall Study|Adverse Event|1|||
148875385|NCT02607228|537020643|FG005|Overall Study|Adverse Event|1|||
149000919|NCT01525602|537479432|FG002|Overall Study|Clinical progression|0|||
149000920|NCT01525602|537479433|FG003|Overall Study|Clinical progression|0|||
148875386|NCT02607228|537020644|FG006|Overall Study|Adverse Event|1|||
148875387|NCT02607228|537020638|FG000|Overall Study|Investigator's Discretion|0|||
148875388|NCT02607228|537020639|FG001|Overall Study|Investigator's Discretion|0|||
148875389|NCT02607228|537020640|FG002|Overall Study|Investigator's Discretion|1|||
148875390|NCT02607228|537020641|FG003|Overall Study|Investigator's Discretion|0|||
148875391|NCT02607228|537020642|FG004|Overall Study|Investigator's Discretion|0|||
148875392|NCT02607228|537020643|FG005|Overall Study|Investigator's Discretion|1|||
148875393|NCT02607228|537020644|FG006|Overall Study|Investigator's Discretion|0|||
148875394|NCT02607228|537020638|FG000|Overall Study|Withdrew Consent|0|||
148875395|NCT02607228|537020639|FG001|Overall Study|Withdrew Consent|1|||
148875396|NCT02607228|537020640|FG002|Overall Study|Withdrew Consent|0|||
148875397|NCT02607228|537020641|FG003|Overall Study|Withdrew Consent|0|||
148875398|NCT02607228|537020642|FG004|Overall Study|Withdrew Consent|0|||
148875399|NCT02607228|537020643|FG005|Overall Study|Withdrew Consent|1|||
148875400|NCT02607228|537020644|FG006|Overall Study|Withdrew Consent|0|||
148875401|NCT02607228|537020638|FG000|Overall Study|Study Terminated by Sponsor|0|||
148875402|NCT02607228|537020639|FG001|Overall Study|Study Terminated by Sponsor|0|||
148875403|NCT02607228|537020640|FG002|Overall Study|Study Terminated by Sponsor|0|||
148875404|NCT02607228|537020641|FG003|Overall Study|Study Terminated by Sponsor|1|||
148875405|NCT02607228|537020642|FG004|Overall Study|Study Terminated by Sponsor|0|||
148875406|NCT02607228|537020643|FG005|Overall Study|Study Terminated by Sponsor|0|||
148875407|NCT02607228|537020644|FG006|Overall Study|Study Terminated by Sponsor|0|||
148875408|NCT01196416|537020650|FG000|Overall Study|Withdrawal by Subject|2|||
148875409|NCT00727558|537020651|FG000|Overall Study|Lens issue|0|||
148875410|NCT00727558|537020652|FG001|Overall Study|Lens issue|1|||
148875411|NCT00727558|537020651|FG000|Overall Study|Adverse Event|0|||
148875412|NCT00727558|537020652|FG001|Overall Study|Adverse Event|1|||
148875413|NCT00727558|537020651|FG000|Overall Study|Subject unable to return for follow-up|1|||
148875414|NCT00727558|537020652|FG001|Overall Study|Subject unable to return for follow-up|1|||
148875415|NCT00727558|537020651|FG000|Overall Study|Lost to Follow-up|1|||
148875416|NCT00727558|537020652|FG001|Overall Study|Lost to Follow-up|0|||
148875417|NCT01717326|537020658|FG000|Overall Study|Death|0|||
148875418|NCT01717326|537020659|FG001|Overall Study|Death|0|||
148875419|NCT01717326|537020660|FG002|Overall Study|Death|0|||
148875420|NCT01717326|537020661|FG003|Overall Study|Death|0|||
148875421|NCT01717326|537020662|FG004|Overall Study|Death|0|||
148875422|NCT01717326|537020663|FG005|Overall Study|Death|0|||
148875423|NCT01717326|537020664|FG006|Overall Study|Death|0|||
148875424|NCT01717326|537020665|FG007|Overall Study|Death|0|||
148875425|NCT01717326|537020666|FG008|Overall Study|Death|0|||
148875426|NCT01717326|537020667|FG009|Overall Study|Death|0|||
148875427|NCT01717326|537020668|FG010|Overall Study|Death|1|||
148875428|NCT01717326|537020669|FG011|Overall Study|Death|0|||
148875429|NCT01717326|537020670|FG012|Overall Study|Death|0|||
148875430|NCT01717326|537020671|FG013|Overall Study|Death|0|||
148875431|NCT01717326|537020672|FG014|Overall Study|Death|0|||
148875432|NCT01717326|537020673|FG015|Overall Study|Death|0|||
148875433|NCT01717326|537020674|FG016|Overall Study|Death|0|||
148875434|NCT01717326|537020675|FG017|Overall Study|Death|0|||
148875435|NCT01717326|537020676|FG018|Overall Study|Death|0|||
148875436|NCT01717326|537020677|FG019|Overall Study|Death|0|||
148875437|NCT01717326|537020658|FG000|Overall Study|Lost to Follow-up|3|||
148875438|NCT01717326|537020659|FG001|Overall Study|Lost to Follow-up|0|||
148875439|NCT01717326|537020660|FG002|Overall Study|Lost to Follow-up|0|||
148875440|NCT01717326|537020661|FG003|Overall Study|Lost to Follow-up|2|||
148875441|NCT01717326|537020662|FG004|Overall Study|Lost to Follow-up|1|||
148875442|NCT01717326|537020663|FG005|Overall Study|Lost to Follow-up|0|||
148875443|NCT01717326|537020664|FG006|Overall Study|Lost to Follow-up|1|||
148875444|NCT01717326|537020665|FG007|Overall Study|Lost to Follow-up|0|||
148875445|NCT01717326|537020666|FG008|Overall Study|Lost to Follow-up|0|||
148875446|NCT01717326|537020667|FG009|Overall Study|Lost to Follow-up|0|||
148875447|NCT01717326|537020668|FG010|Overall Study|Lost to Follow-up|1|||
148875448|NCT01717326|537020669|FG011|Overall Study|Lost to Follow-up|0|||
148875449|NCT01717326|537020670|FG012|Overall Study|Lost to Follow-up|0|||
148875450|NCT01717326|537020671|FG013|Overall Study|Lost to Follow-up|0|||
148875451|NCT01717326|537020672|FG014|Overall Study|Lost to Follow-up|0|||
148875452|NCT01717326|537020673|FG015|Overall Study|Lost to Follow-up|2|||
148875453|NCT01717326|537020674|FG016|Overall Study|Lost to Follow-up|1|||
148875454|NCT01717326|537020675|FG017|Overall Study|Lost to Follow-up|0|||
148875455|NCT01717326|537020676|FG018|Overall Study|Lost to Follow-up|2|||
148875456|NCT01717326|537020677|FG019|Overall Study|Lost to Follow-up|3|||
148875457|NCT01717326|537020658|FG000|Overall Study|Physician Decision|0|||
148875458|NCT01717326|537020659|FG001|Overall Study|Physician Decision|0|||
148875459|NCT01717326|537020660|FG002|Overall Study|Physician Decision|0|||
148875460|NCT01717326|537020661|FG003|Overall Study|Physician Decision|0|||
148875461|NCT01717326|537020662|FG004|Overall Study|Physician Decision|0|||
148875462|NCT01717326|537020663|FG005|Overall Study|Physician Decision|0|||
148875463|NCT01717326|537020664|FG006|Overall Study|Physician Decision|0|||
148875464|NCT01717326|537020665|FG007|Overall Study|Physician Decision|0|||
148875465|NCT01717326|537020666|FG008|Overall Study|Physician Decision|0|||
148875466|NCT01717326|537020667|FG009|Overall Study|Physician Decision|1|||
148875467|NCT01717326|537020668|FG010|Overall Study|Physician Decision|0|||
148875468|NCT01717326|537020669|FG011|Overall Study|Physician Decision|0|||
148875469|NCT01717326|537020670|FG012|Overall Study|Physician Decision|0|||
148875470|NCT01717326|537020671|FG013|Overall Study|Physician Decision|0|||
148875471|NCT01717326|537020672|FG014|Overall Study|Physician Decision|0|||
148875472|NCT01717326|537020673|FG015|Overall Study|Physician Decision|0|||
148875473|NCT01717326|537020674|FG016|Overall Study|Physician Decision|0|||
148875474|NCT01717326|537020675|FG017|Overall Study|Physician Decision|0|||
148875475|NCT01717326|537020676|FG018|Overall Study|Physician Decision|0|||
148875476|NCT01717326|537020677|FG019|Overall Study|Physician Decision|0|||
148875477|NCT01717326|537020658|FG000|Overall Study|Protocol Violation|0|||
148875478|NCT01717326|537020659|FG001|Overall Study|Protocol Violation|0|||
149033696|NCT01838551|537600448|FG000|Overall Study|Lack of Efficacy|10|||
149033697|NCT01838551|537600448|FG000|Overall Study|Physician Decision|4|||
149033698|NCT01838551|537600448|FG000|Overall Study|Withdrawal by Subject|10|||
149033699|NCT01838551|537600448|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
149033700|NCT00906282|537600449|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
149033701|NCT00906282|537600449|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
149033702|NCT00906282|537600449|FG000|Preoperative Chemotherapy|Progressive disease|6|||
148875479|NCT01717326|537020660|FG002|Overall Study|Protocol Violation|0|||
148875480|NCT01717326|537020661|FG003|Overall Study|Protocol Violation|0|||
148875481|NCT01717326|537020662|FG004|Overall Study|Protocol Violation|1|||
148875482|NCT01717326|537020663|FG005|Overall Study|Protocol Violation|0|||
148875483|NCT01717326|537020664|FG006|Overall Study|Protocol Violation|0|||
148875484|NCT01717326|537020665|FG007|Overall Study|Protocol Violation|0|||
148875485|NCT01717326|537020666|FG008|Overall Study|Protocol Violation|0|||
148875486|NCT01717326|537020667|FG009|Overall Study|Protocol Violation|0|||
148875487|NCT01717326|537020668|FG010|Overall Study|Protocol Violation|0|||
148875488|NCT01717326|537020669|FG011|Overall Study|Protocol Violation|0|||
148875489|NCT01717326|537020670|FG012|Overall Study|Protocol Violation|0|||
148875490|NCT01717326|537020671|FG013|Overall Study|Protocol Violation|0|||
148875491|NCT01717326|537020672|FG014|Overall Study|Protocol Violation|0|||
148875492|NCT01717326|537020673|FG015|Overall Study|Protocol Violation|0|||
148875493|NCT01717326|537020674|FG016|Overall Study|Protocol Violation|0|||
148875494|NCT01717326|537020675|FG017|Overall Study|Protocol Violation|0|||
148875495|NCT01717326|537020676|FG018|Overall Study|Protocol Violation|0|||
148875496|NCT01717326|537020677|FG019|Overall Study|Protocol Violation|0|||
148875497|NCT01717326|537020658|FG000|Overall Study|Withdrawal by Subject|0|||
148875498|NCT01717326|537020659|FG001|Overall Study|Withdrawal by Subject|1|||
148875499|NCT01717326|537020660|FG002|Overall Study|Withdrawal by Subject|0|||
148875500|NCT01717326|537020661|FG003|Overall Study|Withdrawal by Subject|0|||
148875501|NCT01717326|537020662|FG004|Overall Study|Withdrawal by Subject|0|||
148875502|NCT01717326|537020663|FG005|Overall Study|Withdrawal by Subject|0|||
148875503|NCT01717326|537020664|FG006|Overall Study|Withdrawal by Subject|0|||
148875504|NCT01717326|537020665|FG007|Overall Study|Withdrawal by Subject|0|||
148875505|NCT01717326|537020666|FG008|Overall Study|Withdrawal by Subject|0|||
148875506|NCT01717326|537020667|FG009|Overall Study|Withdrawal by Subject|1|||
148875507|NCT01717326|537020668|FG010|Overall Study|Withdrawal by Subject|0|||
148875508|NCT01717326|537020669|FG011|Overall Study|Withdrawal by Subject|0|||
148875509|NCT01717326|537020670|FG012|Overall Study|Withdrawal by Subject|1|||
148875510|NCT01717326|537020671|FG013|Overall Study|Withdrawal by Subject|0|||
148875511|NCT01717326|537020672|FG014|Overall Study|Withdrawal by Subject|0|||
148875512|NCT01717326|537020673|FG015|Overall Study|Withdrawal by Subject|1|||
148875513|NCT01717326|537020674|FG016|Overall Study|Withdrawal by Subject|0|||
148875514|NCT01717326|537020675|FG017|Overall Study|Withdrawal by Subject|0|||
148875515|NCT01717326|537020676|FG018|Overall Study|Withdrawal by Subject|2|||
148875516|NCT01717326|537020677|FG019|Overall Study|Withdrawal by Subject|3|||
148875517|NCT01123707|537020679|FG000|Overall Study|Lost to Follow-up|3|||
148875518|NCT01123707|537020680|FG001|Overall Study|Lost to Follow-up|1|||
148875519|NCT01123707|537020681|FG002|Overall Study|Lost to Follow-up|3|||
148875520|NCT01123707|537020682|FG003|Overall Study|Lost to Follow-up|2|||
148875521|NCT01123707|537020679|FG000|Overall Study|Adverse Event|5|||
148875522|NCT01123707|537020680|FG001|Overall Study|Adverse Event|7|||
148875523|NCT01123707|537020681|FG002|Overall Study|Adverse Event|5|||
148875524|NCT01123707|537020682|FG003|Overall Study|Adverse Event|3|||
148875525|NCT01123707|537020679|FG000|Overall Study|Sponsor Discontinued Study|30|||
148875526|NCT01123707|537020680|FG001|Overall Study|Sponsor Discontinued Study|24|||
148875527|NCT01123707|537020681|FG002|Overall Study|Sponsor Discontinued Study|25|||
148875528|NCT01123707|537020682|FG003|Overall Study|Sponsor Discontinued Study|40|||
148875529|NCT01123707|537020679|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
148875530|NCT01123707|537020680|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
148875531|NCT01123707|537020681|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
148875532|NCT01123707|537020682|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
148875533|NCT01123707|537020679|FG000|Overall Study|Investigator Withdrew Participant|0|||
148875534|NCT01123707|537020680|FG001|Overall Study|Investigator Withdrew Participant|1|||
148875535|NCT01123707|537020681|FG002|Overall Study|Investigator Withdrew Participant|1|||
148875536|NCT01123707|537020682|FG003|Overall Study|Investigator Withdrew Participant|1|||
148875537|NCT01123707|537020679|FG000|Overall Study|Subject Withdrew Consent|4|||
148875538|NCT01123707|537020680|FG001|Overall Study|Subject Withdrew Consent|5|||
148875539|NCT01123707|537020681|FG002|Overall Study|Subject Withdrew Consent|1|||
148875540|NCT01123707|537020682|FG003|Overall Study|Subject Withdrew Consent|2|||
148875541|NCT01123707|537020679|FG000|Overall Study|Lack of Efficacy|1|||
148875542|NCT01123707|537020680|FG001|Overall Study|Lack of Efficacy|2|||
148875543|NCT01123707|537020681|FG002|Overall Study|Lack of Efficacy|1|||
148875544|NCT01123707|537020682|FG003|Overall Study|Lack of Efficacy|0|||
148875545|NCT01123707|537020679|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
148875546|NCT01123707|537020680|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
148875547|NCT01123707|537020681|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
148875548|NCT01123707|537020682|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
148875549|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
148875550|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
148875551|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
148875552|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
148875553|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
148875554|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
148875555|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
148875556|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
148875557|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Death|0|||
148875558|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Death|1|||
148875559|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
148875560|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
148875561|NCT03281304|537020683|FG000|Treatment Phase (up to 42 Months)|Other|0|||
148875562|NCT03281304|537020684|FG001|Treatment Phase (up to 42 Months)|Other|2|||
148875563|NCT03281304|537020683|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
148875564|NCT03281304|537020684|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
148875565|NCT01114438|537020685|FG000|Overall Study|Adverse Event|10|||
148875566|NCT01114438|537020685|FG000|Overall Study|concomitant medication|1|||
148875567|NCT01114438|537020685|FG000|Overall Study|Physician Decision|1|||
148875568|NCT01114438|537020685|FG000|Overall Study|Withdrawal by Subject|2|||
148875569|NCT02577016|537020690|FG000|Overall Study|Adverse Event|2|||
148875570|NCT02577016|537020691|FG001|Overall Study|Adverse Event|1|||
148875571|NCT02577016|537020690|FG000|Overall Study|Physician Decision|0|||
148875572|NCT02577016|537020691|FG001|Overall Study|Physician Decision|1|||
148875573|NCT00566254|537020692|FG000|Overall Study|Adverse Event|3|||
148875574|NCT00566254|537020693|FG001|Overall Study|Adverse Event|1|||
148875575|NCT00566254|537020692|FG000|Overall Study|Protocol Violation|1|||
148875576|NCT00566254|537020693|FG001|Overall Study|Protocol Violation|3|||
148875577|NCT00566254|537020692|FG000|Overall Study|Withdrawal by Subject|1|||
148875578|NCT00566254|537020693|FG001|Overall Study|Withdrawal by Subject|2|||
148875579|NCT00566254|537020692|FG000|Overall Study|Lack of Efficacy|5|||
148875580|NCT00566254|537020693|FG001|Overall Study|Lack of Efficacy|6|||
148875581|NCT00566254|537020692|FG000|Overall Study|Other|0|||
148875582|NCT00566254|537020693|FG001|Overall Study|Other|2|||
148875583|NCT00687531|537020694|FG000|Overall Study|Did not meet protocol eligibility|104|||
148875584|NCT00687531|537020694|FG000|Overall Study|Adverse Event|5|||
148875585|NCT00687531|537020694|FG000|Overall Study|Lost to Follow-up|26|||
148875586|NCT02301624|537020695|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
148875587|NCT02301624|537020696|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
148875588|NCT02301624|537020695|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
148875589|NCT02301624|537020696|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
149033703|NCT00906282|537600449|FG000|Preoperative Chemotherapy|Toxicity|1|||
149033704|NCT02685033|537600450|FG000|Overall Study|Withdrawal of Consent|0|||
149033705|NCT02685033|537600451|FG001|Overall Study|Withdrawal of Consent|1|||
148875590|NCT02301624|537020695|FG000|Open-label Maintenance Phase|Adverse Event|2|||
148875591|NCT02301624|537020696|FG001|Open-label Maintenance Phase|Adverse Event|5|||
148875592|NCT02301624|537020695|FG000|Open-label Maintenance Phase|Physician Decision|3|||
148875593|NCT02301624|537020696|FG001|Open-label Maintenance Phase|Physician Decision|3|||
148875594|NCT02301624|537020695|FG000|Open-label Maintenance Phase|Death|2|||
148875595|NCT02301624|537020696|FG001|Open-label Maintenance Phase|Death|1|||
148875596|NCT02301624|537020695|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
148875597|NCT02301624|537020696|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
148875598|NCT00666224|537022792|FG000|Double-Blind|Adverse Event|15|||
148875599|NCT00666224|537022793|FG001|Double-Blind|Adverse Event|5|||
149033706|NCT02685033|537600450|FG000|Overall Study|Lost to Follow-up|2|||
148875600|NCT00666224|537022792|FG000|Double-Blind|Lost to Follow-up|2|||
148875601|NCT00666224|537022793|FG001|Double-Blind|Lost to Follow-up|2|||
148875602|NCT00666224|537022792|FG000|Double-Blind|Withdrawal by Subject|18|||
148875603|NCT00666224|537022793|FG001|Double-Blind|Withdrawal by Subject|14|||
148875604|NCT00666224|537022792|FG000|Double-Blind|Physician Decision|0|||
148875605|NCT00666224|537022793|FG001|Double-Blind|Physician Decision|3|||
148875606|NCT00666224|537022792|FG000|Double-Blind|Sponsor decision|1|||
148875607|NCT00666224|537022793|FG001|Double-Blind|Sponsor decision|0|||
148875608|NCT00666224|537022792|FG000|Double-Blind|Pregnancy|3|||
148875609|NCT00666224|537022793|FG001|Double-Blind|Pregnancy|2|||
148875610|NCT00666224|537022792|FG000|Double-Blind|Noncompliance|1|||
149033707|NCT02685033|537600451|FG001|Overall Study|Lost to Follow-up|1|||
148875611|NCT00666224|537022793|FG001|Double-Blind|Noncompliance|0|||
148875612|NCT00666224|537022792|FG000|Double-Blind|Death|1|||
148875613|NCT00666224|537022793|FG001|Double-Blind|Death|0|||
148875614|NCT00666224|537022792|FG000|Double-Blind|Undefined/Unknown|4|||
148875615|NCT00666224|537022793|FG001|Double-Blind|Undefined/Unknown|1|||
148875616|NCT00666224|537022792|FG000|Open-Label|Adverse Event|8|||
148875617|NCT00666224|537022793|FG001|Open-Label|Adverse Event|43|||
148875618|NCT00666224|537022792|FG000|Open-Label|Lost to Follow-up|4|||
148875619|NCT00666224|537022793|FG001|Open-Label|Lost to Follow-up|5|||
149033708|NCT02685033|537600450|FG000|Overall Study|Adverse Event|1|||
149033709|NCT02685033|537600451|FG001|Overall Study|Adverse Event|0|||
149033710|NCT00708097|537600452|FG000|Period 1|Protocol Violation|0|||
149033711|NCT00708097|537600453|FG001|Period 1|Protocol Violation|1|||
149033712|NCT00708097|537600454|FG002|Period 1|Protocol Violation|0|||
149033713|NCT00708097|537600455|FG003|Period 1|Protocol Violation|2|||
149033714|NCT00708097|537600456|FG004|Period 1|Protocol Violation|0|||
149033715|NCT00708097|537600452|FG000|Period 1|Other Reason|0|||
149033716|NCT00708097|537600453|FG001|Period 1|Other Reason|0|||
149033717|NCT00708097|537600454|FG002|Period 1|Other Reason|0|||
149033718|NCT00708097|537600455|FG003|Period 1|Other Reason|0|||
149033719|NCT00708097|537600456|FG004|Period 1|Other Reason|1|||
149033720|NCT00708097|537600452|FG000|Period 2|Protocol Violation|0|||
149033721|NCT00708097|537600453|FG001|Period 2|Protocol Violation|1|||
149033722|NCT00708097|537600454|FG002|Period 2|Protocol Violation|1|||
149033723|NCT00708097|537600455|FG003|Period 2|Protocol Violation|1|||
149033724|NCT00708097|537600456|FG004|Period 2|Protocol Violation|0|||
149033725|NCT03425643|537600459|FG000|Overall Study|Withdrawal by Subject|10|||
149033726|NCT03425643|537600460|FG001|Overall Study|Withdrawal by Subject|12|||
149033727|NCT03425643|537600459|FG000|Overall Study|Lost to Follow-up|2|||
149033728|NCT03425643|537600460|FG001|Overall Study|Lost to Follow-up|0|||
149033729|NCT03425643|537600459|FG000|Overall Study|Death|109|||
149033730|NCT03425643|537600460|FG001|Overall Study|Death|141|||
149033731|NCT03425643|537600459|FG000|Overall Study|Ongoing in study|276|||
149033732|NCT03425643|537600460|FG001|Overall Study|Ongoing in study|247|||
149033733|NCT04133363|537600461|FG000|Overall Study|Lost to Follow-up|2|||
149033734|NCT04133363|537600462|FG001|Overall Study|Lost to Follow-up|1|||
149033735|NCT04133363|537600463|FG002|Overall Study|Lost to Follow-up|4|||
149033736|NCT01838200|537600464|FG000|Overall Study|Adverse Event|0|||
149033737|NCT01838200|537600465|FG001|Overall Study|Adverse Event|2|||
149033738|NCT01838200|537600464|FG000|Overall Study|Progressive disease|3|||
149033739|NCT01838200|537600465|FG001|Overall Study|Progressive disease|0|||
149033740|NCT02962674|537601898|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
149033741|NCT00628862|537601899|FG000|Overall Study|Adverse Event|6|||
149033742|NCT00628862|537601900|FG001|Overall Study|Adverse Event|8|||
149033743|NCT00628862|537601901|FG002|Overall Study|Adverse Event|10|||
149033744|NCT00628862|537601899|FG000|Overall Study|Withdrawal by Subject|4|||
149033745|NCT00628862|537601900|FG001|Overall Study|Withdrawal by Subject|6|||
149033746|NCT00628862|537601901|FG002|Overall Study|Withdrawal by Subject|11|||
148875620|NCT00666224|537022792|FG000|Open-Label|Withdrawal by Subject|12|||
148875621|NCT00666224|537022793|FG001|Open-Label|Withdrawal by Subject|25|||
148875622|NCT00666224|537022792|FG000|Open-Label|Physician Decision|7|||
148875623|NCT00666224|537022793|FG001|Open-Label|Physician Decision|5|||
149000921|NCT01525602|537479434|FG004|Overall Study|Clinical progression|0|||
149000922|NCT01525602|537479435|FG005|Overall Study|Clinical progression|0|||
149000923|NCT01525602|537479436|FG006|Overall Study|Clinical progression|1|||
149000924|NCT01525602|537479437|FG007|Overall Study|Clinical progression|1|||
149000925|NCT01525602|537479430|FG000|Overall Study|Non-compliance|0|||
149000926|NCT01525602|537479431|FG001|Overall Study|Non-compliance|0|||
149000927|NCT01525602|537479432|FG002|Overall Study|Non-compliance|0|||
149000928|NCT01525602|537479433|FG003|Overall Study|Non-compliance|0|||
149000929|NCT01525602|537479434|FG004|Overall Study|Non-compliance|1|||
149000930|NCT01525602|537479435|FG005|Overall Study|Non-compliance|0|||
149000931|NCT01525602|537479436|FG006|Overall Study|Non-compliance|0|||
149000932|NCT01525602|537479437|FG007|Overall Study|Non-compliance|0|||
149000933|NCT01525602|537479430|FG000|Overall Study|Withdrawal by Subject|0|||
149000934|NCT01525602|537479431|FG001|Overall Study|Withdrawal by Subject|0|||
149000935|NCT01525602|537479432|FG002|Overall Study|Withdrawal by Subject|0|||
149000936|NCT01525602|537479433|FG003|Overall Study|Withdrawal by Subject|0|||
149000937|NCT01525602|537479434|FG004|Overall Study|Withdrawal by Subject|3|||
149000938|NCT01525602|537479435|FG005|Overall Study|Withdrawal by Subject|1|||
149000939|NCT01525602|537479436|FG006|Overall Study|Withdrawal by Subject|0|||
149000940|NCT01525602|537479437|FG007|Overall Study|Withdrawal by Subject|1|||
149000941|NCT01525602|537479430|FG000|Overall Study|Physician Decision|0|||
149000942|NCT01525602|537479431|FG001|Overall Study|Physician Decision|0|||
149000943|NCT01525602|537479432|FG002|Overall Study|Physician Decision|0|||
149000944|NCT01525602|537479433|FG003|Overall Study|Physician Decision|0|||
149000945|NCT01525602|537479434|FG004|Overall Study|Physician Decision|3|||
149000946|NCT01525602|537479435|FG005|Overall Study|Physician Decision|0|||
149000947|NCT01525602|537479436|FG006|Overall Study|Physician Decision|1|||
149000948|NCT01525602|537479437|FG007|Overall Study|Physician Decision|0|||
149033747|NCT00628862|537601899|FG000|Overall Study|Lost to Follow-up|0|||
149033748|NCT00628862|537601900|FG001|Overall Study|Lost to Follow-up|2|||
149033749|NCT00628862|537601901|FG002|Overall Study|Lost to Follow-up|1|||
149033750|NCT00628862|537601899|FG000|Overall Study|Protocol Violation|1|||
149033751|NCT00628862|537601900|FG001|Overall Study|Protocol Violation|0|||
149033752|NCT00628862|537601901|FG002|Overall Study|Protocol Violation|0|||
149033753|NCT00628862|537601899|FG000|Overall Study|COPD Exacerbation|0|||
149033754|NCT00628862|537601900|FG001|Overall Study|COPD Exacerbation|1|||
149033755|NCT00628862|537601901|FG002|Overall Study|COPD Exacerbation|0|||
149033756|NCT02614560|537601904|FG000|Overall Study|Death|6|||
149033757|NCT02614560|537601905|FG001|Overall Study|Death|2|||
149033758|NCT03720210|537601906|FG000|Overall Study|Lost to Follow-up|1|||
149033759|NCT04033432|537601907|FG000|Overall Study|Progressive Disease|8|||
149033760|NCT04033432|537601907|FG000|Overall Study|Adverse Event|4|||
149033761|NCT04033432|537601907|FG000|Overall Study|Death|1|||
149033762|NCT00738699|537601913|FG000|Overall Study|Withdrawal by Subject|5|||
149033763|NCT00738699|537601914|FG001|Overall Study|Withdrawal by Subject|0|||
149033764|NCT00738699|537601913|FG000|Overall Study|Lost to Follow-up|1|||
149033765|NCT00738699|537601914|FG001|Overall Study|Lost to Follow-up|0|||
149033766|NCT00738699|537601913|FG000|Overall Study|Death|144|||
149033767|NCT00738699|537601914|FG001|Overall Study|Death|68|||
149033768|NCT00738699|537601913|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
149033769|NCT00738699|537601914|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
149033770|NCT00738699|537601913|FG000|Overall Study|Other|2|||
149033771|NCT00738699|537601914|FG001|Overall Study|Other|0|||
149033772|NCT00549848|537601915|FG000|Overall Study|Death|1|||
149033773|NCT00549848|537601916|FG001|Overall Study|Death|4|||
149033774|NCT00549848|537601917|FG002|Overall Study|Death|13|||
149033775|NCT00549848|537601915|FG000|Overall Study|Physician Decision|0|||
149033776|NCT00549848|537601916|FG001|Overall Study|Physician Decision|0|||
149033777|NCT00549848|537601917|FG002|Overall Study|Physician Decision|4|||
149033778|NCT00549848|537601915|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
149033779|NCT00549848|537601916|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
149033780|NCT00549848|537601917|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
149033781|NCT00549848|537601915|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
149033782|NCT00549848|537601916|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
149033783|NCT00549848|537601917|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
149033784|NCT00549848|537601915|FG000|Overall Study|Participant/Family Withdraw|2|||
149033785|NCT00549848|537601916|FG001|Overall Study|Participant/Family Withdraw|3|||
149033786|NCT00549848|537601917|FG002|Overall Study|Participant/Family Withdraw|5|||
149033787|NCT00549848|537601915|FG000|Overall Study|Second Malignancy|1|||
149033788|NCT00549848|537601916|FG001|Overall Study|Second Malignancy|0|||
149033789|NCT00549848|537601917|FG002|Overall Study|Second Malignancy|0|||
149033790|NCT00549848|537601915|FG000|Overall Study|Transplant|3|||
149033791|NCT00549848|537601916|FG001|Overall Study|Transplant|3|||
149033792|NCT00549848|537601917|FG002|Overall Study|Transplant|18|||
149033793|NCT00549848|537601915|FG000|Overall Study|Unacceptable Toxicity|1|||
149033794|NCT00549848|537601916|FG001|Overall Study|Unacceptable Toxicity|6|||
149033795|NCT00549848|537601917|FG002|Overall Study|Unacceptable Toxicity|6|||
149033796|NCT00868192|537601919|FG000|Overall Study|Ineligible|4|||
149033797|NCT02174562|537601920|FG000|Overall Study|Withdrawal by Subject|7|||
149033798|NCT02174562|537601921|FG001|Overall Study|Withdrawal by Subject|2|||
148875624|NCT00666224|537022792|FG000|Open-Label|Pregnancy|1|||
149033799|NCT02174562|537601920|FG000|Overall Study|Death|2|||
149033800|NCT02174562|537601921|FG001|Overall Study|Death|0|||
149033801|NCT02174562|537601920|FG000|Overall Study|Lost to Follow-up|0|||
149033802|NCT02174562|537601921|FG001|Overall Study|Lost to Follow-up|3|||
149033803|NCT05193318|537601922|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
149033804|NCT05193318|537601922|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
149033805|NCT03201809|537601923|FG000|Overall Study|Lost to Follow-up|2|||
149033806|NCT03201809|537601924|FG001|Overall Study|Lost to Follow-up|0|||
149033807|NCT02046616|537601929|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
149033808|NCT02046616|537601929|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
149033809|NCT02046616|537601929|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
149033810|NCT02046616|537601929|FG000|24-Week Treatment Period|Physician Decision|3|||
149033811|NCT02046616|537601929|FG000|24-Week Treatment Period|Other|1|||
149033812|NCT02046616|537601929|FG000|8-Week FU Period|Lost to Follow-up|1|||
149033813|NCT00130637|537601932|FG000|Overall Study|Adverse Event|2|||
149033814|NCT00130637|537601932|FG000|Overall Study|Withdrawal by Subject|1|||
149033815|NCT01591616|537601934|FG000|Overall Study|Withdrawal by Subject|1|||
149033816|NCT01959412|537601935|FG000|Overall Study|Protocol deviation|1|||
149033817|NCT01959412|537601936|FG001|Overall Study|Protocol deviation|1|||
149033818|NCT01959412|537601937|FG002|Overall Study|Protocol deviation|0|||
149033819|NCT01959412|537601938|FG003|Overall Study|Protocol deviation|1|||
149033820|NCT01959412|537601939|FG004|Overall Study|Protocol deviation|3|||
149033821|NCT01959412|537601940|FG005|Overall Study|Protocol deviation|0|||
149033822|NCT01959412|537601935|FG000|Overall Study|Adverse Event|0|||
149033823|NCT01959412|537601936|FG001|Overall Study|Adverse Event|0|||
149033824|NCT01959412|537601937|FG002|Overall Study|Adverse Event|0|||
149033825|NCT01959412|537601938|FG003|Overall Study|Adverse Event|1|||
149033826|NCT01959412|537601939|FG004|Overall Study|Adverse Event|0|||
149033827|NCT01959412|537601940|FG005|Overall Study|Adverse Event|0|||
149033828|NCT00158054|537601941|FG000|Overall Study|Refused to continue|3|||
149033829|NCT00158054|537601942|FG001|Overall Study|Refused to continue|0|||
149033830|NCT00158054|537601941|FG000|Overall Study|Unavailable for follow up|7|||
149033831|NCT00158054|537601942|FG001|Overall Study|Unavailable for follow up|3|||
149033832|NCT04567888|537601947|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
149033833|NCT04567888|537601948|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
149033834|NCT04567888|537601947|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
149033835|NCT04567888|537601948|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
149033836|NCT04567888|537601947|FG000|Overall Study|Reported Unusual Birth Year|2|||
149033837|NCT04567888|537601948|FG001|Overall Study|Reported Unusual Birth Year|3|||
149033838|NCT04567888|537601947|FG000|Overall Study|Duplicate Responses|0|||
149033839|NCT04567888|537601948|FG001|Overall Study|Duplicate Responses|1|||
149033840|NCT00414648|537601949|FG000|Overall Study|Adverse Event|5|||
149033841|NCT00414648|537601950|FG001|Overall Study|Adverse Event|5|||
149033842|NCT00414648|537601949|FG000|Overall Study|Death|0|||
149033843|NCT00414648|537601950|FG001|Overall Study|Death|1|||
149033844|NCT00414648|537601949|FG000|Overall Study|Lack of Efficacy|0|||
149033845|NCT00414648|537601950|FG001|Overall Study|Lack of Efficacy|2|||
149033846|NCT00414648|537601949|FG000|Overall Study|Withdrawal by Subject|0|||
149033847|NCT00414648|537601950|FG001|Overall Study|Withdrawal by Subject|1|||
149033848|NCT04173572|537601951|FG000|Overall Study|Withdrawal by Subject|1|||
149033849|NCT04173572|537601952|FG001|Overall Study|Withdrawal by Subject|5|||
149033850|NCT04173572|537601951|FG000|Overall Study|Lost to Follow-up|3|||
149033851|NCT04173572|537601952|FG001|Overall Study|Lost to Follow-up|1|||
149033852|NCT01490580|537601953|FG000|Overall Study|Parents withdrew consent|0|||
149033853|NCT01490580|537601954|FG001|Overall Study|Parents withdrew consent|2|||
149033854|NCT00383188|537601957|FG000|Overall Study|Adverse Event|4|||
149033855|NCT00383188|537601958|FG001|Overall Study|Adverse Event|7|||
149033856|NCT00383188|537601959|FG002|Overall Study|Adverse Event|9|||
149033857|NCT00383188|537601960|FG003|Overall Study|Adverse Event|8|||
149033858|NCT00383188|537601961|FG004|Overall Study|Adverse Event|8|||
149033859|NCT00383188|537601957|FG000|Overall Study|Lack of Efficacy|9|||
149033860|NCT00383188|537601958|FG001|Overall Study|Lack of Efficacy|3|||
149033861|NCT00383188|537601959|FG002|Overall Study|Lack of Efficacy|3|||
149033862|NCT00383188|537601960|FG003|Overall Study|Lack of Efficacy|2|||
149033863|NCT00383188|537601961|FG004|Overall Study|Lack of Efficacy|6|||
149033864|NCT00383188|537601957|FG000|Overall Study|Other|3|||
149033865|NCT00383188|537601958|FG001|Overall Study|Other|1|||
149033866|NCT00383188|537601959|FG002|Overall Study|Other|0|||
149033867|NCT00383188|537601960|FG003|Overall Study|Other|2|||
149033868|NCT00383188|537601961|FG004|Overall Study|Other|6|||
149033869|NCT00383188|537601957|FG000|Overall Study|No longer willing to participate|1|||
149033870|NCT00383188|537601958|FG001|Overall Study|No longer willing to participate|0|||
149033871|NCT00383188|537601959|FG002|Overall Study|No longer willing to participate|1|||
149033872|NCT00383188|537601960|FG003|Overall Study|No longer willing to participate|0|||
149033873|NCT00383188|537601961|FG004|Overall Study|No longer willing to participate|2|||
149033874|NCT00383188|537601957|FG000|Overall Study|Lost to Follow-up|0|||
149033875|NCT00383188|537601958|FG001|Overall Study|Lost to Follow-up|0|||
149033876|NCT00383188|537601959|FG002|Overall Study|Lost to Follow-up|0|||
149033877|NCT00383188|537601960|FG003|Overall Study|Lost to Follow-up|0|||
149033878|NCT00383188|537601961|FG004|Overall Study|Lost to Follow-up|1|||
149033879|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
149033880|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
149033881|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
149033882|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
149033883|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
149033884|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
149033885|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
149033886|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
149033887|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
149033888|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
149033889|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
149033890|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
149033891|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Death|7|||
149033892|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Death|4|||
149033893|NCT00410124|537601962|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
149033894|NCT00410124|537601963|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
149033895|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
149033896|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
149033897|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
149033898|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
149033899|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
149033900|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
149033901|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
149033902|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
149033903|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
149033904|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
149033905|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
149033906|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
149033907|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
149033908|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
149033909|NCT00410124|537601962|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
149033910|NCT00410124|537601963|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
149033911|NCT01321606|537601969|FG000|Overall Study|Lost to Follow-up|0|||
149033912|NCT01321606|537601970|FG001|Overall Study|Lost to Follow-up|0|||
149033913|NCT01321606|537601971|FG002|Overall Study|Lost to Follow-up|0|||
149033914|NCT01321606|537601972|FG003|Overall Study|Lost to Follow-up|1|||
149033915|NCT00988637|537601976|FG000|Overall Study|Lost to Follow-up|2|||
149033916|NCT00988637|537601977|FG001|Overall Study|Lost to Follow-up|1|||
149033917|NCT00988637|537601976|FG000|Overall Study|Withdrawal by Subject|1|||
149033918|NCT00988637|537601977|FG001|Overall Study|Withdrawal by Subject|1|||
149033919|NCT00988637|537601976|FG000|Overall Study|non-compliance with study drug|0|||
149033920|NCT00988637|537601977|FG001|Overall Study|non-compliance with study drug|1|||
149033921|NCT03593070|537601978|FG000|Overall Study|administrative withdrawal|1|||
149033922|NCT03593070|537601979|FG001|Overall Study|administrative withdrawal|1|||
149033923|NCT03098030|537601982|FG000|Overall Study|Death|10|||
149033924|NCT03098030|537601983|FG001|Overall Study|Death|156|||
149033925|NCT03098030|537601984|FG002|Overall Study|Death|156|||
149033926|NCT03098030|537601985|FG003|Overall Study|Death|82|||
149033927|NCT03098030|537601982|FG000|Overall Study|Withdrawal by Subject|0|||
149033928|NCT03098030|537601983|FG001|Overall Study|Withdrawal by Subject|7|||
149033929|NCT03098030|537601984|FG002|Overall Study|Withdrawal by Subject|8|||
149033930|NCT03098030|537601985|FG003|Overall Study|Withdrawal by Subject|2|||
149033931|NCT03098030|537601982|FG000|Overall Study|Lost to Follow-up|0|||
149033932|NCT03098030|537601983|FG001|Overall Study|Lost to Follow-up|0|||
149033933|NCT03098030|537601984|FG002|Overall Study|Lost to Follow-up|2|||
149033934|NCT03098030|537601985|FG003|Overall Study|Lost to Follow-up|1|||
149033935|NCT03310983|537601989|FG000|Overall Study|Lost to Follow-up|15|||
149033936|NCT03310983|537601990|FG001|Overall Study|Lost to Follow-up|17|||
149033937|NCT03368001|537601991|FG000|Allocation|Lost to Pretest|16|||
149033938|NCT03368001|537601992|FG001|Allocation|Lost to Pretest|25|||
149033939|NCT03368001|537601991|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
149033940|NCT03368001|537601992|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
149033941|NCT03368001|537601991|FG000|Posttest|Lost to Posttest|7|||
149033942|NCT03368001|537601992|FG001|Posttest|Lost to Posttest|11|||
149033943|NCT03368001|537601991|FG000|Posttest|Discontinued Intervention|6|||
149033944|NCT03368001|537601992|FG001|Posttest|Discontinued Intervention|19|||
149033945|NCT03368001|537601991|FG000|Follow-up|Lost to Follow-up|6|||
149033946|NCT03368001|537601992|FG001|Follow-up|Lost to Follow-up|3|||
149033947|NCT03612804|537601993|FG000|Overall Study|Death|0|||
149033948|NCT03612804|537601994|FG001|Overall Study|Death|7|||
149033949|NCT03612804|537601995|FG002|Overall Study|Death|0|||
149033950|NCT03612804|537601996|FG003|Overall Study|Death|8|||
149033951|NCT03612804|537601993|FG000|Overall Study|Medication copay coverage issues|0|||
149033952|NCT03612804|537601994|FG001|Overall Study|Medication copay coverage issues|0|||
149033953|NCT03612804|537601995|FG002|Overall Study|Medication copay coverage issues|0|||
149033954|NCT03612804|537601996|FG003|Overall Study|Medication copay coverage issues|17|||
149033955|NCT03612804|537601993|FG000|Overall Study|Not current smoker at time of screening|0|||
149033956|NCT03612804|537601994|FG001|Overall Study|Not current smoker at time of screening|1|||
149033957|NCT03612804|537601995|FG002|Overall Study|Not current smoker at time of screening|0|||
149033958|NCT03612804|537601996|FG003|Overall Study|Not current smoker at time of screening|3|||
149033959|NCT03612804|537601993|FG000|Overall Study|Non-veteran status|0|||
149033960|NCT03612804|537601994|FG001|Overall Study|Non-veteran status|1|||
149033961|NCT03612804|537601995|FG002|Overall Study|Non-veteran status|0|||
149033962|NCT03612804|537601996|FG003|Overall Study|Non-veteran status|0|||
149033963|NCT03612804|537601993|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
149033964|NCT03612804|537601994|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
149033965|NCT03612804|537601995|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
149033966|NCT03612804|537601996|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
149033967|NCT03612804|537601993|FG000|Overall Study|Provider retired from VA|0|||
149033968|NCT03612804|537601994|FG001|Overall Study|Provider retired from VA|0|||
149033969|NCT03612804|537601995|FG002|Overall Study|Provider retired from VA|2|||
149033970|NCT03612804|537601996|FG003|Overall Study|Provider retired from VA|0|||
149033971|NCT03612804|537601993|FG000|Overall Study|Withdrawal by Subject|0|||
149033972|NCT03612804|537601994|FG001|Overall Study|Withdrawal by Subject|0|||
149033973|NCT03612804|537601995|FG002|Overall Study|Withdrawal by Subject|7|||
149033974|NCT03612804|537601996|FG003|Overall Study|Withdrawal by Subject|0|||
149033975|NCT03612804|537601993|FG000|Overall Study|Provider involved with study activities|1|||
149033976|NCT03612804|537601994|FG001|Overall Study|Provider involved with study activities|0|||
149033977|NCT03612804|537601995|FG002|Overall Study|Provider involved with study activities|0|||
149033978|NCT03612804|537601996|FG003|Overall Study|Provider involved with study activities|0|||
149033979|NCT01656304|537601997|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
149033980|NCT04391309|537601998|FG000|Overall Study|Death|1|||
149033981|NCT04391309|537601999|FG001|Overall Study|Death|1|||
149033982|NCT04391309|537601998|FG000|Overall Study|Lost to Follow-up|3|||
149033983|NCT04391309|537601999|FG001|Overall Study|Lost to Follow-up|2|||
149033984|NCT04391309|537601998|FG000|Overall Study|Withdrawal by Subject|2|||
149033985|NCT04391309|537601999|FG001|Overall Study|Withdrawal by Subject|2|||
149033986|NCT05826431|537602000|FG000|Overall Study|Withdrawal by Subject|1|||
149033987|NCT00768651|537602005|FG000|Overall Study|Withdrawal by Subject|1|||
149033988|NCT02104765|537602006|FG000|Overall Study|Lost to Follow-up|0|||
149033989|NCT02104765|537602007|FG001|Overall Study|Lost to Follow-up|0|||
149033990|NCT02104765|537602008|FG002|Overall Study|Lost to Follow-up|1|||
149033991|NCT02104765|537602009|FG003|Overall Study|Lost to Follow-up|0|||
149033992|NCT02104765|537602010|FG004|Overall Study|Lost to Follow-up|0|||
149033993|NCT02104765|537602011|FG005|Overall Study|Lost to Follow-up|0|||
149033994|NCT02104765|537602012|FG006|Overall Study|Lost to Follow-up|0|||
149033995|NCT02104765|537602006|FG000|Overall Study|Withdrawal by Subject|0|||
149033996|NCT02104765|537602007|FG001|Overall Study|Withdrawal by Subject|0|||
149033997|NCT02104765|537602008|FG002|Overall Study|Withdrawal by Subject|0|||
149033998|NCT02104765|537602009|FG003|Overall Study|Withdrawal by Subject|1|||
149033999|NCT02104765|537602010|FG004|Overall Study|Withdrawal by Subject|1|||
149034000|NCT02104765|537602011|FG005|Overall Study|Withdrawal by Subject|0|||
149034001|NCT02104765|537602012|FG006|Overall Study|Withdrawal by Subject|1|||
149034002|NCT04771273|537602013|FG000|Dose Escalation Period|Not treated with trial medication|0|||
149034003|NCT04771273|537602014|FG001|Dose Escalation Period|Not treated with trial medication|1|||
149034004|NCT04771273|537602015|FG002|Dose Escalation Period|Not treated with trial medication|1|||
149034005|NCT04771273|537602016|FG003|Dose Escalation Period|Not treated with trial medication|0|||
149034006|NCT04771273|537602013|FG000|Dose Escalation Period|Other reasons than listed|2|||
149034007|NCT04771273|537602014|FG001|Dose Escalation Period|Other reasons than listed|0|||
149034008|NCT04771273|537602015|FG002|Dose Escalation Period|Other reasons than listed|2|||
149034009|NCT04771273|537602016|FG003|Dose Escalation Period|Other reasons than listed|1|||
149034010|NCT04771273|537602013|FG000|Dose Escalation Period|Protocol Violation|0|||
149034011|NCT04771273|537602014|FG001|Dose Escalation Period|Protocol Violation|0|||
149034012|NCT04771273|537602015|FG002|Dose Escalation Period|Protocol Violation|3|||
149034013|NCT04771273|537602016|FG003|Dose Escalation Period|Protocol Violation|1|||
149034014|NCT04771273|537602013|FG000|Dose Escalation Period|Burden of study procedures|1|||
149034015|NCT04771273|537602014|FG001|Dose Escalation Period|Burden of study procedures|0|||
149034016|NCT04771273|537602015|FG002|Dose Escalation Period|Burden of study procedures|0|||
149034017|NCT04771273|537602016|FG003|Dose Escalation Period|Burden of study procedures|0|||
149034018|NCT04771273|537602013|FG000|Dose Escalation Period|Change of residence|0|||
149034019|NCT04771273|537602014|FG001|Dose Escalation Period|Change of residence|0|||
149034020|NCT04771273|537602015|FG002|Dose Escalation Period|Change of residence|0|||
149034021|NCT04771273|537602016|FG003|Dose Escalation Period|Change of residence|1|||
149034022|NCT04771273|537602013|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
149034023|NCT04771273|537602014|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
149034024|NCT04771273|537602015|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
149034025|NCT04771273|537602016|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
149034026|NCT04771273|537602013|FG000|Dose Escalation Period|Adverse Event|8|||
149034027|NCT04771273|537602014|FG001|Dose Escalation Period|Adverse Event|9|||
149034028|NCT04771273|537602015|FG002|Dose Escalation Period|Adverse Event|12|||
149034029|NCT04771273|537602016|FG003|Dose Escalation Period|Adverse Event|2|||
149034030|NCT04771273|537602013|FG000|Maintenance Period|Other than listed|4|||
149034031|NCT04771273|537602014|FG001|Maintenance Period|Other than listed|2|||
149034032|NCT04771273|537602015|FG002|Maintenance Period|Other than listed|0|||
149034033|NCT04771273|537602016|FG003|Maintenance Period|Other than listed|3|||
149034034|NCT04771273|537602013|FG000|Maintenance Period|Burden of study procedures|1|||
149034035|NCT04771273|537602014|FG001|Maintenance Period|Burden of study procedures|0|||
149034036|NCT04771273|537602015|FG002|Maintenance Period|Burden of study procedures|0|||
149034037|NCT04771273|537602016|FG003|Maintenance Period|Burden of study procedures|0|||
149034038|NCT04771273|537602013|FG000|Maintenance Period|Change of residence|0|||
149034039|NCT04771273|537602014|FG001|Maintenance Period|Change of residence|1|||
149034040|NCT04771273|537602015|FG002|Maintenance Period|Change of residence|3|||
149034041|NCT04771273|537602016|FG003|Maintenance Period|Change of residence|0|||
149034042|NCT04771273|537602013|FG000|Maintenance Period|Perceived lack of efficacy|0|||
148875625|NCT00666224|537022793|FG001|Open-Label|Pregnancy|5|||
149034043|NCT04771273|537602014|FG001|Maintenance Period|Perceived lack of efficacy|0|||
149034044|NCT04771273|537602015|FG002|Maintenance Period|Perceived lack of efficacy|0|||
149034045|NCT04771273|537602016|FG003|Maintenance Period|Perceived lack of efficacy|1|||
149034046|NCT04771273|537602013|FG000|Maintenance Period|Adverse Event|4|||
149034047|NCT04771273|537602014|FG001|Maintenance Period|Adverse Event|5|||
148875626|NCT00666224|537022792|FG000|Open-Label|Noncompliance|2|||
149034048|NCT04771273|537602015|FG002|Maintenance Period|Adverse Event|5|||
149034049|NCT04771273|537602016|FG003|Maintenance Period|Adverse Event|0|||
149034050|NCT02357784|537602020|FG000|Overall Study|Withdrawal by Subject|1|||
149034051|NCT00995709|537602021|FG000|Overall Study|Adverse Event|4|||
149034052|NCT00995709|537602022|FG001|Overall Study|Adverse Event|2|||
149034053|NCT00995709|537602023|FG002|Overall Study|Adverse Event|0|||
149034054|NCT00995709|537602021|FG000|Overall Study|Lack of Efficacy|0|||
149034055|NCT00995709|537602022|FG001|Overall Study|Lack of Efficacy|1|||
149034056|NCT00995709|537602023|FG002|Overall Study|Lack of Efficacy|4|||
149034057|NCT00995709|537602021|FG000|Overall Study|Withdrawal by Subject|0|||
149034058|NCT00995709|537602022|FG001|Overall Study|Withdrawal by Subject|4|||
149034059|NCT00995709|537602023|FG002|Overall Study|Withdrawal by Subject|1|||
149034060|NCT00995709|537602021|FG000|Overall Study|Lost to Follow-up|1|||
149034061|NCT00995709|537602022|FG001|Overall Study|Lost to Follow-up|0|||
149034062|NCT00995709|537602023|FG002|Overall Study|Lost to Follow-up|0|||
149034063|NCT00995709|537602021|FG000|Overall Study|Death|0|||
149034064|NCT00995709|537602022|FG001|Overall Study|Death|1|||
149034065|NCT00995709|537602023|FG002|Overall Study|Death|0|||
149034066|NCT00995709|537602021|FG000|Overall Study|Protocol Violation|2|||
149034067|NCT00995709|537602022|FG001|Overall Study|Protocol Violation|1|||
149034068|NCT00995709|537602023|FG002|Overall Study|Protocol Violation|0|||
149034069|NCT00604721|537602028|FG000|Overall Study|Physician Decision|1|||
149034070|NCT00604721|537602028|FG000|Overall Study|Withdrawal by Subject|1|||
149034071|NCT04776213|537602031|FG000|Overall Study|Other|1|||
149034072|NCT04776213|537602031|FG000|Overall Study|Withdrawal by Subject|7|||
149034073|NCT04776213|537602031|FG000|Overall Study|Protocol Violation|1|||
149034074|NCT04776213|537602031|FG000|Overall Study|Lost to Follow-up|2|||
149034075|NCT01278862|537602033|FG000|Overall Study|Lost to Follow-up|1|||
149034076|NCT01278862|537602034|FG001|Overall Study|Lost to Follow-up|1|||
149034077|NCT02952261|537602035|FG000|Overall Study|Withdrawal by Subject|4|||
149034078|NCT02952261|537602036|FG001|Overall Study|Withdrawal by Subject|5|||
149034079|NCT02952261|537602035|FG000|Overall Study|Protocol Violation|1|||
149034080|NCT02952261|537602036|FG001|Overall Study|Protocol Violation|0|||
149034081|NCT00798265|537602037|FG000|Overall Study|Lost to Follow-up|1|||
149034082|NCT00798265|537602038|FG001|Overall Study|Lost to Follow-up|10|||
149034083|NCT00798265|537602037|FG000|Overall Study|Study closing|7|||
149034084|NCT00798265|537602038|FG001|Overall Study|Study closing|6|||
149034085|NCT00798265|537602037|FG000|Overall Study|Withdrawal by Subject|0|||
149034086|NCT00798265|537602038|FG001|Overall Study|Withdrawal by Subject|1|||
149034087|NCT00798265|537602037|FG000|Overall Study|Screen failure|0|||
149034088|NCT00798265|537602038|FG001|Overall Study|Screen failure|1|||
149034089|NCT03141788|537602039|FG000|Overall Study|Lost to Follow-up|1|||
149034090|NCT03141788|537602039|FG000|Overall Study|Protocol Violation|3|||
149034091|NCT03141788|537602039|FG000|Overall Study|Withdrawal by Subject|4|||
149034092|NCT03354390|537602040|FG000|Level 1|Death|2|||
149034093|NCT03354390|537602041|FG001|Level 1|Death|0|||
149034094|NCT03354390|537602042|FG002|Level 1|Death|0|||
149034095|NCT03354390|537602043|FG003|Level 1|Death|0|||
149034096|NCT03354390|537602040|FG000|Level 1|Physician Decision|1|||
149034097|NCT03354390|537602041|FG001|Level 1|Physician Decision|0|||
149034098|NCT03354390|537602042|FG002|Level 1|Physician Decision|0|||
149034099|NCT03354390|537602043|FG003|Level 1|Physician Decision|0|||
149034100|NCT03354390|537602040|FG000|Level 2|Physician Decision|0|||
149034101|NCT03354390|537602041|FG001|Level 2|Physician Decision|2|||
149034102|NCT03354390|537602042|FG002|Level 2|Physician Decision|0|||
149034103|NCT03354390|537602043|FG003|Level 2|Physician Decision|0|||
149034104|NCT03354390|537602040|FG000|Level 2|Lack of Efficacy|0|||
149034105|NCT03354390|537602041|FG001|Level 2|Lack of Efficacy|1|||
148875627|NCT00666224|537022793|FG001|Open-Label|Noncompliance|1|||
148875628|NCT00666224|537022792|FG000|Open-Label|Undefined/Unknown|1|||
149034106|NCT03354390|537602042|FG002|Level 2|Lack of Efficacy|0|||
148875629|NCT00666224|537022793|FG001|Open-Label|Undefined/Unknown|1|||
148875630|NCT03828617|537022802|FG000|Overall Study|Lost to Follow-up|22|||
149034107|NCT03354390|537602043|FG003|Level 2|Lack of Efficacy|0|||
149034108|NCT03354390|537602040|FG000|Level 2|Lost to Follow-up|0|||
149034109|NCT03354390|537602041|FG001|Level 2|Lost to Follow-up|1|||
149034110|NCT03354390|537602042|FG002|Level 2|Lost to Follow-up|0|||
149034111|NCT03354390|537602043|FG003|Level 2|Lost to Follow-up|0|||
148875631|NCT03828617|537022803|FG001|Overall Study|Lost to Follow-up|12|||
149034112|NCT03354390|537602040|FG000|Level 3|Death|0|||
149034113|NCT03354390|537602041|FG001|Level 3|Death|0|||
149034114|NCT03354390|537602042|FG002|Level 3|Death|1|||
149034115|NCT03354390|537602043|FG003|Level 3|Death|0|||
149034116|NCT03354390|537602040|FG000|Level 3|Physician Decision|0|||
149034117|NCT03354390|537602041|FG001|Level 3|Physician Decision|0|||
149034118|NCT03354390|537602042|FG002|Level 3|Physician Decision|2|||
149034119|NCT03354390|537602043|FG003|Level 3|Physician Decision|0|||
149034120|NCT03354390|537602040|FG000|Level 4|Death|0|||
149034121|NCT03354390|537602041|FG001|Level 4|Death|0|||
149034122|NCT03354390|537602042|FG002|Level 4|Death|0|||
149034123|NCT03354390|537602043|FG003|Level 4|Death|3|||
149034124|NCT00589667|537603545|FG000|Overall Study|Adverse Event|2|||
149034125|NCT00589667|537603545|FG000|Overall Study|Withdrawal by Subject|1|||
149034126|NCT03538041|537603548|FG000|12-Week Treatment Period|Adverse Event|1|||
149034127|NCT03538041|537603549|FG001|12-Week Treatment Period|Adverse Event|1|||
149034128|NCT03538041|537603548|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
149034129|NCT03538041|537603549|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
149034130|NCT03538041|537603548|FG000|Treatment Extension Period|Adverse Event|4|||
149034131|NCT03538041|537603549|FG001|Treatment Extension Period|Adverse Event|1|||
149034132|NCT03538041|537603548|FG000|Treatment Extension Period|Physician Decision|1|||
149034133|NCT03538041|537603549|FG001|Treatment Extension Period|Physician Decision|1|||
149034134|NCT03538041|537603548|FG000|Treatment Extension Period|Lack of Efficacy|1|||
149034135|NCT03538041|537603549|FG001|Treatment Extension Period|Lack of Efficacy|4|||
149034136|NCT03538041|537603548|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
149034137|NCT03538041|537603549|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
149034138|NCT03538041|537603548|FG000|Treatment Extension Period|Death|0|||
149034139|NCT03538041|537603549|FG001|Treatment Extension Period|Death|1|||
149034140|NCT00726596|537603550|FG000|Overall Study|Adverse Event|2|||
149034141|NCT00726596|537603551|FG001|Overall Study|Adverse Event|1|||
149034142|NCT00726596|537603550|FG000|Overall Study|Withdrawal by Subject|3|||
149034143|NCT00726596|537603551|FG001|Overall Study|Withdrawal by Subject|3|||
149034144|NCT03670602|537603563|FG000|Overall Study|Lost to Follow-up|1|||
149034145|NCT03670602|537603564|FG001|Overall Study|Lost to Follow-up|0|||
149034146|NCT03670602|537603563|FG000|Overall Study|Withdrawal by Subject|0|||
149034147|NCT03670602|537603564|FG001|Overall Study|Withdrawal by Subject|3|||
149034148|NCT00864682|537603566|FG000|Overall Study|Protocol Violation|2|||
149034149|NCT00864682|537603567|FG001|Overall Study|Protocol Violation|1|||
149034150|NCT00864682|537603568|FG002|Overall Study|Protocol Violation|2|||
149034151|NCT00957658|537603569|FG000|Overall Study|Death|1|||
149034152|NCT00957658|537603569|FG000|Overall Study|Lost to Follow-up|4|||
149034153|NCT00957658|537603569|FG000|Overall Study|Withdrawal by Subject|12|||
149034154|NCT00957658|537603569|FG000|Overall Study|Revision|1|||
149034155|NCT00957658|537603569|FG000|Overall Study|Incomplete 2 yr data|28|||
149034156|NCT00957658|537603569|FG000|Overall Study|Site termination|10|||
149034157|NCT00957658|537603569|FG000|Overall Study|unwilling/unable to return|2|||
149034158|NCT00957658|537603569|FG000|Overall Study|surgery cancelled|2|||
149034159|NCT00957658|537603569|FG000|Overall Study|Protocol Violation|5|||
149034160|NCT01585038|537603570|FG000|Overall Study|Adverse Event|2|||
149034161|NCT01585038|537603571|FG001|Overall Study|Adverse Event|2|||
149034162|NCT00344019|537603576|FG000|Overall Study|did not meet final inclusion criteria|0|||
149034163|NCT00344019|537603577|FG001|Overall Study|did not meet final inclusion criteria|0|||
149034164|NCT00344019|537603578|FG002|Overall Study|did not meet final inclusion criteria|74|||
149034165|NCT00217672|537603582|FG000|Allocation|Ineligible|2|||
149034166|NCT00217672|537603583|FG001|Allocation|Ineligible|0|||
149034167|NCT00217672|537603582|FG000|Treatment|disease progression|33|||
149034168|NCT00217672|537603583|FG001|Treatment|disease progression|4|||
149034169|NCT00217672|537603582|FG000|Treatment|Adverse Event|18|||
149034170|NCT00217672|537603583|FG001|Treatment|Adverse Event|2|||
149034171|NCT00217672|537603582|FG000|Treatment|reqd treatment not permitted by protocol|6|||
149034172|NCT00217672|537603583|FG001|Treatment|reqd treatment not permitted by protocol|0|||
149034173|NCT00217672|537603582|FG000|Treatment|Physician Decision|6|||
149034174|NCT00217672|537603583|FG001|Treatment|Physician Decision|0|||
149034175|NCT00217672|537603582|FG000|Treatment|insurance issues|1|||
149034176|NCT00217672|537603583|FG001|Treatment|insurance issues|1|||
149034177|NCT00217672|537603582|FG000|Treatment|Death|2|||
149034178|NCT00217672|537603583|FG001|Treatment|Death|0|||
149034179|NCT00217672|537603582|FG000|Treatment|secondary malignancy|1|||
149034180|NCT00217672|537603583|FG001|Treatment|secondary malignancy|0|||
149034181|NCT00217672|537603582|FG000|Follow-up|Withdrawal by Subject|4|||
149034182|NCT00217672|537603583|FG001|Follow-up|Withdrawal by Subject|0|||
149034183|NCT00217672|537603582|FG000|Follow-up|Lost to Follow-up|1|||
149034184|NCT00217672|537603583|FG001|Follow-up|Lost to Follow-up|0|||
149034185|NCT00619645|537603592|FG000|Overall Study|Adverse Event|1|||
149034186|NCT02026258|537603593|FG000|Randomized|Did not start treatment|2|||
148875632|NCT03828617|537022804|FG002|Overall Study|Lost to Follow-up|23|||
149034187|NCT02026258|537603594|FG001|Randomized|Did not start treatment|1|||
149034188|NCT02026258|537603593|FG000|Randomized|Change in treatment plan|1|||
148875633|NCT03828617|537022805|FG003|Overall Study|Lost to Follow-up|7|||
148875634|NCT03828617|537022802|FG000|Overall Study|No longer met eligibility criteria|0|||
149034189|NCT02026258|537603594|FG001|Randomized|Change in treatment plan|0|||
149034190|NCT02026258|537603593|FG000|Randomized|Presence of periodontal disease|1|||
149034191|NCT02026258|537603594|FG001|Randomized|Presence of periodontal disease|1|||
149034192|NCT02026258|537603593|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
149034193|NCT02026258|537603594|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
149034194|NCT02026258|537603593|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
149034195|NCT02026258|537603594|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
149034196|NCT00878722|537603595|FG000|Overall Study|Progressive disease|3|||
149034197|NCT00878722|537603596|FG001|Overall Study|Progressive disease|3|||
149034198|NCT00878722|537603597|FG002|Overall Study|Progressive disease|3|||
149034199|NCT00878722|537603598|FG003|Overall Study|Progressive disease|7|||
149034200|NCT00878722|537603599|FG004|Overall Study|Progressive disease|7|||
149034201|NCT00878722|537603600|FG005|Overall Study|Progressive disease|1|||
149034202|NCT00878722|537603601|FG006|Overall Study|Progressive disease|4|||
148875635|NCT03828617|537022803|FG001|Overall Study|No longer met eligibility criteria|1|||
148875636|NCT03828617|537022804|FG002|Overall Study|No longer met eligibility criteria|1|||
148875637|NCT03828617|537022805|FG003|Overall Study|No longer met eligibility criteria|3|||
148875638|NCT03828617|537022802|FG000|Overall Study|Protocol Violation|0|||
148875639|NCT03828617|537022803|FG001|Overall Study|Protocol Violation|2|||
148875640|NCT03828617|537022804|FG002|Overall Study|Protocol Violation|0|||
148875641|NCT03828617|537022805|FG003|Overall Study|Protocol Violation|0|||
149000949|NCT01525602|537479430|FG000|Overall Study|Death|0|||
149000950|NCT01525602|537479431|FG001|Overall Study|Death|0|||
149000951|NCT01525602|537479432|FG002|Overall Study|Death|0|||
149000952|NCT01525602|537479433|FG003|Overall Study|Death|0|||
149000953|NCT01525602|537479434|FG004|Overall Study|Death|1|||
149000954|NCT01525602|537479435|FG005|Overall Study|Death|1|||
149000955|NCT01525602|537479436|FG006|Overall Study|Death|0|||
149000956|NCT01525602|537479437|FG007|Overall Study|Death|0|||
149000957|NCT01525602|537479430|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
149000958|NCT01525602|537479431|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
149000959|NCT01525602|537479432|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
149000960|NCT01525602|537479433|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
149000961|NCT01525602|537479434|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
149000962|NCT01525602|537479435|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
149000963|NCT01525602|537479436|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
149000964|NCT01525602|537479437|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
149000965|NCT02412137|537479438|FG000|Overall Study|Withdrawal by Subject|2|||
149000966|NCT02412137|537479439|FG001|Overall Study|Withdrawal by Subject|0|||
149000967|NCT02412137|537479438|FG000|Overall Study|Lost to Follow-up|21|||
149000968|NCT02412137|537479439|FG001|Overall Study|Lost to Follow-up|14|||
149000969|NCT02412137|537479438|FG000|Overall Study|Physician Decision|28|||
149000970|NCT02412137|537479439|FG001|Overall Study|Physician Decision|9|||
149000971|NCT02532179|537480827|FG000|Overall Study|Lost to Follow-up|1|||
149000972|NCT02532179|537480827|FG000|Overall Study|Pregnancy|1|||
149000973|NCT02532179|537480827|FG000|Overall Study|Subject received depot steroid injection|1|||
149000974|NCT03076970|537480831|FG000|Washout Period 2|Adverse Event|0|||
149000975|NCT03076970|537480832|FG001|Washout Period 2|Adverse Event|0|||
149000976|NCT03076970|537480833|FG002|Washout Period 2|Adverse Event|0|||
149000977|NCT03076970|537480834|FG003|Washout Period 2|Adverse Event|0|||
149000978|NCT03076970|537480835|FG004|Washout Period 2|Adverse Event|1|||
149000979|NCT03076970|537480836|FG005|Washout Period 2|Adverse Event|0|||
149000980|NCT03076970|537480831|FG000|Period 3|Withdrawal by Subject|0|||
149000981|NCT03076970|537480832|FG001|Period 3|Withdrawal by Subject|0|||
149000982|NCT03076970|537480833|FG002|Period 3|Withdrawal by Subject|0|||
149000983|NCT03076970|537480834|FG003|Period 3|Withdrawal by Subject|0|||
149000984|NCT03076970|537480835|FG004|Period 3|Withdrawal by Subject|0|||
149000985|NCT03076970|537480836|FG005|Period 3|Withdrawal by Subject|1|||
149000986|NCT03076970|537480831|FG000|Period 3|Failure to meet I/E criteria|0|||
149000987|NCT03076970|537480832|FG001|Period 3|Failure to meet I/E criteria|0|||
149000988|NCT03076970|537480833|FG002|Period 3|Failure to meet I/E criteria|0|||
149000989|NCT03076970|537480834|FG003|Period 3|Failure to meet I/E criteria|0|||
149000990|NCT03076970|537480835|FG004|Period 3|Failure to meet I/E criteria|1|||
149000991|NCT03076970|537480836|FG005|Period 3|Failure to meet I/E criteria|0|||
149000992|NCT02240108|537480837|FG000|Overall Study|Other than specified|8|||
149000993|NCT02240108|537480838|FG001|Overall Study|Other than specified|6|||
149000994|NCT02240108|537480837|FG000|Overall Study|Adverse Event|1|||
149000995|NCT02240108|537480838|FG001|Overall Study|Adverse Event|9|||
149000996|NCT02240108|537480837|FG000|Overall Study|Pregnancy|1|||
149000997|NCT02240108|537480838|FG001|Overall Study|Pregnancy|0|||
149000998|NCT02240108|537480837|FG000|Overall Study|Withdrawal by Subject|4|||
149000999|NCT02240108|537480838|FG001|Overall Study|Withdrawal by Subject|9|||
149001000|NCT02240108|537480837|FG000|Overall Study|StudyTerminated by Sponsor|0|||
149001001|NCT02240108|537480838|FG001|Overall Study|StudyTerminated by Sponsor|1|||
149001002|NCT00789815|537480839|FG000|Overall Study|Protocol Violation|6|||
149001003|NCT00789815|537480840|FG001|Overall Study|Protocol Violation|1|||
149001004|NCT00789815|537480839|FG000|Overall Study|Intubation due to massive bleeding|1|||
149001005|NCT00789815|537480840|FG001|Overall Study|Intubation due to massive bleeding|0|||
149001006|NCT00119405|537480841|FG000|Overall Study|Withdrawal by Subject|1|||
149001007|NCT04958785|537480845|FG000|Overall Study|Study Terminated by Sponsor|4|||
149034203|NCT00878722|537603602|FG007|Overall Study|Progressive disease|3|||
149034204|NCT00878722|537603595|FG000|Overall Study|Death|0|||
149034205|NCT00878722|537603596|FG001|Overall Study|Death|0|||
149034206|NCT00878722|537603597|FG002|Overall Study|Death|0|||
149034207|NCT00878722|537603598|FG003|Overall Study|Death|1|||
149034208|NCT00878722|537603599|FG004|Overall Study|Death|0|||
149034209|NCT00878722|537603600|FG005|Overall Study|Death|1|||
149034210|NCT00878722|537603601|FG006|Overall Study|Death|0|||
149034211|NCT00878722|537603602|FG007|Overall Study|Death|2|||
149034212|NCT00878722|537603595|FG000|Overall Study|Adverse Event|0|||
149034213|NCT00878722|537603596|FG001|Overall Study|Adverse Event|0|||
149034214|NCT00878722|537603597|FG002|Overall Study|Adverse Event|0|||
149034215|NCT00878722|537603598|FG003|Overall Study|Adverse Event|0|||
149034216|NCT00878722|537603599|FG004|Overall Study|Adverse Event|0|||
149034217|NCT00878722|537603600|FG005|Overall Study|Adverse Event|0|||
149034218|NCT00878722|537603601|FG006|Overall Study|Adverse Event|2|||
149034219|NCT00878722|537603602|FG007|Overall Study|Adverse Event|0|||
149034220|NCT00878722|537603595|FG000|Overall Study|Withdrawal by Subject|0|||
149034221|NCT00878722|537603596|FG001|Overall Study|Withdrawal by Subject|0|||
149034222|NCT00878722|537603597|FG002|Overall Study|Withdrawal by Subject|0|||
149034223|NCT00878722|537603598|FG003|Overall Study|Withdrawal by Subject|0|||
149034224|NCT00878722|537603599|FG004|Overall Study|Withdrawal by Subject|0|||
149034225|NCT00878722|537603600|FG005|Overall Study|Withdrawal by Subject|0|||
149034226|NCT00878722|537603601|FG006|Overall Study|Withdrawal by Subject|0|||
149034227|NCT00878722|537603602|FG007|Overall Study|Withdrawal by Subject|2|||
149034228|NCT00878722|537603595|FG000|Overall Study|Relapse|0|||
149034229|NCT00878722|537603596|FG001|Overall Study|Relapse|0|||
149034230|NCT00878722|537603597|FG002|Overall Study|Relapse|0|||
149034231|NCT00878722|537603598|FG003|Overall Study|Relapse|1|||
149034232|NCT00878722|537603599|FG004|Overall Study|Relapse|0|||
149034233|NCT00878722|537603600|FG005|Overall Study|Relapse|0|||
149034234|NCT00878722|537603601|FG006|Overall Study|Relapse|0|||
149034235|NCT00878722|537603602|FG007|Overall Study|Relapse|0|||
149034236|NCT02341625|537603607|FG000|Overall Study|Disease Progression|2|||
149034237|NCT02341625|537603608|FG001|Overall Study|Disease Progression|2|||
149034238|NCT02341625|537603609|FG002|Overall Study|Disease Progression|3|||
149034239|NCT02341625|537603610|FG003|Overall Study|Disease Progression|6|||
149034240|NCT02341625|537603611|FG004|Overall Study|Disease Progression|7|||
149034241|NCT02341625|537603612|FG005|Overall Study|Disease Progression|7|||
149034242|NCT02341625|537603613|FG006|Overall Study|Disease Progression|28|||
149034243|NCT02341625|537603614|FG007|Overall Study|Disease Progression|5|||
149034244|NCT02341625|537603615|FG008|Overall Study|Disease Progression|4|||
149034245|NCT02341625|537603616|FG009|Overall Study|Disease Progression|19|||
149034246|NCT02341625|537603607|FG000|Overall Study|Study Drug Toxicity|0|||
149034247|NCT02341625|537603608|FG001|Overall Study|Study Drug Toxicity|0|||
149034248|NCT02341625|537603609|FG002|Overall Study|Study Drug Toxicity|0|||
149034249|NCT02341625|537603610|FG003|Overall Study|Study Drug Toxicity|1|||
149034250|NCT02341625|537603611|FG004|Overall Study|Study Drug Toxicity|0|||
149034251|NCT02341625|537603612|FG005|Overall Study|Study Drug Toxicity|3|||
149034252|NCT02341625|537603613|FG006|Overall Study|Study Drug Toxicity|10|||
149034253|NCT02341625|537603614|FG007|Overall Study|Study Drug Toxicity|0|||
149034254|NCT02341625|537603615|FG008|Overall Study|Study Drug Toxicity|0|||
149034255|NCT02341625|537603616|FG009|Overall Study|Study Drug Toxicity|3|||
149034256|NCT02341625|537603607|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034257|NCT02341625|537603608|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034258|NCT02341625|537603609|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034259|NCT02341625|537603610|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034260|NCT02341625|537603611|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034261|NCT02341625|537603612|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034262|NCT02341625|537603613|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
149034263|NCT02341625|537603614|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
149034264|NCT02341625|537603615|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
149034265|NCT02341625|537603616|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
149034266|NCT02341625|537603607|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
148875642|NCT03828617|537022802|FG000|Overall Study|Withdrawal by Subject|2|||
148875643|NCT03828617|537022803|FG001|Overall Study|Withdrawal by Subject|0|||
148875644|NCT03828617|537022804|FG002|Overall Study|Withdrawal by Subject|2|||
149034267|NCT02341625|537603608|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034268|NCT02341625|537603609|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034269|NCT02341625|537603610|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034270|NCT02341625|537603611|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034271|NCT02341625|537603612|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034272|NCT02341625|537603613|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
149034273|NCT02341625|537603614|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
149034274|NCT02341625|537603615|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034275|NCT02341625|537603616|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
149034276|NCT02341625|537603607|FG000|Overall Study|Participant Withdrew Consent|0|||
149034277|NCT02341625|537603608|FG001|Overall Study|Participant Withdrew Consent|0|||
149034278|NCT02341625|537603609|FG002|Overall Study|Participant Withdrew Consent|0|||
149034279|NCT02341625|537603610|FG003|Overall Study|Participant Withdrew Consent|1|||
149034280|NCT02341625|537603611|FG004|Overall Study|Participant Withdrew Consent|0|||
149034281|NCT02341625|537603612|FG005|Overall Study|Participant Withdrew Consent|0|||
149034282|NCT02341625|537603613|FG006|Overall Study|Participant Withdrew Consent|0|||
149034283|NCT02341625|537603614|FG007|Overall Study|Participant Withdrew Consent|0|||
149034284|NCT02341625|537603615|FG008|Overall Study|Participant Withdrew Consent|0|||
149034285|NCT02341625|537603616|FG009|Overall Study|Participant Withdrew Consent|0|||
149034286|NCT02341625|537603607|FG000|Overall Study|Completed Treatment as per Protocol|0|||
149034287|NCT02341625|537603608|FG001|Overall Study|Completed Treatment as per Protocol|0|||
149034288|NCT02341625|537603609|FG002|Overall Study|Completed Treatment as per Protocol|0|||
149034289|NCT02341625|537603610|FG003|Overall Study|Completed Treatment as per Protocol|0|||
149034290|NCT02341625|537603611|FG004|Overall Study|Completed Treatment as per Protocol|0|||
149034291|NCT02341625|537603612|FG005|Overall Study|Completed Treatment as per Protocol|0|||
149034292|NCT02341625|537603613|FG006|Overall Study|Completed Treatment as per Protocol|0|||
149034293|NCT02341625|537603614|FG007|Overall Study|Completed Treatment as per Protocol|0|||
149034294|NCT02341625|537603615|FG008|Overall Study|Completed Treatment as per Protocol|0|||
149034295|NCT02341625|537603616|FG009|Overall Study|Completed Treatment as per Protocol|1|||
149034296|NCT02341625|537603607|FG000|Overall Study|Other Reasons|0|||
149034297|NCT02341625|537603608|FG001|Overall Study|Other Reasons|0|||
149034298|NCT02341625|537603609|FG002|Overall Study|Other Reasons|0|||
149034299|NCT02341625|537603610|FG003|Overall Study|Other Reasons|0|||
149034300|NCT02341625|537603611|FG004|Overall Study|Other Reasons|1|||
149034301|NCT02341625|537603612|FG005|Overall Study|Other Reasons|0|||
149034302|NCT02341625|537603613|FG006|Overall Study|Other Reasons|5|||
149034303|NCT02341625|537603614|FG007|Overall Study|Other Reasons|0|||
149034304|NCT02341625|537603615|FG008|Overall Study|Other Reasons|0|||
149034305|NCT02341625|537603616|FG009|Overall Study|Other Reasons|2|||
149034306|NCT02341625|537603607|FG000|Overall Study|Not Reported|0|||
149034307|NCT02341625|537603608|FG001|Overall Study|Not Reported|0|||
149034308|NCT02341625|537603609|FG002|Overall Study|Not Reported|0|||
149034309|NCT02341625|537603610|FG003|Overall Study|Not Reported|0|||
149034310|NCT02341625|537603611|FG004|Overall Study|Not Reported|0|||
149034311|NCT02341625|537603612|FG005|Overall Study|Not Reported|0|||
149034312|NCT02341625|537603613|FG006|Overall Study|Not Reported|0|||
149034313|NCT02341625|537603614|FG007|Overall Study|Not Reported|0|||
149034314|NCT02341625|537603615|FG008|Overall Study|Not Reported|0|||
149034315|NCT02341625|537603616|FG009|Overall Study|Not Reported|3|||
149034316|NCT01839877|537603619|FG000|Overall Study|Protocol Violation|1|||
149034317|NCT00597519|537603622|FG000|Overall Study|Death|1|||
149034318|NCT05484726|537603623|FG000|Overall Study|Protocol Violation|3|||
149034319|NCT05484726|537603624|FG001|Overall Study|Protocol Violation|3|||
149034320|NCT05484726|537603623|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
149034321|NCT05484726|537603624|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
149034322|NCT05484726|537603623|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
149034323|NCT05484726|537603624|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
149034324|NCT05484726|537603623|FG000|Overall Study|continued need of mechanical ventilation|2|||
149034325|NCT05484726|537603624|FG001|Overall Study|continued need of mechanical ventilation|3|||
149034326|NCT05484726|537603623|FG000|Overall Study|Withdrawal by Subject|2|||
149034327|NCT05484726|537603624|FG001|Overall Study|Withdrawal by Subject|3|||
149034328|NCT05484726|537603623|FG000|Overall Study|IVH (G III & IV)|2|||
149034329|NCT05484726|537603624|FG001|Overall Study|IVH (G III & IV)|1|||
149034330|NCT05484726|537603623|FG000|Overall Study|NEC (stage II & III)|2|||
149034331|NCT05484726|537603624|FG001|Overall Study|NEC (stage II & III)|3|||
149034332|NCT03396913|537603625|FG000|Overall Study|Lost to Follow-up|0|||
149034333|NCT03396913|537603626|FG001|Overall Study|Lost to Follow-up|6|||
149034334|NCT02781584|537603627|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
149034335|NCT02781584|537603628|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
149034336|NCT02781584|537603629|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
149034337|NCT02781584|537603630|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
149034338|NCT02781584|537603631|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
149034339|NCT02781584|537603632|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
149034340|NCT02781584|537603633|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
149034341|NCT02781584|537603634|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
149034342|NCT02781584|537603635|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
149034343|NCT02781584|537603636|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
149034344|NCT02781584|537603637|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
149034345|NCT02781584|537603638|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
149034346|NCT02781584|537603639|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
149034347|NCT02781584|537603627|FG000|Pre-treatment Phase|Adverse Event|0|||
149034348|NCT02781584|537603628|FG001|Pre-treatment Phase|Adverse Event|0|||
149034349|NCT02781584|537603629|FG002|Pre-treatment Phase|Adverse Event|0|||
149034350|NCT02781584|537603630|FG003|Pre-treatment Phase|Adverse Event|0|||
149034351|NCT02781584|537603631|FG004|Pre-treatment Phase|Adverse Event|0|||
149034352|NCT02781584|537603632|FG005|Pre-treatment Phase|Adverse Event|0|||
149034353|NCT02781584|537603633|FG006|Pre-treatment Phase|Adverse Event|0|||
149034354|NCT02781584|537603634|FG007|Pre-treatment Phase|Adverse Event|0|||
149034355|NCT02781584|537603635|FG008|Pre-treatment Phase|Adverse Event|0|||
149034356|NCT02781584|537603636|FG009|Pre-treatment Phase|Adverse Event|0|||
149034357|NCT02781584|537603637|FG010|Pre-treatment Phase|Adverse Event|0|||
149034358|NCT02781584|537603638|FG011|Pre-treatment Phase|Adverse Event|1|||
149034359|NCT02781584|537603639|FG012|Pre-treatment Phase|Adverse Event|0|||
149034360|NCT02781584|537603627|FG000|Treatment Phase|Withdrew Consent|0|||
149034361|NCT02781584|537603628|FG001|Treatment Phase|Withdrew Consent|0|||
149034362|NCT02781584|537603629|FG002|Treatment Phase|Withdrew Consent|0|||
149034363|NCT02781584|537603630|FG003|Treatment Phase|Withdrew Consent|0|||
149034364|NCT02781584|537603631|FG004|Treatment Phase|Withdrew Consent|0|||
149034365|NCT02781584|537603632|FG005|Treatment Phase|Withdrew Consent|1|||
149034366|NCT02781584|537603633|FG006|Treatment Phase|Withdrew Consent|0|||
149034367|NCT02781584|537603634|FG007|Treatment Phase|Withdrew Consent|0|||
149034368|NCT02781584|537603635|FG008|Treatment Phase|Withdrew Consent|0|||
149034369|NCT02781584|537603636|FG009|Treatment Phase|Withdrew Consent|0|||
149034370|NCT02781584|537603637|FG010|Treatment Phase|Withdrew Consent|1|||
149034371|NCT02781584|537603638|FG011|Treatment Phase|Withdrew Consent|2|||
149034372|NCT02781584|537603639|FG012|Treatment Phase|Withdrew Consent|0|||
149034373|NCT02781584|537603627|FG000|Treatment Phase|Adverse Event|0|||
149034374|NCT02781584|537603628|FG001|Treatment Phase|Adverse Event|0|||
149034375|NCT02781584|537603629|FG002|Treatment Phase|Adverse Event|0|||
149034376|NCT02781584|537603630|FG003|Treatment Phase|Adverse Event|0|||
149034377|NCT02781584|537603631|FG004|Treatment Phase|Adverse Event|0|||
149034378|NCT02781584|537603632|FG005|Treatment Phase|Adverse Event|0|||
149034379|NCT02781584|537603633|FG006|Treatment Phase|Adverse Event|0|||
149034380|NCT02781584|537603634|FG007|Treatment Phase|Adverse Event|1|||
149034381|NCT02781584|537603635|FG008|Treatment Phase|Adverse Event|0|||
149034382|NCT02781584|537603636|FG009|Treatment Phase|Adverse Event|0|||
149034383|NCT02781584|537603637|FG010|Treatment Phase|Adverse Event|0|||
149034384|NCT02781584|537603638|FG011|Treatment Phase|Adverse Event|0|||
149034385|NCT02781584|537603639|FG012|Treatment Phase|Adverse Event|0|||
149034386|NCT01093534|537603640|FG000|Overall Study|Adverse Event|2|||
149034387|NCT01093534|537603641|FG001|Overall Study|Adverse Event|5|||
149034388|NCT01093534|537603642|FG002|Overall Study|Adverse Event|2|||
149034389|NCT01093534|537603640|FG000|Overall Study|Lack of Efficacy|2|||
149034390|NCT01093534|537603641|FG001|Overall Study|Lack of Efficacy|1|||
149034391|NCT01093534|537603642|FG002|Overall Study|Lack of Efficacy|1|||
149034392|NCT01093534|537603640|FG000|Overall Study|Withdrawal by Subject|5|||
149034393|NCT01093534|537603641|FG001|Overall Study|Withdrawal by Subject|7|||
149034394|NCT01093534|537603642|FG002|Overall Study|Withdrawal by Subject|2|||
149034395|NCT01093534|537603640|FG000|Overall Study|Other|1|||
149034396|NCT01093534|537603641|FG001|Overall Study|Other|3|||
149034397|NCT01093534|537603642|FG002|Overall Study|Other|4|||
149034398|NCT04436120|537603643|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
149034399|NCT04436120|537603644|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
149034400|NCT04436120|537603645|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
149034401|NCT04436120|537603646|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
149034402|NCT04436120|537603647|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
149034403|NCT04436120|537603648|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
149034404|NCT04436120|537603649|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
149034405|NCT03008915|537603656|FG000|Treatment 1|Withdrawal by Subject|0|||
149034406|NCT03008915|537603657|FG001|Treatment 1|Withdrawal by Subject|1|||
149034407|NCT00712166|537603658|FG000|Overall Study|Noncompliance|0|||
149034408|NCT00712166|537603659|FG001|Overall Study|Noncompliance|1|||
149034409|NCT01773122|537603660|FG000|Overall Study|Due to amended age eligibility criteria|3|||
149034410|NCT01773122|537603661|FG001|Overall Study|Due to amended age eligibility criteria|1|||
149034411|NCT01773122|537603662|FG002|Overall Study|Due to amended age eligibility criteria|0|||
149034412|NCT01773122|537603663|FG003|Overall Study|Due to amended age eligibility criteria|1|||
149034413|NCT02540213|537603666|FG000|Overall Study|Death/adverse event|18|||
149034414|NCT02540213|537603666|FG000|Overall Study|Administrative reasons|3|||
149034415|NCT02540213|537603666|FG000|Overall Study|Kidney transplant|3|||
149034416|NCT02540213|537603666|FG000|Overall Study|Lack of Efficacy|6|||
149034417|NCT02540213|537603666|FG000|Overall Study|Consent withdrawn|7|||
149034418|NCT02540213|537603666|FG000|Overall Study|Enrolled but not treated|2|||
149034419|NCT02289560|537603667|FG000|Overall Study|Lost to Follow-up|6|||
149034420|NCT02289560|537603667|FG000|Overall Study|Alternative Treatment|4|||
149034421|NCT02289560|537603667|FG000|Overall Study|Inadequate Treatment|2|||
149034422|NCT02289560|537603667|FG000|Overall Study|Withdrawal by Subject|23|||
149034423|NCT01769391|537603670|FG000|Overall Study|Death|10|||
149034424|NCT01769391|537603671|FG001|Overall Study|Death|1|||
149034425|NCT01769391|537603670|FG000|Overall Study|Adverse Event|0|||
149034426|NCT01769391|537603671|FG001|Overall Study|Adverse Event|3|||
149034427|NCT01769391|537603670|FG000|Overall Study|Progressive Disease|1|||
149034428|NCT01769391|537603671|FG001|Overall Study|Progressive Disease|2|||
149034429|NCT01769391|537603670|FG000|Overall Study|Withdrawal by Subject|4|||
149034430|NCT01769391|537603671|FG001|Overall Study|Withdrawal by Subject|3|||
149034431|NCT01769391|537603670|FG000|Overall Study|Investigator Decision|2|||
149034432|NCT01769391|537603671|FG001|Overall Study|Investigator Decision|0|||
149034433|NCT03386929|537603672|FG000|Overall Study|Death|0|||
149034434|NCT03386929|537603673|FG001|Overall Study|Death|0|||
149034435|NCT03386929|537603674|FG002|Overall Study|Death|1|||
149034436|NCT03386929|537603672|FG000|Overall Study|Withdrawal by Subject|0|||
149034437|NCT03386929|537603673|FG001|Overall Study|Withdrawal by Subject|1|||
149034438|NCT03386929|537603674|FG002|Overall Study|Withdrawal by Subject|0|||
148875645|NCT03828617|537022805|FG003|Overall Study|Withdrawal by Subject|0|||
148875646|NCT00655629|537022811|FG000|Overall Study|Adverse Event|4|||
148875647|NCT00655629|537022812|FG001|Overall Study|Adverse Event|1|||
148875648|NCT00655629|537022811|FG000|Overall Study|Lack of Efficacy|2|||
148875649|NCT00655629|537022812|FG001|Overall Study|Lack of Efficacy|12|||
148875650|NCT00655629|537022811|FG000|Overall Study|Lost to Follow-up|4|||
148875651|NCT00655629|537022812|FG001|Overall Study|Lost to Follow-up|3|||
148875652|NCT00655629|537022811|FG000|Overall Study|Protocol Violation|5|||
148875653|NCT00655629|537022812|FG001|Overall Study|Protocol Violation|3|||
148875654|NCT00655629|537022811|FG000|Overall Study|consent withdrawn|6|||
148875655|NCT00655629|537022812|FG001|Overall Study|consent withdrawn|4|||
148875656|NCT01610336|537022813|FG000|Overall Study|Progressive Disease|4|||
148875657|NCT01610336|537022814|FG001|Overall Study|Progressive Disease|6|||
148875658|NCT01610336|537022815|FG002|Overall Study|Progressive Disease|6|||
148875659|NCT01610336|537022816|FG003|Overall Study|Progressive Disease|5|||
148875660|NCT01610336|537022817|FG004|Overall Study|Progressive Disease|3|||
148875661|NCT01610336|537022818|FG005|Overall Study|Progressive Disease|10|||
148875662|NCT01610336|537022819|FG006|Overall Study|Progressive Disease|1|||
148875663|NCT01610336|537022820|FG007|Overall Study|Progressive Disease|6|||
148875664|NCT01610336|537022821|FG008|Overall Study|Progressive Disease|6|||
148875665|NCT01610336|537022822|FG009|Overall Study|Progressive Disease|40|||
148875666|NCT01610336|537022823|FG010|Overall Study|Progressive Disease|36|||
148875667|NCT01610336|537022813|FG000|Overall Study|Adverse Event|0|||
148875668|NCT01610336|537022814|FG001|Overall Study|Adverse Event|0|||
148875669|NCT01610336|537022815|FG002|Overall Study|Adverse Event|0|||
148875670|NCT01610336|537022816|FG003|Overall Study|Adverse Event|1|||
148875671|NCT01610336|537022817|FG004|Overall Study|Adverse Event|1|||
148875672|NCT01610336|537022818|FG005|Overall Study|Adverse Event|1|||
148875673|NCT01610336|537022819|FG006|Overall Study|Adverse Event|0|||
148875674|NCT01610336|537022820|FG007|Overall Study|Adverse Event|0|||
148875675|NCT01610336|537022821|FG008|Overall Study|Adverse Event|2|||
148875676|NCT01610336|537022822|FG009|Overall Study|Adverse Event|8|||
148875677|NCT01610336|537022823|FG010|Overall Study|Adverse Event|6|||
148875678|NCT01610336|537022813|FG000|Overall Study|Subject/Guardian decision|1|||
148875679|NCT01610336|537022814|FG001|Overall Study|Subject/Guardian decision|1|||
148875680|NCT01610336|537022815|FG002|Overall Study|Subject/Guardian decision|0|||
148875681|NCT01610336|537022816|FG003|Overall Study|Subject/Guardian decision|1|||
148875682|NCT01610336|537022817|FG004|Overall Study|Subject/Guardian decision|0|||
148875683|NCT01610336|537022818|FG005|Overall Study|Subject/Guardian decision|0|||
148875684|NCT01610336|537022819|FG006|Overall Study|Subject/Guardian decision|0|||
148875685|NCT01610336|537022820|FG007|Overall Study|Subject/Guardian decision|1|||
148875686|NCT01610336|537022821|FG008|Overall Study|Subject/Guardian decision|0|||
148875687|NCT01610336|537022822|FG009|Overall Study|Subject/Guardian decision|2|||
148875688|NCT01610336|537022823|FG010|Overall Study|Subject/Guardian decision|2|||
148875689|NCT01610336|537022813|FG000|Overall Study|Death|0|||
148875690|NCT01610336|537022814|FG001|Overall Study|Death|0|||
148875691|NCT01610336|537022815|FG002|Overall Study|Death|0|||
148875692|NCT01610336|537022816|FG003|Overall Study|Death|0|||
148875693|NCT01610336|537022817|FG004|Overall Study|Death|0|||
148875694|NCT01610336|537022818|FG005|Overall Study|Death|1|||
148875695|NCT01610336|537022819|FG006|Overall Study|Death|3|||
148875696|NCT01610336|537022820|FG007|Overall Study|Death|0|||
148875697|NCT01610336|537022821|FG008|Overall Study|Death|0|||
148875698|NCT01610336|537022822|FG009|Overall Study|Death|1|||
148875699|NCT01610336|537022823|FG010|Overall Study|Death|2|||
149034439|NCT03386929|537603672|FG000|Overall Study|Physician Decision|0|||
149034440|NCT03386929|537603673|FG001|Overall Study|Physician Decision|0|||
148875700|NCT01610336|537022813|FG000|Overall Study|Non-Compliance with study treatment|0|||
148875701|NCT01610336|537022814|FG001|Overall Study|Non-Compliance with study treatment|0|||
148875702|NCT01610336|537022815|FG002|Overall Study|Non-Compliance with study treatment|0|||
148875703|NCT01610336|537022816|FG003|Overall Study|Non-Compliance with study treatment|0|||
148875704|NCT01610336|537022817|FG004|Overall Study|Non-Compliance with study treatment|0|||
148875705|NCT01610336|537022818|FG005|Overall Study|Non-Compliance with study treatment|0|||
148875706|NCT01610336|537022819|FG006|Overall Study|Non-Compliance with study treatment|0|||
148875707|NCT01610336|537022820|FG007|Overall Study|Non-Compliance with study treatment|0|||
148875708|NCT01610336|537022821|FG008|Overall Study|Non-Compliance with study treatment|0|||
149034441|NCT03386929|537603674|FG002|Overall Study|Physician Decision|1|||
148875709|NCT01610336|537022822|FG009|Overall Study|Non-Compliance with study treatment|1|||
148875710|NCT01610336|537022823|FG010|Overall Study|Non-Compliance with study treatment|0|||
148875711|NCT01610336|537022813|FG000|Overall Study|Physician Decision|0|||
148875712|NCT01610336|537022814|FG001|Overall Study|Physician Decision|0|||
148875713|NCT01610336|537022815|FG002|Overall Study|Physician Decision|0|||
148875714|NCT01610336|537022816|FG003|Overall Study|Physician Decision|0|||
148875715|NCT01610336|537022817|FG004|Overall Study|Physician Decision|0|||
148875716|NCT01610336|537022818|FG005|Overall Study|Physician Decision|0|||
148875717|NCT01610336|537022819|FG006|Overall Study|Physician Decision|1|||
148875718|NCT01610336|537022820|FG007|Overall Study|Physician Decision|0|||
148875719|NCT01610336|537022821|FG008|Overall Study|Physician Decision|0|||
148875720|NCT01610336|537022822|FG009|Overall Study|Physician Decision|0|||
148875721|NCT01610336|537022823|FG010|Overall Study|Physician Decision|0|||
148875722|NCT01610336|537022813|FG000|Overall Study|Protocol Deviation|0|||
148875723|NCT01610336|537022814|FG001|Overall Study|Protocol Deviation|0|||
148875724|NCT01610336|537022815|FG002|Overall Study|Protocol Deviation|0|||
148875725|NCT01610336|537022816|FG003|Overall Study|Protocol Deviation|0|||
148875726|NCT01610336|537022817|FG004|Overall Study|Protocol Deviation|0|||
148875727|NCT01610336|537022818|FG005|Overall Study|Protocol Deviation|0|||
148875728|NCT01610336|537022819|FG006|Overall Study|Protocol Deviation|0|||
148875729|NCT01610336|537022820|FG007|Overall Study|Protocol Deviation|0|||
148875730|NCT01610336|537022821|FG008|Overall Study|Protocol Deviation|0|||
148875731|NCT01610336|537022822|FG009|Overall Study|Protocol Deviation|1|||
148875732|NCT01610336|537022823|FG010|Overall Study|Protocol Deviation|0|||
148875733|NCT01610336|537022813|FG000|Overall Study|Transfer to another trial|0|||
148875734|NCT01610336|537022814|FG001|Overall Study|Transfer to another trial|0|||
148875735|NCT01610336|537022815|FG002|Overall Study|Transfer to another trial|0|||
148875736|NCT01610336|537022816|FG003|Overall Study|Transfer to another trial|0|||
148875737|NCT01610336|537022817|FG004|Overall Study|Transfer to another trial|0|||
148875738|NCT01610336|537022818|FG005|Overall Study|Transfer to another trial|0|||
148875739|NCT01610336|537022819|FG006|Overall Study|Transfer to another trial|0|||
148875740|NCT01610336|537022820|FG007|Overall Study|Transfer to another trial|0|||
148875741|NCT01610336|537022821|FG008|Overall Study|Transfer to another trial|0|||
148875742|NCT01610336|537022822|FG009|Overall Study|Transfer to another trial|0|||
148875743|NCT01610336|537022823|FG010|Overall Study|Transfer to another trial|1|||
148875744|NCT01559675|537022824|FG000|Overall Study|Protocol Violation|1|||
148875745|NCT01559675|537022825|FG001|Overall Study|Protocol Violation|2|||
148875746|NCT01559675|537022824|FG000|Overall Study|2nd operation on same patient excluded|14|||
148875747|NCT01559675|537022825|FG001|Overall Study|2nd operation on same patient excluded|12|||
148875748|NCT02516592|537022826|FG000|Overall Study|Patient withdrew consent|5|||
148875749|NCT02516592|537022827|FG001|Overall Study|Patient withdrew consent|2|||
148875750|NCT02516592|537022826|FG000|Overall Study|Protocol deviation|4|||
148875751|NCT02516592|537022827|FG001|Overall Study|Protocol deviation|4|||
148875752|NCT02516592|537022826|FG000|Overall Study|Lost to Follow-up|2|||
148875753|NCT02516592|537022827|FG001|Overall Study|Lost to Follow-up|3|||
148875754|NCT02516592|537022826|FG000|Overall Study|Patient/guardian decision|2|||
148875755|NCT02516592|537022827|FG001|Overall Study|Patient/guardian decision|1|||
148875756|NCT02516592|537022826|FG000|Overall Study|Adverse Event|1|||
148875757|NCT02516592|537022827|FG001|Overall Study|Adverse Event|2|||
148875758|NCT02516592|537022826|FG000|Overall Study|Abnormal test procedure result|1|||
148875759|NCT02516592|537022827|FG001|Overall Study|Abnormal test procedure result|0|||
148875760|NCT02516592|537022826|FG000|Overall Study|Death|1|||
148875761|NCT02516592|537022827|FG001|Overall Study|Death|1|||
148875762|NCT01110382|537022829|FG000|Overall Study|Withdrawal by Subject|0|||
148875763|NCT01110382|537022830|FG001|Overall Study|Withdrawal by Subject|1|||
148875764|NCT01110382|537022829|FG000|Overall Study|Protocol Violation|0|||
148875765|NCT01110382|537022830|FG001|Overall Study|Protocol Violation|1|||
148875766|NCT00098306|537022831|FG000|Double Blind|Randomized, not treated|9|||
148875767|NCT00098306|537022832|FG001|Double Blind|Randomized, not treated|5|||
148875768|NCT00098306|537022833|FG002|Double Blind|Randomized, not treated|2|||
148875769|NCT00098306|537022834|FG003|Double Blind|Randomized, not treated|0|||
148875770|NCT00098306|537022835|FG004|Double Blind|Randomized, not treated|0|||
148875771|NCT00098306|537022836|FG005|Double Blind|Randomized, not treated|0|||
148875772|NCT00098306|537022837|FG006|Double Blind|Randomized, not treated|0|||
148875773|NCT00098306|537022831|FG000|Double Blind|Ongoing at cut-off date|151|||
148875774|NCT00098306|537022832|FG001|Double Blind|Ongoing at cut-off date|166|||
148875775|NCT00098306|537022833|FG002|Double Blind|Ongoing at cut-off date|72|||
148875776|NCT00098306|537022834|FG003|Double Blind|Ongoing at cut-off date|0|||
148875777|NCT00098306|537022835|FG004|Double Blind|Ongoing at cut-off date|0|||
148875778|NCT00098306|537022836|FG005|Double Blind|Ongoing at cut-off date|0|||
148875779|NCT00098306|537022837|FG006|Double Blind|Ongoing at cut-off date|0|||
148875780|NCT00098306|537022831|FG000|Double Blind|Adverse Event|11|||
148875781|NCT00098306|537022832|FG001|Double Blind|Adverse Event|10|||
148875782|NCT00098306|537022833|FG002|Double Blind|Adverse Event|6|||
148875783|NCT00098306|537022834|FG003|Double Blind|Adverse Event|0|||
148875784|NCT00098306|537022835|FG004|Double Blind|Adverse Event|0|||
148875785|NCT00098306|537022836|FG005|Double Blind|Adverse Event|0|||
148875786|NCT00098306|537022837|FG006|Double Blind|Adverse Event|0|||
148875787|NCT00098306|537022831|FG000|Double Blind|Lack of Efficacy|43|||
148875788|NCT00098306|537022832|FG001|Double Blind|Lack of Efficacy|34|||
148875789|NCT00098306|537022833|FG002|Double Blind|Lack of Efficacy|17|||
148875790|NCT00098306|537022834|FG003|Double Blind|Lack of Efficacy|0|||
148875791|NCT00098306|537022835|FG004|Double Blind|Lack of Efficacy|0|||
148875792|NCT00098306|537022836|FG005|Double Blind|Lack of Efficacy|0|||
148875793|NCT00098306|537022837|FG006|Double Blind|Lack of Efficacy|0|||
148875794|NCT00098306|537022831|FG000|Double Blind|Death|1|||
148875795|NCT00098306|537022832|FG001|Double Blind|Death|4|||
148875796|NCT00098306|537022833|FG002|Double Blind|Death|1|||
148875797|NCT00098306|537022834|FG003|Double Blind|Death|0|||
148875798|NCT00098306|537022835|FG004|Double Blind|Death|0|||
148875799|NCT00098306|537022836|FG005|Double Blind|Death|0|||
148875800|NCT00098306|537022837|FG006|Double Blind|Death|0|||
148875801|NCT00098306|537022831|FG000|Double Blind|Participant defaulted|19|||
148875802|NCT00098306|537022832|FG001|Double Blind|Participant defaulted|18|||
148875803|NCT00098306|537022833|FG002|Double Blind|Participant defaulted|11|||
148875804|NCT00098306|537022834|FG003|Double Blind|Participant defaulted|0|||
148875805|NCT00098306|537022835|FG004|Double Blind|Participant defaulted|0|||
148875806|NCT00098306|537022836|FG005|Double Blind|Participant defaulted|0|||
148875807|NCT00098306|537022837|FG006|Double Blind|Participant defaulted|0|||
148875808|NCT00098306|537022831|FG000|Double Blind|Un-specified|7|||
148875809|NCT00098306|537022832|FG001|Double Blind|Un-specified|3|||
148875810|NCT00098306|537022833|FG002|Double Blind|Un-specified|11|||
148875811|NCT00098306|537022834|FG003|Double Blind|Un-specified|0|||
148875812|NCT00098306|537022835|FG004|Double Blind|Un-specified|0|||
148875813|NCT00098306|537022836|FG005|Double Blind|Un-specified|0|||
148875814|NCT00098306|537022837|FG006|Double Blind|Un-specified|0|||
148875815|NCT00098306|537022831|FG000|Open Label|Lack of Efficacy|0|||
148875816|NCT00098306|537022832|FG001|Open Label|Lack of Efficacy|0|||
148875817|NCT00098306|537022833|FG002|Open Label|Lack of Efficacy|0|||
148875818|NCT00098306|537022834|FG003|Open Label|Lack of Efficacy|13|||
148875819|NCT00098306|537022835|FG004|Open Label|Lack of Efficacy|0|||
148875820|NCT00098306|537022836|FG005|Open Label|Lack of Efficacy|0|||
148875821|NCT00098306|537022837|FG006|Open Label|Lack of Efficacy|0|||
148875822|NCT00098306|537022831|FG000|Open Label|Adverse Event|0|||
148875823|NCT00098306|537022832|FG001|Open Label|Adverse Event|0|||
148875824|NCT00098306|537022833|FG002|Open Label|Adverse Event|0|||
148875825|NCT00098306|537022834|FG003|Open Label|Adverse Event|2|||
148875826|NCT00098306|537022835|FG004|Open Label|Adverse Event|0|||
148875827|NCT00098306|537022836|FG005|Open Label|Adverse Event|0|||
148875828|NCT00098306|537022837|FG006|Open Label|Adverse Event|0|||
148875829|NCT00098306|537022831|FG000|Open Label|Death|0|||
148875830|NCT00098306|537022832|FG001|Open Label|Death|0|||
148875831|NCT00098306|537022833|FG002|Open Label|Death|0|||
148875832|NCT00098306|537022834|FG003|Open Label|Death|4|||
148875833|NCT00098306|537022835|FG004|Open Label|Death|0|||
148875834|NCT00098306|537022836|FG005|Open Label|Death|0|||
148875835|NCT00098306|537022837|FG006|Open Label|Death|0|||
148875836|NCT00098306|537022831|FG000|Open Label|Participant defaulted|0|||
148875837|NCT00098306|537022832|FG001|Open Label|Participant defaulted|0|||
148875838|NCT00098306|537022833|FG002|Open Label|Participant defaulted|0|||
148875839|NCT00098306|537022834|FG003|Open Label|Participant defaulted|24|||
148875840|NCT00098306|537022835|FG004|Open Label|Participant defaulted|0|||
148875841|NCT00098306|537022836|FG005|Open Label|Participant defaulted|0|||
148875842|NCT00098306|537022837|FG006|Open Label|Participant defaulted|0|||
148875843|NCT00098306|537022831|FG000|Open Label|Un-specified|0|||
148875844|NCT00098306|537022832|FG001|Open Label|Un-specified|0|||
148875845|NCT00098306|537022833|FG002|Open Label|Un-specified|0|||
148875846|NCT00098306|537022834|FG003|Open Label|Un-specified|15|||
148875847|NCT00098306|537022835|FG004|Open Label|Un-specified|0|||
148875848|NCT00098306|537022836|FG005|Open Label|Un-specified|0|||
148875849|NCT00098306|537022837|FG006|Open Label|Un-specified|0|||
148875850|NCT00098306|537022831|FG000|Open Label|Ongoing at cut-off date|0|||
148875851|NCT00098306|537022832|FG001|Open Label|Ongoing at cut-off date|0|||
148875852|NCT00098306|537022833|FG002|Open Label|Ongoing at cut-off date|0|||
148875853|NCT00098306|537022834|FG003|Open Label|Ongoing at cut-off date|269|||
148875854|NCT00098306|537022835|FG004|Open Label|Ongoing at cut-off date|62|||
148875855|NCT00098306|537022836|FG005|Open Label|Ongoing at cut-off date|0|||
148875856|NCT00098306|537022837|FG006|Open Label|Ongoing at cut-off date|0|||
148875857|NCT00098306|537022831|FG000|Observational Phase|Death|0|||
148875858|NCT00098306|537022832|FG001|Observational Phase|Death|0|||
148875859|NCT00098306|537022833|FG002|Observational Phase|Death|0|||
148875860|NCT00098306|537022834|FG003|Observational Phase|Death|0|||
148875861|NCT00098306|537022835|FG004|Observational Phase|Death|0|||
148875862|NCT00098306|537022836|FG005|Observational Phase|Death|5|||
148875863|NCT00098306|537022837|FG006|Observational Phase|Death|4|||
148875864|NCT00098306|537022831|FG000|Observational Phase|Participant defaulted|0|||
148875865|NCT00098306|537022832|FG001|Observational Phase|Participant defaulted|0|||
148875866|NCT00098306|537022833|FG002|Observational Phase|Participant defaulted|0|||
148875867|NCT00098306|537022834|FG003|Observational Phase|Participant defaulted|0|||
148875868|NCT00098306|537022835|FG004|Observational Phase|Participant defaulted|0|||
148875869|NCT00098306|537022836|FG005|Observational Phase|Participant defaulted|34|||
148875870|NCT00098306|537022837|FG006|Observational Phase|Participant defaulted|18|||
148875871|NCT00098306|537022831|FG000|Observational Phase|Un-specified|0|||
148875872|NCT00098306|537022832|FG001|Observational Phase|Un-specified|0|||
148875873|NCT00098306|537022833|FG002|Observational Phase|Un-specified|0|||
148875874|NCT00098306|537022834|FG003|Observational Phase|Un-specified|0|||
148875875|NCT00098306|537022835|FG004|Observational Phase|Un-specified|0|||
148875876|NCT00098306|537022836|FG005|Observational Phase|Un-specified|7|||
148875877|NCT00098306|537022837|FG006|Observational Phase|Un-specified|4|||
148875878|NCT00077649|537022838|FG000|Overall Study|Adverse Event|5|||
148875879|NCT00077649|537022839|FG001|Overall Study|Adverse Event|1|||
148875880|NCT00077649|537022840|FG002|Overall Study|Adverse Event|7|||
148875881|NCT00077649|537022841|FG003|Overall Study|Adverse Event|9|||
148875882|NCT00077649|537022838|FG000|Overall Study|Lack of Efficacy|5|||
148875883|NCT00077649|537022839|FG001|Overall Study|Lack of Efficacy|3|||
148875884|NCT00077649|537022840|FG002|Overall Study|Lack of Efficacy|3|||
148875885|NCT00077649|537022841|FG003|Overall Study|Lack of Efficacy|2|||
148875886|NCT00077649|537022838|FG000|Overall Study|Withdrawal by Subject|0|||
148875887|NCT00077649|537022839|FG001|Overall Study|Withdrawal by Subject|1|||
148875888|NCT00077649|537022840|FG002|Overall Study|Withdrawal by Subject|1|||
148875889|NCT00077649|537022841|FG003|Overall Study|Withdrawal by Subject|2|||
148875890|NCT00077649|537022838|FG000|Overall Study|Lost to Follow-up|2|||
148875891|NCT00077649|537022839|FG001|Overall Study|Lost to Follow-up|2|||
148875892|NCT00077649|537022840|FG002|Overall Study|Lost to Follow-up|3|||
148875893|NCT00077649|537022841|FG003|Overall Study|Lost to Follow-up|2|||
148875894|NCT00077649|537022838|FG000|Overall Study|Abnormality of Laboratory Test|1|||
148875895|NCT00077649|537022839|FG001|Overall Study|Abnormality of Laboratory Test|2|||
148875896|NCT00077649|537022840|FG002|Overall Study|Abnormality of Laboratory Test|1|||
148875897|NCT00077649|537022841|FG003|Overall Study|Abnormality of Laboratory Test|2|||
148875898|NCT00077649|537022838|FG000|Overall Study|Randomized but never dosed|1|||
148875899|NCT00077649|537022839|FG001|Overall Study|Randomized but never dosed|0|||
148875900|NCT00077649|537022840|FG002|Overall Study|Randomized but never dosed|0|||
148875901|NCT00077649|537022841|FG003|Overall Study|Randomized but never dosed|0|||
148875902|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
148875903|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
148875904|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
148875905|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
148875906|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
148875907|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
148875908|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
148875909|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
148875910|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
148875911|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
148875912|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
148875913|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
148875914|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
148875915|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
148875916|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
148875917|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
148875918|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
148875919|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
148875920|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
148875921|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
148875922|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
148875923|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
148875924|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
148875925|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
148875926|NCT01532869|537022842|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
148875927|NCT01532869|537022843|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
148875928|NCT01532869|537022842|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
148875929|NCT01532869|537022843|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
148875930|NCT01532869|537022842|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
148875931|NCT01532869|537022843|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
148875932|NCT01532869|537022842|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
148875933|NCT01532869|537022843|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
148875934|NCT01532869|537022842|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
148875935|NCT01532869|537022843|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
148875936|NCT01331291|537022844|FG000|Overall Study|Lack of Efficacy|2|||
148875937|NCT01331291|537022845|FG001|Overall Study|Lack of Efficacy|8|||
148875938|NCT01331291|537022844|FG000|Overall Study|Death|0|||
148875939|NCT01331291|537022845|FG001|Overall Study|Death|1|||
149034442|NCT03386929|537603672|FG000|Overall Study|Progression|4|||
149034443|NCT03386929|537603673|FG001|Overall Study|Progression|4|||
149034444|NCT03386929|537603674|FG002|Overall Study|Progression|0|||
148875940|NCT00778895|537022846|FG000|Active Phase|Adverse Event|3|||
148875941|NCT00778895|537022847|FG001|Active Phase|Adverse Event|1|||
148875942|NCT00778895|537022848|FG002|Active Phase|Adverse Event|0|||
148875943|NCT00778895|537022846|FG000|Active Phase|Withdrawal by Subject|1|||
148875944|NCT00778895|537022847|FG001|Active Phase|Withdrawal by Subject|4|||
148875945|NCT00778895|537022848|FG002|Active Phase|Withdrawal by Subject|0|||
148875946|NCT00778895|537022846|FG000|Active Phase|Lost to Follow-up|1|||
148875947|NCT00778895|537022847|FG001|Active Phase|Lost to Follow-up|1|||
148875948|NCT00778895|537022848|FG002|Active Phase|Lost to Follow-up|0|||
148875949|NCT00778895|537022846|FG000|Active Phase|Other|2|||
148875950|NCT00778895|537022847|FG001|Active Phase|Other|0|||
148875951|NCT00778895|537022848|FG002|Active Phase|Other|0|||
148875952|NCT00778895|537022846|FG000|ESFU Phase|Adverse Event|2|||
148875953|NCT00778895|537022847|FG001|ESFU Phase|Adverse Event|1|||
148875954|NCT00778895|537022848|FG002|ESFU Phase|Adverse Event|0|||
148875955|NCT00778895|537022846|FG000|ESFU Phase|Withdrawal by Subject|1|||
148875956|NCT00778895|537022847|FG001|ESFU Phase|Withdrawal by Subject|4|||
148875957|NCT00778895|537022848|FG002|ESFU Phase|Withdrawal by Subject|0|||
148875958|NCT00778895|537022846|FG000|ESFU Phase|Lost to Follow-up|6|||
148875959|NCT00778895|537022847|FG001|ESFU Phase|Lost to Follow-up|7|||
148875960|NCT00778895|537022848|FG002|ESFU Phase|Lost to Follow-up|2|||
148875961|NCT00778895|537022846|FG000|ESFU Phase|Other|2|||
148875962|NCT00778895|537022847|FG001|ESFU Phase|Other|0|||
148875963|NCT00778895|537022848|FG002|ESFU Phase|Other|0|||
148875964|NCT01009086|537022850|FG000|Overall Study|Lack of Efficacy|16|||
148875965|NCT01009086|537022851|FG001|Overall Study|Lack of Efficacy|15|||
148875966|NCT01009086|537022852|FG002|Overall Study|Lack of Efficacy|9|||
148875967|NCT01009086|537022850|FG000|Overall Study|Lost to Follow-up|4|||
148875968|NCT01009086|537022851|FG001|Overall Study|Lost to Follow-up|5|||
148875969|NCT01009086|537022852|FG002|Overall Study|Lost to Follow-up|3|||
148875970|NCT01009086|537022850|FG000|Overall Study|Adverse Event|12|||
148875971|NCT01009086|537022851|FG001|Overall Study|Adverse Event|11|||
148875972|NCT01009086|537022852|FG002|Overall Study|Adverse Event|8|||
148875973|NCT01009086|537022850|FG000|Overall Study|Withdrawal by Subject|9|||
148875974|NCT01009086|537022851|FG001|Overall Study|Withdrawal by Subject|11|||
148875975|NCT01009086|537022852|FG002|Overall Study|Withdrawal by Subject|13|||
148875976|NCT01009086|537022850|FG000|Overall Study|Other|3|||
148875977|NCT01009086|537022851|FG001|Overall Study|Other|5|||
148875978|NCT01009086|537022852|FG002|Overall Study|Other|1|||
148875979|NCT01424228|537022854|FG000|Overall Study|Withdrawal by Subject|27|||
148875980|NCT01424228|537022855|FG001|Overall Study|Withdrawal by Subject|11|||
148875981|NCT01424228|537022854|FG000|Overall Study|Adverse Event|10|||
148875982|NCT01424228|537022855|FG001|Overall Study|Adverse Event|14|||
148875983|NCT01424228|537022854|FG000|Overall Study|Sponsor's decision|9|||
148875984|NCT01424228|537022855|FG001|Overall Study|Sponsor's decision|12|||
148875985|NCT01424228|537022854|FG000|Overall Study|Lack of Efficacy|5|||
148875986|NCT01424228|537022855|FG001|Overall Study|Lack of Efficacy|7|||
148875987|NCT01424228|537022854|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
148875988|NCT01424228|537022855|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
148875989|NCT01424228|537022854|FG000|Overall Study|Non-compliance|2|||
148875990|NCT01424228|537022855|FG001|Overall Study|Non-compliance|0|||
148875991|NCT01424228|537022854|FG000|Overall Study|Worsening of symptoms|1|||
148875992|NCT01424228|537022855|FG001|Overall Study|Worsening of symptoms|0|||
148875993|NCT01424228|537022854|FG000|Overall Study|Unplanned journey|0|||
148875994|NCT01424228|537022855|FG001|Overall Study|Unplanned journey|1|||
148875995|NCT00590577|537022859|FG000|Overall Study|Lack of Efficacy|31|||
148875996|NCT00590577|537022860|FG001|Overall Study|Lack of Efficacy|28|||
148875997|NCT00590577|537022861|FG002|Overall Study|Lack of Efficacy|23|||
148875998|NCT00590577|537022862|FG003|Overall Study|Lack of Efficacy|45|||
148875999|NCT00590577|537022859|FG000|Overall Study|Withdrawal by Subject|23|||
148876000|NCT00590577|537022860|FG001|Overall Study|Withdrawal by Subject|28|||
148876001|NCT00590577|537022861|FG002|Overall Study|Withdrawal by Subject|30|||
148876002|NCT00590577|537022862|FG003|Overall Study|Withdrawal by Subject|26|||
148876003|NCT00590577|537022859|FG000|Overall Study|Adverse Event|10|||
148876004|NCT00590577|537022860|FG001|Overall Study|Adverse Event|10|||
148876005|NCT00590577|537022861|FG002|Overall Study|Adverse Event|13|||
148876006|NCT00590577|537022862|FG003|Overall Study|Adverse Event|11|||
148876007|NCT00590577|537022859|FG000|Overall Study|Lost to Follow-up|12|||
148876008|NCT00590577|537022860|FG001|Overall Study|Lost to Follow-up|6|||
148876009|NCT00590577|537022861|FG002|Overall Study|Lost to Follow-up|6|||
148876010|NCT00590577|537022862|FG003|Overall Study|Lost to Follow-up|9|||
148876011|NCT00590577|537022859|FG000|Overall Study|Pregnancy|0|||
149034445|NCT03386929|537603672|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
148876012|NCT00590577|537022860|FG001|Overall Study|Pregnancy|1|||
148876013|NCT00590577|537022861|FG002|Overall Study|Pregnancy|0|||
148876014|NCT00590577|537022862|FG003|Overall Study|Pregnancy|0|||
148876015|NCT00590577|537022859|FG000|Overall Study|Various reasons|1|||
148876016|NCT00590577|537022860|FG001|Overall Study|Various reasons|3|||
148876017|NCT00590577|537022861|FG002|Overall Study|Various reasons|1|||
148876018|NCT00590577|537022862|FG003|Overall Study|Various reasons|2|||
148876019|NCT01300260|537022863|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
148876020|NCT01300260|537022864|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
148876021|NCT01300260|537022863|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
148876022|NCT01300260|537022864|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
148876023|NCT01300260|537022863|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
148876024|NCT01300260|537022864|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
148876025|NCT00293020|537022866|FG000|Overall Study|Withdrawal by Subject|34|||
148876026|NCT00293020|537022866|FG000|Overall Study|Adverse Event|30|||
148876027|NCT00293020|537022866|FG000|Overall Study|Death|32|||
148876028|NCT00293020|537022866|FG000|Overall Study|Lack of Efficacy|12|||
148876029|NCT00293020|537022866|FG000|Overall Study|Lost to Follow-up|4|||
148876030|NCT00293020|537022866|FG000|Overall Study|Protocol Violation|6|||
148876031|NCT00293020|537022866|FG000|Overall Study|Physician Decision|21|||
148876032|NCT00293020|537022866|FG000|Overall Study|Other Reason|22|||
148876033|NCT00293020|537022866|FG000|Overall Study|No dose taken|1|||
148876034|NCT01147848|537022867|FG000|Run-in Period|Screen Failure|623|||
148876035|NCT01147848|537022868|FG001|Run-in Period|Screen Failure|0|||
148876036|NCT01147848|537022869|FG002|Run-in Period|Screen Failure|0|||
148876037|NCT01147848|537022867|FG000|Run-in Period|Run-in Failure|135|||
148876038|NCT01147848|537022868|FG001|Run-in Period|Run-in Failure|0|||
148876039|NCT01147848|537022869|FG002|Run-in Period|Run-in Failure|0|||
148876040|NCT01147848|537022867|FG000|Randomized Phase|Adverse Event|0|||
148876041|NCT01147848|537022868|FG001|Randomized Phase|Adverse Event|6|||
148876042|NCT01147848|537022869|FG002|Randomized Phase|Adverse Event|8|||
148876043|NCT01147848|537022867|FG000|Randomized Phase|Lack of Efficacy|0|||
148876044|NCT01147848|537022868|FG001|Randomized Phase|Lack of Efficacy|20|||
148876045|NCT01147848|537022869|FG002|Randomized Phase|Lack of Efficacy|11|||
148876046|NCT01147848|537022867|FG000|Randomized Phase|Protocol Violation|0|||
148876047|NCT01147848|537022868|FG001|Randomized Phase|Protocol Violation|7|||
148876048|NCT01147848|537022869|FG002|Randomized Phase|Protocol Violation|10|||
148876049|NCT01147848|537022867|FG000|Randomized Phase|Lost to Follow-up|0|||
148876050|NCT01147848|537022868|FG001|Randomized Phase|Lost to Follow-up|5|||
148876051|NCT01147848|537022869|FG002|Randomized Phase|Lost to Follow-up|7|||
148876052|NCT01147848|537022867|FG000|Randomized Phase|Physician Decision|0|||
148876053|NCT01147848|537022868|FG001|Randomized Phase|Physician Decision|0|||
148876054|NCT01147848|537022869|FG002|Randomized Phase|Physician Decision|1|||
148876055|NCT01147848|537022867|FG000|Randomized Phase|Withdrawal by Subject|0|||
148876056|NCT01147848|537022868|FG001|Randomized Phase|Withdrawal by Subject|7|||
148876057|NCT01147848|537022869|FG002|Randomized Phase|Withdrawal by Subject|9|||
148876058|NCT04058886|537022879|FG000|Overall Study|Withdrawal by Subject|4|||
148876059|NCT04058886|537022879|FG000|Overall Study|Inadequate deafness interpreter service|1|||
148876060|NCT03624127|537022880|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
148876061|NCT03624127|537022881|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
148876062|NCT03624127|537022882|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
148876063|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
148876064|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
148876065|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
148876066|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Death|0|||
148876067|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Death|1|||
148876068|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Death|0|||
148876069|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
148876070|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
148876071|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
148876072|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
148876073|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
148876074|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
148876075|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
148876076|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
148876077|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
148876078|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
148876079|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
148876080|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
148876081|NCT03624127|537022880|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
148876082|NCT03624127|537022881|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
148876083|NCT03624127|537022882|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
148876084|NCT03624127|537022880|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
148876085|NCT03624127|537022881|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
148876086|NCT03624127|537022882|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
148876087|NCT03624127|537022880|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
148876088|NCT03624127|537022881|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
148876089|NCT03624127|537022882|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
148876090|NCT03624127|537022880|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
148876091|NCT03624127|537022881|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
148876092|NCT03624127|537022882|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
148876093|NCT03624127|537022880|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
148876094|NCT03624127|537022881|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
148876095|NCT03624127|537022882|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
148876096|NCT03624127|537022880|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
148876097|NCT03624127|537022881|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
148876098|NCT03624127|537022882|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
148876099|NCT03624127|537022880|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
148876100|NCT03624127|537022881|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
148876101|NCT03624127|537022882|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
148876102|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
148876103|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
148876104|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
148876105|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
148876106|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
148876107|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
148876108|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
148876109|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
148876110|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
148876111|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
148876112|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
148876113|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
148876114|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
148876115|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
148876116|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
148876117|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
148876118|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
148876119|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
148876120|NCT03624127|537022880|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
148876121|NCT03624127|537022881|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
148876122|NCT03624127|537022882|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
148876123|NCT00235716|537022883|FG000|Overall Study|Death|26|||
148876124|NCT00235716|537022884|FG001|Overall Study|Death|39|||
148876125|NCT00235716|537022885|FG002|Overall Study|Death|32|||
148876126|NCT00235716|537022886|FG003|Overall Study|Death|31|||
148876127|NCT00235716|537022883|FG000|Overall Study|Withdrawal by Subject|23|||
148876128|NCT00235716|537022884|FG001|Overall Study|Withdrawal by Subject|19|||
148876129|NCT00235716|537022885|FG002|Overall Study|Withdrawal by Subject|17|||
148876130|NCT00235716|537022886|FG003|Overall Study|Withdrawal by Subject|18|||
148876131|NCT00235716|537022883|FG000|Overall Study|Lost to Follow-up|12|||
148876132|NCT00235716|537022884|FG001|Overall Study|Lost to Follow-up|7|||
148876133|NCT00235716|537022885|FG002|Overall Study|Lost to Follow-up|14|||
148876134|NCT00235716|537022886|FG003|Overall Study|Lost to Follow-up|10|||
148876135|NCT00235716|537022883|FG000|Overall Study|Adverse Event|1|||
148876136|NCT00235716|537022884|FG001|Overall Study|Adverse Event|1|||
148876137|NCT00235716|537022885|FG002|Overall Study|Adverse Event|1|||
148876138|NCT00235716|537022886|FG003|Overall Study|Adverse Event|0|||
148876139|NCT00235716|537022883|FG000|Overall Study|Physician Decision|0|||
148876140|NCT00235716|537022884|FG001|Overall Study|Physician Decision|1|||
148876141|NCT00235716|537022885|FG002|Overall Study|Physician Decision|1|||
148876142|NCT00235716|537022886|FG003|Overall Study|Physician Decision|3|||
148876143|NCT03262441|537022887|FG000|Overall Study|Withdrawal by Subject|1|||
148876144|NCT01545050|537022888|FG000|Overall Study|Lack of Efficacy|0|||
148876145|NCT01545050|537022889|FG001|Overall Study|Lack of Efficacy|0|||
148876146|NCT01545050|537022890|FG002|Overall Study|Lack of Efficacy|0|||
148876147|NCT01545050|537022891|FG003|Overall Study|Lack of Efficacy|3|||
148876148|NCT01545050|537022892|FG004|Overall Study|Lack of Efficacy|2|||
148876149|NCT01545050|537022888|FG000|Overall Study|Adverse Event|1|||
148876150|NCT01545050|537022889|FG001|Overall Study|Adverse Event|1|||
148876151|NCT01545050|537022890|FG002|Overall Study|Adverse Event|2|||
148876152|NCT01545050|537022891|FG003|Overall Study|Adverse Event|2|||
148876153|NCT01545050|537022892|FG004|Overall Study|Adverse Event|0|||
148876154|NCT01545050|537022888|FG000|Overall Study|Discontinued study treatment|1|||
148876155|NCT01545050|537022889|FG001|Overall Study|Discontinued study treatment|0|||
148876156|NCT01545050|537022890|FG002|Overall Study|Discontinued study treatment|0|||
148876157|NCT01545050|537022891|FG003|Overall Study|Discontinued study treatment|0|||
148876158|NCT01545050|537022892|FG004|Overall Study|Discontinued study treatment|0|||
148876159|NCT01545050|537022888|FG000|Overall Study|Withdrawal by Subject|1|||
148876160|NCT01545050|537022889|FG001|Overall Study|Withdrawal by Subject|0|||
148876161|NCT01545050|537022890|FG002|Overall Study|Withdrawal by Subject|0|||
148876162|NCT01545050|537022891|FG003|Overall Study|Withdrawal by Subject|2|||
148876163|NCT01545050|537022892|FG004|Overall Study|Withdrawal by Subject|1|||
148876164|NCT01545050|537022888|FG000|Overall Study|Participant no longer meets study criteria|0|||
148876165|NCT01545050|537022889|FG001|Overall Study|Participant no longer meets study criteria|2|||
148876166|NCT01545050|537022890|FG002|Overall Study|Participant no longer meets study criteria|0|||
148876167|NCT01545050|537022891|FG003|Overall Study|Participant no longer meets study criteria|0|||
148876168|NCT01545050|537022892|FG004|Overall Study|Participant no longer meets study criteria|1|||
148876169|NCT01545050|537022888|FG000|Overall Study|Administrative reason by sponsor|4|||
148876170|NCT01545050|537022889|FG001|Overall Study|Administrative reason by sponsor|2|||
148876171|NCT01545050|537022890|FG002|Overall Study|Administrative reason by sponsor|3|||
148876172|NCT01545050|537022891|FG003|Overall Study|Administrative reason by sponsor|5|||
148876173|NCT01545050|537022892|FG004|Overall Study|Administrative reason by sponsor|5|||
148876174|NCT03235089|537022893|FG000|Overall Study|Lost to Follow-up|1|||
148876175|NCT03235089|537022894|FG001|Overall Study|Lost to Follow-up|1|||
148876176|NCT03235089|537022893|FG000|Overall Study|Physician Decision|2|||
148876177|NCT03235089|537022894|FG001|Overall Study|Physician Decision|2|||
148876178|NCT00559988|537022901|FG000|Overall Study|Death|147|||
148876179|NCT00559988|537022902|FG001|Overall Study|Death|140|||
148876180|NCT00559988|537022901|FG000|Overall Study|Withdrawal by Subject|152|||
148876181|NCT00559988|537022902|FG001|Overall Study|Withdrawal by Subject|139|||
148876182|NCT00559988|537022901|FG000|Overall Study|Lost to Follow-up|42|||
148876183|NCT00559988|537022902|FG001|Overall Study|Lost to Follow-up|56|||
148876184|NCT00559988|537022901|FG000|Overall Study|ICD device explanted|10|||
148876185|NCT00559988|537022902|FG001|Overall Study|ICD device explanted|17|||
148876186|NCT02891382|537022903|FG000|Overall Study|Lost to Follow-up|3|||
148876187|NCT02891382|537022904|FG001|Overall Study|Lost to Follow-up|4|||
148876188|NCT02891382|537022905|FG002|Overall Study|Lost to Follow-up|5|||
148876189|NCT02891382|537022906|FG003|Overall Study|Lost to Follow-up|3|||
148876190|NCT02891382|537022907|FG004|Overall Study|Lost to Follow-up|4|||
148876191|NCT01455194|537022908|FG000|Overall Study|Screen Failure|20|||
148876192|NCT01455194|537022909|FG001|Overall Study|Screen Failure|0|||
148876193|NCT01455194|537022910|FG002|Overall Study|Screen Failure|0|||
148876194|NCT01455194|537022911|FG003|Overall Study|Screen Failure|0|||
148876195|NCT01455194|537022908|FG000|Overall Study|Randomisation Failure|90|||
148876196|NCT01455194|537022909|FG001|Overall Study|Randomisation Failure|0|||
148876197|NCT01455194|537022910|FG002|Overall Study|Randomisation Failure|0|||
148876198|NCT01455194|537022911|FG003|Overall Study|Randomisation Failure|0|||
148876199|NCT01455194|537022908|FG000|Overall Study|Deterioration in asthma|12|||
148876200|NCT01455194|537022909|FG001|Overall Study|Deterioration in asthma|6|||
148876201|NCT01455194|537022910|FG002|Overall Study|Deterioration in asthma|14|||
148876202|NCT01455194|537022911|FG003|Overall Study|Deterioration in asthma|9|||
148876203|NCT01455194|537022908|FG000|Overall Study|Adverse Event|1|||
148876204|NCT01455194|537022909|FG001|Overall Study|Adverse Event|1|||
148876205|NCT01455194|537022910|FG002|Overall Study|Adverse Event|1|||
148876206|NCT01455194|537022911|FG003|Overall Study|Adverse Event|3|||
148876207|NCT01455194|537022908|FG000|Overall Study|Withdrawal by Subject|21|||
148876208|NCT01455194|537022909|FG001|Overall Study|Withdrawal by Subject|16|||
148876209|NCT01455194|537022910|FG002|Overall Study|Withdrawal by Subject|12|||
148876210|NCT01455194|537022911|FG003|Overall Study|Withdrawal by Subject|9|||
148876211|NCT01455194|537022908|FG000|Overall Study|Lost to Follow-up|2|||
148876212|NCT01455194|537022909|FG001|Overall Study|Lost to Follow-up|0|||
148876213|NCT01455194|537022910|FG002|Overall Study|Lost to Follow-up|1|||
148876214|NCT01455194|537022911|FG003|Overall Study|Lost to Follow-up|1|||
148876215|NCT01455194|537022908|FG000|Overall Study|Pregnancy|0|||
148876216|NCT01455194|537022909|FG001|Overall Study|Pregnancy|1|||
148876217|NCT01455194|537022910|FG002|Overall Study|Pregnancy|1|||
148876218|NCT01455194|537022911|FG003|Overall Study|Pregnancy|0|||
148876219|NCT01455194|537022908|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
148876220|NCT01455194|537022909|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
148876221|NCT01455194|537022910|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
148876222|NCT01455194|537022911|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
148876223|NCT01455194|537022908|FG000|Overall Study|Miscellaneous|4|||
148876224|NCT01455194|537022909|FG001|Overall Study|Miscellaneous|5|||
148876225|NCT01455194|537022910|FG002|Overall Study|Miscellaneous|1|||
148876226|NCT01455194|537022911|FG003|Overall Study|Miscellaneous|4|||
148876227|NCT02516228|537022912|FG000|Overall Study|Lost to Follow-up|1|||
148876228|NCT02516228|537022912|FG000|Overall Study|Withdrawal by Subject|1|||
148876229|NCT02516228|537022912|FG000|Overall Study|Physician Decision|1|||
148876230|NCT03916484|537022913|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148876231|NCT03916484|537022914|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
148876232|NCT03916484|537022915|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148876233|NCT03916484|537022916|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
148876234|NCT03916484|537022913|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
148876235|NCT03916484|537022914|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
148876236|NCT03916484|537022915|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
148876237|NCT03916484|537022916|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
148876238|NCT00788710|537022917|FG000|Overall Study|Adverse Event|1|||
148876239|NCT00788710|537022918|FG001|Overall Study|Adverse Event|3|||
148876240|NCT00788710|537022919|FG002|Overall Study|Adverse Event|4|||
148876241|NCT00788710|537022917|FG000|Overall Study|Lack of Efficacy|0|||
148876242|NCT00788710|537022918|FG001|Overall Study|Lack of Efficacy|0|||
148876243|NCT00788710|537022919|FG002|Overall Study|Lack of Efficacy|1|||
148876244|NCT00788710|537022917|FG000|Overall Study|Lost to Follow-up|0|||
148876245|NCT00788710|537022918|FG001|Overall Study|Lost to Follow-up|1|||
148876246|NCT00788710|537022919|FG002|Overall Study|Lost to Follow-up|0|||
148876247|NCT00788710|537022917|FG000|Overall Study|Physician Decision|2|||
148876248|NCT00788710|537022918|FG001|Overall Study|Physician Decision|1|||
148876249|NCT00788710|537022919|FG002|Overall Study|Physician Decision|0|||
148876250|NCT00788710|537022917|FG000|Overall Study|Protocol Violation|0|||
148876251|NCT00788710|537022918|FG001|Overall Study|Protocol Violation|1|||
148876252|NCT00788710|537022919|FG002|Overall Study|Protocol Violation|1|||
148876253|NCT00788710|537022917|FG000|Overall Study|Withdrawal by Subject|2|||
148876254|NCT00788710|537022918|FG001|Overall Study|Withdrawal by Subject|2|||
148876255|NCT00788710|537022919|FG002|Overall Study|Withdrawal by Subject|0|||
148876256|NCT01008904|537022920|FG000|Overall Study|Lost to Follow-up|1|||
148876257|NCT01008904|537022920|FG000|Overall Study|Adverse Event|2|||
148876258|NCT01008904|537022920|FG000|Overall Study|unexpected unrelated surgery|1|||
148876259|NCT00360568|537022923|FG000|Overall Study|Adverse Event|1|||
148876260|NCT00360568|537022924|FG001|Overall Study|Adverse Event|2|||
148876261|NCT00360568|537022923|FG000|Overall Study|Lack of Efficacy|1|||
148876262|NCT00360568|537022924|FG001|Overall Study|Lack of Efficacy|0|||
148876263|NCT00360568|537022923|FG000|Overall Study|Withdrawal by Subject|0|||
148876264|NCT00360568|537022924|FG001|Overall Study|Withdrawal by Subject|3|||
148876265|NCT01008449|537022925|FG000|Overall Study|Lost to Follow-up|29|||
148876266|NCT01008449|537022926|FG001|Overall Study|Lost to Follow-up|19|||
148876267|NCT01220180|537022927|FG000|Overall Study|Lost to Follow-up|76|||
148876268|NCT01220180|537022927|FG000|Overall Study|Other|72|||
148876269|NCT01220180|537022927|FG000|Overall Study|Adverse Event|35|||
148876270|NCT01220180|537022927|FG000|Overall Study|Lack of Efficacy|22|||
148876271|NCT01220180|537022927|FG000|Overall Study|Death|1|||
148876272|NCT01220180|537022927|FG000|Overall Study|Randomized but not treated|1|||
148876273|NCT01990859|537022928|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
148876274|NCT01990859|537022928|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
148876275|NCT02262754|537022929|FG000|Overall Study|Adverse Event|3|||
148876276|NCT02262754|537022930|FG001|Overall Study|Adverse Event|4|||
148876277|NCT02262754|537022931|FG002|Overall Study|Adverse Event|0|||
148876278|NCT02262754|537022929|FG000|Overall Study|Lack of Efficacy|2|||
148876279|NCT02262754|537022930|FG001|Overall Study|Lack of Efficacy|0|||
148876280|NCT02262754|537022931|FG002|Overall Study|Lack of Efficacy|1|||
148876281|NCT02262754|537022929|FG000|Overall Study|Lost to Follow-up|0|||
148876282|NCT02262754|537022930|FG001|Overall Study|Lost to Follow-up|0|||
148876283|NCT02262754|537022931|FG002|Overall Study|Lost to Follow-up|1|||
148876284|NCT02262754|537022929|FG000|Overall Study|No longer meets eligibility criteria|0|||
148876285|NCT02262754|537022930|FG001|Overall Study|No longer meets eligibility criteria|1|||
148876286|NCT02262754|537022931|FG002|Overall Study|No longer meets eligibility criteria|0|||
148876287|NCT02262754|537022929|FG000|Overall Study|Study terminated by sponsor|5|||
148876288|NCT02262754|537022930|FG001|Overall Study|Study terminated by sponsor|4|||
148876289|NCT02262754|537022931|FG002|Overall Study|Study terminated by sponsor|4|||
148876290|NCT02262754|537022929|FG000|Overall Study|Protocol Violation|1|||
148876291|NCT02262754|537022930|FG001|Overall Study|Protocol Violation|0|||
148876292|NCT02262754|537022931|FG002|Overall Study|Protocol Violation|0|||
148876293|NCT02262754|537022929|FG000|Overall Study|Withdrawal by Subject|1|||
148876294|NCT02262754|537022930|FG001|Overall Study|Withdrawal by Subject|0|||
148876295|NCT02262754|537022931|FG002|Overall Study|Withdrawal by Subject|1|||
148876296|NCT02262754|537022929|FG000|Overall Study|Other|4|||
148876297|NCT02262754|537022930|FG001|Overall Study|Other|0|||
148876298|NCT02262754|537022931|FG002|Overall Study|Other|2|||
148876299|NCT01067469|537022932|FG000|Overall Study|Withdrawal by Subject|0|||
148876300|NCT01067469|537022933|FG001|Overall Study|Withdrawal by Subject|1|||
148876301|NCT01067469|537022932|FG000|Overall Study|Disease Progression|0|||
148876302|NCT01067469|537022933|FG001|Overall Study|Disease Progression|1|||
148876303|NCT04079114|537022935|FG000|Overall Study|Study prematuely terminated.|166|||
148876304|NCT01364389|537022939|FG000|Overall Study|Withdrawal by Subject|0|||
148876305|NCT01364389|537022940|FG001|Overall Study|Withdrawal by Subject|1|||
148876306|NCT01364389|537022941|FG002|Overall Study|Withdrawal by Subject|0|||
148876307|NCT01364389|537022939|FG000|Overall Study|Protocol deviation|0|||
149034446|NCT03386929|537603673|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
148876308|NCT01364389|537022940|FG001|Overall Study|Protocol deviation|0|||
148876309|NCT01364389|537022941|FG002|Overall Study|Protocol deviation|1|||
148876310|NCT01364389|537022939|FG000|Overall Study|Administrative problems|1|||
148876311|NCT01364389|537022940|FG001|Overall Study|Administrative problems|0|||
149034447|NCT03386929|537603674|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
148876312|NCT01364389|537022941|FG002|Overall Study|Administrative problems|0|||
148876313|NCT01364389|537022939|FG000|Overall Study|Adverse Event|1|||
148876314|NCT01364389|537022940|FG001|Overall Study|Adverse Event|0|||
148876315|NCT01364389|537022941|FG002|Overall Study|Adverse Event|0|||
148876316|NCT00629798|537022946|FG000|Overall Study|Not Treated|4|||
148876317|NCT02554981|537022947|FG000|Overall Study|Adverse Event|1|||
149055923|NCT01369355|537689000|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
148876318|NCT02554981|537022947|FG000|Overall Study|Administrative Reasons|1|||
148876319|NCT02554981|537022947|FG000|Overall Study|Other Miscellaneous Reasons|3|||
148876320|NCT02292706|537022950|FG000|Overall Study|Lost to Follow-up|20|||
148876321|NCT02292706|537022951|FG001|Overall Study|Lost to Follow-up|44|||
148876322|NCT02292706|537022952|FG002|Overall Study|Lost to Follow-up|24|||
148876323|NCT02292706|537022953|FG003|Overall Study|Lost to Follow-up|61|||
148876324|NCT02292706|537022954|FG004|Overall Study|Lost to Follow-up|21|||
148876325|NCT02292706|537022955|FG005|Overall Study|Lost to Follow-up|52|||
148876326|NCT02292706|537022956|FG006|Overall Study|Lost to Follow-up|25|||
148876327|NCT02292706|537022957|FG007|Overall Study|Lost to Follow-up|0|||
148876328|NCT02292706|537022950|FG000|Overall Study|Withdrew consent|15|||
148876329|NCT02292706|537022951|FG001|Overall Study|Withdrew consent|56|||
148876330|NCT02292706|537022952|FG002|Overall Study|Withdrew consent|43|||
148876331|NCT02292706|537022953|FG003|Overall Study|Withdrew consent|36|||
148876332|NCT02292706|537022954|FG004|Overall Study|Withdrew consent|13|||
148876333|NCT02292706|537022955|FG005|Overall Study|Withdrew consent|51|||
148876334|NCT02292706|537022956|FG006|Overall Study|Withdrew consent|20|||
148876335|NCT02292706|537022957|FG007|Overall Study|Withdrew consent|0|||
148876336|NCT02292706|537022950|FG000|Overall Study|Death|3|||
148876337|NCT02292706|537022951|FG001|Overall Study|Death|11|||
148876338|NCT02292706|537022952|FG002|Overall Study|Death|16|||
148876339|NCT02292706|537022953|FG003|Overall Study|Death|22|||
148876340|NCT02292706|537022954|FG004|Overall Study|Death|8|||
148876341|NCT02292706|537022955|FG005|Overall Study|Death|17|||
148876342|NCT02292706|537022956|FG006|Overall Study|Death|3|||
148876343|NCT02292706|537022957|FG007|Overall Study|Death|0|||
148876344|NCT02292706|537022950|FG000|Overall Study|Study terminated by sponsor|0|||
148876345|NCT02292706|537022951|FG001|Overall Study|Study terminated by sponsor|9|||
148876346|NCT02292706|537022952|FG002|Overall Study|Study terminated by sponsor|4|||
148876347|NCT02292706|537022953|FG003|Overall Study|Study terminated by sponsor|21|||
148876348|NCT02292706|537022954|FG004|Overall Study|Study terminated by sponsor|11|||
148876349|NCT02292706|537022955|FG005|Overall Study|Study terminated by sponsor|13|||
148876350|NCT02292706|537022956|FG006|Overall Study|Study terminated by sponsor|3|||
148876351|NCT02292706|537022957|FG007|Overall Study|Study terminated by sponsor|0|||
148876352|NCT02292706|537022950|FG000|Overall Study|Investigator's discretion|4|||
148876353|NCT02292706|537022951|FG001|Overall Study|Investigator's discretion|9|||
148876354|NCT02292706|537022952|FG002|Overall Study|Investigator's discretion|7|||
148876355|NCT02292706|537022953|FG003|Overall Study|Investigator's discretion|11|||
148876356|NCT02292706|537022954|FG004|Overall Study|Investigator's discretion|4|||
148876357|NCT02292706|537022955|FG005|Overall Study|Investigator's discretion|10|||
148876358|NCT02292706|537022956|FG006|Overall Study|Investigator's discretion|1|||
148876359|NCT02292706|537022957|FG007|Overall Study|Investigator's discretion|0|||
148876360|NCT02292706|537022950|FG000|Overall Study|Liver transplant|1|||
148876361|NCT02292706|537022951|FG001|Overall Study|Liver transplant|1|||
148876362|NCT02292706|537022952|FG002|Overall Study|Liver transplant|11|||
148876363|NCT02292706|537022953|FG003|Overall Study|Liver transplant|16|||
148876364|NCT02292706|537022954|FG004|Overall Study|Liver transplant|5|||
148876365|NCT02292706|537022955|FG005|Overall Study|Liver transplant|6|||
148876366|NCT02292706|537022956|FG006|Overall Study|Liver transplant|5|||
148876367|NCT02292706|537022957|FG007|Overall Study|Liver transplant|0|||
148876368|NCT02292706|537022950|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
148876369|NCT02292706|537022951|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
148876370|NCT02292706|537022952|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
148876371|NCT02292706|537022953|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
148876372|NCT02292706|537022954|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
148876373|NCT02292706|537022955|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
148876374|NCT02292706|537022956|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
148876375|NCT02292706|537022957|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
148876376|NCT02292706|537022950|FG000|Overall Study|Subject terminated by sponsor|1|||
148876377|NCT02292706|537022951|FG001|Overall Study|Subject terminated by sponsor|0|||
148876378|NCT02292706|537022952|FG002|Overall Study|Subject terminated by sponsor|0|||
148876379|NCT02292706|537022953|FG003|Overall Study|Subject terminated by sponsor|2|||
148876380|NCT02292706|537022954|FG004|Overall Study|Subject terminated by sponsor|1|||
148876381|NCT02292706|537022955|FG005|Overall Study|Subject terminated by sponsor|0|||
148876382|NCT02292706|537022956|FG006|Overall Study|Subject terminated by sponsor|0|||
148876383|NCT02292706|537022957|FG007|Overall Study|Subject terminated by sponsor|0|||
148876384|NCT02292706|537022950|FG000|Overall Study|Missing|0|||
148876385|NCT02292706|537022951|FG001|Overall Study|Missing|0|||
148876386|NCT02292706|537022952|FG002|Overall Study|Missing|1|||
148876387|NCT02292706|537022953|FG003|Overall Study|Missing|1|||
148876388|NCT02292706|537022954|FG004|Overall Study|Missing|0|||
148876389|NCT02292706|537022955|FG005|Overall Study|Missing|1|||
148876390|NCT02292706|537022956|FG006|Overall Study|Missing|0|||
148876391|NCT02292706|537022957|FG007|Overall Study|Missing|0|||
148876392|NCT02292706|537022950|FG000|Overall Study|Virologic relapse or reinfection|1|||
148876393|NCT02292706|537022951|FG001|Overall Study|Virologic relapse or reinfection|0|||
148876394|NCT02292706|537022952|FG002|Overall Study|Virologic relapse or reinfection|0|||
148876395|NCT02292706|537022953|FG003|Overall Study|Virologic relapse or reinfection|1|||
148876396|NCT02292706|537022954|FG004|Overall Study|Virologic relapse or reinfection|0|||
148876397|NCT02292706|537022955|FG005|Overall Study|Virologic relapse or reinfection|1|||
148876398|NCT02292706|537022956|FG006|Overall Study|Virologic relapse or reinfection|0|||
148876399|NCT02292706|537022957|FG007|Overall Study|Virologic relapse or reinfection|0|||
148876400|NCT02725866|537022960|FG000|Overall Study|Failure to return|6|||
148876401|NCT02725866|537022960|FG000|Overall Study|Withdrew consent|3|||
148876402|NCT02725866|537022960|FG000|Overall Study|Insufficient virological response|1|||
148876403|NCT02725866|537022960|FG000|Overall Study|Other, not specified|4|||
148876404|NCT01990612|537022961|FG000|Overall Study|Lost to Follow-up|2|||
148876405|NCT01990612|537022962|FG001|Overall Study|Lost to Follow-up|1|||
148876406|NCT01990612|537022961|FG000|Overall Study|Withdrawal by Subject|5|||
148876407|NCT01990612|537022962|FG001|Overall Study|Withdrawal by Subject|2|||
148876408|NCT02188849|537022965|FG000|Overall Study|Lost to Follow-up|3|||
148876409|NCT02188849|537022966|FG001|Overall Study|Lost to Follow-up|8|||
148876410|NCT00812565|537022968|FG000|Overall Study|Did Not Receive Study Medication|1|||
148876411|NCT00812565|537022969|FG001|Overall Study|Did Not Receive Study Medication|1|||
148876412|NCT00812565|537022970|FG002|Overall Study|Did Not Receive Study Medication|0|||
148876413|NCT00812565|537022971|FG003|Overall Study|Did Not Receive Study Medication|0|||
148876414|NCT00812565|537022972|FG004|Overall Study|Did Not Receive Study Medication|0|||
148876415|NCT00812565|537022973|FG005|Overall Study|Did Not Receive Study Medication|0|||
148876416|NCT00812565|537022974|FG006|Overall Study|Did Not Receive Study Medication|0|||
148876417|NCT00812565|537022975|FG007|Overall Study|Did Not Receive Study Medication|0|||
148876418|NCT00812565|537022968|FG000|Overall Study|Adverse Event|0|||
148876419|NCT00812565|537022969|FG001|Overall Study|Adverse Event|0|||
148876420|NCT00812565|537022970|FG002|Overall Study|Adverse Event|0|||
148876421|NCT00812565|537022971|FG003|Overall Study|Adverse Event|2|||
148876422|NCT00812565|537022972|FG004|Overall Study|Adverse Event|0|||
148876423|NCT00812565|537022973|FG005|Overall Study|Adverse Event|0|||
148876424|NCT00812565|537022974|FG006|Overall Study|Adverse Event|0|||
148876425|NCT00812565|537022975|FG007|Overall Study|Adverse Event|1|||
148876426|NCT00812565|537022968|FG000|Overall Study|Did Not Come to Study Visit|1|||
148876427|NCT00812565|537022969|FG001|Overall Study|Did Not Come to Study Visit|0|||
148876428|NCT00812565|537022970|FG002|Overall Study|Did Not Come to Study Visit|0|||
148876429|NCT00812565|537022971|FG003|Overall Study|Did Not Come to Study Visit|0|||
148876430|NCT00812565|537022972|FG004|Overall Study|Did Not Come to Study Visit|0|||
148876431|NCT00812565|537022973|FG005|Overall Study|Did Not Come to Study Visit|0|||
148876432|NCT00812565|537022974|FG006|Overall Study|Did Not Come to Study Visit|0|||
148876433|NCT00812565|537022975|FG007|Overall Study|Did Not Come to Study Visit|0|||
148876434|NCT00812565|537022968|FG000|Overall Study|Withdrawal of Consent|1|||
148876435|NCT00812565|537022969|FG001|Overall Study|Withdrawal of Consent|0|||
148876436|NCT00812565|537022970|FG002|Overall Study|Withdrawal of Consent|0|||
148876437|NCT00812565|537022971|FG003|Overall Study|Withdrawal of Consent|0|||
148876438|NCT00812565|537022972|FG004|Overall Study|Withdrawal of Consent|1|||
148876439|NCT00812565|537022973|FG005|Overall Study|Withdrawal of Consent|0|||
148876440|NCT00812565|537022974|FG006|Overall Study|Withdrawal of Consent|0|||
148876441|NCT00812565|537022975|FG007|Overall Study|Withdrawal of Consent|0|||
148876442|NCT00812565|537022968|FG000|Overall Study|Reason Not Specified|0|||
148876443|NCT00812565|537022969|FG001|Overall Study|Reason Not Specified|0|||
148876444|NCT00812565|537022970|FG002|Overall Study|Reason Not Specified|0|||
148876445|NCT00812565|537022971|FG003|Overall Study|Reason Not Specified|0|||
148876446|NCT00812565|537022972|FG004|Overall Study|Reason Not Specified|0|||
148876447|NCT00812565|537022973|FG005|Overall Study|Reason Not Specified|1|||
148876448|NCT00812565|537022974|FG006|Overall Study|Reason Not Specified|0|||
148876449|NCT00812565|537022975|FG007|Overall Study|Reason Not Specified|0|||
148876450|NCT01793883|537022978|FG000|Overall Study|Withdrawal by Subject|3|||
148876451|NCT01793883|537022979|FG001|Overall Study|Withdrawal by Subject|7|||
148876452|NCT01793883|537022980|FG002|Overall Study|Withdrawal by Subject|3|||
148876453|NCT01793883|537022978|FG000|Overall Study|Subject noncompliance|0|||
148876454|NCT01793883|537022979|FG001|Overall Study|Subject noncompliance|1|||
148876455|NCT01793883|537022980|FG002|Overall Study|Subject noncompliance|1|||
148876456|NCT01793883|537022978|FG000|Overall Study|Lost to Follow-up|5|||
148876457|NCT01793883|537022979|FG001|Overall Study|Lost to Follow-up|1|||
149034448|NCT03386929|537603672|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
149034449|NCT03386929|537603673|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
149034450|NCT03386929|537603674|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
149034451|NCT00038103|537603675|FG000|Overall Study|Adverse Event|5|||
148876458|NCT01793883|537022980|FG002|Overall Study|Lost to Follow-up|3|||
148876459|NCT01793883|537022978|FG000|Overall Study|Randomized in error|1|||
148876460|NCT01793883|537022979|FG001|Overall Study|Randomized in error|0|||
148876461|NCT01793883|537022980|FG002|Overall Study|Randomized in error|0|||
148876462|NCT01793883|537022978|FG000|Overall Study|Unable to complete spriometry|1|||
148876463|NCT01793883|537022979|FG001|Overall Study|Unable to complete spriometry|0|||
148876464|NCT01793883|537022980|FG002|Overall Study|Unable to complete spriometry|0|||
148876465|NCT01793883|537022978|FG000|Overall Study|Unable to complete measurements|1|||
148876466|NCT01793883|537022979|FG001|Overall Study|Unable to complete measurements|0|||
148876467|NCT01793883|537022980|FG002|Overall Study|Unable to complete measurements|0|||
148876468|NCT01793883|537022978|FG000|Overall Study|Met exclusion criteria|1|||
148876469|NCT01793883|537022979|FG001|Overall Study|Met exclusion criteria|0|||
148876470|NCT01793883|537022980|FG002|Overall Study|Met exclusion criteria|0|||
148876471|NCT01793883|537022978|FG000|Overall Study|Dosing error|0|||
148876472|NCT01793883|537022979|FG001|Overall Study|Dosing error|1|||
148876473|NCT01793883|537022980|FG002|Overall Study|Dosing error|0|||
148876474|NCT01793883|537022978|FG000|Overall Study|Respiratory distress during spirometry|0|||
148876475|NCT01793883|537022979|FG001|Overall Study|Respiratory distress during spirometry|0|||
148876476|NCT01793883|537022980|FG002|Overall Study|Respiratory distress during spirometry|1|||
148876477|NCT02353728|537022981|FG000|Overall Study|Subject non-compliance|1|||
148876478|NCT00895310|537022982|FG000|Overall Study|Withdrawal by Subject|1|||
148876479|NCT00659230|537022983|FG000|Overall Study|Lost to Follow-up|2|||
148876480|NCT00659230|537022984|FG001|Overall Study|Lost to Follow-up|5|||
148876481|NCT00659230|537022983|FG000|Overall Study|Lost source documentation|5|||
148876482|NCT00659230|537022984|FG001|Overall Study|Lost source documentation|4|||
148876483|NCT00659230|537022983|FG000|Overall Study|Did not return post-randomization|2|||
148876484|NCT00659230|537022984|FG001|Overall Study|Did not return post-randomization|3|||
148876485|NCT05066165|537025105|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
148876486|NCT05066165|537025106|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
148876487|NCT05066165|537025105|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
148876488|NCT05066165|537025106|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
148876489|NCT02467582|537025107|FG000|Allocation|Withdrawal by Subject|1|||
148876490|NCT02467582|537025108|FG001|Allocation|Withdrawal by Subject|0|||
148876491|NCT02467582|537025107|FG000|Follow-up|Death|5|||
148876492|NCT02467582|537025108|FG001|Follow-up|Death|4|||
148876493|NCT02467582|537025107|FG000|Follow-up|Lost to Follow-up|6|||
148876494|NCT02467582|537025108|FG001|Follow-up|Lost to Follow-up|5|||
148876495|NCT01370265|537025109|FG000|First Intervention|Adverse Event|1|||
148876496|NCT01370265|537025110|FG001|First Intervention|Adverse Event|1|||
148876497|NCT03343626|537025111|FG000|Overall Study|Lost to Follow-up|4|||
148876498|NCT03343626|537025112|FG001|Overall Study|Lost to Follow-up|3|||
148876499|NCT03343626|537025113|FG002|Overall Study|Lost to Follow-up|2|||
148876500|NCT03343626|537025114|FG003|Overall Study|Lost to Follow-up|5|||
148876501|NCT03343626|537025115|FG004|Overall Study|Lost to Follow-up|4|||
148876502|NCT03343626|537025116|FG005|Overall Study|Lost to Follow-up|4|||
148876503|NCT03343626|537025117|FG006|Overall Study|Lost to Follow-up|4|||
148876504|NCT03343626|537025118|FG007|Overall Study|Lost to Follow-up|7|||
148876505|NCT03343626|537025111|FG000|Overall Study|Withdrawal of Consent|2|||
148876506|NCT03343626|537025112|FG001|Overall Study|Withdrawal of Consent|1|||
148876507|NCT03343626|537025113|FG002|Overall Study|Withdrawal of Consent|0|||
148876508|NCT03343626|537025114|FG003|Overall Study|Withdrawal of Consent|3|||
148876509|NCT03343626|537025115|FG004|Overall Study|Withdrawal of Consent|3|||
148876510|NCT03343626|537025116|FG005|Overall Study|Withdrawal of Consent|1|||
148876511|NCT03343626|537025117|FG006|Overall Study|Withdrawal of Consent|1|||
148876512|NCT03343626|537025118|FG007|Overall Study|Withdrawal of Consent|2|||
148876513|NCT03343626|537025111|FG000|Overall Study|Reason not Specified|0|||
148876514|NCT03343626|537025112|FG001|Overall Study|Reason not Specified|1|||
148876515|NCT03343626|537025113|FG002|Overall Study|Reason not Specified|0|||
148876516|NCT03343626|537025114|FG003|Overall Study|Reason not Specified|0|||
148876517|NCT03343626|537025115|FG004|Overall Study|Reason not Specified|0|||
148876518|NCT03343626|537025116|FG005|Overall Study|Reason not Specified|0|||
148876519|NCT03343626|537025117|FG006|Overall Study|Reason not Specified|0|||
148876520|NCT03343626|537025118|FG007|Overall Study|Reason not Specified|1|||
148876521|NCT03343626|537025111|FG000|Overall Study|Data Entry Error|0|||
148876522|NCT03343626|537025112|FG001|Overall Study|Data Entry Error|0|||
148876523|NCT03343626|537025113|FG002|Overall Study|Data Entry Error|0|||
148876524|NCT03343626|537025114|FG003|Overall Study|Data Entry Error|0|||
148876525|NCT03343626|537025115|FG004|Overall Study|Data Entry Error|0|||
148876526|NCT03343626|537025116|FG005|Overall Study|Data Entry Error|0|||
148876527|NCT03343626|537025117|FG006|Overall Study|Data Entry Error|0|||
148876528|NCT03343626|537025118|FG007|Overall Study|Data Entry Error|1|||
148876529|NCT00703924|537025119|FG000|Overall Study|Withdrawal by Subject|1|||
148876530|NCT00703924|537025120|FG001|Overall Study|Withdrawal by Subject|1|||
148876531|NCT01031979|537025123|FG000|Overall Study|Lost to Follow-up|5|||
148876532|NCT01031979|537025124|FG001|Overall Study|Lost to Follow-up|4|||
148876533|NCT03592368|537025125|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
148876534|NCT03592368|537025126|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
148876535|NCT03592368|537025127|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
148876536|NCT03592368|537025128|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
148876537|NCT03592368|537025125|FG000|Overall Study|Adverse Event|0|||
148876538|NCT03592368|537025126|FG001|Overall Study|Adverse Event|0|||
148876539|NCT03592368|537025127|FG002|Overall Study|Adverse Event|0|||
148876540|NCT03592368|537025128|FG003|Overall Study|Adverse Event|1|||
148876541|NCT03592368|537025125|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
148876542|NCT03592368|537025126|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
148876543|NCT03592368|537025127|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
148876544|NCT03592368|537025128|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
148876545|NCT02454478|537025135|FG000|Overall Study|Incomplete DLT Evaluation|1|||
148876546|NCT01732770|537025140|FG000|Overall Study|Lost to Follow-up|2|||
148876547|NCT01732770|537025141|FG001|Overall Study|Lost to Follow-up|3|||
148876548|NCT01732770|537025140|FG000|Overall Study|Withdrawal by Subject|5|||
148876549|NCT01732770|537025141|FG001|Overall Study|Withdrawal by Subject|3|||
148876550|NCT01732770|537025140|FG000|Overall Study|Decision by Sponsor|2|||
148876551|NCT01732770|537025141|FG001|Overall Study|Decision by Sponsor|2|||
148876552|NCT01732770|537025140|FG000|Overall Study|Death|1|||
148876553|NCT01732770|537025141|FG001|Overall Study|Death|0|||
148876554|NCT01959841|537025144|FG000|Overall Study|Adverse Event|1|||
148876555|NCT01959841|537025145|FG001|Overall Study|Adverse Event|3|||
148876556|NCT01959841|537025146|FG002|Overall Study|Adverse Event|2|||
148876557|NCT01959841|537025144|FG000|Overall Study|Lack of Efficacy|5|||
148876558|NCT01959841|537025145|FG001|Overall Study|Lack of Efficacy|0|||
148876559|NCT01959841|537025146|FG002|Overall Study|Lack of Efficacy|0|||
148876560|NCT01959841|537025144|FG000|Overall Study|Lost to Follow-up|1|||
148876561|NCT01959841|537025145|FG001|Overall Study|Lost to Follow-up|1|||
148876562|NCT01959841|537025146|FG002|Overall Study|Lost to Follow-up|0|||
148876563|NCT01959841|537025144|FG000|Overall Study|Physician Decision|0|||
148876564|NCT01959841|537025145|FG001|Overall Study|Physician Decision|2|||
148876565|NCT01959841|537025146|FG002|Overall Study|Physician Decision|3|||
148876566|NCT01959841|537025144|FG000|Overall Study|Protocol Violation|16|||
148876567|NCT01959841|537025145|FG001|Overall Study|Protocol Violation|23|||
148876568|NCT01959841|537025146|FG002|Overall Study|Protocol Violation|16|||
148876569|NCT01959841|537025144|FG000|Overall Study|Withdrawal by Subject|7|||
148876570|NCT01959841|537025145|FG001|Overall Study|Withdrawal by Subject|7|||
148876571|NCT01959841|537025146|FG002|Overall Study|Withdrawal by Subject|5|||
148876572|NCT01959841|537025144|FG000|Overall Study|Clinical laboratory value|2|||
148876573|NCT01959841|537025145|FG001|Overall Study|Clinical laboratory value|6|||
148876574|NCT01959841|537025146|FG002|Overall Study|Clinical laboratory value|6|||
148876575|NCT01959841|537025144|FG000|Overall Study|Platelet count below on day1 or 4|11|||
148876576|NCT01959841|537025145|FG001|Overall Study|Platelet count below on day1 or 4|15|||
148876577|NCT01959841|537025146|FG002|Overall Study|Platelet count below on day1 or 4|11|||
148876578|NCT00780416|537025147|FG000|Overall Study|Physician Decision|3|||
148876579|NCT00780416|537025148|FG001|Overall Study|Physician Decision|3|||
148876580|NCT00780416|537025147|FG000|Overall Study|Protocol Violation|1|||
148876581|NCT00780416|537025148|FG001|Overall Study|Protocol Violation|0|||
148876582|NCT00780416|537025147|FG000|Overall Study|Withdrawal by Subject|8|||
148876583|NCT00780416|537025148|FG001|Overall Study|Withdrawal by Subject|6|||
148876584|NCT03521141|537025155|FG000|Overall Study|Death|1|||
148876585|NCT03521141|537025156|FG001|Overall Study|Death|0|||
148876586|NCT03521141|537025157|FG002|Overall Study|Death|1|||
148876587|NCT01271725|537025163|FG000|Part A|Progressive disease according to RECIST|8|||
148876588|NCT01271725|537025164|FG001|Part A|Progressive disease according to RECIST|0|||
148876589|NCT01271725|537025163|FG000|Part A|Clinical signs/symptoms of progression|2|||
148876590|NCT01271725|537025164|FG001|Part A|Clinical signs/symptoms of progression|0|||
148876591|NCT01271725|537025163|FG000|Part A|Other Adverse Event|8|||
148876592|NCT01271725|537025164|FG001|Part A|Other Adverse Event|0|||
148876593|NCT01271725|537025163|FG000|Part A|Lost to Follow-up|1|||
148876594|NCT01271725|537025164|FG001|Part A|Lost to Follow-up|0|||
148876595|NCT01271725|537025163|FG000|Part A|Withdrawal by Subject|12|||
148876596|NCT01271725|537025164|FG001|Part A|Withdrawal by Subject|0|||
148876597|NCT01271725|537025163|FG000|Part A|Other than specified|3|||
148876598|NCT01271725|537025164|FG001|Part A|Other than specified|0|||
148876599|NCT01271725|537025163|FG000|Part A|Protocol Violation|1|||
148876600|NCT01271725|537025164|FG001|Part A|Protocol Violation|0|||
148876601|NCT01271725|537025163|FG000|Part B|Other than specified|0|||
148876602|NCT01271725|537025164|FG001|Part B|Other than specified|2|||
148876603|NCT01271725|537025163|FG000|Part B|Clinical signs/symptoms of progression|0|||
148876604|NCT01271725|537025164|FG001|Part B|Clinical signs/symptoms of progression|2|||
148876605|NCT01271725|537025163|FG000|Part B|Other Adverse Event|0|||
148876606|NCT01271725|537025164|FG001|Part B|Other Adverse Event|1|||
148876607|NCT01271725|537025163|FG000|Part B|Protocol Violation|0|||
148876608|NCT01271725|537025164|FG001|Part B|Protocol Violation|1|||
148876609|NCT01271725|537025163|FG000|Part B|Withdrawal by Subject|0|||
148876610|NCT01271725|537025164|FG001|Part B|Withdrawal by Subject|6|||
148876611|NCT01496469|537025172|FG000|Overall Study|Adverse Event|1|||
148876612|NCT01496469|537025173|FG001|Overall Study|Adverse Event|0|||
148876613|NCT01496469|537025172|FG000|Overall Study|Protocol Violation|2|||
148876614|NCT01496469|537025173|FG001|Overall Study|Protocol Violation|0|||
148876615|NCT01496469|537025172|FG000|Overall Study|Lost to Follow-up|1|||
148876616|NCT01496469|537025173|FG001|Overall Study|Lost to Follow-up|1|||
148876617|NCT01496469|537025172|FG000|Overall Study|Withdrawal by Subject|4|||
148876618|NCT01496469|537025173|FG001|Overall Study|Withdrawal by Subject|4|||
148876619|NCT01496469|537025172|FG000|Overall Study|BP exceeds protocol limits|1|||
148876620|NCT01496469|537025173|FG001|Overall Study|BP exceeds protocol limits|2|||
148876621|NCT01496469|537025172|FG000|Overall Study|Other|1|||
148876622|NCT01496469|537025173|FG001|Overall Study|Other|1|||
148876623|NCT00193180|537025176|FG000|Overall Study|Lack of Efficacy|1|||
148876624|NCT00193180|537025176|FG000|Overall Study|Adverse Event|8|||
148876625|NCT00193180|537025176|FG000|Overall Study|Protocol Violation|1|||
148876626|NCT01393639|537025177|FG000|Overall Study|Protocol Violation|0|||
148876627|NCT01393639|537025178|FG001|Overall Study|Protocol Violation|0|||
148876628|NCT01393639|537025179|FG002|Overall Study|Protocol Violation|0|||
148876629|NCT01393639|537025180|FG003|Overall Study|Protocol Violation|1|||
148876630|NCT01393639|537025181|FG004|Overall Study|Protocol Violation|0|||
148876631|NCT01393639|537025182|FG005|Overall Study|Protocol Violation|0|||
148876632|NCT01393639|537025183|FG006|Overall Study|Protocol Violation|0|||
148876633|NCT01393639|537025177|FG000|Overall Study|Other|0|||
148876634|NCT01393639|537025178|FG001|Overall Study|Other|2|||
148876635|NCT01393639|537025179|FG002|Overall Study|Other|0|||
148876636|NCT01393639|537025180|FG003|Overall Study|Other|2|||
148876637|NCT01393639|537025181|FG004|Overall Study|Other|1|||
148876638|NCT01393639|537025182|FG005|Overall Study|Other|0|||
148876639|NCT01393639|537025183|FG006|Overall Study|Other|1|||
148876640|NCT01393639|537025177|FG000|Overall Study|Withdrawal by Subject|1|||
148876641|NCT01393639|537025178|FG001|Overall Study|Withdrawal by Subject|1|||
148876642|NCT01393639|537025179|FG002|Overall Study|Withdrawal by Subject|0|||
148876643|NCT01393639|537025180|FG003|Overall Study|Withdrawal by Subject|0|||
148876644|NCT01393639|537025181|FG004|Overall Study|Withdrawal by Subject|0|||
148876645|NCT01393639|537025182|FG005|Overall Study|Withdrawal by Subject|0|||
148876646|NCT01393639|537025183|FG006|Overall Study|Withdrawal by Subject|1|||
148876647|NCT01393639|537025177|FG000|Overall Study|Medication error without associated AE|0|||
148876648|NCT01393639|537025178|FG001|Overall Study|Medication error without associated AE|0|||
148876649|NCT01393639|537025179|FG002|Overall Study|Medication error without associated AE|0|||
148876650|NCT01393639|537025180|FG003|Overall Study|Medication error without associated AE|0|||
148876651|NCT01393639|537025181|FG004|Overall Study|Medication error without associated AE|0|||
148876652|NCT01393639|537025182|FG005|Overall Study|Medication error without associated AE|0|||
148876653|NCT01393639|537025183|FG006|Overall Study|Medication error without associated AE|1|||
148876654|NCT01393639|537025177|FG000|Overall Study|Lost to Follow-up|0|||
148876655|NCT01393639|537025178|FG001|Overall Study|Lost to Follow-up|1|||
148876656|NCT01393639|537025179|FG002|Overall Study|Lost to Follow-up|0|||
148876657|NCT01393639|537025180|FG003|Overall Study|Lost to Follow-up|0|||
148876658|NCT01393639|537025181|FG004|Overall Study|Lost to Follow-up|0|||
148876659|NCT01393639|537025182|FG005|Overall Study|Lost to Follow-up|0|||
148876660|NCT01393639|537025183|FG006|Overall Study|Lost to Follow-up|1|||
148876661|NCT01393639|537025177|FG000|Overall Study|Lack of Efficacy|0|||
148876662|NCT01393639|537025178|FG001|Overall Study|Lack of Efficacy|0|||
148876663|NCT01393639|537025179|FG002|Overall Study|Lack of Efficacy|0|||
148876664|NCT01393639|537025180|FG003|Overall Study|Lack of Efficacy|0|||
148876665|NCT01393639|537025181|FG004|Overall Study|Lack of Efficacy|0|||
148876666|NCT01393639|537025182|FG005|Overall Study|Lack of Efficacy|0|||
148876667|NCT01393639|537025183|FG006|Overall Study|Lack of Efficacy|1|||
148876668|NCT01393639|537025177|FG000|Overall Study|Adverse Event|2|||
148876669|NCT01393639|537025178|FG001|Overall Study|Adverse Event|3|||
148876670|NCT01393639|537025179|FG002|Overall Study|Adverse Event|1|||
148876671|NCT01393639|537025180|FG003|Overall Study|Adverse Event|2|||
148876672|NCT01393639|537025181|FG004|Overall Study|Adverse Event|0|||
148876673|NCT01393639|537025182|FG005|Overall Study|Adverse Event|2|||
148876674|NCT01393639|537025183|FG006|Overall Study|Adverse Event|3|||
148876675|NCT01832155|537025184|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
148876676|NCT01832155|537025185|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
148876677|NCT01832155|537025184|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
148876678|NCT01832155|537025185|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
149034452|NCT00038103|537603676|FG001|Overall Study|Adverse Event|6|||
149034453|NCT00038103|537603675|FG000|Overall Study|Lack of Efficacy|48|||
149034454|NCT00038103|537603676|FG001|Overall Study|Lack of Efficacy|41|||
149034455|NCT00038103|537603675|FG000|Overall Study|Withdrawal by Subject|0|||
149034456|NCT00038103|537603676|FG001|Overall Study|Withdrawal by Subject|3|||
148876679|NCT00183625|537025186|FG000|Overall Study|Withdrawal by Subject|18|||
148876680|NCT00183625|537025187|FG001|Overall Study|Withdrawal by Subject|18|||
148876681|NCT00183625|537025188|FG002|Overall Study|Withdrawal by Subject|19|||
148876682|NCT00183625|537025189|FG003|Overall Study|Withdrawal by Subject|14|||
148876683|NCT01369641|537025192|FG000|Overall Study|Withdrawal by Subject|1|||
148876684|NCT00842543|537025193|FG000|Overall Study|Withdrawal by Subject|2|||
148876685|NCT00842543|537025194|FG001|Overall Study|Withdrawal by Subject|0|||
148876686|NCT00842543|537025195|FG002|Overall Study|Withdrawal by Subject|3|||
148876687|NCT00842543|537025196|FG003|Overall Study|Withdrawal by Subject|4|||
148876688|NCT01483183|537025201|FG000|Overall Study|Physician Decision|0|||
148876689|NCT01483183|537025202|FG001|Overall Study|Physician Decision|0|||
148876690|NCT01483183|537025203|FG002|Overall Study|Physician Decision|0|||
148876691|NCT01483183|537025204|FG003|Overall Study|Physician Decision|0|||
148876692|NCT01483183|537025205|FG004|Overall Study|Physician Decision|0|||
148876693|NCT01483183|537025206|FG005|Overall Study|Physician Decision|0|||
148876694|NCT01483183|537025207|FG006|Overall Study|Physician Decision|2|||
148876695|NCT01483183|537025208|FG007|Overall Study|Physician Decision|0|||
148876696|NCT01483183|537025209|FG008|Overall Study|Physician Decision|0|||
148876697|NCT01483183|537025210|FG009|Overall Study|Physician Decision|0|||
148876698|NCT01483183|537025201|FG000|Overall Study|Withdrawal by Subject|0|||
148876699|NCT01483183|537025202|FG001|Overall Study|Withdrawal by Subject|0|||
148876700|NCT01483183|537025203|FG002|Overall Study|Withdrawal by Subject|0|||
148876701|NCT01483183|537025204|FG003|Overall Study|Withdrawal by Subject|0|||
148876702|NCT01483183|537025205|FG004|Overall Study|Withdrawal by Subject|0|||
148876703|NCT01483183|537025206|FG005|Overall Study|Withdrawal by Subject|0|||
148876704|NCT01483183|537025207|FG006|Overall Study|Withdrawal by Subject|0|||
148876705|NCT01483183|537025208|FG007|Overall Study|Withdrawal by Subject|0|||
148876706|NCT01483183|537025209|FG008|Overall Study|Withdrawal by Subject|0|||
148876707|NCT01483183|537025210|FG009|Overall Study|Withdrawal by Subject|1|||
148876708|NCT00239928|537025211|FG000|Overall Study|Lack of Efficacy|1|||
148876709|NCT00239928|537025211|FG000|Overall Study|Adverse Event|4|||
148876710|NCT00239928|537025211|FG000|Overall Study|Not need to continue study|3|||
148876711|NCT00239928|537025211|FG000|Overall Study|Withdrawal by Subject|2|||
148876712|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876713|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876714|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
148876715|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
148876716|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
148876717|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876718|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
148876719|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
148876720|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
148876721|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876722|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876723|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876724|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
148876725|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
148876726|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
148876727|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
148876728|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
148876729|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
148876730|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
148876731|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
148876732|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
148876733|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
148876734|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
148876735|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
148876736|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
149034457|NCT00038103|537603675|FG000|Overall Study|Lost to Follow-up|0|||
148876737|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
148876738|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876739|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
148876740|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
148876741|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876742|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876743|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
148876744|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
148876745|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876746|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876747|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876748|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876749|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876750|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
148876751|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876752|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
149034458|NCT00038103|537603676|FG001|Overall Study|Lost to Follow-up|3|||
148876753|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
148876754|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876755|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876756|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876757|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
148876758|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876759|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
148876760|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876761|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876762|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876763|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
148876764|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876765|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876766|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876767|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
148876768|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876769|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876770|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876771|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
148876772|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876773|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876774|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876775|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876776|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
148876777|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876778|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876779|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876780|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
148876781|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876782|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876783|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
148876784|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876785|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876786|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876787|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876788|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876789|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
148876790|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876791|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
148876792|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876793|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876794|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876795|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876796|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876797|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876798|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876799|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876800|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876801|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876802|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
148876803|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
148876804|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876805|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876806|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876807|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876808|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876809|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876810|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876811|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876812|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876813|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876814|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876815|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
148876816|NCT03100058|537025213|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876817|NCT03100058|537025214|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
149034459|NCT00038103|537603675|FG000|Overall Study|Protocol Violation|0|||
149034460|NCT00038103|537603676|FG001|Overall Study|Protocol Violation|2|||
148876818|NCT03100058|537025215|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876819|NCT03100058|537025216|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876820|NCT03100058|537025217|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
149034461|NCT00038103|537603675|FG000|Overall Study|Sponsor Decision|0|||
149034462|NCT00038103|537603676|FG001|Overall Study|Sponsor Decision|1|||
149034463|NCT00038103|537603675|FG000|Overall Study|Randomized/never treated|2|||
148876821|NCT03100058|537025218|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876822|NCT03100058|537025219|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
148876823|NCT03100058|537025220|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876824|NCT03100058|537025221|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876825|NCT03100058|537025222|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876826|NCT03100058|537025223|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876827|NCT03100058|537025224|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876828|NCT03100058|537025225|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
148876829|NCT03100058|537025213|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876830|NCT03100058|537025214|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876831|NCT03100058|537025215|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876832|NCT03100058|537025216|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876833|NCT03100058|537025217|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876834|NCT03100058|537025218|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876835|NCT03100058|537025219|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876836|NCT03100058|537025220|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876837|NCT03100058|537025221|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876838|NCT03100058|537025222|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
148876839|NCT03100058|537025223|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
148876840|NCT03100058|537025224|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
148876841|NCT03100058|537025225|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
148876842|NCT03100058|537025213|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876843|NCT03100058|537025214|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876844|NCT03100058|537025215|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876845|NCT03100058|537025216|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876846|NCT03100058|537025217|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876847|NCT03100058|537025218|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876848|NCT03100058|537025219|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876849|NCT03100058|537025220|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876850|NCT03100058|537025221|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876851|NCT03100058|537025222|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876852|NCT03100058|537025223|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
148876853|NCT03100058|537025224|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
148876854|NCT03100058|537025225|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
148876855|NCT03100058|537025213|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876856|NCT03100058|537025214|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876857|NCT03100058|537025215|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876858|NCT03100058|537025216|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876859|NCT03100058|537025217|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876860|NCT03100058|537025218|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876861|NCT03100058|537025219|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876862|NCT03100058|537025220|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876863|NCT03100058|537025221|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876864|NCT03100058|537025222|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
148876865|NCT03100058|537025223|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
148876866|NCT03100058|537025224|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
148876867|NCT03100058|537025225|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
148876868|NCT03100058|537025213|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876869|NCT03100058|537025214|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876870|NCT03100058|537025215|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876871|NCT03100058|537025216|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876872|NCT03100058|537025217|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876873|NCT03100058|537025218|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876874|NCT03100058|537025219|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876875|NCT03100058|537025220|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876876|NCT03100058|537025221|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876877|NCT03100058|537025222|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876878|NCT03100058|537025223|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
148876879|NCT03100058|537025224|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876880|NCT03100058|537025225|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
148876881|NCT03100058|537025213|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876882|NCT03100058|537025214|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876883|NCT03100058|537025215|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876884|NCT03100058|537025216|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876885|NCT03100058|537025217|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876886|NCT03100058|537025218|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876887|NCT03100058|537025219|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876888|NCT03100058|537025220|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876889|NCT03100058|537025221|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876890|NCT03100058|537025222|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876891|NCT03100058|537025223|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876892|NCT03100058|537025224|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
148876893|NCT03100058|537025225|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
148876894|NCT03100058|537025213|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876895|NCT03100058|537025214|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876896|NCT03100058|537025215|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876897|NCT03100058|537025216|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876898|NCT03100058|537025217|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876899|NCT03100058|537025218|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876900|NCT03100058|537025219|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876901|NCT03100058|537025220|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876902|NCT03100058|537025221|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876903|NCT03100058|537025222|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
148876904|NCT03100058|537025223|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876905|NCT03100058|537025224|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876906|NCT03100058|537025225|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
148876907|NCT02718716|537025227|FG000|Overall Study|Lack of Efficacy|1|||
148876908|NCT02718716|537025228|FG001|Overall Study|Lack of Efficacy|0|||
148876909|NCT02718716|537025229|FG002|Overall Study|Lack of Efficacy|0|||
148876910|NCT02718716|537025230|FG003|Overall Study|Lack of Efficacy|0|||
148876911|NCT02718716|537025231|FG004|Overall Study|Lack of Efficacy|0|||
148876912|NCT02942485|537025232|FG000|Overall Study|Lost to Follow-up|1|||
148876913|NCT02942485|537025233|FG001|Overall Study|Lost to Follow-up|0|||
148876914|NCT04302545|537025240|FG000|Overall Study|Lost to Follow-up|3|||
148876915|NCT04302545|537025241|FG001|Overall Study|Lost to Follow-up|4|||
148876916|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
148876917|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
148876918|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
148876919|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
148876920|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Death|2|||
148876921|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Death|2|||
148876922|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Death|0|||
148876923|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Death|0|||
148876924|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
148876925|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
148876926|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
148876927|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
148876928|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
148876929|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
148876930|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
148876931|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
148876932|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
148876933|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
148876934|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
148876935|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
148876936|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
148876937|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
148876938|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
148876939|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
148876940|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
148876941|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
148876942|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
148876943|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
148876944|NCT03068754|537025242|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
148876945|NCT03068754|537025243|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
148876946|NCT03068754|537025244|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
148876947|NCT03068754|537025245|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
148876948|NCT03068754|537025242|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
148876949|NCT03068754|537025243|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
148876950|NCT03068754|537025244|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
149034464|NCT00038103|537603676|FG001|Overall Study|Randomized/never treated|0|||
148876951|NCT03068754|537025245|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
148876952|NCT03068754|537025242|FG000|Open Label Extension Period (OLE)|Death|0|||
148876953|NCT03068754|537025243|FG001|Open Label Extension Period (OLE)|Death|0|||
148876954|NCT03068754|537025244|FG002|Open Label Extension Period (OLE)|Death|0|||
148876955|NCT03068754|537025245|FG003|Open Label Extension Period (OLE)|Death|1|||
148876956|NCT03068754|537025242|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
148876957|NCT03068754|537025243|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
148876958|NCT03068754|537025244|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
148876959|NCT03068754|537025245|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
148876960|NCT03068754|537025242|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
148876961|NCT03068754|537025243|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
148876962|NCT03068754|537025244|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
148876963|NCT03068754|537025245|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
148876964|NCT03068754|537025242|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
148876965|NCT03068754|537025243|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
148876966|NCT03068754|537025244|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
148876967|NCT03068754|537025245|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
148876968|NCT03068754|537025242|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
148876969|NCT03068754|537025243|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
148876970|NCT03068754|537025244|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
148876971|NCT03068754|537025245|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
148876972|NCT03550404|537025246|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
148876973|NCT03550404|537025247|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
148876974|NCT03550404|537025248|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
148876975|NCT03550404|537025246|FG000|Phase 2|Vacated position|1|||
148876976|NCT03550404|537025247|FG001|Phase 2|Vacated position|0|||
148876977|NCT03550404|537025248|FG002|Phase 2|Vacated position|0|||
148876978|NCT00820222|537025249|FG000|Overall Study|Lost to Follow-up|10|||
148876979|NCT00820222|537025250|FG001|Overall Study|Lost to Follow-up|9|||
148876980|NCT00820222|537025249|FG000|Overall Study|Withdrawal by Subject|19|||
148876981|NCT00820222|537025250|FG001|Overall Study|Withdrawal by Subject|21|||
148876982|NCT00820222|537025249|FG000|Overall Study|Physician Decision|93|||
148876983|NCT00820222|537025250|FG001|Overall Study|Physician Decision|88|||
148876984|NCT00820222|537025249|FG000|Overall Study|Sponsor Terminated Study|43|||
148876985|NCT00820222|537025250|FG001|Overall Study|Sponsor Terminated Study|65|||
148876986|NCT00820222|537025249|FG000|Overall Study|Unkown|11|||
148876987|NCT00820222|537025250|FG001|Overall Study|Unkown|7|||
148876988|NCT00932165|537025251|FG000|Overall Study|Lost to Follow-up|1|||
148876989|NCT02690714|537025252|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
148876990|NCT02690714|537025252|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
148876991|NCT01894022|537025258|FG000|Overall Study|Death|1|||
148876992|NCT01894022|537025259|FG001|Overall Study|Death|0|||
148876993|NCT01894022|537025258|FG000|Overall Study|Adverse Event, non-fatal|1|||
148876994|NCT01894022|537025259|FG001|Overall Study|Adverse Event, non-fatal|0|||
148876995|NCT01894022|537025258|FG000|Overall Study|Study Closed/terminated|7|||
148876996|NCT01894022|537025259|FG001|Overall Study|Study Closed/terminated|10|||
148876997|NCT03238924|537025269|FG000|Overall Study|Withdrawal by Subject|2|||
148876998|NCT03238924|537025270|FG001|Overall Study|Withdrawal by Subject|2|||
148876999|NCT03576716|537025271|FG000|Overall Study|Withdrawal by Subject|0|||
148877000|NCT03576716|537025272|FG001|Overall Study|Withdrawal by Subject|1|||
148877001|NCT02249182|537025273|FG000|Treatment Phase|Lost to Follow-up|4|||
148877002|NCT02249182|537025274|FG001|Treatment Phase|Lost to Follow-up|0|||
148877003|NCT02249182|537025275|FG002|Treatment Phase|Lost to Follow-up|0|||
148877004|NCT02249182|537025276|FG003|Treatment Phase|Lost to Follow-up|0|||
148877005|NCT02249182|537025277|FG004|Treatment Phase|Lost to Follow-up|0|||
148877006|NCT00504894|537025278|FG000|Overall Study|fMRI technical problems|1|||
148877007|NCT00504894|537025279|FG001|Overall Study|fMRI technical problems|1|||
148877008|NCT00504894|537025280|FG002|Overall Study|fMRI technical problems|0|||
148877009|NCT00504894|537025278|FG000|Overall Study|Withdrawal by Subject|0|||
148877010|NCT00504894|537025279|FG001|Overall Study|Withdrawal by Subject|1|||
148877011|NCT00504894|537025280|FG002|Overall Study|Withdrawal by Subject|0|||
148877012|NCT00504894|537025278|FG000|Overall Study|Infusion technical problems|0|||
148877013|NCT00504894|537025279|FG001|Overall Study|Infusion technical problems|1|||
148877014|NCT00504894|537025280|FG002|Overall Study|Infusion technical problems|0|||
148877015|NCT00504894|537025278|FG000|Overall Study|poor subject data|2|||
148877016|NCT00504894|537025279|FG001|Overall Study|poor subject data|0|||
148877017|NCT00504894|537025280|FG002|Overall Study|poor subject data|0|||
148877018|NCT05090852|537025281|FG000|Overall Study|Physician Decision|5|||
148877019|NCT00148941|537025282|FG000|Overall Study|Lost to Follow-up|17|||
148877020|NCT00148941|537025283|FG001|Overall Study|Lost to Follow-up|24|||
148877021|NCT00148941|537025284|FG002|Overall Study|Lost to Follow-up|18|||
148877022|NCT00148941|537025285|FG003|Overall Study|Lost to Follow-up|22|||
148877023|NCT00148941|537025282|FG000|Overall Study|Withdrawal by Subject|1|||
148877024|NCT00148941|537025283|FG001|Overall Study|Withdrawal by Subject|0|||
148877025|NCT00148941|537025284|FG002|Overall Study|Withdrawal by Subject|1|||
148877026|NCT00148941|537025285|FG003|Overall Study|Withdrawal by Subject|0|||
148877027|NCT00148941|537025282|FG000|Overall Study|Other|0|||
148877028|NCT00148941|537025283|FG001|Overall Study|Other|0|||
148877029|NCT00148941|537025284|FG002|Overall Study|Other|1|||
148877030|NCT00148941|537025285|FG003|Overall Study|Other|2|||
148877031|NCT03244826|537025286|FG000|Overall Study|Withdrawal by Subject|2|||
148877032|NCT03244826|537025287|FG001|Overall Study|Withdrawal by Subject|0|||
148877033|NCT03244826|537025286|FG000|Overall Study|Transplant delayed or withdrawn|12|||
148877034|NCT03244826|537025287|FG001|Overall Study|Transplant delayed or withdrawn|10|||
148877035|NCT02673684|537025288|FG000|Overall Study|Study not completed d/t loss of funding|9|||
148877036|NCT02673684|537025289|FG001|Overall Study|Study not completed d/t loss of funding|8|||
148877037|NCT04356040|537025292|FG000|Overall Study|Death|2|||
148877038|NCT04356040|537025293|FG001|Overall Study|Death|0|||
148877039|NCT04356040|537025292|FG000|Overall Study|Lost to Follow-up|1|||
148877040|NCT04356040|537025293|FG001|Overall Study|Lost to Follow-up|0|||
148877041|NCT04356040|537025292|FG000|Overall Study|Physician Decision|0|||
148877042|NCT04356040|537025293|FG001|Overall Study|Physician Decision|1|||
148877043|NCT04356040|537025292|FG000|Overall Study|Withdrawal by Subject|13|||
148877044|NCT04356040|537025293|FG001|Overall Study|Withdrawal by Subject|1|||
148877045|NCT04356040|537025292|FG000|Overall Study|Enrollment Pause|10|||
148877046|NCT04356040|537025293|FG001|Overall Study|Enrollment Pause|0|||
148877047|NCT04356040|537025292|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
148877048|NCT04356040|537025293|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
148877049|NCT04356040|537025292|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
148877050|NCT04356040|537025293|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
148877051|NCT04356040|537025292|FG000|Overall Study|PI left institution|3|||
148877052|NCT04356040|537025293|FG001|Overall Study|PI left institution|0|||
148877053|NCT01092663|537025294|FG000|Overall Study|Withdrawal by Subject|3|||
148877054|NCT01092663|537025295|FG001|Overall Study|Withdrawal by Subject|2|||
148877055|NCT01092663|537025294|FG000|Overall Study|Glucose >300mg/dL|1|||
148877056|NCT01092663|537025295|FG001|Overall Study|Glucose >300mg/dL|0|||
148877057|NCT01092663|537025294|FG000|Overall Study|High fasting triglyceride|2|||
148877058|NCT01092663|537025295|FG001|Overall Study|High fasting triglyceride|0|||
148877059|NCT01092663|537025294|FG000|Overall Study|Adverse Event|1|||
148877060|NCT01092663|537025295|FG001|Overall Study|Adverse Event|1|||
148877061|NCT01092663|537025294|FG000|Overall Study|Protocol Violation|0|||
148877062|NCT01092663|537025295|FG001|Overall Study|Protocol Violation|1|||
148877063|NCT01534195|537025296|FG000|Overall Study|Withdrawal by Subject|1|||
148877064|NCT01534195|537025297|FG001|Overall Study|Withdrawal by Subject|1|||
148877065|NCT01959243|537025304|FG000|Overall Study|Investigator Decision|3|||
148877066|NCT01959243|537025305|FG001|Overall Study|Investigator Decision|0|||
148877067|NCT01959243|537025304|FG000|Overall Study|Adverse Event|5|||
148877068|NCT01959243|537025305|FG001|Overall Study|Adverse Event|2|||
148877069|NCT01959243|537025304|FG000|Overall Study|Administrative reasons|2|||
148877070|NCT01959243|537025305|FG001|Overall Study|Administrative reasons|1|||
148877071|NCT01959243|537025304|FG000|Overall Study|Lost to Follow-up|3|||
148877072|NCT01959243|537025305|FG001|Overall Study|Lost to Follow-up|1|||
148877073|NCT01345669|537025306|FG000|Overall Study|Primary tumour recurrence|53|||
148877074|NCT01345669|537025307|FG001|Overall Study|Primary tumour recurrence|32|||
148877075|NCT01345669|537025306|FG000|Overall Study|Second primary tumour|4|||
148877076|NCT01345669|537025307|FG001|Overall Study|Second primary tumour|3|||
148877077|NCT01345669|537025306|FG000|Overall Study|Adverse Event|63|||
148877078|NCT01345669|537025307|FG001|Overall Study|Adverse Event|9|||
148877079|NCT01345669|537025306|FG000|Overall Study|Protocol Violation|3|||
148877080|NCT01345669|537025307|FG001|Overall Study|Protocol Violation|1|||
148877081|NCT01345669|537025306|FG000|Overall Study|Lost to Follow-up|1|||
148877082|NCT01345669|537025307|FG001|Overall Study|Lost to Follow-up|1|||
148877083|NCT01345669|537025306|FG000|Overall Study|Withdrawal by Subject|52|||
148877084|NCT01345669|537025307|FG001|Overall Study|Withdrawal by Subject|13|||
148877085|NCT01345669|537025306|FG000|Overall Study|Other Reasons|111|||
148877086|NCT01345669|537025307|FG001|Overall Study|Other Reasons|60|||
148877087|NCT00547521|537025313|FG000|Short Term Study (4 Months)|Adverse Event|1|||
148877088|NCT00547521|537025314|FG001|Short Term Study (4 Months)|Adverse Event|0|||
148877089|NCT00547521|537025313|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
148877090|NCT00547521|537025314|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
148877091|NCT00547521|537025313|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
149034465|NCT01144182|537603678|FG000|Overall Study|Death|5|||
148877092|NCT00547521|537025314|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
148877093|NCT00547521|537025313|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
148877094|NCT00547521|537025314|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
148877095|NCT00547521|537025313|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
148877096|NCT00547521|537025314|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
148877097|NCT00547521|537025313|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
148877098|NCT00547521|537025314|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
149034466|NCT01144182|537603679|FG001|Overall Study|Death|6|||
148877099|NCT00547521|537025313|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
148877100|NCT00547521|537025314|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
148877101|NCT00547521|537025313|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
148877102|NCT00547521|537025314|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
148877103|NCT00547521|537025313|FG000|Long Term Extension (LTE) Study|Other|0|||
148877104|NCT00547521|537025314|FG001|Long Term Extension (LTE) Study|Other|2|||
148877105|NCT00547521|537025313|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
148877106|NCT00547521|537025314|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
148877107|NCT01487265|537026636|FG000|Overall Study|Adverse Event|8|||
148877108|NCT01487265|537026636|FG000|Overall Study|Withdrawal by Subject|5|||
148877109|NCT01487265|537026636|FG000|Overall Study|Disease Progression|21|||
148877110|NCT01487265|537026636|FG000|Overall Study|Death|2|||
148877111|NCT01487265|537026636|FG000|Overall Study|Still on Treatment|1|||
148877112|NCT02291419|537026637|FG000|Overall Study|Early study termination|1|||
148877113|NCT02291419|537026638|FG001|Overall Study|Early study termination|5|||
148877114|NCT00303485|537026643|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
148877115|NCT00303485|537026644|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
148877116|NCT00303485|537026643|FG000|Overall Study|Failure to return|0|||
148877117|NCT00303485|537026644|FG001|Overall Study|Failure to return|1|||
148877118|NCT00303485|537026643|FG000|Overall Study|Withdrawal by Subject|1|||
148877119|NCT00303485|537026644|FG001|Overall Study|Withdrawal by Subject|0|||
148877120|NCT01378325|537026648|FG000|Overall Study|Protocol Violation|0|||
148877121|NCT01378325|537026649|FG001|Overall Study|Protocol Violation|1|||
148877122|NCT00891228|537026652|FG000|Overall Study|Adverse Event|0|||
148877123|NCT00891228|537026653|FG001|Overall Study|Adverse Event|2|||
148877124|NCT00891228|537026654|FG002|Overall Study|Adverse Event|3|||
148877125|NCT00891228|537026652|FG000|Overall Study|Withdrawal by Subject|2|||
148877126|NCT00891228|537026653|FG001|Overall Study|Withdrawal by Subject|4|||
148877127|NCT00891228|537026654|FG002|Overall Study|Withdrawal by Subject|5|||
148877128|NCT00891228|537026652|FG000|Overall Study|Protocol Violation|3|||
148877129|NCT00891228|537026653|FG001|Overall Study|Protocol Violation|1|||
148877130|NCT00891228|537026654|FG002|Overall Study|Protocol Violation|2|||
148877131|NCT00891228|537026652|FG000|Overall Study|Physician Decision|2|||
148877132|NCT00891228|537026653|FG001|Overall Study|Physician Decision|1|||
148877133|NCT00891228|537026654|FG002|Overall Study|Physician Decision|0|||
148877134|NCT00891228|537026652|FG000|Overall Study|Lost to Follow-up|4|||
148877135|NCT00891228|537026653|FG001|Overall Study|Lost to Follow-up|4|||
148877136|NCT00891228|537026654|FG002|Overall Study|Lost to Follow-up|5|||
148877137|NCT00891228|537026652|FG000|Overall Study|Pregnancy|0|||
148877138|NCT00891228|537026653|FG001|Overall Study|Pregnancy|1|||
148877139|NCT00891228|537026654|FG002|Overall Study|Pregnancy|0|||
148877140|NCT02688985|537026663|FG000|Overall Study|Adverse Event|1|||
148877141|NCT02688985|537026664|FG001|Overall Study|Adverse Event|2|||
148877142|NCT02688985|537026665|FG002|Overall Study|Adverse Event|2|||
148877143|NCT02688985|537026666|FG003|Overall Study|Adverse Event|0|||
148877144|NCT02688985|537026667|FG004|Overall Study|Adverse Event|0|||
148877145|NCT02688985|537026663|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
148877146|NCT02688985|537026664|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
148877147|NCT02688985|537026665|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
148877148|NCT02688985|537026666|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
148877149|NCT02688985|537026667|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
148877150|NCT02688985|537026663|FG000|Overall Study|Death|0|||
148877151|NCT02688985|537026664|FG001|Overall Study|Death|0|||
148877152|NCT02688985|537026665|FG002|Overall Study|Death|0|||
148877153|NCT02688985|537026666|FG003|Overall Study|Death|0|||
148877154|NCT02688985|537026667|FG004|Overall Study|Death|1|||
148877155|NCT02688985|537026663|FG000|Overall Study|Lack of Efficacy|0|||
148877156|NCT02688985|537026664|FG001|Overall Study|Lack of Efficacy|0|||
148877157|NCT02688985|537026665|FG002|Overall Study|Lack of Efficacy|0|||
148877158|NCT02688985|537026666|FG003|Overall Study|Lack of Efficacy|0|||
148877159|NCT02688985|537026667|FG004|Overall Study|Lack of Efficacy|1|||
148877160|NCT02688985|537026663|FG000|Overall Study|Lost to Follow-up|2|||
148877161|NCT02688985|537026664|FG001|Overall Study|Lost to Follow-up|0|||
148877162|NCT02688985|537026665|FG002|Overall Study|Lost to Follow-up|1|||
148877163|NCT02688985|537026666|FG003|Overall Study|Lost to Follow-up|1|||
148877164|NCT02688985|537026667|FG004|Overall Study|Lost to Follow-up|1|||
148877165|NCT02688985|537026663|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148877166|NCT02688985|537026664|FG001|Overall Study|Non-Compliance With Study Drug|3|||
148877167|NCT02688985|537026665|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148877168|NCT02688985|537026666|FG003|Overall Study|Non-Compliance With Study Drug|0|||
148877169|NCT02688985|537026667|FG004|Overall Study|Non-Compliance With Study Drug|1|||
148877170|NCT02688985|537026663|FG000|Overall Study|Other|3|||
148877171|NCT02688985|537026664|FG001|Overall Study|Other|4|||
148877172|NCT02688985|537026665|FG002|Overall Study|Other|1|||
148877173|NCT02688985|537026666|FG003|Overall Study|Other|0|||
148877174|NCT02688985|537026667|FG004|Overall Study|Other|0|||
148877175|NCT02688985|537026663|FG000|Overall Study|Physician Decision|2|||
148877176|NCT02688985|537026664|FG001|Overall Study|Physician Decision|2|||
148877177|NCT02688985|537026665|FG002|Overall Study|Physician Decision|0|||
148877178|NCT02688985|537026666|FG003|Overall Study|Physician Decision|0|||
148877179|NCT02688985|537026667|FG004|Overall Study|Physician Decision|1|||
148877180|NCT02688985|537026663|FG000|Overall Study|Pregnancy|0|||
148877181|NCT02688985|537026664|FG001|Overall Study|Pregnancy|0|||
148877182|NCT02688985|537026665|FG002|Overall Study|Pregnancy|2|||
148877183|NCT02688985|537026666|FG003|Overall Study|Pregnancy|1|||
148877184|NCT02688985|537026667|FG004|Overall Study|Pregnancy|0|||
148877185|NCT02688985|537026663|FG000|Overall Study|Study Terminated By Sponsor|0|||
148877186|NCT02688985|537026664|FG001|Overall Study|Study Terminated By Sponsor|0|||
148877187|NCT02688985|537026665|FG002|Overall Study|Study Terminated By Sponsor|0|||
148877188|NCT02688985|537026666|FG003|Overall Study|Study Terminated By Sponsor|1|||
148877189|NCT02688985|537026667|FG004|Overall Study|Study Terminated By Sponsor|0|||
148877190|NCT02688985|537026663|FG000|Overall Study|Withdrawal by Subject|2|||
148877191|NCT02688985|537026664|FG001|Overall Study|Withdrawal by Subject|8|||
148877192|NCT02688985|537026665|FG002|Overall Study|Withdrawal by Subject|7|||
148877193|NCT02688985|537026666|FG003|Overall Study|Withdrawal by Subject|1|||
148877194|NCT02688985|537026667|FG004|Overall Study|Withdrawal by Subject|4|||
148877195|NCT01964963|537026670|FG000|Overall Study|Case Report Forms Uncollected|888|||
148877196|NCT01964963|537026670|FG000|Overall Study|Protocol Deviation|50|||
148877197|NCT01964963|537026670|FG000|Overall Study|Data Reliability was not Assured|5|||
148877198|NCT00930553|537026671|FG000|Overall Study|Adverse Event|1|||
148877199|NCT00930553|537026671|FG000|Overall Study|Lack of Efficacy|7|||
148877200|NCT00930553|537026671|FG000|Overall Study|Physician Decision|39|||
148877201|NCT00930553|537026671|FG000|Overall Study|Protocol Violation|1|||
148877202|NCT00930553|537026671|FG000|Overall Study|Pregnancy|1|||
148877203|NCT00930553|537026671|FG000|Overall Study|Withdrawal by Subject|88|||
148877204|NCT00930553|537026671|FG000|Overall Study|Lost to Follow-up|25|||
148877205|NCT00930553|537026671|FG000|Overall Study|Death|9|||
148877206|NCT00930553|537026671|FG000|Overall Study|Study terminated by sponsor|24|||
148877207|NCT00930553|537026671|FG000|Overall Study|Other than specified above|28|||
148877208|NCT01726582|537026672|FG000|Overall Study|Physician Decision|99|||
148877209|NCT01726582|537026672|FG000|Overall Study|Death|85|||
148877210|NCT01235234|537026673|FG000|Overall Study|Adverse Event|2|||
148877211|NCT01235234|537026674|FG001|Overall Study|Adverse Event|2|||
148877212|NCT01235234|537026675|FG002|Overall Study|Adverse Event|1|||
148877213|NCT02630472|537026676|FG000|Overall Study|Physician Decision|10|||
148877214|NCT02630472|537026677|FG001|Overall Study|Physician Decision|0|||
148877215|NCT01279616|537026682|FG000|Overall Study|donor could not be located|5|||
148877216|NCT01279616|537026682|FG000|Overall Study|no signs of sickle cell disease|2|||
148877217|NCT00413036|537026683|FG000|Overall Study|Adverse Event|44|||
148877218|NCT00413036|537026683|FG000|Overall Study|Lack of Efficacy|129|||
148877219|NCT00413036|537026683|FG000|Overall Study|Withdrawal by Subject|7|||
148877220|NCT00413036|537026683|FG000|Overall Study|Death|9|||
148877221|NCT00413036|537026683|FG000|Overall Study|Other|26|||
148877222|NCT00413036|537026683|FG000|Overall Study|Missing|2|||
148877223|NCT03250182|537026686|FG000|Overall Study|Withdrawal by Subject|1|||
148877224|NCT03194646|537026691|FG000|Overall Study|Adverse Event|24|||
148877225|NCT03194646|537026692|FG001|Overall Study|Adverse Event|25|||
148877226|NCT03194646|537026693|FG002|Overall Study|Adverse Event|14|||
148877227|NCT03194646|537026694|FG003|Overall Study|Adverse Event|17|||
148877228|NCT03194646|537026691|FG000|Overall Study|Lack of Efficacy|4|||
148877229|NCT03194646|537026692|FG001|Overall Study|Lack of Efficacy|2|||
148877230|NCT03194646|537026693|FG002|Overall Study|Lack of Efficacy|2|||
148877231|NCT03194646|537026694|FG003|Overall Study|Lack of Efficacy|12|||
148877232|NCT03194646|537026691|FG000|Overall Study|Lost to Follow-up|30|||
148877233|NCT03194646|537026692|FG001|Overall Study|Lost to Follow-up|22|||
148877234|NCT03194646|537026693|FG002|Overall Study|Lost to Follow-up|12|||
148877235|NCT03194646|537026694|FG003|Overall Study|Lost to Follow-up|35|||
148877236|NCT03194646|537026691|FG000|Overall Study|Non-compliance with study drug|4|||
148877237|NCT03194646|537026692|FG001|Overall Study|Non-compliance with study drug|0|||
148877238|NCT03194646|537026693|FG002|Overall Study|Non-compliance with study drug|1|||
148877239|NCT03194646|537026694|FG003|Overall Study|Non-compliance with study drug|1|||
148877240|NCT03194646|537026691|FG000|Overall Study|Other|89|||
148877241|NCT03194646|537026692|FG001|Overall Study|Other|68|||
148877242|NCT03194646|537026693|FG002|Overall Study|Other|34|||
149034467|NCT01144182|537603678|FG000|Overall Study|Withdrawal by Subject|3|||
148877243|NCT03194646|537026694|FG003|Overall Study|Other|31|||
148877244|NCT03194646|537026691|FG000|Overall Study|Physician Decision|7|||
148877245|NCT03194646|537026692|FG001|Overall Study|Physician Decision|9|||
148877246|NCT03194646|537026693|FG002|Overall Study|Physician Decision|5|||
148877247|NCT03194646|537026694|FG003|Overall Study|Physician Decision|4|||
148877248|NCT03194646|537026691|FG000|Overall Study|Pregnancy|4|||
148877249|NCT03194646|537026692|FG001|Overall Study|Pregnancy|5|||
148877250|NCT03194646|537026693|FG002|Overall Study|Pregnancy|1|||
148877251|NCT03194646|537026694|FG003|Overall Study|Pregnancy|2|||
148877252|NCT03194646|537026691|FG000|Overall Study|Protocol Violation|4|||
148877253|NCT03194646|537026692|FG001|Overall Study|Protocol Violation|2|||
148877254|NCT03194646|537026693|FG002|Overall Study|Protocol Violation|1|||
148877255|NCT03194646|537026694|FG003|Overall Study|Protocol Violation|1|||
148877256|NCT03194646|537026691|FG000|Overall Study|Site terminated by sponsor|0|||
148877257|NCT03194646|537026692|FG001|Overall Study|Site terminated by sponsor|0|||
148877258|NCT03194646|537026693|FG002|Overall Study|Site terminated by sponsor|2|||
148877259|NCT03194646|537026694|FG003|Overall Study|Site terminated by sponsor|0|||
148877260|NCT03194646|537026691|FG000|Overall Study|Study terminated by sponsor|62|||
148877261|NCT03194646|537026692|FG001|Overall Study|Study terminated by sponsor|61|||
148877262|NCT03194646|537026693|FG002|Overall Study|Study terminated by sponsor|30|||
148877263|NCT03194646|537026694|FG003|Overall Study|Study terminated by sponsor|34|||
148877264|NCT03194646|537026691|FG000|Overall Study|Withdrawal by Subject|75|||
148877265|NCT03194646|537026692|FG001|Overall Study|Withdrawal by Subject|74|||
148877266|NCT03194646|537026693|FG002|Overall Study|Withdrawal by Subject|36|||
148877267|NCT03194646|537026694|FG003|Overall Study|Withdrawal by Subject|131|||
148877268|NCT03194646|537026691|FG000|Overall Study|Missing|1|||
148877269|NCT03194646|537026692|FG001|Overall Study|Missing|0|||
148877270|NCT03194646|537026693|FG002|Overall Study|Missing|1|||
148877271|NCT03194646|537026694|FG003|Overall Study|Missing|12|||
148877272|NCT04869358|537026695|FG000|Overall Study|Wish to have children.|1|||
148877273|NCT04869358|537026696|FG001|Overall Study|Wish to have children.|0|||
148877274|NCT04869358|537026697|FG002|Overall Study|Wish to have children.|0|||
148877275|NCT04869358|537026698|FG003|Overall Study|Wish to have children.|0|||
148877276|NCT02141360|537026699|FG000|Overall Study|Withdrawal by Subject|6|||
148877277|NCT02141360|537026700|FG001|Overall Study|Withdrawal by Subject|0|||
148877278|NCT02141360|537026701|FG002|Overall Study|Withdrawal by Subject|0|||
148877279|NCT02141360|537026699|FG000|Overall Study|Study Terminated before Visit|1|||
148877280|NCT02141360|537026700|FG001|Overall Study|Study Terminated before Visit|0|||
148877281|NCT02141360|537026701|FG002|Overall Study|Study Terminated before Visit|0|||
148877282|NCT00129467|537026707|FG000|Received Intervention|Death|1|||
148877283|NCT00129467|537026708|FG001|Received Intervention|Death|1|||
148877284|NCT00129467|537026707|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
148877285|NCT00129467|537026708|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
148877286|NCT00129467|537026707|FG000|Received Intervention|Delirium|2|||
148877287|NCT00129467|537026708|FG001|Received Intervention|Delirium|0|||
148877288|NCT00129467|537026707|FG000|Received Intervention|Withdrawal by Subject|1|||
148877289|NCT00129467|537026708|FG001|Received Intervention|Withdrawal by Subject|0|||
148877290|NCT00129467|537026707|FG000|Received Intervention|Nausea|1|||
148877291|NCT00129467|537026708|FG001|Received Intervention|Nausea|0|||
148877292|NCT00129467|537026707|FG000|Received Intervention|Intolerance to citalopram|0|||
148877293|NCT00129467|537026708|FG001|Received Intervention|Intolerance to citalopram|1|||
148877294|NCT00129467|537026707|FG000|Received Intervention|Dizzyness, fatigue|0|||
148877295|NCT00129467|537026708|FG001|Received Intervention|Dizzyness, fatigue|1|||
148877296|NCT00129467|537026707|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
148877297|NCT00129467|537026708|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
148877298|NCT00129467|537026707|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
148877299|NCT00129467|537026708|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
148877300|NCT01336023|537026709|FG000|Week 0 to Week 26|Adverse Event|8|||
148877301|NCT01336023|537026710|FG001|Week 0 to Week 26|Adverse Event|10|||
148877302|NCT01336023|537026711|FG002|Week 0 to Week 26|Adverse Event|24|||
148877303|NCT01336023|537026709|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
148877304|NCT01336023|537026710|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
148877305|NCT01336023|537026711|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
148877306|NCT01336023|537026709|FG000|Week 0 to Week 26|Protocol Violation|1|||
148877307|NCT01336023|537026710|FG001|Week 0 to Week 26|Protocol Violation|2|||
148877308|NCT01336023|537026711|FG002|Week 0 to Week 26|Protocol Violation|0|||
148877309|NCT01336023|537026709|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
148877310|NCT01336023|537026710|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
148877311|NCT01336023|537026711|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
148877312|NCT01336023|537026709|FG000|Week 0 to Week 26|Unclassified|5|||
148877313|NCT01336023|537026710|FG001|Week 0 to Week 26|Unclassified|16|||
148877314|NCT01336023|537026711|FG002|Week 0 to Week 26|Unclassified|9|||
148877315|NCT01336023|537026709|FG000|Week 27 to 52|Adverse Event|1|||
148877316|NCT01336023|537026710|FG001|Week 27 to 52|Adverse Event|5|||
149034468|NCT01144182|537603679|FG001|Overall Study|Withdrawal by Subject|6|||
148877317|NCT01336023|537026711|FG002|Week 27 to 52|Adverse Event|2|||
148877318|NCT01336023|537026709|FG000|Week 27 to 52|Protocol Violation|0|||
148877319|NCT01336023|537026710|FG001|Week 27 to 52|Protocol Violation|2|||
148877320|NCT01336023|537026711|FG002|Week 27 to 52|Protocol Violation|1|||
148877321|NCT01336023|537026709|FG000|Week 27 to 52|Withdrawal Criteria|14|||
148877322|NCT01336023|537026710|FG001|Week 27 to 52|Withdrawal Criteria|19|||
149034469|NCT01144182|537603678|FG000|Overall Study|Lost to Follow-up|9|||
148877323|NCT01336023|537026711|FG002|Week 27 to 52|Withdrawal Criteria|16|||
148877324|NCT01336023|537026709|FG000|Week 27 to 52|Unclassified|13|||
148877325|NCT01336023|537026710|FG001|Week 27 to 52|Unclassified|18|||
148877326|NCT01336023|537026711|FG002|Week 27 to 52|Unclassified|9|||
148877327|NCT00666965|537026712|FG000|Overall Study|Adverse Event|0|||
148877328|NCT00666965|537026713|FG001|Overall Study|Adverse Event|2|||
148877329|NCT00666965|537026714|FG002|Overall Study|Adverse Event|1|||
148877330|NCT00666965|537026715|FG003|Overall Study|Adverse Event|9|||
148877331|NCT00666965|537026712|FG000|Overall Study|Lack of Efficacy|1|||
148877332|NCT00666965|537026713|FG001|Overall Study|Lack of Efficacy|1|||
148877333|NCT00666965|537026714|FG002|Overall Study|Lack of Efficacy|0|||
148877334|NCT00666965|537026715|FG003|Overall Study|Lack of Efficacy|0|||
148877335|NCT00666965|537026712|FG000|Overall Study|Protocol Violation|0|||
148877336|NCT00666965|537026713|FG001|Overall Study|Protocol Violation|0|||
148877337|NCT00666965|537026714|FG002|Overall Study|Protocol Violation|0|||
148877338|NCT00666965|537026715|FG003|Overall Study|Protocol Violation|2|||
148877339|NCT00666965|537026712|FG000|Overall Study|Discontinuation criteria|2|||
148877340|NCT00666965|537026713|FG001|Overall Study|Discontinuation criteria|1|||
148877341|NCT00666965|537026714|FG002|Overall Study|Discontinuation criteria|1|||
148877342|NCT00666965|537026715|FG003|Overall Study|Discontinuation criteria|2|||
148877343|NCT00666965|537026712|FG000|Overall Study|Withdrawal by Subject|0|||
148877344|NCT00666965|537026713|FG001|Overall Study|Withdrawal by Subject|0|||
148877345|NCT00666965|537026714|FG002|Overall Study|Withdrawal by Subject|0|||
148877346|NCT00666965|537026715|FG003|Overall Study|Withdrawal by Subject|2|||
148877347|NCT04496453|537026718|FG000|Overall Study|Lost to Follow-up|6|||
148877348|NCT01361178|537026719|FG000|Overall Study|Death|13|||
148877349|NCT01361178|537026720|FG001|Overall Study|Death|0|||
148877350|NCT04294147|537026723|FG000|Overall Study|Protocol Violation|2|||
148877351|NCT04294147|537026724|FG001|Overall Study|Protocol Violation|0|||
148877352|NCT05392803|537026725|FG000|Overall Study|Lost to Follow-up|0|||
148877353|NCT05392803|537026726|FG001|Overall Study|Lost to Follow-up|2|||
148877354|NCT02726022|537026729|FG000|Overall Study|Adverse Event|14|||
148877355|NCT02726022|537026729|FG000|Overall Study|Treatment Failure|8|||
148877356|NCT02726022|537026729|FG000|Overall Study|Poor Compliance|13|||
148877357|NCT02726022|537026729|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
148877358|NCT01894243|537026738|FG000|Overall Study|Adverse Event|0|||
148877359|NCT01894243|537026739|FG001|Overall Study|Adverse Event|1|||
148877360|NCT01894243|537026740|FG002|Overall Study|Adverse Event|2|||
148877361|NCT01894243|537026738|FG000|Overall Study|Death|0|||
148877362|NCT01894243|537026739|FG001|Overall Study|Death|0|||
148877363|NCT01894243|537026740|FG002|Overall Study|Death|3|||
148877364|NCT01894243|537026738|FG000|Overall Study|Lack of Efficacy|3|||
148877365|NCT01894243|537026739|FG001|Overall Study|Lack of Efficacy|3|||
148877366|NCT01894243|537026740|FG002|Overall Study|Lack of Efficacy|1|||
148877367|NCT01894243|537026738|FG000|Overall Study|Condition under investigation worsened|8|||
148877368|NCT01894243|537026739|FG001|Overall Study|Condition under investigation worsened|6|||
148877369|NCT01894243|537026740|FG002|Overall Study|Condition under investigation worsened|2|||
148877370|NCT01894243|537026738|FG000|Overall Study|Subject decision|1|||
148877371|NCT01894243|537026739|FG001|Overall Study|Subject decision|0|||
148877372|NCT01894243|537026740|FG002|Overall Study|Subject decision|0|||
148877373|NCT01894243|537026738|FG000|Overall Study|Other|1|||
148877374|NCT01894243|537026739|FG001|Overall Study|Other|0|||
148877375|NCT01894243|537026740|FG002|Overall Study|Other|0|||
148877376|NCT00828750|537026743|FG000|Overall Study|Lack of Efficacy|3|||
148877377|NCT00828750|537026743|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
148877378|NCT01630889|537026747|FG000|Overall Study|Death|2|||
148877379|NCT01630889|537026747|FG000|Overall Study|Withdrawal by Subject|1|||
148877380|NCT01630889|537026747|FG000|Overall Study|Other than Specified|2|||
148877381|NCT01630889|537026747|FG000|Overall Study|Lost to Follow-up|4|||
148877382|NCT01630889|537026747|FG000|Overall Study|Other|1|||
148877383|NCT02974842|537026748|FG000|Overall Study|Withdrawal by Subject|4|||
148877384|NCT02974842|537026748|FG000|Overall Study|Screen failures|4|||
148877385|NCT01368081|537026759|FG000|Overall Study|Adverse Event|4|||
148877386|NCT01368081|537026760|FG001|Overall Study|Adverse Event|4|||
148877387|NCT01368081|537026761|FG002|Overall Study|Adverse Event|3|||
148877388|NCT01368081|537026762|FG003|Overall Study|Adverse Event|2|||
148877389|NCT01368081|537026763|FG004|Overall Study|Adverse Event|2|||
148877390|NCT01368081|537026764|FG005|Overall Study|Adverse Event|5|||
148877391|NCT01368081|537026765|FG006|Overall Study|Adverse Event|6|||
148877392|NCT01368081|537026766|FG007|Overall Study|Adverse Event|2|||
148877393|NCT01368081|537026767|FG008|Overall Study|Adverse Event|3|||
148877394|NCT01368081|537026768|FG009|Overall Study|Adverse Event|5|||
148877395|NCT01368081|537026769|FG010|Overall Study|Adverse Event|6|||
148877396|NCT01368081|537026770|FG011|Overall Study|Adverse Event|1|||
148877397|NCT01368081|537026771|FG012|Overall Study|Adverse Event|3|||
148877398|NCT01368081|537026759|FG000|Overall Study|Lack of Efficacy|0|||
148877399|NCT01368081|537026760|FG001|Overall Study|Lack of Efficacy|1|||
148877400|NCT01368081|537026761|FG002|Overall Study|Lack of Efficacy|0|||
148877401|NCT01368081|537026762|FG003|Overall Study|Lack of Efficacy|1|||
148877402|NCT01368081|537026763|FG004|Overall Study|Lack of Efficacy|0|||
148877403|NCT01368081|537026764|FG005|Overall Study|Lack of Efficacy|0|||
148877404|NCT01368081|537026765|FG006|Overall Study|Lack of Efficacy|0|||
148877405|NCT01368081|537026766|FG007|Overall Study|Lack of Efficacy|2|||
148877406|NCT01368081|537026767|FG008|Overall Study|Lack of Efficacy|0|||
148877407|NCT01368081|537026768|FG009|Overall Study|Lack of Efficacy|0|||
148877408|NCT01368081|537026769|FG010|Overall Study|Lack of Efficacy|0|||
148877409|NCT01368081|537026770|FG011|Overall Study|Lack of Efficacy|0|||
148877410|NCT01368081|537026771|FG012|Overall Study|Lack of Efficacy|0|||
148877411|NCT01368081|537026759|FG000|Overall Study|Protocol Violation|0|||
148877412|NCT01368081|537026760|FG001|Overall Study|Protocol Violation|0|||
148877413|NCT01368081|537026761|FG002|Overall Study|Protocol Violation|0|||
148877414|NCT01368081|537026762|FG003|Overall Study|Protocol Violation|0|||
148877415|NCT01368081|537026763|FG004|Overall Study|Protocol Violation|0|||
148877416|NCT01368081|537026764|FG005|Overall Study|Protocol Violation|1|||
148877417|NCT01368081|537026765|FG006|Overall Study|Protocol Violation|0|||
148877418|NCT01368081|537026766|FG007|Overall Study|Protocol Violation|1|||
148877419|NCT01368081|537026767|FG008|Overall Study|Protocol Violation|0|||
148877420|NCT01368081|537026768|FG009|Overall Study|Protocol Violation|0|||
148877421|NCT01368081|537026769|FG010|Overall Study|Protocol Violation|0|||
148877422|NCT01368081|537026770|FG011|Overall Study|Protocol Violation|0|||
148877423|NCT01368081|537026771|FG012|Overall Study|Protocol Violation|0|||
148877424|NCT01368081|537026759|FG000|Overall Study|Lost to Follow-up|0|||
148877425|NCT01368081|537026760|FG001|Overall Study|Lost to Follow-up|0|||
148877426|NCT01368081|537026761|FG002|Overall Study|Lost to Follow-up|0|||
148877427|NCT01368081|537026762|FG003|Overall Study|Lost to Follow-up|0|||
148877428|NCT01368081|537026763|FG004|Overall Study|Lost to Follow-up|0|||
148877429|NCT01368081|537026764|FG005|Overall Study|Lost to Follow-up|0|||
148877430|NCT01368081|537026765|FG006|Overall Study|Lost to Follow-up|0|||
148877431|NCT01368081|537026766|FG007|Overall Study|Lost to Follow-up|0|||
148877432|NCT01368081|537026767|FG008|Overall Study|Lost to Follow-up|0|||
148877433|NCT01368081|537026768|FG009|Overall Study|Lost to Follow-up|0|||
148877434|NCT01368081|537026769|FG010|Overall Study|Lost to Follow-up|0|||
148877435|NCT01368081|537026770|FG011|Overall Study|Lost to Follow-up|0|||
148877436|NCT01368081|537026771|FG012|Overall Study|Lost to Follow-up|1|||
148877437|NCT01368081|537026759|FG000|Overall Study|Withdrawal by Subject|4|||
148877438|NCT01368081|537026760|FG001|Overall Study|Withdrawal by Subject|4|||
148877439|NCT01368081|537026761|FG002|Overall Study|Withdrawal by Subject|1|||
148877440|NCT01368081|537026762|FG003|Overall Study|Withdrawal by Subject|1|||
148877441|NCT01368081|537026763|FG004|Overall Study|Withdrawal by Subject|0|||
148877442|NCT01368081|537026764|FG005|Overall Study|Withdrawal by Subject|3|||
148877443|NCT01368081|537026765|FG006|Overall Study|Withdrawal by Subject|4|||
148877444|NCT01368081|537026766|FG007|Overall Study|Withdrawal by Subject|2|||
148877445|NCT01368081|537026767|FG008|Overall Study|Withdrawal by Subject|5|||
148877446|NCT01368081|537026768|FG009|Overall Study|Withdrawal by Subject|4|||
148877447|NCT01368081|537026769|FG010|Overall Study|Withdrawal by Subject|3|||
148877448|NCT01368081|537026770|FG011|Overall Study|Withdrawal by Subject|2|||
148877449|NCT01368081|537026771|FG012|Overall Study|Withdrawal by Subject|0|||
148877450|NCT01368081|537026759|FG000|Overall Study|Other reason not defined above|2|||
148877451|NCT01368081|537026760|FG001|Overall Study|Other reason not defined above|0|||
148877452|NCT01368081|537026761|FG002|Overall Study|Other reason not defined above|0|||
148877453|NCT01368081|537026762|FG003|Overall Study|Other reason not defined above|1|||
148877454|NCT01368081|537026763|FG004|Overall Study|Other reason not defined above|0|||
148877455|NCT01368081|537026764|FG005|Overall Study|Other reason not defined above|1|||
148877456|NCT01368081|537026765|FG006|Overall Study|Other reason not defined above|2|||
148877457|NCT01368081|537026766|FG007|Overall Study|Other reason not defined above|0|||
148877458|NCT01368081|537026767|FG008|Overall Study|Other reason not defined above|0|||
148877459|NCT01368081|537026768|FG009|Overall Study|Other reason not defined above|1|||
148877460|NCT01368081|537026769|FG010|Overall Study|Other reason not defined above|0|||
148877461|NCT01368081|537026770|FG011|Overall Study|Other reason not defined above|0|||
148877462|NCT01368081|537026771|FG012|Overall Study|Other reason not defined above|3|||
148877463|NCT00238238|537026773|FG000|Overall Study|Withdrawal by Subject|0|||
148877464|NCT00238238|537026774|FG001|Overall Study|Withdrawal by Subject|3|||
148877465|NCT00238238|537026775|FG002|Overall Study|Withdrawal by Subject|0|||
148877466|NCT01007838|537026779|FG000|Overall Study|Withdrawal by Subject|1|||
148877467|NCT01007838|537026780|FG001|Overall Study|Withdrawal by Subject|0|||
148877468|NCT01007838|537026781|FG002|Overall Study|Withdrawal by Subject|0|||
148877469|NCT01007838|537026782|FG003|Overall Study|Withdrawal by Subject|0|||
148877470|NCT01007838|537026779|FG000|Overall Study|Physician Decision|1|||
148877471|NCT01007838|537026780|FG001|Overall Study|Physician Decision|0|||
148877472|NCT01007838|537026781|FG002|Overall Study|Physician Decision|0|||
148877473|NCT01007838|537026782|FG003|Overall Study|Physician Decision|0|||
148877474|NCT01007838|537026779|FG000|Overall Study|Started home haemodialysis|1|||
148877475|NCT01007838|537026780|FG001|Overall Study|Started home haemodialysis|0|||
148877476|NCT01007838|537026781|FG002|Overall Study|Started home haemodialysis|0|||
148877477|NCT01007838|537026782|FG003|Overall Study|Started home haemodialysis|0|||
148877478|NCT02277119|537026783|FG000|Overall Study|Lack of Efficacy|1|||
149034470|NCT01144182|537603679|FG001|Overall Study|Lost to Follow-up|9|||
148877479|NCT02277119|537026784|FG001|Overall Study|Lack of Efficacy|1|||
148877480|NCT02277119|537026785|FG002|Overall Study|Lack of Efficacy|1|||
148877481|NCT02277119|537026783|FG000|Overall Study|Protocol Violation|2|||
148877482|NCT02277119|537026784|FG001|Overall Study|Protocol Violation|3|||
148877483|NCT02277119|537026785|FG002|Overall Study|Protocol Violation|7|||
148877484|NCT02478255|537026786|FG000|Overall Study|Physician Decision|6|||
148877485|NCT02478255|537026787|FG001|Overall Study|Physician Decision|0|||
148877486|NCT02478255|537026786|FG000|Overall Study|Withdrawal by Subject|2|||
148877487|NCT02478255|537026787|FG001|Overall Study|Withdrawal by Subject|0|||
148877488|NCT03068767|537026793|FG000|Overall Study|Lost to Follow-up|7|||
148877489|NCT03068767|537026794|FG001|Overall Study|Lost to Follow-up|3|||
148877490|NCT03068767|537026793|FG000|Overall Study|Protocol Violation|3|||
148877491|NCT03068767|537026794|FG001|Overall Study|Protocol Violation|0|||
148877492|NCT01730586|537026795|FG000|Overall Study|Progressive Disease|2|||
148877493|NCT01730586|537026795|FG000|Overall Study|Inadequate Trial|8|||
148877494|NCT01730586|537026795|FG000|Overall Study|Adverse Event|2|||
148877495|NCT01730586|537026795|FG000|Overall Study|Hospice|1|||
148877496|NCT00061633|537026796|FG000|Overall Study|Adverse Event|1|||
148877497|NCT00061633|537026797|FG001|Overall Study|Adverse Event|2|||
148877498|NCT00061633|537026796|FG000|Overall Study|Withdrawal by Subject|2|||
148877499|NCT00061633|537026797|FG001|Overall Study|Withdrawal by Subject|2|||
148877500|NCT00061633|537026796|FG000|Overall Study|Lost to Follow-up|1|||
148877501|NCT00061633|537026797|FG001|Overall Study|Lost to Follow-up|4|||
148877502|NCT00061633|537026796|FG000|Overall Study|Other|1|||
148877503|NCT00061633|537026797|FG001|Overall Study|Other|1|||
148877504|NCT00061633|537026796|FG000|Overall Study|Never received study treatment|0|||
148877505|NCT00061633|537026797|FG001|Overall Study|Never received study treatment|2|||
148877506|NCT01431963|537026798|FG000|Overall Study|Adverse Event|18|||
148877507|NCT01431963|537026798|FG000|Overall Study|Lack of Efficacy|7|||
149034471|NCT02317016|537603691|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
149034472|NCT02317016|537603691|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
149034473|NCT02317016|537603691|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
149034474|NCT02317016|537603691|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
148877508|NCT01431963|537026798|FG000|Overall Study|Protocol Violation|1|||
148877509|NCT01431963|537026798|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
148877510|NCT01431963|537026798|FG000|Overall Study|Physician Decision|4|||
148877511|NCT01431963|537026798|FG000|Overall Study|Withdrawal by Subject|3|||
148877512|NCT02611817|537028557|FG000|Open-label Induction Phase|Reason not Specified|9|||
148877513|NCT02611817|537028558|FG001|Open-label Induction Phase|Reason not Specified|0|||
148877514|NCT02611817|537028559|FG002|Open-label Induction Phase|Reason not Specified|0|||
148877515|NCT02611817|537028557|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
148877516|NCT02611817|537028558|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
148877517|NCT02611817|537028559|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
148877518|NCT02611817|537028557|FG000|Open-label Induction Phase|Pregnancy|1|||
148877519|NCT02611817|537028558|FG001|Open-label Induction Phase|Pregnancy|0|||
148877520|NCT02611817|537028559|FG002|Open-label Induction Phase|Pregnancy|0|||
148877521|NCT02611817|537028557|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
148877522|NCT02611817|537028558|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
148877523|NCT02611817|537028559|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
148877524|NCT02611817|537028557|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
148877525|NCT02611817|537028558|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
148877526|NCT02611817|537028559|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
148877527|NCT02611817|537028557|FG000|Open-label Induction Phase|Protocol Violation|5|||
148877528|NCT02611817|537028558|FG001|Open-label Induction Phase|Protocol Violation|0|||
148877529|NCT02611817|537028559|FG002|Open-label Induction Phase|Protocol Violation|0|||
148877530|NCT02611817|537028557|FG000|Open-label Induction Phase|Adverse Event|16|||
148877531|NCT02611817|537028558|FG001|Open-label Induction Phase|Adverse Event|0|||
148877532|NCT02611817|537028559|FG002|Open-label Induction Phase|Adverse Event|0|||
148877533|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
148877534|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
148877535|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
148877536|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
148877537|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
148877538|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
148877539|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
148877540|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
148877541|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
148877542|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
148877543|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
148877544|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
148877545|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
148877546|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
148877547|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
148877548|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
148877549|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
148877550|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
148877551|NCT02611817|537028557|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
148877552|NCT02611817|537028558|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
148877553|NCT02611817|537028559|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
148877554|NCT03077919|537028560|FG000|Overall Study|Lost to Follow-up|4|||
148877555|NCT03077919|537028561|FG001|Overall Study|Lost to Follow-up|1|||
148877556|NCT00826618|537028562|FG000|Overall Study|Withdrawal by Subject|1|||
148877557|NCT01618695|537028563|FG000|Core Phase|Adverse Event|4|||
148877558|NCT01618695|537028564|FG001|Core Phase|Adverse Event|5|||
148877559|NCT01618695|537028565|FG002|Core Phase|Adverse Event|15|||
148877560|NCT01618695|537028566|FG003|Core Phase|Adverse Event|20|||
148877561|NCT01618695|537028563|FG000|Core Phase|Lost to Follow-up|0|||
148877562|NCT01618695|537028564|FG001|Core Phase|Lost to Follow-up|0|||
148877563|NCT01618695|537028565|FG002|Core Phase|Lost to Follow-up|1|||
148877564|NCT01618695|537028566|FG003|Core Phase|Lost to Follow-up|0|||
148877565|NCT01618695|537028563|FG000|Core Phase|Withdrawal by Subject|16|||
148877566|NCT01618695|537028564|FG001|Core Phase|Withdrawal by Subject|11|||
148877567|NCT01618695|537028565|FG002|Core Phase|Withdrawal by Subject|9|||
148877568|NCT01618695|537028566|FG003|Core Phase|Withdrawal by Subject|13|||
148877569|NCT01618695|537028563|FG000|Core Phase|Pregnancy|2|||
148877570|NCT01618695|537028564|FG001|Core Phase|Pregnancy|0|||
148877571|NCT01618695|537028565|FG002|Core Phase|Pregnancy|0|||
148877572|NCT01618695|537028566|FG003|Core Phase|Pregnancy|0|||
148877573|NCT01618695|537028563|FG000|Core Phase|Lack of Efficacy|1|||
148877574|NCT01618695|537028564|FG001|Core Phase|Lack of Efficacy|2|||
148877575|NCT01618695|537028565|FG002|Core Phase|Lack of Efficacy|1|||
148877576|NCT01618695|537028566|FG003|Core Phase|Lack of Efficacy|1|||
148877577|NCT01618695|537028563|FG000|Core Phase|Other than specified|1|||
148877578|NCT01618695|537028564|FG001|Core Phase|Other than specified|2|||
148877579|NCT01618695|537028565|FG002|Core Phase|Other than specified|2|||
148877580|NCT01618695|537028566|FG003|Core Phase|Other than specified|2|||
148877581|NCT01618695|537028563|FG000|Core Phase|Not treated|1|||
148877582|NCT01618695|537028564|FG001|Core Phase|Not treated|0|||
148877583|NCT01618695|537028565|FG002|Core Phase|Not treated|2|||
148877584|NCT01618695|537028566|FG003|Core Phase|Not treated|0|||
148877585|NCT01618695|537028563|FG000|Extension Phase|Lack of Efficacy|17|||
148877586|NCT01618695|537028564|FG001|Extension Phase|Lack of Efficacy|33|||
148877587|NCT01618695|537028565|FG002|Extension Phase|Lack of Efficacy|26|||
148877588|NCT01618695|537028566|FG003|Extension Phase|Lack of Efficacy|24|||
148877589|NCT01618695|537028563|FG000|Extension Phase|Pregnancy|2|||
148877590|NCT01618695|537028564|FG001|Extension Phase|Pregnancy|0|||
148877591|NCT01618695|537028565|FG002|Extension Phase|Pregnancy|1|||
148877592|NCT01618695|537028566|FG003|Extension Phase|Pregnancy|1|||
148877593|NCT01618695|537028563|FG000|Extension Phase|Withdrawal by Subject|43|||
148877594|NCT01618695|537028564|FG001|Extension Phase|Withdrawal by Subject|48|||
148877595|NCT01618695|537028565|FG002|Extension Phase|Withdrawal by Subject|42|||
148877596|NCT01618695|537028566|FG003|Extension Phase|Withdrawal by Subject|33|||
148877597|NCT01618695|537028563|FG000|Extension Phase|Adverse Event|18|||
148877598|NCT01618695|537028564|FG001|Extension Phase|Adverse Event|16|||
148877599|NCT01618695|537028565|FG002|Extension Phase|Adverse Event|9|||
148877600|NCT01618695|537028566|FG003|Extension Phase|Adverse Event|20|||
148877601|NCT01618695|537028563|FG000|Extension Phase|Lost to Follow-up|2|||
148877602|NCT01618695|537028564|FG001|Extension Phase|Lost to Follow-up|1|||
148877603|NCT01618695|537028565|FG002|Extension Phase|Lost to Follow-up|1|||
148877604|NCT01618695|537028566|FG003|Extension Phase|Lost to Follow-up|1|||
148877605|NCT01618695|537028563|FG000|Extension Phase|Other than specified|13|||
148877606|NCT01618695|537028564|FG001|Extension Phase|Other than specified|18|||
148877607|NCT01618695|537028565|FG002|Extension Phase|Other than specified|13|||
148877608|NCT01618695|537028566|FG003|Extension Phase|Other than specified|18|||
148877609|NCT02950480|537028573|FG000|Overall Study|Withdrawal by Subject|1|||
148877610|NCT02950480|537028574|FG001|Overall Study|Withdrawal by Subject|0|||
148877611|NCT01363661|537028575|FG000|Overall Study|Adverse Event|9|||
148877612|NCT01363661|537028576|FG001|Overall Study|Adverse Event|2|||
148877613|NCT01363661|537028575|FG000|Overall Study|Withdrawal by Subject|1|||
148877614|NCT01363661|537028576|FG001|Overall Study|Withdrawal by Subject|1|||
148877615|NCT01363661|537028575|FG000|Overall Study|Protocol Violation|1|||
148877616|NCT01363661|537028576|FG001|Overall Study|Protocol Violation|0|||
148877617|NCT01363661|537028575|FG000|Overall Study|Lost to Follow-up|3|||
148877618|NCT01363661|537028576|FG001|Overall Study|Lost to Follow-up|1|||
148877619|NCT01835223|537028583|FG000|Overall Study|Adverse Event|1|||
148877620|NCT01835223|537028584|FG001|Overall Study|Adverse Event|0|||
148877621|NCT01835223|537028583|FG000|Overall Study|Withdrawal by Subject|2|||
148877622|NCT01835223|537028584|FG001|Overall Study|Withdrawal by Subject|0|||
148877623|NCT01835223|537028583|FG000|Overall Study|Disease progression|2|||
148877624|NCT01835223|537028584|FG001|Overall Study|Disease progression|1|||
148877625|NCT01835223|537028583|FG000|Overall Study|Became Inelligible|4|||
148877626|NCT01835223|537028584|FG001|Overall Study|Became Inelligible|0|||
148877627|NCT03149055|537028589|FG000|Overall Study|Not treated|4|||
148877628|NCT00630344|537028592|FG000|Overall Study|Adverse Event|5|||
148877629|NCT00630344|537028592|FG000|Overall Study|Progressive Disease|19|||
148877630|NCT00630344|537028592|FG000|Overall Study|Physician Decision|9|||
148877631|NCT00630344|537028592|FG000|Overall Study|Withdrawal by Subject|1|||
148877632|NCT00630344|537028592|FG000|Overall Study|Intercurrent Illness|1|||
148877633|NCT00630344|537028592|FG000|Overall Study|Other|1|||
148877634|NCT01357551|537028593|FG000|Overall Study|Withdrawal by Subject|6|||
148877635|NCT01357551|537028594|FG001|Overall Study|Withdrawal by Subject|4|||
148877636|NCT01357551|537028593|FG000|Overall Study|Death|0|||
148877637|NCT01357551|537028594|FG001|Overall Study|Death|1|||
148877638|NCT01357551|537028593|FG000|Overall Study|Lost to Follow-up|16|||
148877639|NCT01357551|537028594|FG001|Overall Study|Lost to Follow-up|6|||
148877640|NCT00711971|537028596|FG000|Overall Study|Lost to Follow-up|3|||
148877641|NCT00711971|537028597|FG001|Overall Study|Lost to Follow-up|4|||
148877642|NCT00711971|537028598|FG002|Overall Study|Lost to Follow-up|1|||
148877643|NCT03704688|537028601|FG000|Overall Study|Adverse Event|0|||
148877644|NCT03704688|537028602|FG001|Overall Study|Adverse Event|0|||
148877645|NCT03704688|537028603|FG002|Overall Study|Adverse Event|0|||
148877646|NCT03704688|537028604|FG003|Overall Study|Adverse Event|4|||
148877647|NCT03704688|537028605|FG004|Overall Study|Adverse Event|1|||
148877648|NCT03704688|537028606|FG005|Overall Study|Adverse Event|0|||
148877649|NCT03704688|537028601|FG000|Overall Study|Disease Progression|0|||
148877650|NCT03704688|537028602|FG001|Overall Study|Disease Progression|0|||
148877651|NCT03704688|537028603|FG002|Overall Study|Disease Progression|0|||
148877652|NCT03704688|537028604|FG003|Overall Study|Disease Progression|3|||
148877653|NCT03704688|537028605|FG004|Overall Study|Disease Progression|1|||
148877654|NCT03704688|537028606|FG005|Overall Study|Disease Progression|0|||
148877655|NCT03704688|537028601|FG000|Overall Study|Death|0|||
148877656|NCT03704688|537028602|FG001|Overall Study|Death|0|||
148877657|NCT03704688|537028603|FG002|Overall Study|Death|0|||
148877658|NCT03704688|537028604|FG003|Overall Study|Death|0|||
148877659|NCT03704688|537028605|FG004|Overall Study|Death|3|||
148877660|NCT03704688|537028606|FG005|Overall Study|Death|0|||
148877661|NCT00847886|537028607|FG000|Overall Study|Adverse Event|0|||
148877662|NCT00847886|537028608|FG001|Overall Study|Adverse Event|1|||
148877663|NCT02462720|537028609|FG000|Part 2|Withdrawal by Subject|1|||
148877664|NCT02462720|537028610|FG001|Part 2|Withdrawal by Subject|0|||
148877665|NCT02462720|537028609|FG000|Part 2|Protocol Violation|0|||
148877666|NCT02462720|537028610|FG001|Part 2|Protocol Violation|1|||
148877667|NCT01068769|537028611|FG000|Overall Study|Ineligible|1|||
148877668|NCT03671304|537028616|FG000|Overall Study|study terminated|7|||
148877669|NCT00596830|537028617|FG000|Overall Study|Death|258|||
148877670|NCT00596830|537028618|FG001|Overall Study|Death|247|||
148877671|NCT00596830|537028617|FG000|Overall Study|Lost to Follow-up|7|||
148877672|NCT00596830|537028618|FG001|Overall Study|Lost to Follow-up|11|||
148877673|NCT00596830|537028617|FG000|Overall Study|Withdrawal by Subject|22|||
148877674|NCT00596830|537028618|FG001|Overall Study|Withdrawal by Subject|12|||
148877675|NCT00596830|537028617|FG000|Overall Study|Study terminated by sponsor|51|||
148877676|NCT00596830|537028618|FG001|Overall Study|Study terminated by sponsor|62|||
148877677|NCT00596830|537028617|FG000|Overall Study|Follow-up was discontinued|1|||
148877678|NCT00596830|537028618|FG001|Overall Study|Follow-up was discontinued|0|||
148877679|NCT00596830|537028617|FG000|Overall Study|Randomized but not treated|3|||
148877680|NCT00596830|537028618|FG001|Overall Study|Randomized but not treated|7|||
148877681|NCT00887926|537028619|FG000|Overall Study|Withdrawal by Subject|0|||
148877682|NCT00887926|537028620|FG001|Overall Study|Withdrawal by Subject|1|||
148877683|NCT00887926|537028621|FG002|Overall Study|Withdrawal by Subject|0|||
148877684|NCT00887926|537028622|FG003|Overall Study|Withdrawal by Subject|0|||
148877685|NCT02097030|537028623|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
148877686|NCT02097030|537028624|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
148877687|NCT02097030|537028623|FG000|First Intervention (3 Days)|Visual Acuity|0|||
148877688|NCT02097030|537028624|FG001|First Intervention (3 Days)|Visual Acuity|1|||
148877689|NCT00844558|537028625|FG000|Overall Study|Withdrawal by Subject|9|||
148877690|NCT00844558|537028626|FG001|Overall Study|Withdrawal by Subject|2|||
148877691|NCT00844558|537028625|FG000|Overall Study|Death|1|||
148877692|NCT00844558|537028626|FG001|Overall Study|Death|0|||
148877693|NCT00844558|537028625|FG000|Overall Study|Protocol Violation|1|||
148877694|NCT00844558|537028626|FG001|Overall Study|Protocol Violation|1|||
148877695|NCT00844558|537028625|FG000|Overall Study|Lost to Follow-up|0|||
148877696|NCT00844558|537028626|FG001|Overall Study|Lost to Follow-up|1|||
148877697|NCT00844558|537028625|FG000|Overall Study|Physician Decision|1|||
148877698|NCT00844558|537028626|FG001|Overall Study|Physician Decision|0|||
148877699|NCT00588094|537028627|FG000|Overall Study|Adverse Event|3|||
148877700|NCT00588094|537028627|FG000|Overall Study|Progression of Disease|2|||
148877701|NCT03916081|537028635|FG000|Overall Study|Adverse Event|1|||
148877702|NCT03916081|537028636|FG001|Overall Study|Adverse Event|0|||
148877703|NCT03916081|537028637|FG002|Overall Study|Adverse Event|0|||
148877704|NCT03916081|537028635|FG000|Overall Study|Physician Decision|0|||
148877705|NCT03916081|537028636|FG001|Overall Study|Physician Decision|0|||
148877706|NCT03916081|537028637|FG002|Overall Study|Physician Decision|1|||
148877707|NCT03916081|537028635|FG000|Overall Study|Lost to Follow-up|0|||
148877708|NCT03916081|537028636|FG001|Overall Study|Lost to Follow-up|1|||
148877709|NCT03916081|537028637|FG002|Overall Study|Lost to Follow-up|0|||
148877710|NCT03916081|537028635|FG000|Overall Study|Withdrawal by Subject|3|||
148877711|NCT03916081|537028636|FG001|Overall Study|Withdrawal by Subject|0|||
148877712|NCT03916081|537028637|FG002|Overall Study|Withdrawal by Subject|1|||
148877713|NCT03916081|537028635|FG000|Overall Study|Worsening of AD|0|||
148877714|NCT03916081|537028636|FG001|Overall Study|Worsening of AD|0|||
148877715|NCT03916081|537028637|FG002|Overall Study|Worsening of AD|1|||
148877716|NCT01240135|537028638|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
148877717|NCT01240135|537028639|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
148877718|NCT01240135|537028638|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
148877719|NCT01240135|537028639|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
148877720|NCT02828020|537028654|FG000|Treatment Period|Adverse Event|3|||
148877721|NCT02828020|537028655|FG001|Treatment Period|Adverse Event|1|||
148877722|NCT02828020|537028656|FG002|Treatment Period|Adverse Event|1|||
148877723|NCT02828020|537028654|FG000|Treatment Period|Withdrawal of Consent|10|||
148877724|NCT02828020|537028655|FG001|Treatment Period|Withdrawal of Consent|14|||
148877725|NCT02828020|537028656|FG002|Treatment Period|Withdrawal of Consent|9|||
148877726|NCT02828020|537028654|FG000|Treatment Period|Lost to Follow-up|21|||
148877727|NCT02828020|537028655|FG001|Treatment Period|Lost to Follow-up|24|||
148877728|NCT02828020|537028656|FG002|Treatment Period|Lost to Follow-up|18|||
148877729|NCT02828020|537028654|FG000|Treatment Period|Lack of Qualifying Event|44|||
148877730|NCT02828020|537028655|FG001|Treatment Period|Lack of Qualifying Event|53|||
148877731|NCT02828020|537028656|FG002|Treatment Period|Lack of Qualifying Event|43|||
148877732|NCT02828020|537028654|FG000|Treatment Period|Pregnancy|0|||
148877733|NCT02828020|537028655|FG001|Treatment Period|Pregnancy|2|||
148877734|NCT02828020|537028656|FG002|Treatment Period|Pregnancy|0|||
148877735|NCT02828020|537028654|FG000|Treatment Period|Protocol Violation|2|||
148877736|NCT02828020|537028655|FG001|Treatment Period|Protocol Violation|4|||
148877737|NCT02828020|537028656|FG002|Treatment Period|Protocol Violation|7|||
148877738|NCT02828020|537028654|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
148877739|NCT02828020|537028655|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
148877740|NCT02828020|537028656|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
148877741|NCT02828020|537028654|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
148877742|NCT02828020|537028655|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
148877743|NCT02828020|537028656|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
148877744|NCT02828020|537028654|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
148877745|NCT02828020|537028655|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
148877746|NCT02828020|537028656|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
148877747|NCT02828020|537028654|FG000|Safety Follow-up Period|Protocol Violation|0|||
148877748|NCT02828020|537028655|FG001|Safety Follow-up Period|Protocol Violation|2|||
148877749|NCT02828020|537028656|FG002|Safety Follow-up Period|Protocol Violation|1|||
148877750|NCT02828020|537028654|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
148877751|NCT02828020|537028655|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
148877752|NCT02828020|537028656|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
148877753|NCT03688620|537028657|FG000|Overall Study|Other|0|||
148877754|NCT03688620|537028658|FG001|Overall Study|Other|0|||
148877755|NCT03688620|537028659|FG002|Overall Study|Other|1|||
148877756|NCT03688620|537028657|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
148877757|NCT03688620|537028658|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
148877758|NCT03688620|537028659|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
148877759|NCT03688620|537028657|FG000|Overall Study|Lost to Follow-up|16|||
148877760|NCT03688620|537028658|FG001|Overall Study|Lost to Follow-up|0|||
148877761|NCT03688620|537028659|FG002|Overall Study|Lost to Follow-up|1|||
148877762|NCT03688620|537028657|FG000|Overall Study|Withdrawal by Subject|0|||
148877763|NCT03688620|537028658|FG001|Overall Study|Withdrawal by Subject|0|||
148877764|NCT03688620|537028659|FG002|Overall Study|Withdrawal by Subject|6|||
148877765|NCT04356352|537028660|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
148877766|NCT04356352|537028661|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
148877767|NCT04356352|537028662|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
148877768|NCT04356352|537028660|FG000|Overall Study|Protocol Violation|0|||
148877769|NCT04356352|537028661|FG001|Overall Study|Protocol Violation|3|||
148877770|NCT04356352|537028662|FG002|Overall Study|Protocol Violation|1|||
148877771|NCT01183065|537028663|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
148877772|NCT00416455|537028665|FG000|Overall Study|PET / CT not done|3|||
148877773|NCT00416455|537028666|FG001|Overall Study|PET / CT not done|5|||
148877774|NCT00416455|537028665|FG000|Overall Study|PET / CT poor quality|2|||
148877775|NCT00416455|537028666|FG001|Overall Study|PET / CT poor quality|1|||
148877776|NCT00416455|537028665|FG000|Overall Study|Inadequate pathology|11|||
148877777|NCT00416455|537028666|FG001|Overall Study|Inadequate pathology|2|||
148877778|NCT02456857|537028667|FG000|Overall Study|Disease Progression|4|||
148877779|NCT00781859|537028668|FG000|Overall Study|Adverse Event|2|||
148877780|NCT00781859|537028669|FG001|Overall Study|Adverse Event|2|||
148877781|NCT00781859|537028668|FG000|Overall Study|Withdrawal by Subject|8|||
148877782|NCT00781859|537028669|FG001|Overall Study|Withdrawal by Subject|4|||
148877783|NCT00781859|537028668|FG000|Overall Study|Lost to Follow-up|6|||
148877784|NCT00781859|537028669|FG001|Overall Study|Lost to Follow-up|3|||
148877785|NCT00781859|537028668|FG000|Overall Study|Death|3|||
148877786|NCT00781859|537028669|FG001|Overall Study|Death|0|||
148877787|NCT01983774|537028673|FG000|Overall Study|Lung Transplant|0|||
148877788|NCT01983774|537028674|FG001|Overall Study|Lung Transplant|1|||
148877789|NCT01983774|537028673|FG000|Overall Study|Lost to Follow-up|1|||
148877790|NCT01983774|537028674|FG001|Overall Study|Lost to Follow-up|0|||
148877791|NCT01138501|537028675|FG000|Overall Study|Protocol Violation|2|||
148877792|NCT01138501|537028675|FG000|Overall Study|Withdrawal by Subject|3|||
148877793|NCT01339897|537028676|FG000|Overall Study|Adverse Event|1|||
148877794|NCT01339897|537028677|FG001|Overall Study|Adverse Event|0|||
148877795|NCT01339897|537028678|FG002|Overall Study|Adverse Event|0|||
148877796|NCT01339897|537028679|FG003|Overall Study|Adverse Event|1|||
148877797|NCT03657095|537028682|FG000|Overall Study|Withdrawal by Subject|1|||
148877798|NCT03657095|537028683|FG001|Overall Study|Withdrawal by Subject|1|||
148877799|NCT03657095|537028682|FG000|Overall Study|Adverse Event|0|||
148877800|NCT03657095|537028683|FG001|Overall Study|Adverse Event|3|||
148877801|NCT03657095|537028682|FG000|Overall Study|Study Terminated by Sponsor|58|||
148877802|NCT03657095|537028683|FG001|Overall Study|Study Terminated by Sponsor|49|||
148877803|NCT00348309|537028686|FG000|Overall Study|Adverse Event|56|||
148877804|NCT00348309|537028687|FG001|Overall Study|Adverse Event|28|||
148877805|NCT00348309|537028688|FG002|Overall Study|Adverse Event|63|||
148877806|NCT00348309|537028686|FG000|Overall Study|Lost to Follow-up|6|||
148877807|NCT00348309|537028687|FG001|Overall Study|Lost to Follow-up|7|||
148877808|NCT00348309|537028688|FG002|Overall Study|Lost to Follow-up|4|||
148877809|NCT00348309|537028686|FG000|Overall Study|Protocol Violation|7|||
148877810|NCT00348309|537028687|FG001|Overall Study|Protocol Violation|12|||
148877811|NCT00348309|537028688|FG002|Overall Study|Protocol Violation|7|||
148877812|NCT00348309|537028686|FG000|Overall Study|Withdrawal by Subject|33|||
148877813|NCT00348309|537028687|FG001|Overall Study|Withdrawal by Subject|37|||
148877814|NCT00348309|537028688|FG002|Overall Study|Withdrawal by Subject|40|||
148877815|NCT00348309|537028686|FG000|Overall Study|Non-compliance|8|||
148877816|NCT00348309|537028687|FG001|Overall Study|Non-compliance|6|||
148877817|NCT00348309|537028688|FG002|Overall Study|Non-compliance|8|||
148877818|NCT00348309|537028686|FG000|Overall Study|Death of caregiver|1|||
148877819|NCT00348309|537028687|FG001|Overall Study|Death of caregiver|0|||
148877820|NCT00348309|537028688|FG002|Overall Study|Death of caregiver|1|||
148877821|NCT00348309|537028686|FG000|Overall Study|Lack of insight, dementia|1|||
148877822|NCT00348309|537028687|FG001|Overall Study|Lack of insight, dementia|0|||
148877823|NCT00348309|537028688|FG002|Overall Study|Lack of insight, dementia|0|||
148877824|NCT00348309|537028686|FG000|Overall Study|Wrong bottle allocated|1|||
148877825|NCT00348309|537028687|FG001|Overall Study|Wrong bottle allocated|0|||
148877826|NCT00348309|537028688|FG002|Overall Study|Wrong bottle allocated|0|||
148877827|NCT00348309|537028686|FG000|Overall Study|Caregiver sick|1|||
148877828|NCT00348309|537028687|FG001|Overall Study|Caregiver sick|0|||
148877829|NCT00348309|537028688|FG002|Overall Study|Caregiver sick|0|||
148877830|NCT00348309|537028686|FG000|Overall Study|Use of prohibited medication|5|||
148877831|NCT00348309|537028687|FG001|Overall Study|Use of prohibited medication|2|||
148877832|NCT00348309|537028688|FG002|Overall Study|Use of prohibited medication|2|||
148877833|NCT00348309|537028686|FG000|Overall Study|Caregiver withdrawal|3|||
148877834|NCT00348309|537028687|FG001|Overall Study|Caregiver withdrawal|0|||
148877835|NCT00348309|537028688|FG002|Overall Study|Caregiver withdrawal|7|||
148877836|NCT00348309|537028686|FG000|Overall Study|Unable to complete ET visit|1|||
148877837|NCT00348309|537028687|FG001|Overall Study|Unable to complete ET visit|0|||
148877838|NCT00348309|537028688|FG002|Overall Study|Unable to complete ET visit|0|||
148877839|NCT00348309|537028686|FG000|Overall Study|PI closing medical practice|1|||
148877840|NCT00348309|537028687|FG001|Overall Study|PI closing medical practice|0|||
148877841|NCT00348309|537028688|FG002|Overall Study|PI closing medical practice|0|||
148877842|NCT00348309|537028686|FG000|Overall Study|Principal investigator's decision|1|||
148877843|NCT00348309|537028687|FG001|Overall Study|Principal investigator's decision|0|||
148877844|NCT00348309|537028688|FG002|Overall Study|Principal investigator's decision|0|||
148877845|NCT00348309|537028686|FG000|Overall Study|No disponibility of medication|1|||
148877846|NCT00348309|537028687|FG001|Overall Study|No disponibility of medication|0|||
148877847|NCT00348309|537028688|FG002|Overall Study|No disponibility of medication|0|||
148877848|NCT00348309|537028686|FG000|Overall Study|Worsened neurodegenerative disease|1|||
148877849|NCT00348309|537028687|FG001|Overall Study|Worsened neurodegenerative disease|0|||
148877850|NCT00348309|537028688|FG002|Overall Study|Worsened neurodegenerative disease|0|||
148877851|NCT00348309|537028686|FG000|Overall Study|Cognitive and behaviour worsening|2|||
148877852|NCT00348309|537028687|FG001|Overall Study|Cognitive and behaviour worsening|0|||
148877853|NCT00348309|537028688|FG002|Overall Study|Cognitive and behaviour worsening|0|||
148877854|NCT00348309|537028686|FG000|Overall Study|Worsening of alzheimer|1|||
148877855|NCT00348309|537028687|FG001|Overall Study|Worsening of alzheimer|0|||
148877856|NCT00348309|537028688|FG002|Overall Study|Worsening of alzheimer|1|||
148877857|NCT00348309|537028686|FG000|Overall Study|Did not appear in time for Visit 3|1|||
148877858|NCT00348309|537028687|FG001|Overall Study|Did not appear in time for Visit 3|0|||
148877859|NCT00348309|537028688|FG002|Overall Study|Did not appear in time for Visit 3|0|||
148877860|NCT00348309|537028686|FG000|Overall Study|Participant died|2|||
148877861|NCT00348309|537028687|FG001|Overall Study|Participant died|1|||
148877862|NCT00348309|537028688|FG002|Overall Study|Participant died|1|||
148877863|NCT00348309|537028686|FG000|Overall Study|Decision of sponsor|1|||
148877864|NCT00348309|537028687|FG001|Overall Study|Decision of sponsor|0|||
148877865|NCT00348309|537028688|FG002|Overall Study|Decision of sponsor|0|||
148877866|NCT00348309|537028686|FG000|Overall Study|Ineffectiveness of treatment|0|||
148877867|NCT00348309|537028687|FG001|Overall Study|Ineffectiveness of treatment|1|||
148877868|NCT00348309|537028688|FG002|Overall Study|Ineffectiveness of treatment|0|||
148877869|NCT00348309|537028686|FG000|Overall Study|A foul of exclusion criteria|0|||
148877870|NCT00348309|537028687|FG001|Overall Study|A foul of exclusion criteria|1|||
148877871|NCT00348309|537028688|FG002|Overall Study|A foul of exclusion criteria|0|||
148877872|NCT00348309|537028686|FG000|Overall Study|Participant was hospitalized|0|||
148877873|NCT00348309|537028687|FG001|Overall Study|Participant was hospitalized|1|||
148877874|NCT00348309|537028688|FG002|Overall Study|Participant was hospitalized|0|||
148877875|NCT00348309|537028686|FG000|Overall Study|Sponsor refuseal|0|||
148877876|NCT00348309|537028687|FG001|Overall Study|Sponsor refuseal|1|||
148877877|NCT00348309|537028688|FG002|Overall Study|Sponsor refuseal|1|||
148877878|NCT00348309|537028686|FG000|Overall Study|Forgot often medication|0|||
148877879|NCT00348309|537028687|FG001|Overall Study|Forgot often medication|1|||
148877880|NCT00348309|537028688|FG002|Overall Study|Forgot often medication|0|||
148877881|NCT00348309|537028686|FG000|Overall Study|Medical Monitor decision|0|||
148877882|NCT00348309|537028687|FG001|Overall Study|Medical Monitor decision|0|||
148877883|NCT00348309|537028688|FG002|Overall Study|Medical Monitor decision|1|||
148877884|NCT00348309|537028686|FG000|Overall Study|Increased dose of Aricept|0|||
148877885|NCT00348309|537028687|FG001|Overall Study|Increased dose of Aricept|0|||
148877886|NCT00348309|537028688|FG002|Overall Study|Increased dose of Aricept|1|||
148877887|NCT00348309|537028686|FG000|Overall Study|Site closure|0|||
148877888|NCT00348309|537028687|FG001|Overall Study|Site closure|0|||
148877889|NCT00348309|537028688|FG002|Overall Study|Site closure|1|||
148877890|NCT00348309|537028686|FG000|Overall Study|Adverse event not attended|0|||
148877891|NCT00348309|537028687|FG001|Overall Study|Adverse event not attended|0|||
148877892|NCT00348309|537028688|FG002|Overall Study|Adverse event not attended|1|||
148877893|NCT00348309|537028686|FG000|Overall Study|ECG abnormal|0|||
148877894|NCT00348309|537028687|FG001|Overall Study|ECG abnormal|0|||
148877895|NCT00348309|537028688|FG002|Overall Study|ECG abnormal|2|||
148877896|NCT00348309|537028686|FG000|Overall Study|Cardiologist recommendations|0|||
148877897|NCT00348309|537028687|FG001|Overall Study|Cardiologist recommendations|0|||
148877898|NCT00348309|537028688|FG002|Overall Study|Cardiologist recommendations|1|||
148877899|NCT00348309|537028686|FG000|Overall Study|HCV career|0|||
148877900|NCT00348309|537028687|FG001|Overall Study|HCV career|0|||
148877901|NCT00348309|537028688|FG002|Overall Study|HCV career|1|||
148877902|NCT00622388|537028689|FG000|Overall Study|Disease Progression|47|||
148877903|NCT00622388|537028689|FG000|Overall Study|Adverse Event|6|||
148877904|NCT00622388|537028689|FG000|Overall Study|Protocol Violation|3|||
148877905|NCT00622388|537028689|FG000|Overall Study|Participant Refusal|1|||
148877906|NCT00622388|537028689|FG000|Overall Study|Death|3|||
148877907|NCT00622388|537028689|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
148877908|NCT00622388|537028689|FG000|Overall Study|Took Prohibited Medication|2|||
148877909|NCT00622388|537028689|FG000|Overall Study|Withdrew Consent|1|||
148877910|NCT00622388|537028689|FG000|Overall Study|Insurance Expired|1|||
148877911|NCT01743040|537028690|FG000|Overall Study|Death|1|||
148877912|NCT01743040|537028690|FG000|Overall Study|Lost to Follow-up|66|||
148877913|NCT01743040|537028690|FG000|Overall Study|Physician Decision|40|||
148877914|NCT01743040|537028690|FG000|Overall Study|Protocol Violation|1|||
148877915|NCT01743040|537028690|FG000|Overall Study|Withdrawal by Subject|121|||
148877916|NCT04006392|537028691|FG000|Overall Study|Lost to Follow-up|0|||
148877917|NCT04006392|537028692|FG001|Overall Study|Lost to Follow-up|1|||
148877918|NCT01299116|537028693|FG000|Overall Study|Lost to Follow-up|65|||
148877919|NCT01299116|537028694|FG001|Overall Study|Lost to Follow-up|9|||
148877920|NCT01299116|537028695|FG002|Overall Study|Lost to Follow-up|11|||
148877921|NCT03043651|537028698|FG000|Overall Study|Death|1|||
148877922|NCT03043651|537028698|FG000|Overall Study|Progressive Disease|2|||
148877923|NCT03043651|537028698|FG000|Overall Study|Adverse Event|2|||
148877924|NCT03043651|537028698|FG000|Overall Study|Withdrawal by Subject|4|||
148877925|NCT03043651|537028698|FG000|Overall Study|Study Terminated by Sponsor|39|||
148877926|NCT02980133|537028699|FG000|Overall Study|Other than specified|1|||
148877927|NCT02980133|537028700|FG001|Overall Study|Other than specified|1|||
148877928|NCT02980133|537028701|FG002|Overall Study|Other than specified|2|||
148877929|NCT02980133|537028702|FG003|Overall Study|Other than specified|2|||
148877930|NCT02980133|537028699|FG000|Overall Study|Lost to Follow-up|0|||
148877931|NCT02980133|537028700|FG001|Overall Study|Lost to Follow-up|0|||
148877932|NCT02980133|537028701|FG002|Overall Study|Lost to Follow-up|1|||
148877933|NCT02980133|537028702|FG003|Overall Study|Lost to Follow-up|3|||
148877934|NCT02980133|537028699|FG000|Overall Study|Protocol Violation|0|||
148877935|NCT02980133|537028700|FG001|Overall Study|Protocol Violation|1|||
148877936|NCT02980133|537028701|FG002|Overall Study|Protocol Violation|0|||
148877937|NCT02980133|537028702|FG003|Overall Study|Protocol Violation|0|||
148877938|NCT02980133|537028699|FG000|Overall Study|Withdrawal by parent/guardian|6|||
148877939|NCT02980133|537028700|FG001|Overall Study|Withdrawal by parent/guardian|3|||
148877940|NCT02980133|537028701|FG002|Overall Study|Withdrawal by parent/guardian|3|||
148877941|NCT02980133|537028702|FG003|Overall Study|Withdrawal by parent/guardian|1|||
148877942|NCT02980133|537028699|FG000|Overall Study|Withdrawal by Subject|0|||
148877943|NCT02980133|537028700|FG001|Overall Study|Withdrawal by Subject|0|||
148877944|NCT02980133|537028701|FG002|Overall Study|Withdrawal by Subject|1|||
148877945|NCT02980133|537028702|FG003|Overall Study|Withdrawal by Subject|0|||
148877946|NCT01068158|537028704|FG000|Overall Study|Withdrawal by Subject|1|||
148877947|NCT01068158|537028705|FG001|Overall Study|Withdrawal by Subject|2|||
148877948|NCT01068158|537028704|FG000|Overall Study|Lost to Follow-up|7|||
148877949|NCT01068158|537028705|FG001|Overall Study|Lost to Follow-up|0|||
148877950|NCT01068158|537028704|FG000|Overall Study|Protocol Violation|0|||
148877951|NCT01068158|537028705|FG001|Overall Study|Protocol Violation|2|||
148877952|NCT02596945|537028706|FG000|Overall Study|No documentation of study drug dosing|3|||
148877953|NCT02596945|537028706|FG000|Overall Study|Other|32|||
148877954|NCT02596945|537028706|FG000|Overall Study|Change to hemodialysis|15|||
148877955|NCT02596945|537028706|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
148877956|NCT02596945|537028706|FG000|Overall Study|Withdrawal by Subject|1|||
148877957|NCT02596945|537028706|FG000|Overall Study|Missing|1|||
148877958|NCT04699461|537028711|FG000|Overall Study|Withdrawal by Subject|1|||
148877959|NCT04699461|537028712|FG001|Overall Study|Withdrawal by Subject|0|||
148877960|NCT04699461|537028711|FG000|Overall Study|Study termination by sponsor|2|||
148877961|NCT04699461|537028712|FG001|Overall Study|Study termination by sponsor|1|||
148877962|NCT04699461|537028711|FG000|Overall Study|Death|1|||
148877963|NCT04699461|537028712|FG001|Overall Study|Death|0|||
148877964|NCT04699461|537028711|FG000|Overall Study|Radiographic progression|0|||
148877965|NCT04699461|537028712|FG001|Overall Study|Radiographic progression|1|||
148877966|NCT03738618|537031366|FG000|Overall Study|Protocol deviation|23|||
148877967|NCT03738618|537031367|FG001|Overall Study|Protocol deviation|0|||
148877968|NCT03738618|537031366|FG000|Overall Study|Adverse Event|4|||
148877969|NCT03738618|537031367|FG001|Overall Study|Adverse Event|0|||
148877970|NCT03738618|537031366|FG000|Overall Study|Lost to Follow-up|2|||
148877971|NCT03738618|537031367|FG001|Overall Study|Lost to Follow-up|0|||
148877972|NCT03738618|537031366|FG000|Overall Study|Randomization failure|1|||
148877973|NCT03738618|537031367|FG001|Overall Study|Randomization failure|0|||
148877974|NCT03738618|537031366|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
148877975|NCT03738618|537031367|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
148877976|NCT03738618|537031366|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
148877977|NCT03738618|537031367|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
148877978|NCT03499314|537031370|FG000|Overall Study|Time Commitment|1|||
148877979|NCT03499314|537031371|FG001|Overall Study|Time Commitment|2|||
148877980|NCT03499314|537031370|FG000|Overall Study|Medical issue unrelated to research study|1|||
148877981|NCT03499314|537031371|FG001|Overall Study|Medical issue unrelated to research study|1|||
148877982|NCT00931606|537031375|FG000|Overall Study|Death|1|||
148877983|NCT00931606|537031376|FG001|Overall Study|Death|3|||
148877984|NCT00931606|537031377|FG002|Overall Study|Death|2|||
148877985|NCT00931606|537031378|FG003|Overall Study|Death|0|||
148877986|NCT00931606|537031375|FG000|Overall Study|Lost to Follow-up|0|||
148877987|NCT00931606|537031376|FG001|Overall Study|Lost to Follow-up|1|||
148877988|NCT00931606|537031377|FG002|Overall Study|Lost to Follow-up|0|||
148877989|NCT00931606|537031378|FG003|Overall Study|Lost to Follow-up|0|||
148877990|NCT00931606|537031375|FG000|Overall Study|Physician Decision|0|||
148877991|NCT00931606|537031376|FG001|Overall Study|Physician Decision|0|||
148877992|NCT00931606|537031377|FG002|Overall Study|Physician Decision|3|||
148877993|NCT00931606|537031378|FG003|Overall Study|Physician Decision|0|||
148877994|NCT00931606|537031375|FG000|Overall Study|Sponsor Decision|1|||
148877995|NCT00931606|537031376|FG001|Overall Study|Sponsor Decision|4|||
148877996|NCT00931606|537031377|FG002|Overall Study|Sponsor Decision|0|||
148877997|NCT00931606|537031378|FG003|Overall Study|Sponsor Decision|2|||
148877998|NCT00931606|537031375|FG000|Overall Study|Withdrawal by Subject|3|||
148877999|NCT00931606|537031376|FG001|Overall Study|Withdrawal by Subject|1|||
148878000|NCT00931606|537031377|FG002|Overall Study|Withdrawal by Subject|1|||
148878001|NCT00931606|537031378|FG003|Overall Study|Withdrawal by Subject|1|||
148878002|NCT00871338|537031379|FG000|Prior to Booster|Withdrawal by Subject|1|||
148878003|NCT00871338|537031380|FG001|Prior to Booster|Withdrawal by Subject|3|||
148878004|NCT00871338|537031379|FG000|Prior to Booster|Lost to Follow-up|1|||
148878005|NCT00871338|537031380|FG001|Prior to Booster|Lost to Follow-up|0|||
148878006|NCT01016600|537031381|FG000|Overall Study|Did not start treatment|1|||
148878007|NCT01016600|537031382|FG001|Overall Study|Did not start treatment|0|||
148878008|NCT01016600|537031383|FG002|Overall Study|Did not start treatment|0|||
148878009|NCT01016600|537031384|FG003|Overall Study|Did not start treatment|0|||
148878010|NCT00872599|537031385|FG000|Second Washout Period|Adverse Event|1|||
148878011|NCT00872599|537031386|FG001|Second Washout Period|Adverse Event|1|||
148878012|NCT04794270|537031387|FG000|Period 1|Non Compliance|1|||
148878013|NCT04794270|537031388|FG001|Period 1|Non Compliance|0|||
148878014|NCT04794270|537031387|FG000|Period 1|Adverse Event|1|||
148878015|NCT04794270|537031388|FG001|Period 1|Adverse Event|0|||
148878016|NCT04794270|537031387|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
148878017|NCT04794270|537031388|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
148878018|NCT00801229|537031391|FG000|Signed Consent|Withdrawal by Subject|2|||
148878019|NCT00801229|537031392|FG001|Signed Consent|Withdrawal by Subject|2|||
148878020|NCT00801229|537031391|FG000|Signed Consent|Found Ineligible|1|||
148878021|NCT00801229|537031392|FG001|Signed Consent|Found Ineligible|1|||
148878022|NCT00801229|537031391|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
148878023|NCT00801229|537031392|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
148878024|NCT00801229|537031391|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
148878025|NCT00801229|537031392|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
148878026|NCT00801229|537031391|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
148878027|NCT00801229|537031392|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
148878028|NCT00801229|537031391|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
148878029|NCT00801229|537031392|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
148878030|NCT00801229|537031391|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
148878031|NCT00801229|537031392|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
148878032|NCT00801229|537031391|FG000|Received Study Drug/Placebo|Adverse Event|1|||
148878033|NCT00801229|537031392|FG001|Received Study Drug/Placebo|Adverse Event|1|||
148878034|NCT03826186|537031393|FG000|Overall Study|Protocol Violation|2|||
148878035|NCT03826186|537031394|FG001|Overall Study|Protocol Violation|0|||
148878036|NCT03826186|537031393|FG000|Overall Study|Withdrawal by Subject|1|||
148878037|NCT03826186|537031394|FG001|Overall Study|Withdrawal by Subject|0|||
148878038|NCT02510001|537031395|FG000|Overall Study|Early disease progression|0|||
148878039|NCT02510001|537031396|FG001|Overall Study|Early disease progression|0|||
148878040|NCT02510001|537031397|FG002|Overall Study|Early disease progression|0|||
148878041|NCT02510001|537031398|FG003|Overall Study|Early disease progression|1|||
148878042|NCT02510001|537031399|FG004|Overall Study|Early disease progression|1|||
148878043|NCT02510001|537031400|FG005|Overall Study|Early disease progression|1|||
148878044|NCT02510001|537031401|FG006|Overall Study|Early disease progression|0|||
148878045|NCT02510001|537031402|FG007|Overall Study|Early disease progression|0|||
148878046|NCT02510001|537031395|FG000|Overall Study|Adverse Event|0|||
148878047|NCT02510001|537031396|FG001|Overall Study|Adverse Event|0|||
148878048|NCT02510001|537031397|FG002|Overall Study|Adverse Event|0|||
148878049|NCT02510001|537031398|FG003|Overall Study|Adverse Event|1|||
148878050|NCT02510001|537031399|FG004|Overall Study|Adverse Event|2|||
148878051|NCT02510001|537031400|FG005|Overall Study|Adverse Event|1|||
148878052|NCT02510001|537031401|FG006|Overall Study|Adverse Event|2|||
148878053|NCT02510001|537031402|FG007|Overall Study|Adverse Event|5|||
148878054|NCT02510001|537031395|FG000|Overall Study|Physician Decision|0|||
148878055|NCT02510001|537031396|FG001|Overall Study|Physician Decision|0|||
148878056|NCT02510001|537031397|FG002|Overall Study|Physician Decision|0|||
148878057|NCT02510001|537031398|FG003|Overall Study|Physician Decision|0|||
148878058|NCT02510001|537031399|FG004|Overall Study|Physician Decision|1|||
148878059|NCT02510001|537031400|FG005|Overall Study|Physician Decision|0|||
148878060|NCT02510001|537031401|FG006|Overall Study|Physician Decision|0|||
148878061|NCT02510001|537031402|FG007|Overall Study|Physician Decision|0|||
148878062|NCT02510001|537031395|FG000|Overall Study|Withdrawal by Subject|0|||
148878063|NCT02510001|537031396|FG001|Overall Study|Withdrawal by Subject|0|||
148878064|NCT02510001|537031397|FG002|Overall Study|Withdrawal by Subject|0|||
148878065|NCT02510001|537031398|FG003|Overall Study|Withdrawal by Subject|0|||
148878066|NCT02510001|537031399|FG004|Overall Study|Withdrawal by Subject|0|||
148878067|NCT02510001|537031400|FG005|Overall Study|Withdrawal by Subject|0|||
148878068|NCT02510001|537031401|FG006|Overall Study|Withdrawal by Subject|0|||
148878069|NCT02510001|537031402|FG007|Overall Study|Withdrawal by Subject|2|||
148878070|NCT01504841|537031408|FG000|Overall Study|Withdrawal by Subject|1|||
148878071|NCT01504841|537031409|FG001|Overall Study|Withdrawal by Subject|1|||
148878072|NCT01504841|537031410|FG002|Overall Study|Withdrawal by Subject|0|||
148878073|NCT04440813|537031413|FG000|Overall Study|Lost to Follow-up|5|||
148878074|NCT04440813|537031414|FG001|Overall Study|Lost to Follow-up|5|||
148878075|NCT00291018|537031419|FG000|Overall Study|Not Consented or Declined PAS|12|||
148878076|NCT00291018|537031420|FG001|Overall Study|Not Consented or Declined PAS|15|||
148878077|NCT00291018|537031421|FG002|Overall Study|Not Consented or Declined PAS|15|||
148878078|NCT00291018|537031419|FG000|Overall Study|Death|3|||
148878079|NCT00291018|537031420|FG001|Overall Study|Death|3|||
148878080|NCT00291018|537031421|FG002|Overall Study|Death|4|||
148878081|NCT00291018|537031419|FG000|Overall Study|Withdrawal by Subject|2|||
148878082|NCT00291018|537031420|FG001|Overall Study|Withdrawal by Subject|8|||
148878083|NCT00291018|537031421|FG002|Overall Study|Withdrawal by Subject|1|||
148878084|NCT00291018|537031419|FG000|Overall Study|Failures|5|||
148878085|NCT00291018|537031420|FG001|Overall Study|Failures|12|||
148878086|NCT00291018|537031421|FG002|Overall Study|Failures|5|||
148878087|NCT00291018|537031419|FG000|Overall Study|Lost to Follow-up|3|||
148878088|NCT00291018|537031420|FG001|Overall Study|Lost to Follow-up|4|||
148878089|NCT00291018|537031421|FG002|Overall Study|Lost to Follow-up|18|||
148878090|NCT02219334|537031423|FG000|Overall Study|Withdrawal by Subject|1|||
148878091|NCT02219334|537031424|FG001|Overall Study|Withdrawal by Subject|0|||
148878092|NCT02219334|537031423|FG000|Overall Study|Protocol Violation|7|||
148878093|NCT02219334|537031424|FG001|Overall Study|Protocol Violation|3|||
148878094|NCT05362058|537031425|FG000|Treatment Period|Adverse Event|3|||
148878095|NCT05362058|537031426|FG001|Treatment Period|Adverse Event|3|||
148878096|NCT05362058|537031425|FG000|Treatment Period|Assigned treatment by mistake|3|||
148878097|NCT05362058|537031426|FG001|Treatment Period|Assigned treatment by mistake|4|||
148878098|NCT05362058|537031425|FG000|Treatment Period|Death|1|||
148878099|NCT05362058|537031426|FG001|Treatment Period|Death|1|||
148878100|NCT05362058|537031425|FG000|Treatment Period|Lost to Follow-up|6|||
148878101|NCT05362058|537031426|FG001|Treatment Period|Lost to Follow-up|3|||
148878102|NCT05362058|537031425|FG000|Treatment Period|Non-compliance with study drug|0|||
148878103|NCT05362058|537031426|FG001|Treatment Period|Non-compliance with study drug|1|||
148878104|NCT05362058|537031425|FG000|Treatment Period|Physician Decision|1|||
148878105|NCT05362058|537031426|FG001|Treatment Period|Physician Decision|0|||
148878106|NCT05362058|537031425|FG000|Treatment Period|Protocol deviation|1|||
148878107|NCT05362058|537031426|FG001|Treatment Period|Protocol deviation|0|||
148878108|NCT05362058|537031425|FG000|Treatment Period|Withdrawal by Subject|10|||
148878109|NCT05362058|537031426|FG001|Treatment Period|Withdrawal by Subject|11|||
148878110|NCT05362058|537031425|FG000|Follow-Up Period|Death|1|||
148878111|NCT05362058|537031426|FG001|Follow-Up Period|Death|0|||
148878112|NCT05362058|537031425|FG000|Follow-Up Period|Lost to Follow-up|2|||
148878113|NCT05362058|537031426|FG001|Follow-Up Period|Lost to Follow-up|1|||
148878114|NCT05362058|537031425|FG000|Follow-Up Period|Protocol deviation|1|||
148878115|NCT05362058|537031426|FG001|Follow-Up Period|Protocol deviation|1|||
148878116|NCT05362058|537031425|FG000|Follow-Up Period|Withdrawal by Subject|0|||
148878117|NCT05362058|537031426|FG001|Follow-Up Period|Withdrawal by Subject|3|||
148878118|NCT04774926|537031428|FG000|Overall Study|Adverse Event|15|||
148878119|NCT04774926|537031428|FG000|Overall Study|Lost to Follow-up|3|||
148878120|NCT04774926|537031428|FG000|Overall Study|Physician Decision|6|||
148878121|NCT04774926|537031428|FG000|Overall Study|Withdrawal by Subject|3|||
148878122|NCT04774926|537031428|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
148878123|NCT00787189|537031429|FG000|Overall Study|Lost to Follow-up|2|||
148878124|NCT00787189|537031430|FG001|Overall Study|Lost to Follow-up|2|||
148878125|NCT04207060|537031433|FG000|Overall Study|Lost to Follow-up|2|||
148878126|NCT04207060|537031434|FG001|Overall Study|Lost to Follow-up|0|||
148878127|NCT02524158|537031435|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
148878128|NCT02524158|537031436|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
148878129|NCT02524158|537031435|FG000|12-weeks Assessment|Lost to Follow-up|18|||
148878130|NCT02524158|537031436|FG001|12-weeks Assessment|Lost to Follow-up|12|||
148878131|NCT02524158|537031435|FG000|6-month Assessment|Withdrawal by Subject|1|||
148878132|NCT02524158|537031436|FG001|6-month Assessment|Withdrawal by Subject|1|||
148878133|NCT02524158|537031435|FG000|6-month Assessment|Lost to Follow-up|21|||
148878134|NCT02524158|537031436|FG001|6-month Assessment|Lost to Follow-up|20|||
148878135|NCT00774800|537031440|FG000|Intervention 4|Withdrawal by Subject|1|||
148878136|NCT01973998|537031445|FG000|Overall Study|Death|2|||
148878137|NCT01973998|537031446|FG001|Overall Study|Death|2|||
148878138|NCT00646399|537031447|FG000|Overall Study|Death|63|||
148878139|NCT00646399|537031448|FG001|Overall Study|Death|53|||
148878140|NCT00646399|537031447|FG000|Overall Study|Withdrawal by Subject|9|||
148878141|NCT00646399|537031448|FG001|Overall Study|Withdrawal by Subject|10|||
148878142|NCT00646399|537031447|FG000|Overall Study|Other Reason|11|||
148878143|NCT00646399|537031448|FG001|Overall Study|Other Reason|11|||
148878144|NCT04929249|537031453|FG000|Overall Study|Adverse Event|2|||
148878145|NCT04929249|537031454|FG001|Overall Study|Adverse Event|1|||
148878146|NCT04929249|537031453|FG000|Overall Study|Death|2|||
148878147|NCT04929249|537031454|FG001|Overall Study|Death|1|||
148878148|NCT04929249|537031453|FG000|Overall Study|Lost to Follow-up|3|||
148878149|NCT04929249|537031454|FG001|Overall Study|Lost to Follow-up|11|||
148878150|NCT04929249|537031453|FG000|Overall Study|Technical problems|0|||
148878151|NCT04929249|537031454|FG001|Overall Study|Technical problems|1|||
148878152|NCT04929249|537031453|FG000|Overall Study|Subject decision|6|||
148878153|NCT04929249|537031454|FG001|Overall Study|Subject decision|8|||
148878154|NCT04929249|537031453|FG000|Overall Study|Withdrew consent|0|||
148878155|NCT04929249|537031454|FG001|Overall Study|Withdrew consent|8|||
148878156|NCT02540993|537031455|FG000|Overall Study|Lost to Follow-up|5|||
148878157|NCT02540993|537031456|FG001|Overall Study|Lost to Follow-up|3|||
148878158|NCT02540993|537031455|FG000|Overall Study|Withdrawal by Subject|4|||
148878159|NCT02540993|537031456|FG001|Overall Study|Withdrawal by Subject|6|||
148878160|NCT02540993|537031455|FG000|Overall Study|GCP violations|33|||
148878161|NCT02540993|537031456|FG001|Overall Study|GCP violations|27|||
148878162|NCT02951429|537031463|FG000|Overall Study|Adverse Event|3|||
148878163|NCT02951429|537031464|FG001|Overall Study|Adverse Event|7|||
148878164|NCT02951429|537031463|FG000|Overall Study|Death|28|||
148878165|NCT02951429|537031464|FG001|Overall Study|Death|36|||
148878166|NCT02951429|537031463|FG000|Overall Study|Lack of Efficacy|0|||
148878167|NCT02951429|537031464|FG001|Overall Study|Lack of Efficacy|1|||
148878168|NCT02951429|537031463|FG000|Overall Study|Lost to Follow-up|0|||
148878169|NCT02951429|537031464|FG001|Overall Study|Lost to Follow-up|1|||
148878170|NCT02951429|537031463|FG000|Overall Study|Lung Transplantation|9|||
148878171|NCT02951429|537031464|FG001|Overall Study|Lung Transplantation|6|||
148878172|NCT02951429|537031463|FG000|Overall Study|Other|1|||
148878173|NCT02951429|537031464|FG001|Overall Study|Other|3|||
148878174|NCT02951429|537031463|FG000|Overall Study|Progressive Disease|1|||
148878175|NCT02951429|537031464|FG001|Overall Study|Progressive Disease|1|||
148878176|NCT02951429|537031463|FG000|Overall Study|Withdrawal by Subject|7|||
148878177|NCT02951429|537031464|FG001|Overall Study|Withdrawal by Subject|11|||
148878178|NCT02951429|537031463|FG000|Overall Study|Participant ongoing in the study|23|||
148878179|NCT02951429|537031464|FG001|Overall Study|Participant ongoing in the study|17|||
148878180|NCT01620528|537031465|FG000|Treatment Period|Did Not Receive Study Drug|0|||
148878181|NCT01620528|537031466|FG001|Treatment Period|Did Not Receive Study Drug|0|||
148878182|NCT01620528|537031467|FG002|Treatment Period|Did Not Receive Study Drug|1|||
148878183|NCT01620528|537031465|FG000|Treatment Period|Withdrawal by Subject|35|||
148878184|NCT01620528|537031466|FG001|Treatment Period|Withdrawal by Subject|21|||
148878185|NCT01620528|537031467|FG002|Treatment Period|Withdrawal by Subject|16|||
148878186|NCT01620528|537031465|FG000|Treatment Period|Adverse Event|17|||
148878187|NCT01620528|537031466|FG001|Treatment Period|Adverse Event|13|||
148878188|NCT01620528|537031467|FG002|Treatment Period|Adverse Event|21|||
148878189|NCT01620528|537031465|FG000|Treatment Period|Lost to Follow-up|16|||
148878190|NCT01620528|537031466|FG001|Treatment Period|Lost to Follow-up|8|||
148878191|NCT01620528|537031467|FG002|Treatment Period|Lost to Follow-up|14|||
148878192|NCT01620528|537031465|FG000|Treatment Period|Other|9|||
148878193|NCT01620528|537031466|FG001|Treatment Period|Other|5|||
148878194|NCT01620528|537031467|FG002|Treatment Period|Other|7|||
148878195|NCT01620528|537031465|FG000|Treatment Period|Subject Noncompliant|11|||
148878196|NCT01620528|537031466|FG001|Treatment Period|Subject Noncompliant|2|||
148878197|NCT01620528|537031467|FG002|Treatment Period|Subject Noncompliant|2|||
148878198|NCT01620528|537031465|FG000|Treatment Period|Pregnancy|7|||
148878199|NCT01620528|537031466|FG001|Treatment Period|Pregnancy|2|||
148878200|NCT01620528|537031467|FG002|Treatment Period|Pregnancy|2|||
148878201|NCT01620528|537031465|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
148878202|NCT01620528|537031466|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
148878203|NCT01620528|537031467|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
148878204|NCT01620528|537031465|FG000|Treatment Period|Exclusionary Medication Received|0|||
148878205|NCT01620528|537031466|FG001|Treatment Period|Exclusionary Medication Received|1|||
148878206|NCT01620528|537031467|FG002|Treatment Period|Exclusionary Medication Received|0|||
148878207|NCT01620528|537031465|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
148878208|NCT01620528|537031466|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
148878209|NCT01620528|537031467|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
148878210|NCT01620528|537031465|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
148878211|NCT01620528|537031466|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
148878212|NCT01620528|537031467|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
148878213|NCT01620528|537031465|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
148878214|NCT01620528|537031466|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
148878215|NCT01620528|537031467|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
148878216|NCT01620528|537031465|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
148878217|NCT01620528|537031466|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
148878218|NCT01620528|537031467|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
148878219|NCT01620528|537031465|FG000|Post-Treatment Follow-Up Period|Other|6|||
148878220|NCT01620528|537031466|FG001|Post-Treatment Follow-Up Period|Other|4|||
148878221|NCT01620528|537031467|FG002|Post-Treatment Follow-Up Period|Other|2|||
148878222|NCT02202538|537031468|FG000|Overall Study|Withdrawal by Subject|5|||
148878223|NCT02202538|537031468|FG000|Overall Study|Did not meet all inclusion criteria|2|||
148878224|NCT02202538|537031468|FG000|Overall Study|Investigator Decision|1|||
148878225|NCT01457846|537031469|FG000|Overall Study|Death before treatment|1|||
148878226|NCT01457846|537031470|FG001|Overall Study|Death before treatment|2|||
148878227|NCT01457846|537031469|FG000|Overall Study|Did not receive treatment|0|||
148878228|NCT01457846|537031470|FG001|Overall Study|Did not receive treatment|1|||
148878229|NCT01457846|537031469|FG000|Overall Study|Death|27|||
148878230|NCT01457846|537031470|FG001|Overall Study|Death|16|||
148878231|NCT01457846|537031469|FG000|Overall Study|Unclassified reason for not completed|11|||
148878232|NCT01457846|537031470|FG001|Overall Study|Unclassified reason for not completed|10|||
148878233|NCT01457846|537031469|FG000|Overall Study|Withdrawal by Subject|1|||
148878234|NCT01457846|537031470|FG001|Overall Study|Withdrawal by Subject|1|||
148878235|NCT01457846|537031469|FG000|Overall Study|Lost to Follow-up|1|||
148878236|NCT01457846|537031470|FG001|Overall Study|Lost to Follow-up|0|||
148878237|NCT01846741|537031471|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
148878238|NCT01853878|537031472|FG000|Overall Study|Recurrence|2|||
148878239|NCT01853878|537031473|FG001|Overall Study|Recurrence|0|||
148878240|NCT01853878|537031472|FG000|Overall Study|Adverse Event|2|||
148878241|NCT01853878|537031473|FG001|Overall Study|Adverse Event|0|||
148878242|NCT01853878|537031472|FG000|Overall Study|Withdrawal by Subject|3|||
148878243|NCT01853878|537031473|FG001|Overall Study|Withdrawal by Subject|1|||
148878244|NCT01853878|537031472|FG000|Overall Study|Migrated/moved from the study area|1|||
148878245|NCT01853878|537031473|FG001|Overall Study|Migrated/moved from the study area|0|||
148878246|NCT01853878|537031472|FG000|Overall Study|Other|55|||
148878247|NCT01853878|537031473|FG001|Overall Study|Other|43|||
148878248|NCT03997825|537031474|FG000|Overall Study|Death|3|||
148878249|NCT03997825|537031474|FG000|Overall Study|Lost to Follow-up|10|||
148878250|NCT03997825|537031474|FG000|Overall Study|Withdrawal by Subject|3|||
148878251|NCT03997825|537031474|FG000|Overall Study|Refused participation|1|||
148878252|NCT00383162|537031475|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
148878253|NCT00383162|537031476|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
148878254|NCT00383162|537031475|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
148878255|NCT00383162|537031476|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
148878256|NCT00383162|537031475|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
148878257|NCT00383162|537031476|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
148878258|NCT00383162|537031475|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
148878259|NCT00383162|537031476|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
148878260|NCT00383162|537031475|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
148878261|NCT00383162|537031476|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
148878262|NCT00383162|537031475|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
148878263|NCT00383162|537031476|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
148878264|NCT00383162|537031475|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
148878265|NCT00383162|537031476|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
148878266|NCT00383162|537031475|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
148878267|NCT00383162|537031476|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
148878268|NCT00383162|537031475|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
148878269|NCT00383162|537031476|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
148878270|NCT01153698|537031477|FG000|Overall Study|Adverse Event|12|||
148878271|NCT01153698|537031477|FG000|Overall Study|Lost to Follow-up|4|||
148878272|NCT01153698|537031477|FG000|Overall Study|Withdrawal by Subject|2|||
148878273|NCT01153698|537031477|FG000|Overall Study|Switch to other anticoagulants|4|||
148878274|NCT01153698|537031477|FG000|Overall Study|Other|2|||
148878275|NCT01153698|537031477|FG000|Overall Study|Not treated with Pradaxa|5|||
148878276|NCT00767819|537031478|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
148878277|NCT00767819|537031479|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
148878278|NCT00767819|537031480|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
148878279|NCT00767819|537031478|FG000|Overall Study|Withdrawal by Subject|1|||
148878280|NCT00767819|537031479|FG001|Overall Study|Withdrawal by Subject|1|||
148878281|NCT00767819|537031480|FG002|Overall Study|Withdrawal by Subject|0|||
148878282|NCT00767819|537031478|FG000|Overall Study|Administrative problems|0|||
148878283|NCT00767819|537031479|FG001|Overall Study|Administrative problems|1|||
148878284|NCT00767819|537031480|FG002|Overall Study|Administrative problems|0|||
148878285|NCT00767819|537031478|FG000|Overall Study|Death|2|||
148878286|NCT00767819|537031479|FG001|Overall Study|Death|3|||
148878287|NCT00767819|537031480|FG002|Overall Study|Death|0|||
148878288|NCT00767819|537031478|FG000|Overall Study|Adverse Event|2|||
148878289|NCT00767819|537031479|FG001|Overall Study|Adverse Event|0|||
148878290|NCT00767819|537031480|FG002|Overall Study|Adverse Event|0|||
148878291|NCT00767819|537031478|FG000|Overall Study|Abnormal lab values|1|||
148878292|NCT00767819|537031479|FG001|Overall Study|Abnormal lab values|0|||
148878293|NCT00767819|537031480|FG002|Overall Study|Abnormal lab values|0|||
148878294|NCT00767819|537031478|FG000|Overall Study|Lost to Follow-up|1|||
148878295|NCT00767819|537031479|FG001|Overall Study|Lost to Follow-up|0|||
148878296|NCT00767819|537031480|FG002|Overall Study|Lost to Follow-up|0|||
148878297|NCT02332291|537031488|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
148878298|NCT02332291|537031489|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
148878299|NCT02332291|537031488|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
148878300|NCT02332291|537031489|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
148878301|NCT02332291|537031488|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
148878302|NCT02332291|537031489|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
148878303|NCT02332291|537031488|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
148878304|NCT02332291|537031489|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
148878305|NCT02332291|537031488|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
148878306|NCT02332291|537031489|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
148878307|NCT02332291|537031488|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
148878308|NCT02332291|537031489|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
148878309|NCT00465647|537031490|FG000|Overall Study|Administrative|2|||
148878310|NCT00465647|537031491|FG001|Overall Study|Administrative|2|||
148878311|NCT00465647|537031492|FG002|Overall Study|Administrative|3|||
148878312|NCT00465647|537031493|FG003|Overall Study|Administrative|2|||
148878313|NCT00465647|537031490|FG000|Overall Study|Adverse Event|2|||
148878314|NCT00465647|537031491|FG001|Overall Study|Adverse Event|0|||
148878315|NCT00465647|537031492|FG002|Overall Study|Adverse Event|3|||
148878316|NCT00465647|537031493|FG003|Overall Study|Adverse Event|2|||
148878317|NCT00465647|537031490|FG000|Overall Study|Withdrawal by Subject|1|||
148878318|NCT00465647|537031491|FG001|Overall Study|Withdrawal by Subject|2|||
148878319|NCT00465647|537031492|FG002|Overall Study|Withdrawal by Subject|2|||
148878320|NCT00465647|537031493|FG003|Overall Study|Withdrawal by Subject|7|||
148878321|NCT00465647|537031490|FG000|Overall Study|"The other reasons included loss of IV"|8|||
148878322|NCT00465647|537031491|FG001|Overall Study|"The other reasons included loss of IV"|4|||
148878323|NCT00465647|537031492|FG002|Overall Study|"The other reasons included loss of IV"|3|||
148878324|NCT00465647|537031493|FG003|Overall Study|"The other reasons included loss of IV"|2|||
148878325|NCT00699335|537031494|FG000|Overall Study|Combination of multiple reasons|176|||
148878326|NCT00699335|537031494|FG000|Overall Study|Missing data|52|||
148878327|NCT01371305|537031499|FG000|Overall Study|Adverse Event|0|||
148878328|NCT01371305|537031500|FG001|Overall Study|Adverse Event|0|||
148878329|NCT01371305|537031501|FG002|Overall Study|Adverse Event|0|||
148878330|NCT01371305|537031502|FG003|Overall Study|Adverse Event|2|||
148878331|NCT01371305|537031503|FG004|Overall Study|Adverse Event|1|||
148878332|NCT01371305|537031504|FG005|Overall Study|Adverse Event|0|||
148878333|NCT01371305|537031499|FG000|Overall Study|Study terminated by sponsor|0|||
148878334|NCT01371305|537031500|FG001|Overall Study|Study terminated by sponsor|0|||
148878335|NCT01371305|537031501|FG002|Overall Study|Study terminated by sponsor|0|||
148878336|NCT01371305|537031502|FG003|Overall Study|Study terminated by sponsor|0|||
148878337|NCT01371305|537031503|FG004|Overall Study|Study terminated by sponsor|3|||
148878338|NCT01371305|537031504|FG005|Overall Study|Study terminated by sponsor|1|||
148878339|NCT01371305|537031499|FG000|Overall Study|Subject request|0|||
148878340|NCT01371305|537031500|FG001|Overall Study|Subject request|0|||
148878341|NCT01371305|537031501|FG002|Overall Study|Subject request|0|||
148878342|NCT01371305|537031502|FG003|Overall Study|Subject request|0|||
148878343|NCT01371305|537031503|FG004|Overall Study|Subject request|0|||
148878344|NCT01371305|537031504|FG005|Overall Study|Subject request|1|||
148878345|NCT04038567|537031505|FG000|Overall Study|Lost to Follow-up|6|||
148878346|NCT04038567|537031506|FG001|Overall Study|Lost to Follow-up|4|||
148878347|NCT04038567|537031507|FG002|Overall Study|Lost to Follow-up|5|||
148878348|NCT04038567|537031508|FG003|Overall Study|Lost to Follow-up|4|||
148878349|NCT04038567|537031509|FG004|Overall Study|Lost to Follow-up|6|||
148878350|NCT04038567|537031510|FG005|Overall Study|Lost to Follow-up|4|||
148878351|NCT04038567|537031511|FG006|Overall Study|Lost to Follow-up|4|||
148878352|NCT04038567|537031512|FG007|Overall Study|Lost to Follow-up|1|||
148878353|NCT04038567|537031505|FG000|Overall Study|Withdrawal by Subject|2|||
148878354|NCT04038567|537031506|FG001|Overall Study|Withdrawal by Subject|1|||
148878355|NCT04038567|537031507|FG002|Overall Study|Withdrawal by Subject|1|||
148878356|NCT04038567|537031508|FG003|Overall Study|Withdrawal by Subject|1|||
148878357|NCT04038567|537031509|FG004|Overall Study|Withdrawal by Subject|4|||
148878358|NCT04038567|537031510|FG005|Overall Study|Withdrawal by Subject|1|||
148878359|NCT04038567|537031511|FG006|Overall Study|Withdrawal by Subject|1|||
148878360|NCT04038567|537031512|FG007|Overall Study|Withdrawal by Subject|1|||
148878361|NCT04038567|537031505|FG000|Overall Study|missed survey window|1|||
148878362|NCT04038567|537031506|FG001|Overall Study|missed survey window|2|||
148878363|NCT04038567|537031507|FG002|Overall Study|missed survey window|0|||
148878364|NCT04038567|537031508|FG003|Overall Study|missed survey window|0|||
148878365|NCT04038567|537031509|FG004|Overall Study|missed survey window|1|||
148878366|NCT04038567|537031510|FG005|Overall Study|missed survey window|1|||
148878367|NCT04038567|537031511|FG006|Overall Study|missed survey window|2|||
148878368|NCT04038567|537031512|FG007|Overall Study|missed survey window|2|||
148878369|NCT04038567|537031505|FG000|Overall Study|technical issues|0|||
148878370|NCT04038567|537031506|FG001|Overall Study|technical issues|0|||
148878371|NCT04038567|537031507|FG002|Overall Study|technical issues|0|||
148878372|NCT04038567|537031508|FG003|Overall Study|technical issues|0|||
148878373|NCT04038567|537031509|FG004|Overall Study|technical issues|0|||
148878374|NCT04038567|537031510|FG005|Overall Study|technical issues|0|||
148878375|NCT04038567|537031511|FG006|Overall Study|technical issues|1|||
148878376|NCT04038567|537031512|FG007|Overall Study|technical issues|0|||
148878377|NCT04038567|537031505|FG000|Overall Study|Medical issues (i.e., illness)|0|||
148878378|NCT04038567|537031506|FG001|Overall Study|Medical issues (i.e., illness)|1|||
148878379|NCT04038567|537031507|FG002|Overall Study|Medical issues (i.e., illness)|2|||
148878380|NCT04038567|537031508|FG003|Overall Study|Medical issues (i.e., illness)|1|||
148878381|NCT04038567|537031509|FG004|Overall Study|Medical issues (i.e., illness)|1|||
148878382|NCT04038567|537031510|FG005|Overall Study|Medical issues (i.e., illness)|1|||
148878383|NCT04038567|537031511|FG006|Overall Study|Medical issues (i.e., illness)|0|||
148878384|NCT04038567|537031512|FG007|Overall Study|Medical issues (i.e., illness)|0|||
148878385|NCT04038567|537031505|FG000|Overall Study|Death|0|||
148878386|NCT04038567|537031506|FG001|Overall Study|Death|0|||
148878387|NCT04038567|537031507|FG002|Overall Study|Death|0|||
148878388|NCT04038567|537031508|FG003|Overall Study|Death|1|||
148878389|NCT04038567|537031509|FG004|Overall Study|Death|1|||
148878390|NCT04038567|537031510|FG005|Overall Study|Death|0|||
148878391|NCT04038567|537031511|FG006|Overall Study|Death|0|||
148878392|NCT04038567|537031512|FG007|Overall Study|Death|1|||
148878393|NCT02220712|537031513|FG000|Overall Study|Adverse Event|1|||
148878394|NCT02220712|537031513|FG000|Overall Study|Withdrawal by Subject|2|||
148878395|NCT02220712|537031513|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
148878396|NCT00760838|537031517|FG000|Overall Study|Adverse Event|1|||
148878397|NCT00760838|537031518|FG001|Overall Study|Adverse Event|1|||
148878398|NCT00760838|537031517|FG000|Overall Study|Lack of Efficacy|1|||
148878399|NCT00760838|537031518|FG001|Overall Study|Lack of Efficacy|0|||
148878400|NCT00760838|537031517|FG000|Overall Study|Lost to Follow-up|2|||
148878401|NCT00760838|537031518|FG001|Overall Study|Lost to Follow-up|0|||
148878402|NCT00760838|537031517|FG000|Overall Study|Withdrawal by Subject|1|||
148878403|NCT00760838|537031518|FG001|Overall Study|Withdrawal by Subject|1|||
148878404|NCT01817959|537031519|FG000|Overall Study|Graft loss|1|||
148878405|NCT01817959|537031520|FG001|Overall Study|Graft loss|1|||
148878406|NCT01817959|537031519|FG000|Overall Study|forbidden medication|1|||
148878407|NCT01817959|537031520|FG001|Overall Study|forbidden medication|1|||
148878408|NCT01817959|537031519|FG000|Overall Study|Adverse Event|1|||
148878409|NCT01817959|537031520|FG001|Overall Study|Adverse Event|0|||
148878410|NCT01817959|537031519|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
148878411|NCT01817959|537031520|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
148878412|NCT01628965|537031527|FG000|Overall Study|Adverse Event|30|||
148878413|NCT01628965|537031527|FG000|Overall Study|Lack of Efficacy|7|||
148878414|NCT01628965|537031527|FG000|Overall Study|Withdrawal by Subject|3|||
148878415|NCT01628965|537031527|FG000|Overall Study|Lost to Follow-up|1|||
148878416|NCT01628965|537031527|FG000|Overall Study|Discontinuation criteria|8|||
148878417|NCT00330681|537031528|FG000|Overall Study|Adverse Event|3|||
148878418|NCT00330681|537031529|FG001|Overall Study|Adverse Event|6|||
148878419|NCT00330681|537031528|FG000|Overall Study|Protocol Violation|0|||
148878420|NCT00330681|537031529|FG001|Overall Study|Protocol Violation|1|||
148878421|NCT00330681|537031528|FG000|Overall Study|Withdrawal by Subject|5|||
148878422|NCT00330681|537031529|FG001|Overall Study|Withdrawal by Subject|5|||
148878423|NCT00330681|537031528|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
148878424|NCT00330681|537031529|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
148878425|NCT02160145|537031530|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
148878426|NCT02160145|537031531|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
148878427|NCT02160145|537031532|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
148878428|NCT02160145|537031530|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
148878429|NCT02160145|537031531|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
148878430|NCT02160145|537031532|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
148878431|NCT02160145|537031530|FG000|Randomized Double-blind Period|Subject decision|0|||
148878432|NCT02160145|537031531|FG001|Randomized Double-blind Period|Subject decision|21|||
148878433|NCT02160145|537031532|FG002|Randomized Double-blind Period|Subject decision|20|||
148878434|NCT02160145|537031530|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
148878435|NCT02160145|537031531|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
148878436|NCT02160145|537031532|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
148878437|NCT02160145|537031530|FG000|Randomized Double-blind Period|Physician Decision|0|||
148878438|NCT02160145|537031531|FG001|Randomized Double-blind Period|Physician Decision|7|||
148878439|NCT02160145|537031532|FG002|Randomized Double-blind Period|Physician Decision|5|||
148878440|NCT03597061|537031533|FG000|Overall Study|Lost to Follow-up|1|||
148878441|NCT03597061|537031534|FG001|Overall Study|Lost to Follow-up|0|||
148878442|NCT03597061|537031533|FG000|Overall Study|Protocol Violation|0|||
148878443|NCT03597061|537031534|FG001|Overall Study|Protocol Violation|1|||
148878444|NCT02006979|537031535|FG000|Overall Study|Withdrawal by Subject|1|||
148878445|NCT02006979|537031536|FG001|Overall Study|Withdrawal by Subject|1|||
148878446|NCT02006979|537031535|FG000|Overall Study|Protocol Violation|0|||
148878447|NCT02006979|537031536|FG001|Overall Study|Protocol Violation|1|||
148878448|NCT03170193|537031537|FG000|Overall Study|Withdrawal by Subject|0|||
148878449|NCT03170193|537031538|FG001|Overall Study|Withdrawal by Subject|0|||
148878450|NCT03170193|537031539|FG002|Overall Study|Withdrawal by Subject|0|||
148878451|NCT03170193|537031540|FG003|Overall Study|Withdrawal by Subject|1|||
148878452|NCT03170193|537031541|FG004|Overall Study|Withdrawal by Subject|0|||
148878453|NCT03170193|537031542|FG005|Overall Study|Withdrawal by Subject|0|||
148878454|NCT03170193|537031543|FG006|Overall Study|Withdrawal by Subject|0|||
148878455|NCT03170193|537031537|FG000|Overall Study|Lost to Follow-up|1|||
148878456|NCT03170193|537031538|FG001|Overall Study|Lost to Follow-up|1|||
148878457|NCT03170193|537031539|FG002|Overall Study|Lost to Follow-up|0|||
148878458|NCT03170193|537031540|FG003|Overall Study|Lost to Follow-up|0|||
148878459|NCT03170193|537031541|FG004|Overall Study|Lost to Follow-up|0|||
148878460|NCT03170193|537031542|FG005|Overall Study|Lost to Follow-up|0|||
148878461|NCT03170193|537031543|FG006|Overall Study|Lost to Follow-up|0|||
148878462|NCT00375518|537031544|FG000|Overall Study|Withdrawal by Subject|2|||
148878463|NCT00375518|537031545|FG001|Overall Study|Withdrawal by Subject|10|||
148878464|NCT00375518|537031544|FG000|Overall Study|Patient Not Treated|6|||
148878465|NCT00375518|537031545|FG001|Overall Study|Patient Not Treated|6|||
148878466|NCT00375518|537031544|FG000|Overall Study|Death|0|||
149034475|NCT02317016|537603691|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
148878467|NCT00375518|537031545|FG001|Overall Study|Death|1|||
148878468|NCT03052816|537031548|FG000|Overall Study|Withdrawal by Subject|1|||
148878469|NCT03052816|537031549|FG001|Overall Study|Withdrawal by Subject|0|||
148878470|NCT03052816|537031548|FG000|Overall Study|Desired opioids|2|||
148878471|NCT03052816|537031549|FG001|Overall Study|Desired opioids|0|||
148878472|NCT03755661|537031552|FG000|Overall Study|Lost to Follow-up|1|||
148878473|NCT03755661|537031553|FG001|Overall Study|Lost to Follow-up|0|||
148878474|NCT02461745|537031554|FG000|Overall Study|Lack of Efficacy|9|||
148878475|NCT02461745|537031555|FG001|Overall Study|Lack of Efficacy|1|||
148878476|NCT02461745|537031554|FG000|Overall Study|Lost to Follow-up|2|||
148878477|NCT02461745|537031555|FG001|Overall Study|Lost to Follow-up|2|||
148878478|NCT02461745|537031554|FG000|Overall Study|Withdrawal by Subject|3|||
148878479|NCT02461745|537031555|FG001|Overall Study|Withdrawal by Subject|1|||
148878480|NCT02475278|537034878|FG000|Overall Study|Lost to Follow-up|1|||
148878481|NCT02475278|537034878|FG000|Overall Study|Reason Not Specified|1|||
148878482|NCT02391363|537034879|FG000|Overall Study|Lost to Follow-up|5|||
148878483|NCT02391363|537034880|FG001|Overall Study|Lost to Follow-up|5|||
148878484|NCT02391363|537034879|FG000|Overall Study|Withdrawal by Subject|6|||
148878485|NCT02391363|537034880|FG001|Overall Study|Withdrawal by Subject|3|||
148878486|NCT00265317|537034884|FG000|Lead-In|Objective progression or relapse|6|||
148878487|NCT00265317|537034885|FG001|Lead-In|Objective progression or relapse|11|||
148878488|NCT00265317|537034886|FG002|Lead-In|Objective progression or relapse|0|||
148878489|NCT00265317|537034887|FG003|Lead-In|Objective progression or relapse|0|||
148878490|NCT00265317|537034884|FG000|Lead-In|Adverse Event|2|||
148878491|NCT00265317|537034885|FG001|Lead-In|Adverse Event|1|||
148878492|NCT00265317|537034886|FG002|Lead-In|Adverse Event|0|||
148878493|NCT00265317|537034887|FG003|Lead-In|Adverse Event|0|||
148878494|NCT00265317|537034884|FG000|Lead-In|Death|3|||
148878495|NCT00265317|537034885|FG001|Lead-In|Death|5|||
148878496|NCT00265317|537034886|FG002|Lead-In|Death|0|||
148878497|NCT00265317|537034887|FG003|Lead-In|Death|0|||
148878498|NCT00265317|537034884|FG000|Lead-In|Withdrawal/other than adverse event|1|||
148878499|NCT00265317|537034885|FG001|Lead-In|Withdrawal/other than adverse event|0|||
148878500|NCT00265317|537034886|FG002|Lead-In|Withdrawal/other than adverse event|0|||
148878501|NCT00265317|537034887|FG003|Lead-In|Withdrawal/other than adverse event|0|||
148878502|NCT00265317|537034884|FG000|Phase 2|Objective progression or relapse|0|||
148878503|NCT00265317|537034885|FG001|Phase 2|Objective progression or relapse|0|||
148878504|NCT00265317|537034886|FG002|Phase 2|Objective progression or relapse|37|||
148878505|NCT00265317|537034887|FG003|Phase 2|Objective progression or relapse|38|||
148878506|NCT00265317|537034884|FG000|Phase 2|Global deterioration of health status|0|||
148878507|NCT00265317|537034885|FG001|Phase 2|Global deterioration of health status|0|||
148878508|NCT00265317|537034886|FG002|Phase 2|Global deterioration of health status|3|||
148878509|NCT00265317|537034887|FG003|Phase 2|Global deterioration of health status|0|||
148878510|NCT00265317|537034884|FG000|Phase 2|Adverse Event|0|||
148878511|NCT00265317|537034885|FG001|Phase 2|Adverse Event|0|||
148878512|NCT00265317|537034886|FG002|Phase 2|Adverse Event|7|||
148878513|NCT00265317|537034887|FG003|Phase 2|Adverse Event|5|||
148878514|NCT00265317|537034884|FG000|Phase 2|Death|0|||
148878515|NCT00265317|537034885|FG001|Phase 2|Death|0|||
148878516|NCT00265317|537034886|FG002|Phase 2|Death|12|||
148878517|NCT00265317|537034887|FG003|Phase 2|Death|15|||
148878518|NCT00265317|537034884|FG000|Phase 2|Protocol Violation|0|||
148878519|NCT00265317|537034885|FG001|Phase 2|Protocol Violation|0|||
148878520|NCT00265317|537034886|FG002|Phase 2|Protocol Violation|1|||
148878521|NCT00265317|537034887|FG003|Phase 2|Protocol Violation|4|||
148878522|NCT00265317|537034884|FG000|Phase 2|Lost to Follow-up|0|||
148878523|NCT00265317|537034885|FG001|Phase 2|Lost to Follow-up|0|||
148878524|NCT00265317|537034886|FG002|Phase 2|Lost to Follow-up|0|||
148878525|NCT00265317|537034887|FG003|Phase 2|Lost to Follow-up|1|||
148878526|NCT00265317|537034884|FG000|Phase 2|Withdrawal/other than adverse event|0|||
148878527|NCT00265317|537034885|FG001|Phase 2|Withdrawal/other than adverse event|0|||
148878528|NCT00265317|537034886|FG002|Phase 2|Withdrawal/other than adverse event|2|||
148878529|NCT00265317|537034887|FG003|Phase 2|Withdrawal/other than adverse event|1|||
148878530|NCT00265317|537034884|FG000|Phase 2|Study terminated by sponsor|0|||
148878531|NCT00265317|537034885|FG001|Phase 2|Study terminated by sponsor|0|||
148878532|NCT00265317|537034886|FG002|Phase 2|Study terminated by sponsor|1|||
148878533|NCT00265317|537034887|FG003|Phase 2|Study terminated by sponsor|0|||
148878534|NCT00265317|537034884|FG000|Phase 2|Other|0|||
148878535|NCT00265317|537034885|FG001|Phase 2|Other|0|||
149034476|NCT02317016|537603691|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
148878536|NCT00265317|537034886|FG002|Phase 2|Other|1|||
148878537|NCT00265317|537034887|FG003|Phase 2|Other|1|||
148878538|NCT02300259|537034888|FG000|Period 1|Adverse Event|0|||
148878539|NCT02300259|537034889|FG001|Period 1|Adverse Event|0|||
148878540|NCT02300259|537034890|FG002|Period 1|Adverse Event|1|||
148878541|NCT02300259|537034888|FG000|Period 1|Withdrawal by Subject|0|||
148878542|NCT02300259|537034889|FG001|Period 1|Withdrawal by Subject|0|||
148878543|NCT02300259|537034890|FG002|Period 1|Withdrawal by Subject|1|||
148878544|NCT02300259|537034888|FG000|Period 2|Adverse Event|1|||
148878545|NCT02300259|537034889|FG001|Period 2|Adverse Event|0|||
148878546|NCT02300259|537034890|FG002|Period 2|Adverse Event|0|||
148878547|NCT02300259|537034888|FG000|Period 2|Withdrawal by Subject|0|||
148878548|NCT02300259|537034889|FG001|Period 2|Withdrawal by Subject|0|||
148878549|NCT02300259|537034890|FG002|Period 2|Withdrawal by Subject|1|||
148878550|NCT02737475|537034891|FG000|Overall Study|Other reasons|0|||
148878551|NCT02737475|537034892|FG001|Overall Study|Other reasons|0|||
148878552|NCT02737475|537034893|FG002|Overall Study|Other reasons|0|||
148878553|NCT02737475|537034894|FG003|Overall Study|Other reasons|0|||
148878554|NCT02737475|537034895|FG004|Overall Study|Other reasons|1|||
148878555|NCT02737475|537034896|FG005|Overall Study|Other reasons|1|||
148878556|NCT02737475|537034897|FG006|Overall Study|Other reasons|0|||
148878557|NCT02737475|537034898|FG007|Overall Study|Other reasons|0|||
148878558|NCT02737475|537034899|FG008|Overall Study|Other reasons|1|||
148878559|NCT02737475|537034900|FG009|Overall Study|Other reasons|0|||
148878560|NCT02737475|537034901|FG010|Overall Study|Other reasons|1|||
148878561|NCT02737475|537034902|FG011|Overall Study|Other reasons|0|||
148878562|NCT02737475|537034903|FG012|Overall Study|Other reasons|0|||
148878563|NCT02737475|537034904|FG013|Overall Study|Other reasons|0|||
148878564|NCT02737475|537034905|FG014|Overall Study|Other reasons|0|||
148878565|NCT02737475|537034906|FG015|Overall Study|Other reasons|0|||
148878566|NCT02737475|537034907|FG016|Overall Study|Other reasons|0|||
148878567|NCT02737475|537034908|FG017|Overall Study|Other reasons|0|||
148878568|NCT02737475|537034909|FG018|Overall Study|Other reasons|0|||
148878569|NCT02737475|537034910|FG019|Overall Study|Other reasons|0|||
148878570|NCT02737475|537034911|FG020|Overall Study|Other reasons|0|||
148878571|NCT02737475|537034912|FG021|Overall Study|Other reasons|1|||
148878572|NCT02737475|537034913|FG022|Overall Study|Other reasons|0|||
148878573|NCT02737475|537034914|FG023|Overall Study|Other reasons|1|||
148878574|NCT02737475|537034915|FG024|Overall Study|Other reasons|1|||
148878575|NCT02737475|537034916|FG025|Overall Study|Other reasons|1|||
148878576|NCT02737475|537034917|FG026|Overall Study|Other reasons|0|||
148878577|NCT02737475|537034891|FG000|Overall Study|Death|1|||
148878578|NCT02737475|537034892|FG001|Overall Study|Death|0|||
148878579|NCT02737475|537034893|FG002|Overall Study|Death|0|||
148878580|NCT02737475|537034894|FG003|Overall Study|Death|1|||
148878581|NCT02737475|537034895|FG004|Overall Study|Death|0|||
148878582|NCT02737475|537034896|FG005|Overall Study|Death|0|||
148878583|NCT02737475|537034897|FG006|Overall Study|Death|0|||
148878584|NCT02737475|537034898|FG007|Overall Study|Death|2|||
148878585|NCT02737475|537034899|FG008|Overall Study|Death|0|||
148878586|NCT02737475|537034900|FG009|Overall Study|Death|0|||
148878587|NCT02737475|537034901|FG010|Overall Study|Death|0|||
148878588|NCT02737475|537034902|FG011|Overall Study|Death|4|||
148878589|NCT02737475|537034903|FG012|Overall Study|Death|2|||
148878590|NCT02737475|537034904|FG013|Overall Study|Death|2|||
148878591|NCT02737475|537034905|FG014|Overall Study|Death|0|||
148878592|NCT02737475|537034906|FG015|Overall Study|Death|2|||
148878593|NCT02737475|537034907|FG016|Overall Study|Death|2|||
148878594|NCT02737475|537034908|FG017|Overall Study|Death|2|||
148878595|NCT02737475|537034909|FG018|Overall Study|Death|1|||
148878596|NCT02737475|537034910|FG019|Overall Study|Death|0|||
148878597|NCT02737475|537034911|FG020|Overall Study|Death|0|||
148878598|NCT02737475|537034912|FG021|Overall Study|Death|0|||
148878599|NCT02737475|537034913|FG022|Overall Study|Death|0|||
148878600|NCT02737475|537034914|FG023|Overall Study|Death|0|||
148878601|NCT02737475|537034915|FG024|Overall Study|Death|0|||
148878602|NCT02737475|537034916|FG025|Overall Study|Death|0|||
148878603|NCT02737475|537034917|FG026|Overall Study|Death|0|||
148878604|NCT02737475|537034891|FG000|Overall Study|Participant withdrew consent|0|||
148878605|NCT02737475|537034892|FG001|Overall Study|Participant withdrew consent|0|||
148878606|NCT02737475|537034893|FG002|Overall Study|Participant withdrew consent|0|||
148878607|NCT02737475|537034894|FG003|Overall Study|Participant withdrew consent|0|||
148878608|NCT02737475|537034895|FG004|Overall Study|Participant withdrew consent|0|||
148878609|NCT02737475|537034896|FG005|Overall Study|Participant withdrew consent|2|||
148878610|NCT02737475|537034897|FG006|Overall Study|Participant withdrew consent|0|||
148878611|NCT02737475|537034898|FG007|Overall Study|Participant withdrew consent|0|||
148878612|NCT02737475|537034899|FG008|Overall Study|Participant withdrew consent|0|||
148878613|NCT02737475|537034900|FG009|Overall Study|Participant withdrew consent|0|||
148878614|NCT02737475|537034901|FG010|Overall Study|Participant withdrew consent|0|||
148878615|NCT02737475|537034902|FG011|Overall Study|Participant withdrew consent|0|||
148878616|NCT02737475|537034903|FG012|Overall Study|Participant withdrew consent|0|||
148878617|NCT02737475|537034904|FG013|Overall Study|Participant withdrew consent|0|||
148878618|NCT02737475|537034905|FG014|Overall Study|Participant withdrew consent|1|||
148878619|NCT02737475|537034906|FG015|Overall Study|Participant withdrew consent|0|||
148878620|NCT02737475|537034907|FG016|Overall Study|Participant withdrew consent|0|||
148878621|NCT02737475|537034908|FG017|Overall Study|Participant withdrew consent|2|||
148878622|NCT02737475|537034909|FG018|Overall Study|Participant withdrew consent|1|||
148878623|NCT02737475|537034910|FG019|Overall Study|Participant withdrew consent|0|||
148878624|NCT02737475|537034911|FG020|Overall Study|Participant withdrew consent|2|||
148878625|NCT02737475|537034912|FG021|Overall Study|Participant withdrew consent|0|||
148878626|NCT02737475|537034913|FG022|Overall Study|Participant withdrew consent|0|||
148878627|NCT02737475|537034914|FG023|Overall Study|Participant withdrew consent|0|||
148878628|NCT02737475|537034915|FG024|Overall Study|Participant withdrew consent|0|||
148878629|NCT02737475|537034916|FG025|Overall Study|Participant withdrew consent|0|||
148878630|NCT02737475|537034917|FG026|Overall Study|Participant withdrew consent|0|||
148878631|NCT02737475|537034891|FG000|Overall Study|Lost to Follow-up|0|||
148878632|NCT02737475|537034892|FG001|Overall Study|Lost to Follow-up|0|||
148878633|NCT02737475|537034893|FG002|Overall Study|Lost to Follow-up|0|||
148878634|NCT02737475|537034894|FG003|Overall Study|Lost to Follow-up|0|||
148878635|NCT02737475|537034895|FG004|Overall Study|Lost to Follow-up|0|||
148878636|NCT02737475|537034896|FG005|Overall Study|Lost to Follow-up|0|||
148878637|NCT02737475|537034897|FG006|Overall Study|Lost to Follow-up|0|||
148878638|NCT02737475|537034898|FG007|Overall Study|Lost to Follow-up|0|||
148878639|NCT02737475|537034899|FG008|Overall Study|Lost to Follow-up|0|||
148878640|NCT02737475|537034900|FG009|Overall Study|Lost to Follow-up|0|||
148878641|NCT02737475|537034901|FG010|Overall Study|Lost to Follow-up|0|||
148878642|NCT02737475|537034902|FG011|Overall Study|Lost to Follow-up|0|||
148878643|NCT02737475|537034903|FG012|Overall Study|Lost to Follow-up|0|||
148878644|NCT02737475|537034904|FG013|Overall Study|Lost to Follow-up|0|||
148878645|NCT02737475|537034905|FG014|Overall Study|Lost to Follow-up|0|||
148878646|NCT02737475|537034906|FG015|Overall Study|Lost to Follow-up|1|||
148878647|NCT02737475|537034907|FG016|Overall Study|Lost to Follow-up|0|||
148878648|NCT02737475|537034908|FG017|Overall Study|Lost to Follow-up|0|||
148878649|NCT02737475|537034909|FG018|Overall Study|Lost to Follow-up|0|||
148878650|NCT02737475|537034910|FG019|Overall Study|Lost to Follow-up|0|||
148878651|NCT02737475|537034911|FG020|Overall Study|Lost to Follow-up|0|||
148878652|NCT02737475|537034912|FG021|Overall Study|Lost to Follow-up|0|||
148878653|NCT02737475|537034913|FG022|Overall Study|Lost to Follow-up|0|||
148878654|NCT02737475|537034914|FG023|Overall Study|Lost to Follow-up|0|||
148878655|NCT02737475|537034915|FG024|Overall Study|Lost to Follow-up|0|||
148878656|NCT02737475|537034916|FG025|Overall Study|Lost to Follow-up|0|||
148878657|NCT02737475|537034917|FG026|Overall Study|Lost to Follow-up|0|||
148878658|NCT02737475|537034891|FG000|Overall Study|Disease Progression|0|||
148878659|NCT02737475|537034892|FG001|Overall Study|Disease Progression|0|||
148878660|NCT02737475|537034893|FG002|Overall Study|Disease Progression|0|||
148878661|NCT02737475|537034894|FG003|Overall Study|Disease Progression|0|||
148878662|NCT02737475|537034895|FG004|Overall Study|Disease Progression|0|||
148878663|NCT02737475|537034896|FG005|Overall Study|Disease Progression|0|||
148878664|NCT02737475|537034897|FG006|Overall Study|Disease Progression|0|||
148878665|NCT02737475|537034898|FG007|Overall Study|Disease Progression|0|||
148878666|NCT02737475|537034899|FG008|Overall Study|Disease Progression|0|||
148878667|NCT02737475|537034900|FG009|Overall Study|Disease Progression|0|||
148878668|NCT02737475|537034901|FG010|Overall Study|Disease Progression|0|||
148878669|NCT02737475|537034902|FG011|Overall Study|Disease Progression|0|||
148878670|NCT02737475|537034903|FG012|Overall Study|Disease Progression|0|||
148878671|NCT02737475|537034904|FG013|Overall Study|Disease Progression|0|||
148878672|NCT02737475|537034905|FG014|Overall Study|Disease Progression|0|||
148878673|NCT02737475|537034906|FG015|Overall Study|Disease Progression|0|||
148878674|NCT02737475|537034907|FG016|Overall Study|Disease Progression|0|||
148878675|NCT02737475|537034908|FG017|Overall Study|Disease Progression|0|||
148878676|NCT02737475|537034909|FG018|Overall Study|Disease Progression|0|||
148878677|NCT02737475|537034910|FG019|Overall Study|Disease Progression|0|||
148878678|NCT02737475|537034911|FG020|Overall Study|Disease Progression|0|||
148878679|NCT02737475|537034912|FG021|Overall Study|Disease Progression|0|||
148878680|NCT02737475|537034913|FG022|Overall Study|Disease Progression|0|||
148878681|NCT02737475|537034914|FG023|Overall Study|Disease Progression|0|||
148878682|NCT02737475|537034915|FG024|Overall Study|Disease Progression|0|||
148878683|NCT02737475|537034916|FG025|Overall Study|Disease Progression|0|||
148878684|NCT02737475|537034917|FG026|Overall Study|Disease Progression|1|||
148878685|NCT02255461|537034918|FG000|Overall Study|Adverse Event|0|||
148878686|NCT02255461|537034919|FG001|Overall Study|Adverse Event|1|||
148878687|NCT02255461|537034920|FG002|Overall Study|Adverse Event|0|||
148878688|NCT02255461|537034921|FG003|Overall Study|Adverse Event|0|||
148878689|NCT02255461|537034922|FG004|Overall Study|Adverse Event|1|||
148878690|NCT02255461|537034918|FG000|Overall Study|Withdrawal by Subject|0|||
148878691|NCT02255461|537034919|FG001|Overall Study|Withdrawal by Subject|0|||
148878692|NCT02255461|537034920|FG002|Overall Study|Withdrawal by Subject|1|||
148878693|NCT02255461|537034921|FG003|Overall Study|Withdrawal by Subject|0|||
148878694|NCT02255461|537034922|FG004|Overall Study|Withdrawal by Subject|1|||
148878695|NCT02255461|537034918|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
148878696|NCT02255461|537034919|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
148878697|NCT02255461|537034920|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
148878698|NCT02255461|537034921|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
148878699|NCT02255461|537034922|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
148878700|NCT03668613|537034934|FG000|Overall Study|Adverse Event|1|||
148878701|NCT03668613|537034935|FG001|Overall Study|Adverse Event|2|||
148878702|NCT03668613|537034934|FG000|Overall Study|Lack of Efficacy|5|||
148878703|NCT03668613|537034935|FG001|Overall Study|Lack of Efficacy|1|||
148878704|NCT03668613|537034934|FG000|Overall Study|Pregnancy|0|||
148878705|NCT03668613|537034935|FG001|Overall Study|Pregnancy|2|||
148878706|NCT03668613|537034934|FG000|Overall Study|Protocol Violation|1|||
148878707|NCT03668613|537034935|FG001|Overall Study|Protocol Violation|0|||
148878708|NCT03668613|537034934|FG000|Overall Study|Physician Decision|1|||
148878709|NCT03668613|537034935|FG001|Overall Study|Physician Decision|0|||
148878710|NCT03668613|537034934|FG000|Overall Study|Withdrawal by Subject|2|||
148878711|NCT03668613|537034935|FG001|Overall Study|Withdrawal by Subject|1|||
148878712|NCT03668613|537034934|FG000|Overall Study|Guardian decision|1|||
148878713|NCT03668613|537034935|FG001|Overall Study|Guardian decision|0|||
148878714|NCT01858740|537034938|FG000|Overall Study|Death|4|||
148878715|NCT03386487|537034939|FG000|Overall Study|Lost to Follow-up|5|||
148878716|NCT03386487|537034940|FG001|Overall Study|Lost to Follow-up|6|||
148878717|NCT03386487|537034939|FG000|Overall Study|Withdrawal by Subject|11|||
148878718|NCT03386487|537034940|FG001|Overall Study|Withdrawal by Subject|7|||
148878719|NCT03386487|537034939|FG000|Overall Study|Physician Decision|11|||
148878720|NCT03386487|537034940|FG001|Overall Study|Physician Decision|8|||
148878721|NCT00286494|537034947|FG000|Overall Study|Hyperglycemic rescue|12|||
148878722|NCT00286494|537034948|FG001|Overall Study|Hyperglycemic rescue|19|||
148878723|NCT00286494|537034949|FG002|Overall Study|Hyperglycemic rescue|18|||
148878724|NCT00286494|537034947|FG000|Overall Study|Withdrawal by Subject|2|||
148878725|NCT00286494|537034948|FG001|Overall Study|Withdrawal by Subject|10|||
148878726|NCT00286494|537034949|FG002|Overall Study|Withdrawal by Subject|9|||
148878727|NCT00286494|537034947|FG000|Overall Study|Adverse Event|3|||
148878728|NCT00286494|537034948|FG001|Overall Study|Adverse Event|8|||
148878729|NCT00286494|537034949|FG002|Overall Study|Adverse Event|6|||
148878730|NCT00286494|537034947|FG000|Overall Study|Physician Decision|5|||
148878731|NCT00286494|537034948|FG001|Overall Study|Physician Decision|5|||
148878732|NCT00286494|537034949|FG002|Overall Study|Physician Decision|1|||
148878733|NCT00286494|537034947|FG000|Overall Study|Lost to Follow-up|3|||
148878734|NCT00286494|537034948|FG001|Overall Study|Lost to Follow-up|1|||
148878735|NCT00286494|537034949|FG002|Overall Study|Lost to Follow-up|3|||
148878736|NCT00286494|537034947|FG000|Overall Study|Protocol Violation|1|||
148878737|NCT00286494|537034948|FG001|Overall Study|Protocol Violation|1|||
148878738|NCT00286494|537034949|FG002|Overall Study|Protocol Violation|2|||
148878739|NCT04776317|537034950|FG000|Overall Study|Physician Decision|0|||
148878740|NCT04776317|537034951|FG001|Overall Study|Physician Decision|1|||
148878741|NCT04776317|537034952|FG002|Overall Study|Physician Decision|0|||
148878742|NCT04776317|537034953|FG003|Overall Study|Physician Decision|0|||
148878743|NCT04776317|537034954|FG004|Overall Study|Physician Decision|0|||
148878744|NCT04776317|537034955|FG005|Overall Study|Physician Decision|0|||
148878745|NCT04776317|537034956|FG006|Overall Study|Physician Decision|0|||
148878746|NCT04776317|537034957|FG007|Overall Study|Physician Decision|0|||
148878747|NCT04776317|537034958|FG008|Overall Study|Physician Decision|0|||
148878748|NCT04776317|537034959|FG009|Overall Study|Physician Decision|0|||
148878749|NCT04776317|537034960|FG010|Overall Study|Physician Decision|0|||
148878750|NCT04776317|537034961|FG011|Overall Study|Physician Decision|0|||
148878751|NCT04776317|537034962|FG012|Overall Study|Physician Decision|0|||
148878752|NCT04776317|537034963|FG013|Overall Study|Physician Decision|0|||
148878753|NCT04776317|537034964|FG014|Overall Study|Physician Decision|0|||
148878754|NCT04776317|537034950|FG000|Overall Study|Protocol Violation|0|||
148878755|NCT04776317|537034951|FG001|Overall Study|Protocol Violation|0|||
148878756|NCT04776317|537034952|FG002|Overall Study|Protocol Violation|1|||
148878757|NCT04776317|537034953|FG003|Overall Study|Protocol Violation|0|||
148878758|NCT04776317|537034954|FG004|Overall Study|Protocol Violation|0|||
148878759|NCT04776317|537034955|FG005|Overall Study|Protocol Violation|0|||
148878760|NCT04776317|537034956|FG006|Overall Study|Protocol Violation|0|||
148878761|NCT04776317|537034957|FG007|Overall Study|Protocol Violation|0|||
148878762|NCT04776317|537034958|FG008|Overall Study|Protocol Violation|0|||
148878763|NCT04776317|537034959|FG009|Overall Study|Protocol Violation|0|||
148878764|NCT04776317|537034960|FG010|Overall Study|Protocol Violation|0|||
148878765|NCT04776317|537034961|FG011|Overall Study|Protocol Violation|0|||
148878766|NCT04776317|537034962|FG012|Overall Study|Protocol Violation|0|||
148878767|NCT04776317|537034963|FG013|Overall Study|Protocol Violation|0|||
148878768|NCT04776317|537034964|FG014|Overall Study|Protocol Violation|0|||
148878769|NCT04776317|537034950|FG000|Overall Study|Withdrawal by Subject|0|||
148878770|NCT04776317|537034951|FG001|Overall Study|Withdrawal by Subject|0|||
148878771|NCT04776317|537034952|FG002|Overall Study|Withdrawal by Subject|0|||
148878772|NCT04776317|537034953|FG003|Overall Study|Withdrawal by Subject|0|||
148878773|NCT04776317|537034954|FG004|Overall Study|Withdrawal by Subject|1|||
148878774|NCT04776317|537034955|FG005|Overall Study|Withdrawal by Subject|0|||
148878775|NCT04776317|537034956|FG006|Overall Study|Withdrawal by Subject|0|||
148878776|NCT04776317|537034957|FG007|Overall Study|Withdrawal by Subject|0|||
148878777|NCT04776317|537034958|FG008|Overall Study|Withdrawal by Subject|0|||
149034477|NCT02317016|537603691|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
149034478|NCT01981356|537603692|FG000|Overall Study|Lost to Follow-up|4|||
149034479|NCT01981356|537603693|FG001|Overall Study|Lost to Follow-up|1|||
149034480|NCT01981356|537603692|FG000|Overall Study|Withdrawal by Subject|1|||
149034481|NCT01981356|537603693|FG001|Overall Study|Withdrawal by Subject|1|||
149034482|NCT01981356|537603692|FG000|Overall Study|Protocol Violation|2|||
148878778|NCT04776317|537034959|FG009|Overall Study|Withdrawal by Subject|0|||
148878779|NCT04776317|537034960|FG010|Overall Study|Withdrawal by Subject|0|||
148878780|NCT04776317|537034961|FG011|Overall Study|Withdrawal by Subject|0|||
148878781|NCT04776317|537034962|FG012|Overall Study|Withdrawal by Subject|0|||
148878782|NCT04776317|537034963|FG013|Overall Study|Withdrawal by Subject|0|||
148878783|NCT04776317|537034964|FG014|Overall Study|Withdrawal by Subject|0|||
148878784|NCT05438576|537034965|FG000|Overall Study|Death|1|||
148878785|NCT05438576|537034966|FG001|Overall Study|Death|1|||
148878786|NCT05438576|537034965|FG000|Overall Study|Withdrawal by Subject|4|||
148878787|NCT05438576|537034966|FG001|Overall Study|Withdrawal by Subject|2|||
148878788|NCT05438576|537034965|FG000|Overall Study|Not Eligible|2|||
148878789|NCT05438576|537034966|FG001|Overall Study|Not Eligible|1|||
148878790|NCT05438576|537034965|FG000|Overall Study|Did not complete baseline testing|22|||
148878791|NCT05438576|537034966|FG001|Overall Study|Did not complete baseline testing|4|||
148878792|NCT01067144|537034967|FG000|Treatment|Did not receive allocated intervention|4|||
148878793|NCT01067144|537034968|FG001|Treatment|Did not receive allocated intervention|7|||
148878794|NCT01067144|537034967|FG000|Follow-up|Lost to Follow-up|22|||
148878795|NCT01067144|537034968|FG001|Follow-up|Lost to Follow-up|12|||
148878796|NCT01067144|537034967|FG000|Follow-up|Censored owing to second surgery|19|||
148878797|NCT01067144|537034968|FG001|Follow-up|Censored owing to second surgery|28|||
148878798|NCT01067144|537034967|FG000|Follow-up|Withdrawal by Subject|18|||
148878799|NCT01067144|537034968|FG001|Follow-up|Withdrawal by Subject|14|||
148878800|NCT01067144|537034967|FG000|Follow-up|Surgery cancelled|0|||
148878801|NCT01067144|537034968|FG001|Follow-up|Surgery cancelled|1|||
148878802|NCT01067144|537034967|FG000|Follow-up|Death|0|||
148878803|NCT01067144|537034968|FG001|Follow-up|Death|1|||
148878804|NCT01835158|537034970|FG000|Overall Study|Withdrawal by Subject|1|||
148878805|NCT01835158|537034971|FG001|Overall Study|Withdrawal by Subject|6|||
148878806|NCT00296140|537034972|FG000|Overall Study|Lost to Follow-up|1|||
148878807|NCT00296140|537034973|FG001|Overall Study|Lost to Follow-up|0|||
148878808|NCT00296140|537034972|FG000|Overall Study|Withdrawal by Subject|1|||
148878809|NCT00296140|537034973|FG001|Overall Study|Withdrawal by Subject|0|||
148878810|NCT00296140|537034972|FG000|Overall Study|Discharge to Nursing Home|1|||
148878811|NCT00296140|537034973|FG001|Overall Study|Discharge to Nursing Home|0|||
148878812|NCT01856582|537034974|FG000|Overall Study|Died prior to Boost infusion|1|||
148878813|NCT00880191|537034978|FG000|Overall Study|Refused further treatment|4|||
148878814|NCT00880191|537034979|FG001|Overall Study|Refused further treatment|1|||
148878815|NCT00880191|537034978|FG000|Overall Study|Adverse Event|8|||
148878816|NCT00880191|537034979|FG001|Overall Study|Adverse Event|6|||
148878817|NCT00880191|537034978|FG000|Overall Study|Hospitalization/efficacy|1|||
148878818|NCT00880191|537034979|FG001|Overall Study|Hospitalization/efficacy|1|||
148878819|NCT01919801|537034982|FG000|Overall Study|Withdrawal by Subject|1|||
148878820|NCT01919801|537034983|FG001|Overall Study|Withdrawal by Subject|0|||
148878821|NCT01919801|537034982|FG000|Overall Study|Physician Decision|0|||
148878822|NCT01919801|537034983|FG001|Overall Study|Physician Decision|1|||
148878823|NCT01919801|537034982|FG000|Overall Study|Lost to Follow-up|0|||
148878824|NCT01919801|537034983|FG001|Overall Study|Lost to Follow-up|1|||
148878825|NCT01919801|537034982|FG000|Overall Study|Other|0|||
148878826|NCT01919801|537034983|FG001|Overall Study|Other|1|||
148878827|NCT01843062|537034984|FG000|Overall Study|Protocol Violation|1|||
148878828|NCT01843062|537034985|FG001|Overall Study|Protocol Violation|0|||
148878829|NCT01843062|537034984|FG000|Overall Study|New treatment following progression|2|||
148878830|NCT01843062|537034985|FG001|Overall Study|New treatment following progression|0|||
148878831|NCT01843062|537034984|FG000|Overall Study|Pregnancy|1|||
148878832|NCT01843062|537034985|FG001|Overall Study|Pregnancy|0|||
148878833|NCT01843062|537034984|FG000|Overall Study|Adverse Event|2|||
148878834|NCT01843062|537034985|FG001|Overall Study|Adverse Event|0|||
148878835|NCT01843062|537034984|FG000|Overall Study|Incorrect randomisation|1|||
148878836|NCT01843062|537034985|FG001|Overall Study|Incorrect randomisation|0|||
148878837|NCT01843062|537034984|FG000|Overall Study|Withdrawal by Subject|12|||
148878838|NCT01843062|537034985|FG001|Overall Study|Withdrawal by Subject|3|||
148878839|NCT01843062|537034984|FG000|Overall Study|Death|1|||
148878840|NCT01843062|537034985|FG001|Overall Study|Death|2|||
148878841|NCT01843062|537034984|FG000|Overall Study|Lost to Follow-up|2|||
148878842|NCT01843062|537034985|FG001|Overall Study|Lost to Follow-up|4|||
148878843|NCT01677858|537034986|FG000|Overall Study|Adverse Event|0|||
148878844|NCT01677858|537034987|FG001|Overall Study|Adverse Event|0|||
148878845|NCT01677858|537034988|FG002|Overall Study|Adverse Event|2|||
148878846|NCT01677858|537034989|FG003|Overall Study|Adverse Event|3|||
148878847|NCT01677858|537034990|FG004|Overall Study|Adverse Event|13|||
148878848|NCT01677858|537034986|FG000|Overall Study|Death|0|||
148878849|NCT01677858|537034987|FG001|Overall Study|Death|0|||
148878850|NCT01677858|537034988|FG002|Overall Study|Death|0|||
148878851|NCT01677858|537034989|FG003|Overall Study|Death|0|||
148878852|NCT01677858|537034990|FG004|Overall Study|Death|1|||
148878853|NCT01677858|537034986|FG000|Overall Study|Physician Decision|1|||
148878854|NCT01677858|537034987|FG001|Overall Study|Physician Decision|0|||
148878855|NCT01677858|537034988|FG002|Overall Study|Physician Decision|2|||
148878856|NCT01677858|537034989|FG003|Overall Study|Physician Decision|0|||
148878857|NCT01677858|537034990|FG004|Overall Study|Physician Decision|12|||
148878858|NCT01677858|537034986|FG000|Overall Study|Progressive Disease|2|||
148878859|NCT01677858|537034987|FG001|Overall Study|Progressive Disease|1|||
148878860|NCT01677858|537034988|FG002|Overall Study|Progressive Disease|9|||
148878861|NCT01677858|537034989|FG003|Overall Study|Progressive Disease|3|||
148878862|NCT01677858|537034990|FG004|Overall Study|Progressive Disease|43|||
148878863|NCT01677858|537034986|FG000|Overall Study|Withdrawal by Subject|0|||
148878864|NCT01677858|537034987|FG001|Overall Study|Withdrawal by Subject|1|||
148878865|NCT01677858|537034988|FG002|Overall Study|Withdrawal by Subject|1|||
148878866|NCT01677858|537034989|FG003|Overall Study|Withdrawal by Subject|0|||
148878867|NCT01677858|537034990|FG004|Overall Study|Withdrawal by Subject|15|||
148878868|NCT01677858|537034986|FG000|Overall Study|Lost to Follow-up|0|||
148878869|NCT01677858|537034987|FG001|Overall Study|Lost to Follow-up|0|||
148878870|NCT01677858|537034988|FG002|Overall Study|Lost to Follow-up|0|||
148878871|NCT01677858|537034989|FG003|Overall Study|Lost to Follow-up|0|||
148878872|NCT01677858|537034990|FG004|Overall Study|Lost to Follow-up|1|||
148878873|NCT01331109|537034991|FG000|Overall Study|Adverse Event|6|||
148878874|NCT01331109|537034991|FG000|Overall Study|Lack of Efficacy|2|||
148878875|NCT01331109|537034991|FG000|Overall Study|Protocol Violation|3|||
148878876|NCT01331109|537034991|FG000|Overall Study|Withdrawal by Subject|7|||
148878877|NCT01331109|537034991|FG000|Overall Study|Lost to Follow-up|1|||
148878878|NCT01331109|537034991|FG000|Overall Study|Study Terminated by Sponsor|38|||
148878879|NCT00988091|537034995|FG000|Double-blind Period|Withdrawal by Subject|15|||
148878880|NCT00988091|537034996|FG001|Double-blind Period|Withdrawal by Subject|13|||
148878881|NCT00988091|537034995|FG000|Double-blind Period|Lost to Follow-up|12|||
148878882|NCT00988091|537034996|FG001|Double-blind Period|Lost to Follow-up|14|||
148878883|NCT00988091|537034995|FG000|Double-blind Period|Other|8|||
148878884|NCT00988091|537034996|FG001|Double-blind Period|Other|8|||
148878885|NCT00988091|537034995|FG000|Double-blind Period|Adverse Event|6|||
148878886|NCT00988091|537034996|FG001|Double-blind Period|Adverse Event|9|||
148878887|NCT00988091|537034995|FG000|Double-blind Period|Use of exclusionary medication|2|||
148878888|NCT00988091|537034996|FG001|Double-blind Period|Use of exclusionary medication|3|||
148878889|NCT00988091|537034995|FG000|Open-label Period|Adverse Event|4|||
148878890|NCT00988091|537034996|FG001|Open-label Period|Adverse Event|7|||
148878891|NCT00988091|537034995|FG000|Open-label Period|Use of exclusionary medication|1|||
148878892|NCT00988091|537034996|FG001|Open-label Period|Use of exclusionary medication|1|||
148878893|NCT00988091|537034995|FG000|Open-label Period|Protocol Violation|1|||
148878894|NCT00988091|537034996|FG001|Open-label Period|Protocol Violation|1|||
148878895|NCT00988091|537034995|FG000|Open-label Period|Withdrawal by Subject|10|||
148878896|NCT00988091|537034996|FG001|Open-label Period|Withdrawal by Subject|16|||
148878897|NCT00988091|537034995|FG000|Open-label Period|Lost to Follow-up|3|||
148878898|NCT00988091|537034996|FG001|Open-label Period|Lost to Follow-up|5|||
148878899|NCT00988091|537034995|FG000|Open-label Period|Other|2|||
148878900|NCT00988091|537034996|FG001|Open-label Period|Other|3|||
148878901|NCT00773747|537034997|FG000|Overall Study|Lack of Efficacy|112|||
148878902|NCT00773747|537034998|FG001|Overall Study|Lack of Efficacy|144|||
148878903|NCT00773747|537034997|FG000|Overall Study|Physician Decision|26|||
148878904|NCT00773747|537034998|FG001|Overall Study|Physician Decision|18|||
148878905|NCT00773747|537034997|FG000|Overall Study|Lost to Follow-up|0|||
148878906|NCT00773747|537034998|FG001|Overall Study|Lost to Follow-up|1|||
148878907|NCT00773747|537034997|FG000|Overall Study|Protocol Violation|2|||
148878908|NCT00773747|537034998|FG001|Overall Study|Protocol Violation|2|||
148878909|NCT00773747|537034997|FG000|Overall Study|Withdrawal by Subject|89|||
148878910|NCT00773747|537034998|FG001|Overall Study|Withdrawal by Subject|61|||
148878911|NCT00773747|537034997|FG000|Overall Study|Adverse Event|61|||
148878912|NCT00773747|537034998|FG001|Overall Study|Adverse Event|62|||
148878913|NCT00773747|537034997|FG000|Overall Study|Death|5|||
148878914|NCT00773747|537034998|FG001|Overall Study|Death|8|||
148878915|NCT00773747|537034997|FG000|Overall Study|Not Treated|2|||
148878916|NCT00773747|537034998|FG001|Overall Study|Not Treated|0|||
148878917|NCT00994422|537035001|FG000|Overall Study|Lost to Follow-up|7|||
148878918|NCT00994422|537035002|FG001|Overall Study|Lost to Follow-up|1|||
148878919|NCT02669212|537035003|FG000|Overall Study|Lost to Follow-up|1|||
148878920|NCT02669212|537035004|FG001|Overall Study|Lost to Follow-up|0|||
148878921|NCT02669212|537035003|FG000|Overall Study|Medical Condition|3|||
148878922|NCT02669212|537035004|FG001|Overall Study|Medical Condition|4|||
148878923|NCT02669212|537035003|FG000|Overall Study|Withdrawal by Subject|0|||
148878924|NCT02669212|537035004|FG001|Overall Study|Withdrawal by Subject|2|||
148878925|NCT02669212|537035003|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
148878926|NCT02669212|537035004|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
148878927|NCT03549104|537035005|FG000|Overall Study|Withdrawal by Subject|5|||
148878928|NCT03549104|537035006|FG001|Overall Study|Withdrawal by Subject|2|||
148878929|NCT03549104|537035005|FG000|Overall Study|Covid shelter in place|1|||
148878930|NCT03549104|537035006|FG001|Overall Study|Covid shelter in place|2|||
149034483|NCT01981356|537603693|FG001|Overall Study|Protocol Violation|0|||
149034484|NCT01751724|537603697|FG000|Overall Study|extubated bef.start assigned treatment|1|||
149034485|NCT01751724|537603698|FG001|Overall Study|extubated bef.start assigned treatment|0|||
148878931|NCT03078855|537035010|FG000|Overall Study|Lack of Efficacy|62|||
148878932|NCT03078855|537035011|FG001|Overall Study|Lack of Efficacy|31|||
148878933|NCT03078855|537035010|FG000|Overall Study|Death|1|||
148878934|NCT03078855|537035011|FG001|Overall Study|Death|0|||
148878935|NCT03078855|537035010|FG000|Overall Study|Withdrawal by Subject|12|||
148878936|NCT03078855|537035011|FG001|Overall Study|Withdrawal by Subject|6|||
148878937|NCT03078855|537035010|FG000|Overall Study|Physician Decision|3|||
148878938|NCT03078855|537035011|FG001|Overall Study|Physician Decision|2|||
148878939|NCT03078855|537035010|FG000|Overall Study|Second Malignancy|4|||
148878940|NCT03078855|537035011|FG001|Overall Study|Second Malignancy|0|||
148878941|NCT03078855|537035010|FG000|Overall Study|Ineligible|2|||
148878942|NCT03078855|537035011|FG001|Overall Study|Ineligible|0|||
148878943|NCT03078855|537035010|FG000|Overall Study|Withdrew before day 1 treatment|2|||
148878944|NCT03078855|537035011|FG001|Overall Study|Withdrew before day 1 treatment|1|||
148878945|NCT00391027|537035012|FG000|Overall Study|Adverse Event|8|||
148878946|NCT00391027|537035013|FG001|Overall Study|Adverse Event|8|||
148878947|NCT00391027|537035012|FG000|Overall Study|Lack of Efficacy|3|||
148878948|NCT00391027|537035013|FG001|Overall Study|Lack of Efficacy|0|||
148878949|NCT00391027|537035012|FG000|Overall Study|Withdrawal by Subject|10|||
148878950|NCT00391027|537035013|FG001|Overall Study|Withdrawal by Subject|1|||
148878951|NCT00391027|537035012|FG000|Overall Study|Other|4|||
148878952|NCT00391027|537035013|FG001|Overall Study|Other|3|||
148878953|NCT03422536|537035014|FG000|Randomized|Physician Decision|1|||
148878954|NCT03422536|537035015|FG001|Randomized|Physician Decision|1|||
148878955|NCT03422536|537035014|FG000|Allocation - Received Intervention|Disease progression|19|||
148878956|NCT03422536|537035015|FG001|Allocation - Received Intervention|Disease progression|25|||
148878957|NCT03422536|537035014|FG000|Allocation - Received Intervention|Death|1|||
148878958|NCT03422536|537035015|FG001|Allocation - Received Intervention|Death|3|||
148878959|NCT03422536|537035014|FG000|Allocation - Received Intervention|Adverse Event|1|||
148878960|NCT03422536|537035015|FG001|Allocation - Received Intervention|Adverse Event|0|||
148878961|NCT03422536|537035014|FG000|Allocation - Received Intervention|Physician Decision|1|||
148878962|NCT03422536|537035015|FG001|Allocation - Received Intervention|Physician Decision|1|||
148878963|NCT03422536|537035014|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
148878964|NCT03422536|537035015|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
148878965|NCT03422536|537035014|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
148878966|NCT03422536|537035015|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
148878967|NCT04164732|537035018|FG000|Treatment run-in Period|Adverse Event|4|||
148878968|NCT04164732|537035019|FG001|Treatment run-in Period|Adverse Event|0|||
148878969|NCT04164732|537035020|FG002|Treatment run-in Period|Adverse Event|0|||
148878970|NCT04164732|537035018|FG000|Treatment run-in Period|Physician Decision|1|||
148878971|NCT04164732|537035019|FG001|Treatment run-in Period|Physician Decision|0|||
148878972|NCT04164732|537035020|FG002|Treatment run-in Period|Physician Decision|0|||
148878973|NCT04164732|537035018|FG000|Treatment run-in Period|Screen Failure|1|||
148878974|NCT04164732|537035019|FG001|Treatment run-in Period|Screen Failure|0|||
148878975|NCT04164732|537035020|FG002|Treatment run-in Period|Screen Failure|0|||
148878976|NCT04164732|537035018|FG000|Randomized Treatment Period|Adverse Event|0|||
148878977|NCT04164732|537035019|FG001|Randomized Treatment Period|Adverse Event|1|||
148878978|NCT04164732|537035020|FG002|Randomized Treatment Period|Adverse Event|0|||
148878979|NCT04164732|537035018|FG000|Randomized Treatment Period|Protocol Deviation|0|||
148878980|NCT04164732|537035019|FG001|Randomized Treatment Period|Protocol Deviation|1|||
148878981|NCT04164732|537035020|FG002|Randomized Treatment Period|Protocol Deviation|1|||
148878982|NCT04164732|537035018|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
148878983|NCT04164732|537035019|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
148878984|NCT04164732|537035020|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
148878985|NCT00661622|537035021|FG000|Overall Study|Protocol Violation|1|||
148878986|NCT00661622|537035022|FG001|Overall Study|Protocol Violation|0|||
148878987|NCT04765202|537035025|FG000|Overall Study|Lost to Follow-up|1|||
148878988|NCT04765202|537035026|FG001|Overall Study|Lost to Follow-up|1|||
148878989|NCT04765202|537035027|FG002|Overall Study|Lost to Follow-up|2|||
148878990|NCT04765202|537035028|FG003|Overall Study|Lost to Follow-up|2|||
148878991|NCT04765202|537035025|FG000|Overall Study|Physician Decision|0|||
148878992|NCT04765202|537035026|FG001|Overall Study|Physician Decision|0|||
148878993|NCT04765202|537035027|FG002|Overall Study|Physician Decision|1|||
148878994|NCT04765202|537035028|FG003|Overall Study|Physician Decision|1|||
148878995|NCT01620762|537035031|FG000|Overall Study|Protocol Violation|1|||
148878996|NCT01620762|537035032|FG001|Overall Study|Protocol Violation|1|||
148878997|NCT01620762|537035033|FG002|Overall Study|Protocol Violation|1|||
148878998|NCT01620762|537035031|FG000|Overall Study|Adverse Event|9|||
148878999|NCT01620762|537035032|FG001|Overall Study|Adverse Event|5|||
148879000|NCT01620762|537035033|FG002|Overall Study|Adverse Event|2|||
148879001|NCT01620762|537035031|FG000|Overall Study|Withdrawal by Subject|23|||
148879002|NCT01620762|537035032|FG001|Overall Study|Withdrawal by Subject|26|||
148879003|NCT01620762|537035033|FG002|Overall Study|Withdrawal by Subject|27|||
148879004|NCT01620762|537035031|FG000|Overall Study|Lost to Follow-up|11|||
148879005|NCT01620762|537035032|FG001|Overall Study|Lost to Follow-up|17|||
148879006|NCT01620762|537035033|FG002|Overall Study|Lost to Follow-up|10|||
148879007|NCT01620762|537035031|FG000|Overall Study|Protocol deviation|1|||
148879008|NCT01620762|537035032|FG001|Overall Study|Protocol deviation|1|||
148879009|NCT01620762|537035033|FG002|Overall Study|Protocol deviation|6|||
148879010|NCT01620762|537035031|FG000|Overall Study|Subject deterioration|0|||
148879011|NCT01620762|537035032|FG001|Overall Study|Subject deterioration|1|||
149034486|NCT01751724|537603697|FG000|Overall Study|withdrawn by parent|0|||
148879012|NCT01620762|537035033|FG002|Overall Study|Subject deterioration|1|||
148879013|NCT01620762|537035031|FG000|Overall Study|Non-specified|3|||
148879014|NCT01620762|537035032|FG001|Overall Study|Non-specified|6|||
148879015|NCT01620762|537035033|FG002|Overall Study|Non-specified|5|||
148879016|NCT01620762|537035031|FG000|Overall Study|Use of prohibted therapies|0|||
148879017|NCT01620762|537035032|FG001|Overall Study|Use of prohibted therapies|1|||
148879018|NCT01620762|537035033|FG002|Overall Study|Use of prohibted therapies|1|||
148879019|NCT00705146|537035034|FG000|Overall Study|Lost to Follow-up|1|||
148879020|NCT00705146|537035035|FG001|Overall Study|Lost to Follow-up|1|||
148879021|NCT00095173|537035036|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
148879022|NCT00095173|537035037|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
148879023|NCT00095173|537035038|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
148879024|NCT00095173|537035039|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
148879025|NCT00095173|537035040|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
148879026|NCT00095173|537035041|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
148879027|NCT00095173|537035036|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
148879028|NCT00095173|537035037|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
148879029|NCT00095173|537035038|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
148879030|NCT00095173|537035039|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
148879031|NCT00095173|537035040|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
148879032|NCT00095173|537035041|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
148879033|NCT00095173|537035036|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
148879034|NCT00095173|537035037|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
148879035|NCT00095173|537035038|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
148879036|NCT00095173|537035039|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
148879037|NCT00095173|537035040|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
148879038|NCT00095173|537035041|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
148879039|NCT00095173|537035036|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
148879040|NCT00095173|537035037|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
148879041|NCT00095173|537035038|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
148879042|NCT00095173|537035039|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
148879043|NCT00095173|537035040|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
148879044|NCT00095173|537035041|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
148879045|NCT00095173|537035036|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
148879046|NCT00095173|537035037|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
148879047|NCT00095173|537035038|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
148879048|NCT00095173|537035039|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
148879049|NCT00095173|537035040|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
148879050|NCT00095173|537035041|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
148879051|NCT00095173|537035036|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
148879052|NCT00095173|537035037|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
148879053|NCT00095173|537035038|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
148879054|NCT00095173|537035039|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
148879055|NCT00095173|537035040|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
148879056|NCT00095173|537035041|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
148879057|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Death|0|||
148879058|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Death|0|||
148879059|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Death|0|||
148879060|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Death|0|||
148879061|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Death|0|||
148879062|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Death|1|||
148879063|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
148879064|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
148879065|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
148879066|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
148879067|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
148879068|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
148879069|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
148879070|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
148879071|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
148879072|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
148879073|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
148879074|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
148879075|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
148879076|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
148879077|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
148879078|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
149034487|NCT01751724|537603698|FG001|Overall Study|withdrawn by parent|2|||
149034488|NCT03395353|537603699|FG000|Overall Study|Adverse Event|20|||
149034489|NCT03395353|537603699|FG000|Overall Study|Protocol Violation|1|||
149034490|NCT03395353|537603699|FG000|Overall Study|Lack of Efficacy|3|||
149034491|NCT03395353|537603699|FG000|Overall Study|Withdrawal by Subject|24|||
149034492|NCT03395353|537603699|FG000|Overall Study|Discontinued visit|1|||
148879079|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
148879080|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
148879081|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
148879082|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
148879083|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
148879084|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
148879085|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
148879086|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
148879087|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
148879088|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
148879089|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
148879090|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
148879091|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
148879092|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
148879093|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
148879094|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
148879095|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
148879096|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
148879097|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
148879098|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
148879099|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
148879100|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
148879101|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
148879102|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
148879103|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
148879104|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
148879105|NCT00095173|537035036|FG000|Open-Label Extension Phase (Period C)|Other|0|||
148879106|NCT00095173|537035037|FG001|Open-Label Extension Phase (Period C)|Other|0|||
148879107|NCT00095173|537035038|FG002|Open-Label Extension Phase (Period C)|Other|0|||
148879108|NCT00095173|537035039|FG003|Open-Label Extension Phase (Period C)|Other|4|||
148879109|NCT00095173|537035040|FG004|Open-Label Extension Phase (Period C)|Other|6|||
148879110|NCT00095173|537035041|FG005|Open-Label Extension Phase (Period C)|Other|8|||
148879111|NCT02161757|537035044|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
148879112|NCT02161757|537035045|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
148879113|NCT02161757|537035046|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
148879114|NCT02161757|537035044|FG000|Treatment Through Study Completion|Adverse Event|1|||
148879115|NCT02161757|537035045|FG001|Treatment Through Study Completion|Adverse Event|1|||
148879116|NCT02161757|537035046|FG002|Treatment Through Study Completion|Adverse Event|0|||
148879117|NCT02161757|537035044|FG000|Treatment Through Study Completion|Protocol Violation|0|||
148879118|NCT02161757|537035045|FG001|Treatment Through Study Completion|Protocol Violation|1|||
148879119|NCT02161757|537035046|FG002|Treatment Through Study Completion|Protocol Violation|2|||
148879120|NCT02161757|537035044|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
148879121|NCT02161757|537035045|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
148879122|NCT02161757|537035046|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
148879123|NCT02161757|537035044|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
148879124|NCT02161757|537035045|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
148879125|NCT02161757|537035046|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
148879126|NCT02161757|537035044|FG000|Treatment Through Study Completion|Other|20|||
148879127|NCT02161757|537035045|FG001|Treatment Through Study Completion|Other|19|||
148879128|NCT02161757|537035046|FG002|Treatment Through Study Completion|Other|12|||
148879129|NCT02161757|537035044|FG000|Treatment Through Study Completion|Death|2|||
148879130|NCT02161757|537035045|FG001|Treatment Through Study Completion|Death|1|||
148879131|NCT02161757|537035046|FG002|Treatment Through Study Completion|Death|1|||
148879132|NCT00847197|537035047|FG000|Overall Study|Adverse Event|21|||
148879133|NCT00847197|537035048|FG001|Overall Study|Adverse Event|3|||
148879134|NCT00847197|537035047|FG000|Overall Study|Protocol Violation|0|||
148879135|NCT00847197|537035048|FG001|Overall Study|Protocol Violation|1|||
148879136|NCT00847197|537035047|FG000|Overall Study|Withdrawal by Subject|3|||
148879137|NCT00847197|537035048|FG001|Overall Study|Withdrawal by Subject|1|||
148879138|NCT01620944|537035049|FG000|Overall Study|Early termination of Study|2|||
148879139|NCT01620944|537035050|FG001|Overall Study|Early termination of Study|1|||
148879140|NCT04378114|537035051|FG000|Overall Study|Withdrawal by Subject|5|||
148879141|NCT00830180|537035052|FG000|Overall Study|Adverse Event|6|||
148879142|NCT00830180|537035052|FG000|Overall Study|Death|11|||
148879143|NCT00830180|537035052|FG000|Overall Study|Insufficient clinical response|1|||
148879144|NCT00830180|537035052|FG000|Overall Study|Withdrawal by Subject|5|||
148879145|NCT00830180|537035052|FG000|Overall Study|Progressive disease|2|||
149034493|NCT03395353|537603699|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
148879146|NCT00830180|537035052|FG000|Overall Study|Other - Unspecified|1|||
148879147|NCT01832532|537035053|FG000|Overall Study|Withdrawal by Subject|5|||
148879148|NCT01832532|537035054|FG001|Overall Study|Withdrawal by Subject|2|||
148879149|NCT00392990|537035056|FG000|Treatment on Study|Adverse Event|3|||
148879150|NCT00392990|537035057|FG001|Treatment on Study|Adverse Event|1|||
148879151|NCT00392990|537035056|FG000|Follow up for 2 Years|Death|4|||
148879152|NCT00392990|537035057|FG001|Follow up for 2 Years|Death|0|||
148879153|NCT00825812|537035061|FG000|Overall Study|Never entered follow up|0|||
148879154|NCT00825812|537035062|FG001|Overall Study|Never entered follow up|0|||
148879155|NCT00825812|537035063|FG002|Overall Study|Never entered follow up|0|||
148879156|NCT00825812|537035064|FG003|Overall Study|Never entered follow up|1|||
148879157|NCT00825812|537035061|FG000|Overall Study|Adverse Event|0|||
148879158|NCT00825812|537035062|FG001|Overall Study|Adverse Event|0|||
148879159|NCT00825812|537035063|FG002|Overall Study|Adverse Event|0|||
148879160|NCT00825812|537035064|FG003|Overall Study|Adverse Event|1|||
148879161|NCT00825812|537035061|FG000|Overall Study|Subject withdrew consent|0|||
148879162|NCT00825812|537035062|FG001|Overall Study|Subject withdrew consent|0|||
148879163|NCT00825812|537035063|FG002|Overall Study|Subject withdrew consent|3|||
148879164|NCT00825812|537035064|FG003|Overall Study|Subject withdrew consent|2|||
148879165|NCT00825812|537035061|FG000|Overall Study|Non-compliance with protocol|0|||
148879166|NCT00825812|537035062|FG001|Overall Study|Non-compliance with protocol|0|||
148879167|NCT00825812|537035063|FG002|Overall Study|Non-compliance with protocol|0|||
148879168|NCT00825812|537035064|FG003|Overall Study|Non-compliance with protocol|1|||
148879169|NCT00825812|537035061|FG000|Overall Study|Administrative|0|||
148879170|NCT00825812|537035062|FG001|Overall Study|Administrative|1|||
148879171|NCT00825812|537035063|FG002|Overall Study|Administrative|3|||
148879172|NCT00825812|537035064|FG003|Overall Study|Administrative|5|||
148879173|NCT00991406|537035066|FG000|Overall Study|One participant did not respond to FES.|1|||
148879174|NCT03824587|537035067|FG000|Run-in Period|Screen Failure|0|||
148879175|NCT03824587|537035068|FG001|Run-in Period|Screen Failure|275|||
148879176|NCT03824587|537035067|FG000|Treatment Period|Adverse Event|4|||
148879177|NCT03824587|537035068|FG001|Treatment Period|Adverse Event|1|||
148879178|NCT03824587|537035067|FG000|Treatment Period|Withdrawal by Subject|0|||
148879179|NCT03824587|537035068|FG001|Treatment Period|Withdrawal by Subject|1|||
148879180|NCT03824587|537035067|FG000|Treatment Period|Kidney Transplant|1|||
148879181|NCT03824587|537035068|FG001|Treatment Period|Kidney Transplant|1|||
148879182|NCT00986362|537035069|FG000|Overall Study|Death|2|||
148879183|NCT00986362|537035070|FG001|Overall Study|Death|0|||
148879184|NCT00986362|537035069|FG000|Overall Study|Lost to Follow-up|0|||
148879185|NCT00986362|537035070|FG001|Overall Study|Lost to Follow-up|1|||
148879186|NCT01300572|537035071|FG000|Overall Study|HAMA + post dosimetry|1|||
148879187|NCT00895453|537035072|FG000|Overall Study|Lost to Follow-up|25|||
148879188|NCT00895453|537035073|FG001|Overall Study|Lost to Follow-up|25|||
148879189|NCT00895453|537035074|FG002|Overall Study|Lost to Follow-up|23|||
148879190|NCT01736618|537035075|FG000|Overall Study|Death|294|||
148879191|NCT01736618|537035075|FG000|Overall Study|Lost to Follow-up|193|||
148879192|NCT01736618|537035075|FG000|Overall Study|Withdrawal by Subject|54|||
148879193|NCT01736618|537035075|FG000|Overall Study|Subject unable to be followed at study location|223|||
148879194|NCT01736618|537035075|FG000|Overall Study|Physician Decision|33|||
148879195|NCT01736618|537035075|FG000|Overall Study|Transplant or removal of target organ|19|||
148879196|NCT01736618|537035075|FG000|Overall Study|Change in indication or condition|78|||
148879197|NCT01736618|537035075|FG000|Overall Study|Study device explant|103|||
148879198|NCT01736618|537035075|FG000|Overall Study|Unable to complete implant|2|||
148879199|NCT04167137|537035076|FG000|Overall Study|Disease progression|1|||
148879200|NCT04167137|537035077|FG001|Overall Study|Disease progression|1|||
148879201|NCT04167137|537035078|FG002|Overall Study|Disease progression|3|||
148879202|NCT04167137|537035079|FG003|Overall Study|Disease progression|3|||
148879203|NCT04167137|537035080|FG004|Overall Study|Disease progression|2|||
148879204|NCT04167137|537035081|FG005|Overall Study|Disease progression|3|||
148879205|NCT04167137|537035082|FG006|Overall Study|Disease progression|2|||
148879206|NCT04167137|537035083|FG007|Overall Study|Disease progression|2|||
148879207|NCT04167137|537035076|FG000|Overall Study|Withdrawal by Subject|1|||
148879208|NCT04167137|537035077|FG001|Overall Study|Withdrawal by Subject|0|||
148879209|NCT04167137|537035078|FG002|Overall Study|Withdrawal by Subject|0|||
148879210|NCT04167137|537035079|FG003|Overall Study|Withdrawal by Subject|1|||
148879211|NCT04167137|537035080|FG004|Overall Study|Withdrawal by Subject|0|||
148879212|NCT04167137|537035081|FG005|Overall Study|Withdrawal by Subject|2|||
148879213|NCT04167137|537035082|FG006|Overall Study|Withdrawal by Subject|1|||
148879214|NCT04167137|537035083|FG007|Overall Study|Withdrawal by Subject|0|||
148879215|NCT04167137|537035076|FG000|Overall Study|Adverse Event|0|||
148879216|NCT04167137|537035077|FG001|Overall Study|Adverse Event|0|||
149034494|NCT03395353|537603699|FG000|Overall Study|Physician Decision|4|||
148879217|NCT04167137|537035078|FG002|Overall Study|Adverse Event|0|||
148879218|NCT04167137|537035079|FG003|Overall Study|Adverse Event|0|||
148879219|NCT04167137|537035080|FG004|Overall Study|Adverse Event|0|||
148879220|NCT04167137|537035081|FG005|Overall Study|Adverse Event|1|||
148879221|NCT04167137|537035082|FG006|Overall Study|Adverse Event|0|||
148879222|NCT04167137|537035083|FG007|Overall Study|Adverse Event|1|||
148879223|NCT04167137|537035076|FG000|Overall Study|Physician Decision|0|||
148879224|NCT04167137|537035077|FG001|Overall Study|Physician Decision|0|||
148879225|NCT04167137|537035078|FG002|Overall Study|Physician Decision|0|||
148879226|NCT04167137|537035079|FG003|Overall Study|Physician Decision|1|||
148879227|NCT04167137|537035080|FG004|Overall Study|Physician Decision|0|||
148879228|NCT04167137|537035081|FG005|Overall Study|Physician Decision|0|||
148879229|NCT04167137|537035082|FG006|Overall Study|Physician Decision|1|||
148879230|NCT04167137|537035083|FG007|Overall Study|Physician Decision|0|||
148879231|NCT04167137|537035076|FG000|Overall Study|Death|0|||
148879232|NCT04167137|537035077|FG001|Overall Study|Death|1|||
148879233|NCT04167137|537035078|FG002|Overall Study|Death|0|||
148879234|NCT04167137|537035079|FG003|Overall Study|Death|0|||
148879235|NCT04167137|537035080|FG004|Overall Study|Death|0|||
148879236|NCT04167137|537035081|FG005|Overall Study|Death|0|||
148879237|NCT04167137|537035082|FG006|Overall Study|Death|0|||
148879238|NCT04167137|537035083|FG007|Overall Study|Death|0|||
148879239|NCT04167137|537035076|FG000|Overall Study|Study terminated by Sponsor|0|||
148879240|NCT04167137|537035077|FG001|Overall Study|Study terminated by Sponsor|0|||
148879241|NCT04167137|537035078|FG002|Overall Study|Study terminated by Sponsor|0|||
148879242|NCT04167137|537035079|FG003|Overall Study|Study terminated by Sponsor|0|||
148879243|NCT04167137|537035080|FG004|Overall Study|Study terminated by Sponsor|0|||
148879244|NCT04167137|537035081|FG005|Overall Study|Study terminated by Sponsor|0|||
148879245|NCT04167137|537035082|FG006|Overall Study|Study terminated by Sponsor|0|||
148879246|NCT04167137|537035083|FG007|Overall Study|Study terminated by Sponsor|1|||
148879247|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Adverse Event|33|||
148879248|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
148879249|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
148879250|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
148879251|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Physician Decision|6|||
148879252|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
148879253|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
148879254|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
148879255|NCT00965419|537035088|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
148879256|NCT00965419|537035088|FG000|Follow-up Phase|Adverse Event|9|||
148879257|NCT00965419|537035088|FG000|Follow-up Phase|Protocol Violation|4|||
148879258|NCT00965419|537035088|FG000|Follow-up Phase|Withdrawal by Subject|8|||
148879259|NCT00965419|537035088|FG000|Follow-up Phase|Physician Decision|4|||
148879260|NCT00965419|537035088|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
148879261|NCT00965419|537035088|FG000|Follow-up Phase|Lack of Efficacy|28|||
148879262|NCT01946152|537036552|FG000|Overall Study|Adverse Event|1|||
148879263|NCT01946152|537036553|FG001|Overall Study|Adverse Event|0|||
148879264|NCT01946152|537036554|FG002|Overall Study|Adverse Event|0|||
148879265|NCT01946152|537036555|FG003|Overall Study|Adverse Event|0|||
148879266|NCT01946152|537036552|FG000|Overall Study|Withdrawal by Subject|0|||
148879267|NCT01946152|537036553|FG001|Overall Study|Withdrawal by Subject|2|||
148879268|NCT01946152|537036554|FG002|Overall Study|Withdrawal by Subject|0|||
148879269|NCT01946152|537036555|FG003|Overall Study|Withdrawal by Subject|0|||
148879270|NCT01946152|537036552|FG000|Overall Study|Progression|0|||
148879271|NCT01946152|537036553|FG001|Overall Study|Progression|1|||
148879272|NCT01946152|537036554|FG002|Overall Study|Progression|4|||
148879273|NCT01946152|537036555|FG003|Overall Study|Progression|7|||
148879274|NCT01946152|537036552|FG000|Overall Study|Physician Decision|0|||
148879275|NCT01946152|537036553|FG001|Overall Study|Physician Decision|0|||
148879276|NCT01946152|537036554|FG002|Overall Study|Physician Decision|1|||
148879277|NCT01946152|537036555|FG003|Overall Study|Physician Decision|0|||
148879278|NCT01946152|537036552|FG000|Overall Study|Second malignancy|0|||
148879279|NCT01946152|537036553|FG001|Overall Study|Second malignancy|0|||
148879280|NCT01946152|537036554|FG002|Overall Study|Second malignancy|1|||
148879281|NCT01946152|537036555|FG003|Overall Study|Second malignancy|0|||
148879282|NCT01946152|537036552|FG000|Overall Study|Adverse Event|0|||
148879283|NCT01946152|537036553|FG001|Overall Study|Adverse Event|0|||
148879284|NCT01946152|537036554|FG002|Overall Study|Adverse Event|0|||
148879285|NCT01946152|537036555|FG003|Overall Study|Adverse Event|1|||
148879286|NCT03712787|537036556|FG000|Overall Study|Adverse Event|2|||
148879287|NCT03712787|537036557|FG001|Overall Study|Adverse Event|3|||
148879288|NCT03712787|537036558|FG002|Overall Study|Adverse Event|0|||
148879289|NCT03712787|537036559|FG003|Overall Study|Adverse Event|4|||
148879290|NCT03712787|537036556|FG000|Overall Study|Withdrawal by Subject|4|||
148879291|NCT03712787|537036557|FG001|Overall Study|Withdrawal by Subject|14|||
148879292|NCT03712787|537036558|FG002|Overall Study|Withdrawal by Subject|12|||
148879293|NCT03712787|537036559|FG003|Overall Study|Withdrawal by Subject|8|||
148879294|NCT03712787|537036556|FG000|Overall Study|Lost to Follow-up|1|||
148879295|NCT03712787|537036557|FG001|Overall Study|Lost to Follow-up|1|||
148879296|NCT03712787|537036558|FG002|Overall Study|Lost to Follow-up|2|||
148879297|NCT03712787|537036559|FG003|Overall Study|Lost to Follow-up|1|||
148879298|NCT03712787|537036556|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
148879299|NCT03712787|537036557|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
148879300|NCT03712787|537036558|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
148879301|NCT03712787|537036559|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
148879302|NCT03712787|537036556|FG000|Overall Study|COVID-19 Infection|0|||
148879303|NCT03712787|537036557|FG001|Overall Study|COVID-19 Infection|1|||
148879304|NCT03712787|537036558|FG002|Overall Study|COVID-19 Infection|0|||
148879305|NCT03712787|537036559|FG003|Overall Study|COVID-19 Infection|0|||
148879306|NCT03712787|537036556|FG000|Overall Study|Other, Not Specified|79|||
148879307|NCT03712787|537036557|FG001|Overall Study|Other, Not Specified|77|||
148879308|NCT03712787|537036558|FG002|Overall Study|Other, Not Specified|74|||
148879309|NCT03712787|537036559|FG003|Overall Study|Other, Not Specified|78|||
148879310|NCT01865448|537036560|FG000|Overall Study|Adverse Event|1|||
148879311|NCT01865448|537036561|FG001|Overall Study|Adverse Event|1|||
148879312|NCT01865448|537036560|FG000|Overall Study|Pregnancy|0|||
148879313|NCT01865448|537036561|FG001|Overall Study|Pregnancy|1|||
148879314|NCT01865448|537036560|FG000|Overall Study|dropout unrelated to study|1|||
148879315|NCT01865448|537036561|FG001|Overall Study|dropout unrelated to study|1|||
148879316|NCT05111249|537036566|FG000|Overall Study|Lost to Follow-up|0|||
148879317|NCT05111249|537036567|FG001|Overall Study|Lost to Follow-up|2|||
148879318|NCT05111249|537036566|FG000|Overall Study|Physician Decision|0|||
148879319|NCT05111249|537036567|FG001|Overall Study|Physician Decision|1|||
148879320|NCT05111249|537036566|FG000|Overall Study|Participant decision|1|||
148879321|NCT05111249|537036567|FG001|Overall Study|Participant decision|5|||
148879322|NCT05128578|537036568|FG000|Overall Study|Withdrawal by Subject|9|||
148879323|NCT05128578|537036568|FG000|Overall Study|Lost to Follow-up|5|||
148879324|NCT00799266|537036573|FG000|Overall Study|Adverse Event|0|||
148879325|NCT00799266|537036574|FG001|Overall Study|Adverse Event|1|||
148879326|NCT00799266|537036573|FG000|Overall Study|Subject withdrew consent|3|||
148879327|NCT00799266|537036574|FG001|Overall Study|Subject withdrew consent|0|||
148879328|NCT01702025|537036575|FG000|Overall Study|Equipment failure|1|||
148879329|NCT01702025|537036576|FG001|Overall Study|Equipment failure|0|||
148879330|NCT01702025|537036577|FG002|Overall Study|Equipment failure|0|||
148879331|NCT01702025|537036578|FG003|Overall Study|Equipment failure|0|||
148879332|NCT01702025|537036575|FG000|Overall Study|Adverse Event|1|||
148879333|NCT01702025|537036576|FG001|Overall Study|Adverse Event|1|||
148879334|NCT01702025|537036577|FG002|Overall Study|Adverse Event|1|||
148879335|NCT01702025|537036578|FG003|Overall Study|Adverse Event|0|||
148879336|NCT02679755|537036579|FG000|Overall Study|Death|0|||
148879337|NCT02679755|537036580|FG001|Overall Study|Death|3|||
148879338|NCT02679755|537036579|FG000|Overall Study|Global deterioration of health status|1|||
148879339|NCT02679755|537036580|FG001|Overall Study|Global deterioration of health status|8|||
148879340|NCT02679755|537036579|FG000|Overall Study|Lost to Follow-up|1|||
148879341|NCT02679755|537036580|FG001|Overall Study|Lost to Follow-up|0|||
148879342|NCT02679755|537036579|FG000|Overall Study|Objective progression or relapse|24|||
148879343|NCT02679755|537036580|FG001|Overall Study|Objective progression or relapse|83|||
148879344|NCT02679755|537036579|FG000|Overall Study|Not defined|0|||
148879345|NCT02679755|537036580|FG001|Overall Study|Not defined|2|||
148879346|NCT02679755|537036579|FG000|Overall Study|Withdrawal by participant|6|||
148879347|NCT02679755|537036580|FG001|Overall Study|Withdrawal by participant|3|||
148879348|NCT02679755|537036579|FG000|Overall Study|Adverse Event|1|||
148879349|NCT02679755|537036580|FG001|Overall Study|Adverse Event|4|||
148879350|NCT02679755|537036579|FG000|Overall Study|Adverse events not related to study drug|1|||
148879351|NCT02679755|537036580|FG001|Overall Study|Adverse events not related to study drug|2|||
148879352|NCT01061359|537036581|FG000|Overall Study|Death|32|||
148879353|NCT01061359|537036581|FG000|Overall Study|Lost to Follow-up|1072|||
148879354|NCT01061359|537036581|FG000|Overall Study|Relapse|187|||
148879355|NCT01061359|537036581|FG000|Overall Study|Secondary neoplasm|11|||
148879356|NCT02610777|537036584|FG000|Overall Study|Lost to Follow-up|1|||
148879357|NCT02610777|537036585|FG001|Overall Study|Lost to Follow-up|0|||
148879358|NCT02610777|537036584|FG000|Overall Study|Site Terminated by Sponsor|9|||
148879359|NCT02610777|537036585|FG001|Overall Study|Site Terminated by Sponsor|8|||
148879360|NCT02610777|537036584|FG000|Overall Study|Withdrawal by Subject|2|||
148879361|NCT02610777|537036585|FG001|Overall Study|Withdrawal by Subject|2|||
148879362|NCT02610777|537036584|FG000|Overall Study|Reason not Specified|0|||
148879363|NCT02610777|537036585|FG001|Overall Study|Reason not Specified|1|||
148879364|NCT02610777|537036584|FG000|Overall Study|Death|50|||
148879365|NCT02610777|537036585|FG001|Overall Study|Death|47|||
148879366|NCT00732875|537036586|FG000|Overall Study|Adverse Event|16|||
148879367|NCT00732875|537036586|FG000|Overall Study|Withdrawal by Subject|6|||
148879368|NCT00732875|537036586|FG000|Overall Study|Lack of Efficacy|13|||
148879369|NCT00660179|537036591|FG000|Overall Study|Death|44|||
148879370|NCT00660179|537036592|FG001|Overall Study|Death|47|||
148879371|NCT00660179|537036593|FG002|Overall Study|Death|34|||
148879372|NCT00660179|537036591|FG000|Overall Study|Withdrawal of consent|4|||
148879373|NCT00660179|537036592|FG001|Overall Study|Withdrawal of consent|6|||
148879374|NCT00660179|537036593|FG002|Overall Study|Withdrawal of consent|4|||
148879375|NCT00660179|537036591|FG000|Overall Study|Lost to Follow-up|7|||
148879376|NCT00660179|537036592|FG001|Overall Study|Lost to Follow-up|5|||
148879377|NCT00660179|537036593|FG002|Overall Study|Lost to Follow-up|2|||
148879378|NCT00660179|537036591|FG000|Overall Study|Administrative reason|0|||
148879379|NCT00660179|537036592|FG001|Overall Study|Administrative reason|0|||
148879380|NCT00660179|537036593|FG002|Overall Study|Administrative reason|1|||
148879381|NCT00660179|537036591|FG000|Overall Study|Incorrect randomization|1|||
148879382|NCT00660179|537036592|FG001|Overall Study|Incorrect randomization|0|||
148879383|NCT00660179|537036593|FG002|Overall Study|Incorrect randomization|0|||
148879384|NCT03056339|537036596|FG000|Overall Study|Failed Requirements|0|||
148879385|NCT03056339|537036597|FG001|Overall Study|Failed Requirements|2|||
148879386|NCT03056339|537036598|FG002|Overall Study|Failed Requirements|7|||
148879387|NCT03056339|537036599|FG003|Overall Study|Failed Requirements|1|||
148879388|NCT04171219|537036602|FG000|Overall Study|Adverse Event|1|||
148879389|NCT04171219|537036603|FG001|Overall Study|Adverse Event|0|||
148879390|NCT04171219|537036602|FG000|Overall Study|Death|0|||
148879391|NCT04171219|537036603|FG001|Overall Study|Death|1|||
148879392|NCT04171219|537036602|FG000|Overall Study|Lack of Efficacy|9|||
148879393|NCT04171219|537036603|FG001|Overall Study|Lack of Efficacy|13|||
148879394|NCT04171219|537036602|FG000|Overall Study|Withdrawal by Subject|1|||
148879395|NCT04171219|537036603|FG001|Overall Study|Withdrawal by Subject|2|||
148879396|NCT04171219|537036602|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
148879397|NCT04171219|537036603|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
148879398|NCT04171219|537036602|FG000|Overall Study|Clinical PD/Patient choice|1|||
148879399|NCT04171219|537036603|FG001|Overall Study|Clinical PD/Patient choice|0|||
148879400|NCT04171219|537036602|FG000|Overall Study|Toxicity/ Patient choice|1|||
148879401|NCT04171219|537036603|FG001|Overall Study|Toxicity/ Patient choice|0|||
148879402|NCT02974257|537036606|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
148879403|NCT02974257|537036607|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
149034495|NCT03395353|537603699|FG000|Overall Study|Early termination of overall study|33|||
149034496|NCT02013037|537603704|FG000|Overall Study|Death|6|||
149034497|NCT02013037|537603704|FG000|Overall Study|Withdrawal by Subject|1|||
149034498|NCT02013037|537603704|FG000|Overall Study|Awaiting Transplantation|7|||
149034499|NCT02013037|537603704|FG000|Overall Study|Transplanted without DSA|2|||
149034500|NCT02465359|537603705|FG000|Overall Study|Lack of Efficacy|1|||
149034501|NCT02465359|537603705|FG000|Overall Study|Withdrawal by Subject|1|||
149034502|NCT02465359|537603705|FG000|Overall Study|Adverse Event|1|||
149034503|NCT00954707|537605452|FG000|Overall Study|Death|34|||
149034504|NCT00954707|537605452|FG000|Overall Study|Withdrawal by Subject|100|||
149034505|NCT00954707|537605452|FG000|Overall Study|Lost to Follow-up|33|||
149034506|NCT01070888|537605453|FG000|First Intervention (14 Days)|Adverse Event|0|||
149034507|NCT01070888|537605454|FG001|First Intervention (14 Days)|Adverse Event|1|||
149034508|NCT01070888|537605453|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
149034509|NCT01070888|537605454|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
149034510|NCT01070888|537605453|FG000|Washout (14 Days)|Physician Decision|1|||
149034511|NCT01070888|537605454|FG001|Washout (14 Days)|Physician Decision|0|||
149034512|NCT02631148|537605457|FG000|Overall Study|8 were ineligible|8|||
149034513|NCT02631148|537605458|FG001|Overall Study|8 were ineligible|0|||
148879404|NCT02974257|537036606|FG000|Overall Study|Clinical indication for thiamine|1|||
148879405|NCT02974257|537036607|FG001|Overall Study|Clinical indication for thiamine|0|||
148879406|NCT02974257|537036606|FG000|Overall Study|Already on thiamine|1|||
148879407|NCT02974257|537036607|FG001|Overall Study|Already on thiamine|0|||
148879408|NCT02974257|537036606|FG000|Overall Study|Extubated prior to study drug|0|||
148879409|NCT02974257|537036607|FG001|Overall Study|Extubated prior to study drug|1|||
148879410|NCT02974257|537036606|FG000|Overall Study|Death|0|||
148879411|NCT02974257|537036607|FG001|Overall Study|Death|1|||
148879412|NCT00398567|537036608|FG000|Overall Study|Disease Progression|3|||
148879413|NCT00398567|537036609|FG001|Overall Study|Disease Progression|4|||
148879414|NCT00398567|537036610|FG002|Overall Study|Disease Progression|27|||
148879415|NCT00398567|537036608|FG000|Overall Study|Withdrawal by Subject|1|||
148879416|NCT00398567|537036609|FG001|Overall Study|Withdrawal by Subject|0|||
148879417|NCT00398567|537036610|FG002|Overall Study|Withdrawal by Subject|4|||
148879418|NCT00398567|537036608|FG000|Overall Study|Adverse Event|0|||
148879419|NCT00398567|537036609|FG001|Overall Study|Adverse Event|0|||
148879420|NCT00398567|537036610|FG002|Overall Study|Adverse Event|2|||
148879421|NCT00398567|537036608|FG000|Overall Study|Protocol Violation|0|||
148879422|NCT00398567|537036609|FG001|Overall Study|Protocol Violation|0|||
148879423|NCT00398567|537036610|FG002|Overall Study|Protocol Violation|1|||
148879424|NCT01363908|537036611|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
149034514|NCT02631148|537605457|FG000|Overall Study|Withdrawal by Subject|1|||
149034515|NCT02631148|537605458|FG001|Overall Study|Withdrawal by Subject|0|||
149034516|NCT02631148|537605457|FG000|Overall Study|PAH not available to study participant|1|||
149034517|NCT02631148|537605458|FG001|Overall Study|PAH not available to study participant|0|||
148879425|NCT01363908|537036612|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
148879426|NCT01363908|537036611|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
148879427|NCT01363908|537036612|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
148879428|NCT01363908|537036611|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
148879429|NCT01363908|537036612|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
148879430|NCT01363908|537036611|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
149001008|NCT04958785|537480846|FG001|Overall Study|Study Terminated by Sponsor|10|||
149001009|NCT04958785|537480847|FG002|Overall Study|Study Terminated by Sponsor|7|||
149001010|NCT04958785|537480848|FG003|Overall Study|Study Terminated by Sponsor|6|||
149001011|NCT04958785|537480849|FG004|Overall Study|Study Terminated by Sponsor|34|||
149001012|NCT04958785|537480845|FG000|Overall Study|Death|2|||
149001013|NCT04958785|537480846|FG001|Overall Study|Death|3|||
149001014|NCT04958785|537480847|FG002|Overall Study|Death|4|||
149001015|NCT04958785|537480848|FG003|Overall Study|Death|5|||
149001016|NCT04958785|537480849|FG004|Overall Study|Death|5|||
149001017|NCT04958785|537480845|FG000|Overall Study|Withdrew consent|2|||
149001018|NCT04958785|537480846|FG001|Overall Study|Withdrew consent|0|||
149001019|NCT04958785|537480847|FG002|Overall Study|Withdrew consent|3|||
149001020|NCT04958785|537480848|FG003|Overall Study|Withdrew consent|1|||
149001021|NCT04958785|537480849|FG004|Overall Study|Withdrew consent|0|||
149001022|NCT04958785|537480845|FG000|Overall Study|Investigator's discretion|0|||
149001023|NCT04958785|537480846|FG001|Overall Study|Investigator's discretion|1|||
149001024|NCT04958785|537480847|FG002|Overall Study|Investigator's discretion|0|||
149001025|NCT04958785|537480848|FG003|Overall Study|Investigator's discretion|1|||
149001026|NCT04958785|537480849|FG004|Overall Study|Investigator's discretion|2|||
149001027|NCT04958785|537480845|FG000|Overall Study|Adverse Event|0|||
149001028|NCT04958785|537480846|FG001|Overall Study|Adverse Event|0|||
149001029|NCT04958785|537480847|FG002|Overall Study|Adverse Event|0|||
149001030|NCT04958785|537480848|FG003|Overall Study|Adverse Event|0|||
149001031|NCT04958785|537480849|FG004|Overall Study|Adverse Event|1|||
149001032|NCT04958785|537480845|FG000|Overall Study|Lost to Follow-up|0|||
149001033|NCT04958785|537480846|FG001|Overall Study|Lost to Follow-up|0|||
149001034|NCT04958785|537480847|FG002|Overall Study|Lost to Follow-up|0|||
149001035|NCT04958785|537480848|FG003|Overall Study|Lost to Follow-up|0|||
149001036|NCT04958785|537480849|FG004|Overall Study|Lost to Follow-up|1|||
149001037|NCT01224925|537480850|FG000|Overall Study|Lost to Follow-up|3|||
149001038|NCT01224925|537480851|FG001|Overall Study|Lost to Follow-up|2|||
149001039|NCT00949884|537480854|FG000|Overall Study|Adverse Event|14|||
149001040|NCT00949884|537480855|FG001|Overall Study|Adverse Event|3|||
149001041|NCT00949884|537480856|FG002|Overall Study|Adverse Event|12|||
149001042|NCT00949884|537480854|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
149001043|NCT00949884|537480855|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
149001044|NCT00949884|537480856|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
149001045|NCT00949884|537480854|FG000|Overall Study|Lost to Follow-up|7|||
149001046|NCT00949884|537480855|FG001|Overall Study|Lost to Follow-up|5|||
149001047|NCT00949884|537480856|FG002|Overall Study|Lost to Follow-up|5|||
149001048|NCT00949884|537480854|FG000|Overall Study|Physician Decision|5|||
149001049|NCT00949884|537480855|FG001|Overall Study|Physician Decision|0|||
149001050|NCT00949884|537480856|FG002|Overall Study|Physician Decision|6|||
149001051|NCT00949884|537480854|FG000|Overall Study|Treatment non-compliance|5|||
149001052|NCT00949884|537480855|FG001|Overall Study|Treatment non-compliance|0|||
149001053|NCT00949884|537480856|FG002|Overall Study|Treatment non-compliance|8|||
149001054|NCT00949884|537480854|FG000|Overall Study|Withdrawal by Subject|13|||
149001055|NCT00949884|537480855|FG001|Overall Study|Withdrawal by Subject|4|||
149001056|NCT00949884|537480856|FG002|Overall Study|Withdrawal by Subject|16|||
149001057|NCT00949884|537480854|FG000|Overall Study|Lack of Efficacy|4|||
149001058|NCT00949884|537480855|FG001|Overall Study|Lack of Efficacy|2|||
149001059|NCT00949884|537480856|FG002|Overall Study|Lack of Efficacy|7|||
149001060|NCT00949884|537480854|FG000|Overall Study|Study terminated by sponsor|0|||
149001061|NCT00949884|537480855|FG001|Overall Study|Study terminated by sponsor|0|||
149001062|NCT00949884|537480856|FG002|Overall Study|Study terminated by sponsor|1|||
149001063|NCT00245102|537480857|FG000|Overall Study|Not Treated|1|||
149001064|NCT00245102|537480858|FG001|Overall Study|Not Treated|0|||
149001065|NCT00245102|537480859|FG002|Overall Study|Not Treated|1|||
149001066|NCT00245102|537480860|FG003|Overall Study|Not Treated|0|||
149001067|NCT00245102|537480861|FG004|Overall Study|Not Treated|0|||
149001068|NCT00245102|537480862|FG005|Overall Study|Not Treated|0|||
149001069|NCT00245102|537480857|FG000|Overall Study|Protocol Violation|1|||
149001070|NCT00245102|537480858|FG001|Overall Study|Protocol Violation|0|||
149001071|NCT00245102|537480859|FG002|Overall Study|Protocol Violation|0|||
149001072|NCT00245102|537480860|FG003|Overall Study|Protocol Violation|0|||
149001073|NCT00245102|537480861|FG004|Overall Study|Protocol Violation|0|||
149001074|NCT00245102|537480862|FG005|Overall Study|Protocol Violation|0|||
149001075|NCT00245102|537480857|FG000|Overall Study|Death|0|||
149001076|NCT00245102|537480858|FG001|Overall Study|Death|0|||
149001077|NCT00245102|537480859|FG002|Overall Study|Death|0|||
149001078|NCT00245102|537480860|FG003|Overall Study|Death|1|||
149001079|NCT00245102|537480861|FG004|Overall Study|Death|0|||
149001080|NCT00245102|537480862|FG005|Overall Study|Death|0|||
149001081|NCT00245102|537480857|FG000|Overall Study|Adverse Event|4|||
149001082|NCT00245102|537480858|FG001|Overall Study|Adverse Event|2|||
149001083|NCT00245102|537480859|FG002|Overall Study|Adverse Event|5|||
149001084|NCT00245102|537480860|FG003|Overall Study|Adverse Event|1|||
149001085|NCT00245102|537480861|FG004|Overall Study|Adverse Event|0|||
149001086|NCT00245102|537480862|FG005|Overall Study|Adverse Event|2|||
149001087|NCT00245102|537480857|FG000|Overall Study|Decline in performance|0|||
149034518|NCT00357396|537605459|FG000|Overall Study|Adverse Event|1|||
149001088|NCT00245102|537480858|FG001|Overall Study|Decline in performance|2|||
149001089|NCT00245102|537480859|FG002|Overall Study|Decline in performance|0|||
149001090|NCT00245102|537480860|FG003|Overall Study|Decline in performance|1|||
149001091|NCT00245102|537480861|FG004|Overall Study|Decline in performance|0|||
149001092|NCT00245102|537480862|FG005|Overall Study|Decline in performance|2|||
149001093|NCT00245102|537480857|FG000|Overall Study|Participant needed surgery|0|||
149001094|NCT00245102|537480858|FG001|Overall Study|Participant needed surgery|0|||
149001095|NCT00245102|537480859|FG002|Overall Study|Participant needed surgery|1|||
149001096|NCT00245102|537480860|FG003|Overall Study|Participant needed surgery|0|||
149001097|NCT00245102|537480861|FG004|Overall Study|Participant needed surgery|0|||
149001098|NCT00245102|537480862|FG005|Overall Study|Participant needed surgery|0|||
149001099|NCT00245102|537480857|FG000|Overall Study|Clinical progression|1|||
149001100|NCT00245102|537480858|FG001|Overall Study|Clinical progression|0|||
149001101|NCT00245102|537480859|FG002|Overall Study|Clinical progression|0|||
149001102|NCT00245102|537480860|FG003|Overall Study|Clinical progression|0|||
149001103|NCT00245102|537480861|FG004|Overall Study|Clinical progression|0|||
149001104|NCT00245102|537480862|FG005|Overall Study|Clinical progression|0|||
149001105|NCT02472652|537480868|FG000|Overall Study|Lost to Follow-up|1|||
149001106|NCT00998400|537480873|FG000|Overall Study|Lack of interest/motivation|1|||
149001107|NCT00998400|537480874|FG001|Overall Study|Lack of interest/motivation|2|||
149001108|NCT00998400|537480873|FG000|Overall Study|Logistical problems|1|||
149001109|NCT00998400|537480874|FG001|Overall Study|Logistical problems|0|||
149001110|NCT03704584|537480875|FG000|Overall Study|Withdrawal by Subject|1|||
149001111|NCT03704584|537480876|FG001|Overall Study|Withdrawal by Subject|0|||
149001112|NCT03185832|537480877|FG000|Overall Study|Death|9|||
149001113|NCT03185832|537480878|FG001|Overall Study|Death|14|||
149001114|NCT03185832|537480879|FG002|Overall Study|Death|9|||
149001115|NCT03185832|537480880|FG003|Overall Study|Death|7|||
149001116|NCT03185832|537480877|FG000|Overall Study|Withdrawn - vital status available|0|||
149001117|NCT03185832|537480878|FG001|Overall Study|Withdrawn - vital status available|1|||
149001118|NCT03185832|537480879|FG002|Overall Study|Withdrawn - vital status available|1|||
149001119|NCT03185832|537480880|FG003|Overall Study|Withdrawn - vital status available|4|||
149001120|NCT01083641|537480881|FG000|Overall Study|Withdrawal by Subject|2|||
149001121|NCT03439189|537480882|FG000|Overall Study|Protocol Violation|19|||
149001122|NCT03439189|537480882|FG000|Overall Study|Lack of Efficacy|63|||
149001123|NCT03412812|537480883|FG000|Level 1|Death|3|||
149001124|NCT03412812|537480884|FG001|Level 1|Death|0|||
149001125|NCT03412812|537480883|FG000|Level 1|Adverse Event|0|||
149001126|NCT03412812|537480884|FG001|Level 1|Adverse Event|1|||
149001127|NCT01777321|537480885|FG000|Overall Study|Withdrawal by Subject|0|||
149001128|NCT01777321|537480886|FG001|Overall Study|Withdrawal by Subject|1|||
149001129|NCT03837509|537480887|FG000|Phase 1|Death|5|||
149001130|NCT03837509|537480888|FG001|Phase 1|Death|2|||
149001131|NCT03837509|537480889|FG002|Phase 1|Death|0|||
149001132|NCT03837509|537480890|FG003|Phase 1|Death|0|||
149001133|NCT03837509|537480891|FG004|Phase 1|Death|0|||
149001134|NCT03837509|537480887|FG000|Phase 2|Death|0|||
149001135|NCT03837509|537480888|FG001|Phase 2|Death|0|||
149001136|NCT03837509|537480889|FG002|Phase 2|Death|0|||
149001137|NCT03837509|537480890|FG003|Phase 2|Death|1|||
149001138|NCT03837509|537480891|FG004|Phase 2|Death|1|||
149001139|NCT05131165|537480895|FG000|Overall Study|Death|1|||
149001140|NCT05131165|537480896|FG001|Overall Study|Death|1|||
149001141|NCT05131165|537480897|FG002|Overall Study|Death|0|||
149001142|NCT05131165|537480895|FG000|Overall Study|Lost to Follow-up|2|||
149001143|NCT05131165|537480896|FG001|Overall Study|Lost to Follow-up|2|||
149001144|NCT05131165|537480897|FG002|Overall Study|Lost to Follow-up|5|||
149001145|NCT05131165|537480895|FG000|Overall Study|Transferred out of clinic|1|||
149001146|NCT05131165|537480896|FG001|Overall Study|Transferred out of clinic|0|||
149001147|NCT05131165|537480897|FG002|Overall Study|Transferred out of clinic|3|||
149001148|NCT05131165|537480895|FG000|Overall Study|Dropped out|1|||
149001149|NCT05131165|537480896|FG001|Overall Study|Dropped out|2|||
149001150|NCT05131165|537480897|FG002|Overall Study|Dropped out|0|||
149001151|NCT01050816|537480911|FG000|Overall Study|Lost to Follow-up|2|||
149001152|NCT01050816|537480911|FG000|Overall Study|patient's refusal|2|||
149034519|NCT00357396|537605460|FG001|Overall Study|Adverse Event|0|||
149001153|NCT04570436|537480915|FG000|Overall Study|Adverse Event|0|||
149001154|NCT04570436|537480916|FG001|Overall Study|Adverse Event|0|||
149001155|NCT04570436|537480917|FG002|Overall Study|Adverse Event|1|||
149001156|NCT04570436|537480918|FG003|Overall Study|Adverse Event|0|||
149001157|NCT04570436|537480919|FG004|Overall Study|Adverse Event|0|||
149001158|NCT04570436|537480920|FG005|Overall Study|Adverse Event|0|||
149001159|NCT04570436|537480921|FG006|Overall Study|Adverse Event|0|||
149001160|NCT04570436|537480922|FG007|Overall Study|Adverse Event|0|||
149001161|NCT04570436|537480923|FG008|Overall Study|Adverse Event|0|||
149001162|NCT04570436|537480924|FG009|Overall Study|Adverse Event|0|||
149001163|NCT04570436|537480915|FG000|Overall Study|Physician Decision|1|||
149001164|NCT04570436|537480916|FG001|Overall Study|Physician Decision|0|||
149001165|NCT04570436|537480917|FG002|Overall Study|Physician Decision|0|||
149001166|NCT04570436|537480918|FG003|Overall Study|Physician Decision|0|||
149034520|NCT00487578|537605462|FG000|Overall Study|Adverse Event|1|||
148879431|NCT01363908|537036612|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
148879432|NCT04878211|537036615|FG000|Overall Study|Lost to Follow-up|0|||
148879433|NCT04878211|537036616|FG001|Overall Study|Lost to Follow-up|0|||
148879434|NCT04878211|537036617|FG002|Overall Study|Lost to Follow-up|0|||
148879435|NCT04878211|537036618|FG003|Overall Study|Lost to Follow-up|1|||
148879436|NCT04878211|537036619|FG004|Overall Study|Lost to Follow-up|0|||
148879437|NCT04878211|537036620|FG005|Overall Study|Lost to Follow-up|1|||
148879438|NCT04878211|537036615|FG000|Overall Study|Protocol deviation|1|||
149001167|NCT04570436|537480919|FG004|Overall Study|Physician Decision|0|||
149001168|NCT04570436|537480920|FG005|Overall Study|Physician Decision|0|||
149001169|NCT04570436|537480921|FG006|Overall Study|Physician Decision|0|||
149001170|NCT04570436|537480922|FG007|Overall Study|Physician Decision|0|||
149001171|NCT04570436|537480923|FG008|Overall Study|Physician Decision|0|||
149001172|NCT04570436|537480924|FG009|Overall Study|Physician Decision|0|||
149001173|NCT01274182|537480925|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
149001174|NCT01274182|537480926|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
149001175|NCT01274182|537480927|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
149001176|NCT01274182|537480925|FG000|Overall Study|Adverse Event|4|||
149001177|NCT01274182|537480926|FG001|Overall Study|Adverse Event|5|||
149001178|NCT01274182|537480927|FG002|Overall Study|Adverse Event|3|||
149001179|NCT01274182|537480925|FG000|Overall Study|Withdrawal by Subject|5|||
149001180|NCT01274182|537480926|FG001|Overall Study|Withdrawal by Subject|5|||
149001181|NCT01274182|537480927|FG002|Overall Study|Withdrawal by Subject|3|||
149001182|NCT01274182|537480925|FG000|Overall Study|Lost to Follow-up|2|||
149001183|NCT01274182|537480926|FG001|Overall Study|Lost to Follow-up|3|||
149001184|NCT01274182|537480927|FG002|Overall Study|Lost to Follow-up|1|||
149001185|NCT01274182|537480925|FG000|Overall Study|Protocol Violation|3|||
149001186|NCT01274182|537480926|FG001|Overall Study|Protocol Violation|2|||
149001187|NCT01274182|537480927|FG002|Overall Study|Protocol Violation|0|||
149001188|NCT01274182|537480925|FG000|Overall Study|Death|1|||
149001189|NCT01274182|537480926|FG001|Overall Study|Death|0|||
149001190|NCT01274182|537480927|FG002|Overall Study|Death|1|||
149001191|NCT01822587|537480928|FG000|Overall Study|Lost to Follow-up|7|||
149001192|NCT01822587|537480929|FG001|Overall Study|Lost to Follow-up|9|||
149001193|NCT01822587|537480930|FG002|Overall Study|Lost to Follow-up|12|||
149001194|NCT01822587|537480928|FG000|Overall Study|Physician Decision|9|||
149001195|NCT01822587|537480929|FG001|Overall Study|Physician Decision|6|||
149001196|NCT01822587|537480930|FG002|Overall Study|Physician Decision|6|||
149001197|NCT00658567|537480931|FG000|Overall Study|Adverse Event|5|||
149001198|NCT00658567|537480932|FG001|Overall Study|Adverse Event|2|||
149001199|NCT00658567|537480933|FG002|Overall Study|Adverse Event|3|||
149001200|NCT00658567|537480931|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
149001201|NCT00658567|537480932|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
149001202|NCT00658567|537480933|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
149001203|NCT00658567|537480931|FG000|Overall Study|Physician Decision|0|||
149001204|NCT00658567|537480932|FG001|Overall Study|Physician Decision|1|||
149001205|NCT00658567|537480933|FG002|Overall Study|Physician Decision|0|||
149001206|NCT00658567|537480931|FG000|Overall Study|At Discretion of Sponsor|1|||
149001207|NCT00658567|537480932|FG001|Overall Study|At Discretion of Sponsor|1|||
149001208|NCT00658567|537480933|FG002|Overall Study|At Discretion of Sponsor|1|||
149001209|NCT00691938|537480934|FG000|Overall Study|QTc prolongation|1|||
149001210|NCT00691938|537480935|FG001|Overall Study|QTc prolongation|0|||
149001211|NCT00691938|537480936|FG002|Overall Study|QTc prolongation|0|||
149001212|NCT00691938|537480937|FG003|Overall Study|QTc prolongation|0|||
149001213|NCT00691938|537480938|FG004|Overall Study|QTc prolongation|0|||
149001214|NCT00691938|537480939|FG005|Overall Study|QTc prolongation|0|||
149001215|NCT00691938|537480940|FG006|Overall Study|QTc prolongation|0|||
149001216|NCT04860518|537480941|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
149001217|NCT04860518|537480942|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
149001218|NCT00594854|537480945|FG000|Overall Study|Study terminated|7|||
149001219|NCT00594854|537480946|FG001|Overall Study|Study terminated|10|||
149001220|NCT03172702|537480949|FG000|Overall Study|Adverse Event|9|||
149001221|NCT03172702|537480949|FG000|Overall Study|Death|2|||
148879439|NCT04878211|537036616|FG001|Overall Study|Protocol deviation|0|||
148879440|NCT04878211|537036617|FG002|Overall Study|Protocol deviation|0|||
148879441|NCT04878211|537036618|FG003|Overall Study|Protocol deviation|0|||
149001222|NCT03172702|537480949|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
149001223|NCT03172702|537480949|FG000|Overall Study|Withdrawal by Subject|5|||
149001224|NCT03172702|537480949|FG000|Overall Study|Other|2|||
149001225|NCT03292146|537480950|FG000|Baseline to 12 months|Relocation|1|||
149001226|NCT03292146|537480951|FG001|Baseline to 12 months|Relocation|0|||
149001227|NCT03292146|537480950|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
149001228|NCT03292146|537480951|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
149001229|NCT03292146|537480950|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
149001230|NCT03292146|537480951|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
149001231|NCT03292146|537480950|FG000|12 months to 24 months|Planning pregnancy|2|||
149034521|NCT00487578|537605463|FG001|Overall Study|Adverse Event|2|||
149034522|NCT00487578|537605462|FG000|Overall Study|Lack of Efficacy|0|||
148879442|NCT04878211|537036619|FG004|Overall Study|Protocol deviation|0|||
148879443|NCT04878211|537036620|FG005|Overall Study|Protocol deviation|0|||
148879444|NCT04878211|537036615|FG000|Overall Study|Study terminated by sponsor|0|||
148879445|NCT04878211|537036616|FG001|Overall Study|Study terminated by sponsor|0|||
148879446|NCT04878211|537036617|FG002|Overall Study|Study terminated by sponsor|0|||
148879447|NCT04878211|537036618|FG003|Overall Study|Study terminated by sponsor|0|||
148879448|NCT04878211|537036619|FG004|Overall Study|Study terminated by sponsor|9|||
148879449|NCT04878211|537036620|FG005|Overall Study|Study terminated by sponsor|4|||
148879450|NCT04878211|537036615|FG000|Overall Study|Subject decision|0|||
148879451|NCT04878211|537036616|FG001|Overall Study|Subject decision|0|||
148879452|NCT04878211|537036617|FG002|Overall Study|Subject decision|0|||
148879453|NCT04878211|537036618|FG003|Overall Study|Subject decision|0|||
148879454|NCT04878211|537036619|FG004|Overall Study|Subject decision|1|||
148879455|NCT04878211|537036620|FG005|Overall Study|Subject decision|0|||
148879456|NCT01687101|537036627|FG000|Overall Study|Lost to Follow-up|7|||
149034523|NCT00487578|537605463|FG001|Overall Study|Lack of Efficacy|1|||
149034524|NCT00487578|537605462|FG000|Overall Study|Lost to Follow-up|0|||
149034525|NCT00487578|537605463|FG001|Overall Study|Lost to Follow-up|1|||
149034526|NCT02525796|537605468|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
149034527|NCT02525796|537605469|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
149034528|NCT02525796|537605470|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
149034529|NCT02525796|537605468|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
149034530|NCT02525796|537605469|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
149034531|NCT02525796|537605470|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
149034532|NCT02525796|537605468|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
149034533|NCT02525796|537605469|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
149034534|NCT02525796|537605470|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
149034535|NCT02525796|537605468|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
149034536|NCT02525796|537605469|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
149034537|NCT02525796|537605470|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
149034538|NCT02525796|537605468|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
149034539|NCT02525796|537605469|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
149034540|NCT02525796|537605470|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
149034541|NCT00726999|537605471|FG000|Overall Study|Physician Decision|0|||
149034542|NCT00726999|537605472|FG001|Overall Study|Physician Decision|1|||
149034543|NCT00726999|537605471|FG000|Overall Study|Withdrawal by Subject|2|||
149034544|NCT00726999|537605472|FG001|Overall Study|Withdrawal by Subject|0|||
149034545|NCT00726999|537605471|FG000|Overall Study|Protocol Violation|1|||
149034546|NCT00726999|537605472|FG001|Overall Study|Protocol Violation|0|||
149034547|NCT00955825|537605473|FG000|Overall Study|Adverse Event|15|||
149034548|NCT00955825|537605474|FG001|Overall Study|Adverse Event|2|||
149034549|NCT00955825|537605473|FG000|Overall Study|Withdrawal by Subject|4|||
149034550|NCT00955825|537605474|FG001|Overall Study|Withdrawal by Subject|6|||
149034551|NCT00955825|537605473|FG000|Overall Study|Any other reason not above-mentioned|7|||
149034552|NCT00955825|537605474|FG001|Overall Study|Any other reason not above-mentioned|9|||
149034553|NCT02488980|537605475|FG000|Overall Study|Protocol Violation|2|||
149034554|NCT02488980|537605476|FG001|Overall Study|Protocol Violation|2|||
149034555|NCT02488980|537605477|FG002|Overall Study|Protocol Violation|2|||
149034556|NCT02385669|537605479|FG000|Overall Study|Adverse Event|2|||
149034557|NCT02810080|537605480|FG000|Overall Study|Adverse Event|3|||
149034558|NCT02810080|537605481|FG001|Overall Study|Adverse Event|0|||
149034559|NCT02810080|537605480|FG000|Overall Study|Death|0|||
149034560|NCT02810080|537605481|FG001|Overall Study|Death|2|||
149034561|NCT02810080|537605480|FG000|Overall Study|Physician Decision|4|||
149034562|NCT02810080|537605481|FG001|Overall Study|Physician Decision|0|||
149034563|NCT02810080|537605480|FG000|Overall Study|Withdrawal by Subject|0|||
148879457|NCT05274269|537036628|FG000|Overall Study|Adverse Event|0|||
148879458|NCT05274269|537036629|FG001|Overall Study|Adverse Event|3|||
148879459|NCT05274269|537036628|FG000|Overall Study|Death|0|||
149034564|NCT02810080|537605481|FG001|Overall Study|Withdrawal by Subject|2|||
149034565|NCT05174013|537605487|FG000|Overall Study|Lost to Follow-up|0|||
149034566|NCT05174013|537605488|FG001|Overall Study|Lost to Follow-up|0|||
149034567|NCT05174013|537605489|FG002|Overall Study|Lost to Follow-up|0|||
149034568|NCT05174013|537605490|FG003|Overall Study|Lost to Follow-up|1|||
149034569|NCT05174013|537605491|FG004|Overall Study|Lost to Follow-up|0|||
149034570|NCT05174013|537605492|FG005|Overall Study|Lost to Follow-up|0|||
149034571|NCT05174013|537605487|FG000|Overall Study|Withdrawal by Subject|0|||
148879460|NCT05274269|537036629|FG001|Overall Study|Death|1|||
149034572|NCT05174013|537605488|FG001|Overall Study|Withdrawal by Subject|0|||
149034573|NCT05174013|537605489|FG002|Overall Study|Withdrawal by Subject|1|||
149034574|NCT05174013|537605490|FG003|Overall Study|Withdrawal by Subject|0|||
149034575|NCT05174013|537605491|FG004|Overall Study|Withdrawal by Subject|0|||
149034576|NCT05174013|537605492|FG005|Overall Study|Withdrawal by Subject|0|||
148879461|NCT05274269|537036628|FG000|Overall Study|Other|0|||
148879462|NCT05274269|537036629|FG001|Overall Study|Other|2|||
148879463|NCT05274269|537036628|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
149034577|NCT02034916|537605493|FG000|Overall Study|Death|39|||
149034578|NCT02034916|537605494|FG001|Overall Study|Death|28|||
149034579|NCT02034916|537605493|FG000|Overall Study|Withdrawal by Subject|2|||
149034580|NCT02034916|537605494|FG001|Overall Study|Withdrawal by Subject|1|||
149034581|NCT02034916|537605493|FG000|Overall Study|Lost to Follow-up|4|||
149034582|NCT02034916|537605494|FG001|Overall Study|Lost to Follow-up|1|||
149034583|NCT02034916|537605493|FG000|Overall Study|Study terminated by sponsor|4|||
149034584|NCT02034916|537605494|FG001|Overall Study|Study terminated by sponsor|5|||
149034585|NCT00798096|537605497|FG000|Overall Study|Ongoing|2|||
149034586|NCT02957539|537605498|FG000|Baseline to Week 16|Lost to Follow-up|8|||
149034587|NCT02957539|537605499|FG001|Baseline to Week 16|Lost to Follow-up|10|||
149034588|NCT02957539|537605500|FG002|Baseline to Week 16|Lost to Follow-up|16|||
149034589|NCT02957539|537605498|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
149034590|NCT02957539|537605499|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
149034591|NCT02957539|537605500|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
149034592|NCT02957539|537605498|FG000|Week 16 to 32|Withdrawal by Subject|3|||
149034593|NCT02957539|537605499|FG001|Week 16 to 32|Withdrawal by Subject|3|||
149034594|NCT02957539|537605500|FG002|Week 16 to 32|Withdrawal by Subject|1|||
149034595|NCT02957539|537605498|FG000|Week 16 to 32|Lost to Follow-up|8|||
149034596|NCT02957539|537605499|FG001|Week 16 to 32|Lost to Follow-up|7|||
149034597|NCT02957539|537605500|FG002|Week 16 to 32|Lost to Follow-up|5|||
149034598|NCT02957539|537605498|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
149034599|NCT02957539|537605499|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
149034600|NCT02957539|537605500|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
149034601|NCT02957539|537605498|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
149034602|NCT02957539|537605499|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
149034603|NCT02957539|537605500|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
149034604|NCT02503202|537605503|FG000|Base Study: Up to Month 6|Death|1|||
149034605|NCT02503202|537605504|FG001|Base Study: Up to Month 6|Death|1|||
149034606|NCT02503202|537605505|FG002|Base Study: Up to Month 6|Death|0|||
149034607|NCT02503202|537605506|FG003|Base Study: Up to Month 6|Death|0|||
149034608|NCT02503202|537605507|FG004|Base Study: Up to Month 6|Death|0|||
149034609|NCT02503202|537605503|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
149034610|NCT02503202|537605504|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
149034611|NCT02503202|537605505|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
149034612|NCT02503202|537605506|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
149034613|NCT02503202|537605507|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
149034614|NCT02503202|537605503|FG000|Base Study: Up to Month 6|Physician Decision|0|||
149034615|NCT02503202|537605504|FG001|Base Study: Up to Month 6|Physician Decision|0|||
149034616|NCT02503202|537605505|FG002|Base Study: Up to Month 6|Physician Decision|0|||
149034617|NCT02503202|537605506|FG003|Base Study: Up to Month 6|Physician Decision|0|||
149034618|NCT02503202|537605507|FG004|Base Study: Up to Month 6|Physician Decision|1|||
149034619|NCT02503202|537605503|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
149034620|NCT02503202|537605504|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
149034621|NCT02503202|537605505|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
149034622|NCT02503202|537605506|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
149034623|NCT02503202|537605507|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
149034624|NCT02503202|537605503|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
149034625|NCT02503202|537605504|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
149034626|NCT02503202|537605505|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
149034627|NCT02503202|537605506|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
149034628|NCT02503202|537605507|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
149034629|NCT02503202|537605503|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
149034630|NCT02503202|537605504|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
149034631|NCT02503202|537605505|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
149034632|NCT02503202|537605506|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
149034633|NCT02503202|537605507|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
149034634|NCT02503202|537605503|FG000|Extension: Month 6 to 24|Death|1|||
149034635|NCT02503202|537605504|FG001|Extension: Month 6 to 24|Death|0|||
149034636|NCT02503202|537605505|FG002|Extension: Month 6 to 24|Death|0|||
149034637|NCT02503202|537605506|FG003|Extension: Month 6 to 24|Death|0|||
149034638|NCT02503202|537605507|FG004|Extension: Month 6 to 24|Death|0|||
149034639|NCT02503202|537605503|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
149034640|NCT02503202|537605504|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
149034641|NCT02503202|537605505|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
149034642|NCT02503202|537605506|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
149034643|NCT02503202|537605507|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
149034644|NCT02503202|537605503|FG000|Extension: Month 6 to 24|Physician Decision|1|||
149034645|NCT02503202|537605504|FG001|Extension: Month 6 to 24|Physician Decision|0|||
149034646|NCT02503202|537605505|FG002|Extension: Month 6 to 24|Physician Decision|1|||
149034647|NCT02503202|537605506|FG003|Extension: Month 6 to 24|Physician Decision|3|||
149034648|NCT02503202|537605507|FG004|Extension: Month 6 to 24|Physician Decision|0|||
149034649|NCT02503202|537605503|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
149034650|NCT02503202|537605504|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
149034651|NCT02503202|537605505|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
149034652|NCT02503202|537605506|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
149034653|NCT02503202|537605507|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
149034654|NCT00139737|537605510|FG000|Overall Study|Withdrawal by Subject|190|||
149034655|NCT00139737|537605510|FG000|Overall Study|Adverse Event|58|||
149034656|NCT00139737|537605510|FG000|Overall Study|Lack of Efficacy|40|||
149034657|NCT00139737|537605510|FG000|Overall Study|Lost to Follow-up|8|||
149034658|NCT00139737|537605510|FG000|Overall Study|Death|3|||
149034659|NCT00139737|537605510|FG000|Overall Study|Laboratory Abnormality|2|||
149034660|NCT00139737|537605510|FG000|Overall Study|Protocol Violation|18|||
149034661|NCT00139737|537605510|FG000|Overall Study|Withdrew During Screening Phase|8|||
149034662|NCT00139737|537605510|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
149034663|NCT00139737|537605510|FG000|Overall Study|Screened, Not Treated|13|||
149034664|NCT01191788|537605513|FG000|Overall Study|Lost to Follow-up|21|||
149034665|NCT01191788|537605514|FG001|Overall Study|Lost to Follow-up|22|||
149034666|NCT02613364|537605524|FG000|Overall Study|Other|19|||
149034667|NCT02613364|537605525|FG001|Overall Study|Other|29|||
149034668|NCT02613364|537605526|FG002|Overall Study|Other|17|||
149034669|NCT02613364|537605524|FG000|Overall Study|Too time consuming|21|||
149034670|NCT02613364|537605525|FG001|Overall Study|Too time consuming|26|||
149034671|NCT02613364|537605526|FG002|Overall Study|Too time consuming|26|||
149034672|NCT02613364|537605524|FG000|Overall Study|Withdrawal by Subject|13|||
149034673|NCT02613364|537605525|FG001|Overall Study|Withdrawal by Subject|18|||
149034674|NCT02613364|537605526|FG002|Overall Study|Withdrawal by Subject|17|||
149034675|NCT02613364|537605524|FG000|Overall Study|Medical|12|||
149034676|NCT02613364|537605525|FG001|Overall Study|Medical|13|||
149034677|NCT02613364|537605526|FG002|Overall Study|Medical|9|||
149034678|NCT02613364|537605524|FG000|Overall Study|Disliked Study Procedure|1|||
149034679|NCT02613364|537605525|FG001|Overall Study|Disliked Study Procedure|1|||
149034680|NCT02613364|537605526|FG002|Overall Study|Disliked Study Procedure|4|||
149034681|NCT02613364|537605524|FG000|Overall Study|Disliked Intervention|0|||
149034682|NCT02613364|537605525|FG001|Overall Study|Disliked Intervention|3|||
149034683|NCT02613364|537605526|FG002|Overall Study|Disliked Intervention|3|||
149034684|NCT01909336|537605527|FG000|Overall Study|Lost to Follow-up|4|||
149034685|NCT01909336|537605528|FG001|Overall Study|Lost to Follow-up|2|||
149034686|NCT01909336|537605529|FG002|Overall Study|Lost to Follow-up|2|||
149034687|NCT01909336|537605527|FG000|Overall Study|Physician Decision|0|||
149034688|NCT01909336|537605528|FG001|Overall Study|Physician Decision|1|||
149034689|NCT01909336|537605529|FG002|Overall Study|Physician Decision|1|||
149034690|NCT01235949|537605530|FG000|Primary Phase|Migrated/moved from study area|1|||
149034691|NCT01235949|537605531|FG001|Primary Phase|Migrated/moved from study area|1|||
149034692|NCT01235949|537605532|FG002|Primary Phase|Migrated/moved from study area|0|||
149034693|NCT01235949|537605533|FG003|Primary Phase|Migrated/moved from study area|0|||
149034694|NCT01235949|537605534|FG004|Primary Phase|Migrated/moved from study area|1|||
149034695|NCT01235949|537605535|FG005|Primary Phase|Migrated/moved from study area|2|||
149034696|NCT01235949|537605536|FG006|Primary Phase|Migrated/moved from study area|0|||
149034697|NCT01235949|537605537|FG007|Primary Phase|Migrated/moved from study area|0|||
149034698|NCT01235949|537605538|FG008|Primary Phase|Migrated/moved from study area|0|||
149034699|NCT01235949|537605539|FG009|Primary Phase|Migrated/moved from study area|0|||
149034700|NCT01235949|537605540|FG010|Primary Phase|Migrated/moved from study area|0|||
149034701|NCT01235949|537605541|FG011|Primary Phase|Migrated/moved from study area|0|||
149034702|NCT01235949|537605542|FG012|Primary Phase|Migrated/moved from study area|0|||
149034703|NCT01235949|537605543|FG013|Primary Phase|Migrated/moved from study area|0|||
149034704|NCT01235949|537605544|FG014|Primary Phase|Migrated/moved from study area|0|||
149034705|NCT01235949|537605545|FG015|Primary Phase|Migrated/moved from study area|0|||
149034706|NCT01235949|537605546|FG016|Primary Phase|Migrated/moved from study area|0|||
149034707|NCT01235949|537605547|FG017|Primary Phase|Migrated/moved from study area|0|||
149034708|NCT01235949|537605530|FG000|Primary Phase|Adverse Event|0|||
149034709|NCT01235949|537605531|FG001|Primary Phase|Adverse Event|0|||
148879464|NCT05274269|537036629|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
148879465|NCT02206035|537036630|FG000|Overall Study|Physician Decision|10|||
149034710|NCT01235949|537605532|FG002|Primary Phase|Adverse Event|0|||
149034711|NCT01235949|537605533|FG003|Primary Phase|Adverse Event|1|||
149034712|NCT01235949|537605534|FG004|Primary Phase|Adverse Event|0|||
149034713|NCT01235949|537605535|FG005|Primary Phase|Adverse Event|0|||
149034714|NCT01235949|537605536|FG006|Primary Phase|Adverse Event|0|||
149034715|NCT01235949|537605537|FG007|Primary Phase|Adverse Event|0|||
149034716|NCT01235949|537605538|FG008|Primary Phase|Adverse Event|0|||
148879466|NCT02206035|537036631|FG001|Overall Study|Physician Decision|0|||
148879467|NCT02206035|537036632|FG002|Overall Study|Physician Decision|175|||
149034717|NCT01235949|537605539|FG009|Primary Phase|Adverse Event|0|||
149034718|NCT01235949|537605540|FG010|Primary Phase|Adverse Event|0|||
149034719|NCT01235949|537605541|FG011|Primary Phase|Adverse Event|0|||
149034720|NCT01235949|537605542|FG012|Primary Phase|Adverse Event|0|||
149034721|NCT01235949|537605543|FG013|Primary Phase|Adverse Event|0|||
149034722|NCT01235949|537605544|FG014|Primary Phase|Adverse Event|0|||
149034723|NCT01235949|537605545|FG015|Primary Phase|Adverse Event|0|||
149034724|NCT01235949|537605546|FG016|Primary Phase|Adverse Event|0|||
149034725|NCT01235949|537605547|FG017|Primary Phase|Adverse Event|0|||
149034726|NCT01235949|537605530|FG000|Primary Phase|Withdrawal by Subject|3|||
149034727|NCT01235949|537605531|FG001|Primary Phase|Withdrawal by Subject|2|||
149034728|NCT01235949|537605532|FG002|Primary Phase|Withdrawal by Subject|2|||
149034729|NCT01235949|537605533|FG003|Primary Phase|Withdrawal by Subject|0|||
149034730|NCT01235949|537605534|FG004|Primary Phase|Withdrawal by Subject|0|||
149034731|NCT01235949|537605535|FG005|Primary Phase|Withdrawal by Subject|3|||
149034732|NCT01235949|537605536|FG006|Primary Phase|Withdrawal by Subject|0|||
149034733|NCT01235949|537605537|FG007|Primary Phase|Withdrawal by Subject|0|||
149034734|NCT01235949|537605538|FG008|Primary Phase|Withdrawal by Subject|0|||
149034735|NCT01235949|537605539|FG009|Primary Phase|Withdrawal by Subject|0|||
149034736|NCT01235949|537605540|FG010|Primary Phase|Withdrawal by Subject|0|||
149034737|NCT01235949|537605541|FG011|Primary Phase|Withdrawal by Subject|0|||
149034738|NCT01235949|537605542|FG012|Primary Phase|Withdrawal by Subject|0|||
149034739|NCT01235949|537605543|FG013|Primary Phase|Withdrawal by Subject|0|||
149034740|NCT01235949|537605544|FG014|Primary Phase|Withdrawal by Subject|0|||
149034741|NCT01235949|537605545|FG015|Primary Phase|Withdrawal by Subject|0|||
149034742|NCT01235949|537605546|FG016|Primary Phase|Withdrawal by Subject|0|||
149034743|NCT01235949|537605547|FG017|Primary Phase|Withdrawal by Subject|0|||
149034744|NCT01235949|537605530|FG000|Primary Phase|Lost to Follow-up|0|||
149034745|NCT01235949|537605531|FG001|Primary Phase|Lost to Follow-up|0|||
149034746|NCT01235949|537605532|FG002|Primary Phase|Lost to Follow-up|1|||
149034747|NCT01235949|537605533|FG003|Primary Phase|Lost to Follow-up|1|||
149034748|NCT01235949|537605534|FG004|Primary Phase|Lost to Follow-up|0|||
149034749|NCT01235949|537605535|FG005|Primary Phase|Lost to Follow-up|2|||
149034750|NCT01235949|537605536|FG006|Primary Phase|Lost to Follow-up|0|||
149034751|NCT01235949|537605537|FG007|Primary Phase|Lost to Follow-up|0|||
149034752|NCT01235949|537605538|FG008|Primary Phase|Lost to Follow-up|0|||
149034753|NCT01235949|537605539|FG009|Primary Phase|Lost to Follow-up|0|||
149034754|NCT01235949|537605540|FG010|Primary Phase|Lost to Follow-up|0|||
149034755|NCT01235949|537605541|FG011|Primary Phase|Lost to Follow-up|0|||
149034756|NCT01235949|537605542|FG012|Primary Phase|Lost to Follow-up|0|||
149034757|NCT01235949|537605543|FG013|Primary Phase|Lost to Follow-up|0|||
149034758|NCT01235949|537605544|FG014|Primary Phase|Lost to Follow-up|0|||
149034759|NCT01235949|537605545|FG015|Primary Phase|Lost to Follow-up|0|||
149034760|NCT01235949|537605546|FG016|Primary Phase|Lost to Follow-up|0|||
149034761|NCT01235949|537605547|FG017|Primary Phase|Lost to Follow-up|0|||
149034762|NCT01235949|537605530|FG000|Booster Phase|Migrated/moved from study area|0|||
149034763|NCT01235949|537605531|FG001|Booster Phase|Migrated/moved from study area|0|||
149034764|NCT01235949|537605532|FG002|Booster Phase|Migrated/moved from study area|0|||
149034765|NCT01235949|537605533|FG003|Booster Phase|Migrated/moved from study area|0|||
149034766|NCT01235949|537605534|FG004|Booster Phase|Migrated/moved from study area|0|||
149034767|NCT01235949|537605535|FG005|Booster Phase|Migrated/moved from study area|0|||
149034768|NCT01235949|537605536|FG006|Booster Phase|Migrated/moved from study area|0|||
149034769|NCT01235949|537605537|FG007|Booster Phase|Migrated/moved from study area|0|||
149034770|NCT01235949|537605538|FG008|Booster Phase|Migrated/moved from study area|0|||
149034771|NCT01235949|537605539|FG009|Booster Phase|Migrated/moved from study area|0|||
149034772|NCT01235949|537605540|FG010|Booster Phase|Migrated/moved from study area|0|||
149034773|NCT01235949|537605541|FG011|Booster Phase|Migrated/moved from study area|1|||
149034774|NCT01235949|537605542|FG012|Booster Phase|Migrated/moved from study area|1|||
149034775|NCT01235949|537605543|FG013|Booster Phase|Migrated/moved from study area|0|||
148879468|NCT02936843|537036633|FG000|Overall Study|Lost to Follow-up|3|||
148879469|NCT02936843|537036634|FG001|Overall Study|Lost to Follow-up|1|||
148879470|NCT02936843|537036633|FG000|Overall Study|Withdrawal by Subject|1|||
149034776|NCT01235949|537605544|FG014|Booster Phase|Migrated/moved from study area|0|||
149034777|NCT01235949|537605545|FG015|Booster Phase|Migrated/moved from study area|0|||
149034778|NCT01235949|537605546|FG016|Booster Phase|Migrated/moved from study area|0|||
149034779|NCT01235949|537605547|FG017|Booster Phase|Migrated/moved from study area|1|||
149034780|NCT01235949|537605530|FG000|Booster Phase|Adverse Event|0|||
149034781|NCT01235949|537605531|FG001|Booster Phase|Adverse Event|0|||
149034782|NCT01235949|537605532|FG002|Booster Phase|Adverse Event|0|||
149034783|NCT01235949|537605533|FG003|Booster Phase|Adverse Event|0|||
149034784|NCT01235949|537605534|FG004|Booster Phase|Adverse Event|0|||
148879471|NCT02936843|537036634|FG001|Overall Study|Withdrawal by Subject|1|||
148879472|NCT00709618|537036635|FG000|Overall Study|Withdrawal by Subject|4|||
149034785|NCT01235949|537605535|FG005|Booster Phase|Adverse Event|0|||
149034786|NCT01235949|537605536|FG006|Booster Phase|Adverse Event|0|||
149034787|NCT01235949|537605537|FG007|Booster Phase|Adverse Event|0|||
149034788|NCT01235949|537605538|FG008|Booster Phase|Adverse Event|0|||
149034789|NCT01235949|537605539|FG009|Booster Phase|Adverse Event|0|||
149034790|NCT01235949|537605540|FG010|Booster Phase|Adverse Event|0|||
149034791|NCT01235949|537605541|FG011|Booster Phase|Adverse Event|0|||
149034792|NCT01235949|537605542|FG012|Booster Phase|Adverse Event|0|||
149034793|NCT01235949|537605543|FG013|Booster Phase|Adverse Event|0|||
149034794|NCT01235949|537605544|FG014|Booster Phase|Adverse Event|0|||
149034795|NCT01235949|537605545|FG015|Booster Phase|Adverse Event|1|||
149034796|NCT01235949|537605546|FG016|Booster Phase|Adverse Event|0|||
149034797|NCT01235949|537605547|FG017|Booster Phase|Adverse Event|0|||
149034798|NCT01235949|537605530|FG000|Booster Phase|Withdrawal by Subject|0|||
149034799|NCT01235949|537605531|FG001|Booster Phase|Withdrawal by Subject|0|||
149034800|NCT01235949|537605532|FG002|Booster Phase|Withdrawal by Subject|0|||
149034801|NCT01235949|537605533|FG003|Booster Phase|Withdrawal by Subject|0|||
149034802|NCT01235949|537605534|FG004|Booster Phase|Withdrawal by Subject|0|||
149034803|NCT01235949|537605535|FG005|Booster Phase|Withdrawal by Subject|0|||
149034804|NCT01235949|537605536|FG006|Booster Phase|Withdrawal by Subject|0|||
149034805|NCT01235949|537605537|FG007|Booster Phase|Withdrawal by Subject|1|||
149034806|NCT01235949|537605538|FG008|Booster Phase|Withdrawal by Subject|1|||
149034807|NCT01235949|537605539|FG009|Booster Phase|Withdrawal by Subject|0|||
149034808|NCT01235949|537605540|FG010|Booster Phase|Withdrawal by Subject|1|||
149034809|NCT01235949|537605541|FG011|Booster Phase|Withdrawal by Subject|1|||
149034810|NCT01235949|537605542|FG012|Booster Phase|Withdrawal by Subject|2|||
149034811|NCT01235949|537605543|FG013|Booster Phase|Withdrawal by Subject|0|||
149034812|NCT01235949|537605544|FG014|Booster Phase|Withdrawal by Subject|2|||
149034813|NCT01235949|537605545|FG015|Booster Phase|Withdrawal by Subject|0|||
149034814|NCT01235949|537605546|FG016|Booster Phase|Withdrawal by Subject|0|||
149034815|NCT01235949|537605547|FG017|Booster Phase|Withdrawal by Subject|0|||
149034816|NCT01235949|537605530|FG000|Booster Phase|Lost to Follow-up|0|||
149034817|NCT01235949|537605531|FG001|Booster Phase|Lost to Follow-up|0|||
149034818|NCT01235949|537605532|FG002|Booster Phase|Lost to Follow-up|0|||
149034819|NCT01235949|537605533|FG003|Booster Phase|Lost to Follow-up|0|||
149034820|NCT01235949|537605534|FG004|Booster Phase|Lost to Follow-up|0|||
149034821|NCT01235949|537605535|FG005|Booster Phase|Lost to Follow-up|0|||
149034822|NCT01235949|537605536|FG006|Booster Phase|Lost to Follow-up|0|||
149034823|NCT01235949|537605537|FG007|Booster Phase|Lost to Follow-up|0|||
149034824|NCT01235949|537605538|FG008|Booster Phase|Lost to Follow-up|1|||
149034825|NCT01235949|537605539|FG009|Booster Phase|Lost to Follow-up|1|||
149034826|NCT01235949|537605540|FG010|Booster Phase|Lost to Follow-up|1|||
149034827|NCT01235949|537605541|FG011|Booster Phase|Lost to Follow-up|1|||
149034828|NCT01235949|537605542|FG012|Booster Phase|Lost to Follow-up|0|||
149034829|NCT01235949|537605543|FG013|Booster Phase|Lost to Follow-up|0|||
149034830|NCT01235949|537605544|FG014|Booster Phase|Lost to Follow-up|0|||
149034831|NCT01235949|537605545|FG015|Booster Phase|Lost to Follow-up|0|||
149034832|NCT01235949|537605546|FG016|Booster Phase|Lost to Follow-up|0|||
149034833|NCT01235949|537605547|FG017|Booster Phase|Lost to Follow-up|1|||
149034834|NCT00754936|537605548|FG000|Overall Study|Lost to Follow-up|3|||
149034835|NCT00754936|537605548|FG000|Overall Study|Physician Decision|1|||
149034836|NCT00754936|537605548|FG000|Overall Study|Withdrawal by Subject|2|||
149034837|NCT00754936|537605548|FG000|Overall Study|Side Effects|3|||
149034838|NCT00754936|537605548|FG000|Overall Study|Inter-current medical events|3|||
149034839|NCT00371566|537605553|FG000|Treatment Phase|Withdrawal by Subject|0|||
149034840|NCT00371566|537605554|FG001|Treatment Phase|Withdrawal by Subject|1|||
149034841|NCT00371566|537605553|FG000|Treatment Phase|Adverse Event|0|||
149034842|NCT00371566|537605554|FG001|Treatment Phase|Adverse Event|1|||
149034843|NCT00371566|537605553|FG000|Treatment Phase|Protocol Violation|0|||
149034844|NCT00371566|537605554|FG001|Treatment Phase|Protocol Violation|1|||
149034845|NCT00371566|537605553|FG000|Chemoradiation Phase|Physician Decision|2|||
149034846|NCT00371566|537605554|FG001|Chemoradiation Phase|Physician Decision|0|||
149034847|NCT00371566|537605553|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
149034848|NCT00371566|537605554|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
149034849|NCT00371566|537605553|FG000|Chemoradiation Phase|Non compliant|0|||
149034850|NCT00371566|537605554|FG001|Chemoradiation Phase|Non compliant|1|||
149034851|NCT00371566|537605553|FG000|Chemoradiation Phase|Progressive Disease|1|||
149034852|NCT00371566|537605554|FG001|Chemoradiation Phase|Progressive Disease|1|||
149034853|NCT00371566|537605553|FG000|Chemoradiation Phase|Death|2|||
149034854|NCT00371566|537605554|FG001|Chemoradiation Phase|Death|0|||
149034855|NCT00371566|537605553|FG000|Follow Up Phase|Death|0|||
149034856|NCT00371566|537605554|FG001|Follow Up Phase|Death|5|||
149034857|NCT00371566|537605553|FG000|Follow Up Phase|Disease progression|1|||
149034858|NCT00371566|537605554|FG001|Follow Up Phase|Disease progression|0|||
149034859|NCT00371566|537605553|FG000|Follow Up Phase|Withdrawal by Subject|0|||
149034860|NCT00371566|537605554|FG001|Follow Up Phase|Withdrawal by Subject|1|||
149034861|NCT00371566|537605553|FG000|Follow Up Phase|Physician Decision|1|||
149034862|NCT00371566|537605554|FG001|Follow Up Phase|Physician Decision|1|||
148879473|NCT00709618|537036635|FG000|Overall Study|Lost to Follow-up|1|||
149034863|NCT00371566|537605553|FG000|Follow Up Phase|Lost to Follow-up|1|||
149034864|NCT00371566|537605554|FG001|Follow Up Phase|Lost to Follow-up|0|||
149034865|NCT00972504|537605555|FG000|Overall Study|Adverse Event|2|||
149034866|NCT00972504|537605555|FG000|Overall Study|Investigator discretion|1|||
149034867|NCT02878330|537605556|FG000|Overall Study|Death|3|||
149034868|NCT02878330|537605557|FG001|Overall Study|Death|2|||
149034869|NCT02878330|537605556|FG000|Overall Study|Lost to Follow-up|11|||
149034870|NCT02878330|537605557|FG001|Overall Study|Lost to Follow-up|26|||
149034871|NCT02878330|537605556|FG000|Overall Study|Withdrawal by Subject|11|||
149034872|NCT02878330|537605557|FG001|Overall Study|Withdrawal by Subject|21|||
149034873|NCT02878330|537605556|FG000|Overall Study|Other|4|||
149034874|NCT02878330|537605557|FG001|Overall Study|Other|7|||
149034875|NCT04246762|537605558|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
149034876|NCT00082810|537605563|FG000|Overall Study|Adverse Event|3|||
149034877|NCT00082810|537605563|FG000|Overall Study|Progressive disease|24|||
149034878|NCT00082810|537605563|FG000|Overall Study|Withdrawal by Subject|4|||
149034879|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
149034880|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
149034881|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
149034882|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
149034883|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
149034884|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
149034885|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
149034886|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
149034887|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
149034888|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
149034889|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
149034890|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
149034891|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
149034892|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
149034893|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
149034894|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
149034895|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
149034896|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
149034897|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
149034898|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
149034899|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
149034900|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
149034901|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
149034902|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
149034903|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
149034904|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
149034905|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
149034906|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
149034907|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
149034908|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
149034909|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
149034910|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
149034911|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
149034912|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034913|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
149034914|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
149034915|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
149034916|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034917|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034918|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034919|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034920|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034921|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034922|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
149034923|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034924|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034925|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034926|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034927|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
149034928|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034929|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034930|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
148879474|NCT00709618|537036635|FG000|Overall Study|Study Closed/Terminated|25|||
148879475|NCT04042909|537036636|FG000|Overall Study|Withdrawal by Subject|1|||
148879476|NCT04042909|537036637|FG001|Overall Study|Withdrawal by Subject|0|||
149034931|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034932|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034933|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
149034934|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
149034935|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034936|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034937|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034938|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149001232|NCT03292146|537480951|FG001|12 months to 24 months|Planning pregnancy|2|||
149001233|NCT03292146|537480950|FG000|12 months to 24 months|Personal reasons|1|||
149001234|NCT03292146|537480951|FG001|12 months to 24 months|Personal reasons|0|||
149001235|NCT03292146|537480950|FG000|12 months to 24 months|Lost to Follow-up|0|||
149001236|NCT03292146|537480951|FG001|12 months to 24 months|Lost to Follow-up|1|||
149001237|NCT02954354|537480952|FG000|Overall Study|Adverse Event|2|||
149001238|NCT02954354|537480953|FG001|Overall Study|Adverse Event|2|||
149001239|NCT02954354|537480954|FG002|Overall Study|Adverse Event|4|||
149001240|NCT02954354|537480952|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
149001241|NCT02954354|537480953|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
149001242|NCT02954354|537480954|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
149001243|NCT02954354|537480952|FG000|Overall Study|Lack of Efficacy|0|||
149001244|NCT02954354|537480953|FG001|Overall Study|Lack of Efficacy|2|||
149001245|NCT02954354|537480954|FG002|Overall Study|Lack of Efficacy|0|||
149001246|NCT02954354|537480952|FG000|Overall Study|Withdrawal by Subject|17|||
149001247|NCT02954354|537480953|FG001|Overall Study|Withdrawal by Subject|9|||
149001248|NCT02954354|537480954|FG002|Overall Study|Withdrawal by Subject|11|||
149001249|NCT02954354|537480952|FG000|Overall Study|Lost to Follow-up|12|||
149001250|NCT02954354|537480953|FG001|Overall Study|Lost to Follow-up|5|||
149001251|NCT02954354|537480954|FG002|Overall Study|Lost to Follow-up|0|||
149001252|NCT02954354|537480952|FG000|Overall Study|Miscellaneous|2|||
149001253|NCT02954354|537480953|FG001|Overall Study|Miscellaneous|2|||
149001254|NCT02954354|537480954|FG002|Overall Study|Miscellaneous|1|||
149001255|NCT06134180|537480957|FG000|Overall Study|Lost to Follow-up|4|||
149001256|NCT04559568|537480963|FG000|Overall Study|Physician Decision|0|||
149001257|NCT04559568|537480964|FG001|Overall Study|Physician Decision|0|||
149001258|NCT04559568|537480965|FG002|Overall Study|Physician Decision|0|||
149001259|NCT04559568|537480966|FG003|Overall Study|Physician Decision|0|||
149001260|NCT04559568|537480967|FG004|Overall Study|Physician Decision|0|||
149001261|NCT04559568|537480968|FG005|Overall Study|Physician Decision|0|||
149001262|NCT04559568|537480969|FG006|Overall Study|Physician Decision|0|||
149001263|NCT04559568|537480970|FG007|Overall Study|Physician Decision|0|||
149001264|NCT04559568|537480971|FG008|Overall Study|Physician Decision|0|||
149001265|NCT04559568|537480972|FG009|Overall Study|Physician Decision|1|||
149001266|NCT04559568|537480973|FG010|Overall Study|Physician Decision|0|||
149001267|NCT04559568|537480963|FG000|Overall Study|Withdrawal by Subject|0|||
149001268|NCT04559568|537480964|FG001|Overall Study|Withdrawal by Subject|0|||
149001269|NCT04559568|537480965|FG002|Overall Study|Withdrawal by Subject|0|||
149001270|NCT04559568|537480966|FG003|Overall Study|Withdrawal by Subject|0|||
149001271|NCT04559568|537480967|FG004|Overall Study|Withdrawal by Subject|0|||
149001272|NCT04559568|537480968|FG005|Overall Study|Withdrawal by Subject|0|||
149001273|NCT04559568|537480969|FG006|Overall Study|Withdrawal by Subject|0|||
149001274|NCT04559568|537480970|FG007|Overall Study|Withdrawal by Subject|0|||
149001275|NCT04559568|537480971|FG008|Overall Study|Withdrawal by Subject|0|||
149001276|NCT04559568|537480972|FG009|Overall Study|Withdrawal by Subject|0|||
149001277|NCT04559568|537480973|FG010|Overall Study|Withdrawal by Subject|1|||
149001278|NCT05103384|537480976|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
149001279|NCT05608499|537480977|FG000|Overall Study|Lack of Efficacy|1|||
149001280|NCT05608499|537480978|FG001|Overall Study|Lack of Efficacy|0|||
149001281|NCT05608499|537480977|FG000|Overall Study|Lost to Follow-up|0|||
149001282|NCT05608499|537480978|FG001|Overall Study|Lost to Follow-up|1|||
149001283|NCT02660827|537480979|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
149001284|NCT02660827|537480979|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
149001285|NCT02660827|537480979|FG000|From Study to End of Continued Access|Adverse Event|3|||
149001286|NCT02660827|537480979|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
149001287|NCT02660827|537480979|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
149001288|NCT02660827|537480979|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
148879477|NCT04042909|537036638|FG002|Overall Study|Withdrawal by Subject|0|||
148879478|NCT04042909|537036636|FG000|Overall Study|duplicate cases|2|||
148879479|NCT04042909|537036637|FG001|Overall Study|duplicate cases|0|||
148879480|NCT04042909|537036638|FG002|Overall Study|duplicate cases|0|||
148879481|NCT04042909|537036636|FG000|Overall Study|technical problem|0|||
148879482|NCT04042909|537036637|FG001|Overall Study|technical problem|1|||
148879483|NCT04042909|537036638|FG002|Overall Study|technical problem|0|||
148879484|NCT00894361|537036641|FG000|Overall Study|deaths and less than 2 years followup|24|||
148879485|NCT00894361|537036642|FG001|Overall Study|deaths and less than 2 years followup|64|||
149001289|NCT02660827|537480979|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
148879486|NCT02881762|537036643|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
149001290|NCT02660827|537480979|FG000|Period 2: Continued Access Period|Adverse Event|3|||
149001291|NCT01422408|537480980|FG000|Overall Study|Adverse Event|1|||
149001292|NCT01422408|537480980|FG000|Overall Study|Withdrawal by Subject|3|||
149001293|NCT04672941|537480981|FG000|Overall Study|Investigator decision|1|||
149001294|NCT04672941|537480981|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
149001295|NCT04672941|537480981|FG000|Overall Study|COVID-19 related but no adverse event|1|||
149001296|NCT04672941|537480981|FG000|Overall Study|Adverse Event|2|||
149034939|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034940|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034941|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034942|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034943|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034944|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
149034945|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
149034946|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
149034947|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
149034948|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
149034949|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
149034950|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
149034951|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
149034952|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
149034953|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
149034954|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
149034955|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
149034956|NCT02914522|537605564|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034957|NCT02914522|537605565|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
149034958|NCT02914522|537605566|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034959|NCT02914522|537605567|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034960|NCT02914522|537605568|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
149034961|NCT02914522|537605569|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
149034962|NCT02914522|537605570|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034963|NCT02914522|537605571|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034964|NCT02914522|537605572|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034965|NCT02914522|537605573|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034966|NCT02914522|537605574|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
149034967|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149034968|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149034969|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149034970|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149034971|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149034972|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
149034973|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
149034974|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
149034975|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
149034976|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
149034977|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
149034978|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149034979|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149034980|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149034981|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149034982|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149034983|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
149034984|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
149034985|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
149034986|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
148879487|NCT02881762|537036644|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
149034987|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
149034988|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
149034989|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034990|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034991|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034992|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034993|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034994|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034995|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
149034996|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
149034997|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
149034998|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
149034999|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
149035000|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
149035001|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
148879488|NCT01415401|537036652|FG000|Overall Study|Adverse Event|5|||
148879489|NCT01415401|537036652|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
148879490|NCT01415401|537036652|FG000|Overall Study|Terminated by Sponsor|1|||
149001297|NCT04672941|537480981|FG000|Overall Study|Lost to Follow-up|2|||
149001298|NCT01936857|537480982|FG000|Overall Study|Sent to prison or 06 center|11|||
149001299|NCT01936857|537480983|FG001|Overall Study|Sent to prison or 06 center|12|||
149001300|NCT01936857|537480982|FG000|Overall Study|Lost to Follow-up|10|||
149001301|NCT01936857|537480983|FG001|Overall Study|Lost to Follow-up|7|||
149001302|NCT01936857|537480982|FG000|Overall Study|Death|7|||
149001303|NCT01936857|537480983|FG001|Overall Study|Death|3|||
149001304|NCT01936857|537480982|FG000|Overall Study|Moved|2|||
149001305|NCT01936857|537480983|FG001|Overall Study|Moved|1|||
149001306|NCT01936857|537480982|FG000|Overall Study|Withdrawal by Subject|1|||
149001307|NCT01936857|537480983|FG001|Overall Study|Withdrawal by Subject|0|||
149001308|NCT01936857|537480982|FG000|Overall Study|Side effect of medication|1|||
149001309|NCT01936857|537480983|FG001|Overall Study|Side effect of medication|0|||
149001310|NCT01936857|537480982|FG000|Overall Study|Other|2|||
149001311|NCT01936857|537480983|FG001|Overall Study|Other|2|||
149001312|NCT02279043|537480984|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
149001313|NCT02279043|537480985|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
149001314|NCT02279043|537480986|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
149001315|NCT02279043|537480984|FG000|Overall Study|Lost to Follow-up|46|||
149001316|NCT02279043|537480985|FG001|Overall Study|Lost to Follow-up|88|||
149001317|NCT02279043|537480986|FG002|Overall Study|Lost to Follow-up|0|||
149001318|NCT00490282|537480987|FG000|Overall Study|Withdrawal by Subject|3|||
149001319|NCT02453685|537480995|FG000|Overall Study|Adverse Event|0|||
149001320|NCT02453685|537480996|FG001|Overall Study|Adverse Event|1|||
149001321|NCT02453685|537480995|FG000|Overall Study|Protocol Violation|7|||
149001322|NCT02453685|537480996|FG001|Overall Study|Protocol Violation|4|||
149001323|NCT02453685|537480995|FG000|Overall Study|Lost to Follow-up|0|||
149001324|NCT02453685|537480996|FG001|Overall Study|Lost to Follow-up|1|||
149001325|NCT02453685|537480995|FG000|Overall Study|Withdrawal by Subject|8|||
149001326|NCT02453685|537480996|FG001|Overall Study|Withdrawal by Subject|4|||
149001327|NCT02453685|537480995|FG000|Overall Study|Unclassified|4|||
149001328|NCT02453685|537480996|FG001|Overall Study|Unclassified|2|||
149001329|NCT00608582|537481004|FG000|Overall Study|Lost to Follow-up|2|||
149001330|NCT00608582|537481005|FG001|Overall Study|Lost to Follow-up|0|||
149001331|NCT00608582|537481004|FG000|Overall Study|No Best Response in Phase 1 located|1|||
149001332|NCT00608582|537481005|FG001|Overall Study|No Best Response in Phase 1 located|1|||
149001333|NCT00608582|537481004|FG000|Overall Study|Illicit Drug Use|1|||
149001334|NCT00608582|537481005|FG001|Overall Study|Illicit Drug Use|0|||
149001335|NCT00608582|537481004|FG000|Overall Study|Early stage Design Change|0|||
149001336|NCT00608582|537481005|FG001|Overall Study|Early stage Design Change|3|||
149001337|NCT04525547|537483030|FG000|Overall Study|Not treated with Ofev|2|||
149001338|NCT04525547|537483030|FG000|Overall Study|Off-label use|2|||
149001339|NCT04525547|537483030|FG000|Overall Study|Lost to Follow-up|1|||
149001340|NCT00800202|537483031|FG000|Overall Study|Adverse Event|7|||
149001341|NCT00800202|537483032|FG001|Overall Study|Adverse Event|6|||
149001342|NCT00800202|537483031|FG000|Overall Study|Death|1|||
149001343|NCT00800202|537483032|FG001|Overall Study|Death|0|||
148879491|NCT00532298|537036653|FG000|Overall Study|Adverse Event|1|||
148879492|NCT00532298|537036654|FG001|Overall Study|Adverse Event|0|||
148879493|NCT00532298|537036655|FG002|Overall Study|Adverse Event|0|||
148879494|NCT00532298|537036656|FG003|Overall Study|Adverse Event|0|||
148879495|NCT00532298|537036657|FG004|Overall Study|Adverse Event|1|||
148879496|NCT00532298|537036658|FG005|Overall Study|Adverse Event|1|||
148879497|NCT00532298|537036653|FG000|Overall Study|Lost to Follow-up|1|||
148879498|NCT00532298|537036654|FG001|Overall Study|Lost to Follow-up|1|||
148879499|NCT00532298|537036655|FG002|Overall Study|Lost to Follow-up|1|||
148879500|NCT00532298|537036656|FG003|Overall Study|Lost to Follow-up|0|||
148879501|NCT00532298|537036657|FG004|Overall Study|Lost to Follow-up|0|||
148879502|NCT00532298|537036658|FG005|Overall Study|Lost to Follow-up|1|||
148879503|NCT00479856|537036659|FG000|Overall Study|Adverse Event|1|||
148879504|NCT00479856|537036659|FG000|Overall Study|Withdrawal by Subject|1|||
149001344|NCT00800202|537483031|FG000|Overall Study|Other|5|||
149001345|NCT00800202|537483032|FG001|Overall Study|Other|0|||
149001346|NCT00800202|537483031|FG000|Overall Study|Disease Progression|54|||
149001347|NCT00800202|537483032|FG001|Overall Study|Disease Progression|18|||
149001348|NCT03315143|537483036|FG000|Overall Study|Death|240|||
149001349|NCT03315143|537483037|FG001|Overall Study|Death|246|||
149001350|NCT03315143|537483036|FG000|Overall Study|Withdrawal by Subject|57|||
149001351|NCT03315143|537483037|FG001|Overall Study|Withdrawal by Subject|68|||
149001352|NCT03315143|537483036|FG000|Overall Study|Site Terminated by Sponsor|256|||
148879505|NCT00479856|537036659|FG000|Overall Study|Physician Decision|1|||
148879506|NCT01636986|537036664|FG000|Overall Study|Withdrawal by Subject|0|||
148879507|NCT01636986|537036665|FG001|Overall Study|Withdrawal by Subject|1|||
149001353|NCT03315143|537483037|FG001|Overall Study|Site Terminated by Sponsor|282|||
149001354|NCT03315143|537483036|FG000|Overall Study|Study Terminated by Sponsor|4723|||
149001355|NCT03315143|537483037|FG001|Overall Study|Study Terminated by Sponsor|4664|||
149035002|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
149035003|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
149035004|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
149035005|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
149035006|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
149035007|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
149035008|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
149035009|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
149035010|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
149035011|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
149035012|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
149035013|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
149035014|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
149035015|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
149035016|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
149035017|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
149035018|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
149035019|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
149035020|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
149035021|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
149035022|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035023|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035024|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035025|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035026|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035027|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035028|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035029|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
149035030|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
149035031|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035032|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
149035033|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035034|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035035|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035036|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035037|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035038|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035039|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035040|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035041|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
149035042|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
149035043|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
149035044|NCT02914522|537605564|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035045|NCT02914522|537605565|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035046|NCT02914522|537605566|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035047|NCT02914522|537605567|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035048|NCT02914522|537605568|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035049|NCT02914522|537605569|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035050|NCT02914522|537605570|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035051|NCT02914522|537605571|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035052|NCT02914522|537605572|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035053|NCT02914522|537605573|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
149035054|NCT02914522|537605574|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
149035055|NCT00177216|537605575|FG000|Overall Study|Withdrawal by Subject|6|||
149035056|NCT00177216|537605576|FG001|Overall Study|Withdrawal by Subject|3|||
149035057|NCT00177216|537605577|FG002|Overall Study|Withdrawal by Subject|1|||
149035058|NCT00811057|537605578|FG000|Overall Study|Protocol Violation|5|||
149035059|NCT00811057|537605579|FG001|Overall Study|Protocol Violation|10|||
149035060|NCT00811057|537605580|FG002|Overall Study|Protocol Violation|10|||
149035061|NCT01264718|537605581|FG000|Overall Study|Lost to Follow-up|3|||
149035062|NCT01264718|537605582|FG001|Overall Study|Lost to Follow-up|2|||
149035063|NCT01264718|537605581|FG000|Overall Study|Withdrawal by Subject|9|||
149035064|NCT01264718|537605582|FG001|Overall Study|Withdrawal by Subject|15|||
149035065|NCT01264718|537605581|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
149035066|NCT01264718|537605582|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
149035067|NCT03545984|537605585|FG000|Overall Study|CSF cases not present during rotation|11|||
149035068|NCT03545984|537605586|FG001|Overall Study|CSF cases not present during rotation|9|||
148879508|NCT01636986|537036664|FG000|Overall Study|Corneal Staining|0|||
148879509|NCT01636986|537036665|FG001|Overall Study|Corneal Staining|1|||
149035069|NCT01768676|537605587|FG000|Overall Study|Adverse Event|3|||
149035070|NCT01768676|537605588|FG001|Overall Study|Adverse Event|3|||
149035071|NCT01768676|537605587|FG000|Overall Study|Lost to Follow-up|13|||
149035072|NCT01768676|537605588|FG001|Overall Study|Lost to Follow-up|16|||
149035073|NCT01768676|537605587|FG000|Overall Study|Protocol Violation|1|||
149035074|NCT01768676|537605588|FG001|Overall Study|Protocol Violation|1|||
149035075|NCT01768676|537605587|FG000|Overall Study|Physician Decision|4|||
149035076|NCT01768676|537605588|FG001|Overall Study|Physician Decision|1|||
149035077|NCT01768676|537605587|FG000|Overall Study|Withdrawal by Subject|3|||
149035078|NCT01768676|537605588|FG001|Overall Study|Withdrawal by Subject|10|||
149035079|NCT03121950|537605590|FG000|Overall Study|Withdrawal by Subject|11|||
149035080|NCT03121950|537605591|FG001|Overall Study|Withdrawal by Subject|2|||
149035081|NCT03183518|537605597|FG000|Overall Study|Other (Not specified)|2|||
149035082|NCT03183518|537605597|FG000|Overall Study|Other (Withdrawal of consent)|1|||
149035083|NCT04248829|537605598|FG000|Overall Study|Disease progression|44|||
149035084|NCT04248829|537605599|FG001|Overall Study|Disease progression|109|||
149035085|NCT04248829|537605598|FG000|Overall Study|Adverse Event|19|||
149035086|NCT04248829|537605599|FG001|Overall Study|Adverse Event|18|||
149035087|NCT04248829|537605598|FG000|Overall Study|Withdrawal by Subject|11|||
149035088|NCT04248829|537605599|FG001|Overall Study|Withdrawal by Subject|2|||
149035089|NCT04248829|537605598|FG000|Overall Study|Lost to Follow-up|0|||
149035090|NCT04248829|537605599|FG001|Overall Study|Lost to Follow-up|1|||
149035091|NCT04248829|537605598|FG000|Overall Study|Death|12|||
149035092|NCT04248829|537605599|FG001|Overall Study|Death|14|||
149035093|NCT04248829|537605598|FG000|Overall Study|Physician Decision|2|||
149035094|NCT04248829|537605599|FG001|Overall Study|Physician Decision|4|||
149035095|NCT04248829|537605598|FG000|Overall Study|Any reason not specifically recorded|0|||
149035096|NCT04248829|537605599|FG001|Overall Study|Any reason not specifically recorded|2|||
149035097|NCT02132702|537605600|FG000|Overall Study|Protocol Violation|2|||
149035098|NCT02132702|537605600|FG000|Overall Study|Adverse Event|3|||
149035099|NCT02132702|537605600|FG000|Overall Study|Withdrawal by Subject|3|||
149035100|NCT01867580|537605602|FG000|Overall Study|Withdrawal by Subject|2|||
149035101|NCT01867580|537605603|FG001|Overall Study|Withdrawal by Subject|3|||
149035102|NCT01867580|537605602|FG000|Overall Study|Physician Decision|17|||
149035103|NCT01867580|537605603|FG001|Overall Study|Physician Decision|12|||
149035104|NCT01867580|537605602|FG000|Overall Study|Lost to Follow-up|3|||
149035105|NCT01867580|537605603|FG001|Overall Study|Lost to Follow-up|5|||
149035106|NCT01867580|537605602|FG000|Overall Study|Sponsor terminated study|1|||
149035107|NCT01867580|537605603|FG001|Overall Study|Sponsor terminated study|0|||
149035108|NCT01867580|537605602|FG000|Overall Study|Missed follow-up assessment|2|||
149035109|NCT01867580|537605603|FG001|Overall Study|Missed follow-up assessment|1|||
149035110|NCT01867580|537605602|FG000|Overall Study|Interruption to therapy|3|||
149035111|NCT01867580|537605603|FG001|Overall Study|Interruption to therapy|0|||
149035112|NCT01867580|537605602|FG000|Overall Study|Osteomyelitis|0|||
149035113|NCT01867580|537605603|FG001|Overall Study|Osteomyelitis|1|||
149035114|NCT01867580|537605602|FG000|Overall Study|Continuation of therapy|0|||
149035115|NCT01867580|537605603|FG001|Overall Study|Continuation of therapy|1|||
149035116|NCT01867580|537605602|FG000|Overall Study|Wound recurrence|0|||
149035117|NCT01867580|537605603|FG001|Overall Study|Wound recurrence|1|||
149035118|NCT01304147|537605604|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
149035119|NCT01304147|537605605|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
149035120|NCT01244828|537605606|FG000|Overall Study|Adverse Event|37|||
149035121|NCT01244828|537605606|FG000|Overall Study|Withdrawal by Subject|31|||
149035122|NCT01244828|537605606|FG000|Overall Study|Lack of Efficacy|7|||
149035123|NCT01244828|537605606|FG000|Overall Study|Lost to Follow-up|2|||
149035124|NCT01244828|537605606|FG000|Overall Study|Other reason (not specified)|1|||
149035125|NCT05233085|537605608|FG000|Overall Study|Adverse Event|1|||
149035126|NCT05233085|537605609|FG001|Overall Study|Adverse Event|0|||
149035127|NCT05233085|537605610|FG002|Overall Study|Adverse Event|0|||
149035128|NCT05233085|537605611|FG003|Overall Study|Adverse Event|0|||
149035129|NCT05052983|537605612|FG000|Overall Study|Lack of Efficacy|3|||
149035130|NCT05052983|537605613|FG001|Overall Study|Lack of Efficacy|12|||
148879510|NCT00395850|537036673|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
149035131|NCT05052983|537605612|FG000|Overall Study|Adverse Event|1|||
149035132|NCT05052983|537605613|FG001|Overall Study|Adverse Event|0|||
149035133|NCT02812966|537605616|FG000|Overall Study|Death|1|||
149035134|NCT02812966|537605617|FG001|Overall Study|Death|0|||
149035135|NCT01066923|537605618|FG000|Overall Study|Withdrawal by Subject|3|||
149035136|NCT01066923|537605619|FG001|Overall Study|Withdrawal by Subject|3|||
149035137|NCT01066923|537605620|FG002|Overall Study|Withdrawal by Subject|8|||
149035138|NCT01066923|537605621|FG003|Overall Study|Withdrawal by Subject|8|||
149035139|NCT00150176|537607175|FG000|Overall Study|Adverse Event|16|||
149035140|NCT00150176|537607176|FG001|Overall Study|Adverse Event|53|||
149035141|NCT00150176|537607175|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
149035142|NCT00150176|537607176|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
149035143|NCT00150176|537607175|FG000|Overall Study|Withdrawal by Subject|19|||
149035144|NCT00150176|537607176|FG001|Overall Study|Withdrawal by Subject|12|||
149035145|NCT00150176|537607175|FG000|Overall Study|Lost to Follow-up|3|||
149035146|NCT00150176|537607176|FG001|Overall Study|Lost to Follow-up|3|||
149035147|NCT00150176|537607175|FG000|Overall Study|OTHER|11|||
149035148|NCT00150176|537607176|FG001|Overall Study|OTHER|13|||
149035149|NCT00393848|537607177|FG000|Overall Study|Surgical schedule|0|||
149035150|NCT00393848|537607178|FG001|Overall Study|Surgical schedule|0|||
149035151|NCT00393848|537607179|FG002|Overall Study|Surgical schedule|0|||
149035152|NCT00393848|537607180|FG003|Overall Study|Surgical schedule|1|||
149035153|NCT00393848|537607177|FG000|Overall Study|Personal reasons|0|||
149035154|NCT00393848|537607178|FG001|Overall Study|Personal reasons|0|||
149035155|NCT00393848|537607179|FG002|Overall Study|Personal reasons|2|||
149035156|NCT00393848|537607180|FG003|Overall Study|Personal reasons|0|||
149035157|NCT02192606|537607181|FG000|Overall Study|surgery type was changed|1|||
149035158|NCT02192606|537607182|FG001|Overall Study|surgery type was changed|1|||
149035159|NCT02192606|537607181|FG000|Overall Study|Physician Decision|1|||
149035160|NCT02192606|537607182|FG001|Overall Study|Physician Decision|2|||
149035161|NCT02192606|537607181|FG000|Overall Study|3D equipment rep unable to join|0|||
149035162|NCT02192606|537607182|FG001|Overall Study|3D equipment rep unable to join|1|||
149035163|NCT01458210|537607189|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
149035164|NCT01458210|537607189|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
149035165|NCT01458210|537607189|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
149035166|NCT01458210|537607189|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
149035167|NCT02224924|537607190|FG000|Overall Study|Withdrawal by Subject|7|||
149035168|NCT02224924|537607191|FG001|Overall Study|Withdrawal by Subject|6|||
149035169|NCT02224924|537607190|FG000|Overall Study|Biopsy cancelled|20|||
149035170|NCT02224924|537607191|FG001|Overall Study|Biopsy cancelled|14|||
149035171|NCT02224924|537607190|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
149035172|NCT02224924|537607191|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
149035173|NCT02224924|537607190|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
149035174|NCT02224924|537607191|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
149035175|NCT01616654|537607192|FG000|Overall Study|Lack of Efficacy|1|||
149035176|NCT01616654|537607193|FG001|Overall Study|Lack of Efficacy|0|||
149035177|NCT01616654|537607194|FG002|Overall Study|Lack of Efficacy|0|||
149035178|NCT01616654|537607195|FG003|Overall Study|Lack of Efficacy|0|||
149035179|NCT01616654|537607196|FG004|Overall Study|Lack of Efficacy|1|||
149035180|NCT01616654|537607192|FG000|Overall Study|Adverse Event|0|||
149035181|NCT01616654|537607193|FG001|Overall Study|Adverse Event|1|||
149035182|NCT01616654|537607194|FG002|Overall Study|Adverse Event|2|||
149035183|NCT01616654|537607195|FG003|Overall Study|Adverse Event|1|||
149035184|NCT01616654|537607196|FG004|Overall Study|Adverse Event|0|||
149035185|NCT01616654|537607192|FG000|Overall Study|Withdrawal by Subject|2|||
149035186|NCT01616654|537607193|FG001|Overall Study|Withdrawal by Subject|2|||
149035187|NCT01616654|537607194|FG002|Overall Study|Withdrawal by Subject|3|||
149035188|NCT01616654|537607195|FG003|Overall Study|Withdrawal by Subject|1|||
149035189|NCT01616654|537607196|FG004|Overall Study|Withdrawal by Subject|5|||
149035190|NCT01616654|537607192|FG000|Overall Study|Protocol Violation|0|||
149035191|NCT01616654|537607193|FG001|Overall Study|Protocol Violation|5|||
149035192|NCT01616654|537607194|FG002|Overall Study|Protocol Violation|2|||
149035193|NCT01616654|537607195|FG003|Overall Study|Protocol Violation|4|||
149035194|NCT01616654|537607196|FG004|Overall Study|Protocol Violation|4|||
149035195|NCT01616654|537607192|FG000|Overall Study|Lost to Follow-up|1|||
149035196|NCT01616654|537607193|FG001|Overall Study|Lost to Follow-up|0|||
149035197|NCT01616654|537607194|FG002|Overall Study|Lost to Follow-up|3|||
149035198|NCT01616654|537607195|FG003|Overall Study|Lost to Follow-up|2|||
149035199|NCT01616654|537607196|FG004|Overall Study|Lost to Follow-up|1|||
149035200|NCT01616654|537607192|FG000|Overall Study|Pregnancy|1|||
149035201|NCT01616654|537607193|FG001|Overall Study|Pregnancy|0|||
149035202|NCT01616654|537607194|FG002|Overall Study|Pregnancy|0|||
149035203|NCT01616654|537607195|FG003|Overall Study|Pregnancy|0|||
149035204|NCT01616654|537607196|FG004|Overall Study|Pregnancy|1|||
149035205|NCT00094809|537607200|FG000|Overall Study|Protocol deviation|2|||
149035206|NCT00094809|537607201|FG001|Overall Study|Protocol deviation|2|||
149035207|NCT00094809|537607200|FG000|Overall Study|Noncompliance|1|||
149035208|NCT00094809|537607201|FG001|Overall Study|Noncompliance|0|||
149035209|NCT00094809|537607200|FG000|Overall Study|Adverse Event|3|||
149035210|NCT00094809|537607201|FG001|Overall Study|Adverse Event|1|||
149035211|NCT00094809|537607200|FG000|Overall Study|Withdrawal by Subject|8|||
149035212|NCT00094809|537607201|FG001|Overall Study|Withdrawal by Subject|9|||
149035213|NCT00094809|537607200|FG000|Overall Study|Disease progression|3|||
149035214|NCT00094809|537607201|FG001|Overall Study|Disease progression|3|||
149035215|NCT00094809|537607200|FG000|Overall Study|Physician Decision|3|||
149035216|NCT00094809|537607201|FG001|Overall Study|Physician Decision|5|||
149035217|NCT00094809|537607200|FG000|Overall Study|Lost to Follow-up|6|||
149035218|NCT00094809|537607201|FG001|Overall Study|Lost to Follow-up|6|||
149035219|NCT00094809|537607200|FG000|Overall Study|Death|19|||
149035220|NCT00094809|537607201|FG001|Overall Study|Death|25|||
149035221|NCT00094809|537607200|FG000|Overall Study|Protocol-specified criteria|1|||
149035222|NCT00094809|537607201|FG001|Overall Study|Protocol-specified criteria|1|||
149035223|NCT00094809|537607200|FG000|Overall Study|Other|2|||
149035224|NCT00094809|537607201|FG001|Overall Study|Other|4|||
149035225|NCT00094809|537607200|FG000|Overall Study|Informed consent signed after treatment|1|||
149035226|NCT00094809|537607201|FG001|Overall Study|Informed consent signed after treatment|0|||
149035227|NCT00094809|537607200|FG000|Overall Study|Study drug not received|2|||
149035228|NCT00094809|537607201|FG001|Overall Study|Study drug not received|8|||
149035229|NCT00094809|537607200|FG000|Overall Study|Other|1|||
149035230|NCT00094809|537607201|FG001|Overall Study|Other|1|||
149035231|NCT04842604|537607205|FG000|Overall Study|Death|1|||
149035232|NCT04842604|537607206|FG001|Overall Study|Death|0|||
149035233|NCT04842604|537607205|FG000|Overall Study|Other|4|||
149035234|NCT04842604|537607206|FG001|Overall Study|Other|4|||
149035235|NCT04842604|537607205|FG000|Overall Study|Randomized but not treated|1|||
149035236|NCT04842604|537607206|FG001|Overall Study|Randomized but not treated|0|||
149035237|NCT03525119|537607212|FG000|Overall Study|Adverse Event|0|||
149035238|NCT03525119|537607213|FG001|Overall Study|Adverse Event|1|||
149035239|NCT03525119|537607214|FG002|Overall Study|Adverse Event|0|||
149035240|NCT03525119|537607212|FG000|Overall Study|Lost to Follow-up|32|||
149035241|NCT03525119|537607213|FG001|Overall Study|Lost to Follow-up|33|||
149035242|NCT03525119|537607214|FG002|Overall Study|Lost to Follow-up|37|||
149035243|NCT03525119|537607212|FG000|Overall Study|Withdrawal by Subject|5|||
149035244|NCT03525119|537607213|FG001|Overall Study|Withdrawal by Subject|4|||
149035245|NCT03525119|537607214|FG002|Overall Study|Withdrawal by Subject|2|||
149035246|NCT03525119|537607212|FG000|Overall Study|Reason not Specified|2|||
149035247|NCT03525119|537607213|FG001|Overall Study|Reason not Specified|1|||
149035248|NCT03525119|537607214|FG002|Overall Study|Reason not Specified|2|||
149035249|NCT03525119|537607212|FG000|Overall Study|Randomized but not Vaccinated|1|||
149035250|NCT03525119|537607213|FG001|Overall Study|Randomized but not Vaccinated|0|||
149035251|NCT03525119|537607214|FG002|Overall Study|Randomized but not Vaccinated|2|||
149035252|NCT03939819|537607215|FG000|Overall Study|Death|2|||
149035253|NCT03939819|537607216|FG001|Overall Study|Death|0|||
148879511|NCT00395850|537036674|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
148879512|NCT00395850|537036675|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
148879513|NCT00395850|537036676|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
148879514|NCT00395850|537036673|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
148879515|NCT00395850|537036674|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
148879516|NCT00395850|537036675|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
148879517|NCT00395850|537036676|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
148879518|NCT00395850|537036673|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
148879519|NCT00395850|537036674|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
148879520|NCT00395850|537036675|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
148879521|NCT00395850|537036676|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
148879522|NCT00395850|537036673|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
148879523|NCT00395850|537036674|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
148879524|NCT00395850|537036675|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
148879525|NCT00395850|537036676|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
148879526|NCT00395850|537036673|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
148879527|NCT00395850|537036674|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
148879528|NCT00395850|537036675|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
148879529|NCT00395850|537036676|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
148879530|NCT00395850|537036673|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
148879531|NCT00395850|537036674|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
148879532|NCT00395850|537036675|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
148879533|NCT00395850|537036676|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
148879534|NCT00395850|537036673|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
148879535|NCT00395850|537036674|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
148879536|NCT00395850|537036675|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
148879537|NCT00395850|537036676|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
149035254|NCT03781336|537607217|FG000|Overall Study|Withdrawal by Subject|2|||
149035255|NCT03781336|537607218|FG001|Overall Study|Withdrawal by Subject|2|||
149035256|NCT01183780|537607224|FG000|Overall Study|Withdrawal by Subject|25|||
149035257|NCT01183780|537607225|FG001|Overall Study|Withdrawal by Subject|14|||
149035258|NCT01183780|537607224|FG000|Overall Study|Lost to Follow-up|6|||
149035259|NCT01183780|537607225|FG001|Overall Study|Lost to Follow-up|11|||
149035260|NCT04379713|537607226|FG000|Overall Study|Adverse Event|2|||
149035261|NCT04379713|537607227|FG001|Overall Study|Adverse Event|0|||
149035262|NCT04379713|537607226|FG000|Overall Study|Physician Decision|2|||
149035263|NCT04379713|537607227|FG001|Overall Study|Physician Decision|1|||
149035264|NCT04379713|537607226|FG000|Overall Study|Protocol Violation|11|||
148879538|NCT01844778|537036683|FG000|Overall Study|Protocol deviation|0|||
148879539|NCT01844778|537036684|FG001|Overall Study|Protocol deviation|1|||
148879540|NCT01844778|537036685|FG002|Overall Study|Protocol deviation|2|||
148879541|NCT01844778|537036683|FG000|Overall Study|Withdrawal by Subject|2|||
148879542|NCT01844778|537036684|FG001|Overall Study|Withdrawal by Subject|0|||
148879543|NCT01844778|537036685|FG002|Overall Study|Withdrawal by Subject|0|||
148879544|NCT01844778|537036683|FG000|Overall Study|Adverse Event|0|||
148879545|NCT01844778|537036684|FG001|Overall Study|Adverse Event|2|||
148879546|NCT01844778|537036685|FG002|Overall Study|Adverse Event|2|||
148879547|NCT00391625|537036692|FG000|Month 14|Withdrawal by Subject|1|||
148879548|NCT00391625|537036692|FG000|Month 50|Physician Decision|1|||
148879549|NCT03664765|537036693|FG000|Overall Study|Withdrawal by Subject|4|||
148879550|NCT03664765|537036694|FG001|Overall Study|Withdrawal by Subject|1|||
148879551|NCT03664765|537036693|FG000|Overall Study|Lost to Follow-up|0|||
148879552|NCT03664765|537036694|FG001|Overall Study|Lost to Follow-up|1|||
148879553|NCT01496846|537036695|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
148879554|NCT01496846|537036696|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
148879555|NCT01496846|537036697|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
148879556|NCT01496846|537036698|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
148879557|NCT01496846|537036699|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
148879558|NCT01496846|537036700|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
148879559|NCT01772576|537036701|FG000|Overall Study|Death|15|||
148879560|NCT01772576|537036701|FG000|Overall Study|Protocol Violation|1|||
148879561|NCT01772576|537036701|FG000|Overall Study|Lost to Follow-up|3|||
148879562|NCT01772576|537036701|FG000|Overall Study|Study device not used|3|||
148879563|NCT01772576|537036701|FG000|Overall Study|Adverse Event|6|||
148879564|NCT01772576|537036701|FG000|Overall Study|Withdrawal by Subject|6|||
148879565|NCT00923845|537036702|FG000|Induction Therapy|Poor performance status|0|||
148879566|NCT00923845|537036703|FG001|Induction Therapy|Poor performance status|2|||
148879567|NCT00379912|537036704|FG000|Overall Study|Lack of Efficacy|1|||
148879568|NCT00379912|537036705|FG001|Overall Study|Lack of Efficacy|0|||
148879569|NCT02578186|537036706|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
148879570|NCT02578186|537036707|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
148879571|NCT02578186|537036706|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
148879572|NCT02578186|537036707|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
148879573|NCT02873338|537036708|FG000|Overall Study|Adverse Event|0|||
148879574|NCT02873338|537036709|FG001|Overall Study|Adverse Event|2|||
148879575|NCT02873338|537036710|FG002|Overall Study|Adverse Event|1|||
148879576|NCT02873338|537036708|FG000|Overall Study|Death|2|||
148879577|NCT02873338|537036709|FG001|Overall Study|Death|1|||
149001356|NCT03315143|537483036|FG000|Overall Study|Reason not Specified|16|||
149001357|NCT03315143|537483037|FG001|Overall Study|Reason not Specified|32|||
149001358|NCT03320018|537483038|FG000|Treatment Period|Withdrawal by Subject|1|||
149001359|NCT03320018|537483039|FG001|Treatment Period|Withdrawal by Subject|0|||
149001360|NCT03320018|537483038|FG000|Day 90 Follow up|Death|0|||
149001361|NCT03320018|537483039|FG001|Day 90 Follow up|Death|1|||
149001362|NCT02641392|537483042|FG000|Overall Study|Lost to Follow-up|0|||
149001363|NCT02641392|537483043|FG001|Overall Study|Lost to Follow-up|0|||
149001364|NCT02641392|537483044|FG002|Overall Study|Lost to Follow-up|2|||
149001365|NCT02641392|537483042|FG000|Overall Study|Withdrawal by Subject|0|||
149001366|NCT02641392|537483043|FG001|Overall Study|Withdrawal by Subject|0|||
149001367|NCT02641392|537483044|FG002|Overall Study|Withdrawal by Subject|17|||
149001368|NCT02641392|537483042|FG000|Overall Study|Adverse Event|0|||
149001369|NCT02641392|537483043|FG001|Overall Study|Adverse Event|1|||
149001370|NCT02641392|537483044|FG002|Overall Study|Adverse Event|25|||
149001371|NCT02641392|537483042|FG000|Overall Study|Study Terminated by Sponsor|4|||
149001372|NCT02641392|537483043|FG001|Overall Study|Study Terminated by Sponsor|12|||
149001373|NCT02641392|537483044|FG002|Overall Study|Study Terminated by Sponsor|144|||
149001374|NCT02641392|537483042|FG000|Overall Study|Lack of Efficacy|0|||
148879578|NCT02873338|537036710|FG002|Overall Study|Death|1|||
148879579|NCT02873338|537036708|FG000|Overall Study|Withdrawal by Subject|2|||
148879580|NCT02873338|537036709|FG001|Overall Study|Withdrawal by Subject|1|||
148879581|NCT02873338|537036710|FG002|Overall Study|Withdrawal by Subject|3|||
148879582|NCT02873338|537036708|FG000|Overall Study|Lack of Efficacy|0|||
148879583|NCT02873338|537036709|FG001|Overall Study|Lack of Efficacy|2|||
148879584|NCT02873338|537036710|FG002|Overall Study|Lack of Efficacy|0|||
148879585|NCT02873338|537036708|FG000|Overall Study|Other or Missing|14|||
148879586|NCT02873338|537036709|FG001|Overall Study|Other or Missing|15|||
149001375|NCT02641392|537483043|FG001|Overall Study|Lack of Efficacy|0|||
149001376|NCT02641392|537483044|FG002|Overall Study|Lack of Efficacy|101|||
149001377|NCT02641392|537483042|FG000|Overall Study|Miscellaneous|0|||
149001378|NCT02641392|537483043|FG001|Overall Study|Miscellaneous|0|||
149035265|NCT04379713|537607227|FG001|Overall Study|Protocol Violation|6|||
148879587|NCT02873338|537036710|FG002|Overall Study|Other or Missing|13|||
148879588|NCT00400569|537036711|FG000|Overall Study|Death|1|||
148879589|NCT01748825|537036712|FG000|Dose Escalation|Refused further treatment|2|||
148879590|NCT01748825|537036713|FG001|Dose Escalation|Refused further treatment|2|||
148879591|NCT01748825|537036714|FG002|Dose Escalation|Refused further treatment|0|||
148879592|NCT01748825|537036715|FG003|Dose Escalation|Refused further treatment|0|||
148879593|NCT01748825|537036716|FG004|Dose Escalation|Refused further treatment|1|||
148879594|NCT01748825|537036717|FG005|Dose Escalation|Refused further treatment|2|||
148879595|NCT01748825|537036718|FG006|Dose Escalation|Refused further treatment|0|||
148879596|NCT01748825|537036719|FG007|Dose Escalation|Refused further treatment|0|||
148879597|NCT01748825|537036720|FG008|Dose Escalation|Refused further treatment|0|||
148879598|NCT01748825|537036721|FG009|Dose Escalation|Refused further treatment|0|||
149001379|NCT02641392|537483044|FG002|Overall Study|Miscellaneous|3|||
149001380|NCT02641392|537483042|FG000|Overall Study|Death|0|||
149001381|NCT02641392|537483043|FG001|Overall Study|Death|0|||
149001382|NCT02641392|537483044|FG002|Overall Study|Death|1|||
149001383|NCT02691182|537483045|FG000|Overall Study|Withdrawal by Subject|4|||
149001384|NCT02691182|537483046|FG001|Overall Study|Withdrawal by Subject|7|||
149001385|NCT02691182|537483047|FG002|Overall Study|Withdrawal by Subject|6|||
149001386|NCT02691182|537483048|FG003|Overall Study|Withdrawal by Subject|8|||
149001387|NCT02691182|537483045|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
149001388|NCT02691182|537483046|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
149001389|NCT02691182|537483047|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
149001390|NCT02691182|537483048|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
149001391|NCT02691182|537483045|FG000|Overall Study|Lost to Follow-up|8|||
149001392|NCT02691182|537483046|FG001|Overall Study|Lost to Follow-up|33|||
149001393|NCT02691182|537483047|FG002|Overall Study|Lost to Follow-up|19|||
149001394|NCT02691182|537483048|FG003|Overall Study|Lost to Follow-up|22|||
149001395|NCT02691182|537483045|FG000|Overall Study|Adverse Event|3|||
149001396|NCT02691182|537483046|FG001|Overall Study|Adverse Event|10|||
149001397|NCT02691182|537483047|FG002|Overall Study|Adverse Event|10|||
149001398|NCT02691182|537483048|FG003|Overall Study|Adverse Event|11|||
149001399|NCT02691182|537483045|FG000|Overall Study|Physician Decision|3|||
149001400|NCT02691182|537483046|FG001|Overall Study|Physician Decision|7|||
149001401|NCT02691182|537483047|FG002|Overall Study|Physician Decision|14|||
149001402|NCT02691182|537483048|FG003|Overall Study|Physician Decision|8|||
149001403|NCT02691182|537483045|FG000|Overall Study|Lack of Efficacy|0|||
149001404|NCT02691182|537483046|FG001|Overall Study|Lack of Efficacy|0|||
149001405|NCT02691182|537483047|FG002|Overall Study|Lack of Efficacy|0|||
149001406|NCT02691182|537483048|FG003|Overall Study|Lack of Efficacy|4|||
149001407|NCT02691182|537483045|FG000|Overall Study|Protocol Violation|2|||
149001408|NCT02691182|537483046|FG001|Overall Study|Protocol Violation|6|||
149001409|NCT02691182|537483047|FG002|Overall Study|Protocol Violation|6|||
149001410|NCT02691182|537483048|FG003|Overall Study|Protocol Violation|8|||
149001411|NCT02691182|537483045|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
149001412|NCT02691182|537483046|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
149001413|NCT02691182|537483047|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
149001414|NCT02691182|537483048|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
149001415|NCT02691182|537483045|FG000|Overall Study|Missing|0|||
149001416|NCT02691182|537483046|FG001|Overall Study|Missing|5|||
149001417|NCT02691182|537483047|FG002|Overall Study|Missing|1|||
149001418|NCT02691182|537483048|FG003|Overall Study|Missing|5|||
149001419|NCT02563002|537483051|FG000|Overall Study|Death|72|||
149001420|NCT02563002|537483052|FG001|Overall Study|Death|87|||
149001421|NCT02563002|537483051|FG000|Overall Study|Lost to Follow-up|5|||
149001422|NCT02563002|537483052|FG001|Overall Study|Lost to Follow-up|0|||
149001423|NCT02563002|537483051|FG000|Overall Study|Physician Decision|0|||
149001424|NCT02563002|537483052|FG001|Overall Study|Physician Decision|2|||
149001425|NCT02563002|537483051|FG000|Overall Study|Withdrawal by Subject|2|||
149001426|NCT02563002|537483052|FG001|Overall Study|Withdrawal by Subject|10|||
149001427|NCT02563002|537483051|FG000|Overall Study|Sponsor decision|74|||
149001428|NCT02563002|537483052|FG001|Overall Study|Sponsor decision|55|||
149001429|NCT03518125|537483059|FG000|Overall Study|Lost to Follow-up|0|||
149001430|NCT03518125|537483060|FG001|Overall Study|Lost to Follow-up|2|||
149001431|NCT03518125|537483061|FG002|Overall Study|Lost to Follow-up|0|||
149001432|NCT03518125|537483062|FG003|Overall Study|Lost to Follow-up|0|||
149001433|NCT03518125|537483063|FG004|Overall Study|Lost to Follow-up|3|||
149001434|NCT03518125|537483064|FG005|Overall Study|Lost to Follow-up|5|||
149001435|NCT03518125|537483059|FG000|Overall Study|Physician Decision|0|||
149001436|NCT03518125|537483060|FG001|Overall Study|Physician Decision|1|||
149001437|NCT03518125|537483061|FG002|Overall Study|Physician Decision|0|||
149001438|NCT03518125|537483062|FG003|Overall Study|Physician Decision|0|||
149001439|NCT03518125|537483063|FG004|Overall Study|Physician Decision|0|||
149001440|NCT03518125|537483064|FG005|Overall Study|Physician Decision|0|||
149001441|NCT03518125|537483059|FG000|Overall Study|Withdrawal by Subject|1|||
149001442|NCT03518125|537483060|FG001|Overall Study|Withdrawal by Subject|1|||
149001443|NCT03518125|537483061|FG002|Overall Study|Withdrawal by Subject|0|||
149001444|NCT03518125|537483062|FG003|Overall Study|Withdrawal by Subject|1|||
148879599|NCT01748825|537036712|FG000|Dose Escalation|Switched to alternative treatment|0|||
148879600|NCT01748825|537036713|FG001|Dose Escalation|Switched to alternative treatment|0|||
148879601|NCT01748825|537036714|FG002|Dose Escalation|Switched to alternative treatment|0|||
148879602|NCT01748825|537036715|FG003|Dose Escalation|Switched to alternative treatment|1|||
148879603|NCT01748825|537036716|FG004|Dose Escalation|Switched to alternative treatment|0|||
149001445|NCT03518125|537483063|FG004|Overall Study|Withdrawal by Subject|1|||
149001446|NCT03518125|537483064|FG005|Overall Study|Withdrawal by Subject|3|||
149001447|NCT03518125|537483059|FG000|Overall Study|Missed Day 394 Visit|1|||
149001448|NCT03518125|537483060|FG001|Overall Study|Missed Day 394 Visit|0|||
149001449|NCT03518125|537483061|FG002|Overall Study|Missed Day 394 Visit|0|||
149001450|NCT03518125|537483062|FG003|Overall Study|Missed Day 394 Visit|0|||
149001451|NCT03518125|537483063|FG004|Overall Study|Missed Day 394 Visit|0|||
149001452|NCT03518125|537483064|FG005|Overall Study|Missed Day 394 Visit|0|||
149001453|NCT04452877|537483065|FG000|Overall Study|Adverse Event|5|||
149001454|NCT04452877|537483065|FG000|Overall Study|Lost to Follow-up|1|||
149001455|NCT04452877|537483065|FG000|Overall Study|Physician Decision|4|||
149001456|NCT04452877|537483065|FG000|Overall Study|Progressive Disease|18|||
149001457|NCT04452877|537483065|FG000|Overall Study|Withdrawal by Subject|3|||
149001458|NCT05453110|537483070|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
149001459|NCT05453110|537483071|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
149001460|NCT05453110|537483072|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
149001461|NCT05906368|537483073|FG000|Overall Study|Withdrawal by Subject|1|||
149001462|NCT05906368|537483074|FG001|Overall Study|Withdrawal by Subject|1|||
149001463|NCT05906368|537483073|FG000|Overall Study|Ineligibility criteria identified|2|||
149001464|NCT05906368|537483074|FG001|Overall Study|Ineligibility criteria identified|0|||
149001465|NCT02799784|537483075|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
149001466|NCT02799784|537483076|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
149001467|NCT02799784|537483075|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
149001468|NCT02799784|537483076|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
149001469|NCT02799784|537483075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
149001470|NCT02799784|537483076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
149001471|NCT02799784|537483075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
149001472|NCT02799784|537483076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
149001473|NCT02799784|537483075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
149001474|NCT02799784|537483076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
149001475|NCT02799784|537483075|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
149001476|NCT02799784|537483076|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
149001477|NCT01804816|537483080|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
149001478|NCT01804816|537483080|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
149001479|NCT03086330|537483081|FG000|Overall Study|Withdrawal by Subject|3|||
149001480|NCT03086330|537483082|FG001|Overall Study|Withdrawal by Subject|2|||
149001481|NCT03086330|537483081|FG000|Overall Study|Lost to Follow-up|1|||
149001482|NCT03086330|537483082|FG001|Overall Study|Lost to Follow-up|2|||
149001483|NCT01123382|537483085|FG000|Overall Study|Withdrawal by Subject|1|||
149001484|NCT01123382|537483086|FG001|Overall Study|Withdrawal by Subject|4|||
149001485|NCT01123382|537483085|FG000|Overall Study|Lost to Follow-up|1|||
149001486|NCT01123382|537483086|FG001|Overall Study|Lost to Follow-up|2|||
149001487|NCT01256411|537483087|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
149001488|NCT01256411|537483088|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
149001489|NCT01256411|537483089|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
149001490|NCT01256411|537483090|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
149001491|NCT01256411|537483091|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
149001492|NCT01256411|537483092|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
149001493|NCT01256411|537483087|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
149001494|NCT01256411|537483088|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
149001495|NCT01256411|537483089|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
149001496|NCT01256411|537483090|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
149001497|NCT01256411|537483091|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
149001498|NCT01256411|537483092|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
149001499|NCT01256411|537483087|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
149001500|NCT01256411|537483088|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
149001501|NCT01256411|537483089|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
149001502|NCT01256411|537483090|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
149001503|NCT01256411|537483091|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
149001504|NCT01256411|537483092|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
149001505|NCT01256411|537483087|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
149001506|NCT01256411|537483088|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
149001507|NCT01256411|537483089|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
149001508|NCT01256411|537483090|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
149001509|NCT01256411|537483091|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
149001510|NCT01256411|537483092|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
149035266|NCT04379713|537607226|FG000|Overall Study|No longer met eligibility criteria|14|||
149035267|NCT04379713|537607227|FG001|Overall Study|No longer met eligibility criteria|11|||
149035268|NCT04379713|537607226|FG000|Overall Study|Withdrawal by parent/guardian|36|||
149035269|NCT04379713|537607227|FG001|Overall Study|Withdrawal by parent/guardian|15|||
149035270|NCT04379713|537607226|FG000|Overall Study|Lost to Follow-up|31|||
149035271|NCT04379713|537607227|FG001|Overall Study|Lost to Follow-up|21|||
149035272|NCT02148133|537607231|FG000|Overall Study|Investigator discretion|1|||
149035273|NCT02148133|537607231|FG000|Overall Study|Lack of Efficacy|1|||
149035274|NCT02148133|537607231|FG000|Overall Study|Protocol deviation|1|||
149035275|NCT02148133|537607231|FG000|Overall Study|Protocol-defined stopping criteria|2|||
149035276|NCT03808883|537607232|FG000|Overall Study|Withdrawal by Subject|2|||
149035277|NCT03808883|537607233|FG001|Overall Study|Withdrawal by Subject|0|||
149035278|NCT03808883|537607232|FG000|Overall Study|Did not complete pre test or post test survey|4|||
149035279|NCT03808883|537607233|FG001|Overall Study|Did not complete pre test or post test survey|3|||
149035280|NCT00855465|537607235|FG000|Treatment Period|Adverse Event|4|||
149035281|NCT00855465|537607236|FG001|Treatment Period|Adverse Event|2|||
149035282|NCT00855465|537607235|FG000|Treatment Period|Death|2|||
149035283|NCT00855465|537607236|FG001|Treatment Period|Death|2|||
149035284|NCT00855465|537607235|FG000|Treatment Period|Lack of Efficacy|2|||
149035285|NCT00855465|537607236|FG001|Treatment Period|Lack of Efficacy|1|||
149035286|NCT00855465|537607235|FG000|Treatment Period|Non-compliance|1|||
149035287|NCT00855465|537607236|FG001|Treatment Period|Non-compliance|0|||
149035288|NCT00855465|537607235|FG000|Treatment Period|Protocol Violation|2|||
149035289|NCT00855465|537607236|FG001|Treatment Period|Protocol Violation|0|||
149035290|NCT00855465|537607235|FG000|Treatment Period|Withdrawal by Subject|2|||
149035291|NCT00855465|537607236|FG001|Treatment Period|Withdrawal by Subject|0|||
149035292|NCT00855465|537607235|FG000|Treatment Period|Not treated|1|||
149035293|NCT00855465|537607236|FG001|Treatment Period|Not treated|0|||
149035294|NCT00855465|537607235|FG000|Follow-up Period (FUP)|Adverse Event|0|||
149035295|NCT00855465|537607236|FG001|Follow-up Period (FUP)|Adverse Event|1|||
149035296|NCT00855465|537607235|FG000|Follow-up Period (FUP)|Death|0|||
149035297|NCT00855465|537607236|FG001|Follow-up Period (FUP)|Death|1|||
149035298|NCT00855465|537607235|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
149035299|NCT00855465|537607236|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
149035300|NCT00855465|537607235|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
149035301|NCT00855465|537607236|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
149035302|NCT00855465|537607235|FG000|Follow-up Period (FUP)|Missing|1|||
149035303|NCT00855465|537607236|FG001|Follow-up Period (FUP)|Missing|0|||
149035304|NCT00079183|537607242|FG000|Overall Study|Withdrawal by Subject|4|||
149035305|NCT00079183|537607242|FG000|Overall Study|Study medication non-compliance|2|||
149035306|NCT00079183|537607242|FG000|Overall Study|Specimen collection non-compliance|1|||
149035307|NCT00770965|537607243|FG000|Safety Set|Withdrawal by Subject|0|||
149035308|NCT00770965|537607244|FG001|Safety Set|Withdrawal by Subject|0|||
149035309|NCT00770965|537607245|FG002|Safety Set|Withdrawal by Subject|0|||
149035310|NCT00770965|537607246|FG003|Safety Set|Withdrawal by Subject|1|||
149035311|NCT00770965|537607243|FG000|Safety Set|Protocol deviation|0|||
149035312|NCT00770965|537607244|FG001|Safety Set|Protocol deviation|0|||
149035313|NCT00770965|537607245|FG002|Safety Set|Protocol deviation|1|||
149035314|NCT00770965|537607246|FG003|Safety Set|Protocol deviation|0|||
149035315|NCT00770965|537607243|FG000|Excluded Set|Administrative problems|14|||
149035316|NCT00770965|537607244|FG001|Excluded Set|Administrative problems|12|||
149035317|NCT00770965|537607245|FG002|Excluded Set|Administrative problems|12|||
149035318|NCT00770965|537607246|FG003|Excluded Set|Administrative problems|10|||
149035319|NCT00770965|537607243|FG000|Excluded Set|Withdrawal by Subject|1|||
149035320|NCT00770965|537607244|FG001|Excluded Set|Withdrawal by Subject|1|||
149035321|NCT00770965|537607245|FG002|Excluded Set|Withdrawal by Subject|2|||
149035322|NCT00770965|537607246|FG003|Excluded Set|Withdrawal by Subject|3|||
149035323|NCT02371746|537607247|FG000|Overall Study|Consent withdrawn|0|||
149035324|NCT02371746|537607248|FG001|Overall Study|Consent withdrawn|0|||
149035325|NCT02371746|537607249|FG002|Overall Study|Consent withdrawn|0|||
149035326|NCT02371746|537607250|FG003|Overall Study|Consent withdrawn|0|||
149035327|NCT02371746|537607251|FG004|Overall Study|Consent withdrawn|0|||
149035328|NCT02371746|537607252|FG005|Overall Study|Consent withdrawn|0|||
149035329|NCT02371746|537607253|FG006|Overall Study|Consent withdrawn|1|||
149035330|NCT00436644|537607254|FG000|Overall Study|Adverse Event|2|||
149035331|NCT00436644|537607254|FG000|Overall Study|Death|1|||
149035332|NCT01157182|537607255|FG000|Washout of 28 Days|Adverse Event|2|||
149035333|NCT01157182|537607256|FG001|Washout of 28 Days|Adverse Event|0|||
149035334|NCT04364269|537607257|FG000|Overall Study|Adverse Event|1|||
149035335|NCT04364269|537607258|FG001|Overall Study|Adverse Event|0|||
149035336|NCT04364269|537607259|FG002|Overall Study|Adverse Event|0|||
149035337|NCT04364269|537607257|FG000|Overall Study|Withdrawal by Subject|0|||
149035338|NCT04364269|537607258|FG001|Overall Study|Withdrawal by Subject|1|||
149035339|NCT04364269|537607259|FG002|Overall Study|Withdrawal by Subject|0|||
149035340|NCT02534350|537607260|FG000|Overall Study|Randomized But Not Treated|1|||
149035341|NCT02534350|537607261|FG001|Overall Study|Randomized But Not Treated|0|||
149035342|NCT02534350|537607260|FG000|Overall Study|Protocol Violation|1|||
149035343|NCT02534350|537607261|FG001|Overall Study|Protocol Violation|0|||
149035344|NCT02534350|537607260|FG000|Overall Study|Withdrew Consent|2|||
149035345|NCT02534350|537607261|FG001|Overall Study|Withdrew Consent|0|||
149035346|NCT00319436|537607266|FG000|Overall Study|Withdrawal by Subject|6|||
149035347|NCT00319436|537607267|FG001|Overall Study|Withdrawal by Subject|7|||
149035348|NCT00790790|537607268|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
149035349|NCT00790790|537607269|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
149035350|NCT00790790|537607270|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
149035351|NCT00790790|537607268|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
149035352|NCT00790790|537607269|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
149035353|NCT00790790|537607270|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
149035354|NCT00790790|537607268|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
149035355|NCT00790790|537607269|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
149035356|NCT00790790|537607270|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
149035357|NCT00790790|537607268|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
149035358|NCT00790790|537607269|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
149035359|NCT00790790|537607270|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
149035360|NCT00790790|537607268|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
149035361|NCT00790790|537607269|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
149035362|NCT00790790|537607270|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
149035363|NCT01161498|537607273|FG000|Overall Study|Disease Progression|0|||
149035364|NCT01161498|537607274|FG001|Overall Study|Disease Progression|1|||
149035365|NCT02807493|537607275|FG000|Overall Study|Adverse Event|5|||
149035366|NCT02807493|537607276|FG001|Overall Study|Adverse Event|2|||
148879604|NCT01748825|537036717|FG005|Dose Escalation|Switched to alternative treatment|0|||
148879605|NCT01748825|537036718|FG006|Dose Escalation|Switched to alternative treatment|0|||
148879606|NCT01748825|537036719|FG007|Dose Escalation|Switched to alternative treatment|0|||
149035367|NCT02807493|537607275|FG000|Overall Study|Lost to Follow-up|6|||
149035368|NCT02807493|537607276|FG001|Overall Study|Lost to Follow-up|0|||
149035369|NCT02807493|537607275|FG000|Overall Study|Physician Decision|4|||
149035370|NCT02807493|537607276|FG001|Overall Study|Physician Decision|1|||
149035371|NCT02807493|537607275|FG000|Overall Study|Protocol Violation|7|||
149035372|NCT02807493|537607276|FG001|Overall Study|Protocol Violation|0|||
149035373|NCT02807493|537607275|FG000|Overall Study|Withdrawal by Subject|17|||
149035374|NCT02807493|537607276|FG001|Overall Study|Withdrawal by Subject|10|||
149035375|NCT02807493|537607275|FG000|Overall Study|Other withdrawal|17|||
149035376|NCT02807493|537607276|FG001|Overall Study|Other withdrawal|0|||
149035377|NCT02807493|537607275|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
149035378|NCT02807493|537607276|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
149035379|NCT01493778|537607277|FG000|Overall Study|Withdrawal by Subject|8|||
149035380|NCT01227707|537607278|FG000|Overall Study|Adverse Event|10|||
149035381|NCT01227707|537607278|FG000|Overall Study|Progression of disease|3|||
149035382|NCT01227707|537607278|FG000|Overall Study|Withdrawal by Subject|1|||
149035383|NCT01227707|537607278|FG000|Overall Study|Patient non-compliance|3|||
149035384|NCT01227707|537607278|FG000|Overall Study|Medical decision|6|||
149035385|NCT01227707|537607278|FG000|Overall Study|Death|1|||
149035386|NCT00823979|537607293|FG000|Overall Study|Lack of Efficacy|13|||
149035387|NCT00823979|537607294|FG001|Overall Study|Lack of Efficacy|16|||
149035388|NCT00823979|537607295|FG002|Overall Study|Lack of Efficacy|9|||
149035389|NCT00823979|537607293|FG000|Overall Study|Lost to Follow-up|2|||
149035390|NCT00823979|537607294|FG001|Overall Study|Lost to Follow-up|1|||
149035391|NCT00823979|537607295|FG002|Overall Study|Lost to Follow-up|0|||
149035392|NCT00823979|537607293|FG000|Overall Study|Withdrawal by Subject|2|||
149035393|NCT00823979|537607294|FG001|Overall Study|Withdrawal by Subject|3|||
149035394|NCT00823979|537607295|FG002|Overall Study|Withdrawal by Subject|2|||
149035395|NCT00823979|537607293|FG000|Overall Study|Protocol Violation|1|||
148879607|NCT01748825|537036720|FG008|Dose Escalation|Switched to alternative treatment|0|||
148879608|NCT01748825|537036721|FG009|Dose Escalation|Switched to alternative treatment|0|||
148879609|NCT01748825|537036712|FG000|Dose Escalation|Adverse Event|0|||
149035396|NCT00823979|537607294|FG001|Overall Study|Protocol Violation|1|||
149035397|NCT00823979|537607295|FG002|Overall Study|Protocol Violation|0|||
149035398|NCT00823979|537607293|FG000|Overall Study|Pregnancy|0|||
149035399|NCT00823979|537607294|FG001|Overall Study|Pregnancy|1|||
149035400|NCT00823979|537607295|FG002|Overall Study|Pregnancy|0|||
149035401|NCT00823979|537607293|FG000|Overall Study|Adverse Event|0|||
149035402|NCT00823979|537607294|FG001|Overall Study|Adverse Event|2|||
149035403|NCT00823979|537607295|FG002|Overall Study|Adverse Event|4|||
149035404|NCT00823979|537607293|FG000|Overall Study|Other|2|||
149035405|NCT00823979|537607294|FG001|Overall Study|Other|0|||
149035406|NCT00823979|537607295|FG002|Overall Study|Other|1|||
149035407|NCT00823979|537607293|FG000|Overall Study|Randomized but not Treated|4|||
148879610|NCT01748825|537036713|FG001|Dose Escalation|Adverse Event|0|||
149035408|NCT00823979|537607294|FG001|Overall Study|Randomized but not Treated|3|||
149035409|NCT00823979|537607295|FG002|Overall Study|Randomized but not Treated|1|||
149035410|NCT00823979|537607293|FG000|Overall Study|Study Terminated by Sponsor|5|||
149035411|NCT00823979|537607294|FG001|Overall Study|Study Terminated by Sponsor|5|||
149035412|NCT00823979|537607295|FG002|Overall Study|Study Terminated by Sponsor|7|||
149035413|NCT03523091|537607296|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
149035414|NCT03523091|537607297|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
149035415|NCT03523091|537607296|FG000|Overall Study|Withdrawal by Subject|0|||
149035416|NCT03523091|537607297|FG001|Overall Study|Withdrawal by Subject|3|||
149035417|NCT03523091|537607296|FG000|Overall Study|Increase Botox dose|0|||
149035418|NCT03523091|537607297|FG001|Overall Study|Increase Botox dose|1|||
149035419|NCT00741988|537607298|FG000|Overall Study|Adverse Event|2|||
149035420|NCT00741988|537607299|FG001|Overall Study|Adverse Event|4|||
149035421|NCT00741988|537607298|FG000|Overall Study|Lack of Efficacy|2|||
149035422|NCT00741988|537607299|FG001|Overall Study|Lack of Efficacy|0|||
149035423|NCT02685488|537607306|FG000|Overall Study|Withdrawal by Subject|0|||
149035424|NCT02685488|537607307|FG001|Overall Study|Withdrawal by Subject|1|||
149035425|NCT05019729|537607308|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
149035426|NCT05019729|537607309|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
149035427|NCT05019729|537607310|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
149035428|NCT05019729|537607311|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
149035429|NCT05019729|537607312|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
149035430|NCT05019729|537607313|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
149035431|NCT03254394|537607316|FG000|Overall Study|Withdrawal by Subject|0|||
149035432|NCT03254394|537607317|FG001|Overall Study|Withdrawal by Subject|2|||
149035433|NCT00536380|537607318|FG000|Overall Study|Adverse Event|0|||
149035434|NCT00536380|537607319|FG001|Overall Study|Adverse Event|2|||
149035435|NCT00536380|537607320|FG002|Overall Study|Adverse Event|2|||
149035436|NCT00536380|537607318|FG000|Overall Study|Lost to Follow-up|0|||
149035437|NCT00536380|537607319|FG001|Overall Study|Lost to Follow-up|0|||
149035438|NCT00536380|537607320|FG002|Overall Study|Lost to Follow-up|1|||
149035439|NCT00536380|537607318|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
149035440|NCT00536380|537607319|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
149035441|NCT00536380|537607320|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
149035442|NCT00536380|537607318|FG000|Overall Study|Withdrawal related to study drug|7|||
149035443|NCT00536380|537607319|FG001|Overall Study|Withdrawal related to study drug|5|||
149035444|NCT00536380|537607320|FG002|Overall Study|Withdrawal related to study drug|2|||
149035445|NCT00536380|537607318|FG000|Overall Study|Noncompliance with protocol|3|||
149035446|NCT00536380|537607319|FG001|Overall Study|Noncompliance with protocol|2|||
149035447|NCT00536380|537607320|FG002|Overall Study|Noncompliance with protocol|2|||
149035448|NCT00536380|537607318|FG000|Overall Study|Did not meet protocol eligibility|0|||
149035449|NCT00536380|537607319|FG001|Overall Study|Did not meet protocol eligibility|0|||
149035450|NCT00536380|537607320|FG002|Overall Study|Did not meet protocol eligibility|1|||
149035451|NCT00536380|537607318|FG000|Overall Study|Administrative|0|||
149035452|NCT00536380|537607319|FG001|Overall Study|Administrative|0|||
149035453|NCT00536380|537607320|FG002|Overall Study|Administrative|1|||
149035454|NCT00387465|537607321|FG000|Overall Study|Withdrawal by Subject|0|||
149035455|NCT00387465|537607322|FG001|Overall Study|Withdrawal by Subject|1|||
149035456|NCT00387465|537607323|FG002|Overall Study|Withdrawal by Subject|0|||
149035457|NCT03418324|537607324|FG000|Overall Study|Death|0|||
149035458|NCT03418324|537607325|FG001|Overall Study|Death|1|||
149035459|NCT03418324|537607324|FG000|Overall Study|Physician Decision|1|||
149035460|NCT03418324|537607325|FG001|Overall Study|Physician Decision|1|||
149035461|NCT05147233|537609441|FG000|Overall Study|Adverse Event|0|||
149035462|NCT05147233|537609442|FG001|Overall Study|Adverse Event|1|||
149035463|NCT05147233|537609441|FG000|Overall Study|Lost to Follow-up|1|||
149035464|NCT05147233|537609442|FG001|Overall Study|Lost to Follow-up|1|||
149035465|NCT05147233|537609441|FG000|Overall Study|Protocol Violation|0|||
148879611|NCT01748825|537036714|FG002|Dose Escalation|Adverse Event|0|||
148879612|NCT01748825|537036715|FG003|Dose Escalation|Adverse Event|0|||
148879613|NCT01748825|537036716|FG004|Dose Escalation|Adverse Event|0|||
148879614|NCT01748825|537036717|FG005|Dose Escalation|Adverse Event|0|||
149035466|NCT05147233|537609442|FG001|Overall Study|Protocol Violation|1|||
149035467|NCT05147233|537609441|FG000|Overall Study|Withdrawal by Subject|2|||
149035468|NCT05147233|537609442|FG001|Overall Study|Withdrawal by Subject|1|||
149035469|NCT02577523|537609445|FG000|Overall Study|Adverse Event|1|||
148879615|NCT01748825|537036718|FG006|Dose Escalation|Adverse Event|1|||
148879616|NCT01748825|537036719|FG007|Dose Escalation|Adverse Event|0|||
149035470|NCT02577523|537609446|FG001|Overall Study|Adverse Event|1|||
149035471|NCT02577523|537609445|FG000|Overall Study|Lack of Efficacy|1|||
149035472|NCT02577523|537609446|FG001|Overall Study|Lack of Efficacy|1|||
149035473|NCT02577523|537609445|FG000|Overall Study|Withdrawal by Subject|1|||
149035474|NCT02577523|537609446|FG001|Overall Study|Withdrawal by Subject|0|||
149035475|NCT01198275|537609447|FG000|Overall Study|Adverse Event|2|||
149035476|NCT01198275|537609448|FG001|Overall Study|Adverse Event|3|||
149035477|NCT01198275|537609447|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
149035478|NCT01198275|537609448|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
149035479|NCT00391846|537609449|FG000|Overall Study|Adverse Event|4|||
149035480|NCT00391846|537609450|FG001|Overall Study|Adverse Event|1|||
149035481|NCT00391846|537609449|FG000|Overall Study|Did not meet the required elig. crit|2|||
149035482|NCT00391846|537609450|FG001|Overall Study|Did not meet the required elig. crit|2|||
149035483|NCT00391846|537609449|FG000|Overall Study|Withdrawal by Subject|2|||
149035484|NCT00391846|537609450|FG001|Overall Study|Withdrawal by Subject|3|||
149035485|NCT00391846|537609449|FG000|Overall Study|Developed study specific DC criteria|0|||
149035486|NCT00391846|537609450|FG001|Overall Study|Developed study specific DC criteria|1|||
149035487|NCT03923491|537609453|FG000|Overall Study|Lost to Follow-up|5|||
149035488|NCT03923491|537609454|FG001|Overall Study|Lost to Follow-up|8|||
149035489|NCT03923491|537609453|FG000|Overall Study|Withdrawal by Subject|4|||
149035490|NCT03923491|537609454|FG001|Overall Study|Withdrawal by Subject|6|||
149035491|NCT00753012|537609459|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
149035492|NCT00753012|537609460|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
149035493|NCT00753012|537609459|FG000|Overall Study|Adverse Event|2|||
149035494|NCT00753012|537609460|FG001|Overall Study|Adverse Event|0|||
149035495|NCT00753012|537609459|FG000|Overall Study|Withdrawal by Subject|0|||
149035496|NCT00753012|537609460|FG001|Overall Study|Withdrawal by Subject|1|||
149035497|NCT00753012|537609459|FG000|Overall Study|Lost to Follow-up|4|||
149035498|NCT00753012|537609460|FG001|Overall Study|Lost to Follow-up|0|||
149035499|NCT00753012|537609459|FG000|Overall Study|Confounded endpoint data|1|||
149035500|NCT00753012|537609460|FG001|Overall Study|Confounded endpoint data|0|||
149035501|NCT01027286|537609461|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
149035502|NCT01027286|537609462|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
149035503|NCT01027286|537609461|FG000|Overall Study|Lost to Follow-up|0|||
149035504|NCT01027286|537609462|FG001|Overall Study|Lost to Follow-up|1|||
149035505|NCT00545844|537609463|FG000|Overall Study|Lost to Follow-up|9|||
149035506|NCT00545844|537609463|FG000|Overall Study|Protocol Violation|1|||
149035507|NCT00545844|537609463|FG000|Overall Study|Withdrawal by Subject|2|||
149035508|NCT01329328|537609464|FG000|Overall Study|Withdrawal by Subject|2|||
149035509|NCT01329328|537609465|FG001|Overall Study|Withdrawal by Subject|4|||
149035510|NCT01329328|537609466|FG002|Overall Study|Withdrawal by Subject|3|||
149035511|NCT02506257|537609476|FG000|Overall Study|Adverse Event|0|||
149035512|NCT02506257|537609477|FG001|Overall Study|Adverse Event|2|||
149035513|NCT02506257|537609478|FG002|Overall Study|Adverse Event|3|||
149035514|NCT02506257|537609479|FG003|Overall Study|Adverse Event|0|||
148879617|NCT01748825|537036720|FG008|Dose Escalation|Adverse Event|0|||
148879618|NCT01748825|537036721|FG009|Dose Escalation|Adverse Event|0|||
148879619|NCT01748825|537036712|FG000|Dose Expansion|Refused further treatment|0|||
148879620|NCT01748825|537036713|FG001|Dose Expansion|Refused further treatment|0|||
148879621|NCT01748825|537036714|FG002|Dose Expansion|Refused further treatment|0|||
148879622|NCT01748825|537036715|FG003|Dose Expansion|Refused further treatment|0|||
148879623|NCT01748825|537036716|FG004|Dose Expansion|Refused further treatment|0|||
148879624|NCT01748825|537036717|FG005|Dose Expansion|Refused further treatment|0|||
148879625|NCT01748825|537036718|FG006|Dose Expansion|Refused further treatment|0|||
148879626|NCT01748825|537036719|FG007|Dose Expansion|Refused further treatment|0|||
148879627|NCT01748825|537036720|FG008|Dose Expansion|Refused further treatment|1|||
148879628|NCT01748825|537036721|FG009|Dose Expansion|Refused further treatment|1|||
148879629|NCT01748825|537036712|FG000|Dose Expansion|Switched to alternative treatment|0|||
148879630|NCT01748825|537036713|FG001|Dose Expansion|Switched to alternative treatment|0|||
148879631|NCT01748825|537036714|FG002|Dose Expansion|Switched to alternative treatment|0|||
148879632|NCT01748825|537036715|FG003|Dose Expansion|Switched to alternative treatment|0|||
148879633|NCT01748825|537036716|FG004|Dose Expansion|Switched to alternative treatment|0|||
148879634|NCT01748825|537036717|FG005|Dose Expansion|Switched to alternative treatment|0|||
148879635|NCT01748825|537036718|FG006|Dose Expansion|Switched to alternative treatment|0|||
148879636|NCT01748825|537036719|FG007|Dose Expansion|Switched to alternative treatment|0|||
148879637|NCT01748825|537036720|FG008|Dose Expansion|Switched to alternative treatment|0|||
148879638|NCT01748825|537036721|FG009|Dose Expansion|Switched to alternative treatment|1|||
149035515|NCT02506257|537609476|FG000|Overall Study|Protocol Violation|0|||
149035516|NCT02506257|537609477|FG001|Overall Study|Protocol Violation|0|||
149035517|NCT02506257|537609478|FG002|Overall Study|Protocol Violation|1|||
149035518|NCT02506257|537609479|FG003|Overall Study|Protocol Violation|0|||
149035519|NCT00964366|537609480|FG000|Overall Study|Did not qualify at Day 1|1|||
149035520|NCT00964366|537609481|FG001|Overall Study|Did not qualify at Day 1|0|||
148879639|NCT01748825|537036712|FG000|Dose Expansion|Adverse Event|0|||
148879640|NCT01748825|537036713|FG001|Dose Expansion|Adverse Event|0|||
148879641|NCT01748825|537036714|FG002|Dose Expansion|Adverse Event|0|||
148879642|NCT01748825|537036715|FG003|Dose Expansion|Adverse Event|0|||
149035521|NCT00964366|537609480|FG000|Overall Study|Withdrawal by Subject|0|||
149035522|NCT00964366|537609481|FG001|Overall Study|Withdrawal by Subject|1|||
149035523|NCT01370694|537609482|FG000|Overall Study|Switched to rituximab|4|||
149035524|NCT01370694|537609482|FG000|Overall Study|Progressive disease|2|||
149035525|NCT02393716|537609483|FG000|Overall Study|Death|29|||
149035526|NCT02393716|537609483|FG000|Overall Study|Withdrawal by Subject|8|||
149035527|NCT02393716|537609483|FG000|Overall Study|Device Explanted|8|||
149035528|NCT02393716|537609483|FG000|Overall Study|Missed visit|16|||
149035529|NCT01924767|537609486|FG000|Overall Study|Adverse Event|1|||
148879643|NCT01748825|537036716|FG004|Dose Expansion|Adverse Event|0|||
148879644|NCT01748825|537036717|FG005|Dose Expansion|Adverse Event|0|||
148879645|NCT01748825|537036718|FG006|Dose Expansion|Adverse Event|0|||
149035530|NCT01924767|537609487|FG001|Overall Study|Adverse Event|0|||
149035531|NCT01924767|537609488|FG002|Overall Study|Adverse Event|1|||
149035532|NCT01924767|537609489|FG003|Overall Study|Adverse Event|0|||
149035533|NCT01924767|537609490|FG004|Overall Study|Adverse Event|0|||
149035534|NCT01193153|537609491|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
149035535|NCT01193153|537609492|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
149035536|NCT01193153|537609491|FG000|Open-label Lead in Period|Pregnancy|1|||
149035537|NCT01193153|537609492|FG001|Open-label Lead in Period|Pregnancy|0|||
149035538|NCT01193153|537609491|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
149035539|NCT01193153|537609492|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
149035540|NCT01193153|537609491|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
149035541|NCT01193153|537609492|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
149035542|NCT01193153|537609491|FG000|Open-label Lead in Period|Other|14|||
149035543|NCT01193153|537609492|FG001|Open-label Lead in Period|Other|0|||
149035544|NCT01193153|537609491|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
149035545|NCT01193153|537609492|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
149035546|NCT01193153|537609491|FG000|Open-label Lead in Period|Adverse Event|41|||
149035547|NCT01193153|537609492|FG001|Open-label Lead in Period|Adverse Event|0|||
149035548|NCT01193153|537609491|FG000|Open-label Lead in Period|Death|1|||
149035549|NCT01193153|537609492|FG001|Open-label Lead in Period|Death|0|||
149035550|NCT01193153|537609491|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
149035551|NCT01193153|537609492|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
149035552|NCT01193153|537609491|FG000|Open-label Stabilization Period|Adverse Event|9|||
149035553|NCT01193153|537609492|FG001|Open-label Stabilization Period|Adverse Event|0|||
149035554|NCT01193153|537609491|FG000|Open-label Stabilization Period|Death|2|||
149035555|NCT01193153|537609492|FG001|Open-label Stabilization Period|Death|0|||
149035556|NCT01193153|537609491|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
149035557|NCT01193153|537609492|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
149035558|NCT01193153|537609491|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
149035559|NCT01193153|537609492|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
149035560|NCT01193153|537609491|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
149035561|NCT01193153|537609492|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
149035562|NCT01193153|537609491|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
149035563|NCT01193153|537609492|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
149035564|NCT01193153|537609491|FG000|Open-label Stabilization Period|Other|8|||
149035565|NCT01193153|537609492|FG001|Open-label Stabilization Period|Other|0|||
149035566|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Other|2|||
149035567|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Other|3|||
149035568|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
149035569|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
149035570|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Death|2|||
149035571|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Death|0|||
149035572|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
149035573|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
149035574|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
149035575|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
149035576|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
149035577|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
149035578|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
149035579|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
149035580|NCT01193153|537609491|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
149035581|NCT01193153|537609492|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
149035582|NCT01648140|537609493|FG000|Overall Study|Physician Decision|1|||
149035583|NCT01648140|537609494|FG001|Overall Study|Physician Decision|0|||
149035584|NCT01648140|537609495|FG002|Overall Study|Physician Decision|0|||
149035585|NCT01648140|537609496|FG003|Overall Study|Physician Decision|0|||
149035586|NCT01648140|537609493|FG000|Overall Study|Lack of Efficacy|4|||
148879646|NCT01748825|537036719|FG007|Dose Expansion|Adverse Event|0|||
148879647|NCT01748825|537036720|FG008|Dose Expansion|Adverse Event|0|||
148879648|NCT01748825|537036721|FG009|Dose Expansion|Adverse Event|3|||
149035587|NCT01648140|537609494|FG001|Overall Study|Lack of Efficacy|7|||
148879649|NCT01748825|537036712|FG000|Dose Expansion|Physician Decision|0|||
149035588|NCT01648140|537609495|FG002|Overall Study|Lack of Efficacy|1|||
149035589|NCT01648140|537609496|FG003|Overall Study|Lack of Efficacy|0|||
149035590|NCT01648140|537609493|FG000|Overall Study|Adverse Event|3|||
149035591|NCT01648140|537609494|FG001|Overall Study|Adverse Event|1|||
149035592|NCT01648140|537609495|FG002|Overall Study|Adverse Event|2|||
148879650|NCT01748825|537036713|FG001|Dose Expansion|Physician Decision|0|||
148879651|NCT01748825|537036714|FG002|Dose Expansion|Physician Decision|0|||
148879652|NCT01748825|537036715|FG003|Dose Expansion|Physician Decision|0|||
148879653|NCT01748825|537036716|FG004|Dose Expansion|Physician Decision|0|||
148879654|NCT01748825|537036717|FG005|Dose Expansion|Physician Decision|0|||
148879655|NCT01748825|537036718|FG006|Dose Expansion|Physician Decision|0|||
148879656|NCT01748825|537036719|FG007|Dose Expansion|Physician Decision|0|||
148879657|NCT01748825|537036720|FG008|Dose Expansion|Physician Decision|1|||
148879658|NCT01748825|537036721|FG009|Dose Expansion|Physician Decision|0|||
148879659|NCT00211887|537036722|FG000|Overall Study|Adverse Event|8|||
148879660|NCT00211887|537036723|FG001|Overall Study|Adverse Event|4|||
148879661|NCT00211887|537036724|FG002|Overall Study|Adverse Event|6|||
148879662|NCT00211887|537036722|FG000|Overall Study|Death|1|||
148879663|NCT00211887|537036723|FG001|Overall Study|Death|1|||
148879664|NCT00211887|537036724|FG002|Overall Study|Death|1|||
148879665|NCT00211887|537036722|FG000|Overall Study|Lost to Follow-up|28|||
148879666|NCT00211887|537036723|FG001|Overall Study|Lost to Follow-up|13|||
148879667|NCT00211887|537036724|FG002|Overall Study|Lost to Follow-up|9|||
148879668|NCT00211887|537036722|FG000|Overall Study|Non-medical reason|31|||
148879669|NCT00211887|537036723|FG001|Overall Study|Non-medical reason|14|||
148879670|NCT00211887|537036724|FG002|Overall Study|Non-medical reason|8|||
148879671|NCT00211887|537036722|FG000|Overall Study|Other medical reason|15|||
148879672|NCT00211887|537036723|FG001|Overall Study|Other medical reason|11|||
148879673|NCT00211887|537036724|FG002|Overall Study|Other medical reason|7|||
148879674|NCT00211887|537036722|FG000|Overall Study|Side effects|19|||
148879675|NCT00211887|537036723|FG001|Overall Study|Side effects|13|||
148879676|NCT00211887|537036724|FG002|Overall Study|Side effects|5|||
148879677|NCT03848949|537036725|FG000|Overall Study|Lost to Follow-up|5|||
148879678|NCT03848949|537036726|FG001|Overall Study|Lost to Follow-up|7|||
148879679|NCT03688074|537038127|FG000|Overall Study|Adverse Event|0|||
148879680|NCT03688074|537038128|FG001|Overall Study|Adverse Event|1|||
148879681|NCT03688074|537038127|FG000|Overall Study|Other|1|||
148879682|NCT03688074|537038128|FG001|Overall Study|Other|0|||
148879683|NCT01504412|537038129|FG000|Overall Study|Adverse Event|1|||
148879684|NCT01504412|537038130|FG001|Overall Study|Adverse Event|8|||
148879685|NCT01504412|537038131|FG002|Overall Study|Adverse Event|1|||
148879686|NCT01504412|537038132|FG003|Overall Study|Adverse Event|7|||
148879687|NCT01504412|537038133|FG004|Overall Study|Adverse Event|10|||
148879688|NCT01504412|537038129|FG000|Overall Study|Withdrawal by Subject|2|||
148879689|NCT01504412|537038130|FG001|Overall Study|Withdrawal by Subject|1|||
148879690|NCT01504412|537038131|FG002|Overall Study|Withdrawal by Subject|1|||
148879691|NCT01504412|537038132|FG003|Overall Study|Withdrawal by Subject|5|||
148879692|NCT01504412|537038133|FG004|Overall Study|Withdrawal by Subject|1|||
148879693|NCT01504412|537038129|FG000|Overall Study|Other|2|||
148879694|NCT01504412|537038130|FG001|Overall Study|Other|1|||
148879695|NCT01504412|537038131|FG002|Overall Study|Other|1|||
148879696|NCT01504412|537038132|FG003|Overall Study|Other|6|||
148879697|NCT01504412|537038133|FG004|Overall Study|Other|1|||
148879698|NCT01504412|537038129|FG000|Overall Study|Lost to Follow-up|0|||
148879699|NCT01504412|537038130|FG001|Overall Study|Lost to Follow-up|2|||
148879700|NCT01504412|537038131|FG002|Overall Study|Lost to Follow-up|0|||
149001511|NCT01256411|537483087|FG000|Extension by Maximum Treatment|Adverse Event|4|||
149001512|NCT01256411|537483088|FG001|Extension by Maximum Treatment|Adverse Event|2|||
149001513|NCT01256411|537483089|FG002|Extension by Maximum Treatment|Adverse Event|1|||
149001514|NCT01256411|537483090|FG003|Extension by Maximum Treatment|Adverse Event|0|||
149001515|NCT01256411|537483091|FG004|Extension by Maximum Treatment|Adverse Event|0|||
149001516|NCT01256411|537483092|FG005|Extension by Maximum Treatment|Adverse Event|0|||
149001517|NCT01256411|537483087|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
149001518|NCT01256411|537483088|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
149001519|NCT01256411|537483089|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
149001520|NCT01256411|537483090|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
149001521|NCT01256411|537483091|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
149001522|NCT01256411|537483092|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
149001523|NCT01256411|537483087|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
149001524|NCT01256411|537483088|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
149001525|NCT01256411|537483089|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
149001526|NCT01256411|537483090|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
149001527|NCT01256411|537483091|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
149001528|NCT01256411|537483092|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
149001529|NCT01256411|537483087|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
149001530|NCT01256411|537483088|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
149001531|NCT01256411|537483089|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
149001532|NCT01256411|537483090|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
149001533|NCT01256411|537483091|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
149001534|NCT01256411|537483092|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
149001535|NCT01256411|537483087|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
149035593|NCT01648140|537609496|FG003|Overall Study|Adverse Event|0|||
149035594|NCT01648140|537609493|FG000|Overall Study|Withdrawal by Subject|2|||
149035595|NCT01648140|537609494|FG001|Overall Study|Withdrawal by Subject|3|||
149035596|NCT01648140|537609495|FG002|Overall Study|Withdrawal by Subject|3|||
149035597|NCT01648140|537609496|FG003|Overall Study|Withdrawal by Subject|2|||
149035598|NCT01648140|537609493|FG000|Overall Study|Lost to Follow-up|2|||
149035599|NCT01648140|537609494|FG001|Overall Study|Lost to Follow-up|1|||
149035600|NCT01648140|537609495|FG002|Overall Study|Lost to Follow-up|2|||
149035601|NCT01648140|537609496|FG003|Overall Study|Lost to Follow-up|0|||
149035602|NCT01563354|537609499|FG000|Core Phase|Adverse Event|5|||
149035603|NCT01563354|537609500|FG001|Core Phase|Adverse Event|15|||
149035604|NCT01563354|537609501|FG002|Core Phase|Adverse Event|13|||
149035605|NCT01563354|537609499|FG000|Core Phase|Withdrawal by Subject|1|||
149035606|NCT01563354|537609500|FG001|Core Phase|Withdrawal by Subject|0|||
149035607|NCT01563354|537609501|FG002|Core Phase|Withdrawal by Subject|3|||
149035608|NCT01563354|537609499|FG000|Core Phase|Lost to Follow-up|1|||
149035609|NCT01563354|537609500|FG001|Core Phase|Lost to Follow-up|0|||
149035610|NCT01563354|537609501|FG002|Core Phase|Lost to Follow-up|0|||
149035611|NCT01563354|537609499|FG000|Core Phase|Death|1|||
149035612|NCT01563354|537609500|FG001|Core Phase|Death|5|||
149035613|NCT01563354|537609501|FG002|Core Phase|Death|2|||
149035614|NCT01563354|537609499|FG000|Core Phase|Diseasse progression|18|||
149035615|NCT01563354|537609500|FG001|Core Phase|Diseasse progression|7|||
149035616|NCT01563354|537609501|FG002|Core Phase|Diseasse progression|8|||
149035617|NCT01563354|537609499|FG000|Core Phase|Protocol deviation|2|||
149035618|NCT01563354|537609500|FG001|Core Phase|Protocol deviation|0|||
149035619|NCT01563354|537609501|FG002|Core Phase|Protocol deviation|0|||
149035620|NCT01563354|537609499|FG000|Core Phase|PI decision - did not enter extension|0|||
149035621|NCT01563354|537609500|FG001|Core Phase|PI decision - did not enter extension|1|||
149035622|NCT01563354|537609501|FG002|Core Phase|PI decision - did not enter extension|0|||
149035623|NCT01563354|537609499|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
149035624|NCT01563354|537609500|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
149035625|NCT01563354|537609501|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
149035626|NCT01563354|537609499|FG000|Extension Phase|Adverse Event|0|||
149035627|NCT01563354|537609500|FG001|Extension Phase|Adverse Event|3|||
149035628|NCT01563354|537609501|FG002|Extension Phase|Adverse Event|2|||
149035629|NCT01563354|537609499|FG000|Extension Phase|Withdrawal by Subject|0|||
149035630|NCT01563354|537609500|FG001|Extension Phase|Withdrawal by Subject|1|||
149035631|NCT01563354|537609501|FG002|Extension Phase|Withdrawal by Subject|0|||
149035632|NCT01563354|537609499|FG000|Extension Phase|Administration problems|3|||
149035633|NCT01563354|537609500|FG001|Extension Phase|Administration problems|2|||
149035634|NCT01563354|537609501|FG002|Extension Phase|Administration problems|3|||
149035635|NCT01563354|537609499|FG000|Extension Phase|Disease progression|9|||
149035636|NCT01563354|537609500|FG001|Extension Phase|Disease progression|8|||
149035637|NCT01563354|537609501|FG002|Extension Phase|Disease progression|10|||
149035638|NCT01565928|537609502|FG000|Overall Study|Adverse Event|3|||
149035639|NCT01565928|537609502|FG000|Overall Study|Other|3|||
149035640|NCT01565928|537609502|FG000|Overall Study|Progressive Disease|13|||
149035641|NCT01565928|537609502|FG000|Overall Study|Withdrawal by Subject|1|||
149035642|NCT01565928|537609502|FG000|Overall Study|Death|2|||
149035643|NCT01119950|537609503|FG000|Overall Study|Adverse Event|25|||
149035644|NCT01119950|537609503|FG000|Overall Study|Withdrawal by Subject|9|||
149035645|NCT01119950|537609503|FG000|Overall Study|Protocol Violation|5|||
149035646|NCT01119950|537609503|FG000|Overall Study|Lost to Follow-up|4|||
149035647|NCT01119950|537609503|FG000|Overall Study|Administrative|2|||
149035648|NCT01119950|537609503|FG000|Overall Study|Abnormal lab value|1|||
149035649|NCT01119950|537609503|FG000|Overall Study|Death|1|||
149035650|NCT01988233|537609511|FG000|Overall Study|Lost to Follow-up|64|||
149035651|NCT01988233|537609512|FG001|Overall Study|Lost to Follow-up|51|||
149035652|NCT01713530|537609519|FG000|Overall Study|Adverse Event|0|||
149035653|NCT01713530|537609520|FG001|Overall Study|Adverse Event|5|||
149035654|NCT01713530|537609519|FG000|Overall Study|Withdrawal criteria|21|||
149035655|NCT01713530|537609520|FG001|Overall Study|Withdrawal criteria|12|||
149035656|NCT01713530|537609519|FG000|Overall Study|Unclassified|4|||
149035657|NCT01713530|537609520|FG001|Overall Study|Unclassified|2|||
149035658|NCT03743246|537609521|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
149035659|NCT03743246|537609522|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
149035660|NCT03743246|537609523|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
149035661|NCT03743246|537609524|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
149035662|NCT03743246|537609521|FG000|Pre-Treatment Period|Death|0|||
149035663|NCT03743246|537609522|FG001|Pre-Treatment Period|Death|1|||
149035664|NCT03743246|537609523|FG002|Pre-Treatment Period|Death|0|||
149035665|NCT03743246|537609524|FG003|Pre-Treatment Period|Death|1|||
149035666|NCT03743246|537609521|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
149035667|NCT03743246|537609522|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
149035668|NCT03743246|537609523|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
149035669|NCT03743246|537609524|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
149035670|NCT03743246|537609521|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
148879701|NCT01504412|537038132|FG003|Overall Study|Lost to Follow-up|0|||
148879702|NCT01504412|537038133|FG004|Overall Study|Lost to Follow-up|0|||
148879703|NCT01504412|537038129|FG000|Overall Study|Lack of Efficacy|0|||
149001536|NCT01256411|537483088|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
149001537|NCT01256411|537483089|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
149001538|NCT01256411|537483090|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
149001539|NCT01256411|537483091|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
149001540|NCT01256411|537483092|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
149001541|NCT01256411|537483087|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
149001542|NCT01256411|537483088|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
149001543|NCT01256411|537483089|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
149001544|NCT01256411|537483090|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
149001545|NCT01256411|537483091|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
149001546|NCT01256411|537483092|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
149001547|NCT02274857|537483093|FG000|Overall Study|Adverse Event|1|||
149001548|NCT02274857|537483094|FG001|Overall Study|Adverse Event|0|||
149001549|NCT02274857|537483093|FG000|Overall Study|Death|1|||
149001550|NCT02274857|537483094|FG001|Overall Study|Death|2|||
149001551|NCT02274857|537483093|FG000|Overall Study|Lost to Follow-up|3|||
149001552|NCT02274857|537483094|FG001|Overall Study|Lost to Follow-up|0|||
149001553|NCT02274857|537483093|FG000|Overall Study|Physician Decision|2|||
149001554|NCT02274857|537483094|FG001|Overall Study|Physician Decision|0|||
149001555|NCT02274857|537483093|FG000|Overall Study|Trial screen failure|0|||
149001556|NCT02274857|537483094|FG001|Overall Study|Trial screen failure|2|||
149001557|NCT02274857|537483093|FG000|Overall Study|Withdrawal by Subject|11|||
149001558|NCT02274857|537483094|FG001|Overall Study|Withdrawal by Subject|2|||
149001559|NCT02274857|537483093|FG000|Overall Study|Other|2|||
149001560|NCT02274857|537483094|FG001|Overall Study|Other|0|||
149001561|NCT02403180|537483097|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
149001562|NCT02403180|537483098|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
149001563|NCT02403180|537483097|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
149001564|NCT02403180|537483098|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
149001565|NCT01445652|537483099|FG000|Overall Study|Not comfortable in lenses|5|||
149001566|NCT01445652|537483100|FG001|Overall Study|Not comfortable in lenses|0|||
149001567|NCT01445652|537483099|FG000|Overall Study|Failed to attend scheduled visit|2|||
149001568|NCT01445652|537483100|FG001|Overall Study|Failed to attend scheduled visit|3|||
149001569|NCT01445652|537483099|FG000|Overall Study|Failed teach session|2|||
149001570|NCT01445652|537483100|FG001|Overall Study|Failed teach session|0|||
149001571|NCT01445652|537483099|FG000|Overall Study|Adverse Event|1|||
149001572|NCT01445652|537483100|FG001|Overall Study|Adverse Event|0|||
149001573|NCT00929162|537483101|FG000|Overall Study|Adverse Event|8|||
149001574|NCT00929162|537483102|FG001|Overall Study|Adverse Event|5|||
149001575|NCT00929162|537483101|FG000|Overall Study|Withdrawal by Subject|3|||
149001576|NCT00929162|537483102|FG001|Overall Study|Withdrawal by Subject|1|||
149001577|NCT00929162|537483101|FG000|Overall Study|Protocol Violation|32|||
149001578|NCT00929162|537483102|FG001|Overall Study|Protocol Violation|30|||
149001579|NCT00929162|537483101|FG000|Overall Study|Other termination reason|5|||
149001580|NCT00929162|537483102|FG001|Overall Study|Other termination reason|6|||
149001581|NCT00117676|537483105|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
149001582|NCT00117676|537483106|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
149001583|NCT00117676|537483105|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
149001584|NCT00117676|537483106|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
149001585|NCT00117676|537483105|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
149001586|NCT00117676|537483106|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
149001587|NCT00117676|537483105|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
149001588|NCT00117676|537483106|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
149001589|NCT00117676|537483105|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
149001590|NCT00117676|537483106|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
149001591|NCT00117676|537483105|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
149001592|NCT00117676|537483106|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
149001593|NCT00117676|537483105|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
149001594|NCT00117676|537483106|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
149001595|NCT00117676|537483105|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
149001596|NCT00117676|537483106|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
149001597|NCT00117676|537483105|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
149001598|NCT00117676|537483106|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
149001599|NCT00117676|537483105|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
149001600|NCT00117676|537483106|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
149001601|NCT00117676|537483105|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
148879704|NCT01504412|537038130|FG001|Overall Study|Lack of Efficacy|0|||
148879705|NCT01504412|537038131|FG002|Overall Study|Lack of Efficacy|1|||
149001602|NCT00117676|537483106|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
149001603|NCT00117676|537483105|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
149001604|NCT00117676|537483106|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
149001605|NCT00117676|537483105|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
149001606|NCT00117676|537483106|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
149001607|NCT00117676|537483105|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
149001608|NCT00117676|537483106|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
149001609|NCT00117676|537483105|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
149001610|NCT00117676|537483106|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
149001611|NCT00117676|537483105|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
149001612|NCT00117676|537483106|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
149001613|NCT00117676|537483105|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
149001614|NCT00117676|537483106|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
149001615|NCT00117676|537483105|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
149001616|NCT00117676|537483106|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
149001617|NCT00117676|537483105|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
149001618|NCT00117676|537483106|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
149001619|NCT00117676|537483105|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
149001620|NCT00117676|537483106|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
149001621|NCT00117676|537483105|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
149001622|NCT00117676|537483106|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
149001623|NCT00117676|537483105|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
149001624|NCT00117676|537483106|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
149001625|NCT00117676|537483105|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
149001626|NCT00117676|537483106|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
149001627|NCT00117676|537483105|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
149001628|NCT00117676|537483106|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
149001629|NCT00117676|537483105|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
149001630|NCT00117676|537483106|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
149001631|NCT00117676|537483105|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
149001632|NCT00117676|537483106|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
149001633|NCT00117676|537483105|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
149001634|NCT00117676|537483106|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
149001635|NCT00117676|537483105|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
149001636|NCT00117676|537483106|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
149001637|NCT00117676|537483105|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
149001638|NCT00117676|537483106|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
149001639|NCT00117676|537483105|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
149001640|NCT00117676|537483106|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
149001641|NCT00117676|537483105|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
149001642|NCT00117676|537483106|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
149001643|NCT00117676|537483105|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
149001644|NCT00117676|537483106|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
149001645|NCT00117676|537483105|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
149001646|NCT00117676|537483106|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
149001647|NCT00117676|537483105|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
149001648|NCT00117676|537483106|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
149001649|NCT00117676|537483105|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
149001650|NCT00117676|537483106|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
149001651|NCT00952822|537483107|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
149001652|NCT00952822|537483108|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
149001653|NCT00952822|537483109|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
149001654|NCT00952822|537483110|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
149001655|NCT00952822|537483107|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
149001656|NCT00952822|537483108|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
149001657|NCT00952822|537483109|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
149001658|NCT00952822|537483110|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
149001659|NCT01281644|537483113|FG000|Overall Study|Lost to Follow-up|3|||
149001660|NCT01281644|537483113|FG000|Overall Study|Withdrawal by Subject|2|||
149001661|NCT01755702|537483114|FG000|Wash Out Period I|Other Reason|3|||
149001662|NCT01755702|537483114|FG000|Washout Period II|Other Reason|5|||
149001663|NCT03039023|537483117|FG000|Overall Study|Withdrawal by Subject|1|||
148879706|NCT01504412|537038132|FG003|Overall Study|Lack of Efficacy|0|||
149035671|NCT03743246|537609522|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
149035672|NCT03743246|537609523|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
149035673|NCT03743246|537609524|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
149035674|NCT03743246|537609521|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
149035675|NCT03743246|537609522|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
149035676|NCT03743246|537609523|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
149035677|NCT03743246|537609524|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
149035678|NCT03743246|537609521|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
149035679|NCT03743246|537609522|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
149035680|NCT03743246|537609523|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
149035681|NCT03743246|537609524|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
149035682|NCT03743246|537609521|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
149035683|NCT03743246|537609522|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
149035684|NCT03743246|537609523|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
149035685|NCT03743246|537609524|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
149035686|NCT03743246|537609521|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
149035687|NCT03743246|537609522|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
149035688|NCT03743246|537609523|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
149035689|NCT03743246|537609524|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
149035690|NCT03743246|537609521|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
149035691|NCT03743246|537609522|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
149035692|NCT03743246|537609523|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
149035693|NCT03743246|537609524|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
149035694|NCT01184508|537609527|FG000|Overall Study|Adverse Event|4|||
149035695|NCT01184508|537609528|FG001|Overall Study|Adverse Event|6|||
149035696|NCT01184508|537609527|FG000|Overall Study|Lack of Efficacy|1|||
149035697|NCT01184508|537609528|FG001|Overall Study|Lack of Efficacy|1|||
149035698|NCT01184508|537609527|FG000|Overall Study|Lost to Follow-up|1|||
149035699|NCT01184508|537609528|FG001|Overall Study|Lost to Follow-up|1|||
149035700|NCT01184508|537609527|FG000|Overall Study|Physician Decision|1|||
149035701|NCT01184508|537609528|FG001|Overall Study|Physician Decision|0|||
149035702|NCT01184508|537609527|FG000|Overall Study|Protocol Violation|3|||
149035703|NCT01184508|537609528|FG001|Overall Study|Protocol Violation|1|||
149035704|NCT01184508|537609527|FG000|Overall Study|Sponsor Decision|5|||
149035705|NCT01184508|537609528|FG001|Overall Study|Sponsor Decision|2|||
149035706|NCT01184508|537609527|FG000|Overall Study|Withdrawal by Subject|1|||
149035707|NCT01184508|537609528|FG001|Overall Study|Withdrawal by Subject|3|||
149035708|NCT01184508|537609527|FG000|Overall Study|Randomized, Not Treated|0|||
149035709|NCT01184508|537609528|FG001|Overall Study|Randomized, Not Treated|1|||
149035710|NCT00756730|537609534|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
149035711|NCT00756730|537609535|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
149035712|NCT00756730|537609534|FG000|Overall Study|persistent low-level viremmia|0|||
149035713|NCT00756730|537609535|FG001|Overall Study|persistent low-level viremmia|1|||
149035714|NCT00639002|537609538|FG000|Overall Study|Death|1|||
149035715|NCT00639002|537609538|FG000|Overall Study|Adverse Event|1|||
149035716|NCT00639002|537609538|FG000|Overall Study|Protocol Violation|1|||
149035717|NCT00639002|537609538|FG000|Overall Study|Disease progression|3|||
149035718|NCT00639002|537609538|FG000|Overall Study|Physician Decision|6|||
149035719|NCT00639002|537609538|FG000|Overall Study|Lack of Efficacy|1|||
149035720|NCT04210180|537609544|FG000|Overall Study|Withdrawal by Subject|2|||
149035721|NCT05190419|537609545|FG000|Overall Study|Lack of Efficacy|8|||
149035722|NCT05190419|537609546|FG001|Overall Study|Lack of Efficacy|0|||
149035723|NCT05190419|537609547|FG002|Overall Study|Lack of Efficacy|1|||
149035724|NCT05190419|537609548|FG003|Overall Study|Lack of Efficacy|0|||
149035725|NCT05190419|537609545|FG000|Overall Study|Withdrawal by Subject|7|||
149035726|NCT05190419|537609546|FG001|Overall Study|Withdrawal by Subject|1|||
149035727|NCT05190419|537609547|FG002|Overall Study|Withdrawal by Subject|2|||
149035728|NCT05190419|537609548|FG003|Overall Study|Withdrawal by Subject|2|||
149035729|NCT05190419|537609545|FG000|Overall Study|Adverse Event|2|||
149035730|NCT05190419|537609546|FG001|Overall Study|Adverse Event|10|||
149035731|NCT05190419|537609547|FG002|Overall Study|Adverse Event|11|||
149035732|NCT05190419|537609548|FG003|Overall Study|Adverse Event|21|||
149035733|NCT05190419|537609545|FG000|Overall Study|Lost to Follow-up|1|||
149035734|NCT05190419|537609546|FG001|Overall Study|Lost to Follow-up|2|||
149035735|NCT05190419|537609547|FG002|Overall Study|Lost to Follow-up|3|||
149035736|NCT05190419|537609548|FG003|Overall Study|Lost to Follow-up|1|||
149035737|NCT05190419|537609545|FG000|Overall Study|Other|1|||
149035738|NCT05190419|537609546|FG001|Overall Study|Other|1|||
149035739|NCT05190419|537609547|FG002|Overall Study|Other|0|||
149035740|NCT05190419|537609548|FG003|Overall Study|Other|3|||
149035741|NCT03210402|537609549|FG000|Overall Study|Withdrawal by Subject|0|||
149035742|NCT03210402|537609550|FG001|Overall Study|Withdrawal by Subject|1|||
149035743|NCT02517307|537609565|FG000|Overall Study|Withdrawal by Subject|1|||
149035744|NCT02517307|537609566|FG001|Overall Study|Withdrawal by Subject|0|||
149035745|NCT02517307|537609567|FG002|Overall Study|Withdrawal by Subject|1|||
148879707|NCT01504412|537038133|FG004|Overall Study|Lack of Efficacy|1|||
148879708|NCT01504412|537038129|FG000|Overall Study|Death|0|||
148879709|NCT01504412|537038130|FG001|Overall Study|Death|0|||
148879710|NCT01504412|537038131|FG002|Overall Study|Death|0|||
148879711|NCT01504412|537038132|FG003|Overall Study|Death|1|||
148879712|NCT01504412|537038133|FG004|Overall Study|Death|0|||
149001664|NCT03039023|537483118|FG001|Overall Study|Withdrawal by Subject|0|||
149001665|NCT03039023|537483119|FG002|Overall Study|Withdrawal by Subject|1|||
149001666|NCT03039023|537483120|FG003|Overall Study|Withdrawal by Subject|1|||
149001667|NCT03039023|537483121|FG004|Overall Study|Withdrawal by Subject|0|||
149001668|NCT03039023|537483117|FG000|Overall Study|Physician Decision|0|||
149001669|NCT03039023|537483118|FG001|Overall Study|Physician Decision|0|||
149001670|NCT03039023|537483119|FG002|Overall Study|Physician Decision|0|||
149001671|NCT03039023|537483120|FG003|Overall Study|Physician Decision|1|||
149001672|NCT03039023|537483121|FG004|Overall Study|Physician Decision|0|||
149001673|NCT03701399|537483122|FG000|Overall Study|Adverse Event|3|||
149001674|NCT03701399|537483123|FG001|Overall Study|Adverse Event|5|||
149001675|NCT03701399|537483122|FG000|Overall Study|Withdrawal by Subject|6|||
149001676|NCT03701399|537483123|FG001|Overall Study|Withdrawal by Subject|3|||
149001677|NCT03701399|537483122|FG000|Overall Study|Investigators decision|1|||
149001678|NCT03701399|537483123|FG001|Overall Study|Investigators decision|2|||
149001679|NCT03701399|537483122|FG000|Overall Study|Lost to Follow-up|1|||
149001680|NCT03701399|537483123|FG001|Overall Study|Lost to Follow-up|2|||
149001681|NCT03701399|537483122|FG000|Overall Study|Death|1|||
149001682|NCT03701399|537483123|FG001|Overall Study|Death|1|||
149001683|NCT03701399|537483122|FG000|Overall Study|Randomized but not treated|1|||
149001684|NCT03701399|537483123|FG001|Overall Study|Randomized but not treated|0|||
149001685|NCT03440372|537483124|FG000|Treatment|Adverse Event|16|||
149001686|NCT03440372|537483125|FG001|Treatment|Adverse Event|8|||
149001687|NCT03440372|537483124|FG000|Treatment|Lack of Efficacy|4|||
149001688|NCT03440372|537483125|FG001|Treatment|Lack of Efficacy|2|||
149001689|NCT03440372|537483124|FG000|Treatment|Withdrawal by Subject|12|||
149001690|NCT03440372|537483125|FG001|Treatment|Withdrawal by Subject|8|||
149001691|NCT03440372|537483124|FG000|Treatment|Lost to Follow-up|1|||
149001692|NCT03440372|537483125|FG001|Treatment|Lost to Follow-up|0|||
149001693|NCT03440372|537483124|FG000|Treatment|Pregnancy|1|||
149001694|NCT03440372|537483125|FG001|Treatment|Pregnancy|0|||
149001695|NCT03440372|537483124|FG000|Treatment|Study Terminated by Sponsor|2|||
149001696|NCT03440372|537483125|FG001|Treatment|Study Terminated by Sponsor|1|||
149001697|NCT03440372|537483124|FG000|Treatment|Other Reason|2|||
149001698|NCT03440372|537483125|FG001|Treatment|Other Reason|3|||
149001699|NCT00448448|537483126|FG000|Overall Study|Withdrawal by Subject|13|||
149001700|NCT00448448|537483127|FG001|Overall Study|Withdrawal by Subject|2|||
149001701|NCT00448448|537483126|FG000|Overall Study|On protocol when study ended|83|||
149001702|NCT00448448|537483127|FG001|Overall Study|On protocol when study ended|36|||
149001703|NCT00448448|537483126|FG000|Overall Study|Lost to Follow-up|2|||
149001704|NCT00448448|537483127|FG001|Overall Study|Lost to Follow-up|1|||
149001705|NCT00448448|537483126|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
149001706|NCT00448448|537483127|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
149001707|NCT00448448|537483126|FG000|Overall Study|Signed consent lost|0|||
149001708|NCT00448448|537483127|FG001|Overall Study|Signed consent lost|1|||
149001709|NCT02340026|537483128|FG000|Treatment Phase|Withdrawal by Subject|2|||
149001710|NCT02340026|537483129|FG001|Treatment Phase|Withdrawal by Subject|2|||
149001711|NCT02340026|537483128|FG000|Follow-up Phase|Lost to Follow-up|1|||
149001712|NCT02340026|537483129|FG001|Follow-up Phase|Lost to Follow-up|0|||
149001713|NCT03945292|537483130|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
149001714|NCT03945292|537483131|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
149001715|NCT03945292|537483132|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
149001716|NCT03945292|537483133|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
149001717|NCT03945292|537483134|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
149001718|NCT03945292|537483135|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
149001719|NCT03945292|537483136|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
148879713|NCT02644343|537038136|FG000|Overall Study|Withdrawal by Subject|1|||
149001720|NCT03945292|537483137|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
149001721|NCT03945292|537483130|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
149001722|NCT03945292|537483131|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
149001723|NCT03945292|537483132|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
149001724|NCT03945292|537483133|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
149001725|NCT03945292|537483134|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
149001726|NCT03945292|537483135|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
149001727|NCT03945292|537483136|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
149001728|NCT03945292|537483137|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
148879714|NCT03437577|537038137|FG000|Pre-Randomization|Withdrawal by Subject|0|||
148879715|NCT03437577|537038138|FG001|Pre-Randomization|Withdrawal by Subject|0|||
148879716|NCT03437577|537038139|FG002|Pre-Randomization|Withdrawal by Subject|10|||
148879717|NCT03437577|537038137|FG000|Post-Randomization|Physician Decision|0|||
148879718|NCT03437577|537038138|FG001|Post-Randomization|Physician Decision|2|||
148879719|NCT03437577|537038139|FG002|Post-Randomization|Physician Decision|0|||
148879720|NCT00536471|537038140|FG000|Overall Study|Lost to Follow-up|48|||
148879721|NCT00536471|537038141|FG001|Overall Study|Lost to Follow-up|23|||
148879722|NCT00536471|537038142|FG002|Overall Study|Lost to Follow-up|48|||
148879723|NCT00536471|537038143|FG003|Overall Study|Lost to Follow-up|22|||
149001729|NCT03945292|537483130|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001730|NCT03945292|537483131|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001731|NCT03945292|537483132|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001732|NCT03945292|537483133|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001733|NCT03945292|537483134|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001734|NCT03945292|537483135|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001735|NCT03945292|537483136|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
149001736|NCT03945292|537483137|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
149001737|NCT02684006|537483138|FG000|Overall Study|Other|18|||
149001738|NCT02684006|537483139|FG001|Overall Study|Other|6|||
149001739|NCT02684006|537483138|FG000|Overall Study|Protocol Violation|2|||
149001740|NCT02684006|537483139|FG001|Overall Study|Protocol Violation|1|||
149001741|NCT02684006|537483138|FG000|Overall Study|Non-compliance with study drug|1|||
149001742|NCT02684006|537483139|FG001|Overall Study|Non-compliance with study drug|1|||
149001743|NCT02684006|537483138|FG000|Overall Study|No longer met eligibility criteria|6|||
149001744|NCT02684006|537483139|FG001|Overall Study|No longer met eligibility criteria|2|||
149001745|NCT02684006|537483138|FG000|Overall Study|Lost to Follow-up|0|||
149001746|NCT02684006|537483139|FG001|Overall Study|Lost to Follow-up|1|||
149001747|NCT02684006|537483138|FG000|Overall Study|Death|25|||
149001748|NCT02684006|537483139|FG001|Overall Study|Death|22|||
149001749|NCT02684006|537483138|FG000|Overall Study|Global deterioration of health status|18|||
149001750|NCT02684006|537483139|FG001|Overall Study|Global deterioration of health status|20|||
149001751|NCT02684006|537483138|FG000|Overall Study|Physician Decision|15|||
149001752|NCT02684006|537483139|FG001|Overall Study|Physician Decision|8|||
149001753|NCT02684006|537483138|FG000|Overall Study|Adverse Event|86|||
149001754|NCT02684006|537483139|FG001|Overall Study|Adverse Event|65|||
149001755|NCT02684006|537483138|FG000|Overall Study|Withdrawal by Subject|29|||
149001756|NCT02684006|537483139|FG001|Overall Study|Withdrawal by Subject|43|||
149001757|NCT02684006|537483138|FG000|Overall Study|Progressive disease|236|||
149001758|NCT02684006|537483139|FG001|Overall Study|Progressive disease|266|||
149001759|NCT02684006|537483138|FG000|Overall Study|Participation terminated by sponsor|6|||
149001760|NCT02684006|537483139|FG001|Overall Study|Participation terminated by sponsor|9|||
149001761|NCT04642898|537483140|FG000|Overall Study|Withdrawal by Subject|2|||
149001762|NCT04642898|537483141|FG001|Overall Study|Withdrawal by Subject|4|||
149001763|NCT04642898|537483142|FG002|Overall Study|Withdrawal by Subject|4|||
149001764|NCT04642898|537483143|FG003|Overall Study|Withdrawal by Subject|6|||
149001765|NCT04642898|537483144|FG004|Overall Study|Withdrawal by Subject|2|||
149001766|NCT04642898|537483145|FG005|Overall Study|Withdrawal by Subject|6|||
149001767|NCT04642898|537483140|FG000|Overall Study|Lost to Follow-up|0|||
149001768|NCT04642898|537483141|FG001|Overall Study|Lost to Follow-up|0|||
149001769|NCT04642898|537483142|FG002|Overall Study|Lost to Follow-up|0|||
149001770|NCT04642898|537483143|FG003|Overall Study|Lost to Follow-up|2|||
149001771|NCT04642898|537483144|FG004|Overall Study|Lost to Follow-up|0|||
149001772|NCT04642898|537483145|FG005|Overall Study|Lost to Follow-up|1|||
149001773|NCT04642898|537483140|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
149001774|NCT04642898|537483141|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
149001775|NCT04642898|537483142|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
149001776|NCT04642898|537483143|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
149001777|NCT04642898|537483144|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
149001778|NCT04642898|537483145|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
149001779|NCT04642898|537483140|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
149001780|NCT04642898|537483141|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
149001781|NCT04642898|537483142|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
149001782|NCT04642898|537483143|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
149001783|NCT04642898|537483144|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
149001784|NCT04642898|537483145|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
149001785|NCT04280562|537483146|FG000|Study|Adverse Event|2|||
149001786|NCT04280562|537483147|FG001|Study|Adverse Event|0|||
149001787|NCT04280562|537483146|FG000|Study|Lost to Follow-up|3|||
149001788|NCT04280562|537483147|FG001|Study|Lost to Follow-up|3|||
148879724|NCT00536471|537038140|FG000|Overall Study|Adverse Event|32|||
149001789|NCT02618967|537483151|FG000|Overall Study|Lost to Follow-up|0|||
149001790|NCT02618967|537483152|FG001|Overall Study|Lost to Follow-up|0|||
149001791|NCT02618967|537483153|FG002|Overall Study|Lost to Follow-up|1|||
148879725|NCT00536471|537038141|FG001|Overall Study|Adverse Event|16|||
148879726|NCT00536471|537038142|FG002|Overall Study|Adverse Event|28|||
148879727|NCT00536471|537038143|FG003|Overall Study|Adverse Event|13|||
148879728|NCT00536471|537038140|FG000|Overall Study|Withdrawal by Subject|40|||
148879729|NCT00536471|537038141|FG001|Overall Study|Withdrawal by Subject|24|||
148879730|NCT00536471|537038142|FG002|Overall Study|Withdrawal by Subject|43|||
148879731|NCT00536471|537038143|FG003|Overall Study|Withdrawal by Subject|21|||
148879732|NCT00536471|537038140|FG000|Overall Study|Lack of Efficacy|17|||
148879733|NCT00536471|537038141|FG001|Overall Study|Lack of Efficacy|18|||
148879734|NCT00536471|537038142|FG002|Overall Study|Lack of Efficacy|11|||
148879735|NCT00536471|537038143|FG003|Overall Study|Lack of Efficacy|9|||
148879736|NCT00536471|537038140|FG000|Overall Study|Protocol Violation|8|||
148879737|NCT00536471|537038141|FG001|Overall Study|Protocol Violation|1|||
148879738|NCT00536471|537038142|FG002|Overall Study|Protocol Violation|2|||
148879739|NCT00536471|537038143|FG003|Overall Study|Protocol Violation|3|||
148879740|NCT00536471|537038140|FG000|Overall Study|Physician Decision|11|||
148879741|NCT00536471|537038141|FG001|Overall Study|Physician Decision|1|||
148879742|NCT00536471|537038142|FG002|Overall Study|Physician Decision|3|||
148879743|NCT00536471|537038143|FG003|Overall Study|Physician Decision|2|||
148879744|NCT00536471|537038140|FG000|Overall Study|Death|0|||
148879745|NCT00536471|537038141|FG001|Overall Study|Death|0|||
148879746|NCT00536471|537038142|FG002|Overall Study|Death|1|||
148879747|NCT00536471|537038143|FG003|Overall Study|Death|2|||
148879748|NCT00536471|537038140|FG000|Overall Study|Sponsor Decision|0|||
148879749|NCT00536471|537038141|FG001|Overall Study|Sponsor Decision|1|||
148879750|NCT00536471|537038142|FG002|Overall Study|Sponsor Decision|3|||
148879751|NCT00536471|537038143|FG003|Overall Study|Sponsor Decision|2|||
149035746|NCT02517307|537609568|FG003|Overall Study|Withdrawal by Subject|0|||
149035747|NCT02517307|537609565|FG000|Overall Study|Protocol Violation|0|||
149035748|NCT02517307|537609566|FG001|Overall Study|Protocol Violation|0|||
149035749|NCT02517307|537609567|FG002|Overall Study|Protocol Violation|1|||
149035750|NCT02517307|537609568|FG003|Overall Study|Protocol Violation|1|||
149035751|NCT03863834|537609569|FG000|Overall Study|Lost to Follow-up|3|||
149035752|NCT02770248|537609570|FG000|Overall Study|Adverse Event|0|||
149035753|NCT02770248|537609571|FG001|Overall Study|Adverse Event|1|||
149035754|NCT02770248|537609570|FG000|Overall Study|Randomized in error, prior to treatment|0|||
149035755|NCT02770248|537609571|FG001|Overall Study|Randomized in error, prior to treatment|1|||
149035756|NCT03538054|537609572|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
149035757|NCT03538054|537609572|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
149035758|NCT03538054|537609572|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
149035759|NCT02351180|537609577|FG000|Overall Study|Withdrawal by Subject|1|||
149035760|NCT02351180|537609578|FG001|Overall Study|Withdrawal by Subject|0|||
149035761|NCT00208767|537609585|FG000|Overall Study|Adverse Event|9|||
149035762|NCT00208767|537609586|FG001|Overall Study|Adverse Event|1|||
149035763|NCT00208767|537609585|FG000|Overall Study|Withdrawal by Subject|14|||
149035764|NCT00208767|537609586|FG001|Overall Study|Withdrawal by Subject|3|||
149035765|NCT00208767|537609585|FG000|Overall Study|Death|1|||
149035766|NCT00208767|537609586|FG001|Overall Study|Death|0|||
149035767|NCT00208767|537609585|FG000|Overall Study|Lost to Follow-up|3|||
149035768|NCT00208767|537609586|FG001|Overall Study|Lost to Follow-up|3|||
149035769|NCT00605033|537609587|FG000|Overall Study|Adverse Event|2|||
149035770|NCT00605033|537609588|FG001|Overall Study|Adverse Event|2|||
149035771|NCT00605033|537609587|FG000|Overall Study|Lost to Follow-up|1|||
149035772|NCT00605033|537609588|FG001|Overall Study|Lost to Follow-up|1|||
149035773|NCT00605033|537609587|FG000|Overall Study|Withdrawal by Subject|3|||
149035774|NCT00605033|537609588|FG001|Overall Study|Withdrawal by Subject|4|||
149035775|NCT00605033|537609587|FG000|Overall Study|Protocol Violation|1|||
149035776|NCT00605033|537609588|FG001|Overall Study|Protocol Violation|1|||
149035777|NCT01196429|537609589|FG000|Overall Study|Ineligible - inadequate pathology|1|||
149035778|NCT01196429|537609590|FG001|Overall Study|Ineligible - inadequate pathology|0|||
149035779|NCT01196429|537609589|FG000|Overall Study|Ineligible - wrong cell type|1|||
149035780|NCT01196429|537609590|FG001|Overall Study|Ineligible - wrong cell type|0|||
149035781|NCT01196429|537609589|FG000|Overall Study|Refused - Never Treated|1|||
149035782|NCT01196429|537609590|FG001|Overall Study|Refused - Never Treated|0|||
149035783|NCT03768206|537609591|FG000|Overall Study|Lost to Follow-up|2|||
149035784|NCT03768206|537609592|FG001|Overall Study|Lost to Follow-up|1|||
148879752|NCT04273893|537038148|FG000|Overall Study|Withdrawal by Subject|0|||
148879753|NCT04273893|537038149|FG001|Overall Study|Withdrawal by Subject|2|||
149035785|NCT03768206|537609591|FG000|Overall Study|Withdrawal by Subject|0|||
149035786|NCT03768206|537609592|FG001|Overall Study|Withdrawal by Subject|1|||
149035787|NCT02299336|537609597|FG000|Overall Study|Withdrawal by Subject|11|||
149035788|NCT02299336|537609597|FG000|Overall Study|Adverse Event|1|||
148879754|NCT04273893|537038148|FG000|Overall Study|Treatment of Disease Progression|0|||
149035789|NCT02299336|537609597|FG000|Overall Study|Death|1|||
149035790|NCT02299336|537609597|FG000|Overall Study|Lost to Follow-up|1|||
149035791|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
149035792|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
149035793|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
148879755|NCT04273893|537038149|FG001|Overall Study|Treatment of Disease Progression|2|||
149035794|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149035795|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149035796|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149035797|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149035798|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149035799|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
149035800|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
149035801|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
149035802|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
149035803|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149035804|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149035805|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149035806|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149035807|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149035808|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
149035809|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
149035810|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
149035811|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
149035812|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149035813|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149035814|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149035815|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149035816|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149035817|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
149035818|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
149035819|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035820|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
149035821|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035822|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035823|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035824|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035825|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035826|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
149035827|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
149035828|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
149035829|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
149035830|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149035831|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149035832|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149035833|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149035834|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149035835|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
149035836|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035837|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
149035838|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
149035839|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035840|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035841|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035842|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035843|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035844|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
149035845|NCT01212757|537609601|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
149035846|NCT01212757|537609602|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
149035847|NCT01212757|537609603|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149035848|NCT01212757|537609604|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149035849|NCT01212757|537609605|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149035850|NCT01212757|537609606|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149035851|NCT01212757|537609607|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
148879756|NCT04273893|537038148|FG000|Overall Study|Death|1|||
148879757|NCT04273893|537038149|FG001|Overall Study|Death|2|||
149035852|NCT01212757|537609608|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149035853|NCT01212757|537609609|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
149035854|NCT01212757|537609601|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
148879758|NCT04273893|537038148|FG000|Overall Study|Lost to Follow-up|0|||
148879759|NCT04273893|537038149|FG001|Overall Study|Lost to Follow-up|2|||
148879760|NCT04273893|537038148|FG000|Overall Study|Physician Decision|1|||
149035855|NCT01212757|537609602|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
149035856|NCT01212757|537609603|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
149035857|NCT01212757|537609604|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
149035858|NCT01212757|537609605|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
149035859|NCT01212757|537609606|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
149035860|NCT01212757|537609607|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
149035861|NCT01212757|537609608|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
149035862|NCT01212757|537609609|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
149035863|NCT01212757|537609601|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
149035864|NCT01212757|537609602|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
149035865|NCT01212757|537609603|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
149035866|NCT01212757|537609604|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
149035867|NCT01212757|537609605|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
149035868|NCT01212757|537609606|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
149035869|NCT01212757|537609607|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
149035870|NCT01212757|537609608|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
149035871|NCT01212757|537609609|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
149035872|NCT01212757|537609601|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035873|NCT01212757|537609602|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035874|NCT01212757|537609603|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
149035875|NCT01212757|537609604|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035876|NCT01212757|537609605|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035877|NCT01212757|537609606|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035878|NCT01212757|537609607|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035879|NCT01212757|537609608|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035880|NCT01212757|537609609|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
149035881|NCT01212757|537609601|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149035882|NCT01212757|537609602|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
149035883|NCT01212757|537609603|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
149035884|NCT01212757|537609604|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
149035885|NCT01212757|537609605|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
149035886|NCT01212757|537609606|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
149035887|NCT01212757|537609607|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149035888|NCT01212757|537609608|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149035889|NCT01212757|537609609|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
149035890|NCT01212757|537609601|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035891|NCT01212757|537609602|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
149035892|NCT01212757|537609603|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035893|NCT01212757|537609604|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035894|NCT01212757|537609605|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
149035895|NCT01212757|537609606|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035896|NCT01212757|537609607|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035897|NCT01212757|537609608|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035898|NCT01212757|537609609|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
149035899|NCT01212757|537609601|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035900|NCT01212757|537609602|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
149035901|NCT01212757|537609603|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
149035902|NCT01212757|537609604|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035903|NCT01212757|537609605|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035904|NCT01212757|537609606|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035905|NCT01212757|537609607|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035906|NCT01212757|537609608|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035907|NCT01212757|537609609|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
149035908|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035909|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035910|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035911|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035912|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035913|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035914|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035915|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
149035916|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
149035917|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
149035918|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
149035919|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
149035920|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
149035921|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
149035922|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
149035923|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
149035924|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
149035925|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
149035926|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
149035927|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
149035928|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
149035929|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
149035930|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
149035931|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
149035932|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
149035933|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
149035934|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
149035935|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149035936|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
149035937|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
149035938|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149035939|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149035940|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149035941|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
149035942|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
149035943|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
149035944|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035945|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035946|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
149035947|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035948|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035949|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035950|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035951|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035952|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
149035953|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
149035954|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
149035955|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
149035956|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
149035957|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
149035958|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
149035959|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
149035960|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
149035961|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
149035962|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
149035963|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
149035964|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
149035965|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
149035966|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
149035967|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
149035968|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
149035969|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
149035970|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
149035971|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035972|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035973|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
149035974|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035975|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035976|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035977|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035978|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035979|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
149035980|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149035981|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
149035982|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
149035983|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149035984|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149035985|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149035986|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
149035987|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
149035988|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
149035989|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035990|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035991|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035992|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035993|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035994|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035995|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035996|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
149035997|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
149035998|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149035999|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
149036000|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036001|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036002|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036003|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036004|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036005|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036006|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
149036007|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036008|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036009|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
149036010|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036011|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036012|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036013|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036014|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
149036015|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
149036016|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036017|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
149036018|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036019|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036020|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036021|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036022|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036023|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
149036024|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
149036025|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149036026|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
149036027|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
149036028|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149036029|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149036030|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149036031|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
149036032|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
149036033|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
149036034|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
149036035|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
149036036|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
149036037|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
149036038|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
149036039|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
149036040|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
149036041|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
149036042|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
149036043|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149036044|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
149036045|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
149036046|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149036047|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149036048|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149036049|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
149036050|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
149036051|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
149036052|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
149036053|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
149036054|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
149036055|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
149036056|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
149001792|NCT02618967|537483154|FG003|Overall Study|Lost to Follow-up|0|||
149001793|NCT02618967|537483155|FG004|Overall Study|Lost to Follow-up|2|||
149001794|NCT02618967|537483156|FG005|Overall Study|Lost to Follow-up|0|||
149001795|NCT02618967|537483157|FG006|Overall Study|Lost to Follow-up|0|||
149001796|NCT02618967|537483158|FG007|Overall Study|Lost to Follow-up|0|||
149001797|NCT02618967|537483151|FG000|Overall Study|Withdrawal by Subject|1|||
149001798|NCT02618967|537483152|FG001|Overall Study|Withdrawal by Subject|0|||
149001799|NCT02618967|537483153|FG002|Overall Study|Withdrawal by Subject|0|||
149001800|NCT02618967|537483154|FG003|Overall Study|Withdrawal by Subject|0|||
149001801|NCT02618967|537483155|FG004|Overall Study|Withdrawal by Subject|0|||
149001802|NCT02618967|537483156|FG005|Overall Study|Withdrawal by Subject|0|||
149001803|NCT02618967|537483157|FG006|Overall Study|Withdrawal by Subject|0|||
149001804|NCT02618967|537483158|FG007|Overall Study|Withdrawal by Subject|0|||
149001805|NCT01368965|537483159|FG000|Overall Study|Lost to Follow-up|12|||
149001806|NCT00514735|537483160|FG000|Overall Study|Withdrawal by Subject|13|||
149001807|NCT00514735|537483161|FG001|Overall Study|Withdrawal by Subject|5|||
149001808|NCT00514735|537483160|FG000|Overall Study|Death|1|||
149001809|NCT00514735|537483161|FG001|Overall Study|Death|0|||
149001810|NCT00514735|537483160|FG000|Overall Study|Lost to Follow-up|0|||
149001811|NCT00514735|537483161|FG001|Overall Study|Lost to Follow-up|1|||
149001812|NCT00771810|537483167|FG000|Overall Study|Adverse Event|3|||
149001813|NCT00771810|537483168|FG001|Overall Study|Adverse Event|0|||
149001814|NCT00771810|537483169|FG002|Overall Study|Adverse Event|2|||
149001815|NCT00771810|537483167|FG000|Overall Study|Lost to Follow-up|0|||
149001816|NCT00771810|537483168|FG001|Overall Study|Lost to Follow-up|0|||
149001817|NCT00771810|537483169|FG002|Overall Study|Lost to Follow-up|1|||
149001818|NCT00771810|537483167|FG000|Overall Study|Physician Decision|1|||
149001819|NCT00771810|537483168|FG001|Overall Study|Physician Decision|2|||
149001820|NCT00771810|537483169|FG002|Overall Study|Physician Decision|2|||
149001821|NCT00771810|537483167|FG000|Overall Study|Protocol Violation|0|||
149001822|NCT00771810|537483168|FG001|Overall Study|Protocol Violation|1|||
149001823|NCT00771810|537483169|FG002|Overall Study|Protocol Violation|1|||
149001824|NCT00771810|537483167|FG000|Overall Study|Withdrawal by Subject|1|||
149001825|NCT00771810|537483168|FG001|Overall Study|Withdrawal by Subject|2|||
149001826|NCT00771810|537483169|FG002|Overall Study|Withdrawal by Subject|0|||
149001827|NCT00771810|537483167|FG000|Overall Study|Other|0|||
149001828|NCT00771810|537483168|FG001|Overall Study|Other|0|||
149001829|NCT00771810|537483169|FG002|Overall Study|Other|1|||
149001830|NCT02953938|537483175|FG000|Overall Study|Adverse Event|0|||
149001831|NCT02953938|537483176|FG001|Overall Study|Adverse Event|1|||
149001832|NCT02953938|537483175|FG000|Overall Study|Withdrawal by Subject|1|||
149001833|NCT02953938|537483176|FG001|Overall Study|Withdrawal by Subject|1|||
149001834|NCT00045305|537483181|FG000|Overall Study|Lack of Efficacy|6|||
149001835|NCT00045305|537483181|FG000|Overall Study|Adverse Event|3|||
149001836|NCT00045305|537483181|FG000|Overall Study|Death|3|||
149001837|NCT00045305|537483181|FG000|Overall Study|site error|2|||
149001838|NCT04274894|537483182|FG000|Overall Study|Adverse Event|7|||
149001839|NCT04274894|537483182|FG000|Overall Study|Withdrew consent|5|||
149001840|NCT04274894|537483182|FG000|Overall Study|Lost to Follow-up|9|||
149001841|NCT04274894|537483182|FG000|Overall Study|COVID-19 infection|1|||
149001842|NCT04274894|537483182|FG000|Overall Study|Other, not specified|20|||
149001843|NCT03848403|537483183|FG000|Period 2 (Day 8)|Adverse Event|1|||
149001844|NCT03848403|537483184|FG001|Period 2 (Day 8)|Adverse Event|2|||
149001845|NCT03848403|537483185|FG002|Period 2 (Day 8)|Adverse Event|2|||
149001846|NCT03848403|537483183|FG000|Period 2 (Day 8)|Physician Decision|0|||
149001847|NCT03848403|537483184|FG001|Period 2 (Day 8)|Physician Decision|1|||
149001848|NCT03848403|537483185|FG002|Period 2 (Day 8)|Physician Decision|0|||
149001849|NCT03848403|537483183|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
149001850|NCT03848403|537483184|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
149001851|NCT03848403|537483185|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
149001852|NCT06213701|537483187|FG000|Overall Study|Withdrawal by Subject|2|||
149001853|NCT06213701|537483188|FG001|Overall Study|Withdrawal by Subject|1|||
149001854|NCT06213701|537483189|FG002|Overall Study|Withdrawal by Subject|0|||
149001855|NCT00453986|537483190|FG000|Overall Study|Lost to Follow-up|6|||
149001856|NCT00453986|537483191|FG001|Overall Study|Lost to Follow-up|5|||
149001857|NCT00453986|537483192|FG002|Overall Study|Lost to Follow-up|6|||
149001858|NCT00453986|537483193|FG003|Overall Study|Lost to Follow-up|2|||
149001859|NCT00453986|537483194|FG004|Overall Study|Lost to Follow-up|0|||
149001860|NCT01024608|537483197|FG000|Overall Study|Adverse Event|1|||
149001861|NCT01024608|537483198|FG001|Overall Study|Adverse Event|0|||
149001862|NCT01024608|537483197|FG000|Overall Study|Withdrawal by Subject|1|||
149001863|NCT01024608|537483198|FG001|Overall Study|Withdrawal by Subject|0|||
149001864|NCT01024608|537483197|FG000|Overall Study|Lost to Follow-up|0|||
149001865|NCT01024608|537483198|FG001|Overall Study|Lost to Follow-up|1|||
149001866|NCT01024608|537483197|FG000|Overall Study|Protocol Violation|0|||
149001867|NCT01024608|537483198|FG001|Overall Study|Protocol Violation|3|||
149001868|NCT01024608|537483197|FG000|Overall Study|Never received study treatment|2|||
149001869|NCT01024608|537483198|FG001|Overall Study|Never received study treatment|0|||
149001870|NCT00939484|537484729|FG000|Overall Study|Progression/Relapse|8|||
149001871|NCT00939484|537484730|FG001|Overall Study|Progression/Relapse|20|||
149001872|NCT00939484|537484731|FG002|Overall Study|Progression/Relapse|3|||
149001873|NCT04233372|537484732|FG000|Overall Study|Lost to Follow-up|104|||
149001874|NCT04233372|537484732|FG000|Overall Study|Adverse Event|8|||
149001875|NCT04233372|537484732|FG000|Overall Study|Withdrawal by Subject|2|||
149001876|NCT03938454|537484733|FG000|Overall Study|Protocol Violation|1|||
149001877|NCT03938454|537484733|FG000|Overall Study|Withdrawal by Subject|2|||
149001878|NCT03938454|537484733|FG000|Overall Study|Lost to Follow-up|3|||
149001879|NCT01090310|537484734|FG000|Core Study|Adverse Event|2|||
149001880|NCT01090310|537484735|FG001|Core Study|Adverse Event|2|||
149001881|NCT01090310|537484736|FG002|Core Study|Adverse Event|1|||
149001882|NCT01090310|537484737|FG003|Core Study|Adverse Event|1|||
149001883|NCT01090310|537484734|FG000|Core Study|Subject withdrew consent|0|||
149001884|NCT01090310|537484735|FG001|Core Study|Subject withdrew consent|3|||
149001885|NCT01090310|537484736|FG002|Core Study|Subject withdrew consent|1|||
149001886|NCT01090310|537484737|FG003|Core Study|Subject withdrew consent|1|||
149001887|NCT01090310|537484734|FG000|Core Study|Abnormal test procedure result|0|||
149001888|NCT01090310|537484735|FG001|Core Study|Abnormal test procedure result|0|||
149001889|NCT01090310|537484736|FG002|Core Study|Abnormal test procedure result|1|||
149001890|NCT01090310|537484737|FG003|Core Study|Abnormal test procedure result|0|||
149001891|NCT01090310|537484734|FG000|Core Study|Administrative reasons|5|||
149001892|NCT01090310|537484735|FG001|Core Study|Administrative reasons|6|||
149001893|NCT01090310|537484736|FG002|Core Study|Administrative reasons|4|||
149001894|NCT01090310|537484737|FG003|Core Study|Administrative reasons|4|||
149001895|NCT01090310|537484734|FG000|Core Study|Protocol deviation|1|||
149001896|NCT01090310|537484735|FG001|Core Study|Protocol deviation|0|||
149001897|NCT01090310|537484736|FG002|Core Study|Protocol deviation|0|||
149001898|NCT01090310|537484737|FG003|Core Study|Protocol deviation|1|||
149001899|NCT01090310|537484734|FG000|Extension Study|Aministrative problems|13|||
149001900|NCT01090310|537484735|FG001|Extension Study|Aministrative problems|15|||
149001901|NCT01090310|537484736|FG002|Extension Study|Aministrative problems|14|||
149001902|NCT01090310|537484737|FG003|Extension Study|Aministrative problems|18|||
149001903|NCT01090310|537484734|FG000|Extension Study|Adverse Event|0|||
149001904|NCT01090310|537484735|FG001|Extension Study|Adverse Event|0|||
149001905|NCT01090310|537484736|FG002|Extension Study|Adverse Event|0|||
149001906|NCT01090310|537484737|FG003|Extension Study|Adverse Event|1|||
149001907|NCT01090310|537484734|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
149001908|NCT01090310|537484735|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
149001909|NCT01090310|537484736|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
149001910|NCT01090310|537484737|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
149001911|NCT01090310|537484734|FG000|Extension Study|Subject withdrew consent|0|||
149001912|NCT01090310|537484735|FG001|Extension Study|Subject withdrew consent|1|||
149001913|NCT01090310|537484736|FG002|Extension Study|Subject withdrew consent|0|||
149001914|NCT01090310|537484737|FG003|Extension Study|Subject withdrew consent|0|||
149001915|NCT00695786|537484738|FG000|Overall Study|Adverse Event|0|||
149001916|NCT00695786|537484739|FG001|Overall Study|Adverse Event|3|||
149001917|NCT00695786|537484740|FG002|Overall Study|Adverse Event|4|||
149001918|NCT00695786|537484741|FG003|Overall Study|Adverse Event|2|||
149001919|NCT00695786|537484738|FG000|Overall Study|Lost to Follow-up|0|||
149001920|NCT00695786|537484739|FG001|Overall Study|Lost to Follow-up|5|||
149001921|NCT00695786|537484740|FG002|Overall Study|Lost to Follow-up|1|||
149001922|NCT00695786|537484741|FG003|Overall Study|Lost to Follow-up|1|||
149001923|NCT00695786|537484738|FG000|Overall Study|Withdrawal by Subject|0|||
149001924|NCT00695786|537484739|FG001|Overall Study|Withdrawal by Subject|4|||
149001925|NCT00695786|537484740|FG002|Overall Study|Withdrawal by Subject|3|||
149001926|NCT00695786|537484741|FG003|Overall Study|Withdrawal by Subject|1|||
149001927|NCT00695786|537484738|FG000|Overall Study|Deemed Ineligible|1|||
149001928|NCT00695786|537484739|FG001|Overall Study|Deemed Ineligible|0|||
149001929|NCT00695786|537484740|FG002|Overall Study|Deemed Ineligible|0|||
149001930|NCT00695786|537484741|FG003|Overall Study|Deemed Ineligible|0|||
149001931|NCT00695786|537484738|FG000|Overall Study|Lack of Efficacy|0|||
149001932|NCT00695786|537484739|FG001|Overall Study|Lack of Efficacy|0|||
149001933|NCT00695786|537484740|FG002|Overall Study|Lack of Efficacy|0|||
149001934|NCT00695786|537484741|FG003|Overall Study|Lack of Efficacy|4|||
149001935|NCT01364922|537484747|FG000|Open-label (OL) Period|Adverse Event|7|||
149001936|NCT01364922|537484748|FG001|Open-label (OL) Period|Adverse Event|0|||
149001937|NCT01364922|537484749|FG002|Open-label (OL) Period|Adverse Event|0|||
149001938|NCT01364922|537484747|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
149001939|NCT01364922|537484748|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
149001940|NCT01364922|537484749|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
149001941|NCT01364922|537484747|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
149001942|NCT01364922|537484748|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
149001943|NCT01364922|537484749|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
149001944|NCT01364922|537484747|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
149001945|NCT01364922|537484748|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
149001946|NCT01364922|537484749|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
149001947|NCT01364922|537484747|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
149001948|NCT01364922|537484748|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
149036057|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
149036058|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
149036059|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
149036060|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
149036061|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036062|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036063|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036064|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036065|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036066|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036067|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036068|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
149036069|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
149036070|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149036071|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
149036072|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
149036073|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149036074|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149036075|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149036076|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
149036077|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
149036078|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
149036079|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
149036080|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
149036081|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
149036082|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
149036083|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
149036084|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
149036085|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
149036086|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
149036087|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
149036088|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
149036089|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
149036090|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
149036091|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
149036092|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
149036093|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
149036094|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
149036095|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
149036096|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
149036097|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036098|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
149036099|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036100|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036101|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036102|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036103|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036104|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036105|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
149036106|NCT01212757|537609601|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036107|NCT01212757|537609602|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
149036108|NCT01212757|537609603|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
149036109|NCT01212757|537609604|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036110|NCT01212757|537609605|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036111|NCT01212757|537609606|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036112|NCT01212757|537609607|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036113|NCT01212757|537609608|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036114|NCT01212757|537609609|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
149036115|NCT00573833|537609610|FG000|Overall Study|Not Treated|2|||
149036116|NCT04493242|537609611|FG000|Overall Study|Death|10|||
149036117|NCT04493242|537609612|FG001|Overall Study|Death|14|||
148879761|NCT04273893|537038149|FG001|Overall Study|Physician Decision|0|||
148879762|NCT00856544|537038156|FG000|Overall Study|Randomized but not treated|3|||
148879763|NCT00856544|537038157|FG001|Overall Study|Randomized but not treated|0|||
148879764|NCT00856544|537038158|FG002|Overall Study|Randomized but not treated|0|||
149036118|NCT04493242|537609613|FG002|Overall Study|Death|16|||
149036119|NCT04493242|537609611|FG000|Overall Study|Lost to Follow-up|1|||
149036120|NCT04493242|537609612|FG001|Overall Study|Lost to Follow-up|1|||
149036121|NCT04493242|537609613|FG002|Overall Study|Lost to Follow-up|0|||
149036122|NCT04493242|537609611|FG000|Overall Study|Withdrawal by Subject|1|||
149036123|NCT04493242|537609612|FG001|Overall Study|Withdrawal by Subject|0|||
149036124|NCT04493242|537609613|FG002|Overall Study|Withdrawal by Subject|0|||
149036125|NCT04493242|537609611|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
149036126|NCT04493242|537609612|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
149036127|NCT04493242|537609613|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
149036128|NCT04493242|537609611|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
149036129|NCT04493242|537609612|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
149036130|NCT04493242|537609613|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
149036131|NCT00849147|537609614|FG000|Overall Study|Withdrawal by Subject|1|||
149036132|NCT00849147|537609614|FG000|Overall Study|Protocol Violation|2|||
149036133|NCT00849147|537609614|FG000|Overall Study|Disease Relapse/Progression|2|||
149055924|NCT01369355|537689001|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
149055925|NCT01369355|537689002|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
149055926|NCT01369355|537689003|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
149055927|NCT01369355|537689004|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
149055928|NCT01369355|537689005|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
149055929|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
149055930|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
149055931|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
149055932|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
149055933|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
149055934|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
149055935|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
149055936|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
149055937|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
149055938|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Death|0|||
149055939|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Death|0|||
149055940|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Death|0|||
149055941|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Death|0|||
149055942|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Death|0|||
149055943|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Death|0|||
149055944|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Death|0|||
149055945|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Death|1|||
149055946|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Death|3|||
149055947|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
149055948|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
149055949|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
149055950|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
149055951|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
149055952|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
149055953|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
149055954|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
149055955|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
149055956|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055957|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055958|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055959|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055960|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055961|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055962|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
149055963|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
149055964|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
149055965|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
149055966|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
149055967|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
149055968|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
149055969|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
149055970|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
149055971|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
149055972|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
149055973|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
149055974|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
149055975|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
149055976|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
149055977|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
149055978|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
149055979|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
149055980|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
149036134|NCT04517864|537612003|FG000|Placebo-Controlled Phase|Adverse Event|1|||
149036135|NCT04517864|537612004|FG001|Placebo-Controlled Phase|Adverse Event|0|||
149036136|NCT04517864|537612005|FG002|Placebo-Controlled Phase|Adverse Event|0|||
149036137|NCT04517864|537612003|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
149036138|NCT04517864|537612004|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
149036139|NCT04517864|537612005|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
149036140|NCT04517864|537612003|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
149036141|NCT04517864|537612004|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
149036142|NCT04517864|537612005|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
149036143|NCT04517864|537612003|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
149036144|NCT04517864|537612004|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
149036145|NCT04517864|537612005|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
149036146|NCT04517864|537612003|FG000|Active Therapy Extension Phase|Adverse Event|1|||
149036147|NCT04517864|537612004|FG001|Active Therapy Extension Phase|Adverse Event|0|||
149036148|NCT04517864|537612005|FG002|Active Therapy Extension Phase|Adverse Event|0|||
149036149|NCT04517864|537612003|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
149036150|NCT04517864|537612004|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
149036151|NCT04517864|537612005|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
149036152|NCT04517864|537612003|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
149036153|NCT04517864|537612004|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
149036154|NCT04517864|537612005|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
149036155|NCT04517864|537612003|FG000|Active Therapy Extension Phase|Physician Decision|1|||
149036156|NCT04517864|537612004|FG001|Active Therapy Extension Phase|Physician Decision|0|||
149036157|NCT04517864|537612005|FG002|Active Therapy Extension Phase|Physician Decision|0|||
149036158|NCT04517864|537612003|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
149036159|NCT04517864|537612004|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
149036160|NCT04517864|537612005|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
149036161|NCT04517864|537612003|FG000|Extension Phase|Adverse Event|0|||
149036162|NCT04517864|537612004|FG001|Extension Phase|Adverse Event|0|||
149036163|NCT04517864|537612005|FG002|Extension Phase|Adverse Event|1|||
149036164|NCT04517864|537612003|FG000|Extension Phase|Lack of Efficacy|0|||
148879765|NCT00856544|537038159|FG003|Overall Study|Randomized but not treated|0|||
148879766|NCT00856544|537038156|FG000|Overall Study|Death|0|||
148879767|NCT00856544|537038157|FG001|Overall Study|Death|2|||
148879768|NCT00856544|537038158|FG002|Overall Study|Death|0|||
148879769|NCT00856544|537038159|FG003|Overall Study|Death|0|||
148879770|NCT00856544|537038156|FG000|Overall Study|Adverse Event|20|||
148879771|NCT00856544|537038157|FG001|Overall Study|Adverse Event|29|||
148879772|NCT00856544|537038158|FG002|Overall Study|Adverse Event|2|||
149036165|NCT04517864|537612004|FG001|Extension Phase|Lack of Efficacy|0|||
149036166|NCT04517864|537612005|FG002|Extension Phase|Lack of Efficacy|2|||
149036167|NCT04517864|537612003|FG000|Extension Phase|Study Terminated By Sponsor|0|||
149036168|NCT04517864|537612004|FG001|Extension Phase|Study Terminated By Sponsor|0|||
149036169|NCT04517864|537612005|FG002|Extension Phase|Study Terminated By Sponsor|32|||
149036170|NCT04517864|537612003|FG000|Extension Phase|Withdrawal by Subject|0|||
149036171|NCT04517864|537612004|FG001|Extension Phase|Withdrawal by Subject|0|||
149036172|NCT04517864|537612005|FG002|Extension Phase|Withdrawal by Subject|3|||
149036173|NCT04517864|537612003|FG000|Extension Phase|Approved Drug Available for Indication|0|||
149036174|NCT04517864|537612004|FG001|Extension Phase|Approved Drug Available for Indication|0|||
149036175|NCT04517864|537612005|FG002|Extension Phase|Approved Drug Available for Indication|7|||
149036176|NCT01049503|537612006|FG000|Overall Study|Lost to Follow-up|11|||
149036177|NCT01049503|537612007|FG001|Overall Study|Lost to Follow-up|12|||
149036178|NCT01049503|537612008|FG002|Overall Study|Lost to Follow-up|24|||
149036179|NCT01049503|537612009|FG003|Overall Study|Lost to Follow-up|26|||
149036180|NCT01049503|537612010|FG004|Overall Study|Lost to Follow-up|27|||
149036181|NCT01049503|537612011|FG005|Overall Study|Lost to Follow-up|8|||
149036182|NCT03169244|537612012|FG000|Overall Study|Lost to Follow-up|1|||
148879773|NCT00856544|537038159|FG003|Overall Study|Adverse Event|3|||
148879774|NCT00856544|537038156|FG000|Overall Study|Lack of Efficacy|16|||
148879775|NCT00856544|537038157|FG001|Overall Study|Lack of Efficacy|12|||
148879776|NCT00856544|537038158|FG002|Overall Study|Lack of Efficacy|3|||
148879777|NCT00856544|537038159|FG003|Overall Study|Lack of Efficacy|3|||
149036183|NCT03169244|537612013|FG001|Overall Study|Lost to Follow-up|2|||
148879778|NCT00856544|537038156|FG000|Overall Study|Other|9|||
149036184|NCT03169244|537612012|FG000|Overall Study|Adverse Event|1|||
149036185|NCT03169244|537612013|FG001|Overall Study|Adverse Event|0|||
149036186|NCT03169244|537612012|FG000|Overall Study|Withdrawal by Subject|2|||
149036187|NCT03169244|537612013|FG001|Overall Study|Withdrawal by Subject|2|||
149036188|NCT03169244|537612012|FG000|Overall Study|Physician Decision|1|||
149036189|NCT03169244|537612013|FG001|Overall Study|Physician Decision|0|||
149036190|NCT00028769|537612017|FG000|Overall Study|Adverse Event|2|||
149036191|NCT00028769|537612017|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
149036192|NCT00028769|537612017|FG000|Overall Study|Progression or Death|31|||
148879779|NCT00856544|537038157|FG001|Overall Study|Other|16|||
148879780|NCT00856544|537038158|FG002|Overall Study|Other|1|||
148879781|NCT00856544|537038159|FG003|Overall Study|Other|6|||
148879782|NCT00856544|537038156|FG000|Overall Study|Lost to Follow-up|1|||
148879783|NCT00856544|537038157|FG001|Overall Study|Lost to Follow-up|2|||
148879784|NCT00856544|537038158|FG002|Overall Study|Lost to Follow-up|2|||
149001949|NCT01364922|537484749|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
149001950|NCT01364922|537484747|FG000|Open-label (OL) Period|Other, Unspecified|1|||
149001951|NCT01364922|537484748|FG001|Open-label (OL) Period|Other, Unspecified|0|||
149001952|NCT01364922|537484749|FG002|Open-label (OL) Period|Other, Unspecified|0|||
149001953|NCT01364922|537484747|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
149001954|NCT01364922|537484748|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
149001955|NCT01364922|537484749|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
149001956|NCT01364922|537484747|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
149001957|NCT01364922|537484748|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
149001958|NCT01364922|537484749|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
149001959|NCT01364922|537484747|FG000|Double-Blind (DB) Period|Adverse Event|0|||
149001960|NCT01364922|537484748|FG001|Double-Blind (DB) Period|Adverse Event|0|||
149001961|NCT01364922|537484749|FG002|Double-Blind (DB) Period|Adverse Event|1|||
149001962|NCT01364922|537484747|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
149001963|NCT01364922|537484748|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
149001964|NCT01364922|537484749|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
149001965|NCT04244396|537484752|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
149001966|NCT04244396|537484752|FG000|Overall Study|Withdrawal by Subject|2|||
149001967|NCT04244396|537484752|FG000|Overall Study|Study termination|37|||
149001968|NCT01787097|537484753|FG000|Overall Study|Withdrawal by Subject|1|||
149001969|NCT01787097|537484754|FG001|Overall Study|Withdrawal by Subject|0|||
149001970|NCT01787097|537484755|FG002|Overall Study|Withdrawal by Subject|0|||
149001971|NCT01787097|537484756|FG003|Overall Study|Withdrawal by Subject|0|||
149001972|NCT05178121|537484757|FG000|Overall Study|Other|4|||
149001973|NCT05178121|537484757|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
149001974|NCT01953003|537484758|FG000|Overall Study|Not treated|0|||
149001975|NCT01953003|537484759|FG001|Overall Study|Not treated|1|||
149001976|NCT01953003|537484758|FG000|Overall Study|Progressive disease|35|||
149001977|NCT01953003|537484759|FG001|Overall Study|Progressive disease|45|||
149001978|NCT01953003|537484758|FG000|Overall Study|Related Adverse events|7|||
149001979|NCT01953003|537484759|FG001|Overall Study|Related Adverse events|2|||
149001980|NCT01953003|537484758|FG000|Overall Study|Non-related adverse events|0|||
149001981|NCT01953003|537484759|FG001|Overall Study|Non-related adverse events|2|||
149001982|NCT01953003|537484758|FG000|Overall Study|Protocol Violation|0|||
149001983|NCT01953003|537484759|FG001|Overall Study|Protocol Violation|1|||
149001984|NCT01953003|537484758|FG000|Overall Study|Withdrawal by Subject|14|||
149001985|NCT01953003|537484759|FG001|Overall Study|Withdrawal by Subject|4|||
149001986|NCT00553501|537484762|FG000|Overall Study|Adverse Event|2|||
149001987|NCT00553501|537484762|FG000|Overall Study|Death|1|||
149001988|NCT00553501|537484762|FG000|Overall Study|Progression|1|||
149001989|NCT03391765|537484766|FG000|Overall Study|Adverse Event|2|||
149001990|NCT03391765|537484767|FG001|Overall Study|Adverse Event|0|||
149001991|NCT03391765|537484768|FG002|Overall Study|Adverse Event|0|||
149001992|NCT03391765|537484769|FG003|Overall Study|Adverse Event|2|||
149001993|NCT03391765|537484766|FG000|Overall Study|Withdrew consent|5|||
149001994|NCT03391765|537484767|FG001|Overall Study|Withdrew consent|7|||
149001995|NCT03391765|537484768|FG002|Overall Study|Withdrew consent|2|||
149001996|NCT03391765|537484769|FG003|Overall Study|Withdrew consent|5|||
149001997|NCT03391765|537484766|FG000|Overall Study|Other, not specified|44|||
149001998|NCT03391765|537484767|FG001|Overall Study|Other, not specified|38|||
149001999|NCT03391765|537484768|FG002|Overall Study|Other, not specified|21|||
149002000|NCT03391765|537484769|FG003|Overall Study|Other, not specified|16|||
149002001|NCT00944658|537484770|FG000|Treatment 12 Weeks|Adverse Event|0|||
149002002|NCT00944658|537484771|FG001|Treatment 12 Weeks|Adverse Event|2|||
149002003|NCT01255592|537484772|FG000|Overall Study|Adverse Event|5|||
149002004|NCT01255592|537484773|FG001|Overall Study|Adverse Event|0|||
149002005|NCT01255592|537484772|FG000|Overall Study|Withdrawal by Subject|1|||
149002006|NCT01255592|537484773|FG001|Overall Study|Withdrawal by Subject|0|||
149002007|NCT01255592|537484772|FG000|Overall Study|Other|0|||
149002008|NCT01255592|537484773|FG001|Overall Study|Other|1|||
149002009|NCT00838682|537484779|FG000|Overall Study|Lost to Follow-up|21|||
149002010|NCT00838682|537484780|FG001|Overall Study|Lost to Follow-up|14|||
149002011|NCT00838682|537484779|FG000|Overall Study|detection of exclusion criteria|4|||
149002012|NCT00838682|537484780|FG001|Overall Study|detection of exclusion criteria|3|||
149002013|NCT00838682|537484779|FG000|Overall Study|Protocol Violation|0|||
149002014|NCT00838682|537484780|FG001|Overall Study|Protocol Violation|1|||
149002015|NCT00838682|537484779|FG000|Overall Study|Withdrawal by Subject|0|||
149002016|NCT00838682|537484780|FG001|Overall Study|Withdrawal by Subject|1|||
149002017|NCT03928028|537484793|FG000|Overall Study|Physician Decision|9|||
149002018|NCT03928028|537484794|FG001|Overall Study|Physician Decision|6|||
149002019|NCT03928028|537484795|FG002|Overall Study|Physician Decision|3|||
149002020|NCT03928028|537484793|FG000|Overall Study|Withdrawal by Subject|12|||
149002021|NCT03928028|537484794|FG001|Overall Study|Withdrawal by Subject|3|||
149002022|NCT03928028|537484795|FG002|Overall Study|Withdrawal by Subject|3|||
149036193|NCT00028769|537612017|FG000|Overall Study|Other - Not Protocol Specified|1|||
149036194|NCT00028769|537612017|FG000|Overall Study|Ineligible|5|||
149036195|NCT00028769|537612017|FG000|Overall Study|Not Analyzable|1|||
149036196|NCT01499134|537612020|FG000|Overall Study|Withdrawal by Subject|0|||
149036197|NCT01499134|537612021|FG001|Overall Study|Withdrawal by Subject|1|||
149036198|NCT04035668|537612022|FG000|Overall Study|Adverse Event|3|||
149036199|NCT04035668|537612023|FG001|Overall Study|Adverse Event|4|||
149036200|NCT04035668|537612024|FG002|Overall Study|Adverse Event|2|||
149036201|NCT04035668|537612022|FG000|Overall Study|Lost to Follow-up|0|||
149036202|NCT04035668|537612023|FG001|Overall Study|Lost to Follow-up|1|||
149036203|NCT04035668|537612024|FG002|Overall Study|Lost to Follow-up|0|||
149036204|NCT04035668|537612022|FG000|Overall Study|Physician Decision|2|||
149036205|NCT04035668|537612023|FG001|Overall Study|Physician Decision|1|||
149036206|NCT04035668|537612024|FG002|Overall Study|Physician Decision|1|||
149036207|NCT04035668|537612022|FG000|Overall Study|Subject Decision|2|||
149036208|NCT04035668|537612023|FG001|Overall Study|Subject Decision|2|||
149036209|NCT04035668|537612024|FG002|Overall Study|Subject Decision|0|||
149036210|NCT02477670|537612026|FG000|Stage 1|Adverse Event|2|||
149036211|NCT02477670|537612027|FG001|Stage 1|Adverse Event|7|||
149036212|NCT02477670|537612028|FG002|Stage 1|Adverse Event|0|||
149036213|NCT02477670|537612029|FG003|Stage 1|Adverse Event|0|||
149036214|NCT02477670|537612030|FG004|Stage 1|Adverse Event|0|||
149036215|NCT02477670|537612031|FG005|Stage 1|Adverse Event|0|||
149036216|NCT02477670|537612032|FG006|Stage 1|Adverse Event|0|||
149036217|NCT02477670|537612026|FG000|Stage 1|Lost to Follow-up|0|||
149036218|NCT02477670|537612027|FG001|Stage 1|Lost to Follow-up|2|||
149036219|NCT02477670|537612028|FG002|Stage 1|Lost to Follow-up|0|||
149036220|NCT02477670|537612029|FG003|Stage 1|Lost to Follow-up|0|||
149036221|NCT02477670|537612030|FG004|Stage 1|Lost to Follow-up|0|||
149036222|NCT02477670|537612031|FG005|Stage 1|Lost to Follow-up|0|||
149036223|NCT02477670|537612032|FG006|Stage 1|Lost to Follow-up|0|||
149036224|NCT02477670|537612026|FG000|Stage 1|Withdrawal by Subject|1|||
149036225|NCT02477670|537612027|FG001|Stage 1|Withdrawal by Subject|2|||
149036226|NCT02477670|537612028|FG002|Stage 1|Withdrawal by Subject|0|||
149036227|NCT02477670|537612029|FG003|Stage 1|Withdrawal by Subject|0|||
149036228|NCT02477670|537612030|FG004|Stage 1|Withdrawal by Subject|0|||
149036229|NCT02477670|537612031|FG005|Stage 1|Withdrawal by Subject|0|||
149036230|NCT02477670|537612032|FG006|Stage 1|Withdrawal by Subject|0|||
149036231|NCT02477670|537612026|FG000|Stage 1|Non-compliance with Study Drug|1|||
149036232|NCT02477670|537612027|FG001|Stage 1|Non-compliance with Study Drug|2|||
149036233|NCT02477670|537612028|FG002|Stage 1|Non-compliance with Study Drug|0|||
149036234|NCT02477670|537612029|FG003|Stage 1|Non-compliance with Study Drug|0|||
149036235|NCT02477670|537612030|FG004|Stage 1|Non-compliance with Study Drug|0|||
149036236|NCT02477670|537612031|FG005|Stage 1|Non-compliance with Study Drug|0|||
149036237|NCT02477670|537612032|FG006|Stage 1|Non-compliance with Study Drug|0|||
149036238|NCT02477670|537612026|FG000|Stage 2|Adverse Event|0|||
149036239|NCT02477670|537612027|FG001|Stage 2|Adverse Event|0|||
149036240|NCT02477670|537612028|FG002|Stage 2|Adverse Event|1|||
149036241|NCT02477670|537612029|FG003|Stage 2|Adverse Event|0|||
149036242|NCT02477670|537612030|FG004|Stage 2|Adverse Event|0|||
149036243|NCT02477670|537612031|FG005|Stage 2|Adverse Event|0|||
149036244|NCT02477670|537612032|FG006|Stage 2|Adverse Event|0|||
149036245|NCT02477670|537612026|FG000|Stage 2|Antipsychotic Medication Changed|0|||
149036246|NCT02477670|537612027|FG001|Stage 2|Antipsychotic Medication Changed|0|||
149036247|NCT02477670|537612028|FG002|Stage 2|Antipsychotic Medication Changed|1|||
149036248|NCT02477670|537612029|FG003|Stage 2|Antipsychotic Medication Changed|0|||
149036249|NCT02477670|537612030|FG004|Stage 2|Antipsychotic Medication Changed|0|||
149036250|NCT02477670|537612031|FG005|Stage 2|Antipsychotic Medication Changed|0|||
149036251|NCT02477670|537612032|FG006|Stage 2|Antipsychotic Medication Changed|0|||
149036252|NCT02477670|537612026|FG000|Stage 2|Withdrawal by Subject|0|||
149036253|NCT02477670|537612027|FG001|Stage 2|Withdrawal by Subject|0|||
149036254|NCT02477670|537612028|FG002|Stage 2|Withdrawal by Subject|0|||
149036255|NCT02477670|537612029|FG003|Stage 2|Withdrawal by Subject|1|||
149036256|NCT02477670|537612030|FG004|Stage 2|Withdrawal by Subject|0|||
149036257|NCT02477670|537612031|FG005|Stage 2|Withdrawal by Subject|0|||
149036258|NCT02477670|537612032|FG006|Stage 2|Withdrawal by Subject|0|||
149036259|NCT00970307|537612033|FG000|Overall Study|Serious Adverse Event|1|||
149036260|NCT00970307|537612034|FG001|Overall Study|Serious Adverse Event|0|||
149036261|NCT00970307|537612035|FG002|Overall Study|Serious Adverse Event|0|||
149036262|NCT00970307|537612033|FG000|Overall Study|Withdrawal by Subject|2|||
149036263|NCT00970307|537612034|FG001|Overall Study|Withdrawal by Subject|3|||
149036264|NCT00970307|537612035|FG002|Overall Study|Withdrawal by Subject|2|||
149036265|NCT02937831|537612036|FG000|Overall Study|Protocol Violation|4|||
148879785|NCT00856544|537038159|FG003|Overall Study|Lost to Follow-up|0|||
149036266|NCT02027558|537612041|FG000|Overall Study|Death|0|||
149036267|NCT02027558|537612042|FG001|Overall Study|Death|1|||
149036268|NCT02027558|537612041|FG000|Overall Study|Withdrawal by Subject|2|||
149036269|NCT02027558|537612042|FG001|Overall Study|Withdrawal by Subject|0|||
149036270|NCT02027558|537612041|FG000|Overall Study|Lost to Follow-up|4|||
149036271|NCT02027558|537612042|FG001|Overall Study|Lost to Follow-up|1|||
149036272|NCT02027558|537612041|FG000|Overall Study|Refused assessment|3|||
149036273|NCT02027558|537612042|FG001|Overall Study|Refused assessment|0|||
149036274|NCT00114244|537612047|FG000|Overall Study|Adverse Event|2|||
149036275|NCT00114244|537612048|FG001|Overall Study|Adverse Event|5|||
149036276|NCT00114244|537612047|FG000|Overall Study|Withdrawal by Subject|0|||
149036277|NCT00114244|537612048|FG001|Overall Study|Withdrawal by Subject|2|||
149036278|NCT02694978|537612049|FG000|Overall Study|Adverse Event|10|||
149036279|NCT02694978|537612050|FG001|Overall Study|Adverse Event|9|||
149036280|NCT02694978|537612049|FG000|Overall Study|Withdrawal by Subject|22|||
149036281|NCT02694978|537612050|FG001|Overall Study|Withdrawal by Subject|19|||
149036282|NCT02694978|537612049|FG000|Overall Study|Lost to Follow-up|14|||
149036283|NCT02694978|537612050|FG001|Overall Study|Lost to Follow-up|17|||
149036284|NCT02694978|537612049|FG000|Overall Study|Death|4|||
149036285|NCT02694978|537612050|FG001|Overall Study|Death|1|||
149036286|NCT02694978|537612049|FG000|Overall Study|Other-Decision of Participant|6|||
149036287|NCT02694978|537612050|FG001|Overall Study|Other-Decision of Participant|1|||
149036288|NCT02694978|537612049|FG000|Overall Study|Other-Investigator's decision|1|||
149036289|NCT02694978|537612050|FG001|Overall Study|Other-Investigator's decision|0|||
149036290|NCT02694978|537612049|FG000|Overall Study|Other-Unable to be reached|0|||
149036291|NCT02694978|537612050|FG001|Overall Study|Other-Unable to be reached|1|||
149036292|NCT02694978|537612049|FG000|Overall Study|Other-Protocol noncompliant|2|||
149036293|NCT02694978|537612050|FG001|Overall Study|Other-Protocol noncompliant|1|||
149036294|NCT02694978|537612049|FG000|Overall Study|Other-Personal reasons|3|||
148879786|NCT00856544|537038156|FG000|Overall Study|Withdrawal by Subject|8|||
148879787|NCT00856544|537038157|FG001|Overall Study|Withdrawal by Subject|5|||
148879788|NCT00856544|537038158|FG002|Overall Study|Withdrawal by Subject|0|||
148879789|NCT00856544|537038159|FG003|Overall Study|Withdrawal by Subject|1|||
148879790|NCT01036321|537038160|FG000|Overall Study|Ineligible after randomization|0|||
148879791|NCT01036321|537038161|FG001|Overall Study|Ineligible after randomization|1|||
148879792|NCT01036321|537038160|FG000|Overall Study|Withdrawal by Subject|3|||
149002023|NCT02052310|537484808|FG000|Overall Study|Death|64|||
149002024|NCT02052310|537484809|FG001|Overall Study|Death|54|||
149002025|NCT02052310|537484808|FG000|Overall Study|Withdrawal by Subject|37|||
149002026|NCT02052310|537484809|FG001|Overall Study|Withdrawal by Subject|49|||
149002027|NCT02052310|537484808|FG000|Overall Study|Other than specified|32|||
149002028|NCT02052310|537484809|FG001|Overall Study|Other than specified|29|||
149002029|NCT02052310|537484808|FG000|Overall Study|Adverse Event|29|||
149002030|NCT02052310|537484809|FG001|Overall Study|Adverse Event|22|||
149002031|NCT02052310|537484808|FG000|Overall Study|Kidney Transplant|23|||
149002032|NCT02052310|537484809|FG001|Overall Study|Kidney Transplant|29|||
149002033|NCT02052310|537484808|FG000|Overall Study|Physician Decision|14|||
149002034|NCT02052310|537484809|FG001|Overall Study|Physician Decision|7|||
149002035|NCT02052310|537484808|FG000|Overall Study|Lack of Efficacy|6|||
149002036|NCT02052310|537484809|FG001|Overall Study|Lack of Efficacy|1|||
149002037|NCT02052310|537484808|FG000|Overall Study|Site Terminated by Sponsor|5|||
149002038|NCT02052310|537484809|FG001|Overall Study|Site Terminated by Sponsor|13|||
149002039|NCT02052310|537484808|FG000|Overall Study|Lost to Follow-up|4|||
149002040|NCT02052310|537484809|FG001|Overall Study|Lost to Follow-up|2|||
149002041|NCT02052310|537484808|FG000|Overall Study|Protocol Violation|1|||
149002042|NCT02052310|537484809|FG001|Overall Study|Protocol Violation|6|||
149002043|NCT00595504|537484810|FG000|Overall Study|Withdrawal by Subject|1|||
149002044|NCT00595504|537484811|FG001|Overall Study|Withdrawal by Subject|3|||
149002045|NCT00595504|537484810|FG000|Overall Study|Physician Decision|1|||
149002046|NCT00595504|537484811|FG001|Overall Study|Physician Decision|0|||
149002047|NCT01949870|537484812|FG000|Overall Study|Lack of Efficacy|2|||
149002048|NCT01949870|537484812|FG000|Overall Study|Adverse Event|1|||
149002049|NCT01949870|537484812|FG000|Overall Study|Study termination|1|||
149002050|NCT01949870|537484812|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
149002051|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
149002052|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
149002053|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
149002054|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
149002055|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
149002056|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
149002057|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
149002058|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
149002059|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
149002060|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
149002061|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
149036295|NCT02694978|537612050|FG001|Overall Study|Other-Personal reasons|3|||
149002062|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
149002063|NCT00293267|537484813|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
149036296|NCT02694978|537612049|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
149036297|NCT02694978|537612050|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
149036298|NCT01613716|537612051|FG000|Overall Study|screen failures|3|||
148879793|NCT01036321|537038161|FG001|Overall Study|Withdrawal by Subject|2|||
149002064|NCT00293267|537484814|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
149002065|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
149002066|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
149002067|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
149002068|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
149002069|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
149002070|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
149002071|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
149002072|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
149002073|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Death|3|||
149002074|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Death|0|||
149002075|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
149002076|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
149002077|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
149002078|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
149002079|NCT00293267|537484813|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
149002080|NCT00293267|537484814|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
149002081|NCT00293267|537484813|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
149002082|NCT00293267|537484814|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
149002083|NCT00293267|537484813|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
149002084|NCT00293267|537484814|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
149002085|NCT00293267|537484813|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
149002086|NCT00293267|537484814|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
149002087|NCT00293267|537484813|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
149002088|NCT00293267|537484814|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
149002089|NCT00293267|537484813|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
149002090|NCT00293267|537484814|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
149002091|NCT00293267|537484813|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
149002092|NCT00293267|537484814|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
149002093|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
149002094|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
149002095|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
149002096|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
149002097|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
149002098|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
149002099|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
149002100|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
149002101|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
149002102|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
149002103|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
149002104|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
149002105|NCT00293267|537484813|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
149002106|NCT00293267|537484814|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
149002107|NCT02182973|537484815|FG000|Overall Study|Withdrawal by Subject|3|||
149002108|NCT02182973|537484816|FG001|Overall Study|Withdrawal by Subject|0|||
149002109|NCT01235546|537484817|FG000|Overall Study|Staff error, medication not administered|1|||
149002110|NCT01235546|537484818|FG001|Overall Study|Staff error, medication not administered|0|||
149002111|NCT01235546|537484817|FG000|Overall Study|Protocol Violation|1|||
149002112|NCT01235546|537484818|FG001|Overall Study|Protocol Violation|1|||
149002113|NCT02740049|537484819|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
149002114|NCT00645164|537484823|FG000|Overall Study|Lost to Follow-up|2|||
149002115|NCT00645164|537484823|FG000|Overall Study|Withdrawal by Subject|4|||
149002116|NCT00645164|537484823|FG000|Overall Study|Protocol Violation|1|||
149002117|NCT03338829|537484828|FG000|Overall Study|Lost to Follow-up|4|||
149002118|NCT03338829|537484829|FG001|Overall Study|Lost to Follow-up|2|||
149002119|NCT03338829|537484830|FG002|Overall Study|Lost to Follow-up|4|||
149002120|NCT03338829|537484828|FG000|Overall Study|Pregnancy loss|1|||
149002121|NCT03338829|537484829|FG001|Overall Study|Pregnancy loss|1|||
149002122|NCT03338829|537484830|FG002|Overall Study|Pregnancy loss|0|||
149002123|NCT03338829|537484828|FG000|Overall Study|Protocol Violation|0|||
149002124|NCT03338829|537484829|FG001|Overall Study|Protocol Violation|1|||
149002125|NCT03338829|537484830|FG002|Overall Study|Protocol Violation|0|||
149002126|NCT04393441|537484835|FG000|Overall Study|Adverse Event|0|||
149002127|NCT04393441|537484836|FG001|Overall Study|Adverse Event|3|||
149002128|NCT04393441|537484835|FG000|Overall Study|Withdrawal by Subject|5|||
149002129|NCT04393441|537484836|FG001|Overall Study|Withdrawal by Subject|7|||
149002130|NCT04393441|537484835|FG000|Overall Study|Lost to Follow-up|0|||
149002131|NCT04393441|537484836|FG001|Overall Study|Lost to Follow-up|2|||
149002132|NCT04393441|537484835|FG000|Overall Study|Protocol Deviation|2|||
149002133|NCT04393441|537484836|FG001|Overall Study|Protocol Deviation|1|||
149002134|NCT04393441|537484835|FG000|Overall Study|Reason not Specified|1|||
149002135|NCT04393441|537484836|FG001|Overall Study|Reason not Specified|1|||
149002136|NCT04003610|537484837|FG000|Overall Study|Lost to Follow-up|0|||
149002137|NCT04003610|537484838|FG001|Overall Study|Lost to Follow-up|1|||
149002138|NCT04003610|537484839|FG002|Overall Study|Lost to Follow-up|0|||
149002139|NCT04003610|537484837|FG000|Overall Study|Death|0|||
149002140|NCT04003610|537484838|FG001|Overall Study|Death|0|||
149002141|NCT04003610|537484839|FG002|Overall Study|Death|3|||
149002142|NCT04003610|537484837|FG000|Overall Study|Study Terminated by Sponsor|0|||
149002143|NCT04003610|537484838|FG001|Overall Study|Study Terminated by Sponsor|0|||
149002144|NCT04003610|537484839|FG002|Overall Study|Study Terminated by Sponsor|3|||
149002145|NCT00168038|537484842|FG000|Overall Study|Adverse Event|1|||
149002146|NCT00168038|537484842|FG000|Overall Study|Therapy failure|1|||
149002147|NCT04198805|537484845|FG000|Overall Study|Death|0|||
149002148|NCT04198805|537484846|FG001|Overall Study|Death|0|||
149002149|NCT04198805|537484847|FG002|Overall Study|Death|0|||
149002150|NCT04198805|537484848|FG003|Overall Study|Death|1|||
149002151|NCT04198805|537484845|FG000|Overall Study|Early Termination|8|||
149002152|NCT04198805|537484846|FG001|Overall Study|Early Termination|4|||
149002153|NCT04198805|537484847|FG002|Overall Study|Early Termination|6|||
149002154|NCT04198805|537484848|FG003|Overall Study|Early Termination|9|||
149002155|NCT03599349|537484853|FG000|Overall Study|Lost to Follow-up|1|||
149002156|NCT02638948|537484856|FG000|Overall Study|Withdrawal by Subject|4|||
149002157|NCT02638948|537484857|FG001|Overall Study|Withdrawal by Subject|5|||
149002158|NCT02638948|537484858|FG002|Overall Study|Withdrawal by Subject|3|||
149002159|NCT02638948|537484859|FG003|Overall Study|Withdrawal by Subject|1|||
149002160|NCT02638948|537484856|FG000|Overall Study|Administrative Reason by Sponsor|0|||
149002161|NCT02638948|537484857|FG001|Overall Study|Administrative Reason by Sponsor|1|||
149002162|NCT02638948|537484858|FG002|Overall Study|Administrative Reason by Sponsor|0|||
149002163|NCT02638948|537484859|FG003|Overall Study|Administrative Reason by Sponsor|4|||
149002164|NCT02638948|537484856|FG000|Overall Study|Adverse Event|0|||
149002165|NCT02638948|537484857|FG001|Overall Study|Adverse Event|0|||
149002166|NCT02638948|537484858|FG002|Overall Study|Adverse Event|1|||
149002167|NCT02638948|537484859|FG003|Overall Study|Adverse Event|1|||
149002168|NCT02638948|537484856|FG000|Overall Study|Lack of Efficacy|1|||
149002169|NCT02638948|537484857|FG001|Overall Study|Lack of Efficacy|1|||
149002170|NCT02638948|537484858|FG002|Overall Study|Lack of Efficacy|0|||
149002171|NCT02638948|537484859|FG003|Overall Study|Lack of Efficacy|0|||
149002172|NCT02638948|537484856|FG000|Overall Study|Lost to Follow-up|0|||
149002173|NCT02638948|537484857|FG001|Overall Study|Lost to Follow-up|0|||
149002174|NCT02638948|537484858|FG002|Overall Study|Lost to Follow-up|1|||
149002175|NCT02638948|537484859|FG003|Overall Study|Lost to Follow-up|1|||
149002176|NCT02638948|537484856|FG000|Overall Study|Poor/Non-Compliance|0|||
149002177|NCT02638948|537484857|FG001|Overall Study|Poor/Non-Compliance|2|||
149002178|NCT02638948|537484858|FG002|Overall Study|Poor/Non-Compliance|1|||
149002179|NCT02638948|537484859|FG003|Overall Study|Poor/Non-Compliance|0|||
149002180|NCT02638948|537484856|FG000|Overall Study|Participant no longer met study criteria|0|||
149002181|NCT02638948|537484857|FG001|Overall Study|Participant no longer met study criteria|1|||
149002182|NCT02638948|537484858|FG002|Overall Study|Participant no longer met study criteria|0|||
149002183|NCT02638948|537484859|FG003|Overall Study|Participant no longer met study criteria|0|||
149002184|NCT02638948|537484856|FG000|Overall Study|Other than specified above|4|||
149002185|NCT02638948|537484857|FG001|Overall Study|Other than specified above|1|||
149002186|NCT02638948|537484858|FG002|Overall Study|Other than specified above|1|||
149002187|NCT02638948|537484859|FG003|Overall Study|Other than specified above|1|||
149002188|NCT05007392|537484860|FG000|Overall Study|Randomized but not treated|1|||
149002189|NCT05007392|537484861|FG001|Overall Study|Randomized but not treated|2|||
149002190|NCT05007392|537484860|FG000|Overall Study|Other|5|||
149002191|NCT05007392|537484861|FG001|Overall Study|Other|4|||
149002192|NCT05007392|537484860|FG000|Overall Study|Lost to Follow-up|1|||
149002193|NCT05007392|537484861|FG001|Overall Study|Lost to Follow-up|2|||
149002194|NCT05007392|537484860|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
149002195|NCT05007392|537484861|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
149002196|NCT05007392|537484860|FG000|Overall Study|Use of prohibited concomitant drug|1|||
149002197|NCT05007392|537484861|FG001|Overall Study|Use of prohibited concomitant drug|1|||
149002198|NCT05007392|537484860|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
149002199|NCT05007392|537484861|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
149002200|NCT05007392|537484860|FG000|Overall Study|Adverse Event|10|||
149002201|NCT05007392|537484861|FG001|Overall Study|Adverse Event|6|||
149036299|NCT01613716|537612051|FG000|Overall Study|Lost to Follow-up|4|||
149002202|NCT05007392|537484860|FG000|Overall Study|Participant choice|5|||
149002203|NCT05007392|537484861|FG001|Overall Study|Participant choice|10|||
149002204|NCT05007392|537484860|FG000|Overall Study|Withdrawal of consent|5|||
149002205|NCT05007392|537484861|FG001|Overall Study|Withdrawal of consent|4|||
149002206|NCT01218126|537484864|FG000|Overall Study|Adverse Event|8|||
149036300|NCT01376089|537612053|FG000|Overall Study|Patient received no contrast media|3|||
149036301|NCT01376089|537612054|FG001|Overall Study|Patient received no contrast media|4|||
149036302|NCT00419094|537612057|FG000|Overall Study|Adverse Event|3|||
149036303|NCT00419094|537612058|FG001|Overall Study|Adverse Event|7|||
149036304|NCT00419094|537612057|FG000|Overall Study|Lack of Efficacy|1|||
149036305|NCT00419094|537612058|FG001|Overall Study|Lack of Efficacy|0|||
149036306|NCT00419094|537612057|FG000|Overall Study|Lost to Follow-up|0|||
149002207|NCT01218126|537484865|FG001|Overall Study|Adverse Event|10|||
149002208|NCT01218126|537484866|FG002|Overall Study|Adverse Event|12|||
149002209|NCT01218126|537484867|FG003|Overall Study|Adverse Event|16|||
149002210|NCT01218126|537484864|FG000|Overall Study|Lack of Efficacy|7|||
149002211|NCT01218126|537484865|FG001|Overall Study|Lack of Efficacy|2|||
149002212|NCT01218126|537484866|FG002|Overall Study|Lack of Efficacy|2|||
149002213|NCT01218126|537484867|FG003|Overall Study|Lack of Efficacy|6|||
149002214|NCT01218126|537484864|FG000|Overall Study|Protocol Violation|5|||
149002215|NCT01218126|537484865|FG001|Overall Study|Protocol Violation|2|||
149002216|NCT01218126|537484866|FG002|Overall Study|Protocol Violation|2|||
149002217|NCT01218126|537484867|FG003|Overall Study|Protocol Violation|3|||
149002218|NCT01218126|537484864|FG000|Overall Study|Protocol-defined stopping criteria|1|||
149002219|NCT01218126|537484865|FG001|Overall Study|Protocol-defined stopping criteria|1|||
149002220|NCT01218126|537484866|FG002|Overall Study|Protocol-defined stopping criteria|0|||
149002221|NCT01218126|537484867|FG003|Overall Study|Protocol-defined stopping criteria|0|||
149002222|NCT01218126|537484864|FG000|Overall Study|Lost to Follow-up|0|||
149002223|NCT01218126|537484865|FG001|Overall Study|Lost to Follow-up|0|||
149002224|NCT01218126|537484866|FG002|Overall Study|Lost to Follow-up|0|||
149002225|NCT01218126|537484867|FG003|Overall Study|Lost to Follow-up|2|||
149002226|NCT01218126|537484864|FG000|Overall Study|Physician Decision|1|||
149002227|NCT01218126|537484865|FG001|Overall Study|Physician Decision|2|||
149002228|NCT01218126|537484866|FG002|Overall Study|Physician Decision|4|||
149002229|NCT01218126|537484867|FG003|Overall Study|Physician Decision|2|||
149002230|NCT01218126|537484864|FG000|Overall Study|Withdrawal by Subject|2|||
149002231|NCT01218126|537484865|FG001|Overall Study|Withdrawal by Subject|5|||
149002232|NCT01218126|537484866|FG002|Overall Study|Withdrawal by Subject|4|||
149002233|NCT01218126|537484867|FG003|Overall Study|Withdrawal by Subject|6|||
149002234|NCT00803452|537484870|FG000|Overall Study|Adverse Event|0|||
149002235|NCT00803452|537484871|FG001|Overall Study|Adverse Event|2|||
149002236|NCT00803452|537484870|FG000|Overall Study|Lost to Follow-up|0|||
149002237|NCT00803452|537484871|FG001|Overall Study|Lost to Follow-up|3|||
149002238|NCT01659151|537484874|FG000|Overall Study|Inadequate TIL growth|1|||
149002239|NCT05774197|537484875|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
149002240|NCT06223373|537484879|FG000|Overall Study|Lost to Follow-up|1|||
149002241|NCT06223373|537484880|FG001|Overall Study|Lost to Follow-up|2|||
149002242|NCT04922554|537484881|FG000|Overall Study|Adverse Event|4|||
149002243|NCT04922554|537484882|FG001|Overall Study|Adverse Event|0|||
149002244|NCT04922554|537484881|FG000|Overall Study|Withdrawal by Subject|1|||
149002245|NCT04922554|537484882|FG001|Overall Study|Withdrawal by Subject|0|||
149002246|NCT01464021|537486089|FG000|Overall Study|Withdrawal by Subject|13|||
149002247|NCT01464021|537486089|FG000|Overall Study|Lost to Follow-up|1|||
149002248|NCT01464021|537486089|FG000|Overall Study|Lack of Efficacy|1|||
149002249|NCT01464021|537486089|FG000|Overall Study|various|11|||
149002250|NCT00526630|537486094|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
149002251|NCT00526630|537486095|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
149002252|NCT00526630|537486094|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
149002253|NCT00526630|537486095|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
149002254|NCT02459262|537486096|FG000|Overall Study|Withdrawal by Subject|0|||
149002255|NCT02459262|537486097|FG001|Overall Study|Withdrawal by Subject|0|||
149002256|NCT02459262|537486098|FG002|Overall Study|Withdrawal by Subject|0|||
149002257|NCT02459262|537486099|FG003|Overall Study|Withdrawal by Subject|0|||
149002258|NCT02459262|537486100|FG004|Overall Study|Withdrawal by Subject|0|||
149002259|NCT02459262|537486101|FG005|Overall Study|Withdrawal by Subject|0|||
149002260|NCT02459262|537486102|FG006|Overall Study|Withdrawal by Subject|0|||
149002261|NCT02459262|537486103|FG007|Overall Study|Withdrawal by Subject|0|||
149002262|NCT02459262|537486104|FG008|Overall Study|Withdrawal by Subject|0|||
149002263|NCT02459262|537486105|FG009|Overall Study|Withdrawal by Subject|1|||
149002264|NCT02459262|537486106|FG010|Overall Study|Withdrawal by Subject|0|||
149002265|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
149002266|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
149002267|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
149002268|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
149002269|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
149002270|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
149002271|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
149002272|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
149036307|NCT00419094|537612058|FG001|Overall Study|Lost to Follow-up|2|||
149036308|NCT00419094|537612057|FG000|Overall Study|Protocol Violation|1|||
149036309|NCT00419094|537612058|FG001|Overall Study|Protocol Violation|14|||
149036310|NCT00419094|537612057|FG000|Overall Study|Withdrawal of consent|1|||
149036311|NCT00419094|537612058|FG001|Overall Study|Withdrawal of consent|5|||
149036312|NCT00419094|537612057|FG000|Overall Study|Other: Error determining exit criteria|1|||
149036313|NCT00419094|537612058|FG001|Overall Study|Other: Error determining exit criteria|0|||
149036314|NCT00419094|537612057|FG000|Overall Study|Other: Patient non-compliant|0|||
149036315|NCT00419094|537612058|FG001|Overall Study|Other: Patient non-compliant|1|||
149036316|NCT00419094|537612057|FG000|Overall Study|Other: No contact for extended period|0|||
149036317|NCT00419094|537612058|FG001|Overall Study|Other: No contact for extended period|1|||
149036318|NCT01811706|537612059|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
149036319|NCT01811706|537612060|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
149036320|NCT03020745|537612063|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036321|NCT03020745|537612064|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036322|NCT03020745|537612065|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036323|NCT03020745|537612066|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036324|NCT03020745|537612067|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036325|NCT03020745|537612068|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036326|NCT03020745|537612069|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036327|NCT03020745|537612070|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036328|NCT03020745|537612071|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
149036329|NCT03020745|537612072|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
149036330|NCT03020745|537612063|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036331|NCT03020745|537612064|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036332|NCT03020745|537612065|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036333|NCT03020745|537612066|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036334|NCT03020745|537612067|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036335|NCT03020745|537612068|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036336|NCT03020745|537612069|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036337|NCT03020745|537612070|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
149036338|NCT03020745|537612071|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036339|NCT03020745|537612072|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
149036340|NCT03020745|537612063|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036341|NCT03020745|537612064|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036342|NCT03020745|537612065|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036343|NCT03020745|537612066|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036344|NCT03020745|537612067|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036345|NCT03020745|537612068|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
149036346|NCT03020745|537612069|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036347|NCT03020745|537612070|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036348|NCT03020745|537612071|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
149036349|NCT03020745|537612072|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
149036350|NCT03020745|537612063|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036351|NCT03020745|537612064|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036352|NCT03020745|537612065|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036353|NCT03020745|537612066|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036354|NCT03020745|537612067|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036355|NCT03020745|537612068|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036356|NCT03020745|537612069|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036357|NCT03020745|537612070|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036358|NCT03020745|537612071|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
149036359|NCT03020745|537612072|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
149036360|NCT00743444|537612073|FG000|First Intervention|Catheter placement problems|0|||
149036361|NCT00743444|537612074|FG001|First Intervention|Catheter placement problems|1|||
149036362|NCT00743444|537612073|FG000|Washout Period|Adverse Event|0|||
149036363|NCT00743444|537612074|FG001|Washout Period|Adverse Event|1|||
149036364|NCT03287622|537612080|FG000|Overall Study|Withdrawal by Subject|1|||
149036365|NCT03287622|537612081|FG001|Overall Study|Withdrawal by Subject|0|||
149036366|NCT03287622|537612080|FG000|Overall Study|Lost to Follow-up|27|||
149036367|NCT03287622|537612081|FG001|Overall Study|Lost to Follow-up|15|||
149036368|NCT03287622|537612080|FG000|Overall Study|No prescripion after surgery|28|||
149036369|NCT03287622|537612081|FG001|Overall Study|No prescripion after surgery|31|||
149036370|NCT03287622|537612080|FG000|Overall Study|prolonged Length of stay|2|||
149036371|NCT03287622|537612081|FG001|Overall Study|prolonged Length of stay|0|||
149036372|NCT03287622|537612080|FG000|Overall Study|surgery related|0|||
149036373|NCT03287622|537612081|FG001|Overall Study|surgery related|2|||
149036374|NCT02057692|537612082|FG000|Overall Study|Adverse Event|1|||
149036375|NCT02057692|537612083|FG001|Overall Study|Adverse Event|0|||
149036376|NCT02057692|537612084|FG002|Overall Study|Adverse Event|0|||
149036377|NCT02057692|537612085|FG003|Overall Study|Adverse Event|0|||
149036378|NCT02057692|537612082|FG000|Overall Study|Lost to Follow-up|0|||
149036379|NCT02057692|537612083|FG001|Overall Study|Lost to Follow-up|0|||
148879794|NCT01036321|537038160|FG000|Overall Study|Adverse Event|2|||
148879795|NCT01036321|537038161|FG001|Overall Study|Adverse Event|1|||
148879796|NCT03040674|537038164|FG000|Overall Study|Lost to Follow-up|225|||
148879797|NCT03040674|537038164|FG000|Overall Study|Death|23|||
148879798|NCT03517228|537038165|FG000|Overall Study|Withdrawal by Subject|2|||
148879799|NCT03517228|537038165|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
148879800|NCT03517228|537038165|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
148879801|NCT03517228|537038165|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
148879802|NCT03517228|537038165|FG000|Overall Study|Canceled due to device being updated|1|||
148879803|NCT03517228|537038165|FG000|Overall Study|No V Cares in stock|1|||
148879804|NCT03517228|537038165|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
148879805|NCT03781414|537038170|FG000|Overall Study|Study terminated by sponsor|39|||
148879806|NCT03781414|537038171|FG001|Overall Study|Study terminated by sponsor|34|||
148879807|NCT03781414|537038172|FG002|Overall Study|Study terminated by sponsor|25|||
148879808|NCT03781414|537038170|FG000|Overall Study|Adverse Event|3|||
148879809|NCT03781414|537038171|FG001|Overall Study|Adverse Event|6|||
148879810|NCT03781414|537038172|FG002|Overall Study|Adverse Event|3|||
148879811|NCT03781414|537038170|FG000|Overall Study|Physician Decision|2|||
148879812|NCT03781414|537038171|FG001|Overall Study|Physician Decision|0|||
149002273|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
149002274|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
149002275|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
149002276|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
149002277|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
149002278|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
149002279|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
149002280|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
149002281|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
149002282|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
149002283|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
149002284|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
149002285|NCT00549757|537486113|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
149002286|NCT00549757|537486114|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
149002287|NCT00549757|537486113|FG000|Extension Period (in Average 9 Months)|Death|143|||
149002288|NCT00549757|537486114|FG001|Extension Period (in Average 9 Months)|Death|136|||
149002289|NCT00549757|537486113|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
149002290|NCT00549757|537486114|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
149002291|NCT00549757|537486113|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
149002292|NCT00549757|537486114|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
149002293|NCT00549757|537486113|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
149002294|NCT00549757|537486114|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
149002295|NCT01964326|537486115|FG000|Overall Study|Adverse Event|48|||
149002296|NCT01964326|537486115|FG000|Overall Study|Death|2|||
149002297|NCT01964326|537486115|FG000|Overall Study|Protocol Violation|4|||
149002298|NCT01964326|537486115|FG000|Overall Study|Lost to Follow-up|88|||
149002299|NCT01964326|537486115|FG000|Overall Study|Withdrawal by Subject|87|||
149002300|NCT01964326|537486115|FG000|Overall Study|Pregnancy|1|||
149002301|NCT01964326|537486115|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
149002302|NCT01964326|537486115|FG000|Overall Study|Physician Decision|55|||
149002303|NCT01964326|537486115|FG000|Overall Study|Investigator Discretion|1|||
149002304|NCT01964326|537486115|FG000|Overall Study|Other|9|||
149002305|NCT01964326|537486115|FG000|Overall Study|Did not meet eligibility criteria|1|||
149002306|NCT02347657|537486116|FG000|Overall Study|Physician Decision|0|||
149002307|NCT02347657|537486117|FG001|Overall Study|Physician Decision|1|||
149002308|NCT02347657|537486116|FG000|Overall Study|Adverse Event|8|||
149002309|NCT02347657|537486117|FG001|Overall Study|Adverse Event|4|||
149002310|NCT02347657|537486116|FG000|Overall Study|Withdrawal by Subject|6|||
149002311|NCT02347657|537486117|FG001|Overall Study|Withdrawal by Subject|7|||
149002312|NCT02347657|537486116|FG000|Overall Study|Randomized but not treated|1|||
149002313|NCT02347657|537486117|FG001|Overall Study|Randomized but not treated|0|||
149002314|NCT02347657|537486116|FG000|Overall Study|Other|3|||
149002315|NCT02347657|537486117|FG001|Overall Study|Other|3|||
149002316|NCT02093663|537486122|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
149002317|NCT02093663|537486123|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
149002318|NCT02093663|537486124|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
149002319|NCT02093663|537486125|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
149002320|NCT02093663|537486126|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
148879813|NCT03781414|537038172|FG002|Overall Study|Physician Decision|1|||
149036380|NCT02057692|537612084|FG002|Overall Study|Lost to Follow-up|0|||
149036381|NCT02057692|537612085|FG003|Overall Study|Lost to Follow-up|1|||
148879814|NCT03781414|537038170|FG000|Overall Study|Withdrawal by Subject|2|||
148879815|NCT03781414|537038171|FG001|Overall Study|Withdrawal by Subject|3|||
149036382|NCT03823300|537612090|FG000|Overall Study|Withdrawal by Subject|16|||
149036383|NCT03823300|537612091|FG001|Overall Study|Withdrawal by Subject|22|||
149036384|NCT03823300|537612090|FG000|Overall Study|Death|10|||
149036385|NCT03823300|537612091|FG001|Overall Study|Death|14|||
149036386|NCT03823300|537612090|FG000|Overall Study|Adverse Event|3|||
149036387|NCT03823300|537612091|FG001|Overall Study|Adverse Event|5|||
149036388|NCT03823300|537612090|FG000|Overall Study|Physician Decision|1|||
149036389|NCT03823300|537612091|FG001|Overall Study|Physician Decision|7|||
149036390|NCT03823300|537612090|FG000|Overall Study|Lost to Follow-up|1|||
149036391|NCT03823300|537612091|FG001|Overall Study|Lost to Follow-up|3|||
149036392|NCT03823300|537612090|FG000|Overall Study|Protocol Violation|1|||
149036393|NCT03823300|537612091|FG001|Overall Study|Protocol Violation|1|||
149036394|NCT03823300|537612090|FG000|Overall Study|Lack of Efficacy|1|||
149036395|NCT03823300|537612091|FG001|Overall Study|Lack of Efficacy|1|||
149036396|NCT03823300|537612090|FG000|Overall Study|Not Eligible|0|||
149036397|NCT03823300|537612091|FG001|Overall Study|Not Eligible|1|||
149036398|NCT03823300|537612090|FG000|Overall Study|Other|1|||
149036399|NCT03823300|537612091|FG001|Overall Study|Other|0|||
149036400|NCT01930045|537612095|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
149036401|NCT01930045|537612096|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
149036402|NCT01930045|537612097|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
149036403|NCT01930045|537612098|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
149036404|NCT01930045|537612099|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
149036405|NCT01930045|537612100|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
149036406|NCT01930045|537612095|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
149036407|NCT01930045|537612096|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
149036408|NCT01930045|537612097|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
149036409|NCT01930045|537612098|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
149036410|NCT01930045|537612099|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
149036411|NCT01930045|537612100|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
149036412|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
149036413|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
149036414|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
149036415|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
149036416|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
149036417|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
149036418|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
149036419|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
149036420|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
149036421|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
149036422|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
149036423|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
149036424|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
149036425|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
149036426|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
149036427|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
149036428|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
149036429|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
149036430|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
149036431|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
148879816|NCT03781414|537038172|FG002|Overall Study|Withdrawal by Subject|3|||
148879817|NCT03781414|537038170|FG000|Overall Study|Death|1|||
148879818|NCT03781414|537038171|FG001|Overall Study|Death|4|||
148879819|NCT03781414|537038172|FG002|Overall Study|Death|0|||
148879820|NCT03781414|537038170|FG000|Overall Study|Lost to Follow-up|1|||
148879821|NCT03781414|537038171|FG001|Overall Study|Lost to Follow-up|1|||
148879822|NCT03781414|537038172|FG002|Overall Study|Lost to Follow-up|0|||
148879823|NCT04752358|537038176|FG000|Overall Study|Death|2|||
148879824|NCT04752358|537038177|FG001|Overall Study|Death|1|||
148879825|NCT01053988|537038178|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
148879826|NCT01053988|537038179|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148879827|NCT01053988|537038180|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148879828|NCT01053988|537038181|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148879829|NCT01053988|537038182|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148879830|NCT01053988|537038183|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
148879831|NCT01053988|537038178|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
148879832|NCT01053988|537038179|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148879833|NCT01053988|537038180|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148879834|NCT01053988|537038181|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
149036432|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
149036433|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
149036434|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
149036435|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
149036436|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
149036437|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
149036438|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
149036439|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
149036440|NCT00241644|537612101|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
149036441|NCT00241644|537612102|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
149036442|NCT00241644|537612103|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
149036443|NCT00241644|537612104|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
149036444|NCT00241644|537612101|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
149036445|NCT00241644|537612102|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
149036446|NCT00241644|537612103|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
149036447|NCT00241644|537612104|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
149036448|NCT00241644|537612101|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
149036449|NCT00241644|537612102|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
149036450|NCT00241644|537612103|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
149036451|NCT00241644|537612104|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
149036452|NCT00241644|537612101|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
149036453|NCT00241644|537612102|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
149036454|NCT00241644|537612103|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
149036455|NCT00241644|537612104|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
149036456|NCT00241644|537612101|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
149036457|NCT00241644|537612102|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
149036458|NCT00241644|537612103|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
149036459|NCT00241644|537612104|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
149036460|NCT00241644|537612101|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
149036461|NCT00241644|537612102|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
149036462|NCT00241644|537612103|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
149036463|NCT00241644|537612104|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
149036464|NCT00943735|537612105|FG000|Overall Study|Adverse Event|12|||
149036465|NCT00943735|537612105|FG000|Overall Study|Withdrawal by Subject|8|||
149036466|NCT00943735|537612105|FG000|Overall Study|Death|1|||
149036467|NCT00943735|537612105|FG000|Overall Study|Other|8|||
149036468|NCT00943735|537612105|FG000|Overall Study|Other|3|||
149036469|NCT00486330|537612106|FG000|Overall Study|Adverse Event|2|||
149036470|NCT03804918|537612107|FG000|Overall Study|Participant did not use the app|1|||
149036471|NCT01087762|537612108|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
149036472|NCT01087762|537612109|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
149036473|NCT01087762|537612110|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
149036474|NCT01087762|537612111|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
149036475|NCT01087762|537612112|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
149036476|NCT01087762|537612108|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
149036477|NCT01087762|537612109|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
149036478|NCT01087762|537612110|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
149036479|NCT01087762|537612111|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
149036480|NCT01087762|537612112|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
149036481|NCT01087762|537612108|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
149036482|NCT01087762|537612109|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
149036483|NCT01087762|537612110|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
149036484|NCT01087762|537612111|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
149036485|NCT01087762|537612112|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
149036486|NCT01087762|537612108|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
149036487|NCT01087762|537612109|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
149036488|NCT01087762|537612110|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
149036489|NCT01087762|537612111|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
149036490|NCT01087762|537612112|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
149036491|NCT01087762|537612108|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
149036492|NCT01087762|537612109|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
149036493|NCT01087762|537612110|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
148879835|NCT01053988|537038182|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148879836|NCT01053988|537038183|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
148879837|NCT01053988|537038178|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
148879838|NCT01053988|537038179|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
149036494|NCT01087762|537612111|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
149036495|NCT01087762|537612112|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
149036496|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
149036497|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
149036498|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
149036499|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
149036500|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
149036501|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
149036502|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
149036503|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
149036504|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
149036505|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
149036506|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
149036507|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
149036508|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
149036509|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
149036510|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
149036511|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
149036512|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
149036513|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
149036514|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
149036515|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
149036516|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
149036517|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
149036518|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
149036519|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
149036520|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
149036521|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
149036522|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
149036523|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
149036524|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
149036525|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
149036526|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
149002321|NCT02093663|537486122|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
149002322|NCT02093663|537486123|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002323|NCT02093663|537486124|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002324|NCT02093663|537486125|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002325|NCT02093663|537486126|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002326|NCT02093663|537486122|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
149002327|NCT02093663|537486123|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
149002328|NCT02093663|537486124|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
149002329|NCT02093663|537486125|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
149002330|NCT02093663|537486126|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
149002331|NCT02093663|537486122|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
149002332|NCT02093663|537486123|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
149002333|NCT02093663|537486124|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
149002334|NCT02093663|537486125|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
149002335|NCT02093663|537486126|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
149002336|NCT02093663|537486122|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002337|NCT02093663|537486123|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002338|NCT02093663|537486124|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
149002339|NCT02093663|537486125|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002340|NCT02093663|537486126|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
149002341|NCT02093663|537486122|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
149002342|NCT02093663|537486123|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
149002343|NCT02093663|537486124|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
149002344|NCT02093663|537486125|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
149002345|NCT02093663|537486126|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
149002346|NCT02093663|537486122|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
149002347|NCT02093663|537486123|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
149002348|NCT02093663|537486124|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
149002349|NCT02093663|537486125|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
149002350|NCT02093663|537486126|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
149002351|NCT02093663|537486122|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
149002352|NCT02093663|537486123|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
149002353|NCT02093663|537486124|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
149002354|NCT02093663|537486125|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
149002355|NCT02093663|537486126|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
149036527|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
149036528|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
149002356|NCT02093663|537486122|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
149002357|NCT02093663|537486123|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
149002358|NCT02093663|537486124|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
149002359|NCT02093663|537486125|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
149002360|NCT02093663|537486126|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
149002361|NCT01505387|537486127|FG000|Overall Study|Protocol Violation|1|||
149002362|NCT01505387|537486128|FG001|Overall Study|Protocol Violation|0|||
149002363|NCT01505387|537486127|FG000|Overall Study|Withdrawal by Subject|1|||
149002364|NCT01505387|537486128|FG001|Overall Study|Withdrawal by Subject|1|||
149002365|NCT01301391|537486129|FG000|Overall Study|Death|13|||
149002366|NCT01301391|537486129|FG000|Overall Study|Lost to Follow-up|3|||
149002367|NCT01301391|537486129|FG000|Overall Study|Physician Decision|2|||
149002368|NCT01301391|537486129|FG000|Overall Study|Sponsor's decision|8|||
149002369|NCT01621880|537486132|FG000|Overall Study|Adverse Event|5|||
149002370|NCT01621880|537486133|FG001|Overall Study|Adverse Event|1|||
149002371|NCT01621880|537486132|FG000|Overall Study|Withdrawal by Subject|5|||
149002372|NCT01621880|537486133|FG001|Overall Study|Withdrawal by Subject|4|||
149002373|NCT01814748|537486140|FG000|Overall Study|Lost to Follow-up|1|||
149002374|NCT01814748|537486141|FG001|Overall Study|Lost to Follow-up|2|||
149002375|NCT01814748|537486140|FG000|Overall Study|Study site terminated by sponsor|1|||
149002376|NCT01814748|537486141|FG001|Overall Study|Study site terminated by sponsor|1|||
149002377|NCT01814748|537486140|FG000|Overall Study|Withdrawal by Subject|6|||
149002378|NCT01814748|537486141|FG001|Overall Study|Withdrawal by Subject|4|||
149002379|NCT02782169|537486148|FG000|Overall Study|Lost to Follow-up|1|||
149002380|NCT02782169|537486149|FG001|Overall Study|Lost to Follow-up|2|||
149002381|NCT04751942|537486150|FG000|Overall Study|Lost to Follow-up|9|||
149002382|NCT04751942|537486151|FG001|Overall Study|Lost to Follow-up|6|||
149002383|NCT00724152|537486161|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
149002384|NCT00724152|537486162|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
149002385|NCT00724152|537486163|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
149002386|NCT00724152|537486161|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
149002387|NCT00724152|537486162|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
149002388|NCT00724152|537486163|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
149002389|NCT00386022|537486164|FG000|Plus Estrogen|Lost to Follow-up|2|||
149002390|NCT00386022|537486165|FG001|Plus Estrogen|Lost to Follow-up|0|||
149002391|NCT00386022|537486164|FG000|Plus Estrogen|Adverse Event|0|||
149002392|NCT00386022|537486165|FG001|Plus Estrogen|Adverse Event|1|||
149002393|NCT03266770|537486168|FG000|Overall Study|Physician Decision|3|||
149002394|NCT03266770|537486168|FG000|Overall Study|Insufficient study supplies|1|||
149002395|NCT03266770|537486168|FG000|Overall Study|Adverse Event|1|||
149002396|NCT02657031|537486172|FG000|Overall Study|Adverse Event|1|||
149002397|NCT02657031|537486173|FG001|Overall Study|Adverse Event|2|||
149002398|NCT03078816|537486174|FG000|Overall Study|Withdrawal by Subject|1|||
149002399|NCT02114151|537486175|FG000|Overall Study|Death|1|||
149002400|NCT02114151|537486175|FG000|Overall Study|Lost to Follow-up|1|||
149002401|NCT02114151|537486175|FG000|Overall Study|Withdrawal by Subject|5|||
149002402|NCT00265889|537486176|FG000|Overall Study|Physician Decision|1|||
149002403|NCT00265889|537486176|FG000|Overall Study|Protocol Violation|1|||
149002404|NCT00265889|537486176|FG000|Overall Study|Insurance denied the request|3|||
149002405|NCT02134587|537486177|FG000|Overall Study|Did not completed all meetings|30|||
149002406|NCT02778100|537486179|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
149002407|NCT02778100|537486180|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
149002408|NCT01515748|537486188|FG000|Overall Study|Withdrawal by Subject|32|||
149002409|NCT01515748|537486189|FG001|Overall Study|Withdrawal by Subject|41|||
149002410|NCT01515748|537486188|FG000|Overall Study|Lost to Follow-up|2|||
149002411|NCT01515748|537486189|FG001|Overall Study|Lost to Follow-up|4|||
149002412|NCT01515748|537486188|FG000|Overall Study|Other than specified above|5|||
149002413|NCT01515748|537486189|FG001|Overall Study|Other than specified above|10|||
149002414|NCT03221387|537486190|FG000|Overall Study|Lost to Follow-up|1|||
149002415|NCT03221387|537486190|FG000|Overall Study|Lung transplant|1|||
149002416|NCT00657618|537486191|FG000|Overall Study|Adverse Event|32|||
149002417|NCT00657618|537486191|FG000|Overall Study|Withdrawal by Subject|8|||
149002418|NCT00657618|537486191|FG000|Overall Study|negative for leishmaniasis|2|||
149002419|NCT00657618|537486191|FG000|Overall Study|didn't start due to schedule conflicts|1|||
149002420|NCT05073133|537486195|FG000|Overall Study|Death|2|||
149002421|NCT05002218|537486196|FG000|Overall Study|Lost to Follow-up|5|||
149036529|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
149002422|NCT05002218|537486197|FG001|Overall Study|Lost to Follow-up|6|||
149002423|NCT04120233|537486198|FG000|Overall Study|Adverse Event|0|||
149002424|NCT04120233|537486199|FG001|Overall Study|Adverse Event|0|||
149002425|NCT04120233|537486200|FG002|Overall Study|Adverse Event|0|||
149002426|NCT04120233|537486201|FG003|Overall Study|Adverse Event|0|||
149002427|NCT04120233|537486202|FG004|Overall Study|Adverse Event|1|||
149002428|NCT04120233|537486203|FG005|Overall Study|Adverse Event|0|||
149002429|NCT04981678|537486205|FG000|Overall Study|Lost to Follow-up|0|||
149002430|NCT04981678|537486206|FG001|Overall Study|Lost to Follow-up|1|||
149002431|NCT03421808|537486207|FG000|Overall Study|COVID related problems|2|||
149002432|NCT03421808|537486208|FG001|Overall Study|COVID related problems|0|||
149002433|NCT03421808|537486207|FG000|Overall Study|Withdrawal by Subject|1|||
149002434|NCT03421808|537486208|FG001|Overall Study|Withdrawal by Subject|0|||
149002435|NCT03421808|537486207|FG000|Overall Study|Protocol Violation|0|||
149002436|NCT03421808|537486208|FG001|Overall Study|Protocol Violation|1|||
149002437|NCT03764774|537486211|FG000|Overall Study|Withdrawal by Subject|0|||
149002438|NCT03764774|537486212|FG001|Overall Study|Withdrawal by Subject|0|||
149002439|NCT03764774|537486213|FG002|Overall Study|Withdrawal by Subject|0|||
149002440|NCT03764774|537486214|FG003|Overall Study|Withdrawal by Subject|0|||
149002441|NCT03764774|537486215|FG004|Overall Study|Withdrawal by Subject|0|||
149002442|NCT03764774|537486216|FG005|Overall Study|Withdrawal by Subject|0|||
149002443|NCT03764774|537486217|FG006|Overall Study|Withdrawal by Subject|0|||
149002444|NCT03764774|537486218|FG007|Overall Study|Withdrawal by Subject|0|||
149002445|NCT03764774|537486219|FG008|Overall Study|Withdrawal by Subject|0|||
149002446|NCT03764774|537486220|FG009|Overall Study|Withdrawal by Subject|0|||
149002447|NCT03764774|537486221|FG010|Overall Study|Withdrawal by Subject|1|||
149002448|NCT03764774|537486222|FG011|Overall Study|Withdrawal by Subject|0|||
149002449|NCT03764774|537486223|FG012|Overall Study|Withdrawal by Subject|0|||
149002450|NCT03764774|537486224|FG013|Overall Study|Withdrawal by Subject|0|||
149002451|NCT03764774|537486211|FG000|Overall Study|Adverse Event|0|||
149002452|NCT03764774|537486212|FG001|Overall Study|Adverse Event|0|||
149002453|NCT03764774|537486213|FG002|Overall Study|Adverse Event|0|||
149002454|NCT03764774|537486214|FG003|Overall Study|Adverse Event|0|||
149002455|NCT03764774|537486215|FG004|Overall Study|Adverse Event|0|||
149002456|NCT03764774|537486216|FG005|Overall Study|Adverse Event|0|||
149002457|NCT03764774|537486217|FG006|Overall Study|Adverse Event|0|||
149002458|NCT03764774|537486218|FG007|Overall Study|Adverse Event|0|||
149002459|NCT03764774|537486219|FG008|Overall Study|Adverse Event|0|||
149002460|NCT03764774|537486220|FG009|Overall Study|Adverse Event|0|||
149002461|NCT03764774|537486221|FG010|Overall Study|Adverse Event|0|||
149002462|NCT03764774|537486222|FG011|Overall Study|Adverse Event|0|||
149002463|NCT03764774|537486223|FG012|Overall Study|Adverse Event|2|||
149002464|NCT03764774|537486224|FG013|Overall Study|Adverse Event|0|||
149002465|NCT03764774|537486211|FG000|Overall Study|Lost to Follow-up|0|||
149002466|NCT03764774|537486212|FG001|Overall Study|Lost to Follow-up|0|||
149002467|NCT03764774|537486213|FG002|Overall Study|Lost to Follow-up|0|||
149002468|NCT03764774|537486214|FG003|Overall Study|Lost to Follow-up|0|||
149002469|NCT03764774|537486215|FG004|Overall Study|Lost to Follow-up|0|||
149002470|NCT03764774|537486216|FG005|Overall Study|Lost to Follow-up|0|||
149002471|NCT03764774|537486217|FG006|Overall Study|Lost to Follow-up|0|||
149002472|NCT03764774|537486218|FG007|Overall Study|Lost to Follow-up|0|||
149002473|NCT03764774|537486219|FG008|Overall Study|Lost to Follow-up|0|||
149002474|NCT03764774|537486220|FG009|Overall Study|Lost to Follow-up|0|||
149002475|NCT03764774|537486221|FG010|Overall Study|Lost to Follow-up|0|||
149002476|NCT03764774|537486222|FG011|Overall Study|Lost to Follow-up|0|||
149002477|NCT03764774|537486223|FG012|Overall Study|Lost to Follow-up|0|||
149002478|NCT03764774|537486224|FG013|Overall Study|Lost to Follow-up|1|||
149002479|NCT03764774|537486211|FG000|Overall Study|Physician Decision|0|||
149002480|NCT03764774|537486212|FG001|Overall Study|Physician Decision|0|||
149002481|NCT03764774|537486213|FG002|Overall Study|Physician Decision|0|||
149002482|NCT03764774|537486214|FG003|Overall Study|Physician Decision|0|||
149002483|NCT03764774|537486215|FG004|Overall Study|Physician Decision|0|||
149002484|NCT03764774|537486216|FG005|Overall Study|Physician Decision|0|||
149002485|NCT03764774|537486217|FG006|Overall Study|Physician Decision|0|||
149002486|NCT03764774|537486218|FG007|Overall Study|Physician Decision|0|||
149002487|NCT03764774|537486219|FG008|Overall Study|Physician Decision|0|||
149002488|NCT03764774|537486220|FG009|Overall Study|Physician Decision|4|||
149002489|NCT03764774|537486221|FG010|Overall Study|Physician Decision|1|||
149002490|NCT03764774|537486222|FG011|Overall Study|Physician Decision|4|||
149002491|NCT03764774|537486223|FG012|Overall Study|Physician Decision|9|||
149002492|NCT03764774|537486224|FG013|Overall Study|Physician Decision|0|||
149002493|NCT03764774|537486211|FG000|Overall Study|Study Termination|0|||
149036530|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
149002494|NCT03764774|537486212|FG001|Overall Study|Study Termination|0|||
149002495|NCT03764774|537486213|FG002|Overall Study|Study Termination|0|||
149002496|NCT03764774|537486214|FG003|Overall Study|Study Termination|0|||
149002497|NCT03764774|537486215|FG004|Overall Study|Study Termination|0|||
149002498|NCT03764774|537486216|FG005|Overall Study|Study Termination|0|||
149002499|NCT03764774|537486217|FG006|Overall Study|Study Termination|0|||
149002500|NCT03764774|537486218|FG007|Overall Study|Study Termination|0|||
149002501|NCT03764774|537486219|FG008|Overall Study|Study Termination|0|||
149002502|NCT03764774|537486220|FG009|Overall Study|Study Termination|1|||
149002503|NCT03764774|537486221|FG010|Overall Study|Study Termination|0|||
149002504|NCT03764774|537486222|FG011|Overall Study|Study Termination|0|||
149002505|NCT03764774|537486223|FG012|Overall Study|Study Termination|0|||
149002506|NCT03764774|537486224|FG013|Overall Study|Study Termination|2|||
149002507|NCT05809596|537486227|FG000|Overall Study|Death|16|||
149002508|NCT05809596|537486227|FG000|Overall Study|Withdrawal by Subject|4|||
149036531|NCT01087762|537612108|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
149036532|NCT01087762|537612109|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
149036533|NCT01087762|537612110|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
149036534|NCT01087762|537612111|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
149036535|NCT01087762|537612112|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
149036536|NCT00813904|537612113|FG000|Overall Study|Death|1|||
149036537|NCT01405924|537612114|FG000|Overall Study|Protocol Violation|8|||
149036538|NCT01405924|537612114|FG000|Overall Study|Missing/Incomplete Data|2|||
149036539|NCT03621761|537612116|FG000|Overall Study|Lost to Follow-up|1|||
149036540|NCT03621761|537612117|FG001|Overall Study|Lost to Follow-up|1|||
149036541|NCT03621761|537612118|FG002|Overall Study|Lost to Follow-up|2|||
149036542|NCT03621761|537612116|FG000|Overall Study|Withdrawal by Subject|2|||
149036543|NCT03621761|537612117|FG001|Overall Study|Withdrawal by Subject|1|||
149036544|NCT03621761|537612118|FG002|Overall Study|Withdrawal by Subject|1|||
149036545|NCT03621761|537612116|FG000|Overall Study|Became Ineligible|0|||
149036546|NCT03621761|537612117|FG001|Overall Study|Became Ineligible|2|||
149036547|NCT03621761|537612118|FG002|Overall Study|Became Ineligible|0|||
149036548|NCT01050569|537612119|FG000|Overall Study|Lost to Follow-up|20|||
149036549|NCT01050569|537612120|FG001|Overall Study|Lost to Follow-up|14|||
149036550|NCT01050569|537612121|FG002|Overall Study|Lost to Follow-up|16|||
149036551|NCT01050569|537612119|FG000|Overall Study|Withdrawal by Subject|9|||
149036552|NCT01050569|537612120|FG001|Overall Study|Withdrawal by Subject|3|||
149036553|NCT01050569|537612121|FG002|Overall Study|Withdrawal by Subject|11|||
149036554|NCT01050569|537612119|FG000|Overall Study|Lack of Efficacy|5|||
149036555|NCT01050569|537612120|FG001|Overall Study|Lack of Efficacy|4|||
149036556|NCT01050569|537612121|FG002|Overall Study|Lack of Efficacy|3|||
149036557|NCT01050569|537612119|FG000|Overall Study|Adverse Event|1|||
149036558|NCT01050569|537612120|FG001|Overall Study|Adverse Event|0|||
149036559|NCT01050569|537612121|FG002|Overall Study|Adverse Event|0|||
149036560|NCT01050569|537612119|FG000|Overall Study|Physician Decision|3|||
148879839|NCT01053988|537038180|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
149002509|NCT05809596|537486227|FG000|Overall Study|Physician Decision|1|||
149002510|NCT05809596|537486227|FG000|Overall Study|Missed Visit|2|||
149002511|NCT05809596|537486227|FG000|Overall Study|Other|3|||
149002512|NCT03770494|537486229|FG000|Overall Study|Lost to Follow-up|0|||
149002513|NCT03770494|537486230|FG001|Overall Study|Lost to Follow-up|0|||
149002514|NCT03770494|537486231|FG002|Overall Study|Lost to Follow-up|1|||
149002515|NCT03770494|537486232|FG003|Overall Study|Lost to Follow-up|1|||
149002516|NCT03770494|537486233|FG004|Overall Study|Lost to Follow-up|1|||
149002517|NCT03770494|537486234|FG005|Overall Study|Lost to Follow-up|0|||
149002518|NCT03770494|537486235|FG006|Overall Study|Lost to Follow-up|0|||
149002519|NCT03770494|537486236|FG007|Overall Study|Lost to Follow-up|0|||
149002520|NCT03770494|537486237|FG008|Overall Study|Lost to Follow-up|0|||
149002521|NCT03770494|537486238|FG009|Overall Study|Lost to Follow-up|0|||
149002522|NCT03770494|537486239|FG010|Overall Study|Lost to Follow-up|0|||
149002523|NCT03770494|537486240|FG011|Overall Study|Lost to Follow-up|0|||
149002524|NCT03770494|537486241|FG012|Overall Study|Lost to Follow-up|0|||
149002525|NCT03770494|537486242|FG013|Overall Study|Lost to Follow-up|0|||
149002526|NCT03770494|537486229|FG000|Overall Study|Study terminated by sponsor|1|||
149002527|NCT03770494|537486230|FG001|Overall Study|Study terminated by sponsor|2|||
149002528|NCT03770494|537486231|FG002|Overall Study|Study terminated by sponsor|1|||
149002529|NCT03770494|537486232|FG003|Overall Study|Study terminated by sponsor|1|||
149002530|NCT03770494|537486233|FG004|Overall Study|Study terminated by sponsor|1|||
149002531|NCT03770494|537486234|FG005|Overall Study|Study terminated by sponsor|2|||
149002532|NCT03770494|537486235|FG006|Overall Study|Study terminated by sponsor|1|||
149002533|NCT03770494|537486236|FG007|Overall Study|Study terminated by sponsor|2|||
149002534|NCT03770494|537486237|FG008|Overall Study|Study terminated by sponsor|1|||
148879840|NCT01053988|537038181|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148879841|NCT01053988|537038182|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148879842|NCT01053988|537038183|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
148879843|NCT01053988|537038178|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
148879844|NCT01053988|537038179|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
148879845|NCT01053988|537038180|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
148879846|NCT01053988|537038181|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
148879847|NCT01053988|537038182|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
149002535|NCT03770494|537486238|FG009|Overall Study|Study terminated by sponsor|2|||
149002536|NCT03770494|537486239|FG010|Overall Study|Study terminated by sponsor|1|||
149036561|NCT01050569|537612120|FG001|Overall Study|Physician Decision|3|||
149036562|NCT01050569|537612121|FG002|Overall Study|Physician Decision|3|||
149036563|NCT00758602|537612124|FG000|Overall Study|Adverse Event|11|||
149036564|NCT00758602|537612125|FG001|Overall Study|Adverse Event|10|||
149036565|NCT00758602|537612124|FG000|Overall Study|Lost to Follow-up|4|||
149002537|NCT03770494|537486240|FG011|Overall Study|Study terminated by sponsor|2|||
149002538|NCT03770494|537486241|FG012|Overall Study|Study terminated by sponsor|0|||
149002539|NCT03770494|537486242|FG013|Overall Study|Study terminated by sponsor|0|||
149002540|NCT03770494|537486229|FG000|Overall Study|Withdrawal by Subject|1|||
148879848|NCT01053988|537038183|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
148879849|NCT01053988|537038178|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
148879850|NCT01053988|537038179|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
148879851|NCT01053988|537038180|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
149002541|NCT03770494|537486230|FG001|Overall Study|Withdrawal by Subject|1|||
149002542|NCT03770494|537486231|FG002|Overall Study|Withdrawal by Subject|0|||
149002543|NCT03770494|537486232|FG003|Overall Study|Withdrawal by Subject|0|||
149002544|NCT03770494|537486233|FG004|Overall Study|Withdrawal by Subject|2|||
149002545|NCT03770494|537486234|FG005|Overall Study|Withdrawal by Subject|2|||
149002546|NCT03770494|537486235|FG006|Overall Study|Withdrawal by Subject|2|||
149002547|NCT03770494|537486236|FG007|Overall Study|Withdrawal by Subject|0|||
149002548|NCT03770494|537486237|FG008|Overall Study|Withdrawal by Subject|2|||
149002549|NCT03770494|537486238|FG009|Overall Study|Withdrawal by Subject|3|||
149002550|NCT03770494|537486239|FG010|Overall Study|Withdrawal by Subject|1|||
149002551|NCT03770494|537486240|FG011|Overall Study|Withdrawal by Subject|0|||
149002552|NCT03770494|537486241|FG012|Overall Study|Withdrawal by Subject|0|||
149002553|NCT03770494|537486242|FG013|Overall Study|Withdrawal by Subject|0|||
149002554|NCT01345630|537487570|FG000|Overall Study|Adverse Event|22|||
149002555|NCT01345630|537487571|FG001|Overall Study|Adverse Event|23|||
149002556|NCT01345630|537487570|FG000|Overall Study|Lost to Follow-up|17|||
149002557|NCT01345630|537487571|FG001|Overall Study|Lost to Follow-up|16|||
149002558|NCT01345630|537487570|FG000|Overall Study|Protocol Violation|4|||
149002559|NCT01345630|537487571|FG001|Overall Study|Protocol Violation|1|||
149002560|NCT01345630|537487570|FG000|Overall Study|Medication error without associated AE|0|||
149002561|NCT01345630|537487571|FG001|Overall Study|Medication error without associated AE|1|||
149002562|NCT01345630|537487570|FG000|Overall Study|Study terminated by sponsor|254|||
149002563|NCT01345630|537487571|FG001|Overall Study|Study terminated by sponsor|285|||
149002564|NCT01345630|537487570|FG000|Overall Study|Other reasons|6|||
149002565|NCT01345630|537487571|FG001|Overall Study|Other reasons|8|||
149002566|NCT01345630|537487570|FG000|Overall Study|Withdrawn due to pregnancy|1|||
149002567|NCT01345630|537487571|FG001|Overall Study|Withdrawn due to pregnancy|2|||
149002568|NCT01345630|537487570|FG000|Overall Study|No longer willing to participate|9|||
149002569|NCT01345630|537487571|FG001|Overall Study|No longer willing to participate|12|||
149002570|NCT01345630|537487570|FG000|Overall Study|Insufficient clinical response|48|||
149002571|NCT01345630|537487571|FG001|Overall Study|Insufficient clinical response|11|||
149002572|NCT01289418|537487572|FG000|Day 8 Survey|email address invalid|283|||
149002573|NCT01289418|537487572|FG000|Day 8 Survey|participants did not complete the survey|1935|||
149002574|NCT01289418|537487572|FG000|Day 29 Survey|email address invalid|283|||
149002575|NCT01289418|537487572|FG000|Day 29 Survey|participants did not complete the survey|2185|||
149002576|NCT01352585|537487574|FG000|Overall Study|Adverse Event|2|||
149002577|NCT01352585|537487575|FG001|Overall Study|Adverse Event|1|||
149002578|NCT01352585|537487574|FG000|Overall Study|Lost to Follow-up|1|||
149002579|NCT01352585|537487575|FG001|Overall Study|Lost to Follow-up|0|||
149002580|NCT01352585|537487574|FG000|Overall Study|Other|5|||
149002581|NCT01352585|537487575|FG001|Overall Study|Other|2|||
149002582|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
149002583|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
149002584|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
149002585|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
149002586|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
149002587|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
149002588|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
149002589|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
149002590|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
149002591|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
149002592|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
149002593|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
149002594|NCT01493687|537487581|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
149002595|NCT01493687|537487582|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
149002596|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
149002597|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
149002598|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
149002599|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
149002600|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
149002601|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
149002602|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
149002603|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
149002604|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
149002605|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
149002606|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
148879852|NCT01053988|537038181|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
149036566|NCT00758602|537612125|FG001|Overall Study|Lost to Follow-up|3|||
149036567|NCT00758602|537612124|FG000|Overall Study|Withdrawal by Subject|1|||
149036568|NCT00758602|537612125|FG001|Overall Study|Withdrawal by Subject|3|||
149036569|NCT00758602|537612124|FG000|Overall Study|Protocol Violation|0|||
149036570|NCT00758602|537612125|FG001|Overall Study|Protocol Violation|2|||
149036571|NCT00758602|537612124|FG000|Overall Study|Death|0|||
149036572|NCT00758602|537612125|FG001|Overall Study|Death|1|||
149036573|NCT00758602|537612124|FG000|Overall Study|Reason not specified|3|||
149036574|NCT00758602|537612125|FG001|Overall Study|Reason not specified|3|||
149036575|NCT05046132|537612126|FG000|Overall Study|Adverse Event|4|||
149036576|NCT05046132|537612127|FG001|Overall Study|Adverse Event|0|||
149036577|NCT05046132|537612128|FG002|Overall Study|Adverse Event|0|||
149036578|NCT05046132|537612126|FG000|Overall Study|Withdrawal by Subject|3|||
149036579|NCT05046132|537612127|FG001|Overall Study|Withdrawal by Subject|0|||
149036580|NCT05046132|537612128|FG002|Overall Study|Withdrawal by Subject|0|||
149036581|NCT05046132|537612126|FG000|Overall Study|Positive Covid19 Result.|0|||
149036582|NCT05046132|537612127|FG001|Overall Study|Positive Covid19 Result.|1|||
149036583|NCT05046132|537612128|FG002|Overall Study|Positive Covid19 Result.|0|||
149036584|NCT03987451|537612129|FG000|Overall Study|Lost to Follow-up|1|||
149036585|NCT03987451|537612130|FG001|Overall Study|Lost to Follow-up|0|||
149036586|NCT03987451|537612129|FG000|Overall Study|Withdrawal by Subject|1|||
149036587|NCT03987451|537612130|FG001|Overall Study|Withdrawal by Subject|1|||
149036588|NCT00612586|537612131|FG000|Overall Study|Adverse Event|6|||
149036589|NCT00612586|537612132|FG001|Overall Study|Adverse Event|2|||
149036590|NCT00612586|537612131|FG000|Overall Study|Death|1|||
149036591|NCT00612586|537612132|FG001|Overall Study|Death|0|||
149036592|NCT00612586|537612131|FG000|Overall Study|Entry Criteria Not Met|0|||
149036593|NCT00612586|537612132|FG001|Overall Study|Entry Criteria Not Met|2|||
149036594|NCT00612586|537612131|FG000|Overall Study|Withdrawal by Subject|7|||
149036595|NCT00612586|537612132|FG001|Overall Study|Withdrawal by Subject|9|||
149036596|NCT00612586|537612131|FG000|Overall Study|Physician Decision|1|||
149036597|NCT00612586|537612132|FG001|Overall Study|Physician Decision|2|||
149036598|NCT00612586|537612131|FG000|Overall Study|Sponsor Decision|1|||
149036599|NCT00612586|537612132|FG001|Overall Study|Sponsor Decision|1|||
149036600|NCT00612586|537612131|FG000|Overall Study|Progressive Disease|26|||
149036601|NCT00612586|537612132|FG001|Overall Study|Progressive Disease|24|||
149036602|NCT00612586|537612131|FG000|Overall Study|Randomized and Not Treated|1|||
149036603|NCT00612586|537612132|FG001|Overall Study|Randomized and Not Treated|1|||
149036604|NCT00395018|537612133|FG000|On-Treatment|Death|4|||
149036605|NCT00395018|537612133|FG000|On-Treatment|Other Reason|2|||
149036606|NCT00395018|537612133|FG000|On-Treatment|Poor/non-compliance|2|||
149036607|NCT00395018|537612133|FG000|On-Treatment|Subject no longer meets study criteria|2|||
149036608|NCT00395018|537612133|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
149036609|NCT00395018|537612133|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
149036610|NCT00395018|537612133|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
149036611|NCT00530842|537612134|FG000|Overall Study|Adverse Event|10|||
149036612|NCT00530842|537612135|FG001|Overall Study|Adverse Event|6|||
149036613|NCT00530842|537612134|FG000|Overall Study|Lack of Efficacy|2|||
149036614|NCT00530842|537612135|FG001|Overall Study|Lack of Efficacy|1|||
149036615|NCT00530842|537612134|FG000|Overall Study|Lost to Follow-up|0|||
149036616|NCT00530842|537612135|FG001|Overall Study|Lost to Follow-up|4|||
149036617|NCT00530842|537612134|FG000|Overall Study|Protocol Violation|3|||
149036618|NCT00530842|537612135|FG001|Overall Study|Protocol Violation|2|||
149036619|NCT00530842|537612134|FG000|Overall Study|Withdrawal by Subject|4|||
149036620|NCT00530842|537612135|FG001|Overall Study|Withdrawal by Subject|5|||
149036621|NCT00530842|537612134|FG000|Overall Study|Individual different reasons|4|||
149036622|NCT00530842|537612135|FG001|Overall Study|Individual different reasons|3|||
149036623|NCT00530842|537612134|FG000|Period 1|Adverse Event|7|||
149036624|NCT00530842|537612135|FG001|Period 1|Adverse Event|3|||
149036625|NCT00530842|537612134|FG000|Period 1|Lack of Efficacy|1|||
149036626|NCT00530842|537612135|FG001|Period 1|Lack of Efficacy|1|||
149036627|NCT00530842|537612134|FG000|Period 1|Protocol Violation|2|||
149036628|NCT00530842|537612135|FG001|Period 1|Protocol Violation|1|||
149036629|NCT00530842|537612134|FG000|Period 1|Withdrawal by Subject|2|||
149036630|NCT00530842|537612135|FG001|Period 1|Withdrawal by Subject|3|||
149036631|NCT00530842|537612134|FG000|Period 1|Individual different reasons|2|||
149036632|NCT00530842|537612135|FG001|Period 1|Individual different reasons|3|||
149036633|NCT00530842|537612134|FG000|Period 2|Adverse Event|3|||
149036634|NCT00530842|537612135|FG001|Period 2|Adverse Event|3|||
149036635|NCT00530842|537612134|FG000|Period 2|Lack of Efficacy|1|||
149036636|NCT00530842|537612135|FG001|Period 2|Lack of Efficacy|0|||
149036637|NCT00530842|537612134|FG000|Period 2|Lost to Follow-up|0|||
149036638|NCT00530842|537612135|FG001|Period 2|Lost to Follow-up|4|||
149036639|NCT00530842|537612134|FG000|Period 2|Protocol Violation|1|||
149036640|NCT00530842|537612135|FG001|Period 2|Protocol Violation|0|||
149036641|NCT00530842|537612134|FG000|Period 2|Withdrawal by Subject|1|||
149036642|NCT00530842|537612135|FG001|Period 2|Withdrawal by Subject|2|||
149036643|NCT00530842|537612134|FG000|Period 2|Individual different reasons|2|||
149036644|NCT00530842|537612135|FG001|Period 2|Individual different reasons|0|||
149002607|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
149002608|NCT01493687|537487581|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
149002609|NCT01493687|537487582|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
149002610|NCT01493687|537487581|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
149002611|NCT01493687|537487582|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
149002612|NCT02323646|537487586|FG000|Treatment Course 1|Adverse Event|1|||
149002613|NCT02323646|537487587|FG001|Treatment Course 1|Adverse Event|0|||
149002614|NCT02323646|537487588|FG002|Treatment Course 1|Adverse Event|1|||
149002615|NCT02323646|537487586|FG000|Treatment Course 1|Heavy Bleeding|1|||
149002616|NCT02323646|537487587|FG001|Treatment Course 1|Heavy Bleeding|1|||
149002617|NCT02323646|537487588|FG002|Treatment Course 1|Heavy Bleeding|0|||
149002618|NCT02323646|537487586|FG000|Treatment Course 1|Lost to Follow-up|1|||
149002619|NCT02323646|537487587|FG001|Treatment Course 1|Lost to Follow-up|0|||
149002620|NCT02323646|537487588|FG002|Treatment Course 1|Lost to Follow-up|2|||
149002621|NCT02323646|537487586|FG000|Treatment Course 1|Withdrawal by Subject|0|||
149002622|NCT02323646|537487587|FG001|Treatment Course 1|Withdrawal by Subject|2|||
149002623|NCT02323646|537487588|FG002|Treatment Course 1|Withdrawal by Subject|0|||
149002624|NCT02323646|537487586|FG000|Treatment Course 2|Adverse Event|1|||
149002625|NCT02323646|537487587|FG001|Treatment Course 2|Adverse Event|0|||
149002626|NCT02323646|537487588|FG002|Treatment Course 2|Adverse Event|1|||
149002627|NCT02323646|537487586|FG000|Treatment Course 2|Lost to Follow-up|0|||
149002628|NCT02323646|537487587|FG001|Treatment Course 2|Lost to Follow-up|0|||
149002629|NCT02323646|537487588|FG002|Treatment Course 2|Lost to Follow-up|1|||
149002630|NCT02323646|537487586|FG000|Treatment Course 2|Non-compliance|0|||
149002631|NCT02323646|537487587|FG001|Treatment Course 2|Non-compliance|1|||
149002632|NCT02323646|537487588|FG002|Treatment Course 2|Non-compliance|1|||
149002633|NCT00521144|537487589|FG000|Overall Study|Not Treated|0|||
149002634|NCT00521144|537487590|FG001|Overall Study|Not Treated|0|||
149002635|NCT00521144|537487591|FG002|Overall Study|Not Treated|0|||
149002636|NCT00521144|537487592|FG003|Overall Study|Not Treated|1|||
149002637|NCT00521144|537487593|FG004|Overall Study|Not Treated|0|||
149002638|NCT00521144|537487589|FG000|Overall Study|Adverse Event|0|||
149002639|NCT00521144|537487590|FG001|Overall Study|Adverse Event|1|||
149002640|NCT00521144|537487591|FG002|Overall Study|Adverse Event|0|||
149002641|NCT00521144|537487592|FG003|Overall Study|Adverse Event|0|||
149002642|NCT00521144|537487593|FG004|Overall Study|Adverse Event|1|||
149002643|NCT00521144|537487589|FG000|Overall Study|Progressive Disease|4|||
149002644|NCT00521144|537487590|FG001|Overall Study|Progressive Disease|2|||
149002645|NCT00521144|537487591|FG002|Overall Study|Progressive Disease|2|||
149002646|NCT00521144|537487592|FG003|Overall Study|Progressive Disease|0|||
149002647|NCT00521144|537487593|FG004|Overall Study|Progressive Disease|6|||
149002648|NCT01370525|537487594|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
149002649|NCT01370525|537487595|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
149002650|NCT01370525|537487594|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
149002651|NCT01370525|537487595|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
149002652|NCT01370525|537487594|FG000|Overall Study|Adverse Event|0|||
149002653|NCT01370525|537487595|FG001|Overall Study|Adverse Event|1|||
149002654|NCT01370525|537487594|FG000|Overall Study|Protocol Violation|2|||
149002655|NCT01370525|537487595|FG001|Overall Study|Protocol Violation|1|||
149002656|NCT01370525|537487594|FG000|Overall Study|Lost to follow up|2|||
149002657|NCT01370525|537487595|FG001|Overall Study|Lost to follow up|6|||
149002658|NCT04791761|537487596|FG000|Overall Study|Lost to Follow-up|8|||
149002659|NCT04791761|537487597|FG001|Overall Study|Lost to Follow-up|6|||
149002660|NCT04791761|537487598|FG002|Overall Study|Lost to Follow-up|10|||
149002661|NCT04791761|537487596|FG000|Overall Study|Withdrawal by Subject|0|||
149002662|NCT04791761|537487597|FG001|Overall Study|Withdrawal by Subject|1|||
149002663|NCT04791761|537487598|FG002|Overall Study|Withdrawal by Subject|1|||
149002664|NCT04791761|537487596|FG000|Overall Study|Protocol Violation|0|||
149002665|NCT04791761|537487597|FG001|Overall Study|Protocol Violation|1|||
149002666|NCT04791761|537487598|FG002|Overall Study|Protocol Violation|1|||
149002667|NCT00180479|537487601|FG000|Overall Study|Death|4|||
149002668|NCT00180479|537487602|FG001|Overall Study|Death|2|||
149002669|NCT00180479|537487601|FG000|Overall Study|Lost to Follow-up|9|||
149002670|NCT00180479|537487602|FG001|Overall Study|Lost to Follow-up|7|||
149002671|NCT00180479|537487601|FG000|Overall Study|Withdrawal by Subject|3|||
149002672|NCT00180479|537487602|FG001|Overall Study|Withdrawal by Subject|3|||
149002673|NCT00180479|537487601|FG000|Overall Study|Informed consent not signed|0|||
149002674|NCT00180479|537487602|FG001|Overall Study|Informed consent not signed|1|||
149002675|NCT05168579|537487603|FG000|Overall Study|Lack of Consent|1|||
149002676|NCT05168579|537487604|FG001|Overall Study|Lack of Consent|0|||
149002677|NCT05168579|537487603|FG000|Overall Study|Conflicts with time|2|||
149002678|NCT05168579|537487604|FG001|Overall Study|Conflicts with time|0|||
149002679|NCT05168579|537487603|FG000|Overall Study|Time slots were full|3|||
149002680|NCT05168579|537487604|FG001|Overall Study|Time slots were full|0|||
149002681|NCT05168579|537487603|FG000|Overall Study|Lost to Follow-up|0|||
149002682|NCT05168579|537487604|FG001|Overall Study|Lost to Follow-up|15|||
149002683|NCT00105235|537487605|FG000|Overall Study|Death|4|||
149002684|NCT00105235|537487605|FG000|Overall Study|Physician Decision|1|||
149036645|NCT03478696|537612151|FG000|Overall Study|Adverse Event|1|||
149036646|NCT03478696|537612152|FG001|Overall Study|Adverse Event|5|||
149036647|NCT03478696|537612151|FG000|Overall Study|Lost to Follow-up|1|||
149036648|NCT03478696|537612152|FG001|Overall Study|Lost to Follow-up|0|||
149036649|NCT03478696|537612151|FG000|Overall Study|Physician Decision|6|||
149036650|NCT03478696|537612152|FG001|Overall Study|Physician Decision|3|||
149036651|NCT03478696|537612151|FG000|Overall Study|Withdrawal by Subject|9|||
149036652|NCT03478696|537612152|FG001|Overall Study|Withdrawal by Subject|4|||
149036653|NCT03257813|537612153|FG000|Overall Study|Protocol Violation|6|||
149036654|NCT03257813|537612154|FG001|Overall Study|Protocol Violation|3|||
149036655|NCT03615924|537612155|FG000|Overall Study|Withdrawal by Subject|2|||
149036656|NCT03615924|537612156|FG001|Overall Study|Withdrawal by Subject|5|||
149036657|NCT03615924|537612155|FG000|Overall Study|Death|3|||
149036658|NCT03615924|537612156|FG001|Overall Study|Death|1|||
149036659|NCT03615924|537612155|FG000|Overall Study|Lost to Follow-up|1|||
149036660|NCT03615924|537612156|FG001|Overall Study|Lost to Follow-up|0|||
149036661|NCT03615924|537612155|FG000|Overall Study|Randomized in error|1|||
149036662|NCT03615924|537612156|FG001|Overall Study|Randomized in error|0|||
149036663|NCT03615924|537612155|FG000|Overall Study|Study termination by Sponsor|94|||
149036664|NCT03615924|537612156|FG001|Overall Study|Study termination by Sponsor|86|||
149036665|NCT00716144|537612157|FG000|Overall Study|Withdrawal by Subject|4|||
149036666|NCT00716144|537612158|FG001|Overall Study|Withdrawal by Subject|2|||
149036667|NCT00716144|537612159|FG002|Overall Study|Withdrawal by Subject|6|||
149036668|NCT00716144|537612160|FG003|Overall Study|Withdrawal by Subject|6|||
149036669|NCT00716144|537612157|FG000|Overall Study|Lost to Follow-up|2|||
149036670|NCT00716144|537612158|FG001|Overall Study|Lost to Follow-up|2|||
149036671|NCT00716144|537612159|FG002|Overall Study|Lost to Follow-up|1|||
149036672|NCT00716144|537612160|FG003|Overall Study|Lost to Follow-up|2|||
149036673|NCT00716144|537612157|FG000|Overall Study|Adverse Event|0|||
149036674|NCT00716144|537612158|FG001|Overall Study|Adverse Event|0|||
149036675|NCT00716144|537612159|FG002|Overall Study|Adverse Event|0|||
149036676|NCT00716144|537612160|FG003|Overall Study|Adverse Event|2|||
149036677|NCT00716144|537612157|FG000|Overall Study|Non-compliance|1|||
149036678|NCT00716144|537612158|FG001|Overall Study|Non-compliance|0|||
149036679|NCT00716144|537612159|FG002|Overall Study|Non-compliance|0|||
149036680|NCT00716144|537612160|FG003|Overall Study|Non-compliance|0|||
149036681|NCT00716144|537612157|FG000|Overall Study|Protocol Violation|2|||
149036682|NCT00716144|537612158|FG001|Overall Study|Protocol Violation|0|||
149036683|NCT00716144|537612159|FG002|Overall Study|Protocol Violation|1|||
149036684|NCT00716144|537612160|FG003|Overall Study|Protocol Violation|0|||
149036685|NCT00716144|537612157|FG000|Overall Study|Physician Decision|0|||
149036686|NCT00716144|537612158|FG001|Overall Study|Physician Decision|1|||
149036687|NCT00716144|537612159|FG002|Overall Study|Physician Decision|2|||
149036688|NCT00716144|537612160|FG003|Overall Study|Physician Decision|2|||
149036689|NCT00716144|537612157|FG000|Overall Study|Intercurrent illness|0|||
149036690|NCT00716144|537612158|FG001|Overall Study|Intercurrent illness|0|||
149036691|NCT00716144|537612159|FG002|Overall Study|Intercurrent illness|1|||
149036692|NCT00716144|537612160|FG003|Overall Study|Intercurrent illness|0|||
149036693|NCT00716144|537612157|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
149036694|NCT00716144|537612158|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
149036695|NCT00716144|537612159|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
149036696|NCT00716144|537612160|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
149036697|NCT00716144|537612157|FG000|Overall Study|Adverse event: left foot pain|0|||
149036698|NCT00716144|537612158|FG001|Overall Study|Adverse event: left foot pain|1|||
149036699|NCT00716144|537612159|FG002|Overall Study|Adverse event: left foot pain|0|||
149036700|NCT00716144|537612160|FG003|Overall Study|Adverse event: left foot pain|0|||
149036701|NCT00716144|537612157|FG000|Overall Study|Clinical Depression|0|||
149036702|NCT00716144|537612158|FG001|Overall Study|Clinical Depression|1|||
149036703|NCT00716144|537612159|FG002|Overall Study|Clinical Depression|0|||
149036704|NCT00716144|537612160|FG003|Overall Study|Clinical Depression|0|||
149036705|NCT00880048|537612161|FG000|Overall Study|Adverse Event|2|||
149036706|NCT00880048|537612162|FG001|Overall Study|Adverse Event|3|||
149036707|NCT00880048|537612163|FG002|Overall Study|Adverse Event|5|||
149036708|NCT00880048|537612161|FG000|Overall Study|Lack of Efficacy|1|||
149036709|NCT00880048|537612162|FG001|Overall Study|Lack of Efficacy|2|||
149036710|NCT00880048|537612163|FG002|Overall Study|Lack of Efficacy|2|||
149036711|NCT00880048|537612161|FG000|Overall Study|Protocol Violation|4|||
149036712|NCT00880048|537612162|FG001|Overall Study|Protocol Violation|6|||
149036713|NCT00880048|537612163|FG002|Overall Study|Protocol Violation|5|||
149036714|NCT00880048|537612161|FG000|Overall Study|Lost to Follow-up|6|||
149036715|NCT00880048|537612162|FG001|Overall Study|Lost to Follow-up|6|||
149036716|NCT00880048|537612163|FG002|Overall Study|Lost to Follow-up|5|||
149036717|NCT00880048|537612161|FG000|Overall Study|Physician Decision|1|||
149036718|NCT00880048|537612162|FG001|Overall Study|Physician Decision|1|||
149036719|NCT00880048|537612163|FG002|Overall Study|Physician Decision|7|||
149036720|NCT00880048|537612161|FG000|Overall Study|Withdrawal by Subject|5|||
149036721|NCT00880048|537612162|FG001|Overall Study|Withdrawal by Subject|8|||
149036722|NCT00880048|537612163|FG002|Overall Study|Withdrawal by Subject|5|||
149036723|NCT00880048|537612161|FG000|Overall Study|Study closed/terminated|9|||
149036724|NCT00880048|537612162|FG001|Overall Study|Study closed/terminated|7|||
149036725|NCT00880048|537612163|FG002|Overall Study|Study closed/terminated|6|||
149036726|NCT01069341|537612164|FG000|Overall Study|Lost to Follow-up|1|||
149036727|NCT02950558|537612166|FG000|Overall Study|Lost to Follow-up|2|||
149036728|NCT02950558|537612167|FG001|Overall Study|Lost to Follow-up|0|||
149036729|NCT00290706|537612171|FG000|Overall Study|Withdrawal by Subject|2|||
149036730|NCT00290706|537612172|FG001|Overall Study|Withdrawal by Subject|0|||
149036731|NCT00290706|537612173|FG002|Overall Study|Withdrawal by Subject|0|||
149036732|NCT00290706|537612174|FG003|Overall Study|Withdrawal by Subject|0|||
149036733|NCT00290706|537612171|FG000|Overall Study|Progressive Disease|3|||
149036734|NCT00290706|537612172|FG001|Overall Study|Progressive Disease|5|||
149036735|NCT00290706|537612173|FG002|Overall Study|Progressive Disease|4|||
149036736|NCT00290706|537612174|FG003|Overall Study|Progressive Disease|10|||
149036737|NCT00290706|537612171|FG000|Overall Study|Adverse Event|0|||
149036738|NCT00290706|537612172|FG001|Overall Study|Adverse Event|1|||
149036739|NCT00290706|537612173|FG002|Overall Study|Adverse Event|2|||
149036740|NCT00290706|537612174|FG003|Overall Study|Adverse Event|0|||
149036741|NCT00290706|537612171|FG000|Overall Study|Receive auto transplant or radiation|0|||
149036742|NCT00290706|537612172|FG001|Overall Study|Receive auto transplant or radiation|0|||
149036743|NCT00290706|537612173|FG002|Overall Study|Receive auto transplant or radiation|0|||
149036744|NCT00290706|537612174|FG003|Overall Study|Receive auto transplant or radiation|1|||
149036745|NCT00290706|537612171|FG000|Overall Study|Physician Decision|0|||
149036746|NCT00290706|537612172|FG001|Overall Study|Physician Decision|0|||
149036747|NCT00290706|537612173|FG002|Overall Study|Physician Decision|0|||
149036748|NCT00290706|537612174|FG003|Overall Study|Physician Decision|1|||
149036749|NCT02754479|537612176|FG000|Overall Study|Lost to Follow-up|1|||
149036750|NCT05328297|537614275|FG000|Overall Study|Adverse Event|5|||
149036751|NCT05328297|537614276|FG001|Overall Study|Adverse Event|7|||
148879853|NCT01053988|537038182|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
148879854|NCT01053988|537038183|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
149002685|NCT00105235|537487605|FG000|Overall Study|Withdrawal by Subject|2|||
149002686|NCT00508404|537487610|FG000|Overall Study|Ongoing at Data Cut-off|12|||
149002687|NCT00508404|537487610|FG000|Overall Study|Adverse Event|2|||
149002688|NCT00508404|537487610|FG000|Overall Study|Death|16|||
149002689|NCT00508404|537487610|FG000|Overall Study|Physician Decision|2|||
149002690|NCT00508404|537487610|FG000|Overall Study|Withdrawal by Subject|3|||
149002691|NCT00508404|537487610|FG000|Overall Study|Protocol-specified Criteria|2|||
149002692|NCT00508404|537487610|FG000|Overall Study|Lost to Follow-up|2|||
149002693|NCT00508404|537487610|FG000|Overall Study|Other - Not Specified|3|||
149002694|NCT01424930|537487611|FG000|Overall Study|Adverse Event|0|||
149002695|NCT01424930|537487612|FG001|Overall Study|Adverse Event|1|||
149002696|NCT01424930|537487611|FG000|Overall Study|Death|1|||
149002697|NCT01424930|537487612|FG001|Overall Study|Death|0|||
149002698|NCT01424930|537487611|FG000|Overall Study|Progressive Disease|3|||
149002699|NCT01424930|537487612|FG001|Overall Study|Progressive Disease|6|||
149002700|NCT01424930|537487611|FG000|Overall Study|Screen Failure|0|||
149002701|NCT01424930|537487612|FG001|Overall Study|Screen Failure|1|||
149002702|NCT01424930|537487611|FG000|Overall Study|Reason not specified|0|||
149002703|NCT01424930|537487612|FG001|Overall Study|Reason not specified|6|||
149002704|NCT01197508|537487615|FG000|Overall Study|Withdrawal by Subject|8|||
149002705|NCT01197508|537487616|FG001|Overall Study|Withdrawal by Subject|7|||
149002706|NCT01197508|537487617|FG002|Overall Study|Withdrawal by Subject|15|||
149002707|NCT01197508|537487618|FG003|Overall Study|Withdrawal by Subject|4|||
149002708|NCT01197508|537487615|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
149002709|NCT01197508|537487616|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
149002710|NCT01197508|537487617|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
149002711|NCT01197508|537487618|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
149002712|NCT01197508|537487615|FG000|Overall Study|Adverse Event|10|||
149002713|NCT01197508|537487616|FG001|Overall Study|Adverse Event|13|||
149002714|NCT01197508|537487617|FG002|Overall Study|Adverse Event|23|||
149002715|NCT01197508|537487618|FG003|Overall Study|Adverse Event|3|||
149002716|NCT01197508|537487615|FG000|Overall Study|Severe non-compliance to protocol|0|||
149002717|NCT01197508|537487616|FG001|Overall Study|Severe non-compliance to protocol|3|||
149002718|NCT01197508|537487617|FG002|Overall Study|Severe non-compliance to protocol|1|||
149002719|NCT01197508|537487618|FG003|Overall Study|Severe non-compliance to protocol|3|||
149002720|NCT01197508|537487615|FG000|Overall Study|Condition under investigation worsened|1|||
149002721|NCT01197508|537487616|FG001|Overall Study|Condition under investigation worsened|1|||
149002722|NCT01197508|537487617|FG002|Overall Study|Condition under investigation worsened|1|||
149036752|NCT05328297|537614275|FG000|Overall Study|Withdrawal by Subject|4|||
149036753|NCT05328297|537614276|FG001|Overall Study|Withdrawal by Subject|3|||
149036754|NCT05328297|537614275|FG000|Overall Study|Lack of Efficacy|1|||
149036755|NCT05328297|537614276|FG001|Overall Study|Lack of Efficacy|0|||
149036756|NCT05328297|537614275|FG000|Overall Study|Lost to Follow-up|1|||
149036757|NCT05328297|537614276|FG001|Overall Study|Lost to Follow-up|0|||
149036758|NCT05328297|537614275|FG000|Overall Study|Protocol Violation|1|||
149036759|NCT05328297|537614276|FG001|Overall Study|Protocol Violation|0|||
149036760|NCT05328297|537614275|FG000|Overall Study|Randomized but not treated|1|||
149036761|NCT05328297|537614276|FG001|Overall Study|Randomized but not treated|1|||
149036762|NCT04513522|537614277|FG000|Overall Study|Other reasons|1|||
149036763|NCT04513522|537614277|FG000|Overall Study|Adverse event unrelated to study drug|9|||
149036764|NCT04513522|537614277|FG000|Overall Study|Study drug toxicity|14|||
149036765|NCT04513522|537614277|FG000|Overall Study|Disease progression|39|||
149036766|NCT04513522|537614277|FG000|Overall Study|Participants withdrew consent|2|||
149036767|NCT04722003|537614280|FG000|Overall Study|Lost to Follow-up|2|||
149036768|NCT04722003|537614281|FG001|Overall Study|Lost to Follow-up|0|||
149036769|NCT04722003|537614280|FG000|Overall Study|Physician Decision|1|||
149036770|NCT04722003|537614281|FG001|Overall Study|Physician Decision|0|||
149036771|NCT03351075|537614282|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
149036772|NCT03351075|537614283|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
149036773|NCT03351075|537614282|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
149036774|NCT03351075|537614283|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
149036775|NCT03351075|537614282|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
149036776|NCT03351075|537614283|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
149036777|NCT03351075|537614282|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
149036778|NCT03351075|537614283|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
149036779|NCT05219253|537614293|FG000|Overall Study|Withdrawal by Subject|1|||
149036780|NCT05219253|537614294|FG001|Overall Study|Withdrawal by Subject|2|||
149036781|NCT03086369|537614295|FG000|Overall Study|Lost to Follow-up|1|||
149036782|NCT03086369|537614296|FG001|Overall Study|Lost to Follow-up|0|||
149036783|NCT03086369|537614297|FG002|Overall Study|Lost to Follow-up|0|||
149036784|NCT03086369|537614298|FG003|Overall Study|Lost to Follow-up|2|||
149036785|NCT03086369|537614299|FG004|Overall Study|Lost to Follow-up|1|||
149036786|NCT03086369|537614295|FG000|Overall Study|Physician Decision|0|||
149036787|NCT03086369|537614296|FG001|Overall Study|Physician Decision|0|||
149036788|NCT03086369|537614297|FG002|Overall Study|Physician Decision|0|||
149036789|NCT03086369|537614298|FG003|Overall Study|Physician Decision|1|||
149036790|NCT03086369|537614299|FG004|Overall Study|Physician Decision|2|||
149036791|NCT03086369|537614295|FG000|Overall Study|Withdrawal by Subject|0|||
149036792|NCT03086369|537614296|FG001|Overall Study|Withdrawal by Subject|0|||
149036793|NCT03086369|537614297|FG002|Overall Study|Withdrawal by Subject|0|||
149036794|NCT03086369|537614298|FG003|Overall Study|Withdrawal by Subject|5|||
149036795|NCT03086369|537614299|FG004|Overall Study|Withdrawal by Subject|3|||
149036796|NCT03086369|537614295|FG000|Overall Study|Progressive Disease|0|||
149002723|NCT01197508|537487618|FG003|Overall Study|Condition under investigation worsened|1|||
149002724|NCT01197508|537487615|FG000|Overall Study|Lack of Efficacy|1|||
149002725|NCT01197508|537487616|FG001|Overall Study|Lack of Efficacy|2|||
149002726|NCT01197508|537487617|FG002|Overall Study|Lack of Efficacy|2|||
149002727|NCT01197508|537487618|FG003|Overall Study|Lack of Efficacy|1|||
149002728|NCT01197508|537487615|FG000|Overall Study|Study-specific withdrawal criteria|0|||
149002729|NCT01197508|537487616|FG001|Overall Study|Study-specific withdrawal criteria|0|||
149002730|NCT01197508|537487617|FG002|Overall Study|Study-specific withdrawal criteria|1|||
149002731|NCT01197508|537487618|FG003|Overall Study|Study-specific withdrawal criteria|2|||
149002732|NCT01197508|537487615|FG000|Overall Study|Lost to Follow-up|1|||
149002733|NCT01197508|537487616|FG001|Overall Study|Lost to Follow-up|1|||
149002734|NCT01197508|537487617|FG002|Overall Study|Lost to Follow-up|2|||
149002735|NCT01197508|537487618|FG003|Overall Study|Lost to Follow-up|0|||
149002736|NCT01197508|537487615|FG000|Overall Study|Other|2|||
149002737|NCT01197508|537487616|FG001|Overall Study|Other|3|||
149002738|NCT01197508|537487617|FG002|Overall Study|Other|2|||
149002739|NCT01197508|537487618|FG003|Overall Study|Other|2|||
149002740|NCT03286751|537487619|FG000|Washout Period 1|Withdrawal by Subject|0|||
149002741|NCT03286751|537487620|FG001|Washout Period 1|Withdrawal by Subject|0|||
149002742|NCT03286751|537487621|FG002|Washout Period 1|Withdrawal by Subject|0|||
149002743|NCT03286751|537487622|FG003|Washout Period 1|Withdrawal by Subject|0|||
149002744|NCT03286751|537487623|FG004|Washout Period 1|Withdrawal by Subject|1|||
149002745|NCT03286751|537487624|FG005|Washout Period 1|Withdrawal by Subject|0|||
149002746|NCT03286751|537487619|FG000|Washout Period 2|Personal Reasons|0|||
149036797|NCT03086369|537614296|FG001|Overall Study|Progressive Disease|0|||
149036798|NCT03086369|537614297|FG002|Overall Study|Progressive Disease|0|||
149036799|NCT03086369|537614298|FG003|Overall Study|Progressive Disease|1|||
149036800|NCT03086369|537614299|FG004|Overall Study|Progressive Disease|1|||
149036801|NCT03175172|537614300|FG000|Overall Study|Death|3|||
149036802|NCT03175172|537614300|FG000|Overall Study|Withdrawal by Subject|3|||
149036803|NCT03175172|537614300|FG000|Overall Study|Lost to Follow-up|1|||
149036804|NCT03175172|537614300|FG000|Overall Study|Study Terminated by Sponsor|3|||
149036805|NCT02974634|537614301|FG000|Overall Study|Advanced disease|12|||
149036806|NCT02974634|537614302|FG001|Overall Study|Advanced disease|3|||
149002747|NCT03286751|537487620|FG001|Washout Period 2|Personal Reasons|1|||
149002748|NCT03286751|537487621|FG002|Washout Period 2|Personal Reasons|0|||
149002749|NCT03286751|537487622|FG003|Washout Period 2|Personal Reasons|0|||
149002750|NCT03286751|537487623|FG004|Washout Period 2|Personal Reasons|0|||
149002751|NCT03286751|537487624|FG005|Washout Period 2|Personal Reasons|0|||
149036807|NCT02974634|537614301|FG000|Overall Study|Noncompliance|3|||
149036808|NCT02974634|537614302|FG001|Overall Study|Noncompliance|7|||
149036809|NCT02974634|537614301|FG000|Overall Study|intervention technology related issues|5|||
149036810|NCT02974634|537614302|FG001|Overall Study|intervention technology related issues|0|||
149036811|NCT02974634|537614301|FG000|Overall Study|Death|8|||
149036812|NCT02974634|537614302|FG001|Overall Study|Death|11|||
149036813|NCT04668339|537614305|FG000|Overall Study|Physician Decision|1|||
149036814|NCT04668339|537614306|FG001|Overall Study|Physician Decision|0|||
149036815|NCT04668339|537614307|FG002|Overall Study|Physician Decision|1|||
149036816|NCT04668339|537614308|FG003|Overall Study|Physician Decision|1|||
149036817|NCT04668339|537614305|FG000|Overall Study|Lost to Follow-up|14|||
149036818|NCT04668339|537614306|FG001|Overall Study|Lost to Follow-up|12|||
149036819|NCT04668339|537614307|FG002|Overall Study|Lost to Follow-up|8|||
149036820|NCT04668339|537614308|FG003|Overall Study|Lost to Follow-up|5|||
149036821|NCT04668339|537614305|FG000|Overall Study|Adverse Event|0|||
149036822|NCT04668339|537614306|FG001|Overall Study|Adverse Event|0|||
149036823|NCT04668339|537614307|FG002|Overall Study|Adverse Event|1|||
149036824|NCT04668339|537614308|FG003|Overall Study|Adverse Event|0|||
149036825|NCT04668339|537614305|FG000|Overall Study|Other than specified|3|||
149036826|NCT04668339|537614306|FG001|Overall Study|Other than specified|0|||
149036827|NCT04668339|537614307|FG002|Overall Study|Other than specified|1|||
149036828|NCT04668339|537614308|FG003|Overall Study|Other than specified|0|||
149036829|NCT04668339|537614305|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
149036830|NCT04668339|537614306|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
149036831|NCT04668339|537614307|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
149036832|NCT04668339|537614308|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
149036833|NCT04668339|537614305|FG000|Overall Study|Vaccine not Administered|0|||
149036834|NCT04668339|537614306|FG001|Overall Study|Vaccine not Administered|0|||
149036835|NCT04668339|537614307|FG002|Overall Study|Vaccine not Administered|1|||
149036836|NCT04668339|537614308|FG003|Overall Study|Vaccine not Administered|0|||
149036837|NCT04668339|537614305|FG000|Overall Study|Protocol Violation|18|||
149036838|NCT04668339|537614306|FG001|Overall Study|Protocol Violation|23|||
149036839|NCT04668339|537614307|FG002|Overall Study|Protocol Violation|12|||
149036840|NCT04668339|537614308|FG003|Overall Study|Protocol Violation|20|||
149036841|NCT04668339|537614305|FG000|Overall Study|Withdrawal by Subject|45|||
149036842|NCT04668339|537614306|FG001|Overall Study|Withdrawal by Subject|46|||
149036843|NCT04668339|537614307|FG002|Overall Study|Withdrawal by Subject|46|||
149036844|NCT04668339|537614308|FG003|Overall Study|Withdrawal by Subject|27|||
149036845|NCT04668339|537614305|FG000|Overall Study|Study Terminated by Sponsor|59|||
149036846|NCT04668339|537614306|FG001|Overall Study|Study Terminated by Sponsor|59|||
149036847|NCT04668339|537614307|FG002|Overall Study|Study Terminated by Sponsor|71|||
149036848|NCT04668339|537614308|FG003|Overall Study|Study Terminated by Sponsor|1|||
149036849|NCT00178399|537614309|FG000|Overall Study|Physician Decision|4|||
149036850|NCT00178399|537614309|FG000|Overall Study|Withdrawal by Subject|8|||
149036851|NCT00178399|537614309|FG000|Overall Study|Lost to Follow-up|1|||
149036852|NCT04860258|537614310|FG000|Overall Study|Withdrawal by Subject|0|||
149036853|NCT04860258|537614311|FG001|Overall Study|Withdrawal by Subject|0|||
149036854|NCT04860258|537614312|FG002|Overall Study|Withdrawal by Subject|4|||
149036855|NCT04860258|537614313|FG003|Overall Study|Withdrawal by Subject|1|||
149036856|NCT04860258|537614314|FG004|Overall Study|Withdrawal by Subject|4|||
149036857|NCT04860258|537614315|FG005|Overall Study|Withdrawal by Subject|1|||
149036858|NCT04860258|537614316|FG006|Overall Study|Withdrawal by Subject|0|||
149036859|NCT02496702|537614321|FG000|Overall Study|Lost to Follow-up|8|||
149036860|NCT02496702|537614322|FG001|Overall Study|Lost to Follow-up|6|||
149036861|NCT02496702|537614321|FG000|Overall Study|Only partially tested|0|||
149036862|NCT02496702|537614322|FG001|Overall Study|Only partially tested|2|||
149036863|NCT00708032|537614325|FG000|Overall Study|Adverse Event|0|||
149036864|NCT00708032|537614326|FG001|Overall Study|Adverse Event|2|||
149036865|NCT00708032|537614325|FG000|Overall Study|Lost to Follow-up|1|||
149036866|NCT00708032|537614326|FG001|Overall Study|Lost to Follow-up|2|||
149036867|NCT00708032|537614325|FG000|Overall Study|Pregnancy|0|||
148879855|NCT01053988|537038178|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
148879856|NCT01053988|537038179|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148879857|NCT01053988|537038180|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148879858|NCT01053988|537038181|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148879859|NCT01053988|537038182|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
148879860|NCT01053988|537038183|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
149036868|NCT00708032|537614326|FG001|Overall Study|Pregnancy|1|||
149036869|NCT00708032|537614325|FG000|Overall Study|Poor vision|0|||
149036870|NCT00708032|537614326|FG001|Overall Study|Poor vision|6|||
149036871|NCT00708032|537614325|FG000|Overall Study|Visit out of range at month 12|4|||
149036872|NCT00708032|537614326|FG001|Overall Study|Visit out of range at month 12|1|||
149036873|NCT00708032|537614325|FG000|Overall Study|Did not meet protocol criteria|1|||
149036874|NCT00708032|537614326|FG001|Overall Study|Did not meet protocol criteria|2|||
149036875|NCT00708032|537614325|FG000|Overall Study|Protocol Violation|4|||
149036876|NCT00708032|537614326|FG001|Overall Study|Protocol Violation|1|||
149036877|NCT00708032|537614325|FG000|Overall Study|Withdrawal by Subject|0|||
149036878|NCT00708032|537614326|FG001|Overall Study|Withdrawal by Subject|1|||
149036879|NCT01400776|537614327|FG000|Overall Study|Adverse Event|7|||
149036880|NCT01400776|537614328|FG001|Overall Study|Adverse Event|2|||
149036881|NCT01400776|537614329|FG002|Overall Study|Adverse Event|9|||
149036882|NCT01400776|537614330|FG003|Overall Study|Adverse Event|2|||
149036883|NCT01400776|537614327|FG000|Overall Study|Lost to Follow-up|1|||
149036884|NCT01400776|537614328|FG001|Overall Study|Lost to Follow-up|0|||
149036885|NCT01400776|537614329|FG002|Overall Study|Lost to Follow-up|4|||
149036886|NCT01400776|537614330|FG003|Overall Study|Lost to Follow-up|1|||
149036887|NCT01400776|537614327|FG000|Overall Study|Withdrew Consent|4|||
149036888|NCT01400776|537614328|FG001|Overall Study|Withdrew Consent|2|||
149036889|NCT01400776|537614329|FG002|Overall Study|Withdrew Consent|6|||
149036890|NCT01400776|537614330|FG003|Overall Study|Withdrew Consent|1|||
149036891|NCT01400776|537614327|FG000|Overall Study|Protocol Deviation|6|||
149036892|NCT01400776|537614328|FG001|Overall Study|Protocol Deviation|1|||
149036893|NCT01400776|537614329|FG002|Overall Study|Protocol Deviation|5|||
149036894|NCT01400776|537614330|FG003|Overall Study|Protocol Deviation|2|||
149036895|NCT01400776|537614327|FG000|Overall Study|Reason not Specified|3|||
149036896|NCT01400776|537614328|FG001|Overall Study|Reason not Specified|0|||
149036897|NCT01400776|537614329|FG002|Overall Study|Reason not Specified|4|||
149036898|NCT01400776|537614330|FG003|Overall Study|Reason not Specified|3|||
149036899|NCT00941655|537614333|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
149036900|NCT00941655|537614334|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
149036901|NCT00941655|537614333|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
149036902|NCT00941655|537614334|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
149036903|NCT00941655|537614333|FG000|Overall Study|progressed while on chemo|0|||
149036904|NCT00941655|537614334|FG001|Overall Study|progressed while on chemo|2|||
149036905|NCT00941655|537614333|FG000|Overall Study|refused further treatment|0|||
149036906|NCT00941655|537614334|FG001|Overall Study|refused further treatment|1|||
149036907|NCT00941655|537614333|FG000|Overall Study|withdrew consent|0|||
149036908|NCT00941655|537614334|FG001|Overall Study|withdrew consent|1|||
149036909|NCT00941655|537614333|FG000|Overall Study|non-compliant|0|||
149036910|NCT00941655|537614334|FG001|Overall Study|non-compliant|1|||
149036911|NCT00004124|537614339|FG000|Overall Study|Received no protocol therapy|12|||
149036912|NCT00004124|537614340|FG001|Overall Study|Received no protocol therapy|20|||
149036913|NCT01171625|537614341|FG000|Overall Study|On-Protocol|67|||
149036914|NCT01171625|537614341|FG000|Overall Study|Death|38|||
149036915|NCT01171625|537614341|FG000|Overall Study|Withdrawal by Subject|31|||
149036916|NCT01171625|537614341|FG000|Overall Study|Explanted|10|||
149036917|NCT01171625|537614341|FG000|Overall Study|Lost to Follow-up|5|||
149036918|NCT01171625|537614341|FG000|Overall Study|Patient received valve-in-valve|3|||
149036919|NCT01171625|537614341|FG000|Overall Study|Other|1|||
149036920|NCT01171625|537614341|FG000|Overall Study|Consented but did not receive device|25|||
149036921|NCT03262935|537614342|FG000|Overall Study|Withdrawal by Subject|6|||
149036922|NCT03262935|537614343|FG001|Overall Study|Withdrawal by Subject|7|||
149036923|NCT03262935|537614342|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
149036924|NCT03262935|537614343|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
149036925|NCT03262935|537614342|FG000|Overall Study|Death|181|||
149036926|NCT03262935|537614343|FG001|Overall Study|Death|94|||
149036927|NCT03262935|537614342|FG000|Overall Study|Lost to Follow-up|9|||
149036928|NCT03262935|537614343|FG001|Overall Study|Lost to Follow-up|4|||
149036929|NCT03262935|537614342|FG000|Overall Study|Other reason|5|||
149036930|NCT03262935|537614343|FG001|Overall Study|Other reason|0|||
149036931|NCT00186186|537614344|FG000|Overall Study|Lack of Efficacy|3|||
149036932|NCT00186186|537614344|FG000|Overall Study|Withdrawal by Subject|3|||
149036933|NCT00186186|537614344|FG000|Overall Study|Not reported as to reason|2|||
149036934|NCT00807144|537614345|FG000|Overall Study|Lost to Follow-up|0|||
149036935|NCT00807144|537614346|FG001|Overall Study|Lost to Follow-up|1|||
149036936|NCT02567656|537614347|FG000|Overall Study|Premature discontinuation due to PD|1|||
149036937|NCT02567656|537614348|FG001|Overall Study|Premature discontinuation due to PD|1|||
149036938|NCT02567656|537614349|FG002|Overall Study|Premature discontinuation due to PD|2|||
149036939|NCT02567656|537614350|FG003|Overall Study|Premature discontinuation due to PD|0|||
149036940|NCT02567656|537614351|FG004|Overall Study|Premature discontinuation due to PD|0|||
149036941|NCT02567656|537614352|FG005|Overall Study|Premature discontinuation due to PD|0|||
149036942|NCT03622580|537614361|FG000|Overall Study|Death|16|||
149036943|NCT03622580|537614362|FG001|Overall Study|Death|21|||
149036944|NCT03622580|537614363|FG002|Overall Study|Death|13|||
149036945|NCT03622580|537614361|FG000|Overall Study|Adverse Event|6|||
149036946|NCT03622580|537614362|FG001|Overall Study|Adverse Event|6|||
149036947|NCT03622580|537614363|FG002|Overall Study|Adverse Event|5|||
149036948|NCT03622580|537614361|FG000|Overall Study|Withdrawal by Subject|12|||
149036949|NCT03622580|537614362|FG001|Overall Study|Withdrawal by Subject|7|||
149036950|NCT03622580|537614363|FG002|Overall Study|Withdrawal by Subject|19|||
149036951|NCT03622580|537614361|FG000|Overall Study|Lost to Follow-up|12|||
149036952|NCT03622580|537614362|FG001|Overall Study|Lost to Follow-up|9|||
149036953|NCT03622580|537614363|FG002|Overall Study|Lost to Follow-up|9|||
149036954|NCT03622580|537614361|FG000|Overall Study|Protocol Violation|1|||
149036955|NCT03622580|537614362|FG001|Overall Study|Protocol Violation|0|||
149036956|NCT03622580|537614363|FG002|Overall Study|Protocol Violation|1|||
149036957|NCT03622580|537614361|FG000|Overall Study|Physician Decision|3|||
149036958|NCT03622580|537614362|FG001|Overall Study|Physician Decision|0|||
149036959|NCT03622580|537614363|FG002|Overall Study|Physician Decision|1|||
149036960|NCT03622580|537614361|FG000|Overall Study|Pregnancy|0|||
149036961|NCT03622580|537614362|FG001|Overall Study|Pregnancy|1|||
149036962|NCT03622580|537614363|FG002|Overall Study|Pregnancy|0|||
149002752|NCT03286751|537487619|FG000|Washout Period 5|Adverse Event|0|||
149002753|NCT03286751|537487620|FG001|Washout Period 5|Adverse Event|0|||
149002754|NCT03286751|537487621|FG002|Washout Period 5|Adverse Event|0|||
149002755|NCT03286751|537487622|FG003|Washout Period 5|Adverse Event|0|||
149002756|NCT03286751|537487623|FG004|Washout Period 5|Adverse Event|1|||
149002757|NCT03286751|537487624|FG005|Washout Period 5|Adverse Event|0|||
149002758|NCT01078155|537487625|FG000|Overall Study|Adverse Event|7|||
149002759|NCT01078155|537487625|FG000|Overall Study|Lack of Efficacy|16|||
149002760|NCT01078155|537487625|FG000|Overall Study|Participant's Decision|6|||
149002761|NCT01078155|537487625|FG000|Overall Study|Lost to Follow-up|15|||
149002762|NCT01662063|537487626|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
149002763|NCT01662063|537487627|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
149002764|NCT01662063|537487628|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
149002765|NCT01662063|537487626|FG000|Overall Study|Lack of Efficacy|1|||
149002766|NCT01662063|537487627|FG001|Overall Study|Lack of Efficacy|6|||
149002767|NCT01662063|537487628|FG002|Overall Study|Lack of Efficacy|0|||
149002768|NCT01662063|537487626|FG000|Overall Study|Lost to Follow-up|0|||
149002769|NCT01662063|537487627|FG001|Overall Study|Lost to Follow-up|4|||
149002770|NCT01662063|537487628|FG002|Overall Study|Lost to Follow-up|0|||
149002771|NCT01662063|537487626|FG000|Overall Study|Protocol Violation|1|||
149002772|NCT01662063|537487627|FG001|Overall Study|Protocol Violation|0|||
149002773|NCT01662063|537487628|FG002|Overall Study|Protocol Violation|0|||
149002774|NCT01662063|537487626|FG000|Overall Study|Withdrawal by Subject|2|||
149002775|NCT01662063|537487627|FG001|Overall Study|Withdrawal by Subject|4|||
149002776|NCT01662063|537487628|FG002|Overall Study|Withdrawal by Subject|1|||
149002777|NCT01662063|537487626|FG000|Overall Study|Physician Decision|0|||
149002778|NCT01662063|537487627|FG001|Overall Study|Physician Decision|2|||
149002779|NCT01662063|537487628|FG002|Overall Study|Physician Decision|0|||
149002780|NCT01662063|537487626|FG000|Overall Study|Other|0|||
149002781|NCT01662063|537487627|FG001|Overall Study|Other|1|||
149036963|NCT03622580|537614361|FG000|Overall Study|Lack of Efficacy|0|||
149036964|NCT03622580|537614362|FG001|Overall Study|Lack of Efficacy|0|||
149036965|NCT03622580|537614363|FG002|Overall Study|Lack of Efficacy|1|||
149036966|NCT03622580|537614361|FG000|Overall Study|Other|2|||
149036967|NCT03622580|537614362|FG001|Overall Study|Other|0|||
149036968|NCT03622580|537614363|FG002|Overall Study|Other|3|||
149036969|NCT03959241|537614364|FG000|Overall Study|Withdrawal by Subject|7|||
149036970|NCT03959241|537614365|FG001|Overall Study|Withdrawal by Subject|8|||
149036971|NCT03959241|537614364|FG000|Overall Study|Lost to Follow-up|1|||
149036972|NCT03959241|537614365|FG001|Overall Study|Lost to Follow-up|0|||
149036973|NCT03959241|537614364|FG000|Overall Study|Move to Hospice Care|1|||
149036974|NCT03959241|537614365|FG001|Overall Study|Move to Hospice Care|0|||
149036975|NCT03959241|537614364|FG000|Overall Study|Screen Failure|1|||
149036976|NCT03959241|537614365|FG001|Overall Study|Screen Failure|0|||
149036977|NCT03959241|537614364|FG000|Overall Study|Disease Relapse|0|||
149036978|NCT03959241|537614365|FG001|Overall Study|Disease Relapse|1|||
149036979|NCT03959241|537614364|FG000|Overall Study|Off Study|1|||
149036980|NCT03959241|537614365|FG001|Overall Study|Off Study|0|||
149036981|NCT02441036|537614370|FG000|Overall Study|No tissue resected|0|||
149036982|NCT02441036|537614371|FG001|Overall Study|No tissue resected|1|||
149036983|NCT02441036|537614372|FG002|Overall Study|No tissue resected|0|||
149036984|NCT02441036|537614373|FG003|Overall Study|No tissue resected|1|||
149036985|NCT02441036|537614374|FG004|Overall Study|No tissue resected|0|||
149036986|NCT03192046|537614377|FG000|Overall Study|Withdrawal by Subject|1|||
149036987|NCT03192046|537614378|FG001|Overall Study|Withdrawal by Subject|1|||
149036988|NCT01194154|537614379|FG000|Overall Study|Adverse Event|12|||
149036989|NCT01194154|537614380|FG001|Overall Study|Adverse Event|7|||
149036990|NCT01194154|537614379|FG000|Overall Study|Lost to Follow-up|2|||
149036991|NCT01194154|537614380|FG001|Overall Study|Lost to Follow-up|3|||
149036992|NCT01194154|537614379|FG000|Overall Study|Protocol Violation|0|||
149036993|NCT01194154|537614380|FG001|Overall Study|Protocol Violation|1|||
149036994|NCT01194154|537614379|FG000|Overall Study|Withdrawal by Subject|5|||
149036995|NCT01194154|537614380|FG001|Overall Study|Withdrawal by Subject|6|||
149036996|NCT01194154|537614379|FG000|Overall Study|Blood pressure increase|5|||
149036997|NCT01194154|537614380|FG001|Overall Study|Blood pressure increase|3|||
149036998|NCT01194154|537614379|FG000|Overall Study|Hemoglobin decrease|0|||
149002782|NCT01662063|537487628|FG002|Overall Study|Other|0|||
149002783|NCT01477853|537487629|FG000|Phase A|Adverse Event|1|||
149002784|NCT01477853|537487630|FG001|Phase A|Adverse Event|2|||
149002785|NCT01477853|537487631|FG002|Phase A|Adverse Event|2|||
149036999|NCT01194154|537614380|FG001|Overall Study|Hemoglobin decrease|1|||
149037000|NCT01194154|537614379|FG000|Overall Study|Hemoglobin increase|12|||
149002786|NCT01477853|537487629|FG000|Phase A|Lost to Follow-up|4|||
149002787|NCT01477853|537487630|FG001|Phase A|Lost to Follow-up|3|||
149002788|NCT01477853|537487631|FG002|Phase A|Lost to Follow-up|2|||
149002789|NCT01477853|537487629|FG000|Phase A|Physician Decision|1|||
149002790|NCT01477853|537487630|FG001|Phase A|Physician Decision|0|||
149002791|NCT01477853|537487631|FG002|Phase A|Physician Decision|1|||
149002792|NCT01477853|537487629|FG000|Phase A|Study terminated by sponsor|37|||
149002793|NCT01477853|537487630|FG001|Phase A|Study terminated by sponsor|40|||
149002794|NCT01477853|537487631|FG002|Phase A|Study terminated by sponsor|39|||
149002795|NCT01477853|537487629|FG000|Phase B|Lost to Follow-up|0|||
149002796|NCT01477853|537487630|FG001|Phase B|Lost to Follow-up|1|||
149002797|NCT01477853|537487631|FG002|Phase B|Lost to Follow-up|0|||
149002798|NCT01477853|537487629|FG000|Phase B|Study terminated by sponsor|12|||
149002799|NCT01477853|537487630|FG001|Phase B|Study terminated by sponsor|10|||
149002800|NCT01477853|537487631|FG002|Phase B|Study terminated by sponsor|11|||
149002801|NCT00677352|537487637|FG000|Treatment Phase|Adverse Event|14|||
149002802|NCT00677352|537487638|FG001|Treatment Phase|Adverse Event|22|||
149002803|NCT00677352|537487637|FG000|Treatment Phase|Lack of Efficacy|2|||
149002804|NCT00677352|537487638|FG001|Treatment Phase|Lack of Efficacy|3|||
149002805|NCT00677352|537487637|FG000|Treatment Phase|Lost to Follow-up|0|||
149002806|NCT00677352|537487638|FG001|Treatment Phase|Lost to Follow-up|1|||
149002807|NCT00677352|537487637|FG000|Treatment Phase|Withdrawal by Subject|7|||
149002808|NCT00677352|537487638|FG001|Treatment Phase|Withdrawal by Subject|7|||
149002809|NCT00677352|537487637|FG000|Treatment Phase|Physician Decision|1|||
149002810|NCT00677352|537487638|FG001|Treatment Phase|Physician Decision|0|||
149002811|NCT00677352|537487637|FG000|Treatment Phase|Pregnancy|0|||
149002812|NCT00677352|537487638|FG001|Treatment Phase|Pregnancy|1|||
149002813|NCT00677352|537487637|FG000|Treatment Phase|Protocol Violation|1|||
149002814|NCT00677352|537487638|FG001|Treatment Phase|Protocol Violation|1|||
149002815|NCT00677352|537487637|FG000|Treatment Phase|Transference or work related matter|0|||
149002816|NCT00677352|537487638|FG001|Treatment Phase|Transference or work related matter|5|||
149002817|NCT00677352|537487637|FG000|Treatment Phase|Not treated|0|||
149002818|NCT00677352|537487638|FG001|Treatment Phase|Not treated|2|||
149002819|NCT00677352|537487637|FG000|Tapering Phase|Adverse Event|1|||
149002820|NCT00677352|537487638|FG001|Tapering Phase|Adverse Event|5|||
149002821|NCT00677352|537487637|FG000|Tapering Phase|Withdrawal by Subject|5|||
149002822|NCT00677352|537487638|FG001|Tapering Phase|Withdrawal by Subject|3|||
149002823|NCT00677352|537487637|FG000|Tapering Phase|Pregnancy|0|||
149002824|NCT00677352|537487638|FG001|Tapering Phase|Pregnancy|1|||
149002825|NCT00677352|537487637|FG000|Tapering Phase|Job transfer|0|||
149002826|NCT00677352|537487638|FG001|Tapering Phase|Job transfer|1|||
149002827|NCT04044456|537487641|FG000|Overall Study|Lost to Follow-up|4|||
149002828|NCT04044456|537487642|FG001|Overall Study|Lost to Follow-up|1|||
149002829|NCT04044456|537487641|FG000|Overall Study|Withdrawal by Subject|1|||
149002830|NCT04044456|537487642|FG001|Overall Study|Withdrawal by Subject|0|||
149002831|NCT01972529|537487643|FG000|Overall Study|Adverse Event|0|||
149002832|NCT01972529|537487644|FG001|Overall Study|Adverse Event|1|||
149002833|NCT01972529|537487645|FG002|Overall Study|Adverse Event|0|||
149002834|NCT01972529|537487646|FG003|Overall Study|Adverse Event|0|||
149002835|NCT01972529|537487643|FG000|Overall Study|Lost to Follow-up|1|||
149002836|NCT01972529|537487644|FG001|Overall Study|Lost to Follow-up|0|||
149002837|NCT01972529|537487645|FG002|Overall Study|Lost to Follow-up|0|||
149002838|NCT01972529|537487646|FG003|Overall Study|Lost to Follow-up|0|||
149002839|NCT01972529|537487643|FG000|Overall Study|Participant Choice|0|||
149002840|NCT01972529|537487644|FG001|Overall Study|Participant Choice|1|||
149002841|NCT01972529|537487645|FG002|Overall Study|Participant Choice|0|||
149002842|NCT01972529|537487646|FG003|Overall Study|Participant Choice|0|||
149002843|NCT01972529|537487643|FG000|Overall Study|Withdrawl of Consent|1|||
149002844|NCT01972529|537487644|FG001|Overall Study|Withdrawl of Consent|2|||
149002845|NCT01972529|537487645|FG002|Overall Study|Withdrawl of Consent|0|||
149002846|NCT01972529|537487646|FG003|Overall Study|Withdrawl of Consent|1|||
149002847|NCT01972529|537487643|FG000|Overall Study|Other|0|||
149002848|NCT01972529|537487644|FG001|Overall Study|Other|0|||
149002849|NCT01972529|537487645|FG002|Overall Study|Other|0|||
149002850|NCT01972529|537487646|FG003|Overall Study|Other|2|||
149002851|NCT01972529|537487643|FG000|Overall Study|Not treated|0|||
149002852|NCT01972529|537487644|FG001|Overall Study|Not treated|1|||
149002853|NCT01972529|537487645|FG002|Overall Study|Not treated|2|||
149002854|NCT01972529|537487646|FG003|Overall Study|Not treated|1|||
149002855|NCT00330174|537487648|FG000|Overall Study|Withdrawal by Subject|7|||
149002856|NCT00330174|537487649|FG001|Overall Study|Withdrawal by Subject|7|||
149002857|NCT00330174|537487648|FG000|Overall Study|Lost to Follow-up|4|||
149002858|NCT00330174|537487649|FG001|Overall Study|Lost to Follow-up|1|||
149002859|NCT00330174|537487648|FG000|Overall Study|Clinical deterioration|1|||
149002860|NCT00330174|537487649|FG001|Overall Study|Clinical deterioration|2|||
149002861|NCT00330174|537487648|FG000|Overall Study|Excessive missed visits|3|||
149002862|NCT00330174|537487649|FG001|Overall Study|Excessive missed visits|8|||
149002863|NCT00330174|537487648|FG000|Overall Study|Miscellaneous reasons|7|||
149002864|NCT00330174|537487649|FG001|Overall Study|Miscellaneous reasons|1|||
149002865|NCT02316769|537487652|FG000|Overall Study|Physician Decision|1|||
149037001|NCT01194154|537614380|FG001|Overall Study|Hemoglobin increase|3|||
149037002|NCT01194154|537614379|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
149037003|NCT01194154|537614380|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
149037004|NCT01194154|537614379|FG000|Overall Study|Treatment with prohibited medication|4|||
149037005|NCT01194154|537614380|FG001|Overall Study|Treatment with prohibited medication|5|||
149037006|NCT01194154|537614379|FG000|Overall Study|Other|4|||
149037007|NCT01194154|537614380|FG001|Overall Study|Other|0|||
149037008|NCT01194154|537614379|FG000|Overall Study|Did not receive study medication|2|||
149037009|NCT01194154|537614380|FG001|Overall Study|Did not receive study medication|4|||
149037010|NCT01505881|537614381|FG000|Overall Study|Adverse Event|0|||
149037011|NCT01505881|537614382|FG001|Overall Study|Adverse Event|1|||
149037012|NCT01505881|537614381|FG000|Overall Study|Lost to Follow-up|2|||
149037013|NCT01505881|537614382|FG001|Overall Study|Lost to Follow-up|0|||
149037014|NCT01505881|537614381|FG000|Overall Study|Withdrawal by Subject|2|||
149037015|NCT01505881|537614382|FG001|Overall Study|Withdrawal by Subject|0|||
149037016|NCT00842257|537614383|FG000|Overall Study|Adverse Event|1|||
149037017|NCT01596504|537614384|FG000|Overall Study|Participant's Private Reason|0|||
149037018|NCT01596504|537614385|FG001|Overall Study|Participant's Private Reason|1|||
149037019|NCT01596504|537614386|FG002|Overall Study|Participant's Private Reason|0|||
149037020|NCT01596504|537614384|FG000|Overall Study|Adverse Event|1|||
149037021|NCT01596504|537614385|FG001|Overall Study|Adverse Event|2|||
149037022|NCT01596504|537614386|FG002|Overall Study|Adverse Event|1|||
149037023|NCT01596504|537614384|FG000|Overall Study|Withdrawal by Subject|1|||
149037024|NCT01596504|537614385|FG001|Overall Study|Withdrawal by Subject|0|||
149037025|NCT01596504|537614386|FG002|Overall Study|Withdrawal by Subject|0|||
149037026|NCT01901276|537614387|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
149037027|NCT01901276|537614388|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
149037028|NCT02314117|537614389|FG000|Overall Study|Lost to Follow-up|9|||
149037029|NCT02314117|537614390|FG001|Overall Study|Lost to Follow-up|14|||
149037030|NCT02314117|537614389|FG000|Overall Study|Withdrawal by Subject|3|||
149037031|NCT02314117|537614390|FG001|Overall Study|Withdrawal by Subject|2|||
149037032|NCT04439799|537614391|FG000|Overall Study|Lost to Follow-up|6|||
149037033|NCT04439799|537614392|FG001|Overall Study|Lost to Follow-up|6|||
149037034|NCT04439799|537614391|FG000|Overall Study|Withdrawal by Subject|2|||
149037035|NCT04439799|537614392|FG001|Overall Study|Withdrawal by Subject|6|||
149037036|NCT04439799|537614391|FG000|Overall Study|Adverse Event|2|||
149037037|NCT04439799|537614392|FG001|Overall Study|Adverse Event|5|||
149037038|NCT04347954|537614393|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
149037039|NCT04347954|537614394|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
149037040|NCT04347954|537614395|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
149037041|NCT04347954|537614393|FG000|Overall Study|Lost to Follow-up|0|||
149037042|NCT04347954|537614394|FG001|Overall Study|Lost to Follow-up|1|||
149037043|NCT04347954|537614395|FG002|Overall Study|Lost to Follow-up|0|||
149037044|NCT00909363|537614396|FG000|Overall Study|Withdrawal by Subject|1|||
149037045|NCT00909363|537614397|FG001|Overall Study|Withdrawal by Subject|0|||
149037046|NCT00909363|537614398|FG002|Overall Study|Withdrawal by Subject|0|||
149037047|NCT00909363|537614396|FG000|Overall Study|Lack of Efficacy|1|||
149037048|NCT00909363|537614397|FG001|Overall Study|Lack of Efficacy|0|||
149037049|NCT00909363|537614398|FG002|Overall Study|Lack of Efficacy|0|||
149037050|NCT02954848|537614406|FG000|Overall Study|Randomized but Not Treated|0|||
149037051|NCT02954848|537614407|FG001|Overall Study|Randomized but Not Treated|1|||
149037052|NCT02954848|537614406|FG000|Overall Study|Adverse Event|2|||
149037053|NCT02954848|537614407|FG001|Overall Study|Adverse Event|3|||
149037054|NCT02954848|537614406|FG000|Overall Study|Withdrawal by Participant|0|||
149037055|NCT02954848|537614407|FG001|Overall Study|Withdrawal by Participant|1|||
149037056|NCT02808338|537614408|FG000|Screening|Screen Failure|10|||
149037057|NCT02808338|537614408|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
149037058|NCT02808338|537614408|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
149037059|NCT02194933|537614409|FG000|Overall Study|Lost to Follow-up|1|||
149037060|NCT02194933|537614410|FG001|Overall Study|Lost to Follow-up|2|||
149037061|NCT02194933|537614409|FG000|Overall Study|Participant met withdrawal criteria|1|||
149037062|NCT02194933|537614410|FG001|Overall Study|Participant met withdrawal criteria|3|||
149037063|NCT02194933|537614409|FG000|Overall Study|Withdrawal by Subject|0|||
149037064|NCT02194933|537614410|FG001|Overall Study|Withdrawal by Subject|2|||
149037065|NCT02194933|537614409|FG000|Overall Study|Lack of Efficacy|1|||
149037066|NCT02194933|537614410|FG001|Overall Study|Lack of Efficacy|2|||
149037067|NCT02000817|537614413|FG000|Overall Study|Withdrawal by Subject|2|||
149037068|NCT02000817|537614414|FG001|Overall Study|Withdrawal by Subject|0|||
149037069|NCT02000817|537614415|FG002|Overall Study|Withdrawal by Subject|0|||
149037070|NCT02000817|537614416|FG003|Overall Study|Withdrawal by Subject|0|||
149037071|NCT02000817|537614413|FG000|Overall Study|Adverse Event|0|||
149037072|NCT02000817|537614414|FG001|Overall Study|Adverse Event|1|||
149037073|NCT02000817|537614415|FG002|Overall Study|Adverse Event|0|||
149037074|NCT02000817|537614416|FG003|Overall Study|Adverse Event|0|||
149037075|NCT02000817|537614413|FG000|Overall Study|Lost to Follow-up|0|||
149037076|NCT02000817|537614414|FG001|Overall Study|Lost to Follow-up|0|||
148879861|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
149002866|NCT02316769|537487653|FG001|Overall Study|Physician Decision|0|||
149002867|NCT02316769|537487652|FG000|Overall Study|Withdrawal by Subject|1|||
149002868|NCT02316769|537487653|FG001|Overall Study|Withdrawal by Subject|0|||
149002869|NCT01201811|537487654|FG000|Overall Study|Adverse Event|6|||
149002870|NCT01201811|537487654|FG000|Overall Study|Disease progression|3|||
149002871|NCT01201811|537487654|FG000|Overall Study|Withdrawal by Subject|3|||
149002872|NCT01201811|537487654|FG000|Overall Study|Death|4|||
149002873|NCT01201811|537487654|FG000|Overall Study|Treatment Failure|2|||
149002874|NCT01201811|537487654|FG000|Overall Study|Physician Decision|1|||
149002875|NCT02277990|537487660|FG000|Overall Study|Death|170|||
149002876|NCT02277990|537487661|FG001|Overall Study|Death|188|||
149002877|NCT02277990|537487660|FG000|Overall Study|Withdrawal by Subject|64|||
149002878|NCT02277990|537487661|FG001|Overall Study|Withdrawal by Subject|53|||
149002879|NCT02277990|537487660|FG000|Overall Study|Physician Decision|40|||
149002880|NCT02277990|537487661|FG001|Overall Study|Physician Decision|34|||
149002881|NCT02277990|537487660|FG000|Overall Study|Lost to Follow-up|66|||
149002882|NCT02277990|537487661|FG001|Overall Study|Lost to Follow-up|69|||
149002883|NCT02277990|537487660|FG000|Overall Study|Had other reason|26|||
149002884|NCT02277990|537487661|FG001|Overall Study|Had other reason|32|||
149002885|NCT00946296|537487662|FG000|Overall Study|Physician Decision|3|||
149002886|NCT00946296|537487663|FG001|Overall Study|Physician Decision|0|||
149002887|NCT03434678|537487666|FG000|Overall Study|Withdrawal by Subject|13|||
149002888|NCT03434678|537487667|FG001|Overall Study|Withdrawal by Subject|13|||
149002889|NCT03434678|537487666|FG000|Overall Study|Found to be ineligible post randomization|2|||
149002890|NCT03434678|537487667|FG001|Overall Study|Found to be ineligible post randomization|1|||
149002891|NCT06060457|537487670|FG000|Overall Study|Adverse Event|1|||
149002892|NCT06060457|537487671|FG001|Overall Study|Adverse Event|1|||
149002893|NCT06060457|537487670|FG000|Overall Study|Death|2|||
149002894|NCT06060457|537487671|FG001|Overall Study|Death|2|||
149002895|NCT06060457|537487670|FG000|Overall Study|Lost to Follow-up|17|||
149002896|NCT06060457|537487671|FG001|Overall Study|Lost to Follow-up|19|||
149002897|NCT06060457|537487670|FG000|Overall Study|Physician Decision|0|||
149002898|NCT06060457|537487671|FG001|Overall Study|Physician Decision|1|||
149002899|NCT06060457|537487670|FG000|Overall Study|Protocol Violation|1|||
149002900|NCT06060457|537487671|FG001|Overall Study|Protocol Violation|1|||
149002901|NCT06060457|537487670|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
149002902|NCT06060457|537487671|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
149002903|NCT06060457|537487670|FG000|Overall Study|Withdrawal by Subject|12|||
149002904|NCT06060457|537487671|FG001|Overall Study|Withdrawal by Subject|15|||
149002905|NCT06060457|537487670|FG000|Overall Study|Other Than Specified|2|||
149002906|NCT06060457|537487671|FG001|Overall Study|Other Than Specified|1|||
149002907|NCT02061202|537487672|FG000|Overall Study|Lost to Follow-up|1|||
149002908|NCT02061202|537487673|FG001|Overall Study|Lost to Follow-up|1|||
149002909|NCT01533493|537487674|FG000|Overall Study|Adverse Event|2|||
149002910|NCT01533493|537487675|FG001|Overall Study|Adverse Event|1|||
149002911|NCT01533493|537487674|FG000|Overall Study|Withdrawal by Subject|1|||
149002912|NCT01533493|537487675|FG001|Overall Study|Withdrawal by Subject|2|||
149002913|NCT01533493|537487674|FG000|Overall Study|Lost to Follow-up|2|||
149002914|NCT01533493|537487675|FG001|Overall Study|Lost to Follow-up|0|||
149002915|NCT01860703|537487676|FG000|Overall Study|Adverse Event|1|||
149002916|NCT01860703|537487677|FG001|Overall Study|Adverse Event|4|||
149002917|NCT01860703|537487678|FG002|Overall Study|Adverse Event|0|||
149002918|NCT01860703|537487679|FG003|Overall Study|Adverse Event|2|||
149002919|NCT01860703|537487676|FG000|Overall Study|Withdrawal by Subject|0|||
149002920|NCT01860703|537487677|FG001|Overall Study|Withdrawal by Subject|1|||
149002921|NCT01860703|537487678|FG002|Overall Study|Withdrawal by Subject|0|||
149002922|NCT01860703|537487679|FG003|Overall Study|Withdrawal by Subject|0|||
149002923|NCT01860703|537487676|FG000|Overall Study|Personal reason|1|||
149002924|NCT01860703|537487677|FG001|Overall Study|Personal reason|0|||
149002925|NCT01860703|537487678|FG002|Overall Study|Personal reason|1|||
149002926|NCT01860703|537487679|FG003|Overall Study|Personal reason|0|||
149002927|NCT00696410|537487683|FG000|Overall Study|Lost to Follow-up|2|||
149002928|NCT00696410|537487684|FG001|Overall Study|Lost to Follow-up|0|||
149002929|NCT00696410|537487683|FG000|Overall Study|Withdrawal by Subject|8|||
149002930|NCT00696410|537487684|FG001|Overall Study|Withdrawal by Subject|0|||
149002931|NCT00696410|537487683|FG000|Overall Study|Physician Decision|3|||
149002932|NCT00696410|537487684|FG001|Overall Study|Physician Decision|0|||
149002933|NCT03184792|537487688|FG000|Overall Study|Pandemic|2|||
149002934|NCT03184792|537487689|FG001|Overall Study|Pandemic|2|||
149002935|NCT02495025|537487690|FG000|Overall Study|Lost to Follow-up|21|||
149002936|NCT02495025|537487691|FG001|Overall Study|Lost to Follow-up|14|||
149002937|NCT02495025|537487690|FG000|Overall Study|Withdrawal by Subject|5|||
149002938|NCT02495025|537487691|FG001|Overall Study|Withdrawal by Subject|0|||
149002939|NCT02365519|537487695|FG000|Randomized and Treated|Adverse Event|0|||
149002940|NCT02365519|537487696|FG001|Randomized and Treated|Adverse Event|1|||
149002941|NCT02365519|537487697|FG002|Randomized and Treated|Adverse Event|0|||
149002942|NCT02365519|537487695|FG000|Randomized and Treated|Withdrawal by Subject|0|||
148879862|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
148879863|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
148879864|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
148879865|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
149037077|NCT02000817|537614415|FG002|Overall Study|Lost to Follow-up|1|||
149037078|NCT02000817|537614416|FG003|Overall Study|Lost to Follow-up|0|||
149037079|NCT03383146|537614418|FG000|Overall Study|Screen Failure|1|||
149037080|NCT03383146|537614419|FG001|Overall Study|Screen Failure|0|||
149037081|NCT03383146|537614418|FG000|Overall Study|Adverse Event|6|||
149037082|NCT03383146|537614419|FG001|Overall Study|Adverse Event|18|||
149037083|NCT03383146|537614418|FG000|Overall Study|Lack of Efficacy|0|||
149037084|NCT03383146|537614419|FG001|Overall Study|Lack of Efficacy|3|||
149037085|NCT03383146|537614418|FG000|Overall Study|Withdrawal by Subject|20|||
149037086|NCT03383146|537614419|FG001|Overall Study|Withdrawal by Subject|36|||
149037087|NCT03383146|537614418|FG000|Overall Study|Lost to Follow-up|5|||
149037088|NCT03383146|537614419|FG001|Overall Study|Lost to Follow-up|15|||
149037089|NCT03383146|537614418|FG000|Overall Study|Death|0|||
149037090|NCT03383146|537614419|FG001|Overall Study|Death|2|||
149037091|NCT03383146|537614418|FG000|Overall Study|Physician Decision|0|||
149037092|NCT03383146|537614419|FG001|Overall Study|Physician Decision|1|||
149037093|NCT03383146|537614418|FG000|Overall Study|Protocol Deviation|1|||
149037094|NCT03383146|537614419|FG001|Overall Study|Protocol Deviation|8|||
149037095|NCT03383146|537614418|FG000|Overall Study|Study Terminated by the Sponsor|48|||
149037096|NCT03383146|537614419|FG001|Overall Study|Study Terminated by the Sponsor|95|||
149037097|NCT03383146|537614418|FG000|Overall Study|Reason not Specified|4|||
149037098|NCT03383146|537614419|FG001|Overall Study|Reason not Specified|6|||
149037099|NCT05382104|537614420|FG000|Period 2 (2 Days)|Adverse Event|0|||
149037100|NCT05382104|537614421|FG001|Period 2 (2 Days)|Adverse Event|1|||
149037101|NCT05382104|537614422|FG002|Period 2 (2 Days)|Adverse Event|0|||
149037102|NCT05382104|537614423|FG003|Period 2 (2 Days)|Adverse Event|0|||
149037103|NCT05382104|537614424|FG004|Period 2 (2 Days)|Adverse Event|0|||
149037104|NCT05382104|537614425|FG005|Period 2 (2 Days)|Adverse Event|0|||
149037105|NCT01317420|537614430|FG000|Overall Study|Progressive disease according to RECIST|2|||
149037106|NCT01317420|537614431|FG001|Overall Study|Progressive disease according to RECIST|3|||
149037107|NCT01317420|537614432|FG002|Overall Study|Progressive disease according to RECIST|3|||
149037108|NCT01317420|537614433|FG003|Overall Study|Progressive disease according to RECIST|3|||
149037109|NCT01317420|537614434|FG004|Overall Study|Progressive disease according to RECIST|3|||
149037110|NCT01317420|537614435|FG005|Overall Study|Progressive disease according to RECIST|3|||
149037111|NCT01317420|537614436|FG006|Overall Study|Progressive disease according to RECIST|3|||
149037112|NCT01317420|537614437|FG007|Overall Study|Progressive disease according to RECIST|3|||
149037113|NCT01317420|537614438|FG008|Overall Study|Progressive disease according to RECIST|3|||
149037114|NCT01317420|537614439|FG009|Overall Study|Progressive disease according to RECIST|2|||
149037115|NCT01317420|537614440|FG010|Overall Study|Progressive disease according to RECIST|3|||
149037116|NCT01317420|537614441|FG011|Overall Study|Progressive disease according to RECIST|11|||
149037117|NCT01317420|537614442|FG012|Overall Study|Progressive disease according to RECIST|16|||
149037118|NCT01317420|537614430|FG000|Overall Study|Other adverse event|1|||
149037119|NCT01317420|537614431|FG001|Overall Study|Other adverse event|0|||
149037120|NCT01317420|537614432|FG002|Overall Study|Other adverse event|0|||
149037121|NCT01317420|537614433|FG003|Overall Study|Other adverse event|0|||
149037122|NCT01317420|537614434|FG004|Overall Study|Other adverse event|0|||
149037123|NCT01317420|537614435|FG005|Overall Study|Other adverse event|0|||
149037124|NCT01317420|537614436|FG006|Overall Study|Other adverse event|0|||
149037125|NCT01317420|537614437|FG007|Overall Study|Other adverse event|0|||
149002943|NCT02365519|537487696|FG001|Randomized and Treated|Withdrawal by Subject|1|||
149002944|NCT02365519|537487697|FG002|Randomized and Treated|Withdrawal by Subject|1|||
149002945|NCT01971723|537487698|FG000|Overall Study|Withdrawal by Subject|1|||
148879866|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
149002946|NCT01971723|537487699|FG001|Overall Study|Withdrawal by Subject|1|||
149002947|NCT01971723|537487698|FG000|Overall Study|Protocol Violation|1|||
149002948|NCT01971723|537487699|FG001|Overall Study|Protocol Violation|2|||
149002949|NCT03657277|537487703|FG000|Overall Study|Physician Decision|2|||
149002950|NCT03657277|537487703|FG000|Overall Study|Lost to Follow-up|1|||
149002951|NCT03657277|537487703|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
149002952|NCT03779906|537487706|FG000|Overall Study|Lost to Follow-up|7|||
149037126|NCT01317420|537614438|FG008|Overall Study|Other adverse event|0|||
149037127|NCT01317420|537614439|FG009|Overall Study|Other adverse event|0|||
149037128|NCT01317420|537614440|FG010|Overall Study|Other adverse event|0|||
149037129|NCT01317420|537614441|FG011|Overall Study|Other adverse event|0|||
149037130|NCT01317420|537614442|FG012|Overall Study|Other adverse event|2|||
149037131|NCT01317420|537614430|FG000|Overall Study|Non-compliant with protocol|0|||
149037132|NCT01317420|537614431|FG001|Overall Study|Non-compliant with protocol|0|||
149037133|NCT01317420|537614432|FG002|Overall Study|Non-compliant with protocol|0|||
149037134|NCT01317420|537614433|FG003|Overall Study|Non-compliant with protocol|0|||
149037135|NCT01317420|537614434|FG004|Overall Study|Non-compliant with protocol|0|||
149037136|NCT01317420|537614435|FG005|Overall Study|Non-compliant with protocol|0|||
149037137|NCT01317420|537614436|FG006|Overall Study|Non-compliant with protocol|0|||
149037138|NCT01317420|537614437|FG007|Overall Study|Non-compliant with protocol|0|||
149037139|NCT01317420|537614438|FG008|Overall Study|Non-compliant with protocol|0|||
149037140|NCT01317420|537614439|FG009|Overall Study|Non-compliant with protocol|0|||
149037141|NCT01317420|537614440|FG010|Overall Study|Non-compliant with protocol|0|||
149037142|NCT01317420|537614441|FG011|Overall Study|Non-compliant with protocol|0|||
149037143|NCT01317420|537614442|FG012|Overall Study|Non-compliant with protocol|1|||
149037144|NCT01317420|537614430|FG000|Overall Study|Refused to cont. taking trial medication|0|||
149037145|NCT01317420|537614431|FG001|Overall Study|Refused to cont. taking trial medication|0|||
149037146|NCT01317420|537614432|FG002|Overall Study|Refused to cont. taking trial medication|0|||
149037147|NCT01317420|537614433|FG003|Overall Study|Refused to cont. taking trial medication|0|||
149037148|NCT01317420|537614434|FG004|Overall Study|Refused to cont. taking trial medication|0|||
149037149|NCT01317420|537614435|FG005|Overall Study|Refused to cont. taking trial medication|0|||
149037150|NCT01317420|537614436|FG006|Overall Study|Refused to cont. taking trial medication|0|||
149037151|NCT01317420|537614437|FG007|Overall Study|Refused to cont. taking trial medication|0|||
149037152|NCT01317420|537614438|FG008|Overall Study|Refused to cont. taking trial medication|0|||
149037153|NCT01317420|537614439|FG009|Overall Study|Refused to cont. taking trial medication|0|||
149037154|NCT01317420|537614440|FG010|Overall Study|Refused to cont. taking trial medication|0|||
149037155|NCT01317420|537614441|FG011|Overall Study|Refused to cont. taking trial medication|0|||
149037156|NCT01317420|537614442|FG012|Overall Study|Refused to cont. taking trial medication|1|||
149037157|NCT01317420|537614430|FG000|Overall Study|Reason other than those specified|0|||
149037158|NCT01317420|537614431|FG001|Overall Study|Reason other than those specified|0|||
149037159|NCT01317420|537614432|FG002|Overall Study|Reason other than those specified|0|||
149037160|NCT01317420|537614433|FG003|Overall Study|Reason other than those specified|0|||
149037161|NCT01317420|537614434|FG004|Overall Study|Reason other than those specified|0|||
149037162|NCT01317420|537614435|FG005|Overall Study|Reason other than those specified|0|||
149037163|NCT01317420|537614436|FG006|Overall Study|Reason other than those specified|0|||
149037164|NCT01317420|537614437|FG007|Overall Study|Reason other than those specified|0|||
149037165|NCT01317420|537614438|FG008|Overall Study|Reason other than those specified|0|||
149037166|NCT01317420|537614439|FG009|Overall Study|Reason other than those specified|1|||
149037167|NCT01317420|537614440|FG010|Overall Study|Reason other than those specified|0|||
149037168|NCT01317420|537614441|FG011|Overall Study|Reason other than those specified|0|||
149037169|NCT01317420|537614442|FG012|Overall Study|Reason other than those specified|0|||
149037170|NCT05686421|537614443|FG000|Overall Study|Screen failure|22|||
149037171|NCT05686421|537614444|FG001|Overall Study|Screen failure|0|||
149037172|NCT05686421|537614445|FG002|Overall Study|Screen failure|0|||
149037173|NCT05686421|537614446|FG003|Overall Study|Screen failure|0|||
149037174|NCT00857649|537614447|FG000|Overall Study|Adverse Event|15|||
149037175|NCT00857649|537614448|FG001|Overall Study|Adverse Event|10|||
149037176|NCT00857649|537614447|FG000|Overall Study|Non-compliance|1|||
149037177|NCT00857649|537614448|FG001|Overall Study|Non-compliance|1|||
149037178|NCT00857649|537614447|FG000|Overall Study|Protocol Violation|2|||
149037179|NCT00857649|537614448|FG001|Overall Study|Protocol Violation|2|||
149037180|NCT00857649|537614447|FG000|Overall Study|Withdrawal of Consent|10|||
149037181|NCT00857649|537614448|FG001|Overall Study|Withdrawal of Consent|7|||
149037182|NCT00857649|537614447|FG000|Overall Study|Nursing Home Placement|2|||
149037183|NCT00857649|537614448|FG001|Overall Study|Nursing Home Placement|9|||
149037184|NCT00857649|537614447|FG000|Overall Study|Other Reasons|1|||
149037185|NCT00857649|537614448|FG001|Overall Study|Other Reasons|3|||
149037186|NCT00367055|537614450|FG000|Overall Study|Adverse Event|6|||
149037187|NCT00367055|537614451|FG001|Overall Study|Adverse Event|3|||
148879867|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148879868|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
149037188|NCT00367055|537614450|FG000|Overall Study|Patient's Willing|3|||
149037189|NCT00367055|537614451|FG001|Overall Study|Patient's Willing|2|||
149037190|NCT00367055|537614450|FG000|Overall Study|Lack of Efficacy|1|||
149037191|NCT00367055|537614451|FG001|Overall Study|Lack of Efficacy|2|||
149037192|NCT00367055|537614450|FG000|Overall Study|Lost to Follow-up|1|||
149037193|NCT00367055|537614451|FG001|Overall Study|Lost to Follow-up|1|||
149037194|NCT00367055|537614450|FG000|Overall Study|Protocol Violation|0|||
149037195|NCT00367055|537614451|FG001|Overall Study|Protocol Violation|1|||
149037196|NCT00367055|537614450|FG000|Overall Study|Stopping Criterion Met|0|||
149037197|NCT00367055|537614451|FG001|Overall Study|Stopping Criterion Met|1|||
149037198|NCT00367055|537614450|FG000|Overall Study|Participant Living too Far from Hospital|0|||
149037199|NCT00367055|537614451|FG001|Overall Study|Participant Living too Far from Hospital|1|||
149037200|NCT01123083|537614454|FG000|Overall Study|Investigator recommendation|1|||
149037201|NCT01123083|537614455|FG001|Overall Study|Investigator recommendation|1|||
149037202|NCT01123083|537614454|FG000|Overall Study|Administrative reasons|0|||
149037203|NCT01123083|537614455|FG001|Overall Study|Administrative reasons|4|||
149037204|NCT01123083|537614454|FG000|Overall Study|Lost to Follow-up|2|||
149037205|NCT01123083|537614455|FG001|Overall Study|Lost to Follow-up|6|||
149037206|NCT01123083|537614454|FG000|Overall Study|Adverse Event|1|||
149037207|NCT01123083|537614455|FG001|Overall Study|Adverse Event|0|||
149037208|NCT01123083|537614454|FG000|Overall Study|Withdrew for another reason not covered|0|||
149037209|NCT01123083|537614455|FG001|Overall Study|Withdrew for another reason not covered|1|||
149037210|NCT01123083|537614454|FG000|Overall Study|Participant/legal representative request|7|||
149037211|NCT01123083|537614455|FG001|Overall Study|Participant/legal representative request|3|||
149037212|NCT00961636|537614456|FG000|Overall Study|Adverse Event|35|||
149037213|NCT00961636|537614457|FG001|Overall Study|Adverse Event|54|||
149037214|NCT00961636|537614458|FG002|Overall Study|Adverse Event|13|||
149037215|NCT00961636|537614456|FG000|Overall Study|Flushing Symptoms|29|||
149037216|NCT00961636|537614457|FG001|Overall Study|Flushing Symptoms|46|||
149037217|NCT00961636|537614458|FG002|Overall Study|Flushing Symptoms|3|||
149037218|NCT00961636|537614456|FG000|Overall Study|Lost to Follow-up|2|||
149037219|NCT00961636|537614457|FG001|Overall Study|Lost to Follow-up|3|||
149037220|NCT00961636|537614458|FG002|Overall Study|Lost to Follow-up|1|||
149037221|NCT00961636|537614456|FG000|Overall Study|Physician Decision|3|||
149037222|NCT00961636|537614457|FG001|Overall Study|Physician Decision|1|||
149037223|NCT00961636|537614458|FG002|Overall Study|Physician Decision|1|||
149037224|NCT00961636|537614456|FG000|Overall Study|Protocol Violation|9|||
149037225|NCT00961636|537614457|FG001|Overall Study|Protocol Violation|5|||
149037226|NCT00961636|537614458|FG002|Overall Study|Protocol Violation|1|||
149037227|NCT00961636|537614456|FG000|Overall Study|Withdrawal by Subject|29|||
149037228|NCT00961636|537614457|FG001|Overall Study|Withdrawal by Subject|22|||
149037229|NCT00961636|537614458|FG002|Overall Study|Withdrawal by Subject|13|||
149037230|NCT02486588|537614461|FG000|Overall Study|Randomized in error- ineligible|738|||
149037231|NCT02486588|537614462|FG001|Overall Study|Randomized in error- ineligible|750|||
149037232|NCT02486588|537614463|FG002|Overall Study|Randomized in error- ineligible|755|||
149037233|NCT02486588|537614464|FG003|Overall Study|Randomized in error- ineligible|738|||
149037234|NCT02486588|537614465|FG004|Overall Study|Randomized in error- ineligible|746|||
149037235|NCT02486588|537614466|FG005|Overall Study|Randomized in error- ineligible|746|||
149037236|NCT02106442|537614467|FG000|Overall Study|Case Report Forms Uncollected|7|||
149037237|NCT02106442|537614467|FG000|Overall Study|Protocol Deviation|30|||
149037238|NCT03284957|537616210|FG000|Overall Study|Adverse Event|0|||
149037239|NCT03284957|537616211|FG001|Overall Study|Adverse Event|0|||
149037240|NCT03284957|537616212|FG002|Overall Study|Adverse Event|0|||
149037241|NCT03284957|537616213|FG003|Overall Study|Adverse Event|0|||
149037242|NCT03284957|537616214|FG004|Overall Study|Adverse Event|0|||
149037243|NCT03284957|537616215|FG005|Overall Study|Adverse Event|1|||
149037244|NCT03284957|537616216|FG006|Overall Study|Adverse Event|1|||
149037245|NCT03284957|537616217|FG007|Overall Study|Adverse Event|1|||
149037246|NCT03284957|537616218|FG008|Overall Study|Adverse Event|0|||
149037247|NCT03284957|537616219|FG009|Overall Study|Adverse Event|4|||
149037248|NCT03284957|537616220|FG010|Overall Study|Adverse Event|1|||
149037249|NCT03284957|537616221|FG011|Overall Study|Adverse Event|1|||
149037250|NCT03284957|537616222|FG012|Overall Study|Adverse Event|0|||
149037251|NCT03284957|537616223|FG013|Overall Study|Adverse Event|0|||
149037252|NCT03284957|537616224|FG014|Overall Study|Adverse Event|0|||
149037253|NCT03284957|537616225|FG015|Overall Study|Adverse Event|0|||
149037254|NCT03284957|537616210|FG000|Overall Study|Progressive Disease|3|||
149037255|NCT03284957|537616211|FG001|Overall Study|Progressive Disease|3|||
149037256|NCT03284957|537616212|FG002|Overall Study|Progressive Disease|4|||
149037257|NCT03284957|537616213|FG003|Overall Study|Progressive Disease|3|||
149037258|NCT03284957|537616214|FG004|Overall Study|Progressive Disease|3|||
149037259|NCT03284957|537616215|FG005|Overall Study|Progressive Disease|5|||
149037260|NCT03284957|537616216|FG006|Overall Study|Progressive Disease|45|||
149037261|NCT03284957|537616217|FG007|Overall Study|Progressive Disease|8|||
149037262|NCT03284957|537616218|FG008|Overall Study|Progressive Disease|5|||
149037263|NCT03284957|537616219|FG009|Overall Study|Progressive Disease|18|||
149037264|NCT03284957|537616220|FG010|Overall Study|Progressive Disease|7|||
149037265|NCT03284957|537616221|FG011|Overall Study|Progressive Disease|2|||
149037266|NCT03284957|537616222|FG012|Overall Study|Progressive Disease|3|||
149037267|NCT03284957|537616223|FG013|Overall Study|Progressive Disease|1|||
149037268|NCT03284957|537616224|FG014|Overall Study|Progressive Disease|1|||
149037269|NCT03284957|537616225|FG015|Overall Study|Progressive Disease|2|||
149037270|NCT03284957|537616210|FG000|Overall Study|Withdrawal by Subject|0|||
149037271|NCT03284957|537616211|FG001|Overall Study|Withdrawal by Subject|0|||
149037272|NCT03284957|537616212|FG002|Overall Study|Withdrawal by Subject|0|||
149037273|NCT03284957|537616213|FG003|Overall Study|Withdrawal by Subject|0|||
149037274|NCT03284957|537616214|FG004|Overall Study|Withdrawal by Subject|0|||
149037275|NCT03284957|537616215|FG005|Overall Study|Withdrawal by Subject|0|||
149037276|NCT03284957|537616216|FG006|Overall Study|Withdrawal by Subject|0|||
149037277|NCT03284957|537616217|FG007|Overall Study|Withdrawal by Subject|0|||
149037278|NCT03284957|537616218|FG008|Overall Study|Withdrawal by Subject|0|||
149037279|NCT03284957|537616219|FG009|Overall Study|Withdrawal by Subject|2|||
149037280|NCT03284957|537616220|FG010|Overall Study|Withdrawal by Subject|0|||
149037281|NCT03284957|537616221|FG011|Overall Study|Withdrawal by Subject|0|||
149037282|NCT03284957|537616222|FG012|Overall Study|Withdrawal by Subject|0|||
149037283|NCT03284957|537616223|FG013|Overall Study|Withdrawal by Subject|0|||
149037284|NCT03284957|537616224|FG014|Overall Study|Withdrawal by Subject|0|||
149037285|NCT03284957|537616225|FG015|Overall Study|Withdrawal by Subject|0|||
149037286|NCT03284957|537616210|FG000|Overall Study|Other|0|||
149037287|NCT03284957|537616211|FG001|Overall Study|Other|0|||
149037288|NCT03284957|537616212|FG002|Overall Study|Other|0|||
149037289|NCT03284957|537616213|FG003|Overall Study|Other|0|||
149037290|NCT03284957|537616214|FG004|Overall Study|Other|0|||
149037291|NCT03284957|537616215|FG005|Overall Study|Other|0|||
149037292|NCT03284957|537616216|FG006|Overall Study|Other|3|||
149037293|NCT03284957|537616217|FG007|Overall Study|Other|0|||
149037294|NCT03284957|537616218|FG008|Overall Study|Other|1|||
149037295|NCT03284957|537616219|FG009|Overall Study|Other|6|||
149037296|NCT03284957|537616220|FG010|Overall Study|Other|0|||
149037297|NCT03284957|537616221|FG011|Overall Study|Other|0|||
149037298|NCT03284957|537616222|FG012|Overall Study|Other|0|||
149037299|NCT03284957|537616223|FG013|Overall Study|Other|0|||
149037300|NCT03284957|537616224|FG014|Overall Study|Other|2|||
149037301|NCT03284957|537616225|FG015|Overall Study|Other|0|||
149037302|NCT03544515|537616228|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
149037303|NCT03544515|537616229|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
149037304|NCT03544515|537616228|FG000|Overall Study|Lost to Follow-up|2|||
149037305|NCT03544515|537616229|FG001|Overall Study|Lost to Follow-up|0|||
149037306|NCT00446550|537616237|FG000|Overall Study|Adverse Event|1|||
149037307|NCT00446550|537616238|FG001|Overall Study|Adverse Event|0|||
149037308|NCT01759264|537616239|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
149037309|NCT01759264|537616239|FG000|Overall Study|Adverse Event|1|||
149037310|NCT01759264|537616239|FG000|Overall Study|Other|2|||
149037311|NCT01759264|537616239|FG000|Overall Study|Lost to Follow-up|2|||
149037312|NCT01759264|537616239|FG000|Overall Study|Withdrawal by Subject|3|||
149037313|NCT01759264|537616239|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
149037314|NCT02698891|537616240|FG000|Overall Study|Withdrawal by Subject|2|||
149037315|NCT02698891|537616240|FG000|Overall Study|deemed ineligible|1|||
149037316|NCT02698891|537616240|FG000|Overall Study|Adverse Event|9|||
149037317|NCT00711958|537616241|FG000|Overall Study|Withdrawal by Subject|6|||
149037318|NCT00711958|537616242|FG001|Overall Study|Withdrawal by Subject|8|||
149037319|NCT00711958|537616241|FG000|Overall Study|Lack of Efficacy|3|||
149037320|NCT00711958|537616242|FG001|Overall Study|Lack of Efficacy|1|||
149037321|NCT00711958|537616241|FG000|Overall Study|Clinical deterioration|1|||
149037322|NCT00711958|537616242|FG001|Overall Study|Clinical deterioration|0|||
149037323|NCT00711958|537616241|FG000|Overall Study|Adverse Event|9|||
149037324|NCT00711958|537616242|FG001|Overall Study|Adverse Event|7|||
149037325|NCT00711958|537616241|FG000|Overall Study|Protocol Violation|1|||
149037326|NCT00711958|537616242|FG001|Overall Study|Protocol Violation|0|||
149037327|NCT00711958|537616241|FG000|Overall Study|Lost to Follow-up|2|||
149037328|NCT00711958|537616242|FG001|Overall Study|Lost to Follow-up|2|||
149037329|NCT00711958|537616241|FG000|Overall Study|Death|10|||
149037330|NCT00711958|537616242|FG001|Overall Study|Death|5|||
149037331|NCT00711958|537616241|FG000|Overall Study|Progression of disease|1|||
149037332|NCT00711958|537616242|FG001|Overall Study|Progression of disease|0|||
149037333|NCT02383472|537616243|FG000|Overall Study|Withdrawal by Subject|1|||
149037334|NCT02383472|537616244|FG001|Overall Study|Withdrawal by Subject|1|||
149037335|NCT02013830|537616245|FG000|Overall Study|Adverse Event|3|||
149037336|NCT02013830|537616245|FG000|Overall Study|Death|1|||
149037337|NCT02013830|537616245|FG000|Overall Study|Insufficient therapeutic response|25|||
149037338|NCT02013830|537616245|FG000|Overall Study|Refused treatment|1|||
149037339|NCT01111526|537616246|FG000|Overall Study|GVHD Disease Progression|0|||
149037340|NCT01111526|537616247|FG001|Overall Study|GVHD Disease Progression|1|||
149037341|NCT01111526|537616248|FG002|Overall Study|GVHD Disease Progression|2|||
149037342|NCT04424641|537616251|FG000|Overall Study|Death|1|||
149037343|NCT04424641|537616252|FG001|Overall Study|Death|2|||
149037344|NCT04424641|537616253|FG002|Overall Study|Death|3|||
149037345|NCT04424641|537616254|FG003|Overall Study|Death|0|||
149037346|NCT04424641|537616255|FG004|Overall Study|Death|3|||
149037347|NCT04424641|537616256|FG005|Overall Study|Death|0|||
149037348|NCT04424641|537616257|FG006|Overall Study|Death|1|||
149037349|NCT04424641|537616258|FG007|Overall Study|Death|2|||
149037350|NCT04424641|537616251|FG000|Overall Study|Sponsor decision|0|||
149037351|NCT04424641|537616252|FG001|Overall Study|Sponsor decision|2|||
149037352|NCT04424641|537616253|FG002|Overall Study|Sponsor decision|3|||
149037353|NCT04424641|537616254|FG003|Overall Study|Sponsor decision|7|||
149037354|NCT04424641|537616255|FG004|Overall Study|Sponsor decision|2|||
149037355|NCT04424641|537616256|FG005|Overall Study|Sponsor decision|2|||
149037356|NCT04424641|537616257|FG006|Overall Study|Sponsor decision|3|||
149037357|NCT04424641|537616258|FG007|Overall Study|Sponsor decision|4|||
149037358|NCT04424641|537616251|FG000|Overall Study|Withdrawal by Subject|0|||
149037359|NCT04424641|537616252|FG001|Overall Study|Withdrawal by Subject|0|||
149037360|NCT04424641|537616253|FG002|Overall Study|Withdrawal by Subject|0|||
149037361|NCT04424641|537616254|FG003|Overall Study|Withdrawal by Subject|0|||
149037362|NCT04424641|537616255|FG004|Overall Study|Withdrawal by Subject|1|||
149037363|NCT04424641|537616256|FG005|Overall Study|Withdrawal by Subject|0|||
149037364|NCT04424641|537616257|FG006|Overall Study|Withdrawal by Subject|0|||
149037365|NCT04424641|537616258|FG007|Overall Study|Withdrawal by Subject|0|||
149037366|NCT04424641|537616251|FG000|Overall Study|Other|0|||
149037367|NCT04424641|537616252|FG001|Overall Study|Other|0|||
149037368|NCT04424641|537616253|FG002|Overall Study|Other|1|||
149037369|NCT04424641|537616254|FG003|Overall Study|Other|0|||
149037370|NCT04424641|537616255|FG004|Overall Study|Other|0|||
149037371|NCT04424641|537616256|FG005|Overall Study|Other|0|||
149037372|NCT04424641|537616257|FG006|Overall Study|Other|0|||
149037373|NCT04424641|537616258|FG007|Overall Study|Other|0|||
149037374|NCT03557008|537616267|FG000|Overall Study|Withdrawal by Subject|2|||
149037375|NCT03557008|537616268|FG001|Overall Study|Withdrawal by Subject|2|||
149037376|NCT03557008|537616267|FG000|Overall Study|Early termination from study|3|||
149037377|NCT03557008|537616268|FG001|Overall Study|Early termination from study|1|||
149037378|NCT00762606|537616269|FG000|Overall Study|Lost to Follow-up|18|||
149037379|NCT00762606|537616270|FG001|Overall Study|Lost to Follow-up|13|||
149037380|NCT01147341|537616273|FG000|Double Blind Period|Lack of Efficacy|1|||
149037381|NCT01147341|537616274|FG001|Double Blind Period|Lack of Efficacy|1|||
149037382|NCT01147341|537616273|FG000|Double Blind Period|Withdrawal by Subject|0|||
149037383|NCT01147341|537616274|FG001|Double Blind Period|Withdrawal by Subject|1|||
149037384|NCT01147341|537616273|FG000|Open Label Period|Lack of Efficacy|3|||
149037385|NCT01147341|537616274|FG001|Open Label Period|Lack of Efficacy|0|||
149037386|NCT01147341|537616273|FG000|Open Label Period|Subject moved|1|||
149037387|NCT01147341|537616274|FG001|Open Label Period|Subject moved|0|||
149037388|NCT00949975|537616282|FG000|Overall Study|Voluntary discontinuation|6|||
149037389|NCT00949975|537616283|FG001|Overall Study|Voluntary discontinuation|5|||
149037390|NCT00949975|537616284|FG002|Overall Study|Voluntary discontinuation|3|||
149037391|NCT00949975|537616285|FG003|Overall Study|Voluntary discontinuation|6|||
149037392|NCT00949975|537616282|FG000|Overall Study|Adverse Event|11|||
149037393|NCT00949975|537616283|FG001|Overall Study|Adverse Event|11|||
149037394|NCT00949975|537616284|FG002|Overall Study|Adverse Event|10|||
149037395|NCT00949975|537616285|FG003|Overall Study|Adverse Event|10|||
149002953|NCT03779906|537487706|FG000|Overall Study|COVID pandemic|1|||
149002954|NCT01984697|537489439|FG000|Overall Study|Adverse Event|0|||
149002955|NCT01984697|537489440|FG001|Overall Study|Adverse Event|0|||
149002956|NCT01984697|537489441|FG002|Overall Study|Adverse Event|2|||
149002957|NCT01984697|537489442|FG003|Overall Study|Adverse Event|0|||
149002958|NCT01984697|537489443|FG004|Overall Study|Adverse Event|0|||
149002959|NCT01984697|537489439|FG000|Overall Study|Lost to Follow-up|14|||
149002960|NCT01984697|537489440|FG001|Overall Study|Lost to Follow-up|5|||
149002961|NCT01984697|537489441|FG002|Overall Study|Lost to Follow-up|10|||
149002962|NCT01984697|537489442|FG003|Overall Study|Lost to Follow-up|6|||
149002963|NCT01984697|537489443|FG004|Overall Study|Lost to Follow-up|21|||
149002964|NCT01984697|537489439|FG000|Overall Study|Physician Decision|3|||
149002965|NCT01984697|537489440|FG001|Overall Study|Physician Decision|0|||
149002966|NCT01984697|537489441|FG002|Overall Study|Physician Decision|0|||
149002967|NCT01984697|537489442|FG003|Overall Study|Physician Decision|1|||
149002968|NCT01984697|537489443|FG004|Overall Study|Physician Decision|0|||
149002969|NCT01984697|537489439|FG000|Overall Study|Protocol Violation|8|||
149002970|NCT01984697|537489440|FG001|Overall Study|Protocol Violation|5|||
149002971|NCT01984697|537489441|FG002|Overall Study|Protocol Violation|3|||
149002972|NCT01984697|537489442|FG003|Overall Study|Protocol Violation|2|||
149002973|NCT01984697|537489443|FG004|Overall Study|Protocol Violation|0|||
149002974|NCT01984697|537489439|FG000|Overall Study|Withdrawal by Subject|15|||
149002975|NCT01984697|537489440|FG001|Overall Study|Withdrawal by Subject|21|||
149002976|NCT01984697|537489441|FG002|Overall Study|Withdrawal by Subject|13|||
149002977|NCT01984697|537489442|FG003|Overall Study|Withdrawal by Subject|11|||
149002978|NCT01984697|537489443|FG004|Overall Study|Withdrawal by Subject|13|||
149002979|NCT01984697|537489439|FG000|Overall Study|Missed last follow-up visit|1|||
149002980|NCT01984697|537489440|FG001|Overall Study|Missed last follow-up visit|0|||
149002981|NCT01984697|537489441|FG002|Overall Study|Missed last follow-up visit|0|||
149002982|NCT01984697|537489442|FG003|Overall Study|Missed last follow-up visit|0|||
149002983|NCT01984697|537489443|FG004|Overall Study|Missed last follow-up visit|0|||
149002984|NCT01984697|537489439|FG000|Overall Study|Death|0|||
149002985|NCT01984697|537489440|FG001|Overall Study|Death|0|||
149002986|NCT01984697|537489441|FG002|Overall Study|Death|0|||
149002987|NCT01984697|537489442|FG003|Overall Study|Death|1|||
149002988|NCT01984697|537489443|FG004|Overall Study|Death|0|||
149002989|NCT01984697|537489439|FG000|Overall Study|Pregnancy|2|||
149002990|NCT01984697|537489440|FG001|Overall Study|Pregnancy|0|||
149002991|NCT01984697|537489441|FG002|Overall Study|Pregnancy|1|||
149002992|NCT01984697|537489442|FG003|Overall Study|Pregnancy|0|||
149002993|NCT01984697|537489443|FG004|Overall Study|Pregnancy|1|||
149002994|NCT04737109|537489451|FG000|Study Treatment|Disease Progression|5|||
149002995|NCT04737109|537489452|FG001|Study Treatment|Disease Progression|0|||
149002996|NCT04737109|537489453|FG002|Study Treatment|Disease Progression|0|||
149002997|NCT04737109|537489454|FG003|Study Treatment|Disease Progression|0|||
149002998|NCT04737109|537489451|FG000|Study Treatment|Death on study|1|||
149002999|NCT04737109|537489452|FG001|Study Treatment|Death on study|0|||
149003000|NCT04737109|537489453|FG002|Study Treatment|Death on study|0|||
149003001|NCT04737109|537489454|FG003|Study Treatment|Death on study|0|||
149037396|NCT00949975|537616282|FG000|Overall Study|Safety reason|0|||
149037397|NCT00949975|537616283|FG001|Overall Study|Safety reason|1|||
149037398|NCT00949975|537616284|FG002|Overall Study|Safety reason|0|||
149037399|NCT00949975|537616285|FG003|Overall Study|Safety reason|0|||
149037400|NCT00949975|537616282|FG000|Overall Study|Study-specific criteria|0|||
149037401|NCT00949975|537616283|FG001|Overall Study|Study-specific criteria|1|||
149037402|NCT00949975|537616284|FG002|Overall Study|Study-specific criteria|1|||
149037403|NCT00949975|537616285|FG003|Overall Study|Study-specific criteria|0|||
149037404|NCT00949975|537616282|FG000|Overall Study|Incorrect enrolment|5|||
149037405|NCT00949975|537616283|FG001|Overall Study|Incorrect enrolment|10|||
149037406|NCT00949975|537616284|FG002|Overall Study|Incorrect enrolment|4|||
149037407|NCT00949975|537616285|FG003|Overall Study|Incorrect enrolment|7|||
149037408|NCT00949975|537616282|FG000|Overall Study|Severe non-compliance|3|||
149037409|NCT00949975|537616283|FG001|Overall Study|Severe non-compliance|1|||
149037410|NCT00949975|537616284|FG002|Overall Study|Severe non-compliance|0|||
149037411|NCT00949975|537616285|FG003|Overall Study|Severe non-compliance|2|||
149037412|NCT00949975|537616282|FG000|Overall Study|Lost to Follow-up|1|||
149037413|NCT00949975|537616283|FG001|Overall Study|Lost to Follow-up|0|||
149037414|NCT00949975|537616284|FG002|Overall Study|Lost to Follow-up|1|||
149037415|NCT00949975|537616285|FG003|Overall Study|Lost to Follow-up|3|||
149037416|NCT00949975|537616282|FG000|Overall Study|Other|1|||
149037417|NCT00949975|537616283|FG001|Overall Study|Other|0|||
149037418|NCT00949975|537616284|FG002|Overall Study|Other|0|||
149037419|NCT00949975|537616285|FG003|Overall Study|Other|0|||
149037420|NCT05641311|537616288|FG000|Dosing Period 1|Adverse Event|1|||
149037421|NCT05641311|537616289|FG001|Dosing Period 1|Adverse Event|0|||
149037422|NCT00922207|537616294|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
149037423|NCT00922207|537616295|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
149037424|NCT00922207|537616296|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
149037425|NCT00922207|537616294|FG000|Overall Study|Insufficient Therapeutic Response|0|||
149037426|NCT00922207|537616295|FG001|Overall Study|Insufficient Therapeutic Response|0|||
149037427|NCT00922207|537616296|FG002|Overall Study|Insufficient Therapeutic Response|1|||
149037428|NCT00922207|537616294|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
149037429|NCT00922207|537616295|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
149037430|NCT00922207|537616296|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
149037431|NCT00922207|537616294|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
149037432|NCT00922207|537616295|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
149037433|NCT00922207|537616296|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
149037434|NCT00922207|537616294|FG000|Overall Study|Withdrew Consent|2|||
149037435|NCT00922207|537616295|FG001|Overall Study|Withdrew Consent|5|||
149037436|NCT00922207|537616296|FG002|Overall Study|Withdrew Consent|2|||
149037437|NCT00922207|537616294|FG000|Overall Study|Abnormality of Laboratory Test|0|||
149037438|NCT00922207|537616295|FG001|Overall Study|Abnormality of Laboratory Test|1|||
149037439|NCT00922207|537616296|FG002|Overall Study|Abnormality of Laboratory Test|1|||
149037440|NCT01802632|537616297|FG000|Overall Study|Death|28|||
149037441|NCT01802632|537616298|FG001|Overall Study|Death|1|||
149037442|NCT01802632|537616299|FG002|Overall Study|Death|38|||
149037443|NCT01802632|537616300|FG003|Overall Study|Death|0|||
149037444|NCT01802632|537616301|FG004|Overall Study|Death|2|||
149037445|NCT01802632|537616302|FG005|Overall Study|Death|0|||
149037446|NCT01802632|537616297|FG000|Overall Study|Withdrawal by Subject|4|||
149037447|NCT01802632|537616298|FG001|Overall Study|Withdrawal by Subject|2|||
149037448|NCT01802632|537616299|FG002|Overall Study|Withdrawal by Subject|7|||
149037449|NCT01802632|537616300|FG003|Overall Study|Withdrawal by Subject|3|||
149037450|NCT01802632|537616301|FG004|Overall Study|Withdrawal by Subject|0|||
149037451|NCT01802632|537616302|FG005|Overall Study|Withdrawal by Subject|1|||
149037452|NCT01802632|537616297|FG000|Overall Study|Objective Disease Progression|1|||
148879869|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
149003002|NCT03092375|537489455|FG000|Overall Study|Lack of Efficacy|0|||
149003003|NCT03092375|537489456|FG001|Overall Study|Lack of Efficacy|1|||
149003004|NCT03092375|537489457|FG002|Overall Study|Lack of Efficacy|1|||
149003005|NCT03092375|537489458|FG003|Overall Study|Lack of Efficacy|0|||
149003006|NCT00949715|537489459|FG000|Overall Study|Physician Decision|1|||
149003007|NCT00949715|537489460|FG001|Overall Study|Physician Decision|0|||
149003008|NCT00949715|537489459|FG000|Overall Study|Lost to Follow-up|1|||
149003009|NCT00949715|537489460|FG001|Overall Study|Lost to Follow-up|0|||
149003010|NCT00949715|537489459|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
149003011|NCT00949715|537489460|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
149003012|NCT01582789|537489462|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
149003013|NCT01582789|537489463|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
149003014|NCT00861614|537489464|FG000|Overall Study|Disease Progression|182|||
149003015|NCT00861614|537489465|FG001|Overall Study|Disease Progression|263|||
149003016|NCT00861614|537489464|FG000|Overall Study|Study Drug Toxicity|79|||
149003017|NCT00861614|537489465|FG001|Overall Study|Study Drug Toxicity|6|||
149003018|NCT00861614|537489464|FG000|Overall Study|Death|32|||
149003019|NCT00861614|537489465|FG001|Overall Study|Death|19|||
148879870|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
148879871|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
148879872|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
148879873|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
148879874|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
148879875|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
148879876|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
148879877|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
148879878|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
149003020|NCT00861614|537489464|FG000|Overall Study|Adverse Event|27|||
149003021|NCT00861614|537489465|FG001|Overall Study|Adverse Event|23|||
149003022|NCT00861614|537489464|FG000|Overall Study|Withdrawal by Subject|34|||
149003023|NCT00861614|537489465|FG001|Overall Study|Withdrawal by Subject|35|||
149003024|NCT00861614|537489464|FG000|Overall Study|Other|17|||
149003025|NCT00861614|537489465|FG001|Overall Study|Other|22|||
149003026|NCT02276066|537489466|FG000|Overall Study|Lost to Follow-up|21|||
149003027|NCT02276066|537489467|FG001|Overall Study|Lost to Follow-up|11|||
149003028|NCT05050578|537489468|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
149003029|NCT05050578|537489469|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
149003030|NCT05050578|537489468|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
149003031|NCT05050578|537489469|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
149003032|NCT05050578|537489468|FG000|Period 2, 30 Days|Protocol Violation|0|||
149003033|NCT05050578|537489469|FG001|Period 2, 30 Days|Protocol Violation|1|||
149003034|NCT02243280|537489470|FG000|Treated|Adverse Event|1|||
149003035|NCT02243280|537489471|FG001|Treated|Adverse Event|0|||
149003036|NCT02243280|537489472|FG002|Treated|Adverse Event|0|||
149003037|NCT02243280|537489473|FG003|Treated|Adverse Event|0|||
149003038|NCT02243280|537489474|FG004|Treated|Adverse Event|0|||
149003039|NCT02243280|537489475|FG005|Treated|Adverse Event|0|||
149003040|NCT02243280|537489476|FG006|Treated|Adverse Event|0|||
149003041|NCT02243280|537489477|FG007|Treated|Adverse Event|0|||
149003042|NCT02243280|537489478|FG008|Treated|Adverse Event|0|||
149003043|NCT02243280|537489479|FG009|Treated|Adverse Event|0|||
149003044|NCT02243280|537489480|FG010|Treated|Adverse Event|1|||
149003045|NCT02243280|537489470|FG000|Treated|Lost to Follow-up|0|||
149003046|NCT02243280|537489471|FG001|Treated|Lost to Follow-up|0|||
149003047|NCT02243280|537489472|FG002|Treated|Lost to Follow-up|0|||
149003048|NCT02243280|537489473|FG003|Treated|Lost to Follow-up|0|||
149003049|NCT02243280|537489474|FG004|Treated|Lost to Follow-up|0|||
149003050|NCT02243280|537489475|FG005|Treated|Lost to Follow-up|0|||
149003051|NCT02243280|537489476|FG006|Treated|Lost to Follow-up|0|||
149003052|NCT02243280|537489477|FG007|Treated|Lost to Follow-up|0|||
149003053|NCT02243280|537489478|FG008|Treated|Lost to Follow-up|1|||
149003054|NCT02243280|537489479|FG009|Treated|Lost to Follow-up|0|||
149003055|NCT02243280|537489480|FG010|Treated|Lost to Follow-up|2|||
149003056|NCT03386032|537489482|FG000|Overall Study|Lack of Efficacy|6|||
149003057|NCT03386032|537489483|FG001|Overall Study|Lack of Efficacy|2|||
149003058|NCT03386032|537489484|FG002|Overall Study|Lack of Efficacy|0|||
149003059|NCT03386032|537489482|FG000|Overall Study|Adverse Event|2|||
149003060|NCT03386032|537489483|FG001|Overall Study|Adverse Event|2|||
149003061|NCT03386032|537489484|FG002|Overall Study|Adverse Event|0|||
149003062|NCT03386032|537489482|FG000|Overall Study|Withdrawal by Subject|1|||
149003063|NCT03386032|537489483|FG001|Overall Study|Withdrawal by Subject|0|||
149003064|NCT03386032|537489484|FG002|Overall Study|Withdrawal by Subject|0|||
149003065|NCT03386032|537489482|FG000|Overall Study|Lost to Follow-up|9|||
149003066|NCT03386032|537489483|FG001|Overall Study|Lost to Follow-up|3|||
149003067|NCT03386032|537489484|FG002|Overall Study|Lost to Follow-up|0|||
149003068|NCT01807156|537489485|FG000|Overall Study|Physician Decision|1|||
149003069|NCT02710292|537489490|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
149003070|NCT02710292|537489491|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
149003071|NCT02710292|537489490|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
149003072|NCT02710292|537489491|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
149003073|NCT03122119|537489492|FG000|Overall Study|Did not meet eligibility critria|1|||
149003074|NCT02364180|537489498|FG000|Overall Study|Screen Fail|1|||
149003075|NCT01783418|537489499|FG000|Overall Study|Withdrawal by Subject|1|||
149003076|NCT01783418|537489500|FG001|Overall Study|Withdrawal by Subject|0|||
149003077|NCT00089141|537489501|FG000|Overall Study|Termination of trial|18|||
149003078|NCT00089141|537489502|FG001|Overall Study|Termination of trial|24|||
149003079|NCT00840801|537489503|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
149003080|NCT00840801|537489504|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
149003081|NCT00840801|537489505|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
149003082|NCT00840801|537489503|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
149003083|NCT00840801|537489504|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
149037453|NCT01802632|537616298|FG001|Overall Study|Objective Disease Progression|12|||
149037454|NCT01802632|537616299|FG002|Overall Study|Objective Disease Progression|104|||
149037455|NCT01802632|537616300|FG003|Overall Study|Objective Disease Progression|6|||
149037456|NCT01802632|537616301|FG004|Overall Study|Objective Disease Progression|4|||
149037457|NCT01802632|537616302|FG005|Overall Study|Objective Disease Progression|4|||
149037458|NCT01802632|537616297|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
149037459|NCT01802632|537616298|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
149037460|NCT01802632|537616299|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
149037461|NCT01802632|537616300|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
149037462|NCT01802632|537616301|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
148879879|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
148879880|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
148879881|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
148879882|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
148879883|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
148879884|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
148879885|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
148879886|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
148879887|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
148879888|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
148879889|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
148879890|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
148879891|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148879892|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
148879893|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
148879894|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
148879895|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
148879896|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
148879897|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
148879898|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
148879899|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
148879900|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
148879901|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
148879902|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
148879903|NCT01053988|537038178|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
148879904|NCT01053988|537038179|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
148879905|NCT01053988|537038180|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
148879906|NCT01053988|537038181|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
148879907|NCT01053988|537038182|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
148879908|NCT01053988|537038183|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
148879909|NCT00719355|537038184|FG000|Overall Study|Death|0|||
148879910|NCT00719355|537038185|FG001|Overall Study|Death|1|||
148879911|NCT00719355|537038184|FG000|Overall Study|Medical|14|||
148879912|NCT00719355|537038185|FG001|Overall Study|Medical|5|||
148879913|NCT00719355|537038184|FG000|Overall Study|Compliance|4|||
148879914|NCT00719355|537038185|FG001|Overall Study|Compliance|6|||
148879915|NCT00719355|537038184|FG000|Overall Study|Moved|0|||
148879916|NCT00719355|537038185|FG001|Overall Study|Moved|1|||
148879917|NCT01824355|537038186|FG000|Overall Study|Adverse Event|2|||
148879918|NCT01824355|537038186|FG000|Overall Study|unevaluable reference method results per|1|||
148879919|NCT00836186|537038189|FG000|Overall Study|Blood could not be drawn|1|||
148879920|NCT04124705|537038192|FG000|Titration Period|Adverse Event|9|||
148879921|NCT04124705|537038193|FG001|Titration Period|Adverse Event|5|||
148879922|NCT04124705|537038192|FG000|Titration Period|Withdrawal by Subject|6|||
148879923|NCT04124705|537038193|FG001|Titration Period|Withdrawal by Subject|3|||
148879924|NCT04124705|537038192|FG000|Titration Period|Lost to Follow-up|0|||
148879925|NCT04124705|537038193|FG001|Titration Period|Lost to Follow-up|1|||
149037463|NCT01802632|537616302|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
149037464|NCT01802632|537616297|FG000|Overall Study|Other (not specified)|0|||
149037465|NCT01802632|537616298|FG001|Overall Study|Other (not specified)|0|||
149037466|NCT01802632|537616299|FG002|Overall Study|Other (not specified)|7|||
149037467|NCT01802632|537616300|FG003|Overall Study|Other (not specified)|1|||
148879926|NCT04124705|537038192|FG000|Titration Period|Death|1|||
148879927|NCT04124705|537038193|FG001|Titration Period|Death|1|||
148879928|NCT04124705|537038192|FG000|Titration Period|Lack of Efficacy|2|||
149037468|NCT01802632|537616301|FG004|Overall Study|Other (not specified)|0|||
149037469|NCT01802632|537616302|FG005|Overall Study|Other (not specified)|1|||
148879929|NCT04124705|537038193|FG001|Titration Period|Lack of Efficacy|0|||
148879930|NCT04124705|537038192|FG000|Titration Period|Physician Decision|2|||
148879931|NCT04124705|537038193|FG001|Titration Period|Physician Decision|0|||
149037470|NCT03299816|537616303|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
149037471|NCT03299816|537616304|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
149037472|NCT03299816|537616303|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
149037473|NCT03299816|537616304|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
149037474|NCT03299816|537616303|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
149037475|NCT03299816|537616304|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
149037476|NCT00367991|537616307|FG000|Overall Study|Withdrawal by Subject|1|||
149037477|NCT00367991|537616308|FG001|Overall Study|Withdrawal by Subject|1|||
149037478|NCT00367991|537616307|FG000|Overall Study|Adverse Event|1|||
149037479|NCT00367991|537616308|FG001|Overall Study|Adverse Event|1|||
149037480|NCT03515304|537616310|FG000|Overall Study|Lost to Follow-up|0|||
149037481|NCT03515304|537616311|FG001|Overall Study|Lost to Follow-up|3|||
149037482|NCT00324038|537616315|FG000|Overall Study|Adverse Event|38|||
149037483|NCT00324038|537616316|FG001|Overall Study|Adverse Event|23|||
149037484|NCT00324038|537616315|FG000|Overall Study|Lack of Efficacy|5|||
149037485|NCT00324038|537616316|FG001|Overall Study|Lack of Efficacy|13|||
149037486|NCT00324038|537616315|FG000|Overall Study|Lost to Follow-up|0|||
149037487|NCT00324038|537616316|FG001|Overall Study|Lost to Follow-up|2|||
149037488|NCT00324038|537616315|FG000|Overall Study|Other|6|||
149037489|NCT00324038|537616316|FG001|Overall Study|Other|13|||
149037490|NCT02031471|537616321|FG000|24 Week Treatment Period|Adverse Event|6|||
149037491|NCT02031471|537616321|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
149037492|NCT02031471|537616321|FG000|24 Week Treatment Period|Protocol Violation|1|||
149037493|NCT02031471|537616321|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
149037494|NCT02031471|537616321|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
149037495|NCT02031471|537616321|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
149037496|NCT02031471|537616321|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
149037497|NCT03070483|537616322|FG000|Overall Study|Lost to Follow-up|2|||
149037498|NCT00361283|537616326|FG000|Overall Study|Lost to Follow-up|27|||
149037499|NCT01837641|537616327|FG000|Overall Study|Sponsor decision|1|||
149037500|NCT01837641|537616328|FG001|Overall Study|Sponsor decision|0|||
149037501|NCT01837641|537616329|FG002|Overall Study|Sponsor decision|0|||
149037502|NCT01837641|537616330|FG003|Overall Study|Sponsor decision|0|||
149037503|NCT01837641|537616331|FG004|Overall Study|Sponsor decision|0|||
149037504|NCT01837641|537616332|FG005|Overall Study|Sponsor decision|1|||
149037505|NCT01837641|537616333|FG006|Overall Study|Sponsor decision|0|||
149037506|NCT01837641|537616334|FG007|Overall Study|Sponsor decision|0|||
149037507|NCT01837641|537616327|FG000|Overall Study|Adverse Event|0|||
149037508|NCT01837641|537616328|FG001|Overall Study|Adverse Event|0|||
149037509|NCT01837641|537616329|FG002|Overall Study|Adverse Event|0|||
149037510|NCT01837641|537616330|FG003|Overall Study|Adverse Event|0|||
149037511|NCT01837641|537616331|FG004|Overall Study|Adverse Event|0|||
149037512|NCT01837641|537616332|FG005|Overall Study|Adverse Event|1|||
149037513|NCT01837641|537616333|FG006|Overall Study|Adverse Event|0|||
149037514|NCT01837641|537616334|FG007|Overall Study|Adverse Event|0|||
149037515|NCT01837641|537616327|FG000|Overall Study|Withdrawal by Subject|0|||
149037516|NCT01837641|537616328|FG001|Overall Study|Withdrawal by Subject|0|||
149037517|NCT01837641|537616329|FG002|Overall Study|Withdrawal by Subject|0|||
149037518|NCT01837641|537616330|FG003|Overall Study|Withdrawal by Subject|0|||
149037519|NCT01837641|537616331|FG004|Overall Study|Withdrawal by Subject|1|||
149037520|NCT01837641|537616332|FG005|Overall Study|Withdrawal by Subject|0|||
148879932|NCT04124705|537038192|FG000|Titration Period|Non-compliance with Study Drug|2|||
148879933|NCT04124705|537038193|FG001|Titration Period|Non-compliance with Study Drug|0|||
148879934|NCT04124705|537038192|FG000|Titration Period|Other|4|||
148879935|NCT04124705|537038193|FG001|Titration Period|Other|9|||
148879936|NCT04124705|537038192|FG000|Stabilization Period|Adverse Event|4|||
148879937|NCT04124705|537038193|FG001|Stabilization Period|Adverse Event|2|||
148879938|NCT04124705|537038192|FG000|Stabilization Period|Withdrawal by Subject|1|||
148879939|NCT04124705|537038193|FG001|Stabilization Period|Withdrawal by Subject|1|||
148879940|NCT04124705|537038192|FG000|Stabilization Period|Lost to Follow-up|0|||
148879941|NCT04124705|537038193|FG001|Stabilization Period|Lost to Follow-up|1|||
149037521|NCT01837641|537616333|FG006|Overall Study|Withdrawal by Subject|1|||
149037522|NCT01837641|537616334|FG007|Overall Study|Withdrawal by Subject|0|||
149037523|NCT01579916|537616335|FG000|Overall Study|Lost to Follow-up|6|||
148879942|NCT04124705|537038192|FG000|Stabilization Period|Lack of Efficacy|4|||
148879943|NCT04124705|537038193|FG001|Stabilization Period|Lack of Efficacy|2|||
148879944|NCT04124705|537038192|FG000|Stabilization Period|Protocol Deviation|0|||
148879945|NCT04124705|537038193|FG001|Stabilization Period|Protocol Deviation|2|||
148879946|NCT04124705|537038192|FG000|Stabilization Period|Other|2|||
149037524|NCT01579916|537616336|FG001|Overall Study|Lost to Follow-up|1|||
149037525|NCT01579916|537616335|FG000|Overall Study|Withdrawal by Subject|1|||
149037526|NCT01579916|537616336|FG001|Overall Study|Withdrawal by Subject|1|||
149037527|NCT01579916|537616335|FG000|Overall Study|Death|1|||
149037528|NCT01579916|537616336|FG001|Overall Study|Death|0|||
149037529|NCT03264456|537616337|FG000|Overall Study|Withdrawal by Subject|3|||
149037530|NCT03264456|537616337|FG000|Overall Study|Lost to Follow-up|1|||
148879947|NCT04124705|537038193|FG001|Stabilization Period|Other|2|||
148879948|NCT04427072|537038198|FG000|Randomized Treatment Phase|Progressive disease|9|||
148879949|NCT04427072|537038199|FG001|Randomized Treatment Phase|Progressive disease|4|||
148879950|NCT04427072|537038198|FG000|Randomized Treatment Phase|Adverse Event|3|||
148879951|NCT04427072|537038199|FG001|Randomized Treatment Phase|Adverse Event|1|||
149003084|NCT00840801|537489505|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
149003085|NCT00840801|537489503|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
149003086|NCT00840801|537489504|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
149003087|NCT00840801|537489505|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
149003088|NCT00840801|537489503|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
149003089|NCT00840801|537489504|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
149003090|NCT00840801|537489505|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
149003091|NCT01242748|537489506|FG000|Overall Study|Adverse Event|10|||
149003092|NCT01242748|537489507|FG001|Overall Study|Adverse Event|5|||
149003093|NCT01242748|537489506|FG000|Overall Study|Lost to Follow-up|6|||
149003094|NCT01242748|537489507|FG001|Overall Study|Lost to Follow-up|2|||
149003095|NCT01242748|537489506|FG000|Overall Study|Physician Decision|3|||
149003096|NCT01242748|537489507|FG001|Overall Study|Physician Decision|2|||
149003097|NCT01242748|537489506|FG000|Overall Study|Protocol Violation|1|||
149003098|NCT01242748|537489507|FG001|Overall Study|Protocol Violation|0|||
149003099|NCT01242748|537489506|FG000|Overall Study|Withdrawal by Subject|10|||
149003100|NCT01242748|537489507|FG001|Overall Study|Withdrawal by Subject|2|||
149003101|NCT01242748|537489506|FG000|Overall Study|Miscellaneous reasons|8|||
149003102|NCT01242748|537489507|FG001|Overall Study|Miscellaneous reasons|3|||
149003103|NCT00335452|537489508|FG000|Overall Study|Death|156|||
149003104|NCT00335452|537489509|FG001|Overall Study|Death|144|||
149003105|NCT00335452|537489510|FG002|Overall Study|Death|158|||
149003106|NCT00335452|537489511|FG003|Overall Study|Death|129|||
149003107|NCT00335452|537489508|FG000|Overall Study|Lost to Follow-up|2|||
149003108|NCT00335452|537489509|FG001|Overall Study|Lost to Follow-up|3|||
149003109|NCT00335452|537489510|FG002|Overall Study|Lost to Follow-up|1|||
149003110|NCT00335452|537489511|FG003|Overall Study|Lost to Follow-up|2|||
149003111|NCT02736825|537489513|FG000|Overall Study|Lost to Follow-up|10|||
149003112|NCT02736825|537489514|FG001|Overall Study|Lost to Follow-up|11|||
149003113|NCT02736825|537489513|FG000|Overall Study|Early Termination|0|||
149003114|NCT02736825|537489514|FG001|Overall Study|Early Termination|1|||
149003115|NCT00790452|537489515|FG000|Overall Study|Drug supply issue|1|||
149003116|NCT00790452|537489516|FG001|Overall Study|Drug supply issue|0|||
149003117|NCT02940574|537489517|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
149003118|NCT02940574|537489518|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
149003119|NCT02940574|537489517|FG000|1-year Follow-up|Lost to Follow-up|3|||
149003120|NCT02940574|537489518|FG001|1-year Follow-up|Lost to Follow-up|4|||
149003121|NCT00659490|537489521|FG000|Overall Study|Lost to Follow-up|2|||
149003122|NCT00659490|537489522|FG001|Overall Study|Lost to Follow-up|0|||
149003123|NCT00659490|537489523|FG002|Overall Study|Lost to Follow-up|1|||
149003124|NCT05674890|537489524|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
149003125|NCT05674890|537489525|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
149003126|NCT05674890|537489524|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
149003127|NCT05674890|537489525|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
149003128|NCT05674890|537489524|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
149003129|NCT05674890|537489525|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
149003130|NCT00827541|537489526|FG000|Overall Study|Exitus|1|||
149003131|NCT00827541|537489527|FG001|Overall Study|Exitus|8|||
149003132|NCT00827541|537489526|FG000|Overall Study|Other|1|||
149003133|NCT00827541|537489527|FG001|Overall Study|Other|3|||
149003134|NCT00827541|537489526|FG000|Overall Study|Pathogen not susceptible|1|||
149003135|NCT00827541|537489527|FG001|Overall Study|Pathogen not susceptible|0|||
149003136|NCT00827541|537489526|FG000|Overall Study|Lack of effectiveness|1|||
149003137|NCT00827541|537489527|FG001|Overall Study|Lack of effectiveness|0|||
149003138|NCT01649232|537489528|FG000|Overall Study|Physician Decision|2|||
149003139|NCT01649232|537489529|FG001|Overall Study|Physician Decision|0|||
149003140|NCT01750879|537489530|FG000|Overall Study|Adverse Event|8|||
149003141|NCT01750879|537489531|FG001|Overall Study|Adverse Event|0|||
149003142|NCT01750879|537489530|FG000|Overall Study|Lack of Efficacy|1|||
149003143|NCT01750879|537489531|FG001|Overall Study|Lack of Efficacy|0|||
149003144|NCT01750879|537489530|FG000|Overall Study|Withdrawal by Subject|1|||
149003145|NCT01750879|537489531|FG001|Overall Study|Withdrawal by Subject|0|||
149003146|NCT01750879|537489530|FG000|Overall Study|Did not complete per protocol|0|||
149003147|NCT01750879|537489531|FG001|Overall Study|Did not complete per protocol|3|||
149003148|NCT02421666|537489532|FG000|6-month Follow-up|Lost to Follow-up|8|||
149003149|NCT02421666|537489533|FG001|6-month Follow-up|Lost to Follow-up|7|||
149003150|NCT02421666|537489532|FG000|6-month Follow-up|Withdrawal by Subject|5|||
149003151|NCT02421666|537489533|FG001|6-month Follow-up|Withdrawal by Subject|6|||
149003152|NCT02421666|537489532|FG000|12-month Follow-up|Lost to Follow-up|5|||
148879952|NCT04427072|537038198|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
148879953|NCT04427072|537038199|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
148879954|NCT04427072|537038198|FG000|Randomized Treatment Phase|Death|0|||
148879955|NCT04427072|537038199|FG001|Randomized Treatment Phase|Death|1|||
148879956|NCT04427072|537038198|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
148879957|NCT04427072|537038199|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
148879958|NCT04427072|537038198|FG000|Extension Treatment Phase|Progressive disease|0|||
148879959|NCT04427072|537038199|FG001|Extension Treatment Phase|Progressive disease|5|||
149003153|NCT02421666|537489533|FG001|12-month Follow-up|Lost to Follow-up|5|||
149003154|NCT02421666|537489532|FG000|12-month Follow-up|Withdrawal by Subject|6|||
149003155|NCT02421666|537489533|FG001|12-month Follow-up|Withdrawal by Subject|11|||
149003156|NCT04810221|537489534|FG000|Overall Study|Physician Decision|3|||
149003157|NCT03642938|537489535|FG000|Overall Study|Withdrawal by Subject|0|||
149003158|NCT03642938|537489536|FG001|Overall Study|Withdrawal by Subject|0|||
149003159|NCT03642938|537489537|FG002|Overall Study|Withdrawal by Subject|0|||
149003160|NCT03642938|537489538|FG003|Overall Study|Withdrawal by Subject|1|||
149003161|NCT01119768|537489542|FG000|Treatment Period|Lack of Efficacy|18|||
149003162|NCT01119768|537489543|FG001|Treatment Period|Lack of Efficacy|25|||
149003163|NCT01059643|537489544|FG000|Overall Study|Adverse Event|3|||
149003164|NCT01059643|537489544|FG000|Overall Study|Withdrawal by Subject|2|||
149003165|NCT01059643|537489544|FG000|Overall Study|Physician Decision|1|||
149003166|NCT00246337|537489545|FG000|Overall Study|Lost to Follow-up|3|||
149003167|NCT00246337|537489546|FG001|Overall Study|Lost to Follow-up|0|||
149003168|NCT00246337|537489547|FG002|Overall Study|Lost to Follow-up|0|||
149003169|NCT00246337|537489548|FG003|Overall Study|Lost to Follow-up|0|||
149003170|NCT00246337|537489549|FG004|Overall Study|Lost to Follow-up|2|||
149003171|NCT00246337|537489550|FG005|Overall Study|Lost to Follow-up|2|||
149003172|NCT00246337|537489551|FG006|Overall Study|Lost to Follow-up|1|||
149003173|NCT00246337|537489552|FG007|Overall Study|Lost to Follow-up|2|||
149003174|NCT00246337|537489553|FG008|Overall Study|Lost to Follow-up|0|||
149003175|NCT00246337|537489545|FG000|Overall Study|Protocol Violation|1|||
149003176|NCT00246337|537489546|FG001|Overall Study|Protocol Violation|0|||
149003177|NCT00246337|537489547|FG002|Overall Study|Protocol Violation|0|||
149003178|NCT00246337|537489548|FG003|Overall Study|Protocol Violation|0|||
149003179|NCT00246337|537489549|FG004|Overall Study|Protocol Violation|1|||
149003180|NCT00246337|537489550|FG005|Overall Study|Protocol Violation|0|||
149003181|NCT00246337|537489551|FG006|Overall Study|Protocol Violation|1|||
149003182|NCT00246337|537489552|FG007|Overall Study|Protocol Violation|1|||
149003183|NCT00246337|537489553|FG008|Overall Study|Protocol Violation|0|||
149003184|NCT00246337|537489545|FG000|Overall Study|Withdrawal by Subject|2|||
149003185|NCT00246337|537489546|FG001|Overall Study|Withdrawal by Subject|0|||
149003186|NCT00246337|537489547|FG002|Overall Study|Withdrawal by Subject|0|||
149003187|NCT00246337|537489548|FG003|Overall Study|Withdrawal by Subject|0|||
149003188|NCT00246337|537489549|FG004|Overall Study|Withdrawal by Subject|0|||
149003189|NCT00246337|537489550|FG005|Overall Study|Withdrawal by Subject|0|||
149003190|NCT00246337|537489551|FG006|Overall Study|Withdrawal by Subject|1|||
149003191|NCT00246337|537489552|FG007|Overall Study|Withdrawal by Subject|1|||
149003192|NCT00246337|537489553|FG008|Overall Study|Withdrawal by Subject|0|||
149003193|NCT00246337|537489545|FG000|Overall Study|Lack of Qualifying Event|8|||
149003194|NCT00246337|537489546|FG001|Overall Study|Lack of Qualifying Event|2|||
149003195|NCT00246337|537489547|FG002|Overall Study|Lack of Qualifying Event|1|||
149003196|NCT00246337|537489548|FG003|Overall Study|Lack of Qualifying Event|1|||
149003197|NCT00246337|537489549|FG004|Overall Study|Lack of Qualifying Event|1|||
149003198|NCT00246337|537489550|FG005|Overall Study|Lack of Qualifying Event|3|||
149003199|NCT00246337|537489551|FG006|Overall Study|Lack of Qualifying Event|3|||
149003200|NCT00246337|537489552|FG007|Overall Study|Lack of Qualifying Event|2|||
149003201|NCT00246337|537489553|FG008|Overall Study|Lack of Qualifying Event|5|||
149003202|NCT00246337|537489545|FG000|Overall Study|Site Terminated|10|||
149003203|NCT00246337|537489546|FG001|Overall Study|Site Terminated|0|||
149003204|NCT00246337|537489547|FG002|Overall Study|Site Terminated|0|||
149003205|NCT00246337|537489548|FG003|Overall Study|Site Terminated|0|||
149003206|NCT00246337|537489549|FG004|Overall Study|Site Terminated|0|||
149003207|NCT00246337|537489550|FG005|Overall Study|Site Terminated|7|||
149003208|NCT00246337|537489551|FG006|Overall Study|Site Terminated|1|||
149003209|NCT00246337|537489552|FG007|Overall Study|Site Terminated|6|||
149003210|NCT00246337|537489553|FG008|Overall Study|Site Terminated|2|||
149003211|NCT00246337|537489545|FG000|Overall Study|Abnormal baseline lab values|7|||
149003212|NCT00246337|537489546|FG001|Overall Study|Abnormal baseline lab values|0|||
149037531|NCT00688519|537616340|FG000|Overall Study|Adverse Event|2|||
149037532|NCT00688519|537616341|FG001|Overall Study|Adverse Event|3|||
148879960|NCT05232864|537038200|FG000|Overall Study|Adverse Event|0|||
149003213|NCT00246337|537489547|FG002|Overall Study|Abnormal baseline lab values|2|||
149003214|NCT00246337|537489548|FG003|Overall Study|Abnormal baseline lab values|0|||
149003215|NCT00246337|537489549|FG004|Overall Study|Abnormal baseline lab values|0|||
149003216|NCT00246337|537489550|FG005|Overall Study|Abnormal baseline lab values|2|||
149003217|NCT00246337|537489551|FG006|Overall Study|Abnormal baseline lab values|2|||
149037533|NCT00688519|537616340|FG000|Overall Study|Lost to Follow-up|3|||
149037534|NCT00688519|537616341|FG001|Overall Study|Lost to Follow-up|3|||
149037535|NCT00688519|537616340|FG000|Overall Study|Lack of Efficacy|3|||
149037536|NCT00688519|537616341|FG001|Overall Study|Lack of Efficacy|1|||
149037537|NCT00688519|537616340|FG000|Overall Study|Withdrawal by Subject|7|||
149037538|NCT00688519|537616341|FG001|Overall Study|Withdrawal by Subject|6|||
149037539|NCT00688519|537616340|FG000|Overall Study|Prohibited medication|1|||
149037540|NCT00688519|537616341|FG001|Overall Study|Prohibited medication|0|||
149037541|NCT00688519|537616340|FG000|Overall Study|Non-compliance|0|||
149037542|NCT00688519|537616341|FG001|Overall Study|Non-compliance|1|||
149037543|NCT00688519|537616340|FG000|Overall Study|Subject moved out of state|1|||
149037544|NCT00688519|537616341|FG001|Overall Study|Subject moved out of state|0|||
149037545|NCT00688519|537616340|FG000|Overall Study|Investigator decision|1|||
149037546|NCT00688519|537616341|FG001|Overall Study|Investigator decision|0|||
149037547|NCT00688519|537616340|FG000|Overall Study|Subject moved out of area|1|||
149037548|NCT00688519|537616341|FG001|Overall Study|Subject moved out of area|0|||
149037549|NCT00688519|537616340|FG000|Overall Study|Pregnancy|0|||
149037550|NCT00688519|537616341|FG001|Overall Study|Pregnancy|1|||
149037551|NCT02551055|537616344|FG000|Overall Study|Death|2|||
149037552|NCT02551055|537616345|FG001|Overall Study|Death|4|||
149037553|NCT02551055|537616346|FG002|Overall Study|Death|2|||
149037554|NCT02551055|537616347|FG003|Overall Study|Death|2|||
149037555|NCT02551055|537616348|FG004|Overall Study|Death|2|||
149037556|NCT02551055|537616349|FG005|Overall Study|Death|1|||
149037557|NCT02551055|537616350|FG006|Overall Study|Death|2|||
149037558|NCT02551055|537616351|FG007|Overall Study|Death|0|||
149037559|NCT02551055|537616344|FG000|Overall Study|Study Terminated by Sponsor|1|||
149037560|NCT02551055|537616345|FG001|Overall Study|Study Terminated by Sponsor|1|||
149037561|NCT02551055|537616346|FG002|Overall Study|Study Terminated by Sponsor|0|||
149037562|NCT02551055|537616347|FG003|Overall Study|Study Terminated by Sponsor|2|||
149037563|NCT02551055|537616348|FG004|Overall Study|Study Terminated by Sponsor|2|||
149037564|NCT02551055|537616349|FG005|Overall Study|Study Terminated by Sponsor|0|||
149037565|NCT02551055|537616350|FG006|Overall Study|Study Terminated by Sponsor|0|||
149037566|NCT02551055|537616351|FG007|Overall Study|Study Terminated by Sponsor|0|||
149037567|NCT02551055|537616344|FG000|Overall Study|Withdrawal by Subject|1|||
149037568|NCT02551055|537616345|FG001|Overall Study|Withdrawal by Subject|1|||
149037569|NCT02551055|537616346|FG002|Overall Study|Withdrawal by Subject|0|||
149037570|NCT02551055|537616347|FG003|Overall Study|Withdrawal by Subject|1|||
149037571|NCT02551055|537616348|FG004|Overall Study|Withdrawal by Subject|2|||
149037572|NCT02551055|537616349|FG005|Overall Study|Withdrawal by Subject|0|||
149037573|NCT02551055|537616350|FG006|Overall Study|Withdrawal by Subject|0|||
149037574|NCT02551055|537616351|FG007|Overall Study|Withdrawal by Subject|0|||
149037575|NCT02551055|537616344|FG000|Overall Study|Reason not specified|0|||
149037576|NCT02551055|537616345|FG001|Overall Study|Reason not specified|0|||
149037577|NCT02551055|537616346|FG002|Overall Study|Reason not specified|0|||
149037578|NCT02551055|537616347|FG003|Overall Study|Reason not specified|0|||
149037579|NCT02551055|537616348|FG004|Overall Study|Reason not specified|1|||
149037580|NCT02551055|537616349|FG005|Overall Study|Reason not specified|0|||
149037581|NCT02551055|537616350|FG006|Overall Study|Reason not specified|1|||
149037582|NCT02551055|537616351|FG007|Overall Study|Reason not specified|0|||
149037583|NCT00430300|537616352|FG000|Overall Study|Adverse Event|0|||
149037584|NCT00430300|537616353|FG001|Overall Study|Adverse Event|2|||
149037585|NCT00430300|537616354|FG002|Overall Study|Adverse Event|1|||
149037586|NCT00430300|537616355|FG003|Overall Study|Adverse Event|1|||
149037587|NCT00430300|537616352|FG000|Overall Study|Withdrawal by Subject|1|||
149037588|NCT00430300|537616353|FG001|Overall Study|Withdrawal by Subject|0|||
149037589|NCT00430300|537616354|FG002|Overall Study|Withdrawal by Subject|5|||
149037590|NCT00430300|537616355|FG003|Overall Study|Withdrawal by Subject|0|||
149037591|NCT00430300|537616352|FG000|Overall Study|Laboratory abnormality|1|||
149037592|NCT00430300|537616353|FG001|Overall Study|Laboratory abnormality|0|||
149037593|NCT00430300|537616354|FG002|Overall Study|Laboratory abnormality|0|||
149037594|NCT00430300|537616355|FG003|Overall Study|Laboratory abnormality|0|||
149037595|NCT00430300|537616352|FG000|Overall Study|Other|0|||
149037596|NCT00430300|537616353|FG001|Overall Study|Other|0|||
149037597|NCT00430300|537616354|FG002|Overall Study|Other|0|||
149037598|NCT00430300|537616355|FG003|Overall Study|Other|1|||
149037599|NCT00546871|537616358|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
149037600|NCT00546871|537616359|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
149037601|NCT00546871|537616358|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
149037602|NCT00546871|537616359|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
149037603|NCT00546871|537616358|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
149037604|NCT00546871|537616359|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
149037605|NCT00546871|537616358|FG000|Study Extension Period|Protocol Violation|1|||
149037606|NCT00546871|537616359|FG001|Study Extension Period|Protocol Violation|0|||
149037607|NCT00546871|537616358|FG000|Study Extension Period|Withdrawal by Subject|0|||
149037608|NCT00546871|537616359|FG001|Study Extension Period|Withdrawal by Subject|1|||
149037609|NCT01713946|537616360|FG000|Overall Study|Death|0|||
149037610|NCT01713946|537616361|FG001|Overall Study|Death|2|||
148879961|NCT05232864|537038201|FG001|Overall Study|Adverse Event|1|||
148879962|NCT05232864|537038200|FG000|Overall Study|Study terminated by sponsor|16|||
148879963|NCT05232864|537038201|FG001|Overall Study|Study terminated by sponsor|14|||
148879964|NCT02023996|537038202|FG000|Overall Study|Protocol Violation|6|||
148879965|NCT02106403|537038216|FG000|Follow-Up Visit 3|Other Reason|0|||
148879966|NCT02106403|537038217|FG001|Follow-Up Visit 3|Other Reason|0|||
149003218|NCT00246337|537489552|FG007|Overall Study|Abnormal baseline lab values|0|||
149003219|NCT00246337|537489553|FG008|Overall Study|Abnormal baseline lab values|4|||
149003220|NCT00246337|537489545|FG000|Overall Study|Overwhelmed|0|||
149003221|NCT00246337|537489546|FG001|Overall Study|Overwhelmed|0|||
149003222|NCT00246337|537489547|FG002|Overall Study|Overwhelmed|0|||
149003223|NCT00246337|537489548|FG003|Overall Study|Overwhelmed|0|||
149003224|NCT00246337|537489549|FG004|Overall Study|Overwhelmed|0|||
149003225|NCT00246337|537489550|FG005|Overall Study|Overwhelmed|1|||
149003226|NCT00246337|537489551|FG006|Overall Study|Overwhelmed|0|||
149003227|NCT00246337|537489552|FG007|Overall Study|Overwhelmed|0|||
149003228|NCT00246337|537489553|FG008|Overall Study|Overwhelmed|0|||
149003229|NCT00246337|537489545|FG000|Overall Study|Protocol Violator|1|||
149003230|NCT00246337|537489546|FG001|Overall Study|Protocol Violator|0|||
149003231|NCT00246337|537489547|FG002|Overall Study|Protocol Violator|0|||
149003232|NCT00246337|537489548|FG003|Overall Study|Protocol Violator|0|||
149003233|NCT00246337|537489549|FG004|Overall Study|Protocol Violator|0|||
149003234|NCT00246337|537489550|FG005|Overall Study|Protocol Violator|0|||
149003235|NCT00246337|537489551|FG006|Overall Study|Protocol Violator|0|||
149003236|NCT00246337|537489552|FG007|Overall Study|Protocol Violator|0|||
149003237|NCT00246337|537489553|FG008|Overall Study|Protocol Violator|0|||
149003238|NCT00246337|537489545|FG000|Overall Study|Reported as completing trial in error|0|||
149003239|NCT00246337|537489546|FG001|Overall Study|Reported as completing trial in error|0|||
149003240|NCT00246337|537489547|FG002|Overall Study|Reported as completing trial in error|0|||
149003241|NCT00246337|537489548|FG003|Overall Study|Reported as completing trial in error|0|||
149003242|NCT00246337|537489549|FG004|Overall Study|Reported as completing trial in error|0|||
149003243|NCT00246337|537489550|FG005|Overall Study|Reported as completing trial in error|0|||
149003244|NCT00246337|537489551|FG006|Overall Study|Reported as completing trial in error|0|||
149003245|NCT00246337|537489552|FG007|Overall Study|Reported as completing trial in error|1|||
149003246|NCT00246337|537489553|FG008|Overall Study|Reported as completing trial in error|0|||
149003247|NCT01226511|537489558|FG000|Acute Treatment Period|Adverse Event|7|||
149003248|NCT01226511|537489559|FG001|Acute Treatment Period|Adverse Event|6|||
149003249|NCT01226511|537489558|FG000|Acute Treatment Period|Lack of Efficacy|2|||
149003250|NCT01226511|537489559|FG001|Acute Treatment Period|Lack of Efficacy|1|||
149003251|NCT01226511|537489558|FG000|Acute Treatment Period|Lost to Follow-up|3|||
149003252|NCT01226511|537489559|FG001|Acute Treatment Period|Lost to Follow-up|6|||
149003253|NCT01226511|537489558|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
149003254|NCT01226511|537489559|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
149003255|NCT01226511|537489558|FG000|Acute Treatment Period|Protocol Violation|5|||
149003256|NCT01226511|537489559|FG001|Acute Treatment Period|Protocol Violation|5|||
149003257|NCT01226511|537489558|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
149003258|NCT01226511|537489559|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
149003259|NCT01226511|537489558|FG000|Extension Treatment Period|Adverse Event|8|||
149003260|NCT01226511|537489559|FG001|Extension Treatment Period|Adverse Event|8|||
149003261|NCT01226511|537489558|FG000|Extension Treatment Period|Lack of Efficacy|3|||
149003262|NCT01226511|537489559|FG001|Extension Treatment Period|Lack of Efficacy|2|||
149003263|NCT01226511|537489558|FG000|Extension Treatment Period|Lost to Follow-up|4|||
149003264|NCT01226511|537489559|FG001|Extension Treatment Period|Lost to Follow-up|3|||
149003265|NCT01226511|537489558|FG000|Extension Treatment Period|Protocol Violation|2|||
149003266|NCT01226511|537489559|FG001|Extension Treatment Period|Protocol Violation|2|||
149003267|NCT01226511|537489558|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
149003268|NCT01226511|537489559|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
149003269|NCT01226511|537489558|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
149003270|NCT01226511|537489559|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
149003271|NCT01226511|537489558|FG000|Extension Treatment Period|Sponsor Decision|1|||
149003272|NCT01226511|537489559|FG001|Extension Treatment Period|Sponsor Decision|1|||
149003273|NCT01226511|537489558|FG000|Taper Period|Adverse Event|1|||
149003274|NCT01226511|537489559|FG001|Taper Period|Adverse Event|0|||
149003275|NCT01226511|537489558|FG000|Taper Period|Lost to Follow-up|2|||
149003276|NCT01226511|537489559|FG001|Taper Period|Lost to Follow-up|2|||
148879967|NCT02106403|537038218|FG002|Follow-Up Visit 3|Other Reason|0|||
148879968|NCT02106403|537038219|FG003|Follow-Up Visit 3|Other Reason|0|||
148879969|NCT02106403|537038220|FG004|Follow-Up Visit 3|Other Reason|0|||
149003277|NCT01226511|537489558|FG000|Taper Period|Protocol Violation|1|||
149003278|NCT01226511|537489559|FG001|Taper Period|Protocol Violation|0|||
149003279|NCT01226511|537489558|FG000|Taper Period|Parent/Caregiver Decision|1|||
149003280|NCT01226511|537489559|FG001|Taper Period|Parent/Caregiver Decision|1|||
149003281|NCT05614089|537489573|FG000|Overall Study|Pregnancy|5|||
149003282|NCT05614089|537489574|FG001|Overall Study|Pregnancy|2|||
149003283|NCT05614089|537489573|FG000|Overall Study|Lost to Follow-up|5|||
149003284|NCT05614089|537489574|FG001|Overall Study|Lost to Follow-up|1|||
148879970|NCT02106403|537038221|FG005|Follow-Up Visit 3|Other Reason|1|||
148879971|NCT02038075|537038227|FG000|Overall Study|Withdrawal by Subject|3|||
149003285|NCT05614089|537489573|FG000|Overall Study|Death|0|||
149003286|NCT05614089|537489574|FG001|Overall Study|Death|1|||
149003287|NCT05614089|537489573|FG000|Overall Study|Adverse Event|1|||
149003288|NCT05614089|537489574|FG001|Overall Study|Adverse Event|0|||
149003289|NCT05163522|537489575|FG000|Overall Study|Withdrawal by Subject|0|||
149003290|NCT05163522|537489576|FG001|Overall Study|Withdrawal by Subject|0|||
149003291|NCT05163522|537489577|FG002|Overall Study|Withdrawal by Subject|1|||
149003292|NCT05163522|537489578|FG003|Overall Study|Withdrawal by Subject|0|||
149003293|NCT05163522|537489579|FG004|Overall Study|Withdrawal by Subject|0|||
149003294|NCT05163522|537489580|FG005|Overall Study|Withdrawal by Subject|0|||
149003295|NCT05163522|537489581|FG006|Overall Study|Withdrawal by Subject|0|||
149003296|NCT05163522|537489582|FG007|Overall Study|Withdrawal by Subject|0|||
149003297|NCT05163522|537489583|FG008|Overall Study|Withdrawal by Subject|0|||
149003298|NCT05163522|537489584|FG009|Overall Study|Withdrawal by Subject|0|||
149003299|NCT05163522|537489585|FG010|Overall Study|Withdrawal by Subject|0|||
149003300|NCT02521285|537489587|FG000|Overall Study|Lost to Follow-up|1|||
149003301|NCT02521285|537489588|FG001|Overall Study|Lost to Follow-up|1|||
149003302|NCT02521285|537489587|FG000|Overall Study|Withdrawal by Subject|1|||
149003303|NCT02521285|537489588|FG001|Overall Study|Withdrawal by Subject|1|||
149003304|NCT02521285|537489587|FG000|Overall Study|Adverse Event|0|||
149003305|NCT02521285|537489588|FG001|Overall Study|Adverse Event|1|||
149003306|NCT05701995|537489590|FG000|Pre-Treatment|Randomization Error|1|||
149003307|NCT05701995|537489591|FG001|Pre-Treatment|Randomization Error|1|||
149003308|NCT05701995|537489590|FG000|Treatment|Withdrawal by Subject|8|||
149003309|NCT05701995|537489591|FG001|Treatment|Withdrawal by Subject|4|||
149003310|NCT05701995|537489590|FG000|Treatment|Lost to Follow-up|2|||
149003311|NCT05701995|537489591|FG001|Treatment|Lost to Follow-up|3|||
149003312|NCT05701995|537489590|FG000|Treatment|Adverse Event|3|||
149003313|NCT05701995|537489591|FG001|Treatment|Adverse Event|1|||
149003314|NCT05701995|537489590|FG000|Treatment|Other Reason|1|||
149003315|NCT05701995|537489591|FG001|Treatment|Other Reason|1|||
149003316|NCT05701995|537489590|FG000|Treatment|Death|1|||
149003317|NCT05701995|537489591|FG001|Treatment|Death|0|||
149003318|NCT05701995|537489590|FG000|Treatment|Physician Decision|0|||
149003319|NCT05701995|537489591|FG001|Treatment|Physician Decision|1|||
149003320|NCT00715429|537489592|FG000|Overall Study|Did not complete the study diary|0|||
149003321|NCT00715429|537489593|FG001|Overall Study|Did not complete the study diary|1|||
149003322|NCT04899245|537489598|FG000|Overall Study|Withdrawal by Subject|3|||
149003323|NCT04899245|537489599|FG001|Overall Study|Withdrawal by Subject|5|||
149003324|NCT04899245|537489600|FG002|Overall Study|Withdrawal by Subject|2|||
149003325|NCT04899245|537489598|FG000|Overall Study|No longer eligible - Left staff position|0|||
149003326|NCT04899245|537489599|FG001|Overall Study|No longer eligible - Left staff position|0|||
149003327|NCT04899245|537489600|FG002|Overall Study|No longer eligible - Left staff position|1|||
149003328|NCT04899245|537489598|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
149003329|NCT04899245|537489599|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
149003330|NCT04899245|537489600|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
149003331|NCT04899245|537489598|FG000|Overall Study|No longer eligible - Moved away from area|2|||
149003332|NCT04899245|537489599|FG001|Overall Study|No longer eligible - Moved away from area|2|||
149003333|NCT04899245|537489600|FG002|Overall Study|No longer eligible - Moved away from area|0|||
149003334|NCT03419364|537489614|FG000|Overall Study|Delivery due to maternal condition|2|||
149003335|NCT03419364|537489615|FG001|Overall Study|Delivery due to maternal condition|0|||
149003336|NCT03419364|537489616|FG002|Overall Study|Delivery due to maternal condition|0|||
149003337|NCT00552084|537489617|FG000|Overall Study|Adverse Event|2|||
149003338|NCT00552084|537489618|FG001|Overall Study|Adverse Event|3|||
149003339|NCT00552084|537489617|FG000|Overall Study|Withdrawal by Subject|4|||
149003340|NCT00552084|537489618|FG001|Overall Study|Withdrawal by Subject|5|||
149003341|NCT00552084|537489617|FG000|Overall Study|Protocol Violation|1|||
149003342|NCT00552084|537489618|FG001|Overall Study|Protocol Violation|0|||
149003343|NCT00552084|537489617|FG000|Overall Study|change in anti-arrythmic drug|1|||
149003344|NCT00552084|537489618|FG001|Overall Study|change in anti-arrythmic drug|1|||
149003345|NCT01338025|537489619|FG000|Overall Study|Unexpected closure of study|10|||
149003346|NCT01338025|537489620|FG001|Overall Study|Unexpected closure of study|9|||
149003347|NCT01338025|537489619|FG000|Overall Study|Withdrawal by Subject|0|||
149003348|NCT01338025|537489620|FG001|Overall Study|Withdrawal by Subject|2|||
149003349|NCT01338025|537489619|FG000|Overall Study|Found ineligible after starting|1|||
149003350|NCT01338025|537489620|FG001|Overall Study|Found ineligible after starting|0|||
149003351|NCT03188055|537489621|FG000|Overall Study|Unavailable for training|0|||
149003352|NCT03188055|537489622|FG001|Overall Study|Unavailable for training|0|||
149003353|NCT03188055|537489623|FG002|Overall Study|Unavailable for training|19|||
149003354|NCT03188055|537489624|FG003|Overall Study|Unavailable for training|0|||
149003355|NCT03188055|537489625|FG004|Overall Study|Unavailable for training|0|||
149003356|NCT03188055|537489626|FG005|Overall Study|Unavailable for training|0|||
149003357|NCT03188055|537489621|FG000|Overall Study|Lost to Follow-up|0|||
149003358|NCT03188055|537489622|FG001|Overall Study|Lost to Follow-up|18|||
148879972|NCT02038075|537038228|FG001|Overall Study|Withdrawal by Subject|0|||
148879973|NCT04000581|537038229|FG000|Overall Study|Withdrawal by Subject|0|||
149003359|NCT03188055|537489623|FG002|Overall Study|Lost to Follow-up|0|||
149003360|NCT03188055|537489624|FG003|Overall Study|Lost to Follow-up|11|||
149003361|NCT03188055|537489625|FG004|Overall Study|Lost to Follow-up|0|||
149003362|NCT03188055|537489626|FG005|Overall Study|Lost to Follow-up|0|||
149003363|NCT03188055|537489621|FG000|Overall Study|Withdrawal by Subject|0|||
149003364|NCT03188055|537489622|FG001|Overall Study|Withdrawal by Subject|1|||
149003365|NCT03188055|537489623|FG002|Overall Study|Withdrawal by Subject|0|||
149003366|NCT03188055|537489624|FG003|Overall Study|Withdrawal by Subject|1|||
149003367|NCT03188055|537489625|FG004|Overall Study|Withdrawal by Subject|0|||
149003368|NCT03188055|537489626|FG005|Overall Study|Withdrawal by Subject|0|||
149003369|NCT03017079|537489627|FG000|Overall Study|Physician Decision|1|||
149003370|NCT03017079|537489628|FG001|Overall Study|Physician Decision|1|||
149003371|NCT03017079|537489627|FG000|Overall Study|Death|3|||
149003372|NCT03017079|537489628|FG001|Overall Study|Death|2|||
149003373|NCT03017079|537489627|FG000|Overall Study|Lack of Efficacy|2|||
149003374|NCT03017079|537489628|FG001|Overall Study|Lack of Efficacy|2|||
149003375|NCT03017079|537489627|FG000|Overall Study|Protocol Violation|0|||
149003376|NCT03017079|537489628|FG001|Overall Study|Protocol Violation|1|||
149003377|NCT04349280|537489629|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
149003378|NCT04349280|537489630|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
149003379|NCT04349280|537489629|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
149003380|NCT04349280|537489630|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
149003381|NCT04349280|537489629|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
149003382|NCT04349280|537489630|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
149003383|NCT02286089|537489633|FG000|Overall Study|Ongoing in Study|1|||
149003384|NCT02286089|537489634|FG001|Overall Study|Ongoing in Study|1|||
149003385|NCT02286089|537489635|FG002|Overall Study|Ongoing in Study|4|||
149003386|NCT02286089|537489636|FG003|Overall Study|Ongoing in Study|10|||
149003387|NCT02286089|537489633|FG000|Overall Study|Withdrawal by Subject|0|||
149003388|NCT02286089|537489634|FG001|Overall Study|Withdrawal by Subject|0|||
149003389|NCT02286089|537489635|FG002|Overall Study|Withdrawal by Subject|2|||
149003390|NCT02286089|537489636|FG003|Overall Study|Withdrawal by Subject|2|||
149003391|NCT00508261|537491414|FG000|Overall Study|Other|0|||
149003392|NCT00508261|537491415|FG001|Overall Study|Other|1|||
149003393|NCT00508261|537491416|FG002|Overall Study|Other|1|||
149003394|NCT00508261|537491417|FG003|Overall Study|Other|0|||
149003395|NCT00508261|537491414|FG000|Overall Study|Serious Adverse Event|0|||
149003396|NCT00508261|537491415|FG001|Overall Study|Serious Adverse Event|1|||
149003397|NCT00508261|537491416|FG002|Overall Study|Serious Adverse Event|0|||
149003398|NCT00508261|537491417|FG003|Overall Study|Serious Adverse Event|0|||
149003399|NCT00508261|537491414|FG000|Overall Study|Withdrawal by Subject|3|||
149003400|NCT00508261|537491415|FG001|Overall Study|Withdrawal by Subject|4|||
149003401|NCT00508261|537491416|FG002|Overall Study|Withdrawal by Subject|4|||
149003402|NCT00508261|537491417|FG003|Overall Study|Withdrawal by Subject|0|||
149003403|NCT00508261|537491414|FG000|Overall Study|Migrated/ moved from study area|0|||
149003404|NCT00508261|537491415|FG001|Overall Study|Migrated/ moved from study area|1|||
149003405|NCT00508261|537491416|FG002|Overall Study|Migrated/ moved from study area|0|||
149003406|NCT00508261|537491417|FG003|Overall Study|Migrated/ moved from study area|0|||
149003407|NCT00508261|537491414|FG000|Overall Study|Lost to Follow-up|0|||
149003408|NCT00508261|537491415|FG001|Overall Study|Lost to Follow-up|1|||
149003409|NCT00508261|537491416|FG002|Overall Study|Lost to Follow-up|1|||
149003410|NCT00508261|537491417|FG003|Overall Study|Lost to Follow-up|1|||
149003411|NCT02901626|537491418|FG000|Overall Study|Lost to Follow-up|1|||
149003412|NCT02901626|537491419|FG001|Overall Study|Lost to Follow-up|1|||
149003413|NCT04082884|537491420|FG000|Overall Study|Withdrawal by Subject|1|||
149003414|NCT04857034|537491422|FG000|Placebo-Controlled Period|Request to discontinue|2|||
149003415|NCT04857034|537491423|FG001|Placebo-Controlled Period|Request to discontinue|2|||
149003416|NCT04857034|537491424|FG002|Placebo-Controlled Period|Request to discontinue|0|||
149003417|NCT04857034|537491425|FG003|Placebo-Controlled Period|Request to discontinue|0|||
149003418|NCT04857034|537491426|FG004|Placebo-Controlled Period|Request to discontinue|0|||
149003419|NCT04857034|537491422|FG000|Placebo-Controlled Period|withdrew consent|1|||
149003420|NCT04857034|537491423|FG001|Placebo-Controlled Period|withdrew consent|1|||
149003421|NCT04857034|537491424|FG002|Placebo-Controlled Period|withdrew consent|2|||
149003422|NCT04857034|537491425|FG003|Placebo-Controlled Period|withdrew consent|0|||
149003423|NCT04857034|537491426|FG004|Placebo-Controlled Period|withdrew consent|0|||
149003424|NCT04857034|537491422|FG000|Placebo-Controlled Period|Pregnancy|1|||
149003425|NCT04857034|537491423|FG001|Placebo-Controlled Period|Pregnancy|1|||
149003426|NCT04857034|537491424|FG002|Placebo-Controlled Period|Pregnancy|0|||
149003427|NCT04857034|537491425|FG003|Placebo-Controlled Period|Pregnancy|0|||
149003428|NCT04857034|537491426|FG004|Placebo-Controlled Period|Pregnancy|0|||
149003429|NCT04857034|537491422|FG000|Placebo-Controlled Period|Ongoing study period|0|||
148879974|NCT04000581|537038230|FG001|Overall Study|Withdrawal by Subject|1|||
149003430|NCT04857034|537491423|FG001|Placebo-Controlled Period|Ongoing study period|1|||
149003431|NCT04857034|537491424|FG002|Placebo-Controlled Period|Ongoing study period|0|||
148879975|NCT03477838|537038231|FG000|Overall Study|Lost to Follow-up|14|||
148879976|NCT02519595|537038233|FG000|Overall Study|Protocol Violation|8|||
148879977|NCT02519595|537038234|FG001|Overall Study|Protocol Violation|22|||
148879978|NCT02519595|537038235|FG002|Overall Study|Protocol Violation|16|||
148879979|NCT00850538|537038238|FG000|Overall Study|unable/unwilling to complete MRI|13|||
148879980|NCT00850538|537038238|FG000|Overall Study|specimen missed due to scheduling error|14|||
148879981|NCT00850538|537038238|FG000|Overall Study|specimen unusable|7|||
148879982|NCT00850538|537038238|FG000|Overall Study|Withdrawal by Subject|3|||
148879983|NCT00850538|537038238|FG000|Overall Study|radiology error|2|||
148879984|NCT00850538|537038238|FG000|Overall Study|Protocol Violation|2|||
148879985|NCT03188510|537038244|FG000|Overall Study|Inappropriate behavior with site staff|0|||
148879986|NCT03188510|537038245|FG001|Overall Study|Inappropriate behavior with site staff|1|||
148879987|NCT03188510|537038246|FG002|Overall Study|Inappropriate behavior with site staff|0|||
148879988|NCT01088399|537038255|FG000|Overall Study|Adverse Event|211|||
148879989|NCT01088399|537038256|FG001|Overall Study|Adverse Event|16|||
148879990|NCT01088399|537038257|FG002|Overall Study|Adverse Event|0|||
148879991|NCT01088399|537038255|FG000|Overall Study|Death|204|||
148879992|NCT01088399|537038256|FG001|Overall Study|Death|45|||
148879993|NCT01088399|537038257|FG002|Overall Study|Death|0|||
148879994|NCT01088399|537038255|FG000|Overall Study|Lack of Efficacy|298|||
148879995|NCT01088399|537038256|FG001|Overall Study|Lack of Efficacy|7|||
148879996|NCT01088399|537038257|FG002|Overall Study|Lack of Efficacy|5|||
148879997|NCT01088399|537038255|FG000|Overall Study|Lost to Follow-up|1070|||
148879998|NCT01088399|537038256|FG001|Overall Study|Lost to Follow-up|278|||
148879999|NCT01088399|537038257|FG002|Overall Study|Lost to Follow-up|58|||
148880000|NCT01088399|537038255|FG000|Overall Study|Physician Decision|531|||
148880001|NCT01088399|537038256|FG001|Overall Study|Physician Decision|88|||
148880002|NCT01088399|537038257|FG002|Overall Study|Physician Decision|16|||
148880003|NCT01088399|537038255|FG000|Overall Study|Withdrawal by Subject|544|||
148880004|NCT01088399|537038256|FG001|Overall Study|Withdrawal by Subject|195|||
148880005|NCT01088399|537038257|FG002|Overall Study|Withdrawal by Subject|33|||
148880006|NCT01088399|537038255|FG000|Overall Study|Change to or start of somatropin therapy|234|||
149003432|NCT04857034|537491425|FG003|Placebo-Controlled Period|Ongoing study period|0|||
149003433|NCT04857034|537491426|FG004|Placebo-Controlled Period|Ongoing study period|0|||
149003434|NCT04857034|537491422|FG000|Active Treatment Period|Lack of Efficacy|1|||
149003435|NCT04857034|537491423|FG001|Active Treatment Period|Lack of Efficacy|0|||
149003436|NCT04857034|537491424|FG002|Active Treatment Period|Lack of Efficacy|0|||
149003437|NCT04857034|537491425|FG003|Active Treatment Period|Lack of Efficacy|0|||
149003438|NCT04857034|537491426|FG004|Active Treatment Period|Lack of Efficacy|0|||
149003439|NCT04857034|537491422|FG000|Active Treatment Period|request to discontinue|0|||
149003440|NCT04857034|537491423|FG001|Active Treatment Period|request to discontinue|1|||
149003441|NCT04857034|537491424|FG002|Active Treatment Period|request to discontinue|0|||
149003442|NCT04857034|537491425|FG003|Active Treatment Period|request to discontinue|1|||
149003443|NCT04857034|537491426|FG004|Active Treatment Period|request to discontinue|0|||
149003444|NCT04857034|537491422|FG000|Active Treatment Period|administrative reason by sponsor|1|||
149003445|NCT04857034|537491423|FG001|Active Treatment Period|administrative reason by sponsor|5|||
149003446|NCT04857034|537491424|FG002|Active Treatment Period|administrative reason by sponsor|0|||
149003447|NCT04857034|537491425|FG003|Active Treatment Period|administrative reason by sponsor|2|||
149003448|NCT04857034|537491426|FG004|Active Treatment Period|administrative reason by sponsor|2|||
149003449|NCT04857034|537491422|FG000|Active Treatment Period|other reasons|1|||
149003450|NCT04857034|537491423|FG001|Active Treatment Period|other reasons|1|||
149003451|NCT04857034|537491424|FG002|Active Treatment Period|other reasons|0|||
149003452|NCT04857034|537491425|FG003|Active Treatment Period|other reasons|0|||
149003453|NCT04857034|537491426|FG004|Active Treatment Period|other reasons|1|||
149003454|NCT04857034|537491422|FG000|Active Treatment Period|Ongoing Study Period|2|||
149003455|NCT04857034|537491423|FG001|Active Treatment Period|Ongoing Study Period|4|||
149003456|NCT04857034|537491424|FG002|Active Treatment Period|Ongoing Study Period|0|||
149003457|NCT04857034|537491425|FG003|Active Treatment Period|Ongoing Study Period|1|||
149003458|NCT04857034|537491426|FG004|Active Treatment Period|Ongoing Study Period|0|||
149003459|NCT00387894|537491427|FG000|Overall Study|Withdrawal by Subject|1|||
149003460|NCT02923739|537491428|FG000|Overall Study|Withdrawal by Subject|2|||
149003461|NCT02923739|537491429|FG001|Overall Study|Withdrawal by Subject|0|||
149003462|NCT02923739|537491430|FG002|Overall Study|Withdrawal by Subject|0|||
149003463|NCT02923739|537491431|FG003|Overall Study|Withdrawal by Subject|0|||
149003464|NCT02923739|537491428|FG000|Overall Study|Failed Screening|3|||
148880007|NCT01088399|537038256|FG001|Overall Study|Change to or start of somatropin therapy|17|||
148880008|NCT01088399|537038257|FG002|Overall Study|Change to or start of somatropin therapy|12|||
148880009|NCT01088399|537038255|FG000|Overall Study|Sponsor decision|1573|||
148880010|NCT01088399|537038256|FG001|Overall Study|Sponsor decision|298|||
149003465|NCT02923739|537491429|FG001|Overall Study|Failed Screening|0|||
149003466|NCT02923739|537491430|FG002|Overall Study|Failed Screening|0|||
149003467|NCT02923739|537491431|FG003|Overall Study|Failed Screening|0|||
149003468|NCT00948974|537491434|FG000|Overall Study|Lost to Follow-up|23|||
148880011|NCT01088399|537038257|FG002|Overall Study|Sponsor decision|7|||
148880012|NCT01088399|537038255|FG000|Overall Study|Protocol Violation|10|||
149037611|NCT01713946|537616362|FG002|Overall Study|Death|2|||
149037612|NCT01713946|537616360|FG000|Overall Study|Adverse Event|19|||
149037613|NCT01713946|537616361|FG001|Overall Study|Adverse Event|14|||
149037614|NCT01713946|537616362|FG002|Overall Study|Adverse Event|13|||
149037615|NCT01713946|537616360|FG000|Overall Study|Withdrawal by Subject|12|||
149037616|NCT01713946|537616361|FG001|Overall Study|Withdrawal by Subject|12|||
149037617|NCT01713946|537616362|FG002|Overall Study|Withdrawal by Subject|8|||
149037618|NCT01713946|537616360|FG000|Overall Study|Lack of Efficacy|8|||
149037619|NCT01713946|537616361|FG001|Overall Study|Lack of Efficacy|8|||
149037620|NCT01713946|537616362|FG002|Overall Study|Lack of Efficacy|14|||
149037621|NCT01713946|537616360|FG000|Overall Study|Protocol Violation|2|||
149037622|NCT01713946|537616361|FG001|Overall Study|Protocol Violation|4|||
149037623|NCT01713946|537616362|FG002|Overall Study|Protocol Violation|1|||
149037624|NCT01713946|537616360|FG000|Overall Study|Lost to Follow-up|0|||
149037625|NCT01713946|537616361|FG001|Overall Study|Lost to Follow-up|0|||
149037626|NCT01713946|537616362|FG002|Overall Study|Lost to Follow-up|1|||
149037627|NCT01713946|537616360|FG000|Overall Study|Administrative problems|1|||
149037628|NCT01713946|537616361|FG001|Overall Study|Administrative problems|0|||
149037629|NCT01713946|537616362|FG002|Overall Study|Administrative problems|0|||
149037630|NCT01713946|537616360|FG000|Overall Study|Did not continue in Ext|0|||
149037631|NCT01713946|537616361|FG001|Overall Study|Did not continue in Ext|3|||
149037632|NCT01713946|537616362|FG002|Overall Study|Did not continue in Ext|0|||
149037633|NCT01713946|537616360|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
149037634|NCT01713946|537616361|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
149037635|NCT01713946|537616362|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
149037636|NCT01713946|537616360|FG000|Overall Study|Patients never switched to everolimus|0|||
149037637|NCT01713946|537616361|FG001|Overall Study|Patients never switched to everolimus|0|||
149037638|NCT01713946|537616362|FG002|Overall Study|Patients never switched to everolimus|5|||
149037639|NCT04001829|537617575|FG000|Overall Study|Never start protocol therapy|5|||
149037640|NCT04001829|537617576|FG001|Overall Study|Never start protocol therapy|5|||
149037641|NCT04001829|537617575|FG000|Overall Study|Adverse Event|11|||
149037642|NCT04001829|537617576|FG001|Overall Study|Adverse Event|7|||
149037643|NCT04001829|537617575|FG000|Overall Study|Alternative therapy|1|||
149037644|NCT04001829|537617576|FG001|Overall Study|Alternative therapy|2|||
149037645|NCT04001829|537617575|FG000|Overall Study|Disease progression/relapse|2|||
149037646|NCT04001829|537617576|FG001|Overall Study|Disease progression/relapse|1|||
149037647|NCT04001829|537617575|FG000|Overall Study|Other complicating disease|1|||
149037648|NCT04001829|537617576|FG001|Overall Study|Other complicating disease|0|||
149037649|NCT04001829|537617575|FG000|Overall Study|Withdrawal by Subject|1|||
149037650|NCT04001829|537617576|FG001|Overall Study|Withdrawal by Subject|4|||
149037651|NCT04001829|537617575|FG000|Overall Study|Ineligible|2|||
149037652|NCT04001829|537617576|FG001|Overall Study|Ineligible|2|||
149037653|NCT04001829|537617575|FG000|Overall Study|Reason missing due to delinquent data|1|||
149037654|NCT04001829|537617576|FG001|Overall Study|Reason missing due to delinquent data|0|||
149037655|NCT05011396|537617577|FG000|Overall Study|Lost to Follow-up|3|||
149037656|NCT05011396|537617578|FG001|Overall Study|Lost to Follow-up|1|||
149037657|NCT05011396|537617577|FG000|Overall Study|Withdrawal by Subject|0|||
149037658|NCT05011396|537617578|FG001|Overall Study|Withdrawal by Subject|1|||
149037659|NCT05011396|537617577|FG000|Overall Study|Positive Drug Screen|0|||
149037660|NCT05011396|537617578|FG001|Overall Study|Positive Drug Screen|1|||
149037661|NCT03253848|537617579|FG000|Overall Study|Adverse Event|7|||
149037662|NCT03253848|537617579|FG000|Overall Study|Death|5|||
149037663|NCT03253848|537617579|FG000|Overall Study|initiation of other treatments|3|||
149037664|NCT03253848|537617579|FG000|Overall Study|Other complicating disease|1|||
149037665|NCT03253848|537617579|FG000|Overall Study|Withdrawal by Subject|1|||
149037666|NCT03253848|537617579|FG000|Overall Study|Declining health|1|||
149037667|NCT01393119|537617580|FG000|Overall Study|Adverse Event|1|||
149037668|NCT01393119|537617581|FG001|Overall Study|Adverse Event|1|||
149037669|NCT01393119|537617582|FG002|Overall Study|Adverse Event|0|||
149037670|NCT01393119|537617583|FG003|Overall Study|Adverse Event|1|||
149037671|NCT01393119|537617580|FG000|Overall Study|Withdrawal by Subject|0|||
149037672|NCT01393119|537617581|FG001|Overall Study|Withdrawal by Subject|1|||
149037673|NCT01393119|537617582|FG002|Overall Study|Withdrawal by Subject|1|||
149037674|NCT01393119|537617583|FG003|Overall Study|Withdrawal by Subject|0|||
149037675|NCT01393119|537617580|FG000|Overall Study|Lack of Efficacy|1|||
149037676|NCT01393119|537617581|FG001|Overall Study|Lack of Efficacy|0|||
149037677|NCT01393119|537617582|FG002|Overall Study|Lack of Efficacy|2|||
149037678|NCT01393119|537617583|FG003|Overall Study|Lack of Efficacy|1|||
149037679|NCT01393119|537617580|FG000|Overall Study|Protocol Violation|0|||
149037680|NCT01393119|537617581|FG001|Overall Study|Protocol Violation|0|||
149037681|NCT01393119|537617582|FG002|Overall Study|Protocol Violation|1|||
149037682|NCT01393119|537617583|FG003|Overall Study|Protocol Violation|0|||
149037683|NCT01393119|537617580|FG000|Overall Study|Death|0|||
149037684|NCT01393119|537617581|FG001|Overall Study|Death|0|||
149037685|NCT01393119|537617582|FG002|Overall Study|Death|0|||
149037686|NCT01393119|537617583|FG003|Overall Study|Death|1|||
149037687|NCT01393119|537617580|FG000|Overall Study|Randomized but Not treated|1|||
149037688|NCT01393119|537617581|FG001|Overall Study|Randomized but Not treated|0|||
148880013|NCT01088399|537038256|FG001|Overall Study|Protocol Violation|1|||
148880014|NCT01088399|537038257|FG002|Overall Study|Protocol Violation|0|||
148880015|NCT01088399|537038255|FG000|Overall Study|Enrollment criteria not met|48|||
148880016|NCT01088399|537038256|FG001|Overall Study|Enrollment criteria not met|119|||
148880017|NCT01088399|537038257|FG002|Overall Study|Enrollment criteria not met|70|||
148880018|NCT01088399|537038255|FG000|Overall Study|Study summary visit not completed|2398|||
148880019|NCT01088399|537038256|FG001|Overall Study|Study summary visit not completed|283|||
148880020|NCT01088399|537038257|FG002|Overall Study|Study summary visit not completed|80|||
148880021|NCT02921087|537038258|FG000|Overall Study|Withdrawal by Subject|0|||
148880022|NCT02921087|537038259|FG001|Overall Study|Withdrawal by Subject|1|||
148880023|NCT00852241|537038260|FG000|Overall Study|Physician Decision|18|||
148880024|NCT00619307|537038262|FG000|Overall Study|Adverse Event|0|||
149003469|NCT00948974|537491435|FG001|Overall Study|Lost to Follow-up|20|||
149003470|NCT00409682|537491447|FG000|Open-label Induction Period|Adverse Event|1|||
149003471|NCT00409682|537491448|FG001|Open-label Induction Period|Adverse Event|0|||
149003472|NCT00409682|537491449|FG002|Open-label Induction Period|Adverse Event|0|||
149003473|NCT00409682|537491447|FG000|Open-label Induction Period|Lack of Efficacy|1|||
149003474|NCT00409682|537491448|FG001|Open-label Induction Period|Lack of Efficacy|0|||
149003475|NCT00409682|537491449|FG002|Open-label Induction Period|Lack of Efficacy|0|||
149003476|NCT00409682|537491447|FG000|Open-label Induction Period|Protocol Violation|1|||
149003477|NCT00409682|537491448|FG001|Open-label Induction Period|Protocol Violation|0|||
149003478|NCT00409682|537491449|FG002|Open-label Induction Period|Protocol Violation|0|||
149003479|NCT00409682|537491447|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
149003480|NCT00409682|537491448|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
149003481|NCT00409682|537491449|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
149003482|NCT00409682|537491447|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
149003483|NCT00409682|537491448|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
149003484|NCT00409682|537491449|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
149003485|NCT00409682|537491447|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
149003486|NCT00409682|537491448|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
149003487|NCT00409682|537491449|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
149003488|NCT00409682|537491447|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
149003489|NCT00409682|537491448|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
149003490|NCT00409682|537491449|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
149003491|NCT00409682|537491447|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
149003492|NCT00409682|537491448|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
149003493|NCT00409682|537491449|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
149003494|NCT00409682|537491447|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
149003495|NCT00409682|537491448|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
149003496|NCT00409682|537491449|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
149003497|NCT00409682|537491447|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
149003498|NCT00409682|537491448|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
149003499|NCT00409682|537491449|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
149003500|NCT01896869|537491452|FG000|Overall Study|Withdrawal by Subject|0|||
149003501|NCT01896869|537491453|FG001|Overall Study|Withdrawal by Subject|6|||
149003502|NCT01896869|537491452|FG000|Overall Study|Lost to Follow-up|1|||
149003503|NCT01896869|537491453|FG001|Overall Study|Lost to Follow-up|0|||
149003504|NCT04710927|537491461|FG000|Overall Study|Lost to Follow-up|7|||
149003505|NCT04710927|537491462|FG001|Overall Study|Lost to Follow-up|6|||
149003506|NCT04710927|537491463|FG002|Overall Study|Lost to Follow-up|5|||
149003507|NCT00118716|537491465|FG000|Overall Study|Adverse Event|2|||
149003508|NCT00118716|537491466|FG001|Overall Study|Adverse Event|7|||
149003509|NCT00118716|537491465|FG000|Overall Study|Protocol Violation|5|||
149003510|NCT00118716|537491466|FG001|Overall Study|Protocol Violation|4|||
149003511|NCT00118716|537491465|FG000|Overall Study|Withdrawal by Subject|0|||
149003512|NCT00118716|537491466|FG001|Overall Study|Withdrawal by Subject|1|||
149003513|NCT00118716|537491465|FG000|Overall Study|Exacerbation|2|||
149003514|NCT00118716|537491466|FG001|Overall Study|Exacerbation|2|||
149003515|NCT00118716|537491465|FG000|Overall Study|Discontinued by sponsor|1|||
149003516|NCT00118716|537491466|FG001|Overall Study|Discontinued by sponsor|1|||
149003517|NCT00118716|537491465|FG000|Overall Study|Non-compliance|1|||
149003518|NCT00118716|537491466|FG001|Overall Study|Non-compliance|3|||
149003519|NCT00118716|537491465|FG000|Overall Study|misrandomized|1|||
149003520|NCT00118716|537491466|FG001|Overall Study|misrandomized|1|||
149003521|NCT00118716|537491465|FG000|Overall Study|Expired drug use|1|||
149003522|NCT00118716|537491466|FG001|Overall Study|Expired drug use|2|||
149003523|NCT00118716|537491465|FG000|Overall Study|Investigator discretion|0|||
149003524|NCT00118716|537491466|FG001|Overall Study|Investigator discretion|1|||
149003525|NCT00855062|537491467|FG000|Step1|Early Study Closure|5|||
148880025|NCT00619307|537038263|FG001|Overall Study|Adverse Event|1|||
148880026|NCT00619307|537038262|FG000|Overall Study|Lost to Follow-up|0|||
149003526|NCT00855062|537491468|FG001|Step1|Early Study Closure|7|||
149003527|NCT00855062|537491467|FG000|Step1|Adverse Event|1|||
149003528|NCT00855062|537491468|FG001|Step1|Adverse Event|1|||
149003529|NCT00855062|537491467|FG000|Step1|Protocol Violation|1|||
149003530|NCT00855062|537491468|FG001|Step1|Protocol Violation|0|||
149003531|NCT00855062|537491467|FG000|Step1|Pregnancy|1|||
149003532|NCT00855062|537491468|FG001|Step1|Pregnancy|0|||
149003533|NCT00855062|537491467|FG000|Step1|Withdrawal by Subject|2|||
149003534|NCT00855062|537491468|FG001|Step1|Withdrawal by Subject|3|||
149003535|NCT00855062|537491467|FG000|Step2|Early Study Closure|6|||
149003536|NCT00855062|537491468|FG001|Step2|Early Study Closure|2|||
149003537|NCT00855062|537491467|FG000|Step2|Adverse Event|0|||
149003538|NCT00855062|537491468|FG001|Step2|Adverse Event|3|||
149003539|NCT00855062|537491467|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
149003540|NCT00855062|537491468|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
149003541|NCT01780935|537491474|FG000|Overall Study|Admin problems due to early termination|321|||
149003542|NCT01780935|537491475|FG001|Overall Study|Admin problems due to early termination|309|||
149003543|NCT01780935|537491474|FG000|Overall Study|Adverse Event|2|||
149003544|NCT01780935|537491475|FG001|Overall Study|Adverse Event|4|||
149003545|NCT01780935|537491474|FG000|Overall Study|Death|1|||
149003546|NCT01780935|537491475|FG001|Overall Study|Death|6|||
149003547|NCT01780935|537491474|FG000|Overall Study|Lost to Follow-up|2|||
149003548|NCT01780935|537491475|FG001|Overall Study|Lost to Follow-up|6|||
149003549|NCT01780935|537491474|FG000|Overall Study|Physician Decision|1|||
149003550|NCT01780935|537491475|FG001|Overall Study|Physician Decision|1|||
149003551|NCT01780935|537491474|FG000|Overall Study|Protocol deviation|0|||
149003552|NCT01780935|537491475|FG001|Overall Study|Protocol deviation|1|||
149003553|NCT01780935|537491474|FG000|Overall Study|Patient withdrew consent|8|||
149003554|NCT01780935|537491475|FG001|Overall Study|Patient withdrew consent|9|||
149003555|NCT00855595|537491476|FG000|Overall Study|Withdrawal by Subject|1|||
149003556|NCT00855595|537491477|FG001|Overall Study|Withdrawal by Subject|2|||
149003557|NCT00855595|537491476|FG000|Overall Study|Lost to Follow-up|3|||
149003558|NCT00855595|537491477|FG001|Overall Study|Lost to Follow-up|3|||
149003559|NCT00855595|537491476|FG000|Overall Study|Adverse Event|1|||
149003560|NCT00855595|537491477|FG001|Overall Study|Adverse Event|1|||
149003561|NCT00855595|537491476|FG000|Overall Study|patient moved out of state|1|||
149003562|NCT00855595|537491477|FG001|Overall Study|patient moved out of state|0|||
149003563|NCT00855595|537491476|FG000|Overall Study|patient left country|0|||
149003564|NCT00855595|537491477|FG001|Overall Study|patient left country|1|||
149003565|NCT02831257|537491478|FG000|Overall Study|Lack of Efficacy|3|||
149003566|NCT02831257|537491478|FG000|Overall Study|Adverse Event|2|||
149003567|NCT02831257|537491478|FG000|Overall Study|Physician Decision|1|||
149003568|NCT02831257|537491478|FG000|Overall Study|Withdrawal by Subject|6|||
149003569|NCT01844284|537491479|FG000|Overall Study|Lost to Follow-up|12|||
149003570|NCT01844284|537491480|FG001|Overall Study|Lost to Follow-up|7|||
149003571|NCT00611858|537491481|FG000|Overall Study|Adverse Event|2|||
149003572|NCT00611858|537491481|FG000|Overall Study|Withdrawal by Subject|2|||
149003573|NCT01820559|537491482|FG000|Overall Study|Adverse Event|4|||
149003574|NCT01820559|537491483|FG001|Overall Study|Adverse Event|6|||
149003575|NCT01820559|537491484|FG002|Overall Study|Adverse Event|13|||
149003576|NCT01820559|537491482|FG000|Overall Study|Withdrawal by Subject|1|||
149003577|NCT01820559|537491483|FG001|Overall Study|Withdrawal by Subject|2|||
149003578|NCT01820559|537491484|FG002|Overall Study|Withdrawal by Subject|5|||
149003579|NCT01820559|537491482|FG000|Overall Study|Protocol Violation|2|||
149003580|NCT01820559|537491483|FG001|Overall Study|Protocol Violation|1|||
149003581|NCT01820559|537491484|FG002|Overall Study|Protocol Violation|3|||
149003582|NCT01820559|537491482|FG000|Overall Study|Subject's non-compliance|1|||
149003583|NCT01820559|537491483|FG001|Overall Study|Subject's non-compliance|0|||
149003584|NCT01820559|537491484|FG002|Overall Study|Subject's non-compliance|2|||
149003585|NCT01820559|537491482|FG000|Overall Study|Lost to Follow-up|3|||
149003586|NCT01820559|537491483|FG001|Overall Study|Lost to Follow-up|2|||
149003587|NCT01820559|537491484|FG002|Overall Study|Lost to Follow-up|2|||
149003588|NCT01820559|537491482|FG000|Overall Study|At sponsor request|0|||
149003589|NCT01820559|537491483|FG001|Overall Study|At sponsor request|0|||
149037689|NCT01393119|537617582|FG002|Overall Study|Randomized but Not treated|1|||
149037690|NCT01393119|537617583|FG003|Overall Study|Randomized but Not treated|1|||
149003590|NCT01820559|537491484|FG002|Overall Study|At sponsor request|1|||
149003591|NCT01820559|537491482|FG000|Overall Study|Lack of Efficacy|3|||
149003592|NCT01820559|537491483|FG001|Overall Study|Lack of Efficacy|2|||
149003593|NCT01820559|537491484|FG002|Overall Study|Lack of Efficacy|3|||
149003594|NCT00166296|537491486|FG000|Overall Study|Withdrawal by Subject|1|||
149003595|NCT00166296|537491487|FG001|Overall Study|Withdrawal by Subject|3|||
149003596|NCT00166296|537491486|FG000|Overall Study|Adverse Event|2|||
149003597|NCT00166296|537491487|FG001|Overall Study|Adverse Event|4|||
149003598|NCT00166296|537491486|FG000|Overall Study|Lost to Follow-up|4|||
149003599|NCT00166296|537491487|FG001|Overall Study|Lost to Follow-up|2|||
149003600|NCT04035200|537491488|FG000|Overall Study|Lost to Follow-up|0|||
149003601|NCT04035200|537491489|FG001|Overall Study|Lost to Follow-up|1|||
149003602|NCT04035200|537491490|FG002|Overall Study|Lost to Follow-up|0|||
149003603|NCT04035200|537491488|FG000|Overall Study|Withdrawal by Subject|1|||
149003604|NCT04035200|537491489|FG001|Overall Study|Withdrawal by Subject|4|||
149003605|NCT04035200|537491490|FG002|Overall Study|Withdrawal by Subject|4|||
148880027|NCT00619307|537038263|FG001|Overall Study|Lost to Follow-up|1|||
148880028|NCT00619307|537038262|FG000|Overall Study|Protocol Violation|3|||
148880029|NCT00619307|537038263|FG001|Overall Study|Protocol Violation|0|||
148880030|NCT00619307|537038262|FG000|Overall Study|Withdrew consent|1|||
148880031|NCT00619307|537038263|FG001|Overall Study|Withdrew consent|0|||
148880032|NCT00619307|537038262|FG000|Overall Study|Severe migraine|0|||
148880033|NCT00619307|537038263|FG001|Overall Study|Severe migraine|1|||
148880034|NCT00619307|537038262|FG000|Overall Study|MS attack plus steroids|0|||
148880035|NCT00619307|537038263|FG001|Overall Study|MS attack plus steroids|1|||
148880036|NCT00118430|537038266|FG000|Overall Study|Withdrawal by Subject|6|||
148880037|NCT00118430|537038267|FG001|Overall Study|Withdrawal by Subject|2|||
148880038|NCT00118430|537038268|FG002|Overall Study|Withdrawal by Subject|0|||
148880039|NCT00118430|537038266|FG000|Overall Study|Lost to Follow-up|15|||
148880040|NCT00118430|537038267|FG001|Overall Study|Lost to Follow-up|22|||
148880041|NCT00118430|537038268|FG002|Overall Study|Lost to Follow-up|28|||
148880042|NCT02147288|537038269|FG000|Overall Study|post-operative hematoma|1|||
148880043|NCT02147288|537038270|FG001|Overall Study|post-operative hematoma|1|||
148880044|NCT02147288|537038271|FG002|Overall Study|post-operative hematoma|0|||
148880045|NCT02147288|537038272|FG003|Overall Study|post-operative hematoma|0|||
148880046|NCT02147288|537038273|FG004|Overall Study|post-operative hematoma|0|||
148880047|NCT02147288|537038274|FG005|Overall Study|post-operative hematoma|0|||
148880048|NCT02147288|537038275|FG006|Overall Study|post-operative hematoma|0|||
148880049|NCT02147288|537038276|FG007|Overall Study|post-operative hematoma|0|||
148880050|NCT02147288|537038277|FG008|Overall Study|post-operative hematoma|0|||
148880051|NCT02147288|537038278|FG009|Overall Study|post-operative hematoma|0|||
148880052|NCT02147288|537038269|FG000|Overall Study|complications from concurrent hernia rep|0|||
148880053|NCT02147288|537038270|FG001|Overall Study|complications from concurrent hernia rep|1|||
148880054|NCT02147288|537038271|FG002|Overall Study|complications from concurrent hernia rep|0|||
148880055|NCT02147288|537038272|FG003|Overall Study|complications from concurrent hernia rep|0|||
148880056|NCT02147288|537038273|FG004|Overall Study|complications from concurrent hernia rep|0|||
148880057|NCT02147288|537038274|FG005|Overall Study|complications from concurrent hernia rep|0|||
148880058|NCT02147288|537038275|FG006|Overall Study|complications from concurrent hernia rep|0|||
148880059|NCT02147288|537038276|FG007|Overall Study|complications from concurrent hernia rep|0|||
149003606|NCT04035200|537491488|FG000|Overall Study|COVID-19|1|||
149037691|NCT01393119|537617580|FG000|Overall Study|Sponsor Termination of Study|11|||
149003607|NCT04035200|537491489|FG001|Overall Study|COVID-19|0|||
149003608|NCT04035200|537491490|FG002|Overall Study|COVID-19|0|||
149003609|NCT04035200|537491488|FG000|Overall Study|Early Termination|0|||
149003610|NCT04035200|537491489|FG001|Overall Study|Early Termination|1|||
149003611|NCT04035200|537491490|FG002|Overall Study|Early Termination|0|||
149003612|NCT04035200|537491488|FG000|Overall Study|Non-compliance|0|||
149003613|NCT04035200|537491489|FG001|Overall Study|Non-compliance|1|||
149003614|NCT04035200|537491490|FG002|Overall Study|Non-compliance|0|||
149003615|NCT03351738|537491491|FG000|Overall Study|Withdrawal by Subject|0|||
149003616|NCT03351738|537491492|FG001|Overall Study|Withdrawal by Subject|1|||
149003617|NCT03351738|537491493|FG002|Overall Study|Withdrawal by Subject|0|||
149003618|NCT03351738|537491494|FG003|Overall Study|Withdrawal by Subject|1|||
149003619|NCT03351738|537491495|FG004|Overall Study|Withdrawal by Subject|0|||
149003620|NCT03351738|537491496|FG005|Overall Study|Withdrawal by Subject|0|||
149003621|NCT05479604|537491499|FG000|Overall Study|Lost to Follow-up|1|||
149003622|NCT05479604|537491500|FG001|Overall Study|Lost to Follow-up|5|||
149003623|NCT03138733|537491503|FG000|Overall Study|Death|17|||
149003624|NCT03138733|537491504|FG001|Overall Study|Death|18|||
149003625|NCT03138733|537491503|FG000|Overall Study|Withdrawal by Subject|11|||
149003626|NCT03138733|537491504|FG001|Overall Study|Withdrawal by Subject|6|||
149003627|NCT03138733|537491503|FG000|Overall Study|Lost to Follow-up|3|||
149003628|NCT03138733|537491504|FG001|Overall Study|Lost to Follow-up|2|||
149003629|NCT03138733|537491503|FG000|Overall Study|Adverse Event|1|||
149003630|NCT03138733|537491504|FG001|Overall Study|Adverse Event|0|||
149003631|NCT03138733|537491503|FG000|Overall Study|Protocol Violation|1|||
149003632|NCT03138733|537491504|FG001|Overall Study|Protocol Violation|3|||
149037692|NCT01393119|537617581|FG001|Overall Study|Sponsor Termination of Study|12|||
149037693|NCT01393119|537617582|FG002|Overall Study|Sponsor Termination of Study|9|||
149037694|NCT01393119|537617583|FG003|Overall Study|Sponsor Termination of Study|12|||
149037695|NCT01266265|537617584|FG000|Overall Study|Death|95|||
149037696|NCT01266265|537617585|FG001|Overall Study|Death|73|||
149037697|NCT01266265|537617584|FG000|Overall Study|Lost to Follow-up|23|||
148880060|NCT02147288|537038277|FG008|Overall Study|complications from concurrent hernia rep|0|||
148880061|NCT02147288|537038278|FG009|Overall Study|complications from concurrent hernia rep|0|||
149003633|NCT03138733|537491503|FG000|Overall Study|Administrative or logistical reason|1|||
149003634|NCT03138733|537491504|FG001|Overall Study|Administrative or logistical reason|0|||
149003635|NCT03138733|537491503|FG000|Overall Study|The patient was transferred to another hospital|1|||
149003636|NCT03138733|537491504|FG001|Overall Study|The patient was transferred to another hospital|0|||
149003637|NCT01089374|537491505|FG000|Overall Study|Lost to Follow-up|3|||
149037698|NCT01266265|537617585|FG001|Overall Study|Lost to Follow-up|28|||
149037699|NCT01266265|537617584|FG000|Overall Study|Withdrawal by Subject|13|||
149037700|NCT01266265|537617585|FG001|Overall Study|Withdrawal by Subject|11|||
149037701|NCT01266265|537617584|FG000|Overall Study|Respiratory-related adverse event|2|||
149037702|NCT01266265|537617585|FG001|Overall Study|Respiratory-related adverse event|1|||
149037703|NCT01266265|537617584|FG000|Overall Study|Transferred care to another provider|22|||
149037704|NCT01266265|537617585|FG001|Overall Study|Transferred care to another provider|28|||
149037705|NCT01266265|537617584|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
149037706|NCT01266265|537617585|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
149037707|NCT01266265|537617584|FG000|Overall Study|Enrolled in another clinical study|15|||
149037708|NCT01266265|537617585|FG001|Overall Study|Enrolled in another clinical study|26|||
149037709|NCT01266265|537617584|FG000|Overall Study|Non-compliance|8|||
149037710|NCT01266265|537617585|FG001|Overall Study|Non-compliance|5|||
149037711|NCT01266265|537617584|FG000|Overall Study|Lung transplant|6|||
149037712|NCT01266265|537617585|FG001|Overall Study|Lung transplant|5|||
149037713|NCT01266265|537617584|FG000|Overall Study|Site closed early|4|||
149037714|NCT01266265|537617585|FG001|Overall Study|Site closed early|3|||
149037715|NCT01266265|537617584|FG000|Overall Study|Clinical worsening|1|||
149037716|NCT01266265|537617585|FG001|Overall Study|Clinical worsening|1|||
149037717|NCT01580293|537617586|FG000|Part A_Main Trial|Adverse Event|0|||
149037718|NCT01580293|537617587|FG001|Part A_Main Trial|Adverse Event|2|||
149037719|NCT01580293|537617588|FG002|Part A_Main Trial|Adverse Event|0|||
149037720|NCT01580293|537617586|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
149037721|NCT01580293|537617587|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
149037722|NCT01580293|537617588|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
149037723|NCT01580293|537617586|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
149037724|NCT01580293|537617587|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
149037725|NCT01580293|537617588|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
149037726|NCT01580293|537617586|FG000|Part A_Extension|Adverse Event|0|||
149037727|NCT01580293|537617587|FG001|Part A_Extension|Adverse Event|2|||
149037728|NCT01580293|537617588|FG002|Part A_Extension|Adverse Event|0|||
149037729|NCT01580293|537617586|FG000|Part A_Extension|Withdrawal by Subject|0|||
149037730|NCT01580293|537617587|FG001|Part A_Extension|Withdrawal by Subject|3|||
149037731|NCT01580293|537617588|FG002|Part A_Extension|Withdrawal by Subject|0|||
149037732|NCT01580293|537617586|FG000|Part A_Extension|Lost to Follow-up|0|||
149037733|NCT01580293|537617587|FG001|Part A_Extension|Lost to Follow-up|1|||
149037734|NCT01580293|537617588|FG002|Part A_Extension|Lost to Follow-up|0|||
149037735|NCT01580293|537617586|FG000|Part A_Extension|Other Reason|0|||
149037736|NCT01580293|537617587|FG001|Part A_Extension|Other Reason|1|||
149037737|NCT01580293|537617588|FG002|Part A_Extension|Other Reason|0|||
149037738|NCT01580293|537617586|FG000|Part A_Extension|Completed Japan only|0|||
149037739|NCT01580293|537617587|FG001|Part A_Extension|Completed Japan only|5|||
149037740|NCT01580293|537617588|FG002|Part A_Extension|Completed Japan only|0|||
149037741|NCT01580293|537617586|FG000|Part B|Withdrawal by Subject|0|||
149037742|NCT01580293|537617587|FG001|Part B|Withdrawal by Subject|0|||
149037743|NCT01580293|537617588|FG002|Part B|Withdrawal by Subject|1|||
149037744|NCT01580293|537617586|FG000|Part B|Other reason|0|||
149037745|NCT01580293|537617587|FG001|Part B|Other reason|0|||
149037746|NCT01580293|537617588|FG002|Part B|Other reason|1|||
149037747|NCT02983617|537617590|FG000|Overall Study|Adverse Event|0|||
149037748|NCT02983617|537617591|FG001|Overall Study|Adverse Event|7|||
149037749|NCT02983617|537617590|FG000|Overall Study|Death|0|||
149037750|NCT02983617|537617591|FG001|Overall Study|Death|1|||
149037751|NCT02983617|537617590|FG000|Overall Study|Investigator's Discretion|0|||
149037752|NCT02983617|537617591|FG001|Overall Study|Investigator's Discretion|1|||
149037753|NCT00516386|537617594|FG000|Overall Study|not interested in the study|4|||
149037754|NCT00516386|537617594|FG000|Overall Study|Lost to Follow-up|2|||
149037755|NCT04218110|537617595|FG000|Overall Study|Withdrawal by Subject|0|||
149037756|NCT04218110|537617596|FG001|Overall Study|Withdrawal by Subject|0|||
149037757|NCT04218110|537617597|FG002|Overall Study|Withdrawal by Subject|0|||
149037758|NCT04218110|537617598|FG003|Overall Study|Withdrawal by Subject|1|||
149037759|NCT00002842|537617599|FG000|Overall Study|ineligible for surgical resection|27|||
149037760|NCT02015546|537617600|FG000|Overall Study|Withdrawal by Subject|1|||
149037761|NCT02015546|537617601|FG001|Overall Study|Withdrawal by Subject|1|||
149037762|NCT02015546|537617602|FG002|Overall Study|Withdrawal by Subject|1|||
149037763|NCT02015546|537617600|FG000|Overall Study|Screem Failure|2|||
149037764|NCT02015546|537617601|FG001|Overall Study|Screem Failure|1|||
149037765|NCT02015546|537617602|FG002|Overall Study|Screem Failure|3|||
149037766|NCT05855655|537617603|FG000|Overall Study|Withdrawal by Subject|0|||
149037767|NCT05855655|537617604|FG001|Overall Study|Withdrawal by Subject|1|||
149037768|NCT05855655|537617603|FG000|Overall Study|Lost to Follow-up|4|||
149037769|NCT05855655|537617604|FG001|Overall Study|Lost to Follow-up|0|||
149037770|NCT02296424|537617606|FG000|Part 1|New therapy for study indication|0|||
149037771|NCT02296424|537617607|FG001|Part 1|New therapy for study indication|1|||
149037772|NCT02296424|537617608|FG002|Part 1|New therapy for study indication|0|||
149037773|NCT02296424|537617609|FG003|Part 1|New therapy for study indication|0|||
149037774|NCT02296424|537617606|FG000|Part 1|Protocol Violation|0|||
149037775|NCT02296424|537617607|FG001|Part 1|Protocol Violation|1|||
149037776|NCT02296424|537617608|FG002|Part 1|Protocol Violation|0|||
149037777|NCT02296424|537617609|FG003|Part 1|Protocol Violation|0|||
149037778|NCT02296424|537617606|FG000|Part 1|Withdrawal by Subject|0|||
149037779|NCT02296424|537617607|FG001|Part 1|Withdrawal by Subject|2|||
149037780|NCT02296424|537617608|FG002|Part 1|Withdrawal by Subject|0|||
149037781|NCT02296424|537617609|FG003|Part 1|Withdrawal by Subject|0|||
149037782|NCT02296424|537617606|FG000|Part 1|Study terminated by sponsor|0|||
149037783|NCT02296424|537617607|FG001|Part 1|Study terminated by sponsor|1|||
148880062|NCT00546000|537039656|FG000|Overall Study|Adverse Event|1|||
148880063|NCT00546000|537039656|FG000|Overall Study|Lost to Follow-up|1|||
148880064|NCT00546000|537039656|FG000|Overall Study|Baseline HPA Axis Supression|2|||
148880065|NCT01362608|537039663|FG000|Overall Study|Protocol Violation|0|||
148880066|NCT01362608|537039664|FG001|Overall Study|Protocol Violation|1|||
148880067|NCT01362608|537039663|FG000|Overall Study|Lost to Follow-up|3|||
148880068|NCT01362608|537039664|FG001|Overall Study|Lost to Follow-up|1|||
148880069|NCT01362608|537039663|FG000|Overall Study|Withdrawal by Subject|1|||
148880070|NCT01362608|537039664|FG001|Overall Study|Withdrawal by Subject|2|||
148880071|NCT01362608|537039663|FG000|Overall Study|Lack of Efficacy|0|||
148880072|NCT01362608|537039664|FG001|Overall Study|Lack of Efficacy|2|||
148880073|NCT01362608|537039663|FG000|Overall Study|Adverse Event|0|||
148880074|NCT01362608|537039664|FG001|Overall Study|Adverse Event|2|||
148880075|NCT04809285|537039673|FG000|Phase 1|Lost to Follow-up|6|||
148880076|NCT04809285|537039673|FG000|Phase 1|Protocol Violation|2|||
148880077|NCT04809285|537039673|FG000|Phase 1|Physician Decision|3|||
148880078|NCT04809285|537039673|FG000|Phase 1|Withdrawal by Subject|29|||
148880079|NCT04809285|537039673|FG000|Phase 2|Protocol Violation|3|||
148880080|NCT04809285|537039673|FG000|Phase 2|Withdrawal by Subject|4|||
148880081|NCT02783599|537039674|FG000|Overall Study|Progressive disease|23|||
148880082|NCT02783599|537039674|FG000|Overall Study|Surgical Resection|10|||
148880083|NCT02783599|537039674|FG000|Overall Study|Adverse Event|4|||
148880084|NCT02783599|537039674|FG000|Overall Study|Physician Decision|2|||
148880085|NCT02783599|537039674|FG000|Overall Study|Death|1|||
148880086|NCT01564732|537039679|FG000|Overall Study|Early termination by the study sponsor|6|||
148880087|NCT01564732|537039680|FG001|Overall Study|Early termination by the study sponsor|5|||
148880088|NCT00381693|537039685|FG000|Overall Study|Death|1|||
149037784|NCT02296424|537617608|FG002|Part 1|Study terminated by sponsor|0|||
148880089|NCT00381693|537039685|FG000|Overall Study|Adverse Event|4|||
148880090|NCT00381693|537039685|FG000|Overall Study|Patient Choice|1|||
148880091|NCT00381693|537039685|FG000|Overall Study|Progression|2|||
148880092|NCT02598297|537039686|FG000|Overall Study|Study terminated by Sponsor|21|||
148880093|NCT02598297|537039687|FG001|Overall Study|Study terminated by Sponsor|23|||
148880094|NCT02598297|537039686|FG000|Overall Study|Adverse Event|1|||
148880095|NCT02598297|537039687|FG001|Overall Study|Adverse Event|1|||
148880096|NCT02598297|537039686|FG000|Overall Study|Physician Decision|1|||
148880097|NCT02598297|537039687|FG001|Overall Study|Physician Decision|0|||
148880098|NCT02598297|537039686|FG000|Overall Study|Subject/guardian decision|1|||
148880099|NCT02598297|537039687|FG001|Overall Study|Subject/guardian decision|0|||
148880100|NCT02598297|537039686|FG000|Overall Study|Followed for survival|1|||
148880101|NCT02598297|537039687|FG001|Overall Study|Followed for survival|0|||
148880102|NCT02003534|537039702|FG000|Overall Study|Lost to Follow-up|47|||
148880103|NCT03920254|537039704|FG000|Overall Study|Adverse Event|1|||
148880104|NCT03920254|537039705|FG001|Overall Study|Adverse Event|0|||
148880105|NCT03920254|537039706|FG002|Overall Study|Adverse Event|0|||
148880106|NCT03920254|537039704|FG000|Overall Study|Physician Decision|0|||
148880107|NCT03920254|537039705|FG001|Overall Study|Physician Decision|1|||
148880108|NCT03920254|537039706|FG002|Overall Study|Physician Decision|2|||
148880109|NCT03920254|537039704|FG000|Overall Study|Study Terminated By Sponsor|12|||
148880110|NCT03920254|537039705|FG001|Overall Study|Study Terminated By Sponsor|17|||
148880111|NCT03920254|537039706|FG002|Overall Study|Study Terminated By Sponsor|12|||
148880112|NCT03920254|537039704|FG000|Overall Study|Withdrawal by Subject|0|||
148880113|NCT03920254|537039705|FG001|Overall Study|Withdrawal by Subject|0|||
148880114|NCT03920254|537039706|FG002|Overall Study|Withdrawal by Subject|1|||
148880115|NCT00887549|537039707|FG000|Induction Therapy|Adverse Event|8|||
148880116|NCT00887549|537039707|FG000|Induction Therapy|Physician Decision|1|||
148880117|NCT00887549|537039707|FG000|Induction Therapy|Progressive Disease|13|||
148880118|NCT00887549|537039707|FG000|Induction Therapy|Death due to Study Disease|4|||
148880119|NCT00887549|537039707|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
148880120|NCT00887549|537039707|FG000|Maintenance Therapy|Adverse Event|16|||
148880121|NCT00887549|537039707|FG000|Maintenance Therapy|Physician Decision|1|||
148880122|NCT00887549|537039707|FG000|Maintenance Therapy|Progressive Disease|25|||
148880123|NCT00887549|537039707|FG000|Maintenance Therapy|Death due to adverse event|1|||
148880124|NCT01934010|537039708|FG000|Overall Study|Adverse Event|1|||
148880125|NCT01934010|537039709|FG001|Overall Study|Adverse Event|1|||
148880126|NCT01934010|537039710|FG002|Overall Study|Adverse Event|0|||
148880127|NCT01934010|537039708|FG000|Overall Study|Withdrawal by Subject|15|||
148880128|NCT01934010|537039709|FG001|Overall Study|Withdrawal by Subject|6|||
148880129|NCT01934010|537039710|FG002|Overall Study|Withdrawal by Subject|2|||
148880130|NCT01934010|537039708|FG000|Overall Study|Lost to Follow-up|7|||
149037785|NCT02296424|537617609|FG003|Part 1|Study terminated by sponsor|0|||
148880131|NCT01934010|537039709|FG001|Overall Study|Lost to Follow-up|4|||
148880132|NCT01934010|537039710|FG002|Overall Study|Lost to Follow-up|0|||
148880133|NCT04112303|537039711|FG000|Overall Study|Death|1|||
148880134|NCT05173012|537039712|FG000|Overall Study|Adverse Event|2|||
148880135|NCT05173012|537039713|FG001|Overall Study|Adverse Event|3|||
148880136|NCT05173012|537039714|FG002|Overall Study|Adverse Event|4|||
148880137|NCT05173012|537039715|FG003|Overall Study|Adverse Event|13|||
148880138|NCT05173012|537039716|FG004|Overall Study|Adverse Event|0|||
148880139|NCT05173012|537039717|FG005|Overall Study|Adverse Event|0|||
148880140|NCT05173012|537039718|FG006|Overall Study|Adverse Event|2|||
148880141|NCT05173012|537039719|FG007|Overall Study|Adverse Event|4|||
148880142|NCT05173012|537039712|FG000|Overall Study|Lost to Follow-up|0|||
148880143|NCT05173012|537039713|FG001|Overall Study|Lost to Follow-up|0|||
148880144|NCT05173012|537039714|FG002|Overall Study|Lost to Follow-up|0|||
148880145|NCT05173012|537039715|FG003|Overall Study|Lost to Follow-up|1|||
148880146|NCT05173012|537039716|FG004|Overall Study|Lost to Follow-up|0|||
148880147|NCT05173012|537039717|FG005|Overall Study|Lost to Follow-up|0|||
148880148|NCT05173012|537039718|FG006|Overall Study|Lost to Follow-up|0|||
148880149|NCT05173012|537039719|FG007|Overall Study|Lost to Follow-up|0|||
149003638|NCT01089374|537491506|FG001|Overall Study|Lost to Follow-up|0|||
149003639|NCT01089374|537491505|FG000|Overall Study|Withdrawal by Subject|1|||
149003640|NCT01089374|537491506|FG001|Overall Study|Withdrawal by Subject|0|||
149003641|NCT01089374|537491505|FG000|Overall Study|Study closed early - low accrual|6|||
149003642|NCT01089374|537491506|FG001|Overall Study|Study closed early - low accrual|0|||
149003643|NCT01591382|537491507|FG000|Overall Study|Discharged Prior to Study Completion|2|||
149003644|NCT01591382|537491508|FG001|Overall Study|Discharged Prior to Study Completion|1|||
149003645|NCT01591382|537491507|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
149003646|NCT01591382|537491508|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
149003647|NCT03641313|537491522|FG000|Overall Study|Death|1|||
149003648|NCT03641313|537491522|FG000|Overall Study|Withdrawal by Subject|2|||
149003649|NCT03641313|537491522|FG000|Overall Study|Declining health|1|||
149003650|NCT03641313|537491522|FG000|Overall Study|Adverse Event|1|||
149003651|NCT03033225|537491523|FG000|Overall Study|Withdrawal by Subject|5|||
149003652|NCT00689026|537491528|FG000|Overall Study|Withdrawal by Subject|13|||
149003653|NCT00689026|537491529|FG001|Overall Study|Withdrawal by Subject|6|||
149003654|NCT01666808|537491530|FG000|Overall Study|Lost to Follow-up|9|||
149003655|NCT01666808|537491531|FG001|Overall Study|Lost to Follow-up|15|||
149003656|NCT01666808|537491530|FG000|Overall Study|Withdrawal by Subject|3|||
149003657|NCT01666808|537491531|FG001|Overall Study|Withdrawal by Subject|1|||
149003658|NCT01666808|537491530|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
149003659|NCT01666808|537491531|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
149003660|NCT03933826|537491532|FG000|Overall Study|Withdrawal by Subject|8|||
149003661|NCT03933826|537491533|FG001|Overall Study|Withdrawal by Subject|1|||
149003662|NCT03933826|537491532|FG000|Overall Study|Death|19|||
149003663|NCT03933826|537491533|FG001|Overall Study|Death|11|||
149003664|NCT03933826|537491532|FG000|Overall Study|Lost to Follow-up|41|||
149003665|NCT03933826|537491533|FG001|Overall Study|Lost to Follow-up|13|||
149003666|NCT04992546|537491534|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
149003667|NCT04992546|537491534|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
149003668|NCT04992546|537491534|FG000|Open-Label Treatment Period|Adverse Event|3|||
149003669|NCT04992546|537491534|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
149003670|NCT02703922|537491536|FG000|Overall Study|Death|5|||
149003671|NCT02703922|537491537|FG001|Overall Study|Death|8|||
149003672|NCT02703922|537491536|FG000|Overall Study|Lost to Follow-up|10|||
149003673|NCT02703922|537491537|FG001|Overall Study|Lost to Follow-up|10|||
149003674|NCT00500903|537491540|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
149003675|NCT00500903|537491541|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
149003676|NCT00500903|537491542|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
149003677|NCT00500903|537491540|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
149003678|NCT00500903|537491541|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
149003679|NCT00500903|537491542|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
149003680|NCT00500903|537491540|FG000|Overall Study|Progressive Disease|41|||
149003681|NCT00500903|537491541|FG001|Overall Study|Progressive Disease|2|||
149003682|NCT00500903|537491542|FG002|Overall Study|Progressive Disease|15|||
149003683|NCT00500903|537491540|FG000|Overall Study|Patient Declined Further Treatment|0|||
148880150|NCT05173012|537039712|FG000|Overall Study|Withdrawal by Subject|1|||
148880151|NCT05173012|537039713|FG001|Overall Study|Withdrawal by Subject|0|||
149003684|NCT00500903|537491541|FG001|Overall Study|Patient Declined Further Treatment|0|||
149003685|NCT00500903|537491542|FG002|Overall Study|Patient Declined Further Treatment|3|||
149003686|NCT00500903|537491540|FG000|Overall Study|Symptomatic Deterioration|2|||
149003687|NCT00500903|537491541|FG001|Overall Study|Symptomatic Deterioration|0|||
149003688|NCT00500903|537491542|FG002|Overall Study|Symptomatic Deterioration|0|||
148880152|NCT05173012|537039714|FG002|Overall Study|Withdrawal by Subject|1|||
148880153|NCT05173012|537039715|FG003|Overall Study|Withdrawal by Subject|3|||
148880154|NCT05173012|537039716|FG004|Overall Study|Withdrawal by Subject|1|||
148880155|NCT05173012|537039717|FG005|Overall Study|Withdrawal by Subject|0|||
149037786|NCT02296424|537617606|FG000|Part 1|Adverse Event|2|||
149037787|NCT02296424|537617607|FG001|Part 1|Adverse Event|11|||
149037788|NCT02296424|537617608|FG002|Part 1|Adverse Event|0|||
149037789|NCT02296424|537617609|FG003|Part 1|Adverse Event|0|||
149037790|NCT02296424|537617606|FG000|Part 1|Lack of Efficacy|5|||
149037791|NCT02296424|537617607|FG001|Part 1|Lack of Efficacy|17|||
149037792|NCT02296424|537617608|FG002|Part 1|Lack of Efficacy|0|||
149037793|NCT02296424|537617609|FG003|Part 1|Lack of Efficacy|0|||
149037794|NCT02296424|537617606|FG000|Part 1|16 directly started part II|16|||
149037795|NCT02296424|537617607|FG001|Part 1|16 directly started part II|0|||
149037796|NCT02296424|537617608|FG002|Part 1|16 directly started part II|0|||
149037797|NCT02296424|537617609|FG003|Part 1|16 directly started part II|0|||
149037798|NCT02296424|537617606|FG000|Part 2|Lack of Efficacy|0|||
149037799|NCT02296424|537617607|FG001|Part 2|Lack of Efficacy|0|||
149037800|NCT02296424|537617608|FG002|Part 2|Lack of Efficacy|1|||
149037801|NCT02296424|537617609|FG003|Part 2|Lack of Efficacy|0|||
149037802|NCT02296424|537617606|FG000|Part 2|Adverse Event|0|||
149037803|NCT02296424|537617607|FG001|Part 2|Adverse Event|0|||
149037804|NCT02296424|537617608|FG002|Part 2|Adverse Event|1|||
149037805|NCT02296424|537617609|FG003|Part 2|Adverse Event|0|||
149037806|NCT02296424|537617606|FG000|Part 2|Lost to Follow-up|0|||
149037807|NCT02296424|537617607|FG001|Part 2|Lost to Follow-up|0|||
149037808|NCT02296424|537617608|FG002|Part 2|Lost to Follow-up|1|||
149037809|NCT02296424|537617609|FG003|Part 2|Lost to Follow-up|0|||
149037810|NCT01337635|537617610|FG000|Overall Study|Lost to Follow-up|0|||
149037811|NCT01337635|537617611|FG001|Overall Study|Lost to Follow-up|1|||
149037812|NCT01113931|537617614|FG000|Overall Study|Adverse Event|2|||
149037813|NCT01113931|537617615|FG001|Overall Study|Adverse Event|2|||
149037814|NCT01113931|537617614|FG000|Overall Study|Physician Decision|0|||
149037815|NCT01113931|537617615|FG001|Overall Study|Physician Decision|2|||
149037816|NCT01113931|537617614|FG000|Overall Study|Lost to Follow-up|12|||
149037817|NCT01113931|537617615|FG001|Overall Study|Lost to Follow-up|9|||
149037818|NCT01113931|537617614|FG000|Overall Study|Various|2|||
149037819|NCT01113931|537617615|FG001|Overall Study|Various|4|||
149037820|NCT01113931|537617614|FG000|Overall Study|Withdrawal by Subject|3|||
149037821|NCT01113931|537617615|FG001|Overall Study|Withdrawal by Subject|0|||
149037822|NCT01290224|537617616|FG000|Overall Study|Adverse Event|1|||
149037823|NCT01290224|537617616|FG000|Overall Study|Refused Further Treatment|4|||
149037824|NCT02969863|537617622|FG000|Overall Study|Physician Decision|1|||
149037825|NCT02969863|537617623|FG001|Overall Study|Physician Decision|0|||
149037826|NCT02969863|537617624|FG002|Overall Study|Physician Decision|0|||
149037827|NCT02969863|537617625|FG003|Overall Study|Physician Decision|0|||
149037828|NCT02969863|537617626|FG004|Overall Study|Physician Decision|0|||
149037829|NCT02969863|537617627|FG005|Overall Study|Physician Decision|0|||
149037830|NCT02705586|537617628|FG000|Overall Study|Health Issues|2|||
149037831|NCT02705586|537617628|FG000|Overall Study|Transportation Difficulties|5|||
149037832|NCT02705586|537617628|FG000|Overall Study|Vacation/Planned Absence|1|||
149037833|NCT02045836|537617632|FG000|Overall Study|Adverse Event|4|||
149037834|NCT02045836|537617633|FG001|Overall Study|Adverse Event|4|||
149037835|NCT02045836|537617632|FG000|Overall Study|Withdrawal by Subject|1|||
149037836|NCT02045836|537617633|FG001|Overall Study|Withdrawal by Subject|1|||
149037837|NCT02045836|537617632|FG000|Overall Study|Lost to Follow-up|4|||
149037838|NCT02045836|537617633|FG001|Overall Study|Lost to Follow-up|7|||
149037839|NCT02045836|537617632|FG000|Overall Study|Migrated from study area|0|||
149037840|NCT02045836|537617633|FG001|Overall Study|Migrated from study area|2|||
148880156|NCT05173012|537039718|FG006|Overall Study|Withdrawal by Subject|1|||
148880157|NCT05173012|537039719|FG007|Overall Study|Withdrawal by Subject|0|||
148880158|NCT05173012|537039712|FG000|Overall Study|Protocol Deviation|0|||
149037841|NCT03920215|537617635|FG000|Overall Study|Lost to Follow-up|1|||
149037842|NCT03920215|537617636|FG001|Overall Study|Lost to Follow-up|2|||
149037843|NCT03920215|537617637|FG002|Overall Study|Lost to Follow-up|0|||
149037844|NCT03920215|537617638|FG003|Overall Study|Lost to Follow-up|0|||
149037845|NCT03920215|537617635|FG000|Overall Study|Death|0|||
149037846|NCT03920215|537617636|FG001|Overall Study|Death|0|||
149037847|NCT03920215|537617637|FG002|Overall Study|Death|0|||
149037848|NCT03920215|537617638|FG003|Overall Study|Death|1|||
149037849|NCT03024606|537617645|FG000|Overall Study|Withdrawal by Subject|9|||
149037850|NCT03024606|537617646|FG001|Overall Study|Withdrawal by Subject|10|||
149037851|NCT02547922|537617653|FG000|Overall Study|Withdrawal by Subject|9|||
149037852|NCT02547922|537617654|FG001|Overall Study|Withdrawal by Subject|6|||
149037853|NCT02547922|537617655|FG002|Overall Study|Withdrawal by Subject|10|||
149037854|NCT02547922|537617653|FG000|Overall Study|Adverse Event|3|||
149037855|NCT02547922|537617654|FG001|Overall Study|Adverse Event|1|||
149037856|NCT02547922|537617655|FG002|Overall Study|Adverse Event|2|||
149037857|NCT02547922|537617653|FG000|Overall Study|Lost to Follow-up|1|||
149037858|NCT02547922|537617654|FG001|Overall Study|Lost to Follow-up|0|||
149037859|NCT02547922|537617655|FG002|Overall Study|Lost to Follow-up|0|||
149037860|NCT02547922|537617653|FG000|Overall Study|Lack of Efficacy|5|||
148880159|NCT05173012|537039713|FG001|Overall Study|Protocol Deviation|0|||
149037861|NCT02547922|537617654|FG001|Overall Study|Lack of Efficacy|7|||
149037862|NCT02547922|537617655|FG002|Overall Study|Lack of Efficacy|4|||
149037863|NCT02547922|537617653|FG000|Overall Study|Death|1|||
149037864|NCT02547922|537617654|FG001|Overall Study|Death|0|||
149037865|NCT02547922|537617655|FG002|Overall Study|Death|0|||
149037866|NCT02547922|537617653|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
149037867|NCT02547922|537617654|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
149037868|NCT02547922|537617655|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
149037869|NCT02547922|537617653|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
149037870|NCT02547922|537617654|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
149037871|NCT02547922|537617655|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
149037872|NCT02547922|537617653|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
149037873|NCT02547922|537617654|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
149037874|NCT02547922|537617655|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
149037875|NCT02547922|537617653|FG000|Overall Study|Physician Decision|2|||
149037876|NCT02547922|537617654|FG001|Overall Study|Physician Decision|1|||
149037877|NCT02547922|537617655|FG002|Overall Study|Physician Decision|2|||
149037878|NCT02547922|537617653|FG000|Overall Study|Patients did not receive IP|1|||
149037879|NCT02547922|537617654|FG001|Overall Study|Patients did not receive IP|1|||
149037880|NCT02547922|537617655|FG002|Overall Study|Patients did not receive IP|0|||
149037881|NCT00102063|537617660|FG000|Overall Study|Lack of Efficacy|5|||
149037882|NCT00102063|537617661|FG001|Overall Study|Lack of Efficacy|1|||
149037883|NCT00102063|537617662|FG002|Overall Study|Lack of Efficacy|1|||
149037884|NCT00102063|537617660|FG000|Overall Study|Adverse Event|7|||
149037885|NCT00102063|537617661|FG001|Overall Study|Adverse Event|4|||
149037886|NCT00102063|537617662|FG002|Overall Study|Adverse Event|2|||
149037887|NCT00102063|537617660|FG000|Overall Study|Withdrawal by Subject|4|||
149037888|NCT00102063|537617661|FG001|Overall Study|Withdrawal by Subject|12|||
149037889|NCT00102063|537617662|FG002|Overall Study|Withdrawal by Subject|5|||
149037890|NCT00102063|537617660|FG000|Overall Study|Lost to Follow-up|0|||
149037891|NCT00102063|537617661|FG001|Overall Study|Lost to Follow-up|0|||
149037892|NCT00102063|537617662|FG002|Overall Study|Lost to Follow-up|1|||
149037893|NCT00102063|537617660|FG000|Overall Study|Protocol Violation|0|||
149037894|NCT00102063|537617661|FG001|Overall Study|Protocol Violation|1|||
149037895|NCT00102063|537617662|FG002|Overall Study|Protocol Violation|1|||
149037896|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
149037897|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
149037898|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
149037899|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
149037900|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
149037901|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
149037902|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
149037903|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
149037904|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
149037905|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
149037906|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
149037907|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
149037908|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
149037909|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
149037910|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
149037911|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037912|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037913|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
149037914|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037915|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037916|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037917|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
148880160|NCT05173012|537039714|FG002|Overall Study|Protocol Deviation|0|||
148880161|NCT05173012|537039715|FG003|Overall Study|Protocol Deviation|1|||
148880162|NCT05173012|537039716|FG004|Overall Study|Protocol Deviation|0|||
149037918|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037919|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037920|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037921|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
149037922|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
149037923|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
149037924|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
149037925|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
149037926|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
149037927|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
149037928|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
149037929|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
149037930|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
148880163|NCT05173012|537039717|FG005|Overall Study|Protocol Deviation|0|||
149037931|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
149037932|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
149037933|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
149037934|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
149037935|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037936|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
149037937|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
149037938|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037939|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
149037940|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037941|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037942|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037943|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037944|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037945|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037946|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037947|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
149037948|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
149037949|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
149037950|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
149037951|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
149037952|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
149037953|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037954|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037955|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037956|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
149037957|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037958|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037959|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037960|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
149037961|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
149037962|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037963|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037964|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037965|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037966|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
149037967|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
149037968|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
149037969|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037970|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037971|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037972|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037973|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
149037974|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
149037975|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
149037976|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
149037977|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
149037978|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
149037979|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
149037980|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
149037981|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
149037982|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
149037983|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
149037984|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
148880164|NCT05173012|537039718|FG006|Overall Study|Protocol Deviation|0|||
148880165|NCT05173012|537039719|FG007|Overall Study|Protocol Deviation|0|||
148880166|NCT05173012|537039712|FG000|Overall Study|Other|0|||
148880167|NCT05173012|537039713|FG001|Overall Study|Other|0|||
149037985|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
149037986|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
149037987|NCT04707313|537617665|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037988|NCT04707313|537617666|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037989|NCT04707313|537617667|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
149037990|NCT04707313|537617668|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037991|NCT04707313|537617669|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
148880168|NCT05173012|537039714|FG002|Overall Study|Other|0|||
148880169|NCT05173012|537039715|FG003|Overall Study|Other|2|||
149037992|NCT04707313|537617670|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037993|NCT04707313|537617671|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037994|NCT04707313|537617672|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
149037995|NCT04707313|537617673|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037996|NCT04707313|537617674|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037997|NCT04707313|537617675|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037998|NCT04707313|537617676|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149037999|NCT04707313|537617677|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
149038000|NCT04707313|537617665|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038001|NCT04707313|537617666|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038002|NCT04707313|537617667|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038003|NCT04707313|537617668|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038004|NCT04707313|537617669|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038005|NCT04707313|537617670|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038006|NCT04707313|537617671|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038007|NCT04707313|537617672|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038008|NCT04707313|537617673|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038009|NCT04707313|537617674|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
149038010|NCT04707313|537617675|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
149038011|NCT04707313|537617676|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
149038012|NCT04707313|537617677|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
149038013|NCT04707313|537617665|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038014|NCT04707313|537617666|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038015|NCT04707313|537617667|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038016|NCT04707313|537617668|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038017|NCT04707313|537617669|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038018|NCT04707313|537617670|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038019|NCT04707313|537617671|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038020|NCT04707313|537617672|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038021|NCT04707313|537617673|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038022|NCT04707313|537617674|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
149038023|NCT04707313|537617675|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
149038024|NCT04707313|537617676|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
149038025|NCT04707313|537617677|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
149038026|NCT04707313|537617665|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038027|NCT04707313|537617666|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038028|NCT04707313|537617667|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038029|NCT04707313|537617668|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038030|NCT04707313|537617669|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038031|NCT04707313|537617670|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038032|NCT04707313|537617671|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038033|NCT04707313|537617672|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038034|NCT04707313|537617673|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
149038035|NCT04707313|537617674|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
149038036|NCT04707313|537617675|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
149038037|NCT04707313|537617676|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
149038038|NCT04707313|537617677|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
149038039|NCT04707313|537617665|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038040|NCT04707313|537617666|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038041|NCT04707313|537617667|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038042|NCT04707313|537617668|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038043|NCT04707313|537617669|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038044|NCT04707313|537617670|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038045|NCT04707313|537617671|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038046|NCT04707313|537617672|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038047|NCT04707313|537617673|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038048|NCT04707313|537617674|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038049|NCT04707313|537617675|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
148880170|NCT05173012|537039716|FG004|Overall Study|Other|0|||
148880171|NCT05173012|537039717|FG005|Overall Study|Other|0|||
148880172|NCT05173012|537039718|FG006|Overall Study|Other|0|||
148880173|NCT05173012|537039719|FG007|Overall Study|Other|0|||
148880174|NCT01393821|537039720|FG000|Overall Study|Cancel|1|||
149038050|NCT04707313|537617676|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
149038051|NCT04707313|537617677|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
149038052|NCT04707313|537617665|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038053|NCT04707313|537617666|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038054|NCT04707313|537617667|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
148880175|NCT01393821|537039721|FG001|Overall Study|Cancel|1|||
148880176|NCT01393821|537039720|FG000|Overall Study|not evaluable for primary endpoint|4|||
149038055|NCT04707313|537617668|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038056|NCT04707313|537617669|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038057|NCT04707313|537617670|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038058|NCT04707313|537617671|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038059|NCT04707313|537617672|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038060|NCT04707313|537617673|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038061|NCT04707313|537617674|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
149038062|NCT04707313|537617675|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
149038063|NCT04707313|537617676|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038064|NCT04707313|537617677|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
149038065|NCT04707313|537617665|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038066|NCT04707313|537617666|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038067|NCT04707313|537617667|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038068|NCT04707313|537617668|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038069|NCT04707313|537617669|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038070|NCT04707313|537617670|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038071|NCT04707313|537617671|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038072|NCT04707313|537617672|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038073|NCT04707313|537617673|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
149038074|NCT04707313|537617674|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
149038075|NCT04707313|537617675|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
149038076|NCT04707313|537617676|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
149038077|NCT04707313|537617677|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
149038078|NCT02459899|537617678|FG000|Overall Study|Adverse Event|1|||
149038079|NCT02459899|537617679|FG001|Overall Study|Adverse Event|1|||
149038080|NCT02459899|537617680|FG002|Overall Study|Adverse Event|0|||
149038081|NCT02459899|537617681|FG003|Overall Study|Adverse Event|0|||
149038082|NCT02459899|537617678|FG000|Overall Study|Lost to Follow-up|1|||
149038083|NCT02459899|537617679|FG001|Overall Study|Lost to Follow-up|2|||
149038084|NCT02459899|537617680|FG002|Overall Study|Lost to Follow-up|0|||
149038085|NCT02459899|537617681|FG003|Overall Study|Lost to Follow-up|1|||
149038086|NCT02459899|537617678|FG000|Overall Study|Non-compliance with the treatment|0|||
149038087|NCT02459899|537617679|FG001|Overall Study|Non-compliance with the treatment|0|||
149038088|NCT02459899|537617680|FG002|Overall Study|Non-compliance with the treatment|0|||
149038089|NCT02459899|537617681|FG003|Overall Study|Non-compliance with the treatment|1|||
149038090|NCT02459899|537617678|FG000|Overall Study|Withdrawal by Subject|1|||
149038091|NCT02459899|537617679|FG001|Overall Study|Withdrawal by Subject|3|||
149038092|NCT02459899|537617680|FG002|Overall Study|Withdrawal by Subject|0|||
149038093|NCT02459899|537617681|FG003|Overall Study|Withdrawal by Subject|0|||
149038094|NCT00940992|537617683|FG000|Overall Study|Adverse Event|2|||
149038095|NCT00940992|537617684|FG001|Overall Study|Adverse Event|0|||
149038096|NCT00940992|537617685|FG002|Overall Study|Adverse Event|1|||
149038097|NCT00940992|537617683|FG000|Overall Study|subject request|2|||
149038098|NCT00940992|537617684|FG001|Overall Study|subject request|1|||
149038099|NCT00940992|537617685|FG002|Overall Study|subject request|0|||
149038100|NCT00940992|537617683|FG000|Overall Study|Lost to Follow-up|0|||
149038101|NCT00940992|537617684|FG001|Overall Study|Lost to Follow-up|1|||
149038102|NCT00940992|537617685|FG002|Overall Study|Lost to Follow-up|1|||
149038103|NCT03586544|537617686|FG000|First Intervention|Adverse Event|0|||
149038104|NCT03586544|537617687|FG001|First Intervention|Adverse Event|1|||
149038105|NCT03586544|537617686|FG000|Second Intervention|Withdrawal by Subject|0|||
149038106|NCT03586544|537617687|FG001|Second Intervention|Withdrawal by Subject|1|||
149038107|NCT00539292|537617691|FG000|Overall Study|Physician Decision|1|||
149038108|NCT00539292|537617692|FG001|Overall Study|Physician Decision|0|||
149038109|NCT02020616|537617696|FG000|Overall Study|Adverse Event|0|||
149038110|NCT02020616|537617697|FG001|Overall Study|Adverse Event|0|||
149038111|NCT02020616|537617698|FG002|Overall Study|Adverse Event|0|||
149038112|NCT02020616|537617699|FG003|Overall Study|Adverse Event|0|||
149038113|NCT02020616|537617700|FG004|Overall Study|Adverse Event|0|||
149038114|NCT02020616|537617701|FG005|Overall Study|Adverse Event|1|||
149038115|NCT02020616|537617702|FG006|Overall Study|Adverse Event|1|||
148880177|NCT01393821|537039721|FG001|Overall Study|not evaluable for primary endpoint|2|||
148880178|NCT00377858|537039732|FG000|Overall Study|Withdrawal by Subject|12|||
148880179|NCT00377858|537039733|FG001|Overall Study|Withdrawal by Subject|11|||
148880180|NCT00377858|537039732|FG000|Overall Study|Lost to Follow-up|6|||
149038116|NCT02020616|537617696|FG000|Overall Study|Physician Decision|0|||
149038117|NCT02020616|537617697|FG001|Overall Study|Physician Decision|0|||
149038118|NCT02020616|537617698|FG002|Overall Study|Physician Decision|0|||
148880181|NCT00377858|537039733|FG001|Overall Study|Lost to Follow-up|1|||
149038119|NCT02020616|537617699|FG003|Overall Study|Physician Decision|0|||
149038120|NCT02020616|537617700|FG004|Overall Study|Physician Decision|0|||
149038121|NCT02020616|537617701|FG005|Overall Study|Physician Decision|1|||
149038122|NCT02020616|537617702|FG006|Overall Study|Physician Decision|2|||
148880182|NCT00377858|537039732|FG000|Overall Study|Physician Decision|5|||
149038123|NCT02020616|537617696|FG000|Overall Study|Withdrawal by Subject|0|||
149038124|NCT02020616|537617697|FG001|Overall Study|Withdrawal by Subject|0|||
148880183|NCT00377858|537039733|FG001|Overall Study|Physician Decision|5|||
149038125|NCT02020616|537617698|FG002|Overall Study|Withdrawal by Subject|1|||
149038126|NCT02020616|537617699|FG003|Overall Study|Withdrawal by Subject|0|||
149038127|NCT02020616|537617700|FG004|Overall Study|Withdrawal by Subject|0|||
149038128|NCT02020616|537617701|FG005|Overall Study|Withdrawal by Subject|1|||
149038129|NCT02020616|537617702|FG006|Overall Study|Withdrawal by Subject|1|||
149038130|NCT02020616|537617696|FG000|Overall Study|Lost to Follow-up|0|||
149038131|NCT02020616|537617697|FG001|Overall Study|Lost to Follow-up|1|||
149038132|NCT02020616|537617698|FG002|Overall Study|Lost to Follow-up|0|||
149038133|NCT02020616|537617699|FG003|Overall Study|Lost to Follow-up|1|||
149038134|NCT02020616|537617700|FG004|Overall Study|Lost to Follow-up|1|||
149038135|NCT02020616|537617701|FG005|Overall Study|Lost to Follow-up|1|||
149038136|NCT02020616|537617702|FG006|Overall Study|Lost to Follow-up|0|||
149038137|NCT02020616|537617696|FG000|Overall Study|Early Termination Criteria Met|0|||
149038138|NCT02020616|537617697|FG001|Overall Study|Early Termination Criteria Met|0|||
149038139|NCT02020616|537617698|FG002|Overall Study|Early Termination Criteria Met|1|||
149038140|NCT02020616|537617699|FG003|Overall Study|Early Termination Criteria Met|0|||
149038141|NCT02020616|537617700|FG004|Overall Study|Early Termination Criteria Met|0|||
149038142|NCT02020616|537617701|FG005|Overall Study|Early Termination Criteria Met|1|||
149038143|NCT02020616|537617702|FG006|Overall Study|Early Termination Criteria Met|0|||
149038144|NCT02020616|537617696|FG000|Overall Study|Randomized in Error|0|||
149038145|NCT02020616|537617697|FG001|Overall Study|Randomized in Error|0|||
149038146|NCT02020616|537617698|FG002|Overall Study|Randomized in Error|0|||
149038147|NCT02020616|537617699|FG003|Overall Study|Randomized in Error|1|||
149038148|NCT02020616|537617700|FG004|Overall Study|Randomized in Error|0|||
149038149|NCT02020616|537617701|FG005|Overall Study|Randomized in Error|0|||
149038150|NCT02020616|537617702|FG006|Overall Study|Randomized in Error|0|||
149038151|NCT02020616|537617696|FG000|Overall Study|Lack of Efficacy|0|||
149038152|NCT02020616|537617697|FG001|Overall Study|Lack of Efficacy|0|||
149038153|NCT02020616|537617698|FG002|Overall Study|Lack of Efficacy|0|||
149038154|NCT02020616|537617699|FG003|Overall Study|Lack of Efficacy|0|||
149038155|NCT02020616|537617700|FG004|Overall Study|Lack of Efficacy|1|||
149038156|NCT02020616|537617701|FG005|Overall Study|Lack of Efficacy|0|||
149038157|NCT02020616|537617702|FG006|Overall Study|Lack of Efficacy|0|||
149038158|NCT02041104|537617703|FG000|Overall Study|Lost to Follow-up|1|||
149038159|NCT02041104|537617704|FG001|Overall Study|Lost to Follow-up|4|||
149038160|NCT02041104|537617703|FG000|Overall Study|discomfort during OGTT|0|||
149038161|NCT02041104|537617704|FG001|Overall Study|discomfort during OGTT|3|||
149038162|NCT01063517|537617705|FG000|Overall Study|Consent withdrawal|1|||
149038163|NCT01063517|537617706|FG001|Overall Study|Consent withdrawal|0|||
149038164|NCT01063517|537617705|FG000|Overall Study|Study reached data cut-off|19|||
149038165|NCT01063517|537617706|FG001|Overall Study|Study reached data cut-off|7|||
149038166|NCT01063517|537617705|FG000|Overall Study|Lost to Follow-up|4|||
149038167|NCT01063517|537617706|FG001|Overall Study|Lost to Follow-up|3|||
149038168|NCT01063517|537617705|FG000|Overall Study|Withdrawal by Subject|1|||
149038169|NCT01063517|537617706|FG001|Overall Study|Withdrawal by Subject|2|||
149038170|NCT01063517|537617705|FG000|Overall Study|Death|33|||
149038171|NCT01063517|537617706|FG001|Overall Study|Death|48|||
149038172|NCT01286272|537619550|FG000|Overall Study|Ineligible after beginning treatment|1|||
149038173|NCT01286272|537619551|FG001|Overall Study|Ineligible after beginning treatment|3|||
149038174|NCT03622593|537619553|FG000|Overall Study|Withdrawal by Subject|11|||
149038175|NCT03622593|537619554|FG001|Overall Study|Withdrawal by Subject|9|||
149038176|NCT03622593|537619555|FG002|Overall Study|Withdrawal by Subject|13|||
149038177|NCT03622593|537619553|FG000|Overall Study|Death|12|||
149038178|NCT03622593|537619554|FG001|Overall Study|Death|9|||
149038179|NCT03622593|537619555|FG002|Overall Study|Death|10|||
149038180|NCT03622593|537619553|FG000|Overall Study|Lost to Follow-up|11|||
149038181|NCT03622593|537619554|FG001|Overall Study|Lost to Follow-up|5|||
149038182|NCT03622593|537619555|FG002|Overall Study|Lost to Follow-up|8|||
149038183|NCT03622593|537619553|FG000|Overall Study|Adverse Event|4|||
149038184|NCT03622593|537619554|FG001|Overall Study|Adverse Event|5|||
149038185|NCT03622593|537619555|FG002|Overall Study|Adverse Event|6|||
149038186|NCT03622593|537619553|FG000|Overall Study|Physician Decision|2|||
149038187|NCT03622593|537619554|FG001|Overall Study|Physician Decision|1|||
149038188|NCT03622593|537619555|FG002|Overall Study|Physician Decision|6|||
149038189|NCT03622593|537619553|FG000|Overall Study|Other|2|||
149038190|NCT03622593|537619554|FG001|Overall Study|Other|2|||
149038191|NCT03622593|537619555|FG002|Overall Study|Other|3|||
149038192|NCT03622593|537619553|FG000|Overall Study|Protocol Violation|0|||
149038193|NCT03622593|537619554|FG001|Overall Study|Protocol Violation|0|||
149038194|NCT03622593|537619555|FG002|Overall Study|Protocol Violation|1|||
149038195|NCT03622593|537619553|FG000|Overall Study|Pregnancy|0|||
149038196|NCT03622593|537619554|FG001|Overall Study|Pregnancy|0|||
149038197|NCT03622593|537619555|FG002|Overall Study|Pregnancy|1|||
149038198|NCT01134562|537619556|FG000|Overall Study|Adverse Event|0|||
149038199|NCT01134562|537619557|FG001|Overall Study|Adverse Event|1|||
149038200|NCT01134562|537619558|FG002|Overall Study|Adverse Event|0|||
149038201|NCT01134562|537619559|FG003|Overall Study|Adverse Event|0|||
149038202|NCT01134562|537619560|FG004|Overall Study|Adverse Event|0|||
149038203|NCT00768664|537619561|FG000|Overall Study|Death|57|||
148880184|NCT00377858|537039732|FG000|Overall Study|Protocol Violation|3|||
148880185|NCT00377858|537039733|FG001|Overall Study|Protocol Violation|4|||
148880186|NCT00377858|537039732|FG000|Overall Study|Adverse Event|2|||
148880187|NCT00377858|537039733|FG001|Overall Study|Adverse Event|1|||
148880188|NCT00377858|537039732|FG000|Overall Study|Entry Criteria Not Met|2|||
148880189|NCT00377858|537039733|FG001|Overall Study|Entry Criteria Not Met|0|||
148880190|NCT00377858|537039732|FG000|Overall Study|Sponsor Decision|1|||
148880191|NCT00377858|537039733|FG001|Overall Study|Sponsor Decision|2|||
148880192|NCT00377858|537039732|FG000|Overall Study|Death|0|||
148880193|NCT00377858|537039733|FG001|Overall Study|Death|3|||
148880194|NCT03534141|537039734|FG000|Overall Study|Enrolled in other clinical trial|1|||
148880195|NCT03534141|537039735|FG001|Overall Study|Enrolled in other clinical trial|0|||
148880196|NCT03534141|537039734|FG000|Overall Study|Liver transplant aborted after randomization|0|||
148880197|NCT03534141|537039735|FG001|Overall Study|Liver transplant aborted after randomization|2|||
148880198|NCT03534141|537039734|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
148880199|NCT03534141|537039735|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
148880200|NCT00517361|537039736|FG000|Overall Study|Death|6|||
148880201|NCT00517361|537039736|FG000|Overall Study|The study was terminated|5|||
148880202|NCT04303572|537039738|FG000|Overall Study|Study closed due to poor enrollment|1|||
148880203|NCT06312592|537039739|FG000|Overall Study|Lost to Follow-up|29|||
148880204|NCT06312592|537039740|FG001|Overall Study|Lost to Follow-up|13|||
148880205|NCT03785405|537039743|FG000|Overall Study|Adverse Event|16|||
148880206|NCT03785405|537039744|FG001|Overall Study|Adverse Event|1|||
148880207|NCT03785405|537039743|FG000|Overall Study|Death|6|||
148880208|NCT03785405|537039744|FG001|Overall Study|Death|4|||
148880209|NCT03785405|537039743|FG000|Overall Study|Guardian decision|4|||
148880210|NCT03785405|537039744|FG001|Overall Study|Guardian decision|1|||
148880211|NCT03785405|537039743|FG000|Overall Study|Lost to Follow-up|1|||
148880212|NCT03785405|537039744|FG001|Overall Study|Lost to Follow-up|0|||
148880213|NCT03785405|537039743|FG000|Overall Study|Physician Decision|8|||
148880214|NCT03785405|537039744|FG001|Overall Study|Physician Decision|5|||
148880215|NCT03785405|537039743|FG000|Overall Study|Participant decision|2|||
148880216|NCT03785405|537039744|FG001|Overall Study|Participant decision|0|||
148880217|NCT03785405|537039743|FG000|Overall Study|Other|1|||
149003689|NCT00500903|537491540|FG000|Overall Study|Reason Not Specified|10|||
149003690|NCT00500903|537491541|FG001|Overall Study|Reason Not Specified|0|||
149003691|NCT00500903|537491542|FG002|Overall Study|Reason Not Specified|2|||
149003692|NCT01648348|537491544|FG000|Overall Study|Cancel|1|||
149003693|NCT01648348|537491545|FG001|Overall Study|Cancel|0|||
149003694|NCT01648348|537491546|FG002|Overall Study|Cancel|0|||
149003695|NCT01648348|537491547|FG003|Overall Study|Cancel|0|||
149003696|NCT01648348|537491548|FG004|Overall Study|Cancel|3|||
149003697|NCT01648348|537491549|FG005|Overall Study|Cancel|6|||
149003698|NCT01648348|537491544|FG000|Overall Study|Replaced for MTD analysis|1|||
149003699|NCT01648348|537491545|FG001|Overall Study|Replaced for MTD analysis|0|||
149003700|NCT01648348|537491546|FG002|Overall Study|Replaced for MTD analysis|1|||
149003701|NCT01648348|537491547|FG003|Overall Study|Replaced for MTD analysis|0|||
149003702|NCT01648348|537491548|FG004|Overall Study|Replaced for MTD analysis|0|||
149003703|NCT01648348|537491549|FG005|Overall Study|Replaced for MTD analysis|0|||
149003704|NCT00717860|537491550|FG000|Overall Study|Clinical adverse experience|5|||
149003705|NCT00717860|537491551|FG001|Overall Study|Clinical adverse experience|9|||
149003706|NCT00717860|537491550|FG000|Overall Study|Laboratory adverse experience|2|||
149003707|NCT00717860|537491551|FG001|Overall Study|Laboratory adverse experience|2|||
149003708|NCT00717860|537491550|FG000|Overall Study|Lack of Efficacy|7|||
149003709|NCT00717860|537491551|FG001|Overall Study|Lack of Efficacy|13|||
149003710|NCT00717860|537491550|FG000|Overall Study|Discontinued for other reason|6|||
149003711|NCT00717860|537491551|FG001|Overall Study|Discontinued for other reason|1|||
149003712|NCT00717860|537491550|FG000|Overall Study|Withdrew consent|7|||
149003713|NCT00717860|537491551|FG001|Overall Study|Withdrew consent|3|||
149003714|NCT04058353|537491552|FG000|Overall Study|Adverse Event|2|||
149003715|NCT04058353|537491553|FG001|Overall Study|Adverse Event|1|||
149003716|NCT04058353|537491552|FG000|Overall Study|Physician Decision|1|||
149003717|NCT04058353|537491553|FG001|Overall Study|Physician Decision|0|||
149003718|NCT04058353|537491552|FG000|Overall Study|Other|1|||
149003719|NCT04058353|537491553|FG001|Overall Study|Other|0|||
149003720|NCT00847405|537493066|FG000|First Intervention|Adverse Event|0|||
149003721|NCT00847405|537493067|FG001|First Intervention|Adverse Event|1|||
149003722|NCT00847405|537493066|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
149003723|NCT00847405|537493067|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
149003724|NCT01728792|537493068|FG000|Overall Study|Withdrawal of Consent|1|||
149003725|NCT01728792|537493069|FG001|Overall Study|Withdrawal of Consent|1|||
148880218|NCT03785405|537039744|FG001|Overall Study|Other|0|||
148880219|NCT03785405|537039743|FG000|Overall Study|No treatment was received|0|||
148880220|NCT03785405|537039744|FG001|Overall Study|No treatment was received|1|||
148880221|NCT01948063|537039745|FG000|Overall Study|Boston MCI halted research protocol|0|||
148880222|NCT01948063|537039746|FG001|Overall Study|Boston MCI halted research protocol|1|||
148880223|NCT01948063|537039745|FG000|Overall Study|Discovered an enrollment in other study|0|||
149003726|NCT01728792|537493070|FG002|Overall Study|Withdrawal of Consent|0|||
148880224|NCT01948063|537039746|FG001|Overall Study|Discovered an enrollment in other study|1|||
148880225|NCT01948063|537039745|FG000|Overall Study|Blood samples were accidentally thawed|1|||
148880226|NCT01948063|537039746|FG001|Overall Study|Blood samples were accidentally thawed|0|||
148880227|NCT01858766|537039747|FG000|Overall Study|Randomized but Never Treated|0|||
148880228|NCT01858766|537039748|FG001|Overall Study|Randomized but Never Treated|0|||
148880229|NCT01858766|537039749|FG002|Overall Study|Randomized but Never Treated|0|||
148880230|NCT01858766|537039750|FG003|Overall Study|Randomized but Never Treated|0|||
148880231|NCT01858766|537039751|FG004|Overall Study|Randomized but Never Treated|0|||
148880232|NCT01858766|537039752|FG005|Overall Study|Randomized but Never Treated|1|||
148880233|NCT01858766|537039753|FG006|Overall Study|Randomized but Never Treated|0|||
148880234|NCT01858766|537039754|FG007|Overall Study|Randomized but Never Treated|0|||
148880235|NCT01858766|537039755|FG008|Overall Study|Randomized but Never Treated|0|||
148880236|NCT01858766|537039756|FG009|Overall Study|Randomized but Never Treated|0|||
148880237|NCT01858766|537039757|FG010|Overall Study|Randomized but Never Treated|0|||
148880238|NCT01858766|537039758|FG011|Overall Study|Randomized but Never Treated|0|||
148880239|NCT01858766|537039759|FG012|Overall Study|Randomized but Never Treated|0|||
149038204|NCT00768664|537619561|FG000|Overall Study|Lost to Follow-up|2|||
149038205|NCT00768664|537619561|FG000|Overall Study|Other|9|||
149038206|NCT00768664|537619561|FG000|Overall Study|Participant refused|1|||
149038207|NCT02544152|537619562|FG000|Overall Study|Adverse Event|0|||
149038208|NCT02544152|537619563|FG001|Overall Study|Adverse Event|4|||
149038209|NCT02544152|537619562|FG000|Overall Study|Withdrawal by Subject|0|||
149038210|NCT02544152|537619563|FG001|Overall Study|Withdrawal by Subject|3|||
149038211|NCT02544152|537619562|FG000|Overall Study|Other|1|||
149038212|NCT02544152|537619563|FG001|Overall Study|Other|0|||
149038213|NCT00423098|537619564|FG000|Overall Study|Adverse Event|1|||
149038214|NCT00423098|537619565|FG001|Overall Study|Adverse Event|2|||
149038215|NCT00423098|537619564|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149038216|NCT00423098|537619565|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149038217|NCT00423098|537619564|FG000|Overall Study|Administrative problems|0|||
149038218|NCT00423098|537619565|FG001|Overall Study|Administrative problems|1|||
149038219|NCT00423098|537619564|FG000|Overall Study|Death|2|||
149038220|NCT00423098|537619565|FG001|Overall Study|Death|0|||
149038221|NCT02320123|537619567|FG000|Overall Study|Lost to Follow-up|4|||
149038222|NCT02320123|537619568|FG001|Overall Study|Lost to Follow-up|6|||
149038223|NCT02320123|537619567|FG000|Overall Study|Death|6|||
149038224|NCT02320123|537619568|FG001|Overall Study|Death|5|||
149038225|NCT04480827|537619569|FG000|Overall Study|Adverse Event|0|||
149038226|NCT04480827|537619570|FG001|Overall Study|Adverse Event|0|||
149038227|NCT04480827|537619571|FG002|Overall Study|Adverse Event|0|||
149038228|NCT04480827|537619572|FG003|Overall Study|Adverse Event|0|||
149038229|NCT04480827|537619573|FG004|Overall Study|Adverse Event|0|||
149038230|NCT04480827|537619574|FG005|Overall Study|Adverse Event|1|||
149038231|NCT04480827|537619575|FG006|Overall Study|Adverse Event|0|||
149038232|NCT03593876|537619580|FG000|Overall Study|Withdrawal by Subject|1|||
149038233|NCT03593876|537619580|FG000|Overall Study|Discharged home before intervention completion|2|||
149038234|NCT00854906|537619583|FG000|Overall Study|One person had no ocular history|1|||
149038235|NCT00071799|537619584|FG000|Overall Study|Adverse Event|19|||
149038236|NCT00071799|537619585|FG001|Overall Study|Adverse Event|10|||
149038237|NCT00071799|537619584|FG000|Overall Study|Protocol Violation|1|||
149038238|NCT00071799|537619585|FG001|Overall Study|Protocol Violation|7|||
149038239|NCT00071799|537619584|FG000|Overall Study|Lost to Follow-up|1|||
149038240|NCT00071799|537619585|FG001|Overall Study|Lost to Follow-up|1|||
149038241|NCT00071799|537619584|FG000|Overall Study|Withdrawal by Subject|15|||
149038242|NCT00071799|537619585|FG001|Overall Study|Withdrawal by Subject|37|||
148880240|NCT01858766|537039760|FG013|Overall Study|Randomized but Never Treated|0|||
148880241|NCT01858766|537039761|FG014|Overall Study|Randomized but Never Treated|0|||
148880242|NCT01858766|537039762|FG015|Overall Study|Randomized but Never Treated|0|||
148880243|NCT01858766|537039763|FG016|Overall Study|Randomized but Never Treated|0|||
148880244|NCT01858766|537039764|FG017|Overall Study|Randomized but Never Treated|1|||
148880245|NCT01858766|537039765|FG018|Overall Study|Randomized but Never Treated|0|||
148880246|NCT01858766|537039747|FG000|Overall Study|Death|0|||
148880247|NCT01858766|537039748|FG001|Overall Study|Death|0|||
149038243|NCT00071799|537619584|FG000|Overall Study|Physician Decision|0|||
149038244|NCT00071799|537619585|FG001|Overall Study|Physician Decision|2|||
149038245|NCT00071799|537619584|FG000|Overall Study|Lack of Efficacy|11|||
149038246|NCT00071799|537619585|FG001|Overall Study|Lack of Efficacy|18|||
149038247|NCT00071799|537619584|FG000|Overall Study|Disease Progression|23|||
149038248|NCT00071799|537619585|FG001|Overall Study|Disease Progression|20|||
149038249|NCT00071799|537619584|FG000|Overall Study|Different Central+Local Pathology Review|0|||
149038250|NCT00071799|537619585|FG001|Overall Study|Different Central+Local Pathology Review|1|||
149038251|NCT00071799|537619584|FG000|Overall Study|Not Documented|0|||
149038252|NCT00071799|537619585|FG001|Overall Study|Not Documented|2|||
149038253|NCT04527549|537619588|FG000|Overall Study|Withdrawal by Subject|1|||
149038254|NCT04527549|537619589|FG001|Overall Study|Withdrawal by Subject|1|||
148880248|NCT01858766|537039749|FG002|Overall Study|Death|1|||
148880249|NCT01858766|537039750|FG003|Overall Study|Death|0|||
148880250|NCT01858766|537039751|FG004|Overall Study|Death|0|||
148880251|NCT01858766|537039752|FG005|Overall Study|Death|0|||
148880252|NCT01858766|537039753|FG006|Overall Study|Death|0|||
148880253|NCT01858766|537039754|FG007|Overall Study|Death|0|||
148880254|NCT01858766|537039755|FG008|Overall Study|Death|0|||
148880255|NCT01858766|537039756|FG009|Overall Study|Death|0|||
148880256|NCT01858766|537039757|FG010|Overall Study|Death|0|||
148880257|NCT01858766|537039758|FG011|Overall Study|Death|0|||
148880258|NCT01858766|537039759|FG012|Overall Study|Death|0|||
148880259|NCT01858766|537039760|FG013|Overall Study|Death|0|||
148880260|NCT01858766|537039761|FG014|Overall Study|Death|0|||
148880261|NCT01858766|537039762|FG015|Overall Study|Death|0|||
148880262|NCT01858766|537039763|FG016|Overall Study|Death|0|||
148880263|NCT01858766|537039764|FG017|Overall Study|Death|0|||
148880264|NCT01858766|537039765|FG018|Overall Study|Death|0|||
148880265|NCT01858766|537039747|FG000|Overall Study|Lack of Efficacy|1|||
148880266|NCT01858766|537039748|FG001|Overall Study|Lack of Efficacy|0|||
148880267|NCT01858766|537039749|FG002|Overall Study|Lack of Efficacy|0|||
148880268|NCT01858766|537039750|FG003|Overall Study|Lack of Efficacy|0|||
148880269|NCT01858766|537039751|FG004|Overall Study|Lack of Efficacy|1|||
148880270|NCT01858766|537039752|FG005|Overall Study|Lack of Efficacy|2|||
148880271|NCT01858766|537039753|FG006|Overall Study|Lack of Efficacy|0|||
148880272|NCT01858766|537039754|FG007|Overall Study|Lack of Efficacy|0|||
148880273|NCT01858766|537039755|FG008|Overall Study|Lack of Efficacy|0|||
148880274|NCT01858766|537039756|FG009|Overall Study|Lack of Efficacy|0|||
148880275|NCT01858766|537039757|FG010|Overall Study|Lack of Efficacy|0|||
148880276|NCT01858766|537039758|FG011|Overall Study|Lack of Efficacy|3|||
148880277|NCT01858766|537039759|FG012|Overall Study|Lack of Efficacy|5|||
148880278|NCT01858766|537039760|FG013|Overall Study|Lack of Efficacy|3|||
148880279|NCT01858766|537039761|FG014|Overall Study|Lack of Efficacy|5|||
148880280|NCT01858766|537039762|FG015|Overall Study|Lack of Efficacy|5|||
148880281|NCT01858766|537039763|FG016|Overall Study|Lack of Efficacy|2|||
148880282|NCT01858766|537039764|FG017|Overall Study|Lack of Efficacy|3|||
148880283|NCT01858766|537039765|FG018|Overall Study|Lack of Efficacy|3|||
148880284|NCT01858766|537039747|FG000|Overall Study|Lost to Follow-up|0|||
148880285|NCT01858766|537039748|FG001|Overall Study|Lost to Follow-up|0|||
148880286|NCT01858766|537039749|FG002|Overall Study|Lost to Follow-up|0|||
148880287|NCT01858766|537039750|FG003|Overall Study|Lost to Follow-up|0|||
148880288|NCT01858766|537039751|FG004|Overall Study|Lost to Follow-up|0|||
148880289|NCT01858766|537039752|FG005|Overall Study|Lost to Follow-up|1|||
148880290|NCT01858766|537039753|FG006|Overall Study|Lost to Follow-up|0|||
148880291|NCT01858766|537039754|FG007|Overall Study|Lost to Follow-up|2|||
148880292|NCT01858766|537039755|FG008|Overall Study|Lost to Follow-up|0|||
148880293|NCT01858766|537039756|FG009|Overall Study|Lost to Follow-up|0|||
148880294|NCT01858766|537039757|FG010|Overall Study|Lost to Follow-up|0|||
148880295|NCT01858766|537039758|FG011|Overall Study|Lost to Follow-up|1|||
148880296|NCT01858766|537039759|FG012|Overall Study|Lost to Follow-up|0|||
148880297|NCT01858766|537039760|FG013|Overall Study|Lost to Follow-up|0|||
148880298|NCT01858766|537039761|FG014|Overall Study|Lost to Follow-up|3|||
148880299|NCT01858766|537039762|FG015|Overall Study|Lost to Follow-up|1|||
148880300|NCT01858766|537039763|FG016|Overall Study|Lost to Follow-up|1|||
149038255|NCT00814346|537619590|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
149038256|NCT00814346|537619591|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
149038257|NCT00814346|537619590|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
149038258|NCT00814346|537619591|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
149038259|NCT00814346|537619590|FG000|Open Phase (17 Months)|Adverse Event|5|||
149038260|NCT00814346|537619591|FG001|Open Phase (17 Months)|Adverse Event|0|||
149038261|NCT00814346|537619590|FG000|Open Phase (17 Months)|Consent|2|||
149038262|NCT00814346|537619591|FG001|Open Phase (17 Months)|Consent|0|||
149038263|NCT00814346|537619590|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
149038264|NCT00814346|537619591|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
149038265|NCT00814346|537619590|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
149038266|NCT00814346|537619591|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
149038267|NCT05136443|537619593|FG000|Overall Study|Lost to Follow-up|2|||
148880301|NCT01858766|537039764|FG017|Overall Study|Lost to Follow-up|0|||
148880302|NCT01858766|537039765|FG018|Overall Study|Lost to Follow-up|1|||
148880303|NCT01858766|537039747|FG000|Overall Study|Withdrew Consent|0|||
148880304|NCT01858766|537039748|FG001|Overall Study|Withdrew Consent|0|||
148880305|NCT01858766|537039749|FG002|Overall Study|Withdrew Consent|0|||
149038268|NCT05136443|537619593|FG000|Overall Study|Adverse Event|2|||
149038269|NCT03718767|537619604|FG000|Overall Study|Declined to participate (before treatment started)|0|||
148880306|NCT01858766|537039750|FG003|Overall Study|Withdrew Consent|0|||
148880307|NCT01858766|537039751|FG004|Overall Study|Withdrew Consent|0|||
148880308|NCT01858766|537039752|FG005|Overall Study|Withdrew Consent|0|||
148880309|NCT01858766|537039753|FG006|Overall Study|Withdrew Consent|0|||
148880310|NCT01858766|537039754|FG007|Overall Study|Withdrew Consent|0|||
148880311|NCT01858766|537039755|FG008|Overall Study|Withdrew Consent|0|||
148880312|NCT01858766|537039756|FG009|Overall Study|Withdrew Consent|0|||
148880313|NCT01858766|537039757|FG010|Overall Study|Withdrew Consent|0|||
148880314|NCT01858766|537039758|FG011|Overall Study|Withdrew Consent|1|||
148880315|NCT01858766|537039759|FG012|Overall Study|Withdrew Consent|0|||
148880316|NCT01858766|537039760|FG013|Overall Study|Withdrew Consent|0|||
148880317|NCT01858766|537039761|FG014|Overall Study|Withdrew Consent|0|||
148880318|NCT01858766|537039762|FG015|Overall Study|Withdrew Consent|0|||
148880319|NCT01858766|537039763|FG016|Overall Study|Withdrew Consent|0|||
148880320|NCT01858766|537039764|FG017|Overall Study|Withdrew Consent|0|||
148880321|NCT01858766|537039765|FG018|Overall Study|Withdrew Consent|0|||
148880322|NCT00245037|537039772|FG000|Overall Study|Death|17|||
148880323|NCT00203424|537039773|FG000|Treatment Period|Withdrawal by Subject|4|||
148880324|NCT00203424|537039773|FG000|Treatment Period|Adverse Event|5|||
148880325|NCT00203424|537039773|FG000|Treatment Period|progressive disease|2|||
148880326|NCT00203424|537039773|FG000|Follow-up Period|Withdrawal by Subject|1|||
148880327|NCT00203424|537039773|FG000|Follow-up Period|progressive disease|4|||
149003727|NCT01728792|537493071|FG003|Overall Study|Withdrawal of Consent|1|||
149003728|NCT01728792|537493072|FG004|Overall Study|Withdrawal of Consent|0|||
149003729|NCT01728792|537493068|FG000|Overall Study|Lost to Follow-up|2|||
149003730|NCT01728792|537493069|FG001|Overall Study|Lost to Follow-up|1|||
149003731|NCT01728792|537493070|FG002|Overall Study|Lost to Follow-up|4|||
149003732|NCT01728792|537493071|FG003|Overall Study|Lost to Follow-up|2|||
149003733|NCT01728792|537493072|FG004|Overall Study|Lost to Follow-up|0|||
149003734|NCT03559218|537493073|FG000|Overall Study|Withdrawal by Subject|1|||
149003735|NCT03559218|537493074|FG001|Overall Study|Withdrawal by Subject|0|||
149003736|NCT04277455|537493075|FG000|Overall Study|Lost to Follow-up|1|||
149003737|NCT01679301|537493078|FG000|Screening Period|screen failure|3|||
149003738|NCT01679301|537493079|FG001|Screening Period|screen failure|0|||
149003739|NCT01679301|537493080|FG002|Screening Period|screen failure|0|||
149003740|NCT02259517|537493081|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
149003741|NCT02259517|537493082|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
149003742|NCT02259517|537493083|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
149003743|NCT02259517|537493081|FG000|Overall Study|Withdrawal by Subject|0|||
149003744|NCT02259517|537493082|FG001|Overall Study|Withdrawal by Subject|0|||
149003745|NCT02259517|537493083|FG002|Overall Study|Withdrawal by Subject|3|||
149003746|NCT02305381|537493084|FG000|Overall Study|Unclassified|5|||
149003747|NCT02305381|537493085|FG001|Overall Study|Unclassified|5|||
149003748|NCT02305381|537493086|FG002|Overall Study|Unclassified|7|||
149003749|NCT01564368|537493094|FG000|Overall Study|Ineligible|18|||
149003750|NCT01564368|537493094|FG000|Overall Study|Not Randomized in Parent study|116|||
149003751|NCT01564368|537493094|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
149003752|NCT01564368|537493094|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
149003753|NCT01802437|537493098|FG000|Overall Study|Lost to Follow-up|1|||
149003754|NCT01802437|537493099|FG001|Overall Study|Lost to Follow-up|0|||
149003755|NCT01802437|537493098|FG000|Overall Study|Withdrawal by Subject|3|||
149003756|NCT01802437|537493099|FG001|Overall Study|Withdrawal by Subject|4|||
149003757|NCT02228967|537493100|FG000|Overall Study|Lost to Follow-up|146|||
149003758|NCT02228967|537493101|FG001|Overall Study|Lost to Follow-up|142|||
149003759|NCT02228967|537493100|FG000|Overall Study|Withdrawal by Subject|13|||
149003760|NCT02228967|537493101|FG001|Overall Study|Withdrawal by Subject|18|||
149003761|NCT00520975|537493102|FG000|Overall Study|Disease progression|31|||
149003762|NCT00520975|537493103|FG001|Overall Study|Disease progression|23|||
149003763|NCT00520975|537493102|FG000|Overall Study|Adverse Event|7|||
149003764|NCT00520975|537493103|FG001|Overall Study|Adverse Event|10|||
149003765|NCT00520975|537493102|FG000|Overall Study|Death|0|||
149003766|NCT00520975|537493103|FG001|Overall Study|Death|2|||
149003767|NCT00520975|537493102|FG000|Overall Study|Withdrawal by Subject|3|||
149003768|NCT00520975|537493103|FG001|Overall Study|Withdrawal by Subject|5|||
149003769|NCT00520975|537493102|FG000|Overall Study|Other therapy|2|||
149003770|NCT00520975|537493103|FG001|Overall Study|Other therapy|4|||
149003771|NCT00520975|537493102|FG000|Overall Study|Other reasons|4|||
149003772|NCT00520975|537493103|FG001|Overall Study|Other reasons|2|||
149003773|NCT00520975|537493102|FG000|Overall Study|Not start protocol therapy|1|||
149003774|NCT00520975|537493103|FG001|Overall Study|Not start protocol therapy|2|||
149003775|NCT00106184|537493105|FG000|Overall Study|Withdrawal by Subject|3|||
149003776|NCT00106184|537493106|FG001|Overall Study|Withdrawal by Subject|2|||
149003777|NCT02313909|537493110|FG000|Overall Study|Consent withdrawn by participant|33|||
149003778|NCT02313909|537493111|FG001|Overall Study|Consent withdrawn by participant|33|||
149003779|NCT02313909|537493110|FG000|Overall Study|Lost to Follow-up|24|||
149003780|NCT02313909|537493111|FG001|Overall Study|Lost to Follow-up|17|||
149003781|NCT05292534|537493117|FG000|Overall Study|Protocol Violation|3|||
149003782|NCT05292534|537493118|FG001|Overall Study|Protocol Violation|4|||
148880328|NCT00203424|537039773|FG000|Follow-up Period|Lost to Follow-up|1|||
148880329|NCT00555672|537039774|FG000|Overall Study|Death|0|||
149003783|NCT05292534|537493117|FG000|Overall Study|Withdrawal by Subject|0|||
149003784|NCT05292534|537493118|FG001|Overall Study|Withdrawal by Subject|1|||
149003785|NCT00643123|537493119|FG000|Overall Study|Lost to Follow-up|4|||
149003786|NCT00643123|537493120|FG001|Overall Study|Lost to Follow-up|0|||
148880330|NCT00555672|537039775|FG001|Overall Study|Death|2|||
148880331|NCT00555672|537039774|FG000|Overall Study|Adverse Event|8|||
148880332|NCT00555672|537039775|FG001|Overall Study|Adverse Event|2|||
149038270|NCT03718767|537619605|FG001|Overall Study|Declined to participate (before treatment started)|0|||
149003787|NCT00643123|537493119|FG000|Overall Study|Withdrawal by Subject|1|||
149003788|NCT00643123|537493120|FG001|Overall Study|Withdrawal by Subject|1|||
149003789|NCT01538472|537493121|FG000|Overall Study|Disease Progression|3|||
149003790|NCT01538472|537493121|FG000|Overall Study|Death|1|||
149003791|NCT02309112|537493122|FG000|Overall Study|Withdrawal by Subject|1|||
149003792|NCT02309112|537493123|FG001|Overall Study|Withdrawal by Subject|0|||
149003793|NCT02309112|537493124|FG002|Overall Study|Withdrawal by Subject|1|||
149003794|NCT02309112|537493122|FG000|Overall Study|Lost to Follow-up|0|||
149003795|NCT02309112|537493123|FG001|Overall Study|Lost to Follow-up|1|||
149003796|NCT02309112|537493124|FG002|Overall Study|Lost to Follow-up|0|||
149003797|NCT02133872|537493125|FG000|Overall Study|Withdrawal by Subject|5|||
149003798|NCT02133872|537493126|FG001|Overall Study|Withdrawal by Subject|3|||
149003799|NCT02133872|537493127|FG002|Overall Study|Withdrawal by Subject|0|||
149003800|NCT00238433|537493131|FG000|Overall Study|Screen failure|1|||
149003801|NCT00238433|537493131|FG000|Overall Study|Lost to Follow-up|1|||
149003802|NCT00238433|537493131|FG000|Overall Study|Death|1|||
149003803|NCT01376323|537493132|FG000|Overall Study|Adverse Event|1|||
149003804|NCT01376323|537493133|FG001|Overall Study|Adverse Event|0|||
149003805|NCT01376323|537493134|FG002|Overall Study|Adverse Event|0|||
149003806|NCT01376323|537493135|FG003|Overall Study|Adverse Event|2|||
149003807|NCT01376323|537493136|FG004|Overall Study|Adverse Event|0|||
149003808|NCT01376323|537493132|FG000|Overall Study|Lost to Follow-up|0|||
149003809|NCT01376323|537493133|FG001|Overall Study|Lost to Follow-up|0|||
149003810|NCT01376323|537493134|FG002|Overall Study|Lost to Follow-up|0|||
149003811|NCT01376323|537493135|FG003|Overall Study|Lost to Follow-up|2|||
149003812|NCT01376323|537493136|FG004|Overall Study|Lost to Follow-up|0|||
149003813|NCT01376323|537493132|FG000|Overall Study|Physician Decision|1|||
149003814|NCT01376323|537493133|FG001|Overall Study|Physician Decision|0|||
149003815|NCT01376323|537493134|FG002|Overall Study|Physician Decision|2|||
149003816|NCT01376323|537493135|FG003|Overall Study|Physician Decision|1|||
149003817|NCT01376323|537493136|FG004|Overall Study|Physician Decision|1|||
149003818|NCT01376323|537493132|FG000|Overall Study|Withdrawal by Subject|0|||
149003819|NCT01376323|537493133|FG001|Overall Study|Withdrawal by Subject|1|||
149003820|NCT01376323|537493134|FG002|Overall Study|Withdrawal by Subject|1|||
149003821|NCT01376323|537493135|FG003|Overall Study|Withdrawal by Subject|0|||
149003822|NCT01376323|537493136|FG004|Overall Study|Withdrawal by Subject|0|||
149003823|NCT00454571|537493137|FG000|Overall Study|Adverse Event|2|||
149003824|NCT00454571|537493138|FG001|Overall Study|Adverse Event|0|||
149003825|NCT00454571|537493137|FG000|Overall Study|Physician Decision|0|||
149003826|NCT00454571|537493138|FG001|Overall Study|Physician Decision|1|||
149003827|NCT00454571|537493137|FG000|Overall Study|Protocol Violation|1|||
149003828|NCT00454571|537493138|FG001|Overall Study|Protocol Violation|0|||
149003829|NCT00454571|537493137|FG000|Overall Study|Withdrawal by Subject|10|||
149003830|NCT00454571|537493138|FG001|Overall Study|Withdrawal by Subject|5|||
149003831|NCT04681729|537493139|FG000|Overall Study|Lack of Efficacy|2|||
149003832|NCT04681729|537493140|FG001|Overall Study|Lack of Efficacy|2|||
149003833|NCT04681729|537493139|FG000|Overall Study|Withdrawal by Subject|8|||
149003834|NCT04681729|537493140|FG001|Overall Study|Withdrawal by Subject|9|||
149003835|NCT02436811|537493141|FG000|Overall Study|Lost to Follow-up|2|||
149003836|NCT02436811|537493142|FG001|Overall Study|Lost to Follow-up|9|||
149003837|NCT02436811|537493143|FG002|Overall Study|Lost to Follow-up|7|||
149003838|NCT03595332|537493144|FG000|Overall Study|Lost to Follow-up|16|||
149003839|NCT03595332|537493145|FG001|Overall Study|Lost to Follow-up|22|||
149003840|NCT03595332|537493144|FG000|Overall Study|Unable to retrieve ID from school|0|||
149003841|NCT03595332|537493145|FG001|Overall Study|Unable to retrieve ID from school|2|||
149003842|NCT02227875|537493146|FG000|Overall Study|Protocol Violation|10|||
149003843|NCT02227875|537493147|FG001|Overall Study|Protocol Violation|7|||
149003844|NCT02227875|537493146|FG000|Overall Study|Other|1|||
149003845|NCT02227875|537493147|FG001|Overall Study|Other|3|||
149003846|NCT02227875|537493146|FG000|Overall Study|Physician Decision|1|||
149003847|NCT02227875|537493147|FG001|Overall Study|Physician Decision|0|||
149003848|NCT02227875|537493146|FG000|Overall Study|Adverse Event|3|||
149003849|NCT02227875|537493147|FG001|Overall Study|Adverse Event|0|||
149003850|NCT02227875|537493146|FG000|Overall Study|Withdrawal by Subject|12|||
149003851|NCT02227875|537493147|FG001|Overall Study|Withdrawal by Subject|13|||
149003852|NCT02227875|537493146|FG000|Overall Study|Lost to Follow-up|10|||
149003853|NCT02227875|537493147|FG001|Overall Study|Lost to Follow-up|10|||
149003854|NCT04209725|537493150|FG000|Overall Study|Adverse Event|1|||
149003855|NCT02657317|537493151|FG000|Overall Study|Withdrawal by Subject|2|||
149003856|NCT02657317|537493152|FG001|Overall Study|Withdrawal by Subject|0|||
149003857|NCT02657317|537493151|FG000|Overall Study|Lost to Follow-up|3|||
149003858|NCT02657317|537493152|FG001|Overall Study|Lost to Follow-up|3|||
149003859|NCT02856113|537493153|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
149003860|NCT02856113|537493154|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
149003861|NCT02856113|537493153|FG000|Overall Study|Significant Protocol Deviation|1|||
149003862|NCT02856113|537493154|FG001|Overall Study|Significant Protocol Deviation|0|||
149003863|NCT02856113|537493153|FG000|Overall Study|Lost to Follow-up|3|||
149003864|NCT02856113|537493154|FG001|Overall Study|Lost to Follow-up|5|||
149038271|NCT03718767|537619606|FG002|Overall Study|Declined to participate (before treatment started)|7|||
149038272|NCT03718767|537619604|FG000|Overall Study|Ineligible|0|||
149038273|NCT03718767|537619605|FG001|Overall Study|Ineligible|0|||
149038274|NCT03718767|537619606|FG002|Overall Study|Ineligible|17|||
149038275|NCT00346333|537619607|FG000|Overall Study|Death|1|||
149038276|NCT00346333|537619608|FG001|Overall Study|Death|0|||
149038277|NCT00346333|537619607|FG000|Overall Study|unwilling or unable to continue|4|||
149038278|NCT00346333|537619608|FG001|Overall Study|unwilling or unable to continue|8|||
149038279|NCT03460756|537619610|FG000|Overall Study|Adverse Event|0|||
149038280|NCT03460756|537619611|FG001|Overall Study|Adverse Event|0|||
149038281|NCT03460756|537619612|FG002|Overall Study|Adverse Event|0|||
149038282|NCT03460756|537619613|FG003|Overall Study|Adverse Event|1|||
149038283|NCT03460756|537619610|FG000|Overall Study|Lack of Efficacy|0|||
149038284|NCT03460756|537619611|FG001|Overall Study|Lack of Efficacy|0|||
149038285|NCT03460756|537619612|FG002|Overall Study|Lack of Efficacy|0|||
149038286|NCT03460756|537619613|FG003|Overall Study|Lack of Efficacy|2|||
149038287|NCT03460756|537619610|FG000|Overall Study|Lost to Follow-up|0|||
149038288|NCT03460756|537619611|FG001|Overall Study|Lost to Follow-up|1|||
149038289|NCT03460756|537619612|FG002|Overall Study|Lost to Follow-up|2|||
149038290|NCT03460756|537619613|FG003|Overall Study|Lost to Follow-up|1|||
149038291|NCT03460756|537619610|FG000|Overall Study|Pregnancy|0|||
149038292|NCT03460756|537619611|FG001|Overall Study|Pregnancy|0|||
149038293|NCT03460756|537619612|FG002|Overall Study|Pregnancy|0|||
149038294|NCT03460756|537619613|FG003|Overall Study|Pregnancy|1|||
149038295|NCT03460756|537619610|FG000|Overall Study|Protocol Violation|0|||
149038296|NCT03460756|537619611|FG001|Overall Study|Protocol Violation|0|||
149038297|NCT03460756|537619612|FG002|Overall Study|Protocol Violation|0|||
149038298|NCT03460756|537619613|FG003|Overall Study|Protocol Violation|1|||
149038299|NCT03460756|537619610|FG000|Overall Study|Withdrawal by Subject|0|||
149038300|NCT03460756|537619611|FG001|Overall Study|Withdrawal by Subject|4|||
149038301|NCT03460756|537619612|FG002|Overall Study|Withdrawal by Subject|7|||
149038302|NCT03460756|537619613|FG003|Overall Study|Withdrawal by Subject|3|||
149038303|NCT03946670|537619620|FG000|Overall Study|Progressive Disease|34|||
149038304|NCT03946670|537619621|FG001|Overall Study|Progressive Disease|27|||
149038305|NCT03946670|537619620|FG000|Overall Study|Adverse Event|7|||
149038306|NCT03946670|537619621|FG001|Overall Study|Adverse Event|10|||
149038307|NCT03946670|537619620|FG000|Overall Study|Physician Decision|6|||
149038308|NCT03946670|537619621|FG001|Overall Study|Physician Decision|5|||
149038309|NCT03946670|537619620|FG000|Overall Study|Death|5|||
149038310|NCT03946670|537619621|FG001|Overall Study|Death|8|||
149038311|NCT03946670|537619620|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
149038312|NCT03946670|537619621|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
149038313|NCT03946670|537619620|FG000|Overall Study|Subject Decision|4|||
149038314|NCT03946670|537619621|FG001|Overall Study|Subject Decision|5|||
149038315|NCT03946670|537619620|FG000|Overall Study|Study Terminated By Sponsor|2|||
149038316|NCT03946670|537619621|FG001|Overall Study|Study Terminated By Sponsor|0|||
149038317|NCT03946670|537619620|FG000|Overall Study|New Therapy For Study Indication|1|||
149038318|NCT03946670|537619621|FG001|Overall Study|New Therapy For Study Indication|0|||
149038319|NCT03946670|537619620|FG000|Overall Study|Not Treated|1|||
149038320|NCT03946670|537619621|FG001|Overall Study|Not Treated|1|||
149038321|NCT00057837|537619628|FG000|Overall Study|Progression/relapse|12|||
149038322|NCT00057837|537619629|FG001|Overall Study|Progression/relapse|14|||
149038323|NCT00057837|537619628|FG000|Overall Study|Adverse Event|2|||
149038324|NCT00057837|537619629|FG001|Overall Study|Adverse Event|12|||
149038325|NCT00057837|537619628|FG000|Overall Study|Death|5|||
149038326|NCT00057837|537619629|FG001|Overall Study|Death|4|||
149038327|NCT00057837|537619628|FG000|Overall Study|Withdrawal by Subject|5|||
149038328|NCT00057837|537619629|FG001|Overall Study|Withdrawal by Subject|3|||
149038329|NCT00057837|537619628|FG000|Overall Study|Alternative therapy|0|||
149038330|NCT00057837|537619629|FG001|Overall Study|Alternative therapy|1|||
149038331|NCT00057837|537619628|FG000|Overall Study|Other complicating disease|2|||
149038332|NCT00057837|537619629|FG001|Overall Study|Other complicating disease|1|||
149038333|NCT00057837|537619628|FG000|Overall Study|Physician Decision|1|||
149038334|NCT00057837|537619629|FG001|Overall Study|Physician Decision|0|||
149038335|NCT00057837|537619628|FG000|Overall Study|Ineligible|3|||
149038336|NCT00057837|537619629|FG001|Overall Study|Ineligible|3|||
149038337|NCT00057837|537619628|FG000|Overall Study|Never started treatment|1|||
149038338|NCT00057837|537619629|FG001|Overall Study|Never started treatment|1|||
149038339|NCT02425111|537619630|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
149038340|NCT02425111|537619630|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
149038341|NCT02425111|537619630|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
149038342|NCT02425111|537619630|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
149038343|NCT02425111|537619630|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
149038344|NCT02425111|537619630|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
149038345|NCT00585533|537619631|FG000|Overall Study|objective or symptomatic progression|9|||
149038346|NCT02798835|537619632|FG000|Overall Study|Protocol Violation|0|||
149038347|NCT02798835|537619633|FG001|Overall Study|Protocol Violation|0|||
149038348|NCT02798835|537619634|FG002|Overall Study|Protocol Violation|3|||
148880333|NCT00555672|537039774|FG000|Overall Study|Objective progression or relapse|11|||
148880334|NCT00555672|537039775|FG001|Overall Study|Objective progression or relapse|5|||
148880335|NCT00555672|537039774|FG000|Overall Study|Other|3|||
148880336|NCT00555672|537039775|FG001|Overall Study|Other|1|||
148880337|NCT00555672|537039774|FG000|Overall Study|Participant refused|2|||
148880338|NCT00555672|537039775|FG001|Overall Study|Participant refused|0|||
148880339|NCT01922271|537039776|FG000|WASHOUT Period|Withdrawal by Subject|1|||
148880340|NCT01922271|537039777|FG001|WASHOUT Period|Withdrawal by Subject|0|||
148880341|NCT02123823|537039779|FG000|Overall Study|Lack of Efficacy|0|||
148880342|NCT02123823|537039780|FG001|Overall Study|Lack of Efficacy|2|||
148880343|NCT02123823|537039781|FG002|Overall Study|Lack of Efficacy|8|||
148880344|NCT02123823|537039782|FG003|Overall Study|Lack of Efficacy|10|||
148880345|NCT02123823|537039779|FG000|Overall Study|Progressive disease|3|||
148880346|NCT02123823|537039780|FG001|Overall Study|Progressive disease|19|||
148880347|NCT02123823|537039781|FG002|Overall Study|Progressive disease|52|||
148880348|NCT02123823|537039782|FG003|Overall Study|Progressive disease|53|||
148880349|NCT02123823|537039779|FG000|Overall Study|Withdrawal by Subject|0|||
148880350|NCT02123823|537039780|FG001|Overall Study|Withdrawal by Subject|0|||
148880351|NCT02123823|537039781|FG002|Overall Study|Withdrawal by Subject|7|||
148880352|NCT02123823|537039782|FG003|Overall Study|Withdrawal by Subject|2|||
148880353|NCT02123823|537039779|FG000|Overall Study|Adverse Event|0|||
148880354|NCT02123823|537039780|FG001|Overall Study|Adverse Event|0|||
148880355|NCT02123823|537039781|FG002|Overall Study|Adverse Event|3|||
148880356|NCT02123823|537039782|FG003|Overall Study|Adverse Event|5|||
148880357|NCT04698993|537039786|FG000|Overall Study|PCR results not accessible|2|||
148880358|NCT04698993|537039787|FG001|Overall Study|PCR results not accessible|7|||
148880359|NCT04698993|537039786|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
148880360|NCT04698993|537039787|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
148880361|NCT01128946|537039788|FG000|Period I|Protocol Violation|0|||
148880362|NCT01128946|537039789|FG001|Period I|Protocol Violation|1|||
148880363|NCT01128946|537039790|FG002|Period I|Protocol Violation|0|||
148880364|NCT01128946|537039791|FG003|Period I|Protocol Violation|0|||
148880365|NCT01128946|537039788|FG000|Period I|Withdrawal by Subject|0|||
148880366|NCT01128946|537039789|FG001|Period I|Withdrawal by Subject|0|||
148880367|NCT01128946|537039790|FG002|Period I|Withdrawal by Subject|1|||
148880368|NCT01128946|537039791|FG003|Period I|Withdrawal by Subject|1|||
148880369|NCT01128946|537039788|FG000|Period II|Protocol Violation|0|||
148880370|NCT01128946|537039789|FG001|Period II|Protocol Violation|1|||
148880371|NCT01128946|537039790|FG002|Period II|Protocol Violation|0|||
148880372|NCT01128946|537039791|FG003|Period II|Protocol Violation|0|||
148880373|NCT01128946|537039788|FG000|Period II|Withdrawal by Subject|0|||
148880374|NCT01128946|537039789|FG001|Period II|Withdrawal by Subject|0|||
148880375|NCT01128946|537039790|FG002|Period II|Withdrawal by Subject|0|||
148880376|NCT01128946|537039791|FG003|Period II|Withdrawal by Subject|1|||
148880377|NCT01128946|537039788|FG000|Period III|Protocol Violation|1|||
148880378|NCT01128946|537039789|FG001|Period III|Protocol Violation|0|||
148880379|NCT01128946|537039790|FG002|Period III|Protocol Violation|0|||
148880380|NCT01128946|537039791|FG003|Period III|Protocol Violation|0|||
148880381|NCT00621140|537039792|FG000|Overall Study|Adverse Event|4|||
148880382|NCT00621140|537039793|FG001|Overall Study|Adverse Event|5|||
148880383|NCT00621140|537039792|FG000|Overall Study|Lost to Follow-up|1|||
148880384|NCT00621140|537039793|FG001|Overall Study|Lost to Follow-up|2|||
148880385|NCT00621140|537039792|FG000|Overall Study|Withdrawal by Subject|4|||
148880386|NCT00621140|537039793|FG001|Overall Study|Withdrawal by Subject|6|||
148880387|NCT00621140|537039792|FG000|Overall Study|Other incl. lack of efficacy|6|||
148880388|NCT00621140|537039793|FG001|Overall Study|Other incl. lack of efficacy|5|||
148880389|NCT00145574|537039794|FG000|Double Blind|Adverse Event|0|||
148880390|NCT00145574|537039795|FG001|Double Blind|Adverse Event|3|||
148880391|NCT00145574|537039796|FG002|Double Blind|Adverse Event|1|||
148880392|NCT00145574|537039794|FG000|Double Blind|Withdrawal by Subject|1|||
148880393|NCT00145574|537039795|FG001|Double Blind|Withdrawal by Subject|1|||
148880394|NCT00145574|537039796|FG002|Double Blind|Withdrawal by Subject|1|||
148880395|NCT00145574|537039794|FG000|Double Blind|required restricted medicine|0|||
148880396|NCT00145574|537039795|FG001|Double Blind|required restricted medicine|1|||
148880397|NCT00145574|537039796|FG002|Double Blind|required restricted medicine|0|||
148880398|NCT00145574|537039794|FG000|Open Label Long-term Extension|Adverse Event|0|||
148880399|NCT00145574|537039795|FG001|Open Label Long-term Extension|Adverse Event|0|||
148880400|NCT00145574|537039796|FG002|Open Label Long-term Extension|Adverse Event|5|||
148880401|NCT00145574|537039794|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
148880402|NCT00145574|537039795|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
148880403|NCT00145574|537039796|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
148880404|NCT00145574|537039794|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
148880405|NCT00145574|537039795|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
148880406|NCT00145574|537039796|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
148880407|NCT00145574|537039794|FG000|Open Label Long-term Extension|required restricted medicine|0|||
148880408|NCT00145574|537039795|FG001|Open Label Long-term Extension|required restricted medicine|0|||
149038349|NCT03482011|537619635|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
149038350|NCT03482011|537619636|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
149038351|NCT03482011|537619637|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
149038352|NCT03482011|537619638|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
149038353|NCT03482011|537619639|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
149038354|NCT03482011|537619640|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
149038355|NCT03482011|537619641|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
149038356|NCT03482011|537619642|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
149038357|NCT03482011|537619635|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
149038358|NCT03482011|537619636|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
149038359|NCT03482011|537619637|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149038360|NCT03482011|537619638|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149038361|NCT03482011|537619639|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149038362|NCT03482011|537619640|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149038363|NCT03482011|537619641|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149038364|NCT03482011|537619642|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
149038365|NCT03482011|537619635|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038366|NCT03482011|537619636|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
149038367|NCT03482011|537619637|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038368|NCT03482011|537619638|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038369|NCT03482011|537619639|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038370|NCT03482011|537619640|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038371|NCT03482011|537619641|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038372|NCT03482011|537619642|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
149038373|NCT03482011|537619635|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
149038374|NCT03482011|537619636|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
149038375|NCT03482011|537619637|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
149038376|NCT03482011|537619638|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
149038377|NCT03482011|537619639|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
149038378|NCT03482011|537619640|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
149038379|NCT03482011|537619641|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
149038380|NCT03482011|537619642|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
149038381|NCT03482011|537619635|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
149038382|NCT03482011|537619636|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
149038383|NCT03482011|537619637|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149038384|NCT03482011|537619638|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149038385|NCT03482011|537619639|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149038386|NCT03482011|537619640|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149038387|NCT03482011|537619641|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149038388|NCT03482011|537619642|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
149038389|NCT03482011|537619635|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
149038390|NCT03482011|537619636|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
149038391|NCT03482011|537619637|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
149038392|NCT03482011|537619638|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
149038393|NCT03482011|537619639|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
149038394|NCT03482011|537619640|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
149038395|NCT03482011|537619641|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
149038396|NCT03482011|537619642|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
149038397|NCT03482011|537619635|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
149038398|NCT03482011|537619636|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
149038399|NCT03482011|537619637|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
149038400|NCT03482011|537619638|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
149038401|NCT03482011|537619639|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
149038402|NCT03482011|537619640|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
149038403|NCT03482011|537619641|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
149038404|NCT03482011|537619642|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
149038405|NCT03482011|537619635|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149038406|NCT03482011|537619636|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149038407|NCT03482011|537619637|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149038408|NCT03482011|537619638|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149038409|NCT03482011|537619639|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
149038410|NCT03482011|537619640|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149038411|NCT03482011|537619641|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
149038412|NCT03482011|537619642|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
149038413|NCT03482011|537619635|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
149038414|NCT03482011|537619636|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
149038415|NCT03482011|537619637|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
149038416|NCT03482011|537619638|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
149038417|NCT03482011|537619639|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
149038418|NCT03482011|537619640|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
148880409|NCT00145574|537039796|FG002|Open Label Long-term Extension|required restricted medicine|1|||
148880410|NCT00527904|537039797|FG000|Overall Study|Adverse Event|45|||
148880411|NCT00527904|537039797|FG000|Overall Study|Withdrawal by Subject|21|||
148880412|NCT00527904|537039797|FG000|Overall Study|Lost to Follow-up|8|||
148880413|NCT00527904|537039797|FG000|Overall Study|misc|22|||
148880414|NCT02669121|537039799|FG000|Overall Study|Adverse Event|4|||
148880415|NCT02669121|537039800|FG001|Overall Study|Adverse Event|5|||
148880416|NCT02669121|537039799|FG000|Overall Study|Lost to Follow-up|15|||
148880417|NCT02669121|537039800|FG001|Overall Study|Lost to Follow-up|27|||
148880418|NCT02669121|537039799|FG000|Overall Study|Withdrawal by Subject|132|||
148880419|NCT02669121|537039800|FG001|Overall Study|Withdrawal by Subject|140|||
148880420|NCT02669121|537039799|FG000|Overall Study|Pregnancy|0|||
148880421|NCT02669121|537039800|FG001|Overall Study|Pregnancy|1|||
148880422|NCT02669121|537039799|FG000|Overall Study|Discharged from US Military Active Service|117|||
148880423|NCT02669121|537039800|FG001|Overall Study|Discharged from US Military Active Service|91|||
148880424|NCT02669121|537039799|FG000|Overall Study|Reason not Specified|22|||
148880425|NCT02669121|537039800|FG001|Overall Study|Reason not Specified|18|||
148880426|NCT02687581|537039801|FG000|Overall Study|Withdrawal by Subject|1|||
148880427|NCT02687581|537039802|FG001|Overall Study|Withdrawal by Subject|0|||
148880428|NCT02687581|537039803|FG002|Overall Study|Withdrawal by Subject|0|||
148880429|NCT02687581|537039804|FG003|Overall Study|Withdrawal by Subject|1|||
148880430|NCT02687581|537039801|FG000|Overall Study|Lost to Follow-up|2|||
148880431|NCT02687581|537039802|FG001|Overall Study|Lost to Follow-up|2|||
149038419|NCT03482011|537619641|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
149038420|NCT03482011|537619642|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
149038421|NCT03482011|537619635|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149038422|NCT03482011|537619636|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149038423|NCT03482011|537619637|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
149038424|NCT03482011|537619638|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
149038425|NCT03482011|537619639|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
149038426|NCT03482011|537619640|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
149038427|NCT03482011|537619641|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
149038428|NCT03482011|537619642|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
149038429|NCT03482011|537619635|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149038430|NCT03482011|537619636|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149038431|NCT03482011|537619637|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149038432|NCT03482011|537619638|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
149038433|NCT03482011|537619639|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
149038434|NCT03482011|537619640|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
149038435|NCT03482011|537619641|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
149038436|NCT03482011|537619642|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
149038437|NCT03482011|537619635|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
149038438|NCT03482011|537619636|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
149038439|NCT03482011|537619637|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
149038440|NCT03482011|537619638|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
149038441|NCT03482011|537619639|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
149038442|NCT03482011|537619640|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
149038443|NCT03482011|537619641|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
149038444|NCT03482011|537619642|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
149038445|NCT03482011|537619635|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
149038446|NCT03482011|537619636|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
149038447|NCT03482011|537619637|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
149038448|NCT03482011|537619638|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
149038449|NCT03482011|537619639|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
149038450|NCT03482011|537619640|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
149038451|NCT03482011|537619641|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
149038452|NCT03482011|537619642|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
149038453|NCT03482011|537619635|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038454|NCT03482011|537619636|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038455|NCT03482011|537619637|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038456|NCT03482011|537619638|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038457|NCT03482011|537619639|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038458|NCT03482011|537619640|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038459|NCT03482011|537619641|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
149038460|NCT03482011|537619642|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
148880432|NCT02687581|537039803|FG002|Overall Study|Lost to Follow-up|0|||
148880433|NCT02687581|537039804|FG003|Overall Study|Lost to Follow-up|0|||
148880434|NCT02687581|537039801|FG000|Overall Study|the device is too small for the patient.|1|||
148880435|NCT02687581|537039802|FG001|Overall Study|the device is too small for the patient.|0|||
148880436|NCT02687581|537039803|FG002|Overall Study|the device is too small for the patient.|0|||
149038461|NCT03482011|537619635|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149038462|NCT03482011|537619636|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
148880437|NCT02687581|537039804|FG003|Overall Study|the device is too small for the patient.|0|||
148880438|NCT00835341|537039805|FG000|Overall Study|Lost to Follow-up|3|||
148880439|NCT00835341|537039806|FG001|Overall Study|Lost to Follow-up|12|||
148880440|NCT04405076|537039808|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
149038463|NCT03482011|537619637|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149038464|NCT03482011|537619638|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149038465|NCT03482011|537619639|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149038466|NCT03482011|537619640|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149038467|NCT03482011|537619641|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149038468|NCT03482011|537619642|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
149038469|NCT00468052|537619643|FG000|Overall Study|Protocol Violation|7|||
149038470|NCT00468052|537619644|FG001|Overall Study|Protocol Violation|8|||
149038471|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
149038472|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
149038473|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
149038474|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
149038475|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
149038476|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
149038477|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
149038478|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
149038479|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
149038480|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
149038481|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
149038482|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
149038483|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
149038484|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
149038485|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
149038486|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
149038487|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
149038488|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
149038489|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
149038490|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
149038491|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
149038492|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
149038493|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
149038494|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
149038495|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
149038496|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
149038497|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
149038498|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
149038499|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
149038500|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
149038501|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
149038502|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149038503|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149038504|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149038505|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
149038506|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
149038507|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
149038508|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
149038509|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
149038510|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
149038511|NCT02709655|537619645|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
149038512|NCT02709655|537619646|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
149038513|NCT02709655|537619647|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
149038514|NCT02709655|537619648|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
149038515|NCT02709655|537619649|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
149038516|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
149038517|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
149038518|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
149038519|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
149038520|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
148880441|NCT04405076|537039809|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
148880442|NCT04405076|537039810|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
148880443|NCT04405076|537039811|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
148880444|NCT04405076|537039812|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
148880445|NCT04405076|537039813|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
148880446|NCT04405076|537039814|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
149038521|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
149038522|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
149038523|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
149038524|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
149038525|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
149038526|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
149038527|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
149038528|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
149038529|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
149038530|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
149038531|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
148880447|NCT04405076|537039815|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
148880448|NCT04405076|537039816|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
148880449|NCT04405076|537039808|FG000|Part A (Blinded Phase)|Physician Decision|1|||
148880450|NCT04405076|537039809|FG001|Part A (Blinded Phase)|Physician Decision|2|||
148880451|NCT04405076|537039810|FG002|Part A (Blinded Phase)|Physician Decision|0|||
148880452|NCT04405076|537039811|FG003|Part A (Blinded Phase)|Physician Decision|0|||
148880453|NCT04405076|537039812|FG004|Part A (Blinded Phase)|Physician Decision|0|||
148880454|NCT04405076|537039813|FG005|Part A (Blinded Phase)|Physician Decision|0|||
148880455|NCT04405076|537039814|FG006|Part A (Blinded Phase)|Physician Decision|0|||
148880456|NCT04405076|537039815|FG007|Part A (Blinded Phase)|Physician Decision|0|||
148880457|NCT04405076|537039816|FG008|Part A (Blinded Phase)|Physician Decision|0|||
148880458|NCT04405076|537039808|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
148880459|NCT04405076|537039809|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
148880460|NCT04405076|537039810|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
148880461|NCT04405076|537039811|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
148880462|NCT04405076|537039812|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
148880463|NCT04405076|537039813|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
148880464|NCT04405076|537039814|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
148880465|NCT04405076|537039815|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
148880466|NCT04405076|537039816|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
148880467|NCT04405076|537039808|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
148880468|NCT04405076|537039809|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
149038532|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
149038533|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
149038534|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
149038535|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
149038536|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
149038537|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
149038538|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
149038539|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
149038540|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
149038541|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
149038542|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
149038543|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
149038544|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
149038545|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
149038546|NCT02709655|537619645|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
149038547|NCT02709655|537619646|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
149038548|NCT02709655|537619647|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
148880469|NCT04405076|537039810|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880470|NCT04405076|537039811|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880471|NCT04405076|537039812|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880472|NCT04405076|537039813|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880473|NCT04405076|537039814|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880474|NCT04405076|537039815|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880475|NCT04405076|537039816|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
148880476|NCT04405076|537039808|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
149038549|NCT02709655|537619648|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
149038550|NCT02709655|537619649|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
149038551|NCT02739035|537619653|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
149038552|NCT02739035|537619654|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
149038553|NCT02739035|537619653|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
149038554|NCT02739035|537619654|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
149038555|NCT02739035|537619653|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
149038556|NCT02739035|537619654|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
149038557|NCT02739035|537619653|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
149038558|NCT02739035|537619654|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
149038559|NCT04221438|537619662|FG000|Overall Study|Adverse Event|1|||
148880477|NCT04405076|537039809|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
148880478|NCT04405076|537039810|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880479|NCT04405076|537039811|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880480|NCT04405076|537039812|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880481|NCT04405076|537039813|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880482|NCT04405076|537039814|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880483|NCT04405076|537039815|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880484|NCT04405076|537039816|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
148880485|NCT04405076|537039808|FG000|Part A (Blinded Phase)|Other than Specified|0|||
148880486|NCT04405076|537039809|FG001|Part A (Blinded Phase)|Other than Specified|0|||
148880487|NCT04405076|537039810|FG002|Part A (Blinded Phase)|Other than Specified|3|||
148880488|NCT04405076|537039811|FG003|Part A (Blinded Phase)|Other than Specified|0|||
148880489|NCT04405076|537039812|FG004|Part A (Blinded Phase)|Other than Specified|0|||
148880490|NCT04405076|537039813|FG005|Part A (Blinded Phase)|Other than Specified|0|||
148880491|NCT04405076|537039814|FG006|Part A (Blinded Phase)|Other than Specified|0|||
148880492|NCT04405076|537039815|FG007|Part A (Blinded Phase)|Other than Specified|0|||
148880493|NCT04405076|537039816|FG008|Part A (Blinded Phase)|Other than Specified|0|||
148880494|NCT04405076|537039808|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
148880495|NCT04405076|537039809|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
148880496|NCT04405076|537039810|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
148880497|NCT04405076|537039811|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
148880498|NCT04405076|537039812|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
148880499|NCT04405076|537039813|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
148880500|NCT04405076|537039814|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
148880501|NCT04405076|537039815|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
148880502|NCT04405076|537039816|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
148880503|NCT04405076|537039808|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880504|NCT04405076|537039809|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880505|NCT04405076|537039810|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880506|NCT04405076|537039811|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880507|NCT04405076|537039812|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
148880508|NCT04405076|537039813|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880509|NCT04405076|537039814|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880510|NCT04405076|537039815|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880511|NCT04405076|537039816|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
148880512|NCT04405076|537039808|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
148880513|NCT04405076|537039809|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
148880514|NCT04405076|537039810|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
148880515|NCT04405076|537039811|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
148880516|NCT04405076|537039812|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
148880517|NCT04405076|537039813|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
148880518|NCT04405076|537039814|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
148880519|NCT04405076|537039815|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
148880520|NCT04405076|537039816|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
148880521|NCT04405076|537039808|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880522|NCT04405076|537039809|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880523|NCT04405076|537039810|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880524|NCT04405076|537039811|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880525|NCT04405076|537039812|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880526|NCT04405076|537039813|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880527|NCT04405076|537039814|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
148880528|NCT04405076|537039815|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
148880529|NCT04405076|537039816|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
149003865|NCT02856113|537493153|FG000|Overall Study|Voluntary Withdrawal|3|||
149003866|NCT02856113|537493154|FG001|Overall Study|Voluntary Withdrawal|5|||
149003867|NCT02856113|537493153|FG000|Overall Study|Pregnancy|0|||
149003868|NCT02856113|537493154|FG001|Overall Study|Pregnancy|1|||
149003869|NCT02856113|537493153|FG000|Overall Study|Principal Investigator Discretion|2|||
149003870|NCT02856113|537493154|FG001|Overall Study|Principal Investigator Discretion|1|||
149003871|NCT02856113|537493153|FG000|Overall Study|Randomized but not Treated|1|||
149003872|NCT02856113|537493154|FG001|Overall Study|Randomized but not Treated|0|||
149003873|NCT02856113|537493153|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
149003874|NCT02856113|537493154|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
149003875|NCT03494166|537493155|FG000|Overall Study|Death|0|||
149003876|NCT03494166|537493156|FG001|Overall Study|Death|0|||
148880530|NCT04405076|537039808|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880531|NCT04405076|537039809|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880532|NCT04405076|537039810|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880533|NCT04405076|537039811|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880534|NCT04405076|537039812|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880535|NCT04405076|537039813|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880536|NCT04405076|537039814|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
148880537|NCT04405076|537039815|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880538|NCT04405076|537039816|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
148880539|NCT04310566|537039817|FG000|Period 1|Study Termination due to COVID-19|15|||
148880540|NCT04310566|537039818|FG001|Period 1|Study Termination due to COVID-19|17|||
148880541|NCT04310566|537039817|FG000|Period 1|Protocol Violation|0|||
148880542|NCT04310566|537039818|FG001|Period 1|Protocol Violation|1|||
148880543|NCT04310566|537039817|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
148880544|NCT04310566|537039818|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
148880545|NCT04310566|537039817|FG000|Period 1|Lost to Follow-up|1|||
148880546|NCT04310566|537039818|FG001|Period 1|Lost to Follow-up|0|||
148880547|NCT04310566|537039817|FG000|Period 1|Withdrawal by Subject|0|||
148880548|NCT04310566|537039818|FG001|Period 1|Withdrawal by Subject|1|||
148880549|NCT04310566|537039817|FG000|Period 2|Study Termination|7|||
148880550|NCT04310566|537039818|FG001|Period 2|Study Termination|5|||
148880551|NCT00384332|537039826|FG000|Overall Study|Lost to Follow-up|4|||
148880552|NCT00384332|537039827|FG001|Overall Study|Lost to Follow-up|0|||
148880553|NCT02560012|537039828|FG000|Overall Study|Study Terminated|2|||
148880554|NCT02218008|537039831|FG000|Stage 1 (S1)|Adverse Event|6|||
148880555|NCT02218008|537039832|FG001|Stage 1 (S1)|Adverse Event|5|||
148880556|NCT02218008|537039833|FG002|Stage 1 (S1)|Adverse Event|11|||
148880557|NCT02218008|537039834|FG003|Stage 1 (S1)|Adverse Event|0|||
148880558|NCT02218008|537039835|FG004|Stage 1 (S1)|Adverse Event|0|||
148880559|NCT02218008|537039836|FG005|Stage 1 (S1)|Adverse Event|0|||
148880560|NCT02218008|537039831|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
148880561|NCT02218008|537039832|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
148880562|NCT02218008|537039833|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
148880563|NCT02218008|537039834|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
148880564|NCT02218008|537039835|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
148880565|NCT02218008|537039836|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
148880566|NCT02218008|537039831|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
149003877|NCT03494166|537493157|FG002|Overall Study|Death|0|||
149003878|NCT03494166|537493158|FG003|Overall Study|Death|1|||
149003879|NCT03494166|537493159|FG004|Overall Study|Death|3|||
149003880|NCT03494166|537493160|FG005|Overall Study|Death|0|||
149003881|NCT03494166|537493155|FG000|Overall Study|Lost to Follow-up|2|||
149003882|NCT03494166|537493156|FG001|Overall Study|Lost to Follow-up|2|||
149003883|NCT03494166|537493157|FG002|Overall Study|Lost to Follow-up|2|||
149003884|NCT03494166|537493158|FG003|Overall Study|Lost to Follow-up|2|||
149003885|NCT03494166|537493159|FG004|Overall Study|Lost to Follow-up|14|||
149003886|NCT03494166|537493160|FG005|Overall Study|Lost to Follow-up|0|||
149003887|NCT03494166|537493155|FG000|Overall Study|Withdrawal by Subject|10|||
149003888|NCT03494166|537493156|FG001|Overall Study|Withdrawal by Subject|7|||
149003889|NCT03494166|537493157|FG002|Overall Study|Withdrawal by Subject|0|||
149003890|NCT03494166|537493158|FG003|Overall Study|Withdrawal by Subject|5|||
149003891|NCT03494166|537493159|FG004|Overall Study|Withdrawal by Subject|3|||
149003892|NCT03494166|537493160|FG005|Overall Study|Withdrawal by Subject|17|||
149003893|NCT03494166|537493155|FG000|Overall Study|Screen failure|1|||
149003894|NCT03494166|537493156|FG001|Overall Study|Screen failure|0|||
149003895|NCT03494166|537493157|FG002|Overall Study|Screen failure|0|||
149003896|NCT03494166|537493158|FG003|Overall Study|Screen failure|0|||
149003897|NCT03494166|537493159|FG004|Overall Study|Screen failure|1|||
149003898|NCT03494166|537493160|FG005|Overall Study|Screen failure|0|||
149003899|NCT02857426|537493161|FG000|Overall Study|Disease progression|34|||
149003900|NCT02857426|537493162|FG001|Overall Study|Disease progression|13|||
148880567|NCT02218008|537039832|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
148880568|NCT02218008|537039833|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
148880569|NCT02218008|537039834|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
148880570|NCT02218008|537039835|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
148880571|NCT02218008|537039836|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
148880572|NCT02218008|537039831|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
148880573|NCT02218008|537039832|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
148880574|NCT02218008|537039833|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
149003901|NCT02857426|537493161|FG000|Overall Study|Study drug toxicity|4|||
149003902|NCT02857426|537493162|FG001|Overall Study|Study drug toxicity|1|||
149003903|NCT02857426|537493161|FG000|Overall Study|Death|1|||
149003904|NCT02857426|537493162|FG001|Overall Study|Death|0|||
149003905|NCT02857426|537493161|FG000|Overall Study|Adverse event unrelated to study drug|6|||
149038560|NCT04221438|537619662|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
148880575|NCT02218008|537039834|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
148880576|NCT02218008|537039835|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
148880577|NCT02218008|537039836|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
148880578|NCT02218008|537039831|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
148880579|NCT02218008|537039832|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
149038561|NCT00588770|537619665|FG000|Overall Study|Disease progression|85|||
149038562|NCT00588770|537619666|FG001|Overall Study|Disease progression|68|||
149038563|NCT00588770|537619665|FG000|Overall Study|Adverse Event|29|||
149038564|NCT00588770|537619666|FG001|Overall Study|Adverse Event|58|||
149038565|NCT00588770|537619665|FG000|Overall Study|Death|13|||
149038566|NCT00588770|537619666|FG001|Overall Study|Death|22|||
149038567|NCT00588770|537619665|FG000|Overall Study|Withdrawal by Subject|15|||
149038568|NCT00588770|537619666|FG001|Overall Study|Withdrawal by Subject|25|||
149038569|NCT00588770|537619665|FG000|Overall Study|Alternative therapy|2|||
149038570|NCT00588770|537619666|FG001|Overall Study|Alternative therapy|4|||
149038571|NCT00588770|537619665|FG000|Overall Study|Other complicating disease|3|||
149038572|NCT00588770|537619666|FG001|Overall Study|Other complicating disease|2|||
149038573|NCT00588770|537619665|FG000|Overall Study|Not start protocol therapy|0|||
149038574|NCT00588770|537619666|FG001|Overall Study|Not start protocol therapy|9|||
149038575|NCT00588770|537619665|FG000|Overall Study|Lack of Efficacy|8|||
149038576|NCT00588770|537619666|FG001|Overall Study|Lack of Efficacy|10|||
149038577|NCT00588770|537619665|FG000|Overall Study|Physician discretion|2|||
149038578|NCT00588770|537619666|FG001|Overall Study|Physician discretion|0|||
149038579|NCT00588770|537619665|FG000|Overall Study|Patient non-compliance|2|||
149038580|NCT00588770|537619666|FG001|Overall Study|Patient non-compliance|2|||
149038581|NCT00630786|537619668|FG000|Overall Study|Physician Decision|0|||
149038582|NCT00630786|537619669|FG001|Overall Study|Physician Decision|0|||
149038583|NCT00630786|537619670|FG002|Overall Study|Physician Decision|1|||
149038584|NCT00630786|537619668|FG000|Overall Study|Withdrawal by Subject|0|||
149038585|NCT00630786|537619669|FG001|Overall Study|Withdrawal by Subject|1|||
149038586|NCT00630786|537619670|FG002|Overall Study|Withdrawal by Subject|1|||
149038587|NCT00630786|537619668|FG000|Overall Study|Lost to Follow-up|0|||
149038588|NCT00630786|537619669|FG001|Overall Study|Lost to Follow-up|1|||
149038589|NCT00630786|537619670|FG002|Overall Study|Lost to Follow-up|0|||
149038590|NCT00630786|537619668|FG000|Overall Study|Other|1|||
149038591|NCT00630786|537619669|FG001|Overall Study|Other|0|||
149038592|NCT00630786|537619670|FG002|Overall Study|Other|0|||
149038593|NCT01585558|537619676|FG000|Overall Study|Withdrawal by Subject|4|||
149038594|NCT01585558|537619677|FG001|Overall Study|Withdrawal by Subject|5|||
149038595|NCT01585558|537619678|FG002|Overall Study|Withdrawal by Subject|8|||
149038596|NCT01585558|537619676|FG000|Overall Study|Lost to Follow-up|2|||
149038597|NCT01585558|537619677|FG001|Overall Study|Lost to Follow-up|0|||
149038598|NCT01585558|537619678|FG002|Overall Study|Lost to Follow-up|3|||
149038599|NCT01585558|537619676|FG000|Overall Study|Adverse Event|3|||
149038600|NCT01585558|537619677|FG001|Overall Study|Adverse Event|4|||
149038601|NCT01585558|537619678|FG002|Overall Study|Adverse Event|1|||
149038602|NCT01585558|537619676|FG000|Overall Study|Protocol Violation|4|||
149038603|NCT01585558|537619677|FG001|Overall Study|Protocol Violation|3|||
149038604|NCT01585558|537619678|FG002|Overall Study|Protocol Violation|2|||
149038605|NCT01585558|537619676|FG000|Overall Study|Lack of Efficacy|0|||
149038606|NCT01585558|537619677|FG001|Overall Study|Lack of Efficacy|0|||
149038607|NCT01585558|537619678|FG002|Overall Study|Lack of Efficacy|1|||
149038608|NCT00617201|537619681|FG000|Overall Study|Lost to Follow-up|9|||
149038609|NCT00617201|537619682|FG001|Overall Study|Lost to Follow-up|13|||
149038610|NCT01350804|537619683|FG000|Core Study|Withdrawal by Subject|11|||
149038611|NCT01350804|537619684|FG001|Core Study|Withdrawal by Subject|17|||
149038612|NCT01350804|537619685|FG002|Core Study|Withdrawal by Subject|16|||
149038613|NCT01350804|537619686|FG003|Core Study|Withdrawal by Subject|7|||
149038614|NCT01350804|537619683|FG000|Core Study|Study terminated by Sponsor|0|||
149038615|NCT01350804|537619684|FG001|Core Study|Study terminated by Sponsor|0|||
148880580|NCT02218008|537039833|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
148880581|NCT02218008|537039834|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
148880582|NCT02218008|537039835|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
148880583|NCT02218008|537039836|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
148880584|NCT02218008|537039831|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
148880585|NCT02218008|537039832|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
149038616|NCT01350804|537619685|FG002|Core Study|Study terminated by Sponsor|0|||
149038617|NCT01350804|537619686|FG003|Core Study|Study terminated by Sponsor|2|||
149038618|NCT01350804|537619683|FG000|Core Study|Protocol deviation|1|||
149038619|NCT01350804|537619684|FG001|Core Study|Protocol deviation|0|||
149038620|NCT01350804|537619685|FG002|Core Study|Protocol deviation|1|||
149038621|NCT01350804|537619686|FG003|Core Study|Protocol deviation|0|||
149038622|NCT01350804|537619683|FG000|Core Study|Physician Decision|1|||
149038623|NCT01350804|537619684|FG001|Core Study|Physician Decision|0|||
149038624|NCT01350804|537619685|FG002|Core Study|Physician Decision|1|||
149038625|NCT01350804|537619686|FG003|Core Study|Physician Decision|3|||
149038626|NCT01350804|537619683|FG000|Core Study|Lost to Follow-up|3|||
148880586|NCT02218008|537039833|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
149038627|NCT01350804|537619684|FG001|Core Study|Lost to Follow-up|0|||
149038628|NCT01350804|537619685|FG002|Core Study|Lost to Follow-up|2|||
149038629|NCT01350804|537619686|FG003|Core Study|Lost to Follow-up|1|||
148880587|NCT02218008|537039834|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
148880588|NCT02218008|537039835|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
148880589|NCT02218008|537039836|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
148880590|NCT02218008|537039831|FG000|Stage 1 (S1)|Pregnancy|0|||
148880591|NCT02218008|537039832|FG001|Stage 1 (S1)|Pregnancy|0|||
148880592|NCT02218008|537039833|FG002|Stage 1 (S1)|Pregnancy|1|||
148880593|NCT02218008|537039834|FG003|Stage 1 (S1)|Pregnancy|0|||
148880594|NCT02218008|537039835|FG004|Stage 1 (S1)|Pregnancy|0|||
148880595|NCT02218008|537039836|FG005|Stage 1 (S1)|Pregnancy|0|||
148880596|NCT02218008|537039831|FG000|Stage 1 (S1)|Protocol Violation|0|||
148880597|NCT02218008|537039832|FG001|Stage 1 (S1)|Protocol Violation|0|||
148880598|NCT02218008|537039833|FG002|Stage 1 (S1)|Protocol Violation|1|||
148880599|NCT02218008|537039834|FG003|Stage 1 (S1)|Protocol Violation|0|||
148880600|NCT02218008|537039835|FG004|Stage 1 (S1)|Protocol Violation|0|||
148880601|NCT02218008|537039836|FG005|Stage 1 (S1)|Protocol Violation|0|||
149038630|NCT01350804|537619683|FG000|Core Study|Lack of Efficacy|16|||
149038631|NCT01350804|537619684|FG001|Core Study|Lack of Efficacy|19|||
149038632|NCT01350804|537619685|FG002|Core Study|Lack of Efficacy|18|||
149038633|NCT01350804|537619686|FG003|Core Study|Lack of Efficacy|5|||
149038634|NCT01350804|537619683|FG000|Core Study|Death|1|||
148880602|NCT02218008|537039831|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
148880603|NCT02218008|537039832|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
148880604|NCT02218008|537039833|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
148880605|NCT02218008|537039834|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
148880606|NCT02218008|537039835|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
148880607|NCT02218008|537039836|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
148880608|NCT02218008|537039831|FG000|Stage 2 (S2)|Adverse Event|0|||
148880609|NCT02218008|537039832|FG001|Stage 2 (S2)|Adverse Event|0|||
148880610|NCT02218008|537039833|FG002|Stage 2 (S2)|Adverse Event|0|||
148880611|NCT02218008|537039834|FG003|Stage 2 (S2)|Adverse Event|2|||
148880612|NCT02218008|537039835|FG004|Stage 2 (S2)|Adverse Event|3|||
149038635|NCT01350804|537619684|FG001|Core Study|Death|1|||
149038636|NCT01350804|537619685|FG002|Core Study|Death|1|||
149038637|NCT01350804|537619686|FG003|Core Study|Death|0|||
149038638|NCT01350804|537619683|FG000|Core Study|Adverse Event|8|||
149038639|NCT01350804|537619684|FG001|Core Study|Adverse Event|10|||
149038640|NCT01350804|537619685|FG002|Core Study|Adverse Event|8|||
149038641|NCT01350804|537619686|FG003|Core Study|Adverse Event|8|||
149038642|NCT01350804|537619683|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
149038643|NCT01350804|537619684|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
149038644|NCT01350804|537619685|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
149038645|NCT01350804|537619686|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
149038646|NCT01350804|537619683|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
149038647|NCT01350804|537619684|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
149038648|NCT01350804|537619685|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
149038649|NCT01350804|537619686|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
149038650|NCT01350804|537619683|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
149038651|NCT01350804|537619684|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
149038652|NCT01350804|537619685|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
149038653|NCT01350804|537619686|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
149038654|NCT01350804|537619683|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
149038655|NCT01350804|537619684|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
149038656|NCT01350804|537619685|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
149038657|NCT01350804|537619686|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
149038658|NCT01350804|537619683|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
149038659|NCT01350804|537619684|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
149038660|NCT01350804|537619685|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
149038661|NCT01350804|537619686|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
149038662|NCT01350804|537619683|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
149038663|NCT01350804|537619684|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
149038664|NCT01350804|537619685|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
149038665|NCT01350804|537619686|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
149038666|NCT03215927|537620473|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
148880613|NCT02218008|537039836|FG005|Stage 2 (S2)|Adverse Event|3|||
148880614|NCT02218008|537039831|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
149038667|NCT03215927|537620474|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
149038668|NCT03215927|537620473|FG000|Open Label Extension|Adverse Event|1|||
149038669|NCT03215927|537620474|FG001|Open Label Extension|Adverse Event|0|||
149038670|NCT03215927|537620473|FG000|Open Label Extension|Lack of Efficacy|1|||
148880615|NCT02218008|537039832|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
148880616|NCT02218008|537039833|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
148880617|NCT02218008|537039834|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
148880618|NCT02218008|537039835|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
148880619|NCT02218008|537039836|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
148880620|NCT02218008|537039831|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
148880621|NCT02218008|537039832|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
148880622|NCT02218008|537039833|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
148880623|NCT02218008|537039834|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
148880624|NCT02218008|537039835|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
148880625|NCT02218008|537039836|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
148880626|NCT02218008|537039831|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
148880627|NCT02218008|537039832|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
148880628|NCT02218008|537039833|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
148880629|NCT02218008|537039834|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
148880630|NCT02218008|537039835|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
148880631|NCT02218008|537039836|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
148880632|NCT02218008|537039831|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
148880633|NCT02218008|537039832|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
148880634|NCT02218008|537039833|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
148880635|NCT02218008|537039834|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
148880636|NCT02218008|537039835|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
148880637|NCT02218008|537039836|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
148880638|NCT01278797|537039837|FG000|Period 1|Adverse Event|0|||
148880639|NCT01278797|537039838|FG001|Period 1|Adverse Event|1|||
148880640|NCT01278797|537039837|FG000|Period 1|Protocol Violation|1|||
148880641|NCT01278797|537039838|FG001|Period 1|Protocol Violation|0|||
148880642|NCT00620113|537039842|FG000|Overall Study|Adverse Event|3|||
148880643|NCT00620113|537039843|FG001|Overall Study|Adverse Event|2|||
148880644|NCT00620113|537039844|FG002|Overall Study|Adverse Event|2|||
148880645|NCT00620113|537039845|FG003|Overall Study|Adverse Event|1|||
148880646|NCT00620113|537039842|FG000|Overall Study|Lack of Efficacy|2|||
148880647|NCT00620113|537039843|FG001|Overall Study|Lack of Efficacy|3|||
148880648|NCT00620113|537039844|FG002|Overall Study|Lack of Efficacy|0|||
148880649|NCT00620113|537039845|FG003|Overall Study|Lack of Efficacy|2|||
148880650|NCT00620113|537039842|FG000|Overall Study|Physician Decision|1|||
148880651|NCT00620113|537039843|FG001|Overall Study|Physician Decision|0|||
148880652|NCT00620113|537039844|FG002|Overall Study|Physician Decision|0|||
148880653|NCT00620113|537039845|FG003|Overall Study|Physician Decision|2|||
148880654|NCT00620113|537039842|FG000|Overall Study|Protocol Violation|2|||
148880655|NCT00620113|537039843|FG001|Overall Study|Protocol Violation|1|||
148880656|NCT00620113|537039844|FG002|Overall Study|Protocol Violation|0|||
148880657|NCT00620113|537039845|FG003|Overall Study|Protocol Violation|0|||
148880658|NCT00620113|537039842|FG000|Overall Study|Withdrawal by Subject|5|||
148880659|NCT00620113|537039843|FG001|Overall Study|Withdrawal by Subject|1|||
148880660|NCT00620113|537039844|FG002|Overall Study|Withdrawal by Subject|3|||
148880661|NCT00620113|537039845|FG003|Overall Study|Withdrawal by Subject|5|||
148880662|NCT02069392|537039846|FG000|Overall Study|Withdrawal by Subject|4|||
148880663|NCT02069392|537039847|FG001|Overall Study|Withdrawal by Subject|2|||
148880664|NCT00269633|537039848|FG000|Overall Study|Withdrawal by Subject|1|||
148880665|NCT00269633|537039849|FG001|Overall Study|Withdrawal by Subject|0|||
148880666|NCT04412707|537039850|FG000|Cycle 1|Death|0|||
148880667|NCT04412707|537039851|FG001|Cycle 1|Death|3|||
148880668|NCT04412707|537039850|FG000|Cycle 1|Disease progression|1|||
149003906|NCT02857426|537493162|FG001|Overall Study|Adverse event unrelated to study drug|2|||
149003907|NCT02857426|537493161|FG000|Overall Study|Participant withdrew consent|1|||
149003908|NCT02857426|537493162|FG001|Overall Study|Participant withdrew consent|1|||
149003909|NCT02857426|537493161|FG000|Overall Study|Maximum clinical benefit|1|||
149003910|NCT02857426|537493162|FG001|Overall Study|Maximum clinical benefit|0|||
149003911|NCT02857426|537493161|FG000|Overall Study|Completed treatment|0|||
149003912|NCT02857426|537493162|FG001|Overall Study|Completed treatment|2|||
149003913|NCT01960725|537493163|FG000|Overall Study|Lost to Follow-up|4|||
149003914|NCT01960725|537493164|FG001|Overall Study|Lost to Follow-up|3|||
149003915|NCT01960725|537493163|FG000|Overall Study|Withdrawal by Subject|1|||
149003916|NCT01960725|537493164|FG001|Overall Study|Withdrawal by Subject|0|||
149003917|NCT01960725|537493163|FG000|Overall Study|unable to obtain blood sample|1|||
149003918|NCT01960725|537493164|FG001|Overall Study|unable to obtain blood sample|2|||
149003919|NCT02634788|537493169|FG000|Overall Study|Adverse Event|0|||
149003920|NCT02634788|537493170|FG001|Overall Study|Adverse Event|8|||
148880669|NCT04412707|537039851|FG001|Cycle 1|Disease progression|2|||
148880670|NCT04412707|537039850|FG000|Cycle 2|Death|0|||
148880671|NCT04412707|537039851|FG001|Cycle 2|Death|1|||
148880672|NCT04412707|537039850|FG000|Cycle 2|Disease progression|3|||
148880673|NCT04412707|537039851|FG001|Cycle 2|Disease progression|0|||
148880674|NCT04412707|537039850|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
148880675|NCT04412707|537039851|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
148880676|NCT04412707|537039850|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
148880677|NCT04412707|537039851|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
148880678|NCT04412707|537039850|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
149003921|NCT02634788|537493171|FG002|Overall Study|Adverse Event|3|||
149003922|NCT02634788|537493172|FG003|Overall Study|Adverse Event|1|||
149003923|NCT02634788|537493169|FG000|Overall Study|Lack of Efficacy|4|||
148880679|NCT04412707|537039851|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
148880680|NCT04412707|537039850|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
148880681|NCT04412707|537039851|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
148880682|NCT02927938|537039852|FG000|Overall Study|Death|0|||
148880683|NCT02927938|537039853|FG001|Overall Study|Death|1|||
148880684|NCT02927938|537039854|FG002|Overall Study|Death|0|||
148880685|NCT02927938|537039855|FG003|Overall Study|Death|4|||
148880686|NCT02927938|537039852|FG000|Overall Study|Early Study Termination|1|||
148880687|NCT02927938|537039853|FG001|Overall Study|Early Study Termination|5|||
148880688|NCT02927938|537039854|FG002|Overall Study|Early Study Termination|4|||
148880689|NCT02927938|537039855|FG003|Overall Study|Early Study Termination|3|||
148880690|NCT02813889|537042331|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
148880691|NCT02813889|537042332|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
148880692|NCT04014062|537042336|FG000|Period I: Dosing|Medical Grounds|4|||
148880693|NCT04014062|537042337|FG001|Period I: Dosing|Medical Grounds|5|||
148880694|NCT04014062|537042336|FG000|Period I: Dosing|Withdrawal by Subject|3|||
148880695|NCT04014062|537042337|FG001|Period I: Dosing|Withdrawal by Subject|1|||
148880696|NCT03038126|537042338|FG000|Overall Study|Death|1|||
148880697|NCT03038126|537042339|FG001|Overall Study|Death|1|||
148880698|NCT03038126|537042338|FG000|Overall Study|Withdrawal by Subject|5|||
148880699|NCT03038126|537042339|FG001|Overall Study|Withdrawal by Subject|0|||
148880700|NCT03038126|537042338|FG000|Overall Study|Lost to Follow-up|0|||
148880701|NCT03038126|537042339|FG001|Overall Study|Lost to Follow-up|1|||
148880702|NCT03038126|537042338|FG000|Overall Study|Long Term Hospitalization|2|||
148880703|NCT03038126|537042339|FG001|Overall Study|Long Term Hospitalization|0|||
148880704|NCT03038126|537042338|FG000|Overall Study|Too Ill to Participate|1|||
148880705|NCT03038126|537042339|FG001|Overall Study|Too Ill to Participate|2|||
148880706|NCT02451917|537042340|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
148880707|NCT02451917|537042341|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
148880708|NCT02451917|537042340|FG000|First Intervention (24 Weeks)|Death|0|||
148880709|NCT02451917|537042341|FG001|First Intervention (24 Weeks)|Death|1|||
148880710|NCT02451917|537042340|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
148880711|NCT02451917|537042341|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
148880712|NCT01724866|537042342|FG000|Overall Study|Adverse Event|0|||
148880713|NCT01724866|537042343|FG001|Overall Study|Adverse Event|0|||
148880714|NCT01724866|537042344|FG002|Overall Study|Adverse Event|1|||
148880715|NCT01724866|537042345|FG003|Overall Study|Adverse Event|1|||
148880716|NCT01724866|537042342|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
148880717|NCT01724866|537042343|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
148880718|NCT01724866|537042344|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
148880719|NCT01724866|537042345|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
148880720|NCT01724866|537042342|FG000|Overall Study|Investigator's Discretion|0|||
148880721|NCT01724866|537042343|FG001|Overall Study|Investigator's Discretion|1|||
148880722|NCT01724866|537042344|FG002|Overall Study|Investigator's Discretion|1|||
148880723|NCT01724866|537042345|FG003|Overall Study|Investigator's Discretion|0|||
148880724|NCT01724866|537042342|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
148880725|NCT01724866|537042343|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
148880726|NCT01724866|537042344|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
148880727|NCT01724866|537042345|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
148880728|NCT01724866|537042342|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
148880729|NCT01724866|537042343|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
148880730|NCT01724866|537042344|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
148880731|NCT01724866|537042345|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
148880732|NCT00411671|537042348|FG000|Overall Study|Adverse Event|15|||
148880733|NCT00411671|537042348|FG000|Overall Study|Death|2|||
148880734|NCT00411671|537042348|FG000|Overall Study|Lost to Follow-up|3|||
148880735|NCT01424501|537042349|FG000|Overall Study|Withdrawal by Subject|1|||
148880736|NCT01424501|537042350|FG001|Overall Study|Withdrawal by Subject|0|||
148880737|NCT01424501|537042351|FG002|Overall Study|Withdrawal by Subject|1|||
148880738|NCT01424501|537042352|FG003|Overall Study|Withdrawal by Subject|0|||
148880739|NCT01424501|537042353|FG004|Overall Study|Withdrawal by Subject|0|||
148880740|NCT01424501|537042354|FG005|Overall Study|Withdrawal by Subject|0|||
148880741|NCT01424501|537042349|FG000|Overall Study|Lost to Follow-up|0|||
148880742|NCT01424501|537042350|FG001|Overall Study|Lost to Follow-up|1|||
148880743|NCT01424501|537042351|FG002|Overall Study|Lost to Follow-up|1|||
148880744|NCT01424501|537042352|FG003|Overall Study|Lost to Follow-up|0|||
149003924|NCT02634788|537493170|FG001|Overall Study|Lack of Efficacy|0|||
148880745|NCT01424501|537042353|FG004|Overall Study|Lost to Follow-up|0|||
148880746|NCT01424501|537042354|FG005|Overall Study|Lost to Follow-up|0|||
148880747|NCT01980095|537042355|FG000|Overall Study|Lost to Follow-up|6|||
148880748|NCT01980095|537042356|FG001|Overall Study|Lost to Follow-up|7|||
148880749|NCT01980095|537042355|FG000|Overall Study|Withdrawal by Subject|2|||
148880750|NCT01980095|537042356|FG001|Overall Study|Withdrawal by Subject|3|||
148880751|NCT01980095|537042355|FG000|Overall Study|Poor compliance|5|||
148880752|NCT01980095|537042356|FG001|Overall Study|Poor compliance|0|||
148880753|NCT01980095|537042355|FG000|Overall Study|Safety issue|0|||
148880754|NCT01980095|537042356|FG001|Overall Study|Safety issue|1|||
148880755|NCT01980095|537042355|FG000|Overall Study|Study drug discontinued|1|||
148880756|NCT01980095|537042356|FG001|Overall Study|Study drug discontinued|0|||
148880757|NCT01980095|537042355|FG000|Overall Study|Randomized by mistake|1|||
148880758|NCT01980095|537042356|FG001|Overall Study|Randomized by mistake|0|||
148880759|NCT02837029|537042363|FG000|Screening|Failed to meet screening requirements.|7|||
148880760|NCT02837029|537042364|FG001|Screening|Failed to meet screening requirements.|3|||
148880761|NCT02837029|537042365|FG002|Screening|Failed to meet screening requirements.|0|||
148880762|NCT02837029|537042363|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
148880763|NCT02837029|537042364|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
148880764|NCT02837029|537042365|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
148880765|NCT02837029|537042363|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
148880766|NCT02837029|537042364|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
148880767|NCT02837029|537042365|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
148880768|NCT02837029|537042363|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
148880769|NCT02837029|537042364|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
148880770|NCT02837029|537042365|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
148880771|NCT02837029|537042363|FG000|Cycle 2 and Beyond|Adverse Event|1|||
148880772|NCT02837029|537042364|FG001|Cycle 2 and Beyond|Adverse Event|0|||
148880773|NCT02837029|537042365|FG002|Cycle 2 and Beyond|Adverse Event|0|||
148880774|NCT02837029|537042363|FG000|2 Year Follow-up|Death|6|||
148880775|NCT02837029|537042364|FG001|2 Year Follow-up|Death|7|||
148880776|NCT02837029|537042365|FG002|2 Year Follow-up|Death|0|||
148880777|NCT02034877|537042368|FG000|Overall Study|Lost to Follow-up|0|||
148880778|NCT02034877|537042369|FG001|Overall Study|Lost to Follow-up|3|||
148880779|NCT02034877|537042368|FG000|Overall Study|No Longer Willing to Participate|0|||
148880780|NCT02034877|537042369|FG001|Overall Study|No Longer Willing to Participate|3|||
148880781|NCT00394706|537042375|FG000|Overall Study|Withdrawal by Subject|2|||
148880782|NCT00394706|537042376|FG001|Overall Study|Withdrawal by Subject|0|||
148880783|NCT00394706|537042377|FG002|Overall Study|Withdrawal by Subject|1|||
148880784|NCT00394706|537042378|FG003|Overall Study|Withdrawal by Subject|0|||
148880785|NCT00394706|537042379|FG004|Overall Study|Withdrawal by Subject|0|||
148880786|NCT00394706|537042380|FG005|Overall Study|Withdrawal by Subject|2|||
148880787|NCT00394706|537042381|FG006|Overall Study|Withdrawal by Subject|1|||
148880788|NCT00394706|537042382|FG007|Overall Study|Withdrawal by Subject|0|||
148880789|NCT00394706|537042375|FG000|Overall Study|Lost to Follow-up|2|||
148880790|NCT00394706|537042376|FG001|Overall Study|Lost to Follow-up|2|||
148880791|NCT00394706|537042377|FG002|Overall Study|Lost to Follow-up|8|||
148880792|NCT00394706|537042378|FG003|Overall Study|Lost to Follow-up|1|||
148880793|NCT00394706|537042379|FG004|Overall Study|Lost to Follow-up|2|||
148880794|NCT00394706|537042380|FG005|Overall Study|Lost to Follow-up|5|||
148880795|NCT00394706|537042381|FG006|Overall Study|Lost to Follow-up|2|||
148880796|NCT00394706|537042382|FG007|Overall Study|Lost to Follow-up|0|||
148880797|NCT00100789|537042383|FG000|Overall Study|Adverse Event|10|||
148880798|NCT00100789|537042383|FG000|Overall Study|Withdrawal by Subject|1|||
148880799|NCT00100789|537042383|FG000|Overall Study|Progression/relapse|42|||
148880800|NCT00100789|537042383|FG000|Overall Study|Death|2|||
148880801|NCT00100789|537042383|FG000|Overall Study|Not protocol specified|5|||
148880802|NCT00100789|537042383|FG000|Overall Study|Ineligible|3|||
148880803|NCT00100789|537042383|FG000|Overall Study|Never received treatment|1|||
148880804|NCT03472950|537042384|FG000|Overall Study|Lost to Follow-up|0|||
148880805|NCT03472950|537042385|FG001|Overall Study|Lost to Follow-up|1|||
148880806|NCT03472950|537042384|FG000|Overall Study|Adverse Event|0|||
148880807|NCT03472950|537042385|FG001|Overall Study|Adverse Event|3|||
148880808|NCT02506192|537042389|FG000|Overall Study|Withdrawal by Subject|1|||
148880809|NCT02506192|537042390|FG001|Overall Study|Withdrawal by Subject|1|||
149003925|NCT02634788|537493171|FG002|Overall Study|Lack of Efficacy|1|||
149003926|NCT02634788|537493172|FG003|Overall Study|Lack of Efficacy|4|||
149003927|NCT02634788|537493169|FG000|Overall Study|Lost to Follow-up|0|||
148880810|NCT01685697|537042391|FG000|Overall Study|Protocol Violation|3|||
148880811|NCT01685697|537042392|FG001|Overall Study|Protocol Violation|3|||
148880812|NCT02703324|537042393|FG000|Period Two|Withdrawal by Subject|0|||
148880813|NCT02703324|537042394|FG001|Period Two|Withdrawal by Subject|0|||
148880814|NCT02703324|537042395|FG002|Period Two|Withdrawal by Subject|1|||
148880815|NCT02703324|537042396|FG003|Period Two|Withdrawal by Subject|0|||
148880816|NCT02703324|537042397|FG004|Period Two|Withdrawal by Subject|0|||
148880817|NCT02703324|537042398|FG005|Period Two|Withdrawal by Subject|0|||
148880818|NCT03705559|537042400|FG000|Overall Study|COVID Shut down|1|||
149003928|NCT02634788|537493170|FG001|Overall Study|Lost to Follow-up|1|||
148880819|NCT00195091|537042401|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
148880820|NCT01979952|537042411|FG000|Overall Study|Adverse Event|4|||
148880821|NCT01979952|537042412|FG001|Overall Study|Adverse Event|5|||
148880822|NCT01979952|537042411|FG000|Overall Study|Protocol Violation|1|||
148880823|NCT01979952|537042412|FG001|Overall Study|Protocol Violation|0|||
148880824|NCT01979952|537042411|FG000|Overall Study|Withdrawal by Subject|2|||
148880825|NCT01979952|537042412|FG001|Overall Study|Withdrawal by Subject|1|||
148880826|NCT01979952|537042411|FG000|Overall Study|Other than specified above|1|||
148880827|NCT01979952|537042412|FG001|Overall Study|Other than specified above|0|||
148880828|NCT00475709|537042417|FG000|Overall Study|Did not meet eligibility criteria|8|||
148880829|NCT00475709|537042417|FG000|Overall Study|Death|41|||
148880830|NCT00475709|537042417|FG000|Overall Study|Device Explant|6|||
148880831|NCT00475709|537042417|FG000|Overall Study|Lost to Follow-up|21|||
148880832|NCT03364738|537042428|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
148880833|NCT03364738|537042428|FG000|Overall Study|Withdrawal by Subject|1|||
148880834|NCT03364738|537042428|FG000|Overall Study|Adverse Event|1|||
148880835|NCT03245398|537042429|FG000|Overall Study|Travelled to another island|1|||
148880836|NCT03245398|537042430|FG001|Overall Study|Travelled to another island|0|||
148880837|NCT04079816|537042431|FG000|Overall Study|Request of Subject|2|||
148880838|NCT04079816|537042431|FG000|Overall Study|Unable to draw samples|1|||
148880839|NCT04531241|537042432|FG000|Period 1|Withdrawal by Subject|2|||
148880840|NCT04531241|537042433|FG001|Period 1|Withdrawal by Subject|0|||
148880841|NCT04531241|537042432|FG000|Period 1|Dispesed incorrect lens power|1|||
148880842|NCT04531241|537042433|FG001|Period 1|Dispesed incorrect lens power|0|||
148880843|NCT04531241|537042432|FG000|Period 1|Protocol Violation|1|||
148880844|NCT04531241|537042433|FG001|Period 1|Protocol Violation|0|||
148880845|NCT04531241|537042432|FG000|Period 1|No longer eligible|0|||
148880846|NCT04531241|537042433|FG001|Period 1|No longer eligible|1|||
148880847|NCT04531241|537042432|FG000|Period 1|Lens Discomfort|0|||
148880848|NCT04531241|537042433|FG001|Period 1|Lens Discomfort|1|||
148880849|NCT04531241|537042432|FG000|Period 2|Covid-19 Related|1|||
148880850|NCT04531241|537042433|FG001|Period 2|Covid-19 Related|1|||
148880851|NCT02576795|537042434|FG000|Overall Study|Lost to Follow-up|0|||
148880852|NCT02576795|537042435|FG001|Overall Study|Lost to Follow-up|0|||
148880853|NCT02576795|537042436|FG002|Overall Study|Lost to Follow-up|1|||
148880854|NCT02576795|537042437|FG003|Overall Study|Lost to Follow-up|0|||
148880855|NCT01702246|537042438|FG000|Overall Study|Lost to Follow-up|2|||
148880856|NCT01702246|537042438|FG000|Overall Study|Withdrawal by Subject|2|||
148880857|NCT01702246|537042438|FG000|Overall Study|Physician Decision|1|||
148880858|NCT03724890|537042439|FG000|Overall Study|Death|2|||
148880859|NCT03724890|537042440|FG001|Overall Study|Death|6|||
148880860|NCT03724890|537042441|FG002|Overall Study|Death|3|||
148880861|NCT03724890|537042442|FG003|Overall Study|Death|5|||
148880862|NCT03724890|537042443|FG004|Overall Study|Death|2|||
148880863|NCT03724890|537042444|FG005|Overall Study|Death|0|||
148880864|NCT03724890|537042445|FG006|Overall Study|Death|2|||
148880865|NCT03724890|537042446|FG007|Overall Study|Death|3|||
148880866|NCT03724890|537042447|FG008|Overall Study|Death|4|||
148880867|NCT03724890|537042448|FG009|Overall Study|Death|2|||
148880868|NCT03724890|537042449|FG010|Overall Study|Death|2|||
148880869|NCT03724890|537042439|FG000|Overall Study|Lost to Follow-up|0|||
148880870|NCT03724890|537042440|FG001|Overall Study|Lost to Follow-up|3|||
148880871|NCT03724890|537042441|FG002|Overall Study|Lost to Follow-up|0|||
148880872|NCT03724890|537042442|FG003|Overall Study|Lost to Follow-up|1|||
148880873|NCT03724890|537042443|FG004|Overall Study|Lost to Follow-up|2|||
148880874|NCT03724890|537042444|FG005|Overall Study|Lost to Follow-up|2|||
148880875|NCT03724890|537042445|FG006|Overall Study|Lost to Follow-up|1|||
148880876|NCT03724890|537042446|FG007|Overall Study|Lost to Follow-up|0|||
148880877|NCT03724890|537042447|FG008|Overall Study|Lost to Follow-up|2|||
148880878|NCT03724890|537042448|FG009|Overall Study|Lost to Follow-up|0|||
148880879|NCT03724890|537042449|FG010|Overall Study|Lost to Follow-up|0|||
148880880|NCT03724890|537042439|FG000|Overall Study|Withdrawal by Subject|1|||
148880881|NCT03724890|537042440|FG001|Overall Study|Withdrawal by Subject|2|||
148880882|NCT03724890|537042441|FG002|Overall Study|Withdrawal by Subject|1|||
148880883|NCT03724890|537042442|FG003|Overall Study|Withdrawal by Subject|0|||
148880884|NCT03724890|537042443|FG004|Overall Study|Withdrawal by Subject|0|||
148880885|NCT03724890|537042444|FG005|Overall Study|Withdrawal by Subject|1|||
148880886|NCT03724890|537042445|FG006|Overall Study|Withdrawal by Subject|0|||
148880887|NCT03724890|537042446|FG007|Overall Study|Withdrawal by Subject|0|||
148880888|NCT03724890|537042447|FG008|Overall Study|Withdrawal by Subject|2|||
148880889|NCT03724890|537042448|FG009|Overall Study|Withdrawal by Subject|2|||
148880890|NCT03724890|537042449|FG010|Overall Study|Withdrawal by Subject|1|||
148880891|NCT03724890|537042439|FG000|Overall Study|Other|1|||
148880892|NCT03724890|537042440|FG001|Overall Study|Other|0|||
148880893|NCT03724890|537042441|FG002|Overall Study|Other|0|||
148880894|NCT03724890|537042442|FG003|Overall Study|Other|0|||
148880895|NCT03724890|537042443|FG004|Overall Study|Other|0|||
148880896|NCT03724890|537042444|FG005|Overall Study|Other|0|||
148880897|NCT03724890|537042445|FG006|Overall Study|Other|0|||
148880898|NCT03724890|537042446|FG007|Overall Study|Other|1|||
148880899|NCT03724890|537042447|FG008|Overall Study|Other|1|||
148880900|NCT03724890|537042448|FG009|Overall Study|Other|0|||
148880901|NCT03724890|537042449|FG010|Overall Study|Other|2|||
148880902|NCT03400176|537042460|FG000|Dose Escalation|Progressive disease|1|||
148880903|NCT03400176|537042461|FG001|Dose Escalation|Progressive disease|1|||
148880904|NCT03400176|537042462|FG002|Dose Escalation|Progressive disease|0|||
148880905|NCT03400176|537042463|FG003|Dose Escalation|Progressive disease|0|||
148880906|NCT03400176|537042464|FG004|Dose Escalation|Progressive disease|1|||
148880907|NCT03400176|537042460|FG000|Dose Escalation|Patient decision|0|||
148880908|NCT03400176|537042461|FG001|Dose Escalation|Patient decision|0|||
148880909|NCT03400176|537042462|FG002|Dose Escalation|Patient decision|0|||
148880910|NCT03400176|537042463|FG003|Dose Escalation|Patient decision|0|||
148880911|NCT03400176|537042464|FG004|Dose Escalation|Patient decision|1|||
148880912|NCT03400176|537042460|FG000|Dose Expansion|Patient decision|0|||
148880913|NCT03400176|537042461|FG001|Dose Expansion|Patient decision|0|||
148880914|NCT03400176|537042462|FG002|Dose Expansion|Patient decision|0|||
148880915|NCT03400176|537042463|FG003|Dose Expansion|Patient decision|1|||
148880916|NCT03400176|537042464|FG004|Dose Expansion|Patient decision|0|||
148880917|NCT03400176|537042460|FG000|Dose Expansion|Adverse Event|0|||
148880918|NCT03400176|537042461|FG001|Dose Expansion|Adverse Event|0|||
148880919|NCT03400176|537042462|FG002|Dose Expansion|Adverse Event|0|||
148880920|NCT03400176|537042463|FG003|Dose Expansion|Adverse Event|1|||
148880921|NCT03400176|537042464|FG004|Dose Expansion|Adverse Event|0|||
148880922|NCT03400176|537042460|FG000|Dose Expansion|Physician Decision|0|||
148880923|NCT03400176|537042461|FG001|Dose Expansion|Physician Decision|0|||
148880924|NCT03400176|537042462|FG002|Dose Expansion|Physician Decision|0|||
148880925|NCT03400176|537042463|FG003|Dose Expansion|Physician Decision|1|||
148880926|NCT03400176|537042464|FG004|Dose Expansion|Physician Decision|0|||
148880927|NCT03400176|537042460|FG000|Dose Expansion|Progressive disease|0|||
148880928|NCT03400176|537042461|FG001|Dose Expansion|Progressive disease|0|||
148880929|NCT03400176|537042462|FG002|Dose Expansion|Progressive disease|1|||
148880930|NCT03400176|537042463|FG003|Dose Expansion|Progressive disease|1|||
148880931|NCT03400176|537042464|FG004|Dose Expansion|Progressive disease|0|||
148880932|NCT02104947|537042469|FG000|Overall Study|Withdrawal by Subject|10|||
148880933|NCT02104947|537042470|FG001|Overall Study|Withdrawal by Subject|3|||
148880934|NCT02104947|537042469|FG000|Overall Study|Lost to Follow-up|4|||
148880935|NCT02104947|537042470|FG001|Overall Study|Lost to Follow-up|4|||
148880936|NCT02104947|537042469|FG000|Overall Study|Protocol Violation|6|||
148880937|NCT02104947|537042470|FG001|Overall Study|Protocol Violation|8|||
148880938|NCT02104947|537042469|FG000|Overall Study|Adverse Event|57|||
148880939|NCT02104947|537042470|FG001|Overall Study|Adverse Event|38|||
148880940|NCT02104947|537042469|FG000|Overall Study|Other than stated above|2|||
148880941|NCT02104947|537042470|FG001|Overall Study|Other than stated above|3|||
148880942|NCT01090063|537042471|FG000|Screen|Screen Failed|4|||
148880943|NCT01090063|537042471|FG000|Treatment|Withdrawal by Subject|4|||
148880944|NCT03216746|537042475|FG000|Overall Study|Lost to Follow-up|6|||
148880945|NCT03216746|537042476|FG001|Overall Study|Lost to Follow-up|8|||
148880946|NCT03216746|537042477|FG002|Overall Study|Lost to Follow-up|5|||
148880947|NCT03216746|537042478|FG003|Overall Study|Lost to Follow-up|6|||
148880948|NCT01320202|537042479|FG000|Overall Study|Adverse Event|5|||
148880949|NCT01320202|537042480|FG001|Overall Study|Adverse Event|5|||
148880950|NCT01320202|537042479|FG000|Overall Study|Death|5|||
148880951|NCT01320202|537042480|FG001|Overall Study|Death|3|||
148880952|NCT01320202|537042479|FG000|Overall Study|Lost to Follow-up|1|||
148880953|NCT01320202|537042480|FG001|Overall Study|Lost to Follow-up|0|||
148880954|NCT01320202|537042479|FG000|Overall Study|Physician Decision|3|||
148880955|NCT01320202|537042480|FG001|Overall Study|Physician Decision|1|||
148880956|NCT01320202|537042479|FG000|Overall Study|Protocol Violation|2|||
148880957|NCT01320202|537042480|FG001|Overall Study|Protocol Violation|1|||
148880958|NCT01320202|537042479|FG000|Overall Study|Withdrawal by Subject|10|||
148880959|NCT01320202|537042480|FG001|Overall Study|Withdrawal by Subject|3|||
148880960|NCT01320202|537042479|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
148880961|NCT01320202|537042480|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
148880962|NCT01320202|537042479|FG000|Overall Study|kidney transplant|1|||
148880963|NCT01320202|537042480|FG001|Overall Study|kidney transplant|2|||
148880964|NCT01320202|537042479|FG000|Overall Study|blood transfusion|1|||
148880965|NCT01320202|537042480|FG001|Overall Study|blood transfusion|7|||
149003929|NCT02634788|537493171|FG002|Overall Study|Lost to Follow-up|0|||
149003930|NCT02634788|537493172|FG003|Overall Study|Lost to Follow-up|0|||
148880966|NCT01320202|537042479|FG000|Overall Study|moved/changed dialysis|5|||
148880967|NCT01320202|537042480|FG001|Overall Study|moved/changed dialysis|2|||
148880968|NCT01320202|537042479|FG000|Overall Study|sponsor request|2|||
148880969|NCT01320202|537042480|FG001|Overall Study|sponsor request|0|||
148880970|NCT01320202|537042479|FG000|Overall Study|ineligible|3|||
148880971|NCT01320202|537042480|FG001|Overall Study|ineligible|0|||
148880972|NCT01320202|537042479|FG000|Overall Study|regained renal function|1|||
148880973|NCT01320202|537042480|FG001|Overall Study|regained renal function|0|||
148880974|NCT00635882|537042481|FG000|Overall Study|Protocol Violation|1|||
148880975|NCT00635882|537042482|FG001|Overall Study|Protocol Violation|0|||
148880976|NCT00635882|537042483|FG002|Overall Study|Protocol Violation|0|||
148880977|NCT00635882|537042484|FG003|Overall Study|Protocol Violation|0|||
148880978|NCT00635882|537042485|FG004|Overall Study|Protocol Violation|0|||
148880979|NCT00635882|537042486|FG005|Overall Study|Protocol Violation|0|||
148880980|NCT04090242|537042487|FG000|Overall Study|Withdrawal by Subject|1|||
148880981|NCT04090242|537042488|FG001|Overall Study|Withdrawal by Subject|0|||
148880982|NCT02305238|537042489|FG000|Overall Study|Death|2|||
148880983|NCT02305238|537042490|FG001|Overall Study|Death|1|||
148880984|NCT02305238|537042491|FG002|Overall Study|Death|0|||
148880985|NCT02305238|537042489|FG000|Overall Study|Progressive disease|4|||
148880986|NCT02305238|537042490|FG001|Overall Study|Progressive disease|4|||
148880987|NCT02305238|537042491|FG002|Overall Study|Progressive disease|0|||
148880988|NCT02305238|537042489|FG000|Overall Study|Logistical difficulties|1|||
148880989|NCT02305238|537042490|FG001|Overall Study|Logistical difficulties|3|||
148880990|NCT02305238|537042491|FG002|Overall Study|Logistical difficulties|0|||
148880991|NCT02305238|537042489|FG000|Overall Study|Protocol Violation|0|||
148880992|NCT02305238|537042490|FG001|Overall Study|Protocol Violation|3|||
148880993|NCT02305238|537042491|FG002|Overall Study|Protocol Violation|0|||
148880994|NCT02305238|537042489|FG000|Overall Study|Physician Decision|2|||
148880995|NCT02305238|537042490|FG001|Overall Study|Physician Decision|1|||
148880996|NCT02305238|537042491|FG002|Overall Study|Physician Decision|0|||
148880997|NCT02305238|537042489|FG000|Overall Study|Adverse Event|4|||
148880998|NCT02305238|537042490|FG001|Overall Study|Adverse Event|2|||
148880999|NCT02305238|537042491|FG002|Overall Study|Adverse Event|0|||
148881000|NCT02305238|537042489|FG000|Overall Study|Withdrawal by Subject|3|||
148881001|NCT02305238|537042490|FG001|Overall Study|Withdrawal by Subject|4|||
148881002|NCT02305238|537042491|FG002|Overall Study|Withdrawal by Subject|0|||
148881003|NCT02305238|537042489|FG000|Overall Study|Randomized failure|0|||
148881004|NCT02305238|537042490|FG001|Overall Study|Randomized failure|0|||
148881005|NCT02305238|537042491|FG002|Overall Study|Randomized failure|8|||
148881006|NCT02305238|537042489|FG000|Overall Study|Required procedure failed|0|||
148881007|NCT02305238|537042490|FG001|Overall Study|Required procedure failed|1|||
148881008|NCT02305238|537042491|FG002|Overall Study|Required procedure failed|0|||
148881009|NCT01019369|537042492|FG000|Overall Study|Lost to Follow-up|10|||
148881010|NCT01019369|537042493|FG001|Overall Study|Lost to Follow-up|6|||
148881011|NCT01019369|537042492|FG000|Overall Study|Withdrawal by Subject|0|||
148881012|NCT01019369|537042493|FG001|Overall Study|Withdrawal by Subject|1|||
148881013|NCT02513472|537042494|FG000|Overall Study|Radiological Disease Progression|45|||
148881014|NCT02513472|537042495|FG001|Overall Study|Radiological Disease Progression|57|||
148881015|NCT02513472|537042494|FG000|Overall Study|Clinical Disease Progression|5|||
148881016|NCT02513472|537042495|FG001|Overall Study|Clinical Disease Progression|13|||
148881017|NCT02513472|537042494|FG000|Overall Study|Adverse Event|8|||
148881018|NCT02513472|537042495|FG001|Overall Study|Adverse Event|11|||
148881019|NCT02513472|537042494|FG000|Overall Study|Withdrawal by Subject|0|||
148881020|NCT02513472|537042495|FG001|Overall Study|Withdrawal by Subject|4|||
148881021|NCT02513472|537042494|FG000|Overall Study|Subject Choice|2|||
148881022|NCT02513472|537042495|FG001|Overall Study|Subject Choice|7|||
148881023|NCT02513472|537042494|FG000|Overall Study|Treatment Completed as per Protocol|3|||
148881024|NCT02513472|537042495|FG001|Overall Study|Treatment Completed as per Protocol|3|||
148881025|NCT02513472|537042494|FG000|Overall Study|Other|3|||
148881026|NCT02513472|537042495|FG001|Overall Study|Other|6|||
148881027|NCT01711645|537042498|FG000|Overall Study|Withdrawal by Subject|8|||
148881028|NCT01711645|537042498|FG000|Overall Study|Lost to Follow-up|6|||
148881029|NCT01711645|537042498|FG000|Overall Study|Physician Decision|5|||
148881030|NCT00408434|537042499|FG000|Overall Study|Adverse Event|0|||
148881031|NCT00408434|537042500|FG001|Overall Study|Adverse Event|0|||
148881032|NCT00408434|537042501|FG002|Overall Study|Adverse Event|1|||
148881033|NCT00408434|537042502|FG003|Overall Study|Adverse Event|0|||
148881034|NCT00408434|537042503|FG004|Overall Study|Adverse Event|0|||
148881035|NCT00408434|537042504|FG005|Overall Study|Adverse Event|0|||
148881036|NCT00408434|537042505|FG006|Overall Study|Adverse Event|0|||
148881037|NCT00408434|537042499|FG000|Overall Study|Progressive disease|6|||
148881038|NCT00408434|537042500|FG001|Overall Study|Progressive disease|3|||
148881039|NCT00408434|537042501|FG002|Overall Study|Progressive disease|4|||
148881040|NCT00408434|537042502|FG003|Overall Study|Progressive disease|3|||
148881041|NCT00408434|537042503|FG004|Overall Study|Progressive disease|3|||
148881042|NCT00408434|537042504|FG005|Overall Study|Progressive disease|1|||
148881043|NCT00408434|537042505|FG006|Overall Study|Progressive disease|4|||
148881044|NCT00408434|537042499|FG000|Overall Study|Other|0|||
148881045|NCT00408434|537042500|FG001|Overall Study|Other|0|||
149038671|NCT03215927|537620474|FG001|Open Label Extension|Lack of Efficacy|0|||
148881046|NCT00408434|537042501|FG002|Overall Study|Other|1|||
148881047|NCT00408434|537042502|FG003|Overall Study|Other|0|||
148881048|NCT00408434|537042503|FG004|Overall Study|Other|2|||
148881049|NCT00408434|537042504|FG005|Overall Study|Other|1|||
148881050|NCT00408434|537042505|FG006|Overall Study|Other|0|||
148881051|NCT00408434|537042499|FG000|Overall Study|Terminated by Investigator|0|||
148881052|NCT00408434|537042500|FG001|Overall Study|Terminated by Investigator|0|||
148881053|NCT00408434|537042501|FG002|Overall Study|Terminated by Investigator|0|||
148881054|NCT00408434|537042502|FG003|Overall Study|Terminated by Investigator|0|||
148881055|NCT00408434|537042503|FG004|Overall Study|Terminated by Investigator|1|||
148881056|NCT00408434|537042504|FG005|Overall Study|Terminated by Investigator|1|||
148881057|NCT00408434|537042505|FG006|Overall Study|Terminated by Investigator|0|||
148881058|NCT00588354|537042506|FG000|Baseline to 2 Weeks|Adverse Event|1|||
148881059|NCT00588354|537042507|FG001|Baseline to 2 Weeks|Adverse Event|0|||
148881060|NCT00588354|537042506|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
148881061|NCT00588354|537042507|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
148881062|NCT00588354|537042506|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
148881063|NCT00588354|537042507|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
148881064|NCT04230213|537042516|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
148881065|NCT04230213|537042517|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
148881066|NCT04230213|537042518|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
148881067|NCT04230213|537042516|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
148881068|NCT04230213|537042517|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
148881069|NCT04230213|537042518|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
148881070|NCT04230213|537042516|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
148881071|NCT04230213|537042517|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
148881072|NCT04230213|537042518|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
148881073|NCT04230213|537042516|FG000|TP2: Week 10 to Week 16|Other|0|||
148881074|NCT04230213|537042517|FG001|TP2: Week 10 to Week 16|Other|2|||
148881075|NCT04230213|537042518|FG002|TP2: Week 10 to Week 16|Other|1|||
148881076|NCT04230213|537042516|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
148881077|NCT04230213|537042517|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
148881078|NCT04230213|537042518|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
148881079|NCT04230213|537042516|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
148881080|NCT04230213|537042517|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
148881081|NCT04230213|537042518|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
148881082|NCT04230213|537042516|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
148881083|NCT04230213|537042517|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
148881084|NCT04230213|537042518|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
148881085|NCT04230213|537042516|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
148881086|NCT04230213|537042517|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
148881087|NCT04230213|537042518|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
148881088|NCT04230213|537042516|FG000|TP3: Week 16 to Week 22|Other|0|||
148881089|NCT04230213|537042517|FG001|TP3: Week 16 to Week 22|Other|1|||
148881090|NCT04230213|537042518|FG002|TP3: Week 16 to Week 22|Other|3|||
148881091|NCT04230213|537042516|FG000|TP4: Week 22 to Week 32|Other|0|||
148881092|NCT04230213|537042517|FG001|TP4: Week 22 to Week 32|Other|5|||
148881093|NCT04230213|537042518|FG002|TP4: Week 22 to Week 32|Other|5|||
148881094|NCT04230213|537042516|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
148881095|NCT04230213|537042517|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
148881096|NCT04230213|537042518|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
148881097|NCT04230213|537042516|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
148881098|NCT04230213|537042517|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
148881099|NCT04230213|537042518|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
148881100|NCT04230213|537042516|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
148881101|NCT04230213|537042517|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
148881102|NCT04230213|537042518|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
148881103|NCT04230213|537042516|FG000|Follow up: Week 32 to Week 36|Other|0|||
148881104|NCT04230213|537042517|FG001|Follow up: Week 32 to Week 36|Other|1|||
148881105|NCT04230213|537042518|FG002|Follow up: Week 32 to Week 36|Other|1|||
148881106|NCT02476006|537042538|FG000|Overall Study|Death|4|||
148881107|NCT02476006|537042538|FG000|Overall Study|Lack of treatment efficacy|2|||
148881108|NCT02476006|537042538|FG000|Overall Study|Pregnancy|1|||
148881109|NCT02476006|537042538|FG000|Overall Study|Participant did not wish to continue|39|||
148881110|NCT02476006|537042538|FG000|Overall Study|Adverse Event|41|||
148881111|NCT02476006|537042538|FG000|Overall Study|Poor compliance to study protocol|3|||
148881112|NCT02476006|537042538|FG000|Overall Study|Sponsor decision|6|||
148881113|NCT02476006|537042538|FG000|Overall Study|Lost to Follow-up|5|||
148881114|NCT02476006|537042538|FG000|Overall Study|Physician Decision|5|||
148881115|NCT02476006|537042538|FG000|Overall Study|Study ended treatment not available|4|||
148881116|NCT02476006|537042538|FG000|Overall Study|Switched to commercial drug|4|||
148881117|NCT02476006|537042538|FG000|Overall Study|Excluded from study|1|||
149003931|NCT02634788|537493169|FG000|Overall Study|Withdrawal by Subject|0|||
149003932|NCT02634788|537493170|FG001|Overall Study|Withdrawal by Subject|1|||
149003933|NCT02634788|537493171|FG002|Overall Study|Withdrawal by Subject|1|||
149003934|NCT02634788|537493172|FG003|Overall Study|Withdrawal by Subject|0|||
149003935|NCT00758459|537493173|FG000|Overall Study|Adverse Event|3|||
149003936|NCT00758459|537493174|FG001|Overall Study|Adverse Event|2|||
149003937|NCT00758459|537493173|FG000|Overall Study|Protocol Violation|0|||
149003938|NCT00758459|537493174|FG001|Overall Study|Protocol Violation|1|||
148881118|NCT02476006|537042538|FG000|Overall Study|Protocol Violation|1|||
148881119|NCT02476006|537042538|FG000|Overall Study|Enrolled but not treated|4|||
148881120|NCT03058692|537043744|FG000|Overall Study|Lost to Follow-up|2|||
148881121|NCT03058692|537043745|FG001|Overall Study|Lost to Follow-up|1|||
148881122|NCT03058692|537043744|FG000|Overall Study|Withdrawal by Subject|1|||
148881123|NCT03058692|537043745|FG001|Overall Study|Withdrawal by Subject|1|||
148881124|NCT00806988|537043746|FG000|Overall Study|Death|15|||
149003939|NCT00758459|537493173|FG000|Overall Study|Withdrawal by Subject|0|||
148881125|NCT00806988|537043747|FG001|Overall Study|Death|16|||
148881126|NCT00806988|537043746|FG000|Overall Study|Withdrawal by Subject|8|||
148881127|NCT00806988|537043747|FG001|Overall Study|Withdrawal by Subject|8|||
148881128|NCT00806988|537043746|FG000|Overall Study|Lost to Follow-up|4|||
148881129|NCT00806988|537043747|FG001|Overall Study|Lost to Follow-up|19|||
148881130|NCT04775953|537043749|FG000|Overall Study|Lost to Follow-up|6|||
148881131|NCT04775953|537043750|FG001|Overall Study|Lost to Follow-up|11|||
148881132|NCT04775953|537043749|FG000|Overall Study|Death|5|||
148881133|NCT04775953|537043750|FG001|Overall Study|Death|4|||
148881134|NCT04775953|537043749|FG000|Overall Study|Withdrawal by Subject|3|||
148881135|NCT04775953|537043750|FG001|Overall Study|Withdrawal by Subject|3|||
148881136|NCT04775953|537043749|FG000|Overall Study|Protocol Violation|2|||
148881137|NCT04775953|537043750|FG001|Overall Study|Protocol Violation|0|||
148881138|NCT04775953|537043749|FG000|Overall Study|Participant non-compliance|0|||
148881139|NCT04775953|537043750|FG001|Overall Study|Participant non-compliance|1|||
148881140|NCT01698814|537043751|FG000|Overall Study|Adverse Event|0|||
148881141|NCT01698814|537043752|FG001|Overall Study|Adverse Event|2|||
148881142|NCT01698814|537043751|FG000|Overall Study|Lost to Follow-up|0|||
148881143|NCT01698814|537043752|FG001|Overall Study|Lost to Follow-up|1|||
148881144|NCT01698814|537043751|FG000|Overall Study|Pregnancy|1|||
148881145|NCT01698814|537043752|FG001|Overall Study|Pregnancy|0|||
148881146|NCT01698814|537043751|FG000|Overall Study|Randomized in error|1|||
148881147|NCT01698814|537043752|FG001|Overall Study|Randomized in error|0|||
148881148|NCT00855959|537043753|FG000|Overall Study|Adverse Event|2|||
148881149|NCT00855959|537043753|FG000|Overall Study|Lost to Follow-up|2|||
148881150|NCT00855959|537043753|FG000|Overall Study|Withdrawal by Subject|3|||
148881151|NCT00855959|537043753|FG000|Overall Study|Pregnancy|1|||
148881152|NCT00855959|537043753|FG000|Overall Study|Incorrect enrolment|1|||
148881153|NCT00368641|537043757|FG000|Overall Study|Adverse Event|2|||
148881154|NCT00368641|537043758|FG001|Overall Study|Adverse Event|1|||
148881155|NCT00368641|537043757|FG000|Overall Study|Death|1|||
148881156|NCT00368641|537043758|FG001|Overall Study|Death|0|||
148881157|NCT00368641|537043757|FG000|Overall Study|Withdrawal by Subject|1|||
148881158|NCT00368641|537043758|FG001|Overall Study|Withdrawal by Subject|0|||
148881159|NCT00368641|537043757|FG000|Overall Study|Sponsor decision to terminate study|2|||
148881160|NCT00368641|537043758|FG001|Overall Study|Sponsor decision to terminate study|5|||
148881161|NCT04737278|537043760|FG000|Overall Study|Lost to Follow-up|1|||
148881162|NCT04737278|537043761|FG001|Overall Study|Lost to Follow-up|1|||
148881163|NCT04737278|537043760|FG000|Overall Study|Withdrawal by Subject|1|||
148881164|NCT04737278|537043761|FG001|Overall Study|Withdrawal by Subject|0|||
148881165|NCT04737278|537043760|FG000|Overall Study|Protocol Violation|1|||
148881166|NCT04737278|537043761|FG001|Overall Study|Protocol Violation|1|||
148881167|NCT04737278|537043760|FG000|Overall Study|failure to complete questionnaire|1|||
148881168|NCT04737278|537043761|FG001|Overall Study|failure to complete questionnaire|1|||
148881169|NCT01128244|537043764|FG000|Overall Study|Adverse Event|1|||
148881170|NCT01128244|537043764|FG000|Overall Study|Scheduling conflict|2|||
148881171|NCT04506502|537043769|FG000|Overall Study|Withdrawal by Subject|1|||
148881172|NCT04506502|537043769|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
148881173|NCT01449006|537043770|FG000|Overall Study|Lost to Follow-up|1|||
148881174|NCT01449006|537043771|FG001|Overall Study|Lost to Follow-up|0|||
148881175|NCT01449006|537043770|FG000|Overall Study|Withdrawal by Subject|1|||
148881176|NCT01449006|537043771|FG001|Overall Study|Withdrawal by Subject|0|||
148881177|NCT01449006|537043770|FG000|Overall Study|Protocol Violation|1|||
148881178|NCT01449006|537043771|FG001|Overall Study|Protocol Violation|0|||
148881179|NCT03350815|537043772|FG000|Period 1|Adverse Event|10|||
148881180|NCT03350815|537043773|FG001|Period 1|Adverse Event|0|||
148881181|NCT03350815|537043774|FG002|Period 1|Adverse Event|0|||
148881182|NCT03350815|537043775|FG003|Period 1|Adverse Event|0|||
148881183|NCT03350815|537043772|FG000|Period 1|Technical problems|1|||
148881184|NCT03350815|537043773|FG001|Period 1|Technical problems|0|||
148881185|NCT03350815|537043774|FG002|Period 1|Technical problems|0|||
149003940|NCT00758459|537493174|FG001|Overall Study|Withdrawal by Subject|1|||
149003941|NCT01058304|537493187|FG000|Overall Study|Withdrawal by Subject|8|||
149003942|NCT01058304|537493188|FG001|Overall Study|Withdrawal by Subject|5|||
149003943|NCT01058304|537493187|FG000|Overall Study|Lost to Follow-up|13|||
149003944|NCT01058304|537493188|FG001|Overall Study|Lost to Follow-up|16|||
149003945|NCT01058304|537493187|FG000|Overall Study|Developed exclusion criterion|6|||
148881186|NCT03350815|537043775|FG003|Period 1|Technical problems|0|||
148881187|NCT03350815|537043772|FG000|Period 1|Lost to Follow-up|3|||
148881188|NCT03350815|537043773|FG001|Period 1|Lost to Follow-up|0|||
148881189|NCT03350815|537043774|FG002|Period 1|Lost to Follow-up|0|||
148881190|NCT03350815|537043775|FG003|Period 1|Lost to Follow-up|0|||
148881191|NCT03350815|537043772|FG000|Period 1|Physician Decision|1|||
148881192|NCT03350815|537043773|FG001|Period 1|Physician Decision|0|||
148881193|NCT03350815|537043774|FG002|Period 1|Physician Decision|0|||
148881194|NCT03350815|537043775|FG003|Period 1|Physician Decision|0|||
148881195|NCT03350815|537043772|FG000|Period 1|Withdrawal by Subject|8|||
148881196|NCT03350815|537043773|FG001|Period 1|Withdrawal by Subject|0|||
148881197|NCT03350815|537043774|FG002|Period 1|Withdrawal by Subject|0|||
148881198|NCT03350815|537043775|FG003|Period 1|Withdrawal by Subject|0|||
148881199|NCT03350815|537043772|FG000|Period 1|Lack of Efficacy|15|||
149038672|NCT03215927|537620473|FG000|Open Label Extension|Death|0|||
148881200|NCT03350815|537043773|FG001|Period 1|Lack of Efficacy|0|||
148881201|NCT03350815|537043774|FG002|Period 1|Lack of Efficacy|0|||
148881202|NCT03350815|537043775|FG003|Period 1|Lack of Efficacy|0|||
148881203|NCT03350815|537043772|FG000|Period 1|Non-compliance with study treatment|2|||
148881204|NCT03350815|537043773|FG001|Period 1|Non-compliance with study treatment|0|||
148881205|NCT03350815|537043774|FG002|Period 1|Non-compliance with study treatment|0|||
148881206|NCT03350815|537043775|FG003|Period 1|Non-compliance with study treatment|0|||
148881207|NCT03350815|537043772|FG000|Period 1|Protocol Violation|3|||
148881208|NCT03350815|537043773|FG001|Period 1|Protocol Violation|0|||
148881209|NCT03350815|537043774|FG002|Period 1|Protocol Violation|0|||
148881210|NCT03350815|537043775|FG003|Period 1|Protocol Violation|0|||
148881211|NCT03350815|537043772|FG000|Period 2|Adverse Event|0|||
148881212|NCT03350815|537043773|FG001|Period 2|Adverse Event|3|||
148881213|NCT03350815|537043774|FG002|Period 2|Adverse Event|5|||
148881214|NCT03350815|537043775|FG003|Period 2|Adverse Event|0|||
148881215|NCT03350815|537043772|FG000|Period 2|Technical problem|0|||
148881216|NCT03350815|537043773|FG001|Period 2|Technical problem|1|||
148881217|NCT03350815|537043774|FG002|Period 2|Technical problem|0|||
148881218|NCT03350815|537043775|FG003|Period 2|Technical problem|0|||
148881219|NCT03350815|537043772|FG000|Period 2|Lost to Follow-up|0|||
148881220|NCT03350815|537043773|FG001|Period 2|Lost to Follow-up|3|||
148881221|NCT03350815|537043774|FG002|Period 2|Lost to Follow-up|3|||
148881222|NCT03350815|537043775|FG003|Period 2|Lost to Follow-up|0|||
148881223|NCT03350815|537043772|FG000|Period 2|Physician Decision|0|||
148881224|NCT03350815|537043773|FG001|Period 2|Physician Decision|0|||
148881225|NCT03350815|537043774|FG002|Period 2|Physician Decision|1|||
148881226|NCT03350815|537043775|FG003|Period 2|Physician Decision|0|||
148881227|NCT03350815|537043772|FG000|Period 2|Withdrawal by Subject|0|||
148881228|NCT03350815|537043773|FG001|Period 2|Withdrawal by Subject|3|||
148881229|NCT03350815|537043774|FG002|Period 2|Withdrawal by Subject|4|||
148881230|NCT03350815|537043775|FG003|Period 2|Withdrawal by Subject|0|||
148881231|NCT03350815|537043772|FG000|Period 2|Lack of Efficacy|0|||
148881232|NCT03350815|537043773|FG001|Period 2|Lack of Efficacy|6|||
148881233|NCT03350815|537043774|FG002|Period 2|Lack of Efficacy|2|||
148881234|NCT03350815|537043775|FG003|Period 2|Lack of Efficacy|0|||
148881235|NCT03350815|537043772|FG000|Period 2|Protocol Violation|0|||
148881236|NCT03350815|537043773|FG001|Period 2|Protocol Violation|0|||
148881237|NCT03350815|537043774|FG002|Period 2|Protocol Violation|1|||
148881238|NCT03350815|537043775|FG003|Period 2|Protocol Violation|0|||
148881239|NCT03350815|537043772|FG000|Period 2|New therapy for study indication|0|||
148881240|NCT03350815|537043773|FG001|Period 2|New therapy for study indication|0|||
148881241|NCT03350815|537043774|FG002|Period 2|New therapy for study indication|1|||
148881242|NCT03350815|537043775|FG003|Period 2|New therapy for study indication|0|||
148881243|NCT03526146|537043776|FG000|Overall Study|Lost to Follow-up|5|||
148881244|NCT03526146|537043776|FG000|Overall Study|Withdrawal by Subject|6|||
148881245|NCT03526146|537043776|FG000|Overall Study|class canceled due to COVID-19|4|||
148881246|NCT02517541|537043781|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
148881247|NCT02517541|537043781|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
148881248|NCT02517541|537043781|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
148881249|NCT02517541|537043781|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
148881250|NCT02517541|537043781|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
148881251|NCT02517541|537043781|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
148881252|NCT02588261|537043782|FG000|Overall Study|Study Terminated by Sponsor|157|||
148881253|NCT02588261|537043783|FG001|Overall Study|Study Terminated by Sponsor|142|||
148881254|NCT02588261|537043782|FG000|Overall Study|Protocol Deviation|1|||
149003946|NCT01058304|537493188|FG001|Overall Study|Developed exclusion criterion|12|||
149003947|NCT02755597|537493189|FG000|Overall Study|Withdrew consent|27|||
149003948|NCT02755597|537493190|FG001|Overall Study|Withdrew consent|11|||
149003949|NCT02755597|537493189|FG000|Overall Study|Lost to Follow-up|1|||
149003950|NCT02755597|537493190|FG001|Overall Study|Lost to Follow-up|0|||
149003951|NCT02755597|537493189|FG000|Overall Study|Death|78|||
149003952|NCT02755597|537493190|FG001|Overall Study|Death|36|||
149038673|NCT03215927|537620474|FG001|Open Label Extension|Death|1|||
148881255|NCT02588261|537043783|FG001|Overall Study|Protocol Deviation|0|||
148881256|NCT02588261|537043782|FG000|Overall Study|Death|1|||
148881257|NCT02588261|537043783|FG001|Overall Study|Death|2|||
148881258|NCT02588261|537043782|FG000|Overall Study|Withdrawal by Subject|12|||
148881259|NCT02588261|537043783|FG001|Overall Study|Withdrawal by Subject|8|||
149003953|NCT02755597|537493189|FG000|Overall Study|Study terminated by Sponsor|67|||
148881260|NCT02588261|537043782|FG000|Overall Study|Noncompliance with Study Drug|0|||
148881261|NCT02588261|537043783|FG001|Overall Study|Noncompliance with Study Drug|1|||
148881262|NCT02588261|537043782|FG000|Overall Study|Miscellaneous|5|||
148881263|NCT02588261|537043783|FG001|Overall Study|Miscellaneous|4|||
148881264|NCT02588261|537043782|FG000|Overall Study|Progressive Disease|61|||
149003954|NCT02755597|537493190|FG001|Overall Study|Study terminated by Sponsor|47|||
149003955|NCT02755597|537493189|FG000|Overall Study|Other, not specified|20|||
148881265|NCT02588261|537043783|FG001|Overall Study|Progressive Disease|82|||
148881266|NCT02588261|537043782|FG000|Overall Study|Adverse Event|29|||
148881267|NCT02588261|537043783|FG001|Overall Study|Adverse Event|24|||
148881268|NCT02588261|537043782|FG000|Overall Study|Lost to Follow-up|1|||
148881269|NCT02588261|537043783|FG001|Overall Study|Lost to Follow-up|0|||
148881270|NCT01746368|537043788|FG000|Overall Study|Lost to Follow-up|2|||
148881271|NCT01746368|537043789|FG001|Overall Study|Lost to Follow-up|0|||
148881272|NCT01746368|537043788|FG000|Overall Study|Withdrawal by Subject|0|||
148881273|NCT01746368|537043789|FG001|Overall Study|Withdrawal by Subject|1|||
148881274|NCT05636852|537043790|FG000|Overall Study|Withdrawal by Subject|1|||
148881275|NCT05636852|537043790|FG000|Overall Study|Other than specified|1|||
148881276|NCT02557542|537043792|FG000|Overall Study|Poor recruitment|3|||
148881277|NCT02557542|537043793|FG001|Overall Study|Poor recruitment|0|||
148881278|NCT04390880|537043794|FG000|Overall Study|Withdrawal by Subject|1|||
148881279|NCT01635855|537043827|FG000|Overall Study|Withdrawal by Subject|4|||
148881280|NCT00206440|537043835|FG000|Overall Study|Protocol Violation|1|||
148881281|NCT00206440|537043836|FG001|Overall Study|Protocol Violation|2|||
148881282|NCT00206440|537043835|FG000|Overall Study|Adverse Event|4|||
148881283|NCT00206440|537043836|FG001|Overall Study|Adverse Event|2|||
148881284|NCT00958165|537043837|FG000|Overall Study|Lost to Follow-up|5|||
148881285|NCT00958165|537043837|FG000|Overall Study|Not eligible|9|||
148881286|NCT01371734|537043838|FG000|Overall Study|Other|2|||
148881287|NCT01371734|537043839|FG001|Overall Study|Other|1|||
148881288|NCT01371734|537043840|FG002|Overall Study|Other|2|||
148881289|NCT01371734|537043838|FG000|Overall Study|Withdrawal by Subject|3|||
148881290|NCT01371734|537043839|FG001|Overall Study|Withdrawal by Subject|4|||
148881291|NCT01371734|537043840|FG002|Overall Study|Withdrawal by Subject|9|||
148881292|NCT01371734|537043838|FG000|Overall Study|Lost to Follow-up|5|||
148881293|NCT01371734|537043839|FG001|Overall Study|Lost to Follow-up|3|||
148881294|NCT01371734|537043840|FG002|Overall Study|Lost to Follow-up|1|||
148881295|NCT01371734|537043838|FG000|Overall Study|Protocol Violation|3|||
148881296|NCT01371734|537043839|FG001|Overall Study|Protocol Violation|1|||
148881297|NCT01371734|537043840|FG002|Overall Study|Protocol Violation|2|||
148881298|NCT01371734|537043838|FG000|Overall Study|Adverse Event|8|||
148881299|NCT01371734|537043839|FG001|Overall Study|Adverse Event|8|||
148881300|NCT01371734|537043840|FG002|Overall Study|Adverse Event|3|||
148881301|NCT01371734|537043838|FG000|Overall Study|Lack of Efficacy|2|||
148881302|NCT01371734|537043839|FG001|Overall Study|Lack of Efficacy|2|||
148881303|NCT01371734|537043840|FG002|Overall Study|Lack of Efficacy|0|||
148881304|NCT01298765|537043841|FG000|Titration Period|Adverse Event|26|||
148881305|NCT01298765|537043841|FG000|Titration Period|Death|1|||
148881306|NCT01298765|537043841|FG000|Titration Period|Lack of Efficacy|21|||
148881307|NCT01298765|537043841|FG000|Titration Period|Lost to Follow-up|9|||
148881308|NCT01298765|537043841|FG000|Titration Period|Physician Decision|1|||
148881309|NCT01298765|537043841|FG000|Titration Period|Withdrawal by Subject|10|||
148881310|NCT01298765|537043841|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
148881311|NCT01298765|537043841|FG000|Long-Term Treatment Period|Adverse Event|19|||
148881312|NCT01298765|537043841|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
148881313|NCT01298765|537043841|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
148881314|NCT01298765|537043841|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
148881315|NCT01298765|537043841|FG000|Long-Term Treatment Period|Physician Decision|1|||
148881316|NCT01298765|537043841|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
148881317|NCT03565237|537043842|FG000|Overall Study|Non-compliance of Investigational Product|1|||
148881318|NCT03565237|537043842|FG000|Overall Study|Physician Decision|1|||
148881319|NCT01140061|537043848|FG000|Part I|Adverse Event|1|||
148881320|NCT01140061|537043849|FG001|Part I|Adverse Event|0|||
148881321|NCT01140061|537043850|FG002|Part I|Adverse Event|0|||
148881322|NCT01140061|537043851|FG003|Part I|Adverse Event|0|||
148881323|NCT01140061|537043852|FG004|Part I|Adverse Event|0|||
148881324|NCT01140061|537043853|FG005|Part I|Adverse Event|0|||
148881325|NCT01140061|537043854|FG006|Part I|Adverse Event|0|||
148881326|NCT01140061|537043855|FG007|Part I|Adverse Event|0|||
148881327|NCT01140061|537043856|FG008|Part I|Adverse Event|0|||
148881328|NCT01140061|537043857|FG009|Part I|Adverse Event|0|||
148881329|NCT01140061|537043848|FG000|Extension|Laboratory Adverse Event|0|||
148881330|NCT01140061|537043849|FG001|Extension|Laboratory Adverse Event|0|||
148881331|NCT01140061|537043850|FG002|Extension|Laboratory Adverse Event|0|||
148881332|NCT01140061|537043851|FG003|Extension|Laboratory Adverse Event|0|||
148881333|NCT01140061|537043852|FG004|Extension|Laboratory Adverse Event|0|||
148881334|NCT01140061|537043853|FG005|Extension|Laboratory Adverse Event|0|||
148881335|NCT01140061|537043854|FG006|Extension|Laboratory Adverse Event|0|||
148881336|NCT01140061|537043855|FG007|Extension|Laboratory Adverse Event|0|||
148881337|NCT01140061|537043856|FG008|Extension|Laboratory Adverse Event|0|||
148881338|NCT01140061|537043857|FG009|Extension|Laboratory Adverse Event|1|||
148881339|NCT00428389|537043859|FG000|Core Phase|Adverse Event|6|||
148881340|NCT00428389|537043860|FG001|Core Phase|Adverse Event|4|||
148881341|NCT00428389|537043859|FG000|Core Phase|Lack of Efficacy|2|||
148881342|NCT00428389|537043860|FG001|Core Phase|Lack of Efficacy|0|||
148881343|NCT00428389|537043859|FG000|Core Phase|Abnormal test procedure result(s)|0|||
148881344|NCT00428389|537043860|FG001|Core Phase|Abnormal test procedure result(s)|1|||
148881345|NCT00428389|537043859|FG000|Core Phase|Withdrawal by Subject|3|||
148881346|NCT00428389|537043860|FG001|Core Phase|Withdrawal by Subject|4|||
148881347|NCT00428389|537043859|FG000|Core Phase|Protocol deviation|0|||
148881348|NCT00428389|537043860|FG001|Core Phase|Protocol deviation|2|||
148881349|NCT00428389|537043859|FG000|Extension Phase|Adverse Event|17|||
148881350|NCT00428389|537043860|FG001|Extension Phase|Adverse Event|11|||
148881351|NCT00428389|537043859|FG000|Extension Phase|Lack of Efficacy|4|||
148881352|NCT00428389|537043860|FG001|Extension Phase|Lack of Efficacy|3|||
148881353|NCT00428389|537043859|FG000|Extension Phase|Withdrawal by Subject|6|||
148881354|NCT00428389|537043860|FG001|Extension Phase|Withdrawal by Subject|6|||
148881355|NCT00428389|537043859|FG000|Extension Phase|Lost to Follow-up|0|||
148881356|NCT00428389|537043860|FG001|Extension Phase|Lost to Follow-up|3|||
148881357|NCT00428389|537043859|FG000|Extension Phase|Death|1|||
148881358|NCT00428389|537043860|FG001|Extension Phase|Death|0|||
148881359|NCT00428389|537043859|FG000|Extension Phase|Protocol Violation|3|||
148881360|NCT00428389|537043860|FG001|Extension Phase|Protocol Violation|2|||
148881361|NCT00428389|537043859|FG000|Extension Phase|Administrative problems|1|||
148881362|NCT00428389|537043860|FG001|Extension Phase|Administrative problems|1|||
148881363|NCT00766051|537043861|FG000|Overall Study|Withdrawal by Subject|2|||
148881364|NCT00766051|537043862|FG001|Overall Study|Withdrawal by Subject|0|||
148881365|NCT02708355|537043863|FG000|Overall Study|Adverse Event|1|||
148881366|NCT02708355|537043864|FG001|Overall Study|Adverse Event|0|||
148881367|NCT02708355|537043865|FG002|Overall Study|Adverse Event|0|||
148881368|NCT04384523|537043866|FG000|Overall Study|Lost to Follow-up|0|||
149038674|NCT03779048|537620475|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
149038675|NCT03779048|537620476|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
149038676|NCT03779048|537620477|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
149038677|NCT03779048|537620475|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
149038678|NCT03779048|537620476|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
149038679|NCT03779048|537620477|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
149038680|NCT03779048|537620475|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
148881369|NCT04384523|537043867|FG001|Overall Study|Lost to Follow-up|0|||
148881370|NCT04384523|537043868|FG002|Overall Study|Lost to Follow-up|0|||
148881371|NCT04384523|537043869|FG003|Overall Study|Lost to Follow-up|0|||
148881372|NCT04384523|537043870|FG004|Overall Study|Lost to Follow-up|0|||
148881373|NCT04384523|537043871|FG005|Overall Study|Lost to Follow-up|1|||
148881374|NCT04384523|537043866|FG000|Overall Study|Protocol Violation|0|||
148881375|NCT04384523|537043867|FG001|Overall Study|Protocol Violation|1|||
148881376|NCT04384523|537043868|FG002|Overall Study|Protocol Violation|0|||
148881377|NCT04384523|537043869|FG003|Overall Study|Protocol Violation|0|||
148881378|NCT04384523|537043870|FG004|Overall Study|Protocol Violation|0|||
148881379|NCT04384523|537043871|FG005|Overall Study|Protocol Violation|0|||
148881380|NCT04384523|537043866|FG000|Overall Study|Withdrawal by Subject|1|||
148881381|NCT04384523|537043867|FG001|Overall Study|Withdrawal by Subject|0|||
148881382|NCT04384523|537043868|FG002|Overall Study|Withdrawal by Subject|0|||
148881383|NCT04384523|537043869|FG003|Overall Study|Withdrawal by Subject|0|||
148881384|NCT04384523|537043870|FG004|Overall Study|Withdrawal by Subject|0|||
148881385|NCT04384523|537043871|FG005|Overall Study|Withdrawal by Subject|0|||
148881386|NCT01098305|537043872|FG000|Overall Study|Lost to Follow-up|31|||
148881387|NCT01098305|537043873|FG001|Overall Study|Lost to Follow-up|33|||
148881388|NCT04565951|537043875|FG000|Overall Study|Lost to Follow-up|66|||
148881389|NCT04565951|537043876|FG001|Overall Study|Lost to Follow-up|38|||
148881390|NCT04565951|537043875|FG000|Overall Study|Withdrawal by Subject|14|||
148881391|NCT04565951|537043876|FG001|Overall Study|Withdrawal by Subject|7|||
148881392|NCT04565951|537043875|FG000|Overall Study|Death|0|||
148881393|NCT04565951|537043876|FG001|Overall Study|Death|1|||
148881394|NCT01746173|537043877|FG000|Overall Study|Disease Progression|2|||
148881395|NCT01811186|537043881|FG000|Overall Study|Adverse Event|54|||
148881396|NCT01811186|537043882|FG001|Overall Study|Adverse Event|38|||
148881397|NCT01811186|537043881|FG000|Overall Study|Protocol Violation|5|||
148881398|NCT01811186|537043882|FG001|Overall Study|Protocol Violation|6|||
148881399|NCT01811186|537043881|FG000|Overall Study|Withdrawal by Subject|5|||
148881400|NCT01811186|537043882|FG001|Overall Study|Withdrawal by Subject|10|||
148881401|NCT01811186|537043881|FG000|Overall Study|Lack of Efficacy|3|||
148881402|NCT01811186|537043882|FG001|Overall Study|Lack of Efficacy|6|||
148881403|NCT01811186|537043881|FG000|Overall Study|Lost to Follow-up|4|||
148881404|NCT01811186|537043882|FG001|Overall Study|Lost to Follow-up|2|||
148881405|NCT00534976|537043889|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
148881406|NCT00534976|537043890|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
148881407|NCT00534976|537043889|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
148881408|NCT00534976|537043890|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
148881409|NCT00534976|537043889|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
148881410|NCT00534976|537043890|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
148881411|NCT00861471|537043891|FG000|Overall Study|Withdrawal by Subject|1|||
148881412|NCT00861471|537043891|FG000|Overall Study|Adverse Event|2|||
148881413|NCT00861471|537043891|FG000|Overall Study|Lack of Efficacy|3|||
148881414|NCT00861471|537043891|FG000|Overall Study|treatment for lumbar laminectomy|1|||
148881415|NCT00861471|537043891|FG000|Overall Study|Physician Decision|2|||
148881416|NCT02092025|537043892|FG000|Overall Study|Case Report Forms Uncollected|44|||
148881417|NCT02092025|537043892|FG000|Overall Study|Protocol Deviation|24|||
148881418|NCT00264537|537043893|FG000|Overall Study|Death|0|||
148881419|NCT00264537|537043894|FG001|Overall Study|Death|3|||
149038681|NCT03779048|537620476|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
149038682|NCT03779048|537620477|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
149038683|NCT00465816|537620478|FG000|Overall Study|Lost to Follow-up|0|||
149038684|NCT00465816|537620479|FG001|Overall Study|Lost to Follow-up|0|||
149038685|NCT00465816|537620480|FG002|Overall Study|Lost to Follow-up|2|||
149038686|NCT01426269|537620481|FG000|Period 1: 12 Weeks|Adverse Event|5|||
149038687|NCT01426269|537620482|FG001|Period 1: 12 Weeks|Adverse Event|0|||
149038688|NCT01426269|537620483|FG002|Period 1: 12 Weeks|Adverse Event|0|||
149038689|NCT01426269|537620481|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
149038690|NCT01426269|537620482|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
149038691|NCT01426269|537620483|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
149038692|NCT01426269|537620481|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
149038693|NCT01426269|537620482|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
148881420|NCT00264537|537043895|FG002|Overall Study|Death|3|||
148881421|NCT00264537|537043896|FG003|Overall Study|Death|2|||
148881422|NCT00264537|537043893|FG000|Overall Study|Lost to Follow-up|3|||
148881423|NCT00264537|537043894|FG001|Overall Study|Lost to Follow-up|4|||
148881424|NCT00264537|537043895|FG002|Overall Study|Lost to Follow-up|7|||
148881425|NCT00264537|537043896|FG003|Overall Study|Lost to Follow-up|6|||
148881426|NCT00264537|537043893|FG000|Overall Study|Adverse Event|21|||
148881427|NCT00264537|537043894|FG001|Overall Study|Adverse Event|32|||
148881428|NCT00264537|537043895|FG002|Overall Study|Adverse Event|24|||
148881429|NCT00264537|537043896|FG003|Overall Study|Adverse Event|34|||
148881430|NCT00264537|537043893|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
148881431|NCT00264537|537043894|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
148881432|NCT00264537|537043895|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
148881433|NCT00264537|537043896|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
148881434|NCT00264537|537043893|FG000|Overall Study|Other|21|||
148881435|NCT00264537|537043894|FG001|Overall Study|Other|11|||
148881436|NCT00264537|537043895|FG002|Overall Study|Other|10|||
148881437|NCT00264537|537043896|FG003|Overall Study|Other|11|||
148881438|NCT00264537|537043893|FG000|Overall Study|Not treated|0|||
148881439|NCT00264537|537043894|FG001|Overall Study|Not treated|2|||
148881440|NCT00264537|537043895|FG002|Overall Study|Not treated|1|||
148881441|NCT00264537|537043896|FG003|Overall Study|Not treated|0|||
148881442|NCT00615017|537045861|FG000|Overall Study|Adverse Event|0|||
148881443|NCT00615017|537045862|FG001|Overall Study|Adverse Event|1|||
148881444|NCT00615017|537045863|FG002|Overall Study|Adverse Event|2|||
148881445|NCT00615017|537045864|FG003|Overall Study|Adverse Event|0|||
149003956|NCT02755597|537493190|FG001|Overall Study|Other, not specified|3|||
149003957|NCT02755597|537493189|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
149003958|NCT02755597|537493190|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
149003959|NCT02496767|537493191|FG000|Open-label Lead-in Phase|Adverse Event|176|||
149003960|NCT02496767|537493192|FG001|Open-label Lead-in Phase|Adverse Event|0|||
149003961|NCT02496767|537493193|FG002|Open-label Lead-in Phase|Adverse Event|0|||
149003962|NCT02496767|537493194|FG003|Open-label Lead-in Phase|Adverse Event|0|||
149003963|NCT02496767|537493195|FG004|Open-label Lead-in Phase|Adverse Event|0|||
149003964|NCT02496767|537493196|FG005|Open-label Lead-in Phase|Adverse Event|0|||
149003965|NCT02496767|537493197|FG006|Open-label Lead-in Phase|Adverse Event|0|||
149003966|NCT02496767|537493198|FG007|Open-label Lead-in Phase|Adverse Event|0|||
149003967|NCT02496767|537493191|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
149003968|NCT02496767|537493192|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
149003969|NCT02496767|537493193|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
149003970|NCT02496767|537493194|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
149003971|NCT02496767|537493195|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
149003972|NCT02496767|537493196|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
149003973|NCT02496767|537493197|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
149003974|NCT02496767|537493198|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
149003975|NCT02496767|537493191|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
149003976|NCT02496767|537493192|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
149003977|NCT02496767|537493193|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
149038694|NCT01426269|537620483|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
148881446|NCT00615017|537045865|FG004|Overall Study|Adverse Event|0|||
148881447|NCT00615017|537045866|FG005|Overall Study|Adverse Event|1|||
148881448|NCT00615017|537045861|FG000|Overall Study|Death|0|||
148881449|NCT00615017|537045862|FG001|Overall Study|Death|0|||
148881450|NCT00615017|537045863|FG002|Overall Study|Death|2|||
148881451|NCT00615017|537045864|FG003|Overall Study|Death|0|||
148881452|NCT00615017|537045865|FG004|Overall Study|Death|1|||
148881453|NCT00615017|537045866|FG005|Overall Study|Death|1|||
148881454|NCT00615017|537045861|FG000|Overall Study|Sepsis resolved|0|||
148881455|NCT00615017|537045862|FG001|Overall Study|Sepsis resolved|0|||
148881456|NCT00615017|537045863|FG002|Overall Study|Sepsis resolved|1|||
148881457|NCT00615017|537045864|FG003|Overall Study|Sepsis resolved|0|||
148881458|NCT00615017|537045865|FG004|Overall Study|Sepsis resolved|0|||
148881459|NCT00615017|537045866|FG005|Overall Study|Sepsis resolved|0|||
148881460|NCT00615017|537045861|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
148881461|NCT00615017|537045862|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
148881462|NCT00615017|537045863|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
148881463|NCT00615017|537045864|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
148881464|NCT00615017|537045865|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
148881465|NCT00615017|537045866|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
148881466|NCT00615017|537045861|FG000|Overall Study|Physician discontinued drug|0|||
148881467|NCT00615017|537045862|FG001|Overall Study|Physician discontinued drug|0|||
148881468|NCT00615017|537045863|FG002|Overall Study|Physician discontinued drug|0|||
148881469|NCT00615017|537045864|FG003|Overall Study|Physician discontinued drug|0|||
148881470|NCT00615017|537045865|FG004|Overall Study|Physician discontinued drug|0|||
148881471|NCT00615017|537045866|FG005|Overall Study|Physician discontinued drug|1|||
148881472|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
148881473|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
148881474|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
148881475|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
148881476|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
148881477|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
148881478|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
148881479|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
148881480|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
148881481|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
148881482|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
148881483|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
148881484|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
148881485|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
148881486|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
148881487|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
148881488|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
148881489|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
148881490|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
148881491|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
148881492|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
148881493|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
148881494|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
148881495|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
148881496|NCT03777059|537045867|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
148881497|NCT03777059|537045868|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
148881498|NCT03777059|537045869|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
148881499|NCT03777059|537045870|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
148881500|NCT03777059|537045867|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
148881501|NCT03777059|537045868|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
148881502|NCT03777059|537045869|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
148881503|NCT03777059|537045870|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
148881504|NCT03777059|537045867|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
148881505|NCT03777059|537045868|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
148881506|NCT03777059|537045869|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
148881507|NCT03777059|537045870|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
148881508|NCT03777059|537045867|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
148881509|NCT03777059|537045868|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
148881510|NCT03777059|537045869|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
148881511|NCT03777059|537045870|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
148881512|NCT03777059|537045867|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
148881513|NCT03777059|537045868|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
148881514|NCT03777059|537045869|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
149003978|NCT02496767|537493194|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
149003979|NCT02496767|537493195|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
149003980|NCT02496767|537493196|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
149003981|NCT02496767|537493197|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
149003982|NCT02496767|537493198|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
149003983|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
148881515|NCT03777059|537045870|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
148881516|NCT00699608|537045871|FG000|First Intervention|Withdrawal by Subject|0|||
148881517|NCT00699608|537045872|FG001|First Intervention|Withdrawal by Subject|0|||
148881518|NCT00699608|537045873|FG002|First Intervention|Withdrawal by Subject|1|||
148881519|NCT00699608|537045874|FG003|First Intervention|Withdrawal by Subject|0|||
148881520|NCT00699608|537045875|FG004|First Intervention|Withdrawal by Subject|0|||
148881521|NCT00699608|537045876|FG005|First Intervention|Withdrawal by Subject|0|||
148881522|NCT00699608|537045871|FG000|First Intervention|Protocol Violation|0|||
148881523|NCT00699608|537045872|FG001|First Intervention|Protocol Violation|0|||
148881524|NCT00699608|537045873|FG002|First Intervention|Protocol Violation|0|||
148881525|NCT00699608|537045874|FG003|First Intervention|Protocol Violation|0|||
148881526|NCT00699608|537045875|FG004|First Intervention|Protocol Violation|1|||
148881527|NCT00699608|537045876|FG005|First Intervention|Protocol Violation|0|||
148881528|NCT00699608|537045871|FG000|Second Intervention|Adverse Event|0|||
148881529|NCT00699608|537045872|FG001|Second Intervention|Adverse Event|0|||
148881530|NCT00699608|537045873|FG002|Second Intervention|Adverse Event|1|||
148881531|NCT00699608|537045874|FG003|Second Intervention|Adverse Event|0|||
148881532|NCT00699608|537045875|FG004|Second Intervention|Adverse Event|0|||
148881533|NCT00699608|537045876|FG005|Second Intervention|Adverse Event|0|||
148881534|NCT00699608|537045871|FG000|Second Intervention|Withdrawal by Subject|0|||
148881535|NCT00699608|537045872|FG001|Second Intervention|Withdrawal by Subject|0|||
148881536|NCT00699608|537045873|FG002|Second Intervention|Withdrawal by Subject|0|||
148881537|NCT00699608|537045874|FG003|Second Intervention|Withdrawal by Subject|1|||
148881538|NCT00699608|537045875|FG004|Second Intervention|Withdrawal by Subject|0|||
148881539|NCT00699608|537045876|FG005|Second Intervention|Withdrawal by Subject|0|||
148881540|NCT02828436|537045877|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
148881541|NCT02828436|537045878|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
148881542|NCT02828436|537045877|FG000|Period 1|Lost to Follow-up|0|||
148881543|NCT02828436|537045878|FG001|Period 1|Lost to Follow-up|1|||
148881544|NCT02828436|537045877|FG000|Period 2|Withdrawal by Subject|4|||
148881545|NCT02828436|537045878|FG001|Period 2|Withdrawal by Subject|0|||
148881546|NCT02828436|537045877|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
148881547|NCT02828436|537045878|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
148881548|NCT02828436|537045877|FG000|Period 2|Lost to Follow-up|1|||
148881549|NCT02828436|537045878|FG001|Period 2|Lost to Follow-up|0|||
148881550|NCT01136408|537045879|FG000|Overall Study|Adverse Event|4|||
148881551|NCT01136408|537045880|FG001|Overall Study|Adverse Event|8|||
148881552|NCT01136408|537045881|FG002|Overall Study|Adverse Event|4|||
148881553|NCT01136408|537045879|FG000|Overall Study|Protocol Violation|1|||
148881554|NCT01136408|537045880|FG001|Overall Study|Protocol Violation|1|||
148881555|NCT01136408|537045881|FG002|Overall Study|Protocol Violation|1|||
148881556|NCT03078556|537045884|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
148881557|NCT03078556|537045885|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
148881558|NCT03078556|537045886|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
148881559|NCT03078556|537045887|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
148881560|NCT03078556|537045884|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
148881561|NCT03078556|537045885|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
148881562|NCT03078556|537045886|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
148881563|NCT03078556|537045887|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
148881564|NCT03078556|537045884|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
148881565|NCT03078556|537045885|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
148881566|NCT03078556|537045886|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
148881567|NCT03078556|537045887|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
148881568|NCT03078556|537045884|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
148881569|NCT03078556|537045885|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
148881570|NCT03078556|537045886|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
148881571|NCT03078556|537045887|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
148881572|NCT04421482|537045889|FG000|Overall Study|Physician Decision|1|||
148881573|NCT03010319|537045890|FG000|Overall Study|Adverse Event|15|||
148881574|NCT03010319|537045891|FG001|Overall Study|Adverse Event|9|||
148881575|NCT03010319|537045890|FG000|Overall Study|Withdrawal by Subject|1|||
148881576|NCT03010319|537045891|FG001|Overall Study|Withdrawal by Subject|6|||
148881577|NCT03010319|537045890|FG000|Overall Study|Physician Decision|2|||
148881578|NCT03010319|537045891|FG001|Overall Study|Physician Decision|4|||
148881579|NCT03010319|537045890|FG000|Overall Study|Sponsor requested withdrawal|2|||
148881580|NCT03010319|537045891|FG001|Overall Study|Sponsor requested withdrawal|2|||
148881581|NCT03010319|537045890|FG000|Overall Study|Death|1|||
148881582|NCT03010319|537045891|FG001|Overall Study|Death|0|||
148881583|NCT03010319|537045890|FG000|Overall Study|Lost to Follow-up|0|||
148881584|NCT03010319|537045891|FG001|Overall Study|Lost to Follow-up|1|||
148881585|NCT03010319|537045890|FG000|Overall Study|Other Reason|5|||
148881586|NCT03010319|537045891|FG001|Overall Study|Other Reason|7|||
148881587|NCT02128724|537045892|FG000|Overall Study|Death|1|||
148881588|NCT02128724|537045893|FG001|Overall Study|Death|0|||
148881589|NCT02128724|537045894|FG002|Overall Study|Death|0|||
148881590|NCT02128724|537045895|FG003|Overall Study|Death|0|||
148881591|NCT02128724|537045892|FG000|Overall Study|Adverse Event|0|||
148881592|NCT02128724|537045893|FG001|Overall Study|Adverse Event|1|||
148881593|NCT02128724|537045894|FG002|Overall Study|Adverse Event|0|||
148881594|NCT02128724|537045895|FG003|Overall Study|Adverse Event|0|||
148881595|NCT02128724|537045892|FG000|Overall Study|Physician Decision|0|||
148881596|NCT02128724|537045893|FG001|Overall Study|Physician Decision|0|||
148881597|NCT02128724|537045894|FG002|Overall Study|Physician Decision|0|||
148881598|NCT02128724|537045895|FG003|Overall Study|Physician Decision|2|||
148881599|NCT02128724|537045892|FG000|Overall Study|Withdrawal by Subject|0|||
148881600|NCT02128724|537045893|FG001|Overall Study|Withdrawal by Subject|0|||
148881601|NCT02128724|537045894|FG002|Overall Study|Withdrawal by Subject|0|||
148881602|NCT02128724|537045895|FG003|Overall Study|Withdrawal by Subject|1|||
148881603|NCT01442714|537045896|FG000|Overall Study|Death|11|||
148881604|NCT01442714|537045896|FG000|Overall Study|Withdrawal by Subject|1|||
148881605|NCT04306510|537045897|FG000|Overall Study|Voluntarily withdrawal|1|||
148881606|NCT04306510|537045897|FG000|Overall Study|Enrolled but Not Treated|1|||
148881607|NCT04720417|537045900|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
148881608|NCT03329092|537045901|FG000|Overall Study|Other|2|||
148881609|NCT03329092|537045902|FG001|Overall Study|Other|2|||
148881610|NCT03329092|537045901|FG000|Overall Study|Withdrawal by Subject|16|||
148881611|NCT03329092|537045902|FG001|Overall Study|Withdrawal by Subject|3|||
148881612|NCT03329092|537045901|FG000|Overall Study|Physician Decision|1|||
148881613|NCT03329092|537045902|FG001|Overall Study|Physician Decision|0|||
148881614|NCT03329092|537045901|FG000|Overall Study|Death|17|||
148881615|NCT03329092|537045902|FG001|Overall Study|Death|11|||
148881616|NCT03329092|537045901|FG000|Overall Study|Adverse Event|3|||
148881617|NCT03329092|537045902|FG001|Overall Study|Adverse Event|1|||
148881618|NCT03329092|537045901|FG000|Overall Study|Lost to Follow-up|1|||
148881619|NCT03329092|537045902|FG001|Overall Study|Lost to Follow-up|1|||
148881620|NCT03314987|537045903|FG000|Overall Study|Lost to Follow-up|13|||
148881621|NCT03314987|537045904|FG001|Overall Study|Lost to Follow-up|13|||
148881622|NCT03574779|537045905|FG000|Overall Study|Screening failure|13|||
148881623|NCT03574779|537045906|FG001|Overall Study|Screening failure|83|||
148881624|NCT02751580|537045907|FG000|Overall Study|Lost to Follow-up|4|||
148881625|NCT02751580|537045907|FG000|Overall Study|Death|2|||
148881626|NCT03755882|537045912|FG000|Period 1|Protocol Violation|1|||
148881627|NCT03755882|537045913|FG001|Period 1|Protocol Violation|0|||
148881628|NCT03755882|537045912|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
148881629|NCT03755882|537045913|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
148881630|NCT01076036|537045918|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
148881631|NCT02221674|537045919|FG000|Overall Study|Lost to Follow-up|1|||
148881632|NCT02221674|537045920|FG001|Overall Study|Lost to Follow-up|0|||
148881633|NCT02221674|537045921|FG002|Overall Study|Lost to Follow-up|0|||
148881634|NCT05292131|537045922|FG000|Overall Study|Lost to Follow-up|1|||
148881635|NCT05292131|537045923|FG001|Overall Study|Lost to Follow-up|1|||
148881636|NCT05292131|537045922|FG000|Overall Study|Withdrawal by Subject|0|||
148881637|NCT05292131|537045923|FG001|Overall Study|Withdrawal by Subject|1|||
148881638|NCT01345188|537045924|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
148881639|NCT01345188|537045924|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
148881640|NCT06041919|537045927|FG000|Overall Study|Lost to Follow-up|1|||
148881641|NCT06041919|537045928|FG001|Overall Study|Lost to Follow-up|0|||
148881642|NCT06041919|537045929|FG002|Overall Study|Lost to Follow-up|0|||
148881643|NCT06041919|537045930|FG003|Overall Study|Lost to Follow-up|0|||
148881644|NCT06041919|537045931|FG004|Overall Study|Lost to Follow-up|0|||
148881645|NCT06041919|537045927|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
148881646|NCT06041919|537045928|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
148881647|NCT06041919|537045929|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
148881648|NCT06041919|537045930|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
148881649|NCT06041919|537045931|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
148881650|NCT04526145|537045932|FG000|Overall Study|Withdrawal by Subject|5|||
148881651|NCT00577824|537045934|FG000|Overall Study|Adverse Event|6|||
148881652|NCT00577824|537045935|FG001|Overall Study|Adverse Event|18|||
148881653|NCT00577824|537045936|FG002|Overall Study|Adverse Event|1|||
148881654|NCT00577824|537045934|FG000|Overall Study|Patient decision|0|||
148881655|NCT00577824|537045935|FG001|Overall Study|Patient decision|1|||
148881656|NCT00577824|537045936|FG002|Overall Study|Patient decision|1|||
148881657|NCT00577824|537045934|FG000|Overall Study|Protocol Violation|1|||
148881658|NCT00577824|537045935|FG001|Overall Study|Protocol Violation|1|||
148881659|NCT00577824|537045936|FG002|Overall Study|Protocol Violation|0|||
148881660|NCT00048347|537045939|FG000|Overall Study|Screen failure|2|||
148881661|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
148881662|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
148881663|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
148881664|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Death|0|||
148881665|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Death|2|||
148881666|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Death|0|||
148881667|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
148881668|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
148881669|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
148881670|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
148881671|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
148881672|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
148881673|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
148881674|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
148881675|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
148881676|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
148881677|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
148881678|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
148881679|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
148881680|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
148881681|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
148881682|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Recovery|1|||
148881683|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Recovery|0|||
148881684|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Recovery|1|||
148881685|NCT00195663|537045940|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
148881686|NCT00195663|537045941|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
148881687|NCT00195663|537045942|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
148881688|NCT00195663|537045940|FG000|Open-Label Extension Period|Adverse Event|21|||
148881689|NCT00195663|537045941|FG001|Open-Label Extension Period|Adverse Event|32|||
148881690|NCT00195663|537045942|FG002|Open-Label Extension Period|Adverse Event|36|||
148881691|NCT00195663|537045940|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
148881692|NCT00195663|537045941|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
148881693|NCT00195663|537045942|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
148881694|NCT00195663|537045940|FG000|Open-Label Extension Period|Recovery|0|||
148881695|NCT00195663|537045941|FG001|Open-Label Extension Period|Recovery|2|||
148881696|NCT00195663|537045942|FG002|Open-Label Extension Period|Recovery|2|||
148881697|NCT00195663|537045940|FG000|Open-Label Extension Period|Protocol Violation|3|||
148881698|NCT00195663|537045941|FG001|Open-Label Extension Period|Protocol Violation|4|||
148881699|NCT00195663|537045942|FG002|Open-Label Extension Period|Protocol Violation|4|||
148881700|NCT00195663|537045940|FG000|Open-Label Extension Period|Death|2|||
148881701|NCT00195663|537045941|FG001|Open-Label Extension Period|Death|2|||
148881702|NCT00195663|537045942|FG002|Open-Label Extension Period|Death|2|||
148881703|NCT00195663|537045940|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
148881704|NCT00195663|537045941|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
148881705|NCT00195663|537045942|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
148881706|NCT00195663|537045940|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
148881707|NCT00195663|537045941|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
148881708|NCT00195663|537045942|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
148881709|NCT00195663|537045940|FG000|Open-Label Extension Period|Administrative reasons|11|||
148881710|NCT00195663|537045941|FG001|Open-Label Extension Period|Administrative reasons|11|||
148881711|NCT00195663|537045942|FG002|Open-Label Extension Period|Administrative reasons|13|||
148881712|NCT00604695|537045943|FG000|Overall Study|Did not receive first bolus.|0|||
148881713|NCT00604695|537045944|FG001|Overall Study|Did not receive first bolus.|4|||
148881714|NCT03214406|537045945|FG000|Overall Study|did not meet enrollment criteria|9|||
148881715|NCT03214406|537045946|FG001|Overall Study|did not meet enrollment criteria|13|||
148881716|NCT03214406|537045945|FG000|Overall Study|Withdrawal by Subject|1|||
148881717|NCT03214406|537045946|FG001|Overall Study|Withdrawal by Subject|0|||
148881718|NCT03214406|537045945|FG000|Overall Study|Lost to Follow-up|0|||
148881719|NCT03214406|537045946|FG001|Overall Study|Lost to Follow-up|2|||
148881720|NCT03182907|537045955|FG000|Overall Study|Death|3|||
148881721|NCT03182907|537045956|FG001|Overall Study|Death|0|||
148881722|NCT03182907|537045955|FG000|Overall Study|Protocol Violation|4|||
148881723|NCT03182907|537045956|FG001|Overall Study|Protocol Violation|0|||
148881724|NCT03182907|537045955|FG000|Overall Study|Lost to Follow-up|1|||
148881725|NCT03182907|537045956|FG001|Overall Study|Lost to Follow-up|0|||
148881726|NCT03182907|537045955|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
148881727|NCT03182907|537045956|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
148881728|NCT00429169|537045957|FG000|Overall Study|Lost to Follow-up|0|||
148881729|NCT00429169|537045958|FG001|Overall Study|Lost to Follow-up|1|||
148881730|NCT00429169|537045957|FG000|Overall Study|Ineligibility discovered after entry|2|||
148881731|NCT00429169|537045958|FG001|Overall Study|Ineligibility discovered after entry|1|||
148881732|NCT00172042|537045965|FG000|Overall Study|Adverse Event|27|||
148881733|NCT00172042|537045966|FG001|Overall Study|Adverse Event|13|||
148881734|NCT00172042|537045965|FG000|Overall Study|Abnormal laboratory value(s)|5|||
148881735|NCT00172042|537045966|FG001|Overall Study|Abnormal laboratory value(s)|1|||
148881736|NCT00172042|537045965|FG000|Overall Study|Abnormal test procedure(s)|0|||
148881737|NCT00172042|537045966|FG001|Overall Study|Abnormal test procedure(s)|3|||
148881738|NCT00172042|537045965|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
148881739|NCT00172042|537045966|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
148881740|NCT00172042|537045965|FG000|Overall Study|Patient no longer requires study drug|10|||
148881741|NCT00172042|537045966|FG001|Overall Study|Patient no longer requires study drug|8|||
148881742|NCT00172042|537045965|FG000|Overall Study|Protocol Violation|8|||
148881743|NCT00172042|537045966|FG001|Overall Study|Protocol Violation|7|||
148881744|NCT00172042|537045965|FG000|Overall Study|Withdrawal by Subject|37|||
148881745|NCT00172042|537045966|FG001|Overall Study|Withdrawal by Subject|25|||
148881746|NCT00172042|537045965|FG000|Overall Study|Lost to Follow-up|3|||
148881747|NCT00172042|537045966|FG001|Overall Study|Lost to Follow-up|5|||
148881748|NCT00172042|537045965|FG000|Overall Study|Administrative problems|13|||
148881749|NCT00172042|537045966|FG001|Overall Study|Administrative problems|10|||
148881750|NCT00172042|537045965|FG000|Overall Study|Death|42|||
148881751|NCT00172042|537045966|FG001|Overall Study|Death|42|||
148881752|NCT01771250|537045967|FG000|Period 1|Met exclusion criteria|1|||
148881753|NCT01771250|537045968|FG001|Period 1|Met exclusion criteria|0|||
148881754|NCT00166439|537045969|FG000|Overall Study|Ineligible|5|||
148881755|NCT01180296|537045970|FG000|Overall Study|Protocol Violation|1|||
148881756|NCT01180296|537045971|FG001|Overall Study|Protocol Violation|2|||
148881757|NCT00483938|537045972|FG000|Overall Study|Protocol Violation|0|||
148881758|NCT00483938|537045973|FG001|Overall Study|Protocol Violation|0|||
148881759|NCT00483938|537045974|FG002|Overall Study|Protocol Violation|0|||
148881760|NCT00483938|537045975|FG003|Overall Study|Protocol Violation|0|||
148881761|NCT00483938|537045976|FG004|Overall Study|Protocol Violation|0|||
148881762|NCT00483938|537045977|FG005|Overall Study|Protocol Violation|0|||
148881763|NCT00483938|537045978|FG006|Overall Study|Protocol Violation|3|||
148881764|NCT00483938|537045972|FG000|Overall Study|Withdrawal by Subject|1|||
148881765|NCT00483938|537045973|FG001|Overall Study|Withdrawal by Subject|6|||
148881766|NCT00483938|537045974|FG002|Overall Study|Withdrawal by Subject|0|||
148881767|NCT00483938|537045975|FG003|Overall Study|Withdrawal by Subject|0|||
148881768|NCT00483938|537045976|FG004|Overall Study|Withdrawal by Subject|1|||
148881769|NCT00483938|537045977|FG005|Overall Study|Withdrawal by Subject|3|||
148881770|NCT00483938|537045978|FG006|Overall Study|Withdrawal by Subject|2|||
148881771|NCT00483938|537045972|FG000|Overall Study|Lost to Follow-up|1|||
148881772|NCT00483938|537045973|FG001|Overall Study|Lost to Follow-up|2|||
148881773|NCT00483938|537045974|FG002|Overall Study|Lost to Follow-up|0|||
148881774|NCT00483938|537045975|FG003|Overall Study|Lost to Follow-up|2|||
148881775|NCT00483938|537045976|FG004|Overall Study|Lost to Follow-up|1|||
148881776|NCT00483938|537045977|FG005|Overall Study|Lost to Follow-up|1|||
148881777|NCT00483938|537045978|FG006|Overall Study|Lost to Follow-up|3|||
148881778|NCT00483938|537045972|FG000|Overall Study|Death|0|||
148881779|NCT00483938|537045973|FG001|Overall Study|Death|2|||
148881780|NCT00483938|537045974|FG002|Overall Study|Death|0|||
148881781|NCT00483938|537045975|FG003|Overall Study|Death|0|||
148881782|NCT00483938|537045976|FG004|Overall Study|Death|0|||
148881783|NCT00483938|537045977|FG005|Overall Study|Death|0|||
148881784|NCT00483938|537045978|FG006|Overall Study|Death|0|||
148881785|NCT00483938|537045972|FG000|Overall Study|Other|3|||
148881786|NCT00483938|537045973|FG001|Overall Study|Other|9|||
148881787|NCT00483938|537045974|FG002|Overall Study|Other|0|||
148881788|NCT00483938|537045975|FG003|Overall Study|Other|4|||
148881789|NCT00483938|537045976|FG004|Overall Study|Other|0|||
148881790|NCT00483938|537045977|FG005|Overall Study|Other|4|||
148881791|NCT00483938|537045978|FG006|Overall Study|Other|32|||
148881792|NCT00106353|537045983|FG000|Part 1|Disease progression|3|||
148881793|NCT00106353|537045984|FG001|Part 1|Disease progression|4|||
148881794|NCT00106353|537045985|FG002|Part 1|Disease progression|1|||
148881795|NCT00106353|537045986|FG003|Part 1|Disease progression|3|||
148881796|NCT00106353|537045987|FG004|Part 1|Disease progression|0|||
148881797|NCT00106353|537045988|FG005|Part 1|Disease progression|0|||
148881798|NCT00106353|537045989|FG006|Part 1|Disease progression|0|||
148881799|NCT00106353|537045983|FG000|Part 1|Withdrawal by Subject|0|||
148881800|NCT00106353|537045984|FG001|Part 1|Withdrawal by Subject|0|||
148881801|NCT00106353|537045985|FG002|Part 1|Withdrawal by Subject|1|||
148881802|NCT00106353|537045986|FG003|Part 1|Withdrawal by Subject|2|||
148881803|NCT00106353|537045987|FG004|Part 1|Withdrawal by Subject|0|||
148881804|NCT00106353|537045988|FG005|Part 1|Withdrawal by Subject|0|||
148881805|NCT00106353|537045989|FG006|Part 1|Withdrawal by Subject|0|||
148881806|NCT00106353|537045983|FG000|Part 1|Symptomatic deterioration|0|||
148881807|NCT00106353|537045984|FG001|Part 1|Symptomatic deterioration|0|||
148881808|NCT00106353|537045985|FG002|Part 1|Symptomatic deterioration|1|||
148881809|NCT00106353|537045986|FG003|Part 1|Symptomatic deterioration|0|||
148881810|NCT00106353|537045987|FG004|Part 1|Symptomatic deterioration|0|||
148881811|NCT00106353|537045988|FG005|Part 1|Symptomatic deterioration|0|||
148881812|NCT00106353|537045989|FG006|Part 1|Symptomatic deterioration|0|||
148881813|NCT00106353|537045983|FG000|Part 1|Entered follow-up phase|1|||
148881814|NCT00106353|537045984|FG001|Part 1|Entered follow-up phase|1|||
148881815|NCT00106353|537045985|FG002|Part 1|Entered follow-up phase|0|||
148881816|NCT00106353|537045986|FG003|Part 1|Entered follow-up phase|1|||
148881817|NCT00106353|537045987|FG004|Part 1|Entered follow-up phase|0|||
148881818|NCT00106353|537045988|FG005|Part 1|Entered follow-up phase|0|||
148881819|NCT00106353|537045989|FG006|Part 1|Entered follow-up phase|0|||
149038695|NCT01426269|537620481|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
148881820|NCT00106353|537045983|FG000|Part 1|Adverse Event|0|||
148881821|NCT00106353|537045984|FG001|Part 1|Adverse Event|0|||
148881822|NCT00106353|537045985|FG002|Part 1|Adverse Event|0|||
148881823|NCT00106353|537045986|FG003|Part 1|Adverse Event|1|||
148881824|NCT00106353|537045987|FG004|Part 1|Adverse Event|0|||
148881825|NCT00106353|537045988|FG005|Part 1|Adverse Event|0|||
148881826|NCT00106353|537045989|FG006|Part 1|Adverse Event|0|||
148881827|NCT00106353|537045983|FG000|Part 2|Disease progression|0|||
148881828|NCT00106353|537045984|FG001|Part 2|Disease progression|0|||
148881829|NCT00106353|537045985|FG002|Part 2|Disease progression|0|||
148881830|NCT00106353|537045986|FG003|Part 2|Disease progression|0|||
148881831|NCT00106353|537045987|FG004|Part 2|Disease progression|8|||
148881832|NCT00106353|537045988|FG005|Part 2|Disease progression|14|||
148881833|NCT00106353|537045989|FG006|Part 2|Disease progression|13|||
148881834|NCT00106353|537045983|FG000|Part 2|Death|0|||
148881835|NCT00106353|537045984|FG001|Part 2|Death|0|||
148881836|NCT00106353|537045985|FG002|Part 2|Death|0|||
148881837|NCT00106353|537045986|FG003|Part 2|Death|0|||
148881838|NCT00106353|537045987|FG004|Part 2|Death|3|||
148881839|NCT00106353|537045988|FG005|Part 2|Death|0|||
148881840|NCT00106353|537045989|FG006|Part 2|Death|1|||
148881841|NCT00106353|537045983|FG000|Part 2|Symptomatic deterioration|0|||
148881842|NCT00106353|537045984|FG001|Part 2|Symptomatic deterioration|0|||
148881843|NCT00106353|537045985|FG002|Part 2|Symptomatic deterioration|0|||
148881844|NCT00106353|537045986|FG003|Part 2|Symptomatic deterioration|0|||
148881845|NCT00106353|537045987|FG004|Part 2|Symptomatic deterioration|3|||
148881846|NCT00106353|537045988|FG005|Part 2|Symptomatic deterioration|0|||
148881847|NCT00106353|537045989|FG006|Part 2|Symptomatic deterioration|0|||
148881848|NCT00106353|537045983|FG000|Part 2|Adverse Event|0|||
148881849|NCT00106353|537045984|FG001|Part 2|Adverse Event|0|||
148881850|NCT00106353|537045985|FG002|Part 2|Adverse Event|0|||
148881851|NCT00106353|537045986|FG003|Part 2|Adverse Event|0|||
148881852|NCT00106353|537045987|FG004|Part 2|Adverse Event|0|||
148881853|NCT00106353|537045988|FG005|Part 2|Adverse Event|2|||
148881854|NCT00106353|537045989|FG006|Part 2|Adverse Event|1|||
148881855|NCT00106353|537045983|FG000|Part 2|Other|0|||
148881856|NCT00106353|537045984|FG001|Part 2|Other|0|||
148881857|NCT00106353|537045985|FG002|Part 2|Other|0|||
148881858|NCT00106353|537045986|FG003|Part 2|Other|0|||
148881859|NCT00106353|537045987|FG004|Part 2|Other|1|||
148881860|NCT00106353|537045988|FG005|Part 2|Other|1|||
148881861|NCT00106353|537045989|FG006|Part 2|Other|1|||
148881862|NCT00106353|537045983|FG000|Part 2|Withdrawal by Subject|0|||
148881863|NCT00106353|537045984|FG001|Part 2|Withdrawal by Subject|0|||
148881864|NCT00106353|537045985|FG002|Part 2|Withdrawal by Subject|0|||
148881865|NCT00106353|537045986|FG003|Part 2|Withdrawal by Subject|0|||
148881866|NCT00106353|537045987|FG004|Part 2|Withdrawal by Subject|1|||
148881867|NCT00106353|537045988|FG005|Part 2|Withdrawal by Subject|0|||
148881868|NCT00106353|537045989|FG006|Part 2|Withdrawal by Subject|0|||
149038696|NCT01426269|537620482|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
149038697|NCT01426269|537620483|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
149038698|NCT01426269|537620481|FG000|Period 1: 12 Weeks|Pregnancy|1|||
149038699|NCT01426269|537620482|FG001|Period 1: 12 Weeks|Pregnancy|0|||
149038700|NCT01426269|537620483|FG002|Period 1: 12 Weeks|Pregnancy|0|||
149038701|NCT01426269|537620481|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
149038702|NCT01426269|537620482|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
149038703|NCT01426269|537620483|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
149038704|NCT01426269|537620481|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
149038705|NCT01426269|537620482|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
149038706|NCT01426269|537620483|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
149038707|NCT01426269|537620481|FG000|Period 2: 40 Weeks|Adverse Event|0|||
149038708|NCT01426269|537620482|FG001|Period 2: 40 Weeks|Adverse Event|1|||
149038709|NCT01426269|537620483|FG002|Period 2: 40 Weeks|Adverse Event|2|||
149038710|NCT01426269|537620481|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
148881869|NCT00106353|537045983|FG000|Part 2|Physician Decision|0|||
148881870|NCT00106353|537045984|FG001|Part 2|Physician Decision|0|||
148881871|NCT00106353|537045985|FG002|Part 2|Physician Decision|0|||
148881872|NCT00106353|537045986|FG003|Part 2|Physician Decision|0|||
149038711|NCT01426269|537620482|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
149038712|NCT01426269|537620483|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
148881873|NCT00106353|537045987|FG004|Part 2|Physician Decision|0|||
148881874|NCT00106353|537045988|FG005|Part 2|Physician Decision|1|||
148881875|NCT00106353|537045989|FG006|Part 2|Physician Decision|0|||
148881876|NCT03364309|537045990|FG000|Induction Period|Adverse Event|4|||
148881877|NCT03364309|537045991|FG001|Induction Period|Adverse Event|0|||
148881878|NCT03364309|537045992|FG002|Induction Period|Adverse Event|1|||
148881879|NCT03364309|537045993|FG003|Induction Period|Adverse Event|0|||
148881880|NCT03364309|537045994|FG004|Induction Period|Adverse Event|0|||
148881881|NCT03364309|537045995|FG005|Induction Period|Adverse Event|0|||
148881882|NCT03364309|537045996|FG006|Induction Period|Adverse Event|0|||
148881883|NCT03364309|537045997|FG007|Induction Period|Adverse Event|0|||
148881884|NCT03364309|537045998|FG008|Induction Period|Adverse Event|0|||
149038713|NCT01426269|537620481|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
149038714|NCT01426269|537620482|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
149038715|NCT01426269|537620483|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
149038716|NCT01426269|537620481|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
149038717|NCT01426269|537620482|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
149038718|NCT01426269|537620483|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
149038719|NCT01426269|537620481|FG000|Period 2: 40 Weeks|Site closed|0|||
149038720|NCT01426269|537620482|FG001|Period 2: 40 Weeks|Site closed|6|||
149038721|NCT01426269|537620483|FG002|Period 2: 40 Weeks|Site closed|5|||
149038722|NCT01426269|537620481|FG000|Period 2: 40 Weeks|Relapsed|0|||
149038723|NCT01426269|537620482|FG001|Period 2: 40 Weeks|Relapsed|9|||
149038724|NCT01426269|537620483|FG002|Period 2: 40 Weeks|Relapsed|18|||
149038725|NCT00799396|537620485|FG000|Clopidogrel Treatment|Adverse Event|6|||
149038726|NCT00799396|537620485|FG000|Clopidogrel Treatment|Physician Decision|5|||
149038727|NCT00799396|537620485|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
149038728|NCT00799396|537620485|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
149038729|NCT00799396|537620485|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
149038730|NCT01867216|537620486|FG000|Overall Study|Withdrawal by Subject|2|||
149038731|NCT01867216|537620487|FG001|Overall Study|Withdrawal by Subject|0|||
149038732|NCT01867216|537620488|FG002|Overall Study|Withdrawal by Subject|0|||
149038733|NCT01867216|537620489|FG003|Overall Study|Withdrawal by Subject|0|||
149038734|NCT01867216|537620490|FG004|Overall Study|Withdrawal by Subject|1|||
149038735|NCT01867216|537620491|FG005|Overall Study|Withdrawal by Subject|0|||
149038736|NCT01867216|537620492|FG006|Overall Study|Withdrawal by Subject|1|||
149038737|NCT01867216|537620486|FG000|Overall Study|Physician Decision|1|||
149038738|NCT01867216|537620487|FG001|Overall Study|Physician Decision|0|||
148881885|NCT03364309|537045999|FG009|Induction Period|Adverse Event|0|||
148881886|NCT03364309|537046000|FG010|Induction Period|Adverse Event|0|||
148881887|NCT03364309|537046001|FG011|Induction Period|Adverse Event|0|||
148881888|NCT03364309|537046002|FG012|Induction Period|Adverse Event|0|||
148881889|NCT03364309|537046003|FG013|Induction Period|Adverse Event|0|||
148881890|NCT03364309|537046004|FG014|Induction Period|Adverse Event|0|||
148881891|NCT03364309|537046005|FG015|Induction Period|Adverse Event|0|||
148881892|NCT03364309|537046006|FG016|Induction Period|Adverse Event|0|||
148881893|NCT03364309|537046007|FG017|Induction Period|Adverse Event|0|||
148881894|NCT03364309|537046008|FG018|Induction Period|Adverse Event|0|||
148881895|NCT03364309|537045990|FG000|Induction Period|Withdrawal by Subject|1|||
148881896|NCT03364309|537045991|FG001|Induction Period|Withdrawal by Subject|3|||
148881897|NCT03364309|537045992|FG002|Induction Period|Withdrawal by Subject|0|||
148881898|NCT03364309|537045993|FG003|Induction Period|Withdrawal by Subject|0|||
148881899|NCT03364309|537045994|FG004|Induction Period|Withdrawal by Subject|0|||
148881900|NCT03364309|537045995|FG005|Induction Period|Withdrawal by Subject|0|||
148881901|NCT03364309|537045996|FG006|Induction Period|Withdrawal by Subject|0|||
148881902|NCT03364309|537045997|FG007|Induction Period|Withdrawal by Subject|0|||
148881903|NCT03364309|537045998|FG008|Induction Period|Withdrawal by Subject|0|||
148881904|NCT03364309|537045999|FG009|Induction Period|Withdrawal by Subject|0|||
148881905|NCT03364309|537046000|FG010|Induction Period|Withdrawal by Subject|0|||
148881906|NCT03364309|537046001|FG011|Induction Period|Withdrawal by Subject|0|||
148881907|NCT03364309|537046002|FG012|Induction Period|Withdrawal by Subject|0|||
148881908|NCT03364309|537046003|FG013|Induction Period|Withdrawal by Subject|0|||
148881909|NCT03364309|537046004|FG014|Induction Period|Withdrawal by Subject|0|||
148881910|NCT03364309|537046005|FG015|Induction Period|Withdrawal by Subject|0|||
148881911|NCT03364309|537046006|FG016|Induction Period|Withdrawal by Subject|0|||
148881912|NCT03364309|537046007|FG017|Induction Period|Withdrawal by Subject|0|||
148881913|NCT03364309|537046008|FG018|Induction Period|Withdrawal by Subject|0|||
148881914|NCT03364309|537045990|FG000|Induction Period|Lost to Follow-up|1|||
148881915|NCT03364309|537045991|FG001|Induction Period|Lost to Follow-up|0|||
148881916|NCT03364309|537045992|FG002|Induction Period|Lost to Follow-up|0|||
148881917|NCT03364309|537045993|FG003|Induction Period|Lost to Follow-up|0|||
148881918|NCT03364309|537045994|FG004|Induction Period|Lost to Follow-up|0|||
148881919|NCT03364309|537045995|FG005|Induction Period|Lost to Follow-up|0|||
148881920|NCT03364309|537045996|FG006|Induction Period|Lost to Follow-up|0|||
148881921|NCT03364309|537045997|FG007|Induction Period|Lost to Follow-up|0|||
148881922|NCT03364309|537045998|FG008|Induction Period|Lost to Follow-up|0|||
148881923|NCT03364309|537045999|FG009|Induction Period|Lost to Follow-up|0|||
148881924|NCT03364309|537046000|FG010|Induction Period|Lost to Follow-up|0|||
148881925|NCT03364309|537046001|FG011|Induction Period|Lost to Follow-up|0|||
148881926|NCT03364309|537046002|FG012|Induction Period|Lost to Follow-up|0|||
148881927|NCT03364309|537046003|FG013|Induction Period|Lost to Follow-up|0|||
148881928|NCT03364309|537046004|FG014|Induction Period|Lost to Follow-up|0|||
148881929|NCT03364309|537046005|FG015|Induction Period|Lost to Follow-up|0|||
148881930|NCT03364309|537046006|FG016|Induction Period|Lost to Follow-up|0|||
148881931|NCT03364309|537046007|FG017|Induction Period|Lost to Follow-up|0|||
148881932|NCT03364309|537046008|FG018|Induction Period|Lost to Follow-up|0|||
148881933|NCT03364309|537045990|FG000|Induction Period|Physician Decision|0|||
149038739|NCT01867216|537620488|FG002|Overall Study|Physician Decision|0|||
149038740|NCT01867216|537620489|FG003|Overall Study|Physician Decision|0|||
149038741|NCT01867216|537620490|FG004|Overall Study|Physician Decision|0|||
149038742|NCT01867216|537620491|FG005|Overall Study|Physician Decision|0|||
149038743|NCT01867216|537620492|FG006|Overall Study|Physician Decision|0|||
149038744|NCT01867216|537620486|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
149038745|NCT01867216|537620487|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
149038746|NCT01867216|537620488|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
149038747|NCT01867216|537620489|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
149038748|NCT01867216|537620490|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
149038749|NCT01867216|537620491|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
148881934|NCT03364309|537045991|FG001|Induction Period|Physician Decision|1|||
148881935|NCT03364309|537045992|FG002|Induction Period|Physician Decision|0|||
148881936|NCT03364309|537045993|FG003|Induction Period|Physician Decision|0|||
148881937|NCT03364309|537045994|FG004|Induction Period|Physician Decision|0|||
148881938|NCT03364309|537045995|FG005|Induction Period|Physician Decision|0|||
148881939|NCT03364309|537045996|FG006|Induction Period|Physician Decision|0|||
148881940|NCT03364309|537045997|FG007|Induction Period|Physician Decision|0|||
148881941|NCT03364309|537045998|FG008|Induction Period|Physician Decision|0|||
148881942|NCT03364309|537045999|FG009|Induction Period|Physician Decision|0|||
148881943|NCT03364309|537046000|FG010|Induction Period|Physician Decision|0|||
148881944|NCT03364309|537046001|FG011|Induction Period|Physician Decision|0|||
148881945|NCT03364309|537046002|FG012|Induction Period|Physician Decision|0|||
148881946|NCT03364309|537046003|FG013|Induction Period|Physician Decision|0|||
148881947|NCT03364309|537046004|FG014|Induction Period|Physician Decision|0|||
148881948|NCT03364309|537046005|FG015|Induction Period|Physician Decision|0|||
148881949|NCT03364309|537046006|FG016|Induction Period|Physician Decision|0|||
148881950|NCT03364309|537046007|FG017|Induction Period|Physician Decision|0|||
148881951|NCT03364309|537046008|FG018|Induction Period|Physician Decision|0|||
148881952|NCT03364309|537045990|FG000|Maintenance Period|Withdrawal by Subject|0|||
148881953|NCT03364309|537045991|FG001|Maintenance Period|Withdrawal by Subject|0|||
148881954|NCT03364309|537045992|FG002|Maintenance Period|Withdrawal by Subject|0|||
148881955|NCT03364309|537045993|FG003|Maintenance Period|Withdrawal by Subject|1|||
148881956|NCT03364309|537045994|FG004|Maintenance Period|Withdrawal by Subject|3|||
148881957|NCT03364309|537045995|FG005|Maintenance Period|Withdrawal by Subject|1|||
148881958|NCT03364309|537045996|FG006|Maintenance Period|Withdrawal by Subject|3|||
148881959|NCT03364309|537045997|FG007|Maintenance Period|Withdrawal by Subject|0|||
148881960|NCT03364309|537045998|FG008|Maintenance Period|Withdrawal by Subject|1|||
148881961|NCT03364309|537045999|FG009|Maintenance Period|Withdrawal by Subject|1|||
148881962|NCT03364309|537046000|FG010|Maintenance Period|Withdrawal by Subject|2|||
148881963|NCT03364309|537046001|FG011|Maintenance Period|Withdrawal by Subject|0|||
148881964|NCT03364309|537046002|FG012|Maintenance Period|Withdrawal by Subject|0|||
148881965|NCT03364309|537046003|FG013|Maintenance Period|Withdrawal by Subject|0|||
148881966|NCT03364309|537046004|FG014|Maintenance Period|Withdrawal by Subject|0|||
148881967|NCT03364309|537046005|FG015|Maintenance Period|Withdrawal by Subject|0|||
148881968|NCT03364309|537046006|FG016|Maintenance Period|Withdrawal by Subject|0|||
148881969|NCT03364309|537046007|FG017|Maintenance Period|Withdrawal by Subject|0|||
148881970|NCT03364309|537046008|FG018|Maintenance Period|Withdrawal by Subject|0|||
148881971|NCT03364309|537045990|FG000|Maintenance Period|Adverse Event|0|||
148881972|NCT03364309|537045991|FG001|Maintenance Period|Adverse Event|0|||
149038750|NCT01867216|537620492|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
149038751|NCT01765543|537620503|FG000|Overall Study|Death|1|||
149038752|NCT01765543|537620503|FG000|Overall Study|Withdrawal by Subject|2|||
149038753|NCT03454529|537620504|FG000|Overall Study|Did not receive treatment|6|||
148881973|NCT03364309|537045992|FG002|Maintenance Period|Adverse Event|0|||
148881974|NCT03364309|537045993|FG003|Maintenance Period|Adverse Event|0|||
148881975|NCT03364309|537045994|FG004|Maintenance Period|Adverse Event|2|||
148881976|NCT03364309|537045995|FG005|Maintenance Period|Adverse Event|0|||
148881977|NCT03364309|537045996|FG006|Maintenance Period|Adverse Event|3|||
148881978|NCT03364309|537045997|FG007|Maintenance Period|Adverse Event|0|||
148881979|NCT03364309|537045998|FG008|Maintenance Period|Adverse Event|1|||
149038754|NCT03454529|537620504|FG000|Overall Study|Received < 80% doses|1|||
149038755|NCT05694065|537620505|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
149038756|NCT05694065|537620505|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
149038757|NCT05694065|537620505|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
149038758|NCT01145885|537620506|FG000|Overall Study|Progressive Disease|7|||
148881980|NCT03364309|537045999|FG009|Maintenance Period|Adverse Event|0|||
148881981|NCT03364309|537046000|FG010|Maintenance Period|Adverse Event|2|||
148881982|NCT03364309|537046001|FG011|Maintenance Period|Adverse Event|0|||
148881983|NCT03364309|537046002|FG012|Maintenance Period|Adverse Event|0|||
148881984|NCT03364309|537046003|FG013|Maintenance Period|Adverse Event|0|||
148881985|NCT03364309|537046004|FG014|Maintenance Period|Adverse Event|0|||
148881986|NCT03364309|537046005|FG015|Maintenance Period|Adverse Event|0|||
148881987|NCT03364309|537046006|FG016|Maintenance Period|Adverse Event|0|||
148881988|NCT03364309|537046007|FG017|Maintenance Period|Adverse Event|0|||
148881989|NCT03364309|537046008|FG018|Maintenance Period|Adverse Event|0|||
148881990|NCT03364309|537045990|FG000|Maintenance Period|Relapsed|0|||
148881991|NCT03364309|537045991|FG001|Maintenance Period|Relapsed|0|||
148881992|NCT03364309|537045992|FG002|Maintenance Period|Relapsed|0|||
148881993|NCT03364309|537045993|FG003|Maintenance Period|Relapsed|43|||
148881994|NCT03364309|537045994|FG004|Maintenance Period|Relapsed|7|||
149038759|NCT05299606|537620507|FG000|Overall Study|Death|1|||
149038760|NCT00723450|537620508|FG000|Open-Label Phase|Adverse Event|26|||
149038761|NCT00723450|537620509|FG001|Open-Label Phase|Adverse Event|0|||
149038762|NCT00723450|537620510|FG002|Open-Label Phase|Adverse Event|0|||
149038763|NCT00723450|537620508|FG000|Open-Label Phase|Lack of Efficacy|18|||
149038764|NCT00723450|537620509|FG001|Open-Label Phase|Lack of Efficacy|0|||
149038765|NCT00723450|537620510|FG002|Open-Label Phase|Lack of Efficacy|0|||
149038766|NCT00723450|537620508|FG000|Open-Label Phase|Protocol Violation|35|||
149038767|NCT00723450|537620509|FG001|Open-Label Phase|Protocol Violation|0|||
149038768|NCT00723450|537620510|FG002|Open-Label Phase|Protocol Violation|0|||
149038769|NCT00723450|537620508|FG000|Open-Label Phase|Lost to Follow-up|7|||
149038770|NCT00723450|537620509|FG001|Open-Label Phase|Lost to Follow-up|0|||
149038771|NCT00723450|537620510|FG002|Open-Label Phase|Lost to Follow-up|0|||
149038772|NCT00723450|537620508|FG000|Open-Label Phase|Physician Decision|2|||
149038773|NCT00723450|537620509|FG001|Open-Label Phase|Physician Decision|0|||
149038774|NCT00723450|537620510|FG002|Open-Label Phase|Physician Decision|0|||
149038775|NCT00723450|537620508|FG000|Open-Label Phase|Withdrawal by Subject|37|||
149038776|NCT00723450|537620509|FG001|Open-Label Phase|Withdrawal by Subject|0|||
149038777|NCT00723450|537620510|FG002|Open-Label Phase|Withdrawal by Subject|0|||
149038778|NCT00723450|537620508|FG000|Randomized Phase|Adverse Event|0|||
149038779|NCT00723450|537620509|FG001|Randomized Phase|Adverse Event|26|||
149038780|NCT00723450|537620510|FG002|Randomized Phase|Adverse Event|17|||
149038781|NCT00723450|537620508|FG000|Randomized Phase|Lack of Efficacy|0|||
149038782|NCT00723450|537620509|FG001|Randomized Phase|Lack of Efficacy|11|||
149038783|NCT00723450|537620510|FG002|Randomized Phase|Lack of Efficacy|11|||
149038784|NCT00723450|537620508|FG000|Randomized Phase|Protocol Violation|0|||
149038785|NCT00723450|537620509|FG001|Randomized Phase|Protocol Violation|9|||
149038786|NCT00723450|537620510|FG002|Randomized Phase|Protocol Violation|13|||
149038787|NCT00723450|537620508|FG000|Randomized Phase|Lost to Follow-up|0|||
149038788|NCT00723450|537620509|FG001|Randomized Phase|Lost to Follow-up|2|||
149038789|NCT00723450|537620510|FG002|Randomized Phase|Lost to Follow-up|3|||
149038790|NCT00723450|537620508|FG000|Randomized Phase|Physician Decision|0|||
149038791|NCT00723450|537620509|FG001|Randomized Phase|Physician Decision|3|||
149038792|NCT00723450|537620510|FG002|Randomized Phase|Physician Decision|1|||
149038793|NCT00723450|537620508|FG000|Randomized Phase|Withdrawal by Subject|0|||
149038794|NCT00723450|537620509|FG001|Randomized Phase|Withdrawal by Subject|14|||
149038795|NCT00723450|537620510|FG002|Randomized Phase|Withdrawal by Subject|22|||
149038796|NCT02880241|537620511|FG000|Overall Study|Lack of Efficacy|1|||
149038797|NCT02880241|537620512|FG001|Overall Study|Lack of Efficacy|0|||
149038798|NCT02880241|537620513|FG002|Overall Study|Lack of Efficacy|0|||
149038799|NCT02880241|537620514|FG003|Overall Study|Lack of Efficacy|0|||
149038800|NCT02880241|537620515|FG004|Overall Study|Lack of Efficacy|0|||
149038801|NCT02880241|537620516|FG005|Overall Study|Lack of Efficacy|0|||
149038802|NCT02537522|537620517|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
149038803|NCT02537522|537620518|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
149038804|NCT02537522|537620519|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
149038805|NCT02537522|537620520|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
149038806|NCT02537522|537620517|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
149038807|NCT02537522|537620518|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
149038808|NCT02537522|537620519|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
149038809|NCT02537522|537620520|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
149038810|NCT02537522|537620517|FG000|Phase I - Contralateral|incorrect randomization|0|||
149038811|NCT02537522|537620518|FG001|Phase I - Contralateral|incorrect randomization|1|||
149038812|NCT02537522|537620519|FG002|Phase I - Contralateral|incorrect randomization|0|||
149038813|NCT02537522|537620520|FG003|Phase I - Contralateral|incorrect randomization|0|||
149038814|NCT02537522|537620517|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
149038815|NCT02537522|537620518|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
149038816|NCT02537522|537620519|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
148881995|NCT03364309|537045995|FG005|Maintenance Period|Relapsed|45|||
149038817|NCT02537522|537620520|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
149038818|NCT02537522|537620517|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
149038819|NCT02537522|537620518|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
149038820|NCT02537522|537620519|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
149038821|NCT02537522|537620520|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
149038822|NCT00545077|537620522|FG000|Overall Study|Treatment not received|5|||
149038823|NCT00545077|537620523|FG001|Overall Study|Treatment not received|1|||
149038824|NCT00545077|537620522|FG000|Overall Study|Disease Progression|131|||
148881996|NCT03364309|537045996|FG006|Maintenance Period|Relapsed|10|||
148881997|NCT03364309|537045997|FG007|Maintenance Period|Relapsed|2|||
148881998|NCT03364309|537045998|FG008|Maintenance Period|Relapsed|0|||
149038825|NCT00545077|537620523|FG001|Overall Study|Disease Progression|98|||
149038826|NCT00545077|537620522|FG000|Overall Study|Withdrawal by Subject|3|||
148881999|NCT03364309|537045999|FG009|Maintenance Period|Relapsed|0|||
148882000|NCT03364309|537046000|FG010|Maintenance Period|Relapsed|0|||
148882001|NCT03364309|537046001|FG011|Maintenance Period|Relapsed|0|||
148882002|NCT03364309|537046002|FG012|Maintenance Period|Relapsed|0|||
148882003|NCT03364309|537046003|FG013|Maintenance Period|Relapsed|0|||
148882004|NCT03364309|537046004|FG014|Maintenance Period|Relapsed|0|||
148882005|NCT03364309|537046005|FG015|Maintenance Period|Relapsed|0|||
149038827|NCT00545077|537620523|FG001|Overall Study|Withdrawal by Subject|14|||
149038828|NCT00545077|537620522|FG000|Overall Study|Physician Decision|6|||
149038829|NCT00545077|537620523|FG001|Overall Study|Physician Decision|3|||
149038830|NCT00545077|537620522|FG000|Overall Study|Lost to Follow-up|2|||
149038831|NCT00545077|537620523|FG001|Overall Study|Lost to Follow-up|0|||
149038832|NCT00545077|537620522|FG000|Overall Study|Protocol Violation|1|||
149038833|NCT00545077|537620523|FG001|Overall Study|Protocol Violation|0|||
149038834|NCT00545077|537620522|FG000|Overall Study|Adverse Event|0|||
149038835|NCT00545077|537620523|FG001|Overall Study|Adverse Event|31|||
149038836|NCT00545077|537620522|FG000|Overall Study|Death|0|||
149038837|NCT00545077|537620523|FG001|Overall Study|Death|8|||
149038838|NCT00843882|537620524|FG000|Step 1|Lack of Efficacy|14|||
149038839|NCT00843882|537620525|FG001|Step 1|Lack of Efficacy|10|||
148882006|NCT03364309|537046006|FG016|Maintenance Period|Relapsed|0|||
148882007|NCT03364309|537046007|FG017|Maintenance Period|Relapsed|0|||
148882008|NCT03364309|537046008|FG018|Maintenance Period|Relapsed|0|||
148882009|NCT03364309|537045990|FG000|Maintenance Period|Lack of Efficacy|0|||
148882010|NCT03364309|537045991|FG001|Maintenance Period|Lack of Efficacy|0|||
148882011|NCT03364309|537045992|FG002|Maintenance Period|Lack of Efficacy|0|||
148882012|NCT03364309|537045993|FG003|Maintenance Period|Lack of Efficacy|0|||
148882013|NCT03364309|537045994|FG004|Maintenance Period|Lack of Efficacy|0|||
148882014|NCT03364309|537045995|FG005|Maintenance Period|Lack of Efficacy|0|||
149038840|NCT00843882|537620526|FG002|Step 1|Lack of Efficacy|21|||
149038841|NCT00843882|537620524|FG000|Step 1|Adverse Event|8|||
149038842|NCT00843882|537620525|FG001|Step 1|Adverse Event|17|||
149038843|NCT00843882|537620526|FG002|Step 1|Adverse Event|20|||
149038844|NCT00843882|537620524|FG000|Step 1|Death|1|||
149038845|NCT00843882|537620525|FG001|Step 1|Death|2|||
149038846|NCT00843882|537620526|FG002|Step 1|Death|4|||
149038847|NCT00843882|537620524|FG000|Step 1|Withdrawal by Subject|6|||
149038848|NCT00843882|537620525|FG001|Step 1|Withdrawal by Subject|12|||
149038849|NCT00843882|537620526|FG002|Step 1|Withdrawal by Subject|9|||
149038850|NCT00843882|537620524|FG000|Step 1|Physician Decision|0|||
149038851|NCT00843882|537620525|FG001|Step 1|Physician Decision|5|||
149038852|NCT00843882|537620526|FG002|Step 1|Physician Decision|1|||
149038853|NCT00843882|537620524|FG000|Step 1|Patient and physician's decision|0|||
149038854|NCT00843882|537620525|FG001|Step 1|Patient and physician's decision|0|||
149038855|NCT00843882|537620526|FG002|Step 1|Patient and physician's decision|1|||
149038856|NCT00843882|537620524|FG000|Step 1|Other complicating disease|1|||
149038857|NCT00843882|537620525|FG001|Step 1|Other complicating disease|3|||
149038858|NCT00843882|537620526|FG002|Step 1|Other complicating disease|4|||
149038859|NCT00843882|537620524|FG000|Step 1|Alternative therapy|0|||
149038860|NCT00843882|537620525|FG001|Step 1|Alternative therapy|1|||
149038861|NCT00843882|537620526|FG002|Step 1|Alternative therapy|1|||
149038862|NCT00843882|537620524|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
149038863|NCT00843882|537620525|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
149038864|NCT00843882|537620526|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
149038865|NCT00843882|537620524|FG000|Step 1|Off treatment reason unknown|0|||
149038866|NCT00843882|537620525|FG001|Step 1|Off treatment reason unknown|1|||
149038867|NCT00843882|537620526|FG002|Step 1|Off treatment reason unknown|4|||
149038868|NCT00843882|537620524|FG000|Step 1|Never started treatment|2|||
149038869|NCT00843882|537620525|FG001|Step 1|Never started treatment|0|||
149038870|NCT00843882|537620526|FG002|Step 1|Never started treatment|0|||
149038871|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
149038872|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
149038873|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
149038874|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
149038875|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
149038876|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
149038877|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
149038878|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
148882015|NCT03364309|537045996|FG006|Maintenance Period|Lack of Efficacy|0|||
148882016|NCT03364309|537045997|FG007|Maintenance Period|Lack of Efficacy|0|||
149038879|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
149038880|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
149038881|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
149038882|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
149038883|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
148882017|NCT03364309|537045998|FG008|Maintenance Period|Lack of Efficacy|1|||
148882018|NCT03364309|537045999|FG009|Maintenance Period|Lack of Efficacy|3|||
148882019|NCT03364309|537046000|FG010|Maintenance Period|Lack of Efficacy|2|||
148882020|NCT03364309|537046001|FG011|Maintenance Period|Lack of Efficacy|0|||
148882021|NCT03364309|537046002|FG012|Maintenance Period|Lack of Efficacy|0|||
148882022|NCT03364309|537046003|FG013|Maintenance Period|Lack of Efficacy|0|||
148882023|NCT03364309|537046004|FG014|Maintenance Period|Lack of Efficacy|0|||
148882024|NCT03364309|537046005|FG015|Maintenance Period|Lack of Efficacy|0|||
148882025|NCT03364309|537046006|FG016|Maintenance Period|Lack of Efficacy|0|||
148882026|NCT03364309|537046007|FG017|Maintenance Period|Lack of Efficacy|0|||
148882027|NCT03364309|537046008|FG018|Maintenance Period|Lack of Efficacy|0|||
148882028|NCT03364309|537045990|FG000|Maintenance Period|Death|0|||
148882029|NCT03364309|537045991|FG001|Maintenance Period|Death|0|||
148882030|NCT03364309|537045992|FG002|Maintenance Period|Death|0|||
148882031|NCT03364309|537045993|FG003|Maintenance Period|Death|0|||
148882032|NCT03364309|537045994|FG004|Maintenance Period|Death|0|||
148882033|NCT03364309|537045995|FG005|Maintenance Period|Death|0|||
148882034|NCT03364309|537045996|FG006|Maintenance Period|Death|0|||
148882035|NCT03364309|537045997|FG007|Maintenance Period|Death|0|||
148882036|NCT03364309|537045998|FG008|Maintenance Period|Death|1|||
148882037|NCT03364309|537045999|FG009|Maintenance Period|Death|0|||
148882038|NCT03364309|537046000|FG010|Maintenance Period|Death|0|||
148882039|NCT03364309|537046001|FG011|Maintenance Period|Death|0|||
148882040|NCT03364309|537046002|FG012|Maintenance Period|Death|0|||
148882041|NCT03364309|537046003|FG013|Maintenance Period|Death|0|||
148882042|NCT03364309|537046004|FG014|Maintenance Period|Death|0|||
148882043|NCT03364309|537046005|FG015|Maintenance Period|Death|0|||
148882044|NCT03364309|537046006|FG016|Maintenance Period|Death|0|||
148882045|NCT03364309|537046007|FG017|Maintenance Period|Death|0|||
148882046|NCT03364309|537046008|FG018|Maintenance Period|Death|0|||
148882047|NCT03364309|537045990|FG000|Maintenance Period|Lost to Follow-up|0|||
148882048|NCT03364309|537045991|FG001|Maintenance Period|Lost to Follow-up|0|||
148882049|NCT03364309|537045992|FG002|Maintenance Period|Lost to Follow-up|0|||
148882050|NCT03364309|537045993|FG003|Maintenance Period|Lost to Follow-up|0|||
148882051|NCT03364309|537045994|FG004|Maintenance Period|Lost to Follow-up|0|||
148882052|NCT03364309|537045995|FG005|Maintenance Period|Lost to Follow-up|0|||
148882053|NCT03364309|537045996|FG006|Maintenance Period|Lost to Follow-up|0|||
148882054|NCT03364309|537045997|FG007|Maintenance Period|Lost to Follow-up|0|||
148882055|NCT03364309|537045998|FG008|Maintenance Period|Lost to Follow-up|1|||
148882056|NCT03364309|537045999|FG009|Maintenance Period|Lost to Follow-up|0|||
148882057|NCT03364309|537046000|FG010|Maintenance Period|Lost to Follow-up|0|||
148882058|NCT03364309|537046001|FG011|Maintenance Period|Lost to Follow-up|0|||
148882059|NCT03364309|537046002|FG012|Maintenance Period|Lost to Follow-up|0|||
148882060|NCT03364309|537046003|FG013|Maintenance Period|Lost to Follow-up|0|||
148882061|NCT03364309|537046004|FG014|Maintenance Period|Lost to Follow-up|0|||
148882062|NCT03364309|537046005|FG015|Maintenance Period|Lost to Follow-up|0|||
148882063|NCT03364309|537046006|FG016|Maintenance Period|Lost to Follow-up|0|||
148882064|NCT03364309|537046007|FG017|Maintenance Period|Lost to Follow-up|0|||
148882065|NCT03364309|537046008|FG018|Maintenance Period|Lost to Follow-up|0|||
148882066|NCT03364309|537045990|FG000|Maintenance Period|Miscellaneous|0|||
148882067|NCT03364309|537045991|FG001|Maintenance Period|Miscellaneous|0|||
149003984|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
149003985|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
149003986|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
149003987|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
149003988|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
149003989|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
149003990|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
149003991|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
149003992|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
149003993|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
149003994|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
149003995|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
149003996|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
149003997|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
148882068|NCT03364309|537045992|FG002|Maintenance Period|Miscellaneous|0|||
149003998|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
149003999|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
149038884|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
148882069|NCT03364309|537045993|FG003|Maintenance Period|Miscellaneous|0|||
148882070|NCT03364309|537045994|FG004|Maintenance Period|Miscellaneous|0|||
148882071|NCT03364309|537045995|FG005|Maintenance Period|Miscellaneous|0|||
148882072|NCT03364309|537045996|FG006|Maintenance Period|Miscellaneous|0|||
148882073|NCT03364309|537045997|FG007|Maintenance Period|Miscellaneous|0|||
148882074|NCT03364309|537045998|FG008|Maintenance Period|Miscellaneous|1|||
148882075|NCT03364309|537045999|FG009|Maintenance Period|Miscellaneous|0|||
148882076|NCT03364309|537046000|FG010|Maintenance Period|Miscellaneous|0|||
148882077|NCT03364309|537046001|FG011|Maintenance Period|Miscellaneous|0|||
148882078|NCT03364309|537046002|FG012|Maintenance Period|Miscellaneous|0|||
148882079|NCT03364309|537046003|FG013|Maintenance Period|Miscellaneous|0|||
148882080|NCT03364309|537046004|FG014|Maintenance Period|Miscellaneous|0|||
148882081|NCT03364309|537046005|FG015|Maintenance Period|Miscellaneous|0|||
148882082|NCT03364309|537046006|FG016|Maintenance Period|Miscellaneous|0|||
148882083|NCT03364309|537046007|FG017|Maintenance Period|Miscellaneous|0|||
148882084|NCT03364309|537046008|FG018|Maintenance Period|Miscellaneous|0|||
148882085|NCT03364309|537045990|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882086|NCT03364309|537045991|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882087|NCT03364309|537045992|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882088|NCT03364309|537045993|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882089|NCT03364309|537045994|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882090|NCT03364309|537045995|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882091|NCT03364309|537045996|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882092|NCT03364309|537045997|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882093|NCT03364309|537045998|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882094|NCT03364309|537045999|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882095|NCT03364309|537046000|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882096|NCT03364309|537046001|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882097|NCT03364309|537046002|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882098|NCT03364309|537046003|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
148882099|NCT03364309|537046004|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
148882100|NCT03364309|537046005|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
148882101|NCT03364309|537046006|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882102|NCT03364309|537046007|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882103|NCT03364309|537046008|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
148882104|NCT03364309|537045990|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882105|NCT03364309|537045991|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882106|NCT03364309|537045992|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882107|NCT03364309|537045993|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882108|NCT03364309|537045994|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882109|NCT03364309|537045995|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882110|NCT03364309|537045996|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882111|NCT03364309|537045997|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882112|NCT03364309|537045998|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882113|NCT03364309|537045999|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882114|NCT03364309|537046000|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882115|NCT03364309|537046001|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882116|NCT03364309|537046002|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882117|NCT03364309|537046003|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882118|NCT03364309|537046004|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
148882119|NCT03364309|537046005|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882120|NCT03364309|537046006|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882121|NCT03364309|537046007|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882122|NCT03364309|537046008|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
148882123|NCT03364309|537045990|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
148882124|NCT03364309|537045991|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
148882125|NCT03364309|537045992|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
148882126|NCT03364309|537045993|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
148882127|NCT03364309|537045994|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
148882128|NCT03364309|537045995|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
148882129|NCT03364309|537045996|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
148882130|NCT03364309|537045997|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
148882131|NCT03364309|537045998|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
148882132|NCT03364309|537045999|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
148882133|NCT03364309|537046000|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
148882134|NCT03364309|537046001|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
148882135|NCT03364309|537046002|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
148882136|NCT03364309|537046003|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
148882137|NCT03364309|537046004|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
148882138|NCT03364309|537046005|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
148882139|NCT03364309|537046006|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
148882140|NCT03364309|537046007|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
148882141|NCT03364309|537046008|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
148882142|NCT03364309|537045990|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882143|NCT03364309|537045991|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882144|NCT03364309|537045992|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882145|NCT03364309|537045993|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882146|NCT03364309|537045994|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882147|NCT03364309|537045995|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882148|NCT03364309|537045996|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882149|NCT03364309|537045997|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882150|NCT03364309|537045998|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882151|NCT03364309|537045999|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882152|NCT03364309|537046000|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882153|NCT03364309|537046001|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882154|NCT03364309|537046002|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882155|NCT03364309|537046003|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882156|NCT03364309|537046004|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882157|NCT03364309|537046005|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
148882158|NCT03364309|537046006|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
148882159|NCT03364309|537046007|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
148882160|NCT03364309|537046008|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
148882161|NCT03364309|537045990|FG000|Post-Treatment Followup Period|Adverse Event|0|||
148882162|NCT03364309|537045991|FG001|Post-Treatment Followup Period|Adverse Event|0|||
148882163|NCT03364309|537045992|FG002|Post-Treatment Followup Period|Adverse Event|0|||
148882164|NCT03364309|537045993|FG003|Post-Treatment Followup Period|Adverse Event|0|||
148882165|NCT03364309|537045994|FG004|Post-Treatment Followup Period|Adverse Event|0|||
148882166|NCT03364309|537045995|FG005|Post-Treatment Followup Period|Adverse Event|0|||
148882167|NCT03364309|537045996|FG006|Post-Treatment Followup Period|Adverse Event|0|||
148882168|NCT03364309|537045997|FG007|Post-Treatment Followup Period|Adverse Event|0|||
148882169|NCT03364309|537045998|FG008|Post-Treatment Followup Period|Adverse Event|0|||
148882170|NCT03364309|537045999|FG009|Post-Treatment Followup Period|Adverse Event|0|||
148882171|NCT03364309|537046000|FG010|Post-Treatment Followup Period|Adverse Event|0|||
148882172|NCT03364309|537046001|FG011|Post-Treatment Followup Period|Adverse Event|0|||
148882173|NCT03364309|537046002|FG012|Post-Treatment Followup Period|Adverse Event|0|||
148882174|NCT03364309|537046003|FG013|Post-Treatment Followup Period|Adverse Event|0|||
148882175|NCT03364309|537046004|FG014|Post-Treatment Followup Period|Adverse Event|0|||
148882176|NCT03364309|537046005|FG015|Post-Treatment Followup Period|Adverse Event|0|||
148882177|NCT03364309|537046006|FG016|Post-Treatment Followup Period|Adverse Event|2|||
148882178|NCT03364309|537046007|FG017|Post-Treatment Followup Period|Adverse Event|6|||
148882179|NCT03364309|537046008|FG018|Post-Treatment Followup Period|Adverse Event|1|||
148882180|NCT03364309|537045990|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882181|NCT03364309|537045991|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882182|NCT03364309|537045992|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882183|NCT03364309|537045993|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882184|NCT03364309|537045994|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882185|NCT03364309|537045995|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882186|NCT03364309|537045996|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882187|NCT03364309|537045997|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882188|NCT03364309|537045998|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882189|NCT03364309|537045999|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882190|NCT03364309|537046000|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882191|NCT03364309|537046001|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882192|NCT03364309|537046002|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882193|NCT03364309|537046003|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882194|NCT03364309|537046004|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882195|NCT03364309|537046005|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882196|NCT03364309|537046006|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882197|NCT03364309|537046007|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
148882198|NCT03364309|537046008|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
148882199|NCT03364309|537045990|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
149004000|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
149004001|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
149004002|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
149004003|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
149004004|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
148882200|NCT03364309|537045991|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
148882201|NCT03364309|537045992|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
149004005|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
149004006|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
149004007|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
148882202|NCT03364309|537045993|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
148882203|NCT03364309|537045994|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
148882204|NCT03364309|537045995|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
148882205|NCT03364309|537045996|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
148882206|NCT03364309|537045997|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
148882207|NCT03364309|537045998|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
148882208|NCT03364309|537045999|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
148882209|NCT03364309|537046000|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
148882210|NCT03364309|537046001|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
148882211|NCT03364309|537046002|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
148882212|NCT03364309|537046003|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
148882213|NCT03364309|537046004|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
148882214|NCT03364309|537046005|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
148882215|NCT03364309|537046006|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
148882216|NCT03364309|537046007|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
148882217|NCT03364309|537046008|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
148882218|NCT01371552|537046009|FG000|Part 1, First 3 Days|Inconvenience|0|||
148882219|NCT01371552|537046010|FG001|Part 1, First 3 Days|Inconvenience|0|||
148882220|NCT01371552|537046011|FG002|Part 1, First 3 Days|Inconvenience|1|||
148882221|NCT01371552|537046012|FG003|Part 1, First 3 Days|Inconvenience|0|||
148882222|NCT01371552|537046013|FG004|Part 1, First 3 Days|Inconvenience|0|||
148882223|NCT01371552|537046014|FG005|Part 1, First 3 Days|Inconvenience|0|||
148882224|NCT00615992|537046015|FG000|Overall Study|Protocol Violation|67|||
148882225|NCT03319212|537046016|FG000|Overall Study|Discontinued as moving out of local area|0|||
148882226|NCT03319212|537046017|FG001|Overall Study|Discontinued as moving out of local area|1|||
148882227|NCT03319212|537046016|FG000|Overall Study|Adverse Event|2|||
148882228|NCT03319212|537046017|FG001|Overall Study|Adverse Event|2|||
148882229|NCT03319212|537046016|FG000|Overall Study|Withdrawal by Subject|0|||
148882230|NCT03319212|537046017|FG001|Overall Study|Withdrawal by Subject|1|||
148882231|NCT03319212|537046016|FG000|Overall Study|Lost to Follow-up|0|||
148882232|NCT03319212|537046017|FG001|Overall Study|Lost to Follow-up|1|||
148882233|NCT03319212|537046016|FG000|Overall Study|Physician Decision|1|||
148882234|NCT03319212|537046017|FG001|Overall Study|Physician Decision|0|||
148882235|NCT04072887|537046019|FG000|Overall Study|Withdrawal by Subject|3|||
148882236|NCT04072887|537046020|FG001|Overall Study|Withdrawal by Subject|8|||
148882237|NCT04072887|537046021|FG002|Overall Study|Withdrawal by Subject|1|||
148882238|NCT04072887|537046022|FG003|Overall Study|Withdrawal by Subject|3|||
148882239|NCT04072887|537046023|FG004|Overall Study|Withdrawal by Subject|3|||
148882240|NCT04072887|537046024|FG005|Overall Study|Withdrawal by Subject|13|||
148882241|NCT04072887|537046019|FG000|Overall Study|Adverse Event|2|||
148882242|NCT04072887|537046020|FG001|Overall Study|Adverse Event|4|||
148882243|NCT04072887|537046021|FG002|Overall Study|Adverse Event|1|||
148882244|NCT04072887|537046022|FG003|Overall Study|Adverse Event|4|||
148882245|NCT04072887|537046023|FG004|Overall Study|Adverse Event|0|||
148882246|NCT04072887|537046024|FG005|Overall Study|Adverse Event|1|||
148882247|NCT04072887|537046019|FG000|Overall Study|Physician Decision|2|||
148882248|NCT04072887|537046020|FG001|Overall Study|Physician Decision|0|||
148882249|NCT04072887|537046021|FG002|Overall Study|Physician Decision|0|||
148882250|NCT04072887|537046022|FG003|Overall Study|Physician Decision|0|||
148882251|NCT04072887|537046023|FG004|Overall Study|Physician Decision|0|||
148882252|NCT04072887|537046024|FG005|Overall Study|Physician Decision|1|||
148882253|NCT04072887|537046019|FG000|Overall Study|Lost to Follow-up|1|||
148882254|NCT04072887|537046020|FG001|Overall Study|Lost to Follow-up|3|||
148882255|NCT04072887|537046021|FG002|Overall Study|Lost to Follow-up|0|||
148882256|NCT04072887|537046022|FG003|Overall Study|Lost to Follow-up|0|||
148882257|NCT04072887|537046023|FG004|Overall Study|Lost to Follow-up|0|||
148882258|NCT04072887|537046024|FG005|Overall Study|Lost to Follow-up|0|||
148882259|NCT04072887|537046019|FG000|Overall Study|Death|0|||
148882260|NCT04072887|537046020|FG001|Overall Study|Death|2|||
148882261|NCT04072887|537046021|FG002|Overall Study|Death|0|||
148882262|NCT04072887|537046022|FG003|Overall Study|Death|2|||
148882263|NCT04072887|537046023|FG004|Overall Study|Death|3|||
148882264|NCT04072887|537046024|FG005|Overall Study|Death|0|||
148882265|NCT00856297|537046025|FG000|Overall Study|Unable to classify|2|||
148882266|NCT00856297|537046026|FG001|Overall Study|Unable to classify|0|||
148882267|NCT00856297|537046027|FG002|Overall Study|Unable to classify|0|||
148882268|NCT00856297|537046028|FG003|Overall Study|Unable to classify|0|||
149038885|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
148882269|NCT00856297|537046029|FG004|Overall Study|Unable to classify|0|||
148882270|NCT02508428|537046032|FG000|Overall Study|Death|32|||
148882271|NCT02508428|537046033|FG001|Overall Study|Death|33|||
148882272|NCT02508428|537046032|FG000|Overall Study|Liner revised|3|||
148882273|NCT02508428|537046033|FG001|Overall Study|Liner revised|19|||
148882274|NCT02508428|537046032|FG000|Overall Study|Incomplete follow-up|17|||
148882275|NCT02508428|537046033|FG001|Overall Study|Incomplete follow-up|15|||
148882276|NCT04371666|537046035|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
149038886|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
148882277|NCT04371666|537046036|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
148882278|NCT04371666|537046035|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
148882279|NCT04371666|537046036|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
148882280|NCT04371666|537046035|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
148882281|NCT04371666|537046036|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
148882282|NCT04371666|537046035|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
148882283|NCT04371666|537046036|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
148882284|NCT04371666|537046035|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
148882285|NCT04371666|537046036|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
148882286|NCT04371666|537046035|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
148882287|NCT04371666|537046036|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
148882288|NCT02123576|537046037|FG000|Overall Study|Adverse Event|1|||
148882289|NCT02123576|537046038|FG001|Overall Study|Adverse Event|0|||
148882290|NCT03228212|537046039|FG000|Period 1|Adverse Event|1|||
148882291|NCT03228212|537046040|FG001|Period 1|Adverse Event|0|||
148882292|NCT03228212|537046039|FG000|Period 1|no longer meets eligibility criteria|0|||
148882293|NCT03228212|537046040|FG001|Period 1|no longer meets eligibility criteria|1|||
148882294|NCT03228212|537046039|FG000|Period 2|Lost to Follow-up|1|||
148882295|NCT03228212|537046040|FG001|Period 2|Lost to Follow-up|0|||
148882296|NCT00934128|537046041|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
148882297|NCT00934128|537046042|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
148882298|NCT00934128|537046041|FG000|First Intervention (2 Hours)|Adverse Event|4|||
148882299|NCT00934128|537046042|FG001|First Intervention (2 Hours)|Adverse Event|1|||
148882300|NCT00934128|537046041|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
148882301|NCT00934128|537046042|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
148882302|NCT00934128|537046041|FG000|Washout Period (1 Hour)|Patient preference|1|||
148882303|NCT00934128|537046042|FG001|Washout Period (1 Hour)|Patient preference|3|||
148882304|NCT00934128|537046041|FG000|Washout Period (1 Hour)|Pain|1|||
148882305|NCT00934128|537046042|FG001|Washout Period (1 Hour)|Pain|0|||
148882306|NCT00934128|537046041|FG000|Washout Period (1 Hour)|Too tired|1|||
148882307|NCT00934128|537046042|FG001|Washout Period (1 Hour)|Too tired|0|||
148882308|NCT00934128|537046041|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
148882309|NCT00934128|537046042|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
148882310|NCT00934128|537046041|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
148882311|NCT00934128|537046042|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
148882312|NCT02834247|537046043|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
148882313|NCT02834247|537046044|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
148882314|NCT02834247|537046045|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
148882315|NCT02834247|537046046|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
148882316|NCT02834247|537046043|FG000|Dose Escalation Phase|Death|5|||
148882317|NCT02834247|537046044|FG001|Dose Escalation Phase|Death|6|||
148882318|NCT02834247|537046045|FG002|Dose Escalation Phase|Death|5|||
148882319|NCT02834247|537046046|FG003|Dose Escalation Phase|Death|0|||
148882320|NCT02834247|537046043|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
148882321|NCT02834247|537046044|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
148882322|NCT02834247|537046045|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
148882323|NCT02834247|537046046|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
148882324|NCT02834247|537046043|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
148882325|NCT02834247|537046044|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
148882326|NCT02834247|537046045|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
148882327|NCT02834247|537046046|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
148882328|NCT02834247|537046043|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
148882329|NCT02834247|537046044|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
148882330|NCT02834247|537046045|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
148882331|NCT02834247|537046046|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
148882332|NCT02834247|537046043|FG000|Dose Expansion Phase|Death|0|||
148882333|NCT02834247|537046044|FG001|Dose Expansion Phase|Death|0|||
148882334|NCT02834247|537046045|FG002|Dose Expansion Phase|Death|0|||
148882335|NCT02834247|537046046|FG003|Dose Expansion Phase|Death|8|||
148882336|NCT02834247|537046043|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
148882337|NCT02834247|537046044|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
148882338|NCT02834247|537046045|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
148882339|NCT02834247|537046046|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
148882340|NCT02834247|537046043|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
148882341|NCT02834247|537046044|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
148882342|NCT02834247|537046045|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
148882343|NCT02834247|537046046|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
148882344|NCT01807299|537046047|FG000|Overall Study|Protocol Violation|3|||
148882345|NCT01807299|537046048|FG001|Overall Study|Protocol Violation|1|||
148882346|NCT01807299|537046049|FG002|Overall Study|Protocol Violation|0|||
148882347|NCT01807299|537046050|FG003|Overall Study|Protocol Violation|2|||
148882348|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
148882349|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
148882350|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
148882351|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149038887|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
148882352|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
148882353|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
148882354|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
148882355|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
148882356|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
148882357|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
148882358|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
148882359|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
148882360|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
148882361|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
148882362|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
148882363|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
148882364|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
148882365|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
148882366|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
148882367|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
148882368|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
148882369|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
148882370|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
148882371|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
148882372|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
148882373|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
148882374|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
148882375|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
148882376|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
148882377|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
148882378|NCT01173601|537047307|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
148882379|NCT01173601|537047308|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
148882380|NCT01173601|537047309|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
148882381|NCT01173601|537047310|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
148882382|NCT01173601|537047311|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
148882383|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
148882384|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
148882385|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
148882386|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
148882387|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
148882388|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
148882389|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
148882390|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
148882391|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
148882392|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
148882393|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
148882394|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
148882395|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
148882396|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
148882397|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
148882398|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
148882399|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
148882400|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
148882401|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
148882402|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
148882403|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
148882404|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
148882405|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
148882406|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
148882407|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
148882408|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
148882409|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
148882410|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
148882411|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
148882412|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
148882413|NCT01173601|537047307|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
148882414|NCT01173601|537047308|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
148882415|NCT01173601|537047309|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
148882416|NCT01173601|537047310|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
148882417|NCT01173601|537047311|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
148882418|NCT05258149|537047318|FG000|Period 1|Protocol Deviation|1|||
148882419|NCT05258149|537047319|FG001|Period 1|Protocol Deviation|0|||
148882420|NCT05258149|537047318|FG000|Period 1|Adverse Event|0|||
148882421|NCT05258149|537047319|FG001|Period 1|Adverse Event|1|||
148882422|NCT05258149|537047318|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
148882423|NCT05258149|537047319|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
148882424|NCT05258149|537047318|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
148882425|NCT05258149|537047319|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
148882426|NCT05258149|537047318|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
148882427|NCT05258149|537047319|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
148882428|NCT01456169|537047322|FG000|Overall Study|Adverse Event|1|||
148882429|NCT01456169|537047323|FG001|Overall Study|Adverse Event|2|||
148882430|NCT01456169|537047324|FG002|Overall Study|Adverse Event|7|||
148882431|NCT01456169|537047322|FG000|Overall Study|Major Protocol Deviation|3|||
148882432|NCT01456169|537047323|FG001|Overall Study|Major Protocol Deviation|2|||
148882433|NCT01456169|537047324|FG002|Overall Study|Major Protocol Deviation|3|||
148882434|NCT01456169|537047322|FG000|Overall Study|Voluntary Withdrawal|3|||
148882435|NCT01456169|537047323|FG001|Overall Study|Voluntary Withdrawal|0|||
148882436|NCT01456169|537047324|FG002|Overall Study|Voluntary Withdrawal|2|||
148882437|NCT01456169|537047322|FG000|Overall Study|Lack of Efficacy|2|||
148882438|NCT01456169|537047323|FG001|Overall Study|Lack of Efficacy|0|||
148882439|NCT01456169|537047324|FG002|Overall Study|Lack of Efficacy|0|||
148882440|NCT01456169|537047322|FG000|Overall Study|Other|1|||
148882441|NCT01456169|537047323|FG001|Overall Study|Other|1|||
148882442|NCT01456169|537047324|FG002|Overall Study|Other|0|||
148882443|NCT02292446|537047325|FG000|Overall Study|Adverse Event|12|||
148882444|NCT02292446|537047325|FG000|Overall Study|Death|1|||
148882445|NCT02292446|537047325|FG000|Overall Study|Disease progression|2|||
148882446|NCT02292446|537047325|FG000|Overall Study|Subject/guardian decision|2|||
148882447|NCT02292446|537047325|FG000|Overall Study|Withdrawal by Subject|3|||
148882448|NCT01290757|537047326|FG000|Overall Study|Adverse Event|1|||
148882449|NCT01290757|537047327|FG001|Overall Study|Adverse Event|0|||
148882450|NCT01290757|537047326|FG000|Overall Study|Protocol Violation|1|||
148882451|NCT01290757|537047327|FG001|Overall Study|Protocol Violation|1|||
148882452|NCT01290757|537047326|FG000|Overall Study|Other|0|||
148882453|NCT01290757|537047327|FG001|Overall Study|Other|1|||
148882454|NCT00570310|537047328|FG000|Overall Study|Adverse Event|1|||
148882455|NCT00570310|537047329|FG001|Overall Study|Adverse Event|2|||
148882456|NCT00570310|537047328|FG000|Overall Study|Lack of Efficacy|1|||
148882457|NCT00570310|537047329|FG001|Overall Study|Lack of Efficacy|4|||
148882458|NCT03329846|537047332|FG000|Overall Study|Disease progression|4|||
148882459|NCT03329846|537047333|FG001|Overall Study|Disease progression|6|||
148882460|NCT03329846|537047332|FG000|Overall Study|Study drug toxicity|1|||
148882461|NCT03329846|537047333|FG001|Overall Study|Study drug toxicity|0|||
148882462|NCT03329846|537047332|FG000|Overall Study|Participant request to discontinue treatment|0|||
148882463|NCT03329846|537047333|FG001|Overall Study|Participant request to discontinue treatment|1|||
148882464|NCT03329846|537047332|FG000|Overall Study|Participant withdrew consent|1|||
148882465|NCT03329846|537047333|FG001|Overall Study|Participant withdrew consent|0|||
148882466|NCT03329846|537047332|FG000|Overall Study|Other reasons|2|||
148882467|NCT03329846|537047333|FG001|Overall Study|Other reasons|2|||
148882468|NCT00108862|537047334|FG000|Overall Study|Death|31|||
148882469|NCT00108862|537047335|FG001|Overall Study|Death|37|||
148882470|NCT00108862|537047334|FG000|Overall Study|Withdrawal by Subject|10|||
148882471|NCT00108862|537047335|FG001|Overall Study|Withdrawal by Subject|6|||
148882472|NCT00108862|537047334|FG000|Overall Study|Lost to Follow-up|27|||
148882473|NCT00108862|537047335|FG001|Overall Study|Lost to Follow-up|19|||
148882474|NCT02021643|537047336|FG000|Overall Study|Enrolled but Never Treated|1|||
148882475|NCT02021643|537047337|FG001|Overall Study|Enrolled but Never Treated|0|||
148882476|NCT02021643|537047338|FG002|Overall Study|Enrolled but Never Treated|0|||
148882477|NCT02021643|537047339|FG003|Overall Study|Enrolled but Never Treated|0|||
148882478|NCT02021643|537047336|FG000|Overall Study|Adverse Event|0|||
148882479|NCT02021643|537047337|FG001|Overall Study|Adverse Event|1|||
148882480|NCT02021643|537047338|FG002|Overall Study|Adverse Event|0|||
148882481|NCT02021643|537047339|FG003|Overall Study|Adverse Event|0|||
149038888|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
148882482|NCT02021643|537047336|FG000|Overall Study|Death|0|||
148882483|NCT02021643|537047337|FG001|Overall Study|Death|1|||
148882484|NCT02021643|537047338|FG002|Overall Study|Death|0|||
148882485|NCT02021643|537047339|FG003|Overall Study|Death|0|||
148882486|NCT02021643|537047336|FG000|Overall Study|Investigator's Discretion|1|||
148882487|NCT02021643|537047337|FG001|Overall Study|Investigator's Discretion|0|||
148882488|NCT02021643|537047338|FG002|Overall Study|Investigator's Discretion|0|||
148882489|NCT02021643|537047339|FG003|Overall Study|Investigator's Discretion|0|||
148882490|NCT02021643|537047336|FG000|Overall Study|Lack of Efficacy|7|||
148882491|NCT02021643|537047337|FG001|Overall Study|Lack of Efficacy|6|||
148882492|NCT02021643|537047338|FG002|Overall Study|Lack of Efficacy|0|||
148882493|NCT02021643|537047339|FG003|Overall Study|Lack of Efficacy|12|||
148882494|NCT02021643|537047336|FG000|Overall Study|Lost to Follow-up|0|||
148882495|NCT02021643|537047337|FG001|Overall Study|Lost to Follow-up|1|||
148882496|NCT02021643|537047338|FG002|Overall Study|Lost to Follow-up|0|||
148882497|NCT02021643|537047339|FG003|Overall Study|Lost to Follow-up|0|||
148882498|NCT02021643|537047336|FG000|Overall Study|Withdrew Consent|0|||
148882499|NCT02021643|537047337|FG001|Overall Study|Withdrew Consent|1|||
148882500|NCT02021643|537047338|FG002|Overall Study|Withdrew Consent|0|||
148882501|NCT02021643|537047339|FG003|Overall Study|Withdrew Consent|0|||
148882502|NCT05888181|537047344|FG000|Overall Study|Lost to Follow-up|1|||
148882503|NCT05888181|537047345|FG001|Overall Study|Lost to Follow-up|1|||
148882504|NCT05888181|537047346|FG002|Overall Study|Lost to Follow-up|0|||
148882505|NCT01625000|537047359|FG000|Overall Study|Physician Decision|15|||
148882506|NCT01625000|537047360|FG001|Overall Study|Physician Decision|7|||
148882507|NCT01625000|537047361|FG002|Overall Study|Physician Decision|7|||
148882508|NCT01625000|537047362|FG003|Overall Study|Physician Decision|2|||
148882509|NCT01625000|537047363|FG004|Overall Study|Physician Decision|15|||
148882510|NCT01625000|537047359|FG000|Overall Study|Protocol Violation|3|||
148882511|NCT01625000|537047360|FG001|Overall Study|Protocol Violation|10|||
148882512|NCT01625000|537047361|FG002|Overall Study|Protocol Violation|4|||
148882513|NCT01625000|537047362|FG003|Overall Study|Protocol Violation|1|||
148882514|NCT01625000|537047363|FG004|Overall Study|Protocol Violation|2|||
148882515|NCT01625000|537047359|FG000|Overall Study|Withdrawal by Subject|19|||
148882516|NCT01625000|537047360|FG001|Overall Study|Withdrawal by Subject|16|||
148882517|NCT01625000|537047361|FG002|Overall Study|Withdrawal by Subject|11|||
148882518|NCT01625000|537047362|FG003|Overall Study|Withdrawal by Subject|9|||
149004008|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
149004009|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
149004010|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
149004011|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
149004012|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
149004013|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
149004014|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
149004015|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149004016|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
149004017|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
149004018|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
149004019|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
149004020|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149004021|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149004022|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
149004023|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149004024|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
149004025|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
149004026|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149004027|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149004028|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149004029|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149004030|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
149004031|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149004032|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
149004033|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149004034|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
149004035|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
149004036|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149004037|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149004038|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
149004039|NCT02496767|537493191|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004040|NCT02496767|537493192|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
149004041|NCT02496767|537493193|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004042|NCT02496767|537493194|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004043|NCT02496767|537493195|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004044|NCT02496767|537493196|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004045|NCT02496767|537493197|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004046|NCT02496767|537493198|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
149004047|NCT02496767|537493191|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
149004048|NCT02496767|537493192|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
149004049|NCT02496767|537493193|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
148882519|NCT01625000|537047363|FG004|Overall Study|Withdrawal by Subject|17|||
148882520|NCT01625000|537047359|FG000|Overall Study|Adverse Event (including Death)|15|||
148882521|NCT01625000|537047360|FG001|Overall Study|Adverse Event (including Death)|19|||
148882522|NCT01625000|537047361|FG002|Overall Study|Adverse Event (including Death)|11|||
148882523|NCT01625000|537047362|FG003|Overall Study|Adverse Event (including Death)|7|||
149038889|NCT00843882|537620524|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
149038890|NCT00843882|537620525|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
149038891|NCT00843882|537620526|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
149038892|NCT00256243|537620527|FG000|Overall Study|Lost to Follow-up|2|||
149038893|NCT00256243|537620527|FG000|Overall Study|Death|7|||
149038894|NCT00256243|537620527|FG000|Overall Study|Not treated|1|||
149038895|NCT02248480|537620528|FG000|Overall Study|Lack of Efficacy|4|||
149038896|NCT02248480|537620529|FG001|Overall Study|Lack of Efficacy|6|||
149038897|NCT02248480|537620528|FG000|Overall Study|Adverse Event|11|||
149038898|NCT02248480|537620529|FG001|Overall Study|Adverse Event|2|||
149038899|NCT02248480|537620528|FG000|Overall Study|Withdrawal by Subject|2|||
149038900|NCT02248480|537620529|FG001|Overall Study|Withdrawal by Subject|4|||
149038901|NCT02248480|537620528|FG000|Overall Study|Entry Criteria Not Met|0|||
149038902|NCT02248480|537620529|FG001|Overall Study|Entry Criteria Not Met|1|||
149038903|NCT02248480|537620528|FG000|Overall Study|Other:Physician Decision|0|||
149038904|NCT02248480|537620529|FG001|Overall Study|Other:Physician Decision|1|||
149038905|NCT04795752|537620530|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
149038906|NCT04795752|537620531|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
149038907|NCT04795752|537620530|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
149038908|NCT04795752|537620531|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
149038909|NCT04795752|537620530|FG000|Primary Endpoint Phase|Physician Decision|2|||
149038910|NCT04795752|537620531|FG001|Primary Endpoint Phase|Physician Decision|0|||
149038911|NCT04795752|537620530|FG000|Primary Endpoint Phase|Other|4|||
149038912|NCT04795752|537620531|FG001|Primary Endpoint Phase|Other|1|||
149038913|NCT04795752|537620530|FG000|Primary Endpoint Phase|Protocol Violation|1|||
149038914|NCT04795752|537620531|FG001|Primary Endpoint Phase|Protocol Violation|0|||
149038915|NCT04795752|537620530|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
149038916|NCT04795752|537620531|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
149038917|NCT04795752|537620530|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
149038918|NCT04795752|537620531|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
149038919|NCT04795752|537620530|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
149038920|NCT04795752|537620531|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
149038921|NCT04795752|537620530|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
149038922|NCT04795752|537620531|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
149038923|NCT04795752|537620530|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
149038924|NCT04795752|537620531|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
149038925|NCT00792948|537620532|FG000|Overall Study|Adverse Event|6|||
149038926|NCT00792948|537620532|FG000|Overall Study|Death|4|||
149038927|NCT00792948|537620532|FG000|Overall Study|Withdrawal by Subject|3|||
149038928|NCT00792948|537620532|FG000|Overall Study|Ineligible|2|||
149038929|NCT00792948|537620532|FG000|Overall Study|Insurance denial - not treated|1|||
149038930|NCT00792948|537620532|FG000|Overall Study|Physician Decision|11|||
149038931|NCT00792948|537620532|FG000|Overall Study|Protocol Violation|1|||
149038932|NCT06129045|537620533|FG000|Overall Study|Lost to Follow-up|1|||
149038933|NCT06129045|537620534|FG001|Overall Study|Lost to Follow-up|1|||
149038934|NCT06129045|537620535|FG002|Overall Study|Lost to Follow-up|4|||
149038935|NCT01582269|537620538|FG000|Overall Study|Withdrawal by Subject|1|||
149038936|NCT01582269|537620539|FG001|Overall Study|Withdrawal by Subject|0|||
149038937|NCT01582269|537620540|FG002|Overall Study|Withdrawal by Subject|0|||
149038938|NCT06218251|537620541|FG000|Overall Study|Lost to Follow-up|4|||
149038939|NCT05076266|537620542|FG000|Overall Study|Survey not complete - Participant refusal|2|||
149038940|NCT05076266|537620543|FG001|Overall Study|Survey not complete - Participant refusal|0|||
149038941|NCT00997386|537620544|FG000|Overall Study|Death|7|||
149038942|NCT03516942|537620545|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
149038943|NCT03516942|537620545|FG000|Registration through baseline survey com|Death|8|||
149038944|NCT03516942|537620545|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
149038945|NCT03516942|537620545|FG000|T0: Baseline|LOST|13|||
149038946|NCT03516942|537620545|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
149038947|NCT03516942|537620545|FG000|T1: 3 Months Survey|Death|10|||
149038948|NCT03516942|537620545|FG000|T1: 3 Months Survey|Lost|163|||
149038949|NCT03516942|537620545|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
149038950|NCT03516942|537620545|FG000|T2: 6 Month Survey|Death|14|||
149038951|NCT03516942|537620545|FG000|T2: 6 Month Survey|Lost|180|||
149038952|NCT03516942|537620545|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
149038953|NCT03516942|537620545|FG000|T3: 12 Month Survey|Death|19|||
149038954|NCT03516942|537620545|FG000|T3: 12 Month Survey|Lost|209|||
149038955|NCT03785782|537622245|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
149038956|NCT03785782|537622246|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
149038957|NCT03785782|537622245|FG000|Overall Study|Withdrawal by Subject|1|||
149038958|NCT03785782|537622246|FG001|Overall Study|Withdrawal by Subject|1|||
149038959|NCT03785782|537622245|FG000|Overall Study|insufficient image quality.|3|||
149038960|NCT03785782|537622246|FG001|Overall Study|insufficient image quality.|0|||
149038961|NCT01307267|537622251|FG000|Overall Study|Death|4|||
149038962|NCT01307267|537622252|FG001|Overall Study|Death|3|||
149038963|NCT01307267|537622253|FG002|Overall Study|Death|5|||
149038964|NCT01307267|537622254|FG003|Overall Study|Death|3|||
149038965|NCT01307267|537622255|FG004|Overall Study|Death|1|||
149038966|NCT01307267|537622256|FG005|Overall Study|Death|26|||
149038967|NCT01307267|537622257|FG006|Overall Study|Death|2|||
149038968|NCT01307267|537622258|FG007|Overall Study|Death|2|||
149038969|NCT01307267|537622259|FG008|Overall Study|Death|21|||
149038970|NCT01307267|537622260|FG009|Overall Study|Death|2|||
149038971|NCT01307267|537622261|FG010|Overall Study|Death|3|||
149038972|NCT01307267|537622262|FG011|Overall Study|Death|9|||
149038973|NCT01307267|537622263|FG012|Overall Study|Death|0|||
149038974|NCT01307267|537622264|FG013|Overall Study|Death|0|||
149038975|NCT01307267|537622265|FG014|Overall Study|Death|0|||
149038976|NCT01307267|537622266|FG015|Overall Study|Death|0|||
149038977|NCT01307267|537622267|FG016|Overall Study|Death|1|||
149038978|NCT01307267|537622268|FG017|Overall Study|Death|1|||
149038979|NCT01307267|537622269|FG018|Overall Study|Death|2|||
149038980|NCT01307267|537622270|FG019|Overall Study|Death|8|||
149038981|NCT01307267|537622271|FG020|Overall Study|Death|1|||
149038982|NCT01307267|537622272|FG021|Overall Study|Death|2|||
149038983|NCT01307267|537622273|FG022|Overall Study|Death|2|||
149038984|NCT01307267|537622251|FG000|Overall Study|Lost to Follow-up|0|||
149038985|NCT01307267|537622252|FG001|Overall Study|Lost to Follow-up|0|||
149038986|NCT01307267|537622253|FG002|Overall Study|Lost to Follow-up|0|||
149038987|NCT01307267|537622254|FG003|Overall Study|Lost to Follow-up|0|||
149038988|NCT01307267|537622255|FG004|Overall Study|Lost to Follow-up|0|||
149038989|NCT01307267|537622256|FG005|Overall Study|Lost to Follow-up|7|||
149038990|NCT01307267|537622257|FG006|Overall Study|Lost to Follow-up|0|||
149038991|NCT01307267|537622258|FG007|Overall Study|Lost to Follow-up|0|||
149038992|NCT01307267|537622259|FG008|Overall Study|Lost to Follow-up|1|||
149038993|NCT01307267|537622260|FG009|Overall Study|Lost to Follow-up|2|||
149038994|NCT01307267|537622261|FG010|Overall Study|Lost to Follow-up|1|||
149038995|NCT01307267|537622262|FG011|Overall Study|Lost to Follow-up|0|||
149038996|NCT01307267|537622263|FG012|Overall Study|Lost to Follow-up|0|||
149038997|NCT01307267|537622264|FG013|Overall Study|Lost to Follow-up|0|||
149038998|NCT01307267|537622265|FG014|Overall Study|Lost to Follow-up|0|||
149038999|NCT01307267|537622266|FG015|Overall Study|Lost to Follow-up|0|||
149039000|NCT01307267|537622267|FG016|Overall Study|Lost to Follow-up|0|||
149039001|NCT01307267|537622268|FG017|Overall Study|Lost to Follow-up|0|||
149039002|NCT01307267|537622269|FG018|Overall Study|Lost to Follow-up|0|||
149039003|NCT01307267|537622270|FG019|Overall Study|Lost to Follow-up|2|||
149039004|NCT01307267|537622271|FG020|Overall Study|Lost to Follow-up|0|||
149039005|NCT01307267|537622272|FG021|Overall Study|Lost to Follow-up|0|||
149039006|NCT01307267|537622273|FG022|Overall Study|Lost to Follow-up|0|||
149039007|NCT01307267|537622251|FG000|Overall Study|Withdrawal by Subject|0|||
149039008|NCT01307267|537622252|FG001|Overall Study|Withdrawal by Subject|0|||
149039009|NCT01307267|537622253|FG002|Overall Study|Withdrawal by Subject|0|||
149039010|NCT01307267|537622254|FG003|Overall Study|Withdrawal by Subject|0|||
149039011|NCT01307267|537622255|FG004|Overall Study|Withdrawal by Subject|0|||
149039012|NCT01307267|537622256|FG005|Overall Study|Withdrawal by Subject|1|||
149039013|NCT01307267|537622257|FG006|Overall Study|Withdrawal by Subject|0|||
149039014|NCT01307267|537622258|FG007|Overall Study|Withdrawal by Subject|1|||
149039015|NCT01307267|537622259|FG008|Overall Study|Withdrawal by Subject|5|||
149039016|NCT01307267|537622260|FG009|Overall Study|Withdrawal by Subject|1|||
149039017|NCT01307267|537622261|FG010|Overall Study|Withdrawal by Subject|1|||
149039018|NCT01307267|537622262|FG011|Overall Study|Withdrawal by Subject|1|||
149039019|NCT01307267|537622263|FG012|Overall Study|Withdrawal by Subject|0|||
149039020|NCT01307267|537622264|FG013|Overall Study|Withdrawal by Subject|0|||
149039021|NCT01307267|537622265|FG014|Overall Study|Withdrawal by Subject|0|||
149039022|NCT01307267|537622266|FG015|Overall Study|Withdrawal by Subject|0|||
149039023|NCT01307267|537622267|FG016|Overall Study|Withdrawal by Subject|0|||
149039024|NCT01307267|537622268|FG017|Overall Study|Withdrawal by Subject|0|||
149039025|NCT01307267|537622269|FG018|Overall Study|Withdrawal by Subject|0|||
149039026|NCT01307267|537622270|FG019|Overall Study|Withdrawal by Subject|3|||
149039027|NCT01307267|537622271|FG020|Overall Study|Withdrawal by Subject|0|||
149039028|NCT01307267|537622272|FG021|Overall Study|Withdrawal by Subject|0|||
149039029|NCT01307267|537622273|FG022|Overall Study|Withdrawal by Subject|0|||
149039030|NCT01307267|537622251|FG000|Overall Study|Other|0|||
149039031|NCT01307267|537622252|FG001|Overall Study|Other|0|||
149039032|NCT01307267|537622253|FG002|Overall Study|Other|0|||
149039033|NCT01307267|537622254|FG003|Overall Study|Other|0|||
149039034|NCT01307267|537622255|FG004|Overall Study|Other|0|||
149039035|NCT01307267|537622256|FG005|Overall Study|Other|7|||
149039036|NCT01307267|537622257|FG006|Overall Study|Other|0|||
149039037|NCT01307267|537622258|FG007|Overall Study|Other|1|||
149039038|NCT01307267|537622259|FG008|Overall Study|Other|3|||
149039039|NCT01307267|537622260|FG009|Overall Study|Other|0|||
149039040|NCT01307267|537622261|FG010|Overall Study|Other|1|||
149039041|NCT01307267|537622262|FG011|Overall Study|Other|1|||
149039042|NCT01307267|537622263|FG012|Overall Study|Other|1|||
149039043|NCT01307267|537622264|FG013|Overall Study|Other|0|||
149039044|NCT01307267|537622265|FG014|Overall Study|Other|2|||
149039045|NCT01307267|537622266|FG015|Overall Study|Other|1|||
148882524|NCT01625000|537047363|FG004|Overall Study|Adverse Event (including Death)|21|||
148882525|NCT00566852|537047364|FG000|Overall Study|Protocol Violation|22|||
149004050|NCT02496767|537493194|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
149004051|NCT02496767|537493195|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
149004052|NCT02496767|537493196|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
149004053|NCT02496767|537493197|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
149004054|NCT02496767|537493198|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
149004055|NCT02496767|537493191|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
149004056|NCT02496767|537493192|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
149004057|NCT02496767|537493193|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
149004058|NCT02496767|537493194|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
149004059|NCT02496767|537493195|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
149004060|NCT02496767|537493196|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
149004061|NCT02496767|537493197|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
149004062|NCT02496767|537493198|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
149004063|NCT02496767|537493191|FG000|Double-blind, Withdrawal Phase|Death|0|||
149004064|NCT02496767|537493192|FG001|Double-blind, Withdrawal Phase|Death|0|||
149004065|NCT02496767|537493193|FG002|Double-blind, Withdrawal Phase|Death|0|||
149004066|NCT02496767|537493194|FG003|Double-blind, Withdrawal Phase|Death|0|||
149004067|NCT02496767|537493195|FG004|Double-blind, Withdrawal Phase|Death|0|||
149004068|NCT02496767|537493196|FG005|Double-blind, Withdrawal Phase|Death|0|||
149004069|NCT02496767|537493197|FG006|Double-blind, Withdrawal Phase|Death|1|||
149004070|NCT02496767|537493198|FG007|Double-blind, Withdrawal Phase|Death|2|||
149004071|NCT02496767|537493191|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
149004072|NCT02496767|537493192|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
149004073|NCT02496767|537493193|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
149004074|NCT02496767|537493194|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
149004075|NCT02496767|537493195|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
149004076|NCT02496767|537493196|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
149004077|NCT02496767|537493197|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
149004078|NCT02496767|537493198|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
149004079|NCT04252742|537493200|FG000|Overall Study|Decision by sponsor|0|||
149004080|NCT04252742|537493201|FG001|Overall Study|Decision by sponsor|2|||
149004081|NCT04252742|537493200|FG000|Overall Study|Withdrawal by Subject|15|||
149004082|NCT04252742|537493201|FG001|Overall Study|Withdrawal by Subject|9|||
149004083|NCT04252742|537493200|FG000|Overall Study|Lost to Follow-up|0|||
149004084|NCT04252742|537493201|FG001|Overall Study|Lost to Follow-up|1|||
149004085|NCT04179032|537493202|FG000|Part B (Up to Week 52)|Adverse Event|1|||
149004086|NCT04179032|537493202|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
149004087|NCT04179032|537493202|FG000|Access Extension Phase|Ongoing|11|||
149004088|NCT02597036|537493204|FG000|Overall Study|Progressive Disease|0|||
149004089|NCT02597036|537493205|FG001|Overall Study|Progressive Disease|0|||
149004090|NCT02597036|537493206|FG002|Overall Study|Progressive Disease|0|||
149004091|NCT02597036|537493207|FG003|Overall Study|Progressive Disease|0|||
149004092|NCT02597036|537493208|FG004|Overall Study|Progressive Disease|1|||
149004093|NCT02597036|537493209|FG005|Overall Study|Progressive Disease|1|||
149004094|NCT02597036|537493210|FG006|Overall Study|Progressive Disease|1|||
149004095|NCT02597036|537493211|FG007|Overall Study|Progressive Disease|0|||
149004096|NCT02597036|537493212|FG008|Overall Study|Progressive Disease|0|||
149004097|NCT02597036|537493213|FG009|Overall Study|Progressive Disease|0|||
149004098|NCT02597036|537493214|FG010|Overall Study|Progressive Disease|0|||
149004099|NCT02597036|537493215|FG011|Overall Study|Progressive Disease|0|||
149004100|NCT02597036|537493204|FG000|Overall Study|Adverse Event|0|||
149004101|NCT02597036|537493205|FG001|Overall Study|Adverse Event|0|||
149004102|NCT02597036|537493206|FG002|Overall Study|Adverse Event|0|||
149004103|NCT02597036|537493207|FG003|Overall Study|Adverse Event|0|||
149004104|NCT02597036|537493208|FG004|Overall Study|Adverse Event|0|||
149004105|NCT02597036|537493209|FG005|Overall Study|Adverse Event|0|||
149004106|NCT02597036|537493210|FG006|Overall Study|Adverse Event|0|||
149004107|NCT02597036|537493211|FG007|Overall Study|Adverse Event|1|||
149004108|NCT02597036|537493212|FG008|Overall Study|Adverse Event|0|||
149004109|NCT02597036|537493213|FG009|Overall Study|Adverse Event|0|||
149004110|NCT02597036|537493214|FG010|Overall Study|Adverse Event|0|||
149004111|NCT02597036|537493215|FG011|Overall Study|Adverse Event|1|||
148882526|NCT00566852|537047365|FG001|Overall Study|Protocol Violation|24|||
148882527|NCT00566852|537047364|FG000|Overall Study|Death|95|||
149004112|NCT02597036|537493204|FG000|Overall Study|Death|0|||
149004113|NCT02597036|537493205|FG001|Overall Study|Death|0|||
149004114|NCT02597036|537493206|FG002|Overall Study|Death|0|||
149004115|NCT02597036|537493207|FG003|Overall Study|Death|0|||
148882528|NCT00566852|537047365|FG001|Overall Study|Death|78|||
149004116|NCT02597036|537493208|FG004|Overall Study|Death|0|||
149004117|NCT02597036|537493209|FG005|Overall Study|Death|0|||
149004118|NCT02597036|537493210|FG006|Overall Study|Death|0|||
149004119|NCT02597036|537493211|FG007|Overall Study|Death|0|||
149004120|NCT02597036|537493212|FG008|Overall Study|Death|0|||
149004121|NCT02597036|537493213|FG009|Overall Study|Death|1|||
148882529|NCT00566852|537047364|FG000|Overall Study|Withdrawal by Subject|30|||
148882530|NCT00566852|537047365|FG001|Overall Study|Withdrawal by Subject|25|||
149004122|NCT02597036|537493214|FG010|Overall Study|Death|1|||
149004123|NCT02597036|537493215|FG011|Overall Study|Death|0|||
149004124|NCT02597036|537493204|FG000|Overall Study|Lost to Follow-up|0|||
149004125|NCT02597036|537493205|FG001|Overall Study|Lost to Follow-up|0|||
149004126|NCT02597036|537493206|FG002|Overall Study|Lost to Follow-up|0|||
149004127|NCT02597036|537493207|FG003|Overall Study|Lost to Follow-up|0|||
149004128|NCT02597036|537493208|FG004|Overall Study|Lost to Follow-up|0|||
149004129|NCT02597036|537493209|FG005|Overall Study|Lost to Follow-up|0|||
149004130|NCT02597036|537493210|FG006|Overall Study|Lost to Follow-up|0|||
149004131|NCT02597036|537493211|FG007|Overall Study|Lost to Follow-up|0|||
149004132|NCT02597036|537493212|FG008|Overall Study|Lost to Follow-up|0|||
149004133|NCT02597036|537493213|FG009|Overall Study|Lost to Follow-up|0|||
149004134|NCT02597036|537493214|FG010|Overall Study|Lost to Follow-up|1|||
149004135|NCT02597036|537493215|FG011|Overall Study|Lost to Follow-up|0|||
149004136|NCT02597036|537493204|FG000|Overall Study|Withdrawal by Subject|0|||
149004137|NCT02597036|537493205|FG001|Overall Study|Withdrawal by Subject|0|||
149004138|NCT02597036|537493206|FG002|Overall Study|Withdrawal by Subject|0|||
149004139|NCT02597036|537493207|FG003|Overall Study|Withdrawal by Subject|0|||
149004140|NCT02597036|537493208|FG004|Overall Study|Withdrawal by Subject|0|||
149004141|NCT02597036|537493209|FG005|Overall Study|Withdrawal by Subject|0|||
149004142|NCT02597036|537493210|FG006|Overall Study|Withdrawal by Subject|0|||
149004143|NCT02597036|537493211|FG007|Overall Study|Withdrawal by Subject|0|||
149004144|NCT02597036|537493212|FG008|Overall Study|Withdrawal by Subject|0|||
149004145|NCT02597036|537493213|FG009|Overall Study|Withdrawal by Subject|0|||
149004146|NCT02597036|537493214|FG010|Overall Study|Withdrawal by Subject|0|||
149004147|NCT02597036|537493215|FG011|Overall Study|Withdrawal by Subject|1|||
149004148|NCT03371940|537493219|FG000|Overall Study|Withdrawal by Subject|8|||
149004149|NCT03371940|537493220|FG001|Overall Study|Withdrawal by Subject|1|||
149004150|NCT03371940|537493221|FG002|Overall Study|Withdrawal by Subject|3|||
149004151|NCT03371940|537493222|FG003|Overall Study|Withdrawal by Subject|4|||
149004152|NCT05099926|537493225|FG000|Overall Study|Lost to Follow-up|1|||
149004153|NCT00031486|537493233|FG000|Overall Study|Adverse Event|1|||
149004154|NCT00031486|537493234|FG001|Overall Study|Adverse Event|0|||
149004155|NCT00031486|537493233|FG000|Overall Study|Lost to Follow-up|0|||
149004156|NCT00031486|537493234|FG001|Overall Study|Lost to Follow-up|1|||
149004157|NCT00031486|537493233|FG000|Overall Study|Withdrawal by Subject|3|||
149004158|NCT00031486|537493234|FG001|Overall Study|Withdrawal by Subject|2|||
149004159|NCT00031486|537493233|FG000|Overall Study|Death|0|||
149004160|NCT00031486|537493234|FG001|Overall Study|Death|3|||
149004161|NCT00031486|537493233|FG000|Overall Study|Non-compliant|0|||
149004162|NCT00031486|537493234|FG001|Overall Study|Non-compliant|4|||
149004163|NCT00031486|537493233|FG000|Overall Study|Did not meet eligibility requirement|2|||
149004164|NCT00031486|537493234|FG001|Overall Study|Did not meet eligibility requirement|1|||
149004165|NCT00031486|537493233|FG000|Overall Study|Other|1|||
149004166|NCT00031486|537493234|FG001|Overall Study|Other|1|||
149004167|NCT03685591|537493235|FG000|Overall Study|Global Deterioration of Health Status|0|||
149004168|NCT03685591|537493236|FG001|Overall Study|Global Deterioration of Health Status|0|||
149004169|NCT03685591|537493237|FG002|Overall Study|Global Deterioration of Health Status|0|||
149004170|NCT03685591|537493238|FG003|Overall Study|Global Deterioration of Health Status|1|||
149004171|NCT03685591|537493239|FG004|Overall Study|Global Deterioration of Health Status|2|||
149004172|NCT03685591|537493240|FG005|Overall Study|Global Deterioration of Health Status|4|||
149004173|NCT03685591|537493241|FG006|Overall Study|Global Deterioration of Health Status|1|||
149004174|NCT03685591|537493242|FG007|Overall Study|Global Deterioration of Health Status|1|||
149004175|NCT03685591|537493243|FG008|Overall Study|Global Deterioration of Health Status|0|||
149004176|NCT03685591|537493235|FG000|Overall Study|Progressive Disease|1|||
149004177|NCT03685591|537493236|FG001|Overall Study|Progressive Disease|1|||
149004178|NCT03685591|537493237|FG002|Overall Study|Progressive Disease|0|||
149004179|NCT03685591|537493238|FG003|Overall Study|Progressive Disease|3|||
149004180|NCT03685591|537493239|FG004|Overall Study|Progressive Disease|5|||
149004181|NCT03685591|537493240|FG005|Overall Study|Progressive Disease|4|||
149004182|NCT03685591|537493241|FG006|Overall Study|Progressive Disease|3|||
148882531|NCT00566852|537047364|FG000|Overall Study|Patient refusal|37|||
149004183|NCT03685591|537493242|FG007|Overall Study|Progressive Disease|2|||
149004184|NCT03685591|537493243|FG008|Overall Study|Progressive Disease|1|||
149004185|NCT03685591|537493235|FG000|Overall Study|Other|0|||
149004186|NCT03685591|537493236|FG001|Overall Study|Other|0|||
149004187|NCT03685591|537493237|FG002|Overall Study|Other|1|||
149004188|NCT03685591|537493238|FG003|Overall Study|Other|0|||
149004189|NCT03685591|537493239|FG004|Overall Study|Other|2|||
149004190|NCT03685591|537493240|FG005|Overall Study|Other|3|||
148882532|NCT00566852|537047365|FG001|Overall Study|Patient refusal|37|||
149004191|NCT03685591|537493241|FG006|Overall Study|Other|0|||
149004192|NCT03685591|537493242|FG007|Overall Study|Other|0|||
149004193|NCT03685591|537493243|FG008|Overall Study|Other|0|||
149004194|NCT03685591|537493235|FG000|Overall Study|Withdrawal by Subject|0|||
149004195|NCT03685591|537493236|FG001|Overall Study|Withdrawal by Subject|0|||
149039046|NCT01307267|537622267|FG016|Overall Study|Other|0|||
148882533|NCT00566852|537047364|FG000|Overall Study|Not tested due to disability|6|||
148882534|NCT00566852|537047365|FG001|Overall Study|Not tested due to disability|12|||
148882535|NCT00566852|537047364|FG000|Overall Study|Missing reason not specified|1|||
149039047|NCT01307267|537622268|FG017|Overall Study|Other|0|||
149039048|NCT01307267|537622269|FG018|Overall Study|Other|0|||
149039049|NCT01307267|537622270|FG019|Overall Study|Other|19|||
149039050|NCT01307267|537622271|FG020|Overall Study|Other|2|||
149039051|NCT01307267|537622272|FG021|Overall Study|Other|3|||
149039052|NCT01307267|537622273|FG022|Overall Study|Other|2|||
149039053|NCT04956575|537622275|FG000|Overall Study|Death|1|||
149039054|NCT04956575|537622276|FG001|Overall Study|Death|0|||
149039055|NCT04956575|537622277|FG002|Overall Study|Death|0|||
149039056|NCT04956575|537622278|FG003|Overall Study|Death|0|||
149039057|NCT04956575|537622279|FG004|Overall Study|Death|0|||
149039058|NCT04956575|537622280|FG005|Overall Study|Death|0|||
149039059|NCT04956575|537622281|FG006|Overall Study|Death|0|||
149039060|NCT04956575|537622282|FG007|Overall Study|Death|1|||
149039061|NCT04956575|537622283|FG008|Overall Study|Death|0|||
149039062|NCT04956575|537622284|FG009|Overall Study|Death|1|||
149039063|NCT04956575|537622285|FG010|Overall Study|Death|0|||
149039064|NCT04956575|537622286|FG011|Overall Study|Death|0|||
149039065|NCT04956575|537622275|FG000|Overall Study|Lost to Follow-up|3|||
149039066|NCT04956575|537622276|FG001|Overall Study|Lost to Follow-up|4|||
149039067|NCT04956575|537622277|FG002|Overall Study|Lost to Follow-up|2|||
149039068|NCT04956575|537622278|FG003|Overall Study|Lost to Follow-up|3|||
149039069|NCT04956575|537622279|FG004|Overall Study|Lost to Follow-up|1|||
149039070|NCT04956575|537622280|FG005|Overall Study|Lost to Follow-up|10|||
149039071|NCT04956575|537622281|FG006|Overall Study|Lost to Follow-up|11|||
149039072|NCT04956575|537622282|FG007|Overall Study|Lost to Follow-up|7|||
149039073|NCT04956575|537622283|FG008|Overall Study|Lost to Follow-up|4|||
149039074|NCT04956575|537622284|FG009|Overall Study|Lost to Follow-up|2|||
149039075|NCT04956575|537622285|FG010|Overall Study|Lost to Follow-up|3|||
149039076|NCT04956575|537622286|FG011|Overall Study|Lost to Follow-up|8|||
149039077|NCT04956575|537622275|FG000|Overall Study|Withdrawal by Subject|1|||
149039078|NCT04956575|537622276|FG001|Overall Study|Withdrawal by Subject|2|||
149039079|NCT04956575|537622277|FG002|Overall Study|Withdrawal by Subject|1|||
149039080|NCT04956575|537622278|FG003|Overall Study|Withdrawal by Subject|4|||
149039081|NCT04956575|537622279|FG004|Overall Study|Withdrawal by Subject|2|||
149039082|NCT04956575|537622280|FG005|Overall Study|Withdrawal by Subject|8|||
149039083|NCT04956575|537622281|FG006|Overall Study|Withdrawal by Subject|5|||
149039084|NCT04956575|537622282|FG007|Overall Study|Withdrawal by Subject|1|||
149039085|NCT04956575|537622283|FG008|Overall Study|Withdrawal by Subject|1|||
149039086|NCT04956575|537622284|FG009|Overall Study|Withdrawal by Subject|0|||
149039087|NCT04956575|537622285|FG010|Overall Study|Withdrawal by Subject|3|||
149039088|NCT04956575|537622286|FG011|Overall Study|Withdrawal by Subject|1|||
149039089|NCT05764161|537622292|FG000|12-week DBVC Period|Lack of Efficacy|2|||
149039090|NCT05764161|537622293|FG001|12-week DBVC Period|Lack of Efficacy|1|||
149039091|NCT05764161|537622292|FG000|12-week DBVC Period|Lost to Follow-up|0|||
149039092|NCT05764161|537622293|FG001|12-week DBVC Period|Lost to Follow-up|2|||
149039093|NCT05764161|537622292|FG000|12-week DBVC Period|Protocol Violation|2|||
149039094|NCT05764161|537622293|FG001|12-week DBVC Period|Protocol Violation|4|||
149039095|NCT05764161|537622292|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
148882536|NCT00566852|537047365|FG001|Overall Study|Missing reason not specified|2|||
148882537|NCT00566852|537047364|FG000|Overall Study|Missing reason not reported|16|||
148882538|NCT00566852|537047365|FG001|Overall Study|Missing reason not reported|20|||
148882539|NCT01147055|537047366|FG000|First Intervention Period|Lost to Follow-up|1|||
148882540|NCT01147055|537047367|FG001|First Intervention Period|Lost to Follow-up|0|||
148882541|NCT01518374|537047371|FG000|Overall Study|Withdrawal by Subject|2|||
148882542|NCT01518374|537047371|FG000|Overall Study|Protocol Violation|3|||
148882543|NCT01518374|537047371|FG000|Overall Study|Lost to Follow-up|2|||
148882544|NCT04300309|537047372|FG000|Overall Study|Lost to Follow-up|1|||
148882545|NCT04300309|537047373|FG001|Overall Study|Lost to Follow-up|0|||
149039096|NCT05764161|537622293|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
149039097|NCT05764161|537622292|FG000|40-week OLE Period|Lack of Efficacy|0|||
149039098|NCT05764161|537622293|FG001|40-week OLE Period|Lack of Efficacy|1|||
149039099|NCT05764161|537622292|FG000|40-week OLE Period|Lost to Follow-up|1|||
149039100|NCT05764161|537622293|FG001|40-week OLE Period|Lost to Follow-up|4|||
149039101|NCT05764161|537622292|FG000|40-week OLE Period|Withdrawal by Subject|2|||
149039102|NCT05764161|537622293|FG001|40-week OLE Period|Withdrawal by Subject|7|||
149039103|NCT05764161|537622292|FG000|40-week OLE Period|Extended Travel|0|||
149039104|NCT05764161|537622293|FG001|40-week OLE Period|Extended Travel|1|||
149039105|NCT05764161|537622292|FG000|40-week OLE Period|Ongoing|66|||
149039106|NCT05764161|537622293|FG001|40-week OLE Period|Ongoing|59|||
149039107|NCT02613871|537622294|FG000|Overall Study|Death|2|||
149039108|NCT02613871|537622294|FG000|Overall Study|Withdrew Consent|1|||
148882546|NCT04607837|537047379|FG000|Overall Study|Adverse Event|8|||
149039109|NCT00507689|537622295|FG000|Pre-Randomization Period|Adverse Event|1|||
149039110|NCT00507689|537622296|FG001|Pre-Randomization Period|Adverse Event|0|||
149039111|NCT00507689|537622295|FG000|Pre-Randomization Period|Physician Decision|1|||
149039112|NCT00507689|537622296|FG001|Pre-Randomization Period|Physician Decision|0|||
149039113|NCT00507689|537622295|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
149039114|NCT00507689|537622296|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
149039115|NCT00507689|537622295|FG000|Randomized Period|Adverse Event|1|||
149039116|NCT00507689|537622296|FG001|Randomized Period|Adverse Event|1|||
149039117|NCT00507689|537622295|FG000|Randomized Period|Withdrawal by Subject|0|||
149039118|NCT00507689|537622296|FG001|Randomized Period|Withdrawal by Subject|1|||
149039119|NCT00831415|537622297|FG000|Overall Study|Adverse Event|14|||
149039120|NCT00831415|537622297|FG000|Overall Study|Failed to return|3|||
149039121|NCT00831415|537622297|FG000|Overall Study|Physician Decision|6|||
149039122|NCT00831415|537622297|FG000|Overall Study|Lost to Follow-up|9|||
149039123|NCT00831415|537622297|FG000|Overall Study|Protocol Violation|3|||
149039124|NCT00831415|537622297|FG000|Overall Study|Withdrawal by Subject|35|||
149039125|NCT00831415|537622297|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
149039126|NCT00831415|537622297|FG000|Overall Study|Death|1|||
149039127|NCT03034915|537622298|FG000|Overall Study|Adverse Event|29|||
149039128|NCT03034915|537622299|FG001|Overall Study|Adverse Event|32|||
149039129|NCT03034915|537622300|FG002|Overall Study|Adverse Event|22|||
149039130|NCT03034915|537622298|FG000|Overall Study|Lost to Follow-up|5|||
149039131|NCT03034915|537622299|FG001|Overall Study|Lost to Follow-up|13|||
149039132|NCT03034915|537622300|FG002|Overall Study|Lost to Follow-up|3|||
149039133|NCT03034915|537622298|FG000|Overall Study|Withdrawal by Subject|29|||
149039134|NCT03034915|537622299|FG001|Overall Study|Withdrawal by Subject|46|||
149039135|NCT03034915|537622300|FG002|Overall Study|Withdrawal by Subject|41|||
149039136|NCT03034915|537622298|FG000|Overall Study|Protocol Deviation|2|||
149039137|NCT03034915|537622299|FG001|Overall Study|Protocol Deviation|14|||
149039138|NCT03034915|537622300|FG002|Overall Study|Protocol Deviation|7|||
149039139|NCT03034915|537622298|FG000|Overall Study|Lack of Efficacy|8|||
149039140|NCT03034915|537622299|FG001|Overall Study|Lack of Efficacy|16|||
149039141|NCT03034915|537622300|FG002|Overall Study|Lack of Efficacy|18|||
149039142|NCT03034915|537622298|FG000|Overall Study|Site closed|2|||
149039143|NCT03034915|537622299|FG001|Overall Study|Site closed|2|||
149039144|NCT03034915|537622300|FG002|Overall Study|Site closed|4|||
149039145|NCT03034915|537622298|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
149039146|NCT03034915|537622299|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
149039147|NCT03034915|537622300|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
148882547|NCT04607837|537047380|FG001|Overall Study|Adverse Event|2|||
149039148|NCT03034915|537622298|FG000|Overall Study|Physician Decision|1|||
149039149|NCT03034915|537622299|FG001|Overall Study|Physician Decision|5|||
149039150|NCT03034915|537622300|FG002|Overall Study|Physician Decision|2|||
149039151|NCT03861767|537622303|FG000|Overall Study|Withdrawal by Subject|2|||
149039152|NCT03861767|537622304|FG001|Overall Study|Withdrawal by Subject|1|||
149039153|NCT03861767|537622305|FG002|Overall Study|Withdrawal by Subject|0|||
149039154|NCT03861767|537622306|FG003|Overall Study|Withdrawal by Subject|5|||
149039155|NCT03861767|537622307|FG004|Overall Study|Withdrawal by Subject|2|||
149039156|NCT03861767|537622308|FG005|Overall Study|Withdrawal by Subject|1|||
149039157|NCT03861767|537622309|FG006|Overall Study|Withdrawal by Subject|3|||
149039158|NCT03861767|537622310|FG007|Overall Study|Withdrawal by Subject|1|||
149039159|NCT03861767|537622311|FG008|Overall Study|Withdrawal by Subject|0|||
148882548|NCT04607837|537047379|FG000|Overall Study|Withdrawal by Subject|8|||
148882549|NCT04607837|537047380|FG001|Overall Study|Withdrawal by Subject|7|||
148882550|NCT04607837|537047379|FG000|Overall Study|Physician Decision|2|||
148882551|NCT04607837|537047380|FG001|Overall Study|Physician Decision|0|||
148882552|NCT04607837|537047379|FG000|Overall Study|Lack of Efficacy|2|||
148882553|NCT04607837|537047380|FG001|Overall Study|Lack of Efficacy|0|||
148882554|NCT04607837|537047379|FG000|Overall Study|Participant terminated by sponsor|1|||
148882555|NCT04607837|537047380|FG001|Overall Study|Participant terminated by sponsor|0|||
148882556|NCT04607837|537047379|FG000|Overall Study|Disease worsening|36|||
148882557|NCT04607837|537047380|FG001|Overall Study|Disease worsening|36|||
148882558|NCT04607837|537047379|FG000|Overall Study|Other|1|||
148882559|NCT04607837|537047380|FG001|Overall Study|Other|0|||
148882560|NCT02362464|537047381|FG000|Overall Study|Switched to alternative therapy|1|||
149039160|NCT03861767|537622312|FG009|Overall Study|Withdrawal by Subject|5|||
149039161|NCT00424762|537622318|FG000|Overall Study|Withdrawal by Subject|18|||
149039162|NCT00424762|537622319|FG001|Overall Study|Withdrawal by Subject|19|||
149039163|NCT00424762|537622318|FG000|Overall Study|Lost to Follow-up|2|||
149039164|NCT00424762|537622319|FG001|Overall Study|Lost to Follow-up|3|||
149039165|NCT03184558|537622320|FG000|Overall Study|Withdrawal by Subject|2|||
149039166|NCT03184558|537622320|FG000|Overall Study|Death|16|||
149039167|NCT03184558|537622320|FG000|Overall Study|Lost to Follow-up|2|||
149039168|NCT03184558|537622320|FG000|Overall Study|Other|9|||
149039169|NCT03061474|537622321|FG000|Overall Study|Adverse Event|2|||
149039170|NCT03061474|537622322|FG001|Overall Study|Adverse Event|0|||
148882561|NCT02362464|537047381|FG000|Overall Study|Refused further treatment|1|||
148882562|NCT02362464|537047381|FG000|Overall Study|Physician Decision|4|||
148882563|NCT00465452|537047382|FG000|Overall Study|Adverse Event|1|||
148882564|NCT04209205|537047389|FG000|Overall Study|Adverse Event|2|||
149039171|NCT03061474|537622321|FG000|Overall Study|Safety Risk|0|||
149039172|NCT03061474|537622322|FG001|Overall Study|Safety Risk|1|||
149039173|NCT03061474|537622321|FG000|Overall Study|Participant unwilling or unable to participate|0|||
149039174|NCT03061474|537622322|FG001|Overall Study|Participant unwilling or unable to participate|2|||
149039175|NCT03061474|537622321|FG000|Overall Study|Lost to Follow-up|0|||
149039176|NCT03061474|537622322|FG001|Overall Study|Lost to Follow-up|1|||
149039177|NCT01391130|537622323|FG000|Overall Study|Withdrawal by Subject|3|||
149039178|NCT01391130|537622324|FG001|Overall Study|Withdrawal by Subject|2|||
149039179|NCT01391130|537622323|FG000|Overall Study|Physician Decision|2|||
149039180|NCT01391130|537622324|FG001|Overall Study|Physician Decision|3|||
149039181|NCT01391130|537622323|FG000|Overall Study|Did not Receive Drug|1|||
149039182|NCT01391130|537622324|FG001|Overall Study|Did not Receive Drug|1|||
149039183|NCT00189202|537622325|FG000|Overall Study|Physician Decision|5|||
149039184|NCT01135511|537622326|FG000|Overall Study|Adverse Event|0|||
149039185|NCT01135511|537622327|FG001|Overall Study|Adverse Event|1|||
149039186|NCT01135511|537622328|FG002|Overall Study|Adverse Event|2|||
149039187|NCT01135511|537622329|FG003|Overall Study|Adverse Event|0|||
149039188|NCT01135511|537622330|FG004|Overall Study|Adverse Event|0|||
149039189|NCT01135511|537622331|FG005|Overall Study|Adverse Event|1|||
149039190|NCT01135511|537622332|FG006|Overall Study|Adverse Event|0|||
149039191|NCT01135511|537622333|FG007|Overall Study|Adverse Event|1|||
149039192|NCT01135511|537622334|FG008|Overall Study|Adverse Event|0|||
149039193|NCT01135511|537622326|FG000|Overall Study|Lack of Efficacy|0|||
149039194|NCT01135511|537622327|FG001|Overall Study|Lack of Efficacy|1|||
149039195|NCT01135511|537622328|FG002|Overall Study|Lack of Efficacy|1|||
149039196|NCT01135511|537622329|FG003|Overall Study|Lack of Efficacy|2|||
149039197|NCT01135511|537622330|FG004|Overall Study|Lack of Efficacy|0|||
149039198|NCT01135511|537622331|FG005|Overall Study|Lack of Efficacy|0|||
149039199|NCT01135511|537622332|FG006|Overall Study|Lack of Efficacy|0|||
149039200|NCT01135511|537622333|FG007|Overall Study|Lack of Efficacy|0|||
149039201|NCT01135511|537622334|FG008|Overall Study|Lack of Efficacy|0|||
149039202|NCT01135511|537622326|FG000|Overall Study|Protocol Violation|0|||
149039203|NCT01135511|537622327|FG001|Overall Study|Protocol Violation|0|||
149039204|NCT01135511|537622328|FG002|Overall Study|Protocol Violation|3|||
149039205|NCT01135511|537622329|FG003|Overall Study|Protocol Violation|0|||
149039206|NCT01135511|537622330|FG004|Overall Study|Protocol Violation|0|||
149039207|NCT01135511|537622331|FG005|Overall Study|Protocol Violation|0|||
149039208|NCT01135511|537622332|FG006|Overall Study|Protocol Violation|0|||
149039209|NCT01135511|537622333|FG007|Overall Study|Protocol Violation|0|||
149039210|NCT01135511|537622334|FG008|Overall Study|Protocol Violation|0|||
149039211|NCT01135511|537622326|FG000|Overall Study|Pregnancy|0|||
149039212|NCT01135511|537622327|FG001|Overall Study|Pregnancy|0|||
149039213|NCT01135511|537622328|FG002|Overall Study|Pregnancy|0|||
149039214|NCT01135511|537622329|FG003|Overall Study|Pregnancy|1|||
149039215|NCT01135511|537622330|FG004|Overall Study|Pregnancy|0|||
149039216|NCT01135511|537622331|FG005|Overall Study|Pregnancy|0|||
148882565|NCT04209205|537047390|FG001|Overall Study|Adverse Event|3|||
148882566|NCT04209205|537047389|FG000|Overall Study|Lost to Follow-up|3|||
148882567|NCT04209205|537047390|FG001|Overall Study|Lost to Follow-up|1|||
148882568|NCT04209205|537047389|FG000|Overall Study|Physician Decision|1|||
148882569|NCT04209205|537047390|FG001|Overall Study|Physician Decision|1|||
148882570|NCT04209205|537047389|FG000|Overall Study|Subject decision|10|||
148882571|NCT04209205|537047390|FG001|Overall Study|Subject decision|10|||
148882572|NCT04209205|537047389|FG000|Overall Study|Progressive disease|1|||
149039217|NCT01135511|537622332|FG006|Overall Study|Pregnancy|0|||
149039218|NCT01135511|537622333|FG007|Overall Study|Pregnancy|0|||
149039219|NCT01135511|537622334|FG008|Overall Study|Pregnancy|0|||
149039220|NCT01135511|537622326|FG000|Overall Study|could not visit the clinic|0|||
149039221|NCT01135511|537622327|FG001|Overall Study|could not visit the clinic|1|||
149039222|NCT01135511|537622328|FG002|Overall Study|could not visit the clinic|2|||
149039223|NCT01135511|537622329|FG003|Overall Study|could not visit the clinic|0|||
148882573|NCT04209205|537047390|FG001|Overall Study|Progressive disease|0|||
148882574|NCT04209205|537047389|FG000|Overall Study|Protocol deviation|0|||
148882575|NCT04209205|537047390|FG001|Overall Study|Protocol deviation|1|||
148882576|NCT04209205|537047389|FG000|Overall Study|New therapy for study indication|1|||
149039224|NCT01135511|537622330|FG004|Overall Study|could not visit the clinic|0|||
149039225|NCT01135511|537622331|FG005|Overall Study|could not visit the clinic|0|||
149039226|NCT01135511|537622332|FG006|Overall Study|could not visit the clinic|0|||
149039227|NCT01135511|537622333|FG007|Overall Study|could not visit the clinic|0|||
149039228|NCT01135511|537622334|FG008|Overall Study|could not visit the clinic|0|||
149039229|NCT01135511|537622326|FG000|Overall Study|noncompliance with study drug taken|0|||
149039230|NCT01135511|537622327|FG001|Overall Study|noncompliance with study drug taken|0|||
148882577|NCT04209205|537047390|FG001|Overall Study|New therapy for study indication|0|||
148882578|NCT04209205|537047389|FG000|Overall Study|Adverse event - placebo not switched|0|||
149039231|NCT01135511|537622328|FG002|Overall Study|noncompliance with study drug taken|0|||
149039232|NCT01135511|537622329|FG003|Overall Study|noncompliance with study drug taken|0|||
149039233|NCT01135511|537622330|FG004|Overall Study|noncompliance with study drug taken|1|||
148882579|NCT04209205|537047390|FG001|Overall Study|Adverse event - placebo not switched|1|||
149039234|NCT01135511|537622331|FG005|Overall Study|noncompliance with study drug taken|0|||
148882580|NCT04209205|537047389|FG000|Overall Study|Subject decision - placebo not switched|0|||
148882581|NCT04209205|537047390|FG001|Overall Study|Subject decision - placebo not switched|5|||
148882582|NCT04209205|537047389|FG000|Overall Study|Death - placebo not switched|0|||
148882583|NCT04209205|537047390|FG001|Overall Study|Death - placebo not switched|1|||
148882584|NCT03828019|537047395|FG000|Overall Study|Withdrawal by Subject|3|||
148882585|NCT03828019|537047396|FG001|Overall Study|Withdrawal by Subject|8|||
148882586|NCT03828019|537047395|FG000|Overall Study|Lost to Follow-up|1|||
148882587|NCT03828019|537047396|FG001|Overall Study|Lost to Follow-up|6|||
149004196|NCT03685591|537493237|FG002|Overall Study|Withdrawal by Subject|0|||
149004197|NCT03685591|537493238|FG003|Overall Study|Withdrawal by Subject|0|||
149004198|NCT03685591|537493239|FG004|Overall Study|Withdrawal by Subject|3|||
149004199|NCT03685591|537493240|FG005|Overall Study|Withdrawal by Subject|2|||
149004200|NCT03685591|537493241|FG006|Overall Study|Withdrawal by Subject|0|||
149004201|NCT03685591|537493242|FG007|Overall Study|Withdrawal by Subject|0|||
149004202|NCT03685591|537493243|FG008|Overall Study|Withdrawal by Subject|1|||
149004203|NCT03685591|537493235|FG000|Overall Study|Adverse Event|0|||
149004204|NCT03685591|537493236|FG001|Overall Study|Adverse Event|0|||
149004205|NCT03685591|537493237|FG002|Overall Study|Adverse Event|0|||
149004206|NCT03685591|537493238|FG003|Overall Study|Adverse Event|1|||
149004207|NCT03685591|537493239|FG004|Overall Study|Adverse Event|1|||
149004208|NCT03685591|537493240|FG005|Overall Study|Adverse Event|4|||
149004209|NCT03685591|537493241|FG006|Overall Study|Adverse Event|0|||
149004210|NCT03685591|537493242|FG007|Overall Study|Adverse Event|1|||
149004211|NCT03685591|537493243|FG008|Overall Study|Adverse Event|1|||
149004212|NCT01685138|537493246|FG000|Overall Study|Lost to Follow-up|1|||
149004213|NCT01685138|537493246|FG000|Overall Study|Protocol Violation|1|||
149004214|NCT01685138|537493246|FG000|Overall Study|No longer requires treatment|1|||
149004215|NCT01685138|537493246|FG000|Overall Study|Subject/guardian decision|2|||
149004216|NCT01685138|537493246|FG000|Overall Study|Physician Decision|6|||
149004217|NCT01685138|537493246|FG000|Overall Study|Death|10|||
149004218|NCT01685138|537493246|FG000|Overall Study|Adverse Event|18|||
149004219|NCT01685138|537493246|FG000|Overall Study|Progressive disease|53|||
149004220|NCT02068495|537493247|FG000|Overall Study|Case Report Forms Uncollected|60|||
149004221|NCT02068495|537493247|FG000|Overall Study|Protocol Deviation|49|||
149004222|NCT03988166|537493248|FG000|Overall Study|Lost to Follow-up|2|||
149004223|NCT03988166|537493248|FG000|Overall Study|Death|1|||
149004224|NCT01951638|537493249|FG000|Treatment Period|Protocol Violation|0|||
149004225|NCT01951638|537493250|FG001|Treatment Period|Protocol Violation|0|||
149004226|NCT01951638|537493251|FG002|Treatment Period|Protocol Violation|0|||
149004227|NCT01951638|537493252|FG003|Treatment Period|Protocol Violation|2|||
149004228|NCT01951638|537493253|FG004|Treatment Period|Protocol Violation|0|||
149004229|NCT01951638|537493249|FG000|Treatment Period|Protocol-driven decision point|1|||
149004230|NCT01951638|537493250|FG001|Treatment Period|Protocol-driven decision point|3|||
149004231|NCT01951638|537493251|FG002|Treatment Period|Protocol-driven decision point|0|||
149004232|NCT01951638|537493252|FG003|Treatment Period|Protocol-driven decision point|0|||
149004233|NCT01951638|537493253|FG004|Treatment Period|Protocol-driven decision point|0|||
149004234|NCT01951638|537493249|FG000|Treatment Period|Logistical difficulties|0|||
149004235|NCT01951638|537493250|FG001|Treatment Period|Logistical difficulties|1|||
149004236|NCT01951638|537493251|FG002|Treatment Period|Logistical difficulties|1|||
149004237|NCT01951638|537493252|FG003|Treatment Period|Logistical difficulties|0|||
149004238|NCT01951638|537493253|FG004|Treatment Period|Logistical difficulties|0|||
149004239|NCT01951638|537493249|FG000|Treatment Period|Withdrawal by Subject|9|||
149004240|NCT01951638|537493250|FG001|Treatment Period|Withdrawal by Subject|6|||
149004241|NCT01951638|537493251|FG002|Treatment Period|Withdrawal by Subject|4|||
149004242|NCT01951638|537493252|FG003|Treatment Period|Withdrawal by Subject|5|||
149004243|NCT01951638|537493253|FG004|Treatment Period|Withdrawal by Subject|4|||
149004244|NCT01951638|537493249|FG000|Treatment Period|Death|0|||
149004245|NCT01951638|537493250|FG001|Treatment Period|Death|0|||
149004246|NCT01951638|537493251|FG002|Treatment Period|Death|0|||
149004247|NCT01951638|537493252|FG003|Treatment Period|Death|3|||
149004248|NCT01951638|537493253|FG004|Treatment Period|Death|1|||
149004249|NCT01951638|537493249|FG000|Treatment Period|Adverse Event|3|||
149039235|NCT01135511|537622332|FG006|Overall Study|noncompliance with study drug taken|0|||
148882588|NCT03828019|537047395|FG000|Overall Study|Incarcerated|1|||
148882589|NCT03828019|537047396|FG001|Overall Study|Incarcerated|0|||
149004250|NCT01951638|537493250|FG001|Treatment Period|Adverse Event|4|||
149004251|NCT01951638|537493251|FG002|Treatment Period|Adverse Event|8|||
149004252|NCT01951638|537493252|FG003|Treatment Period|Adverse Event|6|||
149004253|NCT01951638|537493253|FG004|Treatment Period|Adverse Event|5|||
149004254|NCT01951638|537493249|FG000|Follow-up Period|Protocol Violation|0|||
149004255|NCT01951638|537493250|FG001|Follow-up Period|Protocol Violation|0|||
149004256|NCT01951638|537493251|FG002|Follow-up Period|Protocol Violation|0|||
149004257|NCT01951638|537493252|FG003|Follow-up Period|Protocol Violation|1|||
149004258|NCT01951638|537493253|FG004|Follow-up Period|Protocol Violation|0|||
149004259|NCT01951638|537493249|FG000|Follow-up Period|Logistical difficulties|0|||
149004260|NCT01951638|537493250|FG001|Follow-up Period|Logistical difficulties|2|||
149004261|NCT01951638|537493251|FG002|Follow-up Period|Logistical difficulties|0|||
149039236|NCT01135511|537622333|FG007|Overall Study|noncompliance with study drug taken|0|||
149039237|NCT01135511|537622334|FG008|Overall Study|noncompliance with study drug taken|0|||
149039238|NCT01135511|537622326|FG000|Overall Study|Withdrawal by Subject|0|||
148882590|NCT03828019|537047395|FG000|Overall Study|Adverse Event|0|||
148882591|NCT03828019|537047396|FG001|Overall Study|Adverse Event|1|||
148882592|NCT05715242|537047397|FG000|Overall Study|Lost to Follow-up|0|||
148882593|NCT05715242|537047398|FG001|Overall Study|Lost to Follow-up|0|||
148882594|NCT05715242|537047399|FG002|Overall Study|Lost to Follow-up|1|||
148882595|NCT05715242|537047400|FG003|Overall Study|Lost to Follow-up|0|||
148882596|NCT05715242|537047401|FG004|Overall Study|Lost to Follow-up|0|||
148882597|NCT05715242|537047402|FG005|Overall Study|Lost to Follow-up|1|||
148882598|NCT05715242|537047403|FG006|Overall Study|Lost to Follow-up|0|||
148882599|NCT05715242|537047404|FG007|Overall Study|Lost to Follow-up|0|||
149039239|NCT01135511|537622327|FG001|Overall Study|Withdrawal by Subject|0|||
149039240|NCT01135511|537622328|FG002|Overall Study|Withdrawal by Subject|0|||
149039241|NCT01135511|537622329|FG003|Overall Study|Withdrawal by Subject|0|||
149039242|NCT01135511|537622330|FG004|Overall Study|Withdrawal by Subject|0|||
149039243|NCT01135511|537622331|FG005|Overall Study|Withdrawal by Subject|0|||
149039244|NCT01135511|537622332|FG006|Overall Study|Withdrawal by Subject|1|||
149039245|NCT01135511|537622333|FG007|Overall Study|Withdrawal by Subject|0|||
149039246|NCT01135511|537622334|FG008|Overall Study|Withdrawal by Subject|1|||
149039247|NCT05001945|537622337|FG000|Overall Study|Adverse Event|0|||
149039248|NCT05001945|537622338|FG001|Overall Study|Adverse Event|0|||
149039249|NCT05001945|537622339|FG002|Overall Study|Adverse Event|0|||
149039250|NCT05001945|537622340|FG003|Overall Study|Adverse Event|1|||
149039251|NCT05001945|537622341|FG004|Overall Study|Adverse Event|0|||
149039252|NCT05001945|537622342|FG005|Overall Study|Adverse Event|0|||
149039253|NCT05001945|537622343|FG006|Overall Study|Adverse Event|0|||
149039254|NCT05001945|537622344|FG007|Overall Study|Adverse Event|0|||
149039255|NCT05001945|537622337|FG000|Overall Study|Lost to Follow-up|0|||
149039256|NCT05001945|537622338|FG001|Overall Study|Lost to Follow-up|1|||
149039257|NCT05001945|537622339|FG002|Overall Study|Lost to Follow-up|1|||
149039258|NCT05001945|537622340|FG003|Overall Study|Lost to Follow-up|2|||
149039259|NCT05001945|537622341|FG004|Overall Study|Lost to Follow-up|0|||
149039260|NCT05001945|537622342|FG005|Overall Study|Lost to Follow-up|1|||
149039261|NCT05001945|537622343|FG006|Overall Study|Lost to Follow-up|0|||
149039262|NCT05001945|537622344|FG007|Overall Study|Lost to Follow-up|0|||
149039263|NCT05001945|537622337|FG000|Overall Study|Protocol Violation|1|||
149039264|NCT05001945|537622338|FG001|Overall Study|Protocol Violation|0|||
149039265|NCT05001945|537622339|FG002|Overall Study|Protocol Violation|1|||
149039266|NCT05001945|537622340|FG003|Overall Study|Protocol Violation|1|||
149039267|NCT05001945|537622341|FG004|Overall Study|Protocol Violation|0|||
149039268|NCT05001945|537622342|FG005|Overall Study|Protocol Violation|1|||
149039269|NCT05001945|537622343|FG006|Overall Study|Protocol Violation|0|||
149039270|NCT05001945|537622344|FG007|Overall Study|Protocol Violation|0|||
149039271|NCT05001945|537622337|FG000|Overall Study|Withdrawal by Subject|0|||
149039272|NCT05001945|537622338|FG001|Overall Study|Withdrawal by Subject|0|||
149039273|NCT05001945|537622339|FG002|Overall Study|Withdrawal by Subject|0|||
149039274|NCT05001945|537622340|FG003|Overall Study|Withdrawal by Subject|1|||
149039275|NCT05001945|537622341|FG004|Overall Study|Withdrawal by Subject|1|||
149039276|NCT05001945|537622342|FG005|Overall Study|Withdrawal by Subject|1|||
149039277|NCT05001945|537622343|FG006|Overall Study|Withdrawal by Subject|0|||
149039278|NCT05001945|537622344|FG007|Overall Study|Withdrawal by Subject|1|||
149039279|NCT05001945|537622337|FG000|Overall Study|Not specified by Investigator|0|||
149039280|NCT05001945|537622338|FG001|Overall Study|Not specified by Investigator|3|||
149039281|NCT05001945|537622339|FG002|Overall Study|Not specified by Investigator|0|||
149039282|NCT05001945|537622340|FG003|Overall Study|Not specified by Investigator|0|||
149039283|NCT05001945|537622341|FG004|Overall Study|Not specified by Investigator|1|||
149039284|NCT05001945|537622342|FG005|Overall Study|Not specified by Investigator|0|||
149039285|NCT05001945|537622343|FG006|Overall Study|Not specified by Investigator|0|||
149039286|NCT05001945|537622344|FG007|Overall Study|Not specified by Investigator|0|||
149039287|NCT02570711|537622345|FG000|Overall Study|Death|1|||
149039288|NCT02570711|537622346|FG001|Overall Study|Death|0|||
148882600|NCT05715242|537047405|FG008|Overall Study|Lost to Follow-up|0|||
149039289|NCT02570711|537622345|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
149039290|NCT02570711|537622346|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
149039291|NCT01595321|537622347|FG000|Overall Study|Adverse Event|1|||
149039292|NCT01595321|537622348|FG001|Overall Study|Adverse Event|1|||
149039293|NCT01595321|537622349|FG002|Overall Study|Adverse Event|1|||
148882601|NCT05715242|537047406|FG009|Overall Study|Lost to Follow-up|0|||
149039294|NCT01595321|537622347|FG000|Overall Study|Lack of Efficacy|0|||
149039295|NCT01595321|537622348|FG001|Overall Study|Lack of Efficacy|0|||
148882602|NCT05715242|537047407|FG010|Overall Study|Lost to Follow-up|0|||
148882603|NCT05715242|537047408|FG011|Overall Study|Lost to Follow-up|0|||
149039296|NCT01595321|537622349|FG002|Overall Study|Lack of Efficacy|4|||
149039297|NCT05797155|537622350|FG000|Overall Study|Lost to Follow-up|33|||
149039298|NCT05797155|537622351|FG001|Overall Study|Lost to Follow-up|12|||
149039299|NCT00026312|537622352|FG000|Overall Study|Adverse Event|0|||
149039300|NCT00026312|537622353|FG001|Overall Study|Adverse Event|32|||
149039301|NCT00026312|537622352|FG000|Overall Study|Death|1|||
149039302|NCT00026312|537622353|FG001|Overall Study|Death|7|||
149039303|NCT00026312|537622352|FG000|Overall Study|Lack of Efficacy|19|||
149039304|NCT00026312|537622353|FG001|Overall Study|Lack of Efficacy|114|||
149039305|NCT00026312|537622352|FG000|Overall Study|Lost to Follow-up|0|||
149039306|NCT00026312|537622353|FG001|Overall Study|Lost to Follow-up|5|||
149039307|NCT00026312|537622352|FG000|Overall Study|Physician Decision|1|||
149039308|NCT00026312|537622353|FG001|Overall Study|Physician Decision|37|||
149039309|NCT00026312|537622352|FG000|Overall Study|Protocol Violation|0|||
148882604|NCT05715242|537047409|FG012|Overall Study|Lost to Follow-up|0|||
148882605|NCT05715242|537047410|FG013|Overall Study|Lost to Follow-up|0|||
148882606|NCT05715242|537047411|FG014|Overall Study|Lost to Follow-up|0|||
148882607|NCT05715242|537047412|FG015|Overall Study|Lost to Follow-up|0|||
148882608|NCT02343406|537047413|FG000|Overall Study|Progressive disease|72|||
148882609|NCT02343406|537047414|FG001|Overall Study|Progressive disease|70|||
149039310|NCT00026312|537622353|FG001|Overall Study|Protocol Violation|3|||
149039311|NCT00026312|537622352|FG000|Overall Study|Withdrawal by Subject|1|||
149039312|NCT00026312|537622353|FG001|Overall Study|Withdrawal by Subject|6|||
149039313|NCT00026312|537622352|FG000|Overall Study|Ineligible|4|||
149039314|NCT00026312|537622353|FG001|Overall Study|Ineligible|5|||
149039315|NCT00026312|537622352|FG000|Overall Study|Entry onto another COG study|0|||
149039316|NCT00026312|537622353|FG001|Overall Study|Entry onto another COG study|1|||
149039317|NCT00026312|537622352|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
149039318|NCT00026312|537622353|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
149039319|NCT02445391|537622354|FG000|Overall Study|No active protocol treatment|3|||
149039320|NCT02445391|537622355|FG001|Overall Study|No active protocol treatment|0|||
149039321|NCT02445391|537622356|FG002|Overall Study|No active protocol treatment|0|||
148882610|NCT02343406|537047415|FG002|Overall Study|Progressive disease|43|||
148882611|NCT02343406|537047416|FG003|Overall Study|Progressive disease|15|||
148882612|NCT02343406|537047417|FG004|Overall Study|Progressive disease|5|||
148882613|NCT02343406|537047413|FG000|Overall Study|Adverse Event|6|||
148882614|NCT02343406|537047414|FG001|Overall Study|Adverse Event|8|||
148882615|NCT02343406|537047415|FG002|Overall Study|Adverse Event|6|||
149039322|NCT02445391|537622354|FG000|Overall Study|Adverse Event|0|||
149039323|NCT02445391|537622355|FG001|Overall Study|Adverse Event|21|||
149039324|NCT02445391|537622356|FG002|Overall Study|Adverse Event|12|||
149039325|NCT02445391|537622354|FG000|Overall Study|Alternative therapy|0|||
148882616|NCT02343406|537047416|FG003|Overall Study|Adverse Event|3|||
148882617|NCT02343406|537047417|FG004|Overall Study|Adverse Event|0|||
148882618|NCT02343406|537047413|FG000|Overall Study|Withdrawal by Subject|6|||
148882619|NCT02343406|537047414|FG001|Overall Study|Withdrawal by Subject|4|||
149039326|NCT02445391|537622355|FG001|Overall Study|Alternative therapy|0|||
149039327|NCT02445391|537622356|FG002|Overall Study|Alternative therapy|1|||
149039328|NCT02445391|537622354|FG000|Overall Study|Disease progression|0|||
149039329|NCT02445391|537622355|FG001|Overall Study|Disease progression|7|||
149039330|NCT02445391|537622356|FG002|Overall Study|Disease progression|22|||
149039331|NCT02445391|537622354|FG000|Overall Study|Complicating disease|0|||
149039332|NCT02445391|537622355|FG001|Overall Study|Complicating disease|2|||
149039333|NCT02445391|537622356|FG002|Overall Study|Complicating disease|1|||
149039334|NCT02445391|537622354|FG000|Overall Study|Withdrawal by Subject|0|||
149039335|NCT02445391|537622355|FG001|Overall Study|Withdrawal by Subject|4|||
149039336|NCT02445391|537622356|FG002|Overall Study|Withdrawal by Subject|9|||
149039337|NCT02445391|537622354|FG000|Overall Study|Financial issue|0|||
149039338|NCT02445391|537622355|FG001|Overall Study|Financial issue|0|||
149039339|NCT02445391|537622356|FG002|Overall Study|Financial issue|2|||
149039340|NCT02445391|537622354|FG000|Overall Study|Still on treatment|0|||
148882620|NCT02343406|537047415|FG002|Overall Study|Withdrawal by Subject|8|||
148882621|NCT02343406|537047416|FG003|Overall Study|Withdrawal by Subject|3|||
148882622|NCT02343406|537047417|FG004|Overall Study|Withdrawal by Subject|0|||
149039341|NCT02445391|537622355|FG001|Overall Study|Still on treatment|7|||
149039342|NCT02445391|537622356|FG002|Overall Study|Still on treatment|16|||
149039343|NCT02445391|537622354|FG000|Overall Study|Not start protocol therapy|0|||
149039344|NCT02445391|537622355|FG001|Overall Study|Not start protocol therapy|12|||
149039345|NCT02445391|537622356|FG002|Overall Study|Not start protocol therapy|9|||
149039350|NCT03889925|537623570|FG000|Overall Study|Lost to Follow-up|11|||
149039351|NCT03889925|537623571|FG001|Overall Study|Lost to Follow-up|10|||
148882623|NCT02343406|537047413|FG000|Overall Study|Death|2|||
148882624|NCT02343406|537047414|FG001|Overall Study|Death|1|||
148882625|NCT02343406|537047415|FG002|Overall Study|Death|0|||
148882626|NCT02343406|537047416|FG003|Overall Study|Death|0|||
149039352|NCT03762668|537623572|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
149039353|NCT03762668|537623573|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
149039354|NCT00818454|537623574|FG000|Treatment Period 1|Adverse Event|0|||
148882627|NCT02343406|537047417|FG004|Overall Study|Death|0|||
148882628|NCT02343406|537047413|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
148882629|NCT02343406|537047414|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
148882630|NCT02343406|537047415|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
148882631|NCT02343406|537047416|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
148882632|NCT02343406|537047417|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
149004262|NCT01951638|537493252|FG003|Follow-up Period|Logistical difficulties|0|||
149004263|NCT01951638|537493253|FG004|Follow-up Period|Logistical difficulties|1|||
149004264|NCT01951638|537493249|FG000|Follow-up Period|Withdrawal by Subject|1|||
149004265|NCT01951638|537493250|FG001|Follow-up Period|Withdrawal by Subject|5|||
149004266|NCT01951638|537493251|FG002|Follow-up Period|Withdrawal by Subject|2|||
149004267|NCT01951638|537493252|FG003|Follow-up Period|Withdrawal by Subject|1|||
149004268|NCT01951638|537493253|FG004|Follow-up Period|Withdrawal by Subject|2|||
149004269|NCT01951638|537493249|FG000|Follow-up Period|Lost to Follow-up|0|||
149004270|NCT01951638|537493250|FG001|Follow-up Period|Lost to Follow-up|1|||
149004271|NCT01951638|537493251|FG002|Follow-up Period|Lost to Follow-up|0|||
149004272|NCT01951638|537493252|FG003|Follow-up Period|Lost to Follow-up|1|||
149004273|NCT01951638|537493253|FG004|Follow-up Period|Lost to Follow-up|0|||
149004274|NCT01951638|537493249|FG000|Follow-up Period|Death|1|||
149004275|NCT01951638|537493250|FG001|Follow-up Period|Death|0|||
149004276|NCT01951638|537493251|FG002|Follow-up Period|Death|1|||
149004277|NCT01951638|537493252|FG003|Follow-up Period|Death|4|||
149004278|NCT01951638|537493253|FG004|Follow-up Period|Death|1|||
149004279|NCT01951638|537493249|FG000|Follow-up Period|Adverse Event|0|||
149004280|NCT01951638|537493250|FG001|Follow-up Period|Adverse Event|1|||
149004281|NCT01951638|537493251|FG002|Follow-up Period|Adverse Event|2|||
149004282|NCT01951638|537493252|FG003|Follow-up Period|Adverse Event|1|||
149004283|NCT01951638|537493253|FG004|Follow-up Period|Adverse Event|1|||
149004284|NCT00766675|537494974|FG000|Overall Study|Adverse Event|16|||
149004285|NCT00766675|537494974|FG000|Overall Study|Lost to Follow-up|2|||
149004286|NCT00766675|537494974|FG000|Overall Study|Withdrawal by Subject|11|||
149004287|NCT00766675|537494974|FG000|Overall Study|Protocol Violation|8|||
149004288|NCT00766675|537494974|FG000|Overall Study|Participant took prohibited medication|1|||
149004289|NCT00766675|537494974|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
149004290|NCT00766675|537494974|FG000|Overall Study|Insufficient therapy|1|||
149004291|NCT03308825|537494975|FG000|Overall Study|Lost to Follow-up|2|||
149004292|NCT03308825|537494976|FG001|Overall Study|Lost to Follow-up|2|||
149004293|NCT03308825|537494977|FG002|Overall Study|Lost to Follow-up|1|||
149004294|NCT03308825|537494978|FG003|Overall Study|Lost to Follow-up|0|||
149004295|NCT03308825|537494975|FG000|Overall Study|Protocol Violation|0|||
149004296|NCT03308825|537494976|FG001|Overall Study|Protocol Violation|2|||
149004297|NCT03308825|537494977|FG002|Overall Study|Protocol Violation|0|||
149004298|NCT03308825|537494978|FG003|Overall Study|Protocol Violation|0|||
149004299|NCT02044848|537494979|FG000|Overall Study|Administrative Problems|2|||
149004300|NCT02044848|537494980|FG001|Overall Study|Administrative Problems|3|||
149004301|NCT00045708|537494981|FG000|Phase 1|early progressive disease|0|||
149004302|NCT00045708|537494982|FG001|Phase 1|early progressive disease|1|||
149004303|NCT00045708|537494983|FG002|Phase 1|early progressive disease|0|||
149004304|NCT00685945|537494985|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
149004305|NCT03183388|537494986|FG000|Overall Study|Lost to Follow-up|3|||
149004306|NCT03183388|537494987|FG001|Overall Study|Lost to Follow-up|5|||
149004307|NCT03183388|537494986|FG000|Overall Study|Physician Decision|1|||
149004308|NCT03183388|537494987|FG001|Overall Study|Physician Decision|4|||
149004309|NCT03183388|537494986|FG000|Overall Study|Withdrawal by Subject|4|||
149004310|NCT03183388|537494987|FG001|Overall Study|Withdrawal by Subject|1|||
149004311|NCT03183388|537494986|FG000|Overall Study|Moved|1|||
149004312|NCT03183388|537494987|FG001|Overall Study|Moved|0|||
149004313|NCT03183388|537494986|FG000|Overall Study|Met Exclusion Criteria|2|||
149004314|NCT03183388|537494987|FG001|Overall Study|Met Exclusion Criteria|2|||
149004315|NCT03183388|537494986|FG000|Overall Study|COVID Pandemic Related|2|||
149004316|NCT03183388|537494987|FG001|Overall Study|COVID Pandemic Related|4|||
149004317|NCT01493960|537494990|FG000|Overall Study|Adverse Event|0|||
149004318|NCT01493960|537494991|FG001|Overall Study|Adverse Event|1|||
149004319|NCT01493960|537494990|FG000|Overall Study|Lack of Efficacy|15|||
149004320|NCT01493960|537494991|FG001|Overall Study|Lack of Efficacy|9|||
149004321|NCT01493960|537494990|FG000|Overall Study|Protocol Violation|3|||
149004322|NCT01493960|537494991|FG001|Overall Study|Protocol Violation|0|||
149004323|NCT01493960|537494990|FG000|Overall Study|Withdrawal by Subject|10|||
149004324|NCT01493960|537494991|FG001|Overall Study|Withdrawal by Subject|4|||
149004325|NCT01493960|537494990|FG000|Overall Study|Non-specified|4|||
149004326|NCT01493960|537494991|FG001|Overall Study|Non-specified|4|||
149004327|NCT01679236|537494996|FG000|Overall Study|Lost to Follow-up|15|||
149004328|NCT01679236|537494997|FG001|Overall Study|Lost to Follow-up|15|||
149004329|NCT03935217|537495000|FG000|Overall Study|Adverse Event|1|||
149004330|NCT03935217|537495001|FG001|Overall Study|Adverse Event|0|||
149004331|NCT03935217|537495000|FG000|Overall Study|Lost to Follow-up|0|||
149004332|NCT03935217|537495001|FG001|Overall Study|Lost to Follow-up|1|||
149004333|NCT03935217|537495000|FG000|Overall Study|Withdrawal by Subject|0|||
149004334|NCT03935217|537495001|FG001|Overall Study|Withdrawal by Subject|2|||
149039355|NCT00818454|537623575|FG001|Treatment Period 1|Adverse Event|1|||
149039356|NCT00818454|537623576|FG002|Treatment Period 1|Adverse Event|0|||
149039357|NCT00818454|537623577|FG003|Treatment Period 1|Adverse Event|0|||
149039358|NCT00818454|537623574|FG000|Treatment Period 1|Other|3|||
149039359|NCT00818454|537623575|FG001|Treatment Period 1|Other|0|||
149039360|NCT00818454|537623576|FG002|Treatment Period 1|Other|0|||
149039361|NCT00818454|537623577|FG003|Treatment Period 1|Other|0|||
149039362|NCT00818454|537623574|FG000|Washout Period of 1 Week|Adverse Event|1|||
149039363|NCT00818454|537623575|FG001|Washout Period of 1 Week|Adverse Event|1|||
149039364|NCT00818454|537623576|FG002|Washout Period of 1 Week|Adverse Event|0|||
149039365|NCT00818454|537623577|FG003|Washout Period of 1 Week|Adverse Event|0|||
149039366|NCT00818454|537623574|FG000|Washout Period of 1 Week|Protocol Violation|2|||
149039367|NCT00818454|537623575|FG001|Washout Period of 1 Week|Protocol Violation|0|||
149039368|NCT00818454|537623576|FG002|Washout Period of 1 Week|Protocol Violation|0|||
149039369|NCT00818454|537623577|FG003|Washout Period of 1 Week|Protocol Violation|0|||
149039370|NCT00818454|537623574|FG000|Washout Period of 1 Week|Other|1|||
149039371|NCT00818454|537623575|FG001|Washout Period of 1 Week|Other|2|||
149039372|NCT00818454|537623576|FG002|Washout Period of 1 Week|Other|0|||
149039373|NCT00818454|537623577|FG003|Washout Period of 1 Week|Other|0|||
149039374|NCT00818454|537623574|FG000|Treatment Period 2|Other|2|||
149039375|NCT00818454|537623575|FG001|Treatment Period 2|Other|1|||
149039376|NCT00818454|537623576|FG002|Treatment Period 2|Other|0|||
149039377|NCT00818454|537623577|FG003|Treatment Period 2|Other|0|||
149039378|NCT00818454|537623574|FG000|Treatment Period 3|Adverse Event|0|||
149039379|NCT00818454|537623575|FG001|Treatment Period 3|Adverse Event|0|||
149039380|NCT00818454|537623576|FG002|Treatment Period 3|Adverse Event|0|||
149039381|NCT00818454|537623577|FG003|Treatment Period 3|Adverse Event|1|||
149039382|NCT01786564|537623580|FG000|Overall Study|Lost to Follow-up|47|||
149039383|NCT01786564|537623580|FG000|Overall Study|Ineligible|17|||
149039384|NCT00494442|537623581|FG000|Overall Study|Death|1|||
149039385|NCT00494442|537623582|FG001|Overall Study|Death|1|||
149039386|NCT00494442|537623581|FG000|Overall Study|Lack of Efficacy|16|||
149039387|NCT00494442|537623582|FG001|Overall Study|Lack of Efficacy|10|||
149039388|NCT00494442|537623581|FG000|Overall Study|Adverse Event|0|||
149039389|NCT00494442|537623582|FG001|Overall Study|Adverse Event|2|||
149039390|NCT00494442|537623581|FG000|Overall Study|Physician Decision|0|||
149039391|NCT00494442|537623582|FG001|Overall Study|Physician Decision|1|||
149039392|NCT00494442|537623581|FG000|Overall Study|Non-compliance|0|||
149039393|NCT00494442|537623582|FG001|Overall Study|Non-compliance|1|||
149039394|NCT00494442|537623581|FG000|Overall Study|Intercurrent illness|0|||
149039395|NCT00494442|537623582|FG001|Overall Study|Intercurrent illness|1|||
149039396|NCT01241292|537623585|FG000|Overall Study|Administrative Reason by Sponsor|1|||
149039397|NCT01241292|537623586|FG001|Overall Study|Administrative Reason by Sponsor|0|||
148882633|NCT02343406|537047413|FG000|Overall Study|Other primary malignancy|0|||
148882634|NCT02343406|537047414|FG001|Overall Study|Other primary malignancy|1|||
148882635|NCT02343406|537047415|FG002|Overall Study|Other primary malignancy|0|||
148882636|NCT02343406|537047416|FG003|Overall Study|Other primary malignancy|0|||
148882637|NCT02343406|537047417|FG004|Overall Study|Other primary malignancy|0|||
148882638|NCT02343406|537047413|FG000|Overall Study|Other, not specified|2|||
148882639|NCT02343406|537047414|FG001|Overall Study|Other, not specified|1|||
148882640|NCT02343406|537047415|FG002|Overall Study|Other, not specified|1|||
148882641|NCT02343406|537047416|FG003|Overall Study|Other, not specified|4|||
148882642|NCT02343406|537047417|FG004|Overall Study|Other, not specified|0|||
148882643|NCT02058563|537047418|FG000|Overall Study|Lost to Follow-up|26|||
148882644|NCT02058563|537047419|FG001|Overall Study|Lost to Follow-up|22|||
148882645|NCT02058563|537047418|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
148882646|NCT02058563|537047419|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
148882647|NCT02058563|537047418|FG000|Overall Study|Consent Withdrawal|1|||
148882648|NCT02058563|537047419|FG001|Overall Study|Consent Withdrawal|1|||
148882649|NCT02058563|537047418|FG000|Overall Study|Other (patient incarcerated)|0|||
148882650|NCT02058563|537047419|FG001|Overall Study|Other (patient incarcerated)|1|||
148882651|NCT04039217|537047420|FG000|Overall Study|Lost to Follow-up|1|||
149039398|NCT01241292|537623585|FG000|Overall Study|Disease Progression|2|||
148882652|NCT02328027|537047421|FG000|Overall Study|Withdrawal by Subject|0|||
149039399|NCT01241292|537623586|FG001|Overall Study|Disease Progression|0|||
149039400|NCT01241292|537623585|FG000|Overall Study|Study Drug Toxicity|0|||
149039401|NCT01241292|537623586|FG001|Overall Study|Study Drug Toxicity|1|||
148882653|NCT02328027|537047422|FG001|Overall Study|Withdrawal by Subject|1|||
148882654|NCT02465203|537047423|FG000|Overall Study|Protocol Violation|1|||
148882655|NCT02465203|537047424|FG001|Overall Study|Protocol Violation|1|||
149039402|NCT01241292|537623585|FG000|Overall Study|Participant Discontinued Treatment|0|||
149039403|NCT01241292|537623586|FG001|Overall Study|Participant Discontinued Treatment|2|||
149039404|NCT01831791|537623587|FG000|Overall Study|Withdrawal by Subject|10|||
149039405|NCT00494780|537623588|FG000|Overall Study|Adverse Event|1|||
149039406|NCT00494780|537623589|FG001|Overall Study|Adverse Event|0|||
149039407|NCT00494780|537623588|FG000|Overall Study|Withdrew before Dosed|0|||
149039408|NCT00494780|537623589|FG001|Overall Study|Withdrew before Dosed|1|||
149039409|NCT00494780|537623588|FG000|Overall Study|Progression of Study Disease|7|||
148882656|NCT02465203|537047425|FG002|Overall Study|Protocol Violation|1|||
148882657|NCT02465203|537047423|FG000|Overall Study|Study terminated by sponsor|50|||
149004335|NCT01782742|537495002|FG000|Double-blind Treatment Phase|Adverse Event|1|||
149004336|NCT01782742|537495003|FG001|Double-blind Treatment Phase|Adverse Event|0|||
149004337|NCT00803101|537495004|FG000|Overall Study|Death / Serious Adverse Event|4|||
149004338|NCT00803101|537495005|FG001|Overall Study|Death / Serious Adverse Event|6|||
149004339|NCT00803101|537495004|FG000|Overall Study|Withdrawal by Subject|6|||
149004340|NCT00803101|537495005|FG001|Overall Study|Withdrawal by Subject|4|||
149004341|NCT00803101|537495004|FG000|Overall Study|Lost to Follow-up|2|||
149004342|NCT00803101|537495005|FG001|Overall Study|Lost to Follow-up|2|||
149004343|NCT00803101|537495004|FG000|Overall Study|Protocol Violation|1|||
149004344|NCT00803101|537495005|FG001|Overall Study|Protocol Violation|7|||
149004345|NCT00803101|537495004|FG000|Overall Study|Surgery finished outside protocol window|1|||
149004346|NCT00803101|537495005|FG001|Overall Study|Surgery finished outside protocol window|1|||
149004347|NCT00803101|537495004|FG000|Overall Study|Patient died outside SAE report period|1|||
149004348|NCT00803101|537495005|FG001|Overall Study|Patient died outside SAE report period|0|||
149004349|NCT00803101|537495004|FG000|Overall Study|Patient did not attend scheduled visit|2|||
149004350|NCT00803101|537495005|FG001|Overall Study|Patient did not attend scheduled visit|1|||
149004351|NCT00803101|537495004|FG000|Overall Study|Patient did not have surgery|1|||
149004352|NCT00803101|537495005|FG001|Overall Study|Patient did not have surgery|1|||
149004353|NCT02882282|537495006|FG000|Overall Study|Adverse Event|1|||
149004354|NCT02882282|537495007|FG001|Overall Study|Adverse Event|0|||
149004355|NCT00514683|537495008|FG000|Overall Study|Not treated|2|||
149004356|NCT00514683|537495009|FG001|Overall Study|Not treated|1|||
149004357|NCT00514683|537495010|FG002|Overall Study|Not treated|0|||
149004358|NCT00514683|537495011|FG003|Overall Study|Not treated|0|||
149004359|NCT00514683|537495012|FG004|Overall Study|Not treated|1|||
149004360|NCT00514683|537495008|FG000|Overall Study|Adverse Event|21|||
149004361|NCT00514683|537495009|FG001|Overall Study|Adverse Event|20|||
149004362|NCT00514683|537495010|FG002|Overall Study|Adverse Event|15|||
149004363|NCT00514683|537495011|FG003|Overall Study|Adverse Event|13|||
149004364|NCT00514683|537495012|FG004|Overall Study|Adverse Event|27|||
149004365|NCT00514683|537495008|FG000|Overall Study|Protocol Violation|1|||
149004366|NCT00514683|537495009|FG001|Overall Study|Protocol Violation|1|||
149004367|NCT00514683|537495010|FG002|Overall Study|Protocol Violation|0|||
149004368|NCT00514683|537495011|FG003|Overall Study|Protocol Violation|1|||
149004369|NCT00514683|537495012|FG004|Overall Study|Protocol Violation|0|||
149004370|NCT00514683|537495008|FG000|Overall Study|Withdrawal by Subject|2|||
149004371|NCT00514683|537495009|FG001|Overall Study|Withdrawal by Subject|2|||
149004372|NCT00514683|537495010|FG002|Overall Study|Withdrawal by Subject|1|||
149004373|NCT00514683|537495011|FG003|Overall Study|Withdrawal by Subject|0|||
149004374|NCT00514683|537495012|FG004|Overall Study|Withdrawal by Subject|4|||
149004375|NCT00514683|537495008|FG000|Overall Study|Reason other than listed above|0|||
149004376|NCT00514683|537495009|FG001|Overall Study|Reason other than listed above|1|||
149004377|NCT00514683|537495010|FG002|Overall Study|Reason other than listed above|2|||
149004378|NCT00514683|537495011|FG003|Overall Study|Reason other than listed above|0|||
149004379|NCT00514683|537495012|FG004|Overall Study|Reason other than listed above|1|||
149004380|NCT02487498|537495013|FG000|Period: Period 1|Adverse Event|2|||
149004381|NCT02487498|537495014|FG001|Period: Period 1|Adverse Event|4|||
149004382|NCT02487498|537495013|FG000|Period: Period 1|Subject/guardian decision|2|||
149004383|NCT02487498|537495014|FG001|Period: Period 1|Subject/guardian decision|4|||
149004384|NCT02487498|537495013|FG000|Period: Period 1|Lost to Follow-up|0|||
149004385|NCT02487498|537495014|FG001|Period: Period 1|Lost to Follow-up|2|||
149004386|NCT02487498|537495013|FG000|Period: Period 1|Lack of Efficacy|1|||
149004387|NCT02487498|537495014|FG001|Period: Period 1|Lack of Efficacy|0|||
149004388|NCT02487498|537495013|FG000|Period: Period 1|Physician Decision|0|||
149004389|NCT02487498|537495014|FG001|Period: Period 1|Physician Decision|1|||
149004390|NCT02487498|537495013|FG000|Period: Period 1|Protocol deviation|1|||
149004391|NCT02487498|537495014|FG001|Period: Period 1|Protocol deviation|0|||
149004392|NCT02487498|537495013|FG000|Period: Washout|Subject/guardian decision|0|||
149004393|NCT02487498|537495014|FG001|Period: Washout|Subject/guardian decision|5|||
149004394|NCT02487498|537495013|FG000|Period: Washout|Lack of Efficacy|1|||
149004395|NCT02487498|537495014|FG001|Period: Washout|Lack of Efficacy|1|||
149004396|NCT02487498|537495013|FG000|Period: Washout|Physician Decision|1|||
149004397|NCT02487498|537495014|FG001|Period: Washout|Physician Decision|0|||
149004398|NCT02487498|537495013|FG000|Period: Washout|Non-compliance with study treatment|0|||
148882658|NCT02465203|537047424|FG001|Overall Study|Study terminated by sponsor|34|||
148882659|NCT02465203|537047425|FG002|Overall Study|Study terminated by sponsor|11|||
149004399|NCT02487498|537495014|FG001|Period: Washout|Non-compliance with study treatment|1|||
149004400|NCT02487498|537495013|FG000|Period: Period 2|Adverse Event|2|||
149004401|NCT02487498|537495014|FG001|Period: Period 2|Adverse Event|2|||
149004402|NCT02487498|537495013|FG000|Period: Period 2|Subject/guardian decision|2|||
149004403|NCT02487498|537495014|FG001|Period: Period 2|Subject/guardian decision|1|||
149004404|NCT02487498|537495013|FG000|Period: Period 2|Lost to Follow-up|1|||
149004405|NCT02487498|537495014|FG001|Period: Period 2|Lost to Follow-up|1|||
149004406|NCT02487498|537495013|FG000|Period: Period 2|Death|0|||
148882660|NCT02465203|537047423|FG000|Overall Study|New therapy for study indication|4|||
148882661|NCT02465203|537047424|FG001|Overall Study|New therapy for study indication|0|||
148882662|NCT02465203|537047425|FG002|Overall Study|New therapy for study indication|0|||
148882663|NCT02465203|537047423|FG000|Overall Study|Patient/guardian decision|1|||
148882664|NCT02465203|537047424|FG001|Overall Study|Patient/guardian decision|1|||
148882665|NCT02465203|537047425|FG002|Overall Study|Patient/guardian decision|1|||
148882666|NCT03193736|537047430|FG000|Overall Study|Death|2|||
148882667|NCT03193736|537047430|FG000|Overall Study|Withdrawal by Subject|1|||
148882668|NCT03193736|537047430|FG000|Overall Study|Lost to Follow-up|1|||
148882669|NCT03193736|537047430|FG000|Overall Study|implant not received|1|||
148882670|NCT03369236|537047433|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
148882671|NCT03369236|537047434|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
148882672|NCT03369236|537047433|FG000|Open-label Extension Period|Lack of Efficacy|2|||
148882673|NCT03369236|537047434|FG001|Open-label Extension Period|Lack of Efficacy|1|||
148882674|NCT03369236|537047433|FG000|Open-label Extension Period|Adverse Event|0|||
148882675|NCT03369236|537047434|FG001|Open-label Extension Period|Adverse Event|1|||
148882676|NCT03369236|537047433|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
148882677|NCT03369236|537047434|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
148882678|NCT00423449|537047437|FG000|Overall Study|Clinical Adverse Event|1|||
148882679|NCT00423449|537047438|FG001|Overall Study|Clinical Adverse Event|0|||
148882680|NCT00423449|537047439|FG002|Overall Study|Clinical Adverse Event|1|||
148882681|NCT00423449|537047440|FG003|Overall Study|Clinical Adverse Event|8|||
149004407|NCT02487498|537495014|FG001|Period: Period 2|Death|1|||
149004408|NCT02487498|537495013|FG000|Period: Period 2|Physician Decision|1|||
149004409|NCT02487498|537495014|FG001|Period: Period 2|Physician Decision|0|||
149004410|NCT00676130|537495015|FG000|Overall Study|Lost to Follow-up|0|||
149004411|NCT00676130|537495016|FG001|Overall Study|Lost to Follow-up|1|||
149004412|NCT00676130|537495015|FG000|Overall Study|Found ineligible|3|||
149004413|NCT00676130|537495016|FG001|Overall Study|Found ineligible|2|||
149004414|NCT00676130|537495015|FG000|Overall Study|Withdrawal by Subject|0|||
149004415|NCT00676130|537495016|FG001|Overall Study|Withdrawal by Subject|1|||
149004416|NCT04538144|537495021|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
149004417|NCT04538144|537495022|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
149004418|NCT04538144|537495023|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
149004419|NCT04538144|537495024|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
149004420|NCT01181726|537495025|FG000|First Intervention|Adverse Event|1|||
149004421|NCT01181726|537495026|FG001|First Intervention|Adverse Event|0|||
149004422|NCT04998604|537495027|FG000|Overall Study|Adverse Event|3|||
149004423|NCT04998604|537495028|FG001|Overall Study|Adverse Event|2|||
149004424|NCT04998604|537495027|FG000|Overall Study|Withdrawal by Subject|2|||
149004425|NCT04998604|537495028|FG001|Overall Study|Withdrawal by Subject|4|||
149004426|NCT04998604|537495027|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
149004427|NCT04998604|537495028|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
149004428|NCT00642902|537495029|FG000|Overall Study|Adverse Event|0|||
149004429|NCT00642902|537495030|FG001|Overall Study|Adverse Event|1|||
149004430|NCT00642902|537495031|FG002|Overall Study|Adverse Event|3|||
149004431|NCT00642902|537495032|FG003|Overall Study|Adverse Event|1|||
149004432|NCT00642902|537495029|FG000|Overall Study|Lost to Follow-up|1|||
149004433|NCT00642902|537495030|FG001|Overall Study|Lost to Follow-up|1|||
149004434|NCT00642902|537495031|FG002|Overall Study|Lost to Follow-up|0|||
149004435|NCT00642902|537495032|FG003|Overall Study|Lost to Follow-up|0|||
149004436|NCT00642902|537495029|FG000|Overall Study|Lack of Efficacy|0|||
149004437|NCT00642902|537495030|FG001|Overall Study|Lack of Efficacy|3|||
149004438|NCT00642902|537495031|FG002|Overall Study|Lack of Efficacy|3|||
149004439|NCT00642902|537495032|FG003|Overall Study|Lack of Efficacy|0|||
149004440|NCT00642902|537495029|FG000|Overall Study|Death|1|||
149004441|NCT00642902|537495030|FG001|Overall Study|Death|0|||
149004442|NCT00642902|537495031|FG002|Overall Study|Death|0|||
149004443|NCT00642902|537495032|FG003|Overall Study|Death|0|||
149004444|NCT00642902|537495029|FG000|Overall Study|Premature termination of clinical trial|37|||
149004445|NCT00642902|537495030|FG001|Overall Study|Premature termination of clinical trial|32|||
149004446|NCT00642902|537495031|FG002|Overall Study|Premature termination of clinical trial|35|||
149004447|NCT00642902|537495032|FG003|Overall Study|Premature termination of clinical trial|35|||
149004448|NCT00642902|537495029|FG000|Overall Study|Randomized, but not treated|0|||
149004449|NCT00642902|537495030|FG001|Overall Study|Randomized, but not treated|0|||
149004450|NCT00642902|537495031|FG002|Overall Study|Randomized, but not treated|1|||
148882682|NCT00423449|537047441|FG004|Overall Study|Clinical Adverse Event|2|||
148882683|NCT00423449|537047437|FG000|Overall Study|Death|1|||
148882684|NCT00423449|537047438|FG001|Overall Study|Death|0|||
148882685|NCT00423449|537047439|FG002|Overall Study|Death|2|||
149004451|NCT00642902|537495032|FG003|Overall Study|Randomized, but not treated|0|||
149004452|NCT00642902|537495029|FG000|Overall Study|Other|1|||
149004453|NCT00642902|537495030|FG001|Overall Study|Other|5|||
149004454|NCT00642902|537495031|FG002|Overall Study|Other|1|||
149004455|NCT00642902|537495032|FG003|Overall Study|Other|4|||
149004456|NCT00429663|537495033|FG000|Overall Study|Lost to Follow-up|24|||
149004457|NCT00429663|537495034|FG001|Overall Study|Lost to Follow-up|31|||
148882686|NCT00423449|537047440|FG003|Overall Study|Death|1|||
148882687|NCT00423449|537047441|FG004|Overall Study|Death|1|||
148882688|NCT00423449|537047437|FG000|Overall Study|Progressive Disease|1|||
148882689|NCT00423449|537047438|FG001|Overall Study|Progressive Disease|3|||
148882690|NCT00423449|537047439|FG002|Overall Study|Progressive Disease|8|||
148882691|NCT00423449|537047440|FG003|Overall Study|Progressive Disease|11|||
148882692|NCT00423449|537047441|FG004|Overall Study|Progressive Disease|4|||
148882693|NCT00423449|537047437|FG000|Overall Study|Laboratory Adverse Event|0|||
148882694|NCT00423449|537047438|FG001|Overall Study|Laboratory Adverse Event|1|||
148882695|NCT00423449|537047439|FG002|Overall Study|Laboratory Adverse Event|2|||
148882696|NCT00423449|537047440|FG003|Overall Study|Laboratory Adverse Event|0|||
148882697|NCT00423449|537047441|FG004|Overall Study|Laboratory Adverse Event|0|||
148882698|NCT00423449|537047437|FG000|Overall Study|Other|0|||
148882699|NCT00423449|537047438|FG001|Overall Study|Other|0|||
148882700|NCT00423449|537047439|FG002|Overall Study|Other|0|||
148882701|NCT00423449|537047440|FG003|Overall Study|Other|1|||
148882702|NCT00423449|537047441|FG004|Overall Study|Other|0|||
148882703|NCT00423449|537047437|FG000|Overall Study|Protocol Violation|0|||
148882704|NCT00423449|537047438|FG001|Overall Study|Protocol Violation|0|||
148882705|NCT00423449|537047439|FG002|Overall Study|Protocol Violation|2|||
148882706|NCT00423449|537047440|FG003|Overall Study|Protocol Violation|1|||
148882707|NCT00423449|537047441|FG004|Overall Study|Protocol Violation|0|||
148882708|NCT01153724|537047442|FG000|Treatment Period 1|Withdrawal by Subject|1|||
148882709|NCT01153724|537047442|FG000|Treatment Period 2|Adverse Event|1|||
148882710|NCT01153724|537047442|FG000|Treatment Period 2|Other reason not defined above|1|||
148882711|NCT02697435|537047447|FG000|Overall Study|Withdrawal by Subject|1|||
148882712|NCT02697435|537047448|FG001|Overall Study|Withdrawal by Subject|0|||
148882713|NCT02697435|537047447|FG000|Overall Study|Physician Decision|0|||
148882714|NCT02697435|537047448|FG001|Overall Study|Physician Decision|4|||
148882715|NCT00367835|537047449|FG000|Overall Study|Adverse Event|14|||
148882716|NCT00367835|537047450|FG001|Overall Study|Adverse Event|1|||
149039410|NCT00494780|537623589|FG001|Overall Study|Progression of Study Disease|8|||
149039411|NCT00494780|537623588|FG000|Overall Study|New Treatment|2|||
149039412|NCT00494780|537623589|FG001|Overall Study|New Treatment|2|||
149039413|NCT00494780|537623588|FG000|Overall Study|Non-compliance|1|||
149039414|NCT00494780|537623589|FG001|Overall Study|Non-compliance|0|||
149039415|NCT00494780|537623588|FG000|Overall Study|Residual Tumour Mass|0|||
149039416|NCT00494780|537623589|FG001|Overall Study|Residual Tumour Mass|1|||
149039417|NCT00494780|537623588|FG000|Overall Study|Insurance Issues|0|||
149039418|NCT00494780|537623589|FG001|Overall Study|Insurance Issues|1|||
149039419|NCT01190007|537623590|FG000|Overall Study|Withdrawal by Subject|4|||
149039420|NCT01190007|537623590|FG000|Overall Study|Adverse Event|8|||
149039421|NCT01190007|537623590|FG000|Overall Study|Difficulty of visit for complications|1|||
149039422|NCT01190007|537623590|FG000|Overall Study|Participant was arrested|1|||
149039423|NCT01254019|537623595|FG000|Overall Study|Adverse Event|0|||
149039424|NCT01254019|537623596|FG001|Overall Study|Adverse Event|2|||
149039425|NCT01254019|537623595|FG000|Overall Study|Protocol Violation|1|||
149039426|NCT01254019|537623596|FG001|Overall Study|Protocol Violation|0|||
149039427|NCT01254019|537623595|FG000|Overall Study|Withdrawal by Subject|0|||
149039428|NCT01254019|537623596|FG001|Overall Study|Withdrawal by Subject|2|||
149039429|NCT00845832|537623599|FG000|Treatment Period|Adverse Event|0|||
149039430|NCT00845832|537623600|FG001|Treatment Period|Adverse Event|2|||
149039431|NCT00845832|537623601|FG002|Treatment Period|Adverse Event|0|||
149039432|NCT00845832|537623599|FG000|Treatment Period|Protocol Violation|1|||
149039433|NCT00845832|537623600|FG001|Treatment Period|Protocol Violation|1|||
149039434|NCT00845832|537623601|FG002|Treatment Period|Protocol Violation|0|||
149039435|NCT00845832|537623599|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
149039436|NCT00845832|537623600|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
149039437|NCT00845832|537623601|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
149039438|NCT00845832|537623599|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
149039439|NCT00845832|537623600|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
149039440|NCT00845832|537623601|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
149039441|NCT00668863|537623606|FG000|Overall Study|Objective Progression or Relapse|42|||
149039442|NCT00668863|537623606|FG000|Overall Study|Adverse Event|13|||
149039443|NCT00668863|537623606|FG000|Overall Study|Study Terminated by Sponsor|8|||
149039444|NCT00668863|537623606|FG000|Overall Study|Global Deterioration of Health Status|4|||
149039445|NCT00668863|537623606|FG000|Overall Study|Withdrawal by Subject|1|||
148882717|NCT00367835|537047449|FG000|Overall Study|Protocol Violation|1|||
148882718|NCT00367835|537047450|FG001|Overall Study|Protocol Violation|7|||
148882719|NCT00367835|537047449|FG000|Overall Study|Withdrawal by Subject|7|||
148882720|NCT00367835|537047450|FG001|Overall Study|Withdrawal by Subject|6|||
148882721|NCT00367835|537047449|FG000|Overall Study|Lost to Follow-up|1|||
148882722|NCT00367835|537047450|FG001|Overall Study|Lost to Follow-up|4|||
148882723|NCT00367835|537047449|FG000|Overall Study|Lack of Efficacy|3|||
148882724|NCT00367835|537047450|FG001|Overall Study|Lack of Efficacy|12|||
148882725|NCT00367835|537047449|FG000|Overall Study|Subject in juvenile detention center|1|||
149039446|NCT00668863|537623606|FG000|Overall Study|Surgery|1|||
149039447|NCT00668863|537623606|FG000|Overall Study|Subject's work scheduling problem|1|||
149039448|NCT00668863|537623606|FG000|Overall Study|Physician Decision|1|||
149039449|NCT00869323|537623609|FG000|Maintenance Therapy|concurrent illness|1|||
149039450|NCT01068743|537623610|FG000|Period 3|Adverse Event|0|||
149039451|NCT01068743|537623611|FG001|Period 3|Adverse Event|1|||
149039452|NCT01068743|537623612|FG002|Period 3|Adverse Event|0|||
149039453|NCT01068743|537623613|FG003|Period 3|Adverse Event|0|||
149039454|NCT00638963|537623614|FG000|Overall Study|Withdrawal by Subject|1|||
149039455|NCT00638963|537623615|FG001|Overall Study|Withdrawal by Subject|0|||
149039456|NCT03260140|537623616|FG000|Overall Study|Death|4|||
149039457|NCT03260140|537623617|FG001|Overall Study|Death|1|||
149039458|NCT03260140|537623616|FG000|Overall Study|Withdrawal by Subject|1|||
149039459|NCT03260140|537623617|FG001|Overall Study|Withdrawal by Subject|4|||
149039460|NCT00463788|537623618|FG000|Overall Study|Progressive Disease|86|||
149039461|NCT00463788|537623619|FG001|Overall Study|Progressive Disease|42|||
149039462|NCT00463788|537623618|FG000|Overall Study|Adverse Event|6|||
149039463|NCT00463788|537623619|FG001|Overall Study|Adverse Event|2|||
149039464|NCT00463788|537623618|FG000|Overall Study|Withdrawal by Subject|6|||
149039465|NCT00463788|537623619|FG001|Overall Study|Withdrawal by Subject|2|||
149039466|NCT00463788|537623618|FG000|Overall Study|Death|4|||
149039467|NCT00463788|537623619|FG001|Overall Study|Death|3|||
149039468|NCT00463788|537623618|FG000|Overall Study|Symptomatic Deterioration|2|||
149039469|NCT00463788|537623619|FG001|Overall Study|Symptomatic Deterioration|3|||
149039470|NCT00463788|537623618|FG000|Overall Study|Lost to Follow-up|1|||
149039471|NCT00463788|537623619|FG001|Overall Study|Lost to Follow-up|0|||
149039472|NCT00463788|537623618|FG000|Overall Study|Protocol Violation|0|||
149039473|NCT00463788|537623619|FG001|Overall Study|Protocol Violation|1|||
149039474|NCT00463788|537623618|FG000|Overall Study|Other|3|||
149039475|NCT00463788|537623619|FG001|Overall Study|Other|0|||
149039476|NCT00463788|537623618|FG000|Overall Study|Randomized but not treated|1|||
149039477|NCT00463788|537623619|FG001|Overall Study|Randomized but not treated|1|||
149039478|NCT00360698|537623620|FG000|Run-In|Physician Decision|0|||
149039479|NCT00360698|537623621|FG001|Run-In|Physician Decision|1|||
149039480|NCT00360698|537623620|FG000|Run-In|Withdrawal by Subject|0|||
149039481|NCT00360698|537623621|FG001|Run-In|Withdrawal by Subject|2|||
149039482|NCT00360698|537623620|FG000|Run-In|Non compliance with treatment procedure|0|||
149039483|NCT00360698|537623621|FG001|Run-In|Non compliance with treatment procedure|1|||
149039484|NCT00360698|537623620|FG000|Run-In|Sponsor request|0|||
149039485|NCT00360698|537623621|FG001|Run-In|Sponsor request|2|||
149039486|NCT00360698|537623620|FG000|Run-In|Patient did not meet inclusion criteria|0|||
149039487|NCT00360698|537623621|FG001|Run-In|Patient did not meet inclusion criteria|1|||
149039488|NCT00360698|537623620|FG000|Run-In|Patient personal reasons|0|||
149039489|NCT00360698|537623621|FG001|Run-In|Patient personal reasons|2|||
149039490|NCT00360698|537623620|FG000|Run-In|Need of insulin with meals|0|||
149039491|NCT00360698|537623621|FG001|Run-In|Need of insulin with meals|1|||
149039492|NCT00360698|537623620|FG000|Treatment Period|Non compliance with treatment procedure|1|||
149039493|NCT00360698|537623621|FG001|Treatment Period|Non compliance with treatment procedure|0|||
149039494|NCT00360698|537623620|FG000|Treatment Period|Early termination by error|0|||
149039495|NCT00360698|537623621|FG001|Treatment Period|Early termination by error|1|||
149039496|NCT01692938|537623630|FG000|Overall Study|Protocol Deviation|1|||
149039497|NCT01692938|537623631|FG001|Overall Study|Protocol Deviation|1|||
149039498|NCT01692938|537623630|FG000|Overall Study|Study completed prior to site completion|3|||
149039499|NCT01692938|537623631|FG001|Overall Study|Study completed prior to site completion|3|||
149039500|NCT02423291|537623633|FG000|Overall Study|Lack of Efficacy|14|||
149039501|NCT02423291|537623633|FG000|Overall Study|Adverse Event|1|||
149039502|NCT05283395|537623636|FG000|Overall Study|Adverse Event|4|||
149039503|NCT05283395|537623637|FG001|Overall Study|Adverse Event|4|||
149039504|NCT05283395|537623638|FG002|Overall Study|Adverse Event|0|||
149039505|NCT05283395|537623636|FG000|Overall Study|Patient Lost to Follow-Up|0|||
149039506|NCT05283395|537623637|FG001|Overall Study|Patient Lost to Follow-Up|0|||
149039507|NCT05283395|537623638|FG002|Overall Study|Patient Lost to Follow-Up|1|||
149039508|NCT05283395|537623636|FG000|Overall Study|Patient Withdrawal|2|||
149039509|NCT05283395|537623637|FG001|Overall Study|Patient Withdrawal|4|||
149039510|NCT05283395|537623638|FG002|Overall Study|Patient Withdrawal|2|||
149039511|NCT05283395|537623636|FG000|Overall Study|Investigator Decision|1|||
149039512|NCT05283395|537623637|FG001|Overall Study|Investigator Decision|0|||
149039513|NCT05283395|537623638|FG002|Overall Study|Investigator Decision|1|||
149039514|NCT05283395|537623636|FG000|Overall Study|Enrolled in error|0|||
149039515|NCT05283395|537623637|FG001|Overall Study|Enrolled in error|0|||
149039516|NCT05283395|537623638|FG002|Overall Study|Enrolled in error|1|||
149039517|NCT01063972|537623639|FG000|Overall Study|Death|12|||
149039518|NCT01063972|537623640|FG001|Overall Study|Death|11|||
149039519|NCT01063972|537623639|FG000|Overall Study|Incarcerated|2|||
149039520|NCT01063972|537623640|FG001|Overall Study|Incarcerated|1|||
149039521|NCT00712335|537623641|FG000|Overall Study|Withdrawal by Subject|0|||
149039522|NCT00712335|537623642|FG001|Overall Study|Withdrawal by Subject|7|||
149039523|NCT00712335|537623643|FG002|Overall Study|Withdrawal by Subject|2|||
149039524|NCT00712335|537623644|FG003|Overall Study|Withdrawal by Subject|3|||
149039525|NCT00712335|537623645|FG004|Overall Study|Withdrawal by Subject|0|||
149039526|NCT00712335|537623641|FG000|Overall Study|Lost to Follow-up|2|||
149039527|NCT00712335|537623642|FG001|Overall Study|Lost to Follow-up|5|||
149039528|NCT00712335|537623643|FG002|Overall Study|Lost to Follow-up|0|||
149039529|NCT00712335|537623644|FG003|Overall Study|Lost to Follow-up|1|||
149039530|NCT00712335|537623645|FG004|Overall Study|Lost to Follow-up|0|||
149039531|NCT00712335|537623641|FG000|Overall Study|Protocol Violation|1|||
149039532|NCT00712335|537623642|FG001|Overall Study|Protocol Violation|2|||
149039533|NCT00712335|537623643|FG002|Overall Study|Protocol Violation|1|||
149039534|NCT00712335|537623644|FG003|Overall Study|Protocol Violation|0|||
149039535|NCT00712335|537623645|FG004|Overall Study|Protocol Violation|0|||
149039536|NCT00712335|537623641|FG000|Overall Study|Lack of Efficacy|0|||
149039537|NCT00712335|537623642|FG001|Overall Study|Lack of Efficacy|0|||
149039538|NCT00712335|537623643|FG002|Overall Study|Lack of Efficacy|1|||
149039539|NCT00712335|537623644|FG003|Overall Study|Lack of Efficacy|1|||
149039540|NCT00712335|537623645|FG004|Overall Study|Lack of Efficacy|0|||
149039541|NCT00712335|537623641|FG000|Overall Study|Other Reason|0|||
149039542|NCT00712335|537623642|FG001|Overall Study|Other Reason|3|||
149039543|NCT00712335|537623643|FG002|Overall Study|Other Reason|1|||
149039544|NCT00712335|537623644|FG003|Overall Study|Other Reason|0|||
149039545|NCT00712335|537623645|FG004|Overall Study|Other Reason|0|||
149039546|NCT03401112|537623646|FG000|Overall Study|Adverse Event|1|||
149039547|NCT03401112|537623647|FG001|Overall Study|Adverse Event|2|||
149039548|NCT03401112|537623648|FG002|Overall Study|Adverse Event|3|||
149039549|NCT03401112|537623649|FG003|Overall Study|Adverse Event|2|||
149039550|NCT03401112|537623650|FG004|Overall Study|Adverse Event|0|||
149039551|NCT03401112|537623646|FG000|Overall Study|Lost to Follow-up|1|||
149039552|NCT03401112|537623647|FG001|Overall Study|Lost to Follow-up|0|||
149039553|NCT03401112|537623648|FG002|Overall Study|Lost to Follow-up|0|||
148882726|NCT00367835|537047450|FG001|Overall Study|Subject in juvenile detention center|0|||
148882727|NCT00367835|537047449|FG000|Overall Study|refused blood collection|1|||
148882728|NCT00367835|537047450|FG001|Overall Study|refused blood collection|0|||
148882729|NCT00367835|537047449|FG000|Overall Study|Did not respond to calls|1|||
148882730|NCT00367835|537047450|FG001|Overall Study|Did not respond to calls|0|||
148882731|NCT00367835|537047449|FG000|Overall Study|History of lead poisoning|0|||
148882732|NCT00367835|537047450|FG001|Overall Study|History of lead poisoning|1|||
148882733|NCT00445770|537047455|FG000|Overall Study|Adverse Event|9|||
148882734|NCT00445770|537047456|FG001|Overall Study|Adverse Event|15|||
148882735|NCT00445770|537047457|FG002|Overall Study|Adverse Event|19|||
149039554|NCT03401112|537623649|FG003|Overall Study|Lost to Follow-up|0|||
149039555|NCT03401112|537623650|FG004|Overall Study|Lost to Follow-up|0|||
149039556|NCT03401112|537623646|FG000|Overall Study|Noncompliance|1|||
149039557|NCT03401112|537623647|FG001|Overall Study|Noncompliance|2|||
149039558|NCT03401112|537623648|FG002|Overall Study|Noncompliance|3|||
149039559|NCT03401112|537623649|FG003|Overall Study|Noncompliance|0|||
149039560|NCT03401112|537623650|FG004|Overall Study|Noncompliance|0|||
149039561|NCT03401112|537623646|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
149039562|NCT03401112|537623647|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
149039563|NCT03401112|537623648|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
148882736|NCT00445770|537047455|FG000|Overall Study|Lack of Efficacy|38|||
148882737|NCT00445770|537047456|FG001|Overall Study|Lack of Efficacy|13|||
148882738|NCT00445770|537047457|FG002|Overall Study|Lack of Efficacy|6|||
148882739|NCT00445770|537047455|FG000|Overall Study|Lost to Follow-up|0|||
148882740|NCT00445770|537047456|FG001|Overall Study|Lost to Follow-up|2|||
148882741|NCT00445770|537047457|FG002|Overall Study|Lost to Follow-up|0|||
148882742|NCT00445770|537047455|FG000|Overall Study|Other|6|||
148882743|NCT00445770|537047456|FG001|Overall Study|Other|5|||
148882744|NCT00445770|537047457|FG002|Overall Study|Other|6|||
148882745|NCT00811174|537047459|FG000|Overall Study|Protocol Violation|2|||
148882746|NCT00811174|537047459|FG000|Overall Study|Sponsors Decision|1|||
148882747|NCT00999544|537049118|FG000|Overall Study|Withdrawal by Subject|1|||
148882748|NCT01392547|537049119|FG000|Overall Study|Adverse Event|2|||
148882749|NCT01392547|537049119|FG000|Overall Study|Non-compliance|2|||
148882750|NCT01392547|537049119|FG000|Overall Study|Withdrawal criteria|3|||
148882751|NCT01392547|537049119|FG000|Overall Study|Unclassified|1|||
149039564|NCT03401112|537623649|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
149039565|NCT03401112|537623650|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
149039566|NCT03401112|537623646|FG000|Overall Study|Withdrawal by Subject|0|||
149039567|NCT03401112|537623647|FG001|Overall Study|Withdrawal by Subject|3|||
149039568|NCT03401112|537623648|FG002|Overall Study|Withdrawal by Subject|2|||
149039569|NCT03401112|537623649|FG003|Overall Study|Withdrawal by Subject|1|||
149039570|NCT03401112|537623650|FG004|Overall Study|Withdrawal by Subject|0|||
149039571|NCT03401112|537623646|FG000|Overall Study|Physician Decision|0|||
149039572|NCT03401112|537623647|FG001|Overall Study|Physician Decision|0|||
148882752|NCT02936635|537049120|FG000|Overall Study|Adverse Event|43|||
148882753|NCT02936635|537049121|FG001|Overall Study|Adverse Event|25|||
148882754|NCT02936635|537049120|FG000|Overall Study|Progressive Disease|10|||
148882755|NCT02936635|537049121|FG001|Overall Study|Progressive Disease|18|||
148882756|NCT02936635|537049120|FG000|Overall Study|Sponsor Discretion|10|||
148882757|NCT02936635|537049121|FG001|Overall Study|Sponsor Discretion|16|||
148882758|NCT02936635|537049120|FG000|Overall Study|Death|9|||
148882759|NCT02936635|537049121|FG001|Overall Study|Death|15|||
148882760|NCT02936635|537049120|FG000|Overall Study|Withdrawal by Subject|8|||
148882761|NCT02936635|537049121|FG001|Overall Study|Withdrawal by Subject|15|||
148882762|NCT02936635|537049120|FG000|Overall Study|Physician Decision|2|||
148882763|NCT02936635|537049121|FG001|Overall Study|Physician Decision|9|||
148882764|NCT02936635|537049120|FG000|Overall Study|Lost to Follow-up|1|||
148882765|NCT02936635|537049121|FG001|Overall Study|Lost to Follow-up|2|||
148882766|NCT02936635|537049120|FG000|Overall Study|Protocol Violation|1|||
148882767|NCT02936635|537049121|FG001|Overall Study|Protocol Violation|0|||
148882768|NCT02936635|537049120|FG000|Overall Study|Lack of effect/Entry into other study|31|||
148882769|NCT02936635|537049121|FG001|Overall Study|Lack of effect/Entry into other study|65|||
148882770|NCT00447226|537049122|FG000|12-Week Open-label Phase|Adverse Event|0|||
148882771|NCT00447226|537049123|FG001|12-Week Open-label Phase|Adverse Event|3|||
148882772|NCT00447226|537049122|FG000|12-Week Open-label Phase|Protocol Violation|0|||
148882773|NCT00447226|537049123|FG001|12-Week Open-label Phase|Protocol Violation|1|||
148882774|NCT00447226|537049122|FG000|12-Week Open-label Phase|Disease Progression|0|||
148882775|NCT00447226|537049123|FG001|12-Week Open-label Phase|Disease Progression|20|||
148882776|NCT00447226|537049122|FG000|12-Week Open-label Phase|Physician Decision|0|||
148882777|NCT00447226|537049123|FG001|12-Week Open-label Phase|Physician Decision|1|||
148882778|NCT00447226|537049122|FG000|Double-blind Phase|Disease Progression|4|||
148882779|NCT00447226|537049123|FG001|Double-blind Phase|Disease Progression|3|||
148882780|NCT00584012|537049131|FG000|Overall Study|Withdrawal by Subject|1|||
148882781|NCT04404556|537049132|FG000|Intervention|Withdrawal by Subject|15|||
148882782|NCT04404556|537049133|FG001|Intervention|Withdrawal by Subject|3|||
148882783|NCT04404556|537049132|FG000|Intervention|Did not complete all intervention sessions|2|||
148882784|NCT04404556|537049133|FG001|Intervention|Did not complete all intervention sessions|1|||
148882785|NCT04404556|537049132|FG000|Post-Intervention|Missing Data|1|||
148882786|NCT04404556|537049133|FG001|Post-Intervention|Missing Data|2|||
149039573|NCT03401112|537623648|FG002|Overall Study|Physician Decision|0|||
149039574|NCT03401112|537623649|FG003|Overall Study|Physician Decision|2|||
149039575|NCT03401112|537623650|FG004|Overall Study|Physician Decision|0|||
149039576|NCT03401112|537623646|FG000|Overall Study|Study was Terminated by Sponsor|0|||
149039577|NCT03401112|537623647|FG001|Overall Study|Study was Terminated by Sponsor|0|||
149039578|NCT03401112|537623648|FG002|Overall Study|Study was Terminated by Sponsor|0|||
148882787|NCT04404556|537049132|FG000|Follow-up 1|Withdrawal by Subject|5|||
148882788|NCT04404556|537049133|FG001|Follow-up 1|Withdrawal by Subject|1|||
148882789|NCT04404556|537049132|FG000|Follow-up 1|Missing Data|4|||
148882790|NCT04404556|537049133|FG001|Follow-up 1|Missing Data|7|||
148882791|NCT04404556|537049132|FG000|Follow-up 2|Withdrawal by Subject|1|||
148882792|NCT04404556|537049133|FG001|Follow-up 2|Withdrawal by Subject|1|||
148882793|NCT04404556|537049132|FG000|Follow-up 2|Missing Data|6|||
148882794|NCT04404556|537049133|FG001|Follow-up 2|Missing Data|5|||
148882795|NCT00763386|537049135|FG000|Overall Study|Adverse Event|43|||
148882796|NCT00763386|537049136|FG001|Overall Study|Adverse Event|33|||
148882797|NCT00763386|537049135|FG000|Overall Study|Death|1|||
148882798|NCT00763386|537049136|FG001|Overall Study|Death|2|||
148882799|NCT00763386|537049135|FG000|Overall Study|Lost to Follow-up|3|||
148882800|NCT00763386|537049136|FG001|Overall Study|Lost to Follow-up|3|||
148882801|NCT00763386|537049135|FG000|Overall Study|Withdrawal by Subject|0|||
148882802|NCT00763386|537049136|FG001|Overall Study|Withdrawal by Subject|1|||
148882803|NCT00763386|537049135|FG000|Overall Study|CRF missing|0|||
148882804|NCT00763386|537049136|FG001|Overall Study|CRF missing|1|||
148882805|NCT00763386|537049135|FG000|Overall Study|Study Prosthesis Removed|1|||
148882806|NCT00763386|537049136|FG001|Overall Study|Study Prosthesis Removed|0|||
148882807|NCT02871635|537049137|FG000|Overall Study|Primary lack of efficacy|4|||
148882808|NCT02871635|537049138|FG001|Overall Study|Primary lack of efficacy|4|||
148882809|NCT02871635|537049137|FG000|Overall Study|Protocol Violation|3|||
148882810|NCT02871635|537049138|FG001|Overall Study|Protocol Violation|1|||
148882811|NCT02871635|537049137|FG000|Overall Study|Lost to Follow-up|1|||
148882812|NCT02871635|537049138|FG001|Overall Study|Lost to Follow-up|2|||
148882813|NCT02871635|537049137|FG000|Overall Study|Pregnancy|0|||
148882814|NCT02871635|537049138|FG001|Overall Study|Pregnancy|2|||
148882815|NCT02871635|537049137|FG000|Overall Study|Physician Decision|1|||
148882816|NCT02871635|537049138|FG001|Overall Study|Physician Decision|1|||
148882817|NCT02871635|537049137|FG000|Overall Study|Withdrawal by Subject|3|||
148882818|NCT02871635|537049138|FG001|Overall Study|Withdrawal by Subject|4|||
148882819|NCT02871635|537049137|FG000|Overall Study|Adverse Event|4|||
148882820|NCT02871635|537049138|FG001|Overall Study|Adverse Event|4|||
148882821|NCT02871635|537049137|FG000|Overall Study|Secondary lack of efficacy|2|||
149039579|NCT03401112|537623649|FG003|Overall Study|Study was Terminated by Sponsor|1|||
149039580|NCT03401112|537623650|FG004|Overall Study|Study was Terminated by Sponsor|0|||
148882822|NCT02871635|537049138|FG001|Overall Study|Secondary lack of efficacy|1|||
148882823|NCT01402817|537049139|FG000|Overall Study|Withdrawal by Subject|3|||
148882824|NCT01402817|537049139|FG000|Overall Study|Study Suspended by FDA|8|||
148882825|NCT00502671|537049140|FG000|Overall Study|Disease Progression|13|||
148882826|NCT00502671|537049140|FG000|Overall Study|Personal Reasons|22|||
148882827|NCT00502671|537049140|FG000|Overall Study|Lost to Follow-up|7|||
148882828|NCT00502671|537049140|FG000|Overall Study|Protocol Violation|16|||
148882829|NCT00502671|537049140|FG000|Overall Study|Adverse Event|19|||
148882830|NCT00681629|537049141|FG000|Overall Study|Study termination|4|||
148882831|NCT00681629|537049142|FG001|Overall Study|Study termination|2|||
148882832|NCT00681629|537049141|FG000|Overall Study|Adverse Event|1|||
148882833|NCT00681629|537049142|FG001|Overall Study|Adverse Event|0|||
148882834|NCT02274792|537049144|FG000|Overall Study|Withdrawal by Subject|13|||
148882835|NCT02274792|537049144|FG000|Overall Study|Lost to Follow-up|8|||
148882836|NCT02274792|537049144|FG000|Overall Study|Protocol Specified Criteria|2|||
148882837|NCT02274792|537049144|FG000|Overall Study|Sponsor Decision|2|||
148882838|NCT01510158|537049145|FG000|Overall Study|Adverse Event|7|||
148882839|NCT01510158|537049146|FG001|Overall Study|Adverse Event|8|||
148882840|NCT01510158|537049147|FG002|Overall Study|Adverse Event|5|||
148882841|NCT01510158|537049145|FG000|Overall Study|Gout flare|1|||
148882842|NCT01510158|537049146|FG001|Overall Study|Gout flare|0|||
148882843|NCT01510158|537049147|FG002|Overall Study|Gout flare|0|||
148882844|NCT01510158|537049145|FG000|Overall Study|Protocol Violation|17|||
148882845|NCT01510158|537049146|FG001|Overall Study|Protocol Violation|16|||
148882846|NCT01510158|537049147|FG002|Overall Study|Protocol Violation|24|||
148882847|NCT01510158|537049145|FG000|Overall Study|Sponsor terminated study.|2|||
148882848|NCT01510158|537049146|FG001|Overall Study|Sponsor terminated study.|0|||
148882849|NCT01510158|537049147|FG002|Overall Study|Sponsor terminated study.|2|||
148882850|NCT01510158|537049145|FG000|Overall Study|Lost to Follow-up|13|||
148882851|NCT01510158|537049146|FG001|Overall Study|Lost to Follow-up|16|||
148882852|NCT01510158|537049147|FG002|Overall Study|Lost to Follow-up|9|||
149004458|NCT00429663|537495033|FG000|Overall Study|Physician Decision|6|||
149004459|NCT00429663|537495034|FG001|Overall Study|Physician Decision|3|||
149004460|NCT00429663|537495033|FG000|Overall Study|Withdrawal by Subject|2|||
149004461|NCT00429663|537495034|FG001|Overall Study|Withdrawal by Subject|5|||
149004462|NCT00429663|537495033|FG000|Overall Study|Death|4|||
149004463|NCT00429663|537495034|FG001|Overall Study|Death|0|||
149004464|NCT03953898|537495040|FG000|Overall Study|Lack of Efficacy|8|||
149004465|NCT03953898|537495040|FG000|Overall Study|Death|3|||
149004466|NCT03953898|537495040|FG000|Overall Study|Withdrawal by Subject|2|||
149004467|NCT03953898|537495040|FG000|Overall Study|Adverse Event|1|||
149004468|NCT03261271|537495041|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
149004469|NCT03261271|537495042|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
149004470|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
149004471|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
149004472|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
149004473|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
149004474|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
149004475|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
149004476|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
149004477|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
149004478|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
149004479|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
149004480|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
149004481|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
149004482|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
149004483|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
149004484|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
149004485|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
149004486|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
149004487|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
149004488|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
149004489|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
149004490|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Death|2|||
149004491|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Death|2|||
149004492|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Death|0|||
149004493|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Death|0|||
149004494|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Death|0|||
149004495|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
149004496|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
149004497|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
149004498|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
149004499|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
149004500|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
149004501|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
149004502|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
149004503|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
149004504|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
149004505|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
149004506|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
149039581|NCT03401112|537623646|FG000|Overall Study|Day 1 Assessment not Done|1|||
149039582|NCT03401112|537623647|FG001|Overall Study|Day 1 Assessment not Done|0|||
149039583|NCT03401112|537623648|FG002|Overall Study|Day 1 Assessment not Done|0|||
149039584|NCT03401112|537623649|FG003|Overall Study|Day 1 Assessment not Done|0|||
148882853|NCT01510158|537049145|FG000|Overall Study|Withdrawal by Subject|10|||
148882854|NCT01510158|537049146|FG001|Overall Study|Withdrawal by Subject|13|||
148882855|NCT01510158|537049147|FG002|Overall Study|Withdrawal by Subject|10|||
148882856|NCT01510158|537049145|FG000|Overall Study|Death|1|||
148882857|NCT01510158|537049146|FG001|Overall Study|Death|0|||
148882858|NCT01510158|537049147|FG002|Overall Study|Death|0|||
148882859|NCT00832416|537049148|FG000|Overall Study|Lack of Efficacy|17|||
148882860|NCT00832416|537049149|FG001|Overall Study|Lack of Efficacy|15|||
148882861|NCT00832416|537049150|FG002|Overall Study|Lack of Efficacy|13|||
148882862|NCT00832416|537049151|FG003|Overall Study|Lack of Efficacy|52|||
149039585|NCT03401112|537623650|FG004|Overall Study|Day 1 Assessment not Done|0|||
149039586|NCT03401112|537623646|FG000|Overall Study|Not Dosed|0|||
149039587|NCT03401112|537623647|FG001|Overall Study|Not Dosed|0|||
149039588|NCT03401112|537623648|FG002|Overall Study|Not Dosed|1|||
149039589|NCT03401112|537623649|FG003|Overall Study|Not Dosed|0|||
149039590|NCT03401112|537623650|FG004|Overall Study|Not Dosed|0|||
149039591|NCT03401112|537623646|FG000|Overall Study|Missed Clinical Visit|0|||
149039592|NCT03401112|537623647|FG001|Overall Study|Missed Clinical Visit|0|||
149039593|NCT03401112|537623648|FG002|Overall Study|Missed Clinical Visit|1|||
149039594|NCT03401112|537623649|FG003|Overall Study|Missed Clinical Visit|0|||
149039595|NCT03401112|537623650|FG004|Overall Study|Missed Clinical Visit|0|||
149039596|NCT03401112|537623646|FG000|Overall Study|Missed Doses|0|||
149039597|NCT03401112|537623647|FG001|Overall Study|Missed Doses|0|||
149039598|NCT03401112|537623648|FG002|Overall Study|Missed Doses|1|||
149039599|NCT03401112|537623649|FG003|Overall Study|Missed Doses|0|||
149039600|NCT03401112|537623650|FG004|Overall Study|Missed Doses|0|||
149039601|NCT01264679|537623651|FG000|Overall Study|Participation in Another Clinical Trial|1|||
149039602|NCT01264679|537623651|FG000|Overall Study|Physician Decision|1|||
149039603|NCT01264679|537623651|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
149039604|NCT01264679|537623651|FG000|Overall Study|Withdrawal by Subject|1|||
149039605|NCT03475316|537623652|FG000|6 Month Intervention|Adverse Event|2|||
149039606|NCT03475316|537623653|FG001|6 Month Intervention|Adverse Event|1|||
149039607|NCT03475316|537623652|FG000|6 Month Intervention|Withdrawal by Subject|2|||
149039608|NCT03475316|537623653|FG001|6 Month Intervention|Withdrawal by Subject|0|||
149039609|NCT03475316|537623652|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
149039610|NCT03475316|537623653|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
149039611|NCT03475316|537623652|FG000|9 Months|Study stopped due to COVID pandemic|3|||
149039612|NCT03475316|537623653|FG001|9 Months|Study stopped due to COVID pandemic|4|||
149039613|NCT00424645|537623654|FG000|Overall Study|Death|1|||
149039614|NCT00424645|537623655|FG001|Overall Study|Death|0|||
149039615|NCT01595061|537623656|FG000|Overall Study|Never Treated|3|||
149039616|NCT01595061|537623656|FG000|Overall Study|Inadequate Pathology|1|||
149039617|NCT03194958|537623659|FG000|Overall Study|Death|0|||
149039618|NCT03194958|537623660|FG001|Overall Study|Death|1|||
149039619|NCT03194958|537623661|FG002|Overall Study|Death|1|||
149039620|NCT03194958|537623662|FG003|Overall Study|Death|1|||
149039621|NCT03194958|537623659|FG000|Overall Study|Withdrawal by Subject|24|||
149039622|NCT03194958|537623660|FG001|Overall Study|Withdrawal by Subject|27|||
149039623|NCT03194958|537623661|FG002|Overall Study|Withdrawal by Subject|7|||
149039624|NCT03194958|537623662|FG003|Overall Study|Withdrawal by Subject|22|||
149039625|NCT03194958|537623659|FG000|Overall Study|Lost to Follow-up|168|||
149039626|NCT03194958|537623660|FG001|Overall Study|Lost to Follow-up|196|||
149039627|NCT03194958|537623661|FG002|Overall Study|Lost to Follow-up|174|||
149039628|NCT03194958|537623662|FG003|Overall Study|Lost to Follow-up|186|||
149039629|NCT00959946|537623664|FG000|Overall Study|Adverse Event|0|||
149039630|NCT00959946|537623665|FG001|Overall Study|Adverse Event|0|||
149039631|NCT00959946|537623666|FG002|Overall Study|Adverse Event|2|||
149039632|NCT00959946|537623667|FG003|Overall Study|Adverse Event|1|||
148882863|NCT00832416|537049148|FG000|Overall Study|Withdrawal by Subject|5|||
148882864|NCT00832416|537049149|FG001|Overall Study|Withdrawal by Subject|7|||
148882865|NCT00832416|537049150|FG002|Overall Study|Withdrawal by Subject|2|||
149039633|NCT00959946|537623668|FG004|Overall Study|Adverse Event|0|||
148882866|NCT00832416|537049151|FG003|Overall Study|Withdrawal by Subject|10|||
148882867|NCT00832416|537049148|FG000|Overall Study|Physician Decision|2|||
148882868|NCT00832416|537049149|FG001|Overall Study|Physician Decision|12|||
149039634|NCT00959946|537623669|FG005|Overall Study|Adverse Event|1|||
149039635|NCT00959946|537623670|FG006|Overall Study|Adverse Event|0|||
149039636|NCT00959946|537623671|FG007|Overall Study|Adverse Event|0|||
149039637|NCT00959946|537623664|FG000|Overall Study|Death|0|||
149039638|NCT00959946|537623665|FG001|Overall Study|Death|0|||
149039639|NCT00959946|537623666|FG002|Overall Study|Death|0|||
149039640|NCT00959946|537623667|FG003|Overall Study|Death|0|||
149039641|NCT00959946|537623668|FG004|Overall Study|Death|0|||
149039642|NCT00959946|537623669|FG005|Overall Study|Death|1|||
149039643|NCT00959946|537623670|FG006|Overall Study|Death|0|||
149039644|NCT00959946|537623671|FG007|Overall Study|Death|0|||
149039645|NCT00959946|537623664|FG000|Overall Study|Disease Progression|2|||
149039646|NCT00959946|537623665|FG001|Overall Study|Disease Progression|4|||
149039647|NCT00959946|537623666|FG002|Overall Study|Disease Progression|2|||
149039648|NCT00959946|537623667|FG003|Overall Study|Disease Progression|4|||
149039649|NCT00959946|537623668|FG004|Overall Study|Disease Progression|4|||
149039650|NCT00959946|537623669|FG005|Overall Study|Disease Progression|6|||
149039651|NCT00959946|537623670|FG006|Overall Study|Disease Progression|2|||
149039652|NCT00959946|537623671|FG007|Overall Study|Disease Progression|2|||
149039653|NCT00959946|537623664|FG000|Overall Study|Withdrawal by Subject|0|||
149039654|NCT00959946|537623665|FG001|Overall Study|Withdrawal by Subject|0|||
149039655|NCT00959946|537623666|FG002|Overall Study|Withdrawal by Subject|0|||
149039656|NCT00959946|537623667|FG003|Overall Study|Withdrawal by Subject|0|||
149039657|NCT00959946|537623668|FG004|Overall Study|Withdrawal by Subject|0|||
149039658|NCT00959946|537623669|FG005|Overall Study|Withdrawal by Subject|1|||
149039659|NCT00959946|537623670|FG006|Overall Study|Withdrawal by Subject|0|||
149039660|NCT00959946|537623671|FG007|Overall Study|Withdrawal by Subject|0|||
149039661|NCT00356265|537623672|FG000|Overall Study|Withdrawal by Subject|0|||
149039662|NCT00356265|537623673|FG001|Overall Study|Withdrawal by Subject|0|||
149039663|NCT00356265|537623674|FG002|Overall Study|Withdrawal by Subject|1|||
149039664|NCT01179334|537623678|FG000|Treatment Period|Adverse Event|1|||
149039665|NCT01179334|537623679|FG001|Treatment Period|Adverse Event|0|||
149039666|NCT01179334|537623678|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
149039667|NCT01179334|537623679|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
149039668|NCT01179334|537623678|FG000|Long-term Extension (LTE) Period|Death|3|||
149039669|NCT01179334|537623679|FG001|Long-term Extension (LTE) Period|Death|0|||
149039670|NCT01179334|537623678|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
149039671|NCT01179334|537623679|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
149039672|NCT04177394|537623680|FG000|Overall Study|Death|16|||
149039673|NCT04177394|537623680|FG000|Overall Study|Withdrawal by Subject|19|||
149039674|NCT04177394|537623680|FG000|Overall Study|Missed visits|61|||
149039675|NCT04177394|537623680|FG000|Overall Study|Expected Visits|15|||
149039676|NCT00258895|537623681|FG000|Overall Study|Lost to Follow-up|3|||
149039677|NCT00258895|537623682|FG001|Overall Study|Lost to Follow-up|1|||
149039678|NCT00258895|537623681|FG000|Overall Study|Protocol Violation|6|||
149039679|NCT00258895|537623682|FG001|Overall Study|Protocol Violation|2|||
149039680|NCT00258895|537623681|FG000|Overall Study|Withdrawal by Subject|1|||
149039681|NCT00258895|537623682|FG001|Overall Study|Withdrawal by Subject|0|||
149039682|NCT00547118|537623683|FG000|Overall Study|Did not qualify prior to starting drug|1|||
149039683|NCT00547118|537623684|FG001|Overall Study|Did not qualify prior to starting drug|1|||
149039684|NCT00547118|537623683|FG000|Overall Study|Study suspended|7|||
149039685|NCT00547118|537623684|FG001|Overall Study|Study suspended|8|||
149039686|NCT00373529|537623687|FG000|Overall Study|Physician Decision|19|||
149039687|NCT00373529|537623687|FG000|Overall Study|Withdrawal by Subject|7|||
149039688|NCT00373529|537623687|FG000|Overall Study|Adverse Event|7|||
149039689|NCT00373529|537623687|FG000|Overall Study|Treatment failure|36|||
149039690|NCT00373529|537623687|FG000|Overall Study|Disease recurrence|10|||
149039691|NCT00373529|537623687|FG000|Overall Study|Death|16|||
149039692|NCT00373529|537623687|FG000|Overall Study|Need for treatment prohibited by study|1|||
149039693|NCT00373529|537623687|FG000|Overall Study|Other|8|||
149039694|NCT00373529|537623687|FG000|Overall Study|Failed independent confirmation of AML|3|||
149039695|NCT00373529|537623687|FG000|Overall Study|Consent violation|1|||
149039696|NCT01390402|537623699|FG000|Overall Study|Death|1|||
149039697|NCT01390402|537623699|FG000|Overall Study|Disease Progression|4|||
149039698|NCT04789408|537623700|FG000|Overall Study|Death|4|||
149039699|NCT04789408|537623701|FG001|Overall Study|Death|3|||
149039700|NCT04789408|537623702|FG002|Overall Study|Death|6|||
149039701|NCT04789408|537623700|FG000|Overall Study|Did not meet eligibility criteria|1|||
149039702|NCT04789408|537623701|FG001|Overall Study|Did not meet eligibility criteria|0|||
149039703|NCT04789408|537623702|FG002|Overall Study|Did not meet eligibility criteria|0|||
149039704|NCT04789408|537623700|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
149039705|NCT04789408|537623701|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
149039706|NCT04789408|537623702|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
149039707|NCT01170026|537624730|FG000|Overall Study|Lost to Follow-up|4|||
149039708|NCT01170026|537624731|FG001|Overall Study|Lost to Follow-up|2|||
149039709|NCT05777785|537624732|FG000|Overall Study|Withdrawal by Subject|5|||
149039710|NCT05777785|537624732|FG000|Overall Study|Lost to Follow-up|1|||
149039711|NCT05644444|537624737|FG000|Tolerance Phase|Adverse Event|0|||
149039712|NCT05644444|537624738|FG001|Tolerance Phase|Adverse Event|2|||
149039713|NCT05644444|537624737|FG000|Treatment Phase|Adverse Event|0|||
149039714|NCT05644444|537624738|FG001|Treatment Phase|Adverse Event|2|||
149039715|NCT04817670|537624739|FG000|Overall Study|Withdrawal by Subject|1|||
149039716|NCT04817670|537624740|FG001|Overall Study|Withdrawal by Subject|0|||
149039717|NCT04817670|537624741|FG002|Overall Study|Withdrawal by Subject|0|||
149039718|NCT04817670|537624742|FG003|Overall Study|Withdrawal by Subject|0|||
149039719|NCT04817670|537624743|FG004|Overall Study|Withdrawal by Subject|0|||
149039720|NCT04817670|537624739|FG000|Overall Study|Lost to Follow-up|0|||
149039721|NCT04817670|537624740|FG001|Overall Study|Lost to Follow-up|0|||
149039722|NCT04817670|537624741|FG002|Overall Study|Lost to Follow-up|1|||
149039723|NCT04817670|537624742|FG003|Overall Study|Lost to Follow-up|0|||
149039724|NCT04817670|537624743|FG004|Overall Study|Lost to Follow-up|0|||
149039725|NCT02396316|537624744|FG000|Overall Study|Physician Decision|1|||
149039726|NCT02396316|537624745|FG001|Overall Study|Physician Decision|0|||
149039727|NCT02396316|537624744|FG000|Overall Study|Progressive disease|6|||
149039728|NCT02396316|537624745|FG001|Overall Study|Progressive disease|3|||
149039729|NCT02396316|537624744|FG000|Overall Study|Protocol Violation|0|||
149039730|NCT02396316|537624745|FG001|Overall Study|Protocol Violation|1|||
149039731|NCT02396316|537624744|FG000|Overall Study|Treatment unblinded|0|||
149039732|NCT02396316|537624745|FG001|Overall Study|Treatment unblinded|1|||
149039733|NCT01662336|537624746|FG000|Overall Study|Adverse Event|1|||
149039734|NCT01662336|537624746|FG000|Overall Study|No longer on LPV/r|30|||
149039735|NCT01662336|537624746|FG000|Overall Study|Other|29|||
149039736|NCT01662336|537624746|FG000|Overall Study|Withdrawal by Subject|6|||
149039737|NCT02189252|537624747|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
149039738|NCT02189252|537624748|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
149039739|NCT02189252|537624749|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
149039740|NCT02189252|537624750|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
149039741|NCT02189252|537624747|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
149039742|NCT02189252|537624748|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
149039743|NCT02189252|537624749|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
149039744|NCT02189252|537624750|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
149039745|NCT00566735|537624751|FG000|Overall Study|Withdrawal by Subject|0|||
149039746|NCT00566735|537624752|FG001|Overall Study|Withdrawal by Subject|1|||
149039747|NCT00566735|537624751|FG000|Overall Study|Refused neuropsychological testing|2|||
149039748|NCT00566735|537624752|FG001|Overall Study|Refused neuropsychological testing|5|||
149039749|NCT00566735|537624751|FG000|Overall Study|Switched into a manic episode|0|||
149039750|NCT00566735|537624752|FG001|Overall Study|Switched into a manic episode|1|||
149039751|NCT04603924|537624753|FG000|Overall Study|Not Dosed|2|||
149039752|NCT04603924|537624754|FG001|Overall Study|Not Dosed|1|||
149039753|NCT04603924|537624753|FG000|Overall Study|Withdrawal by Subject|6|||
149039754|NCT04603924|537624754|FG001|Overall Study|Withdrawal by Subject|6|||
149039755|NCT04603924|537624753|FG000|Overall Study|Adverse Event|2|||
149039756|NCT04603924|537624754|FG001|Overall Study|Adverse Event|2|||
149039757|NCT00686855|537624760|FG000|Overall Study|Lost to Follow-up|1|||
149039758|NCT00686855|537624761|FG001|Overall Study|Lost to Follow-up|0|||
149039759|NCT00686855|537624760|FG000|Overall Study|Progressive GVHD|0|||
149039760|NCT00686855|537624761|FG001|Overall Study|Progressive GVHD|1|||
149039761|NCT02731755|537624764|FG000|First Intervention|Withdrawal by Subject|0|||
149039762|NCT02731755|537624765|FG001|First Intervention|Withdrawal by Subject|2|||
149039763|NCT01460446|537624766|FG000|Overall Study|Non-compliance|2|||
149039764|NCT01460446|537624767|FG001|Overall Study|Non-compliance|9|||
149039765|NCT01460446|537624766|FG000|Overall Study|Consent Withdrawn|0|||
149039766|NCT01460446|537624767|FG001|Overall Study|Consent Withdrawn|4|||
149039767|NCT01460446|537624766|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
149039768|NCT01460446|537624767|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
149039769|NCT01460446|537624766|FG000|Overall Study|Surgery/Illness|1|||
149039770|NCT01460446|537624767|FG001|Overall Study|Surgery/Illness|1|||
149039771|NCT01460446|537624766|FG000|Overall Study|Pregnancy|1|||
149039772|NCT01460446|537624767|FG001|Overall Study|Pregnancy|0|||
149039773|NCT01460446|537624766|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
149039774|NCT01460446|537624767|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
149039775|NCT02139046|537624768|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
149039776|NCT02139046|537624769|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
149039777|NCT02139046|537624770|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
149039778|NCT02139046|537624771|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
149039779|NCT02139046|537624772|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
149039780|NCT02139046|537624768|FG000|Overall Study|Major Protocol Deviation|9|||
149039781|NCT02139046|537624769|FG001|Overall Study|Major Protocol Deviation|10|||
149039782|NCT02139046|537624770|FG002|Overall Study|Major Protocol Deviation|16|||
148882869|NCT00832416|537049150|FG002|Overall Study|Physician Decision|5|||
149039783|NCT02139046|537624771|FG003|Overall Study|Major Protocol Deviation|12|||
149039784|NCT02139046|537624772|FG004|Overall Study|Major Protocol Deviation|6|||
148882870|NCT00832416|537049151|FG003|Overall Study|Physician Decision|10|||
149039785|NCT02139046|537624768|FG000|Overall Study|Lost to Follow-up|13|||
149039786|NCT02139046|537624769|FG001|Overall Study|Lost to Follow-up|16|||
149039787|NCT02139046|537624770|FG002|Overall Study|Lost to Follow-up|16|||
149039788|NCT02139046|537624771|FG003|Overall Study|Lost to Follow-up|18|||
149039789|NCT02139046|537624772|FG004|Overall Study|Lost to Follow-up|13|||
149039790|NCT02139046|537624768|FG000|Overall Study|Voluntary Withdrawal|20|||
149039791|NCT02139046|537624769|FG001|Overall Study|Voluntary Withdrawal|8|||
149039792|NCT02139046|537624770|FG002|Overall Study|Voluntary Withdrawal|10|||
149039793|NCT02139046|537624771|FG003|Overall Study|Voluntary Withdrawal|15|||
149039794|NCT02139046|537624772|FG004|Overall Study|Voluntary Withdrawal|16|||
148882871|NCT00832416|537049148|FG000|Overall Study|Administrative|0|||
148882872|NCT00832416|537049149|FG001|Overall Study|Administrative|0|||
148882873|NCT00832416|537049150|FG002|Overall Study|Administrative|0|||
148882874|NCT00832416|537049151|FG003|Overall Study|Administrative|1|||
148882875|NCT00832416|537049148|FG000|Overall Study|Adverse Event|21|||
148882876|NCT00832416|537049149|FG001|Overall Study|Adverse Event|19|||
148882877|NCT00832416|537049150|FG002|Overall Study|Adverse Event|41|||
148882878|NCT00832416|537049151|FG003|Overall Study|Adverse Event|10|||
148882879|NCT00832416|537049148|FG000|Overall Study|Death|1|||
148882880|NCT00832416|537049149|FG001|Overall Study|Death|0|||
148882881|NCT00832416|537049150|FG002|Overall Study|Death|0|||
148882882|NCT00832416|537049151|FG003|Overall Study|Death|0|||
148882883|NCT02114606|537049152|FG000|Overall Study|Unable to swallow Cytosponge|6|||
148882884|NCT05786508|537049160|FG000|Overall Study|Withdrawal by Subject|2|||
148882885|NCT05786508|537049161|FG001|Overall Study|Withdrawal by Subject|0|||
148882886|NCT04426318|537049162|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
148882887|NCT04426318|537049163|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
148882888|NCT04829916|537049166|FG000|Overall Study|Withdrawal by Subject|1|||
148882889|NCT04829916|537049167|FG001|Overall Study|Withdrawal by Subject|0|||
148882890|NCT02287467|537049169|FG000|Overall Study|Protocol Violation|12|||
148882891|NCT02287467|537049170|FG001|Overall Study|Protocol Violation|9|||
148882892|NCT03781778|537049171|FG000|Overall Study|Withdrawal by Subject|2|||
148882893|NCT03781778|537049172|FG001|Overall Study|Withdrawal by Subject|2|||
148882894|NCT02152761|537049176|FG000|Epoch: Treatment Epoch|Technical problems|0|||
148882895|NCT02152761|537049177|FG001|Epoch: Treatment Epoch|Technical problems|0|||
148882896|NCT02152761|537049178|FG002|Epoch: Treatment Epoch|Technical problems|0|||
148882897|NCT02152761|537049179|FG003|Epoch: Treatment Epoch|Technical problems|1|||
148882898|NCT02152761|537049176|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
148882899|NCT02152761|537049177|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
148882900|NCT02152761|537049178|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
148882901|NCT02152761|537049179|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
148882902|NCT02152761|537049176|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
148882903|NCT02152761|537049177|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
148882904|NCT02152761|537049178|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
148882905|NCT02152761|537049179|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
148882906|NCT02152761|537049176|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
148882907|NCT02152761|537049177|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
148882908|NCT02152761|537049178|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
148882909|NCT02152761|537049179|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
148882910|NCT02152761|537049176|FG000|Epoch: Treatment Epoch|Death|0|||
148882911|NCT02152761|537049177|FG001|Epoch: Treatment Epoch|Death|3|||
148882912|NCT02152761|537049178|FG002|Epoch: Treatment Epoch|Death|1|||
148882913|NCT02152761|537049179|FG003|Epoch: Treatment Epoch|Death|0|||
148882914|NCT02152761|537049176|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
148882915|NCT02152761|537049177|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
148882916|NCT02152761|537049178|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
148882917|NCT02152761|537049179|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
148882918|NCT02152761|537049176|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
148882919|NCT02152761|537049177|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
148882920|NCT02152761|537049178|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
148882921|NCT02152761|537049179|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
148882922|NCT02152761|537049176|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
148882923|NCT02152761|537049177|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
148882924|NCT02152761|537049178|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
148882925|NCT02152761|537049179|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
148882926|NCT02152761|537049176|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
148882927|NCT02152761|537049177|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
149039795|NCT02139046|537624768|FG000|Overall Study|Lack of Efficacy|0|||
149039796|NCT02139046|537624769|FG001|Overall Study|Lack of Efficacy|1|||
149039797|NCT02139046|537624770|FG002|Overall Study|Lack of Efficacy|2|||
149039798|NCT02139046|537624771|FG003|Overall Study|Lack of Efficacy|1|||
149039799|NCT02139046|537624772|FG004|Overall Study|Lack of Efficacy|2|||
149039800|NCT02139046|537624768|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
149039801|NCT02139046|537624769|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
149039802|NCT02139046|537624770|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
149039803|NCT02139046|537624771|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
149039804|NCT02139046|537624772|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
148882928|NCT02152761|537049178|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
148882929|NCT02152761|537049179|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
148882930|NCT02152761|537049176|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
148882931|NCT02152761|537049177|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
149039805|NCT02139046|537624768|FG000|Overall Study|Other Miscellaneous Reasons|10|||
149039806|NCT02139046|537624769|FG001|Overall Study|Other Miscellaneous Reasons|9|||
148882932|NCT02152761|537049178|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
148882933|NCT02152761|537049179|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
148882934|NCT04343755|537049180|FG000|Overall Study|Death|11|||
148882935|NCT04343755|537049180|FG000|Overall Study|Screen Failure|1|||
148882936|NCT01957202|537049181|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882937|NCT01957202|537049182|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
148882938|NCT01957202|537049183|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882939|NCT01957202|537049184|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882940|NCT01957202|537049185|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882941|NCT01957202|537049186|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882942|NCT01957202|537049187|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882943|NCT01957202|537049188|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882944|NCT01957202|537049189|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882945|NCT01957202|537049190|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882946|NCT01957202|537049191|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882947|NCT01957202|537049192|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882948|NCT01957202|537049193|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882949|NCT01957202|537049194|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882950|NCT01957202|537049195|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882951|NCT01957202|537049196|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882952|NCT01957202|537049197|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
148882953|NCT01957202|537049198|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
148882954|NCT01957202|537049181|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882955|NCT01957202|537049182|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882956|NCT01957202|537049183|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882957|NCT01957202|537049184|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882958|NCT01957202|537049185|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882959|NCT01957202|537049186|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882960|NCT01957202|537049187|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882961|NCT01957202|537049188|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882962|NCT01957202|537049189|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882963|NCT01957202|537049190|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882964|NCT01957202|537049191|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882965|NCT01957202|537049192|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882966|NCT01957202|537049193|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882967|NCT01957202|537049194|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882968|NCT01957202|537049195|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882969|NCT01957202|537049196|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882970|NCT01957202|537049197|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
148882971|NCT01957202|537049198|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
148882972|NCT03066193|537049205|FG000|Overall Study|Withdrawal by Subject|1|||
148882973|NCT05280717|537049206|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
148882974|NCT05280717|537049207|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
148882975|NCT05280717|537049208|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
148882976|NCT05280717|537049209|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
148882977|NCT05280717|537049210|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
148882978|NCT05280717|537049211|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
148882979|NCT05280717|537049212|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
148882980|NCT05280717|537049206|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
148882981|NCT05280717|537049207|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
148882982|NCT05280717|537049208|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
148882983|NCT05280717|537049209|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
148882984|NCT05280717|537049210|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
148882985|NCT05280717|537049211|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
148882986|NCT05280717|537049212|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
149039807|NCT02139046|537624770|FG002|Overall Study|Other Miscellaneous Reasons|4|||
149039808|NCT02139046|537624771|FG003|Overall Study|Other Miscellaneous Reasons|9|||
149039809|NCT02139046|537624772|FG004|Overall Study|Other Miscellaneous Reasons|12|||
149039810|NCT01582100|537624776|FG000|Overall Study|Adverse Event|1|||
149039811|NCT01582100|537624776|FG000|Overall Study|Withdrawal by Subject|1|||
149039812|NCT01040689|537624777|FG000|Overall Study|Adverse Event|0|||
149039813|NCT01040689|537624778|FG001|Overall Study|Adverse Event|0|||
149039814|NCT01040689|537624779|FG002|Overall Study|Adverse Event|2|||
149039815|NCT01040689|537624780|FG003|Overall Study|Adverse Event|4|||
149039816|NCT01040689|537624777|FG000|Overall Study|Lack of Efficacy|0|||
149039817|NCT01040689|537624778|FG001|Overall Study|Lack of Efficacy|0|||
149039818|NCT01040689|537624779|FG002|Overall Study|Lack of Efficacy|1|||
149039819|NCT01040689|537624780|FG003|Overall Study|Lack of Efficacy|0|||
149039820|NCT01040689|537624777|FG000|Overall Study|Lost to Follow-up|1|||
149039821|NCT01040689|537624778|FG001|Overall Study|Lost to Follow-up|0|||
149039822|NCT01040689|537624779|FG002|Overall Study|Lost to Follow-up|0|||
149039823|NCT01040689|537624780|FG003|Overall Study|Lost to Follow-up|0|||
149039824|NCT01040689|537624777|FG000|Overall Study|Withdrawal by Subject|2|||
148882987|NCT05280717|537049206|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
148882988|NCT05280717|537049207|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
148882989|NCT05280717|537049208|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
148882990|NCT05280717|537049209|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
148882991|NCT05280717|537049210|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
148882992|NCT05280717|537049211|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
148882993|NCT05280717|537049212|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
148882994|NCT05280717|537049206|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
148882995|NCT05280717|537049207|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
148882996|NCT05280717|537049208|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
148882997|NCT05280717|537049209|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
148882998|NCT05280717|537049210|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
148882999|NCT05280717|537049211|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
148883000|NCT05280717|537049212|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
148883001|NCT05280717|537049206|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
148883002|NCT05280717|537049207|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
148883003|NCT05280717|537049208|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
148883004|NCT05280717|537049209|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
148883005|NCT05280717|537049210|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
148883006|NCT05280717|537049211|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
148883007|NCT05280717|537049212|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
148883008|NCT05280717|537049206|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
148883009|NCT05280717|537049207|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
148883010|NCT05280717|537049208|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
148883011|NCT05280717|537049209|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
148883012|NCT05280717|537049210|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
148883013|NCT05280717|537049211|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
148883014|NCT05280717|537049212|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
148883015|NCT00080301|537049213|FG000|Overall Study|Randomized but Never Treated|5|||
148883016|NCT00080301|537049214|FG001|Overall Study|Randomized but Never Treated|10|||
148883017|NCT00080301|537049213|FG000|Overall Study|Still on Treatment as of CSR date|0|||
148883018|NCT00080301|537049214|FG001|Overall Study|Still on Treatment as of CSR date|1|||
148883019|NCT00779025|537049221|FG000|Overall Study|Withdrawal by Subject|1|||
148883020|NCT01397461|537049223|FG000|Overall Study|Withdrawal by Subject|2|||
149004507|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
149004508|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
149004509|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
149004510|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
149004511|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
149004512|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
149004513|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
149004514|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
149004515|NCT03420781|537495043|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
149004516|NCT03420781|537495044|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
149004517|NCT03420781|537495045|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
149004518|NCT03420781|537495046|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
149004519|NCT03420781|537495047|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
149004520|NCT03420781|537495043|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
149004521|NCT03420781|537495044|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
149004522|NCT03420781|537495045|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
149004523|NCT03420781|537495046|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
149004524|NCT03420781|537495047|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
149004525|NCT03420781|537495043|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
149004526|NCT03420781|537495044|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
149004527|NCT03420781|537495045|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
149004528|NCT03420781|537495046|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
149004529|NCT03420781|537495047|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
149004530|NCT03420781|537495043|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
149004531|NCT03420781|537495044|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
149004532|NCT03420781|537495045|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
148883021|NCT01397461|537049224|FG001|Overall Study|Withdrawal by Subject|1|||
148883022|NCT01397461|537049225|FG002|Overall Study|Withdrawal by Subject|0|||
148883023|NCT01397461|537049223|FG000|Overall Study|Lost to Follow-up|0|||
148883024|NCT01397461|537049224|FG001|Overall Study|Lost to Follow-up|2|||
148883025|NCT01397461|537049225|FG002|Overall Study|Lost to Follow-up|1|||
148883026|NCT01397461|537049223|FG000|Overall Study|Lack of Efficacy|0|||
148883027|NCT01397461|537049224|FG001|Overall Study|Lack of Efficacy|3|||
148883028|NCT01397461|537049225|FG002|Overall Study|Lack of Efficacy|0|||
148883029|NCT01397461|537049223|FG000|Overall Study|Not treated|0|||
148883030|NCT01397461|537049224|FG001|Overall Study|Not treated|0|||
148883031|NCT01397461|537049225|FG002|Overall Study|Not treated|1|||
148883032|NCT04181762|537049242|FG000|Overall Study|Adverse Event|1|||
148883033|NCT04181762|537049243|FG001|Overall Study|Adverse Event|3|||
148883034|NCT04181762|537049242|FG000|Overall Study|Lost to Follow-up|1|||
148883035|NCT04181762|537049243|FG001|Overall Study|Lost to Follow-up|1|||
148883036|NCT04181762|537049242|FG000|Overall Study|Physician Decision|1|||
148883037|NCT04181762|537049243|FG001|Overall Study|Physician Decision|3|||
148883038|NCT04181762|537049242|FG000|Overall Study|Pregnancy|0|||
148883039|NCT04181762|537049243|FG001|Overall Study|Pregnancy|1|||
148883040|NCT04181762|537049242|FG000|Overall Study|Lack of Efficacy|2|||
148883041|NCT04181762|537049243|FG001|Overall Study|Lack of Efficacy|2|||
148883042|NCT04181762|537049242|FG000|Overall Study|Study terminated by sponsor|95|||
148883043|NCT04181762|537049243|FG001|Overall Study|Study terminated by sponsor|97|||
148883044|NCT04181762|537049242|FG000|Overall Study|Subject decision|11|||
148883045|NCT04181762|537049243|FG001|Overall Study|Subject decision|4|||
148883046|NCT04181762|537049242|FG000|Overall Study|Death|1|||
148883047|NCT04181762|537049243|FG001|Overall Study|Death|1|||
148883048|NCT04181762|537049242|FG000|Overall Study|Protocol deviation|1|||
148883049|NCT04181762|537049243|FG001|Overall Study|Protocol deviation|0|||
148883050|NCT04181762|537049242|FG000|Overall Study|Withdrawal of informed consent|1|||
148883051|NCT04181762|537049243|FG001|Overall Study|Withdrawal of informed consent|3|||
148883052|NCT01514201|537049253|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
148883053|NCT01514201|537049254|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
148883054|NCT01514201|537049255|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
148883055|NCT01514201|537049256|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
148883056|NCT01514201|537049253|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
148883057|NCT01514201|537049254|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
148883058|NCT01514201|537049255|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
148883059|NCT01514201|537049256|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
148883060|NCT01514201|537049253|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
148883061|NCT01514201|537049254|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
148883062|NCT01514201|537049255|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
148883063|NCT01514201|537049256|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
148883064|NCT01514201|537049253|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
148883065|NCT01514201|537049254|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
148883066|NCT01514201|537049255|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
148883067|NCT01514201|537049256|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
148883068|NCT01514201|537049253|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
148883069|NCT01514201|537049254|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
148883070|NCT01514201|537049255|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
148883071|NCT01514201|537049256|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
148883072|NCT01514201|537049253|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
148883073|NCT01514201|537049254|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
148883074|NCT01514201|537049255|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
148883075|NCT01514201|537049256|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
148883076|NCT01514201|537049253|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
148883077|NCT01514201|537049254|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
148883078|NCT01514201|537049255|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
148883079|NCT01514201|537049256|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
148883080|NCT01514201|537049253|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
148883081|NCT01514201|537049254|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
148883082|NCT01514201|537049255|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
148883083|NCT01514201|537049256|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
148883084|NCT01514201|537049253|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
148883085|NCT01514201|537049254|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
148883086|NCT01514201|537049255|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
148883087|NCT01514201|537049256|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
148883088|NCT01514201|537049253|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
148883089|NCT01514201|537049254|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
148883090|NCT01514201|537049255|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
148883091|NCT01514201|537049256|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
148883092|NCT01514201|537049253|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
148883093|NCT01514201|537049254|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
148883094|NCT01514201|537049255|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
148883095|NCT01514201|537049256|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
148883096|NCT01514201|537049253|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
148883097|NCT01514201|537049254|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
148883098|NCT01514201|537049255|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
148883099|NCT01514201|537049256|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
148883100|NCT02735343|537049260|FG000|Overall Study|screen fail|0|||
148883101|NCT02735343|537049261|FG001|Overall Study|screen fail|2|||
148883102|NCT00637416|537049262|FG000|Overall Study|Lost to Follow-up|1|||
148883103|NCT00637416|537049263|FG001|Overall Study|Lost to Follow-up|1|||
148883104|NCT00637416|537049262|FG000|Overall Study|Unable to take study drug|0|||
148883105|NCT00637416|537049263|FG001|Overall Study|Unable to take study drug|1|||
148883106|NCT02534909|537049266|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
148883107|NCT00132808|537049269|FG000|Stratum I|Adverse Event|2|||
148883108|NCT00132808|537049270|FG001|Stratum I|Adverse Event|1|||
148883109|NCT00132808|537049271|FG002|Stratum I|Adverse Event|0|||
148883110|NCT00132808|537049269|FG000|Stratum I|Lost to Follow-up|3|||
148883111|NCT00132808|537049270|FG001|Stratum I|Lost to Follow-up|4|||
148883112|NCT00132808|537049271|FG002|Stratum I|Lost to Follow-up|1|||
148883113|NCT00132808|537049269|FG000|Stratum I|Withdrawal by Subject|4|||
148883114|NCT00132808|537049270|FG001|Stratum I|Withdrawal by Subject|7|||
148883115|NCT00132808|537049271|FG002|Stratum I|Withdrawal by Subject|3|||
148883116|NCT00132808|537049269|FG000|Stratum I|Abnormal test procedure result (s)|0|||
148883117|NCT00132808|537049270|FG001|Stratum I|Abnormal test procedure result (s)|0|||
148883118|NCT00132808|537049271|FG002|Stratum I|Abnormal test procedure result (s)|1|||
148883119|NCT00132808|537049269|FG000|Stratum II|Adverse Event|1|||
148883120|NCT00132808|537049270|FG001|Stratum II|Adverse Event|2|||
148883121|NCT00132808|537049271|FG002|Stratum II|Adverse Event|1|||
148883122|NCT00132808|537049269|FG000|Stratum II|Death|1|||
148883123|NCT00132808|537049270|FG001|Stratum II|Death|0|||
148883124|NCT00132808|537049271|FG002|Stratum II|Death|0|||
148883125|NCT00132808|537049269|FG000|Stratum II|Lost to Follow-up|2|||
148883126|NCT00132808|537049270|FG001|Stratum II|Lost to Follow-up|2|||
148883127|NCT00132808|537049271|FG002|Stratum II|Lost to Follow-up|1|||
148883128|NCT00132808|537049269|FG000|Stratum II|Protocol Violation|0|||
148883129|NCT00132808|537049270|FG001|Stratum II|Protocol Violation|2|||
148883130|NCT00132808|537049271|FG002|Stratum II|Protocol Violation|1|||
148883131|NCT00132808|537049269|FG000|Stratum II|Withdrawal by Subject|4|||
148883132|NCT00132808|537049270|FG001|Stratum II|Withdrawal by Subject|9|||
148883133|NCT00132808|537049271|FG002|Stratum II|Withdrawal by Subject|6|||
148883134|NCT03983304|537049274|FG000|Overall Study|Withdrawal by Subject|5|||
148883135|NCT03983304|537049274|FG000|Overall Study|Lost to Follow-up|2|||
148883136|NCT01587040|537049275|FG000|Overall Study|Protocol Violation|0|||
148883137|NCT01587040|537049276|FG001|Overall Study|Protocol Violation|0|||
148883138|NCT01587040|537049277|FG002|Overall Study|Protocol Violation|1|||
148883139|NCT01587040|537049278|FG003|Overall Study|Protocol Violation|0|||
148883140|NCT01587040|537049275|FG000|Overall Study|Adverse Event|0|||
148883141|NCT01587040|537049276|FG001|Overall Study|Adverse Event|1|||
149039825|NCT01040689|537624778|FG001|Overall Study|Withdrawal by Subject|1|||
149039826|NCT01040689|537624779|FG002|Overall Study|Withdrawal by Subject|1|||
149039827|NCT01040689|537624780|FG003|Overall Study|Withdrawal by Subject|0|||
149039828|NCT01040689|537624777|FG000|Overall Study|Other reasons not listed above|0|||
149039829|NCT01040689|537624778|FG001|Overall Study|Other reasons not listed above|1|||
149039830|NCT01040689|537624779|FG002|Overall Study|Other reasons not listed above|0|||
148883142|NCT01587040|537049277|FG002|Overall Study|Adverse Event|10|||
148883143|NCT01587040|537049278|FG003|Overall Study|Adverse Event|0|||
148883144|NCT01587040|537049275|FG000|Overall Study|Disease progression|12|||
148883145|NCT01587040|537049276|FG001|Overall Study|Disease progression|1|||
148883146|NCT01587040|537049277|FG002|Overall Study|Disease progression|15|||
148883147|NCT01587040|537049278|FG003|Overall Study|Disease progression|3|||
148883148|NCT01587040|537049275|FG000|Overall Study|Other than specified|5|||
148883149|NCT01587040|537049276|FG001|Overall Study|Other than specified|1|||
148883150|NCT01587040|537049277|FG002|Overall Study|Other than specified|11|||
148883151|NCT01587040|537049278|FG003|Overall Study|Other than specified|1|||
148883152|NCT04346654|537049282|FG000|Overall Study|Adverse Event|2|||
148883153|NCT04346654|537049283|FG001|Overall Study|Adverse Event|0|||
148883154|NCT04346654|537049282|FG000|Overall Study|Non-response|1|||
148883155|NCT04346654|537049283|FG001|Overall Study|Non-response|1|||
148883156|NCT04346654|537049282|FG000|Overall Study|Withdrawal by Subject|2|||
148883157|NCT04346654|537049283|FG001|Overall Study|Withdrawal by Subject|0|||
148883158|NCT04346654|537049282|FG000|Overall Study|Lost to Follow-up|0|||
148883159|NCT04346654|537049283|FG001|Overall Study|Lost to Follow-up|1|||
148883160|NCT04346654|537049282|FG000|Overall Study|Pregnancy|0|||
148883161|NCT04346654|537049283|FG001|Overall Study|Pregnancy|1|||
148883162|NCT05870865|537049284|FG000|Randomized|Did not receive study treatment|2|||
148883163|NCT05870865|537049285|FG001|Randomized|Did not receive study treatment|4|||
149039831|NCT01040689|537624780|FG003|Overall Study|Other reasons not listed above|0|||
149039832|NCT05876949|537624781|FG000|Overall Study|Withdrawal by Subject|1|||
149039833|NCT05876949|537624782|FG001|Overall Study|Withdrawal by Subject|3|||
149039834|NCT05876949|537624781|FG000|Overall Study|Physician Decision|0|||
149039835|NCT05876949|537624782|FG001|Overall Study|Physician Decision|2|||
149039836|NCT05876949|537624781|FG000|Overall Study|Death|0|||
149039837|NCT05876949|537624782|FG001|Overall Study|Death|1|||
149039838|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
149039839|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
149039840|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
149039841|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
149039842|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
149039843|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
149039844|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
149039845|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
149039846|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
149039847|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
149039848|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
149039849|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
149039850|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
149039851|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
149039852|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
149039853|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
149039854|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
149039855|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
149039856|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
149039857|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
149039858|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
149039859|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
149039860|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
149039861|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
149039862|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
149039863|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
149039864|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
149039865|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
149039866|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
149039867|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
149039868|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
149039869|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
149039870|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
149039871|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
149039872|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
149039873|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
149039874|NCT03593213|537624787|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
149039875|NCT03593213|537624788|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
149039876|NCT03593213|537624789|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
149039877|NCT03593213|537624790|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
149039878|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
149039879|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
149039880|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
149039881|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
149039882|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
149039883|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
149039884|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
149039885|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
149039886|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
149039887|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
149039888|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
149039889|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
149039890|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
149039891|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
148883164|NCT05870865|537049286|FG002|Randomized|Did not receive study treatment|4|||
148883165|NCT05870865|537049287|FG003|Randomized|Did not receive study treatment|3|||
149039892|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
149039893|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
149039894|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
149039895|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
149039896|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
149039897|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
149039898|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
149039899|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
149039900|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
149039901|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
149039902|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
149039903|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
149039904|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
149039905|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
149039906|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
149039907|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
149039908|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
149039909|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
149039910|NCT03593213|537624787|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
149039911|NCT03593213|537624788|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
149039912|NCT03593213|537624789|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
149039913|NCT03593213|537624790|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
149039914|NCT02755116|537624797|FG000|Overall Study|surgery converted to open, pt admitted|3|||
149039915|NCT02755116|537624798|FG001|Overall Study|surgery converted to open, pt admitted|1|||
149039916|NCT02200770|537624799|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
149039917|NCT02200770|537624800|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
149039918|NCT02200770|537624799|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
149039919|NCT02200770|537624800|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
149039920|NCT02200770|537624799|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
149039921|NCT02200770|537624800|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
149039922|NCT02200770|537624799|FG000|Randomized-controlled Period (RCP)|Other|1|||
149039923|NCT02200770|537624800|FG001|Randomized-controlled Period (RCP)|Other|2|||
149039924|NCT02200770|537624799|FG000|Open-label Period (OLP)|Adverse Event|1|||
149039925|NCT02200770|537624800|FG001|Open-label Period (OLP)|Adverse Event|2|||
149039926|NCT02200770|537624799|FG000|Open-label Period (OLP)|Death|1|||
149039927|NCT02200770|537624800|FG001|Open-label Period (OLP)|Death|2|||
149039928|NCT02200770|537624799|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
149039929|NCT02200770|537624800|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
149039930|NCT02200770|537624799|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
149039931|NCT02200770|537624800|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
149039932|NCT02200770|537624799|FG000|Open-label Period (OLP)|Other|6|||
149039933|NCT02200770|537624800|FG001|Open-label Period (OLP)|Other|15|||
149039934|NCT01124734|537624802|FG000|Overall Study|Disease progression|13|||
149039935|NCT01124734|537624802|FG000|Overall Study|Adverse Event|1|||
149039936|NCT01124734|537624802|FG000|Overall Study|Withdrawal by Subject|1|||
149039937|NCT01124734|537624802|FG000|Overall Study|Elected for alternative treatment|2|||
149039938|NCT01510717|537624805|FG000|Overall Study|Adverse Event|1|||
149039939|NCT01510717|537624806|FG001|Overall Study|Adverse Event|2|||
149039940|NCT01510717|537624805|FG000|Overall Study|Death|1|||
149039941|NCT01510717|537624806|FG001|Overall Study|Death|0|||
149039942|NCT01510717|537624805|FG000|Overall Study|Lost to Follow-up|0|||
149039943|NCT01510717|537624806|FG001|Overall Study|Lost to Follow-up|1|||
149039944|NCT01510717|537624805|FG000|Overall Study|Withdrawal by Subject|0|||
149039945|NCT01510717|537624806|FG001|Overall Study|Withdrawal by Subject|2|||
149039946|NCT02555215|537624809|FG000|Overall Study|Other|1|||
149039947|NCT02555215|537624809|FG000|Overall Study|Investigator Decision|2|||
149039948|NCT00529789|537624810|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
149039949|NCT00529789|537624810|FG000|Study Period II/III|Adverse Event|3|||
149039950|NCT00529789|537624810|FG000|Study Period II/III|Lack of Efficacy|2|||
149039951|NCT00529789|537624810|FG000|Study Period II/III|Withdrawal by Subject|1|||
149039952|NCT00529789|537624810|FG000|Study Period II/III|Protocol Violation|3|||
149039953|NCT00529789|537624810|FG000|Study Period II/III|Physician Decision|3|||
149039954|NCT00529789|537624810|FG000|Study Period II/III|Lost to Follow-up|3|||
149039955|NCT00529789|537624810|FG000|Study Period IV|Parent/Caregiver Decision|1|||
149039956|NCT00529789|537624810|FG000|Study Period IV|Adverse Event|1|||
149039957|NCT00529789|537624810|FG000|Study Period IV|Lack of Efficacy|1|||
149039958|NCT00529789|537624810|FG000|Study Period IV|Lost to Follow-up|3|||
149039959|NCT01202955|537624811|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
149039960|NCT01202955|537624812|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
149039961|NCT04975308|537624816|FG000|Overall Study|Withdrawal by Subject|6|||
149039962|NCT04975308|537624817|FG001|Overall Study|Withdrawal by Subject|16|||
149039963|NCT04975308|537624818|FG002|Overall Study|Withdrawal by Subject|6|||
149039964|NCT04975308|537624816|FG000|Overall Study|Physician Decision|0|||
149039965|NCT04975308|537624817|FG001|Overall Study|Physician Decision|3|||
149039966|NCT04975308|537624818|FG002|Overall Study|Physician Decision|1|||
149039967|NCT04975308|537624816|FG000|Overall Study|Adverse Event|10|||
149039968|NCT04975308|537624817|FG001|Overall Study|Adverse Event|1|||
149039969|NCT04975308|537624818|FG002|Overall Study|Adverse Event|12|||
148883166|NCT05870865|537049284|FG000|Treatment Period|Adverse Event|1|||
148883167|NCT05870865|537049285|FG001|Treatment Period|Adverse Event|1|||
148883168|NCT05870865|537049286|FG002|Treatment Period|Adverse Event|1|||
148883169|NCT05870865|537049287|FG003|Treatment Period|Adverse Event|1|||
148883170|NCT05870865|537049284|FG000|Treatment Period|Lost to Follow-up|0|||
148883171|NCT05870865|537049285|FG001|Treatment Period|Lost to Follow-up|1|||
148883172|NCT05870865|537049286|FG002|Treatment Period|Lost to Follow-up|2|||
148883173|NCT05870865|537049287|FG003|Treatment Period|Lost to Follow-up|0|||
148883174|NCT05870865|537049284|FG000|Treatment Period|Protocol Violation|0|||
148883175|NCT05870865|537049285|FG001|Treatment Period|Protocol Violation|0|||
148883176|NCT05870865|537049286|FG002|Treatment Period|Protocol Violation|0|||
148883177|NCT05870865|537049287|FG003|Treatment Period|Protocol Violation|1|||
148883178|NCT05870865|537049284|FG000|Treatment Period|Withdrawal by Subject|0|||
148883179|NCT05870865|537049285|FG001|Treatment Period|Withdrawal by Subject|1|||
148883180|NCT05870865|537049286|FG002|Treatment Period|Withdrawal by Subject|1|||
148883181|NCT05870865|537049287|FG003|Treatment Period|Withdrawal by Subject|1|||
148883182|NCT02915978|537049288|FG000|Overall Study|Adverse Event|2|||
148883183|NCT02915978|537049289|FG001|Overall Study|Adverse Event|1|||
148883184|NCT02915978|537049290|FG002|Overall Study|Adverse Event|0|||
148883185|NCT00548145|537049292|FG000|Overall Study|Death|0|||
148883186|NCT00548145|537049293|FG001|Overall Study|Death|1|||
148883187|NCT00548145|537049292|FG000|Overall Study|Withdrawal by Subject|0|||
149039970|NCT04975308|537624816|FG000|Overall Study|On study treatment (Ongoing)|65|||
149039971|NCT04975308|537624817|FG001|Overall Study|On study treatment (Ongoing)|43|||
149039972|NCT04975308|537624818|FG002|Overall Study|On study treatment (Ongoing)|75|||
149039973|NCT04975308|537624816|FG000|Overall Study|Protocol Deviation|4|||
149039974|NCT04975308|537624817|FG001|Overall Study|Protocol Deviation|3|||
149039975|NCT04975308|537624818|FG002|Overall Study|Protocol Deviation|2|||
149039976|NCT01278394|537624821|FG000|Overall Study|Lost to Follow-up|1|||
149039977|NCT02115139|537624822|FG000|Overall Study|Protocol Violation|1|||
149039978|NCT02115139|537624822|FG000|Overall Study|treatment discontinuation|6|||
149039979|NCT00468910|537624823|FG000|Overall Study|Lost to Follow-up|2|||
149039980|NCT00468910|537624824|FG001|Overall Study|Lost to Follow-up|1|||
149039981|NCT00468910|537624823|FG000|Overall Study|Withdrawal by Subject|2|||
149039982|NCT00468910|537624824|FG001|Overall Study|Withdrawal by Subject|1|||
149039983|NCT00468910|537624823|FG000|Overall Study|Medical Contraindication|0|||
149039984|NCT00468910|537624824|FG001|Overall Study|Medical Contraindication|1|||
149039985|NCT01909778|537624825|FG000|Overall Study|failed screening|1|||
149039986|NCT01152190|537624826|FG000|Overall Study|Adverse Event|2|||
149039987|NCT01152190|537624827|FG001|Overall Study|Adverse Event|4|||
148883188|NCT00548145|537049293|FG001|Overall Study|Withdrawal by Subject|2|||
149039988|NCT01152190|537624826|FG000|Overall Study|Death|1|||
149039989|NCT01152190|537624827|FG001|Overall Study|Death|0|||
149039990|NCT01152190|537624826|FG000|Overall Study|Protocol Violation|1|||
149039991|NCT01152190|537624827|FG001|Overall Study|Protocol Violation|1|||
149039992|NCT01152190|537624826|FG000|Overall Study|Withdrawal by Subject|1|||
149039993|NCT01152190|537624827|FG001|Overall Study|Withdrawal by Subject|3|||
149039994|NCT00834834|537624828|FG000|Overall Study|Withdrawal by Subject|4|||
149039995|NCT00834834|537624829|FG001|Overall Study|Withdrawal by Subject|3|||
149039996|NCT01810263|537624841|FG000|Overall Study|Lost to Follow-up|8|||
149039997|NCT01810263|537624842|FG001|Overall Study|Lost to Follow-up|7|||
149039998|NCT01121549|537624843|FG000|Overall Study|Adverse Event|10|||
149039999|NCT01121549|537624843|FG000|Overall Study|Lack of Efficacy|11|||
149040000|NCT01121549|537624843|FG000|Overall Study|Lost to Follow-up|12|||
148883189|NCT00548145|537049292|FG000|Overall Study|Physician Decision|1|||
148883190|NCT00548145|537049293|FG001|Overall Study|Physician Decision|1|||
149040001|NCT01121549|537624843|FG000|Overall Study|Did not meet entrance criteria|9|||
148883191|NCT00874848|537049294|FG000|Overall Study|Adverse Event|13|||
148883192|NCT00874848|537049295|FG001|Overall Study|Adverse Event|2|||
148883193|NCT00874848|537049294|FG000|Overall Study|Progressive neoplastic disease|38|||
148883194|NCT00874848|537049295|FG001|Overall Study|Progressive neoplastic disease|18|||
148883195|NCT00874848|537049294|FG000|Overall Study|Withdrawal by Subject|7|||
149040002|NCT01121549|537624843|FG000|Overall Study|Study terminated by sponsor|197|||
149040003|NCT01121549|537624843|FG000|Overall Study|Pregnancy|1|||
149040004|NCT01121549|537624843|FG000|Overall Study|Protocol Violation|33|||
149040005|NCT01121549|537624843|FG000|Overall Study|Withdrawal by Subject|16|||
149040006|NCT01121549|537624843|FG000|Overall Study|Other|58|||
149040007|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
149040008|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
149040009|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
149040010|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
149040011|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
149040012|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
149040013|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
149040014|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
149040015|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
149040016|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
149040017|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
149040018|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
149040019|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
149040020|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
149040021|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
149040022|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
149040023|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
149040024|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
149040025|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
149040026|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
149040027|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
149040028|NCT00304031|537626342|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
149040029|NCT00304031|537626343|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
149040030|NCT00304031|537626344|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
149040031|NCT00304031|537626342|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
149040032|NCT00304031|537626343|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
149040033|NCT00304031|537626344|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
149040034|NCT01188655|537626348|FG000|Overall Study|Lack of Efficacy|1|||
149040035|NCT01188655|537626348|FG000|Overall Study|Lost to Follow-up|1|||
149040036|NCT01188655|537626348|FG000|Overall Study|Other|11|||
149040037|NCT00493649|537626349|FG000|Overall Study|Adverse Event|44|||
149040038|NCT00493649|537626349|FG000|Overall Study|Patient Request|21|||
149040039|NCT00493649|537626349|FG000|Overall Study|Investigator Request|2|||
149040040|NCT00493649|537626349|FG000|Overall Study|Disease Progression|1|||
149040041|NCT00493649|537626349|FG000|Overall Study|Lost to Follow-up|1|||
149040042|NCT00493649|537626349|FG000|Overall Study|Other|13|||
149040043|NCT00925899|537626352|FG000|Part 1|Death|1|||
149040044|NCT00925899|537626353|FG001|Part 1|Death|2|||
149040045|NCT00925899|537626352|FG000|Part 1|Withdrawal by Subject|10|||
149040046|NCT00925899|537626353|FG001|Part 1|Withdrawal by Subject|9|||
149040047|NCT00089544|537626354|FG000|Overall Study|Ineligible|1|||
149040048|NCT00089544|537626355|FG001|Overall Study|Ineligible|0|||
149040049|NCT00683696|537626356|FG000|Overall Study|Withdrawn due to study closure|337|||
149040050|NCT00683696|537626357|FG001|Overall Study|Withdrawn due to study closure|338|||
149040051|NCT00683696|537626356|FG000|Overall Study|Withdrawn prior to study closure|13|||
149040052|NCT00683696|537626357|FG001|Overall Study|Withdrawn prior to study closure|28|||
149040053|NCT00683696|537626356|FG000|Overall Study|Lost to Follow-up|5|||
149040054|NCT00683696|537626357|FG001|Overall Study|Lost to Follow-up|6|||
149040055|NCT00683696|537626356|FG000|Overall Study|Vital status follow-up only|3|||
149040056|NCT00683696|537626357|FG001|Overall Study|Vital status follow-up only|3|||
149040057|NCT00683696|537626356|FG000|Overall Study|Death|46|||
149040058|NCT00683696|537626357|FG001|Overall Study|Death|30|||
149040059|NCT01823536|537626360|FG000|Overall Study|Lost to Follow-up|1|||
149040060|NCT01823536|537626361|FG001|Overall Study|Lost to Follow-up|0|||
149040061|NCT01823536|537626362|FG002|Overall Study|Lost to Follow-up|0|||
149040062|NCT01823536|537626363|FG003|Overall Study|Lost to Follow-up|1|||
149040063|NCT01823536|537626364|FG004|Overall Study|Lost to Follow-up|1|||
149040064|NCT01823536|537626365|FG005|Overall Study|Lost to Follow-up|0|||
149040065|NCT01823536|537626360|FG000|Overall Study|Protocol Violation|0|||
149040066|NCT01823536|537626361|FG001|Overall Study|Protocol Violation|1|||
149040067|NCT01823536|537626362|FG002|Overall Study|Protocol Violation|0|||
149040068|NCT01823536|537626363|FG003|Overall Study|Protocol Violation|0|||
149040069|NCT01823536|537626364|FG004|Overall Study|Protocol Violation|0|||
149040070|NCT01823536|537626365|FG005|Overall Study|Protocol Violation|0|||
149040071|NCT01823536|537626360|FG000|Overall Study|Withdrawal by Subject|1|||
149040072|NCT01823536|537626361|FG001|Overall Study|Withdrawal by Subject|1|||
149040073|NCT01823536|537626362|FG002|Overall Study|Withdrawal by Subject|0|||
149040074|NCT01823536|537626363|FG003|Overall Study|Withdrawal by Subject|0|||
149040075|NCT01823536|537626364|FG004|Overall Study|Withdrawal by Subject|0|||
149040076|NCT01823536|537626365|FG005|Overall Study|Withdrawal by Subject|0|||
149040077|NCT01823536|537626360|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
149040078|NCT01823536|537626361|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
149040079|NCT01823536|537626362|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
149040080|NCT01823536|537626363|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
149004533|NCT03420781|537495046|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
149004534|NCT03420781|537495047|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
149004535|NCT02696564|537495051|FG000|Overall Study|Death|1|||
149004536|NCT02696564|537495052|FG001|Overall Study|Death|2|||
149004537|NCT02696564|537495051|FG000|Overall Study|Withdrawal by Subject|3|||
149004538|NCT02696564|537495052|FG001|Overall Study|Withdrawal by Subject|2|||
149004539|NCT02696564|537495051|FG000|Overall Study|Lost to Follow-up|3|||
149004540|NCT02696564|537495052|FG001|Overall Study|Lost to Follow-up|3|||
149004541|NCT02696564|537495051|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
149004542|NCT02696564|537495052|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
149004543|NCT02696564|537495051|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
149004544|NCT02696564|537495052|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
149004545|NCT02696564|537495051|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
149004546|NCT02696564|537495052|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
149004547|NCT02696564|537495051|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
149004548|NCT02696564|537495052|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
149004549|NCT02696564|537495051|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
149004550|NCT02696564|537495052|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
149004551|NCT05267600|537495053|FG000|Overall Study|Adverse Event|1|||
149004552|NCT05267600|537495054|FG001|Overall Study|Adverse Event|4|||
149004553|NCT05267600|537495053|FG000|Overall Study|Death|1|||
149040081|NCT01823536|537626364|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
149040082|NCT01823536|537626365|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
149040083|NCT01823536|537626360|FG000|Overall Study|Met exclusion criterion No 6|0|||
149040084|NCT01823536|537626361|FG001|Overall Study|Met exclusion criterion No 6|0|||
149040085|NCT01823536|537626362|FG002|Overall Study|Met exclusion criterion No 6|0|||
149040086|NCT01823536|537626363|FG003|Overall Study|Met exclusion criterion No 6|1|||
149040087|NCT01823536|537626364|FG004|Overall Study|Met exclusion criterion No 6|0|||
149040088|NCT01823536|537626365|FG005|Overall Study|Met exclusion criterion No 6|0|||
149040089|NCT01823536|537626360|FG000|Overall Study|Subject moved out of the state|0|||
149040090|NCT01823536|537626361|FG001|Overall Study|Subject moved out of the state|0|||
149040091|NCT01823536|537626362|FG002|Overall Study|Subject moved out of the state|0|||
149040092|NCT01823536|537626363|FG003|Overall Study|Subject moved out of the state|0|||
149040093|NCT01823536|537626364|FG004|Overall Study|Subject moved out of the state|1|||
149040094|NCT01823536|537626365|FG005|Overall Study|Subject moved out of the state|0|||
149040095|NCT03648762|537626366|FG000|Overall Study|Lost to Follow-up|1|||
149040096|NCT03648762|537626367|FG001|Overall Study|Lost to Follow-up|2|||
149040097|NCT03648762|537626368|FG002|Overall Study|Lost to Follow-up|0|||
149040098|NCT03648762|537626366|FG000|Overall Study|Withdrawal by Subject|5|||
149040099|NCT03648762|537626367|FG001|Overall Study|Withdrawal by Subject|2|||
149004554|NCT05267600|537495054|FG001|Overall Study|Death|2|||
149004555|NCT05267600|537495053|FG000|Overall Study|Lack of Efficacy|1|||
149004556|NCT05267600|537495054|FG001|Overall Study|Lack of Efficacy|2|||
149004557|NCT05267600|537495053|FG000|Overall Study|Lost to Follow-up|3|||
149004558|NCT05267600|537495054|FG001|Overall Study|Lost to Follow-up|0|||
149004559|NCT05267600|537495053|FG000|Overall Study|Physician Decision|4|||
149004560|NCT05267600|537495054|FG001|Overall Study|Physician Decision|0|||
149004561|NCT05267600|537495053|FG000|Overall Study|Treatment Unblinded|0|||
149004562|NCT05267600|537495054|FG001|Overall Study|Treatment Unblinded|1|||
149004563|NCT05267600|537495053|FG000|Overall Study|Withdrawal by Subject|5|||
149004564|NCT05267600|537495054|FG001|Overall Study|Withdrawal by Subject|4|||
149004565|NCT04067401|537495055|FG000|Overall Study|Withdrawal by Subject|7|||
149004566|NCT04067401|537495056|FG001|Overall Study|Withdrawal by Subject|0|||
149004567|NCT04067401|537495055|FG000|Overall Study|no data provided|1|||
149004568|NCT04067401|537495056|FG001|Overall Study|no data provided|0|||
149004569|NCT01722162|537495057|FG000|Overall Study|Withdrawal by Subject|1|||
149004570|NCT01722162|537495058|FG001|Overall Study|Withdrawal by Subject|1|||
149004571|NCT01722162|537495057|FG000|Overall Study|Found ineligible|1|||
149004572|NCT01722162|537495058|FG001|Overall Study|Found ineligible|0|||
149004573|NCT01722162|537495057|FG000|Overall Study|Unrelated to study adverse event|2|||
149004574|NCT01722162|537495058|FG001|Overall Study|Unrelated to study adverse event|2|||
149004575|NCT01722162|537495057|FG000|Overall Study|Adverse Event|1|||
149004576|NCT01722162|537495058|FG001|Overall Study|Adverse Event|1|||
149004577|NCT01722162|537495057|FG000|Overall Study|Insurance denial post enrollment|0|||
149004578|NCT01722162|537495058|FG001|Overall Study|Insurance denial post enrollment|1|||
149004579|NCT01722162|537495057|FG000|Overall Study|Noncompliance|0|||
149004580|NCT01722162|537495058|FG001|Overall Study|Noncompliance|1|||
149004581|NCT01889186|537495060|FG000|Overall Study|Adverse event- not related to progression|18|||
149004582|NCT01889186|537495061|FG001|Overall Study|Adverse event- not related to progression|5|||
149004583|NCT01889186|537495060|FG000|Overall Study|Adverse event- related to progression|7|||
149040100|NCT03648762|537626368|FG002|Overall Study|Withdrawal by Subject|1|||
148883196|NCT00874848|537049295|FG001|Overall Study|Withdrawal by Subject|4|||
148883197|NCT00874848|537049294|FG000|Overall Study|Noncompliance|1|||
148883198|NCT00874848|537049295|FG001|Overall Study|Noncompliance|1|||
149004584|NCT01889186|537495061|FG001|Overall Study|Adverse event- related to progression|2|||
149004585|NCT01889186|537495060|FG000|Overall Study|COVID-19 logistical restrictions|1|||
149004586|NCT01889186|537495061|FG001|Overall Study|COVID-19 logistical restrictions|0|||
149004587|NCT01889186|537495060|FG000|Overall Study|Investigator request|1|||
149004588|NCT01889186|537495061|FG001|Overall Study|Investigator request|1|||
149004589|NCT01889186|537495060|FG000|Overall Study|Progressive disease- Richter's|12|||
149004590|NCT01889186|537495061|FG001|Overall Study|Progressive disease- Richter's|7|||
149004591|NCT01889186|537495060|FG000|Overall Study|Progressive disease per protocol|46|||
149004592|NCT01889186|537495061|FG001|Overall Study|Progressive disease per protocol|17|||
149004593|NCT01889186|537495060|FG000|Overall Study|Stem cell transplant|2|||
149004594|NCT01889186|537495061|FG001|Overall Study|Stem cell transplant|1|||
149004595|NCT01889186|537495060|FG000|Overall Study|Withdrew consent|2|||
149004596|NCT01889186|537495061|FG001|Overall Study|Withdrew consent|3|||
149004597|NCT01889186|537495060|FG000|Overall Study|Other, not specified|18|||
149004598|NCT01889186|537495061|FG001|Overall Study|Other, not specified|15|||
149004599|NCT02110901|537495062|FG000|Overall Study|Death|6|||
149004600|NCT02110901|537495063|FG001|Overall Study|Death|3|||
149004601|NCT02110901|537495062|FG000|Overall Study|Lost to Follow-up|12|||
149004602|NCT02110901|537495063|FG001|Overall Study|Lost to Follow-up|8|||
149004603|NCT02110901|537495062|FG000|Overall Study|Withdrawal by Subject|7|||
149004604|NCT02110901|537495063|FG001|Overall Study|Withdrawal by Subject|3|||
149004605|NCT02110901|537495062|FG000|Overall Study|received a kidney transplant|5|||
149004606|NCT02110901|537495063|FG001|Overall Study|received a kidney transplant|0|||
149004607|NCT02889133|537495066|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
149004608|NCT02889133|537495067|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
149004609|NCT02889133|537495066|FG000|Completed Primary Outcome|Manufacturing error|3|||
149004610|NCT02889133|537495067|FG001|Completed Primary Outcome|Manufacturing error|8|||
149004611|NCT02889133|537495066|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
149004612|NCT02889133|537495067|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
149004613|NCT02889133|537495066|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
149004614|NCT02889133|537495067|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
149004615|NCT02889133|537495066|FG000|Completed Primary Outcome|Protocol Violation|1|||
149004616|NCT02889133|537495067|FG001|Completed Primary Outcome|Protocol Violation|0|||
149004617|NCT02889133|537495066|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
149004618|NCT02889133|537495067|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
149004619|NCT02889133|537495066|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
149004620|NCT02889133|537495067|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
149004621|NCT02889133|537495066|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
149004622|NCT02889133|537495067|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
149004623|NCT02889133|537495066|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
149004624|NCT02889133|537495067|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
149004625|NCT02889133|537495066|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
149004626|NCT02889133|537495067|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
149004627|NCT04711603|537495068|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
149004628|NCT04711603|537495069|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
149004629|NCT04711603|537495070|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
149004630|NCT04711603|537495071|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
149004631|NCT04711603|537495068|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
149004632|NCT04711603|537495069|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
149004633|NCT04711603|537495070|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
149004634|NCT04711603|537495071|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
149004635|NCT04711603|537495068|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
149004636|NCT04711603|537495069|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
149004637|NCT04711603|537495070|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
149004638|NCT04711603|537495071|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
149004639|NCT04711603|537495068|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
149004640|NCT04711603|537495069|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
149004641|NCT04711603|537495070|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
149004642|NCT04711603|537495071|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
149004643|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
149004644|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
149004645|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
149004646|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
149004647|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
149004648|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
149004649|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
149004650|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
149004651|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
149004652|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
149004653|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
149004654|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
149004655|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
149004656|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
149004657|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
149004658|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
149004659|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
149004660|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
149004661|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
149004662|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
149004663|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
149004664|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
149004665|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
149004666|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
149004667|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
149004668|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
149004669|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
149004670|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
149004671|NCT04711603|537495068|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
149004672|NCT04711603|537495069|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
149004673|NCT04711603|537495070|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
149040101|NCT01391832|537626381|FG000|Overall Study|Withdrawal by Subject|21|||
149040102|NCT01391832|537626382|FG001|Overall Study|Withdrawal by Subject|22|||
149040103|NCT01391832|537626381|FG000|Overall Study|Lost to Follow-up|0|||
149040104|NCT01391832|537626382|FG001|Overall Study|Lost to Follow-up|1|||
149040105|NCT03345901|537626388|FG000|Overall Study|The study was terminated|18|||
149040106|NCT00722046|537626389|FG000|Overall Study|Adverse Event|0|||
149040107|NCT00722046|537626390|FG001|Overall Study|Adverse Event|1|||
149040108|NCT00722046|537626391|FG002|Overall Study|Adverse Event|2|||
149040109|NCT00722046|537626392|FG003|Overall Study|Adverse Event|1|||
149040110|NCT00722046|537626393|FG004|Overall Study|Adverse Event|2|||
149040111|NCT00722046|537626394|FG005|Overall Study|Adverse Event|1|||
149040112|NCT00722046|537626395|FG006|Overall Study|Adverse Event|0|||
149040113|NCT00722046|537626389|FG000|Overall Study|Death|0|||
149040114|NCT00722046|537626390|FG001|Overall Study|Death|1|||
149040115|NCT00722046|537626391|FG002|Overall Study|Death|0|||
149040116|NCT00722046|537626392|FG003|Overall Study|Death|0|||
149040117|NCT00722046|537626393|FG004|Overall Study|Death|0|||
149040118|NCT00722046|537626394|FG005|Overall Study|Death|0|||
149040119|NCT00722046|537626395|FG006|Overall Study|Death|2|||
149040120|NCT00722046|537626389|FG000|Overall Study|Protocol Violation|1|||
149040121|NCT00722046|537626390|FG001|Overall Study|Protocol Violation|0|||
149040122|NCT00722046|537626391|FG002|Overall Study|Protocol Violation|0|||
149040123|NCT00722046|537626392|FG003|Overall Study|Protocol Violation|0|||
149040124|NCT00722046|537626393|FG004|Overall Study|Protocol Violation|0|||
149040125|NCT00722046|537626394|FG005|Overall Study|Protocol Violation|1|||
149040126|NCT00722046|537626395|FG006|Overall Study|Protocol Violation|0|||
149040127|NCT00722046|537626389|FG000|Overall Study|Withdrawal by Subject|3|||
149040128|NCT00722046|537626390|FG001|Overall Study|Withdrawal by Subject|3|||
149040129|NCT00722046|537626391|FG002|Overall Study|Withdrawal by Subject|4|||
149040130|NCT00722046|537626392|FG003|Overall Study|Withdrawal by Subject|4|||
149040131|NCT00722046|537626393|FG004|Overall Study|Withdrawal by Subject|4|||
149040132|NCT00722046|537626394|FG005|Overall Study|Withdrawal by Subject|7|||
149040133|NCT00722046|537626395|FG006|Overall Study|Withdrawal by Subject|3|||
149040134|NCT00722046|537626389|FG000|Overall Study|Randomized, but not treated|1|||
149040135|NCT00722046|537626390|FG001|Overall Study|Randomized, but not treated|1|||
149040136|NCT00722046|537626391|FG002|Overall Study|Randomized, but not treated|0|||
149040137|NCT00722046|537626392|FG003|Overall Study|Randomized, but not treated|2|||
149040138|NCT00722046|537626393|FG004|Overall Study|Randomized, but not treated|0|||
149040139|NCT00722046|537626394|FG005|Overall Study|Randomized, but not treated|0|||
149040140|NCT00722046|537626395|FG006|Overall Study|Randomized, but not treated|0|||
149040141|NCT00722046|537626389|FG000|Overall Study|Other|0|||
149040142|NCT00722046|537626390|FG001|Overall Study|Other|0|||
149040143|NCT00722046|537626391|FG002|Overall Study|Other|1|||
149040144|NCT00722046|537626392|FG003|Overall Study|Other|1|||
149040145|NCT00722046|537626393|FG004|Overall Study|Other|3|||
149040146|NCT00722046|537626394|FG005|Overall Study|Other|2|||
149040147|NCT00722046|537626395|FG006|Overall Study|Other|1|||
149040148|NCT00925587|537626396|FG000|Overall Study|Protocol Specified Criteria|6|||
149040149|NCT00925587|537626397|FG001|Overall Study|Protocol Specified Criteria|6|||
149040150|NCT00925587|537626396|FG000|Overall Study|Physician Decision|4|||
149040151|NCT00925587|537626397|FG001|Overall Study|Physician Decision|1|||
149040152|NCT00925587|537626396|FG000|Overall Study|Protocol Violation|6|||
149040153|NCT00925587|537626397|FG001|Overall Study|Protocol Violation|4|||
149040154|NCT00925587|537626396|FG000|Overall Study|Withdrawal by Subject|9|||
149040155|NCT00925587|537626397|FG001|Overall Study|Withdrawal by Subject|6|||
149040156|NCT00925587|537626396|FG000|Overall Study|Death|5|||
149040157|NCT00925587|537626397|FG001|Overall Study|Death|5|||
149040158|NCT00925587|537626396|FG000|Overall Study|Adverse Event|6|||
149040159|NCT00925587|537626397|FG001|Overall Study|Adverse Event|2|||
149040160|NCT00925587|537626396|FG000|Overall Study|Lost to Follow-up|0|||
149040161|NCT00925587|537626397|FG001|Overall Study|Lost to Follow-up|1|||
149040162|NCT00516321|537626405|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
149040163|NCT00516321|537626406|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
149040164|NCT00516321|537626407|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
149040165|NCT00516321|537626405|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
149040166|NCT00516321|537626406|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
149040167|NCT00516321|537626407|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
149040168|NCT00516321|537626405|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
149040169|NCT00516321|537626406|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
149040170|NCT00516321|537626407|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
149040171|NCT00516321|537626405|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
149040172|NCT00516321|537626406|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
149040173|NCT00516321|537626407|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
149040174|NCT00516321|537626405|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
149040175|NCT00516321|537626406|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
149040176|NCT00516321|537626407|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
149040177|NCT00516321|537626405|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
149040178|NCT00516321|537626406|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
149040179|NCT00516321|537626407|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
149040180|NCT00516321|537626405|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
149040181|NCT00516321|537626406|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
149040182|NCT00516321|537626407|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
149040183|NCT00516321|537626405|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
149040184|NCT00516321|537626406|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
149040185|NCT00516321|537626407|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
149040186|NCT00516321|537626405|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
149040187|NCT00516321|537626406|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
149040188|NCT00516321|537626407|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
149040189|NCT00516321|537626405|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
149040190|NCT00516321|537626406|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
149040191|NCT00516321|537626407|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
149040192|NCT00516321|537626405|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
149040193|NCT00516321|537626406|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
149040194|NCT00516321|537626407|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
149040195|NCT01078116|537626413|FG000|Overall Study|Lost to Follow-up|17|||
149040196|NCT01078116|537626413|FG000|Overall Study|Adverse Event|5|||
149040197|NCT01078116|537626413|FG000|Overall Study|Withdrawal by Subject|8|||
149040198|NCT01078116|537626413|FG000|Overall Study|Lack of effectiveness|15|||
149040199|NCT01078116|537626413|FG000|Overall Study|Case report form not completed|3|||
149040200|NCT02252042|537626416|FG000|Overall Study|Adverse Event|9|||
149040201|NCT02252042|537626417|FG001|Overall Study|Adverse Event|6|||
149040202|NCT02252042|537626416|FG000|Overall Study|Death|209|||
149040203|NCT02252042|537626417|FG001|Overall Study|Death|217|||
149040204|NCT02252042|537626416|FG000|Overall Study|Physician Decision|0|||
149040205|NCT02252042|537626417|FG001|Overall Study|Physician Decision|2|||
149040206|NCT02252042|537626416|FG000|Overall Study|Transferred to Extension Study|7|||
149040207|NCT02252042|537626417|FG001|Overall Study|Transferred to Extension Study|1|||
149040208|NCT02252042|537626416|FG000|Overall Study|Did Not Continue on Extension Study|7|||
149040209|NCT02252042|537626417|FG001|Overall Study|Did Not Continue on Extension Study|2|||
149040210|NCT02252042|537626416|FG000|Overall Study|Withdrawal by Subject|15|||
149040211|NCT02252042|537626417|FG001|Overall Study|Withdrawal by Subject|20|||
149040212|NCT04532528|537626418|FG000|Overall Study|Adverse Event|12|||
149040213|NCT04532528|537626419|FG001|Overall Study|Adverse Event|17|||
149040214|NCT04532528|537626418|FG000|Overall Study|Withdrawal of consent|16|||
149040215|NCT04532528|537626419|FG001|Overall Study|Withdrawal of consent|17|||
149040216|NCT04532528|537626418|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
149040217|NCT04532528|537626419|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
149040218|NCT04532528|537626418|FG000|Overall Study|Lost to Follow-up|69|||
149040219|NCT04532528|537626419|FG001|Overall Study|Lost to Follow-up|68|||
149040220|NCT04532528|537626418|FG000|Overall Study|Administrative problems|12|||
149040221|NCT04532528|537626419|FG001|Overall Study|Administrative problems|14|||
149040222|NCT04532528|537626418|FG000|Overall Study|Death|3|||
149040223|NCT04532528|537626419|FG001|Overall Study|Death|3|||
149040224|NCT04532528|537626418|FG000|Overall Study|Other|38|||
148883199|NCT00874848|537049294|FG000|Overall Study|Failure to comply with protocol|0|||
148883200|NCT00874848|537049295|FG001|Overall Study|Failure to comply with protocol|1|||
148883201|NCT00874848|537049294|FG000|Overall Study|Physician Decision|0|||
148883202|NCT00874848|537049295|FG001|Overall Study|Physician Decision|2|||
148883203|NCT00858637|537049300|FG000|Active Comparison Phase|Adverse Event|14|||
148883204|NCT00858637|537049301|FG001|Active Comparison Phase|Adverse Event|0|||
148883205|NCT00858637|537049302|FG002|Active Comparison Phase|Adverse Event|0|||
148883206|NCT00858637|537049303|FG003|Active Comparison Phase|Adverse Event|9|||
148883207|NCT00858637|537049304|FG004|Active Comparison Phase|Adverse Event|0|||
149040225|NCT04532528|537626419|FG001|Overall Study|Other|46|||
149040226|NCT03691428|537626422|FG000|Overall Study|Withdrawal by Subject|6|||
149040227|NCT03691428|537626423|FG001|Overall Study|Withdrawal by Subject|8|||
149040228|NCT01460290|537626424|FG000|Overall Study|Adverse Event|3|||
149040229|NCT01460290|537626424|FG000|Overall Study|Elevated liver function|1|||
149040230|NCT02527148|537626425|FG000|Overall Study|Did not receive study intervention|1|||
149040231|NCT02527148|537626426|FG001|Overall Study|Did not receive study intervention|0|||
149040232|NCT01140048|537626427|FG000|Overall Study|Physician Decision|1|||
149040233|NCT01140048|537626427|FG000|Overall Study|Withdrawal by Subject|13|||
149040234|NCT01140048|537626427|FG000|Overall Study|Lost to Follow-up|31|||
149040235|NCT00891930|537626430|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
149040236|NCT00891930|537626430|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
149040237|NCT00891930|537626430|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
149040238|NCT00891930|537626430|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
149040239|NCT00891930|537626430|FG000|Part 2 Panitumumab + AMG479|Death|30|||
149040240|NCT02448446|537626431|FG000|Overall Study|Withdrawal by Subject|1|||
149040241|NCT02448446|537626432|FG001|Overall Study|Withdrawal by Subject|0|||
149040242|NCT01254188|537626433|FG000|Overall Study|Disease Progression|6|||
149040243|NCT01254188|537626433|FG000|Overall Study|Protocol Violation|6|||
149040244|NCT01254188|537626433|FG000|Overall Study|Pregnancy|2|||
149040245|NCT01254188|537626433|FG000|Overall Study|Death|4|||
149040246|NCT01254188|537626433|FG000|Overall Study|Lost to Follow-up|5|||
149040247|NCT01254188|537626433|FG000|Overall Study|Withdrawal by Subject|7|||
149040248|NCT01254188|537626433|FG000|Overall Study|Adverse Event|43|||
149040249|NCT01254188|537626433|FG000|Overall Study|per investigator discretion|20|||
149040250|NCT02957136|537626435|FG000|Overall Study|Withdrawal by Subject|2|||
149040251|NCT02957136|537626436|FG001|Overall Study|Withdrawal by Subject|1|||
149040252|NCT00442117|537626437|FG000|Overall Study|Adverse Event|3|||
149040253|NCT00442117|537626438|FG001|Overall Study|Adverse Event|2|||
149040254|NCT00442117|537626437|FG000|Overall Study|Lack of Efficacy|2|||
149040255|NCT00442117|537626438|FG001|Overall Study|Lack of Efficacy|6|||
149040256|NCT00442117|537626437|FG000|Overall Study|Lost to Follow-up|1|||
149040257|NCT00442117|537626438|FG001|Overall Study|Lost to Follow-up|2|||
149040258|NCT00442117|537626437|FG000|Overall Study|Withdrawal by Subject|2|||
149040259|NCT00442117|537626438|FG001|Overall Study|Withdrawal by Subject|2|||
149040260|NCT00442117|537626437|FG000|Overall Study|Major Deviation|25|||
149040261|NCT00442117|537626438|FG001|Overall Study|Major Deviation|20|||
149040262|NCT00442117|537626437|FG000|Overall Study|Non compliance with protocol|3|||
149040263|NCT00442117|537626438|FG001|Overall Study|Non compliance with protocol|5|||
149040264|NCT00442117|537626437|FG000|Overall Study|Met Withdrawal Criteria|2|||
149040265|NCT00442117|537626438|FG001|Overall Study|Met Withdrawal Criteria|1|||
149040266|NCT04009577|537626444|FG000|Core Study|Adverse Event|1|||
149040267|NCT04009577|537626445|FG001|Core Study|Adverse Event|0|||
149040268|NCT04009577|537626446|FG002|Core Study|Adverse Event|2|||
149040269|NCT04009577|537626447|FG003|Core Study|Adverse Event|4|||
149040270|NCT04009577|537626444|FG000|Core Study|Withdrawal by Subject|0|||
149040271|NCT04009577|537626445|FG001|Core Study|Withdrawal by Subject|0|||
149040272|NCT04009577|537626446|FG002|Core Study|Withdrawal by Subject|2|||
149040273|NCT04009577|537626447|FG003|Core Study|Withdrawal by Subject|0|||
149040274|NCT04009577|537626444|FG000|Core Study|Other|0|||
149040275|NCT04009577|537626445|FG001|Core Study|Other|0|||
149040276|NCT04009577|537626446|FG002|Core Study|Other|0|||
149040277|NCT04009577|537626447|FG003|Core Study|Other|1|||
149040278|NCT04009577|537626444|FG000|Extension Phase|Adverse Event|0|||
148883208|NCT00858637|537049305|FG005|Active Comparison Phase|Adverse Event|0|||
149040279|NCT04009577|537626445|FG001|Extension Phase|Adverse Event|0|||
149040280|NCT04009577|537626446|FG002|Extension Phase|Adverse Event|0|||
149040281|NCT04009577|537626447|FG003|Extension Phase|Adverse Event|1|||
148883209|NCT00858637|537049300|FG000|Active Comparison Phase|Death|1|||
149040282|NCT04009577|537626444|FG000|Extension Phase|Inadequate therapeutic effect|0|||
149040283|NCT04009577|537626445|FG001|Extension Phase|Inadequate therapeutic effect|0|||
149040284|NCT04009577|537626446|FG002|Extension Phase|Inadequate therapeutic effect|1|||
149040285|NCT04009577|537626447|FG003|Extension Phase|Inadequate therapeutic effect|0|||
149040286|NCT04009577|537626444|FG000|Extension Phase|Withdrawal by Subject|0|||
149040287|NCT04009577|537626445|FG001|Extension Phase|Withdrawal by Subject|0|||
149040288|NCT04009577|537626446|FG002|Extension Phase|Withdrawal by Subject|1|||
149040289|NCT04009577|537626447|FG003|Extension Phase|Withdrawal by Subject|0|||
149040290|NCT04009577|537626444|FG000|Extension Phase|Not Treated|0|||
148883210|NCT00858637|537049301|FG001|Active Comparison Phase|Death|0|||
148883211|NCT00858637|537049302|FG002|Active Comparison Phase|Death|0|||
148883212|NCT00858637|537049303|FG003|Active Comparison Phase|Death|1|||
148883213|NCT00858637|537049304|FG004|Active Comparison Phase|Death|0|||
148883214|NCT00858637|537049305|FG005|Active Comparison Phase|Death|0|||
148883215|NCT00858637|537049300|FG000|Active Comparison Phase|Physician Decision|1|||
148883216|NCT00858637|537049301|FG001|Active Comparison Phase|Physician Decision|0|||
148883217|NCT00858637|537049302|FG002|Active Comparison Phase|Physician Decision|0|||
148883218|NCT00858637|537049303|FG003|Active Comparison Phase|Physician Decision|1|||
148883219|NCT00858637|537049304|FG004|Active Comparison Phase|Physician Decision|0|||
148883220|NCT00858637|537049305|FG005|Active Comparison Phase|Physician Decision|0|||
148883221|NCT00858637|537049300|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
148883222|NCT00858637|537049301|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
148883223|NCT00858637|537049302|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
148883224|NCT00858637|537049303|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
148883225|NCT00858637|537049304|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
148883226|NCT00858637|537049305|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
148883227|NCT00858637|537049300|FG000|Active Comparison Phase|Other Reasons|1|||
148883228|NCT00858637|537049301|FG001|Active Comparison Phase|Other Reasons|0|||
148883229|NCT00858637|537049302|FG002|Active Comparison Phase|Other Reasons|0|||
148883230|NCT00858637|537049303|FG003|Active Comparison Phase|Other Reasons|1|||
148883231|NCT00858637|537049304|FG004|Active Comparison Phase|Other Reasons|0|||
148883232|NCT00858637|537049305|FG005|Active Comparison Phase|Other Reasons|0|||
148883233|NCT00858637|537049300|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
148883234|NCT00858637|537049301|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
148883235|NCT00858637|537049302|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
148883236|NCT00858637|537049303|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
148883237|NCT00858637|537049304|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
148883238|NCT00858637|537049305|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
148883239|NCT00858637|537049300|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
148883240|NCT00858637|537049301|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
148883241|NCT00858637|537049302|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
148883242|NCT00858637|537049303|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
148883243|NCT00858637|537049304|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
148883244|NCT00858637|537049305|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
148883245|NCT01380834|537049306|FG000|Overall Study|Physician Decision|1|||
148883246|NCT01380834|537049307|FG001|Overall Study|Physician Decision|0|||
148883247|NCT04677504|537049310|FG000|Overall Study|Death|51|||
148883248|NCT04677504|537049311|FG001|Overall Study|Death|49|||
148883249|NCT04677504|537049310|FG000|Overall Study|Progressive Disease|1|||
148883250|NCT04677504|537049311|FG001|Overall Study|Progressive Disease|0|||
148883251|NCT04677504|537049310|FG000|Overall Study|Symptomatic Deterioration|1|||
149004674|NCT04711603|537495071|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
149004675|NCT06351371|537495072|FG000|Overall Study|Mutation Status Not Confirmed|9|||
149004676|NCT06351371|537495072|FG000|Overall Study|Ineligible|1|||
149004677|NCT06351371|537495072|FG000|Overall Study|Adverse Event|4|||
149004678|NCT06351371|537495072|FG000|Overall Study|Death|1|||
149004679|NCT06351371|537495072|FG000|Overall Study|Disease progression|14|||
149004680|NCT06351371|537495072|FG000|Overall Study|Withdrawal by Subject|3|||
149004681|NCT06351371|537495072|FG000|Overall Study|Physician Decision|3|||
149004682|NCT03759834|537495073|FG000|Overall Study|Withdrawal by Subject|1|||
149004683|NCT04359784|537495075|FG000|Overall Study|Death|2|||
149004684|NCT02753595|537495079|FG000|Overall Study|Sponsor termination|2|||
149004685|NCT02753595|537495080|FG001|Overall Study|Sponsor termination|2|||
149004686|NCT03937219|537495084|FG000|Overall Study|Death|223|||
149004687|NCT03937219|537495085|FG001|Overall Study|Death|211|||
149004688|NCT03937219|537495084|FG000|Overall Study|Withdrawal by Subject|17|||
149004689|NCT03937219|537495085|FG001|Overall Study|Withdrawal by Subject|25|||
149004690|NCT03937219|537495084|FG000|Overall Study|Lost to Follow-up|3|||
149004691|NCT03937219|537495085|FG001|Overall Study|Lost to Follow-up|4|||
148883252|NCT04677504|537049311|FG001|Overall Study|Symptomatic Deterioration|0|||
148883253|NCT04677504|537049310|FG000|Overall Study|Withdrawal by Subject|2|||
148883254|NCT04677504|537049311|FG001|Overall Study|Withdrawal by Subject|5|||
148883255|NCT04677504|537049310|FG000|Overall Study|Study Terminated By Sponsor|28|||
148883256|NCT04677504|537049311|FG001|Overall Study|Study Terminated By Sponsor|24|||
148883257|NCT04677504|537049310|FG000|Overall Study|Adverse Event|0|||
149004692|NCT02515279|537495088|FG000|Overall Study|Adverse Event|7|||
149004693|NCT02515279|537495088|FG000|Overall Study|Lack of Efficacy|31|||
149004694|NCT02515279|537495088|FG000|Overall Study|Lost to Follow-up|9|||
149004695|NCT02515279|537495088|FG000|Overall Study|Withdrawal by Subject|18|||
149040291|NCT04009577|537626445|FG001|Extension Phase|Not Treated|0|||
148883258|NCT04677504|537049311|FG001|Overall Study|Adverse Event|1|||
148883259|NCT00167310|537049314|FG000|Overall Study|Protocol Violation|5|||
148883260|NCT00167310|537049315|FG001|Overall Study|Protocol Violation|3|||
148883261|NCT00167310|537049314|FG000|Overall Study|Withdrawal by Subject|3|||
148883262|NCT00167310|537049315|FG001|Overall Study|Withdrawal by Subject|7|||
148883263|NCT04522141|537049316|FG000|Overall Study|Withdrawal by Subject|1|||
148883264|NCT04522141|537049317|FG001|Overall Study|Withdrawal by Subject|0|||
148883265|NCT03052049|537049318|FG000|Overall Study|Withdrawal by Subject|2|||
148883266|NCT03304873|537049319|FG000|Overall Study|Lost to Follow-up|1|||
148883267|NCT03304873|537049320|FG001|Overall Study|Lost to Follow-up|8|||
148883268|NCT01868477|537049322|FG000|Overall Study|Adverse Event|2|||
148883269|NCT01868477|537049323|FG001|Overall Study|Adverse Event|4|||
148883270|NCT01868477|537049322|FG000|Overall Study|Disease progression|1|||
148883271|NCT01868477|537049323|FG001|Overall Study|Disease progression|1|||
148883272|NCT01868477|537049322|FG000|Overall Study|Withdrawal by Subject|1|||
148883273|NCT01868477|537049323|FG001|Overall Study|Withdrawal by Subject|0|||
148883274|NCT00042991|537049324|FG000|Overall Study|Adverse Event|1|||
148883275|NCT00042991|537049325|FG001|Overall Study|Adverse Event|4|||
148883276|NCT00042991|537049326|FG002|Overall Study|Adverse Event|2|||
148883277|NCT00042991|537049327|FG003|Overall Study|Adverse Event|0|||
148883278|NCT00042991|537049328|FG004|Overall Study|Adverse Event|0|||
148883279|NCT00042991|537049329|FG005|Overall Study|Adverse Event|1|||
148883280|NCT00042991|537049330|FG006|Overall Study|Adverse Event|0|||
148883281|NCT00042991|537049324|FG000|Overall Study|Withdrawal by Subject|0|||
148883282|NCT00042991|537049325|FG001|Overall Study|Withdrawal by Subject|7|||
148883283|NCT00042991|537049326|FG002|Overall Study|Withdrawal by Subject|2|||
148883284|NCT00042991|537049327|FG003|Overall Study|Withdrawal by Subject|0|||
148883285|NCT00042991|537049328|FG004|Overall Study|Withdrawal by Subject|1|||
148883286|NCT00042991|537049329|FG005|Overall Study|Withdrawal by Subject|0|||
148883287|NCT00042991|537049330|FG006|Overall Study|Withdrawal by Subject|0|||
148883288|NCT00042991|537049324|FG000|Overall Study|Disease Progression|5|||
149040292|NCT04009577|537626446|FG002|Extension Phase|Not Treated|2|||
149040293|NCT04009577|537626447|FG003|Extension Phase|Not Treated|0|||
149040294|NCT00305695|537626451|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
149040295|NCT00305695|537626452|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
149040296|NCT00305695|537626451|FG000|Overall Study|Did not have baseline scan|1|||
149040297|NCT00305695|537626452|FG001|Overall Study|Did not have baseline scan|1|||
149040298|NCT00841035|537626455|FG000|Phase 1 Overall Study|Physician Decision|13|||
149040299|NCT00433199|537626460|FG000|Double-Blind Period|Adverse Event|0|||
149040300|NCT00433199|537626461|FG001|Double-Blind Period|Adverse Event|25|||
149040301|NCT00433199|537626460|FG000|Double-Blind Period|Lack of Efficacy|0|||
149040302|NCT00433199|537626461|FG001|Double-Blind Period|Lack of Efficacy|2|||
149040303|NCT00433199|537626460|FG000|Double-Blind Period|Lost to Follow-up|2|||
149040304|NCT00433199|537626461|FG001|Double-Blind Period|Lost to Follow-up|5|||
149040305|NCT00433199|537626460|FG000|Double-Blind Period|Withdrawal by Subject|8|||
149040306|NCT00433199|537626461|FG001|Double-Blind Period|Withdrawal by Subject|19|||
149040307|NCT00433199|537626460|FG000|Double-Blind Period|Protocol Violation|1|||
149040308|NCT00433199|537626461|FG001|Double-Blind Period|Protocol Violation|10|||
149040309|NCT00433199|537626460|FG000|Double-Blind Period|Administrative|1|||
149040310|NCT00433199|537626461|FG001|Double-Blind Period|Administrative|5|||
149040311|NCT00433199|537626460|FG000|Open-Label Period|Adverse Event|0|||
149040312|NCT00433199|537626461|FG001|Open-Label Period|Adverse Event|19|||
149040313|NCT00433199|537626460|FG000|Open-Label Period|Lack of Efficacy|0|||
149040314|NCT00433199|537626461|FG001|Open-Label Period|Lack of Efficacy|2|||
149040315|NCT00433199|537626460|FG000|Open-Label Period|Lost to Follow-up|0|||
149040316|NCT00433199|537626461|FG001|Open-Label Period|Lost to Follow-up|3|||
149040317|NCT00433199|537626460|FG000|Open-Label Period|Withdrawal by Subject|0|||
149040318|NCT00433199|537626461|FG001|Open-Label Period|Withdrawal by Subject|7|||
149040319|NCT00433199|537626460|FG000|Open-Label Period|Protocol Violation|0|||
149040320|NCT00433199|537626461|FG001|Open-Label Period|Protocol Violation|2|||
149040321|NCT00433199|537626460|FG000|Open-Label Period|Administrative|0|||
149040322|NCT00433199|537626461|FG001|Open-Label Period|Administrative|1|||
149040323|NCT00357097|537626462|FG000|Overall Study|Did not meet inclusion criteria|5|||
149040324|NCT00357097|537626463|FG001|Overall Study|Did not meet inclusion criteria|3|||
149040325|NCT00357097|537626462|FG000|Overall Study|Adverse Event|34|||
149040326|NCT00357097|537626463|FG001|Overall Study|Adverse Event|6|||
149040327|NCT00357097|537626462|FG000|Overall Study|Withdrawal by Subject|8|||
149040328|NCT00357097|537626463|FG001|Overall Study|Withdrawal by Subject|7|||
149040329|NCT00357097|537626462|FG000|Overall Study|Non-compliance|1|||
148883289|NCT00042991|537049325|FG001|Overall Study|Disease Progression|29|||
148883290|NCT00042991|537049326|FG002|Overall Study|Disease Progression|2|||
148883291|NCT00042991|537049327|FG003|Overall Study|Disease Progression|2|||
148883292|NCT00042991|537049328|FG004|Overall Study|Disease Progression|1|||
148883293|NCT00042991|537049329|FG005|Overall Study|Disease Progression|4|||
149040330|NCT00357097|537626463|FG001|Overall Study|Non-compliance|2|||
149040331|NCT00357097|537626462|FG000|Overall Study|Lack of Efficacy|2|||
149040332|NCT00357097|537626463|FG001|Overall Study|Lack of Efficacy|8|||
148883294|NCT00042991|537049330|FG006|Overall Study|Disease Progression|2|||
148883295|NCT00042991|537049324|FG000|Overall Study|Alternative Therapy|0|||
148883296|NCT00042991|537049325|FG001|Overall Study|Alternative Therapy|0|||
148883297|NCT00042991|537049326|FG002|Overall Study|Alternative Therapy|0|||
148883298|NCT00042991|537049327|FG003|Overall Study|Alternative Therapy|0|||
148883299|NCT00042991|537049328|FG004|Overall Study|Alternative Therapy|1|||
148883300|NCT00042991|537049329|FG005|Overall Study|Alternative Therapy|0|||
148883301|NCT00042991|537049330|FG006|Overall Study|Alternative Therapy|0|||
148883302|NCT01574651|537049331|FG000|Overall Study|Lost to Follow-up|2|||
148883303|NCT01574651|537049332|FG001|Overall Study|Lost to Follow-up|4|||
148883304|NCT01574651|537049331|FG000|Overall Study|Administrative problems|0|||
148883305|NCT01574651|537049332|FG001|Overall Study|Administrative problems|1|||
148883306|NCT01574651|537049331|FG000|Overall Study|Death|3|||
148883307|NCT01574651|537049332|FG001|Overall Study|Death|3|||
148883308|NCT01574651|537049331|FG000|Overall Study|Patient's inability to use the device|0|||
148883309|NCT01574651|537049332|FG001|Overall Study|Patient's inability to use the device|1|||
148883310|NCT01574651|537049331|FG000|Overall Study|Adverse Event|36|||
148883311|NCT01574651|537049332|FG001|Overall Study|Adverse Event|27|||
148883312|NCT01574651|537049331|FG000|Overall Study|Abnormal laboratory value(s)|1|||
148883313|NCT01574651|537049332|FG001|Overall Study|Abnormal laboratory value(s)|0|||
148883314|NCT01574651|537049331|FG000|Overall Study|Abnormal test procedure result(s)|1|||
148883315|NCT01574651|537049332|FG001|Overall Study|Abnormal test procedure result(s)|1|||
148883316|NCT01574651|537049331|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
148883317|NCT01574651|537049332|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
148883318|NCT01574651|537049331|FG000|Overall Study|Protocol Violation|3|||
148883319|NCT01574651|537049332|FG001|Overall Study|Protocol Violation|5|||
148883320|NCT01574651|537049331|FG000|Overall Study|Withdrawal by Subject|9|||
148883321|NCT01574651|537049332|FG001|Overall Study|Withdrawal by Subject|10|||
148883322|NCT03887221|537049333|FG000|Overall Study|Protocol Violation|1|||
148883323|NCT03887221|537049334|FG001|Overall Study|Protocol Violation|0|||
148883324|NCT00947115|537049335|FG000|Overall Study|Missed reporting interval|3|||
148883325|NCT00947115|537049336|FG001|Overall Study|Missed reporting interval|4|||
148883326|NCT00947115|537049337|FG002|Overall Study|Missed reporting interval|2|||
148883327|NCT00947115|537049335|FG000|Overall Study|Physician Decision|0|||
148883328|NCT00947115|537049336|FG001|Overall Study|Physician Decision|2|||
148883329|NCT00947115|537049337|FG002|Overall Study|Physician Decision|0|||
148883330|NCT00947115|537049335|FG000|Overall Study|Death|0|||
148883331|NCT00947115|537049336|FG001|Overall Study|Death|1|||
148883332|NCT00947115|537049337|FG002|Overall Study|Death|1|||
148883333|NCT00947115|537049335|FG000|Overall Study|Migrated from study area|2|||
148883334|NCT00947115|537049336|FG001|Overall Study|Migrated from study area|0|||
148883335|NCT00947115|537049337|FG002|Overall Study|Migrated from study area|0|||
148883336|NCT00947115|537049335|FG000|Overall Study|Withdrawal by Subject|1|||
148883337|NCT00947115|537049336|FG001|Overall Study|Withdrawal by Subject|3|||
148883338|NCT00947115|537049337|FG002|Overall Study|Withdrawal by Subject|4|||
148883339|NCT00947115|537049335|FG000|Overall Study|Lost to Follow-up|11|||
148883340|NCT00947115|537049336|FG001|Overall Study|Lost to Follow-up|12|||
148883341|NCT00947115|537049337|FG002|Overall Study|Lost to Follow-up|8|||
148883342|NCT02407223|537051567|FG000|Overall Study|Adverse Event|1|||
148883343|NCT02407223|537051568|FG001|Overall Study|Adverse Event|0|||
148883344|NCT02407223|537051569|FG002|Overall Study|Adverse Event|1|||
148883345|NCT02407223|537051567|FG000|Overall Study|Lack of Efficacy|6|||
148883346|NCT02407223|537051568|FG001|Overall Study|Lack of Efficacy|6|||
148883347|NCT02407223|537051569|FG002|Overall Study|Lack of Efficacy|4|||
148883348|NCT02407223|537051567|FG000|Overall Study|Lost to Follow-up|1|||
148883349|NCT02407223|537051568|FG001|Overall Study|Lost to Follow-up|0|||
148883350|NCT02407223|537051569|FG002|Overall Study|Lost to Follow-up|2|||
148883351|NCT02407223|537051567|FG000|Overall Study|Withdrawal by Subject|2|||
148883352|NCT02407223|537051568|FG001|Overall Study|Withdrawal by Subject|4|||
148883353|NCT02407223|537051569|FG002|Overall Study|Withdrawal by Subject|4|||
148883354|NCT02407223|537051567|FG000|Overall Study|Study Terminated by Sponsor|77|||
148883355|NCT02407223|537051568|FG001|Overall Study|Study Terminated by Sponsor|80|||
148883356|NCT02407223|537051569|FG002|Overall Study|Study Terminated by Sponsor|86|||
148883357|NCT02407223|537051567|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
148883358|NCT02407223|537051568|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
148883359|NCT02407223|537051569|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
148883360|NCT02407223|537051567|FG000|Overall Study|Other|29|||
148883361|NCT02407223|537051568|FG001|Overall Study|Other|27|||
148883362|NCT02407223|537051569|FG002|Overall Study|Other|25|||
148883363|NCT01101035|537051570|FG000|Overall Study|Adverse Event|191|||
148883364|NCT01101035|537051571|FG001|Overall Study|Adverse Event|172|||
148883365|NCT01101035|537051570|FG000|Overall Study|Major Protocol Deviation|52|||
148883366|NCT01101035|537051571|FG001|Overall Study|Major Protocol Deviation|46|||
148883367|NCT01101035|537051570|FG000|Overall Study|Lost to Follow-up|226|||
148883368|NCT01101035|537051571|FG001|Overall Study|Lost to Follow-up|223|||
148883369|NCT01101035|537051570|FG000|Overall Study|Voluntary Withdrawal|595|||
148883370|NCT01101035|537051571|FG001|Overall Study|Voluntary Withdrawal|587|||
148883371|NCT01101035|537051570|FG000|Overall Study|Reason not Specified|333|||
148883372|NCT01101035|537051571|FG001|Overall Study|Reason not Specified|363|||
148883373|NCT00412893|537051574|FG000|Overall Study|Adverse Event|31|||
148883374|NCT00412893|537051575|FG001|Overall Study|Adverse Event|53|||
148883375|NCT00412893|537051574|FG000|Overall Study|Death|17|||
148883376|NCT00412893|537051575|FG001|Overall Study|Death|21|||
148883377|NCT00412893|537051574|FG000|Overall Study|Insufficient Therapeutic Response|39|||
148883378|NCT00412893|537051575|FG001|Overall Study|Insufficient Therapeutic Response|23|||
148883379|NCT00412893|537051574|FG000|Overall Study|Lost to Follow-up|2|||
148883380|NCT00412893|537051575|FG001|Overall Study|Lost to Follow-up|1|||
148883381|NCT00412893|537051574|FG000|Overall Study|Violation of Selection at Entry|17|||
148883382|NCT00412893|537051575|FG001|Overall Study|Violation of Selection at Entry|10|||
148883383|NCT00412893|537051574|FG000|Overall Study|Other Protocol Violation|10|||
148883384|NCT00412893|537051575|FG001|Overall Study|Other Protocol Violation|6|||
148883385|NCT00412893|537051574|FG000|Overall Study|Did Not Cooperate|12|||
148883386|NCT00412893|537051575|FG001|Overall Study|Did Not Cooperate|9|||
148883387|NCT00412893|537051574|FG000|Overall Study|Administrative Reason|12|||
148883388|NCT00412893|537051575|FG001|Overall Study|Administrative Reason|15|||
148883389|NCT00412893|537051574|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
148883390|NCT00412893|537051575|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
148883391|NCT00853151|537051576|FG000|Overall Study|Adverse Event|1|||
148883392|NCT00853151|537051577|FG001|Overall Study|Adverse Event|4|||
148883393|NCT00853151|537051578|FG002|Overall Study|Adverse Event|2|||
148883394|NCT00853151|537051579|FG003|Overall Study|Adverse Event|0|||
148883395|NCT00853151|537051576|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
148883396|NCT00853151|537051577|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
148883397|NCT00853151|537051578|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
148883398|NCT00853151|537051579|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
148883399|NCT00853151|537051576|FG000|Overall Study|Lost to Follow-up|2|||
148883400|NCT00853151|537051577|FG001|Overall Study|Lost to Follow-up|0|||
148883401|NCT00853151|537051578|FG002|Overall Study|Lost to Follow-up|3|||
148883402|NCT00853151|537051579|FG003|Overall Study|Lost to Follow-up|0|||
148883403|NCT00853151|537051576|FG000|Overall Study|Death|1|||
148883404|NCT00853151|537051577|FG001|Overall Study|Death|0|||
148883405|NCT00853151|537051578|FG002|Overall Study|Death|0|||
148883406|NCT00853151|537051579|FG003|Overall Study|Death|1|||
148883407|NCT00853151|537051576|FG000|Overall Study|Protocol Violation|0|||
148883408|NCT00853151|537051577|FG001|Overall Study|Protocol Violation|0|||
148883409|NCT00853151|537051578|FG002|Overall Study|Protocol Violation|0|||
148883410|NCT00853151|537051579|FG003|Overall Study|Protocol Violation|1|||
149040333|NCT00357097|537626462|FG000|Overall Study|Met Exclusion Criteria|3|||
149040334|NCT00357097|537626463|FG001|Overall Study|Met Exclusion Criteria|1|||
149040335|NCT00357097|537626462|FG000|Overall Study|Other|1|||
149040336|NCT00357097|537626463|FG001|Overall Study|Other|1|||
149040337|NCT00357097|537626462|FG000|Overall Study|Increase of RLS Symptoms|0|||
149040338|NCT00357097|537626463|FG001|Overall Study|Increase of RLS Symptoms|1|||
149040339|NCT00658996|537626464|FG000|First Intervention|Positive slit lamp finding|1|||
149040340|NCT00658996|537626465|FG001|First Intervention|Positive slit lamp finding|0|||
149040341|NCT00658996|537626464|FG000|First Intervention|Lack of lenses|0|||
149040342|NCT00658996|537626465|FG001|First Intervention|Lack of lenses|1|||
149040343|NCT00658996|537626464|FG000|Crossover Period|Physician Decision|1|||
149040344|NCT00658996|537626465|FG001|Crossover Period|Physician Decision|0|||
149040345|NCT00658996|537626464|FG000|Crossover Period|Ineligible|1|||
149040346|NCT00658996|537626465|FG001|Crossover Period|Ineligible|1|||
149040347|NCT00658996|537626464|FG000|Second Intervention|Developed a stye on upper lid|1|||
149040348|NCT00658996|537626465|FG001|Second Intervention|Developed a stye on upper lid|0|||
149040349|NCT00658996|537626464|FG000|Second Intervention|Positive slit lamp finding|0|||
149040350|NCT00658996|537626465|FG001|Second Intervention|Positive slit lamp finding|1|||
149040351|NCT02994654|537626466|FG000|Overall Study|Lost to Follow-up|1|||
149040352|NCT03603717|537626469|FG000|Overall Study|Lost to Follow-up|20|||
149040353|NCT03603717|537626470|FG001|Overall Study|Lost to Follow-up|20|||
149040354|NCT03603717|537626469|FG000|Overall Study|Withdrawal by Subject|16|||
149040355|NCT03603717|537626470|FG001|Overall Study|Withdrawal by Subject|10|||
149040356|NCT00732381|537626473|FG000|Overall Study|Adverse Event|1|||
149040357|NCT00732381|537626474|FG001|Overall Study|Adverse Event|0|||
149040358|NCT00732381|537626473|FG000|Overall Study|Treatment Failure|1|||
149040359|NCT00732381|537626474|FG001|Overall Study|Treatment Failure|1|||
149040360|NCT00457691|537626475|FG000|Overall Study|Adverse Event|4|||
149040361|NCT00457691|537626476|FG001|Overall Study|Adverse Event|1|||
148883411|NCT00853151|537051576|FG000|Overall Study|Withdrawal by Subject|5|||
148883412|NCT00853151|537051577|FG001|Overall Study|Withdrawal by Subject|4|||
148883413|NCT00853151|537051578|FG002|Overall Study|Withdrawal by Subject|2|||
149040362|NCT00457691|537626475|FG000|Overall Study|Death|163|||
148883414|NCT00853151|537051579|FG003|Overall Study|Withdrawal by Subject|1|||
148883415|NCT00853151|537051576|FG000|Overall Study|Physician Decision|0|||
148883416|NCT00853151|537051577|FG001|Overall Study|Physician Decision|2|||
148883417|NCT00853151|537051578|FG002|Overall Study|Physician Decision|1|||
149040363|NCT00457691|537626476|FG001|Overall Study|Death|148|||
149040364|NCT00457691|537626475|FG000|Overall Study|Protocol Violation|1|||
148883418|NCT00853151|537051579|FG003|Overall Study|Physician Decision|0|||
148883419|NCT00853151|537051576|FG000|Overall Study|Sponsor Decision|0|||
148883420|NCT00853151|537051577|FG001|Overall Study|Sponsor Decision|3|||
148883421|NCT00853151|537051578|FG002|Overall Study|Sponsor Decision|0|||
148883422|NCT00853151|537051579|FG003|Overall Study|Sponsor Decision|0|||
148883423|NCT01751984|537051580|FG000|Overall Study|Adverse Event|5|||
148883424|NCT01751984|537051581|FG001|Overall Study|Adverse Event|3|||
148883425|NCT01751984|537051580|FG000|Overall Study|Withdrawal by Subject|0|||
148883426|NCT01751984|537051581|FG001|Overall Study|Withdrawal by Subject|1|||
148883427|NCT01751984|537051580|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
148883428|NCT01751984|537051581|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
148883429|NCT02652156|537051585|FG000|Overall Study|Physician Decision|1|||
148883430|NCT02652156|537051586|FG001|Overall Study|Physician Decision|0|||
148883431|NCT02652156|537051587|FG002|Overall Study|Physician Decision|0|||
148883432|NCT00496080|537051590|FG000|Overall Study|Lost to Follow-up|9|||
148883433|NCT00496080|537051590|FG000|Overall Study|Surgical re-intervention|7|||
148883434|NCT00496080|537051590|FG000|Overall Study|Withdrawal by Subject|5|||
148883435|NCT00496080|537051590|FG000|Overall Study|Physician Decision|6|||
148883436|NCT04098809|537051591|FG000|Overall Study|Withdrawal by Subject|1|||
148883437|NCT04098809|537051592|FG001|Overall Study|Withdrawal by Subject|3|||
148883438|NCT04098809|537051591|FG000|Overall Study|Physician Decision|2|||
148883439|NCT04098809|537051592|FG001|Overall Study|Physician Decision|1|||
148883440|NCT01200368|537051593|FG000|Infant Series|Adverse Event|2|||
148883441|NCT01200368|537051594|FG001|Infant Series|Adverse Event|2|||
148883442|NCT01200368|537051595|FG002|Infant Series|Adverse Event|3|||
148883443|NCT01200368|537051593|FG000|Infant Series|Withdrawal by Subject|0|||
148883444|NCT01200368|537051594|FG001|Infant Series|Withdrawal by Subject|2|||
148883445|NCT01200368|537051595|FG002|Infant Series|Withdrawal by Subject|2|||
148883446|NCT01200368|537051593|FG000|Infant Series|Did not meet entrance criteria|0|||
148883447|NCT01200368|537051594|FG001|Infant Series|Did not meet entrance criteria|1|||
148883448|NCT01200368|537051595|FG002|Infant Series|Did not meet entrance criteria|0|||
148883449|NCT01200368|537051593|FG000|Infant Series|Randomized, not vaccinated|0|||
148883450|NCT01200368|537051594|FG001|Infant Series|Randomized, not vaccinated|1|||
148883451|NCT01200368|537051595|FG002|Infant Series|Randomized, not vaccinated|1|||
148883452|NCT01200368|537051593|FG000|Infant Series|Other|1|||
148883453|NCT01200368|537051594|FG001|Infant Series|Other|0|||
148883454|NCT01200368|537051595|FG002|Infant Series|Other|0|||
148883455|NCT01200368|537051593|FG000|After Infant Series|Adverse Event|6|||
148883456|NCT01200368|537051594|FG001|After Infant Series|Adverse Event|6|||
148883457|NCT01200368|537051595|FG002|After Infant Series|Adverse Event|3|||
148883458|NCT01200368|537051593|FG000|After Infant Series|Withdrawal by Subject|10|||
148883459|NCT01200368|537051594|FG001|After Infant Series|Withdrawal by Subject|8|||
148883460|NCT01200368|537051595|FG002|After Infant Series|Withdrawal by Subject|4|||
149040365|NCT00457691|537626476|FG001|Overall Study|Protocol Violation|3|||
149040366|NCT00457691|537626475|FG000|Overall Study|Lost to Follow-up|23|||
149040367|NCT00457691|537626476|FG001|Overall Study|Lost to Follow-up|14|||
149040368|NCT00457691|537626475|FG000|Overall Study|Study terminated by Sponsor|1|||
149040369|NCT00457691|537626476|FG001|Overall Study|Study terminated by Sponsor|1|||
149040370|NCT00457691|537626475|FG000|Overall Study|Subject refused (reason other than AE)|14|||
149040371|NCT00457691|537626476|FG001|Overall Study|Subject refused (reason other than AE)|19|||
149040372|NCT00457691|537626475|FG000|Overall Study|Disease progression, study terminated|180|||
149040373|NCT00457691|537626476|FG001|Overall Study|Disease progression, study terminated|196|||
149040374|NCT03073941|537628246|FG000|Overall Study|Received non-study device intraoperatively|0|||
149040375|NCT03073941|537628247|FG001|Overall Study|Received non-study device intraoperatively|2|||
149040376|NCT03073941|537628246|FG000|Overall Study|Death|1|||
149040377|NCT03073941|537628247|FG001|Overall Study|Death|0|||
149040378|NCT03073941|537628246|FG000|Overall Study|Withdrawal by Subject|1|||
149040379|NCT03073941|537628247|FG001|Overall Study|Withdrawal by Subject|3|||
149040380|NCT03073941|537628246|FG000|Overall Study|Lost to Follow-up|5|||
149040381|NCT03073941|537628247|FG001|Overall Study|Lost to Follow-up|4|||
149040382|NCT03073941|537628246|FG000|Overall Study|Adverse Event|4|||
149040383|NCT03073941|537628247|FG001|Overall Study|Adverse Event|2|||
149040384|NCT03073941|537628246|FG000|Overall Study|Met an exclusion criterion|0|||
149040385|NCT03073941|537628247|FG001|Overall Study|Met an exclusion criterion|1|||
149040386|NCT00714714|537628250|FG000|Overall Study|Adverse Event|1|||
149040387|NCT01149369|537628251|FG000|Overall Study|Adverse Event|6|||
148883461|NCT01200368|537051593|FG000|After Infant Series|Lost to Follow-up|1|||
148883462|NCT01200368|537051594|FG001|After Infant Series|Lost to Follow-up|0|||
148883463|NCT01200368|537051595|FG002|After Infant Series|Lost to Follow-up|0|||
148883464|NCT01200368|537051593|FG000|After Infant Series|Other|1|||
148883465|NCT01200368|537051594|FG001|After Infant Series|Other|2|||
148883466|NCT01200368|537051595|FG002|After Infant Series|Other|2|||
148883467|NCT01200368|537051593|FG000|Toddler Dose|Adverse Event|0|||
148883468|NCT01200368|537051594|FG001|Toddler Dose|Adverse Event|3|||
148883469|NCT01200368|537051595|FG002|Toddler Dose|Adverse Event|1|||
148883470|NCT00479336|537051596|FG000|Overall Study|Adverse Event|1|||
148883471|NCT00479336|537051597|FG001|Overall Study|Adverse Event|1|||
148883472|NCT00479336|537051598|FG002|Overall Study|Adverse Event|1|||
148883473|NCT00479336|537051599|FG003|Overall Study|Adverse Event|3|||
148883474|NCT00479336|537051596|FG000|Overall Study|Lack of Efficacy|1|||
148883475|NCT00479336|537051597|FG001|Overall Study|Lack of Efficacy|0|||
148883476|NCT00479336|537051598|FG002|Overall Study|Lack of Efficacy|0|||
148883477|NCT00479336|537051599|FG003|Overall Study|Lack of Efficacy|0|||
148883478|NCT00479336|537051596|FG000|Overall Study|Protocol Violation|0|||
148883479|NCT00479336|537051597|FG001|Overall Study|Protocol Violation|1|||
148883480|NCT00479336|537051598|FG002|Overall Study|Protocol Violation|0|||
148883481|NCT00479336|537051599|FG003|Overall Study|Protocol Violation|0|||
148883482|NCT00479336|537051596|FG000|Overall Study|Withdrawal by Subject|1|||
148883483|NCT00479336|537051597|FG001|Overall Study|Withdrawal by Subject|2|||
148883484|NCT00479336|537051598|FG002|Overall Study|Withdrawal by Subject|0|||
148883485|NCT00479336|537051599|FG003|Overall Study|Withdrawal by Subject|0|||
148883486|NCT00479336|537051596|FG000|Overall Study|Physician Decision|0|||
148883487|NCT00479336|537051597|FG001|Overall Study|Physician Decision|1|||
148883488|NCT00479336|537051598|FG002|Overall Study|Physician Decision|0|||
148883489|NCT00479336|537051599|FG003|Overall Study|Physician Decision|2|||
148883490|NCT00479336|537051596|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
148883491|NCT00479336|537051597|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
148883492|NCT00479336|537051598|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
148883493|NCT00479336|537051599|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
148883494|NCT02741596|537051600|FG000|Overall Study|Adverse Event|1|||
148883495|NCT02741596|537051601|FG001|Overall Study|Adverse Event|5|||
148883496|NCT02741596|537051600|FG000|Overall Study|Lost to Follow-up|1|||
148883497|NCT02741596|537051601|FG001|Overall Study|Lost to Follow-up|1|||
148883498|NCT02741596|537051600|FG000|Overall Study|Physician Decision|2|||
148883499|NCT02741596|537051601|FG001|Overall Study|Physician Decision|1|||
148883500|NCT02741596|537051600|FG000|Overall Study|Pregnancy|3|||
148883501|NCT02741596|537051601|FG001|Overall Study|Pregnancy|1|||
148883502|NCT02741596|537051600|FG000|Overall Study|Other (Unspecified)|0|||
148883503|NCT02741596|537051601|FG001|Overall Study|Other (Unspecified)|3|||
148883504|NCT02741596|537051600|FG000|Overall Study|Subject withdrawn-Other|17|||
148883505|NCT02741596|537051601|FG001|Overall Study|Subject withdrawn-Other|4|||
148883506|NCT02741596|537051600|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
148883507|NCT02741596|537051601|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
148883508|NCT02631551|537051602|FG000|Overall Study|Adverse Event|1|||
148883509|NCT02631551|537051603|FG001|Overall Study|Adverse Event|2|||
148883510|NCT02631551|537051604|FG002|Overall Study|Adverse Event|4|||
148883511|NCT02631551|537051605|FG003|Overall Study|Adverse Event|0|||
148883512|NCT02631551|537051602|FG000|Overall Study|Lack of Efficacy|0|||
148883513|NCT02631551|537051603|FG001|Overall Study|Lack of Efficacy|0|||
148883514|NCT02631551|537051604|FG002|Overall Study|Lack of Efficacy|1|||
148883515|NCT02631551|537051605|FG003|Overall Study|Lack of Efficacy|0|||
148883516|NCT02631551|537051602|FG000|Overall Study|Lost to Follow-up|1|||
148883517|NCT02631551|537051603|FG001|Overall Study|Lost to Follow-up|2|||
148883518|NCT02631551|537051604|FG002|Overall Study|Lost to Follow-up|0|||
148883519|NCT02631551|537051605|FG003|Overall Study|Lost to Follow-up|3|||
148883520|NCT02631551|537051602|FG000|Overall Study|Withdrawal by Subject|2|||
148883521|NCT02631551|537051603|FG001|Overall Study|Withdrawal by Subject|2|||
148883522|NCT02631551|537051604|FG002|Overall Study|Withdrawal by Subject|0|||
148883523|NCT02631551|537051605|FG003|Overall Study|Withdrawal by Subject|5|||
148883524|NCT02631551|537051602|FG000|Overall Study|Protocol deviation|3|||
148883525|NCT02631551|537051603|FG001|Overall Study|Protocol deviation|6|||
148883526|NCT02631551|537051604|FG002|Overall Study|Protocol deviation|3|||
148883527|NCT02631551|537051605|FG003|Overall Study|Protocol deviation|0|||
148883528|NCT02631551|537051602|FG000|Overall Study|Non-compliance with study procedures|0|||
148883529|NCT02631551|537051603|FG001|Overall Study|Non-compliance with study procedures|0|||
148883530|NCT02631551|537051604|FG002|Overall Study|Non-compliance with study procedures|1|||
148883531|NCT02631551|537051605|FG003|Overall Study|Non-compliance with study procedures|1|||
148883532|NCT02631551|537051602|FG000|Overall Study|Non-compliance with study drug|1|||
148883533|NCT02631551|537051603|FG001|Overall Study|Non-compliance with study drug|0|||
148883534|NCT02631551|537051604|FG002|Overall Study|Non-compliance with study drug|0|||
148883535|NCT02631551|537051605|FG003|Overall Study|Non-compliance with study drug|0|||
148883536|NCT02631551|537051602|FG000|Overall Study|Other, specific reasons not collected|5|||
149004696|NCT02515279|537495088|FG000|Overall Study|End-of-treatment visit not attended|17|||
149004697|NCT02515279|537495088|FG000|Overall Study|Other|22|||
149004698|NCT01800968|537495089|FG000|Overall Study|Death|23|||
149004699|NCT01800968|537495090|FG001|Overall Study|Death|16|||
149004700|NCT01800968|537495089|FG000|Overall Study|Lost to Follow-up|5|||
149004701|NCT01800968|537495090|FG001|Overall Study|Lost to Follow-up|7|||
148883537|NCT02631551|537051603|FG001|Overall Study|Other, specific reasons not collected|7|||
148883538|NCT02631551|537051604|FG002|Overall Study|Other, specific reasons not collected|2|||
148883539|NCT02631551|537051605|FG003|Overall Study|Other, specific reasons not collected|2|||
148883540|NCT02859246|537051606|FG000|Overall Study|Screen fails|3|||
149004702|NCT01800968|537495089|FG000|Overall Study|Withdrawal by Subject|7|||
149040388|NCT01149369|537628252|FG001|Overall Study|Adverse Event|3|||
148883541|NCT02859246|537051606|FG000|Overall Study|Adverse Event|1|||
148883542|NCT02859246|537051606|FG000|Overall Study|Withdrawal by Subject|1|||
148883543|NCT01196026|537051607|FG000|Overall Study|Withdrawal by Subject|1|||
148883544|NCT01196026|537051608|FG001|Overall Study|Withdrawal by Subject|4|||
148883545|NCT01196026|537051609|FG002|Overall Study|Withdrawal by Subject|0|||
148883546|NCT01196026|537051610|FG003|Overall Study|Withdrawal by Subject|0|||
148883547|NCT01196026|537051611|FG004|Overall Study|Withdrawal by Subject|0|||
148883548|NCT01196026|537051612|FG005|Overall Study|Withdrawal by Subject|0|||
148883549|NCT01196026|537051607|FG000|Overall Study|Lost to Follow-up|0|||
148883550|NCT01196026|537051608|FG001|Overall Study|Lost to Follow-up|3|||
148883551|NCT01196026|537051609|FG002|Overall Study|Lost to Follow-up|0|||
148883552|NCT01196026|537051610|FG003|Overall Study|Lost to Follow-up|0|||
148883553|NCT01196026|537051611|FG004|Overall Study|Lost to Follow-up|1|||
148883554|NCT01196026|537051612|FG005|Overall Study|Lost to Follow-up|0|||
148883555|NCT01196026|537051607|FG000|Overall Study|Other|0|||
148883556|NCT01196026|537051608|FG001|Overall Study|Other|1|||
148883557|NCT01196026|537051609|FG002|Overall Study|Other|0|||
148883558|NCT01196026|537051610|FG003|Overall Study|Other|0|||
148883559|NCT01196026|537051611|FG004|Overall Study|Other|0|||
148883560|NCT01196026|537051612|FG005|Overall Study|Other|0|||
148883561|NCT04034004|537051613|FG000|Overall Study|Withdrawal by Subject|1|||
148883562|NCT04034004|537051614|FG001|Overall Study|Withdrawal by Subject|2|||
148883563|NCT04034004|537051615|FG002|Overall Study|Withdrawal by Subject|2|||
148883564|NCT04034004|537051616|FG003|Overall Study|Withdrawal by Subject|3|||
148883565|NCT04034004|537051613|FG000|Overall Study|could not find vein to administer IV|2|||
148883566|NCT04034004|537051614|FG001|Overall Study|could not find vein to administer IV|1|||
148883567|NCT04034004|537051615|FG002|Overall Study|could not find vein to administer IV|0|||
148883568|NCT04034004|537051616|FG003|Overall Study|could not find vein to administer IV|0|||
148883569|NCT04034004|537051613|FG000|Overall Study|nurse accidentally unblinded subject|0|||
148883570|NCT04034004|537051614|FG001|Overall Study|nurse accidentally unblinded subject|0|||
148883571|NCT04034004|537051615|FG002|Overall Study|nurse accidentally unblinded subject|0|||
148883572|NCT04034004|537051616|FG003|Overall Study|nurse accidentally unblinded subject|1|||
148883573|NCT04317040|537051618|FG000|Overall Study|Lost to Follow-up|2|||
148883574|NCT04317040|537051619|FG001|Overall Study|Lost to Follow-up|0|||
148883575|NCT04317040|537051618|FG000|Overall Study|Death|16|||
148883576|NCT04317040|537051619|FG001|Overall Study|Death|18|||
148883577|NCT04317040|537051618|FG000|Overall Study|Withdrawal by Subject|0|||
148883578|NCT04317040|537051619|FG001|Overall Study|Withdrawal by Subject|1|||
148883579|NCT04317040|537051618|FG000|Overall Study|Incomplete assessments|0|||
148883580|NCT04317040|537051619|FG001|Overall Study|Incomplete assessments|1|||
148883581|NCT03672292|537051620|FG000|Overall Study|Adverse Event|3|||
148883582|NCT03672292|537051621|FG001|Overall Study|Adverse Event|1|||
148883583|NCT03672292|537051620|FG000|Overall Study|Physician Decision|0|||
148883584|NCT03672292|537051621|FG001|Overall Study|Physician Decision|1|||
148883585|NCT03672292|537051620|FG000|Overall Study|Withdrawal by Subject|1|||
148883586|NCT03672292|537051621|FG001|Overall Study|Withdrawal by Subject|2|||
148883587|NCT00799903|537051622|FG000|Overall Study|Investigator Site Closed|25|||
148883588|NCT00799903|537051623|FG001|Overall Study|Investigator Site Closed|23|||
148883589|NCT00799903|537051622|FG000|Overall Study|Withdrawal by Subject|179|||
148883590|NCT00799903|537051623|FG001|Overall Study|Withdrawal by Subject|175|||
148883591|NCT00799903|537051622|FG000|Overall Study|Lost to Follow-up|69|||
148883592|NCT00799903|537051623|FG001|Overall Study|Lost to Follow-up|80|||
148883593|NCT02518971|537051624|FG000|Overall Study|Lost to Follow-up|0|||
148883594|NCT02518971|537051625|FG001|Overall Study|Lost to Follow-up|1|||
148883595|NCT02518971|537051624|FG000|Overall Study|Physician Decision|6|||
148883596|NCT02518971|537051625|FG001|Overall Study|Physician Decision|6|||
148883597|NCT02518971|537051624|FG000|Overall Study|Protocol Violation|6|||
148883598|NCT02518971|537051625|FG001|Overall Study|Protocol Violation|4|||
148883599|NCT02518971|537051624|FG000|Overall Study|Withdrawal by Subject|4|||
148883600|NCT02518971|537051625|FG001|Overall Study|Withdrawal by Subject|5|||
148883601|NCT02518971|537051624|FG000|Overall Study|Side effects|1|||
148883602|NCT02518971|537051625|FG001|Overall Study|Side effects|0|||
148883603|NCT02518971|537051624|FG000|Overall Study|medication lost in mail|0|||
148883604|NCT02518971|537051625|FG001|Overall Study|medication lost in mail|1|||
148883605|NCT02518971|537051624|FG000|Overall Study|eligibility criteria no longer met|6|||
148883606|NCT02518971|537051625|FG001|Overall Study|eligibility criteria no longer met|3|||
148883607|NCT03088917|537051626|FG000|Overall Study|In care/cured elsewhere|15|||
148883608|NCT03088917|537051626|FG000|Overall Study|Refuse re-evaluation|13|||
148883609|NCT03088917|537051626|FG000|Overall Study|Contact not established|13|||
148883610|NCT03088917|537051626|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
148883611|NCT03088917|537051626|FG000|Overall Study|Moved outside study region|50|||
148883612|NCT00757237|537051627|FG000|Overall Study|Lost to Follow-up|0|||
148883613|NCT00757237|537051628|FG001|Overall Study|Lost to Follow-up|1|||
148883614|NCT00757237|537051627|FG000|Overall Study|Protocol Violation|0|||
148883615|NCT00757237|537051628|FG001|Overall Study|Protocol Violation|2|||
148883616|NCT00757237|537051627|FG000|Overall Study|Physician Decision|2|||
148883617|NCT00757237|537051628|FG001|Overall Study|Physician Decision|3|||
148883618|NCT00757237|537051627|FG000|Overall Study|Withdrawal by Subject|8|||
148883619|NCT00757237|537051628|FG001|Overall Study|Withdrawal by Subject|12|||
148883620|NCT00757237|537051627|FG000|Overall Study|Safety or Tolerability|3|||
148883621|NCT00757237|537051628|FG001|Overall Study|Safety or Tolerability|5|||
148883622|NCT00757237|537051627|FG000|Overall Study|Other|0|||
148883623|NCT00757237|537051628|FG001|Overall Study|Other|2|||
148883624|NCT05150990|537051629|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
148883625|NCT05150990|537051630|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
148883626|NCT05150990|537051629|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
148883627|NCT05150990|537051630|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
148883628|NCT05150990|537051629|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
148883629|NCT05150990|537051630|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
148883630|NCT05150990|537051629|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
148883631|NCT05150990|537051630|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
148883632|NCT05150990|537051629|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
148883633|NCT05150990|537051630|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
148883634|NCT05150990|537051629|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
148883635|NCT05150990|537051630|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
148883636|NCT05150990|537051629|FG000|Overall Study|Death (unrelated to the intervention)|1|||
148883637|NCT05150990|537051630|FG001|Overall Study|Death (unrelated to the intervention)|2|||
148883638|NCT05729568|537051631|FG000|Overall Study|Still on Study|52|||
148883639|NCT05729568|537051632|FG001|Overall Study|Still on Study|26|||
148883640|NCT05729568|537051631|FG000|Overall Study|Randomized but Never Treated|3|||
148883641|NCT05729568|537051632|FG001|Overall Study|Randomized but Never Treated|0|||
148883642|NCT05729568|537051631|FG000|Overall Study|Adverse Event|0|||
148883643|NCT05729568|537051632|FG001|Overall Study|Adverse Event|1|||
148883644|NCT05729568|537051631|FG000|Overall Study|Investigator's Discretion|1|||
148883645|NCT05729568|537051632|FG001|Overall Study|Investigator's Discretion|0|||
148883646|NCT01221350|537051635|FG000|Overall Study|Discontinued intervention (GERD)|1|||
148883647|NCT01221350|537051636|FG001|Overall Study|Discontinued intervention (GERD)|0|||
148883648|NCT01221350|537051635|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
148883649|NCT01221350|537051636|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
148883650|NCT01221350|537051635|FG000|Overall Study|Withdrawal by Subject|4|||
148883651|NCT01221350|537051636|FG001|Overall Study|Withdrawal by Subject|2|||
148883652|NCT04137731|537051637|FG000|Overall Study|Surgery Cancellation|1|||
148883653|NCT04137731|537051638|FG001|Overall Study|Surgery Cancellation|2|||
148883654|NCT04137731|537051637|FG000|Overall Study|Withdrawal by Subject|2|||
148883655|NCT04137731|537051638|FG001|Overall Study|Withdrawal by Subject|0|||
148883656|NCT04137731|537051637|FG000|Overall Study|Protocol Violation|0|||
148883657|NCT04137731|537051638|FG001|Overall Study|Protocol Violation|1|||
148883658|NCT02715609|537051646|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
148883659|NCT02715609|537051647|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
148883660|NCT02715609|537051648|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
148883661|NCT02715609|537051646|FG000|Overall Study|Withdrawal by Subject|0|||
148883662|NCT02715609|537051647|FG001|Overall Study|Withdrawal by Subject|0|||
148883663|NCT02715609|537051648|FG002|Overall Study|Withdrawal by Subject|1|||
148883664|NCT00362648|537051649|FG000|Overall Study|Adverse Event|12|||
148883665|NCT00362648|537051650|FG001|Overall Study|Adverse Event|21|||
148883666|NCT00362648|537051651|FG002|Overall Study|Adverse Event|1|||
148883667|NCT00362648|537051652|FG003|Overall Study|Adverse Event|0|||
148883668|NCT00362648|537051649|FG000|Overall Study|Lost to Follow-up|62|||
148883669|NCT00362648|537051650|FG001|Overall Study|Lost to Follow-up|69|||
148883670|NCT00362648|537051651|FG002|Overall Study|Lost to Follow-up|4|||
149040389|NCT01185561|537628253|FG000|Overall Study|Lost to Follow-up|0|||
149040390|NCT01185561|537628254|FG001|Overall Study|Lost to Follow-up|4|||
149040391|NCT01185561|537628253|FG000|Overall Study|Withdrawal by Subject|2|||
149040392|NCT01185561|537628254|FG001|Overall Study|Withdrawal by Subject|8|||
149040393|NCT02616900|537628255|FG000|Overall Study|Lack of Efficacy|7|||
149040394|NCT02616900|537628255|FG000|Overall Study|Lost to Follow-up|2|||
149040395|NCT02616900|537628255|FG000|Overall Study|Protocol Violation|5|||
149040396|NCT02616900|537628255|FG000|Overall Study|Withdrawal by Subject|3|||
149040397|NCT02616900|537628255|FG000|Overall Study|Incomplete data|6|||
148883671|NCT00362648|537051652|FG003|Overall Study|Lost to Follow-up|3|||
149040398|NCT02242487|537628256|FG000|Overall Study|Adverse Event|13|||
149040399|NCT02242487|537628257|FG001|Overall Study|Adverse Event|15|||
149040400|NCT02242487|537628256|FG000|Overall Study|Lack of Efficacy|4|||
149040401|NCT02242487|537628257|FG001|Overall Study|Lack of Efficacy|6|||
149040402|NCT02242487|537628256|FG000|Overall Study|Protocol Violation|2|||
149040403|NCT02242487|537628257|FG001|Overall Study|Protocol Violation|0|||
149040404|NCT02242487|537628256|FG000|Overall Study|Lost to Follow-up|2|||
149040405|NCT02242487|537628257|FG001|Overall Study|Lost to Follow-up|1|||
149040406|NCT02242487|537628256|FG000|Overall Study|Other - Miscellaneous|4|||
149040407|NCT02242487|537628257|FG001|Overall Study|Other - Miscellaneous|6|||
149040408|NCT02242487|537628256|FG000|Overall Study|Withdrawal by Subject|37|||
149040409|NCT02242487|537628257|FG001|Overall Study|Withdrawal by Subject|19|||
149040410|NCT03644849|537628258|FG000|Overall Study|Lost to Follow-up|1|||
149040411|NCT03644849|537628259|FG001|Overall Study|Lost to Follow-up|3|||
149040412|NCT00508924|537628260|FG000|Overall Study|Protocol Violation|0|||
149040413|NCT00508924|537628261|FG001|Overall Study|Protocol Violation|0|||
149040414|NCT00508924|537628262|FG002|Overall Study|Protocol Violation|1|||
149040415|NCT00508924|537628263|FG003|Overall Study|Protocol Violation|1|||
149040416|NCT02755805|537628264|FG000|Overall Study|Lost to Follow-up|1|||
149040417|NCT02755805|537628265|FG001|Overall Study|Lost to Follow-up|2|||
149040418|NCT02755805|537628264|FG000|Overall Study|Refused assessments|1|||
149040419|NCT02755805|537628265|FG001|Overall Study|Refused assessments|0|||
149040420|NCT02755805|537628264|FG000|Overall Study|Withdrawal by Subject|0|||
149040421|NCT02755805|537628265|FG001|Overall Study|Withdrawal by Subject|2|||
149040422|NCT02593149|537628268|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
149040423|NCT02593149|537628269|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
149040424|NCT02593149|537628268|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
149040425|NCT02593149|537628269|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
149040426|NCT00979992|537628270|FG000|Overall Study|Ineligible - inadequate pathology|1|||
149040427|NCT00979992|537628270|FG000|Overall Study|Ineligible - wrong cell type|2|||
149040428|NCT00979992|537628270|FG000|Overall Study|Refused - Never Treated|2|||
149040429|NCT01636687|537628271|FG000|Induction Period|Withdrawal by Subject|1|||
149040430|NCT01636687|537628272|FG001|Induction Period|Withdrawal by Subject|0|||
149040431|NCT01636687|537628273|FG002|Induction Period|Withdrawal by Subject|0|||
149040432|NCT01636687|537628274|FG003|Induction Period|Withdrawal by Subject|0|||
149040433|NCT01636687|537628275|FG004|Induction Period|Withdrawal by Subject|0|||
149040434|NCT01636687|537628271|FG000|Induction Period|Adverse Event|1|||
149040435|NCT01636687|537628272|FG001|Induction Period|Adverse Event|0|||
149040436|NCT01636687|537628273|FG002|Induction Period|Adverse Event|0|||
149040437|NCT01636687|537628274|FG003|Induction Period|Adverse Event|0|||
149040438|NCT01636687|537628275|FG004|Induction Period|Adverse Event|1|||
149040439|NCT01636687|537628271|FG000|Induction Period|Lack of Efficacy|0|||
149040440|NCT01636687|537628272|FG001|Induction Period|Lack of Efficacy|0|||
149040441|NCT01636687|537628273|FG002|Induction Period|Lack of Efficacy|0|||
149040442|NCT01636687|537628274|FG003|Induction Period|Lack of Efficacy|0|||
148883672|NCT00362648|537051649|FG000|Overall Study|Protocol Violation|4|||
148883673|NCT00362648|537051650|FG001|Overall Study|Protocol Violation|2|||
148883674|NCT00362648|537051651|FG002|Overall Study|Protocol Violation|2|||
148883675|NCT00362648|537051652|FG003|Overall Study|Protocol Violation|2|||
148883676|NCT00362648|537051649|FG000|Overall Study|Withdrawal by Subject|48|||
148883677|NCT00362648|537051650|FG001|Overall Study|Withdrawal by Subject|42|||
148883678|NCT00362648|537051651|FG002|Overall Study|Withdrawal by Subject|2|||
148883679|NCT00362648|537051652|FG003|Overall Study|Withdrawal by Subject|6|||
148883680|NCT02204072|537051653|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
148883681|NCT02204072|537051654|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
148883682|NCT02204072|537051655|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
148883683|NCT02204072|537051656|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
148883684|NCT02204072|537051657|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
148883685|NCT02204072|537051653|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
148883686|NCT02204072|537051654|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
148883687|NCT02204072|537051655|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
149040443|NCT01636687|537628275|FG004|Induction Period|Lack of Efficacy|1|||
149040444|NCT01636687|537628271|FG000|Induction Period|Physician Decision|1|||
149040445|NCT01636687|537628272|FG001|Induction Period|Physician Decision|0|||
148883688|NCT02204072|537051656|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
149040446|NCT01636687|537628273|FG002|Induction Period|Physician Decision|0|||
149040447|NCT01636687|537628274|FG003|Induction Period|Physician Decision|0|||
149040448|NCT01636687|537628275|FG004|Induction Period|Physician Decision|0|||
149040449|NCT01636687|537628271|FG000|Maintenance Period|Withdrawal by Subject|2|||
148883689|NCT02204072|537051657|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
149040450|NCT01636687|537628272|FG001|Maintenance Period|Withdrawal by Subject|0|||
148883690|NCT02204072|537051653|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
149040451|NCT01636687|537628273|FG002|Maintenance Period|Withdrawal by Subject|2|||
149040452|NCT01636687|537628274|FG003|Maintenance Period|Withdrawal by Subject|0|||
149040453|NCT01636687|537628275|FG004|Maintenance Period|Withdrawal by Subject|0|||
149040454|NCT01636687|537628271|FG000|Maintenance Period|Adverse Event|1|||
149040455|NCT01636687|537628272|FG001|Maintenance Period|Adverse Event|0|||
149040456|NCT01636687|537628273|FG002|Maintenance Period|Adverse Event|0|||
149040457|NCT01636687|537628274|FG003|Maintenance Period|Adverse Event|0|||
148883691|NCT02204072|537051654|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
149040458|NCT01636687|537628275|FG004|Maintenance Period|Adverse Event|0|||
149040459|NCT01636687|537628271|FG000|Maintenance Period|Lack of Efficacy|4|||
149040460|NCT01636687|537628272|FG001|Maintenance Period|Lack of Efficacy|1|||
149040461|NCT01636687|537628273|FG002|Maintenance Period|Lack of Efficacy|0|||
149040462|NCT01636687|537628274|FG003|Maintenance Period|Lack of Efficacy|0|||
149040463|NCT01636687|537628275|FG004|Maintenance Period|Lack of Efficacy|0|||
149040464|NCT01636687|537628271|FG000|Maintenance Period|Lost to Follow-up|1|||
149040465|NCT01636687|537628272|FG001|Maintenance Period|Lost to Follow-up|1|||
149040466|NCT01636687|537628273|FG002|Maintenance Period|Lost to Follow-up|0|||
149040467|NCT01636687|537628274|FG003|Maintenance Period|Lost to Follow-up|0|||
149040468|NCT01636687|537628275|FG004|Maintenance Period|Lost to Follow-up|1|||
149040469|NCT01636687|537628271|FG000|Maintenance Period|Physician Decision|0|||
149040470|NCT01636687|537628272|FG001|Maintenance Period|Physician Decision|0|||
149040471|NCT01636687|537628273|FG002|Maintenance Period|Physician Decision|0|||
149040472|NCT01636687|537628274|FG003|Maintenance Period|Physician Decision|0|||
149040473|NCT01636687|537628275|FG004|Maintenance Period|Physician Decision|1|||
149040474|NCT01636687|537628271|FG000|Extension Period|technical problems|0|||
149040475|NCT01636687|537628272|FG001|Extension Period|technical problems|1|||
149040476|NCT01636687|537628273|FG002|Extension Period|technical problems|2|||
149040477|NCT01636687|537628274|FG003|Extension Period|technical problems|1|||
149040478|NCT01636687|537628275|FG004|Extension Period|technical problems|0|||
149040479|NCT01636687|537628271|FG000|Extension Period|Adverse Event|4|||
149040480|NCT01636687|537628272|FG001|Extension Period|Adverse Event|3|||
149040481|NCT01636687|537628273|FG002|Extension Period|Adverse Event|2|||
149040482|NCT01636687|537628274|FG003|Extension Period|Adverse Event|1|||
149040483|NCT01636687|537628275|FG004|Extension Period|Adverse Event|0|||
149040484|NCT01636687|537628271|FG000|Extension Period|Lack of Efficacy|7|||
149040485|NCT01636687|537628272|FG001|Extension Period|Lack of Efficacy|0|||
149040486|NCT01636687|537628273|FG002|Extension Period|Lack of Efficacy|2|||
149040487|NCT01636687|537628274|FG003|Extension Period|Lack of Efficacy|1|||
149040488|NCT01636687|537628275|FG004|Extension Period|Lack of Efficacy|0|||
149040489|NCT01636687|537628271|FG000|Extension Period|Lost to Follow-up|1|||
149040490|NCT01636687|537628272|FG001|Extension Period|Lost to Follow-up|0|||
149040491|NCT01636687|537628273|FG002|Extension Period|Lost to Follow-up|1|||
149040492|NCT01636687|537628274|FG003|Extension Period|Lost to Follow-up|0|||
149040493|NCT01636687|537628275|FG004|Extension Period|Lost to Follow-up|0|||
149040494|NCT01636687|537628271|FG000|Extension Period|Physician Decision|1|||
149040495|NCT01636687|537628272|FG001|Extension Period|Physician Decision|0|||
149040496|NCT01636687|537628273|FG002|Extension Period|Physician Decision|0|||
149040497|NCT01636687|537628274|FG003|Extension Period|Physician Decision|1|||
149040498|NCT01636687|537628275|FG004|Extension Period|Physician Decision|0|||
149040499|NCT01636687|537628271|FG000|Extension Period|study terminated by sponsor|33|||
149040500|NCT01636687|537628272|FG001|Extension Period|study terminated by sponsor|50|||
149040501|NCT01636687|537628273|FG002|Extension Period|study terminated by sponsor|17|||
149040502|NCT01636687|537628274|FG003|Extension Period|study terminated by sponsor|23|||
149040503|NCT01636687|537628275|FG004|Extension Period|study terminated by sponsor|0|||
149040504|NCT01636687|537628271|FG000|Extension Period|Withdrawal by Subject|1|||
149040505|NCT01636687|537628272|FG001|Extension Period|Withdrawal by Subject|0|||
149040506|NCT01636687|537628273|FG002|Extension Period|Withdrawal by Subject|1|||
149040507|NCT01636687|537628274|FG003|Extension Period|Withdrawal by Subject|1|||
149040508|NCT01636687|537628275|FG004|Extension Period|Withdrawal by Subject|0|||
149040509|NCT01636687|537628271|FG000|Follow-up Period|Withdrawal by Subject|1|||
149040510|NCT01636687|537628272|FG001|Follow-up Period|Withdrawal by Subject|0|||
149040511|NCT01636687|537628273|FG002|Follow-up Period|Withdrawal by Subject|0|||
149040512|NCT01636687|537628274|FG003|Follow-up Period|Withdrawal by Subject|0|||
149040513|NCT01636687|537628275|FG004|Follow-up Period|Withdrawal by Subject|1|||
149040514|NCT00980330|537628280|FG000|Overall Study|Adverse Event|0|||
149040515|NCT00980330|537628281|FG001|Overall Study|Adverse Event|0|||
149040516|NCT00980330|537628282|FG002|Overall Study|Adverse Event|0|||
149040517|NCT00980330|537628283|FG003|Overall Study|Adverse Event|1|||
149040518|NCT00980330|537628284|FG004|Overall Study|Adverse Event|0|||
149040519|NCT00980330|537628285|FG005|Overall Study|Adverse Event|0|||
149040520|NCT00980330|537628286|FG006|Overall Study|Adverse Event|0|||
149040521|NCT00980330|537628280|FG000|Overall Study|Lost to Follow-up|1|||
149040522|NCT00980330|537628281|FG001|Overall Study|Lost to Follow-up|1|||
149040523|NCT00980330|537628282|FG002|Overall Study|Lost to Follow-up|4|||
149040524|NCT00980330|537628283|FG003|Overall Study|Lost to Follow-up|2|||
149040525|NCT00980330|537628284|FG004|Overall Study|Lost to Follow-up|1|||
149040526|NCT00980330|537628285|FG005|Overall Study|Lost to Follow-up|1|||
149040527|NCT00980330|537628286|FG006|Overall Study|Lost to Follow-up|2|||
149040528|NCT00980330|537628280|FG000|Overall Study|Withdrawal by Subject|2|||
149040529|NCT00980330|537628281|FG001|Overall Study|Withdrawal by Subject|4|||
149040530|NCT00980330|537628282|FG002|Overall Study|Withdrawal by Subject|4|||
149040531|NCT00980330|537628283|FG003|Overall Study|Withdrawal by Subject|1|||
149040532|NCT00980330|537628284|FG004|Overall Study|Withdrawal by Subject|3|||
149040533|NCT00980330|537628285|FG005|Overall Study|Withdrawal by Subject|2|||
149040534|NCT00980330|537628286|FG006|Overall Study|Withdrawal by Subject|5|||
149040535|NCT00980330|537628280|FG000|Overall Study|(not specified)|2|||
149040536|NCT00980330|537628281|FG001|Overall Study|(not specified)|0|||
149040537|NCT00980330|537628282|FG002|Overall Study|(not specified)|0|||
149040538|NCT00980330|537628283|FG003|Overall Study|(not specified)|1|||
149040539|NCT00980330|537628284|FG004|Overall Study|(not specified)|1|||
149040540|NCT00980330|537628285|FG005|Overall Study|(not specified)|1|||
149040541|NCT00980330|537628286|FG006|Overall Study|(not specified)|0|||
149040542|NCT01039688|537628287|FG000|Overall Study|Adverse Event|38|||
149040543|NCT01039688|537628288|FG001|Overall Study|Adverse Event|39|||
149040544|NCT01039688|537628289|FG002|Overall Study|Adverse Event|24|||
149040545|NCT01039688|537628287|FG000|Overall Study|Lack of Efficacy|20|||
149040546|NCT01039688|537628288|FG001|Overall Study|Lack of Efficacy|11|||
149040547|NCT01039688|537628289|FG002|Overall Study|Lack of Efficacy|26|||
149040548|NCT01039688|537628287|FG000|Overall Study|Lost to Follow-up|11|||
149040549|NCT01039688|537628288|FG001|Overall Study|Lost to Follow-up|9|||
149040550|NCT01039688|537628289|FG002|Overall Study|Lost to Follow-up|5|||
149040551|NCT01039688|537628287|FG000|Overall Study|Other|13|||
149040552|NCT01039688|537628288|FG001|Overall Study|Other|25|||
149040553|NCT01039688|537628289|FG002|Overall Study|Other|12|||
149040554|NCT01039688|537628287|FG000|Overall Study|Withdrawal by Subject|23|||
149040555|NCT01039688|537628288|FG001|Overall Study|Withdrawal by Subject|27|||
149040556|NCT01039688|537628289|FG002|Overall Study|Withdrawal by Subject|13|||
149040557|NCT01039688|537628287|FG000|Overall Study|Death|2|||
149040558|NCT01039688|537628288|FG001|Overall Study|Death|0|||
149040559|NCT01039688|537628289|FG002|Overall Study|Death|0|||
149040560|NCT03520413|537628293|FG000|Overall Study|Lost to Follow-up|1|||
149040561|NCT03520413|537628294|FG001|Overall Study|Lost to Follow-up|1|||
149040562|NCT03520413|537628293|FG000|Overall Study|Withdrawal by Subject|1|||
149040563|NCT03520413|537628294|FG001|Overall Study|Withdrawal by Subject|2|||
149040564|NCT03520413|537628293|FG000|Overall Study|Death|0|||
149040565|NCT03520413|537628294|FG001|Overall Study|Death|1|||
148883692|NCT02204072|537051655|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
148883693|NCT02204072|537051656|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
149040566|NCT03520413|537628293|FG000|Overall Study|Physician Decision|3|||
149040567|NCT03520413|537628294|FG001|Overall Study|Physician Decision|3|||
149040568|NCT03520413|537628293|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
149040569|NCT03520413|537628294|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
149040570|NCT00346151|537628295|FG000|Overall Study|Withdrawal by Subject|3|||
149040571|NCT04054635|537628298|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
149040572|NCT04054635|537628299|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
149040573|NCT04054635|537628300|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
149040574|NCT04054635|537628298|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
149040575|NCT04054635|537628299|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
148883694|NCT02204072|537051657|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
148883695|NCT02204072|537051653|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
148883696|NCT02204072|537051654|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
148883697|NCT02204072|537051655|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
148883698|NCT02204072|537051656|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
148883699|NCT02204072|537051657|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
148883700|NCT00310817|537051658|FG000|Overall Study|AE or Death|3|||
148883701|NCT00310817|537051659|FG001|Overall Study|AE or Death|1|||
148883702|NCT00310817|537051660|FG002|Overall Study|AE or Death|0|||
148883703|NCT00310817|537051661|FG003|Overall Study|AE or Death|0|||
148883704|NCT00310817|537051658|FG000|Overall Study|Withdrawal by Subject|1|||
148883705|NCT00310817|537051659|FG001|Overall Study|Withdrawal by Subject|4|||
148883706|NCT00310817|537051660|FG002|Overall Study|Withdrawal by Subject|6|||
148883707|NCT00310817|537051661|FG003|Overall Study|Withdrawal by Subject|7|||
148883708|NCT00310817|537051658|FG000|Overall Study|Lost to Follow-up|2|||
148883709|NCT00310817|537051659|FG001|Overall Study|Lost to Follow-up|1|||
148883710|NCT00310817|537051660|FG002|Overall Study|Lost to Follow-up|0|||
148883711|NCT00310817|537051661|FG003|Overall Study|Lost to Follow-up|0|||
148883712|NCT00310817|537051658|FG000|Overall Study|Inappropriate Enrollment|1|||
148883713|NCT00310817|537051659|FG001|Overall Study|Inappropriate Enrollment|0|||
148883714|NCT00310817|537051660|FG002|Overall Study|Inappropriate Enrollment|1|||
149040576|NCT04054635|537628300|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
148883715|NCT00310817|537051661|FG003|Overall Study|Inappropriate Enrollment|0|||
149040577|NCT03737240|537628301|FG000|Overall Study|Lost to Follow-up|16|||
149040578|NCT03737240|537628302|FG001|Overall Study|Lost to Follow-up|15|||
149040579|NCT02202499|537628308|FG000|Overall Study|Cancer diagnosis|0|||
149040580|NCT02202499|537628309|FG001|Overall Study|Cancer diagnosis|0|||
149040581|NCT02202499|537628310|FG002|Overall Study|Cancer diagnosis|1|||
149040582|NCT02202499|537628308|FG000|Overall Study|Moved from area|0|||
149040583|NCT02202499|537628309|FG001|Overall Study|Moved from area|0|||
149040584|NCT02202499|537628310|FG002|Overall Study|Moved from area|1|||
149040585|NCT02202499|537628308|FG000|Overall Study|Declined before randomization|1|||
148883716|NCT00310817|537051658|FG000|Overall Study|Protocol Violation|1|||
148883717|NCT00310817|537051659|FG001|Overall Study|Protocol Violation|1|||
149040586|NCT02202499|537628309|FG001|Overall Study|Declined before randomization|0|||
148883718|NCT00310817|537051660|FG002|Overall Study|Protocol Violation|1|||
148883719|NCT00310817|537051661|FG003|Overall Study|Protocol Violation|1|||
148883720|NCT00310817|537051658|FG000|Overall Study|Unable to classify|3|||
148883721|NCT00310817|537051659|FG001|Overall Study|Unable to classify|1|||
148883722|NCT00310817|537051660|FG002|Overall Study|Unable to classify|0|||
148883723|NCT00310817|537051661|FG003|Overall Study|Unable to classify|0|||
148883724|NCT02451124|537051669|FG000|Overall Study|Withdrawal by Subject|1|||
148883725|NCT03301350|537051670|FG000|Overall Study|Withdrawal by Subject|4|||
148883726|NCT03301350|537051670|FG000|Overall Study|Adverse Event|1|||
148883727|NCT03301350|537051670|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
148883728|NCT03301350|537051670|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
148883729|NCT03301350|537051670|FG000|Overall Study|no detail provided|1|||
148883730|NCT01248949|537051671|FG000|Overall Study|Lost to Follow-up|2|||
148883731|NCT01248949|537051672|FG001|Overall Study|Lost to Follow-up|2|||
148883732|NCT01248949|537051673|FG002|Overall Study|Lost to Follow-up|2|||
148883733|NCT01248949|537051674|FG003|Overall Study|Lost to Follow-up|1|||
148883734|NCT01248949|537051675|FG004|Overall Study|Lost to Follow-up|0|||
148883735|NCT01248949|537051671|FG000|Overall Study|Withdrawal by Subject|5|||
148883736|NCT01248949|537051672|FG001|Overall Study|Withdrawal by Subject|3|||
148883737|NCT01248949|537051673|FG002|Overall Study|Withdrawal by Subject|11|||
148883738|NCT01248949|537051674|FG003|Overall Study|Withdrawal by Subject|3|||
148883739|NCT01248949|537051675|FG004|Overall Study|Withdrawal by Subject|1|||
148883740|NCT01248949|537051671|FG000|Overall Study|Death|22|||
148883741|NCT01248949|537051672|FG001|Overall Study|Death|7|||
148883742|NCT01248949|537051673|FG002|Overall Study|Death|21|||
148883743|NCT01248949|537051674|FG003|Overall Study|Death|6|||
148883744|NCT01248949|537051675|FG004|Overall Study|Death|2|||
148883745|NCT01248949|537051671|FG000|Overall Study|Alternative Therapy|1|||
148883746|NCT01248949|537051672|FG001|Overall Study|Alternative Therapy|0|||
148883747|NCT01248949|537051673|FG002|Overall Study|Alternative Therapy|0|||
148883748|NCT01248949|537051674|FG003|Overall Study|Alternative Therapy|0|||
148883749|NCT01248949|537051675|FG004|Overall Study|Alternative Therapy|0|||
148883750|NCT01248949|537051671|FG000|Overall Study|Alternative Therapy.|1|||
148883751|NCT01248949|537051672|FG001|Overall Study|Alternative Therapy.|0|||
148883752|NCT01248949|537051673|FG002|Overall Study|Alternative Therapy.|0|||
148883753|NCT01248949|537051674|FG003|Overall Study|Alternative Therapy.|0|||
148883754|NCT01248949|537051675|FG004|Overall Study|Alternative Therapy.|0|||
148883755|NCT01248949|537051671|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
148883756|NCT01248949|537051672|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
148883757|NCT01248949|537051673|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
148883758|NCT01248949|537051674|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
148883759|NCT01248949|537051675|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
148883760|NCT01248949|537051671|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
148883761|NCT01248949|537051672|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
148883762|NCT01248949|537051673|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
148883763|NCT01248949|537051674|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
148883764|NCT01248949|537051675|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
148883765|NCT01248949|537051671|FG000|Overall Study|Participant Went To Hospice|0|||
148883766|NCT01248949|537051672|FG001|Overall Study|Participant Went To Hospice|0|||
148883767|NCT01248949|537051673|FG002|Overall Study|Participant Went To Hospice|1|||
148883768|NCT01248949|537051674|FG003|Overall Study|Participant Went To Hospice|0|||
148883769|NCT01248949|537051675|FG004|Overall Study|Participant Went To Hospice|0|||
148883770|NCT01248949|537051671|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
148883771|NCT01248949|537051672|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
148883772|NCT01248949|537051673|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
148883773|NCT01248949|537051674|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
148883774|NCT01248949|537051675|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
148883775|NCT01248949|537051671|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
148883776|NCT01248949|537051672|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
148883777|NCT01248949|537051673|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
148883778|NCT01248949|537051674|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
148883779|NCT01248949|537051675|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
148883780|NCT01248949|537051671|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
148883781|NCT01248949|537051672|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
148883782|NCT01248949|537051673|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
148883783|NCT01248949|537051674|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
148883784|NCT01248949|537051675|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
148883785|NCT01248949|537051671|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
148883786|NCT01248949|537051672|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
148883787|NCT01248949|537051673|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
148883788|NCT01248949|537051674|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
148883789|NCT01248949|537051675|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
148883790|NCT00286429|537051676|FG000|Overall Study|Adverse Event|4|||
148883791|NCT00286429|537051677|FG001|Overall Study|Adverse Event|1|||
148883792|NCT00286429|537051678|FG002|Overall Study|Adverse Event|6|||
148883793|NCT00286429|537051676|FG000|Overall Study|Lack of Efficacy|52|||
148883794|NCT00286429|537051677|FG001|Overall Study|Lack of Efficacy|27|||
148883795|NCT00286429|537051678|FG002|Overall Study|Lack of Efficacy|25|||
148883796|NCT00286429|537051676|FG000|Overall Study|Lost to Follow-up|2|||
148883797|NCT00286429|537051677|FG001|Overall Study|Lost to Follow-up|4|||
148883798|NCT00286429|537051678|FG002|Overall Study|Lost to Follow-up|3|||
148883799|NCT00286429|537051676|FG000|Overall Study|Physician Decision|10|||
148883800|NCT00286429|537051677|FG001|Overall Study|Physician Decision|7|||
148883801|NCT00286429|537051678|FG002|Overall Study|Physician Decision|7|||
148883802|NCT00286429|537051676|FG000|Overall Study|Protocol Violation|3|||
148883803|NCT00286429|537051677|FG001|Overall Study|Protocol Violation|5|||
148883804|NCT00286429|537051678|FG002|Overall Study|Protocol Violation|4|||
148883805|NCT00286429|537051676|FG000|Overall Study|Withdrawal by Subject|3|||
148883806|NCT00286429|537051677|FG001|Overall Study|Withdrawal by Subject|2|||
148883807|NCT00286429|537051678|FG002|Overall Study|Withdrawal by Subject|6|||
148883808|NCT00286429|537051676|FG000|Overall Study|Administrative Error|1|||
148883809|NCT00286429|537051677|FG001|Overall Study|Administrative Error|1|||
148883810|NCT00286429|537051678|FG002|Overall Study|Administrative Error|1|||
148883811|NCT00286429|537051676|FG000|Overall Study|Administrative Decision|0|||
148883812|NCT00286429|537051677|FG001|Overall Study|Administrative Decision|1|||
148883813|NCT00286429|537051678|FG002|Overall Study|Administrative Decision|0|||
148883814|NCT01746225|537051681|FG000|Overall Study|Death|1|||
148883815|NCT01746225|537051682|FG001|Overall Study|Death|0|||
148883816|NCT01746225|537051683|FG002|Overall Study|Death|1|||
148883817|NCT01746225|537051681|FG000|Overall Study|Withdrawal by Subject|5|||
148883818|NCT01746225|537051682|FG001|Overall Study|Withdrawal by Subject|15|||
148883819|NCT01746225|537051683|FG002|Overall Study|Withdrawal by Subject|19|||
148883820|NCT01746225|537051681|FG000|Overall Study|Physician Decision|14|||
148883821|NCT01746225|537051682|FG001|Overall Study|Physician Decision|11|||
148883822|NCT01746225|537051683|FG002|Overall Study|Physician Decision|3|||
148883823|NCT01746225|537051681|FG000|Overall Study|Adverse Event|15|||
148883824|NCT01746225|537051682|FG001|Overall Study|Adverse Event|12|||
149040587|NCT02202499|537628310|FG002|Overall Study|Declined before randomization|0|||
149040588|NCT02202499|537628308|FG000|Overall Study|Auto accident|1|||
149040589|NCT02202499|537628309|FG001|Overall Study|Auto accident|0|||
149040590|NCT02202499|537628310|FG002|Overall Study|Auto accident|0|||
149040591|NCT00535145|537628314|FG000|Phase I|Adverse Event|3|||
149040592|NCT00535145|537628314|FG000|Phase I|Lost to Follow-up|7|||
149040593|NCT00535145|537628314|FG000|Phase I|Withdrawal by Subject|6|||
149040594|NCT00535145|537628314|FG000|Phase I|(eligibility)|8|||
149040595|NCT00535145|537628314|FG000|Phase I|(protocol violation)|1|||
149040596|NCT00535145|537628314|FG000|Phase I|(PI decision)|1|||
149040597|NCT00535145|537628314|FG000|Phase I|(diagnosis)|3|||
149040598|NCT00535145|537628314|FG000|Phase II|Adverse Event|2|||
149040599|NCT00535145|537628314|FG000|Phase II|Lack of Efficacy|1|||
149040600|NCT00535145|537628314|FG000|Phase II|Lost to Follow-up|5|||
149040601|NCT00535145|537628314|FG000|Phase II|Withdrawal by Subject|5|||
149040602|NCT00535145|537628314|FG000|Phase II|Subject non-compliance|2|||
149040603|NCT00439569|537628320|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
149040604|NCT00439569|537628320|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
149040605|NCT00439569|537628320|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
149040606|NCT02214160|537628321|FG000|Overall Study|Withdrawal by Subject|1|||
149040607|NCT02214160|537628322|FG001|Overall Study|Withdrawal by Subject|0|||
149040608|NCT02214160|537628323|FG002|Overall Study|Withdrawal by Subject|6|||
149040609|NCT02214160|537628321|FG000|Overall Study|Death|2|||
149040610|NCT02214160|537628322|FG001|Overall Study|Death|2|||
149040611|NCT02214160|537628323|FG002|Overall Study|Death|1|||
149040612|NCT02214160|537628321|FG000|Overall Study|Subject Non-Compliance|0|||
149040613|NCT02214160|537628322|FG001|Overall Study|Subject Non-Compliance|3|||
149040614|NCT02214160|537628323|FG002|Overall Study|Subject Non-Compliance|1|||
149040615|NCT02214160|537628321|FG000|Overall Study|Adverse Event|0|||
148883825|NCT01746225|537051683|FG002|Overall Study|Adverse Event|17|||
148883826|NCT01746225|537051681|FG000|Overall Study|Continuing Treatment|5|||
148883827|NCT01746225|537051682|FG001|Overall Study|Continuing Treatment|8|||
148883828|NCT01746225|537051683|FG002|Overall Study|Continuing Treatment|3|||
148883829|NCT03508609|537051686|FG000|Overall Study|Withdrawal by Subject|1|||
148883830|NCT00999518|537051687|FG000|Overall Study|Adverse Event|1|||
148883831|NCT00999518|537051688|FG001|Overall Study|Adverse Event|6|||
148883832|NCT00999518|537051689|FG002|Overall Study|Adverse Event|3|||
149040616|NCT02214160|537628322|FG001|Overall Study|Adverse Event|1|||
149040617|NCT02214160|537628323|FG002|Overall Study|Adverse Event|1|||
149040618|NCT02214160|537628321|FG000|Overall Study|Sponsor Decision|0|||
149040619|NCT02214160|537628322|FG001|Overall Study|Sponsor Decision|2|||
148883833|NCT00999518|537051690|FG003|Overall Study|Adverse Event|1|||
148883834|NCT00999518|537051691|FG004|Overall Study|Adverse Event|2|||
149040620|NCT02214160|537628323|FG002|Overall Study|Sponsor Decision|0|||
149040621|NCT02214160|537628321|FG000|Overall Study|Protocol Violation|1|||
149040622|NCT02214160|537628322|FG001|Overall Study|Protocol Violation|0|||
148883835|NCT00999518|537051687|FG000|Overall Study|Lack of Efficacy|2|||
148883836|NCT00999518|537051688|FG001|Overall Study|Lack of Efficacy|0|||
148883837|NCT00999518|537051689|FG002|Overall Study|Lack of Efficacy|0|||
148883838|NCT00999518|537051690|FG003|Overall Study|Lack of Efficacy|2|||
148883839|NCT00999518|537051691|FG004|Overall Study|Lack of Efficacy|2|||
148883840|NCT00999518|537051687|FG000|Overall Study|Lost to Follow-up|0|||
148883841|NCT00999518|537051688|FG001|Overall Study|Lost to Follow-up|0|||
148883842|NCT00999518|537051689|FG002|Overall Study|Lost to Follow-up|0|||
148883843|NCT00999518|537051690|FG003|Overall Study|Lost to Follow-up|4|||
148883844|NCT00999518|537051691|FG004|Overall Study|Lost to Follow-up|1|||
148883845|NCT00999518|537051687|FG000|Overall Study|Did not meet entrance criteria|0|||
148883846|NCT00999518|537051688|FG001|Overall Study|Did not meet entrance criteria|0|||
148883847|NCT00999518|537051689|FG002|Overall Study|Did not meet entrance criteria|0|||
148883848|NCT00999518|537051690|FG003|Overall Study|Did not meet entrance criteria|0|||
148883849|NCT00999518|537051691|FG004|Overall Study|Did not meet entrance criteria|1|||
148883850|NCT00999518|537051687|FG000|Overall Study|Study terminated by sponsor|10|||
148883851|NCT00999518|537051688|FG001|Overall Study|Study terminated by sponsor|6|||
148883852|NCT00999518|537051689|FG002|Overall Study|Study terminated by sponsor|5|||
148883853|NCT00999518|537051690|FG003|Overall Study|Study terminated by sponsor|5|||
148883854|NCT00999518|537051691|FG004|Overall Study|Study terminated by sponsor|9|||
148883855|NCT00999518|537051687|FG000|Overall Study|Pregnancy|0|||
148883856|NCT00999518|537051688|FG001|Overall Study|Pregnancy|0|||
148883857|NCT00999518|537051689|FG002|Overall Study|Pregnancy|1|||
148883858|NCT00999518|537051690|FG003|Overall Study|Pregnancy|0|||
148883859|NCT00999518|537051691|FG004|Overall Study|Pregnancy|0|||
148883860|NCT00999518|537051687|FG000|Overall Study|Protocol Violation|0|||
148883861|NCT00999518|537051688|FG001|Overall Study|Protocol Violation|1|||
148883862|NCT00999518|537051689|FG002|Overall Study|Protocol Violation|0|||
148883863|NCT00999518|537051690|FG003|Overall Study|Protocol Violation|0|||
148883864|NCT00999518|537051691|FG004|Overall Study|Protocol Violation|2|||
148883865|NCT00999518|537051687|FG000|Overall Study|Withdrawal by Subject|5|||
148883866|NCT00999518|537051688|FG001|Overall Study|Withdrawal by Subject|4|||
148883867|NCT00999518|537051689|FG002|Overall Study|Withdrawal by Subject|10|||
148883868|NCT00999518|537051690|FG003|Overall Study|Withdrawal by Subject|6|||
148883869|NCT00999518|537051691|FG004|Overall Study|Withdrawal by Subject|1|||
148883870|NCT00999518|537051687|FG000|Overall Study|Other|5|||
148883871|NCT00999518|537051688|FG001|Overall Study|Other|7|||
148883872|NCT00999518|537051689|FG002|Overall Study|Other|1|||
148883873|NCT00999518|537051690|FG003|Overall Study|Other|4|||
148883874|NCT00999518|537051691|FG004|Overall Study|Other|5|||
148883875|NCT00999518|537051687|FG000|Overall Study|Randomized but not Treated|1|||
148883876|NCT00999518|537051688|FG001|Overall Study|Randomized but not Treated|1|||
148883877|NCT00999518|537051689|FG002|Overall Study|Randomized but not Treated|2|||
148883878|NCT00999518|537051690|FG003|Overall Study|Randomized but not Treated|0|||
148883879|NCT00999518|537051691|FG004|Overall Study|Randomized but not Treated|1|||
148883880|NCT00250276|537051695|FG000|Overall Study|Serious Adverse Event|0|||
148883881|NCT00250276|537051696|FG001|Overall Study|Serious Adverse Event|0|||
148883882|NCT00250276|537051697|FG002|Overall Study|Serious Adverse Event|1|||
148883883|NCT00250276|537051698|FG003|Overall Study|Serious Adverse Event|0|||
148883884|NCT00250276|537051695|FG000|Overall Study|Non-serious Adverse Event|2|||
148883885|NCT00250276|537051696|FG001|Overall Study|Non-serious Adverse Event|0|||
148883886|NCT00250276|537051697|FG002|Overall Study|Non-serious Adverse Event|0|||
148883887|NCT00250276|537051698|FG003|Overall Study|Non-serious Adverse Event|2|||
148883888|NCT00250276|537051695|FG000|Overall Study|Protocol Violation|0|||
148883889|NCT00250276|537051696|FG001|Overall Study|Protocol Violation|1|||
148883890|NCT00250276|537051697|FG002|Overall Study|Protocol Violation|0|||
148883891|NCT00250276|537051698|FG003|Overall Study|Protocol Violation|0|||
148883892|NCT00250276|537051695|FG000|Overall Study|Withdrawal by Subject|1|||
148883893|NCT00250276|537051696|FG001|Overall Study|Withdrawal by Subject|2|||
148883894|NCT00250276|537051697|FG002|Overall Study|Withdrawal by Subject|3|||
148883895|NCT00250276|537051698|FG003|Overall Study|Withdrawal by Subject|2|||
148883896|NCT00250276|537051695|FG000|Overall Study|Migrated/moved from study area|3|||
148883897|NCT00250276|537051696|FG001|Overall Study|Migrated/moved from study area|0|||
148883898|NCT00250276|537051697|FG002|Overall Study|Migrated/moved from study area|2|||
148883899|NCT00250276|537051698|FG003|Overall Study|Migrated/moved from study area|7|||
148883900|NCT00250276|537051695|FG000|Overall Study|Lost to Follow-up|11|||
148883901|NCT00250276|537051696|FG001|Overall Study|Lost to Follow-up|18|||
148883902|NCT00250276|537051697|FG002|Overall Study|Lost to Follow-up|13|||
148883903|NCT00250276|537051698|FG003|Overall Study|Lost to Follow-up|8|||
148883904|NCT01546688|537051699|FG000|Overall Study|Adverse Event|0|||
148883905|NCT01546688|537051700|FG001|Overall Study|Adverse Event|4|||
148883906|NCT01546688|537051699|FG000|Overall Study|Withdrawal by Subject|2|||
148883907|NCT01546688|537051700|FG001|Overall Study|Withdrawal by Subject|1|||
148883908|NCT01546688|537051699|FG000|Overall Study|Lack of Efficacy|1|||
148883909|NCT01546688|537051700|FG001|Overall Study|Lack of Efficacy|0|||
148883910|NCT03543137|537051703|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
148883911|NCT03543137|537051704|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
148883912|NCT03543137|537051703|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
148883913|NCT03543137|537051704|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
148883914|NCT03543137|537051703|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
148883915|NCT03543137|537051704|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
148883916|NCT00782483|537051705|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
148883917|NCT01052077|537051707|FG000|Phase A|Lost to Follow-up|22|||
148883918|NCT01052077|537051708|FG001|Phase A|Lost to Follow-up|0|||
148883919|NCT01052077|537051709|FG002|Phase A|Lost to Follow-up|0|||
148883920|NCT01052077|537051710|FG003|Phase A|Lost to Follow-up|0|||
148883921|NCT01052077|537051707|FG000|Phase A|Adverse Event|32|||
148883922|NCT01052077|537051708|FG001|Phase A|Adverse Event|0|||
148883923|NCT01052077|537051709|FG002|Phase A|Adverse Event|0|||
148883924|NCT01052077|537051710|FG003|Phase A|Adverse Event|0|||
148883925|NCT01052077|537051707|FG000|Phase A|Met Withdrawal Criteria|26|||
148883926|NCT01052077|537051708|FG001|Phase A|Met Withdrawal Criteria|0|||
148883927|NCT01052077|537051709|FG002|Phase A|Met Withdrawal Criteria|0|||
148883928|NCT01052077|537051710|FG003|Phase A|Met Withdrawal Criteria|0|||
148883929|NCT01052077|537051707|FG000|Phase A|Physician Decision|10|||
148883930|NCT01052077|537051708|FG001|Phase A|Physician Decision|0|||
148883931|NCT01052077|537051709|FG002|Phase A|Physician Decision|0|||
149040623|NCT02214160|537628323|FG002|Overall Study|Protocol Violation|0|||
149040624|NCT02214160|537628321|FG000|Overall Study|Physician Decision|0|||
149040625|NCT02214160|537628322|FG001|Overall Study|Physician Decision|0|||
149040626|NCT02214160|537628323|FG002|Overall Study|Physician Decision|1|||
148883932|NCT01052077|537051710|FG003|Phase A|Physician Decision|0|||
148883933|NCT01052077|537051707|FG000|Phase A|Withdrawal by Subject|29|||
148883934|NCT01052077|537051708|FG001|Phase A|Withdrawal by Subject|0|||
148883935|NCT01052077|537051709|FG002|Phase A|Withdrawal by Subject|0|||
148883936|NCT01052077|537051710|FG003|Phase A|Withdrawal by Subject|0|||
148883937|NCT01052077|537051707|FG000|Phase A|Protocol Deviation|27|||
148883938|NCT01052077|537051708|FG001|Phase A|Protocol Deviation|0|||
148883939|NCT01052077|537051709|FG002|Phase A|Protocol Deviation|0|||
148883940|NCT01052077|537051710|FG003|Phase A|Protocol Deviation|0|||
148883941|NCT01052077|537051707|FG000|Phase B|Lost to Follow-up|0|||
148883942|NCT01052077|537051708|FG001|Phase B|Lost to Follow-up|2|||
148883943|NCT01052077|537051709|FG002|Phase B|Lost to Follow-up|3|||
148883944|NCT01052077|537051710|FG003|Phase B|Lost to Follow-up|0|||
148883945|NCT01052077|537051707|FG000|Phase B|Adverse Event|0|||
148883946|NCT01052077|537051708|FG001|Phase B|Adverse Event|9|||
148883947|NCT01052077|537051709|FG002|Phase B|Adverse Event|2|||
148883948|NCT01052077|537051710|FG003|Phase B|Adverse Event|0|||
148883949|NCT01052077|537051707|FG000|Phase B|Met Withdrawal Criteria|0|||
148883950|NCT01052077|537051708|FG001|Phase B|Met Withdrawal Criteria|2|||
148883951|NCT01052077|537051709|FG002|Phase B|Met Withdrawal Criteria|1|||
148883952|NCT01052077|537051710|FG003|Phase B|Met Withdrawal Criteria|0|||
148883953|NCT01052077|537051707|FG000|Phase B|Physician Decision|0|||
148883954|NCT01052077|537051708|FG001|Phase B|Physician Decision|1|||
148883955|NCT01052077|537051709|FG002|Phase B|Physician Decision|1|||
148883956|NCT01052077|537051710|FG003|Phase B|Physician Decision|0|||
148883957|NCT01052077|537051707|FG000|Phase B|Withdrawal by Subject|0|||
148883958|NCT01052077|537051708|FG001|Phase B|Withdrawal by Subject|0|||
148883959|NCT01052077|537051709|FG002|Phase B|Withdrawal by Subject|5|||
148883960|NCT01052077|537051710|FG003|Phase B|Withdrawal by Subject|0|||
148883961|NCT01052077|537051707|FG000|Phase B|Protocol Deviation|0|||
148883962|NCT01052077|537051708|FG001|Phase B|Protocol Deviation|3|||
148883963|NCT01052077|537051709|FG002|Phase B|Protocol Deviation|4|||
148883964|NCT01052077|537051710|FG003|Phase B|Protocol Deviation|0|||
148883965|NCT01052077|537051707|FG000|Phase B|Lack of Efficacy|0|||
148883966|NCT01052077|537051708|FG001|Phase B|Lack of Efficacy|1|||
148883967|NCT01052077|537051709|FG002|Phase B|Lack of Efficacy|0|||
148883968|NCT01052077|537051710|FG003|Phase B|Lack of Efficacy|0|||
148883969|NCT01052077|537051707|FG000|Phase A+|Lost to Follow-up|0|||
148883970|NCT01052077|537051708|FG001|Phase A+|Lost to Follow-up|0|||
148883971|NCT01052077|537051709|FG002|Phase A+|Lost to Follow-up|0|||
148883972|NCT01052077|537051710|FG003|Phase A+|Lost to Follow-up|8|||
148883973|NCT01052077|537051707|FG000|Phase A+|Adverse Event|0|||
148883974|NCT01052077|537051708|FG001|Phase A+|Adverse Event|0|||
148883975|NCT01052077|537051709|FG002|Phase A+|Adverse Event|0|||
148883976|NCT01052077|537051710|FG003|Phase A+|Adverse Event|4|||
148883977|NCT01052077|537051707|FG000|Phase A+|Met Withdrawal Criteria|0|||
148883978|NCT01052077|537051708|FG001|Phase A+|Met Withdrawal Criteria|0|||
148883979|NCT01052077|537051709|FG002|Phase A+|Met Withdrawal Criteria|0|||
148883980|NCT01052077|537051710|FG003|Phase A+|Met Withdrawal Criteria|2|||
148883981|NCT01052077|537051707|FG000|Phase A+|Withdrawal by Subject|0|||
148883982|NCT01052077|537051708|FG001|Phase A+|Withdrawal by Subject|0|||
148883983|NCT01052077|537051709|FG002|Phase A+|Withdrawal by Subject|0|||
148883984|NCT01052077|537051710|FG003|Phase A+|Withdrawal by Subject|7|||
148883985|NCT01445080|537051711|FG000|Overall Study|Adverse Event|5|||
148883986|NCT01445080|537051712|FG001|Overall Study|Adverse Event|3|||
148883987|NCT01445080|537051713|FG002|Overall Study|Adverse Event|11|||
148883988|NCT01445080|537051714|FG003|Overall Study|Adverse Event|6|||
148883989|NCT01445080|537051715|FG004|Overall Study|Adverse Event|2|||
148883990|NCT01445080|537051716|FG005|Overall Study|Adverse Event|3|||
148883991|NCT01445080|537051717|FG006|Overall Study|Adverse Event|0|||
148883992|NCT01445080|537051718|FG007|Overall Study|Adverse Event|3|||
148883993|NCT01445080|537051719|FG008|Overall Study|Adverse Event|10|||
148883994|NCT01445080|537051711|FG000|Overall Study|Physician Decision|0|||
148883995|NCT01445080|537051712|FG001|Overall Study|Physician Decision|0|||
148883996|NCT01445080|537051713|FG002|Overall Study|Physician Decision|1|||
148883997|NCT01445080|537051714|FG003|Overall Study|Physician Decision|0|||
148883998|NCT01445080|537051715|FG004|Overall Study|Physician Decision|0|||
148883999|NCT01445080|537051716|FG005|Overall Study|Physician Decision|3|||
148884000|NCT01445080|537051717|FG006|Overall Study|Physician Decision|2|||
148884001|NCT01445080|537051718|FG007|Overall Study|Physician Decision|2|||
148884002|NCT01445080|537051719|FG008|Overall Study|Physician Decision|0|||
148884003|NCT01445080|537051711|FG000|Overall Study|Withdrawal by Subject|1|||
148884004|NCT01445080|537051712|FG001|Overall Study|Withdrawal by Subject|0|||
148884005|NCT01445080|537051713|FG002|Overall Study|Withdrawal by Subject|0|||
148884006|NCT01445080|537051714|FG003|Overall Study|Withdrawal by Subject|1|||
148884007|NCT01445080|537051715|FG004|Overall Study|Withdrawal by Subject|0|||
148884008|NCT01445080|537051716|FG005|Overall Study|Withdrawal by Subject|0|||
148884009|NCT01445080|537051717|FG006|Overall Study|Withdrawal by Subject|0|||
148884010|NCT01445080|537051718|FG007|Overall Study|Withdrawal by Subject|0|||
148884011|NCT01445080|537051719|FG008|Overall Study|Withdrawal by Subject|2|||
148884012|NCT01445080|537051711|FG000|Overall Study|Ineligible/Inevaluable|1|||
148884013|NCT01445080|537051712|FG001|Overall Study|Ineligible/Inevaluable|2|||
148884014|NCT01445080|537051713|FG002|Overall Study|Ineligible/Inevaluable|0|||
148884015|NCT01445080|537051714|FG003|Overall Study|Ineligible/Inevaluable|1|||
148884016|NCT01445080|537051715|FG004|Overall Study|Ineligible/Inevaluable|2|||
148884017|NCT01445080|537051716|FG005|Overall Study|Ineligible/Inevaluable|3|||
148884018|NCT01445080|537051717|FG006|Overall Study|Ineligible/Inevaluable|0|||
148884019|NCT01445080|537051718|FG007|Overall Study|Ineligible/Inevaluable|0|||
148884020|NCT01445080|537051719|FG008|Overall Study|Ineligible/Inevaluable|6|||
148884021|NCT02487030|537051720|FG000|Overall Study|Lack of Efficacy|2|||
148884022|NCT02487030|537051721|FG001|Overall Study|Lack of Efficacy|4|||
148884023|NCT02487030|537051722|FG002|Overall Study|Lack of Efficacy|1|||
148884024|NCT02487030|537051723|FG003|Overall Study|Lack of Efficacy|0|||
148884025|NCT02487030|537051724|FG004|Overall Study|Lack of Efficacy|1|||
148884026|NCT02487030|537051725|FG005|Overall Study|Lack of Efficacy|0|||
148884027|NCT02487030|537051726|FG006|Overall Study|Lack of Efficacy|0|||
148884028|NCT02487030|537051720|FG000|Overall Study|Lost to Follow-up|0|||
148884029|NCT02487030|537051721|FG001|Overall Study|Lost to Follow-up|0|||
148884030|NCT02487030|537051722|FG002|Overall Study|Lost to Follow-up|1|||
148884031|NCT02487030|537051723|FG003|Overall Study|Lost to Follow-up|1|||
148884032|NCT02487030|537051724|FG004|Overall Study|Lost to Follow-up|0|||
148884033|NCT02487030|537051725|FG005|Overall Study|Lost to Follow-up|1|||
148884034|NCT02487030|537051726|FG006|Overall Study|Lost to Follow-up|0|||
148884035|NCT02487030|537051720|FG000|Overall Study|Adverse Event|0|||
148884036|NCT02487030|537051721|FG001|Overall Study|Adverse Event|0|||
148884037|NCT02487030|537051722|FG002|Overall Study|Adverse Event|0|||
148884038|NCT02487030|537051723|FG003|Overall Study|Adverse Event|1|||
148884039|NCT02487030|537051724|FG004|Overall Study|Adverse Event|0|||
148884040|NCT02487030|537051725|FG005|Overall Study|Adverse Event|0|||
148884041|NCT02487030|537051726|FG006|Overall Study|Adverse Event|0|||
148884042|NCT02487030|537051720|FG000|Overall Study|Death|0|||
148884043|NCT02487030|537051721|FG001|Overall Study|Death|0|||
148884044|NCT02487030|537051722|FG002|Overall Study|Death|0|||
148884045|NCT02487030|537051723|FG003|Overall Study|Death|0|||
148884046|NCT02487030|537051724|FG004|Overall Study|Death|1|||
148884047|NCT02487030|537051725|FG005|Overall Study|Death|0|||
148884048|NCT02487030|537051726|FG006|Overall Study|Death|0|||
148884049|NCT03857542|537051727|FG000|Overall Study|Adverse Event|1|||
148884050|NCT03857542|537051728|FG001|Overall Study|Adverse Event|3|||
148884051|NCT03857542|537051727|FG000|Overall Study|Withdrawal by Subject|2|||
148884052|NCT03857542|537051728|FG001|Overall Study|Withdrawal by Subject|1|||
148884053|NCT03857542|537051727|FG000|Overall Study|Lost to Follow-up|2|||
148884054|NCT03857542|537051728|FG001|Overall Study|Lost to Follow-up|1|||
148884055|NCT03857542|537051727|FG000|Overall Study|Reason not Specified|1|||
148884056|NCT03857542|537051728|FG001|Overall Study|Reason not Specified|0|||
148884057|NCT01594931|537053265|FG000|Overall Study|Adverse Event|3|||
148884058|NCT01594931|537053266|FG001|Overall Study|Adverse Event|1|||
148884059|NCT01594931|537053267|FG002|Overall Study|Adverse Event|1|||
148884060|NCT01594931|537053265|FG000|Overall Study|Withdrawal by Subject|2|||
148884061|NCT01594931|537053266|FG001|Overall Study|Withdrawal by Subject|1|||
148884062|NCT01594931|537053267|FG002|Overall Study|Withdrawal by Subject|1|||
148884063|NCT01594931|537053265|FG000|Overall Study|Lack of Efficacy|7|||
148884064|NCT01594931|537053266|FG001|Overall Study|Lack of Efficacy|2|||
148884065|NCT01594931|537053267|FG002|Overall Study|Lack of Efficacy|2|||
148884066|NCT01594931|537053265|FG000|Overall Study|Lost to Follow-up|4|||
148884067|NCT01594931|537053266|FG001|Overall Study|Lost to Follow-up|3|||
148884068|NCT01594931|537053267|FG002|Overall Study|Lost to Follow-up|3|||
148884069|NCT01594931|537053265|FG000|Overall Study|Protocol Violation|2|||
148884070|NCT01594931|537053266|FG001|Overall Study|Protocol Violation|1|||
148884071|NCT01594931|537053267|FG002|Overall Study|Protocol Violation|0|||
148884072|NCT01594931|537053265|FG000|Overall Study|No defiined|11|||
148884073|NCT01594931|537053266|FG001|Overall Study|No defiined|4|||
148884074|NCT01594931|537053267|FG002|Overall Study|No defiined|7|||
148884075|NCT04864639|537053269|FG000|Overall Study|Death|1|||
148884076|NCT04864639|537053269|FG000|Overall Study|Lost to Follow-up|1|||
148884077|NCT03449758|537053270|FG000|Overall Study|Major protocol deviation|1|||
148884078|NCT03449758|537053270|FG000|Overall Study|Treatment inefficacy|5|||
148884079|NCT03449758|537053270|FG000|Overall Study|Adverse Event|9|||
148884080|NCT03449758|537053270|FG000|Overall Study|Consent withdrawal|1|||
148884081|NCT03449758|537053270|FG000|Overall Study|Other unspecified reason|3|||
148884082|NCT01478971|537053279|FG000|Standard of Care Period|Adverse Event|1|||
148884083|NCT01478971|537053279|FG000|Standard of Care Period|Withdrawal by Subject|3|||
148884084|NCT01478971|537053279|FG000|Standard of Care Period|Death|8|||
148884085|NCT01478971|537053279|FG000|Standard of Care Period|Lost to Follow-up|9|||
148884086|NCT01478971|537053279|FG000|Standard of Care Period|Other|4|||
148884087|NCT01478971|537053279|FG000|Peginesatide Treatment Period|Adverse Event|1|||
148884088|NCT01478971|537053279|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
148884089|NCT01478971|537053279|FG000|Peginesatide Treatment Period|Death|4|||
148884090|NCT01478971|537053279|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
148884091|NCT01478971|537053279|FG000|Peginesatide Treatment Period|Other|4|||
148884092|NCT01525615|537053280|FG000|Overall Study|Adverse Event|11|||
148884093|NCT01525615|537053281|FG001|Overall Study|Adverse Event|7|||
148884094|NCT01525615|537053282|FG002|Overall Study|Adverse Event|5|||
148884095|NCT01525615|537053280|FG000|Overall Study|Lost to Follow-up|1|||
148884096|NCT01525615|537053281|FG001|Overall Study|Lost to Follow-up|0|||
148884097|NCT01525615|537053282|FG002|Overall Study|Lost to Follow-up|0|||
148884098|NCT01525615|537053280|FG000|Overall Study|Withdrawal by Subject|1|||
148884099|NCT01525615|537053281|FG001|Overall Study|Withdrawal by Subject|0|||
148884100|NCT01525615|537053282|FG002|Overall Study|Withdrawal by Subject|0|||
148884101|NCT01525615|537053280|FG000|Overall Study|Other reason not described above|1|||
148884102|NCT01525615|537053281|FG001|Overall Study|Other reason not described above|0|||
148884103|NCT01525615|537053282|FG002|Overall Study|Other reason not described above|1|||
148884104|NCT04050618|537053283|FG000|First Intervention|Withdrawal by Subject|2|||
148884105|NCT04050618|537053284|FG001|First Intervention|Withdrawal by Subject|0|||
148884106|NCT04050618|537053283|FG000|Second Intervention|Withdrawal by Subject|1|||
148884107|NCT04050618|537053284|FG001|Second Intervention|Withdrawal by Subject|0|||
148884108|NCT02451943|537053294|FG000|Overall Study|Withdrawal by Subject|13|||
148884109|NCT02451943|537053295|FG001|Overall Study|Withdrawal by Subject|16|||
148884110|NCT02451943|537053294|FG000|Overall Study|Lost to Follow-up|3|||
148884111|NCT02451943|537053295|FG001|Overall Study|Lost to Follow-up|4|||
148884112|NCT02451943|537053294|FG000|Overall Study|Sponsor Decision|0|||
148884113|NCT02451943|537053295|FG001|Overall Study|Sponsor Decision|4|||
148884114|NCT03937713|537053296|FG000|Overall Study|Withdrawal by Subject|3|||
148884115|NCT03937713|537053297|FG001|Overall Study|Withdrawal by Subject|6|||
148884116|NCT03937713|537053296|FG000|Overall Study|Lost to Follow-up|1|||
148884117|NCT03937713|537053297|FG001|Overall Study|Lost to Follow-up|0|||
148884118|NCT00922623|537053303|FG000|Overall Study|Other|4|||
148884119|NCT00922623|537053303|FG000|Overall Study|Lost to Follow-up|1|||
148884120|NCT03951077|537053306|FG000|Overall Study|Adverse Event|1|||
148884121|NCT03951077|537053307|FG001|Overall Study|Adverse Event|0|||
148884122|NCT03951077|537053308|FG002|Overall Study|Adverse Event|0|||
148884123|NCT03951077|537053309|FG003|Overall Study|Adverse Event|0|||
148884124|NCT03951077|537053310|FG004|Overall Study|Adverse Event|0|||
148884125|NCT03951077|537053311|FG005|Overall Study|Adverse Event|0|||
148884126|NCT03951077|537053306|FG000|Overall Study|Withdrawal by Subject|3|||
148884127|NCT03951077|537053307|FG001|Overall Study|Withdrawal by Subject|3|||
148884128|NCT03951077|537053308|FG002|Overall Study|Withdrawal by Subject|0|||
148884129|NCT03951077|537053309|FG003|Overall Study|Withdrawal by Subject|3|||
148884130|NCT03951077|537053310|FG004|Overall Study|Withdrawal by Subject|3|||
148884131|NCT03951077|537053311|FG005|Overall Study|Withdrawal by Subject|2|||
148884132|NCT03951077|537053306|FG000|Overall Study|Lost to Follow-up|1|||
148884133|NCT03951077|537053307|FG001|Overall Study|Lost to Follow-up|1|||
149040627|NCT02423798|537628324|FG000|Overall Study|Withdrawal by Subject|3|||
149040628|NCT01430611|537628331|FG000|Overall Study|Adverse Event|0|||
149040629|NCT01430611|537628332|FG001|Overall Study|Adverse Event|1|||
149040630|NCT01430611|537628331|FG000|Overall Study|Protocol Violation|1|||
149040631|NCT01430611|537628332|FG001|Overall Study|Protocol Violation|0|||
149040632|NCT01430611|537628331|FG000|Overall Study|Lost to Follow-up|1|||
149040633|NCT01430611|537628332|FG001|Overall Study|Lost to Follow-up|0|||
149040634|NCT01430611|537628331|FG000|Overall Study|Withdrawal by Subject|15|||
149040635|NCT01430611|537628332|FG001|Overall Study|Withdrawal by Subject|14|||
149040636|NCT02204982|537628333|FG000|Overall Study|Patient ineligible-medical monitor|1|||
149040637|NCT02204982|537628334|FG001|Overall Study|Patient ineligible-medical monitor|0|||
148884134|NCT03951077|537053308|FG002|Overall Study|Lost to Follow-up|2|||
148884135|NCT03951077|537053309|FG003|Overall Study|Lost to Follow-up|3|||
149040638|NCT02204982|537628333|FG000|Overall Study|Withdrawal by Subject|1|||
149040639|NCT02204982|537628334|FG001|Overall Study|Withdrawal by Subject|0|||
148884136|NCT03951077|537053310|FG004|Overall Study|Lost to Follow-up|2|||
148884137|NCT03951077|537053311|FG005|Overall Study|Lost to Follow-up|3|||
148884138|NCT03951077|537053306|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
148884139|NCT03951077|537053307|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
148884140|NCT03951077|537053308|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
148884141|NCT03951077|537053309|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
148884142|NCT03951077|537053310|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
148884143|NCT03951077|537053311|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
148884144|NCT03951077|537053306|FG000|Overall Study|Other, Not Specified|12|||
148884145|NCT03951077|537053307|FG001|Overall Study|Other, Not Specified|10|||
148884146|NCT03951077|537053308|FG002|Overall Study|Other, Not Specified|10|||
148884147|NCT03951077|537053309|FG003|Overall Study|Other, Not Specified|5|||
148884148|NCT03951077|537053310|FG004|Overall Study|Other, Not Specified|9|||
148884149|NCT03951077|537053311|FG005|Overall Study|Other, Not Specified|6|||
148884150|NCT03951077|537053306|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
148884151|NCT03951077|537053307|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
148884152|NCT03951077|537053308|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
148884153|NCT03951077|537053309|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
148884154|NCT03951077|537053310|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
148884155|NCT03951077|537053311|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
148884156|NCT00950846|537053314|FG000|Overall Study|Death|6|||
148884157|NCT00950846|537053314|FG000|Overall Study|Lost to Follow-up|3|||
148884158|NCT00950846|537053314|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
148884159|NCT01799226|537053317|FG000|Overall Study|Withdrawal by Subject|1|||
148884160|NCT01799226|537053318|FG001|Overall Study|Withdrawal by Subject|0|||
148884161|NCT01799226|537053317|FG000|Overall Study|Disqualified at Day 14|1|||
148884162|NCT01799226|537053318|FG001|Overall Study|Disqualified at Day 14|0|||
148884163|NCT02178995|537053319|FG000|Double Blind|Adverse Event|0|||
148884164|NCT02178995|537053320|FG001|Double Blind|Adverse Event|0|||
148884165|NCT02178995|537053321|FG002|Double Blind|Adverse Event|0|||
148884166|NCT02178995|537053322|FG003|Double Blind|Adverse Event|0|||
148884167|NCT02178995|537053323|FG004|Double Blind|Adverse Event|0|||
148884168|NCT02178995|537053324|FG005|Double Blind|Adverse Event|1|||
148884169|NCT02178995|537053325|FG006|Double Blind|Adverse Event|0|||
148884170|NCT02178995|537053326|FG007|Double Blind|Adverse Event|1|||
148884171|NCT02178995|537053327|FG008|Double Blind|Adverse Event|1|||
148884172|NCT02178995|537053319|FG000|Double Blind|Lost to Follow-up|0|||
148884173|NCT02178995|537053320|FG001|Double Blind|Lost to Follow-up|1|||
148884174|NCT02178995|537053321|FG002|Double Blind|Lost to Follow-up|0|||
148884175|NCT02178995|537053322|FG003|Double Blind|Lost to Follow-up|0|||
148884176|NCT02178995|537053323|FG004|Double Blind|Lost to Follow-up|0|||
148884177|NCT02178995|537053324|FG005|Double Blind|Lost to Follow-up|0|||
148884178|NCT02178995|537053325|FG006|Double Blind|Lost to Follow-up|0|||
148884179|NCT02178995|537053326|FG007|Double Blind|Lost to Follow-up|1|||
149040640|NCT02204982|537628333|FG000|Overall Study|Adverse Event|1|||
149040641|NCT02204982|537628334|FG001|Overall Study|Adverse Event|0|||
149040642|NCT02204982|537628333|FG000|Overall Study|Adverse Event and Investigator decision|1|||
149040643|NCT02204982|537628334|FG001|Overall Study|Adverse Event and Investigator decision|0|||
149040644|NCT02204982|537628333|FG000|Overall Study|Physician Decision|0|||
149040645|NCT02204982|537628334|FG001|Overall Study|Physician Decision|2|||
148884180|NCT02178995|537053327|FG008|Double Blind|Lost to Follow-up|0|||
148884181|NCT02178995|537053319|FG000|Open Label|Adverse Event|2|||
148884182|NCT02178995|537053320|FG001|Open Label|Adverse Event|0|||
148884183|NCT02178995|537053321|FG002|Open Label|Adverse Event|0|||
148884184|NCT02178995|537053322|FG003|Open Label|Adverse Event|0|||
148884185|NCT02178995|537053323|FG004|Open Label|Adverse Event|0|||
148884186|NCT02178995|537053324|FG005|Open Label|Adverse Event|0|||
148884187|NCT02178995|537053325|FG006|Open Label|Adverse Event|0|||
148884188|NCT02178995|537053326|FG007|Open Label|Adverse Event|0|||
148884189|NCT02178995|537053327|FG008|Open Label|Adverse Event|0|||
148884190|NCT00587158|537053328|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
148884191|NCT00587158|537053329|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
148884192|NCT00587158|537053328|FG000|Overall Study|Physician Decision|0|||
148884193|NCT00587158|537053329|FG001|Overall Study|Physician Decision|1|||
148884194|NCT00587158|537053328|FG000|Overall Study|Lost to Follow-up|1|||
148884195|NCT00587158|537053329|FG001|Overall Study|Lost to Follow-up|2|||
149040646|NCT02204982|537628333|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
149040647|NCT02204982|537628334|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
149040648|NCT02204982|537628333|FG000|Overall Study|Termination of Study bySponsor|0|||
149040649|NCT02204982|537628334|FG001|Overall Study|Termination of Study bySponsor|1|||
148884196|NCT00587158|537053328|FG000|Overall Study|Death|0|||
149040650|NCT00457743|537628338|FG000|Overall Study|Adverse Event|0|||
149040651|NCT00457743|537628339|FG001|Overall Study|Adverse Event|4|||
148884197|NCT00587158|537053329|FG001|Overall Study|Death|1|||
148884198|NCT00587158|537053328|FG000|Overall Study|Subject did not want to take study med|0|||
148884199|NCT00587158|537053329|FG001|Overall Study|Subject did not want to take study med|1|||
148884200|NCT00981461|537053330|FG000|Overall Study|Lost to Follow-up|5|||
148884201|NCT00981461|537053331|FG001|Overall Study|Lost to Follow-up|2|||
148884202|NCT00483405|537053332|FG000|Overall Study|Adverse Event|8|||
148884203|NCT00483405|537053332|FG000|Overall Study|Lack of Efficacy|14|||
148884204|NCT00483405|537053332|FG000|Overall Study|Death|3|||
148884205|NCT00483405|537053332|FG000|Overall Study|Withdrawal by Subject|2|||
148884206|NCT00483405|537053332|FG000|Overall Study|Other complicating disease|1|||
148884207|NCT00571038|537053333|FG000|Overall Study|Lost to Follow-up|1|||
148884208|NCT00571038|537053334|FG001|Overall Study|Lost to Follow-up|4|||
148884209|NCT00571038|537053333|FG000|Overall Study|Death|7|||
148884210|NCT00571038|537053334|FG001|Overall Study|Death|5|||
148884211|NCT00571038|537053333|FG000|Overall Study|Withdrawal by Subject|1|||
148884212|NCT00571038|537053334|FG001|Overall Study|Withdrawal by Subject|3|||
148884213|NCT00571038|537053333|FG000|Overall Study|Moved out of state|2|||
148884214|NCT00571038|537053334|FG001|Overall Study|Moved out of state|2|||
148884215|NCT01797263|537053335|FG000|Overall Study|Withdrawal by Subject|21|||
148884216|NCT01797263|537053336|FG001|Overall Study|Withdrawal by Subject|25|||
148884217|NCT01797263|537053335|FG000|Overall Study|Death|1|||
148884218|NCT01797263|537053336|FG001|Overall Study|Death|0|||
148884219|NCT01797263|537053335|FG000|Overall Study|Lost to Follow-up|15|||
148884220|NCT01797263|537053336|FG001|Overall Study|Lost to Follow-up|15|||
148884221|NCT02342223|537053337|FG000|Overall Study|Lost to Follow-up|1|||
148884222|NCT04854551|537053340|FG000|Overall Study|Withdrawal by Subject|1|||
148884223|NCT04854551|537053341|FG001|Overall Study|Withdrawal by Subject|1|||
148884224|NCT00181766|537053345|FG000|Overall Study|Lost to Follow-up|6|||
148884225|NCT00181766|537053345|FG000|Overall Study|Adverse Event|4|||
148884226|NCT00181766|537053345|FG000|Overall Study|non-compliance|2|||
148884227|NCT00687804|537053346|FG000|Core Study|Adverse Event|5|||
148884228|NCT00687804|537053347|FG001|Core Study|Adverse Event|3|||
148884229|NCT00687804|537053348|FG002|Core Study|Adverse Event|3|||
148884230|NCT00687804|537053346|FG000|Core Study|Abnormal laboratory value(s)|1|||
148884231|NCT00687804|537053347|FG001|Core Study|Abnormal laboratory value(s)|0|||
148884232|NCT00687804|537053348|FG002|Core Study|Abnormal laboratory value(s)|0|||
148884233|NCT00687804|537053346|FG000|Core Study|Lack of Efficacy|1|||
148884234|NCT00687804|537053347|FG001|Core Study|Lack of Efficacy|1|||
148884235|NCT00687804|537053348|FG002|Core Study|Lack of Efficacy|1|||
148884236|NCT00687804|537053346|FG000|Core Study|Withdrawal by Subject|4|||
148884237|NCT00687804|537053347|FG001|Core Study|Withdrawal by Subject|7|||
148884238|NCT00687804|537053348|FG002|Core Study|Withdrawal by Subject|7|||
148884239|NCT00687804|537053346|FG000|Core Study|Lost to Follow-up|0|||
148884240|NCT00687804|537053347|FG001|Core Study|Lost to Follow-up|1|||
148884241|NCT00687804|537053348|FG002|Core Study|Lost to Follow-up|0|||
148884242|NCT00687804|537053346|FG000|Core Study|Death|2|||
148884243|NCT00687804|537053347|FG001|Core Study|Death|2|||
148884244|NCT00687804|537053348|FG002|Core Study|Death|2|||
148884245|NCT00687804|537053346|FG000|Core Study|Protocol Violation|1|||
148884246|NCT00687804|537053347|FG001|Core Study|Protocol Violation|1|||
148884247|NCT00687804|537053348|FG002|Core Study|Protocol Violation|0|||
148884248|NCT00687804|537053346|FG000|Open-Label Extension Study|Adverse Event|2|||
148884249|NCT00687804|537053347|FG001|Open-Label Extension Study|Adverse Event|2|||
148884250|NCT00687804|537053348|FG002|Open-Label Extension Study|Adverse Event|2|||
148884251|NCT00687804|537053346|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
148884252|NCT00687804|537053347|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
148884253|NCT00687804|537053348|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
148884254|NCT00687804|537053346|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
148884255|NCT00687804|537053347|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
148884256|NCT00687804|537053348|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
148884257|NCT00687804|537053346|FG000|Open-Label Extension Study|Administrative problems|1|||
148884258|NCT00687804|537053347|FG001|Open-Label Extension Study|Administrative problems|1|||
148884259|NCT00687804|537053348|FG002|Open-Label Extension Study|Administrative problems|0|||
148884260|NCT00687804|537053346|FG000|Open-Label Extension Study|Death|2|||
148884261|NCT00687804|537053347|FG001|Open-Label Extension Study|Death|3|||
148884262|NCT00687804|537053348|FG002|Open-Label Extension Study|Death|3|||
148884263|NCT04390243|537053349|FG000|Overall Study|Death|1|||
148884264|NCT04390243|537053349|FG000|Overall Study|Disease Progression|4|||
149040652|NCT00457743|537628340|FG002|Overall Study|Adverse Event|0|||
149040653|NCT00457743|537628338|FG000|Overall Study|Lack of Efficacy|3|||
149040654|NCT00457743|537628339|FG001|Overall Study|Lack of Efficacy|23|||
148884265|NCT04390243|537053349|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
148884266|NCT00413218|537053356|FG000|Overall Study|Randomized but didn't receive study drug|2|||
148884267|NCT00413218|537053357|FG001|Overall Study|Randomized but didn't receive study drug|8|||
148884268|NCT00413218|537053356|FG000|Overall Study|Death|57|||
148884269|NCT00413218|537053357|FG001|Overall Study|Death|56|||
148884270|NCT00413218|537053356|FG000|Overall Study|Lost to Follow-up|14|||
148884271|NCT00413218|537053357|FG001|Overall Study|Lost to Follow-up|17|||
148884272|NCT00413218|537053356|FG000|Overall Study|Admin|20|||
148884273|NCT00413218|537053357|FG001|Overall Study|Admin|14|||
148884274|NCT00413218|537053356|FG000|Overall Study|Missing|1|||
148884275|NCT00413218|537053357|FG001|Overall Study|Missing|0|||
148884276|NCT00413218|537053356|FG000|Overall Study|Withdrawal by Subject|9|||
148884277|NCT00413218|537053357|FG001|Overall Study|Withdrawal by Subject|1|||
148884278|NCT04669301|537053359|FG000|Overall Study|Lost to Follow-up|0|||
148884279|NCT04669301|537053360|FG001|Overall Study|Lost to Follow-up|1|||
148884280|NCT04669301|537053361|FG002|Overall Study|Lost to Follow-up|0|||
148884281|NCT04669301|537053359|FG000|Overall Study|Withdrawal by Subject|3|||
148884282|NCT04669301|537053360|FG001|Overall Study|Withdrawal by Subject|2|||
148884283|NCT04669301|537053361|FG002|Overall Study|Withdrawal by Subject|0|||
148884284|NCT05236257|537053363|FG000|Overall Study|Ongoing with study treatment|29|||
148884285|NCT05236257|537053364|FG001|Overall Study|Ongoing with study treatment|1|||
148884286|NCT05236257|537053363|FG000|Overall Study|Discontinued study treatment|22|||
148884287|NCT05236257|537053364|FG001|Overall Study|Discontinued study treatment|41|||
148884288|NCT04752332|537053365|FG000|Overall Study|Adverse Event|3|||
148884289|NCT04752332|537053366|FG001|Overall Study|Adverse Event|1|||
148884290|NCT04752332|537053365|FG000|Overall Study|Disease Relapse|1|||
148884291|NCT04752332|537053366|FG001|Overall Study|Disease Relapse|0|||
148884292|NCT04752332|537053365|FG000|Overall Study|Non-compliance With Study Drug|2|||
149040655|NCT00457743|537628340|FG002|Overall Study|Lack of Efficacy|3|||
149040656|NCT01837966|537628341|FG000|Overall Study|Withdrawal by Subject|2|||
149040657|NCT01837966|537628342|FG001|Overall Study|Withdrawal by Subject|1|||
149040658|NCT00159783|537628347|FG000|Overall Study|Adverse Event|5|||
149040659|NCT00159783|537628348|FG001|Overall Study|Adverse Event|7|||
149040660|NCT00159783|537628349|FG002|Overall Study|Adverse Event|9|||
148884293|NCT04752332|537053366|FG001|Overall Study|Non-compliance With Study Drug|0|||
148884294|NCT04752332|537053365|FG000|Overall Study|Physician Decision|2|||
148884295|NCT04752332|537053366|FG001|Overall Study|Physician Decision|1|||
148884296|NCT04752332|537053365|FG000|Overall Study|Protocol Violation|1|||
148884297|NCT04752332|537053366|FG001|Overall Study|Protocol Violation|1|||
148884298|NCT04752332|537053365|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
148884299|NCT04752332|537053366|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
148884300|NCT04752332|537053365|FG000|Overall Study|Study Terminated by Sponsor|10|||
148884301|NCT04752332|537053366|FG001|Overall Study|Study Terminated by Sponsor|48|||
148884302|NCT04752332|537053365|FG000|Overall Study|Withdrawal by Subject|11|||
148884303|NCT04752332|537053366|FG001|Overall Study|Withdrawal by Subject|3|||
148884304|NCT00924443|537053369|FG000|Overall Study|Physician Decision|2|||
148884305|NCT00924443|537053369|FG000|Overall Study|Protocol Violation|1|||
148884306|NCT02863328|537053370|FG000|Overall Study|Lost to Follow-up|4|||
148884307|NCT02863328|537053371|FG001|Overall Study|Lost to Follow-up|10|||
148884308|NCT02863328|537053370|FG000|Overall Study|Withdrawal by Subject|7|||
148884309|NCT02863328|537053371|FG001|Overall Study|Withdrawal by Subject|12|||
148884310|NCT02863328|537053370|FG000|Overall Study|Died|0|||
148884311|NCT02863328|537053371|FG001|Overall Study|Died|1|||
149040661|NCT00159783|537628347|FG000|Overall Study|Lack of Efficacy|1|||
149040662|NCT00159783|537628348|FG001|Overall Study|Lack of Efficacy|2|||
149040663|NCT00159783|537628349|FG002|Overall Study|Lack of Efficacy|3|||
149040664|NCT00159783|537628347|FG000|Overall Study|Withdrawal by Subject|7|||
149040665|NCT00159783|537628348|FG001|Overall Study|Withdrawal by Subject|11|||
149040666|NCT00159783|537628349|FG002|Overall Study|Withdrawal by Subject|12|||
149040667|NCT00159783|537628347|FG000|Overall Study|Lost to Follow-up|6|||
149040668|NCT00159783|537628348|FG001|Overall Study|Lost to Follow-up|5|||
149040669|NCT00159783|537628349|FG002|Overall Study|Lost to Follow-up|11|||
149040670|NCT00159783|537628347|FG000|Overall Study|Other|0|||
149040671|NCT00159783|537628348|FG001|Overall Study|Other|2|||
149040672|NCT00159783|537628349|FG002|Overall Study|Other|4|||
149040673|NCT02928224|537628350|FG000|Overall Study|Lost to Follow-up|1|||
149040674|NCT02928224|537628351|FG001|Overall Study|Lost to Follow-up|1|||
148884312|NCT00595478|537053372|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
148884313|NCT00595478|537053373|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
148884314|NCT00595478|537053372|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
148884315|NCT00595478|537053373|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
148884316|NCT03245775|537053374|FG000|Overall Study|Lost to Follow-up|25|||
148884317|NCT03245775|537053375|FG001|Overall Study|Lost to Follow-up|26|||
148884318|NCT03245775|537053376|FG002|Overall Study|Lost to Follow-up|16|||
148884319|NCT03245775|537053377|FG003|Overall Study|Lost to Follow-up|16|||
148884320|NCT02713828|537053380|FG000|Overall Study|Death|2|||
148884321|NCT02713828|537053381|FG001|Overall Study|Death|0|||
149040675|NCT02928224|537628352|FG002|Overall Study|Lost to Follow-up|3|||
149040676|NCT02928224|537628353|FG003|Overall Study|Lost to Follow-up|0|||
149040677|NCT02928224|537628350|FG000|Overall Study|Death|30|||
149040678|NCT02928224|537628351|FG001|Overall Study|Death|209|||
149040679|NCT02928224|537628352|FG002|Overall Study|Death|193|||
148884322|NCT02713828|537053380|FG000|Overall Study|Withdrawal by Subject|1|||
148884323|NCT02713828|537053381|FG001|Overall Study|Withdrawal by Subject|0|||
148884324|NCT02713828|537053380|FG000|Overall Study|study terminated but patient allowed to|2|||
149040680|NCT02928224|537628353|FG003|Overall Study|Death|198|||
149040681|NCT02928224|537628350|FG000|Overall Study|Withdrawal by Subject|0|||
149040682|NCT02928224|537628351|FG001|Overall Study|Withdrawal by Subject|3|||
149040683|NCT02928224|537628352|FG002|Overall Study|Withdrawal by Subject|7|||
148884325|NCT02713828|537053381|FG001|Overall Study|study terminated but patient allowed to|0|||
148884326|NCT03302247|537053385|FG000|Overall Study|the study has closed prematurely|2|||
148884327|NCT03302247|537053385|FG000|Overall Study|Death|1|||
148884328|NCT03197376|537053386|FG000|Primary and Booster Phase|Adverse Event|0|||
148884329|NCT03197376|537053387|FG001|Primary and Booster Phase|Adverse Event|0|||
148884330|NCT03197376|537053388|FG002|Primary and Booster Phase|Adverse Event|0|||
148884331|NCT03197376|537053389|FG003|Primary and Booster Phase|Adverse Event|1|||
148884332|NCT03197376|537053386|FG000|Primary and Booster Phase|Death|1|||
148884333|NCT03197376|537053387|FG001|Primary and Booster Phase|Death|0|||
148884334|NCT03197376|537053388|FG002|Primary and Booster Phase|Death|0|||
148884335|NCT03197376|537053389|FG003|Primary and Booster Phase|Death|2|||
148884336|NCT03197376|537053386|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
148884337|NCT03197376|537053387|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
148884338|NCT03197376|537053388|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
148884339|NCT03197376|537053389|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
148884340|NCT03197376|537053386|FG000|Primary and Booster Phase|Physician Decision|1|||
148884341|NCT03197376|537053387|FG001|Primary and Booster Phase|Physician Decision|0|||
148884342|NCT03197376|537053388|FG002|Primary and Booster Phase|Physician Decision|1|||
148884343|NCT03197376|537053389|FG003|Primary and Booster Phase|Physician Decision|3|||
148884344|NCT03197376|537053386|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
148884345|NCT03197376|537053387|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
148884346|NCT03197376|537053388|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
148884347|NCT03197376|537053389|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
148884348|NCT03197376|537053386|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
148884349|NCT03197376|537053387|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
148884350|NCT03197376|537053388|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
148884351|NCT03197376|537053389|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
148884352|NCT03197376|537053386|FG000|Primary and Booster Phase|Not vaccine related|1|||
148884353|NCT03197376|537053387|FG001|Primary and Booster Phase|Not vaccine related|2|||
148884354|NCT03197376|537053388|FG002|Primary and Booster Phase|Not vaccine related|0|||
148884355|NCT03197376|537053389|FG003|Primary and Booster Phase|Not vaccine related|6|||
148884356|NCT03197376|537053386|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
148884357|NCT03197376|537053387|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
148884358|NCT03197376|537053388|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
148884359|NCT03197376|537053389|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
148884360|NCT03197376|537053386|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
148884361|NCT03197376|537053387|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
148884362|NCT03197376|537053388|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
148884363|NCT03197376|537053389|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
148884364|NCT03197376|537053386|FG000|Immune Persistence Phase|Not vaccine related|1|||
148884365|NCT03197376|537053387|FG001|Immune Persistence Phase|Not vaccine related|0|||
148884366|NCT03197376|537053388|FG002|Immune Persistence Phase|Not vaccine related|1|||
148884367|NCT03197376|537053389|FG003|Immune Persistence Phase|Not vaccine related|1|||
148884368|NCT02978833|537053393|FG000|Overall Study|Study terminated|1|||
148884369|NCT02978833|537053394|FG001|Overall Study|Study terminated|1|||
148884370|NCT01123395|537053395|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
148884371|NCT01123395|537053396|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
148884372|NCT03691571|537053397|FG000|Overall Study|Withdrawal by Subject|9|||
148884373|NCT03691571|537053398|FG001|Overall Study|Withdrawal by Subject|2|||
148884374|NCT00186901|537053399|FG000|Overall Study|Pregnancy|6|||
148884375|NCT00186901|537053400|FG001|Overall Study|Pregnancy|3|||
148884376|NCT00186901|537053401|FG002|Overall Study|Pregnancy|0|||
148884377|NCT00186901|537053399|FG000|Overall Study|Lost to Follow-up|6|||
148884378|NCT00186901|537053400|FG001|Overall Study|Lost to Follow-up|3|||
148884379|NCT00186901|537053401|FG002|Overall Study|Lost to Follow-up|0|||
148884380|NCT00186901|537053399|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
148884381|NCT00186901|537053400|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
148884382|NCT00186901|537053401|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
148884383|NCT00186901|537053399|FG000|Overall Study|ALL relapse or second malignancy|1|||
148884384|NCT00186901|537053400|FG001|Overall Study|ALL relapse or second malignancy|2|||
148884385|NCT00186901|537053401|FG002|Overall Study|ALL relapse or second malignancy|0|||
148884386|NCT00186901|537053399|FG000|Overall Study|Withdrawal by Subject|4|||
149004703|NCT01800968|537495090|FG001|Overall Study|Withdrawal by Subject|9|||
149004704|NCT01800968|537495089|FG000|Overall Study|Physician Decision|1|||
149004705|NCT01800968|537495090|FG001|Overall Study|Physician Decision|0|||
149004706|NCT03185481|537495094|FG000|Overall Study|Adverse Event|1|||
149004707|NCT03185481|537495094|FG000|Overall Study|Study Terminated by Sponsor|4|||
149004708|NCT00701038|537495098|FG000|Overall Study|study amended pilot group of patients|4|||
149004709|NCT00701038|537495099|FG001|Overall Study|study amended pilot group of patients|4|||
149004710|NCT00504426|537495100|FG000|Overall Study|Adverse Event|0|||
149004711|NCT00504426|537495101|FG001|Overall Study|Adverse Event|0|||
149004712|NCT00504426|537495102|FG002|Overall Study|Adverse Event|2|||
149004713|NCT00504426|537495103|FG003|Overall Study|Adverse Event|0|||
148884387|NCT00186901|537053400|FG001|Overall Study|Withdrawal by Subject|5|||
148884388|NCT00186901|537053401|FG002|Overall Study|Withdrawal by Subject|0|||
148884389|NCT00186901|537053399|FG000|Overall Study|Open label|3|||
148884390|NCT00186901|537053400|FG001|Overall Study|Open label|2|||
148884391|NCT00186901|537053401|FG002|Overall Study|Open label|0|||
148884392|NCT00186901|537053399|FG000|Overall Study|Limited adherence to study requirements|20|||
148884393|NCT00186901|537053400|FG001|Overall Study|Limited adherence to study requirements|23|||
148884394|NCT00186901|537053401|FG002|Overall Study|Limited adherence to study requirements|0|||
148884395|NCT00186901|537053399|FG000|Overall Study|Bone Mineral Density > 0|0|||
148884396|NCT00186901|537053400|FG001|Overall Study|Bone Mineral Density > 0|0|||
148884397|NCT00186901|537053401|FG002|Overall Study|Bone Mineral Density > 0|149|||
148884398|NCT02420379|537054857|FG000|Overall Study|Withdrawal by Subject|0|||
148884399|NCT02420379|537054858|FG001|Overall Study|Withdrawal by Subject|3|||
148884400|NCT02420379|537054857|FG000|Overall Study|Unable to complete due to schooling|0|||
148884401|NCT02420379|537054858|FG001|Overall Study|Unable to complete due to schooling|1|||
148884402|NCT02420379|537054857|FG000|Overall Study|Transitioned to commercial drug|1|||
148884403|NCT02420379|537054858|FG001|Overall Study|Transitioned to commercial drug|0|||
148884404|NCT00859547|537054865|FG000|Overall Study|Lost to Follow-up|1|||
148884405|NCT00859547|537054865|FG000|Overall Study|Parent withdrew consent|1|||
148884406|NCT00217425|537054867|FG000|Overall Study|Never started treatment|2|||
148884407|NCT00217425|537054867|FG000|Overall Study|Patient ineligible|5|||
148884408|NCT00217425|537054867|FG000|Overall Study|Lack of Efficacy|13|||
148884409|NCT00217425|537054867|FG000|Overall Study|Adverse Event|8|||
148884410|NCT00217425|537054867|FG000|Overall Study|Withdrawal by Subject|4|||
148884411|NCT00217425|537054867|FG000|Overall Study|Other complicating disease|1|||
148884412|NCT00217425|537054867|FG000|Overall Study|Other|4|||
148884413|NCT00086047|537054869|FG000|Overall Study|Lost to Follow-up|7|||
148884414|NCT00086047|537054870|FG001|Overall Study|Lost to Follow-up|6|||
148884415|NCT00086047|537054869|FG000|Overall Study|Physician Decision|0|||
148884416|NCT00086047|537054870|FG001|Overall Study|Physician Decision|1|||
148884417|NCT01473732|537054871|FG000|Overall Study|Adverse Event|1|||
148884418|NCT01473732|537054872|FG001|Overall Study|Adverse Event|0|||
148884419|NCT01473732|537054871|FG000|Overall Study|Death|1|||
148884420|NCT01473732|537054872|FG001|Overall Study|Death|0|||
148884421|NCT01395901|537054873|FG000|Overall Study|Lost to Follow-up|4|||
148884422|NCT01395901|537054874|FG001|Overall Study|Lost to Follow-up|0|||
148884423|NCT01395901|537054873|FG000|Overall Study|Randomized but not received study drug|5|||
148884424|NCT01395901|537054874|FG001|Overall Study|Randomized but not received study drug|4|||
148884425|NCT01395901|537054873|FG000|Overall Study|Adverse Event|0|||
148884426|NCT01395901|537054874|FG001|Overall Study|Adverse Event|1|||
148884427|NCT01395901|537054873|FG000|Overall Study|Withdrawal of consent|1|||
148884428|NCT01395901|537054874|FG001|Overall Study|Withdrawal of consent|0|||
148884429|NCT03579940|537054880|FG000|Period 2|Withdrawal by Subject|0|||
148884430|NCT03579940|537054881|FG001|Period 2|Withdrawal by Subject|0|||
148884431|NCT03579940|537054882|FG002|Period 2|Withdrawal by Subject|1|||
148884432|NCT03579940|537054883|FG003|Period 2|Withdrawal by Subject|0|||
148884433|NCT03579940|537054884|FG004|Period 2|Withdrawal by Subject|0|||
148884434|NCT03579940|537054885|FG005|Period 2|Withdrawal by Subject|0|||
148884435|NCT03579940|537054886|FG006|Period 2|Withdrawal by Subject|0|||
148884436|NCT03579940|537054887|FG007|Period 2|Withdrawal by Subject|0|||
148884437|NCT03579940|537054888|FG008|Period 2|Withdrawal by Subject|0|||
148884438|NCT03579940|537054889|FG009|Period 2|Withdrawal by Subject|0|||
148884439|NCT03579940|537054890|FG010|Period 2|Withdrawal by Subject|0|||
148884440|NCT01217944|537054891|FG000|Overall Study|Protocol Violation|1|||
148884441|NCT01217944|537054892|FG001|Overall Study|Protocol Violation|1|||
149040684|NCT02928224|537628353|FG003|Overall Study|Withdrawal by Subject|20|||
148884442|NCT01217944|537054893|FG002|Overall Study|Protocol Violation|0|||
148884443|NCT01217944|537054891|FG000|Overall Study|Lost to Follow-up|3|||
148884444|NCT01217944|537054892|FG001|Overall Study|Lost to Follow-up|1|||
148884445|NCT01217944|537054893|FG002|Overall Study|Lost to Follow-up|0|||
148884446|NCT01217944|537054891|FG000|Overall Study|Withdrawal by Subject|1|||
148884447|NCT01217944|537054892|FG001|Overall Study|Withdrawal by Subject|2|||
148884448|NCT01217944|537054893|FG002|Overall Study|Withdrawal by Subject|0|||
148884449|NCT01217944|537054891|FG000|Overall Study|Lack of Efficacy|1|||
148884450|NCT01217944|537054892|FG001|Overall Study|Lack of Efficacy|0|||
148884451|NCT01217944|537054893|FG002|Overall Study|Lack of Efficacy|0|||
148884452|NCT00671034|537054894|FG000|Overall Study|Adverse Event|5|||
148884453|NCT00671034|537054895|FG001|Overall Study|Adverse Event|7|||
148884454|NCT00671034|537054896|FG002|Overall Study|Adverse Event|1|||
148884455|NCT00671034|537054894|FG000|Overall Study|Death|3|||
148884456|NCT00671034|537054895|FG001|Overall Study|Death|2|||
148884457|NCT00671034|537054896|FG002|Overall Study|Death|1|||
148884458|NCT00671034|537054894|FG000|Overall Study|Physician Decision|12|||
148884459|NCT00671034|537054895|FG001|Overall Study|Physician Decision|4|||
148884460|NCT00671034|537054896|FG002|Overall Study|Physician Decision|5|||
148884461|NCT00671034|537054894|FG000|Overall Study|VHR ALL feature|8|||
148884462|NCT00671034|537054895|FG001|Overall Study|VHR ALL feature|3|||
148884463|NCT00671034|537054896|FG002|Overall Study|VHR ALL feature|5|||
148884464|NCT00671034|537054894|FG000|Overall Study|Refusal|5|||
148884465|NCT00671034|537054895|FG001|Overall Study|Refusal|3|||
148884466|NCT00671034|537054896|FG002|Overall Study|Refusal|5|||
148884467|NCT00671034|537054894|FG000|Overall Study|includes Alternative therapy, etc.|6|||
148884468|NCT00671034|537054895|FG001|Overall Study|includes Alternative therapy, etc.|1|||
148884469|NCT00671034|537054896|FG002|Overall Study|includes Alternative therapy, etc.|7|||
148884470|NCT00713544|537054900|FG000|Overall Study|Adverse Event|5|||
148884471|NCT00713544|537054901|FG001|Overall Study|Adverse Event|3|||
148884472|NCT00713544|537054902|FG002|Overall Study|Adverse Event|7|||
148884473|NCT00713544|537054903|FG003|Overall Study|Adverse Event|7|||
148884474|NCT00713544|537054904|FG004|Overall Study|Adverse Event|3|||
148884475|NCT00713544|537054905|FG005|Overall Study|Adverse Event|5|||
148884476|NCT00713544|537054900|FG000|Overall Study|Withdrawal by Subject|2|||
148884477|NCT00713544|537054901|FG001|Overall Study|Withdrawal by Subject|0|||
148884478|NCT00713544|537054902|FG002|Overall Study|Withdrawal by Subject|3|||
148884479|NCT00713544|537054903|FG003|Overall Study|Withdrawal by Subject|2|||
148884480|NCT00713544|537054904|FG004|Overall Study|Withdrawal by Subject|3|||
148884481|NCT00713544|537054905|FG005|Overall Study|Withdrawal by Subject|1|||
148884482|NCT00713544|537054900|FG000|Overall Study|Protocol Violation|0|||
148884483|NCT00713544|537054901|FG001|Overall Study|Protocol Violation|0|||
148884484|NCT00713544|537054902|FG002|Overall Study|Protocol Violation|0|||
148884485|NCT00713544|537054903|FG003|Overall Study|Protocol Violation|0|||
148884486|NCT00713544|537054904|FG004|Overall Study|Protocol Violation|0|||
148884487|NCT00713544|537054905|FG005|Overall Study|Protocol Violation|1|||
148884488|NCT00713544|537054900|FG000|Overall Study|Physician Decision|0|||
148884489|NCT00713544|537054901|FG001|Overall Study|Physician Decision|0|||
148884490|NCT00713544|537054902|FG002|Overall Study|Physician Decision|0|||
148884491|NCT00713544|537054903|FG003|Overall Study|Physician Decision|0|||
148884492|NCT00713544|537054904|FG004|Overall Study|Physician Decision|0|||
148884493|NCT00713544|537054905|FG005|Overall Study|Physician Decision|2|||
148884494|NCT00713544|537054900|FG000|Overall Study|Lack of Efficacy|0|||
148884495|NCT00713544|537054901|FG001|Overall Study|Lack of Efficacy|1|||
148884496|NCT00713544|537054902|FG002|Overall Study|Lack of Efficacy|0|||
148884497|NCT00713544|537054903|FG003|Overall Study|Lack of Efficacy|1|||
148884498|NCT00713544|537054904|FG004|Overall Study|Lack of Efficacy|1|||
148884499|NCT00713544|537054905|FG005|Overall Study|Lack of Efficacy|0|||
148884500|NCT00713544|537054900|FG000|Overall Study|Lost to Follow-up|0|||
148884501|NCT00713544|537054901|FG001|Overall Study|Lost to Follow-up|0|||
148884502|NCT00713544|537054902|FG002|Overall Study|Lost to Follow-up|1|||
148884503|NCT00713544|537054903|FG003|Overall Study|Lost to Follow-up|0|||
148884504|NCT00713544|537054904|FG004|Overall Study|Lost to Follow-up|0|||
148884505|NCT00713544|537054905|FG005|Overall Study|Lost to Follow-up|0|||
148884506|NCT00713544|537054900|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
148884507|NCT00713544|537054901|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
148884508|NCT00713544|537054902|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
148884509|NCT00713544|537054903|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
148884510|NCT00713544|537054904|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
148884511|NCT00713544|537054905|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
148884512|NCT00713544|537054900|FG000|Overall Study|Incorrect enrollment|0|||
148884513|NCT00713544|537054901|FG001|Overall Study|Incorrect enrollment|1|||
148884514|NCT00713544|537054902|FG002|Overall Study|Incorrect enrollment|0|||
148884515|NCT00713544|537054903|FG003|Overall Study|Incorrect enrollment|0|||
148884516|NCT00713544|537054904|FG004|Overall Study|Incorrect enrollment|0|||
148884517|NCT00713544|537054905|FG005|Overall Study|Incorrect enrollment|0|||
148884518|NCT00713544|537054900|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
148884519|NCT00713544|537054901|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
148884520|NCT00713544|537054902|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
148884521|NCT00713544|537054903|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
148884522|NCT00713544|537054904|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
148884523|NCT00713544|537054905|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
149040685|NCT02928224|537628350|FG000|Overall Study|Study participation terminated by sponsor|3|||
149040686|NCT02928224|537628351|FG001|Overall Study|Study participation terminated by sponsor|8|||
149040687|NCT02928224|537628352|FG002|Overall Study|Study participation terminated by sponsor|12|||
149040688|NCT02928224|537628353|FG003|Overall Study|Study participation terminated by sponsor|3|||
149040689|NCT02928224|537628350|FG000|Overall Study|Other|3|||
149040690|NCT02928224|537628351|FG001|Overall Study|Other|3|||
149040691|NCT02928224|537628352|FG002|Overall Study|Other|5|||
149040692|NCT02928224|537628353|FG003|Overall Study|Other|0|||
149040693|NCT02538107|537628354|FG000|Overall Study|Did not receive any Mircera dose|11|||
149040694|NCT02538107|537628354|FG000|Overall Study|Missing|5|||
149040695|NCT02538107|537628354|FG000|Overall Study|Necessity of dialysis|20|||
149040696|NCT02538107|537628354|FG000|Overall Study|Administration of other ESA|11|||
149040697|NCT02538107|537628354|FG000|Overall Study|No further treatment necessary|18|||
149040698|NCT02538107|537628354|FG000|Overall Study|Withdrawal by Subject|17|||
149040699|NCT02538107|537628354|FG000|Overall Study|Death|4|||
149040700|NCT02538107|537628354|FG000|Overall Study|Administrative reason|5|||
148884524|NCT00269919|537054906|FG000|Overall Study|Other|26|||
148884525|NCT00269919|537054906|FG000|Overall Study|Started but not treated|1|||
148884526|NCT02471014|537054909|FG000|Overall Study|Lost to Follow-up|2|||
148884527|NCT02471014|537054910|FG001|Overall Study|Lost to Follow-up|2|||
148884528|NCT00786799|537054911|FG000|Overall Study|Lost to Follow-up|1|||
148884529|NCT00786799|537054912|FG001|Overall Study|Lost to Follow-up|1|||
148884530|NCT02380287|537054913|FG000|Overall Study|Adverse Event|0|||
148884531|NCT02380287|537054914|FG001|Overall Study|Adverse Event|0|||
148884532|NCT02380287|537054915|FG002|Overall Study|Adverse Event|1|||
148884533|NCT02380287|537054916|FG003|Overall Study|Adverse Event|0|||
148884534|NCT02380287|537054917|FG004|Overall Study|Adverse Event|0|||
148884535|NCT02380287|537054918|FG005|Overall Study|Adverse Event|0|||
148884536|NCT02380287|537054919|FG006|Overall Study|Adverse Event|0|||
148884537|NCT02380287|537054920|FG007|Overall Study|Adverse Event|0|||
148884538|NCT04473963|537054921|FG000|Overall Study|Withdrawal by Subject|1|||
148884539|NCT04473963|537054922|FG001|Overall Study|Withdrawal by Subject|1|||
148884540|NCT04473963|537054923|FG002|Overall Study|Withdrawal by Subject|0|||
148884541|NCT04473963|537054921|FG000|Overall Study|Not inducible in AF|0|||
148884542|NCT04473963|537054922|FG001|Overall Study|Not inducible in AF|0|||
148884543|NCT04473963|537054923|FG002|Overall Study|Not inducible in AF|2|||
148884544|NCT01641601|537054924|FG000|Overall Study|Study discontinued.|3|||
148884545|NCT01641601|537054925|FG001|Overall Study|Study discontinued.|5|||
148884546|NCT03361293|537054928|FG000|Overall Study|Lost to Follow-up|0|||
148884547|NCT03361293|537054929|FG001|Overall Study|Lost to Follow-up|2|||
148884548|NCT03361293|537054928|FG000|Overall Study|Withdrawal by Subject|1|||
148884549|NCT03361293|537054929|FG001|Overall Study|Withdrawal by Subject|3|||
148884550|NCT01426958|537054930|FG000|Overall Study|Adverse Event|2|||
148884551|NCT01450761|537054935|FG000|Randomization|Subject no longer meets study criteria|1|||
148884552|NCT01450761|537054936|FG001|Randomization|Subject no longer meets study criteria|2|||
148884553|NCT01450761|537054935|FG000|Randomization|Withdrawal by Subject|2|||
148884554|NCT01450761|537054936|FG001|Randomization|Withdrawal by Subject|0|||
148884555|NCT01450761|537054935|FG000|Randomization|Disease progression|0|||
148884556|NCT01450761|537054936|FG001|Randomization|Disease progression|2|||
148884557|NCT01450761|537054935|FG000|Randomization|Adverse Event unrelated to study drug|1|||
148884558|NCT01450761|537054936|FG001|Randomization|Adverse Event unrelated to study drug|0|||
148884559|NCT01450761|537054935|FG000|Randomization|Other|0|||
148884560|NCT01450761|537054936|FG001|Randomization|Other|1|||
148884561|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Disease progression|33|||
148884562|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Disease progression|32|||
148884563|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
148884564|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
148884565|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
148884566|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
148884567|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
148884568|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
149040701|NCT02538107|537628354|FG000|Overall Study|Adverse Event|4|||
149040702|NCT02538107|537628354|FG000|Overall Study|Surgery|1|||
149040703|NCT02538107|537628354|FG000|Overall Study|Other|7|||
149040704|NCT02538107|537628354|FG000|Overall Study|Not recorded|7|||
149040705|NCT01236560|537628355|FG000|Overall Study|Adverse Event|0|||
149040706|NCT01236560|537628356|FG001|Overall Study|Adverse Event|2|||
149040707|NCT01236560|537628357|FG002|Overall Study|Adverse Event|1|||
149040708|NCT01236560|537628358|FG003|Overall Study|Adverse Event|3|||
149040709|NCT01236560|537628359|FG004|Overall Study|Adverse Event|0|||
149040710|NCT01236560|537628360|FG005|Overall Study|Adverse Event|0|||
149040711|NCT01236560|537628355|FG000|Overall Study|Death|0|||
149040712|NCT01236560|537628356|FG001|Overall Study|Death|1|||
149040713|NCT01236560|537628357|FG002|Overall Study|Death|0|||
149040714|NCT01236560|537628358|FG003|Overall Study|Death|1|||
149040715|NCT01236560|537628359|FG004|Overall Study|Death|0|||
149040716|NCT01236560|537628360|FG005|Overall Study|Death|0|||
149040717|NCT01236560|537628355|FG000|Overall Study|Lost to Follow-up|0|||
149040718|NCT01236560|537628356|FG001|Overall Study|Lost to Follow-up|1|||
149040719|NCT01236560|537628357|FG002|Overall Study|Lost to Follow-up|1|||
149040720|NCT01236560|537628358|FG003|Overall Study|Lost to Follow-up|0|||
149040721|NCT01236560|537628359|FG004|Overall Study|Lost to Follow-up|0|||
149040722|NCT01236560|537628360|FG005|Overall Study|Lost to Follow-up|0|||
149040723|NCT01236560|537628355|FG000|Overall Study|Physician Decision|0|||
149040724|NCT01236560|537628356|FG001|Overall Study|Physician Decision|1|||
149040725|NCT01236560|537628357|FG002|Overall Study|Physician Decision|8|||
149040726|NCT01236560|537628358|FG003|Overall Study|Physician Decision|0|||
148884569|NCT01450761|537054935|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
148884570|NCT01450761|537054936|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
149040727|NCT01236560|537628359|FG004|Overall Study|Physician Decision|0|||
148884571|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Death|3|||
148884572|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Death|3|||
148884573|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Other|2|||
148884574|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Other|2|||
148884575|NCT01450761|537054935|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
149040728|NCT01236560|537628360|FG005|Overall Study|Physician Decision|0|||
149040729|NCT01236560|537628355|FG000|Overall Study|Withdrawal by Subject|0|||
148884576|NCT01450761|537054936|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
148884577|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
148884578|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
148884579|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
148884580|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
148884581|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
148884582|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
148884583|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
148884584|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
148884585|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
148884586|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
148884587|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Death|5|||
148884588|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Death|6|||
148884589|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
148884590|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
148884591|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
148884592|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
148884593|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
148884594|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
148884595|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
148884596|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
148884597|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
148884598|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
148884599|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
148884600|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
148884601|NCT01450761|537054935|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
148884602|NCT01450761|537054936|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
148884603|NCT02073682|537054948|FG000|Overall Study|Low Creatinine Clearance|1|||
148884604|NCT02073682|537054949|FG001|Overall Study|Low Creatinine Clearance|2|||
148884605|NCT02073682|537054948|FG000|Overall Study|Death|86|||
148884606|NCT02073682|537054949|FG001|Overall Study|Death|100|||
148884607|NCT02073682|537054948|FG000|Overall Study|Cancer Cured|10|||
148884608|NCT02073682|537054949|FG001|Overall Study|Cancer Cured|15|||
148884609|NCT02073682|537054948|FG000|Overall Study|ID: Patient Noncompliance|1|||
148884610|NCT02073682|537054949|FG001|Overall Study|ID: Patient Noncompliance|2|||
148884611|NCT02073682|537054948|FG000|Overall Study|ID: Palliative Treatment Only|10|||
148884612|NCT02073682|537054949|FG001|Overall Study|ID: Palliative Treatment Only|7|||
148884613|NCT02073682|537054948|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
148884614|NCT02073682|537054949|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
148884615|NCT02073682|537054948|FG000|Overall Study|Platelet Count <50,000/mL|1|||
148884616|NCT02073682|537054949|FG001|Overall Study|Platelet Count <50,000/mL|2|||
148884617|NCT02073682|537054948|FG000|Overall Study|Surgery/Medical Procedure|3|||
148884618|NCT02073682|537054949|FG001|Overall Study|Surgery/Medical Procedure|1|||
148884619|NCT02073682|537054948|FG000|Overall Study|Withdrawal by Subject|6|||
148884620|NCT02073682|537054949|FG001|Overall Study|Withdrawal by Subject|8|||
148884621|NCT02073682|537054948|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
148884622|NCT02073682|537054949|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
148884623|NCT02073682|537054948|FG000|Overall Study|Cancer Progression|53|||
148884624|NCT02073682|537054949|FG001|Overall Study|Cancer Progression|33|||
148884625|NCT02073682|537054948|FG000|Overall Study|Protocol Violation|1|||
148884626|NCT02073682|537054949|FG001|Overall Study|Protocol Violation|0|||
148884627|NCT02073682|537054948|FG000|Overall Study|Adverse Event|79|||
148884628|NCT02073682|537054949|FG001|Overall Study|Adverse Event|62|||
148884629|NCT02073682|537054948|FG000|Overall Study|No reason provided|11|||
148884630|NCT02073682|537054949|FG001|Overall Study|No reason provided|9|||
148884631|NCT02073682|537054948|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
148884632|NCT02073682|537054949|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
148884633|NCT02073682|537054948|FG000|Overall Study|Lost to Follow-up|1|||
148884634|NCT02073682|537054949|FG001|Overall Study|Lost to Follow-up|1|||
149040730|NCT01236560|537628356|FG001|Overall Study|Withdrawal by Subject|0|||
149040731|NCT01236560|537628357|FG002|Overall Study|Withdrawal by Subject|1|||
149040732|NCT01236560|537628358|FG003|Overall Study|Withdrawal by Subject|2|||
149040733|NCT01236560|537628359|FG004|Overall Study|Withdrawal by Subject|0|||
149040734|NCT01236560|537628360|FG005|Overall Study|Withdrawal by Subject|0|||
148884635|NCT02073682|537054948|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
148884636|NCT02073682|537054949|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
148884637|NCT03801174|537054950|FG000|Overall Study|Withdrawal by Subject|14|||
148884638|NCT03801174|537054951|FG001|Overall Study|Withdrawal by Subject|15|||
148884639|NCT03801174|537054950|FG000|Overall Study|Death|1|||
148884640|NCT03801174|537054951|FG001|Overall Study|Death|0|||
149040735|NCT01236560|537628355|FG000|Overall Study|Progressive disease|5|||
148884641|NCT03801174|537054950|FG000|Overall Study|Pregnancy|2|||
148884642|NCT03801174|537054951|FG001|Overall Study|Pregnancy|2|||
148884643|NCT03801174|537054950|FG000|Overall Study|Lost to Follow-up|19|||
148884644|NCT03801174|537054951|FG001|Overall Study|Lost to Follow-up|10|||
148884645|NCT03801174|537054950|FG000|Overall Study|Other|4|||
148884646|NCT03801174|537054951|FG001|Overall Study|Other|3|||
148884647|NCT03801174|537054950|FG000|Overall Study|Lack of Efficacy|4|||
148884648|NCT03801174|537054951|FG001|Overall Study|Lack of Efficacy|0|||
148884649|NCT03801174|537054950|FG000|Overall Study|Unwilling to complete activities|5|||
148884650|NCT03801174|537054951|FG001|Overall Study|Unwilling to complete activities|6|||
148884651|NCT03801174|537054950|FG000|Overall Study|Moved out of area|3|||
148884652|NCT03801174|537054951|FG001|Overall Study|Moved out of area|0|||
148884653|NCT00855816|537054952|FG000|Overall Study|Withdrawal by Subject|22|||
148884654|NCT00855816|537054953|FG001|Overall Study|Withdrawal by Subject|15|||
148884655|NCT00855816|537054952|FG000|Overall Study|Lost to Follow-up|3|||
148884656|NCT00855816|537054953|FG001|Overall Study|Lost to Follow-up|5|||
148884657|NCT00855816|537054952|FG000|Overall Study|Death|1|||
148884658|NCT00855816|537054953|FG001|Overall Study|Death|0|||
148884659|NCT00855816|537054952|FG000|Overall Study|Became ineligible|0|||
148884660|NCT00855816|537054953|FG001|Overall Study|Became ineligible|1|||
148884661|NCT01965704|537054957|FG000|Overall Study|Withdrawal by Subject|2|||
148884662|NCT01965704|537054958|FG001|Overall Study|Withdrawal by Subject|2|||
148884663|NCT01965704|537054959|FG002|Overall Study|Withdrawal by Subject|1|||
148884664|NCT01965704|537054960|FG003|Overall Study|Withdrawal by Subject|1|||
148884665|NCT01965704|537054957|FG000|Overall Study|Delivered at home|1|||
148884666|NCT01965704|537054958|FG001|Overall Study|Delivered at home|1|||
148884667|NCT01965704|537054959|FG002|Overall Study|Delivered at home|0|||
148884668|NCT01965704|537054960|FG003|Overall Study|Delivered at home|0|||
148884669|NCT01965704|537054957|FG000|Overall Study|Experienced complications|0|||
148884670|NCT01965704|537054958|FG001|Overall Study|Experienced complications|0|||
148884671|NCT01965704|537054959|FG002|Overall Study|Experienced complications|2|||
148884672|NCT01965704|537054960|FG003|Overall Study|Experienced complications|2|||
148884673|NCT01965704|537054957|FG000|Overall Study|Adverse Event|0|||
148884674|NCT01965704|537054958|FG001|Overall Study|Adverse Event|0|||
148884675|NCT01965704|537054959|FG002|Overall Study|Adverse Event|1|||
148884676|NCT01965704|537054960|FG003|Overall Study|Adverse Event|1|||
148884677|NCT01965704|537054957|FG000|Overall Study|Did not meet inclusion criteria|0|||
148884678|NCT01965704|537054958|FG001|Overall Study|Did not meet inclusion criteria|0|||
148884679|NCT01965704|537054959|FG002|Overall Study|Did not meet inclusion criteria|1|||
148884680|NCT01965704|537054960|FG003|Overall Study|Did not meet inclusion criteria|1|||
148884681|NCT01521507|537054968|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
148884682|NCT01521507|537054969|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
148884683|NCT01521507|537054968|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
148884684|NCT01521507|537054969|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
148884685|NCT01521507|537054968|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
148884686|NCT01521507|537054969|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
148884687|NCT01521507|537054968|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
148884688|NCT01521507|537054969|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
148884689|NCT01521507|537054968|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
149040736|NCT01236560|537628356|FG001|Overall Study|Progressive disease|19|||
149040737|NCT01236560|537628357|FG002|Overall Study|Progressive disease|9|||
149040738|NCT01236560|537628358|FG003|Overall Study|Progressive disease|16|||
149040739|NCT01236560|537628359|FG004|Overall Study|Progressive disease|0|||
149040740|NCT01236560|537628360|FG005|Overall Study|Progressive disease|0|||
149040741|NCT00919763|537628361|FG000|Overall Study|Adverse Event|7|||
149040742|NCT00919763|537628362|FG001|Overall Study|Adverse Event|1|||
149040743|NCT00919763|537628361|FG000|Overall Study|Lost to Follow-up|1|||
149040744|NCT00919763|537628362|FG001|Overall Study|Lost to Follow-up|0|||
149040745|NCT00919763|537628361|FG000|Overall Study|Protocol Violation|1|||
149040746|NCT00919763|537628362|FG001|Overall Study|Protocol Violation|1|||
148884690|NCT01521507|537054969|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
148884691|NCT01521507|537054968|FG000|Stage 2: Observational Design|Physician Decision|1|||
148884692|NCT01521507|537054969|FG001|Stage 2: Observational Design|Physician Decision|0|||
148884693|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
148884694|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
148884695|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
148884696|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
148884697|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
148884698|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
148884699|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
148884700|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
148884701|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
148884702|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
148884703|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
148884704|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
148884705|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
148884706|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
148884707|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
148884708|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
148884709|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
148884710|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
148884711|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
148884712|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
148884713|NCT03573323|537054970|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
148884714|NCT03573323|537054971|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
148884715|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
148884716|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
148884717|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
148884718|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
148884719|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
148884720|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
148884721|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
148884722|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
148884723|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
148884724|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
148884725|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
148884726|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
148884727|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
148884728|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
148884729|NCT03573323|537054970|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
148884730|NCT03573323|537054971|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
148884731|NCT03188432|537054972|FG000|Overall Study|Death|3|||
148884732|NCT03188432|537054972|FG000|Overall Study|Withdrawal by Subject|15|||
148884733|NCT03188432|537054972|FG000|Overall Study|Did not complete protocol treatment|9|||
148884734|NCT01843023|537054979|FG000|Overall Study|Death|1|||
148884735|NCT01843023|537054980|FG001|Overall Study|Death|0|||
148884736|NCT01843023|537054979|FG000|Overall Study|Lost to Follow-up|24|||
148884737|NCT01843023|537054980|FG001|Overall Study|Lost to Follow-up|29|||
148884738|NCT01843023|537054979|FG000|Overall Study|Withdrawal by Subject|8|||
148884739|NCT01843023|537054980|FG001|Overall Study|Withdrawal by Subject|6|||
148884740|NCT00466921|537054981|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
148884741|NCT00466921|537054981|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
148884742|NCT00466921|537054981|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
148884743|NCT00466921|537054981|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
148884744|NCT00466921|537054981|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
148884745|NCT00466921|537054981|FG000|Follow up for a Minimum of 1 Year|Death|6|||
148884746|NCT02741635|537054987|FG000|Overall Study|Withdrawal by Subject|1|||
148884747|NCT01427933|537054991|FG000|Overall Study|Withdrawal by Subject|5|||
148884748|NCT01427933|537054992|FG001|Overall Study|Withdrawal by Subject|8|||
148884749|NCT01427933|537054991|FG000|Overall Study|Lost to Follow-up|1|||
148884750|NCT01427933|537054992|FG001|Overall Study|Lost to Follow-up|5|||
148884751|NCT01427933|537054991|FG000|Overall Study|Other|1|||
148884752|NCT01427933|537054992|FG001|Overall Study|Other|0|||
148884753|NCT01427933|537054991|FG000|Overall Study|Investigator's Decision|1|||
148884754|NCT01427933|537054992|FG001|Overall Study|Investigator's Decision|0|||
148884755|NCT01633541|537054995|FG000|Overall Study|Death|1|||
148884756|NCT01633541|537054996|FG001|Overall Study|Death|0|||
148884757|NCT03472326|537054997|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
148884758|NCT03472326|537054998|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
149040747|NCT00919763|537628361|FG000|Overall Study|Withdrawal by Subject|3|||
149040748|NCT00919763|537628362|FG001|Overall Study|Withdrawal by Subject|1|||
149040749|NCT00919763|537628361|FG000|Overall Study|Non-compliance|0|||
149040750|NCT00919763|537628362|FG001|Overall Study|Non-compliance|1|||
149040751|NCT02471755|537628363|FG000|Overall Study|Withdrawal by Subject|1|||
149040752|NCT02471755|537628364|FG001|Overall Study|Withdrawal by Subject|0|||
149040753|NCT02471755|537628363|FG000|Overall Study|Lost to Follow-up|0|||
149040754|NCT02471755|537628364|FG001|Overall Study|Lost to Follow-up|1|||
149040755|NCT04740164|537628366|FG000|Overall Study|Lack of Efficacy|4|||
149040756|NCT04740164|537628367|FG001|Overall Study|Lack of Efficacy|0|||
148884759|NCT03472326|537054999|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
148884760|NCT03472326|537055000|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
149040757|NCT04740164|537628366|FG000|Overall Study|Physician Decision|3|||
149040758|NCT04740164|537628367|FG001|Overall Study|Physician Decision|3|||
148884761|NCT03472326|537054997|FG000|Part 2: Combination Therapy|Pregnancy|0|||
148884762|NCT03472326|537054998|FG001|Part 2: Combination Therapy|Pregnancy|0|||
148884763|NCT03472326|537054999|FG002|Part 2: Combination Therapy|Pregnancy|0|||
148884764|NCT03472326|537055000|FG003|Part 2: Combination Therapy|Pregnancy|1|||
148884765|NCT05447663|537055001|FG000|Overall Study|Study terminated by Sponsor|5|||
148884766|NCT05447663|537055001|FG000|Overall Study|Death|2|||
148884767|NCT05447663|537055001|FG000|Overall Study|Withdrawal by Subject|1|||
148884768|NCT01100320|537055004|FG000|Period 1|Withdrawal by Subject|2|||
148884769|NCT01100320|537055005|FG001|Period 1|Withdrawal by Subject|4|||
148884770|NCT01100320|537055004|FG000|Period 1|Positive Drug Screen|1|||
148884771|NCT01100320|537055005|FG001|Period 1|Positive Drug Screen|1|||
148884772|NCT01100320|537055004|FG000|Period 1|Adverse Event|2|||
148884773|NCT01100320|537055005|FG001|Period 1|Adverse Event|2|||
148884774|NCT01100320|537055004|FG000|Period 2|Withdrawal by Subject|1|||
148884775|NCT01100320|537055005|FG001|Period 2|Withdrawal by Subject|1|||
148884776|NCT04980612|537055006|FG000|Overall Study|Withdrawal by Subject|7|||
148884777|NCT04980612|537055007|FG001|Overall Study|Withdrawal by Subject|5|||
148884778|NCT01502228|537055010|FG000|Overall Study|Death|1|||
148884779|NCT05730387|537055011|FG000|Overall Study|Stillbirth|0|||
148884780|NCT05730387|537055012|FG001|Overall Study|Stillbirth|262|||
148884781|NCT05730387|537055011|FG000|Overall Study|Died during or after delivery|2|||
148884782|NCT05730387|537055012|FG001|Overall Study|Died during or after delivery|85|||
148884783|NCT05730387|537055011|FG000|Overall Study|Died after being admitted|0|||
148884784|NCT05730387|537055012|FG001|Overall Study|Died after being admitted|44|||
148884785|NCT05730387|537055011|FG000|Overall Study|Lost to Follow-up|69|||
148884786|NCT05730387|537055012|FG001|Overall Study|Lost to Follow-up|77|||
148884787|NCT02728089|537055013|FG000|Overall Study|Physician Decision|2|||
148884788|NCT02728089|537055013|FG000|Overall Study|Withdrawal by Subject|1|||
148884789|NCT01219985|537055014|FG000|Overall Study|Physician Decision|20|||
148884790|NCT00596752|537055015|FG000|Overall Study|Other Reason|44|||
148884791|NCT00596752|537055016|FG001|Overall Study|Other Reason|49|||
148884792|NCT00596752|537055015|FG000|Overall Study|Adverse Event|34|||
148884793|NCT00596752|537055016|FG001|Overall Study|Adverse Event|34|||
148884794|NCT00596752|537055015|FG000|Overall Study|Lost to Follow-up|22|||
148884795|NCT00596752|537055016|FG001|Overall Study|Lost to Follow-up|38|||
148884796|NCT00596752|537055015|FG000|Overall Study|Withdrawal by Subject|12|||
148884797|NCT00596752|537055016|FG001|Overall Study|Withdrawal by Subject|9|||
148884798|NCT00596752|537055015|FG000|Overall Study|Unsatisfactory Compliance|9|||
148884799|NCT00596752|537055016|FG001|Overall Study|Unsatisfactory Compliance|6|||
148884800|NCT00596752|537055015|FG000|Overall Study|Lack of Efficacy|4|||
148884801|NCT00596752|537055016|FG001|Overall Study|Lack of Efficacy|7|||
148884802|NCT00596752|537055015|FG000|Overall Study|Protocol Violation|1|||
148884803|NCT00596752|537055016|FG001|Overall Study|Protocol Violation|0|||
148884804|NCT01870726|537055017|FG000|Overall Study|Withdrawal of informed consent|0|||
148884805|NCT01870726|537055018|FG001|Overall Study|Withdrawal of informed consent|0|||
148884806|NCT01870726|537055019|FG002|Overall Study|Withdrawal of informed consent|0|||
148884807|NCT01870726|537055020|FG003|Overall Study|Withdrawal of informed consent|1|||
148884808|NCT01870726|537055021|FG004|Overall Study|Withdrawal of informed consent|0|||
148884809|NCT01870726|537055022|FG005|Overall Study|Withdrawal of informed consent|0|||
148884810|NCT01870726|537055023|FG006|Overall Study|Withdrawal of informed consent|0|||
148884811|NCT01870726|537055017|FG000|Overall Study|Withdrawal by Subject|0|||
148884812|NCT01870726|537055018|FG001|Overall Study|Withdrawal by Subject|1|||
148884813|NCT01870726|537055019|FG002|Overall Study|Withdrawal by Subject|0|||
148884814|NCT01870726|537055020|FG003|Overall Study|Withdrawal by Subject|0|||
148884815|NCT01870726|537055021|FG004|Overall Study|Withdrawal by Subject|0|||
148884816|NCT01870726|537055022|FG005|Overall Study|Withdrawal by Subject|0|||
148884817|NCT01870726|537055023|FG006|Overall Study|Withdrawal by Subject|0|||
148884818|NCT01870726|537055017|FG000|Overall Study|Adverse Event|0|||
148884819|NCT01870726|537055018|FG001|Overall Study|Adverse Event|0|||
148884820|NCT01870726|537055019|FG002|Overall Study|Adverse Event|0|||
148884821|NCT01870726|537055020|FG003|Overall Study|Adverse Event|0|||
148884822|NCT01870726|537055021|FG004|Overall Study|Adverse Event|1|||
148884823|NCT01870726|537055022|FG005|Overall Study|Adverse Event|1|||
148884824|NCT01870726|537055023|FG006|Overall Study|Adverse Event|0|||
148884825|NCT01870726|537055017|FG000|Overall Study|Progressive disease|5|||
148884826|NCT01870726|537055018|FG001|Overall Study|Progressive disease|5|||
148884827|NCT01870726|537055019|FG002|Overall Study|Progressive disease|4|||
148884828|NCT01870726|537055020|FG003|Overall Study|Progressive disease|5|||
148884829|NCT01870726|537055021|FG004|Overall Study|Progressive disease|6|||
148884830|NCT01870726|537055022|FG005|Overall Study|Progressive disease|4|||
148884831|NCT01870726|537055023|FG006|Overall Study|Progressive disease|10|||
148884832|NCT00555217|537055025|FG000|Overall Study|Withdrawal by Subject|35|||
148884833|NCT00555217|537055026|FG001|Overall Study|Withdrawal by Subject|31|||
148884834|NCT00555217|537055025|FG000|Overall Study|Lost to Follow-up|19|||
148884835|NCT00555217|537055026|FG001|Overall Study|Lost to Follow-up|20|||
148884836|NCT00555217|537055025|FG000|Overall Study|close out sites|21|||
148884837|NCT00555217|537055026|FG001|Overall Study|close out sites|17|||
148884838|NCT00983385|537055027|FG000|Observation Period|Not eligible to be dosed|20|||
148884839|NCT00983385|537055027|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
148884840|NCT00900029|537055028|FG000|Overall Study|Lost to Follow-up|0|||
148884841|NCT00900029|537055029|FG001|Overall Study|Lost to Follow-up|2|||
148884842|NCT00900029|537055030|FG002|Overall Study|Lost to Follow-up|1|||
148884843|NCT00900029|537055031|FG003|Overall Study|Lost to Follow-up|4|||
148884844|NCT00900029|537055032|FG004|Overall Study|Lost to Follow-up|4|||
148884845|NCT00900029|537055028|FG000|Overall Study|Withdrawal by Subject|2|||
148884846|NCT00900029|537055029|FG001|Overall Study|Withdrawal by Subject|2|||
148884847|NCT00900029|537055030|FG002|Overall Study|Withdrawal by Subject|1|||
148884848|NCT00900029|537055031|FG003|Overall Study|Withdrawal by Subject|1|||
148884849|NCT00900029|537055032|FG004|Overall Study|Withdrawal by Subject|1|||
148884850|NCT00900029|537055028|FG000|Overall Study|Adverse Event|0|||
148884851|NCT00900029|537055029|FG001|Overall Study|Adverse Event|0|||
148884852|NCT00900029|537055030|FG002|Overall Study|Adverse Event|1|||
148884853|NCT00900029|537055031|FG003|Overall Study|Adverse Event|1|||
148884854|NCT00900029|537055032|FG004|Overall Study|Adverse Event|1|||
148884855|NCT00900029|537055028|FG000|Overall Study|Death|1|||
148884856|NCT00900029|537055029|FG001|Overall Study|Death|0|||
148884857|NCT00900029|537055030|FG002|Overall Study|Death|0|||
148884858|NCT00900029|537055031|FG003|Overall Study|Death|1|||
148884859|NCT00900029|537055032|FG004|Overall Study|Death|0|||
148884860|NCT02709330|537055033|FG000|Overall Study|Death|5|||
148884861|NCT02709330|537055034|FG001|Overall Study|Death|0|||
148884862|NCT02709330|537055033|FG000|Overall Study|Lost to Follow-up|2|||
148884863|NCT02709330|537055034|FG001|Overall Study|Lost to Follow-up|0|||
148884864|NCT02709330|537055033|FG000|Overall Study|Physician Decision|2|||
148884865|NCT02709330|537055034|FG001|Overall Study|Physician Decision|0|||
148884866|NCT02709330|537055033|FG000|Overall Study|Withdrawal by Subject|4|||
148884867|NCT02709330|537055034|FG001|Overall Study|Withdrawal by Subject|0|||
148884868|NCT02587819|537055035|FG000|Overall Study|Adverse Event|1|||
148884869|NCT02587819|537055035|FG000|Overall Study|Lost to Follow-up|1|||
148884870|NCT00511238|537055038|FG000|Overall Study|Adverse Event|13|||
148884871|NCT00511238|537055039|FG001|Overall Study|Adverse Event|33|||
148884872|NCT00511238|537055038|FG000|Overall Study|Withdrawal by Subject|2|||
148884873|NCT00511238|537055039|FG001|Overall Study|Withdrawal by Subject|22|||
148884874|NCT00511238|537055038|FG000|Overall Study|Progressive Disease|23|||
148884875|NCT00511238|537055039|FG001|Overall Study|Progressive Disease|157|||
148884876|NCT00511238|537055038|FG000|Overall Study|various reasons|4|||
148884877|NCT00511238|537055039|FG001|Overall Study|various reasons|14|||
148884878|NCT01410890|537056865|FG000|Overall Study|Withdrawal by Subject|0|||
148884879|NCT01410890|537056866|FG001|Overall Study|Withdrawal by Subject|1|||
148884880|NCT00997035|537056870|FG000|3-week Followup Visit|Lost to Follow-up|9|||
148884881|NCT00997035|537056871|FG001|3-week Followup Visit|Lost to Follow-up|6|||
148884882|NCT00997035|537056870|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
148884883|NCT00997035|537056871|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
148884884|NCT02544503|537056877|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
148884885|NCT02544503|537056878|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
148884886|NCT02544503|537056877|FG000|Overall Study|Lost to Follow-up|9|||
148884887|NCT02544503|537056878|FG001|Overall Study|Lost to Follow-up|0|||
148884888|NCT02544503|537056877|FG000|Overall Study|Withdrawal by Subject|1|||
148884889|NCT02544503|537056878|FG001|Overall Study|Withdrawal by Subject|0|||
148884890|NCT04640311|537056879|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
148884891|NCT04640311|537056880|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884892|NCT04640311|537056881|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884893|NCT04640311|537056882|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884894|NCT04640311|537056883|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884895|NCT04640311|537056884|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884896|NCT04640311|537056885|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884897|NCT04640311|537056886|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884898|NCT04640311|537056887|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884899|NCT04640311|537056888|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884900|NCT04640311|537056889|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884901|NCT04640311|537056890|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884902|NCT04640311|537056891|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884903|NCT04640311|537056879|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884904|NCT04640311|537056880|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
148884905|NCT04640311|537056881|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884906|NCT04640311|537056882|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884907|NCT04640311|537056883|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884908|NCT04640311|537056884|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884909|NCT04640311|537056885|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884910|NCT04640311|537056886|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884911|NCT04640311|537056887|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884912|NCT04640311|537056888|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884913|NCT04640311|537056889|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884914|NCT04640311|537056890|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884915|NCT04640311|537056891|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
148884916|NCT04640311|537056879|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884917|NCT04640311|537056880|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
148884918|NCT04640311|537056881|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884919|NCT04640311|537056882|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884920|NCT04640311|537056883|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884921|NCT04640311|537056884|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884922|NCT04640311|537056885|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884923|NCT04640311|537056886|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884924|NCT04640311|537056887|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884925|NCT04640311|537056888|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884926|NCT04640311|537056889|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884927|NCT04640311|537056890|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884928|NCT04640311|537056891|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884929|NCT04640311|537056879|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
148884930|NCT04640311|537056880|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
148884931|NCT04640311|537056881|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
148884932|NCT04640311|537056882|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884933|NCT04640311|537056883|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884934|NCT04640311|537056884|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884935|NCT04640311|537056885|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884936|NCT04640311|537056886|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884937|NCT04640311|537056887|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884938|NCT04640311|537056888|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884939|NCT04640311|537056889|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884940|NCT04640311|537056890|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884941|NCT04640311|537056891|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
148884942|NCT04640311|537056879|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884943|NCT04640311|537056880|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884944|NCT04640311|537056881|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
148884945|NCT04640311|537056882|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884946|NCT04640311|537056883|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
149004714|NCT00504426|537495100|FG000|Overall Study|Protocol Violation|1|||
149004715|NCT00504426|537495101|FG001|Overall Study|Protocol Violation|1|||
149004716|NCT00504426|537495102|FG002|Overall Study|Protocol Violation|2|||
149004717|NCT00504426|537495103|FG003|Overall Study|Protocol Violation|0|||
149004718|NCT00504426|537495100|FG000|Overall Study|Withdrawal by Subject|2|||
149004719|NCT00504426|537495101|FG001|Overall Study|Withdrawal by Subject|0|||
149004720|NCT00504426|537495102|FG002|Overall Study|Withdrawal by Subject|0|||
149004721|NCT00504426|537495103|FG003|Overall Study|Withdrawal by Subject|0|||
149004722|NCT02220894|537495107|FG000|Overall Study|Adverse Event|127|||
149004723|NCT02220894|537495108|FG001|Overall Study|Adverse Event|74|||
149004724|NCT02220894|537495107|FG000|Overall Study|Death|418|||
149004725|NCT02220894|537495108|FG001|Overall Study|Death|508|||
149004726|NCT02220894|537495107|FG000|Overall Study|Lost to Follow-up|0|||
149004727|NCT02220894|537495108|FG001|Overall Study|Lost to Follow-up|4|||
149004728|NCT02220894|537495107|FG000|Overall Study|Site Terminated by Sponsor|2|||
149004729|NCT02220894|537495108|FG001|Overall Study|Site Terminated by Sponsor|0|||
149004730|NCT02220894|537495107|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
149004731|NCT02220894|537495108|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
149004732|NCT02220894|537495107|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149004733|NCT02220894|537495108|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149004734|NCT02220894|537495107|FG000|Overall Study|Withdrawal by Subject|10|||
149004735|NCT02220894|537495108|FG001|Overall Study|Withdrawal by Subject|9|||
149004736|NCT04098250|537495111|FG000|Overall Study|Withdrawal by Subject|1|||
149040759|NCT05323734|537628371|FG000|Overall Study|Adverse Event|5|||
149040760|NCT05323734|537628372|FG001|Overall Study|Adverse Event|2|||
149040761|NCT05323734|537628371|FG000|Overall Study|Physician Decision|1|||
149040762|NCT05323734|537628372|FG001|Overall Study|Physician Decision|0|||
149040763|NCT05323734|537628371|FG000|Overall Study|Lack of Efficacy|1|||
149040764|NCT05323734|537628372|FG001|Overall Study|Lack of Efficacy|2|||
149040765|NCT05323734|537628371|FG000|Overall Study|Withdrawal by Subject|2|||
149040766|NCT05323734|537628372|FG001|Overall Study|Withdrawal by Subject|0|||
149040767|NCT05323734|537628371|FG000|Overall Study|Participant Withdrawn Due|0|||
149040768|NCT05323734|537628372|FG001|Overall Study|Participant Withdrawn Due|1|||
149040769|NCT05061693|537628373|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
149040770|NCT05061693|537628374|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
149040771|NCT05061693|537628375|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
149040772|NCT05061693|537628376|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040773|NCT05061693|537628377|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040774|NCT05061693|537628378|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040775|NCT05061693|537628379|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040776|NCT05061693|537628380|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040777|NCT05061693|537628381|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040778|NCT05061693|537628382|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040779|NCT05061693|537628383|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040780|NCT05061693|537628384|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
149040781|NCT05061693|537628373|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
149040782|NCT05061693|537628374|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
149040783|NCT05061693|537628375|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
149040784|NCT05061693|537628376|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
149040785|NCT05061693|537628377|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
149040786|NCT05061693|537628378|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
149040787|NCT05061693|537628379|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
149040788|NCT05061693|537628380|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
148884947|NCT04640311|537056884|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884948|NCT04640311|537056885|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884949|NCT04640311|537056886|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884950|NCT04640311|537056887|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
149040789|NCT05061693|537628381|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
149040790|NCT05061693|537628382|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
149040791|NCT05061693|537628383|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
149040792|NCT05061693|537628384|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
149040793|NCT05061693|537628373|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
149040794|NCT05061693|537628374|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040795|NCT05061693|537628375|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040796|NCT05061693|537628376|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040797|NCT05061693|537628377|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040798|NCT05061693|537628378|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040799|NCT05061693|537628379|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040800|NCT05061693|537628380|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040801|NCT05061693|537628381|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040802|NCT05061693|537628382|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040803|NCT05061693|537628383|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040804|NCT05061693|537628384|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
149040805|NCT05061693|537628373|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040806|NCT05061693|537628374|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040807|NCT05061693|537628375|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
149040808|NCT05061693|537628376|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040809|NCT05061693|537628377|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040810|NCT05061693|537628378|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040811|NCT05061693|537628379|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040812|NCT05061693|537628380|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040813|NCT05061693|537628381|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040814|NCT05061693|537628382|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040815|NCT05061693|537628383|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
148884951|NCT04640311|537056888|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
149040816|NCT05061693|537628384|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
149040817|NCT05061693|537628373|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
149040818|NCT05061693|537628374|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
149040819|NCT05061693|537628375|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
149040820|NCT05061693|537628376|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
149040821|NCT05061693|537628377|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
148884952|NCT04640311|537056889|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884953|NCT04640311|537056890|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884954|NCT04640311|537056891|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
148884955|NCT04640311|537056879|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884956|NCT04640311|537056880|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884957|NCT04640311|537056881|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884958|NCT04640311|537056882|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
148884959|NCT04640311|537056883|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884960|NCT04640311|537056884|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884961|NCT04640311|537056885|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
148884962|NCT04640311|537056886|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884963|NCT04640311|537056887|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884964|NCT04640311|537056888|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884965|NCT04640311|537056889|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884966|NCT04640311|537056890|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884967|NCT04640311|537056891|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
148884968|NCT04640311|537056879|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884969|NCT04640311|537056880|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884970|NCT04640311|537056881|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884971|NCT04640311|537056882|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884972|NCT04640311|537056883|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884973|NCT04640311|537056884|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
148884974|NCT04640311|537056885|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884975|NCT04640311|537056886|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884976|NCT04640311|537056887|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
148884977|NCT04640311|537056888|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884978|NCT04640311|537056889|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884979|NCT04640311|537056890|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884980|NCT04640311|537056891|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
148884981|NCT04640311|537056879|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884982|NCT04640311|537056880|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
149040822|NCT05061693|537628378|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040823|NCT05061693|537628379|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040824|NCT05061693|537628380|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040825|NCT05061693|537628381|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040826|NCT05061693|537628382|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040827|NCT05061693|537628383|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040828|NCT05061693|537628384|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
149040829|NCT05061693|537628373|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
149040830|NCT05061693|537628374|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
149040831|NCT05061693|537628375|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
149040832|NCT05061693|537628376|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
149040833|NCT05061693|537628377|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040834|NCT05061693|537628378|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040835|NCT05061693|537628379|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040836|NCT05061693|537628380|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040837|NCT05061693|537628381|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040838|NCT05061693|537628382|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040839|NCT05061693|537628383|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040840|NCT05061693|537628384|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
149040841|NCT05061693|537628373|FG000|24-week Extension Period|Adverse Event|0|||
149040842|NCT05061693|537628374|FG001|24-week Extension Period|Adverse Event|0|||
149040843|NCT05061693|537628375|FG002|24-week Extension Period|Adverse Event|0|||
149040844|NCT05061693|537628376|FG003|24-week Extension Period|Adverse Event|0|||
149040845|NCT05061693|537628377|FG004|24-week Extension Period|Adverse Event|0|||
149040846|NCT05061693|537628378|FG005|24-week Extension Period|Adverse Event|0|||
149040847|NCT05061693|537628379|FG006|24-week Extension Period|Adverse Event|0|||
149040848|NCT05061693|537628380|FG007|24-week Extension Period|Adverse Event|2|||
149040849|NCT05061693|537628381|FG008|24-week Extension Period|Adverse Event|2|||
149040850|NCT05061693|537628382|FG009|24-week Extension Period|Adverse Event|0|||
149040851|NCT05061693|537628383|FG010|24-week Extension Period|Adverse Event|1|||
149040852|NCT05061693|537628384|FG011|24-week Extension Period|Adverse Event|3|||
149040853|NCT05061693|537628373|FG000|24-week Extension Period|Lack of Efficacy|0|||
149040854|NCT05061693|537628374|FG001|24-week Extension Period|Lack of Efficacy|0|||
149040855|NCT05061693|537628375|FG002|24-week Extension Period|Lack of Efficacy|0|||
148884983|NCT04640311|537056881|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884984|NCT04640311|537056882|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884985|NCT04640311|537056883|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884986|NCT04640311|537056884|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884987|NCT04640311|537056885|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
148884988|NCT04640311|537056886|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884989|NCT04640311|537056887|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884990|NCT04640311|537056888|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884991|NCT04640311|537056889|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
148884992|NCT04640311|537056890|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884993|NCT04640311|537056891|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
148884994|NCT04640311|537056879|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148884995|NCT04640311|537056880|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148884996|NCT04640311|537056881|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148884997|NCT04640311|537056882|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148884998|NCT04640311|537056883|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148884999|NCT04640311|537056884|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885000|NCT04640311|537056885|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885001|NCT04640311|537056886|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885002|NCT04640311|537056887|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885003|NCT04640311|537056888|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885004|NCT04640311|537056889|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885005|NCT04640311|537056890|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
148885006|NCT04640311|537056891|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
148885007|NCT00991939|537056894|FG000|Overall Study|Lost to Follow-up|0|||
148885008|NCT00991939|537056895|FG001|Overall Study|Lost to Follow-up|1|||
148885009|NCT00991939|537056894|FG000|Overall Study|Withdrawal by Subject|1|||
148885010|NCT00991939|537056895|FG001|Overall Study|Withdrawal by Subject|0|||
148885011|NCT00991939|537056894|FG000|Overall Study|Entire study terminated|4|||
148885012|NCT00991939|537056895|FG001|Overall Study|Entire study terminated|1|||
148885013|NCT00714415|537056896|FG000|Overall Study|Lack of Efficacy|1|||
148885014|NCT00714415|537056897|FG001|Overall Study|Lack of Efficacy|0|||
148885015|NCT00714415|537056896|FG000|Overall Study|Death|1|||
148885016|NCT00714415|537056897|FG001|Overall Study|Death|0|||
148885017|NCT01461707|537056900|FG000|Overall Study|Withdrawal by Subject|1|||
148885018|NCT01461707|537056901|FG001|Overall Study|Withdrawal by Subject|0|||
148885019|NCT00337207|537056912|FG000|Overall Study|Withdrawal by Subject|3|||
148885020|NCT01687296|537056913|FG000|Overall Study|Lack of Efficacy|1|||
148885021|NCT01687296|537056914|FG001|Overall Study|Lack of Efficacy|1|||
148885022|NCT01687296|537056913|FG000|Overall Study|Protocol Violation|0|||
148885023|NCT01687296|537056914|FG001|Overall Study|Protocol Violation|1|||
148885024|NCT01687296|537056913|FG000|Overall Study|Withdrawal by Subject|6|||
148885025|NCT01687296|537056914|FG001|Overall Study|Withdrawal by Subject|3|||
148885026|NCT01479868|537056919|FG000|Overall Study|Adverse Event|1|||
148885027|NCT01479868|537056919|FG000|Overall Study|Lost to Follow-up|4|||
148885028|NCT01479868|537056919|FG000|Overall Study|Protocol Violation|1|||
148885029|NCT01479868|537056919|FG000|Overall Study|Withdrawal by Subject|1|||
148885030|NCT01479868|537056919|FG000|Overall Study|Sponsor's Decision|1|||
148885031|NCT01479868|537056919|FG000|Overall Study|Initiation of new HCV Therapy|1|||
148885032|NCT01177007|537056920|FG000|Overall Study|Lost to Follow-up|2|||
148885033|NCT01177007|537056920|FG000|Overall Study|Death|4|||
148885034|NCT01177007|537056920|FG000|Overall Study|Entered hospice care|5|||
148885035|NCT01177007|537056920|FG000|Overall Study|Required additional Y90 treatment|6|||
148885036|NCT01177007|537056920|FG000|Overall Study|Change in treatment modality|21|||
148885037|NCT02336230|537056923|FG000|Overall Study|Adverse Event|1|||
148885038|NCT02336230|537056923|FG000|Overall Study|Withdrawal of consent|1|||
148885039|NCT02336230|537056923|FG000|Overall Study|Death|9|||
148885040|NCT02336230|537056923|FG000|Overall Study|Dose not received due to shipping delay|1|||
148885041|NCT02336230|537056923|FG000|Overall Study|Discontinuation of MSC infusion|1|||
148885042|NCT02524171|537056924|FG000|6-month Follow-up|Lost to Follow-up|53|||
148885043|NCT02524171|537056925|FG001|6-month Follow-up|Lost to Follow-up|45|||
148885044|NCT02524171|537056924|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
148885045|NCT02524171|537056925|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
148885046|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Progressive disease|50|||
148885047|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Progressive disease|110|||
148885048|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Progressive disease|0|||
149040856|NCT05061693|537628376|FG003|24-week Extension Period|Lack of Efficacy|0|||
148885049|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Progressive disease|0|||
148885050|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
148885051|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
149040857|NCT05061693|537628377|FG004|24-week Extension Period|Lack of Efficacy|0|||
148885052|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148885053|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
148885054|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Adverse Event|7|||
148885055|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Adverse Event|7|||
148885056|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Adverse Event|0|||
148885057|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Adverse Event|0|||
148885058|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Other|1|||
148885059|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Other|3|||
148885060|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Other|0|||
148885061|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Other|0|||
148885062|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Physician Decision|6|||
148885063|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Physician Decision|3|||
148885064|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Physician Decision|0|||
148885065|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Physician Decision|0|||
148885066|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Death|1|||
148885067|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Death|1|||
148885068|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Death|0|||
148885069|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Death|0|||
148885070|NCT01695135|537056932|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
148885071|NCT01695135|537056933|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
148885072|NCT01695135|537056934|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
148885073|NCT01695135|537056935|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
148885074|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
148885075|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
148885076|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
148885077|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
149040858|NCT05061693|537628378|FG005|24-week Extension Period|Lack of Efficacy|0|||
149040859|NCT05061693|537628379|FG006|24-week Extension Period|Lack of Efficacy|0|||
149040860|NCT05061693|537628380|FG007|24-week Extension Period|Lack of Efficacy|0|||
149040861|NCT05061693|537628381|FG008|24-week Extension Period|Lack of Efficacy|0|||
149040862|NCT05061693|537628382|FG009|24-week Extension Period|Lack of Efficacy|0|||
149040863|NCT05061693|537628383|FG010|24-week Extension Period|Lack of Efficacy|2|||
149040864|NCT05061693|537628384|FG011|24-week Extension Period|Lack of Efficacy|0|||
149040865|NCT05061693|537628373|FG000|24-week Extension Period|Lost to Follow-up|0|||
149040866|NCT05061693|537628374|FG001|24-week Extension Period|Lost to Follow-up|0|||
149040867|NCT05061693|537628375|FG002|24-week Extension Period|Lost to Follow-up|0|||
149040868|NCT05061693|537628376|FG003|24-week Extension Period|Lost to Follow-up|0|||
149040869|NCT05061693|537628377|FG004|24-week Extension Period|Lost to Follow-up|0|||
149040870|NCT05061693|537628378|FG005|24-week Extension Period|Lost to Follow-up|0|||
149040871|NCT05061693|537628379|FG006|24-week Extension Period|Lost to Follow-up|1|||
149040872|NCT05061693|537628380|FG007|24-week Extension Period|Lost to Follow-up|0|||
149040873|NCT05061693|537628381|FG008|24-week Extension Period|Lost to Follow-up|1|||
149040874|NCT05061693|537628382|FG009|24-week Extension Period|Lost to Follow-up|1|||
149040875|NCT05061693|537628383|FG010|24-week Extension Period|Lost to Follow-up|0|||
149040876|NCT05061693|537628384|FG011|24-week Extension Period|Lost to Follow-up|0|||
149040877|NCT05061693|537628373|FG000|24-week Extension Period|Withdrawal by Subject|0|||
149040878|NCT05061693|537628374|FG001|24-week Extension Period|Withdrawal by Subject|0|||
149040879|NCT05061693|537628375|FG002|24-week Extension Period|Withdrawal by Subject|0|||
149040880|NCT05061693|537628376|FG003|24-week Extension Period|Withdrawal by Subject|0|||
149040881|NCT05061693|537628377|FG004|24-week Extension Period|Withdrawal by Subject|0|||
149040882|NCT05061693|537628378|FG005|24-week Extension Period|Withdrawal by Subject|0|||
149040883|NCT05061693|537628379|FG006|24-week Extension Period|Withdrawal by Subject|0|||
149040884|NCT05061693|537628380|FG007|24-week Extension Period|Withdrawal by Subject|0|||
149040885|NCT05061693|537628381|FG008|24-week Extension Period|Withdrawal by Subject|1|||
149040886|NCT05061693|537628382|FG009|24-week Extension Period|Withdrawal by Subject|2|||
149040887|NCT05061693|537628383|FG010|24-week Extension Period|Withdrawal by Subject|2|||
149040888|NCT05061693|537628384|FG011|24-week Extension Period|Withdrawal by Subject|1|||
149040889|NCT05061693|537628373|FG000|24-week Extension Period|Sponsor Decision|0|||
149040890|NCT05061693|537628374|FG001|24-week Extension Period|Sponsor Decision|0|||
149040891|NCT05061693|537628375|FG002|24-week Extension Period|Sponsor Decision|0|||
149040892|NCT05061693|537628376|FG003|24-week Extension Period|Sponsor Decision|0|||
149040893|NCT05061693|537628377|FG004|24-week Extension Period|Sponsor Decision|0|||
149040894|NCT05061693|537628378|FG005|24-week Extension Period|Sponsor Decision|0|||
149040895|NCT05061693|537628379|FG006|24-week Extension Period|Sponsor Decision|0|||
149040896|NCT05061693|537628380|FG007|24-week Extension Period|Sponsor Decision|1|||
149040897|NCT05061693|537628381|FG008|24-week Extension Period|Sponsor Decision|0|||
149040898|NCT05061693|537628382|FG009|24-week Extension Period|Sponsor Decision|0|||
149040899|NCT05061693|537628383|FG010|24-week Extension Period|Sponsor Decision|0|||
149040900|NCT05061693|537628384|FG011|24-week Extension Period|Sponsor Decision|0|||
149040901|NCT05061693|537628373|FG000|24-week Extension Period|Site Closure|0|||
149040902|NCT05061693|537628374|FG001|24-week Extension Period|Site Closure|0|||
149040903|NCT05061693|537628375|FG002|24-week Extension Period|Site Closure|0|||
149040904|NCT05061693|537628376|FG003|24-week Extension Period|Site Closure|0|||
149040905|NCT05061693|537628377|FG004|24-week Extension Period|Site Closure|0|||
149040906|NCT05061693|537628378|FG005|24-week Extension Period|Site Closure|0|||
149040907|NCT05061693|537628379|FG006|24-week Extension Period|Site Closure|0|||
149040908|NCT05061693|537628380|FG007|24-week Extension Period|Site Closure|0|||
149040909|NCT05061693|537628381|FG008|24-week Extension Period|Site Closure|1|||
149040910|NCT05061693|537628382|FG009|24-week Extension Period|Site Closure|0|||
149040911|NCT05061693|537628383|FG010|24-week Extension Period|Site Closure|0|||
149040912|NCT05061693|537628384|FG011|24-week Extension Period|Site Closure|1|||
149040913|NCT01353963|537628385|FG000|Overall Study|Adverse Event|2|||
149040914|NCT01420549|537628386|FG000|Overall Study|Adverse Event|1|||
149040915|NCT01420549|537628387|FG001|Overall Study|Adverse Event|1|||
149040916|NCT01420549|537628386|FG000|Overall Study|Lost to Follow-up|2|||
149040917|NCT01420549|537628387|FG001|Overall Study|Lost to Follow-up|2|||
149040918|NCT01420549|537628386|FG000|Overall Study|Protocol Violation|0|||
149040919|NCT01420549|537628387|FG001|Overall Study|Protocol Violation|1|||
149040920|NCT01420549|537628386|FG000|Overall Study|Non-adherence to medication|4|||
149040921|NCT01420549|537628387|FG001|Overall Study|Non-adherence to medication|1|||
149040922|NCT02499159|537629679|FG000|Randomization|Protocol Violation|1|||
149040923|NCT02499159|537629680|FG001|Randomization|Protocol Violation|1|||
149040924|NCT02499159|537629679|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
149040925|NCT02499159|537629680|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
149040926|NCT02499159|537629679|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
149040927|NCT02499159|537629680|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
149040928|NCT02499159|537629679|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
149040929|NCT02499159|537629680|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
149040930|NCT02499159|537629679|FG000|30-Day Follow-Up Phone Call|Other|1|||
149040931|NCT02499159|537629680|FG001|30-Day Follow-Up Phone Call|Other|0|||
149040932|NCT02564744|537629683|FG000|Overall Study|Investigator decision|0|||
149040933|NCT02564744|537629684|FG001|Overall Study|Investigator decision|0|||
149040934|NCT02564744|537629685|FG002|Overall Study|Investigator decision|0|||
149040935|NCT02564744|537629686|FG003|Overall Study|Investigator decision|0|||
149040936|NCT02564744|537629687|FG004|Overall Study|Investigator decision|1|||
149040937|NCT02564744|537629683|FG000|Overall Study|Death|10|||
149040938|NCT02564744|537629684|FG001|Overall Study|Death|5|||
149040939|NCT02564744|537629685|FG002|Overall Study|Death|4|||
149040940|NCT02564744|537629686|FG003|Overall Study|Death|16|||
149040941|NCT02564744|537629687|FG004|Overall Study|Death|16|||
149040942|NCT02564744|537629683|FG000|Overall Study|End of study Page Missing|0|||
149040943|NCT02564744|537629684|FG001|Overall Study|End of study Page Missing|0|||
149040944|NCT02564744|537629685|FG002|Overall Study|End of study Page Missing|3|||
149040945|NCT02564744|537629686|FG003|Overall Study|End of study Page Missing|3|||
149040946|NCT02564744|537629687|FG004|Overall Study|End of study Page Missing|0|||
149040947|NCT02564744|537629683|FG000|Overall Study|Subject Withdrew Consent|1|||
149040948|NCT02564744|537629684|FG001|Overall Study|Subject Withdrew Consent|1|||
149040949|NCT02564744|537629685|FG002|Overall Study|Subject Withdrew Consent|1|||
149040950|NCT02564744|537629686|FG003|Overall Study|Subject Withdrew Consent|0|||
149040951|NCT02564744|537629687|FG004|Overall Study|Subject Withdrew Consent|2|||
149040952|NCT02564744|537629683|FG000|Overall Study|Lost to Follow-up|0|||
149040953|NCT02564744|537629684|FG001|Overall Study|Lost to Follow-up|1|||
149040954|NCT02564744|537629685|FG002|Overall Study|Lost to Follow-up|0|||
148885078|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
148885079|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
148885080|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
148885081|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
148885082|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
148885083|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
148885084|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
149040955|NCT02564744|537629686|FG003|Overall Study|Lost to Follow-up|0|||
149040956|NCT02564744|537629687|FG004|Overall Study|Lost to Follow-up|1|||
149040957|NCT02564744|537629683|FG000|Overall Study|Reason not specified|1|||
149040958|NCT02564744|537629684|FG001|Overall Study|Reason not specified|0|||
149040959|NCT02564744|537629685|FG002|Overall Study|Reason not specified|0|||
149040960|NCT02564744|537629686|FG003|Overall Study|Reason not specified|0|||
149040961|NCT02564744|537629687|FG004|Overall Study|Reason not specified|0|||
149040962|NCT01177670|537629693|FG000|Overall Study|Study Terminated|115|||
149040963|NCT01177670|537629693|FG000|Overall Study|Physician Decision|50|||
149040964|NCT01177670|537629693|FG000|Overall Study|Withdrawal by Subject|4|||
149040965|NCT02918279|537629702|FG000|Overall Study|Lost to Follow-up|3|||
149040966|NCT02918279|537629703|FG001|Overall Study|Lost to Follow-up|6|||
149040967|NCT02918279|537629702|FG000|Overall Study|Withdrawal by Subject|5|||
149040968|NCT02918279|537629703|FG001|Overall Study|Withdrawal by Subject|15|||
149040969|NCT02918279|537629702|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149040970|NCT02918279|537629703|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149040971|NCT02918279|537629702|FG000|Overall Study|Other|3|||
149040972|NCT02918279|537629703|FG001|Overall Study|Other|1|||
149040973|NCT00309907|537629704|FG000|Overall Study|Death|4|||
149040974|NCT00309907|537629704|FG000|Overall Study|Physician Decision|1|||
149040975|NCT00309907|537629704|FG000|Overall Study|Ineligible|11|||
149040976|NCT00309907|537629704|FG000|Overall Study|Major infectious event|4|||
149040977|NCT00869258|537629705|FG000|Overall Study|Physician Decision|1|||
149040978|NCT00636207|537629706|FG000|Overall Study|Adverse Event|1|||
149040979|NCT00636207|537629707|FG001|Overall Study|Adverse Event|0|||
149040980|NCT00636207|537629708|FG002|Overall Study|Adverse Event|0|||
149040981|NCT00636207|537629709|FG003|Overall Study|Adverse Event|0|||
149040982|NCT00636207|537629710|FG004|Overall Study|Adverse Event|0|||
149040983|NCT00636207|537629711|FG005|Overall Study|Adverse Event|0|||
149040984|NCT00636207|537629712|FG006|Overall Study|Adverse Event|0|||
149040985|NCT00636207|537629706|FG000|Overall Study|Withdrawal by Subject|0|||
149040986|NCT00636207|537629707|FG001|Overall Study|Withdrawal by Subject|1|||
149040987|NCT00636207|537629708|FG002|Overall Study|Withdrawal by Subject|0|||
149040988|NCT00636207|537629709|FG003|Overall Study|Withdrawal by Subject|0|||
149040989|NCT00636207|537629710|FG004|Overall Study|Withdrawal by Subject|1|||
149040990|NCT00636207|537629711|FG005|Overall Study|Withdrawal by Subject|0|||
149040991|NCT00636207|537629712|FG006|Overall Study|Withdrawal by Subject|0|||
149040992|NCT02888080|537629713|FG000|Overall Study|Subject / Guardian decision|1|||
149040993|NCT02888080|537629714|FG001|Overall Study|Subject / Guardian decision|3|||
149040994|NCT02888080|537629713|FG000|Overall Study|New Therapy for study indication|1|||
149040995|NCT02888080|537629714|FG001|Overall Study|New Therapy for study indication|0|||
149040996|NCT02888080|537629713|FG000|Overall Study|Lack of Efficacy|0|||
149040997|NCT02888080|537629714|FG001|Overall Study|Lack of Efficacy|1|||
149040998|NCT02888080|537629713|FG000|Overall Study|Adverse Event|0|||
149040999|NCT02888080|537629714|FG001|Overall Study|Adverse Event|1|||
149041000|NCT01641198|537629715|FG000|After 12 Months of Function|Lost to Follow-up|3|||
149041001|NCT01641198|537629716|FG001|After 12 Months of Function|Lost to Follow-up|2|||
149041002|NCT01641198|537629717|FG002|After 12 Months of Function|Lost to Follow-up|2|||
149041003|NCT01641198|537629715|FG000|After 12 Months of Function|Protocol Violation|1|||
149041004|NCT01641198|537629716|FG001|After 12 Months of Function|Protocol Violation|0|||
149041005|NCT01641198|537629717|FG002|After 12 Months of Function|Protocol Violation|0|||
149041006|NCT01641198|537629715|FG000|After 12 Months of Function|Adverse Event|0|||
149041007|NCT01641198|537629716|FG001|After 12 Months of Function|Adverse Event|1|||
149041008|NCT01641198|537629717|FG002|After 12 Months of Function|Adverse Event|0|||
149041009|NCT01641198|537629715|FG000|After 24 Months of Function|Lost to Follow-up|4|||
149041010|NCT01641198|537629716|FG001|After 24 Months of Function|Lost to Follow-up|9|||
149041011|NCT01641198|537629717|FG002|After 24 Months of Function|Lost to Follow-up|6|||
149041012|NCT01641198|537629715|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
149041013|NCT01641198|537629716|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
149041014|NCT01641198|537629717|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
149041015|NCT01641198|537629715|FG000|At 15-20 Years of Function|Death|1|||
149041016|NCT01641198|537629716|FG001|At 15-20 Years of Function|Death|0|||
149041017|NCT01641198|537629717|FG002|At 15-20 Years of Function|Death|1|||
149041018|NCT00666276|537629720|FG000|Overall Study|Protocol Violation|34|||
149041019|NCT02594735|537629721|FG000|Overall Study|Adverse Event|1|||
149041020|NCT03844269|537629725|FG000|Overall Study|Withdrawal pre-intervention|1|||
149041021|NCT03844269|537629725|FG000|Overall Study|Did not complete the intervention|2|||
149041022|NCT00665444|537629726|FG000|Overall Study|Physician Decision|1|||
149041023|NCT00665444|537629726|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
149041024|NCT00101010|537629727|FG000|Overall Study|Physician Decision|1|||
149041025|NCT01075217|537629728|FG000|Overall Study|Adverse Event|1|||
149041026|NCT01075217|537629729|FG001|Overall Study|Adverse Event|1|||
149041027|NCT01075217|537629728|FG000|Overall Study|Physician Decision|1|||
149041028|NCT01075217|537629729|FG001|Overall Study|Physician Decision|0|||
149041029|NCT01369498|537629734|FG000|Overall Study|Lack of Efficacy|9|||
149041030|NCT01369498|537629735|FG001|Overall Study|Lack of Efficacy|9|||
149041031|NCT01369498|537629736|FG002|Overall Study|Lack of Efficacy|1|||
149041032|NCT01369498|537629737|FG003|Overall Study|Lack of Efficacy|3|||
149041033|NCT01369498|537629734|FG000|Overall Study|Adverse Event|1|||
149041034|NCT01369498|537629735|FG001|Overall Study|Adverse Event|2|||
149041035|NCT01369498|537629736|FG002|Overall Study|Adverse Event|0|||
149041036|NCT01369498|537629737|FG003|Overall Study|Adverse Event|1|||
149041037|NCT01369498|537629734|FG000|Overall Study|Withdrawal of Consent|0|||
149041038|NCT01369498|537629735|FG001|Overall Study|Withdrawal of Consent|1|||
149041039|NCT01369498|537629736|FG002|Overall Study|Withdrawal of Consent|1|||
149041040|NCT01369498|537629737|FG003|Overall Study|Withdrawal of Consent|1|||
149041041|NCT01369498|537629734|FG000|Overall Study|Death|0|||
149041042|NCT01369498|537629735|FG001|Overall Study|Death|0|||
149041043|NCT01369498|537629736|FG002|Overall Study|Death|1|||
149041044|NCT01369498|537629737|FG003|Overall Study|Death|0|||
149041045|NCT01369498|537629734|FG000|Overall Study|Investigator's Discretion|1|||
149041046|NCT01369498|537629735|FG001|Overall Study|Investigator's Discretion|0|||
149041047|NCT01369498|537629736|FG002|Overall Study|Investigator's Discretion|1|||
149041048|NCT01369498|537629737|FG003|Overall Study|Investigator's Discretion|3|||
149041049|NCT01369498|537629734|FG000|Overall Study|Unknown Reason|1|||
149041050|NCT01369498|537629735|FG001|Overall Study|Unknown Reason|0|||
149041051|NCT01369498|537629736|FG002|Overall Study|Unknown Reason|11|||
149041052|NCT01369498|537629737|FG003|Overall Study|Unknown Reason|6|||
149041053|NCT01369498|537629734|FG000|Overall Study|Disease Progression|0|||
149041054|NCT01369498|537629735|FG001|Overall Study|Disease Progression|0|||
149041055|NCT01369498|537629736|FG002|Overall Study|Disease Progression|0|||
149041056|NCT01369498|537629737|FG003|Overall Study|Disease Progression|1|||
149041057|NCT00566527|537629740|FG000|Overall Study|Reason not provided|3|||
149041058|NCT00566527|537629741|FG001|Overall Study|Reason not provided|11|||
149041059|NCT00566527|537629742|FG002|Overall Study|Reason not provided|10|||
149041060|NCT00566527|537629740|FG000|Overall Study|Adverse Event|2|||
149041061|NCT00566527|537629741|FG001|Overall Study|Adverse Event|0|||
149041062|NCT00566527|537629742|FG002|Overall Study|Adverse Event|1|||
149041063|NCT00566527|537629740|FG000|Overall Study|Physician Decision|3|||
149041064|NCT00566527|537629741|FG001|Overall Study|Physician Decision|8|||
149041065|NCT00566527|537629742|FG002|Overall Study|Physician Decision|20|||
149041066|NCT00566527|537629740|FG000|Overall Study|Lost to Follow-up|3|||
149041067|NCT00566527|537629741|FG001|Overall Study|Lost to Follow-up|4|||
149041068|NCT00566527|537629742|FG002|Overall Study|Lost to Follow-up|4|||
149041069|NCT00566527|537629740|FG000|Overall Study|Withdrawal by Subject|6|||
149041070|NCT00566527|537629741|FG001|Overall Study|Withdrawal by Subject|43|||
149041071|NCT00566527|537629742|FG002|Overall Study|Withdrawal by Subject|43|||
149041072|NCT01943916|537629743|FG000|Overall Study|Technically invalid images|10|||
149041073|NCT01943916|537629743|FG000|Overall Study|Enrollment Failure|23|||
149041074|NCT01943916|537629743|FG000|Overall Study|Pilot Phase exclusion|100|||
149041075|NCT01943916|537629743|FG000|Overall Study|Quality Assurance Reader Fail|130|||
149041076|NCT01943916|537629743|FG000|Overall Study|Technical Failure|39|||
149041077|NCT01943916|537629743|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
149041078|NCT01943916|537629743|FG000|Overall Study|No Truth Panel Review|38|||
149041079|NCT01943916|537629743|FG000|Overall Study|Protocol Deviation|1|||
149041080|NCT01576484|537629744|FG000|Overall Study|Adverse Event|1|||
149041081|NCT01576484|537629745|FG001|Overall Study|Adverse Event|1|||
149041082|NCT01576484|537629744|FG000|Overall Study|Protocol Violation|0|||
149041083|NCT01576484|537629745|FG001|Overall Study|Protocol Violation|2|||
149041084|NCT01576484|537629744|FG000|Overall Study|Sponsor Decision|2|||
149041085|NCT01576484|537629745|FG001|Overall Study|Sponsor Decision|8|||
149041086|NCT01576484|537629744|FG000|Overall Study|Withdrawal by Subject|0|||
149041087|NCT01576484|537629745|FG001|Overall Study|Withdrawal by Subject|3|||
149041088|NCT01576484|537629744|FG000|Overall Study|Other|2|||
149041089|NCT01576484|537629745|FG001|Overall Study|Other|5|||
149041090|NCT03823911|537629747|FG000|Overall Study|Lost to Follow-up|1|||
149041091|NCT03823911|537629748|FG001|Overall Study|Lost to Follow-up|5|||
149041092|NCT03823911|537629749|FG002|Overall Study|Lost to Follow-up|2|||
149041093|NCT03823911|537629747|FG000|Overall Study|Did not meet eligibility criteria|13|||
149041094|NCT03823911|537629748|FG001|Overall Study|Did not meet eligibility criteria|7|||
149041095|NCT03823911|537629749|FG002|Overall Study|Did not meet eligibility criteria|4|||
149041096|NCT03823911|537629747|FG000|Overall Study|Death|0|||
149041097|NCT03823911|537629748|FG001|Overall Study|Death|1|||
149041098|NCT03823911|537629749|FG002|Overall Study|Death|0|||
149041099|NCT00958633|537629754|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
149041100|NCT00958633|537629755|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
149041101|NCT00958633|537629756|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
149041102|NCT00958633|537629754|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
149041103|NCT00958633|537629755|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
149041104|NCT00958633|537629756|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
149041105|NCT00958633|537629754|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
149041106|NCT00958633|537629755|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
149041107|NCT00958633|537629756|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
149041108|NCT00958633|537629754|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
149041109|NCT00958633|537629755|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
149041110|NCT00958633|537629756|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
149041111|NCT00958633|537629754|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
149041112|NCT00958633|537629755|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
149041113|NCT00958633|537629756|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
149041114|NCT00958633|537629754|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
148885085|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
148885086|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Other|0|||
148885087|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Other|0|||
149041115|NCT00958633|537629755|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
148885088|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Other|4|||
148885089|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Other|7|||
149041116|NCT00958633|537629756|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
149041117|NCT00958633|537629754|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
149041118|NCT00958633|537629755|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
149041119|NCT00958633|537629756|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
149041120|NCT00094575|537629760|FG000|Overall Study|Death|146|||
149041121|NCT00094575|537629761|FG001|Overall Study|Death|146|||
149041122|NCT00794118|537629762|FG000|Overall Study|Lost to Follow-up|16|||
149041123|NCT00794118|537629762|FG000|Overall Study|Withdrawal by Subject|9|||
149041124|NCT00794118|537629762|FG000|Overall Study|Changed hospital center|2|||
149041125|NCT04305405|537629763|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149041126|NCT04305405|537629764|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149041127|NCT00206375|537629766|FG000|Overall Study|Lost to Follow-up|1|||
149041128|NCT00206375|537629767|FG001|Overall Study|Lost to Follow-up|0|||
149041129|NCT00206375|537629768|FG002|Overall Study|Lost to Follow-up|0|||
149041130|NCT00206375|537629766|FG000|Overall Study|Withdrawal by Subject|2|||
149041131|NCT00206375|537629767|FG001|Overall Study|Withdrawal by Subject|1|||
149041132|NCT00206375|537629768|FG002|Overall Study|Withdrawal by Subject|3|||
149041133|NCT00206375|537629766|FG000|Overall Study|Study terminated due to lack of funds|0|||
149041134|NCT00206375|537629767|FG001|Overall Study|Study terminated due to lack of funds|1|||
149041135|NCT00206375|537629768|FG002|Overall Study|Study terminated due to lack of funds|1|||
149041136|NCT00837616|537629771|FG000|Overall Study|Withdrawal by Subject|0|||
149041137|NCT00837616|537629772|FG001|Overall Study|Withdrawal by Subject|1|||
149041138|NCT02674750|537629774|FG000|Overall Study|Death|4|||
149041139|NCT02674750|537629775|FG001|Overall Study|Death|5|||
149041140|NCT02674750|537629776|FG002|Overall Study|Death|8|||
149041141|NCT02674750|537629774|FG000|Overall Study|Lost to Follow-up|0|||
149041142|NCT02674750|537629775|FG001|Overall Study|Lost to Follow-up|8|||
149041143|NCT02674750|537629776|FG002|Overall Study|Lost to Follow-up|0|||
149041144|NCT02674750|537629774|FG000|Overall Study|Lack of Efficacy|1|||
149041145|NCT02674750|537629775|FG001|Overall Study|Lack of Efficacy|17|||
149041146|NCT02674750|537629776|FG002|Overall Study|Lack of Efficacy|3|||
149041147|NCT02674750|537629774|FG000|Overall Study|Withdrawal by Subject|0|||
149041148|NCT02674750|537629775|FG001|Overall Study|Withdrawal by Subject|7|||
149041149|NCT02674750|537629776|FG002|Overall Study|Withdrawal by Subject|1|||
149041150|NCT02674750|537629774|FG000|Overall Study|Other|0|||
149041151|NCT02674750|537629775|FG001|Overall Study|Other|8|||
149041152|NCT02674750|537629776|FG002|Overall Study|Other|0|||
149041153|NCT01685606|537629779|FG000|Overall Study|Withdrawal by Subject|1|||
149041154|NCT01787760|537629780|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
149041155|NCT01787760|537629781|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
149041156|NCT01787760|537629782|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
149041157|NCT01787760|537629780|FG000|Overall Study|Decompensated on left exotropia|0|||
149041158|NCT01787760|537629781|FG001|Overall Study|Decompensated on left exotropia|0|||
149041159|NCT01787760|537629782|FG002|Overall Study|Decompensated on left exotropia|1|||
149041160|NCT01787760|537629780|FG000|Overall Study|Dryness|0|||
149041161|NCT01787760|537629781|FG001|Overall Study|Dryness|1|||
149041162|NCT01787760|537629782|FG002|Overall Study|Dryness|0|||
149041163|NCT01787760|537629780|FG000|Overall Study|Relocation|1|||
149041164|NCT01787760|537629781|FG001|Overall Study|Relocation|1|||
149041165|NCT01787760|537629782|FG002|Overall Study|Relocation|0|||
149041166|NCT01787760|537629780|FG000|Overall Study|Lens discomfort|3|||
149041167|NCT01787760|537629781|FG001|Overall Study|Lens discomfort|0|||
149041168|NCT01787760|537629782|FG002|Overall Study|Lens discomfort|0|||
149041169|NCT01787760|537629780|FG000|Overall Study|Lens handling difficulty|1|||
149041170|NCT01787760|537629781|FG001|Overall Study|Lens handling difficulty|2|||
149041171|NCT01787760|537629782|FG002|Overall Study|Lens handling difficulty|0|||
149041172|NCT01787760|537629780|FG000|Overall Study|Protocol Violation|6|||
149041173|NCT01787760|537629781|FG001|Overall Study|Protocol Violation|0|||
149041174|NCT01787760|537629782|FG002|Overall Study|Protocol Violation|1|||
149041175|NCT01787760|537629780|FG000|Overall Study|Withdrawal by Subject|5|||
149041176|NCT01787760|537629781|FG001|Overall Study|Withdrawal by Subject|1|||
149041177|NCT01787760|537629782|FG002|Overall Study|Withdrawal by Subject|2|||
149041178|NCT01787760|537629780|FG000|Overall Study|Lost to Follow-up|1|||
148885090|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
148885091|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
148885092|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
148885093|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
148885094|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Death|0|||
148885095|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Death|0|||
149041179|NCT01787760|537629781|FG001|Overall Study|Lost to Follow-up|0|||
149041180|NCT01787760|537629782|FG002|Overall Study|Lost to Follow-up|1|||
149041181|NCT01787760|537629780|FG000|Overall Study|Stroke|1|||
149041182|NCT01787760|537629781|FG001|Overall Study|Stroke|0|||
149041183|NCT01787760|537629782|FG002|Overall Study|Stroke|0|||
149041184|NCT01787760|537629780|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
149041185|NCT01787760|537629781|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
149041186|NCT01787760|537629782|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
149041187|NCT01787760|537629780|FG000|Overall Study|Unsatisfactory physiological response|2|||
148885096|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Death|2|||
149041188|NCT01787760|537629781|FG001|Overall Study|Unsatisfactory physiological response|4|||
149041189|NCT01787760|537629782|FG002|Overall Study|Unsatisfactory physiological response|0|||
149041190|NCT01787760|537629780|FG000|Overall Study|Unsatisfactory visual response|1|||
149041191|NCT01787760|537629781|FG001|Overall Study|Unsatisfactory visual response|1|||
149041192|NCT01787760|537629782|FG002|Overall Study|Unsatisfactory visual response|0|||
149041193|NCT01787760|537629780|FG000|Overall Study|Near vision blur|1|||
149041194|NCT01787760|537629781|FG001|Overall Study|Near vision blur|0|||
149041195|NCT01787760|537629782|FG002|Overall Study|Near vision blur|0|||
149041196|NCT03512756|537629783|FG000|Part 1|Death|23|||
149041197|NCT03512756|537629784|FG001|Part 1|Death|18|||
149041198|NCT03512756|537629785|FG002|Part 1|Death|0|||
149041199|NCT03512756|537629786|FG003|Part 1|Death|0|||
149041200|NCT03512756|537629783|FG000|Part 1|Lost to Follow-up|0|||
149041201|NCT03512756|537629784|FG001|Part 1|Lost to Follow-up|3|||
149041202|NCT03512756|537629785|FG002|Part 1|Lost to Follow-up|0|||
149041203|NCT03512756|537629786|FG003|Part 1|Lost to Follow-up|0|||
149041204|NCT03512756|537629783|FG000|Part 1|Physician Decision|0|||
149041205|NCT03512756|537629784|FG001|Part 1|Physician Decision|1|||
149041206|NCT03512756|537629785|FG002|Part 1|Physician Decision|0|||
149041207|NCT03512756|537629786|FG003|Part 1|Physician Decision|0|||
149041208|NCT03512756|537629783|FG000|Part 1|Withdrawal by Subject|2|||
149041209|NCT03512756|537629784|FG001|Part 1|Withdrawal by Subject|2|||
149041210|NCT03512756|537629785|FG002|Part 1|Withdrawal by Subject|0|||
149041211|NCT03512756|537629786|FG003|Part 1|Withdrawal by Subject|0|||
149041212|NCT03512756|537629783|FG000|Part 2|Death|0|||
149041213|NCT03512756|537629784|FG001|Part 2|Death|0|||
149041214|NCT03512756|537629785|FG002|Part 2|Death|32|||
149041215|NCT03512756|537629786|FG003|Part 2|Death|21|||
149041216|NCT03512756|537629783|FG000|Part 2|Lost to Follow-up|0|||
149041217|NCT03512756|537629784|FG001|Part 2|Lost to Follow-up|0|||
149041218|NCT03512756|537629785|FG002|Part 2|Lost to Follow-up|1|||
149041219|NCT03512756|537629786|FG003|Part 2|Lost to Follow-up|0|||
149041220|NCT03512756|537629783|FG000|Part 2|Physician Decision|0|||
149041221|NCT03512756|537629784|FG001|Part 2|Physician Decision|0|||
149041222|NCT03512756|537629785|FG002|Part 2|Physician Decision|2|||
149041223|NCT03512756|537629786|FG003|Part 2|Physician Decision|4|||
149041224|NCT03512756|537629783|FG000|Part 2|Study Terminated by Sponsor|0|||
149041225|NCT03512756|537629784|FG001|Part 2|Study Terminated by Sponsor|0|||
149041226|NCT03512756|537629785|FG002|Part 2|Study Terminated by Sponsor|2|||
149041227|NCT03512756|537629786|FG003|Part 2|Study Terminated by Sponsor|6|||
149041228|NCT03512756|537629783|FG000|Part 2|Protocol Violation|0|||
149041229|NCT03512756|537629784|FG001|Part 2|Protocol Violation|0|||
149041230|NCT03512756|537629785|FG002|Part 2|Protocol Violation|1|||
149041231|NCT03512756|537629786|FG003|Part 2|Protocol Violation|0|||
149041232|NCT03512756|537629783|FG000|Part 2|Withdrawal by Subject|0|||
149041233|NCT03512756|537629784|FG001|Part 2|Withdrawal by Subject|0|||
149041234|NCT03512756|537629785|FG002|Part 2|Withdrawal by Subject|3|||
149041235|NCT03512756|537629786|FG003|Part 2|Withdrawal by Subject|9|||
149041236|NCT01597258|537629787|FG000|Overall Study|No Drug Administration|1|||
149041237|NCT00933400|537629788|FG000|Overall Study|Withdrawal by Subject|21|||
149041238|NCT00933400|537629789|FG001|Overall Study|Withdrawal by Subject|1|||
149041239|NCT01764464|537629790|FG000|First Intervention|Withdrawal by Subject|1|||
149041240|NCT01764464|537629791|FG001|First Intervention|Withdrawal by Subject|0|||
149041241|NCT01764464|537629790|FG000|First Intervention|Lost to Follow-up|1|||
149041242|NCT01764464|537629791|FG001|First Intervention|Lost to Follow-up|0|||
149041243|NCT01764464|537629790|FG000|First Intervention|Adverse Event|0|||
149041244|NCT01764464|537629791|FG001|First Intervention|Adverse Event|2|||
149041245|NCT01764464|537629790|FG000|First Intervention|did not receive study drug|0|||
149041246|NCT01764464|537629791|FG001|First Intervention|did not receive study drug|1|||
149041247|NCT01764464|537629790|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
149041248|NCT01764464|537629791|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
149041249|NCT02079844|537629792|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
149041250|NCT02079844|537629793|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
149041251|NCT02079844|537629794|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
149041252|NCT02079844|537629792|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
149041253|NCT02079844|537629793|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
149041254|NCT02079844|537629794|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
149041255|NCT04623008|537631046|FG000|Baseline to T2|Withdrawal by Subject|4|||
149041256|NCT04623008|537631047|FG001|Baseline to T2|Withdrawal by Subject|2|||
149041257|NCT04623008|537631046|FG000|Baseline to T3|Withdrawal by Subject|4|||
149041258|NCT04623008|537631047|FG001|Baseline to T3|Withdrawal by Subject|2|||
149041259|NCT04250883|537631061|FG000|Overall Study|Lost to Follow-up|1|||
149041260|NCT04250883|537631062|FG001|Overall Study|Lost to Follow-up|0|||
149041261|NCT02763319|537631063|FG000|Overall Study|Adverse Event|12|||
149041262|NCT02763319|537631064|FG001|Overall Study|Adverse Event|3|||
149041263|NCT02763319|537631063|FG000|Overall Study|Death|123|||
149041264|NCT02763319|537631064|FG001|Overall Study|Death|123|||
149041265|NCT02763319|537631063|FG000|Overall Study|Lost to Follow-up|6|||
149041266|NCT02763319|537631064|FG001|Overall Study|Lost to Follow-up|7|||
149041267|NCT02763319|537631063|FG000|Overall Study|Noncompliance with Study Drug|2|||
149041268|NCT02763319|537631064|FG001|Overall Study|Noncompliance with Study Drug|0|||
149041269|NCT02763319|537631063|FG000|Overall Study|"Captured as Other in Database"|29|||
149041270|NCT02763319|537631064|FG001|Overall Study|"Captured as Other in Database"|34|||
149041271|NCT02763319|537631063|FG000|Overall Study|Physician Decision|1|||
149041272|NCT02763319|537631064|FG001|Overall Study|Physician Decision|7|||
149041273|NCT02763319|537631063|FG000|Overall Study|Progressive Disease|24|||
149041274|NCT02763319|537631064|FG001|Overall Study|Progressive Disease|27|||
149041275|NCT02763319|537631063|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
149041276|NCT02763319|537631064|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
149041277|NCT02763319|537631063|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
149041278|NCT02763319|537631064|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
149041279|NCT02763319|537631063|FG000|Overall Study|Withdrawal by Subject|26|||
149041280|NCT02763319|537631064|FG001|Overall Study|Withdrawal by Subject|25|||
149041281|NCT03936660|537631066|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
149041282|NCT03936660|537631067|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
149041283|NCT01875848|537631071|FG000|Overall Study|Withdrawal by Subject|2|||
149041284|NCT01875848|537631072|FG001|Overall Study|Withdrawal by Subject|0|||
149041285|NCT02407249|537631073|FG000|Overall Study|Did not complete 12-month follow-up|13|||
149041286|NCT02407249|537631073|FG000|Overall Study|Not treated|13|||
149041287|NCT00840177|537631074|FG000|Overall Study|Adverse Event|5|||
149041288|NCT00840177|537631075|FG001|Overall Study|Adverse Event|1|||
149041289|NCT00840177|537631076|FG002|Overall Study|Adverse Event|1|||
149041290|NCT00840177|537631074|FG000|Overall Study|Refusal unrelated to adverse events|1|||
149041291|NCT00840177|537631075|FG001|Overall Study|Refusal unrelated to adverse events|0|||
149041292|NCT00840177|537631076|FG002|Overall Study|Refusal unrelated to adverse events|1|||
149041293|NCT00840177|537631074|FG000|Overall Study|Progression/relapse|2|||
149041294|NCT00840177|537631075|FG001|Overall Study|Progression/relapse|0|||
149041295|NCT00840177|537631076|FG002|Overall Study|Progression/relapse|0|||
149041296|NCT00840177|537631074|FG000|Overall Study|Death|4|||
149041297|NCT00840177|537631075|FG001|Overall Study|Death|5|||
149041298|NCT00840177|537631076|FG002|Overall Study|Death|5|||
149041299|NCT00840177|537631074|FG000|Overall Study|not protocol specified|6|||
149041300|NCT00840177|537631075|FG001|Overall Study|not protocol specified|3|||
149041301|NCT00840177|537631076|FG002|Overall Study|not protocol specified|0|||
149041302|NCT00840177|537631074|FG000|Overall Study|Ineligible|0|||
149041303|NCT00840177|537631075|FG001|Overall Study|Ineligible|0|||
149041304|NCT00840177|537631076|FG002|Overall Study|Ineligible|3|||
149041305|NCT00840177|537631074|FG000|Overall Study|Did not start treatment|0|||
149041306|NCT00840177|537631075|FG001|Overall Study|Did not start treatment|0|||
149041307|NCT00840177|537631076|FG002|Overall Study|Did not start treatment|1|||
149041308|NCT01622868|537631077|FG000|Overall Study|Protocol Violation|7|||
149041309|NCT01622868|537631078|FG001|Overall Study|Protocol Violation|0|||
149041310|NCT01318382|537631080|FG000|Overall Study|Physician Decision|2|||
149041311|NCT01318382|537631080|FG000|Overall Study|Device Malfunction|10|||
149041312|NCT01318382|537631080|FG000|Overall Study|Protocol Violation|1|||
149041313|NCT01599104|537631081|FG000|Overall Study|Withdrawal by Subject|1|||
149041314|NCT01599104|537631082|FG001|Overall Study|Withdrawal by Subject|1|||
149041315|NCT01599104|537631083|FG002|Overall Study|Withdrawal by Subject|2|||
149041316|NCT01599104|537631081|FG000|Overall Study|Technical Problems|1|||
149041317|NCT01599104|537631082|FG001|Overall Study|Technical Problems|0|||
149041318|NCT01599104|537631083|FG002|Overall Study|Technical Problems|0|||
149041319|NCT01599104|537631081|FG000|Overall Study|Physician Decision|3|||
149041320|NCT01599104|537631082|FG001|Overall Study|Physician Decision|2|||
149041321|NCT01599104|537631083|FG002|Overall Study|Physician Decision|2|||
149041322|NCT01599104|537631081|FG000|Overall Study|Non-compliance with study treatment|0|||
149041323|NCT01599104|537631082|FG001|Overall Study|Non-compliance with study treatment|1|||
149041324|NCT01599104|537631083|FG002|Overall Study|Non-compliance with study treatment|0|||
149041325|NCT01599104|537631081|FG000|Overall Study|Lack of Efficacy|4|||
149041326|NCT01599104|537631082|FG001|Overall Study|Lack of Efficacy|4|||
149041327|NCT01599104|537631083|FG002|Overall Study|Lack of Efficacy|10|||
148885097|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Death|7|||
148885098|NCT01695135|537056932|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
148885099|NCT01695135|537056933|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
149041328|NCT01599104|537631081|FG000|Overall Study|Adverse Event|7|||
149041329|NCT01599104|537631082|FG001|Overall Study|Adverse Event|6|||
149041330|NCT01599104|537631083|FG002|Overall Study|Adverse Event|12|||
148885100|NCT01695135|537056934|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
149041331|NCT02271854|537631088|FG000|Overall Study|Withdrawal by Subject|2|||
149041332|NCT02271854|537631088|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
149041333|NCT02271854|537631088|FG000|Overall Study|Lost to Follow-up|1|||
149041334|NCT01308567|537631089|FG000|Overall Study|Lost to Follow-up|2|||
149041335|NCT01308567|537631090|FG001|Overall Study|Lost to Follow-up|4|||
149041336|NCT01308567|537631091|FG002|Overall Study|Lost to Follow-up|4|||
149041337|NCT00542789|537631092|FG000|Overall Study|Adverse Event|18|||
149041338|NCT00542789|537631093|FG001|Overall Study|Adverse Event|17|||
149041339|NCT00542789|537631092|FG000|Overall Study|Withdrawal by Subject|7|||
149041340|NCT00542789|537631093|FG001|Overall Study|Withdrawal by Subject|3|||
149041341|NCT00542789|537631092|FG000|Overall Study|Protocol Violation|8|||
149041342|NCT00542789|537631093|FG001|Overall Study|Protocol Violation|1|||
149041343|NCT00542789|537631092|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
149041344|NCT00542789|537631093|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
149041345|NCT01571596|537631094|FG000|Overall Study|Adverse Event|2|||
149041346|NCT01571596|537631095|FG001|Overall Study|Adverse Event|0|||
149041347|NCT01571596|537631096|FG002|Overall Study|Adverse Event|0|||
149041348|NCT01571596|537631094|FG000|Overall Study|Study Terminated by the Sponsor|0|||
149041349|NCT01571596|537631095|FG001|Overall Study|Study Terminated by the Sponsor|1|||
149041350|NCT01571596|537631096|FG002|Overall Study|Study Terminated by the Sponsor|1|||
149041351|NCT00585052|537631107|FG000|Overall Study|Withdrawal by Subject|1|||
149041352|NCT00774397|537631108|FG000|Overall Study|Adverse Event|1|||
149041353|NCT00774397|537631109|FG001|Overall Study|Adverse Event|3|||
149041354|NCT00774397|537631110|FG002|Overall Study|Adverse Event|16|||
149041355|NCT00774397|537631111|FG003|Overall Study|Adverse Event|8|||
149041356|NCT00774397|537631112|FG004|Overall Study|Adverse Event|8|||
149041357|NCT00774397|537631113|FG005|Overall Study|Adverse Event|3|||
149041358|NCT00774397|537631114|FG006|Overall Study|Adverse Event|16|||
149041359|NCT00774397|537631108|FG000|Overall Study|Lack of Efficacy|11|||
149041360|NCT00774397|537631109|FG001|Overall Study|Lack of Efficacy|4|||
149041361|NCT00774397|537631110|FG002|Overall Study|Lack of Efficacy|5|||
149041362|NCT00774397|537631111|FG003|Overall Study|Lack of Efficacy|3|||
149041363|NCT00774397|537631112|FG004|Overall Study|Lack of Efficacy|27|||
149041364|NCT00774397|537631113|FG005|Overall Study|Lack of Efficacy|15|||
149041365|NCT00774397|537631114|FG006|Overall Study|Lack of Efficacy|9|||
149041366|NCT00774397|537631108|FG000|Overall Study|Protocol Violation|0|||
149041367|NCT00774397|537631109|FG001|Overall Study|Protocol Violation|1|||
149041368|NCT00774397|537631110|FG002|Overall Study|Protocol Violation|3|||
149041369|NCT00774397|537631111|FG003|Overall Study|Protocol Violation|1|||
149041370|NCT00774397|537631112|FG004|Overall Study|Protocol Violation|2|||
149041371|NCT00774397|537631113|FG005|Overall Study|Protocol Violation|1|||
149041372|NCT00774397|537631114|FG006|Overall Study|Protocol Violation|0|||
149041373|NCT00774397|537631108|FG000|Overall Study|Lost to Follow-up|0|||
149041374|NCT00774397|537631109|FG001|Overall Study|Lost to Follow-up|1|||
149041375|NCT00774397|537631110|FG002|Overall Study|Lost to Follow-up|1|||
149041376|NCT00774397|537631111|FG003|Overall Study|Lost to Follow-up|1|||
149041377|NCT00774397|537631112|FG004|Overall Study|Lost to Follow-up|0|||
149041378|NCT00774397|537631113|FG005|Overall Study|Lost to Follow-up|1|||
149041379|NCT00774397|537631114|FG006|Overall Study|Lost to Follow-up|0|||
149041380|NCT00774397|537631108|FG000|Overall Study|Refused to continue trial medication|1|||
149041381|NCT00774397|537631109|FG001|Overall Study|Refused to continue trial medication|3|||
149041382|NCT00774397|537631110|FG002|Overall Study|Refused to continue trial medication|2|||
149041383|NCT00774397|537631111|FG003|Overall Study|Refused to continue trial medication|2|||
149041384|NCT00774397|537631112|FG004|Overall Study|Refused to continue trial medication|6|||
149041385|NCT00774397|537631113|FG005|Overall Study|Refused to continue trial medication|2|||
149041386|NCT00774397|537631114|FG006|Overall Study|Refused to continue trial medication|3|||
149041387|NCT00774397|537631108|FG000|Overall Study|Not treated|0|||
149041388|NCT00774397|537631109|FG001|Overall Study|Not treated|0|||
149041389|NCT00774397|537631110|FG002|Overall Study|Not treated|0|||
149041390|NCT00774397|537631111|FG003|Overall Study|Not treated|0|||
149041391|NCT00774397|537631112|FG004|Overall Study|Not treated|1|||
149041392|NCT00774397|537631113|FG005|Overall Study|Not treated|0|||
149041393|NCT00774397|537631114|FG006|Overall Study|Not treated|1|||
149041394|NCT00774397|537631108|FG000|Overall Study|Other than those stated above|1|||
149041395|NCT00774397|537631109|FG001|Overall Study|Other than those stated above|1|||
149041396|NCT00774397|537631110|FG002|Overall Study|Other than those stated above|3|||
149041397|NCT00774397|537631111|FG003|Overall Study|Other than those stated above|2|||
149041398|NCT00774397|537631112|FG004|Overall Study|Other than those stated above|2|||
149041399|NCT00774397|537631113|FG005|Overall Study|Other than those stated above|0|||
149041400|NCT00774397|537631114|FG006|Overall Study|Other than those stated above|1|||
149041401|NCT00077675|537631115|FG000|Overall Study|Adverse Event|1|||
149041402|NCT00077675|537631116|FG001|Overall Study|Adverse Event|2|||
149041403|NCT00077675|537631115|FG000|Overall Study|Lost to Follow-up|6|||
149041404|NCT00077675|537631116|FG001|Overall Study|Lost to Follow-up|3|||
149041405|NCT00077675|537631115|FG000|Overall Study|Withdrawal by Subject|1|||
149041406|NCT00077675|537631116|FG001|Overall Study|Withdrawal by Subject|0|||
149041407|NCT00077675|537631115|FG000|Overall Study|Other|0|||
149041408|NCT00077675|537631116|FG001|Overall Study|Other|1|||
149041409|NCT00077675|537631115|FG000|Overall Study|Never received study treatment|3|||
148889315|NCT00101686|537074376|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
149041410|NCT00077675|537631116|FG001|Overall Study|Never received study treatment|3|||
149041411|NCT04425863|537631117|FG000|Overall Study|Death|0|||
149041412|NCT04425863|537631118|FG001|Overall Study|Death|0|||
149041413|NCT04425863|537631119|FG002|Overall Study|Death|1|||
149041414|NCT02601820|537631120|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
149041415|NCT02601820|537631120|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
149041416|NCT02601820|537631120|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
149041417|NCT02601820|537631120|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
149041418|NCT01599793|537631121|FG000|Overall Study|Adverse Event|2|||
149041419|NCT00277355|537631129|FG000|Overall Study|Withdrawal by Subject|3|||
149041420|NCT00277355|537631130|FG001|Overall Study|Withdrawal by Subject|3|||
149041421|NCT00277355|537631129|FG000|Overall Study|Lost to Follow-up|2|||
149041422|NCT00277355|537631130|FG001|Overall Study|Lost to Follow-up|2|||
149041423|NCT00277355|537631129|FG000|Overall Study|Adverse Event|5|||
149041424|NCT00277355|537631130|FG001|Overall Study|Adverse Event|0|||
149041425|NCT00277355|537631129|FG000|Overall Study|Death|3|||
149041426|NCT00277355|537631130|FG001|Overall Study|Death|0|||
149041427|NCT00277355|537631129|FG000|Overall Study|Physician Decision|1|||
149041428|NCT00277355|537631130|FG001|Overall Study|Physician Decision|0|||
149041429|NCT02765100|537631131|FG000|Overall Study|subject found ineligible after baseline|1|||
149041430|NCT02765100|537631132|FG001|Overall Study|subject found ineligible after baseline|1|||
149041431|NCT02765100|537631131|FG000|Overall Study|Lost to Follow-up|0|||
149041432|NCT02765100|537631132|FG001|Overall Study|Lost to Follow-up|1|||
149041433|NCT02675244|537631142|FG000|Overall Study|Death|9|||
149041434|NCT02675244|537631143|FG001|Overall Study|Death|6|||
149041435|NCT02675244|537631142|FG000|Overall Study|Withdrawal by Subject|3|||
149041436|NCT02675244|537631143|FG001|Overall Study|Withdrawal by Subject|6|||
149041437|NCT02675244|537631142|FG000|Overall Study|Lost to Follow-up|1|||
149041438|NCT02675244|537631143|FG001|Overall Study|Lost to Follow-up|1|||
149041439|NCT02675244|537631142|FG000|Overall Study|Ongoing at 2 Years|190|||
149041440|NCT02675244|537631143|FG001|Overall Study|Ongoing at 2 Years|185|||
149041441|NCT02652442|537631144|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
149041442|NCT00391898|537631145|FG000|Overall Study|Adverse Event|3|||
149041443|NCT00391898|537631146|FG001|Overall Study|Adverse Event|0|||
149041444|NCT00391898|537631145|FG000|Overall Study|Other|8|||
149041445|NCT00391898|537631146|FG001|Overall Study|Other|10|||
149041446|NCT02529995|537631148|FG000|Part A|Ongoing Study at Data Cut-off|14|||
149041447|NCT02529995|537631149|FG001|Part A|Ongoing Study at Data Cut-off|16|||
149041448|NCT02529995|537631148|FG000|Part A|Discontinued Study|1|||
149041449|NCT02529995|537631149|FG001|Part A|Discontinued Study|0|||
149041450|NCT02529995|537631148|FG000|Part B|Ongoing Study at Data Cut-off|0|||
149041451|NCT02529995|537631149|FG001|Part B|Ongoing Study at Data Cut-off|7|||
149041452|NCT02529995|537631148|FG000|Part B|Discontinued Study|6|||
149041453|NCT02529995|537631149|FG001|Part B|Discontinued Study|5|||
149041454|NCT01444417|537631156|FG000|Overall Study|Ineligibility Determined|0|||
149041455|NCT01444417|537631157|FG001|Overall Study|Ineligibility Determined|1|||
149041456|NCT01444417|537631156|FG000|Overall Study|Withdrawal by Subject|2|||
149041457|NCT01444417|537631157|FG001|Overall Study|Withdrawal by Subject|0|||
149041458|NCT01968226|537631158|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
149041459|NCT02584829|537632534|FG000|Overall Study|Physician Decision|1|||
149041460|NCT02584829|537632535|FG001|Overall Study|Physician Decision|0|||
149041461|NCT02584829|537632534|FG000|Overall Study|Withdrawal by Subject|0|||
149041462|NCT02584829|537632535|FG001|Overall Study|Withdrawal by Subject|1|||
149041463|NCT02584829|537632534|FG000|Overall Study|Progressive Disease|0|||
149041464|NCT02584829|537632535|FG001|Overall Study|Progressive Disease|3|||
149041465|NCT00434304|537632538|FG000|Overall Study|Adverse Event|14|||
149041466|NCT00434304|537632538|FG000|Overall Study|Lack of Efficacy|2|||
149041467|NCT00434304|537632538|FG000|Overall Study|Withdrawal by Subject|4|||
148885101|NCT01695135|537056935|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
149041468|NCT05262738|537632539|FG000|Overall Study|Withdrawal by Subject|1|||
149041469|NCT05262738|537632540|FG001|Overall Study|Withdrawal by Subject|0|||
149041470|NCT02374463|537632543|FG000|Overall Study|Withdrawal by Subject|3|||
149041471|NCT02374463|537632544|FG001|Overall Study|Withdrawal by Subject|3|||
149041472|NCT01424397|537632546|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041473|NCT01424397|537632547|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041474|NCT01424397|537632548|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
149041475|NCT01424397|537632549|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041476|NCT01424397|537632550|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
148885102|NCT02753946|537056938|FG000|Overall Study|Adverse Event|7|||
148885103|NCT02753946|537056939|FG001|Overall Study|Adverse Event|6|||
148885104|NCT02753946|537056938|FG000|Overall Study|Withdrawal by Subject|6|||
148885105|NCT02753946|537056939|FG001|Overall Study|Withdrawal by Subject|1|||
148885106|NCT02753946|537056938|FG000|Overall Study|Lack of Efficacy|1|||
148885107|NCT02753946|537056939|FG001|Overall Study|Lack of Efficacy|0|||
148885108|NCT02753946|537056938|FG000|Overall Study|Physician Decision|0|||
149041477|NCT01424397|537632551|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041478|NCT01424397|537632552|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041479|NCT01424397|537632553|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041480|NCT01424397|537632554|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041481|NCT01424397|537632555|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041482|NCT01424397|537632556|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041483|NCT01424397|537632557|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
149041484|NCT02767765|537632558|FG000|Overall Study|Adverse Event|4|||
148885109|NCT02753946|537056939|FG001|Overall Study|Physician Decision|2|||
148885110|NCT00216671|537056940|FG000|Overall Study|Adverse Event|4|||
149041485|NCT02767765|537632558|FG000|Overall Study|Death|1|||
149041486|NCT02767765|537632558|FG000|Overall Study|Insufficient response|1|||
149041487|NCT02767765|537632558|FG000|Overall Study|Lost to Follow-up|2|||
149041488|NCT02767765|537632558|FG000|Overall Study|Investigator decision|1|||
149041489|NCT02767765|537632558|FG000|Overall Study|Non-Compliance|1|||
149041490|NCT02767765|537632558|FG000|Overall Study|Withdrawal by Subject|1|||
149041491|NCT01951170|537632560|FG000|Overall Study|Investigator decision|1|||
149041492|NCT00446459|537632571|FG000|8 Months|Protocol Violation|12|||
149041493|NCT00446459|537632571|FG000|12 Months|Protocol Violation|4|||
149041494|NCT00446459|537632571|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
149041495|NCT00244855|537632577|FG000|Overall Study|Withdrawal by Subject|0|||
149041496|NCT00244855|537632578|FG001|Overall Study|Withdrawal by Subject|1|||
149041497|NCT00364013|537632581|FG000|Overall Study|Ineligibility determined|4|||
149041498|NCT00364013|537632582|FG001|Overall Study|Ineligibility determined|2|||
149041499|NCT00364013|537632581|FG000|Overall Study|Adverse Event|4|||
149041500|NCT00364013|537632582|FG001|Overall Study|Adverse Event|3|||
149041501|NCT00364013|537632581|FG000|Overall Study|Withdrawal by Subject|13|||
149041502|NCT00364013|537632582|FG001|Overall Study|Withdrawal by Subject|18|||
149041503|NCT00364013|537632581|FG000|Overall Study|Physician Decision|3|||
149041504|NCT00364013|537632582|FG001|Overall Study|Physician Decision|3|||
149041505|NCT00364013|537632581|FG000|Overall Study|Lost to Follow-up|10|||
149041506|NCT00364013|537632582|FG001|Overall Study|Lost to Follow-up|3|||
149041507|NCT00364013|537632581|FG000|Overall Study|Protocol-specified criteria|6|||
149041508|NCT00364013|537632582|FG001|Overall Study|Protocol-specified criteria|6|||
149041509|NCT00364013|537632581|FG000|Overall Study|Other|41|||
149041510|NCT00364013|537632582|FG001|Overall Study|Other|47|||
149041511|NCT00364013|537632581|FG000|Overall Study|Ongoing|20|||
149041512|NCT00364013|537632582|FG001|Overall Study|Ongoing|13|||
149041513|NCT00293293|537632583|FG000|Overall Study|Withdrawal by Subject|1|||
149041514|NCT00293293|537632584|FG001|Overall Study|Withdrawal by Subject|1|||
149041515|NCT00293293|537632583|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
149041516|NCT00293293|537632584|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
149041517|NCT00293293|537632583|FG000|Overall Study|Patient discontinued chemotherapy|0|||
149041518|NCT00293293|537632584|FG001|Overall Study|Patient discontinued chemotherapy|1|||
148885111|NCT00216671|537056941|FG001|Overall Study|Adverse Event|9|||
148885112|NCT00216671|537056940|FG000|Overall Study|Pregnancy|0|||
148885113|NCT00216671|537056941|FG001|Overall Study|Pregnancy|1|||
148885114|NCT00216671|537056940|FG000|Overall Study|Withdrawal by Subject|4|||
148885115|NCT00216671|537056941|FG001|Overall Study|Withdrawal by Subject|2|||
148885116|NCT00216671|537056940|FG000|Overall Study|Refused Injections|3|||
148885117|NCT00216671|537056941|FG001|Overall Study|Refused Injections|13|||
148885118|NCT00216671|537056940|FG000|Overall Study|No Need to Continue Medication|1|||
148885119|NCT00216671|537056941|FG001|Overall Study|No Need to Continue Medication|1|||
149041519|NCT02512965|537632589|FG000|Overall Study|Withdrawal by Subject|0|||
149041520|NCT02512965|537632590|FG001|Overall Study|Withdrawal by Subject|4|||
149041521|NCT00835770|537632591|FG000|Overall Study|MS Relapse|17|||
149041522|NCT00835770|537632592|FG001|Overall Study|MS Relapse|23|||
149041523|NCT00835770|537632591|FG000|Overall Study|MS Progression|14|||
149041524|NCT00835770|537632592|FG001|Overall Study|MS Progression|9|||
149041525|NCT00835770|537632591|FG000|Overall Study|Adverse Event|113|||
149041526|NCT00835770|537632592|FG001|Overall Study|Adverse Event|124|||
149041527|NCT00835770|537632591|FG000|Overall Study|Lost to Follow-up|22|||
149041528|NCT00835770|537632592|FG001|Overall Study|Lost to Follow-up|19|||
149041529|NCT00835770|537632591|FG000|Overall Study|Consent Withdrawn|144|||
149041530|NCT00835770|537632592|FG001|Overall Study|Consent Withdrawn|156|||
148885120|NCT00216671|537056940|FG000|Overall Study|Insufficient Response|9|||
148885121|NCT00216671|537056941|FG001|Overall Study|Insufficient Response|4|||
148885122|NCT00216671|537056940|FG000|Overall Study|Lost to Follow-up|3|||
149041531|NCT00835770|537632591|FG000|Overall Study|Investigator Decision|42|||
149041532|NCT00835770|537632592|FG001|Overall Study|Investigator Decision|42|||
149041533|NCT00835770|537632591|FG000|Overall Study|Participant Non-Compliance|11|||
149041534|NCT00835770|537632592|FG001|Overall Study|Participant Non-Compliance|9|||
149041535|NCT00835770|537632591|FG000|Overall Study|Death|4|||
149041536|NCT00835770|537632592|FG001|Overall Study|Death|6|||
149041537|NCT00835770|537632591|FG000|Overall Study|Other|115|||
149041538|NCT00835770|537632592|FG001|Overall Study|Other|104|||
149041539|NCT00835770|537632591|FG000|Overall Study|Other|2|||
148885123|NCT00216671|537056941|FG001|Overall Study|Lost to Follow-up|5|||
148885124|NCT00216671|537056940|FG000|Overall Study|Non compliant|2|||
148885125|NCT00216671|537056941|FG001|Overall Study|Non compliant|2|||
148885126|NCT00216671|537056940|FG000|Overall Study|Ineligible|0|||
148885127|NCT00216671|537056941|FG001|Overall Study|Ineligible|2|||
149041540|NCT00835770|537632592|FG001|Overall Study|Other|1|||
148885128|NCT00216671|537056940|FG000|Overall Study|Physician Decision|1|||
148885129|NCT00216671|537056941|FG001|Overall Study|Physician Decision|1|||
149041541|NCT01185782|537632593|FG000|Overall Study|Adverse Event|0|||
149041542|NCT01185782|537632594|FG001|Overall Study|Adverse Event|1|||
149041543|NCT01185782|537632593|FG000|Overall Study|Protocol Violation|1|||
149041544|NCT01185782|537632594|FG001|Overall Study|Protocol Violation|0|||
148885130|NCT00216671|537056940|FG000|Overall Study|Protocol Violation|3|||
148885131|NCT00216671|537056941|FG001|Overall Study|Protocol Violation|5|||
148885132|NCT00216671|537056940|FG000|Overall Study|Relapse|1|||
148885133|NCT00216671|537056941|FG001|Overall Study|Relapse|0|||
148885134|NCT00216671|537056940|FG000|Overall Study|Investigator Illness|0|||
148885135|NCT00216671|537056941|FG001|Overall Study|Investigator Illness|1|||
148885136|NCT00216671|537056940|FG000|Overall Study|Patient Moved|0|||
149041545|NCT01185782|537632593|FG000|Overall Study|Poor Response to Treatment|3|||
149041546|NCT01185782|537632594|FG001|Overall Study|Poor Response to Treatment|1|||
149041547|NCT01185782|537632593|FG000|Overall Study|Other|2|||
149041548|NCT01185782|537632594|FG001|Overall Study|Other|5|||
149041549|NCT01185782|537632593|FG000|Overall Study|Randomized but not treated|0|||
149041550|NCT01185782|537632594|FG001|Overall Study|Randomized but not treated|4|||
149041551|NCT02507752|537632595|FG000|Overall Study|Adverse Event|1|||
149041552|NCT02507752|537632595|FG000|Overall Study|Protocol Violation|6|||
149041553|NCT02507752|537632595|FG000|Overall Study|Lost to Follow-up|7|||
149041554|NCT02507752|537632595|FG000|Overall Study|Infusion reaction at first infusion|1|||
149041555|NCT02507752|537632595|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
149041556|NCT02507752|537632595|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
149041557|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
149041558|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
149041559|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
149041560|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
149041561|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
149041562|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
149041563|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
149041564|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
149041565|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
149041566|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
149041567|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
149041568|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
149041569|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
149041570|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
149041571|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
149041572|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
149041573|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
149041574|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
149041575|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
149041576|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
149041577|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
149041578|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
149041579|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
149041580|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
149041581|NCT01061151|537632600|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
149041582|NCT01061151|537632601|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
149041583|NCT01061151|537632602|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
149041584|NCT01061151|537632603|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
149041585|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
149041586|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
149041587|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
149041588|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
149041589|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
149041590|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
149041591|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
149041592|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
149041593|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
149041594|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
149041595|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
149041596|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
149041597|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
148885137|NCT00216671|537056941|FG001|Overall Study|Patient Moved|1|||
148885138|NCT00216671|537056940|FG000|Overall Study|Ineligible, no efficacy data|2|||
149041598|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
149041599|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
149041600|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
149041601|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
148885139|NCT00216671|537056941|FG001|Overall Study|Ineligible, no efficacy data|2|||
148885140|NCT00216671|537056940|FG000|Overall Study|Insufficient Response Adverse Event|2|||
148885141|NCT00216671|537056941|FG001|Overall Study|Insufficient Response Adverse Event|1|||
148885142|NCT02714569|537056942|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
149041602|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
149041603|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
149041604|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
149041605|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
149041606|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
149041607|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
149041608|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
149041609|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
149041610|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
149041611|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
149041612|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
149041613|NCT01061151|537632600|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
149041614|NCT01061151|537632601|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
149041615|NCT01061151|537632602|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
149041616|NCT01061151|537632603|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
149041617|NCT04530747|537632607|FG000|Overall Study|Withdrawal by Subject|1|||
149041618|NCT04530747|537632608|FG001|Overall Study|Withdrawal by Subject|0|||
149041619|NCT03292913|537632609|FG000|Overall Study|Death|9|||
149041620|NCT03292913|537632610|FG001|Overall Study|Death|3|||
149041621|NCT03292913|537632609|FG000|Overall Study|Lost to Follow-up|49|||
149041622|NCT03292913|537632610|FG001|Overall Study|Lost to Follow-up|49|||
149041623|NCT03292913|537632609|FG000|Overall Study|Withdrawal by Subject|2|||
149041624|NCT03292913|537632610|FG001|Overall Study|Withdrawal by Subject|0|||
149041625|NCT03292913|537632609|FG000|Overall Study|Clinic closed due to COVID|22|||
149041626|NCT03292913|537632610|FG001|Overall Study|Clinic closed due to COVID|36|||
149041627|NCT03950622|537632611|FG000|Overall Study|Withdrawal by Subject|1|||
149041628|NCT03950622|537632612|FG001|Overall Study|Withdrawal by Subject|0|||
149041629|NCT03950622|537632611|FG000|Overall Study|Protocol Deviation|0|||
149041630|NCT03950622|537632612|FG001|Overall Study|Protocol Deviation|1|||
149041631|NCT03950622|537632611|FG000|Overall Study|Physician Decision|1|||
149041632|NCT03950622|537632612|FG001|Overall Study|Physician Decision|0|||
149041633|NCT03950622|537632611|FG000|Overall Study|Lost to Follow-up|5|||
149041634|NCT03950622|537632612|FG001|Overall Study|Lost to Follow-up|5|||
149041635|NCT03950622|537632611|FG000|Overall Study|Death|1|||
149041636|NCT03950622|537632612|FG001|Overall Study|Death|1|||
149041637|NCT04056624|537632613|FG000|Overall Study|Withdrawal by Subject|0|||
149041638|NCT04056624|537632614|FG001|Overall Study|Withdrawal by Subject|0|||
149041639|NCT04056624|537632615|FG002|Overall Study|Withdrawal by Subject|1|||
149041640|NCT04056624|537632613|FG000|Overall Study|Protocol Violation|1|||
149041641|NCT04056624|537632614|FG001|Overall Study|Protocol Violation|2|||
149041642|NCT04056624|537632615|FG002|Overall Study|Protocol Violation|0|||
149041643|NCT03531840|537632620|FG000|Overall Study|Death on study|3|||
149041644|NCT03531840|537632621|FG001|Overall Study|Death on study|2|||
149041645|NCT03531840|537632622|FG002|Overall Study|Death on study|1|||
149041646|NCT03531840|537632623|FG003|Overall Study|Death on study|2|||
149041647|NCT03531840|537632620|FG000|Overall Study|Death during follow up|2|||
149041648|NCT03531840|537632621|FG001|Overall Study|Death during follow up|3|||
149041649|NCT03531840|537632622|FG002|Overall Study|Death during follow up|4|||
149041650|NCT03531840|537632623|FG003|Overall Study|Death during follow up|1|||
149041651|NCT02092116|537632624|FG000|Overall Study|Withdrawal by Subject|0|||
149041652|NCT02092116|537632625|FG001|Overall Study|Withdrawal by Subject|3|||
149041653|NCT02092116|537632624|FG000|Overall Study|Adverse Event|0|||
149041654|NCT02092116|537632625|FG001|Overall Study|Adverse Event|1|||
149041655|NCT02267824|537632627|FG000|Overall Study|Pregnancy|1|||
149041656|NCT02267824|537632628|FG001|Overall Study|Pregnancy|1|||
149041657|NCT02267824|537632627|FG000|Overall Study|Lost to Follow-up|4|||
149041658|NCT02267824|537632628|FG001|Overall Study|Lost to Follow-up|0|||
149041659|NCT02267824|537632627|FG000|Overall Study|Protocol Violation|3|||
149041660|NCT02267824|537632628|FG001|Overall Study|Protocol Violation|0|||
149041661|NCT02267824|537632627|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
149041662|NCT02267824|537632628|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
149041663|NCT00939510|537632629|FG000|Overall Study|Withdrawal by Subject|1|||
149041664|NCT02261467|537632630|FG000|Overall Study|Enrolled in Error|1|||
149041665|NCT02261467|537632631|FG001|Overall Study|Enrolled in Error|0|||
149041666|NCT02261467|537632630|FG000|Overall Study|Protocol Violation|0|||
149041667|NCT02261467|537632631|FG001|Overall Study|Protocol Violation|1|||
149041668|NCT02261467|537632630|FG000|Overall Study|Personal Reasons|17|||
149041669|NCT02261467|537632631|FG001|Overall Study|Personal Reasons|22|||
149041670|NCT02261467|537632630|FG000|Overall Study|Lost to Follow-up|2|||
149041671|NCT02261467|537632631|FG001|Overall Study|Lost to Follow-up|13|||
149041672|NCT02261467|537632630|FG000|Overall Study|Adverse Event|1|||
149041673|NCT02261467|537632631|FG001|Overall Study|Adverse Event|1|||
149041674|NCT00736853|537632640|FG000|Open-Label Period|Physician Decision|2|||
149041675|NCT00736853|537632641|FG001|Open-Label Period|Physician Decision|0|||
149041676|NCT00736853|537632642|FG002|Open-Label Period|Physician Decision|0|||
149041677|NCT00736853|537632640|FG000|Open-Label Period|Adverse Event|31|||
149041678|NCT00736853|537632641|FG001|Open-Label Period|Adverse Event|0|||
149041679|NCT00736853|537632642|FG002|Open-Label Period|Adverse Event|0|||
149041680|NCT00736853|537632640|FG000|Open-Label Period|Withdrawal by Subject|16|||
149041681|NCT00736853|537632641|FG001|Open-Label Period|Withdrawal by Subject|0|||
149041682|NCT00736853|537632642|FG002|Open-Label Period|Withdrawal by Subject|0|||
149041683|NCT00736853|537632640|FG000|Open-Label Period|Started but not treated|42|||
149041684|NCT00736853|537632641|FG001|Open-Label Period|Started but not treated|0|||
149041685|NCT00736853|537632642|FG002|Open-Label Period|Started but not treated|0|||
149041686|NCT00736853|537632640|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
149041687|NCT00736853|537632641|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
149041688|NCT00736853|537632642|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
149041689|NCT00736853|537632640|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
149041690|NCT00736853|537632641|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
149041691|NCT00736853|537632642|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
149041692|NCT00736853|537632640|FG000|Double-Blind Period|Lack of Efficacy|0|||
149041693|NCT00736853|537632641|FG001|Double-Blind Period|Lack of Efficacy|19|||
149041694|NCT00736853|537632642|FG002|Double-Blind Period|Lack of Efficacy|42|||
149041695|NCT00736853|537632640|FG000|Double-Blind Period|Adverse Event|0|||
149041696|NCT00736853|537632641|FG001|Double-Blind Period|Adverse Event|3|||
149041697|NCT00736853|537632642|FG002|Double-Blind Period|Adverse Event|2|||
149041698|NCT00736853|537632640|FG000|Double-Blind Period|Withdrawal by Subject|0|||
149041699|NCT00736853|537632641|FG001|Double-Blind Period|Withdrawal by Subject|1|||
149041700|NCT00736853|537632642|FG002|Double-Blind Period|Withdrawal by Subject|4|||
149041701|NCT00736853|537632640|FG000|Double-Blind Period|Ineligible to participate the study|0|||
149041702|NCT00736853|537632641|FG001|Double-Blind Period|Ineligible to participate the study|1|||
149041703|NCT00736853|537632642|FG002|Double-Blind Period|Ineligible to participate the study|0|||
149041704|NCT01199705|537632643|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
149041705|NCT01415349|537632644|FG000|Treatment Period 1|Adverse Event|0|||
149041706|NCT01415349|537632645|FG001|Treatment Period 1|Adverse Event|1|||
149041707|NCT01415349|537632644|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149041708|NCT01415349|537632645|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149041709|NCT01041417|537632646|FG000|Overall Study|Adverse Event|5|||
149041710|NCT01041417|537632647|FG001|Overall Study|Adverse Event|2|||
149041711|NCT01041417|537632646|FG000|Overall Study|Lost to Follow-up|1|||
149041712|NCT01041417|537632647|FG001|Overall Study|Lost to Follow-up|1|||
149041713|NCT01041417|537632646|FG000|Overall Study|Death|1|||
149041714|NCT01041417|537632647|FG001|Overall Study|Death|0|||
149041715|NCT02918071|537632648|FG000|Overall Study|Withdrawal by Subject|2|||
149041716|NCT02918071|537632648|FG000|Overall Study|Lost to Follow-up|1|||
149041717|NCT03473340|537632649|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
149041718|NCT03473340|537632650|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
149041719|NCT03473340|537632649|FG000|Overall Study|Withdrawal by Subject|1|||
149041720|NCT03473340|537632650|FG001|Overall Study|Withdrawal by Subject|0|||
149041721|NCT03473340|537632649|FG000|Overall Study|Lost to Follow-up|1|||
149041722|NCT03473340|537632650|FG001|Overall Study|Lost to Follow-up|2|||
149041723|NCT01616459|537632651|FG000|Overall Study|Adverse Event|1|||
149041724|NCT01616459|537632652|FG001|Overall Study|Adverse Event|1|||
149041725|NCT01616459|537632653|FG002|Overall Study|Adverse Event|2|||
149041726|NCT01616459|537632654|FG003|Overall Study|Adverse Event|0|||
149041727|NCT01616459|537632651|FG000|Overall Study|Lost to Follow-up|1|||
149041728|NCT01616459|537632652|FG001|Overall Study|Lost to Follow-up|11|||
149041729|NCT01616459|537632653|FG002|Overall Study|Lost to Follow-up|3|||
149041730|NCT01616459|537632654|FG003|Overall Study|Lost to Follow-up|2|||
149041731|NCT01616459|537632651|FG000|Overall Study|Protocol Violation|0|||
149041732|NCT01616459|537632652|FG001|Overall Study|Protocol Violation|0|||
149041733|NCT01616459|537632653|FG002|Overall Study|Protocol Violation|0|||
149041734|NCT01616459|537632654|FG003|Overall Study|Protocol Violation|2|||
149041735|NCT01616459|537632651|FG000|Overall Study|Withdrawal by Subject|2|||
149041736|NCT01616459|537632652|FG001|Overall Study|Withdrawal by Subject|4|||
149041737|NCT01616459|537632653|FG002|Overall Study|Withdrawal by Subject|4|||
149041738|NCT01616459|537632654|FG003|Overall Study|Withdrawal by Subject|4|||
149041739|NCT01616459|537632651|FG000|Overall Study|Other reason|0|||
149041740|NCT01616459|537632652|FG001|Overall Study|Other reason|1|||
149041741|NCT01616459|537632653|FG002|Overall Study|Other reason|1|||
149041742|NCT01616459|537632654|FG003|Overall Study|Other reason|0|||
149041743|NCT03394885|537632655|FG000|Overall Study|Adverse Event|4|||
149041744|NCT03394885|537632655|FG000|Overall Study|Lack of Efficacy|1|||
149041745|NCT03394885|537632655|FG000|Overall Study|Physician Decision|1|||
149041746|NCT03394885|537632655|FG000|Overall Study|Withdrawal by Subject|8|||
149041747|NCT03394885|537632655|FG000|Overall Study|Alternative Therapy|1|||
149041748|NCT00203411|537632659|FG000|Follow-up|Progressive Disease|4|||
149041749|NCT04980755|537632660|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
149041750|NCT04980755|537632660|FG000|Body Reprogramming Courses|Work commitment|2|||
149041751|NCT04980755|537632660|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
149041752|NCT04980755|537632660|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
149041753|NCT01212991|537632661|FG000|Double-blind|Lost to Follow-up|8|||
149041754|NCT01212991|537632662|FG001|Double-blind|Lost to Follow-up|4|||
149041755|NCT01212991|537632663|FG002|Double-blind|Lost to Follow-up|0|||
149041756|NCT01212991|537632661|FG000|Double-blind|Death|699|||
149041757|NCT01212991|537632662|FG001|Double-blind|Death|550|||
149041758|NCT01212991|537632663|FG002|Double-blind|Death|0|||
149041759|NCT01212991|537632661|FG000|Double-blind|Withdrawal by Subject|16|||
149041760|NCT01212991|537632662|FG001|Double-blind|Withdrawal by Subject|19|||
149041761|NCT01212991|537632663|FG002|Double-blind|Withdrawal by Subject|0|||
149041762|NCT01212991|537632661|FG000|Double-blind|Other|7|||
149041763|NCT01212991|537632662|FG001|Double-blind|Other|0|||
149041764|NCT01212991|537632663|FG002|Double-blind|Other|0|||
149041765|NCT01212991|537632661|FG000|Double-blind|Sponsor decision|142|||
149041766|NCT01212991|537632662|FG001|Double-blind|Sponsor decision|38|||
149041767|NCT01212991|537632663|FG002|Double-blind|Sponsor decision|0|||
149041768|NCT01212991|537632661|FG000|Open-label|Death|0|||
149041769|NCT01212991|537632662|FG001|Open-label|Death|0|||
149041770|NCT01212991|537632663|FG002|Open-label|Death|166|||
149041771|NCT01212991|537632661|FG000|Open-label|Lost to Follow-up|0|||
149041772|NCT01212991|537632662|FG001|Open-label|Lost to Follow-up|0|||
149041773|NCT01212991|537632663|FG002|Open-label|Lost to Follow-up|5|||
149041774|NCT01212991|537632661|FG000|Open-label|Withdrawal by Subject|0|||
149041775|NCT01212991|537632662|FG001|Open-label|Withdrawal by Subject|0|||
149041776|NCT01212991|537632663|FG002|Open-label|Withdrawal by Subject|7|||
149041777|NCT01212991|537632661|FG000|Open-label|Sponsor decision|0|||
149041778|NCT01212991|537632662|FG001|Open-label|Sponsor decision|0|||
149041779|NCT01212991|537632663|FG002|Open-label|Sponsor decision|53|||
149041780|NCT01212991|537632661|FG000|Open-label|Other|0|||
149041781|NCT01212991|537632662|FG001|Open-label|Other|0|||
149041782|NCT01212991|537632663|FG002|Open-label|Other|3|||
149041783|NCT00632424|537632670|FG000|Overall Study|Disease Progression|17|||
149041784|NCT00632424|537632670|FG000|Overall Study|Study Drug Toxicity|1|||
149041785|NCT02531113|537632671|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
149041786|NCT02531113|537632671|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
149041787|NCT02531113|537632671|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
149041788|NCT02531113|537632671|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
149041789|NCT02531113|537632671|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
149041790|NCT02531113|537632671|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
149041791|NCT02531113|537632671|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
149041792|NCT02531113|537632671|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
149041793|NCT00801983|537632672|FG000|Period 1|Lost to Follow-up|2|||
149041794|NCT00801983|537632673|FG001|Period 1|Lost to Follow-up|0|||
149041795|NCT00801983|537632672|FG000|Period 1|Withdrawal by Subject|2|||
149041796|NCT00801983|537632673|FG001|Period 1|Withdrawal by Subject|8|||
149041797|NCT00801983|537632672|FG000|Period 2|Withdrawal by Subject|2|||
149041798|NCT00801983|537632673|FG001|Period 2|Withdrawal by Subject|1|||
149041799|NCT03122886|537634556|FG000|Overall Study|Withdrawal by Subject|1|||
149041800|NCT03122886|537634557|FG001|Overall Study|Withdrawal by Subject|2|||
149041801|NCT04252586|537634558|FG000|Overall Study|Withdrawal by parent/guardian|3|||
149041802|NCT04252586|537634558|FG000|Overall Study|Adverse Event|1|||
149041803|NCT04252586|537634558|FG000|Overall Study|Death|2|||
149041804|NCT04252586|537634558|FG000|Overall Study|Study terminated by sponsor|4|||
149041805|NCT04252586|537634558|FG000|Overall Study|Sponsor request|10|||
149041806|NCT04252586|537634558|FG000|Overall Study|Did not complete treatment period|1|||
149041807|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Death|186|||
149041808|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Death|222|||
149041809|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Death|0|||
149041810|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
149041811|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
149041812|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
149041813|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
149041814|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
149041815|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
149041816|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
149041817|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
149041818|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
149041819|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Adverse Event|83|||
149041820|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Adverse Event|100|||
149041821|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Adverse Event|0|||
149041822|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Other|70|||
149041823|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Other|75|||
149041824|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Other|0|||
149041825|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
149041826|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
149041827|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
149041828|NCT00232180|537634559|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
149041829|NCT00232180|537634560|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
149041830|NCT00232180|537634561|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
149041831|NCT00232180|537634559|FG000|Open Label Phase|Death|0|||
149041832|NCT00232180|537634560|FG001|Open Label Phase|Death|0|||
149041833|NCT00232180|537634561|FG002|Open Label Phase|Death|48|||
149041834|NCT00232180|537634559|FG000|Open Label Phase|Lost to Follow-up|0|||
149041835|NCT00232180|537634560|FG001|Open Label Phase|Lost to Follow-up|0|||
149041836|NCT00232180|537634561|FG002|Open Label Phase|Lost to Follow-up|5|||
149041837|NCT00232180|537634559|FG000|Open Label Phase|Protocol Violation|0|||
149041838|NCT00232180|537634560|FG001|Open Label Phase|Protocol Violation|0|||
149041839|NCT00232180|537634561|FG002|Open Label Phase|Protocol Violation|3|||
149041840|NCT00232180|537634559|FG000|Open Label Phase|Study terminated by sponsor|0|||
149041841|NCT00232180|537634560|FG001|Open Label Phase|Study terminated by sponsor|0|||
149041842|NCT00232180|537634561|FG002|Open Label Phase|Study terminated by sponsor|3|||
149041843|NCT00232180|537634559|FG000|Open Label Phase|Withdrawal by Subject|0|||
149041844|NCT00232180|537634560|FG001|Open Label Phase|Withdrawal by Subject|0|||
149041845|NCT00232180|537634561|FG002|Open Label Phase|Withdrawal by Subject|37|||
149041846|NCT00232180|537634559|FG000|Open Label Phase|Other|0|||
149041847|NCT00232180|537634560|FG001|Open Label Phase|Other|0|||
149041848|NCT00232180|537634561|FG002|Open Label Phase|Other|16|||
149041849|NCT00232180|537634559|FG000|Open Label Phase|Adverse Event|0|||
149041850|NCT00232180|537634560|FG001|Open Label Phase|Adverse Event|0|||
149041851|NCT00232180|537634561|FG002|Open Label Phase|Adverse Event|25|||
149041852|NCT00232180|537634559|FG000|Open Label Phase|Laboratory abnormality|0|||
149041853|NCT00232180|537634560|FG001|Open Label Phase|Laboratory abnormality|0|||
149041854|NCT00232180|537634561|FG002|Open Label Phase|Laboratory abnormality|10|||
149041855|NCT00232180|537634559|FG000|Open Label Phase|Randomized but not treated|0|||
149041856|NCT00232180|537634560|FG001|Open Label Phase|Randomized but not treated|0|||
149041857|NCT00232180|537634561|FG002|Open Label Phase|Randomized but not treated|1|||
149041858|NCT02748317|537634562|FG000|Overall Study|Withdrawal by Subject|14|||
149041859|NCT02748317|537634562|FG000|Overall Study|Lost to Follow-up|8|||
149041860|NCT02748317|537634562|FG000|Overall Study|Death|1|||
149041861|NCT00414544|537634563|FG000|Overall Study|Lost to Follow-up|14|||
149041862|NCT04259450|537634564|FG000|Overall Study|Adverse event/ Toxicity|0|||
149041863|NCT04259450|537634565|FG001|Overall Study|Adverse event/ Toxicity|3|||
149041864|NCT04259450|537634566|FG002|Overall Study|Adverse event/ Toxicity|0|||
149041865|NCT04259450|537634567|FG003|Overall Study|Adverse event/ Toxicity|1|||
149041866|NCT04259450|537634568|FG004|Overall Study|Adverse event/ Toxicity|0|||
149041867|NCT04259450|537634569|FG005|Overall Study|Adverse event/ Toxicity|0|||
149041868|NCT04259450|537634570|FG006|Overall Study|Adverse event/ Toxicity|0|||
149041869|NCT04259450|537634571|FG007|Overall Study|Adverse event/ Toxicity|1|||
149041870|NCT04259450|537634572|FG008|Overall Study|Adverse event/ Toxicity|0|||
149041871|NCT04259450|537634573|FG009|Overall Study|Adverse event/ Toxicity|3|||
149041872|NCT04259450|537634564|FG000|Overall Study|Disease progression|2|||
149041873|NCT04259450|537634565|FG001|Overall Study|Disease progression|3|||
149041874|NCT04259450|537634566|FG002|Overall Study|Disease progression|4|||
149041875|NCT04259450|537634567|FG003|Overall Study|Disease progression|4|||
149041876|NCT04259450|537634568|FG004|Overall Study|Disease progression|6|||
149041877|NCT04259450|537634569|FG005|Overall Study|Disease progression|6|||
149041878|NCT04259450|537634570|FG006|Overall Study|Disease progression|6|||
149041879|NCT04259450|537634571|FG007|Overall Study|Disease progression|15|||
149041880|NCT04259450|537634572|FG008|Overall Study|Disease progression|6|||
149041881|NCT04259450|537634573|FG009|Overall Study|Disease progression|18|||
149041882|NCT04259450|537634564|FG000|Overall Study|Death|0|||
149041883|NCT04259450|537634565|FG001|Overall Study|Death|0|||
149041884|NCT04259450|537634566|FG002|Overall Study|Death|0|||
149041885|NCT04259450|537634567|FG003|Overall Study|Death|0|||
149041886|NCT04259450|537634568|FG004|Overall Study|Death|0|||
149041887|NCT04259450|537634569|FG005|Overall Study|Death|0|||
149041888|NCT04259450|537634570|FG006|Overall Study|Death|0|||
149041889|NCT04259450|537634571|FG007|Overall Study|Death|1|||
149041890|NCT04259450|537634572|FG008|Overall Study|Death|1|||
149041891|NCT04259450|537634573|FG009|Overall Study|Death|0|||
149041892|NCT04259450|537634564|FG000|Overall Study|Withdrawal by Subject|0|||
149041893|NCT04259450|537634565|FG001|Overall Study|Withdrawal by Subject|0|||
148885143|NCT02714569|537056943|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
148885144|NCT02714569|537056944|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
148885145|NCT02714569|537056945|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
148885146|NCT02714569|537056946|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
148885147|NCT02714569|537056947|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
149041894|NCT04259450|537634566|FG002|Overall Study|Withdrawal by Subject|0|||
149041895|NCT04259450|537634567|FG003|Overall Study|Withdrawal by Subject|0|||
149041896|NCT04259450|537634568|FG004|Overall Study|Withdrawal by Subject|0|||
149041897|NCT04259450|537634569|FG005|Overall Study|Withdrawal by Subject|0|||
149041898|NCT04259450|537634570|FG006|Overall Study|Withdrawal by Subject|0|||
149041899|NCT04259450|537634571|FG007|Overall Study|Withdrawal by Subject|1|||
149041900|NCT04259450|537634572|FG008|Overall Study|Withdrawal by Subject|0|||
149041901|NCT04259450|537634573|FG009|Overall Study|Withdrawal by Subject|0|||
149041902|NCT04259450|537634564|FG000|Overall Study|Other than listed|0|||
149041903|NCT04259450|537634565|FG001|Overall Study|Other than listed|0|||
149041904|NCT04259450|537634566|FG002|Overall Study|Other than listed|0|||
149041905|NCT04259450|537634567|FG003|Overall Study|Other than listed|0|||
149041906|NCT04259450|537634568|FG004|Overall Study|Other than listed|0|||
149041907|NCT04259450|537634569|FG005|Overall Study|Other than listed|0|||
149041908|NCT04259450|537634570|FG006|Overall Study|Other than listed|0|||
149041909|NCT04259450|537634571|FG007|Overall Study|Other than listed|1|||
149041910|NCT04259450|537634572|FG008|Overall Study|Other than listed|1|||
149041911|NCT04259450|537634573|FG009|Overall Study|Other than listed|2|||
149041912|NCT03452189|537634574|FG000|First Intervention (3 Months)|Adverse Event|1|||
149041913|NCT03452189|537634575|FG001|First Intervention (3 Months)|Adverse Event|0|||
149041914|NCT03452189|537634574|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
149041915|NCT03452189|537634575|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
149041916|NCT02724592|537634582|FG000|Overall Study|Lost to Follow-up|4|||
149041917|NCT02724592|537634583|FG001|Overall Study|Lost to Follow-up|1|||
149041918|NCT04723394|537634587|FG000|Overall Study|Adverse Event|0|||
149041919|NCT04723394|537634588|FG001|Overall Study|Adverse Event|3|||
149041920|NCT04723394|537634587|FG000|Overall Study|Death|8|||
149041921|NCT04723394|537634588|FG001|Overall Study|Death|8|||
149041922|NCT04723394|537634587|FG000|Overall Study|Lost to Follow-up|20|||
149041923|NCT04723394|537634588|FG001|Overall Study|Lost to Follow-up|17|||
149041924|NCT04723394|537634587|FG000|Overall Study|Physician Decision|1|||
149041925|NCT04723394|537634588|FG001|Overall Study|Physician Decision|0|||
149041926|NCT04723394|537634587|FG000|Overall Study|Withdrawal by Subject|20|||
149041927|NCT04723394|537634588|FG001|Overall Study|Withdrawal by Subject|34|||
149041928|NCT04723394|537634587|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
149041929|NCT04723394|537634588|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
149041930|NCT00858117|537634590|FG000|Treatment on Study|Adverse Event|2|||
149041931|NCT00858117|537634590|FG000|Follow up for 5 Years|Death|4|||
149041932|NCT00858117|537634590|FG000|Follow up for 5 Years|No further data collected for study|9|||
149041933|NCT00371787|537634593|FG000|Overall Study|Withdrawal by Subject|3|||
149041934|NCT00371787|537634594|FG001|Overall Study|Withdrawal by Subject|1|||
149041935|NCT01972724|537634596|FG000|Double-Blind|Rescue Criteria Met|1|||
149041936|NCT01972724|537634597|FG001|Double-Blind|Rescue Criteria Met|0|||
149041937|NCT01972724|537634598|FG002|Double-Blind|Rescue Criteria Met|0|||
149041938|NCT01972724|537634596|FG000|Double-Blind|Adverse Event|1|||
149041939|NCT01972724|537634597|FG001|Double-Blind|Adverse Event|0|||
149041940|NCT01972724|537634598|FG002|Double-Blind|Adverse Event|0|||
149041941|NCT01972724|537634596|FG000|Double-Blind|Withdrawal of Consent|2|||
149041942|NCT01972724|537634597|FG001|Double-Blind|Withdrawal of Consent|1|||
149041943|NCT01972724|537634598|FG002|Double-Blind|Withdrawal of Consent|0|||
149041944|NCT01972724|537634596|FG000|Double-Blind|Significant Protocol Deviation|5|||
149041945|NCT01972724|537634597|FG001|Double-Blind|Significant Protocol Deviation|8|||
149041946|NCT01972724|537634598|FG002|Double-Blind|Significant Protocol Deviation|0|||
149041947|NCT01972724|537634596|FG000|Open-Label|Withdrew Consent|0|||
149041948|NCT01972724|537634597|FG001|Open-Label|Withdrew Consent|0|||
149041949|NCT01972724|537634598|FG002|Open-Label|Withdrew Consent|3|||
149041950|NCT01972724|537634596|FG000|Open-Label|Significant Protocol Deviation|0|||
149041951|NCT01972724|537634597|FG001|Open-Label|Significant Protocol Deviation|0|||
149041952|NCT01972724|537634598|FG002|Open-Label|Significant Protocol Deviation|2|||
149041953|NCT03740009|537634606|FG000|Overall Study|Physician Decision|9|||
149041954|NCT03740009|537634606|FG000|Overall Study|Lost to Follow-up|1|||
149041955|NCT01236001|537634607|FG000|Overall Study|Adverse Event|5|||
148885148|NCT02714569|537056948|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
148885149|NCT02714569|537056949|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
149041956|NCT01236001|537634608|FG001|Overall Study|Adverse Event|14|||
149041957|NCT01236001|537634607|FG000|Overall Study|Lack of Efficacy|6|||
149041958|NCT01236001|537634608|FG001|Overall Study|Lack of Efficacy|6|||
149041959|NCT01236001|537634607|FG000|Overall Study|Lost to Follow-up|6|||
149041960|NCT01236001|537634608|FG001|Overall Study|Lost to Follow-up|1|||
149041961|NCT01236001|537634607|FG000|Overall Study|Incompliance|1|||
149041962|NCT01236001|537634608|FG001|Overall Study|Incompliance|0|||
149041963|NCT01236001|537634607|FG000|Overall Study|Planned Visit After End of Study|0|||
148885150|NCT02714569|537056950|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
149041964|NCT01236001|537634608|FG001|Overall Study|Planned Visit After End of Study|1|||
149041965|NCT02988817|537634609|FG000|Overall Study|Withdrawal by Subject|1|||
149041966|NCT02988817|537634610|FG001|Overall Study|Withdrawal by Subject|0|||
149041967|NCT02988817|537634611|FG002|Overall Study|Withdrawal by Subject|0|||
149041968|NCT02988817|537634612|FG003|Overall Study|Withdrawal by Subject|1|||
149041969|NCT02988817|537634613|FG004|Overall Study|Withdrawal by Subject|3|||
149041970|NCT02988817|537634614|FG005|Overall Study|Withdrawal by Subject|1|||
149041971|NCT02988817|537634615|FG006|Overall Study|Withdrawal by Subject|2|||
149041972|NCT02988817|537634616|FG007|Overall Study|Withdrawal by Subject|1|||
149041973|NCT02988817|537634617|FG008|Overall Study|Withdrawal by Subject|1|||
149041974|NCT02988817|537634618|FG009|Overall Study|Withdrawal by Subject|1|||
149041975|NCT02988817|537634619|FG010|Overall Study|Withdrawal by Subject|1|||
149041976|NCT02988817|537634620|FG011|Overall Study|Withdrawal by Subject|12|||
149041977|NCT02988817|537634621|FG012|Overall Study|Withdrawal by Subject|6|||
149041978|NCT02988817|537634622|FG013|Overall Study|Withdrawal by Subject|6|||
149041979|NCT02988817|537634623|FG014|Overall Study|Withdrawal by Subject|4|||
149041980|NCT02988817|537634624|FG015|Overall Study|Withdrawal by Subject|5|||
149041981|NCT02988817|537634625|FG016|Overall Study|Withdrawal by Subject|4|||
149041982|NCT02988817|537634626|FG017|Overall Study|Withdrawal by Subject|11|||
149041983|NCT02988817|537634627|FG018|Overall Study|Withdrawal by Subject|4|||
149041984|NCT02988817|537634628|FG019|Overall Study|Withdrawal by Subject|2|||
149041985|NCT02988817|537634609|FG000|Overall Study|Death|0|||
149041986|NCT02988817|537634610|FG001|Overall Study|Death|1|||
149041987|NCT02988817|537634611|FG002|Overall Study|Death|3|||
149041988|NCT02988817|537634612|FG003|Overall Study|Death|1|||
149041989|NCT02988817|537634613|FG004|Overall Study|Death|6|||
149041990|NCT02988817|537634614|FG005|Overall Study|Death|10|||
149041991|NCT02988817|537634615|FG006|Overall Study|Death|1|||
149041992|NCT02988817|537634616|FG007|Overall Study|Death|2|||
149041993|NCT02988817|537634617|FG008|Overall Study|Death|1|||
149041994|NCT02988817|537634618|FG009|Overall Study|Death|5|||
149041995|NCT02988817|537634619|FG010|Overall Study|Death|1|||
149041996|NCT02988817|537634620|FG011|Overall Study|Death|8|||
149041997|NCT02988817|537634621|FG012|Overall Study|Death|9|||
149041998|NCT02988817|537634622|FG013|Overall Study|Death|17|||
149041999|NCT02988817|537634623|FG014|Overall Study|Death|18|||
149042000|NCT02988817|537634624|FG015|Overall Study|Death|30|||
149042001|NCT02988817|537634625|FG016|Overall Study|Death|17|||
149042002|NCT02988817|537634626|FG017|Overall Study|Death|38|||
149042003|NCT02988817|537634627|FG018|Overall Study|Death|14|||
149042004|NCT02988817|537634628|FG019|Overall Study|Death|16|||
149042005|NCT02988817|537634609|FG000|Overall Study|Other|0|||
149042006|NCT02988817|537634610|FG001|Overall Study|Other|0|||
149042007|NCT02988817|537634611|FG002|Overall Study|Other|0|||
149042008|NCT02988817|537634612|FG003|Overall Study|Other|1|||
149042009|NCT02988817|537634613|FG004|Overall Study|Other|1|||
149042010|NCT02988817|537634614|FG005|Overall Study|Other|0|||
149042011|NCT02988817|537634615|FG006|Overall Study|Other|0|||
149042012|NCT02988817|537634616|FG007|Overall Study|Other|0|||
149042013|NCT02988817|537634617|FG008|Overall Study|Other|0|||
149042014|NCT02988817|537634618|FG009|Overall Study|Other|0|||
149042015|NCT02988817|537634619|FG010|Overall Study|Other|0|||
149042016|NCT02988817|537634620|FG011|Overall Study|Other|0|||
149042017|NCT02988817|537634621|FG012|Overall Study|Other|0|||
149042018|NCT02988817|537634622|FG013|Overall Study|Other|0|||
149042019|NCT02988817|537634623|FG014|Overall Study|Other|0|||
149042020|NCT02988817|537634624|FG015|Overall Study|Other|1|||
149042021|NCT02988817|537634625|FG016|Overall Study|Other|0|||
149042022|NCT02988817|537634626|FG017|Overall Study|Other|0|||
149042023|NCT02988817|537634627|FG018|Overall Study|Other|0|||
149042024|NCT02988817|537634628|FG019|Overall Study|Other|0|||
149042025|NCT02988817|537634609|FG000|Overall Study|Lost to Follow-up|0|||
149042026|NCT02988817|537634610|FG001|Overall Study|Lost to Follow-up|0|||
149042027|NCT02988817|537634611|FG002|Overall Study|Lost to Follow-up|0|||
149042028|NCT02988817|537634612|FG003|Overall Study|Lost to Follow-up|0|||
149042029|NCT02988817|537634613|FG004|Overall Study|Lost to Follow-up|0|||
149042030|NCT02988817|537634614|FG005|Overall Study|Lost to Follow-up|0|||
149042031|NCT02988817|537634615|FG006|Overall Study|Lost to Follow-up|0|||
149042032|NCT02988817|537634616|FG007|Overall Study|Lost to Follow-up|0|||
149042033|NCT02988817|537634617|FG008|Overall Study|Lost to Follow-up|1|||
149042034|NCT02988817|537634618|FG009|Overall Study|Lost to Follow-up|0|||
149042035|NCT02988817|537634619|FG010|Overall Study|Lost to Follow-up|1|||
149042036|NCT02988817|537634620|FG011|Overall Study|Lost to Follow-up|1|||
149042037|NCT02988817|537634621|FG012|Overall Study|Lost to Follow-up|0|||
149042038|NCT02988817|537634622|FG013|Overall Study|Lost to Follow-up|0|||
149042039|NCT02988817|537634623|FG014|Overall Study|Lost to Follow-up|1|||
149042040|NCT02988817|537634624|FG015|Overall Study|Lost to Follow-up|1|||
148885151|NCT02714569|537056951|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
149042041|NCT02988817|537634625|FG016|Overall Study|Lost to Follow-up|2|||
149042042|NCT02988817|537634626|FG017|Overall Study|Lost to Follow-up|3|||
149042043|NCT02988817|537634627|FG018|Overall Study|Lost to Follow-up|0|||
149042044|NCT02988817|537634628|FG019|Overall Study|Lost to Follow-up|0|||
149042045|NCT02988817|537634609|FG000|Overall Study|Sponsor decision|0|||
149042046|NCT02988817|537634610|FG001|Overall Study|Sponsor decision|0|||
149042047|NCT02988817|537634611|FG002|Overall Study|Sponsor decision|0|||
149042048|NCT02988817|537634612|FG003|Overall Study|Sponsor decision|0|||
149042049|NCT02988817|537634613|FG004|Overall Study|Sponsor decision|0|||
149042050|NCT02988817|537634614|FG005|Overall Study|Sponsor decision|0|||
149042051|NCT02988817|537634615|FG006|Overall Study|Sponsor decision|0|||
149042052|NCT02988817|537634616|FG007|Overall Study|Sponsor decision|0|||
149042053|NCT02988817|537634617|FG008|Overall Study|Sponsor decision|0|||
149042054|NCT02988817|537634618|FG009|Overall Study|Sponsor decision|0|||
149042055|NCT02988817|537634619|FG010|Overall Study|Sponsor decision|0|||
149042056|NCT02988817|537634620|FG011|Overall Study|Sponsor decision|1|||
149042057|NCT02988817|537634621|FG012|Overall Study|Sponsor decision|1|||
149042058|NCT02988817|537634622|FG013|Overall Study|Sponsor decision|2|||
149042059|NCT02988817|537634623|FG014|Overall Study|Sponsor decision|2|||
149042060|NCT02988817|537634624|FG015|Overall Study|Sponsor decision|6|||
149042061|NCT02988817|537634625|FG016|Overall Study|Sponsor decision|2|||
149042062|NCT02988817|537634626|FG017|Overall Study|Sponsor decision|3|||
149042063|NCT02988817|537634627|FG018|Overall Study|Sponsor decision|2|||
149042064|NCT02988817|537634628|FG019|Overall Study|Sponsor decision|7|||
149042065|NCT02988817|537634609|FG000|Overall Study|Physician Decision|0|||
149042066|NCT02988817|537634610|FG001|Overall Study|Physician Decision|0|||
149042067|NCT02988817|537634611|FG002|Overall Study|Physician Decision|0|||
149042068|NCT02988817|537634612|FG003|Overall Study|Physician Decision|0|||
149042069|NCT02988817|537634613|FG004|Overall Study|Physician Decision|0|||
149042070|NCT02988817|537634614|FG005|Overall Study|Physician Decision|0|||
149042071|NCT02988817|537634615|FG006|Overall Study|Physician Decision|0|||
149042072|NCT02988817|537634616|FG007|Overall Study|Physician Decision|0|||
149042073|NCT02988817|537634617|FG008|Overall Study|Physician Decision|0|||
149042074|NCT02988817|537634618|FG009|Overall Study|Physician Decision|0|||
149042075|NCT02988817|537634619|FG010|Overall Study|Physician Decision|0|||
149042076|NCT02988817|537634620|FG011|Overall Study|Physician Decision|0|||
149042077|NCT02988817|537634621|FG012|Overall Study|Physician Decision|0|||
149042078|NCT02988817|537634622|FG013|Overall Study|Physician Decision|0|||
149042079|NCT02988817|537634623|FG014|Overall Study|Physician Decision|0|||
149042080|NCT02988817|537634624|FG015|Overall Study|Physician Decision|1|||
149042081|NCT02988817|537634625|FG016|Overall Study|Physician Decision|0|||
149042082|NCT02988817|537634626|FG017|Overall Study|Physician Decision|0|||
149042083|NCT02988817|537634627|FG018|Overall Study|Physician Decision|1|||
149042084|NCT02988817|537634628|FG019|Overall Study|Physician Decision|1|||
149042085|NCT05082935|537634631|FG000|Overall Study|Lost to Follow-up|549|||
149042086|NCT05082935|537634632|FG001|Overall Study|Lost to Follow-up|631|||
149042087|NCT05082935|537634631|FG000|Overall Study|Withdrawal by Subject|27|||
149042088|NCT05082935|537634632|FG001|Overall Study|Withdrawal by Subject|58|||
149042089|NCT02379819|537634633|FG000|Overall Study|Withdrawal by Subject|10|||
149042090|NCT02379819|537634633|FG000|Overall Study|Death|2|||
149042091|NCT02379819|537634633|FG000|Overall Study|Lack of Efficacy|1|||
149042092|NCT02379819|537634633|FG000|Overall Study|Lost to Follow-up|1|||
149042093|NCT01839331|537634634|FG000|Overall Study|Early Termination|3|||
149042094|NCT01839331|537634635|FG001|Overall Study|Early Termination|0|||
149042095|NCT01839331|537634636|FG002|Overall Study|Early Termination|1|||
149042096|NCT01839331|537634637|FG003|Overall Study|Early Termination|2|||
149042097|NCT01839331|537634634|FG000|Overall Study|Protocol Violation|1|||
149042098|NCT01839331|537634635|FG001|Overall Study|Protocol Violation|6|||
149042099|NCT01839331|537634636|FG002|Overall Study|Protocol Violation|4|||
149042100|NCT01839331|537634637|FG003|Overall Study|Protocol Violation|3|||
149042101|NCT03752151|537634638|FG000|Overall Study|Withdrawal by Subject|1|||
149042102|NCT03752151|537634638|FG000|Overall Study|Protocol Violation|1|||
149042103|NCT03074331|537634640|FG000|Overall Study|Enrolled but Not Treated|1|||
149042104|NCT03074331|537634640|FG000|Overall Study|Lost to Follow-up|5|||
149042105|NCT03074331|537634640|FG000|Overall Study|Withdrew Consent|1|||
149042106|NCT03451721|537634641|FG000|Overall Study|Death|1|||
149042107|NCT00350792|537634642|FG000|Overall Study|Adverse Event|11|||
149042108|NCT00350792|537634642|FG000|Overall Study|Death from Study Disease|1|||
149042109|NCT00350792|537634642|FG000|Overall Study|Death from Study Drug Toxicity|1|||
149042110|NCT00350792|537634642|FG000|Overall Study|Death Not Study Drug Related|2|||
149042111|NCT00350792|537634642|FG000|Overall Study|Protocol Violation|1|||
149042112|NCT00350792|537634642|FG000|Overall Study|Withdrawal by Subject|4|||
149042113|NCT00350792|537634642|FG000|Overall Study|Physician Decision|2|||
149042114|NCT00350792|537634642|FG000|Overall Study|Lack of Efficacy|11|||
149042115|NCT00960141|537634643|FG000|Overall Study|Adverse Event|4|||
149042116|NCT00960141|537634644|FG001|Overall Study|Adverse Event|8|||
149042117|NCT00960141|537634645|FG002|Overall Study|Adverse Event|2|||
149042118|NCT00960141|537634643|FG000|Overall Study|Lack of Efficacy|3|||
149042119|NCT00960141|537634644|FG001|Overall Study|Lack of Efficacy|4|||
149042120|NCT00960141|537634645|FG002|Overall Study|Lack of Efficacy|2|||
149042121|NCT00960141|537634643|FG000|Overall Study|Lost to Follow-up|1|||
149042122|NCT00960141|537634644|FG001|Overall Study|Lost to Follow-up|0|||
149042123|NCT00960141|537634645|FG002|Overall Study|Lost to Follow-up|0|||
149042124|NCT00960141|537634643|FG000|Overall Study|Protocol Violation|1|||
149042125|NCT00960141|537634644|FG001|Overall Study|Protocol Violation|3|||
149042126|NCT00960141|537634645|FG002|Overall Study|Protocol Violation|2|||
149042127|NCT00960141|537634643|FG000|Overall Study|Withdrawal by Subject|1|||
149042128|NCT00960141|537634644|FG001|Overall Study|Withdrawal by Subject|2|||
149042129|NCT00960141|537634645|FG002|Overall Study|Withdrawal by Subject|1|||
149042130|NCT03036813|537634648|FG000|Overall Study|Adverse Event|6|||
149042131|NCT03036813|537634649|FG001|Overall Study|Adverse Event|11|||
149042132|NCT03036813|537634650|FG002|Overall Study|Adverse Event|6|||
149042133|NCT03036813|537634648|FG000|Overall Study|Withdrawal by Subject|12|||
149042134|NCT03036813|537634649|FG001|Overall Study|Withdrawal by Subject|6|||
149042135|NCT03036813|537634650|FG002|Overall Study|Withdrawal by Subject|10|||
149042136|NCT03036813|537634648|FG000|Overall Study|Lost to Follow-up|1|||
149042137|NCT03036813|537634649|FG001|Overall Study|Lost to Follow-up|1|||
149042138|NCT03036813|537634650|FG002|Overall Study|Lost to Follow-up|0|||
149042139|NCT03036813|537634648|FG000|Overall Study|Physician Decision|2|||
149042140|NCT03036813|537634649|FG001|Overall Study|Physician Decision|1|||
149042141|NCT03036813|537634650|FG002|Overall Study|Physician Decision|1|||
149042142|NCT03036813|537634648|FG000|Overall Study|Non-Compliance|1|||
149042143|NCT03036813|537634649|FG001|Overall Study|Non-Compliance|5|||
149042144|NCT03036813|537634650|FG002|Overall Study|Non-Compliance|3|||
149042145|NCT03036813|537634648|FG000|Overall Study|Pregnancy|0|||
149042146|NCT03036813|537634649|FG001|Overall Study|Pregnancy|0|||
149042147|NCT03036813|537634650|FG002|Overall Study|Pregnancy|1|||
149042148|NCT03036813|537634648|FG000|Overall Study|Other|0|||
149042149|NCT03036813|537634649|FG001|Overall Study|Other|3|||
149042150|NCT03036813|537634650|FG002|Overall Study|Other|5|||
149042151|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
149042152|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
149042153|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
149042154|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
149042155|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
149042156|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
149042157|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
149042158|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
149042159|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
149042160|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
149042161|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
149042162|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
149042163|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
149042164|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
149042165|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
149042166|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
149042167|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
149042168|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
149042169|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
149042170|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
149042171|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
149042172|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
149042173|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
149042174|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
149042175|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042176|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
149042177|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042178|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042179|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042180|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042181|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042182|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
149042183|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
149042184|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
149042185|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
149042186|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
149042187|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
149042188|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
149042189|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
149042190|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
149042191|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
149042192|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
149042193|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
149042194|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
149042195|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
149042196|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
149042197|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
149042198|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
148885152|NCT02714569|537056952|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
148885153|NCT02714569|537056942|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
148885154|NCT02714569|537056943|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
149042199|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
149042200|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
149042201|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
149042202|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
149042203|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
149042204|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
149042205|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
149042206|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
149042207|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
149042208|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
149042209|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
149042210|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
149042211|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
149042212|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
149042213|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
149042214|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
149042215|NCT03903822|537634651|FG000|Treatment Phase (6 Weeks)|Other|2|||
149042216|NCT03903822|537634652|FG001|Treatment Phase (6 Weeks)|Other|1|||
149042217|NCT03903822|537634653|FG002|Treatment Phase (6 Weeks)|Other|0|||
149042218|NCT03903822|537634654|FG003|Treatment Phase (6 Weeks)|Other|0|||
149042219|NCT03903822|537634655|FG004|Treatment Phase (6 Weeks)|Other|1|||
149042220|NCT03903822|537634656|FG005|Treatment Phase (6 Weeks)|Other|1|||
149042221|NCT03903822|537634657|FG006|Treatment Phase (6 Weeks)|Other|0|||
149042222|NCT03903822|537634658|FG007|Treatment Phase (6 Weeks)|Other|0|||
149042223|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
149042224|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
149042225|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
149042226|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
149042227|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
149042228|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
149042229|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
149042230|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
149042231|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042232|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042233|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042234|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042235|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
149042236|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042237|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042238|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
149042239|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
149042240|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
149042241|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
149042242|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
149042243|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
149042244|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
149042245|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
149042246|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
149042247|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
149042248|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
149042249|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
149042250|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
149042251|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
149042252|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
149042253|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
149042254|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
149042255|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
149042256|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
149042257|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
149042258|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
149042259|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
149042260|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
149042261|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
149042262|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
149042263|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042264|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042265|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042266|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042267|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042268|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
149042269|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042270|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
149042271|NCT03903822|537634651|FG000|Follow up Phase (4 Weeks)|Other|1|||
149042272|NCT03903822|537634652|FG001|Follow up Phase (4 Weeks)|Other|1|||
149042273|NCT03903822|537634653|FG002|Follow up Phase (4 Weeks)|Other|0|||
148885155|NCT02714569|537056944|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
149042274|NCT03903822|537634654|FG003|Follow up Phase (4 Weeks)|Other|0|||
149042275|NCT03903822|537634655|FG004|Follow up Phase (4 Weeks)|Other|0|||
149042276|NCT03903822|537634656|FG005|Follow up Phase (4 Weeks)|Other|0|||
149042277|NCT03903822|537634657|FG006|Follow up Phase (4 Weeks)|Other|0|||
149042278|NCT03903822|537634658|FG007|Follow up Phase (4 Weeks)|Other|0|||
149042279|NCT01792830|537634670|FG000|Overall Study|Withdrawal by Subject|22|||
149042280|NCT01792830|537634671|FG001|Overall Study|Withdrawal by Subject|0|||
149042281|NCT01792830|537634672|FG002|Overall Study|Withdrawal by Subject|0|||
149042282|NCT01792830|537634673|FG003|Overall Study|Withdrawal by Subject|2|||
149042283|NCT01792830|537634674|FG004|Overall Study|Withdrawal by Subject|1|||
149042284|NCT01792830|537634675|FG005|Overall Study|Withdrawal by Subject|1|||
149042285|NCT01792830|537634676|FG006|Overall Study|Withdrawal by Subject|1|||
149042286|NCT01792830|537634677|FG007|Overall Study|Withdrawal by Subject|1|||
149042287|NCT01792830|537634678|FG008|Overall Study|Withdrawal by Subject|7|||
149042288|NCT01792830|537634679|FG009|Overall Study|Withdrawal by Subject|0|||
149042289|NCT01792830|537634680|FG010|Overall Study|Withdrawal by Subject|2|||
149042290|NCT01792830|537634670|FG000|Overall Study|Death|3|||
149042291|NCT01792830|537634671|FG001|Overall Study|Death|0|||
149042292|NCT01792830|537634672|FG002|Overall Study|Death|0|||
149042293|NCT01792830|537634673|FG003|Overall Study|Death|1|||
149042294|NCT01792830|537634674|FG004|Overall Study|Death|0|||
149042295|NCT01792830|537634675|FG005|Overall Study|Death|0|||
149042296|NCT01792830|537634676|FG006|Overall Study|Death|1|||
149042297|NCT01792830|537634677|FG007|Overall Study|Death|0|||
149042298|NCT01792830|537634678|FG008|Overall Study|Death|1|||
149042299|NCT01792830|537634679|FG009|Overall Study|Death|0|||
149042300|NCT01792830|537634680|FG010|Overall Study|Death|1|||
149042301|NCT01792830|537634670|FG000|Overall Study|Adverse Event|0|||
149042302|NCT01792830|537634671|FG001|Overall Study|Adverse Event|0|||
149042303|NCT01792830|537634672|FG002|Overall Study|Adverse Event|0|||
149042304|NCT01792830|537634673|FG003|Overall Study|Adverse Event|0|||
149042305|NCT01792830|537634674|FG004|Overall Study|Adverse Event|0|||
149042306|NCT01792830|537634675|FG005|Overall Study|Adverse Event|0|||
149042307|NCT01792830|537634676|FG006|Overall Study|Adverse Event|0|||
149042308|NCT01792830|537634677|FG007|Overall Study|Adverse Event|0|||
149042309|NCT01792830|537634678|FG008|Overall Study|Adverse Event|1|||
149042310|NCT01792830|537634679|FG009|Overall Study|Adverse Event|0|||
149042311|NCT01792830|537634680|FG010|Overall Study|Adverse Event|0|||
149042312|NCT01943799|537634696|FG000|Overall Study|Lost to Follow-up|0|||
149042313|NCT01943799|537634697|FG001|Overall Study|Lost to Follow-up|1|||
149042314|NCT01943799|537634698|FG002|Overall Study|Lost to Follow-up|1|||
149042315|NCT01943799|537634699|FG003|Overall Study|Lost to Follow-up|0|||
149042316|NCT01943799|537634696|FG000|Overall Study|Protocol Violation|1|||
149042317|NCT01943799|537634697|FG001|Overall Study|Protocol Violation|0|||
149042318|NCT01943799|537634698|FG002|Overall Study|Protocol Violation|0|||
149042319|NCT01943799|537634699|FG003|Overall Study|Protocol Violation|0|||
149042320|NCT01943799|537634696|FG000|Overall Study|Withdrawal by Subject|4|||
149042321|NCT01943799|537634697|FG001|Overall Study|Withdrawal by Subject|2|||
149042322|NCT01943799|537634698|FG002|Overall Study|Withdrawal by Subject|1|||
149042323|NCT01943799|537634699|FG003|Overall Study|Withdrawal by Subject|0|||
149042324|NCT04594759|537634700|FG000|Overall Study|Lost to Follow-up|3|||
149042325|NCT01832480|537634703|FG000|Overall Study|Lost to Follow-up|33|||
149042326|NCT01832480|537634704|FG001|Overall Study|Lost to Follow-up|30|||
149042327|NCT01832480|537634703|FG000|Overall Study|Withdrawal by Subject|0|||
149042328|NCT01832480|537634704|FG001|Overall Study|Withdrawal by Subject|2|||
149042329|NCT01832480|537634703|FG000|Overall Study|post randomization ineligible|8|||
149042330|NCT01832480|537634704|FG001|Overall Study|post randomization ineligible|10|||
149042331|NCT03764475|537634707|FG000|Overall Study|Adverse Event|11|||
149042332|NCT03764475|537634708|FG001|Overall Study|Adverse Event|2|||
149042333|NCT03764475|537634707|FG000|Overall Study|Lost to Follow-up|24|||
149042334|NCT03764475|537634708|FG001|Overall Study|Lost to Follow-up|10|||
149042335|NCT03764475|537634707|FG000|Overall Study|Withdrawal by Subject|26|||
149042336|NCT03764475|537634708|FG001|Overall Study|Withdrawal by Subject|10|||
149042337|NCT03764475|537634707|FG000|Overall Study|Lack of Efficacy|3|||
149042338|NCT03764475|537634708|FG001|Overall Study|Lack of Efficacy|0|||
149042339|NCT03764475|537634707|FG000|Overall Study|COVID-19 Disruption|2|||
149042340|NCT03764475|537634708|FG001|Overall Study|COVID-19 Disruption|0|||
149042341|NCT03144674|537634709|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
149042342|NCT03144674|537634710|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
149042343|NCT03144674|537634711|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
149042344|NCT03144674|537634712|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
149042345|NCT03144674|537634709|FG000|Overall Study|Death|3|||
149042346|NCT03144674|537634710|FG001|Overall Study|Death|2|||
149042347|NCT03144674|537634711|FG002|Overall Study|Death|6|||
149042348|NCT03144674|537634712|FG003|Overall Study|Death|24|||
149042349|NCT03144674|537634709|FG000|Overall Study|Lost to Follow-up|0|||
149042350|NCT03144674|537634710|FG001|Overall Study|Lost to Follow-up|1|||
149042351|NCT03144674|537634711|FG002|Overall Study|Lost to Follow-up|0|||
149042352|NCT03144674|537634712|FG003|Overall Study|Lost to Follow-up|4|||
149042353|NCT03144674|537634709|FG000|Overall Study|Withdrawal by Participant|0|||
149042354|NCT03144674|537634710|FG001|Overall Study|Withdrawal by Participant|0|||
148885156|NCT02714569|537056945|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
148885157|NCT02714569|537056946|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
148885158|NCT02714569|537056947|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
148885159|NCT02714569|537056948|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
149042355|NCT03144674|537634711|FG002|Overall Study|Withdrawal by Participant|2|||
149042356|NCT03144674|537634712|FG003|Overall Study|Withdrawal by Participant|6|||
149042357|NCT03144674|537634709|FG000|Overall Study|Discharged from the Trust|0|||
149042358|NCT03144674|537634710|FG001|Overall Study|Discharged from the Trust|0|||
149042359|NCT03144674|537634711|FG002|Overall Study|Discharged from the Trust|1|||
149042360|NCT03144674|537634712|FG003|Overall Study|Discharged from the Trust|0|||
149042361|NCT03144674|537634709|FG000|Overall Study|Exclusion Criteria Met|0|||
149042362|NCT03144674|537634710|FG001|Overall Study|Exclusion Criteria Met|0|||
149042363|NCT03144674|537634711|FG002|Overall Study|Exclusion Criteria Met|1|||
149042364|NCT03144674|537634712|FG003|Overall Study|Exclusion Criteria Met|0|||
149042365|NCT03144674|537634709|FG000|Overall Study|Changed Physicians|0|||
149042366|NCT03144674|537634710|FG001|Overall Study|Changed Physicians|0|||
149042367|NCT03144674|537634711|FG002|Overall Study|Changed Physicians|0|||
149042368|NCT03144674|537634712|FG003|Overall Study|Changed Physicians|1|||
149042369|NCT03144674|537634709|FG000|Overall Study|Removed for Safety|0|||
149042370|NCT03144674|537634710|FG001|Overall Study|Removed for Safety|0|||
149042371|NCT03144674|537634711|FG002|Overall Study|Removed for Safety|0|||
149042372|NCT03144674|537634712|FG003|Overall Study|Removed for Safety|1|||
149042373|NCT03144674|537634709|FG000|Overall Study|Site Closed|0|||
149042374|NCT03144674|537634710|FG001|Overall Study|Site Closed|0|||
149042375|NCT03144674|537634711|FG002|Overall Study|Site Closed|0|||
149042376|NCT03144674|537634712|FG003|Overall Study|Site Closed|1|||
149042377|NCT03144674|537634709|FG000|Overall Study|Histological Criteria Not Met|0|||
149042378|NCT03144674|537634710|FG001|Overall Study|Histological Criteria Not Met|0|||
149042379|NCT03144674|537634711|FG002|Overall Study|Histological Criteria Not Met|0|||
149042380|NCT03144674|537634712|FG003|Overall Study|Histological Criteria Not Met|1|||
149042381|NCT03144674|537634709|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
149042382|NCT03144674|537634710|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
149042383|NCT03144674|537634711|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
149042384|NCT03144674|537634712|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
149042385|NCT03144674|537634709|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
149042386|NCT03144674|537634710|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
149042387|NCT03144674|537634711|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
149042388|NCT03144674|537634712|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
149042389|NCT00970359|537634715|FG000|Overall Study|Not Treated|4|||
149042390|NCT01395758|537634716|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
149042391|NCT01395758|537634717|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
149042392|NCT01395758|537634718|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
149042393|NCT03942042|537634723|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
149042394|NCT03942042|537634724|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
149042395|NCT03942042|537634723|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
149042396|NCT03942042|537634724|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
149042397|NCT05135000|537634725|FG000|Overall Study|Adverse Event|2|||
149042398|NCT05135000|537634726|FG001|Overall Study|Adverse Event|0|||
149042399|NCT05135000|537634725|FG000|Overall Study|Lost to Follow-up|1|||
149042400|NCT05135000|537634726|FG001|Overall Study|Lost to Follow-up|0|||
149042401|NCT05135000|537634725|FG000|Overall Study|Study Terminated by Sponsor|6|||
149042402|NCT05135000|537634726|FG001|Overall Study|Study Terminated by Sponsor|3|||
149042403|NCT05985044|537636592|FG000|Overall Study|Death|6|||
149042404|NCT05985044|537636592|FG000|Overall Study|Lost to Follow-up|4|||
149042405|NCT05985044|537636592|FG000|Overall Study|Incapacitation|3|||
149042406|NCT05985044|537636592|FG000|Overall Study|Withdrawal by Subject|2|||
149042407|NCT03312907|537636596|FG000|Overall Study|Adverse Event|1|||
149042408|NCT03312907|537636597|FG001|Overall Study|Adverse Event|6|||
149042409|NCT03312907|537636598|FG002|Overall Study|Adverse Event|1|||
149042410|NCT03312907|537636596|FG000|Overall Study|Protocol Violation|2|||
149042411|NCT03312907|537636597|FG001|Overall Study|Protocol Violation|3|||
149042412|NCT03312907|537636598|FG002|Overall Study|Protocol Violation|4|||
149042413|NCT03312907|537636596|FG000|Overall Study|Lost to Follow-up|2|||
149042414|NCT03312907|537636597|FG001|Overall Study|Lost to Follow-up|3|||
149042415|NCT03312907|537636598|FG002|Overall Study|Lost to Follow-up|2|||
149042416|NCT03312907|537636596|FG000|Overall Study|Physician Decision|3|||
149042417|NCT03312907|537636597|FG001|Overall Study|Physician Decision|4|||
149042418|NCT03312907|537636598|FG002|Overall Study|Physician Decision|2|||
149042419|NCT03312907|537636596|FG000|Overall Study|Withdrawal by Subject|9|||
149042420|NCT03312907|537636597|FG001|Overall Study|Withdrawal by Subject|14|||
149042421|NCT03312907|537636598|FG002|Overall Study|Withdrawal by Subject|10|||
149042422|NCT04688450|537636603|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
149042423|NCT04688450|537636603|FG000|Overall Study|Withdrawal by Subject|1|||
149042424|NCT02544074|537636604|FG000|Overall Study|Withdrawal by Subject|0|||
149042425|NCT02544074|537636605|FG001|Overall Study|Withdrawal by Subject|1|||
149042426|NCT02544074|537636606|FG002|Overall Study|Withdrawal by Subject|0|||
149042427|NCT02544074|537636607|FG003|Overall Study|Withdrawal by Subject|0|||
149042428|NCT02544074|537636608|FG004|Overall Study|Withdrawal by Subject|0|||
149042429|NCT02544074|537636609|FG005|Overall Study|Withdrawal by Subject|0|||
149042430|NCT02544074|537636610|FG006|Overall Study|Withdrawal by Subject|0|||
149042431|NCT02544074|537636611|FG007|Overall Study|Withdrawal by Subject|0|||
149042432|NCT02544074|537636612|FG008|Overall Study|Withdrawal by Subject|0|||
149042433|NCT02544074|537636613|FG009|Overall Study|Withdrawal by Subject|0|||
149042434|NCT02544074|537636614|FG010|Overall Study|Withdrawal by Subject|0|||
149042435|NCT02544074|537636615|FG011|Overall Study|Withdrawal by Subject|0|||
149042436|NCT02544074|537636616|FG012|Overall Study|Withdrawal by Subject|0|||
149042437|NCT02544074|537636617|FG013|Overall Study|Withdrawal by Subject|0|||
149042438|NCT02544074|537636618|FG014|Overall Study|Withdrawal by Subject|0|||
149042439|NCT02544074|537636619|FG015|Overall Study|Withdrawal by Subject|0|||
149042440|NCT02544074|537636620|FG016|Overall Study|Withdrawal by Subject|0|||
149042441|NCT02544074|537636621|FG017|Overall Study|Withdrawal by Subject|0|||
149042442|NCT02544074|537636622|FG018|Overall Study|Withdrawal by Subject|0|||
149042443|NCT02544074|537636623|FG019|Overall Study|Withdrawal by Subject|0|||
149042444|NCT02544074|537636624|FG020|Overall Study|Withdrawal by Subject|0|||
149042445|NCT02544074|537636604|FG000|Overall Study|Tablet error|0|||
149042446|NCT02544074|537636605|FG001|Overall Study|Tablet error|0|||
149042447|NCT02544074|537636606|FG002|Overall Study|Tablet error|0|||
149042448|NCT02544074|537636607|FG003|Overall Study|Tablet error|0|||
149042449|NCT02544074|537636608|FG004|Overall Study|Tablet error|0|||
149042450|NCT02544074|537636609|FG005|Overall Study|Tablet error|1|||
149042451|NCT02544074|537636610|FG006|Overall Study|Tablet error|0|||
149042452|NCT02544074|537636611|FG007|Overall Study|Tablet error|0|||
149042453|NCT02544074|537636612|FG008|Overall Study|Tablet error|0|||
149042454|NCT02544074|537636613|FG009|Overall Study|Tablet error|1|||
149042455|NCT02544074|537636614|FG010|Overall Study|Tablet error|0|||
149042456|NCT02544074|537636615|FG011|Overall Study|Tablet error|0|||
149042457|NCT02544074|537636616|FG012|Overall Study|Tablet error|0|||
149042458|NCT02544074|537636617|FG013|Overall Study|Tablet error|0|||
149042459|NCT02544074|537636618|FG014|Overall Study|Tablet error|0|||
149042460|NCT02544074|537636619|FG015|Overall Study|Tablet error|0|||
149042461|NCT02544074|537636620|FG016|Overall Study|Tablet error|0|||
149042462|NCT02544074|537636621|FG017|Overall Study|Tablet error|0|||
149042463|NCT02544074|537636622|FG018|Overall Study|Tablet error|0|||
149042464|NCT02544074|537636623|FG019|Overall Study|Tablet error|0|||
149042465|NCT02544074|537636624|FG020|Overall Study|Tablet error|0|||
149042466|NCT03189524|537636626|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
149042467|NCT03189524|537636627|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
149042468|NCT03189524|537636628|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
149042469|NCT03189524|537636626|FG000|Overall Study|Death|2|||
149042470|NCT03189524|537636627|FG001|Overall Study|Death|2|||
149042471|NCT03189524|537636628|FG002|Overall Study|Death|1|||
149042472|NCT03189524|537636626|FG000|Overall Study|Lost to Follow-up|1|||
149042473|NCT03189524|537636627|FG001|Overall Study|Lost to Follow-up|0|||
149042474|NCT03189524|537636628|FG002|Overall Study|Lost to Follow-up|8|||
149042475|NCT03189524|537636626|FG000|Overall Study|Withdrawal by Subject|1|||
149042476|NCT03189524|537636627|FG001|Overall Study|Withdrawal by Subject|1|||
149042477|NCT03189524|537636628|FG002|Overall Study|Withdrawal by Subject|3|||
149042478|NCT03189524|537636626|FG000|Overall Study|Progressive Disease|0|||
149042479|NCT03189524|537636627|FG001|Overall Study|Progressive Disease|2|||
149042480|NCT03189524|537636628|FG002|Overall Study|Progressive Disease|0|||
149042481|NCT01780298|537636630|FG000|Overall Study|Physician Decision|1|||
149042482|NCT01780298|537636631|FG001|Overall Study|Physician Decision|5|||
149042483|NCT01780298|537636632|FG002|Overall Study|Physician Decision|1|||
149042484|NCT01780298|537636633|FG003|Overall Study|Physician Decision|1|||
149042485|NCT01780298|537636630|FG000|Overall Study|Subject not matched|1|||
149042486|NCT01780298|537636631|FG001|Overall Study|Subject not matched|0|||
149042487|NCT01780298|537636632|FG002|Overall Study|Subject not matched|1|||
149042488|NCT01780298|537636633|FG003|Overall Study|Subject not matched|0|||
149042489|NCT01780298|537636630|FG000|Overall Study|Adverse Event|0|||
149042490|NCT01780298|537636631|FG001|Overall Study|Adverse Event|0|||
149042491|NCT01780298|537636632|FG002|Overall Study|Adverse Event|2|||
149042492|NCT01780298|537636633|FG003|Overall Study|Adverse Event|0|||
149042493|NCT04300647|537636639|FG000|Pre-Crossover|Death|19|||
149042494|NCT04300647|537636640|FG001|Pre-Crossover|Death|58|||
149042495|NCT04300647|537636641|FG002|Pre-Crossover|Death|0|||
149042496|NCT04300647|537636639|FG000|Pre-Crossover|Lost to Follow-up|0|||
149042497|NCT04300647|537636640|FG001|Pre-Crossover|Lost to Follow-up|3|||
149042498|NCT04300647|537636641|FG002|Pre-Crossover|Lost to Follow-up|0|||
149042499|NCT04300647|537636639|FG000|Pre-Crossover|Withdrawal by Subject|2|||
149042500|NCT04300647|537636640|FG001|Pre-Crossover|Withdrawal by Subject|4|||
149042501|NCT04300647|537636641|FG002|Pre-Crossover|Withdrawal by Subject|0|||
149042502|NCT04300647|537636639|FG000|Pre-Crossover|On-going in Study|24|||
149042503|NCT04300647|537636640|FG001|Pre-Crossover|On-going in Study|61|||
149042504|NCT04300647|537636641|FG002|Pre-Crossover|On-going in Study|0|||
149042505|NCT04300647|537636639|FG000|Post-Crossover|Death|0|||
149042506|NCT04300647|537636640|FG001|Post-Crossover|Death|0|||
149042507|NCT04300647|537636641|FG002|Post-Crossover|Death|3|||
149042508|NCT04300647|537636639|FG000|Post-Crossover|Lost to Follow-up|0|||
149042509|NCT04300647|537636640|FG001|Post-Crossover|Lost to Follow-up|0|||
149042510|NCT04300647|537636641|FG002|Post-Crossover|Lost to Follow-up|1|||
149042511|NCT04300647|537636639|FG000|Post-Crossover|Withdrawal by Subject|0|||
149042512|NCT04300647|537636640|FG001|Post-Crossover|Withdrawal by Subject|0|||
149042513|NCT04300647|537636641|FG002|Post-Crossover|Withdrawal by Subject|1|||
149042514|NCT04300647|537636639|FG000|Post-Crossover|On-going in Study|0|||
149042515|NCT04300647|537636640|FG001|Post-Crossover|On-going in Study|0|||
149042516|NCT04300647|537636641|FG002|Post-Crossover|On-going in Study|8|||
149042517|NCT04714320|537636643|FG000|Overall Study|Voluntary Withdrawal|4|||
149042518|NCT04714320|537636644|FG001|Overall Study|Voluntary Withdrawal|1|||
149042519|NCT04714320|537636645|FG002|Overall Study|Voluntary Withdrawal|2|||
149042520|NCT04714320|537636643|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
149042521|NCT04714320|537636644|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
149042522|NCT04714320|537636645|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
149042523|NCT04714320|537636643|FG000|Overall Study|Reason Not Specified|1|||
149042524|NCT04714320|537636644|FG001|Overall Study|Reason Not Specified|3|||
149042525|NCT04714320|537636645|FG002|Overall Study|Reason Not Specified|3|||
149042526|NCT04755660|537636650|FG000|Overall Study|Lost to Follow-up|1|||
149042527|NCT04755660|537636651|FG001|Overall Study|Lost to Follow-up|1|||
149042528|NCT04755660|537636652|FG002|Overall Study|Lost to Follow-up|0|||
149042529|NCT04755660|537636650|FG000|Overall Study|Withdrawal by Subject|0|||
149042530|NCT04755660|537636651|FG001|Overall Study|Withdrawal by Subject|1|||
149042531|NCT04755660|537636652|FG002|Overall Study|Withdrawal by Subject|1|||
149042532|NCT04755660|537636650|FG000|Overall Study|Physician Decision|0|||
149042533|NCT04755660|537636651|FG001|Overall Study|Physician Decision|0|||
149042534|NCT04755660|537636652|FG002|Overall Study|Physician Decision|1|||
149042535|NCT02824029|537636654|FG000|Overall Study|Didn't receive treatment|2|||
149042536|NCT02824029|537636654|FG000|Overall Study|Patient decision to discontinue treatment|3|||
149042537|NCT02824029|537636654|FG000|Overall Study|Non-compliant|5|||
149042538|NCT02824029|537636654|FG000|Overall Study|Progression of disease|15|||
149042539|NCT02824029|537636654|FG000|Overall Study|Inadequate response to therapy|2|||
149042540|NCT02824029|537636654|FG000|Overall Study|Possible progression per treating physician|1|||
149042541|NCT03873779|537636655|FG000|Overall Study|Withdrawal by Subject|1|||
149042542|NCT02581215|537636656|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
149042543|NCT02581215|537636657|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
149042544|NCT02581215|537636656|FG000|Overall Study|Eligibility Criteria Not Met|0|||
149042545|NCT02581215|537636657|FG001|Overall Study|Eligibility Criteria Not Met|1|||
149042546|NCT02566902|537636666|FG000|Overall Study|Protocol Violation|2|||
149042547|NCT02566902|537636667|FG001|Overall Study|Protocol Violation|1|||
149042548|NCT04425629|537636670|FG000|Overall Study|Adverse Event|0|||
149042549|NCT04425629|537636671|FG001|Overall Study|Adverse Event|0|||
149042550|NCT04425629|537636672|FG002|Overall Study|Adverse Event|0|||
149042551|NCT04425629|537636673|FG003|Overall Study|Adverse Event|0|||
149042552|NCT04425629|537636674|FG004|Overall Study|Adverse Event|1|||
149042553|NCT04425629|537636675|FG005|Overall Study|Adverse Event|0|||
149042554|NCT04425629|537636676|FG006|Overall Study|Adverse Event|0|||
149042555|NCT04425629|537636677|FG007|Overall Study|Adverse Event|0|||
149042556|NCT04425629|537636678|FG008|Overall Study|Adverse Event|0|||
149042557|NCT04425629|537636679|FG009|Overall Study|Adverse Event|3|||
149042558|NCT04425629|537636680|FG010|Overall Study|Adverse Event|2|||
149042559|NCT04425629|537636681|FG011|Overall Study|Adverse Event|1|||
149042560|NCT04425629|537636682|FG012|Overall Study|Adverse Event|1|||
149042561|NCT04425629|537636683|FG013|Overall Study|Adverse Event|0|||
149042562|NCT04425629|537636684|FG014|Overall Study|Adverse Event|0|||
149042563|NCT04425629|537636685|FG015|Overall Study|Adverse Event|0|||
149042564|NCT04425629|537636686|FG016|Overall Study|Adverse Event|0|||
149042565|NCT04425629|537636687|FG017|Overall Study|Adverse Event|0|||
149042566|NCT04425629|537636688|FG018|Overall Study|Adverse Event|0|||
149042567|NCT04425629|537636670|FG000|Overall Study|Lost to Follow-up|1|||
149042568|NCT04425629|537636671|FG001|Overall Study|Lost to Follow-up|3|||
149042569|NCT04425629|537636672|FG002|Overall Study|Lost to Follow-up|1|||
149042570|NCT04425629|537636673|FG003|Overall Study|Lost to Follow-up|7|||
149042571|NCT04425629|537636674|FG004|Overall Study|Lost to Follow-up|1|||
149042572|NCT04425629|537636675|FG005|Overall Study|Lost to Follow-up|2|||
148885160|NCT02714569|537056949|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
149042573|NCT04425629|537636676|FG006|Overall Study|Lost to Follow-up|1|||
149042574|NCT04425629|537636677|FG007|Overall Study|Lost to Follow-up|0|||
149042575|NCT04425629|537636678|FG008|Overall Study|Lost to Follow-up|1|||
149042576|NCT04425629|537636679|FG009|Overall Study|Lost to Follow-up|64|||
149042577|NCT04425629|537636680|FG010|Overall Study|Lost to Follow-up|70|||
149042578|NCT04425629|537636681|FG011|Overall Study|Lost to Follow-up|98|||
149042579|NCT04425629|537636682|FG012|Overall Study|Lost to Follow-up|30|||
149042580|NCT04425629|537636683|FG013|Overall Study|Lost to Follow-up|0|||
149042581|NCT04425629|537636684|FG014|Overall Study|Lost to Follow-up|5|||
149042582|NCT04425629|537636685|FG015|Overall Study|Lost to Follow-up|4|||
149042583|NCT04425629|537636686|FG016|Overall Study|Lost to Follow-up|0|||
149042584|NCT04425629|537636687|FG017|Overall Study|Lost to Follow-up|3|||
149042585|NCT04425629|537636688|FG018|Overall Study|Lost to Follow-up|1|||
149042586|NCT04425629|537636670|FG000|Overall Study|Subject Decision|0|||
149042587|NCT04425629|537636671|FG001|Overall Study|Subject Decision|2|||
149042588|NCT04425629|537636672|FG002|Overall Study|Subject Decision|1|||
149042589|NCT04425629|537636673|FG003|Overall Study|Subject Decision|3|||
149042590|NCT04425629|537636674|FG004|Overall Study|Subject Decision|6|||
149042591|NCT04425629|537636675|FG005|Overall Study|Subject Decision|6|||
149042592|NCT04425629|537636676|FG006|Overall Study|Subject Decision|3|||
149042593|NCT04425629|537636677|FG007|Overall Study|Subject Decision|3|||
149042594|NCT04425629|537636678|FG008|Overall Study|Subject Decision|1|||
149042595|NCT04425629|537636679|FG009|Overall Study|Subject Decision|70|||
149042596|NCT04425629|537636680|FG010|Overall Study|Subject Decision|95|||
149042597|NCT04425629|537636681|FG011|Overall Study|Subject Decision|124|||
149042598|NCT04425629|537636682|FG012|Overall Study|Subject Decision|25|||
149042599|NCT04425629|537636683|FG013|Overall Study|Subject Decision|0|||
149042600|NCT04425629|537636684|FG014|Overall Study|Subject Decision|1|||
149042601|NCT04425629|537636685|FG015|Overall Study|Subject Decision|4|||
149042602|NCT04425629|537636686|FG016|Overall Study|Subject Decision|1|||
149042603|NCT04425629|537636687|FG017|Overall Study|Subject Decision|0|||
149042604|NCT04425629|537636688|FG018|Overall Study|Subject Decision|2|||
149042605|NCT04425629|537636670|FG000|Overall Study|Death|0|||
149042606|NCT04425629|537636671|FG001|Overall Study|Death|0|||
149042607|NCT04425629|537636672|FG002|Overall Study|Death|0|||
149042608|NCT04425629|537636673|FG003|Overall Study|Death|0|||
149042609|NCT04425629|537636674|FG004|Overall Study|Death|0|||
149042610|NCT04425629|537636675|FG005|Overall Study|Death|0|||
149042611|NCT04425629|537636676|FG006|Overall Study|Death|0|||
149042612|NCT04425629|537636677|FG007|Overall Study|Death|0|||
149042613|NCT04425629|537636678|FG008|Overall Study|Death|0|||
149042614|NCT04425629|537636679|FG009|Overall Study|Death|11|||
149042615|NCT04425629|537636680|FG010|Overall Study|Death|2|||
149042616|NCT04425629|537636681|FG011|Overall Study|Death|4|||
149042617|NCT04425629|537636682|FG012|Overall Study|Death|0|||
149042618|NCT04425629|537636683|FG013|Overall Study|Death|0|||
149042619|NCT04425629|537636684|FG014|Overall Study|Death|0|||
149042620|NCT04425629|537636685|FG015|Overall Study|Death|0|||
149042621|NCT04425629|537636686|FG016|Overall Study|Death|0|||
149042622|NCT04425629|537636687|FG017|Overall Study|Death|0|||
149042623|NCT04425629|537636688|FG018|Overall Study|Death|0|||
149042624|NCT04425629|537636670|FG000|Overall Study|Sponsor Request|0|||
149042625|NCT04425629|537636671|FG001|Overall Study|Sponsor Request|0|||
149042626|NCT04425629|537636672|FG002|Overall Study|Sponsor Request|0|||
149042627|NCT04425629|537636673|FG003|Overall Study|Sponsor Request|2|||
149042628|NCT04425629|537636674|FG004|Overall Study|Sponsor Request|2|||
149042629|NCT04425629|537636675|FG005|Overall Study|Sponsor Request|2|||
149042630|NCT04425629|537636676|FG006|Overall Study|Sponsor Request|1|||
149042631|NCT04425629|537636677|FG007|Overall Study|Sponsor Request|0|||
149042632|NCT04425629|537636678|FG008|Overall Study|Sponsor Request|0|||
149042633|NCT04425629|537636679|FG009|Overall Study|Sponsor Request|9|||
149042634|NCT04425629|537636680|FG010|Overall Study|Sponsor Request|9|||
149042635|NCT04425629|537636681|FG011|Overall Study|Sponsor Request|10|||
149042636|NCT04425629|537636682|FG012|Overall Study|Sponsor Request|8|||
149042637|NCT04425629|537636683|FG013|Overall Study|Sponsor Request|0|||
149042638|NCT04425629|537636684|FG014|Overall Study|Sponsor Request|0|||
149042639|NCT04425629|537636685|FG015|Overall Study|Sponsor Request|1|||
149042640|NCT04425629|537636686|FG016|Overall Study|Sponsor Request|0|||
149042641|NCT04425629|537636687|FG017|Overall Study|Sponsor Request|0|||
149042642|NCT04425629|537636688|FG018|Overall Study|Sponsor Request|0|||
149042643|NCT04425629|537636670|FG000|Overall Study|Physician Decision|0|||
148885161|NCT02714569|537056950|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
148885162|NCT02714569|537056951|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
148885163|NCT02714569|537056952|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
149042644|NCT04425629|537636671|FG001|Overall Study|Physician Decision|0|||
149042645|NCT04425629|537636672|FG002|Overall Study|Physician Decision|0|||
149042646|NCT04425629|537636673|FG003|Overall Study|Physician Decision|0|||
149042647|NCT04425629|537636674|FG004|Overall Study|Physician Decision|0|||
149042648|NCT04425629|537636675|FG005|Overall Study|Physician Decision|0|||
149042649|NCT04425629|537636676|FG006|Overall Study|Physician Decision|0|||
149042650|NCT04425629|537636677|FG007|Overall Study|Physician Decision|0|||
149042651|NCT04425629|537636678|FG008|Overall Study|Physician Decision|0|||
149042652|NCT04425629|537636679|FG009|Overall Study|Physician Decision|4|||
149042653|NCT04425629|537636680|FG010|Overall Study|Physician Decision|3|||
149042654|NCT04425629|537636681|FG011|Overall Study|Physician Decision|5|||
149042655|NCT04425629|537636682|FG012|Overall Study|Physician Decision|1|||
149042656|NCT04425629|537636683|FG013|Overall Study|Physician Decision|0|||
149042657|NCT04425629|537636684|FG014|Overall Study|Physician Decision|0|||
149042658|NCT04425629|537636685|FG015|Overall Study|Physician Decision|1|||
149042659|NCT04425629|537636686|FG016|Overall Study|Physician Decision|0|||
149042660|NCT04425629|537636687|FG017|Overall Study|Physician Decision|0|||
149042661|NCT04425629|537636688|FG018|Overall Study|Physician Decision|0|||
149042662|NCT04425629|537636670|FG000|Overall Study|Lack of Efficacy|0|||
149042663|NCT04425629|537636671|FG001|Overall Study|Lack of Efficacy|0|||
149042664|NCT04425629|537636672|FG002|Overall Study|Lack of Efficacy|0|||
149042665|NCT04425629|537636673|FG003|Overall Study|Lack of Efficacy|0|||
149042666|NCT04425629|537636674|FG004|Overall Study|Lack of Efficacy|0|||
149042667|NCT04425629|537636675|FG005|Overall Study|Lack of Efficacy|0|||
149042668|NCT04425629|537636676|FG006|Overall Study|Lack of Efficacy|0|||
149042669|NCT04425629|537636677|FG007|Overall Study|Lack of Efficacy|0|||
149042670|NCT04425629|537636678|FG008|Overall Study|Lack of Efficacy|0|||
149042671|NCT04425629|537636679|FG009|Overall Study|Lack of Efficacy|0|||
149042672|NCT04425629|537636680|FG010|Overall Study|Lack of Efficacy|1|||
149042673|NCT04425629|537636681|FG011|Overall Study|Lack of Efficacy|0|||
149042674|NCT04425629|537636682|FG012|Overall Study|Lack of Efficacy|0|||
149042675|NCT04425629|537636683|FG013|Overall Study|Lack of Efficacy|0|||
149042676|NCT04425629|537636684|FG014|Overall Study|Lack of Efficacy|0|||
149042677|NCT04425629|537636685|FG015|Overall Study|Lack of Efficacy|0|||
149042678|NCT04425629|537636686|FG016|Overall Study|Lack of Efficacy|0|||
149042679|NCT04425629|537636687|FG017|Overall Study|Lack of Efficacy|0|||
149042680|NCT04425629|537636688|FG018|Overall Study|Lack of Efficacy|0|||
149042681|NCT01546753|537636698|FG000|Overall Study|anxiety|1|||
149042682|NCT01546753|537636699|FG001|Overall Study|anxiety|1|||
149042683|NCT01546753|537636698|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
149042684|NCT01546753|537636699|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
149042685|NCT01102231|537636700|FG000|Overall Study|Protocol Violation|3|||
149042686|NCT01102231|537636700|FG000|Overall Study|Lack of Efficacy|2|||
149042687|NCT01102231|537636700|FG000|Overall Study|Death|2|||
149042688|NCT01102231|537636700|FG000|Overall Study|Adverse Event|3|||
149042689|NCT01102231|537636700|FG000|Overall Study|Withdrawal by Subject|1|||
149042690|NCT01102231|537636700|FG000|Overall Study|Did not received the treatment|4|||
149042691|NCT05274217|537636701|FG000|Overall Study|Study terminated.|11|||
149042692|NCT05274217|537636702|FG001|Overall Study|Study terminated.|0|||
149042693|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
149042694|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
149042695|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
149042696|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
149042697|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
149042698|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
149042699|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
149042700|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
149042701|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
149042702|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
149042703|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
149042704|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
149042705|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
149042706|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
149042707|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
149042708|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
149042709|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
149042710|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
149042711|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
149042712|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
149042713|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
149042714|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
149042715|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
149042716|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
149042717|NCT00311363|537636703|FG000|24-Week Single-Blind Treatment Period|Death|1|||
149042718|NCT00311363|537636704|FG001|24-Week Single-Blind Treatment Period|Death|0|||
149042719|NCT00311363|537636705|FG002|24-Week Single-Blind Treatment Period|Death|0|||
149042720|NCT00311363|537636703|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
149042721|NCT00311363|537636704|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
149042722|NCT00311363|537636705|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
148885164|NCT02714569|537056942|FG000|Part A Third Intervention|Adverse Event|0|||
149042723|NCT00311363|537636703|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
148885165|NCT02714569|537056943|FG001|Part A Third Intervention|Adverse Event|0|||
149042724|NCT00311363|537636704|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
149042725|NCT00311363|537636705|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
149042726|NCT00311363|537636703|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
149042727|NCT00311363|537636704|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
149042728|NCT00311363|537636705|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
149042729|NCT00311363|537636703|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
149042730|NCT00311363|537636704|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
149042731|NCT00311363|537636705|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
149042732|NCT00311363|537636703|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
149042733|NCT00311363|537636704|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
149042734|NCT00311363|537636705|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
149042735|NCT00311363|537636703|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
149042736|NCT00311363|537636704|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
149042737|NCT00311363|537636705|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
149042738|NCT03811574|537636706|FG000|Overall Study|Withdrawal by Subject|2|||
149042739|NCT03811574|537636707|FG001|Overall Study|Withdrawal by Subject|4|||
149042740|NCT03811574|537636708|FG002|Overall Study|Withdrawal by Subject|0|||
149042741|NCT01697969|537636711|FG000|Overall Study|Did not meet inc/exc criteria|3|||
149042742|NCT05609032|537636713|FG000|Overall Study|Lost to Follow-up|3|||
149042743|NCT05609032|537636714|FG001|Overall Study|Lost to Follow-up|1|||
149042744|NCT05609032|537636713|FG000|Overall Study|Withdrawal by Subject|1|||
149042745|NCT05609032|537636714|FG001|Overall Study|Withdrawal by Subject|0|||
149042746|NCT02574455|537636716|FG000|Overall Study|Death|197|||
149042747|NCT02574455|537636717|FG001|Overall Study|Death|210|||
149042748|NCT02574455|537636716|FG000|Overall Study|Withdrawal of Consent|11|||
149042749|NCT02574455|537636717|FG001|Overall Study|Withdrawal of Consent|28|||
149042750|NCT02574455|537636716|FG000|Overall Study|Lost to Follow-up|4|||
149042751|NCT02574455|537636717|FG001|Overall Study|Lost to Follow-up|4|||
149042752|NCT02574455|537636716|FG000|Overall Study|Sponsor's Decision|55|||
149042753|NCT02574455|537636717|FG001|Overall Study|Sponsor's Decision|20|||
149042754|NCT05510245|537636720|FG000|Overall Study|Withdrawal by Subject|1|||
149042755|NCT05510245|537636721|FG001|Overall Study|Withdrawal by Subject|0|||
149042756|NCT05510245|537636722|FG002|Overall Study|Withdrawal by Subject|0|||
149042757|NCT01373346|537636726|FG000|Overall Study|Death|1|||
149042758|NCT01199575|537636732|FG000|Overall Study|Withdrawal by Subject|5|||
149042759|NCT00716859|537636735|FG000|Overall Study|Adverse Event|4|||
149042760|NCT00716859|537636736|FG001|Overall Study|Adverse Event|1|||
149042761|NCT00716859|537636735|FG000|Overall Study|Lack of Efficacy|3|||
149042762|NCT00716859|537636736|FG001|Overall Study|Lack of Efficacy|0|||
149042763|NCT00716859|537636735|FG000|Overall Study|Withdrawal by Subject|1|||
149042764|NCT00716859|537636736|FG001|Overall Study|Withdrawal by Subject|3|||
149042765|NCT00716859|537636735|FG000|Overall Study|Not treated|1|||
149042766|NCT00716859|537636736|FG001|Overall Study|Not treated|1|||
149042767|NCT00411216|537636747|FG000|Overall Study|Ten participants were entered into the c|0|||
149042768|NCT00411216|537636748|FG001|Overall Study|Ten participants were entered into the c|2|||
149042769|NCT01251354|537636752|FG000|Overall Study|Adverse Event|1|||
149042770|NCT01251354|537636752|FG000|Overall Study|Investigator's Decision|1|||
149042771|NCT01251354|537636752|FG000|Overall Study|Disease Progression|4|||
149042772|NCT04411056|537638600|FG000|Overall Study|surgery cancelled|1|||
149042773|NCT04411056|537638601|FG001|Overall Study|surgery cancelled|0|||
149042774|NCT04411056|537638600|FG000|Overall Study|Equipment problem during intubation|0|||
149042775|NCT04411056|537638601|FG001|Overall Study|Equipment problem during intubation|1|||
149042776|NCT03422276|537638609|FG000|Overall Study|Withdrawal by Subject|21|||
149042777|NCT03422276|537638610|FG001|Overall Study|Withdrawal by Subject|25|||
149042778|NCT03422276|537638611|FG002|Overall Study|Withdrawal by Subject|14|||
149042779|NCT03422276|537638612|FG003|Overall Study|Withdrawal by Subject|16|||
149042780|NCT03422276|537638609|FG000|Overall Study|Death|14|||
149042781|NCT03422276|537638610|FG001|Overall Study|Death|21|||
149042782|NCT03422276|537638611|FG002|Overall Study|Death|3|||
149042783|NCT03422276|537638612|FG003|Overall Study|Death|1|||
149042784|NCT03422276|537638609|FG000|Overall Study|Discontinued, ineligible|4|||
149042785|NCT03422276|537638610|FG001|Overall Study|Discontinued, ineligible|3|||
149042786|NCT03422276|537638611|FG002|Overall Study|Discontinued, ineligible|0|||
149042787|NCT03422276|537638612|FG003|Overall Study|Discontinued, ineligible|0|||
149042788|NCT03422276|537638609|FG000|Overall Study|Lost to Follow-up|15|||
149042789|NCT03422276|537638610|FG001|Overall Study|Lost to Follow-up|8|||
148885166|NCT02714569|537056944|FG002|Part A Third Intervention|Adverse Event|1|||
148885167|NCT02714569|537056945|FG003|Part A Third Intervention|Adverse Event|0|||
149042790|NCT03422276|537638611|FG002|Overall Study|Lost to Follow-up|13|||
149042791|NCT03422276|537638612|FG003|Overall Study|Lost to Follow-up|4|||
149042792|NCT03422276|537638609|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
149042793|NCT03422276|537638610|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
149042794|NCT03422276|537638611|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
149042795|NCT03422276|537638612|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
149042796|NCT03422276|537638609|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
149042797|NCT03422276|537638610|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
149042798|NCT03422276|537638611|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
149042799|NCT03422276|537638612|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
149042800|NCT03422276|537638609|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
149042801|NCT03422276|537638610|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
149042802|NCT03422276|537638611|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
149042803|NCT03422276|537638612|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
149042804|NCT03422276|537638609|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
149042805|NCT03422276|537638610|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
149042806|NCT03422276|537638611|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
149042807|NCT03422276|537638612|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
149042808|NCT03422276|537638609|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
149042809|NCT03422276|537638610|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
149042810|NCT03422276|537638611|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
149042811|NCT03422276|537638612|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
149042812|NCT02279095|537638617|FG000|Overall Study|Non-Compliance|1|||
149042813|NCT02279095|537638617|FG000|Overall Study|Withdrawal by Subject|8|||
149042814|NCT02279095|537638617|FG000|Overall Study|Adverse Event|2|||
149042815|NCT02279095|537638617|FG000|Overall Study|Other|7|||
149042816|NCT02279095|537638617|FG000|Overall Study|Lost to Follow-up|1|||
149042817|NCT05938413|537638618|FG000|Overall Study|Lost to Follow-up|1|||
149042818|NCT05938413|537638619|FG001|Overall Study|Lost to Follow-up|7|||
149042819|NCT05938413|537638618|FG000|Overall Study|Withdrawal by Subject|1|||
149042820|NCT05938413|537638619|FG001|Overall Study|Withdrawal by Subject|1|||
149042821|NCT04922021|537638620|FG000|Overall Study|Withdrawal by Subject|4|||
149042822|NCT04922021|537638621|FG001|Overall Study|Withdrawal by Subject|10|||
149042823|NCT04922021|537638620|FG000|Overall Study|Adverse Event|2|||
149042824|NCT04922021|537638621|FG001|Overall Study|Adverse Event|2|||
149042825|NCT04922021|537638620|FG000|Overall Study|Lack of Efficacy|0|||
149042826|NCT04922021|537638621|FG001|Overall Study|Lack of Efficacy|1|||
149042827|NCT04922021|537638620|FG000|Overall Study|Multiple reasons|1|||
149042828|NCT04922021|537638621|FG001|Overall Study|Multiple reasons|0|||
149042829|NCT03237481|537638626|FG000|Overall Study|Lost to Follow-up|1|||
149042830|NCT03237481|537638627|FG001|Overall Study|Lost to Follow-up|0|||
149042831|NCT03237481|537638628|FG002|Overall Study|Lost to Follow-up|0|||
149042832|NCT03237481|537638626|FG000|Overall Study|Protocol Violation|1|||
149042833|NCT03237481|537638627|FG001|Overall Study|Protocol Violation|0|||
149042834|NCT03237481|537638628|FG002|Overall Study|Protocol Violation|0|||
149042835|NCT03237481|537638626|FG000|Overall Study|Withdrawal by Subject|3|||
149042836|NCT03237481|537638627|FG001|Overall Study|Withdrawal by Subject|2|||
149042837|NCT03237481|537638628|FG002|Overall Study|Withdrawal by Subject|1|||
149042838|NCT03481777|537638629|FG000|Overall Study|Withdrawal by Subject|36|||
149042839|NCT03481777|537638630|FG001|Overall Study|Withdrawal by Subject|31|||
149042840|NCT03481777|537638629|FG000|Overall Study|Non stroke = non target population|277|||
149042841|NCT03481777|537638630|FG001|Overall Study|Non stroke = non target population|254|||
149042842|NCT04139668|537638635|FG000|Overall Study|Withdrawal by Subject|1|||
149042843|NCT05386238|537638641|FG000|Overall Study|Lost to Follow-up|3|||
149042844|NCT05386238|537638642|FG001|Overall Study|Lost to Follow-up|2|||
149042845|NCT05386238|537638641|FG000|Overall Study|Withdrawal by Subject|0|||
149042846|NCT05386238|537638642|FG001|Overall Study|Withdrawal by Subject|1|||
149042847|NCT04907474|537638643|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
149042848|NCT04907474|537638644|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
149042849|NCT01353313|537638645|FG000|Overall Study|Lost to Follow-up|22|||
149042850|NCT01353313|537638646|FG001|Overall Study|Lost to Follow-up|23|||
149042851|NCT01353313|537638645|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
149042852|NCT01353313|537638646|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
149042853|NCT01414738|537638647|FG000|Overall Study|Death|26|||
149042854|NCT01414738|537638647|FG000|Overall Study|Refused testing|5|||
149042855|NCT01414738|537638647|FG000|Overall Study|Lost to Follow-up|2|||
149042856|NCT01414738|537638647|FG000|Overall Study|Refused, disease progression|8|||
149042857|NCT01414738|537638647|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
149042858|NCT01266122|537638649|FG000|Overall Study|Lost to Follow-up|6|||
149042859|NCT01266122|537638650|FG001|Overall Study|Lost to Follow-up|6|||
149042860|NCT00421889|537638651|FG000|Overall Study|Adverse Event|1|||
149042861|NCT00421889|537638652|FG001|Overall Study|Adverse Event|0|||
149042862|NCT00421889|537638653|FG002|Overall Study|Adverse Event|1|||
149042863|NCT00421889|537638654|FG003|Overall Study|Adverse Event|1|||
149042864|NCT00421889|537638655|FG004|Overall Study|Adverse Event|1|||
149042865|NCT00421889|537638656|FG005|Overall Study|Adverse Event|4|||
148885168|NCT02714569|537056946|FG004|Part A Third Intervention|Adverse Event|0|||
148885169|NCT02714569|537056947|FG005|Part A Third Intervention|Adverse Event|0|||
148885170|NCT02714569|537056948|FG006|Part A Third Intervention|Adverse Event|0|||
149042866|NCT00421889|537638657|FG006|Overall Study|Adverse Event|1|||
149042867|NCT00421889|537638658|FG007|Overall Study|Adverse Event|0|||
149042868|NCT00421889|537638659|FG008|Overall Study|Adverse Event|2|||
149042869|NCT00421889|537638651|FG000|Overall Study|Withdrawal by Subject|1|||
149042870|NCT00421889|537638652|FG001|Overall Study|Withdrawal by Subject|3|||
149042871|NCT00421889|537638653|FG002|Overall Study|Withdrawal by Subject|0|||
149042872|NCT00421889|537638654|FG003|Overall Study|Withdrawal by Subject|0|||
149042873|NCT00421889|537638655|FG004|Overall Study|Withdrawal by Subject|2|||
149042874|NCT00421889|537638656|FG005|Overall Study|Withdrawal by Subject|0|||
149042875|NCT00421889|537638657|FG006|Overall Study|Withdrawal by Subject|0|||
149042876|NCT00421889|537638658|FG007|Overall Study|Withdrawal by Subject|0|||
149042877|NCT00421889|537638659|FG008|Overall Study|Withdrawal by Subject|0|||
149042878|NCT00421889|537638651|FG000|Overall Study|Death|0|||
149042879|NCT00421889|537638652|FG001|Overall Study|Death|0|||
149042880|NCT00421889|537638653|FG002|Overall Study|Death|0|||
149042881|NCT00421889|537638654|FG003|Overall Study|Death|0|||
149042882|NCT00421889|537638655|FG004|Overall Study|Death|1|||
149042883|NCT00421889|537638656|FG005|Overall Study|Death|1|||
149042884|NCT00421889|537638657|FG006|Overall Study|Death|0|||
149042885|NCT00421889|537638658|FG007|Overall Study|Death|0|||
149042886|NCT00421889|537638659|FG008|Overall Study|Death|0|||
149042887|NCT00421889|537638651|FG000|Overall Study|Progressive disease|3|||
149042888|NCT00421889|537638652|FG001|Overall Study|Progressive disease|2|||
149042889|NCT00421889|537638653|FG002|Overall Study|Progressive disease|2|||
149042890|NCT00421889|537638654|FG003|Overall Study|Progressive disease|3|||
149042891|NCT00421889|537638655|FG004|Overall Study|Progressive disease|2|||
149042892|NCT00421889|537638656|FG005|Overall Study|Progressive disease|21|||
149042893|NCT00421889|537638657|FG006|Overall Study|Progressive disease|3|||
149042894|NCT00421889|537638658|FG007|Overall Study|Progressive disease|1|||
149042895|NCT00421889|537638659|FG008|Overall Study|Progressive disease|5|||
149042896|NCT00421889|537638651|FG000|Overall Study|Patient/Investigator request|0|||
149042897|NCT00421889|537638652|FG001|Overall Study|Patient/Investigator request|0|||
149042898|NCT00421889|537638653|FG002|Overall Study|Patient/Investigator request|0|||
149042899|NCT00421889|537638654|FG003|Overall Study|Patient/Investigator request|0|||
149042900|NCT00421889|537638655|FG004|Overall Study|Patient/Investigator request|0|||
149042901|NCT00421889|537638656|FG005|Overall Study|Patient/Investigator request|9|||
149042902|NCT00421889|537638657|FG006|Overall Study|Patient/Investigator request|0|||
149042903|NCT00421889|537638658|FG007|Overall Study|Patient/Investigator request|1|||
149042904|NCT00421889|537638659|FG008|Overall Study|Patient/Investigator request|3|||
149042905|NCT00421889|537638651|FG000|Overall Study|Lost to Follow-up|0|||
149042906|NCT00421889|537638652|FG001|Overall Study|Lost to Follow-up|0|||
149042907|NCT00421889|537638653|FG002|Overall Study|Lost to Follow-up|0|||
149042908|NCT00421889|537638654|FG003|Overall Study|Lost to Follow-up|0|||
149042909|NCT00421889|537638655|FG004|Overall Study|Lost to Follow-up|0|||
149042910|NCT00421889|537638656|FG005|Overall Study|Lost to Follow-up|0|||
149042911|NCT00421889|537638657|FG006|Overall Study|Lost to Follow-up|0|||
149042912|NCT00421889|537638658|FG007|Overall Study|Lost to Follow-up|0|||
149042913|NCT00421889|537638659|FG008|Overall Study|Lost to Follow-up|1|||
149042914|NCT00978042|537638660|FG000|Initial Treatment Period|Treated in Error|0|||
149042915|NCT00978042|537638661|FG001|Initial Treatment Period|Treated in Error|3|||
149042916|NCT00978042|537638660|FG000|Initial Treatment Period|Ineligibility|1|||
149042917|NCT00978042|537638661|FG001|Initial Treatment Period|Ineligibility|0|||
149042918|NCT00978042|537638660|FG000|Initial Treatment Period|Lost to Follow-up|21|||
149042919|NCT00978042|537638661|FG001|Initial Treatment Period|Lost to Follow-up|3|||
149042920|NCT00978042|537638660|FG000|Initial Treatment Period|Adverse Event|2|||
149042921|NCT00978042|537638661|FG001|Initial Treatment Period|Adverse Event|0|||
149042922|NCT00978042|537638660|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
149042923|NCT00978042|537638661|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
149042924|NCT00978042|537638660|FG000|Initial Treatment Period|Consent withdrawn|22|||
149042925|NCT00978042|537638661|FG001|Initial Treatment Period|Consent withdrawn|9|||
148885171|NCT02714569|537056949|FG007|Part A Third Intervention|Adverse Event|0|||
148885172|NCT02714569|537056950|FG008|Part A Third Intervention|Adverse Event|0|||
148885173|NCT02714569|537056951|FG009|Part A Third Intervention|Adverse Event|0|||
148885174|NCT02714569|537056952|FG010|Part A Third Intervention|Adverse Event|0|||
148885175|NCT02714569|537056942|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
148885176|NCT02714569|537056943|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885177|NCT02714569|537056944|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885178|NCT02714569|537056945|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885179|NCT02714569|537056946|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885180|NCT02714569|537056947|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
148885181|NCT02714569|537056948|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885182|NCT02714569|537056949|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885183|NCT02714569|537056950|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885184|NCT02714569|537056951|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885185|NCT02714569|537056952|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
148885186|NCT02714569|537056942|FG000|Part B (Overall)|Lost to Follow-up|0|||
149042926|NCT00978042|537638660|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
149042927|NCT00978042|537638661|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
149042928|NCT00529516|537638662|FG000|Overall Study|Adverse Event|2|||
149042929|NCT00529516|537638663|FG001|Overall Study|Adverse Event|1|||
149042930|NCT00529516|537638664|FG002|Overall Study|Adverse Event|0|||
149042931|NCT00529516|537638662|FG000|Overall Study|Withdrawal by Subject|1|||
149042932|NCT00529516|537638663|FG001|Overall Study|Withdrawal by Subject|1|||
149042933|NCT00529516|537638664|FG002|Overall Study|Withdrawal by Subject|0|||
149042934|NCT00529516|537638662|FG000|Overall Study|Lost to Follow-up|0|||
149042935|NCT00529516|537638663|FG001|Overall Study|Lost to Follow-up|0|||
149042936|NCT00529516|537638664|FG002|Overall Study|Lost to Follow-up|1|||
149042937|NCT00703820|537638667|FG000|Overall Study|Adverse Event|12|||
149042938|NCT00703820|537638668|FG001|Overall Study|Adverse Event|17|||
149042939|NCT00703820|537638667|FG000|Overall Study|Death|5|||
149042940|NCT00703820|537638668|FG001|Overall Study|Death|0|||
149042941|NCT00703820|537638667|FG000|Overall Study|Lack of Efficacy|11|||
149042942|NCT00703820|537638668|FG001|Overall Study|Lack of Efficacy|11|||
149042943|NCT00703820|537638667|FG000|Overall Study|Received non-protocol therapy|1|||
149042944|NCT00703820|537638668|FG001|Overall Study|Received non-protocol therapy|0|||
149042945|NCT00703820|537638667|FG000|Overall Study|Physician Decision|4|||
149042946|NCT00703820|537638668|FG001|Overall Study|Physician Decision|5|||
149042947|NCT00703820|537638667|FG000|Overall Study|Withdrawal by Subject|2|||
149042948|NCT00703820|537638668|FG001|Overall Study|Withdrawal by Subject|1|||
149042949|NCT00761605|537638671|FG000|Overall Study|Adverse Event|26|||
149042950|NCT00761605|537638671|FG000|Overall Study|Death|2|||
149042951|NCT00761605|537638671|FG000|Overall Study|Lack of Efficacy|26|||
149042952|NCT00761605|537638671|FG000|Overall Study|Lost to Follow-up|29|||
149042953|NCT00761605|537638671|FG000|Overall Study|Withdrawal by Subject|37|||
149042954|NCT00761605|537638671|FG000|Overall Study|Other|21|||
149042955|NCT01985334|537638676|FG000|Overall Study|Administrative problems|1|||
149042956|NCT01985334|537638677|FG001|Overall Study|Administrative problems|1|||
149042957|NCT01985334|537638678|FG002|Overall Study|Administrative problems|0|||
149042958|NCT01985334|537638679|FG003|Overall Study|Administrative problems|2|||
149042959|NCT01985334|537638680|FG004|Overall Study|Administrative problems|0|||
149042960|NCT01985334|537638681|FG005|Overall Study|Administrative problems|1|||
149042961|NCT01985334|537638682|FG006|Overall Study|Administrative problems|1|||
149042962|NCT01985334|537638683|FG007|Overall Study|Administrative problems|3|||
149042963|NCT01985334|537638676|FG000|Overall Study|Death|1|||
149042964|NCT01985334|537638677|FG001|Overall Study|Death|0|||
149042965|NCT01985334|537638678|FG002|Overall Study|Death|0|||
149042966|NCT01985334|537638679|FG003|Overall Study|Death|3|||
149042967|NCT01985334|537638680|FG004|Overall Study|Death|0|||
149042968|NCT01985334|537638681|FG005|Overall Study|Death|0|||
149042969|NCT01985334|537638682|FG006|Overall Study|Death|1|||
149042970|NCT01985334|537638683|FG007|Overall Study|Death|2|||
149042971|NCT01985334|537638676|FG000|Overall Study|Worsening of disease|0|||
149042972|NCT01985334|537638677|FG001|Overall Study|Worsening of disease|0|||
149042973|NCT01985334|537638678|FG002|Overall Study|Worsening of disease|0|||
149042974|NCT01985334|537638679|FG003|Overall Study|Worsening of disease|1|||
149042975|NCT01985334|537638680|FG004|Overall Study|Worsening of disease|0|||
149042976|NCT01985334|537638681|FG005|Overall Study|Worsening of disease|3|||
149042977|NCT01985334|537638682|FG006|Overall Study|Worsening of disease|0|||
149042978|NCT01985334|537638683|FG007|Overall Study|Worsening of disease|1|||
149042979|NCT01985334|537638676|FG000|Overall Study|Other|2|||
149042980|NCT01985334|537638677|FG001|Overall Study|Other|9|||
149042981|NCT01985334|537638678|FG002|Overall Study|Other|7|||
149042982|NCT01985334|537638679|FG003|Overall Study|Other|17|||
149042983|NCT01985334|537638680|FG004|Overall Study|Other|4|||
149042984|NCT01985334|537638681|FG005|Overall Study|Other|8|||
149042985|NCT01985334|537638682|FG006|Overall Study|Other|4|||
148885187|NCT02714569|537056943|FG001|Part B (Overall)|Lost to Follow-up|0|||
148885188|NCT02714569|537056944|FG002|Part B (Overall)|Lost to Follow-up|0|||
148885189|NCT02714569|537056945|FG003|Part B (Overall)|Lost to Follow-up|0|||
148885190|NCT02714569|537056946|FG004|Part B (Overall)|Lost to Follow-up|0|||
148885191|NCT02714569|537056947|FG005|Part B (Overall)|Lost to Follow-up|0|||
148885192|NCT02714569|537056948|FG006|Part B (Overall)|Lost to Follow-up|1|||
148885193|NCT02714569|537056949|FG007|Part B (Overall)|Lost to Follow-up|0|||
148885194|NCT02714569|537056950|FG008|Part B (Overall)|Lost to Follow-up|0|||
148885195|NCT02714569|537056951|FG009|Part B (Overall)|Lost to Follow-up|0|||
148885196|NCT02714569|537056952|FG010|Part B (Overall)|Lost to Follow-up|0|||
148885197|NCT02714569|537056942|FG000|Part B (Overall)|Withdrawal by Subject|0|||
149042986|NCT01985334|537638683|FG007|Overall Study|Other|7|||
149042987|NCT01985334|537638676|FG000|Overall Study|Protocol deviation|6|||
149042988|NCT01985334|537638677|FG001|Overall Study|Protocol deviation|31|||
149042989|NCT01985334|537638678|FG002|Overall Study|Protocol deviation|25|||
149042990|NCT01985334|537638679|FG003|Overall Study|Protocol deviation|84|||
149042991|NCT01985334|537638680|FG004|Overall Study|Protocol deviation|17|||
149042992|NCT01985334|537638681|FG005|Overall Study|Protocol deviation|47|||
149042993|NCT01985334|537638682|FG006|Overall Study|Protocol deviation|15|||
149042994|NCT01985334|537638683|FG007|Overall Study|Protocol deviation|42|||
148885198|NCT02714569|537056943|FG001|Part B (Overall)|Withdrawal by Subject|0|||
148885199|NCT02714569|537056944|FG002|Part B (Overall)|Withdrawal by Subject|0|||
148885200|NCT02714569|537056945|FG003|Part B (Overall)|Withdrawal by Subject|0|||
148885201|NCT02714569|537056946|FG004|Part B (Overall)|Withdrawal by Subject|0|||
148885202|NCT02714569|537056947|FG005|Part B (Overall)|Withdrawal by Subject|0|||
148885203|NCT02714569|537056948|FG006|Part B (Overall)|Withdrawal by Subject|0|||
148885204|NCT02714569|537056949|FG007|Part B (Overall)|Withdrawal by Subject|1|||
148885205|NCT02714569|537056950|FG008|Part B (Overall)|Withdrawal by Subject|0|||
148885206|NCT02714569|537056951|FG009|Part B (Overall)|Withdrawal by Subject|1|||
148885207|NCT02714569|537056952|FG010|Part B (Overall)|Withdrawal by Subject|0|||
148885208|NCT02714569|537056942|FG000|Part B (Overall)|Adverse Event|0|||
148885209|NCT02714569|537056943|FG001|Part B (Overall)|Adverse Event|0|||
148885210|NCT02714569|537056944|FG002|Part B (Overall)|Adverse Event|0|||
148885211|NCT02714569|537056945|FG003|Part B (Overall)|Adverse Event|0|||
148885212|NCT02714569|537056946|FG004|Part B (Overall)|Adverse Event|0|||
148885213|NCT02714569|537056947|FG005|Part B (Overall)|Adverse Event|0|||
148885214|NCT02714569|537056948|FG006|Part B (Overall)|Adverse Event|0|||
148885215|NCT02714569|537056949|FG007|Part B (Overall)|Adverse Event|0|||
148885216|NCT02714569|537056950|FG008|Part B (Overall)|Adverse Event|0|||
148885217|NCT02714569|537056951|FG009|Part B (Overall)|Adverse Event|1|||
148885218|NCT02714569|537056952|FG010|Part B (Overall)|Adverse Event|0|||
148885219|NCT01684202|537056953|FG000|Dose-escalation Period|Adverse Event|0|||
148885220|NCT01684202|537056954|FG001|Dose-escalation Period|Adverse Event|1|||
148885221|NCT01684202|537056955|FG002|Dose-escalation Period|Adverse Event|0|||
148885222|NCT01684202|537056956|FG003|Dose-escalation Period|Adverse Event|0|||
148885223|NCT01684202|537056953|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
148885224|NCT01684202|537056954|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
148885225|NCT01684202|537056955|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
148885226|NCT01684202|537056956|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
148885227|NCT01684202|537056953|FG000|Maintenance Period|Adverse Event|1|||
148885228|NCT01684202|537056954|FG001|Maintenance Period|Adverse Event|1|||
148885229|NCT01684202|537056955|FG002|Maintenance Period|Adverse Event|1|||
148885230|NCT01684202|537056956|FG003|Maintenance Period|Adverse Event|1|||
148885231|NCT01684202|537056953|FG000|Maintenance Period|Physician Decision|0|||
148885232|NCT01684202|537056954|FG001|Maintenance Period|Physician Decision|1|||
148885233|NCT01684202|537056955|FG002|Maintenance Period|Physician Decision|0|||
148885234|NCT01684202|537056956|FG003|Maintenance Period|Physician Decision|0|||
148885235|NCT01684202|537056953|FG000|Maintenance Period|Withdrawal by Subject|0|||
148885236|NCT01684202|537056954|FG001|Maintenance Period|Withdrawal by Subject|1|||
148885237|NCT01684202|537056955|FG002|Maintenance Period|Withdrawal by Subject|0|||
148885238|NCT01684202|537056956|FG003|Maintenance Period|Withdrawal by Subject|0|||
148885239|NCT03305770|537056957|FG000|Overall Study|Physician Decision - prior to dispense|0|||
148885240|NCT03305770|537056958|FG001|Overall Study|Physician Decision - prior to dispense|1|||
148885241|NCT03305770|537056957|FG000|Overall Study|Subject moved|1|||
148885242|NCT03305770|537056958|FG001|Overall Study|Subject moved|0|||
148885243|NCT03539601|537056959|FG000|Overall Study|Withdraw by parent/guardian|1|||
148885244|NCT03539601|537056960|FG001|Overall Study|Withdraw by parent/guardian|0|||
148885245|NCT03539601|537056961|FG002|Overall Study|Withdraw by parent/guardian|1|||
148885246|NCT03539601|537056962|FG003|Overall Study|Withdraw by parent/guardian|0|||
148885247|NCT03539601|537056959|FG000|Overall Study|Adverse Event|0|||
148885248|NCT03539601|537056960|FG001|Overall Study|Adverse Event|2|||
148885249|NCT03539601|537056961|FG002|Overall Study|Adverse Event|0|||
148885250|NCT03539601|537056962|FG003|Overall Study|Adverse Event|0|||
148885251|NCT03539601|537056959|FG000|Overall Study|Lost to Follow-up|2|||
148885252|NCT03539601|537056960|FG001|Overall Study|Lost to Follow-up|4|||
148885253|NCT03539601|537056961|FG002|Overall Study|Lost to Follow-up|5|||
148885254|NCT03539601|537056962|FG003|Overall Study|Lost to Follow-up|0|||
148885255|NCT03539601|537056959|FG000|Overall Study|Withdrawal by Subject|2|||
148885256|NCT03539601|537056960|FG001|Overall Study|Withdrawal by Subject|0|||
148885257|NCT03539601|537056961|FG002|Overall Study|Withdrawal by Subject|0|||
148885258|NCT03539601|537056962|FG003|Overall Study|Withdrawal by Subject|1|||
148885259|NCT03539601|537056959|FG000|Overall Study|Randomized but not treated|1|||
148885260|NCT03539601|537056960|FG001|Overall Study|Randomized but not treated|1|||
148885261|NCT03539601|537056961|FG002|Overall Study|Randomized but not treated|0|||
149042995|NCT01985334|537638676|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
149042996|NCT01985334|537638677|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
149042997|NCT01985334|537638678|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
148885262|NCT03539601|537056962|FG003|Overall Study|Randomized but not treated|0|||
148885263|NCT01970306|537056963|FG000|Overall Study|Not eligible|3|||
149042998|NCT01985334|537638679|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
149042999|NCT01985334|537638680|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
149043000|NCT01985334|537638681|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
149043001|NCT01985334|537638682|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
148885264|NCT01970306|537056963|FG000|Overall Study|Not able to be treated|9|||
148885265|NCT00226811|537056964|FG000|Overall Study|Death|8|||
148885266|NCT00226811|537056964|FG000|Overall Study|Adverse Event|11|||
149043002|NCT01985334|537638683|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
149043003|NCT01985334|537638676|FG000|Overall Study|Subject withdrawal of consent|3|||
149043004|NCT01985334|537638677|FG001|Overall Study|Subject withdrawal of consent|6|||
149043005|NCT01985334|537638678|FG002|Overall Study|Subject withdrawal of consent|2|||
149043006|NCT01985334|537638679|FG003|Overall Study|Subject withdrawal of consent|28|||
149043007|NCT01985334|537638680|FG004|Overall Study|Subject withdrawal of consent|4|||
149043008|NCT01985334|537638681|FG005|Overall Study|Subject withdrawal of consent|19|||
149043009|NCT01985334|537638682|FG006|Overall Study|Subject withdrawal of consent|0|||
149043010|NCT01985334|537638683|FG007|Overall Study|Subject withdrawal of consent|20|||
149043011|NCT01985334|537638676|FG000|Overall Study|Adverse Event|0|||
149043012|NCT01985334|537638677|FG001|Overall Study|Adverse Event|8|||
149043013|NCT01985334|537638678|FG002|Overall Study|Adverse Event|2|||
149043014|NCT01985334|537638679|FG003|Overall Study|Adverse Event|26|||
149043015|NCT01985334|537638680|FG004|Overall Study|Adverse Event|3|||
149043016|NCT01985334|537638681|FG005|Overall Study|Adverse Event|18|||
149043017|NCT01985334|537638682|FG006|Overall Study|Adverse Event|3|||
149043018|NCT01985334|537638683|FG007|Overall Study|Adverse Event|15|||
149043019|NCT01985334|537638676|FG000|Overall Study|Other|4|||
149043020|NCT01985334|537638677|FG001|Overall Study|Other|2|||
149043021|NCT01985334|537638678|FG002|Overall Study|Other|3|||
149043022|NCT01985334|537638679|FG003|Overall Study|Other|10|||
149043023|NCT01985334|537638680|FG004|Overall Study|Other|1|||
149043024|NCT01985334|537638681|FG005|Overall Study|Other|6|||
149043025|NCT01985334|537638682|FG006|Overall Study|Other|2|||
149043026|NCT01985334|537638683|FG007|Overall Study|Other|2|||
149043027|NCT01985334|537638676|FG000|Overall Study|Medication non-compliance|0|||
149043028|NCT01985334|537638677|FG001|Overall Study|Medication non-compliance|4|||
149043029|NCT01985334|537638678|FG002|Overall Study|Medication non-compliance|1|||
149043030|NCT01985334|537638679|FG003|Overall Study|Medication non-compliance|6|||
149043031|NCT01985334|537638680|FG004|Overall Study|Medication non-compliance|2|||
149043032|NCT01985334|537638681|FG005|Overall Study|Medication non-compliance|3|||
149043033|NCT01985334|537638682|FG006|Overall Study|Medication non-compliance|1|||
149043034|NCT01985334|537638683|FG007|Overall Study|Medication non-compliance|3|||
149043035|NCT01985334|537638676|FG000|Overall Study|Use of prohibited treatment|1|||
149043036|NCT01985334|537638677|FG001|Overall Study|Use of prohibited treatment|4|||
149043037|NCT01985334|537638678|FG002|Overall Study|Use of prohibited treatment|1|||
149043038|NCT01985334|537638679|FG003|Overall Study|Use of prohibited treatment|2|||
149043039|NCT01985334|537638680|FG004|Overall Study|Use of prohibited treatment|1|||
149043040|NCT01985334|537638681|FG005|Overall Study|Use of prohibited treatment|6|||
149043041|NCT01985334|537638682|FG006|Overall Study|Use of prohibited treatment|2|||
149043042|NCT01985334|537638683|FG007|Overall Study|Use of prohibited treatment|0|||
149043043|NCT01985334|537638676|FG000|Overall Study|Investigator decision|0|||
149043044|NCT01985334|537638677|FG001|Overall Study|Investigator decision|3|||
149043045|NCT01985334|537638678|FG002|Overall Study|Investigator decision|0|||
149043046|NCT01985334|537638679|FG003|Overall Study|Investigator decision|7|||
149043047|NCT01985334|537638680|FG004|Overall Study|Investigator decision|1|||
149043048|NCT01985334|537638681|FG005|Overall Study|Investigator decision|1|||
149043049|NCT01985334|537638682|FG006|Overall Study|Investigator decision|0|||
149043050|NCT01985334|537638683|FG007|Overall Study|Investigator decision|4|||
149043051|NCT01985334|537638676|FG000|Overall Study|Lost to Follow-up|0|||
149043052|NCT01985334|537638677|FG001|Overall Study|Lost to Follow-up|2|||
149043053|NCT01985334|537638678|FG002|Overall Study|Lost to Follow-up|0|||
149043054|NCT01985334|537638679|FG003|Overall Study|Lost to Follow-up|3|||
149043055|NCT01985334|537638680|FG004|Overall Study|Lost to Follow-up|1|||
149043056|NCT01985334|537638681|FG005|Overall Study|Lost to Follow-up|4|||
149043057|NCT01985334|537638682|FG006|Overall Study|Lost to Follow-up|0|||
149043058|NCT01985334|537638683|FG007|Overall Study|Lost to Follow-up|3|||
149043059|NCT00785512|537638684|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
149043060|NCT00785512|537638685|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
149043061|NCT00785512|537638684|FG000|Overall Study|Adverse Event|0|||
149043062|NCT00785512|537638685|FG001|Overall Study|Adverse Event|0|||
149043063|NCT00785512|537638684|FG000|Overall Study|Lack of Efficacy|0|||
149043064|NCT00785512|537638685|FG001|Overall Study|Lack of Efficacy|2|||
149043065|NCT00785512|537638684|FG000|Overall Study|Withdrawal by Subject|0|||
149043066|NCT00785512|537638685|FG001|Overall Study|Withdrawal by Subject|1|||
149043067|NCT00785512|537638684|FG000|Overall Study|Lost to Follow-up|3|||
149043068|NCT00785512|537638685|FG001|Overall Study|Lost to Follow-up|0|||
149043069|NCT00785512|537638684|FG000|Overall Study|Precedure Refused|0|||
149043070|NCT00785512|537638685|FG001|Overall Study|Precedure Refused|0|||
149043071|NCT00785512|537638684|FG000|Overall Study|IVRS Programing Error|0|||
149043072|NCT00785512|537638685|FG001|Overall Study|IVRS Programing Error|0|||
149043073|NCT00785512|537638684|FG000|Overall Study|Physician Decision|0|||
149043074|NCT00785512|537638685|FG001|Overall Study|Physician Decision|0|||
149043075|NCT00785512|537638684|FG000|Overall Study|Lack of compliance|0|||
149043076|NCT00785512|537638685|FG001|Overall Study|Lack of compliance|1|||
149043077|NCT00546754|537638686|FG000|Overall Study|Serious Adverse Event|1|||
149043078|NCT00546754|537638687|FG001|Overall Study|Serious Adverse Event|1|||
149043079|NCT00546754|537638686|FG000|Overall Study|Adverse Event|11|||
149043080|NCT00546754|537638687|FG001|Overall Study|Adverse Event|16|||
149043081|NCT00546754|537638686|FG000|Overall Study|Lack of Efficacy|1|||
149043082|NCT00546754|537638687|FG001|Overall Study|Lack of Efficacy|1|||
149043083|NCT00546754|537638686|FG000|Overall Study|Lost to Follow-up|9|||
149043084|NCT00546754|537638687|FG001|Overall Study|Lost to Follow-up|15|||
149043085|NCT00546754|537638686|FG000|Overall Study|Protocol Violation|3|||
149043086|NCT00546754|537638687|FG001|Overall Study|Protocol Violation|0|||
149043087|NCT00546754|537638686|FG000|Overall Study|Withdrawal by Subject|6|||
149043088|NCT00546754|537638687|FG001|Overall Study|Withdrawal by Subject|7|||
149043089|NCT00546754|537638686|FG000|Overall Study|Dyspnea|1|||
149043090|NCT00546754|537638687|FG001|Overall Study|Dyspnea|0|||
149043091|NCT00546754|537638686|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
149043092|NCT00546754|537638687|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
149043093|NCT00546754|537638686|FG000|Overall Study|Hip Replacement|1|||
149043094|NCT00546754|537638687|FG001|Overall Study|Hip Replacement|0|||
149043095|NCT00546754|537638686|FG000|Overall Study|Suicide|1|||
149043096|NCT00546754|537638687|FG001|Overall Study|Suicide|0|||
149043097|NCT00546754|537638686|FG000|Overall Study|Missing Cooperation|1|||
149043098|NCT00546754|537638687|FG001|Overall Study|Missing Cooperation|0|||
149043099|NCT00546754|537638686|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
149043100|NCT00546754|537638687|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
149043101|NCT00546754|537638686|FG000|Overall Study|Patient's Decision|0|||
149043102|NCT00546754|537638687|FG001|Overall Study|Patient's Decision|1|||
149043103|NCT00546754|537638686|FG000|Overall Study|Missing|14|||
149043104|NCT00546754|537638687|FG001|Overall Study|Missing|7|||
149043105|NCT00396084|537638688|FG000|Overall Study|Adverse Event|0|||
149043106|NCT00396084|537638689|FG001|Overall Study|Adverse Event|0|||
149043107|NCT00396084|537638690|FG002|Overall Study|Adverse Event|0|||
149043108|NCT00396084|537638691|FG003|Overall Study|Adverse Event|0|||
149043109|NCT00396084|537638692|FG004|Overall Study|Adverse Event|1|||
149043110|NCT00396084|537638693|FG005|Overall Study|Adverse Event|2|||
149043111|NCT00396084|537638688|FG000|Overall Study|Withdrawal by Subject|0|||
149043112|NCT00396084|537638689|FG001|Overall Study|Withdrawal by Subject|0|||
149043113|NCT00396084|537638690|FG002|Overall Study|Withdrawal by Subject|0|||
149043114|NCT00396084|537638691|FG003|Overall Study|Withdrawal by Subject|1|||
149043115|NCT00396084|537638692|FG004|Overall Study|Withdrawal by Subject|0|||
149043116|NCT00396084|537638693|FG005|Overall Study|Withdrawal by Subject|0|||
149043117|NCT04556981|537638694|FG000|Overall Study|Death|0|||
149043118|NCT04556981|537638695|FG001|Overall Study|Death|1|||
149043119|NCT04556981|537638694|FG000|Overall Study|Lost to Follow-up|2|||
149043120|NCT04556981|537638695|FG001|Overall Study|Lost to Follow-up|11|||
149043121|NCT04556981|537638694|FG000|Overall Study|Moved from the study area|1|||
149043122|NCT04556981|537638695|FG001|Overall Study|Moved from the study area|4|||
149043123|NCT04556981|537638694|FG000|Overall Study|Withdrawal by Subject|2|||
149043124|NCT04556981|537638695|FG001|Overall Study|Withdrawal by Subject|2|||
149043125|NCT04556981|537638694|FG000|Overall Study|Other|2|||
149043126|NCT04556981|537638695|FG001|Overall Study|Other|1|||
149043127|NCT01198028|537638702|FG000|Overall Study|Adverse Event|5|||
149043128|NCT01198028|537638702|FG000|Overall Study|Death|3|||
149043129|NCT01198028|537638702|FG000|Overall Study|Physician Decision|2|||
149043130|NCT01565148|537638705|FG000|Overall Study|Withdrawal by Subject|1|||
149043131|NCT01565148|537638706|FG001|Overall Study|Withdrawal by Subject|1|||
149043132|NCT01565148|537638707|FG002|Overall Study|Withdrawal by Subject|1|||
149043133|NCT01565148|537638708|FG003|Overall Study|Withdrawal by Subject|2|||
149043134|NCT01565148|537638705|FG000|Overall Study|Lost to Follow-up|4|||
149043135|NCT01565148|537638706|FG001|Overall Study|Lost to Follow-up|4|||
149043136|NCT01565148|537638707|FG002|Overall Study|Lost to Follow-up|0|||
149043137|NCT01565148|537638708|FG003|Overall Study|Lost to Follow-up|3|||
149043138|NCT01565148|537638705|FG000|Overall Study|Rescue Therapy|8|||
149043139|NCT01565148|537638706|FG001|Overall Study|Rescue Therapy|5|||
149043140|NCT01565148|537638707|FG002|Overall Study|Rescue Therapy|5|||
149043141|NCT01565148|537638708|FG003|Overall Study|Rescue Therapy|8|||
149043142|NCT01565148|537638705|FG000|Overall Study|Death|0|||
149043143|NCT01565148|537638706|FG001|Overall Study|Death|0|||
149043144|NCT01565148|537638707|FG002|Overall Study|Death|1|||
149043145|NCT01565148|537638708|FG003|Overall Study|Death|0|||
149043146|NCT01565148|537638705|FG000|Overall Study|Physician Decision|2|||
149043147|NCT01565148|537638706|FG001|Overall Study|Physician Decision|5|||
149043148|NCT01565148|537638707|FG002|Overall Study|Physician Decision|0|||
149043149|NCT01565148|537638708|FG003|Overall Study|Physician Decision|0|||
149043150|NCT01759771|537638710|FG000|Overall Study|Withdrawal by Subject|1|||
149043151|NCT01759771|537638711|FG001|Overall Study|Withdrawal by Subject|1|||
149043152|NCT02528188|537638712|FG000|Overall Study|Adverse Event|23|||
149043153|NCT02528188|537638713|FG001|Overall Study|Adverse Event|22|||
149043154|NCT02528188|537638714|FG002|Overall Study|Adverse Event|8|||
149043155|NCT02528188|537638712|FG000|Overall Study|Protocol Violation|4|||
149043156|NCT02528188|537638713|FG001|Overall Study|Protocol Violation|6|||
149043157|NCT02528188|537638714|FG002|Overall Study|Protocol Violation|4|||
149043158|NCT02528188|537638712|FG000|Overall Study|Lack of Efficacy|19|||
149043159|NCT02528188|537638713|FG001|Overall Study|Lack of Efficacy|21|||
149043160|NCT02528188|537638714|FG002|Overall Study|Lack of Efficacy|22|||
149043161|NCT02528188|537638712|FG000|Overall Study|Withdrawal by Subject|97|||
149043162|NCT02528188|537638713|FG001|Overall Study|Withdrawal by Subject|104|||
149043163|NCT02528188|537638714|FG002|Overall Study|Withdrawal by Subject|100|||
149043164|NCT02528188|537638712|FG000|Overall Study|Lost to Follow-up|25|||
149043165|NCT02528188|537638713|FG001|Overall Study|Lost to Follow-up|21|||
149043166|NCT02528188|537638714|FG002|Overall Study|Lost to Follow-up|31|||
149043167|NCT02528188|537638712|FG000|Overall Study|Death|4|||
149043168|NCT02528188|537638713|FG001|Overall Study|Death|4|||
149043169|NCT02528188|537638714|FG002|Overall Study|Death|0|||
149043170|NCT02528188|537638712|FG000|Overall Study|Other|89|||
149043171|NCT02528188|537638713|FG001|Overall Study|Other|91|||
149043172|NCT02528188|537638714|FG002|Overall Study|Other|74|||
149043173|NCT02528188|537638712|FG000|Overall Study|Randomized but not treated|6|||
149043174|NCT02528188|537638713|FG001|Overall Study|Randomized but not treated|7|||
149043175|NCT02528188|537638714|FG002|Overall Study|Randomized but not treated|12|||
149043176|NCT05368831|537638715|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
149043177|NCT00529659|537638718|FG000|Overall Study|Adverse Event|8|||
149043178|NCT00529659|537638719|FG001|Overall Study|Adverse Event|7|||
149043179|NCT00529659|537638718|FG000|Overall Study|Lost to Follow-up|0|||
149043180|NCT00529659|537638719|FG001|Overall Study|Lost to Follow-up|2|||
149043181|NCT00529659|537638718|FG000|Overall Study|Physician Decision|0|||
149043182|NCT00529659|537638719|FG001|Overall Study|Physician Decision|2|||
149043183|NCT00529659|537638718|FG000|Overall Study|Protocol Violation|2|||
149043184|NCT00529659|537638719|FG001|Overall Study|Protocol Violation|6|||
149043185|NCT00529659|537638718|FG000|Overall Study|Withdrawal by Subject|1|||
149043186|NCT00529659|537638719|FG001|Overall Study|Withdrawal by Subject|6|||
149043187|NCT03565315|537638720|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
149043188|NCT03565315|537638721|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
149043189|NCT03565315|537638722|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
149043190|NCT03565315|537638723|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
149043191|NCT03887650|537638725|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
149043192|NCT03887650|537638726|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
149043193|NCT03887650|537638725|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
149043194|NCT03887650|537638726|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
149043195|NCT03887650|537638725|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
149043196|NCT03887650|537638726|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
149043197|NCT01170962|537638727|FG000|Treatment Period|Lack of Efficacy|96|||
149043198|NCT01170962|537638728|FG001|Treatment Period|Lack of Efficacy|91|||
149043199|NCT01170962|537638729|FG002|Treatment Period|Lack of Efficacy|7|||
149043200|NCT01170962|537638727|FG000|Treatment Period|Adverse Event|11|||
149043201|NCT01170962|537638728|FG001|Treatment Period|Adverse Event|12|||
149043202|NCT01170962|537638729|FG002|Treatment Period|Adverse Event|3|||
149043203|NCT01170962|537638727|FG000|Treatment Period|Withdrawal by Subject|2|||
149043204|NCT01170962|537638728|FG001|Treatment Period|Withdrawal by Subject|1|||
149043205|NCT01170962|537638729|FG002|Treatment Period|Withdrawal by Subject|0|||
149043206|NCT01170962|537638727|FG000|Treatment Period|Lost to Follow-up|1|||
149043207|NCT01170962|537638728|FG001|Treatment Period|Lost to Follow-up|1|||
149043208|NCT01170962|537638729|FG002|Treatment Period|Lost to Follow-up|1|||
149043209|NCT01170962|537638727|FG000|Treatment Period|Participant no longer meets criteria|0|||
149043210|NCT01170962|537638728|FG001|Treatment Period|Participant no longer meets criteria|1|||
149043211|NCT01170962|537638729|FG002|Treatment Period|Participant no longer meets criteria|0|||
149043212|NCT01170962|537638727|FG000|Treatment Period|Request to discontinue treatment|7|||
149043213|NCT01170962|537638728|FG001|Treatment Period|Request to discontinue treatment|3|||
149043214|NCT01170962|537638729|FG002|Treatment Period|Request to discontinue treatment|1|||
149043215|NCT01170962|537638727|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
149043216|NCT01170962|537638728|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
149043217|NCT01170962|537638729|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
149043218|NCT01170962|537638727|FG000|Follow up Period|Withdrawal by Subject|14|||
149043219|NCT01170962|537638728|FG001|Follow up Period|Withdrawal by Subject|10|||
149043220|NCT01170962|537638729|FG002|Follow up Period|Withdrawal by Subject|2|||
149043221|NCT01170962|537638727|FG000|Follow up Period|Lost to Follow-up|13|||
149043222|NCT01170962|537638728|FG001|Follow up Period|Lost to Follow-up|8|||
149043223|NCT01170962|537638729|FG002|Follow up Period|Lost to Follow-up|1|||
149043224|NCT01170962|537638727|FG000|Follow up Period|Death|2|||
149043225|NCT01170962|537638728|FG001|Follow up Period|Death|2|||
149043226|NCT01170962|537638729|FG002|Follow up Period|Death|0|||
149043227|NCT01170962|537638727|FG000|Follow up Period|Others|10|||
149043228|NCT01170962|537638728|FG001|Follow up Period|Others|7|||
149043229|NCT01170962|537638729|FG002|Follow up Period|Others|3|||
149043230|NCT01083316|537638733|FG000|Overall Study|Adverse Event|2|||
149043231|NCT01083316|537638733|FG000|Overall Study|Withdrawal by Subject|1|||
149043232|NCT04200365|537638734|FG000|Overall Study|Adverse Event|2|||
149043233|NCT04200365|537638734|FG000|Overall Study|Progressive Disease|4|||
149043234|NCT04200365|537638734|FG000|Overall Study|Lack of Efficacy|1|||
149043235|NCT04200365|537638734|FG000|Overall Study|Study Closure|4|||
149043236|NCT01499199|537638735|FG000|Overall Study|Adverse Event|1|||
149043237|NCT01499199|537638735|FG000|Overall Study|Lack of Efficacy|1|||
149043238|NCT01692730|537638736|FG000|Overall Study|Lost to Follow-up|225|||
149043239|NCT01692730|537638737|FG001|Overall Study|Lost to Follow-up|227|||
149043240|NCT01849055|537638738|FG000|Overall Study|Withdrawal by Subject|0|||
149043241|NCT01849055|537638739|FG001|Overall Study|Withdrawal by Subject|0|||
149043242|NCT01849055|537638740|FG002|Overall Study|Withdrawal by Subject|1|||
149043243|NCT01849055|537638741|FG003|Overall Study|Withdrawal by Subject|0|||
149043244|NCT01849055|537638742|FG004|Overall Study|Withdrawal by Subject|0|||
149043245|NCT01849055|537638743|FG005|Overall Study|Withdrawal by Subject|0|||
149043246|NCT00223795|537638748|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
149043247|NCT00223795|537638749|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
149043248|NCT00223795|537638748|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
149043249|NCT00223795|537638749|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
149043250|NCT02139943|537638750|FG000|Overall Study|Adverse Event|0|||
149043251|NCT02139943|537638751|FG001|Overall Study|Adverse Event|1|||
149043252|NCT02139943|537638752|FG002|Overall Study|Adverse Event|2|||
149043253|NCT02139943|537638750|FG000|Overall Study|Lost to Follow-up|3|||
149043254|NCT02139943|537638751|FG001|Overall Study|Lost to Follow-up|2|||
149043255|NCT02139943|537638752|FG002|Overall Study|Lost to Follow-up|2|||
149043256|NCT02139943|537638750|FG000|Overall Study|Withdrawal by Subject|4|||
149043257|NCT02139943|537638751|FG001|Overall Study|Withdrawal by Subject|3|||
149043258|NCT02139943|537638752|FG002|Overall Study|Withdrawal by Subject|0|||
149043259|NCT02139943|537638750|FG000|Overall Study|Other|0|||
148885267|NCT00226811|537056964|FG000|Overall Study|Lack of Efficacy|55|||
148885268|NCT00226811|537056964|FG000|Overall Study|Withdrawal by Subject|2|||
148885269|NCT01010971|537056965|FG000|Overall Study|Adverse Event|2|||
148885270|NCT01010971|537056966|FG001|Overall Study|Adverse Event|4|||
148885271|NCT01010971|537056967|FG002|Overall Study|Adverse Event|3|||
148885272|NCT01010971|537056965|FG000|Overall Study|Withdrawal by Subject|0|||
148885273|NCT01010971|537056966|FG001|Overall Study|Withdrawal by Subject|2|||
149043260|NCT02139943|537638751|FG001|Overall Study|Other|0|||
149043261|NCT02139943|537638752|FG002|Overall Study|Other|1|||
149043262|NCT02139943|537638750|FG000|Overall Study|Participant wishes to discontinue|2|||
149043263|NCT02139943|537638751|FG001|Overall Study|Participant wishes to discontinue|0|||
149043264|NCT02139943|537638752|FG002|Overall Study|Participant wishes to discontinue|0|||
149043265|NCT02139943|537638750|FG000|Overall Study|Participant in Poor Compliance|1|||
149043266|NCT02139943|537638751|FG001|Overall Study|Participant in Poor Compliance|0|||
149043267|NCT02139943|537638752|FG002|Overall Study|Participant in Poor Compliance|1|||
149043268|NCT02139943|537638750|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
149043269|NCT02139943|537638751|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
149043270|NCT02139943|537638752|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
149043271|NCT02299375|537638755|FG000|Overall Study|Adverse Event, serious fatal|1|||
149043272|NCT02299375|537638756|FG001|Overall Study|Adverse Event, serious fatal|3|||
149043273|NCT02299375|537638755|FG000|Overall Study|Adverse Event, non-fatal|8|||
149043274|NCT02299375|537638756|FG001|Overall Study|Adverse Event, non-fatal|9|||
149043275|NCT02299375|537638755|FG000|Overall Study|Lack of Efficacy|1|||
149043276|NCT02299375|537638756|FG001|Overall Study|Lack of Efficacy|3|||
149043277|NCT02299375|537638755|FG000|Overall Study|Protocol Violation|1|||
149043278|NCT02299375|537638756|FG001|Overall Study|Protocol Violation|3|||
149043279|NCT02299375|537638755|FG000|Overall Study|Other: Met stopping criteria|1|||
149043280|NCT02299375|537638756|FG001|Overall Study|Other: Met stopping criteria|0|||
149043281|NCT02299375|537638755|FG000|Overall Study|Other: Study closed/terminated|66|||
149043282|NCT02299375|537638756|FG001|Overall Study|Other: Study closed/terminated|55|||
149043283|NCT02299375|537638755|FG000|Overall Study|Lost to Follow-up|0|||
149043284|NCT02299375|537638756|FG001|Overall Study|Lost to Follow-up|2|||
149043285|NCT02299375|537638755|FG000|Overall Study|Physician Decision|1|||
149043286|NCT02299375|537638756|FG001|Overall Study|Physician Decision|1|||
149043287|NCT02299375|537638755|FG000|Overall Study|Withdrawal by Subject|1|||
149043288|NCT02299375|537638756|FG001|Overall Study|Withdrawal by Subject|4|||
149043289|NCT00704184|537638761|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
149043290|NCT00704184|537638762|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
149043291|NCT00704184|537638763|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
149043292|NCT00704184|537638764|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
148885274|NCT01010971|537056967|FG002|Overall Study|Withdrawal by Subject|5|||
148885275|NCT01010971|537056965|FG000|Overall Study|Lost to Follow-up|0|||
149043293|NCT00704184|537638765|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
149043294|NCT00704184|537638761|FG000|Open-Label Treatment|Adverse Event|0|||
149043295|NCT00704184|537638762|FG001|Open-Label Treatment|Adverse Event|0|||
149043296|NCT00704184|537638763|FG002|Open-Label Treatment|Adverse Event|2|||
149043297|NCT00704184|537638764|FG003|Open-Label Treatment|Adverse Event|0|||
149043298|NCT00704184|537638765|FG004|Open-Label Treatment|Adverse Event|1|||
149043299|NCT00704184|537638761|FG000|Open-Label Treatment|Lack of Efficacy|0|||
149043300|NCT00704184|537638762|FG001|Open-Label Treatment|Lack of Efficacy|2|||
149043301|NCT00704184|537638763|FG002|Open-Label Treatment|Lack of Efficacy|2|||
149043302|NCT00704184|537638764|FG003|Open-Label Treatment|Lack of Efficacy|2|||
149043303|NCT00704184|537638765|FG004|Open-Label Treatment|Lack of Efficacy|1|||
149043304|NCT00704184|537638761|FG000|Open-Label Treatment|Physician Decision|0|||
149043305|NCT00704184|537638762|FG001|Open-Label Treatment|Physician Decision|0|||
149043306|NCT00704184|537638763|FG002|Open-Label Treatment|Physician Decision|0|||
149043307|NCT00704184|537638764|FG003|Open-Label Treatment|Physician Decision|0|||
149043308|NCT00704184|537638765|FG004|Open-Label Treatment|Physician Decision|1|||
149043309|NCT00704184|537638761|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
149043310|NCT00704184|537638762|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
149043311|NCT00704184|537638763|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
149043312|NCT00704184|537638764|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
149043313|NCT00704184|537638765|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
149043314|NCT03613740|537640180|FG000|Overall Study|Lost to Follow-up|1|||
149043315|NCT03613740|537640181|FG001|Overall Study|Lost to Follow-up|1|||
149043316|NCT04279574|537640182|FG000|Overall Study|Death|1|||
149043317|NCT04279574|537640183|FG001|Overall Study|Death|0|||
149043318|NCT04279574|537640182|FG000|Overall Study|lost restoration, tooth fracture|1|||
149043319|NCT04279574|537640183|FG001|Overall Study|lost restoration, tooth fracture|0|||
149043320|NCT04279574|537640182|FG000|Overall Study|Lost to Follow-up|0|||
149043321|NCT04279574|537640183|FG001|Overall Study|Lost to Follow-up|1|||
149043322|NCT03575052|537640184|FG000|Overall Study|Adverse Event|6|||
149043323|NCT03575052|537640185|FG001|Overall Study|Adverse Event|10|||
149043324|NCT03575052|537640184|FG000|Overall Study|Not further specified|5|||
149043325|NCT03575052|537640185|FG001|Overall Study|Not further specified|7|||
149043326|NCT03575052|537640184|FG000|Overall Study|Withdrawal by Subject|5|||
149043327|NCT03575052|537640185|FG001|Overall Study|Withdrawal by Subject|6|||
149043328|NCT03575052|537640184|FG000|Overall Study|Lost to Follow-up|3|||
149043329|NCT03575052|537640185|FG001|Overall Study|Lost to Follow-up|0|||
149043330|NCT03575052|537640184|FG000|Overall Study|Death|2|||
149043331|NCT03575052|537640185|FG001|Overall Study|Death|1|||
149043332|NCT03575052|537640184|FG000|Overall Study|Lack of Efficacy|2|||
149043333|NCT03575052|537640185|FG001|Overall Study|Lack of Efficacy|1|||
149043334|NCT03575052|537640184|FG000|Overall Study|Study drug noncompliance|1|||
149043335|NCT03575052|537640185|FG001|Overall Study|Study drug noncompliance|2|||
149043336|NCT03575052|537640184|FG000|Overall Study|Protocol Violation|0|||
149043337|NCT03575052|537640185|FG001|Overall Study|Protocol Violation|2|||
149043338|NCT03575052|537640184|FG000|Overall Study|Physician Decision|1|||
149043339|NCT03575052|537640185|FG001|Overall Study|Physician Decision|0|||
149043340|NCT04188379|537640186|FG000|Overall Study|Withdrawal by Subject|10|||
149043341|NCT04188379|537640187|FG001|Overall Study|Withdrawal by Subject|3|||
149043342|NCT04188379|537640186|FG000|Overall Study|Physician Decision|0|||
149043343|NCT04188379|537640187|FG001|Overall Study|Physician Decision|1|||
149043344|NCT04188379|537640186|FG000|Overall Study|Adverse Event|3|||
149043345|NCT04188379|537640187|FG001|Overall Study|Adverse Event|1|||
149043346|NCT04188379|537640186|FG000|Overall Study|Pregnancy|1|||
149043347|NCT04188379|537640187|FG001|Overall Study|Pregnancy|0|||
149043348|NCT04188379|537640186|FG000|Overall Study|Lack of Efficacy|8|||
149043349|NCT04188379|537640187|FG001|Overall Study|Lack of Efficacy|5|||
149043350|NCT04188379|537640186|FG000|Overall Study|Other|0|||
149043351|NCT04188379|537640187|FG001|Overall Study|Other|3|||
149043352|NCT01693120|537640190|FG000|Enrollment|Lost to Follow-up|1|||
149043353|NCT01693120|537640190|FG000|Enrollment|Withdrawal by Subject|10|||
149043354|NCT01693120|537640190|FG000|Enrollment|Protocol Violation|46|||
149043355|NCT01693120|537640190|FG000|Enrollment|Physician Decision|3|||
149043356|NCT01693120|537640190|FG000|Enrollment|Adverse Event|1|||
149043357|NCT01693120|537640190|FG000|Enrollment|Study closed|8|||
149043358|NCT01693120|537640190|FG000|Enrollment|Other|1|||
149043359|NCT01693120|537640190|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
149043360|NCT01693120|537640190|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
149043361|NCT01693120|537640190|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
149043362|NCT01693120|537640190|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
149043363|NCT01693120|537640190|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
149043364|NCT02411084|537640200|FG000|Overall Study|Lack of Efficacy|6|||
149043365|NCT02411084|537640201|FG001|Overall Study|Lack of Efficacy|3|||
149043366|NCT02411084|537640200|FG000|Overall Study|Death|5|||
149043367|NCT02411084|537640201|FG001|Overall Study|Death|4|||
149043368|NCT02411084|537640200|FG000|Overall Study|Adverse Event|2|||
149043369|NCT02411084|537640201|FG001|Overall Study|Adverse Event|1|||
149043370|NCT02411084|537640200|FG000|Overall Study|Other reasons|0|||
149043371|NCT02411084|537640201|FG001|Overall Study|Other reasons|5|||
149043372|NCT03624972|537640202|FG000|Overall Study|Lost to Follow-up|2|||
149043373|NCT03624972|537640203|FG001|Overall Study|Lost to Follow-up|0|||
149043374|NCT03624972|537640204|FG002|Overall Study|Lost to Follow-up|0|||
149043375|NCT03624972|537640202|FG000|Overall Study|Withdrawal by Subject|0|||
149043376|NCT03624972|537640203|FG001|Overall Study|Withdrawal by Subject|2|||
149043377|NCT03624972|537640204|FG002|Overall Study|Withdrawal by Subject|0|||
149043378|NCT03112174|537640205|FG000|Overall Study|Withdrawal by Subject|3|||
149043379|NCT03112174|537640206|FG001|Overall Study|Withdrawal by Subject|0|||
149043380|NCT03112174|537640207|FG002|Overall Study|Withdrawal by Subject|11|||
149043381|NCT03112174|537640208|FG003|Overall Study|Withdrawal by Subject|9|||
149043382|NCT03112174|537640209|FG004|Overall Study|Withdrawal by Subject|7|||
149043383|NCT03112174|537640205|FG000|Overall Study|Lost to Follow-up|1|||
149043384|NCT03112174|537640206|FG001|Overall Study|Lost to Follow-up|1|||
149043385|NCT03112174|537640207|FG002|Overall Study|Lost to Follow-up|2|||
149043386|NCT03112174|537640208|FG003|Overall Study|Lost to Follow-up|3|||
149043387|NCT03112174|537640209|FG004|Overall Study|Lost to Follow-up|2|||
149043388|NCT03112174|537640205|FG000|Overall Study|Death|8|||
149043389|NCT03112174|537640206|FG001|Overall Study|Death|3|||
149043390|NCT03112174|537640207|FG002|Overall Study|Death|67|||
149043391|NCT03112174|537640208|FG003|Overall Study|Death|73|||
149043392|NCT03112174|537640209|FG004|Overall Study|Death|18|||
149043393|NCT03112174|537640205|FG000|Overall Study|Other, Not Specified|1|||
149043394|NCT03112174|537640206|FG001|Overall Study|Other, Not Specified|0|||
149043395|NCT03112174|537640207|FG002|Overall Study|Other, Not Specified|1|||
149043396|NCT03112174|537640208|FG003|Overall Study|Other, Not Specified|2|||
149043397|NCT03112174|537640209|FG004|Overall Study|Other, Not Specified|0|||
149043398|NCT00610649|537640214|FG000|Overall Study|Adverse Event|1|||
149043399|NCT00610649|537640215|FG001|Overall Study|Adverse Event|0|||
149043400|NCT00610649|537640216|FG002|Overall Study|Adverse Event|0|||
149043401|NCT00610649|537640217|FG003|Overall Study|Adverse Event|0|||
149043402|NCT00610649|537640218|FG004|Overall Study|Adverse Event|0|||
149043403|NCT00610649|537640219|FG005|Overall Study|Adverse Event|0|||
149043404|NCT00610649|537640220|FG006|Overall Study|Adverse Event|0|||
149043405|NCT00610649|537640221|FG007|Overall Study|Adverse Event|0|||
149043406|NCT00610649|537640222|FG008|Overall Study|Adverse Event|0|||
149043407|NCT00610649|537640223|FG009|Overall Study|Adverse Event|0|||
149043408|NCT00610649|537640224|FG010|Overall Study|Adverse Event|1|||
149043409|NCT00610649|537640214|FG000|Overall Study|Family Emergency|0|||
149043410|NCT00610649|537640215|FG001|Overall Study|Family Emergency|1|||
149043411|NCT00610649|537640216|FG002|Overall Study|Family Emergency|0|||
149043412|NCT00610649|537640217|FG003|Overall Study|Family Emergency|0|||
149043413|NCT00610649|537640218|FG004|Overall Study|Family Emergency|0|||
149043414|NCT00610649|537640219|FG005|Overall Study|Family Emergency|0|||
149043415|NCT00610649|537640220|FG006|Overall Study|Family Emergency|0|||
148885276|NCT01010971|537056966|FG001|Overall Study|Lost to Follow-up|2|||
148885277|NCT01010971|537056967|FG002|Overall Study|Lost to Follow-up|3|||
149043416|NCT00610649|537640221|FG007|Overall Study|Family Emergency|0|||
149043417|NCT00610649|537640222|FG008|Overall Study|Family Emergency|0|||
149043418|NCT00610649|537640223|FG009|Overall Study|Family Emergency|0|||
149043419|NCT00610649|537640224|FG010|Overall Study|Family Emergency|0|||
149043420|NCT00610649|537640214|FG000|Overall Study|Withdrawal by Subject|0|||
149043421|NCT00610649|537640215|FG001|Overall Study|Withdrawal by Subject|0|||
149043422|NCT00610649|537640216|FG002|Overall Study|Withdrawal by Subject|0|||
149043423|NCT00610649|537640217|FG003|Overall Study|Withdrawal by Subject|0|||
149043424|NCT00610649|537640218|FG004|Overall Study|Withdrawal by Subject|0|||
149043425|NCT00610649|537640219|FG005|Overall Study|Withdrawal by Subject|0|||
149043426|NCT00610649|537640220|FG006|Overall Study|Withdrawal by Subject|0|||
149043427|NCT00610649|537640221|FG007|Overall Study|Withdrawal by Subject|0|||
149043428|NCT00610649|537640222|FG008|Overall Study|Withdrawal by Subject|0|||
149043429|NCT00610649|537640223|FG009|Overall Study|Withdrawal by Subject|1|||
149043430|NCT00610649|537640224|FG010|Overall Study|Withdrawal by Subject|0|||
149043431|NCT02597920|537640228|FG000|Overall Study|Worsening of other pre-existing disease|0|||
149043432|NCT02597920|537640229|FG001|Overall Study|Worsening of other pre-existing disease|1|||
149043433|NCT02597920|537640230|FG002|Overall Study|Worsening of other pre-existing disease|0|||
149043434|NCT02597920|537640228|FG000|Overall Study|Other adverse event|20|||
149043435|NCT02597920|537640229|FG001|Overall Study|Other adverse event|30|||
149043436|NCT02597920|537640230|FG002|Overall Study|Other adverse event|0|||
149043437|NCT02597920|537640228|FG000|Overall Study|Lost to Follow-up|7|||
149043438|NCT02597920|537640229|FG001|Overall Study|Lost to Follow-up|9|||
149043439|NCT02597920|537640230|FG002|Overall Study|Lost to Follow-up|0|||
149043440|NCT02597920|537640228|FG000|Overall Study|Refuse to continue in the study|3|||
149043441|NCT02597920|537640229|FG001|Overall Study|Refuse to continue in the study|13|||
149043442|NCT02597920|537640230|FG002|Overall Study|Refuse to continue in the study|1|||
149043443|NCT02597920|537640228|FG000|Overall Study|Other than specified|10|||
149043444|NCT02597920|537640229|FG001|Overall Study|Other than specified|31|||
149043445|NCT02597920|537640230|FG002|Overall Study|Other than specified|5|||
149043446|NCT02597920|537640228|FG000|Overall Study|Other|1|||
149043447|NCT02597920|537640229|FG001|Overall Study|Other|0|||
149043448|NCT02597920|537640230|FG002|Overall Study|Other|0|||
149043449|NCT00642850|537640231|FG000|Overall Study|Death|7|||
149043450|NCT00642850|537640231|FG000|Overall Study|Adverse Event|2|||
149043451|NCT00642850|537640231|FG000|Overall Study|Lack of Efficacy|1|||
149043452|NCT00642850|537640231|FG000|Overall Study|Protocol Violation|2|||
149043453|NCT00642850|537640231|FG000|Overall Study|Kidney transplantation|8|||
149043454|NCT00642850|537640231|FG000|Overall Study|Blood transfusion|6|||
149043455|NCT00642850|537640231|FG000|Overall Study|Other reasons|7|||
148885278|NCT01010971|537056965|FG000|Overall Study|Other|1|||
149043456|NCT05489484|537640238|FG000|Overall Study|withdrawn|1|||
149043457|NCT02706717|537640241|FG000|Overall Study|Withdrawal by Subject|1|||
149043458|NCT02706717|537640242|FG001|Overall Study|Withdrawal by Subject|8|||
149043459|NCT02706717|537640241|FG000|Overall Study|Lost to Follow-up|0|||
149043460|NCT02706717|537640242|FG001|Overall Study|Lost to Follow-up|1|||
149043461|NCT02706717|537640241|FG000|Overall Study|Physician Decision|0|||
149043462|NCT02706717|537640242|FG001|Overall Study|Physician Decision|1|||
149043463|NCT02706717|537640241|FG000|Overall Study|Death|0|||
149043464|NCT02706717|537640242|FG001|Overall Study|Death|1|||
149043465|NCT00444600|537640246|FG000|Overall Study|Death|7|||
149043466|NCT00444600|537640247|FG001|Overall Study|Death|5|||
149043467|NCT00444600|537640248|FG002|Overall Study|Death|3|||
149043468|NCT00444600|537640249|FG003|Overall Study|Death|2|||
149043469|NCT00444600|537640246|FG000|Overall Study|Dropped|11|||
149043470|NCT00444600|537640247|FG001|Overall Study|Dropped|11|||
149043471|NCT00444600|537640248|FG002|Overall Study|Dropped|7|||
149043472|NCT00444600|537640249|FG003|Overall Study|Dropped|7|||
149043473|NCT00444600|537640246|FG000|Overall Study|Missed visit|1|||
149043474|NCT00444600|537640247|FG001|Overall Study|Missed visit|0|||
149043475|NCT00444600|537640248|FG002|Overall Study|Missed visit|0|||
149043476|NCT00444600|537640249|FG003|Overall Study|Missed visit|1|||
149043477|NCT05132478|537640250|FG000|Overall Study|did not complete survey after consent|1|||
149043478|NCT05132478|537640251|FG001|Overall Study|did not complete survey after consent|1|||
149043479|NCT05132478|537640250|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
149043480|NCT05132478|537640251|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
149043481|NCT00106080|537640252|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
149043482|NCT00106080|537640253|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
149043483|NCT03756571|537640257|FG000|Overall Study|Lost to Follow-up|1|||
149043484|NCT03756571|537640258|FG001|Overall Study|Lost to Follow-up|1|||
149043485|NCT01290341|537640261|FG000|Overall Study|Protocol Violation|7|||
149043486|NCT01290341|537640262|FG001|Overall Study|Protocol Violation|3|||
148885279|NCT01010971|537056966|FG001|Overall Study|Other|0|||
148885280|NCT01010971|537056967|FG002|Overall Study|Other|2|||
148885281|NCT03386721|537056968|FG000|Overall Study|Death|12|||
149043487|NCT01290341|537640261|FG000|Overall Study|Adverse Event|1|||
149043488|NCT01290341|537640262|FG001|Overall Study|Adverse Event|0|||
149043489|NCT01290341|537640261|FG000|Overall Study|Lost to Follow-up|21|||
149043490|NCT01290341|537640262|FG001|Overall Study|Lost to Follow-up|10|||
149043491|NCT01290341|537640261|FG000|Overall Study|Withdrawal by Subject|19|||
149043492|NCT01290341|537640262|FG001|Overall Study|Withdrawal by Subject|5|||
149043493|NCT01290341|537640261|FG000|Overall Study|Negative baseline culture and others|44|||
149043494|NCT01290341|537640262|FG001|Overall Study|Negative baseline culture and others|11|||
149043495|NCT00580866|537640279|FG000|Overall Study|Lost to Follow-up|2|||
149043496|NCT00580866|537640280|FG001|Overall Study|Lost to Follow-up|2|||
149043497|NCT01388361|537640281|FG000|Overall Study|Adverse Event|0|||
149043498|NCT01388361|537640282|FG001|Overall Study|Adverse Event|5|||
149043499|NCT01388361|537640283|FG002|Overall Study|Adverse Event|1|||
149043500|NCT01388361|537640281|FG000|Overall Study|Protocol Violation|0|||
149043501|NCT01388361|537640282|FG001|Overall Study|Protocol Violation|0|||
149043502|NCT01388361|537640283|FG002|Overall Study|Protocol Violation|2|||
149043503|NCT01388361|537640281|FG000|Overall Study|Withdrawal criteria|12|||
149043504|NCT01388361|537640282|FG001|Overall Study|Withdrawal criteria|7|||
149043505|NCT01388361|537640283|FG002|Overall Study|Withdrawal criteria|10|||
149043506|NCT01388361|537640281|FG000|Overall Study|Unclassified|0|||
149043507|NCT01388361|537640282|FG001|Overall Study|Unclassified|0|||
148885282|NCT03386721|537056969|FG001|Overall Study|Death|21|||
148885283|NCT03386721|537056970|FG002|Overall Study|Death|2|||
148885284|NCT03386721|537056971|FG003|Overall Study|Death|5|||
149043508|NCT01388361|537640283|FG002|Overall Study|Unclassified|1|||
149043509|NCT00440011|537640285|FG000|Overall Study|Adverse Event|2|||
149043510|NCT00440011|537640286|FG001|Overall Study|Adverse Event|0|||
149043511|NCT00440011|537640285|FG000|Overall Study|Lost to Follow-up|0|||
149043512|NCT00440011|537640286|FG001|Overall Study|Lost to Follow-up|2|||
148885285|NCT03386721|537056972|FG004|Overall Study|Death|1|||
149043513|NCT00440011|537640285|FG000|Overall Study|Protocol Violation|1|||
149043514|NCT00440011|537640286|FG001|Overall Study|Protocol Violation|1|||
149043515|NCT00440011|537640285|FG000|Overall Study|Withdrawal by Subject|1|||
149043516|NCT00440011|537640286|FG001|Overall Study|Withdrawal by Subject|0|||
149043517|NCT00419341|537640287|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
149043518|NCT00419341|537640287|FG000|Wash in/Wash Out Period|Adverse Event|2|||
149043519|NCT00419341|537640287|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
149043520|NCT00419341|537640287|FG000|Efficacy Period|Withdrawal by Subject|6|||
149043521|NCT00419341|537640287|FG000|Efficacy Period|Protocol Violation|1|||
149043522|NCT00419341|537640287|FG000|Efficacy Period|Lost to Follow-up|1|||
149043523|NCT00419341|537640287|FG000|Efficacy Period|Non-compliance|1|||
148885286|NCT03386721|537056973|FG005|Overall Study|Death|12|||
148885287|NCT03386721|537056974|FG006|Overall Study|Death|1|||
149043524|NCT00419341|537640287|FG000|Efficacy Period|Termination of study site|1|||
149043525|NCT01239316|537640296|FG000|Overall Study|Progression/Relapse|11|||
149043526|NCT01239316|537640296|FG000|Overall Study|Adverse Event|1|||
149043527|NCT03960463|537641666|FG000|Overall Study|Withdrawal by Subject|2|||
149043528|NCT03960463|537641667|FG001|Overall Study|Withdrawal by Subject|0|||
149043529|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
149043530|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
149043531|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
149043532|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
149043533|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
149043534|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
149043535|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
149043536|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
149043537|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
149043538|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
149043539|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
149043540|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
149043541|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
149043542|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
149043543|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
149043544|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
149043545|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
149043546|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
149043547|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
149043548|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
149043549|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
149043550|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
149043551|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
149043552|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
149043553|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149043554|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
149043555|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149043556|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149043557|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149043558|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
149043559|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
149043560|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
149043561|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
149043562|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
149043563|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
149043564|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
149043565|NCT04043455|537641668|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
149043566|NCT04043455|537641669|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
149043567|NCT04043455|537641670|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
149043568|NCT04043455|537641671|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
149043569|NCT04043455|537641672|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
149043570|NCT04043455|537641673|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
149043571|NCT04043455|537641668|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
149043572|NCT04043455|537641669|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
149043573|NCT04043455|537641670|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
149043574|NCT04043455|537641671|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
149043575|NCT04043455|537641672|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
149043576|NCT04043455|537641673|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
149043577|NCT04043455|537641668|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
149043578|NCT04043455|537641669|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
149043579|NCT04043455|537641670|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
149043580|NCT04043455|537641671|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
148885288|NCT03386721|537056975|FG007|Overall Study|Death|1|||
148885289|NCT03386721|537056976|FG008|Overall Study|Death|12|||
148885290|NCT03386721|537056977|FG009|Overall Study|Death|20|||
148885291|NCT03386721|537056978|FG010|Overall Study|Death|21|||
148885292|NCT03386721|537056979|FG011|Overall Study|Death|21|||
148885293|NCT03386721|537056980|FG012|Overall Study|Death|14|||
148885294|NCT03386721|537056981|FG013|Overall Study|Death|2|||
148885295|NCT03386721|537056982|FG014|Overall Study|Death|1|||
148885296|NCT03386721|537056968|FG000|Overall Study|Lost to Follow-up|1|||
149043581|NCT04043455|537641672|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
149043582|NCT04043455|537641673|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
149043583|NCT04043455|537641668|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
149043584|NCT04043455|537641669|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
149043585|NCT04043455|537641670|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
149043586|NCT04043455|537641671|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
149043587|NCT04043455|537641672|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
149043588|NCT04043455|537641673|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
149043589|NCT04043455|537641668|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
149043590|NCT04043455|537641669|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
149043591|NCT04043455|537641670|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
149043592|NCT04043455|537641671|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
149043593|NCT04043455|537641672|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
149043594|NCT04043455|537641673|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
149043595|NCT05568615|537641674|FG000|Overall Study|Death|1|||
149043596|NCT05568615|537641674|FG000|Overall Study|Physician Decision|1|||
149043597|NCT05194917|537641675|FG000|Overall Study|Lost to Follow-up|7|||
149043598|NCT05194917|537641676|FG001|Overall Study|Lost to Follow-up|5|||
149043599|NCT05194917|537641677|FG002|Overall Study|Lost to Follow-up|6|||
149043600|NCT05194917|537641678|FG003|Overall Study|Lost to Follow-up|5|||
149043601|NCT05505045|537641686|FG000|Overall Study|Withdrawal by Subject|2|||
149043602|NCT05505045|537641687|FG001|Overall Study|Withdrawal by Subject|1|||
149043603|NCT01998984|537641691|FG000|Overall Study|Adverse Event|0|||
149043604|NCT01998984|537641692|FG001|Overall Study|Adverse Event|0|||
149043605|NCT01998984|537641693|FG002|Overall Study|Adverse Event|0|||
149043606|NCT01998984|537641694|FG003|Overall Study|Adverse Event|1|||
149043607|NCT01998984|537641691|FG000|Overall Study|Lost to Follow-up|0|||
149043608|NCT01998984|537641692|FG001|Overall Study|Lost to Follow-up|1|||
149043609|NCT01998984|537641693|FG002|Overall Study|Lost to Follow-up|0|||
149043610|NCT01998984|537641694|FG003|Overall Study|Lost to Follow-up|1|||
149043611|NCT01998984|537641691|FG000|Overall Study|Withdrawal by Subject|0|||
149043612|NCT01998984|537641692|FG001|Overall Study|Withdrawal by Subject|0|||
149043613|NCT01998984|537641693|FG002|Overall Study|Withdrawal by Subject|1|||
149043614|NCT01998984|537641694|FG003|Overall Study|Withdrawal by Subject|0|||
149043615|NCT01998984|537641691|FG000|Overall Study|Other|0|||
149043616|NCT01998984|537641692|FG001|Overall Study|Other|0|||
149043617|NCT01998984|537641693|FG002|Overall Study|Other|0|||
149043618|NCT01998984|537641694|FG003|Overall Study|Other|1|||
149043619|NCT03025789|537641695|FG000|Overall Study|Lack of Efficacy|6|||
149043620|NCT03025789|537641696|FG001|Overall Study|Lack of Efficacy|1|||
149043621|NCT03025789|537641695|FG000|Overall Study|Death|1|||
148885297|NCT03386721|537056969|FG001|Overall Study|Lost to Follow-up|3|||
148885298|NCT03386721|537056970|FG002|Overall Study|Lost to Follow-up|0|||
148885299|NCT03386721|537056971|FG003|Overall Study|Lost to Follow-up|0|||
148885300|NCT03386721|537056972|FG004|Overall Study|Lost to Follow-up|0|||
148885301|NCT03386721|537056973|FG005|Overall Study|Lost to Follow-up|2|||
148885302|NCT03386721|537056974|FG006|Overall Study|Lost to Follow-up|1|||
148885303|NCT03386721|537056975|FG007|Overall Study|Lost to Follow-up|0|||
148885304|NCT03386721|537056976|FG008|Overall Study|Lost to Follow-up|1|||
148885305|NCT03386721|537056977|FG009|Overall Study|Lost to Follow-up|2|||
148885306|NCT03386721|537056978|FG010|Overall Study|Lost to Follow-up|1|||
148885307|NCT03386721|537056979|FG011|Overall Study|Lost to Follow-up|0|||
148885308|NCT03386721|537056980|FG012|Overall Study|Lost to Follow-up|0|||
148885309|NCT03386721|537056981|FG013|Overall Study|Lost to Follow-up|0|||
148885310|NCT03386721|537056982|FG014|Overall Study|Lost to Follow-up|0|||
149043622|NCT03025789|537641696|FG001|Overall Study|Death|0|||
149043623|NCT03025789|537641695|FG000|Overall Study|Withdrawal by Subject|0|||
149043624|NCT03025789|537641696|FG001|Overall Study|Withdrawal by Subject|2|||
149043625|NCT05057897|537641698|FG000|Overall Study|Site closure|2|||
148885311|NCT03386721|537056968|FG000|Overall Study|Reason not specified|3|||
149043626|NCT05057897|537641699|FG001|Overall Study|Site closure|2|||
149043627|NCT05057897|537641698|FG000|Overall Study|Death|1|||
149043628|NCT05057897|537641699|FG001|Overall Study|Death|0|||
148885312|NCT03386721|537056969|FG001|Overall Study|Reason not specified|0|||
148885313|NCT03386721|537056970|FG002|Overall Study|Reason not specified|0|||
149043629|NCT03346538|537641700|FG000|Overall Study|Physician Decision|0|||
149043630|NCT03346538|537641701|FG001|Overall Study|Physician Decision|1|||
149043631|NCT03346538|537641702|FG002|Overall Study|Physician Decision|0|||
149043632|NCT03346538|537641700|FG000|Overall Study|Withdrawal by Subject|3|||
149043633|NCT03346538|537641701|FG001|Overall Study|Withdrawal by Subject|2|||
149043634|NCT03346538|537641702|FG002|Overall Study|Withdrawal by Subject|0|||
149043635|NCT03346538|537641700|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
149043636|NCT03346538|537641701|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
149043637|NCT03346538|537641702|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
149043638|NCT05672667|537641703|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
149043639|NCT04524390|537641704|FG000|Double Blind|Consent Withdrawal by subject|2|||
149043640|NCT04524390|537641705|FG001|Double Blind|Consent Withdrawal by subject|1|||
149043641|NCT04524390|537641706|FG002|Double Blind|Consent Withdrawal by subject|0|||
149043642|NCT04524390|537641704|FG000|Double Blind|Adverse Event|5|||
149043643|NCT04524390|537641705|FG001|Double Blind|Adverse Event|3|||
149043644|NCT04524390|537641706|FG002|Double Blind|Adverse Event|0|||
149043645|NCT04524390|537641704|FG000|Double Blind|Liver Transplant|5|||
149043646|NCT04524390|537641705|FG001|Double Blind|Liver Transplant|6|||
149043647|NCT04524390|537641706|FG002|Double Blind|Liver Transplant|0|||
149043648|NCT04524390|537641704|FG000|Double Blind|Disease Progression|0|||
149043649|NCT04524390|537641705|FG001|Double Blind|Disease Progression|1|||
149043650|NCT04524390|537641706|FG002|Double Blind|Disease Progression|0|||
149043651|NCT04524390|537641704|FG000|Open-Label|Drug interruption criteria|0|||
149043652|NCT04524390|537641705|FG001|Open-Label|Drug interruption criteria|0|||
149043653|NCT04524390|537641706|FG002|Open-Label|Drug interruption criteria|1|||
149043654|NCT04524390|537641704|FG000|Open-Label|Liver Transplant|0|||
149043655|NCT04524390|537641705|FG001|Open-Label|Liver Transplant|0|||
149043656|NCT04524390|537641706|FG002|Open-Label|Liver Transplant|1|||
149043657|NCT04524390|537641704|FG000|Open-Label|Disease Progression|0|||
149043658|NCT04524390|537641705|FG001|Open-Label|Disease Progression|0|||
149043659|NCT04524390|537641706|FG002|Open-Label|Disease Progression|1|||
149043660|NCT04524390|537641704|FG000|Open-Label|Adverse Event|0|||
149043661|NCT04524390|537641705|FG001|Open-Label|Adverse Event|0|||
149043662|NCT04524390|537641706|FG002|Open-Label|Adverse Event|3|||
149043663|NCT04524390|537641704|FG000|Open-Label|Study Termination by sponsor|0|||
149043664|NCT04524390|537641705|FG001|Open-Label|Study Termination by sponsor|0|||
149043665|NCT04524390|537641706|FG002|Open-Label|Study Termination by sponsor|45|||
149043666|NCT01631214|537641707|FG000|Overall Study|Withdrawal by Subject|276|||
149043667|NCT01631214|537641708|FG001|Overall Study|Withdrawal by Subject|290|||
149043668|NCT01631214|537641707|FG000|Overall Study|Death|113|||
149043669|NCT01631214|537641708|FG001|Overall Study|Death|106|||
149043670|NCT01631214|537641707|FG000|Overall Study|Lost to Follow-up|54|||
149043671|NCT01631214|537641708|FG001|Overall Study|Lost to Follow-up|40|||
149043672|NCT01631214|537641707|FG000|Overall Study|Adverse Event|45|||
149043673|NCT01631214|537641708|FG001|Overall Study|Adverse Event|45|||
149043674|NCT01631214|537641707|FG000|Overall Study|Other|22|||
149043675|NCT01631214|537641708|FG001|Overall Study|Other|19|||
149043676|NCT01631214|537641707|FG000|Overall Study|Noncompliance|16|||
149043677|NCT01631214|537641708|FG001|Overall Study|Noncompliance|15|||
149043678|NCT01631214|537641707|FG000|Overall Study|Requirement for Alternative Therapy|8|||
149043679|NCT01631214|537641708|FG001|Overall Study|Requirement for Alternative Therapy|3|||
149043680|NCT01631214|537641707|FG000|Overall Study|Protocol Deviation|4|||
149043681|NCT01631214|537641708|FG001|Overall Study|Protocol Deviation|3|||
149043682|NCT01631214|537641707|FG000|Overall Study|Ineligibility determined|5|||
149043683|NCT01631214|537641708|FG001|Overall Study|Ineligibility determined|2|||
149043684|NCT01631214|537641707|FG000|Overall Study|Administrative Decision|1|||
149043685|NCT01631214|537641708|FG001|Overall Study|Administrative Decision|0|||
149043686|NCT05288283|537641709|FG000|Overall Study|Study Terminated Early|1|||
149043687|NCT05288283|537641710|FG001|Overall Study|Study Terminated Early|1|||
149043688|NCT03285763|537641711|FG000|Overall Study|Death|470|||
149043689|NCT03285763|537641711|FG000|Overall Study|Lost to Follow-up|18|||
149043690|NCT03285763|537641711|FG000|Overall Study|Physician Decision|2|||
149043691|NCT03285763|537641711|FG000|Overall Study|Study Terminated By Sponsor|79|||
149043692|NCT03285763|537641711|FG000|Overall Study|Withdrawal by Subject|33|||
149043693|NCT00332241|537641713|FG000|Overall Study|Lack of Efficacy|6|||
149043694|NCT00332241|537641714|FG001|Overall Study|Lack of Efficacy|1|||
149043695|NCT00332241|537641713|FG000|Overall Study|Adverse Event|3|||
149043696|NCT00332241|537641714|FG001|Overall Study|Adverse Event|5|||
149043697|NCT00332241|537641713|FG000|Overall Study|Withdrawal by Subject|2|||
148885314|NCT03386721|537056971|FG003|Overall Study|Reason not specified|0|||
148885315|NCT03386721|537056972|FG004|Overall Study|Reason not specified|0|||
149043698|NCT00332241|537641714|FG001|Overall Study|Withdrawal by Subject|1|||
149043699|NCT00332241|537641713|FG000|Overall Study|Lost to Follow-up|4|||
149043700|NCT00332241|537641714|FG001|Overall Study|Lost to Follow-up|1|||
149043701|NCT05137236|537641715|FG000|Part A|Other than Specified|1|||
149043702|NCT05137236|537641716|FG001|Part A|Other than Specified|0|||
149043703|NCT05137236|537641717|FG002|Part A|Other than Specified|0|||
149043704|NCT05137236|537641718|FG003|Part A|Other than Specified|0|||
149043705|NCT05137236|537641719|FG004|Part A|Other than Specified|0|||
149043706|NCT05137236|537641720|FG005|Part A|Other than Specified|0|||
149043707|NCT05137236|537641721|FG006|Part A|Other than Specified|0|||
149043708|NCT05137236|537641722|FG007|Part A|Other than Specified|0|||
149043709|NCT05137236|537641715|FG000|Part A|Withdrawal by Subject|0|||
149043710|NCT05137236|537641716|FG001|Part A|Withdrawal by Subject|4|||
149043711|NCT05137236|537641717|FG002|Part A|Withdrawal by Subject|1|||
149043712|NCT05137236|537641718|FG003|Part A|Withdrawal by Subject|1|||
149043713|NCT05137236|537641719|FG004|Part A|Withdrawal by Subject|3|||
149043714|NCT05137236|537641720|FG005|Part A|Withdrawal by Subject|2|||
149043715|NCT05137236|537641721|FG006|Part A|Withdrawal by Subject|0|||
149043716|NCT05137236|537641722|FG007|Part A|Withdrawal by Subject|0|||
149043717|NCT05137236|537641715|FG000|Part A|Lost to Follow-up|5|||
149043718|NCT05137236|537641716|FG001|Part A|Lost to Follow-up|7|||
149043719|NCT05137236|537641717|FG002|Part A|Lost to Follow-up|1|||
149043720|NCT05137236|537641718|FG003|Part A|Lost to Follow-up|3|||
149043721|NCT05137236|537641719|FG004|Part A|Lost to Follow-up|3|||
149043722|NCT05137236|537641720|FG005|Part A|Lost to Follow-up|8|||
149043723|NCT05137236|537641721|FG006|Part A|Lost to Follow-up|0|||
149043724|NCT05137236|537641722|FG007|Part A|Lost to Follow-up|0|||
149043725|NCT05137236|537641715|FG000|Part B|Withdrawal by Subject|0|||
149043726|NCT05137236|537641716|FG001|Part B|Withdrawal by Subject|0|||
149043727|NCT05137236|537641717|FG002|Part B|Withdrawal by Subject|0|||
149043728|NCT05137236|537641718|FG003|Part B|Withdrawal by Subject|0|||
149043729|NCT05137236|537641719|FG004|Part B|Withdrawal by Subject|0|||
149043730|NCT05137236|537641720|FG005|Part B|Withdrawal by Subject|0|||
149043731|NCT05137236|537641721|FG006|Part B|Withdrawal by Subject|0|||
149043732|NCT05137236|537641722|FG007|Part B|Withdrawal by Subject|2|||
149043733|NCT05137236|537641715|FG000|Part B|Lost to Follow-up|0|||
149043734|NCT05137236|537641716|FG001|Part B|Lost to Follow-up|0|||
149043735|NCT05137236|537641717|FG002|Part B|Lost to Follow-up|0|||
149043736|NCT05137236|537641718|FG003|Part B|Lost to Follow-up|0|||
149043737|NCT05137236|537641719|FG004|Part B|Lost to Follow-up|0|||
149043738|NCT05137236|537641720|FG005|Part B|Lost to Follow-up|0|||
149043739|NCT05137236|537641721|FG006|Part B|Lost to Follow-up|5|||
149043740|NCT05137236|537641722|FG007|Part B|Lost to Follow-up|5|||
149043741|NCT05137236|537641715|FG000|Part B|Death|0|||
149043742|NCT05137236|537641716|FG001|Part B|Death|0|||
149043743|NCT05137236|537641717|FG002|Part B|Death|0|||
149043744|NCT05137236|537641718|FG003|Part B|Death|0|||
149043745|NCT05137236|537641719|FG004|Part B|Death|0|||
149043746|NCT05137236|537641720|FG005|Part B|Death|0|||
149043747|NCT05137236|537641721|FG006|Part B|Death|0|||
149043748|NCT05137236|537641722|FG007|Part B|Death|2|||
149043749|NCT01534494|537641723|FG000|Overall Study|Withdrawal by Subject|1|||
149043750|NCT00802464|537641725|FG000|Month 0 - Month 8|Adverse Event|0|||
149043751|NCT00802464|537641726|FG001|Month 0 - Month 8|Adverse Event|1|||
149043752|NCT00802464|537641727|FG002|Month 0 - Month 8|Adverse Event|1|||
149043753|NCT00802464|537641728|FG003|Month 0 - Month 8|Adverse Event|2|||
149043754|NCT00802464|537641725|FG000|Month 0 - Month 8|Protocol Violation|0|||
149043755|NCT00802464|537641726|FG001|Month 0 - Month 8|Protocol Violation|0|||
149043756|NCT00802464|537641727|FG002|Month 0 - Month 8|Protocol Violation|1|||
149043757|NCT00802464|537641728|FG003|Month 0 - Month 8|Protocol Violation|0|||
149043758|NCT00802464|537641725|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
149043759|NCT00802464|537641726|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
149043760|NCT00802464|537641727|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
149043761|NCT00802464|537641728|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
149043762|NCT00802464|537641725|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
149043763|NCT00802464|537641726|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
149043764|NCT00802464|537641727|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
149043765|NCT00802464|537641728|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
149043766|NCT00802464|537641725|FG000|Month 0 - Month 8|Other|0|||
149043767|NCT00802464|537641726|FG001|Month 0 - Month 8|Other|0|||
149043768|NCT00802464|537641727|FG002|Month 0 - Month 8|Other|1|||
149043769|NCT00802464|537641728|FG003|Month 0 - Month 8|Other|0|||
149043770|NCT00802464|537641725|FG000|Month 8 - Month 14|Adverse Event|0|||
149043771|NCT00802464|537641726|FG001|Month 8 - Month 14|Adverse Event|1|||
149043772|NCT00802464|537641727|FG002|Month 8 - Month 14|Adverse Event|0|||
149043773|NCT00802464|537641728|FG003|Month 8 - Month 14|Adverse Event|0|||
149043774|NCT00802464|537641725|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
149043775|NCT00802464|537641726|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
149043776|NCT00802464|537641727|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
149043777|NCT00802464|537641728|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
149043778|NCT00802464|537641725|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
149043779|NCT00802464|537641726|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
149043780|NCT00802464|537641727|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
149043781|NCT00802464|537641728|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
149043782|NCT00431834|537641736|FG000|Overall Study|Withdrawal by Subject|7|||
149043783|NCT00431834|537641736|FG000|Overall Study|Death|3|||
149043784|NCT00431834|537641736|FG000|Overall Study|Missed Endpoint Visit|2|||
149043785|NCT00431834|537641736|FG000|Overall Study|Lost to Follow-up|1|||
149043786|NCT02622568|537641744|FG000|Overall Study|Lost to Follow-up|5|||
149043787|NCT02622568|537641745|FG001|Overall Study|Lost to Follow-up|5|||
149043788|NCT04512482|537641746|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
149043789|NCT04512482|537641747|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
149043790|NCT01939899|537641748|FG000|Lead-in Dose Finding Phase|Death|0|||
149043791|NCT01939899|537641749|FG001|Lead-in Dose Finding Phase|Death|3|||
149043792|NCT01939899|537641750|FG002|Lead-in Dose Finding Phase|Death|1|||
149043793|NCT01939899|537641751|FG003|Lead-in Dose Finding Phase|Death|0|||
149043794|NCT01939899|537641752|FG004|Lead-in Dose Finding Phase|Death|0|||
149043795|NCT01939899|537641748|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
149043796|NCT01939899|537641749|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
148885316|NCT03386721|537056973|FG005|Overall Study|Reason not specified|3|||
149043797|NCT01939899|537641750|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
149043798|NCT01939899|537641751|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
149043799|NCT01939899|537641752|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
149043800|NCT01939899|537641748|FG000|Lead-in Dose Finding Phase|Other|0|||
149043801|NCT01939899|537641749|FG001|Lead-in Dose Finding Phase|Other|0|||
149043802|NCT01939899|537641750|FG002|Lead-in Dose Finding Phase|Other|1|||
149043803|NCT01939899|537641751|FG003|Lead-in Dose Finding Phase|Other|0|||
149043804|NCT01939899|537641752|FG004|Lead-in Dose Finding Phase|Other|0|||
149043805|NCT01939899|537641748|FG000|Phase 2|Withdrawal by Subject|0|||
149043806|NCT01939899|537641749|FG001|Phase 2|Withdrawal by Subject|0|||
149043807|NCT01939899|537641750|FG002|Phase 2|Withdrawal by Subject|0|||
149043808|NCT01939899|537641751|FG003|Phase 2|Withdrawal by Subject|2|||
149043809|NCT01939899|537641752|FG004|Phase 2|Withdrawal by Subject|0|||
149043810|NCT01939899|537641748|FG000|Phase 2|Disease Progression|0|||
149043811|NCT01939899|537641749|FG001|Phase 2|Disease Progression|0|||
149043812|NCT01939899|537641750|FG002|Phase 2|Disease Progression|0|||
149043813|NCT01939899|537641751|FG003|Phase 2|Disease Progression|9|||
149043814|NCT01939899|537641752|FG004|Phase 2|Disease Progression|1|||
149043815|NCT02647905|537641755|FG000|Overall Study|Lost to Follow-up|1|||
149043816|NCT02647905|537641755|FG000|Overall Study|Withdrawal by Subject|2|||
149043817|NCT05119855|537641759|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
149043818|NCT05119855|537641760|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
149043819|NCT05119855|537641759|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
149043820|NCT05119855|537641760|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
149043821|NCT05119855|537641759|FG000|Overall Study|Lost to Follow-up|6|||
149043822|NCT05119855|537641760|FG001|Overall Study|Lost to Follow-up|8|||
149043823|NCT02932579|537641761|FG000|Overall Study|Withdrawal by Subject|4|||
149043824|NCT02932579|537641762|FG001|Overall Study|Withdrawal by Subject|1|||
149043825|NCT02549170|537641765|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
149043826|NCT02549170|537641766|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
149043827|NCT02549170|537641767|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
149043828|NCT02549170|537641768|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
149043829|NCT02549170|537641769|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
149043830|NCT02549170|537641765|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
149043831|NCT02549170|537641766|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
149043832|NCT02549170|537641767|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
149043833|NCT02549170|537641768|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
149043834|NCT02549170|537641769|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
149043835|NCT02549170|537641765|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
149043836|NCT02549170|537641766|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
149043837|NCT02549170|537641767|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
149043838|NCT02549170|537641768|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
149043839|NCT02549170|537641769|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
149043840|NCT00111813|537641770|FG000|Overall Study|Adverse Event|1|||
149043841|NCT00111813|537641771|FG001|Overall Study|Adverse Event|2|||
149043842|NCT00111813|537641772|FG002|Overall Study|Adverse Event|4|||
149043843|NCT00111813|537641773|FG003|Overall Study|Adverse Event|2|||
149043844|NCT00111813|537641774|FG004|Overall Study|Adverse Event|2|||
149043845|NCT00111813|537641775|FG005|Overall Study|Adverse Event|2|||
149043846|NCT00111813|537641770|FG000|Overall Study|Progressive disease|2|||
149043847|NCT00111813|537641771|FG001|Overall Study|Progressive disease|1|||
149043848|NCT00111813|537641772|FG002|Overall Study|Progressive disease|5|||
149043849|NCT00111813|537641773|FG003|Overall Study|Progressive disease|3|||
149043850|NCT00111813|537641774|FG004|Overall Study|Progressive disease|4|||
149043851|NCT00111813|537641775|FG005|Overall Study|Progressive disease|3|||
149043852|NCT00111813|537641770|FG000|Overall Study|Lack of Efficacy|0|||
149043853|NCT00111813|537641771|FG001|Overall Study|Lack of Efficacy|0|||
149043854|NCT00111813|537641772|FG002|Overall Study|Lack of Efficacy|0|||
149043855|NCT00111813|537641773|FG003|Overall Study|Lack of Efficacy|0|||
149043856|NCT00111813|537641774|FG004|Overall Study|Lack of Efficacy|0|||
149043857|NCT00111813|537641775|FG005|Overall Study|Lack of Efficacy|1|||
148885317|NCT03386721|537056974|FG006|Overall Study|Reason not specified|1|||
148885318|NCT03386721|537056975|FG007|Overall Study|Reason not specified|0|||
148885319|NCT03386721|537056976|FG008|Overall Study|Reason not specified|0|||
148885320|NCT03386721|537056977|FG009|Overall Study|Reason not specified|1|||
149043858|NCT00111813|537641770|FG000|Overall Study|Other|0|||
149043859|NCT00111813|537641771|FG001|Overall Study|Other|0|||
149043860|NCT00111813|537641772|FG002|Overall Study|Other|1|||
149043861|NCT00111813|537641773|FG003|Overall Study|Other|0|||
148885321|NCT03386721|537056978|FG010|Overall Study|Reason not specified|2|||
148885322|NCT03386721|537056979|FG011|Overall Study|Reason not specified|6|||
149043862|NCT00111813|537641774|FG004|Overall Study|Other|0|||
149043863|NCT00111813|537641775|FG005|Overall Study|Other|0|||
149043864|NCT03051165|537641777|FG000|Overall Study|Withdrawal by Subject|1|||
149043865|NCT03051165|537641777|FG000|Overall Study|Early termination of study|12|||
149043866|NCT00818246|537641778|FG000|Overall Study|Impossible to match pictures|5|||
149043867|NCT02121002|537641782|FG000|Overall Study|Physician Decision|2|||
149043868|NCT02121002|537641783|FG001|Overall Study|Physician Decision|0|||
149043869|NCT02121002|537641784|FG002|Overall Study|Physician Decision|0|||
149043870|NCT02121002|537641782|FG000|Overall Study|Withdrawal by Subject|3|||
149043871|NCT02121002|537641783|FG001|Overall Study|Withdrawal by Subject|1|||
149043872|NCT02121002|537641784|FG002|Overall Study|Withdrawal by Subject|4|||
149043873|NCT02121002|537641782|FG000|Overall Study|Protocol Violation|1|||
149043874|NCT02121002|537641783|FG001|Overall Study|Protocol Violation|2|||
149043875|NCT02121002|537641784|FG002|Overall Study|Protocol Violation|4|||
149043876|NCT02121002|537641782|FG000|Overall Study|Concomitant therapy|0|||
149043877|NCT02121002|537641783|FG001|Overall Study|Concomitant therapy|1|||
149043878|NCT02121002|537641784|FG002|Overall Study|Concomitant therapy|1|||
149043879|NCT02121002|537641782|FG000|Overall Study|Others|1|||
149043880|NCT02121002|537641783|FG001|Overall Study|Others|0|||
149043881|NCT02121002|537641784|FG002|Overall Study|Others|1|||
149043882|NCT01007396|537641785|FG000|Overall Study|Lost to Follow-up|47|||
149043883|NCT04788641|537641786|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
149043884|NCT04788641|537641787|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
149043885|NCT04788641|537641788|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
149043886|NCT04788641|537641789|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
149043887|NCT04788641|537641786|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
149043888|NCT04788641|537641787|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
149043889|NCT04788641|537641788|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
149043890|NCT04788641|537641789|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
149043891|NCT04788641|537641786|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
149043892|NCT04788641|537641787|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
149043893|NCT04788641|537641788|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
149043894|NCT04788641|537641789|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
149043895|NCT01250769|537641790|FG000|Overall Study|Withdrawal by Subject|0|||
149043896|NCT01250769|537641791|FG001|Overall Study|Withdrawal by Subject|1|||
149043897|NCT01250769|537641792|FG002|Overall Study|Withdrawal by Subject|1|||
149043898|NCT01250769|537641793|FG003|Overall Study|Withdrawal by Subject|0|||
149043899|NCT01250769|537641790|FG000|Overall Study|Adverse Event|0|||
149043900|NCT01250769|537641791|FG001|Overall Study|Adverse Event|0|||
149043901|NCT01250769|537641792|FG002|Overall Study|Adverse Event|1|||
149043902|NCT01250769|537641793|FG003|Overall Study|Adverse Event|0|||
149043903|NCT03283371|537641794|FG000|Placebo-controlled|Adverse Event|1|||
149043904|NCT03283371|537641795|FG001|Placebo-controlled|Adverse Event|1|||
149043905|NCT03283371|537641796|FG002|Placebo-controlled|Adverse Event|0|||
149043906|NCT03283371|537641797|FG003|Placebo-controlled|Adverse Event|0|||
149043907|NCT03283371|537641794|FG000|Placebo-controlled|Lack of Efficacy|1|||
149043908|NCT03283371|537641795|FG001|Placebo-controlled|Lack of Efficacy|0|||
149043909|NCT03283371|537641796|FG002|Placebo-controlled|Lack of Efficacy|0|||
149043910|NCT03283371|537641797|FG003|Placebo-controlled|Lack of Efficacy|0|||
149043911|NCT03283371|537641794|FG000|Placebo-controlled|Withdrawal by Subject|1|||
149043912|NCT03283371|537641795|FG001|Placebo-controlled|Withdrawal by Subject|1|||
149043913|NCT03283371|537641796|FG002|Placebo-controlled|Withdrawal by Subject|0|||
149043914|NCT03283371|537641797|FG003|Placebo-controlled|Withdrawal by Subject|0|||
149043915|NCT03283371|537641794|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
149043916|NCT03283371|537641795|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
149043917|NCT03283371|537641796|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
149043918|NCT03283371|537641797|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
149043919|NCT03283371|537641794|FG000|Open-label Phase|Adverse Event|0|||
149043920|NCT03283371|537641795|FG001|Open-label Phase|Adverse Event|0|||
149043921|NCT03283371|537641796|FG002|Open-label Phase|Adverse Event|2|||
149043922|NCT03283371|537641797|FG003|Open-label Phase|Adverse Event|0|||
149043923|NCT03283371|537641794|FG000|Open-label Phase|Withdrawal by Subject|0|||
149043924|NCT03283371|537641795|FG001|Open-label Phase|Withdrawal by Subject|0|||
149043925|NCT03283371|537641796|FG002|Open-label Phase|Withdrawal by Subject|1|||
149043926|NCT03283371|537641797|FG003|Open-label Phase|Withdrawal by Subject|0|||
149043927|NCT03283371|537641794|FG000|Open-label Phase|Other|0|||
149043928|NCT03283371|537641795|FG001|Open-label Phase|Other|0|||
149043929|NCT03283371|537641796|FG002|Open-label Phase|Other|1|||
149043930|NCT03283371|537641797|FG003|Open-label Phase|Other|1|||
149043931|NCT00914589|537641798|FG000|Overall Study|Adverse Event|1|||
149043932|NCT00914589|537641799|FG001|Overall Study|Adverse Event|0|||
149043933|NCT00914589|537641800|FG002|Overall Study|Adverse Event|1|||
149043934|NCT00914589|537641798|FG000|Overall Study|Protocol Violation|8|||
149043935|NCT00914589|537641799|FG001|Overall Study|Protocol Violation|6|||
149043936|NCT00914589|537641800|FG002|Overall Study|Protocol Violation|3|||
149043937|NCT00914589|537641798|FG000|Overall Study|unclassified|16|||
149043938|NCT00914589|537641799|FG001|Overall Study|unclassified|9|||
149043939|NCT00914589|537641800|FG002|Overall Study|unclassified|7|||
149043940|NCT00914589|537641798|FG000|Overall Study|Death|0|||
149043941|NCT00914589|537641799|FG001|Overall Study|Death|1|||
149043942|NCT00914589|537641800|FG002|Overall Study|Death|1|||
149043943|NCT03783026|537643088|FG000|Treatment Phase|Adverse Event|15|||
149043944|NCT03783026|537643088|FG000|Treatment Phase|Lack of Efficacy|11|||
149043945|NCT03783026|537643088|FG000|Treatment Phase|Withdrawal by Subject|6|||
149043946|NCT03783026|537643088|FG000|Treatment Phase|Lost to Follow-up|2|||
149043947|NCT03783026|537643088|FG000|Treatment Phase|Protocol Deviation|8|||
149043948|NCT03783026|537643088|FG000|Treatment Phase|Did Not Receive Treatment|1|||
149043949|NCT03783026|537643088|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
149043950|NCT04814186|537643089|FG000|Treatment Phase|Adverse Event|1|||
149043951|NCT04814186|537643089|FG000|Treatment Phase|Death|6|||
149043952|NCT04814186|537643089|FG000|Treatment Phase|Withdrawal by Subject|2|||
149043953|NCT04814186|537643089|FG000|Treatment Phase|Other|1|||
149043954|NCT04814186|537643089|FG000|Follow-Up Phase|Adverse Event|1|||
149043955|NCT04814186|537643089|FG000|Follow-Up Phase|Death|6|||
149043956|NCT04814186|537643089|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
149043957|NCT04814186|537643089|FG000|Follow-Up Phase|Other|1|||
149043958|NCT01853748|537643093|FG000|Allocation|Withdrawal by Subject|1|||
149043959|NCT01853748|537643094|FG001|Allocation|Withdrawal by Subject|13|||
149043960|NCT01853748|537643093|FG000|Allocation|not sufficient to receive intervention|0|||
149043961|NCT01853748|537643094|FG001|Allocation|not sufficient to receive intervention|1|||
149043962|NCT01853748|537643093|FG000|Follow-Up|Withdrawal by Subject|7|||
149043963|NCT01853748|537643094|FG001|Follow-Up|Withdrawal by Subject|6|||
149043964|NCT01853748|537643093|FG000|Follow-Up|Adverse Event|67|||
149043965|NCT01853748|537643094|FG001|Follow-Up|Adverse Event|7|||
149043966|NCT01853748|537643093|FG000|Follow-Up|not available for data collection|16|||
149043967|NCT01853748|537643094|FG001|Follow-Up|not available for data collection|4|||
149043968|NCT01643070|537643099|FG000|Overall Study|Withdrawal by Subject|3|||
149043969|NCT01643070|537643100|FG001|Overall Study|Withdrawal by Subject|1|||
149043970|NCT01643070|537643099|FG000|Overall Study|Death|1|||
149043971|NCT01643070|537643100|FG001|Overall Study|Death|0|||
149043972|NCT01643070|537643099|FG000|Overall Study|Pregressive disease|0|||
149043973|NCT01643070|537643100|FG001|Overall Study|Pregressive disease|2|||
149043974|NCT04941287|537643101|FG000|Overall Study|Rapid decline before starting treatment|3|||
149043975|NCT04941287|537643102|FG001|Overall Study|Rapid decline before starting treatment|1|||
149043976|NCT03088813|537643105|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
149043977|NCT03088813|537643106|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
149043978|NCT03088813|537643107|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
149043979|NCT03088813|537643108|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
149043980|NCT03088813|537643105|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
149043981|NCT03088813|537643106|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
149043982|NCT03088813|537643107|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
149043983|NCT03088813|537643108|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
149043984|NCT03088813|537643105|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
149043985|NCT03088813|537643106|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
149043986|NCT03088813|537643107|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
149043987|NCT03088813|537643108|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
149043988|NCT03088813|537643105|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
149043989|NCT03088813|537643106|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
149043990|NCT03088813|537643107|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
149043991|NCT03088813|537643108|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
149043992|NCT03088813|537643105|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
149043993|NCT03088813|537643106|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
149043994|NCT03088813|537643107|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
149043995|NCT03088813|537643108|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
149043996|NCT03088813|537643105|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
148885323|NCT03386721|537056980|FG012|Overall Study|Reason not specified|1|||
148885324|NCT03386721|537056981|FG013|Overall Study|Reason not specified|0|||
148885325|NCT03386721|537056982|FG014|Overall Study|Reason not specified|0|||
148885326|NCT03386721|537056968|FG000|Overall Study|Progressive Disease|0|||
148885327|NCT03386721|537056969|FG001|Overall Study|Progressive Disease|0|||
149043997|NCT03088813|537643106|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
149043998|NCT03088813|537643107|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
149043999|NCT03088813|537643108|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
149044000|NCT03088813|537643105|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
149044001|NCT03088813|537643106|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
149044002|NCT03088813|537643107|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
148885328|NCT03386721|537056970|FG002|Overall Study|Progressive Disease|1|||
148885329|NCT03386721|537056971|FG003|Overall Study|Progressive Disease|0|||
149044003|NCT03088813|537643108|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
149044004|NCT01903811|537643117|FG000|Overall Study|No measurable disease|1|||
149044005|NCT01903811|537643118|FG001|Overall Study|No measurable disease|1|||
149044006|NCT01903811|537643117|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
149044007|NCT01903811|537643118|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
149044008|NCT01903811|537643117|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
149044009|NCT01903811|537643118|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
149044010|NCT01903811|537643117|FG000|Overall Study|Withdrawal by Subject|0|||
149044011|NCT01903811|537643118|FG001|Overall Study|Withdrawal by Subject|1|||
149044012|NCT04540913|537643119|FG000|Overall Study|Withdrawal by Subject|14|||
149044013|NCT04540913|537643120|FG001|Overall Study|Withdrawal by Subject|3|||
149044014|NCT04440176|537643121|FG000|Overall Study|Withdrawal by Subject|5|||
149044015|NCT04440176|537643122|FG001|Overall Study|Withdrawal by Subject|3|||
149044016|NCT04440176|537643121|FG000|Overall Study|Withdrawal by parent/guardian|4|||
149044017|NCT04440176|537643122|FG001|Overall Study|Withdrawal by parent/guardian|5|||
149044018|NCT04440176|537643121|FG000|Overall Study|Adverse Event|2|||
149044019|NCT04440176|537643122|FG001|Overall Study|Adverse Event|6|||
149044020|NCT04440176|537643121|FG000|Overall Study|Lost to Follow-up|22|||
149044021|NCT04440176|537643122|FG001|Overall Study|Lost to Follow-up|23|||
149044022|NCT04440176|537643121|FG000|Overall Study|Medication error without associated adverse event|0|||
149044023|NCT04440176|537643122|FG001|Overall Study|Medication error without associated adverse event|1|||
149044024|NCT04440176|537643121|FG000|Overall Study|No longer met eligibility criteria|7|||
149044025|NCT04440176|537643122|FG001|Overall Study|No longer met eligibility criteria|1|||
149044026|NCT04440176|537643121|FG000|Overall Study|Other|1|||
149044027|NCT04440176|537643122|FG001|Overall Study|Other|2|||
149044028|NCT04440176|537643121|FG000|Overall Study|Protocol deviation|6|||
149044029|NCT04440176|537643122|FG001|Overall Study|Protocol deviation|8|||
149044030|NCT04440176|537643121|FG000|Overall Study|Randomized but not vaccinated|6|||
149044031|NCT04440176|537643122|FG001|Overall Study|Randomized but not vaccinated|3|||
149044032|NCT04153565|537643123|FG000|Overall Study|Death|13|||
149044033|NCT02991807|537643124|FG000|Overall Study|Withdrawal by Subject|2|||
149044034|NCT02991807|537643125|FG001|Overall Study|Withdrawal by Subject|1|||
149044035|NCT02991807|537643124|FG000|Overall Study|Physician Decision|0|||
149044036|NCT02991807|537643125|FG001|Overall Study|Physician Decision|1|||
149044037|NCT02991807|537643124|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
149044038|NCT02991807|537643125|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
149044039|NCT02300298|537643126|FG000|Disposition for Nintedanib|Progressive disease|10|||
149044040|NCT02300298|537643127|FG001|Disposition for Nintedanib|Progressive disease|0|||
149044041|NCT02300298|537643126|FG000|Disposition for Docetaxel|Progressive disease|0|||
149044042|NCT02300298|537643127|FG001|Disposition for Docetaxel|Progressive disease|6|||
149044043|NCT02300298|537643126|FG000|Disposition for Docetaxel|other adverse event|0|||
149044044|NCT02300298|537643127|FG001|Disposition for Docetaxel|other adverse event|4|||
149044045|NCT00402246|537643128|FG000|Overall Study|Death|62|||
149044046|NCT00402246|537643129|FG001|Overall Study|Death|58|||
149044047|NCT00402246|537643128|FG000|Overall Study|Lost to Follow-up|20|||
149044048|NCT00402246|537643129|FG001|Overall Study|Lost to Follow-up|28|||
149044049|NCT00402246|537643128|FG000|Overall Study|Withdrawal by Subject|72|||
149044050|NCT00402246|537643129|FG001|Overall Study|Withdrawal by Subject|87|||
149044051|NCT00402246|537643128|FG000|Overall Study|Physician Decision|24|||
149044052|NCT00402246|537643129|FG001|Overall Study|Physician Decision|26|||
149044053|NCT00402246|537643128|FG000|Overall Study|Protocol Violation|25|||
149044054|NCT00402246|537643129|FG001|Overall Study|Protocol Violation|24|||
149044055|NCT00402246|537643128|FG000|Overall Study|Missed Final Visit|1|||
149044056|NCT00402246|537643129|FG001|Overall Study|Missed Final Visit|2|||
149044057|NCT00402246|537643128|FG000|Overall Study|Insurance Issues|2|||
149044058|NCT00402246|537643129|FG001|Overall Study|Insurance Issues|1|||
149044059|NCT00402246|537643128|FG000|Overall Study|Heart Transplant|0|||
149044060|NCT00402246|537643129|FG001|Overall Study|Heart Transplant|1|||
149044061|NCT00402246|537643128|FG000|Overall Study|Patient's device explanted|6|||
149044062|NCT00402246|537643129|FG001|Overall Study|Patient's device explanted|2|||
149044063|NCT00402246|537643128|FG000|Overall Study|Center Closure|5|||
149044064|NCT00402246|537643129|FG001|Overall Study|Center Closure|3|||
149044065|NCT00402246|537643128|FG000|Overall Study|Deterioriating Condition|3|||
149044066|NCT00402246|537643129|FG001|Overall Study|Deterioriating Condition|2|||
149044067|NCT01808339|537643130|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044068|NCT01808339|537643131|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044069|NCT01808339|537643132|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044070|NCT01808339|537643133|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
149044071|NCT01808339|537643134|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
149044072|NCT01808339|537643135|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
149044073|NCT01808339|537643130|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
148885330|NCT03386721|537056972|FG004|Overall Study|Progressive Disease|0|||
149044074|NCT01808339|537643131|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149044075|NCT01808339|537643132|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149044076|NCT01808339|537643133|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
149044077|NCT01808339|537643134|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149044078|NCT01808339|537643135|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
149044079|NCT01808339|537643130|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044080|NCT01808339|537643131|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044081|NCT01808339|537643132|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
149044082|NCT01808339|537643133|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044083|NCT01808339|537643134|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044084|NCT01808339|537643135|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
149044085|NCT00409838|537643138|FG000|Short-term Period|Adverse Event|0|||
149044086|NCT00409838|537643139|FG001|Short-term Period|Adverse Event|1|||
149044087|NCT00409838|537643138|FG000|Short-term Period|Lost to Follow-up|0|||
149044088|NCT00409838|537643139|FG001|Short-term Period|Lost to Follow-up|1|||
149044089|NCT00409838|537643138|FG000|Short-term Period|Withdrawal by Subject|2|||
149044090|NCT00409838|537643139|FG001|Short-term Period|Withdrawal by Subject|3|||
149044091|NCT00409838|537643138|FG000|Short-term Period|Never Treated|1|||
149044092|NCT00409838|537643139|FG001|Short-term Period|Never Treated|0|||
149044093|NCT00409838|537643138|FG000|Long-term Extension Period|Adverse Event|10|||
149044094|NCT00409838|537643139|FG001|Long-term Extension Period|Adverse Event|0|||
149044095|NCT00409838|537643138|FG000|Long-term Extension Period|Death|1|||
149044096|NCT00409838|537643139|FG001|Long-term Extension Period|Death|0|||
149044097|NCT00409838|537643138|FG000|Long-term Extension Period|Lack of Efficacy|2|||
149044098|NCT00409838|537643139|FG001|Long-term Extension Period|Lack of Efficacy|0|||
149044099|NCT00409838|537643138|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
149044100|NCT00409838|537643139|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
149044101|NCT00409838|537643138|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
149044102|NCT00409838|537643139|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
149044103|NCT00409838|537643138|FG000|Long-term Extension Period|Pregnancy|1|||
149044104|NCT00409838|537643139|FG001|Long-term Extension Period|Pregnancy|0|||
149044105|NCT00243503|537643140|FG000|Overall Study|Adverse Event|11|||
149044106|NCT00243503|537643140|FG000|Overall Study|Withdrawal by Subject|1|||
149044107|NCT00243503|537643140|FG000|Overall Study|Lack of Efficacy|44|||
149044108|NCT00243503|537643140|FG000|Overall Study|Death|1|||
149044109|NCT00243503|537643140|FG000|Overall Study|Other|1|||
149044110|NCT00093015|537643145|FG000|Overall Study|Withdrawal by Subject|194|||
149044111|NCT00093015|537643146|FG001|Overall Study|Withdrawal by Subject|171|||
149044112|NCT00093015|537643145|FG000|Overall Study|Lost to Follow-up|96|||
149044113|NCT00093015|537643146|FG001|Overall Study|Lost to Follow-up|108|||
149044114|NCT00093015|537643145|FG000|Overall Study|Death|375|||
149044115|NCT00093015|537643146|FG001|Overall Study|Death|385|||
149044116|NCT00520546|537643149|FG000|Overall Study|Withdrawal by Subject|1|||
149044117|NCT00520546|537643149|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
149044118|NCT03076515|537643150|FG000|Overall Study|DMC decision based on interim analysis|25|||
149044119|NCT03076515|537643151|FG001|Overall Study|DMC decision based on interim analysis|29|||
149044120|NCT03988023|537643155|FG000|Overall Study|Non-compliance|3|||
149044121|NCT03988023|537643156|FG001|Overall Study|Non-compliance|0|||
149044122|NCT03988023|537643155|FG000|Overall Study|Withdrawal by Subject|39|||
149044123|NCT03988023|537643156|FG001|Overall Study|Withdrawal by Subject|37|||
149044124|NCT03988023|537643155|FG000|Overall Study|Adverse Event|0|||
149044125|NCT03988023|537643156|FG001|Overall Study|Adverse Event|2|||
149044126|NCT03988023|537643155|FG000|Overall Study|Physician Decision|0|||
149044127|NCT03988023|537643156|FG001|Overall Study|Physician Decision|1|||
149044128|NCT03988023|537643155|FG000|Overall Study|Lost to Follow-up|5|||
149044129|NCT03988023|537643156|FG001|Overall Study|Lost to Follow-up|8|||
149044130|NCT03988023|537643155|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
149044131|NCT03988023|537643156|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
149044132|NCT03988023|537643155|FG000|Overall Study|Lack of Efficacy|3|||
149044133|NCT03988023|537643156|FG001|Overall Study|Lack of Efficacy|1|||
149044134|NCT03988023|537643155|FG000|Overall Study|COVID-19 pandemic|225|||
149044135|NCT03988023|537643156|FG001|Overall Study|COVID-19 pandemic|227|||
149044136|NCT02101281|537643157|FG000|Overall Study|Adverse Event|0|||
149044137|NCT02101281|537643158|FG001|Overall Study|Adverse Event|1|||
149044138|NCT00174382|537643159|FG000|Overall Study|Death|2|||
149044139|NCT00174382|537643159|FG000|Overall Study|Adverse Event|19|||
149044140|NCT00174382|537643159|FG000|Overall Study|Withdrawal by Subject|6|||
149044141|NCT00174382|537643159|FG000|Overall Study|Protocol Violation|3|||
149044142|NCT00174382|537643159|FG000|Overall Study|Arrived early for last visit in error|1|||
149044143|NCT00174382|537643159|FG000|Overall Study|Subject felt pill not effective enough|1|||
149044144|NCT00174382|537643159|FG000|Overall Study|Lost to Follow-up|1|||
148885331|NCT03386721|537056973|FG005|Overall Study|Progressive Disease|1|||
149044145|NCT00296036|537643160|FG000|Overall Study|Withdrawal by Subject|1|||
149044146|NCT00296036|537643161|FG001|Overall Study|Withdrawal by Subject|0|||
149044147|NCT00296036|537643162|FG002|Overall Study|Withdrawal by Subject|2|||
149044148|NCT00296036|537643163|FG003|Overall Study|Withdrawal by Subject|1|||
149044149|NCT00296036|537643164|FG004|Overall Study|Withdrawal by Subject|2|||
149044150|NCT00296036|537643165|FG005|Overall Study|Withdrawal by Subject|1|||
149044151|NCT00296036|537643160|FG000|Overall Study|Protocol Violation|0|||
149044152|NCT00296036|537643161|FG001|Overall Study|Protocol Violation|0|||
149044153|NCT00296036|537643162|FG002|Overall Study|Protocol Violation|0|||
149044154|NCT00296036|537643163|FG003|Overall Study|Protocol Violation|0|||
149044155|NCT00296036|537643164|FG004|Overall Study|Protocol Violation|0|||
149044156|NCT00296036|537643165|FG005|Overall Study|Protocol Violation|3|||
149044157|NCT03403413|537643167|FG000|Overall Study|Lack of Efficacy|2|||
149044158|NCT00529100|537643170|FG000|Overall Study|Adverse Event|0|||
149044159|NCT00529100|537643171|FG001|Overall Study|Adverse Event|5|||
149044160|NCT00529100|537643170|FG000|Overall Study|Protocol Violation|0|||
149044161|NCT00529100|537643171|FG001|Overall Study|Protocol Violation|1|||
149044162|NCT00529100|537643170|FG000|Overall Study|Progressive Disease|0|||
149044163|NCT00529100|537643171|FG001|Overall Study|Progressive Disease|1|||
149044164|NCT00529100|537643170|FG000|Overall Study|Withdrawal by Subject|0|||
149044165|NCT00529100|537643171|FG001|Overall Study|Withdrawal by Subject|1|||
149044166|NCT00529100|537643170|FG000|Overall Study|Participant Ineligibility|0|||
149044167|NCT00529100|537643171|FG001|Overall Study|Participant Ineligibility|1|||
149044168|NCT03733119|537643172|FG000|Overall Study|Physician Decision|2|||
149044169|NCT03733119|537643173|FG001|Overall Study|Physician Decision|1|||
149044170|NCT03733119|537643172|FG000|Overall Study|ineligible to treat per protocol|0|||
149044171|NCT03733119|537643173|FG001|Overall Study|ineligible to treat per protocol|1|||
149044172|NCT03951805|537643175|FG000|Overall Study|Adverse Event|1|||
149044173|NCT03951805|537643176|FG001|Overall Study|Adverse Event|0|||
149044174|NCT03951805|537643177|FG002|Overall Study|Adverse Event|0|||
149044175|NCT03951805|537643178|FG003|Overall Study|Adverse Event|0|||
149044176|NCT03684044|537643179|FG000|Overall Study|Adverse Event|3|||
149044177|NCT03684044|537643180|FG001|Overall Study|Adverse Event|0|||
149044178|NCT03684044|537643179|FG000|Overall Study|Death|4|||
149044179|NCT03684044|537643180|FG001|Overall Study|Death|7|||
149044180|NCT03684044|537643179|FG000|Overall Study|Lost to Follow-up|3|||
149044181|NCT03684044|537643180|FG001|Overall Study|Lost to Follow-up|2|||
149044182|NCT03684044|537643179|FG000|Overall Study|Patient Not Available|0|||
149044183|NCT03684044|537643180|FG001|Overall Study|Patient Not Available|2|||
149044184|NCT03684044|537643179|FG000|Overall Study|Physician Decision|1|||
149044185|NCT03684044|537643180|FG001|Overall Study|Physician Decision|0|||
149044186|NCT03684044|537643179|FG000|Overall Study|Withdrawal by Subject|11|||
149044187|NCT03684044|537643180|FG001|Overall Study|Withdrawal by Subject|9|||
149044188|NCT03703336|537643181|FG000|Overall Study|Parent withdrew consent|29|||
149044189|NCT03703336|537643182|FG001|Overall Study|Parent withdrew consent|8|||
149044190|NCT03703336|537643181|FG000|Overall Study|Migration|3|||
149044191|NCT03703336|537643182|FG001|Overall Study|Migration|3|||
149044192|NCT03703336|537643181|FG000|Overall Study|Protocol Violation|3|||
149044193|NCT03703336|537643182|FG001|Overall Study|Protocol Violation|1|||
149044194|NCT03703336|537643181|FG000|Overall Study|Physician Decision|2|||
149044195|NCT03703336|537643182|FG001|Overall Study|Physician Decision|0|||
149044196|NCT03703336|537643181|FG000|Overall Study|Adverse Event|0|||
149044197|NCT03703336|537643182|FG001|Overall Study|Adverse Event|2|||
149044198|NCT03703336|537643181|FG000|Overall Study|Lost to Follow-up|1|||
149044199|NCT03703336|537643182|FG001|Overall Study|Lost to Follow-up|0|||
149044200|NCT00595413|537643183|FG000|Overall Study|Adverse Event|0|||
149044201|NCT00595413|537643184|FG001|Overall Study|Adverse Event|2|||
149044202|NCT00595413|537643185|FG002|Overall Study|Adverse Event|1|||
149044203|NCT00595413|537643186|FG003|Overall Study|Adverse Event|1|||
149044204|NCT00595413|537643183|FG000|Overall Study|Lost to Follow-up|2|||
149044205|NCT00595413|537643184|FG001|Overall Study|Lost to Follow-up|2|||
149044206|NCT00595413|537643185|FG002|Overall Study|Lost to Follow-up|1|||
149044207|NCT00595413|537643186|FG003|Overall Study|Lost to Follow-up|3|||
149044208|NCT00595413|537643183|FG000|Overall Study|Death|0|||
149044209|NCT00595413|537643184|FG001|Overall Study|Death|0|||
149044210|NCT00595413|537643185|FG002|Overall Study|Death|1|||
149044211|NCT00595413|537643186|FG003|Overall Study|Death|0|||
149044212|NCT00595413|537643183|FG000|Overall Study|Other|5|||
149044213|NCT00595413|537643184|FG001|Overall Study|Other|1|||
149044214|NCT00595413|537643185|FG002|Overall Study|Other|5|||
149044215|NCT00595413|537643186|FG003|Overall Study|Other|0|||
149044216|NCT00807937|537643187|FG000|Overall Study|Adverse Event|12|||
148885332|NCT03386721|537056974|FG006|Overall Study|Progressive Disease|0|||
149044217|NCT00807937|537643188|FG001|Overall Study|Adverse Event|12|||
148885333|NCT03386721|537056975|FG007|Overall Study|Progressive Disease|0|||
149044218|NCT00807937|537643189|FG002|Overall Study|Adverse Event|5|||
149044219|NCT00807937|537643190|FG003|Overall Study|Adverse Event|4|||
149044220|NCT00807937|537643187|FG000|Overall Study|Protocol Violation|4|||
149044221|NCT00807937|537643188|FG001|Overall Study|Protocol Violation|5|||
149044222|NCT00807937|537643189|FG002|Overall Study|Protocol Violation|3|||
149044223|NCT00807937|537643190|FG003|Overall Study|Protocol Violation|3|||
149044224|NCT00807937|537643187|FG000|Overall Study|Withdrawal by Subject|5|||
149044225|NCT00807937|537643188|FG001|Overall Study|Withdrawal by Subject|4|||
149044226|NCT00807937|537643189|FG002|Overall Study|Withdrawal by Subject|1|||
149044227|NCT00807937|537643190|FG003|Overall Study|Withdrawal by Subject|4|||
149044228|NCT00807937|537643187|FG000|Overall Study|Lost to Follow-up|4|||
149044229|NCT00807937|537643188|FG001|Overall Study|Lost to Follow-up|0|||
149044230|NCT00807937|537643189|FG002|Overall Study|Lost to Follow-up|2|||
149044231|NCT00807937|537643190|FG003|Overall Study|Lost to Follow-up|1|||
149044232|NCT00807937|537643187|FG000|Overall Study|Lack of Efficacy|0|||
149044233|NCT00807937|537643188|FG001|Overall Study|Lack of Efficacy|0|||
149044234|NCT00807937|537643189|FG002|Overall Study|Lack of Efficacy|1|||
149044235|NCT00807937|537643190|FG003|Overall Study|Lack of Efficacy|2|||
149044236|NCT00807937|537643187|FG000|Overall Study|Intake of prohibited medicine|0|||
149044237|NCT00807937|537643188|FG001|Overall Study|Intake of prohibited medicine|0|||
149044238|NCT00807937|537643189|FG002|Overall Study|Intake of prohibited medicine|2|||
149044239|NCT00807937|537643190|FG003|Overall Study|Intake of prohibited medicine|0|||
149044240|NCT00807937|537643187|FG000|Overall Study|All other reasons (not provided)|2|||
149044241|NCT00807937|537643188|FG001|Overall Study|All other reasons (not provided)|4|||
149044242|NCT00807937|537643189|FG002|Overall Study|All other reasons (not provided)|0|||
149044243|NCT00807937|537643190|FG003|Overall Study|All other reasons (not provided)|1|||
149044244|NCT04629950|537643193|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
149044245|NCT04629950|537643194|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
149044246|NCT04629950|537643195|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
149044247|NCT04629950|537643196|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
149044248|NCT04629950|537643193|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
149044249|NCT04629950|537643194|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
149044250|NCT04629950|537643195|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
149044251|NCT04629950|537643196|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
149044252|NCT04629950|537643193|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
149044253|NCT04629950|537643194|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
149044254|NCT04629950|537643195|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
149044255|NCT04629950|537643196|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
149044256|NCT04629950|537643193|FG000|Extension Study|Withdrawal by Subject|0|||
149044257|NCT04629950|537643194|FG001|Extension Study|Withdrawal by Subject|0|||
149044258|NCT04629950|537643195|FG002|Extension Study|Withdrawal by Subject|1|||
149044259|NCT04629950|537643196|FG003|Extension Study|Withdrawal by Subject|0|||
149044260|NCT04629950|537643193|FG000|Extension Study|Adverse Event|0|||
149044261|NCT04629950|537643194|FG001|Extension Study|Adverse Event|0|||
149044262|NCT04629950|537643195|FG002|Extension Study|Adverse Event|0|||
149044263|NCT04629950|537643196|FG003|Extension Study|Adverse Event|1|||
149044264|NCT03233633|537643197|FG000|Overall Study|Adverse Event|2|||
149044265|NCT03233633|537643197|FG000|Overall Study|Less Than 3 Days of Data|6|||
149044266|NCT02088853|537643198|FG000|Overall Study|Pregnancy|1|||
149044267|NCT02088853|537643199|FG001|Overall Study|Pregnancy|0|||
149044268|NCT01198145|537643202|FG000|Overall Study|Withdrawal by Subject|1|||
149044269|NCT01198145|537643203|FG001|Overall Study|Withdrawal by Subject|1|||
149044270|NCT00603954|537643204|FG000|Overall Study|Protocol Violation|1|||
149044271|NCT00603954|537643205|FG001|Overall Study|Protocol Violation|2|||
149044272|NCT03830866|537643206|FG000|Overall Study|Death|90|||
149044273|NCT03830866|537643207|FG001|Overall Study|Death|111|||
149044274|NCT03830866|537643206|FG000|Overall Study|Lost to Follow-up|7|||
149044275|NCT03830866|537643207|FG001|Overall Study|Lost to Follow-up|7|||
149044276|NCT03830866|537643206|FG000|Overall Study|Withdrawal by Subject|19|||
149044277|NCT03830866|537643207|FG001|Overall Study|Withdrawal by Subject|16|||
149044278|NCT03830866|537643206|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
149044279|NCT03830866|537643207|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
149044280|NCT03830866|537643206|FG000|Overall Study|Other|1|||
149044281|NCT03830866|537643207|FG001|Overall Study|Other|1|||
149044282|NCT02708108|537643208|FG000|Overall Study|Death|1|||
149044283|NCT02708108|537643209|FG001|Overall Study|Death|2|||
148885334|NCT03386721|537056976|FG008|Overall Study|Progressive Disease|2|||
148885335|NCT03386721|537056977|FG009|Overall Study|Progressive Disease|1|||
148885336|NCT03386721|537056978|FG010|Overall Study|Progressive Disease|1|||
148885337|NCT03386721|537056979|FG011|Overall Study|Progressive Disease|0|||
148885338|NCT03386721|537056980|FG012|Overall Study|Progressive Disease|1|||
148885339|NCT03386721|537056981|FG013|Overall Study|Progressive Disease|0|||
149044284|NCT02708108|537643208|FG000|Overall Study|Regimen change|1|||
148885340|NCT03386721|537056982|FG014|Overall Study|Progressive Disease|0|||
148885341|NCT03386721|537056968|FG000|Overall Study|Site Terminated by Sponsor|5|||
148885342|NCT03386721|537056969|FG001|Overall Study|Site Terminated by Sponsor|5|||
148885343|NCT03386721|537056970|FG002|Overall Study|Site Terminated by Sponsor|0|||
149044285|NCT02708108|537643209|FG001|Overall Study|Regimen change|0|||
149044286|NCT02708108|537643208|FG000|Overall Study|No MRD and no imaging available|0|||
149044287|NCT02708108|537643209|FG001|Overall Study|No MRD and no imaging available|1|||
149044288|NCT00510887|537643211|FG000|Overall Study|Lost to Follow-up|1|||
149044289|NCT02568683|537643212|FG000|Overall Study|Death|0|||
149044290|NCT02568683|537643213|FG001|Overall Study|Death|2|||
149044291|NCT02568683|537643212|FG000|Overall Study|Withdrew Consent|1|||
149044292|NCT02568683|537643213|FG001|Overall Study|Withdrew Consent|0|||
149044293|NCT02568683|537643212|FG000|Overall Study|Study Terminated By Sponsor|5|||
149044294|NCT02568683|537643213|FG001|Overall Study|Study Terminated By Sponsor|2|||
149044295|NCT01248936|537643229|FG000|Overall Study|Sponsor Decision|259|||
149044296|NCT01248936|537643229|FG000|Overall Study|Progression of Disease|50|||
149044297|NCT01248936|537643229|FG000|Overall Study|Death|26|||
149044298|NCT01248936|537643229|FG000|Overall Study|Withdrawal of Consent|20|||
149044299|NCT01248936|537643229|FG000|Overall Study|Adverse Event|8|||
149044300|NCT01248936|537643229|FG000|Overall Study|Lost to Follow-up|7|||
149044301|NCT01248936|537643229|FG000|Overall Study|Refused Treatment|1|||
149044302|NCT01248936|537643229|FG000|Overall Study|Other reason|3|||
149044303|NCT03485950|537643230|FG000|Overall Study|Adverse Event|1|||
149044304|NCT03485950|537643231|FG001|Overall Study|Adverse Event|0|||
149044305|NCT03485950|537643230|FG000|Overall Study|Death|3|||
149044306|NCT03485950|537643231|FG001|Overall Study|Death|2|||
149044307|NCT03485950|537643230|FG000|Overall Study|Withdrawal by Subject|3|||
149044308|NCT03485950|537643231|FG001|Overall Study|Withdrawal by Subject|0|||
149044309|NCT02980276|537645439|FG000|Overall Study|Withdrawal by Subject|4|||
149044310|NCT02980276|537645440|FG001|Overall Study|Withdrawal by Subject|4|||
149044311|NCT02980276|537645439|FG000|Overall Study|Physician Decision|0|||
149044312|NCT02980276|537645440|FG001|Overall Study|Physician Decision|1|||
149044313|NCT02980276|537645439|FG000|Overall Study|Lost to Follow-up|18|||
149044314|NCT02980276|537645440|FG001|Overall Study|Lost to Follow-up|18|||
149044315|NCT02980276|537645439|FG000|Overall Study|Death|1|||
149044316|NCT02980276|537645440|FG001|Overall Study|Death|0|||
149044317|NCT02980276|537645439|FG000|Overall Study|Miscellaneous other|10|||
149044318|NCT02980276|537645440|FG001|Overall Study|Miscellaneous other|4|||
149044319|NCT03554265|537645442|FG000|Overall Study|Withdrawal by Subject|2|||
149044320|NCT03554265|537645443|FG001|Overall Study|Withdrawal by Subject|2|||
149044321|NCT03554265|537645444|FG002|Overall Study|Withdrawal by Subject|3|||
149044322|NCT03554265|537645442|FG000|Overall Study|Physician Decision|0|||
149044323|NCT03554265|537645443|FG001|Overall Study|Physician Decision|0|||
149044324|NCT03554265|537645444|FG002|Overall Study|Physician Decision|1|||
149044325|NCT02652260|537645445|FG000|Base Study|Pregnancy|0|||
149044326|NCT02652260|537645446|FG001|Base Study|Pregnancy|1|||
149044327|NCT02652260|537645445|FG000|Base Study|Withdrawal by Subject|0|||
149044328|NCT02652260|537645446|FG001|Base Study|Withdrawal by Subject|1|||
149044329|NCT02652260|537645445|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
149044330|NCT02652260|537645446|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
149044331|NCT02652260|537645445|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
149044332|NCT02652260|537645446|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
149044333|NCT02652260|537645445|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
149044334|NCT02652260|537645446|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
149044335|NCT02652260|537645445|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
149044336|NCT02652260|537645446|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
149044337|NCT02652260|537645445|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
149044338|NCT02652260|537645446|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
149044339|NCT02652260|537645445|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
149044340|NCT02652260|537645446|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
149044341|NCT02652260|537645445|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
149044342|NCT02652260|537645446|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
149044343|NCT02652260|537645445|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
149044344|NCT02652260|537645446|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
149044345|NCT02652260|537645445|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
149044346|NCT02652260|537645446|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
149044347|NCT02652260|537645445|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
149044348|NCT02652260|537645446|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
149044349|NCT02652260|537645445|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
149044350|NCT02652260|537645446|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
149044351|NCT02652260|537645445|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
149044352|NCT02652260|537645446|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
149044353|NCT02723955|537645447|FG000|Escalation Phase|Death|1|||
149044354|NCT02723955|537645448|FG001|Escalation Phase|Death|1|||
149044355|NCT02723955|537645449|FG002|Escalation Phase|Death|2|||
149044356|NCT02723955|537645450|FG003|Escalation Phase|Death|7|||
149044357|NCT02723955|537645451|FG004|Escalation Phase|Death|18|||
149044358|NCT02723955|537645452|FG005|Escalation Phase|Death|17|||
149044359|NCT02723955|537645453|FG006|Escalation Phase|Death|11|||
149044360|NCT02723955|537645454|FG007|Escalation Phase|Death|21|||
148885344|NCT03386721|537056971|FG003|Overall Study|Site Terminated by Sponsor|0|||
149044361|NCT02723955|537645455|FG008|Escalation Phase|Death|3|||
149044362|NCT02723955|537645456|FG009|Escalation Phase|Death|0|||
149044363|NCT02723955|537645457|FG010|Escalation Phase|Death|0|||
149044364|NCT02723955|537645458|FG011|Escalation Phase|Death|0|||
148885345|NCT03386721|537056972|FG004|Overall Study|Site Terminated by Sponsor|1|||
149044365|NCT02723955|537645459|FG012|Escalation Phase|Death|2|||
149044366|NCT02723955|537645460|FG013|Escalation Phase|Death|4|||
149044367|NCT02723955|537645461|FG014|Escalation Phase|Death|5|||
149044368|NCT02723955|537645462|FG015|Escalation Phase|Death|6|||
149044369|NCT02723955|537645463|FG016|Escalation Phase|Death|6|||
149044370|NCT02723955|537645464|FG017|Escalation Phase|Death|7|||
149044371|NCT02723955|537645465|FG018|Escalation Phase|Death|1|||
149044372|NCT02723955|537645466|FG019|Escalation Phase|Death|3|||
149044373|NCT02723955|537645467|FG020|Escalation Phase|Death|13|||
148885346|NCT03386721|537056973|FG005|Overall Study|Site Terminated by Sponsor|3|||
148885347|NCT03386721|537056974|FG006|Overall Study|Site Terminated by Sponsor|0|||
148885348|NCT03386721|537056975|FG007|Overall Study|Site Terminated by Sponsor|1|||
149044374|NCT02723955|537645468|FG021|Escalation Phase|Death|3|||
149044375|NCT02723955|537645469|FG022|Escalation Phase|Death|2|||
149044376|NCT02723955|537645470|FG023|Escalation Phase|Death|4|||
149044377|NCT02723955|537645471|FG024|Escalation Phase|Death|31|||
149044378|NCT02723955|537645472|FG025|Escalation Phase|Death|7|||
149044379|NCT02723955|537645473|FG026|Escalation Phase|Death|13|||
149044380|NCT02723955|537645474|FG027|Escalation Phase|Death|0|||
149044381|NCT02723955|537645475|FG028|Escalation Phase|Death|1|||
149044382|NCT02723955|537645476|FG029|Escalation Phase|Death|0|||
149044383|NCT02723955|537645477|FG030|Escalation Phase|Death|0|||
149044384|NCT02723955|537645478|FG031|Escalation Phase|Death|0|||
149044385|NCT02723955|537645479|FG032|Escalation Phase|Death|0|||
149044386|NCT02723955|537645480|FG033|Escalation Phase|Death|0|||
149044387|NCT02723955|537645481|FG034|Escalation Phase|Death|0|||
149044388|NCT02723955|537645482|FG035|Escalation Phase|Death|0|||
149044389|NCT02723955|537645483|FG036|Escalation Phase|Death|0|||
149044390|NCT02723955|537645484|FG037|Escalation Phase|Death|0|||
149044391|NCT02723955|537645485|FG038|Escalation Phase|Death|0|||
149044392|NCT02723955|537645486|FG039|Escalation Phase|Death|0|||
149044393|NCT02723955|537645487|FG040|Escalation Phase|Death|0|||
149044394|NCT02723955|537645488|FG041|Escalation Phase|Death|0|||
149044395|NCT02723955|537645489|FG042|Escalation Phase|Death|0|||
149044396|NCT02723955|537645447|FG000|Escalation Phase|Lost to Follow-up|0|||
149044397|NCT02723955|537645448|FG001|Escalation Phase|Lost to Follow-up|0|||
149044398|NCT02723955|537645449|FG002|Escalation Phase|Lost to Follow-up|0|||
149044399|NCT02723955|537645450|FG003|Escalation Phase|Lost to Follow-up|0|||
149044400|NCT02723955|537645451|FG004|Escalation Phase|Lost to Follow-up|0|||
149044401|NCT02723955|537645452|FG005|Escalation Phase|Lost to Follow-up|2|||
149044402|NCT02723955|537645453|FG006|Escalation Phase|Lost to Follow-up|1|||
149044403|NCT02723955|537645454|FG007|Escalation Phase|Lost to Follow-up|1|||
149044404|NCT02723955|537645455|FG008|Escalation Phase|Lost to Follow-up|1|||
149044405|NCT02723955|537645456|FG009|Escalation Phase|Lost to Follow-up|0|||
149044406|NCT02723955|537645457|FG010|Escalation Phase|Lost to Follow-up|0|||
149044407|NCT02723955|537645458|FG011|Escalation Phase|Lost to Follow-up|0|||
149044408|NCT02723955|537645459|FG012|Escalation Phase|Lost to Follow-up|1|||
149044409|NCT02723955|537645460|FG013|Escalation Phase|Lost to Follow-up|0|||
149044410|NCT02723955|537645461|FG014|Escalation Phase|Lost to Follow-up|0|||
149044411|NCT02723955|537645462|FG015|Escalation Phase|Lost to Follow-up|0|||
149044412|NCT02723955|537645463|FG016|Escalation Phase|Lost to Follow-up|1|||
149044413|NCT02723955|537645464|FG017|Escalation Phase|Lost to Follow-up|2|||
149044414|NCT02723955|537645465|FG018|Escalation Phase|Lost to Follow-up|0|||
149044415|NCT02723955|537645466|FG019|Escalation Phase|Lost to Follow-up|1|||
149044416|NCT02723955|537645467|FG020|Escalation Phase|Lost to Follow-up|2|||
149044417|NCT02723955|537645468|FG021|Escalation Phase|Lost to Follow-up|1|||
149044418|NCT02723955|537645469|FG022|Escalation Phase|Lost to Follow-up|0|||
149044419|NCT02723955|537645470|FG023|Escalation Phase|Lost to Follow-up|0|||
149044420|NCT02723955|537645471|FG024|Escalation Phase|Lost to Follow-up|1|||
149044421|NCT02723955|537645472|FG025|Escalation Phase|Lost to Follow-up|1|||
149044422|NCT02723955|537645473|FG026|Escalation Phase|Lost to Follow-up|3|||
149044423|NCT02723955|537645474|FG027|Escalation Phase|Lost to Follow-up|0|||
149044424|NCT02723955|537645475|FG028|Escalation Phase|Lost to Follow-up|1|||
149044425|NCT02723955|537645476|FG029|Escalation Phase|Lost to Follow-up|0|||
149044426|NCT02723955|537645477|FG030|Escalation Phase|Lost to Follow-up|0|||
149044427|NCT02723955|537645478|FG031|Escalation Phase|Lost to Follow-up|0|||
149044428|NCT02723955|537645479|FG032|Escalation Phase|Lost to Follow-up|0|||
149044429|NCT02723955|537645480|FG033|Escalation Phase|Lost to Follow-up|0|||
149044430|NCT02723955|537645481|FG034|Escalation Phase|Lost to Follow-up|0|||
149044431|NCT02723955|537645482|FG035|Escalation Phase|Lost to Follow-up|0|||
149044432|NCT02723955|537645483|FG036|Escalation Phase|Lost to Follow-up|0|||
149044433|NCT02723955|537645484|FG037|Escalation Phase|Lost to Follow-up|0|||
149044434|NCT02723955|537645485|FG038|Escalation Phase|Lost to Follow-up|0|||
149044435|NCT02723955|537645486|FG039|Escalation Phase|Lost to Follow-up|0|||
149044436|NCT02723955|537645487|FG040|Escalation Phase|Lost to Follow-up|0|||
149044437|NCT02723955|537645488|FG041|Escalation Phase|Lost to Follow-up|0|||
149044438|NCT02723955|537645489|FG042|Escalation Phase|Lost to Follow-up|0|||
148885349|NCT03386721|537056976|FG008|Overall Study|Site Terminated by Sponsor|4|||
149044439|NCT02723955|537645447|FG000|Escalation Phase|Physician Decision|0|||
149044440|NCT02723955|537645448|FG001|Escalation Phase|Physician Decision|0|||
149044441|NCT02723955|537645449|FG002|Escalation Phase|Physician Decision|0|||
149044442|NCT02723955|537645450|FG003|Escalation Phase|Physician Decision|0|||
149044443|NCT02723955|537645451|FG004|Escalation Phase|Physician Decision|0|||
149044444|NCT02723955|537645452|FG005|Escalation Phase|Physician Decision|2|||
149044445|NCT02723955|537645453|FG006|Escalation Phase|Physician Decision|0|||
149044446|NCT02723955|537645454|FG007|Escalation Phase|Physician Decision|0|||
149044447|NCT02723955|537645455|FG008|Escalation Phase|Physician Decision|0|||
149044448|NCT02723955|537645456|FG009|Escalation Phase|Physician Decision|0|||
149044449|NCT02723955|537645457|FG010|Escalation Phase|Physician Decision|0|||
149044450|NCT02723955|537645458|FG011|Escalation Phase|Physician Decision|0|||
149044451|NCT02723955|537645459|FG012|Escalation Phase|Physician Decision|0|||
149044452|NCT02723955|537645460|FG013|Escalation Phase|Physician Decision|0|||
149044453|NCT02723955|537645461|FG014|Escalation Phase|Physician Decision|0|||
149044454|NCT02723955|537645462|FG015|Escalation Phase|Physician Decision|0|||
149044455|NCT02723955|537645463|FG016|Escalation Phase|Physician Decision|0|||
149044456|NCT02723955|537645464|FG017|Escalation Phase|Physician Decision|0|||
149044457|NCT02723955|537645465|FG018|Escalation Phase|Physician Decision|0|||
149044458|NCT02723955|537645466|FG019|Escalation Phase|Physician Decision|0|||
149044459|NCT02723955|537645467|FG020|Escalation Phase|Physician Decision|0|||
149044460|NCT02723955|537645468|FG021|Escalation Phase|Physician Decision|0|||
149044461|NCT02723955|537645469|FG022|Escalation Phase|Physician Decision|0|||
149044462|NCT02723955|537645470|FG023|Escalation Phase|Physician Decision|0|||
149044463|NCT02723955|537645471|FG024|Escalation Phase|Physician Decision|0|||
149044464|NCT02723955|537645472|FG025|Escalation Phase|Physician Decision|0|||
149044465|NCT02723955|537645473|FG026|Escalation Phase|Physician Decision|2|||
149044466|NCT02723955|537645474|FG027|Escalation Phase|Physician Decision|0|||
149044467|NCT02723955|537645475|FG028|Escalation Phase|Physician Decision|0|||
149044468|NCT02723955|537645476|FG029|Escalation Phase|Physician Decision|0|||
149044469|NCT02723955|537645477|FG030|Escalation Phase|Physician Decision|0|||
149044470|NCT02723955|537645478|FG031|Escalation Phase|Physician Decision|0|||
149044471|NCT02723955|537645479|FG032|Escalation Phase|Physician Decision|0|||
149044472|NCT02723955|537645480|FG033|Escalation Phase|Physician Decision|0|||
149044473|NCT02723955|537645481|FG034|Escalation Phase|Physician Decision|0|||
149044474|NCT02723955|537645482|FG035|Escalation Phase|Physician Decision|0|||
149044475|NCT02723955|537645483|FG036|Escalation Phase|Physician Decision|0|||
149044476|NCT02723955|537645484|FG037|Escalation Phase|Physician Decision|0|||
149044477|NCT02723955|537645485|FG038|Escalation Phase|Physician Decision|0|||
149044478|NCT02723955|537645486|FG039|Escalation Phase|Physician Decision|0|||
149044479|NCT02723955|537645487|FG040|Escalation Phase|Physician Decision|0|||
149044480|NCT02723955|537645488|FG041|Escalation Phase|Physician Decision|0|||
149044481|NCT02723955|537645489|FG042|Escalation Phase|Physician Decision|0|||
149044482|NCT02723955|537645447|FG000|Escalation Phase|Withdrawal by Subject|0|||
149044483|NCT02723955|537645448|FG001|Escalation Phase|Withdrawal by Subject|0|||
149044484|NCT02723955|537645449|FG002|Escalation Phase|Withdrawal by Subject|0|||
149044485|NCT02723955|537645450|FG003|Escalation Phase|Withdrawal by Subject|0|||
149044486|NCT02723955|537645451|FG004|Escalation Phase|Withdrawal by Subject|1|||
149044487|NCT02723955|537645452|FG005|Escalation Phase|Withdrawal by Subject|1|||
149044488|NCT02723955|537645453|FG006|Escalation Phase|Withdrawal by Subject|1|||
149044489|NCT02723955|537645454|FG007|Escalation Phase|Withdrawal by Subject|1|||
149044490|NCT02723955|537645455|FG008|Escalation Phase|Withdrawal by Subject|0|||
149044491|NCT02723955|537645456|FG009|Escalation Phase|Withdrawal by Subject|0|||
149044492|NCT02723955|537645457|FG010|Escalation Phase|Withdrawal by Subject|0|||
149044493|NCT02723955|537645458|FG011|Escalation Phase|Withdrawal by Subject|0|||
149044494|NCT02723955|537645459|FG012|Escalation Phase|Withdrawal by Subject|1|||
149044495|NCT02723955|537645460|FG013|Escalation Phase|Withdrawal by Subject|0|||
149044496|NCT02723955|537645461|FG014|Escalation Phase|Withdrawal by Subject|0|||
149044497|NCT02723955|537645462|FG015|Escalation Phase|Withdrawal by Subject|0|||
149044498|NCT02723955|537645463|FG016|Escalation Phase|Withdrawal by Subject|1|||
148885350|NCT03386721|537056977|FG009|Overall Study|Site Terminated by Sponsor|5|||
148885351|NCT03386721|537056978|FG010|Overall Study|Site Terminated by Sponsor|3|||
148885352|NCT03386721|537056979|FG011|Overall Study|Site Terminated by Sponsor|11|||
148885353|NCT03386721|537056980|FG012|Overall Study|Site Terminated by Sponsor|6|||
149044499|NCT02723955|537645464|FG017|Escalation Phase|Withdrawal by Subject|0|||
149044500|NCT02723955|537645465|FG018|Escalation Phase|Withdrawal by Subject|0|||
149044501|NCT02723955|537645466|FG019|Escalation Phase|Withdrawal by Subject|0|||
149044502|NCT02723955|537645467|FG020|Escalation Phase|Withdrawal by Subject|0|||
149044503|NCT02723955|537645468|FG021|Escalation Phase|Withdrawal by Subject|0|||
149044504|NCT02723955|537645469|FG022|Escalation Phase|Withdrawal by Subject|0|||
149044505|NCT02723955|537645470|FG023|Escalation Phase|Withdrawal by Subject|2|||
149044506|NCT02723955|537645471|FG024|Escalation Phase|Withdrawal by Subject|0|||
149044507|NCT02723955|537645472|FG025|Escalation Phase|Withdrawal by Subject|1|||
149044508|NCT02723955|537645473|FG026|Escalation Phase|Withdrawal by Subject|0|||
149044509|NCT02723955|537645474|FG027|Escalation Phase|Withdrawal by Subject|0|||
149044510|NCT02723955|537645475|FG028|Escalation Phase|Withdrawal by Subject|1|||
149044511|NCT02723955|537645476|FG029|Escalation Phase|Withdrawal by Subject|0|||
148885354|NCT03386721|537056981|FG013|Overall Study|Site Terminated by Sponsor|0|||
149044512|NCT02723955|537645477|FG030|Escalation Phase|Withdrawal by Subject|0|||
149044513|NCT02723955|537645478|FG031|Escalation Phase|Withdrawal by Subject|0|||
149044514|NCT02723955|537645479|FG032|Escalation Phase|Withdrawal by Subject|0|||
149044515|NCT02723955|537645480|FG033|Escalation Phase|Withdrawal by Subject|0|||
149044516|NCT02723955|537645481|FG034|Escalation Phase|Withdrawal by Subject|0|||
149044517|NCT02723955|537645482|FG035|Escalation Phase|Withdrawal by Subject|0|||
149044518|NCT02723955|537645483|FG036|Escalation Phase|Withdrawal by Subject|0|||
149044519|NCT02723955|537645484|FG037|Escalation Phase|Withdrawal by Subject|0|||
149044520|NCT02723955|537645485|FG038|Escalation Phase|Withdrawal by Subject|0|||
149044521|NCT02723955|537645486|FG039|Escalation Phase|Withdrawal by Subject|0|||
149044522|NCT02723955|537645487|FG040|Escalation Phase|Withdrawal by Subject|0|||
149044523|NCT02723955|537645488|FG041|Escalation Phase|Withdrawal by Subject|0|||
149044524|NCT02723955|537645489|FG042|Escalation Phase|Withdrawal by Subject|0|||
149044525|NCT02723955|537645447|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044526|NCT02723955|537645448|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044527|NCT02723955|537645449|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044528|NCT02723955|537645450|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
148885355|NCT03386721|537056982|FG014|Overall Study|Site Terminated by Sponsor|0|||
148885356|NCT03386721|537056968|FG000|Overall Study|Symptomatic Deterioration|0|||
148885357|NCT03386721|537056969|FG001|Overall Study|Symptomatic Deterioration|0|||
148885358|NCT03386721|537056970|FG002|Overall Study|Symptomatic Deterioration|0|||
148885359|NCT03386721|537056971|FG003|Overall Study|Symptomatic Deterioration|0|||
148885360|NCT03386721|537056972|FG004|Overall Study|Symptomatic Deterioration|0|||
148885361|NCT03386721|537056973|FG005|Overall Study|Symptomatic Deterioration|0|||
148885362|NCT03386721|537056974|FG006|Overall Study|Symptomatic Deterioration|0|||
148885363|NCT03386721|537056975|FG007|Overall Study|Symptomatic Deterioration|0|||
148885364|NCT03386721|537056976|FG008|Overall Study|Symptomatic Deterioration|1|||
148885365|NCT03386721|537056977|FG009|Overall Study|Symptomatic Deterioration|0|||
148885366|NCT03386721|537056978|FG010|Overall Study|Symptomatic Deterioration|0|||
148885367|NCT03386721|537056979|FG011|Overall Study|Symptomatic Deterioration|1|||
148885368|NCT03386721|537056980|FG012|Overall Study|Symptomatic Deterioration|0|||
148885369|NCT03386721|537056981|FG013|Overall Study|Symptomatic Deterioration|0|||
148885370|NCT03386721|537056982|FG014|Overall Study|Symptomatic Deterioration|0|||
148885371|NCT03386721|537056968|FG000|Overall Study|Withdrawal by Subject|1|||
148885372|NCT03386721|537056969|FG001|Overall Study|Withdrawal by Subject|2|||
148885373|NCT03386721|537056970|FG002|Overall Study|Withdrawal by Subject|0|||
148885374|NCT03386721|537056971|FG003|Overall Study|Withdrawal by Subject|0|||
148885375|NCT03386721|537056972|FG004|Overall Study|Withdrawal by Subject|0|||
148885376|NCT03386721|537056973|FG005|Overall Study|Withdrawal by Subject|0|||
148885377|NCT03386721|537056974|FG006|Overall Study|Withdrawal by Subject|0|||
148885378|NCT03386721|537056975|FG007|Overall Study|Withdrawal by Subject|0|||
148885379|NCT03386721|537056976|FG008|Overall Study|Withdrawal by Subject|2|||
148885380|NCT03386721|537056977|FG009|Overall Study|Withdrawal by Subject|1|||
148885381|NCT03386721|537056978|FG010|Overall Study|Withdrawal by Subject|3|||
148885382|NCT03386721|537056979|FG011|Overall Study|Withdrawal by Subject|2|||
148885383|NCT03386721|537056980|FG012|Overall Study|Withdrawal by Subject|3|||
148885384|NCT03386721|537056981|FG013|Overall Study|Withdrawal by Subject|0|||
148885385|NCT03386721|537056982|FG014|Overall Study|Withdrawal by Subject|0|||
148885386|NCT00700713|537056984|FG000|Overall Study|Protocol Violation|1|||
148885387|NCT00700713|537056985|FG001|Overall Study|Protocol Violation|0|||
148885388|NCT00700713|537056986|FG002|Overall Study|Protocol Violation|1|||
148885389|NCT00700713|537056984|FG000|Overall Study|Withdrawal by Subject|0|||
148885390|NCT00700713|537056985|FG001|Overall Study|Withdrawal by Subject|0|||
148885391|NCT00700713|537056986|FG002|Overall Study|Withdrawal by Subject|1|||
149044529|NCT02723955|537645451|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
149044530|NCT02723955|537645452|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
149044531|NCT02723955|537645453|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
148885392|NCT00550953|537056987|FG000|Overall Study|Adverse Event|4|||
149044532|NCT02723955|537645454|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
149044533|NCT02723955|537645455|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
149044534|NCT02723955|537645456|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044535|NCT02723955|537645457|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044536|NCT02723955|537645458|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
148885393|NCT00550953|537056988|FG001|Overall Study|Adverse Event|3|||
148885394|NCT00550953|537056987|FG000|Overall Study|Not able to visit the site|2|||
148885395|NCT00550953|537056988|FG001|Overall Study|Not able to visit the site|3|||
148885396|NCT03797586|537056989|FG000|Overall Study|Lost to Follow-up|3|||
148885397|NCT03797586|537056990|FG001|Overall Study|Lost to Follow-up|6|||
148885398|NCT03797586|537056989|FG000|Overall Study|Death|1|||
148885399|NCT03797586|537056990|FG001|Overall Study|Death|1|||
148885400|NCT03797586|537056989|FG000|Overall Study|Adverse Event|0|||
148885401|NCT03797586|537056990|FG001|Overall Study|Adverse Event|2|||
148885402|NCT01369784|537056991|FG000|Overall Study|Protocol Violation|12|||
148885403|NCT04797780|537056992|FG000|Overall Study|Lost to Follow-up|1|||
149044537|NCT02723955|537645459|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044538|NCT02723955|537645460|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044539|NCT02723955|537645461|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044540|NCT02723955|537645462|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044541|NCT02723955|537645463|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044542|NCT02723955|537645464|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044543|NCT02723955|537645465|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044544|NCT02723955|537645466|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044545|NCT02723955|537645467|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044546|NCT02723955|537645468|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044547|NCT02723955|537645469|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044548|NCT02723955|537645470|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044549|NCT02723955|537645471|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044550|NCT02723955|537645472|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044551|NCT02723955|537645473|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044552|NCT02723955|537645474|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044553|NCT02723955|537645475|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044554|NCT02723955|537645476|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044555|NCT02723955|537645477|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044556|NCT02723955|537645478|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044557|NCT02723955|537645479|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044558|NCT02723955|537645480|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044559|NCT02723955|537645481|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044560|NCT02723955|537645482|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044561|NCT02723955|537645483|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044562|NCT02723955|537645484|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044563|NCT02723955|537645485|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044564|NCT02723955|537645486|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044565|NCT02723955|537645487|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044566|NCT02723955|537645488|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044567|NCT02723955|537645489|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
149044568|NCT02723955|537645447|FG000|Escalation Phase|Site Closed|0|||
149044569|NCT02723955|537645448|FG001|Escalation Phase|Site Closed|0|||
149044570|NCT02723955|537645449|FG002|Escalation Phase|Site Closed|0|||
149044571|NCT02723955|537645450|FG003|Escalation Phase|Site Closed|0|||
149044572|NCT02723955|537645451|FG004|Escalation Phase|Site Closed|0|||
149044573|NCT02723955|537645452|FG005|Escalation Phase|Site Closed|0|||
149044574|NCT02723955|537645453|FG006|Escalation Phase|Site Closed|0|||
149044575|NCT02723955|537645454|FG007|Escalation Phase|Site Closed|0|||
149044576|NCT02723955|537645455|FG008|Escalation Phase|Site Closed|0|||
149044577|NCT02723955|537645456|FG009|Escalation Phase|Site Closed|0|||
149044578|NCT02723955|537645457|FG010|Escalation Phase|Site Closed|0|||
149044579|NCT02723955|537645458|FG011|Escalation Phase|Site Closed|0|||
149044580|NCT02723955|537645459|FG012|Escalation Phase|Site Closed|0|||
149044581|NCT02723955|537645460|FG013|Escalation Phase|Site Closed|0|||
149044582|NCT02723955|537645461|FG014|Escalation Phase|Site Closed|0|||
149044583|NCT02723955|537645462|FG015|Escalation Phase|Site Closed|1|||
149044584|NCT02723955|537645463|FG016|Escalation Phase|Site Closed|0|||
149044585|NCT02723955|537645464|FG017|Escalation Phase|Site Closed|2|||
149044586|NCT02723955|537645465|FG018|Escalation Phase|Site Closed|0|||
149044587|NCT02723955|537645466|FG019|Escalation Phase|Site Closed|0|||
149044588|NCT02723955|537645467|FG020|Escalation Phase|Site Closed|1|||
149044589|NCT02723955|537645468|FG021|Escalation Phase|Site Closed|0|||
149044590|NCT02723955|537645469|FG022|Escalation Phase|Site Closed|0|||
149044591|NCT02723955|537645470|FG023|Escalation Phase|Site Closed|0|||
149044592|NCT02723955|537645471|FG024|Escalation Phase|Site Closed|3|||
149044593|NCT02723955|537645472|FG025|Escalation Phase|Site Closed|1|||
149044594|NCT02723955|537645473|FG026|Escalation Phase|Site Closed|3|||
149044595|NCT02723955|537645474|FG027|Escalation Phase|Site Closed|1|||
149044596|NCT02723955|537645475|FG028|Escalation Phase|Site Closed|1|||
148885404|NCT04797780|537056993|FG001|Overall Study|Lost to Follow-up|1|||
149044597|NCT02723955|537645476|FG029|Escalation Phase|Site Closed|0|||
149044598|NCT02723955|537645477|FG030|Escalation Phase|Site Closed|0|||
149044599|NCT02723955|537645478|FG031|Escalation Phase|Site Closed|0|||
149044600|NCT02723955|537645479|FG032|Escalation Phase|Site Closed|0|||
149044601|NCT02723955|537645480|FG033|Escalation Phase|Site Closed|0|||
149044602|NCT02723955|537645481|FG034|Escalation Phase|Site Closed|0|||
149044603|NCT02723955|537645482|FG035|Escalation Phase|Site Closed|0|||
149044604|NCT02723955|537645483|FG036|Escalation Phase|Site Closed|0|||
149044605|NCT02723955|537645484|FG037|Escalation Phase|Site Closed|0|||
149044606|NCT02723955|537645485|FG038|Escalation Phase|Site Closed|0|||
149044607|NCT02723955|537645486|FG039|Escalation Phase|Site Closed|0|||
149044608|NCT02723955|537645487|FG040|Escalation Phase|Site Closed|0|||
149044609|NCT02723955|537645488|FG041|Escalation Phase|Site Closed|0|||
149044610|NCT02723955|537645489|FG042|Escalation Phase|Site Closed|0|||
149044611|NCT02723955|537645447|FG000|Expansion Phase|Death|0|||
149044612|NCT02723955|537645448|FG001|Expansion Phase|Death|0|||
149044613|NCT02723955|537645449|FG002|Expansion Phase|Death|0|||
149044614|NCT02723955|537645450|FG003|Expansion Phase|Death|0|||
149044615|NCT02723955|537645451|FG004|Expansion Phase|Death|0|||
149044616|NCT02723955|537645452|FG005|Expansion Phase|Death|0|||
149044617|NCT02723955|537645453|FG006|Expansion Phase|Death|0|||
149044618|NCT02723955|537645454|FG007|Expansion Phase|Death|0|||
149044619|NCT02723955|537645455|FG008|Expansion Phase|Death|0|||
149044620|NCT02723955|537645456|FG009|Expansion Phase|Death|25|||
149044621|NCT02723955|537645457|FG010|Expansion Phase|Death|69|||
149044622|NCT02723955|537645458|FG011|Expansion Phase|Death|48|||
149044623|NCT02723955|537645459|FG012|Expansion Phase|Death|0|||
149044624|NCT02723955|537645460|FG013|Expansion Phase|Death|0|||
149044625|NCT02723955|537645461|FG014|Expansion Phase|Death|0|||
149044626|NCT02723955|537645462|FG015|Expansion Phase|Death|0|||
149044627|NCT02723955|537645463|FG016|Expansion Phase|Death|0|||
149044628|NCT02723955|537645464|FG017|Expansion Phase|Death|0|||
149044629|NCT02723955|537645465|FG018|Expansion Phase|Death|0|||
149044630|NCT02723955|537645466|FG019|Expansion Phase|Death|0|||
149044631|NCT02723955|537645467|FG020|Expansion Phase|Death|0|||
149044632|NCT02723955|537645468|FG021|Expansion Phase|Death|0|||
149044633|NCT02723955|537645469|FG022|Expansion Phase|Death|0|||
149044634|NCT02723955|537645470|FG023|Expansion Phase|Death|0|||
149044635|NCT02723955|537645471|FG024|Expansion Phase|Death|0|||
149044636|NCT02723955|537645472|FG025|Expansion Phase|Death|0|||
149044637|NCT02723955|537645473|FG026|Expansion Phase|Death|0|||
149044638|NCT02723955|537645474|FG027|Expansion Phase|Death|0|||
149044639|NCT02723955|537645475|FG028|Expansion Phase|Death|0|||
149044640|NCT02723955|537645476|FG029|Expansion Phase|Death|12|||
148885405|NCT04797780|537056992|FG000|Overall Study|Withdrawal by Subject|14|||
148885406|NCT04797780|537056993|FG001|Overall Study|Withdrawal by Subject|9|||
148885407|NCT04797780|537056992|FG000|Overall Study|Death|49|||
148885408|NCT04797780|537056993|FG001|Overall Study|Death|20|||
148885409|NCT01099397|537057000|FG000|Overall Study|Lost to Follow-up|4|||
148885410|NCT01099397|537057000|FG000|Overall Study|Protocol Violation|4|||
148885411|NCT01099397|537057000|FG000|Overall Study|Withdrawal by Subject|5|||
148885412|NCT02363959|537057001|FG000|Overall Study|Medical instability|1|||
148885413|NCT02363959|537057002|FG001|Overall Study|Medical instability|0|||
148885414|NCT00950248|537057004|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
148885415|NCT00950248|537057005|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
148885416|NCT00950248|537057006|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
148885417|NCT00950248|537057004|FG000|Year 1: Baseline|worsening of symptoms|2|||
148885418|NCT00950248|537057005|FG001|Year 1: Baseline|worsening of symptoms|0|||
149044641|NCT02723955|537645477|FG030|Expansion Phase|Death|202|||
149044642|NCT02723955|537645478|FG031|Expansion Phase|Death|31|||
149044643|NCT02723955|537645479|FG032|Expansion Phase|Death|17|||
149044644|NCT02723955|537645480|FG033|Expansion Phase|Death|2|||
149044645|NCT02723955|537645481|FG034|Expansion Phase|Death|3|||
149044646|NCT02723955|537645482|FG035|Expansion Phase|Death|3|||
149044647|NCT02723955|537645483|FG036|Expansion Phase|Death|1|||
149044648|NCT02723955|537645484|FG037|Expansion Phase|Death|0|||
149044649|NCT02723955|537645485|FG038|Expansion Phase|Death|0|||
149044650|NCT02723955|537645486|FG039|Expansion Phase|Death|0|||
149044651|NCT02723955|537645487|FG040|Expansion Phase|Death|0|||
149044652|NCT02723955|537645488|FG041|Expansion Phase|Death|0|||
148885419|NCT00950248|537057006|FG002|Year 1: Baseline|worsening of symptoms|0|||
148885420|NCT00950248|537057004|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
149044653|NCT02723955|537645489|FG042|Expansion Phase|Death|0|||
149044654|NCT02723955|537645447|FG000|Expansion Phase|Lost to Follow-up|0|||
149044655|NCT02723955|537645448|FG001|Expansion Phase|Lost to Follow-up|0|||
149044656|NCT02723955|537645449|FG002|Expansion Phase|Lost to Follow-up|0|||
149044657|NCT02723955|537645450|FG003|Expansion Phase|Lost to Follow-up|0|||
149044658|NCT02723955|537645451|FG004|Expansion Phase|Lost to Follow-up|0|||
149044659|NCT02723955|537645452|FG005|Expansion Phase|Lost to Follow-up|0|||
149044660|NCT02723955|537645453|FG006|Expansion Phase|Lost to Follow-up|0|||
149044661|NCT02723955|537645454|FG007|Expansion Phase|Lost to Follow-up|0|||
149044662|NCT02723955|537645455|FG008|Expansion Phase|Lost to Follow-up|0|||
149044663|NCT02723955|537645456|FG009|Expansion Phase|Lost to Follow-up|0|||
149044664|NCT02723955|537645457|FG010|Expansion Phase|Lost to Follow-up|4|||
149044665|NCT02723955|537645458|FG011|Expansion Phase|Lost to Follow-up|1|||
149044666|NCT02723955|537645459|FG012|Expansion Phase|Lost to Follow-up|0|||
149044667|NCT02723955|537645460|FG013|Expansion Phase|Lost to Follow-up|0|||
149044668|NCT02723955|537645461|FG014|Expansion Phase|Lost to Follow-up|0|||
149044669|NCT02723955|537645462|FG015|Expansion Phase|Lost to Follow-up|0|||
149044670|NCT02723955|537645463|FG016|Expansion Phase|Lost to Follow-up|0|||
149044671|NCT02723955|537645464|FG017|Expansion Phase|Lost to Follow-up|0|||
149044672|NCT02723955|537645465|FG018|Expansion Phase|Lost to Follow-up|0|||
149044673|NCT02723955|537645466|FG019|Expansion Phase|Lost to Follow-up|0|||
149044674|NCT02723955|537645467|FG020|Expansion Phase|Lost to Follow-up|0|||
149044675|NCT02723955|537645468|FG021|Expansion Phase|Lost to Follow-up|0|||
149044676|NCT02723955|537645469|FG022|Expansion Phase|Lost to Follow-up|0|||
149044677|NCT02723955|537645470|FG023|Expansion Phase|Lost to Follow-up|0|||
149044678|NCT02723955|537645471|FG024|Expansion Phase|Lost to Follow-up|0|||
149044679|NCT02723955|537645472|FG025|Expansion Phase|Lost to Follow-up|0|||
149044680|NCT02723955|537645473|FG026|Expansion Phase|Lost to Follow-up|0|||
149044681|NCT02723955|537645474|FG027|Expansion Phase|Lost to Follow-up|0|||
149044682|NCT02723955|537645475|FG028|Expansion Phase|Lost to Follow-up|0|||
149044683|NCT02723955|537645476|FG029|Expansion Phase|Lost to Follow-up|1|||
149044684|NCT02723955|537645477|FG030|Expansion Phase|Lost to Follow-up|19|||
149044685|NCT02723955|537645478|FG031|Expansion Phase|Lost to Follow-up|2|||
149044686|NCT02723955|537645479|FG032|Expansion Phase|Lost to Follow-up|1|||
149044687|NCT02723955|537645480|FG033|Expansion Phase|Lost to Follow-up|0|||
148885421|NCT00950248|537057005|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
148885422|NCT00950248|537057006|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
148885423|NCT00950248|537057004|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
148885424|NCT00950248|537057005|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
148885425|NCT00950248|537057006|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
148885426|NCT00950248|537057004|FG000|Year 2&3 Treatment Randomization|Death|0|||
148885427|NCT00950248|537057005|FG001|Year 2&3 Treatment Randomization|Death|0|||
148885428|NCT00950248|537057006|FG002|Year 2&3 Treatment Randomization|Death|1|||
149044688|NCT02723955|537645481|FG034|Expansion Phase|Lost to Follow-up|0|||
149044689|NCT02723955|537645482|FG035|Expansion Phase|Lost to Follow-up|0|||
149044690|NCT02723955|537645483|FG036|Expansion Phase|Lost to Follow-up|0|||
149044691|NCT02723955|537645484|FG037|Expansion Phase|Lost to Follow-up|0|||
149044692|NCT02723955|537645485|FG038|Expansion Phase|Lost to Follow-up|0|||
149044693|NCT02723955|537645486|FG039|Expansion Phase|Lost to Follow-up|0|||
149044694|NCT02723955|537645487|FG040|Expansion Phase|Lost to Follow-up|0|||
149044695|NCT02723955|537645488|FG041|Expansion Phase|Lost to Follow-up|0|||
149044696|NCT02723955|537645489|FG042|Expansion Phase|Lost to Follow-up|0|||
149044697|NCT02723955|537645447|FG000|Expansion Phase|Physician Decision|0|||
149044698|NCT02723955|537645448|FG001|Expansion Phase|Physician Decision|0|||
149044699|NCT02723955|537645449|FG002|Expansion Phase|Physician Decision|0|||
149044700|NCT02723955|537645450|FG003|Expansion Phase|Physician Decision|0|||
149044701|NCT02723955|537645451|FG004|Expansion Phase|Physician Decision|0|||
149044702|NCT02723955|537645452|FG005|Expansion Phase|Physician Decision|0|||
149044703|NCT02723955|537645453|FG006|Expansion Phase|Physician Decision|0|||
149044704|NCT02723955|537645454|FG007|Expansion Phase|Physician Decision|0|||
149044705|NCT02723955|537645455|FG008|Expansion Phase|Physician Decision|0|||
149044706|NCT02723955|537645456|FG009|Expansion Phase|Physician Decision|0|||
149044707|NCT02723955|537645457|FG010|Expansion Phase|Physician Decision|0|||
149044708|NCT02723955|537645458|FG011|Expansion Phase|Physician Decision|0|||
149044709|NCT02723955|537645459|FG012|Expansion Phase|Physician Decision|0|||
149044710|NCT02723955|537645460|FG013|Expansion Phase|Physician Decision|0|||
149044711|NCT02723955|537645461|FG014|Expansion Phase|Physician Decision|0|||
149044712|NCT02723955|537645462|FG015|Expansion Phase|Physician Decision|0|||
149044713|NCT02723955|537645463|FG016|Expansion Phase|Physician Decision|0|||
149044714|NCT02723955|537645464|FG017|Expansion Phase|Physician Decision|0|||
149044715|NCT02723955|537645465|FG018|Expansion Phase|Physician Decision|0|||
149044716|NCT02723955|537645466|FG019|Expansion Phase|Physician Decision|0|||
149044717|NCT02723955|537645467|FG020|Expansion Phase|Physician Decision|0|||
149044718|NCT02723955|537645468|FG021|Expansion Phase|Physician Decision|0|||
149044719|NCT02723955|537645469|FG022|Expansion Phase|Physician Decision|0|||
149044720|NCT02723955|537645470|FG023|Expansion Phase|Physician Decision|0|||
149044721|NCT02723955|537645471|FG024|Expansion Phase|Physician Decision|0|||
149044722|NCT02723955|537645472|FG025|Expansion Phase|Physician Decision|0|||
149044723|NCT02723955|537645473|FG026|Expansion Phase|Physician Decision|0|||
149044724|NCT02723955|537645474|FG027|Expansion Phase|Physician Decision|0|||
149044725|NCT02723955|537645475|FG028|Expansion Phase|Physician Decision|0|||
149044726|NCT02723955|537645476|FG029|Expansion Phase|Physician Decision|0|||
149044727|NCT02723955|537645477|FG030|Expansion Phase|Physician Decision|1|||
149044728|NCT02723955|537645478|FG031|Expansion Phase|Physician Decision|1|||
149044729|NCT02723955|537645479|FG032|Expansion Phase|Physician Decision|0|||
149044730|NCT02723955|537645480|FG033|Expansion Phase|Physician Decision|0|||
149044731|NCT02723955|537645481|FG034|Expansion Phase|Physician Decision|0|||
149044732|NCT02723955|537645482|FG035|Expansion Phase|Physician Decision|0|||
149044733|NCT02723955|537645483|FG036|Expansion Phase|Physician Decision|0|||
149044734|NCT02723955|537645484|FG037|Expansion Phase|Physician Decision|0|||
149044735|NCT02723955|537645485|FG038|Expansion Phase|Physician Decision|0|||
149044736|NCT02723955|537645486|FG039|Expansion Phase|Physician Decision|0|||
149044737|NCT02723955|537645487|FG040|Expansion Phase|Physician Decision|0|||
149044738|NCT02723955|537645488|FG041|Expansion Phase|Physician Decision|0|||
149044739|NCT02723955|537645489|FG042|Expansion Phase|Physician Decision|0|||
149044740|NCT02723955|537645447|FG000|Expansion Phase|Withdrawal by Subject|0|||
149044741|NCT02723955|537645448|FG001|Expansion Phase|Withdrawal by Subject|0|||
149044742|NCT02723955|537645449|FG002|Expansion Phase|Withdrawal by Subject|0|||
149044743|NCT02723955|537645450|FG003|Expansion Phase|Withdrawal by Subject|0|||
149044744|NCT02723955|537645451|FG004|Expansion Phase|Withdrawal by Subject|0|||
149044745|NCT02723955|537645452|FG005|Expansion Phase|Withdrawal by Subject|0|||
149044746|NCT02723955|537645453|FG006|Expansion Phase|Withdrawal by Subject|0|||
149044747|NCT02723955|537645454|FG007|Expansion Phase|Withdrawal by Subject|0|||
149044748|NCT02723955|537645455|FG008|Expansion Phase|Withdrawal by Subject|0|||
149044749|NCT02723955|537645456|FG009|Expansion Phase|Withdrawal by Subject|2|||
149044750|NCT02723955|537645457|FG010|Expansion Phase|Withdrawal by Subject|1|||
149044751|NCT02723955|537645458|FG011|Expansion Phase|Withdrawal by Subject|0|||
149044752|NCT02723955|537645459|FG012|Expansion Phase|Withdrawal by Subject|0|||
149044753|NCT02723955|537645460|FG013|Expansion Phase|Withdrawal by Subject|0|||
149044754|NCT02723955|537645461|FG014|Expansion Phase|Withdrawal by Subject|0|||
149044755|NCT02723955|537645462|FG015|Expansion Phase|Withdrawal by Subject|0|||
149044756|NCT02723955|537645463|FG016|Expansion Phase|Withdrawal by Subject|0|||
149044757|NCT02723955|537645464|FG017|Expansion Phase|Withdrawal by Subject|0|||
149044758|NCT02723955|537645465|FG018|Expansion Phase|Withdrawal by Subject|0|||
149044759|NCT02723955|537645466|FG019|Expansion Phase|Withdrawal by Subject|0|||
149044760|NCT02723955|537645467|FG020|Expansion Phase|Withdrawal by Subject|0|||
149044761|NCT02723955|537645468|FG021|Expansion Phase|Withdrawal by Subject|0|||
149044762|NCT02723955|537645469|FG022|Expansion Phase|Withdrawal by Subject|0|||
149044763|NCT02723955|537645470|FG023|Expansion Phase|Withdrawal by Subject|0|||
149044764|NCT02723955|537645471|FG024|Expansion Phase|Withdrawal by Subject|0|||
149044765|NCT02723955|537645472|FG025|Expansion Phase|Withdrawal by Subject|0|||
149044766|NCT02723955|537645473|FG026|Expansion Phase|Withdrawal by Subject|0|||
149044767|NCT02723955|537645474|FG027|Expansion Phase|Withdrawal by Subject|0|||
149044768|NCT02723955|537645475|FG028|Expansion Phase|Withdrawal by Subject|0|||
149044769|NCT02723955|537645476|FG029|Expansion Phase|Withdrawal by Subject|0|||
149044770|NCT02723955|537645477|FG030|Expansion Phase|Withdrawal by Subject|8|||
149044771|NCT02723955|537645478|FG031|Expansion Phase|Withdrawal by Subject|4|||
149044772|NCT02723955|537645479|FG032|Expansion Phase|Withdrawal by Subject|0|||
149044773|NCT02723955|537645480|FG033|Expansion Phase|Withdrawal by Subject|0|||
149044774|NCT02723955|537645481|FG034|Expansion Phase|Withdrawal by Subject|0|||
149044775|NCT02723955|537645482|FG035|Expansion Phase|Withdrawal by Subject|1|||
149044776|NCT02723955|537645483|FG036|Expansion Phase|Withdrawal by Subject|0|||
149044777|NCT02723955|537645484|FG037|Expansion Phase|Withdrawal by Subject|0|||
149044778|NCT02723955|537645485|FG038|Expansion Phase|Withdrawal by Subject|0|||
149044779|NCT02723955|537645486|FG039|Expansion Phase|Withdrawal by Subject|0|||
149044780|NCT02723955|537645487|FG040|Expansion Phase|Withdrawal by Subject|0|||
149044781|NCT02723955|537645488|FG041|Expansion Phase|Withdrawal by Subject|0|||
149044782|NCT02723955|537645489|FG042|Expansion Phase|Withdrawal by Subject|0|||
149044783|NCT02723955|537645447|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044784|NCT02723955|537645448|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044785|NCT02723955|537645449|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044786|NCT02723955|537645450|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044787|NCT02723955|537645451|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044788|NCT02723955|537645452|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044789|NCT02723955|537645453|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044790|NCT02723955|537645454|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044791|NCT02723955|537645455|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044792|NCT02723955|537645456|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
149044793|NCT02723955|537645457|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
149044794|NCT02723955|537645458|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
149044795|NCT02723955|537645459|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044796|NCT02723955|537645460|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044797|NCT02723955|537645461|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044798|NCT02723955|537645462|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044799|NCT02723955|537645463|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044800|NCT02723955|537645464|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044801|NCT02723955|537645465|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044802|NCT02723955|537645466|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044803|NCT02723955|537645467|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044804|NCT02723955|537645468|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044805|NCT02723955|537645469|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044806|NCT02723955|537645470|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044807|NCT02723955|537645471|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044808|NCT02723955|537645472|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044809|NCT02723955|537645473|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044810|NCT02723955|537645474|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044811|NCT02723955|537645475|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044812|NCT02723955|537645476|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044813|NCT02723955|537645477|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
149044814|NCT02723955|537645478|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044815|NCT02723955|537645479|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044816|NCT02723955|537645480|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044817|NCT02723955|537645481|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044818|NCT02723955|537645482|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044819|NCT02723955|537645483|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044820|NCT02723955|537645484|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044821|NCT02723955|537645485|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044822|NCT02723955|537645486|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044823|NCT02723955|537645487|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044824|NCT02723955|537645488|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044825|NCT02723955|537645489|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
149044826|NCT02723955|537645447|FG000|Expansion Phase|Site Closed|0|||
149044827|NCT02723955|537645448|FG001|Expansion Phase|Site Closed|0|||
149044828|NCT02723955|537645449|FG002|Expansion Phase|Site Closed|0|||
149044829|NCT02723955|537645450|FG003|Expansion Phase|Site Closed|0|||
149044830|NCT02723955|537645451|FG004|Expansion Phase|Site Closed|0|||
149044831|NCT02723955|537645452|FG005|Expansion Phase|Site Closed|0|||
149044832|NCT02723955|537645453|FG006|Expansion Phase|Site Closed|0|||
149044833|NCT02723955|537645454|FG007|Expansion Phase|Site Closed|0|||
149044834|NCT02723955|537645455|FG008|Expansion Phase|Site Closed|0|||
149044835|NCT02723955|537645456|FG009|Expansion Phase|Site Closed|1|||
149044836|NCT02723955|537645457|FG010|Expansion Phase|Site Closed|2|||
149044837|NCT02723955|537645458|FG011|Expansion Phase|Site Closed|6|||
149044838|NCT02723955|537645459|FG012|Expansion Phase|Site Closed|0|||
149044839|NCT02723955|537645460|FG013|Expansion Phase|Site Closed|0|||
149044840|NCT02723955|537645461|FG014|Expansion Phase|Site Closed|0|||
149044841|NCT02723955|537645462|FG015|Expansion Phase|Site Closed|0|||
149044842|NCT02723955|537645463|FG016|Expansion Phase|Site Closed|0|||
149044843|NCT02723955|537645464|FG017|Expansion Phase|Site Closed|0|||
149044844|NCT02723955|537645465|FG018|Expansion Phase|Site Closed|0|||
149044845|NCT02723955|537645466|FG019|Expansion Phase|Site Closed|0|||
149044846|NCT02723955|537645467|FG020|Expansion Phase|Site Closed|0|||
149044847|NCT02723955|537645468|FG021|Expansion Phase|Site Closed|0|||
149044848|NCT02723955|537645469|FG022|Expansion Phase|Site Closed|0|||
149044849|NCT02723955|537645470|FG023|Expansion Phase|Site Closed|0|||
149044850|NCT02723955|537645471|FG024|Expansion Phase|Site Closed|0|||
149044851|NCT02723955|537645472|FG025|Expansion Phase|Site Closed|0|||
149044852|NCT02723955|537645473|FG026|Expansion Phase|Site Closed|0|||
149044853|NCT02723955|537645474|FG027|Expansion Phase|Site Closed|0|||
149044854|NCT02723955|537645475|FG028|Expansion Phase|Site Closed|0|||
149044855|NCT02723955|537645476|FG029|Expansion Phase|Site Closed|0|||
149044856|NCT02723955|537645477|FG030|Expansion Phase|Site Closed|8|||
149044857|NCT02723955|537645478|FG031|Expansion Phase|Site Closed|4|||
149044858|NCT02723955|537645479|FG032|Expansion Phase|Site Closed|2|||
149044859|NCT02723955|537645480|FG033|Expansion Phase|Site Closed|2|||
149044860|NCT02723955|537645481|FG034|Expansion Phase|Site Closed|0|||
149044861|NCT02723955|537645482|FG035|Expansion Phase|Site Closed|0|||
149044862|NCT02723955|537645483|FG036|Expansion Phase|Site Closed|0|||
149044863|NCT02723955|537645484|FG037|Expansion Phase|Site Closed|0|||
149044864|NCT02723955|537645485|FG038|Expansion Phase|Site Closed|0|||
149044865|NCT02723955|537645486|FG039|Expansion Phase|Site Closed|0|||
148885429|NCT00950248|537057004|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
149044866|NCT02723955|537645487|FG040|Expansion Phase|Site Closed|0|||
149044867|NCT02723955|537645488|FG041|Expansion Phase|Site Closed|0|||
149044868|NCT02723955|537645489|FG042|Expansion Phase|Site Closed|0|||
149044869|NCT02723955|537645447|FG000|Crossover/ Re-treatment Phase|Death|0|||
149044870|NCT02723955|537645448|FG001|Crossover/ Re-treatment Phase|Death|0|||
149044871|NCT02723955|537645449|FG002|Crossover/ Re-treatment Phase|Death|0|||
149044872|NCT02723955|537645450|FG003|Crossover/ Re-treatment Phase|Death|0|||
149044873|NCT02723955|537645451|FG004|Crossover/ Re-treatment Phase|Death|0|||
149044874|NCT02723955|537645452|FG005|Crossover/ Re-treatment Phase|Death|0|||
149044875|NCT02723955|537645453|FG006|Crossover/ Re-treatment Phase|Death|0|||
149044876|NCT02723955|537645454|FG007|Crossover/ Re-treatment Phase|Death|0|||
149044877|NCT02723955|537645455|FG008|Crossover/ Re-treatment Phase|Death|0|||
149044878|NCT02723955|537645456|FG009|Crossover/ Re-treatment Phase|Death|0|||
149044879|NCT02723955|537645457|FG010|Crossover/ Re-treatment Phase|Death|0|||
149044880|NCT02723955|537645458|FG011|Crossover/ Re-treatment Phase|Death|0|||
149044881|NCT02723955|537645459|FG012|Crossover/ Re-treatment Phase|Death|0|||
149044882|NCT02723955|537645460|FG013|Crossover/ Re-treatment Phase|Death|0|||
149044883|NCT02723955|537645461|FG014|Crossover/ Re-treatment Phase|Death|0|||
149044884|NCT02723955|537645462|FG015|Crossover/ Re-treatment Phase|Death|0|||
149044885|NCT02723955|537645463|FG016|Crossover/ Re-treatment Phase|Death|0|||
149044886|NCT02723955|537645464|FG017|Crossover/ Re-treatment Phase|Death|0|||
149044887|NCT02723955|537645465|FG018|Crossover/ Re-treatment Phase|Death|0|||
149044888|NCT02723955|537645466|FG019|Crossover/ Re-treatment Phase|Death|0|||
149044889|NCT02723955|537645467|FG020|Crossover/ Re-treatment Phase|Death|0|||
149044890|NCT02723955|537645468|FG021|Crossover/ Re-treatment Phase|Death|0|||
149044891|NCT02723955|537645469|FG022|Crossover/ Re-treatment Phase|Death|0|||
149044892|NCT02723955|537645470|FG023|Crossover/ Re-treatment Phase|Death|0|||
149044893|NCT02723955|537645471|FG024|Crossover/ Re-treatment Phase|Death|0|||
149044894|NCT02723955|537645472|FG025|Crossover/ Re-treatment Phase|Death|0|||
149044895|NCT02723955|537645473|FG026|Crossover/ Re-treatment Phase|Death|0|||
149044896|NCT02723955|537645474|FG027|Crossover/ Re-treatment Phase|Death|0|||
149044897|NCT02723955|537645475|FG028|Crossover/ Re-treatment Phase|Death|0|||
149044898|NCT02723955|537645476|FG029|Crossover/ Re-treatment Phase|Death|0|||
149044899|NCT02723955|537645477|FG030|Crossover/ Re-treatment Phase|Death|0|||
149044900|NCT02723955|537645478|FG031|Crossover/ Re-treatment Phase|Death|0|||
149044901|NCT02723955|537645479|FG032|Crossover/ Re-treatment Phase|Death|0|||
149044902|NCT02723955|537645480|FG033|Crossover/ Re-treatment Phase|Death|0|||
149044903|NCT02723955|537645481|FG034|Crossover/ Re-treatment Phase|Death|0|||
149044904|NCT02723955|537645482|FG035|Crossover/ Re-treatment Phase|Death|0|||
149044905|NCT02723955|537645483|FG036|Crossover/ Re-treatment Phase|Death|0|||
149044906|NCT02723955|537645484|FG037|Crossover/ Re-treatment Phase|Death|1|||
149044907|NCT02723955|537645485|FG038|Crossover/ Re-treatment Phase|Death|14|||
149044908|NCT02723955|537645486|FG039|Crossover/ Re-treatment Phase|Death|32|||
149044909|NCT02723955|537645487|FG040|Crossover/ Re-treatment Phase|Death|2|||
149044910|NCT02723955|537645488|FG041|Crossover/ Re-treatment Phase|Death|1|||
149044911|NCT02723955|537645489|FG042|Crossover/ Re-treatment Phase|Death|0|||
149044912|NCT02723955|537645447|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044913|NCT02723955|537645448|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044914|NCT02723955|537645449|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044915|NCT02723955|537645450|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044916|NCT02723955|537645451|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044917|NCT02723955|537645452|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044918|NCT02723955|537645453|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044919|NCT02723955|537645454|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044920|NCT02723955|537645455|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044921|NCT02723955|537645456|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044922|NCT02723955|537645457|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044923|NCT02723955|537645458|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044924|NCT02723955|537645459|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044925|NCT02723955|537645460|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044926|NCT02723955|537645461|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044927|NCT02723955|537645462|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044928|NCT02723955|537645463|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
148885430|NCT00950248|537057005|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
148885431|NCT00950248|537057006|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
149044929|NCT02723955|537645464|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044930|NCT02723955|537645465|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044931|NCT02723955|537645466|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044932|NCT02723955|537645467|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044933|NCT02723955|537645468|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044934|NCT02723955|537645469|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044935|NCT02723955|537645470|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044936|NCT02723955|537645471|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044937|NCT02723955|537645472|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044938|NCT02723955|537645473|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044939|NCT02723955|537645474|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044940|NCT02723955|537645475|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044941|NCT02723955|537645476|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044942|NCT02723955|537645477|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044943|NCT02723955|537645478|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044944|NCT02723955|537645479|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044945|NCT02723955|537645480|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044946|NCT02723955|537645481|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044947|NCT02723955|537645482|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044948|NCT02723955|537645483|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044949|NCT02723955|537645484|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
148885432|NCT00003199|537057007|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
148885433|NCT00003199|537057007|FG000|Overall Study|Lack of insurance clearance|2|||
148885434|NCT00003199|537057007|FG000|Overall Study|Screen fail|15|||
148885435|NCT00940498|537057008|FG000|Overall Study|Death|2|||
148885436|NCT00940498|537057009|FG001|Overall Study|Death|0|||
148885437|NCT00940498|537057010|FG002|Overall Study|Death|0|||
148885438|NCT00940498|537057011|FG003|Overall Study|Death|1|||
148885439|NCT00940498|537057012|FG004|Overall Study|Death|5|||
148885440|NCT00940498|537057013|FG005|Overall Study|Death|0|||
148885441|NCT00940498|537057014|FG006|Overall Study|Death|1|||
148885442|NCT00940498|537057015|FG007|Overall Study|Death|0|||
148885443|NCT00940498|537057008|FG000|Overall Study|Lost to Follow-up|1|||
148885444|NCT00940498|537057009|FG001|Overall Study|Lost to Follow-up|1|||
148885445|NCT00940498|537057010|FG002|Overall Study|Lost to Follow-up|2|||
148885446|NCT00940498|537057011|FG003|Overall Study|Lost to Follow-up|0|||
148885447|NCT00940498|537057012|FG004|Overall Study|Lost to Follow-up|1|||
148885448|NCT00940498|537057013|FG005|Overall Study|Lost to Follow-up|0|||
148885449|NCT00940498|537057014|FG006|Overall Study|Lost to Follow-up|0|||
148885450|NCT00940498|537057015|FG007|Overall Study|Lost to Follow-up|1|||
148885451|NCT00940498|537057008|FG000|Overall Study|Disease Progression|0|||
148885452|NCT00940498|537057009|FG001|Overall Study|Disease Progression|0|||
148885453|NCT00940498|537057010|FG002|Overall Study|Disease Progression|1|||
148885454|NCT00940498|537057011|FG003|Overall Study|Disease Progression|1|||
148885455|NCT00940498|537057012|FG004|Overall Study|Disease Progression|0|||
148885456|NCT00940498|537057013|FG005|Overall Study|Disease Progression|1|||
148885457|NCT00940498|537057014|FG006|Overall Study|Disease Progression|0|||
148885458|NCT00940498|537057015|FG007|Overall Study|Disease Progression|0|||
148885459|NCT00940498|537057008|FG000|Overall Study|Physician Decision|0|||
148885460|NCT00940498|537057009|FG001|Overall Study|Physician Decision|0|||
148885461|NCT00940498|537057010|FG002|Overall Study|Physician Decision|0|||
148885462|NCT00940498|537057011|FG003|Overall Study|Physician Decision|0|||
148885463|NCT00940498|537057012|FG004|Overall Study|Physician Decision|2|||
148885464|NCT00940498|537057013|FG005|Overall Study|Physician Decision|0|||
148885465|NCT00940498|537057014|FG006|Overall Study|Physician Decision|0|||
148885466|NCT00940498|537057015|FG007|Overall Study|Physician Decision|0|||
148885467|NCT00940498|537057008|FG000|Overall Study|Not treated due to disease related pain|0|||
148885468|NCT00940498|537057009|FG001|Overall Study|Not treated due to disease related pain|0|||
148885469|NCT00940498|537057010|FG002|Overall Study|Not treated due to disease related pain|0|||
149044950|NCT02723955|537645485|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044951|NCT02723955|537645486|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
149044952|NCT02723955|537645487|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044953|NCT02723955|537645488|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
149044954|NCT02723955|537645489|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
148885470|NCT00940498|537057011|FG003|Overall Study|Not treated due to disease related pain|0|||
148885471|NCT00940498|537057012|FG004|Overall Study|Not treated due to disease related pain|1|||
148885472|NCT00940498|537057013|FG005|Overall Study|Not treated due to disease related pain|0|||
148885473|NCT00940498|537057014|FG006|Overall Study|Not treated due to disease related pain|0|||
148885474|NCT00940498|537057015|FG007|Overall Study|Not treated due to disease related pain|0|||
148885475|NCT00650845|537057016|FG000|Overall Study|Withdrawal by Subject|5|||
148885476|NCT00650845|537057017|FG001|Overall Study|Withdrawal by Subject|0|||
148885477|NCT00650845|537057016|FG000|Overall Study|Protocol Violation|0|||
148885478|NCT00650845|537057017|FG001|Overall Study|Protocol Violation|13|||
148885479|NCT03761810|537057018|FG000|Overall Study|Adverse Event|12|||
148885480|NCT03761810|537057019|FG001|Overall Study|Adverse Event|0|||
148885481|NCT03761810|537057018|FG000|Overall Study|Lost to Follow-up|15|||
148885482|NCT03761810|537057019|FG001|Overall Study|Lost to Follow-up|7|||
148885483|NCT03761810|537057018|FG000|Overall Study|Pregnancy|1|||
148885484|NCT03761810|537057019|FG001|Overall Study|Pregnancy|0|||
148885485|NCT03761810|537057018|FG000|Overall Study|Withdrawal by Subject|14|||
148885486|NCT03761810|537057019|FG001|Overall Study|Withdrawal by Subject|5|||
148885487|NCT03761810|537057018|FG000|Overall Study|Physician Decision|1|||
148885488|NCT03761810|537057019|FG001|Overall Study|Physician Decision|0|||
148885489|NCT03761810|537057018|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
148885490|NCT03761810|537057019|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149044955|NCT02723955|537645447|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044956|NCT02723955|537645448|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044957|NCT02723955|537645449|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044958|NCT02723955|537645450|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044959|NCT02723955|537645451|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044960|NCT02723955|537645452|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044961|NCT02723955|537645453|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044962|NCT02723955|537645454|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044963|NCT02723955|537645455|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044964|NCT02723955|537645456|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044965|NCT02723955|537645457|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044966|NCT02723955|537645458|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044967|NCT02723955|537645459|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044968|NCT02723955|537645460|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044969|NCT02723955|537645461|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044970|NCT02723955|537645462|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044971|NCT02723955|537645463|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044972|NCT02723955|537645464|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044973|NCT02723955|537645465|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044974|NCT02723955|537645466|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044975|NCT02723955|537645467|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044976|NCT02723955|537645468|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044977|NCT02723955|537645469|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044978|NCT02723955|537645470|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044979|NCT02723955|537645471|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044980|NCT02723955|537645472|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044981|NCT02723955|537645473|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044982|NCT02723955|537645474|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044983|NCT02723955|537645475|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044984|NCT02723955|537645476|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044985|NCT02723955|537645477|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044986|NCT02723955|537645478|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044987|NCT02723955|537645479|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044988|NCT02723955|537645480|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044989|NCT02723955|537645481|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044990|NCT02723955|537645482|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044991|NCT02723955|537645483|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044992|NCT02723955|537645484|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044993|NCT02723955|537645485|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
149044994|NCT02723955|537645486|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
149044995|NCT02723955|537645487|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044996|NCT02723955|537645488|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
149044997|NCT02723955|537645489|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
149044998|NCT02723955|537645447|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
149044999|NCT02723955|537645448|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
149045000|NCT02723955|537645449|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
149045001|NCT02723955|537645450|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
149045002|NCT02723955|537645451|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
148885491|NCT03761810|537057018|FG000|Overall Study|Other Than Specified|1|||
148885492|NCT03761810|537057019|FG001|Overall Study|Other Than Specified|0|||
148885493|NCT00869518|537057020|FG000|Overall Study|Lost to Follow-up|1|||
148885494|NCT00869518|537057021|FG001|Overall Study|Lost to Follow-up|1|||
148885495|NCT04178720|537057022|FG000|Overall Study|Withdrawal by Subject|2|||
148885496|NCT04178720|537057023|FG001|Overall Study|Withdrawal by Subject|0|||
148885497|NCT04178720|537057022|FG000|Overall Study|Relocation|0|||
148885498|NCT04178720|537057023|FG001|Overall Study|Relocation|1|||
148885499|NCT02663622|537057024|FG000|Overall Study|Death|3|||
148885500|NCT02663622|537057025|FG001|Overall Study|Death|1|||
148885501|NCT02663622|537057026|FG002|Overall Study|Death|1|||
148885502|NCT02663622|537057027|FG003|Overall Study|Death|8|||
148885503|NCT02663622|537057024|FG000|Overall Study|Protocol Violation|0|||
148885504|NCT02663622|537057025|FG001|Overall Study|Protocol Violation|0|||
148885505|NCT02663622|537057026|FG002|Overall Study|Protocol Violation|0|||
148885506|NCT02663622|537057027|FG003|Overall Study|Protocol Violation|1|||
148885507|NCT00930930|537057030|FG000|Overall Study|Death|1|||
148885508|NCT00930930|537057031|FG001|Overall Study|Death|0|||
148885509|NCT00930930|537057030|FG000|Overall Study|Physician Decision|1|||
148885510|NCT00930930|537057031|FG001|Overall Study|Physician Decision|0|||
148885511|NCT00930930|537057030|FG000|Overall Study|Adverse Event|13|||
148885512|NCT00930930|537057031|FG001|Overall Study|Adverse Event|3|||
148885513|NCT00930930|537057030|FG000|Overall Study|Withdrawal by Subject|3|||
148885514|NCT00930930|537057031|FG001|Overall Study|Withdrawal by Subject|1|||
148885515|NCT00930930|537057030|FG000|Overall Study|Disease progression|2|||
148885516|NCT00930930|537057031|FG001|Overall Study|Disease progression|3|||
149045003|NCT02723955|537645452|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
149045004|NCT02723955|537645453|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
149045005|NCT02723955|537645454|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
149045006|NCT02723955|537645455|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
149045007|NCT02723955|537645456|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
149045008|NCT02723955|537645457|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
149045009|NCT02723955|537645458|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
149045010|NCT02723955|537645459|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
149045011|NCT02723955|537645460|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
149045012|NCT02723955|537645461|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
149045013|NCT02723955|537645462|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
149045014|NCT02723955|537645463|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
149045015|NCT02723955|537645464|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
149045016|NCT02723955|537645465|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
149045017|NCT02723955|537645466|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
149045018|NCT02723955|537645467|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
149045019|NCT02723955|537645468|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
149045020|NCT02723955|537645469|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
149045021|NCT02723955|537645470|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
149045022|NCT02723955|537645471|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
149045023|NCT02723955|537645472|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
149045024|NCT02723955|537645473|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
149045025|NCT02723955|537645474|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
149045026|NCT02723955|537645475|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
149045027|NCT02723955|537645476|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
149045028|NCT02723955|537645477|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
149045029|NCT02723955|537645478|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
149045030|NCT02723955|537645479|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
149045031|NCT02723955|537645480|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
149045032|NCT02723955|537645481|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
149045033|NCT02723955|537645482|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
149045034|NCT02723955|537645483|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
149045035|NCT02723955|537645484|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
149045036|NCT02723955|537645485|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
149045037|NCT02723955|537645486|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
149045038|NCT02723955|537645487|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
149045039|NCT02723955|537645488|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
149045040|NCT02723955|537645489|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
149045041|NCT04999085|537645492|FG000|Overall Study|Death|1|||
149045042|NCT03990649|537645505|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
149045043|NCT03990649|537645506|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
149045044|NCT03990649|537645507|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
149045045|NCT03990649|537645505|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
149045046|NCT03990649|537645506|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
149045047|NCT03990649|537645507|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
149045048|NCT03990649|537645505|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
149045049|NCT03990649|537645506|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
149045050|NCT03990649|537645507|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
149045051|NCT03990649|537645505|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
149045052|NCT03990649|537645506|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
149045053|NCT03990649|537645507|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
149045054|NCT03990649|537645505|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
149045055|NCT03990649|537645506|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
149045056|NCT03990649|537645507|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
149045057|NCT03990649|537645505|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
149045058|NCT03990649|537645506|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
149045059|NCT03990649|537645507|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
149045060|NCT03990649|537645505|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
149045061|NCT03990649|537645506|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
149045062|NCT03990649|537645507|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
149045063|NCT05773313|537645508|FG000|Overall Study|Lost to Follow-up|3|||
149045064|NCT03050814|537645509|FG000|Overall Study|Screen failures|0|||
149045065|NCT03050814|537645510|FG001|Overall Study|Screen failures|0|||
149045066|NCT03050814|537645511|FG002|Overall Study|Screen failures|4|||
149045067|NCT01443845|537645512|FG000|Overall Study|Protocol Violation|43|||
149045068|NCT01443845|537645513|FG001|Overall Study|Protocol Violation|45|||
149045069|NCT01443845|537645512|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
149045070|NCT01443845|537645513|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
149045071|NCT01443845|537645512|FG000|Overall Study|Deterioration in pulmonary function|1|||
149045072|NCT01443845|537645513|FG001|Overall Study|Deterioration in pulmonary function|4|||
149045073|NCT01443845|537645512|FG000|Overall Study|Lack of Efficacy|10|||
149045074|NCT01443845|537645513|FG001|Overall Study|Lack of Efficacy|5|||
149045075|NCT01443845|537645512|FG000|Overall Study|Adverse Event|64|||
149045076|NCT01443845|537645513|FG001|Overall Study|Adverse Event|138|||
149045077|NCT01443845|537645512|FG000|Overall Study|Withdrawal by Subject|63|||
149045078|NCT01443845|537645513|FG001|Overall Study|Withdrawal by Subject|67|||
149045079|NCT01443845|537645512|FG000|Overall Study|Military Conflict - Site Terminated|20|||
149045080|NCT01443845|537645513|FG001|Overall Study|Military Conflict - Site Terminated|21|||
149045081|NCT01443845|537645512|FG000|Overall Study|Lost to Follow-up|9|||
149045082|NCT01443845|537645513|FG001|Overall Study|Lost to Follow-up|13|||
149045083|NCT01471691|537645514|FG000|Overall Study|Lack of Efficacy|0|||
149045084|NCT01471691|537645515|FG001|Overall Study|Lack of Efficacy|1|||
149045085|NCT01854385|537645516|FG000|Pre-Treatment|Withdrawal by Subject|4|||
149045086|NCT01854385|537645516|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
149045087|NCT01854385|537645516|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
149045088|NCT01854385|537645516|FG000|Pre-Treatment|Unable to come for study visits|1|||
149045089|NCT01854385|537645516|FG000|Treatment|Lost to Follow-up|1|||
149045090|NCT02386553|537645517|FG000|Overall Study|Reason Not Specified|1|||
149045091|NCT02386553|537645518|FG001|Overall Study|Reason Not Specified|1|||
149045092|NCT02386553|537645517|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
149045093|NCT02386553|537645518|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
149045094|NCT01610297|537645519|FG000|Overall Study|Lost to Follow-up|1|||
149045095|NCT00609336|537645521|FG000|Overall Study|Protocol Violation|3|||
149045096|NCT00609336|537645521|FG000|Overall Study|Death|1|||
149045097|NCT00609336|537645521|FG000|Overall Study|LA or Met at Surgery|9|||
149045098|NCT02477605|537645522|FG000|Overall Study|Discontinued prior to treatment|1|||
149045099|NCT02477605|537645523|FG001|Overall Study|Discontinued prior to treatment|0|||
149045100|NCT02477605|537645522|FG000|Overall Study|Lost to Follow-up|0|||
149045101|NCT02477605|537645523|FG001|Overall Study|Lost to Follow-up|2|||
149045102|NCT02477605|537645522|FG000|Overall Study|Withdrawal by Subject|0|||
149045103|NCT02477605|537645523|FG001|Overall Study|Withdrawal by Subject|1|||
149045104|NCT02477605|537645522|FG000|Overall Study|Administered gas during surgery|0|||
149045105|NCT02477605|537645523|FG001|Overall Study|Administered gas during surgery|1|||
149045106|NCT00567489|537645524|FG000|Overall Study|Adverse Event|6|||
149045107|NCT00567489|537645525|FG001|Overall Study|Adverse Event|14|||
149045108|NCT00567489|537645524|FG000|Overall Study|Physician Decision|0|||
149045109|NCT00567489|537645525|FG001|Overall Study|Physician Decision|4|||
149045110|NCT00567489|537645524|FG000|Overall Study|Withdrawal by Subject|0|||
149045111|NCT00567489|537645525|FG001|Overall Study|Withdrawal by Subject|2|||
149045112|NCT00567489|537645524|FG000|Overall Study|Renal Transplantation|0|||
149045113|NCT00567489|537645525|FG001|Overall Study|Renal Transplantation|3|||
149045114|NCT00567489|537645524|FG000|Overall Study|Other|1|||
149045115|NCT00567489|537645525|FG001|Overall Study|Other|0|||
149045116|NCT01061671|537645528|FG000|Overall Study|Withdrawal by Subject|16|||
149045117|NCT01061671|537645529|FG001|Overall Study|Withdrawal by Subject|20|||
149045118|NCT01061671|537645528|FG000|Overall Study|Lost to Follow-up|3|||
149045119|NCT01061671|537645529|FG001|Overall Study|Lost to Follow-up|5|||
149045120|NCT01061671|537645528|FG000|Overall Study|Death|28|||
149045121|NCT01061671|537645529|FG001|Overall Study|Death|30|||
149045122|NCT00068601|537645530|FG000|Overall Study|Ineligible|11|||
149045123|NCT00068601|537645531|FG001|Overall Study|Ineligible|13|||
149045124|NCT00068601|537645530|FG000|Overall Study|Not evaluable: withdrew consent|5|||
149045125|NCT00068601|537645531|FG001|Overall Study|Not evaluable: withdrew consent|4|||
149045126|NCT00068601|537645530|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
149045127|NCT00068601|537645531|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
149045128|NCT00068601|537645530|FG000|Overall Study|Death|11|||
149045129|NCT00068601|537645531|FG001|Overall Study|Death|3|||
149045130|NCT00068601|537645530|FG000|Overall Study|Lost to Follow-up|3|||
149045131|NCT00068601|537645531|FG001|Overall Study|Lost to Follow-up|2|||
149045132|NCT00068601|537645530|FG000|Overall Study|Missing primary outcome data|30|||
149045133|NCT00068601|537645531|FG001|Overall Study|Missing primary outcome data|34|||
149045134|NCT02692417|537645545|FG000|Overall Study|Withdrawal by Subject|5|||
149045135|NCT02692417|537645546|FG001|Overall Study|Withdrawal by Subject|1|||
149045136|NCT02692417|537645545|FG000|Overall Study|Adverse Event|1|||
149045137|NCT02692417|537645546|FG001|Overall Study|Adverse Event|0|||
149045138|NCT02372253|537645555|FG000|Overall Study|Non Compliance|2|||
149045139|NCT02372253|537645556|FG001|Overall Study|Non Compliance|0|||
149045140|NCT01803555|537645559|FG000|Overall Study|Adverse Event|3|||
149045141|NCT01803555|537645560|FG001|Overall Study|Adverse Event|2|||
149045142|NCT01803555|537645559|FG000|Overall Study|Withdrawal by Subject|3|||
149045143|NCT01803555|537645560|FG001|Overall Study|Withdrawal by Subject|3|||
149045144|NCT01803555|537645559|FG000|Overall Study|Non-compliance|1|||
149045145|NCT01803555|537645560|FG001|Overall Study|Non-compliance|1|||
149045146|NCT01803555|537645559|FG000|Overall Study|Protocol Violation|3|||
149045147|NCT01803555|537645560|FG001|Overall Study|Protocol Violation|5|||
149045148|NCT01803555|537645559|FG000|Overall Study|Lost to Follow-up|0|||
149045149|NCT01803555|537645560|FG001|Overall Study|Lost to Follow-up|2|||
149045150|NCT01803555|537645559|FG000|Overall Study|Other than specified|3|||
149045151|NCT01803555|537645560|FG001|Overall Study|Other than specified|5|||
149045152|NCT01551355|537645567|FG000|Overall Study|Lost to Follow-up|51|||
149045153|NCT01551355|537645568|FG001|Overall Study|Lost to Follow-up|49|||
149045154|NCT01551355|537645569|FG002|Overall Study|Lost to Follow-up|34|||
149045155|NCT01551355|537645570|FG003|Overall Study|Lost to Follow-up|24|||
149045156|NCT01551355|537645571|FG004|Overall Study|Lost to Follow-up|9|||
149045157|NCT01551355|537645572|FG005|Overall Study|Lost to Follow-up|6|||
149045158|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
149045159|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
149045160|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
149045161|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
149045162|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
149045163|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
149045164|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
149045165|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
149045166|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
149045167|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
149045168|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
149045169|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
149045170|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
149045171|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
149045172|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
149045173|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
149045174|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
149045175|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
149045176|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
149045177|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
149045178|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
149045179|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
149045180|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
149045181|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
149045182|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
149045183|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
149045184|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
149045185|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
149045186|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
149045187|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
149045188|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
149045189|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
149045190|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
149045191|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
149045192|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
149045193|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
149045194|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
149045195|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
149045196|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
149045197|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
149045198|NCT02409667|537645573|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
149045199|NCT02409667|537645574|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
149045200|NCT02409667|537645575|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
149045201|NCT02409667|537645576|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
149045202|NCT02409667|537645577|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
149045203|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
149045204|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
149045205|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
149045206|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
149045207|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
149045208|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
149045209|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
149045210|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
149045211|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
149045212|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
149045213|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
148885517|NCT00930930|537057030|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
149045214|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
149045215|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
149045216|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
149045217|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
149045218|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
149045219|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
149045220|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
149045221|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
149045222|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
149045223|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
149045224|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
149045225|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
149045226|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
149045227|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
149045228|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
149045229|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
149045230|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
149045231|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
149045232|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
149045233|NCT02409667|537645573|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
149045234|NCT02409667|537645574|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
149045235|NCT02409667|537645575|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
149045236|NCT02409667|537645576|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
149045237|NCT02409667|537645577|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
149045238|NCT01925339|537645578|FG000|Overall Study|Adverse Event|2|||
149045239|NCT01925339|537645579|FG001|Overall Study|Adverse Event|0|||
149045240|NCT01205048|537645582|FG000|Overall Study|Withdrawal by Subject|14|||
149045241|NCT01205048|537645582|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
149045242|NCT01205048|537645582|FG000|Overall Study|Lost to Follow-up|4|||
149045243|NCT01205048|537645582|FG000|Overall Study|Other|2|||
149045244|NCT01255670|537645583|FG000|Overall Study|Adverse Event|10|||
149045245|NCT01255670|537645584|FG001|Overall Study|Adverse Event|10|||
149045246|NCT01255670|537645583|FG000|Overall Study|Lost to Follow-up|16|||
149045247|NCT01255670|537645584|FG001|Overall Study|Lost to Follow-up|10|||
149045248|NCT03664960|537645585|FG000|Overall Study|Adverse Event|0|||
149045249|NCT03664960|537645586|FG001|Overall Study|Adverse Event|3|||
149045250|NCT03664960|537645585|FG000|Overall Study|Lost to Follow-up|3|||
149045251|NCT03664960|537645586|FG001|Overall Study|Lost to Follow-up|2|||
149045252|NCT03664960|537645585|FG000|Overall Study|Physician Decision|1|||
149045253|NCT03664960|537645586|FG001|Overall Study|Physician Decision|0|||
149045254|NCT03664960|537645585|FG000|Overall Study|Withdrawal by Subject|3|||
149045255|NCT03664960|537645586|FG001|Overall Study|Withdrawal by Subject|14|||
149045256|NCT03664960|537645585|FG000|Overall Study|Sponsor Decision|1|||
149045257|NCT03664960|537645586|FG001|Overall Study|Sponsor Decision|1|||
149045258|NCT03664960|537645585|FG000|Overall Study|Other|1|||
149045259|NCT03664960|537645586|FG001|Overall Study|Other|2|||
149045260|NCT00823472|537645587|FG000|Overall Study|Physician Decision|24|||
149045261|NCT00823472|537645588|FG001|Overall Study|Physician Decision|28|||
149045262|NCT04019444|537645589|FG000|Overall Study|Withdrawal by Subject|0|||
149045263|NCT04019444|537645590|FG001|Overall Study|Withdrawal by Subject|1|||
149045264|NCT04019444|537645591|FG002|Overall Study|Withdrawal by Subject|0|||
149045265|NCT04019444|537645592|FG003|Overall Study|Withdrawal by Subject|1|||
149045266|NCT04019444|537645589|FG000|Overall Study|Solicited Event|0|||
149045267|NCT04019444|537645590|FG001|Overall Study|Solicited Event|0|||
149045268|NCT04019444|537645591|FG002|Overall Study|Solicited Event|2|||
149045269|NCT04019444|537645592|FG003|Overall Study|Solicited Event|0|||
149045270|NCT03997916|537645601|FG000|Overall Study|Protocol Violation|35|||
149045271|NCT04992390|537645607|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
149045272|NCT04992390|537645608|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
149045273|NCT04992390|537645609|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
149045274|NCT04992390|537645607|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
149045275|NCT04992390|537645608|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
149045276|NCT04992390|537645609|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
149045277|NCT04992390|537645607|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
149045278|NCT04992390|537645608|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
148885518|NCT00930930|537057031|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
148885519|NCT00930930|537057030|FG000|Overall Study|patients not compliant|1|||
149045279|NCT04992390|537645609|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
149045280|NCT04992390|537645607|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
149045281|NCT04992390|537645608|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
149045282|NCT04992390|537645609|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
149045283|NCT04992390|537645607|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
149045284|NCT04992390|537645608|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
149045285|NCT04992390|537645609|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
149045286|NCT04992390|537645607|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
149045287|NCT04992390|537645608|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
149045288|NCT04992390|537645609|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
149045289|NCT04992390|537645607|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
149045290|NCT04992390|537645608|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
149045291|NCT04992390|537645609|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
149045292|NCT04992390|537645607|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
149045293|NCT04992390|537645608|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
149045294|NCT04992390|537645609|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
149045295|NCT04992390|537645607|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
149045296|NCT04992390|537645608|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
149045297|NCT04992390|537645609|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
149045298|NCT04992390|537645607|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
149045299|NCT04992390|537645608|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
149045300|NCT04992390|537645609|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
149045301|NCT04992390|537645607|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
149045302|NCT04992390|537645608|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
149045303|NCT04992390|537645609|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
149045304|NCT04992390|537645607|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
149045305|NCT04992390|537645608|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
149045306|NCT04992390|537645609|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
149045307|NCT04992390|537645607|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
149045308|NCT04992390|537645608|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
149045309|NCT04992390|537645609|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
149045310|NCT04992390|537645607|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
149045311|NCT04992390|537645608|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
149045312|NCT04992390|537645609|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
149045313|NCT04992390|537645607|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
149045314|NCT04992390|537645608|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
149045315|NCT04992390|537645609|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
149045316|NCT04992390|537645607|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
149045317|NCT04992390|537645608|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
149045318|NCT04992390|537645609|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
149045319|NCT03807778|537645612|FG000|Overall Study|Adverse Event|0|||
149045320|NCT03807778|537645613|FG001|Overall Study|Adverse Event|0|||
149045321|NCT03807778|537645614|FG002|Overall Study|Adverse Event|3|||
149045322|NCT03807778|537645615|FG003|Overall Study|Adverse Event|5|||
149045323|NCT03807778|537645612|FG000|Overall Study|Progressive Disease|4|||
149045324|NCT03807778|537645613|FG001|Overall Study|Progressive Disease|2|||
149045325|NCT03807778|537645614|FG002|Overall Study|Progressive Disease|8|||
149045326|NCT03807778|537645615|FG003|Overall Study|Progressive Disease|15|||
149045327|NCT03807778|537645612|FG000|Overall Study|Symptomatic Deterioration|0|||
149045328|NCT03807778|537645613|FG001|Overall Study|Symptomatic Deterioration|1|||
149045329|NCT03807778|537645614|FG002|Overall Study|Symptomatic Deterioration|0|||
149045330|NCT03807778|537645615|FG003|Overall Study|Symptomatic Deterioration|1|||
149045331|NCT03807778|537645612|FG000|Overall Study|Withdrawal by Subject|0|||
149045332|NCT03807778|537645613|FG001|Overall Study|Withdrawal by Subject|1|||
149045333|NCT03807778|537645614|FG002|Overall Study|Withdrawal by Subject|0|||
149045334|NCT03807778|537645615|FG003|Overall Study|Withdrawal by Subject|1|||
149045335|NCT03807778|537645612|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
149045336|NCT03807778|537645613|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
149045337|NCT03807778|537645614|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
149045338|NCT03807778|537645615|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
149045339|NCT01207492|537645616|FG000|Overall Study|Still on study|1|||
149045340|NCT01207492|537645616|FG000|Overall Study|Withdrawal by Subject|9|||
149045341|NCT01207492|537645616|FG000|Overall Study|Physician Decision|1|||
149045342|NCT01207492|537645616|FG000|Overall Study|Progressive disease|3|||
149045343|NCT01207492|537645616|FG000|Overall Study|Toxicity|1|||
149045344|NCT02769858|537645617|FG000|Overall Study|Withdrawal by Subject|2|||
149045345|NCT04939246|537645619|FG000|After Treatment|Death|4|||
149045346|NCT04939246|537645619|FG000|After Treatment|Lost to Follow-up|1|||
149045347|NCT04939246|537645619|FG000|After Treatment|Discharged to hospice|2|||
149045348|NCT01216176|537647217|FG000|Overall Study|Adverse Event|0|||
149045349|NCT01216176|537647218|FG001|Overall Study|Adverse Event|8|||
149045350|NCT01216176|537647219|FG002|Overall Study|Adverse Event|0|||
149045351|NCT01216176|537647217|FG000|Overall Study|Physician Decision|0|||
149045352|NCT01216176|537647218|FG001|Overall Study|Physician Decision|0|||
149045353|NCT01216176|537647219|FG002|Overall Study|Physician Decision|1|||
149045354|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
149045355|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
149045356|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
149045357|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
149045358|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
149045359|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
149045360|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
149045361|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
149045362|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
149045363|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
149045364|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
149045365|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
149045366|NCT01600014|537647222|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
149045367|NCT01600014|537647223|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
149045368|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
149045369|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
149045370|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
149045371|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
149045372|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
149045373|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
149045374|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
149045375|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
149045376|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
149045377|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
149045378|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
149045379|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
149045380|NCT01600014|537647222|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
149045381|NCT01600014|537647223|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
149045382|NCT01600014|537647222|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
149045383|NCT01600014|537647223|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
149045384|NCT01600014|537647222|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
149045385|NCT01600014|537647223|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
149045386|NCT01600014|537647222|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
149045387|NCT01600014|537647223|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
149045388|NCT04201834|537647233|FG000|Overall Study|Screen fail|1|||
149045389|NCT04104321|537647234|FG000|Overall Study|didn't take the study drug|3|||
149045390|NCT05056246|537647237|FG000|Overall Study|Adverse Event|0|||
149045391|NCT05056246|537647238|FG001|Overall Study|Adverse Event|0|||
149045392|NCT05056246|537647239|FG002|Overall Study|Adverse Event|0|||
149045393|NCT05056246|537647240|FG003|Overall Study|Adverse Event|0|||
149045394|NCT05056246|537647241|FG004|Overall Study|Adverse Event|1|||
149045395|NCT05056246|537647237|FG000|Overall Study|Lost to Follow-up|0|||
149045396|NCT05056246|537647238|FG001|Overall Study|Lost to Follow-up|0|||
149045397|NCT05056246|537647239|FG002|Overall Study|Lost to Follow-up|0|||
149045398|NCT05056246|537647240|FG003|Overall Study|Lost to Follow-up|2|||
149045399|NCT05056246|537647241|FG004|Overall Study|Lost to Follow-up|0|||
149045400|NCT05056246|537647237|FG000|Overall Study|Withdrawal by Subject|0|||
149045401|NCT05056246|537647238|FG001|Overall Study|Withdrawal by Subject|1|||
149045402|NCT05056246|537647239|FG002|Overall Study|Withdrawal by Subject|0|||
149045403|NCT05056246|537647240|FG003|Overall Study|Withdrawal by Subject|0|||
149045404|NCT05056246|537647241|FG004|Overall Study|Withdrawal by Subject|0|||
149045405|NCT05096819|537647246|FG000|Overall Study|Withdrawal by Subject|3|||
149045406|NCT05096819|537647247|FG001|Overall Study|Withdrawal by Subject|0|||
149045407|NCT03324984|537647248|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
149045408|NCT03324984|537647249|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
149045409|NCT02152137|537647251|FG000|Overall Study|Withdrawal by Subject|1|||
149045410|NCT02152137|537647251|FG000|Overall Study|Originally assigned to Arm B|3|||
149045411|NCT04878354|537647252|FG000|Overall Study|Adverse Event|4|||
149045412|NCT04878354|537647253|FG001|Overall Study|Adverse Event|13|||
149045413|NCT04878354|537647252|FG000|Overall Study|Withdrawal by Subject|14|||
149045414|NCT04878354|537647253|FG001|Overall Study|Withdrawal by Subject|12|||
149045415|NCT04878354|537647252|FG000|Overall Study|Lost to Follow-up|4|||
149045416|NCT04878354|537647253|FG001|Overall Study|Lost to Follow-up|1|||
149045417|NCT04878354|537647252|FG000|Overall Study|Lack of Efficacy|1|||
149045418|NCT04878354|537647253|FG001|Overall Study|Lack of Efficacy|0|||
149045419|NCT04878354|537647252|FG000|Overall Study|Protocol Violation|0|||
149045420|NCT04878354|537647253|FG001|Overall Study|Protocol Violation|1|||
149045421|NCT04878354|537647252|FG000|Overall Study|"Reason stated as other in CRF"|2|||
149045422|NCT04878354|537647253|FG001|Overall Study|"Reason stated as other in CRF"|3|||
149045423|NCT03358875|537647254|FG000|Overall Study|Death|409|||
149045424|NCT03358875|537647255|FG001|Overall Study|Death|223|||
149045425|NCT03358875|537647254|FG000|Overall Study|Study Closed by Sponsor|66|||
149045426|NCT03358875|537647255|FG001|Overall Study|Study Closed by Sponsor|29|||
149045427|NCT03358875|537647254|FG000|Overall Study|Withdrawal by Subject|13|||
149045428|NCT03358875|537647255|FG001|Overall Study|Withdrawal by Subject|16|||
149045429|NCT03358875|537647254|FG000|Overall Study|Lost to Follow-up|13|||
149045430|NCT03358875|537647255|FG001|Overall Study|Lost to Follow-up|2|||
149045431|NCT03358875|537647254|FG000|Overall Study|Miscellaneous|33|||
149045432|NCT03358875|537647255|FG001|Overall Study|Miscellaneous|0|||
149045433|NCT03358875|537647254|FG000|Overall Study|Remained on Study|1|||
149045434|NCT03358875|537647255|FG001|Overall Study|Remained on Study|0|||
149045435|NCT06194214|537647268|FG000|Overall Study|Adverse Event|1|||
149045436|NCT05687903|537647269|FG000|Overall Study|Protocol Deviation|1|||
149045437|NCT05687903|537647270|FG001|Overall Study|Protocol Deviation|1|||
149045438|NCT05687903|537647271|FG002|Overall Study|Protocol Deviation|0|||
149045439|NCT05687903|537647272|FG003|Overall Study|Protocol Deviation|1|||
149045440|NCT05687903|537647273|FG004|Overall Study|Protocol Deviation|0|||
149045441|NCT04847999|537647274|FG000|Overall Study|Lost to Follow-up|0|||
149045442|NCT04847999|537647275|FG001|Overall Study|Lost to Follow-up|1|||
149045443|NCT02879448|537647276|FG000|Overall Study|Death|251|||
149045444|NCT02879448|537647277|FG001|Overall Study|Death|263|||
149045445|NCT02879448|537647276|FG000|Overall Study|Lost to Follow-up|23|||
149045446|NCT02879448|537647277|FG001|Overall Study|Lost to Follow-up|28|||
149045447|NCT02879448|537647276|FG000|Overall Study|Withdrawal by Subject|42|||
149045448|NCT02879448|537647277|FG001|Overall Study|Withdrawal by Subject|79|||
149045449|NCT02879448|537647276|FG000|Overall Study|Other Reasons|8|||
149045450|NCT02879448|537647277|FG001|Overall Study|Other Reasons|12|||
149045451|NCT04300231|537647278|FG000|Overall Study|Protocol Violation|4|||
149045452|NCT04300231|537647279|FG001|Overall Study|Protocol Violation|3|||
149045453|NCT04300231|537647280|FG002|Overall Study|Protocol Violation|0|||
149045454|NCT04300231|537647281|FG003|Overall Study|Protocol Violation|2|||
149045455|NCT00998881|537647285|FG000|Overall Study|Adverse Event|2|||
149045456|NCT00998881|537647286|FG001|Overall Study|Adverse Event|2|||
149045457|NCT00998881|537647285|FG000|Overall Study|Lack of Efficacy|1|||
149045458|NCT00998881|537647286|FG001|Overall Study|Lack of Efficacy|0|||
149045459|NCT00998881|537647285|FG000|Overall Study|Physician Decision|3|||
149045460|NCT00998881|537647286|FG001|Overall Study|Physician Decision|0|||
149045461|NCT00998881|537647285|FG000|Overall Study|Withdrawal by Subject|1|||
149045462|NCT00998881|537647286|FG001|Overall Study|Withdrawal by Subject|0|||
149045463|NCT00998881|537647285|FG000|Overall Study|Personal matter|1|||
149045464|NCT00998881|537647286|FG001|Overall Study|Personal matter|0|||
149045465|NCT01121991|537647287|FG000|Overall Study|Lack of Ovarian Response|2|||
149045466|NCT01121991|537647287|FG000|Overall Study|No Oocytes Retrieved|3|||
149045467|NCT01121991|537647287|FG000|Overall Study|No Fertilization|1|||
149045468|NCT02590432|537647291|FG000|Open-label Treatment Period|Adverse Event|97|||
149045469|NCT02590432|537647292|FG001|Open-label Treatment Period|Adverse Event|79|||
149045470|NCT02590432|537647293|FG002|Open-label Treatment Period|Adverse Event|0|||
149045471|NCT02590432|537647294|FG003|Open-label Treatment Period|Adverse Event|0|||
149045472|NCT02590432|537647295|FG004|Open-label Treatment Period|Adverse Event|0|||
149045473|NCT02590432|537647296|FG005|Open-label Treatment Period|Adverse Event|0|||
149045474|NCT02590432|537647297|FG006|Open-label Treatment Period|Adverse Event|0|||
149045475|NCT02590432|537647298|FG007|Open-label Treatment Period|Adverse Event|0|||
149045476|NCT02590432|537647299|FG008|Open-label Treatment Period|Adverse Event|0|||
149045477|NCT02590432|537647291|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
149045478|NCT02590432|537647292|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
149045479|NCT02590432|537647293|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
149045480|NCT02590432|537647294|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
149045481|NCT02590432|537647295|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
149045482|NCT02590432|537647296|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
149045483|NCT02590432|537647297|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
149045484|NCT02590432|537647298|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
149045485|NCT02590432|537647299|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
149045486|NCT02590432|537647291|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
149045487|NCT02590432|537647292|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
149045488|NCT02590432|537647293|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
149045489|NCT02590432|537647294|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
149045490|NCT02590432|537647295|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
149045491|NCT02590432|537647296|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
149045492|NCT02590432|537647297|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
149045493|NCT02590432|537647298|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
149045494|NCT02590432|537647299|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
149045495|NCT02590432|537647291|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
149045496|NCT02590432|537647292|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
148885520|NCT00930930|537057031|FG001|Overall Study|patients not compliant|1|||
149045497|NCT02590432|537647293|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
149045498|NCT02590432|537647294|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
149045499|NCT02590432|537647295|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
149045500|NCT02590432|537647296|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
149045501|NCT02590432|537647297|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
149045502|NCT02590432|537647298|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
149045503|NCT02590432|537647299|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
149045504|NCT02590432|537647291|FG000|Open-label Treatment Period|Protocol Violation|10|||
149045505|NCT02590432|537647292|FG001|Open-label Treatment Period|Protocol Violation|4|||
149045506|NCT02590432|537647293|FG002|Open-label Treatment Period|Protocol Violation|0|||
149045507|NCT02590432|537647294|FG003|Open-label Treatment Period|Protocol Violation|0|||
149045508|NCT02590432|537647295|FG004|Open-label Treatment Period|Protocol Violation|0|||
149045509|NCT02590432|537647296|FG005|Open-label Treatment Period|Protocol Violation|0|||
149045510|NCT02590432|537647297|FG006|Open-label Treatment Period|Protocol Violation|0|||
149045511|NCT02590432|537647298|FG007|Open-label Treatment Period|Protocol Violation|0|||
149045512|NCT02590432|537647299|FG008|Open-label Treatment Period|Protocol Violation|0|||
149045513|NCT02590432|537647291|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
149045514|NCT02590432|537647292|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
149045515|NCT02590432|537647293|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045516|NCT02590432|537647294|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045517|NCT02590432|537647295|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045518|NCT02590432|537647296|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045519|NCT02590432|537647297|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045520|NCT02590432|537647298|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045521|NCT02590432|537647299|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
149045522|NCT02590432|537647291|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
149045523|NCT02590432|537647292|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
149045524|NCT02590432|537647293|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045525|NCT02590432|537647294|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045526|NCT02590432|537647295|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045527|NCT02590432|537647296|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045528|NCT02590432|537647297|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045529|NCT02590432|537647298|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045530|NCT02590432|537647299|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
149045531|NCT02590432|537647291|FG000|Double-blind Treatment Period|Adverse Event|0|||
149045532|NCT02590432|537647292|FG001|Double-blind Treatment Period|Adverse Event|0|||
149045533|NCT02590432|537647293|FG002|Double-blind Treatment Period|Adverse Event|14|||
149045534|NCT02590432|537647294|FG003|Double-blind Treatment Period|Adverse Event|12|||
149045535|NCT02590432|537647295|FG004|Double-blind Treatment Period|Adverse Event|6|||
149045536|NCT02590432|537647296|FG005|Double-blind Treatment Period|Adverse Event|22|||
149045537|NCT02590432|537647297|FG006|Double-blind Treatment Period|Adverse Event|20|||
149045538|NCT02590432|537647298|FG007|Double-blind Treatment Period|Adverse Event|0|||
149045539|NCT02590432|537647299|FG008|Double-blind Treatment Period|Adverse Event|0|||
149045540|NCT02590432|537647291|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
149045541|NCT02590432|537647292|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
149045542|NCT02590432|537647293|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
149045543|NCT02590432|537647294|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
149045544|NCT02590432|537647295|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
149045545|NCT02590432|537647296|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
149045546|NCT02590432|537647297|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
149045547|NCT02590432|537647298|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
149045548|NCT02590432|537647299|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
149045549|NCT02590432|537647291|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
149045550|NCT02590432|537647292|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
149045551|NCT02590432|537647293|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
149045552|NCT02590432|537647294|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
149045553|NCT02590432|537647295|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
149045554|NCT02590432|537647296|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
149045555|NCT02590432|537647297|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
149045556|NCT02590432|537647298|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
149045557|NCT02590432|537647299|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
149045558|NCT02590432|537647291|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
149045559|NCT02590432|537647292|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149045560|NCT02590432|537647293|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
149045561|NCT02590432|537647294|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
149045562|NCT02590432|537647295|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
148885521|NCT04618744|537057032|FG000|Overall Study|Adverse Event|0|||
149045563|NCT02590432|537647296|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
149045564|NCT02590432|537647297|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
149045565|NCT02590432|537647298|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
149045566|NCT02590432|537647299|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
149045567|NCT02590432|537647291|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045568|NCT02590432|537647292|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045569|NCT02590432|537647293|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045570|NCT02590432|537647294|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045571|NCT02590432|537647295|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
148885522|NCT04618744|537057033|FG001|Overall Study|Adverse Event|1|||
148885523|NCT04618744|537057032|FG000|Overall Study|Withdrawal by Subject|0|||
148885524|NCT04618744|537057033|FG001|Overall Study|Withdrawal by Subject|1|||
148885525|NCT03310723|537060130|FG000|Overall Study|Withdrawal by Subject|0|||
148885526|NCT03310723|537060131|FG001|Overall Study|Withdrawal by Subject|1|||
148885527|NCT03310723|537060130|FG000|Overall Study|Protocol Violation|0|||
148885528|NCT03310723|537060131|FG001|Overall Study|Protocol Violation|2|||
148885529|NCT02098746|537060132|FG000|Overall Study|Changes of Investigator|2|||
148885530|NCT02098746|537060132|FG000|Overall Study|Other Miscellaneous Reasons|1|||
148885531|NCT02098746|537060132|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
148885532|NCT02098746|537060132|FG000|Overall Study|Data Not Available After Treatment|1|||
148885533|NCT00330759|537060135|FG000|Overall Study|Death|316|||
148885534|NCT00330759|537060136|FG001|Overall Study|Death|310|||
148885535|NCT00330759|537060135|FG000|Overall Study|Disease progression|104|||
148885536|NCT00330759|537060136|FG001|Overall Study|Disease progression|126|||
149045572|NCT02590432|537647296|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
149045573|NCT02590432|537647297|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045574|NCT02590432|537647298|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045575|NCT02590432|537647299|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
149045576|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045577|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045578|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045579|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045580|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045581|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045582|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
149045583|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
149045584|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
149045585|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045586|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045587|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045588|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045589|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045590|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045591|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045592|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
149045593|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
149045594|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045595|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045596|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045597|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045598|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045599|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045600|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
149045601|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
149045602|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
149045603|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045604|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045605|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045606|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045607|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
148885537|NCT00330759|537060135|FG000|Overall Study|Withdrawal by Subject|143|||
148885538|NCT00330759|537060136|FG001|Overall Study|Withdrawal by Subject|124|||
148885539|NCT00330759|537060135|FG000|Overall Study|Adverse Event|48|||
148885540|NCT00330759|537060136|FG001|Overall Study|Adverse Event|36|||
148885541|NCT00330759|537060135|FG000|Overall Study|Participant request|31|||
148885542|NCT00330759|537060136|FG001|Overall Study|Participant request|22|||
148885543|NCT00330759|537060135|FG000|Overall Study|Lost to Follow-up|16|||
149045608|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045609|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045610|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
149045611|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
149045612|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045613|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045614|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045615|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045616|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045617|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045618|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045619|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
149045620|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
149045621|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045622|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045623|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045624|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045625|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045626|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045627|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045628|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
149045629|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
149045630|NCT02590432|537647291|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045631|NCT02590432|537647292|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045632|NCT02590432|537647293|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045633|NCT02590432|537647294|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045634|NCT02590432|537647295|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045635|NCT02590432|537647296|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045636|NCT02590432|537647297|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045637|NCT02590432|537647298|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
149045638|NCT02590432|537647299|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
149045639|NCT02006758|537647300|FG000|Overall Study|Protocol Violation|1|||
149045640|NCT02006758|537647300|FG000|Overall Study|Death|1|||
149045641|NCT02006758|537647300|FG000|Overall Study|Lost to Follow-up|4|||
149045642|NCT02006758|537647300|FG000|Overall Study|Withdrawal by Subject|4|||
149045643|NCT02006758|537647300|FG000|Overall Study|Procedurally excluded|1|||
149045644|NCT02006758|537647300|FG000|Overall Study|Other|2|||
149045645|NCT02740231|537647302|FG000|Overall Study|Withdrawal by Subject|1|||
149045646|NCT02740231|537647303|FG001|Overall Study|Withdrawal by Subject|1|||
149045647|NCT02740231|537647304|FG002|Overall Study|Withdrawal by Subject|1|||
149045648|NCT02740231|537647305|FG003|Overall Study|Withdrawal by Subject|0|||
149045649|NCT02740231|537647302|FG000|Overall Study|Lack of Efficacy|0|||
149045650|NCT02740231|537647303|FG001|Overall Study|Lack of Efficacy|1|||
149045651|NCT02740231|537647304|FG002|Overall Study|Lack of Efficacy|0|||
149045652|NCT02740231|537647305|FG003|Overall Study|Lack of Efficacy|4|||
148885544|NCT00330759|537060136|FG001|Overall Study|Lost to Follow-up|22|||
148885545|NCT00330759|537060135|FG000|Overall Study|Noncompliance|15|||
148885546|NCT00330759|537060136|FG001|Overall Study|Noncompliance|17|||
148885547|NCT00330759|537060135|FG000|Overall Study|Physician Decision|1|||
148885548|NCT00330759|537060136|FG001|Overall Study|Physician Decision|2|||
148885549|NCT00330759|537060135|FG000|Overall Study|Protocol deviation|0|||
148885550|NCT00330759|537060136|FG001|Overall Study|Protocol deviation|2|||
148885551|NCT00330759|537060135|FG000|Overall Study|Ineligibility determined|2|||
148885552|NCT00330759|537060136|FG001|Overall Study|Ineligibility determined|1|||
148885553|NCT00330759|537060135|FG000|Overall Study|Other|36|||
148885554|NCT00330759|537060136|FG001|Overall Study|Other|44|||
148885555|NCT04070989|537060137|FG000|Overall Study|Death|1|||
148885556|NCT04070989|537060138|FG001|Overall Study|Death|0|||
148885557|NCT04070989|537060139|FG002|Overall Study|Death|0|||
148885558|NCT04070989|537060137|FG000|Overall Study|Study Terminated by Sponsor|7|||
148885559|NCT04070989|537060138|FG001|Overall Study|Study Terminated by Sponsor|8|||
148885560|NCT04070989|537060139|FG002|Overall Study|Study Terminated by Sponsor|23|||
148885561|NCT04070989|537060137|FG000|Overall Study|Withdrawal by Subject|0|||
148885562|NCT04070989|537060138|FG001|Overall Study|Withdrawal by Subject|1|||
148885563|NCT04070989|537060139|FG002|Overall Study|Withdrawal by Subject|0|||
148885564|NCT04070989|537060137|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
148885565|NCT04070989|537060138|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
148885566|NCT04070989|537060139|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
149045653|NCT02740231|537647302|FG000|Overall Study|Lost to Follow-up|1|||
149045654|NCT02740231|537647303|FG001|Overall Study|Lost to Follow-up|3|||
149045655|NCT02740231|537647304|FG002|Overall Study|Lost to Follow-up|0|||
149045656|NCT02740231|537647305|FG003|Overall Study|Lost to Follow-up|3|||
149045657|NCT02740231|537647302|FG000|Overall Study|Adverse Event|0|||
149045658|NCT02740231|537647303|FG001|Overall Study|Adverse Event|1|||
149045659|NCT02740231|537647304|FG002|Overall Study|Adverse Event|0|||
149045660|NCT02740231|537647305|FG003|Overall Study|Adverse Event|1|||
149045661|NCT05052996|537647309|FG000|Overall Study|Still on study|0|||
149045662|NCT05052996|537647310|FG001|Overall Study|Still on study|0|||
149045663|NCT05052996|537647311|FG002|Overall Study|Still on study|47|||
149045664|NCT05052996|537647312|FG003|Overall Study|Still on study|44|||
149045665|NCT05052996|537647309|FG000|Overall Study|Cohort terminated by sponsor|21|||
149045666|NCT05052996|537647310|FG001|Overall Study|Cohort terminated by sponsor|12|||
149045667|NCT05052996|537647311|FG002|Overall Study|Cohort terminated by sponsor|0|||
149045668|NCT05052996|537647312|FG003|Overall Study|Cohort terminated by sponsor|0|||
149045669|NCT05052996|537647309|FG000|Overall Study|Withdrew consent|1|||
149045670|NCT05052996|537647310|FG001|Overall Study|Withdrew consent|0|||
149045671|NCT05052996|537647311|FG002|Overall Study|Withdrew consent|1|||
149045672|NCT05052996|537647312|FG003|Overall Study|Withdrew consent|2|||
149045673|NCT05052996|537647309|FG000|Overall Study|Lost to Follow-up|1|||
149045674|NCT05052996|537647310|FG001|Overall Study|Lost to Follow-up|0|||
149045675|NCT05052996|537647311|FG002|Overall Study|Lost to Follow-up|0|||
149045676|NCT05052996|537647312|FG003|Overall Study|Lost to Follow-up|2|||
149045677|NCT05052996|537647309|FG000|Overall Study|Adverse Event|0|||
149045678|NCT05052996|537647310|FG001|Overall Study|Adverse Event|0|||
149045679|NCT05052996|537647311|FG002|Overall Study|Adverse Event|2|||
149045680|NCT05052996|537647312|FG003|Overall Study|Adverse Event|0|||
149045681|NCT05052996|537647309|FG000|Overall Study|Randomized but never treated|0|||
149045682|NCT05052996|537647310|FG001|Overall Study|Randomized but never treated|0|||
149045683|NCT05052996|537647311|FG002|Overall Study|Randomized but never treated|1|||
149045684|NCT05052996|537647312|FG003|Overall Study|Randomized but never treated|1|||
149045685|NCT05052996|537647309|FG000|Overall Study|Protocol Violation|1|||
149045686|NCT05052996|537647310|FG001|Overall Study|Protocol Violation|0|||
149045687|NCT05052996|537647311|FG002|Overall Study|Protocol Violation|0|||
149045688|NCT05052996|537647312|FG003|Overall Study|Protocol Violation|0|||
149045689|NCT04149002|537647313|FG000|Overall Study|Lost to Follow-up|1|||
149045690|NCT04149002|537647314|FG001|Overall Study|Lost to Follow-up|0|||
149045691|NCT04149002|537647313|FG000|Overall Study|Withdrawal by Subject|1|||
149045692|NCT04149002|537647314|FG001|Overall Study|Withdrawal by Subject|0|||
149045693|NCT04583423|537647316|FG000|Overall Study|Lost to Follow-up|0|||
149045694|NCT04583423|537647317|FG001|Overall Study|Lost to Follow-up|1|||
149045695|NCT04583423|537647318|FG002|Overall Study|Lost to Follow-up|0|||
149045696|NCT04583423|537647319|FG003|Overall Study|Lost to Follow-up|2|||
149045697|NCT04583423|537647316|FG000|Overall Study|Study Terminated by Sponsor|32|||
149045698|NCT04583423|537647317|FG001|Overall Study|Study Terminated by Sponsor|35|||
149045699|NCT04583423|537647318|FG002|Overall Study|Study Terminated by Sponsor|36|||
149045700|NCT04583423|537647319|FG003|Overall Study|Study Terminated by Sponsor|33|||
149045701|NCT04583423|537647316|FG000|Overall Study|Withdrawal by Subject|3|||
149045702|NCT04583423|537647317|FG001|Overall Study|Withdrawal by Subject|1|||
149045703|NCT04583423|537647318|FG002|Overall Study|Withdrawal by Subject|2|||
149045704|NCT04583423|537647319|FG003|Overall Study|Withdrawal by Subject|1|||
148885567|NCT04070989|537060137|FG000|Overall Study|Other|1|||
148885568|NCT04070989|537060138|FG001|Overall Study|Other|1|||
148885569|NCT04070989|537060139|FG002|Overall Study|Other|0|||
148885570|NCT04685798|537060158|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
148885571|NCT00592904|537060163|FG000|Overall Study|Adverse Event|15|||
148885572|NCT00592904|537060164|FG001|Overall Study|Adverse Event|25|||
148885573|NCT00592904|537060165|FG002|Overall Study|Adverse Event|13|||
148885574|NCT00592904|537060166|FG003|Overall Study|Adverse Event|5|||
148885575|NCT00592904|537060163|FG000|Overall Study|Protocol Violation|1|||
148885576|NCT00592904|537060164|FG001|Overall Study|Protocol Violation|1|||
148885577|NCT00592904|537060165|FG002|Overall Study|Protocol Violation|0|||
148885578|NCT00592904|537060166|FG003|Overall Study|Protocol Violation|1|||
149045705|NCT04704284|537647320|FG000|Overall Study|Withdrawal by Subject|1|||
149045706|NCT05782231|537647321|FG000|Overall Study|Withdrawal by Subject|1|||
149045707|NCT01561989|537647324|FG000|Overall Study|accural target not met.|5|||
149045708|NCT01561989|537647325|FG001|Overall Study|accural target not met.|6|||
149045709|NCT01736215|537647326|FG000|Overall Study|Early termination of erythropoietin use|1|||
149045710|NCT01736215|537647326|FG000|Overall Study|Adverse Event|4|||
149045711|NCT01736215|537647326|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
149045712|NCT01736215|537647326|FG000|Overall Study|Insufficient data to perform analysis|8|||
149045713|NCT03447249|537647331|FG000|Overall Study|Adverse Event|1|||
148885579|NCT00592904|537060163|FG000|Overall Study|Withdrawal by Subject|4|||
148885580|NCT00592904|537060164|FG001|Overall Study|Withdrawal by Subject|16|||
148885581|NCT00592904|537060165|FG002|Overall Study|Withdrawal by Subject|1|||
148885582|NCT00592904|537060166|FG003|Overall Study|Withdrawal by Subject|2|||
149045714|NCT03447249|537647332|FG001|Overall Study|Adverse Event|0|||
148885583|NCT00592904|537060163|FG000|Overall Study|Lack of Efficacy|2|||
148885584|NCT00592904|537060164|FG001|Overall Study|Lack of Efficacy|7|||
148885585|NCT00592904|537060165|FG002|Overall Study|Lack of Efficacy|2|||
148885586|NCT00592904|537060166|FG003|Overall Study|Lack of Efficacy|3|||
148885587|NCT00592904|537060163|FG000|Overall Study|Physician Decision|0|||
148885588|NCT00592904|537060164|FG001|Overall Study|Physician Decision|3|||
148885589|NCT00592904|537060165|FG002|Overall Study|Physician Decision|1|||
148885590|NCT00592904|537060166|FG003|Overall Study|Physician Decision|0|||
148885591|NCT00592904|537060163|FG000|Overall Study|Other|3|||
148885592|NCT00592904|537060164|FG001|Overall Study|Other|3|||
149045715|NCT03447249|537647331|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
149045716|NCT03447249|537647332|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
149045717|NCT03447249|537647331|FG000|Overall Study|Other|3|||
149045718|NCT03447249|537647332|FG001|Overall Study|Other|0|||
149045719|NCT00988858|537647333|FG000|Overall Study|Adverse Event|7|||
149045720|NCT00988858|537647333|FG000|Overall Study|Death|1|||
149045721|NCT00988858|537647333|FG000|Overall Study|Physician Decision|1|||
149045722|NCT00988858|537647333|FG000|Overall Study|Sponsor Decision|1|||
149045723|NCT03930420|537647334|FG000|Overall Study|Withdrawal by Subject|7|||
149045724|NCT03930420|537647335|FG001|Overall Study|Withdrawal by Subject|9|||
149045725|NCT02238483|537647336|FG000|Overall Study|Withdrawal by Subject|2|||
149045726|NCT02238483|537647337|FG001|Overall Study|Withdrawal by Subject|7|||
149045727|NCT02238483|537647336|FG000|Overall Study|Lost to Follow-up|1|||
149045728|NCT02238483|537647337|FG001|Overall Study|Lost to Follow-up|1|||
149045729|NCT02238483|537647336|FG000|Overall Study|Protocol Violation|1|||
149045730|NCT02238483|537647337|FG001|Overall Study|Protocol Violation|2|||
149045731|NCT02238483|537647336|FG000|Overall Study|Death|1|||
149045732|NCT02238483|537647337|FG001|Overall Study|Death|0|||
149045733|NCT02238483|537647336|FG000|Overall Study|Adverse Event|7|||
149045734|NCT02238483|537647337|FG001|Overall Study|Adverse Event|3|||
149045735|NCT02238483|537647336|FG000|Overall Study|Withdrawn due to physician decision|1|||
149045736|NCT02238483|537647337|FG001|Overall Study|Withdrawn due to physician decision|0|||
149045737|NCT02238483|537647336|FG000|Overall Study|Completion status not recorded|1|||
149045738|NCT02238483|537647337|FG001|Overall Study|Completion status not recorded|1|||
149045739|NCT02238483|537647336|FG000|Overall Study|Illness in family member|1|||
149045740|NCT02238483|537647337|FG001|Overall Study|Illness in family member|0|||
149045741|NCT00390299|537647338|FG000|Overall Study|Cancellation|1|||
149045742|NCT00390299|537647339|FG001|Overall Study|Cancellation|0|||
149045743|NCT00390299|537647340|FG002|Overall Study|Cancellation|0|||
149045744|NCT00390299|537647341|FG003|Overall Study|Cancellation|0|||
149045745|NCT00390299|537647342|FG004|Overall Study|Cancellation|0|||
149045746|NCT01094184|537647348|FG000|Overall Study|Death|35|||
149045747|NCT01094184|537647349|FG001|Overall Study|Death|11|||
149045748|NCT04766034|537647350|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
149045749|NCT04766034|537647351|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
149045750|NCT04766034|537647352|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
149045751|NCT04766034|537647353|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
149045752|NCT04766034|537647354|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
149045753|NCT04766034|537647350|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
149045754|NCT04766034|537647351|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
149045755|NCT04766034|537647352|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
149045756|NCT04766034|537647353|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
149045757|NCT04766034|537647354|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
149045758|NCT04766034|537647350|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
149045759|NCT04766034|537647351|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
149045760|NCT04766034|537647352|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
149045761|NCT04766034|537647353|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
149045762|NCT04766034|537647354|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
149045763|NCT04766034|537647350|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
149045764|NCT04766034|537647351|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
149045765|NCT04766034|537647352|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
148885593|NCT00592904|537060165|FG002|Overall Study|Other|0|||
148885594|NCT00592904|537060166|FG003|Overall Study|Other|0|||
149045766|NCT04766034|537647353|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
149045767|NCT04766034|537647354|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
149045768|NCT03892564|537647355|FG000|Overall Study|Withdrawal by Subject|2|||
149045769|NCT05094141|537647356|FG000|Overall Study|Death|0|||
148885595|NCT01388907|537060167|FG000|Overall Study|Adverse Event|2|||
149045770|NCT05094141|537647357|FG001|Overall Study|Death|0|||
148885596|NCT01388907|537060168|FG001|Overall Study|Adverse Event|0|||
148885597|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
148885598|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
148885599|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
149045771|NCT05094141|537647358|FG002|Overall Study|Death|1|||
149045772|NCT05094141|537647356|FG000|Overall Study|Withdrawal by Subject|0|||
149045773|NCT05094141|537647357|FG001|Overall Study|Withdrawal by Subject|0|||
149045774|NCT05094141|537647358|FG002|Overall Study|Withdrawal by Subject|1|||
149045775|NCT05094141|537647356|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
149045776|NCT05094141|537647357|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
149045777|NCT05094141|537647358|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
149045778|NCT05094141|537647356|FG000|Overall Study|Did not participate in randomization|0|||
149045779|NCT05094141|537647357|FG001|Overall Study|Did not participate in randomization|0|||
149045780|NCT05094141|537647358|FG002|Overall Study|Did not participate in randomization|33|||
149045781|NCT03954184|537648805|FG000|Overall Study|Lost to Follow-up|500|||
149045782|NCT03954184|537648806|FG001|Overall Study|Lost to Follow-up|0|||
149045783|NCT01649271|537648807|FG000|Overall Study|Progressive disease|4|||
149045784|NCT01649271|537648808|FG001|Overall Study|Progressive disease|5|||
149045785|NCT01649271|537648807|FG000|Overall Study|Other Adverse Event|0|||
149045786|NCT01649271|537648808|FG001|Overall Study|Other Adverse Event|2|||
149045787|NCT01649271|537648807|FG000|Overall Study|Withdrawal by Subject|1|||
149045788|NCT01649271|537648808|FG001|Overall Study|Withdrawal by Subject|0|||
149045789|NCT01649271|537648807|FG000|Overall Study|Other than stated above|1|||
149045790|NCT01649271|537648808|FG001|Overall Study|Other than stated above|0|||
149045791|NCT05644002|537648809|FG000|Overall Study|Lost to Follow-up|1|||
149045792|NCT05644002|537648810|FG001|Overall Study|Lost to Follow-up|2|||
149045793|NCT05644002|537648809|FG000|Overall Study|Withdrawal by Subject|0|||
149045794|NCT05644002|537648810|FG001|Overall Study|Withdrawal by Subject|1|||
149045795|NCT04842500|537648811|FG000|Overall Study|Withdrawal by Subject|4|||
149045796|NCT04842500|537648812|FG001|Overall Study|Withdrawal by Subject|1|||
149045797|NCT04842500|537648813|FG002|Overall Study|Withdrawal by Subject|2|||
149045798|NCT04842500|537648814|FG003|Overall Study|Withdrawal by Subject|3|||
149045799|NCT04842500|537648811|FG000|Overall Study|Protocol Violation|1|||
149045800|NCT04842500|537648812|FG001|Overall Study|Protocol Violation|0|||
149045801|NCT04842500|537648813|FG002|Overall Study|Protocol Violation|0|||
149045802|NCT04842500|537648814|FG003|Overall Study|Protocol Violation|1|||
149045803|NCT04065048|537648817|FG000|Overall Study|Withdrawal by Subject|1|||
149045804|NCT04065048|537648818|FG001|Overall Study|Withdrawal by Subject|2|||
149045805|NCT04065048|537648819|FG002|Overall Study|Withdrawal by Subject|1|||
149045806|NCT04065048|537648820|FG003|Overall Study|Withdrawal by Subject|1|||
149045807|NCT04065048|537648817|FG000|Overall Study|Adverse Event|1|||
149045808|NCT04065048|537648818|FG001|Overall Study|Adverse Event|0|||
149045809|NCT04065048|537648819|FG002|Overall Study|Adverse Event|1|||
149045810|NCT04065048|537648820|FG003|Overall Study|Adverse Event|0|||
149045811|NCT03397108|537648821|FG000|Overall Study|Lost to Follow-up|15|||
149045812|NCT03397108|537648822|FG001|Overall Study|Lost to Follow-up|0|||
149045813|NCT03397108|537648821|FG000|Overall Study|Insufficient milk production|3|||
149045814|NCT03397108|537648822|FG001|Overall Study|Insufficient milk production|2|||
149045815|NCT03397108|537648821|FG000|Overall Study|Withdrawal by Subject|2|||
149045816|NCT03397108|537648822|FG001|Overall Study|Withdrawal by Subject|0|||
149045817|NCT04337372|537648826|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
149045818|NCT04337372|537648827|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
149045819|NCT04337372|537648828|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
149045820|NCT04337372|537648829|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
149045821|NCT04337372|537648826|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
149045822|NCT04337372|537648827|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
149045823|NCT04337372|537648828|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
149045824|NCT04337372|537648829|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
149045825|NCT04337372|537648826|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
149045826|NCT04337372|537648827|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
149045827|NCT04337372|537648828|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
149045828|NCT04337372|537648829|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
149045829|NCT04337372|537648826|FG000|Day 2: EEG Measures|Protocol Violation|6|||
149045830|NCT04337372|537648827|FG001|Day 2: EEG Measures|Protocol Violation|6|||
149045831|NCT04337372|537648828|FG002|Day 2: EEG Measures|Protocol Violation|5|||
149045832|NCT04337372|537648829|FG003|Day 2: EEG Measures|Protocol Violation|17|||
149045833|NCT05307783|537648830|FG000|Overall Study|Death|7|||
149045834|NCT05307783|537648830|FG000|Overall Study|Lost to Follow-up|4|||
149045835|NCT04883645|537648831|FG000|Overall Study|Death|1|||
149045836|NCT03460236|537648835|FG000|Overall Study|failed radiographic screening|16|||
149045837|NCT03460236|537648835|FG000|Overall Study|Withdrawal by Subject|11|||
149045838|NCT04468776|537648836|FG000|Overall Study|Lost to Follow-up|4|||
149045839|NCT04468776|537648837|FG001|Overall Study|Lost to Follow-up|3|||
149045840|NCT04468776|537648838|FG002|Overall Study|Lost to Follow-up|4|||
149045841|NCT04468776|537648836|FG000|Overall Study|Withdrawal by Subject|1|||
149045842|NCT04468776|537648837|FG001|Overall Study|Withdrawal by Subject|10|||
149045843|NCT04468776|537648838|FG002|Overall Study|Withdrawal by Subject|4|||
149045844|NCT04468776|537648836|FG000|Overall Study|Physician Decision|0|||
149045845|NCT04468776|537648837|FG001|Overall Study|Physician Decision|1|||
149045846|NCT04468776|537648838|FG002|Overall Study|Physician Decision|1|||
149045847|NCT05613205|537648839|FG000|Overall Study|Lost to Follow-up|0|||
149045848|NCT05613205|537648840|FG001|Overall Study|Lost to Follow-up|0|||
149045849|NCT05613205|537648841|FG002|Overall Study|Lost to Follow-up|1|||
149045850|NCT05613205|537648842|FG003|Overall Study|Lost to Follow-up|1|||
149045851|NCT05613205|537648843|FG004|Overall Study|Lost to Follow-up|0|||
149045852|NCT05613205|537648839|FG000|Overall Study|Withdrawal by Subject|0|||
149045853|NCT05613205|537648840|FG001|Overall Study|Withdrawal by Subject|0|||
149045854|NCT05613205|537648841|FG002|Overall Study|Withdrawal by Subject|1|||
149045855|NCT05613205|537648842|FG003|Overall Study|Withdrawal by Subject|1|||
149045856|NCT05613205|537648843|FG004|Overall Study|Withdrawal by Subject|0|||
149045857|NCT04869982|537648855|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
149045858|NCT04869982|537648856|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
149045859|NCT04869982|537648855|FG000|Overall Study|Migrated / moved from the study area|1|||
149045860|NCT04869982|537648856|FG001|Overall Study|Migrated / moved from the study area|1|||
149045861|NCT04869982|537648855|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
149045862|NCT04869982|537648856|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
149045863|NCT04869982|537648855|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
149045864|NCT04869982|537648856|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
149045865|NCT04869982|537648855|FG000|Overall Study|Solicited adverse event|2|||
149045866|NCT04869982|537648856|FG001|Overall Study|Solicited adverse event|1|||
149045867|NCT04608045|537648857|FG000|Overall Study|Physician Decision|1|||
149045868|NCT02473250|537648859|FG000|Overall Study|Lost to Follow-up|10|||
149045869|NCT02473250|537648859|FG000|Overall Study|Physician Decision|5|||
149045870|NCT02473250|537648859|FG000|Overall Study|Did not tolerate medication washout|3|||
149045871|NCT02473250|537648859|FG000|Overall Study|Antidepressant effect of divalproex|2|||
149045872|NCT03103321|537648860|FG000|Overall Study|Protocol Violation|1|||
149045873|NCT03103321|537648861|FG001|Overall Study|Protocol Violation|1|||
149045874|NCT03103321|537648862|FG002|Overall Study|Protocol Violation|1|||
149045875|NCT03103321|537648863|FG003|Overall Study|Protocol Violation|0|||
149045876|NCT06023082|537648864|FG000|Overall Study|Withdrawal by Subject|2|||
149045877|NCT06023082|537648864|FG000|Overall Study|Lost to Follow-up|15|||
149045878|NCT06023082|537648864|FG000|Overall Study|Side effects|5|||
149045879|NCT03584516|537648865|FG000|Part 1|Death|2|||
149045880|NCT03584516|537648866|FG001|Part 1|Death|3|||
149045881|NCT03584516|537648867|FG002|Part 1|Death|0|||
149045882|NCT03584516|537648868|FG003|Part 1|Death|0|||
149045883|NCT03584516|537648869|FG004|Part 1|Death|0|||
149045884|NCT03584516|537648870|FG005|Part 1|Death|0|||
149045885|NCT03584516|537648865|FG000|Part 1|Withdrawal by Subject|2|||
149045886|NCT03584516|537648866|FG001|Part 1|Withdrawal by Subject|0|||
149045887|NCT03584516|537648867|FG002|Part 1|Withdrawal by Subject|0|||
149045888|NCT03584516|537648868|FG003|Part 1|Withdrawal by Subject|0|||
149045889|NCT03584516|537648869|FG004|Part 1|Withdrawal by Subject|0|||
149045890|NCT03584516|537648870|FG005|Part 1|Withdrawal by Subject|0|||
149045891|NCT03584516|537648865|FG000|Part 1|Lost to Follow-up|1|||
149045892|NCT03584516|537648866|FG001|Part 1|Lost to Follow-up|0|||
149045893|NCT03584516|537648867|FG002|Part 1|Lost to Follow-up|0|||
149045894|NCT03584516|537648868|FG003|Part 1|Lost to Follow-up|0|||
149045895|NCT03584516|537648869|FG004|Part 1|Lost to Follow-up|0|||
149045896|NCT03584516|537648870|FG005|Part 1|Lost to Follow-up|0|||
149045897|NCT03584516|537648865|FG000|Part 1|Study Terminated by Sponsor|0|||
149045898|NCT03584516|537648866|FG001|Part 1|Study Terminated by Sponsor|2|||
149045899|NCT03584516|537648867|FG002|Part 1|Study Terminated by Sponsor|0|||
149045900|NCT03584516|537648868|FG003|Part 1|Study Terminated by Sponsor|0|||
149045901|NCT03584516|537648869|FG004|Part 1|Study Terminated by Sponsor|0|||
149045902|NCT03584516|537648870|FG005|Part 1|Study Terminated by Sponsor|0|||
149045903|NCT03584516|537648865|FG000|Part 1 Expansion|Death|0|||
149045904|NCT03584516|537648866|FG001|Part 1 Expansion|Death|0|||
149045905|NCT03584516|537648867|FG002|Part 1 Expansion|Death|9|||
149045906|NCT03584516|537648868|FG003|Part 1 Expansion|Death|8|||
149045907|NCT03584516|537648869|FG004|Part 1 Expansion|Death|4|||
149045908|NCT03584516|537648870|FG005|Part 1 Expansion|Death|5|||
149045909|NCT03584516|537648865|FG000|Part 1 Expansion|Lost to Follow-up|0|||
149045910|NCT03584516|537648866|FG001|Part 1 Expansion|Lost to Follow-up|0|||
149045911|NCT03584516|537648867|FG002|Part 1 Expansion|Lost to Follow-up|0|||
149045912|NCT03584516|537648868|FG003|Part 1 Expansion|Lost to Follow-up|1|||
149045913|NCT03584516|537648869|FG004|Part 1 Expansion|Lost to Follow-up|0|||
149045914|NCT03584516|537648870|FG005|Part 1 Expansion|Lost to Follow-up|0|||
149045915|NCT03584516|537648865|FG000|Part 1 Expansion|Physician Decision|0|||
149045916|NCT03584516|537648866|FG001|Part 1 Expansion|Physician Decision|0|||
149045917|NCT03584516|537648867|FG002|Part 1 Expansion|Physician Decision|4|||
149045918|NCT03584516|537648868|FG003|Part 1 Expansion|Physician Decision|3|||
149045919|NCT03584516|537648869|FG004|Part 1 Expansion|Physician Decision|2|||
149045920|NCT03584516|537648870|FG005|Part 1 Expansion|Physician Decision|3|||
149045921|NCT03584516|537648865|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
149045922|NCT03584516|537648866|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
149045923|NCT03584516|537648867|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
149045924|NCT03584516|537648868|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
149045925|NCT03584516|537648869|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
149045926|NCT03584516|537648870|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
149045927|NCT03584516|537648865|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
149045928|NCT03584516|537648866|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
149045929|NCT03584516|537648867|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
149045930|NCT03584516|537648868|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
148885600|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
148885601|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
148885602|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
148885603|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
148885604|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
148885605|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
148885606|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
149045931|NCT03584516|537648869|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
149045932|NCT03584516|537648870|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
149045933|NCT03584516|537648865|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
149045934|NCT03584516|537648866|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
149045935|NCT03584516|537648867|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
149045936|NCT03584516|537648868|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
149045937|NCT03584516|537648869|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
149045938|NCT03584516|537648870|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
149045939|NCT03584516|537648865|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
149045940|NCT03584516|537648866|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
149045941|NCT03584516|537648867|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
149045942|NCT03584516|537648868|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
149045943|NCT03584516|537648869|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
149045944|NCT03584516|537648870|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
149045945|NCT05986565|537648871|FG000|Overall Study|Lost to Follow-up|8|||
149045946|NCT05986565|537648872|FG001|Overall Study|Lost to Follow-up|3|||
149045947|NCT05986565|537648871|FG000|Overall Study|Withdrawal by Subject|0|||
148885607|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
149045948|NCT05986565|537648872|FG001|Overall Study|Withdrawal by Subject|1|||
149045949|NCT05846646|537648874|FG000|Overall Study|Physician Decision|1|||
149045950|NCT05846646|537648875|FG001|Overall Study|Physician Decision|0|||
149045951|NCT05846646|537648876|FG002|Overall Study|Physician Decision|0|||
149045952|NCT05846646|537648874|FG000|Overall Study|Lack of Efficacy|1|||
149045953|NCT05846646|537648875|FG001|Overall Study|Lack of Efficacy|1|||
149045954|NCT05846646|537648876|FG002|Overall Study|Lack of Efficacy|0|||
149045955|NCT05846646|537648874|FG000|Overall Study|Early Study Termination|1|||
149045956|NCT05846646|537648875|FG001|Overall Study|Early Study Termination|2|||
149045957|NCT05846646|537648876|FG002|Overall Study|Early Study Termination|0|||
149045958|NCT00670046|537648877|FG000|Overall Study|Lost to Follow-up|1|||
149045959|NCT00670046|537648878|FG001|Overall Study|Lost to Follow-up|1|||
149045960|NCT00670046|537648877|FG000|Overall Study|Withdrawal by Subject|0|||
149045961|NCT00670046|537648878|FG001|Overall Study|Withdrawal by Subject|1|||
149045962|NCT03655262|537648884|FG000|Overall Study|Withdrawal by Subject|0|||
149045963|NCT03655262|537648885|FG001|Overall Study|Withdrawal by Subject|0|||
149045964|NCT03655262|537648886|FG002|Overall Study|Withdrawal by Subject|1|||
149045965|NCT02538341|537648889|FG000|Overall Study|Lost to Follow-up|51|||
149045966|NCT02538341|537648890|FG001|Overall Study|Lost to Follow-up|46|||
149045967|NCT02538341|537648889|FG000|Overall Study|Withdrawal by Subject|3|||
149045968|NCT02538341|537648890|FG001|Overall Study|Withdrawal by Subject|1|||
149045969|NCT02538341|537648889|FG000|Overall Study|Death|2|||
149045970|NCT02538341|537648890|FG001|Overall Study|Death|0|||
149045971|NCT00331136|537648891|FG000|Overall Study|Adverse Event|3|||
149045972|NCT00331136|537648892|FG001|Overall Study|Adverse Event|5|||
149045973|NCT00331136|537648893|FG002|Overall Study|Adverse Event|0|||
149045974|NCT00331136|537648894|FG003|Overall Study|Adverse Event|1|||
149045975|NCT00331136|537648891|FG000|Overall Study|Withdrawal by Subject|0|||
149045976|NCT00331136|537648892|FG001|Overall Study|Withdrawal by Subject|1|||
149045977|NCT00331136|537648893|FG002|Overall Study|Withdrawal by Subject|0|||
149045978|NCT00331136|537648894|FG003|Overall Study|Withdrawal by Subject|0|||
149045979|NCT00331136|537648891|FG000|Overall Study|Lost to Follow-up|0|||
149045980|NCT00331136|537648892|FG001|Overall Study|Lost to Follow-up|1|||
149045981|NCT00331136|537648893|FG002|Overall Study|Lost to Follow-up|0|||
149045982|NCT00331136|537648894|FG003|Overall Study|Lost to Follow-up|0|||
149045983|NCT00331136|537648891|FG000|Overall Study|Protocol Violation|1|||
149045984|NCT00331136|537648892|FG001|Overall Study|Protocol Violation|0|||
149045985|NCT00331136|537648893|FG002|Overall Study|Protocol Violation|0|||
149045986|NCT00331136|537648894|FG003|Overall Study|Protocol Violation|0|||
149045987|NCT00331136|537648891|FG000|Overall Study|Not treated|1|||
149045988|NCT00331136|537648892|FG001|Overall Study|Not treated|0|||
149045989|NCT00331136|537648893|FG002|Overall Study|Not treated|0|||
149045990|NCT00331136|537648894|FG003|Overall Study|Not treated|0|||
149045991|NCT02321514|537648895|FG000|Overall Study|Death|15|||
149045992|NCT02321514|537648895|FG000|Overall Study|Missed Visit|7|||
149045993|NCT02321514|537648895|FG000|Overall Study|Study Exit|3|||
149045994|NCT04732338|537648899|FG000|Overall Study|Lost to Follow-up|3|||
149045995|NCT04732338|537648900|FG001|Overall Study|Lost to Follow-up|3|||
149045996|NCT00393484|537648903|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
149045997|NCT00393484|537648904|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
149045998|NCT00393484|537648903|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
149045999|NCT00393484|537648904|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
149046000|NCT00393484|537648903|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
149046001|NCT00393484|537648904|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
149046002|NCT00393484|537648903|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
149046003|NCT00393484|537648904|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
149046004|NCT00393484|537648903|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
149046005|NCT00393484|537648904|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
149046006|NCT00393484|537648903|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
149046007|NCT00393484|537648904|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
149046008|NCT00393484|537648903|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
149046009|NCT00393484|537648904|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
149046010|NCT00393484|537648903|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
149046011|NCT00393484|537648904|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
149046012|NCT00393484|537648903|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
149046013|NCT00393484|537648904|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
149046014|NCT00393484|537648903|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
149046015|NCT00393484|537648904|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
149046016|NCT03750968|537648905|FG000|Overall Study|Adverse Event|2|||
149046017|NCT03750968|537648906|FG001|Overall Study|Adverse Event|0|||
149046018|NCT03750968|537648905|FG000|Overall Study|Lost to Follow-up|1|||
149046019|NCT03750968|537648906|FG001|Overall Study|Lost to Follow-up|3|||
149046020|NCT02178098|537648913|FG000|Overall Study|Withdrawal by Subject|0|||
149046021|NCT02178098|537648914|FG001|Overall Study|Withdrawal by Subject|6|||
149046022|NCT02178098|537648913|FG000|Overall Study|Adverse Event|1|||
149046023|NCT02178098|537648914|FG001|Overall Study|Adverse Event|2|||
149046024|NCT02178098|537648913|FG000|Overall Study|Protocol Violation|1|||
149046025|NCT02178098|537648914|FG001|Overall Study|Protocol Violation|1|||
149046026|NCT02178098|537648913|FG000|Overall Study|Lost to Follow-up|0|||
149046027|NCT02178098|537648914|FG001|Overall Study|Lost to Follow-up|1|||
149046028|NCT02178098|537648913|FG000|Overall Study|Sponsor Request|1|||
149046029|NCT02178098|537648914|FG001|Overall Study|Sponsor Request|0|||
149046030|NCT02178098|537648913|FG000|Overall Study|Other|2|||
149046031|NCT02178098|537648914|FG001|Overall Study|Other|2|||
149046032|NCT00088413|537648920|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
149046033|NCT00088413|537648921|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
149046034|NCT00088413|537648922|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
149046035|NCT00088413|537648923|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
149046036|NCT00088413|537648920|FG000|Overall Study|Adverse Events/Side Effects|0|||
149046037|NCT00088413|537648921|FG001|Overall Study|Adverse Events/Side Effects|1|||
149046038|NCT00088413|537648922|FG002|Overall Study|Adverse Events/Side Effects|1|||
149046039|NCT00088413|537648923|FG003|Overall Study|Adverse Events/Side Effects|0|||
149046040|NCT00088413|537648920|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
149046041|NCT00088413|537648921|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
149046042|NCT00088413|537648922|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
149046043|NCT00088413|537648923|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
149046044|NCT00088413|537648920|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
149046045|NCT00088413|537648921|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
149046046|NCT00088413|537648922|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
149046047|NCT00088413|537648923|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
149046048|NCT00088413|537648920|FG000|Overall Study|Death|0|||
149046049|NCT00088413|537648921|FG001|Overall Study|Death|1|||
149046050|NCT00088413|537648922|FG002|Overall Study|Death|0|||
149046051|NCT00088413|537648923|FG003|Overall Study|Death|0|||
149046052|NCT00088413|537648920|FG000|Overall Study|Progressive disease|9|||
149046053|NCT00088413|537648921|FG001|Overall Study|Progressive disease|11|||
149046054|NCT00088413|537648922|FG002|Overall Study|Progressive disease|8|||
149046055|NCT00088413|537648923|FG003|Overall Study|Progressive disease|14|||
149046056|NCT00088413|537648920|FG000|Overall Study|Other|0|||
149046057|NCT00088413|537648921|FG001|Overall Study|Other|1|||
149046058|NCT00088413|537648922|FG002|Overall Study|Other|0|||
149046059|NCT00088413|537648923|FG003|Overall Study|Other|0|||
149046060|NCT00088413|537648920|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
149046061|NCT00088413|537648921|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
149046062|NCT00088413|537648922|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
149046063|NCT00088413|537648923|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
149046064|NCT01044303|537648926|FG000|Overall Study|Lost to Follow-up|2|||
149046065|NCT02539225|537648929|FG000|Part A|Adverse Event|13|||
149046066|NCT02539225|537648930|FG001|Part A|Adverse Event|4|||
149046067|NCT02539225|537648929|FG000|Part A|Withdrawal by Subject|2|||
149046068|NCT02539225|537648930|FG001|Part A|Withdrawal by Subject|4|||
149046069|NCT02539225|537648929|FG000|Part A|Physician Decision|4|||
149046070|NCT02539225|537648930|FG001|Part A|Physician Decision|7|||
149046071|NCT02539225|537648929|FG000|Part A|Did Not Receive study Drug|1|||
149046072|NCT02539225|537648930|FG001|Part A|Did Not Receive study Drug|1|||
149046073|NCT02539225|537648929|FG000|Pre Treatment for Part B|Progressive disease|1|||
149046074|NCT02539225|537648930|FG001|Pre Treatment for Part B|Progressive disease|1|||
149046075|NCT02539225|537648929|FG000|Pre Treatment for Part B|Adverse Event|1|||
149046076|NCT02539225|537648930|FG001|Pre Treatment for Part B|Adverse Event|1|||
149046077|NCT02539225|537648929|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
149046078|NCT02539225|537648930|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
149046079|NCT02539225|537648929|FG000|Pre Treatment for Part B|Physician Decision|2|||
149046080|NCT02539225|537648930|FG001|Pre Treatment for Part B|Physician Decision|0|||
149046081|NCT02539225|537648929|FG000|Part B|Adverse Event|4|||
149046082|NCT02539225|537648930|FG001|Part B|Adverse Event|4|||
149046083|NCT02539225|537648929|FG000|Part B|Withdrawal by Subject|0|||
149046084|NCT02539225|537648930|FG001|Part B|Withdrawal by Subject|3|||
149046085|NCT02539225|537648929|FG000|Part B|Physician Decision|0|||
149046086|NCT02539225|537648930|FG001|Part B|Physician Decision|9|||
149046087|NCT01109524|537648933|FG000|Overall Study|Disease Progression|29|||
149046088|NCT01109524|537648933|FG000|Overall Study|Study Drug toxicity|6|||
149046089|NCT01109524|537648933|FG000|Overall Study|Adverse Event|4|||
149046090|NCT01109524|537648933|FG000|Overall Study|Withdrawal by Subject|2|||
149046091|NCT01109524|537648933|FG000|Overall Study|Maximum clinical benefit|3|||
149046092|NCT01109524|537648933|FG000|Overall Study|Death|2|||
149046093|NCT01109524|537648933|FG000|Overall Study|No longer meets criteria|2|||
149046094|NCT01109524|537648933|FG000|Overall Study|Participant requested to end treatment|4|||
149046095|NCT01109524|537648933|FG000|Overall Study|Other|5|||
149046096|NCT03101371|537648937|FG000|Overall Study|Physician Decision|0|||
149046097|NCT03101371|537648938|FG001|Overall Study|Physician Decision|1|||
149046098|NCT03101371|537648937|FG000|Overall Study|Lost to Follow-up|1|||
149046099|NCT03101371|537648938|FG001|Overall Study|Lost to Follow-up|4|||
149046100|NCT03101371|537648937|FG000|Overall Study|Did not meet eligibility criteria|2|||
149046101|NCT03101371|537648938|FG001|Overall Study|Did not meet eligibility criteria|1|||
149046102|NCT02318134|537648941|FG000|Overall Study|Withdrawal by Subject|2|||
149046103|NCT02318134|537648942|FG001|Overall Study|Withdrawal by Subject|1|||
149046104|NCT00031694|537648943|FG000|Overall Study|Adverse Event|12|||
149046105|NCT00031694|537648943|FG000|Overall Study|Death|2|||
149046106|NCT00031694|537648943|FG000|Overall Study|Withdrawal by Subject|5|||
149046107|NCT05028582|537648950|FG000|Overall Study|Lost to Follow-up|11|||
149046108|NCT05028582|537648951|FG001|Overall Study|Lost to Follow-up|9|||
149046109|NCT05028582|537648950|FG000|Overall Study|Withdrawal by Subject|9|||
149046110|NCT05028582|537648951|FG001|Overall Study|Withdrawal by Subject|10|||
149046111|NCT05028582|537648950|FG000|Overall Study|Adverse Event|5|||
149046112|NCT05028582|537648951|FG001|Overall Study|Adverse Event|2|||
149046113|NCT05028582|537648950|FG000|Overall Study|Miscellaneous|3|||
149046114|NCT05028582|537648951|FG001|Overall Study|Miscellaneous|2|||
149046115|NCT05028582|537648950|FG000|Overall Study|Lack of Efficacy|3|||
149046116|NCT05028582|537648951|FG001|Overall Study|Lack of Efficacy|1|||
148885608|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
148885609|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
148885610|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
148885611|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
148885612|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
148885613|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
149046117|NCT05028582|537648950|FG000|Overall Study|Physician Decision|0|||
149046118|NCT05028582|537648951|FG001|Overall Study|Physician Decision|1|||
149046119|NCT02576509|537650694|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
149046120|NCT02576509|537650695|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
149046121|NCT02576509|537650694|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
149046122|NCT02576509|537650695|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
149046123|NCT02576509|537650694|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
149046124|NCT02576509|537650695|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
149046125|NCT02576509|537650694|FG000|Treatment Period|Disease progression|263|||
149046126|NCT02576509|537650695|FG001|Treatment Period|Disease progression|244|||
149046127|NCT02576509|537650694|FG000|Treatment Period|Study drug toxicity|37|||
149046128|NCT02576509|537650695|FG001|Treatment Period|Study drug toxicity|41|||
149046129|NCT02576509|537650694|FG000|Treatment Period|Death|1|||
149046130|NCT02576509|537650695|FG001|Treatment Period|Death|1|||
149046131|NCT02576509|537650694|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
149046132|NCT02576509|537650695|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
149046133|NCT02576509|537650694|FG000|Treatment Period|Participant request to stop treatment|8|||
149046134|NCT02576509|537650695|FG001|Treatment Period|Participant request to stop treatment|18|||
149046135|NCT02576509|537650694|FG000|Treatment Period|Participant withdrew consent|3|||
149046136|NCT02576509|537650695|FG001|Treatment Period|Participant withdrew consent|7|||
148885614|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
148885615|NCT01910402|537060169|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
148885616|NCT01910402|537060170|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
148885617|NCT01910402|537060171|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
149046137|NCT02576509|537650694|FG000|Treatment Period|Lost to Follow-up|0|||
149046138|NCT02576509|537650695|FG001|Treatment Period|Lost to Follow-up|1|||
149046139|NCT02576509|537650694|FG000|Treatment Period|Maximum clinical benefit|1|||
149046140|NCT02576509|537650695|FG001|Treatment Period|Maximum clinical benefit|0|||
149046141|NCT02576509|537650694|FG000|Treatment Period|Poor/non-compliance|1|||
149046142|NCT02576509|537650695|FG001|Treatment Period|Poor/non-compliance|1|||
149046143|NCT02576509|537650694|FG000|Treatment Period|Participant no longer meets criteria|1|||
149046144|NCT02576509|537650695|FG001|Treatment Period|Participant no longer meets criteria|0|||
149046145|NCT02576509|537650694|FG000|Treatment Period|Other reason|12|||
149046146|NCT02576509|537650695|FG001|Treatment Period|Other reason|8|||
149046147|NCT02576509|537650694|FG000|Treatment Period|NOT REPORTED|1|||
149046148|NCT02576509|537650695|FG001|Treatment Period|NOT REPORTED|0|||
149046149|NCT02576509|537650694|FG000|Treatment Period|Administrative reason by sponsor|0|||
149046150|NCT02576509|537650695|FG001|Treatment Period|Administrative reason by sponsor|1|||
149046151|NCT03398148|537650698|FG000|Substudy 1 Period 1|Adverse Event|5|||
149046152|NCT03398148|537650699|FG001|Substudy 1 Period 1|Adverse Event|2|||
149046153|NCT03398148|537650700|FG002|Substudy 1 Period 1|Adverse Event|2|||
149046154|NCT03398148|537650701|FG003|Substudy 1 Period 1|Adverse Event|0|||
149046155|NCT03398148|537650702|FG004|Substudy 1 Period 1|Adverse Event|8|||
149046156|NCT03398148|537650703|FG005|Substudy 1 Period 1|Adverse Event|0|||
149046157|NCT03398148|537650704|FG006|Substudy 1 Period 1|Adverse Event|0|||
149046158|NCT03398148|537650705|FG007|Substudy 1 Period 1|Adverse Event|0|||
149046159|NCT03398148|537650706|FG008|Substudy 1 Period 1|Adverse Event|0|||
149046160|NCT03398148|537650707|FG009|Substudy 1 Period 1|Adverse Event|0|||
149046161|NCT03398148|537650708|FG010|Substudy 1 Period 1|Adverse Event|0|||
149046162|NCT03398148|537650709|FG011|Substudy 1 Period 1|Adverse Event|0|||
149046163|NCT03398148|537650710|FG012|Substudy 1 Period 1|Adverse Event|0|||
149046164|NCT03398148|537650711|FG013|Substudy 1 Period 1|Adverse Event|0|||
149046165|NCT03398148|537650712|FG014|Substudy 1 Period 1|Adverse Event|0|||
149046166|NCT03398148|537650698|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
149046167|NCT03398148|537650699|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
149046168|NCT03398148|537650700|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046169|NCT03398148|537650701|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
149046170|NCT03398148|537650702|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
149046171|NCT03398148|537650703|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046172|NCT03398148|537650704|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046173|NCT03398148|537650705|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046174|NCT03398148|537650706|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046175|NCT03398148|537650707|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046176|NCT03398148|537650708|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046177|NCT03398148|537650709|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046178|NCT03398148|537650710|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046179|NCT03398148|537650711|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046180|NCT03398148|537650712|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
149046181|NCT03398148|537650698|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
149046182|NCT03398148|537650699|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
149046183|NCT03398148|537650700|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
149046184|NCT03398148|537650701|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
149046185|NCT03398148|537650702|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
149046186|NCT03398148|537650703|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
149046187|NCT03398148|537650704|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
149046188|NCT03398148|537650705|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
149046189|NCT03398148|537650706|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
149046190|NCT03398148|537650707|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
149046191|NCT03398148|537650708|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
149046192|NCT03398148|537650709|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
149046193|NCT03398148|537650710|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
149046194|NCT03398148|537650711|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
149046195|NCT03398148|537650712|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
149046196|NCT03398148|537650698|FG000|Substudy 1 Period 1|Other|0|||
149046197|NCT03398148|537650699|FG001|Substudy 1 Period 1|Other|1|||
149046198|NCT03398148|537650700|FG002|Substudy 1 Period 1|Other|0|||
149046199|NCT03398148|537650701|FG003|Substudy 1 Period 1|Other|0|||
149046200|NCT03398148|537650702|FG004|Substudy 1 Period 1|Other|3|||
149046201|NCT03398148|537650703|FG005|Substudy 1 Period 1|Other|0|||
149046202|NCT03398148|537650704|FG006|Substudy 1 Period 1|Other|0|||
149046203|NCT03398148|537650705|FG007|Substudy 1 Period 1|Other|0|||
149046204|NCT03398148|537650706|FG008|Substudy 1 Period 1|Other|0|||
149046205|NCT03398148|537650707|FG009|Substudy 1 Period 1|Other|0|||
149046206|NCT03398148|537650708|FG010|Substudy 1 Period 1|Other|0|||
149046207|NCT03398148|537650709|FG011|Substudy 1 Period 1|Other|0|||
149046208|NCT03398148|537650710|FG012|Substudy 1 Period 1|Other|0|||
149046209|NCT03398148|537650711|FG013|Substudy 1 Period 1|Other|0|||
149046210|NCT03398148|537650712|FG014|Substudy 1 Period 1|Other|0|||
149046211|NCT03398148|537650698|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046212|NCT03398148|537650699|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046213|NCT03398148|537650700|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046214|NCT03398148|537650701|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046215|NCT03398148|537650702|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
149046216|NCT03398148|537650703|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046217|NCT03398148|537650704|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046218|NCT03398148|537650705|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046219|NCT03398148|537650706|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046220|NCT03398148|537650707|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046221|NCT03398148|537650708|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046222|NCT03398148|537650709|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046223|NCT03398148|537650710|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046224|NCT03398148|537650711|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046225|NCT03398148|537650712|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
149046226|NCT03398148|537650698|FG000|Substudy 1 Period 2|Adverse Event|0|||
149046227|NCT03398148|537650699|FG001|Substudy 1 Period 2|Adverse Event|0|||
149046228|NCT03398148|537650700|FG002|Substudy 1 Period 2|Adverse Event|0|||
149046229|NCT03398148|537650701|FG003|Substudy 1 Period 2|Adverse Event|0|||
149046230|NCT03398148|537650702|FG004|Substudy 1 Period 2|Adverse Event|0|||
149046231|NCT03398148|537650703|FG005|Substudy 1 Period 2|Adverse Event|2|||
149046232|NCT03398148|537650704|FG006|Substudy 1 Period 2|Adverse Event|4|||
149046233|NCT03398148|537650705|FG007|Substudy 1 Period 2|Adverse Event|0|||
149046234|NCT03398148|537650706|FG008|Substudy 1 Period 2|Adverse Event|0|||
149046235|NCT03398148|537650707|FG009|Substudy 1 Period 2|Adverse Event|0|||
149046236|NCT03398148|537650708|FG010|Substudy 1 Period 2|Adverse Event|0|||
149046237|NCT03398148|537650709|FG011|Substudy 1 Period 2|Adverse Event|0|||
149046238|NCT03398148|537650710|FG012|Substudy 1 Period 2|Adverse Event|0|||
149046239|NCT03398148|537650711|FG013|Substudy 1 Period 2|Adverse Event|0|||
149046240|NCT03398148|537650712|FG014|Substudy 1 Period 2|Adverse Event|0|||
149046241|NCT03398148|537650698|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046242|NCT03398148|537650699|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046243|NCT03398148|537650700|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046244|NCT03398148|537650701|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046245|NCT03398148|537650702|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046246|NCT03398148|537650703|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046247|NCT03398148|537650704|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
149046248|NCT03398148|537650705|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
149046249|NCT03398148|537650706|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046250|NCT03398148|537650707|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046251|NCT03398148|537650708|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046252|NCT03398148|537650709|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046253|NCT03398148|537650710|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046254|NCT03398148|537650711|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046255|NCT03398148|537650712|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
149046256|NCT03398148|537650698|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
149046257|NCT03398148|537650699|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
149046258|NCT03398148|537650700|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
149046259|NCT03398148|537650701|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
149046260|NCT03398148|537650702|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
149046261|NCT03398148|537650703|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
149046262|NCT03398148|537650704|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
149046263|NCT03398148|537650705|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
149046264|NCT03398148|537650706|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
149046265|NCT03398148|537650707|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
149046266|NCT03398148|537650708|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
149046267|NCT03398148|537650709|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
149046268|NCT03398148|537650710|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
149046269|NCT03398148|537650711|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
149046270|NCT03398148|537650712|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
149046271|NCT03398148|537650698|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046272|NCT03398148|537650699|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046273|NCT03398148|537650700|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046274|NCT03398148|537650701|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046275|NCT03398148|537650702|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046276|NCT03398148|537650703|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046277|NCT03398148|537650704|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
149046278|NCT03398148|537650705|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046279|NCT03398148|537650706|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046280|NCT03398148|537650707|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046281|NCT03398148|537650708|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046282|NCT03398148|537650709|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046283|NCT03398148|537650710|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046284|NCT03398148|537650711|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046285|NCT03398148|537650712|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046286|NCT03398148|537650698|FG000|Substudy 1 Period 2|Other|0|||
149046287|NCT03398148|537650699|FG001|Substudy 1 Period 2|Other|0|||
149046288|NCT03398148|537650700|FG002|Substudy 1 Period 2|Other|0|||
149046289|NCT03398148|537650701|FG003|Substudy 1 Period 2|Other|0|||
149046290|NCT03398148|537650702|FG004|Substudy 1 Period 2|Other|0|||
149046291|NCT03398148|537650703|FG005|Substudy 1 Period 2|Other|0|||
149046292|NCT03398148|537650704|FG006|Substudy 1 Period 2|Other|1|||
149046293|NCT03398148|537650705|FG007|Substudy 1 Period 2|Other|0|||
149046294|NCT03398148|537650706|FG008|Substudy 1 Period 2|Other|0|||
149046295|NCT03398148|537650707|FG009|Substudy 1 Period 2|Other|0|||
149046296|NCT03398148|537650708|FG010|Substudy 1 Period 2|Other|0|||
149046297|NCT03398148|537650709|FG011|Substudy 1 Period 2|Other|0|||
149046298|NCT03398148|537650710|FG012|Substudy 1 Period 2|Other|0|||
149046299|NCT03398148|537650711|FG013|Substudy 1 Period 2|Other|0|||
149046300|NCT03398148|537650712|FG014|Substudy 1 Period 2|Other|0|||
149046301|NCT03398148|537650698|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046302|NCT03398148|537650699|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
148885618|NCT01910402|537060169|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
148885619|NCT01910402|537060170|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
148885620|NCT01910402|537060171|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
148885621|NCT01910402|537060169|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
148885622|NCT01910402|537060170|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
148885623|NCT01910402|537060171|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
148885624|NCT01910402|537060169|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
148885625|NCT01910402|537060170|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
148885626|NCT01910402|537060171|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
148885627|NCT01910402|537060169|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
148885628|NCT01910402|537060170|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
148885629|NCT01910402|537060171|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
148885630|NCT01910402|537060169|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
148885631|NCT01910402|537060170|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
148885632|NCT01910402|537060171|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
149046303|NCT03398148|537650700|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046304|NCT03398148|537650701|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046305|NCT03398148|537650702|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046306|NCT03398148|537650703|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046307|NCT03398148|537650704|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
149046308|NCT03398148|537650705|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046309|NCT03398148|537650706|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046310|NCT03398148|537650707|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046311|NCT03398148|537650708|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046312|NCT03398148|537650709|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046313|NCT03398148|537650710|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046314|NCT03398148|537650711|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046315|NCT03398148|537650712|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
149046316|NCT03398148|537650698|FG000|Substudy 2 Period 1|Adverse Event|0|||
149046317|NCT03398148|537650699|FG001|Substudy 2 Period 1|Adverse Event|0|||
149046318|NCT03398148|537650700|FG002|Substudy 2 Period 1|Adverse Event|0|||
149046319|NCT03398148|537650701|FG003|Substudy 2 Period 1|Adverse Event|0|||
149046320|NCT03398148|537650702|FG004|Substudy 2 Period 1|Adverse Event|0|||
149046321|NCT03398148|537650703|FG005|Substudy 2 Period 1|Adverse Event|0|||
149046322|NCT03398148|537650704|FG006|Substudy 2 Period 1|Adverse Event|0|||
149046323|NCT03398148|537650705|FG007|Substudy 2 Period 1|Adverse Event|0|||
149046324|NCT03398148|537650706|FG008|Substudy 2 Period 1|Adverse Event|0|||
149046325|NCT03398148|537650707|FG009|Substudy 2 Period 1|Adverse Event|12|||
149046326|NCT03398148|537650708|FG010|Substudy 2 Period 1|Adverse Event|2|||
149046327|NCT03398148|537650709|FG011|Substudy 2 Period 1|Adverse Event|0|||
149046328|NCT03398148|537650710|FG012|Substudy 2 Period 1|Adverse Event|0|||
149046329|NCT03398148|537650711|FG013|Substudy 2 Period 1|Adverse Event|0|||
149046330|NCT03398148|537650712|FG014|Substudy 2 Period 1|Adverse Event|0|||
149046331|NCT03398148|537650698|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046332|NCT03398148|537650699|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046333|NCT03398148|537650700|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046334|NCT03398148|537650701|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046335|NCT03398148|537650702|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046336|NCT03398148|537650703|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046337|NCT03398148|537650704|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046338|NCT03398148|537650705|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046339|NCT03398148|537650706|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046340|NCT03398148|537650707|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
149046341|NCT03398148|537650708|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
149046342|NCT03398148|537650709|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046343|NCT03398148|537650710|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046344|NCT03398148|537650711|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046345|NCT03398148|537650712|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
149046346|NCT03398148|537650698|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
149046347|NCT03398148|537650699|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
149046348|NCT03398148|537650700|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
149046349|NCT03398148|537650701|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
149046350|NCT03398148|537650702|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
149046351|NCT03398148|537650703|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
149046352|NCT03398148|537650704|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
149046353|NCT03398148|537650705|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
149046354|NCT03398148|537650706|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
149046355|NCT03398148|537650707|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
149046356|NCT03398148|537650708|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
149046357|NCT03398148|537650709|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
149046358|NCT03398148|537650710|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
149046359|NCT03398148|537650711|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
149046360|NCT03398148|537650712|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
149046361|NCT03398148|537650698|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046362|NCT03398148|537650699|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046363|NCT03398148|537650700|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046364|NCT03398148|537650701|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046365|NCT03398148|537650702|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046366|NCT03398148|537650703|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046367|NCT03398148|537650704|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046368|NCT03398148|537650705|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046369|NCT03398148|537650706|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046370|NCT03398148|537650707|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046371|NCT03398148|537650708|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
149046372|NCT03398148|537650709|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046373|NCT03398148|537650710|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046374|NCT03398148|537650711|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046375|NCT03398148|537650712|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
149046376|NCT03398148|537650698|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046377|NCT03398148|537650699|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046378|NCT03398148|537650700|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046379|NCT03398148|537650701|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046380|NCT03398148|537650702|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046381|NCT03398148|537650703|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046382|NCT03398148|537650704|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046383|NCT03398148|537650705|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046384|NCT03398148|537650706|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046385|NCT03398148|537650707|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046386|NCT03398148|537650708|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
149046387|NCT03398148|537650709|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046388|NCT03398148|537650710|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046389|NCT03398148|537650711|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046390|NCT03398148|537650712|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
149046391|NCT03398148|537650698|FG000|Substudy 2 Period 1|Other|0|||
149046392|NCT03398148|537650699|FG001|Substudy 2 Period 1|Other|0|||
149046393|NCT03398148|537650700|FG002|Substudy 2 Period 1|Other|0|||
149046394|NCT03398148|537650701|FG003|Substudy 2 Period 1|Other|0|||
149046395|NCT03398148|537650702|FG004|Substudy 2 Period 1|Other|0|||
149046396|NCT03398148|537650703|FG005|Substudy 2 Period 1|Other|0|||
149046397|NCT03398148|537650704|FG006|Substudy 2 Period 1|Other|0|||
149046398|NCT03398148|537650705|FG007|Substudy 2 Period 1|Other|0|||
149046399|NCT03398148|537650706|FG008|Substudy 2 Period 1|Other|0|||
149046400|NCT03398148|537650707|FG009|Substudy 2 Period 1|Other|4|||
149046401|NCT03398148|537650708|FG010|Substudy 2 Period 1|Other|4|||
149046402|NCT03398148|537650709|FG011|Substudy 2 Period 1|Other|0|||
149046403|NCT03398148|537650710|FG012|Substudy 2 Period 1|Other|0|||
149046404|NCT03398148|537650711|FG013|Substudy 2 Period 1|Other|0|||
149046405|NCT03398148|537650712|FG014|Substudy 2 Period 1|Other|0|||
149046406|NCT03398148|537650698|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046407|NCT03398148|537650699|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
148885633|NCT01910402|537060169|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
149046408|NCT03398148|537650700|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046409|NCT03398148|537650701|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046410|NCT03398148|537650702|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046411|NCT03398148|537650703|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046412|NCT03398148|537650704|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046413|NCT03398148|537650705|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046414|NCT03398148|537650706|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046415|NCT03398148|537650707|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046416|NCT03398148|537650708|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
149046417|NCT03398148|537650709|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046418|NCT03398148|537650710|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046419|NCT03398148|537650711|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046420|NCT03398148|537650712|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
149046421|NCT03398148|537650698|FG000|Substudy 2 Period 2|Adverse Event|0|||
149046422|NCT03398148|537650699|FG001|Substudy 2 Period 2|Adverse Event|0|||
149046423|NCT03398148|537650700|FG002|Substudy 2 Period 2|Adverse Event|0|||
149046424|NCT03398148|537650701|FG003|Substudy 2 Period 2|Adverse Event|0|||
149046425|NCT03398148|537650702|FG004|Substudy 2 Period 2|Adverse Event|0|||
149046426|NCT03398148|537650703|FG005|Substudy 2 Period 2|Adverse Event|0|||
149046427|NCT03398148|537650704|FG006|Substudy 2 Period 2|Adverse Event|0|||
149046428|NCT03398148|537650705|FG007|Substudy 2 Period 2|Adverse Event|0|||
149046429|NCT03398148|537650706|FG008|Substudy 2 Period 2|Adverse Event|0|||
149046430|NCT03398148|537650707|FG009|Substudy 2 Period 2|Adverse Event|0|||
149046431|NCT03398148|537650708|FG010|Substudy 2 Period 2|Adverse Event|0|||
149046432|NCT03398148|537650709|FG011|Substudy 2 Period 2|Adverse Event|0|||
149046433|NCT03398148|537650710|FG012|Substudy 2 Period 2|Adverse Event|0|||
149046434|NCT03398148|537650711|FG013|Substudy 2 Period 2|Adverse Event|1|||
149046435|NCT03398148|537650712|FG014|Substudy 2 Period 2|Adverse Event|3|||
149046436|NCT03398148|537650698|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
149046437|NCT03398148|537650699|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
149046438|NCT03398148|537650700|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
149046439|NCT03398148|537650701|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
149046440|NCT03398148|537650702|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
149046441|NCT03398148|537650703|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
149046442|NCT03398148|537650704|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
149046443|NCT03398148|537650705|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
149046444|NCT03398148|537650706|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
149046445|NCT03398148|537650707|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
149046446|NCT03398148|537650708|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
149046447|NCT03398148|537650709|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
149046448|NCT03398148|537650710|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
149046449|NCT03398148|537650711|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
149046450|NCT03398148|537650712|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
149046451|NCT03398148|537650698|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046452|NCT03398148|537650699|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046453|NCT03398148|537650700|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046454|NCT03398148|537650701|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046455|NCT03398148|537650702|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046456|NCT03398148|537650703|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046457|NCT03398148|537650704|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046458|NCT03398148|537650705|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046459|NCT03398148|537650706|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046460|NCT03398148|537650707|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046461|NCT03398148|537650708|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046462|NCT03398148|537650709|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
149046463|NCT03398148|537650710|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
149046464|NCT03398148|537650711|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
149046465|NCT03398148|537650712|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
149046466|NCT03398148|537650698|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
149046467|NCT03398148|537650699|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
149046468|NCT03398148|537650700|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
149046469|NCT03398148|537650701|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
149046470|NCT03398148|537650702|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
149046471|NCT03398148|537650703|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
149046472|NCT03398148|537650704|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
149046473|NCT03398148|537650705|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
149046474|NCT03398148|537650706|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
149046475|NCT03398148|537650707|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
149046476|NCT03398148|537650708|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
149046477|NCT03398148|537650709|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
149046478|NCT03398148|537650710|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
149046479|NCT03398148|537650711|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
149046480|NCT03398148|537650712|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
149046481|NCT03398148|537650698|FG000|Substudy 2 Period 2|Other|0|||
149046482|NCT03398148|537650699|FG001|Substudy 2 Period 2|Other|0|||
149046483|NCT03398148|537650700|FG002|Substudy 2 Period 2|Other|0|||
149046484|NCT03398148|537650701|FG003|Substudy 2 Period 2|Other|0|||
149046485|NCT03398148|537650702|FG004|Substudy 2 Period 2|Other|0|||
149046486|NCT03398148|537650703|FG005|Substudy 2 Period 2|Other|0|||
149046487|NCT03398148|537650704|FG006|Substudy 2 Period 2|Other|0|||
149046488|NCT03398148|537650705|FG007|Substudy 2 Period 2|Other|0|||
149046489|NCT03398148|537650706|FG008|Substudy 2 Period 2|Other|0|||
149046490|NCT03398148|537650707|FG009|Substudy 2 Period 2|Other|0|||
149046491|NCT03398148|537650708|FG010|Substudy 2 Period 2|Other|0|||
149046492|NCT03398148|537650709|FG011|Substudy 2 Period 2|Other|0|||
149046493|NCT03398148|537650710|FG012|Substudy 2 Period 2|Other|0|||
149046494|NCT03398148|537650711|FG013|Substudy 2 Period 2|Other|1|||
149046495|NCT03398148|537650712|FG014|Substudy 2 Period 2|Other|1|||
149046496|NCT03398148|537650698|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046497|NCT03398148|537650699|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046498|NCT03398148|537650700|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046499|NCT03398148|537650701|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046500|NCT03398148|537650702|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046501|NCT03398148|537650703|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046502|NCT03398148|537650704|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046503|NCT03398148|537650705|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046504|NCT03398148|537650706|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046505|NCT03398148|537650707|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046506|NCT03398148|537650708|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046507|NCT03398148|537650709|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046508|NCT03398148|537650710|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
149046509|NCT03398148|537650711|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
149046510|NCT03398148|537650712|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
149046511|NCT04278586|537650713|FG000|Overall Study|Withdrawal by Subject|13|||
149046512|NCT04278586|537650714|FG001|Overall Study|Withdrawal by Subject|6|||
149046513|NCT04278586|537650713|FG000|Overall Study|Lost to Follow-up|37|||
149046514|NCT04278586|537650714|FG001|Overall Study|Lost to Follow-up|24|||
149046515|NCT02791230|537650715|FG000|Overall Study|Adverse Event|10|||
149046516|NCT02791230|537650716|FG001|Overall Study|Adverse Event|9|||
149046517|NCT02791230|537650717|FG002|Overall Study|Adverse Event|66|||
149046518|NCT02791230|537650715|FG000|Overall Study|Death|38|||
149046519|NCT02791230|537650716|FG001|Overall Study|Death|25|||
149046520|NCT02791230|537650717|FG002|Overall Study|Death|184|||
149046521|NCT02791230|537650715|FG000|Overall Study|Lack of Efficacy|1|||
149046522|NCT02791230|537650716|FG001|Overall Study|Lack of Efficacy|0|||
149046523|NCT02791230|537650717|FG002|Overall Study|Lack of Efficacy|3|||
149046524|NCT02791230|537650715|FG000|Overall Study|Lost to Follow-up|0|||
149046525|NCT02791230|537650716|FG001|Overall Study|Lost to Follow-up|0|||
149046526|NCT02791230|537650717|FG002|Overall Study|Lost to Follow-up|10|||
149046527|NCT02791230|537650715|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
149046528|NCT02791230|537650716|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
149046529|NCT02791230|537650717|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
149046530|NCT02791230|537650715|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
149046531|NCT02791230|537650716|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
149046532|NCT02791230|537650717|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
149046533|NCT02791230|537650715|FG000|Overall Study|Study sites terminated by sponsor|1|||
149046534|NCT02791230|537650716|FG001|Overall Study|Study sites terminated by sponsor|0|||
149046535|NCT02791230|537650717|FG002|Overall Study|Study sites terminated by sponsor|5|||
148885634|NCT01910402|537060170|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
149046536|NCT02791230|537650715|FG000|Overall Study|Other|9|||
149046537|NCT02791230|537650716|FG001|Overall Study|Other|1|||
149046538|NCT02791230|537650717|FG002|Overall Study|Other|28|||
149046539|NCT02791230|537650715|FG000|Overall Study|Protocol Violation|0|||
149046540|NCT02791230|537650716|FG001|Overall Study|Protocol Violation|0|||
149046541|NCT02791230|537650717|FG002|Overall Study|Protocol Violation|4|||
149046542|NCT02791230|537650715|FG000|Overall Study|Withdrawal by Subject|24|||
149046543|NCT02791230|537650716|FG001|Overall Study|Withdrawal by Subject|13|||
149046544|NCT02791230|537650717|FG002|Overall Study|Withdrawal by Subject|172|||
149046545|NCT02791230|537650715|FG000|Overall Study|Enrolled but not treated|0|||
149046546|NCT02791230|537650716|FG001|Overall Study|Enrolled but not treated|0|||
149046547|NCT02791230|537650717|FG002|Overall Study|Enrolled but not treated|5|||
149046548|NCT00212355|537650718|FG000|Overall Study|Adverse Event|1|||
149046549|NCT00212355|537650718|FG000|Overall Study|Withdrawal by Subject|1|||
149046550|NCT00212355|537650718|FG000|Overall Study|A change of address|1|||
149046551|NCT04310735|537650724|FG000|Overall Study|Withdrawal by Subject|1|||
149046552|NCT04310735|537650725|FG001|Overall Study|Withdrawal by Subject|3|||
149046553|NCT04310735|537650726|FG002|Overall Study|Withdrawal by Subject|8|||
149046554|NCT04310735|537650724|FG000|Overall Study|Equipment malfunction|0|||
149046555|NCT04310735|537650725|FG001|Overall Study|Equipment malfunction|1|||
149046556|NCT04310735|537650726|FG002|Overall Study|Equipment malfunction|0|||
149046557|NCT03012841|537650727|FG000|Overall Study|Protocol Violation|0|||
149046558|NCT03012841|537650728|FG001|Overall Study|Protocol Violation|10|||
149046559|NCT03012841|537650727|FG000|Overall Study|Lost to Follow-up|6|||
149046560|NCT03012841|537650728|FG001|Overall Study|Lost to Follow-up|1|||
149046561|NCT03012841|537650727|FG000|Overall Study|Withdrawal by Subject|6|||
149046562|NCT03012841|537650728|FG001|Overall Study|Withdrawal by Subject|0|||
149046563|NCT03012841|537650727|FG000|Overall Study|Unable to complete 12 month visit|6|||
149046564|NCT03012841|537650728|FG001|Overall Study|Unable to complete 12 month visit|0|||
149046565|NCT03012841|537650727|FG000|Overall Study|Subject relocation|1|||
149046566|NCT03012841|537650728|FG001|Overall Study|Subject relocation|0|||
149046567|NCT03012841|537650727|FG000|Overall Study|Seasonal winter travel|1|||
149046568|NCT03012841|537650728|FG001|Overall Study|Seasonal winter travel|0|||
149046569|NCT03012841|537650727|FG000|Overall Study|Physician Decision|0|||
149046570|NCT03012841|537650728|FG001|Overall Study|Physician Decision|2|||
149046571|NCT03012841|537650727|FG000|Overall Study|No ablation performed|0|||
149046572|NCT03012841|537650728|FG001|Overall Study|No ablation performed|2|||
149046573|NCT03012841|537650727|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
149046574|NCT03012841|537650728|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
149046575|NCT03012841|537650727|FG000|Overall Study|Insurance change|0|||
149046576|NCT03012841|537650728|FG001|Overall Study|Insurance change|1|||
149046577|NCT05756075|537650731|FG000|Overall Study|Withdrawal by Subject|16|||
149046578|NCT05756075|537650732|FG001|Overall Study|Withdrawal by Subject|9|||
149046579|NCT04038957|537650733|FG000|Overall Study|Withdrawal by Subject|1|||
149046580|NCT04038957|537650733|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
149046581|NCT05104697|537650734|FG000|Overall Study|Withdrawal by Subject|0|||
149046582|NCT05104697|537650735|FG001|Overall Study|Withdrawal by Subject|1|||
149046583|NCT02728557|537650736|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
149046584|NCT02728557|537650737|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
149046585|NCT02728557|537650736|FG000|Overall Study|Dissatisfaction with research tasks|0|||
149046586|NCT02728557|537650737|FG001|Overall Study|Dissatisfaction with research tasks|1|||
149046587|NCT02728557|537650736|FG000|Overall Study|Scheduling or change in availability|1|||
149046588|NCT02728557|537650737|FG001|Overall Study|Scheduling or change in availability|1|||
149046589|NCT03416010|537650738|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
149046590|NCT03416010|537650739|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
149046591|NCT03416010|537650738|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
149046592|NCT03416010|537650739|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
149046593|NCT03416010|537650738|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
149046594|NCT03416010|537650739|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
149046595|NCT03416010|537650738|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
149046596|NCT03416010|537650739|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
149046597|NCT03416010|537650738|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
149046598|NCT03416010|537650739|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
149046599|NCT03416010|537650738|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
149046600|NCT03416010|537650739|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
149046601|NCT03416010|537650738|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
149046602|NCT03416010|537650739|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
149046603|NCT06629454|537650743|FG000|Overall Study|Withdraw by Clinician Decision|1|||
149046604|NCT01704079|537650744|FG000|Overall Study|Withdrawal by Subject|5|||
149046605|NCT01704079|537650745|FG001|Overall Study|Withdrawal by Subject|7|||
149046606|NCT01704079|537650744|FG000|Overall Study|Lost to Follow-up|2|||
149046607|NCT01704079|537650745|FG001|Overall Study|Lost to Follow-up|5|||
149046608|NCT01704079|537650744|FG000|Overall Study|Adverse Event|4|||
149046609|NCT01704079|537650745|FG001|Overall Study|Adverse Event|7|||
149046610|NCT01704079|537650744|FG000|Overall Study|Protocol Violation|1|||
149046611|NCT01704079|537650745|FG001|Overall Study|Protocol Violation|0|||
149046612|NCT01704079|537650744|FG000|Overall Study|Subject noncompliance|2|||
149046613|NCT01704079|537650745|FG001|Overall Study|Subject noncompliance|3|||
149046614|NCT01704079|537650744|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
149046615|NCT01704079|537650745|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
149046616|NCT00505934|537650756|FG000|Overall Study|Adverse Event|1|||
149046617|NCT00505934|537650756|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
149046618|NCT00505934|537650756|FG000|Overall Study|Other: IV dose needed to be changed|1|||
148885635|NCT01910402|537060171|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
149046619|NCT02461628|537650759|FG000|Overall Study|Refused to complete survey|4|||
149046620|NCT02461628|537650760|FG001|Overall Study|Refused to complete survey|7|||
149046621|NCT02015520|537650761|FG000|Overall Study|Lack of Efficacy|1|||
149046622|NCT02015520|537650762|FG001|Overall Study|Lack of Efficacy|0|||
149046623|NCT02015520|537650763|FG002|Overall Study|Lack of Efficacy|3|||
149046624|NCT02015520|537650764|FG003|Overall Study|Lack of Efficacy|2|||
149046625|NCT02015520|537650761|FG000|Overall Study|Adverse Event|0|||
149046626|NCT02015520|537650762|FG001|Overall Study|Adverse Event|0|||
149046627|NCT02015520|537650763|FG002|Overall Study|Adverse Event|0|||
149046628|NCT02015520|537650764|FG003|Overall Study|Adverse Event|1|||
149046629|NCT02015520|537650761|FG000|Overall Study|Withdrawal by Subject|2|||
149046630|NCT02015520|537650762|FG001|Overall Study|Withdrawal by Subject|2|||
149046631|NCT02015520|537650763|FG002|Overall Study|Withdrawal by Subject|1|||
149046632|NCT02015520|537650764|FG003|Overall Study|Withdrawal by Subject|0|||
149046633|NCT02015520|537650761|FG000|Overall Study|Death|1|||
149046634|NCT02015520|537650762|FG001|Overall Study|Death|0|||
149046635|NCT02015520|537650763|FG002|Overall Study|Death|0|||
149046636|NCT02015520|537650764|FG003|Overall Study|Death|0|||
149046637|NCT02015520|537650761|FG000|Overall Study|Lost to Follow-up|0|||
149046638|NCT02015520|537650762|FG001|Overall Study|Lost to Follow-up|0|||
149046639|NCT02015520|537650763|FG002|Overall Study|Lost to Follow-up|1|||
149046640|NCT02015520|537650764|FG003|Overall Study|Lost to Follow-up|0|||
149046641|NCT02015520|537650761|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
149046642|NCT02015520|537650762|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
149046643|NCT02015520|537650763|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
149046644|NCT02015520|537650764|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
149046645|NCT02015520|537650761|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
149046646|NCT02015520|537650762|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
149046647|NCT02015520|537650763|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
149046648|NCT02015520|537650764|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
149046649|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
149046650|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
149046651|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
149046652|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
149046653|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
149046654|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
149046655|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
149046656|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
149046657|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
149046658|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
149046659|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
149046660|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
149046661|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
149046662|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
149046663|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
149046664|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
149046665|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
149046666|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
149046667|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
149046668|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
149046669|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
149046670|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
149046671|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
149046672|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
149046673|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
149046674|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
149046675|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
149046676|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
149046677|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
149046678|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
149046679|NCT04759833|537650765|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
149046680|NCT04759833|537650766|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
149046681|NCT04759833|537650767|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
149046682|NCT04759833|537650768|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
149046683|NCT04759833|537650769|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
149046684|NCT04759833|537650765|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
149046685|NCT04759833|537650766|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
149046686|NCT04759833|537650767|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
149046687|NCT04759833|537650768|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
149046688|NCT04759833|537650769|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
149046689|NCT04759833|537650765|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
149046690|NCT04759833|537650766|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
149046691|NCT04759833|537650767|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
149046692|NCT04759833|537650768|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
149046693|NCT04759833|537650769|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
149046694|NCT04759833|537650765|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
149046695|NCT04759833|537650766|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
149046696|NCT04759833|537650767|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
149046697|NCT04759833|537650768|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
149046698|NCT04759833|537650769|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
149046699|NCT04759833|537650765|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
149046700|NCT04759833|537650766|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
149046701|NCT04759833|537650767|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
149046702|NCT04759833|537650768|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
149046703|NCT04759833|537650769|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
149046704|NCT04759833|537650765|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
149046705|NCT04759833|537650766|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
149046706|NCT04759833|537650767|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
149046707|NCT04759833|537650768|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
149046708|NCT04759833|537650769|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
149046709|NCT04759833|537650765|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
149046710|NCT04759833|537650766|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
149046711|NCT04759833|537650767|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
149046712|NCT04759833|537650768|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
149046713|NCT04759833|537650769|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
149046714|NCT03446157|537650770|FG000|Overall Study|Death|11|||
149046715|NCT03446157|537650771|FG001|Overall Study|Death|9|||
149046716|NCT03446157|537650770|FG000|Overall Study|Lost to Follow-up|0|||
149046717|NCT03446157|537650771|FG001|Overall Study|Lost to Follow-up|1|||
149046718|NCT03446157|537650770|FG000|Overall Study|Withdrawal by Subject|2|||
149046719|NCT03446157|537650771|FG001|Overall Study|Withdrawal by Subject|1|||
149046720|NCT01619410|537650775|FG000|Overall Study|Lost to Follow-up|7|||
149046721|NCT01619410|537650776|FG001|Overall Study|Lost to Follow-up|4|||
149046722|NCT02462759|537650781|FG000|Part 1: Double Blind|Death|1|||
149046723|NCT02462759|537650782|FG001|Part 1: Double Blind|Death|0|||
149046724|NCT02462759|537650783|FG002|Part 1: Double Blind|Death|0|||
149046725|NCT04110054|537650784|FG000|Overall Study|COVID-19 reason other than AE|0|||
149046726|NCT04110054|537650785|FG001|Overall Study|COVID-19 reason other than AE|0|||
149046727|NCT04110054|537650786|FG002|Overall Study|COVID-19 reason other than AE|2|||
149046728|NCT04110054|537650787|FG003|Overall Study|COVID-19 reason other than AE|0|||
149046729|NCT04110054|537650784|FG000|Overall Study|Withdrawal by Subject|0|||
149046730|NCT04110054|537650785|FG001|Overall Study|Withdrawal by Subject|3|||
149046731|NCT04110054|537650786|FG002|Overall Study|Withdrawal by Subject|2|||
149046732|NCT04110054|537650787|FG003|Overall Study|Withdrawal by Subject|0|||
149046733|NCT04110054|537650784|FG000|Overall Study|Adverse Event|1|||
149046734|NCT04110054|537650785|FG001|Overall Study|Adverse Event|1|||
148885636|NCT00824473|537060172|FG000|Overall Study|Adverse Event|4|||
149046735|NCT04110054|537650786|FG002|Overall Study|Adverse Event|4|||
149046736|NCT04110054|537650787|FG003|Overall Study|Adverse Event|3|||
149046737|NCT01000480|537650789|FG000|Induction Phase|Adverse Event|2|||
149046738|NCT01000480|537650789|FG000|Induction Phase|Lost to Follow-up|1|||
149046739|NCT01000480|537650789|FG000|Induction Phase|Physician Decision|1|||
149046740|NCT01000480|537650789|FG000|Induction Phase|Entry Criteria Not Met|3|||
149046741|NCT01000480|537650789|FG000|Concurrent Therapy Phase|Adverse Event|4|||
149046742|NCT01000480|537650789|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
149046743|NCT01000480|537650789|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
149046744|NCT01000480|537650789|FG000|Concurrent Therapy Phase|Physician Decision|1|||
149046745|NCT02554786|537650793|FG000|Overall Study|Subject/guardian decision|29|||
149046746|NCT02554786|537650794|FG001|Overall Study|Subject/guardian decision|17|||
149046747|NCT02554786|537650795|FG002|Overall Study|Subject/guardian decision|18|||
149046748|NCT02554786|537650796|FG003|Overall Study|Subject/guardian decision|30|||
149046749|NCT02554786|537650797|FG004|Overall Study|Subject/guardian decision|20|||
149046750|NCT02554786|537650793|FG000|Overall Study|Lost to Follow-up|4|||
149046751|NCT02554786|537650794|FG001|Overall Study|Lost to Follow-up|3|||
149046752|NCT02554786|537650795|FG002|Overall Study|Lost to Follow-up|4|||
149046753|NCT02554786|537650796|FG003|Overall Study|Lost to Follow-up|2|||
149046754|NCT02554786|537650797|FG004|Overall Study|Lost to Follow-up|2|||
149046755|NCT02554786|537650793|FG000|Overall Study|Protocol deviation|1|||
149046756|NCT02554786|537650794|FG001|Overall Study|Protocol deviation|3|||
149046757|NCT02554786|537650795|FG002|Overall Study|Protocol deviation|3|||
149046758|NCT02554786|537650796|FG003|Overall Study|Protocol deviation|4|||
149046759|NCT02554786|537650797|FG004|Overall Study|Protocol deviation|2|||
148885637|NCT00824473|537060173|FG001|Overall Study|Adverse Event|5|||
149046760|NCT02554786|537650793|FG000|Overall Study|Technical problems|1|||
149046761|NCT02554786|537650794|FG001|Overall Study|Technical problems|1|||
149046762|NCT02554786|537650795|FG002|Overall Study|Technical problems|0|||
149046763|NCT02554786|537650796|FG003|Overall Study|Technical problems|2|||
149046764|NCT02554786|537650797|FG004|Overall Study|Technical problems|1|||
149046765|NCT02554786|537650793|FG000|Overall Study|Adverse Event|0|||
149046766|NCT02554786|537650794|FG001|Overall Study|Adverse Event|0|||
149046767|NCT02554786|537650795|FG002|Overall Study|Adverse Event|0|||
149046768|NCT02554786|537650796|FG003|Overall Study|Adverse Event|0|||
149046769|NCT02554786|537650797|FG004|Overall Study|Adverse Event|2|||
149046770|NCT02554786|537650793|FG000|Overall Study|Death|0|||
149046771|NCT02554786|537650794|FG001|Overall Study|Death|0|||
149046772|NCT02554786|537650795|FG002|Overall Study|Death|0|||
149046773|NCT02554786|537650796|FG003|Overall Study|Death|1|||
149046774|NCT02554786|537650797|FG004|Overall Study|Death|0|||
149046775|NCT02554786|537650793|FG000|Overall Study|Non-compliance with study treatment|0|||
149046776|NCT02554786|537650794|FG001|Overall Study|Non-compliance with study treatment|1|||
149046777|NCT02554786|537650795|FG002|Overall Study|Non-compliance with study treatment|1|||
149046778|NCT02554786|537650796|FG003|Overall Study|Non-compliance with study treatment|0|||
149046779|NCT02554786|537650797|FG004|Overall Study|Non-compliance with study treatment|1|||
149046780|NCT02554786|537650793|FG000|Overall Study|Physician Decision|0|||
149046781|NCT02554786|537650794|FG001|Overall Study|Physician Decision|1|||
149046782|NCT02554786|537650795|FG002|Overall Study|Physician Decision|4|||
149046783|NCT02554786|537650796|FG003|Overall Study|Physician Decision|1|||
149046784|NCT02554786|537650797|FG004|Overall Study|Physician Decision|1|||
149046785|NCT02554786|537650793|FG000|Overall Study|Pregnancy|0|||
149046786|NCT02554786|537650794|FG001|Overall Study|Pregnancy|0|||
149046787|NCT02554786|537650795|FG002|Overall Study|Pregnancy|0|||
149046788|NCT02554786|537650796|FG003|Overall Study|Pregnancy|1|||
149046789|NCT02554786|537650797|FG004|Overall Study|Pregnancy|1|||
149046790|NCT01695954|537650798|FG000|Overall Study|Withdrawal by Subject|4|||
149046791|NCT01695954|537650799|FG001|Overall Study|Withdrawal by Subject|0|||
149046792|NCT01695954|537650798|FG000|Overall Study|Adverse Event|0|||
149046793|NCT01695954|537650799|FG001|Overall Study|Adverse Event|2|||
149046794|NCT04328727|537650801|FG000|Overall Study|Guardian Decision|1|||
149046795|NCT04328727|537650801|FG000|Overall Study|Participant decision|4|||
149046796|NCT04328727|537650801|FG000|Overall Study|Death|3|||
149046797|NCT03330795|537650819|FG000|Overall Study|Death|3|||
149046798|NCT03330795|537650819|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
149046799|NCT01070069|537650821|FG000|Overall Study|Death|1|||
149046800|NCT01070069|537650822|FG001|Overall Study|Death|0|||
149046801|NCT01070069|537650823|FG002|Overall Study|Death|2|||
149046802|NCT01070069|537650824|FG003|Overall Study|Death|0|||
149046803|NCT01070069|537650825|FG004|Overall Study|Death|1|||
149046804|NCT01070069|537650821|FG000|Overall Study|Withdrawal by Subject|1|||
149046805|NCT01070069|537650822|FG001|Overall Study|Withdrawal by Subject|1|||
149046806|NCT01070069|537650823|FG002|Overall Study|Withdrawal by Subject|4|||
149046807|NCT01070069|537650824|FG003|Overall Study|Withdrawal by Subject|0|||
149046808|NCT01070069|537650825|FG004|Overall Study|Withdrawal by Subject|0|||
149046809|NCT01070069|537650821|FG000|Overall Study|Lost to Follow-up|4|||
149046810|NCT01070069|537650822|FG001|Overall Study|Lost to Follow-up|1|||
149046811|NCT01070069|537650823|FG002|Overall Study|Lost to Follow-up|0|||
149046812|NCT01070069|537650824|FG003|Overall Study|Lost to Follow-up|0|||
149046813|NCT01070069|537650825|FG004|Overall Study|Lost to Follow-up|3|||
149046814|NCT03101930|537650828|FG000|Overall Study|Withdrawal by Subject|2|||
149046815|NCT03101930|537650829|FG001|Overall Study|Withdrawal by Subject|1|||
149046816|NCT03101930|537650830|FG002|Overall Study|Withdrawal by Subject|2|||
149046817|NCT00262301|537650831|FG000|Double-blind Phase|Lost to Follow-up|1|||
149046818|NCT00262301|537650832|FG001|Double-blind Phase|Lost to Follow-up|0|||
149046819|NCT00262301|537650833|FG002|Double-blind Phase|Lost to Follow-up|0|||
149046820|NCT00262301|537650831|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
149046821|NCT00262301|537650832|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
149046822|NCT00262301|537650833|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
149046823|NCT01771731|537650834|FG000|Overall Study|Physician Decision|1|||
149046824|NCT01771731|537650835|FG001|Overall Study|Physician Decision|0|||
149046825|NCT01771731|537650834|FG000|Overall Study|Protocol Violation|0|||
149046826|NCT01771731|537650835|FG001|Overall Study|Protocol Violation|1|||
149046827|NCT01771731|537650834|FG000|Overall Study|Adverse event: Pain Crisis|1|||
149046828|NCT01771731|537650835|FG001|Overall Study|Adverse event: Pain Crisis|1|||
149046829|NCT03201562|537650836|FG000|Overall Study|Physician Decision|0|||
148885638|NCT00824473|537060172|FG000|Overall Study|Lack of Efficacy|2|||
149046830|NCT03201562|537650837|FG001|Overall Study|Physician Decision|0|||
149046831|NCT03201562|537650838|FG002|Overall Study|Physician Decision|1|||
149046832|NCT03201562|537650836|FG000|Overall Study|Adverse Event|0|||
149046833|NCT03201562|537650837|FG001|Overall Study|Adverse Event|0|||
149046834|NCT03201562|537650838|FG002|Overall Study|Adverse Event|1|||
149046835|NCT03201562|537650836|FG000|Overall Study|Lost to Follow-up|0|||
149046836|NCT03201562|537650837|FG001|Overall Study|Lost to Follow-up|1|||
149046837|NCT03201562|537650838|FG002|Overall Study|Lost to Follow-up|2|||
149046838|NCT00001277|537650839|FG000|Overall Study|Adverse Event|0|||
149046839|NCT00001277|537650840|FG001|Overall Study|Adverse Event|0|||
149046840|NCT00001277|537650841|FG002|Overall Study|Adverse Event|1|||
149046841|NCT00001277|537650839|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
149046842|NCT00001277|537650840|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
149046843|NCT00001277|537650841|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
149046844|NCT00065260|537650842|FG000|Overall Study|Death|0|||
149046845|NCT00065260|537650843|FG001|Overall Study|Death|1|||
149046846|NCT01976312|537650845|FG000|Overall Study|Pregnancy|0|||
149046847|NCT01976312|537650846|FG001|Overall Study|Pregnancy|1|||
149046848|NCT01976312|537650845|FG000|Overall Study|Lost to Follow-up|2|||
149046849|NCT01976312|537650846|FG001|Overall Study|Lost to Follow-up|0|||
149046850|NCT01976312|537650845|FG000|Overall Study|Withdrawal by Subject|7|||
149046851|NCT01976312|537650846|FG001|Overall Study|Withdrawal by Subject|2|||
149046852|NCT01976312|537650845|FG000|Overall Study|Adverse Event|6|||
149046853|NCT01976312|537650846|FG001|Overall Study|Adverse Event|6|||
149046854|NCT01976312|537650845|FG000|Overall Study|Protocol Violation|2|||
149046855|NCT01976312|537650846|FG001|Overall Study|Protocol Violation|0|||
149046856|NCT01538719|537650851|FG000|Overall Study|Lost to Follow-up|2|||
149046857|NCT01538719|537650852|FG001|Overall Study|Lost to Follow-up|0|||
149046858|NCT02556138|537650853|FG000|Overall Study|Withdrawal by Subject|1|||
149046859|NCT04428112|537650854|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
149046860|NCT04428112|537650855|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
149046861|NCT04428112|537650854|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
149046862|NCT04428112|537650855|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
149046863|NCT04428112|537650854|FG000|Overall Study|Withdrawal by Subject|9|||
149046864|NCT04428112|537650855|FG001|Overall Study|Withdrawal by Subject|4|||
149046865|NCT04428112|537650854|FG000|Overall Study|Lost to Follow-up|27|||
149046866|NCT04428112|537650855|FG001|Overall Study|Lost to Follow-up|7|||
149046867|NCT02807779|537650856|FG000|Overall Study|Lost to Follow-up|1|||
149046868|NCT02807779|537650857|FG001|Overall Study|Lost to Follow-up|0|||
149046869|NCT02807779|537650858|FG002|Overall Study|Lost to Follow-up|0|||
149046870|NCT02807779|537650856|FG000|Overall Study|Physician Decision|2|||
149046871|NCT02807779|537650857|FG001|Overall Study|Physician Decision|0|||
149046872|NCT02807779|537650858|FG002|Overall Study|Physician Decision|1|||
149046873|NCT02807779|537650856|FG000|Overall Study|Death|1|||
149046874|NCT02807779|537650857|FG001|Overall Study|Death|1|||
149046875|NCT02807779|537650858|FG002|Overall Study|Death|0|||
149046876|NCT06024174|537650859|FG000|Overall Study|Other Reasons|1|||
149046877|NCT06024174|537650859|FG000|Overall Study|Study terminated by Sponsor|4|||
149046878|NCT05134337|537652395|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
149046879|NCT05134337|537652396|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
149046880|NCT03725722|537652397|FG000|Overall Study|Lack of Efficacy|2|||
149046881|NCT03725722|537652398|FG001|Overall Study|Lack of Efficacy|1|||
149046882|NCT03725722|537652399|FG002|Overall Study|Lack of Efficacy|2|||
149046883|NCT03725722|537652400|FG003|Overall Study|Lack of Efficacy|0|||
149046884|NCT03725722|537652401|FG004|Overall Study|Lack of Efficacy|2|||
149046885|NCT03725722|537652397|FG000|Overall Study|Adverse Event|2|||
149046886|NCT03725722|537652398|FG001|Overall Study|Adverse Event|2|||
149046887|NCT03725722|537652399|FG002|Overall Study|Adverse Event|1|||
149046888|NCT03725722|537652400|FG003|Overall Study|Adverse Event|0|||
149046889|NCT03725722|537652401|FG004|Overall Study|Adverse Event|6|||
149046890|NCT03725722|537652397|FG000|Overall Study|Withdrawal by Subject|4|||
149046891|NCT03725722|537652398|FG001|Overall Study|Withdrawal by Subject|1|||
149046892|NCT03725722|537652399|FG002|Overall Study|Withdrawal by Subject|0|||
149046893|NCT03725722|537652400|FG003|Overall Study|Withdrawal by Subject|4|||
149046894|NCT03725722|537652401|FG004|Overall Study|Withdrawal by Subject|4|||
149046895|NCT03725722|537652397|FG000|Overall Study|Lost to Follow-up|3|||
149046896|NCT03725722|537652398|FG001|Overall Study|Lost to Follow-up|1|||
149046897|NCT03725722|537652399|FG002|Overall Study|Lost to Follow-up|2|||
149046898|NCT03725722|537652400|FG003|Overall Study|Lost to Follow-up|2|||
149046899|NCT03725722|537652401|FG004|Overall Study|Lost to Follow-up|1|||
149046900|NCT03725722|537652397|FG000|Overall Study|Personal reasons|0|||
149046901|NCT03725722|537652398|FG001|Overall Study|Personal reasons|0|||
149046902|NCT03725722|537652399|FG002|Overall Study|Personal reasons|1|||
149046903|NCT03725722|537652400|FG003|Overall Study|Personal reasons|0|||
149046904|NCT03725722|537652401|FG004|Overall Study|Personal reasons|1|||
149046905|NCT03725722|537652397|FG000|Overall Study|COVID-19 situation|0|||
149046906|NCT03725722|537652398|FG001|Overall Study|COVID-19 situation|1|||
148885639|NCT00824473|537060173|FG001|Overall Study|Lack of Efficacy|2|||
148885640|NCT00824473|537060172|FG000|Overall Study|Protocol Violation|2|||
148885641|NCT00824473|537060173|FG001|Overall Study|Protocol Violation|0|||
148885642|NCT00824473|537060172|FG000|Overall Study|Non-Compliance|4|||
149046907|NCT03725722|537652399|FG002|Overall Study|COVID-19 situation|0|||
149046908|NCT03725722|537652400|FG003|Overall Study|COVID-19 situation|0|||
149046909|NCT03725722|537652401|FG004|Overall Study|COVID-19 situation|0|||
149046910|NCT03481660|537652405|FG000|Overall Study|Adverse Event|5|||
148885643|NCT00824473|537060173|FG001|Overall Study|Non-Compliance|2|||
149046911|NCT03481660|537652406|FG001|Overall Study|Adverse Event|4|||
149046912|NCT03481660|537652405|FG000|Overall Study|Death|13|||
149046913|NCT03481660|537652406|FG001|Overall Study|Death|9|||
149046914|NCT03481660|537652405|FG000|Overall Study|Lost to Follow-up|2|||
149046915|NCT03481660|537652406|FG001|Overall Study|Lost to Follow-up|2|||
149046916|NCT03481660|537652405|FG000|Overall Study|Physician Decision|2|||
149046917|NCT03481660|537652406|FG001|Overall Study|Physician Decision|3|||
149046918|NCT03481660|537652405|FG000|Overall Study|Withdrawal by Subject|14|||
149046919|NCT03481660|537652406|FG001|Overall Study|Withdrawal by Subject|7|||
149046920|NCT00186992|537652407|FG000|Overall Study|Withdrawal by Subject|5|||
149046921|NCT00186992|537652407|FG000|Overall Study|Physician's discretion|13|||
149046922|NCT00186992|537652407|FG000|Overall Study|PI Discretion|4|||
149046923|NCT00186992|537652407|FG000|Overall Study|Ineligible|2|||
149046924|NCT00186992|537652407|FG000|Overall Study|Lost to Follow-up|2|||
149046925|NCT00186992|537652407|FG000|Overall Study|Still on Study|9|||
149046926|NCT05696080|537652408|FG000|Overall Study|Lost to Follow-up|2|||
149046927|NCT05696080|537652409|FG001|Overall Study|Lost to Follow-up|1|||
148885644|NCT00824473|537060172|FG000|Overall Study|Withdrawal by Subject|2|||
148885645|NCT00824473|537060173|FG001|Overall Study|Withdrawal by Subject|3|||
148885646|NCT00824473|537060172|FG000|Overall Study|Other|1|||
148885647|NCT00824473|537060173|FG001|Overall Study|Other|1|||
148885648|NCT01359904|537060174|FG000|Overall Study|Withdrawal by Subject|1|||
148885649|NCT01359904|537060175|FG001|Overall Study|Withdrawal by Subject|0|||
148885650|NCT03594773|537060177|FG000|Overall Study|Withdrawal by Subject|3|||
148885651|NCT03594773|537060178|FG001|Overall Study|Withdrawal by Subject|2|||
148885652|NCT03594773|537060177|FG000|Overall Study|Lost to Follow-up|3|||
148885653|NCT03594773|537060178|FG001|Overall Study|Lost to Follow-up|4|||
148885654|NCT01550757|537060179|FG000|Overall Study|Lost to Follow-up|21|||
148885655|NCT01550757|537060180|FG001|Overall Study|Lost to Follow-up|14|||
149046928|NCT05696080|537652408|FG000|Overall Study|Physician Decision|1|||
149046929|NCT05696080|537652409|FG001|Overall Study|Physician Decision|0|||
149046930|NCT05696080|537652408|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
149046931|NCT05696080|537652409|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
149046932|NCT05696080|537652408|FG000|Overall Study|Withdrawal by Subject|12|||
149046933|NCT05696080|537652409|FG001|Overall Study|Withdrawal by Subject|0|||
149046934|NCT03398200|537652410|FG000|Overall Study|Withdrawal by Subject|0|||
149046935|NCT03398200|537652411|FG001|Overall Study|Withdrawal by Subject|1|||
149046936|NCT02605837|537652415|FG000|Overall Study|Adverse Event|3|||
149046937|NCT02605837|537652416|FG001|Overall Study|Adverse Event|1|||
149046938|NCT02605837|537652415|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149046939|NCT02605837|537652416|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149046940|NCT02605837|537652415|FG000|Overall Study|Withdrawal by Subject|8|||
149046941|NCT02605837|537652416|FG001|Overall Study|Withdrawal by Subject|8|||
149046942|NCT02605837|537652415|FG000|Overall Study|Physician Decision|0|||
149046943|NCT02605837|537652416|FG001|Overall Study|Physician Decision|1|||
149046944|NCT05656911|537652417|FG000|Treatment Phase|Physician Decision|2|||
149046945|NCT05656911|537652418|FG001|Treatment Phase|Physician Decision|0|||
149046946|NCT05656911|537652417|FG000|Treatment Phase|Lack of Efficacy|6|||
149046947|NCT05656911|537652418|FG001|Treatment Phase|Lack of Efficacy|3|||
149046948|NCT05656911|537652417|FG000|Treatment Phase|Subject Decision|4|||
149046949|NCT05656911|537652418|FG001|Treatment Phase|Subject Decision|2|||
149046950|NCT05656911|537652417|FG000|Treatment Phase|Other Reasons|1|||
149046951|NCT05656911|537652418|FG001|Treatment Phase|Other Reasons|0|||
149046952|NCT05656911|537652417|FG000|Treatment Phase|Adverse Event|3|||
149046953|NCT05656911|537652418|FG001|Treatment Phase|Adverse Event|1|||
149046954|NCT05656911|537652417|FG000|Follow-up Phase|Subject Decision|0|||
149046955|NCT05656911|537652418|FG001|Follow-up Phase|Subject Decision|1|||
149046956|NCT05656911|537652417|FG000|Follow-up Phase|Missing|1|||
149046957|NCT05656911|537652418|FG001|Follow-up Phase|Missing|0|||
149046958|NCT04607044|537652425|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
149046959|NCT04607044|537652425|FG000|Overall Study|Adverse Event|1|||
149046960|NCT04607044|537652425|FG000|Overall Study|Did not receive study device|3|||
149046961|NCT04607044|537652425|FG000|Overall Study|Death|1|||
148885656|NCT01550757|537060181|FG002|Overall Study|Lost to Follow-up|42|||
148885657|NCT01550757|537060182|FG003|Overall Study|Lost to Follow-up|53|||
148885658|NCT01550757|537060179|FG000|Overall Study|Withdrawal by Subject|2|||
148885659|NCT01550757|537060180|FG001|Overall Study|Withdrawal by Subject|0|||
149046962|NCT05403801|537652426|FG000|Overall Study|Withdrawal by Subject|2|||
148885660|NCT01550757|537060181|FG002|Overall Study|Withdrawal by Subject|3|||
148885661|NCT01550757|537060182|FG003|Overall Study|Withdrawal by Subject|1|||
148885662|NCT03191630|537060183|FG000|Overall Study|Lost to Follow-up|7|||
148885663|NCT03191630|537060184|FG001|Overall Study|Lost to Follow-up|7|||
148885664|NCT00193206|537060187|FG000|Preoperative Therapy|Lack of Efficacy|2|||
149046963|NCT05075408|537652427|FG000|Overall Study|Withdrawal by Subject|5|||
149046964|NCT05075408|537652428|FG001|Overall Study|Withdrawal by Subject|3|||
149046965|NCT05075408|537652429|FG002|Overall Study|Withdrawal by Subject|4|||
149046966|NCT05075408|537652427|FG000|Overall Study|Adverse Event|5|||
149046967|NCT05075408|537652428|FG001|Overall Study|Adverse Event|7|||
149046968|NCT05075408|537652429|FG002|Overall Study|Adverse Event|8|||
149046969|NCT05075408|537652427|FG000|Overall Study|Protocol Violation|0|||
149046970|NCT05075408|537652428|FG001|Overall Study|Protocol Violation|1|||
149046971|NCT05075408|537652429|FG002|Overall Study|Protocol Violation|0|||
149046972|NCT05075408|537652427|FG000|Overall Study|Lost to Follow-up|2|||
149046973|NCT05075408|537652428|FG001|Overall Study|Lost to Follow-up|1|||
149046974|NCT05075408|537652429|FG002|Overall Study|Lost to Follow-up|1|||
149046975|NCT05075408|537652427|FG000|Overall Study|Physician Decision|1|||
149046976|NCT05075408|537652428|FG001|Overall Study|Physician Decision|0|||
149046977|NCT05075408|537652429|FG002|Overall Study|Physician Decision|0|||
149046978|NCT05075408|537652427|FG000|Overall Study|Other-unspecified|3|||
149046979|NCT05075408|537652428|FG001|Overall Study|Other-unspecified|2|||
149046980|NCT05075408|537652429|FG002|Overall Study|Other-unspecified|0|||
149046981|NCT03416023|537652430|FG000|Overall Study|Exclusion criteria failure|1|||
149046982|NCT03416023|537652430|FG000|Overall Study|Withdrawal by Subject|6|||
149046983|NCT03416023|537652430|FG000|Overall Study|Explanted|7|||
149046984|NCT03416023|537652430|FG000|Overall Study|Physician Decision|1|||
149046985|NCT03416023|537652430|FG000|Overall Study|Lost to Follow-up|1|||
149046986|NCT03416023|537652430|FG000|Overall Study|Death|1|||
149046987|NCT02780388|537652431|FG000|Overall Study|Lost to Follow-up|0|||
149046988|NCT02780388|537652432|FG001|Overall Study|Lost to Follow-up|1|||
149046989|NCT02780388|537652433|FG002|Overall Study|Lost to Follow-up|0|||
149046990|NCT02780388|537652434|FG003|Overall Study|Lost to Follow-up|0|||
149046991|NCT02780388|537652435|FG004|Overall Study|Lost to Follow-up|0|||
149046992|NCT02780388|537652431|FG000|Overall Study|Withdrawal by Subject|1|||
149046993|NCT02780388|537652432|FG001|Overall Study|Withdrawal by Subject|1|||
149046994|NCT02780388|537652433|FG002|Overall Study|Withdrawal by Subject|0|||
149046995|NCT02780388|537652434|FG003|Overall Study|Withdrawal by Subject|0|||
149046996|NCT02780388|537652435|FG004|Overall Study|Withdrawal by Subject|0|||
149046997|NCT04527146|537652436|FG000|Overall Study|Withdrawal by Subject|12|||
149046998|NCT04527146|537652437|FG001|Overall Study|Withdrawal by Subject|15|||
149046999|NCT04527146|537652438|FG002|Overall Study|Withdrawal by Subject|7|||
149047000|NCT04527146|537652439|FG003|Overall Study|Withdrawal by Subject|16|||
149047001|NCT04527146|537652436|FG000|Overall Study|Lost to Follow-up|13|||
149047002|NCT04527146|537652437|FG001|Overall Study|Lost to Follow-up|9|||
149047003|NCT04527146|537652438|FG002|Overall Study|Lost to Follow-up|16|||
149047004|NCT04527146|537652439|FG003|Overall Study|Lost to Follow-up|13|||
149047005|NCT04527146|537652436|FG000|Overall Study|Death|0|||
149047006|NCT04527146|537652437|FG001|Overall Study|Death|1|||
149047007|NCT04527146|537652438|FG002|Overall Study|Death|1|||
149047008|NCT04527146|537652439|FG003|Overall Study|Death|0|||
149047009|NCT04527146|537652436|FG000|Overall Study|Adverse Event|0|||
149047010|NCT04527146|537652437|FG001|Overall Study|Adverse Event|0|||
149047011|NCT04527146|537652438|FG002|Overall Study|Adverse Event|1|||
149047012|NCT04527146|537652439|FG003|Overall Study|Adverse Event|0|||
149047013|NCT04527146|537652436|FG000|Overall Study|Ineligible after randomization|2|||
149047014|NCT04527146|537652437|FG001|Overall Study|Ineligible after randomization|0|||
149047015|NCT04527146|537652438|FG002|Overall Study|Ineligible after randomization|2|||
149047016|NCT04527146|537652439|FG003|Overall Study|Ineligible after randomization|2|||
149047017|NCT04527146|537652436|FG000|Overall Study|Moved to a different group|6|||
149047018|NCT04527146|537652437|FG001|Overall Study|Moved to a different group|3|||
149047019|NCT04527146|537652438|FG002|Overall Study|Moved to a different group|0|||
149047020|NCT04527146|537652439|FG003|Overall Study|Moved to a different group|2|||
149047021|NCT05107401|537652440|FG000|Overall Study|Lost to Follow-up|13|||
149047022|NCT05107401|537652441|FG001|Overall Study|Lost to Follow-up|12|||
149047023|NCT03857620|537652442|FG000|Overall Study|Death|4|||
149047024|NCT03857620|537652443|FG001|Overall Study|Death|5|||
149047025|NCT03857620|537652444|FG002|Overall Study|Death|7|||
149047026|NCT03857620|537652442|FG000|Overall Study|Lost to Follow-up|2|||
149047027|NCT03857620|537652443|FG001|Overall Study|Lost to Follow-up|5|||
149047028|NCT03857620|537652444|FG002|Overall Study|Lost to Follow-up|3|||
149047029|NCT03857620|537652442|FG000|Overall Study|Disease progression or relapse after study registration|1|||
149047030|NCT03857620|537652443|FG001|Overall Study|Disease progression or relapse after study registration|5|||
149047031|NCT03857620|537652444|FG002|Overall Study|Disease progression or relapse after study registration|1|||
149047032|NCT03857620|537652442|FG000|Overall Study|Ineligible|5|||
148885665|NCT00193206|537060187|FG000|Preoperative Therapy|Adverse Event|2|||
148885666|NCT00193206|537060187|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
148885667|NCT00193206|537060187|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
149047033|NCT03857620|537652443|FG001|Overall Study|Ineligible|0|||
149047034|NCT03857620|537652444|FG002|Overall Study|Ineligible|2|||
149047035|NCT03857620|537652442|FG000|Overall Study|No malignancy|1|||
149047036|NCT03857620|537652443|FG001|Overall Study|No malignancy|0|||
149047037|NCT03857620|537652444|FG002|Overall Study|No malignancy|1|||
149047038|NCT03857620|537652442|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
148885668|NCT00193206|537060187|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
149047039|NCT03857620|537652443|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
149047040|NCT03857620|537652444|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
149047041|NCT03857620|537652442|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
149047042|NCT03857620|537652443|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
149047043|NCT03857620|537652444|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
149047044|NCT03857620|537652442|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
149047045|NCT03857620|537652443|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
149047046|NCT03857620|537652444|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
149047047|NCT03857620|537652442|FG000|Overall Study|Surgery not performed, patient decision|0|||
149047048|NCT03857620|537652443|FG001|Overall Study|Surgery not performed, patient decision|3|||
149047049|NCT03857620|537652444|FG002|Overall Study|Surgery not performed, patient decision|1|||
149047050|NCT03857620|537652442|FG000|Overall Study|Surgery not performed, other reason|3|||
149047051|NCT03857620|537652443|FG001|Overall Study|Surgery not performed, other reason|1|||
149047052|NCT03857620|537652444|FG002|Overall Study|Surgery not performed, other reason|4|||
149047053|NCT03857620|537652442|FG000|Overall Study|Worsening performance status after surgery performed|0|||
149047054|NCT03857620|537652443|FG001|Overall Study|Worsening performance status after surgery performed|1|||
149047055|NCT03857620|537652444|FG002|Overall Study|Worsening performance status after surgery performed|1|||
149047056|NCT03438188|537652445|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
149047057|NCT03438188|537652446|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
149047058|NCT03438188|537652447|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
149047059|NCT03438188|537652445|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
149047060|NCT03438188|537652446|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
149047061|NCT03438188|537652447|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
149047062|NCT03438188|537652445|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
149047063|NCT03438188|537652446|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
148885669|NCT00193206|537060187|FG000|Postoperative Therapy|Physician Decision|3|||
148885670|NCT00193206|537060187|FG000|Postoperative Therapy|Intercurrent Illness|2|||
148885671|NCT00193206|537060187|FG000|Postoperative Therapy|Lack of Efficacy|1|||
148885672|NCT00193206|537060187|FG000|Postoperative Therapy|Protocol Violation|1|||
149047064|NCT03438188|537652447|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
149047065|NCT03438188|537652445|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
149047066|NCT03438188|537652446|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
149047067|NCT03438188|537652447|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
149047068|NCT03438188|537652445|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
149047069|NCT03438188|537652446|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
149047070|NCT03438188|537652447|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
149047071|NCT05215847|537652448|FG000|Overall Study|Lost to Follow-up|1|||
149047072|NCT03433339|537652449|FG000|Overall Study|Lost to Follow-up|2|||
149047073|NCT03433339|537652450|FG001|Overall Study|Lost to Follow-up|0|||
149047074|NCT03433339|537652449|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
149047075|NCT03433339|537652450|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
149047076|NCT03433339|537652449|FG000|Overall Study|Withdrawal by Subject|0|||
149047077|NCT03433339|537652450|FG001|Overall Study|Withdrawal by Subject|2|||
149047078|NCT05952076|537652452|FG000|Overall Study|Death|1|||
149047079|NCT05952076|537652453|FG001|Overall Study|Death|1|||
149047080|NCT05952076|537652452|FG000|Overall Study|Lost to Follow-up|0|||
149047081|NCT05952076|537652453|FG001|Overall Study|Lost to Follow-up|1|||
149047082|NCT04143061|537652455|FG000|Overall Study|Protocol Deviation|0|||
149047083|NCT04143061|537652456|FG001|Overall Study|Protocol Deviation|0|||
149047084|NCT04143061|537652457|FG002|Overall Study|Protocol Deviation|0|||
149047085|NCT04143061|537652458|FG003|Overall Study|Protocol Deviation|0|||
149047086|NCT04143061|537652459|FG004|Overall Study|Protocol Deviation|0|||
149047087|NCT04143061|537652460|FG005|Overall Study|Protocol Deviation|0|||
149047088|NCT04143061|537652461|FG006|Overall Study|Protocol Deviation|5|||
149047089|NCT04143061|537652462|FG007|Overall Study|Protocol Deviation|5|||
149047090|NCT04143061|537652455|FG000|Overall Study|Withdrawal by Subject|2|||
149047091|NCT04143061|537652456|FG001|Overall Study|Withdrawal by Subject|0|||
149047092|NCT04143061|537652457|FG002|Overall Study|Withdrawal by Subject|0|||
149047093|NCT04143061|537652458|FG003|Overall Study|Withdrawal by Subject|0|||
149047094|NCT04143061|537652459|FG004|Overall Study|Withdrawal by Subject|0|||
149047095|NCT04143061|537652460|FG005|Overall Study|Withdrawal by Subject|1|||
149047096|NCT04143061|537652461|FG006|Overall Study|Withdrawal by Subject|0|||
149047097|NCT04143061|537652462|FG007|Overall Study|Withdrawal by Subject|0|||
149047098|NCT04143061|537652455|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149047099|NCT04143061|537652456|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149047100|NCT04143061|537652457|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149047101|NCT04143061|537652458|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
149047102|NCT04143061|537652459|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
149047103|NCT04143061|537652460|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
148885673|NCT00740584|537060194|FG000|Overall Study|Withdrawal by Subject|1|||
148885674|NCT01618669|537060196|FG000|Overall Study|Lost to Follow-up|1|||
149047104|NCT04143061|537652461|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
148885675|NCT01618669|537060197|FG001|Overall Study|Lost to Follow-up|1|||
149047105|NCT04143061|537652462|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
149047106|NCT03602014|537652469|FG000|Overall Study|Lost to Follow-up|2|||
149047107|NCT03602014|537652470|FG001|Overall Study|Lost to Follow-up|0|||
149047108|NCT03602014|537652471|FG002|Overall Study|Lost to Follow-up|0|||
149047109|NCT03289039|537652472|FG000|Overall Study|Withdrawal by Subject|0|||
149047110|NCT03289039|537652473|FG001|Overall Study|Withdrawal by Subject|1|||
149047111|NCT03289039|537652472|FG000|Overall Study|Became ineligible prior to treatment start|0|||
149047112|NCT03289039|537652473|FG001|Overall Study|Became ineligible prior to treatment start|1|||
149047113|NCT03289039|537652472|FG000|Overall Study|progressed before treatment start|1|||
149047114|NCT03289039|537652473|FG001|Overall Study|progressed before treatment start|0|||
149047115|NCT04732494|537652476|FG000|Overall Study|Death|39|||
148885676|NCT01618669|537060196|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
148885677|NCT01618669|537060197|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
148885678|NCT01618669|537060196|FG000|Overall Study|Adverse Event|16|||
148885679|NCT01618669|537060197|FG001|Overall Study|Adverse Event|7|||
148885680|NCT01618669|537060196|FG000|Overall Study|Protocol Violation|5|||
148885681|NCT01618669|537060197|FG001|Overall Study|Protocol Violation|3|||
148885682|NCT01618669|537060196|FG000|Overall Study|Withdrawal by Subject|9|||
148885683|NCT01618669|537060197|FG001|Overall Study|Withdrawal by Subject|9|||
148885684|NCT01618669|537060196|FG000|Overall Study|Miscellaneous Reason|0|||
148885685|NCT01618669|537060197|FG001|Overall Study|Miscellaneous Reason|1|||
148885686|NCT03259087|537060198|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
148885687|NCT03259087|537060199|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
149004737|NCT04098250|537495112|FG001|Overall Study|Withdrawal by Subject|0|||
149004738|NCT04098250|537495111|FG000|Overall Study|Lost to Follow-up|0|||
149004739|NCT04098250|537495112|FG001|Overall Study|Lost to Follow-up|1|||
149004740|NCT00633464|537495113|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
149004741|NCT00633464|537495114|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
149004742|NCT00633464|537495113|FG000|Overall Study|Never Treated (Randomized in error)|0|||
149004743|NCT00633464|537495114|FG001|Overall Study|Never Treated (Randomized in error)|1|||
149004744|NCT00394355|537495115|FG000|Overall Study|Adverse Event|10|||
149004745|NCT00394355|537495116|FG001|Overall Study|Adverse Event|6|||
149004746|NCT00394355|537495117|FG002|Overall Study|Adverse Event|7|||
149004747|NCT00394355|537495118|FG003|Overall Study|Adverse Event|8|||
149004748|NCT00394355|537495115|FG000|Overall Study|Did not meet protocol eligibility|1|||
149004749|NCT00394355|537495116|FG001|Overall Study|Did not meet protocol eligibility|5|||
149004750|NCT00394355|537495117|FG002|Overall Study|Did not meet protocol eligibility|4|||
149004751|NCT00394355|537495118|FG003|Overall Study|Did not meet protocol eligibility|2|||
149004752|NCT00394355|537495115|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
149004753|NCT00394355|537495116|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
149004754|NCT00394355|537495117|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
149004755|NCT00394355|537495118|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
149004756|NCT00394355|537495115|FG000|Overall Study|Subject withdrawal - related to drug|1|||
149004757|NCT00394355|537495116|FG001|Overall Study|Subject withdrawal - related to drug|0|||
149004758|NCT00394355|537495117|FG002|Overall Study|Subject withdrawal - related to drug|0|||
149004759|NCT00394355|537495118|FG003|Overall Study|Subject withdrawal - related to drug|0|||
149004760|NCT00394355|537495115|FG000|Overall Study|Lost to Follow-up|7|||
149004761|NCT00394355|537495116|FG001|Overall Study|Lost to Follow-up|5|||
149004762|NCT00394355|537495117|FG002|Overall Study|Lost to Follow-up|4|||
149004763|NCT00394355|537495118|FG003|Overall Study|Lost to Follow-up|3|||
149004764|NCT00394355|537495115|FG000|Overall Study|Noncompliance with protocol|4|||
149004765|NCT00394355|537495116|FG001|Overall Study|Noncompliance with protocol|3|||
149004766|NCT00394355|537495117|FG002|Overall Study|Noncompliance with protocol|10|||
149004767|NCT00394355|537495118|FG003|Overall Study|Noncompliance with protocol|8|||
149004768|NCT00394355|537495115|FG000|Overall Study|Administrative|0|||
149004769|NCT00394355|537495116|FG001|Overall Study|Administrative|1|||
149004770|NCT00394355|537495117|FG002|Overall Study|Administrative|1|||
149004771|NCT00394355|537495118|FG003|Overall Study|Administrative|1|||
149004772|NCT00394355|537495115|FG000|Overall Study|Lack of Efficacy|0|||
149004773|NCT00394355|537495116|FG001|Overall Study|Lack of Efficacy|0|||
149004774|NCT00394355|537495117|FG002|Overall Study|Lack of Efficacy|2|||
149004775|NCT00394355|537495118|FG003|Overall Study|Lack of Efficacy|3|||
149004776|NCT02612064|537495121|FG000|Overall Study|Withdrawal by Subject|1|||
149004777|NCT02612064|537495122|FG001|Overall Study|Withdrawal by Subject|1|||
149004778|NCT02612064|537495121|FG000|Overall Study|Other|0|||
149004779|NCT02612064|537495122|FG001|Overall Study|Other|2|||
149004780|NCT00698646|537495130|FG000|Overall Study|Adverse Event|8|||
149004781|NCT00698646|537495131|FG001|Overall Study|Adverse Event|7|||
149004782|NCT00698646|537495132|FG002|Overall Study|Adverse Event|8|||
149004783|NCT00698646|537495130|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
149004784|NCT00698646|537495131|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
149047116|NCT04732494|537652477|FG001|Overall Study|Death|36|||
149004785|NCT00698646|537495132|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
149004786|NCT00698646|537495130|FG000|Overall Study|Protocol Deviation|6|||
149004787|NCT00698646|537495131|FG001|Overall Study|Protocol Deviation|2|||
149047117|NCT04732494|537652476|FG000|Overall Study|Study Closed by Sponsor|20|||
149047118|NCT04732494|537652477|FG001|Overall Study|Study Closed by Sponsor|15|||
149047119|NCT04732494|537652476|FG000|Overall Study|Withdrawal by Subject|2|||
149047120|NCT04732494|537652477|FG001|Overall Study|Withdrawal by Subject|7|||
149047121|NCT04732494|537652476|FG000|Overall Study|Lost to Follow-up|1|||
149047122|NCT04732494|537652477|FG001|Overall Study|Lost to Follow-up|5|||
149047123|NCT03055858|537652478|FG000|Overall Study|Death|9|||
149047124|NCT03055858|537652478|FG000|Overall Study|Withdrawal by Subject|11|||
149047125|NCT03055858|537652478|FG000|Overall Study|Lost to Follow-up|6|||
149047126|NCT03055858|537652478|FG000|Overall Study|Missed Follow-Up Visits|18|||
149047127|NCT04586920|537652479|FG000|Overall Study|Lost to Follow-up|0|||
149047128|NCT04586920|537652480|FG001|Overall Study|Lost to Follow-up|0|||
149047129|NCT04586920|537652481|FG002|Overall Study|Lost to Follow-up|0|||
149047130|NCT04586920|537652482|FG003|Overall Study|Lost to Follow-up|0|||
149047131|NCT04586920|537652483|FG004|Overall Study|Lost to Follow-up|0|||
149047132|NCT04586920|537652484|FG005|Overall Study|Lost to Follow-up|0|||
149047133|NCT04586920|537652485|FG006|Overall Study|Lost to Follow-up|1|||
149047134|NCT04586920|537652486|FG007|Overall Study|Lost to Follow-up|1|||
149047135|NCT04586920|537652487|FG008|Overall Study|Lost to Follow-up|0|||
149047136|NCT04586920|537652488|FG009|Overall Study|Lost to Follow-up|1|||
149047137|NCT04586920|537652489|FG010|Overall Study|Lost to Follow-up|0|||
149047138|NCT04586920|537652490|FG011|Overall Study|Lost to Follow-up|0|||
149047139|NCT04586920|537652491|FG012|Overall Study|Lost to Follow-up|0|||
149047140|NCT04586920|537652492|FG013|Overall Study|Lost to Follow-up|1|||
149047141|NCT04586920|537652493|FG014|Overall Study|Lost to Follow-up|0|||
149047142|NCT04586920|537652494|FG015|Overall Study|Lost to Follow-up|0|||
149047143|NCT04586920|537652495|FG016|Overall Study|Lost to Follow-up|0|||
149047144|NCT04586920|537652496|FG017|Overall Study|Lost to Follow-up|0|||
149047145|NCT04586920|537652479|FG000|Overall Study|Withdrawal by Subject|0|||
149047146|NCT04586920|537652480|FG001|Overall Study|Withdrawal by Subject|0|||
149047147|NCT04586920|537652481|FG002|Overall Study|Withdrawal by Subject|0|||
149047148|NCT04586920|537652482|FG003|Overall Study|Withdrawal by Subject|0|||
149047149|NCT04586920|537652483|FG004|Overall Study|Withdrawal by Subject|0|||
149047150|NCT04586920|537652484|FG005|Overall Study|Withdrawal by Subject|0|||
149047151|NCT04586920|537652485|FG006|Overall Study|Withdrawal by Subject|0|||
149047152|NCT04586920|537652486|FG007|Overall Study|Withdrawal by Subject|1|||
149047153|NCT04586920|537652487|FG008|Overall Study|Withdrawal by Subject|0|||
149047154|NCT04586920|537652488|FG009|Overall Study|Withdrawal by Subject|1|||
149047155|NCT04586920|537652489|FG010|Overall Study|Withdrawal by Subject|0|||
149047156|NCT04586920|537652490|FG011|Overall Study|Withdrawal by Subject|1|||
149047157|NCT04586920|537652491|FG012|Overall Study|Withdrawal by Subject|0|||
149047158|NCT04586920|537652492|FG013|Overall Study|Withdrawal by Subject|0|||
149047159|NCT04586920|537652493|FG014|Overall Study|Withdrawal by Subject|0|||
149047160|NCT04586920|537652494|FG015|Overall Study|Withdrawal by Subject|0|||
149047161|NCT04586920|537652495|FG016|Overall Study|Withdrawal by Subject|0|||
149047162|NCT04586920|537652496|FG017|Overall Study|Withdrawal by Subject|0|||
149047163|NCT01718743|537652501|FG000|Overall Study|Physician Decision|7|||
149047164|NCT01718743|537652501|FG000|Overall Study|Withdrawal by Subject|14|||
149047165|NCT01718743|537652501|FG000|Overall Study|Progressive Disease|22|||
149047166|NCT01718743|537652501|FG000|Overall Study|Toxicity|1|||
149047167|NCT01718743|537652501|FG000|Overall Study|Malignancy|1|||
149047168|NCT03948763|537652502|FG000|Overall Study|Sponsor's decision|0|||
149047169|NCT03948763|537652503|FG001|Overall Study|Sponsor's decision|2|||
149047170|NCT03948763|537652504|FG002|Overall Study|Sponsor's decision|6|||
149047171|NCT03948763|537652505|FG003|Overall Study|Sponsor's decision|4|||
149047172|NCT03948763|537652506|FG004|Overall Study|Sponsor's decision|0|||
149047173|NCT03948763|537652502|FG000|Overall Study|Physician Decision|0|||
149047174|NCT03948763|537652503|FG001|Overall Study|Physician Decision|0|||
149047175|NCT03948763|537652504|FG002|Overall Study|Physician Decision|1|||
149047176|NCT03948763|537652505|FG003|Overall Study|Physician Decision|0|||
149047177|NCT03948763|537652506|FG004|Overall Study|Physician Decision|0|||
149047178|NCT03948763|537652502|FG000|Overall Study|Lost to Follow-up|0|||
149047179|NCT03948763|537652503|FG001|Overall Study|Lost to Follow-up|0|||
149047180|NCT03948763|537652504|FG002|Overall Study|Lost to Follow-up|0|||
149047181|NCT03948763|537652505|FG003|Overall Study|Lost to Follow-up|0|||
149047182|NCT03948763|537652506|FG004|Overall Study|Lost to Follow-up|1|||
149047183|NCT03948763|537652502|FG000|Overall Study|Death|2|||
149047184|NCT03948763|537652503|FG001|Overall Study|Death|12|||
149047185|NCT03948763|537652504|FG002|Overall Study|Death|13|||
149047186|NCT03948763|537652505|FG003|Overall Study|Death|10|||
149047187|NCT03948763|537652506|FG004|Overall Study|Death|11|||
149047188|NCT03948763|537652502|FG000|Overall Study|Withdrawal by Subject|1|||
149047189|NCT03948763|537652503|FG001|Overall Study|Withdrawal by Subject|1|||
149047190|NCT03948763|537652504|FG002|Overall Study|Withdrawal by Subject|0|||
149047191|NCT03948763|537652505|FG003|Overall Study|Withdrawal by Subject|2|||
149047192|NCT03948763|537652506|FG004|Overall Study|Withdrawal by Subject|4|||
149047193|NCT05136404|537652511|FG000|Period 1|Adverse Event|0|||
149047194|NCT05136404|537652512|FG001|Period 1|Adverse Event|1|||
149047195|NCT05136404|537652513|FG002|Period 1|Adverse Event|1|||
149047196|NCT05136404|537652511|FG000|Period 2|Inappropriate Behavior|0|||
149047197|NCT05136404|537652512|FG001|Period 2|Inappropriate Behavior|0|||
149047198|NCT05136404|537652513|FG002|Period 2|Inappropriate Behavior|1|||
149047199|NCT05136404|537652511|FG000|Period 3|Adverse Event|0|||
149047200|NCT05136404|537652512|FG001|Period 3|Adverse Event|0|||
149047201|NCT05136404|537652513|FG002|Period 3|Adverse Event|1|||
149047202|NCT01426412|537652516|FG000|Overall Study|Withdrawal by Subject|1|||
149047203|NCT01426412|537652517|FG001|Overall Study|Withdrawal by Subject|0|||
149047204|NCT01426412|537652518|FG002|Overall Study|Withdrawal by Subject|0|||
149047205|NCT01426412|537652519|FG003|Overall Study|Withdrawal by Subject|0|||
149047206|NCT01426412|537652520|FG004|Overall Study|Withdrawal by Subject|1|||
149047207|NCT01426412|537652521|FG005|Overall Study|Withdrawal by Subject|0|||
149047208|NCT01426412|537652522|FG006|Overall Study|Withdrawal by Subject|0|||
149047209|NCT01426412|537652523|FG007|Overall Study|Withdrawal by Subject|3|||
149047210|NCT01426412|537652524|FG008|Overall Study|Withdrawal by Subject|1|||
149047211|NCT02376790|537652526|FG000|Overall Study|Withdrawal by Subject|43|||
149047212|NCT02376790|537652527|FG001|Overall Study|Withdrawal by Subject|36|||
149047213|NCT02376790|537652528|FG002|Overall Study|Withdrawal by Subject|37|||
149047214|NCT02376790|537652526|FG000|Overall Study|Decision by Sponsor|2|||
149047215|NCT02376790|537652527|FG001|Overall Study|Decision by Sponsor|1|||
149047216|NCT02376790|537652528|FG002|Overall Study|Decision by Sponsor|4|||
149047217|NCT02376790|537652526|FG000|Overall Study|Lost to Follow-up|15|||
149047218|NCT02376790|537652527|FG001|Overall Study|Lost to Follow-up|10|||
149047219|NCT02376790|537652528|FG002|Overall Study|Lost to Follow-up|12|||
149047220|NCT03014453|537652529|FG000|Overall Study|Lost to Follow-up|12|||
149047221|NCT03014453|537652529|FG000|Overall Study|Discontinued GER|3|||
149047222|NCT03014453|537652529|FG000|Overall Study|Excluded|19|||
149047223|NCT03014453|537652529|FG000|Overall Study|Refused to take part in|37|||
149047224|NCT05450458|537652530|FG000|Overall Study|Lost to Follow-up|4|||
149047225|NCT02141074|537652535|FG000|Pre-prophylaxis|Adverse Event|3|||
149047226|NCT02141074|537652536|FG001|Pre-prophylaxis|Adverse Event|0|||
149047227|NCT02141074|537652535|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
149047228|NCT02141074|537652536|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
149047229|NCT02141074|537652535|FG000|Prophylaxis|Adverse Event|0|||
149047230|NCT02141074|537652536|FG001|Prophylaxis|Adverse Event|4|||
149047231|NCT02141074|537652535|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
149047232|NCT02141074|537652536|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
149047233|NCT02141074|537652535|FG000|Prophylaxis|Withdrawal by Subject|0|||
149047234|NCT02141074|537652536|FG001|Prophylaxis|Withdrawal by Subject|1|||
149047235|NCT00539734|537652537|FG000|Overall Study|Protocol Violation|1|||
149047236|NCT04484935|537652538|FG000|Overall Study|Other|0|||
149047237|NCT04484935|537652539|FG001|Overall Study|Other|1|||
149047238|NCT04484935|537652538|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149047239|NCT04484935|537652539|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149047240|NCT04484935|537652538|FG000|Overall Study|Lost to Follow-up|1|||
149047241|NCT04484935|537652539|FG001|Overall Study|Lost to Follow-up|0|||
149047242|NCT04484935|537652538|FG000|Overall Study|Death|2|||
149047243|NCT04484935|537652539|FG001|Overall Study|Death|1|||
149047244|NCT04048382|537652543|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
149047245|NCT04048382|537652544|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
149047246|NCT04048382|537652543|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
149047247|NCT04048382|537652544|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
149047248|NCT04048382|537652543|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
149047249|NCT04048382|537652544|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
149047250|NCT01037985|537652547|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
149047251|NCT01037985|537652548|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
149047252|NCT01037985|537652547|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
149047253|NCT01037985|537652548|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
149047254|NCT01037985|537652547|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
149047255|NCT01037985|537652548|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
149047256|NCT01037985|537652547|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
149047257|NCT01037985|537652548|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
149047258|NCT01609218|537652550|FG000|Period 1|Adverse Event|3|||
149047259|NCT01609218|537652551|FG001|Period 1|Adverse Event|5|||
149047260|NCT01609218|537652550|FG000|Period 1|Sponsor Decision|0|||
149047261|NCT01609218|537652551|FG001|Period 1|Sponsor Decision|1|||
149047262|NCT01609218|537652550|FG000|Period 2|Adverse Event|1|||
149047263|NCT01609218|537652551|FG001|Period 2|Adverse Event|0|||
149047264|NCT00774852|537652554|FG000|Overall Study|Adverse Event|9|||
149047265|NCT00774852|537652555|FG001|Overall Study|Adverse Event|6|||
149047266|NCT00774852|537652554|FG000|Overall Study|Death|2|||
149047267|NCT00774852|537652555|FG001|Overall Study|Death|1|||
149047268|NCT00774852|537652554|FG000|Overall Study|Lack of Efficacy|3|||
149047269|NCT00774852|537652555|FG001|Overall Study|Lack of Efficacy|7|||
149047270|NCT00774852|537652554|FG000|Overall Study|Lost to Follow-up|9|||
149047271|NCT00774852|537652555|FG001|Overall Study|Lost to Follow-up|5|||
149047272|NCT00774852|537652554|FG000|Overall Study|Physician Decision|2|||
149047273|NCT00774852|537652555|FG001|Overall Study|Physician Decision|6|||
149047274|NCT00774852|537652554|FG000|Overall Study|Pregnancy|1|||
149047275|NCT00774852|537652555|FG001|Overall Study|Pregnancy|2|||
149047276|NCT00774852|537652554|FG000|Overall Study|Withdrawal by Subject|2|||
149047277|NCT00774852|537652555|FG001|Overall Study|Withdrawal by Subject|2|||
149047278|NCT00774852|537652554|FG000|Overall Study|Non-responder|15|||
149047279|NCT00774852|537652555|FG001|Overall Study|Non-responder|11|||
149047280|NCT00774852|537652554|FG000|Overall Study|Subject non-compliance|0|||
149047281|NCT00774852|537652555|FG001|Overall Study|Subject non-compliance|1|||
149047282|NCT00774852|537652554|FG000|Overall Study|Protocol Violation|1|||
149047283|NCT00774852|537652555|FG001|Overall Study|Protocol Violation|0|||
149047284|NCT00774852|537652554|FG000|Overall Study|Subject received prohibited medication|1|||
149047285|NCT00774852|537652555|FG001|Overall Study|Subject received prohibited medication|0|||
149047286|NCT01259401|537654788|FG000|4-month Follow-up|Death|0|||
149047287|NCT01259401|537654789|FG001|4-month Follow-up|Death|1|||
149047288|NCT01259401|537654788|FG000|4-month Follow-up|Lost to Follow-up|0|||
149047289|NCT01259401|537654789|FG001|4-month Follow-up|Lost to Follow-up|1|||
149047290|NCT03683069|537654790|FG000|Overall Study|see limitations|12|||
149047291|NCT03683069|537654791|FG001|Overall Study|see limitations|13|||
149047292|NCT03845465|537654792|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
149047293|NCT03845465|537654793|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
149047294|NCT03845465|537654792|FG000|6-month Data Collection|Withdrawal by Subject|0|||
149047295|NCT03845465|537654793|FG001|6-month Data Collection|Withdrawal by Subject|2|||
149047296|NCT03845465|537654792|FG000|12-month Data Collection|Withdrawal by Subject|0|||
149047297|NCT03845465|537654793|FG001|12-month Data Collection|Withdrawal by Subject|2|||
149047298|NCT03913195|537654794|FG000|Overall Study|Adverse Event|0|||
149047299|NCT03913195|537654795|FG001|Overall Study|Adverse Event|0|||
149047300|NCT03913195|537654796|FG002|Overall Study|Adverse Event|1|||
149047301|NCT03913195|537654797|FG003|Overall Study|Adverse Event|1|||
149047302|NCT03913195|537654798|FG004|Overall Study|Adverse Event|0|||
149047303|NCT03913195|537654794|FG000|Overall Study|Withdrawal by Subject|0|||
149047304|NCT03913195|537654795|FG001|Overall Study|Withdrawal by Subject|0|||
149047305|NCT03913195|537654796|FG002|Overall Study|Withdrawal by Subject|1|||
149047306|NCT03913195|537654797|FG003|Overall Study|Withdrawal by Subject|0|||
149047307|NCT03913195|537654798|FG004|Overall Study|Withdrawal by Subject|1|||
149047308|NCT03913195|537654794|FG000|Overall Study|non adherence to study|0|||
149047309|NCT03913195|537654795|FG001|Overall Study|non adherence to study|0|||
149047310|NCT03913195|537654796|FG002|Overall Study|non adherence to study|1|||
149047311|NCT03913195|537654797|FG003|Overall Study|non adherence to study|0|||
149047312|NCT03913195|537654798|FG004|Overall Study|non adherence to study|0|||
149047313|NCT05307978|537654799|FG000|Overall Study|Lost to Follow-up|0|||
149047314|NCT05307978|537654800|FG001|Overall Study|Lost to Follow-up|1|||
149047315|NCT05307978|537654801|FG002|Overall Study|Lost to Follow-up|0|||
149047316|NCT05307978|537654802|FG003|Overall Study|Lost to Follow-up|4|||
149047317|NCT05307978|537654803|FG004|Overall Study|Lost to Follow-up|0|||
149047318|NCT05307978|537654804|FG005|Overall Study|Lost to Follow-up|0|||
149047319|NCT05307978|537654805|FG006|Overall Study|Lost to Follow-up|1|||
149047320|NCT03547908|537654806|FG000|Blinded Phase|Lost to Follow-up|3|||
149047321|NCT03547908|537654807|FG001|Blinded Phase|Lost to Follow-up|3|||
149047322|NCT03547908|537654808|FG002|Blinded Phase|Lost to Follow-up|0|||
149047323|NCT03547908|537654809|FG003|Blinded Phase|Lost to Follow-up|0|||
149047324|NCT03547908|537654806|FG000|Blinded Phase|Withdrew Consent|2|||
149047325|NCT03547908|537654807|FG001|Blinded Phase|Withdrew Consent|3|||
149047326|NCT03547908|537654808|FG002|Blinded Phase|Withdrew Consent|0|||
149047327|NCT03547908|537654809|FG003|Blinded Phase|Withdrew Consent|0|||
149047328|NCT03547908|537654806|FG000|Blinded Phase|Investigator's Discretion|2|||
149047329|NCT03547908|537654807|FG001|Blinded Phase|Investigator's Discretion|1|||
149047330|NCT03547908|537654808|FG002|Blinded Phase|Investigator's Discretion|0|||
149047331|NCT03547908|537654809|FG003|Blinded Phase|Investigator's Discretion|0|||
149047332|NCT03547908|537654806|FG000|Blinded Phase|Death|2|||
148885688|NCT03259087|537060200|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
148885689|NCT03259087|537060201|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
148885690|NCT03259087|537060202|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
148885691|NCT03259087|537060198|FG000|Period 2 of Part 2|Adverse Event|0|||
148885692|NCT03259087|537060199|FG001|Period 2 of Part 2|Adverse Event|0|||
148885693|NCT03259087|537060200|FG002|Period 2 of Part 2|Adverse Event|0|||
148885694|NCT03259087|537060201|FG003|Period 2 of Part 2|Adverse Event|0|||
148885695|NCT03259087|537060202|FG004|Period 2 of Part 2|Adverse Event|1|||
148885696|NCT05202418|537060203|FG000|Overall Study|Withdrawal by Subject|2|||
148885697|NCT05202418|537060204|FG001|Overall Study|Withdrawal by Subject|1|||
148885698|NCT05202418|537060203|FG000|Overall Study|Lost to Follow-up|1|||
148885699|NCT05202418|537060204|FG001|Overall Study|Lost to Follow-up|1|||
148885700|NCT02562716|537060205|FG000|Overall Study|Adverse Event|7|||
148885701|NCT02562716|537060206|FG001|Overall Study|Adverse Event|14|||
149047333|NCT03547908|537654807|FG001|Blinded Phase|Death|0|||
149047334|NCT03547908|537654808|FG002|Blinded Phase|Death|0|||
149047335|NCT03547908|537654809|FG003|Blinded Phase|Death|0|||
149047336|NCT03547908|537654806|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
149047337|NCT03547908|537654807|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
149047338|NCT03547908|537654808|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
149047339|NCT03547908|537654809|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
149047340|NCT03547908|537654806|FG000|Blinded Phase|Adverse Event|1|||
149047341|NCT03547908|537654807|FG001|Blinded Phase|Adverse Event|0|||
149047342|NCT03547908|537654808|FG002|Blinded Phase|Adverse Event|0|||
149047343|NCT03547908|537654809|FG003|Blinded Phase|Adverse Event|0|||
149047344|NCT03547908|537654806|FG000|Blinded Phase|Randomized But Never Treated|1|||
149047345|NCT03547908|537654807|FG001|Blinded Phase|Randomized But Never Treated|0|||
149047346|NCT03547908|537654808|FG002|Blinded Phase|Randomized But Never Treated|0|||
149047347|NCT03547908|537654809|FG003|Blinded Phase|Randomized But Never Treated|0|||
149047348|NCT03547908|537654806|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
149047349|NCT03547908|537654807|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
149047350|NCT03547908|537654808|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
149047351|NCT03547908|537654809|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
149047352|NCT03547908|537654806|FG000|Open-label Extension Phase|Death|0|||
149047353|NCT03547908|537654807|FG001|Open-label Extension Phase|Death|0|||
149047354|NCT03547908|537654808|FG002|Open-label Extension Phase|Death|1|||
149047355|NCT03547908|537654809|FG003|Open-label Extension Phase|Death|0|||
149047356|NCT03651895|537654810|FG000|First Drug Assignment|Adverse Event|4|||
149047357|NCT03651895|537654811|FG001|First Drug Assignment|Adverse Event|5|||
149047358|NCT03651895|537654810|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
149047359|NCT03651895|537654811|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
149047360|NCT02837510|537654812|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
149047361|NCT02837510|537654813|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
149047362|NCT02837510|537654812|FG000|Washout (2 Weeks)|Adverse Event|0|||
149047363|NCT02837510|537654813|FG001|Washout (2 Weeks)|Adverse Event|1|||
149047364|NCT02837510|537654812|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
149047365|NCT02837510|537654813|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
149047366|NCT02837510|537654812|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
149047367|NCT02837510|537654813|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
149047368|NCT02837510|537654812|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
149047369|NCT02837510|537654813|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
149047370|NCT02837510|537654812|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
149047371|NCT02837510|537654813|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
149047372|NCT05419505|537654815|FG000|Overall Study|Adverse Event|0|||
149047373|NCT05419505|537654816|FG001|Overall Study|Adverse Event|0|||
149047374|NCT05419505|537654817|FG002|Overall Study|Adverse Event|0|||
149047375|NCT05419505|537654818|FG003|Overall Study|Adverse Event|1|||
149047376|NCT05419505|537654819|FG004|Overall Study|Adverse Event|0|||
149047377|NCT05419505|537654820|FG005|Overall Study|Adverse Event|0|||
149047378|NCT05419505|537654821|FG006|Overall Study|Adverse Event|0|||
149047379|NCT05419505|537654822|FG007|Overall Study|Adverse Event|0|||
149047380|NCT05419505|537654815|FG000|Overall Study|Withdrawal by Subject|1|||
149047381|NCT05419505|537654816|FG001|Overall Study|Withdrawal by Subject|2|||
149047382|NCT05419505|537654817|FG002|Overall Study|Withdrawal by Subject|0|||
149047383|NCT05419505|537654818|FG003|Overall Study|Withdrawal by Subject|0|||
149047384|NCT05419505|537654819|FG004|Overall Study|Withdrawal by Subject|0|||
149047385|NCT05419505|537654820|FG005|Overall Study|Withdrawal by Subject|0|||
149047386|NCT05419505|537654821|FG006|Overall Study|Withdrawal by Subject|1|||
149047387|NCT05419505|537654822|FG007|Overall Study|Withdrawal by Subject|0|||
149047388|NCT05419505|537654815|FG000|Overall Study|Lost to Follow-up|2|||
149047389|NCT05419505|537654816|FG001|Overall Study|Lost to Follow-up|1|||
149047390|NCT05419505|537654817|FG002|Overall Study|Lost to Follow-up|0|||
149047391|NCT05419505|537654818|FG003|Overall Study|Lost to Follow-up|0|||
149047392|NCT05419505|537654819|FG004|Overall Study|Lost to Follow-up|1|||
149047393|NCT05419505|537654820|FG005|Overall Study|Lost to Follow-up|2|||
149047394|NCT05419505|537654821|FG006|Overall Study|Lost to Follow-up|0|||
149047395|NCT05419505|537654822|FG007|Overall Study|Lost to Follow-up|1|||
149047396|NCT00979576|537654832|FG000|Combination Treatment Phase|Progressive disease|3|||
149047397|NCT00979576|537654833|FG001|Combination Treatment Phase|Progressive disease|1|||
149047398|NCT00979576|537654834|FG002|Combination Treatment Phase|Progressive disease|5|||
149047399|NCT00979576|537654832|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
149047400|NCT00979576|537654833|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
149047401|NCT00979576|537654834|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
149047402|NCT00979576|537654832|FG000|Combination Treatment Phase|Adverse Event|0|||
149047403|NCT00979576|537654833|FG001|Combination Treatment Phase|Adverse Event|2|||
149047404|NCT00979576|537654834|FG002|Combination Treatment Phase|Adverse Event|2|||
149047405|NCT00979576|537654832|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
149047406|NCT00979576|537654833|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
149047407|NCT00979576|537654834|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
149047408|NCT04855760|537654837|FG000|Overall Study|Adverse Event|21|||
149047409|NCT04855760|537654837|FG000|Overall Study|Withdrawal by Subject|116|||
149047410|NCT04855760|537654837|FG000|Overall Study|Lack of Efficacy|21|||
149047411|NCT04855760|537654837|FG000|Overall Study|Lost to Follow-up|49|||
149047412|NCT04855760|537654837|FG000|Overall Study|Protocol Violation|2|||
149047413|NCT04855760|537654837|FG000|Overall Study|Physician Decision|5|||
149047414|NCT04855760|537654837|FG000|Overall Study|Pregnancy|1|||
149047415|NCT04855760|537654837|FG000|Overall Study|Non-Compliance with Study Drug|11|||
149047416|NCT04855760|537654837|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
149047417|NCT04855760|537654837|FG000|Overall Study|Study Completed by Sponsor|202|||
149047418|NCT04855760|537654837|FG000|Overall Study|Other|13|||
149047419|NCT04840199|537654838|FG000|Overall Study|Study Terminated by Sponsor|8|||
149047420|NCT04840199|537654839|FG001|Overall Study|Study Terminated by Sponsor|9|||
149047421|NCT04840199|537654838|FG000|Overall Study|Lost to Follow-up|0|||
149047422|NCT04840199|537654839|FG001|Overall Study|Lost to Follow-up|2|||
149047423|NCT04840199|537654838|FG000|Overall Study|Withdrawal by Subject|2|||
149047424|NCT04840199|537654839|FG001|Overall Study|Withdrawal by Subject|0|||
149047425|NCT04840199|537654838|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
149047426|NCT04840199|537654839|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
148885702|NCT02562716|537060205|FG000|Overall Study|Withdrawal unrelated to AE|7|||
148885703|NCT02562716|537060206|FG001|Overall Study|Withdrawal unrelated to AE|1|||
148885704|NCT02562716|537060205|FG000|Overall Study|Progression|8|||
148885705|NCT02562716|537060206|FG001|Overall Study|Progression|10|||
149047427|NCT03271151|537654840|FG000|Overall Study|Lost to Follow-up|1|||
149047428|NCT03271151|537654841|FG001|Overall Study|Lost to Follow-up|3|||
149047429|NCT03271151|537654840|FG000|Overall Study|Withdrawal by Subject|1|||
149047430|NCT03271151|537654841|FG001|Overall Study|Withdrawal by Subject|0|||
149047431|NCT02201108|537654842|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
149047432|NCT02201108|537654843|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
149047433|NCT02201108|537654844|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
149047434|NCT02201108|537654842|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
149047435|NCT02201108|537654843|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
149047436|NCT02201108|537654844|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
149047437|NCT02201108|537654842|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
149047438|NCT02201108|537654843|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
149047439|NCT02201108|537654844|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
149047440|NCT02201108|537654842|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
149047441|NCT02201108|537654843|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
149047442|NCT02201108|537654844|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
149047443|NCT02201108|537654842|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
149047444|NCT02201108|537654843|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
149047445|NCT02201108|537654844|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
149047446|NCT02201108|537654842|FG000|Open Label Period (up to Week 192)|Other reason|4|||
149047447|NCT02201108|537654843|FG001|Open Label Period (up to Week 192)|Other reason|7|||
149047448|NCT02201108|537654844|FG002|Open Label Period (up to Week 192)|Other reason|0|||
149047449|NCT02201108|537654842|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
149047450|NCT02201108|537654843|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
149047451|NCT02201108|537654844|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
149047452|NCT02201108|537654842|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
149047453|NCT02201108|537654843|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
149047454|NCT02201108|537654844|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
149047455|NCT02201108|537654842|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
149047456|NCT02201108|537654843|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
149047457|NCT02201108|537654844|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
149047458|NCT04118452|537654845|FG000|Overall Study|Lost to Follow-up|5|||
149047459|NCT04118452|537654846|FG001|Overall Study|Lost to Follow-up|5|||
149047460|NCT04118452|537654845|FG000|Overall Study|Withdrawal by Subject|17|||
149047461|NCT04118452|537654846|FG001|Overall Study|Withdrawal by Subject|17|||
149047462|NCT02553642|537654849|FG000|Overall Study|Withdrawal by Subject|0|||
149047463|NCT02553642|537654850|FG001|Overall Study|Withdrawal by Subject|3|||
149047464|NCT02553642|537654849|FG000|Overall Study|Physician Decision|0|||
149047465|NCT02553642|537654850|FG001|Overall Study|Physician Decision|1|||
149047466|NCT02553642|537654849|FG000|Overall Study|Additional cancer dx|0|||
149047467|NCT02553642|537654850|FG001|Overall Study|Additional cancer dx|1|||
149047468|NCT02553642|537654849|FG000|Overall Study|Never started treatment|0|||
149047469|NCT02553642|537654850|FG001|Overall Study|Never started treatment|1|||
149047470|NCT03732820|537654851|FG000|Overall Study|Death|168|||
149047471|NCT03732820|537654852|FG001|Overall Study|Death|203|||
148885706|NCT02562716|537060205|FG000|Overall Study|Death|2|||
148885707|NCT02562716|537060206|FG001|Overall Study|Death|1|||
148885708|NCT02562716|537060205|FG000|Overall Study|Not protocol specified|4|||
149047472|NCT03732820|537654851|FG000|Overall Study|Other|2|||
149047473|NCT03732820|537654852|FG001|Overall Study|Other|2|||
149047474|NCT03732820|537654851|FG000|Overall Study|Failure to meet randomisation criteria|1|||
149047475|NCT03732820|537654852|FG001|Overall Study|Failure to meet randomisation criteria|1|||
149047476|NCT03732820|537654851|FG000|Overall Study|Patient decision|14|||
149047477|NCT03732820|537654852|FG001|Overall Study|Patient decision|10|||
149047478|NCT03732820|537654851|FG000|Overall Study|Screen failure|0|||
149047479|NCT03732820|537654852|FG001|Overall Study|Screen failure|1|||
149047480|NCT03732820|537654851|FG000|Overall Study|Patients ongoing study at data cut off|210|||
149047481|NCT03732820|537654852|FG001|Overall Study|Patients ongoing study at data cut off|178|||
149047482|NCT03732820|537654851|FG000|Overall Study|Lost to Follow-up|4|||
149047483|NCT03732820|537654852|FG001|Overall Study|Lost to Follow-up|2|||
149047484|NCT02374307|537654853|FG000|3-months Follow-up|Lost to Follow-up|1|||
149047485|NCT02374307|537654854|FG001|3-months Follow-up|Lost to Follow-up|2|||
149047486|NCT02374307|537654853|FG000|3-months Follow-up|Withdrawal by Subject|1|||
149047487|NCT02374307|537654854|FG001|3-months Follow-up|Withdrawal by Subject|4|||
149047488|NCT02374307|537654853|FG000|3-months Follow-up|Death|1|||
149047489|NCT02374307|537654854|FG001|3-months Follow-up|Death|2|||
149047490|NCT02374307|537654853|FG000|3-months Follow-up|Missed first follow-up|5|||
149047491|NCT02374307|537654854|FG001|3-months Follow-up|Missed first follow-up|1|||
149047492|NCT02374307|537654853|FG000|6-months Follow-up|Lost to Follow-up|1|||
149047493|NCT02374307|537654854|FG001|6-months Follow-up|Lost to Follow-up|2|||
149047494|NCT02374307|537654853|FG000|6-months Follow-up|Death|2|||
149047495|NCT02374307|537654854|FG001|6-months Follow-up|Death|1|||
149047496|NCT02374307|537654853|FG000|6-months Follow-up|Withdrawal by Subject|0|||
149047497|NCT02374307|537654854|FG001|6-months Follow-up|Withdrawal by Subject|3|||
149047498|NCT00632203|537654855|FG000|Overall Study|Did not start study treatment|1|||
149047499|NCT00632203|537654856|FG001|Overall Study|Did not start study treatment|0|||
149047500|NCT04452318|537654859|FG000|Overall Study|Physician Decision|1|||
149047501|NCT04452318|537654860|FG001|Overall Study|Physician Decision|2|||
149047502|NCT04452318|537654861|FG002|Overall Study|Physician Decision|0|||
149047503|NCT04452318|537654862|FG003|Overall Study|Physician Decision|2|||
149047504|NCT04452318|537654863|FG004|Overall Study|Physician Decision|0|||
149047505|NCT04452318|537654864|FG005|Overall Study|Physician Decision|2|||
149047506|NCT04452318|537654865|FG006|Overall Study|Physician Decision|5|||
149047507|NCT04452318|537654859|FG000|Overall Study|Death|2|||
149047508|NCT04452318|537654860|FG001|Overall Study|Death|3|||
149047509|NCT04452318|537654861|FG002|Overall Study|Death|0|||
149047510|NCT04452318|537654862|FG003|Overall Study|Death|0|||
149047511|NCT04452318|537654863|FG004|Overall Study|Death|0|||
149047512|NCT04452318|537654864|FG005|Overall Study|Death|0|||
149047513|NCT04452318|537654865|FG006|Overall Study|Death|0|||
149047514|NCT04452318|537654859|FG000|Overall Study|Lost to Follow-up|38|||
149047515|NCT04452318|537654860|FG001|Overall Study|Lost to Follow-up|28|||
149047516|NCT04452318|537654861|FG002|Overall Study|Lost to Follow-up|0|||
149047517|NCT04452318|537654862|FG003|Overall Study|Lost to Follow-up|3|||
149047518|NCT04452318|537654863|FG004|Overall Study|Lost to Follow-up|3|||
149047519|NCT04452318|537654864|FG005|Overall Study|Lost to Follow-up|2|||
149047520|NCT04452318|537654865|FG006|Overall Study|Lost to Follow-up|1|||
149047521|NCT04452318|537654859|FG000|Overall Study|Withdrawal by Subject|46|||
149047522|NCT04452318|537654860|FG001|Overall Study|Withdrawal by Subject|40|||
149047523|NCT04452318|537654861|FG002|Overall Study|Withdrawal by Subject|0|||
149047524|NCT04452318|537654862|FG003|Overall Study|Withdrawal by Subject|18|||
149047525|NCT04452318|537654863|FG004|Overall Study|Withdrawal by Subject|6|||
149047526|NCT04452318|537654864|FG005|Overall Study|Withdrawal by Subject|8|||
149047527|NCT04452318|537654865|FG006|Overall Study|Withdrawal by Subject|6|||
149047528|NCT04287985|537654873|FG000|Overall Study|Adverse Event|1|||
148885709|NCT02562716|537060206|FG001|Overall Study|Not protocol specified|2|||
148885710|NCT00684996|537060207|FG000|Overall Study|Adverse Event|1|||
149047529|NCT04287985|537654874|FG001|Overall Study|Adverse Event|0|||
149047530|NCT04287985|537654875|FG002|Overall Study|Adverse Event|0|||
149047531|NCT04287985|537654876|FG003|Overall Study|Adverse Event|0|||
149047532|NCT04287985|537654873|FG000|Overall Study|Protocol Violation|0|||
149047533|NCT04287985|537654874|FG001|Overall Study|Protocol Violation|1|||
149047534|NCT04287985|537654875|FG002|Overall Study|Protocol Violation|0|||
149047535|NCT04287985|537654876|FG003|Overall Study|Protocol Violation|0|||
149047536|NCT04287985|537654873|FG000|Overall Study|Physician Decision|0|||
149047537|NCT04287985|537654874|FG001|Overall Study|Physician Decision|0|||
149047538|NCT04287985|537654875|FG002|Overall Study|Physician Decision|0|||
149047539|NCT04287985|537654876|FG003|Overall Study|Physician Decision|1|||
149047540|NCT04287985|537654873|FG000|Overall Study|Withdrawal by Subject|2|||
149047541|NCT04287985|537654874|FG001|Overall Study|Withdrawal by Subject|1|||
149047542|NCT04287985|537654875|FG002|Overall Study|Withdrawal by Subject|1|||
149047543|NCT04287985|537654876|FG003|Overall Study|Withdrawal by Subject|2|||
149047544|NCT00604669|537654877|FG000|Overall Study|lack of information in chart|7|||
149047545|NCT01340066|537654878|FG000|Placebo Run in Period|Screen Failures|27|||
149047546|NCT01340066|537654879|FG001|Placebo Run in Period|Screen Failures|0|||
149047547|NCT01340066|537654880|FG002|Placebo Run in Period|Screen Failures|0|||
149047548|NCT01340066|537654878|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
149047549|NCT01340066|537654879|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
149047550|NCT01340066|537654880|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
149047551|NCT01340066|537654878|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
149047552|NCT01340066|537654879|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
149047553|NCT01340066|537654880|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
149047554|NCT01340066|537654878|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
149047555|NCT01340066|537654879|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
149047556|NCT01340066|537654880|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
149047557|NCT01948661|537654891|FG000|Overall Study|Withdrawal by Subject|2|||
149047558|NCT01948661|537654892|FG001|Overall Study|Withdrawal by Subject|4|||
149047559|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Adverse Event|4|||
149047560|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Adverse Event|1|||
149047561|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
149047562|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
149047563|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
149047564|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
149047565|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
149047566|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
149047567|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
149047568|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
149047569|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Other|6|||
149047570|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Other|1|||
149047571|NCT03271489|537654893|FG000|Double-Blind (DB) Period|Missing|1|||
149047572|NCT03271489|537654894|FG001|Double-Blind (DB) Period|Missing|0|||
149047573|NCT03271489|537654893|FG000|Open-Label (OL) Period|Adverse Event|2|||
149047574|NCT03271489|537654894|FG001|Open-Label (OL) Period|Adverse Event|0|||
149047575|NCT03271489|537654893|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
149047576|NCT03271489|537654894|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
149047577|NCT03271489|537654893|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
149047578|NCT03271489|537654894|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
149047579|NCT03271489|537654893|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
149047580|NCT03271489|537654894|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
149047581|NCT03271489|537654893|FG000|Open-Label (OL) Period|No Specified|2|||
149047582|NCT03271489|537654894|FG001|Open-Label (OL) Period|No Specified|2|||
149047583|NCT03271489|537654893|FG000|Open-Label (OL) Period|Missing|2|||
149047584|NCT03271489|537654894|FG001|Open-Label (OL) Period|Missing|0|||
149047585|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
149047586|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
149047587|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
149047588|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
149047589|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
149047590|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
149047591|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
149047592|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
149047593|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
149047594|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
149047595|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
149047596|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
149047597|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
149047598|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
149047599|NCT03271489|537654893|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
149047600|NCT03271489|537654894|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
149047601|NCT06061081|537654895|FG000|Overall Study|Withdrawal by Subject|1|||
148885711|NCT00684996|537060207|FG000|Overall Study|Refusal unrelated to adverse event|1|||
148885712|NCT00684996|537060207|FG000|Overall Study|Progression/relapse|2|||
149047602|NCT06061081|537654896|FG001|Overall Study|Withdrawal by Subject|0|||
149047603|NCT06061081|537654897|FG002|Overall Study|Withdrawal by Subject|0|||
149047604|NCT06061081|537654898|FG003|Overall Study|Withdrawal by Subject|0|||
149047605|NCT06061081|537654899|FG004|Overall Study|Withdrawal by Subject|0|||
149047606|NCT02252172|537654900|FG000|Overall Study|Lost to Follow-up|9|||
149047607|NCT02252172|537654901|FG001|Overall Study|Lost to Follow-up|6|||
149047608|NCT02252172|537654900|FG000|Overall Study|Death|218|||
149047609|NCT02252172|537654901|FG001|Overall Study|Death|175|||
149047610|NCT02252172|537654900|FG000|Overall Study|Withdrawal by Subject|20|||
149047611|NCT02252172|537654901|FG001|Overall Study|Withdrawal by Subject|15|||
149047612|NCT02252172|537654900|FG000|Overall Study|Physician Decision|0|||
149047613|NCT02252172|537654901|FG001|Overall Study|Physician Decision|1|||
149047614|NCT02252172|537654900|FG000|Overall Study|End of data collection|122|||
149047615|NCT02252172|537654901|FG001|Overall Study|End of data collection|170|||
149047616|NCT02252172|537654900|FG000|Overall Study|Site closure|0|||
149047617|NCT02252172|537654901|FG001|Overall Study|Site closure|1|||
149047618|NCT05575076|537654902|FG000|Overall Study|Adverse Event|24|||
149047619|NCT05575076|537654902|FG000|Overall Study|Death|7|||
149047620|NCT05575076|537654902|FG000|Overall Study|Lost to Follow-up|16|||
149047621|NCT05575076|537654902|FG000|Overall Study|Non-Compliance|3|||
149047622|NCT05575076|537654902|FG000|Overall Study|Physician Decision|6|||
149047623|NCT05575076|537654902|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
149047624|NCT05575076|537654902|FG000|Overall Study|Withdrawal by Subject|71|||
149047625|NCT05575076|537654902|FG000|Overall Study|Study Terminated by Sponsor|630|||
149047626|NCT05575076|537654902|FG000|Overall Study|Other|17|||
149047627|NCT03380390|537654903|FG000|Overall Study|Adverse Event|3|||
149047628|NCT02886286|537654904|FG000|Overall Study|pump motor stall|0|||
149047629|NCT02886286|537654905|FG001|Overall Study|pump motor stall|1|||
149047630|NCT01127373|537654906|FG000|Overall Study|Not Treated|3|||
149047631|NCT01127373|537654906|FG000|Overall Study|Lost to Follow-up|7|||
149047632|NCT01127373|537654906|FG000|Overall Study|Withdrawal by Subject|1|||
149047633|NCT01127373|537654906|FG000|Overall Study|Disease progression|1|||
149047634|NCT01017146|537654911|FG000|Overall Study|Adverse Event|11|||
149047635|NCT01017146|537654912|FG001|Overall Study|Adverse Event|1|||
149047636|NCT01017146|537654911|FG000|Overall Study|Lost to Follow-up|14|||
149047637|NCT01017146|537654912|FG001|Overall Study|Lost to Follow-up|14|||
149047638|NCT01017146|537654911|FG000|Overall Study|Noncompliance with Study Product|1|||
149047639|NCT01017146|537654912|FG001|Overall Study|Noncompliance with Study Product|1|||
149047640|NCT01017146|537654911|FG000|Overall Study|Withdrawal by Subject|32|||
149047641|NCT01017146|537654912|FG001|Overall Study|Withdrawal by Subject|16|||
149047642|NCT01017146|537654911|FG000|Overall Study|Relocation|0|||
149047643|NCT01017146|537654912|FG001|Overall Study|Relocation|4|||
149047644|NCT01017146|537654911|FG000|Overall Study|Pregnancy|2|||
149047645|NCT01017146|537654912|FG001|Overall Study|Pregnancy|1|||
149047646|NCT01017146|537654911|FG000|Overall Study|Protocol Violation|2|||
149047647|NCT01017146|537654912|FG001|Overall Study|Protocol Violation|0|||
149047648|NCT01017146|537654911|FG000|Overall Study|Took Excluded Medication|2|||
149047649|NCT01017146|537654912|FG001|Overall Study|Took Excluded Medication|0|||
149047650|NCT01017146|537654911|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
149047651|NCT01017146|537654912|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
149047652|NCT01017146|537654911|FG000|Overall Study|Change in Work Situation|1|||
149047653|NCT01017146|537654912|FG001|Overall Study|Change in Work Situation|0|||
149047654|NCT00087139|537654913|FG000|Overall Study|Adverse Event|18|||
149047655|NCT00087139|537654914|FG001|Overall Study|Adverse Event|17|||
149047656|NCT00087139|537654915|FG002|Overall Study|Adverse Event|13|||
149047657|NCT00087139|537654913|FG000|Overall Study|Death|2|||
149047658|NCT00087139|537654914|FG001|Overall Study|Death|1|||
149047659|NCT00087139|537654915|FG002|Overall Study|Death|0|||
149047660|NCT00087139|537654913|FG000|Overall Study|Withdrawal by Subject|3|||
149047661|NCT00087139|537654914|FG001|Overall Study|Withdrawal by Subject|2|||
149047662|NCT00087139|537654915|FG002|Overall Study|Withdrawal by Subject|2|||
149047663|NCT00087139|537654913|FG000|Overall Study|Physician Decision|1|||
149047664|NCT00087139|537654914|FG001|Overall Study|Physician Decision|1|||
149047665|NCT00087139|537654915|FG002|Overall Study|Physician Decision|1|||
149047666|NCT00087139|537654913|FG000|Overall Study|Disease progression|9|||
149047667|NCT00087139|537654914|FG001|Overall Study|Disease progression|19|||
149047668|NCT00087139|537654915|FG002|Overall Study|Disease progression|12|||
149047669|NCT00087139|537654913|FG000|Overall Study|Ineligible|4|||
149047670|NCT00087139|537654914|FG001|Overall Study|Ineligible|7|||
149047671|NCT00087139|537654915|FG002|Overall Study|Ineligible|4|||
149047672|NCT00087139|537654913|FG000|Overall Study|Symptomatic deterioration|1|||
149047673|NCT00087139|537654914|FG001|Overall Study|Symptomatic deterioration|1|||
149047674|NCT00087139|537654915|FG002|Overall Study|Symptomatic deterioration|3|||
149047675|NCT00087139|537654913|FG000|Overall Study|Use of coumadin|1|||
149047676|NCT00087139|537654914|FG001|Overall Study|Use of coumadin|0|||
149047677|NCT00087139|537654915|FG002|Overall Study|Use of coumadin|0|||
149047678|NCT00087139|537654913|FG000|Overall Study|Response achieved|0|||
149047679|NCT00087139|537654914|FG001|Overall Study|Response achieved|1|||
149047680|NCT00087139|537654915|FG002|Overall Study|Response achieved|0|||
149047681|NCT00087139|537654913|FG000|Overall Study|Extradural disease|0|||
149047682|NCT00087139|537654914|FG001|Overall Study|Extradural disease|0|||
149047683|NCT00087139|537654915|FG002|Overall Study|Extradural disease|1|||
149047684|NCT00976495|537654916|FG000|Overall Study|Withdrawal by Subject|0|||
149047685|NCT00976495|537654917|FG001|Overall Study|Withdrawal by Subject|1|||
149047686|NCT00976495|537654918|FG002|Overall Study|Withdrawal by Subject|0|||
149047687|NCT02272816|537654919|FG000|Overall Study|Adverse Event|1|||
148885713|NCT00684996|537060207|FG000|Overall Study|Other reasons not protocol specified|1|||
149047760|NCT04154384|537654924|FG000|Overall Study|Lost to Follow-up|24|||
149047761|NCT04154384|537654925|FG001|Overall Study|Lost to Follow-up|33|||
149047762|NCT04154384|537654926|FG002|Overall Study|Lost to Follow-up|0|||
149047763|NCT04154384|537654924|FG000|Overall Study|Withdrawal by Subject|7|||
149047764|NCT04154384|537654925|FG001|Overall Study|Withdrawal by Subject|18|||
149047765|NCT04154384|537654926|FG002|Overall Study|Withdrawal by Subject|0|||
149047766|NCT04154384|537654924|FG000|Overall Study|Missing outcome data|1|||
149047767|NCT04154384|537654925|FG001|Overall Study|Missing outcome data|0|||
149047768|NCT04154384|537654926|FG002|Overall Study|Missing outcome data|0|||
149047769|NCT01136876|537654927|FG000|Overall Study|Lost to Follow-up|0|||
149047770|NCT01136876|537654928|FG001|Overall Study|Lost to Follow-up|1|||
149047771|NCT01136876|537654927|FG000|Overall Study|Physician Decision|3|||
149047772|NCT01136876|537654928|FG001|Overall Study|Physician Decision|5|||
149047773|NCT01136876|537654927|FG000|Overall Study|Missing NGAL measurement|2|||
149047774|NCT01136876|537654928|FG001|Overall Study|Missing NGAL measurement|5|||
149047775|NCT05321069|537654929|FG000|Overall Study|Adverse Event|52|||
149047776|NCT05321069|537654930|FG001|Overall Study|Adverse Event|52|||
149047777|NCT05321069|537654931|FG002|Overall Study|Adverse Event|64|||
149047778|NCT05321069|537654929|FG000|Overall Study|Protocol Violation|1|||
149047779|NCT05321069|537654930|FG001|Overall Study|Protocol Violation|1|||
149047780|NCT05321069|537654931|FG002|Overall Study|Protocol Violation|0|||
149047781|NCT05321069|537654929|FG000|Overall Study|Withdrawal by Subject|23|||
149047782|NCT05321069|537654930|FG001|Overall Study|Withdrawal by Subject|18|||
149047783|NCT05321069|537654931|FG002|Overall Study|Withdrawal by Subject|12|||
149047784|NCT05321069|537654929|FG000|Overall Study|Lost to Follow-up|1|||
149047785|NCT05321069|537654930|FG001|Overall Study|Lost to Follow-up|0|||
149047786|NCT05321069|537654931|FG002|Overall Study|Lost to Follow-up|1|||
149047787|NCT05321069|537654929|FG000|Overall Study|No reason stated by the participants|23|||
149047788|NCT05321069|537654930|FG001|Overall Study|No reason stated by the participants|22|||
149047789|NCT05321069|537654931|FG002|Overall Study|No reason stated by the participants|16|||
149047790|NCT05321069|537654929|FG000|Overall Study|Lack of Efficacy|1|||
149047791|NCT05321069|537654930|FG001|Overall Study|Lack of Efficacy|1|||
149047792|NCT05321069|537654931|FG002|Overall Study|Lack of Efficacy|0|||
149047793|NCT02412748|537654934|FG000|Overall Study|Lost to Follow-up|38|||
149047794|NCT02412748|537654935|FG001|Overall Study|Lost to Follow-up|39|||
149047795|NCT04128319|537654936|FG000|Overall Study|Death|3|||
149047796|NCT04820686|537654939|FG000|Overall Study|Withdrawal by Subject|5|||
149047797|NCT04820686|537654940|FG001|Overall Study|Withdrawal by Subject|2|||
149047798|NCT04820686|537654941|FG002|Overall Study|Withdrawal by Subject|3|||
149047799|NCT04820686|537654939|FG000|Overall Study|Study Termination|25|||
149047800|NCT04820686|537654940|FG001|Overall Study|Study Termination|13|||
149047801|NCT04820686|537654941|FG002|Overall Study|Study Termination|14|||
149047802|NCT04820686|537654939|FG000|Overall Study|Adverse Event|0|||
149047803|NCT04820686|537654940|FG001|Overall Study|Adverse Event|1|||
149047804|NCT04820686|537654941|FG002|Overall Study|Adverse Event|0|||
149047805|NCT04377308|537654942|FG000|Overall Study|Withdrawal by Subject|0|||
149047806|NCT04377308|537654943|FG001|Overall Study|Withdrawal by Subject|1|||
149047807|NCT03988842|537654944|FG000|Overall Study|Death|1|||
149047808|NCT02891915|537654947|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
149047809|NCT02891915|537654948|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
149047810|NCT02891915|537654947|FG000|Overall Study|Withdrawal by Subject|3|||
149047811|NCT02891915|537654948|FG001|Overall Study|Withdrawal by Subject|3|||
149047812|NCT02891915|537654947|FG000|Overall Study|Became Ineligible After Enrollment|2|||
149047813|NCT02891915|537654948|FG001|Overall Study|Became Ineligible After Enrollment|1|||
149047814|NCT02891915|537654947|FG000|Overall Study|Lost to Follow-up|1|||
149047815|NCT02891915|537654948|FG001|Overall Study|Lost to Follow-up|4|||
149047816|NCT02891915|537654947|FG000|Overall Study|Physician Decision|1|||
149047817|NCT02891915|537654948|FG001|Overall Study|Physician Decision|0|||
149047818|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
149047819|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
149047820|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
149047821|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
149047822|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
149047823|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
149047824|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
149047825|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
149047826|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
149047827|NCT03939312|537654949|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
149047828|NCT03939312|537654949|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
149047829|NCT03939312|537654949|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
149047830|NCT03481816|537654951|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
149047831|NCT03481816|537654952|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
149047832|NCT03481816|537654951|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
149047833|NCT03481816|537654952|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
149047834|NCT03481816|537654951|FG000|Dose Expansion|Withdrawal by Subject|0|||
149047835|NCT03481816|537654952|FG001|Dose Expansion|Withdrawal by Subject|2|||
149047836|NCT03481816|537654951|FG000|Dose Expansion|Physician Decision|0|||
149047837|NCT03481816|537654952|FG001|Dose Expansion|Physician Decision|5|||
149047838|NCT02730871|537654955|FG000|Overall Study|Adverse Event|6|||
149047839|NCT02730871|537654956|FG001|Overall Study|Adverse Event|0|||
149047840|NCT05368558|537654957|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
148885714|NCT02519439|537060210|FG000|Overall Study|Study Termination|19|||
149047841|NCT05368558|537654958|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
149047842|NCT05368558|537654959|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
149047843|NCT05368558|537654960|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047844|NCT05368558|537654961|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047845|NCT05368558|537654962|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047846|NCT05368558|537654963|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047847|NCT05368558|537654964|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047848|NCT05368558|537654965|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047849|NCT05368558|537654966|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047850|NCT05368558|537654967|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047851|NCT05368558|537654968|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
149047852|NCT05368558|537654957|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047853|NCT05368558|537654958|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047854|NCT05368558|537654959|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047855|NCT05368558|537654960|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
149047856|NCT05368558|537654961|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047857|NCT05368558|537654962|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
149047858|NCT05368558|537654963|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047859|NCT05368558|537654964|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047860|NCT05368558|537654965|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047861|NCT05368558|537654966|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047862|NCT05368558|537654967|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047863|NCT05368558|537654968|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
149047864|NCT05368558|537654957|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047865|NCT05368558|537654958|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047866|NCT05368558|537654959|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047867|NCT05368558|537654960|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
149047868|NCT05368558|537654961|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047869|NCT05368558|537654962|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047870|NCT05368558|537654963|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047871|NCT05368558|537654964|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047872|NCT05368558|537654965|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047873|NCT05368558|537654966|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047874|NCT05368558|537654967|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047875|NCT05368558|537654968|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
149047876|NCT05368558|537654957|FG000|Blinded Extension Period (BEP)|other|0|||
149047877|NCT05368558|537654958|FG001|Blinded Extension Period (BEP)|other|0|||
149047878|NCT05368558|537654959|FG002|Blinded Extension Period (BEP)|other|0|||
149047879|NCT05368558|537654960|FG003|Blinded Extension Period (BEP)|other|0|||
149047880|NCT05368558|537654961|FG004|Blinded Extension Period (BEP)|other|0|||
149047881|NCT05368558|537654962|FG005|Blinded Extension Period (BEP)|other|1|||
149047882|NCT05368558|537654963|FG006|Blinded Extension Period (BEP)|other|0|||
149047883|NCT05368558|537654964|FG007|Blinded Extension Period (BEP)|other|0|||
149047884|NCT05368558|537654965|FG008|Blinded Extension Period (BEP)|other|0|||
149047885|NCT05368558|537654966|FG009|Blinded Extension Period (BEP)|other|0|||
149047886|NCT05368558|537654967|FG010|Blinded Extension Period (BEP)|other|0|||
149047887|NCT05368558|537654968|FG011|Blinded Extension Period (BEP)|other|0|||
149047888|NCT03582722|537654969|FG000|Overall Study|Lost to Follow-up|1|||
149047889|NCT03582722|537654970|FG001|Overall Study|Lost to Follow-up|4|||
149047890|NCT03582722|537654969|FG000|Overall Study|Withdrawal by Subject|3|||
149047891|NCT03582722|537654970|FG001|Overall Study|Withdrawal by Subject|3|||
149047892|NCT04994509|537654971|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
149047893|NCT04994509|537654972|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
149047894|NCT04994509|537654973|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
149047895|NCT04994509|537654971|FG000|Overall Study|Withdrew Consent|73|||
149047896|NCT04994509|537654972|FG001|Overall Study|Withdrew Consent|72|||
149047897|NCT04994509|537654973|FG002|Overall Study|Withdrew Consent|46|||
149047898|NCT04994509|537654971|FG000|Overall Study|Lost to Follow-up|39|||
149047899|NCT04994509|537654972|FG001|Overall Study|Lost to Follow-up|36|||
149047900|NCT04994509|537654973|FG002|Overall Study|Lost to Follow-up|26|||
149047901|NCT04994509|537654971|FG000|Overall Study|HIV-1 Infection|4|||
149047902|NCT04994509|537654972|FG001|Overall Study|HIV-1 Infection|20|||
149047903|NCT04994509|537654973|FG002|Overall Study|HIV-1 Infection|12|||
149047904|NCT04994509|537654971|FG000|Overall Study|Investigator's Discretion|9|||
149047905|NCT04994509|537654972|FG001|Overall Study|Investigator's Discretion|8|||
149047906|NCT04994509|537654973|FG002|Overall Study|Investigator's Discretion|11|||
149047907|NCT04994509|537654971|FG000|Overall Study|Randomized but Never Treated|10|||
149047908|NCT04994509|537654972|FG001|Overall Study|Randomized but Never Treated|10|||
149047909|NCT04994509|537654973|FG002|Overall Study|Randomized but Never Treated|3|||
149047910|NCT04994509|537654971|FG000|Overall Study|Pregnancy|5|||
149047911|NCT04994509|537654972|FG001|Overall Study|Pregnancy|5|||
149047912|NCT04994509|537654973|FG002|Overall Study|Pregnancy|0|||
149047913|NCT04994509|537654971|FG000|Overall Study|Death|0|||
149047914|NCT04994509|537654972|FG001|Overall Study|Death|5|||
149047915|NCT04994509|537654973|FG002|Overall Study|Death|0|||
149047916|NCT04994509|537654971|FG000|Overall Study|Adverse Event|2|||
149047917|NCT04994509|537654972|FG001|Overall Study|Adverse Event|1|||
149047918|NCT04994509|537654973|FG002|Overall Study|Adverse Event|0|||
149047919|NCT04994509|537654971|FG000|Overall Study|Non-compliance With Study Drug|1|||
149047920|NCT04994509|537654972|FG001|Overall Study|Non-compliance With Study Drug|1|||
149047921|NCT04994509|537654973|FG002|Overall Study|Non-compliance With Study Drug|1|||
149047922|NCT04994509|537654971|FG000|Overall Study|Withdrew Assent|3|||
149047923|NCT04994509|537654972|FG001|Overall Study|Withdrew Assent|0|||
149047924|NCT04994509|537654973|FG002|Overall Study|Withdrew Assent|0|||
149047925|NCT04994509|537654971|FG000|Overall Study|Protocol Violation|1|||
149047926|NCT04994509|537654972|FG001|Overall Study|Protocol Violation|0|||
149047927|NCT04994509|537654973|FG002|Overall Study|Protocol Violation|0|||
149047928|NCT04402294|537654974|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
149047929|NCT04402294|537654975|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
149047930|NCT04402294|537654974|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
149047931|NCT04402294|537654975|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
149047932|NCT04459416|537657017|FG000|Overall Study|Lost to Follow-up|2|||
149047933|NCT04459416|537657018|FG001|Overall Study|Lost to Follow-up|0|||
149047934|NCT04459416|537657017|FG000|Overall Study|Withdrawal by Subject|8|||
149047935|NCT04459416|537657018|FG001|Overall Study|Withdrawal by Subject|10|||
149047936|NCT04459416|537657017|FG000|Overall Study|Disease progression|0|||
149047937|NCT04459416|537657018|FG001|Overall Study|Disease progression|3|||
149047938|NCT03744312|537657019|FG000|Overall Study|Withdrawal by Subject|0|||
149047939|NCT03744312|537657020|FG001|Overall Study|Withdrawal by Subject|1|||
149047940|NCT03744312|537657019|FG000|Overall Study|Screen fail|0|||
149047941|NCT03744312|537657020|FG001|Overall Study|Screen fail|1|||
149047942|NCT04579380|537657021|FG000|Overall Study|Death|9|||
149047943|NCT04579380|537657022|FG001|Overall Study|Death|22|||
149047944|NCT04579380|537657023|FG002|Overall Study|Death|22|||
149047945|NCT04579380|537657024|FG003|Overall Study|Death|17|||
149047946|NCT04579380|537657025|FG004|Overall Study|Death|6|||
149047947|NCT04579380|537657026|FG005|Overall Study|Death|21|||
149047948|NCT04579380|537657027|FG006|Overall Study|Death|10|||
149047949|NCT04579380|537657028|FG007|Overall Study|Death|11|||
149047950|NCT04579380|537657029|FG008|Overall Study|Death|25|||
149047951|NCT04579380|537657021|FG000|Overall Study|Withdrawal by Subject|0|||
149047952|NCT04579380|537657022|FG001|Overall Study|Withdrawal by Subject|3|||
149047953|NCT04579380|537657023|FG002|Overall Study|Withdrawal by Subject|4|||
149047954|NCT04579380|537657024|FG003|Overall Study|Withdrawal by Subject|0|||
149047955|NCT04579380|537657025|FG004|Overall Study|Withdrawal by Subject|1|||
149047956|NCT04579380|537657026|FG005|Overall Study|Withdrawal by Subject|2|||
149047957|NCT04579380|537657027|FG006|Overall Study|Withdrawal by Subject|0|||
149047958|NCT04579380|537657028|FG007|Overall Study|Withdrawal by Subject|1|||
149047959|NCT04579380|537657029|FG008|Overall Study|Withdrawal by Subject|2|||
149047960|NCT04579380|537657021|FG000|Overall Study|Ongoing|2|||
149047961|NCT04579380|537657022|FG001|Overall Study|Ongoing|6|||
149047962|NCT04579380|537657023|FG002|Overall Study|Ongoing|4|||
149047963|NCT04579380|537657024|FG003|Overall Study|Ongoing|8|||
149047964|NCT04579380|537657025|FG004|Overall Study|Ongoing|5|||
149047965|NCT04579380|537657026|FG005|Overall Study|Ongoing|8|||
149047966|NCT04579380|537657027|FG006|Overall Study|Ongoing|3|||
149047967|NCT04579380|537657028|FG007|Overall Study|Ongoing|19|||
149047968|NCT04579380|537657029|FG008|Overall Study|Ongoing|6|||
149047969|NCT05478525|537657032|FG000|Overall Study|Withdrawal by Subject|0|||
149047970|NCT05478525|537657033|FG001|Overall Study|Withdrawal by Subject|1|||
149047971|NCT05478525|537657034|FG002|Overall Study|Withdrawal by Subject|2|||
149047972|NCT05478525|537657035|FG003|Overall Study|Withdrawal by Subject|0|||
149047973|NCT05478525|537657032|FG000|Overall Study|COVID-19 Infection|2|||
149047974|NCT05478525|537657033|FG001|Overall Study|COVID-19 Infection|0|||
149047975|NCT05478525|537657034|FG002|Overall Study|COVID-19 Infection|1|||
149047976|NCT05478525|537657035|FG003|Overall Study|COVID-19 Infection|1|||
149047977|NCT01991977|537657036|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
149047978|NCT01991977|537657036|FG000|Overall Study|Withdrew after start of treatment|5|||
149047979|NCT03821844|537657037|FG000|Overall Study|Death|37|||
149047980|NCT03821844|537657038|FG001|Overall Study|Death|31|||
149047981|NCT03821844|537657037|FG000|Overall Study|Discharged|10|||
149047982|NCT03821844|537657038|FG001|Overall Study|Discharged|14|||
149047983|NCT03821844|537657037|FG000|Overall Study|Not present in facility at followup|2|||
149047984|NCT03821844|537657038|FG001|Overall Study|Not present in facility at followup|3|||
149047985|NCT03899961|537657040|FG000|Overall Study|-delivery prior to|2|||
149047986|NCT03899961|537657041|FG001|Overall Study|-delivery prior to|7|||
149047987|NCT03899961|537657040|FG000|Overall Study|req general anesth|1|||
149047988|NCT03899961|537657041|FG001|Overall Study|req general anesth|2|||
149047989|NCT03899961|537657040|FG000|Overall Study|capacity|5|||
149047990|NCT03899961|537657041|FG001|Overall Study|capacity|6|||
149047991|NCT03899961|537657040|FG000|Overall Study|Withdrawal by Subject|1|||
149047992|NCT03899961|537657041|FG001|Overall Study|Withdrawal by Subject|1|||
149047993|NCT02525692|537657042|FG000|Overall Study|Withdrawal by Subject|1|||
149047994|NCT02525692|537657043|FG001|Overall Study|Withdrawal by Subject|1|||
149047995|NCT02525692|537657044|FG002|Overall Study|Withdrawal by Subject|0|||
149047996|NCT02525692|537657045|FG003|Overall Study|Withdrawal by Subject|5|||
149047997|NCT02525692|537657046|FG004|Overall Study|Withdrawal by Subject|0|||
149047998|NCT02525692|537657047|FG005|Overall Study|Withdrawal by Subject|1|||
149047999|NCT02525692|537657042|FG000|Overall Study|Death|16|||
149048000|NCT02525692|537657043|FG001|Overall Study|Death|18|||
149048001|NCT02525692|537657044|FG002|Overall Study|Death|7|||
149048002|NCT02525692|537657045|FG003|Overall Study|Death|20|||
149048003|NCT02525692|537657046|FG004|Overall Study|Death|3|||
149048004|NCT02525692|537657047|FG005|Overall Study|Death|6|||
149048005|NCT02525692|537657042|FG000|Overall Study|Lost to Follow-up|0|||
149048006|NCT02525692|537657043|FG001|Overall Study|Lost to Follow-up|0|||
149048007|NCT02525692|537657044|FG002|Overall Study|Lost to Follow-up|1|||
149048008|NCT02525692|537657045|FG003|Overall Study|Lost to Follow-up|5|||
149048009|NCT02525692|537657046|FG004|Overall Study|Lost to Follow-up|0|||
149048010|NCT02525692|537657047|FG005|Overall Study|Lost to Follow-up|0|||
149048011|NCT05510232|537657048|FG000|Overall Study|Withdrawal by Subject|2|||
149048012|NCT05510232|537657049|FG001|Overall Study|Withdrawal by Subject|7|||
149048013|NCT05510232|537657050|FG002|Overall Study|Withdrawal by Subject|6|||
149048014|NCT03424811|537657055|FG000|Overall Study|Lost to Follow-up|9|||
149048015|NCT03424811|537657056|FG001|Overall Study|Lost to Follow-up|0|||
149048016|NCT00567398|537657062|FG000|Overall Study|Adverse Event|6|||
149048017|NCT00567398|537657063|FG001|Overall Study|Adverse Event|14|||
149048018|NCT00567398|537657062|FG000|Overall Study|Physician Decision|0|||
149048019|NCT00567398|537657063|FG001|Overall Study|Physician Decision|4|||
149048020|NCT00567398|537657062|FG000|Overall Study|Withdrawal by Subject|0|||
149048021|NCT00567398|537657063|FG001|Overall Study|Withdrawal by Subject|2|||
149048022|NCT00567398|537657062|FG000|Overall Study|Renal Transplantation|0|||
149048023|NCT00567398|537657063|FG001|Overall Study|Renal Transplantation|3|||
149048024|NCT00567398|537657062|FG000|Overall Study|Other|1|||
149048025|NCT00567398|537657063|FG001|Overall Study|Other|0|||
149048026|NCT03517553|537657064|FG000|Overall Study|Withdrawal by Subject|2|||
149048027|NCT04093362|537657067|FG000|Overall Study|Study Termination|1|||
149048028|NCT04093362|537657068|FG001|Overall Study|Study Termination|1|||
149048029|NCT04093362|537657067|FG000|Overall Study|Withdrawal of Consent|1|||
149048030|NCT04093362|537657068|FG001|Overall Study|Withdrawal of Consent|0|||
149048031|NCT04093362|537657067|FG000|Overall Study|Death|1|||
149048032|NCT04093362|537657068|FG001|Overall Study|Death|3|||
149048033|NCT04093362|537657067|FG000|Overall Study|Reason not Specified|1|||
149048034|NCT04093362|537657068|FG001|Overall Study|Reason not Specified|2|||
149048035|NCT04247542|537657071|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
149048036|NCT04247542|537657072|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
148885715|NCT02519439|537060210|FG000|Overall Study|Withdrawal by Subject|1|||
148885716|NCT02519439|537060210|FG000|Overall Study|Adverse Event|1|||
148885717|NCT01078441|537060213|FG000|Overall Study|Withdrawal by Subject|1|||
148885718|NCT02868554|537060214|FG000|Overall Study|Lost to Follow-up|3|||
148885719|NCT02868554|537060215|FG001|Overall Study|Lost to Follow-up|0|||
148885720|NCT02868554|537060216|FG002|Overall Study|Lost to Follow-up|1|||
148885721|NCT04915729|537060217|FG000|Overall Study|Lost to Follow-up|20|||
148885722|NCT04915729|537060218|FG001|Overall Study|Lost to Follow-up|10|||
148885723|NCT04915729|537060217|FG000|Overall Study|Withdrawal by Subject|12|||
148885724|NCT04915729|537060218|FG001|Overall Study|Withdrawal by Subject|5|||
148885725|NCT04915729|537060217|FG000|Overall Study|Death|34|||
148885726|NCT04915729|537060218|FG001|Overall Study|Death|44|||
148885727|NCT04915729|537060217|FG000|Overall Study|not treated|3|||
148885728|NCT04915729|537060218|FG001|Overall Study|not treated|6|||
148885729|NCT04915729|537060217|FG000|Overall Study|Investigator removed subject|1|||
149048037|NCT04247542|537657073|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
149048038|NCT04247542|537657071|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
149048039|NCT04247542|537657072|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
148885730|NCT04915729|537060218|FG001|Overall Study|Investigator removed subject|2|||
149048040|NCT04247542|537657073|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
149048041|NCT03055377|537657074|FG000|Treatment Phase|Lost to Follow-up|28|||
148885731|NCT04915729|537060217|FG000|Overall Study|questionnaire result not evaluated|1|||
148885732|NCT04915729|537060218|FG001|Overall Study|questionnaire result not evaluated|0|||
148885733|NCT04915729|537060217|FG000|Overall Study|refuse of hospital visit|1|||
148885734|NCT04915729|537060218|FG001|Overall Study|refuse of hospital visit|3|||
149048042|NCT03055377|537657075|FG001|Treatment Phase|Lost to Follow-up|24|||
149048043|NCT03055377|537657074|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
149048044|NCT03055377|537657075|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
149048045|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
149048046|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
149048047|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
148885735|NCT04915729|537060217|FG000|Overall Study|Subject withdrew|1|||
148885736|NCT04915729|537060218|FG001|Overall Study|Subject withdrew|0|||
148885737|NCT04961541|537060219|FG000|Overall Study|Adverse Event|0|||
148885738|NCT04961541|537060220|FG001|Overall Study|Adverse Event|0|||
148885739|NCT04961541|537060221|FG002|Overall Study|Adverse Event|0|||
148885740|NCT04961541|537060222|FG003|Overall Study|Adverse Event|0|||
148885741|NCT04961541|537060223|FG004|Overall Study|Adverse Event|0|||
148885742|NCT04961541|537060224|FG005|Overall Study|Adverse Event|1|||
148885743|NCT04961541|537060225|FG006|Overall Study|Adverse Event|0|||
148885744|NCT04961541|537060226|FG007|Overall Study|Adverse Event|0|||
148885745|NCT04961541|537060227|FG008|Overall Study|Adverse Event|0|||
148885746|NCT04961541|537060228|FG009|Overall Study|Adverse Event|0|||
148885747|NCT04961541|537060229|FG010|Overall Study|Adverse Event|0|||
149048048|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
149048049|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
149048050|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
149048051|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
149048052|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
149048053|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
149048054|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
149048055|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
149048056|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
149048057|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
149048058|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
149048059|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
149048060|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
149048061|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
149048062|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
149048063|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
149048064|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
149048065|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
149048066|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
149048067|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
149048068|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
149048069|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
149048070|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
149048071|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
149048072|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
149048073|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
149048074|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
149048075|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
149048076|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
149048077|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
149048078|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
149048079|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
149048080|NCT01898494|537657079|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
149048081|NCT01898494|537657080|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
149048082|NCT01898494|537657081|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
149048083|NCT01898494|537657082|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
149048084|NCT01898494|537657083|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
149048085|NCT01898494|537657079|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
149048086|NCT01898494|537657080|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
149048087|NCT01898494|537657081|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
149048088|NCT01898494|537657082|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
149048089|NCT01898494|537657083|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
149048090|NCT01898494|537657079|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
149048091|NCT01898494|537657080|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
149048092|NCT01898494|537657081|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
149048093|NCT01898494|537657082|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
149048094|NCT01898494|537657083|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
149048095|NCT01898494|537657079|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
148885748|NCT04961541|537060230|FG011|Overall Study|Adverse Event|0|||
148885749|NCT04961541|537060231|FG012|Overall Study|Adverse Event|0|||
149048096|NCT01898494|537657080|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
149048097|NCT01898494|537657081|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
148885750|NCT04961541|537060232|FG013|Overall Study|Adverse Event|0|||
148885751|NCT04961541|537060219|FG000|Overall Study|Lost to Follow-up|0|||
148885752|NCT04961541|537060220|FG001|Overall Study|Lost to Follow-up|0|||
148885753|NCT04961541|537060221|FG002|Overall Study|Lost to Follow-up|3|||
148885754|NCT04961541|537060222|FG003|Overall Study|Lost to Follow-up|0|||
148885755|NCT04961541|537060223|FG004|Overall Study|Lost to Follow-up|0|||
149048098|NCT01898494|537657082|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
149048099|NCT01898494|537657083|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
149048100|NCT01898494|537657079|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
149048101|NCT01898494|537657080|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
149048102|NCT01898494|537657081|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
149048103|NCT01898494|537657082|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
149048104|NCT01898494|537657083|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
149048105|NCT01898494|537657079|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
149048106|NCT01898494|537657080|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
149048107|NCT01898494|537657081|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
149048108|NCT01898494|537657082|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
149048109|NCT01898494|537657083|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
149048110|NCT01898494|537657079|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
149048111|NCT01898494|537657080|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
149048112|NCT01898494|537657081|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
149048113|NCT01898494|537657082|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
149048114|NCT01898494|537657083|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
149048115|NCT02819843|537657084|FG000|Overall Study|Disease progression before RT|0|||
149048116|NCT02819843|537657085|FG001|Overall Study|Disease progression before RT|1|||
149048117|NCT04905407|537657087|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
149048118|NCT04905407|537657088|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
149048119|NCT04905407|537657089|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
149048120|NCT04905407|537657090|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
149048121|NCT04905407|537657087|FG000|Part 1 and Part 2|Death|7|||
149048122|NCT04905407|537657088|FG001|Part 1 and Part 2|Death|7|||
149048123|NCT04905407|537657089|FG002|Part 1 and Part 2|Death|7|||
149048124|NCT04905407|537657090|FG003|Part 1 and Part 2|Death|0|||
149048125|NCT04905407|537657087|FG000|Part 1 and Part 2|Other than specified|0|||
149048126|NCT04905407|537657088|FG001|Part 1 and Part 2|Other than specified|0|||
149048127|NCT04905407|537657089|FG002|Part 1 and Part 2|Other than specified|1|||
149048128|NCT04905407|537657090|FG003|Part 1 and Part 2|Other than specified|0|||
149048129|NCT04905407|537657087|FG000|Part 3|Death|0|||
149048130|NCT04905407|537657088|FG001|Part 3|Death|0|||
149048131|NCT04905407|537657089|FG002|Part 3|Death|0|||
149048132|NCT04905407|537657090|FG003|Part 3|Death|2|||
149048133|NCT01938547|537657091|FG000|Overall Study|Physician Decision|1|||
149048134|NCT00150813|537657097|FG000|Overall Study|Adverse Event|1|||
149048135|NCT00150813|537657097|FG000|Overall Study|Lack of Efficacy|1|||
149048136|NCT00150813|537657097|FG000|Overall Study|Lost to Follow-up|5|||
149048137|NCT00150813|537657097|FG000|Overall Study|Withdrawal by Subject|5|||
149048138|NCT00150813|537657097|FG000|Overall Study|Remission|3|||
149048139|NCT00150813|537657097|FG000|Overall Study|Planned pregancy|1|||
149048140|NCT00150813|537657097|FG000|Overall Study|Switch to commercially available LEV|2|||
149048141|NCT01820260|537657099|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048142|NCT01820260|537657100|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048143|NCT01820260|537657101|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048144|NCT01820260|537657102|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048145|NCT01820260|537657103|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048146|NCT01820260|537657104|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048147|NCT01820260|537657105|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
149048148|NCT01820260|537657106|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048149|NCT01820260|537657107|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048150|NCT01820260|537657108|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048151|NCT01820260|537657109|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048152|NCT01820260|537657110|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048153|NCT01820260|537657111|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048154|NCT01820260|537657112|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
149048155|NCT01820260|537657099|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048156|NCT01820260|537657100|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048157|NCT01820260|537657101|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048158|NCT01820260|537657102|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048159|NCT01820260|537657103|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048160|NCT01820260|537657104|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048161|NCT01820260|537657105|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048162|NCT01820260|537657106|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048163|NCT01820260|537657107|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048164|NCT01820260|537657108|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
149048165|NCT01820260|537657109|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048166|NCT01820260|537657110|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048167|NCT01820260|537657111|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
148885756|NCT04961541|537060224|FG005|Overall Study|Lost to Follow-up|0|||
148885757|NCT04961541|537060225|FG006|Overall Study|Lost to Follow-up|1|||
148885758|NCT04961541|537060226|FG007|Overall Study|Lost to Follow-up|1|||
148885759|NCT04961541|537060227|FG008|Overall Study|Lost to Follow-up|0|||
148885760|NCT04961541|537060228|FG009|Overall Study|Lost to Follow-up|1|||
148885761|NCT04961541|537060229|FG010|Overall Study|Lost to Follow-up|0|||
149048168|NCT01820260|537657112|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
149048169|NCT05444192|537657113|FG000|Overall Study|Lost to Follow-up|1|||
148885762|NCT04961541|537060230|FG011|Overall Study|Lost to Follow-up|0|||
148885763|NCT04961541|537060231|FG012|Overall Study|Lost to Follow-up|1|||
149048170|NCT05444192|537657114|FG001|Overall Study|Lost to Follow-up|0|||
149048171|NCT04424927|537657116|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
149048172|NCT04424927|537657117|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
149048173|NCT04424927|537657118|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
149048174|NCT04424927|537657119|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
149048175|NCT04424927|537657120|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
149048176|NCT04424927|537657116|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
149048177|NCT04424927|537657117|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
149048178|NCT04424927|537657118|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
149048179|NCT04424927|537657119|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
149048180|NCT04424927|537657120|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
149048181|NCT04424927|537657116|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
149048182|NCT04424927|537657117|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
149048183|NCT04424927|537657118|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
149048184|NCT04424927|537657119|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
149048185|NCT04424927|537657120|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
149048186|NCT04424927|537657116|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
149048187|NCT04424927|537657117|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
149048188|NCT04424927|537657118|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
149048189|NCT04424927|537657119|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
149048190|NCT04424927|537657120|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
149048191|NCT04424927|537657116|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
149048192|NCT04424927|537657117|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
149048193|NCT04424927|537657118|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
149048194|NCT04424927|537657119|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
149048195|NCT04424927|537657120|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
149048196|NCT04424927|537657116|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
149048197|NCT04424927|537657117|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
149048198|NCT04424927|537657118|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
149048199|NCT04424927|537657119|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
149048200|NCT04424927|537657120|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
149048201|NCT04424927|537657116|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
149048202|NCT04424927|537657117|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
149048203|NCT04424927|537657118|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
149048204|NCT04424927|537657119|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
149048205|NCT04424927|537657120|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
149048206|NCT04424927|537657116|FG000|Double-blind Period (24 Weeks)|Other|0|||
149048207|NCT04424927|537657117|FG001|Double-blind Period (24 Weeks)|Other|1|||
149048208|NCT04424927|537657118|FG002|Double-blind Period (24 Weeks)|Other|3|||
149048209|NCT04424927|537657119|FG003|Double-blind Period (24 Weeks)|Other|1|||
149048210|NCT04424927|537657120|FG004|Double-blind Period (24 Weeks)|Other|0|||
149048211|NCT01376700|537657130|FG000|Overall Study|Sponsor terminated study early|8|||
149048212|NCT01376700|537657130|FG000|Overall Study|Low or high titer inhibitor|8|||
149048213|NCT00727909|537657131|FG000|Overall Study|Withdrawal by Subject|5|||
149048214|NCT00727909|537657132|FG001|Overall Study|Withdrawal by Subject|11|||
149048215|NCT00727909|537657133|FG002|Overall Study|Withdrawal by Subject|8|||
149048216|NCT00727909|537657134|FG003|Overall Study|Withdrawal by Subject|5|||
149048217|NCT00727909|537657131|FG000|Overall Study|Death|0|||
149048218|NCT00727909|537657132|FG001|Overall Study|Death|0|||
149048219|NCT00727909|537657133|FG002|Overall Study|Death|1|||
149048220|NCT00727909|537657134|FG003|Overall Study|Death|0|||
149048221|NCT01696773|537657135|FG000|Days 15-27, Washout|Adverse Event|1|||
149048222|NCT01696773|537657136|FG001|Days 15-27, Washout|Adverse Event|0|||
149048223|NCT05623345|537657145|FG000|Overall Study|Withdrawal by Subject|14|||
149048224|NCT05623345|537657146|FG001|Overall Study|Withdrawal by Subject|0|||
149048225|NCT05623345|537657147|FG002|Overall Study|Withdrawal by Subject|9|||
149048226|NCT05623345|537657148|FG003|Overall Study|Withdrawal by Subject|20|||
148885764|NCT04961541|537060232|FG013|Overall Study|Lost to Follow-up|0|||
149048227|NCT05623345|537657145|FG000|Overall Study|Lost to Follow-up|3|||
149048228|NCT05623345|537657146|FG001|Overall Study|Lost to Follow-up|0|||
149048229|NCT05623345|537657147|FG002|Overall Study|Lost to Follow-up|7|||
149048230|NCT05623345|537657148|FG003|Overall Study|Lost to Follow-up|2|||
149048231|NCT05623345|537657145|FG000|Overall Study|Termination of Study By Sponsor|37|||
149048232|NCT05623345|537657146|FG001|Overall Study|Termination of Study By Sponsor|4|||
149048233|NCT05623345|537657147|FG002|Overall Study|Termination of Study By Sponsor|40|||
149048234|NCT05623345|537657148|FG003|Overall Study|Termination of Study By Sponsor|38|||
149048235|NCT05384730|537657149|FG000|Overall Study|Adverse Event|1|||
149048236|NCT05384730|537657150|FG001|Overall Study|Adverse Event|0|||
149048237|NCT05384730|537657149|FG000|Overall Study|Lack of social support|2|||
149048238|NCT05384730|537657150|FG001|Overall Study|Lack of social support|0|||
149048239|NCT05384730|537657149|FG000|Overall Study|Hospital readmission|2|||
149048240|NCT05384730|537657150|FG001|Overall Study|Hospital readmission|0|||
149048241|NCT05384730|537657149|FG000|Overall Study|Disease progression|5|||
149048242|NCT05384730|537657150|FG001|Overall Study|Disease progression|0|||
149048243|NCT05384730|537657149|FG000|Overall Study|Overwhelmed with College commitments|0|||
149048244|NCT05384730|537657150|FG001|Overall Study|Overwhelmed with College commitments|2|||
149048245|NCT00411151|537657151|FG000|Overall Study|Death|38|||
149048246|NCT00411151|537657151|FG000|Overall Study|Withdrawal by Subject|2|||
149048247|NCT00411151|537657151|FG000|Overall Study|Lost to Follow-up|2|||
149048248|NCT00411151|537657151|FG000|Overall Study|Protocol Violation|1|||
149048249|NCT00411151|537657151|FG000|Overall Study|Trial prematurely closed|4|||
149048250|NCT04600752|537657156|FG000|Overall Study|Physician Decision|0|||
149048251|NCT04600752|537657157|FG001|Overall Study|Physician Decision|0|||
149048252|NCT04600752|537657158|FG002|Overall Study|Physician Decision|1|||
149048253|NCT04600752|537657156|FG000|Overall Study|Adverse Event|0|||
149048254|NCT04600752|537657157|FG001|Overall Study|Adverse Event|1|||
149048255|NCT04600752|537657158|FG002|Overall Study|Adverse Event|0|||
149048256|NCT04600752|537657156|FG000|Overall Study|Withdrawal by Subject|2|||
149048257|NCT04600752|537657157|FG001|Overall Study|Withdrawal by Subject|1|||
149048258|NCT04600752|537657158|FG002|Overall Study|Withdrawal by Subject|0|||
149048259|NCT04600752|537657156|FG000|Overall Study|Lack of Efficacy|1|||
149048260|NCT04600752|537657157|FG001|Overall Study|Lack of Efficacy|0|||
149048261|NCT04600752|537657158|FG002|Overall Study|Lack of Efficacy|0|||
149048262|NCT01989455|537657161|FG000|Overall Study|Adverse Event|0|||
149048263|NCT01989455|537657162|FG001|Overall Study|Adverse Event|1|||
149048264|NCT01989455|537657163|FG002|Overall Study|Adverse Event|0|||
149048265|NCT01989455|537657164|FG003|Overall Study|Adverse Event|0|||
149048266|NCT01989455|537657165|FG004|Overall Study|Adverse Event|0|||
149048267|NCT01989455|537657161|FG000|Overall Study|Withdrawal by Subject|0|||
149048268|NCT01989455|537657162|FG001|Overall Study|Withdrawal by Subject|1|||
149048269|NCT01989455|537657163|FG002|Overall Study|Withdrawal by Subject|0|||
149048270|NCT01989455|537657164|FG003|Overall Study|Withdrawal by Subject|0|||
149048271|NCT01989455|537657165|FG004|Overall Study|Withdrawal by Subject|0|||
149048272|NCT01989455|537657161|FG000|Overall Study|Technical problems with infusion|0|||
149048273|NCT01989455|537657162|FG001|Overall Study|Technical problems with infusion|0|||
149048274|NCT01989455|537657163|FG002|Overall Study|Technical problems with infusion|1|||
149048275|NCT01989455|537657164|FG003|Overall Study|Technical problems with infusion|0|||
149048276|NCT01989455|537657165|FG004|Overall Study|Technical problems with infusion|1|||
149048277|NCT00999167|537657166|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
149048278|NCT00999167|537657167|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
149048279|NCT00999167|537657168|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
149048280|NCT00999167|537657166|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
149048281|NCT00999167|537657167|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
149048282|NCT00999167|537657168|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
149048283|NCT00999167|537657166|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
149048284|NCT00999167|537657167|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
149048285|NCT00999167|537657168|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
149048286|NCT00999167|537657166|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
149048287|NCT00999167|537657167|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
149048288|NCT00999167|537657168|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
148885765|NCT04961541|537060219|FG000|Overall Study|Withdrawal by Subject|0|||
148885766|NCT04961541|537060220|FG001|Overall Study|Withdrawal by Subject|0|||
148885767|NCT04961541|537060221|FG002|Overall Study|Withdrawal by Subject|1|||
148885768|NCT04961541|537060222|FG003|Overall Study|Withdrawal by Subject|1|||
149048289|NCT00999167|537657166|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
149048290|NCT00999167|537657167|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
149048291|NCT00999167|537657168|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
149048292|NCT00999167|537657166|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
149048293|NCT00999167|537657167|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
149048294|NCT00999167|537657168|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
149048295|NCT00999167|537657166|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
149048296|NCT00999167|537657167|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
149048297|NCT00999167|537657168|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
148885769|NCT04961541|537060223|FG004|Overall Study|Withdrawal by Subject|0|||
148885770|NCT04961541|537060224|FG005|Overall Study|Withdrawal by Subject|0|||
148885771|NCT04961541|537060225|FG006|Overall Study|Withdrawal by Subject|0|||
148885772|NCT04961541|537060226|FG007|Overall Study|Withdrawal by Subject|0|||
148885773|NCT04961541|537060227|FG008|Overall Study|Withdrawal by Subject|0|||
148885774|NCT04961541|537060228|FG009|Overall Study|Withdrawal by Subject|1|||
149048298|NCT00999167|537657166|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
149048299|NCT00999167|537657167|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
149048300|NCT00999167|537657168|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
149048301|NCT00448669|537657169|FG000|Overall Study|Lost to Follow-up|52|||
149048302|NCT00448669|537657170|FG001|Overall Study|Lost to Follow-up|63|||
149048303|NCT00448669|537657169|FG000|Overall Study|Withdrawal by Subject|90|||
149048304|NCT00448669|537657170|FG001|Overall Study|Withdrawal by Subject|74|||
149048305|NCT00448669|537657169|FG000|Overall Study|Relocated|49|||
149048306|NCT00448669|537657170|FG001|Overall Study|Relocated|36|||
149048307|NCT00448669|537657169|FG000|Overall Study|Were withdrawn by investigator|10|||
149048308|NCT00448669|537657170|FG001|Overall Study|Were withdrawn by investigator|6|||
149048309|NCT00448669|537657169|FG000|Overall Study|Death|2|||
149048310|NCT00448669|537657170|FG001|Overall Study|Death|4|||
149048311|NCT00448669|537657169|FG000|Overall Study|Had other reasons|5|||
149048312|NCT00448669|537657170|FG001|Overall Study|Had other reasons|6|||
149048313|NCT00448669|537657169|FG000|Overall Study|HIV-infected at enrollment|1|||
149048314|NCT00448669|537657170|FG001|Overall Study|HIV-infected at enrollment|2|||
149048315|NCT00448669|537657169|FG000|Overall Study|Never started drug|9|||
149048316|NCT00448669|537657170|FG001|Overall Study|Never started drug|7|||
149048317|NCT02638337|537657175|FG000|Overall Study|Adverse Event|6|||
149048318|NCT02638337|537657176|FG001|Overall Study|Adverse Event|10|||
149048319|NCT02638337|537657175|FG000|Overall Study|Protocol Violation|3|||
149048320|NCT02638337|537657176|FG001|Overall Study|Protocol Violation|0|||
149048321|NCT02638337|537657175|FG000|Overall Study|Withdrawal by Subject|13|||
149048322|NCT02638337|537657176|FG001|Overall Study|Withdrawal by Subject|16|||
149048323|NCT02638337|537657175|FG000|Overall Study|Lost to Follow-up|7|||
149048324|NCT02638337|537657176|FG001|Overall Study|Lost to Follow-up|7|||
149048325|NCT02638337|537657175|FG000|Overall Study|Other - Miscellaneous|4|||
149048326|NCT02638337|537657176|FG001|Overall Study|Other - Miscellaneous|3|||
149048327|NCT02789020|537657177|FG000|Overall Study|Withdrawal by Subject|6|||
149048328|NCT02789020|537657178|FG001|Overall Study|Withdrawal by Subject|5|||
149048329|NCT03771352|537657179|FG000|Overall Study|Screen failure|2|||
149048330|NCT03771352|537657179|FG000|Overall Study|Withdrawal by Subject|2|||
149048331|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
149048332|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
149048333|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
149048334|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
149048335|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
149048336|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
149048337|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
149048338|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
149048339|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
149048340|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
149048341|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
149048342|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
149048343|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
149048344|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
148885775|NCT04961541|537060229|FG010|Overall Study|Withdrawal by Subject|0|||
149004788|NCT00698646|537495132|FG002|Overall Study|Protocol Deviation|3|||
149004789|NCT00698646|537495130|FG000|Overall Study|Withdrawal by Subject|10|||
149004790|NCT00698646|537495131|FG001|Overall Study|Withdrawal by Subject|11|||
149004791|NCT00698646|537495132|FG002|Overall Study|Withdrawal by Subject|8|||
149004792|NCT00698646|537495130|FG000|Overall Study|Lost to Follow-up|0|||
149004793|NCT00698646|537495131|FG001|Overall Study|Lost to Follow-up|0|||
149004794|NCT00698646|537495132|FG002|Overall Study|Lost to Follow-up|2|||
149004795|NCT00698646|537495130|FG000|Overall Study|Administrative problems|1|||
149004796|NCT00698646|537495131|FG001|Overall Study|Administrative problems|0|||
149004797|NCT00698646|537495132|FG002|Overall Study|Administrative problems|1|||
149004798|NCT00316173|537495138|FG000|Run-in Phase|Adverse Event|1|||
149004799|NCT00316173|537495139|FG001|Run-in Phase|Adverse Event|0|||
149004800|NCT00316173|537495138|FG000|Run-in Phase|Protocol Violation|1|||
149004801|NCT00316173|537495139|FG001|Run-in Phase|Protocol Violation|0|||
149004802|NCT00316173|537495138|FG000|Run-in Phase|Study Follow-up Stopped|5|||
149004803|NCT00316173|537495139|FG001|Run-in Phase|Study Follow-up Stopped|0|||
149004804|NCT00316173|537495138|FG000|Treatment Phase|Adverse Event|0|||
149004805|NCT00316173|537495139|FG001|Treatment Phase|Adverse Event|1|||
149004806|NCT00316173|537495138|FG000|Treatment Phase|Lack of Efficacy|0|||
149004807|NCT00316173|537495139|FG001|Treatment Phase|Lack of Efficacy|3|||
149004808|NCT00316173|537495138|FG000|Treatment Phase|Lost to Follow-up|0|||
149048345|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
149048346|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
149048347|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
149048348|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
149048349|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
149048350|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
149048351|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
149048352|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
149048353|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
149048354|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
149048355|NCT03338816|537657189|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
149048356|NCT03338816|537657190|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
149048357|NCT03338816|537657191|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
149048358|NCT03338816|537657192|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
149048359|NCT05512962|537657193|FG000|Overall Study|Withdrawal by Subject|1|||
149048360|NCT05512962|537657194|FG001|Overall Study|Withdrawal by Subject|0|||
149048361|NCT01711632|537657195|FG000|Overall Study|Adverse Event|4|||
149048362|NCT01711632|537657195|FG000|Overall Study|Death|3|||
149048363|NCT01711632|537657195|FG000|Overall Study|Lost to Follow-up|3|||
149048364|NCT01711632|537657195|FG000|Overall Study|Withdrawal by Subject|4|||
149048365|NCT01711632|537657195|FG000|Overall Study|Progressive disease|2|||
149048366|NCT01711632|537657195|FG000|Overall Study|No follow up required in re-treatment|3|||
149048367|NCT01711632|537657195|FG000|Overall Study|No follow up required in re-treatment|3|||
149048368|NCT04315181|537657196|FG000|Overall Study|Non-responsive to drug conditions.|1|||
149048369|NCT01467427|537657198|FG000|Overall Study|Withdrawal by Subject|1|||
149048370|NCT01467427|537657199|FG001|Overall Study|Withdrawal by Subject|0|||
149048371|NCT01467427|537657198|FG000|Overall Study|Not continuing in extension phase|0|||
149048372|NCT01467427|537657199|FG001|Overall Study|Not continuing in extension phase|2|||
149048373|NCT01467427|537657198|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
149048374|NCT01467427|537657199|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
149048375|NCT01467427|537657198|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
149048376|NCT01467427|537657199|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
149048377|NCT01467427|537657198|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
149048378|NCT01467427|537657199|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
149048379|NCT01467427|537657198|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
149048380|NCT01467427|537657199|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
149048381|NCT00522951|537657200|FG000|Period 1|body motion|0|||
149048382|NCT00522951|537657201|FG001|Period 1|body motion|1|||
149048383|NCT00522951|537657200|FG000|Washout Period|Adverse Event|0|||
149048384|NCT00522951|537657201|FG001|Washout Period|Adverse Event|1|||
149048385|NCT00522951|537657200|FG000|Washout Period|Death|0|||
149048386|NCT00522951|537657201|FG001|Washout Period|Death|1|||
149048387|NCT00522951|537657200|FG000|Period 2|Withdrawal by Subject|1|||
149048388|NCT00522951|537657201|FG001|Period 2|Withdrawal by Subject|0|||
149048389|NCT00522951|537657200|FG000|Period 2|residual contrast medium|1|||
149048390|NCT00522951|537657201|FG001|Period 2|residual contrast medium|1|||
149048391|NCT05494788|537657206|FG000|Initial Treatment Period|Adverse Event|2|||
149048392|NCT05494788|537657206|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
149048393|NCT05494788|537657206|FG000|Extension Period|Adverse Event|1|||
149048394|NCT05494788|537657206|FG000|Extension Period|Withdrawal by Subject|1|||
149048395|NCT01424670|537657207|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
149048396|NCT01424670|537657208|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
149048397|NCT01424670|537657207|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
149048398|NCT01424670|537657208|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
149048399|NCT01424670|537657207|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
149048400|NCT01424670|537657208|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
149048401|NCT01424670|537657207|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
149048402|NCT01424670|537657208|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
149048403|NCT01424670|537657207|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
149048404|NCT01424670|537657208|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
149048405|NCT01424670|537657207|FG000|Continuation Period|Adverse Event|13|||
149048406|NCT01424670|537657208|FG001|Continuation Period|Adverse Event|5|||
149048407|NCT01424670|537657207|FG000|Continuation Period|Lost to Follow-up|2|||
149048408|NCT01424670|537657208|FG001|Continuation Period|Lost to Follow-up|0|||
149048409|NCT01424670|537657207|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
149048410|NCT01424670|537657208|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
149048411|NCT01424670|537657207|FG000|Continuation Period|Physician Decision|5|||
149048412|NCT01424670|537657208|FG001|Continuation Period|Physician Decision|4|||
149048413|NCT01424670|537657207|FG000|Continuation Period|Withdrawal by Subject|13|||
149048414|NCT01424670|537657208|FG001|Continuation Period|Withdrawal by Subject|4|||
149048415|NCT00761189|537657209|FG000|Overall Study|Adverse Event|42|||
149048416|NCT00761189|537657209|FG000|Overall Study|Lack of Efficacy|45|||
149048417|NCT00761189|537657209|FG000|Overall Study|Lost to Follow-up|36|||
149048418|NCT00761189|537657209|FG000|Overall Study|Withdrawal by Subject|49|||
149048419|NCT00761189|537657209|FG000|Overall Study|Other|13|||
149048420|NCT01494922|537657210|FG000|Overall Study|Adverse Event|1|||
149048421|NCT02759016|537657211|FG000|Overall Study|Not treated with BI 836826|1|||
148885776|NCT04961541|537060230|FG011|Overall Study|Withdrawal by Subject|0|||
148885777|NCT04961541|537060231|FG012|Overall Study|Withdrawal by Subject|0|||
148885778|NCT04961541|537060232|FG013|Overall Study|Withdrawal by Subject|0|||
148885779|NCT00191308|537060233|FG000|Overall Study|Adverse Event|1|||
148885780|NCT03710642|537060235|FG000|Overall Study|Adverse Event|5|||
148885781|NCT03710642|537060236|FG001|Overall Study|Adverse Event|1|||
149048422|NCT02759016|537657212|FG001|Overall Study|Not treated with BI 836826|0|||
149048423|NCT02759016|537657211|FG000|Overall Study|Progressive disease|1|||
149048424|NCT02759016|537657212|FG001|Overall Study|Progressive disease|0|||
149048425|NCT02759016|537657211|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
149048426|NCT02759016|537657212|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
149048427|NCT02759016|537657211|FG000|Overall Study|Other not defined above|2|||
149048428|NCT02759016|537657212|FG001|Overall Study|Other not defined above|1|||
149048429|NCT00709098|537657215|FG000|Double-blind Period|Withdrawal of consent|3|||
149048430|NCT00709098|537657216|FG001|Double-blind Period|Withdrawal of consent|3|||
149048431|NCT00709098|537657217|FG002|Double-blind Period|Withdrawal of consent|0|||
149048432|NCT00709098|537657215|FG000|Double-blind Period|Administrative reason|1|||
149048433|NCT00709098|537657216|FG001|Double-blind Period|Administrative reason|3|||
149048434|NCT00709098|537657217|FG002|Double-blind Period|Administrative reason|0|||
149048435|NCT00709098|537657215|FG000|Double-blind Period|Death|1|||
149048436|NCT00709098|537657216|FG001|Double-blind Period|Death|1|||
149048437|NCT00709098|537657217|FG002|Double-blind Period|Death|0|||
149048438|NCT00709098|537657215|FG000|Double-blind Period|Lost to Follow-up|1|||
149048439|NCT00709098|537657216|FG001|Double-blind Period|Lost to Follow-up|1|||
149048440|NCT00709098|537657217|FG002|Double-blind Period|Lost to Follow-up|0|||
149048441|NCT00709098|537657215|FG000|Open-label Period|Withdrawal of consent|0|||
149048442|NCT00709098|537657216|FG001|Open-label Period|Withdrawal of consent|0|||
149048443|NCT00709098|537657217|FG002|Open-label Period|Withdrawal of consent|7|||
149048444|NCT00709098|537657215|FG000|Open-label Period|Administrative reason|0|||
149048445|NCT00709098|537657216|FG001|Open-label Period|Administrative reason|0|||
148885782|NCT03710642|537060235|FG000|Overall Study|non-site physician recommendation|1|||
148885783|NCT03710642|537060236|FG001|Overall Study|non-site physician recommendation|0|||
148885784|NCT03710642|537060235|FG000|Overall Study|Participant unwilling or unable to participate|1|||
148885785|NCT03710642|537060236|FG001|Overall Study|Participant unwilling or unable to participate|1|||
148885786|NCT03710642|537060235|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
148885787|NCT03710642|537060236|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
148885788|NCT03710642|537060235|FG000|Overall Study|NA-no code provided|1|||
148885789|NCT03710642|537060236|FG001|Overall Study|NA-no code provided|0|||
148885790|NCT03710642|537060235|FG000|Overall Study|Withdrawal by Subject|1|||
148885791|NCT03710642|537060236|FG001|Overall Study|Withdrawal by Subject|0|||
148885792|NCT02680665|537060237|FG000|Overall Study|No visit after the first prescription|5|||
148885793|NCT02905266|537060238|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
148885794|NCT02905266|537060239|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
149048446|NCT00709098|537657217|FG002|Open-label Period|Administrative reason|5|||
149048447|NCT00709098|537657215|FG000|Open-label Period|Death|0|||
149048448|NCT00709098|537657216|FG001|Open-label Period|Death|0|||
149048449|NCT00709098|537657217|FG002|Open-label Period|Death|1|||
149048450|NCT00709098|537657215|FG000|Open-label Period|Lost to Follow-up|0|||
149048451|NCT00709098|537657216|FG001|Open-label Period|Lost to Follow-up|0|||
149048452|NCT00709098|537657217|FG002|Open-label Period|Lost to Follow-up|1|||
149048453|NCT02119650|537657218|FG000|Overall Study|Adverse Event|3|||
149048454|NCT02119650|537657219|FG001|Overall Study|Adverse Event|4|||
149048455|NCT02119650|537657218|FG000|Overall Study|Subject decision|2|||
149048456|NCT02119650|537657219|FG001|Overall Study|Subject decision|3|||
149048457|NCT02119650|537657218|FG000|Overall Study|Disease progression|11|||
149048458|NCT02119650|537657219|FG001|Overall Study|Disease progression|14|||
148885795|NCT02905266|537060238|FG000|Treatment Phase Part 1|Disease Progression|6|||
148885796|NCT02905266|537060239|FG001|Treatment Phase Part 1|Disease Progression|7|||
149048459|NCT02119650|537657218|FG000|Overall Study|Death|5|||
149048460|NCT02119650|537657219|FG001|Overall Study|Death|1|||
149048461|NCT02119650|537657218|FG000|Overall Study|Noncompliance with study treatment|1|||
149048462|NCT02119650|537657219|FG001|Overall Study|Noncompliance with study treatment|1|||
149048463|NCT02119650|537657218|FG000|Overall Study|Study terminated by the sponsor|1|||
149048464|NCT02119650|537657219|FG001|Overall Study|Study terminated by the sponsor|0|||
149048465|NCT02119650|537657218|FG000|Overall Study|Physician Decision|0|||
149048466|NCT02119650|537657219|FG001|Overall Study|Physician Decision|2|||
149048467|NCT02119650|537657218|FG000|Overall Study|Multiple reasons for termination|2|||
149048468|NCT02119650|537657219|FG001|Overall Study|Multiple reasons for termination|1|||
148885797|NCT02905266|537060238|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
148885798|NCT02905266|537060239|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
148885799|NCT02905266|537060238|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
148885800|NCT02905266|537060239|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
148885801|NCT02905266|537060238|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
149004809|NCT00316173|537495139|FG001|Treatment Phase|Lost to Follow-up|3|||
149004810|NCT00316173|537495138|FG000|Treatment Phase|Withdrawal by Subject|0|||
149004811|NCT00316173|537495139|FG001|Treatment Phase|Withdrawal by Subject|1|||
149004812|NCT00316173|537495138|FG000|Treatment Phase|Study Follow-up Stopped|0|||
149004813|NCT00316173|537495139|FG001|Treatment Phase|Study Follow-up Stopped|34|||
149004814|NCT02390531|537495140|FG000|Overall Study|Death|0|||
149004815|NCT02390531|537495141|FG001|Overall Study|Death|2|||
149004816|NCT02390531|537495142|FG002|Overall Study|Death|0|||
149004817|NCT02390531|537495143|FG003|Overall Study|Death|1|||
149004818|NCT02390531|537495144|FG004|Overall Study|Death|0|||
149004819|NCT02390531|537495145|FG005|Overall Study|Death|0|||
149004820|NCT02390531|537495146|FG006|Overall Study|Death|0|||
149004821|NCT02390531|537495147|FG007|Overall Study|Death|1|||
149004822|NCT02390531|537495140|FG000|Overall Study|Protocol Violation|0|||
149004823|NCT02390531|537495141|FG001|Overall Study|Protocol Violation|0|||
149004824|NCT02390531|537495142|FG002|Overall Study|Protocol Violation|0|||
149004825|NCT02390531|537495143|FG003|Overall Study|Protocol Violation|0|||
149004826|NCT02390531|537495144|FG004|Overall Study|Protocol Violation|1|||
149004827|NCT02390531|537495145|FG005|Overall Study|Protocol Violation|0|||
149004828|NCT02390531|537495146|FG006|Overall Study|Protocol Violation|2|||
149004829|NCT02390531|537495147|FG007|Overall Study|Protocol Violation|0|||
149004830|NCT00511875|537495148|FG000|Overall Study|Lost to Follow-up|4|||
149004831|NCT00511875|537495149|FG001|Overall Study|Lost to Follow-up|0|||
149004832|NCT00511875|537495148|FG000|Overall Study|Missing variables|1|||
149004833|NCT00511875|537495149|FG001|Overall Study|Missing variables|0|||
149004834|NCT00284141|537496414|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
149004835|NCT00284141|537496414|FG000|Overall Study|Adverse Event|19|||
149004836|NCT00284141|537496414|FG000|Overall Study|Participant's request|9|||
149004837|NCT00284141|537496414|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
149004838|NCT00284141|537496414|FG000|Overall Study|Clinical deterioration / death|2|||
149004839|NCT00284141|537496414|FG000|Overall Study|General decline|1|||
149004840|NCT00284141|537496414|FG000|Overall Study|Pneumonia|1|||
149004841|NCT00284141|537496414|FG000|Overall Study|Did not take study medication|2|||
149004842|NCT00284141|537496414|FG000|Overall Study|Ongoing treatment|2|||
149004843|NCT01160484|537496424|FG000|Overall Study|Lack of Efficacy|9|||
149004844|NCT01160484|537496424|FG000|Overall Study|Adverse Event|6|||
149004845|NCT01160484|537496424|FG000|Overall Study|Withdrawal by Subject|2|||
149004846|NCT01160484|537496424|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
149004847|NCT01529008|537496427|FG000|Bone Marrow Harvesting|Physician Decision|1|||
149004848|NCT01529008|537496428|FG001|Bone Marrow Harvesting|Physician Decision|1|||
149004849|NCT01529008|537496427|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
149004850|NCT01529008|537496428|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
149004851|NCT01529008|537496427|FG000|Treatment|Adverse Event|6|||
149004852|NCT01529008|537496428|FG001|Treatment|Adverse Event|0|||
149004853|NCT01529008|537496427|FG000|Treatment|Other|3|||
149004854|NCT01529008|537496428|FG001|Treatment|Other|1|||
149004855|NCT01529008|537496427|FG000|Efficacy Analysis|Protocol Violation|2|||
149004856|NCT01529008|537496428|FG001|Efficacy Analysis|Protocol Violation|0|||
149004857|NCT01529008|537496427|FG000|Efficacy Analysis|Physician Decision|0|||
149004858|NCT01529008|537496428|FG001|Efficacy Analysis|Physician Decision|1|||
149004859|NCT01529008|537496427|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
149004860|NCT01529008|537496428|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
149004861|NCT00332332|537496429|FG000|Overall Study|Adverse Event|13|||
149004862|NCT00332332|537496429|FG000|Overall Study|Death|1|||
149004863|NCT00332332|537496429|FG000|Overall Study|Withdrawal by Subject|8|||
149004864|NCT00332332|537496429|FG000|Overall Study|Physician Decision|1|||
149004865|NCT00332332|537496429|FG000|Overall Study|Lost to Follow-up|3|||
149004866|NCT00332332|537496429|FG000|Overall Study|Protocol deviation|4|||
149004867|NCT00332332|537496429|FG000|Overall Study|Noncompliance|2|||
149004868|NCT00332332|537496429|FG000|Overall Study|Disease progression|2|||
149004869|NCT00332332|537496429|FG000|Overall Study|Other|18|||
149004870|NCT00332332|537496429|FG000|Overall Study|Did not receive study treatment|16|||
149004871|NCT01382602|537496430|FG000|Overall Study|Protocol Violation|0|||
149004872|NCT01382602|537496431|FG001|Overall Study|Protocol Violation|3|||
149004873|NCT01382602|537496430|FG000|Overall Study|Withdrawal by Subject|0|||
149004874|NCT01382602|537496431|FG001|Overall Study|Withdrawal by Subject|1|||
149004875|NCT02790073|537496434|FG000|Overall Study|Death|1|||
149004876|NCT02790073|537496434|FG000|Overall Study|Withdrawal from HD|1|||
149004877|NCT02790073|537496434|FG000|Overall Study|Withdrawal by Subject|1|||
149004878|NCT04170686|537496435|FG000|Screening|Physician Decision|12|||
149004879|NCT04170686|537496436|FG001|Screening|Physician Decision|13|||
149048469|NCT02269475|537657221|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
149048470|NCT02269475|537657222|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
149048471|NCT02269475|537657221|FG000|Overall Study|Withdrawal by Subject|0|||
149048472|NCT02269475|537657222|FG001|Overall Study|Withdrawal by Subject|1|||
149048473|NCT04924062|537659389|FG000|Overall Study|Death|49|||
149048474|NCT04924062|537659390|FG001|Overall Study|Death|63|||
149048475|NCT04924062|537659389|FG000|Overall Study|Participant On-going|26|||
149048476|NCT04924062|537659390|FG001|Overall Study|Participant On-going|20|||
149048477|NCT03263026|537659395|FG000|Overall Study|Withdrawal by Subject|1|||
149048478|NCT03263026|537659396|FG001|Overall Study|Withdrawal by Subject|0|||
149048479|NCT03263026|537659395|FG000|Overall Study|Death|1|||
149048480|NCT03263026|537659396|FG001|Overall Study|Death|0|||
149048481|NCT03263026|537659395|FG000|Overall Study|Other/ Various|41|||
149048482|NCT03263026|537659396|FG001|Overall Study|Other/ Various|29|||
149048483|NCT04868110|537659397|FG000|Overall Study|Withdrawal by Subject|3|||
149048484|NCT04868110|537659398|FG001|Overall Study|Withdrawal by Subject|4|||
149048485|NCT04823611|537659399|FG000|Overall Study|Adverse Event|2|||
149048486|NCT04823611|537659400|FG001|Overall Study|Adverse Event|0|||
149048487|NCT04823611|537659401|FG002|Overall Study|Adverse Event|1|||
149048488|NCT04823611|537659402|FG003|Overall Study|Adverse Event|0|||
149048489|NCT04823611|537659403|FG004|Overall Study|Adverse Event|0|||
149048490|NCT04823611|537659404|FG005|Overall Study|Adverse Event|0|||
149048491|NCT04823611|537659405|FG006|Overall Study|Adverse Event|0|||
149048492|NCT01673984|537659409|FG000|Overall Study|Adverse Event|1|||
149048493|NCT01673984|537659410|FG001|Overall Study|Adverse Event|0|||
149048494|NCT01673984|537659409|FG000|Overall Study|Study termination|9|||
149048495|NCT01673984|537659410|FG001|Overall Study|Study termination|6|||
149048496|NCT05415410|537659417|FG000|Overall Study|Death|3|||
149048497|NCT05415410|537659418|FG001|Overall Study|Death|6|||
149048498|NCT05415410|537659419|FG002|Overall Study|Death|1|||
149048499|NCT05415410|537659417|FG000|Overall Study|Trial Terminated by Sponsor|1|||
149048500|NCT05415410|537659418|FG001|Overall Study|Trial Terminated by Sponsor|5|||
149048501|NCT05415410|537659419|FG002|Overall Study|Trial Terminated by Sponsor|0|||
149048502|NCT05415410|537659417|FG000|Overall Study|Adverse Event|2|||
149048503|NCT05415410|537659418|FG001|Overall Study|Adverse Event|1|||
149048504|NCT05415410|537659419|FG002|Overall Study|Adverse Event|0|||
149048505|NCT05415410|537659417|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
149048506|NCT05415410|537659418|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
149048507|NCT05415410|537659419|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
149048508|NCT05415410|537659417|FG000|Overall Study|Withdrawal by Subject|1|||
149048509|NCT05415410|537659418|FG001|Overall Study|Withdrawal by Subject|0|||
149048510|NCT05415410|537659419|FG002|Overall Study|Withdrawal by Subject|0|||
149048511|NCT05415410|537659417|FG000|Overall Study|Pregnancy|5|||
149048512|NCT05415410|537659418|FG001|Overall Study|Pregnancy|2|||
149048513|NCT05415410|537659419|FG002|Overall Study|Pregnancy|0|||
149048514|NCT02365766|537659423|FG000|Overall Study|Withdrawal by Subject|0|||
149048515|NCT02365766|537659424|FG001|Overall Study|Withdrawal by Subject|0|||
149048516|NCT02365766|537659425|FG002|Overall Study|Withdrawal by Subject|1|||
149048517|NCT02365766|537659423|FG000|Overall Study|Eligibility Criteria Not Met|0|||
149048518|NCT02365766|537659424|FG001|Overall Study|Eligibility Criteria Not Met|0|||
149048519|NCT02365766|537659425|FG002|Overall Study|Eligibility Criteria Not Met|1|||
149048520|NCT04791709|537659434|FG000|Overall Study|Withdrawal by Subject|3|||
149048521|NCT02724956|537659435|FG000|Overall Study|Physician Decision|1|||
149048522|NCT02724956|537659436|FG001|Overall Study|Physician Decision|0|||
149048523|NCT02724956|537659435|FG000|Overall Study|Lack of Efficacy|0|||
149048524|NCT02724956|537659436|FG001|Overall Study|Lack of Efficacy|1|||
149048525|NCT02724956|537659435|FG000|Overall Study|Withdrawal by Subject|0|||
149048526|NCT02724956|537659436|FG001|Overall Study|Withdrawal by Subject|1|||
149048527|NCT00894543|537659437|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
148885802|NCT02905266|537060239|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
149048528|NCT00894543|537659438|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
149048529|NCT00894543|537659437|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
148885803|NCT02905266|537060238|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
149048530|NCT00894543|537659438|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
149048531|NCT04048681|537659439|FG000|Overall Study|family emergency|0|||
149048532|NCT04048681|537659440|FG001|Overall Study|family emergency|0|||
149048533|NCT04048681|537659441|FG002|Overall Study|family emergency|0|||
148885804|NCT02905266|537060239|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
148885805|NCT02905266|537060238|FG000|Transition From Part 1 to Part 2|Death|0|||
149048534|NCT04048681|537659442|FG003|Overall Study|family emergency|1|||
149048535|NCT04048681|537659443|FG004|Overall Study|family emergency|0|||
149048536|NCT01532388|537659444|FG000|3-month Follow-up|Lost to Follow-up|68|||
149048537|NCT01532388|537659445|FG001|3-month Follow-up|Lost to Follow-up|68|||
149048538|NCT01532388|537659444|FG000|6-month Follow-up|Lost to Follow-up|74|||
149048539|NCT01532388|537659445|FG001|6-month Follow-up|Lost to Follow-up|66|||
149048540|NCT01532388|537659444|FG000|12-month Follow-up|Lost to Follow-up|69|||
149048541|NCT01532388|537659445|FG001|12-month Follow-up|Lost to Follow-up|67|||
148885806|NCT02905266|537060239|FG001|Transition From Part 1 to Part 2|Death|1|||
149004880|NCT04170686|537496435|FG000|Randomization and Treatment|Lost to Follow-up|26|||
149004881|NCT04170686|537496436|FG001|Randomization and Treatment|Lost to Follow-up|15|||
149004882|NCT03328143|537496437|FG000|Overall Study|Declined|3|||
149004883|NCT03328143|537496437|FG000|Overall Study|Required increased sedation|4|||
149004884|NCT03328143|537496437|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
149004885|NCT03328143|537496437|FG000|Overall Study|Surgery cancelled|1|||
149004886|NCT04425902|537496440|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
149004887|NCT01191840|537496441|FG000|Overall Study|withdrew consent|2|||
149004888|NCT01191840|537496442|FG001|Overall Study|withdrew consent|1|||
149004889|NCT01191840|537496441|FG000|Overall Study|Subject discontinued treatment|1|||
149004890|NCT01191840|537496442|FG001|Overall Study|Subject discontinued treatment|2|||
149004891|NCT01191840|537496441|FG000|Overall Study|Lost to Follow-up|4|||
149004892|NCT01191840|537496442|FG001|Overall Study|Lost to Follow-up|6|||
149004893|NCT01191840|537496441|FG000|Overall Study|Non Staph Infection|4|||
149004894|NCT01191840|537496442|FG001|Overall Study|Non Staph Infection|3|||
149004895|NCT01191840|537496441|FG000|Overall Study|ineligible at enrollment|1|||
149004896|NCT01191840|537496442|FG001|Overall Study|ineligible at enrollment|0|||
149004897|NCT01191840|537496441|FG000|Overall Study|IRB approval lapse|0|||
149004898|NCT01191840|537496442|FG001|Overall Study|IRB approval lapse|2|||
149004899|NCT01191840|537496441|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
149004900|NCT01191840|537496442|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
149004901|NCT01191840|537496441|FG000|Overall Study|Withdrawal by Subject|2|||
149004902|NCT01191840|537496442|FG001|Overall Study|Withdrawal by Subject|0|||
149004903|NCT04669600|537496443|FG000|Overall Study|Withdrawal by Subject|1|||
149004904|NCT04669600|537496443|FG000|Overall Study|Other|6|||
149004905|NCT00331344|537496444|FG000|Phase I|Adverse Event|0|||
149004906|NCT00331344|537496445|FG001|Phase I|Adverse Event|0|||
149004907|NCT00331344|537496446|FG002|Phase I|Adverse Event|0|||
149004908|NCT00331344|537496447|FG003|Phase I|Adverse Event|1|||
149004909|NCT00331344|537496448|FG004|Phase I|Adverse Event|2|||
149004910|NCT00331344|537496449|FG005|Phase I|Adverse Event|2|||
149004911|NCT00331344|537496450|FG006|Phase I|Adverse Event|0|||
149004912|NCT00331344|537496451|FG007|Phase I|Adverse Event|1|||
149004913|NCT00331344|537496452|FG008|Phase I|Adverse Event|0|||
149004914|NCT00331344|537496444|FG000|Phase II|Death|0|||
149004915|NCT00331344|537496445|FG001|Phase II|Death|0|||
149004916|NCT00331344|537496446|FG002|Phase II|Death|0|||
149004917|NCT00331344|537496447|FG003|Phase II|Death|0|||
149004918|NCT00331344|537496448|FG004|Phase II|Death|0|||
149004919|NCT00331344|537496449|FG005|Phase II|Death|0|||
149004920|NCT00331344|537496450|FG006|Phase II|Death|0|||
149004921|NCT00331344|537496451|FG007|Phase II|Death|0|||
149004922|NCT00331344|537496452|FG008|Phase II|Death|4|||
149004923|NCT03633929|537496455|FG000|Overall Study|Lost to Follow-up|1|||
149004924|NCT03633929|537496455|FG000|Overall Study|Did not login to software. Did not participate|3|||
149004925|NCT01520402|537496456|FG000|Overall Study|Withdrawal by Subject|2|||
149004926|NCT01520402|537496456|FG000|Overall Study|Physician Decision|3|||
149004927|NCT02487810|537496457|FG000|Overall Study|Withdrawal by Subject|1|||
149004928|NCT02487810|537496458|FG001|Overall Study|Withdrawal by Subject|0|||
149004929|NCT00077064|537496461|FG000|Overall Study|Adverse Event|0|||
149004930|NCT00077064|537496462|FG001|Overall Study|Adverse Event|4|||
149004931|NCT00077064|537496461|FG000|Overall Study|Patient refusal|0|||
149004932|NCT00077064|537496462|FG001|Overall Study|Patient refusal|2|||
149004933|NCT01281202|537496463|FG000|Overall Study|Adverse Event|2|||
149004934|NCT01281202|537496464|FG001|Overall Study|Adverse Event|0|||
149004935|NCT01281202|537496463|FG000|Overall Study|Withdrawal by Subject|2|||
149004936|NCT01281202|537496464|FG001|Overall Study|Withdrawal by Subject|2|||
149004937|NCT01281202|537496463|FG000|Overall Study|Protocol Violation|11|||
149004938|NCT01281202|537496464|FG001|Overall Study|Protocol Violation|10|||
149004939|NCT01281202|537496463|FG000|Overall Study|Administrative|2|||
149004940|NCT01281202|537496464|FG001|Overall Study|Administrative|8|||
149004941|NCT01281202|537496463|FG000|Overall Study|Lost to Follow-up|11|||
149004942|NCT01281202|537496464|FG001|Overall Study|Lost to Follow-up|13|||
149004943|NCT01281202|537496463|FG000|Overall Study|Incarceration|0|||
149004944|NCT01281202|537496464|FG001|Overall Study|Incarceration|3|||
149004945|NCT03483038|537496468|FG000|Overall Study|Subjects still in follow-up|18|||
149004946|NCT04987762|537496469|FG000|Overall Study|Study was Terminated by Sponsor|103|||
149004947|NCT01064297|537496470|FG000|Overall Study|Lost to Follow-up|791|||
149004948|NCT01064297|537496471|FG001|Overall Study|Lost to Follow-up|48|||
149004949|NCT01064297|537496472|FG002|Overall Study|Lost to Follow-up|133|||
149004950|NCT05805657|537496485|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
149004951|NCT05805657|537496486|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
149004952|NCT02618616|537496487|FG000|Overall Study|Lack of Efficacy|4|||
149004953|NCT02618616|537496488|FG001|Overall Study|Lack of Efficacy|0|||
149004954|NCT02618616|537496487|FG000|Overall Study|Pregnancy|0|||
149004955|NCT02618616|537496488|FG001|Overall Study|Pregnancy|1|||
149004956|NCT02618616|537496487|FG000|Overall Study|Adverse Event|8|||
149004957|NCT02618616|537496488|FG001|Overall Study|Adverse Event|0|||
149004958|NCT02618616|537496487|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
148885807|NCT02905266|537060238|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
148885808|NCT02905266|537060239|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
148885809|NCT02905266|537060238|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
148885810|NCT02905266|537060239|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
148885811|NCT02905266|537060238|FG000|Maintenance Phase Part 2|Disease Progression|9|||
148885812|NCT02905266|537060239|FG001|Maintenance Phase Part 2|Disease Progression|2|||
149048542|NCT03385629|537659446|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
149048543|NCT03385629|537659447|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
149048544|NCT03385629|537659446|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
149048545|NCT03385629|537659447|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
149048546|NCT03385629|537659446|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
149048547|NCT03385629|537659447|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
149048548|NCT00792636|537659448|FG000|Overall Study|Protocol Violation|17|||
149048549|NCT00792636|537659449|FG001|Overall Study|Protocol Violation|23|||
149048550|NCT00792636|537659450|FG002|Overall Study|Protocol Violation|20|||
149048551|NCT00792636|537659448|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
149048552|NCT00792636|537659449|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
149048553|NCT00792636|537659450|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
149048554|NCT00792636|537659448|FG000|Overall Study|Lost to Follow-up|13|||
149048555|NCT00792636|537659449|FG001|Overall Study|Lost to Follow-up|19|||
149048556|NCT00792636|537659450|FG002|Overall Study|Lost to Follow-up|14|||
149048557|NCT00792636|537659448|FG000|Overall Study|Withdrew Consent|10|||
149048558|NCT00792636|537659449|FG001|Overall Study|Withdrew Consent|13|||
149048559|NCT00792636|537659450|FG002|Overall Study|Withdrew Consent|9|||
149048560|NCT00792636|537659448|FG000|Overall Study|Lack of Efficacy|3|||
149048561|NCT00792636|537659449|FG001|Overall Study|Lack of Efficacy|4|||
149048562|NCT00792636|537659450|FG002|Overall Study|Lack of Efficacy|13|||
149048563|NCT00792636|537659448|FG000|Overall Study|Adverse Event|4|||
149048564|NCT00792636|537659449|FG001|Overall Study|Adverse Event|2|||
149048565|NCT00792636|537659450|FG002|Overall Study|Adverse Event|3|||
149048566|NCT00792636|537659448|FG000|Overall Study|Investigator Discretion|2|||
149048567|NCT00792636|537659449|FG001|Overall Study|Investigator Discretion|0|||
149048568|NCT00792636|537659450|FG002|Overall Study|Investigator Discretion|2|||
149048569|NCT01046136|537659451|FG000|Overall Study|Withdrawal by Subject|0|||
149048570|NCT01046136|537659452|FG001|Overall Study|Withdrawal by Subject|4|||
149048571|NCT01046136|537659451|FG000|Overall Study|Physician Decision|1|||
149048572|NCT01046136|537659452|FG001|Overall Study|Physician Decision|1|||
149048573|NCT01046136|537659451|FG000|Overall Study|Lost to Follow-up|3|||
149048574|NCT01046136|537659452|FG001|Overall Study|Lost to Follow-up|3|||
149048575|NCT04579250|537659453|FG000|Overall Study|Withdrawal by Subject|1|||
149048576|NCT04579250|537659454|FG001|Overall Study|Withdrawal by Subject|1|||
149048577|NCT04579250|537659455|FG002|Overall Study|Withdrawal by Subject|0|||
149048578|NCT04579250|537659453|FG000|Overall Study|Lost to Follow-up|1|||
149048579|NCT04579250|537659454|FG001|Overall Study|Lost to Follow-up|1|||
149048580|NCT04579250|537659455|FG002|Overall Study|Lost to Follow-up|0|||
149048581|NCT04579250|537659453|FG000|Overall Study|Moved from area|0|||
149048582|NCT04579250|537659454|FG001|Overall Study|Moved from area|1|||
149048583|NCT04579250|537659455|FG002|Overall Study|Moved from area|2|||
149048584|NCT02919449|537659456|FG000|Overall Study|Withdrawal by Subject|1|||
149048585|NCT02919449|537659456|FG000|Overall Study|Investigator decision|1|||
149048586|NCT02058108|537659457|FG000|Overall Study|Abnormal Laboratory Values|0|||
149048587|NCT02058108|537659458|FG001|Overall Study|Abnormal Laboratory Values|1|||
149048588|NCT02058108|537659457|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
149048589|NCT02058108|537659458|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
149048590|NCT02058108|537659457|FG000|Overall Study|No longer requires study drug|0|||
149048591|NCT02058108|537659458|FG001|Overall Study|No longer requires study drug|1|||
149048592|NCT02058108|537659457|FG000|Overall Study|Withdrawal by Subject|1|||
148885813|NCT02905266|537060238|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
148885814|NCT02905266|537060239|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
148885815|NCT02905266|537060238|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
149048593|NCT02058108|537659458|FG001|Overall Study|Withdrawal by Subject|0|||
149048594|NCT02058108|537659457|FG000|Overall Study|Administrative problems|3|||
149048595|NCT02058108|537659458|FG001|Overall Study|Administrative problems|3|||
149048596|NCT02058108|537659457|FG000|Overall Study|Protocol Violation|0|||
149048597|NCT02058108|537659458|FG001|Overall Study|Protocol Violation|1|||
149048598|NCT00274469|537659459|FG000|Overall Study|Death|63|||
149048599|NCT00274469|537659460|FG001|Overall Study|Death|74|||
149048600|NCT00274469|537659459|FG000|Overall Study|Did not consent to OS follow-up|16|||
149048601|NCT00274469|537659460|FG001|Overall Study|Did not consent to OS follow-up|19|||
149048602|NCT04238247|537659461|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
149048603|NCT04238247|537659462|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
149048604|NCT04238247|537659463|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
149048605|NCT04238247|537659464|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
149048606|NCT04238247|537659461|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
148885816|NCT02905266|537060239|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
148885817|NCT02292719|537060245|FG000|Overall Study|Withdrawal by Subject|0|||
148885818|NCT02292719|537060246|FG001|Overall Study|Withdrawal by Subject|0|||
148885819|NCT02292719|537060247|FG002|Overall Study|Withdrawal by Subject|0|||
148885820|NCT02292719|537060248|FG003|Overall Study|Withdrawal by Subject|1|||
148885821|NCT02292719|537060249|FG004|Overall Study|Withdrawal by Subject|1|||
148885822|NCT02292719|537060250|FG005|Overall Study|Withdrawal by Subject|0|||
148885823|NCT02292719|537060245|FG000|Overall Study|Subject enrolled in new study.|0|||
149004959|NCT02618616|537496488|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
149004960|NCT02618616|537496487|FG000|Overall Study|Consent withdrawn by subject|8|||
149004961|NCT02618616|537496488|FG001|Overall Study|Consent withdrawn by subject|5|||
149004962|NCT02618616|537496487|FG000|Overall Study|Lost to Follow-up|0|||
149004963|NCT02618616|537496488|FG001|Overall Study|Lost to Follow-up|1|||
149004964|NCT03764072|537496489|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
149004965|NCT03764072|537496490|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
149004966|NCT03764072|537496491|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
149004967|NCT03764072|537496492|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
149004968|NCT03764072|537496493|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
149004969|NCT03764072|537496494|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
149004970|NCT03764072|537496489|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
149004971|NCT03764072|537496490|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
149004972|NCT03764072|537496491|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
149004973|NCT03764072|537496492|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
149004974|NCT03764072|537496493|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
149004975|NCT03764072|537496494|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
149004976|NCT03764072|537496489|FG000|Overall Study|Lost to Follow-up|0|||
149004977|NCT03764072|537496490|FG001|Overall Study|Lost to Follow-up|0|||
149004978|NCT03764072|537496491|FG002|Overall Study|Lost to Follow-up|0|||
149004979|NCT03764072|537496492|FG003|Overall Study|Lost to Follow-up|0|||
149004980|NCT03764072|537496493|FG004|Overall Study|Lost to Follow-up|1|||
149004981|NCT03764072|537496494|FG005|Overall Study|Lost to Follow-up|0|||
149004982|NCT02686034|537496496|FG000|Run-In Period 1|Eligibility|12|||
149004983|NCT02686034|537496497|FG001|Run-In Period 1|Eligibility|10|||
149004984|NCT02686034|537496496|FG000|Run-In Period 1|Withdrawal by Subject|4|||
149004985|NCT02686034|537496497|FG001|Run-In Period 1|Withdrawal by Subject|3|||
149004986|NCT02686034|537496496|FG000|Run-In Period 1|Lost to Follow-up|4|||
149004987|NCT02686034|537496497|FG001|Run-In Period 1|Lost to Follow-up|4|||
149004988|NCT02686034|537496496|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
149004989|NCT02686034|537496497|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
149004990|NCT02686034|537496496|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
149004991|NCT02686034|537496497|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
149004992|NCT02686034|537496496|FG000|Randomized Controlled Period 2|Adverse Event|0|||
149004993|NCT02686034|537496497|FG001|Randomized Controlled Period 2|Adverse Event|2|||
149004994|NCT02686034|537496496|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
149004995|NCT02686034|537496497|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
149004996|NCT02686034|537496496|FG000|Open Label Period 3|Lost to Follow-up|0|||
149004997|NCT02686034|537496497|FG001|Open Label Period 3|Lost to Follow-up|1|||
149004998|NCT00459342|537496498|FG000|Overall Study|Not eligible|1|||
149004999|NCT00542880|537496499|FG000|Period 1|Eligibility criteria not fulfilled|2|||
149005000|NCT00542880|537496500|FG001|Period 1|Eligibility criteria not fulfilled|6|||
149005001|NCT00542880|537496499|FG000|Period 1|Adverse Event|2|||
149005002|NCT00542880|537496500|FG001|Period 1|Adverse Event|2|||
149005003|NCT00542880|537496499|FG000|Period 1|Development of study-specific criteria|1|||
149005004|NCT00542880|537496500|FG001|Period 1|Development of study-specific criteria|2|||
149005005|NCT00542880|537496499|FG000|Period 1|Withdrawal by Subject|1|||
149005006|NCT00542880|537496500|FG001|Period 1|Withdrawal by Subject|1|||
149005007|NCT00542880|537496499|FG000|Period 1|Protocol Violation|0|||
149005008|NCT00542880|537496500|FG001|Period 1|Protocol Violation|1|||
149005009|NCT00542880|537496499|FG000|Period 2|Adverse Event|5|||
149005010|NCT00542880|537496500|FG001|Period 2|Adverse Event|7|||
149005011|NCT00542880|537496499|FG000|Period 2|Eligibility not fulfilled|0|||
149005012|NCT00542880|537496500|FG001|Period 2|Eligibility not fulfilled|1|||
149005013|NCT00542880|537496499|FG000|Period 2|Discontinuation criteria|2|||
149005014|NCT00542880|537496500|FG001|Period 2|Discontinuation criteria|0|||
149005015|NCT00542880|537496499|FG000|Period 2|Severe non-compliance|0|||
149005016|NCT00542880|537496500|FG001|Period 2|Severe non-compliance|1|||
149005017|NCT00542880|537496499|FG000|Period 2|Other|0|||
149005018|NCT00542880|537496500|FG001|Period 2|Other|1|||
149005019|NCT00542880|537496499|FG000|Period 3|Adverse Event|0|||
149005020|NCT00542880|537496500|FG001|Period 3|Adverse Event|2|||
149005021|NCT00696384|537496501|FG000|Open Label Phase|Adverse Event|27|||
149005022|NCT00696384|537496502|FG001|Open Label Phase|Adverse Event|0|||
149005023|NCT00696384|537496503|FG002|Open Label Phase|Adverse Event|0|||
149005024|NCT00696384|537496501|FG000|Open Label Phase|Protocol Violation|18|||
148885824|NCT02292719|537060246|FG001|Overall Study|Subject enrolled in new study.|0|||
148885825|NCT02292719|537060247|FG002|Overall Study|Subject enrolled in new study.|1|||
148885826|NCT02292719|537060248|FG003|Overall Study|Subject enrolled in new study.|0|||
148885827|NCT02292719|537060249|FG004|Overall Study|Subject enrolled in new study.|0|||
148885828|NCT02292719|537060250|FG005|Overall Study|Subject enrolled in new study.|0|||
148885829|NCT02940496|537060251|FG000|Overall Study|Adverse Event|1|||
149048607|NCT04238247|537659462|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
149048608|NCT04238247|537659463|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
149048609|NCT04238247|537659464|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
149048610|NCT04238247|537659461|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
149048611|NCT04238247|537659462|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
149048612|NCT04238247|537659463|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
149048613|NCT04238247|537659464|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
149048614|NCT04238247|537659461|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
149048615|NCT04238247|537659462|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
149048616|NCT04238247|537659463|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
149048617|NCT04238247|537659464|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
149048618|NCT04950127|537659465|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
149048619|NCT04950127|537659466|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
149048620|NCT04950127|537659467|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
149048621|NCT04950127|537659468|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
149048622|NCT04950127|537659469|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
149048623|NCT04950127|537659470|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
149048624|NCT04950127|537659465|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
149048625|NCT04950127|537659466|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
149048626|NCT04950127|537659467|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
149048627|NCT04950127|537659468|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
149048628|NCT04950127|537659469|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
149048629|NCT04950127|537659470|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
149048630|NCT04950127|537659465|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
149048631|NCT04950127|537659466|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
149048632|NCT04950127|537659467|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
149048633|NCT04950127|537659468|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
149048634|NCT04950127|537659469|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
149048635|NCT04950127|537659470|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
149048636|NCT04950127|537659465|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
149048637|NCT04950127|537659466|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
149048638|NCT04950127|537659467|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
149048639|NCT04950127|537659468|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
149048640|NCT04950127|537659469|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
149048641|NCT04950127|537659470|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
149048642|NCT04950127|537659465|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
149048643|NCT04950127|537659466|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
149048644|NCT04950127|537659467|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
149048645|NCT04950127|537659468|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
149048646|NCT04950127|537659469|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
149048647|NCT04950127|537659470|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
149048648|NCT03833167|537659471|FG000|Overall Study|Withdrawal by Subject|4|||
149048649|NCT03833167|537659472|FG001|Overall Study|Withdrawal by Subject|6|||
149048650|NCT03833167|537659471|FG000|Overall Study|Ongoing|186|||
149048651|NCT03833167|537659472|FG001|Overall Study|Ongoing|194|||
149048652|NCT03833167|537659471|FG000|Overall Study|Lost to Follow-up|1|||
149048653|NCT03833167|537659472|FG001|Overall Study|Lost to Follow-up|1|||
149048654|NCT03833167|537659471|FG000|Overall Study|Physician Decision|0|||
149048655|NCT03833167|537659472|FG001|Overall Study|Physician Decision|2|||
149048656|NCT03833167|537659471|FG000|Overall Study|Death|34|||
149048657|NCT03833167|537659472|FG001|Overall Study|Death|22|||
149048658|NCT02860130|537659473|FG000|Overall Study|Adverse Event|2|||
149048659|NCT02860130|537659474|FG001|Overall Study|Adverse Event|3|||
149048660|NCT02860130|537659473|FG000|Overall Study|Protocol Violation|1|||
149048661|NCT02860130|537659474|FG001|Overall Study|Protocol Violation|1|||
149048662|NCT02860130|537659473|FG000|Overall Study|Withdrawal by Subject|0|||
149048663|NCT02860130|537659474|FG001|Overall Study|Withdrawal by Subject|2|||
149048664|NCT02860130|537659473|FG000|Overall Study|Physician Decision|2|||
148885830|NCT02940496|537060252|FG001|Overall Study|Adverse Event|0|||
148885831|NCT02940496|537060251|FG000|Overall Study|Death|2|||
149048665|NCT02860130|537659474|FG001|Overall Study|Physician Decision|2|||
149048666|NCT02860130|537659473|FG000|Overall Study|Other|2|||
149048667|NCT02860130|537659474|FG001|Overall Study|Other|1|||
149048668|NCT05480943|537659478|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
149048669|NCT05480943|537659478|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
149048670|NCT05480943|537659478|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
148885832|NCT02940496|537060252|FG001|Overall Study|Death|0|||
148885833|NCT02940496|537060251|FG000|Overall Study|Hospice Care|1|||
148885834|NCT02940496|537060252|FG001|Overall Study|Hospice Care|0|||
148885835|NCT02940496|537060251|FG000|Overall Study|No MRE Done|1|||
149005025|NCT00696384|537496502|FG001|Open Label Phase|Protocol Violation|0|||
149005026|NCT00696384|537496503|FG002|Open Label Phase|Protocol Violation|0|||
149005027|NCT00696384|537496501|FG000|Open Label Phase|Lost to Follow-up|24|||
149005028|NCT00696384|537496502|FG001|Open Label Phase|Lost to Follow-up|0|||
149005029|NCT00696384|537496503|FG002|Open Label Phase|Lost to Follow-up|0|||
149005030|NCT00696384|537496501|FG000|Open Label Phase|Withdrawal by Subject|37|||
149005031|NCT00696384|537496502|FG001|Open Label Phase|Withdrawal by Subject|0|||
149005032|NCT00696384|537496503|FG002|Open Label Phase|Withdrawal by Subject|0|||
149005033|NCT00696384|537496501|FG000|Open Label Phase|Other|6|||
149005034|NCT00696384|537496502|FG001|Open Label Phase|Other|0|||
149005035|NCT00696384|537496503|FG002|Open Label Phase|Other|0|||
149005036|NCT00696384|537496501|FG000|Open Label Phase|Lack of Efficacy|3|||
149005037|NCT00696384|537496502|FG001|Open Label Phase|Lack of Efficacy|0|||
149005038|NCT00696384|537496503|FG002|Open Label Phase|Lack of Efficacy|0|||
149005039|NCT00696384|537496501|FG000|Open Label Phase|Physician Decision|4|||
149005040|NCT00696384|537496502|FG001|Open Label Phase|Physician Decision|0|||
149005041|NCT00696384|537496503|FG002|Open Label Phase|Physician Decision|0|||
149005042|NCT00696384|537496501|FG000|Double Blind Phase|Adverse Event|0|||
149005043|NCT00696384|537496502|FG001|Double Blind Phase|Adverse Event|2|||
149005044|NCT00696384|537496503|FG002|Double Blind Phase|Adverse Event|2|||
149005045|NCT00696384|537496501|FG000|Double Blind Phase|Lost to Follow-up|0|||
149005046|NCT00696384|537496502|FG001|Double Blind Phase|Lost to Follow-up|2|||
149005047|NCT00696384|537496503|FG002|Double Blind Phase|Lost to Follow-up|1|||
149005048|NCT00696384|537496501|FG000|Double Blind Phase|Withdrawal by Subject|0|||
149005049|NCT00696384|537496502|FG001|Double Blind Phase|Withdrawal by Subject|4|||
149005050|NCT00696384|537496503|FG002|Double Blind Phase|Withdrawal by Subject|3|||
149005051|NCT00696384|537496501|FG000|Double Blind Phase|Lack of Efficacy|0|||
149005052|NCT00696384|537496502|FG001|Double Blind Phase|Lack of Efficacy|1|||
149005053|NCT00696384|537496503|FG002|Double Blind Phase|Lack of Efficacy|0|||
149005054|NCT00696384|537496501|FG000|Double Blind Phase|Physician Decision|0|||
149005055|NCT00696384|537496502|FG001|Double Blind Phase|Physician Decision|2|||
149005056|NCT00696384|537496503|FG002|Double Blind Phase|Physician Decision|0|||
149005057|NCT01678131|537496504|FG000|Overall Study|Adverse Event|0|||
149005058|NCT01678131|537496505|FG001|Overall Study|Adverse Event|1|||
149005059|NCT01678131|537496506|FG002|Overall Study|Adverse Event|0|||
149005060|NCT01678131|537496504|FG000|Overall Study|Withdrawal by Subject|0|||
149005061|NCT01678131|537496505|FG001|Overall Study|Withdrawal by Subject|0|||
149005062|NCT01678131|537496506|FG002|Overall Study|Withdrawal by Subject|2|||
149005063|NCT04179721|537496509|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
149005064|NCT04179721|537496510|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
149005065|NCT04179721|537496509|FG000|Overall Study|Lost to Follow-up|0|||
149005066|NCT04179721|537496510|FG001|Overall Study|Lost to Follow-up|1|||
149005067|NCT04225988|537496511|FG000|Overall Study|Withdrawal by Subject|2|||
149005068|NCT04225988|537496512|FG001|Overall Study|Withdrawal by Subject|0|||
149005069|NCT01373931|537497829|FG000|Lead-in Period|Adverse Event|2|||
149005070|NCT01373931|537497830|FG001|Lead-in Period|Adverse Event|0|||
149005071|NCT01373931|537497829|FG000|Period 1|Adverse Event|2|||
149005072|NCT01373931|537497830|FG001|Period 1|Adverse Event|0|||
149005073|NCT01373931|537497829|FG000|Period 1|Withdrawal by Subject|0|||
149005074|NCT01373931|537497830|FG001|Period 1|Withdrawal by Subject|2|||
149005075|NCT01682213|537497832|FG000|Overall Study|Withdrawal by Subject|2|||
149005076|NCT01995539|537497833|FG000|Overall Study|Screening Failure|1|||
149005077|NCT01995539|537497833|FG000|Overall Study|Withdrawal by Investigator|15|||
149005078|NCT01995539|537497833|FG000|Overall Study|Withdrawal by Subject|11|||
149005079|NCT01995539|537497833|FG000|Overall Study|Lost to Follow-up|5|||
149005080|NCT01995539|537497833|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
149005081|NCT01264380|537497834|FG000|Period C|Disease Progression|0|||
149005082|NCT01264380|537497835|FG001|Period C|Disease Progression|0|||
149005083|NCT01264380|537497836|FG002|Period C|Disease Progression|4|||
149005084|NCT01264380|537497834|FG000|Period C|Death|0|||
149005085|NCT01264380|537497835|FG001|Period C|Death|0|||
149005086|NCT01264380|537497836|FG002|Period C|Death|2|||
149005087|NCT01264380|537497834|FG000|Period C|Follow-up for survival status|0|||
149005088|NCT01264380|537497835|FG001|Period C|Follow-up for survival status|0|||
149005089|NCT01264380|537497836|FG002|Period C|Follow-up for survival status|6|||
149005090|NCT01264380|537497834|FG000|Period C|Withdrawal by Subject|0|||
149005091|NCT01264380|537497835|FG001|Period C|Withdrawal by Subject|0|||
149005092|NCT01264380|537497836|FG002|Period C|Withdrawal by Subject|1|||
149005093|NCT01264380|537497834|FG000|Period C|Adverse Event|0|||
149005094|NCT01264380|537497835|FG001|Period C|Adverse Event|0|||
149005095|NCT01264380|537497836|FG002|Period C|Adverse Event|1|||
149048671|NCT05480943|537659478|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
149005096|NCT01147822|537497837|FG000|Overall Study|Lost to Follow-up|14|||
149005097|NCT01147822|537497838|FG001|Overall Study|Lost to Follow-up|6|||
149005098|NCT01147822|537497837|FG000|Overall Study|Withdrawal by Subject|10|||
149005099|NCT01147822|537497838|FG001|Overall Study|Withdrawal by Subject|16|||
149048672|NCT00136435|537659479|FG000|Overall Study|Ineligible|8|||
149048673|NCT00136435|537659479|FG000|Overall Study|Induction Death|1|||
149048674|NCT00136435|537659479|FG000|Overall Study|Induction Failure|10|||
149048675|NCT00136435|537659479|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
149048676|NCT00136435|537659479|FG000|Overall Study|Withdrawal by Subject|3|||
149048677|NCT00136435|537659479|FG000|Overall Study|Adverse Event|19|||
149048678|NCT00136435|537659479|FG000|Overall Study|Relapse|4|||
149048679|NCT00136435|537659479|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
149048680|NCT02965846|537659480|FG000|Overall Study|Lost to Follow-up|1|||
149048681|NCT02965846|537659481|FG001|Overall Study|Lost to Follow-up|0|||
149048682|NCT02965846|537659482|FG002|Overall Study|Lost to Follow-up|0|||
149048683|NCT02965846|537659480|FG000|Overall Study|Withdrawal by Subject|0|||
149048684|NCT02965846|537659481|FG001|Overall Study|Withdrawal by Subject|1|||
149048685|NCT02965846|537659482|FG002|Overall Study|Withdrawal by Subject|0|||
149048686|NCT02965846|537659480|FG000|Overall Study|Study Terminated By Sponsor|4|||
149048687|NCT02965846|537659481|FG001|Overall Study|Study Terminated By Sponsor|4|||
149048688|NCT02965846|537659482|FG002|Overall Study|Study Terminated By Sponsor|0|||
149048689|NCT02965846|537659480|FG000|Overall Study|Participants not randomized|0|||
149048690|NCT02965846|537659481|FG001|Overall Study|Participants not randomized|0|||
149048691|NCT02965846|537659482|FG002|Overall Study|Participants not randomized|33|||
149048692|NCT02794480|537659483|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
149048693|NCT02794480|537659484|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
149048694|NCT02794480|537659485|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
149048695|NCT02794480|537659486|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
149048696|NCT02794480|537659483|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
149048697|NCT02794480|537659484|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
149048698|NCT02794480|537659485|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
149048699|NCT02794480|537659486|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
149048700|NCT02794480|537659483|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149048701|NCT02794480|537659484|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149048702|NCT02794480|537659485|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149048703|NCT02794480|537659486|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
149048704|NCT02794480|537659483|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149048705|NCT02794480|537659484|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
149048706|NCT02794480|537659485|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149048707|NCT02794480|537659486|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
149048708|NCT02794480|537659483|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
149048709|NCT02794480|537659484|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149048710|NCT02794480|537659485|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149048711|NCT02794480|537659486|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
149048712|NCT02814838|537659487|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
149048713|NCT02814838|537659488|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
149048714|NCT02814838|537659487|FG000|Overall Study|Consent withdrawal|1|||
149048715|NCT02814838|537659488|FG001|Overall Study|Consent withdrawal|1|||
149048716|NCT00593489|537659489|FG000|Allocation|did not attend workshop; allocation not|2|||
149048717|NCT00593489|537659490|FG001|Allocation|did not attend workshop; allocation not|1|||
149048718|NCT01084707|537659494|FG000|Overall Study|Withdrawal by Subject|6|||
149048719|NCT01747486|537659495|FG000|Stage 1|Physician Decision|3|||
149048720|NCT01747486|537659496|FG001|Stage 1|Physician Decision|0|||
149048721|NCT01747486|537659495|FG000|Stage 1|Withdrawal by Subject|4|||
149048722|NCT01747486|537659496|FG001|Stage 1|Withdrawal by Subject|3|||
149048723|NCT01747486|537659495|FG000|Stage 1|Disease progression|4|||
149048724|NCT01747486|537659496|FG001|Stage 1|Disease progression|9|||
149048725|NCT01747486|537659495|FG000|Stage 1|Death|1|||
149048726|NCT01747486|537659496|FG001|Stage 1|Death|1|||
149048727|NCT01747486|537659495|FG000|Stage 2|Physician Decision|2|||
149048728|NCT01747486|537659496|FG001|Stage 2|Physician Decision|0|||
149048729|NCT01747486|537659495|FG000|Stage 2|Withdrawal by Subject|1|||
149048730|NCT01747486|537659496|FG001|Stage 2|Withdrawal by Subject|0|||
149048731|NCT01747486|537659495|FG000|Stage 2|New Cancer Therapy|3|||
149048732|NCT01747486|537659496|FG001|Stage 2|New Cancer Therapy|0|||
149048733|NCT01747486|537659495|FG000|Stage 2|Disease Progression|3|||
149048734|NCT01747486|537659496|FG001|Stage 2|Disease Progression|0|||
149048735|NCT00901901|537659497|FG000|Treatment Period|Adverse Event|120|||
149048736|NCT00901901|537659498|FG001|Treatment Period|Adverse Event|128|||
149048737|NCT00901901|537659497|FG000|Treatment Period|Withdrawal by Subject|26|||
149048738|NCT00901901|537659498|FG001|Treatment Period|Withdrawal by Subject|24|||
149048739|NCT00901901|537659497|FG000|Treatment Period|Physician Decision|2|||
149048740|NCT00901901|537659498|FG001|Treatment Period|Physician Decision|2|||
149048741|NCT00901901|537659497|FG000|Treatment Period|Lost to Follow-up|3|||
149048742|NCT00901901|537659498|FG001|Treatment Period|Lost to Follow-up|5|||
149048743|NCT00901901|537659497|FG000|Treatment Period|Noncompliance with study medication|4|||
149048744|NCT00901901|537659498|FG001|Treatment Period|Noncompliance with study medication|1|||
149048745|NCT00901901|537659497|FG000|Treatment Period|Missing|1|||
149048746|NCT00901901|537659498|FG001|Treatment Period|Missing|0|||
149048747|NCT00901901|537659497|FG000|Treatment Period|Never treated|0|||
149048748|NCT00901901|537659498|FG001|Treatment Period|Never treated|3|||
149048749|NCT00901901|537659497|FG000|Treatment Period|Protocol driven decision point|0|||
149048750|NCT00901901|537659498|FG001|Treatment Period|Protocol driven decision point|2|||
149048751|NCT00901901|537659497|FG000|Treatment Period|Study terminated by sponsor|2|||
149048752|NCT00901901|537659498|FG001|Treatment Period|Study terminated by sponsor|0|||
149048753|NCT00901901|537659497|FG000|Treatment Period|Protocol Violation|5|||
149048754|NCT00901901|537659498|FG001|Treatment Period|Protocol Violation|9|||
149048755|NCT00901901|537659497|FG000|Treatment Period|Switch to commercial drug|1|||
149048756|NCT00901901|537659498|FG001|Treatment Period|Switch to commercial drug|1|||
149048757|NCT00901901|537659497|FG000|Treatment Period|Transfer to treatment continuation study|5|||
149048758|NCT00901901|537659498|FG001|Treatment Period|Transfer to treatment continuation study|2|||
149048759|NCT00901901|537659497|FG000|Follow-up Period|Death|181|||
149048760|NCT00901901|537659498|FG001|Follow-up Period|Death|208|||
149048761|NCT00901901|537659497|FG000|Follow-up Period|Protocol driven decision point|47|||
149048762|NCT00901901|537659498|FG001|Follow-up Period|Protocol driven decision point|36|||
149048763|NCT00901901|537659497|FG000|Follow-up Period|Withdrawal by Subject|6|||
149048764|NCT00901901|537659498|FG001|Follow-up Period|Withdrawal by Subject|9|||
149048765|NCT00901901|537659497|FG000|Follow-up Period|Lost to Follow-up|12|||
149048766|NCT00901901|537659498|FG001|Follow-up Period|Lost to Follow-up|8|||
149048767|NCT00901901|537659497|FG000|Follow-up Period|Missing|94|||
149048768|NCT00901901|537659498|FG001|Follow-up Period|Missing|80|||
149048769|NCT00073749|537659499|FG000|Overall Study|Disease Progression|2|||
149048770|NCT00073749|537659500|FG001|Overall Study|Disease Progression|0|||
149048771|NCT00073749|537659501|FG002|Overall Study|Disease Progression|3|||
149048772|NCT00073749|537659502|FG003|Overall Study|Disease Progression|2|||
149048773|NCT00073749|537659503|FG004|Overall Study|Disease Progression|3|||
149048774|NCT00073749|537659504|FG005|Overall Study|Disease Progression|1|||
149048775|NCT00073749|537659505|FG006|Overall Study|Disease Progression|3|||
149048776|NCT00073749|537659499|FG000|Overall Study|Death|0|||
149048777|NCT00073749|537659500|FG001|Overall Study|Death|1|||
149048778|NCT00073749|537659501|FG002|Overall Study|Death|1|||
149048779|NCT00073749|537659502|FG003|Overall Study|Death|0|||
149048780|NCT00073749|537659503|FG004|Overall Study|Death|0|||
149048781|NCT00073749|537659504|FG005|Overall Study|Death|0|||
149048782|NCT00073749|537659505|FG006|Overall Study|Death|29|||
149048783|NCT00073749|537659499|FG000|Overall Study|Adverse Event|0|||
149048784|NCT00073749|537659500|FG001|Overall Study|Adverse Event|3|||
149048785|NCT00073749|537659501|FG002|Overall Study|Adverse Event|6|||
149048786|NCT00073749|537659502|FG003|Overall Study|Adverse Event|4|||
149048787|NCT00073749|537659503|FG004|Overall Study|Adverse Event|2|||
149048788|NCT00073749|537659504|FG005|Overall Study|Adverse Event|1|||
149048789|NCT00073749|537659505|FG006|Overall Study|Adverse Event|0|||
149048790|NCT00073749|537659499|FG000|Overall Study|Physician Decision|0|||
149048791|NCT00073749|537659500|FG001|Overall Study|Physician Decision|0|||
149048792|NCT00073749|537659501|FG002|Overall Study|Physician Decision|1|||
149048793|NCT00073749|537659502|FG003|Overall Study|Physician Decision|0|||
149048794|NCT00073749|537659503|FG004|Overall Study|Physician Decision|0|||
149048795|NCT00073749|537659504|FG005|Overall Study|Physician Decision|2|||
149048796|NCT00073749|537659505|FG006|Overall Study|Physician Decision|0|||
149048797|NCT00073749|537659499|FG000|Overall Study|Withdrawal by Subject|0|||
149048798|NCT00073749|537659500|FG001|Overall Study|Withdrawal by Subject|1|||
149048799|NCT00073749|537659501|FG002|Overall Study|Withdrawal by Subject|0|||
149048800|NCT00073749|537659502|FG003|Overall Study|Withdrawal by Subject|0|||
149048801|NCT00073749|537659503|FG004|Overall Study|Withdrawal by Subject|1|||
149048802|NCT00073749|537659504|FG005|Overall Study|Withdrawal by Subject|0|||
149048803|NCT00073749|537659505|FG006|Overall Study|Withdrawal by Subject|2|||
149048804|NCT00073749|537659499|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
149048805|NCT00073749|537659500|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
149048806|NCT00073749|537659501|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
149048807|NCT00073749|537659502|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
148885836|NCT02940496|537060252|FG001|Overall Study|No MRE Done|0|||
148885837|NCT02940496|537060251|FG000|Overall Study|MRE Failure|1|||
149048808|NCT00073749|537659503|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
149048809|NCT00073749|537659504|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
149048810|NCT00073749|537659505|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
149048811|NCT00073749|537659499|FG000|Overall Study|Lost to Follow-up|0|||
149048812|NCT00073749|537659500|FG001|Overall Study|Lost to Follow-up|0|||
149048813|NCT00073749|537659501|FG002|Overall Study|Lost to Follow-up|0|||
149048814|NCT00073749|537659502|FG003|Overall Study|Lost to Follow-up|0|||
149048815|NCT00073749|537659503|FG004|Overall Study|Lost to Follow-up|0|||
149048816|NCT00073749|537659504|FG005|Overall Study|Lost to Follow-up|0|||
149048817|NCT00073749|537659505|FG006|Overall Study|Lost to Follow-up|2|||
149048818|NCT00073749|537659499|FG000|Overall Study|Other|0|||
149048819|NCT00073749|537659500|FG001|Overall Study|Other|0|||
149048820|NCT00073749|537659501|FG002|Overall Study|Other|0|||
149048821|NCT00073749|537659502|FG003|Overall Study|Other|0|||
149048822|NCT00073749|537659503|FG004|Overall Study|Other|0|||
149048823|NCT00073749|537659504|FG005|Overall Study|Other|2|||
149048824|NCT00073749|537659505|FG006|Overall Study|Other|0|||
149048825|NCT00632749|537659506|FG000|Overall Study|Progressive disease|3|||
149048826|NCT00632749|537659507|FG001|Overall Study|Progressive disease|2|||
149048827|NCT00632749|537659508|FG002|Overall Study|Progressive disease|2|||
149048828|NCT00632749|537659509|FG003|Overall Study|Progressive disease|2|||
149048829|NCT00632749|537659510|FG004|Overall Study|Progressive disease|4|||
149048830|NCT00632749|537659511|FG005|Overall Study|Progressive disease|4|||
149048831|NCT00632749|537659512|FG006|Overall Study|Progressive disease|3|||
149048832|NCT00632749|537659513|FG007|Overall Study|Progressive disease|2|||
149048833|NCT00632749|537659514|FG008|Overall Study|Progressive disease|3|||
149048834|NCT00632749|537659515|FG009|Overall Study|Progressive disease|2|||
149048835|NCT00632749|537659516|FG010|Overall Study|Progressive disease|4|||
149048836|NCT00632749|537659517|FG011|Overall Study|Progressive disease|3|||
149048837|NCT00632749|537659518|FG012|Overall Study|Progressive disease|2|||
149048838|NCT00632749|537659519|FG013|Overall Study|Progressive disease|4|||
149048839|NCT00632749|537659506|FG000|Overall Study|Other Adverse event|1|||
149048840|NCT00632749|537659507|FG001|Overall Study|Other Adverse event|1|||
149048841|NCT00632749|537659508|FG002|Overall Study|Other Adverse event|1|||
149048842|NCT00632749|537659509|FG003|Overall Study|Other Adverse event|1|||
149048843|NCT00632749|537659510|FG004|Overall Study|Other Adverse event|2|||
149048844|NCT00632749|537659511|FG005|Overall Study|Other Adverse event|4|||
149048845|NCT00632749|537659512|FG006|Overall Study|Other Adverse event|1|||
149048846|NCT00632749|537659513|FG007|Overall Study|Other Adverse event|2|||
149048847|NCT00632749|537659514|FG008|Overall Study|Other Adverse event|2|||
149048848|NCT00632749|537659515|FG009|Overall Study|Other Adverse event|0|||
149048849|NCT00632749|537659516|FG010|Overall Study|Other Adverse event|1|||
149048850|NCT00632749|537659517|FG011|Overall Study|Other Adverse event|0|||
149048851|NCT00632749|537659518|FG012|Overall Study|Other Adverse event|1|||
149048852|NCT00632749|537659519|FG013|Overall Study|Other Adverse event|0|||
149048853|NCT00632749|537659506|FG000|Overall Study|Refuse to continue medication|0|||
149048854|NCT00632749|537659507|FG001|Overall Study|Refuse to continue medication|0|||
149048855|NCT00632749|537659508|FG002|Overall Study|Refuse to continue medication|0|||
149048856|NCT00632749|537659509|FG003|Overall Study|Refuse to continue medication|1|||
149048857|NCT00632749|537659510|FG004|Overall Study|Refuse to continue medication|0|||
149048858|NCT00632749|537659511|FG005|Overall Study|Refuse to continue medication|0|||
149048859|NCT00632749|537659512|FG006|Overall Study|Refuse to continue medication|0|||
149048860|NCT00632749|537659513|FG007|Overall Study|Refuse to continue medication|0|||
149048861|NCT00632749|537659514|FG008|Overall Study|Refuse to continue medication|0|||
149048862|NCT00632749|537659515|FG009|Overall Study|Refuse to continue medication|1|||
149048863|NCT00632749|537659516|FG010|Overall Study|Refuse to continue medication|0|||
149048864|NCT00632749|537659517|FG011|Overall Study|Refuse to continue medication|0|||
149048865|NCT00632749|537659518|FG012|Overall Study|Refuse to continue medication|0|||
149048866|NCT00632749|537659519|FG013|Overall Study|Refuse to continue medication|0|||
149048867|NCT00632749|537659506|FG000|Overall Study|Reason other than those specified above|0|||
149048868|NCT00632749|537659507|FG001|Overall Study|Reason other than those specified above|2|||
149048869|NCT00632749|537659508|FG002|Overall Study|Reason other than those specified above|0|||
149048870|NCT00632749|537659509|FG003|Overall Study|Reason other than those specified above|0|||
149048871|NCT00632749|537659510|FG004|Overall Study|Reason other than those specified above|1|||
149048872|NCT00632749|537659511|FG005|Overall Study|Reason other than those specified above|0|||
149048873|NCT00632749|537659512|FG006|Overall Study|Reason other than those specified above|1|||
149048874|NCT00632749|537659513|FG007|Overall Study|Reason other than those specified above|0|||
149048875|NCT00632749|537659514|FG008|Overall Study|Reason other than those specified above|0|||
149048876|NCT00632749|537659515|FG009|Overall Study|Reason other than those specified above|0|||
149048877|NCT00632749|537659516|FG010|Overall Study|Reason other than those specified above|2|||
149048878|NCT00632749|537659517|FG011|Overall Study|Reason other than those specified above|1|||
149048879|NCT00632749|537659518|FG012|Overall Study|Reason other than those specified above|0|||
148885838|NCT02940496|537060252|FG001|Overall Study|MRE Failure|0|||
148885839|NCT02586727|537060253|FG000|Overall Study|Lost to Follow-up|1|||
148885840|NCT02586727|537060254|FG001|Overall Study|Lost to Follow-up|0|||
148885841|NCT05973006|537060255|FG000|Overall Study|Early termination|3|||
148885842|NCT05973006|537060256|FG001|Overall Study|Early termination|9|||
148885843|NCT05167825|537060257|FG000|Overall Study|Ongoing|3|||
148885844|NCT02326597|537060266|FG000|Overall Study|Lost to Follow-up|42|||
149048880|NCT00632749|537659519|FG013|Overall Study|Reason other than those specified above|2|||
149048881|NCT04999592|537659520|FG000|Overall Study|Withdrawal by Subject|1|||
149048882|NCT04999592|537659521|FG001|Overall Study|Withdrawal by Subject|0|||
149048883|NCT02671435|537659530|FG000|Overall Study|Death|1|||
149048884|NCT02671435|537659531|FG001|Overall Study|Death|3|||
149048885|NCT02671435|537659532|FG002|Overall Study|Death|0|||
149048886|NCT02671435|537659533|FG003|Overall Study|Death|16|||
149048887|NCT02671435|537659534|FG004|Overall Study|Death|14|||
149048888|NCT02671435|537659535|FG005|Overall Study|Death|29|||
148885845|NCT02326597|537060267|FG001|Overall Study|Lost to Follow-up|32|||
148885846|NCT04089761|537060270|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
149048889|NCT02671435|537659536|FG006|Overall Study|Death|34|||
149048890|NCT02671435|537659537|FG007|Overall Study|Death|28|||
149048891|NCT02671435|537659538|FG008|Overall Study|Death|19|||
149048892|NCT02671435|537659539|FG009|Overall Study|Death|10|||
148885847|NCT04089761|537060270|FG000|"Run In Phase"|Lost to Follow-up|1|||
148885848|NCT04089761|537060270|FG000|"Treatment Phase"|No evaluable data|5|||
148885849|NCT04089761|537060270|FG000|"Treatment Phase"|Lost to Follow-up|1|||
148885850|NCT00770601|537060271|FG000|Overall Study|Withdrawal by Subject|1|||
148885851|NCT00428948|537060273|FG000|Overall Study|Lost to Follow-up|15|||
148885852|NCT00428948|537060274|FG001|Overall Study|Lost to Follow-up|8|||
148885853|NCT00428948|537060273|FG000|Overall Study|Adverse Event|148|||
148885854|NCT00428948|537060274|FG001|Overall Study|Adverse Event|24|||
148885855|NCT00428948|537060273|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
148885856|NCT00428948|537060274|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
148885857|NCT00428948|537060273|FG000|Overall Study|Investigator Withdrew Subject|3|||
148885858|NCT00428948|537060274|FG001|Overall Study|Investigator Withdrew Subject|4|||
148885859|NCT00428948|537060273|FG000|Overall Study|Subject Withdrew Consent|50|||
148885860|NCT00428948|537060274|FG001|Overall Study|Subject Withdrew Consent|30|||
148885861|NCT00428948|537060273|FG000|Overall Study|Protocol Deviation|1|||
148885862|NCT00428948|537060274|FG001|Overall Study|Protocol Deviation|1|||
148885863|NCT03201419|537060277|FG000|Overall Study|Adverse Event|3|||
148885864|NCT03201419|537060278|FG001|Overall Study|Adverse Event|1|||
149048893|NCT02671435|537659540|FG010|Overall Study|Death|8|||
149048894|NCT02671435|537659541|FG011|Overall Study|Death|29|||
149048895|NCT02671435|537659542|FG012|Overall Study|Death|29|||
149048896|NCT02671435|537659543|FG013|Overall Study|Death|29|||
149048897|NCT02671435|537659544|FG014|Overall Study|Death|27|||
149048898|NCT02671435|537659530|FG000|Overall Study|Lost to Follow-up|0|||
149048899|NCT02671435|537659531|FG001|Overall Study|Lost to Follow-up|0|||
149048900|NCT02671435|537659532|FG002|Overall Study|Lost to Follow-up|1|||
149048901|NCT02671435|537659533|FG003|Overall Study|Lost to Follow-up|0|||
149048902|NCT02671435|537659534|FG004|Overall Study|Lost to Follow-up|1|||
149048903|NCT02671435|537659535|FG005|Overall Study|Lost to Follow-up|1|||
149048904|NCT02671435|537659536|FG006|Overall Study|Lost to Follow-up|2|||
149048905|NCT02671435|537659537|FG007|Overall Study|Lost to Follow-up|2|||
149048906|NCT02671435|537659538|FG008|Overall Study|Lost to Follow-up|0|||
149048907|NCT02671435|537659539|FG009|Overall Study|Lost to Follow-up|2|||
149048908|NCT02671435|537659540|FG010|Overall Study|Lost to Follow-up|0|||
149048909|NCT02671435|537659541|FG011|Overall Study|Lost to Follow-up|3|||
149048910|NCT02671435|537659542|FG012|Overall Study|Lost to Follow-up|3|||
149048911|NCT02671435|537659543|FG013|Overall Study|Lost to Follow-up|2|||
149048912|NCT02671435|537659544|FG014|Overall Study|Lost to Follow-up|0|||
149048913|NCT02671435|537659530|FG000|Overall Study|Withdrawal by Subject|2|||
149048914|NCT02671435|537659531|FG001|Overall Study|Withdrawal by Subject|0|||
149048915|NCT02671435|537659532|FG002|Overall Study|Withdrawal by Subject|2|||
149048916|NCT02671435|537659533|FG003|Overall Study|Withdrawal by Subject|2|||
149048917|NCT02671435|537659534|FG004|Overall Study|Withdrawal by Subject|2|||
149048918|NCT02671435|537659535|FG005|Overall Study|Withdrawal by Subject|7|||
149048919|NCT02671435|537659536|FG006|Overall Study|Withdrawal by Subject|2|||
149048920|NCT02671435|537659537|FG007|Overall Study|Withdrawal by Subject|7|||
149048921|NCT02671435|537659538|FG008|Overall Study|Withdrawal by Subject|1|||
149048922|NCT02671435|537659539|FG009|Overall Study|Withdrawal by Subject|1|||
149048923|NCT02671435|537659540|FG010|Overall Study|Withdrawal by Subject|2|||
149048924|NCT02671435|537659541|FG011|Overall Study|Withdrawal by Subject|4|||
149048925|NCT02671435|537659542|FG012|Overall Study|Withdrawal by Subject|4|||
149048926|NCT02671435|537659543|FG013|Overall Study|Withdrawal by Subject|4|||
149048927|NCT02671435|537659544|FG014|Overall Study|Withdrawal by Subject|2|||
149048928|NCT02671435|537659530|FG000|Overall Study|Un-specified|0|||
149048929|NCT02671435|537659531|FG001|Overall Study|Un-specified|0|||
149048930|NCT02671435|537659532|FG002|Overall Study|Un-specified|0|||
149048931|NCT02671435|537659533|FG003|Overall Study|Un-specified|0|||
148885865|NCT03201419|537060279|FG002|Overall Study|Adverse Event|0|||
148885866|NCT03201419|537060280|FG003|Overall Study|Adverse Event|0|||
148885867|NCT03201419|537060281|FG004|Overall Study|Adverse Event|1|||
148885868|NCT03201419|537060282|FG005|Overall Study|Adverse Event|1|||
148885869|NCT03201419|537060283|FG006|Overall Study|Adverse Event|5|||
149048932|NCT02671435|537659534|FG004|Overall Study|Un-specified|1|||
149048933|NCT02671435|537659535|FG005|Overall Study|Un-specified|3|||
149048934|NCT02671435|537659536|FG006|Overall Study|Un-specified|2|||
148885870|NCT03201419|537060284|FG007|Overall Study|Adverse Event|0|||
148885871|NCT03201419|537060285|FG008|Overall Study|Adverse Event|0|||
149048935|NCT02671435|537659537|FG007|Overall Study|Un-specified|3|||
149048936|NCT02671435|537659538|FG008|Overall Study|Un-specified|0|||
149048937|NCT02671435|537659539|FG009|Overall Study|Un-specified|5|||
149048938|NCT02671435|537659540|FG010|Overall Study|Un-specified|8|||
148885872|NCT03201419|537060277|FG000|Overall Study|Lost to Follow-up|1|||
149048939|NCT02671435|537659541|FG011|Overall Study|Un-specified|4|||
149048940|NCT02671435|537659542|FG012|Overall Study|Un-specified|5|||
149048941|NCT02671435|537659543|FG013|Overall Study|Un-specified|9|||
149048942|NCT02671435|537659544|FG014|Overall Study|Un-specified|8|||
149048943|NCT04095104|537659545|FG000|Overall Study|Withdrawal by Subject|0|||
149048944|NCT04095104|537659546|FG001|Overall Study|Withdrawal by Subject|1|||
149048945|NCT05048186|537659549|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
149048946|NCT05048186|537659550|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
149048947|NCT05048186|537659549|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
149048948|NCT05048186|537659550|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
149048949|NCT00976937|537659551|FG000|Overall Study|Adverse Event|4|||
149048950|NCT00976937|537659552|FG001|Overall Study|Adverse Event|5|||
149048951|NCT00976937|537659551|FG000|Overall Study|Lost to Follow-up|2|||
149048952|NCT00976937|537659552|FG001|Overall Study|Lost to Follow-up|1|||
149048953|NCT00976937|537659551|FG000|Overall Study|Withdrawal by Subject|5|||
149048954|NCT00976937|537659552|FG001|Overall Study|Withdrawal by Subject|3|||
149048955|NCT00976937|537659551|FG000|Overall Study|Poor compliance to protocol|3|||
149048956|NCT00976937|537659552|FG001|Overall Study|Poor compliance to protocol|0|||
149048957|NCT00976937|537659551|FG000|Overall Study|Personal and Familial Reason|2|||
149048958|NCT00976937|537659552|FG001|Overall Study|Personal and Familial Reason|2|||
149048959|NCT03069313|537659553|FG000|Overall Study|Adverse Event|5|||
149048960|NCT04218266|537659554|FG000|Overall Study|Death|1|||
149048961|NCT04218266|537659555|FG001|Overall Study|Death|2|||
149048962|NCT04218266|537659556|FG002|Overall Study|Death|3|||
149048963|NCT04218266|537659554|FG000|Overall Study|Adverse Event|13|||
149048964|NCT04218266|537659555|FG001|Overall Study|Adverse Event|14|||
149048965|NCT04218266|537659556|FG002|Overall Study|Adverse Event|11|||
149048966|NCT04218266|537659554|FG000|Overall Study|Other|7|||
149048967|NCT04218266|537659555|FG001|Overall Study|Other|5|||
149048968|NCT04218266|537659556|FG002|Overall Study|Other|14|||
149048969|NCT04218266|537659554|FG000|Overall Study|Physician Decision|1|||
149048970|NCT04218266|537659555|FG001|Overall Study|Physician Decision|3|||
149048971|NCT04218266|537659556|FG002|Overall Study|Physician Decision|2|||
149048972|NCT04218266|537659554|FG000|Overall Study|Non-compliance with study drug|0|||
149048973|NCT04218266|537659555|FG001|Overall Study|Non-compliance with study drug|0|||
149048974|NCT04218266|537659556|FG002|Overall Study|Non-compliance with study drug|1|||
149048975|NCT04218266|537659554|FG000|Overall Study|Withdrawal by Subject|1|||
149048976|NCT04218266|537659555|FG001|Overall Study|Withdrawal by Subject|3|||
149048977|NCT04218266|537659556|FG002|Overall Study|Withdrawal by Subject|1|||
149048978|NCT04218266|537659554|FG000|Overall Study|Study drug never administered|2|||
149048979|NCT04218266|537659555|FG001|Overall Study|Study drug never administered|0|||
149048980|NCT04218266|537659556|FG002|Overall Study|Study drug never administered|0|||
149048981|NCT01011946|537659558|FG000|Overall Study|Transferred to another hospital|2|||
149048982|NCT01011946|537659558|FG000|Overall Study|No pathological lab value|1|||
149048983|NCT01227265|537659560|FG000|Overall Study|Did Not Receive Treatment|1|||
149048984|NCT01227265|537659561|FG001|Overall Study|Did Not Receive Treatment|2|||
149048985|NCT01227265|537659562|FG002|Overall Study|Did Not Receive Treatment|0|||
149048986|NCT01227265|537659560|FG000|Overall Study|Administrative|1|||
149048987|NCT01227265|537659561|FG001|Overall Study|Administrative|0|||
148885873|NCT03201419|537060278|FG001|Overall Study|Lost to Follow-up|0|||
148885874|NCT03201419|537060279|FG002|Overall Study|Lost to Follow-up|0|||
148885875|NCT03201419|537060280|FG003|Overall Study|Lost to Follow-up|0|||
148885876|NCT03201419|537060281|FG004|Overall Study|Lost to Follow-up|0|||
148885877|NCT03201419|537060282|FG005|Overall Study|Lost to Follow-up|0|||
148885878|NCT03201419|537060283|FG006|Overall Study|Lost to Follow-up|0|||
148885879|NCT03201419|537060284|FG007|Overall Study|Lost to Follow-up|0|||
148885880|NCT03201419|537060285|FG008|Overall Study|Lost to Follow-up|0|||
148885881|NCT03201419|537060277|FG000|Overall Study|Protocol Deviation|0|||
148885882|NCT03201419|537060278|FG001|Overall Study|Protocol Deviation|0|||
148885883|NCT03201419|537060279|FG002|Overall Study|Protocol Deviation|0|||
148885884|NCT03201419|537060280|FG003|Overall Study|Protocol Deviation|0|||
148885885|NCT03201419|537060281|FG004|Overall Study|Protocol Deviation|0|||
148885886|NCT03201419|537060282|FG005|Overall Study|Protocol Deviation|0|||
148885887|NCT03201419|537060283|FG006|Overall Study|Protocol Deviation|1|||
148885888|NCT03201419|537060284|FG007|Overall Study|Protocol Deviation|0|||
148885889|NCT03201419|537060285|FG008|Overall Study|Protocol Deviation|0|||
148885890|NCT03201419|537060277|FG000|Overall Study|Withdrawal by Subject|4|||
149048988|NCT01227265|537659562|FG002|Overall Study|Administrative|2|||
149048989|NCT01227265|537659560|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
149048990|NCT01227265|537659561|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
149048991|NCT01227265|537659562|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
149048992|NCT01227265|537659560|FG000|Overall Study|Protocol Violation|2|||
149048993|NCT01227265|537659561|FG001|Overall Study|Protocol Violation|1|||
148885891|NCT03201419|537060278|FG001|Overall Study|Withdrawal by Subject|2|||
148885892|NCT03201419|537060279|FG002|Overall Study|Withdrawal by Subject|1|||
148885893|NCT03201419|537060280|FG003|Overall Study|Withdrawal by Subject|0|||
148885894|NCT03201419|537060281|FG004|Overall Study|Withdrawal by Subject|0|||
148885895|NCT03201419|537060282|FG005|Overall Study|Withdrawal by Subject|0|||
149048994|NCT01227265|537659562|FG002|Overall Study|Protocol Violation|0|||
149048995|NCT01227265|537659560|FG000|Overall Study|Withdrawal by Subject|7|||
148885896|NCT03201419|537060283|FG006|Overall Study|Withdrawal by Subject|0|||
148885897|NCT03201419|537060284|FG007|Overall Study|Withdrawal by Subject|1|||
148885898|NCT03201419|537060285|FG008|Overall Study|Withdrawal by Subject|2|||
148885899|NCT03201419|537060277|FG000|Overall Study|Other|0|||
148885900|NCT03201419|537060278|FG001|Overall Study|Other|0|||
148885901|NCT03201419|537060279|FG002|Overall Study|Other|1|||
148885902|NCT03201419|537060280|FG003|Overall Study|Other|0|||
148885903|NCT03201419|537060281|FG004|Overall Study|Other|0|||
148885904|NCT03201419|537060282|FG005|Overall Study|Other|0|||
148885905|NCT03201419|537060283|FG006|Overall Study|Other|0|||
148885906|NCT03201419|537060284|FG007|Overall Study|Other|0|||
148885907|NCT03201419|537060285|FG008|Overall Study|Other|0|||
148885908|NCT05907395|537060286|FG000|Period 1|No longer met eligibility criteria|0|||
148885909|NCT05907395|537060287|FG001|Period 1|No longer met eligibility criteria|1|||
148885910|NCT05907395|537060288|FG002|Period 1|No longer met eligibility criteria|0|||
148885911|NCT05907395|537060289|FG003|Period 1|No longer met eligibility criteria|0|||
148885912|NCT05907395|537060290|FG004|Period 1|No longer met eligibility criteria|0|||
148885913|NCT05907395|537060291|FG005|Period 1|No longer met eligibility criteria|1|||
148885914|NCT05907395|537060292|FG006|Period 1|No longer met eligibility criteria|1|||
148885915|NCT05907395|537060293|FG007|Period 1|No longer met eligibility criteria|0|||
148885916|NCT05907395|537060294|FG008|Period 1|No longer met eligibility criteria|0|||
148885917|NCT05907395|537060295|FG009|Period 1|No longer met eligibility criteria|0|||
148885918|NCT05907395|537060296|FG010|Period 1|No longer met eligibility criteria|0|||
148885919|NCT05907395|537060297|FG011|Period 1|No longer met eligibility criteria|0|||
148885920|NCT05907395|537060286|FG000|Period 2|Adverse Event|0|||
148885921|NCT05907395|537060287|FG001|Period 2|Adverse Event|0|||
148885922|NCT05907395|537060288|FG002|Period 2|Adverse Event|0|||
148885923|NCT05907395|537060289|FG003|Period 2|Adverse Event|1|||
148885924|NCT05907395|537060290|FG004|Period 2|Adverse Event|0|||
148885925|NCT05907395|537060291|FG005|Period 2|Adverse Event|0|||
148885926|NCT05907395|537060292|FG006|Period 2|Adverse Event|0|||
148885927|NCT05907395|537060293|FG007|Period 2|Adverse Event|1|||
148885928|NCT05907395|537060294|FG008|Period 2|Adverse Event|0|||
148885929|NCT05907395|537060295|FG009|Period 2|Adverse Event|0|||
148885930|NCT05907395|537060296|FG010|Period 2|Adverse Event|0|||
148885931|NCT05907395|537060297|FG011|Period 2|Adverse Event|0|||
148885932|NCT05907395|537060286|FG000|Period 2|Personal reason|0|||
148885933|NCT05907395|537060287|FG001|Period 2|Personal reason|0|||
148885934|NCT05907395|537060288|FG002|Period 2|Personal reason|0|||
148885935|NCT05907395|537060289|FG003|Period 2|Personal reason|0|||
148885936|NCT05907395|537060290|FG004|Period 2|Personal reason|0|||
148885937|NCT05907395|537060291|FG005|Period 2|Personal reason|0|||
148885938|NCT05907395|537060292|FG006|Period 2|Personal reason|0|||
148885939|NCT05907395|537060293|FG007|Period 2|Personal reason|0|||
148885940|NCT05907395|537060294|FG008|Period 2|Personal reason|0|||
148885941|NCT05907395|537060295|FG009|Period 2|Personal reason|1|||
148885942|NCT05907395|537060296|FG010|Period 2|Personal reason|0|||
148885943|NCT05907395|537060297|FG011|Period 2|Personal reason|0|||
148885944|NCT05907395|537060286|FG000|Period 3|Adverse Event|0|||
148885945|NCT05907395|537060287|FG001|Period 3|Adverse Event|0|||
148885946|NCT05907395|537060288|FG002|Period 3|Adverse Event|0|||
148885947|NCT05907395|537060289|FG003|Period 3|Adverse Event|0|||
148885948|NCT05907395|537060290|FG004|Period 3|Adverse Event|1|||
148885949|NCT05907395|537060291|FG005|Period 3|Adverse Event|0|||
148885950|NCT05907395|537060292|FG006|Period 3|Adverse Event|0|||
148885951|NCT05907395|537060293|FG007|Period 3|Adverse Event|0|||
148885952|NCT05907395|537060294|FG008|Period 3|Adverse Event|0|||
148885953|NCT05907395|537060295|FG009|Period 3|Adverse Event|0|||
148885954|NCT05907395|537060296|FG010|Period 3|Adverse Event|0|||
149048996|NCT01227265|537659561|FG001|Overall Study|Withdrawal by Subject|7|||
149048997|NCT01227265|537659562|FG002|Overall Study|Withdrawal by Subject|3|||
149048998|NCT01227265|537659560|FG000|Overall Study|Lost to Follow-up|2|||
149048999|NCT01227265|537659561|FG001|Overall Study|Lost to Follow-up|0|||
148885955|NCT05907395|537060297|FG011|Period 3|Adverse Event|0|||
149049000|NCT01227265|537659562|FG002|Overall Study|Lost to Follow-up|3|||
148885956|NCT04544956|537060298|FG000|Overall Study|Withdrawal by Subject|1|||
148885957|NCT02119663|537060299|FG000|Overall Study|Disease progression|26|||
148885958|NCT02119663|537060300|FG001|Overall Study|Disease progression|27|||
148885959|NCT02119663|537060299|FG000|Overall Study|Adverse Event|5|||
148885960|NCT02119663|537060300|FG001|Overall Study|Adverse Event|5|||
148885961|NCT02119663|537060299|FG000|Overall Study|Death|3|||
148885962|NCT02119663|537060300|FG001|Overall Study|Death|2|||
148885963|NCT02119663|537060299|FG000|Overall Study|Physician Decision|1|||
148885964|NCT02119663|537060300|FG001|Overall Study|Physician Decision|2|||
148885965|NCT02119663|537060299|FG000|Overall Study|Other unspecified|2|||
148885966|NCT02119663|537060300|FG001|Overall Study|Other unspecified|0|||
148885967|NCT02119663|537060299|FG000|Overall Study|Subject decision|0|||
148885968|NCT02119663|537060300|FG001|Overall Study|Subject decision|1|||
148885969|NCT02119663|537060299|FG000|Overall Study|Study Terminated by the Sponsor|3|||
148885970|NCT02119663|537060300|FG001|Overall Study|Study Terminated by the Sponsor|4|||
148885971|NCT00892775|537060301|FG000|Overall Study|Protocol Violation|1|||
148885972|NCT00892775|537060302|FG001|Overall Study|Protocol Violation|0|||
148885973|NCT00892775|537060301|FG000|Overall Study|Subject difficulties with blood drawing|1|||
148885974|NCT00892775|537060302|FG001|Overall Study|Subject difficulties with blood drawing|0|||
148885975|NCT00892775|537060301|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
148885976|NCT00892775|537060302|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
148885977|NCT00892775|537060301|FG000|Overall Study|Migrated/ moved from study area|1|||
148885978|NCT00892775|537060302|FG001|Overall Study|Migrated/ moved from study area|0|||
148885979|NCT00892775|537060301|FG000|Overall Study|Withdrawal by Subject|0|||
148885980|NCT00892775|537060302|FG001|Overall Study|Withdrawal by Subject|1|||
148885981|NCT00892775|537060301|FG000|Overall Study|Lost to Follow-up|1|||
148885982|NCT00892775|537060302|FG001|Overall Study|Lost to Follow-up|0|||
148885983|NCT00699660|537060303|FG000|Overall Study|Lost to Follow-up|4|||
148885984|NCT00699660|537060304|FG001|Overall Study|Lost to Follow-up|2|||
148885985|NCT00699660|537060303|FG000|Overall Study|missing reports and recording failures|10|||
148885986|NCT00699660|537060304|FG001|Overall Study|missing reports and recording failures|6|||
148885987|NCT00103740|537060309|FG000|Period 1 - Core|Adverse Event|1|||
148885988|NCT00103740|537060310|FG001|Period 1 - Core|Adverse Event|0|||
148885989|NCT00103740|537060309|FG000|Period 1 - Core|Protocol Violation|3|||
148885990|NCT00103740|537060310|FG001|Period 1 - Core|Protocol Violation|2|||
148885991|NCT00103740|537060309|FG000|Period 1 - Core|Patient withdrew consent|3|||
148885992|NCT00103740|537060310|FG001|Period 1 - Core|Patient withdrew consent|2|||
148885993|NCT00103740|537060309|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
148885994|NCT00103740|537060310|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
148885995|NCT00103740|537060309|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
148885996|NCT00103740|537060310|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
148885997|NCT00103740|537060309|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
148885998|NCT00103740|537060310|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
148885999|NCT00103740|537060309|FG000|Period 2 - Extended Observation Period|Death|6|||
148886000|NCT00103740|537060310|FG001|Period 2 - Extended Observation Period|Death|2|||
148886001|NCT00103740|537060309|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
148886002|NCT00103740|537060310|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
148886003|NCT01223183|537060312|FG000|Imaging Day 1|Physician Decision|0|||
148886004|NCT01223183|537060313|FG001|Imaging Day 1|Physician Decision|1|||
148886005|NCT01223183|537060312|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
148886006|NCT01223183|537060313|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
148886007|NCT01223183|537060312|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
148886008|NCT01223183|537060313|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
148886009|NCT03772665|537060314|FG000|Overall Study|Protocol Violation|1|||
148886010|NCT03772665|537060315|FG001|Overall Study|Protocol Violation|0|||
148886011|NCT00163020|537060316|FG000|Overall Study|Lost to Follow-up|0|||
148886012|NCT00163020|537060317|FG001|Overall Study|Lost to Follow-up|2|||
148886013|NCT01633788|537062250|FG000|Overall Study|Adverse Event|1|||
148886014|NCT01633788|537062251|FG001|Overall Study|Adverse Event|3|||
148886015|NCT01633788|537062252|FG002|Overall Study|Adverse Event|3|||
148886016|NCT01633788|537062253|FG003|Overall Study|Adverse Event|3|||
148886017|NCT01633788|537062250|FG000|Overall Study|Lost to Follow-up|2|||
148886018|NCT01633788|537062251|FG001|Overall Study|Lost to Follow-up|2|||
148886019|NCT01633788|537062252|FG002|Overall Study|Lost to Follow-up|2|||
148886020|NCT01633788|537062253|FG003|Overall Study|Lost to Follow-up|0|||
148886021|NCT01633788|537062250|FG000|Overall Study|Personal Reasons|3|||
148886022|NCT01633788|537062251|FG001|Overall Study|Personal Reasons|1|||
148886023|NCT01633788|537062252|FG002|Overall Study|Personal Reasons|1|||
148886024|NCT01633788|537062253|FG003|Overall Study|Personal Reasons|3|||
148886025|NCT01633788|537062250|FG000|Overall Study|Protocol Violation|1|||
148886026|NCT01633788|537062251|FG001|Overall Study|Protocol Violation|0|||
148886027|NCT01633788|537062252|FG002|Overall Study|Protocol Violation|1|||
148886028|NCT01633788|537062253|FG003|Overall Study|Protocol Violation|0|||
148886029|NCT01633788|537062250|FG000|Overall Study|Other Reasons|0|||
148886030|NCT01633788|537062251|FG001|Overall Study|Other Reasons|2|||
148886031|NCT01633788|537062252|FG002|Overall Study|Other Reasons|3|||
148886032|NCT01633788|537062253|FG003|Overall Study|Other Reasons|7|||
148886033|NCT01929226|537062254|FG000|Overall Study|Lost to Follow-up|4|||
148886034|NCT01929226|537062255|FG001|Overall Study|Lost to Follow-up|0|||
148886035|NCT01929226|537062254|FG000|Overall Study|Withdrawal by Subject|1|||
148886036|NCT01929226|537062255|FG001|Overall Study|Withdrawal by Subject|1|||
148886037|NCT03553758|537062256|FG000|Overall Study|Lost to Follow-up|1|||
149049001|NCT01227265|537659560|FG000|Overall Study|Adverse Event|6|||
148886038|NCT02640547|537062257|FG000|Overall Study|Failure to Return|1|||
148886039|NCT02640547|537062257|FG000|Overall Study|Withdrawal by Subject|1|||
148886040|NCT02640547|537062257|FG000|Overall Study|Death|6|||
148886041|NCT02640547|537062257|FG000|Overall Study|Miscellaneous|3|||
148886042|NCT02525588|537062258|FG000|Overall Study|Death|3|||
148886043|NCT02525588|537062259|FG001|Overall Study|Death|1|||
148886044|NCT02525588|537062258|FG000|Overall Study|Lost to Follow-up|2|||
148886045|NCT02525588|537062259|FG001|Overall Study|Lost to Follow-up|0|||
148886046|NCT02525588|537062258|FG000|Overall Study|Withdrawal by Subject|1|||
148886047|NCT02525588|537062259|FG001|Overall Study|Withdrawal by Subject|1|||
148886048|NCT02525588|537062258|FG000|Overall Study|Adverse Event|0|||
148886049|NCT02525588|537062259|FG001|Overall Study|Adverse Event|1|||
148886050|NCT03018691|537062260|FG000|Overall Study|Adverse Event|1|||
148886051|NCT03018691|537062261|FG001|Overall Study|Adverse Event|1|||
148886052|NCT03018691|537062262|FG002|Overall Study|Adverse Event|4|||
148886053|NCT03018691|537062260|FG000|Overall Study|Lack of Efficacy|0|||
148886054|NCT03018691|537062261|FG001|Overall Study|Lack of Efficacy|0|||
148886055|NCT03018691|537062262|FG002|Overall Study|Lack of Efficacy|1|||
148886056|NCT03018691|537062260|FG000|Overall Study|Withdrawal by Subject|0|||
148886057|NCT03018691|537062261|FG001|Overall Study|Withdrawal by Subject|0|||
148886058|NCT03018691|537062262|FG002|Overall Study|Withdrawal by Subject|1|||
148886059|NCT03018691|537062260|FG000|Overall Study|Withdrawal by parent/guardian|1|||
148886060|NCT03018691|537062261|FG001|Overall Study|Withdrawal by parent/guardian|0|||
148886061|NCT03018691|537062262|FG002|Overall Study|Withdrawal by parent/guardian|1|||
148886062|NCT03369418|537062264|FG000|Overall Study|Withdrawal by Subject|3|||
148886063|NCT03369418|537062265|FG001|Overall Study|Withdrawal by Subject|3|||
148886064|NCT01485094|537062266|FG000|Overall Study|Adverse Event|1|||
148886065|NCT01485094|537062267|FG001|Overall Study|Adverse Event|1|||
148886066|NCT01485094|537062268|FG002|Overall Study|Adverse Event|1|||
148886067|NCT01485094|537062266|FG000|Overall Study|Lost to Follow-up|1|||
148886068|NCT01485094|537062267|FG001|Overall Study|Lost to Follow-up|0|||
148886069|NCT01485094|537062268|FG002|Overall Study|Lost to Follow-up|0|||
148886070|NCT01485094|537062266|FG000|Overall Study|Withdrawal by Subject|1|||
148886071|NCT01485094|537062267|FG001|Overall Study|Withdrawal by Subject|1|||
148886072|NCT01485094|537062268|FG002|Overall Study|Withdrawal by Subject|0|||
148886073|NCT01172535|537062269|FG000|Overall Study|Death|3|||
148886074|NCT01172535|537062269|FG000|Overall Study|Withdrawal by Subject|2|||
148886075|NCT01172535|537062269|FG000|Overall Study|Lost to Follow-up|1|||
148886076|NCT01172535|537062269|FG000|Overall Study|Ineligible at study entry|1|||
148886077|NCT01172535|537062269|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
148886078|NCT03461146|537062277|FG000|Overall Study|Adverse Event|2|||
148886079|NCT03461146|537062277|FG000|Overall Study|Physician Decision|1|||
148886080|NCT02698826|537062282|FG000|Overall Study|Death|13|||
148886081|NCT02698826|537062282|FG000|Overall Study|Adverse Event|1|||
148886082|NCT02915263|537062287|FG000|Overall Study|Covid|3|||
148886083|NCT02915263|537062288|FG001|Overall Study|Covid|2|||
148886084|NCT02478463|537062289|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
148886085|NCT02478463|537062289|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
148886086|NCT02478463|537062289|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
148886087|NCT01879683|537062290|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
148886088|NCT01508169|537062291|FG000|Overall Study|Adverse Event|1|||
148886089|NCT01508169|537062292|FG001|Overall Study|Adverse Event|0|||
148886090|NCT01508169|537062291|FG000|Overall Study|Withdrawal by Subject|1|||
148886091|NCT01508169|537062292|FG001|Overall Study|Withdrawal by Subject|0|||
148886092|NCT01508169|537062291|FG000|Overall Study|Lost to Follow-up|1|||
148886093|NCT01508169|537062292|FG001|Overall Study|Lost to Follow-up|2|||
148886094|NCT03600740|537062301|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
148886095|NCT01702558|537062302|FG000|Overall Study|Withdrawal by Subject|0|||
148886096|NCT01702558|537062303|FG001|Overall Study|Withdrawal by Subject|0|||
148886097|NCT01702558|537062304|FG002|Overall Study|Withdrawal by Subject|0|||
148886098|NCT01702558|537062305|FG003|Overall Study|Withdrawal by Subject|12|||
148886099|NCT01702558|537062306|FG004|Overall Study|Withdrawal by Subject|4|||
148886100|NCT01702558|537062302|FG000|Overall Study|Lost to Follow-up|0|||
148886101|NCT01702558|537062303|FG001|Overall Study|Lost to Follow-up|0|||
148886102|NCT01702558|537062304|FG002|Overall Study|Lost to Follow-up|0|||
148886103|NCT01702558|537062305|FG003|Overall Study|Lost to Follow-up|3|||
148886104|NCT01702558|537062306|FG004|Overall Study|Lost to Follow-up|0|||
148886105|NCT01702558|537062302|FG000|Overall Study|Death|4|||
148886106|NCT01702558|537062303|FG001|Overall Study|Death|3|||
148886107|NCT01702558|537062304|FG002|Overall Study|Death|3|||
148886108|NCT01702558|537062305|FG003|Overall Study|Death|16|||
148886109|NCT01702558|537062306|FG004|Overall Study|Death|20|||
148886110|NCT01702558|537062302|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
148886111|NCT01702558|537062303|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
148886112|NCT01702558|537062304|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
148886113|NCT01702558|537062305|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
148886114|NCT01702558|537062306|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
148886115|NCT01702558|537062302|FG000|Overall Study|Study Terminated by Sponsor|0|||
148886116|NCT01702558|537062303|FG001|Overall Study|Study Terminated by Sponsor|1|||
148886117|NCT01702558|537062304|FG002|Overall Study|Study Terminated by Sponsor|0|||
148886118|NCT01702558|537062305|FG003|Overall Study|Study Terminated by Sponsor|0|||
148886119|NCT01702558|537062306|FG004|Overall Study|Study Terminated by Sponsor|1|||
148886120|NCT01702558|537062302|FG000|Overall Study|Other|0|||
148886121|NCT01702558|537062303|FG001|Overall Study|Other|0|||
148886122|NCT01702558|537062304|FG002|Overall Study|Other|0|||
148886123|NCT01702558|537062305|FG003|Overall Study|Other|16|||
148886124|NCT01702558|537062306|FG004|Overall Study|Other|17|||
148886125|NCT02396212|537062309|FG000|Overall Study|Adverse Event|1|||
148886126|NCT02396212|537062309|FG000|Overall Study|Lack of Efficacy|2|||
148886127|NCT01623115|537062310|FG000|Overall Study|Randomized but not treated|0|||
148886128|NCT01623115|537062311|FG001|Overall Study|Randomized but not treated|1|||
148886129|NCT01623115|537062310|FG000|Overall Study|Physician Decision|1|||
148886130|NCT01623115|537062311|FG001|Overall Study|Physician Decision|0|||
148886131|NCT01623115|537062310|FG000|Overall Study|Participants moved|1|||
148886132|NCT01623115|537062311|FG001|Overall Study|Participants moved|5|||
148886133|NCT01623115|537062310|FG000|Overall Study|Adverse Event|10|||
148886134|NCT01623115|537062311|FG001|Overall Study|Adverse Event|13|||
148886135|NCT01623115|537062310|FG000|Overall Study|Poor compliance to protocol|4|||
148886136|NCT01623115|537062311|FG001|Overall Study|Poor compliance to protocol|10|||
148886137|NCT01623115|537062310|FG000|Overall Study|Consent withdrawn by participant|2|||
148886138|NCT01623115|537062311|FG001|Overall Study|Consent withdrawn by participant|6|||
148886139|NCT01623115|537062310|FG000|Overall Study|Related to study drug administration|0|||
148886140|NCT01623115|537062311|FG001|Overall Study|Related to study drug administration|2|||
148886141|NCT01623115|537062310|FG000|Overall Study|Last visit outside protocol visit window|14|||
148886142|NCT01623115|537062311|FG001|Overall Study|Last visit outside protocol visit window|26|||
148886143|NCT01623115|537062310|FG000|Overall Study|Site closure|1|||
148886144|NCT01623115|537062311|FG001|Overall Study|Site closure|7|||
148886145|NCT01623115|537062310|FG000|Overall Study|Death|0|||
148886146|NCT01623115|537062311|FG001|Overall Study|Death|4|||
148886147|NCT01623115|537062310|FG000|Overall Study|Other than specified above|0|||
148886148|NCT01623115|537062311|FG001|Overall Study|Other than specified above|3|||
148886149|NCT04950465|537062312|FG000|Overall Study|Lost to Follow-up|1|||
148886150|NCT04950465|537062313|FG001|Overall Study|Lost to Follow-up|0|||
148886151|NCT04950465|537062314|FG002|Overall Study|Lost to Follow-up|0|||
148886152|NCT01338818|537062325|FG000|Overall Study|Adverse Event|8|||
148886153|NCT01338818|537062325|FG000|Overall Study|Lack of Efficacy|5|||
148886154|NCT01338818|537062325|FG000|Overall Study|no longer require study drug|1|||
148886155|NCT01338818|537062325|FG000|Overall Study|Withdrawal by Subject|11|||
148886156|NCT01338818|537062325|FG000|Overall Study|Lost to Follow-up|4|||
148886157|NCT01338818|537062325|FG000|Overall Study|Administrative problems|3|||
148886158|NCT01338818|537062325|FG000|Overall Study|Protocol Deviation|4|||
148886159|NCT01620086|537062326|FG000|Overall Study|Withdrawal by Subject|3|||
148886160|NCT01620086|537062327|FG001|Overall Study|Withdrawal by Subject|3|||
148886161|NCT01620086|537062328|FG002|Overall Study|Withdrawal by Subject|0|||
148886162|NCT01620086|537062326|FG000|Overall Study|failed study criteria|1|||
148886163|NCT01620086|537062327|FG001|Overall Study|failed study criteria|4|||
148886164|NCT01620086|537062328|FG002|Overall Study|failed study criteria|0|||
148886165|NCT01620086|537062326|FG000|Overall Study|Physician Decision|1|||
148886166|NCT01620086|537062327|FG001|Overall Study|Physician Decision|0|||
148886167|NCT01620086|537062328|FG002|Overall Study|Physician Decision|0|||
148886168|NCT00580723|537062334|FG000|Overall Study|Did not want to participate in extension|3|||
148886169|NCT00580723|537062334|FG000|Overall Study|Lost to Follow-up|5|||
148886170|NCT00556998|537062335|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
148886171|NCT00556998|537062335|FG000|Voriconazole Intravenous (IV)|Other|4|||
148886172|NCT00556998|537062335|FG000|Voriconazole Oral|Adverse Event|1|||
148886173|NCT00556998|537062335|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
148886174|NCT01425801|537062338|FG000|Period 1|Withdrawal by Subject|0|||
148886175|NCT01425801|537062339|FG001|Period 1|Withdrawal by Subject|0|||
148886176|NCT01425801|537062340|FG002|Period 1|Withdrawal by Subject|0|||
148886177|NCT01425801|537062341|FG003|Period 1|Withdrawal by Subject|0|||
148886178|NCT01425801|537062342|FG004|Period 1|Withdrawal by Subject|1|||
148886179|NCT01425801|537062343|FG005|Period 1|Withdrawal by Subject|0|||
148886180|NCT01425801|537062338|FG000|Period 2|Withdrawal by Subject|0|||
148886181|NCT01425801|537062339|FG001|Period 2|Withdrawal by Subject|0|||
148886182|NCT01425801|537062340|FG002|Period 2|Withdrawal by Subject|0|||
148886183|NCT01425801|537062341|FG003|Period 2|Withdrawal by Subject|0|||
148886184|NCT01425801|537062342|FG004|Period 2|Withdrawal by Subject|1|||
148886185|NCT01425801|537062343|FG005|Period 2|Withdrawal by Subject|0|||
148886186|NCT01425801|537062338|FG000|Period 3|Stability criteria not fullfilled|0|||
148886187|NCT01425801|537062339|FG001|Period 3|Stability criteria not fullfilled|0|||
148886188|NCT01425801|537062340|FG002|Period 3|Stability criteria not fullfilled|1|||
148886189|NCT01425801|537062341|FG003|Period 3|Stability criteria not fullfilled|0|||
148886190|NCT01425801|537062342|FG004|Period 3|Stability criteria not fullfilled|0|||
148886191|NCT01425801|537062343|FG005|Period 3|Stability criteria not fullfilled|0|||
148886192|NCT01425801|537062338|FG000|Period 4|Not able to maintain visit schedule|0|||
148886193|NCT01425801|537062339|FG001|Period 4|Not able to maintain visit schedule|0|||
148886194|NCT01425801|537062340|FG002|Period 4|Not able to maintain visit schedule|1|||
148886195|NCT01425801|537062341|FG003|Period 4|Not able to maintain visit schedule|0|||
148886196|NCT01425801|537062342|FG004|Period 4|Not able to maintain visit schedule|0|||
148886197|NCT01425801|537062343|FG005|Period 4|Not able to maintain visit schedule|0|||
148886198|NCT03066596|537062344|FG000|Overall Study|Withdrawal by Subject|4|||
148886199|NCT03066596|537062345|FG001|Overall Study|Withdrawal by Subject|2|||
148886200|NCT03066596|537062344|FG000|Overall Study|Lost to Follow-up|14|||
148886201|NCT03066596|537062345|FG001|Overall Study|Lost to Follow-up|10|||
148886202|NCT02330055|537062346|FG000|Overall Study|technical issues|2|||
148886203|NCT02330055|537062347|FG001|Overall Study|technical issues|0|||
148886204|NCT02330055|537062346|FG000|Overall Study|participant forgot to wear device|5|||
148886205|NCT02330055|537062347|FG001|Overall Study|participant forgot to wear device|5|||
148886206|NCT02330055|537062346|FG000|Overall Study|data for less than 60 minutes|3|||
148886207|NCT02330055|537062347|FG001|Overall Study|data for less than 60 minutes|3|||
148886208|NCT02330055|537062346|FG000|Overall Study|participant did not sleep|0|||
148886209|NCT02330055|537062347|FG001|Overall Study|participant did not sleep|1|||
148886210|NCT02959437|537062348|FG000|Overall Study|Death|33|||
148886211|NCT02959437|537062349|FG001|Overall Study|Death|3|||
148886212|NCT02959437|537062350|FG002|Overall Study|Death|0|||
148886213|NCT02959437|537062351|FG003|Overall Study|Death|0|||
148886214|NCT02959437|537062348|FG000|Overall Study|Lost to Follow-up|3|||
148886215|NCT02959437|537062349|FG001|Overall Study|Lost to Follow-up|1|||
148886216|NCT02959437|537062350|FG002|Overall Study|Lost to Follow-up|0|||
148886217|NCT02959437|537062351|FG003|Overall Study|Lost to Follow-up|0|||
148886218|NCT02959437|537062348|FG000|Overall Study|Withdrawal by Subject|11|||
148886219|NCT02959437|537062349|FG001|Overall Study|Withdrawal by Subject|3|||
148886220|NCT02959437|537062350|FG002|Overall Study|Withdrawal by Subject|0|||
148886221|NCT02959437|537062351|FG003|Overall Study|Withdrawal by Subject|0|||
148886222|NCT02959437|537062348|FG000|Overall Study|Progressive Disease|9|||
148886223|NCT02959437|537062349|FG001|Overall Study|Progressive Disease|1|||
148886224|NCT02959437|537062350|FG002|Overall Study|Progressive Disease|0|||
148886225|NCT02959437|537062351|FG003|Overall Study|Progressive Disease|0|||
148886226|NCT02959437|537062348|FG000|Overall Study|Study Terminated by Sponsor|4|||
148886227|NCT02959437|537062349|FG001|Overall Study|Study Terminated by Sponsor|0|||
148886228|NCT02959437|537062350|FG002|Overall Study|Study Terminated by Sponsor|0|||
148886229|NCT02959437|537062351|FG003|Overall Study|Study Terminated by Sponsor|0|||
148886230|NCT02959437|537062348|FG000|Overall Study|Other Unspecified|2|||
148886231|NCT02959437|537062349|FG001|Overall Study|Other Unspecified|0|||
148886232|NCT02959437|537062350|FG002|Overall Study|Other Unspecified|0|||
148886233|NCT02959437|537062351|FG003|Overall Study|Other Unspecified|0|||
148886234|NCT02864901|537062352|FG000|Overall Study|Withdrawal by Subject|1|||
148886235|NCT02864901|537062353|FG001|Overall Study|Withdrawal by Subject|0|||
148886236|NCT00782717|537062356|FG000|Overall Study|Adverse Event|2|||
148886237|NCT00782717|537062357|FG001|Overall Study|Adverse Event|5|||
148886238|NCT00782717|537062356|FG000|Overall Study|Patient decision unrelated to AE|6|||
148886239|NCT00782717|537062357|FG001|Overall Study|Patient decision unrelated to AE|3|||
148886240|NCT00782717|537062356|FG000|Overall Study|Noncompliance|2|||
148886241|NCT00782717|537062357|FG001|Overall Study|Noncompliance|1|||
148886242|NCT00782717|537062356|FG000|Overall Study|Treatment failure|3|||
148886243|NCT00782717|537062357|FG001|Overall Study|Treatment failure|14|||
148886244|NCT00782717|537062356|FG000|Overall Study|Enrollment close prior to surgery|1|||
148886245|NCT00782717|537062357|FG001|Overall Study|Enrollment close prior to surgery|0|||
148886246|NCT00782717|537062356|FG000|Overall Study|Did not meet entrance criteria|1|||
148886247|NCT00782717|537062357|FG001|Overall Study|Did not meet entrance criteria|3|||
148886248|NCT00782717|537062356|FG000|Overall Study|Exited in error|0|||
148886249|NCT00782717|537062357|FG001|Overall Study|Exited in error|2|||
148886250|NCT02446717|537062358|FG000|Overall Study|Adverse Event|0|||
148886251|NCT02446717|537062359|FG001|Overall Study|Adverse Event|0|||
148886252|NCT02446717|537062360|FG002|Overall Study|Adverse Event|1|||
148886253|NCT02446717|537062361|FG003|Overall Study|Adverse Event|0|||
148886254|NCT02446717|537062362|FG004|Overall Study|Adverse Event|0|||
148886255|NCT02446717|537062358|FG000|Overall Study|Lost to Follow-up|0|||
148886256|NCT02446717|537062359|FG001|Overall Study|Lost to Follow-up|1|||
148886257|NCT02446717|537062360|FG002|Overall Study|Lost to Follow-up|1|||
148886258|NCT02446717|537062361|FG003|Overall Study|Lost to Follow-up|0|||
148886259|NCT02446717|537062362|FG004|Overall Study|Lost to Follow-up|1|||
148886260|NCT02446717|537062358|FG000|Overall Study|Withdrew consent|0|||
148886261|NCT02446717|537062359|FG001|Overall Study|Withdrew consent|0|||
148886262|NCT02446717|537062360|FG002|Overall Study|Withdrew consent|0|||
148886263|NCT02446717|537062361|FG003|Overall Study|Withdrew consent|1|||
148886264|NCT02446717|537062362|FG004|Overall Study|Withdrew consent|0|||
148886265|NCT04739436|537062367|FG000|Overall Study|Lost to Follow-up|21|||
148886266|NCT04739436|537062368|FG001|Overall Study|Lost to Follow-up|23|||
148886267|NCT04739436|537062367|FG000|Overall Study|Withdrawal by Subject|4|||
148886268|NCT04739436|537062368|FG001|Overall Study|Withdrawal by Subject|6|||
148886269|NCT04739436|537062367|FG000|Overall Study|not randomized properly|1|||
148886270|NCT04739436|537062368|FG001|Overall Study|not randomized properly|0|||
148886271|NCT03622814|537062369|FG000|Overall Study|Lost to Follow-up|8|||
148886272|NCT03622814|537062370|FG001|Overall Study|Lost to Follow-up|14|||
148886273|NCT03269994|537062371|FG000|Overall Study|Withdrawal by Subject|4|||
148886274|NCT03269994|537062372|FG001|Overall Study|Withdrawal by Subject|5|||
148886275|NCT03269994|537062371|FG000|Overall Study|Unresectable at surgery|39|||
148886276|NCT03269994|537062372|FG001|Overall Study|Unresectable at surgery|58|||
148886277|NCT03269994|537062371|FG000|Overall Study|Patient canceled surgery|5|||
148886278|NCT03269994|537062372|FG001|Overall Study|Patient canceled surgery|14|||
148886279|NCT03269994|537062371|FG000|Overall Study|Preoperative progression|14|||
148886280|NCT03269994|537062372|FG001|Overall Study|Preoperative progression|9|||
148886281|NCT03269994|537062371|FG000|Overall Study|Preoperative infection|10|||
148886282|NCT03269994|537062372|FG001|Overall Study|Preoperative infection|4|||
148886283|NCT03269994|537062371|FG000|Overall Study|Kidney insufficiency|1|||
148886284|NCT03269994|537062372|FG001|Overall Study|Kidney insufficiency|0|||
148886285|NCT03269994|537062371|FG000|Overall Study|Drug allergy|0|||
148886286|NCT03269994|537062372|FG001|Overall Study|Drug allergy|2|||
148886287|NCT03269994|537062371|FG000|Overall Study|Operation changed to different resection|9|||
148886288|NCT03269994|537062372|FG001|Overall Study|Operation changed to different resection|0|||
148886289|NCT03269994|537062371|FG000|Overall Study|Preoperative steroid|0|||
148886290|NCT03269994|537062372|FG001|Overall Study|Preoperative steroid|3|||
148886291|NCT03269994|537062371|FG000|Overall Study|Accrual Closed|2|||
148886292|NCT03269994|537062372|FG001|Overall Study|Accrual Closed|0|||
148886293|NCT03269994|537062371|FG000|Overall Study|Operation changed to different resection|0|||
148886294|NCT03269994|537062372|FG001|Overall Study|Operation changed to different resection|10|||
148886295|NCT04417361|537062373|FG000|Overall Study|Withdrawal by Subject|1|||
148886296|NCT04417361|537062374|FG001|Overall Study|Withdrawal by Subject|0|||
148886297|NCT04417361|537062373|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
148886298|NCT04417361|537062374|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
148886299|NCT04661150|537062377|FG000|Overall Study|Ongoing in study|19|||
148886300|NCT04661150|537062378|FG001|Overall Study|Ongoing in study|20|||
148886301|NCT04661150|537062377|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
148886302|NCT04661150|537062378|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
148886303|NCT04661150|537062377|FG000|Overall Study|Death|2|||
148886304|NCT04661150|537062378|FG001|Overall Study|Death|0|||
148886305|NCT02701283|537062379|FG000|Overall Study|Death|25|||
148886306|NCT02701283|537062380|FG001|Overall Study|Death|29|||
148886307|NCT02701283|537062381|FG002|Overall Study|Death|19|||
148886308|NCT02701283|537062379|FG000|Overall Study|Lost to Follow-up|3|||
148886309|NCT02701283|537062380|FG001|Overall Study|Lost to Follow-up|8|||
148886310|NCT02701283|537062381|FG002|Overall Study|Lost to Follow-up|1|||
148886311|NCT02701283|537062379|FG000|Overall Study|Withdrawal by Subject|12|||
148886312|NCT02701283|537062380|FG001|Overall Study|Withdrawal by Subject|41|||
148886313|NCT02701283|537062381|FG002|Overall Study|Withdrawal by Subject|1|||
148886314|NCT02701283|537062379|FG000|Overall Study|Missed 2-year visit|22|||
148886315|NCT02701283|537062380|FG001|Overall Study|Missed 2-year visit|27|||
148886316|NCT02701283|537062381|FG002|Overall Study|Missed 2-year visit|0|||
148886317|NCT02701283|537062379|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
148886318|NCT02701283|537062380|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
148886319|NCT02701283|537062381|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
148886320|NCT02777827|537062382|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
148886321|NCT02777827|537062383|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
148886322|NCT02777827|537062384|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
148886323|NCT02777827|537062385|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
148886324|NCT02777827|537062386|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
148886325|NCT02777827|537062387|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
148886326|NCT00398320|537062388|FG000|Overall Study|Death|1|||
148886327|NCT00398320|537062388|FG000|Overall Study|Adverse Event|4|||
148886328|NCT00398320|537062388|FG000|Overall Study|Physician Decision|1|||
148886329|NCT00064792|537062389|FG000|Overall Study|Withdrawal by Subject|2|||
148886330|NCT00064792|537062390|FG001|Overall Study|Withdrawal by Subject|0|||
149049002|NCT01227265|537659561|FG001|Overall Study|Adverse Event|10|||
149049003|NCT01227265|537659562|FG002|Overall Study|Adverse Event|5|||
149049004|NCT04623775|537659563|FG000|Randomization|No Longer Meets Study Criteria|2|||
149049005|NCT04623775|537659564|FG001|Randomization|No Longer Meets Study Criteria|1|||
148886331|NCT00064792|537062389|FG000|Overall Study|Adverse Event|3|||
148886332|NCT00064792|537062390|FG001|Overall Study|Adverse Event|0|||
149049006|NCT04623775|537659565|FG002|Randomization|No Longer Meets Study Criteria|0|||
149049007|NCT04623775|537659566|FG003|Randomization|No Longer Meets Study Criteria|0|||
149049008|NCT04623775|537659563|FG000|Randomization|Withdrew Consent|0|||
149049009|NCT04623775|537659564|FG001|Randomization|Withdrew Consent|0|||
149049010|NCT04623775|537659565|FG002|Randomization|Withdrew Consent|0|||
149049011|NCT04623775|537659566|FG003|Randomization|Withdrew Consent|1|||
149049012|NCT04623775|537659563|FG000|Randomization|Other Reasons|0|||
148886333|NCT03160898|537062391|FG000|Overall Study|Adverse Event|4|||
148886334|NCT03160898|537062392|FG001|Overall Study|Adverse Event|8|||
148886335|NCT03160898|537062393|FG002|Overall Study|Adverse Event|7|||
148886336|NCT03160898|537062394|FG003|Overall Study|Adverse Event|10|||
148886337|NCT03160898|537062391|FG000|Overall Study|Death|1|||
148886338|NCT03160898|537062392|FG001|Overall Study|Death|0|||
148886339|NCT03160898|537062393|FG002|Overall Study|Death|0|||
149049013|NCT04623775|537659564|FG001|Randomization|Other Reasons|0|||
149049014|NCT04623775|537659565|FG002|Randomization|Other Reasons|0|||
148886340|NCT03160898|537062394|FG003|Overall Study|Death|1|||
148886341|NCT03160898|537062391|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
148886342|NCT03160898|537062392|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
148886343|NCT03160898|537062393|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
148886344|NCT03160898|537062394|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
148886345|NCT03160898|537062391|FG000|Overall Study|Lost to Follow-up|1|||
148886346|NCT03160898|537062392|FG001|Overall Study|Lost to Follow-up|1|||
148886347|NCT03160898|537062393|FG002|Overall Study|Lost to Follow-up|1|||
148886348|NCT03160898|537062394|FG003|Overall Study|Lost to Follow-up|2|||
148886349|NCT03160898|537062391|FG000|Overall Study|Physician Decision|1|||
148886350|NCT03160898|537062392|FG001|Overall Study|Physician Decision|0|||
148886351|NCT03160898|537062393|FG002|Overall Study|Physician Decision|0|||
148886352|NCT03160898|537062394|FG003|Overall Study|Physician Decision|1|||
148886353|NCT03160898|537062391|FG000|Overall Study|Progressive Disease|4|||
148886354|NCT03160898|537062392|FG001|Overall Study|Progressive Disease|1|||
148886355|NCT03160898|537062393|FG002|Overall Study|Progressive Disease|2|||
148886356|NCT03160898|537062394|FG003|Overall Study|Progressive Disease|1|||
148886357|NCT03160898|537062391|FG000|Overall Study|Protocol Violation|1|||
148886358|NCT03160898|537062392|FG001|Overall Study|Protocol Violation|0|||
148886359|NCT03160898|537062393|FG002|Overall Study|Protocol Violation|2|||
148886360|NCT03160898|537062394|FG003|Overall Study|Protocol Violation|0|||
148886361|NCT03160898|537062391|FG000|Overall Study|Sponsor Discretion|2|||
148886362|NCT03160898|537062392|FG001|Overall Study|Sponsor Discretion|0|||
148886363|NCT03160898|537062393|FG002|Overall Study|Sponsor Discretion|0|||
148886364|NCT03160898|537062394|FG003|Overall Study|Sponsor Discretion|0|||
148886365|NCT03160898|537062391|FG000|Overall Study|Withdrawal by Subject|1|||
148886366|NCT03160898|537062392|FG001|Overall Study|Withdrawal by Subject|3|||
148886367|NCT03160898|537062393|FG002|Overall Study|Withdrawal by Subject|2|||
148886368|NCT03160898|537062394|FG003|Overall Study|Withdrawal by Subject|1|||
148886369|NCT03160898|537062391|FG000|Overall Study|Other|2|||
148886370|NCT03160898|537062392|FG001|Overall Study|Other|0|||
148886371|NCT03160898|537062393|FG002|Overall Study|Other|2|||
148886372|NCT03160898|537062394|FG003|Overall Study|Other|2|||
148886373|NCT03405818|537062395|FG000|Overall Study|Withdrawal by Subject|4|||
148886374|NCT03405818|537062395|FG000|Overall Study|Lost to Follow-up|4|||
148886375|NCT01657292|537062407|FG000|Overall Study|Adverse Event|6|||
148886376|NCT01657292|537062407|FG000|Overall Study|Withdrawal by Subject|2|||
148886377|NCT01657292|537062407|FG000|Overall Study|Violation of eligibility criteria|1|||
148886378|NCT01657292|537062407|FG000|Overall Study|Change of therapy|1|||
148886379|NCT01900652|537062409|FG000|Overall Study|Progressive Disease|1|||
148886380|NCT01900652|537062410|FG001|Overall Study|Progressive Disease|0|||
148886381|NCT01900652|537062409|FG000|Overall Study|Consent withdrawn by subject|1|||
148886382|NCT01900652|537062410|FG001|Overall Study|Consent withdrawn by subject|1|||
148886383|NCT01900652|537062409|FG000|Overall Study|Death|3|||
148886384|NCT01900652|537062410|FG001|Overall Study|Death|0|||
148886385|NCT01900652|537062409|FG000|Overall Study|Adverse Event|2|||
148886386|NCT01900652|537062410|FG001|Overall Study|Adverse Event|1|||
148886387|NCT01900652|537062409|FG000|Overall Study|Physician Decision|1|||
148886388|NCT01900652|537062410|FG001|Overall Study|Physician Decision|1|||
148886389|NCT03932760|537062413|FG000|Overall Study|Became Ineligible|2|||
148886390|NCT03932760|537062414|FG001|Overall Study|Became Ineligible|5|||
148886391|NCT03932760|537062413|FG000|Overall Study|Withdrawal by Subject|6|||
148886392|NCT03932760|537062414|FG001|Overall Study|Withdrawal by Subject|6|||
148886393|NCT03922620|537062417|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
148886394|NCT03922620|537062418|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
148886395|NCT03566082|537062419|FG000|Overall Study|Death|7|||
148886396|NCT03566082|537062419|FG000|Overall Study|Failures (revision required)|2|||
148886397|NCT03566082|537062419|FG000|Overall Study|Lost to Follow-up|8|||
148886398|NCT04725500|537062420|FG000|Screening|Screen Failure|26|||
148886399|NCT04725500|537062420|FG000|Screening|Withdrawal by Subject|1|||
148886400|NCT04725500|537062420|FG000|2 Week Take Home|Screen Fail|5|||
148886401|NCT01467505|537064205|FG000|Overall Study|Adverse Event|1|||
148886402|NCT01467505|537064206|FG001|Overall Study|Adverse Event|0|||
148886403|NCT01467505|537064205|FG000|Overall Study|Withdrawal by Subject|4|||
148886404|NCT01467505|537064206|FG001|Overall Study|Withdrawal by Subject|0|||
148886405|NCT01467505|537064205|FG000|Overall Study|Study Terminated by Sponsor|28|||
148886406|NCT01467505|537064206|FG001|Overall Study|Study Terminated by Sponsor|3|||
148886407|NCT02807623|537064207|FG000|Overall Study|Lost to Follow-up|23|||
148886408|NCT02807623|537064208|FG001|Overall Study|Lost to Follow-up|18|||
148886409|NCT02807623|537064209|FG002|Overall Study|Lost to Follow-up|22|||
148886410|NCT02807623|537064207|FG000|Overall Study|Drug intolerance|0|||
148886411|NCT02807623|537064208|FG001|Overall Study|Drug intolerance|1|||
148886412|NCT02807623|537064209|FG002|Overall Study|Drug intolerance|0|||
148886413|NCT02807623|537064207|FG000|Overall Study|incomplete blood draw|0|||
148886414|NCT02807623|537064208|FG001|Overall Study|incomplete blood draw|2|||
148886415|NCT02807623|537064209|FG002|Overall Study|incomplete blood draw|1|||
148886416|NCT03811340|537064210|FG000|Overall Study|subjects did not complete the survey.|90|||
148886417|NCT05104450|537064211|FG000|Overall Study|Death|1|||
148886418|NCT05104450|537064212|FG001|Overall Study|Death|2|||
148886419|NCT05104450|537064211|FG000|Overall Study|Withdrawal by Subject|3|||
148886420|NCT05104450|537064212|FG001|Overall Study|Withdrawal by Subject|1|||
148886421|NCT02723773|537064213|FG000|Overall Study|Adverse Event|934|||
148886422|NCT02723773|537064214|FG001|Overall Study|Adverse Event|3|||
148886423|NCT02723773|537064215|FG002|Overall Study|Adverse Event|1|||
148886424|NCT02723773|537064216|FG003|Overall Study|Adverse Event|9|||
148886425|NCT02723773|537064213|FG000|Overall Study|Protocol Violation|1|||
148886426|NCT02723773|537064214|FG001|Overall Study|Protocol Violation|0|||
148886427|NCT02723773|537064215|FG002|Overall Study|Protocol Violation|0|||
148886428|NCT02723773|537064216|FG003|Overall Study|Protocol Violation|0|||
148886429|NCT02723773|537064213|FG000|Overall Study|Withdrawal by Subject|360|||
148886430|NCT02723773|537064214|FG001|Overall Study|Withdrawal by Subject|5|||
148886431|NCT02723773|537064215|FG002|Overall Study|Withdrawal by Subject|6|||
148886432|NCT02723773|537064216|FG003|Overall Study|Withdrawal by Subject|10|||
148886433|NCT02723773|537064213|FG000|Overall Study|Migrated/moved from study area|37|||
148886434|NCT02723773|537064214|FG001|Overall Study|Migrated/moved from study area|0|||
149049015|NCT04623775|537659566|FG003|Randomization|Other Reasons|1|||
149049016|NCT04623775|537659563|FG000|Treatment Period|participant withdrew consent|4|||
149049017|NCT04623775|537659564|FG001|Treatment Period|participant withdrew consent|0|||
149049018|NCT04623775|537659565|FG002|Treatment Period|participant withdrew consent|1|||
149049019|NCT04623775|537659566|FG003|Treatment Period|participant withdrew consent|2|||
149049020|NCT04623775|537659563|FG000|Treatment Period|Death|3|||
149049021|NCT04623775|537659564|FG001|Treatment Period|Death|1|||
148886435|NCT02723773|537064215|FG002|Overall Study|Migrated/moved from study area|0|||
148886436|NCT02723773|537064216|FG003|Overall Study|Migrated/moved from study area|1|||
148886437|NCT02723773|537064213|FG000|Overall Study|Lost to Follow-up|198|||
148886438|NCT02723773|537064214|FG001|Overall Study|Lost to Follow-up|0|||
148886439|NCT02723773|537064215|FG002|Overall Study|Lost to Follow-up|0|||
148886440|NCT02723773|537064216|FG003|Overall Study|Lost to Follow-up|0|||
148886441|NCT02723773|537064213|FG000|Overall Study|Other|189|||
148886442|NCT02723773|537064214|FG001|Overall Study|Other|1|||
148886443|NCT02723773|537064215|FG002|Overall Study|Other|2|||
148886444|NCT02723773|537064216|FG003|Overall Study|Other|2|||
148886445|NCT01380769|537064227|FG000|Overall Study|Withdrawal by Subject|7|||
148886446|NCT01380769|537064228|FG001|Overall Study|Withdrawal by Subject|11|||
148886447|NCT01380769|537064227|FG000|Overall Study|Physician Decision|1|||
148886448|NCT01380769|537064228|FG001|Overall Study|Physician Decision|1|||
148886449|NCT01380769|537064227|FG000|Overall Study|Adverse Event|1|||
148886450|NCT01380769|537064228|FG001|Overall Study|Adverse Event|1|||
148886451|NCT01380769|537064227|FG000|Overall Study|Protocol Violation|0|||
148886452|NCT01380769|537064228|FG001|Overall Study|Protocol Violation|1|||
148886453|NCT01080807|537064230|FG000|Overall Study|Adverse Event|9|||
148886454|NCT01080807|537064231|FG001|Overall Study|Adverse Event|1|||
148886455|NCT01080807|537064230|FG000|Overall Study|Lack of Efficacy|0|||
148886456|NCT01080807|537064231|FG001|Overall Study|Lack of Efficacy|1|||
148886457|NCT01080807|537064230|FG000|Overall Study|Withdrawal by Subject|7|||
148886458|NCT01080807|537064231|FG001|Overall Study|Withdrawal by Subject|2|||
148886459|NCT01080807|537064230|FG000|Overall Study|Protocol Violation|7|||
148886460|NCT01080807|537064231|FG001|Overall Study|Protocol Violation|6|||
148886461|NCT01080807|537064230|FG000|Overall Study|Lost to Follow-up|6|||
148886462|NCT01080807|537064231|FG001|Overall Study|Lost to Follow-up|4|||
148886463|NCT01080807|537064230|FG000|Overall Study|Noncompliance with drug administration|1|||
148886464|NCT01080807|537064231|FG001|Overall Study|Noncompliance with drug administration|1|||
148886465|NCT01080807|537064230|FG000|Overall Study|Noncompliance to study procedures|1|||
148886466|NCT01080807|537064231|FG001|Overall Study|Noncompliance to study procedures|1|||
148886467|NCT01080807|537064230|FG000|Overall Study|Began working day shift|0|||
148886468|NCT01080807|537064231|FG001|Overall Study|Began working day shift|2|||
148886469|NCT01080807|537064230|FG000|Overall Study|Laid off or terminated from job|1|||
148886470|NCT01080807|537064231|FG001|Overall Study|Laid off or terminated from job|2|||
148886471|NCT01080807|537064230|FG000|Overall Study|Stopped working consistent night shifts|0|||
149049022|NCT04623775|537659565|FG002|Treatment Period|Death|4|||
148886472|NCT01080807|537064231|FG001|Overall Study|Stopped working consistent night shifts|1|||
148886473|NCT01080807|537064230|FG000|Overall Study|Work schedule changing|1|||
148886474|NCT01080807|537064231|FG001|Overall Study|Work schedule changing|1|||
148886475|NCT01080807|537064230|FG000|Overall Study|Work schedule and travel|0|||
149049023|NCT04623775|537659566|FG003|Treatment Period|Death|2|||
148886476|NCT01080807|537064231|FG001|Overall Study|Work schedule and travel|1|||
148886477|NCT01080807|537064230|FG000|Overall Study|Switched to first shift|1|||
148886478|NCT01080807|537064231|FG001|Overall Study|Switched to first shift|0|||
148886479|NCT01080807|537064230|FG000|Overall Study|Moved away without notifying center|1|||
148886480|NCT01080807|537064231|FG001|Overall Study|Moved away without notifying center|0|||
148886481|NCT03456076|537064244|FG000|Overall Study|Withdrawal by Subject|5|||
148886482|NCT03456076|537064245|FG001|Overall Study|Withdrawal by Subject|9|||
148886483|NCT03456076|537064244|FG000|Overall Study|Protocol deviation|0|||
149049024|NCT04623775|537659563|FG000|Treatment Period|Lost to Follow-up|0|||
149049025|NCT04623775|537659564|FG001|Treatment Period|Lost to Follow-up|2|||
148886484|NCT03456076|537064245|FG001|Overall Study|Protocol deviation|1|||
148886485|NCT03456076|537064244|FG000|Overall Study|Lost to Follow-up|0|||
148886486|NCT03456076|537064245|FG001|Overall Study|Lost to Follow-up|1|||
148886487|NCT03456076|537064244|FG000|Overall Study|Death|2|||
148886488|NCT03456076|537064245|FG001|Overall Study|Death|5|||
148886489|NCT03456076|537064244|FG000|Overall Study|Study ongoing|123|||
148886490|NCT03456076|537064245|FG001|Overall Study|Study ongoing|111|||
148886491|NCT02045095|537064246|FG000|Overall Study|Other|0|||
148886492|NCT02045095|537064247|FG001|Overall Study|Other|0|||
148886493|NCT02045095|537064248|FG002|Overall Study|Other|1|||
148886494|NCT02045095|537064249|FG003|Overall Study|Other|0|||
148886495|NCT02045095|537064250|FG004|Overall Study|Other|0|||
148886496|NCT02045095|537064251|FG005|Overall Study|Other|2|||
148886497|NCT02045095|537064252|FG006|Overall Study|Other|0|||
148886498|NCT02045095|537064246|FG000|Overall Study|Progressive Disease|3|||
148886499|NCT02045095|537064247|FG001|Overall Study|Progressive Disease|3|||
148886500|NCT02045095|537064248|FG002|Overall Study|Progressive Disease|2|||
148886501|NCT02045095|537064249|FG003|Overall Study|Progressive Disease|4|||
148886502|NCT02045095|537064250|FG004|Overall Study|Progressive Disease|2|||
148886503|NCT02045095|537064251|FG005|Overall Study|Progressive Disease|4|||
148886504|NCT02045095|537064252|FG006|Overall Study|Progressive Disease|1|||
148886505|NCT02045095|537064246|FG000|Overall Study|Withdrawal by Subject|0|||
148886506|NCT02045095|537064247|FG001|Overall Study|Withdrawal by Subject|0|||
148886507|NCT02045095|537064248|FG002|Overall Study|Withdrawal by Subject|0|||
148886508|NCT02045095|537064249|FG003|Overall Study|Withdrawal by Subject|0|||
148886509|NCT02045095|537064250|FG004|Overall Study|Withdrawal by Subject|3|||
148886510|NCT02045095|537064251|FG005|Overall Study|Withdrawal by Subject|0|||
148886511|NCT02045095|537064252|FG006|Overall Study|Withdrawal by Subject|0|||
148886512|NCT02045095|537064246|FG000|Overall Study|Adverse Event|0|||
148886513|NCT02045095|537064247|FG001|Overall Study|Adverse Event|1|||
148886514|NCT02045095|537064248|FG002|Overall Study|Adverse Event|1|||
148886515|NCT02045095|537064249|FG003|Overall Study|Adverse Event|0|||
148886516|NCT02045095|537064250|FG004|Overall Study|Adverse Event|0|||
148886517|NCT02045095|537064251|FG005|Overall Study|Adverse Event|2|||
148886518|NCT02045095|537064252|FG006|Overall Study|Adverse Event|0|||
148886519|NCT01818596|537064254|FG000|Overall Study|Enrolled but Not Treated|4|||
148886520|NCT01818596|537064255|FG001|Overall Study|Enrolled but Not Treated|0|||
148886521|NCT01818596|537064254|FG000|Overall Study|Adverse Event|7|||
148886522|NCT01818596|537064255|FG001|Overall Study|Adverse Event|0|||
148886523|NCT01818596|537064254|FG000|Overall Study|Death|3|||
148886524|NCT01818596|537064255|FG001|Overall Study|Death|0|||
148886525|NCT01818596|537064254|FG000|Overall Study|Investigator's Discretion|4|||
148886526|NCT01818596|537064255|FG001|Overall Study|Investigator's Discretion|0|||
148886527|NCT01818596|537064254|FG000|Overall Study|Protocol Violation|1|||
148886528|NCT01818596|537064255|FG001|Overall Study|Protocol Violation|0|||
148886529|NCT01818596|537064254|FG000|Overall Study|Withdrew Consent|5|||
148886530|NCT01818596|537064255|FG001|Overall Study|Withdrew Consent|0|||
148886531|NCT01818596|537064254|FG000|Overall Study|Lost to Follow-up|7|||
148886532|NCT01818596|537064255|FG001|Overall Study|Lost to Follow-up|0|||
148886533|NCT04435366|537064261|FG000|Year 1 (12 Months)|Adverse Event|3|||
149049026|NCT04623775|537659565|FG002|Treatment Period|Lost to Follow-up|0|||
149049027|NCT04623775|537659566|FG003|Treatment Period|Lost to Follow-up|0|||
149049028|NCT04623775|537659563|FG000|Treatment Period|poor/non compliance|0|||
149049029|NCT04623775|537659564|FG001|Treatment Period|poor/non compliance|0|||
149049030|NCT04623775|537659565|FG002|Treatment Period|poor/non compliance|1|||
149049031|NCT04623775|537659566|FG003|Treatment Period|poor/non compliance|0|||
149049032|NCT04623775|537659563|FG000|Treatment Period|participant no longer meets study criteria|0|||
149049033|NCT04623775|537659564|FG001|Treatment Period|participant no longer meets study criteria|1|||
148886534|NCT04435366|537064262|FG001|Year 1 (12 Months)|Adverse Event|0|||
148886535|NCT04435366|537064263|FG002|Year 1 (12 Months)|Adverse Event|2|||
148886536|NCT04435366|537064261|FG000|Year 1 (12 Months)|Death|2|||
148886537|NCT04435366|537064262|FG001|Year 1 (12 Months)|Death|0|||
149049034|NCT04623775|537659565|FG002|Treatment Period|participant no longer meets study criteria|0|||
149049035|NCT04623775|537659566|FG003|Treatment Period|participant no longer meets study criteria|0|||
148886538|NCT04435366|537064263|FG002|Year 1 (12 Months)|Death|1|||
149049036|NCT04623775|537659563|FG000|Treatment Period|administrative reasons by sponsor|3|||
148886539|NCT04435366|537064261|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
148886540|NCT04435366|537064262|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
148886541|NCT04435366|537064263|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
148886542|NCT04435366|537064261|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
148886543|NCT04435366|537064262|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
148886544|NCT04435366|537064263|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
148886545|NCT04435366|537064261|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
148886546|NCT04435366|537064262|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
148886547|NCT04435366|537064263|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
148886548|NCT04435366|537064261|FG000|Year 1 (12 Months)|Not treated|0|||
148886549|NCT04435366|537064262|FG001|Year 1 (12 Months)|Not treated|0|||
148886550|NCT04435366|537064263|FG002|Year 1 (12 Months)|Not treated|1|||
148886551|NCT04435366|537064261|FG000|Year 2 (12 Months)|Death|1|||
148886552|NCT04435366|537064262|FG001|Year 2 (12 Months)|Death|4|||
148886553|NCT04435366|537064263|FG002|Year 2 (12 Months)|Death|6|||
148886554|NCT04435366|537064261|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
148886555|NCT04435366|537064262|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
148886556|NCT04435366|537064263|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
148886557|NCT04435366|537064261|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
148886558|NCT04435366|537064262|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
148886559|NCT04435366|537064263|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
148886560|NCT04435366|537064261|FG000|Year 2 (12 Months)|Adverse Event|2|||
148886561|NCT04435366|537064262|FG001|Year 2 (12 Months)|Adverse Event|1|||
148886562|NCT04435366|537064263|FG002|Year 2 (12 Months)|Adverse Event|6|||
148886563|NCT04112810|537064265|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
148886564|NCT00837213|537064266|FG000|Overall Study|Lost to Follow-up|3|||
148886565|NCT00837213|537064267|FG001|Overall Study|Lost to Follow-up|2|||
148886566|NCT00837213|537064266|FG000|Overall Study|Withdrawal by Subject|2|||
148886567|NCT00837213|537064267|FG001|Overall Study|Withdrawal by Subject|2|||
148886568|NCT00837213|537064266|FG000|Overall Study|not stated|1|||
148886569|NCT00837213|537064267|FG001|Overall Study|not stated|1|||
148886570|NCT04497116|537064270|FG000|Overall Study|Lost to Follow-up|1|||
148886571|NCT04497116|537064271|FG001|Overall Study|Lost to Follow-up|0|||
148886572|NCT04497116|537064272|FG002|Overall Study|Lost to Follow-up|0|||
148886573|NCT04497116|537064273|FG003|Overall Study|Lost to Follow-up|0|||
148886574|NCT04497116|537064274|FG004|Overall Study|Lost to Follow-up|0|||
148886575|NCT04497116|537064275|FG005|Overall Study|Lost to Follow-up|0|||
148886576|NCT04497116|537064276|FG006|Overall Study|Lost to Follow-up|0|||
148886577|NCT04497116|537064277|FG007|Overall Study|Lost to Follow-up|3|||
148886578|NCT04497116|537064278|FG008|Overall Study|Lost to Follow-up|3|||
148886579|NCT04497116|537064279|FG009|Overall Study|Lost to Follow-up|0|||
148886580|NCT04497116|537064280|FG010|Overall Study|Lost to Follow-up|0|||
148886581|NCT04497116|537064281|FG011|Overall Study|Lost to Follow-up|0|||
148886582|NCT04497116|537064282|FG012|Overall Study|Lost to Follow-up|0|||
148886583|NCT04497116|537064283|FG013|Overall Study|Lost to Follow-up|0|||
148886584|NCT04497116|537064284|FG014|Overall Study|Lost to Follow-up|0|||
148886585|NCT04497116|537064285|FG015|Overall Study|Lost to Follow-up|0|||
148886586|NCT04497116|537064286|FG016|Overall Study|Lost to Follow-up|0|||
148886587|NCT04497116|537064287|FG017|Overall Study|Lost to Follow-up|0|||
148886588|NCT04497116|537064288|FG018|Overall Study|Lost to Follow-up|0|||
148886589|NCT04497116|537064289|FG019|Overall Study|Lost to Follow-up|0|||
148886590|NCT04497116|537064290|FG020|Overall Study|Lost to Follow-up|0|||
148886591|NCT04497116|537064291|FG021|Overall Study|Lost to Follow-up|0|||
148886592|NCT04497116|537064292|FG022|Overall Study|Lost to Follow-up|1|||
148886593|NCT04497116|537064293|FG023|Overall Study|Lost to Follow-up|0|||
148886594|NCT04497116|537064294|FG024|Overall Study|Lost to Follow-up|0|||
148886595|NCT04497116|537064270|FG000|Overall Study|Sponsor decision to terminate study|0|||
148886596|NCT04497116|537064271|FG001|Overall Study|Sponsor decision to terminate study|0|||
148886597|NCT04497116|537064272|FG002|Overall Study|Sponsor decision to terminate study|0|||
148886598|NCT04497116|537064273|FG003|Overall Study|Sponsor decision to terminate study|0|||
148886599|NCT04497116|537064274|FG004|Overall Study|Sponsor decision to terminate study|0|||
148886600|NCT04497116|537064275|FG005|Overall Study|Sponsor decision to terminate study|0|||
148886601|NCT04497116|537064276|FG006|Overall Study|Sponsor decision to terminate study|1|||
148886602|NCT04497116|537064277|FG007|Overall Study|Sponsor decision to terminate study|0|||
149049037|NCT04623775|537659564|FG001|Treatment Period|administrative reasons by sponsor|2|||
149049038|NCT04623775|537659565|FG002|Treatment Period|administrative reasons by sponsor|0|||
149049039|NCT04623775|537659566|FG003|Treatment Period|administrative reasons by sponsor|0|||
149049040|NCT04623775|537659563|FG000|Treatment Period|other reasons|2|||
149049041|NCT04623775|537659564|FG001|Treatment Period|other reasons|0|||
149049042|NCT04623775|537659565|FG002|Treatment Period|other reasons|1|||
149049043|NCT04623775|537659566|FG003|Treatment Period|other reasons|1|||
149049044|NCT04623775|537659563|FG000|Treatment Period|disease progression|40|||
149049045|NCT04623775|537659564|FG001|Treatment Period|disease progression|35|||
149049046|NCT04623775|537659565|FG002|Treatment Period|disease progression|63|||
148886603|NCT04497116|537064278|FG008|Overall Study|Sponsor decision to terminate study|0|||
149049047|NCT04623775|537659566|FG003|Treatment Period|disease progression|63|||
149049048|NCT04623775|537659563|FG000|Treatment Period|study drug toxicity|12|||
149049049|NCT04623775|537659564|FG001|Treatment Period|study drug toxicity|15|||
149049050|NCT04623775|537659565|FG002|Treatment Period|study drug toxicity|13|||
149049051|NCT04623775|537659566|FG003|Treatment Period|study drug toxicity|12|||
148886604|NCT04497116|537064279|FG009|Overall Study|Sponsor decision to terminate study|1|||
149049052|NCT04623775|537659563|FG000|Treatment Period|AE unrelated to study drug|4|||
148886605|NCT04497116|537064280|FG010|Overall Study|Sponsor decision to terminate study|0|||
148886606|NCT04497116|537064281|FG011|Overall Study|Sponsor decision to terminate study|0|||
149049053|NCT04623775|537659564|FG001|Treatment Period|AE unrelated to study drug|9|||
149049054|NCT04623775|537659565|FG002|Treatment Period|AE unrelated to study drug|12|||
148886607|NCT04497116|537064282|FG012|Overall Study|Sponsor decision to terminate study|0|||
148886608|NCT04497116|537064283|FG013|Overall Study|Sponsor decision to terminate study|0|||
148886609|NCT04497116|537064284|FG014|Overall Study|Sponsor decision to terminate study|0|||
148886610|NCT04497116|537064285|FG015|Overall Study|Sponsor decision to terminate study|0|||
148886611|NCT04497116|537064286|FG016|Overall Study|Sponsor decision to terminate study|0|||
148886612|NCT04497116|537064287|FG017|Overall Study|Sponsor decision to terminate study|0|||
148886613|NCT04497116|537064288|FG018|Overall Study|Sponsor decision to terminate study|0|||
148886614|NCT04497116|537064289|FG019|Overall Study|Sponsor decision to terminate study|1|||
148886615|NCT04497116|537064290|FG020|Overall Study|Sponsor decision to terminate study|0|||
148886616|NCT04497116|537064291|FG021|Overall Study|Sponsor decision to terminate study|0|||
148886617|NCT04497116|537064292|FG022|Overall Study|Sponsor decision to terminate study|0|||
148886618|NCT04497116|537064293|FG023|Overall Study|Sponsor decision to terminate study|0|||
148886619|NCT04497116|537064294|FG024|Overall Study|Sponsor decision to terminate study|0|||
148886620|NCT04497116|537064270|FG000|Overall Study|Death|4|||
148886621|NCT04497116|537064271|FG001|Overall Study|Death|5|||
148886622|NCT04497116|537064272|FG002|Overall Study|Death|2|||
148886623|NCT04497116|537064273|FG003|Overall Study|Death|2|||
148886624|NCT04497116|537064274|FG004|Overall Study|Death|1|||
148886625|NCT04497116|537064275|FG005|Overall Study|Death|1|||
148886626|NCT04497116|537064276|FG006|Overall Study|Death|3|||
148886627|NCT04497116|537064277|FG007|Overall Study|Death|10|||
148886628|NCT04497116|537064278|FG008|Overall Study|Death|37|||
148886629|NCT04497116|537064279|FG009|Overall Study|Death|17|||
148886630|NCT04497116|537064280|FG010|Overall Study|Death|2|||
148886631|NCT04497116|537064281|FG011|Overall Study|Death|1|||
148886632|NCT04497116|537064282|FG012|Overall Study|Death|1|||
148886633|NCT04497116|537064283|FG013|Overall Study|Death|3|||
148886634|NCT04497116|537064284|FG014|Overall Study|Death|18|||
148886635|NCT04497116|537064285|FG015|Overall Study|Death|3|||
148886636|NCT04497116|537064286|FG016|Overall Study|Death|2|||
148886637|NCT04497116|537064287|FG017|Overall Study|Death|1|||
148886638|NCT04497116|537064288|FG018|Overall Study|Death|4|||
148886639|NCT04497116|537064289|FG019|Overall Study|Death|17|||
148886640|NCT04497116|537064290|FG020|Overall Study|Death|1|||
148886641|NCT04497116|537064291|FG021|Overall Study|Death|0|||
148886642|NCT04497116|537064292|FG022|Overall Study|Death|3|||
148886643|NCT04497116|537064293|FG023|Overall Study|Death|5|||
148886644|NCT04497116|537064294|FG024|Overall Study|Death|4|||
148886645|NCT04497116|537064270|FG000|Overall Study|Withdrawal by Subject|1|||
148886646|NCT04497116|537064271|FG001|Overall Study|Withdrawal by Subject|0|||
148886647|NCT04497116|537064272|FG002|Overall Study|Withdrawal by Subject|1|||
148886648|NCT04497116|537064273|FG003|Overall Study|Withdrawal by Subject|0|||
148886649|NCT04497116|537064274|FG004|Overall Study|Withdrawal by Subject|0|||
148886650|NCT04497116|537064275|FG005|Overall Study|Withdrawal by Subject|0|||
148886651|NCT04497116|537064276|FG006|Overall Study|Withdrawal by Subject|0|||
148886652|NCT04497116|537064277|FG007|Overall Study|Withdrawal by Subject|7|||
148886653|NCT04497116|537064278|FG008|Overall Study|Withdrawal by Subject|14|||
148886654|NCT04497116|537064279|FG009|Overall Study|Withdrawal by Subject|3|||
149005100|NCT01147822|537497837|FG000|Overall Study|Physician Decision|9|||
149005101|NCT01147822|537497838|FG001|Overall Study|Physician Decision|8|||
149005102|NCT01147822|537497837|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
149005103|NCT01147822|537497838|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
149005104|NCT01147822|537497837|FG000|Overall Study|Protocol Violation|1|||
149005105|NCT01147822|537497838|FG001|Overall Study|Protocol Violation|1|||
149005106|NCT00261495|537497844|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
149005107|NCT00261495|537497845|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
149005108|NCT00261495|537497844|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
149005109|NCT00261495|537497845|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
149005110|NCT00261495|537497844|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
149005111|NCT00261495|537497845|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
149005112|NCT00261495|537497844|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
149005113|NCT00261495|537497845|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
149005114|NCT00261495|537497844|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
149005115|NCT00261495|537497845|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
149005116|NCT00261495|537497844|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
149005117|NCT00261495|537497845|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
149005118|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
149005119|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
149005120|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
149005121|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
149005122|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
149005123|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
149005124|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
149005125|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
148886655|NCT04497116|537064280|FG010|Overall Study|Withdrawal by Subject|3|||
148886656|NCT04497116|537064281|FG011|Overall Study|Withdrawal by Subject|0|||
148886657|NCT04497116|537064282|FG012|Overall Study|Withdrawal by Subject|1|||
148886658|NCT04497116|537064283|FG013|Overall Study|Withdrawal by Subject|0|||
148886659|NCT04497116|537064284|FG014|Overall Study|Withdrawal by Subject|7|||
148886660|NCT04497116|537064285|FG015|Overall Study|Withdrawal by Subject|1|||
148886661|NCT04497116|537064286|FG016|Overall Study|Withdrawal by Subject|3|||
148886662|NCT04497116|537064287|FG017|Overall Study|Withdrawal by Subject|1|||
148886663|NCT04497116|537064288|FG018|Overall Study|Withdrawal by Subject|1|||
148886664|NCT04497116|537064289|FG019|Overall Study|Withdrawal by Subject|5|||
148886665|NCT04497116|537064290|FG020|Overall Study|Withdrawal by Subject|2|||
148886666|NCT04497116|537064291|FG021|Overall Study|Withdrawal by Subject|2|||
148886667|NCT04497116|537064292|FG022|Overall Study|Withdrawal by Subject|2|||
148886668|NCT04497116|537064293|FG023|Overall Study|Withdrawal by Subject|4|||
148886669|NCT04497116|537064294|FG024|Overall Study|Withdrawal by Subject|3|||
148886670|NCT04497116|537064270|FG000|Overall Study|Physician Decision|0|||
148886671|NCT04497116|537064271|FG001|Overall Study|Physician Decision|0|||
148886672|NCT04497116|537064272|FG002|Overall Study|Physician Decision|0|||
148886673|NCT04497116|537064273|FG003|Overall Study|Physician Decision|0|||
148886674|NCT04497116|537064274|FG004|Overall Study|Physician Decision|0|||
148886675|NCT04497116|537064275|FG005|Overall Study|Physician Decision|0|||
148886676|NCT04497116|537064276|FG006|Overall Study|Physician Decision|0|||
148886677|NCT04497116|537064277|FG007|Overall Study|Physician Decision|0|||
148886678|NCT04497116|537064278|FG008|Overall Study|Physician Decision|0|||
148886679|NCT04497116|537064279|FG009|Overall Study|Physician Decision|0|||
148886680|NCT04497116|537064280|FG010|Overall Study|Physician Decision|0|||
148886681|NCT04497116|537064281|FG011|Overall Study|Physician Decision|0|||
148886682|NCT04497116|537064282|FG012|Overall Study|Physician Decision|0|||
148886683|NCT04497116|537064283|FG013|Overall Study|Physician Decision|0|||
148886684|NCT04497116|537064284|FG014|Overall Study|Physician Decision|0|||
148886685|NCT04497116|537064285|FG015|Overall Study|Physician Decision|0|||
148886686|NCT04497116|537064286|FG016|Overall Study|Physician Decision|0|||
148886687|NCT04497116|537064287|FG017|Overall Study|Physician Decision|0|||
148886688|NCT04497116|537064288|FG018|Overall Study|Physician Decision|0|||
148886689|NCT04497116|537064289|FG019|Overall Study|Physician Decision|0|||
148886690|NCT04497116|537064290|FG020|Overall Study|Physician Decision|0|||
148886691|NCT04497116|537064291|FG021|Overall Study|Physician Decision|0|||
148886692|NCT04497116|537064292|FG022|Overall Study|Physician Decision|0|||
148886693|NCT04497116|537064293|FG023|Overall Study|Physician Decision|1|||
148886694|NCT04497116|537064294|FG024|Overall Study|Physician Decision|0|||
148886695|NCT04497116|537064270|FG000|Overall Study|Clinical Progression Related|0|||
148886696|NCT04497116|537064271|FG001|Overall Study|Clinical Progression Related|0|||
148886697|NCT04497116|537064272|FG002|Overall Study|Clinical Progression Related|0|||
148886698|NCT04497116|537064273|FG003|Overall Study|Clinical Progression Related|0|||
148886699|NCT04497116|537064274|FG004|Overall Study|Clinical Progression Related|0|||
148886700|NCT04497116|537064275|FG005|Overall Study|Clinical Progression Related|0|||
148886701|NCT04497116|537064276|FG006|Overall Study|Clinical Progression Related|0|||
148886702|NCT04497116|537064277|FG007|Overall Study|Clinical Progression Related|0|||
148886703|NCT04497116|537064278|FG008|Overall Study|Clinical Progression Related|0|||
148886704|NCT04497116|537064279|FG009|Overall Study|Clinical Progression Related|1|||
148886705|NCT04497116|537064280|FG010|Overall Study|Clinical Progression Related|0|||
148886706|NCT04497116|537064281|FG011|Overall Study|Clinical Progression Related|0|||
148886707|NCT04497116|537064282|FG012|Overall Study|Clinical Progression Related|0|||
148886708|NCT04497116|537064283|FG013|Overall Study|Clinical Progression Related|0|||
148886709|NCT04497116|537064284|FG014|Overall Study|Clinical Progression Related|0|||
148886710|NCT04497116|537064285|FG015|Overall Study|Clinical Progression Related|0|||
148886711|NCT04497116|537064286|FG016|Overall Study|Clinical Progression Related|0|||
148886712|NCT04497116|537064287|FG017|Overall Study|Clinical Progression Related|0|||
148886713|NCT04497116|537064288|FG018|Overall Study|Clinical Progression Related|0|||
148886714|NCT04497116|537064289|FG019|Overall Study|Clinical Progression Related|0|||
148886715|NCT04497116|537064290|FG020|Overall Study|Clinical Progression Related|0|||
148886716|NCT04497116|537064291|FG021|Overall Study|Clinical Progression Related|0|||
148886717|NCT04497116|537064292|FG022|Overall Study|Clinical Progression Related|0|||
148886718|NCT04497116|537064293|FG023|Overall Study|Clinical Progression Related|0|||
148886719|NCT04497116|537064294|FG024|Overall Study|Clinical Progression Related|0|||
148886720|NCT05963022|537064298|FG000|Overall Study|Adverse Event|0|||
148886721|NCT05963022|537064299|FG001|Overall Study|Adverse Event|1|||
148886722|NCT05963022|537064300|FG002|Overall Study|Adverse Event|1|||
148886723|NCT05963022|537064301|FG003|Overall Study|Adverse Event|0|||
148886724|NCT05963022|537064298|FG000|Overall Study|Protocol Violation|0|||
148886725|NCT05963022|537064299|FG001|Overall Study|Protocol Violation|3|||
148886726|NCT05963022|537064300|FG002|Overall Study|Protocol Violation|0|||
148886727|NCT05963022|537064301|FG003|Overall Study|Protocol Violation|0|||
148886728|NCT05963022|537064298|FG000|Overall Study|Pregnancy|0|||
148886729|NCT05963022|537064299|FG001|Overall Study|Pregnancy|1|||
148886730|NCT05963022|537064300|FG002|Overall Study|Pregnancy|1|||
148886731|NCT05963022|537064301|FG003|Overall Study|Pregnancy|1|||
148886732|NCT05963022|537064298|FG000|Overall Study|Withdrawal by Subject|0|||
148886733|NCT05963022|537064299|FG001|Overall Study|Withdrawal by Subject|0|||
148886734|NCT05963022|537064300|FG002|Overall Study|Withdrawal by Subject|2|||
148886735|NCT05963022|537064301|FG003|Overall Study|Withdrawal by Subject|1|||
148886736|NCT05963022|537064298|FG000|Overall Study|Lost to Follow-up|0|||
148886737|NCT05963022|537064299|FG001|Overall Study|Lost to Follow-up|0|||
148886738|NCT05963022|537064300|FG002|Overall Study|Lost to Follow-up|0|||
148886739|NCT05963022|537064301|FG003|Overall Study|Lost to Follow-up|1|||
148886740|NCT05963022|537064298|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
148886741|NCT05963022|537064299|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
148886742|NCT05963022|537064300|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
148886743|NCT05963022|537064301|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
148886744|NCT04524858|537064304|FG000|Overall Study|Adverse Event|1|||
148886745|NCT02366195|537064305|FG000|Overall Study|Protocol-specified criteria|3|||
148886746|NCT02366195|537064305|FG000|Overall Study|Withdrawal by Subject|9|||
148886747|NCT02366195|537064305|FG000|Overall Study|Lost to Follow-up|1|||
148886748|NCT02366195|537064305|FG000|Overall Study|Death|41|||
148886749|NCT01788566|537064307|FG000|Overall Study|Death|4|||
148886750|NCT01788566|537064307|FG000|Overall Study|Adverse Event|1|||
148886751|NCT01788566|537064307|FG000|Overall Study|Clinical Progressive Disease|3|||
148886752|NCT03030417|537064308|FG000|Dose Expansion|Disease progression before treatment|0|||
148886753|NCT03030417|537064309|FG001|Dose Expansion|Disease progression before treatment|0|||
148886754|NCT03030417|537064310|FG002|Dose Expansion|Disease progression before treatment|0|||
148886755|NCT03030417|537064311|FG003|Dose Expansion|Disease progression before treatment|0|||
148886756|NCT03030417|537064312|FG004|Dose Expansion|Disease progression before treatment|0|||
148886757|NCT03030417|537064313|FG005|Dose Expansion|Disease progression before treatment|0|||
148886758|NCT03030417|537064314|FG006|Dose Expansion|Disease progression before treatment|0|||
148886759|NCT03030417|537064315|FG007|Dose Expansion|Disease progression before treatment|0|||
148886760|NCT03030417|537064316|FG008|Dose Expansion|Disease progression before treatment|0|||
148886761|NCT03030417|537064317|FG009|Dose Expansion|Disease progression before treatment|0|||
149005126|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
149005127|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
149005128|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
149005129|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
149005130|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
149005131|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
149005132|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
149005133|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
149005134|NCT00261495|537497844|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
149005135|NCT00261495|537497845|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
149005136|NCT00261495|537497844|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
149005137|NCT00261495|537497845|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
149005138|NCT00261495|537497844|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
149005139|NCT00261495|537497845|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
149005140|NCT00261495|537497844|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
149005141|NCT00261495|537497845|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
149005142|NCT00261495|537497844|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
149005143|NCT00261495|537497845|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
149005144|NCT00261495|537497844|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
149005145|NCT00261495|537497845|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
149005146|NCT00261495|537497844|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
149005147|NCT00261495|537497845|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
149005148|NCT03474107|537497846|FG000|Overall Study|Adverse Event|42|||
149005149|NCT03474107|537497847|FG001|Overall Study|Adverse Event|46|||
149005150|NCT03474107|537497846|FG000|Overall Study|Death|2|||
149005151|NCT03474107|537497847|FG001|Overall Study|Death|2|||
149005152|NCT03474107|537497846|FG000|Overall Study|Lost to Follow-up|0|||
149005153|NCT03474107|537497847|FG001|Overall Study|Lost to Follow-up|1|||
149005154|NCT03474107|537497846|FG000|Overall Study|Progressive Disease|177|||
149005155|NCT03474107|537497847|FG001|Overall Study|Progressive Disease|180|||
149005156|NCT03474107|537497846|FG000|Overall Study|Protocol Violation|1|||
149005157|NCT03474107|537497847|FG001|Overall Study|Protocol Violation|1|||
149005158|NCT03474107|537497846|FG000|Overall Study|Withdrawal by Subject|15|||
149005159|NCT03474107|537497847|FG001|Overall Study|Withdrawal by Subject|27|||
149005160|NCT03474107|537497846|FG000|Overall Study|Physician Decision|7|||
149005161|NCT03474107|537497847|FG001|Overall Study|Physician Decision|22|||
149005162|NCT03474107|537497846|FG000|Overall Study|Miscellaneous|1|||
148886762|NCT03030417|537064318|FG010|Dose Expansion|Disease progression before treatment|0|||
149005163|NCT03474107|537497847|FG001|Overall Study|Miscellaneous|6|||
149005164|NCT01932697|537497848|FG000|Overall Study|Received a different amount of tx|1|||
149005165|NCT01932697|537497849|FG001|Overall Study|Received a different amount of tx|0|||
149005166|NCT01932697|537497848|FG000|Overall Study|Ineligible|1|||
149005167|NCT01932697|537497849|FG001|Overall Study|Ineligible|0|||
148886763|NCT03030417|537064319|FG011|Dose Expansion|Disease progression before treatment|0|||
148886764|NCT03030417|537064320|FG012|Dose Expansion|Disease progression before treatment|1|||
148886765|NCT01539759|537064321|FG000|Overall Study|Lost to Follow-up|6|||
148886766|NCT01539759|537064322|FG001|Overall Study|Lost to Follow-up|8|||
148886767|NCT02175017|537064323|FG000|Overall Study|Did not receive the investigational product|1|||
148886768|NCT02175017|537064324|FG001|Overall Study|Did not receive the investigational product|2|||
148886769|NCT02175017|537064323|FG000|Overall Study|Withdrawal by Subject|6|||
148886770|NCT02175017|537064324|FG001|Overall Study|Withdrawal by Subject|3|||
148886771|NCT02175017|537064323|FG000|Overall Study|Met an exclusion criteria|0|||
148886772|NCT02175017|537064324|FG001|Overall Study|Met an exclusion criteria|1|||
148886773|NCT02175017|537064323|FG000|Overall Study|Adverse Event|3|||
148886774|NCT02175017|537064324|FG001|Overall Study|Adverse Event|10|||
148886775|NCT02175017|537064323|FG000|Overall Study|Disease progression|20|||
148886776|NCT02175017|537064324|FG001|Overall Study|Disease progression|27|||
148886777|NCT02175017|537064323|FG000|Overall Study|Other than above reasons|3|||
148886778|NCT02175017|537064324|FG001|Overall Study|Other than above reasons|0|||
148886779|NCT03575403|537064325|FG000|Overall Study|Adverse Event|1|||
148886780|NCT03575403|537064326|FG001|Overall Study|Adverse Event|0|||
148886781|NCT03575403|537064327|FG002|Overall Study|Adverse Event|0|||
148886782|NCT03575403|537064325|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
148886783|NCT03575403|537064326|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
148886784|NCT03575403|537064327|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
148886785|NCT00773513|537064328|FG000|Overall Study|Renal Transplant|254|||
148886786|NCT00773513|537064329|FG001|Overall Study|Renal Transplant|263|||
148886787|NCT00773513|537064328|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
148886788|NCT00773513|537064329|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
148886789|NCT00773513|537064328|FG000|Overall Study|Withdrew Consent|68|||
148886790|NCT00773513|537064329|FG001|Overall Study|Withdrew Consent|69|||
148886791|NCT00773513|537064328|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
148886792|NCT00773513|537064329|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
148886793|NCT00773513|537064328|FG000|Overall Study|Failure to Return|22|||
148886794|NCT00773513|537064329|FG001|Overall Study|Failure to Return|8|||
148886795|NCT00773513|537064328|FG000|Overall Study|Insufficient Therapeutic Response|1|||
148886796|NCT00773513|537064329|FG001|Overall Study|Insufficient Therapeutic Response|18|||
148886797|NCT00773513|537064328|FG000|Overall Study|Reason Not Specified|159|||
148886798|NCT00773513|537064329|FG001|Overall Study|Reason Not Specified|126|||
148886799|NCT00773513|537064328|FG000|Overall Study|Death|531|||
148886800|NCT00773513|537064329|FG001|Overall Study|Death|545|||
148886801|NCT03359174|537064333|FG000|Overall Study|Adverse Event|1|||
148886802|NCT04965688|537064341|FG000|Overall Study|Withdrawal by Subject|2|||
148886803|NCT04186871|537064344|FG000|Overall Study|Lack of Efficacy|0|||
148886804|NCT04186871|537064345|FG001|Overall Study|Lack of Efficacy|1|||
148886805|NCT04186871|537064346|FG002|Overall Study|Lack of Efficacy|0|||
148886806|NCT04186871|537064347|FG003|Overall Study|Lack of Efficacy|0|||
148886807|NCT04186871|537064348|FG004|Overall Study|Lack of Efficacy|1|||
148886808|NCT04186871|537064349|FG005|Overall Study|Lack of Efficacy|1|||
148886809|NCT04186871|537064344|FG000|Overall Study|Adverse Event|1|||
148886810|NCT04186871|537064345|FG001|Overall Study|Adverse Event|1|||
148886811|NCT04186871|537064346|FG002|Overall Study|Adverse Event|0|||
148886812|NCT04186871|537064347|FG003|Overall Study|Adverse Event|0|||
148886813|NCT04186871|537064348|FG004|Overall Study|Adverse Event|0|||
148886814|NCT04186871|537064349|FG005|Overall Study|Adverse Event|2|||
148886815|NCT04186871|537064344|FG000|Overall Study|Study terminated by sponsor|1|||
148886816|NCT04186871|537064345|FG001|Overall Study|Study terminated by sponsor|2|||
148886817|NCT04186871|537064346|FG002|Overall Study|Study terminated by sponsor|0|||
148886818|NCT04186871|537064347|FG003|Overall Study|Study terminated by sponsor|1|||
149005168|NCT01330316|537497853|FG000|Overall Study|Adverse Event|2|||
149005169|NCT01330316|537497854|FG001|Overall Study|Adverse Event|2|||
149005170|NCT01330316|537497853|FG000|Overall Study|Lack of Efficacy|0|||
149005171|NCT01330316|537497854|FG001|Overall Study|Lack of Efficacy|10|||
148886819|NCT04186871|537064348|FG004|Overall Study|Study terminated by sponsor|0|||
148886820|NCT04186871|537064349|FG005|Overall Study|Study terminated by sponsor|0|||
148886821|NCT04186871|537064344|FG000|Overall Study|Other reasons|0|||
148886822|NCT04186871|537064345|FG001|Overall Study|Other reasons|0|||
148886823|NCT04186871|537064346|FG002|Overall Study|Other reasons|0|||
148886824|NCT04186871|537064347|FG003|Overall Study|Other reasons|0|||
148886825|NCT04186871|537064348|FG004|Overall Study|Other reasons|0|||
148886826|NCT04186871|537064349|FG005|Overall Study|Other reasons|1|||
148886827|NCT04186871|537064344|FG000|Overall Study|Withdrawal by Subject|0|||
148886828|NCT04186871|537064345|FG001|Overall Study|Withdrawal by Subject|0|||
149005172|NCT01330316|537497853|FG000|Overall Study|Lost to Follow-up|0|||
149005173|NCT01330316|537497854|FG001|Overall Study|Lost to Follow-up|1|||
149005174|NCT01330316|537497853|FG000|Overall Study|Withdrawal by Subject|0|||
149005175|NCT01330316|537497854|FG001|Overall Study|Withdrawal by Subject|1|||
149005176|NCT01330316|537497853|FG000|Overall Study|other than above|0|||
149005177|NCT01330316|537497854|FG001|Overall Study|other than above|1|||
148886829|NCT04186871|537064346|FG002|Overall Study|Withdrawal by Subject|0|||
148886830|NCT04186871|537064347|FG003|Overall Study|Withdrawal by Subject|0|||
148886831|NCT04186871|537064348|FG004|Overall Study|Withdrawal by Subject|0|||
148886832|NCT04186871|537064349|FG005|Overall Study|Withdrawal by Subject|1|||
148886833|NCT04186871|537064344|FG000|Overall Study|Lost to Follow-up|0|||
148886834|NCT04186871|537064345|FG001|Overall Study|Lost to Follow-up|0|||
148886835|NCT04186871|537064346|FG002|Overall Study|Lost to Follow-up|0|||
148886836|NCT04186871|537064347|FG003|Overall Study|Lost to Follow-up|0|||
148886837|NCT04186871|537064348|FG004|Overall Study|Lost to Follow-up|0|||
148886838|NCT04186871|537064349|FG005|Overall Study|Lost to Follow-up|1|||
148886839|NCT00291486|537064355|FG000|Overall Study|Adverse Event|0|||
148886840|NCT00291486|537064356|FG001|Overall Study|Adverse Event|3|||
148886841|NCT00291486|537064357|FG002|Overall Study|Adverse Event|0|||
148886842|NCT00291486|537064358|FG003|Overall Study|Adverse Event|1|||
148886843|NCT00291486|537064359|FG004|Overall Study|Adverse Event|0|||
148886844|NCT00291486|537064355|FG000|Overall Study|Withdrawal by Subject|0|||
148886845|NCT00291486|537064356|FG001|Overall Study|Withdrawal by Subject|0|||
148886846|NCT00291486|537064357|FG002|Overall Study|Withdrawal by Subject|0|||
148886847|NCT00291486|537064358|FG003|Overall Study|Withdrawal by Subject|0|||
148886848|NCT00291486|537064359|FG004|Overall Study|Withdrawal by Subject|1|||
148886849|NCT00291486|537064355|FG000|Overall Study|Disease progression|1|||
148886850|NCT00291486|537064356|FG001|Overall Study|Disease progression|0|||
148886851|NCT00291486|537064357|FG002|Overall Study|Disease progression|1|||
148886852|NCT00291486|537064358|FG003|Overall Study|Disease progression|0|||
148886853|NCT00291486|537064359|FG004|Overall Study|Disease progression|0|||
148886854|NCT01045694|537064362|FG000|Overall Study|Withdrawal by Subject|2|||
148886855|NCT00992459|537064366|FG000|Overall Study|Withdrawal by Subject|0|||
148886856|NCT00992459|537064367|FG001|Overall Study|Withdrawal by Subject|1|||
148886857|NCT00992459|537064366|FG000|Overall Study|Adverse Event|1|||
148886858|NCT00992459|537064367|FG001|Overall Study|Adverse Event|0|||
148886859|NCT01408459|537064368|FG000|Overall Study|Withdrawal by Subject|1|||
149049055|NCT04623775|537659566|FG003|Treatment Period|AE unrelated to study drug|9|||
149049056|NCT04623775|537659563|FG000|Treatment Period|participant request to discontinue treatment|0|||
149049057|NCT04623775|537659564|FG001|Treatment Period|participant request to discontinue treatment|2|||
149049058|NCT04623775|537659565|FG002|Treatment Period|participant request to discontinue treatment|2|||
149049059|NCT04623775|537659566|FG003|Treatment Period|participant request to discontinue treatment|0|||
149049060|NCT01303445|537659567|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
149049061|NCT01303445|537659568|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
149049062|NCT01303445|537659567|FG000|Second Intervention (7 Days)|Adverse Event|0|||
149049063|NCT01303445|537659568|FG001|Second Intervention (7 Days)|Adverse Event|2|||
149049064|NCT01303445|537659567|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
148886860|NCT01408459|537064369|FG001|Overall Study|Withdrawal by Subject|1|||
148886861|NCT00543387|537064376|FG000|Panel 1 + Panel 2|Adverse Event|0|||
148886862|NCT00543387|537064377|FG001|Panel 1 + Panel 2|Adverse Event|1|||
148886863|NCT00543387|537064378|FG002|Panel 1 + Panel 2|Adverse Event|0|||
148886864|NCT00543387|537064379|FG003|Panel 1 + Panel 2|Adverse Event|0|||
148886865|NCT00543387|537064380|FG004|Panel 1 + Panel 2|Adverse Event|0|||
148886866|NCT00543387|537064381|FG005|Panel 1 + Panel 2|Adverse Event|0|||
148886867|NCT00543387|537064382|FG006|Panel 1 + Panel 2|Adverse Event|0|||
148886868|NCT00543387|537064383|FG007|Panel 1 + Panel 2|Adverse Event|1|||
148886869|NCT00543387|537064384|FG008|Panel 1 + Panel 2|Adverse Event|1|||
148886870|NCT00543387|537064385|FG009|Panel 1 + Panel 2|Adverse Event|0|||
148886871|NCT00543387|537064386|FG010|Panel 1 + Panel 2|Adverse Event|0|||
148886872|NCT00543387|537064376|FG000|Panel 1 + Panel 2|Physician Decision|0|||
148886873|NCT00543387|537064377|FG001|Panel 1 + Panel 2|Physician Decision|0|||
148886874|NCT00543387|537064378|FG002|Panel 1 + Panel 2|Physician Decision|1|||
148886875|NCT00543387|537064379|FG003|Panel 1 + Panel 2|Physician Decision|0|||
148886876|NCT00543387|537064380|FG004|Panel 1 + Panel 2|Physician Decision|0|||
148886877|NCT00543387|537064381|FG005|Panel 1 + Panel 2|Physician Decision|0|||
148886878|NCT00543387|537064382|FG006|Panel 1 + Panel 2|Physician Decision|0|||
148886879|NCT00543387|537064383|FG007|Panel 1 + Panel 2|Physician Decision|1|||
148886880|NCT00543387|537064384|FG008|Panel 1 + Panel 2|Physician Decision|0|||
149049065|NCT01303445|537659568|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
148886881|NCT00543387|537064385|FG009|Panel 1 + Panel 2|Physician Decision|0|||
149049066|NCT01303445|537659567|FG000|Washout (14 Days)|Protocol Violation|1|||
149049067|NCT01303445|537659568|FG001|Washout (14 Days)|Protocol Violation|0|||
149049068|NCT01303445|537659567|FG000|Washout (14 Days)|Lost to Follow-up|0|||
148886882|NCT00543387|537064386|FG010|Panel 1 + Panel 2|Physician Decision|0|||
148886883|NCT00543387|537064376|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
148886884|NCT00543387|537064377|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
148886885|NCT00543387|537064378|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
148886886|NCT00543387|537064379|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
148886887|NCT00543387|537064380|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
148886888|NCT00543387|537064381|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
148886889|NCT00543387|537064382|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
148886890|NCT00543387|537064383|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
148886891|NCT00543387|537064384|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
148886892|NCT00543387|537064385|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
148886893|NCT00543387|537064386|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
148886894|NCT00543387|537064376|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886895|NCT00543387|537064377|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886896|NCT00543387|537064378|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886897|NCT00543387|537064379|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886898|NCT00543387|537064380|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886899|NCT00543387|537064381|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886900|NCT00543387|537064382|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
148886901|NCT00543387|537064383|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886902|NCT00543387|537064384|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886903|NCT00543387|537064385|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886904|NCT00543387|537064386|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
148886905|NCT00543387|537064376|FG000|Crossover Participants|Progressive Disease|0|||
148886906|NCT00543387|537064377|FG001|Crossover Participants|Progressive Disease|0|||
148886907|NCT00543387|537064378|FG002|Crossover Participants|Progressive Disease|0|||
148886908|NCT00543387|537064379|FG003|Crossover Participants|Progressive Disease|0|||
148886909|NCT00543387|537064380|FG004|Crossover Participants|Progressive Disease|0|||
148886910|NCT00543387|537064381|FG005|Crossover Participants|Progressive Disease|0|||
148886911|NCT00543387|537064382|FG006|Crossover Participants|Progressive Disease|0|||
148886912|NCT00543387|537064383|FG007|Crossover Participants|Progressive Disease|0|||
148886913|NCT00543387|537064384|FG008|Crossover Participants|Progressive Disease|0|||
148886914|NCT00543387|537064385|FG009|Crossover Participants|Progressive Disease|1|||
148886915|NCT00543387|537064386|FG010|Crossover Participants|Progressive Disease|2|||
148886916|NCT00543387|537064376|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
148886917|NCT00543387|537064377|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
148886918|NCT00543387|537064378|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
148886919|NCT00543387|537064379|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
148886920|NCT00543387|537064380|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
148886921|NCT00543387|537064381|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
148886922|NCT00543387|537064382|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
148886923|NCT00543387|537064383|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
148886924|NCT00543387|537064384|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
148886925|NCT00543387|537064385|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
148886926|NCT00543387|537064386|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
148886927|NCT00549445|537064387|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
148886928|NCT00549445|537064388|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
148886929|NCT01792115|537064392|FG000|Overall Study|Lost to Follow-up|0|||
148886930|NCT01792115|537064393|FG001|Overall Study|Lost to Follow-up|1|||
148886931|NCT01792115|537064394|FG002|Overall Study|Lost to Follow-up|0|||
148886932|NCT01389882|537066101|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
148886933|NCT01389882|537066102|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
148886934|NCT01389882|537066101|FG000|Overall Study|Withdrawal by Subject|0|||
148886935|NCT01389882|537066102|FG001|Overall Study|Withdrawal by Subject|1|||
148886936|NCT03790111|537066103|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
148886937|NCT00280917|537066106|FG000|Overall Study|Adverse Event|1|||
148886938|NCT00280917|537066107|FG001|Overall Study|Adverse Event|1|||
148886939|NCT00280917|537066108|FG002|Overall Study|Adverse Event|4|||
148886940|NCT00280917|537066109|FG003|Overall Study|Adverse Event|1|||
148886941|NCT00280917|537066106|FG000|Overall Study|Change Therapy|1|||
148886942|NCT00280917|537066107|FG001|Overall Study|Change Therapy|2|||
148886943|NCT00280917|537066108|FG002|Overall Study|Change Therapy|0|||
148886944|NCT00280917|537066109|FG003|Overall Study|Change Therapy|0|||
148886945|NCT00280917|537066106|FG000|Overall Study|Withdrawal by Subject|0|||
148886946|NCT00280917|537066107|FG001|Overall Study|Withdrawal by Subject|2|||
148886947|NCT00280917|537066108|FG002|Overall Study|Withdrawal by Subject|0|||
148886948|NCT00280917|537066109|FG003|Overall Study|Withdrawal by Subject|1|||
149049069|NCT01303445|537659568|FG001|Washout (14 Days)|Lost to Follow-up|2|||
149049070|NCT01303445|537659567|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
149049071|NCT01303445|537659568|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
149049072|NCT01303445|537659567|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
149049073|NCT01303445|537659568|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
148886949|NCT00280917|537066106|FG000|Overall Study|Noncompliance|0|||
148886950|NCT00280917|537066107|FG001|Overall Study|Noncompliance|1|||
148886951|NCT00280917|537066108|FG002|Overall Study|Noncompliance|2|||
148886952|NCT00280917|537066109|FG003|Overall Study|Noncompliance|0|||
148886953|NCT03529110|537066110|FG000|Overall Study|Progressive Disease|66|||
148886954|NCT03529110|537066111|FG001|Overall Study|Progressive Disease|158|||
148886955|NCT03529110|537066110|FG000|Overall Study|Clinical Progression|4|||
148886956|NCT03529110|537066111|FG001|Overall Study|Clinical Progression|12|||
149049074|NCT01959698|537659569|FG000|Overall Study|Adverse Event|0|||
148886957|NCT03529110|537066110|FG000|Overall Study|Adverse Event|35|||
148886958|NCT03529110|537066111|FG001|Overall Study|Adverse Event|17|||
148886959|NCT03529110|537066110|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
148886960|NCT03529110|537066111|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
148886961|NCT03529110|537066110|FG000|Overall Study|Lack of Efficacy|3|||
148886962|NCT03529110|537066111|FG001|Overall Study|Lack of Efficacy|3|||
148886963|NCT03529110|537066110|FG000|Overall Study|Physician Decision|2|||
148886964|NCT03529110|537066111|FG001|Overall Study|Physician Decision|8|||
148886965|NCT03529110|537066110|FG000|Overall Study|Miscellaneous|2|||
148886966|NCT03529110|537066111|FG001|Overall Study|Miscellaneous|5|||
148886967|NCT01584232|537066112|FG000|Overall Study|Adverse Event|3|||
148886968|NCT01584232|537066113|FG001|Overall Study|Adverse Event|1|||
148886969|NCT01584232|537066112|FG000|Overall Study|Withdrawal by Subject|2|||
148886970|NCT01584232|537066113|FG001|Overall Study|Withdrawal by Subject|1|||
148886971|NCT01584232|537066112|FG000|Overall Study|Physician Decision|2|||
148886972|NCT01584232|537066113|FG001|Overall Study|Physician Decision|1|||
148886973|NCT01584232|537066112|FG000|Overall Study|Lost to Follow-up|1|||
148886974|NCT01584232|537066113|FG001|Overall Study|Lost to Follow-up|0|||
148886975|NCT05030350|537066123|FG000|Overall Study|Adverse Event|13|||
148886976|NCT05030350|537066123|FG000|Overall Study|Lack of Efficacy|8|||
148886977|NCT05030350|537066123|FG000|Overall Study|Lost to Follow-up|35|||
148886978|NCT05030350|537066123|FG000|Overall Study|Pregnancy|2|||
148886979|NCT05030350|537066123|FG000|Overall Study|Protocol Violation|2|||
148886980|NCT05030350|537066123|FG000|Overall Study|Withdrawal by Subject|60|||
148886981|NCT05030350|537066123|FG000|Overall Study|Study terminated by sponsor|349|||
148886982|NCT05030350|537066123|FG000|Overall Study|Positive Drug Screen|4|||
148886983|NCT05030350|537066123|FG000|Overall Study|Other|8|||
148886984|NCT03654690|537066124|FG000|Overall Study|Withdrawal by Subject|1|||
148886985|NCT03654690|537066125|FG001|Overall Study|Withdrawal by Subject|0|||
148886986|NCT03654690|537066126|FG002|Overall Study|Withdrawal by Subject|0|||
148886987|NCT02711137|537066127|FG000|Overall Study|Death|1|||
148886988|NCT02711137|537066128|FG001|Overall Study|Death|4|||
148886989|NCT02711137|537066129|FG002|Overall Study|Death|5|||
148886990|NCT02711137|537066130|FG003|Overall Study|Death|5|||
148886991|NCT02711137|537066131|FG004|Overall Study|Death|3|||
148886992|NCT02711137|537066132|FG005|Overall Study|Death|1|||
148886993|NCT02711137|537066133|FG006|Overall Study|Death|61|||
148886994|NCT02711137|537066134|FG007|Overall Study|Death|3|||
148886995|NCT02711137|537066135|FG008|Overall Study|Death|0|||
148886996|NCT02711137|537066136|FG009|Overall Study|Death|1|||
148886997|NCT02711137|537066137|FG010|Overall Study|Death|1|||
148886998|NCT02711137|537066138|FG011|Overall Study|Death|1|||
149049075|NCT01959698|537659570|FG001|Overall Study|Adverse Event|0|||
149049076|NCT01959698|537659571|FG002|Overall Study|Adverse Event|0|||
149049077|NCT01959698|537659572|FG003|Overall Study|Adverse Event|0|||
149049078|NCT01959698|537659573|FG004|Overall Study|Adverse Event|0|||
149049079|NCT01959698|537659574|FG005|Overall Study|Adverse Event|0|||
149049080|NCT01959698|537659575|FG006|Overall Study|Adverse Event|1|||
149049081|NCT01959698|537659569|FG000|Overall Study|Physician Decision|1|||
149049082|NCT01959698|537659570|FG001|Overall Study|Physician Decision|0|||
149049083|NCT01959698|537659571|FG002|Overall Study|Physician Decision|1|||
149049084|NCT01959698|537659572|FG003|Overall Study|Physician Decision|2|||
149049085|NCT01959698|537659573|FG004|Overall Study|Physician Decision|0|||
149049086|NCT01959698|537659574|FG005|Overall Study|Physician Decision|3|||
149049087|NCT01959698|537659575|FG006|Overall Study|Physician Decision|3|||
149049088|NCT04059354|537660892|FG000|Overall Study|COVID-19 pandemic|3|||
149049089|NCT02396199|537660894|FG000|Overall Study|Lost to Follow-up|1|||
148886999|NCT02711137|537066139|FG012|Overall Study|Death|0|||
148887000|NCT02711137|537066140|FG013|Overall Study|Death|0|||
149049090|NCT02396199|537660894|FG000|Overall Study|Death|4|||
149049091|NCT04112316|537660895|FG000|First Period (8 Weeks)|Protocol Violation|1|||
148887001|NCT02711137|537066141|FG014|Overall Study|Death|0|||
148887002|NCT02711137|537066127|FG000|Overall Study|Study Terminated by Sponsor|0|||
148887003|NCT02711137|537066128|FG001|Overall Study|Study Terminated by Sponsor|0|||
148887004|NCT02711137|537066129|FG002|Overall Study|Study Terminated by Sponsor|1|||
148887005|NCT02711137|537066130|FG003|Overall Study|Study Terminated by Sponsor|0|||
148887006|NCT02711137|537066131|FG004|Overall Study|Study Terminated by Sponsor|0|||
149049092|NCT04112316|537660896|FG001|First Period (8 Weeks)|Protocol Violation|0|||
149049093|NCT04112316|537660895|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
149049094|NCT04112316|537660896|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
149049095|NCT02597946|537660906|FG000|Overall Study|Withdrawal by Subject|1|||
149049096|NCT02597946|537660906|FG000|Overall Study|Progressive disease|16|||
149049097|NCT02597946|537660906|FG000|Overall Study|Other than above|1|||
148887007|NCT02711137|537066132|FG005|Overall Study|Study Terminated by Sponsor|0|||
148887008|NCT02711137|537066133|FG006|Overall Study|Study Terminated by Sponsor|1|||
148887009|NCT02711137|537066134|FG007|Overall Study|Study Terminated by Sponsor|0|||
148887010|NCT02711137|537066135|FG008|Overall Study|Study Terminated by Sponsor|0|||
148887011|NCT02711137|537066136|FG009|Overall Study|Study Terminated by Sponsor|0|||
148887012|NCT02711137|537066137|FG010|Overall Study|Study Terminated by Sponsor|0|||
148887013|NCT02711137|537066138|FG011|Overall Study|Study Terminated by Sponsor|0|||
149049098|NCT03655132|537660921|FG000|Overall Study|Lost to Follow-up|2|||
149049099|NCT03655132|537660922|FG001|Overall Study|Lost to Follow-up|1|||
149049100|NCT03655132|537660921|FG000|Overall Study|Withdrawal by Subject|0|||
149049101|NCT03655132|537660922|FG001|Overall Study|Withdrawal by Subject|1|||
149049102|NCT03655132|537660921|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
149049103|NCT03655132|537660922|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
149049104|NCT05919082|537660923|FG000|Overall Study|Adverse Event|3|||
149049105|NCT05919082|537660924|FG001|Overall Study|Adverse Event|0|||
149049106|NCT05919082|537660923|FG000|Overall Study|Lost to Follow-up|0|||
149049107|NCT05919082|537660924|FG001|Overall Study|Lost to Follow-up|1|||
149049108|NCT05919082|537660923|FG000|Overall Study|Withdrawal by Subject|8|||
149049109|NCT05919082|537660924|FG001|Overall Study|Withdrawal by Subject|9|||
149049110|NCT05919082|537660923|FG000|Overall Study|Lack of Efficacy|0|||
149049111|NCT05919082|537660924|FG001|Overall Study|Lack of Efficacy|1|||
149049112|NCT05919082|537660923|FG000|Overall Study|Investigator Decision|1|||
149049113|NCT05919082|537660924|FG001|Overall Study|Investigator Decision|0|||
149049114|NCT00650104|537660925|FG000|Overall Study|Adverse Event|17|||
149049115|NCT00650104|537660925|FG000|Overall Study|Death|2|||
149049116|NCT00650104|537660925|FG000|Overall Study|Withdrawal by Subject|11|||
149049117|NCT00650104|537660925|FG000|Overall Study|Physician Decision|7|||
149049118|NCT00650104|537660925|FG000|Overall Study|Lost to Follow-up|1|||
149049119|NCT00650104|537660925|FG000|Overall Study|Non-compliance|2|||
149049120|NCT00650104|537660925|FG000|Overall Study|Sponsor Terminated Dosing|1|||
149049121|NCT04711135|537660926|FG000|Overall Study|Physician Decision|0|||
149049122|NCT04711135|537660927|FG001|Overall Study|Physician Decision|1|||
149049123|NCT04711135|537660926|FG000|Overall Study|Ongoing treatment|0|||
149049124|NCT04711135|537660927|FG001|Overall Study|Ongoing treatment|1|||
149049125|NCT04436107|537660931|FG000|Overall Study|Sponsor Ended Study|2|||
148887014|NCT02711137|537066139|FG012|Overall Study|Study Terminated by Sponsor|0|||
148887015|NCT02711137|537066140|FG013|Overall Study|Study Terminated by Sponsor|0|||
148887016|NCT02711137|537066141|FG014|Overall Study|Study Terminated by Sponsor|0|||
148887017|NCT02711137|537066127|FG000|Overall Study|Physician Decision|1|||
148887018|NCT02711137|537066128|FG001|Overall Study|Physician Decision|0|||
148887019|NCT02711137|537066129|FG002|Overall Study|Physician Decision|2|||
148887020|NCT02711137|537066130|FG003|Overall Study|Physician Decision|1|||
148887021|NCT02711137|537066131|FG004|Overall Study|Physician Decision|1|||
148887022|NCT02711137|537066132|FG005|Overall Study|Physician Decision|0|||
148887023|NCT02711137|537066133|FG006|Overall Study|Physician Decision|12|||
148887024|NCT02711137|537066134|FG007|Overall Study|Physician Decision|2|||
148887025|NCT02711137|537066135|FG008|Overall Study|Physician Decision|1|||
148887026|NCT02711137|537066136|FG009|Overall Study|Physician Decision|1|||
148887027|NCT02711137|537066137|FG010|Overall Study|Physician Decision|3|||
148887028|NCT02711137|537066138|FG011|Overall Study|Physician Decision|2|||
148887029|NCT02711137|537066139|FG012|Overall Study|Physician Decision|1|||
148887030|NCT02711137|537066140|FG013|Overall Study|Physician Decision|1|||
148887031|NCT02711137|537066141|FG014|Overall Study|Physician Decision|2|||
148887032|NCT02711137|537066127|FG000|Overall Study|Other|0|||
148887033|NCT02711137|537066128|FG001|Overall Study|Other|1|||
148887034|NCT02711137|537066129|FG002|Overall Study|Other|0|||
148887035|NCT02711137|537066130|FG003|Overall Study|Other|0|||
148887036|NCT02711137|537066131|FG004|Overall Study|Other|0|||
148887037|NCT02711137|537066132|FG005|Overall Study|Other|0|||
148887038|NCT02711137|537066133|FG006|Overall Study|Other|3|||
148887039|NCT02711137|537066134|FG007|Overall Study|Other|0|||
148887040|NCT02711137|537066135|FG008|Overall Study|Other|0|||
148887041|NCT02711137|537066136|FG009|Overall Study|Other|0|||
148887042|NCT02711137|537066137|FG010|Overall Study|Other|0|||
148887043|NCT02711137|537066138|FG011|Overall Study|Other|0|||
148887044|NCT02711137|537066139|FG012|Overall Study|Other|0|||
148887045|NCT02711137|537066140|FG013|Overall Study|Other|0|||
148887046|NCT02711137|537066141|FG014|Overall Study|Other|1|||
148887047|NCT02711137|537066127|FG000|Overall Study|Withdrawal by Subject|1|||
148887048|NCT02711137|537066128|FG001|Overall Study|Withdrawal by Subject|0|||
148887049|NCT02711137|537066129|FG002|Overall Study|Withdrawal by Subject|0|||
149049126|NCT04436107|537660932|FG001|Overall Study|Sponsor Ended Study|4|||
149049127|NCT04436107|537660933|FG002|Overall Study|Sponsor Ended Study|8|||
149049128|NCT04436107|537660934|FG003|Overall Study|Sponsor Ended Study|20|||
149049129|NCT04436107|537660931|FG000|Overall Study|Death|3|||
149049130|NCT04436107|537660932|FG001|Overall Study|Death|5|||
149049131|NCT04436107|537660933|FG002|Overall Study|Death|3|||
149049132|NCT04436107|537660934|FG003|Overall Study|Death|18|||
149049133|NCT04436107|537660931|FG000|Overall Study|Withdrawal by Subject|1|||
148887050|NCT02711137|537066130|FG003|Overall Study|Withdrawal by Subject|1|||
148887051|NCT02711137|537066131|FG004|Overall Study|Withdrawal by Subject|1|||
148887052|NCT02711137|537066132|FG005|Overall Study|Withdrawal by Subject|0|||
148887053|NCT02711137|537066133|FG006|Overall Study|Withdrawal by Subject|7|||
148887054|NCT02711137|537066134|FG007|Overall Study|Withdrawal by Subject|0|||
148887055|NCT02711137|537066135|FG008|Overall Study|Withdrawal by Subject|0|||
149049134|NCT04436107|537660932|FG001|Overall Study|Withdrawal by Subject|1|||
148887056|NCT02711137|537066136|FG009|Overall Study|Withdrawal by Subject|0|||
148887057|NCT02711137|537066137|FG010|Overall Study|Withdrawal by Subject|0|||
148887058|NCT02711137|537066138|FG011|Overall Study|Withdrawal by Subject|0|||
148887059|NCT02711137|537066139|FG012|Overall Study|Withdrawal by Subject|0|||
148887060|NCT02711137|537066140|FG013|Overall Study|Withdrawal by Subject|1|||
148887061|NCT02711137|537066141|FG014|Overall Study|Withdrawal by Subject|0|||
148887062|NCT02711137|537066127|FG000|Overall Study|Lost to Follow-up|1|||
148887063|NCT02711137|537066128|FG001|Overall Study|Lost to Follow-up|0|||
148887064|NCT02711137|537066129|FG002|Overall Study|Lost to Follow-up|0|||
148887065|NCT02711137|537066130|FG003|Overall Study|Lost to Follow-up|0|||
148887066|NCT02711137|537066131|FG004|Overall Study|Lost to Follow-up|0|||
148887067|NCT02711137|537066132|FG005|Overall Study|Lost to Follow-up|0|||
148887068|NCT02711137|537066133|FG006|Overall Study|Lost to Follow-up|2|||
148887069|NCT02711137|537066134|FG007|Overall Study|Lost to Follow-up|0|||
148887070|NCT02711137|537066135|FG008|Overall Study|Lost to Follow-up|0|||
148887071|NCT02711137|537066136|FG009|Overall Study|Lost to Follow-up|0|||
148887072|NCT02711137|537066137|FG010|Overall Study|Lost to Follow-up|0|||
148887073|NCT02711137|537066138|FG011|Overall Study|Lost to Follow-up|0|||
148887074|NCT02711137|537066139|FG012|Overall Study|Lost to Follow-up|0|||
148887075|NCT02711137|537066140|FG013|Overall Study|Lost to Follow-up|0|||
148887076|NCT02711137|537066141|FG014|Overall Study|Lost to Follow-up|0|||
148887077|NCT00742183|537066144|FG000|Overall Study|Adverse Event|2|||
148887078|NCT00742183|537066145|FG001|Overall Study|Adverse Event|2|||
148887079|NCT00742183|537066144|FG000|Overall Study|Death|1|||
148887080|NCT00742183|537066145|FG001|Overall Study|Death|0|||
148887081|NCT00742183|537066144|FG000|Overall Study|Physician Decision|0|||
148887082|NCT00742183|537066145|FG001|Overall Study|Physician Decision|2|||
148887083|NCT00742183|537066144|FG000|Overall Study|Lost to Follow-up|4|||
148887084|NCT00742183|537066145|FG001|Overall Study|Lost to Follow-up|4|||
148887085|NCT00742183|537066144|FG000|Overall Study|Required skin-graft|1|||
148887086|NCT00742183|537066145|FG001|Overall Study|Required skin-graft|1|||
148887087|NCT00742183|537066144|FG000|Overall Study|Withdrawal by Subject|1|||
148887088|NCT00742183|537066145|FG001|Overall Study|Withdrawal by Subject|0|||
148887089|NCT00742183|537066144|FG000|Overall Study|Lack of Efficacy|0|||
148887090|NCT00742183|537066145|FG001|Overall Study|Lack of Efficacy|3|||
148887091|NCT03922581|537066153|FG000|Overall Study|Lost to Follow-up|20|||
148887092|NCT03922581|537066154|FG001|Overall Study|Lost to Follow-up|9|||
148887093|NCT03922581|537066153|FG000|Overall Study|Physician Decision|1|||
148887094|NCT03922581|537066154|FG001|Overall Study|Physician Decision|1|||
148887095|NCT03922581|537066153|FG000|Overall Study|Withdrawal by Subject|1|||
148887096|NCT03922581|537066154|FG001|Overall Study|Withdrawal by Subject|0|||
148887097|NCT00764699|537066155|FG000|Overall Study|PI left and study terminated|3|||
148887098|NCT01508312|537066161|FG000|Overall Study|Lost to Follow-up|1|||
148887099|NCT01508312|537066162|FG001|Overall Study|Lost to Follow-up|0|||
148887100|NCT01508312|537066163|FG002|Overall Study|Lost to Follow-up|0|||
148887101|NCT01508312|537066164|FG003|Overall Study|Lost to Follow-up|0|||
148887102|NCT01508312|537066161|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
148887103|NCT01508312|537066162|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
148887104|NCT01508312|537066163|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
148887105|NCT01508312|537066164|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
148887106|NCT01508312|537066161|FG000|Overall Study|Adverse Event|0|||
148887107|NCT01508312|537066162|FG001|Overall Study|Adverse Event|0|||
148887108|NCT01508312|537066163|FG002|Overall Study|Adverse Event|2|||
148887109|NCT01508312|537066164|FG003|Overall Study|Adverse Event|0|||
148887110|NCT01508312|537066161|FG000|Overall Study|Lack of Efficacy|0|||
148887111|NCT01508312|537066162|FG001|Overall Study|Lack of Efficacy|0|||
148887112|NCT01508312|537066163|FG002|Overall Study|Lack of Efficacy|1|||
149049135|NCT04436107|537660933|FG002|Overall Study|Withdrawal by Subject|0|||
148887113|NCT01508312|537066164|FG003|Overall Study|Lack of Efficacy|0|||
148887114|NCT01508312|537066161|FG000|Overall Study|Withdrawal by Subject|0|||
148887115|NCT01508312|537066162|FG001|Overall Study|Withdrawal by Subject|0|||
148887116|NCT01508312|537066163|FG002|Overall Study|Withdrawal by Subject|1|||
148887117|NCT01508312|537066164|FG003|Overall Study|Withdrawal by Subject|0|||
148887118|NCT02223715|537066165|FG000|Overall Study|Death|31|||
148887119|NCT02223715|537066165|FG000|Overall Study|Lost to Follow-up|73|||
148887120|NCT01745367|537066166|FG000|Overall Study|Death|1|||
148887121|NCT01745367|537066167|FG001|Overall Study|Death|0|||
148887122|NCT01745367|537066166|FG000|Overall Study|Withdrawal by Subject|1|||
148887123|NCT01745367|537066167|FG001|Overall Study|Withdrawal by Subject|2|||
148887124|NCT01745367|537066166|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
148887125|NCT01745367|537066167|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
148887126|NCT01745367|537066166|FG000|Overall Study|Other Reasons Unspecified|0|||
148887127|NCT01745367|537066167|FG001|Overall Study|Other Reasons Unspecified|2|||
148887128|NCT02107703|537066171|FG000|Overall Study|Withdrawal by Subject|46|||
148887129|NCT02107703|537066172|FG001|Overall Study|Withdrawal by Subject|21|||
148887130|NCT02107703|537066171|FG000|Overall Study|Lost to Follow-up|20|||
149049136|NCT04436107|537660934|FG003|Overall Study|Withdrawal by Subject|1|||
148887131|NCT02107703|537066172|FG001|Overall Study|Lost to Follow-up|9|||
148887132|NCT02107703|537066171|FG000|Overall Study|On study treatment/follow up|48|||
148887133|NCT02107703|537066172|FG001|Overall Study|On study treatment/follow up|5|||
148887134|NCT00354679|537066173|FG000|Overall Study|Patient Not Treated|1|||
148887135|NCT03906071|537066174|FG000|Overall Study|Death|180|||
148887136|NCT03906071|537066175|FG001|Overall Study|Death|185|||
148887137|NCT03906071|537066174|FG000|Overall Study|Lost to Follow-up|3|||
148887138|NCT03906071|537066175|FG001|Overall Study|Lost to Follow-up|3|||
148887139|NCT03906071|537066174|FG000|Overall Study|Withdrawal by Subject|15|||
148887140|NCT03906071|537066175|FG001|Overall Study|Withdrawal by Subject|27|||
148887141|NCT03906071|537066174|FG000|Overall Study|Other|2|||
148887142|NCT03906071|537066175|FG001|Overall Study|Other|1|||
148887143|NCT00466440|537066176|FG000|Overall Study|Adverse Event|0|||
148887144|NCT00466440|537066177|FG001|Overall Study|Adverse Event|3|||
148887145|NCT00466440|537066178|FG002|Overall Study|Adverse Event|1|||
148887146|NCT00466440|537066176|FG000|Overall Study|Death|1|||
148887147|NCT00466440|537066177|FG001|Overall Study|Death|1|||
148887148|NCT00466440|537066178|FG002|Overall Study|Death|0|||
148887149|NCT00466440|537066176|FG000|Overall Study|Progressive disease|13|||
148887150|NCT00466440|537066177|FG001|Overall Study|Progressive disease|5|||
148887151|NCT00466440|537066178|FG002|Overall Study|Progressive disease|4|||
148887152|NCT00466440|537066176|FG000|Overall Study|Lost to Follow-up|0|||
148887153|NCT00466440|537066177|FG001|Overall Study|Lost to Follow-up|1|||
148887154|NCT00466440|537066178|FG002|Overall Study|Lost to Follow-up|0|||
148887155|NCT00466440|537066176|FG000|Overall Study|Physician Decision|0|||
148887156|NCT00466440|537066177|FG001|Overall Study|Physician Decision|1|||
148887157|NCT00466440|537066178|FG002|Overall Study|Physician Decision|2|||
148887158|NCT00466440|537066176|FG000|Overall Study|Protocol entry criteria not met|0|||
148887159|NCT00466440|537066177|FG001|Overall Study|Protocol entry criteria not met|0|||
148887160|NCT00466440|537066178|FG002|Overall Study|Protocol entry criteria not met|4|||
148887161|NCT00466440|537066176|FG000|Overall Study|Withdrawal by Subject|0|||
148887162|NCT00466440|537066177|FG001|Overall Study|Withdrawal by Subject|1|||
148887163|NCT00466440|537066178|FG002|Overall Study|Withdrawal by Subject|0|||
148887164|NCT00466440|537066176|FG000|Overall Study|Sponsor decision|0|||
148887165|NCT00466440|537066177|FG001|Overall Study|Sponsor decision|0|||
148887166|NCT00466440|537066178|FG002|Overall Study|Sponsor decision|1|||
148887167|NCT03187132|537066179|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
148887168|NCT03187132|537066180|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
148887169|NCT03187132|537066179|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
148887170|NCT03187132|537066180|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
148887171|NCT03187132|537066179|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
148887172|NCT03187132|537066180|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
148887173|NCT03187132|537066179|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
148887174|NCT03187132|537066180|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
148887175|NCT03187132|537066179|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
148887176|NCT03187132|537066180|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
148887177|NCT03187132|537066179|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
148887178|NCT03187132|537066180|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
148887179|NCT03187132|537066179|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
148887180|NCT03187132|537066180|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
148887181|NCT03187132|537066179|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
148887182|NCT03187132|537066180|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
148887183|NCT03187132|537066179|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
148887184|NCT03187132|537066180|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
148887185|NCT03187132|537066179|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
148887186|NCT03187132|537066180|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
148887187|NCT03187132|537066179|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
148887188|NCT03187132|537066180|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
148887189|NCT01020786|537066185|FG000|Induction Period|Entry Criteria Not Met|2|||
148887190|NCT01020786|537066185|FG000|Induction Period|Adverse Event|10|||
148887191|NCT01020786|537066185|FG000|Induction Period|Progressive Disease|31|||
148887192|NCT01020786|537066185|FG000|Induction Period|Investigator Decision|3|||
148887193|NCT01020786|537066185|FG000|Induction Period|Withdrawal by Subject|3|||
148887194|NCT01020786|537066185|FG000|Maintenance Period|Adverse Event|8|||
148887195|NCT01020786|537066185|FG000|Maintenance Period|Progressive Disease|43|||
148887196|NCT01020786|537066185|FG000|Maintenance Period|Withdrawal by Subject|8|||
148887197|NCT01020786|537066185|FG000|Maintenance Period|Sponsor Decision|1|||
148887198|NCT00988598|537066186|FG000|Overall Study|Withdrawal by Subject|2|||
148887199|NCT00988598|537066187|FG001|Overall Study|Withdrawal by Subject|0|||
148887200|NCT01141712|537066191|FG000|Overall Study|Disease progression|3|||
148887201|NCT01358825|537066202|FG000|Overall Study|Blood sample not drawn|0|||
148887202|NCT01358825|537066203|FG001|Overall Study|Blood sample not drawn|1|||
148887203|NCT01012258|537066204|FG000|Overall Study|Death|14|||
148887204|NCT01012258|537066204|FG000|Overall Study|Lost to Follow-up|1|||
148887205|NCT01012258|537066204|FG000|Overall Study|Adverse Event|1|||
148887206|NCT01012258|537066204|FG000|Overall Study|Progressive Disease (PD)|18|||
148887207|NCT01012258|537066204|FG000|Overall Study|Symptomatic Deterioration|1|||
148887208|NCT01012258|537066204|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
148887209|NCT01012258|537066204|FG000|Overall Study|Another Tumor Discovered|1|||
148887210|NCT01012258|537066204|FG000|Overall Study|Ongoing|29|||
148887211|NCT00113841|537066212|FG000|Overall Study|Disease progression|0|||
148887212|NCT00113841|537066213|FG001|Overall Study|Disease progression|2|||
148887213|NCT00113841|537066212|FG000|Overall Study|Non-compliant|1|||
148887214|NCT00113841|537066213|FG001|Overall Study|Non-compliant|0|||
148887215|NCT01076959|537066214|FG000|Overall Study|Adverse Event|767|||
148887216|NCT01076959|537066214|FG000|Overall Study|Lack of Efficacy|849|||
148887217|NCT01076959|537066214|FG000|Overall Study|Non-compliance|274|||
148887218|NCT01076959|537066214|FG000|Overall Study|Lost to Follow-up|241|||
148887219|NCT01076959|537066214|FG000|Overall Study|Other|119|||
148887220|NCT02491983|537066215|FG000|Overall Study|Physician Decision|1|||
148887221|NCT02491983|537066216|FG001|Overall Study|Physician Decision|0|||
148887222|NCT02491983|537066215|FG000|Overall Study|Not meet selection criteria|1|||
148887223|NCT02491983|537066216|FG001|Overall Study|Not meet selection criteria|0|||
148887224|NCT02491983|537066215|FG000|Overall Study|Withdrawal by Subject|0|||
148887225|NCT02491983|537066216|FG001|Overall Study|Withdrawal by Subject|1|||
148887226|NCT01332994|537066220|FG000|Overall Study|Adverse Event|34|||
148887227|NCT01332994|537066220|FG000|Overall Study|Death|1|||
148887228|NCT01332994|537066220|FG000|Overall Study|Lack of Efficacy|1|||
148887229|NCT01332994|537066220|FG000|Overall Study|Lost to Follow-up|4|||
148887230|NCT01332994|537066220|FG000|Overall Study|Protocol Violation|6|||
148887231|NCT01332994|537066220|FG000|Overall Study|Withdrawal by Subject|15|||
148887232|NCT01332994|537066220|FG000|Overall Study|Administrative Problem|2|||
148887233|NCT01332994|537066220|FG000|Overall Study|Other|8|||
148887234|NCT03384940|537066221|FG000|Overall Study|Progressive disease|36|||
148887235|NCT03384940|537066222|FG001|Overall Study|Progressive disease|11|||
148887236|NCT03384940|537066223|FG002|Overall Study|Progressive disease|13|||
148887237|NCT03384940|537066221|FG000|Overall Study|Clinical progression|4|||
148887238|NCT03384940|537066222|FG001|Overall Study|Clinical progression|0|||
148887239|NCT03384940|537066223|FG002|Overall Study|Clinical progression|3|||
148887240|NCT03384940|537066221|FG000|Overall Study|Adverse Event|7|||
148887241|NCT03384940|537066222|FG001|Overall Study|Adverse Event|1|||
148887242|NCT03384940|537066223|FG002|Overall Study|Adverse Event|1|||
148887243|NCT03384940|537066221|FG000|Overall Study|Withdrawal by Subject|3|||
148887244|NCT03384940|537066222|FG001|Overall Study|Withdrawal by Subject|1|||
148887245|NCT03384940|537066223|FG002|Overall Study|Withdrawal by Subject|0|||
148887246|NCT03384940|537066221|FG000|Overall Study|Physician Decision|1|||
148887247|NCT03384940|537066222|FG001|Overall Study|Physician Decision|1|||
148887248|NCT03384940|537066223|FG002|Overall Study|Physician Decision|0|||
148887249|NCT03384940|537066221|FG000|Overall Study|Death|2|||
148887250|NCT03384940|537066222|FG001|Overall Study|Death|1|||
148887251|NCT03384940|537066223|FG002|Overall Study|Death|0|||
148887252|NCT03384940|537066221|FG000|Overall Study|Other|0|||
148887253|NCT03384940|537066222|FG001|Overall Study|Other|0|||
148887254|NCT03384940|537066223|FG002|Overall Study|Other|1|||
148887255|NCT03087513|537066226|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
148887256|NCT04170543|537066227|FG000|Overall Study|Death|1|||
148887257|NCT04170543|537066228|FG001|Overall Study|Death|1|||
148887258|NCT04170543|537066229|FG002|Overall Study|Death|1|||
148887259|NCT04170543|537066230|FG003|Overall Study|Death|1|||
148887260|NCT04170543|537066231|FG004|Overall Study|Death|1|||
148887261|NCT04170543|537066227|FG000|Overall Study|Lost to Follow-up|3|||
148887262|NCT04170543|537066228|FG001|Overall Study|Lost to Follow-up|3|||
148887263|NCT04170543|537066229|FG002|Overall Study|Lost to Follow-up|0|||
148887264|NCT04170543|537066230|FG003|Overall Study|Lost to Follow-up|3|||
148887265|NCT04170543|537066231|FG004|Overall Study|Lost to Follow-up|1|||
148887266|NCT04170543|537066227|FG000|Overall Study|Withdrawal by Subject|13|||
148887267|NCT04170543|537066228|FG001|Overall Study|Withdrawal by Subject|6|||
148887268|NCT04170543|537066229|FG002|Overall Study|Withdrawal by Subject|5|||
148887269|NCT04170543|537066230|FG003|Overall Study|Withdrawal by Subject|4|||
148887270|NCT04170543|537066231|FG004|Overall Study|Withdrawal by Subject|9|||
148887271|NCT04170543|537066227|FG000|Overall Study|Not able to transition to phase 2b|8|||
148887272|NCT04170543|537066228|FG001|Overall Study|Not able to transition to phase 2b|0|||
148887273|NCT04170543|537066229|FG002|Overall Study|Not able to transition to phase 2b|10|||
148887274|NCT04170543|537066230|FG003|Overall Study|Not able to transition to phase 2b|0|||
148887275|NCT04170543|537066231|FG004|Overall Study|Not able to transition to phase 2b|6|||
148887276|NCT04170543|537066227|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
148887277|NCT04170543|537066228|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
149049137|NCT01095796|537660935|FG000|Overall Study|Randomized but Not Treated|5|||
148887278|NCT04170543|537066229|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
148887279|NCT04170543|537066230|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
148887280|NCT04170543|537066231|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
148887281|NCT04170543|537066227|FG000|Overall Study|Not Treated|0|||
148887282|NCT04170543|537066228|FG001|Overall Study|Not Treated|0|||
148887283|NCT04170543|537066229|FG002|Overall Study|Not Treated|0|||
148887284|NCT04170543|537066230|FG003|Overall Study|Not Treated|0|||
148887285|NCT04170543|537066231|FG004|Overall Study|Not Treated|2|||
148887286|NCT04170543|537066227|FG000|Overall Study|(CRF)|16|||
148887287|NCT04170543|537066228|FG001|Overall Study|(CRF)|15|||
148887288|NCT04170543|537066229|FG002|Overall Study|(CRF)|12|||
148887289|NCT04170543|537066230|FG003|Overall Study|(CRF)|17|||
148887290|NCT04170543|537066231|FG004|Overall Study|(CRF)|17|||
148887291|NCT04170543|537066227|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
148887292|NCT04170543|537066228|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
148887293|NCT04170543|537066229|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
148887294|NCT04170543|537066230|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
148887295|NCT04170543|537066231|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
148887296|NCT04628780|537066232|FG000|Overall Study|Death|0|||
148887297|NCT04628780|537066233|FG001|Overall Study|Death|1|||
148887298|NCT04628780|537066234|FG002|Overall Study|Death|0|||
148887299|NCT04628780|537066235|FG003|Overall Study|Death|0|||
148887300|NCT04628780|537066236|FG004|Overall Study|Death|1|||
148887301|NCT04628780|537066237|FG005|Overall Study|Death|0|||
148887302|NCT04628780|537066232|FG000|Overall Study|Physician Decision|2|||
148887303|NCT04628780|537066233|FG001|Overall Study|Physician Decision|0|||
148887304|NCT04628780|537066234|FG002|Overall Study|Physician Decision|0|||
148887305|NCT04628780|537066235|FG003|Overall Study|Physician Decision|0|||
148887306|NCT04628780|537066236|FG004|Overall Study|Physician Decision|2|||
148887307|NCT04628780|537066237|FG005|Overall Study|Physician Decision|0|||
148887308|NCT04628780|537066232|FG000|Overall Study|Progressive disease|2|||
148887309|NCT04628780|537066233|FG001|Overall Study|Progressive disease|2|||
148887310|NCT04628780|537066234|FG002|Overall Study|Progressive disease|2|||
148887311|NCT04628780|537066235|FG003|Overall Study|Progressive disease|3|||
148887312|NCT04628780|537066236|FG004|Overall Study|Progressive disease|9|||
148887313|NCT04628780|537066237|FG005|Overall Study|Progressive disease|4|||
148887314|NCT04628780|537066232|FG000|Overall Study|Withdrawal by Subject|0|||
148887315|NCT04628780|537066233|FG001|Overall Study|Withdrawal by Subject|1|||
148887316|NCT04628780|537066234|FG002|Overall Study|Withdrawal by Subject|2|||
148887317|NCT04628780|537066235|FG003|Overall Study|Withdrawal by Subject|0|||
148887318|NCT04628780|537066236|FG004|Overall Study|Withdrawal by Subject|3|||
148887319|NCT04628780|537066237|FG005|Overall Study|Withdrawal by Subject|1|||
148887320|NCT04628780|537066232|FG000|Overall Study|Global deterioration of health status|0|||
148887321|NCT04628780|537066233|FG001|Overall Study|Global deterioration of health status|0|||
148887322|NCT04628780|537066234|FG002|Overall Study|Global deterioration of health status|0|||
148887323|NCT04628780|537066235|FG003|Overall Study|Global deterioration of health status|0|||
148887324|NCT04628780|537066236|FG004|Overall Study|Global deterioration of health status|1|||
148887325|NCT04628780|537066237|FG005|Overall Study|Global deterioration of health status|1|||
148887326|NCT04303559|537066239|FG000|Overall Study|Study closed due to poor enrollment.|1|||
148887327|NCT01987102|537066240|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
148887328|NCT01987102|537066241|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
148887329|NCT01987102|537066240|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
148887330|NCT01987102|537066241|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
148887331|NCT01987102|537066240|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
148887332|NCT01987102|537066241|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
148887333|NCT01987102|537066240|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
148887334|NCT01987102|537066241|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
148887335|NCT01987102|537066240|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
148887336|NCT01987102|537066241|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
148887337|NCT01987102|537066240|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
148887338|NCT01987102|537066241|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
148887339|NCT04378270|537066244|FG000|Overall Study|Lack of Efficacy|1|||
148887340|NCT04378270|537066244|FG000|Overall Study|Withdrawal by Subject|1|||
148887341|NCT04378270|537066244|FG000|Overall Study|Screen Failure|1|||
148887342|NCT04378270|537066244|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
148887343|NCT01327599|537066245|FG000|Overall Study|Adverse Event|1|||
148887344|NCT01327599|537066245|FG000|Overall Study|Could Not Attend Visit|1|||
148887345|NCT01327599|537066245|FG000|Overall Study|Withdrawal of Consent|1|||
148887346|NCT01132313|537066246|FG000|Overall Study|Lack of Efficacy|1|||
148887347|NCT01132313|537066247|FG001|Overall Study|Lack of Efficacy|0|||
148887348|NCT01132313|537066248|FG002|Overall Study|Lack of Efficacy|0|||
148887349|NCT01132313|537066249|FG003|Overall Study|Lack of Efficacy|0|||
148887350|NCT01132313|537066250|FG004|Overall Study|Lack of Efficacy|0|||
148887351|NCT01132313|537066251|FG005|Overall Study|Lack of Efficacy|0|||
148887352|NCT01132313|537066252|FG006|Overall Study|Lack of Efficacy|0|||
148887353|NCT01132313|537066253|FG007|Overall Study|Lack of Efficacy|3|||
148887354|NCT01132313|537066254|FG008|Overall Study|Lack of Efficacy|14|||
148887355|NCT01132313|537066255|FG009|Overall Study|Lack of Efficacy|16|||
148887356|NCT01132313|537066256|FG010|Overall Study|Lack of Efficacy|0|||
148887357|NCT01132313|537066257|FG011|Overall Study|Lack of Efficacy|0|||
148887358|NCT01132313|537066246|FG000|Overall Study|Not treated|2|||
148887359|NCT01132313|537066247|FG001|Overall Study|Not treated|0|||
148887360|NCT01132313|537066248|FG002|Overall Study|Not treated|0|||
148887361|NCT01132313|537066249|FG003|Overall Study|Not treated|0|||
148887362|NCT01132313|537066250|FG004|Overall Study|Not treated|2|||
148887363|NCT01132313|537066251|FG005|Overall Study|Not treated|1|||
148887364|NCT01132313|537066252|FG006|Overall Study|Not treated|3|||
148887365|NCT01132313|537066253|FG007|Overall Study|Not treated|0|||
148887366|NCT01132313|537066254|FG008|Overall Study|Not treated|0|||
148887367|NCT01132313|537066255|FG009|Overall Study|Not treated|0|||
148887368|NCT01132313|537066256|FG010|Overall Study|Not treated|0|||
148887369|NCT01132313|537066257|FG011|Overall Study|Not treated|0|||
148887370|NCT01132313|537066246|FG000|Overall Study|Adverse Event|0|||
148887371|NCT01132313|537066247|FG001|Overall Study|Adverse Event|0|||
148887372|NCT01132313|537066248|FG002|Overall Study|Adverse Event|4|||
148887373|NCT01132313|537066249|FG003|Overall Study|Adverse Event|10|||
148887374|NCT01132313|537066250|FG004|Overall Study|Adverse Event|19|||
148887375|NCT01132313|537066251|FG005|Overall Study|Adverse Event|6|||
148887376|NCT01132313|537066252|FG006|Overall Study|Adverse Event|5|||
148887377|NCT01132313|537066253|FG007|Overall Study|Adverse Event|3|||
148887378|NCT01132313|537066254|FG008|Overall Study|Adverse Event|7|||
148887379|NCT01132313|537066255|FG009|Overall Study|Adverse Event|2|||
148887380|NCT01132313|537066256|FG010|Overall Study|Adverse Event|0|||
148887381|NCT01132313|537066257|FG011|Overall Study|Adverse Event|0|||
148887382|NCT01132313|537066246|FG000|Overall Study|Protocol Violation|0|||
148887383|NCT01132313|537066247|FG001|Overall Study|Protocol Violation|0|||
148887384|NCT01132313|537066248|FG002|Overall Study|Protocol Violation|0|||
148887385|NCT01132313|537066249|FG003|Overall Study|Protocol Violation|1|||
148887386|NCT01132313|537066250|FG004|Overall Study|Protocol Violation|0|||
148887387|NCT01132313|537066251|FG005|Overall Study|Protocol Violation|0|||
148887388|NCT01132313|537066252|FG006|Overall Study|Protocol Violation|0|||
148887389|NCT01132313|537066253|FG007|Overall Study|Protocol Violation|0|||
148887390|NCT01132313|537066254|FG008|Overall Study|Protocol Violation|0|||
148887391|NCT01132313|537066255|FG009|Overall Study|Protocol Violation|0|||
148887392|NCT01132313|537066256|FG010|Overall Study|Protocol Violation|0|||
148887393|NCT01132313|537066257|FG011|Overall Study|Protocol Violation|0|||
148887394|NCT01132313|537066246|FG000|Overall Study|Lost to Follow-up|0|||
148887395|NCT01132313|537066247|FG001|Overall Study|Lost to Follow-up|0|||
148887396|NCT01132313|537066248|FG002|Overall Study|Lost to Follow-up|1|||
148887397|NCT01132313|537066249|FG003|Overall Study|Lost to Follow-up|0|||
148887398|NCT01132313|537066250|FG004|Overall Study|Lost to Follow-up|0|||
148887399|NCT01132313|537066251|FG005|Overall Study|Lost to Follow-up|0|||
148887400|NCT01132313|537066252|FG006|Overall Study|Lost to Follow-up|0|||
148887401|NCT01132313|537066253|FG007|Overall Study|Lost to Follow-up|1|||
148887402|NCT01132313|537066254|FG008|Overall Study|Lost to Follow-up|0|||
148887403|NCT01132313|537066255|FG009|Overall Study|Lost to Follow-up|0|||
148887404|NCT01132313|537066256|FG010|Overall Study|Lost to Follow-up|0|||
148887405|NCT01132313|537066257|FG011|Overall Study|Lost to Follow-up|0|||
148887406|NCT01132313|537066246|FG000|Overall Study|Withdrawal by Subject|0|||
148887407|NCT01132313|537066247|FG001|Overall Study|Withdrawal by Subject|0|||
148887408|NCT01132313|537066248|FG002|Overall Study|Withdrawal by Subject|3|||
148887409|NCT01132313|537066249|FG003|Overall Study|Withdrawal by Subject|3|||
148887410|NCT01132313|537066250|FG004|Overall Study|Withdrawal by Subject|6|||
148887411|NCT01132313|537066251|FG005|Overall Study|Withdrawal by Subject|0|||
148887412|NCT01132313|537066252|FG006|Overall Study|Withdrawal by Subject|1|||
148887413|NCT01132313|537066253|FG007|Overall Study|Withdrawal by Subject|0|||
148887414|NCT01132313|537066254|FG008|Overall Study|Withdrawal by Subject|0|||
148887415|NCT01132313|537066255|FG009|Overall Study|Withdrawal by Subject|2|||
148887416|NCT01132313|537066256|FG010|Overall Study|Withdrawal by Subject|0|||
148887417|NCT01132313|537066257|FG011|Overall Study|Withdrawal by Subject|0|||
148887418|NCT01132313|537066246|FG000|Overall Study|Lack of antiviral response|0|||
148887419|NCT01132313|537066247|FG001|Overall Study|Lack of antiviral response|0|||
148887420|NCT01132313|537066248|FG002|Overall Study|Lack of antiviral response|12|||
148887421|NCT01132313|537066249|FG003|Overall Study|Lack of antiviral response|18|||
148887422|NCT01132313|537066250|FG004|Overall Study|Lack of antiviral response|18|||
148887423|NCT01132313|537066251|FG005|Overall Study|Lack of antiviral response|18|||
148887424|NCT01132313|537066252|FG006|Overall Study|Lack of antiviral response|21|||
148887425|NCT01132313|537066253|FG007|Overall Study|Lack of antiviral response|0|||
148887426|NCT01132313|537066254|FG008|Overall Study|Lack of antiviral response|0|||
148887427|NCT01132313|537066255|FG009|Overall Study|Lack of antiviral response|0|||
148887428|NCT01132313|537066256|FG010|Overall Study|Lack of antiviral response|1|||
148887429|NCT01132313|537066257|FG011|Overall Study|Lack of antiviral response|0|||
148887430|NCT01132313|537066246|FG000|Overall Study|Other reason not defined above|0|||
148887431|NCT01132313|537066247|FG001|Overall Study|Other reason not defined above|0|||
148887432|NCT01132313|537066248|FG002|Overall Study|Other reason not defined above|0|||
148887433|NCT01132313|537066249|FG003|Overall Study|Other reason not defined above|0|||
148887434|NCT01132313|537066250|FG004|Overall Study|Other reason not defined above|0|||
148887435|NCT01132313|537066251|FG005|Overall Study|Other reason not defined above|0|||
148887436|NCT01132313|537066252|FG006|Overall Study|Other reason not defined above|0|||
148887437|NCT01132313|537066253|FG007|Overall Study|Other reason not defined above|1|||
149005178|NCT01337986|537497855|FG000|Overall Study|Adverse Event|2|||
149005179|NCT01337986|537497856|FG001|Overall Study|Adverse Event|2|||
149005180|NCT01337986|537497855|FG000|Overall Study|Lost to Follow-up|1|||
148887438|NCT01132313|537066254|FG008|Overall Study|Other reason not defined above|0|||
148887439|NCT01132313|537066255|FG009|Overall Study|Other reason not defined above|0|||
148887440|NCT01132313|537066256|FG010|Overall Study|Other reason not defined above|0|||
148887441|NCT01132313|537066257|FG011|Overall Study|Other reason not defined above|0|||
148887442|NCT01156714|537066258|FG000|Overall Study|Withdrawal by Subject|9|||
148887443|NCT01156714|537066259|FG001|Overall Study|Withdrawal by Subject|4|||
148887444|NCT01156714|537066260|FG002|Overall Study|Withdrawal by Subject|3|||
148887445|NCT01236521|537066261|FG000|Overall Study|Withdrawal by Subject|12|||
148887446|NCT01236521|537066262|FG001|Overall Study|Withdrawal by Subject|17|||
148887447|NCT01236521|537066261|FG000|Overall Study|Death|2|||
148887448|NCT01236521|537066262|FG001|Overall Study|Death|1|||
148887449|NCT01236521|537066261|FG000|Overall Study|Lost to Follow-up|9|||
148887450|NCT01236521|537066262|FG001|Overall Study|Lost to Follow-up|7|||
148887451|NCT00165672|537066267|FG000|Overall Study|Adverse Event|0|||
148887452|NCT00165672|537066268|FG001|Overall Study|Adverse Event|1|||
148887453|NCT04266795|537066269|FG000|Overall Study|Adverse Event|10|||
148887454|NCT04266795|537066270|FG001|Overall Study|Adverse Event|19|||
148887455|NCT04266795|537066269|FG000|Overall Study|Death|7|||
148887456|NCT04266795|537066270|FG001|Overall Study|Death|8|||
148887457|NCT04266795|537066269|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
148887458|NCT04266795|537066270|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
148887459|NCT04266795|537066269|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
148887460|NCT04266795|537066270|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
148887461|NCT04266795|537066269|FG000|Overall Study|Progressive Disease|12|||
148887462|NCT04266795|537066270|FG001|Overall Study|Progressive Disease|9|||
148887463|NCT04266795|537066269|FG000|Overall Study|Withdrawal by Patient|5|||
148887464|NCT04266795|537066270|FG001|Overall Study|Withdrawal by Patient|6|||
148887465|NCT04266795|537066269|FG000|Overall Study|Disease Relapse|3|||
148887466|NCT04266795|537066270|FG001|Overall Study|Disease Relapse|6|||
148887467|NCT04266795|537066269|FG000|Overall Study|Reason not Specified|12|||
148887468|NCT04266795|537066270|FG001|Overall Study|Reason not Specified|10|||
148887469|NCT04266795|537066269|FG000|Overall Study|Participants Ongoing on Treatment|25|||
148887470|NCT04266795|537066270|FG001|Overall Study|Participants Ongoing on Treatment|23|||
148887471|NCT03043872|537066271|FG000|Overall Study|Withdrawal by Subject|6|||
148887472|NCT03043872|537066272|FG001|Overall Study|Withdrawal by Subject|6|||
148887473|NCT03043872|537066273|FG002|Overall Study|Withdrawal by Subject|15|||
148887474|NCT03043872|537066271|FG000|Overall Study|Lost to Follow-up|2|||
148887475|NCT03043872|537066272|FG001|Overall Study|Lost to Follow-up|1|||
148887476|NCT03043872|537066273|FG002|Overall Study|Lost to Follow-up|1|||
148887477|NCT03043872|537066271|FG000|Overall Study|Death|270|||
148887478|NCT03043872|537066272|FG001|Overall Study|Death|269|||
148887479|NCT03043872|537066273|FG002|Overall Study|Death|296|||
148887480|NCT03868943|537066274|FG000|Overall Study|Adverse Event|1|||
148887481|NCT04551066|537066275|FG000|Overall Study|Death|5|||
148887482|NCT04551066|537066276|FG001|Overall Study|Death|3|||
148887483|NCT04551066|537066275|FG000|Overall Study|Lost to Follow-up|1|||
148887484|NCT04551066|537066276|FG001|Overall Study|Lost to Follow-up|0|||
148887485|NCT04551066|537066275|FG000|Overall Study|Sponsor Decision|104|||
148887486|NCT04551066|537066276|FG001|Overall Study|Sponsor Decision|117|||
148887487|NCT04551066|537066275|FG000|Overall Study|Withdrawal by Subject|8|||
148887488|NCT04551066|537066276|FG001|Overall Study|Withdrawal by Subject|2|||
148887489|NCT04551066|537066275|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
148887490|NCT04551066|537066276|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
148887491|NCT04551066|537066275|FG000|Overall Study|Adverse Event|2|||
148887492|NCT04551066|537066276|FG001|Overall Study|Adverse Event|0|||
148887493|NCT04551066|537066275|FG000|Overall Study|Physician Decision|2|||
148887494|NCT04551066|537066276|FG001|Overall Study|Physician Decision|0|||
148887495|NCT04551066|537066275|FG000|Overall Study|Protocol Violation|1|||
148887496|NCT04551066|537066276|FG001|Overall Study|Protocol Violation|0|||
148887497|NCT04551066|537066275|FG000|Overall Study|Lack of Efficacy|0|||
148887498|NCT04551066|537066276|FG001|Overall Study|Lack of Efficacy|1|||
148887499|NCT04551066|537066275|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
148887500|NCT04551066|537066276|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
148887501|NCT00369577|537066277|FG000|Overall Study|Withdrawal by Subject|0|||
148887502|NCT00369577|537066278|FG001|Overall Study|Withdrawal by Subject|0|||
148887503|NCT00369577|537066279|FG002|Overall Study|Withdrawal by Subject|1|||
148887504|NCT03915470|537066280|FG000|Overall Study|Death|3|||
148887505|NCT03915470|537066281|FG001|Overall Study|Death|1|||
148887506|NCT03915470|537066280|FG000|Overall Study|Adverse Event|1|||
148887507|NCT03915470|537066281|FG001|Overall Study|Adverse Event|0|||
148887508|NCT03915470|537066280|FG000|Overall Study|Physician Decision|1|||
148887509|NCT03915470|537066281|FG001|Overall Study|Physician Decision|0|||
148887510|NCT03915470|537066280|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
148887511|NCT03915470|537066281|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
148887512|NCT00434109|537066282|FG000|Overall Study|Physician Decision|9|||
148887513|NCT00434109|537066282|FG000|Overall Study|Adverse Event|5|||
149049138|NCT01095796|537660936|FG001|Overall Study|Randomized but Not Treated|2|||
149049139|NCT01095796|537660935|FG000|Overall Study|Adverse Event|9|||
149049140|NCT01095796|537660936|FG001|Overall Study|Adverse Event|19|||
149049141|NCT01095796|537660935|FG000|Overall Study|Death|3|||
149049142|NCT01095796|537660936|FG001|Overall Study|Death|2|||
149049143|NCT01095796|537660935|FG000|Overall Study|Pregnancy|2|||
149049144|NCT01095796|537660936|FG001|Overall Study|Pregnancy|0|||
149049145|NCT01095796|537660935|FG000|Overall Study|Lack of Efficacy|5|||
149049146|NCT01095796|537660936|FG001|Overall Study|Lack of Efficacy|3|||
149049147|NCT01095796|537660935|FG000|Overall Study|Investigator's Discretion|7|||
149049148|NCT01095796|537660936|FG001|Overall Study|Investigator's Discretion|2|||
149049149|NCT01095796|537660935|FG000|Overall Study|Withdrew Consent|16|||
149049150|NCT01095796|537660936|FG001|Overall Study|Withdrew Consent|22|||
149049151|NCT01095796|537660935|FG000|Overall Study|Lost to Follow-up|27|||
149049152|NCT01095796|537660936|FG001|Overall Study|Lost to Follow-up|29|||
149049153|NCT01095796|537660935|FG000|Overall Study|Participant Noncompliance|5|||
149049154|NCT01095796|537660936|FG001|Overall Study|Participant Noncompliance|10|||
149049155|NCT01095796|537660935|FG000|Overall Study|Protocol Violation|1|||
149049156|NCT01095796|537660936|FG001|Overall Study|Protocol Violation|0|||
149049157|NCT01095796|537660935|FG000|Overall Study|Participant Transferred to Another Study|215|||
149049158|NCT01095796|537660936|FG001|Overall Study|Participant Transferred to Another Study|200|||
149049159|NCT03517969|537660937|FG000|Overall Study|Never started protocol treatment|3|||
149049160|NCT03517969|537660938|FG001|Overall Study|Never started protocol treatment|5|||
149049161|NCT03517969|537660937|FG000|Overall Study|Disease progression|11|||
149049162|NCT03517969|537660938|FG001|Overall Study|Disease progression|16|||
149049163|NCT03517969|537660937|FG000|Overall Study|PSA progression|8|||
149049164|NCT03517969|537660938|FG001|Overall Study|PSA progression|1|||
149049165|NCT03517969|537660937|FG000|Overall Study|Clinical progression|4|||
149049166|NCT03517969|537660938|FG001|Overall Study|Clinical progression|2|||
149049167|NCT03517969|537660937|FG000|Overall Study|Adverse Event|5|||
149049168|NCT03517969|537660938|FG001|Overall Study|Adverse Event|4|||
149049169|NCT03517969|537660937|FG000|Overall Study|Intercurrent illness|1|||
149049170|NCT03517969|537660938|FG001|Overall Study|Intercurrent illness|2|||
149049171|NCT03517969|537660937|FG000|Overall Study|Death|1|||
149049172|NCT03517969|537660938|FG001|Overall Study|Death|1|||
149049173|NCT03517969|537660937|FG000|Overall Study|Withdrawal by Subject|1|||
149049174|NCT03517969|537660938|FG001|Overall Study|Withdrawal by Subject|2|||
149049175|NCT03517969|537660937|FG000|Overall Study|Physician Decision|1|||
149049176|NCT03517969|537660938|FG001|Overall Study|Physician Decision|1|||
149049177|NCT03517969|537660937|FG000|Overall Study|No clinical benefit|1|||
149049178|NCT03517969|537660938|FG001|Overall Study|No clinical benefit|0|||
149049179|NCT03517969|537660937|FG000|Overall Study|Delayed treatment for dental treatment|1|||
149049180|NCT03517969|537660938|FG001|Overall Study|Delayed treatment for dental treatment|0|||
149049181|NCT03517969|537660937|FG000|Overall Study|Difficult to maintain appointment|0|||
149049182|NCT03517969|537660938|FG001|Overall Study|Difficult to maintain appointment|1|||
149049183|NCT03517969|537660937|FG000|Overall Study|Protocol Violation|0|||
149049184|NCT03517969|537660938|FG001|Overall Study|Protocol Violation|1|||
149049185|NCT02140645|537660939|FG000|Overall Study|Not linked|5489|||
149049186|NCT02140645|537660940|FG001|Overall Study|Not linked|61654|||
149049187|NCT02140645|537660941|FG002|Overall Study|Not linked|4236|||
149049188|NCT02140645|537660942|FG003|Overall Study|Not linked|13833|||
149049189|NCT02140645|537660943|FG004|Overall Study|Not linked|3286|||
149049190|NCT02140645|537660944|FG005|Overall Study|Not linked|70896|||
149049191|NCT02137850|537660947|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
149049192|NCT02137850|537660948|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
149049193|NCT02137850|537660949|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
149049194|NCT02137850|537660947|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
149049195|NCT02137850|537660948|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
149049196|NCT02137850|537660949|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
149049197|NCT02137850|537660947|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
149049198|NCT02137850|537660948|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
149049199|NCT02137850|537660949|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
149049200|NCT02137850|537660947|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
149049201|NCT02137850|537660948|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
149049202|NCT02137850|537660949|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
149049203|NCT02137850|537660947|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
149049204|NCT02137850|537660948|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
149049205|NCT02137850|537660949|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
149049206|NCT02137850|537660947|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
149049207|NCT02137850|537660948|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
149049208|NCT02137850|537660949|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
149049209|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
149049210|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
149049211|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
149049212|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
149049213|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
149049214|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
149049215|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
149049216|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
149049217|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
149049218|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
149049219|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
149049220|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
149049221|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Other|0|||
149049222|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Other|1|||
149049223|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Other|0|||
149049224|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
149049225|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
149049226|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
149049227|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Early site closure|0|||
149049228|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Early site closure|2|||
149049229|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Early site closure|0|||
149049230|NCT02137850|537660947|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
149049231|NCT02137850|537660948|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
149049232|NCT02137850|537660949|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
149049233|NCT02137850|537660947|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
149049234|NCT02137850|537660948|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
149049235|NCT02137850|537660949|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
149049236|NCT02137850|537660947|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
149049237|NCT02137850|537660948|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
149049238|NCT02137850|537660949|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
149049239|NCT02137850|537660947|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
149049240|NCT02137850|537660948|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
149049241|NCT02137850|537660949|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
149049242|NCT02137850|537660947|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
149049243|NCT02137850|537660948|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
149049244|NCT02137850|537660949|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
149049245|NCT02137850|537660947|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
149049246|NCT02137850|537660948|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
149049247|NCT02137850|537660949|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
149049248|NCT02137850|537660947|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
149049249|NCT02137850|537660948|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
149049250|NCT02137850|537660949|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
149049251|NCT02137850|537660947|FG000|Extension Phase: Prophylaxis|Other|0|||
149049252|NCT02137850|537660948|FG001|Extension Phase: Prophylaxis|Other|1|||
149049253|NCT02137850|537660949|FG002|Extension Phase: Prophylaxis|Other|0|||
149049254|NCT02137850|537660947|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
149049255|NCT02137850|537660948|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
149049256|NCT02137850|537660949|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
149049257|NCT00611559|537660950|FG000|Overall Study|Lost to Follow-up|0|||
149049258|NCT00611559|537660951|FG001|Overall Study|Lost to Follow-up|1|||
149049259|NCT00611559|537660952|FG002|Overall Study|Lost to Follow-up|0|||
149049260|NCT00611559|537660950|FG000|Overall Study|Protocol Violation|1|||
149049261|NCT00611559|537660951|FG001|Overall Study|Protocol Violation|0|||
149049262|NCT00611559|537660952|FG002|Overall Study|Protocol Violation|1|||
149049263|NCT00879333|537660953|FG000|Overall Study|Adverse Event|94|||
149049264|NCT00879333|537660954|FG001|Overall Study|Adverse Event|34|||
149049265|NCT00879333|537660953|FG000|Overall Study|Abnormal Laboratory Value|1|||
149049266|NCT00879333|537660954|FG001|Overall Study|Abnormal Laboratory Value|0|||
149049267|NCT00879333|537660953|FG000|Overall Study|Withdrawal by Subject|20|||
149049268|NCT00879333|537660954|FG001|Overall Study|Withdrawal by Subject|7|||
149049269|NCT00879333|537660953|FG000|Overall Study|Lost to Follow-up|2|||
149049270|NCT00879333|537660954|FG001|Overall Study|Lost to Follow-up|1|||
149049271|NCT00879333|537660953|FG000|Overall Study|Administrative Problems|2|||
149049272|NCT00879333|537660954|FG001|Overall Study|Administrative Problems|0|||
149049273|NCT00879333|537660953|FG000|Overall Study|Death|16|||
149049274|NCT00879333|537660954|FG001|Overall Study|Death|5|||
149049275|NCT00879333|537660953|FG000|Overall Study|Disease Progression|292|||
149049276|NCT00879333|537660954|FG001|Overall Study|Disease Progression|169|||
149049277|NCT00879333|537660953|FG000|Overall Study|Protocol Violation|1|||
149049278|NCT00879333|537660954|FG001|Overall Study|Protocol Violation|1|||
149049279|NCT02742519|537660956|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
149049280|NCT02742519|537660957|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
149049281|NCT02742519|537660958|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
149049282|NCT02742519|537660956|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
149049283|NCT02742519|537660957|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
149049284|NCT02742519|537660958|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
149049285|NCT02742519|537660956|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
149049286|NCT02742519|537660957|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
149049287|NCT02742519|537660958|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
149049288|NCT03432858|537660960|FG000|Overall Study|Protocol Violation|2|||
149049289|NCT03432858|537660961|FG001|Overall Study|Protocol Violation|1|||
149049290|NCT03432858|537660962|FG002|Overall Study|Protocol Violation|9|||
149049291|NCT03432858|537660960|FG000|Overall Study|Withdrawal by Subject|0|||
149049292|NCT03432858|537660961|FG001|Overall Study|Withdrawal by Subject|1|||
149049293|NCT03432858|537660962|FG002|Overall Study|Withdrawal by Subject|1|||
149049294|NCT03432858|537660960|FG000|Overall Study|Procedure canceled/rescheduled|0|||
149049295|NCT03432858|537660961|FG001|Overall Study|Procedure canceled/rescheduled|9|||
149049296|NCT03432858|537660962|FG002|Overall Study|Procedure canceled/rescheduled|6|||
149049297|NCT03432858|537660960|FG000|Overall Study|Required postop mobilization with splinting|0|||
149049298|NCT03432858|537660961|FG001|Overall Study|Required postop mobilization with splinting|0|||
149049299|NCT03432858|537660962|FG002|Overall Study|Required postop mobilization with splinting|1|||
149049300|NCT01872078|537660963|FG000|Overall Study|Adverse Event|0|||
149049301|NCT01872078|537660964|FG001|Overall Study|Adverse Event|0|||
149049302|NCT01872078|537660965|FG002|Overall Study|Adverse Event|1|||
149049303|NCT01872078|537660966|FG003|Overall Study|Adverse Event|0|||
149049304|NCT01872078|537660963|FG000|Overall Study|Dose administration non-compliance|0|||
149049305|NCT01872078|537660964|FG001|Overall Study|Dose administration non-compliance|0|||
149049306|NCT01872078|537660965|FG002|Overall Study|Dose administration non-compliance|0|||
149049307|NCT01872078|537660966|FG003|Overall Study|Dose administration non-compliance|1|||
149049308|NCT01872078|537660963|FG000|Overall Study|Protocol Violation|0|||
149049309|NCT01872078|537660964|FG001|Overall Study|Protocol Violation|0|||
149049310|NCT01872078|537660965|FG002|Overall Study|Protocol Violation|1|||
149049311|NCT01872078|537660966|FG003|Overall Study|Protocol Violation|0|||
149049312|NCT01872078|537660963|FG000|Overall Study|Withdrawal by Subject|0|||
149049313|NCT01872078|537660964|FG001|Overall Study|Withdrawal by Subject|0|||
149049314|NCT01872078|537660965|FG002|Overall Study|Withdrawal by Subject|1|||
149049315|NCT01872078|537660966|FG003|Overall Study|Withdrawal by Subject|0|||
149049316|NCT01872078|537660963|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
149049317|NCT01872078|537660964|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
149049318|NCT01872078|537660965|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
149049319|NCT01872078|537660966|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
149049320|NCT01721291|537660970|FG000|Overall Study|Withdrawal by Subject|1|||
148887514|NCT00434109|537066282|FG000|Overall Study|Protocol Violation|1|||
148887515|NCT00434109|537066282|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
148887516|NCT01463306|537066283|FG000|Overall Study|Adverse Event|6|||
149005181|NCT01337986|537497856|FG001|Overall Study|Lost to Follow-up|0|||
149005182|NCT01337986|537497855|FG000|Overall Study|Protocol Violation|0|||
149005183|NCT01337986|537497856|FG001|Overall Study|Protocol Violation|3|||
149005184|NCT02287584|537497858|FG000|the Double-blind Phase|Adverse Event|17|||
149005185|NCT02287584|537497859|FG001|the Double-blind Phase|Adverse Event|17|||
149005186|NCT02287584|537497860|FG002|the Double-blind Phase|Adverse Event|12|||
149005187|NCT02287584|537497861|FG003|the Double-blind Phase|Adverse Event|0|||
149005188|NCT02287584|537497862|FG004|the Double-blind Phase|Adverse Event|0|||
149005189|NCT02287584|537497863|FG005|the Double-blind Phase|Adverse Event|0|||
149005190|NCT02287584|537497858|FG000|the Double-blind Phase|Lack of Efficacy|18|||
149005191|NCT02287584|537497859|FG001|the Double-blind Phase|Lack of Efficacy|8|||
149005192|NCT02287584|537497860|FG002|the Double-blind Phase|Lack of Efficacy|8|||
149005193|NCT02287584|537497861|FG003|the Double-blind Phase|Lack of Efficacy|0|||
149005194|NCT02287584|537497862|FG004|the Double-blind Phase|Lack of Efficacy|0|||
149005195|NCT02287584|537497863|FG005|the Double-blind Phase|Lack of Efficacy|0|||
149005196|NCT02287584|537497858|FG000|the Double-blind Phase|Lost to Follow-up|0|||
149005197|NCT02287584|537497859|FG001|the Double-blind Phase|Lost to Follow-up|1|||
149005198|NCT02287584|537497860|FG002|the Double-blind Phase|Lost to Follow-up|1|||
149005199|NCT02287584|537497861|FG003|the Double-blind Phase|Lost to Follow-up|0|||
149005200|NCT02287584|537497862|FG004|the Double-blind Phase|Lost to Follow-up|0|||
149005201|NCT02287584|537497863|FG005|the Double-blind Phase|Lost to Follow-up|0|||
149005202|NCT02287584|537497858|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
149005203|NCT02287584|537497859|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
149005204|NCT02287584|537497860|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
149005205|NCT02287584|537497861|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
149005206|NCT02287584|537497862|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
149005207|NCT02287584|537497863|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
149005208|NCT02287584|537497858|FG000|the Double-blind Phase|Pregnancy|0|||
149005209|NCT02287584|537497859|FG001|the Double-blind Phase|Pregnancy|1|||
149005210|NCT02287584|537497860|FG002|the Double-blind Phase|Pregnancy|0|||
149005211|NCT02287584|537497861|FG003|the Double-blind Phase|Pregnancy|0|||
149005212|NCT02287584|537497862|FG004|the Double-blind Phase|Pregnancy|0|||
149049321|NCT01721291|537660971|FG001|Overall Study|Withdrawal by Subject|0|||
149049322|NCT01721291|537660970|FG000|Overall Study|did not like the treatment|1|||
148887517|NCT01463306|537066284|FG001|Overall Study|Adverse Event|9|||
149005213|NCT02287584|537497863|FG005|the Double-blind Phase|Pregnancy|0|||
149049323|NCT01721291|537660971|FG001|Overall Study|did not like the treatment|0|||
149049324|NCT01091168|537660972|FG000|Overall Study|Progressive disease|250|||
149049325|NCT01091168|537660973|FG001|Overall Study|Progressive disease|234|||
149049326|NCT01091168|537660972|FG000|Overall Study|Adverse Event|21|||
149049327|NCT01091168|537660973|FG001|Overall Study|Adverse Event|24|||
149049328|NCT01091168|537660972|FG000|Overall Study|Lost to Follow-up|0|||
149049329|NCT01091168|537660973|FG001|Overall Study|Lost to Follow-up|1|||
149049330|NCT01091168|537660972|FG000|Overall Study|Physician, patient's decision, other|27|||
149049331|NCT01091168|537660973|FG001|Overall Study|Physician, patient's decision, other|37|||
149049332|NCT03767517|537660978|FG000|Overall Study|Lost to Follow-up|16|||
149049333|NCT03767517|537660979|FG001|Overall Study|Lost to Follow-up|10|||
149049334|NCT03767517|537660978|FG000|Overall Study|Death|2|||
149049335|NCT03767517|537660979|FG001|Overall Study|Death|3|||
149049336|NCT05239039|537660981|FG000|Overall Study|Withdrawal by Subject|0|||
149049337|NCT05239039|537660982|FG001|Overall Study|Withdrawal by Subject|1|||
149049338|NCT03690206|537660984|FG000|Overall Study|Withdrawal by Subject|2|||
149049339|NCT03690206|537660985|FG001|Overall Study|Withdrawal by Subject|0|||
149049340|NCT03690206|537660986|FG002|Overall Study|Withdrawal by Subject|0|||
149049341|NCT03690206|537660984|FG000|Overall Study|ICF withdrawal|2|||
149049342|NCT03690206|537660985|FG001|Overall Study|ICF withdrawal|0|||
149049343|NCT03690206|537660986|FG002|Overall Study|ICF withdrawal|0|||
149049344|NCT03978637|537660987|FG000|Overall Study|Death|0|||
149049345|NCT03978637|537660988|FG001|Overall Study|Death|2|||
149049346|NCT03978637|537660989|FG002|Overall Study|Death|2|||
149049347|NCT03978637|537660990|FG003|Overall Study|Death|0|||
149049348|NCT03978637|537660987|FG000|Overall Study|Withdrawal by Subject|0|||
149049349|NCT03978637|537660988|FG001|Overall Study|Withdrawal by Subject|0|||
149049350|NCT03978637|537660989|FG002|Overall Study|Withdrawal by Subject|1|||
149049351|NCT03978637|537660990|FG003|Overall Study|Withdrawal by Subject|0|||
149049352|NCT03978637|537660987|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
149049353|NCT03978637|537660988|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
149049354|NCT03978637|537660989|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
149049355|NCT03978637|537660990|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
149049356|NCT03152786|537662226|FG000|Overall Study|Withdrawal by Subject|2|||
149049357|NCT03152786|537662227|FG001|Overall Study|Withdrawal by Subject|1|||
149049358|NCT04923347|537662228|FG000|Overall Study|Withdrawal by Subject|14|||
149049359|NCT02349412|537662229|FG000|Overall Study|Withdrawal by Subject|7|||
149049360|NCT02349412|537662230|FG001|Overall Study|Withdrawal by Subject|7|||
149049361|NCT04533022|537662231|FG000|Overall Study|Withdrawal by Subject|15|||
149049362|NCT04533022|537662231|FG000|Overall Study|Adverse Event|6|||
149049363|NCT04533022|537662231|FG000|Overall Study|Death|1|||
149049364|NCT04533022|537662231|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
149049365|NCT04533022|537662231|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
149049366|NCT05320432|537662247|FG000|Overall Study|Withdrawal by Subject|0|||
149049367|NCT05320432|537662248|FG001|Overall Study|Withdrawal by Subject|2|||
149049368|NCT05038566|537662249|FG000|Overall Study|Technical Difficulties with the Device|0|||
149049369|NCT05038566|537662250|FG001|Overall Study|Technical Difficulties with the Device|1|||
149049370|NCT00739648|537662255|FG000|Overall Study|Adverse Event|3|||
149049371|NCT00739648|537662256|FG001|Overall Study|Adverse Event|15|||
149049372|NCT00739648|537662255|FG000|Overall Study|Withdrawal by Subject|13|||
149049373|NCT00739648|537662256|FG001|Overall Study|Withdrawal by Subject|25|||
149049374|NCT00739648|537662255|FG000|Overall Study|Lost to Follow-up|4|||
149049375|NCT00739648|537662256|FG001|Overall Study|Lost to Follow-up|7|||
149049376|NCT00739648|537662255|FG000|Overall Study|Death|2|||
149049377|NCT00739648|537662256|FG001|Overall Study|Death|0|||
149049378|NCT00739648|537662255|FG000|Overall Study|Do not know|4|||
149049379|NCT00739648|537662256|FG001|Overall Study|Do not know|6|||
149049380|NCT02840474|537662257|FG000|Overall Study|Lost to Follow-up|1|||
149049381|NCT02840474|537662258|FG001|Overall Study|Lost to Follow-up|0|||
149049382|NCT04850807|537662259|FG000|Overall Study|Death|50|||
149049383|NCT04850807|537662260|FG001|Overall Study|Death|55|||
149049384|NCT04850807|537662259|FG000|Overall Study|Discharged|17|||
149049385|NCT04850807|537662260|FG001|Overall Study|Discharged|13|||
149049386|NCT04850807|537662259|FG000|Overall Study|Incomplete baseline data|3|||
149049387|NCT04850807|537662260|FG001|Overall Study|Incomplete baseline data|2|||
149049388|NCT03739996|537662261|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
149049389|NCT03739996|537662261|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
149049390|NCT03739996|537662261|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
149049391|NCT03739996|537662261|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
149049392|NCT03739996|537662261|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
149049393|NCT03739996|537662261|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
149049394|NCT03739996|537662261|FG000|Step 3 (SOC ART)|Death|1|||
149049395|NCT03739996|537662261|FG000|Step 3 (SOC ART)|Participant moved|1|||
149049396|NCT05141903|537662263|FG000|Overall Study|Withdrawal by Subject|0|||
149049397|NCT05141903|537662264|FG001|Overall Study|Withdrawal by Subject|1|||
149049398|NCT05141903|537662265|FG002|Overall Study|Withdrawal by Subject|1|||
149049399|NCT05141903|537662266|FG003|Overall Study|Withdrawal by Subject|0|||
149049400|NCT05141903|537662267|FG004|Overall Study|Withdrawal by Subject|0|||
149049401|NCT05141903|537662263|FG000|Overall Study|Other|1|||
149049402|NCT05141903|537662264|FG001|Overall Study|Other|1|||
149049403|NCT05141903|537662265|FG002|Overall Study|Other|0|||
149049404|NCT05141903|537662266|FG003|Overall Study|Other|0|||
149049405|NCT05141903|537662267|FG004|Overall Study|Other|0|||
149049406|NCT04716634|537662268|FG000|Overall Study|Death|24|||
149049407|NCT04716634|537662269|FG001|Overall Study|Death|24|||
149049408|NCT04716634|537662270|FG002|Overall Study|Death|8|||
149049409|NCT04716634|537662268|FG000|Overall Study|Closed by Sponsor|4|||
149049410|NCT04716634|537662269|FG001|Overall Study|Closed by Sponsor|4|||
149049411|NCT04716634|537662270|FG002|Overall Study|Closed by Sponsor|5|||
149049412|NCT04716634|537662268|FG000|Overall Study|Lost to Follow-up|1|||
149049413|NCT04716634|537662269|FG001|Overall Study|Lost to Follow-up|0|||
149049414|NCT04716634|537662270|FG002|Overall Study|Lost to Follow-up|1|||
149049415|NCT04716634|537662268|FG000|Overall Study|Withdrawal by Subject|0|||
149049416|NCT04716634|537662269|FG001|Overall Study|Withdrawal by Subject|0|||
149049417|NCT04716634|537662270|FG002|Overall Study|Withdrawal by Subject|1|||
149049418|NCT05387447|537662274|FG000|Overall Study|Participants changed their minds about study participation.|3|||
149049419|NCT05387447|537662275|FG001|Overall Study|Participants changed their minds about study participation.|5|||
149049420|NCT04178733|537662276|FG000|Overall Study|Investigator Decision|0|||
149049421|NCT04178733|537662277|FG001|Overall Study|Investigator Decision|0|||
149049422|NCT04178733|537662278|FG002|Overall Study|Investigator Decision|0|||
149049423|NCT04178733|537662279|FG003|Overall Study|Investigator Decision|1|||
149049424|NCT04178733|537662280|FG004|Overall Study|Investigator Decision|2|||
149049425|NCT02651324|537662284|FG000|Overall Study|drug not administered, due dispensing issue|1|||
149049426|NCT02651324|537662285|FG001|Overall Study|drug not administered, due dispensing issue|0|||
149049427|NCT01707030|537662288|FG000|Overall Study|Death|1|||
149049428|NCT01707030|537662289|FG001|Overall Study|Death|1|||
149049429|NCT01707030|537662288|FG000|Overall Study|Withdrawal by Subject|2|||
149049430|NCT01707030|537662289|FG001|Overall Study|Withdrawal by Subject|3|||
149049431|NCT01707030|537662288|FG000|Overall Study|Lost to Follow-up|8|||
149049432|NCT01707030|537662289|FG001|Overall Study|Lost to Follow-up|13|||
149049433|NCT04437433|537662290|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
149049434|NCT04437433|537662291|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
149049435|NCT04437433|537662290|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
149049436|NCT04437433|537662291|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
149049437|NCT04437433|537662290|FG000|Overall Study|Adverse Event|9|||
149049438|NCT04437433|537662291|FG001|Overall Study|Adverse Event|0|||
149049439|NCT04437433|537662290|FG000|Overall Study|Lack of Efficacy|4|||
149049440|NCT04437433|537662291|FG001|Overall Study|Lack of Efficacy|0|||
149049441|NCT04437433|537662290|FG000|Overall Study|Withdrawal by Subject|4|||
149049442|NCT04437433|537662291|FG001|Overall Study|Withdrawal by Subject|1|||
149049443|NCT04437433|537662290|FG000|Overall Study|Protocol Deviation|0|||
149049444|NCT04437433|537662291|FG001|Overall Study|Protocol Deviation|1|||
149049445|NCT04437433|537662290|FG000|Overall Study|Other, not specified|0|||
149049446|NCT04437433|537662291|FG001|Overall Study|Other, not specified|1|||
149049447|NCT04245501|537662292|FG000|Overall Study|Adverse Event|2|||
149049448|NCT04245501|537662293|FG001|Overall Study|Adverse Event|0|||
149049449|NCT04245501|537662292|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
149049450|NCT04245501|537662293|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
149049451|NCT02697136|537662297|FG000|Overall Study|Adverse Event|3|||
149049452|NCT02697136|537662298|FG001|Overall Study|Adverse Event|0|||
149049453|NCT03578536|537662302|FG000|Overall Study|Lost to Follow-up|1|||
149049454|NCT02538900|537662304|FG000|Overall Study|Death|2|||
149049455|NCT02538900|537662305|FG001|Overall Study|Death|2|||
149049456|NCT02538900|537662306|FG002|Overall Study|Death|2|||
149049457|NCT02538900|537662304|FG000|Overall Study|Withdrawal by Subject|18|||
149049458|NCT02538900|537662305|FG001|Overall Study|Withdrawal by Subject|16|||
149049459|NCT02538900|537662306|FG002|Overall Study|Withdrawal by Subject|15|||
149049460|NCT04093752|537662309|FG000|Overall Study|Adverse Event|7|||
149049461|NCT04093752|537662310|FG001|Overall Study|Adverse Event|19|||
149049462|NCT04093752|537662311|FG002|Overall Study|Adverse Event|18|||
149049463|NCT04093752|537662312|FG003|Overall Study|Adverse Event|4|||
149049464|NCT04093752|537662309|FG000|Overall Study|Withdrawal by Subject|6|||
149049465|NCT04093752|537662310|FG001|Overall Study|Withdrawal by Subject|6|||
149049466|NCT04093752|537662311|FG002|Overall Study|Withdrawal by Subject|8|||
149049467|NCT04093752|537662312|FG003|Overall Study|Withdrawal by Subject|20|||
149049468|NCT04093752|537662309|FG000|Overall Study|Lost to Follow-up|2|||
149049469|NCT04093752|537662310|FG001|Overall Study|Lost to Follow-up|1|||
149049470|NCT04093752|537662311|FG002|Overall Study|Lost to Follow-up|1|||
149049471|NCT04093752|537662312|FG003|Overall Study|Lost to Follow-up|1|||
149049472|NCT04093752|537662309|FG000|Overall Study|Death|0|||
149049473|NCT04093752|537662310|FG001|Overall Study|Death|0|||
149049474|NCT04093752|537662311|FG002|Overall Study|Death|1|||
149049475|NCT04093752|537662312|FG003|Overall Study|Death|2|||
149049476|NCT04093752|537662309|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
149049477|NCT04093752|537662310|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
149049478|NCT04093752|537662311|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
149049479|NCT04093752|537662312|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
149049480|NCT04093752|537662309|FG000|Overall Study|Covid 19|0|||
149049481|NCT04093752|537662310|FG001|Overall Study|Covid 19|0|||
149049482|NCT04093752|537662311|FG002|Overall Study|Covid 19|0|||
149049483|NCT04093752|537662312|FG003|Overall Study|Covid 19|1|||
149049484|NCT04093752|537662309|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
149049485|NCT04093752|537662310|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
149049486|NCT04093752|537662311|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
149049487|NCT04093752|537662312|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
149049488|NCT04093752|537662309|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
149049489|NCT04093752|537662310|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
149049490|NCT04093752|537662311|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
149049491|NCT04093752|537662312|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
149049492|NCT04093752|537662309|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
149049493|NCT04093752|537662310|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
149049494|NCT04093752|537662311|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
149049495|NCT04093752|537662312|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
149049496|NCT01101451|537662313|FG000|Overall Study|Eligible and never treated|0|||
149049497|NCT01101451|537662314|FG001|Overall Study|Eligible and never treated|5|||
149049498|NCT01101451|537662313|FG000|Overall Study|Ineligible and treated|12|||
149049499|NCT01101451|537662314|FG001|Overall Study|Ineligible and treated|8|||
149049500|NCT01101451|537662313|FG000|Overall Study|Ineligible and never treated|2|||
149049501|NCT01101451|537662314|FG001|Overall Study|Ineligible and never treated|2|||
149049502|NCT04838613|537662317|FG000|Overall Study|Withdrawal by Subject|3|||
149049503|NCT04838613|537662318|FG001|Overall Study|Withdrawal by Subject|6|||
149049504|NCT04838613|537662317|FG000|Overall Study|Protocol Deviation|3|||
149049505|NCT04838613|537662318|FG001|Overall Study|Protocol Deviation|2|||
149049506|NCT04838613|537662317|FG000|Overall Study|Technical Problems|0|||
149049507|NCT04838613|537662318|FG001|Overall Study|Technical Problems|5|||
149049508|NCT04838613|537662317|FG000|Overall Study|Physician Decision|2|||
149049509|NCT04838613|537662318|FG001|Overall Study|Physician Decision|0|||
149049510|NCT04970654|537662319|FG000|Overall Study|Withdrawal by parents/guardian|1|||
149049511|NCT04970654|537662320|FG001|Overall Study|Withdrawal by parents/guardian|2|||
149049512|NCT04970654|537662319|FG000|Overall Study|Unclassified|2|||
149049513|NCT04970654|537662320|FG001|Overall Study|Unclassified|1|||
149049514|NCT04970654|537662319|FG000|Overall Study|Lost to Follow-up|1|||
149049515|NCT04970654|537662320|FG001|Overall Study|Lost to Follow-up|0|||
149049516|NCT04854096|537662321|FG000|Overall Study|Adverse Event|1|||
149049517|NCT04854096|537662322|FG001|Overall Study|Adverse Event|0|||
149049518|NCT04854096|537662321|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
149049519|NCT04854096|537662322|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
149049520|NCT04854096|537662321|FG000|Overall Study|Withdrawal by Subject|1|||
149049521|NCT04854096|537662322|FG001|Overall Study|Withdrawal by Subject|0|||
149049522|NCT04854096|537662321|FG000|Overall Study|Other reasons|1|||
149049523|NCT04854096|537662322|FG001|Overall Study|Other reasons|0|||
149049524|NCT00951379|537662328|FG000|Overall Study|Adverse Event|4|||
149049525|NCT00951379|537662329|FG001|Overall Study|Adverse Event|1|||
149049526|NCT00951379|537662328|FG000|Overall Study|Withdrawal by Subject|1|||
149049527|NCT00951379|537662329|FG001|Overall Study|Withdrawal by Subject|0|||
149049528|NCT00951379|537662328|FG000|Overall Study|Noncompliance|1|||
149049529|NCT00951379|537662329|FG001|Overall Study|Noncompliance|0|||
149049530|NCT00951379|537662328|FG000|Overall Study|Disease Progression|0|||
149049531|NCT00951379|537662329|FG001|Overall Study|Disease Progression|1|||
149049532|NCT03912831|537662333|FG000|Overall Study|Death|1|||
149049533|NCT03912831|537662334|FG001|Overall Study|Death|1|||
149049534|NCT03912831|537662335|FG002|Overall Study|Death|1|||
149049535|NCT03912831|537662336|FG003|Overall Study|Death|1|||
149049536|NCT03912831|537662337|FG004|Overall Study|Death|1|||
149049537|NCT03912831|537662338|FG005|Overall Study|Death|1|||
149049538|NCT03912831|537662333|FG000|Overall Study|Reason not Specified|0|||
149049539|NCT03912831|537662334|FG001|Overall Study|Reason not Specified|0|||
149049540|NCT03912831|537662335|FG002|Overall Study|Reason not Specified|0|||
149049541|NCT03912831|537662336|FG003|Overall Study|Reason not Specified|0|||
149049542|NCT03912831|537662337|FG004|Overall Study|Reason not Specified|1|||
149049543|NCT03912831|537662338|FG005|Overall Study|Reason not Specified|0|||
149049544|NCT03912831|537662333|FG000|Overall Study|Withdrawal by Participant|0|||
149049545|NCT03912831|537662334|FG001|Overall Study|Withdrawal by Participant|0|||
149049546|NCT03912831|537662335|FG002|Overall Study|Withdrawal by Participant|0|||
149049547|NCT03912831|537662336|FG003|Overall Study|Withdrawal by Participant|0|||
149049548|NCT03912831|537662337|FG004|Overall Study|Withdrawal by Participant|1|||
149049549|NCT03912831|537662338|FG005|Overall Study|Withdrawal by Participant|0|||
149049550|NCT03580369|537662339|FG000|Overall Study|No treatment due to mis-randomization|1|||
149049551|NCT03580369|537662340|FG001|Overall Study|No treatment due to mis-randomization|0|||
149049552|NCT03580369|537662341|FG002|Overall Study|No treatment due to mis-randomization|0|||
149049553|NCT03580369|537662342|FG003|Overall Study|No treatment due to mis-randomization|0|||
149049554|NCT03580369|537662343|FG004|Overall Study|No treatment due to mis-randomization|3|||
149049555|NCT03580369|537662344|FG005|Overall Study|No treatment due to mis-randomization|0|||
149049556|NCT03580369|537662345|FG006|Overall Study|No treatment due to mis-randomization|0|||
149049557|NCT03580369|537662346|FG007|Overall Study|No treatment due to mis-randomization|0|||
149049558|NCT03580369|537662339|FG000|Overall Study|Reason unknown|0|||
149049559|NCT03580369|537662340|FG001|Overall Study|Reason unknown|0|||
149049560|NCT03580369|537662341|FG002|Overall Study|Reason unknown|1|||
149049561|NCT03580369|537662342|FG003|Overall Study|Reason unknown|0|||
149049562|NCT03580369|537662343|FG004|Overall Study|Reason unknown|0|||
149049563|NCT03580369|537662344|FG005|Overall Study|Reason unknown|0|||
149049564|NCT03580369|537662345|FG006|Overall Study|Reason unknown|0|||
149049565|NCT03580369|537662346|FG007|Overall Study|Reason unknown|0|||
149049566|NCT03580369|537662339|FG000|Overall Study|Technical problems|0|||
149049567|NCT03580369|537662340|FG001|Overall Study|Technical problems|0|||
149049568|NCT03580369|537662341|FG002|Overall Study|Technical problems|0|||
149049569|NCT03580369|537662342|FG003|Overall Study|Technical problems|0|||
149049570|NCT03580369|537662343|FG004|Overall Study|Technical problems|1|||
149049571|NCT03580369|537662344|FG005|Overall Study|Technical problems|0|||
149049572|NCT03580369|537662345|FG006|Overall Study|Technical problems|2|||
149049573|NCT03580369|537662346|FG007|Overall Study|Technical problems|0|||
149049574|NCT03580369|537662339|FG000|Overall Study|Pregnancy|2|||
149049575|NCT03580369|537662340|FG001|Overall Study|Pregnancy|0|||
149049576|NCT03580369|537662341|FG002|Overall Study|Pregnancy|3|||
149049577|NCT03580369|537662342|FG003|Overall Study|Pregnancy|0|||
149049578|NCT03580369|537662343|FG004|Overall Study|Pregnancy|2|||
149049579|NCT03580369|537662344|FG005|Overall Study|Pregnancy|0|||
149049580|NCT03580369|537662345|FG006|Overall Study|Pregnancy|0|||
149049581|NCT03580369|537662346|FG007|Overall Study|Pregnancy|0|||
149049582|NCT03580369|537662339|FG000|Overall Study|Lost to Follow-up|2|||
149049583|NCT03580369|537662340|FG001|Overall Study|Lost to Follow-up|0|||
149049584|NCT03580369|537662341|FG002|Overall Study|Lost to Follow-up|2|||
149049585|NCT03580369|537662342|FG003|Overall Study|Lost to Follow-up|0|||
149049586|NCT03580369|537662343|FG004|Overall Study|Lost to Follow-up|3|||
149049587|NCT03580369|537662344|FG005|Overall Study|Lost to Follow-up|0|||
149049588|NCT03580369|537662345|FG006|Overall Study|Lost to Follow-up|1|||
149049589|NCT03580369|537662346|FG007|Overall Study|Lost to Follow-up|0|||
149049590|NCT03580369|537662339|FG000|Overall Study|Physician Decision|4|||
149049591|NCT03580369|537662340|FG001|Overall Study|Physician Decision|0|||
149049592|NCT03580369|537662341|FG002|Overall Study|Physician Decision|4|||
149049593|NCT03580369|537662342|FG003|Overall Study|Physician Decision|1|||
149049594|NCT03580369|537662343|FG004|Overall Study|Physician Decision|1|||
149049595|NCT03580369|537662344|FG005|Overall Study|Physician Decision|0|||
149049596|NCT03580369|537662345|FG006|Overall Study|Physician Decision|0|||
149049597|NCT03580369|537662346|FG007|Overall Study|Physician Decision|0|||
149049598|NCT03580369|537662339|FG000|Overall Study|Lack of Efficacy|3|||
149049599|NCT03580369|537662340|FG001|Overall Study|Lack of Efficacy|0|||
149049600|NCT03580369|537662341|FG002|Overall Study|Lack of Efficacy|7|||
149049601|NCT03580369|537662342|FG003|Overall Study|Lack of Efficacy|0|||
149049602|NCT03580369|537662343|FG004|Overall Study|Lack of Efficacy|2|||
149049603|NCT03580369|537662344|FG005|Overall Study|Lack of Efficacy|0|||
149049604|NCT03580369|537662345|FG006|Overall Study|Lack of Efficacy|3|||
149049605|NCT03580369|537662346|FG007|Overall Study|Lack of Efficacy|0|||
149049606|NCT03580369|537662339|FG000|Overall Study|Protocol Violation|6|||
149049607|NCT03580369|537662340|FG001|Overall Study|Protocol Violation|0|||
149049608|NCT03580369|537662341|FG002|Overall Study|Protocol Violation|6|||
149049609|NCT03580369|537662342|FG003|Overall Study|Protocol Violation|1|||
149049610|NCT03580369|537662343|FG004|Overall Study|Protocol Violation|8|||
149049611|NCT03580369|537662344|FG005|Overall Study|Protocol Violation|2|||
149049612|NCT03580369|537662345|FG006|Overall Study|Protocol Violation|1|||
149049613|NCT03580369|537662346|FG007|Overall Study|Protocol Violation|0|||
149049614|NCT03580369|537662339|FG000|Overall Study|Adverse Event|7|||
149049615|NCT03580369|537662340|FG001|Overall Study|Adverse Event|0|||
149049616|NCT03580369|537662341|FG002|Overall Study|Adverse Event|14|||
148887518|NCT01463306|537066285|FG002|Overall Study|Adverse Event|3|||
149049617|NCT03580369|537662342|FG003|Overall Study|Adverse Event|1|||
149049618|NCT03580369|537662343|FG004|Overall Study|Adverse Event|6|||
149049619|NCT03580369|537662344|FG005|Overall Study|Adverse Event|0|||
149049620|NCT03580369|537662345|FG006|Overall Study|Adverse Event|1|||
149049621|NCT03580369|537662346|FG007|Overall Study|Adverse Event|0|||
148887519|NCT01463306|537066283|FG000|Overall Study|Death|3|||
149049622|NCT03580369|537662339|FG000|Overall Study|Withdrawal by Subject|19|||
149049623|NCT03580369|537662340|FG001|Overall Study|Withdrawal by Subject|0|||
149049624|NCT03580369|537662341|FG002|Overall Study|Withdrawal by Subject|17|||
149049625|NCT03580369|537662342|FG003|Overall Study|Withdrawal by Subject|0|||
149049626|NCT03580369|537662343|FG004|Overall Study|Withdrawal by Subject|16|||
149049627|NCT03580369|537662344|FG005|Overall Study|Withdrawal by Subject|1|||
149049628|NCT03580369|537662345|FG006|Overall Study|Withdrawal by Subject|7|||
149049629|NCT03580369|537662346|FG007|Overall Study|Withdrawal by Subject|0|||
149049630|NCT03527160|537662347|FG000|Overall Study|No urine collected|13|||
149049631|NCT03527160|537662347|FG000|Overall Study|No clinical serum creatinine collected|6|||
149049632|NCT03527160|537662347|FG000|Overall Study|Did not meet inclusion|2|||
149049633|NCT02910713|537662348|FG000|Overall Study|Protocol Violation|2|||
149049634|NCT02910713|537662348|FG000|Overall Study|Subject Choice|4|||
149049635|NCT02910713|537662348|FG000|Overall Study|Received One Application|10|||
149049636|NCT02910713|537662348|FG000|Overall Study|Received Neither Application|18|||
149049637|NCT02910713|537662348|FG000|Overall Study|Enrollment cap|7|||
149049638|NCT02910713|537662348|FG000|Overall Study|Investigator Discretion|1|||
149049639|NCT04442126|537662357|FG000|Overall Study|Withdrawal by Subject|0|||
149049640|NCT04442126|537662358|FG001|Overall Study|Withdrawal by Subject|0|||
149049641|NCT04442126|537662359|FG002|Overall Study|Withdrawal by Subject|0|||
149049642|NCT04442126|537662360|FG003|Overall Study|Withdrawal by Subject|2|||
149049643|NCT04442126|537662361|FG004|Overall Study|Withdrawal by Subject|1|||
149049644|NCT04442126|537662362|FG005|Overall Study|Withdrawal by Subject|0|||
149049645|NCT04442126|537662363|FG006|Overall Study|Withdrawal by Subject|1|||
149049646|NCT04442126|537662364|FG007|Overall Study|Withdrawal by Subject|1|||
149049647|NCT04442126|537662365|FG008|Overall Study|Withdrawal by Subject|3|||
149049648|NCT04442126|537662357|FG000|Overall Study|Death|1|||
149049649|NCT04442126|537662358|FG001|Overall Study|Death|0|||
149049650|NCT04442126|537662359|FG002|Overall Study|Death|0|||
149049651|NCT04442126|537662360|FG003|Overall Study|Death|1|||
149049652|NCT04442126|537662361|FG004|Overall Study|Death|2|||
149049653|NCT04442126|537662362|FG005|Overall Study|Death|2|||
149049654|NCT04442126|537662363|FG006|Overall Study|Death|4|||
149049655|NCT04442126|537662364|FG007|Overall Study|Death|1|||
149049656|NCT04442126|537662365|FG008|Overall Study|Death|5|||
149049657|NCT04442126|537662357|FG000|Overall Study|Study Terminated by Sponsor|0|||
149049658|NCT04442126|537662358|FG001|Overall Study|Study Terminated by Sponsor|0|||
149049659|NCT04442126|537662359|FG002|Overall Study|Study Terminated by Sponsor|0|||
149049660|NCT04442126|537662360|FG003|Overall Study|Study Terminated by Sponsor|0|||
149049661|NCT04442126|537662361|FG004|Overall Study|Study Terminated by Sponsor|0|||
149049662|NCT04442126|537662362|FG005|Overall Study|Study Terminated by Sponsor|1|||
149049663|NCT04442126|537662363|FG006|Overall Study|Study Terminated by Sponsor|4|||
149049664|NCT04442126|537662364|FG007|Overall Study|Study Terminated by Sponsor|2|||
149049665|NCT04442126|537662365|FG008|Overall Study|Study Terminated by Sponsor|10|||
149049666|NCT04442126|537662357|FG000|Overall Study|Lost to Follow-up|0|||
149049667|NCT04442126|537662358|FG001|Overall Study|Lost to Follow-up|0|||
149049668|NCT04442126|537662359|FG002|Overall Study|Lost to Follow-up|0|||
149049669|NCT04442126|537662360|FG003|Overall Study|Lost to Follow-up|0|||
149049670|NCT04442126|537662361|FG004|Overall Study|Lost to Follow-up|0|||
149049671|NCT04442126|537662362|FG005|Overall Study|Lost to Follow-up|0|||
149049672|NCT04442126|537662363|FG006|Overall Study|Lost to Follow-up|0|||
149049673|NCT04442126|537662364|FG007|Overall Study|Lost to Follow-up|1|||
149049674|NCT04442126|537662365|FG008|Overall Study|Lost to Follow-up|2|||
149049675|NCT04442126|537662357|FG000|Overall Study|Progressive Disease|0|||
149049676|NCT04442126|537662358|FG001|Overall Study|Progressive Disease|1|||
149049677|NCT04442126|537662359|FG002|Overall Study|Progressive Disease|3|||
149049678|NCT04442126|537662360|FG003|Overall Study|Progressive Disease|0|||
149049679|NCT04442126|537662361|FG004|Overall Study|Progressive Disease|3|||
149049680|NCT04442126|537662362|FG005|Overall Study|Progressive Disease|0|||
149049681|NCT04442126|537662363|FG006|Overall Study|Progressive Disease|0|||
149049682|NCT04442126|537662364|FG007|Overall Study|Progressive Disease|0|||
149049683|NCT04442126|537662365|FG008|Overall Study|Progressive Disease|0|||
149049684|NCT04442126|537662357|FG000|Overall Study|Other|0|||
149049685|NCT04442126|537662358|FG001|Overall Study|Other|0|||
149049686|NCT04442126|537662359|FG002|Overall Study|Other|0|||
149049687|NCT04442126|537662360|FG003|Overall Study|Other|0|||
149049688|NCT04442126|537662361|FG004|Overall Study|Other|0|||
149049689|NCT04442126|537662362|FG005|Overall Study|Other|0|||
149049690|NCT04442126|537662363|FG006|Overall Study|Other|0|||
149049691|NCT04442126|537662364|FG007|Overall Study|Other|0|||
148887520|NCT01463306|537066284|FG001|Overall Study|Death|3|||
149049692|NCT04442126|537662365|FG008|Overall Study|Other|1|||
149049693|NCT06066541|537663608|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
149049694|NCT06066541|537663609|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
149049695|NCT06066541|537663610|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
149049696|NCT06066541|537663611|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
149049697|NCT06066541|537663612|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
149049698|NCT06066541|537663613|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
149049699|NCT06066541|537663614|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
149049700|NCT06066541|537663608|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
149049701|NCT06066541|537663609|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
149049702|NCT06066541|537663610|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
149049703|NCT06066541|537663611|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
149049704|NCT06066541|537663612|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
149049705|NCT06066541|537663613|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
149049706|NCT06066541|537663614|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
149049707|NCT02163447|537663615|FG000|Overall Study|Withdrawal by Subject|2|||
149049708|NCT02163447|537663616|FG001|Overall Study|Withdrawal by Subject|0|||
149049709|NCT02163447|537663617|FG002|Overall Study|Withdrawal by Subject|1|||
149049710|NCT02163447|537663615|FG000|Overall Study|Lost to Follow-up|1|||
149049711|NCT02163447|537663616|FG001|Overall Study|Lost to Follow-up|3|||
149049712|NCT02163447|537663617|FG002|Overall Study|Lost to Follow-up|0|||
149049713|NCT02163447|537663615|FG000|Overall Study|Moved out of study area|2|||
149049714|NCT02163447|537663616|FG001|Overall Study|Moved out of study area|3|||
149049715|NCT02163447|537663617|FG002|Overall Study|Moved out of study area|2|||
149049716|NCT02163447|537663615|FG000|Overall Study|Became HIV infected at time of delivery|1|||
149049717|NCT02163447|537663616|FG001|Overall Study|Became HIV infected at time of delivery|0|||
149049718|NCT02163447|537663617|FG002|Overall Study|Became HIV infected at time of delivery|0|||
149049719|NCT05415436|537663619|FG000|Overall Study|Surgeon cancelled procedure|1|||
149049720|NCT05415436|537663620|FG001|Overall Study|Surgeon cancelled procedure|0|||
149049721|NCT05415436|537663619|FG000|Overall Study|Death|1|||
149049722|NCT05415436|537663620|FG001|Overall Study|Death|0|||
149049723|NCT03157167|537663623|FG000|Overall Study|Withdrawal by Subject|1|||
149049724|NCT03157167|537663624|FG001|Overall Study|Withdrawal by Subject|0|||
149049725|NCT03157167|537663625|FG002|Overall Study|Withdrawal by Subject|0|||
149049726|NCT03484702|537663629|FG000|Treatment Period|Death|3|||
149049727|NCT03484702|537663630|FG001|Treatment Period|Death|1|||
149049728|NCT03484702|537663631|FG002|Treatment Period|Death|0|||
149049729|NCT03484702|537663632|FG003|Treatment Period|Death|0|||
149049730|NCT03484702|537663633|FG004|Treatment Period|Death|0|||
149049731|NCT03484702|537663634|FG005|Treatment Period|Death|0|||
149049732|NCT03484702|537663629|FG000|Treatment Period|Adverse Event|1|||
149049733|NCT03484702|537663630|FG001|Treatment Period|Adverse Event|0|||
149049734|NCT03484702|537663631|FG002|Treatment Period|Adverse Event|0|||
149049735|NCT03484702|537663632|FG003|Treatment Period|Adverse Event|0|||
149049736|NCT03484702|537663633|FG004|Treatment Period|Adverse Event|0|||
149049737|NCT03484702|537663634|FG005|Treatment Period|Adverse Event|0|||
149049738|NCT03484702|537663629|FG000|Treatment Period|Participant Withdrew from Study|0|||
149049739|NCT03484702|537663630|FG001|Treatment Period|Participant Withdrew from Study|1|||
149049740|NCT03484702|537663631|FG002|Treatment Period|Participant Withdrew from Study|0|||
149049741|NCT03484702|537663632|FG003|Treatment Period|Participant Withdrew from Study|0|||
149049742|NCT03484702|537663633|FG004|Treatment Period|Participant Withdrew from Study|0|||
149049743|NCT03484702|537663634|FG005|Treatment Period|Participant Withdrew from Study|0|||
149049744|NCT03484702|537663629|FG000|Treatment Period|Physician Decision|0|||
149049745|NCT03484702|537663630|FG001|Treatment Period|Physician Decision|1|||
149049746|NCT03484702|537663631|FG002|Treatment Period|Physician Decision|0|||
149049747|NCT03484702|537663632|FG003|Treatment Period|Physician Decision|0|||
149049748|NCT03484702|537663633|FG004|Treatment Period|Physician Decision|0|||
149049749|NCT03484702|537663634|FG005|Treatment Period|Physician Decision|1|||
149049750|NCT03192891|537663638|FG000|Overall Study|Lost to Follow-up|55|||
149049751|NCT02249949|537663641|FG000|Overall Study|Cancelled prior to treatment|2|||
149049752|NCT05059262|537663644|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
149049753|NCT05059262|537663645|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
148887521|NCT01463306|537066285|FG002|Overall Study|Death|0|||
149049754|NCT05059262|537663644|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
149049755|NCT05059262|537663645|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
149049756|NCT05059262|537663644|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
149049757|NCT05059262|537663645|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
149049758|NCT05059262|537663644|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
149049759|NCT05059262|537663645|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
149049760|NCT05059262|537663644|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
149049761|NCT05059262|537663645|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
149049762|NCT05059262|537663644|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
149049763|NCT05059262|537663645|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
149049764|NCT05059262|537663644|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
149049765|NCT05059262|537663645|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
149049766|NCT05059262|537663644|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
149049767|NCT05059262|537663645|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
149049768|NCT05059262|537663644|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
149049769|NCT05059262|537663645|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
149049770|NCT02549339|537663649|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
149049771|NCT02549339|537663650|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
149049772|NCT02549339|537663649|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
149049773|NCT02549339|537663650|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
149049774|NCT02549339|537663649|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
148887522|NCT01463306|537066283|FG000|Overall Study|Lack of Efficacy|22|||
148887523|NCT01463306|537066284|FG001|Overall Study|Lack of Efficacy|16|||
148887524|NCT01463306|537066285|FG002|Overall Study|Lack of Efficacy|1|||
148887525|NCT01463306|537066283|FG000|Overall Study|Lost to Follow-up|5|||
148887526|NCT01463306|537066284|FG001|Overall Study|Lost to Follow-up|2|||
148887527|NCT01463306|537066285|FG002|Overall Study|Lost to Follow-up|0|||
148887528|NCT01463306|537066283|FG000|Overall Study|Protocol Violation|4|||
148887529|NCT01463306|537066284|FG001|Overall Study|Protocol Violation|0|||
148887530|NCT01463306|537066285|FG002|Overall Study|Protocol Violation|0|||
148887531|NCT01463306|537066283|FG000|Overall Study|Withdrawal by Subject|19|||
148887532|NCT01463306|537066284|FG001|Overall Study|Withdrawal by Subject|9|||
148887533|NCT01463306|537066285|FG002|Overall Study|Withdrawal by Subject|1|||
148887534|NCT01463306|537066283|FG000|Overall Study|Other|26|||
148887535|NCT01463306|537066284|FG001|Overall Study|Other|13|||
148887536|NCT01463306|537066285|FG002|Overall Study|Other|0|||
148887537|NCT01463306|537066283|FG000|Overall Study|Approval expiry at site|1|||
148887538|NCT01463306|537066284|FG001|Overall Study|Approval expiry at site|0|||
148887539|NCT01463306|537066285|FG002|Overall Study|Approval expiry at site|0|||
148887540|NCT03790917|537066286|FG000|Overall Study|Death|1|||
148887541|NCT02614729|537067886|FG000|Overall Study|Withdrawal by Subject|1|||
148887542|NCT02614729|537067887|FG001|Overall Study|Withdrawal by Subject|0|||
148887543|NCT02796677|537067890|FG000|Overall Study|Adverse Event|11|||
148887544|NCT02796677|537067891|FG001|Overall Study|Adverse Event|22|||
148887545|NCT02796677|537067892|FG002|Overall Study|Adverse Event|14|||
148887546|NCT02796677|537067893|FG003|Overall Study|Adverse Event|14|||
148887547|NCT02796677|537067890|FG000|Overall Study|Protocol Violation|7|||
148887548|NCT02796677|537067891|FG001|Overall Study|Protocol Violation|5|||
148887549|NCT02796677|537067892|FG002|Overall Study|Protocol Violation|4|||
148887550|NCT02796677|537067893|FG003|Overall Study|Protocol Violation|8|||
148887551|NCT02796677|537067890|FG000|Overall Study|Lost to Follow-up|1|||
148887552|NCT02796677|537067891|FG001|Overall Study|Lost to Follow-up|5|||
148887553|NCT02796677|537067892|FG002|Overall Study|Lost to Follow-up|2|||
148887554|NCT02796677|537067893|FG003|Overall Study|Lost to Follow-up|2|||
148887555|NCT02796677|537067890|FG000|Overall Study|Lack of Efficacy|7|||
148887556|NCT02796677|537067891|FG001|Overall Study|Lack of Efficacy|9|||
148887557|NCT02796677|537067892|FG002|Overall Study|Lack of Efficacy|14|||
148887558|NCT02796677|537067893|FG003|Overall Study|Lack of Efficacy|20|||
148887559|NCT02796677|537067890|FG000|Overall Study|Withdrawal by Subject|4|||
149049775|NCT02549339|537663650|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
149049776|NCT02549339|537663649|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
149049777|NCT02549339|537663650|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
149049778|NCT02549339|537663649|FG000|12-month Follow-up|Lack of Efficacy|0|||
149049779|NCT02549339|537663650|FG001|12-month Follow-up|Lack of Efficacy|2|||
149049780|NCT02549339|537663649|FG000|12-month Follow-up|Withdrawal by Subject|8|||
149049781|NCT02549339|537663650|FG001|12-month Follow-up|Withdrawal by Subject|3|||
149049782|NCT02549339|537663649|FG000|12-month Follow-up|Lost to Follow-up|1|||
149049783|NCT02549339|537663650|FG001|12-month Follow-up|Lost to Follow-up|3|||
149049784|NCT02549339|537663649|FG000|12-month Follow-up|Other|0|||
149049785|NCT02549339|537663650|FG001|12-month Follow-up|Other|3|||
149049786|NCT02728076|537663651|FG000|Overall Study|Physician Decision|4|||
149049787|NCT05054374|537663668|FG000|Overall Study|Withdrawal by Subject|1|||
149049788|NCT05054374|537663669|FG001|Overall Study|Withdrawal by Subject|0|||
149049789|NCT05054374|537663670|FG002|Overall Study|Withdrawal by Subject|0|||
149049790|NCT05054374|537663671|FG003|Overall Study|Withdrawal by Subject|0|||
149049791|NCT05054374|537663668|FG000|Overall Study|Progressive Disease|5|||
149049792|NCT05054374|537663669|FG001|Overall Study|Progressive Disease|0|||
149049793|NCT05054374|537663670|FG002|Overall Study|Progressive Disease|0|||
148887560|NCT02796677|537067891|FG001|Overall Study|Withdrawal by Subject|14|||
148887561|NCT02796677|537067892|FG002|Overall Study|Withdrawal by Subject|6|||
148887562|NCT02796677|537067893|FG003|Overall Study|Withdrawal by Subject|7|||
148887563|NCT02796677|537067890|FG000|Overall Study|Progressive disease|6|||
148887564|NCT02796677|537067891|FG001|Overall Study|Progressive disease|15|||
148887565|NCT02796677|537067892|FG002|Overall Study|Progressive disease|13|||
149049794|NCT05054374|537663671|FG003|Overall Study|Progressive Disease|0|||
149049795|NCT05691309|537663672|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
149049796|NCT05691309|537663672|FG000|Overall Study|vancomycin levels not evaluable|2|||
149049797|NCT04820855|537663674|FG000|Overall Study|Lost to Follow-up|6|||
149049798|NCT04820855|537663675|FG001|Overall Study|Lost to Follow-up|9|||
149049799|NCT03526861|537663678|FG000|Initial Treatment Period|Not dosed|1|||
149049800|NCT03526861|537663679|FG001|Initial Treatment Period|Not dosed|1|||
148887566|NCT02796677|537067893|FG003|Overall Study|Progressive disease|18|||
148887567|NCT02796677|537067890|FG000|Overall Study|Reason not mentioned|2|||
148887568|NCT02796677|537067891|FG001|Overall Study|Reason not mentioned|3|||
148887569|NCT02796677|537067892|FG002|Overall Study|Reason not mentioned|0|||
149049801|NCT03526861|537663680|FG002|Initial Treatment Period|Not dosed|1|||
148887570|NCT02796677|537067893|FG003|Overall Study|Reason not mentioned|5|||
148887571|NCT03798717|537067894|FG000|Overall Study|Failed Screening|0|||
148887572|NCT03798717|537067895|FG001|Overall Study|Failed Screening|0|||
148887573|NCT03798717|537067896|FG002|Overall Study|Failed Screening|0|||
148887574|NCT03798717|537067897|FG003|Overall Study|Failed Screening|0|||
148887575|NCT03798717|537067898|FG004|Overall Study|Failed Screening|0|||
148887576|NCT03798717|537067899|FG005|Overall Study|Failed Screening|1|||
148887577|NCT03798717|537067894|FG000|Overall Study|Physician Decision|1|||
148887578|NCT03798717|537067895|FG001|Overall Study|Physician Decision|0|||
148887579|NCT03798717|537067896|FG002|Overall Study|Physician Decision|1|||
148887580|NCT03798717|537067897|FG003|Overall Study|Physician Decision|0|||
148887581|NCT03798717|537067898|FG004|Overall Study|Physician Decision|0|||
148887582|NCT03798717|537067899|FG005|Overall Study|Physician Decision|0|||
148887583|NCT03798717|537067894|FG000|Overall Study|Withdrawal by Subject|0|||
148887584|NCT03798717|537067895|FG001|Overall Study|Withdrawal by Subject|0|||
148887585|NCT03798717|537067896|FG002|Overall Study|Withdrawal by Subject|0|||
148887586|NCT03798717|537067897|FG003|Overall Study|Withdrawal by Subject|1|||
148887587|NCT03798717|537067898|FG004|Overall Study|Withdrawal by Subject|0|||
148887588|NCT03798717|537067899|FG005|Overall Study|Withdrawal by Subject|0|||
148887589|NCT03798717|537067894|FG000|Overall Study|Lost to Follow-up|1|||
148887590|NCT03798717|537067895|FG001|Overall Study|Lost to Follow-up|0|||
148887591|NCT03798717|537067896|FG002|Overall Study|Lost to Follow-up|0|||
148887592|NCT03798717|537067897|FG003|Overall Study|Lost to Follow-up|1|||
148887593|NCT03798717|537067898|FG004|Overall Study|Lost to Follow-up|0|||
148887594|NCT03798717|537067899|FG005|Overall Study|Lost to Follow-up|0|||
148887595|NCT03798717|537067894|FG000|Overall Study|Adverse Event|0|||
148887596|NCT03798717|537067895|FG001|Overall Study|Adverse Event|1|||
148887597|NCT03798717|537067896|FG002|Overall Study|Adverse Event|0|||
148887598|NCT03798717|537067897|FG003|Overall Study|Adverse Event|0|||
148887599|NCT03798717|537067898|FG004|Overall Study|Adverse Event|0|||
148887600|NCT03798717|537067899|FG005|Overall Study|Adverse Event|0|||
148887601|NCT03798717|537067894|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
148887602|NCT03798717|537067895|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
148887603|NCT03798717|537067896|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
148887604|NCT03798717|537067897|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
148887605|NCT03798717|537067898|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
148887606|NCT03798717|537067899|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
148887607|NCT04002960|537067901|FG000|Overall Study|Withdrawn prior to Completion|2|||
148887608|NCT00961181|537067902|FG000|Overall Study|Death|2|||
148887609|NCT00961181|537067902|FG000|Overall Study|Withdrawal by Subject|2|||
148887610|NCT00961181|537067902|FG000|Overall Study|Lost to Follow-up|1|||
148887611|NCT01045967|537067903|FG000|Second Intervention|Protocol Violation|0|||
148887612|NCT01045967|537067904|FG001|Second Intervention|Protocol Violation|1|||
148887613|NCT01777308|537067905|FG000|Overall Study|Withdrawal by Subject|5|||
148887614|NCT01777308|537067906|FG001|Overall Study|Withdrawal by Subject|1|||
148887615|NCT01777308|537067905|FG000|Overall Study|Migrated/moved from study area|1|||
148887616|NCT01777308|537067906|FG001|Overall Study|Migrated/moved from study area|0|||
148887617|NCT01777308|537067905|FG000|Overall Study|Lost to Follow-up|7|||
148887618|NCT01777308|537067906|FG001|Overall Study|Lost to Follow-up|2|||
148887619|NCT01777308|537067905|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
148887620|NCT01777308|537067906|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
148887621|NCT03212326|537067908|FG000|Overall Study|Physician Decision|4|||
148887622|NCT03057496|537067918|FG000|Overall Study|Withdrawal by Subject|8|||
148887623|NCT03057496|537067918|FG000|Overall Study|Lost to Follow-up|5|||
148887624|NCT03057496|537067918|FG000|Overall Study|Did not use device during home trial|3|||
148887625|NCT03057496|537067918|FG000|Overall Study|Device failure|2|||
148887626|NCT01790594|537067922|FG000|Overall Study|Death|1|||
148887627|NCT01790594|537067923|FG001|Overall Study|Death|0|||
148887628|NCT01790594|537067924|FG002|Overall Study|Death|0|||
148887629|NCT01790594|537067922|FG000|Overall Study|Physician Decision|2|||
149049802|NCT03526861|537663681|FG003|Initial Treatment Period|Not dosed|0|||
149049803|NCT03526861|537663682|FG004|Initial Treatment Period|Not dosed|0|||
149049804|NCT03526861|537663683|FG005|Initial Treatment Period|Not dosed|0|||
149049805|NCT03526861|537663684|FG006|Initial Treatment Period|Not dosed|0|||
149049806|NCT03526861|537663685|FG007|Initial Treatment Period|Not dosed|0|||
149049807|NCT03526861|537663686|FG008|Initial Treatment Period|Not dosed|0|||
149049808|NCT03526861|537663678|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
149049809|NCT03526861|537663679|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
148887630|NCT01790594|537067923|FG001|Overall Study|Physician Decision|1|||
148887631|NCT01790594|537067924|FG002|Overall Study|Physician Decision|0|||
148887632|NCT01790594|537067922|FG000|Overall Study|Withdrawal by Subject|2|||
148887633|NCT01790594|537067923|FG001|Overall Study|Withdrawal by Subject|0|||
148887634|NCT01790594|537067924|FG002|Overall Study|Withdrawal by Subject|0|||
148887635|NCT01790594|537067922|FG000|Overall Study|Transplant was not done|0|||
148887636|NCT01790594|537067923|FG001|Overall Study|Transplant was not done|0|||
148887637|NCT01790594|537067924|FG002|Overall Study|Transplant was not done|3|||
148887638|NCT01790594|537067922|FG000|Overall Study|Terminated prior to week 76|0|||
148887639|NCT01790594|537067923|FG001|Overall Study|Terminated prior to week 76|2|||
148887640|NCT01790594|537067924|FG002|Overall Study|Terminated prior to week 76|0|||
148887641|NCT00404651|537067926|FG000|Overall Study|Serious Adverse Event|0|||
148887642|NCT00404651|537067927|FG001|Overall Study|Serious Adverse Event|0|||
148887643|NCT00404651|537067928|FG002|Overall Study|Serious Adverse Event|2|||
148887644|NCT00404651|537067929|FG003|Overall Study|Serious Adverse Event|0|||
148887645|NCT00404651|537067926|FG000|Overall Study|Protocol Violation|10|||
148887646|NCT00404651|537067927|FG001|Overall Study|Protocol Violation|5|||
148887647|NCT00404651|537067928|FG002|Overall Study|Protocol Violation|14|||
148887648|NCT00404651|537067929|FG003|Overall Study|Protocol Violation|5|||
148887649|NCT00404651|537067926|FG000|Overall Study|Lost to Follow-up|15|||
148887650|NCT00404651|537067927|FG001|Overall Study|Lost to Follow-up|11|||
148887651|NCT00404651|537067928|FG002|Overall Study|Lost to Follow-up|13|||
149049810|NCT03526861|537663680|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
149049811|NCT03526861|537663681|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049812|NCT03526861|537663682|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049813|NCT03526861|537663683|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049814|NCT03526861|537663684|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049815|NCT03526861|537663685|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049816|NCT03526861|537663686|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049817|NCT03526861|537663678|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
149049818|NCT03526861|537663679|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
149049819|NCT03526861|537663680|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
149049820|NCT03526861|537663681|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
149049821|NCT03526861|537663682|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
149049822|NCT03526861|537663683|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
149049823|NCT03526861|537663684|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
149049824|NCT03526861|537663685|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
149049825|NCT03526861|537663686|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
149049826|NCT03526861|537663678|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049827|NCT03526861|537663679|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049828|NCT03526861|537663680|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049829|NCT03526861|537663681|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
149049830|NCT03526861|537663682|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
149049831|NCT03526861|537663683|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049832|NCT03526861|537663684|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
149049833|NCT03526861|537663685|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049834|NCT03526861|537663686|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049835|NCT03526861|537663678|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
149049836|NCT03526861|537663679|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
149049837|NCT03526861|537663680|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
149049838|NCT03526861|537663681|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
149049839|NCT03526861|537663682|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
149049840|NCT03526861|537663683|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
149049841|NCT03526861|537663684|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
149049842|NCT03526861|537663685|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
149049843|NCT03526861|537663686|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
149049844|NCT03526861|537663678|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049845|NCT03526861|537663679|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049846|NCT03526861|537663680|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049847|NCT03526861|537663681|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
149049848|NCT03526861|537663682|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
148887652|NCT00404651|537067929|FG003|Overall Study|Lost to Follow-up|10|||
148887653|NCT00404651|537067926|FG000|Overall Study|Withdrawal by Subject|14|||
148887654|NCT00404651|537067927|FG001|Overall Study|Withdrawal by Subject|12|||
148887655|NCT00404651|537067928|FG002|Overall Study|Withdrawal by Subject|16|||
148887656|NCT00404651|537067929|FG003|Overall Study|Withdrawal by Subject|6|||
148887657|NCT01132807|537067940|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
149049849|NCT03526861|537663683|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049850|NCT03526861|537663684|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049851|NCT03526861|537663685|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049852|NCT03526861|537663686|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049853|NCT03526861|537663678|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049854|NCT03526861|537663679|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049855|NCT03526861|537663680|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049856|NCT03526861|537663681|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049857|NCT03526861|537663682|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049858|NCT03526861|537663683|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049859|NCT03526861|537663684|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049860|NCT03526861|537663685|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
149049861|NCT03526861|537663686|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
149049862|NCT03526861|537663678|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049863|NCT03526861|537663679|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049864|NCT03526861|537663680|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049865|NCT03526861|537663681|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049866|NCT03526861|537663682|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049867|NCT03526861|537663683|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049868|NCT03526861|537663684|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049869|NCT03526861|537663685|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
149049870|NCT03526861|537663686|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
149049871|NCT03526861|537663678|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049872|NCT03526861|537663679|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049873|NCT03526861|537663680|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049874|NCT03526861|537663681|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049875|NCT03526861|537663682|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049876|NCT03526861|537663683|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049877|NCT03526861|537663684|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049878|NCT03526861|537663685|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
149049879|NCT03526861|537663686|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
149049880|NCT02323321|537663699|FG000|Overall Study|Re-Transplant|1|||
149049881|NCT02323321|537663699|FG000|Overall Study|Death|12|||
149049882|NCT00446225|537663700|FG000|Overall Study|Protocol Violation|1|||
149049883|NCT00446225|537663701|FG001|Overall Study|Protocol Violation|0|||
149049884|NCT04450342|537663702|FG000|Overall Study|Adverse Event|1|||
149049885|NCT04450342|537663703|FG001|Overall Study|Adverse Event|1|||
149049886|NCT04450342|537663704|FG002|Overall Study|Adverse Event|0|||
149049887|NCT04450342|537663702|FG000|Overall Study|Device not used|1|||
149049888|NCT04450342|537663703|FG001|Overall Study|Device not used|0|||
149049889|NCT04450342|537663704|FG002|Overall Study|Device not used|0|||
149049890|NCT04450342|537663702|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
149049891|NCT04450342|537663703|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
149049892|NCT04450342|537663704|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
149049893|NCT04450342|537663702|FG000|Overall Study|Physician Decision|1|||
149049894|NCT04450342|537663703|FG001|Overall Study|Physician Decision|0|||
149049895|NCT04450342|537663704|FG002|Overall Study|Physician Decision|1|||
149049896|NCT04450342|537663702|FG000|Overall Study|Protocol Deviation|0|||
149049897|NCT04450342|537663703|FG001|Overall Study|Protocol Deviation|1|||
149049898|NCT04450342|537663704|FG002|Overall Study|Protocol Deviation|0|||
149049899|NCT04450342|537663702|FG000|Overall Study|Reoperation|1|||
149049900|NCT04450342|537663703|FG001|Overall Study|Reoperation|1|||
149049901|NCT04450342|537663704|FG002|Overall Study|Reoperation|0|||
149049902|NCT04450342|537663702|FG000|Overall Study|Screen Failures|0|||
149049903|NCT04450342|537663703|FG001|Overall Study|Screen Failures|0|||
149049904|NCT04450342|537663704|FG002|Overall Study|Screen Failures|2|||
149049905|NCT04450342|537663702|FG000|Overall Study|Site Terminated by Sponsor|1|||
149049906|NCT04450342|537663703|FG001|Overall Study|Site Terminated by Sponsor|1|||
149049907|NCT04450342|537663704|FG002|Overall Study|Site Terminated by Sponsor|1|||
149049908|NCT04450342|537663702|FG000|Overall Study|Study Terminated by Sponsor|31|||
149049909|NCT04450342|537663703|FG001|Overall Study|Study Terminated by Sponsor|29|||
149049910|NCT04450342|537663704|FG002|Overall Study|Study Terminated by Sponsor|6|||
149049911|NCT04450342|537663702|FG000|Overall Study|Withdrawal by Subject|0|||
149049912|NCT04450342|537663703|FG001|Overall Study|Withdrawal by Subject|1|||
149049913|NCT04450342|537663704|FG002|Overall Study|Withdrawal by Subject|2|||
149049914|NCT02500758|537663705|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
149049915|NCT02500758|537663706|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
149049916|NCT02500758|537663705|FG000|Washout (1 Week)|Lost to Follow-up|2|||
149049917|NCT02500758|537663706|FG001|Washout (1 Week)|Lost to Follow-up|2|||
149049918|NCT02500758|537663705|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
149049919|NCT02500758|537663706|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
149049920|NCT02500758|537663705|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
149049921|NCT02500758|537663706|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
149049922|NCT02500758|537663705|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
149049923|NCT02500758|537663706|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
149049924|NCT02874534|537663707|FG000|Overall Study|Withdrawal by Subject|5|||
149049925|NCT02874534|537663708|FG001|Overall Study|Withdrawal by Subject|8|||
149049926|NCT02874534|537663707|FG000|Overall Study|Lost to Follow-up|2|||
149049927|NCT02874534|537663708|FG001|Overall Study|Lost to Follow-up|2|||
149049928|NCT02874534|537663707|FG000|Overall Study|Ongoing in study|1|||
149049929|NCT02874534|537663708|FG001|Overall Study|Ongoing in study|1|||
149049930|NCT04431726|537663709|FG000|Overall Study|Ongoing in the Study|55|||
149049931|NCT02923180|537663710|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
149049932|NCT02923180|537663710|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
149049933|NCT05198310|537663711|FG000|Overall Study|Lost to Follow-up|0|||
149049934|NCT05198310|537663712|FG001|Overall Study|Lost to Follow-up|1|||
149049935|NCT05198310|537663713|FG002|Overall Study|Lost to Follow-up|0|||
149049936|NCT05198310|537663714|FG003|Overall Study|Lost to Follow-up|0|||
149049937|NCT05198310|537663715|FG004|Overall Study|Lost to Follow-up|0|||
149049938|NCT05198310|537663716|FG005|Overall Study|Lost to Follow-up|0|||
149049939|NCT05198310|537663717|FG006|Overall Study|Lost to Follow-up|0|||
149049940|NCT05198310|537663718|FG007|Overall Study|Lost to Follow-up|0|||
149049941|NCT05198310|537663711|FG000|Overall Study|Withdrawal by Subject|0|||
149049942|NCT05198310|537663712|FG001|Overall Study|Withdrawal by Subject|0|||
149049943|NCT05198310|537663713|FG002|Overall Study|Withdrawal by Subject|0|||
149049944|NCT05198310|537663714|FG003|Overall Study|Withdrawal by Subject|2|||
149049945|NCT05198310|537663715|FG004|Overall Study|Withdrawal by Subject|0|||
149049946|NCT05198310|537663716|FG005|Overall Study|Withdrawal by Subject|2|||
149049947|NCT05198310|537663717|FG006|Overall Study|Withdrawal by Subject|1|||
149049948|NCT05198310|537663718|FG007|Overall Study|Withdrawal by Subject|3|||
149049949|NCT04281485|537663719|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
149049950|NCT04281485|537663720|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
149049951|NCT04281485|537663719|FG000|Overall Study|Ongoing (Safety data collection)|10|||
149049952|NCT04281485|537663720|FG001|Overall Study|Ongoing (Safety data collection)|5|||
149049953|NCT04116736|537663723|FG000|Overall Study|Withdrew consent during study|3|||
149049954|NCT04116736|537663724|FG001|Overall Study|Withdrew consent during study|1|||
149049955|NCT04116736|537663723|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
149049956|NCT04116736|537663724|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
149049957|NCT04116736|537663723|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
149049958|NCT04116736|537663724|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
149049959|NCT04116736|537663723|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
149049960|NCT04116736|537663724|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
149049961|NCT04116736|537663723|FG000|Overall Study|Subject was enrolled in error|2|||
149049962|NCT04116736|537663724|FG001|Overall Study|Subject was enrolled in error|0|||
149049963|NCT04116736|537663723|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
149049964|NCT04116736|537663724|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
149049965|NCT04116736|537663723|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
149005214|NCT02287584|537497858|FG000|the Double-blind Phase|Protocol Violation|0|||
149005215|NCT02287584|537497859|FG001|the Double-blind Phase|Protocol Violation|3|||
149005216|NCT02287584|537497860|FG002|the Double-blind Phase|Protocol Violation|0|||
149005217|NCT02287584|537497861|FG003|the Double-blind Phase|Protocol Violation|0|||
149005218|NCT02287584|537497862|FG004|the Double-blind Phase|Protocol Violation|0|||
149005219|NCT02287584|537497863|FG005|the Double-blind Phase|Protocol Violation|0|||
149005220|NCT02287584|537497858|FG000|the Double-blind Phase|other reasons|0|||
148887658|NCT01132807|537067941|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
149005221|NCT02287584|537497859|FG001|the Double-blind Phase|other reasons|0|||
149005222|NCT02287584|537497860|FG002|the Double-blind Phase|other reasons|1|||
149005223|NCT02287584|537497861|FG003|the Double-blind Phase|other reasons|0|||
149005224|NCT02287584|537497862|FG004|the Double-blind Phase|other reasons|0|||
149005225|NCT02287584|537497863|FG005|the Double-blind Phase|other reasons|0|||
149005226|NCT02287584|537497858|FG000|the Open-label Phase|Did not receive drug|0|||
149049966|NCT04116736|537663724|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
149049967|NCT04116736|537663723|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
149049968|NCT04116736|537663724|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
149049969|NCT04757610|537663731|FG000|Overall Study|Adverse Event|13|||
149049970|NCT04757610|537663732|FG001|Overall Study|Adverse Event|10|||
149049971|NCT04757610|537663733|FG002|Overall Study|Adverse Event|5|||
149049972|NCT04757610|537663731|FG000|Overall Study|Death|5|||
149049973|NCT04757610|537663732|FG001|Overall Study|Death|13|||
149049974|NCT04757610|537663733|FG002|Overall Study|Death|8|||
149049975|NCT04757610|537663731|FG000|Overall Study|Lack of Efficacy|1|||
149049976|NCT04757610|537663732|FG001|Overall Study|Lack of Efficacy|2|||
149049977|NCT04757610|537663733|FG002|Overall Study|Lack of Efficacy|3|||
149049978|NCT04757610|537663731|FG000|Overall Study|Lost to Follow-up|7|||
149049979|NCT04757610|537663732|FG001|Overall Study|Lost to Follow-up|2|||
149049980|NCT04757610|537663733|FG002|Overall Study|Lost to Follow-up|7|||
149049981|NCT04757610|537663731|FG000|Overall Study|Physician Decision|4|||
149049982|NCT04757610|537663732|FG001|Overall Study|Physician Decision|1|||
149049983|NCT04757610|537663733|FG002|Overall Study|Physician Decision|2|||
149049984|NCT04757610|537663731|FG000|Overall Study|Withdrawal by Subject|26|||
149049985|NCT04757610|537663732|FG001|Overall Study|Withdrawal by Subject|25|||
149049986|NCT04757610|537663733|FG002|Overall Study|Withdrawal by Subject|25|||
149049987|NCT04757610|537663731|FG000|Overall Study|Study Terminated by Sponsor|105|||
149049988|NCT04757610|537663732|FG001|Overall Study|Study Terminated by Sponsor|105|||
149049989|NCT04757610|537663733|FG002|Overall Study|Study Terminated by Sponsor|110|||
149049990|NCT04757610|537663731|FG000|Overall Study|Randomized in Error|1|||
149005227|NCT02287584|537497859|FG001|the Open-label Phase|Did not receive drug|0|||
149005228|NCT02287584|537497860|FG002|the Open-label Phase|Did not receive drug|0|||
149005229|NCT02287584|537497861|FG003|the Open-label Phase|Did not receive drug|7|||
149005230|NCT02287584|537497862|FG004|the Open-label Phase|Did not receive drug|6|||
149005231|NCT02287584|537497863|FG005|the Open-label Phase|Did not receive drug|4|||
149005232|NCT02287584|537497858|FG000|the Open-label Phase|Adverse Event|0|||
149005233|NCT02287584|537497859|FG001|the Open-label Phase|Adverse Event|0|||
149005234|NCT02287584|537497860|FG002|the Open-label Phase|Adverse Event|0|||
149005235|NCT02287584|537497861|FG003|the Open-label Phase|Adverse Event|15|||
149005236|NCT02287584|537497862|FG004|the Open-label Phase|Adverse Event|12|||
149005237|NCT02287584|537497863|FG005|the Open-label Phase|Adverse Event|16|||
149005238|NCT02287584|537497858|FG000|the Open-label Phase|Lack of Efficacy|0|||
149005239|NCT02287584|537497859|FG001|the Open-label Phase|Lack of Efficacy|0|||
149005240|NCT02287584|537497860|FG002|the Open-label Phase|Lack of Efficacy|0|||
149005241|NCT02287584|537497861|FG003|the Open-label Phase|Lack of Efficacy|8|||
149005242|NCT02287584|537497862|FG004|the Open-label Phase|Lack of Efficacy|3|||
149005243|NCT02287584|537497863|FG005|the Open-label Phase|Lack of Efficacy|7|||
149005244|NCT02287584|537497858|FG000|the Open-label Phase|Lost to Follow-up|0|||
149005245|NCT02287584|537497859|FG001|the Open-label Phase|Lost to Follow-up|0|||
149005246|NCT02287584|537497860|FG002|the Open-label Phase|Lost to Follow-up|0|||
149005247|NCT02287584|537497861|FG003|the Open-label Phase|Lost to Follow-up|4|||
149005248|NCT02287584|537497862|FG004|the Open-label Phase|Lost to Follow-up|1|||
149005249|NCT02287584|537497863|FG005|the Open-label Phase|Lost to Follow-up|2|||
149005250|NCT02287584|537497858|FG000|the Open-label Phase|Withdrawal by Subject|0|||
149005251|NCT02287584|537497859|FG001|the Open-label Phase|Withdrawal by Subject|0|||
149005252|NCT02287584|537497860|FG002|the Open-label Phase|Withdrawal by Subject|0|||
149005253|NCT02287584|537497861|FG003|the Open-label Phase|Withdrawal by Subject|18|||
149005254|NCT02287584|537497862|FG004|the Open-label Phase|Withdrawal by Subject|29|||
149005255|NCT02287584|537497863|FG005|the Open-label Phase|Withdrawal by Subject|21|||
149005256|NCT02287584|537497858|FG000|the Open-label Phase|non-compliance|0|||
149005257|NCT02287584|537497859|FG001|the Open-label Phase|non-compliance|0|||
149005258|NCT02287584|537497860|FG002|the Open-label Phase|non-compliance|0|||
149005259|NCT02287584|537497861|FG003|the Open-label Phase|non-compliance|2|||
149005260|NCT02287584|537497862|FG004|the Open-label Phase|non-compliance|5|||
149005261|NCT02287584|537497863|FG005|the Open-label Phase|non-compliance|1|||
149005262|NCT02287584|537497858|FG000|the Open-label Phase|other reasons|0|||
149049991|NCT04757610|537663732|FG001|Overall Study|Randomized in Error|0|||
149049992|NCT04757610|537663733|FG002|Overall Study|Randomized in Error|0|||
149049993|NCT06450405|537663736|FG000|Overall Study|Study funding terminated.|0|||
149049994|NCT06450405|537663737|FG001|Overall Study|Study funding terminated.|2|||
149049995|NCT05338086|537665307|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
149005263|NCT02287584|537497859|FG001|the Open-label Phase|other reasons|0|||
149005264|NCT02287584|537497860|FG002|the Open-label Phase|other reasons|0|||
149005265|NCT02287584|537497861|FG003|the Open-label Phase|other reasons|3|||
149005266|NCT02287584|537497862|FG004|the Open-label Phase|other reasons|6|||
149005267|NCT02287584|537497863|FG005|the Open-label Phase|other reasons|6|||
149049996|NCT05338086|537665308|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
149049997|NCT05338086|537665309|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
149049998|NCT05338086|537665310|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
149049999|NCT05338086|537665311|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
149050000|NCT05338086|537665307|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
149050001|NCT05338086|537665308|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
149050002|NCT05338086|537665309|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
149050003|NCT05338086|537665310|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
149050004|NCT05338086|537665311|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
149050005|NCT05338086|537665307|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
149050006|NCT05338086|537665308|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
149050007|NCT05338086|537665309|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
149050008|NCT05338086|537665310|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
149050009|NCT05338086|537665311|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
149050010|NCT05338086|537665307|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
149050011|NCT05338086|537665308|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
149050012|NCT05338086|537665309|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
149050013|NCT05338086|537665310|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
149050014|NCT05338086|537665311|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
149050015|NCT05338086|537665307|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
149050016|NCT05338086|537665308|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
149050017|NCT05338086|537665309|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
149050018|NCT05338086|537665310|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
149050019|NCT05338086|537665311|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
149050020|NCT05338086|537665307|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
149050021|NCT05338086|537665308|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
149050022|NCT05338086|537665309|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
149050023|NCT05338086|537665310|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
149050024|NCT05338086|537665311|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
149050025|NCT05338086|537665307|FG000|Transition Period (M12 to M18)|Death|0|||
149050026|NCT05338086|537665308|FG001|Transition Period (M12 to M18)|Death|0|||
149050027|NCT05338086|537665309|FG002|Transition Period (M12 to M18)|Death|1|||
149050028|NCT05338086|537665310|FG003|Transition Period (M12 to M18)|Death|0|||
149050029|NCT05338086|537665311|FG004|Transition Period (M12 to M18)|Death|0|||
149050030|NCT05338086|537665307|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
149050031|NCT05338086|537665308|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
149050032|NCT05338086|537665309|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
149050033|NCT05338086|537665310|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
149050034|NCT05338086|537665311|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
149050035|NCT05338086|537665307|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
149050036|NCT05338086|537665308|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
149050037|NCT05338086|537665309|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
149050038|NCT05338086|537665310|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
149050039|NCT05338086|537665311|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
149050040|NCT05338086|537665307|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
149050041|NCT05338086|537665308|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
149050042|NCT05338086|537665309|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
149050043|NCT05338086|537665310|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
149050044|NCT05338086|537665311|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
149050045|NCT03940703|537665312|FG000|Overall Study|Still under treatment|31|||
149050046|NCT03940703|537665313|FG001|Overall Study|Still under treatment|0|||
149050047|NCT03897686|537665323|FG000|Overall Study|Protocol Violation|1|||
149050048|NCT03897686|537665324|FG001|Overall Study|Protocol Violation|1|||
149050049|NCT03897686|537665323|FG000|Overall Study|Withdrawal by Subject|1|||
149050050|NCT03897686|537665324|FG001|Overall Study|Withdrawal by Subject|1|||
149050051|NCT04052516|537665325|FG000|Overall Study|Withdrawal by Subject|4|||
149050052|NCT04052516|537665326|FG001|Overall Study|Withdrawal by Subject|5|||
149050053|NCT04052516|537665327|FG002|Overall Study|Withdrawal by Subject|6|||
149050054|NCT04052516|537665325|FG000|Overall Study|Adverse Event|3|||
149050055|NCT04052516|537665326|FG001|Overall Study|Adverse Event|2|||
149050056|NCT04052516|537665327|FG002|Overall Study|Adverse Event|8|||
149050057|NCT04052516|537665325|FG000|Overall Study|Lost to Follow-up|2|||
149050058|NCT04052516|537665326|FG001|Overall Study|Lost to Follow-up|5|||
149050059|NCT04052516|537665327|FG002|Overall Study|Lost to Follow-up|3|||
149050060|NCT04052516|537665325|FG000|Overall Study|Protocol Violation|1|||
149050061|NCT04052516|537665326|FG001|Overall Study|Protocol Violation|1|||
149050062|NCT04052516|537665327|FG002|Overall Study|Protocol Violation|0|||
149050063|NCT04052516|537665325|FG000|Overall Study|Death|1|||
149050064|NCT04052516|537665326|FG001|Overall Study|Death|0|||
149050065|NCT04052516|537665327|FG002|Overall Study|Death|0|||
149050066|NCT04052516|537665325|FG000|Overall Study|Physician Decision|0|||
149050067|NCT04052516|537665326|FG001|Overall Study|Physician Decision|1|||
149050068|NCT04052516|537665327|FG002|Overall Study|Physician Decision|0|||
149050069|NCT04052516|537665325|FG000|Overall Study|Pregnancy|1|||
149050070|NCT04052516|537665326|FG001|Overall Study|Pregnancy|0|||
149050071|NCT04052516|537665327|FG002|Overall Study|Pregnancy|0|||
149050072|NCT04052516|537665325|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
149050073|NCT04052516|537665326|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
149050074|NCT04052516|537665327|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
149050075|NCT04052516|537665325|FG000|Overall Study|Reason not recorded|0|||
149050076|NCT04052516|537665326|FG001|Overall Study|Reason not recorded|1|||
149050077|NCT04052516|537665327|FG002|Overall Study|Reason not recorded|0|||
149050078|NCT03819686|537665329|FG000|Overall Study|Lost to Follow-up|2|||
149050079|NCT03819686|537665330|FG001|Overall Study|Lost to Follow-up|3|||
149050080|NCT05386355|537665331|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
149050081|NCT05386355|537665332|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
149050082|NCT05386355|537665333|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
149050083|NCT05386355|537665334|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
149050084|NCT06143670|537665335|FG000|Overall Study|Lost to Follow-up|0|||
149050085|NCT06143670|537665336|FG001|Overall Study|Lost to Follow-up|1|||
149050086|NCT06143670|537665335|FG000|Overall Study|Withdrawal by Subject|3|||
149050087|NCT06143670|537665336|FG001|Overall Study|Withdrawal by Subject|0|||
149050088|NCT03747484|537665337|FG000|Overall Study|Lack of Efficacy|0|||
149050089|NCT03747484|537665338|FG001|Overall Study|Lack of Efficacy|1|||
149050090|NCT03747484|537665339|FG002|Overall Study|Lack of Efficacy|1|||
149050091|NCT03747484|537665340|FG003|Overall Study|Lack of Efficacy|2|||
149050092|NCT03747484|537665341|FG004|Overall Study|Lack of Efficacy|2|||
149050093|NCT04842643|537665346|FG000|Overall Study|Physician Decision|1|||
149050094|NCT04842643|537665346|FG000|Overall Study|Other|1|||
149050095|NCT01894061|537665347|FG000|Overall Study|Screen failure|1|||
149050096|NCT01894061|537665347|FG000|Overall Study|Withdrawal by Subject|1|||
149050097|NCT04173663|537665348|FG000|Overall Study|Withdrawal by Subject|1|||
149050098|NCT04173663|537665349|FG001|Overall Study|Withdrawal by Subject|6|||
149050099|NCT04173663|537665348|FG000|Overall Study|Lost to Follow-up|17|||
149050100|NCT04173663|537665349|FG001|Overall Study|Lost to Follow-up|24|||
149050101|NCT02630823|537665350|FG000|Overall Study|Withdrawal by Subject|1|||
149050102|NCT02630823|537665350|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
149050103|NCT02287311|537665356|FG000|Cohort 1: Dose Level 1|Death|2|||
149050104|NCT02287311|537665357|FG001|Cohort 1: Dose Level 1|Death|0|||
149050105|NCT02287311|537665358|FG002|Cohort 1: Dose Level 1|Death|0|||
149050106|NCT02287311|537665359|FG003|Cohort 1: Dose Level 1|Death|3|||
149050107|NCT02287311|537665360|FG004|Cohort 1: Dose Level 1|Death|0|||
149050108|NCT02287311|537665361|FG005|Cohort 1: Dose Level 1|Death|0|||
149050109|NCT02287311|537665362|FG006|Cohort 1: Dose Level 1|Death|1|||
149050110|NCT02287311|537665363|FG007|Cohort 1: Dose Level 1|Death|0|||
149050111|NCT02287311|537665364|FG008|Cohort 1: Dose Level 1|Death|0|||
149050112|NCT02287311|537665356|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050113|NCT02287311|537665357|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050114|NCT02287311|537665358|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050115|NCT02287311|537665359|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
149050116|NCT02287311|537665360|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050117|NCT02287311|537665361|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050118|NCT02287311|537665362|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
149050119|NCT02287311|537665363|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050120|NCT02287311|537665364|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
149050121|NCT02287311|537665356|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
148887659|NCT01132807|537067942|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
148887660|NCT01132807|537067940|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
149050122|NCT02287311|537665357|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
149050123|NCT02287311|537665358|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
149050124|NCT02287311|537665359|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
149050125|NCT02287311|537665360|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
149050126|NCT02287311|537665361|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
149050127|NCT02287311|537665362|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
149050128|NCT02287311|537665363|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
149050129|NCT02287311|537665364|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
149050130|NCT02287311|537665356|FG000|Cohort 2: Dose Level 2|Death|0|||
149050131|NCT02287311|537665357|FG001|Cohort 2: Dose Level 2|Death|2|||
149050132|NCT02287311|537665358|FG002|Cohort 2: Dose Level 2|Death|0|||
149050133|NCT02287311|537665359|FG003|Cohort 2: Dose Level 2|Death|0|||
149050134|NCT02287311|537665360|FG004|Cohort 2: Dose Level 2|Death|2|||
149050135|NCT02287311|537665361|FG005|Cohort 2: Dose Level 2|Death|0|||
149050136|NCT02287311|537665362|FG006|Cohort 2: Dose Level 2|Death|0|||
149050137|NCT02287311|537665363|FG007|Cohort 2: Dose Level 2|Death|2|||
149050138|NCT02287311|537665364|FG008|Cohort 2: Dose Level 2|Death|0|||
149050139|NCT02287311|537665356|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050140|NCT02287311|537665357|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050141|NCT02287311|537665358|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050142|NCT02287311|537665359|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050143|NCT02287311|537665360|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
149050144|NCT02287311|537665361|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050145|NCT02287311|537665362|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050146|NCT02287311|537665363|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050147|NCT02287311|537665364|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
149050148|NCT02287311|537665356|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050149|NCT02287311|537665357|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
149050150|NCT02287311|537665358|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050151|NCT02287311|537665359|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050152|NCT02287311|537665360|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050153|NCT02287311|537665361|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050154|NCT02287311|537665362|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050155|NCT02287311|537665363|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050156|NCT02287311|537665364|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
149050157|NCT02287311|537665356|FG000|Cohort 3: Dose Level 3|Death|0|||
149050158|NCT02287311|537665357|FG001|Cohort 3: Dose Level 3|Death|0|||
149050159|NCT02287311|537665358|FG002|Cohort 3: Dose Level 3|Death|4|||
148887661|NCT01132807|537067941|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
149050160|NCT02287311|537665359|FG003|Cohort 3: Dose Level 3|Death|0|||
149050161|NCT02287311|537665360|FG004|Cohort 3: Dose Level 3|Death|0|||
149050162|NCT02287311|537665361|FG005|Cohort 3: Dose Level 3|Death|4|||
149050163|NCT02287311|537665362|FG006|Cohort 3: Dose Level 3|Death|0|||
149050164|NCT02287311|537665363|FG007|Cohort 3: Dose Level 3|Death|0|||
149050165|NCT02287311|537665364|FG008|Cohort 3: Dose Level 3|Death|2|||
149050166|NCT02287311|537665356|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050167|NCT02287311|537665357|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050168|NCT02287311|537665358|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
149050169|NCT02287311|537665359|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050170|NCT02287311|537665360|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050171|NCT02287311|537665361|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
149050172|NCT02287311|537665362|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050173|NCT02287311|537665363|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050174|NCT02287311|537665364|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
149050175|NCT02287311|537665356|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
149050176|NCT02287311|537665357|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
148887662|NCT01132807|537067942|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
148887663|NCT02222558|537067943|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
148887664|NCT02222558|537067944|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
148887665|NCT02222558|537067945|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
148887666|NCT02222558|537067946|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
148887667|NCT02222558|537067947|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
148887668|NCT02222558|537067948|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
148887669|NCT02222558|537067943|FG000|Period 3|Withdrawal by Subject|0|||
148887670|NCT02222558|537067944|FG001|Period 3|Withdrawal by Subject|0|||
148887671|NCT02222558|537067945|FG002|Period 3|Withdrawal by Subject|0|||
148887672|NCT02222558|537067946|FG003|Period 3|Withdrawal by Subject|0|||
148887673|NCT02222558|537067947|FG004|Period 3|Withdrawal by Subject|0|||
148887674|NCT02222558|537067948|FG005|Period 3|Withdrawal by Subject|1|||
148887675|NCT02322281|537067951|FG000|Overall Study|Progressive Disease|42|||
148887676|NCT02322281|537067952|FG001|Overall Study|Progressive Disease|14|||
149050177|NCT02287311|537665358|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
149050178|NCT02287311|537665359|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
149050179|NCT02287311|537665360|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
149050180|NCT02287311|537665361|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
149050181|NCT02287311|537665362|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
149050182|NCT02287311|537665363|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
149050183|NCT02287311|537665364|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
149050184|NCT03896516|537665365|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
149050185|NCT03896516|537665366|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
149050186|NCT03896516|537665365|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
149050187|NCT03896516|537665366|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
149050188|NCT03896516|537665365|FG000|Washout Period|Physician Decision|3|||
149050189|NCT03896516|537665366|FG001|Washout Period|Physician Decision|1|||
149050190|NCT03896516|537665365|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
148887677|NCT02322281|537067953|FG002|Overall Study|Progressive Disease|49|||
148887678|NCT02322281|537067951|FG000|Overall Study|Adverse Event|3|||
149050191|NCT03896516|537665366|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
149050192|NCT04538417|537665371|FG000|Overall Study|Withdrawal by Subject|2|||
149050193|NCT04549168|537665376|FG000|Randomization Phase|Adverse Event|0|||
149050194|NCT04549168|537665377|FG001|Randomization Phase|Adverse Event|0|||
149050195|NCT04549168|537665378|FG002|Randomization Phase|Adverse Event|1|||
149050196|NCT04549168|537665376|FG000|Randomization Phase|Other|0|||
149050197|NCT04549168|537665377|FG001|Randomization Phase|Other|2|||
149050198|NCT04549168|537665378|FG002|Randomization Phase|Other|0|||
149050199|NCT04549168|537665376|FG000|Randomization Phase|Withdrawal by Subject|0|||
149050200|NCT04549168|537665377|FG001|Randomization Phase|Withdrawal by Subject|2|||
149050201|NCT04549168|537665378|FG002|Randomization Phase|Withdrawal by Subject|1|||
149050202|NCT02662062|537665380|FG000|Overall Study|Withdrawal by Subject|1|||
149050203|NCT02097420|537665381|FG000|Overall Study|Death|6|||
149050204|NCT02097420|537665381|FG000|Overall Study|Valve explanted|13|||
149050205|NCT02097420|537665381|FG000|Overall Study|Other Reason|1|||
149050206|NCT03393975|537665385|FG000|Urgent Treatment Period|Physician Decision|0|||
149050207|NCT03393975|537665386|FG001|Urgent Treatment Period|Physician Decision|0|||
149050208|NCT03393975|537665387|FG002|Urgent Treatment Period|Physician Decision|0|||
149050209|NCT03393975|537665388|FG003|Urgent Treatment Period|Physician Decision|1|||
149050210|NCT03393975|537665385|FG000|Prophylaxis Period 1|Reason not Specified|0|||
149050211|NCT03393975|537665386|FG001|Prophylaxis Period 1|Reason not Specified|1|||
149050212|NCT03393975|537665387|FG002|Prophylaxis Period 1|Reason not Specified|0|||
149050213|NCT03393975|537665388|FG003|Prophylaxis Period 1|Reason not Specified|0|||
149050214|NCT03393975|537665385|FG000|Prophylaxis Period 2|Reason not Specified|0|||
149050215|NCT03393975|537665386|FG001|Prophylaxis Period 2|Reason not Specified|1|||
149050216|NCT03393975|537665387|FG002|Prophylaxis Period 2|Reason not Specified|0|||
149050217|NCT03393975|537665388|FG003|Prophylaxis Period 2|Reason not Specified|0|||
149050218|NCT04737772|537665389|FG000|Phase 2 Study|Lost to Follow-up|15|||
149050219|NCT04737772|537665390|FG001|Phase 2 Study|Lost to Follow-up|15|||
149050220|NCT04737772|537665389|FG000|Phase 2 Study|Withdrawal by Subject|0|||
149050221|NCT04737772|537665390|FG001|Phase 2 Study|Withdrawal by Subject|1|||
149050222|NCT04737772|537665389|FG000|Phase 2 Study|Did not take any coaching calls|4|||
149050223|NCT04737772|537665390|FG001|Phase 2 Study|Did not take any coaching calls|0|||
149050224|NCT04737772|537665389|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
149050225|NCT04737772|537665390|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
149050226|NCT04737772|537665389|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
149050227|NCT04737772|537665390|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
149050228|NCT04838262|537665391|FG000|Overall Study|Withdrawal by Subject|9|||
149050229|NCT04838262|537665392|FG001|Overall Study|Withdrawal by Subject|4|||
149050230|NCT04382898|537665396|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
149050231|NCT04382898|537665397|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
149050232|NCT04382898|537665398|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
149050233|NCT04382898|537665399|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
149050234|NCT04382898|537665400|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
149050235|NCT04382898|537665396|FG000|Part 1: Dose Titration|Death|6|||
149050236|NCT04382898|537665397|FG001|Part 1: Dose Titration|Death|0|||
149050237|NCT04382898|537665398|FG002|Part 1: Dose Titration|Death|0|||
149050238|NCT04382898|537665399|FG003|Part 1: Dose Titration|Death|0|||
149050239|NCT04382898|537665400|FG004|Part 1: Dose Titration|Death|0|||
149050240|NCT04382898|537665396|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149050241|NCT04382898|537665397|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149050242|NCT04382898|537665398|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
149050243|NCT04382898|537665399|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
148887679|NCT02322281|537067952|FG001|Overall Study|Adverse Event|4|||
148887680|NCT02322281|537067953|FG002|Overall Study|Adverse Event|6|||
148887681|NCT02322281|537067951|FG000|Overall Study|Death|3|||
148887682|NCT02322281|537067952|FG001|Overall Study|Death|3|||
148887683|NCT02322281|537067953|FG002|Overall Study|Death|3|||
148887684|NCT02322281|537067951|FG000|Overall Study|Withdrawal by Subject|1|||
148887685|NCT02322281|537067952|FG001|Overall Study|Withdrawal by Subject|1|||
148887686|NCT02322281|537067953|FG002|Overall Study|Withdrawal by Subject|6|||
149050244|NCT04382898|537665400|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
149050245|NCT04382898|537665396|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
149050246|NCT04382898|537665397|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
149050247|NCT04382898|537665398|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
149050248|NCT04382898|537665399|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
149050249|NCT04382898|537665400|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
149050250|NCT04382898|537665396|FG000|Part 2: Dose Expansion|Death|0|||
149050251|NCT04382898|537665397|FG001|Part 2: Dose Expansion|Death|17|||
149050252|NCT04382898|537665398|FG002|Part 2: Dose Expansion|Death|13|||
149050253|NCT04382898|537665399|FG003|Part 2: Dose Expansion|Death|1|||
149050254|NCT04382898|537665400|FG004|Part 2: Dose Expansion|Death|0|||
148887687|NCT02322281|537067951|FG000|Overall Study|Physician Decision|2|||
149050255|NCT04382898|537665396|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
149050256|NCT04382898|537665397|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
148887688|NCT02322281|537067952|FG001|Overall Study|Physician Decision|0|||
148887689|NCT02322281|537067953|FG002|Overall Study|Physician Decision|5|||
149050257|NCT04382898|537665398|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
149050258|NCT04382898|537665399|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
149050259|NCT04382898|537665400|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
149050260|NCT04382898|537665396|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
149050261|NCT04382898|537665397|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
149050262|NCT04382898|537665398|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
149050263|NCT04382898|537665399|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
149050264|NCT04382898|537665400|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
149050265|NCT04382898|537665396|FG000|Part 2: Dose Expansion|Other|0|||
149050266|NCT04382898|537665397|FG001|Part 2: Dose Expansion|Other|0|||
149050267|NCT04382898|537665398|FG002|Part 2: Dose Expansion|Other|1|||
149050268|NCT04382898|537665399|FG003|Part 2: Dose Expansion|Other|0|||
149050269|NCT04382898|537665400|FG004|Part 2: Dose Expansion|Other|0|||
149050270|NCT05956002|537665402|FG000|Treatment Period 3|Adverse Event|0|||
149050271|NCT05956002|537665403|FG001|Treatment Period 3|Adverse Event|0|||
149050272|NCT05956002|537665404|FG002|Treatment Period 3|Adverse Event|1|||
149050273|NCT05956002|537665405|FG003|Treatment Period 3|Adverse Event|0|||
149050274|NCT02307565|537665406|FG000|Overall Study|Adverse Event|3|||
149050275|NCT02307565|537665407|FG001|Overall Study|Adverse Event|2|||
149050276|NCT02307565|537665406|FG000|Overall Study|Withdrawal by Subject|2|||
149050277|NCT02307565|537665407|FG001|Overall Study|Withdrawal by Subject|2|||
149050278|NCT04936035|537665408|FG000|Overall Study|Adverse Event|0|||
149050279|NCT04936035|537665409|FG001|Overall Study|Adverse Event|1|||
149050280|NCT04936035|537665410|FG002|Overall Study|Adverse Event|0|||
149050281|NCT04936035|537665411|FG003|Overall Study|Adverse Event|0|||
149050282|NCT04936035|537665412|FG004|Overall Study|Adverse Event|0|||
149050283|NCT04936035|537665408|FG000|Overall Study|Death|0|||
149050284|NCT04936035|537665409|FG001|Overall Study|Death|0|||
149050285|NCT04936035|537665410|FG002|Overall Study|Death|0|||
149050286|NCT04936035|537665411|FG003|Overall Study|Death|1|||
149050287|NCT04936035|537665412|FG004|Overall Study|Death|0|||
149050288|NCT04936035|537665408|FG000|Overall Study|Lost to Follow-up|0|||
149050289|NCT04936035|537665409|FG001|Overall Study|Lost to Follow-up|1|||
149050290|NCT04936035|537665410|FG002|Overall Study|Lost to Follow-up|1|||
149050291|NCT04936035|537665411|FG003|Overall Study|Lost to Follow-up|2|||
149050292|NCT04936035|537665412|FG004|Overall Study|Lost to Follow-up|1|||
149050293|NCT04936035|537665408|FG000|Overall Study|Physician Decision|0|||
149050294|NCT04936035|537665409|FG001|Overall Study|Physician Decision|1|||
149050295|NCT04936035|537665410|FG002|Overall Study|Physician Decision|0|||
149050296|NCT04936035|537665411|FG003|Overall Study|Physician Decision|0|||
149050297|NCT04936035|537665412|FG004|Overall Study|Physician Decision|0|||
149050298|NCT04936035|537665408|FG000|Overall Study|Protocol Deviation|0|||
149050299|NCT04936035|537665409|FG001|Overall Study|Protocol Deviation|0|||
149050300|NCT04936035|537665410|FG002|Overall Study|Protocol Deviation|1|||
149050301|NCT04936035|537665411|FG003|Overall Study|Protocol Deviation|0|||
149050302|NCT04936035|537665412|FG004|Overall Study|Protocol Deviation|0|||
149050303|NCT04936035|537665408|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
149050304|NCT04936035|537665409|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
149050305|NCT04936035|537665410|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
149050306|NCT04936035|537665411|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
149050307|NCT04936035|537665412|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
149050308|NCT04936035|537665408|FG000|Overall Study|Reason Unknown|0|||
149050309|NCT04936035|537665409|FG001|Overall Study|Reason Unknown|0|||
149050310|NCT04936035|537665410|FG002|Overall Study|Reason Unknown|0|||
149050311|NCT04936035|537665411|FG003|Overall Study|Reason Unknown|0|||
149050312|NCT04936035|537665412|FG004|Overall Study|Reason Unknown|1|||
149050313|NCT04936035|537665408|FG000|Overall Study|Withdrawal by Subject|1|||
149050314|NCT04936035|537665409|FG001|Overall Study|Withdrawal by Subject|0|||
149050315|NCT04936035|537665410|FG002|Overall Study|Withdrawal by Subject|0|||
149050316|NCT04936035|537665411|FG003|Overall Study|Withdrawal by Subject|0|||
149050317|NCT04936035|537665412|FG004|Overall Study|Withdrawal by Subject|0|||
149050318|NCT04936035|537665408|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
149050319|NCT04936035|537665409|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
149050320|NCT04936035|537665410|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
149050321|NCT04936035|537665411|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
149050322|NCT04936035|537665412|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
149050323|NCT04936035|537665408|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
149050324|NCT04936035|537665409|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
149050325|NCT04936035|537665410|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
149050326|NCT04936035|537665411|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
149050327|NCT04936035|537665412|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
149050328|NCT04936035|537665408|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
149050329|NCT04936035|537665409|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
149050330|NCT04936035|537665410|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
149050331|NCT04936035|537665411|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
149050332|NCT04936035|537665412|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
149050333|NCT04401800|537665413|FG000|Overall Study|Death|17|||
149050334|NCT04401800|537665413|FG000|Overall Study|Lost to Follow-up|5|||
149050335|NCT04401800|537665413|FG000|Overall Study|Withdrawal by Subject|4|||
149050336|NCT00601900|537665418|FG000|Overall Study|Withdrawal by Subject|0|||
149050337|NCT00601900|537665419|FG001|Overall Study|Withdrawal by Subject|3|||
149050338|NCT01772472|537665420|FG000|Overall Study|Death|126|||
149050339|NCT01772472|537665421|FG001|Overall Study|Death|94|||
149050340|NCT01772472|537665420|FG000|Overall Study|Lost to Follow-up|51|||
149050341|NCT01772472|537665421|FG001|Overall Study|Lost to Follow-up|50|||
149050342|NCT01772472|537665420|FG000|Overall Study|Other|9|||
149050343|NCT01772472|537665421|FG001|Overall Study|Other|7|||
149050344|NCT01772472|537665420|FG000|Overall Study|Physician Decision|1|||
149050345|NCT01772472|537665421|FG001|Overall Study|Physician Decision|7|||
149050346|NCT01772472|537665420|FG000|Overall Study|Withdrawal by Subject|115|||
149050347|NCT01772472|537665421|FG001|Overall Study|Withdrawal by Subject|90|||
149050348|NCT01772472|537665420|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
149050349|NCT01772472|537665421|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
149050350|NCT04391894|537665422|FG000|Overall Study|Adverse Event|1|||
149050351|NCT04391894|537665423|FG001|Overall Study|Adverse Event|1|||
149050352|NCT04391894|537665424|FG002|Overall Study|Adverse Event|1|||
149050353|NCT04391894|537665425|FG003|Overall Study|Adverse Event|1|||
148887690|NCT02322281|537067951|FG000|Overall Study|Study Terminated by Sponsor|2|||
148887691|NCT02322281|537067952|FG001|Overall Study|Study Terminated by Sponsor|0|||
148887692|NCT02322281|537067953|FG002|Overall Study|Study Terminated by Sponsor|0|||
148887693|NCT02322281|537067951|FG000|Overall Study|Missing|0|||
148887694|NCT02322281|537067952|FG001|Overall Study|Missing|0|||
148887695|NCT02322281|537067953|FG002|Overall Study|Missing|1|||
148887696|NCT02322281|537067951|FG000|Overall Study|Miscellaneous|0|||
148887697|NCT02322281|537067952|FG001|Overall Study|Miscellaneous|0|||
148887698|NCT02322281|537067953|FG002|Overall Study|Miscellaneous|4|||
148887699|NCT00936702|537067957|FG000|Overall Study|Disease progression|34|||
148887700|NCT00936702|537067957|FG000|Overall Study|Adverse Event|8|||
148887701|NCT00936702|537067957|FG000|Overall Study|Withdrawal by Subject|2|||
148887702|NCT00936702|537067957|FG000|Overall Study|Alternative Treatment|1|||
149050354|NCT04391894|537665426|FG004|Overall Study|Adverse Event|1|||
149050355|NCT04391894|537665422|FG000|Overall Study|Lost to Follow-up|1|||
149050356|NCT04391894|537665423|FG001|Overall Study|Lost to Follow-up|0|||
149050357|NCT04391894|537665424|FG002|Overall Study|Lost to Follow-up|0|||
149050358|NCT04391894|537665425|FG003|Overall Study|Lost to Follow-up|0|||
149050359|NCT04391894|537665426|FG004|Overall Study|Lost to Follow-up|0|||
149050360|NCT04391894|537665422|FG000|Overall Study|Protocol Violation|0|||
149050361|NCT04391894|537665423|FG001|Overall Study|Protocol Violation|0|||
149050362|NCT04391894|537665424|FG002|Overall Study|Protocol Violation|0|||
149050363|NCT04391894|537665425|FG003|Overall Study|Protocol Violation|1|||
149050364|NCT04391894|537665426|FG004|Overall Study|Protocol Violation|0|||
149050365|NCT04391894|537665422|FG000|Overall Study|Withdrawal by Subject|2|||
149050366|NCT04391894|537665423|FG001|Overall Study|Withdrawal by Subject|0|||
149050367|NCT04391894|537665424|FG002|Overall Study|Withdrawal by Subject|3|||
149050368|NCT04391894|537665425|FG003|Overall Study|Withdrawal by Subject|0|||
149050369|NCT04391894|537665426|FG004|Overall Study|Withdrawal by Subject|1|||
149050370|NCT04391894|537665422|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
149050371|NCT04391894|537665423|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
149050372|NCT04391894|537665424|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
149050373|NCT04391894|537665425|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
149050374|NCT04391894|537665426|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
149050375|NCT05633407|537665430|FG000|Overall Study|Physician Decision|2|||
149050376|NCT05633407|537665431|FG001|Overall Study|Physician Decision|0|||
149050377|NCT05633407|537665430|FG000|Overall Study|Adverse Event|1|||
149050378|NCT05633407|537665431|FG001|Overall Study|Adverse Event|0|||
149050379|NCT05633407|537665430|FG000|Overall Study|Withdrawal by Subject|1|||
149050380|NCT05633407|537665431|FG001|Overall Study|Withdrawal by Subject|0|||
149050381|NCT05633407|537665430|FG000|Overall Study|Other|1|||
149050382|NCT05633407|537665431|FG001|Overall Study|Other|1|||
149050383|NCT00220740|537665436|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
149050384|NCT00220740|537665437|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
149050385|NCT00220740|537665436|FG000|Efficacy Period|Adverse Event|1|||
149050386|NCT00220740|537665437|FG001|Efficacy Period|Adverse Event|1|||
149050387|NCT00220740|537665436|FG000|Efficacy Period|Withdrawal by Subject|1|||
148887703|NCT00936702|537067957|FG000|Overall Study|Other|1|||
148887704|NCT02420093|537067960|FG000|Overall Study|Withdrawal by Subject|1|||
148887705|NCT02420093|537067961|FG001|Overall Study|Withdrawal by Subject|1|||
148887706|NCT03001557|537067963|FG000|Core Phase|Randomized but not treated|0|||
148887707|NCT03001557|537067964|FG001|Core Phase|Randomized but not treated|0|||
148887708|NCT03001557|537067965|FG002|Core Phase|Randomized but not treated|1|||
149050388|NCT00220740|537665437|FG001|Efficacy Period|Withdrawal by Subject|0|||
149050389|NCT00220740|537665436|FG000|Efficacy Period|Protocol Violation|1|||
149050390|NCT00220740|537665437|FG001|Efficacy Period|Protocol Violation|0|||
149050391|NCT00220740|537665436|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
149050392|NCT00220740|537665437|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
149050393|NCT01057433|537665438|FG000|Overall Study|Adverse Event|1|||
149050394|NCT05268302|537665439|FG000|Overall Study|Death|0|||
149050395|NCT05268302|537665440|FG001|Overall Study|Death|1|||
149050396|NCT04774237|537665445|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
149050397|NCT04774237|537665446|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
149050398|NCT04774237|537665447|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
149050399|NCT04774237|537665448|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
149050400|NCT04774237|537665449|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
149050401|NCT04774237|537665450|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
149050402|NCT03625882|537666874|FG000|Overall Study|Protocol Violation|3|||
149050403|NCT03833245|537666875|FG000|Overall Study|Death|0|||
149050404|NCT03833245|537666876|FG001|Overall Study|Death|1|||
149050405|NCT03089398|537666889|FG000|Overall Study|Death|4|||
149050406|NCT03089398|537666890|FG001|Overall Study|Death|9|||
149050407|NCT03089398|537666889|FG000|Overall Study|Lost to Follow-up|21|||
149050408|NCT03089398|537666890|FG001|Overall Study|Lost to Follow-up|30|||
149050409|NCT03089398|537666889|FG000|Overall Study|Withdrawal by Subject|2|||
149050410|NCT03089398|537666890|FG001|Overall Study|Withdrawal by Subject|2|||
149050411|NCT05439603|537666891|FG000|Overall Study|met withdrawal criteria|2|||
149050412|NCT05461131|537666895|FG000|Overall Study|Lost to Follow-up|0|||
149050413|NCT05461131|537666896|FG001|Overall Study|Lost to Follow-up|2|||
149050414|NCT05418296|537666901|FG000|Overall Study|Withdrawal by Subject|4|||
149050415|NCT05418296|537666902|FG001|Overall Study|Withdrawal by Subject|1|||
149050416|NCT02682316|537666903|FG000|Overall Study|Benign Final Pathology|27|||
149050417|NCT02682316|537666904|FG001|Overall Study|Benign Final Pathology|26|||
149050418|NCT02682316|537666903|FG000|Overall Study|Reoperation before 30 days|7|||
149050419|NCT02682316|537666904|FG001|Overall Study|Reoperation before 30 days|6|||
149050420|NCT02682316|537666903|FG000|Overall Study|Ineligible|1|||
149050421|NCT02682316|537666904|FG001|Overall Study|Ineligible|0|||
149050422|NCT02682316|537666903|FG000|Overall Study|Death|1|||
149050423|NCT02682316|537666904|FG001|Overall Study|Death|0|||
149050424|NCT02682316|537666903|FG000|Overall Study|Lost to Follow-up|7|||
149050425|NCT02682316|537666904|FG001|Overall Study|Lost to Follow-up|3|||
149050426|NCT04630262|537666905|FG000|Overall Study|Intraoperative Screen Failure|5|||
149050427|NCT04630262|537666905|FG000|Overall Study|Study terminated prematurely|71|||
149050428|NCT04630262|537666905|FG000|Overall Study|Withdrawal by Subject|2|||
149050429|NCT04630262|537666905|FG000|Overall Study|Physician Decision|2|||
149050430|NCT01195831|537666906|FG000|Overall Study|Lost to Follow-up|2|||
149050431|NCT01195831|537666907|FG001|Overall Study|Lost to Follow-up|4|||
149050432|NCT01195831|537666906|FG000|Overall Study|Withdrawal by Subject|2|||
149050433|NCT01195831|537666907|FG001|Overall Study|Withdrawal by Subject|2|||
149050434|NCT01195831|537666906|FG000|Overall Study|Adverse Event|4|||
149050435|NCT01195831|537666907|FG001|Overall Study|Adverse Event|2|||
149050436|NCT01195831|537666906|FG000|Overall Study|Protocol Violation|0|||
148887709|NCT03001557|537067966|FG003|Core Phase|Randomized but not treated|0|||
148887710|NCT03001557|537067967|FG004|Core Phase|Randomized but not treated|0|||
148887711|NCT03001557|537067968|FG005|Core Phase|Randomized but not treated|0|||
148887712|NCT03001557|537067969|FG006|Core Phase|Randomized but not treated|0|||
149005268|NCT01492686|537497866|FG000|Double-blind Phase|Adverse Event|0|||
149005269|NCT01492686|537497867|FG001|Double-blind Phase|Adverse Event|2|||
149005270|NCT01492686|537497866|FG000|Double-blind Phase|Physician Decision|0|||
149005271|NCT01492686|537497867|FG001|Double-blind Phase|Physician Decision|1|||
149005272|NCT01492686|537497866|FG000|Double-blind Phase|Withdrawal by Subject|0|||
149005273|NCT01492686|537497867|FG001|Double-blind Phase|Withdrawal by Subject|2|||
149005274|NCT01492686|537497866|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
149005275|NCT01492686|537497867|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
149005276|NCT01492686|537497866|FG000|Open-label Phase|Adverse Event|1|||
149005277|NCT01492686|537497867|FG001|Open-label Phase|Adverse Event|2|||
149005278|NCT01492686|537497866|FG000|Open-label Phase|Physician Decision|1|||
149005279|NCT01492686|537497867|FG001|Open-label Phase|Physician Decision|0|||
149005280|NCT01492686|537497866|FG000|Open-label Phase|Withdrawal by Subject|6|||
149005281|NCT01492686|537497867|FG001|Open-label Phase|Withdrawal by Subject|7|||
149005282|NCT01492686|537497866|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
149005283|NCT01492686|537497867|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
149005284|NCT03430063|537497869|FG000|Overall Study|Adverse Event|0|||
149005285|NCT03430063|537497870|FG001|Overall Study|Adverse Event|1|||
149005286|NCT03430063|537497871|FG002|Overall Study|Adverse Event|0|||
149005287|NCT03430063|537497869|FG000|Overall Study|Death|3|||
149050437|NCT01195831|537666907|FG001|Overall Study|Protocol Violation|2|||
149050438|NCT04419168|537666908|FG000|Overall Study|Protocol Violation|1|||
149050439|NCT04419168|537666909|FG001|Overall Study|Protocol Violation|1|||
149050440|NCT04419168|537666908|FG000|Overall Study|Lost to Follow-up|7|||
149050441|NCT04419168|537666909|FG001|Overall Study|Lost to Follow-up|7|||
149050442|NCT04419168|537666908|FG000|Overall Study|Missed 6-month Visit|48|||
149050443|NCT04419168|537666909|FG001|Overall Study|Missed 6-month Visit|45|||
149050444|NCT03713086|537666913|FG000|Overall Study|Withdrawal by Subject|0|||
149050445|NCT03713086|537666914|FG001|Overall Study|Withdrawal by Subject|2|||
149050446|NCT03713086|537666915|FG002|Overall Study|Withdrawal by Subject|1|||
149050447|NCT03713086|537666916|FG003|Overall Study|Withdrawal by Subject|0|||
149050448|NCT03713086|537666913|FG000|Overall Study|Lost to Follow-up|0|||
149050449|NCT03713086|537666914|FG001|Overall Study|Lost to Follow-up|1|||
149050450|NCT03713086|537666915|FG002|Overall Study|Lost to Follow-up|0|||
149050451|NCT03713086|537666916|FG003|Overall Study|Lost to Follow-up|1|||
149050452|NCT05009251|537666917|FG000|Overall Study|Protocol Violation|100|||
149050453|NCT05009251|537666918|FG001|Overall Study|Protocol Violation|105|||
149050454|NCT05009251|537666919|FG002|Overall Study|Protocol Violation|119|||
149050455|NCT05009251|537666920|FG003|Overall Study|Protocol Violation|120|||
149050456|NCT05009251|537666921|FG004|Overall Study|Protocol Violation|119|||
149050457|NCT05009251|537666917|FG000|Overall Study|Death|25|||
149050458|NCT05009251|537666918|FG001|Overall Study|Death|22|||
149050459|NCT05009251|537666919|FG002|Overall Study|Death|24|||
149050460|NCT05009251|537666920|FG003|Overall Study|Death|19|||
149050461|NCT05009251|537666921|FG004|Overall Study|Death|15|||
149050462|NCT05374837|537666926|FG000|Overall Study|Lost to Follow-up|17|||
149050463|NCT05374837|537666927|FG001|Overall Study|Lost to Follow-up|18|||
149050464|NCT05406921|537666933|FG000|Overall Study|Withdrawal by Subject|25|||
149050465|NCT05406921|537666934|FG001|Overall Study|Withdrawal by Subject|0|||
149050466|NCT05406921|537666935|FG002|Overall Study|Withdrawal by Subject|25|||
149050467|NCT05406921|537666933|FG000|Overall Study|Protocol Violation|0|||
149050468|NCT05406921|537666934|FG001|Overall Study|Protocol Violation|12|||
149050469|NCT05406921|537666935|FG002|Overall Study|Protocol Violation|0|||
149050470|NCT00676715|537666936|FG000|Treatment Period (TP)|Adverse Event|0|||
149050471|NCT00676715|537666937|FG001|Treatment Period (TP)|Adverse Event|3|||
149050472|NCT00676715|537666938|FG002|Treatment Period (TP)|Adverse Event|2|||
149050473|NCT00676715|537666939|FG003|Treatment Period (TP)|Adverse Event|2|||
149050474|NCT00676715|537666936|FG000|Treatment Period (TP)|Death|0|||
149050475|NCT00676715|537666937|FG001|Treatment Period (TP)|Death|0|||
149050476|NCT00676715|537666938|FG002|Treatment Period (TP)|Death|1|||
149050477|NCT00676715|537666939|FG003|Treatment Period (TP)|Death|0|||
149050478|NCT00676715|537666936|FG000|Treatment Period (TP)|Failure to return|1|||
149050479|NCT00676715|537666937|FG001|Treatment Period (TP)|Failure to return|0|||
149050480|NCT00676715|537666938|FG002|Treatment Period (TP)|Failure to return|0|||
149050481|NCT00676715|537666939|FG003|Treatment Period (TP)|Failure to return|0|||
149050482|NCT00676715|537666936|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
149050483|NCT00676715|537666937|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
148887713|NCT03001557|537067970|FG007|Core Phase|Randomized but not treated|0|||
148887714|NCT03001557|537067963|FG000|Extension Phase|Adverse Event|0|||
148887715|NCT03001557|537067964|FG001|Extension Phase|Adverse Event|0|||
148887716|NCT03001557|537067965|FG002|Extension Phase|Adverse Event|0|||
148887717|NCT03001557|537067966|FG003|Extension Phase|Adverse Event|0|||
148887718|NCT03001557|537067967|FG004|Extension Phase|Adverse Event|0|||
148887719|NCT03001557|537067968|FG005|Extension Phase|Adverse Event|2|||
148887720|NCT03001557|537067969|FG006|Extension Phase|Adverse Event|0|||
148887721|NCT03001557|537067970|FG007|Extension Phase|Adverse Event|0|||
148887722|NCT03001557|537067963|FG000|Extension Phase|Withdrawal by Subject|0|||
149050484|NCT00676715|537666938|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
149050485|NCT00676715|537666939|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
149050486|NCT00676715|537666936|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
148887723|NCT03001557|537067964|FG001|Extension Phase|Withdrawal by Subject|0|||
148887724|NCT03001557|537067965|FG002|Extension Phase|Withdrawal by Subject|0|||
148887725|NCT03001557|537067966|FG003|Extension Phase|Withdrawal by Subject|0|||
148887726|NCT03001557|537067967|FG004|Extension Phase|Withdrawal by Subject|0|||
148887727|NCT03001557|537067968|FG005|Extension Phase|Withdrawal by Subject|1|||
148887728|NCT03001557|537067969|FG006|Extension Phase|Withdrawal by Subject|5|||
148887729|NCT03001557|537067970|FG007|Extension Phase|Withdrawal by Subject|2|||
149050487|NCT00676715|537666937|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
149050488|NCT00676715|537666938|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
149050489|NCT00676715|537666939|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
149050490|NCT00676715|537666936|FG000|Treatment Period (TP)|Withdrew consent|3|||
149050491|NCT00676715|537666937|FG001|Treatment Period (TP)|Withdrew consent|3|||
149050492|NCT00676715|537666938|FG002|Treatment Period (TP)|Withdrew consent|3|||
149050493|NCT00676715|537666939|FG003|Treatment Period (TP)|Withdrew consent|3|||
149050494|NCT00676715|537666936|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
149050495|NCT00676715|537666937|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
149050496|NCT00676715|537666938|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
149050497|NCT00676715|537666939|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
149050498|NCT00676715|537666936|FG000|Treatment Period (TP)|Administrative|0|||
149050499|NCT00676715|537666937|FG001|Treatment Period (TP)|Administrative|0|||
149050500|NCT00676715|537666938|FG002|Treatment Period (TP)|Administrative|0|||
149050501|NCT00676715|537666939|FG003|Treatment Period (TP)|Administrative|1|||
149050502|NCT00676715|537666936|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
149050503|NCT00676715|537666937|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
149050504|NCT00676715|537666938|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
149050505|NCT00676715|537666939|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
149050506|NCT00676715|537666936|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
149050507|NCT00676715|537666937|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
149050508|NCT00676715|537666938|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
149050509|NCT00676715|537666939|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
149050510|NCT00676715|537666936|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
149050511|NCT00676715|537666937|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
149050512|NCT00676715|537666938|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
149050513|NCT00676715|537666939|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
149050514|NCT00676715|537666936|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
149050515|NCT00676715|537666937|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
149050516|NCT00676715|537666938|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
149050517|NCT00676715|537666939|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
149050518|NCT00676715|537666936|FG000|Treatment-free Period (TFP)|Death|1|||
149050519|NCT00676715|537666937|FG001|Treatment-free Period (TFP)|Death|1|||
149050520|NCT00676715|537666938|FG002|Treatment-free Period (TFP)|Death|1|||
149050521|NCT00676715|537666939|FG003|Treatment-free Period (TFP)|Death|0|||
149050522|NCT00676715|537666936|FG000|Open Label Extension (OLE)|Reason not provided|3|||
149050523|NCT00676715|537666937|FG001|Open Label Extension (OLE)|Reason not provided|4|||
149050524|NCT00676715|537666938|FG002|Open Label Extension (OLE)|Reason not provided|1|||
149050525|NCT00676715|537666939|FG003|Open Label Extension (OLE)|Reason not provided|4|||
149050526|NCT00676715|537666936|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
149050527|NCT00676715|537666937|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
149050528|NCT00676715|537666938|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
149050529|NCT00676715|537666939|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
149050530|NCT00676715|537666936|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
149050531|NCT00676715|537666937|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
149050532|NCT00676715|537666938|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
149050533|NCT00676715|537666939|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
149050534|NCT00676715|537666936|FG000|Open Label Extension (OLE)|Adverse Event|0|||
149050535|NCT00676715|537666937|FG001|Open Label Extension (OLE)|Adverse Event|3|||
149050536|NCT00676715|537666938|FG002|Open Label Extension (OLE)|Adverse Event|1|||
149050537|NCT00676715|537666939|FG003|Open Label Extension (OLE)|Adverse Event|0|||
149050538|NCT00676715|537666936|FG000|Open Label Extension (OLE)|Death|2|||
149050539|NCT00676715|537666937|FG001|Open Label Extension (OLE)|Death|0|||
149050540|NCT00676715|537666938|FG002|Open Label Extension (OLE)|Death|2|||
149050541|NCT00676715|537666939|FG003|Open Label Extension (OLE)|Death|2|||
149050542|NCT04831281|537666943|FG000|Overall Study|Adverse Event|1|||
149050543|NCT04831281|537666944|FG001|Overall Study|Adverse Event|0|||
149050544|NCT04831281|537666945|FG002|Overall Study|Adverse Event|3|||
149050545|NCT04831281|537666943|FG000|Overall Study|Withdrawal by Subject|0|||
149050546|NCT04831281|537666944|FG001|Overall Study|Withdrawal by Subject|1|||
149050547|NCT04831281|537666945|FG002|Overall Study|Withdrawal by Subject|2|||
149050548|NCT04831281|537666943|FG000|Overall Study|Undetermined|1|||
149050549|NCT04831281|537666944|FG001|Overall Study|Undetermined|1|||
149050550|NCT04831281|537666945|FG002|Overall Study|Undetermined|0|||
149050551|NCT05249439|537666946|FG000|Overall Study|Withdrawal by Subject|2|||
149050552|NCT05249439|537666947|FG001|Overall Study|Withdrawal by Subject|5|||
149050553|NCT05249439|537666946|FG000|Overall Study|Physician Decision|3|||
149050554|NCT05249439|537666947|FG001|Overall Study|Physician Decision|1|||
149050555|NCT00616967|537666948|FG000|Overall Study|Withdrawal by Subject|0|||
149050556|NCT00616967|537666949|FG001|Overall Study|Withdrawal by Subject|0|||
149050557|NCT00616967|537666950|FG002|Overall Study|Withdrawal by Subject|1|||
149050558|NCT02910583|537666951|FG000|Overall Study|Death|7|||
149050559|NCT02910583|537666952|FG001|Overall Study|Death|3|||
149050560|NCT02910583|537666951|FG000|Overall Study|Lost to Follow-up|1|||
149050561|NCT02910583|537666952|FG001|Overall Study|Lost to Follow-up|0|||
149050562|NCT02910583|537666951|FG000|Overall Study|Withdrawal by Subject|12|||
149050563|NCT02910583|537666952|FG001|Overall Study|Withdrawal by Subject|8|||
149050564|NCT02910583|537666951|FG000|Overall Study|Other, Not Specified|6|||
149050565|NCT02910583|537666952|FG001|Overall Study|Other, Not Specified|3|||
149050566|NCT03161379|537666953|FG000|Overall Study|Withdrawal by Subject|4|||
149050567|NCT03161379|537666953|FG000|Overall Study|disease progression during chemotherapy|5|||
149050568|NCT03161379|537666953|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
149050569|NCT03161379|537666953|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
149050570|NCT05021640|537666955|FG000|Overall Study|Lost to Follow-up|0|||
149050571|NCT05021640|537666956|FG001|Overall Study|Lost to Follow-up|0|||
149050572|NCT05021640|537666957|FG002|Overall Study|Lost to Follow-up|0|||
149050573|NCT05021640|537666958|FG003|Overall Study|Lost to Follow-up|0|||
149050574|NCT05021640|537666959|FG004|Overall Study|Lost to Follow-up|1|||
149050575|NCT04088630|537666961|FG000|Overall Study|Lost to Follow-up|3|||
149050576|NCT04088630|537666962|FG001|Overall Study|Lost to Follow-up|2|||
149050577|NCT04088630|537666963|FG002|Overall Study|Lost to Follow-up|6|||
149050578|NCT04088630|537666961|FG000|Overall Study|Death|3|||
149050579|NCT04088630|537666962|FG001|Overall Study|Death|1|||
149050580|NCT04088630|537666963|FG002|Overall Study|Death|1|||
149050581|NCT04088630|537666961|FG000|Overall Study|Physician Decision|0|||
149050582|NCT04088630|537666962|FG001|Overall Study|Physician Decision|1|||
149050583|NCT04088630|537666963|FG002|Overall Study|Physician Decision|1|||
149050584|NCT03315754|537666964|FG000|Overall Study|COVID-19 complications leading to death|1|||
149050585|NCT03315754|537666964|FG000|Overall Study|insurance coverage issue|1|||
149050586|NCT02954341|537666965|FG000|Overall Study|Attempted Implant unsuccessful|5|||
149050587|NCT02954341|537666965|FG000|Overall Study|Death|90|||
149050588|NCT02954341|537666965|FG000|Overall Study|Withdrawal by Subject|4|||
149050589|NCT02954341|537666965|FG000|Overall Study|Physician Decision|13|||
149050590|NCT02954341|537666965|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
149050591|NCT02954341|537666965|FG000|Overall Study|Not implanted due to physician's decision|1|||
149050592|NCT02954341|537666965|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
149050593|NCT04089371|537666969|FG000|Overall Study|Withdrawal by Subject|0|||
149050594|NCT04089371|537666970|FG001|Overall Study|Withdrawal by Subject|1|||
149050595|NCT04089371|537666969|FG000|Overall Study|Study terminated early|0|||
149050596|NCT04089371|537666970|FG001|Overall Study|Study terminated early|9|||
149050597|NCT05229120|537666971|FG000|Overall Study|Withdrawal by Subject|8|||
149050598|NCT03932682|537666974|FG000|Overall Study|Death|1|||
149050599|NCT03932682|537666975|FG001|Overall Study|Death|2|||
149050600|NCT03932682|537666974|FG000|Overall Study|Withdrawal by Subject|37|||
149050601|NCT03932682|537666975|FG001|Overall Study|Withdrawal by Subject|45|||
149050602|NCT03932682|537666974|FG000|Overall Study|Lost to Follow-up|19|||
149050603|NCT03932682|537666975|FG001|Overall Study|Lost to Follow-up|25|||
149050604|NCT03932682|537666974|FG000|Overall Study|Protocol Violation|0|||
149050605|NCT03932682|537666975|FG001|Overall Study|Protocol Violation|2|||
149050606|NCT03932682|537666974|FG000|Overall Study|Other|9|||
149050607|NCT03932682|537666975|FG001|Overall Study|Other|23|||
149050608|NCT04410042|537666976|FG000|Overall Study|Not Eligible|1|||
149050609|NCT04410042|537666977|FG001|Overall Study|Not Eligible|1|||
149050610|NCT01494662|537666978|FG000|Overall Study|Withdrawal by Subject|0|||
149050611|NCT01494662|537666979|FG001|Overall Study|Withdrawal by Subject|0|||
149050612|NCT01494662|537666980|FG002|Overall Study|Withdrawal by Subject|1|||
149050613|NCT01494662|537666981|FG003|Overall Study|Withdrawal by Subject|0|||
149050614|NCT01494662|537666982|FG004|Overall Study|Withdrawal by Subject|0|||
149050615|NCT01494662|537666983|FG005|Overall Study|Withdrawal by Subject|0|||
149050616|NCT01494662|537666984|FG006|Overall Study|Withdrawal by Subject|0|||
149050617|NCT01494662|537666978|FG000|Overall Study|Physician Decision|0|||
149050618|NCT01494662|537666979|FG001|Overall Study|Physician Decision|0|||
149050619|NCT01494662|537666980|FG002|Overall Study|Physician Decision|1|||
149050620|NCT01494662|537666981|FG003|Overall Study|Physician Decision|0|||
149050621|NCT01494662|537666982|FG004|Overall Study|Physician Decision|0|||
149050622|NCT01494662|537666983|FG005|Overall Study|Physician Decision|0|||
149050623|NCT01494662|537666984|FG006|Overall Study|Physician Decision|0|||
149050624|NCT04072822|537666985|FG000|Treatment|Adverse Event|9|||
149050625|NCT04072822|537666986|FG001|Treatment|Adverse Event|5|||
149050626|NCT04072822|537666985|FG000|Treatment|Met Stopping Criteria|13|||
149050627|NCT04072822|537666986|FG001|Treatment|Met Stopping Criteria|24|||
149050628|NCT04072822|537666985|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
149050629|NCT04072822|537666986|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
149050630|NCT04072822|537666985|FG000|Treatment|Withdrawal by Subject|0|||
149050631|NCT04072822|537666986|FG001|Treatment|Withdrawal by Subject|2|||
149050632|NCT04072822|537666985|FG000|Treatment|Death|0|||
148887730|NCT03001557|537067963|FG000|Extension Phase|Lost to Follow-up|0|||
148887731|NCT03001557|537067964|FG001|Extension Phase|Lost to Follow-up|0|||
149050633|NCT04072822|537666986|FG001|Treatment|Death|2|||
149050634|NCT04072822|537666985|FG000|Treatment|Lost to Follow-up|11|||
148887732|NCT03001557|537067965|FG002|Extension Phase|Lost to Follow-up|0|||
148887733|NCT03001557|537067966|FG003|Extension Phase|Lost to Follow-up|0|||
148887734|NCT03001557|537067967|FG004|Extension Phase|Lost to Follow-up|0|||
149050635|NCT04072822|537666986|FG001|Treatment|Lost to Follow-up|3|||
149050636|NCT04072822|537666985|FG000|Treatment|Physician Decision|1|||
149050637|NCT04072822|537666986|FG001|Treatment|Physician Decision|0|||
149050638|NCT04072822|537666985|FG000|Treatment|Other|7|||
149050639|NCT04072822|537666986|FG001|Treatment|Other|9|||
149050640|NCT04072822|537666985|FG000|Follow-up|Withdrawal by Subject|1|||
149050641|NCT04072822|537666986|FG001|Follow-up|Withdrawal by Subject|0|||
148887735|NCT03001557|537067968|FG005|Extension Phase|Lost to Follow-up|0|||
149050642|NCT04072822|537666985|FG000|Follow-up|Lost to Follow-up|5|||
149050643|NCT04072822|537666986|FG001|Follow-up|Lost to Follow-up|4|||
149050644|NCT02811679|537666987|FG000|Overall Study|Adverse Event|1|||
149050645|NCT02811679|537666987|FG000|Overall Study|Lack of Efficacy|6|||
149050646|NCT02811679|537666987|FG000|Overall Study|Early study closure due to slow accrual|3|||
149050647|NCT03361748|537666988|FG000|Overall Study|Death|77|||
149050648|NCT03361748|537666988|FG000|Overall Study|Lost to Follow-up|4|||
149050649|NCT03361748|537666988|FG000|Overall Study|Withdrawal by Subject|20|||
149050650|NCT00753090|537668342|FG000|Overall Study|Withdrawal by Subject|10|||
149050651|NCT00753090|537668343|FG001|Overall Study|Withdrawal by Subject|10|||
149050652|NCT00753090|537668342|FG000|Overall Study|Death|17|||
149050653|NCT00753090|537668343|FG001|Overall Study|Death|6|||
149050654|NCT00753090|537668342|FG000|Overall Study|Study Prosthesis Removed|12|||
149050655|NCT00753090|537668343|FG001|Overall Study|Study Prosthesis Removed|3|||
149050656|NCT00753090|537668342|FG000|Overall Study|Lost to Follow-up|2|||
149050657|NCT00753090|537668343|FG001|Overall Study|Lost to Follow-up|2|||
149050658|NCT00753090|537668342|FG000|Overall Study|Other|127|||
149050659|NCT00753090|537668343|FG001|Overall Study|Other|75|||
149050660|NCT05113966|537668346|FG000|Overall Study|Death|21|||
149050661|NCT05113966|537668346|FG000|Overall Study|Study Terminated by Sponsor|9|||
149050662|NCT05058391|537668355|FG000|Overall Study|Adverse Event|1|||
149050663|NCT03775109|537668358|FG000|Overall Study|Adverse Event|1|||
149050664|NCT03775109|537668359|FG001|Overall Study|Adverse Event|0|||
149050665|NCT03775109|537668358|FG000|Overall Study|COVID-19 outbreak|2|||
149050666|NCT03775109|537668359|FG001|Overall Study|COVID-19 outbreak|0|||
149050667|NCT03775109|537668358|FG000|Overall Study|Lost to Follow-up|0|||
149050668|NCT03775109|537668359|FG001|Overall Study|Lost to Follow-up|2|||
149050669|NCT03775109|537668358|FG000|Overall Study|Withdrawal by Subject|1|||
149050670|NCT03775109|537668359|FG001|Overall Study|Withdrawal by Subject|1|||
149050671|NCT03775109|537668358|FG000|Overall Study|Death|0|||
149050672|NCT03775109|537668359|FG001|Overall Study|Death|1|||
149050673|NCT03775109|537668358|FG000|Overall Study|Lack of Efficacy|1|||
149050674|NCT03775109|537668359|FG001|Overall Study|Lack of Efficacy|0|||
149050675|NCT03347383|537668360|FG000|Overall Study|Death|39|||
149050676|NCT03347383|537668360|FG000|Overall Study|Withdrawal by Subject|3|||
149050677|NCT03347383|537668360|FG000|Overall Study|Lost to Follow-up|9|||
149050678|NCT05691452|537668362|FG000|Overall Study|Withdrawal by Subject|1|||
149050679|NCT05691452|537668363|FG001|Overall Study|Withdrawal by Subject|1|||
149050680|NCT05691452|537668364|FG002|Overall Study|Withdrawal by Subject|0|||
149050681|NCT05691452|537668362|FG000|Overall Study|Physician Decision|1|||
149050682|NCT05691452|537668363|FG001|Overall Study|Physician Decision|0|||
149050683|NCT05691452|537668364|FG002|Overall Study|Physician Decision|0|||
149050684|NCT05691452|537668362|FG000|Overall Study|Lost to Follow-up|0|||
149050685|NCT05691452|537668363|FG001|Overall Study|Lost to Follow-up|0|||
149050686|NCT05691452|537668364|FG002|Overall Study|Lost to Follow-up|1|||
149050687|NCT05691452|537668362|FG000|Overall Study|Adverse Event|0|||
149050688|NCT05691452|537668363|FG001|Overall Study|Adverse Event|0|||
149050689|NCT05691452|537668364|FG002|Overall Study|Adverse Event|1|||
149050690|NCT05110495|537668367|FG000|Overall Study|Lost to Follow-up|1|||
149050691|NCT05110495|537668367|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
149050692|NCT04402489|537668370|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
149050693|NCT04402489|537668371|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
149050694|NCT04402489|537668372|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
149050695|NCT04402489|537668373|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
149050696|NCT04402489|537668374|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
149050697|NCT04402489|537668370|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
149050698|NCT04402489|537668371|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
149050699|NCT04402489|537668372|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
149050700|NCT04402489|537668373|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
149050701|NCT04402489|537668374|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
149050702|NCT04402489|537668370|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
149050703|NCT04402489|537668371|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
149050704|NCT04402489|537668372|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
149005288|NCT03430063|537497870|FG001|Overall Study|Death|2|||
149050705|NCT04402489|537668373|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
149050706|NCT04402489|537668374|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
149005289|NCT03430063|537497871|FG002|Overall Study|Death|3|||
149005290|NCT03430063|537497869|FG000|Overall Study|Lost to Follow-up|0|||
149005291|NCT03430063|537497870|FG001|Overall Study|Lost to Follow-up|1|||
149005292|NCT03430063|537497871|FG002|Overall Study|Lost to Follow-up|0|||
149005293|NCT03430063|537497869|FG000|Overall Study|Withdrawal by Subject|0|||
149005294|NCT03430063|537497870|FG001|Overall Study|Withdrawal by Subject|0|||
149005295|NCT03430063|537497871|FG002|Overall Study|Withdrawal by Subject|1|||
149005296|NCT03430063|537497869|FG000|Overall Study|Withdrawal of consent|3|||
149005297|NCT03430063|537497870|FG001|Overall Study|Withdrawal of consent|1|||
149005298|NCT03430063|537497871|FG002|Overall Study|Withdrawal of consent|2|||
149005299|NCT03430063|537497869|FG000|Overall Study|Progressive disease|1|||
149050707|NCT04402489|537668370|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
149050708|NCT04402489|537668371|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
149050709|NCT04402489|537668372|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
149050710|NCT04402489|537668373|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
149050711|NCT04402489|537668374|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
149050712|NCT04402489|537668370|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
149050713|NCT04402489|537668371|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
149050714|NCT04402489|537668372|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
149050715|NCT04402489|537668373|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
149050716|NCT04402489|537668374|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
149050717|NCT04402489|537668370|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
149050718|NCT04402489|537668371|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
149050719|NCT04402489|537668372|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
149050720|NCT04402489|537668373|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
149050721|NCT04402489|537668374|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
149050722|NCT05062265|537668388|FG000|Overall Study|Withdrawal by Subject|1|||
149050723|NCT05062265|537668389|FG001|Overall Study|Withdrawal by Subject|0|||
149050724|NCT05382936|537668392|FG000|Overall Study|Progressive Disease|3|||
149050725|NCT05382936|537668393|FG001|Overall Study|Progressive Disease|5|||
149050726|NCT05382936|537668394|FG002|Overall Study|Progressive Disease|2|||
149050727|NCT05382936|537668395|FG003|Overall Study|Progressive Disease|5|||
149050728|NCT05382936|537668392|FG000|Overall Study|Adverse Event|0|||
149050729|NCT05382936|537668393|FG001|Overall Study|Adverse Event|1|||
149050730|NCT05382936|537668394|FG002|Overall Study|Adverse Event|1|||
149050731|NCT05382936|537668395|FG003|Overall Study|Adverse Event|0|||
149050732|NCT05382936|537668392|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
149050733|NCT05382936|537668393|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
149050734|NCT05382936|537668394|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
149050735|NCT05382936|537668395|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
149050736|NCT05382936|537668392|FG000|Overall Study|Withdrawal by Subject|0|||
149050737|NCT05382936|537668393|FG001|Overall Study|Withdrawal by Subject|0|||
149050738|NCT05382936|537668394|FG002|Overall Study|Withdrawal by Subject|1|||
149050739|NCT05382936|537668395|FG003|Overall Study|Withdrawal by Subject|1|||
149050740|NCT03101904|537668398|FG000|Wash Out (10 Days)|Adverse Event|1|||
149050741|NCT03101904|537668399|FG001|Wash Out (10 Days)|Adverse Event|0|||
149050742|NCT03101904|537668398|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
149050743|NCT03101904|537668399|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
149050744|NCT04703322|537668401|FG000|Overall Study|Ongoing|8|||
149050745|NCT04703322|537668401|FG000|Overall Study|Withdrawal by Subject|1|||
149050746|NCT04638998|537668402|FG000|Overall Study|Withdrawal by Subject|1|||
149050747|NCT04638998|537668403|FG001|Overall Study|Withdrawal by Subject|3|||
149050748|NCT01180634|537668406|FG000|Overall Study|Adverse Event|4|||
149050749|NCT01180634|537668407|FG001|Overall Study|Adverse Event|1|||
149050750|NCT01180634|537668406|FG000|Overall Study|Miscellaneous|2|||
149050751|NCT01180634|537668407|FG001|Overall Study|Miscellaneous|0|||
149050752|NCT01180634|537668406|FG000|Overall Study|Withdrawal by Subject|4|||
149050753|NCT01180634|537668407|FG001|Overall Study|Withdrawal by Subject|0|||
149050754|NCT04490915|537668408|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
149050755|NCT04490915|537668409|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
149050756|NCT04490915|537668408|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149050757|NCT04490915|537668409|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149050758|NCT04490915|537668408|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149050759|NCT04490915|537668409|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
149050760|NCT04490915|537668408|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
149050761|NCT04490915|537668409|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
149050762|NCT04490915|537668408|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
149050763|NCT04490915|537668409|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
149050764|NCT04490915|537668408|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
149050765|NCT04490915|537668409|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
149050766|NCT04490915|537668408|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
149050767|NCT04490915|537668409|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
149050768|NCT06311084|537668410|FG000|Overall Study|Lost to Follow-up|14|||
149050769|NCT03988634|537668411|FG000|Double-Blind|Adverse Event|4|||
149050770|NCT03988634|537668412|FG001|Double-Blind|Adverse Event|0|||
149050771|NCT03988634|537668413|FG002|Double-Blind|Adverse Event|0|||
149050772|NCT03988634|537668411|FG000|Double-Blind|Death|18|||
149050773|NCT03988634|537668412|FG001|Double-Blind|Death|26|||
149050774|NCT03988634|537668413|FG002|Double-Blind|Death|0|||
149050775|NCT03988634|537668411|FG000|Double-Blind|Lost to Follow-up|6|||
149050776|NCT03988634|537668412|FG001|Double-Blind|Lost to Follow-up|7|||
149050777|NCT03988634|537668413|FG002|Double-Blind|Lost to Follow-up|0|||
149050778|NCT03988634|537668411|FG000|Double-Blind|Physician Decision|9|||
149050779|NCT03988634|537668412|FG001|Double-Blind|Physician Decision|5|||
149050780|NCT03988634|537668413|FG002|Double-Blind|Physician Decision|0|||
149050781|NCT03988634|537668411|FG000|Double-Blind|Subject decision|24|||
149050782|NCT03988634|537668412|FG001|Double-Blind|Subject decision|13|||
149050783|NCT03988634|537668413|FG002|Double-Blind|Subject decision|0|||
149050784|NCT03988634|537668411|FG000|Open-Label|Adverse Event|0|||
149050785|NCT03988634|537668412|FG001|Open-Label|Adverse Event|0|||
149050786|NCT03988634|537668413|FG002|Open-Label|Adverse Event|7|||
149050787|NCT03988634|537668411|FG000|Open-Label|Physician Decision|0|||
149050788|NCT03988634|537668412|FG001|Open-Label|Physician Decision|0|||
149050789|NCT03988634|537668413|FG002|Open-Label|Physician Decision|1|||
149050790|NCT03988634|537668411|FG000|Open-Label|Technical problems|0|||
149050791|NCT03988634|537668412|FG001|Open-Label|Technical problems|0|||
149050792|NCT03988634|537668413|FG002|Open-Label|Technical problems|1|||
149050793|NCT04263311|537668418|FG000|Overall Study|Lost to Follow-up|1|||
149050794|NCT04263311|537668419|FG001|Overall Study|Lost to Follow-up|2|||
149050795|NCT04263311|537668420|FG002|Overall Study|Lost to Follow-up|0|||
149050796|NCT04263311|537668418|FG000|Overall Study|Health Issues|1|||
149050797|NCT04263311|537668419|FG001|Overall Study|Health Issues|0|||
149050798|NCT04263311|537668420|FG002|Overall Study|Health Issues|0|||
149050799|NCT04263311|537668418|FG000|Overall Study|Left the country|1|||
149050800|NCT04263311|537668419|FG001|Overall Study|Left the country|0|||
149050801|NCT04263311|537668420|FG002|Overall Study|Left the country|0|||
149050802|NCT04263311|537668418|FG000|Overall Study|Unable to maintain time commitment|1|||
149050803|NCT04263311|537668419|FG001|Overall Study|Unable to maintain time commitment|0|||
149050804|NCT04263311|537668420|FG002|Overall Study|Unable to maintain time commitment|0|||
149050805|NCT04263311|537668418|FG000|Overall Study|No longer interested|1|||
149050806|NCT04263311|537668419|FG001|Overall Study|No longer interested|0|||
149050807|NCT04263311|537668420|FG002|Overall Study|No longer interested|0|||
149050808|NCT04263311|537668418|FG000|Overall Study|Ineligible post consent|0|||
149050809|NCT04263311|537668419|FG001|Overall Study|Ineligible post consent|0|||
149050810|NCT04263311|537668420|FG002|Overall Study|Ineligible post consent|5|||
149050811|NCT03958955|537668421|FG000|Overall Study|Adverse Event|1|||
149050812|NCT04673929|537668422|FG000|Overall Study|Death|73|||
149050813|NCT04673929|537668422|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
149050814|NCT02927769|537668423|FG000|Induction Phase|Study drug toxicity|1|||
149050815|NCT02927769|537668424|FG001|Induction Phase|Study drug toxicity|1|||
149050816|NCT02927769|537668423|FG000|Induction Phase|Disease progression|0|||
149050817|NCT02927769|537668424|FG001|Induction Phase|Disease progression|1|||
149050818|NCT02927769|537668423|FG000|Intensification Phase|Study drug toxicity|1|||
149050819|NCT02927769|537668424|FG001|Intensification Phase|Study drug toxicity|0|||
149050820|NCT05082909|537668425|FG000|Overall Study|Protocol Violation|0|||
149050821|NCT05082909|537668426|FG001|Overall Study|Protocol Violation|0|||
149050822|NCT05082909|537668427|FG002|Overall Study|Protocol Violation|1|||
149050823|NCT05082909|537668428|FG003|Overall Study|Protocol Violation|0|||
149050824|NCT05082909|537668429|FG004|Overall Study|Protocol Violation|0|||
149050825|NCT05082909|537668430|FG005|Overall Study|Protocol Violation|0|||
149050826|NCT05227209|537668431|FG000|Overall Study|Adverse Event|11|||
149050827|NCT05227209|537668431|FG000|Overall Study|Lost to Follow-up|1|||
149050828|NCT05227209|537668431|FG000|Overall Study|Withdrawal by Subject|7|||
149050829|NCT05227209|537668431|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
149050830|NCT04024813|537668432|FG000|Overall Study|Study terminated by Sponsor|1|||
149050831|NCT05337748|537668434|FG000|Overall Study|Withdrawal by Subject|1|||
149050832|NCT05337748|537668435|FG001|Overall Study|Withdrawal by Subject|0|||
149050833|NCT05337748|537668434|FG000|Overall Study|Death|1|||
149050834|NCT05337748|537668435|FG001|Overall Study|Death|0|||
149050835|NCT03453619|537668438|FG000|Core Study (Part A)|Physician Decision|0|||
149050836|NCT03453619|537668439|FG001|Core Study (Part A)|Physician Decision|0|||
149050837|NCT03453619|537668440|FG002|Core Study (Part A)|Physician Decision|2|||
149050838|NCT03453619|537668441|FG003|Core Study (Part A)|Physician Decision|0|||
149050839|NCT03453619|537668438|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
149050840|NCT03453619|537668439|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
149050841|NCT03453619|537668440|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
149050842|NCT03453619|537668441|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
149050843|NCT03453619|537668438|FG000|Core Study (Part A)|Other|0|||
149050844|NCT03453619|537668439|FG001|Core Study (Part A)|Other|1|||
149050845|NCT03453619|537668440|FG002|Core Study (Part A)|Other|0|||
149050846|NCT03453619|537668441|FG003|Core Study (Part A)|Other|0|||
149050847|NCT03453619|537668438|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
149050848|NCT03453619|537668439|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
149050849|NCT03453619|537668440|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
149050850|NCT03453619|537668441|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
149050851|NCT03453619|537668438|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
149050852|NCT03453619|537668439|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
149050853|NCT03453619|537668440|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
149050854|NCT03453619|537668441|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
149050855|NCT03453619|537668438|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
149050856|NCT03453619|537668439|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
149050857|NCT03453619|537668440|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
149050858|NCT03453619|537668441|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
149050859|NCT03453619|537668438|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
149050860|NCT03453619|537668439|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
149050861|NCT03453619|537668440|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
149050862|NCT03453619|537668441|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
149050863|NCT05862870|537668442|FG000|Overall Study|Lost to Follow-up|3|||
149050864|NCT02900924|537668443|FG000|Overall Study|Death|52|||
149050865|NCT02900924|537668443|FG000|Overall Study|Lost to Follow-up|4|||
149050866|NCT02900924|537668443|FG000|Overall Study|Withdrawal by Subject|20|||
149050867|NCT02900924|537668443|FG000|Overall Study|Missed Visit|33|||
149050868|NCT05536440|537668444|FG000|Overall Study|Adverse Event|0|||
149050869|NCT05536440|537668445|FG001|Overall Study|Adverse Event|0|||
149050870|NCT05536440|537668446|FG002|Overall Study|Adverse Event|0|||
149050871|NCT05536440|537668447|FG003|Overall Study|Adverse Event|0|||
149050872|NCT05536440|537668448|FG004|Overall Study|Adverse Event|0|||
149050873|NCT05536440|537668449|FG005|Overall Study|Adverse Event|0|||
149050874|NCT05536440|537668450|FG006|Overall Study|Adverse Event|0|||
149050875|NCT05536440|537668451|FG007|Overall Study|Adverse Event|0|||
149050876|NCT05536440|537668452|FG008|Overall Study|Adverse Event|1|||
149050877|NCT04812535|537668461|FG000|Overall Study|Withdrawal by Subject|0|||
149050878|NCT04812535|537668462|FG001|Overall Study|Withdrawal by Subject|0|||
149050879|NCT04812535|537668463|FG002|Overall Study|Withdrawal by Subject|0|||
149050880|NCT04812535|537668464|FG003|Overall Study|Withdrawal by Subject|1|||
149050881|NCT04812535|537668461|FG000|Overall Study|Death|7|||
149050882|NCT04812535|537668462|FG001|Overall Study|Death|2|||
149050883|NCT04812535|537668463|FG002|Overall Study|Death|4|||
149050884|NCT04812535|537668464|FG003|Overall Study|Death|1|||
149050885|NCT04812535|537668461|FG000|Overall Study|Due to premature study termination by sponsor|2|||
149050886|NCT04812535|537668462|FG001|Overall Study|Due to premature study termination by sponsor|0|||
149050887|NCT04812535|537668463|FG002|Overall Study|Due to premature study termination by sponsor|1|||
149050888|NCT04812535|537668464|FG003|Overall Study|Due to premature study termination by sponsor|3|||
149050889|NCT00931710|537668465|FG000|Overall Study|Adverse Event|16|||
149050890|NCT00931710|537668466|FG001|Overall Study|Adverse Event|10|||
149050891|NCT00931710|537668465|FG000|Overall Study|Abnormal test procedure results|2|||
149050892|NCT00931710|537668466|FG001|Overall Study|Abnormal test procedure results|0|||
149050893|NCT00931710|537668465|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
149050894|NCT00931710|537668466|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
149050895|NCT00931710|537668465|FG000|Overall Study|Patient withdrew consent|4|||
149050896|NCT00931710|537668466|FG001|Overall Study|Patient withdrew consent|9|||
149050897|NCT00931710|537668465|FG000|Overall Study|Lost to Follow-up|6|||
149050898|NCT00931710|537668466|FG001|Overall Study|Lost to Follow-up|5|||
149050899|NCT00931710|537668465|FG000|Overall Study|Protocol deviation|1|||
149050900|NCT00931710|537668466|FG001|Overall Study|Protocol deviation|2|||
149050901|NCT05592418|537668470|FG000|Overall Study|Adverse Event|1|||
149050902|NCT05592418|537668471|FG001|Overall Study|Adverse Event|0|||
149050903|NCT05592418|537668470|FG000|Overall Study|Lost to Follow-up|1|||
149050904|NCT05592418|537668471|FG001|Overall Study|Lost to Follow-up|3|||
149050905|NCT05592418|537668470|FG000|Overall Study|Withdrawal by Subject|2|||
149050906|NCT05592418|537668471|FG001|Overall Study|Withdrawal by Subject|7|||
149050907|NCT04521478|537669996|FG000|Overall Study|Protocol Violation|2|||
149050908|NCT04521478|537669997|FG001|Overall Study|Protocol Violation|0|||
149050909|NCT04521478|537669998|FG002|Overall Study|Protocol Violation|1|||
149050910|NCT04521478|537669999|FG003|Overall Study|Protocol Violation|0|||
149050911|NCT04521478|537670000|FG004|Overall Study|Protocol Violation|0|||
149050912|NCT04521478|537670001|FG005|Overall Study|Protocol Violation|0|||
149050913|NCT04521478|537669996|FG000|Overall Study|Technical Problems|0|||
149050914|NCT04521478|537669997|FG001|Overall Study|Technical Problems|0|||
149050915|NCT04521478|537669998|FG002|Overall Study|Technical Problems|0|||
149050916|NCT04521478|537669999|FG003|Overall Study|Technical Problems|1|||
149050917|NCT04521478|537670000|FG004|Overall Study|Technical Problems|0|||
149050918|NCT04521478|537670001|FG005|Overall Study|Technical Problems|0|||
149050919|NCT04521478|537669996|FG000|Overall Study|Burden of Study Procedures|1|||
149050920|NCT04521478|537669997|FG001|Overall Study|Burden of Study Procedures|0|||
149050921|NCT04521478|537669998|FG002|Overall Study|Burden of Study Procedures|0|||
149050922|NCT04521478|537669999|FG003|Overall Study|Burden of Study Procedures|1|||
149050923|NCT04521478|537670000|FG004|Overall Study|Burden of Study Procedures|0|||
149050924|NCT04521478|537670001|FG005|Overall Study|Burden of Study Procedures|1|||
149050925|NCT04521478|537669996|FG000|Overall Study|Lack of Efficacy|0|||
149050926|NCT04521478|537669997|FG001|Overall Study|Lack of Efficacy|0|||
149050927|NCT04521478|537669998|FG002|Overall Study|Lack of Efficacy|0|||
149050928|NCT04521478|537669999|FG003|Overall Study|Lack of Efficacy|0|||
149050929|NCT04521478|537670000|FG004|Overall Study|Lack of Efficacy|1|||
149050930|NCT04521478|537670001|FG005|Overall Study|Lack of Efficacy|1|||
149050931|NCT04521478|537669996|FG000|Overall Study|Adverse Event|7|||
149050932|NCT04521478|537669997|FG001|Overall Study|Adverse Event|0|||
149050933|NCT04521478|537669998|FG002|Overall Study|Adverse Event|2|||
149050934|NCT04521478|537669999|FG003|Overall Study|Adverse Event|1|||
149050935|NCT04521478|537670000|FG004|Overall Study|Adverse Event|2|||
149050936|NCT04521478|537670001|FG005|Overall Study|Adverse Event|7|||
149050937|NCT04521478|537669996|FG000|Overall Study|No Reason Available|0|||
149050938|NCT04521478|537669997|FG001|Overall Study|No Reason Available|2|||
149050939|NCT04521478|537669998|FG002|Overall Study|No Reason Available|0|||
149050940|NCT04521478|537669999|FG003|Overall Study|No Reason Available|0|||
149050941|NCT04521478|537670000|FG004|Overall Study|No Reason Available|1|||
149050942|NCT04521478|537670001|FG005|Overall Study|No Reason Available|0|||
149050943|NCT04521478|537669996|FG000|Overall Study|Other than listed|3|||
149050944|NCT04521478|537669997|FG001|Overall Study|Other than listed|3|||
149050945|NCT04521478|537669998|FG002|Overall Study|Other than listed|3|||
149050946|NCT04521478|537669999|FG003|Overall Study|Other than listed|2|||
149050947|NCT04521478|537670000|FG004|Overall Study|Other than listed|3|||
149050948|NCT04521478|537670001|FG005|Overall Study|Other than listed|3|||
149050949|NCT04521478|537669996|FG000|Overall Study|Not treated|0|||
149050950|NCT04521478|537669997|FG001|Overall Study|Not treated|0|||
149050951|NCT04521478|537669998|FG002|Overall Study|Not treated|0|||
149050952|NCT04521478|537669999|FG003|Overall Study|Not treated|0|||
149050953|NCT04521478|537670000|FG004|Overall Study|Not treated|0|||
149050954|NCT04521478|537670001|FG005|Overall Study|Not treated|1|||
149050955|NCT04593472|537670002|FG000|Overall Study|Death|31|||
149050956|NCT04593472|537670003|FG001|Overall Study|Death|27|||
149050957|NCT04593472|537670002|FG000|Overall Study|Withdrawal by Subject|12|||
149050958|NCT04593472|537670003|FG001|Overall Study|Withdrawal by Subject|12|||
149050959|NCT04593472|537670002|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
149050960|NCT04593472|537670003|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
149050961|NCT04593472|537670002|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
149050962|NCT04593472|537670003|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
149050963|NCT04593472|537670002|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
149050964|NCT04593472|537670003|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
149050965|NCT04593472|537670002|FG000|Overall Study|Lost to Follow-up|0|||
149050966|NCT04593472|537670003|FG001|Overall Study|Lost to Follow-up|2|||
149050967|NCT04593472|537670002|FG000|Overall Study|Still collecting 24-month assessment|17|||
149050968|NCT04593472|537670003|FG001|Overall Study|Still collecting 24-month assessment|10|||
149050969|NCT03692676|537670005|FG000|Overall Study|exclude patients with prior use|4424|||
149050970|NCT03692676|537670006|FG001|Overall Study|exclude patients with prior use|24726|||
149050971|NCT03692676|537670007|FG002|Overall Study|exclude patients with prior use|0|||
149050972|NCT03692676|537670008|FG003|Overall Study|exclude patients with prior use|0|||
149050973|NCT03692676|537670005|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
149050974|NCT03692676|537670006|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
149050975|NCT03692676|537670007|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
149050976|NCT03692676|537670008|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
149050977|NCT03692676|537670005|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
149050978|NCT03692676|537670006|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
149050979|NCT03692676|537670007|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
149050980|NCT03692676|537670008|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
149050981|NCT03692676|537670005|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
149050982|NCT03692676|537670006|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
149050983|NCT03692676|537670007|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
149050984|NCT03692676|537670008|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
149050985|NCT03692676|537670005|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
149050986|NCT03692676|537670006|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
149050987|NCT03692676|537670007|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
149050988|NCT03692676|537670008|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
149050989|NCT03692676|537670005|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
149050990|NCT03692676|537670006|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
149050991|NCT03692676|537670007|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
149050992|NCT03692676|537670008|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
149050993|NCT03692676|537670005|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
149050994|NCT03692676|537670006|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
149050995|NCT03692676|537670007|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
149050996|NCT03692676|537670008|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
149050997|NCT03692676|537670005|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
149050998|NCT03692676|537670006|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
149050999|NCT03692676|537670007|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
148887736|NCT03001557|537067969|FG006|Extension Phase|Lost to Follow-up|2|||
149051000|NCT03692676|537670008|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
149051001|NCT03692676|537670005|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
149051002|NCT03692676|537670006|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
149051003|NCT03692676|537670007|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
149051004|NCT03692676|537670008|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
149051005|NCT03692676|537670005|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
149051006|NCT03692676|537670006|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
149051007|NCT03692676|537670007|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
149051008|NCT03692676|537670008|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
149051009|NCT03692676|537670005|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
149051010|NCT03692676|537670006|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
149051011|NCT03692676|537670007|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
149051012|NCT03692676|537670008|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
149051013|NCT03692676|537670005|FG000|Overall Study|Other|0|||
149051014|NCT03692676|537670006|FG001|Overall Study|Other|805|||
149051015|NCT03692676|537670007|FG002|Overall Study|Other|758|||
149051016|NCT03692676|537670008|FG003|Overall Study|Other|277|||
149051017|NCT03692676|537670005|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
149051018|NCT03692676|537670006|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
149051019|NCT03692676|537670007|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
149051020|NCT03692676|537670008|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
149051021|NCT03692611|537670009|FG000|Overall Study|Found to be ineligible postrandomization|3|||
149051022|NCT03692611|537670010|FG001|Overall Study|Found to be ineligible postrandomization|0|||
149051023|NCT04725240|537670012|FG000|Overall Study|Adverse Event|2|||
149051024|NCT02312960|537670018|FG000|Overall Study|Death|24|||
149051025|NCT02312960|537670019|FG001|Overall Study|Death|32|||
149051026|NCT02312960|537670020|FG002|Overall Study|Death|25|||
149051027|NCT02312960|537670021|FG003|Overall Study|Death|11|||
149051028|NCT02312960|537670022|FG004|Overall Study|Death|5|||
149051029|NCT02312960|537670023|FG005|Overall Study|Death|5|||
149051030|NCT02312960|537670024|FG006|Overall Study|Death|8|||
149051031|NCT02312960|537670025|FG007|Overall Study|Death|5|||
149051032|NCT02312960|537670026|FG008|Overall Study|Death|7|||
149051033|NCT02312960|537670027|FG009|Overall Study|Death|3|||
149051034|NCT02312960|537670028|FG010|Overall Study|Death|3|||
149051035|NCT02312960|537670029|FG011|Overall Study|Death|1|||
149051036|NCT02312960|537670030|FG012|Overall Study|Death|25|||
149051037|NCT02312960|537670031|FG013|Overall Study|Death|19|||
149051038|NCT02312960|537670018|FG000|Overall Study|Missing|0|||
149051039|NCT02312960|537670019|FG001|Overall Study|Missing|0|||
149051040|NCT02312960|537670020|FG002|Overall Study|Missing|2|||
149051041|NCT02312960|537670021|FG003|Overall Study|Missing|0|||
149051042|NCT02312960|537670022|FG004|Overall Study|Missing|0|||
149051043|NCT02312960|537670023|FG005|Overall Study|Missing|0|||
149051044|NCT02312960|537670024|FG006|Overall Study|Missing|0|||
149051045|NCT02312960|537670025|FG007|Overall Study|Missing|0|||
149051046|NCT02312960|537670026|FG008|Overall Study|Missing|0|||
149051047|NCT02312960|537670027|FG009|Overall Study|Missing|0|||
149051048|NCT02312960|537670028|FG010|Overall Study|Missing|0|||
149051049|NCT02312960|537670029|FG011|Overall Study|Missing|0|||
149051050|NCT02312960|537670030|FG012|Overall Study|Missing|0|||
149051051|NCT02312960|537670031|FG013|Overall Study|Missing|0|||
149051052|NCT02312960|537670018|FG000|Overall Study|Lost to Follow-up|0|||
149051053|NCT02312960|537670019|FG001|Overall Study|Lost to Follow-up|0|||
149051054|NCT02312960|537670020|FG002|Overall Study|Lost to Follow-up|1|||
149051055|NCT02312960|537670021|FG003|Overall Study|Lost to Follow-up|0|||
149051056|NCT02312960|537670022|FG004|Overall Study|Lost to Follow-up|0|||
149051057|NCT02312960|537670023|FG005|Overall Study|Lost to Follow-up|0|||
149051058|NCT02312960|537670024|FG006|Overall Study|Lost to Follow-up|1|||
149051059|NCT02312960|537670025|FG007|Overall Study|Lost to Follow-up|1|||
149051060|NCT02312960|537670026|FG008|Overall Study|Lost to Follow-up|0|||
149051061|NCT02312960|537670027|FG009|Overall Study|Lost to Follow-up|1|||
149051062|NCT02312960|537670028|FG010|Overall Study|Lost to Follow-up|0|||
149051063|NCT02312960|537670029|FG011|Overall Study|Lost to Follow-up|0|||
149051064|NCT02312960|537670030|FG012|Overall Study|Lost to Follow-up|1|||
149051065|NCT02312960|537670031|FG013|Overall Study|Lost to Follow-up|0|||
149051066|NCT02312960|537670018|FG000|Overall Study|Withdrawal by Subject|1|||
149051067|NCT02312960|537670019|FG001|Overall Study|Withdrawal by Subject|2|||
148887737|NCT03001557|537067970|FG007|Extension Phase|Lost to Follow-up|1|||
149051068|NCT02312960|537670020|FG002|Overall Study|Withdrawal by Subject|0|||
149051069|NCT02312960|537670021|FG003|Overall Study|Withdrawal by Subject|0|||
149051070|NCT02312960|537670022|FG004|Overall Study|Withdrawal by Subject|1|||
149051071|NCT02312960|537670023|FG005|Overall Study|Withdrawal by Subject|0|||
149051072|NCT02312960|537670024|FG006|Overall Study|Withdrawal by Subject|1|||
149051073|NCT02312960|537670025|FG007|Overall Study|Withdrawal by Subject|2|||
149051074|NCT02312960|537670026|FG008|Overall Study|Withdrawal by Subject|2|||
149051075|NCT02312960|537670027|FG009|Overall Study|Withdrawal by Subject|3|||
149051076|NCT02312960|537670028|FG010|Overall Study|Withdrawal by Subject|0|||
149051077|NCT02312960|537670029|FG011|Overall Study|Withdrawal by Subject|0|||
149051078|NCT02312960|537670030|FG012|Overall Study|Withdrawal by Subject|2|||
149051079|NCT02312960|537670031|FG013|Overall Study|Withdrawal by Subject|0|||
149051080|NCT04060355|537670032|FG000|Overall Study|Lost to Follow-up|41|||
149051081|NCT01140880|537670033|FG000|Overall Study|Death|0|||
149051082|NCT01140880|537670034|FG001|Overall Study|Death|1|||
149051083|NCT01140880|537670033|FG000|Overall Study|Withdrawal by Subject|6|||
149051084|NCT01140880|537670034|FG001|Overall Study|Withdrawal by Subject|3|||
149051085|NCT01140880|537670033|FG000|Overall Study|Lost to Follow-up|8|||
149051086|NCT01140880|537670034|FG001|Overall Study|Lost to Follow-up|10|||
149051087|NCT01140880|537670033|FG000|Overall Study|Protocol Violation|0|||
149051088|NCT01140880|537670034|FG001|Overall Study|Protocol Violation|30|||
149051089|NCT03779204|537670035|FG000|Overall Study|Lost to Follow-up|2|||
149051090|NCT03779204|537670036|FG001|Overall Study|Lost to Follow-up|0|||
149051091|NCT04421378|537670037|FG000|Overall Study|Adverse Event|2|||
149051092|NCT04421378|537670038|FG001|Overall Study|Adverse Event|7|||
149051093|NCT04421378|537670039|FG002|Overall Study|Adverse Event|0|||
149051094|NCT04421378|537670040|FG003|Overall Study|Adverse Event|1|||
149051095|NCT04421378|537670041|FG004|Overall Study|Adverse Event|0|||
149051096|NCT04421378|537670037|FG000|Overall Study|Physician Decision|1|||
149051097|NCT04421378|537670038|FG001|Overall Study|Physician Decision|2|||
149051098|NCT04421378|537670039|FG002|Overall Study|Physician Decision|0|||
149051099|NCT04421378|537670040|FG003|Overall Study|Physician Decision|0|||
149051100|NCT04421378|537670041|FG004|Overall Study|Physician Decision|0|||
149051101|NCT04421378|537670037|FG000|Overall Study|Progressive Disease|16|||
149051102|NCT04421378|537670038|FG001|Overall Study|Progressive Disease|4|||
149051103|NCT04421378|537670039|FG002|Overall Study|Progressive Disease|18|||
149051104|NCT04421378|537670040|FG003|Overall Study|Progressive Disease|11|||
149051105|NCT04421378|537670041|FG004|Overall Study|Progressive Disease|3|||
149051106|NCT04421378|537670037|FG000|Overall Study|Study Terminated by Sponsor|0|||
149051107|NCT04421378|537670038|FG001|Overall Study|Study Terminated by Sponsor|1|||
149051108|NCT04421378|537670039|FG002|Overall Study|Study Terminated by Sponsor|1|||
149051109|NCT04421378|537670040|FG003|Overall Study|Study Terminated by Sponsor|0|||
149051110|NCT04421378|537670041|FG004|Overall Study|Study Terminated by Sponsor|0|||
149051111|NCT04421378|537670037|FG000|Overall Study|Withdrawal by Subject|3|||
149051112|NCT04421378|537670038|FG001|Overall Study|Withdrawal by Subject|1|||
149051113|NCT04421378|537670039|FG002|Overall Study|Withdrawal by Subject|0|||
149051114|NCT04421378|537670040|FG003|Overall Study|Withdrawal by Subject|2|||
149051115|NCT04421378|537670041|FG004|Overall Study|Withdrawal by Subject|0|||
149051116|NCT04421378|537670037|FG000|Overall Study|Other|1|||
149051117|NCT04421378|537670038|FG001|Overall Study|Other|0|||
149051118|NCT04421378|537670039|FG002|Overall Study|Other|0|||
149051119|NCT04421378|537670040|FG003|Overall Study|Other|0|||
149051120|NCT04421378|537670041|FG004|Overall Study|Other|0|||
149051121|NCT04258709|537670042|FG000|Overall Study|Lost to Follow-up|10|||
149051122|NCT04258709|537670043|FG001|Overall Study|Lost to Follow-up|4|||
149051123|NCT04258709|537670042|FG000|Overall Study|Withdrawal by Subject|1|||
149051124|NCT04258709|537670043|FG001|Overall Study|Withdrawal by Subject|0|||
149051125|NCT04258709|537670042|FG000|Overall Study|Fetal demise|0|||
149051126|NCT04258709|537670043|FG001|Overall Study|Fetal demise|1|||
149051127|NCT04258709|537670042|FG000|Overall Study|Protocol Violation|1|||
149051128|NCT04258709|537670043|FG001|Overall Study|Protocol Violation|1|||
149051129|NCT02592330|537670044|FG000|Overall Study|Withdrawal by Subject|1|||
149051130|NCT02592330|537670045|FG001|Overall Study|Withdrawal by Subject|0|||
149051131|NCT02592330|537670044|FG000|Overall Study|Failed Biopsy|1|||
149051132|NCT02592330|537670045|FG001|Overall Study|Failed Biopsy|0|||
149051133|NCT03090152|537670046|FG000|Overall Study|Withdrawal by Subject|0|||
149051134|NCT03090152|537670047|FG001|Overall Study|Withdrawal by Subject|2|||
149051135|NCT03090152|537670048|FG002|Overall Study|Withdrawal by Subject|1|||
149051136|NCT03090152|537670046|FG000|Overall Study|Surgery Canceled|1|||
149051137|NCT03090152|537670047|FG001|Overall Study|Surgery Canceled|0|||
149051138|NCT03090152|537670048|FG002|Overall Study|Surgery Canceled|0|||
149051139|NCT03090152|537670046|FG000|Overall Study|Epidural catheter could not be placed|0|||
149051140|NCT03090152|537670047|FG001|Overall Study|Epidural catheter could not be placed|2|||
149051141|NCT03090152|537670048|FG002|Overall Study|Epidural catheter could not be placed|0|||
149051142|NCT02807636|537670049|FG000|Overall Study|Lost to Follow-up|10|||
149051143|NCT02807636|537670050|FG001|Overall Study|Lost to Follow-up|13|||
149051144|NCT02807636|537670051|FG002|Overall Study|Lost to Follow-up|6|||
149051145|NCT02807636|537670049|FG000|Overall Study|Protocol Deviation|1|||
149051146|NCT02807636|537670050|FG001|Overall Study|Protocol Deviation|0|||
149051147|NCT02807636|537670051|FG002|Overall Study|Protocol Deviation|0|||
149051148|NCT02807636|537670049|FG000|Overall Study|Symptomatic Deterioration|0|||
149051149|NCT02807636|537670050|FG001|Overall Study|Symptomatic Deterioration|1|||
149051150|NCT02807636|537670051|FG002|Overall Study|Symptomatic Deterioration|0|||
149051151|NCT02807636|537670049|FG000|Overall Study|Withdrawal by Subject|39|||
149051152|NCT02807636|537670050|FG001|Overall Study|Withdrawal by Subject|28|||
149051153|NCT02807636|537670051|FG002|Overall Study|Withdrawal by Subject|24|||
149051154|NCT02807636|537670049|FG000|Overall Study|Death|303|||
149051155|NCT02807636|537670050|FG001|Overall Study|Death|332|||
149051156|NCT02807636|537670051|FG002|Overall Study|Death|272|||
149051157|NCT02807636|537670049|FG000|Overall Study|Study Terminated By Sponsor|47|||
149051158|NCT02807636|537670050|FG001|Overall Study|Study Terminated By Sponsor|76|||
149051159|NCT02807636|537670051|FG002|Overall Study|Study Terminated By Sponsor|60|||
149051160|NCT02807636|537670049|FG000|Overall Study|Physician Decision|0|||
149051161|NCT02807636|537670050|FG001|Overall Study|Physician Decision|1|||
149051162|NCT02807636|537670051|FG002|Overall Study|Physician Decision|0|||
149051163|NCT03175029|537670052|FG000|Overall Study|Withdrawal by Subject|2|||
149051164|NCT03175029|537670053|FG001|Overall Study|Withdrawal by Subject|1|||
149051165|NCT03175029|537670052|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
149051166|NCT03175029|537670053|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
149051167|NCT05633953|537670054|FG000|Overall Study|Adverse Event|7|||
149051168|NCT05633953|537670054|FG000|Overall Study|Death|30|||
149051169|NCT05633953|537670054|FG000|Overall Study|Lost to Follow-up|1|||
149051170|NCT05633953|537670054|FG000|Overall Study|Osilodrostat discontinued|4|||
149051171|NCT05633953|537670054|FG000|Overall Study|Physician Decision|1|||
149051172|NCT05633953|537670054|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
149051173|NCT05633953|537670054|FG000|Overall Study|Progressive disease|2|||
149051174|NCT02729311|537670055|FG000|Overall Study|Withdrawal by Subject|8|||
149051175|NCT02729311|537670056|FG001|Overall Study|Withdrawal by Subject|2|||
149051176|NCT04034251|537670057|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
148887738|NCT03001557|537067963|FG000|Extension Phase|Administrative Reason|0|||
148887739|NCT03001557|537067964|FG001|Extension Phase|Administrative Reason|0|||
148887740|NCT03001557|537067965|FG002|Extension Phase|Administrative Reason|0|||
148887741|NCT03001557|537067966|FG003|Extension Phase|Administrative Reason|0|||
148887742|NCT03001557|537067967|FG004|Extension Phase|Administrative Reason|0|||
148887743|NCT03001557|537067968|FG005|Extension Phase|Administrative Reason|1|||
148887744|NCT03001557|537067969|FG006|Extension Phase|Administrative Reason|3|||
148887745|NCT03001557|537067970|FG007|Extension Phase|Administrative Reason|3|||
148887746|NCT03001557|537067963|FG000|Extension Phase|Loss of caregiver|0|||
148887747|NCT03001557|537067964|FG001|Extension Phase|Loss of caregiver|0|||
148887748|NCT03001557|537067965|FG002|Extension Phase|Loss of caregiver|0|||
148887749|NCT03001557|537067966|FG003|Extension Phase|Loss of caregiver|0|||
148887750|NCT03001557|537067967|FG004|Extension Phase|Loss of caregiver|0|||
148887751|NCT03001557|537067968|FG005|Extension Phase|Loss of caregiver|0|||
148887752|NCT03001557|537067969|FG006|Extension Phase|Loss of caregiver|1|||
148887753|NCT03001557|537067970|FG007|Extension Phase|Loss of caregiver|0|||
148887754|NCT03001557|537067963|FG000|Extension Phase|Others|0|||
148887755|NCT03001557|537067964|FG001|Extension Phase|Others|0|||
148887756|NCT03001557|537067965|FG002|Extension Phase|Others|0|||
148887757|NCT03001557|537067966|FG003|Extension Phase|Others|0|||
148887758|NCT03001557|537067967|FG004|Extension Phase|Others|0|||
148887759|NCT03001557|537067968|FG005|Extension Phase|Others|1|||
148887760|NCT03001557|537067969|FG006|Extension Phase|Others|3|||
148887761|NCT03001557|537067970|FG007|Extension Phase|Others|0|||
148887762|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
148887763|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
148887764|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Death|1|||
148887765|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Death|2|||
148887766|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
148887767|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
148887768|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
148887769|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
148887770|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
148887771|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
148887772|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
148887773|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
148887774|NCT01794000|537067971|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
148887775|NCT01794000|537067972|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
148887776|NCT01794000|537067971|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
148887777|NCT01794000|537067972|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
148887778|NCT00965081|537067973|FG000|Overall Study|Adverse Event|14|||
148887779|NCT00965081|537067974|FG001|Overall Study|Adverse Event|9|||
148887780|NCT00965081|537067973|FG000|Overall Study|Lack of Efficacy|2|||
148887781|NCT00965081|537067974|FG001|Overall Study|Lack of Efficacy|5|||
148887782|NCT00965081|537067973|FG000|Overall Study|Lost to Follow-up|4|||
148887783|NCT00965081|537067974|FG001|Overall Study|Lost to Follow-up|5|||
148887784|NCT00965081|537067973|FG000|Overall Study|Physician Decision|2|||
148887785|NCT00965081|537067974|FG001|Overall Study|Physician Decision|0|||
148887786|NCT00965081|537067973|FG000|Overall Study|Protocol Violation|2|||
148887787|NCT00965081|537067974|FG001|Overall Study|Protocol Violation|5|||
148887788|NCT00965081|537067973|FG000|Overall Study|Sponsor Decision|1|||
148887789|NCT00965081|537067974|FG001|Overall Study|Sponsor Decision|0|||
148887790|NCT00965081|537067973|FG000|Overall Study|Withdrawal by Subject|4|||
148887791|NCT00965081|537067974|FG001|Overall Study|Withdrawal by Subject|7|||
149051177|NCT04034251|537670058|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
149051178|NCT04034251|537670059|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
149051179|NCT05034952|537670060|FG000|Overall Study|Adverse Event|1|||
149051180|NCT05034952|537670061|FG001|Overall Study|Adverse Event|0|||
149051181|NCT05034952|537670062|FG002|Overall Study|Adverse Event|0|||
149051182|NCT05034952|537670063|FG003|Overall Study|Adverse Event|0|||
149051183|NCT05034952|537670060|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
149051184|NCT05034952|537670061|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
149051185|NCT05034952|537670062|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
149051186|NCT05034952|537670063|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
149051187|NCT05034952|537670060|FG000|Overall Study|Lost to Follow-up|1|||
149051188|NCT05034952|537670061|FG001|Overall Study|Lost to Follow-up|4|||
149051189|NCT05034952|537670062|FG002|Overall Study|Lost to Follow-up|3|||
149051190|NCT05034952|537670063|FG003|Overall Study|Lost to Follow-up|3|||
149051191|NCT05034952|537670060|FG000|Overall Study|Other|0|||
149051192|NCT05034952|537670061|FG001|Overall Study|Other|0|||
149051193|NCT05034952|537670062|FG002|Overall Study|Other|0|||
149051194|NCT05034952|537670063|FG003|Overall Study|Other|1|||
149051195|NCT02287610|537670064|FG000|Overall Study|Lost to Follow-up|3|||
149051196|NCT02287610|537670064|FG000|Overall Study|Withdrawal by Subject|8|||
149051197|NCT02287610|537670064|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
149051198|NCT04783935|537670077|FG000|Overall Study|Withdrawal by Subject|6|||
149051199|NCT04783935|537670077|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
149051200|NCT04783935|537670077|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
149051201|NCT04783935|537670077|FG000|Overall Study|Lost to Follow-up|3|||
149051202|NCT04783935|537670077|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
149051203|NCT06074523|537670083|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
149051204|NCT06074523|537670083|FG000|Overall Study|Withdrawal by Subject|1|||
149051205|NCT00961571|537670086|FG000|Overall Study|Physician Decision|39|||
149051206|NCT05524233|537670087|FG000|Overall Study|Lost to Follow-up|2|||
149051207|NCT05524233|537670087|FG000|Overall Study|Adverse Event|2|||
149051208|NCT05524233|537670087|FG000|Overall Study|Withdrawal by Subject|1|||
149051209|NCT02506959|537670094|FG000|Overall Study|Physician Decision|2|||
149051210|NCT02506959|537670095|FG001|Overall Study|Physician Decision|1|||
149051211|NCT04321031|537670096|FG000|Overall Study|Adverse Event|0|||
149051212|NCT04321031|537670097|FG001|Overall Study|Adverse Event|2|||
149051213|NCT04321031|537670098|FG002|Overall Study|Adverse Event|2|||
149051214|NCT04321031|537670099|FG003|Overall Study|Adverse Event|2|||
149051215|NCT04321031|537670100|FG004|Overall Study|Adverse Event|2|||
149051216|NCT04321031|537670101|FG005|Overall Study|Adverse Event|2|||
149051217|NCT04321031|537670102|FG006|Overall Study|Adverse Event|0|||
149051218|NCT04321031|537670096|FG000|Overall Study|Lost to Follow-up|0|||
149051219|NCT04321031|537670097|FG001|Overall Study|Lost to Follow-up|0|||
149051220|NCT04321031|537670098|FG002|Overall Study|Lost to Follow-up|0|||
149051221|NCT04321031|537670099|FG003|Overall Study|Lost to Follow-up|1|||
149051222|NCT04321031|537670100|FG004|Overall Study|Lost to Follow-up|0|||
149051223|NCT04321031|537670101|FG005|Overall Study|Lost to Follow-up|2|||
149051224|NCT04321031|537670102|FG006|Overall Study|Lost to Follow-up|1|||
149051225|NCT04321031|537670096|FG000|Overall Study|Withdrawal by Subject|2|||
149051226|NCT04321031|537670097|FG001|Overall Study|Withdrawal by Subject|2|||
149051227|NCT04321031|537670098|FG002|Overall Study|Withdrawal by Subject|1|||
149051228|NCT04321031|537670099|FG003|Overall Study|Withdrawal by Subject|3|||
149051229|NCT04321031|537670100|FG004|Overall Study|Withdrawal by Subject|1|||
149051230|NCT04321031|537670101|FG005|Overall Study|Withdrawal by Subject|0|||
149051231|NCT04321031|537670102|FG006|Overall Study|Withdrawal by Subject|1|||
149051232|NCT04321031|537670096|FG000|Overall Study|Non-compliance with study drug|0|||
149051233|NCT04321031|537670097|FG001|Overall Study|Non-compliance with study drug|0|||
149051234|NCT04321031|537670098|FG002|Overall Study|Non-compliance with study drug|0|||
149051235|NCT04321031|537670099|FG003|Overall Study|Non-compliance with study drug|0|||
149051236|NCT04321031|537670100|FG004|Overall Study|Non-compliance with study drug|0|||
149051237|NCT04321031|537670101|FG005|Overall Study|Non-compliance with study drug|1|||
149051238|NCT04321031|537670102|FG006|Overall Study|Non-compliance with study drug|0|||
149051239|NCT04321031|537670096|FG000|Overall Study|Other|0|||
149051240|NCT04321031|537670097|FG001|Overall Study|Other|0|||
149051241|NCT04321031|537670098|FG002|Overall Study|Other|0|||
149051242|NCT04321031|537670099|FG003|Overall Study|Other|1|||
149051243|NCT04321031|537670100|FG004|Overall Study|Other|0|||
149051244|NCT04321031|537670101|FG005|Overall Study|Other|0|||
149051245|NCT04321031|537670102|FG006|Overall Study|Other|0|||
149051246|NCT03436745|537670105|FG000|Overall Study|Ineligible|0|||
149051247|NCT03436745|537670106|FG001|Overall Study|Ineligible|0|||
149051248|NCT03436745|537670107|FG002|Overall Study|Ineligible|1|||
149051249|NCT03338790|537670110|FG000|Overall Study|Disease Progression|65|||
149051250|NCT03338790|537670111|FG001|Overall Study|Disease Progression|43|||
149051251|NCT03338790|537670112|FG002|Overall Study|Disease Progression|50|||
149051252|NCT03338790|537670113|FG003|Overall Study|Disease Progression|37|||
149051253|NCT03338790|537670110|FG000|Overall Study|Study Drug Toxicity|9|||
149051254|NCT03338790|537670111|FG001|Overall Study|Study Drug Toxicity|8|||
149051255|NCT03338790|537670112|FG002|Overall Study|Study Drug Toxicity|15|||
149051256|NCT03338790|537670113|FG003|Overall Study|Study Drug Toxicity|0|||
149051257|NCT03338790|537670110|FG000|Overall Study|Death|1|||
149051258|NCT03338790|537670111|FG001|Overall Study|Death|1|||
149051259|NCT03338790|537670112|FG002|Overall Study|Death|1|||
149051260|NCT03338790|537670113|FG003|Overall Study|Death|0|||
149051261|NCT03338790|537670110|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
149051262|NCT03338790|537670111|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
149051263|NCT03338790|537670112|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
149051264|NCT03338790|537670113|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
149051265|NCT03338790|537670110|FG000|Overall Study|Participant request to discontinue study treatment|3|||
149051266|NCT03338790|537670111|FG001|Overall Study|Participant request to discontinue study treatment|3|||
149051267|NCT03338790|537670112|FG002|Overall Study|Participant request to discontinue study treatment|2|||
149051268|NCT03338790|537670113|FG003|Overall Study|Participant request to discontinue study treatment|1|||
149051269|NCT03338790|537670110|FG000|Overall Study|Poor/non-compliance|0|||
149051270|NCT03338790|537670111|FG001|Overall Study|Poor/non-compliance|1|||
149051271|NCT03338790|537670112|FG002|Overall Study|Poor/non-compliance|0|||
149051272|NCT03338790|537670113|FG003|Overall Study|Poor/non-compliance|0|||
149051273|NCT03338790|537670110|FG000|Overall Study|Participant withdrew consent|1|||
149051274|NCT03338790|537670111|FG001|Overall Study|Participant withdrew consent|0|||
149051275|NCT03338790|537670112|FG002|Overall Study|Participant withdrew consent|1|||
149051276|NCT03338790|537670113|FG003|Overall Study|Participant withdrew consent|1|||
149051277|NCT03338790|537670110|FG000|Overall Study|Other reasons|0|||
149051278|NCT03338790|537670111|FG001|Overall Study|Other reasons|5|||
149051279|NCT03338790|537670112|FG002|Overall Study|Other reasons|0|||
149051280|NCT03338790|537670113|FG003|Overall Study|Other reasons|2|||
149051281|NCT03338790|537670110|FG000|Overall Study|Not reported|0|||
149051282|NCT03338790|537670111|FG001|Overall Study|Not reported|0|||
149051283|NCT03338790|537670112|FG002|Overall Study|Not reported|1|||
149051284|NCT03338790|537670113|FG003|Overall Study|Not reported|0|||
149051285|NCT03338790|537670110|FG000|Overall Study|Completed treatment period|1|||
149051286|NCT03338790|537670111|FG001|Overall Study|Completed treatment period|2|||
149051287|NCT03338790|537670112|FG002|Overall Study|Completed treatment period|0|||
149051288|NCT03338790|537670113|FG003|Overall Study|Completed treatment period|0|||
149051289|NCT03846505|537670114|FG000|Treatment Phase|Withdrawal by Subject|9|||
149051290|NCT03846505|537670115|FG001|Treatment Phase|Withdrawal by Subject|11|||
149051291|NCT03846505|537670114|FG000|Treatment Phase|Lost to Follow-up|6|||
149051292|NCT03846505|537670115|FG001|Treatment Phase|Lost to Follow-up|2|||
149051293|NCT03846505|537670114|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
149051294|NCT03846505|537670115|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
149051295|NCT03846505|537670114|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
149051296|NCT03846505|537670115|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
149051297|NCT05481320|537670116|FG000|Overall Study|Withdrawal by Subject|1|||
149051298|NCT05481320|537670117|FG001|Overall Study|Withdrawal by Subject|1|||
149051299|NCT05481320|537670116|FG000|Overall Study|Care recipent passed away|0|||
149051300|NCT05481320|537670117|FG001|Overall Study|Care recipent passed away|1|||
149051301|NCT05481320|537670116|FG000|Overall Study|Out-of-window assessment|0|||
149051302|NCT05481320|537670117|FG001|Overall Study|Out-of-window assessment|1|||
149051303|NCT05481320|537670116|FG000|Overall Study|No longer a primary caregiver|3|||
149051304|NCT05481320|537670117|FG001|Overall Study|No longer a primary caregiver|0|||
149051305|NCT05481320|537670116|FG000|Overall Study|Unable to contact|1|||
149051306|NCT05481320|537670117|FG001|Overall Study|Unable to contact|0|||
149051307|NCT05319860|537670121|FG000|Overall Study|Death|1|||
149051308|NCT05319860|537670122|FG001|Overall Study|Death|1|||
148887792|NCT00965081|537067973|FG000|Overall Study|Switched to Rescue Arm|5|||
148887793|NCT00965081|537067974|FG001|Overall Study|Switched to Rescue Arm|12|||
149051309|NCT05319860|537670121|FG000|Overall Study|Lost to Follow-up|3|||
149051310|NCT05319860|537670122|FG001|Overall Study|Lost to Follow-up|1|||
149051311|NCT05319860|537670121|FG000|Overall Study|Withdrawal by Subject|1|||
149051312|NCT05319860|537670122|FG001|Overall Study|Withdrawal by Subject|7|||
149051313|NCT04314895|537670123|FG000|Overall Study|Lost to Follow-up|1|||
149051314|NCT04314895|537670123|FG000|Overall Study|Death|10|||
149051315|NCT04314895|537670123|FG000|Overall Study|Physician Decision|2|||
149051316|NCT03941860|537670124|FG000|Overall Study|Withdrawal by Subject|0|||
149051317|NCT03941860|537670125|FG001|Overall Study|Withdrawal by Subject|1|||
149051318|NCT03930342|537670129|FG000|Overall Study|Lost to Follow-up|70|||
149051319|NCT03930342|537670130|FG001|Overall Study|Lost to Follow-up|77|||
149051320|NCT02596126|537670131|FG000|Overall Study|Lost to Follow-up|12|||
148887794|NCT01367834|537067977|FG000|Overall Study|Withdrawal by Subject|2|||
149051321|NCT02596126|537670132|FG001|Overall Study|Lost to Follow-up|21|||
149051322|NCT02596126|537670131|FG000|Overall Study|Protocol Violation|7|||
149051323|NCT02596126|537670132|FG001|Overall Study|Protocol Violation|9|||
149051324|NCT05792423|537670138|FG000|Overall Study|Withdrawal by Subject|2|||
149051325|NCT02471638|537670139|FG000|Overall Study|Early Term Withdrawal|10|||
149051326|NCT02187003|537671572|FG000|Overall Study|Adverse Event|2|||
149051327|NCT02187003|537671573|FG001|Overall Study|Adverse Event|0|||
149051328|NCT02187003|537671572|FG000|Overall Study|Lost to Follow-up|14|||
149051329|NCT02187003|537671573|FG001|Overall Study|Lost to Follow-up|10|||
149051330|NCT02187003|537671572|FG000|Overall Study|Withdrawal by Subject|3|||
149051331|NCT02187003|537671573|FG001|Overall Study|Withdrawal by Subject|7|||
149051332|NCT02187003|537671572|FG000|Overall Study|Protocol Violation|2|||
149051333|NCT02187003|537671573|FG001|Overall Study|Protocol Violation|4|||
149051334|NCT02187003|537671572|FG000|Overall Study|Other|5|||
149051335|NCT02187003|537671573|FG001|Overall Study|Other|5|||
149051336|NCT02187003|537671572|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149051337|NCT02187003|537671573|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
149051338|NCT05816551|537671574|FG000|Overall Study|Withdrawal by Subject|0|||
149051339|NCT05816551|537671575|FG001|Overall Study|Withdrawal by Subject|1|||
149051340|NCT05816551|537671574|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
149051341|NCT05816551|537671575|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
149051342|NCT04833777|537671580|FG000|Overall Study|Lost to Follow-up|1|||
149051343|NCT04833777|537671581|FG001|Overall Study|Lost to Follow-up|0|||
149051344|NCT03648840|537671583|FG000|First IV Infusion Session|Adverse Event|0|||
149051345|NCT03648840|537671584|FG001|First IV Infusion Session|Adverse Event|2|||
149051346|NCT03648840|537671583|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
149051347|NCT03648840|537671584|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
149051348|NCT03648840|537671583|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
149051349|NCT03648840|537671584|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
149051350|NCT03648840|537671583|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
149051351|NCT03648840|537671584|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
149051352|NCT05063994|537671587|FG000|Cortef Run-In|Withdrawal of Consent|1|||
149051353|NCT05063994|537671588|FG001|Cortef Run-In|Withdrawal of Consent|0|||
149051354|NCT05063994|537671589|FG002|Cortef Run-In|Withdrawal of Consent|0|||
149051355|NCT05063994|537671587|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
149051356|NCT05063994|537671588|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
149051357|NCT05063994|537671589|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
149051358|NCT05063994|537671587|FG000|Treatment|Physician Decision|0|||
149051359|NCT05063994|537671588|FG001|Treatment|Physician Decision|0|||
149051360|NCT05063994|537671589|FG002|Treatment|Physician Decision|1|||
149051361|NCT05063994|537671587|FG000|Treatment|Withdrawal by Subject|0|||
149051362|NCT05063994|537671588|FG001|Treatment|Withdrawal by Subject|0|||
149051363|NCT05063994|537671589|FG002|Treatment|Withdrawal by Subject|1|||
149051364|NCT05063994|537671587|FG000|Treatment|Withdrawal of Consent|0|||
149051365|NCT05063994|537671588|FG001|Treatment|Withdrawal of Consent|0|||
149051366|NCT05063994|537671589|FG002|Treatment|Withdrawal of Consent|1|||
149051367|NCT01331005|537671598|FG000|Overall Study|Lost to Follow-up|2|||
149051368|NCT01331005|537671599|FG001|Overall Study|Lost to Follow-up|1|||
149051369|NCT01331005|537671598|FG000|Overall Study|Withdrawal by Subject|2|||
149051370|NCT01331005|537671599|FG001|Overall Study|Withdrawal by Subject|3|||
149051371|NCT03016169|537671613|FG000|Overall Study|Lost to Follow-up|4|||
149051372|NCT03016169|537671613|FG000|Overall Study|Death|54|||
149051373|NCT03016169|537671613|FG000|Overall Study|Device Explant|11|||
149051374|NCT03016169|537671613|FG000|Overall Study|Withdrawal by Subject|19|||
149051375|NCT03016169|537671613|FG000|Overall Study|Other Reasons|1|||
149051376|NCT03131648|537671614|FG000|Initial Treatment Period|Not dosed|2|||
149051377|NCT03131648|537671615|FG001|Initial Treatment Period|Not dosed|2|||
149051378|NCT03131648|537671616|FG002|Initial Treatment Period|Not dosed|0|||
149051379|NCT03131648|537671617|FG003|Initial Treatment Period|Not dosed|0|||
149051380|NCT03131648|537671618|FG004|Initial Treatment Period|Not dosed|0|||
149051381|NCT03131648|537671619|FG005|Initial Treatment Period|Not dosed|0|||
149051382|NCT03131648|537671620|FG006|Initial Treatment Period|Not dosed|0|||
149051383|NCT03131648|537671621|FG007|Initial Treatment Period|Not dosed|0|||
149051384|NCT03131648|537671614|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
149051385|NCT03131648|537671615|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
149051386|NCT03131648|537671616|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149051387|NCT03131648|537671617|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149051388|NCT03131648|537671618|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149051389|NCT03131648|537671619|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149051390|NCT03131648|537671620|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149051391|NCT03131648|537671621|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149051392|NCT03131648|537671614|FG000|Open-label Treatment|Discontinued IMP|0|||
149051393|NCT03131648|537671615|FG001|Open-label Treatment|Discontinued IMP|0|||
149051394|NCT03131648|537671616|FG002|Open-label Treatment|Discontinued IMP|0|||
149051395|NCT03131648|537671617|FG003|Open-label Treatment|Discontinued IMP|0|||
149051396|NCT03131648|537671618|FG004|Open-label Treatment|Discontinued IMP|0|||
149051397|NCT03131648|537671619|FG005|Open-label Treatment|Discontinued IMP|0|||
149051398|NCT03131648|537671620|FG006|Open-label Treatment|Discontinued IMP|112|||
149051399|NCT03131648|537671621|FG007|Open-label Treatment|Discontinued IMP|0|||
149051400|NCT03131648|537671614|FG000|Open-label Treatment|Completed Week 50|0|||
149051401|NCT03131648|537671615|FG001|Open-label Treatment|Completed Week 50|0|||
149051402|NCT03131648|537671616|FG002|Open-label Treatment|Completed Week 50|0|||
149051403|NCT03131648|537671617|FG003|Open-label Treatment|Completed Week 50|0|||
149051404|NCT03131648|537671618|FG004|Open-label Treatment|Completed Week 50|0|||
149051405|NCT03131648|537671619|FG005|Open-label Treatment|Completed Week 50|0|||
149051406|NCT03131648|537671620|FG006|Open-label Treatment|Completed Week 50|6|||
149051407|NCT03131648|537671621|FG007|Open-label Treatment|Completed Week 50|0|||
149051408|NCT03131648|537671614|FG000|Maintenance Treatment Period|Not dosed|0|||
149051409|NCT03131648|537671615|FG001|Maintenance Treatment Period|Not dosed|0|||
149051410|NCT03131648|537671616|FG002|Maintenance Treatment Period|Not dosed|3|||
149051411|NCT03131648|537671617|FG003|Maintenance Treatment Period|Not dosed|2|||
149051412|NCT03131648|537671618|FG004|Maintenance Treatment Period|Not dosed|1|||
149051413|NCT03131648|537671619|FG005|Maintenance Treatment Period|Not dosed|0|||
149051414|NCT03131648|537671620|FG006|Maintenance Treatment Period|Not dosed|0|||
149051415|NCT03131648|537671621|FG007|Maintenance Treatment Period|Not dosed|0|||
149051416|NCT03131648|537671614|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
149051417|NCT03131648|537671615|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
149051418|NCT03131648|537671616|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
149051419|NCT03131648|537671617|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
149051420|NCT03131648|537671618|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
149051421|NCT03131648|537671619|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
149051422|NCT03131648|537671620|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
149051423|NCT03131648|537671621|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
149051424|NCT03131648|537671614|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149051425|NCT03131648|537671615|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149051426|NCT03131648|537671616|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
149051427|NCT03131648|537671617|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
149051428|NCT03131648|537671618|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
149051429|NCT03131648|537671619|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
149051430|NCT03131648|537671620|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149051431|NCT03131648|537671621|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149051432|NCT03131648|537671614|FG000|Maintenance Treatment Period|Completed Week 50|0|||
149051433|NCT03131648|537671615|FG001|Maintenance Treatment Period|Completed Week 50|0|||
149051434|NCT03131648|537671616|FG002|Maintenance Treatment Period|Completed Week 50|0|||
149051435|NCT03131648|537671617|FG003|Maintenance Treatment Period|Completed Week 50|0|||
149051436|NCT03131648|537671618|FG004|Maintenance Treatment Period|Completed Week 50|1|||
149051437|NCT03131648|537671619|FG005|Maintenance Treatment Period|Completed Week 50|0|||
149051438|NCT03131648|537671620|FG006|Maintenance Treatment Period|Completed Week 50|0|||
149051439|NCT03131648|537671621|FG007|Maintenance Treatment Period|Completed Week 50|0|||
149051440|NCT03131648|537671614|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051441|NCT03131648|537671615|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051442|NCT03131648|537671616|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051443|NCT03131648|537671617|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051444|NCT03131648|537671618|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051445|NCT03131648|537671619|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051446|NCT03131648|537671620|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
149051447|NCT03131648|537671621|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
149051448|NCT02724878|537671622|FG000|Overall Study|Still on Active Therapy|15|||
149051449|NCT02724878|537671622|FG000|Overall Study|Disease Progression|31|||
149051450|NCT02724878|537671622|FG000|Overall Study|Toxicity|5|||
149051451|NCT02724878|537671622|FG000|Overall Study|Death|1|||
149051452|NCT02724878|537671622|FG000|Overall Study|Withdrawal by Subject|4|||
149051453|NCT02724878|537671622|FG000|Overall Study|Lost to Follow-up|2|||
149051454|NCT02724878|537671622|FG000|Overall Study|Protocol Violation|1|||
149051455|NCT02724878|537671622|FG000|Overall Study|Ineligible for Study Drug|5|||
149051456|NCT02724878|537671622|FG000|Overall Study|not started|1|||
149051457|NCT04150718|537671630|FG000|Overall Study|Withdrawal by Subject|2|||
149051458|NCT04150718|537671631|FG001|Overall Study|Withdrawal by Subject|7|||
149051459|NCT04150718|537671632|FG002|Overall Study|Withdrawal by Subject|1|||
149051460|NCT04150718|537671630|FG000|Overall Study|Lost to Follow-up|1|||
149051461|NCT04150718|537671631|FG001|Overall Study|Lost to Follow-up|2|||
149051462|NCT04150718|537671632|FG002|Overall Study|Lost to Follow-up|0|||
149051463|NCT04150718|537671630|FG000|Overall Study|Ineligible|1|||
149051464|NCT04150718|537671631|FG001|Overall Study|Ineligible|0|||
149051465|NCT04150718|537671632|FG002|Overall Study|Ineligible|10|||
149051466|NCT05324124|537671637|FG000|Period 1|Withdrawal by Subject|1|||
149051467|NCT05324124|537671638|FG001|Period 1|Withdrawal by Subject|0|||
149051468|NCT05324124|537671637|FG000|Period 1|Physician Decision|0|||
149051469|NCT05324124|537671638|FG001|Period 1|Physician Decision|1|||
149051470|NCT04950660|537671639|FG000|Overall Study|Protocol Violation|4|||
149051471|NCT04950660|537671640|FG001|Overall Study|Protocol Violation|2|||
149051472|NCT04950660|537671639|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
149051473|NCT04950660|537671640|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
149051474|NCT04950660|537671639|FG000|Overall Study|Withdrawal by Subject|0|||
149051475|NCT04950660|537671640|FG001|Overall Study|Withdrawal by Subject|1|||
149051476|NCT04950660|537671639|FG000|Overall Study|Hypotension|1|||
149051477|NCT04950660|537671640|FG001|Overall Study|Hypotension|0|||
149051478|NCT02437318|537671647|FG000|Overall Study|Progressive disease|207|||
149051479|NCT02437318|537671648|FG001|Overall Study|Progressive disease|240|||
149051480|NCT02437318|537671647|FG000|Overall Study|Subject/guardian decision|24|||
149051481|NCT02437318|537671648|FG001|Overall Study|Subject/guardian decision|11|||
149051482|NCT02437318|537671647|FG000|Overall Study|Physician Decision|29|||
149051483|NCT02437318|537671648|FG001|Overall Study|Physician Decision|22|||
149051484|NCT02437318|537671647|FG000|Overall Study|Adverse Event|14|||
149051485|NCT02437318|537671648|FG001|Overall Study|Adverse Event|4|||
149051486|NCT02437318|537671647|FG000|Overall Study|Death|4|||
149051487|NCT02437318|537671648|FG001|Overall Study|Death|4|||
149051488|NCT02437318|537671647|FG000|Overall Study|Protocol deviation|5|||
149051489|NCT02437318|537671648|FG001|Overall Study|Protocol deviation|7|||
149051490|NCT02437318|537671647|FG000|Overall Study|Sponsor decision|1|||
149051491|NCT02437318|537671648|FG001|Overall Study|Sponsor decision|0|||
149051492|NCT00512070|537671654|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
149051493|NCT00512070|537671655|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
149051494|NCT00512070|537671656|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
149051495|NCT00512070|537671654|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
149051496|NCT00512070|537671655|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
149051497|NCT00512070|537671656|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
149051498|NCT03143153|537671660|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
149051499|NCT03143153|537671661|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
149051500|NCT03143153|537671662|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
149051501|NCT03143153|537671660|FG000|Pre-Treatment|Participant withdrew consent|0|||
149051502|NCT03143153|537671661|FG001|Pre-Treatment|Participant withdrew consent|1|||
149051503|NCT03143153|537671662|FG002|Pre-Treatment|Participant withdrew consent|12|||
149051504|NCT03143153|537671660|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
149051505|NCT03143153|537671661|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
149051506|NCT03143153|537671662|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
149051507|NCT03143153|537671660|FG000|Pre-Treatment|Other Reasons|1|||
149051508|NCT03143153|537671661|FG001|Pre-Treatment|Other Reasons|2|||
149051509|NCT03143153|537671662|FG002|Pre-Treatment|Other Reasons|1|||
149051510|NCT03143153|537671660|FG000|Pre-Treatment|Disease Progression|1|||
149051511|NCT03143153|537671661|FG001|Pre-Treatment|Disease Progression|1|||
149051512|NCT03143153|537671662|FG002|Pre-Treatment|Disease Progression|2|||
149051513|NCT03143153|537671660|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
149051514|NCT03143153|537671661|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
149051515|NCT03143153|537671662|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
149051516|NCT03143153|537671660|FG000|Treatment|Disease progression|174|||
149051517|NCT03143153|537671661|FG001|Treatment|Disease progression|184|||
149051518|NCT03143153|537671662|FG002|Treatment|Disease progression|193|||
149051519|NCT03143153|537671660|FG000|Treatment|Study drug toxicity|59|||
149051520|NCT03143153|537671661|FG001|Treatment|Study drug toxicity|33|||
149051521|NCT03143153|537671662|FG002|Treatment|Study drug toxicity|40|||
149051522|NCT03143153|537671660|FG000|Treatment|Death|5|||
149051523|NCT03143153|537671661|FG001|Treatment|Death|3|||
149051524|NCT03143153|537671662|FG002|Treatment|Death|4|||
149051525|NCT03143153|537671660|FG000|Treatment|Adverse event unrelated to study drug|19|||
149051526|NCT03143153|537671661|FG001|Treatment|Adverse event unrelated to study drug|28|||
148887795|NCT01367834|537067978|FG001|Overall Study|Withdrawal by Subject|2|||
148887796|NCT01367834|537067977|FG000|Overall Study|Study was ended.|0|||
148887797|NCT01367834|537067978|FG001|Overall Study|Study was ended.|1|||
149051527|NCT03143153|537671662|FG002|Treatment|Adverse event unrelated to study drug|12|||
148887798|NCT01814527|537067985|FG000|Overall Study|RTP greater than 30 days|6|||
148887799|NCT01814527|537067986|FG001|Overall Study|RTP greater than 30 days|1|||
149051528|NCT03143153|537671660|FG000|Treatment|Participant request to discontinue study treatment|13|||
149051529|NCT03143153|537671661|FG001|Treatment|Participant request to discontinue study treatment|15|||
149051530|NCT03143153|537671662|FG002|Treatment|Participant request to discontinue study treatment|20|||
149051531|NCT03143153|537671660|FG000|Treatment|Participant withdrew consent|3|||
149051532|NCT03143153|537671661|FG001|Treatment|Participant withdrew consent|4|||
149051533|NCT03143153|537671662|FG002|Treatment|Participant withdrew consent|12|||
149051534|NCT03143153|537671660|FG000|Treatment|Pregnancy|1|||
149051535|NCT03143153|537671661|FG001|Treatment|Pregnancy|0|||
149051536|NCT03143153|537671662|FG002|Treatment|Pregnancy|0|||
149051537|NCT03143153|537671660|FG000|Treatment|Maximum clinical benefit|1|||
149051538|NCT03143153|537671661|FG001|Treatment|Maximum clinical benefit|3|||
149051539|NCT03143153|537671662|FG002|Treatment|Maximum clinical benefit|4|||
149051540|NCT03143153|537671660|FG000|Treatment|Completed treatment as per Protocol|13|||
149051541|NCT03143153|537671661|FG001|Treatment|Completed treatment as per Protocol|8|||
149051542|NCT03143153|537671662|FG002|Treatment|Completed treatment as per Protocol|0|||
149051543|NCT03143153|537671660|FG000|Treatment|Other reasons|12|||
149051544|NCT03143153|537671661|FG001|Treatment|Other reasons|7|||
149051545|NCT03143153|537671662|FG002|Treatment|Other reasons|15|||
149051546|NCT03143153|537671660|FG000|Treatment|Not reported|1|||
149051547|NCT03143153|537671661|FG001|Treatment|Not reported|0|||
149051548|NCT03143153|537671662|FG002|Treatment|Not reported|0|||
149051549|NCT04237298|537671663|FG000|Overall Study|Lost to Follow-up|4|||
149051550|NCT04237298|537671664|FG001|Overall Study|Lost to Follow-up|5|||
149051551|NCT02530671|537671665|FG000|Overall Study|Lost to Follow-up|2|||
149051552|NCT02530671|537671666|FG001|Overall Study|Lost to Follow-up|0|||
149051553|NCT02530671|537671665|FG000|Overall Study|Withdrawal by Subject|1|||
149051554|NCT02530671|537671666|FG001|Overall Study|Withdrawal by Subject|0|||
149051555|NCT04541706|537671678|FG000|Overall Study|Withdrawal by Subject|3|||
149051556|NCT04541706|537671678|FG000|Overall Study|Progressive disease|33|||
149051557|NCT04541706|537671678|FG000|Overall Study|Physician Decision|1|||
149051558|NCT04541706|537671678|FG000|Overall Study|Lost to Follow-up|2|||
149051559|NCT04541706|537671678|FG000|Overall Study|Death|5|||
149051560|NCT04541706|537671678|FG000|Overall Study|Adverse Event|1|||
149051561|NCT01566695|537671681|FG000|Overall Study|Lack of Efficacy|1|||
149051562|NCT01566695|537671682|FG001|Overall Study|Lack of Efficacy|0|||
149051563|NCT01566695|537671681|FG000|Overall Study|Adverse Event|3|||
149051564|NCT01566695|537671682|FG001|Overall Study|Adverse Event|0|||
149051565|NCT01566695|537671681|FG000|Overall Study|Death|79|||
149051566|NCT01566695|537671682|FG001|Overall Study|Death|86|||
149051567|NCT01566695|537671681|FG000|Overall Study|Withdrawal by Subject|13|||
149051568|NCT01566695|537671682|FG001|Overall Study|Withdrawal by Subject|12|||
149051569|NCT01566695|537671681|FG000|Overall Study|Lost to Follow-up|0|||
149051570|NCT01566695|537671682|FG001|Overall Study|Lost to Follow-up|3|||
149051571|NCT01566695|537671681|FG000|Overall Study|Other reasons|11|||
149051572|NCT01566695|537671682|FG001|Overall Study|Other reasons|8|||
149051573|NCT03763708|537671684|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
149051574|NCT03763708|537671685|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051575|NCT03763708|537671686|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051576|NCT03763708|537671687|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051577|NCT03763708|537671688|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051578|NCT03763708|537671689|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051579|NCT03763708|537671690|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051580|NCT03763708|537671691|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051581|NCT03763708|537671692|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
149051582|NCT03763708|537671684|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051583|NCT03763708|537671685|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051584|NCT03763708|537671686|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
149051585|NCT03763708|537671687|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051586|NCT03763708|537671688|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051587|NCT03763708|537671689|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051588|NCT03763708|537671690|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051589|NCT03763708|537671691|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051590|NCT03763708|537671692|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
149051591|NCT03763708|537671684|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
149051592|NCT03763708|537671685|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
149051593|NCT03763708|537671686|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
149051594|NCT03763708|537671687|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
149051595|NCT03763708|537671688|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
149051596|NCT03763708|537671689|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
149051597|NCT03763708|537671690|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
149051598|NCT03763708|537671691|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
148887800|NCT03571204|537067987|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
148887801|NCT03571204|537067988|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
148887802|NCT03571204|537067989|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
148887803|NCT03571204|537067987|FG000|Overall Study|Physician Decision|0|||
148887804|NCT03571204|537067988|FG001|Overall Study|Physician Decision|1|||
148887805|NCT03571204|537067989|FG002|Overall Study|Physician Decision|0|||
149051599|NCT03763708|537671692|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
148887806|NCT00857285|537067992|FG000|Overall Study|Adverse Event|4|||
149051600|NCT03763708|537671684|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051601|NCT03763708|537671685|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051602|NCT03763708|537671686|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051603|NCT03763708|537671687|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051604|NCT03763708|537671688|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
149051605|NCT03763708|537671689|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051606|NCT03763708|537671690|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051607|NCT03763708|537671691|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051608|NCT03763708|537671692|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
149051609|NCT03763708|537671684|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051610|NCT03763708|537671685|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051611|NCT03763708|537671686|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051612|NCT03763708|537671687|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051613|NCT03763708|537671688|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051614|NCT03763708|537671689|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
149051615|NCT03763708|537671690|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051616|NCT03763708|537671691|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051617|NCT03763708|537671692|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
149051618|NCT03763708|537671684|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051619|NCT03763708|537671685|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051620|NCT03763708|537671686|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051621|NCT03763708|537671687|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051622|NCT03763708|537671688|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051623|NCT03763708|537671689|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051624|NCT03763708|537671690|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
149051625|NCT03763708|537671691|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051626|NCT03763708|537671692|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
149051627|NCT03763708|537671684|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
149051628|NCT03763708|537671685|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
149051629|NCT03763708|537671686|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
149051630|NCT03763708|537671687|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
149051631|NCT03763708|537671688|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
149051632|NCT03763708|537671689|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
149051633|NCT03763708|537671690|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
149051634|NCT03763708|537671691|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
149051635|NCT03763708|537671692|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
149051636|NCT03763708|537671684|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
149051637|NCT03763708|537671685|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
149051638|NCT03763708|537671686|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
149051639|NCT03763708|537671687|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
149051640|NCT03763708|537671688|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
149051641|NCT03763708|537671689|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
149051642|NCT03763708|537671690|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
149051643|NCT03763708|537671691|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
149051644|NCT03763708|537671692|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
149051645|NCT03763708|537671684|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
149051646|NCT03763708|537671685|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
149051647|NCT03763708|537671686|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
149051648|NCT03763708|537671687|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
149051649|NCT03763708|537671688|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
149051650|NCT03763708|537671689|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
149051651|NCT03763708|537671690|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
149051652|NCT03763708|537671691|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
149051653|NCT03763708|537671692|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
149051654|NCT05470400|537671693|FG000|Overall Study|Lost to Follow-up|0|||
149051655|NCT05470400|537671694|FG001|Overall Study|Lost to Follow-up|0|||
149051656|NCT05470400|537671695|FG002|Overall Study|Lost to Follow-up|0|||
149051657|NCT05470400|537671696|FG003|Overall Study|Lost to Follow-up|0|||
149051658|NCT05470400|537671697|FG004|Overall Study|Lost to Follow-up|0|||
149051659|NCT05470400|537671698|FG005|Overall Study|Lost to Follow-up|0|||
149051660|NCT05470400|537671699|FG006|Overall Study|Lost to Follow-up|0|||
149051661|NCT05470400|537671700|FG007|Overall Study|Lost to Follow-up|1|||
149051662|NCT05470400|537671693|FG000|Overall Study|Withdrawal by Subject|1|||
149051663|NCT05470400|537671694|FG001|Overall Study|Withdrawal by Subject|0|||
149051664|NCT05470400|537671695|FG002|Overall Study|Withdrawal by Subject|0|||
149051665|NCT05470400|537671696|FG003|Overall Study|Withdrawal by Subject|0|||
149051666|NCT05470400|537671697|FG004|Overall Study|Withdrawal by Subject|0|||
149051667|NCT05470400|537671698|FG005|Overall Study|Withdrawal by Subject|1|||
149051668|NCT05470400|537671699|FG006|Overall Study|Withdrawal by Subject|0|||
149051669|NCT05470400|537671700|FG007|Overall Study|Withdrawal by Subject|2|||
149051670|NCT04784559|537671701|FG000|Overall Study|Withdrawal by Subject|3|||
149051671|NCT04784559|537671702|FG001|Overall Study|Withdrawal by Subject|2|||
149051672|NCT04784559|537671703|FG002|Overall Study|Withdrawal by Subject|1|||
149051673|NCT04784559|537671701|FG000|Overall Study|Death|2|||
149051674|NCT04784559|537671702|FG001|Overall Study|Death|1|||
149051675|NCT04784559|537671703|FG002|Overall Study|Death|2|||
149051676|NCT04784559|537671701|FG000|Overall Study|Lost to Follow-up|0|||
149051677|NCT04784559|537671702|FG001|Overall Study|Lost to Follow-up|0|||
149051678|NCT04784559|537671703|FG002|Overall Study|Lost to Follow-up|2|||
149051679|NCT04784559|537671701|FG000|Overall Study|Participant worsened, PI decision|1|||
149051680|NCT04784559|537671702|FG001|Overall Study|Participant worsened, PI decision|0|||
149051681|NCT04784559|537671703|FG002|Overall Study|Participant worsened, PI decision|0|||
149051682|NCT04784559|537671701|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
149051683|NCT04784559|537671702|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
149051684|NCT04784559|537671703|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
149051685|NCT04784559|537671701|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
149051686|NCT04784559|537671702|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
149051687|NCT04784559|537671703|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
149051688|NCT04784559|537671701|FG000|Overall Study|Did not meet all inclusion criteria|0|||
149051689|NCT04784559|537671702|FG001|Overall Study|Did not meet all inclusion criteria|1|||
149051690|NCT04784559|537671703|FG002|Overall Study|Did not meet all inclusion criteria|0|||
149051691|NCT04784559|537671701|FG000|Overall Study|The participant was transferred to IRCU|0|||
149051692|NCT04784559|537671702|FG001|Overall Study|The participant was transferred to IRCU|1|||
149051693|NCT04784559|537671703|FG002|Overall Study|The participant was transferred to IRCU|0|||
149051694|NCT04784559|537671701|FG000|Overall Study|SAE|0|||
149051695|NCT04784559|537671702|FG001|Overall Study|SAE|1|||
149051696|NCT04784559|537671703|FG002|Overall Study|SAE|0|||
149051697|NCT04784559|537671701|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
149051698|NCT04784559|537671702|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
149051699|NCT04784559|537671703|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
149051700|NCT05323084|537671705|FG000|Period 2 - Washout|Lost to Follow-up|0|||
149051701|NCT05323084|537671706|FG001|Period 2 - Washout|Lost to Follow-up|1|||
149051702|NCT02907099|537671709|FG000|Overall Study|Adverse Event|1|||
149051703|NCT02907099|537671709|FG000|Overall Study|Withdrawal by Subject|2|||
149051704|NCT02907099|537671709|FG000|Overall Study|Screen Fail|2|||
149051705|NCT05569252|537671710|FG000|Overall Study|Adverse event (central vision loss)|1|||
149051706|NCT05569252|537671711|FG001|Overall Study|Adverse event (central vision loss)|0|||
149051707|NCT05569252|537671712|FG002|Overall Study|Adverse event (central vision loss)|0|||
149051708|NCT05569252|537671713|FG003|Overall Study|Adverse event (central vision loss)|0|||
149051709|NCT04831216|537671714|FG000|Overall Study|Lost to Follow-up|32|||
149051710|NCT04739956|537671715|FG000|Overall Study|Withdrawal by Subject|1|||
149051711|NCT04739956|537671716|FG001|Overall Study|Withdrawal by Subject|1|||
149051712|NCT05371652|537671717|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
149051713|NCT05371652|537671717|FG000|Overall Study|Withdrawal by Subject|12|||
149051714|NCT05371652|537671717|FG000|Overall Study|Adverse Event|1|||
149051715|NCT05371652|537671717|FG000|Overall Study|Other|11|||
149051716|NCT03978871|537671718|FG000|Overall Study|Lost to Follow-up|11|||
149051717|NCT03978871|537671719|FG001|Overall Study|Lost to Follow-up|12|||
149051718|NCT01361711|537671721|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
149051719|NCT01361711|537671721|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
149051720|NCT01361711|537671721|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
149051721|NCT01361711|537671721|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
149051722|NCT01361711|537671721|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
149051723|NCT01361711|537671721|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
149051724|NCT01361711|537671721|FG000|Completed Week 18 of Treatment|Other|9|||
149051725|NCT01361711|537671721|FG000|10 Year Follow-up|Still in follow-up|22|||
149051726|NCT01361711|537671721|FG000|10 Year Follow-up|Death|7|||
149051727|NCT01361711|537671721|FG000|10 Year Follow-up|Developed new cancer|1|||
149051728|NCT01361711|537671721|FG000|10 Year Follow-up|Lost to Follow-up|2|||
149051729|NCT01361711|537671721|FG000|10 Year Follow-up|New treatment started|6|||
149051730|NCT01361711|537671721|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
149051731|NCT01361711|537671721|FG000|10 Year Follow-up|Progressive Disease|1|||
149051732|NCT04083235|537673126|FG000|Overall Study|Death|252|||
149051733|NCT04083235|537673127|FG001|Overall Study|Death|277|||
149051734|NCT04083235|537673126|FG000|Overall Study|Withdrawal by Subject|13|||
149051735|NCT04083235|537673127|FG001|Overall Study|Withdrawal by Subject|17|||
149051736|NCT04083235|537673126|FG000|Overall Study|Lost to Follow-up|1|||
149051737|NCT04083235|537673127|FG001|Overall Study|Lost to Follow-up|1|||
149051738|NCT04083235|537673126|FG000|Overall Study|Does not meet entry criteria|1|||
149051739|NCT04083235|537673127|FG001|Overall Study|Does not meet entry criteria|0|||
149051740|NCT04083235|537673126|FG000|Overall Study|Did not receive treatment|13|||
149051741|NCT04083235|537673127|FG001|Overall Study|Did not receive treatment|8|||
149051742|NCT04083235|537673126|FG000|Overall Study|Ongoing at the time of DCO|44|||
149051743|NCT04083235|537673127|FG001|Overall Study|Ongoing at the time of DCO|7|||
149051744|NCT00920621|537673132|FG000|Overall Study|Lost to Follow-up|16|||
149051745|NCT00920621|537673133|FG001|Overall Study|Lost to Follow-up|17|||
149051746|NCT00920621|537673134|FG002|Overall Study|Lost to Follow-up|19|||
149051747|NCT00920621|537673135|FG003|Overall Study|Lost to Follow-up|21|||
149051748|NCT00920621|537673132|FG000|Overall Study|Fetal/neonatal deaths|16|||
149051749|NCT00920621|537673133|FG001|Overall Study|Fetal/neonatal deaths|14|||
149051750|NCT00920621|537673134|FG002|Overall Study|Fetal/neonatal deaths|16|||
149051751|NCT00920621|537673135|FG003|Overall Study|Fetal/neonatal deaths|14|||
149051752|NCT00920621|537673132|FG000|Overall Study|Blood sample not collected|22|||
148887807|NCT00857285|537067993|FG001|Overall Study|Adverse Event|2|||
148887808|NCT00857285|537067992|FG000|Overall Study|Lack of Efficacy|0|||
148887809|NCT00857285|537067993|FG001|Overall Study|Lack of Efficacy|2|||
148887810|NCT00857285|537067992|FG000|Overall Study|Protocol Violation|3|||
148887811|NCT00857285|537067993|FG001|Overall Study|Protocol Violation|1|||
148887812|NCT00857285|537067992|FG000|Overall Study|Withdrawal by Subject|4|||
148887813|NCT00857285|537067993|FG001|Overall Study|Withdrawal by Subject|0|||
148887814|NCT00857285|537067992|FG000|Overall Study|Randomization criteria not met|1|||
148887815|NCT00857285|537067993|FG001|Overall Study|Randomization criteria not met|1|||
148887816|NCT03081884|537067994|FG000|Overall Study|deferred prostate cancer treatment|1|||
148887817|NCT03081884|537067994|FG000|Overall Study|metastasis managed with systemic therapy|3|||
148887818|NCT03948334|537067995|FG000|Overall Study|Adverse Event|1|||
148887819|NCT03948334|537067996|FG001|Overall Study|Adverse Event|4|||
148887820|NCT03948334|537067995|FG000|Overall Study|Lack of Efficacy|2|||
148887821|NCT03948334|537067996|FG001|Overall Study|Lack of Efficacy|0|||
148887822|NCT03948334|537067995|FG000|Overall Study|Lost to Follow-up|1|||
148887823|NCT03948334|537067996|FG001|Overall Study|Lost to Follow-up|0|||
148887824|NCT03948334|537067995|FG000|Overall Study|Physician Decision|1|||
149051753|NCT00920621|537673133|FG001|Overall Study|Blood sample not collected|14|||
149051754|NCT00920621|537673134|FG002|Overall Study|Blood sample not collected|0|||
149051755|NCT00920621|537673135|FG003|Overall Study|Blood sample not collected|0|||
149051756|NCT01426425|537673136|FG000|Overall Study|Exited prior to EP study|22|||
149051757|NCT01426425|537673136|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
149051758|NCT01426425|537673136|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
149051759|NCT04956861|537673137|FG000|Overall Study|Withdrawal by Subject|4|||
149051760|NCT04956861|537673138|FG001|Overall Study|Withdrawal by Subject|4|||
149051761|NCT04956861|537673139|FG002|Overall Study|Withdrawal by Subject|2|||
149051762|NCT04956861|537673137|FG000|Overall Study|Physician Decision|4|||
149051763|NCT04956861|537673138|FG001|Overall Study|Physician Decision|5|||
149051764|NCT04956861|537673139|FG002|Overall Study|Physician Decision|1|||
149051765|NCT04556656|537673140|FG000|Overall Study|Withdrawal by Subject|14|||
149051766|NCT04556656|537673141|FG001|Overall Study|Withdrawal by Subject|12|||
149051767|NCT04556656|537673140|FG000|Overall Study|Physician Decision|1|||
149051768|NCT04556656|537673141|FG001|Overall Study|Physician Decision|0|||
149051769|NCT04556656|537673140|FG000|Overall Study|Adverse Event|4|||
149051770|NCT04556656|537673141|FG001|Overall Study|Adverse Event|7|||
149051771|NCT04556656|537673140|FG000|Overall Study|Death|4|||
149051772|NCT04556656|537673141|FG001|Overall Study|Death|0|||
149051773|NCT04556656|537673140|FG000|Overall Study|Lost to Follow-up|3|||
149051774|NCT04556656|537673141|FG001|Overall Study|Lost to Follow-up|2|||
149051775|NCT04556656|537673140|FG000|Overall Study|Not further specified|2|||
149051776|NCT04556656|537673141|FG001|Overall Study|Not further specified|1|||
149051777|NCT05563246|537673149|FG000|Overall Study|Withdrawal by Subject|1|||
149051778|NCT05563246|537673150|FG001|Overall Study|Withdrawal by Subject|2|||
149051779|NCT05563246|537673151|FG002|Overall Study|Withdrawal by Subject|0|||
149051780|NCT05563246|537673152|FG003|Overall Study|Withdrawal by Subject|0|||
149051781|NCT05563246|537673149|FG000|Overall Study|Protocol Deviation|0|||
149051782|NCT05563246|537673150|FG001|Overall Study|Protocol Deviation|1|||
149051783|NCT05563246|537673151|FG002|Overall Study|Protocol Deviation|0|||
149051784|NCT05563246|537673152|FG003|Overall Study|Protocol Deviation|0|||
149051785|NCT05563246|537673149|FG000|Overall Study|Physician Decision|0|||
149051786|NCT05563246|537673150|FG001|Overall Study|Physician Decision|1|||
149051787|NCT05563246|537673151|FG002|Overall Study|Physician Decision|0|||
149051788|NCT05563246|537673152|FG003|Overall Study|Physician Decision|0|||
149051789|NCT05563246|537673149|FG000|Overall Study|Adverse Event|0|||
149051790|NCT05563246|537673150|FG001|Overall Study|Adverse Event|0|||
149051791|NCT05563246|537673151|FG002|Overall Study|Adverse Event|2|||
149051792|NCT05563246|537673152|FG003|Overall Study|Adverse Event|0|||
149051793|NCT05563246|537673149|FG000|Overall Study|Lost to Follow-up|0|||
149051794|NCT05563246|537673150|FG001|Overall Study|Lost to Follow-up|0|||
149051795|NCT05563246|537673151|FG002|Overall Study|Lost to Follow-up|1|||
148887825|NCT03948334|537067996|FG001|Overall Study|Physician Decision|0|||
148887826|NCT03948334|537067995|FG000|Overall Study|Pregnancy|0|||
149051796|NCT05563246|537673152|FG003|Overall Study|Lost to Follow-up|0|||
149051797|NCT01416831|537673155|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
149051798|NCT01416831|537673156|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
149051799|NCT03138512|537673159|FG000|Randomization|Participants withdrew consent|0|||
149051800|NCT03138512|537673160|FG001|Randomization|Participants withdrew consent|1|||
149051801|NCT03138512|537673161|FG002|Randomization|Participants withdrew consent|1|||
149051802|NCT03138512|537673162|FG003|Randomization|Participants withdrew consent|0|||
149051803|NCT03138512|537673163|FG004|Randomization|Participants withdrew consent|0|||
148887827|NCT03948334|537067996|FG001|Overall Study|Pregnancy|1|||
148887828|NCT03948334|537067995|FG000|Overall Study|Protocol Deviation|1|||
149051804|NCT03138512|537673159|FG000|Randomization|Participant no longer meets study criteria|0|||
149051805|NCT03138512|537673160|FG001|Randomization|Participant no longer meets study criteria|3|||
149051806|NCT03138512|537673161|FG002|Randomization|Participant no longer meets study criteria|1|||
149051807|NCT03138512|537673162|FG003|Randomization|Participant no longer meets study criteria|1|||
149051808|NCT03138512|537673163|FG004|Randomization|Participant no longer meets study criteria|3|||
149051809|NCT03138512|537673159|FG000|Randomization|Other reasons|1|||
149051810|NCT03138512|537673160|FG001|Randomization|Other reasons|0|||
149051811|NCT03138512|537673161|FG002|Randomization|Other reasons|0|||
149051812|NCT03138512|537673162|FG003|Randomization|Other reasons|0|||
149051813|NCT03138512|537673163|FG004|Randomization|Other reasons|0|||
149051814|NCT03138512|537673159|FG000|Treatment Part A|Disease recurrence|10|||
149051815|NCT03138512|537673160|FG001|Treatment Part A|Disease recurrence|20|||
149051816|NCT03138512|537673161|FG002|Treatment Part A|Disease recurrence|0|||
149051817|NCT03138512|537673162|FG003|Treatment Part A|Disease recurrence|0|||
149051818|NCT03138512|537673163|FG004|Treatment Part A|Disease recurrence|0|||
149051819|NCT03138512|537673159|FG000|Treatment Part A|Study Drug Toxicity|132|||
149051820|NCT03138512|537673160|FG001|Treatment Part A|Study Drug Toxicity|5|||
149051821|NCT03138512|537673161|FG002|Treatment Part A|Study Drug Toxicity|0|||
149051822|NCT03138512|537673162|FG003|Treatment Part A|Study Drug Toxicity|0|||
149051823|NCT03138512|537673163|FG004|Treatment Part A|Study Drug Toxicity|0|||
149051824|NCT03138512|537673159|FG000|Treatment Part A|Death|1|||
149051825|NCT03138512|537673160|FG001|Treatment Part A|Death|0|||
149051826|NCT03138512|537673161|FG002|Treatment Part A|Death|0|||
149051827|NCT03138512|537673162|FG003|Treatment Part A|Death|0|||
149051828|NCT03138512|537673163|FG004|Treatment Part A|Death|0|||
149051829|NCT03138512|537673159|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
149051830|NCT03138512|537673160|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
149051831|NCT03138512|537673161|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
149051832|NCT03138512|537673162|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
149051833|NCT03138512|537673163|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
149051834|NCT03138512|537673159|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
149051835|NCT03138512|537673160|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
149051836|NCT03138512|537673161|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
149051837|NCT03138512|537673162|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
149051838|NCT03138512|537673163|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
149051839|NCT03138512|537673159|FG000|Treatment Part A|Participant withdrew consent|2|||
149051840|NCT03138512|537673160|FG001|Treatment Part A|Participant withdrew consent|4|||
149051841|NCT03138512|537673161|FG002|Treatment Part A|Participant withdrew consent|0|||
149051842|NCT03138512|537673162|FG003|Treatment Part A|Participant withdrew consent|0|||
149051843|NCT03138512|537673163|FG004|Treatment Part A|Participant withdrew consent|0|||
149051844|NCT03138512|537673159|FG000|Treatment Part A|Lost to Follow-up|0|||
149051845|NCT03138512|537673160|FG001|Treatment Part A|Lost to Follow-up|1|||
149051846|NCT03138512|537673161|FG002|Treatment Part A|Lost to Follow-up|0|||
149051847|NCT03138512|537673162|FG003|Treatment Part A|Lost to Follow-up|0|||
149051848|NCT03138512|537673163|FG004|Treatment Part A|Lost to Follow-up|0|||
149051849|NCT03138512|537673159|FG000|Treatment Part A|Poor/non-compliance|1|||
149051850|NCT03138512|537673160|FG001|Treatment Part A|Poor/non-compliance|0|||
148887829|NCT03948334|537067996|FG001|Overall Study|Protocol Deviation|0|||
148887830|NCT03948334|537067995|FG000|Overall Study|Study terminated by Sponsor|50|||
148887831|NCT03948334|537067996|FG001|Overall Study|Study terminated by Sponsor|51|||
148887832|NCT03948334|537067995|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
148887833|NCT03948334|537067996|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
148887834|NCT05114473|537067997|FG000|Overall Study|Lost to Follow-up|2|||
148887835|NCT05114473|537067998|FG001|Overall Study|Lost to Follow-up|2|||
148887836|NCT05114473|537067999|FG002|Overall Study|Lost to Follow-up|0|||
148887837|NCT00279916|537068000|FG000|Overall Study|Withdrawal by Subject|4|||
148887838|NCT00279916|537068001|FG001|Overall Study|Withdrawal by Subject|3|||
148887839|NCT00279916|537068000|FG000|Overall Study|Lost to Follow-up|3|||
148887840|NCT00279916|537068001|FG001|Overall Study|Lost to Follow-up|2|||
148887841|NCT01807598|537068002|FG000|Overall Study|Withdrawal by Subject|4|||
148887842|NCT01807598|537068002|FG000|Overall Study|Adverse Event|1|||
148887843|NCT01807598|537068002|FG000|Overall Study|Other Physician Decision|1|||
148887844|NCT00731679|537068003|FG000|Overall Study|Adverse Event|7|||
148887845|NCT00731679|537068004|FG001|Overall Study|Adverse Event|8|||
148887846|NCT00731679|537068003|FG000|Overall Study|Withdrawal by Subject|8|||
148887847|NCT00731679|537068004|FG001|Overall Study|Withdrawal by Subject|8|||
148887848|NCT00731679|537068003|FG000|Overall Study|Lost to Follow-up|7|||
148887849|NCT00731679|537068004|FG001|Overall Study|Lost to Follow-up|8|||
148887850|NCT00731679|537068003|FG000|Overall Study|Noncompliance|0|||
148887851|NCT00731679|537068004|FG001|Overall Study|Noncompliance|1|||
148887852|NCT00731679|537068003|FG000|Overall Study|Pregnancy|0|||
148887853|NCT00731679|537068004|FG001|Overall Study|Pregnancy|1|||
148887854|NCT03089580|537068008|FG000|Overall Study|Lost to Follow-up|2|||
148887855|NCT01288989|537068009|FG000|Overall Study|Death|0|||
148887856|NCT01288989|537068010|FG001|Overall Study|Death|0|||
148887857|NCT01288989|537068011|FG002|Overall Study|Death|0|||
149051851|NCT03138512|537673161|FG002|Treatment Part A|Poor/non-compliance|0|||
149051852|NCT03138512|537673162|FG003|Treatment Part A|Poor/non-compliance|0|||
149051853|NCT03138512|537673163|FG004|Treatment Part A|Poor/non-compliance|0|||
149051854|NCT03138512|537673159|FG000|Treatment Part A|Pregnancy|0|||
149051855|NCT03138512|537673160|FG001|Treatment Part A|Pregnancy|1|||
149051856|NCT03138512|537673161|FG002|Treatment Part A|Pregnancy|0|||
149051857|NCT03138512|537673162|FG003|Treatment Part A|Pregnancy|0|||
149051858|NCT03138512|537673163|FG004|Treatment Part A|Pregnancy|0|||
149051859|NCT03138512|537673159|FG000|Treatment Part A|Other reasons|11|||
149051860|NCT03138512|537673160|FG001|Treatment Part A|Other reasons|8|||
149051861|NCT03138512|537673161|FG002|Treatment Part A|Other reasons|0|||
149051862|NCT03138512|537673162|FG003|Treatment Part A|Other reasons|0|||
149051863|NCT03138512|537673163|FG004|Treatment Part A|Other reasons|0|||
149051864|NCT03138512|537673159|FG000|Treatment Part B|Disease recurrence|0|||
149051865|NCT03138512|537673160|FG001|Treatment Part B|Disease recurrence|0|||
149051866|NCT03138512|537673161|FG002|Treatment Part B|Disease recurrence|6|||
149051867|NCT03138512|537673162|FG003|Treatment Part B|Disease recurrence|12|||
149051868|NCT03138512|537673163|FG004|Treatment Part B|Disease recurrence|10|||
149051869|NCT03138512|537673159|FG000|Treatment Part B|Study drug toxicity|0|||
149051870|NCT03138512|537673160|FG001|Treatment Part B|Study drug toxicity|0|||
149051871|NCT03138512|537673161|FG002|Treatment Part B|Study drug toxicity|63|||
149051872|NCT03138512|537673162|FG003|Treatment Part B|Study drug toxicity|3|||
149051873|NCT03138512|537673163|FG004|Treatment Part B|Study drug toxicity|45|||
149051874|NCT03138512|537673159|FG000|Treatment Part B|Death|0|||
149051875|NCT03138512|537673160|FG001|Treatment Part B|Death|0|||
149051876|NCT03138512|537673161|FG002|Treatment Part B|Death|1|||
149051877|NCT03138512|537673162|FG003|Treatment Part B|Death|0|||
149051878|NCT03138512|537673163|FG004|Treatment Part B|Death|0|||
149051879|NCT03138512|537673159|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
149051880|NCT03138512|537673160|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
149051881|NCT03138512|537673161|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
149051882|NCT03138512|537673162|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
149051883|NCT03138512|537673163|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
149051884|NCT03138512|537673159|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
149051885|NCT03138512|537673160|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
149051886|NCT03138512|537673161|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
149051887|NCT03138512|537673162|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
149051888|NCT03138512|537673163|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
149051889|NCT03138512|537673159|FG000|Treatment Part B|Participant withdrew consent|0|||
149051890|NCT03138512|537673160|FG001|Treatment Part B|Participant withdrew consent|0|||
149051891|NCT03138512|537673161|FG002|Treatment Part B|Participant withdrew consent|1|||
149051892|NCT03138512|537673162|FG003|Treatment Part B|Participant withdrew consent|1|||
149051893|NCT03138512|537673163|FG004|Treatment Part B|Participant withdrew consent|2|||
149051894|NCT03138512|537673159|FG000|Treatment Part B|Lost to Follow-up|0|||
149051895|NCT03138512|537673160|FG001|Treatment Part B|Lost to Follow-up|0|||
149051896|NCT03138512|537673161|FG002|Treatment Part B|Lost to Follow-up|0|||
149051897|NCT03138512|537673162|FG003|Treatment Part B|Lost to Follow-up|1|||
149051898|NCT03138512|537673163|FG004|Treatment Part B|Lost to Follow-up|0|||
149051899|NCT03138512|537673159|FG000|Treatment Part B|Poor/non-compliance|0|||
149051900|NCT03138512|537673160|FG001|Treatment Part B|Poor/non-compliance|0|||
149051901|NCT03138512|537673161|FG002|Treatment Part B|Poor/non-compliance|1|||
149051902|NCT03138512|537673162|FG003|Treatment Part B|Poor/non-compliance|1|||
149051903|NCT03138512|537673163|FG004|Treatment Part B|Poor/non-compliance|1|||
149051904|NCT03138512|537673159|FG000|Treatment Part B|Other reasons|0|||
149051905|NCT03138512|537673160|FG001|Treatment Part B|Other reasons|0|||
149051906|NCT03138512|537673161|FG002|Treatment Part B|Other reasons|3|||
149051907|NCT03138512|537673162|FG003|Treatment Part B|Other reasons|1|||
149051908|NCT03138512|537673163|FG004|Treatment Part B|Other reasons|5|||
149051909|NCT04382404|537673165|FG000|Overall Study|Adverse Event|1|||
149051910|NCT04382404|537673165|FG000|Overall Study|Lost to Follow-up|2|||
149051911|NCT04294225|537673171|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
149051912|NCT04294225|537673171|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
149051913|NCT04294225|537673171|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
149051914|NCT04294225|537673171|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
149051915|NCT04294225|537673171|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
149051916|NCT01809691|537673173|FG000|Overall Study|Currently on Treatment|192|||
149051917|NCT01809691|537673174|FG001|Overall Study|Currently on Treatment|100|||
149051918|NCT01809691|537673173|FG000|Overall Study|No Protocol Treatment|10|||
149051919|NCT01809691|537673174|FG001|Overall Study|No Protocol Treatment|11|||
149051920|NCT01809691|537673173|FG000|Overall Study|Adverse Event|80|||
149051921|NCT01809691|537673174|FG001|Overall Study|Adverse Event|21|||
149051922|NCT01809691|537673173|FG000|Overall Study|Disease Progression|226|||
149051923|NCT01809691|537673174|FG001|Overall Study|Disease Progression|372|||
149051924|NCT01809691|537673173|FG000|Overall Study|Death|26|||
149051925|NCT01809691|537673174|FG001|Overall Study|Death|13|||
149051926|NCT01809691|537673173|FG000|Overall Study|Participant Refusal|70|||
149051927|NCT01809691|537673174|FG001|Overall Study|Participant Refusal|72|||
149051928|NCT01809691|537673173|FG000|Overall Study|Other, Not Specified|34|||
149051929|NCT01809691|537673174|FG001|Overall Study|Other, Not Specified|52|||
149051930|NCT01580488|537673175|FG000|Overall Study|Withdrawal by Subject|1|||
149051931|NCT03336333|537673176|FG000|Overall Study|Remained on study at time of data cut-off|202|||
149051932|NCT03336333|537673177|FG001|Overall Study|Remained on study at time of data cut-off|219|||
149051933|NCT03336333|537673178|FG002|Overall Study|Remained on study at time of data cut-off|102|||
149051934|NCT03336333|537673176|FG000|Overall Study|Death|14|||
148887858|NCT01288989|537068012|FG003|Overall Study|Death|1|||
148887859|NCT01288989|537068013|FG004|Overall Study|Death|0|||
148887860|NCT01288989|537068009|FG000|Overall Study|Dose limiting toxicity|1|||
148887861|NCT01288989|537068010|FG001|Overall Study|Dose limiting toxicity|0|||
148887862|NCT01288989|537068011|FG002|Overall Study|Dose limiting toxicity|0|||
148887863|NCT01288989|537068012|FG003|Overall Study|Dose limiting toxicity|0|||
148887864|NCT01288989|537068013|FG004|Overall Study|Dose limiting toxicity|0|||
148887865|NCT01288989|537068009|FG000|Overall Study|Adverse Event|0|||
148887866|NCT01288989|537068010|FG001|Overall Study|Adverse Event|0|||
148887867|NCT01288989|537068011|FG002|Overall Study|Adverse Event|0|||
148887868|NCT01288989|537068012|FG003|Overall Study|Adverse Event|0|||
148887869|NCT01288989|537068013|FG004|Overall Study|Adverse Event|2|||
148887870|NCT01288989|537068009|FG000|Overall Study|Physician Decision|0|||
148887871|NCT01288989|537068010|FG001|Overall Study|Physician Decision|0|||
148887872|NCT01288989|537068011|FG002|Overall Study|Physician Decision|0|||
148887873|NCT01288989|537068012|FG003|Overall Study|Physician Decision|0|||
148887874|NCT01288989|537068013|FG004|Overall Study|Physician Decision|1|||
148887875|NCT01288989|537068009|FG000|Overall Study|Withdrawal by Subject|0|||
148887876|NCT01288989|537068010|FG001|Overall Study|Withdrawal by Subject|0|||
148887877|NCT01288989|537068011|FG002|Overall Study|Withdrawal by Subject|0|||
148887878|NCT01288989|537068012|FG003|Overall Study|Withdrawal by Subject|0|||
148887879|NCT01288989|537068013|FG004|Overall Study|Withdrawal by Subject|3|||
148887880|NCT05864586|537068016|FG000|Overall Study|Ineligible|4|||
148887881|NCT05864586|537068017|FG001|Overall Study|Ineligible|12|||
148887882|NCT05864586|537068016|FG000|Overall Study|Pregnancy|0|||
148887883|NCT05864586|537068017|FG001|Overall Study|Pregnancy|1|||
148887884|NCT05864586|537068016|FG000|Overall Study|Withdrawal by Subject|0|||
148887885|NCT05864586|537068017|FG001|Overall Study|Withdrawal by Subject|1|||
148887886|NCT05081219|537068018|FG000|Overall Study|Withdrawal by Subject|4|||
148887887|NCT05081219|537068019|FG001|Overall Study|Withdrawal by Subject|0|||
148887888|NCT05081219|537068020|FG002|Overall Study|Withdrawal by Subject|0|||
148887889|NCT05081219|537068021|FG003|Overall Study|Withdrawal by Subject|1|||
148887890|NCT04896593|537068025|FG000|Overall Study|Withdrawal by Subject|2|||
148887891|NCT04896593|537068025|FG000|Overall Study|Lost to Follow-up|1|||
148887892|NCT04896593|537068025|FG000|Overall Study|Did not complete onboarding|2|||
148887893|NCT00452790|537068026|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
148887894|NCT00452790|537068027|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
148887895|NCT00452790|537068026|FG000|Infant Series|Parent/legal guardian request|8|||
148887896|NCT00452790|537068027|FG001|Infant Series|Parent/legal guardian request|6|||
148887897|NCT00452790|537068026|FG000|Infant Series|Failed to return|4|||
148887898|NCT00452790|537068027|FG001|Infant Series|Failed to return|1|||
148887899|NCT00452790|537068026|FG000|Infant Series|Protocol Violation|1|||
148887900|NCT00452790|537068027|FG001|Infant Series|Protocol Violation|3|||
148887901|NCT00452790|537068026|FG000|Infant Series|Lost to Follow-up|2|||
148887902|NCT00452790|537068027|FG001|Infant Series|Lost to Follow-up|2|||
148887903|NCT00452790|537068026|FG000|Infant Series|Adverse Event|1|||
148887904|NCT00452790|537068027|FG001|Infant Series|Adverse Event|2|||
148887905|NCT00452790|537068026|FG000|Infant Series|Other reasons|1|||
148887906|NCT00452790|537068027|FG001|Infant Series|Other reasons|2|||
148887907|NCT00452790|537068026|FG000|Infant Series|Investigator request|0|||
148887908|NCT00452790|537068027|FG001|Infant Series|Investigator request|1|||
149051935|NCT03336333|537673177|FG001|Overall Study|Death|16|||
148887909|NCT00452790|537068026|FG000|Infant Series|Death|0|||
148887910|NCT00452790|537068027|FG001|Infant Series|Death|1|||
148887911|NCT00452790|537068026|FG000|After Infant Series|Investigator request|10|||
148887912|NCT00452790|537068027|FG001|After Infant Series|Investigator request|10|||
148887913|NCT00452790|537068026|FG000|After Infant Series|Adverse Event|4|||
148887914|NCT00452790|537068027|FG001|After Infant Series|Adverse Event|1|||
148887915|NCT00452790|537068026|FG000|After Infant Series|Parent/legal guardian request|1|||
149051936|NCT03336333|537673178|FG002|Overall Study|Death|8|||
149051937|NCT03336333|537673176|FG000|Overall Study|Withdrawal by Subject|16|||
149051938|NCT03336333|537673177|FG001|Overall Study|Withdrawal by Subject|5|||
149051939|NCT03336333|537673178|FG002|Overall Study|Withdrawal by Subject|1|||
148887916|NCT00452790|537068027|FG001|After Infant Series|Parent/legal guardian request|3|||
148887917|NCT00452790|537068026|FG000|After Infant Series|Lost to Follow-up|4|||
148887918|NCT00452790|537068027|FG001|After Infant Series|Lost to Follow-up|0|||
148887919|NCT00452790|537068026|FG000|After Infant Series|Failed to return|1|||
148887920|NCT00452790|537068027|FG001|After Infant Series|Failed to return|0|||
149051940|NCT03336333|537673176|FG000|Overall Study|Physician Decision|5|||
148887921|NCT00452790|537068026|FG000|After Infant Series|Other reasons|1|||
148887922|NCT00452790|537068027|FG001|After Infant Series|Other reasons|0|||
148887923|NCT00452790|537068026|FG000|Toddler Dose|Failed to return|0|||
148887924|NCT00452790|537068027|FG001|Toddler Dose|Failed to return|1|||
148887925|NCT00452790|537068026|FG000|Toddler Dose|Parent/legal guardian request|0|||
148887926|NCT00452790|537068027|FG001|Toddler Dose|Parent/legal guardian request|1|||
148887927|NCT02452424|537068030|FG000|Overall Study|Death|2|||
148887928|NCT02452424|537068031|FG001|Overall Study|Death|2|||
148887929|NCT02452424|537068032|FG002|Overall Study|Death|2|||
148887930|NCT02452424|537068033|FG003|Overall Study|Death|6|||
148887931|NCT02452424|537068034|FG004|Overall Study|Death|2|||
148887932|NCT02452424|537068035|FG005|Overall Study|Death|0|||
148887933|NCT02452424|537068036|FG006|Overall Study|Death|5|||
148887934|NCT02452424|537068037|FG007|Overall Study|Death|1|||
148887935|NCT02452424|537068038|FG008|Overall Study|Death|3|||
148887936|NCT02452424|537068039|FG009|Overall Study|Death|1|||
148887937|NCT02452424|537068040|FG010|Overall Study|Death|0|||
148887938|NCT02452424|537068030|FG000|Overall Study|Lost to Follow-up|0|||
148887939|NCT02452424|537068031|FG001|Overall Study|Lost to Follow-up|1|||
148887940|NCT02452424|537068032|FG002|Overall Study|Lost to Follow-up|1|||
148887941|NCT02452424|537068033|FG003|Overall Study|Lost to Follow-up|0|||
148887942|NCT02452424|537068034|FG004|Overall Study|Lost to Follow-up|0|||
148887943|NCT02452424|537068035|FG005|Overall Study|Lost to Follow-up|0|||
148887944|NCT02452424|537068036|FG006|Overall Study|Lost to Follow-up|0|||
148887945|NCT02452424|537068037|FG007|Overall Study|Lost to Follow-up|0|||
148887946|NCT02452424|537068038|FG008|Overall Study|Lost to Follow-up|0|||
148887947|NCT02452424|537068039|FG009|Overall Study|Lost to Follow-up|0|||
148887948|NCT02452424|537068040|FG010|Overall Study|Lost to Follow-up|0|||
148887949|NCT02452424|537068030|FG000|Overall Study|Withdrawal by Subject|0|||
148887950|NCT02452424|537068031|FG001|Overall Study|Withdrawal by Subject|0|||
148887951|NCT02452424|537068032|FG002|Overall Study|Withdrawal by Subject|3|||
148887952|NCT02452424|537068033|FG003|Overall Study|Withdrawal by Subject|2|||
149005300|NCT03430063|537497870|FG001|Overall Study|Progressive disease|2|||
149005301|NCT03430063|537497871|FG002|Overall Study|Progressive disease|1|||
149005302|NCT03430063|537497869|FG000|Overall Study|Other un-specified|1|||
149005303|NCT03430063|537497870|FG001|Overall Study|Other un-specified|1|||
149005304|NCT03430063|537497871|FG002|Overall Study|Other un-specified|0|||
149005305|NCT03430063|537497869|FG000|Overall Study|Randomized, but never treated|0|||
149005306|NCT03430063|537497870|FG001|Overall Study|Randomized, but never treated|0|||
149005307|NCT03430063|537497871|FG002|Overall Study|Randomized, but never treated|1|||
149005308|NCT03124199|537497872|FG000|Overall Study|Lost to Follow-up|4|||
149005309|NCT02798211|537497873|FG000|Period 1|Adverse Event|1|||
149005310|NCT02798211|537497874|FG001|Period 1|Adverse Event|1|||
149005311|NCT02798211|537497875|FG002|Period 1|Adverse Event|0|||
149005312|NCT02798211|537497876|FG003|Period 1|Adverse Event|0|||
149005313|NCT02798211|537497877|FG004|Period 1|Adverse Event|0|||
149005314|NCT02798211|537497878|FG005|Period 1|Adverse Event|0|||
149005315|NCT02798211|537497873|FG000|Period 1|Lost to Follow-up|2|||
149005316|NCT02798211|537497874|FG001|Period 1|Lost to Follow-up|1|||
149005317|NCT02798211|537497875|FG002|Period 1|Lost to Follow-up|0|||
149005318|NCT02798211|537497876|FG003|Period 1|Lost to Follow-up|0|||
149005319|NCT02798211|537497877|FG004|Period 1|Lost to Follow-up|0|||
149005320|NCT02798211|537497878|FG005|Period 1|Lost to Follow-up|0|||
149005321|NCT02798211|537497873|FG000|Period 1|Protocol Violation|0|||
149005322|NCT02798211|537497874|FG001|Period 1|Protocol Violation|0|||
149005323|NCT02798211|537497875|FG002|Period 1|Protocol Violation|2|||
149005324|NCT02798211|537497876|FG003|Period 1|Protocol Violation|0|||
149005325|NCT02798211|537497877|FG004|Period 1|Protocol Violation|0|||
149005326|NCT02798211|537497878|FG005|Period 1|Protocol Violation|0|||
149005327|NCT02798211|537497873|FG000|Period 1|Withdrawal by Subject|1|||
149005328|NCT02798211|537497874|FG001|Period 1|Withdrawal by Subject|1|||
149005329|NCT02798211|537497875|FG002|Period 1|Withdrawal by Subject|0|||
149005330|NCT02798211|537497876|FG003|Period 1|Withdrawal by Subject|0|||
149005331|NCT02798211|537497877|FG004|Period 1|Withdrawal by Subject|0|||
149005332|NCT02798211|537497878|FG005|Period 1|Withdrawal by Subject|0|||
149005333|NCT02798211|537497873|FG000|Period 1|Death|0|||
149005334|NCT02798211|537497874|FG001|Period 1|Death|0|||
149005335|NCT02798211|537497875|FG002|Period 1|Death|1|||
149005336|NCT02798211|537497876|FG003|Period 1|Death|0|||
149005337|NCT02798211|537497877|FG004|Period 1|Death|0|||
149005338|NCT02798211|537497878|FG005|Period 1|Death|0|||
149005339|NCT02798211|537497873|FG000|Period 1|Withdrawal of Informed Consent|2|||
149005340|NCT02798211|537497874|FG001|Period 1|Withdrawal of Informed Consent|7|||
149005341|NCT02798211|537497875|FG002|Period 1|Withdrawal of Informed Consent|3|||
149005342|NCT02798211|537497876|FG003|Period 1|Withdrawal of Informed Consent|0|||
149005343|NCT02798211|537497877|FG004|Period 1|Withdrawal of Informed Consent|0|||
149005344|NCT02798211|537497878|FG005|Period 1|Withdrawal of Informed Consent|0|||
149005345|NCT02798211|537497873|FG000|Period 2|Withdrawal by Subject|2|||
149005346|NCT02798211|537497874|FG001|Period 2|Withdrawal by Subject|0|||
149005347|NCT02798211|537497875|FG002|Period 2|Withdrawal by Subject|0|||
148887953|NCT02452424|537068034|FG004|Overall Study|Withdrawal by Subject|0|||
148887954|NCT02452424|537068035|FG005|Overall Study|Withdrawal by Subject|0|||
148887955|NCT02452424|537068036|FG006|Overall Study|Withdrawal by Subject|1|||
148887956|NCT02452424|537068037|FG007|Overall Study|Withdrawal by Subject|0|||
148887957|NCT02452424|537068038|FG008|Overall Study|Withdrawal by Subject|1|||
148887958|NCT02452424|537068039|FG009|Overall Study|Withdrawal by Subject|1|||
148887959|NCT02452424|537068040|FG010|Overall Study|Withdrawal by Subject|0|||
148887960|NCT02452424|537068030|FG000|Overall Study|Other|0|||
148887961|NCT02452424|537068031|FG001|Overall Study|Other|0|||
148887962|NCT02452424|537068032|FG002|Overall Study|Other|1|||
148887963|NCT02452424|537068033|FG003|Overall Study|Other|0|||
148887964|NCT02452424|537068034|FG004|Overall Study|Other|0|||
148887965|NCT02452424|537068035|FG005|Overall Study|Other|1|||
148887966|NCT02452424|537068036|FG006|Overall Study|Other|4|||
148887967|NCT02452424|537068037|FG007|Overall Study|Other|3|||
148887968|NCT02452424|537068038|FG008|Overall Study|Other|0|||
148887969|NCT02452424|537068039|FG009|Overall Study|Other|0|||
148887970|NCT02452424|537068040|FG010|Overall Study|Other|1|||
148887971|NCT02452424|537068030|FG000|Overall Study|Progressive disease (per RECIST)|0|||
148887972|NCT02452424|537068031|FG001|Overall Study|Progressive disease (per RECIST)|0|||
148887973|NCT02452424|537068032|FG002|Overall Study|Progressive disease (per RECIST)|0|||
148887974|NCT02452424|537068033|FG003|Overall Study|Progressive disease (per RECIST)|0|||
148887975|NCT02452424|537068034|FG004|Overall Study|Progressive disease (per RECIST)|0|||
148887976|NCT02452424|537068035|FG005|Overall Study|Progressive disease (per RECIST)|0|||
148887977|NCT02452424|537068036|FG006|Overall Study|Progressive disease (per RECIST)|0|||
148887978|NCT02452424|537068037|FG007|Overall Study|Progressive disease (per RECIST)|0|||
148887979|NCT02452424|537068038|FG008|Overall Study|Progressive disease (per RECIST)|2|||
148887980|NCT02452424|537068039|FG009|Overall Study|Progressive disease (per RECIST)|0|||
148887981|NCT02452424|537068040|FG010|Overall Study|Progressive disease (per RECIST)|0|||
148887982|NCT02452424|537068030|FG000|Overall Study|Adverse Event|0|||
148887983|NCT02452424|537068031|FG001|Overall Study|Adverse Event|0|||
148887984|NCT02452424|537068032|FG002|Overall Study|Adverse Event|0|||
148887985|NCT02452424|537068033|FG003|Overall Study|Adverse Event|0|||
148887986|NCT02452424|537068034|FG004|Overall Study|Adverse Event|0|||
148887987|NCT02452424|537068035|FG005|Overall Study|Adverse Event|0|||
148887988|NCT02452424|537068036|FG006|Overall Study|Adverse Event|0|||
148887989|NCT02452424|537068037|FG007|Overall Study|Adverse Event|0|||
148887990|NCT02452424|537068038|FG008|Overall Study|Adverse Event|0|||
148887991|NCT02452424|537068039|FG009|Overall Study|Adverse Event|0|||
148887992|NCT02452424|537068040|FG010|Overall Study|Adverse Event|1|||
148887993|NCT01059318|537068043|FG000|Core Study (26 Week)|Adverse Event|3|||
148887994|NCT01059318|537068043|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
148887995|NCT01059318|537068043|FG000|Extension (36 Week)|Adverse Event|3|||
148887996|NCT00176462|537068050|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
148887997|NCT00176462|537068051|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
148887998|NCT00176462|537068050|FG000|Induction (4 Weeks)|Death|1|||
148887999|NCT00176462|537068051|FG001|Induction (4 Weeks)|Death|2|||
148888000|NCT00176462|537068050|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
148888001|NCT00176462|537068051|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
148888002|NCT00176462|537068050|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
148888003|NCT00176462|537068051|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
148888004|NCT00176462|537068050|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
148888005|NCT00176462|537068051|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
148888006|NCT00176462|537068050|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
148888007|NCT00176462|537068051|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
148888008|NCT00176462|537068050|FG000|Consolidation (12 Weeks)|Not documented|0|||
148888009|NCT00176462|537068051|FG001|Consolidation (12 Weeks)|Not documented|1|||
148888010|NCT00176462|537068050|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
148888011|NCT00176462|537068051|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
148888012|NCT00176462|537068050|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
148888013|NCT00176462|537068051|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
149051941|NCT03336333|537673177|FG001|Overall Study|Physician Decision|1|||
148888014|NCT01150097|537068053|FG000|Months 24 to 36 Post-transplantation|Death|2|||
148888015|NCT01150097|537068054|FG001|Months 24 to 36 Post-transplantation|Death|0|||
148888016|NCT01150097|537068055|FG002|Months 24 to 36 Post-transplantation|Death|0|||
148888017|NCT01150097|537068053|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
148888018|NCT01150097|537068054|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
149051942|NCT03336333|537673178|FG002|Overall Study|Physician Decision|0|||
148888019|NCT01150097|537068055|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
148888020|NCT01150097|537068053|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
148888021|NCT01150097|537068054|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
148888022|NCT01150097|537068055|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
148888023|NCT01150097|537068053|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
148888024|NCT01150097|537068054|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
149051943|NCT03336333|537673176|FG000|Overall Study|Lost to Follow-up|1|||
148888025|NCT01150097|537068055|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
149051944|NCT03336333|537673177|FG001|Overall Study|Lost to Follow-up|0|||
149051945|NCT03336333|537673178|FG002|Overall Study|Lost to Follow-up|0|||
149051946|NCT04927065|537673179|FG000|First Booster|Adverse Event|1|||
149051947|NCT04927065|537673180|FG001|First Booster|Adverse Event|0|||
149051948|NCT04927065|537673181|FG002|First Booster|Adverse Event|0|||
149051949|NCT04927065|537673182|FG003|First Booster|Adverse Event|0|||
149051950|NCT04927065|537673183|FG004|First Booster|Adverse Event|0|||
149051951|NCT04927065|537673184|FG005|First Booster|Adverse Event|0|||
149051952|NCT04927065|537673185|FG006|First Booster|Adverse Event|0|||
149051953|NCT04927065|537673186|FG007|First Booster|Adverse Event|1|||
149051954|NCT04927065|537673187|FG008|First Booster|Adverse Event|0|||
149051955|NCT04927065|537673188|FG009|First Booster|Adverse Event|0|||
149051956|NCT04927065|537673189|FG010|First Booster|Adverse Event|0|||
149051957|NCT04927065|537673190|FG011|First Booster|Adverse Event|0|||
149051958|NCT04927065|537673191|FG012|First Booster|Adverse Event|0|||
148888026|NCT01150097|537068053|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
148888027|NCT01150097|537068054|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
148888028|NCT01150097|537068055|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
148888029|NCT01150097|537068053|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
148888030|NCT01150097|537068054|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
149051959|NCT04927065|537673192|FG013|First Booster|Adverse Event|0|||
149051960|NCT04927065|537673193|FG014|First Booster|Adverse Event|0|||
149051961|NCT04927065|537673194|FG015|First Booster|Adverse Event|0|||
149051962|NCT04927065|537673179|FG000|First Booster|Death|1|||
149051963|NCT04927065|537673180|FG001|First Booster|Death|0|||
149051964|NCT04927065|537673181|FG002|First Booster|Death|0|||
149051965|NCT04927065|537673182|FG003|First Booster|Death|1|||
149051966|NCT04927065|537673183|FG004|First Booster|Death|0|||
148888031|NCT01150097|537068055|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
148888032|NCT01150097|537068053|FG000|Months 24 to 48 Post-transplantation|Death|2|||
149051967|NCT04927065|537673184|FG005|First Booster|Death|1|||
149051968|NCT04927065|537673185|FG006|First Booster|Death|0|||
149051969|NCT04927065|537673186|FG007|First Booster|Death|0|||
149051970|NCT04927065|537673187|FG008|First Booster|Death|0|||
149051971|NCT04927065|537673188|FG009|First Booster|Death|0|||
149051972|NCT04927065|537673189|FG010|First Booster|Death|0|||
149051973|NCT04927065|537673190|FG011|First Booster|Death|0|||
149051974|NCT04927065|537673191|FG012|First Booster|Death|0|||
149051975|NCT04927065|537673192|FG013|First Booster|Death|0|||
149051976|NCT04927065|537673193|FG014|First Booster|Death|0|||
149051977|NCT04927065|537673194|FG015|First Booster|Death|0|||
149051978|NCT04927065|537673179|FG000|First Booster|Lost to Follow-up|8|||
149051979|NCT04927065|537673180|FG001|First Booster|Lost to Follow-up|20|||
149051980|NCT04927065|537673181|FG002|First Booster|Lost to Follow-up|0|||
149051981|NCT04927065|537673182|FG003|First Booster|Lost to Follow-up|11|||
149051982|NCT04927065|537673183|FG004|First Booster|Lost to Follow-up|43|||
149051983|NCT04927065|537673184|FG005|First Booster|Lost to Follow-up|30|||
149051984|NCT04927065|537673185|FG006|First Booster|Lost to Follow-up|28|||
149051985|NCT04927065|537673186|FG007|First Booster|Lost to Follow-up|23|||
149051986|NCT04927065|537673187|FG008|First Booster|Lost to Follow-up|4|||
149051987|NCT04927065|537673188|FG009|First Booster|Lost to Follow-up|15|||
149051988|NCT04927065|537673189|FG010|First Booster|Lost to Follow-up|0|||
149051989|NCT04927065|537673190|FG011|First Booster|Lost to Follow-up|0|||
149051990|NCT04927065|537673191|FG012|First Booster|Lost to Follow-up|0|||
149051991|NCT04927065|537673192|FG013|First Booster|Lost to Follow-up|0|||
148888033|NCT01150097|537068054|FG001|Months 24 to 48 Post-transplantation|Death|0|||
148888034|NCT01150097|537068055|FG002|Months 24 to 48 Post-transplantation|Death|0|||
148888035|NCT01301833|537068056|FG000|Overall Study|Adverse Event|7|||
149051992|NCT04927065|537673193|FG014|First Booster|Lost to Follow-up|0|||
149051993|NCT04927065|537673194|FG015|First Booster|Lost to Follow-up|0|||
149051994|NCT04927065|537673179|FG000|First Booster|Physician Decision|1|||
148888036|NCT01301833|537068057|FG001|Overall Study|Adverse Event|5|||
148888037|NCT01301833|537068058|FG002|Overall Study|Adverse Event|5|||
148888038|NCT01301833|537068059|FG003|Overall Study|Adverse Event|5|||
149051995|NCT04927065|537673180|FG001|First Booster|Physician Decision|0|||
149051996|NCT04927065|537673181|FG002|First Booster|Physician Decision|0|||
149051997|NCT04927065|537673182|FG003|First Booster|Physician Decision|3|||
149051998|NCT04927065|537673183|FG004|First Booster|Physician Decision|1|||
149051999|NCT04927065|537673184|FG005|First Booster|Physician Decision|1|||
149052000|NCT04927065|537673185|FG006|First Booster|Physician Decision|0|||
149052001|NCT04927065|537673186|FG007|First Booster|Physician Decision|3|||
148888039|NCT01301833|537068056|FG000|Overall Study|Lack of Efficacy|1|||
149052002|NCT04927065|537673187|FG008|First Booster|Physician Decision|0|||
149052003|NCT04927065|537673188|FG009|First Booster|Physician Decision|0|||
149052004|NCT04927065|537673189|FG010|First Booster|Physician Decision|0|||
149052005|NCT04927065|537673190|FG011|First Booster|Physician Decision|0|||
149052006|NCT04927065|537673191|FG012|First Booster|Physician Decision|0|||
149052007|NCT04927065|537673192|FG013|First Booster|Physician Decision|0|||
149052008|NCT04927065|537673193|FG014|First Booster|Physician Decision|0|||
148888040|NCT01301833|537068057|FG001|Overall Study|Lack of Efficacy|1|||
148888041|NCT01301833|537068058|FG002|Overall Study|Lack of Efficacy|0|||
148888042|NCT01301833|537068059|FG003|Overall Study|Lack of Efficacy|0|||
148888043|NCT01301833|537068056|FG000|Overall Study|Physician Decision|3|||
148888044|NCT01301833|537068057|FG001|Overall Study|Physician Decision|1|||
148888045|NCT01301833|537068058|FG002|Overall Study|Physician Decision|1|||
148888046|NCT01301833|537068059|FG003|Overall Study|Physician Decision|0|||
148888047|NCT01301833|537068056|FG000|Overall Study|Withdrawal by Subject|3|||
148888048|NCT01301833|537068057|FG001|Overall Study|Withdrawal by Subject|1|||
148888049|NCT01301833|537068058|FG002|Overall Study|Withdrawal by Subject|1|||
148888050|NCT01301833|537068059|FG003|Overall Study|Withdrawal by Subject|2|||
148888051|NCT01301833|537068056|FG000|Overall Study|Personal matter|1|||
148888052|NCT01301833|537068057|FG001|Overall Study|Personal matter|0|||
148888053|NCT01301833|537068058|FG002|Overall Study|Personal matter|0|||
148888054|NCT01301833|537068059|FG003|Overall Study|Personal matter|0|||
148888055|NCT02719171|537070331|FG000|Overall Study|Adverse Event|1|||
148888056|NCT02719171|537070332|FG001|Overall Study|Adverse Event|2|||
148888057|NCT02719171|537070333|FG002|Overall Study|Adverse Event|0|||
148888058|NCT02719171|537070334|FG003|Overall Study|Adverse Event|0|||
148888059|NCT02719171|537070335|FG004|Overall Study|Adverse Event|2|||
148888060|NCT02719171|537070331|FG000|Overall Study|Lost to Follow-up|0|||
148888061|NCT02719171|537070332|FG001|Overall Study|Lost to Follow-up|0|||
148888062|NCT02719171|537070333|FG002|Overall Study|Lost to Follow-up|1|||
148888063|NCT02719171|537070334|FG003|Overall Study|Lost to Follow-up|0|||
148888064|NCT02719171|537070335|FG004|Overall Study|Lost to Follow-up|0|||
148888065|NCT02719171|537070331|FG000|Overall Study|Subject Withdrawal|0|||
149052009|NCT04927065|537673194|FG015|First Booster|Physician Decision|0|||
149052010|NCT04927065|537673179|FG000|First Booster|Protocol Violation|4|||
149052011|NCT04927065|537673180|FG001|First Booster|Protocol Violation|4|||
149052012|NCT04927065|537673181|FG002|First Booster|Protocol Violation|0|||
149052013|NCT04927065|537673182|FG003|First Booster|Protocol Violation|3|||
149052014|NCT04927065|537673183|FG004|First Booster|Protocol Violation|0|||
149052015|NCT04927065|537673184|FG005|First Booster|Protocol Violation|0|||
149052016|NCT04927065|537673185|FG006|First Booster|Protocol Violation|0|||
149052017|NCT04927065|537673186|FG007|First Booster|Protocol Violation|2|||
149052018|NCT04927065|537673187|FG008|First Booster|Protocol Violation|0|||
149052019|NCT04927065|537673188|FG009|First Booster|Protocol Violation|0|||
149052020|NCT04927065|537673189|FG010|First Booster|Protocol Violation|0|||
149052021|NCT04927065|537673190|FG011|First Booster|Protocol Violation|0|||
148888066|NCT02719171|537070332|FG001|Overall Study|Subject Withdrawal|2|||
148888067|NCT02719171|537070333|FG002|Overall Study|Subject Withdrawal|2|||
148888068|NCT02719171|537070334|FG003|Overall Study|Subject Withdrawal|1|||
148888069|NCT02719171|537070335|FG004|Overall Study|Subject Withdrawal|0|||
148888070|NCT02719171|537070331|FG000|Overall Study|Other|0|||
148888071|NCT02719171|537070332|FG001|Overall Study|Other|0|||
148888072|NCT02719171|537070333|FG002|Overall Study|Other|0|||
148888073|NCT02719171|537070334|FG003|Overall Study|Other|1|||
148888074|NCT02719171|537070335|FG004|Overall Study|Other|0|||
148888075|NCT00227721|537070336|FG000|Overall Study|On study, but never treated.|1|||
148888076|NCT02539797|537070346|FG000|Overall Study|Lost to Follow-up|0|||
148888077|NCT02539797|537070347|FG001|Overall Study|Lost to Follow-up|1|||
148888078|NCT02539797|537070348|FG002|Overall Study|Lost to Follow-up|0|||
148888079|NCT00383786|537070358|FG000|Overall Study|Protocol Violation|2|||
148888080|NCT00383786|537070359|FG001|Overall Study|Protocol Violation|6|||
148888081|NCT00383786|537070358|FG000|Overall Study|Withdrawal by Subject|2|||
148888082|NCT00383786|537070359|FG001|Overall Study|Withdrawal by Subject|5|||
148888083|NCT00383786|537070358|FG000|Overall Study|Physician Decision|0|||
148888084|NCT00383786|537070359|FG001|Overall Study|Physician Decision|1|||
148888085|NCT00985673|537070360|FG000|Overall Study|Lost to Follow-up|6|||
148888086|NCT00985673|537070361|FG001|Overall Study|Lost to Follow-up|7|||
148888087|NCT00985673|537070362|FG002|Overall Study|Lost to Follow-up|6|||
148888088|NCT00985673|537070363|FG003|Overall Study|Lost to Follow-up|10|||
148888089|NCT00985673|537070364|FG004|Overall Study|Lost to Follow-up|5|||
148888090|NCT00985673|537070365|FG005|Overall Study|Lost to Follow-up|3|||
148888091|NCT00985673|537070360|FG000|Overall Study|Withdrawal by Subject|0|||
148888092|NCT00985673|537070361|FG001|Overall Study|Withdrawal by Subject|4|||
148888093|NCT00985673|537070362|FG002|Overall Study|Withdrawal by Subject|5|||
148888094|NCT00985673|537070363|FG003|Overall Study|Withdrawal by Subject|2|||
148888095|NCT00985673|537070364|FG004|Overall Study|Withdrawal by Subject|2|||
148888096|NCT00985673|537070365|FG005|Overall Study|Withdrawal by Subject|3|||
148888097|NCT00985673|537070360|FG000|Overall Study|Other|1|||
148888098|NCT00985673|537070361|FG001|Overall Study|Other|0|||
148888099|NCT00985673|537070362|FG002|Overall Study|Other|1|||
148888100|NCT00985673|537070363|FG003|Overall Study|Other|0|||
148888101|NCT00985673|537070364|FG004|Overall Study|Other|1|||
148888102|NCT00985673|537070365|FG005|Overall Study|Other|0|||
148888103|NCT02252146|537070366|FG000|Overall Study|Lack of Efficacy|4|||
148888104|NCT02252146|537070366|FG000|Overall Study|Entered hospice care|1|||
148888105|NCT02252146|537070366|FG000|Overall Study|Inability to travel to study site|1|||
149052022|NCT04927065|537673191|FG012|First Booster|Protocol Violation|0|||
149052023|NCT04927065|537673192|FG013|First Booster|Protocol Violation|0|||
148888106|NCT00531284|537070369|FG000|Overall Study|Progressive Disease|1|||
148888107|NCT00531284|537070370|FG001|Overall Study|Progressive Disease|3|||
148888108|NCT00531284|537070371|FG002|Overall Study|Progressive Disease|5|||
148888109|NCT00531284|537070372|FG003|Overall Study|Progressive Disease|42|||
148888110|NCT00531284|537070373|FG004|Overall Study|Progressive Disease|4|||
148888111|NCT00531284|537070374|FG005|Overall Study|Progressive Disease|4|||
148888112|NCT00531284|537070375|FG006|Overall Study|Progressive Disease|3|||
148888113|NCT00531284|537070376|FG007|Overall Study|Progressive Disease|8|||
148888114|NCT00531284|537070377|FG008|Overall Study|Progressive Disease|6|||
148888115|NCT00531284|537070378|FG009|Overall Study|Progressive Disease|3|||
148888116|NCT00531284|537070379|FG010|Overall Study|Progressive Disease|3|||
148888117|NCT00531284|537070380|FG011|Overall Study|Progressive Disease|14|||
148888118|NCT00531284|537070381|FG012|Overall Study|Progressive Disease|2|||
148888119|NCT00531284|537070382|FG013|Overall Study|Progressive Disease|1|||
148888120|NCT00531284|537070383|FG014|Overall Study|Progressive Disease|2|||
148888121|NCT00531284|537070384|FG015|Overall Study|Progressive Disease|11|||
148888122|NCT00531284|537070385|FG016|Overall Study|Progressive Disease|5|||
148888123|NCT00531284|537070369|FG000|Overall Study|Adverse Event|0|||
148888124|NCT00531284|537070370|FG001|Overall Study|Adverse Event|1|||
149052024|NCT04927065|537673193|FG014|First Booster|Protocol Violation|0|||
149052025|NCT04927065|537673194|FG015|First Booster|Protocol Violation|0|||
149052026|NCT04927065|537673179|FG000|First Booster|Withdrawal by Subject|8|||
149052027|NCT04927065|537673180|FG001|First Booster|Withdrawal by Subject|23|||
149052028|NCT04927065|537673181|FG002|First Booster|Withdrawal by Subject|0|||
149052029|NCT04927065|537673182|FG003|First Booster|Withdrawal by Subject|19|||
149052030|NCT04927065|537673183|FG004|First Booster|Withdrawal by Subject|20|||
149052031|NCT04927065|537673184|FG005|First Booster|Withdrawal by Subject|15|||
149052032|NCT04927065|537673185|FG006|First Booster|Withdrawal by Subject|6|||
149052033|NCT04927065|537673186|FG007|First Booster|Withdrawal by Subject|24|||
149052034|NCT04927065|537673187|FG008|First Booster|Withdrawal by Subject|0|||
149052035|NCT04927065|537673188|FG009|First Booster|Withdrawal by Subject|4|||
149052036|NCT04927065|537673189|FG010|First Booster|Withdrawal by Subject|0|||
149052037|NCT04927065|537673190|FG011|First Booster|Withdrawal by Subject|0|||
149052038|NCT04927065|537673191|FG012|First Booster|Withdrawal by Subject|0|||
149052039|NCT04927065|537673192|FG013|First Booster|Withdrawal by Subject|0|||
149052040|NCT04927065|537673193|FG014|First Booster|Withdrawal by Subject|0|||
149052041|NCT04927065|537673194|FG015|First Booster|Withdrawal by Subject|0|||
149052042|NCT04927065|537673179|FG000|First Booster|Other Than Specified|1|||
149052043|NCT04927065|537673180|FG001|First Booster|Other Than Specified|1|||
149052044|NCT04927065|537673181|FG002|First Booster|Other Than Specified|0|||
149052045|NCT04927065|537673182|FG003|First Booster|Other Than Specified|1|||
149052046|NCT04927065|537673183|FG004|First Booster|Other Than Specified|2|||
149052047|NCT04927065|537673184|FG005|First Booster|Other Than Specified|3|||
149052048|NCT04927065|537673185|FG006|First Booster|Other Than Specified|2|||
149052049|NCT04927065|537673186|FG007|First Booster|Other Than Specified|6|||
149052050|NCT04927065|537673187|FG008|First Booster|Other Than Specified|0|||
149052051|NCT04927065|537673188|FG009|First Booster|Other Than Specified|4|||
149052052|NCT04927065|537673189|FG010|First Booster|Other Than Specified|0|||
149052053|NCT04927065|537673190|FG011|First Booster|Other Than Specified|0|||
149052054|NCT04927065|537673191|FG012|First Booster|Other Than Specified|0|||
149052055|NCT04927065|537673192|FG013|First Booster|Other Than Specified|0|||
149052056|NCT04927065|537673193|FG014|First Booster|Other Than Specified|0|||
148888125|NCT00531284|537070371|FG002|Overall Study|Adverse Event|1|||
148888126|NCT00531284|537070372|FG003|Overall Study|Adverse Event|7|||
148888127|NCT00531284|537070373|FG004|Overall Study|Adverse Event|0|||
148888128|NCT00531284|537070374|FG005|Overall Study|Adverse Event|2|||
148888129|NCT00531284|537070375|FG006|Overall Study|Adverse Event|3|||
148888130|NCT00531284|537070376|FG007|Overall Study|Adverse Event|2|||
148888131|NCT00531284|537070377|FG008|Overall Study|Adverse Event|3|||
148888132|NCT00531284|537070378|FG009|Overall Study|Adverse Event|0|||
148888133|NCT00531284|537070379|FG010|Overall Study|Adverse Event|0|||
148888134|NCT00531284|537070380|FG011|Overall Study|Adverse Event|5|||
148888135|NCT00531284|537070381|FG012|Overall Study|Adverse Event|0|||
148888136|NCT00531284|537070382|FG013|Overall Study|Adverse Event|1|||
148888137|NCT00531284|537070383|FG014|Overall Study|Adverse Event|1|||
148888138|NCT00531284|537070384|FG015|Overall Study|Adverse Event|0|||
148888139|NCT00531284|537070385|FG016|Overall Study|Adverse Event|2|||
148888140|NCT00531284|537070369|FG000|Overall Study|Withdrawal by Subject|1|||
148888141|NCT00531284|537070370|FG001|Overall Study|Withdrawal by Subject|0|||
148888142|NCT00531284|537070371|FG002|Overall Study|Withdrawal by Subject|0|||
148888143|NCT00531284|537070372|FG003|Overall Study|Withdrawal by Subject|4|||
149052057|NCT04927065|537673194|FG015|First Booster|Other Than Specified|0|||
149052058|NCT04927065|537673179|FG000|Second Booster|Death|0|||
149052059|NCT04927065|537673180|FG001|Second Booster|Death|0|||
149052060|NCT04927065|537673181|FG002|Second Booster|Death|0|||
149052061|NCT04927065|537673182|FG003|Second Booster|Death|0|||
149052062|NCT04927065|537673183|FG004|Second Booster|Death|0|||
149052063|NCT04927065|537673184|FG005|Second Booster|Death|0|||
149052064|NCT04927065|537673185|FG006|Second Booster|Death|0|||
148888144|NCT00531284|537070373|FG004|Overall Study|Withdrawal by Subject|0|||
148888145|NCT00531284|537070374|FG005|Overall Study|Withdrawal by Subject|0|||
148888146|NCT00531284|537070375|FG006|Overall Study|Withdrawal by Subject|0|||
148888147|NCT00531284|537070376|FG007|Overall Study|Withdrawal by Subject|0|||
148888148|NCT00531284|537070377|FG008|Overall Study|Withdrawal by Subject|0|||
148888149|NCT00531284|537070378|FG009|Overall Study|Withdrawal by Subject|0|||
148888150|NCT00531284|537070379|FG010|Overall Study|Withdrawal by Subject|0|||
148888151|NCT00531284|537070380|FG011|Overall Study|Withdrawal by Subject|3|||
148888152|NCT00531284|537070381|FG012|Overall Study|Withdrawal by Subject|0|||
148888153|NCT00531284|537070382|FG013|Overall Study|Withdrawal by Subject|1|||
148888154|NCT00531284|537070383|FG014|Overall Study|Withdrawal by Subject|0|||
148888155|NCT00531284|537070384|FG015|Overall Study|Withdrawal by Subject|1|||
148888156|NCT00531284|537070385|FG016|Overall Study|Withdrawal by Subject|1|||
148888157|NCT00531284|537070369|FG000|Overall Study|Other|1|||
148888158|NCT00531284|537070370|FG001|Overall Study|Other|0|||
148888159|NCT00531284|537070371|FG002|Overall Study|Other|0|||
148888160|NCT00531284|537070372|FG003|Overall Study|Other|10|||
148888161|NCT00531284|537070373|FG004|Overall Study|Other|2|||
148888162|NCT00531284|537070374|FG005|Overall Study|Other|1|||
148888163|NCT00531284|537070375|FG006|Overall Study|Other|0|||
148888164|NCT00531284|537070376|FG007|Overall Study|Other|0|||
148888165|NCT00531284|537070377|FG008|Overall Study|Other|2|||
148888166|NCT00531284|537070378|FG009|Overall Study|Other|1|||
148888167|NCT00531284|537070379|FG010|Overall Study|Other|0|||
148888168|NCT00531284|537070380|FG011|Overall Study|Other|2|||
148888169|NCT00531284|537070381|FG012|Overall Study|Other|0|||
148888170|NCT00531284|537070382|FG013|Overall Study|Other|0|||
148888171|NCT00531284|537070383|FG014|Overall Study|Other|1|||
148888172|NCT00531284|537070384|FG015|Overall Study|Other|0|||
148888173|NCT00531284|537070385|FG016|Overall Study|Other|0|||
148888174|NCT02219464|537070387|FG000|Overall Study|Withdrawal by Subject|1|||
148888175|NCT02219464|537070388|FG001|Overall Study|Withdrawal by Subject|0|||
148888176|NCT02219464|537070387|FG000|Overall Study|case cancelled|1|||
148888177|NCT02219464|537070388|FG001|Overall Study|case cancelled|0|||
148888178|NCT02219464|537070387|FG000|Overall Study|catheter malfunction|1|||
148888179|NCT02219464|537070388|FG001|Overall Study|catheter malfunction|0|||
148888180|NCT00984256|537070389|FG000|Overall Study|Withdrawal by Subject|0|||
148888181|NCT00984256|537070390|FG001|Overall Study|Withdrawal by Subject|1|||
148888182|NCT02544321|537070395|FG000|Overall Study|Withdrawal by Subject|1|||
148888183|NCT02544321|537070396|FG001|Overall Study|Withdrawal by Subject|2|||
148888184|NCT02544321|537070395|FG000|Overall Study|Adverse Event|1|||
148888185|NCT02544321|537070396|FG001|Overall Study|Adverse Event|1|||
148888186|NCT02544321|537070395|FG000|Overall Study|Protocol Violation|0|||
148888187|NCT02544321|537070396|FG001|Overall Study|Protocol Violation|1|||
148888188|NCT03493945|537070397|FG000|Phase I Dose Escalation|Ineligible|0|||
148888189|NCT03493945|537070398|FG001|Phase I Dose Escalation|Ineligible|0|||
148888190|NCT03493945|537070399|FG002|Phase I Dose Escalation|Ineligible|1|||
148888191|NCT03493945|537070400|FG003|Phase I Dose Escalation|Ineligible|0|||
149052065|NCT04927065|537673186|FG007|Second Booster|Death|0|||
149052066|NCT04927065|537673187|FG008|Second Booster|Death|0|||
149052067|NCT04927065|537673188|FG009|Second Booster|Death|0|||
149052068|NCT04927065|537673189|FG010|Second Booster|Death|2|||
149052069|NCT04927065|537673190|FG011|Second Booster|Death|0|||
149052070|NCT04927065|537673191|FG012|Second Booster|Death|2|||
149052071|NCT04927065|537673192|FG013|Second Booster|Death|2|||
149052072|NCT04927065|537673193|FG014|Second Booster|Death|0|||
149052073|NCT04927065|537673194|FG015|Second Booster|Death|0|||
149052074|NCT04927065|537673179|FG000|Second Booster|Lost to Follow-up|0|||
149052075|NCT04927065|537673180|FG001|Second Booster|Lost to Follow-up|0|||
149052076|NCT04927065|537673181|FG002|Second Booster|Lost to Follow-up|3|||
149052077|NCT04927065|537673182|FG003|Second Booster|Lost to Follow-up|0|||
149052078|NCT04927065|537673183|FG004|Second Booster|Lost to Follow-up|0|||
149052079|NCT04927065|537673184|FG005|Second Booster|Lost to Follow-up|0|||
149052080|NCT04927065|537673185|FG006|Second Booster|Lost to Follow-up|0|||
149052081|NCT04927065|537673186|FG007|Second Booster|Lost to Follow-up|0|||
149052082|NCT04927065|537673187|FG008|Second Booster|Lost to Follow-up|0|||
149052083|NCT04927065|537673188|FG009|Second Booster|Lost to Follow-up|0|||
148888192|NCT03493945|537070401|FG004|Phase I Dose Escalation|Ineligible|0|||
148888193|NCT03493945|537070402|FG005|Phase I Dose Escalation|Ineligible|0|||
148888194|NCT03493945|537070403|FG006|Phase I Dose Escalation|Ineligible|0|||
148888195|NCT03493945|537070397|FG000|Phase I Dose Escalation|New therapy|0|||
148888196|NCT03493945|537070398|FG001|Phase I Dose Escalation|New therapy|1|||
148888197|NCT03493945|537070399|FG002|Phase I Dose Escalation|New therapy|0|||
148888198|NCT03493945|537070400|FG003|Phase I Dose Escalation|New therapy|0|||
149052084|NCT04927065|537673189|FG010|Second Booster|Lost to Follow-up|14|||
149052085|NCT04927065|537673190|FG011|Second Booster|Lost to Follow-up|10|||
149052086|NCT04927065|537673191|FG012|Second Booster|Lost to Follow-up|13|||
148888199|NCT03493945|537070401|FG004|Phase I Dose Escalation|New therapy|0|||
148888200|NCT03493945|537070402|FG005|Phase I Dose Escalation|New therapy|0|||
149052087|NCT04927065|537673192|FG013|Second Booster|Lost to Follow-up|16|||
149052088|NCT04927065|537673193|FG014|Second Booster|Lost to Follow-up|0|||
148888201|NCT03493945|537070403|FG006|Phase I Dose Escalation|New therapy|0|||
148888202|NCT03493945|537070397|FG000|Phase II Dose Expansion|Refused further treatment|0|||
148888203|NCT03493945|537070398|FG001|Phase II Dose Expansion|Refused further treatment|0|||
148888204|NCT03493945|537070399|FG002|Phase II Dose Expansion|Refused further treatment|0|||
148888205|NCT03493945|537070400|FG003|Phase II Dose Expansion|Refused further treatment|0|||
148888206|NCT03493945|537070401|FG004|Phase II Dose Expansion|Refused further treatment|1|||
148888207|NCT03493945|537070402|FG005|Phase II Dose Expansion|Refused further treatment|1|||
148888208|NCT03493945|537070403|FG006|Phase II Dose Expansion|Refused further treatment|0|||
148888209|NCT03493945|537070397|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
148888210|NCT03493945|537070398|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
148888211|NCT03493945|537070399|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
148888212|NCT03493945|537070400|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
148888213|NCT03493945|537070401|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
148888214|NCT03493945|537070402|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
148888215|NCT03493945|537070403|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
148888216|NCT01517750|537070404|FG000|Overall Study|Lost to Follow-up|1|||
148888217|NCT01517750|537070405|FG001|Overall Study|Lost to Follow-up|2|||
148888218|NCT01517750|537070406|FG002|Overall Study|Lost to Follow-up|4|||
148888219|NCT01517750|537070407|FG003|Overall Study|Lost to Follow-up|1|||
148888220|NCT01307319|537070408|FG000|Overall Study|Adverse Event|2|||
148888221|NCT01307319|537070409|FG001|Overall Study|Adverse Event|2|||
148888222|NCT01307319|537070410|FG002|Overall Study|Adverse Event|1|||
148888223|NCT01307319|537070408|FG000|Overall Study|Lost to Follow-up|1|||
148888224|NCT01307319|537070409|FG001|Overall Study|Lost to Follow-up|0|||
148888225|NCT01307319|537070410|FG002|Overall Study|Lost to Follow-up|1|||
148888226|NCT01307319|537070408|FG000|Overall Study|Protocol Violation|1|||
148888227|NCT01307319|537070409|FG001|Overall Study|Protocol Violation|1|||
148888228|NCT01307319|537070410|FG002|Overall Study|Protocol Violation|0|||
148888229|NCT01307319|537070408|FG000|Overall Study|Withdrawal by Subject|0|||
148888230|NCT01307319|537070409|FG001|Overall Study|Withdrawal by Subject|1|||
148888231|NCT01307319|537070410|FG002|Overall Study|Withdrawal by Subject|2|||
148888232|NCT01307319|537070408|FG000|Overall Study|Other|0|||
148888233|NCT01307319|537070409|FG001|Overall Study|Other|4|||
148888234|NCT01307319|537070410|FG002|Overall Study|Other|3|||
148888235|NCT02735239|537070411|FG000|Overall Study|Adverse Event|0|||
148888236|NCT02735239|537070412|FG001|Overall Study|Adverse Event|0|||
148888237|NCT02735239|537070413|FG002|Overall Study|Adverse Event|4|||
148888238|NCT02735239|537070414|FG003|Overall Study|Adverse Event|0|||
148888239|NCT02735239|537070415|FG004|Overall Study|Adverse Event|0|||
148888240|NCT02735239|537070416|FG005|Overall Study|Adverse Event|0|||
148888241|NCT02735239|537070411|FG000|Overall Study|Death|1|||
148888242|NCT02735239|537070412|FG001|Overall Study|Death|1|||
148888243|NCT02735239|537070413|FG002|Overall Study|Death|0|||
148888244|NCT02735239|537070414|FG003|Overall Study|Death|0|||
148888245|NCT02735239|537070415|FG004|Overall Study|Death|0|||
148888246|NCT02735239|537070416|FG005|Overall Study|Death|0|||
148888247|NCT02735239|537070411|FG000|Overall Study|Physician Decision|0|||
148888248|NCT02735239|537070412|FG001|Overall Study|Physician Decision|0|||
148888249|NCT02735239|537070413|FG002|Overall Study|Physician Decision|1|||
148888250|NCT02735239|537070414|FG003|Overall Study|Physician Decision|0|||
148888251|NCT02735239|537070415|FG004|Overall Study|Physician Decision|0|||
148888252|NCT02735239|537070416|FG005|Overall Study|Physician Decision|0|||
148888253|NCT02735239|537070411|FG000|Overall Study|Progressive disease|3|||
148888254|NCT02735239|537070412|FG001|Overall Study|Progressive disease|1|||
148888255|NCT02735239|537070413|FG002|Overall Study|Progressive disease|3|||
148888256|NCT02735239|537070414|FG003|Overall Study|Progressive disease|0|||
148888257|NCT02735239|537070415|FG004|Overall Study|Progressive disease|0|||
148888258|NCT02735239|537070416|FG005|Overall Study|Progressive disease|2|||
148888259|NCT02735239|537070411|FG000|Overall Study|Withdrawal by Subject|0|||
148888260|NCT02735239|537070412|FG001|Overall Study|Withdrawal by Subject|1|||
148888261|NCT02735239|537070413|FG002|Overall Study|Withdrawal by Subject|0|||
148888262|NCT02735239|537070414|FG003|Overall Study|Withdrawal by Subject|0|||
148888263|NCT02735239|537070415|FG004|Overall Study|Withdrawal by Subject|0|||
148888264|NCT02735239|537070416|FG005|Overall Study|Withdrawal by Subject|0|||
148888265|NCT02152631|537070418|FG000|Overall Study|Adverse Event|32|||
148888266|NCT02152631|537070419|FG001|Overall Study|Adverse Event|4|||
148888267|NCT02152631|537070418|FG000|Overall Study|Withdrawal by Subject|13|||
148888268|NCT02152631|537070419|FG001|Overall Study|Withdrawal by Subject|16|||
148888269|NCT02152631|537070418|FG000|Overall Study|Noncompliance with study drug|1|||
148888270|NCT02152631|537070419|FG001|Overall Study|Noncompliance with study drug|0|||
148888271|NCT02152631|537070418|FG000|Overall Study|Physician Decision|1|||
148888272|NCT02152631|537070419|FG001|Overall Study|Physician Decision|2|||
148888273|NCT02152631|537070418|FG000|Overall Study|Lost to Follow-up|0|||
148888274|NCT02152631|537070419|FG001|Overall Study|Lost to Follow-up|1|||
148888275|NCT02152631|537070418|FG000|Overall Study|On Treatment|19|||
148888276|NCT02152631|537070419|FG001|Overall Study|On Treatment|3|||
148888277|NCT02038153|537070420|FG000|Overall Study|Withdrawal by Subject|1|||
149005348|NCT02798211|537497876|FG003|Period 2|Withdrawal by Subject|0|||
148888278|NCT02647281|537070421|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888279|NCT02647281|537070422|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888280|NCT02647281|537070423|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888281|NCT02647281|537070424|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888282|NCT02647281|537070425|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888283|NCT02647281|537070426|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888284|NCT02647281|537070427|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888285|NCT02647281|537070428|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
148888286|NCT02647281|537070429|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
148888287|NCT00527735|537070430|FG000|Overall Study|Disease progression|47|||
148888288|NCT00527735|537070431|FG001|Overall Study|Disease progression|61|||
148888289|NCT00527735|537070432|FG002|Overall Study|Disease progression|53|||
148888290|NCT00527735|537070430|FG000|Overall Study|Death|23|||
148888291|NCT00527735|537070431|FG001|Overall Study|Death|13|||
148888292|NCT00527735|537070432|FG002|Overall Study|Death|15|||
148888293|NCT00527735|537070430|FG000|Overall Study|Completed treatment in treatment phase|14|||
148888294|NCT00527735|537070431|FG001|Overall Study|Completed treatment in treatment phase|13|||
148888295|NCT00527735|537070432|FG002|Overall Study|Completed treatment in treatment phase|18|||
148888296|NCT00527735|537070430|FG000|Overall Study|Adverse Event|10|||
148888297|NCT00527735|537070431|FG001|Overall Study|Adverse Event|6|||
148888298|NCT00527735|537070432|FG002|Overall Study|Adverse Event|7|||
148888299|NCT00527735|537070430|FG000|Overall Study|Not identified|5|||
148888300|NCT00527735|537070431|FG001|Overall Study|Not identified|5|||
148888301|NCT00527735|537070432|FG002|Overall Study|Not identified|5|||
148888302|NCT00527735|537070430|FG000|Overall Study|Withdrawal by Subject|5|||
148888303|NCT00527735|537070431|FG001|Overall Study|Withdrawal by Subject|4|||
148888304|NCT00527735|537070432|FG002|Overall Study|Withdrawal by Subject|3|||
148888305|NCT00527735|537070430|FG000|Overall Study|No longer met study criteria|2|||
148888306|NCT00527735|537070431|FG001|Overall Study|No longer met study criteria|2|||
148888307|NCT00527735|537070432|FG002|Overall Study|No longer met study criteria|1|||
148888308|NCT00527735|537070430|FG000|Overall Study|Lost to Follow-up|0|||
148888309|NCT00527735|537070431|FG001|Overall Study|Lost to Follow-up|0|||
148888310|NCT00527735|537070432|FG002|Overall Study|Lost to Follow-up|3|||
148888311|NCT00527735|537070430|FG000|Overall Study|Poor compliance or noncompliance|0|||
148888312|NCT00527735|537070431|FG001|Overall Study|Poor compliance or noncompliance|1|||
148888313|NCT00527735|537070432|FG002|Overall Study|Poor compliance or noncompliance|1|||
148888314|NCT00527735|537070430|FG000|Overall Study|Completed treatment during maintenance|2|||
148888315|NCT00527735|537070431|FG001|Overall Study|Completed treatment during maintenance|2|||
148888316|NCT00527735|537070432|FG002|Overall Study|Completed treatment during maintenance|1|||
148888317|NCT01855412|537070433|FG000|Overall Study|Death|77|||
148888318|NCT01855412|537070434|FG001|Overall Study|Death|123|||
148888319|NCT01855412|537070435|FG002|Overall Study|Death|30|||
148888320|NCT01855412|537070433|FG000|Overall Study|Lost to Follow-up|28|||
148888321|NCT01855412|537070434|FG001|Overall Study|Lost to Follow-up|46|||
148888322|NCT01855412|537070435|FG002|Overall Study|Lost to Follow-up|15|||
148888323|NCT01855412|537070433|FG000|Overall Study|Withdrawal by Subject|77|||
148888324|NCT01855412|537070434|FG001|Overall Study|Withdrawal by Subject|123|||
148888325|NCT01855412|537070435|FG002|Overall Study|Withdrawal by Subject|24|||
148888326|NCT01855412|537070433|FG000|Overall Study|Physician Decision|25|||
148888327|NCT01855412|537070434|FG001|Overall Study|Physician Decision|31|||
148888328|NCT01855412|537070435|FG002|Overall Study|Physician Decision|3|||
148888329|NCT01855412|537070433|FG000|Overall Study|Site Closure|4|||
148888330|NCT01855412|537070434|FG001|Overall Study|Site Closure|18|||
148888331|NCT01855412|537070435|FG002|Overall Study|Site Closure|1|||
148888332|NCT01855412|537070433|FG000|Overall Study|Reason not Specified|1|||
148888333|NCT01855412|537070434|FG001|Overall Study|Reason not Specified|2|||
148888334|NCT01855412|537070435|FG002|Overall Study|Reason not Specified|3|||
148888335|NCT03347123|537070440|FG000|Overall Study|Death|1|||
148888336|NCT03347123|537070441|FG001|Overall Study|Death|2|||
148888337|NCT03347123|537070442|FG002|Overall Study|Death|0|||
148888338|NCT03347123|537070443|FG003|Overall Study|Death|0|||
148888339|NCT03347123|537070444|FG004|Overall Study|Death|0|||
148888340|NCT03347123|537070445|FG005|Overall Study|Death|0|||
148888341|NCT03347123|537070446|FG006|Overall Study|Death|0|||
148888342|NCT03347123|537070440|FG000|Overall Study|Withdrawal by Subject|1|||
148888343|NCT03347123|537070441|FG001|Overall Study|Withdrawal by Subject|0|||
148888344|NCT03347123|537070442|FG002|Overall Study|Withdrawal by Subject|0|||
148888345|NCT03347123|537070443|FG003|Overall Study|Withdrawal by Subject|0|||
148888346|NCT03347123|537070444|FG004|Overall Study|Withdrawal by Subject|0|||
148888347|NCT03347123|537070445|FG005|Overall Study|Withdrawal by Subject|0|||
148888348|NCT03347123|537070446|FG006|Overall Study|Withdrawal by Subject|0|||
148888349|NCT03347123|537070440|FG000|Overall Study|Reason not Specified|3|||
148888350|NCT03347123|537070441|FG001|Overall Study|Reason not Specified|4|||
148888351|NCT03347123|537070442|FG002|Overall Study|Reason not Specified|0|||
148888352|NCT03347123|537070443|FG003|Overall Study|Reason not Specified|0|||
148888353|NCT03347123|537070444|FG004|Overall Study|Reason not Specified|0|||
149052089|NCT04927065|537673194|FG015|Second Booster|Lost to Follow-up|0|||
149052090|NCT04927065|537673179|FG000|Second Booster|Physician Decision|0|||
149052091|NCT04927065|537673180|FG001|Second Booster|Physician Decision|0|||
149052092|NCT04927065|537673181|FG002|Second Booster|Physician Decision|0|||
149052093|NCT04927065|537673182|FG003|Second Booster|Physician Decision|0|||
149052094|NCT04927065|537673183|FG004|Second Booster|Physician Decision|0|||
149052095|NCT04927065|537673184|FG005|Second Booster|Physician Decision|0|||
149052096|NCT04927065|537673185|FG006|Second Booster|Physician Decision|0|||
149052097|NCT04927065|537673186|FG007|Second Booster|Physician Decision|0|||
149052098|NCT04927065|537673187|FG008|Second Booster|Physician Decision|0|||
149052099|NCT04927065|537673188|FG009|Second Booster|Physician Decision|0|||
149052100|NCT04927065|537673189|FG010|Second Booster|Physician Decision|0|||
149052101|NCT04927065|537673190|FG011|Second Booster|Physician Decision|3|||
149052102|NCT04927065|537673191|FG012|Second Booster|Physician Decision|0|||
149052103|NCT04927065|537673192|FG013|Second Booster|Physician Decision|1|||
149052104|NCT04927065|537673193|FG014|Second Booster|Physician Decision|0|||
149052105|NCT04927065|537673194|FG015|Second Booster|Physician Decision|0|||
149052106|NCT04927065|537673179|FG000|Second Booster|Withdrawal by Subject|0|||
149052107|NCT04927065|537673180|FG001|Second Booster|Withdrawal by Subject|0|||
149052108|NCT04927065|537673181|FG002|Second Booster|Withdrawal by Subject|4|||
149052109|NCT04927065|537673182|FG003|Second Booster|Withdrawal by Subject|0|||
149052110|NCT04927065|537673183|FG004|Second Booster|Withdrawal by Subject|0|||
149052111|NCT04927065|537673184|FG005|Second Booster|Withdrawal by Subject|0|||
149052112|NCT04927065|537673185|FG006|Second Booster|Withdrawal by Subject|0|||
149052113|NCT04927065|537673186|FG007|Second Booster|Withdrawal by Subject|0|||
149052114|NCT04927065|537673187|FG008|Second Booster|Withdrawal by Subject|0|||
149052115|NCT04927065|537673188|FG009|Second Booster|Withdrawal by Subject|0|||
149052116|NCT04927065|537673189|FG010|Second Booster|Withdrawal by Subject|3|||
149052117|NCT04927065|537673190|FG011|Second Booster|Withdrawal by Subject|16|||
149052118|NCT04927065|537673191|FG012|Second Booster|Withdrawal by Subject|13|||
149052119|NCT04927065|537673192|FG013|Second Booster|Withdrawal by Subject|9|||
149052120|NCT04927065|537673193|FG014|Second Booster|Withdrawal by Subject|0|||
149052121|NCT04927065|537673194|FG015|Second Booster|Withdrawal by Subject|0|||
149052122|NCT04927065|537673179|FG000|Second Booster|Other Than Specified|0|||
149052123|NCT04927065|537673180|FG001|Second Booster|Other Than Specified|0|||
149052124|NCT04927065|537673181|FG002|Second Booster|Other Than Specified|0|||
149052125|NCT04927065|537673182|FG003|Second Booster|Other Than Specified|0|||
149052126|NCT04927065|537673183|FG004|Second Booster|Other Than Specified|0|||
149052127|NCT04927065|537673184|FG005|Second Booster|Other Than Specified|0|||
149052128|NCT04927065|537673185|FG006|Second Booster|Other Than Specified|0|||
149052129|NCT04927065|537673186|FG007|Second Booster|Other Than Specified|0|||
148888354|NCT03347123|537070445|FG005|Overall Study|Reason not Specified|0|||
148888355|NCT03347123|537070446|FG006|Overall Study|Reason not Specified|0|||
148888356|NCT01121146|537070454|FG000|Overall Study|Death|17|||
148888357|NCT01121146|537070455|FG001|Overall Study|Death|15|||
148888358|NCT01121146|537070454|FG000|Overall Study|Adverse Event|2|||
148888359|NCT01121146|537070455|FG001|Overall Study|Adverse Event|11|||
148888360|NCT01121146|537070454|FG000|Overall Study|Lost to Follow-up|7|||
148888361|NCT01121146|537070455|FG001|Overall Study|Lost to Follow-up|16|||
148888362|NCT00346216|537070456|FG000|Overall Study|Other|181|||
148888363|NCT00346216|537070457|FG001|Overall Study|Other|231|||
148888364|NCT00346216|537070458|FG002|Overall Study|Other|205|||
148888365|NCT00346216|537070456|FG000|Overall Study|No longer willing to participate|600|||
148888366|NCT00346216|537070457|FG001|Overall Study|No longer willing to participate|606|||
148888367|NCT00346216|537070458|FG002|Overall Study|No longer willing to participate|585|||
148888368|NCT00346216|537070456|FG000|Overall Study|Withdrawal by Subject|661|||
148888369|NCT00346216|537070457|FG001|Overall Study|Withdrawal by Subject|692|||
148888370|NCT00346216|537070458|FG002|Overall Study|Withdrawal by Subject|651|||
148888371|NCT00346216|537070456|FG000|Overall Study|Lost to Follow-up|611|||
148888372|NCT00346216|537070457|FG001|Overall Study|Lost to Follow-up|588|||
148888373|NCT00346216|537070458|FG002|Overall Study|Lost to Follow-up|542|||
148888374|NCT00346216|537070456|FG000|Overall Study|Physician Decision|80|||
149052130|NCT04927065|537673187|FG008|Second Booster|Other Than Specified|0|||
149052131|NCT04927065|537673188|FG009|Second Booster|Other Than Specified|0|||
149052132|NCT04927065|537673189|FG010|Second Booster|Other Than Specified|1|||
149052133|NCT04927065|537673190|FG011|Second Booster|Other Than Specified|1|||
149052134|NCT04927065|537673191|FG012|Second Booster|Other Than Specified|4|||
149052135|NCT04927065|537673192|FG013|Second Booster|Other Than Specified|0|||
149052136|NCT04927065|537673193|FG014|Second Booster|Other Than Specified|0|||
149052137|NCT04927065|537673194|FG015|Second Booster|Other Than Specified|0|||
149052138|NCT04927065|537673179|FG000|Third Booster|Lost to Follow-up|0|||
149052139|NCT04927065|537673180|FG001|Third Booster|Lost to Follow-up|0|||
149052140|NCT04927065|537673181|FG002|Third Booster|Lost to Follow-up|0|||
148888375|NCT00346216|537070457|FG001|Overall Study|Physician Decision|76|||
148888376|NCT00346216|537070458|FG002|Overall Study|Physician Decision|59|||
148888377|NCT00346216|537070456|FG000|Overall Study|Does not meet entrance criteria|13|||
148888378|NCT00346216|537070457|FG001|Overall Study|Does not meet entrance criteria|10|||
148888379|NCT00346216|537070458|FG002|Overall Study|Does not meet entrance criteria|8|||
148888380|NCT00346216|537070456|FG000|Overall Study|Death|189|||
148888381|NCT00346216|537070457|FG001|Overall Study|Death|192|||
148888382|NCT00346216|537070458|FG002|Overall Study|Death|228|||
148888383|NCT00346216|537070456|FG000|Overall Study|Study terminated by sponsor|11|||
148888384|NCT00346216|537070457|FG001|Overall Study|Study terminated by sponsor|4|||
149052141|NCT04927065|537673182|FG003|Third Booster|Lost to Follow-up|0|||
149052142|NCT04927065|537673183|FG004|Third Booster|Lost to Follow-up|0|||
148888385|NCT00346216|537070458|FG002|Overall Study|Study terminated by sponsor|8|||
148888386|NCT00346216|537070456|FG000|Overall Study|Missing Subject Summary Status|62|||
148888387|NCT00346216|537070457|FG001|Overall Study|Missing Subject Summary Status|61|||
148888388|NCT00346216|537070458|FG002|Overall Study|Missing Subject Summary Status|62|||
148888389|NCT01276639|537070459|FG000|Week 0 to 16|Death|1|||
148888390|NCT01276639|537070460|FG001|Week 0 to 16|Death|0|||
148888391|NCT01276639|537070461|FG002|Week 0 to 16|Death|0|||
148888392|NCT01276639|537070462|FG003|Week 0 to 16|Death|0|||
148888393|NCT01276639|537070463|FG004|Week 0 to 16|Death|0|||
148888394|NCT01276639|537070459|FG000|Week 0 to 16|Adverse Event|11|||
148888395|NCT01276639|537070460|FG001|Week 0 to 16|Adverse Event|8|||
148888396|NCT01276639|537070461|FG002|Week 0 to 16|Adverse Event|11|||
148888397|NCT01276639|537070462|FG003|Week 0 to 16|Adverse Event|0|||
148888398|NCT01276639|537070463|FG004|Week 0 to 16|Adverse Event|0|||
148888399|NCT01276639|537070459|FG000|Week 0 to 16|Lack of Efficacy|20|||
148888400|NCT01276639|537070460|FG001|Week 0 to 16|Lack of Efficacy|15|||
148888401|NCT01276639|537070461|FG002|Week 0 to 16|Lack of Efficacy|25|||
148888402|NCT01276639|537070462|FG003|Week 0 to 16|Lack of Efficacy|0|||
148888403|NCT01276639|537070463|FG004|Week 0 to 16|Lack of Efficacy|0|||
148888404|NCT01276639|537070459|FG000|Week 0 to 16|Lost to Follow-up|3|||
148888405|NCT01276639|537070460|FG001|Week 0 to 16|Lost to Follow-up|5|||
148888406|NCT01276639|537070461|FG002|Week 0 to 16|Lost to Follow-up|3|||
148888407|NCT01276639|537070462|FG003|Week 0 to 16|Lost to Follow-up|0|||
148888408|NCT01276639|537070463|FG004|Week 0 to 16|Lost to Follow-up|0|||
148888409|NCT01276639|537070459|FG000|Week 0 to 16|Withdrawal by Subject|8|||
148888410|NCT01276639|537070460|FG001|Week 0 to 16|Withdrawal by Subject|5|||
148888411|NCT01276639|537070461|FG002|Week 0 to 16|Withdrawal by Subject|4|||
148888412|NCT01276639|537070462|FG003|Week 0 to 16|Withdrawal by Subject|0|||
148888413|NCT01276639|537070463|FG004|Week 0 to 16|Withdrawal by Subject|0|||
148888414|NCT01276639|537070459|FG000|Week 0 to 16|Other|7|||
148888415|NCT01276639|537070460|FG001|Week 0 to 16|Other|7|||
148888416|NCT01276639|537070461|FG002|Week 0 to 16|Other|2|||
148888417|NCT01276639|537070462|FG003|Week 0 to 16|Other|0|||
148888418|NCT01276639|537070463|FG004|Week 0 to 16|Other|0|||
148888419|NCT01276639|537070459|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
148888420|NCT01276639|537070460|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
148888421|NCT01276639|537070461|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
148888422|NCT01276639|537070462|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
148888423|NCT01276639|537070463|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
148888424|NCT01276639|537070459|FG000|Week 16 to 52|Death|1|||
148888425|NCT01276639|537070460|FG001|Week 16 to 52|Death|0|||
148888426|NCT01276639|537070461|FG002|Week 16 to 52|Death|0|||
148888427|NCT01276639|537070462|FG003|Week 16 to 52|Death|0|||
148888428|NCT01276639|537070463|FG004|Week 16 to 52|Death|0|||
149052143|NCT04927065|537673184|FG005|Third Booster|Lost to Follow-up|0|||
149052144|NCT04927065|537673185|FG006|Third Booster|Lost to Follow-up|0|||
149052145|NCT04927065|537673186|FG007|Third Booster|Lost to Follow-up|0|||
149052146|NCT04927065|537673187|FG008|Third Booster|Lost to Follow-up|0|||
148888429|NCT01276639|537070459|FG000|Week 16 to 52|Adverse Event|10|||
148888430|NCT01276639|537070460|FG001|Week 16 to 52|Adverse Event|13|||
148888431|NCT01276639|537070461|FG002|Week 16 to 52|Adverse Event|0|||
148888432|NCT01276639|537070462|FG003|Week 16 to 52|Adverse Event|1|||
148888433|NCT01276639|537070463|FG004|Week 16 to 52|Adverse Event|3|||
148888434|NCT01276639|537070459|FG000|Week 16 to 52|Lack of Efficacy|99|||
148888435|NCT01276639|537070460|FG001|Week 16 to 52|Lack of Efficacy|71|||
148888436|NCT01276639|537070461|FG002|Week 16 to 52|Lack of Efficacy|0|||
149052147|NCT04927065|537673188|FG009|Third Booster|Lost to Follow-up|0|||
149052148|NCT04927065|537673189|FG010|Third Booster|Lost to Follow-up|0|||
149052149|NCT04927065|537673190|FG011|Third Booster|Lost to Follow-up|0|||
149052150|NCT04927065|537673191|FG012|Third Booster|Lost to Follow-up|0|||
149052151|NCT04927065|537673192|FG013|Third Booster|Lost to Follow-up|0|||
148888437|NCT01276639|537070462|FG003|Week 16 to 52|Lack of Efficacy|14|||
148888438|NCT01276639|537070463|FG004|Week 16 to 52|Lack of Efficacy|13|||
148888439|NCT01276639|537070459|FG000|Week 16 to 52|Lost to Follow-up|3|||
148888440|NCT01276639|537070460|FG001|Week 16 to 52|Lost to Follow-up|1|||
148888441|NCT01276639|537070461|FG002|Week 16 to 52|Lost to Follow-up|0|||
148888442|NCT01276639|537070462|FG003|Week 16 to 52|Lost to Follow-up|0|||
148888443|NCT01276639|537070463|FG004|Week 16 to 52|Lost to Follow-up|1|||
148888444|NCT01276639|537070459|FG000|Week 16 to 52|Withdrawal by Subject|4|||
148888445|NCT01276639|537070460|FG001|Week 16 to 52|Withdrawal by Subject|4|||
148888446|NCT01276639|537070461|FG002|Week 16 to 52|Withdrawal by Subject|0|||
148888447|NCT01276639|537070462|FG003|Week 16 to 52|Withdrawal by Subject|0|||
149052152|NCT04927065|537673193|FG014|Third Booster|Lost to Follow-up|0|||
149052153|NCT04927065|537673194|FG015|Third Booster|Lost to Follow-up|1|||
149052154|NCT04927065|537673179|FG000|Third Booster|Withdrawal by Subject|0|||
149052155|NCT04927065|537673180|FG001|Third Booster|Withdrawal by Subject|0|||
149052156|NCT04927065|537673181|FG002|Third Booster|Withdrawal by Subject|0|||
149052157|NCT04927065|537673182|FG003|Third Booster|Withdrawal by Subject|0|||
149052158|NCT04927065|537673183|FG004|Third Booster|Withdrawal by Subject|0|||
149052159|NCT04927065|537673184|FG005|Third Booster|Withdrawal by Subject|0|||
149052160|NCT04927065|537673185|FG006|Third Booster|Withdrawal by Subject|0|||
149052161|NCT04927065|537673186|FG007|Third Booster|Withdrawal by Subject|0|||
149052162|NCT04927065|537673187|FG008|Third Booster|Withdrawal by Subject|0|||
149052163|NCT04927065|537673188|FG009|Third Booster|Withdrawal by Subject|0|||
149052164|NCT04927065|537673189|FG010|Third Booster|Withdrawal by Subject|0|||
149052165|NCT04927065|537673190|FG011|Third Booster|Withdrawal by Subject|0|||
149052166|NCT04927065|537673191|FG012|Third Booster|Withdrawal by Subject|0|||
149052167|NCT04927065|537673192|FG013|Third Booster|Withdrawal by Subject|0|||
149052168|NCT04927065|537673193|FG014|Third Booster|Withdrawal by Subject|0|||
149052169|NCT04927065|537673194|FG015|Third Booster|Withdrawal by Subject|1|||
149052170|NCT04588298|537673197|FG000|Overall Study|Adverse Event|0|||
149052171|NCT04588298|537673198|FG001|Overall Study|Adverse Event|0|||
149052172|NCT04588298|537673199|FG002|Overall Study|Adverse Event|1|||
149052173|NCT04588298|537673200|FG003|Overall Study|Adverse Event|0|||
149052174|NCT04588298|537673201|FG004|Overall Study|Adverse Event|2|||
149052175|NCT04588298|537673197|FG000|Overall Study|Withdrawal by Subject|1|||
149052176|NCT04588298|537673198|FG001|Overall Study|Withdrawal by Subject|0|||
149052177|NCT04588298|537673199|FG002|Overall Study|Withdrawal by Subject|0|||
149052178|NCT04588298|537673200|FG003|Overall Study|Withdrawal by Subject|1|||
149052179|NCT04588298|537673201|FG004|Overall Study|Withdrawal by Subject|0|||
149052180|NCT02243709|537673202|FG000|Phase 1|Lost to Follow-up|0|||
149052181|NCT02243709|537673203|FG001|Phase 1|Lost to Follow-up|1|||
149052182|NCT02243709|537673202|FG000|Phase 1|Withdrawal by Subject|1|||
149052183|NCT02243709|537673203|FG001|Phase 1|Withdrawal by Subject|0|||
149052184|NCT02243709|537673202|FG000|Phase 1|Protocol Violation|0|||
149052185|NCT02243709|537673203|FG001|Phase 1|Protocol Violation|1|||
149052186|NCT02243709|537673202|FG000|Phase 1|Adverse Event|0|||
149052187|NCT02243709|537673203|FG001|Phase 1|Adverse Event|1|||
149052188|NCT01748448|537673209|FG000|Treatment Period|Consent withdrawn by subject|1|||
149052189|NCT01748448|537673210|FG001|Treatment Period|Consent withdrawn by subject|0|||
149052190|NCT01748448|537673209|FG000|Treatment Period|Adverse Event|1|||
149052191|NCT01748448|537673210|FG001|Treatment Period|Adverse Event|0|||
149052192|NCT01748448|537673209|FG000|Treatment Period|Personal|0|||
149052193|NCT01748448|537673210|FG001|Treatment Period|Personal|1|||
149052194|NCT03924986|537673212|FG000|Overall Study|Death|57|||
149052195|NCT03924986|537673213|FG001|Overall Study|Death|66|||
148888448|NCT01276639|537070463|FG004|Week 16 to 52|Withdrawal by Subject|1|||
148888449|NCT01276639|537070459|FG000|Week 16 to 52|Other|10|||
148888450|NCT01276639|537070460|FG001|Week 16 to 52|Other|12|||
148888451|NCT01276639|537070461|FG002|Week 16 to 52|Other|0|||
148888452|NCT01276639|537070462|FG003|Week 16 to 52|Other|1|||
148888453|NCT01276639|537070463|FG004|Week 16 to 52|Other|3|||
148888454|NCT03985761|537070465|FG000|Overall Study|Withdrawal by Subject|2|||
148888455|NCT03985761|537070466|FG001|Overall Study|Withdrawal by Subject|3|||
148888456|NCT03400852|537070467|FG000|Blinded Treatment Period|Physician Decision|0|||
148888457|NCT03400852|537070468|FG001|Blinded Treatment Period|Physician Decision|1|||
148888458|NCT03400852|537070469|FG002|Blinded Treatment Period|Physician Decision|0|||
148888459|NCT03400852|537070467|FG000|Blinded Treatment Period|Adverse Event|1|||
148888460|NCT03400852|537070468|FG001|Blinded Treatment Period|Adverse Event|1|||
148888461|NCT03400852|537070469|FG002|Blinded Treatment Period|Adverse Event|0|||
148888462|NCT03400852|537070467|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
148888463|NCT03400852|537070468|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
148888464|NCT03400852|537070469|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
148888465|NCT03400852|537070467|FG000|Open Label Period|Physician Decision|0|||
148888466|NCT03400852|537070468|FG001|Open Label Period|Physician Decision|0|||
148888467|NCT03400852|537070469|FG002|Open Label Period|Physician Decision|1|||
148888468|NCT03400852|537070467|FG000|Open Label Period|Study terminated by sponsor|0|||
148888469|NCT03400852|537070468|FG001|Open Label Period|Study terminated by sponsor|0|||
148888470|NCT03400852|537070469|FG002|Open Label Period|Study terminated by sponsor|21|||
148888471|NCT01285401|537070470|FG000|Overall Study|Prematurely withdrawn from the study|17|||
148888472|NCT01285401|537070471|FG001|Overall Study|Prematurely withdrawn from the study|29|||
148888473|NCT02366312|537070472|FG000|Overall Study|Lost to Follow-up|0|||
148888474|NCT02366312|537070473|FG001|Overall Study|Lost to Follow-up|1|||
148888475|NCT02532465|537070474|FG000|Overall Study|Protocol Violation|1|||
148888476|NCT02532465|537070475|FG001|Overall Study|Protocol Violation|0|||
149052196|NCT03924986|537673212|FG000|Overall Study|Study Concluded by Sponsor|51|||
149052197|NCT03924986|537673213|FG001|Overall Study|Study Concluded by Sponsor|41|||
149052198|NCT03924986|537673212|FG000|Overall Study|Withdrawal by Subject|15|||
148888477|NCT02532465|537070474|FG000|Overall Study|Lack of Efficacy|0|||
149052199|NCT03924986|537673213|FG001|Overall Study|Withdrawal by Subject|20|||
148888478|NCT02532465|537070475|FG001|Overall Study|Lack of Efficacy|1|||
148888479|NCT03719131|537070477|FG000|Overall Study|Death|1|||
148888480|NCT03719131|537070478|FG001|Overall Study|Death|2|||
148888481|NCT01544920|537070479|FG000|Overall Study|Adverse Event|0|||
148888482|NCT01544920|537070480|FG001|Overall Study|Adverse Event|3|||
148888483|NCT01544920|537070479|FG000|Overall Study|Death|0|||
148888484|NCT01544920|537070480|FG001|Overall Study|Death|1|||
148888485|NCT01544920|537070479|FG000|Overall Study|Lost to Follow-up|11|||
148888486|NCT01544920|537070480|FG001|Overall Study|Lost to Follow-up|12|||
148888487|NCT01544920|537070479|FG000|Overall Study|Protocol Violation|0|||
148888488|NCT01544920|537070480|FG001|Overall Study|Protocol Violation|2|||
148888489|NCT01544920|537070479|FG000|Overall Study|Physician Decision|4|||
148888490|NCT01544920|537070480|FG001|Overall Study|Physician Decision|1|||
148888491|NCT01544920|537070479|FG000|Overall Study|Withdrawal by Subject|4|||
148888492|NCT01544920|537070480|FG001|Overall Study|Withdrawal by Subject|4|||
148888493|NCT00255190|537070484|FG000|Overall Study|Adverse Event|17|||
148888494|NCT00255190|537070485|FG001|Overall Study|Adverse Event|36|||
148888495|NCT00255190|537070484|FG000|Overall Study|Protocol Violation|2|||
148888496|NCT00255190|537070485|FG001|Overall Study|Protocol Violation|2|||
148888497|NCT00255190|537070484|FG000|Overall Study|Lost to Follow-up|10|||
148888498|NCT00255190|537070485|FG001|Overall Study|Lost to Follow-up|27|||
148888499|NCT00255190|537070484|FG000|Overall Study|Withdrew Consent|17|||
148888500|NCT00255190|537070485|FG001|Overall Study|Withdrew Consent|48|||
148888501|NCT00255190|537070484|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
148888502|NCT00255190|537070485|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
148888503|NCT00255190|537070484|FG000|Overall Study|Erosive esophagitis not healed|0|||
148888504|NCT00255190|537070485|FG001|Overall Study|Erosive esophagitis not healed|20|||
148888505|NCT00255190|537070484|FG000|Overall Study|Various|4|||
148888506|NCT00255190|537070485|FG001|Overall Study|Various|23|||
148888507|NCT01156480|537070487|FG000|Overall Study|change in diagnosis|0|||
148888508|NCT01156480|537070488|FG001|Overall Study|change in diagnosis|1|||
148888509|NCT04537793|537070489|FG000|Part B (24 Weeks)|Adverse Event|0|||
148888510|NCT04537793|537070490|FG001|Part B (24 Weeks)|Adverse Event|1|||
148888511|NCT03367858|537070491|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
148888512|NCT03367858|537070492|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
148888513|NCT03367858|537070491|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
148888514|NCT03367858|537070492|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
148888515|NCT03367858|537070491|FG000|3 Month Follow Up|Lost to Follow-up|8|||
148888516|NCT03367858|537070492|FG001|3 Month Follow Up|Lost to Follow-up|3|||
148888517|NCT03367858|537070491|FG000|3 Month Follow Up|Moved out of study area|2|||
149052200|NCT03924986|537673212|FG000|Overall Study|Lost to Follow-up|7|||
149052201|NCT03924986|537673213|FG001|Overall Study|Lost to Follow-up|5|||
149052202|NCT03924986|537673212|FG000|Overall Study|Miscellaneous|1|||
149052203|NCT03924986|537673213|FG001|Overall Study|Miscellaneous|0|||
149052204|NCT03699709|537673221|FG000|Overall Study|Death|1|||
149052205|NCT03699709|537673222|FG001|Overall Study|Death|2|||
149052206|NCT03699709|537673221|FG000|Overall Study|Lost to Follow-up|10|||
149052207|NCT03699709|537673222|FG001|Overall Study|Lost to Follow-up|3|||
149052208|NCT03699709|537673221|FG000|Overall Study|Withdrawal by Subject|5|||
149052209|NCT03699709|537673222|FG001|Overall Study|Withdrawal by Subject|0|||
149052210|NCT03699709|537673221|FG000|Overall Study|incarcerated|1|||
149052211|NCT03699709|537673222|FG001|Overall Study|incarcerated|0|||
149052212|NCT03699709|537673221|FG000|Overall Study|scheduled, but no show|0|||
149052213|NCT03699709|537673222|FG001|Overall Study|scheduled, but no show|1|||
149052214|NCT02689284|537673223|FG000|Overall Study|Adverse Event|1|||
149052215|NCT02689284|537673224|FG001|Overall Study|Adverse Event|8|||
149052216|NCT02689284|537673223|FG000|Overall Study|Death|0|||
149052217|NCT02689284|537673224|FG001|Overall Study|Death|1|||
149052218|NCT02689284|537673223|FG000|Overall Study|Physician Decision|1|||
149052219|NCT02689284|537673224|FG001|Overall Study|Physician Decision|2|||
149052220|NCT02689284|537673223|FG000|Overall Study|Withdrawal by Subject|0|||
149052221|NCT02689284|537673224|FG001|Overall Study|Withdrawal by Subject|1|||
149052222|NCT02689284|537673223|FG000|Overall Study|progression of cancer|1|||
149052223|NCT02689284|537673224|FG001|Overall Study|progression of cancer|72|||
149052224|NCT02689284|537673223|FG000|Overall Study|decreased heart function|0|||
149052225|NCT02689284|537673224|FG001|Overall Study|decreased heart function|1|||
149052226|NCT02689284|537673223|FG000|Overall Study|concern for anemia|0|||
149052227|NCT02689284|537673224|FG001|Overall Study|concern for anemia|1|||
149052228|NCT02689284|537673223|FG000|Overall Study|no measurable cancer for evaluation|0|||
148888518|NCT03367858|537070492|FG001|3 Month Follow Up|Moved out of study area|6|||
148888519|NCT03367858|537070491|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
148888520|NCT03367858|537070492|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
149052229|NCT02689284|537673224|FG001|Overall Study|no measurable cancer for evaluation|1|||
149052230|NCT03665597|537673225|FG000|Period 1|Adverse Event|1|||
149052231|NCT03665597|537673226|FG001|Period 1|Adverse Event|0|||
149052232|NCT03665597|537673227|FG002|Period 1|Adverse Event|0|||
149052233|NCT03665597|537673228|FG003|Period 1|Adverse Event|1|||
149052234|NCT03665597|537673229|FG004|Period 1|Adverse Event|0|||
148888521|NCT03367858|537070491|FG000|3 Month Follow Up|MRI contraindication|2|||
148888522|NCT03367858|537070492|FG001|3 Month Follow Up|MRI contraindication|1|||
148888523|NCT03367858|537070491|FG000|3 Month Follow Up|Incarcerated|0|||
148888524|NCT03367858|537070492|FG001|3 Month Follow Up|Incarcerated|1|||
148888525|NCT03367858|537070491|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
148888526|NCT03367858|537070492|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
148888527|NCT03367858|537070491|FG000|6 Month Follow Up|Lost to Follow-up|5|||
148888528|NCT03367858|537070492|FG001|6 Month Follow Up|Lost to Follow-up|2|||
148888529|NCT03367858|537070491|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
148888530|NCT03367858|537070492|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
148888531|NCT03367858|537070491|FG000|12 Month Follow Up|Lost to Follow-up|3|||
148888532|NCT03367858|537070492|FG001|12 Month Follow Up|Lost to Follow-up|3|||
148888533|NCT03367858|537070491|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
148888534|NCT03367858|537070492|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
148888535|NCT01176058|537070494|FG000|Overall Study|Adverse Event|1|||
148888536|NCT01176058|537070495|FG001|Overall Study|Adverse Event|0|||
148888537|NCT01176058|537070494|FG000|Overall Study|Insufficient clinical response|2|||
148888538|NCT01176058|537070495|FG001|Overall Study|Insufficient clinical response|2|||
148888539|NCT01176058|537070494|FG000|Overall Study|Insufficient mycological response|0|||
148888540|NCT01176058|537070495|FG001|Overall Study|Insufficient mycological response|1|||
148888541|NCT01176058|537070494|FG000|Overall Study|Withdrawal by Subject|1|||
148888542|NCT01176058|537070495|FG001|Overall Study|Withdrawal by Subject|0|||
148888543|NCT00256724|537070496|FG000|Overall Study|Physician Decision|2|||
148888544|NCT00256724|537070497|FG001|Overall Study|Physician Decision|5|||
148888545|NCT00256724|537070496|FG000|Overall Study|Protocol Violation|3|||
148888546|NCT00256724|537070497|FG001|Overall Study|Protocol Violation|3|||
148888547|NCT01217463|537070498|FG000|Overall Study|Adverse Event|8|||
148888548|NCT01217463|537070499|FG001|Overall Study|Adverse Event|5|||
148888549|NCT01217463|537070498|FG000|Overall Study|Physician Decision|0|||
148888550|NCT01217463|537070499|FG001|Overall Study|Physician Decision|1|||
148888551|NCT01217463|537070498|FG000|Overall Study|Withdrawal by Subject|3|||
148888552|NCT01217463|537070499|FG001|Overall Study|Withdrawal by Subject|0|||
148888553|NCT01217463|537070498|FG000|Overall Study|Surgery on the Target Limb|0|||
148888554|NCT01217463|537070499|FG001|Overall Study|Surgery on the Target Limb|1|||
148888555|NCT01217463|537070498|FG000|Overall Study|Patient Non-compliant|1|||
148888556|NCT01217463|537070499|FG001|Overall Study|Patient Non-compliant|0|||
148888557|NCT01217463|537070498|FG000|Overall Study|Other|1|||
148888558|NCT01217463|537070499|FG001|Overall Study|Other|1|||
148888559|NCT01569841|537070508|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
148888560|NCT01569841|537070509|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
148888561|NCT03901144|537070513|FG000|Overall Study|Lost to Follow-up|1|||
148888562|NCT03901144|537070514|FG001|Overall Study|Lost to Follow-up|1|||
148888563|NCT03901144|537070515|FG002|Overall Study|Lost to Follow-up|1|||
148888564|NCT03901144|537070516|FG003|Overall Study|Lost to Follow-up|1|||
148888565|NCT04445662|537070520|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
148888566|NCT04445662|537070521|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
148888567|NCT04445662|537070520|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
148888568|NCT04445662|537070521|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
148888569|NCT04445662|537070520|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
148888570|NCT04445662|537070521|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
148888571|NCT04445662|537070520|FG000|Post-treatment (12-24 weeks)|Death|1|||
148888572|NCT04445662|537070521|FG001|Post-treatment (12-24 weeks)|Death|0|||
148888573|NCT02488005|537070525|FG000|Overall Study|Lost to Follow-up|2|||
148888574|NCT03635424|537070526|FG000|Overall Study|Adverse Event|1|||
148888575|NCT03635424|537070526|FG000|Overall Study|Death|1|||
148888576|NCT03635424|537070526|FG000|Overall Study|Device not implanted|1|||
148888577|NCT01131507|537072215|FG000|Overall Study|Adverse Event|1|||
148888578|NCT01131507|537072215|FG000|Overall Study|Lost to Follow-up|1|||
148888579|NCT01131507|537072215|FG000|Overall Study|Withdrawal by Subject|1|||
148888580|NCT04388111|537072216|FG000|Overall Study|Lost to Follow-up|5|||
148888581|NCT04388111|537072217|FG001|Overall Study|Lost to Follow-up|3|||
148888582|NCT04388111|537072216|FG000|Overall Study|Adverse Event|1|||
149052235|NCT03665597|537673230|FG005|Period 1|Adverse Event|0|||
149052236|NCT03665597|537673231|FG006|Period 1|Adverse Event|0|||
149052237|NCT03665597|537673225|FG000|Period 1|Screen Failure|0|||
149052238|NCT03665597|537673226|FG001|Period 1|Screen Failure|0|||
149052239|NCT03665597|537673227|FG002|Period 1|Screen Failure|0|||
149052240|NCT03665597|537673228|FG003|Period 1|Screen Failure|1|||
149052241|NCT03665597|537673229|FG004|Period 1|Screen Failure|0|||
149052242|NCT03665597|537673230|FG005|Period 1|Screen Failure|0|||
149052243|NCT03665597|537673231|FG006|Period 1|Screen Failure|0|||
149052244|NCT03665597|537673225|FG000|Period 1|Death|0|||
149052245|NCT03665597|537673226|FG001|Period 1|Death|0|||
148888583|NCT04388111|537072217|FG001|Overall Study|Adverse Event|1|||
148888584|NCT04388111|537072216|FG000|Overall Study|Protocol Violation|2|||
148888585|NCT04388111|537072217|FG001|Overall Study|Protocol Violation|4|||
149052246|NCT03665597|537673227|FG002|Period 1|Death|0|||
149052247|NCT03665597|537673228|FG003|Period 1|Death|0|||
148888586|NCT04388111|537072216|FG000|Overall Study|Withdrawal by Subject|1|||
148888587|NCT04388111|537072217|FG001|Overall Study|Withdrawal by Subject|0|||
148888588|NCT01050634|537072220|FG000|Overall Study|Enrolled, but Not Treated|56|||
148888589|NCT01050634|537072220|FG000|Overall Study|Death|2|||
148888590|NCT01050634|537072220|FG000|Overall Study|Adverse Event|42|||
148888591|NCT01050634|537072220|FG000|Overall Study|Lost to Follow-up|2|||
148888592|NCT01050634|537072220|FG000|Overall Study|Other|21|||
148888593|NCT01050634|537072220|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
148888594|NCT01702844|537072221|FG000|Overall Study|Adverse Event|9|||
149052248|NCT03665597|537673229|FG004|Period 1|Death|0|||
149052249|NCT03665597|537673230|FG005|Period 1|Death|0|||
149052250|NCT03665597|537673231|FG006|Period 1|Death|45|||
149052251|NCT03665597|537673225|FG000|Period 1|Withdrawal by Subject|0|||
149052252|NCT03665597|537673226|FG001|Period 1|Withdrawal by Subject|0|||
149052253|NCT03665597|537673227|FG002|Period 1|Withdrawal by Subject|0|||
148888595|NCT01702844|537072221|FG000|Overall Study|Death|1|||
148888596|NCT01702844|537072221|FG000|Overall Study|Withdrawal by Subject|3|||
148888597|NCT01702844|537072221|FG000|Overall Study|Physician Decision|6|||
148888598|NCT03431441|537072222|FG000|Overall Study|Withdrawal by Subject|2|||
148888599|NCT03431441|537072222|FG000|Overall Study|Adverse Event|2|||
148888600|NCT03431441|537072222|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
148888601|NCT03956550|537072223|FG000|Overall Study|Sponsor decision|65|||
148888602|NCT03956550|537072224|FG001|Overall Study|Sponsor decision|66|||
149052254|NCT03665597|537673228|FG003|Period 1|Withdrawal by Subject|0|||
149052255|NCT03665597|537673229|FG004|Period 1|Withdrawal by Subject|0|||
149052256|NCT03665597|537673230|FG005|Period 1|Withdrawal by Subject|0|||
149052257|NCT03665597|537673231|FG006|Period 1|Withdrawal by Subject|5|||
149052258|NCT03665597|537673225|FG000|Period 2|Adverse Event|0|||
149052259|NCT03665597|537673226|FG001|Period 2|Adverse Event|0|||
148888603|NCT03956550|537072225|FG002|Overall Study|Sponsor decision|64|||
148888604|NCT03956550|537072223|FG000|Overall Study|Adverse Event|0|||
148888605|NCT03956550|537072224|FG001|Overall Study|Adverse Event|1|||
148888606|NCT03956550|537072225|FG002|Overall Study|Adverse Event|0|||
148888607|NCT03956550|537072223|FG000|Overall Study|Withdrawal by Subject|5|||
148888608|NCT03956550|537072224|FG001|Overall Study|Withdrawal by Subject|5|||
148888609|NCT03956550|537072225|FG002|Overall Study|Withdrawal by Subject|6|||
148888610|NCT03244917|537072231|FG000|Overall Study|Lost to Follow-up|2|||
148888611|NCT03244917|537072232|FG001|Overall Study|Lost to Follow-up|2|||
148888612|NCT01272232|537072233|FG000|Weeks 0-56|Adverse Event|39|||
148888613|NCT01272232|537072234|FG001|Weeks 0-56|Adverse Event|18|||
148888614|NCT01272232|537072235|FG002|Weeks 0-56|Adverse Event|7|||
148888615|NCT01272232|537072233|FG000|Weeks 0-56|Lack of Efficacy|0|||
148888616|NCT01272232|537072234|FG001|Weeks 0-56|Lack of Efficacy|0|||
148888617|NCT01272232|537072235|FG002|Weeks 0-56|Lack of Efficacy|3|||
148888618|NCT01272232|537072233|FG000|Weeks 0-56|Protocol Violation|12|||
148888619|NCT01272232|537072234|FG001|Weeks 0-56|Protocol Violation|8|||
149052260|NCT03665597|537673227|FG002|Period 2|Adverse Event|0|||
149052261|NCT03665597|537673228|FG003|Period 2|Adverse Event|0|||
149052262|NCT03665597|537673229|FG004|Period 2|Adverse Event|0|||
149052263|NCT03665597|537673230|FG005|Period 2|Adverse Event|1|||
149052264|NCT03665597|537673231|FG006|Period 2|Adverse Event|0|||
149052265|NCT03665597|537673225|FG000|Period 3|Adverse Event|0|||
149052266|NCT03665597|537673226|FG001|Period 3|Adverse Event|1|||
149052267|NCT03665597|537673227|FG002|Period 3|Adverse Event|0|||
149052268|NCT03665597|537673228|FG003|Period 3|Adverse Event|0|||
149052269|NCT03665597|537673229|FG004|Period 3|Adverse Event|0|||
149052270|NCT03665597|537673230|FG005|Period 3|Adverse Event|0|||
148888620|NCT01272232|537072235|FG002|Weeks 0-56|Protocol Violation|13|||
148888621|NCT01272232|537072233|FG000|Weeks 0-56|Withdrawal criteria|32|||
148888622|NCT01272232|537072234|FG001|Weeks 0-56|Withdrawal criteria|14|||
149052271|NCT03665597|537673231|FG006|Period 3|Adverse Event|0|||
149052272|NCT03665597|537673225|FG000|Period 3|Death|0|||
149052273|NCT03665597|537673226|FG001|Period 3|Death|0|||
149052274|NCT03665597|537673227|FG002|Period 3|Death|0|||
149052275|NCT03665597|537673228|FG003|Period 3|Death|0|||
149052276|NCT03665597|537673229|FG004|Period 3|Death|1|||
148888623|NCT01272232|537072235|FG002|Weeks 0-56|Withdrawal criteria|37|||
148888624|NCT01272232|537072233|FG000|Weeks 0-56|Unclassified|16|||
148888625|NCT01272232|537072234|FG001|Weeks 0-56|Unclassified|7|||
148888626|NCT01272232|537072235|FG002|Weeks 0-56|Unclassified|12|||
148888627|NCT01272232|537072233|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
148888628|NCT01272232|537072234|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
148888629|NCT01272232|537072235|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
148888630|NCT01272232|537072233|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
148888631|NCT01272232|537072234|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
148888632|NCT01272232|537072235|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
149052277|NCT03665597|537673230|FG005|Period 3|Death|0|||
149052278|NCT03665597|537673231|FG006|Period 3|Death|0|||
149052279|NCT03665597|537673225|FG000|Period 4|Adverse Event|2|||
149052280|NCT03665597|537673226|FG001|Period 4|Adverse Event|2|||
149052281|NCT03665597|537673227|FG002|Period 4|Adverse Event|2|||
149052282|NCT03665597|537673228|FG003|Period 4|Adverse Event|2|||
149052283|NCT03665597|537673229|FG004|Period 4|Adverse Event|1|||
148888633|NCT01272232|537072233|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
148888634|NCT01272232|537072234|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
148888635|NCT01272232|537072235|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
148888636|NCT01272232|537072233|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
148888637|NCT01272232|537072234|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
148888638|NCT01272232|537072235|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
148888639|NCT01272232|537072233|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
148888640|NCT01272232|537072234|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
148888641|NCT01272232|537072235|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
148888642|NCT00796666|537072236|FG000|Overall Study|Death|2|||
148888643|NCT00796666|537072237|FG001|Overall Study|Death|4|||
148888644|NCT00796666|537072236|FG000|Overall Study|Withdrawal by Subject|2|||
148888645|NCT00796666|537072237|FG001|Overall Study|Withdrawal by Subject|0|||
148888646|NCT00796666|537072236|FG000|Overall Study|Adverse Event|7|||
148888647|NCT00796666|537072237|FG001|Overall Study|Adverse Event|5|||
148888648|NCT00796666|537072236|FG000|Overall Study|Protocol Violation|1|||
148888649|NCT00796666|537072237|FG001|Overall Study|Protocol Violation|0|||
148888650|NCT00796666|537072236|FG000|Overall Study|Other|1|||
148888651|NCT00796666|537072237|FG001|Overall Study|Other|0|||
148888652|NCT00796666|537072236|FG000|Overall Study|Terminated by sponsor|53|||
148888653|NCT00796666|537072237|FG001|Overall Study|Terminated by sponsor|55|||
148888654|NCT00796666|537072236|FG000|Overall Study|Randomized and not treated|1|||
148888655|NCT00796666|537072237|FG001|Overall Study|Randomized and not treated|0|||
148888656|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
148888657|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
148888658|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
148888659|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888660|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888661|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888662|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888663|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888664|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888665|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888666|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888667|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888668|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
148888669|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
148888670|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
149052284|NCT03665597|537673230|FG005|Period 4|Adverse Event|0|||
149052285|NCT03665597|537673231|FG006|Period 4|Adverse Event|0|||
149052286|NCT03665597|537673225|FG000|Period 4|Death|0|||
149052287|NCT03665597|537673226|FG001|Period 4|Death|0|||
149052288|NCT03665597|537673227|FG002|Period 4|Death|2|||
149052289|NCT03665597|537673228|FG003|Period 4|Death|0|||
149052290|NCT03665597|537673229|FG004|Period 4|Death|0|||
149052291|NCT03665597|537673230|FG005|Period 4|Death|0|||
149052292|NCT03665597|537673231|FG006|Period 4|Death|0|||
149052293|NCT03665597|537673225|FG000|Period 4|Physician Decision|1|||
149052294|NCT03665597|537673226|FG001|Period 4|Physician Decision|2|||
149052295|NCT03665597|537673227|FG002|Period 4|Physician Decision|0|||
149052296|NCT03665597|537673228|FG003|Period 4|Physician Decision|0|||
149052297|NCT03665597|537673229|FG004|Period 4|Physician Decision|0|||
149052298|NCT03665597|537673230|FG005|Period 4|Physician Decision|0|||
149052299|NCT03665597|537673231|FG006|Period 4|Physician Decision|0|||
149052300|NCT02913872|537673236|FG000|Overall Study|Withdrawal by Subject|1|||
149052301|NCT03519581|537673241|FG000|Overall Study|Lost to Follow-up|3|||
149052302|NCT03519581|537673242|FG001|Overall Study|Lost to Follow-up|2|||
149052303|NCT03519581|537673241|FG000|Overall Study|Adverse Event|5|||
149052304|NCT03519581|537673242|FG001|Overall Study|Adverse Event|2|||
149052305|NCT03519581|537673241|FG000|Overall Study|Withdrawal by Subject|2|||
148888671|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
148888672|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
148888673|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
148888674|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
149052306|NCT03519581|537673242|FG001|Overall Study|Withdrawal by Subject|0|||
149052307|NCT03519581|537673241|FG000|Overall Study|Change to insurance|2|||
149052308|NCT03519581|537673242|FG001|Overall Study|Change to insurance|1|||
148888675|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
148888676|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
148888677|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
149052309|NCT03519581|537673241|FG000|Overall Study|Other|2|||
149052310|NCT03519581|537673242|FG001|Overall Study|Other|4|||
149052311|NCT05516147|537673243|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
149052312|NCT03110315|537673244|FG000|Overall Study|Withdrawal by Subject|1|||
149052313|NCT03110315|537673245|FG001|Overall Study|Withdrawal by Subject|0|||
148888678|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
148888679|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
148888680|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
148888681|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
148888682|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
148888683|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
148888684|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
148888685|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
148888686|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
148888687|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
148888688|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
148888689|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
148888690|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
148888691|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
148888692|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
148888693|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
148888694|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
148888695|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
148888696|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
148888697|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
148888698|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
148888699|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
148888700|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
148888701|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
148888702|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888703|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888704|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
148888705|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888706|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888707|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888708|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888709|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888710|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888711|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
148888712|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888713|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888714|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888715|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
148888716|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888717|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888718|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888719|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888720|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
148888721|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
148888722|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888723|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
148888724|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888725|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
148888726|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888727|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
148888728|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888729|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
148888730|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
148888731|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888732|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888733|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888734|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
148888735|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888736|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888737|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888738|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888739|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888740|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888741|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
148888742|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888743|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888744|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
149005349|NCT02798211|537497877|FG004|Period 2|Withdrawal by Subject|2|||
148888745|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
148888746|NCT01147666|537072238|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888747|NCT01147666|537072239|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888748|NCT01147666|537072240|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888749|NCT01147666|537072241|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888750|NCT01147666|537072242|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888751|NCT01147666|537072243|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888752|NCT01147666|537072244|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888753|NCT01147666|537072245|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888754|NCT01147666|537072246|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888755|NCT01147666|537072247|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888756|NCT01147666|537072248|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888757|NCT01147666|537072249|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
148888758|NCT01147666|537072250|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
148888759|NCT01147666|537072251|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
148888760|NCT01147666|537072252|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
148888761|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
148888762|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
148888763|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
149005350|NCT02798211|537497878|FG005|Period 2|Withdrawal by Subject|2|||
149005351|NCT02798211|537497873|FG000|Period 2|Adverse Event|5|||
149005352|NCT02798211|537497874|FG001|Period 2|Adverse Event|0|||
149005353|NCT02798211|537497875|FG002|Period 2|Adverse Event|0|||
149005354|NCT02798211|537497876|FG003|Period 2|Adverse Event|0|||
149005355|NCT02798211|537497877|FG004|Period 2|Adverse Event|1|||
149005356|NCT02798211|537497878|FG005|Period 2|Adverse Event|0|||
149005357|NCT02798211|537497873|FG000|Period 2|Lack of Efficacy|1|||
149005358|NCT02798211|537497874|FG001|Period 2|Lack of Efficacy|0|||
149005359|NCT02798211|537497875|FG002|Period 2|Lack of Efficacy|0|||
149005360|NCT02798211|537497876|FG003|Period 2|Lack of Efficacy|1|||
149005361|NCT02798211|537497877|FG004|Period 2|Lack of Efficacy|0|||
149005362|NCT02798211|537497878|FG005|Period 2|Lack of Efficacy|1|||
149005363|NCT02798211|537497873|FG000|Period 2|Lost to Follow-up|3|||
149005364|NCT02798211|537497874|FG001|Period 2|Lost to Follow-up|0|||
149005365|NCT02798211|537497875|FG002|Period 2|Lost to Follow-up|0|||
149005366|NCT02798211|537497876|FG003|Period 2|Lost to Follow-up|0|||
149005367|NCT02798211|537497877|FG004|Period 2|Lost to Follow-up|2|||
149005368|NCT02798211|537497878|FG005|Period 2|Lost to Follow-up|0|||
149005369|NCT02798211|537497873|FG000|Period 2|Physician Decision|1|||
149005370|NCT02798211|537497874|FG001|Period 2|Physician Decision|0|||
149005371|NCT02798211|537497875|FG002|Period 2|Physician Decision|0|||
149005372|NCT02798211|537497876|FG003|Period 2|Physician Decision|1|||
149005373|NCT02798211|537497877|FG004|Period 2|Physician Decision|1|||
149005374|NCT02798211|537497878|FG005|Period 2|Physician Decision|0|||
149005375|NCT02798211|537497873|FG000|Period 2|Pregnancy|0|||
149005376|NCT02798211|537497874|FG001|Period 2|Pregnancy|0|||
149005377|NCT02798211|537497875|FG002|Period 2|Pregnancy|0|||
149005378|NCT02798211|537497876|FG003|Period 2|Pregnancy|2|||
149005379|NCT02798211|537497877|FG004|Period 2|Pregnancy|0|||
149005380|NCT02798211|537497878|FG005|Period 2|Pregnancy|0|||
149005381|NCT02798211|537497873|FG000|Period 2|Technical problems|1|||
149005382|NCT02798211|537497874|FG001|Period 2|Technical problems|0|||
149005383|NCT02798211|537497875|FG002|Period 2|Technical problems|0|||
149005384|NCT02798211|537497876|FG003|Period 2|Technical problems|1|||
149005385|NCT02798211|537497877|FG004|Period 2|Technical problems|0|||
149005386|NCT02798211|537497878|FG005|Period 2|Technical problems|0|||
149005387|NCT02798211|537497873|FG000|Period 2|Withdrawal of Informed Consent|1|||
149005388|NCT02798211|537497874|FG001|Period 2|Withdrawal of Informed Consent|0|||
149005389|NCT02798211|537497875|FG002|Period 2|Withdrawal of Informed Consent|0|||
149005390|NCT02798211|537497876|FG003|Period 2|Withdrawal of Informed Consent|2|||
149005391|NCT02798211|537497877|FG004|Period 2|Withdrawal of Informed Consent|2|||
149005392|NCT02798211|537497878|FG005|Period 2|Withdrawal of Informed Consent|3|||
149005393|NCT03086018|537497879|FG000|Final Testing for End of Trial|Adverse Event|1|||
149005394|NCT03086018|537497879|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
149005395|NCT01782872|537497880|FG000|Overall Study|Protocol Violation|0|||
149005396|NCT01782872|537497881|FG001|Overall Study|Protocol Violation|0|||
149005397|NCT01782872|537497882|FG002|Overall Study|Protocol Violation|0|||
149005398|NCT01782872|537497883|FG003|Overall Study|Protocol Violation|1|||
149005399|NCT01782872|537497880|FG000|Overall Study|Withdrawal by Subject|0|||
149005400|NCT01782872|537497881|FG001|Overall Study|Withdrawal by Subject|1|||
149005401|NCT01782872|537497882|FG002|Overall Study|Withdrawal by Subject|0|||
149005402|NCT01782872|537497883|FG003|Overall Study|Withdrawal by Subject|0|||
149005403|NCT01892345|537497884|FG000|Overall Study|Adverse Event|0|||
149005404|NCT01892345|537497885|FG001|Overall Study|Adverse Event|2|||
149052314|NCT03281291|537675525|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
149052315|NCT03281291|537675526|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
149052316|NCT03281291|537675527|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
149052317|NCT03281291|537675528|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
149052318|NCT03281291|537675529|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
149052319|NCT03281291|537675525|FG000|Overall Study|Protocol Deviation|2|||
149052320|NCT03281291|537675526|FG001|Overall Study|Protocol Deviation|0|||
149052321|NCT03281291|537675527|FG002|Overall Study|Protocol Deviation|1|||
149052322|NCT03281291|537675528|FG003|Overall Study|Protocol Deviation|2|||
149052323|NCT03281291|537675529|FG004|Overall Study|Protocol Deviation|1|||
149052324|NCT03281291|537675525|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
149052325|NCT03281291|537675526|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
149052326|NCT03281291|537675527|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
149052327|NCT03281291|537675528|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
149052328|NCT03281291|537675529|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
149052329|NCT03281291|537675525|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
149052330|NCT03281291|537675526|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
149052331|NCT03281291|537675527|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
149052332|NCT03281291|537675528|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
149052333|NCT03281291|537675529|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
149052334|NCT03281291|537675525|FG000|Overall Study|Lost to Follow-up|10|||
149052335|NCT03281291|537675526|FG001|Overall Study|Lost to Follow-up|10|||
149052336|NCT03281291|537675527|FG002|Overall Study|Lost to Follow-up|4|||
149052337|NCT03281291|537675528|FG003|Overall Study|Lost to Follow-up|6|||
149052338|NCT03281291|537675529|FG004|Overall Study|Lost to Follow-up|10|||
149052339|NCT03281291|537675525|FG000|Overall Study|Other|0|||
149052340|NCT03281291|537675526|FG001|Overall Study|Other|2|||
149052341|NCT03281291|537675527|FG002|Overall Study|Other|0|||
149052342|NCT03281291|537675528|FG003|Overall Study|Other|2|||
149052343|NCT03281291|537675529|FG004|Overall Study|Other|1|||
149052344|NCT02736409|537675530|FG000|Overall Study|Withdrawal by Subject|4|||
149052345|NCT02736409|537675531|FG001|Overall Study|Withdrawal by Subject|2|||
149052346|NCT02736409|537675532|FG002|Overall Study|Withdrawal by Subject|17|||
149052347|NCT02736409|537675533|FG003|Overall Study|Withdrawal by Subject|3|||
149052348|NCT02736409|537675530|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149052349|NCT02736409|537675531|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149052350|NCT02736409|537675532|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149052351|NCT02736409|537675533|FG003|Overall Study|Non-Compliance with Study Drug|1|||
149052352|NCT02736409|537675530|FG000|Overall Study|Adverse Event|0|||
149052353|NCT02736409|537675531|FG001|Overall Study|Adverse Event|1|||
149052354|NCT02736409|537675532|FG002|Overall Study|Adverse Event|5|||
149052355|NCT02736409|537675533|FG003|Overall Study|Adverse Event|4|||
149052356|NCT02736409|537675530|FG000|Overall Study|Other|0|||
149052357|NCT02736409|537675531|FG001|Overall Study|Other|0|||
149052358|NCT02736409|537675532|FG002|Overall Study|Other|1|||
149052359|NCT02736409|537675533|FG003|Overall Study|Other|1|||
149052360|NCT02736409|537675530|FG000|Overall Study|Pregnancy|0|||
149052361|NCT02736409|537675531|FG001|Overall Study|Pregnancy|0|||
149052362|NCT02736409|537675532|FG002|Overall Study|Pregnancy|1|||
149052363|NCT02736409|537675533|FG003|Overall Study|Pregnancy|0|||
149052364|NCT02736409|537675530|FG000|Overall Study|Lost to Follow-up|0|||
149052365|NCT02736409|537675531|FG001|Overall Study|Lost to Follow-up|0|||
149052366|NCT02736409|537675532|FG002|Overall Study|Lost to Follow-up|2|||
149052367|NCT02736409|537675533|FG003|Overall Study|Lost to Follow-up|1|||
149052368|NCT02736409|537675530|FG000|Overall Study|Physician Decision|0|||
149052369|NCT02736409|537675531|FG001|Overall Study|Physician Decision|0|||
149052370|NCT02736409|537675532|FG002|Overall Study|Physician Decision|0|||
149052371|NCT02736409|537675533|FG003|Overall Study|Physician Decision|2|||
149052372|NCT04390048|537675534|FG000|Overall Study|Withdrawal by Subject|1|||
149052373|NCT04390048|537675535|FG001|Overall Study|Withdrawal by Subject|3|||
149052374|NCT01415154|537675536|FG000|Overall Study|Lack of Efficacy|4|||
149052375|NCT01415154|537675537|FG001|Overall Study|Lack of Efficacy|5|||
149052376|NCT01415154|537675536|FG000|Overall Study|Withdrawal by Subject|7|||
149052377|NCT01415154|537675537|FG001|Overall Study|Withdrawal by Subject|8|||
149052378|NCT01415154|537675536|FG000|Overall Study|Lost to Follow-up|1|||
149052379|NCT01415154|537675537|FG001|Overall Study|Lost to Follow-up|4|||
149052380|NCT01415154|537675536|FG000|Overall Study|Protocol Violation|0|||
149052381|NCT01415154|537675537|FG001|Overall Study|Protocol Violation|1|||
149052382|NCT01415154|537675536|FG000|Overall Study|Satisfactory Response|0|||
149052383|NCT01415154|537675537|FG001|Overall Study|Satisfactory Response|1|||
149052384|NCT01415154|537675536|FG000|Overall Study|Adverse Event|1|||
149052385|NCT01415154|537675537|FG001|Overall Study|Adverse Event|1|||
149052386|NCT03126019|537675539|FG000|Overall Study|Death|5|||
149052387|NCT03126019|537675540|FG001|Overall Study|Death|27|||
149052388|NCT03126019|537675539|FG000|Overall Study|Lost to Follow-up|2|||
149052389|NCT03126019|537675540|FG001|Overall Study|Lost to Follow-up|4|||
149052390|NCT03126019|537675539|FG000|Overall Study|Withdrawal by Subject|1|||
149052391|NCT03126019|537675540|FG001|Overall Study|Withdrawal by Subject|9|||
149052392|NCT03126019|537675539|FG000|Overall Study|Physician Decision|1|||
149052393|NCT03126019|537675540|FG001|Overall Study|Physician Decision|0|||
149052394|NCT03126019|537675539|FG000|Overall Study|Transitioned to Rollover Study|0|||
149052395|NCT03126019|537675540|FG001|Overall Study|Transitioned to Rollover Study|11|||
149052396|NCT03126019|537675539|FG000|Overall Study|Did Not Return to Site for Care|0|||
149052397|NCT03126019|537675540|FG001|Overall Study|Did Not Return to Site for Care|1|||
149052398|NCT03126019|537675539|FG000|Overall Study|Site Closed|0|||
149052399|NCT03126019|537675540|FG001|Overall Study|Site Closed|1|||
149052400|NCT00170573|537675543|FG000|Overall Study|Violation of inclusion criteria|13|||
149052401|NCT05687916|537675575|FG000|Overall Study|Adverse Event|1|||
149052402|NCT05687916|537675576|FG001|Overall Study|Adverse Event|2|||
149052403|NCT05687916|537675577|FG002|Overall Study|Adverse Event|0|||
149052404|NCT05687916|537675575|FG000|Overall Study|Withdrawal by Subject|1|||
149052405|NCT05687916|537675576|FG001|Overall Study|Withdrawal by Subject|0|||
149052406|NCT05687916|537675577|FG002|Overall Study|Withdrawal by Subject|1|||
149052407|NCT05687916|537675575|FG000|Overall Study|Protocol Violation|0|||
149052408|NCT05687916|537675576|FG001|Overall Study|Protocol Violation|2|||
149052409|NCT05687916|537675577|FG002|Overall Study|Protocol Violation|1|||
149052410|NCT05687916|537675575|FG000|Overall Study|Reason not Specified|1|||
149052411|NCT05687916|537675576|FG001|Overall Study|Reason not Specified|0|||
149052412|NCT05687916|537675577|FG002|Overall Study|Reason not Specified|0|||
149052413|NCT03332017|537675578|FG000|Overall Study|Lost to Follow-up|1|||
149052414|NCT03332017|537675579|FG001|Overall Study|Lost to Follow-up|2|||
149052415|NCT03332017|537675578|FG000|Overall Study|Death|17|||
149052416|NCT03332017|537675579|FG001|Overall Study|Death|16|||
149052417|NCT03332017|537675578|FG000|Overall Study|Withdrawal by Subject|6|||
149052418|NCT03332017|537675579|FG001|Overall Study|Withdrawal by Subject|14|||
149052419|NCT03332017|537675578|FG000|Overall Study|Other|1|||
149052420|NCT03332017|537675579|FG001|Overall Study|Other|3|||
149052421|NCT03332017|537675578|FG000|Overall Study|Remained in Study (Ongoing)|47|||
149052422|NCT03332017|537675579|FG001|Overall Study|Remained in Study (Ongoing)|110|||
149052423|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
149052424|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
149052425|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
149052426|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052427|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052428|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052429|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052430|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052431|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052432|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052433|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052434|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052435|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
149052436|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
149052437|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
149052438|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052439|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052440|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052441|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052442|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052443|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052444|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052445|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052446|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052447|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052448|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
149052449|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
149052450|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
149052451|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052452|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052453|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052454|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052455|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052456|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052457|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052458|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052459|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052460|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052461|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
149052462|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
149052463|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
149052464|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052465|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052466|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052467|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052468|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052469|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052470|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052471|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052472|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052473|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052474|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
149052475|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
149052476|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
149052477|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
149052478|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052479|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052480|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052481|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052482|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052483|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052484|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052485|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052486|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052487|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
149052488|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
149052489|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
149052490|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
149052491|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052492|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052493|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052494|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052495|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052496|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052497|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052498|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052499|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052500|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
149052501|NCT01261312|537675580|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
149052502|NCT01261312|537675581|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052503|NCT01261312|537675582|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
149052504|NCT01261312|537675583|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052505|NCT01261312|537675584|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052506|NCT01261312|537675585|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052507|NCT01261312|537675586|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052508|NCT01261312|537675587|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052509|NCT01261312|537675588|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052510|NCT01261312|537675589|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052511|NCT01261312|537675590|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052512|NCT01261312|537675591|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052513|NCT01261312|537675592|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
149052514|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052515|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052516|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052517|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
149052518|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
148888764|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
149052519|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
149052520|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052521|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052522|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052523|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052524|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052525|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052526|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
149052527|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052528|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052529|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052530|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052531|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
149052532|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
149052533|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052534|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052535|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052536|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052537|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052538|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052539|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
149052540|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052541|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052542|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052543|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052544|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
149052545|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
149052546|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052547|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052548|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052549|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052550|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052551|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052552|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
149052553|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052554|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052555|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052556|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
149052557|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
149052558|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
149052559|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052560|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052561|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052562|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052563|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052564|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052565|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
149052566|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052567|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052568|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052569|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052570|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052571|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
149052572|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052573|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052574|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052575|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052576|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052577|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052578|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
149052579|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052580|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052581|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052582|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
149052583|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
149052584|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
149052585|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052586|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052587|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052588|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052589|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052590|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052591|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
149052592|NCT01261312|537675580|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052593|NCT01261312|537675581|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052594|NCT01261312|537675582|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052595|NCT01261312|537675583|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
149052596|NCT01261312|537675584|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
149052597|NCT01261312|537675585|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
149052598|NCT01261312|537675586|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052599|NCT01261312|537675587|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052600|NCT01261312|537675588|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052601|NCT01261312|537675589|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052602|NCT01261312|537675590|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052603|NCT01261312|537675591|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052604|NCT01261312|537675592|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
149052605|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052606|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052607|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052608|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052609|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052610|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052611|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
149052612|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
149052613|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
149052614|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052615|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052616|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052617|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
149052618|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052619|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052620|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052621|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052622|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052623|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052624|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052625|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
149052626|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
149052627|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052628|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052629|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052630|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
149052631|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052632|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052633|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052634|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052635|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052636|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052637|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
149052638|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
149052639|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
149052640|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052641|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052642|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052643|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
149052644|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
149052645|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
149052646|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
149052647|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
149052648|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
149052649|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
149052650|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
149052651|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
149052652|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
148888765|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
148888766|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
148888767|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
148888768|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
148888769|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
148888770|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
148888771|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
148888772|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
148888773|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
149052653|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
149052654|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
149052655|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
149052656|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
149052657|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052658|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052659|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052660|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052661|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052662|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052663|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
149052664|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
149052665|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
149052666|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052667|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052668|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052669|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
149052670|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052671|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052672|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052673|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052674|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052675|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052676|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
149052677|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
149052678|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
149052679|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052680|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052681|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052682|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
149052683|NCT01261312|537675580|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052684|NCT01261312|537675581|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052685|NCT01261312|537675582|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052686|NCT01261312|537675583|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052687|NCT01261312|537675584|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052688|NCT01261312|537675585|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052689|NCT01261312|537675586|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
149052690|NCT01261312|537675587|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
149052691|NCT01261312|537675588|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
149052692|NCT01261312|537675589|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052693|NCT01261312|537675590|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052694|NCT01261312|537675591|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052695|NCT01261312|537675592|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
149052696|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052697|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052698|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052699|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052700|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052701|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052702|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052703|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052704|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
149052705|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
149052706|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
149052707|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
149052708|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
149052709|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052710|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
148888774|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
148888775|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
149052711|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052712|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052713|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052714|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052715|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052716|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052717|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052718|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
149052719|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
149052720|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
149052721|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
149052722|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052723|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052724|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052725|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052726|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052727|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052728|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052729|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052730|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
149052731|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
149052732|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
149052733|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
149052734|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
149052735|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052736|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052737|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052738|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052739|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052740|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052741|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052742|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052743|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
149052744|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
149052745|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
149052746|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
149052747|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
149052748|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052749|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052750|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052751|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052752|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052753|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052754|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052755|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052756|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
149052757|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
149052758|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
149052759|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
149052760|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
149052761|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052762|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052763|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052764|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052765|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052766|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052767|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052768|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052769|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
149052770|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
149052771|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
149052772|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
149052773|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
149052774|NCT01261312|537675580|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052775|NCT01261312|537675581|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052776|NCT01261312|537675582|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052777|NCT01261312|537675583|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052778|NCT01261312|537675584|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052779|NCT01261312|537675585|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052780|NCT01261312|537675586|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052781|NCT01261312|537675587|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052782|NCT01261312|537675588|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
149052783|NCT01261312|537675589|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
149052784|NCT01261312|537675590|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
149052785|NCT01261312|537675591|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
149052786|NCT01261312|537675592|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
149052787|NCT03406871|537675595|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
149052788|NCT03406871|537675596|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
149052789|NCT03406871|537675597|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
149052790|NCT03406871|537675595|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
149052791|NCT03406871|537675596|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
149052792|NCT03406871|537675597|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
149052793|NCT03406871|537675595|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
149052794|NCT03406871|537675596|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
149052795|NCT03406871|537675597|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
149052796|NCT03406871|537675595|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
149052797|NCT03406871|537675596|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
149052798|NCT03406871|537675597|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
149052799|NCT03406871|537675595|FG000|Expansion Cohort(Final Analysis)|Death|0|||
149052800|NCT03406871|537675596|FG001|Expansion Cohort(Final Analysis)|Death|1|||
149052801|NCT03406871|537675597|FG002|Expansion Cohort(Final Analysis)|Death|0|||
149052802|NCT03406871|537675595|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
149052803|NCT03406871|537675596|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
149052804|NCT03406871|537675597|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
149052805|NCT04021602|537675610|FG000|Overall Study|Lost to Follow-up|3|||
149052806|NCT04021602|537675611|FG001|Overall Study|Lost to Follow-up|3|||
149052807|NCT04021602|537675612|FG002|Overall Study|Lost to Follow-up|1|||
149052808|NCT04021602|537675610|FG000|Overall Study|Adverse Event|1|||
149052809|NCT04021602|537675611|FG001|Overall Study|Adverse Event|0|||
149052810|NCT04021602|537675612|FG002|Overall Study|Adverse Event|1|||
149052811|NCT03535272|537675613|FG000|Overall Study|Lost to Follow-up|71|||
149052812|NCT03535272|537675614|FG001|Overall Study|Lost to Follow-up|73|||
149052813|NCT03892616|537675615|FG000|Washout Period 2|Met discontinuation criterion|0|||
149052814|NCT03892616|537675616|FG001|Washout Period 2|Met discontinuation criterion|0|||
149052815|NCT03892616|537675617|FG002|Washout Period 2|Met discontinuation criterion|0|||
149052816|NCT03892616|537675618|FG003|Washout Period 2|Met discontinuation criterion|0|||
149052817|NCT03892616|537675619|FG004|Washout Period 2|Met discontinuation criterion|0|||
149052818|NCT03892616|537675620|FG005|Washout Period 2|Met discontinuation criterion|0|||
149052819|NCT03892616|537675621|FG006|Washout Period 2|Met discontinuation criterion|0|||
149052820|NCT03892616|537675622|FG007|Washout Period 2|Met discontinuation criterion|0|||
149052821|NCT03892616|537675623|FG008|Washout Period 2|Met discontinuation criterion|1|||
149052822|NCT03892616|537675624|FG009|Washout Period 2|Met discontinuation criterion|0|||
149052823|NCT03892616|537675625|FG010|Washout Period 2|Met discontinuation criterion|0|||
149052824|NCT03892616|537675626|FG011|Washout Period 2|Met discontinuation criterion|0|||
149052825|NCT04347161|537675630|FG000|Overall Study|Death|0|||
149052826|NCT04347161|537675631|FG001|Overall Study|Death|2|||
149052827|NCT04347161|537675630|FG000|Overall Study|Withdrawal by Subject|1|||
149052828|NCT04347161|537675631|FG001|Overall Study|Withdrawal by Subject|0|||
149052829|NCT04347161|537675630|FG000|Overall Study|Lost to Follow-up|0|||
149052830|NCT04347161|537675631|FG001|Overall Study|Lost to Follow-up|1|||
149052831|NCT04347161|537675630|FG000|Overall Study|No longer on study medication|1|||
149052832|NCT04347161|537675631|FG001|Overall Study|No longer on study medication|1|||
149052833|NCT04169373|537675632|FG000|Week 1 to Week 14|Adverse Event|1|||
149052834|NCT04169373|537675633|FG001|Week 1 to Week 14|Adverse Event|0|||
149052835|NCT04169373|537675634|FG002|Week 1 to Week 14|Adverse Event|1|||
149052836|NCT04169373|537675635|FG003|Week 1 to Week 14|Adverse Event|2|||
149052837|NCT04169373|537675632|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
149052838|NCT04169373|537675633|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
149052839|NCT04169373|537675634|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
149052840|NCT04169373|537675635|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
149052841|NCT04169373|537675632|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
149052842|NCT04169373|537675633|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
149052843|NCT04169373|537675634|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
149052844|NCT04169373|537675635|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
149052845|NCT04169373|537675632|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
149052846|NCT04169373|537675633|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
149052847|NCT04169373|537675634|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
149052848|NCT04169373|537675635|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
149052849|NCT04169373|537675632|FG000|Week 1 to Week 14|Other|1|||
149052850|NCT04169373|537675633|FG001|Week 1 to Week 14|Other|3|||
149052851|NCT04169373|537675634|FG002|Week 1 to Week 14|Other|3|||
149052852|NCT04169373|537675635|FG003|Week 1 to Week 14|Other|5|||
149052853|NCT04169373|537675632|FG000|Week 14 to Week 52|Adverse Event|1|||
149052854|NCT04169373|537675633|FG001|Week 14 to Week 52|Adverse Event|0|||
149052855|NCT04169373|537675634|FG002|Week 14 to Week 52|Adverse Event|0|||
149052856|NCT04169373|537675635|FG003|Week 14 to Week 52|Adverse Event|1|||
149052857|NCT04169373|537675632|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
149052858|NCT04169373|537675633|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
149052859|NCT04169373|537675634|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
149052860|NCT04169373|537675635|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
149052861|NCT04169373|537675632|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
149052862|NCT04169373|537675633|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
149052863|NCT04169373|537675634|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
149052864|NCT04169373|537675635|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
149052865|NCT04169373|537675632|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
149052866|NCT04169373|537675633|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
149052867|NCT04169373|537675634|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
149052868|NCT04169373|537675635|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
149052869|NCT04169373|537675632|FG000|Week 14 to Week 52|Other|4|||
149052870|NCT04169373|537675633|FG001|Week 14 to Week 52|Other|5|||
149052871|NCT04169373|537675634|FG002|Week 14 to Week 52|Other|4|||
149052872|NCT04169373|537675635|FG003|Week 14 to Week 52|Other|5|||
149052873|NCT04169373|537675632|FG000|Week 14 to Week 52|Ongoing|0|||
149052874|NCT04169373|537675633|FG001|Week 14 to Week 52|Ongoing|1|||
149052875|NCT04169373|537675634|FG002|Week 14 to Week 52|Ongoing|0|||
149052876|NCT04169373|537675635|FG003|Week 14 to Week 52|Ongoing|0|||
149052877|NCT04610892|537675636|FG000|Overall Study|Adverse Event|1|||
149052878|NCT04610892|537675637|FG001|Overall Study|Adverse Event|0|||
149052879|NCT04610892|537675638|FG002|Overall Study|Adverse Event|0|||
149052880|NCT04610892|537675639|FG003|Overall Study|Adverse Event|1|||
149052881|NCT04610892|537675640|FG004|Overall Study|Adverse Event|3|||
149052882|NCT04610892|537675636|FG000|Overall Study|Death|0|||
149052883|NCT04610892|537675637|FG001|Overall Study|Death|1|||
149052884|NCT04610892|537675638|FG002|Overall Study|Death|0|||
149052885|NCT04610892|537675639|FG003|Overall Study|Death|1|||
149052886|NCT04610892|537675640|FG004|Overall Study|Death|0|||
149052887|NCT04610892|537675636|FG000|Overall Study|Withdrawal by Subject|3|||
149052888|NCT04610892|537675637|FG001|Overall Study|Withdrawal by Subject|2|||
149052889|NCT04610892|537675638|FG002|Overall Study|Withdrawal by Subject|0|||
149052890|NCT04610892|537675639|FG003|Overall Study|Withdrawal by Subject|6|||
149052891|NCT04610892|537675640|FG004|Overall Study|Withdrawal by Subject|6|||
149052892|NCT04610892|537675636|FG000|Overall Study|Subjects who did not receive treatment|1|||
149052893|NCT04610892|537675637|FG001|Overall Study|Subjects who did not receive treatment|0|||
149052894|NCT04610892|537675638|FG002|Overall Study|Subjects who did not receive treatment|0|||
149052895|NCT04610892|537675639|FG003|Overall Study|Subjects who did not receive treatment|0|||
149052896|NCT04610892|537675640|FG004|Overall Study|Subjects who did not receive treatment|2|||
149052897|NCT05520190|537675641|FG000|Overall Study|Lost to Follow-up|7|||
149052898|NCT05520190|537675641|FG000|Overall Study|Withdrawal by Subject|2|||
149052899|NCT03683719|537675642|FG000|Overall Study|Lack of Efficacy|1|||
149052900|NCT03683719|537675643|FG001|Overall Study|Lack of Efficacy|3|||
149052901|NCT03683719|537675644|FG002|Overall Study|Lack of Efficacy|4|||
149052902|NCT03683719|537675645|FG003|Overall Study|Lack of Efficacy|0|||
149052903|NCT03683719|537675646|FG004|Overall Study|Lack of Efficacy|4|||
149052904|NCT03683719|537675642|FG000|Overall Study|Adverse Event|6|||
149052905|NCT03683719|537675643|FG001|Overall Study|Adverse Event|6|||
149052906|NCT03683719|537675644|FG002|Overall Study|Adverse Event|0|||
149052907|NCT03683719|537675645|FG003|Overall Study|Adverse Event|1|||
149052908|NCT03683719|537675646|FG004|Overall Study|Adverse Event|3|||
149052909|NCT03683719|537675642|FG000|Overall Study|Withdrawal by Subject|4|||
149052910|NCT03683719|537675643|FG001|Overall Study|Withdrawal by Subject|4|||
149052911|NCT03683719|537675644|FG002|Overall Study|Withdrawal by Subject|3|||
149052912|NCT03683719|537675645|FG003|Overall Study|Withdrawal by Subject|5|||
149052913|NCT03683719|537675646|FG004|Overall Study|Withdrawal by Subject|5|||
149052914|NCT03683719|537675642|FG000|Overall Study|Lost to Follow-up|1|||
149052915|NCT03683719|537675643|FG001|Overall Study|Lost to Follow-up|0|||
149052916|NCT03683719|537675644|FG002|Overall Study|Lost to Follow-up|0|||
149052917|NCT03683719|537675645|FG003|Overall Study|Lost to Follow-up|1|||
149052918|NCT03683719|537675646|FG004|Overall Study|Lost to Follow-up|1|||
149052919|NCT03683719|537675642|FG000|Overall Study|Other personal reasons|0|||
149052920|NCT03683719|537675643|FG001|Overall Study|Other personal reasons|0|||
149052921|NCT03683719|537675644|FG002|Overall Study|Other personal reasons|1|||
149052922|NCT03683719|537675645|FG003|Overall Study|Other personal reasons|0|||
149052923|NCT03683719|537675646|FG004|Overall Study|Other personal reasons|1|||
149052924|NCT03232138|537675648|FG000|Overall Study|Physician Decision|1|||
149052925|NCT03232138|537675649|FG001|Overall Study|Physician Decision|0|||
149052926|NCT03232138|537675648|FG000|Overall Study|Adverse Event|2|||
149052927|NCT03232138|537675649|FG001|Overall Study|Adverse Event|0|||
149052928|NCT03232138|537675648|FG000|Overall Study|Withdrawal by Subject|1|||
149052929|NCT03232138|537675649|FG001|Overall Study|Withdrawal by Subject|2|||
149052930|NCT03850678|537675652|FG000|Overall Study|Withdrawal by Subject|3|||
149052931|NCT03850678|537675653|FG001|Overall Study|Withdrawal by Subject|0|||
149052932|NCT03850678|537675652|FG000|Overall Study|Experimenter Error|1|||
149052933|NCT03850678|537675653|FG001|Overall Study|Experimenter Error|1|||
149052934|NCT03850678|537675652|FG000|Overall Study|Did Not Condition To Experiment|7|||
149052935|NCT03850678|537675653|FG001|Overall Study|Did Not Condition To Experiment|2|||
149052936|NCT03720795|537675654|FG000|Phase 1|Lost to Follow-up|4|||
149052937|NCT03720795|537675654|FG000|Phase 1|Withdrawal by Subject|6|||
149052938|NCT03720795|537675654|FG000|Phase 1|Protocol Violation|1|||
149052939|NCT03720795|537675654|FG000|Phase 1|Other|1|||
149052940|NCT03720795|537675654|FG000|Phase 2|Lost to Follow-up|5|||
149052941|NCT03720795|537675654|FG000|Phase 2|Withdrawal by Subject|10|||
149052942|NCT03720795|537675654|FG000|Phase 2|Protocol Violation|2|||
149052943|NCT03720795|537675654|FG000|3 Month Follow Up|Lost to Follow-up|2|||
149052944|NCT04322643|537675658|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
149052945|NCT03302494|537675659|FG000|Overall Study|Other|7|||
149052946|NCT03302494|537675660|FG001|Overall Study|Other|4|||
149052947|NCT03302494|537675661|FG002|Overall Study|Other|6|||
149052948|NCT03302494|537675659|FG000|Overall Study|Withdrawal by Subject|10|||
149052949|NCT03302494|537675660|FG001|Overall Study|Withdrawal by Subject|2|||
149052950|NCT03302494|537675661|FG002|Overall Study|Withdrawal by Subject|9|||
149052951|NCT03302494|537675659|FG000|Overall Study|Study Terminated by Sponsor|32|||
149052952|NCT03302494|537675660|FG001|Overall Study|Study Terminated by Sponsor|29|||
149052953|NCT03302494|537675661|FG002|Overall Study|Study Terminated by Sponsor|30|||
149052954|NCT03302494|537675659|FG000|Overall Study|Physician Decision|1|||
149052955|NCT03302494|537675660|FG001|Overall Study|Physician Decision|0|||
149052956|NCT03302494|537675661|FG002|Overall Study|Physician Decision|1|||
149052957|NCT03302494|537675659|FG000|Overall Study|Lost to Follow-up|1|||
149052958|NCT03302494|537675660|FG001|Overall Study|Lost to Follow-up|3|||
149052959|NCT03302494|537675661|FG002|Overall Study|Lost to Follow-up|3|||
149052960|NCT03302494|537675659|FG000|Overall Study|Death|13|||
149052961|NCT03302494|537675660|FG001|Overall Study|Death|11|||
149052962|NCT03302494|537675661|FG002|Overall Study|Death|4|||
149052963|NCT03302494|537675659|FG000|Overall Study|Adverse Event|1|||
149052964|NCT03302494|537675660|FG001|Overall Study|Adverse Event|2|||
149052965|NCT03302494|537675661|FG002|Overall Study|Adverse Event|0|||
149052966|NCT03302494|537675659|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
149052967|NCT03302494|537675660|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
149052968|NCT03302494|537675661|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
149052969|NCT05134233|537675662|FG000|Overall Study|Pregnancy|1|||
149052970|NCT05134233|537675662|FG000|Overall Study|MEP value too low|2|||
149052971|NCT05134233|537675662|FG000|Overall Study|Lost to Follow-up|1|||
149052972|NCT01573442|537675663|FG000|Overall Study|Cancels|9|||
149052973|NCT01573442|537675664|FG001|Overall Study|Cancels|10|||
149052974|NCT05710107|537675667|FG000|Overall Study|Withdrawal by Subject|1|||
149052975|NCT05710107|537675668|FG001|Overall Study|Withdrawal by Subject|1|||
149052976|NCT05710107|537675667|FG000|Overall Study|Lost to Follow-up|8|||
149052977|NCT05710107|537675668|FG001|Overall Study|Lost to Follow-up|9|||
149052978|NCT05710107|537675667|FG000|Overall Study|Unable to place assigned block|2|||
149052979|NCT05710107|537675668|FG001|Overall Study|Unable to place assigned block|0|||
149052980|NCT05710107|537675667|FG000|Overall Study|Withdrawn by study team|0|||
149052981|NCT05710107|537675668|FG001|Overall Study|Withdrawn by study team|1|||
149052982|NCT04166773|537675669|FG000|Overall Study|Adverse Event|2|||
149052983|NCT04166773|537675670|FG001|Overall Study|Adverse Event|0|||
149052984|NCT04166773|537675671|FG002|Overall Study|Adverse Event|2|||
149052985|NCT04166773|537675672|FG003|Overall Study|Adverse Event|1|||
149052986|NCT04166773|537675669|FG000|Overall Study|Lost to Follow-up|4|||
149052987|NCT04166773|537675670|FG001|Overall Study|Lost to Follow-up|2|||
149052988|NCT04166773|537675671|FG002|Overall Study|Lost to Follow-up|1|||
149052989|NCT04166773|537675672|FG003|Overall Study|Lost to Follow-up|3|||
149052990|NCT04166773|537675669|FG000|Overall Study|Physician Decision|0|||
149052991|NCT04166773|537675670|FG001|Overall Study|Physician Decision|0|||
149052992|NCT04166773|537675671|FG002|Overall Study|Physician Decision|0|||
149052993|NCT04166773|537675672|FG003|Overall Study|Physician Decision|1|||
149052994|NCT04166773|537675669|FG000|Overall Study|Withdrawal by Subject|1|||
149052995|NCT04166773|537675670|FG001|Overall Study|Withdrawal by Subject|1|||
149052996|NCT04166773|537675671|FG002|Overall Study|Withdrawal by Subject|2|||
149052997|NCT04166773|537675672|FG003|Overall Study|Withdrawal by Subject|5|||
149052998|NCT04763265|537675676|FG000|Overall Study|Adverse Event|1|||
149052999|NCT04763265|537675677|FG001|Overall Study|Adverse Event|0|||
149053000|NCT04763265|537675676|FG000|Overall Study|Lost to Follow-up|2|||
149053001|NCT04763265|537675677|FG001|Overall Study|Lost to Follow-up|4|||
149053002|NCT04763265|537675676|FG000|Overall Study|Withdrawal by Subject|0|||
149053003|NCT04763265|537675677|FG001|Overall Study|Withdrawal by Subject|1|||
149053004|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Other|0|||
149053005|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Other|0|||
149053006|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Other|0|||
149053007|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Other|0|||
149053008|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Other|0|||
149053009|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Other|0|||
149053010|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Other|0|||
149053011|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Other|0|||
149053012|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Other|0|||
149053013|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Other|0|||
149053014|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Other|1|||
149053015|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Other|1|||
149053016|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Other|1|||
149053017|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Other|0|||
149053018|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Other|3|||
149053019|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Other|1|||
149053020|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Other|1|||
149053021|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Other|0|||
149053022|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053023|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053024|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053025|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053026|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053027|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053028|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
149053029|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053030|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
149053031|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053032|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053033|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053034|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
149053035|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053036|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053037|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053038|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053039|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
149053040|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053041|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053042|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053043|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053044|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053045|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053046|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053047|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
149053048|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053049|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053050|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053051|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053052|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053053|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053054|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053055|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053056|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053057|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
149053058|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053059|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053060|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053061|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053062|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053063|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053064|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053065|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053066|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053067|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
149053068|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
148888776|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
149053069|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053070|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053071|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053072|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053073|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053074|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053075|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
149053076|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Death|0|||
149053077|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Death|0|||
149053078|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Death|0|||
149053079|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Death|0|||
149053080|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Death|0|||
149053081|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Death|0|||
149053082|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Death|0|||
149053083|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Death|0|||
149053084|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Death|0|||
149053085|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Death|1|||
149053086|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Death|0|||
149053087|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Death|1|||
149053088|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Death|0|||
149053089|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Death|1|||
149053090|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Death|0|||
149053091|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Death|0|||
149053092|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Death|2|||
149053093|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Death|0|||
149053094|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
149053095|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
149053096|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
149053097|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
149053098|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
149053099|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
149053100|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
149053101|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
149053102|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
149053103|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
149053104|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
149053105|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
149053106|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
149053107|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
149053108|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
149053109|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
149053110|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
149053111|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
149053112|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Adverse Event|0|||
149053113|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Adverse Event|0|||
149053114|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Adverse Event|0|||
149053115|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Adverse Event|0|||
149053116|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Adverse Event|0|||
149053117|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Adverse Event|0|||
149053118|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Adverse Event|2|||
149053119|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Adverse Event|0|||
149053120|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Adverse Event|0|||
149053121|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Adverse Event|0|||
149053122|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Adverse Event|1|||
149053123|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Adverse Event|2|||
149053124|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Adverse Event|0|||
149053125|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Adverse Event|1|||
149053126|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Adverse Event|0|||
149053127|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Adverse Event|0|||
149053128|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Adverse Event|1|||
149053129|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Adverse Event|0|||
149053130|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
149053131|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
148888777|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
149053132|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
149053133|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
149053134|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
149053135|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
149053136|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
148888778|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
149053137|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
149053138|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
149053139|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
149053140|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
149053141|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
149053142|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
149053143|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
149053144|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
149053145|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
149053146|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
149053147|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
149053148|NCT03269136|537675683|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053149|NCT03269136|537675684|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053150|NCT03269136|537675685|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053151|NCT03269136|537675686|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053152|NCT03269136|537675687|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053153|NCT03269136|537675688|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053154|NCT03269136|537675689|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053155|NCT03269136|537675690|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053156|NCT03269136|537675691|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053157|NCT03269136|537675692|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053158|NCT03269136|537675693|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053159|NCT03269136|537675694|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053160|NCT03269136|537675695|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
149053161|NCT03269136|537675696|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
149053162|NCT03269136|537675697|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
149053163|NCT03269136|537675698|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053164|NCT03269136|537675699|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
149053165|NCT03269136|537675700|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
149053166|NCT03269136|537675683|FG000|Part 2A: Dose Expansion|Other|0|||
149053167|NCT03269136|537675684|FG001|Part 2A: Dose Expansion|Other|0|||
149053168|NCT03269136|537675685|FG002|Part 2A: Dose Expansion|Other|0|||
149053169|NCT03269136|537675686|FG003|Part 2A: Dose Expansion|Other|0|||
149053170|NCT03269136|537675687|FG004|Part 2A: Dose Expansion|Other|0|||
149053171|NCT03269136|537675688|FG005|Part 2A: Dose Expansion|Other|0|||
149053172|NCT03269136|537675689|FG006|Part 2A: Dose Expansion|Other|0|||
149053173|NCT03269136|537675690|FG007|Part 2A: Dose Expansion|Other|0|||
149053174|NCT03269136|537675691|FG008|Part 2A: Dose Expansion|Other|0|||
149053175|NCT03269136|537675692|FG009|Part 2A: Dose Expansion|Other|0|||
149053176|NCT03269136|537675693|FG010|Part 2A: Dose Expansion|Other|0|||
149053177|NCT03269136|537675694|FG011|Part 2A: Dose Expansion|Other|0|||
149053178|NCT03269136|537675695|FG012|Part 2A: Dose Expansion|Other|0|||
149053179|NCT03269136|537675696|FG013|Part 2A: Dose Expansion|Other|0|||
149053180|NCT03269136|537675697|FG014|Part 2A: Dose Expansion|Other|0|||
149053181|NCT03269136|537675698|FG015|Part 2A: Dose Expansion|Other|0|||
149053182|NCT03269136|537675699|FG016|Part 2A: Dose Expansion|Other|0|||
149053183|NCT03269136|537675700|FG017|Part 2A: Dose Expansion|Other|1|||
149053184|NCT03269136|537675683|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053185|NCT03269136|537675684|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053186|NCT03269136|537675685|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053187|NCT03269136|537675686|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053188|NCT03269136|537675687|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053189|NCT03269136|537675688|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053190|NCT03269136|537675689|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053191|NCT03269136|537675690|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053192|NCT03269136|537675691|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053193|NCT03269136|537675692|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053194|NCT03269136|537675693|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053195|NCT03269136|537675694|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053196|NCT03269136|537675695|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053197|NCT03269136|537675696|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053198|NCT03269136|537675697|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053199|NCT03269136|537675698|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053200|NCT03269136|537675699|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
149053201|NCT03269136|537675700|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
149053202|NCT03269136|537675683|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
149053203|NCT03269136|537675684|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
149053204|NCT03269136|537675685|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
149053205|NCT03269136|537675686|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
149053206|NCT03269136|537675687|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
148888779|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
149053207|NCT03269136|537675688|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
149053208|NCT03269136|537675689|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
149053209|NCT03269136|537675690|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
149053210|NCT03269136|537675691|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
149053211|NCT03269136|537675692|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
149053212|NCT03269136|537675693|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
148888780|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
149053213|NCT03269136|537675694|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
149053214|NCT03269136|537675695|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
149053215|NCT03269136|537675696|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
149053216|NCT03269136|537675697|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
149053217|NCT03269136|537675698|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
149053218|NCT03269136|537675699|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
149053219|NCT03269136|537675700|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
149053220|NCT03269136|537675683|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
149053221|NCT03269136|537675684|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
149053222|NCT03269136|537675685|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
149053223|NCT03269136|537675686|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
149053224|NCT03269136|537675687|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
149053225|NCT03269136|537675688|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
149053226|NCT03269136|537675689|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
149053227|NCT03269136|537675690|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
149053228|NCT03269136|537675691|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
149053229|NCT03269136|537675692|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
149053230|NCT03269136|537675693|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
149053231|NCT03269136|537675694|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
149053232|NCT03269136|537675695|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
149053233|NCT03269136|537675696|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
149053234|NCT03269136|537675697|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
149053235|NCT03269136|537675698|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
149053236|NCT03269136|537675699|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
149053237|NCT03269136|537675700|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
149053238|NCT03269136|537675683|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
149053239|NCT03269136|537675684|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
148888781|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
148888782|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
148888783|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
148888784|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
148888785|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
148888786|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
149053240|NCT03269136|537675685|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
149053241|NCT03269136|537675686|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
149053242|NCT03269136|537675687|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
149053243|NCT03269136|537675688|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
149053244|NCT03269136|537675689|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
149053245|NCT03269136|537675690|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
149053246|NCT03269136|537675691|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
149053247|NCT03269136|537675692|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
149053248|NCT03269136|537675693|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
149053249|NCT03269136|537675694|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
149053250|NCT03269136|537675695|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
149053251|NCT03269136|537675696|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
149053252|NCT03269136|537675697|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
149053253|NCT03269136|537675698|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
149053254|NCT03269136|537675699|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
149053255|NCT03269136|537675700|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
149053256|NCT05071807|537675701|FG000|Overall Study|Withdrawal by Subject|4|||
149053257|NCT05071807|537675702|FG001|Overall Study|Withdrawal by Subject|0|||
149053258|NCT05071807|537675701|FG000|Overall Study|Unrelated medical issues|3|||
149053259|NCT05071807|537675702|FG001|Overall Study|Unrelated medical issues|0|||
149053260|NCT05071807|537675701|FG000|Overall Study|Relocated|0|||
149053261|NCT05071807|537675702|FG001|Overall Study|Relocated|1|||
149053262|NCT04952909|537675703|FG000|Overall Study|Death|3|||
149053263|NCT05308004|537675705|FG000|Overall Study|Not seen by Palliative Care NP|0|||
148888787|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
148888788|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
148888789|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
148888790|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
148888791|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888792|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888793|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888794|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
148888795|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888796|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888797|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888798|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888799|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888800|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
149053264|NCT05308004|537675706|FG001|Overall Study|Not seen by Palliative Care NP|1|||
149053265|NCT04552223|537675713|FG000|Overall Study|Withdrawal by Subject|1|||
149053266|NCT04856163|537675714|FG000|Overall Study|Lost to Follow-up|97|||
149053267|NCT04856163|537675715|FG001|Overall Study|Lost to Follow-up|100|||
149053268|NCT02515773|537675724|FG000|Overall Study|Withdrawal by Subject|12|||
149053269|NCT02515773|537675725|FG001|Overall Study|Withdrawal by Subject|2|||
149053270|NCT02515773|537675724|FG000|Overall Study|Lost to Follow-up|119|||
149053271|NCT02515773|537675725|FG001|Overall Study|Lost to Follow-up|126|||
149053272|NCT02515773|537675724|FG000|Overall Study|Discharged from Clinic Services|53|||
149053273|NCT02515773|537675725|FG001|Overall Study|Discharged from Clinic Services|84|||
149053274|NCT02515773|537675724|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
149053275|NCT02515773|537675725|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
149053276|NCT02515773|537675724|FG000|Overall Study|Follow-up at non-study site|8|||
149053277|NCT02515773|537675725|FG001|Overall Study|Follow-up at non-study site|16|||
149053278|NCT02515773|537675724|FG000|Overall Study|Moved from area|9|||
149053279|NCT02515773|537675725|FG001|Overall Study|Moved from area|14|||
149053280|NCT05434078|537675727|FG000|Overall Study|Lost to Follow-up|2|||
149053281|NCT05434078|537675728|FG001|Overall Study|Lost to Follow-up|1|||
149053282|NCT05434078|537675727|FG000|Overall Study|Withdrawal by Subject|1|||
149053283|NCT05434078|537675728|FG001|Overall Study|Withdrawal by Subject|0|||
149053284|NCT03652688|537675729|FG000|Baseline|Withdrawal by Subject|0|||
149053285|NCT03652688|537675730|FG001|Baseline|Withdrawal by Subject|3|||
149053286|NCT03652688|537675729|FG000|Follow-up|Lost to Follow-up|56|||
149053287|NCT03652688|537675730|FG001|Follow-up|Lost to Follow-up|54|||
149053288|NCT04072380|537675731|FG000|Overall Study|Adverse Event|4|||
149053289|NCT04072380|537675732|FG001|Overall Study|Adverse Event|6|||
149053290|NCT04072380|537675733|FG002|Overall Study|Adverse Event|0|||
149053291|NCT04072380|537675731|FG000|Overall Study|Withdrawal by Subject|3|||
149053292|NCT04072380|537675732|FG001|Overall Study|Withdrawal by Subject|1|||
149053293|NCT04072380|537675733|FG002|Overall Study|Withdrawal by Subject|1|||
149053294|NCT04072380|537675731|FG000|Overall Study|Physician Decision|2|||
149053295|NCT04072380|537675732|FG001|Overall Study|Physician Decision|0|||
149053296|NCT04072380|537675733|FG002|Overall Study|Physician Decision|0|||
149053297|NCT04072380|537675731|FG000|Overall Study|Protocol Violation|0|||
149053298|NCT04072380|537675732|FG001|Overall Study|Protocol Violation|2|||
149053299|NCT04072380|537675733|FG002|Overall Study|Protocol Violation|3|||
149053300|NCT04072380|537675731|FG000|Overall Study|Intercurrent Illness and Others|3|||
149053301|NCT04072380|537675732|FG001|Overall Study|Intercurrent Illness and Others|5|||
149053302|NCT04072380|537675733|FG002|Overall Study|Intercurrent Illness and Others|6|||
149053303|NCT03468218|537675737|FG000|Overall Study|Adverse Event|5|||
149053304|NCT03468218|537675737|FG000|Overall Study|Progressive Disease|16|||
149053305|NCT03468218|537675737|FG000|Overall Study|Death|1|||
149053306|NCT03468218|537675737|FG000|Overall Study|Alternate therapy|1|||
149053307|NCT03468218|537675737|FG000|Overall Study|Withdrawal by Subject|2|||
149053308|NCT03033576|537675738|FG000|Overall Study|Ineligible|1|||
149053309|NCT03033576|537675739|FG001|Overall Study|Ineligible|1|||
149053310|NCT03033576|537675738|FG000|Overall Study|Adverse Event|4|||
149053311|NCT03033576|537675739|FG001|Overall Study|Adverse Event|20|||
149053312|NCT03033576|537675738|FG000|Overall Study|Progression/relapse|9|||
149053313|NCT03033576|537675739|FG001|Overall Study|Progression/relapse|36|||
149053314|NCT03033576|537675738|FG000|Overall Study|Death|1|||
149053315|NCT03033576|537675739|FG001|Overall Study|Death|1|||
149053316|NCT03033576|537675738|FG000|Overall Study|Patient refusal|1|||
149053317|NCT03033576|537675739|FG001|Overall Study|Patient refusal|6|||
149053318|NCT03033576|537675738|FG000|Overall Study|Other, unspecified reasons|0|||
149053319|NCT03033576|537675739|FG001|Overall Study|Other, unspecified reasons|4|||
149053320|NCT03033576|537675738|FG000|Overall Study|Currently on protocol therapy|0|||
149053321|NCT03033576|537675739|FG001|Overall Study|Currently on protocol therapy|2|||
149053322|NCT03557697|537675740|FG000|Overall Study|Withdrawal by Subject|2|||
149053323|NCT03557697|537675741|FG001|Overall Study|Withdrawal by Subject|4|||
149053324|NCT01214616|537675745|FG000|Overall Study|Progressive disease|2|||
149053325|NCT01214616|537675746|FG001|Overall Study|Progressive disease|2|||
149053326|NCT01214616|537675747|FG002|Overall Study|Progressive disease|2|||
149053327|NCT01214616|537675748|FG003|Overall Study|Progressive disease|4|||
149053328|NCT01214616|537675745|FG000|Overall Study|Dose limiting toxicity|0|||
149053329|NCT01214616|537675746|FG001|Overall Study|Dose limiting toxicity|2|||
149053330|NCT01214616|537675747|FG002|Overall Study|Dose limiting toxicity|0|||
149053331|NCT01214616|537675748|FG003|Overall Study|Dose limiting toxicity|0|||
149053332|NCT01214616|537675745|FG000|Overall Study|Other adverse events|0|||
149053333|NCT01214616|537675746|FG001|Overall Study|Other adverse events|1|||
149053334|NCT01214616|537675747|FG002|Overall Study|Other adverse events|1|||
149053335|NCT01214616|537675748|FG003|Overall Study|Other adverse events|1|||
149053336|NCT01214616|537675745|FG000|Overall Study|Withdrawal by Subject|1|||
149053337|NCT01214616|537675746|FG001|Overall Study|Withdrawal by Subject|0|||
149053338|NCT01214616|537675747|FG002|Overall Study|Withdrawal by Subject|0|||
149053339|NCT01214616|537675748|FG003|Overall Study|Withdrawal by Subject|1|||
149053340|NCT03047928|537677528|FG000|Overall Study|Adverse Event|0|||
149053341|NCT03047928|537677529|FG001|Overall Study|Adverse Event|2|||
149053342|NCT03047928|537677530|FG002|Overall Study|Adverse Event|0|||
149053343|NCT03047928|537677528|FG000|Overall Study|Protocol Violation|0|||
149053344|NCT03047928|537677529|FG001|Overall Study|Protocol Violation|1|||
149053345|NCT03047928|537677530|FG002|Overall Study|Protocol Violation|0|||
149053346|NCT03047928|537677528|FG000|Overall Study|included in another protocol|0|||
149053347|NCT03047928|537677529|FG001|Overall Study|included in another protocol|1|||
149053348|NCT03047928|537677530|FG002|Overall Study|included in another protocol|0|||
149053349|NCT06283173|537677531|FG000|Overall Study|Did not show for first visit|10|||
149053350|NCT06283173|537677531|FG000|Overall Study|Lost to Follow-up|12|||
149053351|NCT06283173|537677531|FG000|Overall Study|Physician Decision|7|||
149053352|NCT02281955|537677546|FG000|Overall Study|Death|1|||
149053353|NCT04005716|537677552|FG000|Overall Study|Death|175|||
149053354|NCT04005716|537677553|FG001|Overall Study|Death|196|||
149053355|NCT04005716|537677552|FG000|Overall Study|Withdrawal by Subject|1|||
149053356|NCT04005716|537677553|FG001|Overall Study|Withdrawal by Subject|6|||
149053357|NCT04005716|537677552|FG000|Overall Study|Lost to Follow-up|2|||
149053358|NCT04005716|537677553|FG001|Overall Study|Lost to Follow-up|2|||
149053359|NCT02783300|537677554|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053360|NCT02783300|537677555|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053361|NCT02783300|537677556|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053362|NCT02783300|537677557|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053363|NCT02783300|537677558|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053364|NCT02783300|537677559|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053365|NCT02783300|537677560|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
149053366|NCT02783300|537677561|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053367|NCT02783300|537677562|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053368|NCT02783300|537677563|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053369|NCT02783300|537677564|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053370|NCT02783300|537677565|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053371|NCT02783300|537677566|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053372|NCT02783300|537677567|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053373|NCT02783300|537677568|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053374|NCT02783300|537677569|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053375|NCT02783300|537677570|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053376|NCT02783300|537677571|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053377|NCT02783300|537677572|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053378|NCT02783300|537677573|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053379|NCT02783300|537677574|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053380|NCT02783300|537677575|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053381|NCT02783300|537677576|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053382|NCT02783300|537677577|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053383|NCT02783300|537677578|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053384|NCT02783300|537677579|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053385|NCT02783300|537677580|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
149053386|NCT02783300|537677554|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053387|NCT02783300|537677555|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053388|NCT02783300|537677556|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053389|NCT02783300|537677557|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
149053390|NCT02783300|537677558|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053391|NCT02783300|537677559|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053392|NCT02783300|537677560|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053393|NCT02783300|537677561|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053394|NCT02783300|537677562|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053395|NCT02783300|537677563|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053396|NCT02783300|537677564|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053397|NCT02783300|537677565|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053398|NCT02783300|537677566|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053399|NCT02783300|537677567|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053400|NCT02783300|537677568|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053401|NCT02783300|537677569|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053402|NCT02783300|537677570|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053403|NCT02783300|537677571|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053404|NCT02783300|537677572|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053405|NCT02783300|537677573|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053406|NCT02783300|537677574|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053407|NCT02783300|537677575|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053408|NCT02783300|537677576|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053409|NCT02783300|537677577|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053410|NCT02783300|537677578|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053411|NCT02783300|537677579|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053412|NCT02783300|537677580|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
149053413|NCT02783300|537677554|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
149053414|NCT02783300|537677555|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
149053415|NCT02783300|537677556|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
149053416|NCT02783300|537677557|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
149053417|NCT02783300|537677558|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
149053418|NCT02783300|537677559|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
149053419|NCT02783300|537677560|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
149053420|NCT02783300|537677561|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
149053421|NCT02783300|537677562|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
149053422|NCT02783300|537677563|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
149053423|NCT02783300|537677564|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
149053424|NCT02783300|537677565|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
149053425|NCT02783300|537677566|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
149053426|NCT02783300|537677567|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
149053427|NCT02783300|537677568|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
149053428|NCT02783300|537677569|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
149053429|NCT02783300|537677570|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
149053430|NCT02783300|537677571|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
149053431|NCT02783300|537677572|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
149053432|NCT02783300|537677573|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
149053433|NCT02783300|537677574|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
149053434|NCT02783300|537677575|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
149053435|NCT02783300|537677576|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
149053436|NCT02783300|537677577|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
149053437|NCT02783300|537677578|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
149053438|NCT02783300|537677579|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
149053439|NCT02783300|537677580|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
149053440|NCT02783300|537677554|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053441|NCT02783300|537677555|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053442|NCT02783300|537677556|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053443|NCT02783300|537677557|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053444|NCT02783300|537677558|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053445|NCT02783300|537677559|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053446|NCT02783300|537677560|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
149053447|NCT02783300|537677561|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053448|NCT02783300|537677562|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053449|NCT02783300|537677563|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053450|NCT02783300|537677564|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053451|NCT02783300|537677565|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053452|NCT02783300|537677566|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
149053453|NCT02783300|537677567|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053454|NCT02783300|537677568|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053455|NCT02783300|537677569|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053456|NCT02783300|537677570|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053457|NCT02783300|537677571|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053458|NCT02783300|537677572|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053459|NCT02783300|537677573|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053460|NCT02783300|537677574|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053461|NCT02783300|537677575|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053462|NCT02783300|537677576|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053463|NCT02783300|537677577|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053464|NCT02783300|537677578|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053465|NCT02783300|537677579|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053466|NCT02783300|537677580|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
149053467|NCT02783300|537677554|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053468|NCT02783300|537677555|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053469|NCT02783300|537677556|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053470|NCT02783300|537677557|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053471|NCT02783300|537677558|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
149053472|NCT02783300|537677559|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053473|NCT02783300|537677560|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
148888801|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
148888802|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
149053474|NCT02783300|537677561|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053475|NCT02783300|537677562|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053476|NCT02783300|537677563|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
149053477|NCT02783300|537677564|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053478|NCT02783300|537677565|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053479|NCT02783300|537677566|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
149053480|NCT02783300|537677567|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053481|NCT02783300|537677568|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053482|NCT02783300|537677569|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053483|NCT02783300|537677570|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053484|NCT02783300|537677571|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053485|NCT02783300|537677572|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053486|NCT02783300|537677573|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053487|NCT02783300|537677574|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053488|NCT02783300|537677575|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053489|NCT02783300|537677576|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053490|NCT02783300|537677577|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053491|NCT02783300|537677578|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053492|NCT02783300|537677579|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053493|NCT02783300|537677580|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
149053494|NCT02783300|537677554|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053495|NCT02783300|537677555|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053496|NCT02783300|537677556|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053497|NCT02783300|537677557|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053498|NCT02783300|537677558|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053499|NCT02783300|537677559|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053500|NCT02783300|537677560|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053501|NCT02783300|537677561|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053502|NCT02783300|537677562|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053503|NCT02783300|537677563|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053504|NCT02783300|537677564|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053505|NCT02783300|537677565|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053506|NCT02783300|537677566|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053507|NCT02783300|537677567|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053508|NCT02783300|537677568|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053509|NCT02783300|537677569|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
149053510|NCT02783300|537677570|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053511|NCT02783300|537677571|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
149053512|NCT02783300|537677572|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
149053513|NCT02783300|537677573|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
149053514|NCT02783300|537677574|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053515|NCT02783300|537677575|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053516|NCT02783300|537677576|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053517|NCT02783300|537677577|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053518|NCT02783300|537677578|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
149053519|NCT02783300|537677579|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053520|NCT02783300|537677580|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
149053521|NCT02783300|537677554|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053522|NCT02783300|537677555|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053523|NCT02783300|537677556|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053524|NCT02783300|537677557|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053525|NCT02783300|537677558|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053526|NCT02783300|537677559|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053527|NCT02783300|537677560|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053528|NCT02783300|537677561|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053529|NCT02783300|537677562|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053530|NCT02783300|537677563|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053531|NCT02783300|537677564|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053532|NCT02783300|537677565|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053533|NCT02783300|537677566|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053534|NCT02783300|537677567|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053535|NCT02783300|537677568|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053536|NCT02783300|537677569|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149055981|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
149053537|NCT02783300|537677570|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
149053538|NCT02783300|537677571|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053539|NCT02783300|537677572|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
149053540|NCT02783300|537677573|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
149053541|NCT02783300|537677574|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053542|NCT02783300|537677575|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053543|NCT02783300|537677576|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053544|NCT02783300|537677577|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053545|NCT02783300|537677578|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053546|NCT02783300|537677579|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053547|NCT02783300|537677580|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
149053548|NCT02783300|537677554|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053549|NCT02783300|537677555|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053550|NCT02783300|537677556|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053551|NCT02783300|537677557|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053552|NCT02783300|537677558|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053553|NCT02783300|537677559|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053554|NCT02783300|537677560|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053555|NCT02783300|537677561|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053556|NCT02783300|537677562|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053557|NCT02783300|537677563|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053558|NCT02783300|537677564|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053559|NCT02783300|537677565|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053560|NCT02783300|537677566|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053561|NCT02783300|537677567|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053562|NCT02783300|537677568|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053563|NCT02783300|537677569|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053564|NCT02783300|537677570|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
149053565|NCT02783300|537677571|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053566|NCT02783300|537677572|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
149053567|NCT02783300|537677573|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
149053568|NCT02783300|537677574|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
149053569|NCT02783300|537677575|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053570|NCT02783300|537677576|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053571|NCT02783300|537677577|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053572|NCT02783300|537677578|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053573|NCT02783300|537677579|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053574|NCT02783300|537677580|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
149053575|NCT02783300|537677554|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053576|NCT02783300|537677555|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053577|NCT02783300|537677556|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053578|NCT02783300|537677557|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053579|NCT02783300|537677558|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053580|NCT02783300|537677559|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053581|NCT02783300|537677560|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053582|NCT02783300|537677561|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053583|NCT02783300|537677562|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053584|NCT02783300|537677563|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053585|NCT02783300|537677564|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053586|NCT02783300|537677565|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053587|NCT02783300|537677566|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053588|NCT02783300|537677567|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053589|NCT02783300|537677568|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053590|NCT02783300|537677569|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
149053591|NCT02783300|537677570|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053592|NCT02783300|537677571|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053593|NCT02783300|537677572|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053594|NCT02783300|537677573|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053595|NCT02783300|537677574|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053596|NCT02783300|537677575|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053597|NCT02783300|537677576|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
149053598|NCT02783300|537677577|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053599|NCT02783300|537677578|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053600|NCT02783300|537677579|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053601|NCT02783300|537677580|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
149053602|NCT02783300|537677554|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053603|NCT02783300|537677555|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053604|NCT02783300|537677556|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053605|NCT02783300|537677557|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053606|NCT02783300|537677558|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053607|NCT02783300|537677559|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053608|NCT02783300|537677560|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053609|NCT02783300|537677561|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053610|NCT02783300|537677562|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053611|NCT02783300|537677563|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053612|NCT02783300|537677564|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053613|NCT02783300|537677565|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053614|NCT02783300|537677566|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053615|NCT02783300|537677567|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
149053616|NCT02783300|537677568|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
149053617|NCT02783300|537677569|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
149053618|NCT02783300|537677570|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
149053619|NCT02783300|537677571|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053620|NCT02783300|537677572|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
149053621|NCT02783300|537677573|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
149053622|NCT02783300|537677574|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053623|NCT02783300|537677575|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053624|NCT02783300|537677576|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053625|NCT02783300|537677577|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053626|NCT02783300|537677578|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053627|NCT02783300|537677579|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053628|NCT02783300|537677580|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
149053629|NCT02783300|537677554|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053630|NCT02783300|537677555|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053631|NCT02783300|537677556|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053632|NCT02783300|537677557|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053633|NCT02783300|537677558|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053634|NCT02783300|537677559|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053635|NCT02783300|537677560|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053636|NCT02783300|537677561|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053637|NCT02783300|537677562|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053638|NCT02783300|537677563|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053639|NCT02783300|537677564|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053640|NCT02783300|537677565|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053641|NCT02783300|537677566|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053642|NCT02783300|537677567|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
149053643|NCT02783300|537677568|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
149053644|NCT02783300|537677569|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
149053645|NCT02783300|537677570|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
149053646|NCT02783300|537677571|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
149053647|NCT02783300|537677572|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
149053648|NCT02783300|537677573|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
149053649|NCT02783300|537677574|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
149053650|NCT02783300|537677575|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
149053651|NCT02783300|537677576|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
149053652|NCT02783300|537677577|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
149053653|NCT02783300|537677578|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
149053654|NCT02783300|537677579|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
149053655|NCT02783300|537677580|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
149053656|NCT02783300|537677554|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053657|NCT02783300|537677555|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053658|NCT02783300|537677556|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053659|NCT02783300|537677557|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053660|NCT02783300|537677558|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053661|NCT02783300|537677559|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053662|NCT02783300|537677560|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053663|NCT02783300|537677561|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053664|NCT02783300|537677562|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053665|NCT02783300|537677563|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053666|NCT02783300|537677564|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053667|NCT02783300|537677565|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053668|NCT02783300|537677566|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053669|NCT02783300|537677567|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053670|NCT02783300|537677568|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053671|NCT02783300|537677569|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053672|NCT02783300|537677570|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053673|NCT02783300|537677571|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053674|NCT02783300|537677572|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053675|NCT02783300|537677573|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053676|NCT02783300|537677574|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053677|NCT02783300|537677575|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053678|NCT02783300|537677576|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053679|NCT02783300|537677577|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053680|NCT02783300|537677578|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053681|NCT02783300|537677579|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
149053682|NCT02783300|537677580|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
149053683|NCT02783300|537677554|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053684|NCT02783300|537677555|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053685|NCT02783300|537677556|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053686|NCT02783300|537677557|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053687|NCT02783300|537677558|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053688|NCT02783300|537677559|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053689|NCT02783300|537677560|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053690|NCT02783300|537677561|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053691|NCT02783300|537677562|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053692|NCT02783300|537677563|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053693|NCT02783300|537677564|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053694|NCT02783300|537677565|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053695|NCT02783300|537677566|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053696|NCT02783300|537677567|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053697|NCT02783300|537677568|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053698|NCT02783300|537677569|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053699|NCT02783300|537677570|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053700|NCT02783300|537677571|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053701|NCT02783300|537677572|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053702|NCT02783300|537677573|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053703|NCT02783300|537677574|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053704|NCT02783300|537677575|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053705|NCT02783300|537677576|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053706|NCT02783300|537677577|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053707|NCT02783300|537677578|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053708|NCT02783300|537677579|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
149053709|NCT02783300|537677580|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
149053710|NCT04177823|537677588|FG000|Overall Study|Physician Decision|1|||
149053711|NCT04177823|537677588|FG000|Overall Study|Withdrawal by Subject|1|||
149053712|NCT04229992|537677589|FG000|Overall Study|Withdrawal by Subject|0|||
149053713|NCT04229992|537677590|FG001|Overall Study|Withdrawal by Subject|2|||
149053714|NCT04229992|537677591|FG002|Overall Study|Withdrawal by Subject|1|||
149053715|NCT04229992|537677592|FG003|Overall Study|Withdrawal by Subject|1|||
149053716|NCT04229992|537677589|FG000|Overall Study|Adverse Event|1|||
149053717|NCT04229992|537677590|FG001|Overall Study|Adverse Event|1|||
149053718|NCT04229992|537677591|FG002|Overall Study|Adverse Event|3|||
149053719|NCT04229992|537677592|FG003|Overall Study|Adverse Event|1|||
149053720|NCT04229992|537677589|FG000|Overall Study|Lost to Follow-up|0|||
148888803|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
149053721|NCT04229992|537677590|FG001|Overall Study|Lost to Follow-up|0|||
149053722|NCT04229992|537677591|FG002|Overall Study|Lost to Follow-up|0|||
149053723|NCT04229992|537677592|FG003|Overall Study|Lost to Follow-up|1|||
149053724|NCT05178316|537677593|FG000|Overall Study|Adverse Event|5|||
149053725|NCT05178316|537677594|FG001|Overall Study|Adverse Event|4|||
149053726|NCT05178316|537677595|FG002|Overall Study|Adverse Event|9|||
149053727|NCT05178316|537677593|FG000|Overall Study|Enrolled in Error|1|||
149053728|NCT05178316|537677594|FG001|Overall Study|Enrolled in Error|2|||
149053729|NCT05178316|537677595|FG002|Overall Study|Enrolled in Error|1|||
149053730|NCT05178316|537677593|FG000|Overall Study|Lost to Follow-up|3|||
149053731|NCT05178316|537677594|FG001|Overall Study|Lost to Follow-up|15|||
149053732|NCT05178316|537677595|FG002|Overall Study|Lost to Follow-up|11|||
149053733|NCT05178316|537677593|FG000|Overall Study|Noncompliance|1|||
149053734|NCT05178316|537677594|FG001|Overall Study|Noncompliance|3|||
149053735|NCT05178316|537677595|FG002|Overall Study|Noncompliance|1|||
149053736|NCT05178316|537677593|FG000|Overall Study|Other|0|||
149053737|NCT05178316|537677594|FG001|Overall Study|Other|1|||
149053738|NCT05178316|537677595|FG002|Overall Study|Other|0|||
149053739|NCT05178316|537677593|FG000|Overall Study|Physician Decision|0|||
149053740|NCT05178316|537677594|FG001|Overall Study|Physician Decision|3|||
149053741|NCT05178316|537677595|FG002|Overall Study|Physician Decision|2|||
149053742|NCT05178316|537677593|FG000|Overall Study|Protocol deviation|1|||
149053743|NCT05178316|537677594|FG001|Overall Study|Protocol deviation|0|||
149053744|NCT05178316|537677595|FG002|Overall Study|Protocol deviation|1|||
149053745|NCT05178316|537677593|FG000|Overall Study|Sponsor decision|1|||
149053746|NCT05178316|537677594|FG001|Overall Study|Sponsor decision|0|||
149053747|NCT05178316|537677595|FG002|Overall Study|Sponsor decision|1|||
149053748|NCT05178316|537677593|FG000|Overall Study|Withdrawal by Subject|5|||
149053749|NCT05178316|537677594|FG001|Overall Study|Withdrawal by Subject|11|||
149053750|NCT05178316|537677595|FG002|Overall Study|Withdrawal by Subject|5|||
149053751|NCT03770273|537677596|FG000|Overall Study|Adverse Event|2|||
149053752|NCT03770273|537677597|FG001|Overall Study|Adverse Event|0|||
149053753|NCT03770273|537677596|FG000|Overall Study|Lost to Follow-up|1|||
149053754|NCT03770273|537677597|FG001|Overall Study|Lost to Follow-up|1|||
149053755|NCT00418886|537677598|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
149053756|NCT00418886|537677599|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
149053757|NCT00418886|537677598|FG000|Randomized Period|Death|122|||
149053758|NCT00418886|537677599|FG001|Randomized Period|Death|147|||
149053759|NCT00418886|537677598|FG000|Randomized Period|Withdrawal by Subject|9|||
149053760|NCT00418886|537677599|FG001|Randomized Period|Withdrawal by Subject|10|||
149053761|NCT00418886|537677598|FG000|Randomized Period|Lost to Follow-up|4|||
149053762|NCT00418886|537677599|FG001|Randomized Period|Lost to Follow-up|6|||
149053763|NCT00418886|537677598|FG000|Randomized Period|withdrawn due to other reason|1|||
149053764|NCT00418886|537677599|FG001|Randomized Period|withdrawn due to other reason|0|||
149053765|NCT00418886|537677598|FG000|Randomized Period|randomised but no treatment received|0|||
149053766|NCT00418886|537677599|FG001|Randomized Period|randomised but no treatment received|1|||
149053767|NCT04533347|537677600|FG000|Overall Study|Adverse Event|1|||
149053768|NCT04533347|537677601|FG001|Overall Study|Adverse Event|2|||
149053769|NCT04533347|537677600|FG000|Overall Study|Lost to Follow-up|2|||
149053770|NCT04533347|537677601|FG001|Overall Study|Lost to Follow-up|0|||
149053771|NCT04533347|537677600|FG000|Overall Study|Withdrawal by Subject|1|||
149053772|NCT04533347|537677601|FG001|Overall Study|Withdrawal by Subject|0|||
149053773|NCT03907397|537677604|FG000|Overall Study|Lost to Follow-up|0|||
149053774|NCT03907397|537677605|FG001|Overall Study|Lost to Follow-up|1|||
149053775|NCT03907397|537677604|FG000|Overall Study|Physician Decision|2|||
149053776|NCT03907397|537677605|FG001|Overall Study|Physician Decision|1|||
149053777|NCT03907397|537677604|FG000|Overall Study|Withdrawal by Subject|5|||
149053778|NCT03907397|537677605|FG001|Overall Study|Withdrawal by Subject|4|||
149053779|NCT03907397|537677604|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
149053780|NCT03907397|537677605|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
149053781|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
149053782|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
149053783|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
149053784|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
149053785|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
149053786|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
149053787|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
149053788|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
149053789|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
149053790|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
149053791|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
149053792|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
149053793|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
149053794|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
149053795|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
149053796|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
149053797|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
149053798|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
149053799|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
149053800|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
148888804|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
149053801|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
149053802|NCT05369403|537677606|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
149053803|NCT05369403|537677607|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
149053804|NCT05369403|537677608|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
149053805|NCT05369403|537677606|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
149053806|NCT05369403|537677607|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
149053807|NCT05369403|537677608|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
149053808|NCT05369403|537677606|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
149053809|NCT05369403|537677607|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
149053810|NCT05369403|537677608|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
149053811|NCT05369403|537677606|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
149053812|NCT05369403|537677607|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
149053813|NCT05369403|537677608|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
149053814|NCT04760678|537677612|FG000|Overall Study|Death|13|||
149053815|NCT04760678|537677612|FG000|Overall Study|Lost to Follow-up|48|||
149053816|NCT04760678|537677612|FG000|Overall Study|Withdrawal by Subject|1|||
149053817|NCT03675282|537677615|FG000|Overall Study|Lost to Follow-up|4|||
149053818|NCT03675282|537677616|FG001|Overall Study|Lost to Follow-up|8|||
149053819|NCT03675282|537677617|FG002|Overall Study|Lost to Follow-up|1|||
149053820|NCT03675282|537677618|FG003|Overall Study|Lost to Follow-up|0|||
149053821|NCT03675282|537677619|FG004|Overall Study|Lost to Follow-up|2|||
149053822|NCT03675282|537677620|FG005|Overall Study|Lost to Follow-up|7|||
149053823|NCT03675282|537677615|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
149053824|NCT03675282|537677616|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
149053825|NCT03675282|537677617|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
149053826|NCT03675282|537677618|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
149053827|NCT03675282|537677619|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
149053828|NCT03675282|537677620|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
149053829|NCT03675282|537677615|FG000|Overall Study|Physician Decision|1|||
149053830|NCT03675282|537677616|FG001|Overall Study|Physician Decision|0|||
149053831|NCT03675282|537677617|FG002|Overall Study|Physician Decision|0|||
149053832|NCT03675282|537677618|FG003|Overall Study|Physician Decision|0|||
149053833|NCT03675282|537677619|FG004|Overall Study|Physician Decision|0|||
149053834|NCT03675282|537677620|FG005|Overall Study|Physician Decision|0|||
149053835|NCT03056040|537677621|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
149053836|NCT03056040|537677622|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
149053837|NCT03056040|537677621|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
149053838|NCT03056040|537677622|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
149053839|NCT03056040|537677621|FG000|Primary Evaluation Period|Pregnancy|0|||
149053840|NCT03056040|537677622|FG001|Primary Evaluation Period|Pregnancy|1|||
149053841|NCT03056040|537677621|FG000|Primary Evaluation Period|Randomized, not treated|1|||
149053842|NCT03056040|537677622|FG001|Primary Evaluation Period|Randomized, not treated|1|||
149053843|NCT03056040|537677621|FG000|Extension Period|Physician Decision|3|||
149053844|NCT03056040|537677622|FG001|Extension Period|Physician Decision|3|||
149053845|NCT03056040|537677621|FG000|Extension Period|Lost to Follow-up|0|||
149053846|NCT03056040|537677622|FG001|Extension Period|Lost to Follow-up|1|||
149053847|NCT03056040|537677621|FG000|Extension Period|Death|0|||
149053848|NCT03056040|537677622|FG001|Extension Period|Death|3|||
149053849|NCT03056040|537677621|FG000|Extension Period|Withdrawal by Subject|1|||
149053850|NCT03056040|537677622|FG001|Extension Period|Withdrawal by Subject|0|||
149053851|NCT03445988|537677625|FG000|Overall Study|Lost to Follow-up|14|||
149053852|NCT03445988|537677626|FG001|Overall Study|Lost to Follow-up|26|||
149053853|NCT03445988|537677627|FG002|Overall Study|Lost to Follow-up|27|||
149053854|NCT03445988|537677628|FG003|Overall Study|Lost to Follow-up|66|||
149053855|NCT03445988|537677625|FG000|Overall Study|Withdrawal by Subject|7|||
149053856|NCT03445988|537677626|FG001|Overall Study|Withdrawal by Subject|4|||
149053857|NCT03445988|537677627|FG002|Overall Study|Withdrawal by Subject|3|||
149053858|NCT03445988|537677628|FG003|Overall Study|Withdrawal by Subject|5|||
149053859|NCT03445988|537677625|FG000|Overall Study|Death (unrelated to study)|5|||
149053860|NCT03445988|537677626|FG001|Overall Study|Death (unrelated to study)|1|||
149053861|NCT03445988|537677627|FG002|Overall Study|Death (unrelated to study)|2|||
149053862|NCT03445988|537677628|FG003|Overall Study|Death (unrelated to study)|4|||
149053863|NCT05784662|537677629|FG000|Overall Study|Lost to Follow-up|21|||
149053864|NCT05784662|537677630|FG001|Overall Study|Lost to Follow-up|17|||
149053865|NCT04274764|537677631|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
149053866|NCT04274764|537677632|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
149053867|NCT03920111|537677640|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
149053868|NCT03920111|537677641|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
149053869|NCT03920111|537677642|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
149053870|NCT05268393|537677643|FG000|Overall Study|Withdrawal by Subject|2|||
149053871|NCT05268393|537677644|FG001|Overall Study|Withdrawal by Subject|1|||
149053872|NCT05177848|537677645|FG000|Overall Study|Lost to Follow-up|1|||
149053873|NCT05177848|537677646|FG001|Overall Study|Lost to Follow-up|4|||
149053874|NCT05177848|537677645|FG000|Overall Study|Discontinued|2|||
149053875|NCT05177848|537677646|FG001|Overall Study|Discontinued|1|||
149053876|NCT03396926|537677648|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
149053877|NCT03396926|537677649|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
149053878|NCT02035787|537677650|FG000|Overall Study- 12 Months|Adverse Event|3|||
149053879|NCT02035787|537677651|FG001|Overall Study- 12 Months|Adverse Event|0|||
149053880|NCT02035787|537677650|FG000|Overall Study- 12 Months|Complete response|4|||
149053881|NCT02035787|537677651|FG001|Overall Study- 12 Months|Complete response|1|||
149053882|NCT02035787|537677650|FG000|Overall Study- 12 Months|Protocol Violation|1|||
149053883|NCT02035787|537677651|FG001|Overall Study- 12 Months|Protocol Violation|1|||
149053884|NCT06414213|537677652|FG000|Overall Study|Lost to Follow-up|1|||
149053885|NCT06414213|537677653|FG001|Overall Study|Lost to Follow-up|1|||
149053886|NCT06414213|537677654|FG002|Overall Study|Lost to Follow-up|3|||
149053887|NCT01997840|537677658|FG000|Overall Study|Lost to Follow-up|0|||
149053888|NCT01997840|537677659|FG001|Overall Study|Lost to Follow-up|0|||
149053889|NCT01997840|537677660|FG002|Overall Study|Lost to Follow-up|1|||
149053890|NCT01997840|537677661|FG003|Overall Study|Lost to Follow-up|0|||
149053891|NCT01997840|537677658|FG000|Overall Study|Withdrawal by participant|0|||
149053892|NCT01997840|537677659|FG001|Overall Study|Withdrawal by participant|0|||
149053893|NCT01997840|537677660|FG002|Overall Study|Withdrawal by participant|8|||
149053894|NCT01997840|537677661|FG003|Overall Study|Withdrawal by participant|1|||
149053895|NCT01997840|537677658|FG000|Overall Study|Physician Decision|0|||
149053896|NCT01997840|537677659|FG001|Overall Study|Physician Decision|0|||
149053897|NCT01997840|537677660|FG002|Overall Study|Physician Decision|3|||
149053898|NCT01997840|537677661|FG003|Overall Study|Physician Decision|0|||
149053899|NCT01997840|537677658|FG000|Overall Study|Progressive disease|3|||
149053900|NCT01997840|537677659|FG001|Overall Study|Progressive disease|4|||
149053901|NCT01997840|537677660|FG002|Overall Study|Progressive disease|57|||
149053902|NCT01997840|537677661|FG003|Overall Study|Progressive disease|8|||
149053903|NCT01997840|537677658|FG000|Overall Study|Other reasons|0|||
149053904|NCT01997840|537677659|FG001|Overall Study|Other reasons|0|||
149053905|NCT01997840|537677660|FG002|Overall Study|Other reasons|1|||
149053906|NCT01997840|537677661|FG003|Overall Study|Other reasons|0|||
149053907|NCT01997840|537677658|FG000|Overall Study|Adverse Event|0|||
149053908|NCT01997840|537677659|FG001|Overall Study|Adverse Event|0|||
149053909|NCT01997840|537677660|FG002|Overall Study|Adverse Event|15|||
149053910|NCT01997840|537677661|FG003|Overall Study|Adverse Event|2|||
149053911|NCT05256706|537677662|FG000|Overall Study|Lost to Follow-up|9|||
149053912|NCT05256706|537677663|FG001|Overall Study|Lost to Follow-up|3|||
149053913|NCT05256706|537677662|FG000|Overall Study|Withdrawal by Subject|7|||
149053914|NCT05256706|537677663|FG001|Overall Study|Withdrawal by Subject|11|||
149053915|NCT05256706|537677662|FG000|Overall Study|Screen Failures|3|||
149053916|NCT05256706|537677663|FG001|Overall Study|Screen Failures|0|||
149053917|NCT05486078|537677668|FG000|Overall Study|4 drop out and one withdrawn|5|||
149053918|NCT02949362|537677669|FG000|Retrospective Period|Inform consent not signed by participant|4|||
149053919|NCT02949362|537677670|FG001|Retrospective Period|Inform consent not signed by participant|1|||
149053920|NCT02949362|537677671|FG002|Retrospective Period|Inform consent not signed by participant|0|||
149053921|NCT02949362|537677672|FG003|Retrospective Period|Inform consent not signed by participant|0|||
149053922|NCT02949362|537677669|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
149053923|NCT02949362|537677670|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
149053924|NCT02949362|537677671|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
149053925|NCT02949362|537677672|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
149053926|NCT02949362|537677669|FG000|Prospective Period|Other|0|||
149053927|NCT02949362|537677670|FG001|Prospective Period|Other|0|||
149053928|NCT02949362|537677671|FG002|Prospective Period|Other|0|||
149053929|NCT02949362|537677672|FG003|Prospective Period|Other|4|||
149053930|NCT04015167|537677673|FG000|Overall Study|Lost to Follow-up|40|||
149053931|NCT04015167|537677673|FG000|Overall Study|Adverse Event|5|||
148888805|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
149053932|NCT04015167|537677673|FG000|Overall Study|Withdrawal by Subject|2|||
149053933|NCT04015167|537677673|FG000|Overall Study|Subject went to jail|1|||
149053934|NCT05008835|537677675|FG000|Overall Study|Adverse Event|5|||
148888806|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
149053935|NCT05008835|537677676|FG001|Overall Study|Adverse Event|2|||
149053936|NCT05008835|537677677|FG002|Overall Study|Adverse Event|1|||
149053937|NCT05008835|537677675|FG000|Overall Study|Lack of Efficacy|0|||
149053938|NCT05008835|537677676|FG001|Overall Study|Lack of Efficacy|0|||
149053939|NCT05008835|537677677|FG002|Overall Study|Lack of Efficacy|1|||
149053940|NCT05008835|537677675|FG000|Overall Study|Study terminated by sponsor|0|||
149053941|NCT05008835|537677676|FG001|Overall Study|Study terminated by sponsor|0|||
149053942|NCT05008835|537677677|FG002|Overall Study|Study terminated by sponsor|1|||
149053943|NCT05008835|537677675|FG000|Overall Study|Not further specified|3|||
149053944|NCT05008835|537677676|FG001|Overall Study|Not further specified|2|||
149053945|NCT05008835|537677677|FG002|Overall Study|Not further specified|1|||
149053946|NCT05089734|537677680|FG000|Overall Study|Still on study|122|||
149053947|NCT05089734|537677681|FG001|Overall Study|Still on study|101|||
149053948|NCT05089734|537677680|FG000|Overall Study|Death|161|||
149053949|NCT05089734|537677681|FG001|Overall Study|Death|179|||
149053950|NCT05089734|537677680|FG000|Overall Study|Withdrew consent|11|||
149053951|NCT05089734|537677681|FG001|Overall Study|Withdrew consent|24|||
149053952|NCT05089734|537677680|FG000|Overall Study|Lost to Follow-up|5|||
149053953|NCT05089734|537677681|FG001|Overall Study|Lost to Follow-up|0|||
149053954|NCT02995434|537679623|FG000|Overall Study|Adverse Event|1|||
149053955|NCT02995434|537679624|FG001|Overall Study|Adverse Event|0|||
149053956|NCT02995434|537679623|FG000|Overall Study|Withdrawal by Subject|6|||
149053957|NCT02995434|537679624|FG001|Overall Study|Withdrawal by Subject|3|||
149053958|NCT05273749|537679625|FG000|Overall Study|Adverse Event|14|||
149053959|NCT05273749|537679626|FG001|Overall Study|Adverse Event|8|||
149053960|NCT05273749|537679625|FG000|Overall Study|Lack of Efficacy|2|||
149053961|NCT05273749|537679626|FG001|Overall Study|Lack of Efficacy|8|||
149053962|NCT05273749|537679625|FG000|Overall Study|Physician Decision|0|||
149053963|NCT05273749|537679626|FG001|Overall Study|Physician Decision|2|||
149053964|NCT05273749|537679625|FG000|Overall Study|Withdrawal by Subject|14|||
149053965|NCT05273749|537679626|FG001|Overall Study|Withdrawal by Subject|16|||
149053966|NCT05273749|537679625|FG000|Overall Study|Lost to Follow-up|10|||
149053967|NCT05273749|537679626|FG001|Overall Study|Lost to Follow-up|10|||
149053968|NCT05273749|537679625|FG000|Overall Study|Pregnancy|1|||
149053969|NCT05273749|537679626|FG001|Overall Study|Pregnancy|0|||
149053970|NCT05273749|537679625|FG000|Overall Study|Non-Compliance|3|||
149053971|NCT05273749|537679626|FG001|Overall Study|Non-Compliance|2|||
149053972|NCT05273749|537679625|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
149053973|NCT05273749|537679626|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
149053974|NCT00378105|537679627|FG000|Overall Study|Adverse Event|3|||
149053975|NCT00378105|537679628|FG001|Overall Study|Adverse Event|1|||
149053976|NCT00378105|537679627|FG000|Overall Study|Withdrawal by Subject|3|||
149053977|NCT00378105|537679628|FG001|Overall Study|Withdrawal by Subject|3|||
149053978|NCT00378105|537679627|FG000|Overall Study|Death|1|||
149053979|NCT00378105|537679628|FG001|Overall Study|Death|0|||
149053980|NCT00378105|537679627|FG000|Overall Study|Going to transplant|7|||
149053981|NCT00378105|537679628|FG001|Overall Study|Going to transplant|8|||
149053982|NCT00378105|537679627|FG000|Overall Study|Progressive disease|3|||
149053983|NCT00378105|537679628|FG001|Overall Study|Progressive disease|3|||
149053984|NCT00378105|537679627|FG000|Overall Study|remain on study|3|||
149053985|NCT00378105|537679628|FG001|Overall Study|remain on study|11|||
149053986|NCT00378105|537679627|FG000|Overall Study|Physician Decision|0|||
149053987|NCT00378105|537679628|FG001|Overall Study|Physician Decision|2|||
149053988|NCT00378105|537679627|FG000|Overall Study|Going non-protocol therapy|0|||
149053989|NCT00378105|537679628|FG001|Overall Study|Going non-protocol therapy|1|||
149053990|NCT00378105|537679627|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
149053991|NCT00378105|537679628|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
149053992|NCT04241068|537679629|FG000|Core Treatment Period|Adverse Event|91|||
149053993|NCT04241068|537679629|FG000|Core Treatment Period|Change of Treatment|4|||
149053994|NCT04241068|537679629|FG000|Core Treatment Period|Consent Withdrawn|143|||
149053995|NCT04241068|537679629|FG000|Core Treatment Period|Death|26|||
149053996|NCT04241068|537679629|FG000|Core Treatment Period|Disease Progression|67|||
149053997|NCT04241068|537679629|FG000|Core Treatment Period|Investigator Decision|40|||
149053998|NCT04241068|537679629|FG000|Core Treatment Period|Loss of Capacity|9|||
149053999|NCT04241068|537679629|FG000|Core Treatment Period|Lost to Follow-up|11|||
149054000|NCT04241068|537679629|FG000|Core Treatment Period|Relocation|4|||
149054001|NCT04241068|537679629|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
149054002|NCT04241068|537679629|FG000|Core Treatment Period|Study Visit Burden|40|||
149054003|NCT04241068|537679629|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
149054004|NCT04241068|537679629|FG000|Core Treatment Period|Missing|2|||
149054005|NCT04241068|537679629|FG000|Core Treatment Period|Reason Not Specified|41|||
149054006|NCT04241068|537679629|FG000|LTE Period|Adverse Event|19|||
149054007|NCT04241068|537679629|FG000|LTE Period|Change of Treatment|1|||
149054008|NCT04241068|537679629|FG000|LTE Period|Consent Withdrawn|71|||
149054009|NCT04241068|537679629|FG000|LTE Period|Death|8|||
149054010|NCT04241068|537679629|FG000|LTE Period|Disease Progression|11|||
149054011|NCT04241068|537679629|FG000|LTE Period|Investigator Decision|12|||
149054012|NCT04241068|537679629|FG000|LTE Period|Loss of Capacity|2|||
149054013|NCT04241068|537679629|FG000|LTE Period|Lost to Follow-up|7|||
149054014|NCT04241068|537679629|FG000|LTE Period|Relocation|6|||
149054015|NCT04241068|537679629|FG000|LTE Period|Site Terminated by Sponsor|26|||
149054016|NCT04241068|537679629|FG000|LTE Period|Study Terminated by Sponsor|276|||
149054017|NCT04241068|537679629|FG000|LTE Period|Study Visit Burden|10|||
149054018|NCT04241068|537679629|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
149054019|NCT04241068|537679629|FG000|LTE Period|Reason Not Specified|65|||
149054020|NCT04060654|537679631|FG000|Overall Study|Withdrawal by Subject|1|||
149054021|NCT04060654|537679631|FG000|Overall Study|Lost to Follow-up|5|||
149054022|NCT03707951|537679632|FG000|Overall Study|Lost to Follow-up|8|||
149054023|NCT03707951|537679633|FG001|Overall Study|Lost to Follow-up|17|||
149054024|NCT03707951|537679632|FG000|Overall Study|Withdrawal by Subject|6|||
149054025|NCT03707951|537679633|FG001|Overall Study|Withdrawal by Subject|6|||
149054026|NCT01999075|537679634|FG000|Overall Study|Lost to Follow-up|0|||
149054027|NCT01999075|537679635|FG001|Overall Study|Lost to Follow-up|2|||
149054028|NCT01999075|537679634|FG000|Overall Study|Withdrawal by Subject|2|||
149054029|NCT01999075|537679635|FG001|Overall Study|Withdrawal by Subject|7|||
149054030|NCT01999075|537679634|FG000|Overall Study|Enrolled in drug trial|3|||
149054031|NCT01999075|537679635|FG001|Overall Study|Enrolled in drug trial|1|||
149054032|NCT01999075|537679634|FG000|Overall Study|Became ineligible|0|||
149054033|NCT01999075|537679635|FG001|Overall Study|Became ineligible|2|||
149054034|NCT03792256|537679637|FG000|Overall Study|Death|0|||
149054035|NCT03792256|537679638|FG001|Overall Study|Death|1|||
149054036|NCT03792256|537679637|FG000|Overall Study|Lack of Efficacy|0|||
149054037|NCT03792256|537679638|FG001|Overall Study|Lack of Efficacy|1|||
149054038|NCT03792256|537679637|FG000|Overall Study|Withdrawal by Subject|0|||
149054039|NCT03792256|537679638|FG001|Overall Study|Withdrawal by Subject|1|||
149054040|NCT04562649|537679639|FG000|Overall Study|Withdrawal by Subject|11|||
149054041|NCT04562649|537679640|FG001|Overall Study|Withdrawal by Subject|8|||
149054042|NCT04562649|537679639|FG000|Overall Study|Lost to Follow-up|26|||
149054043|NCT04562649|537679640|FG001|Overall Study|Lost to Follow-up|20|||
149054044|NCT05368103|537679641|FG000|Overall Study|Withdrawal by Subject|4|||
149054045|NCT05368103|537679641|FG000|Overall Study|Lost to Follow-up|1|||
149054046|NCT05368103|537679641|FG000|Overall Study|Lack of Efficacy|3|||
149054047|NCT03611621|537679663|FG000|Overall Study|Graft loss|3|||
149054048|NCT03611621|537679663|FG000|Overall Study|Death|3|||
149054049|NCT03611621|537679663|FG000|Overall Study|Lost to Follow-up|1|||
149054050|NCT03853746|537679666|FG000|Overall Study|Withdrawal by Subject|1|||
149054051|NCT00450658|537679667|FG000|Overall Study|Adverse Event|24|||
149054052|NCT00450658|537679668|FG001|Overall Study|Adverse Event|15|||
149054053|NCT00450658|537679667|FG000|Overall Study|Withdrawal by Subject|43|||
149054054|NCT00450658|537679668|FG001|Overall Study|Withdrawal by Subject|26|||
149054055|NCT00450658|537679667|FG000|Overall Study|Lost to Follow-up|22|||
149054056|NCT00450658|537679668|FG001|Overall Study|Lost to Follow-up|5|||
149054057|NCT00450658|537679667|FG000|Overall Study|UGI ulcer|33|||
149054058|NCT00450658|537679668|FG001|Overall Study|UGI ulcer|34|||
149054059|NCT00450658|537679667|FG000|Overall Study|misc|21|||
149054060|NCT00450658|537679668|FG001|Overall Study|misc|10|||
149054061|NCT01084876|537679670|FG000|Main Study Treatment Period|Adverse Event|12|||
149054062|NCT01084876|537679671|FG001|Main Study Treatment Period|Adverse Event|7|||
149054063|NCT01084876|537679670|FG000|Main Study Treatment Period|Disease Progression|41|||
149054064|NCT01084876|537679671|FG001|Main Study Treatment Period|Disease Progression|24|||
149054065|NCT01084876|537679670|FG000|Main Study Treatment Period|Physician Decision|2|||
149054066|NCT01084876|537679671|FG001|Main Study Treatment Period|Physician Decision|0|||
149054067|NCT01084876|537679670|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
149054068|NCT01084876|537679671|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
149054069|NCT01084876|537679670|FG000|Main Study Treatment Period|Other Reason|0|||
149054070|NCT01084876|537679671|FG001|Main Study Treatment Period|Other Reason|1|||
149054071|NCT01084876|537679670|FG000|Main Study Treatment Period|Other|0|||
149054072|NCT01084876|537679671|FG001|Main Study Treatment Period|Other|1|||
149054073|NCT01084876|537679670|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
149054074|NCT01084876|537679671|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
149054075|NCT01084876|537679670|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
149054076|NCT01084876|537679671|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
149054077|NCT01084876|537679670|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
149054078|NCT01084876|537679671|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
149054079|NCT01084876|537679670|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
149054080|NCT01084876|537679671|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
149054081|NCT01084876|537679670|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
149054082|NCT01084876|537679671|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
149054083|NCT01084876|537679670|FG000|Treatment Period Beyond Cycle 8|Other|6|||
149054084|NCT01084876|537679671|FG001|Treatment Period Beyond Cycle 8|Other|9|||
149054085|NCT04727554|537679672|FG000|Overall Study|Lost to Follow-up|0|||
149054086|NCT04727554|537679673|FG001|Overall Study|Lost to Follow-up|1|||
149054087|NCT04727554|537679672|FG000|Overall Study|Death|2|||
149054088|NCT04727554|537679673|FG001|Overall Study|Death|6|||
149054089|NCT04727554|537679672|FG000|Overall Study|Withdrawal by Subject|1|||
149054090|NCT04727554|537679673|FG001|Overall Study|Withdrawal by Subject|0|||
149054091|NCT05763823|537679674|FG000|Overall Study|Death|6|||
149054092|NCT05763823|537679674|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149054093|NCT05763823|537679674|FG000|Overall Study|Withdrawal by Subject|6|||
149054094|NCT05311384|537679682|FG000|Overall Study|Uncontrolled health conditions|2|||
149054095|NCT05311384|537679682|FG000|Overall Study|Withdrawal by Subject|1|||
149054096|NCT02908477|537679687|FG000|Overall Study|Withdrawal by Subject|8|||
149054097|NCT02908477|537679688|FG001|Overall Study|Withdrawal by Subject|28|||
149054098|NCT02924272|537679691|FG000|Overall Study|Site Terminated by Sponsor|4|||
149054099|NCT02924272|537679692|FG001|Overall Study|Site Terminated by Sponsor|1|||
149054100|NCT02924272|537679691|FG000|Overall Study|Withdrawal by Subject|2|||
149054101|NCT02924272|537679692|FG001|Overall Study|Withdrawal by Subject|0|||
149054102|NCT02924272|537679691|FG000|Overall Study|Adverse Event|3|||
149054103|NCT02924272|537679692|FG001|Overall Study|Adverse Event|0|||
149054104|NCT02924272|537679691|FG000|Overall Study|Progressive Disease|11|||
149054105|NCT02924272|537679692|FG001|Overall Study|Progressive Disease|8|||
149054106|NCT02924272|537679691|FG000|Overall Study|Clinical Deterioration|1|||
149054107|NCT02924272|537679692|FG001|Overall Study|Clinical Deterioration|0|||
149054108|NCT02924272|537679691|FG000|Overall Study|Death|1|||
149054109|NCT02924272|537679692|FG001|Overall Study|Death|0|||
149054110|NCT02924272|537679691|FG000|Overall Study|Reason Not Specified|1|||
149054111|NCT02924272|537679692|FG001|Overall Study|Reason Not Specified|0|||
149054112|NCT03150810|537679698|FG000|Overall Study|Death|4|||
149054113|NCT03150810|537679699|FG001|Overall Study|Death|8|||
149054114|NCT03150810|537679700|FG002|Overall Study|Death|7|||
149054115|NCT03150810|537679701|FG003|Overall Study|Death|2|||
149054116|NCT03150810|537679702|FG004|Overall Study|Death|2|||
149054117|NCT03150810|537679703|FG005|Overall Study|Death|10|||
149054118|NCT03150810|537679704|FG006|Overall Study|Death|8|||
149054119|NCT03150810|537679705|FG007|Overall Study|Death|6|||
149054120|NCT03150810|537679706|FG008|Overall Study|Death|18|||
149054121|NCT03150810|537679707|FG009|Overall Study|Death|3|||
149054122|NCT03150810|537679708|FG010|Overall Study|Death|19|||
149054123|NCT03150810|537679709|FG011|Overall Study|Death|1|||
149054124|NCT03150810|537679710|FG012|Overall Study|Death|19|||
149054125|NCT03150810|537679698|FG000|Overall Study|Withdrawal by Subject|0|||
149054126|NCT03150810|537679699|FG001|Overall Study|Withdrawal by Subject|1|||
149054127|NCT03150810|537679700|FG002|Overall Study|Withdrawal by Subject|1|||
149054128|NCT03150810|537679701|FG003|Overall Study|Withdrawal by Subject|1|||
149054129|NCT03150810|537679702|FG004|Overall Study|Withdrawal by Subject|0|||
149054130|NCT03150810|537679703|FG005|Overall Study|Withdrawal by Subject|0|||
149054131|NCT03150810|537679704|FG006|Overall Study|Withdrawal by Subject|2|||
149054132|NCT03150810|537679705|FG007|Overall Study|Withdrawal by Subject|0|||
149054133|NCT03150810|537679706|FG008|Overall Study|Withdrawal by Subject|2|||
149054134|NCT03150810|537679707|FG009|Overall Study|Withdrawal by Subject|0|||
149054135|NCT03150810|537679708|FG010|Overall Study|Withdrawal by Subject|1|||
149054136|NCT03150810|537679709|FG011|Overall Study|Withdrawal by Subject|0|||
149054137|NCT03150810|537679710|FG012|Overall Study|Withdrawal by Subject|1|||
149054138|NCT03150810|537679698|FG000|Overall Study|Sponsor Decision|0|||
149054139|NCT03150810|537679699|FG001|Overall Study|Sponsor Decision|2|||
149054140|NCT03150810|537679700|FG002|Overall Study|Sponsor Decision|0|||
149054141|NCT03150810|537679701|FG003|Overall Study|Sponsor Decision|0|||
149054142|NCT03150810|537679702|FG004|Overall Study|Sponsor Decision|1|||
149054143|NCT03150810|537679703|FG005|Overall Study|Sponsor Decision|1|||
149054144|NCT03150810|537679704|FG006|Overall Study|Sponsor Decision|0|||
149054145|NCT03150810|537679705|FG007|Overall Study|Sponsor Decision|0|||
149054146|NCT03150810|537679706|FG008|Overall Study|Sponsor Decision|1|||
149054147|NCT03150810|537679707|FG009|Overall Study|Sponsor Decision|0|||
149054148|NCT03150810|537679708|FG010|Overall Study|Sponsor Decision|0|||
149054149|NCT03150810|537679709|FG011|Overall Study|Sponsor Decision|0|||
149054150|NCT03150810|537679710|FG012|Overall Study|Sponsor Decision|5|||
149054151|NCT03150810|537679698|FG000|Overall Study|Lost to Follow-up|0|||
148888807|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888808|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888809|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888810|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
148888811|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
148888812|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888813|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
148888814|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
149054152|NCT03150810|537679699|FG001|Overall Study|Lost to Follow-up|1|||
149054153|NCT03150810|537679700|FG002|Overall Study|Lost to Follow-up|1|||
149054154|NCT03150810|537679701|FG003|Overall Study|Lost to Follow-up|0|||
149054155|NCT03150810|537679702|FG004|Overall Study|Lost to Follow-up|0|||
149054156|NCT03150810|537679703|FG005|Overall Study|Lost to Follow-up|0|||
149054157|NCT03150810|537679704|FG006|Overall Study|Lost to Follow-up|1|||
149054158|NCT03150810|537679705|FG007|Overall Study|Lost to Follow-up|0|||
149054159|NCT03150810|537679706|FG008|Overall Study|Lost to Follow-up|0|||
149054160|NCT03150810|537679707|FG009|Overall Study|Lost to Follow-up|0|||
149054161|NCT03150810|537679708|FG010|Overall Study|Lost to Follow-up|1|||
149054162|NCT03150810|537679709|FG011|Overall Study|Lost to Follow-up|0|||
149054163|NCT03150810|537679710|FG012|Overall Study|Lost to Follow-up|0|||
149054164|NCT03150810|537679698|FG000|Overall Study|Physician Decision|0|||
149054165|NCT03150810|537679699|FG001|Overall Study|Physician Decision|0|||
149054166|NCT03150810|537679700|FG002|Overall Study|Physician Decision|0|||
149054167|NCT03150810|537679701|FG003|Overall Study|Physician Decision|0|||
149054168|NCT03150810|537679702|FG004|Overall Study|Physician Decision|0|||
149054169|NCT03150810|537679703|FG005|Overall Study|Physician Decision|1|||
149054170|NCT03150810|537679704|FG006|Overall Study|Physician Decision|1|||
149054171|NCT03150810|537679705|FG007|Overall Study|Physician Decision|0|||
149054172|NCT03150810|537679706|FG008|Overall Study|Physician Decision|0|||
149054173|NCT03150810|537679707|FG009|Overall Study|Physician Decision|0|||
149054174|NCT03150810|537679708|FG010|Overall Study|Physician Decision|0|||
149054175|NCT03150810|537679709|FG011|Overall Study|Physician Decision|0|||
149054176|NCT03150810|537679710|FG012|Overall Study|Physician Decision|0|||
149054177|NCT03150810|537679698|FG000|Overall Study|Site withdrawal from study|0|||
149054178|NCT03150810|537679699|FG001|Overall Study|Site withdrawal from study|1|||
149054179|NCT03150810|537679700|FG002|Overall Study|Site withdrawal from study|0|||
149054180|NCT03150810|537679701|FG003|Overall Study|Site withdrawal from study|0|||
149054181|NCT03150810|537679702|FG004|Overall Study|Site withdrawal from study|0|||
149054182|NCT03150810|537679703|FG005|Overall Study|Site withdrawal from study|0|||
149054183|NCT03150810|537679704|FG006|Overall Study|Site withdrawal from study|0|||
149054184|NCT03150810|537679705|FG007|Overall Study|Site withdrawal from study|0|||
149054185|NCT03150810|537679706|FG008|Overall Study|Site withdrawal from study|0|||
149054186|NCT03150810|537679707|FG009|Overall Study|Site withdrawal from study|1|||
149054187|NCT03150810|537679708|FG010|Overall Study|Site withdrawal from study|1|||
149054188|NCT03150810|537679709|FG011|Overall Study|Site withdrawal from study|0|||
149054189|NCT03150810|537679710|FG012|Overall Study|Site withdrawal from study|0|||
149054190|NCT03150810|537679698|FG000|Overall Study|Hospice|0|||
149054191|NCT03150810|537679699|FG001|Overall Study|Hospice|0|||
149054192|NCT03150810|537679700|FG002|Overall Study|Hospice|0|||
149054193|NCT03150810|537679701|FG003|Overall Study|Hospice|0|||
149054194|NCT03150810|537679702|FG004|Overall Study|Hospice|0|||
149054195|NCT03150810|537679703|FG005|Overall Study|Hospice|1|||
149054196|NCT03150810|537679704|FG006|Overall Study|Hospice|0|||
149054197|NCT03150810|537679705|FG007|Overall Study|Hospice|0|||
149054198|NCT03150810|537679706|FG008|Overall Study|Hospice|0|||
149054199|NCT03150810|537679707|FG009|Overall Study|Hospice|0|||
149054200|NCT03150810|537679708|FG010|Overall Study|Hospice|0|||
149054201|NCT03150810|537679709|FG011|Overall Study|Hospice|0|||
149054202|NCT03150810|537679710|FG012|Overall Study|Hospice|0|||
149054203|NCT03150810|537679698|FG000|Overall Study|Participant relocated abroad.|0|||
149054204|NCT03150810|537679699|FG001|Overall Study|Participant relocated abroad.|0|||
149054205|NCT03150810|537679700|FG002|Overall Study|Participant relocated abroad.|0|||
149054206|NCT03150810|537679701|FG003|Overall Study|Participant relocated abroad.|0|||
149054207|NCT03150810|537679702|FG004|Overall Study|Participant relocated abroad.|0|||
149054208|NCT03150810|537679703|FG005|Overall Study|Participant relocated abroad.|1|||
149054209|NCT03150810|537679704|FG006|Overall Study|Participant relocated abroad.|0|||
149054210|NCT03150810|537679705|FG007|Overall Study|Participant relocated abroad.|0|||
149054211|NCT03150810|537679706|FG008|Overall Study|Participant relocated abroad.|0|||
149054212|NCT03150810|537679707|FG009|Overall Study|Participant relocated abroad.|0|||
149054213|NCT03150810|537679708|FG010|Overall Study|Participant relocated abroad.|0|||
149054214|NCT03150810|537679709|FG011|Overall Study|Participant relocated abroad.|0|||
149054215|NCT03150810|537679710|FG012|Overall Study|Participant relocated abroad.|0|||
149054216|NCT03150810|537679698|FG000|Overall Study|Transferred care to oncologist|0|||
149054217|NCT03150810|537679699|FG001|Overall Study|Transferred care to oncologist|0|||
149054218|NCT03150810|537679700|FG002|Overall Study|Transferred care to oncologist|0|||
149054219|NCT03150810|537679701|FG003|Overall Study|Transferred care to oncologist|0|||
149054220|NCT03150810|537679702|FG004|Overall Study|Transferred care to oncologist|0|||
149054221|NCT03150810|537679703|FG005|Overall Study|Transferred care to oncologist|0|||
149054222|NCT03150810|537679704|FG006|Overall Study|Transferred care to oncologist|2|||
149054223|NCT03150810|537679705|FG007|Overall Study|Transferred care to oncologist|0|||
149054224|NCT03150810|537679706|FG008|Overall Study|Transferred care to oncologist|0|||
149054225|NCT03150810|537679707|FG009|Overall Study|Transferred care to oncologist|0|||
149054226|NCT03150810|537679708|FG010|Overall Study|Transferred care to oncologist|0|||
149054227|NCT03150810|537679709|FG011|Overall Study|Transferred care to oncologist|0|||
149054228|NCT03150810|537679710|FG012|Overall Study|Transferred care to oncologist|0|||
149054229|NCT04526704|537679711|FG000|Overall Study|Adverse Event|1|||
149054230|NCT04526704|537679712|FG001|Overall Study|Adverse Event|0|||
149054231|NCT04526704|537679711|FG000|Overall Study|Physician Decision|1|||
149054232|NCT04526704|537679712|FG001|Overall Study|Physician Decision|0|||
149054233|NCT04526704|537679711|FG000|Overall Study|Withdrawal by Subject|2|||
149005405|NCT01892345|537497884|FG000|Overall Study|Death|1|||
149005406|NCT01892345|537497885|FG001|Overall Study|Death|0|||
149005407|NCT01892345|537497884|FG000|Overall Study|Lost to Follow-up|3|||
149005408|NCT01892345|537497885|FG001|Overall Study|Lost to Follow-up|0|||
149005409|NCT01892345|537497884|FG000|Overall Study|Withdrawal by Subject|12|||
149005410|NCT01892345|537497885|FG001|Overall Study|Withdrawal by Subject|1|||
149005411|NCT02063828|537497889|FG000|Overall Study|Withdrawal by Subject|4|||
149005412|NCT02063828|537497890|FG001|Overall Study|Withdrawal by Subject|6|||
149005413|NCT02063828|537497891|FG002|Overall Study|Withdrawal by Subject|3|||
149005414|NCT02063828|537497889|FG000|Overall Study|Death|0|||
149054234|NCT04526704|537679712|FG001|Overall Study|Withdrawal by Subject|0|||
149054235|NCT00881621|537679713|FG000|Overall Study|Physician Decision|34|||
149054236|NCT05116787|537679714|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
149054237|NCT05116787|537679715|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
149054238|NCT05116787|537679714|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
148888815|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
148888816|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888817|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888818|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888819|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
148888820|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
148888821|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
149054239|NCT05116787|537679715|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
149054240|NCT05116787|537679714|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
149054241|NCT05116787|537679715|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
149054242|NCT05116787|537679714|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
149054243|NCT05116787|537679715|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
149054244|NCT02737436|537679716|FG000|Washout Period|Lost to Follow-up|5|||
149054245|NCT02737436|537679717|FG001|Washout Period|Lost to Follow-up|11|||
149054246|NCT02737436|537679716|FG000|Data Analysis|Scanning data problems|5|||
149054247|NCT02737436|537679717|FG001|Data Analysis|Scanning data problems|8|||
149054248|NCT04359108|537679718|FG000|Overall Study|Withdrawal by Subject|1|||
149054249|NCT04359108|537679719|FG001|Overall Study|Withdrawal by Subject|0|||
149054250|NCT04359108|537679718|FG000|Overall Study|Unable or too feeble to walk independently|0|||
149054251|NCT04359108|537679719|FG001|Overall Study|Unable or too feeble to walk independently|2|||
149054252|NCT04359108|537679718|FG000|Overall Study|Argus II system stopped functioning|0|||
149054253|NCT04359108|537679719|FG001|Overall Study|Argus II system stopped functioning|1|||
149054254|NCT04359108|537679718|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
149054255|NCT04359108|537679719|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
149054256|NCT06393088|537679721|FG000|Overall Study|Withdrawal by Subject|0|||
149054257|NCT06393088|537679722|FG001|Overall Study|Withdrawal by Subject|2|||
149054258|NCT04176965|537679723|FG000|Overall Study|Death|1|||
149054259|NCT04176965|537679724|FG001|Overall Study|Death|2|||
149054260|NCT04176965|537679723|FG000|Overall Study|Lost to Follow-up|10|||
149054261|NCT04176965|537679724|FG001|Overall Study|Lost to Follow-up|2|||
149054262|NCT04176965|537679723|FG000|Overall Study|Withdrawal by Subject|6|||
149054263|NCT04176965|537679724|FG001|Overall Study|Withdrawal by Subject|1|||
149054264|NCT03903146|537679725|FG000|Overall Study|Lost to Follow-up|6|||
149054265|NCT03903146|537679726|FG001|Overall Study|Lost to Follow-up|4|||
149054266|NCT03903146|537679725|FG000|Overall Study|Withdrawal by Subject|0|||
149054267|NCT03903146|537679726|FG001|Overall Study|Withdrawal by Subject|1|||
149054268|NCT02919683|537679727|FG000|Post-Surgery Follow-Up|Death|2|||
149054269|NCT02919683|537679728|FG001|Post-Surgery Follow-Up|Death|2|||
149054270|NCT02919683|537679727|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
149054271|NCT02919683|537679728|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
149054272|NCT05551637|537679731|FG000|Overall Study|Lack of Efficacy|0|||
149054273|NCT05551637|537679732|FG001|Overall Study|Lack of Efficacy|6|||
149054274|NCT05551637|537679731|FG000|Overall Study|Lost to Follow-up|1|||
149054275|NCT05551637|537679732|FG001|Overall Study|Lost to Follow-up|1|||
149054276|NCT05179837|537679735|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
149054277|NCT05179837|537679735|FG000|Overall Study|Device malfunctioned|1|||
149054278|NCT05179837|537679735|FG000|Overall Study|Image quality too low|2|||
149054279|NCT03158129|537679736|FG000|Overall Study|Adverse Event|0|||
149054280|NCT03158129|537679737|FG001|Overall Study|Adverse Event|1|||
149054281|NCT03158129|537679738|FG002|Overall Study|Adverse Event|0|||
149054282|NCT03158129|537679739|FG003|Overall Study|Adverse Event|0|||
149054283|NCT03158129|537679736|FG000|Overall Study|Death|0|||
149054284|NCT03158129|537679737|FG001|Overall Study|Death|0|||
149054285|NCT03158129|537679738|FG002|Overall Study|Death|0|||
149054286|NCT03158129|537679739|FG003|Overall Study|Death|1|||
149054287|NCT03158129|537679736|FG000|Overall Study|High surgical risk|1|||
149054288|NCT03158129|537679737|FG001|Overall Study|High surgical risk|1|||
149054289|NCT03158129|537679738|FG002|Overall Study|High surgical risk|0|||
149054290|NCT03158129|537679739|FG003|Overall Study|High surgical risk|0|||
149054291|NCT03158129|537679736|FG000|Overall Study|Progression|1|||
149054292|NCT03158129|537679737|FG001|Overall Study|Progression|1|||
149054293|NCT03158129|537679738|FG002|Overall Study|Progression|0|||
148888822|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
149054294|NCT03158129|537679739|FG003|Overall Study|Progression|0|||
149054295|NCT03158129|537679736|FG000|Overall Study|Lack of resectability|0|||
149054296|NCT03158129|537679737|FG001|Overall Study|Lack of resectability|1|||
149054297|NCT03158129|537679738|FG002|Overall Study|Lack of resectability|0|||
149054298|NCT03158129|537679739|FG003|Overall Study|Lack of resectability|0|||
149054299|NCT03158129|537679736|FG000|Overall Study|Declined surgery|0|||
149054300|NCT03158129|537679737|FG001|Overall Study|Declined surgery|1|||
149054301|NCT03158129|537679738|FG002|Overall Study|Declined surgery|0|||
149054302|NCT03158129|537679739|FG003|Overall Study|Declined surgery|0|||
149054303|NCT03158129|537679736|FG000|Overall Study|No longer surgical candidate|0|||
149054304|NCT03158129|537679737|FG001|Overall Study|No longer surgical candidate|0|||
149054305|NCT03158129|537679738|FG002|Overall Study|No longer surgical candidate|0|||
149054306|NCT03158129|537679739|FG003|Overall Study|No longer surgical candidate|1|||
149054307|NCT03719443|537679740|FG000|Overall Study|Lost to Follow-up|0|||
149054308|NCT03719443|537679741|FG001|Overall Study|Lost to Follow-up|0|||
149054309|NCT03719443|537679742|FG002|Overall Study|Lost to Follow-up|1|||
149054310|NCT03719443|537679743|FG003|Overall Study|Lost to Follow-up|0|||
149054311|NCT03719443|537679744|FG004|Overall Study|Lost to Follow-up|1|||
149054312|NCT03719443|537679745|FG005|Overall Study|Lost to Follow-up|0|||
149054313|NCT03719443|537679746|FG006|Overall Study|Lost to Follow-up|1|||
149054314|NCT03719443|537679740|FG000|Overall Study|Withdrawal by Subject|0|||
149054315|NCT03719443|537679741|FG001|Overall Study|Withdrawal by Subject|0|||
149054316|NCT03719443|537679742|FG002|Overall Study|Withdrawal by Subject|1|||
149054317|NCT03719443|537679743|FG003|Overall Study|Withdrawal by Subject|0|||
149054318|NCT03719443|537679744|FG004|Overall Study|Withdrawal by Subject|0|||
149054319|NCT03719443|537679745|FG005|Overall Study|Withdrawal by Subject|0|||
149054320|NCT03719443|537679746|FG006|Overall Study|Withdrawal by Subject|0|||
149054321|NCT04782973|537679747|FG000|Overall Study|Withdrawal by Subject|5|||
149054322|NCT04782973|537679747|FG000|Overall Study|Protocol Violation|6|||
149054323|NCT04782973|537679747|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
149054324|NCT04924660|537679748|FG000|United States|Death|29|||
149054325|NCT04924660|537679749|FG001|United States|Death|32|||
149054326|NCT04924660|537679750|FG002|United States|Death|34|||
149054327|NCT04924660|537679751|FG003|United States|Death|25|||
149054328|NCT04924660|537679752|FG004|United States|Death|26|||
149054329|NCT04924660|537679753|FG005|United States|Death|23|||
149054330|NCT04924660|537679748|FG000|United States|Lost to Follow-up|15|||
149054331|NCT04924660|537679749|FG001|United States|Lost to Follow-up|10|||
149054332|NCT04924660|537679750|FG002|United States|Lost to Follow-up|13|||
149054333|NCT04924660|537679751|FG003|United States|Lost to Follow-up|5|||
149054334|NCT04924660|537679752|FG004|United States|Lost to Follow-up|19|||
149054335|NCT04924660|537679753|FG005|United States|Lost to Follow-up|20|||
149054336|NCT04924660|537679748|FG000|United States|Withdrawal by Subject|8|||
149054337|NCT04924660|537679749|FG001|United States|Withdrawal by Subject|3|||
149005415|NCT02063828|537497890|FG001|Overall Study|Death|0|||
149005416|NCT02063828|537497891|FG002|Overall Study|Death|1|||
149005417|NCT03217747|537497892|FG000|Overall Study|Adverse Event|0|||
149005418|NCT03217747|537497893|FG001|Overall Study|Adverse Event|1|||
149005419|NCT03217747|537497894|FG002|Overall Study|Adverse Event|0|||
149005420|NCT03217747|537497895|FG003|Overall Study|Adverse Event|0|||
149005421|NCT03217747|537497896|FG004|Overall Study|Adverse Event|0|||
149005422|NCT03217747|537497897|FG005|Overall Study|Adverse Event|0|||
149005423|NCT03217747|537497898|FG006|Overall Study|Adverse Event|0|||
149005424|NCT03217747|537497899|FG007|Overall Study|Adverse Event|0|||
149005425|NCT03217747|537497900|FG008|Overall Study|Adverse Event|0|||
149005426|NCT03217747|537497901|FG009|Overall Study|Adverse Event|0|||
149005427|NCT03217747|537497902|FG010|Overall Study|Adverse Event|0|||
149005428|NCT03217747|537497903|FG011|Overall Study|Adverse Event|0|||
149005429|NCT03217747|537497904|FG012|Overall Study|Adverse Event|1|||
149005430|NCT03217747|537497905|FG013|Overall Study|Adverse Event|1|||
149005431|NCT03217747|537497892|FG000|Overall Study|Death|0|||
149005432|NCT03217747|537497893|FG001|Overall Study|Death|0|||
149005433|NCT03217747|537497894|FG002|Overall Study|Death|0|||
149005434|NCT03217747|537497895|FG003|Overall Study|Death|0|||
149005435|NCT03217747|537497896|FG004|Overall Study|Death|0|||
149005436|NCT03217747|537497897|FG005|Overall Study|Death|0|||
149005437|NCT03217747|537497898|FG006|Overall Study|Death|0|||
149005438|NCT03217747|537497899|FG007|Overall Study|Death|0|||
149005439|NCT03217747|537497900|FG008|Overall Study|Death|1|||
149005440|NCT03217747|537497901|FG009|Overall Study|Death|0|||
149005441|NCT03217747|537497902|FG010|Overall Study|Death|0|||
149005442|NCT03217747|537497903|FG011|Overall Study|Death|0|||
149005443|NCT03217747|537497904|FG012|Overall Study|Death|0|||
149005444|NCT03217747|537497905|FG013|Overall Study|Death|0|||
149005445|NCT03217747|537497892|FG000|Overall Study|Lack of Efficacy|12|||
149005446|NCT03217747|537497893|FG001|Overall Study|Lack of Efficacy|6|||
149005447|NCT03217747|537497894|FG002|Overall Study|Lack of Efficacy|15|||
149005448|NCT03217747|537497895|FG003|Overall Study|Lack of Efficacy|11|||
149005449|NCT03217747|537497896|FG004|Overall Study|Lack of Efficacy|3|||
149005450|NCT03217747|537497897|FG005|Overall Study|Lack of Efficacy|14|||
149005451|NCT03217747|537497898|FG006|Overall Study|Lack of Efficacy|10|||
149005452|NCT03217747|537497899|FG007|Overall Study|Lack of Efficacy|4|||
149005453|NCT03217747|537497900|FG008|Overall Study|Lack of Efficacy|2|||
149005454|NCT03217747|537497901|FG009|Overall Study|Lack of Efficacy|7|||
149005455|NCT03217747|537497902|FG010|Overall Study|Lack of Efficacy|3|||
149005456|NCT03217747|537497903|FG011|Overall Study|Lack of Efficacy|1|||
149054338|NCT04924660|537679750|FG002|United States|Withdrawal by Subject|3|||
149054339|NCT04924660|537679751|FG003|United States|Withdrawal by Subject|3|||
149054340|NCT04924660|537679752|FG004|United States|Withdrawal by Subject|8|||
149054341|NCT04924660|537679753|FG005|United States|Withdrawal by Subject|4|||
149054342|NCT04924660|537679748|FG000|Spain|Death|0|||
149054343|NCT04924660|537679749|FG001|Spain|Death|0|||
149054344|NCT04924660|537679750|FG002|Spain|Death|0|||
149054345|NCT04924660|537679751|FG003|Spain|Death|0|||
149054346|NCT04924660|537679752|FG004|Spain|Death|0|||
149054347|NCT04924660|537679753|FG005|Spain|Death|2|||
149054348|NCT04924660|537679748|FG000|Spain|Lost to Follow-up|0|||
149054349|NCT04924660|537679749|FG001|Spain|Lost to Follow-up|0|||
149054350|NCT04924660|537679750|FG002|Spain|Lost to Follow-up|0|||
149054351|NCT04924660|537679751|FG003|Spain|Lost to Follow-up|0|||
149054352|NCT04924660|537679752|FG004|Spain|Lost to Follow-up|1|||
149054353|NCT04924660|537679753|FG005|Spain|Lost to Follow-up|0|||
149054354|NCT04924660|537679748|FG000|Brazil|Death|0|||
149054355|NCT04924660|537679749|FG001|Brazil|Death|0|||
149054356|NCT04924660|537679750|FG002|Brazil|Death|0|||
149054357|NCT04924660|537679751|FG003|Brazil|Death|0|||
149054358|NCT04924660|537679752|FG004|Brazil|Death|1|||
149054359|NCT04924660|537679753|FG005|Brazil|Death|0|||
149054360|NCT04924660|537679748|FG000|Italy|Lost to Follow-up|0|||
149054361|NCT04924660|537679749|FG001|Italy|Lost to Follow-up|0|||
149054362|NCT04924660|537679750|FG002|Italy|Lost to Follow-up|0|||
149054363|NCT04924660|537679751|FG003|Italy|Lost to Follow-up|0|||
149054364|NCT04924660|537679752|FG004|Italy|Lost to Follow-up|0|||
149054365|NCT04924660|537679753|FG005|Italy|Lost to Follow-up|1|||
149054366|NCT04924660|537679748|FG000|South Africa|Death|0|||
149054367|NCT04924660|537679749|FG001|South Africa|Death|0|||
149054368|NCT04924660|537679750|FG002|South Africa|Death|0|||
149054369|NCT04924660|537679751|FG003|South Africa|Death|0|||
149054370|NCT04924660|537679752|FG004|South Africa|Death|0|||
149054371|NCT04924660|537679753|FG005|South Africa|Death|1|||
149054372|NCT04924660|537679748|FG000|South Africa|Lost to Follow-up|0|||
149054373|NCT04924660|537679749|FG001|South Africa|Lost to Follow-up|0|||
149054374|NCT04924660|537679750|FG002|South Africa|Lost to Follow-up|0|||
149054375|NCT04924660|537679751|FG003|South Africa|Lost to Follow-up|0|||
149054376|NCT04924660|537679752|FG004|South Africa|Lost to Follow-up|0|||
149054377|NCT04924660|537679753|FG005|South Africa|Lost to Follow-up|1|||
149054378|NCT00554788|537679754|FG000|Overall Study|Adverse Event|0|||
149054379|NCT00554788|537679755|FG001|Overall Study|Adverse Event|1|||
149054380|NCT00554788|537679756|FG002|Overall Study|Adverse Event|2|||
149054381|NCT00554788|537679754|FG000|Overall Study|Lost to Follow-up|4|||
149054382|NCT00554788|537679755|FG001|Overall Study|Lost to Follow-up|3|||
149054383|NCT00554788|537679756|FG002|Overall Study|Lost to Follow-up|3|||
149054384|NCT00554788|537679754|FG000|Overall Study|Physician Decision|1|||
149054385|NCT00554788|537679755|FG001|Overall Study|Physician Decision|1|||
149054386|NCT00554788|537679756|FG002|Overall Study|Physician Decision|3|||
149054387|NCT00554788|537679754|FG000|Overall Study|Withdrawal by Subject|0|||
149054388|NCT00554788|537679755|FG001|Overall Study|Withdrawal by Subject|0|||
149054389|NCT00554788|537679756|FG002|Overall Study|Withdrawal by Subject|1|||
149054390|NCT00554788|537679754|FG000|Overall Study|Refusal of further protocol therapy|0|||
149054391|NCT00554788|537679755|FG001|Overall Study|Refusal of further protocol therapy|1|||
149054392|NCT00554788|537679756|FG002|Overall Study|Refusal of further protocol therapy|1|||
149054393|NCT00554788|537679754|FG000|Overall Study|Progressive disease|0|||
149054394|NCT00554788|537679755|FG001|Overall Study|Progressive disease|0|||
148888823|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888824|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
149054395|NCT00554788|537679756|FG002|Overall Study|Progressive disease|3|||
148888825|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888826|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888827|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888828|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888829|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
149054396|NCT00554788|537679754|FG000|Overall Study|Ineligible|2|||
148888830|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
149054397|NCT00554788|537679755|FG001|Overall Study|Ineligible|0|||
149054398|NCT00554788|537679756|FG002|Overall Study|Ineligible|1|||
149054399|NCT06491433|537679757|FG000|Overall Study|Protocol Violation|51|||
149054400|NCT06491433|537679757|FG000|Overall Study|consent withdrawal|2|||
149054401|NCT06491433|537679757|FG000|Overall Study|screen failure|1|||
149054402|NCT05894577|537679761|FG000|Overall Study|No receipt of study drug|14|||
149054403|NCT05894577|537679762|FG001|Overall Study|No receipt of study drug|13|||
149054404|NCT05894577|537679761|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
149054405|NCT05894577|537679762|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
149054406|NCT05894577|537679761|FG000|Overall Study|Screen Fail|2|||
149054407|NCT05894577|537679762|FG001|Overall Study|Screen Fail|0|||
149054408|NCT05894577|537679761|FG000|Overall Study|Study drug recall|86|||
149054409|NCT05894577|537679762|FG001|Overall Study|Study drug recall|63|||
149054410|NCT03197662|537679765|FG000|Overall Study|Withdrawn by family|0|||
149054411|NCT03197662|537679766|FG001|Overall Study|Withdrawn by family|2|||
149054412|NCT03721952|537679767|FG000|Overall Study|Lost to Follow-up|0|||
149054413|NCT03721952|537679768|FG001|Overall Study|Lost to Follow-up|0|||
149054414|NCT03721952|537679769|FG002|Overall Study|Lost to Follow-up|2|||
149054415|NCT03721952|537679770|FG003|Overall Study|Lost to Follow-up|0|||
149054416|NCT03721952|537679771|FG004|Overall Study|Lost to Follow-up|0|||
149054417|NCT03721952|537679767|FG000|Overall Study|Protocol Violation|0|||
149054418|NCT03721952|537679768|FG001|Overall Study|Protocol Violation|1|||
149054419|NCT03721952|537679769|FG002|Overall Study|Protocol Violation|0|||
149054420|NCT03721952|537679770|FG003|Overall Study|Protocol Violation|0|||
149054421|NCT03721952|537679771|FG004|Overall Study|Protocol Violation|0|||
149054422|NCT03721952|537679767|FG000|Overall Study|Withdrawal by Subject|1|||
149054423|NCT03721952|537679768|FG001|Overall Study|Withdrawal by Subject|0|||
149054424|NCT03721952|537679769|FG002|Overall Study|Withdrawal by Subject|40|||
149054425|NCT03721952|537679770|FG003|Overall Study|Withdrawal by Subject|28|||
149054426|NCT03721952|537679771|FG004|Overall Study|Withdrawal by Subject|0|||
149054427|NCT03476460|537679775|FG000|Overall Study|Withdrawal by Subject|3|||
149054428|NCT03476460|537679776|FG001|Overall Study|Withdrawal by Subject|2|||
149054429|NCT03476460|537679775|FG000|Overall Study|Non-compliance with treatment|3|||
149054430|NCT03476460|537679776|FG001|Overall Study|Non-compliance with treatment|0|||
149054431|NCT03476460|537679775|FG000|Overall Study|Missing laboratory tests|5|||
149054432|NCT03476460|537679776|FG001|Overall Study|Missing laboratory tests|5|||
149054433|NCT03476460|537679775|FG000|Overall Study|Adverse Event|0|||
149054434|NCT03476460|537679776|FG001|Overall Study|Adverse Event|1|||
149054435|NCT03640312|537679782|FG000|Overall Study|Lost to Follow-up|3|||
149054436|NCT03640312|537679783|FG001|Overall Study|Lost to Follow-up|6|||
149054437|NCT02761057|537679789|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
149054438|NCT02761057|537679790|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
149054439|NCT02761057|537679791|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
149054440|NCT02761057|537679792|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
149054441|NCT02761057|537679789|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
149054442|NCT02761057|537679790|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
149054443|NCT02761057|537679791|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
149054444|NCT02761057|537679792|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
149054445|NCT02761057|537679789|FG000|Overall Study|Currently On Study Treatment|0|||
149054446|NCT02761057|537679790|FG001|Overall Study|Currently On Study Treatment|3|||
149054447|NCT02761057|537679791|FG002|Overall Study|Currently On Study Treatment|0|||
149054448|NCT02761057|537679792|FG003|Overall Study|Currently On Study Treatment|0|||
149054449|NCT02761057|537679789|FG000|Overall Study|Adverse Event|11|||
149054450|NCT02761057|537679790|FG001|Overall Study|Adverse Event|9|||
149054451|NCT02761057|537679791|FG002|Overall Study|Adverse Event|5|||
149054452|NCT02761057|537679792|FG003|Overall Study|Adverse Event|3|||
149054453|NCT02761057|537679789|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
149054454|NCT02761057|537679790|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
149054455|NCT02761057|537679791|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
149054456|NCT02761057|537679792|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
149054457|NCT02761057|537679789|FG000|Overall Study|Progression/Relapse|29|||
149054458|NCT02761057|537679790|FG001|Overall Study|Progression/Relapse|27|||
149054459|NCT02761057|537679791|FG002|Overall Study|Progression/Relapse|20|||
149054460|NCT02761057|537679792|FG003|Overall Study|Progression/Relapse|23|||
149054461|NCT02761057|537679789|FG000|Overall Study|Death|2|||
149054462|NCT02761057|537679790|FG001|Overall Study|Death|2|||
149054463|NCT02761057|537679791|FG002|Overall Study|Death|1|||
149054464|NCT02761057|537679792|FG003|Overall Study|Death|1|||
149054465|NCT02761057|537679789|FG000|Overall Study|Other - Not Protocol Specified|2|||
149054466|NCT02761057|537679790|FG001|Overall Study|Other - Not Protocol Specified|1|||
149054467|NCT02761057|537679791|FG002|Overall Study|Other - Not Protocol Specified|2|||
149054468|NCT02761057|537679792|FG003|Overall Study|Other - Not Protocol Specified|0|||
149054469|NCT06037369|537679793|FG000|Overall Study|Lost to Follow-up|0|||
149054470|NCT06037369|537679794|FG001|Overall Study|Lost to Follow-up|1|||
149054471|NCT04876118|537679799|FG000|Overall Study|Pregnancy|1|||
148888831|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
148888832|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
149054472|NCT04876118|537679799|FG000|Overall Study|Withdrawal by Subject|14|||
149054473|NCT05179395|537679800|FG000|Overall Study|Lack of Efficacy|1|||
149054474|NCT00812461|537679801|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
149054475|NCT00812461|537679802|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
149054476|NCT00812461|537679801|FG000|All Treated Patients|Adverse Event|8|||
149054477|NCT00812461|537679802|FG001|All Treated Patients|Adverse Event|15|||
149054478|NCT00812461|537679801|FG000|All Treated Patients|Lack of Efficacy|13|||
149054479|NCT00812461|537679802|FG001|All Treated Patients|Lack of Efficacy|7|||
149054480|NCT00812461|537679801|FG000|All Treated Patients|Non-compliance|6|||
149054481|NCT00812461|537679802|FG001|All Treated Patients|Non-compliance|9|||
149054482|NCT00812461|537679801|FG000|All Treated Patients|Protocol Violation|36|||
149054483|NCT00812461|537679802|FG001|All Treated Patients|Protocol Violation|27|||
149054484|NCT00812461|537679801|FG000|All Treated Patients|Withdrawal by Subject|45|||
149054485|NCT00812461|537679802|FG001|All Treated Patients|Withdrawal by Subject|54|||
149054486|NCT00812461|537679801|FG000|All Treated Patients|Lost to Follow-up|11|||
149054487|NCT00812461|537679802|FG001|All Treated Patients|Lost to Follow-up|14|||
149054488|NCT00812461|537679801|FG000|All Treated Patients|Other Reason|13|||
149054489|NCT00812461|537679802|FG001|All Treated Patients|Other Reason|21|||
149054490|NCT05093829|537679803|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
149054491|NCT05093829|537679804|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
149054492|NCT05093829|537679805|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
149054493|NCT05093829|537679806|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
149054494|NCT05093829|537679807|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
149054495|NCT04353661|537681780|FG000|Overall Study|Protocol Violation|0|||
149054496|NCT04353661|537681781|FG001|Overall Study|Protocol Violation|0|||
149054497|NCT04353661|537681782|FG002|Overall Study|Protocol Violation|1|||
149054498|NCT04353661|537681780|FG000|Overall Study|Study termination by the Sponsor|1|||
149054499|NCT04353661|537681781|FG001|Overall Study|Study termination by the Sponsor|1|||
149054500|NCT04353661|537681782|FG002|Overall Study|Study termination by the Sponsor|1|||
149054501|NCT00667251|537681783|FG000|Overall Study|Disease progression|232|||
149054502|NCT00667251|537681784|FG001|Overall Study|Disease progression|203|||
149054503|NCT00667251|537681783|FG000|Overall Study|Toxicity|44|||
149054504|NCT00667251|537681784|FG001|Overall Study|Toxicity|23|||
149054505|NCT00667251|537681783|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
149054506|NCT00667251|537681784|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
149054507|NCT00667251|537681783|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
149054508|NCT00667251|537681784|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
149054509|NCT00667251|537681783|FG000|Overall Study|Symptomatic progression|8|||
149054510|NCT00667251|537681784|FG001|Overall Study|Symptomatic progression|4|||
149054511|NCT00667251|537681783|FG000|Overall Study|Death|6|||
149054512|NCT00667251|537681784|FG001|Overall Study|Death|11|||
149054513|NCT00667251|537681783|FG000|Overall Study|Intercurrent illness|5|||
149054514|NCT00667251|537681784|FG001|Overall Study|Intercurrent illness|6|||
149054515|NCT00667251|537681783|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
149054516|NCT00667251|537681784|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
149054517|NCT00667251|537681783|FG000|Overall Study|Randomized not Treated|4|||
149054518|NCT00667251|537681784|FG001|Overall Study|Randomized not Treated|1|||
149054519|NCT03376321|537681792|FG000|Overall Study|Other|5|||
149054520|NCT03376321|537681793|FG001|Overall Study|Other|1|||
149054521|NCT03376321|537681792|FG000|Overall Study|Withdrawal by Subject|8|||
149054522|NCT03376321|537681793|FG001|Overall Study|Withdrawal by Subject|14|||
149054523|NCT03376321|537681792|FG000|Overall Study|Lost to Follow-up|1|||
149054524|NCT03376321|537681793|FG001|Overall Study|Lost to Follow-up|7|||
149054525|NCT03376321|537681792|FG000|Overall Study|Death|4|||
149054526|NCT03376321|537681793|FG001|Overall Study|Death|0|||
149054527|NCT03376321|537681792|FG000|Overall Study|Randomized, not treated|5|||
149054528|NCT03376321|537681793|FG001|Overall Study|Randomized, not treated|3|||
149054529|NCT02671903|537681794|FG000|Period 0 (Run-In)|Death|0|||
149054530|NCT02671903|537681795|FG001|Period 0 (Run-In)|Death|0|||
149054531|NCT02671903|537681796|FG002|Period 0 (Run-In)|Death|3|||
149054532|NCT02671903|537681794|FG000|Period 0 (Run-In)|Physician Decision|0|||
149054533|NCT02671903|537681795|FG001|Period 0 (Run-In)|Physician Decision|0|||
149054534|NCT02671903|537681796|FG002|Period 0 (Run-In)|Physician Decision|4|||
149054535|NCT02671903|537681794|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
149054536|NCT02671903|537681795|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
149054537|NCT02671903|537681796|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
149054538|NCT02671903|537681794|FG000|Period 0 (Run-In)|Protocol Violation|0|||
149054539|NCT02671903|537681795|FG001|Period 0 (Run-In)|Protocol Violation|0|||
149054540|NCT02671903|537681796|FG002|Period 0 (Run-In)|Protocol Violation|1|||
149054541|NCT02671903|537681794|FG000|Period 0 (Run-In)|Adverse Event|0|||
149054542|NCT02671903|537681795|FG001|Period 0 (Run-In)|Adverse Event|0|||
149054543|NCT02671903|537681796|FG002|Period 0 (Run-In)|Adverse Event|1|||
149054544|NCT02671903|537681794|FG000|Period 0 (Run-In)|Implantation Failure|0|||
149054545|NCT02671903|537681795|FG001|Period 0 (Run-In)|Implantation Failure|0|||
149054546|NCT02671903|537681796|FG002|Period 0 (Run-In)|Implantation Failure|2|||
149054547|NCT02671903|537681794|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
149054548|NCT02671903|537681795|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
149054549|NCT02671903|537681796|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
149054550|NCT02992925|537681797|FG000|Cohort 2|Physician Decision|0|||
149054551|NCT02992925|537681798|FG001|Cohort 2|Physician Decision|0|||
149054552|NCT02992925|537681799|FG002|Cohort 2|Physician Decision|1|||
149054553|NCT02992925|537681800|FG003|Cohort 2|Physician Decision|0|||
149054554|NCT02992925|537681797|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
149054555|NCT02992925|537681798|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
149054556|NCT02992925|537681799|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
149054557|NCT02992925|537681800|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
149054558|NCT02543281|537681805|FG000|Overall Study|Lost to Follow-up|0|||
149054559|NCT02543281|537681806|FG001|Overall Study|Lost to Follow-up|0|||
149054560|NCT02543281|537681807|FG002|Overall Study|Lost to Follow-up|1|||
149054561|NCT05247489|537681808|FG000|Overall Study|Lost to Follow-up|5|||
149054562|NCT05247489|537681809|FG001|Overall Study|Lost to Follow-up|1|||
149054563|NCT05247489|537681808|FG000|Overall Study|Withdrawal by Subject|6|||
149054564|NCT05247489|537681809|FG001|Overall Study|Withdrawal by Subject|7|||
149054565|NCT05247489|537681808|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
149054566|NCT05247489|537681809|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
149054567|NCT05247489|537681808|FG000|Overall Study|Left Country|1|||
149054568|NCT05247489|537681809|FG001|Overall Study|Left Country|0|||
149054569|NCT05247489|537681808|FG000|Overall Study|Noncompliance with Investigational Product|1|||
149054570|NCT05247489|537681809|FG001|Overall Study|Noncompliance with Investigational Product|0|||
149054571|NCT05247489|537681808|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
149054572|NCT05247489|537681809|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
149054573|NCT05215314|537681816|FG000|Overall Study|Lost to Follow-up|2|||
149054574|NCT05215314|537681817|FG001|Overall Study|Lost to Follow-up|2|||
149054575|NCT05215314|537681816|FG000|Overall Study|Withdrawal by Subject|2|||
149054576|NCT05215314|537681817|FG001|Overall Study|Withdrawal by Subject|0|||
149054577|NCT05215314|537681816|FG000|Overall Study|Physician Decision|1|||
149054578|NCT05215314|537681817|FG001|Overall Study|Physician Decision|0|||
149054579|NCT04179500|537681818|FG000|Treatment|Withdrawal by Subject|1|||
149054580|NCT04179500|537681818|FG000|Treatment|Adverse Event|2|||
149054581|NCT04179500|537681818|FG000|Treatment|pyrazinamide resistance|1|||
149054582|NCT03366649|537681823|FG000|Overall Study|Failed preoperative screening|4|||
149054583|NCT03366649|537681824|FG001|Overall Study|Failed preoperative screening|0|||
149054584|NCT03366649|537681825|FG002|Overall Study|Failed preoperative screening|0|||
149054585|NCT03366649|537681823|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
149054586|NCT03366649|537681824|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
149054587|NCT03366649|537681825|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
149054588|NCT03673111|537681826|FG000|Overall Study|Protocol Violation|0|||
149054589|NCT03673111|537681827|FG001|Overall Study|Protocol Violation|0|||
149054590|NCT03673111|537681828|FG002|Overall Study|Protocol Violation|0|||
149054591|NCT03673111|537681829|FG003|Overall Study|Protocol Violation|0|||
149054592|NCT03673111|537681830|FG004|Overall Study|Protocol Violation|0|||
149054593|NCT03673111|537681831|FG005|Overall Study|Protocol Violation|0|||
149054594|NCT03673111|537681832|FG006|Overall Study|Protocol Violation|0|||
149054595|NCT03673111|537681833|FG007|Overall Study|Protocol Violation|0|||
149054596|NCT03673111|537681834|FG008|Overall Study|Protocol Violation|0|||
149054597|NCT03673111|537681835|FG009|Overall Study|Protocol Violation|0|||
149054598|NCT03673111|537681836|FG010|Overall Study|Protocol Violation|1|||
149054599|NCT03673111|537681837|FG011|Overall Study|Protocol Violation|0|||
149054600|NCT03673111|537681838|FG012|Overall Study|Protocol Violation|0|||
149054601|NCT03673111|537681839|FG013|Overall Study|Protocol Violation|0|||
149054602|NCT03673111|537681826|FG000|Overall Study|Adverse Event|1|||
149054603|NCT03673111|537681827|FG001|Overall Study|Adverse Event|0|||
149054604|NCT03673111|537681828|FG002|Overall Study|Adverse Event|0|||
149054605|NCT03673111|537681829|FG003|Overall Study|Adverse Event|0|||
149054606|NCT03673111|537681830|FG004|Overall Study|Adverse Event|0|||
149054607|NCT03673111|537681831|FG005|Overall Study|Adverse Event|0|||
149054608|NCT03673111|537681832|FG006|Overall Study|Adverse Event|0|||
149054609|NCT03673111|537681833|FG007|Overall Study|Adverse Event|0|||
149054610|NCT03673111|537681834|FG008|Overall Study|Adverse Event|0|||
149054611|NCT03673111|537681835|FG009|Overall Study|Adverse Event|0|||
149054612|NCT03673111|537681836|FG010|Overall Study|Adverse Event|0|||
149054613|NCT03673111|537681837|FG011|Overall Study|Adverse Event|0|||
149054614|NCT03673111|537681838|FG012|Overall Study|Adverse Event|0|||
149054615|NCT03673111|537681839|FG013|Overall Study|Adverse Event|0|||
149054616|NCT03792555|537681840|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
149054617|NCT03792555|537681841|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
149054618|NCT03792555|537681842|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
149054619|NCT03792555|537681840|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
149054620|NCT03792555|537681841|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
149054621|NCT03792555|537681842|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
149054622|NCT03792555|537681840|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
149054623|NCT03792555|537681841|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
149054624|NCT03792555|537681842|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
149054625|NCT04485039|537681846|FG000|TPOXX Only|Adverse Event|2|||
149054626|NCT04485039|537681846|FG000|TPOXX Only|Physician Decision|1|||
149054627|NCT04485039|537681846|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
149054628|NCT04485039|537681846|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
149054629|NCT01744782|537681847|FG000|Overall Study|Death|1|||
149054630|NCT02120456|537681849|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054631|NCT02120456|537681850|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054632|NCT02120456|537681851|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054633|NCT02120456|537681852|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054634|NCT02120456|537681853|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054635|NCT02120456|537681854|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054636|NCT02120456|537681855|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
149054637|NCT02120456|537681856|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054638|NCT02120456|537681857|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
149054639|NCT02120456|537681849|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054640|NCT02120456|537681850|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054641|NCT02120456|537681851|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054642|NCT02120456|537681852|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054643|NCT02120456|537681853|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054644|NCT02120456|537681854|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054645|NCT02120456|537681855|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
149054646|NCT02120456|537681856|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054647|NCT02120456|537681857|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
149054648|NCT02120456|537681849|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054649|NCT02120456|537681850|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054650|NCT02120456|537681851|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054651|NCT02120456|537681852|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054652|NCT02120456|537681853|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054653|NCT02120456|537681854|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054654|NCT02120456|537681855|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054655|NCT02120456|537681856|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
149054656|NCT02120456|537681857|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
149054657|NCT05192200|537681858|FG000|Treatment Period|Other|1|||
149054658|NCT05192200|537681858|FG000|Treatment Period|Lack of Efficacy|1|||
149054659|NCT05192200|537681858|FG000|Treatment Period|Withdrawal by Subject|1|||
149054660|NCT05192200|537681858|FG000|Follow-up|Withdrawal by Subject|1|||
149054661|NCT03623321|537681859|FG000|Overall Study|Adverse Event|32|||
149054662|NCT03623321|537681859|FG000|Overall Study|Death|9|||
149054663|NCT03623321|537681859|FG000|Overall Study|Lack of Efficacy|9|||
149054664|NCT03623321|537681859|FG000|Overall Study|Lost to Follow-up|6|||
149054665|NCT03623321|537681859|FG000|Overall Study|Noncompliance with study drug|6|||
149054666|NCT03623321|537681859|FG000|Overall Study|Use of prohibited medication|3|||
149054667|NCT03623321|537681859|FG000|Overall Study|Physician Decision|5|||
149054668|NCT03623321|537681859|FG000|Overall Study|Protocol Violation|1|||
149054669|NCT03623321|537681859|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
149054670|NCT03623321|537681859|FG000|Overall Study|Not further specified|43|||
149054671|NCT01785719|537681862|FG000|4-week Baseline Evaluation|Physician Decision|1|||
149054672|NCT01785719|537681863|FG001|4-week Baseline Evaluation|Physician Decision|0|||
149054673|NCT01785719|537681862|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
149054674|NCT01785719|537681863|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
149054675|NCT01785719|537681862|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
149054676|NCT01785719|537681863|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
149054677|NCT01785719|537681862|FG000|4-week Baseline Evaluation|Pregnancy|0|||
149054678|NCT01785719|537681863|FG001|4-week Baseline Evaluation|Pregnancy|2|||
149054679|NCT01785719|537681862|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
149054680|NCT01785719|537681863|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
149054681|NCT01785719|537681862|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
149054682|NCT01785719|537681863|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
149054683|NCT01785719|537681862|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
149054684|NCT01785719|537681863|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
149054685|NCT01785719|537681862|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
149054686|NCT01785719|537681863|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
149054687|NCT01785719|537681862|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
149054688|NCT01785719|537681863|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
149054689|NCT01785719|537681862|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
149054690|NCT01785719|537681863|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
149054691|NCT01785719|537681862|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
149054692|NCT01785719|537681863|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
149054693|NCT01785719|537681862|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
149054694|NCT01785719|537681863|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
149054695|NCT01785719|537681862|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
149054696|NCT01785719|537681863|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
149054697|NCT01785719|537681862|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
149054698|NCT01785719|537681863|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
149054699|NCT01785719|537681862|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
149054700|NCT01785719|537681863|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
149054701|NCT03443323|537681864|FG000|Overall Study|Lost to Follow-up|2|||
149054702|NCT03443323|537681865|FG001|Overall Study|Lost to Follow-up|2|||
149054703|NCT03443323|537681864|FG000|Overall Study|PI withdrawal|1|||
149054704|NCT03443323|537681865|FG001|Overall Study|PI withdrawal|0|||
149054705|NCT04492007|537681866|FG000|Overall Study|Lost to Follow-up|1|||
149054706|NCT04492007|537681867|FG001|Overall Study|Lost to Follow-up|1|||
149054707|NCT04492007|537681868|FG002|Overall Study|Lost to Follow-up|2|||
149054708|NCT04492007|537681869|FG003|Overall Study|Lost to Follow-up|2|||
149054709|NCT04492007|537681866|FG000|Overall Study|Protocol Violation|1|||
149054710|NCT04492007|537681867|FG001|Overall Study|Protocol Violation|1|||
149054711|NCT04492007|537681868|FG002|Overall Study|Protocol Violation|1|||
149054712|NCT04492007|537681869|FG003|Overall Study|Protocol Violation|1|||
149054713|NCT04492007|537681866|FG000|Overall Study|Withdrawal by Subject|0|||
149054714|NCT04492007|537681867|FG001|Overall Study|Withdrawal by Subject|0|||
149054715|NCT04492007|537681868|FG002|Overall Study|Withdrawal by Subject|1|||
149054716|NCT04492007|537681869|FG003|Overall Study|Withdrawal by Subject|1|||
149054717|NCT03457142|537681872|FG000|Overall Study|Death|1|||
149054718|NCT04887129|537681873|FG000|Overall Study|Lost to Follow-up|0|||
149054719|NCT04887129|537681874|FG001|Overall Study|Lost to Follow-up|24|||
149054720|NCT04887129|537681873|FG000|Overall Study|Withdrawal by Subject|9|||
149054721|NCT04887129|537681874|FG001|Overall Study|Withdrawal by Subject|57|||
149054722|NCT04887129|537681873|FG000|Overall Study|Other|2|||
149054723|NCT04887129|537681874|FG001|Overall Study|Other|9|||
149054724|NCT01413100|537681876|FG000|Overall Study|Withdrawal by Subject|1|||
149054725|NCT04896476|537681888|FG000|Overall Study|Withdrawal by Subject|1|||
149054726|NCT04896476|537681888|FG000|Overall Study|Lost to Follow-up|2|||
149054727|NCT03476187|537681889|FG000|Overall Study|Protocol Violation|7|||
149054728|NCT03476187|537681889|FG000|Overall Study|Physician Decision|5|||
149054729|NCT05948670|537681891|FG000|Overall Study|Protocol Violation|6|||
149054730|NCT05948670|537681892|FG001|Overall Study|Protocol Violation|8|||
149054731|NCT05948670|537681891|FG000|Overall Study|Withdrawal by Subject|0|||
149054732|NCT05948670|537681892|FG001|Overall Study|Withdrawal by Subject|1|||
149054733|NCT02724631|537681895|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
149054734|NCT05076708|537681896|FG000|Overall Study|Withdrawal by Subject|4|||
149054735|NCT05076708|537681896|FG000|Overall Study|Lost to study during switch phase|8|||
149054736|NCT04971395|537681897|FG000|Overall Study|Withdrawal by Subject|0|||
149054737|NCT04971395|537681898|FG001|Overall Study|Withdrawal by Subject|1|||
149054738|NCT04971395|537681899|FG002|Overall Study|Withdrawal by Subject|0|||
149054739|NCT05292365|537681903|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
149054740|NCT05292365|537681904|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
149054741|NCT05292365|537681905|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
149054742|NCT05292365|537681906|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
149054743|NCT04495894|537681913|FG000|Overall Study|Withdrawal by Subject|2|||
149054744|NCT04495894|537681914|FG001|Overall Study|Withdrawal by Subject|0|||
149054745|NCT04495894|537681915|FG002|Overall Study|Withdrawal by Subject|2|||
149054746|NCT04495894|537681916|FG003|Overall Study|Withdrawal by Subject|3|||
149054747|NCT04495894|537681913|FG000|Overall Study|Early termination|0|||
149054748|NCT04495894|537681914|FG001|Overall Study|Early termination|0|||
149054749|NCT04495894|537681915|FG002|Overall Study|Early termination|3|||
149054750|NCT04495894|537681916|FG003|Overall Study|Early termination|0|||
149054751|NCT03364647|537681917|FG000|Overall Study|Withdrawal by Subject|3|||
149054752|NCT03364647|537681918|FG001|Overall Study|Withdrawal by Subject|1|||
149054753|NCT01000961|537681919|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
149054754|NCT01000961|537681920|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
149054755|NCT01000961|537681919|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
149054756|NCT01000961|537681920|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
149054757|NCT03447470|537681927|FG000|Overall Study|Death|0|||
149054758|NCT03447470|537681928|FG001|Overall Study|Death|1|||
149054759|NCT03447470|537681929|FG002|Overall Study|Death|3|||
149054760|NCT03447470|537681930|FG003|Overall Study|Death|0|||
149054761|NCT03447470|537681931|FG004|Overall Study|Death|1|||
149054762|NCT03447470|537681932|FG005|Overall Study|Death|0|||
149054763|NCT03447470|537681933|FG006|Overall Study|Death|3|||
149054764|NCT03447470|537681934|FG007|Overall Study|Death|3|||
149054765|NCT03447470|537681935|FG008|Overall Study|Death|1|||
149054766|NCT03447470|537681927|FG000|Overall Study|Withdrawal by Subject|1|||
149054767|NCT03447470|537681928|FG001|Overall Study|Withdrawal by Subject|0|||
149054768|NCT03447470|537681929|FG002|Overall Study|Withdrawal by Subject|0|||
149054769|NCT03447470|537681930|FG003|Overall Study|Withdrawal by Subject|0|||
149054770|NCT03447470|537681931|FG004|Overall Study|Withdrawal by Subject|1|||
149054771|NCT03447470|537681932|FG005|Overall Study|Withdrawal by Subject|0|||
149054772|NCT03447470|537681933|FG006|Overall Study|Withdrawal by Subject|1|||
149054773|NCT03447470|537681934|FG007|Overall Study|Withdrawal by Subject|1|||
149054774|NCT03447470|537681935|FG008|Overall Study|Withdrawal by Subject|3|||
149054775|NCT03447470|537681927|FG000|Overall Study|Treatment discontinued|3|||
149054776|NCT03447470|537681928|FG001|Overall Study|Treatment discontinued|2|||
149054777|NCT03447470|537681929|FG002|Overall Study|Treatment discontinued|4|||
149054778|NCT03447470|537681930|FG003|Overall Study|Treatment discontinued|6|||
149054779|NCT03447470|537681931|FG004|Overall Study|Treatment discontinued|2|||
149054780|NCT03447470|537681932|FG005|Overall Study|Treatment discontinued|1|||
149054781|NCT03447470|537681933|FG006|Overall Study|Treatment discontinued|2|||
149054782|NCT03447470|537681934|FG007|Overall Study|Treatment discontinued|4|||
149054783|NCT03447470|537681935|FG008|Overall Study|Treatment discontinued|3|||
149054784|NCT04592549|537681936|FG000|Overall Study|Withdrawal by Subject|0|||
149054785|NCT04592549|537681937|FG001|Overall Study|Withdrawal by Subject|1|||
149054786|NCT04592549|537681938|FG002|Overall Study|Withdrawal by Subject|0|||
149054787|NCT04592549|537681939|FG003|Overall Study|Withdrawal by Subject|1|||
149054788|NCT04592549|537681940|FG004|Overall Study|Withdrawal by Subject|1|||
149054789|NCT04592549|537681941|FG005|Overall Study|Withdrawal by Subject|0|||
149054790|NCT04592549|537681936|FG000|Overall Study|Lost to Follow-up|2|||
149054791|NCT04592549|537681937|FG001|Overall Study|Lost to Follow-up|0|||
149054792|NCT04592549|537681938|FG002|Overall Study|Lost to Follow-up|0|||
149054793|NCT04592549|537681939|FG003|Overall Study|Lost to Follow-up|1|||
149054794|NCT04592549|537681940|FG004|Overall Study|Lost to Follow-up|1|||
149054795|NCT04592549|537681941|FG005|Overall Study|Lost to Follow-up|1|||
149054796|NCT05184192|537681942|FG000|Overall Study|Lost to Follow-up|4|||
149054797|NCT05184192|537681943|FG001|Overall Study|Lost to Follow-up|7|||
149054798|NCT05184192|537681942|FG000|Overall Study|Adverse Event|1|||
149054799|NCT05184192|537681943|FG001|Overall Study|Adverse Event|4|||
149054800|NCT05184192|537681942|FG000|Overall Study|PI withdrawal|1|||
149054801|NCT05184192|537681943|FG001|Overall Study|PI withdrawal|2|||
149054802|NCT05184192|537681942|FG000|Overall Study|Withdrew due to adverse effect|1|||
149054803|NCT05184192|537681943|FG001|Overall Study|Withdrew due to adverse effect|0|||
149054804|NCT05184192|537681942|FG000|Overall Study|Medication schedule|1|||
149054805|NCT05184192|537681943|FG001|Overall Study|Medication schedule|0|||
149054806|NCT05184192|537681942|FG000|Overall Study|Concern for adverse effects|0|||
149054807|NCT05184192|537681943|FG001|Overall Study|Concern for adverse effects|4|||
149054808|NCT04295798|537681944|FG000|Overall Study|Lost to Follow-up|1|||
149054809|NCT04624633|537681947|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
149054810|NCT04624633|537681948|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
149054811|NCT04624633|537681947|FG000|Overall Study|Death|1|||
149054812|NCT04624633|537681948|FG001|Overall Study|Death|0|||
149054813|NCT01959425|537681949|FG000|Overall Study|Withdrawal by Subject|5|||
149054814|NCT01959425|537681950|FG001|Overall Study|Withdrawal by Subject|4|||
149054815|NCT01959425|537681949|FG000|Overall Study|Lost to Follow-up|1|||
149054816|NCT01959425|537681950|FG001|Overall Study|Lost to Follow-up|0|||
149054817|NCT01959425|537681949|FG000|Overall Study|Discontinued Subjects|6|||
149054818|NCT01959425|537681950|FG001|Overall Study|Discontinued Subjects|4|||
149054819|NCT01902173|537681956|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
149054820|NCT01902173|537681957|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
149054821|NCT01902173|537681958|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
149054822|NCT01902173|537681959|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
149054823|NCT01902173|537681960|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
149054824|NCT01902173|537681961|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
149054825|NCT01902173|537681956|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
149054826|NCT01902173|537681957|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
148888833|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888834|NCT01147666|537072251|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
148888835|NCT01147666|537072252|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
149054827|NCT01902173|537681958|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
149054828|NCT01902173|537681959|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
149054829|NCT01902173|537681960|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
148888836|NCT01147666|537072238|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888837|NCT01147666|537072239|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888838|NCT01147666|537072240|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888839|NCT01147666|537072241|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888840|NCT01147666|537072242|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888841|NCT01147666|537072243|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888842|NCT01147666|537072244|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
149054830|NCT01902173|537681961|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
149054831|NCT01902173|537681956|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
149054832|NCT01902173|537681957|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
149054833|NCT01902173|537681958|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
149054834|NCT01902173|537681959|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
149054835|NCT01902173|537681960|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
149054836|NCT01902173|537681961|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
149054837|NCT01902173|537681956|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
149054838|NCT01902173|537681957|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
149054839|NCT01902173|537681958|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
149054840|NCT01902173|537681959|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
149054841|NCT01902173|537681960|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
149054842|NCT01902173|537681961|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
149054843|NCT01902173|537681956|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
149054844|NCT01902173|537681957|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
149054845|NCT01902173|537681958|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
149054846|NCT01902173|537681959|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
149054847|NCT01902173|537681960|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
149054848|NCT01902173|537681961|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
149054849|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
149054850|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
149054851|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
149054852|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
149054853|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
149054854|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
149054855|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
149054856|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
149054857|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
149054858|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
149054859|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
149054860|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
149054861|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
149054862|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
149054863|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
149054864|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
149054865|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
149054866|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
149054867|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
149054868|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
149054869|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
149054870|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
149054871|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
149054872|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
149054873|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
149054874|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
149054875|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
149054876|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
149054877|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
149054878|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
149054879|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
149054880|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
149054881|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
149054882|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
149054883|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
149054884|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
149054885|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
149054886|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
149054887|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
149054888|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
149054889|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
149054890|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
149054891|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
149054892|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
149054893|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
149054894|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
149054895|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
149054896|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
149054897|NCT01902173|537681956|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
149054898|NCT01902173|537681957|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
149054899|NCT01902173|537681958|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
149054900|NCT01902173|537681959|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
149054901|NCT01902173|537681960|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
149054902|NCT01902173|537681961|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
149054903|NCT05020249|537681965|FG000|Overall Study|Protocol Violation|1|||
149054904|NCT05020249|537681966|FG001|Overall Study|Protocol Violation|0|||
149054905|NCT05364671|537681967|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
149054906|NCT05364671|537681968|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
149054907|NCT05364671|537681967|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
149054908|NCT05364671|537681968|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
149054909|NCT05364671|537681967|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
149054910|NCT05364671|537681968|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
149054911|NCT05364671|537681967|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
149054912|NCT05364671|537681968|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
149054913|NCT05364671|537681967|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
149054914|NCT05364671|537681968|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
149054915|NCT03382652|537681971|FG000|Overall Study|Lost to Follow-up|6|||
149054916|NCT03382652|537681971|FG000|Overall Study|Death|4|||
149054917|NCT03382652|537681971|FG000|Overall Study|Revision|5|||
149054918|NCT03382652|537681971|FG000|Overall Study|Patient withdrew|3|||
149054919|NCT03382652|537681971|FG000|Overall Study|Other reasons|21|||
149054920|NCT04810650|537681972|FG000|Overall Study|Disenrolled in error|0|||
149054921|NCT04810650|537681973|FG001|Overall Study|Disenrolled in error|0|||
149054922|NCT04810650|537681974|FG002|Overall Study|Disenrolled in error|0|||
149054923|NCT04810650|537681975|FG003|Overall Study|Disenrolled in error|0|||
149054924|NCT04810650|537681976|FG004|Overall Study|Disenrolled in error|0|||
149054925|NCT04810650|537681977|FG005|Overall Study|Disenrolled in error|0|||
149054926|NCT04810650|537681978|FG006|Overall Study|Disenrolled in error|0|||
149054927|NCT04810650|537681979|FG007|Overall Study|Disenrolled in error|0|||
149054928|NCT04810650|537681980|FG008|Overall Study|Disenrolled in error|1|||
149054929|NCT04810650|537681981|FG009|Overall Study|Disenrolled in error|0|||
149054930|NCT04810650|537681982|FG010|Overall Study|Disenrolled in error|0|||
149054931|NCT04810650|537681983|FG011|Overall Study|Disenrolled in error|0|||
149054932|NCT04810650|537681984|FG012|Overall Study|Disenrolled in error|0|||
149054933|NCT04810650|537681985|FG013|Overall Study|Disenrolled in error|0|||
149054934|NCT04810650|537681972|FG000|Overall Study|Death|0|||
149054935|NCT04810650|537681973|FG001|Overall Study|Death|0|||
149054936|NCT04810650|537681974|FG002|Overall Study|Death|0|||
149054937|NCT04810650|537681975|FG003|Overall Study|Death|0|||
149054938|NCT04810650|537681976|FG004|Overall Study|Death|0|||
149054939|NCT04810650|537681977|FG005|Overall Study|Death|0|||
149054940|NCT04810650|537681978|FG006|Overall Study|Death|2|||
149054941|NCT04810650|537681979|FG007|Overall Study|Death|2|||
149054942|NCT04810650|537681980|FG008|Overall Study|Death|0|||
149054943|NCT04810650|537681981|FG009|Overall Study|Death|1|||
149054944|NCT04810650|537681982|FG010|Overall Study|Death|0|||
149054945|NCT04810650|537681983|FG011|Overall Study|Death|0|||
149054946|NCT04810650|537681984|FG012|Overall Study|Death|2|||
149054947|NCT04810650|537681985|FG013|Overall Study|Death|1|||
149054948|NCT04810650|537681972|FG000|Overall Study|Moved/transferred care|0|||
149054949|NCT04810650|537681973|FG001|Overall Study|Moved/transferred care|0|||
149054950|NCT04810650|537681974|FG002|Overall Study|Moved/transferred care|0|||
149054951|NCT04810650|537681975|FG003|Overall Study|Moved/transferred care|0|||
149054952|NCT04810650|537681976|FG004|Overall Study|Moved/transferred care|0|||
149054953|NCT04810650|537681977|FG005|Overall Study|Moved/transferred care|0|||
149054954|NCT04810650|537681978|FG006|Overall Study|Moved/transferred care|0|||
149054955|NCT04810650|537681979|FG007|Overall Study|Moved/transferred care|1|||
149054956|NCT04810650|537681980|FG008|Overall Study|Moved/transferred care|12|||
149054957|NCT04810650|537681981|FG009|Overall Study|Moved/transferred care|10|||
149054958|NCT04810650|537681982|FG010|Overall Study|Moved/transferred care|0|||
149054959|NCT04810650|537681983|FG011|Overall Study|Moved/transferred care|0|||
149054960|NCT04810650|537681984|FG012|Overall Study|Moved/transferred care|0|||
149054961|NCT04810650|537681985|FG013|Overall Study|Moved/transferred care|0|||
149054962|NCT04810650|537681972|FG000|Overall Study|Lost to Follow-up|15|||
149054963|NCT04810650|537681973|FG001|Overall Study|Lost to Follow-up|12|||
149054964|NCT04810650|537681974|FG002|Overall Study|Lost to Follow-up|7|||
149054965|NCT04810650|537681975|FG003|Overall Study|Lost to Follow-up|9|||
149054966|NCT04810650|537681976|FG004|Overall Study|Lost to Follow-up|10|||
149054967|NCT04810650|537681977|FG005|Overall Study|Lost to Follow-up|6|||
149054968|NCT04810650|537681978|FG006|Overall Study|Lost to Follow-up|0|||
149054969|NCT04810650|537681979|FG007|Overall Study|Lost to Follow-up|0|||
149054970|NCT04810650|537681980|FG008|Overall Study|Lost to Follow-up|0|||
149054971|NCT04810650|537681981|FG009|Overall Study|Lost to Follow-up|0|||
149054972|NCT04810650|537681982|FG010|Overall Study|Lost to Follow-up|1|||
149054973|NCT04810650|537681983|FG011|Overall Study|Lost to Follow-up|0|||
149054974|NCT04810650|537681984|FG012|Overall Study|Lost to Follow-up|3|||
149054975|NCT04810650|537681985|FG013|Overall Study|Lost to Follow-up|9|||
149054976|NCT04810650|537681972|FG000|Overall Study|Participant declined|0|||
149054977|NCT04810650|537681973|FG001|Overall Study|Participant declined|0|||
149054978|NCT04810650|537681974|FG002|Overall Study|Participant declined|0|||
149054979|NCT04810650|537681975|FG003|Overall Study|Participant declined|0|||
149054980|NCT04810650|537681976|FG004|Overall Study|Participant declined|0|||
149054981|NCT04810650|537681977|FG005|Overall Study|Participant declined|0|||
149054982|NCT04810650|537681978|FG006|Overall Study|Participant declined|0|||
149054983|NCT04810650|537681979|FG007|Overall Study|Participant declined|0|||
149054984|NCT04810650|537681980|FG008|Overall Study|Participant declined|0|||
149054985|NCT04810650|537681981|FG009|Overall Study|Participant declined|0|||
149054986|NCT04810650|537681982|FG010|Overall Study|Participant declined|2|||
149054987|NCT04810650|537681983|FG011|Overall Study|Participant declined|0|||
149054988|NCT04810650|537681984|FG012|Overall Study|Participant declined|0|||
149054989|NCT04810650|537681985|FG013|Overall Study|Participant declined|0|||
149054990|NCT05794243|537681986|FG000|Overall Study|Withdrawal by Subject|1|||
149054991|NCT05794243|537681987|FG001|Overall Study|Withdrawal by Subject|0|||
149054992|NCT05794243|537681988|FG002|Overall Study|Withdrawal by Subject|1|||
149054993|NCT05794243|537681986|FG000|Overall Study|Physician Decision|0|||
149054994|NCT05794243|537681987|FG001|Overall Study|Physician Decision|3|||
149054995|NCT05794243|537681988|FG002|Overall Study|Physician Decision|1|||
149054996|NCT05603143|537681989|FG000|Overall Study|Withdrew consent|6|||
149054997|NCT05603143|537681990|FG001|Overall Study|Withdrew consent|2|||
149054998|NCT05603143|537681989|FG000|Overall Study|Randomized but never treated|0|||
149054999|NCT05603143|537681990|FG001|Overall Study|Randomized but never treated|3|||
149055000|NCT05603143|537681989|FG000|Overall Study|Adverse Event|2|||
149055001|NCT05603143|537681990|FG001|Overall Study|Adverse Event|0|||
149055002|NCT05603143|537681989|FG000|Overall Study|Death|0|||
149055003|NCT05603143|537681990|FG001|Overall Study|Death|1|||
149055004|NCT05603143|537681989|FG000|Overall Study|Investigator's discretion|1|||
149055005|NCT05603143|537681990|FG001|Overall Study|Investigator's discretion|0|||
149055006|NCT05603143|537681989|FG000|Overall Study|Lost to Follow-up|0|||
149055007|NCT05603143|537681990|FG001|Overall Study|Lost to Follow-up|1|||
149055008|NCT05603143|537681989|FG000|Overall Study|Protocol Violation|0|||
149055009|NCT05603143|537681990|FG001|Overall Study|Protocol Violation|1|||
149055010|NCT05783102|537681991|FG000|Overall Study|Lost to Follow-up|1|||
149055011|NCT05783102|537681991|FG000|Overall Study|Withdrawal by Subject|2|||
149055012|NCT05084508|537681992|FG000|Overall Study|Lost to Follow-up|6|||
149055013|NCT05084508|537681993|FG001|Overall Study|Lost to Follow-up|3|||
149055014|NCT05084508|537681994|FG002|Overall Study|Lost to Follow-up|7|||
149055015|NCT05084508|537681995|FG003|Overall Study|Lost to Follow-up|3|||
149055016|NCT05084508|537681992|FG000|Overall Study|Withdrawal by Subject|0|||
149055017|NCT05084508|537681993|FG001|Overall Study|Withdrawal by Subject|2|||
149055018|NCT05084508|537681994|FG002|Overall Study|Withdrawal by Subject|3|||
149055019|NCT05084508|537681995|FG003|Overall Study|Withdrawal by Subject|1|||
149055020|NCT05084508|537681992|FG000|Overall Study|Other|0|||
149055021|NCT05084508|537681993|FG001|Overall Study|Other|0|||
149055022|NCT05084508|537681994|FG002|Overall Study|Other|0|||
149055023|NCT05084508|537681995|FG003|Overall Study|Other|1|||
149055024|NCT05609760|537682003|FG000|Overall Study|Lost to Follow-up|0|||
149055025|NCT05609760|537682004|FG001|Overall Study|Lost to Follow-up|1|||
149055026|NCT05609760|537682003|FG000|Overall Study|Withdrawal by Subject|1|||
149055027|NCT05609760|537682004|FG001|Overall Study|Withdrawal by Subject|0|||
149055028|NCT03396588|537682005|FG000|Overall Study|Physician Decision|2|||
149055029|NCT03396588|537682006|FG001|Overall Study|Physician Decision|3|||
149055030|NCT05351554|537682008|FG000|Overall Study|Study terminated by sponsor|1|||
149055031|NCT05302596|537682011|FG000|Overall Study|Withdrawal by Subject|1|||
149055032|NCT05302596|537682012|FG001|Overall Study|Withdrawal by Subject|1|||
149055033|NCT04806594|537683991|FG000|Overall Study|Withdrawal by Subject|2|||
149055034|NCT04806594|537683991|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
149055035|NCT04977947|537683995|FG000|Overall Study|Lost to Follow-up|1|||
149055036|NCT04977947|537683996|FG001|Overall Study|Lost to Follow-up|1|||
149055037|NCT04142788|537684006|FG000|Overall Study|Trial terminated prematurely|2|||
149055038|NCT04142788|537684007|FG001|Overall Study|Trial terminated prematurely|2|||
149055039|NCT01396278|537684013|FG000|Overall Study|Adverse Event|0|||
149055040|NCT01396278|537684014|FG001|Overall Study|Adverse Event|0|||
149055041|NCT01396278|537684015|FG002|Overall Study|Adverse Event|0|||
149055042|NCT01396278|537684016|FG003|Overall Study|Adverse Event|2|||
149055043|NCT01396278|537684017|FG004|Overall Study|Adverse Event|0|||
149055044|NCT01396278|537684013|FG000|Overall Study|Withdraw due to trial termination|2|||
149055045|NCT01396278|537684014|FG001|Overall Study|Withdraw due to trial termination|1|||
149055046|NCT01396278|537684015|FG002|Overall Study|Withdraw due to trial termination|1|||
149055047|NCT01396278|537684016|FG003|Overall Study|Withdraw due to trial termination|0|||
149055048|NCT01396278|537684017|FG004|Overall Study|Withdraw due to trial termination|2|||
149055049|NCT00999804|537684020|FG000|Overall Study|Lack of Efficacy|9|||
149055050|NCT00999804|537684021|FG001|Overall Study|Lack of Efficacy|2|||
149055051|NCT00999804|537684020|FG000|Overall Study|Adverse Event|4|||
149055052|NCT00999804|537684021|FG001|Overall Study|Adverse Event|3|||
149055053|NCT00999804|537684020|FG000|Overall Study|Withdrawal by Subject|4|||
149055054|NCT00999804|537684021|FG001|Overall Study|Withdrawal by Subject|0|||
149055055|NCT00999804|537684020|FG000|Overall Study|Death|1|||
149055056|NCT00999804|537684021|FG001|Overall Study|Death|0|||
149055057|NCT00999804|537684020|FG000|Overall Study|Ineligible|3|||
149055058|NCT00999804|537684021|FG001|Overall Study|Ineligible|0|||
149055059|NCT05653427|537684023|FG000|Overall Study|Study Terminated by Sponsor|13|||
149055060|NCT04256941|537684028|FG000|Overall Study|Withdrawal by Subject|0|||
149055061|NCT04256941|537684029|FG001|Overall Study|Withdrawal by Subject|1|||
149055062|NCT04256941|537684028|FG000|Overall Study|Death|1|||
149055063|NCT04256941|537684029|FG001|Overall Study|Death|0|||
149055064|NCT04256941|537684028|FG000|Overall Study|Disease Progession|0|||
149055065|NCT04256941|537684029|FG001|Overall Study|Disease Progession|2|||
149055066|NCT05590403|537684044|FG000|Overall Study|Lost to Follow-up|13|||
149055067|NCT05590403|537684045|FG001|Overall Study|Lost to Follow-up|1|||
149055068|NCT05590403|537684046|FG002|Overall Study|Lost to Follow-up|7|||
149055069|NCT05590403|537684047|FG003|Overall Study|Lost to Follow-up|3|||
149055070|NCT05590403|537684048|FG004|Overall Study|Lost to Follow-up|4|||
149055071|NCT05590403|537684044|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
149055072|NCT05590403|537684045|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
149055073|NCT05590403|537684046|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
149055074|NCT05590403|537684047|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
149055075|NCT05590403|537684048|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
149055076|NCT05590403|537684044|FG000|Overall Study|Other|2|||
149055077|NCT05590403|537684045|FG001|Overall Study|Other|0|||
149055078|NCT05590403|537684046|FG002|Overall Study|Other|2|||
149055079|NCT05590403|537684047|FG003|Overall Study|Other|2|||
149055080|NCT05590403|537684048|FG004|Overall Study|Other|0|||
149055081|NCT05590403|537684044|FG000|Overall Study|Migrated / moved from the study area|1|||
149055082|NCT05590403|537684045|FG001|Overall Study|Migrated / moved from the study area|1|||
149055083|NCT05590403|537684046|FG002|Overall Study|Migrated / moved from the study area|0|||
149055084|NCT05590403|537684047|FG003|Overall Study|Migrated / moved from the study area|3|||
149055085|NCT05590403|537684048|FG004|Overall Study|Migrated / moved from the study area|1|||
149055086|NCT05590403|537684044|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
149055087|NCT05590403|537684045|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
149055088|NCT05590403|537684046|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
149055089|NCT05590403|537684047|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
149055090|NCT05590403|537684048|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
149055091|NCT04717492|537684054|FG000|Overall Study|Withdrawal by Subject|2|||
149055092|NCT04717492|537684055|FG001|Overall Study|Withdrawal by Subject|13|||
149055093|NCT04717492|537684054|FG000|Overall Study|Lost to Follow-up|2|||
149055094|NCT04717492|537684055|FG001|Overall Study|Lost to Follow-up|9|||
149055095|NCT03575897|537684056|FG000|Overall Study|Lost to Follow-up|12|||
149055096|NCT03575897|537684057|FG001|Overall Study|Lost to Follow-up|13|||
149055097|NCT03936322|537684058|FG000|Overall Study|Lost to Follow-up|1|||
149055098|NCT03936322|537684058|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
149055099|NCT01160211|537684059|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
149055100|NCT01160211|537684060|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
149055101|NCT01160211|537684061|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
149055102|NCT01160211|537684059|FG000|Overall Study|Lost to Follow-up|4|||
149055103|NCT01160211|537684060|FG001|Overall Study|Lost to Follow-up|8|||
149055104|NCT01160211|537684061|FG002|Overall Study|Lost to Follow-up|4|||
149055105|NCT01160211|537684059|FG000|Overall Study|Physician Decision|1|||
149055106|NCT01160211|537684060|FG001|Overall Study|Physician Decision|0|||
149055107|NCT01160211|537684061|FG002|Overall Study|Physician Decision|0|||
149055108|NCT01160211|537684059|FG000|Overall Study|Withdrawal by Subject|4|||
149055109|NCT01160211|537684060|FG001|Overall Study|Withdrawal by Subject|2|||
149055110|NCT01160211|537684061|FG002|Overall Study|Withdrawal by Subject|2|||
149055111|NCT01160211|537684059|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
149055112|NCT01160211|537684060|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
149055113|NCT01160211|537684061|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
149055114|NCT03829410|537684062|FG000|Overall Study|Adverse Event|1|||
149055115|NCT03829410|537684063|FG001|Overall Study|Adverse Event|0|||
149055116|NCT03829410|537684064|FG002|Overall Study|Adverse Event|1|||
149055117|NCT03829410|537684065|FG003|Overall Study|Adverse Event|4|||
149055118|NCT03829410|537684062|FG000|Overall Study|Physician Decision|0|||
149055119|NCT03829410|537684063|FG001|Overall Study|Physician Decision|0|||
149055120|NCT03829410|537684064|FG002|Overall Study|Physician Decision|0|||
149055121|NCT03829410|537684065|FG003|Overall Study|Physician Decision|2|||
149055122|NCT03829410|537684062|FG000|Overall Study|Disease Progressing|3|||
149055123|NCT03829410|537684063|FG001|Overall Study|Disease Progressing|4|||
149055124|NCT03829410|537684064|FG002|Overall Study|Disease Progressing|2|||
149055125|NCT03829410|537684065|FG003|Overall Study|Disease Progressing|31|||
149055126|NCT03829410|537684062|FG000|Overall Study|Miscellaneous|2|||
149055127|NCT03829410|537684063|FG001|Overall Study|Miscellaneous|4|||
149055128|NCT03829410|537684064|FG002|Overall Study|Miscellaneous|3|||
149055129|NCT03829410|537684065|FG003|Overall Study|Miscellaneous|10|||
149055130|NCT05051124|537684066|FG000|Overall Study|Lost to Follow-up|2|||
149055131|NCT05051124|537684066|FG000|Overall Study|Withdrawal by Subject|1|||
149055132|NCT05051124|537684066|FG000|Overall Study|Residential relocation|2|||
149055133|NCT05051124|537684066|FG000|Overall Study|Death|1|||
149055134|NCT06205407|537684071|FG000|Period 2|Withdrawal by Subject|0|||
149055135|NCT06205407|537684072|FG001|Period 2|Withdrawal by Subject|1|||
149055136|NCT06205407|537684071|FG000|Period 2|Adverse Event|2|||
149055137|NCT06205407|537684072|FG001|Period 2|Adverse Event|1|||
149055138|NCT02577835|537684073|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
149055139|NCT04749615|537684074|FG000|Overall Study|Lost to Follow-up|6|||
149055140|NCT04749615|537684075|FG001|Overall Study|Lost to Follow-up|10|||
149055141|NCT03611491|537684076|FG000|Overall Study|Lost to Follow-up|1|||
149055142|NCT04676022|537684077|FG000|Overall Study|Screen Failure/|1|||
149055143|NCT04676022|537684078|FG001|Overall Study|Screen Failure/|1|||
149055144|NCT04676022|537684079|FG002|Overall Study|Screen Failure/|85|||
149055145|NCT04676022|537684077|FG000|Overall Study|Lost to Follow-up|1|||
149055146|NCT04676022|537684078|FG001|Overall Study|Lost to Follow-up|1|||
149055147|NCT04676022|537684079|FG002|Overall Study|Lost to Follow-up|0|||
149055148|NCT04676022|537684077|FG000|Overall Study|Adverse Event|2|||
149055149|NCT04676022|537684078|FG001|Overall Study|Adverse Event|0|||
149055150|NCT04676022|537684079|FG002|Overall Study|Adverse Event|1|||
149055151|NCT04676022|537684077|FG000|Overall Study|Physician Decision|2|||
149055152|NCT04676022|537684078|FG001|Overall Study|Physician Decision|0|||
149055153|NCT04676022|537684079|FG002|Overall Study|Physician Decision|1|||
149055154|NCT04676022|537684077|FG000|Overall Study|Withdrawal by Subject|3|||
149055155|NCT04676022|537684078|FG001|Overall Study|Withdrawal by Subject|1|||
149055156|NCT04676022|537684079|FG002|Overall Study|Withdrawal by Subject|6|||
149055157|NCT04676022|537684077|FG000|Overall Study|Will not move forward with permanent implant|6|||
149055158|NCT04676022|537684078|FG001|Overall Study|Will not move forward with permanent implant|0|||
149055159|NCT04676022|537684079|FG002|Overall Study|Will not move forward with permanent implant|0|||
149055160|NCT04676022|537684077|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
149055161|NCT04676022|537684078|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
149055162|NCT04676022|537684079|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
149055163|NCT02274662|537684095|FG000|Overall Study|Death|1|||
149055164|NCT02274662|537684095|FG000|Overall Study|Lost to Follow-up|3|||
149055165|NCT03194217|537684096|FG000|Overall Study|Adverse Event|0|||
149055166|NCT03194217|537684097|FG001|Overall Study|Adverse Event|2|||
149055167|NCT03194217|537684098|FG002|Overall Study|Adverse Event|3|||
149055168|NCT03194217|537684099|FG003|Overall Study|Adverse Event|3|||
149055169|NCT03194217|537684096|FG000|Overall Study|Failure to meet randomisation criteria|0|||
149055170|NCT03194217|537684097|FG001|Overall Study|Failure to meet randomisation criteria|0|||
149055171|NCT03194217|537684098|FG002|Overall Study|Failure to meet randomisation criteria|0|||
149055172|NCT03194217|537684099|FG003|Overall Study|Failure to meet randomisation criteria|1|||
149055173|NCT03194217|537684096|FG000|Overall Study|Other|0|||
149055174|NCT03194217|537684097|FG001|Overall Study|Other|1|||
149055175|NCT03194217|537684098|FG002|Overall Study|Other|1|||
149055176|NCT03194217|537684099|FG003|Overall Study|Other|0|||
149055177|NCT02962895|537684100|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
149055178|NCT02962895|537684101|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
149055179|NCT02962895|537684102|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
149055180|NCT02962895|537684103|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
149055181|NCT02962895|537684104|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
149055182|NCT02962895|537684105|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
149055183|NCT02962895|537684106|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
149055184|NCT02962895|537684100|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
149055185|NCT02962895|537684101|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
149055186|NCT02962895|537684102|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
149055187|NCT02962895|537684103|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
149055188|NCT02962895|537684104|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
149055189|NCT02962895|537684105|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
149055190|NCT02962895|537684106|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
149005457|NCT03217747|537497904|FG012|Overall Study|Lack of Efficacy|3|||
149005458|NCT03217747|537497905|FG013|Overall Study|Lack of Efficacy|1|||
149005459|NCT03217747|537497892|FG000|Overall Study|Withdrawal by Subject|2|||
149005460|NCT03217747|537497893|FG001|Overall Study|Withdrawal by Subject|1|||
149005461|NCT03217747|537497894|FG002|Overall Study|Withdrawal by Subject|1|||
149005462|NCT03217747|537497895|FG003|Overall Study|Withdrawal by Subject|1|||
149005463|NCT03217747|537497896|FG004|Overall Study|Withdrawal by Subject|1|||
149005464|NCT03217747|537497897|FG005|Overall Study|Withdrawal by Subject|2|||
149005465|NCT03217747|537497898|FG006|Overall Study|Withdrawal by Subject|1|||
149005466|NCT03217747|537497899|FG007|Overall Study|Withdrawal by Subject|0|||
149005467|NCT03217747|537497900|FG008|Overall Study|Withdrawal by Subject|0|||
149005468|NCT03217747|537497901|FG009|Overall Study|Withdrawal by Subject|0|||
149005469|NCT03217747|537497902|FG010|Overall Study|Withdrawal by Subject|0|||
149005470|NCT03217747|537497903|FG011|Overall Study|Withdrawal by Subject|1|||
149055191|NCT02962895|537684100|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
149055192|NCT02962895|537684101|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
149055193|NCT02962895|537684102|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
149055194|NCT02962895|537684103|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
149055195|NCT02962895|537684104|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
149055196|NCT02962895|537684105|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
149055197|NCT02962895|537684106|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
149055198|NCT02962895|537684100|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
149055199|NCT02962895|537684101|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
149055200|NCT02962895|537684102|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
149055201|NCT02962895|537684103|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
149055202|NCT02962895|537684104|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
149055203|NCT02962895|537684105|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
149055204|NCT02962895|537684106|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
149055205|NCT02962895|537684100|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
149055206|NCT02962895|537684101|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
149055207|NCT02962895|537684102|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
149055208|NCT02962895|537684103|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
149055209|NCT02962895|537684104|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
149055210|NCT02962895|537684105|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
149055211|NCT02962895|537684106|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
149055212|NCT02962895|537684100|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
149055213|NCT02962895|537684101|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
149055214|NCT02962895|537684102|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
149055215|NCT02962895|537684103|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
149055216|NCT02962895|537684104|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
149055217|NCT02962895|537684105|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
149055218|NCT02962895|537684106|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
149055219|NCT02962895|537684100|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
149055220|NCT02962895|537684101|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
149055221|NCT02962895|537684102|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
149055222|NCT02962895|537684103|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
149055223|NCT02962895|537684104|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
149055224|NCT02962895|537684105|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
149055225|NCT02962895|537684106|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
149055226|NCT02962895|537684100|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
149055227|NCT02962895|537684101|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
149055228|NCT02962895|537684102|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
149055229|NCT02962895|537684103|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
149055230|NCT02962895|537684104|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
149055231|NCT02962895|537684105|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
149055232|NCT02962895|537684106|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
149055233|NCT02962895|537684100|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
149055234|NCT02962895|537684101|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
149055235|NCT02962895|537684102|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
149055236|NCT02962895|537684103|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
149055237|NCT02962895|537684104|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
149055238|NCT02962895|537684105|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
149055239|NCT02962895|537684106|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
149055240|NCT02962895|537684100|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
149055241|NCT02962895|537684101|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
149055242|NCT02962895|537684102|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
149055243|NCT02962895|537684103|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
149055244|NCT02962895|537684104|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
149055245|NCT02962895|537684105|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
149055246|NCT02962895|537684106|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
149055247|NCT02962895|537684100|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
149055248|NCT02962895|537684101|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
149055249|NCT02962895|537684102|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
149055250|NCT02962895|537684103|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
149055251|NCT02962895|537684104|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
149055252|NCT02962895|537684105|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
149055253|NCT02962895|537684106|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
148888843|NCT01147666|537072245|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
149055254|NCT02962895|537684100|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
149055255|NCT02962895|537684101|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
149055256|NCT02962895|537684102|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
149055257|NCT02962895|537684103|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
149055258|NCT02962895|537684104|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
149055259|NCT02962895|537684105|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
149055260|NCT02962895|537684106|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
149055261|NCT02962895|537684100|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
149055262|NCT02962895|537684101|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
149055263|NCT02962895|537684102|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
149055264|NCT02962895|537684103|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
149055265|NCT02962895|537684104|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
149055266|NCT02962895|537684105|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
149055267|NCT02962895|537684106|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
149055268|NCT02962895|537684100|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
149055269|NCT02962895|537684101|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
149055270|NCT02962895|537684102|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
149055271|NCT02962895|537684103|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
149055272|NCT02962895|537684104|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
149055273|NCT02962895|537684105|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
149055274|NCT02962895|537684106|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
149055275|NCT02936752|537684107|FG000|Overall Study|Death|2|||
149055276|NCT02936752|537684108|FG001|Overall Study|Death|1|||
149055277|NCT02936752|537684107|FG000|Overall Study|Physician Decision|4|||
149055278|NCT02936752|537684108|FG001|Overall Study|Physician Decision|0|||
149055279|NCT02936752|537684107|FG000|Overall Study|Withdrawal by Subject|0|||
149055280|NCT02936752|537684108|FG001|Overall Study|Withdrawal by Subject|2|||
149055281|NCT05282173|537684124|FG000|Overall Study|Missed|3|||
149055282|NCT05282173|537684125|FG001|Overall Study|Missed|2|||
149055283|NCT05282173|537684126|FG002|Overall Study|Missed|4|||
149055284|NCT05746455|537684133|FG000|Overall Study|Discharged from Clinical Service|1|||
149055285|NCT05746455|537684133|FG000|Overall Study|Lost to Follow-up|1|||
149055286|NCT03307343|537684134|FG000|Overall Study|Withdrawal by Subject|1|||
149055287|NCT03307343|537684135|FG001|Overall Study|Withdrawal by Subject|2|||
149055288|NCT03307343|537684134|FG000|Overall Study|Pregnancy|0|||
149055289|NCT03307343|537684135|FG001|Overall Study|Pregnancy|2|||
149055290|NCT03307343|537684134|FG000|Overall Study|Physician Decision|1|||
149055291|NCT03307343|537684135|FG001|Overall Study|Physician Decision|0|||
149055292|NCT03307343|537684134|FG000|Overall Study|Lost to Follow-up|0|||
149055293|NCT03307343|537684135|FG001|Overall Study|Lost to Follow-up|2|||
149055294|NCT01798498|537684148|FG000|Overall Study|Lost to Follow-up|1|||
149055295|NCT03896789|537684150|FG000|Baseline|Lost to Follow-up|1|||
149055296|NCT03896789|537684151|FG001|Baseline|Lost to Follow-up|2|||
149055297|NCT03896789|537684150|FG000|Baseline|Death|3|||
149055298|NCT03896789|537684151|FG001|Baseline|Death|6|||
149055299|NCT03896789|537684150|FG000|Post-Randomization|Lost to Follow-up|12|||
149055300|NCT03896789|537684151|FG001|Post-Randomization|Lost to Follow-up|11|||
149055301|NCT03896789|537684150|FG000|Post-Randomization|Death|12|||
149055302|NCT03896789|537684151|FG001|Post-Randomization|Death|13|||
149055303|NCT04625283|537684157|FG000|Overall Study|post randomization exclusion|28|||
149055304|NCT04625283|537684158|FG001|Overall Study|post randomization exclusion|20|||
149055305|NCT01824394|537684159|FG000|Overall Study|Early Termination|1|||
149055306|NCT01824394|537684160|FG001|Overall Study|Early Termination|1|||
149055307|NCT01824394|537684161|FG002|Overall Study|Early Termination|3|||
149055308|NCT01824394|537684159|FG000|Overall Study|Withdrawn due to Study Termination|91|||
149055309|NCT01824394|537684160|FG001|Overall Study|Withdrawn due to Study Termination|83|||
149055310|NCT01824394|537684161|FG002|Overall Study|Withdrawn due to Study Termination|41|||
149055311|NCT01824394|537684159|FG000|Overall Study|Lost to Follow-up|0|||
149055312|NCT01824394|537684160|FG001|Overall Study|Lost to Follow-up|9|||
149055313|NCT01824394|537684161|FG002|Overall Study|Lost to Follow-up|3|||
149055314|NCT01824394|537684159|FG000|Overall Study|Death|3|||
149055315|NCT01824394|537684160|FG001|Overall Study|Death|2|||
149055316|NCT01824394|537684161|FG002|Overall Study|Death|4|||
149055317|NCT01824394|537684159|FG000|Overall Study|Discontinued Subjects|1|||
149055318|NCT01824394|537684160|FG001|Overall Study|Discontinued Subjects|1|||
149055319|NCT01824394|537684161|FG002|Overall Study|Discontinued Subjects|2|||
149055320|NCT01824394|537684159|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
149055321|NCT01824394|537684160|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
149055322|NCT01824394|537684161|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
149055323|NCT03536754|537684162|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
149055324|NCT03536754|537684163|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
149055325|NCT03536754|537684164|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
149055326|NCT03536754|537684165|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
149055327|NCT03536754|537684166|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
149055328|NCT03536754|537684162|FG000|Open Label Extension|Other|0|||
149055329|NCT03536754|537684163|FG001|Open Label Extension|Other|0|||
149055330|NCT03536754|537684164|FG002|Open Label Extension|Other|0|||
149055331|NCT03536754|537684165|FG003|Open Label Extension|Other|0|||
149055332|NCT03536754|537684166|FG004|Open Label Extension|Other|1|||
149055333|NCT00686335|537684173|FG000|Run-in Period|Adverse Event|1|||
149055334|NCT00686335|537684173|FG000|Run-in Period|asthma exacerbation|1|||
149055335|NCT00686335|537684173|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
149055336|NCT04505904|537684176|FG000|Overall Study|Withdrawal by Subject|1|||
149055337|NCT04505904|537684177|FG001|Overall Study|Withdrawal by Subject|2|||
149055338|NCT04505904|537684178|FG002|Overall Study|Withdrawal by Subject|0|||
149055339|NCT04505904|537684179|FG003|Overall Study|Withdrawal by Subject|0|||
149055340|NCT04505904|537684176|FG000|Overall Study|Physician Decision|1|||
149055341|NCT04505904|537684177|FG001|Overall Study|Physician Decision|0|||
149055342|NCT04505904|537684178|FG002|Overall Study|Physician Decision|0|||
149055343|NCT04505904|537684179|FG003|Overall Study|Physician Decision|0|||
149055344|NCT04505904|537684176|FG000|Overall Study|Adverse Event|0|||
149055345|NCT04505904|537684177|FG001|Overall Study|Adverse Event|1|||
149055346|NCT04505904|537684178|FG002|Overall Study|Adverse Event|0|||
149055347|NCT04505904|537684179|FG003|Overall Study|Adverse Event|0|||
149055348|NCT04277442|537684182|FG000|Overall Study|Death|1|||
149055349|NCT02727699|537685962|FG000|Overall Study|Adverse Event|2|||
149055350|NCT02727699|537685963|FG001|Overall Study|Adverse Event|0|||
149055351|NCT02727699|537685962|FG000|Overall Study|Withdrawal by Subject|5|||
149055352|NCT02727699|537685963|FG001|Overall Study|Withdrawal by Subject|3|||
149055353|NCT02727699|537685962|FG000|Overall Study|Protocol Violation|0|||
149055354|NCT02727699|537685963|FG001|Overall Study|Protocol Violation|1|||
149055355|NCT02727699|537685962|FG000|Overall Study|Physician Decision|0|||
149055356|NCT02727699|537685963|FG001|Overall Study|Physician Decision|1|||
149055357|NCT02727699|537685962|FG000|Overall Study|Lost to Follow-up|1|||
149055358|NCT02727699|537685963|FG001|Overall Study|Lost to Follow-up|0|||
149055359|NCT02727699|537685962|FG000|Overall Study|Sponsor Decision|1|||
149055360|NCT02727699|537685963|FG001|Overall Study|Sponsor Decision|0|||
149055361|NCT04318548|537685973|FG000|Overall Study|Adverse Event|0|||
149055362|NCT04318548|537685974|FG001|Overall Study|Adverse Event|0|||
149055363|NCT04318548|537685975|FG002|Overall Study|Adverse Event|1|||
149055364|NCT04318548|537685973|FG000|Overall Study|Lost to Follow-up|6|||
149055365|NCT04318548|537685974|FG001|Overall Study|Lost to Follow-up|13|||
149055366|NCT04318548|537685975|FG002|Overall Study|Lost to Follow-up|9|||
149055367|NCT04318548|537685973|FG000|Overall Study|Protocol Violation|1|||
149055368|NCT04318548|537685974|FG001|Overall Study|Protocol Violation|0|||
149055369|NCT04318548|537685975|FG002|Overall Study|Protocol Violation|2|||
149055370|NCT04318548|537685973|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
149055371|NCT04318548|537685974|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
149055372|NCT04318548|537685975|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
149055373|NCT04318548|537685973|FG000|Overall Study|Migrated / moved from the study area|0|||
149055374|NCT04318548|537685974|FG001|Overall Study|Migrated / moved from the study area|0|||
149055375|NCT04318548|537685975|FG002|Overall Study|Migrated / moved from the study area|1|||
149055376|NCT04318548|537685973|FG000|Overall Study|Other|1|||
149055377|NCT04318548|537685974|FG001|Overall Study|Other|2|||
149055378|NCT04318548|537685975|FG002|Overall Study|Other|3|||
149055379|NCT02921230|537685978|FG000|Overall Study|Withdrawal by Subject|20|||
149055380|NCT02921230|537685979|FG001|Overall Study|Withdrawal by Subject|8|||
149055381|NCT02921230|537685978|FG000|Overall Study|Death|12|||
149055382|NCT02921230|537685979|FG001|Overall Study|Death|3|||
149055383|NCT02921230|537685978|FG000|Overall Study|Protocol Violation|17|||
149055384|NCT02921230|537685979|FG001|Overall Study|Protocol Violation|6|||
149055385|NCT02921230|537685978|FG000|Overall Study|Early completion|5|||
149055386|NCT02921230|537685979|FG001|Overall Study|Early completion|1|||
149055387|NCT02921230|537685978|FG000|Overall Study|Pending data entry|1|||
149055388|NCT02921230|537685979|FG001|Overall Study|Pending data entry|0|||
149055389|NCT05875142|537685980|FG000|Overall Study|Lost to Follow-up|0|||
149055390|NCT05875142|537685981|FG001|Overall Study|Lost to Follow-up|1|||
149055391|NCT05875142|537685982|FG002|Overall Study|Lost to Follow-up|1|||
149055392|NCT03436290|537685983|FG000|Overall Study|Post-randomization Exclusion|1|||
149055393|NCT03436290|537685984|FG001|Overall Study|Post-randomization Exclusion|0|||
149055394|NCT03436290|537685983|FG000|Overall Study|Death|6|||
149055395|NCT03436290|537685984|FG001|Overall Study|Death|0|||
149055396|NCT03436290|537685983|FG000|Overall Study|Withdrawal by Subject|4|||
149055397|NCT03436290|537685984|FG001|Overall Study|Withdrawal by Subject|0|||
149055398|NCT03436290|537685983|FG000|Overall Study|Protocol Violation|30|||
149055399|NCT03436290|537685984|FG001|Overall Study|Protocol Violation|0|||
149055400|NCT02677298|537685985|FG000|Double Blind Phase|Adverse Event|2|||
149055401|NCT02677298|537685986|FG001|Double Blind Phase|Adverse Event|1|||
149055402|NCT02677298|537685987|FG002|Double Blind Phase|Adverse Event|0|||
149055403|NCT02677298|537685985|FG000|Double Blind Phase|Physician Decision|5|||
149055404|NCT02677298|537685986|FG001|Double Blind Phase|Physician Decision|0|||
149055405|NCT02677298|537685987|FG002|Double Blind Phase|Physician Decision|0|||
149055406|NCT02677298|537685985|FG000|Double Blind Phase|Lost to Follow-up|11|||
149055407|NCT02677298|537685986|FG001|Double Blind Phase|Lost to Follow-up|7|||
149055408|NCT02677298|537685987|FG002|Double Blind Phase|Lost to Follow-up|0|||
149055409|NCT02677298|537685985|FG000|Double Blind Phase|Withdrawal by Subject|11|||
149055410|NCT02677298|537685986|FG001|Double Blind Phase|Withdrawal by Subject|8|||
149055411|NCT02677298|537685987|FG002|Double Blind Phase|Withdrawal by Subject|0|||
149055412|NCT02677298|537685985|FG000|Double Blind Phase|No study drug available at site|0|||
149055413|NCT02677298|537685986|FG001|Double Blind Phase|No study drug available at site|1|||
149055414|NCT02677298|537685987|FG002|Double Blind Phase|No study drug available at site|0|||
149055415|NCT02677298|537685985|FG000|Open Label Phase|Adverse Event|0|||
149055416|NCT02677298|537685986|FG001|Open Label Phase|Adverse Event|0|||
149055417|NCT02677298|537685987|FG002|Open Label Phase|Adverse Event|4|||
149055418|NCT02677298|537685985|FG000|Open Label Phase|Physician Decision|0|||
149055419|NCT02677298|537685986|FG001|Open Label Phase|Physician Decision|0|||
149055420|NCT02677298|537685987|FG002|Open Label Phase|Physician Decision|1|||
149055421|NCT02677298|537685985|FG000|Open Label Phase|Lost to Follow-up|0|||
149055422|NCT02677298|537685986|FG001|Open Label Phase|Lost to Follow-up|0|||
149055423|NCT02677298|537685987|FG002|Open Label Phase|Lost to Follow-up|17|||
149055424|NCT02677298|537685985|FG000|Open Label Phase|Withdrawal by Subject|0|||
149055425|NCT02677298|537685986|FG001|Open Label Phase|Withdrawal by Subject|0|||
149055426|NCT02677298|537685987|FG002|Open Label Phase|Withdrawal by Subject|38|||
149055427|NCT03988608|537685988|FG000|Overall Study|Adverse Event|1|||
149055428|NCT03988608|537685988|FG000|Overall Study|Lost to Follow-up|1|||
149055429|NCT03988608|537685988|FG000|Overall Study|Withdrawal by Subject|3|||
149055430|NCT03988608|537685988|FG000|Overall Study|Death|1|||
149055431|NCT03338933|537685993|FG000|Screening Visit|Lost to Follow-up|1|||
149055432|NCT03338933|537685994|FG001|Screening Visit|Lost to Follow-up|3|||
149055433|NCT03338933|537685995|FG002|Screening Visit|Lost to Follow-up|1|||
149055434|NCT03338933|537685996|FG003|Screening Visit|Lost to Follow-up|4|||
149055435|NCT03338933|537685993|FG000|Screening Visit|Screen fail after consent|2|||
149055436|NCT03338933|537685994|FG001|Screening Visit|Screen fail after consent|7|||
149055437|NCT03338933|537685995|FG002|Screening Visit|Screen fail after consent|1|||
149055438|NCT03338933|537685996|FG003|Screening Visit|Screen fail after consent|4|||
149055439|NCT03338933|537685993|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
149055440|NCT03338933|537685994|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
149055441|NCT03338933|537685995|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
149055442|NCT03338933|537685996|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
149055443|NCT03338933|537685993|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
149055444|NCT03338933|537685994|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
149055445|NCT03338933|537685995|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
149055446|NCT03338933|537685996|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
149055447|NCT03338933|537685993|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
149055448|NCT03338933|537685994|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
149055449|NCT03338933|537685995|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
149055450|NCT03338933|537685996|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
149055451|NCT04515576|537685997|FG000|Overall Study|Withdrawal by Subject|0|||
149055452|NCT04515576|537685998|FG001|Overall Study|Withdrawal by Subject|0|||
149055453|NCT04515576|537685999|FG002|Overall Study|Withdrawal by Subject|0|||
149055454|NCT04515576|537686000|FG003|Overall Study|Withdrawal by Subject|0|||
149055455|NCT04515576|537686001|FG004|Overall Study|Withdrawal by Subject|0|||
149055456|NCT04515576|537686002|FG005|Overall Study|Withdrawal by Subject|1|||
149055457|NCT03812679|537686003|FG000|Overall Study|Adverse Event|2|||
149055458|NCT03812679|537686003|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
149055459|NCT03812679|537686003|FG000|Overall Study|Renal transplant|1|||
149055460|NCT03812679|537686003|FG000|Overall Study|Withdrawal by Subject|1|||
149055461|NCT03812679|537686003|FG000|Overall Study|Termination of study|2|||
149055462|NCT03812679|537686003|FG000|Overall Study|Water device replacement|1|||
149055463|NCT03891667|537686007|FG000|Overall Study|Physician Decision|1|||
149055464|NCT03891667|537686008|FG001|Overall Study|Physician Decision|1|||
149055465|NCT03891667|537686007|FG000|Overall Study|COVID related pause|1|||
149055466|NCT03891667|537686008|FG001|Overall Study|COVID related pause|0|||
149055467|NCT03891667|537686007|FG000|Overall Study|Withdrawal by Subject|0|||
149055468|NCT03891667|537686008|FG001|Overall Study|Withdrawal by Subject|1|||
149055469|NCT03891667|537686007|FG000|Overall Study|Adverse Event|0|||
149055470|NCT03891667|537686008|FG001|Overall Study|Adverse Event|1|||
149055471|NCT04456517|537686009|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
149055472|NCT04456517|537686010|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
149055473|NCT03766009|537686011|FG000|Usual Care|Death|0|||
149055474|NCT03766009|537686012|FG001|Usual Care|Death|0|||
149055475|NCT03766009|537686013|FG002|Usual Care|Death|0|||
149055476|NCT03766009|537686014|FG003|Usual Care|Death|1|||
149055477|NCT03766009|537686015|FG004|Usual Care|Death|0|||
149055478|NCT03766009|537686016|FG005|Usual Care|Death|0|||
149055479|NCT03766009|537686011|FG000|Usual Care|Lost to Follow-up|0|||
149055480|NCT03766009|537686012|FG001|Usual Care|Lost to Follow-up|0|||
149055481|NCT03766009|537686013|FG002|Usual Care|Lost to Follow-up|0|||
149055482|NCT03766009|537686014|FG003|Usual Care|Lost to Follow-up|1|||
149055483|NCT03766009|537686015|FG004|Usual Care|Lost to Follow-up|0|||
149055484|NCT03766009|537686016|FG005|Usual Care|Lost to Follow-up|0|||
149055485|NCT03766009|537686011|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
149055486|NCT03766009|537686012|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
149055487|NCT03766009|537686013|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
149055488|NCT03766009|537686014|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
149055489|NCT03766009|537686015|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
149055490|NCT03766009|537686016|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
149055491|NCT03766009|537686011|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
149055492|NCT03766009|537686012|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
149055493|NCT03766009|537686013|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
149055494|NCT03766009|537686014|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
149055495|NCT03766009|537686015|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
149055496|NCT03766009|537686016|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
149055497|NCT03766009|537686011|FG000|Usual Care|No treatment or declined surgery|0|||
149055498|NCT03766009|537686012|FG001|Usual Care|No treatment or declined surgery|0|||
149055499|NCT03766009|537686013|FG002|Usual Care|No treatment or declined surgery|0|||
149055500|NCT03766009|537686014|FG003|Usual Care|No treatment or declined surgery|2|||
149055501|NCT03766009|537686015|FG004|Usual Care|No treatment or declined surgery|0|||
149055502|NCT03766009|537686016|FG005|Usual Care|No treatment or declined surgery|0|||
149055503|NCT03766009|537686011|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
149055504|NCT03766009|537686012|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
149055505|NCT03766009|537686013|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
149055506|NCT03766009|537686014|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
149055507|NCT03766009|537686015|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
149055508|NCT03766009|537686016|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
149055509|NCT03766009|537686011|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
149055510|NCT03766009|537686012|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
149055511|NCT03766009|537686013|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
149055512|NCT03766009|537686014|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
149055513|NCT03766009|537686015|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
149055514|NCT03766009|537686016|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
149055515|NCT03766009|537686011|FG000|Usual Care|Ineligible|0|||
149055516|NCT03766009|537686012|FG001|Usual Care|Ineligible|1|||
149055517|NCT03766009|537686013|FG002|Usual Care|Ineligible|0|||
149055518|NCT03766009|537686014|FG003|Usual Care|Ineligible|0|||
149055519|NCT03766009|537686015|FG004|Usual Care|Ineligible|0|||
149055520|NCT03766009|537686016|FG005|Usual Care|Ineligible|0|||
149055521|NCT03766009|537686011|FG000|Usual Care|Other: Staff turnover|0|||
149055522|NCT03766009|537686012|FG001|Usual Care|Other: Staff turnover|0|||
149055523|NCT03766009|537686013|FG002|Usual Care|Other: Staff turnover|0|||
149055524|NCT03766009|537686014|FG003|Usual Care|Other: Staff turnover|0|||
149055525|NCT03766009|537686015|FG004|Usual Care|Other: Staff turnover|0|||
149055526|NCT03766009|537686016|FG005|Usual Care|Other: Staff turnover|2|||
149055527|NCT02734290|537686021|FG000|Overall Study|Adverse Event|1|||
149055528|NCT02734290|537686022|FG001|Overall Study|Adverse Event|0|||
149055529|NCT02734290|537686021|FG000|Overall Study|Death|1|||
149055530|NCT02734290|537686022|FG001|Overall Study|Death|0|||
149055531|NCT04509674|537686024|FG000|Overall Study|Not treated|33|||
149055532|NCT04509674|537686025|FG001|Overall Study|Not treated|26|||
149055533|NCT04509674|537686024|FG000|Overall Study|Protocol Violation|9|||
149055534|NCT04509674|537686025|FG001|Overall Study|Protocol Violation|10|||
149055535|NCT04509674|537686024|FG000|Overall Study|Lost to Follow-up|31|||
149055536|NCT04509674|537686025|FG001|Overall Study|Lost to Follow-up|39|||
149055537|NCT04509674|537686024|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
149055538|NCT04509674|537686025|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
149055539|NCT04509674|537686024|FG000|Overall Study|Adverse event, serious fatal event|11|||
149055540|NCT04509674|537686025|FG001|Overall Study|Adverse event, serious fatal event|4|||
149055541|NCT04509674|537686024|FG000|Overall Study|Adverse event, non-fatal event|107|||
149055542|NCT04509674|537686025|FG001|Overall Study|Adverse event, non-fatal event|118|||
149055543|NCT04509674|537686024|FG000|Overall Study|Other reason than listed|106|||
149055544|NCT04509674|537686025|FG001|Overall Study|Other reason than listed|95|||
149055545|NCT03134196|537686035|FG000|Overall Study|Death|2|||
149055546|NCT03134196|537686036|FG001|Overall Study|Death|1|||
149055547|NCT03134196|537686035|FG000|Overall Study|Lost to Follow-up|13|||
149055548|NCT03134196|537686036|FG001|Overall Study|Lost to Follow-up|15|||
149055549|NCT03134196|537686035|FG000|Overall Study|Physician Decision|0|||
149055550|NCT03134196|537686036|FG001|Overall Study|Physician Decision|1|||
149055551|NCT03134196|537686035|FG000|Overall Study|Withdrawal by Subject|19|||
149055552|NCT03134196|537686036|FG001|Overall Study|Withdrawal by Subject|12|||
149055553|NCT03134196|537686035|FG000|Overall Study|Site Unable to Contact Participant|2|||
149055554|NCT03134196|537686036|FG001|Overall Study|Site Unable to Contact Participant|0|||
149055555|NCT03134196|537686035|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
149055556|NCT03134196|537686036|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
149055557|NCT03134196|537686035|FG000|Overall Study|Scheduling Conflict|1|||
149055558|NCT03134196|537686036|FG001|Overall Study|Scheduling Conflict|0|||
149055559|NCT04064164|537686046|FG000|Overall Study|Withdrawal by Subject|8|||
149055560|NCT04064164|537686047|FG001|Overall Study|Withdrawal by Subject|8|||
149055561|NCT04059484|537686048|FG000|Overall Study|Adverse Event|2|||
149055562|NCT04059484|537686049|FG001|Overall Study|Adverse Event|5|||
149055563|NCT04059484|537686048|FG000|Overall Study|Withdrawal by Subject|5|||
149055564|NCT04059484|537686049|FG001|Overall Study|Withdrawal by Subject|3|||
149055565|NCT04059484|537686048|FG000|Overall Study|Progressive disease|112|||
149055566|NCT04059484|537686049|FG001|Overall Study|Progressive disease|112|||
149055567|NCT04059484|537686048|FG000|Overall Study|Other|8|||
149055568|NCT04059484|537686049|FG001|Overall Study|Other|3|||
149055569|NCT04059484|537686048|FG000|Overall Study|Ongoing|20|||
149055570|NCT04059484|537686049|FG001|Overall Study|Ongoing|20|||
149055571|NCT04719390|537686050|FG000|Overall Study|Withdrawal by Subject|1|||
149055572|NCT06190691|537686051|FG000|Overall Study|Adverse Event|2|||
149055573|NCT06190691|537686052|FG001|Overall Study|Adverse Event|0|||
149055574|NCT06190691|537686053|FG002|Overall Study|Adverse Event|0|||
149055575|NCT06190691|537686054|FG003|Overall Study|Adverse Event|0|||
149055576|NCT02023866|537686056|FG000|Overall Study|Non-compliance|2|||
149055577|NCT02023866|537686056|FG000|Overall Study|Adverse Event|3|||
149055578|NCT02023866|537686056|FG000|Overall Study|Withdrawal by Subject|1|||
149055579|NCT03016754|537686057|FG000|Overall Study|Death|5|||
149055580|NCT03016754|537686058|FG001|Overall Study|Death|4|||
149055581|NCT03016754|537686059|FG002|Overall Study|Death|5|||
149055582|NCT03016754|537686060|FG003|Overall Study|Death|1|||
149055583|NCT03016754|537686057|FG000|Overall Study|Lost to Follow-up|23|||
149055584|NCT03016754|537686058|FG001|Overall Study|Lost to Follow-up|17|||
149055585|NCT03016754|537686059|FG002|Overall Study|Lost to Follow-up|4|||
149055586|NCT03016754|537686060|FG003|Overall Study|Lost to Follow-up|2|||
149055587|NCT03016754|537686057|FG000|Overall Study|Withdrawal by Subject|6|||
149055588|NCT03016754|537686058|FG001|Overall Study|Withdrawal by Subject|6|||
149055589|NCT03016754|537686059|FG002|Overall Study|Withdrawal by Subject|2|||
149055590|NCT03016754|537686060|FG003|Overall Study|Withdrawal by Subject|2|||
149055591|NCT03016754|537686057|FG000|Overall Study|Other/Unknown|2|||
149055592|NCT03016754|537686058|FG001|Overall Study|Other/Unknown|4|||
149055593|NCT03016754|537686059|FG002|Overall Study|Other/Unknown|2|||
149055594|NCT03016754|537686060|FG003|Overall Study|Other/Unknown|1|||
149055595|NCT03016754|537686057|FG000|Overall Study|Protocol Violation|0|||
149055596|NCT03016754|537686058|FG001|Overall Study|Protocol Violation|0|||
149055597|NCT03016754|537686059|FG002|Overall Study|Protocol Violation|0|||
149055598|NCT03016754|537686060|FG003|Overall Study|Protocol Violation|4|||
149055599|NCT03839940|537686061|FG000|Overall Study|Withdrawal by Subject|3|||
149055600|NCT03839940|537686062|FG001|Overall Study|Withdrawal by Subject|0|||
149055601|NCT03839940|537686061|FG000|Overall Study|Protocol Violation|0|||
149055602|NCT03839940|537686062|FG001|Overall Study|Protocol Violation|1|||
149055603|NCT03839940|537686061|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
149055604|NCT03839940|537686062|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
149055605|NCT04683744|537686064|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
149055606|NCT04683744|537686065|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
149055607|NCT04683744|537686066|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
149055608|NCT04185298|537686067|FG000|Overall Study|Lost to Follow-up|1|||
149055609|NCT04185298|537686068|FG001|Overall Study|Lost to Follow-up|3|||
149055610|NCT04185298|537686067|FG000|Overall Study|Withdrawal by Subject|0|||
149055611|NCT04185298|537686068|FG001|Overall Study|Withdrawal by Subject|3|||
149055612|NCT01606215|537686069|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
149055613|NCT01606215|537686070|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
149055614|NCT04927364|537686073|FG000|Overall Study|Withdrawal by Subject|3|||
149055615|NCT04927364|537686073|FG000|Overall Study|Unable to complete preassessment MRI|1|||
149055616|NCT04316871|537686080|FG000|Overall Study|Protocol Violation|2|||
149055617|NCT04316871|537686081|FG001|Overall Study|Protocol Violation|2|||
149055618|NCT04316871|537686082|FG002|Overall Study|Protocol Violation|2|||
149055619|NCT04316871|537686083|FG003|Overall Study|Protocol Violation|2|||
149055620|NCT04650269|537686084|FG000|Overall Study|Death|3|||
149055621|NCT04650269|537686084|FG000|Overall Study|Lost to Follow-up|6|||
148888844|NCT01147666|537072246|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
149055622|NCT05087992|537686085|FG000|Overall Study|Adverse Event|0|||
149055623|NCT05087992|537686086|FG001|Overall Study|Adverse Event|1|||
149055624|NCT05087992|537686087|FG002|Overall Study|Adverse Event|0|||
149055625|NCT05087992|537686085|FG000|Overall Study|Withdrawal by Subject|2|||
149055626|NCT05087992|537686086|FG001|Overall Study|Withdrawal by Subject|0|||
149055627|NCT05087992|537686087|FG002|Overall Study|Withdrawal by Subject|0|||
149055628|NCT05087992|537686085|FG000|Overall Study|clinical disease progression|3|||
149055629|NCT05087992|537686086|FG001|Overall Study|clinical disease progression|1|||
149055630|NCT05087992|537686087|FG002|Overall Study|clinical disease progression|0|||
149055631|NCT05087992|537686085|FG000|Overall Study|objective disease progression|4|||
149055632|NCT05087992|537686086|FG001|Overall Study|objective disease progression|1|||
149055633|NCT05087992|537686087|FG002|Overall Study|objective disease progression|0|||
149055634|NCT04091750|537686088|FG000|Overall Study|Adverse Event|4|||
149055635|NCT04091750|537686088|FG000|Overall Study|Withdrawal by Subject|1|||
149055636|NCT03560609|537686089|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
149055637|NCT03560609|537686090|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
149055638|NCT02319759|537686102|FG000|Week 0 - 16|Lack of Efficacy|1|||
149055639|NCT02319759|537686103|FG001|Week 0 - 16|Lack of Efficacy|0|||
149055640|NCT02319759|537686104|FG002|Week 0 - 16|Lack of Efficacy|0|||
149055641|NCT02319759|537686105|FG003|Week 0 - 16|Lack of Efficacy|0|||
149055642|NCT02319759|537686106|FG004|Week 0 - 16|Lack of Efficacy|0|||
149055643|NCT02319759|537686102|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
149055644|NCT02319759|537686103|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
149055645|NCT02319759|537686104|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
149055646|NCT02319759|537686105|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
149055647|NCT02319759|537686106|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
149055648|NCT02319759|537686102|FG000|Week 16 - 24|Lack of Efficacy|1|||
149055649|NCT02319759|537686103|FG001|Week 16 - 24|Lack of Efficacy|0|||
149055650|NCT02319759|537686104|FG002|Week 16 - 24|Lack of Efficacy|1|||
149055651|NCT02319759|537686105|FG003|Week 16 - 24|Lack of Efficacy|0|||
149055652|NCT02319759|537686106|FG004|Week 16 - 24|Lack of Efficacy|0|||
149055653|NCT02319759|537686102|FG000|Week 16 - 24|Lost to Follow-up|1|||
149055654|NCT02319759|537686103|FG001|Week 16 - 24|Lost to Follow-up|0|||
149055655|NCT02319759|537686104|FG002|Week 16 - 24|Lost to Follow-up|0|||
149055656|NCT02319759|537686105|FG003|Week 16 - 24|Lost to Follow-up|0|||
149055657|NCT02319759|537686106|FG004|Week 16 - 24|Lost to Follow-up|0|||
149055658|NCT02319759|537686102|FG000|Week 16 - 24|Withdrawal by Subject|0|||
149055659|NCT02319759|537686103|FG001|Week 16 - 24|Withdrawal by Subject|0|||
149055660|NCT02319759|537686104|FG002|Week 16 - 24|Withdrawal by Subject|2|||
149055661|NCT02319759|537686105|FG003|Week 16 - 24|Withdrawal by Subject|0|||
149055662|NCT02319759|537686106|FG004|Week 16 - 24|Withdrawal by Subject|0|||
149055663|NCT02319759|537686102|FG000|Week 24 - 56|Adverse Event|0|||
149055664|NCT02319759|537686103|FG001|Week 24 - 56|Adverse Event|0|||
149055665|NCT02319759|537686104|FG002|Week 24 - 56|Adverse Event|2|||
149055666|NCT02319759|537686105|FG003|Week 24 - 56|Adverse Event|0|||
149055667|NCT02319759|537686106|FG004|Week 24 - 56|Adverse Event|0|||
149055668|NCT02319759|537686102|FG000|Week 24 - 56|Lack of Efficacy|0|||
149055669|NCT02319759|537686103|FG001|Week 24 - 56|Lack of Efficacy|0|||
149055670|NCT02319759|537686104|FG002|Week 24 - 56|Lack of Efficacy|0|||
149055671|NCT02319759|537686105|FG003|Week 24 - 56|Lack of Efficacy|2|||
149055672|NCT02319759|537686106|FG004|Week 24 - 56|Lack of Efficacy|1|||
149055673|NCT02319759|537686102|FG000|Week 24 - 56|Withdrawal by Subject|0|||
149055674|NCT02319759|537686103|FG001|Week 24 - 56|Withdrawal by Subject|1|||
149055675|NCT02319759|537686104|FG002|Week 24 - 56|Withdrawal by Subject|0|||
149055676|NCT02319759|537686105|FG003|Week 24 - 56|Withdrawal by Subject|0|||
149055677|NCT02319759|537686106|FG004|Week 24 - 56|Withdrawal by Subject|0|||
149055678|NCT02319759|537686102|FG000|Week 24 - 56|Lost to Follow-up|0|||
149055679|NCT02319759|537686103|FG001|Week 24 - 56|Lost to Follow-up|0|||
149055680|NCT02319759|537686104|FG002|Week 24 - 56|Lost to Follow-up|0|||
149055681|NCT02319759|537686105|FG003|Week 24 - 56|Lost to Follow-up|0|||
149055682|NCT02319759|537686106|FG004|Week 24 - 56|Lost to Follow-up|1|||
149055683|NCT02262728|537686108|FG000|Follow-up Phase (3 Years)|Death|0|||
149055684|NCT02262728|537686109|FG001|Follow-up Phase (3 Years)|Death|1|||
149055685|NCT02262728|537686108|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
149055686|NCT02262728|537686109|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
149055687|NCT02262728|537686108|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
149055688|NCT02262728|537686109|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
149055689|NCT02619838|537686110|FG000|Overall Study|Lost to Follow-up|9|||
149055690|NCT02619838|537686110|FG000|Overall Study|Withdrawal by Subject|15|||
149055691|NCT00227344|537686111|FG000|Overall Study|study terminated early|12|||
149055692|NCT00227344|537686112|FG001|Overall Study|study terminated early|5|||
149055693|NCT02677805|537686113|FG000|Double Blind Phase|Lost to Follow-up|8|||
149055694|NCT02677805|537686114|FG001|Double Blind Phase|Lost to Follow-up|3|||
149055695|NCT02677805|537686115|FG002|Double Blind Phase|Lost to Follow-up|0|||
149055696|NCT02677805|537686113|FG000|Double Blind Phase|Withdrawal by Subject|5|||
149055697|NCT02677805|537686114|FG001|Double Blind Phase|Withdrawal by Subject|2|||
149055698|NCT02677805|537686115|FG002|Double Blind Phase|Withdrawal by Subject|0|||
149055699|NCT02677805|537686113|FG000|Open Label Phase|Lost to Follow-up|0|||
149055700|NCT02677805|537686114|FG001|Open Label Phase|Lost to Follow-up|0|||
149055701|NCT02677805|537686115|FG002|Open Label Phase|Lost to Follow-up|10|||
149055702|NCT02677805|537686113|FG000|Open Label Phase|Withdrawal by Subject|0|||
149055703|NCT02677805|537686114|FG001|Open Label Phase|Withdrawal by Subject|0|||
149055704|NCT02677805|537686115|FG002|Open Label Phase|Withdrawal by Subject|6|||
149055705|NCT04111536|537686116|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
149055706|NCT04111536|537686117|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
149055707|NCT04111536|537686116|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
149055708|NCT04111536|537686117|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
149055709|NCT04111536|537686116|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
149055710|NCT04111536|537686117|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
149055711|NCT04111536|537686116|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
149055712|NCT04111536|537686117|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
149055713|NCT04187833|537686118|FG000|Overall Study|Withdrawal by Subject|1|||
149055714|NCT04171999|537686119|FG000|Overall Study|deemed ineligible after randomization|2|||
149055715|NCT04171999|537686120|FG001|Overall Study|deemed ineligible after randomization|1|||
149055716|NCT04282148|537686121|FG000|Overall Study|Death|7|||
149055717|NCT04282148|537686121|FG000|Overall Study|Withdrawal by Subject|1|||
149055718|NCT04282148|537686121|FG000|Overall Study|Physician Decision|1|||
149055719|NCT03524612|537686122|FG000|Overall Study|Lack of Efficacy|10|||
149055720|NCT03524612|537686122|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
149055721|NCT03524612|537686122|FG000|Overall Study|Adverse Event|10|||
149055722|NCT03524612|537686122|FG000|Overall Study|Withdrawal by Subject|7|||
149055723|NCT03524612|537686122|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
149055724|NCT03524612|537686122|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
149055725|NCT03524612|537686122|FG000|Overall Study|New therapy for study indication|6|||
149055726|NCT03524612|537686122|FG000|Overall Study|Death|3|||
149055727|NCT03524612|537686122|FG000|Overall Study|Lost to Follow-up|2|||
149055728|NCT03524612|537686122|FG000|Overall Study|Protocol Violation|1|||
149055729|NCT04029688|537688935|FG000|Overall Study|Death|8|||
149055730|NCT04029688|537688936|FG001|Overall Study|Death|3|||
149055731|NCT04029688|537688937|FG002|Overall Study|Death|6|||
149055732|NCT04029688|537688938|FG003|Overall Study|Death|2|||
149055733|NCT04029688|537688939|FG004|Overall Study|Death|5|||
149055734|NCT04029688|537688940|FG005|Overall Study|Death|0|||
149055735|NCT04029688|537688941|FG006|Overall Study|Death|2|||
149055736|NCT04029688|537688942|FG007|Overall Study|Death|3|||
149055737|NCT04029688|537688935|FG000|Overall Study|Study Terminated by Sponsor|0|||
149055738|NCT04029688|537688936|FG001|Overall Study|Study Terminated by Sponsor|0|||
149055739|NCT04029688|537688937|FG002|Overall Study|Study Terminated by Sponsor|0|||
149055740|NCT04029688|537688938|FG003|Overall Study|Study Terminated by Sponsor|0|||
149055741|NCT04029688|537688939|FG004|Overall Study|Study Terminated by Sponsor|1|||
149055742|NCT04029688|537688940|FG005|Overall Study|Study Terminated by Sponsor|3|||
149055743|NCT04029688|537688941|FG006|Overall Study|Study Terminated by Sponsor|1|||
149055744|NCT04029688|537688942|FG007|Overall Study|Study Terminated by Sponsor|3|||
149055745|NCT04029688|537688935|FG000|Overall Study|Withdrawal by Subject|0|||
149055746|NCT04029688|537688936|FG001|Overall Study|Withdrawal by Subject|0|||
149055747|NCT04029688|537688937|FG002|Overall Study|Withdrawal by Subject|0|||
149055748|NCT04029688|537688938|FG003|Overall Study|Withdrawal by Subject|1|||
149055749|NCT04029688|537688939|FG004|Overall Study|Withdrawal by Subject|0|||
149055750|NCT04029688|537688940|FG005|Overall Study|Withdrawal by Subject|0|||
149055751|NCT04029688|537688941|FG006|Overall Study|Withdrawal by Subject|0|||
149055752|NCT04029688|537688942|FG007|Overall Study|Withdrawal by Subject|0|||
149055753|NCT04130438|537688943|FG000|Overall Study|Lost to Follow-up|0|||
149055754|NCT04130438|537688944|FG001|Overall Study|Lost to Follow-up|0|||
149055755|NCT04130438|537688945|FG002|Overall Study|Lost to Follow-up|1|||
149055756|NCT04764448|537688949|FG000|Overall Study|Study terminated by sponsor|2|||
149055757|NCT04764448|537688950|FG001|Overall Study|Study terminated by sponsor|2|||
149055758|NCT04764448|537688951|FG002|Overall Study|Study terminated by sponsor|5|||
149055759|NCT04764448|537688949|FG000|Overall Study|Withdrawal by Subject|3|||
149055760|NCT04764448|537688950|FG001|Overall Study|Withdrawal by Subject|3|||
149055761|NCT04764448|537688951|FG002|Overall Study|Withdrawal by Subject|1|||
149055762|NCT05028634|537688952|FG000|Overall Study|Withdrawal by Subject|0|||
149055763|NCT05028634|537688953|FG001|Overall Study|Withdrawal by Subject|1|||
149055764|NCT02140554|537688954|FG000|Overall Study|Withdrawal of consent|1|||
149055765|NCT02140554|537688955|FG001|Overall Study|Withdrawal of consent|0|||
149055766|NCT02140554|537688956|FG002|Overall Study|Withdrawal of consent|4|||
149055767|NCT02140554|537688954|FG000|Overall Study|Physician Decision|1|||
149055768|NCT02140554|537688955|FG001|Overall Study|Physician Decision|0|||
149055769|NCT02140554|537688956|FG002|Overall Study|Physician Decision|2|||
149055770|NCT02140554|537688954|FG000|Overall Study|Death|0|||
149055771|NCT02140554|537688955|FG001|Overall Study|Death|0|||
149055772|NCT02140554|537688956|FG002|Overall Study|Death|1|||
149055773|NCT02140554|537688954|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
149055774|NCT02140554|537688955|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
148888845|NCT01147666|537072247|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
149055775|NCT02140554|537688956|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
149055776|NCT05659537|537688957|FG000|Overall Study|Adverse Event|5|||
149055777|NCT05659537|537688957|FG000|Overall Study|Lost to Follow-up|4|||
149055778|NCT05659537|537688957|FG000|Overall Study|Withdrawal by Subject|13|||
149055779|NCT05659537|537688957|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
149055780|NCT05659537|537688957|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
149055781|NCT05659537|537688957|FG000|Overall Study|Participant was suffering from anaemia|1|||
149055782|NCT03771417|537688958|FG000|Overall Study|Withdrawal by Subject|1|||
149055783|NCT03771417|537688959|FG001|Overall Study|Withdrawal by Subject|0|||
149055784|NCT03771417|537688960|FG002|Overall Study|Withdrawal by Subject|0|||
149055785|NCT03771417|537688958|FG000|Overall Study|Covid-19 Shutdown|0|||
149055786|NCT03771417|537688959|FG001|Overall Study|Covid-19 Shutdown|1|||
149055787|NCT03771417|537688960|FG002|Overall Study|Covid-19 Shutdown|0|||
149055788|NCT02975882|537688966|FG000|Overall Study|Adverse Event|1|||
149055789|NCT02975882|537688967|FG001|Overall Study|Adverse Event|2|||
149055790|NCT02975882|537688968|FG002|Overall Study|Adverse Event|1|||
149055791|NCT02975882|537688969|FG003|Overall Study|Adverse Event|1|||
149055792|NCT02975882|537688966|FG000|Overall Study|Death|0|||
149055793|NCT02975882|537688967|FG001|Overall Study|Death|1|||
149055794|NCT02975882|537688968|FG002|Overall Study|Death|0|||
149055795|NCT02975882|537688969|FG003|Overall Study|Death|0|||
149055796|NCT02975882|537688966|FG000|Overall Study|Lack of Efficacy|3|||
149055797|NCT02975882|537688967|FG001|Overall Study|Lack of Efficacy|7|||
149055798|NCT02975882|537688968|FG002|Overall Study|Lack of Efficacy|4|||
149055799|NCT02975882|537688969|FG003|Overall Study|Lack of Efficacy|3|||
149055800|NCT02975882|537688966|FG000|Overall Study|Physician Decision|0|||
149055801|NCT02975882|537688967|FG001|Overall Study|Physician Decision|2|||
149055802|NCT02975882|537688968|FG002|Overall Study|Physician Decision|4|||
149055803|NCT02975882|537688969|FG003|Overall Study|Physician Decision|2|||
149055804|NCT02975882|537688966|FG000|Overall Study|Ineligible|0|||
149055805|NCT02975882|537688967|FG001|Overall Study|Ineligible|1|||
149055806|NCT02975882|537688968|FG002|Overall Study|Ineligible|0|||
149055807|NCT02975882|537688969|FG003|Overall Study|Ineligible|0|||
149055808|NCT05119023|537688970|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
149055809|NCT05119023|537688970|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
149055810|NCT05119023|537688970|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
149055811|NCT04806451|537688973|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
149055812|NCT04806451|537688974|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
149055813|NCT04806451|537688973|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
149055814|NCT04806451|537688974|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
149055815|NCT04806451|537688973|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
149055816|NCT04806451|537688974|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
149055817|NCT05835336|537688975|FG000|Overall Study|Withdrawal by Subject|5|||
149055818|NCT05835336|537688975|FG000|Overall Study|Did not complete the personalization process|3|||
149055819|NCT04489771|537688976|FG000|Overall Study|Death|27|||
149055820|NCT04489771|537688977|FG001|Overall Study|Death|25|||
149055821|NCT04489771|537688976|FG000|Overall Study|Withdrawal by Subject|1|||
149055822|NCT04489771|537688977|FG001|Overall Study|Withdrawal by Subject|0|||
149055823|NCT04489771|537688976|FG000|Overall Study|Participants Ongoing in Study|50|||
149055824|NCT04489771|537688977|FG001|Overall Study|Participants Ongoing in Study|51|||
149055825|NCT03524118|537688981|FG000|Overall Study|Lost to Follow-up|0|||
149055826|NCT03524118|537688982|FG001|Overall Study|Lost to Follow-up|0|||
149055827|NCT03524118|537688983|FG002|Overall Study|Lost to Follow-up|0|||
149055828|NCT03524118|537688984|FG003|Overall Study|Lost to Follow-up|0|||
149055829|NCT03524118|537688985|FG004|Overall Study|Lost to Follow-up|1|||
149055830|NCT03524118|537688986|FG005|Overall Study|Lost to Follow-up|0|||
149055831|NCT03524118|537688981|FG000|Overall Study|Other|0|||
149055832|NCT03524118|537688982|FG001|Overall Study|Other|1|||
149055833|NCT03524118|537688983|FG002|Overall Study|Other|0|||
149055834|NCT03524118|537688984|FG003|Overall Study|Other|0|||
149055835|NCT03524118|537688985|FG004|Overall Study|Other|1|||
149055836|NCT03524118|537688986|FG005|Overall Study|Other|1|||
148888846|NCT01147666|537072248|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888847|NCT01147666|537072249|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
148888848|NCT01147666|537072250|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
149055837|NCT03524118|537688981|FG000|Overall Study|Physician Decision|0|||
149055838|NCT03524118|537688982|FG001|Overall Study|Physician Decision|0|||
149055839|NCT03524118|537688983|FG002|Overall Study|Physician Decision|0|||
149055840|NCT03524118|537688984|FG003|Overall Study|Physician Decision|0|||
149055841|NCT03524118|537688985|FG004|Overall Study|Physician Decision|1|||
149055842|NCT03524118|537688986|FG005|Overall Study|Physician Decision|0|||
149055843|NCT03524118|537688981|FG000|Overall Study|Protocol Violation|0|||
149055844|NCT03524118|537688982|FG001|Overall Study|Protocol Violation|0|||
149055845|NCT03524118|537688983|FG002|Overall Study|Protocol Violation|1|||
149055846|NCT03524118|537688984|FG003|Overall Study|Protocol Violation|0|||
149055847|NCT03524118|537688985|FG004|Overall Study|Protocol Violation|1|||
149055848|NCT03524118|537688986|FG005|Overall Study|Protocol Violation|0|||
149055849|NCT03524118|537688981|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149055850|NCT03524118|537688982|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149055851|NCT03524118|537688983|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
149055852|NCT03524118|537688984|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
149055853|NCT03524118|537688985|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
149055854|NCT03524118|537688986|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
149055855|NCT01437709|537688987|FG000|Overall Study|Adverse Event|0|||
149055856|NCT01437709|537688988|FG001|Overall Study|Adverse Event|1|||
149055857|NCT01437709|537688989|FG002|Overall Study|Adverse Event|0|||
149055858|NCT01437709|537688987|FG000|Overall Study|Pt trasnferred care|0|||
149055859|NCT01437709|537688988|FG001|Overall Study|Pt trasnferred care|1|||
149055860|NCT01437709|537688989|FG002|Overall Study|Pt trasnferred care|0|||
149055861|NCT02919306|537688990|FG000|Overall Study|Withdrawal by Subject|1|||
149055862|NCT02919306|537688991|FG001|Overall Study|Withdrawal by Subject|0|||
149055863|NCT02919306|537688990|FG000|Overall Study|Protocol Violation|1|||
149055864|NCT02919306|537688991|FG001|Overall Study|Protocol Violation|0|||
149055865|NCT04473222|537688992|FG000|Overall Study|Lost to Follow-up|13|||
149055866|NCT04473222|537688993|FG001|Overall Study|Lost to Follow-up|13|||
149055867|NCT04473222|537688992|FG000|Overall Study|Withdrawal by Subject|0|||
149055868|NCT04473222|537688993|FG001|Overall Study|Withdrawal by Subject|1|||
149055869|NCT04473222|537688992|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
149055870|NCT04473222|537688993|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
149055871|NCT04293055|537688994|FG000|Overall Study|Lost to Follow-up|1|||
149055872|NCT04293055|537688995|FG001|Overall Study|Lost to Follow-up|1|||
149055873|NCT04293055|537688994|FG000|Overall Study|Did not trigger randomization|6|||
149055874|NCT04293055|537688995|FG001|Overall Study|Did not trigger randomization|5|||
149055875|NCT01369355|537688997|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
149055876|NCT01369355|537688998|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
149055877|NCT01369355|537688999|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
149055878|NCT01369355|537689000|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
149055879|NCT01369355|537689001|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
149055880|NCT01369355|537689002|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
149055881|NCT01369355|537689003|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
149055882|NCT01369355|537689004|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
149055883|NCT01369355|537689005|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
149055884|NCT01369355|537688997|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
149055885|NCT01369355|537688998|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
149055886|NCT01369355|537688999|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
149055887|NCT01369355|537689000|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
149055888|NCT01369355|537689001|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
149055889|NCT01369355|537689002|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
149055890|NCT01369355|537689003|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
149055891|NCT01369355|537689004|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
149055892|NCT01369355|537689005|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
149055893|NCT01369355|537688997|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
149055894|NCT01369355|537688998|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
149055895|NCT01369355|537688999|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
149055896|NCT01369355|537689000|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
149055897|NCT01369355|537689001|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
149055898|NCT01369355|537689002|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
149055899|NCT01369355|537689003|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
149055900|NCT01369355|537689004|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
149055901|NCT01369355|537689005|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
149055902|NCT01369355|537688997|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
149055903|NCT01369355|537688998|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
149055904|NCT01369355|537688999|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
149055905|NCT01369355|537689000|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
149055906|NCT01369355|537689001|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
149055907|NCT01369355|537689002|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
149055908|NCT01369355|537689003|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
149055909|NCT01369355|537689004|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
149055910|NCT01369355|537689005|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
149055911|NCT01369355|537688997|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
149055912|NCT01369355|537688998|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
149055913|NCT01369355|537688999|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
149055914|NCT01369355|537689000|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
149055915|NCT01369355|537689001|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
149055916|NCT01369355|537689002|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
149055917|NCT01369355|537689003|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
149055918|NCT01369355|537689004|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
149055982|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
149055983|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
149055984|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
149055985|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
149055986|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
149055987|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
149055988|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
149055989|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
149055990|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
149055991|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
149055992|NCT01369355|537688997|FG000|Long-term Extension (Week 44-272)|Other|0|||
149055993|NCT01369355|537688998|FG001|Long-term Extension (Week 44-272)|Other|0|||
149055994|NCT01369355|537688999|FG002|Long-term Extension (Week 44-272)|Other|0|||
149055995|NCT01369355|537689000|FG003|Long-term Extension (Week 44-272)|Other|0|||
149055996|NCT01369355|537689001|FG004|Long-term Extension (Week 44-272)|Other|0|||
149055997|NCT01369355|537689002|FG005|Long-term Extension (Week 44-272)|Other|0|||
149055998|NCT01369355|537689003|FG006|Long-term Extension (Week 44-272)|Other|110|||
149055999|NCT01369355|537689004|FG007|Long-term Extension (Week 44-272)|Other|9|||
149056000|NCT01369355|537689005|FG008|Long-term Extension (Week 44-272)|Other|17|||
149056001|NCT06424236|537689008|FG000|Overall Study|Adverse Event|0|||
149056002|NCT06424236|537689009|FG001|Overall Study|Adverse Event|1|||
149056003|NCT06424236|537689010|FG002|Overall Study|Adverse Event|0|||
149056004|NCT06424236|537689008|FG000|Overall Study|Withdrawal by Subject|3|||
149056005|NCT06424236|537689009|FG001|Overall Study|Withdrawal by Subject|1|||
149056006|NCT06424236|537689010|FG002|Overall Study|Withdrawal by Subject|2|||
149056007|NCT06424236|537689008|FG000|Overall Study|Physician Decision|0|||
149056008|NCT06424236|537689009|FG001|Overall Study|Physician Decision|1|||
149056009|NCT06424236|537689010|FG002|Overall Study|Physician Decision|0|||
149056010|NCT06424236|537689008|FG000|Overall Study|Study Terminated by Sponsor|11|||
149056011|NCT06424236|537689009|FG001|Overall Study|Study Terminated by Sponsor|20|||
149056012|NCT06424236|537689010|FG002|Overall Study|Study Terminated by Sponsor|16|||
149056013|NCT06424236|537689008|FG000|Overall Study|Lost to Follow-up|0|||
149056014|NCT06424236|537689009|FG001|Overall Study|Lost to Follow-up|1|||
149056015|NCT06424236|537689010|FG002|Overall Study|Lost to Follow-up|0|||
149056016|NCT06424236|537689008|FG000|Overall Study|Disease Progression|0|||
149056017|NCT06424236|537689009|FG001|Overall Study|Disease Progression|1|||
149056018|NCT06424236|537689010|FG002|Overall Study|Disease Progression|2|||
149056019|NCT06424236|537689008|FG000|Overall Study|Other|0|||
149056020|NCT06424236|537689009|FG001|Overall Study|Other|0|||
149056021|NCT06424236|537689010|FG002|Overall Study|Other|1|||
149056022|NCT01987895|537689011|FG000|Overall Study|Withdrawal by Subject|12|||
149056023|NCT01987895|537689012|FG001|Overall Study|Withdrawal by Subject|7|||
149056024|NCT01987895|537689011|FG000|Overall Study|Physician Decision|8|||
149056025|NCT01987895|537689012|FG001|Overall Study|Physician Decision|10|||
149056026|NCT01987895|537689011|FG000|Overall Study|Death|7|||
149056027|NCT01987895|537689012|FG001|Overall Study|Death|7|||
149056028|NCT01987895|537689011|FG000|Overall Study|Lost to Follow-up|3|||
149056029|NCT01987895|537689012|FG001|Overall Study|Lost to Follow-up|5|||
149056030|NCT01987895|537689011|FG000|Overall Study|randomized before giving IC|0|||
149056031|NCT01987895|537689012|FG001|Overall Study|randomized before giving IC|1|||
149056032|NCT05006872|537689015|FG000|Overall Study|Lost to Follow-up|37|||
149056033|NCT05006872|537689016|FG001|Overall Study|Lost to Follow-up|31|||
149056034|NCT02573493|537689022|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
149056035|NCT02573493|537689023|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
149056036|NCT02573493|537689024|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
149056037|NCT02573493|537689025|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
149056038|NCT04971681|537689026|FG000|Followup|Lost to Follow-up|1|||
149056039|NCT04971681|537689027|FG001|Followup|Lost to Follow-up|0|||
149056040|NCT04350463|537689035|FG000|Overall Study|Other reason|0|||
149056041|NCT04350463|537689036|FG001|Overall Study|Other reason|0|||
149056042|NCT04350463|537689037|FG002|Overall Study|Other reason|0|||
149056043|NCT04350463|537689038|FG003|Overall Study|Other reason|1|||
149056044|NCT04350463|537689035|FG000|Overall Study|Lost to Follow-up|0|||
149056045|NCT04350463|537689036|FG001|Overall Study|Lost to Follow-up|0|||
149056046|NCT04350463|537689037|FG002|Overall Study|Lost to Follow-up|0|||
149056047|NCT04350463|537689038|FG003|Overall Study|Lost to Follow-up|2|||
149056048|NCT04350463|537689035|FG000|Overall Study|Withdrawal by Subject|4|||
149056049|NCT04350463|537689036|FG001|Overall Study|Withdrawal by Subject|0|||
149056050|NCT04350463|537689037|FG002|Overall Study|Withdrawal by Subject|1|||
149056051|NCT04350463|537689038|FG003|Overall Study|Withdrawal by Subject|4|||
149056052|NCT04350463|537689035|FG000|Overall Study|Adverse Event|0|||
149056053|NCT04350463|537689036|FG001|Overall Study|Adverse Event|0|||
149056054|NCT04350463|537689037|FG002|Overall Study|Adverse Event|0|||
149056055|NCT04350463|537689038|FG003|Overall Study|Adverse Event|2|||
149056056|NCT04350463|537689035|FG000|Overall Study|Death|27|||
149056057|NCT04350463|537689036|FG001|Overall Study|Death|2|||
148889571|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
148889572|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
148889573|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
148889574|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
148889575|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
149056058|NCT04350463|537689037|FG002|Overall Study|Death|13|||
149056059|NCT04350463|537689038|FG003|Overall Study|Death|26|||
149056060|NCT04652700|537689039|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
149056061|NCT04652700|537689040|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
149056062|NCT04652700|537689039|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
149056063|NCT04652700|537689040|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
149056064|NCT04652700|537689039|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
149056065|NCT04652700|537689040|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
149056066|NCT04652700|537689039|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
149056067|NCT04652700|537689040|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
149056068|NCT04652700|537689039|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
149056069|NCT04652700|537689040|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
149056070|NCT04652700|537689039|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
149056071|NCT04652700|537689040|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
149056072|NCT04652700|537689039|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
149056073|NCT04652700|537689040|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
149056074|NCT04652700|537689039|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
149056075|NCT04652700|537689040|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
149056076|NCT04652700|537689039|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
149056077|NCT04652700|537689040|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
149056078|NCT04209465|537689043|FG000|Overall Study|Adverse Event|0|||
149056079|NCT04209465|537689044|FG001|Overall Study|Adverse Event|0|||
149056080|NCT04209465|537689045|FG002|Overall Study|Adverse Event|0|||
149056081|NCT04209465|537689046|FG003|Overall Study|Adverse Event|0|||
149056082|NCT04209465|537689047|FG004|Overall Study|Adverse Event|0|||
149056083|NCT04209465|537689048|FG005|Overall Study|Adverse Event|1|||
149056084|NCT04209465|537689049|FG006|Overall Study|Adverse Event|0|||
149056085|NCT04209465|537689050|FG007|Overall Study|Adverse Event|0|||
149056086|NCT04209465|537689051|FG008|Overall Study|Adverse Event|1|||
149056087|NCT04209465|537689052|FG009|Overall Study|Adverse Event|0|||
149056088|NCT04209465|537689053|FG010|Overall Study|Adverse Event|2|||
149056089|NCT04209465|537689054|FG011|Overall Study|Adverse Event|1|||
149056090|NCT04209465|537689055|FG012|Overall Study|Adverse Event|1|||
149056091|NCT04209465|537689043|FG000|Overall Study|Death|1|||
149056092|NCT04209465|537689044|FG001|Overall Study|Death|0|||
149056093|NCT04209465|537689045|FG002|Overall Study|Death|0|||
149056094|NCT04209465|537689046|FG003|Overall Study|Death|0|||
149056095|NCT04209465|537689047|FG004|Overall Study|Death|2|||
149056096|NCT04209465|537689048|FG005|Overall Study|Death|7|||
149056097|NCT04209465|537689049|FG006|Overall Study|Death|2|||
149056098|NCT04209465|537689050|FG007|Overall Study|Death|2|||
149056099|NCT04209465|537689051|FG008|Overall Study|Death|1|||
149056100|NCT04209465|537689052|FG009|Overall Study|Death|1|||
149056101|NCT04209465|537689053|FG010|Overall Study|Death|1|||
149056102|NCT04209465|537689054|FG011|Overall Study|Death|0|||
149056103|NCT04209465|537689055|FG012|Overall Study|Death|10|||
149056104|NCT04209465|537689043|FG000|Overall Study|Physician Decision|0|||
149056105|NCT04209465|537689044|FG001|Overall Study|Physician Decision|1|||
149056106|NCT04209465|537689045|FG002|Overall Study|Physician Decision|0|||
149056107|NCT04209465|537689046|FG003|Overall Study|Physician Decision|0|||
149056108|NCT04209465|537689047|FG004|Overall Study|Physician Decision|0|||
149056109|NCT04209465|537689048|FG005|Overall Study|Physician Decision|0|||
149056110|NCT04209465|537689049|FG006|Overall Study|Physician Decision|0|||
149056111|NCT04209465|537689050|FG007|Overall Study|Physician Decision|0|||
149056112|NCT04209465|537689051|FG008|Overall Study|Physician Decision|0|||
149056113|NCT04209465|537689052|FG009|Overall Study|Physician Decision|0|||
149056114|NCT04209465|537689053|FG010|Overall Study|Physician Decision|0|||
149056115|NCT04209465|537689054|FG011|Overall Study|Physician Decision|0|||
149056116|NCT04209465|537689055|FG012|Overall Study|Physician Decision|0|||
148889576|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
148889577|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Other|1|||
148889578|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Other|0|||
149056117|NCT04209465|537689043|FG000|Overall Study|Progressive Disease|0|||
149056118|NCT04209465|537689044|FG001|Overall Study|Progressive Disease|0|||
149056119|NCT04209465|537689045|FG002|Overall Study|Progressive Disease|1|||
149056120|NCT04209465|537689046|FG003|Overall Study|Progressive Disease|2|||
149056121|NCT04209465|537689047|FG004|Overall Study|Progressive Disease|8|||
149056122|NCT04209465|537689048|FG005|Overall Study|Progressive Disease|5|||
149056123|NCT04209465|537689049|FG006|Overall Study|Progressive Disease|3|||
149056124|NCT04209465|537689050|FG007|Overall Study|Progressive Disease|4|||
149056125|NCT04209465|537689051|FG008|Overall Study|Progressive Disease|1|||
149056126|NCT04209465|537689052|FG009|Overall Study|Progressive Disease|3|||
149056127|NCT04209465|537689053|FG010|Overall Study|Progressive Disease|2|||
149056128|NCT04209465|537689054|FG011|Overall Study|Progressive Disease|1|||
149056129|NCT04209465|537689055|FG012|Overall Study|Progressive Disease|0|||
149056130|NCT04209465|537689043|FG000|Overall Study|Withdrawal by Subject|0|||
149056131|NCT04209465|537689044|FG001|Overall Study|Withdrawal by Subject|0|||
149056132|NCT04209465|537689045|FG002|Overall Study|Withdrawal by Subject|0|||
149056133|NCT04209465|537689046|FG003|Overall Study|Withdrawal by Subject|0|||
149056134|NCT04209465|537689047|FG004|Overall Study|Withdrawal by Subject|0|||
149056135|NCT04209465|537689048|FG005|Overall Study|Withdrawal by Subject|1|||
149056136|NCT04209465|537689049|FG006|Overall Study|Withdrawal by Subject|2|||
149056137|NCT04209465|537689050|FG007|Overall Study|Withdrawal by Subject|0|||
149056138|NCT04209465|537689051|FG008|Overall Study|Withdrawal by Subject|1|||
149056139|NCT04209465|537689052|FG009|Overall Study|Withdrawal by Subject|0|||
149056140|NCT04209465|537689053|FG010|Overall Study|Withdrawal by Subject|0|||
149056141|NCT04209465|537689054|FG011|Overall Study|Withdrawal by Subject|2|||
149056142|NCT04209465|537689055|FG012|Overall Study|Withdrawal by Subject|2|||
149056143|NCT04209465|537689043|FG000|Overall Study|Lost to Follow-up|0|||
149056144|NCT04209465|537689044|FG001|Overall Study|Lost to Follow-up|0|||
149056145|NCT04209465|537689045|FG002|Overall Study|Lost to Follow-up|0|||
149056146|NCT04209465|537689046|FG003|Overall Study|Lost to Follow-up|0|||
149056147|NCT04209465|537689047|FG004|Overall Study|Lost to Follow-up|0|||
149056148|NCT04209465|537689048|FG005|Overall Study|Lost to Follow-up|1|||
149056149|NCT04209465|537689049|FG006|Overall Study|Lost to Follow-up|0|||
149056150|NCT04209465|537689050|FG007|Overall Study|Lost to Follow-up|0|||
149056151|NCT04209465|537689051|FG008|Overall Study|Lost to Follow-up|1|||
149056152|NCT04209465|537689052|FG009|Overall Study|Lost to Follow-up|0|||
149056153|NCT04209465|537689053|FG010|Overall Study|Lost to Follow-up|0|||
149056154|NCT04209465|537689054|FG011|Overall Study|Lost to Follow-up|1|||
149056155|NCT04209465|537689055|FG012|Overall Study|Lost to Follow-up|0|||
149056156|NCT04209465|537689043|FG000|Overall Study|Started new therapy|0|||
149056157|NCT04209465|537689044|FG001|Overall Study|Started new therapy|0|||
149056158|NCT04209465|537689045|FG002|Overall Study|Started new therapy|0|||
149056159|NCT04209465|537689046|FG003|Overall Study|Started new therapy|0|||
149056160|NCT04209465|537689047|FG004|Overall Study|Started new therapy|0|||
149056161|NCT04209465|537689048|FG005|Overall Study|Started new therapy|1|||
149056162|NCT04209465|537689049|FG006|Overall Study|Started new therapy|0|||
149056163|NCT04209465|537689050|FG007|Overall Study|Started new therapy|0|||
149056164|NCT04209465|537689051|FG008|Overall Study|Started new therapy|0|||
149056165|NCT04209465|537689052|FG009|Overall Study|Started new therapy|0|||
149056166|NCT04209465|537689053|FG010|Overall Study|Started new therapy|0|||
149056167|NCT04209465|537689054|FG011|Overall Study|Started new therapy|0|||
149056168|NCT04209465|537689055|FG012|Overall Study|Started new therapy|0|||
149056169|NCT04209465|537689043|FG000|Overall Study|Study terminated early by sponsor|0|||
149056170|NCT04209465|537689044|FG001|Overall Study|Study terminated early by sponsor|0|||
149056171|NCT04209465|537689045|FG002|Overall Study|Study terminated early by sponsor|0|||
149056172|NCT04209465|537689046|FG003|Overall Study|Study terminated early by sponsor|0|||
149056173|NCT04209465|537689047|FG004|Overall Study|Study terminated early by sponsor|0|||
149056174|NCT04209465|537689048|FG005|Overall Study|Study terminated early by sponsor|0|||
149056175|NCT04209465|537689049|FG006|Overall Study|Study terminated early by sponsor|3|||
149056176|NCT04209465|537689050|FG007|Overall Study|Study terminated early by sponsor|0|||
149056177|NCT04209465|537689051|FG008|Overall Study|Study terminated early by sponsor|0|||
149056178|NCT04209465|537689052|FG009|Overall Study|Study terminated early by sponsor|0|||
149056179|NCT04209465|537689053|FG010|Overall Study|Study terminated early by sponsor|0|||
149056180|NCT04209465|537689054|FG011|Overall Study|Study terminated early by sponsor|0|||
149056181|NCT04209465|537689055|FG012|Overall Study|Study terminated early by sponsor|3|||
149056182|NCT04209465|537689043|FG000|Overall Study|Other|0|||
149056183|NCT04209465|537689044|FG001|Overall Study|Other|0|||
149056184|NCT04209465|537689045|FG002|Overall Study|Other|0|||
149056185|NCT04209465|537689046|FG003|Overall Study|Other|0|||
149056186|NCT04209465|537689047|FG004|Overall Study|Other|0|||
148889579|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Other|0|||
149056187|NCT04209465|537689048|FG005|Overall Study|Other|0|||
149056188|NCT04209465|537689049|FG006|Overall Study|Other|0|||
149056189|NCT04209465|537689050|FG007|Overall Study|Other|0|||
149056190|NCT04209465|537689051|FG008|Overall Study|Other|1|||
149056191|NCT04209465|537689052|FG009|Overall Study|Other|0|||
149056192|NCT04209465|537689053|FG010|Overall Study|Other|0|||
149056193|NCT04209465|537689054|FG011|Overall Study|Other|0|||
149056194|NCT04209465|537689055|FG012|Overall Study|Other|0|||
149056195|NCT03097549|537689056|FG000|Overall Study|Withdrawal by Subject|1|||
149056196|NCT03097549|537689057|FG001|Overall Study|Withdrawal by Subject|0|||
149056197|NCT03097549|537689056|FG000|Overall Study|Lost to Follow-up|1|||
149056198|NCT03097549|537689057|FG001|Overall Study|Lost to Follow-up|0|||
149056199|NCT05647304|537689058|FG000|Overall Study|Withdrawal by Subject|1|||
149056200|NCT05647304|537689059|FG001|Overall Study|Withdrawal by Subject|0|||
149056201|NCT03544281|537689060|FG000|Main Study Phase|Death|3|||
149056202|NCT03544281|537689061|FG001|Main Study Phase|Death|2|||
149056203|NCT03544281|537689062|FG002|Main Study Phase|Death|6|||
149056204|NCT03544281|537689063|FG003|Main Study Phase|Death|8|||
149056205|NCT03544281|537689064|FG004|Main Study Phase|Death|4|||
149056206|NCT03544281|537689065|FG005|Main Study Phase|Death|2|||
149056207|NCT03544281|537689066|FG006|Main Study Phase|Death|4|||
149056208|NCT03544281|537689067|FG007|Main Study Phase|Death|5|||
149056209|NCT03544281|537689068|FG008|Main Study Phase|Death|5|||
149056210|NCT03544281|537689069|FG009|Main Study Phase|Death|8|||
149056211|NCT03544281|537689070|FG010|Main Study Phase|Death|6|||
149056212|NCT03544281|537689071|FG011|Main Study Phase|Death|4|||
149056213|NCT03544281|537689072|FG012|Main Study Phase|Death|0|||
149056214|NCT03544281|537689073|FG013|Main Study Phase|Death|0|||
149056215|NCT03544281|537689074|FG014|Main Study Phase|Death|0|||
149056216|NCT03544281|537689075|FG015|Main Study Phase|Death|0|||
149056217|NCT03544281|537689076|FG016|Main Study Phase|Death|0|||
149056218|NCT03544281|537689077|FG017|Main Study Phase|Death|0|||
149056219|NCT03544281|537689078|FG018|Main Study Phase|Death|0|||
149056220|NCT03544281|537689079|FG019|Main Study Phase|Death|0|||
149056221|NCT03544281|537689080|FG020|Main Study Phase|Death|0|||
148889580|NCT00104650|537074436|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
148889581|NCT00104650|537074437|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
148889582|NCT00104650|537074438|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
148889583|NCT00104650|537074436|FG000|Follow-up Period|Physician Decision|1|||
148889584|NCT00104650|537074437|FG001|Follow-up Period|Physician Decision|1|||
148889585|NCT00104650|537074438|FG002|Follow-up Period|Physician Decision|0|||
148889586|NCT00104650|537074436|FG000|Follow-up Period|Adverse Event|1|||
148889587|NCT00104650|537074437|FG001|Follow-up Period|Adverse Event|0|||
148889588|NCT00104650|537074438|FG002|Follow-up Period|Adverse Event|1|||
148889589|NCT00104650|537074436|FG000|Follow-up Period|Withdrawal by Subject|0|||
148889590|NCT00104650|537074437|FG001|Follow-up Period|Withdrawal by Subject|3|||
148889591|NCT00104650|537074438|FG002|Follow-up Period|Withdrawal by Subject|3|||
148889592|NCT00104650|537074436|FG000|Follow-up Period|Death|6|||
148889593|NCT00104650|537074437|FG001|Follow-up Period|Death|6|||
148889594|NCT00104650|537074438|FG002|Follow-up Period|Death|4|||
148889595|NCT00104650|537074436|FG000|Follow-up Period|Disease progression|3|||
148889596|NCT00104650|537074437|FG001|Follow-up Period|Disease progression|1|||
148889597|NCT00104650|537074438|FG002|Follow-up Period|Disease progression|0|||
148889598|NCT00104650|537074436|FG000|Follow-up Period|Lost to Follow-up|0|||
148889599|NCT00104650|537074437|FG001|Follow-up Period|Lost to Follow-up|1|||
148889600|NCT00104650|537074438|FG002|Follow-up Period|Lost to Follow-up|2|||
148889601|NCT00104650|537074436|FG000|Follow-up Period|Other|0|||
148889602|NCT00104650|537074437|FG001|Follow-up Period|Other|1|||
148889603|NCT00104650|537074438|FG002|Follow-up Period|Other|0|||
148889604|NCT02294058|537074439|FG000|Overall Study|Adverse Event|16|||
148889605|NCT02294058|537074440|FG001|Overall Study|Adverse Event|7|||
148889606|NCT02294058|537074441|FG002|Overall Study|Adverse Event|13|||
148889607|NCT02294058|537074439|FG000|Overall Study|Lack of Efficacy|3|||
148889608|NCT02294058|537074440|FG001|Overall Study|Lack of Efficacy|3|||
148889609|NCT02294058|537074441|FG002|Overall Study|Lack of Efficacy|0|||
148889610|NCT02294058|537074439|FG000|Overall Study|Lost to Follow-up|1|||
148889611|NCT02294058|537074440|FG001|Overall Study|Lost to Follow-up|0|||
148889612|NCT02294058|537074441|FG002|Overall Study|Lost to Follow-up|2|||
148889613|NCT02294058|537074439|FG000|Overall Study|Withdrawal by Subject|10|||
148889614|NCT02294058|537074440|FG001|Overall Study|Withdrawal by Subject|14|||
148889615|NCT02294058|537074441|FG002|Overall Study|Withdrawal by Subject|13|||
148889616|NCT02294058|537074439|FG000|Overall Study|Physician Decision|2|||
148889617|NCT02294058|537074440|FG001|Overall Study|Physician Decision|1|||
148889618|NCT02294058|537074441|FG002|Overall Study|Physician Decision|0|||
148889619|NCT02294058|537074439|FG000|Overall Study|Miscellaneous|4|||
148889620|NCT02294058|537074440|FG001|Overall Study|Miscellaneous|1|||
148889621|NCT02294058|537074441|FG002|Overall Study|Miscellaneous|1|||
148889622|NCT01894607|537074442|FG000|Overall Study|Ineligible|1|||
148889623|NCT03084796|537074445|FG000|Overall Study|Adverse Event|4|||
148889624|NCT03084796|537074446|FG001|Overall Study|Adverse Event|5|||
149056222|NCT03544281|537689081|FG021|Main Study Phase|Death|0|||
148889625|NCT03084796|537074447|FG002|Overall Study|Adverse Event|6|||
148889626|NCT03084796|537074448|FG003|Overall Study|Adverse Event|2|||
148889627|NCT03084796|537074449|FG004|Overall Study|Adverse Event|3|||
148889628|NCT03084796|537074450|FG005|Overall Study|Adverse Event|5|||
148889629|NCT03084796|537074445|FG000|Overall Study|Withdrawal by Subject|3|||
148889630|NCT03084796|537074446|FG001|Overall Study|Withdrawal by Subject|5|||
148889631|NCT03084796|537074447|FG002|Overall Study|Withdrawal by Subject|2|||
148889632|NCT03084796|537074448|FG003|Overall Study|Withdrawal by Subject|1|||
148889633|NCT03084796|537074449|FG004|Overall Study|Withdrawal by Subject|3|||
148889634|NCT03084796|537074450|FG005|Overall Study|Withdrawal by Subject|0|||
149056223|NCT03544281|537689060|FG000|Main Study Phase|Lost to Follow-up|0|||
149056224|NCT03544281|537689061|FG001|Main Study Phase|Lost to Follow-up|0|||
149056225|NCT03544281|537689062|FG002|Main Study Phase|Lost to Follow-up|0|||
149056226|NCT03544281|537689063|FG003|Main Study Phase|Lost to Follow-up|0|||
149056227|NCT03544281|537689064|FG004|Main Study Phase|Lost to Follow-up|0|||
149056228|NCT03544281|537689065|FG005|Main Study Phase|Lost to Follow-up|0|||
148889635|NCT03084796|537074445|FG000|Overall Study|Protocol Violation|0|||
148889636|NCT03084796|537074446|FG001|Overall Study|Protocol Violation|0|||
148889637|NCT03084796|537074447|FG002|Overall Study|Protocol Violation|1|||
148889638|NCT03084796|537074448|FG003|Overall Study|Protocol Violation|0|||
148889639|NCT03084796|537074449|FG004|Overall Study|Protocol Violation|1|||
148889640|NCT03084796|537074450|FG005|Overall Study|Protocol Violation|1|||
148889641|NCT03084796|537074445|FG000|Overall Study|Lack of Efficacy|0|||
148889642|NCT03084796|537074446|FG001|Overall Study|Lack of Efficacy|0|||
148889643|NCT03084796|537074447|FG002|Overall Study|Lack of Efficacy|1|||
148889644|NCT03084796|537074448|FG003|Overall Study|Lack of Efficacy|0|||
148889645|NCT03084796|537074449|FG004|Overall Study|Lack of Efficacy|1|||
148889646|NCT03084796|537074450|FG005|Overall Study|Lack of Efficacy|0|||
148889647|NCT03084796|537074445|FG000|Overall Study|Lost to Follow-up|0|||
148889648|NCT03084796|537074446|FG001|Overall Study|Lost to Follow-up|0|||
148889649|NCT03084796|537074447|FG002|Overall Study|Lost to Follow-up|1|||
148889650|NCT03084796|537074448|FG003|Overall Study|Lost to Follow-up|1|||
148889651|NCT03084796|537074449|FG004|Overall Study|Lost to Follow-up|3|||
148889652|NCT03084796|537074450|FG005|Overall Study|Lost to Follow-up|1|||
148889653|NCT03084796|537074445|FG000|Overall Study|Randomization error|0|||
148889654|NCT03084796|537074446|FG001|Overall Study|Randomization error|0|||
148889655|NCT03084796|537074447|FG002|Overall Study|Randomization error|1|||
148889656|NCT03084796|537074448|FG003|Overall Study|Randomization error|0|||
148889657|NCT03084796|537074449|FG004|Overall Study|Randomization error|0|||
148889658|NCT03084796|537074450|FG005|Overall Study|Randomization error|0|||
148889659|NCT03259555|537074457|FG000|Overall Study|Adverse Event|6|||
148889660|NCT03259555|537074458|FG001|Overall Study|Adverse Event|4|||
148889661|NCT03259555|537074457|FG000|Overall Study|Lack of Efficacy|6|||
148889662|NCT03259555|537074458|FG001|Overall Study|Lack of Efficacy|4|||
148889663|NCT03259555|537074457|FG000|Overall Study|Lost to Follow-up|0|||
148889664|NCT03259555|537074458|FG001|Overall Study|Lost to Follow-up|2|||
148889665|NCT03259555|537074457|FG000|Overall Study|Non-Compliance With Study Drug|1|||
148889666|NCT03259555|537074458|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148889667|NCT03259555|537074457|FG000|Overall Study|Progressive Disease|0|||
148889668|NCT03259555|537074458|FG001|Overall Study|Progressive Disease|2|||
148889669|NCT03259555|537074457|FG000|Overall Study|Withdrawal by Subject|19|||
148889670|NCT03259555|537074458|FG001|Overall Study|Withdrawal by Subject|16|||
148889671|NCT03259555|537074457|FG000|Overall Study|Physician Decision|1|||
148889672|NCT03259555|537074458|FG001|Overall Study|Physician Decision|2|||
148889673|NCT03259555|537074457|FG000|Overall Study|Other|1|||
148889674|NCT03259555|537074458|FG001|Overall Study|Other|0|||
148889675|NCT00607087|537074459|FG000|Overall Study|Withdrawal by Subject|9|||
148889676|NCT00607087|537074460|FG001|Overall Study|Withdrawal by Subject|4|||
148889677|NCT00607087|537074461|FG002|Overall Study|Withdrawal by Subject|4|||
148889678|NCT00607087|537074459|FG000|Overall Study|Adverse Event|3|||
148889679|NCT00607087|537074460|FG001|Overall Study|Adverse Event|2|||
148889680|NCT00607087|537074461|FG002|Overall Study|Adverse Event|3|||
148889681|NCT00607087|537074459|FG000|Overall Study|Other reason|1|||
148889682|NCT00607087|537074460|FG001|Overall Study|Other reason|5|||
148889683|NCT00607087|537074461|FG002|Overall Study|Other reason|2|||
148889684|NCT00607087|537074459|FG000|Overall Study|Poor compliance to protocol|1|||
148889685|NCT00607087|537074460|FG001|Overall Study|Poor compliance to protocol|0|||
148889686|NCT00607087|537074461|FG002|Overall Study|Poor compliance to protocol|1|||
148889687|NCT00607087|537074459|FG000|Overall Study|Lost to Follow-up|1|||
148889688|NCT00607087|537074460|FG001|Overall Study|Lost to Follow-up|0|||
148889689|NCT00607087|537074461|FG002|Overall Study|Lost to Follow-up|0|||
148889690|NCT00607087|537074459|FG000|Period 1|Withdrawal by Subject|7|||
148889691|NCT00607087|537074460|FG001|Period 1|Withdrawal by Subject|2|||
148889692|NCT00607087|537074461|FG002|Period 1|Withdrawal by Subject|3|||
148889693|NCT00607087|537074459|FG000|Period 1|Adverse Event|3|||
148889694|NCT00607087|537074460|FG001|Period 1|Adverse Event|0|||
148889695|NCT00607087|537074461|FG002|Period 1|Adverse Event|0|||
148889696|NCT00607087|537074459|FG000|Period 1|Poor compliance to protocol|1|||
148889697|NCT00607087|537074460|FG001|Period 1|Poor compliance to protocol|0|||
148889698|NCT00607087|537074461|FG002|Period 1|Poor compliance to protocol|0|||
148889699|NCT00607087|537074459|FG000|Period 1|Lost to Follow-up|1|||
148889700|NCT00607087|537074460|FG001|Period 1|Lost to Follow-up|0|||
148889701|NCT00607087|537074461|FG002|Period 1|Lost to Follow-up|0|||
148889702|NCT00607087|537074459|FG000|Period 1|Other reason|0|||
149056229|NCT03544281|537689066|FG006|Main Study Phase|Lost to Follow-up|0|||
149056230|NCT03544281|537689067|FG007|Main Study Phase|Lost to Follow-up|0|||
148889703|NCT00607087|537074460|FG001|Period 1|Other reason|4|||
148889704|NCT00607087|537074461|FG002|Period 1|Other reason|2|||
148889705|NCT00607087|537074459|FG000|Period 2|Withdrawal by Subject|0|||
148889706|NCT00607087|537074460|FG001|Period 2|Withdrawal by Subject|1|||
148889707|NCT00607087|537074461|FG002|Period 2|Withdrawal by Subject|1|||
148889708|NCT00607087|537074459|FG000|Period 2|Other reason|1|||
148889709|NCT00607087|537074460|FG001|Period 2|Other reason|1|||
148889710|NCT00607087|537074461|FG002|Period 2|Other reason|0|||
148889711|NCT00607087|537074459|FG000|Period 2|Adverse Event|0|||
148889712|NCT00607087|537074460|FG001|Period 2|Adverse Event|1|||
148889713|NCT00607087|537074461|FG002|Period 2|Adverse Event|3|||
149056231|NCT03544281|537689068|FG008|Main Study Phase|Lost to Follow-up|0|||
149056232|NCT03544281|537689069|FG009|Main Study Phase|Lost to Follow-up|0|||
149056233|NCT03544281|537689070|FG010|Main Study Phase|Lost to Follow-up|1|||
149056234|NCT03544281|537689071|FG011|Main Study Phase|Lost to Follow-up|0|||
149056235|NCT03544281|537689072|FG012|Main Study Phase|Lost to Follow-up|0|||
149056236|NCT03544281|537689073|FG013|Main Study Phase|Lost to Follow-up|0|||
149056237|NCT03544281|537689074|FG014|Main Study Phase|Lost to Follow-up|0|||
149056238|NCT03544281|537689075|FG015|Main Study Phase|Lost to Follow-up|0|||
149056239|NCT03544281|537689076|FG016|Main Study Phase|Lost to Follow-up|0|||
149056240|NCT03544281|537689077|FG017|Main Study Phase|Lost to Follow-up|0|||
149056241|NCT03544281|537689078|FG018|Main Study Phase|Lost to Follow-up|0|||
149056242|NCT03544281|537689079|FG019|Main Study Phase|Lost to Follow-up|0|||
149056243|NCT03544281|537689080|FG020|Main Study Phase|Lost to Follow-up|0|||
149056244|NCT03544281|537689081|FG021|Main Study Phase|Lost to Follow-up|0|||
149056245|NCT03544281|537689060|FG000|Main Study Phase|Physician Decision|0|||
149056246|NCT03544281|537689061|FG001|Main Study Phase|Physician Decision|0|||
149056247|NCT03544281|537689062|FG002|Main Study Phase|Physician Decision|0|||
149056248|NCT03544281|537689063|FG003|Main Study Phase|Physician Decision|0|||
149056249|NCT03544281|537689064|FG004|Main Study Phase|Physician Decision|0|||
149056250|NCT03544281|537689065|FG005|Main Study Phase|Physician Decision|0|||
149056251|NCT03544281|537689066|FG006|Main Study Phase|Physician Decision|0|||
149056252|NCT03544281|537689067|FG007|Main Study Phase|Physician Decision|1|||
149056253|NCT03544281|537689068|FG008|Main Study Phase|Physician Decision|0|||
149056254|NCT03544281|537689069|FG009|Main Study Phase|Physician Decision|0|||
149056255|NCT03544281|537689070|FG010|Main Study Phase|Physician Decision|0|||
149056256|NCT03544281|537689071|FG011|Main Study Phase|Physician Decision|0|||
149056257|NCT03544281|537689072|FG012|Main Study Phase|Physician Decision|0|||
149056258|NCT03544281|537689073|FG013|Main Study Phase|Physician Decision|0|||
149056259|NCT03544281|537689074|FG014|Main Study Phase|Physician Decision|0|||
149056260|NCT03544281|537689075|FG015|Main Study Phase|Physician Decision|0|||
149056261|NCT03544281|537689076|FG016|Main Study Phase|Physician Decision|0|||
149056262|NCT03544281|537689077|FG017|Main Study Phase|Physician Decision|0|||
149056263|NCT03544281|537689078|FG018|Main Study Phase|Physician Decision|0|||
149056264|NCT03544281|537689079|FG019|Main Study Phase|Physician Decision|0|||
149056265|NCT03544281|537689080|FG020|Main Study Phase|Physician Decision|0|||
149056266|NCT03544281|537689081|FG021|Main Study Phase|Physician Decision|0|||
149056267|NCT03544281|537689060|FG000|Main Study Phase|Withdrawal by Subject|2|||
149056268|NCT03544281|537689061|FG001|Main Study Phase|Withdrawal by Subject|0|||
149056269|NCT03544281|537689062|FG002|Main Study Phase|Withdrawal by Subject|1|||
149056270|NCT03544281|537689063|FG003|Main Study Phase|Withdrawal by Subject|2|||
149056271|NCT03544281|537689064|FG004|Main Study Phase|Withdrawal by Subject|0|||
149056272|NCT03544281|537689065|FG005|Main Study Phase|Withdrawal by Subject|0|||
149056273|NCT03544281|537689066|FG006|Main Study Phase|Withdrawal by Subject|0|||
149056274|NCT03544281|537689067|FG007|Main Study Phase|Withdrawal by Subject|0|||
149056275|NCT03544281|537689068|FG008|Main Study Phase|Withdrawal by Subject|2|||
149056276|NCT03544281|537689069|FG009|Main Study Phase|Withdrawal by Subject|3|||
149056277|NCT03544281|537689070|FG010|Main Study Phase|Withdrawal by Subject|0|||
149056278|NCT03544281|537689071|FG011|Main Study Phase|Withdrawal by Subject|4|||
149056279|NCT03544281|537689072|FG012|Main Study Phase|Withdrawal by Subject|0|||
149056280|NCT03544281|537689073|FG013|Main Study Phase|Withdrawal by Subject|0|||
149056281|NCT03544281|537689074|FG014|Main Study Phase|Withdrawal by Subject|0|||
149056282|NCT03544281|537689075|FG015|Main Study Phase|Withdrawal by Subject|0|||
149056283|NCT03544281|537689076|FG016|Main Study Phase|Withdrawal by Subject|0|||
149056284|NCT03544281|537689077|FG017|Main Study Phase|Withdrawal by Subject|0|||
149056285|NCT03544281|537689078|FG018|Main Study Phase|Withdrawal by Subject|0|||
149056286|NCT03544281|537689079|FG019|Main Study Phase|Withdrawal by Subject|0|||
149056287|NCT03544281|537689080|FG020|Main Study Phase|Withdrawal by Subject|0|||
149056288|NCT03544281|537689081|FG021|Main Study Phase|Withdrawal by Subject|0|||
149056289|NCT03544281|537689060|FG000|Main Study Phase|Ongoing|3|||
149056290|NCT03544281|537689061|FG001|Main Study Phase|Ongoing|1|||
149056291|NCT03544281|537689062|FG002|Main Study Phase|Ongoing|2|||
149056292|NCT03544281|537689063|FG003|Main Study Phase|Ongoing|4|||
149056293|NCT03544281|537689064|FG004|Main Study Phase|Ongoing|2|||
149056294|NCT03544281|537689065|FG005|Main Study Phase|Ongoing|4|||
149056295|NCT03544281|537689066|FG006|Main Study Phase|Ongoing|4|||
149056296|NCT03544281|537689067|FG007|Main Study Phase|Ongoing|0|||
149056297|NCT03544281|537689068|FG008|Main Study Phase|Ongoing|2|||
149056298|NCT03544281|537689069|FG009|Main Study Phase|Ongoing|2|||
149056299|NCT03544281|537689070|FG010|Main Study Phase|Ongoing|1|||
149056300|NCT03544281|537689071|FG011|Main Study Phase|Ongoing|0|||
149056301|NCT03544281|537689072|FG012|Main Study Phase|Ongoing|0|||
149056302|NCT03544281|537689073|FG013|Main Study Phase|Ongoing|0|||
149056303|NCT03544281|537689074|FG014|Main Study Phase|Ongoing|0|||
149056304|NCT03544281|537689075|FG015|Main Study Phase|Ongoing|0|||
149056305|NCT03544281|537689076|FG016|Main Study Phase|Ongoing|0|||
149056306|NCT03544281|537689077|FG017|Main Study Phase|Ongoing|0|||
149056307|NCT03544281|537689078|FG018|Main Study Phase|Ongoing|0|||
149056308|NCT03544281|537689079|FG019|Main Study Phase|Ongoing|0|||
149056309|NCT03544281|537689080|FG020|Main Study Phase|Ongoing|0|||
149056310|NCT03544281|537689081|FG021|Main Study Phase|Ongoing|0|||
148889714|NCT00607087|537074459|FG000|Period 2|Poor compliance to protocol|0|||
148889715|NCT00607087|537074460|FG001|Period 2|Poor compliance to protocol|0|||
148889716|NCT00607087|537074461|FG002|Period 2|Poor compliance to protocol|1|||
148889717|NCT00607087|537074459|FG000|Period 3|Withdrawal by Subject|2|||
148889718|NCT00607087|537074460|FG001|Period 3|Withdrawal by Subject|1|||
148889719|NCT00607087|537074461|FG002|Period 3|Withdrawal by Subject|0|||
148889720|NCT00607087|537074459|FG000|Period 3|Adverse Event|0|||
148889721|NCT00607087|537074460|FG001|Period 3|Adverse Event|1|||
148889722|NCT00607087|537074461|FG002|Period 3|Adverse Event|0|||
148889723|NCT02717494|537074462|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
148889724|NCT02717494|537074463|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
148889725|NCT02717494|537074464|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
148889726|NCT02717494|537074462|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
148889727|NCT02717494|537074463|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
148889728|NCT02717494|537074464|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
148889729|NCT02717494|537074462|FG000|First Intervention (Step 1)|Death|0|||
149056311|NCT03544281|537689060|FG000|Main Study Phase|Investigator Site Closed|0|||
149056312|NCT03544281|537689061|FG001|Main Study Phase|Investigator Site Closed|0|||
149056313|NCT03544281|537689062|FG002|Main Study Phase|Investigator Site Closed|0|||
149056314|NCT03544281|537689063|FG003|Main Study Phase|Investigator Site Closed|0|||
149056315|NCT03544281|537689064|FG004|Main Study Phase|Investigator Site Closed|0|||
149056316|NCT03544281|537689065|FG005|Main Study Phase|Investigator Site Closed|0|||
149056317|NCT03544281|537689066|FG006|Main Study Phase|Investigator Site Closed|0|||
149056318|NCT03544281|537689067|FG007|Main Study Phase|Investigator Site Closed|0|||
149056319|NCT03544281|537689068|FG008|Main Study Phase|Investigator Site Closed|0|||
149056320|NCT03544281|537689069|FG009|Main Study Phase|Investigator Site Closed|1|||
149056321|NCT03544281|537689070|FG010|Main Study Phase|Investigator Site Closed|0|||
149056322|NCT03544281|537689071|FG011|Main Study Phase|Investigator Site Closed|0|||
149056323|NCT03544281|537689072|FG012|Main Study Phase|Investigator Site Closed|0|||
149056324|NCT03544281|537689073|FG013|Main Study Phase|Investigator Site Closed|0|||
149056325|NCT03544281|537689074|FG014|Main Study Phase|Investigator Site Closed|0|||
149056326|NCT03544281|537689075|FG015|Main Study Phase|Investigator Site Closed|0|||
149056327|NCT03544281|537689076|FG016|Main Study Phase|Investigator Site Closed|0|||
149056328|NCT03544281|537689077|FG017|Main Study Phase|Investigator Site Closed|0|||
149056329|NCT03544281|537689078|FG018|Main Study Phase|Investigator Site Closed|0|||
149056330|NCT03544281|537689079|FG019|Main Study Phase|Investigator Site Closed|0|||
149056331|NCT03544281|537689080|FG020|Main Study Phase|Investigator Site Closed|0|||
149056332|NCT03544281|537689081|FG021|Main Study Phase|Investigator Site Closed|0|||
149056333|NCT03544281|537689060|FG000|Main Study Phase|Did not receive study treatment|0|||
149056334|NCT03544281|537689061|FG001|Main Study Phase|Did not receive study treatment|0|||
149056335|NCT03544281|537689062|FG002|Main Study Phase|Did not receive study treatment|0|||
149056336|NCT03544281|537689063|FG003|Main Study Phase|Did not receive study treatment|0|||
149056337|NCT03544281|537689064|FG004|Main Study Phase|Did not receive study treatment|0|||
149056338|NCT03544281|537689065|FG005|Main Study Phase|Did not receive study treatment|0|||
149056339|NCT03544281|537689066|FG006|Main Study Phase|Did not receive study treatment|1|||
149056340|NCT03544281|537689067|FG007|Main Study Phase|Did not receive study treatment|0|||
149056341|NCT03544281|537689068|FG008|Main Study Phase|Did not receive study treatment|0|||
149056342|NCT03544281|537689069|FG009|Main Study Phase|Did not receive study treatment|0|||
149056343|NCT03544281|537689070|FG010|Main Study Phase|Did not receive study treatment|0|||
149056344|NCT03544281|537689071|FG011|Main Study Phase|Did not receive study treatment|0|||
149056345|NCT03544281|537689072|FG012|Main Study Phase|Did not receive study treatment|0|||
149056346|NCT03544281|537689073|FG013|Main Study Phase|Did not receive study treatment|0|||
149056347|NCT03544281|537689074|FG014|Main Study Phase|Did not receive study treatment|0|||
149056348|NCT03544281|537689075|FG015|Main Study Phase|Did not receive study treatment|0|||
149056349|NCT03544281|537689076|FG016|Main Study Phase|Did not receive study treatment|0|||
149056350|NCT03544281|537689077|FG017|Main Study Phase|Did not receive study treatment|0|||
149056351|NCT03544281|537689078|FG018|Main Study Phase|Did not receive study treatment|0|||
148889730|NCT02717494|537074463|FG001|First Intervention (Step 1)|Death|0|||
149056352|NCT03544281|537689079|FG019|Main Study Phase|Did not receive study treatment|0|||
149056353|NCT03544281|537689080|FG020|Main Study Phase|Did not receive study treatment|0|||
149056354|NCT03544281|537689081|FG021|Main Study Phase|Did not receive study treatment|0|||
149056355|NCT03544281|537689060|FG000|PACT Phase|Adverse Event|0|||
149056356|NCT03544281|537689061|FG001|PACT Phase|Adverse Event|0|||
149056357|NCT03544281|537689062|FG002|PACT Phase|Adverse Event|0|||
149056358|NCT03544281|537689063|FG003|PACT Phase|Adverse Event|0|||
148889731|NCT02717494|537074464|FG002|First Intervention (Step 1)|Death|1|||
148889732|NCT02717494|537074462|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
148889733|NCT02717494|537074463|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
148889734|NCT02717494|537074464|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
149056359|NCT03544281|537689064|FG004|PACT Phase|Adverse Event|0|||
148889735|NCT00154297|537074467|FG000|Overall Study|Death|5|||
148889736|NCT00154297|537074468|FG001|Overall Study|Death|2|||
149056360|NCT03544281|537689065|FG005|PACT Phase|Adverse Event|0|||
148889737|NCT00154297|537074467|FG000|Overall Study|Withdrawal by Subject|0|||
148889738|NCT00154297|537074468|FG001|Overall Study|Withdrawal by Subject|5|||
148889739|NCT00154297|537074467|FG000|Overall Study|Lost to Follow-up|3|||
148889740|NCT00154297|537074468|FG001|Overall Study|Lost to Follow-up|0|||
148889741|NCT01125800|537074469|FG000|Phase I|Protocol Violation|0|||
148889742|NCT01125800|537074470|FG001|Phase I|Protocol Violation|3|||
148889743|NCT01125800|537074471|FG002|Phase I|Protocol Violation|1|||
148889744|NCT01125800|537074472|FG003|Phase I|Protocol Violation|1|||
148889745|NCT01125800|537074473|FG004|Phase I|Protocol Violation|0|||
148889746|NCT01125800|537074469|FG000|Phase I|Adverse Event|2|||
148889747|NCT01125800|537074470|FG001|Phase I|Adverse Event|2|||
148889748|NCT01125800|537074471|FG002|Phase I|Adverse Event|1|||
148889749|NCT01125800|537074472|FG003|Phase I|Adverse Event|7|||
148889750|NCT01125800|537074473|FG004|Phase I|Adverse Event|0|||
148889751|NCT01125800|537074469|FG000|Phase I|Administrative problems|1|||
148889752|NCT01125800|537074470|FG001|Phase I|Administrative problems|0|||
148889753|NCT01125800|537074471|FG002|Phase I|Administrative problems|0|||
148889754|NCT01125800|537074472|FG003|Phase I|Administrative problems|0|||
148889755|NCT01125800|537074473|FG004|Phase I|Administrative problems|0|||
148889756|NCT01125800|537074469|FG000|Phase I|Withdrawal by Subject|0|||
148889757|NCT01125800|537074470|FG001|Phase I|Withdrawal by Subject|0|||
148889758|NCT01125800|537074471|FG002|Phase I|Withdrawal by Subject|1|||
148889759|NCT01125800|537074472|FG003|Phase I|Withdrawal by Subject|0|||
148889760|NCT01125800|537074473|FG004|Phase I|Withdrawal by Subject|0|||
148889761|NCT01125800|537074469|FG000|Phase I|Disease progression|5|||
148889762|NCT01125800|537074470|FG001|Phase I|Disease progression|4|||
148889763|NCT01125800|537074471|FG002|Phase I|Disease progression|1|||
148889764|NCT01125800|537074472|FG003|Phase I|Disease progression|3|||
148889765|NCT01125800|537074473|FG004|Phase I|Disease progression|0|||
148889766|NCT01125800|537074469|FG000|Phase II|Protocol Violation|0|||
148889767|NCT01125800|537074470|FG001|Phase II|Protocol Violation|0|||
148889768|NCT01125800|537074471|FG002|Phase II|Protocol Violation|0|||
148889769|NCT01125800|537074472|FG003|Phase II|Protocol Violation|0|||
148889770|NCT01125800|537074473|FG004|Phase II|Protocol Violation|1|||
148889771|NCT01125800|537074469|FG000|Phase II|Adverse Event|0|||
148889772|NCT01125800|537074470|FG001|Phase II|Adverse Event|0|||
148889773|NCT01125800|537074471|FG002|Phase II|Adverse Event|0|||
148889774|NCT01125800|537074472|FG003|Phase II|Adverse Event|0|||
148889775|NCT01125800|537074473|FG004|Phase II|Adverse Event|2|||
148889776|NCT01125800|537074469|FG000|Phase II|Disease progression|0|||
148889777|NCT01125800|537074470|FG001|Phase II|Disease progression|0|||
148889778|NCT01125800|537074471|FG002|Phase II|Disease progression|0|||
148889779|NCT01125800|537074472|FG003|Phase II|Disease progression|1|||
148889780|NCT01125800|537074473|FG004|Phase II|Disease progression|8|||
148889781|NCT03370718|537074477|FG000|Overall Study|Withdrawal by Subject|1|||
148889782|NCT05477485|537074482|FG000|Overall Study|Lost to Follow-up|0|||
148889783|NCT05477485|537074483|FG001|Overall Study|Lost to Follow-up|4|||
148889784|NCT03116685|537074484|FG000|Overall Study|Physician Decision|0|||
148889785|NCT03116685|537074485|FG001|Overall Study|Physician Decision|1|||
148889786|NCT05274958|537074486|FG000|Overall Study|Only completed 1 set of PROMs|22|||
148889787|NCT05274958|537074487|FG001|Overall Study|Only completed 1 set of PROMs|35|||
148889788|NCT05579977|537074489|FG000|Treatment Phase|Other|0|||
148889789|NCT05579977|537074490|FG001|Treatment Phase|Other|0|||
148889790|NCT05579977|537074491|FG002|Treatment Phase|Other|0|||
148889791|NCT05579977|537074492|FG003|Treatment Phase|Other|2|||
148889792|NCT05579977|537074493|FG004|Treatment Phase|Other|1|||
149056361|NCT03544281|537689066|FG006|PACT Phase|Adverse Event|0|||
149056362|NCT03544281|537689067|FG007|PACT Phase|Adverse Event|0|||
149056363|NCT03544281|537689068|FG008|PACT Phase|Adverse Event|0|||
149056364|NCT03544281|537689069|FG009|PACT Phase|Adverse Event|0|||
149056365|NCT03544281|537689070|FG010|PACT Phase|Adverse Event|0|||
148889793|NCT05579977|537074494|FG005|Treatment Phase|Other|2|||
149056366|NCT03544281|537689071|FG011|PACT Phase|Adverse Event|0|||
148889794|NCT05579977|537074495|FG006|Treatment Phase|Other|1|||
148889795|NCT05579977|537074496|FG007|Treatment Phase|Other|2|||
148889796|NCT05579977|537074497|FG008|Treatment Phase|Other|2|||
148889797|NCT05579977|537074498|FG009|Treatment Phase|Other|1|||
148889798|NCT05579977|537074499|FG010|Treatment Phase|Other|0|||
148889799|NCT05579977|537074500|FG011|Treatment Phase|Other|0|||
148889800|NCT05579977|537074501|FG012|Treatment Phase|Other|3|||
149056367|NCT03544281|537689072|FG012|PACT Phase|Adverse Event|1|||
148889801|NCT05579977|537074489|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
148889802|NCT05579977|537074490|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
148889803|NCT05579977|537074491|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
148889804|NCT05579977|537074492|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
148889805|NCT05579977|537074493|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
148889806|NCT05579977|537074494|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
148889807|NCT05579977|537074495|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
148889808|NCT05579977|537074496|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
149056368|NCT03544281|537689073|FG013|PACT Phase|Adverse Event|0|||
149056369|NCT03544281|537689074|FG014|PACT Phase|Adverse Event|0|||
148889809|NCT05579977|537074497|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
148889810|NCT05579977|537074498|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
148889811|NCT05579977|537074499|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
148889812|NCT05579977|537074500|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
148889813|NCT05579977|537074501|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
148889814|NCT05579977|537074489|FG000|Treatment Phase|Withdrawal by Subject|2|||
148889815|NCT05579977|537074490|FG001|Treatment Phase|Withdrawal by Subject|0|||
148889816|NCT05579977|537074491|FG002|Treatment Phase|Withdrawal by Subject|0|||
148889817|NCT05579977|537074492|FG003|Treatment Phase|Withdrawal by Subject|1|||
148889818|NCT05579977|537074493|FG004|Treatment Phase|Withdrawal by Subject|2|||
148889819|NCT05579977|537074494|FG005|Treatment Phase|Withdrawal by Subject|0|||
148889820|NCT05579977|537074495|FG006|Treatment Phase|Withdrawal by Subject|1|||
148889821|NCT05579977|537074496|FG007|Treatment Phase|Withdrawal by Subject|8|||
148889822|NCT05579977|537074497|FG008|Treatment Phase|Withdrawal by Subject|3|||
148889823|NCT05579977|537074498|FG009|Treatment Phase|Withdrawal by Subject|3|||
148889824|NCT05579977|537074499|FG010|Treatment Phase|Withdrawal by Subject|5|||
148889825|NCT05579977|537074500|FG011|Treatment Phase|Withdrawal by Subject|1|||
148889826|NCT05579977|537074501|FG012|Treatment Phase|Withdrawal by Subject|3|||
148889827|NCT05579977|537074489|FG000|Treatment Phase|Study terminated by sponsor|70|||
148889828|NCT05579977|537074490|FG001|Treatment Phase|Study terminated by sponsor|70|||
148889829|NCT05579977|537074491|FG002|Treatment Phase|Study terminated by sponsor|61|||
148889830|NCT05579977|537074492|FG003|Treatment Phase|Study terminated by sponsor|59|||
148889831|NCT05579977|537074493|FG004|Treatment Phase|Study terminated by sponsor|63|||
148889832|NCT05579977|537074494|FG005|Treatment Phase|Study terminated by sponsor|53|||
148889833|NCT05579977|537074495|FG006|Treatment Phase|Study terminated by sponsor|66|||
148889834|NCT05579977|537074496|FG007|Treatment Phase|Study terminated by sponsor|48|||
148889835|NCT05579977|537074497|FG008|Treatment Phase|Study terminated by sponsor|47|||
148889836|NCT05579977|537074498|FG009|Treatment Phase|Study terminated by sponsor|37|||
148889837|NCT05579977|537074499|FG010|Treatment Phase|Study terminated by sponsor|44|||
148889838|NCT05579977|537074500|FG011|Treatment Phase|Study terminated by sponsor|36|||
148889839|NCT05579977|537074501|FG012|Treatment Phase|Study terminated by sponsor|32|||
148889840|NCT05579977|537074489|FG000|Treatment Phase|Pregnancy|0|||
148889841|NCT05579977|537074490|FG001|Treatment Phase|Pregnancy|0|||
148889842|NCT05579977|537074491|FG002|Treatment Phase|Pregnancy|0|||
148889843|NCT05579977|537074492|FG003|Treatment Phase|Pregnancy|0|||
148889844|NCT05579977|537074493|FG004|Treatment Phase|Pregnancy|0|||
148889845|NCT05579977|537074494|FG005|Treatment Phase|Pregnancy|0|||
148889846|NCT05579977|537074495|FG006|Treatment Phase|Pregnancy|0|||
148889847|NCT05579977|537074496|FG007|Treatment Phase|Pregnancy|0|||
148889848|NCT05579977|537074497|FG008|Treatment Phase|Pregnancy|0|||
148889849|NCT05579977|537074498|FG009|Treatment Phase|Pregnancy|1|||
148889850|NCT05579977|537074499|FG010|Treatment Phase|Pregnancy|0|||
148889851|NCT05579977|537074500|FG011|Treatment Phase|Pregnancy|0|||
148889852|NCT05579977|537074501|FG012|Treatment Phase|Pregnancy|0|||
148889853|NCT05579977|537074489|FG000|Treatment Phase|Physician Decision|0|||
148889854|NCT05579977|537074490|FG001|Treatment Phase|Physician Decision|0|||
148889855|NCT05579977|537074491|FG002|Treatment Phase|Physician Decision|0|||
148889856|NCT05579977|537074492|FG003|Treatment Phase|Physician Decision|0|||
148889857|NCT05579977|537074493|FG004|Treatment Phase|Physician Decision|0|||
148889858|NCT05579977|537074494|FG005|Treatment Phase|Physician Decision|0|||
148889859|NCT05579977|537074495|FG006|Treatment Phase|Physician Decision|0|||
148889860|NCT05579977|537074496|FG007|Treatment Phase|Physician Decision|0|||
148889861|NCT05579977|537074497|FG008|Treatment Phase|Physician Decision|0|||
148889862|NCT05579977|537074498|FG009|Treatment Phase|Physician Decision|0|||
148889863|NCT05579977|537074499|FG010|Treatment Phase|Physician Decision|0|||
148889864|NCT05579977|537074500|FG011|Treatment Phase|Physician Decision|1|||
148889865|NCT05579977|537074501|FG012|Treatment Phase|Physician Decision|0|||
148889866|NCT05579977|537074489|FG000|Treatment Phase|Lost to Follow-up|0|||
148889867|NCT05579977|537074490|FG001|Treatment Phase|Lost to Follow-up|0|||
148889868|NCT05579977|537074491|FG002|Treatment Phase|Lost to Follow-up|0|||
148889869|NCT05579977|537074492|FG003|Treatment Phase|Lost to Follow-up|1|||
148889870|NCT05579977|537074493|FG004|Treatment Phase|Lost to Follow-up|1|||
149056370|NCT03544281|537689075|FG015|PACT Phase|Adverse Event|0|||
148889871|NCT05579977|537074494|FG005|Treatment Phase|Lost to Follow-up|1|||
148889872|NCT05579977|537074495|FG006|Treatment Phase|Lost to Follow-up|0|||
148889873|NCT05579977|537074496|FG007|Treatment Phase|Lost to Follow-up|1|||
148889874|NCT05579977|537074497|FG008|Treatment Phase|Lost to Follow-up|2|||
148889875|NCT05579977|537074498|FG009|Treatment Phase|Lost to Follow-up|2|||
148889876|NCT05579977|537074499|FG010|Treatment Phase|Lost to Follow-up|1|||
148889877|NCT05579977|537074500|FG011|Treatment Phase|Lost to Follow-up|4|||
148889878|NCT05579977|537074501|FG012|Treatment Phase|Lost to Follow-up|3|||
148889879|NCT05579977|537074489|FG000|Treatment Phase|Death|1|||
148889880|NCT05579977|537074490|FG001|Treatment Phase|Death|0|||
148889881|NCT05579977|537074491|FG002|Treatment Phase|Death|0|||
148889882|NCT05579977|537074492|FG003|Treatment Phase|Death|0|||
148889883|NCT05579977|537074493|FG004|Treatment Phase|Death|0|||
148889884|NCT05579977|537074494|FG005|Treatment Phase|Death|0|||
149056371|NCT03544281|537689076|FG016|PACT Phase|Adverse Event|0|||
149056372|NCT03544281|537689077|FG017|PACT Phase|Adverse Event|1|||
149056373|NCT03544281|537689078|FG018|PACT Phase|Adverse Event|1|||
149056374|NCT03544281|537689079|FG019|PACT Phase|Adverse Event|0|||
149056375|NCT03544281|537689080|FG020|PACT Phase|Adverse Event|0|||
149056376|NCT03544281|537689081|FG021|PACT Phase|Adverse Event|0|||
149056377|NCT02547987|537689084|FG000|Overall Study|Withdrawal by Subject|1|||
149056378|NCT02547987|537689084|FG000|Overall Study|Adverse Event|2|||
149056379|NCT06181760|537689085|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
149056380|NCT06181760|537689086|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
149056381|NCT06181760|537689087|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
149056382|NCT06181760|537689088|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
149056383|NCT03865498|537689092|FG000|Overall Study|Lack of Efficacy|12|||
149056384|NCT03865498|537689093|FG001|Overall Study|Lack of Efficacy|11|||
149056385|NCT03865498|537689092|FG000|Overall Study|Lost to Follow-up|125|||
149056386|NCT03865498|537689093|FG001|Overall Study|Lost to Follow-up|133|||
149056387|NCT03865498|537689092|FG000|Overall Study|Withdrawal by Subject|2|||
149056388|NCT03865498|537689093|FG001|Overall Study|Withdrawal by Subject|4|||
149056389|NCT01648023|537689098|FG000|Overall Study|Screen Fail Post Randomization|1|||
149056390|NCT01648023|537689099|FG001|Overall Study|Screen Fail Post Randomization|2|||
149056391|NCT05296525|537689102|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
149056392|NCT05296525|537689103|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
149056393|NCT05296525|537689104|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
149056394|NCT05296525|537689105|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
149056395|NCT04137289|537689106|FG000|Overall Study|Death|0|||
149056396|NCT04137289|537689107|FG001|Overall Study|Death|0|||
149056397|NCT04137289|537689108|FG002|Overall Study|Death|0|||
149056398|NCT04137289|537689109|FG003|Overall Study|Death|0|||
149056399|NCT04137289|537689110|FG004|Overall Study|Death|0|||
149056400|NCT04137289|537689111|FG005|Overall Study|Death|0|||
149056401|NCT04137289|537689112|FG006|Overall Study|Death|1|||
149056402|NCT04137289|537689113|FG007|Overall Study|Death|0|||
149056403|NCT04137289|537689114|FG008|Overall Study|Death|0|||
149056404|NCT04137289|537689106|FG000|Overall Study|Clinical disease progression|0|||
149056405|NCT04137289|537689107|FG001|Overall Study|Clinical disease progression|0|||
149056406|NCT04137289|537689108|FG002|Overall Study|Clinical disease progression|0|||
149056407|NCT04137289|537689109|FG003|Overall Study|Clinical disease progression|4|||
149056408|NCT04137289|537689110|FG004|Overall Study|Clinical disease progression|4|||
149056409|NCT04137289|537689111|FG005|Overall Study|Clinical disease progression|2|||
149056410|NCT04137289|537689112|FG006|Overall Study|Clinical disease progression|5|||
149056411|NCT04137289|537689113|FG007|Overall Study|Clinical disease progression|1|||
149056412|NCT04137289|537689114|FG008|Overall Study|Clinical disease progression|0|||
149056413|NCT04137289|537689106|FG000|Overall Study|Lost to Follow-up|0|||
149056414|NCT04137289|537689107|FG001|Overall Study|Lost to Follow-up|0|||
149056415|NCT04137289|537689108|FG002|Overall Study|Lost to Follow-up|0|||
149056416|NCT04137289|537689109|FG003|Overall Study|Lost to Follow-up|1|||
149056417|NCT04137289|537689110|FG004|Overall Study|Lost to Follow-up|0|||
149056418|NCT04137289|537689111|FG005|Overall Study|Lost to Follow-up|0|||
149056419|NCT04137289|537689112|FG006|Overall Study|Lost to Follow-up|0|||
149056420|NCT04137289|537689113|FG007|Overall Study|Lost to Follow-up|0|||
149056421|NCT04137289|537689114|FG008|Overall Study|Lost to Follow-up|0|||
149056422|NCT04137289|537689106|FG000|Overall Study|Adverse Event|0|||
149056423|NCT04137289|537689107|FG001|Overall Study|Adverse Event|0|||
149056424|NCT04137289|537689108|FG002|Overall Study|Adverse Event|1|||
149056425|NCT04137289|537689109|FG003|Overall Study|Adverse Event|0|||
149056426|NCT04137289|537689110|FG004|Overall Study|Adverse Event|0|||
149056427|NCT04137289|537689111|FG005|Overall Study|Adverse Event|1|||
149056428|NCT04137289|537689112|FG006|Overall Study|Adverse Event|0|||
149056429|NCT04137289|537689113|FG007|Overall Study|Adverse Event|0|||
149056430|NCT04137289|537689114|FG008|Overall Study|Adverse Event|0|||
149056431|NCT04137289|537689106|FG000|Overall Study|Lack of clinical benefit|0|||
149056432|NCT04137289|537689107|FG001|Overall Study|Lack of clinical benefit|0|||
149056433|NCT04137289|537689108|FG002|Overall Study|Lack of clinical benefit|0|||
149056434|NCT04137289|537689109|FG003|Overall Study|Lack of clinical benefit|0|||
149056435|NCT04137289|537689110|FG004|Overall Study|Lack of clinical benefit|0|||
149056436|NCT04137289|537689111|FG005|Overall Study|Lack of clinical benefit|0|||
149056437|NCT04137289|537689112|FG006|Overall Study|Lack of clinical benefit|0|||
149056438|NCT04137289|537689113|FG007|Overall Study|Lack of clinical benefit|0|||
149056439|NCT04137289|537689114|FG008|Overall Study|Lack of clinical benefit|1|||
149056440|NCT04137289|537689106|FG000|Overall Study|Objective disease progression|1|||
149056441|NCT04137289|537689107|FG001|Overall Study|Objective disease progression|1|||
149056442|NCT04137289|537689108|FG002|Overall Study|Objective disease progression|6|||
149056443|NCT04137289|537689109|FG003|Overall Study|Objective disease progression|18|||
149056444|NCT04137289|537689110|FG004|Overall Study|Objective disease progression|12|||
149056445|NCT04137289|537689111|FG005|Overall Study|Objective disease progression|20|||
149056446|NCT04137289|537689112|FG006|Overall Study|Objective disease progression|18|||
149119371|NCT00275262|537916292|FG000|Overall Study|Lost to Follow-up|0|||
149056447|NCT04137289|537689113|FG007|Overall Study|Objective disease progression|7|||
149056448|NCT04137289|537689114|FG008|Overall Study|Objective disease progression|6|||
149056449|NCT01420237|537689115|FG000|Overall Study|Death|13|||
149056450|NCT01420237|537689115|FG000|Overall Study|Withdrawal by Subject|41|||
149056451|NCT01420237|537689115|FG000|Overall Study|Lost to Follow-up|32|||
149056452|NCT01420237|537689115|FG000|Overall Study|Adverse Event|10|||
149056453|NCT01420237|537689115|FG000|Overall Study|Investigative Site Termination|43|||
149056454|NCT01420237|537689115|FG000|Overall Study|Censored because study device not implanted|21|||
149056455|NCT01420237|537689115|FG000|Overall Study|Censored because surgery not performed|2|||
149056456|NCT01420237|537689115|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
149056457|NCT01420237|537689115|FG000|Overall Study|Sponsor terminated study early|127|||
149056458|NCT04492722|537689119|FG000|Overall Study|Adverse Event|7|||
149056459|NCT04492722|537689120|FG001|Overall Study|Adverse Event|2|||
149056460|NCT04492722|537689121|FG002|Overall Study|Adverse Event|3|||
149056461|NCT04492722|537689122|FG003|Overall Study|Adverse Event|0|||
149056462|NCT04492722|537689119|FG000|Overall Study|Death|0|||
149056463|NCT04492722|537689120|FG001|Overall Study|Death|0|||
149056464|NCT04492722|537689121|FG002|Overall Study|Death|0|||
149056465|NCT04492722|537689122|FG003|Overall Study|Death|1|||
149056466|NCT04492722|537689119|FG000|Overall Study|Lost to Follow-up|0|||
149056467|NCT04492722|537689120|FG001|Overall Study|Lost to Follow-up|1|||
149056468|NCT04492722|537689121|FG002|Overall Study|Lost to Follow-up|0|||
149056469|NCT04492722|537689122|FG003|Overall Study|Lost to Follow-up|1|||
149056470|NCT04492722|537689119|FG000|Overall Study|Physician Decision|0|||
149056471|NCT04492722|537689120|FG001|Overall Study|Physician Decision|3|||
149056472|NCT04492722|537689121|FG002|Overall Study|Physician Decision|1|||
149056473|NCT04492722|537689122|FG003|Overall Study|Physician Decision|1|||
149056474|NCT04492722|537689119|FG000|Overall Study|Withdrawal by Subject|6|||
149056475|NCT04492722|537689120|FG001|Overall Study|Withdrawal by Subject|6|||
149056476|NCT04492722|537689121|FG002|Overall Study|Withdrawal by Subject|0|||
149056477|NCT04492722|537689122|FG003|Overall Study|Withdrawal by Subject|3|||
149056478|NCT04492722|537689119|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
149056479|NCT04492722|537689120|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
149056480|NCT04492722|537689121|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
149056481|NCT04492722|537689122|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
149056482|NCT04492722|537689119|FG000|Overall Study|Due to Covid-19 pandemic|7|||
149056483|NCT04492722|537689120|FG001|Overall Study|Due to Covid-19 pandemic|3|||
149056484|NCT04492722|537689121|FG002|Overall Study|Due to Covid-19 pandemic|7|||
149056485|NCT04492722|537689122|FG003|Overall Study|Due to Covid-19 pandemic|6|||
149056486|NCT04492722|537689119|FG000|Overall Study|Failure to meet randomisation criteria|2|||
149056487|NCT04492722|537689120|FG001|Overall Study|Failure to meet randomisation criteria|3|||
149056488|NCT04492722|537689121|FG002|Overall Study|Failure to meet randomisation criteria|4|||
149056489|NCT04492722|537689122|FG003|Overall Study|Failure to meet randomisation criteria|2|||
149056490|NCT04492722|537689119|FG000|Overall Study|Early termination from the study|54|||
149056491|NCT04492722|537689120|FG001|Overall Study|Early termination from the study|51|||
149056492|NCT04492722|537689121|FG002|Overall Study|Early termination from the study|50|||
149056493|NCT04492722|537689122|FG003|Overall Study|Early termination from the study|50|||
149056494|NCT04492722|537689119|FG000|Overall Study|Missing|3|||
149056495|NCT04492722|537689120|FG001|Overall Study|Missing|0|||
149056496|NCT04492722|537689121|FG002|Overall Study|Missing|0|||
149056497|NCT04492722|537689122|FG003|Overall Study|Missing|5|||
149056498|NCT04492722|537689119|FG000|Overall Study|Participants who did not receive treatment|0|||
149056499|NCT04492722|537689120|FG001|Overall Study|Participants who did not receive treatment|1|||
149056500|NCT04492722|537689121|FG002|Overall Study|Participants who did not receive treatment|4|||
149056501|NCT04492722|537689122|FG003|Overall Study|Participants who did not receive treatment|0|||
149056502|NCT02547363|537689124|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
149056503|NCT02547363|537689125|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
149056504|NCT02547363|537689124|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
149056505|NCT02547363|537689125|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
149056506|NCT02547363|537689124|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
149056507|NCT02547363|537689125|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
149056508|NCT02547363|537689124|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
149056509|NCT02547363|537689125|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
149056510|NCT02547363|537689124|FG000|12-month Follow-up|Withdrawal by Subject|4|||
149056511|NCT02547363|537689125|FG001|12-month Follow-up|Withdrawal by Subject|3|||
149056512|NCT02547363|537689124|FG000|12-month Follow-up|Lost to Follow-up|4|||
149056513|NCT02547363|537689125|FG001|12-month Follow-up|Lost to Follow-up|1|||
149056514|NCT02547363|537689124|FG000|12-month Follow-up|Lack of Efficacy|1|||
149056515|NCT02547363|537689125|FG001|12-month Follow-up|Lack of Efficacy|1|||
149056516|NCT02547363|537689124|FG000|12-month Follow-up|Other|1|||
149056517|NCT02547363|537689125|FG001|12-month Follow-up|Other|0|||
149056518|NCT03931174|537689126|FG000|Providers|Staff left organization|26|||
149056519|NCT03931174|537689127|FG001|Providers|Staff left organization|25|||
149119372|NCT00275262|537916293|FG001|Overall Study|Lost to Follow-up|2|||
149056520|NCT03931174|537689126|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
149056521|NCT03931174|537689127|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
149056522|NCT03931174|537689126|FG000|Providers|Lost to Follow-up|4|||
149056523|NCT03931174|537689127|FG001|Providers|Lost to Follow-up|4|||
149056524|NCT03931174|537689126|FG000|Patients|Post-consent screening failure|1|||
149056525|NCT03931174|537689127|FG001|Patients|Post-consent screening failure|1|||
149056526|NCT03931174|537689126|FG000|Patients|Death|1|||
149056527|NCT03931174|537689127|FG001|Patients|Death|1|||
149056528|NCT03931174|537689126|FG000|Patients|Lost to Follow-up|60|||
149056529|NCT03931174|537689127|FG001|Patients|Lost to Follow-up|89|||
149056530|NCT05386030|537689128|FG000|Overall Study|Death|1|||
149056531|NCT05386030|537689129|FG001|Overall Study|Death|0|||
149056532|NCT05386030|537689128|FG000|Overall Study|Physician Decision|2|||
149056533|NCT05386030|537689129|FG001|Overall Study|Physician Decision|1|||
149056534|NCT05386030|537689128|FG000|Overall Study|Lost to Follow-up|19|||
149056535|NCT05386030|537689129|FG001|Overall Study|Lost to Follow-up|7|||
149056536|NCT05386030|537689128|FG000|Overall Study|Withdrawal by Subject|20|||
149056537|NCT05386030|537689129|FG001|Overall Study|Withdrawal by Subject|10|||
149056538|NCT05386030|537689128|FG000|Overall Study|Eligibility criteria violation|1|||
149056539|NCT05386030|537689129|FG001|Overall Study|Eligibility criteria violation|1|||
149056540|NCT05386030|537689128|FG000|Overall Study|Personal Reasons|1|||
149056541|NCT05386030|537689129|FG001|Overall Study|Personal Reasons|0|||
149056542|NCT05228457|537689130|FG000|Overall Study|Withdrawal by Subject|1|||
149056543|NCT05228457|537689131|FG001|Overall Study|Withdrawal by Subject|1|||
149056544|NCT03213691|537689136|FG000|Overall Study|Adverse Event|2|||
149056545|NCT03213691|537689136|FG000|Overall Study|Death|3|||
149056546|NCT03213691|537689136|FG000|Overall Study|Physician Decision|1|||
149056547|NCT03213691|537689136|FG000|Overall Study|Progressive Disease|14|||
149056548|NCT03213691|537689136|FG000|Overall Study|Ineligible|1|||
149056549|NCT03161028|537689137|FG000|Overall Study|Withdrawal by Subject|6|||
149056550|NCT03161028|537689138|FG001|Overall Study|Withdrawal by Subject|4|||
149056551|NCT03161028|537689137|FG000|Overall Study|Adverse Event|5|||
149056552|NCT03161028|537689138|FG001|Overall Study|Adverse Event|1|||
149056553|NCT03161028|537689137|FG000|Overall Study|Study drug side effects|2|||
149056554|NCT03161028|537689138|FG001|Overall Study|Study drug side effects|2|||
149056555|NCT03161028|537689137|FG000|Overall Study|Administrative PD/UP|4|||
149056556|NCT03161028|537689138|FG001|Overall Study|Administrative PD/UP|2|||
149056557|NCT03161028|537689137|FG000|Overall Study|Lost to Follow-up|2|||
149056558|NCT03161028|537689138|FG001|Overall Study|Lost to Follow-up|0|||
149056559|NCT03161028|537689137|FG000|Overall Study|Unable to comply with procedures|1|||
149056560|NCT03161028|537689138|FG001|Overall Study|Unable to comply with procedures|1|||
149056561|NCT03492216|537689141|FG000|Overall Study|Death|1|||
149056562|NCT03492216|537689142|FG001|Overall Study|Death|0|||
149056563|NCT03492216|537689143|FG002|Overall Study|Death|4|||
149056564|NCT03492216|537689144|FG003|Overall Study|Death|0|||
149056565|NCT03492216|537689141|FG000|Overall Study|Withdrawal by Subject|5|||
149056566|NCT03492216|537689142|FG001|Overall Study|Withdrawal by Subject|3|||
149056567|NCT03492216|537689143|FG002|Overall Study|Withdrawal by Subject|1|||
149056568|NCT03492216|537689144|FG003|Overall Study|Withdrawal by Subject|1|||
149056569|NCT03492216|537689141|FG000|Overall Study|Lost to Follow-up|9|||
149056570|NCT03492216|537689142|FG001|Overall Study|Lost to Follow-up|2|||
148889885|NCT05579977|537074495|FG006|Treatment Phase|Death|0|||
149056571|NCT03492216|537689143|FG002|Overall Study|Lost to Follow-up|7|||
149056572|NCT03492216|537689144|FG003|Overall Study|Lost to Follow-up|8|||
149056573|NCT03492216|537689141|FG000|Overall Study|Moved|5|||
149056574|NCT03492216|537689142|FG001|Overall Study|Moved|3|||
148889886|NCT05579977|537074496|FG007|Treatment Phase|Death|0|||
149056575|NCT03492216|537689143|FG002|Overall Study|Moved|3|||
148889887|NCT05579977|537074497|FG008|Treatment Phase|Death|0|||
148889888|NCT05579977|537074498|FG009|Treatment Phase|Death|0|||
148889889|NCT05579977|537074499|FG010|Treatment Phase|Death|0|||
148889890|NCT05579977|537074500|FG011|Treatment Phase|Death|0|||
148889891|NCT05579977|537074501|FG012|Treatment Phase|Death|0|||
148889892|NCT05579977|537074489|FG000|Treatment Phase|Adverse Event|0|||
148889893|NCT05579977|537074490|FG001|Treatment Phase|Adverse Event|3|||
148889894|NCT05579977|537074491|FG002|Treatment Phase|Adverse Event|11|||
148889895|NCT05579977|537074492|FG003|Treatment Phase|Adverse Event|10|||
149056576|NCT03492216|537689144|FG003|Overall Study|Moved|5|||
149056577|NCT03492216|537689141|FG000|Overall Study|Too ill|0|||
149056578|NCT03492216|537689142|FG001|Overall Study|Too ill|1|||
148889896|NCT05579977|537074493|FG004|Treatment Phase|Adverse Event|5|||
148889897|NCT05579977|537074494|FG005|Treatment Phase|Adverse Event|17|||
148889898|NCT05579977|537074495|FG006|Treatment Phase|Adverse Event|5|||
149056579|NCT03492216|537689143|FG002|Overall Study|Too ill|0|||
149056580|NCT03492216|537689144|FG003|Overall Study|Too ill|0|||
149056581|NCT03492216|537689141|FG000|Overall Study|Incarcerated|0|||
149056582|NCT03492216|537689142|FG001|Overall Study|Incarcerated|0|||
149056583|NCT03492216|537689143|FG002|Overall Study|Incarcerated|2|||
149056584|NCT03492216|537689144|FG003|Overall Study|Incarcerated|0|||
149056585|NCT00736723|537689145|FG000|Overall Study|Withdrawal by Subject|4|||
149119373|NCT00275262|537916292|FG000|Overall Study|Protocol Violation|0|||
149056586|NCT00736723|537689146|FG001|Overall Study|Withdrawal by Subject|3|||
149056587|NCT01799265|537689149|FG000|Overall Study|Lost to Follow-up|1|||
149056588|NCT01799265|537689150|FG001|Overall Study|Lost to Follow-up|0|||
149056589|NCT01799265|537689149|FG000|Overall Study|Protocol Violation|2|||
149056590|NCT01799265|537689150|FG001|Overall Study|Protocol Violation|1|||
149056591|NCT01799265|537689149|FG000|Overall Study|inadequate sleep study|0|||
149056592|NCT01799265|537689150|FG001|Overall Study|inadequate sleep study|2|||
149056608|NCT05030233|537689157|FG000|Overall Study|withdrawn for transfer|1|||
149056609|NCT05030233|537689158|FG001|Overall Study|withdrawn for transfer|0|||
149056610|NCT03953508|537691199|FG000|Baseline|Lost to Follow-up|3|||
149056611|NCT03953508|537691200|FG001|Baseline|Lost to Follow-up|2|||
149056612|NCT03953508|537691199|FG000|6-month Follow-up|Lost to Follow-up|62|||
149056613|NCT03953508|537691200|FG001|6-month Follow-up|Lost to Follow-up|70|||
149056614|NCT02100813|537691201|FG000|Overall Study|Adverse Event|0|||
149005497|NCT03217747|537497902|FG010|Overall Study|Removal of sole target lesion|0|||
149005498|NCT03217747|537497903|FG011|Overall Study|Removal of sole target lesion|0|||
149005499|NCT03217747|537497904|FG012|Overall Study|Removal of sole target lesion|0|||
149005500|NCT03217747|537497905|FG013|Overall Study|Removal of sole target lesion|0|||
149005501|NCT03217747|537497892|FG000|Overall Study|Stroke|0|||
149005502|NCT03217747|537497893|FG001|Overall Study|Stroke|0|||
149005503|NCT03217747|537497894|FG002|Overall Study|Stroke|0|||
149005504|NCT03217747|537497895|FG003|Overall Study|Stroke|0|||
149005505|NCT03217747|537497896|FG004|Overall Study|Stroke|0|||
149005506|NCT03217747|537497897|FG005|Overall Study|Stroke|1|||
149005507|NCT03217747|537497898|FG006|Overall Study|Stroke|0|||
149005508|NCT03217747|537497899|FG007|Overall Study|Stroke|0|||
149056615|NCT02100813|537691202|FG001|Overall Study|Adverse Event|0|||
149056616|NCT02100813|537691203|FG002|Overall Study|Adverse Event|0|||
149056617|NCT02100813|537691204|FG003|Overall Study|Adverse Event|0|||
149056618|NCT02100813|537691205|FG004|Overall Study|Adverse Event|0|||
149056619|NCT02100813|537691206|FG005|Overall Study|Adverse Event|0|||
149056620|NCT02100813|537691207|FG006|Overall Study|Adverse Event|0|||
149056621|NCT02100813|537691208|FG007|Overall Study|Adverse Event|1|||
149056622|NCT00506519|537691210|FG000|Overall Study|Death|4|||
149056623|NCT00506519|537691211|FG001|Overall Study|Death|6|||
149056624|NCT00506519|537691212|FG002|Overall Study|Death|0|||
149056625|NCT00506519|537691210|FG000|Overall Study|Adverse Event|1|||
149056626|NCT00506519|537691211|FG001|Overall Study|Adverse Event|0|||
149056627|NCT00506519|537691212|FG002|Overall Study|Adverse Event|0|||
149056628|NCT02985957|537691215|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149056629|NCT02985957|537691216|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149056630|NCT02985957|537691217|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149056631|NCT02985957|537691218|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149056632|NCT02985957|537691219|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
149056633|NCT02985957|537691220|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149056634|NCT02985957|537691221|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
149056635|NCT02985957|537691215|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
149056636|NCT02985957|537691216|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
149056637|NCT02985957|537691217|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
149056638|NCT02985957|537691218|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
149056639|NCT02985957|537691219|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
149056640|NCT02985957|537691220|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
149056641|NCT02985957|537691221|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
149056642|NCT02985957|537691215|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149056643|NCT02985957|537691216|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149056644|NCT02985957|537691217|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149056645|NCT02985957|537691218|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149056646|NCT02985957|537691219|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149005509|NCT03217747|537497900|FG008|Overall Study|Stroke|0|||
149005510|NCT03217747|537497901|FG009|Overall Study|Stroke|0|||
149056647|NCT02985957|537691220|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
149056648|NCT02985957|537691221|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
149056649|NCT02985957|537691215|FG000|Treatment Period|Death|0|||
149056650|NCT02985957|537691216|FG001|Treatment Period|Death|0|||
149056651|NCT02985957|537691217|FG002|Treatment Period|Death|0|||
148889899|NCT05579977|537074496|FG007|Treatment Phase|Adverse Event|5|||
148889900|NCT05579977|537074497|FG008|Treatment Phase|Adverse Event|12|||
148889901|NCT05579977|537074498|FG009|Treatment Phase|Adverse Event|20|||
148889902|NCT05579977|537074499|FG010|Treatment Phase|Adverse Event|15|||
148889903|NCT05579977|537074500|FG011|Treatment Phase|Adverse Event|24|||
148889904|NCT05579977|537074501|FG012|Treatment Phase|Adverse Event|23|||
148889905|NCT05579977|537074489|FG000|Treatment Phase|Randomized not treated|0|||
148889906|NCT05579977|537074490|FG001|Treatment Phase|Randomized not treated|0|||
148889907|NCT05579977|537074491|FG002|Treatment Phase|Randomized not treated|0|||
148889908|NCT05579977|537074492|FG003|Treatment Phase|Randomized not treated|0|||
148889909|NCT05579977|537074493|FG004|Treatment Phase|Randomized not treated|1|||
148889910|NCT05579977|537074494|FG005|Treatment Phase|Randomized not treated|0|||
148889911|NCT05579977|537074495|FG006|Treatment Phase|Randomized not treated|0|||
148889912|NCT05579977|537074496|FG007|Treatment Phase|Randomized not treated|0|||
148889913|NCT05579977|537074497|FG008|Treatment Phase|Randomized not treated|0|||
148889914|NCT05579977|537074498|FG009|Treatment Phase|Randomized not treated|0|||
148889915|NCT05579977|537074499|FG010|Treatment Phase|Randomized not treated|0|||
148889916|NCT05579977|537074500|FG011|Treatment Phase|Randomized not treated|0|||
148889917|NCT05579977|537074501|FG012|Treatment Phase|Randomized not treated|0|||
149056652|NCT02985957|537691218|FG003|Treatment Period|Death|0|||
149056653|NCT02985957|537691219|FG004|Treatment Period|Death|1|||
149056654|NCT02985957|537691220|FG005|Treatment Period|Death|0|||
148889918|NCT05579977|537074489|FG000|Follow up|Death|1|||
148889919|NCT05579977|537074490|FG001|Follow up|Death|0|||
148889920|NCT05579977|537074491|FG002|Follow up|Death|0|||
148889921|NCT05579977|537074492|FG003|Follow up|Death|0|||
148889922|NCT05579977|537074493|FG004|Follow up|Death|0|||
148889923|NCT05579977|537074494|FG005|Follow up|Death|0|||
148889924|NCT05579977|537074495|FG006|Follow up|Death|0|||
148889925|NCT05579977|537074496|FG007|Follow up|Death|0|||
148889926|NCT05579977|537074497|FG008|Follow up|Death|0|||
148889927|NCT05579977|537074498|FG009|Follow up|Death|0|||
148889928|NCT05579977|537074499|FG010|Follow up|Death|0|||
148889929|NCT05579977|537074500|FG011|Follow up|Death|0|||
148889930|NCT05579977|537074501|FG012|Follow up|Death|0|||
148889931|NCT05579977|537074489|FG000|Follow up|Lost to Follow-up|0|||
148889932|NCT05579977|537074490|FG001|Follow up|Lost to Follow-up|0|||
148889933|NCT05579977|537074491|FG002|Follow up|Lost to Follow-up|0|||
148889934|NCT05579977|537074492|FG003|Follow up|Lost to Follow-up|1|||
148889935|NCT05579977|537074493|FG004|Follow up|Lost to Follow-up|1|||
148889936|NCT05579977|537074494|FG005|Follow up|Lost to Follow-up|2|||
148889937|NCT05579977|537074495|FG006|Follow up|Lost to Follow-up|1|||
148889938|NCT05579977|537074496|FG007|Follow up|Lost to Follow-up|1|||
148889939|NCT05579977|537074497|FG008|Follow up|Lost to Follow-up|3|||
148889940|NCT05579977|537074498|FG009|Follow up|Lost to Follow-up|2|||
148889941|NCT05579977|537074499|FG010|Follow up|Lost to Follow-up|2|||
148889942|NCT05579977|537074500|FG011|Follow up|Lost to Follow-up|4|||
148889943|NCT05579977|537074501|FG012|Follow up|Lost to Follow-up|4|||
148889944|NCT05579977|537074489|FG000|Follow up|Withdrawal by Subject|2|||
148889945|NCT05579977|537074490|FG001|Follow up|Withdrawal by Subject|0|||
148889946|NCT05579977|537074491|FG002|Follow up|Withdrawal by Subject|0|||
148889947|NCT05579977|537074492|FG003|Follow up|Withdrawal by Subject|0|||
148889948|NCT05579977|537074493|FG004|Follow up|Withdrawal by Subject|1|||
148889949|NCT05579977|537074494|FG005|Follow up|Withdrawal by Subject|0|||
148889950|NCT05579977|537074495|FG006|Follow up|Withdrawal by Subject|1|||
148889951|NCT05579977|537074496|FG007|Follow up|Withdrawal by Subject|4|||
148889952|NCT05579977|537074497|FG008|Follow up|Withdrawal by Subject|2|||
148889953|NCT05579977|537074498|FG009|Follow up|Withdrawal by Subject|3|||
148889954|NCT05579977|537074499|FG010|Follow up|Withdrawal by Subject|3|||
148889955|NCT05579977|537074500|FG011|Follow up|Withdrawal by Subject|1|||
148889956|NCT05579977|537074501|FG012|Follow up|Withdrawal by Subject|3|||
148889957|NCT01611194|537074503|FG000|Overall Study|Lost to Follow-up|0|||
148889958|NCT01611194|537074504|FG001|Overall Study|Lost to Follow-up|1|||
148889959|NCT01611194|537074503|FG000|Overall Study|Withdrawal by Subject|0|||
148889960|NCT01611194|537074504|FG001|Overall Study|Withdrawal by Subject|1|||
148889961|NCT01611194|537074503|FG000|Overall Study|drug use|0|||
148889962|NCT01611194|537074504|FG001|Overall Study|drug use|1|||
148889963|NCT00348673|537074506|FG000|Stage 1|Randomized but not Treated|0|||
148889964|NCT00348673|537074507|FG001|Stage 1|Randomized but not Treated|0|||
148889965|NCT00348673|537074508|FG002|Stage 1|Randomized but not Treated|1|||
148889966|NCT00348673|537074509|FG003|Stage 1|Randomized but not Treated|0|||
148889967|NCT00348673|537074510|FG004|Stage 1|Randomized but not Treated|0|||
148889968|NCT00348673|537074511|FG005|Stage 1|Randomized but not Treated|0|||
148889969|NCT00348673|537074512|FG006|Stage 1|Randomized but not Treated|0|||
148889970|NCT00348673|537074513|FG007|Stage 1|Randomized but not Treated|0|||
148889971|NCT00348673|537074514|FG008|Stage 1|Randomized but not Treated|0|||
149056655|NCT02985957|537691221|FG006|Treatment Period|Death|0|||
149056656|NCT02985957|537691215|FG000|Treatment Period|Participant withdrew consent|0|||
149056657|NCT02985957|537691216|FG001|Treatment Period|Participant withdrew consent|0|||
149056658|NCT02985957|537691217|FG002|Treatment Period|Participant withdrew consent|0|||
149056659|NCT02985957|537691218|FG003|Treatment Period|Participant withdrew consent|1|||
149056660|NCT02985957|537691219|FG004|Treatment Period|Participant withdrew consent|3|||
149056661|NCT02985957|537691220|FG005|Treatment Period|Participant withdrew consent|0|||
149056662|NCT02985957|537691221|FG006|Treatment Period|Participant withdrew consent|1|||
149056663|NCT02985957|537691215|FG000|Treatment Period|Lost to Follow-up|0|||
149056664|NCT02985957|537691216|FG001|Treatment Period|Lost to Follow-up|0|||
149056665|NCT02985957|537691217|FG002|Treatment Period|Lost to Follow-up|0|||
149056666|NCT02985957|537691218|FG003|Treatment Period|Lost to Follow-up|0|||
149056667|NCT02985957|537691219|FG004|Treatment Period|Lost to Follow-up|1|||
149056668|NCT02985957|537691220|FG005|Treatment Period|Lost to Follow-up|0|||
149056669|NCT02985957|537691221|FG006|Treatment Period|Lost to Follow-up|0|||
149056670|NCT02985957|537691215|FG000|Treatment Period|Other reasons|0|||
149056671|NCT02985957|537691216|FG001|Treatment Period|Other reasons|0|||
149056672|NCT02985957|537691217|FG002|Treatment Period|Other reasons|1|||
149056673|NCT02985957|537691218|FG003|Treatment Period|Other reasons|3|||
149056674|NCT02985957|537691219|FG004|Treatment Period|Other reasons|6|||
149056675|NCT02985957|537691220|FG005|Treatment Period|Other reasons|0|||
149056676|NCT02985957|537691221|FG006|Treatment Period|Other reasons|1|||
149056677|NCT02985957|537691215|FG000|Treatment Period|Not reported|0|||
149056678|NCT02985957|537691216|FG001|Treatment Period|Not reported|1|||
149056679|NCT02985957|537691217|FG002|Treatment Period|Not reported|2|||
149056680|NCT02985957|537691218|FG003|Treatment Period|Not reported|5|||
149056681|NCT02985957|537691219|FG004|Treatment Period|Not reported|0|||
149056682|NCT02985957|537691220|FG005|Treatment Period|Not reported|0|||
149056683|NCT02985957|537691221|FG006|Treatment Period|Not reported|0|||
149056684|NCT02985957|537691215|FG000|Treatment Period|Maximum clinical benefit|0|||
149056685|NCT02985957|537691216|FG001|Treatment Period|Maximum clinical benefit|0|||
149056686|NCT02985957|537691217|FG002|Treatment Period|Maximum clinical benefit|1|||
149056687|NCT02985957|537691218|FG003|Treatment Period|Maximum clinical benefit|1|||
149056688|NCT02985957|537691219|FG004|Treatment Period|Maximum clinical benefit|0|||
149056689|NCT02985957|537691220|FG005|Treatment Period|Maximum clinical benefit|0|||
149056690|NCT02985957|537691221|FG006|Treatment Period|Maximum clinical benefit|2|||
149056691|NCT02985957|537691215|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
149056692|NCT02985957|537691216|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
149056693|NCT02985957|537691217|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
149056694|NCT02985957|537691218|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
149056695|NCT02985957|537691219|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
149056696|NCT02985957|537691220|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
149056697|NCT02985957|537691221|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
149056698|NCT02985957|537691215|FG000|Treatment Period|Study drug toxicity|1|||
149056699|NCT02985957|537691216|FG001|Treatment Period|Study drug toxicity|23|||
149056700|NCT02985957|537691217|FG002|Treatment Period|Study drug toxicity|20|||
149056701|NCT02985957|537691218|FG003|Treatment Period|Study drug toxicity|11|||
149056702|NCT02985957|537691219|FG004|Treatment Period|Study drug toxicity|19|||
149056703|NCT02985957|537691220|FG005|Treatment Period|Study drug toxicity|3|||
149056704|NCT02985957|537691221|FG006|Treatment Period|Study drug toxicity|5|||
149056705|NCT02985957|537691215|FG000|Treatment Period|Disease progression|0|||
149056706|NCT02985957|537691216|FG001|Treatment Period|Disease progression|16|||
149056707|NCT02985957|537691217|FG002|Treatment Period|Disease progression|20|||
149056708|NCT02985957|537691218|FG003|Treatment Period|Disease progression|39|||
149056709|NCT02985957|537691219|FG004|Treatment Period|Disease progression|29|||
149056710|NCT02985957|537691220|FG005|Treatment Period|Disease progression|11|||
149056711|NCT02985957|537691221|FG006|Treatment Period|Disease progression|28|||
149056712|NCT02985957|537691215|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
149056713|NCT02985957|537691216|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
149056714|NCT02985957|537691217|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
149056715|NCT02985957|537691218|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
149056716|NCT02985957|537691219|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
149056717|NCT02985957|537691220|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
149056718|NCT02985957|537691221|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
149056719|NCT02985957|537691215|FG000|Treatment Period|Poor/Non-Compliance|0|||
149056720|NCT02985957|537691216|FG001|Treatment Period|Poor/Non-Compliance|0|||
149056721|NCT02985957|537691217|FG002|Treatment Period|Poor/Non-Compliance|0|||
149056722|NCT02985957|537691218|FG003|Treatment Period|Poor/Non-Compliance|0|||
149056723|NCT02985957|537691219|FG004|Treatment Period|Poor/Non-Compliance|1|||
149056724|NCT02985957|537691220|FG005|Treatment Period|Poor/Non-Compliance|1|||
149056725|NCT02985957|537691221|FG006|Treatment Period|Poor/Non-Compliance|0|||
149056726|NCT02985957|537691215|FG000|Treatment Period|Continuing in Treatment Period|0|||
149056727|NCT02985957|537691216|FG001|Treatment Period|Continuing in Treatment Period|1|||
149056728|NCT02985957|537691217|FG002|Treatment Period|Continuing in Treatment Period|0|||
149056729|NCT02985957|537691218|FG003|Treatment Period|Continuing in Treatment Period|4|||
149056730|NCT02985957|537691219|FG004|Treatment Period|Continuing in Treatment Period|4|||
149056731|NCT02985957|537691220|FG005|Treatment Period|Continuing in Treatment Period|0|||
149056732|NCT02985957|537691221|FG006|Treatment Period|Continuing in Treatment Period|0|||
149056733|NCT04342494|537691222|FG000|Overall Study|Questionnaire partially completed|1|||
149056734|NCT04342494|537691223|FG001|Overall Study|Questionnaire partially completed|0|||
149056735|NCT04342494|537691224|FG002|Overall Study|Questionnaire partially completed|2|||
149056736|NCT04342494|537691225|FG003|Overall Study|Questionnaire partially completed|0|||
149056737|NCT04342494|537691226|FG004|Overall Study|Questionnaire partially completed|1|||
149056738|NCT04342494|537691222|FG000|Overall Study|Lost to Follow-up|49|||
149056739|NCT04342494|537691223|FG001|Overall Study|Lost to Follow-up|38|||
149056740|NCT04342494|537691224|FG002|Overall Study|Lost to Follow-up|34|||
149056741|NCT04342494|537691225|FG003|Overall Study|Lost to Follow-up|34|||
149056742|NCT04342494|537691226|FG004|Overall Study|Lost to Follow-up|35|||
149056743|NCT05409183|537691228|FG000|Complete Study|Adverse Event|1|||
149056744|NCT05409183|537691229|FG001|Complete Study|Adverse Event|2|||
149056745|NCT05409183|537691228|FG000|Complete Study|Withdrawal by Subject|3|||
149056746|NCT05409183|537691229|FG001|Complete Study|Withdrawal by Subject|0|||
149056747|NCT04292223|537691232|FG000|Overall Study|Adverse Event|1|||
149056748|NCT04292223|537691232|FG000|Overall Study|Lost to Follow-up|1|||
149056749|NCT04292223|537691232|FG000|Overall Study|Noncompliance with study drug|2|||
149056750|NCT04292223|537691232|FG000|Overall Study|Patient moved out of the state|1|||
149056751|NCT00753545|537691233|FG000|Overall Study|Death|98|||
149056752|NCT00753545|537691234|FG001|Overall Study|Death|112|||
149056753|NCT00753545|537691233|FG000|Overall Study|Lost to Follow-up|2|||
149056754|NCT00753545|537691234|FG001|Overall Study|Lost to Follow-up|3|||
149056755|NCT00753545|537691233|FG000|Overall Study|Protocol Violation|1|||
149056756|NCT00753545|537691234|FG001|Overall Study|Protocol Violation|0|||
149056757|NCT00753545|537691233|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
149056758|NCT00753545|537691234|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
149056759|NCT02485938|537691235|FG000|Overall Study|Withdrawal of consent|2|||
149056760|NCT02485938|537691236|FG001|Overall Study|Withdrawal of consent|0|||
149056761|NCT04633122|537691237|FG000|Overall Study|Remained on treatment|19|||
149056762|NCT04633122|537691238|FG001|Overall Study|Remained on treatment|14|||
149056763|NCT04633122|537691237|FG000|Overall Study|Survival follow-up stopped|22|||
149056764|NCT04633122|537691238|FG001|Overall Study|Survival follow-up stopped|25|||
149056765|NCT04019873|537691239|FG000|Overall Study|Discontinued from the treatment|1|||
149056766|NCT04019873|537691240|FG001|Overall Study|Discontinued from the treatment|39|||
149056767|NCT04019873|537691241|FG002|Overall Study|Discontinued from the treatment|2|||
149056768|NCT01098812|537691243|FG000|Overall Study|Death|2|||
149056769|NCT01098812|537691244|FG001|Overall Study|Death|0|||
149056770|NCT01098812|537691245|FG002|Overall Study|Death|1|||
149056771|NCT01098812|537691243|FG000|Overall Study|Lost to Follow-up|0|||
149056772|NCT01098812|537691244|FG001|Overall Study|Lost to Follow-up|1|||
149056773|NCT01098812|537691245|FG002|Overall Study|Lost to Follow-up|0|||
149056774|NCT04908722|537691246|FG000|Overall Study|Protocol deviation|1|||
149056775|NCT04908722|537691247|FG001|Overall Study|Protocol deviation|0|||
149056776|NCT04908722|537691248|FG002|Overall Study|Protocol deviation|0|||
149056777|NCT04908722|537691249|FG003|Overall Study|Protocol deviation|0|||
149056778|NCT04908722|537691250|FG004|Overall Study|Protocol deviation|0|||
149056779|NCT04908722|537691251|FG005|Overall Study|Protocol deviation|1|||
149056780|NCT04908722|537691246|FG000|Overall Study|Lost to Follow-up|33|||
149056781|NCT04908722|537691247|FG001|Overall Study|Lost to Follow-up|33|||
149056782|NCT04908722|537691248|FG002|Overall Study|Lost to Follow-up|36|||
149056783|NCT04908722|537691249|FG003|Overall Study|Lost to Follow-up|30|||
149056784|NCT04908722|537691250|FG004|Overall Study|Lost to Follow-up|32|||
149056785|NCT04908722|537691251|FG005|Overall Study|Lost to Follow-up|34|||
149056786|NCT04908722|537691246|FG000|Overall Study|Physician Decision|1|||
149056787|NCT04908722|537691247|FG001|Overall Study|Physician Decision|1|||
149056788|NCT04908722|537691248|FG002|Overall Study|Physician Decision|1|||
149056789|NCT04908722|537691249|FG003|Overall Study|Physician Decision|2|||
149056790|NCT04908722|537691250|FG004|Overall Study|Physician Decision|0|||
149056791|NCT04908722|537691251|FG005|Overall Study|Physician Decision|0|||
149056792|NCT04908722|537691246|FG000|Overall Study|Death|1|||
149056793|NCT04908722|537691247|FG001|Overall Study|Death|0|||
149056794|NCT04908722|537691248|FG002|Overall Study|Death|0|||
149056795|NCT04908722|537691249|FG003|Overall Study|Death|0|||
149056796|NCT04908722|537691250|FG004|Overall Study|Death|0|||
149056797|NCT04908722|537691251|FG005|Overall Study|Death|1|||
149056798|NCT04908722|537691246|FG000|Overall Study|Withdrawal by Subject|12|||
149056799|NCT04908722|537691247|FG001|Overall Study|Withdrawal by Subject|8|||
149056800|NCT04908722|537691248|FG002|Overall Study|Withdrawal by Subject|7|||
149056801|NCT04908722|537691249|FG003|Overall Study|Withdrawal by Subject|6|||
149056802|NCT04908722|537691250|FG004|Overall Study|Withdrawal by Subject|12|||
149056803|NCT04908722|537691251|FG005|Overall Study|Withdrawal by Subject|14|||
149056804|NCT04908722|537691246|FG000|Overall Study|Other|3|||
149056805|NCT04908722|537691247|FG001|Overall Study|Other|1|||
149056806|NCT04908722|537691248|FG002|Overall Study|Other|3|||
149056807|NCT04908722|537691249|FG003|Overall Study|Other|2|||
149056808|NCT04908722|537691250|FG004|Overall Study|Other|4|||
149056809|NCT04908722|537691251|FG005|Overall Study|Other|1|||
149056810|NCT04908722|537691246|FG000|Overall Study|Initiated prohibited medication|0|||
149056811|NCT04908722|537691247|FG001|Overall Study|Initiated prohibited medication|0|||
149056812|NCT04908722|537691248|FG002|Overall Study|Initiated prohibited medication|0|||
149056813|NCT04908722|537691249|FG003|Overall Study|Initiated prohibited medication|1|||
149056814|NCT04908722|537691250|FG004|Overall Study|Initiated prohibited medication|0|||
149056815|NCT04908722|537691251|FG005|Overall Study|Initiated prohibited medication|1|||
149056816|NCT04908722|537691246|FG000|Overall Study|Randomized but not vaccinated|3|||
149056817|NCT04908722|537691247|FG001|Overall Study|Randomized but not vaccinated|1|||
149056818|NCT04908722|537691248|FG002|Overall Study|Randomized but not vaccinated|2|||
149056819|NCT04908722|537691249|FG003|Overall Study|Randomized but not vaccinated|2|||
149056820|NCT04908722|537691250|FG004|Overall Study|Randomized but not vaccinated|3|||
149056821|NCT04908722|537691251|FG005|Overall Study|Randomized but not vaccinated|4|||
149056822|NCT03339713|537691254|FG000|Overall Study|Lost to Follow-up|2|||
149056823|NCT03339713|537691255|FG001|Overall Study|Lost to Follow-up|1|||
149056824|NCT03339713|537691254|FG000|Overall Study|Protocol Violation|1|||
149056825|NCT03339713|537691255|FG001|Overall Study|Protocol Violation|0|||
149056826|NCT03339713|537691254|FG000|Overall Study|Withdrawal by Subject|1|||
149056827|NCT03339713|537691255|FG001|Overall Study|Withdrawal by Subject|1|||
149056828|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
149056829|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
149056830|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
149056831|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
149056832|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
149056833|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
149056834|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
149056835|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
149056836|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
149056837|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
149056838|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
149056839|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
149056840|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
149056841|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
149056842|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
149056843|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
149056844|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
149056845|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
149056846|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
149056847|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
149056848|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
149056849|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
149056850|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
149056851|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
149056852|NCT01715285|537691258|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
149056853|NCT01715285|537691259|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
149056854|NCT01715285|537691260|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
149056855|NCT01715285|537691258|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
149056856|NCT01715285|537691259|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
149056857|NCT01715285|537691260|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
149056858|NCT01715285|537691258|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
149056859|NCT01715285|537691259|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
149056860|NCT01715285|537691260|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
149056861|NCT01715285|537691258|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
149056862|NCT01715285|537691259|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
149056863|NCT01715285|537691260|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
149056864|NCT01715285|537691258|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
149056865|NCT01715285|537691259|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
149056866|NCT01715285|537691260|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
149056867|NCT01715285|537691258|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
149056868|NCT01715285|537691259|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
149056869|NCT01715285|537691260|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
149056870|NCT05780437|537691261|FG000|Overall Study|Withdrawal by Subject|22|||
149056871|NCT05780437|537691262|FG001|Overall Study|Withdrawal by Subject|16|||
149056872|NCT04858321|537691263|FG000|Overall Study|Withdrawal by Subject|3|||
149056873|NCT03092518|537691265|FG000|Overall Study|Ineligible|2|||
148889972|NCT01712204|537074516|FG000|Overall Study|Adverse Event|3|||
148889973|NCT01712204|537074517|FG001|Overall Study|Adverse Event|1|||
149056874|NCT02146378|537691266|FG000|Overall Study|No information of administration|2|||
149056875|NCT04973254|537691275|FG000|Overall Study|Not adherent|0|||
149056876|NCT04973254|537691276|FG001|Overall Study|Not adherent|1|||
149056877|NCT04973254|537691277|FG002|Overall Study|Not adherent|0|||
149056878|NCT05089019|537691281|FG000|Period 1|Withdrawal by Subject|0|||
149056879|NCT05089019|537691282|FG001|Period 1|Withdrawal by Subject|1|||
149056880|NCT05089019|537691281|FG000|Washout Period|Adverse Event|3|||
149056881|NCT05089019|537691282|FG001|Washout Period|Adverse Event|4|||
149056882|NCT05089019|537691281|FG000|Washout Period|Lost to Follow-up|1|||
149056883|NCT05089019|537691282|FG001|Washout Period|Lost to Follow-up|0|||
149056884|NCT05089019|537691281|FG000|Washout Period|Physician Decision|2|||
149056885|NCT05089019|537691282|FG001|Washout Period|Physician Decision|0|||
149056886|NCT05089019|537691281|FG000|Washout Period|Withdrawal by Subject|6|||
149056887|NCT05089019|537691282|FG001|Washout Period|Withdrawal by Subject|3|||
149056888|NCT05089019|537691281|FG000|Period 2|Adverse Event|4|||
149056889|NCT05089019|537691282|FG001|Period 2|Adverse Event|2|||
149056890|NCT05089019|537691281|FG000|Period 2|Lost to Follow-up|1|||
149056891|NCT05089019|537691282|FG001|Period 2|Lost to Follow-up|0|||
149056892|NCT05089019|537691281|FG000|Period 2|Withdrawal by Subject|0|||
149056893|NCT05089019|537691282|FG001|Period 2|Withdrawal by Subject|1|||
149056894|NCT05170009|537691283|FG000|Overall Study|Physician Decision|0|||
149056895|NCT05170009|537691284|FG001|Overall Study|Physician Decision|1|||
149056896|NCT04925986|537691285|FG000|Overall Study|Death|0|||
149056897|NCT04925986|537691286|FG001|Overall Study|Death|0|||
149056898|NCT04925986|537691287|FG002|Overall Study|Death|2|||
149056899|NCT04925986|537691288|FG003|Overall Study|Death|0|||
149056900|NCT04925986|537691285|FG000|Overall Study|Lack of Efficacy|1|||
149056901|NCT04925986|537691286|FG001|Overall Study|Lack of Efficacy|2|||
149056902|NCT04925986|537691287|FG002|Overall Study|Lack of Efficacy|0|||
149056903|NCT04925986|537691288|FG003|Overall Study|Lack of Efficacy|1|||
149056904|NCT04925986|537691285|FG000|Overall Study|Withdrawal by Subject|0|||
149056905|NCT04925986|537691286|FG001|Overall Study|Withdrawal by Subject|0|||
149056906|NCT04925986|537691287|FG002|Overall Study|Withdrawal by Subject|1|||
149056907|NCT04925986|537691288|FG003|Overall Study|Withdrawal by Subject|2|||
149056908|NCT04629716|537691290|FG000|Overall Study|Lost to Follow-up|7|||
149056909|NCT04629716|537691291|FG001|Overall Study|Lost to Follow-up|3|||
149056910|NCT04770532|537691292|FG000|Overall Study|Withdrawal by Subject|0|||
149056911|NCT04770532|537691293|FG001|Overall Study|Withdrawal by Subject|3|||
149056912|NCT04770532|537691292|FG000|Overall Study|Physician Decision|1|||
149056913|NCT04770532|537691293|FG001|Overall Study|Physician Decision|0|||
149056914|NCT04770532|537691292|FG000|Overall Study|Death|2|||
149056915|NCT04770532|537691293|FG001|Overall Study|Death|2|||
149056916|NCT05457647|537691294|FG000|Overall Study|Lost to Follow-up|3|||
149056917|NCT04938492|537691295|FG000|Overall Study|Lost to Follow-up|17|||
149056918|NCT04938492|537691296|FG001|Overall Study|Lost to Follow-up|18|||
149056919|NCT04623671|537691299|FG000|Overall Study|Adverse Event|0|||
149056920|NCT04623671|537691300|FG001|Overall Study|Adverse Event|1|||
149056921|NCT04623671|537691299|FG000|Overall Study|Lost to Follow-up|2|||
149056922|NCT04623671|537691300|FG001|Overall Study|Lost to Follow-up|1|||
149056923|NCT04623671|537691299|FG000|Overall Study|Death|5|||
149056924|NCT04623671|537691300|FG001|Overall Study|Death|5|||
149056925|NCT03448107|537691301|FG000|Overall Study|Lost to Follow-up|229|||
149056926|NCT03448107|537691302|FG001|Overall Study|Lost to Follow-up|258|||
149056927|NCT04025554|537691303|FG000|Overall Study|Adverse Event|3|||
149056928|NCT03115476|537691304|FG000|LP0084-1369|Death|1|||
148889974|NCT01712204|537074516|FG000|Overall Study|Withdrawal by Subject|3|||
148889975|NCT01712204|537074517|FG001|Overall Study|Withdrawal by Subject|3|||
148889976|NCT01712204|537074516|FG000|Overall Study|Lost to Follow-up|1|||
148889977|NCT01712204|537074517|FG001|Overall Study|Lost to Follow-up|0|||
149056929|NCT03115476|537691305|FG001|LP0084-1369|Death|0|||
149056930|NCT03115476|537691306|FG002|LP0084-1369|Death|2|||
149056931|NCT03115476|537691304|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
149056932|NCT03115476|537691305|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
149056933|NCT03115476|537691306|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
149056934|NCT05257486|537691310|FG000|Overall Study|Protocol Violation|3|||
148889978|NCT01712204|537074516|FG000|Overall Study|Protocol Violation|1|||
149056935|NCT02310646|537691311|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
149056936|NCT02310646|537691312|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
149056937|NCT02310646|537691311|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
149056938|NCT02310646|537691312|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
148889979|NCT01712204|537074517|FG001|Overall Study|Protocol Violation|1|||
149056939|NCT04700163|537691313|FG000|Overall Study|Lost to Follow-up|0|||
149056940|NCT04700163|537691314|FG001|Overall Study|Lost to Follow-up|0|||
149056941|NCT04700163|537691315|FG002|Overall Study|Lost to Follow-up|0|||
148889980|NCT02360228|537074518|FG000|Overall Study|Withdrawal by Subject|1|||
149056942|NCT04700163|537691316|FG003|Overall Study|Lost to Follow-up|0|||
149056943|NCT04700163|537691317|FG004|Overall Study|Lost to Follow-up|0|||
149056944|NCT04700163|537691318|FG005|Overall Study|Lost to Follow-up|1|||
149056945|NCT00613106|537691319|FG000|Overall Study|Adverse Event|3|||
149056946|NCT00613106|537691320|FG001|Overall Study|Adverse Event|1|||
149056947|NCT00613106|537691319|FG000|Overall Study|Withdrawal by Subject|6|||
149056948|NCT00613106|537691320|FG001|Overall Study|Withdrawal by Subject|3|||
149056949|NCT00613106|537691319|FG000|Overall Study|Lost to Follow-up|7|||
149056950|NCT00613106|537691320|FG001|Overall Study|Lost to Follow-up|2|||
149056951|NCT00613106|537691319|FG000|Overall Study|misc|4|||
149056952|NCT00613106|537691320|FG001|Overall Study|misc|3|||
149056953|NCT05543629|537691321|FG000|Overall Study|Death|1|||
149056954|NCT05543629|537691322|FG001|Overall Study|Death|0|||
149056955|NCT05543629|537691323|FG002|Overall Study|Death|1|||
149056956|NCT05543629|537691324|FG003|Overall Study|Death|0|||
149056957|NCT05543629|537691325|FG004|Overall Study|Death|0|||
149056958|NCT05543629|537691326|FG005|Overall Study|Death|1|||
149056959|NCT05543629|537691327|FG006|Overall Study|Death|2|||
149056960|NCT05543629|537691328|FG007|Overall Study|Death|2|||
149056961|NCT05543629|537691321|FG000|Overall Study|Other Reasons|0|||
149056962|NCT05543629|537691322|FG001|Overall Study|Other Reasons|0|||
149056963|NCT05543629|537691323|FG002|Overall Study|Other Reasons|0|||
149056964|NCT05543629|537691324|FG003|Overall Study|Other Reasons|0|||
149056965|NCT05543629|537691325|FG004|Overall Study|Other Reasons|1|||
149056966|NCT05543629|537691326|FG005|Overall Study|Other Reasons|0|||
149056967|NCT05543629|537691327|FG006|Overall Study|Other Reasons|0|||
149056968|NCT05543629|537691328|FG007|Overall Study|Other Reasons|0|||
149056969|NCT05543629|537691321|FG000|Overall Study|Physician Decision|0|||
148889981|NCT02360228|537074519|FG001|Overall Study|Withdrawal by Subject|0|||
148889982|NCT02360228|537074520|FG002|Overall Study|Withdrawal by Subject|0|||
148889983|NCT02360228|537074518|FG000|Overall Study|Self-discontinued medication|0|||
148889984|NCT02360228|537074519|FG001|Overall Study|Self-discontinued medication|1|||
148889985|NCT02360228|537074520|FG002|Overall Study|Self-discontinued medication|0|||
148889986|NCT02360228|537074518|FG000|Overall Study|Unstable symptoms during screening|0|||
148889987|NCT02360228|537074519|FG001|Overall Study|Unstable symptoms during screening|0|||
148889988|NCT02360228|537074520|FG002|Overall Study|Unstable symptoms during screening|1|||
148889989|NCT02464410|537074521|FG000|Overall Study|Death|3|||
148889990|NCT02464410|537074522|FG001|Overall Study|Death|4|||
148889991|NCT02464410|537074521|FG000|Overall Study|Lost to Follow-up|7|||
148889992|NCT02464410|537074522|FG001|Overall Study|Lost to Follow-up|9|||
148889993|NCT02464410|537074521|FG000|Overall Study|Withdrawal by Subject|12|||
148889994|NCT02464410|537074522|FG001|Overall Study|Withdrawal by Subject|3|||
148889995|NCT02679287|537074523|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
148889996|NCT02679287|537074524|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
148889997|NCT02679287|537074523|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
148889998|NCT02679287|537074524|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
148889999|NCT02679287|537074523|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
148890000|NCT02679287|537074524|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
148890001|NCT02679287|537074523|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
148890002|NCT02679287|537074524|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
148890003|NCT02679287|537074523|FG000|Period 2|Work/Scheduling Conflict|1|||
148890004|NCT02679287|537074524|FG001|Period 2|Work/Scheduling Conflict|0|||
148890005|NCT02679287|537074523|FG000|Period 2|Disliked Mobile System|2|||
149056970|NCT05543629|537691322|FG001|Overall Study|Physician Decision|0|||
149056971|NCT05543629|537691323|FG002|Overall Study|Physician Decision|3|||
149056972|NCT05543629|537691324|FG003|Overall Study|Physician Decision|0|||
149056973|NCT05543629|537691325|FG004|Overall Study|Physician Decision|0|||
149056974|NCT05543629|537691326|FG005|Overall Study|Physician Decision|0|||
149056975|NCT05543629|537691327|FG006|Overall Study|Physician Decision|1|||
149056976|NCT05543629|537691328|FG007|Overall Study|Physician Decision|0|||
149056977|NCT05543629|537691321|FG000|Overall Study|Study terminated by Sponsor|1|||
149056978|NCT05543629|537691322|FG001|Overall Study|Study terminated by Sponsor|0|||
149056979|NCT05543629|537691323|FG002|Overall Study|Study terminated by Sponsor|0|||
149056980|NCT05543629|537691324|FG003|Overall Study|Study terminated by Sponsor|1|||
149056981|NCT05543629|537691325|FG004|Overall Study|Study terminated by Sponsor|0|||
149056982|NCT05543629|537691326|FG005|Overall Study|Study terminated by Sponsor|4|||
149056983|NCT05543629|537691327|FG006|Overall Study|Study terminated by Sponsor|1|||
149056984|NCT05543629|537691328|FG007|Overall Study|Study terminated by Sponsor|0|||
149056985|NCT05543629|537691321|FG000|Overall Study|Withdrawal by Subject|1|||
149056986|NCT05543629|537691322|FG001|Overall Study|Withdrawal by Subject|1|||
149056987|NCT05543629|537691323|FG002|Overall Study|Withdrawal by Subject|0|||
149056988|NCT05543629|537691324|FG003|Overall Study|Withdrawal by Subject|2|||
149056989|NCT05543629|537691325|FG004|Overall Study|Withdrawal by Subject|1|||
149056990|NCT05543629|537691326|FG005|Overall Study|Withdrawal by Subject|1|||
149056991|NCT05543629|537691327|FG006|Overall Study|Withdrawal by Subject|1|||
149056992|NCT05543629|537691328|FG007|Overall Study|Withdrawal by Subject|1|||
148890006|NCT02679287|537074524|FG001|Period 2|Disliked Mobile System|0|||
148890007|NCT02679287|537074523|FG000|Period 3|Work/Scheduling Conflict|0|||
149056993|NCT05543629|537691321|FG000|Overall Study|Not Reported|2|||
149056994|NCT05543629|537691322|FG001|Overall Study|Not Reported|2|||
149056995|NCT05543629|537691323|FG002|Overall Study|Not Reported|0|||
149056996|NCT05543629|537691324|FG003|Overall Study|Not Reported|0|||
149056997|NCT05543629|537691325|FG004|Overall Study|Not Reported|1|||
149056998|NCT05543629|537691326|FG005|Overall Study|Not Reported|1|||
149056999|NCT05543629|537691327|FG006|Overall Study|Not Reported|3|||
149057000|NCT05543629|537691328|FG007|Overall Study|Not Reported|0|||
149057001|NCT03313076|537691329|FG000|Overall Study|Withdrawal by Subject|2|||
149057002|NCT03313076|537691330|FG001|Overall Study|Withdrawal by Subject|0|||
149057003|NCT03313076|537691331|FG002|Overall Study|Withdrawal by Subject|0|||
149057004|NCT03313076|537691332|FG003|Overall Study|Withdrawal by Subject|0|||
149057005|NCT03313076|537691329|FG000|Overall Study|Lost to Follow-up|0|||
149057006|NCT03313076|537691330|FG001|Overall Study|Lost to Follow-up|2|||
149057007|NCT03313076|537691331|FG002|Overall Study|Lost to Follow-up|2|||
149057008|NCT03313076|537691332|FG003|Overall Study|Lost to Follow-up|2|||
149057009|NCT05869383|537691333|FG000|Overall Study|Withdrawal by Subject|2|||
149057010|NCT05869383|537691334|FG001|Overall Study|Withdrawal by Subject|0|||
149057011|NCT04307355|537691339|FG000|Overall Study|Non-Compliance|3|||
149057012|NCT04307355|537691340|FG001|Overall Study|Non-Compliance|3|||
149057013|NCT04307355|537691341|FG002|Overall Study|Non-Compliance|0|||
149057014|NCT04065841|537691342|FG000|Overall Study|Adverse Event|4|||
149057015|NCT04065841|537691343|FG001|Overall Study|Adverse Event|2|||
149057016|NCT04065841|537691344|FG002|Overall Study|Adverse Event|10|||
149057017|NCT04065841|537691345|FG003|Overall Study|Adverse Event|1|||
149057018|NCT04065841|537691342|FG000|Overall Study|Lost to Follow-up|1|||
149057019|NCT04065841|537691343|FG001|Overall Study|Lost to Follow-up|2|||
149057020|NCT04065841|537691344|FG002|Overall Study|Lost to Follow-up|2|||
149057021|NCT04065841|537691345|FG003|Overall Study|Lost to Follow-up|2|||
149057022|NCT04065841|537691342|FG000|Overall Study|Physician Decision|1|||
149057023|NCT04065841|537691343|FG001|Overall Study|Physician Decision|0|||
149057024|NCT04065841|537691344|FG002|Overall Study|Physician Decision|0|||
149057025|NCT04065841|537691345|FG003|Overall Study|Physician Decision|0|||
149057026|NCT04065841|537691342|FG000|Overall Study|Protocol Violation|0|||
149057027|NCT04065841|537691343|FG001|Overall Study|Protocol Violation|1|||
149057028|NCT04065841|537691344|FG002|Overall Study|Protocol Violation|0|||
149057029|NCT04065841|537691345|FG003|Overall Study|Protocol Violation|0|||
149057030|NCT04065841|537691342|FG000|Overall Study|Study terminated by Sponsor|22|||
149057031|NCT04065841|537691343|FG001|Overall Study|Study terminated by Sponsor|16|||
149057032|NCT04065841|537691344|FG002|Overall Study|Study terminated by Sponsor|28|||
149057033|NCT04065841|537691345|FG003|Overall Study|Study terminated by Sponsor|17|||
149057034|NCT04065841|537691342|FG000|Overall Study|Withdrawal by Subject|1|||
149057035|NCT04065841|537691343|FG001|Overall Study|Withdrawal by Subject|1|||
149057036|NCT04065841|537691344|FG002|Overall Study|Withdrawal by Subject|2|||
149057037|NCT04065841|537691345|FG003|Overall Study|Withdrawal by Subject|0|||
149057038|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
149057039|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
149057040|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
149057041|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
149057042|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
149057043|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
149057044|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
149057045|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
149057046|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
149057047|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
149057048|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
149057049|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
149057050|NCT04338061|537691348|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
149057051|NCT04338061|537691349|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
149057052|NCT04338061|537691348|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
149057053|NCT04338061|537691349|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
149057054|NCT04338061|537691348|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
149057055|NCT04338061|537691349|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
149057056|NCT04338061|537691348|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
149057057|NCT04338061|537691349|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
149057058|NCT04338061|537691348|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
149057059|NCT04338061|537691349|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
149057060|NCT04338061|537691348|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
149057061|NCT04338061|537691349|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
149057062|NCT04074759|537691350|FG000|Overall Study|Withdrawal by Subject|0|||
149057063|NCT04074759|537691351|FG001|Overall Study|Withdrawal by Subject|0|||
149057064|NCT04074759|537691352|FG002|Overall Study|Withdrawal by Subject|0|||
149057065|NCT04074759|537691353|FG003|Overall Study|Withdrawal by Subject|0|||
149057066|NCT04074759|537691354|FG004|Overall Study|Withdrawal by Subject|0|||
149057067|NCT04074759|537691355|FG005|Overall Study|Withdrawal by Subject|2|||
149057068|NCT04074759|537691356|FG006|Overall Study|Withdrawal by Subject|0|||
149057069|NCT04074759|537691357|FG007|Overall Study|Withdrawal by Subject|2|||
149057070|NCT04074759|537691358|FG008|Overall Study|Withdrawal by Subject|1|||
149057071|NCT04074759|537691359|FG009|Overall Study|Withdrawal by Subject|2|||
149057072|NCT04074759|537691360|FG010|Overall Study|Withdrawal by Subject|9|||
149057073|NCT04074759|537691361|FG011|Overall Study|Withdrawal by Subject|2|||
149057074|NCT04074759|537691362|FG012|Overall Study|Withdrawal by Subject|1|||
149057075|NCT04074759|537691363|FG013|Overall Study|Withdrawal by Subject|3|||
149057076|NCT04074759|537691364|FG014|Overall Study|Withdrawal by Subject|2|||
149057077|NCT04074759|537691365|FG015|Overall Study|Withdrawal by Subject|0|||
149057078|NCT04074759|537691366|FG016|Overall Study|Withdrawal by Subject|0|||
149057079|NCT04074759|537691367|FG017|Overall Study|Withdrawal by Subject|3|||
149057080|NCT04074759|537691368|FG018|Overall Study|Withdrawal by Subject|1|||
149057081|NCT04074759|537691350|FG000|Overall Study|Death|1|||
149057082|NCT04074759|537691351|FG001|Overall Study|Death|0|||
149057083|NCT04074759|537691352|FG002|Overall Study|Death|1|||
149057084|NCT04074759|537691353|FG003|Overall Study|Death|1|||
149057085|NCT04074759|537691354|FG004|Overall Study|Death|2|||
149057086|NCT04074759|537691355|FG005|Overall Study|Death|0|||
149057087|NCT04074759|537691356|FG006|Overall Study|Death|1|||
149057088|NCT04074759|537691357|FG007|Overall Study|Death|0|||
149057089|NCT04074759|537691358|FG008|Overall Study|Death|3|||
149057090|NCT04074759|537691359|FG009|Overall Study|Death|2|||
149057091|NCT04074759|537691360|FG010|Overall Study|Death|4|||
149057092|NCT04074759|537691361|FG011|Overall Study|Death|1|||
149057093|NCT04074759|537691362|FG012|Overall Study|Death|0|||
149057094|NCT04074759|537691363|FG013|Overall Study|Death|2|||
149057095|NCT04074759|537691364|FG014|Overall Study|Death|1|||
149057096|NCT04074759|537691365|FG015|Overall Study|Death|0|||
149057097|NCT04074759|537691366|FG016|Overall Study|Death|1|||
149057098|NCT04074759|537691367|FG017|Overall Study|Death|0|||
149057099|NCT04074759|537691368|FG018|Overall Study|Death|1|||
149057100|NCT04074759|537691350|FG000|Overall Study|Lost to Follow-up|0|||
149057101|NCT04074759|537691351|FG001|Overall Study|Lost to Follow-up|0|||
149057102|NCT04074759|537691352|FG002|Overall Study|Lost to Follow-up|0|||
149057103|NCT04074759|537691353|FG003|Overall Study|Lost to Follow-up|0|||
149057104|NCT04074759|537691354|FG004|Overall Study|Lost to Follow-up|0|||
149057105|NCT04074759|537691355|FG005|Overall Study|Lost to Follow-up|0|||
149057106|NCT04074759|537691356|FG006|Overall Study|Lost to Follow-up|0|||
149057107|NCT04074759|537691357|FG007|Overall Study|Lost to Follow-up|0|||
149057108|NCT04074759|537691358|FG008|Overall Study|Lost to Follow-up|0|||
149057109|NCT04074759|537691359|FG009|Overall Study|Lost to Follow-up|0|||
149057110|NCT04074759|537691360|FG010|Overall Study|Lost to Follow-up|1|||
149057111|NCT04074759|537691361|FG011|Overall Study|Lost to Follow-up|0|||
149057112|NCT04074759|537691362|FG012|Overall Study|Lost to Follow-up|0|||
149057113|NCT04074759|537691363|FG013|Overall Study|Lost to Follow-up|0|||
149057114|NCT04074759|537691364|FG014|Overall Study|Lost to Follow-up|0|||
149057115|NCT04074759|537691365|FG015|Overall Study|Lost to Follow-up|0|||
149057116|NCT04074759|537691366|FG016|Overall Study|Lost to Follow-up|1|||
149057117|NCT04074759|537691367|FG017|Overall Study|Lost to Follow-up|0|||
149057118|NCT04074759|537691368|FG018|Overall Study|Lost to Follow-up|1|||
149057119|NCT04074759|537691350|FG000|Overall Study|Other|0|||
149057120|NCT04074759|537691351|FG001|Overall Study|Other|1|||
149057121|NCT04074759|537691352|FG002|Overall Study|Other|1|||
149057122|NCT04074759|537691353|FG003|Overall Study|Other|0|||
149057123|NCT04074759|537691354|FG004|Overall Study|Other|2|||
149057124|NCT04074759|537691355|FG005|Overall Study|Other|1|||
149057125|NCT04074759|537691356|FG006|Overall Study|Other|2|||
149057126|NCT04074759|537691357|FG007|Overall Study|Other|1|||
149057127|NCT04074759|537691358|FG008|Overall Study|Other|1|||
149057128|NCT04074759|537691359|FG009|Overall Study|Other|4|||
149057129|NCT04074759|537691360|FG010|Overall Study|Other|4|||
149057130|NCT04074759|537691361|FG011|Overall Study|Other|2|||
149057131|NCT04074759|537691362|FG012|Overall Study|Other|0|||
149057132|NCT04074759|537691363|FG013|Overall Study|Other|0|||
149057133|NCT04074759|537691364|FG014|Overall Study|Other|0|||
149057134|NCT04074759|537691365|FG015|Overall Study|Other|1|||
149057135|NCT04074759|537691366|FG016|Overall Study|Other|0|||
149057136|NCT04074759|537691367|FG017|Overall Study|Other|0|||
149057137|NCT04074759|537691368|FG018|Overall Study|Other|0|||
149057138|NCT04074759|537691350|FG000|Overall Study|Missing end of study status|0|||
149057139|NCT04074759|537691351|FG001|Overall Study|Missing end of study status|0|||
149057140|NCT04074759|537691352|FG002|Overall Study|Missing end of study status|0|||
149057141|NCT04074759|537691353|FG003|Overall Study|Missing end of study status|0|||
149057142|NCT04074759|537691354|FG004|Overall Study|Missing end of study status|0|||
149057143|NCT04074759|537691355|FG005|Overall Study|Missing end of study status|0|||
149057144|NCT04074759|537691356|FG006|Overall Study|Missing end of study status|0|||
149057145|NCT04074759|537691357|FG007|Overall Study|Missing end of study status|0|||
149057146|NCT04074759|537691358|FG008|Overall Study|Missing end of study status|0|||
149057147|NCT04074759|537691359|FG009|Overall Study|Missing end of study status|0|||
149057148|NCT04074759|537691360|FG010|Overall Study|Missing end of study status|2|||
149057149|NCT04074759|537691361|FG011|Overall Study|Missing end of study status|0|||
149057150|NCT04074759|537691362|FG012|Overall Study|Missing end of study status|0|||
149057151|NCT04074759|537691363|FG013|Overall Study|Missing end of study status|0|||
149057152|NCT04074759|537691364|FG014|Overall Study|Missing end of study status|0|||
149057153|NCT04074759|537691365|FG015|Overall Study|Missing end of study status|0|||
149057154|NCT04074759|537691366|FG016|Overall Study|Missing end of study status|1|||
149057155|NCT04074759|537691367|FG017|Overall Study|Missing end of study status|0|||
149057156|NCT04074759|537691368|FG018|Overall Study|Missing end of study status|0|||
149057157|NCT03631784|537691369|FG000|Overall Study|Participants Ongoing|1|||
149057158|NCT03631784|537691370|FG001|Overall Study|Participants Ongoing|0|||
149057159|NCT03631784|537691369|FG000|Overall Study|Withdrawal by Subject|3|||
149057160|NCT03631784|537691370|FG001|Overall Study|Withdrawal by Subject|3|||
149057161|NCT03631784|537691369|FG000|Overall Study|Sponsor's Decision|36|||
149057162|NCT03631784|537691370|FG001|Overall Study|Sponsor's Decision|52|||
149057163|NCT03631784|537691369|FG000|Overall Study|Lost to Follow-up|1|||
149057164|NCT03631784|537691370|FG001|Overall Study|Lost to Follow-up|0|||
149057165|NCT03631784|537691369|FG000|Overall Study|Death|71|||
149057166|NCT03631784|537691370|FG001|Overall Study|Death|49|||
149057167|NCT05329220|537691371|FG000|Active Trial Period|Adverse Event|0|||
149057168|NCT05329220|537691372|FG001|Active Trial Period|Adverse Event|0|||
149057169|NCT05329220|537691373|FG002|Active Trial Period|Adverse Event|0|||
149057170|NCT05329220|537691374|FG003|Active Trial Period|Adverse Event|0|||
149057171|NCT05329220|537691375|FG004|Active Trial Period|Adverse Event|1|||
149057172|NCT05329220|537691376|FG005|Active Trial Period|Adverse Event|0|||
149057173|NCT05329220|537691371|FG000|Active Trial Period|Lost to Follow-up|0|||
149057174|NCT05329220|537691372|FG001|Active Trial Period|Lost to Follow-up|0|||
149057175|NCT05329220|537691373|FG002|Active Trial Period|Lost to Follow-up|0|||
149057176|NCT05329220|537691374|FG003|Active Trial Period|Lost to Follow-up|0|||
149057177|NCT05329220|537691375|FG004|Active Trial Period|Lost to Follow-up|32|||
149057178|NCT05329220|537691376|FG005|Active Trial Period|Lost to Follow-up|28|||
149057179|NCT05329220|537691371|FG000|Active Trial Period|Physician Decision|0|||
149057180|NCT05329220|537691372|FG001|Active Trial Period|Physician Decision|0|||
149057181|NCT05329220|537691373|FG002|Active Trial Period|Physician Decision|0|||
149057182|NCT05329220|537691374|FG003|Active Trial Period|Physician Decision|0|||
149057183|NCT05329220|537691375|FG004|Active Trial Period|Physician Decision|2|||
149057184|NCT05329220|537691376|FG005|Active Trial Period|Physician Decision|0|||
149057185|NCT05329220|537691371|FG000|Active Trial Period|Protocol Violation|0|||
149057186|NCT05329220|537691372|FG001|Active Trial Period|Protocol Violation|0|||
149057187|NCT05329220|537691373|FG002|Active Trial Period|Protocol Violation|0|||
149057188|NCT05329220|537691374|FG003|Active Trial Period|Protocol Violation|0|||
149057189|NCT05329220|537691375|FG004|Active Trial Period|Protocol Violation|1|||
149057190|NCT05329220|537691376|FG005|Active Trial Period|Protocol Violation|3|||
149057191|NCT05329220|537691371|FG000|Active Trial Period|Withdrawal by Subject|0|||
149057192|NCT05329220|537691372|FG001|Active Trial Period|Withdrawal by Subject|0|||
149057193|NCT05329220|537691373|FG002|Active Trial Period|Withdrawal by Subject|0|||
149057194|NCT05329220|537691374|FG003|Active Trial Period|Withdrawal by Subject|1|||
149057195|NCT05329220|537691375|FG004|Active Trial Period|Withdrawal by Subject|12|||
149057196|NCT05329220|537691376|FG005|Active Trial Period|Withdrawal by Subject|13|||
149057197|NCT05329220|537691371|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
149057198|NCT05329220|537691372|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
149057199|NCT05329220|537691373|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
149057200|NCT05329220|537691374|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
149057201|NCT05329220|537691375|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
149057202|NCT05329220|537691376|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
149057203|NCT05329220|537691371|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
149057204|NCT05329220|537691372|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
149057205|NCT05329220|537691373|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
149057206|NCT05329220|537691374|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
149057207|NCT05329220|537691375|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
149057208|NCT05329220|537691376|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
149057209|NCT05329220|537691371|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
149057210|NCT05329220|537691372|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
149057211|NCT05329220|537691373|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
149057212|NCT05329220|537691374|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
149057213|NCT05329220|537691375|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
149057214|NCT05329220|537691376|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
149057215|NCT05329220|537691371|FG000|Follow-up Period|Adverse Event|0|||
149057216|NCT05329220|537691372|FG001|Follow-up Period|Adverse Event|0|||
149057217|NCT05329220|537691373|FG002|Follow-up Period|Adverse Event|0|||
149057218|NCT05329220|537691374|FG003|Follow-up Period|Adverse Event|0|||
149057219|NCT05329220|537691375|FG004|Follow-up Period|Adverse Event|2|||
149057220|NCT05329220|537691376|FG005|Follow-up Period|Adverse Event|1|||
149057221|NCT05329220|537691371|FG000|Follow-up Period|Death|0|||
149057222|NCT05329220|537691372|FG001|Follow-up Period|Death|0|||
149057223|NCT05329220|537691373|FG002|Follow-up Period|Death|1|||
149057224|NCT05329220|537691374|FG003|Follow-up Period|Death|1|||
149057225|NCT05329220|537691375|FG004|Follow-up Period|Death|0|||
149057226|NCT05329220|537691376|FG005|Follow-up Period|Death|1|||
149057227|NCT05329220|537691371|FG000|Follow-up Period|Lost to Follow-up|0|||
149057228|NCT05329220|537691372|FG001|Follow-up Period|Lost to Follow-up|1|||
149057229|NCT05329220|537691373|FG002|Follow-up Period|Lost to Follow-up|2|||
149057230|NCT05329220|537691374|FG003|Follow-up Period|Lost to Follow-up|2|||
149057231|NCT05329220|537691375|FG004|Follow-up Period|Lost to Follow-up|113|||
149057232|NCT05329220|537691376|FG005|Follow-up Period|Lost to Follow-up|89|||
149057233|NCT05329220|537691371|FG000|Follow-up Period|Physician Decision|0|||
149057234|NCT05329220|537691372|FG001|Follow-up Period|Physician Decision|0|||
149057235|NCT05329220|537691373|FG002|Follow-up Period|Physician Decision|0|||
149057236|NCT05329220|537691374|FG003|Follow-up Period|Physician Decision|0|||
149057237|NCT05329220|537691375|FG004|Follow-up Period|Physician Decision|2|||
149057238|NCT05329220|537691376|FG005|Follow-up Period|Physician Decision|2|||
149057239|NCT05329220|537691371|FG000|Follow-up Period|Protocol Violation|0|||
149057240|NCT05329220|537691372|FG001|Follow-up Period|Protocol Violation|0|||
149057241|NCT05329220|537691373|FG002|Follow-up Period|Protocol Violation|0|||
149057242|NCT05329220|537691374|FG003|Follow-up Period|Protocol Violation|0|||
149057243|NCT05329220|537691375|FG004|Follow-up Period|Protocol Violation|0|||
149057244|NCT05329220|537691376|FG005|Follow-up Period|Protocol Violation|1|||
149057245|NCT05329220|537691371|FG000|Follow-up Period|Withdrawal by Subject|0|||
149057246|NCT05329220|537691372|FG001|Follow-up Period|Withdrawal by Subject|0|||
149057247|NCT05329220|537691373|FG002|Follow-up Period|Withdrawal by Subject|1|||
149057248|NCT05329220|537691374|FG003|Follow-up Period|Withdrawal by Subject|1|||
149057249|NCT05329220|537691375|FG004|Follow-up Period|Withdrawal by Subject|34|||
149057250|NCT05329220|537691376|FG005|Follow-up Period|Withdrawal by Subject|35|||
149057251|NCT05329220|537691371|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
149057252|NCT05329220|537691372|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
149057253|NCT05329220|537691373|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
149057254|NCT05329220|537691374|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
149057255|NCT05329220|537691375|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
149057256|NCT05329220|537691376|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
149057257|NCT05329220|537691371|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
149057258|NCT05329220|537691372|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
149057259|NCT05329220|537691373|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
149057260|NCT05329220|537691374|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
149057261|NCT05329220|537691375|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
149057262|NCT05329220|537691376|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
149057263|NCT05329220|537691371|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
149057264|NCT05329220|537691372|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
149057265|NCT05329220|537691373|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
149057266|NCT05329220|537691374|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
149057267|NCT05329220|537691375|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
149057268|NCT05329220|537691376|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
149057269|NCT05329220|537691371|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
149057270|NCT05329220|537691372|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
149057271|NCT05329220|537691373|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
149057272|NCT05329220|537691374|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
149057273|NCT05329220|537691375|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
149057274|NCT05329220|537691376|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
149057275|NCT05329220|537691371|FG000|Follow-up Period|EARLY TERMINATION|0|||
149057276|NCT05329220|537691372|FG001|Follow-up Period|EARLY TERMINATION|0|||
149057277|NCT05329220|537691373|FG002|Follow-up Period|EARLY TERMINATION|0|||
149057278|NCT05329220|537691374|FG003|Follow-up Period|EARLY TERMINATION|0|||
149057279|NCT05329220|537691375|FG004|Follow-up Period|EARLY TERMINATION|0|||
149057280|NCT05329220|537691376|FG005|Follow-up Period|EARLY TERMINATION|1|||
149057281|NCT05329220|537691371|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
149057282|NCT05329220|537691372|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
149057283|NCT05329220|537691373|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
149057284|NCT05329220|537691374|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
149057285|NCT05329220|537691375|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
149057286|NCT05329220|537691376|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
149057287|NCT05329220|537691371|FG000|Follow-up Period|DROPPED|0|||
149057288|NCT05329220|537691372|FG001|Follow-up Period|DROPPED|0|||
149057289|NCT05329220|537691373|FG002|Follow-up Period|DROPPED|0|||
149057290|NCT05329220|537691374|FG003|Follow-up Period|DROPPED|0|||
149057291|NCT05329220|537691375|FG004|Follow-up Period|DROPPED|0|||
149057292|NCT05329220|537691376|FG005|Follow-up Period|DROPPED|1|||
149057293|NCT05329220|537691371|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
149057294|NCT05329220|537691372|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
149057295|NCT05329220|537691373|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
149057296|NCT05329220|537691374|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
149057297|NCT05329220|537691375|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
149057298|NCT05329220|537691376|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
149057299|NCT02465268|537691378|FG000|Overall Study|Withdrawal by Subject|4|||
149057300|NCT02465268|537691379|FG001|Overall Study|Withdrawal by Subject|3|||
149057301|NCT02465268|537691380|FG002|Overall Study|Withdrawal by Subject|1|||
149057302|NCT02465268|537691378|FG000|Overall Study|Not evaluable per protocol criteria|3|||
149057303|NCT02465268|537691379|FG001|Overall Study|Not evaluable per protocol criteria|2|||
149057304|NCT02465268|537691380|FG002|Overall Study|Not evaluable per protocol criteria|1|||
149057305|NCT02465268|537691378|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
149057306|NCT02465268|537691379|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
149057307|NCT02465268|537691380|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
149057308|NCT02465268|537691378|FG000|Overall Study|Study drug did not pass QA/QC|1|||
149057309|NCT02465268|537691379|FG001|Overall Study|Study drug did not pass QA/QC|0|||
149057310|NCT02465268|537691380|FG002|Overall Study|Study drug did not pass QA/QC|0|||
149057311|NCT02465268|537691378|FG000|Overall Study|Adverse Event|0|||
149057312|NCT02465268|537691379|FG001|Overall Study|Adverse Event|1|||
149057313|NCT02465268|537691380|FG002|Overall Study|Adverse Event|0|||
149057314|NCT02465268|537691378|FG000|Overall Study|Physician Decision|0|||
149057315|NCT02465268|537691379|FG001|Overall Study|Physician Decision|1|||
149057316|NCT02465268|537691380|FG002|Overall Study|Physician Decision|0|||
149057317|NCT03322267|537691381|FG000|Overall Study|Lack of Efficacy|11|||
149057318|NCT03322267|537691381|FG000|Overall Study|Adverse Event|1|||
149057319|NCT03322267|537691381|FG000|Overall Study|Withdrawal by Subject|2|||
149057320|NCT05792085|537691382|FG000|Overall Study|Death|0|||
149057321|NCT05792085|537691383|FG001|Overall Study|Death|0|||
149057322|NCT05792085|537691384|FG002|Overall Study|Death|0|||
149057323|NCT05792085|537691385|FG003|Overall Study|Death|0|||
149057324|NCT05792085|537691386|FG004|Overall Study|Death|1|||
149057325|NCT04797897|537691389|FG000|Overall Study|Study Termination by Sponsor|1|||
149057326|NCT04797897|537691390|FG001|Overall Study|Study Termination by Sponsor|1|||
149057327|NCT03084536|537691392|FG000|Overall Study|Determined to be ineligible|0|||
149057328|NCT03084536|537691393|FG001|Overall Study|Determined to be ineligible|0|||
149057329|NCT03084536|537691394|FG002|Overall Study|Determined to be ineligible|16|||
149057330|NCT03084536|537691392|FG000|Overall Study|Withdrawal by Subject|0|||
149057331|NCT03084536|537691393|FG001|Overall Study|Withdrawal by Subject|0|||
149057332|NCT03084536|537691394|FG002|Overall Study|Withdrawal by Subject|4|||
149057333|NCT03084536|537691392|FG000|Overall Study|Physician Decision|0|||
149057334|NCT03084536|537691393|FG001|Overall Study|Physician Decision|0|||
149057335|NCT03084536|537691394|FG002|Overall Study|Physician Decision|3|||
149057336|NCT03084536|537691392|FG000|Overall Study|Death|0|||
149057337|NCT03084536|537691393|FG001|Overall Study|Death|0|||
149057338|NCT03084536|537691394|FG002|Overall Study|Death|1|||
149057339|NCT03084536|537691392|FG000|Overall Study|Lost to Follow-up|0|||
149057340|NCT03084536|537691393|FG001|Overall Study|Lost to Follow-up|0|||
149057341|NCT03084536|537691394|FG002|Overall Study|Lost to Follow-up|1|||
149057342|NCT03084536|537691392|FG000|Overall Study|Protocol Violation|0|||
149057343|NCT03084536|537691393|FG001|Overall Study|Protocol Violation|0|||
148890008|NCT02679287|537074524|FG001|Period 3|Work/Scheduling Conflict|1|||
149057344|NCT03084536|537691394|FG002|Overall Study|Protocol Violation|1|||
149057345|NCT03084536|537691392|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
149057346|NCT03084536|537691393|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
149057347|NCT03084536|537691394|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
149057348|NCT04049643|537691397|FG000|Overall Study|Lack of Efficacy|1|||
149057349|NCT04049643|537691398|FG001|Overall Study|Lack of Efficacy|1|||
149057350|NCT04049643|537691399|FG002|Overall Study|Lack of Efficacy|0|||
149057351|NCT04049643|537691397|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
149057352|NCT04049643|537691398|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
149057353|NCT04049643|537691399|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
149057354|NCT04728347|537692730|FG000|Overall Study|Sponsor decision|0|||
149057355|NCT04728347|537692731|FG001|Overall Study|Sponsor decision|0|||
149057356|NCT04728347|537692732|FG002|Overall Study|Sponsor decision|1|||
149057357|NCT04728347|537692733|FG003|Overall Study|Sponsor decision|0|||
149057358|NCT01186367|537692734|FG000|Overall Study|Lost to Follow-up|7|||
149057359|NCT01186367|537692735|FG001|Overall Study|Lost to Follow-up|4|||
149057360|NCT01186367|537692736|FG002|Overall Study|Lost to Follow-up|7|||
149057361|NCT01186367|537692734|FG000|Overall Study|Did not receive study treatment|0|||
149057362|NCT01186367|537692735|FG001|Overall Study|Did not receive study treatment|1|||
149057363|NCT01186367|537692736|FG002|Overall Study|Did not receive study treatment|0|||
149057364|NCT02105766|537692737|FG000|Overall Study|Physician Decision|1|||
149057365|NCT02105766|537692738|FG001|Overall Study|Physician Decision|1|||
149057366|NCT02105766|537692739|FG002|Overall Study|Physician Decision|0|||
149057367|NCT02105766|537692737|FG000|Overall Study|Lost to Follow-up|2|||
149057368|NCT02105766|537692738|FG001|Overall Study|Lost to Follow-up|0|||
149057369|NCT02105766|537692739|FG002|Overall Study|Lost to Follow-up|0|||
149057370|NCT02105766|537692737|FG000|Overall Study|Death|1|||
149057371|NCT02105766|537692738|FG001|Overall Study|Death|1|||
149057372|NCT02105766|537692739|FG002|Overall Study|Death|0|||
149057373|NCT03867500|537692740|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
149057374|NCT04799899|537692742|FG000|Overall Study|Lost to Follow-up|2|||
149057375|NCT04799899|537692743|FG001|Overall Study|Lost to Follow-up|4|||
149057376|NCT01842542|537692744|FG000|Overall Study|Withdrawal by Subject|2|||
149057377|NCT01842542|537692744|FG000|Overall Study|Lack of Efficacy|1|||
149057378|NCT01842542|537692744|FG000|Overall Study|Protocol Non-compliance|2|||
149057379|NCT01842542|537692744|FG000|Overall Study|Lost to Follow-up|1|||
149057380|NCT03452579|537692757|FG000|Overall Study|Death|0|||
149057381|NCT03452579|537692758|FG001|Overall Study|Death|1|||
149057382|NCT03452579|537692757|FG000|Overall Study|Withdrawal by Subject|2|||
149057383|NCT03452579|537692758|FG001|Overall Study|Withdrawal by Subject|0|||
149057384|NCT03452579|537692757|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
149057385|NCT03452579|537692758|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
149057386|NCT03452579|537692757|FG000|Overall Study|Physician Decision|1|||
149057387|NCT03452579|537692758|FG001|Overall Study|Physician Decision|1|||
149057388|NCT03452579|537692757|FG000|Overall Study|Adverse Event|1|||
149057389|NCT03452579|537692758|FG001|Overall Study|Adverse Event|4|||
149057390|NCT05499377|537692759|FG000|Overall Study|Withdrawal by Subject|2|||
149057391|NCT05499377|537692760|FG001|Overall Study|Withdrawal by Subject|0|||
149057392|NCT05499377|537692759|FG000|Overall Study|Physician Decision|1|||
149057393|NCT05499377|537692760|FG001|Overall Study|Physician Decision|0|||
149057394|NCT04149704|537692764|FG000|Three Month Follow-up|Death|2|||
148890009|NCT01114828|537074525|FG000|Overall Study|Adverse Event|1|||
148890010|NCT01114828|537074526|FG001|Overall Study|Adverse Event|1|||
148890011|NCT01114828|537074525|FG000|Overall Study|Lack of Efficacy|0|||
148890012|NCT01114828|537074526|FG001|Overall Study|Lack of Efficacy|2|||
148890013|NCT01114828|537074525|FG000|Overall Study|Protocol Violation|2|||
148890014|NCT01114828|537074526|FG001|Overall Study|Protocol Violation|0|||
148890015|NCT01114828|537074525|FG000|Overall Study|Withdrawal by Subject|0|||
148890016|NCT01114828|537074526|FG001|Overall Study|Withdrawal by Subject|1|||
148890017|NCT00794950|537074527|FG000|BCG Induction|Withdrawal by Subject|2|||
148890018|NCT00794950|537074527|FG000|BCG Induction|ineligible|3|||
148890019|NCT00794950|537074527|FG000|BCG Induction|noncompliant w. BCG|1|||
148890020|NCT00794950|537074527|FG000|BCG Induction|Adverse Event|1|||
148890021|NCT00794950|537074527|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
148890022|NCT00794950|537074527|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
148890023|NCT00794950|537074527|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
148890024|NCT00794950|537074527|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
148890025|NCT02485704|537074528|FG000|Overall Study|Lost to Follow-up|4|||
148890026|NCT02485704|537074529|FG001|Overall Study|Lost to Follow-up|5|||
148890027|NCT02485704|537074528|FG000|Overall Study|Withdrawal by Subject|0|||
148890028|NCT02485704|537074529|FG001|Overall Study|Withdrawal by Subject|3|||
148890029|NCT02485704|537074528|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
148890030|NCT02485704|537074529|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
148890031|NCT00865345|537077093|FG000|Overall Study|Withdrawal by Subject|2|||
148890032|NCT01519323|537077094|FG000|Overall Study|Death|3|||
148890033|NCT01519323|537077095|FG001|Overall Study|Death|2|||
148890034|NCT01519323|537077094|FG000|Overall Study|Study terminated by sponsor|0|||
148890035|NCT01519323|537077095|FG001|Overall Study|Study terminated by sponsor|1|||
148890036|NCT03858049|537077096|FG000|Overall Study|Adverse Event|16|||
148890037|NCT03858049|537077097|FG001|Overall Study|Adverse Event|9|||
148890038|NCT03858049|537077096|FG000|Overall Study|Other|1|||
148890039|NCT03858049|537077097|FG001|Overall Study|Other|1|||
148890040|NCT02079740|537077098|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
149057395|NCT04149704|537692765|FG001|Three Month Follow-up|Death|0|||
149057396|NCT04149704|537692766|FG002|Three Month Follow-up|Death|0|||
149057397|NCT04149704|537692767|FG003|Three Month Follow-up|Death|0|||
149057398|NCT04149704|537692764|FG000|Three Month Follow-up|Lost to Follow-up|1|||
149057399|NCT04149704|537692765|FG001|Three Month Follow-up|Lost to Follow-up|4|||
149057400|NCT04149704|537692766|FG002|Three Month Follow-up|Lost to Follow-up|5|||
149057401|NCT04149704|537692767|FG003|Three Month Follow-up|Lost to Follow-up|5|||
148890041|NCT02079740|537077099|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
148890042|NCT02079740|537077100|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
148890043|NCT02079740|537077101|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
148890044|NCT02079740|537077102|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
148890045|NCT02079740|537077103|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
148890046|NCT02079740|537077104|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
149057402|NCT04149704|537692764|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
149057403|NCT04149704|537692765|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
149057404|NCT04149704|537692766|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
149057405|NCT04149704|537692767|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
149057406|NCT04149704|537692764|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
149057407|NCT04149704|537692765|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
149057408|NCT04149704|537692766|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
149057409|NCT04149704|537692767|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
149057410|NCT04332926|537692768|FG000|Overall Study|Withdrawal by Subject|6|||
149057411|NCT04332926|537692768|FG000|Overall Study|Physician Decision|6|||
149057412|NCT04632992|537692773|FG000|Overall Study|Adverse Event|0|||
149057413|NCT04632992|537692774|FG001|Overall Study|Adverse Event|0|||
149057414|NCT04632992|537692775|FG002|Overall Study|Adverse Event|0|||
149057415|NCT04632992|537692776|FG003|Overall Study|Adverse Event|0|||
149057416|NCT04632992|537692777|FG004|Overall Study|Adverse Event|0|||
149057417|NCT04632992|537692778|FG005|Overall Study|Adverse Event|0|||
149057418|NCT04632992|537692779|FG006|Overall Study|Adverse Event|0|||
149057419|NCT04632992|537692780|FG007|Overall Study|Adverse Event|0|||
149057420|NCT04632992|537692781|FG008|Overall Study|Adverse Event|0|||
149057421|NCT04632992|537692782|FG009|Overall Study|Adverse Event|0|||
149057422|NCT04632992|537692783|FG010|Overall Study|Adverse Event|0|||
149057423|NCT04632992|537692784|FG011|Overall Study|Adverse Event|0|||
149057424|NCT04632992|537692785|FG012|Overall Study|Adverse Event|1|||
149057425|NCT04632992|537692786|FG013|Overall Study|Adverse Event|0|||
149057426|NCT04632992|537692773|FG000|Overall Study|Death|17|||
149057427|NCT04632992|537692774|FG001|Overall Study|Death|1|||
149057428|NCT04632992|537692775|FG002|Overall Study|Death|14|||
149057429|NCT04632992|537692776|FG003|Overall Study|Death|14|||
149057430|NCT04632992|537692777|FG004|Overall Study|Death|13|||
149057431|NCT04632992|537692778|FG005|Overall Study|Death|6|||
149057432|NCT04632992|537692779|FG006|Overall Study|Death|7|||
149057433|NCT04632992|537692780|FG007|Overall Study|Death|12|||
149057434|NCT04632992|537692781|FG008|Overall Study|Death|15|||
149057435|NCT04632992|537692782|FG009|Overall Study|Death|20|||
149057436|NCT04632992|537692783|FG010|Overall Study|Death|8|||
149057437|NCT04632992|537692784|FG011|Overall Study|Death|2|||
149057438|NCT04632992|537692785|FG012|Overall Study|Death|10|||
149057439|NCT04632992|537692786|FG013|Overall Study|Death|1|||
149057440|NCT04632992|537692773|FG000|Overall Study|Lost to Follow-up|1|||
149057441|NCT04632992|537692774|FG001|Overall Study|Lost to Follow-up|0|||
149057442|NCT04632992|537692775|FG002|Overall Study|Lost to Follow-up|1|||
149057443|NCT04632992|537692776|FG003|Overall Study|Lost to Follow-up|0|||
149057444|NCT04632992|537692777|FG004|Overall Study|Lost to Follow-up|2|||
149057445|NCT04632992|537692778|FG005|Overall Study|Lost to Follow-up|0|||
149057446|NCT04632992|537692779|FG006|Overall Study|Lost to Follow-up|1|||
149057447|NCT04632992|537692780|FG007|Overall Study|Lost to Follow-up|1|||
149057448|NCT04632992|537692781|FG008|Overall Study|Lost to Follow-up|1|||
149057449|NCT04632992|537692782|FG009|Overall Study|Lost to Follow-up|1|||
149057450|NCT04632992|537692783|FG010|Overall Study|Lost to Follow-up|2|||
149057451|NCT04632992|537692784|FG011|Overall Study|Lost to Follow-up|0|||
149057452|NCT04632992|537692785|FG012|Overall Study|Lost to Follow-up|0|||
149057453|NCT04632992|537692786|FG013|Overall Study|Lost to Follow-up|0|||
149057454|NCT04632992|537692773|FG000|Overall Study|Reason not Specified|2|||
149057455|NCT04632992|537692774|FG001|Overall Study|Reason not Specified|0|||
149057456|NCT04632992|537692775|FG002|Overall Study|Reason not Specified|1|||
149057457|NCT04632992|537692776|FG003|Overall Study|Reason not Specified|1|||
149057458|NCT04632992|537692777|FG004|Overall Study|Reason not Specified|0|||
149057459|NCT04632992|537692778|FG005|Overall Study|Reason not Specified|0|||
149057460|NCT04632992|537692779|FG006|Overall Study|Reason not Specified|0|||
149057461|NCT04632992|537692780|FG007|Overall Study|Reason not Specified|0|||
149057462|NCT04632992|537692781|FG008|Overall Study|Reason not Specified|0|||
149057463|NCT04632992|537692782|FG009|Overall Study|Reason not Specified|0|||
149057464|NCT04632992|537692783|FG010|Overall Study|Reason not Specified|1|||
149057465|NCT04632992|537692784|FG011|Overall Study|Reason not Specified|0|||
149057466|NCT04632992|537692785|FG012|Overall Study|Reason not Specified|0|||
149057467|NCT04632992|537692786|FG013|Overall Study|Reason not Specified|0|||
149057468|NCT04632992|537692773|FG000|Overall Study|Physician Decision|0|||
149057469|NCT04632992|537692774|FG001|Overall Study|Physician Decision|0|||
149057470|NCT04632992|537692775|FG002|Overall Study|Physician Decision|0|||
149057471|NCT04632992|537692776|FG003|Overall Study|Physician Decision|2|||
149057472|NCT04632992|537692777|FG004|Overall Study|Physician Decision|1|||
149057473|NCT04632992|537692778|FG005|Overall Study|Physician Decision|0|||
149057474|NCT04632992|537692779|FG006|Overall Study|Physician Decision|0|||
149057475|NCT04632992|537692780|FG007|Overall Study|Physician Decision|0|||
149057476|NCT04632992|537692781|FG008|Overall Study|Physician Decision|0|||
149057477|NCT04632992|537692782|FG009|Overall Study|Physician Decision|0|||
149057478|NCT04632992|537692783|FG010|Overall Study|Physician Decision|0|||
149057479|NCT04632992|537692784|FG011|Overall Study|Physician Decision|0|||
149057480|NCT04632992|537692785|FG012|Overall Study|Physician Decision|3|||
149057481|NCT04632992|537692786|FG013|Overall Study|Physician Decision|0|||
149057482|NCT04632992|537692773|FG000|Overall Study|Progressive Disease|0|||
149057483|NCT04632992|537692774|FG001|Overall Study|Progressive Disease|0|||
149057484|NCT04632992|537692775|FG002|Overall Study|Progressive Disease|0|||
149057485|NCT04632992|537692776|FG003|Overall Study|Progressive Disease|0|||
149057486|NCT04632992|537692777|FG004|Overall Study|Progressive Disease|1|||
149057487|NCT04632992|537692778|FG005|Overall Study|Progressive Disease|0|||
149057488|NCT04632992|537692779|FG006|Overall Study|Progressive Disease|0|||
149057489|NCT04632992|537692780|FG007|Overall Study|Progressive Disease|0|||
149057490|NCT04632992|537692781|FG008|Overall Study|Progressive Disease|0|||
149057491|NCT04632992|537692782|FG009|Overall Study|Progressive Disease|1|||
149057492|NCT04632992|537692783|FG010|Overall Study|Progressive Disease|1|||
149057493|NCT04632992|537692784|FG011|Overall Study|Progressive Disease|0|||
149057494|NCT04632992|537692785|FG012|Overall Study|Progressive Disease|2|||
149057495|NCT04632992|537692786|FG013|Overall Study|Progressive Disease|0|||
149057496|NCT04632992|537692773|FG000|Overall Study|Withdrawal by Subject|4|||
149057497|NCT04632992|537692774|FG001|Overall Study|Withdrawal by Subject|1|||
149057498|NCT04632992|537692775|FG002|Overall Study|Withdrawal by Subject|5|||
149057499|NCT04632992|537692776|FG003|Overall Study|Withdrawal by Subject|4|||
149057500|NCT04632992|537692777|FG004|Overall Study|Withdrawal by Subject|3|||
149057501|NCT04632992|537692778|FG005|Overall Study|Withdrawal by Subject|3|||
149057502|NCT04632992|537692779|FG006|Overall Study|Withdrawal by Subject|0|||
149057503|NCT04632992|537692780|FG007|Overall Study|Withdrawal by Subject|5|||
149057504|NCT04632992|537692781|FG008|Overall Study|Withdrawal by Subject|0|||
149057505|NCT04632992|537692782|FG009|Overall Study|Withdrawal by Subject|2|||
149057506|NCT04632992|537692783|FG010|Overall Study|Withdrawal by Subject|8|||
149057507|NCT04632992|537692784|FG011|Overall Study|Withdrawal by Subject|0|||
149057508|NCT04632992|537692785|FG012|Overall Study|Withdrawal by Subject|1|||
149057509|NCT04632992|537692786|FG013|Overall Study|Withdrawal by Subject|1|||
149057510|NCT05714761|537692787|FG000|Overall Study|Lost to Follow-up|3|||
149057511|NCT05714761|537692787|FG000|Overall Study|Withdrawal by Subject|3|||
149057512|NCT05714761|537692787|FG000|Overall Study|unblinding of sensor data|1|||
149057513|NCT05714761|537692787|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
149057514|NCT05714761|537692787|FG000|Overall Study|did not return second CGM sensor|4|||
149057515|NCT05949788|537692789|FG000|Overall Study|severe birth deformity|2|||
149057516|NCT05949788|537692790|FG001|Overall Study|severe birth deformity|7|||
149057517|NCT05949788|537692789|FG000|Overall Study|twin-twin transfusion syndrome|2|||
149057518|NCT05949788|537692790|FG001|Overall Study|twin-twin transfusion syndrome|7|||
149057519|NCT05949788|537692789|FG000|Overall Study|neonatal hemolytic disease|3|||
149057520|NCT05949788|537692790|FG001|Overall Study|neonatal hemolytic disease|8|||
149057521|NCT05949788|537692789|FG000|Overall Study|death within 14 days after birth|2|||
149057522|NCT05949788|537692790|FG001|Overall Study|death within 14 days after birth|6|||
149057523|NCT05949788|537692789|FG000|Overall Study|transfer to another hospital|2|||
149057524|NCT05949788|537692790|FG001|Overall Study|transfer to another hospital|6|||
149057525|NCT05213390|537692791|FG000|Overall Study|Withdrawal by Subject|2|||
149057526|NCT05213390|537692791|FG000|Overall Study|Lost to Follow-up|12|||
149057527|NCT05213390|537692791|FG000|Overall Study|Protocol Violation|9|||
149057528|NCT03808818|537692796|FG000|Overall Study|Death|6|||
149057529|NCT03808818|537692797|FG001|Overall Study|Death|6|||
149057530|NCT03808818|537692796|FG000|Overall Study|Withdrawal by Subject|7|||
149057531|NCT03808818|537692797|FG001|Overall Study|Withdrawal by Subject|18|||
149057532|NCT03808818|537692796|FG000|Overall Study|Lost to Follow-up|31|||
149057533|NCT03808818|537692797|FG001|Overall Study|Lost to Follow-up|33|||
149057534|NCT05415722|537692798|FG000|Overall Study|Lost to Follow-up|0|||
149057535|NCT05415722|537692799|FG001|Overall Study|Lost to Follow-up|2|||
149057536|NCT05415722|537692800|FG002|Overall Study|Lost to Follow-up|0|||
149057537|NCT05415722|537692801|FG003|Overall Study|Lost to Follow-up|1|||
149057538|NCT05415722|537692802|FG004|Overall Study|Lost to Follow-up|0|||
149057539|NCT05415722|537692803|FG005|Overall Study|Lost to Follow-up|0|||
149057540|NCT05415722|537692804|FG006|Overall Study|Lost to Follow-up|1|||
148890047|NCT02079740|537077105|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
148890048|NCT02079740|537077106|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
149057541|NCT05415722|537692798|FG000|Overall Study|Physician Decision|0|||
149057542|NCT05415722|537692799|FG001|Overall Study|Physician Decision|0|||
149057543|NCT05415722|537692800|FG002|Overall Study|Physician Decision|0|||
149057544|NCT05415722|537692801|FG003|Overall Study|Physician Decision|1|||
149057545|NCT05415722|537692802|FG004|Overall Study|Physician Decision|0|||
149057546|NCT05415722|537692803|FG005|Overall Study|Physician Decision|0|||
149057547|NCT05415722|537692804|FG006|Overall Study|Physician Decision|1|||
149057548|NCT05415722|537692798|FG000|Overall Study|Protocol Violation|0|||
149057549|NCT05415722|537692799|FG001|Overall Study|Protocol Violation|0|||
149057550|NCT05415722|537692800|FG002|Overall Study|Protocol Violation|0|||
149057551|NCT05415722|537692801|FG003|Overall Study|Protocol Violation|1|||
149057552|NCT05415722|537692802|FG004|Overall Study|Protocol Violation|0|||
149057553|NCT05415722|537692803|FG005|Overall Study|Protocol Violation|0|||
149057554|NCT05415722|537692804|FG006|Overall Study|Protocol Violation|0|||
149057555|NCT05415722|537692798|FG000|Overall Study|Sponsor Discretion|0|||
149057556|NCT05415722|537692799|FG001|Overall Study|Sponsor Discretion|0|||
149057557|NCT05415722|537692800|FG002|Overall Study|Sponsor Discretion|0|||
149057558|NCT05415722|537692801|FG003|Overall Study|Sponsor Discretion|0|||
149057559|NCT05415722|537692802|FG004|Overall Study|Sponsor Discretion|1|||
149057560|NCT05415722|537692803|FG005|Overall Study|Sponsor Discretion|1|||
149057561|NCT05415722|537692804|FG006|Overall Study|Sponsor Discretion|0|||
149057562|NCT05415722|537692798|FG000|Overall Study|Withdrawal by Subject|0|||
149057563|NCT05415722|537692799|FG001|Overall Study|Withdrawal by Subject|1|||
149057564|NCT05415722|537692800|FG002|Overall Study|Withdrawal by Subject|0|||
149057565|NCT05415722|537692801|FG003|Overall Study|Withdrawal by Subject|1|||
149057566|NCT05415722|537692802|FG004|Overall Study|Withdrawal by Subject|1|||
149057567|NCT05415722|537692803|FG005|Overall Study|Withdrawal by Subject|0|||
149057568|NCT05415722|537692804|FG006|Overall Study|Withdrawal by Subject|1|||
149057569|NCT04537715|537692810|FG000|Overall Study|Death|3|||
149057570|NCT04537715|537692811|FG001|Overall Study|Death|1|||
149057571|NCT04537715|537692810|FG000|Overall Study|Withdrawal by Subject|3|||
149057572|NCT04537715|537692811|FG001|Overall Study|Withdrawal by Subject|1|||
149057573|NCT04537715|537692810|FG000|Overall Study|Other|4|||
149057574|NCT04537715|537692811|FG001|Overall Study|Other|3|||
149057575|NCT04537715|537692810|FG000|Overall Study|Progressive disease|1|||
149057576|NCT04537715|537692811|FG001|Overall Study|Progressive disease|0|||
149057577|NCT02191618|537692812|FG000|Overall Study|Withdrawal by Subject|3|||
149057578|NCT02191618|537692812|FG000|Overall Study|Missed Visit|4|||
149057579|NCT03031470|537692814|FG000|Overall Study|Adverse Event|3|||
149057580|NCT03031470|537692815|FG001|Overall Study|Adverse Event|0|||
149057581|NCT03031470|537692814|FG000|Overall Study|Death|3|||
149057582|NCT03031470|537692815|FG001|Overall Study|Death|1|||
149057583|NCT03031470|537692814|FG000|Overall Study|Lost to Follow-up|1|||
149057584|NCT03031470|537692815|FG001|Overall Study|Lost to Follow-up|1|||
149057585|NCT03031470|537692814|FG000|Overall Study|Withdrawal by Subject|1|||
149057586|NCT03031470|537692815|FG001|Overall Study|Withdrawal by Subject|0|||
149057587|NCT03031470|537692814|FG000|Overall Study|Protocol entry criteria not met|0|||
149057588|NCT03031470|537692815|FG001|Overall Study|Protocol entry criteria not met|1|||
149057589|NCT03031470|537692814|FG000|Overall Study|Cancel the operation|0|||
149057590|NCT03031470|537692815|FG001|Overall Study|Cancel the operation|1|||
149057591|NCT02683447|537692818|FG000|Overall Study|Lost to Follow-up|2|||
149057592|NCT01943409|537692822|FG000|Overall Study|resumed oral/entral|24|||
149057593|NCT01943409|537692823|FG001|Overall Study|resumed oral/entral|20|||
149057594|NCT01943409|537692822|FG000|Overall Study|Protocol Violation|14|||
149057595|NCT01943409|537692823|FG001|Overall Study|Protocol Violation|24|||
149057596|NCT01943409|537692822|FG000|Overall Study|Death|3|||
149057597|NCT01943409|537692823|FG001|Overall Study|Death|1|||
149057598|NCT01943409|537692822|FG000|Overall Study|Withdrawal by Subject|4|||
149057599|NCT01943409|537692823|FG001|Overall Study|Withdrawal by Subject|3|||
149057600|NCT02489903|537692824|FG000|Screening|Screen Failure|24|||
149057601|NCT02489903|537692825|FG001|Screening|Screen Failure|0|||
149057602|NCT02489903|537692826|FG002|Screening|Screen Failure|0|||
149057603|NCT02489903|537692827|FG003|Screening|Screen Failure|8|||
149057604|NCT02489903|537692824|FG000|Randomized and Received Treatment|Protocol Violation|0|||
149057605|NCT02489903|537692825|FG001|Randomized and Received Treatment|Protocol Violation|1|||
149057606|NCT02489903|537692826|FG002|Randomized and Received Treatment|Protocol Violation|0|||
149057607|NCT02489903|537692827|FG003|Randomized and Received Treatment|Protocol Violation|0|||
149057608|NCT02489903|537692824|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
149057609|NCT02489903|537692825|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
149057610|NCT02489903|537692826|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
149057611|NCT02489903|537692827|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
149057612|NCT02489903|537692824|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
149057613|NCT02489903|537692825|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
148890049|NCT02079740|537077107|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
148890050|NCT02079740|537077108|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
149057614|NCT02489903|537692826|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
149057615|NCT02489903|537692827|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
149057616|NCT02489903|537692824|FG000|Randomized and Received Treatment|Death|10|||
149057617|NCT02489903|537692825|FG001|Randomized and Received Treatment|Death|1|||
149057618|NCT02489903|537692826|FG002|Randomized and Received Treatment|Death|0|||
148890051|NCT02079740|537077109|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
148890052|NCT02079740|537077110|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
149057619|NCT02489903|537692827|FG003|Randomized and Received Treatment|Death|0|||
149057620|NCT04542317|537692828|FG000|Overall Study|Care recipients passed away|18|||
149057621|NCT04542317|537692829|FG001|Overall Study|Care recipients passed away|13|||
149057622|NCT04542317|537692828|FG000|Overall Study|No longer a primary caregiver|5|||
149057623|NCT04542317|537692829|FG001|Overall Study|No longer a primary caregiver|1|||
149057624|NCT04542317|537692828|FG000|Overall Study|Withdrawal by Subject|4|||
149057625|NCT04542317|537692829|FG001|Overall Study|Withdrawal by Subject|2|||
149057626|NCT04542317|537692828|FG000|Overall Study|Caregivers passed away|0|||
149057627|NCT04542317|537692829|FG001|Overall Study|Caregivers passed away|2|||
149057628|NCT03021096|537692832|FG000|Overall Study|Lost to Follow-up|4|||
149057629|NCT03021096|537692832|FG000|Overall Study|Protocol Violation|2|||
149057630|NCT03848065|537692835|FG000|Overall Study|Death|0|||
149057631|NCT03848065|537692836|FG001|Overall Study|Death|1|||
149057632|NCT03848065|537692837|FG002|Overall Study|Death|0|||
149057633|NCT03848065|537692835|FG000|Overall Study|Lost to Follow-up|0|||
149057634|NCT03848065|537692836|FG001|Overall Study|Lost to Follow-up|0|||
149057635|NCT03848065|537692837|FG002|Overall Study|Lost to Follow-up|1|||
149057636|NCT03848065|537692835|FG000|Overall Study|Physician Decision|0|||
149057637|NCT03848065|537692836|FG001|Overall Study|Physician Decision|0|||
149057638|NCT03848065|537692837|FG002|Overall Study|Physician Decision|1|||
149057639|NCT04137367|537692849|FG000|Overall Study|Lost to Follow-up|8|||
149057640|NCT04137367|537692850|FG001|Overall Study|Lost to Follow-up|6|||
149057641|NCT04137367|537692851|FG002|Overall Study|Lost to Follow-up|4|||
149057642|NCT05144009|537692852|FG000|Overall Study|Lost to Follow-up|0|||
149057643|NCT05144009|537692853|FG001|Overall Study|Lost to Follow-up|1|||
149057644|NCT05144009|537692852|FG000|Overall Study|Study Termination by the Sponsor|11|||
149057645|NCT05144009|537692853|FG001|Overall Study|Study Termination by the Sponsor|11|||
149057646|NCT05144009|537692852|FG000|Overall Study|Disease Progression|1|||
149057647|NCT05144009|537692853|FG001|Overall Study|Disease Progression|0|||
149057648|NCT05144009|537692852|FG000|Overall Study|Participant Decision|0|||
149057649|NCT05144009|537692853|FG001|Overall Study|Participant Decision|2|||
149057650|NCT05144009|537692852|FG000|Overall Study|Death|5|||
149057651|NCT05144009|537692853|FG001|Overall Study|Death|10|||
149057652|NCT03270501|537692854|FG000|Overall Study|Screen failure|6|||
149057653|NCT03270501|537692854|FG000|Overall Study|Lost to Follow-up|2|||
149057654|NCT03270501|537692854|FG000|Overall Study|Adverse Event|1|||
149057655|NCT00764751|537692857|FG000|Overall Study|Adverse Event|1|||
149057656|NCT00764751|537692858|FG001|Overall Study|Adverse Event|1|||
149057657|NCT00764751|537692857|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
149057658|NCT00764751|537692858|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
149057659|NCT01175356|537692877|FG000|Overall Study|Death|1|||
149057660|NCT01175356|537692877|FG000|Overall Study|Lack of Efficacy|12|||
149057661|NCT01175356|537692877|FG000|Overall Study|Lost to Follow-up|1|||
149057662|NCT01175356|537692877|FG000|Overall Study|Physician Decision|23|||
149057663|NCT01175356|537692877|FG000|Overall Study|Ineligible|1|||
149057664|NCT01175356|537692877|FG000|Overall Study|Treatment Slot Not Available|18|||
149057665|NCT01175356|537692877|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
149057666|NCT01175356|537692877|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
149057667|NCT01175356|537692877|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
149057668|NCT01175356|537692877|FG000|Overall Study|Inadequate stem cell for transplant|1|||
149057669|NCT01175356|537692877|FG000|Overall Study|Initiation other tx prior to completion|9|||
149057670|NCT00324805|537692878|FG000|Overall Study|Adverse Event|62|||
149057671|NCT00324805|537692879|FG001|Overall Study|Adverse Event|203|||
149057672|NCT00324805|537692878|FG000|Overall Study|Progression|7|||
149057673|NCT00324805|537692879|FG001|Overall Study|Progression|35|||
149057674|NCT00324805|537692878|FG000|Overall Study|Withdrawal by Subject|51|||
149057675|NCT00324805|537692879|FG001|Overall Study|Withdrawal by Subject|174|||
149057676|NCT00324805|537692878|FG000|Overall Study|Death|6|||
149057677|NCT00324805|537692879|FG001|Overall Study|Death|9|||
149057678|NCT00324805|537692878|FG000|Overall Study|Alternative therapy|4|||
149057679|NCT00324805|537692879|FG001|Overall Study|Alternative therapy|8|||
149057680|NCT00324805|537692878|FG000|Overall Study|Other complicating disease|1|||
149057681|NCT00324805|537692879|FG001|Overall Study|Other complicating disease|9|||
149057682|NCT00324805|537692878|FG000|Overall Study|Other reasons|7|||
149057683|NCT00324805|537692879|FG001|Overall Study|Other reasons|26|||
149057684|NCT00324805|537692878|FG000|Overall Study|Other|0|||
149057685|NCT00324805|537692879|FG001|Overall Study|Other|2|||
149057686|NCT00324805|537692878|FG000|Overall Study|Did not start therapy|12|||
149057687|NCT00324805|537692879|FG001|Overall Study|Did not start therapy|17|||
149057688|NCT05977530|537692881|FG000|Overall Study|Withdrawal by Subject|1|||
149057689|NCT05977530|537692881|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
149057690|NCT04719832|537692884|FG000|Overall Study|Adverse Event|2|||
149057691|NCT04719832|537692885|FG001|Overall Study|Adverse Event|0|||
149057692|NCT04719832|537692884|FG000|Overall Study|Lack of Efficacy|2|||
149057693|NCT04719832|537692885|FG001|Overall Study|Lack of Efficacy|4|||
149057694|NCT04719832|537692884|FG000|Overall Study|Lost to Follow-up|0|||
149057695|NCT04719832|537692885|FG001|Overall Study|Lost to Follow-up|2|||
149057696|NCT04719832|537692884|FG000|Overall Study|Physician Decision|0|||
149057697|NCT04719832|537692885|FG001|Overall Study|Physician Decision|1|||
149057698|NCT04719832|537692884|FG000|Overall Study|Pregnancy|1|||
149057699|NCT04719832|537692885|FG001|Overall Study|Pregnancy|1|||
149057700|NCT04719832|537692884|FG000|Overall Study|Withdrawal by Subject|5|||
149057701|NCT04719832|537692885|FG001|Overall Study|Withdrawal by Subject|5|||
149057702|NCT04719832|537692884|FG000|Overall Study|Randomized, not treated|0|||
149057703|NCT04719832|537692885|FG001|Overall Study|Randomized, not treated|2|||
149057704|NCT04719832|537692884|FG000|Overall Study|GCP violations|4|||
149057705|NCT04719832|537692885|FG001|Overall Study|GCP violations|7|||
149057706|NCT05192109|537692886|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
149057707|NCT05192109|537692887|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
149057708|NCT05192109|537692888|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149057709|NCT05192109|537692889|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149057710|NCT05192109|537692886|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
149057711|NCT05192109|537692887|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
149057712|NCT05192109|537692888|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149057713|NCT05192109|537692889|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
149057714|NCT02696707|537694878|FG000|Per Protocol Population|Physician Decision|2|||
149057715|NCT02696707|537694879|FG001|Per Protocol Population|Physician Decision|1|||
149057716|NCT02696707|537694878|FG000|Per Protocol Population|Participant Decision|0|||
149057717|NCT02696707|537694879|FG001|Per Protocol Population|Participant Decision|2|||
149057718|NCT02696707|537694878|FG000|Completed Study as Planned|Reason = LVEF|2|||
149057719|NCT02696707|537694879|FG001|Completed Study as Planned|Reason = LVEF|2|||
149057720|NCT02696707|537694878|FG000|Completed Study as Planned|Protocol Violation|2|||
149057721|NCT02696707|537694879|FG001|Completed Study as Planned|Protocol Violation|6|||
149057722|NCT02696707|537694878|FG000|Completed Study as Planned|Metastatic disease|3|||
149057723|NCT02696707|537694879|FG001|Completed Study as Planned|Metastatic disease|0|||
149057724|NCT02696707|537694878|FG000|Completed Study as Planned|Location|1|||
149057725|NCT02696707|537694879|FG001|Completed Study as Planned|Location|1|||
149057726|NCT05453773|537694893|FG000|Overall Study|Withdrawal by Subject|3|||
149057727|NCT05453773|537694893|FG000|Overall Study|Lost to Follow-up|3|||
149057728|NCT05453773|537694893|FG000|Overall Study|Difficult Blood Draw|3|||
149057729|NCT03241745|537694896|FG000|Overall Study|Adverse Event|7|||
149057730|NCT03241745|537694896|FG000|Overall Study|Death|1|||
149057731|NCT03241745|537694896|FG000|Overall Study|Withdrawal by Subject|5|||
149057732|NCT03241745|537694896|FG000|Overall Study|Treatment delay >28 days|2|||
149057733|NCT03241745|537694896|FG000|Overall Study|Lack of Efficacy|14|||
149057734|NCT00470704|537694897|FG000|Overall Study|Withdrawal by Subject|4|||
149057735|NCT00470704|537694898|FG001|Overall Study|Withdrawal by Subject|3|||
149057736|NCT00470704|537694897|FG000|Overall Study|Relapse/Progression|37|||
149057737|NCT00470704|537694898|FG001|Overall Study|Relapse/Progression|42|||
149057738|NCT00470704|537694897|FG000|Overall Study|toxicity|0|||
149057739|NCT00470704|537694898|FG001|Overall Study|toxicity|1|||
149057740|NCT02561247|537694903|FG000|Overall Study|Protocol Violation|1|||
149057741|NCT02561247|537694903|FG000|Overall Study|Withdrawal by Subject|1|||
149057742|NCT02561247|537694903|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
149057743|NCT04963270|537694905|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
149057744|NCT04963270|537694906|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
149057745|NCT04963270|537694907|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
149057746|NCT04963270|537694908|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
149057747|NCT04963270|537694905|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
149057748|NCT04963270|537694906|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
149057749|NCT04963270|537694907|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
149057750|NCT04963270|537694908|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
149057751|NCT04963270|537694905|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
149057752|NCT04963270|537694906|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
149057753|NCT04963270|537694907|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
149057754|NCT04963270|537694908|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
149057755|NCT04963270|537694905|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
148890053|NCT02079740|537077098|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
148890054|NCT02079740|537077099|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
148890055|NCT02079740|537077100|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
148890056|NCT02079740|537077101|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
148890057|NCT02079740|537077102|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
148890058|NCT02079740|537077103|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
148890059|NCT02079740|537077104|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
148890060|NCT02079740|537077105|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
148890061|NCT02079740|537077106|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
148890062|NCT02079740|537077107|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
148890063|NCT02079740|537077108|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
148890064|NCT02079740|537077109|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
148890065|NCT02079740|537077110|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
148890066|NCT02079740|537077098|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890067|NCT02079740|537077099|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890068|NCT02079740|537077100|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
149057756|NCT04963270|537694906|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
149057757|NCT04963270|537694907|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
149057758|NCT04963270|537694908|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
149057759|NCT04963270|537694905|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
149119374|NCT00275262|537916293|FG001|Overall Study|Protocol Violation|2|||
149057760|NCT04963270|537694906|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
149057761|NCT04963270|537694907|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
149057762|NCT04963270|537694908|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
149057763|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
149057764|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
149057765|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
149057766|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
149057767|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
149057768|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
149057769|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
149057770|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
149057771|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
149057772|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
149057773|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
149057774|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
149057775|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
149057776|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
149057777|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
149057778|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
149057779|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
149057780|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
149057781|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
149057782|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
149057783|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
149057784|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
149057785|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
149057786|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
149057787|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
149057788|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
149057789|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
149057790|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
149057791|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
149057792|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
149057793|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
149057794|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
149057795|NCT04963270|537694905|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
149057796|NCT04963270|537694906|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
149057797|NCT04963270|537694907|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
149057798|NCT04963270|537694908|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
149057799|NCT04802967|537694909|FG000|Part B|Withdrawal by Subject|0|||
149057800|NCT04802967|537694910|FG001|Part B|Withdrawal by Subject|0|||
149057801|NCT04802967|537694911|FG002|Part B|Withdrawal by Subject|0|||
149057802|NCT04802967|537694912|FG003|Part B|Withdrawal by Subject|0|||
149057803|NCT04802967|537694913|FG004|Part B|Withdrawal by Subject|0|||
149057804|NCT04802967|537694914|FG005|Part B|Withdrawal by Subject|1|||
149057805|NCT04802967|537694915|FG006|Part B|Withdrawal by Subject|0|||
149057806|NCT04802967|537694916|FG007|Part B|Withdrawal by Subject|0|||
149057807|NCT04802967|537694917|FG008|Part B|Withdrawal by Subject|0|||
149057808|NCT04802967|537694918|FG009|Part B|Withdrawal by Subject|0|||
149057809|NCT02979327|537694925|FG000|First Intervention|Protocol Violation|1|||
149057810|NCT02979327|537694926|FG001|First Intervention|Protocol Violation|0|||
149057811|NCT01073566|537694927|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
149057812|NCT01073566|537694928|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
149057813|NCT03474679|537694936|FG000|Overall Study|Death|7|||
149057814|NCT03474679|537694936|FG000|Overall Study|Withdrawal by Subject|1|||
149057815|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
149057816|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
149057817|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
149057818|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
149057819|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
149057820|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
149057821|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Death|6|||
149057822|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Death|0|||
149057823|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Death|0|||
149057824|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
149057825|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
149057826|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
149057827|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
148890069|NCT02079740|537077101|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890070|NCT02079740|537077102|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890071|NCT02079740|537077103|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890072|NCT02079740|537077104|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890073|NCT02079740|537077105|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
148890074|NCT02079740|537077106|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890075|NCT02079740|537077107|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890076|NCT02079740|537077108|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890077|NCT02079740|537077109|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890078|NCT02079740|537077110|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
148890079|NCT02079740|537077098|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890080|NCT02079740|537077099|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890081|NCT02079740|537077100|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890082|NCT02079740|537077101|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890083|NCT02079740|537077102|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890084|NCT02079740|537077103|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890085|NCT02079740|537077104|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890086|NCT02079740|537077105|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
148890087|NCT02079740|537077106|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890088|NCT02079740|537077107|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890089|NCT02079740|537077108|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890090|NCT02079740|537077109|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890091|NCT02079740|537077110|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
148890092|NCT02079740|537077098|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890093|NCT02079740|537077099|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890094|NCT02079740|537077100|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890095|NCT02079740|537077101|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890096|NCT02079740|537077102|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890097|NCT02079740|537077103|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890098|NCT02079740|537077104|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890099|NCT02079740|537077105|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890100|NCT02079740|537077106|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890101|NCT02079740|537077107|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
148890102|NCT02079740|537077108|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
148890103|NCT02079740|537077109|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
148890104|NCT02079740|537077110|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
149057828|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
149057829|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
149057830|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
149057831|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
149057832|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
149057833|NCT01539083|537694943|FG000|Before Randomization (VCD Induction)|Other|5|||
149057834|NCT01539083|537694944|FG001|Before Randomization (VCD Induction)|Other|0|||
149057835|NCT01539083|537694945|FG002|Before Randomization (VCD Induction)|Other|0|||
149057836|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
149057837|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
149057838|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
149057839|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Other|0|||
149057840|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Other|1|||
149057841|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Other|1|||
149057842|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
149057843|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
149057844|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
149057845|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
149057846|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
149057847|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
149057848|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
149057849|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
149057850|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
149057851|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
149057852|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
149057853|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
149057854|NCT01539083|537694943|FG000|After Randomization (TP and VTP)|Death|0|||
149057855|NCT01539083|537694944|FG001|After Randomization (TP and VTP)|Death|6|||
149057856|NCT01539083|537694945|FG002|After Randomization (TP and VTP)|Death|11|||
149057857|NCT04376502|537694958|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
149057858|NCT02268253|537694959|FG000|Stage 1|Withdrawal by Subject|1|||
149057859|NCT02268253|537694960|FG001|Stage 1|Withdrawal by Subject|0|||
149057860|NCT02268253|537694961|FG002|Stage 1|Withdrawal by Subject|0|||
149057861|NCT02268253|537694962|FG003|Stage 1|Withdrawal by Subject|0|||
149057862|NCT02268253|537694963|FG004|Stage 1|Withdrawal by Subject|0|||
149057863|NCT02268253|537694964|FG005|Stage 1|Withdrawal by Subject|0|||
149057864|NCT02268253|537694965|FG006|Stage 1|Withdrawal by Subject|0|||
149057865|NCT02268253|537694959|FG000|Stage 1|Death|0|||
149057866|NCT02268253|537694960|FG001|Stage 1|Death|2|||
149057867|NCT02268253|537694961|FG002|Stage 1|Death|2|||
149057868|NCT02268253|537694962|FG003|Stage 1|Death|2|||
149057869|NCT02268253|537694963|FG004|Stage 1|Death|1|||
149057870|NCT02268253|537694964|FG005|Stage 1|Death|1|||
149057871|NCT02268253|537694965|FG006|Stage 1|Death|0|||
149057872|NCT02268253|537694959|FG000|Stage 2|Disease Recurrence/ Progression|0|||
149057873|NCT02268253|537694960|FG001|Stage 2|Disease Recurrence/ Progression|0|||
149057874|NCT02268253|537694961|FG002|Stage 2|Disease Recurrence/ Progression|1|||
149057875|NCT02268253|537694962|FG003|Stage 2|Disease Recurrence/ Progression|0|||
149057876|NCT02268253|537694963|FG004|Stage 2|Disease Recurrence/ Progression|0|||
149057877|NCT02268253|537694964|FG005|Stage 2|Disease Recurrence/ Progression|0|||
149057878|NCT02268253|537694965|FG006|Stage 2|Disease Recurrence/ Progression|0|||
149057879|NCT02268253|537694959|FG000|Stage 2|Withdrawal by Subject|0|||
149057880|NCT02268253|537694960|FG001|Stage 2|Withdrawal by Subject|0|||
149057881|NCT02268253|537694961|FG002|Stage 2|Withdrawal by Subject|2|||
149057882|NCT02268253|537694962|FG003|Stage 2|Withdrawal by Subject|0|||
149057883|NCT02268253|537694963|FG004|Stage 2|Withdrawal by Subject|0|||
149057884|NCT02268253|537694964|FG005|Stage 2|Withdrawal by Subject|2|||
149057885|NCT02268253|537694965|FG006|Stage 2|Withdrawal by Subject|0|||
149057886|NCT02268253|537694959|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
149057887|NCT02268253|537694960|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
149057888|NCT02268253|537694961|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
149057889|NCT02268253|537694962|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
149057890|NCT02268253|537694963|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
149057891|NCT02268253|537694964|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
149057892|NCT02268253|537694965|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
149057893|NCT02268253|537694959|FG000|Stage 2|Death|0|||
149057894|NCT02268253|537694960|FG001|Stage 2|Death|0|||
149057895|NCT02268253|537694961|FG002|Stage 2|Death|19|||
149057896|NCT02268253|537694962|FG003|Stage 2|Death|0|||
149057897|NCT02268253|537694963|FG004|Stage 2|Death|0|||
149057898|NCT02268253|537694964|FG005|Stage 2|Death|20|||
149057899|NCT02268253|537694965|FG006|Stage 2|Death|1|||
149057900|NCT02268253|537694959|FG000|Stage 2|Lost to Follow-up|0|||
149057901|NCT02268253|537694960|FG001|Stage 2|Lost to Follow-up|0|||
149057902|NCT02268253|537694961|FG002|Stage 2|Lost to Follow-up|0|||
149057903|NCT02268253|537694962|FG003|Stage 2|Lost to Follow-up|0|||
149057904|NCT02268253|537694963|FG004|Stage 2|Lost to Follow-up|0|||
149057905|NCT02268253|537694964|FG005|Stage 2|Lost to Follow-up|4|||
149057906|NCT02268253|537694965|FG006|Stage 2|Lost to Follow-up|0|||
149057907|NCT02268253|537694959|FG000|Stage 2|Transferred to Hospice|0|||
148890105|NCT04617782|537077111|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
148890106|NCT04617782|537077111|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
148890107|NCT04617782|537077111|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
148890108|NCT04617782|537077111|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
148890109|NCT04617782|537077111|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
148890110|NCT04617782|537077111|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
149057908|NCT02268253|537694960|FG001|Stage 2|Transferred to Hospice|0|||
149057909|NCT02268253|537694961|FG002|Stage 2|Transferred to Hospice|0|||
149057910|NCT02268253|537694962|FG003|Stage 2|Transferred to Hospice|0|||
149057911|NCT02268253|537694963|FG004|Stage 2|Transferred to Hospice|0|||
149057912|NCT02268253|537694964|FG005|Stage 2|Transferred to Hospice|2|||
149057913|NCT02268253|537694965|FG006|Stage 2|Transferred to Hospice|0|||
149057914|NCT02268253|537694959|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
149057915|NCT02268253|537694960|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
149057916|NCT02268253|537694961|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
149057917|NCT02268253|537694962|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
149057918|NCT02268253|537694963|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
149057919|NCT02268253|537694964|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
148890111|NCT01474317|537077119|FG000|Overall Study|Adverse Event|1|||
148890112|NCT01474317|537077119|FG000|Overall Study|Subject ineligible for study|1|||
149057920|NCT02268253|537694965|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
149057921|NCT02268253|537694959|FG000|Stage 3A|Withdrawal by Subject|0|||
149057922|NCT02268253|537694960|FG001|Stage 3A|Withdrawal by Subject|0|||
149057923|NCT02268253|537694961|FG002|Stage 3A|Withdrawal by Subject|2|||
149057924|NCT02268253|537694962|FG003|Stage 3A|Withdrawal by Subject|0|||
149057925|NCT02268253|537694963|FG004|Stage 3A|Withdrawal by Subject|0|||
149057926|NCT02268253|537694964|FG005|Stage 3A|Withdrawal by Subject|0|||
149057927|NCT02268253|537694965|FG006|Stage 3A|Withdrawal by Subject|0|||
149057928|NCT02268253|537694959|FG000|Stage 3A|Physician Decision|0|||
149057929|NCT02268253|537694960|FG001|Stage 3A|Physician Decision|0|||
149057930|NCT02268253|537694961|FG002|Stage 3A|Physician Decision|2|||
149057931|NCT02268253|537694962|FG003|Stage 3A|Physician Decision|0|||
149057932|NCT02268253|537694963|FG004|Stage 3A|Physician Decision|0|||
149057933|NCT02268253|537694964|FG005|Stage 3A|Physician Decision|0|||
149057934|NCT02268253|537694965|FG006|Stage 3A|Physician Decision|0|||
149057935|NCT02268253|537694959|FG000|Stage 3A|Study Terminated by Sponsor|0|||
149057936|NCT02268253|537694960|FG001|Stage 3A|Study Terminated by Sponsor|0|||
149057937|NCT02268253|537694961|FG002|Stage 3A|Study Terminated by Sponsor|2|||
149057938|NCT02268253|537694962|FG003|Stage 3A|Study Terminated by Sponsor|0|||
149057939|NCT02268253|537694963|FG004|Stage 3A|Study Terminated by Sponsor|0|||
149057940|NCT02268253|537694964|FG005|Stage 3A|Study Terminated by Sponsor|0|||
149057941|NCT02268253|537694965|FG006|Stage 3A|Study Terminated by Sponsor|0|||
149057942|NCT02268253|537694959|FG000|Stage 3A|Lost to Follow-up|0|||
149057943|NCT02268253|537694960|FG001|Stage 3A|Lost to Follow-up|0|||
149057944|NCT02268253|537694961|FG002|Stage 3A|Lost to Follow-up|1|||
149057945|NCT02268253|537694962|FG003|Stage 3A|Lost to Follow-up|0|||
149057946|NCT02268253|537694963|FG004|Stage 3A|Lost to Follow-up|0|||
149057947|NCT02268253|537694964|FG005|Stage 3A|Lost to Follow-up|0|||
149057948|NCT02268253|537694965|FG006|Stage 3A|Lost to Follow-up|0|||
149057949|NCT02268253|537694959|FG000|Stage 3A|Death|0|||
149057950|NCT02268253|537694960|FG001|Stage 3A|Death|0|||
149057951|NCT02268253|537694961|FG002|Stage 3A|Death|5|||
149057952|NCT02268253|537694962|FG003|Stage 3A|Death|0|||
149057953|NCT02268253|537694963|FG004|Stage 3A|Death|0|||
149057954|NCT02268253|537694964|FG005|Stage 3A|Death|0|||
149057955|NCT02268253|537694965|FG006|Stage 3A|Death|0|||
149057956|NCT02547233|537694968|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
149057957|NCT02547233|537694969|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
149057958|NCT02547233|537694968|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
149057959|NCT02547233|537694969|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
149057960|NCT02547233|537694968|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
149057961|NCT02547233|537694969|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
149057962|NCT02547233|537694968|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
149057963|NCT02547233|537694969|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
149057964|NCT02547233|537694968|FG000|12-month Follow-up|Withdrawal by Subject|10|||
149057965|NCT02547233|537694969|FG001|12-month Follow-up|Withdrawal by Subject|10|||
149057966|NCT02547233|537694968|FG000|12-month Follow-up|Lost to Follow-up|3|||
149057967|NCT02547233|537694969|FG001|12-month Follow-up|Lost to Follow-up|3|||
149057968|NCT02547233|537694968|FG000|12-month Follow-up|Lack of Efficacy|1|||
149057969|NCT02547233|537694969|FG001|12-month Follow-up|Lack of Efficacy|2|||
149057970|NCT02547233|537694968|FG000|12-month Follow-up|Protocol Violation|0|||
149057971|NCT02547233|537694969|FG001|12-month Follow-up|Protocol Violation|1|||
149057972|NCT02547233|537694968|FG000|12-month Follow-up|Other|0|||
149057973|NCT02547233|537694969|FG001|12-month Follow-up|Other|1|||
149057974|NCT06019559|537694970|FG000|Overall Study|Withdrawal by Subject|7|||
149057975|NCT06019559|537694971|FG001|Overall Study|Withdrawal by Subject|6|||
149057976|NCT06019559|537694972|FG002|Overall Study|Withdrawal by Subject|5|||
149057977|NCT06019559|537694970|FG000|Overall Study|Lost to Follow-up|2|||
149057978|NCT06019559|537694971|FG001|Overall Study|Lost to Follow-up|0|||
149057979|NCT06019559|537694972|FG002|Overall Study|Lost to Follow-up|3|||
149057980|NCT01824537|537694973|FG000|Overall Study|Lost to Follow-up|78|||
149057981|NCT01824537|537694974|FG001|Overall Study|Lost to Follow-up|87|||
149057982|NCT05362487|537694975|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
149057983|NCT06215521|537694977|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
149057984|NCT06215521|537694978|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
149057985|NCT06215521|537694979|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
149057986|NCT06215521|537694980|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
149057987|NCT06215521|537694981|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
149057988|NCT06215521|537694982|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
149057989|NCT04096040|537694983|FG000|Overall Study|Protocol Violation|12|||
149057990|NCT04096040|537694983|FG000|Overall Study|Non-compliant site|4|||
149057991|NCT03603600|537694986|FG000|Overall Study|Withdrawal by Subject|5|||
149057992|NCT03603600|537694987|FG001|Overall Study|Withdrawal by Subject|7|||
149057993|NCT03603600|537694986|FG000|Overall Study|Lost to Follow-up|2|||
149057994|NCT03603600|537694987|FG001|Overall Study|Lost to Follow-up|3|||
149057995|NCT03603600|537694986|FG000|Overall Study|Death|3|||
149057996|NCT03603600|537694987|FG001|Overall Study|Death|1|||
149057997|NCT03603600|537694986|FG000|Overall Study|Physician Decision|2|||
149057998|NCT03603600|537694987|FG001|Overall Study|Physician Decision|1|||
149057999|NCT03603600|537694986|FG000|Overall Study|Other reason|1|||
149058000|NCT03603600|537694987|FG001|Overall Study|Other reason|0|||
149058001|NCT04044768|537694988|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
149058002|NCT04044768|537694989|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
149058003|NCT03858634|537694990|FG000|Overall Study|Withdrawal by Subject|1|||
149058004|NCT03858634|537694991|FG001|Overall Study|Withdrawal by Subject|0|||
149058005|NCT03858634|537694990|FG000|Overall Study|Adverse Event|1|||
149058006|NCT03858634|537694991|FG001|Overall Study|Adverse Event|0|||
149058007|NCT03858634|537694990|FG000|Overall Study|Lost to Follow-up|0|||
149058008|NCT03858634|537694991|FG001|Overall Study|Lost to Follow-up|1|||
149058009|NCT03858634|537694990|FG000|Overall Study|Other, Not Specified|1|||
149058010|NCT03858634|537694991|FG001|Overall Study|Other, Not Specified|1|||
149058013|NCT03461276|537694995|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
149058014|NCT03461276|537694996|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
149058015|NCT03461276|537694995|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
149058016|NCT03461276|537694996|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
149058017|NCT03461276|537694995|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
149058018|NCT03461276|537694996|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
149058019|NCT03461276|537694995|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
149058020|NCT03461276|537694996|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
149058021|NCT03461276|537694995|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
149058022|NCT03461276|537694996|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
149058023|NCT03461276|537694995|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
149058024|NCT03461276|537694996|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
149058025|NCT03461276|537694995|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
149058026|NCT03461276|537694996|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
149058027|NCT03461276|537694995|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
149058028|NCT03461276|537694996|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
149058029|NCT03461276|537694995|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
149058030|NCT03461276|537694996|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
149058031|NCT03461276|537694995|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
149058032|NCT03461276|537694996|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
149058033|NCT01802788|537694998|FG000|Overall Study|Withdrawal by Subject|102|||
149058034|NCT01802788|537694999|FG001|Overall Study|Withdrawal by Subject|5|||
149058035|NCT01802788|537694998|FG000|Overall Study|Death|382|||
149058036|NCT01802788|537694999|FG001|Overall Study|Death|18|||
149058037|NCT01802788|537694998|FG000|Overall Study|Lost to Follow-up|31|||
149058038|NCT01802788|537694999|FG001|Overall Study|Lost to Follow-up|2|||
149058039|NCT01802788|537694998|FG000|Overall Study|Physician Decision|3|||
149058040|NCT01802788|537694999|FG001|Overall Study|Physician Decision|0|||
149058041|NCT01802788|537694998|FG000|Overall Study|Patient Non-Compliance|1|||
149058042|NCT01802788|537694999|FG001|Overall Study|Patient Non-Compliance|0|||
149058043|NCT01802788|537694998|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
149058044|NCT01802788|537694999|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
149058045|NCT01802788|537694998|FG000|Overall Study|Other Reasons|19|||
149058046|NCT01802788|537694999|FG001|Overall Study|Other Reasons|0|||
149058047|NCT03496168|537695000|FG000|Overall Study|Other Reasons|1|||
149058048|NCT03496168|537695000|FG000|Overall Study|Adverse Event|1|||
149058049|NCT02043678|537695003|FG000|Overall Study|Never treated|11|||
149058050|NCT02043678|537695004|FG001|Overall Study|Never treated|9|||
149058051|NCT02043678|537695003|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
149058052|NCT02043678|537695004|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
149058053|NCT02043678|537695003|FG000|Overall Study|AE without clinical PD|54|||
149058054|NCT02043678|537695004|FG001|Overall Study|AE without clinical PD|36|||
149058055|NCT02043678|537695003|FG000|Overall Study|Lost to Follow-up|1|||
149058056|NCT02043678|537695004|FG001|Overall Study|Lost to Follow-up|1|||
149058057|NCT02043678|537695003|FG000|Overall Study|Other|10|||
148890113|NCT00387881|537077120|FG000|Overall Study|Lost to Follow-up|23|||
148890114|NCT00387881|537077121|FG001|Overall Study|Lost to Follow-up|23|||
148890115|NCT00387881|537077120|FG000|Overall Study|Protocol Violation|2|||
148890116|NCT00387881|537077121|FG001|Overall Study|Protocol Violation|12|||
148890117|NCT00387881|537077120|FG000|Overall Study|Withdrawal by Subject|15|||
148890118|NCT00387881|537077121|FG001|Overall Study|Withdrawal by Subject|18|||
148890119|NCT00387881|537077120|FG000|Overall Study|Sponsor terminated Study|0|||
148890120|NCT00387881|537077121|FG001|Overall Study|Sponsor terminated Study|1|||
148890121|NCT00387881|537077120|FG000|Overall Study|Not eligible|6|||
148890122|NCT00387881|537077121|FG001|Overall Study|Not eligible|7|||
148890123|NCT00387881|537077120|FG000|Overall Study|No opportunity to treat headache|32|||
148890124|NCT00387881|537077121|FG001|Overall Study|No opportunity to treat headache|34|||
148890125|NCT00387881|537077120|FG000|Overall Study|Not otherwise specified|11|||
148890126|NCT00387881|537077121|FG001|Overall Study|Not otherwise specified|7|||
148890127|NCT00453154|537077124|FG000|Double BIind Maintenance|Adverse Event|0|||
148890128|NCT00453154|537077125|FG001|Double BIind Maintenance|Adverse Event|0|||
149058058|NCT02043678|537695004|FG001|Overall Study|Other|14|||
149058059|NCT02043678|537695003|FG000|Overall Study|Clinical PD|114|||
149058060|NCT02043678|537695004|FG001|Overall Study|Clinical PD|148|||
149058061|NCT02043678|537695003|FG000|Overall Study|Radiological PD|100|||
149058062|NCT02043678|537695004|FG001|Overall Study|Radiological PD|90|||
149058063|NCT02043678|537695003|FG000|Overall Study|Protocol-driven decision point|59|||
149058064|NCT02043678|537695004|FG001|Overall Study|Protocol-driven decision point|58|||
149058065|NCT02043678|537695003|FG000|Overall Study|Withdrawal by Subject|16|||
149058066|NCT02043678|537695004|FG001|Overall Study|Withdrawal by Subject|20|||
149058067|NCT02043678|537695003|FG000|Overall Study|Protocol Violation|1|||
149058068|NCT02043678|537695004|FG001|Overall Study|Protocol Violation|0|||
149058069|NCT02043678|537695003|FG000|Overall Study|Deterioration of general conditions|1|||
149058070|NCT02043678|537695004|FG001|Overall Study|Deterioration of general conditions|1|||
149058071|NCT02043678|537695003|FG000|Overall Study|Logistical difficulties|2|||
149058072|NCT02043678|537695004|FG001|Overall Study|Logistical difficulties|0|||
149058073|NCT02043678|537695003|FG000|Overall Study|Non-compliance with study drug|3|||
149058074|NCT02043678|537695004|FG001|Overall Study|Non-compliance with study drug|1|||
149058075|NCT02043678|537695003|FG000|Overall Study|Physician Decision|4|||
149058076|NCT02043678|537695004|FG001|Overall Study|Physician Decision|3|||
149058077|NCT02043678|537695003|FG000|Overall Study|Subject decision|0|||
149058078|NCT02043678|537695004|FG001|Overall Study|Subject decision|1|||
149058079|NCT02043678|537695003|FG000|Overall Study|Switching to other therapy|3|||
149058080|NCT02043678|537695004|FG001|Overall Study|Switching to other therapy|2|||
149058081|NCT02043678|537695003|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
149058082|NCT02043678|537695004|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
149058083|NCT02043678|537695003|FG000|Overall Study|Missing|1|||
149058084|NCT02043678|537695004|FG001|Overall Study|Missing|0|||
149058085|NCT02043678|537695003|FG000|Overall Study|Adverse Event|0|||
149058086|NCT02043678|537695004|FG001|Overall Study|Adverse Event|1|||
149058087|NCT03216057|537695005|FG000|Overall Study|Lost to Follow-up|2|||
149058088|NCT03216057|537695006|FG001|Overall Study|Lost to Follow-up|2|||
149058089|NCT04568603|537695007|FG000|Overall Study|Physician Decision|1|||
149058090|NCT04564742|537695008|FG000|Overall Study|Lost to Follow-up|1|||
149058091|NCT04564742|537695009|FG001|Overall Study|Lost to Follow-up|0|||
149058092|NCT04564742|537695008|FG000|Overall Study|Consent Withdrawal|4|||
149058093|NCT04564742|537695009|FG001|Overall Study|Consent Withdrawal|4|||
149058094|NCT05126433|537695010|FG000|Overall Study|Withdrawal by Subject|3|||
149058095|NCT05126433|537695011|FG001|Overall Study|Withdrawal by Subject|0|||
149058096|NCT05126433|537695012|FG002|Overall Study|Withdrawal by Subject|4|||
149058097|NCT05126433|537695010|FG000|Overall Study|Death|9|||
149058098|NCT05126433|537695011|FG001|Overall Study|Death|3|||
149058099|NCT05126433|537695012|FG002|Overall Study|Death|5|||
149058100|NCT05126433|537695010|FG000|Overall Study|Study Terminated by sponsor|0|||
149058101|NCT05126433|537695011|FG001|Overall Study|Study Terminated by sponsor|1|||
149058102|NCT05126433|537695012|FG002|Overall Study|Study Terminated by sponsor|2|||
149058103|NCT05126433|537695010|FG000|Overall Study|Progressive Disease|1|||
149058104|NCT05126433|537695011|FG001|Overall Study|Progressive Disease|4|||
149058105|NCT05126433|537695012|FG002|Overall Study|Progressive Disease|3|||
149058106|NCT05126433|537695010|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
149058107|NCT05126433|537695011|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
149058108|NCT05126433|537695012|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
149058109|NCT05269667|537695016|FG000|Overall Study|Study Terminated by Sponsor|4|||
149058110|NCT05270408|537695018|FG000|Started Treatment|Withdrawal by Subject|0|||
149058111|NCT05270408|537695019|FG001|Started Treatment|Withdrawal by Subject|0|||
149058112|NCT05270408|537695020|FG002|Started Treatment|Withdrawal by Subject|3|||
149058113|NCT05270408|537695018|FG000|Started Treatment|Adverse Event|0|||
149058114|NCT05270408|537695019|FG001|Started Treatment|Adverse Event|0|||
149058115|NCT05270408|537695020|FG002|Started Treatment|Adverse Event|1|||
149058116|NCT05270408|537695018|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
149058117|NCT05270408|537695019|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
149058118|NCT05270408|537695020|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
149058119|NCT03768505|537695021|FG000|Overall Study|sponsor decision|76|||
149058120|NCT03768505|537695021|FG000|Overall Study|Death|35|||
149058121|NCT03768505|537695021|FG000|Overall Study|Other -Various|30|||
149058122|NCT03768505|537695021|FG000|Overall Study|Withdrawal by Subject|22|||
149058123|NCT03768505|537695021|FG000|Overall Study|Lost to Follow-up|6|||
149058124|NCT04948697|537695022|FG000|Overall Study|Progressive disease|27|||
149058125|NCT04948697|537695023|FG001|Overall Study|Progressive disease|18|||
149058126|NCT04948697|537695022|FG000|Overall Study|Adverse Event|14|||
148890129|NCT00453154|537077126|FG002|Double BIind Maintenance|Adverse Event|3|||
149058127|NCT04948697|537695023|FG001|Overall Study|Adverse Event|4|||
149058128|NCT04948697|537695022|FG000|Overall Study|Participant moved to long term extension study|7|||
149058129|NCT04948697|537695023|FG001|Overall Study|Participant moved to long term extension study|4|||
149058130|NCT04948697|537695022|FG000|Overall Study|Withdrawal by Subject|10|||
149058131|NCT04948697|537695023|FG001|Overall Study|Withdrawal by Subject|0|||
148890130|NCT00453154|537077127|FG003|Double BIind Maintenance|Adverse Event|12|||
149058132|NCT04948697|537695022|FG000|Overall Study|Closed by Sponsor|3|||
149058133|NCT04948697|537695023|FG001|Overall Study|Closed by Sponsor|2|||
149058134|NCT04948697|537695022|FG000|Overall Study|Physician Decision|0|||
149058135|NCT04948697|537695023|FG001|Overall Study|Physician Decision|2|||
149058136|NCT04948697|537695022|FG000|Overall Study|Lost to Follow-up|0|||
149058137|NCT04948697|537695023|FG001|Overall Study|Lost to Follow-up|1|||
149058138|NCT04948697|537695022|FG000|Overall Study|Other-Miscellaneous|1|||
149058139|NCT04948697|537695023|FG001|Overall Study|Other-Miscellaneous|0|||
149058140|NCT04948697|537695022|FG000|Overall Study|Randomized but not treated|0|||
149058141|NCT04948697|537695023|FG001|Overall Study|Randomized but not treated|1|||
149058142|NCT04599062|537695025|FG000|Overall Study|Physician Decision|1|||
149058143|NCT04599062|537695026|FG001|Overall Study|Physician Decision|0|||
149058144|NCT03058289|537695027|FG000|Overall Study|Radiographic Deterioration|0|||
149058145|NCT03058289|537695028|FG001|Overall Study|Radiographic Deterioration|3|||
149058146|NCT03058289|537695029|FG002|Overall Study|Radiographic Deterioration|1|||
149058147|NCT03058289|537695030|FG003|Overall Study|Radiographic Deterioration|2|||
149058148|NCT03058289|537695031|FG004|Overall Study|Radiographic Deterioration|6|||
149058149|NCT03058289|537695032|FG005|Overall Study|Radiographic Deterioration|3|||
149058150|NCT03058289|537695033|FG006|Overall Study|Radiographic Deterioration|0|||
149058151|NCT03058289|537695034|FG007|Overall Study|Radiographic Deterioration|4|||
149058152|NCT03058289|537695035|FG008|Overall Study|Radiographic Deterioration|2|||
149058153|NCT03058289|537695027|FG000|Overall Study|Adverse Event|2|||
149058154|NCT03058289|537695028|FG001|Overall Study|Adverse Event|0|||
149058155|NCT03058289|537695029|FG002|Overall Study|Adverse Event|1|||
149058156|NCT03058289|537695030|FG003|Overall Study|Adverse Event|3|||
149058157|NCT03058289|537695031|FG004|Overall Study|Adverse Event|1|||
149058158|NCT03058289|537695032|FG005|Overall Study|Adverse Event|0|||
149058159|NCT03058289|537695033|FG006|Overall Study|Adverse Event|1|||
149058160|NCT03058289|537695034|FG007|Overall Study|Adverse Event|3|||
149058161|NCT03058289|537695035|FG008|Overall Study|Adverse Event|0|||
149058162|NCT03058289|537695027|FG000|Overall Study|Withdrawal by Subject|0|||
149058163|NCT03058289|537695028|FG001|Overall Study|Withdrawal by Subject|0|||
149058164|NCT03058289|537695029|FG002|Overall Study|Withdrawal by Subject|0|||
149058165|NCT03058289|537695030|FG003|Overall Study|Withdrawal by Subject|2|||
149058166|NCT03058289|537695031|FG004|Overall Study|Withdrawal by Subject|0|||
149058167|NCT03058289|537695032|FG005|Overall Study|Withdrawal by Subject|2|||
149058168|NCT03058289|537695033|FG006|Overall Study|Withdrawal by Subject|0|||
149058169|NCT03058289|537695034|FG007|Overall Study|Withdrawal by Subject|4|||
149058170|NCT03058289|537695035|FG008|Overall Study|Withdrawal by Subject|1|||
149058171|NCT03058289|537695027|FG000|Overall Study|Physician Decision|1|||
149058172|NCT03058289|537695028|FG001|Overall Study|Physician Decision|0|||
149058173|NCT03058289|537695029|FG002|Overall Study|Physician Decision|0|||
149058174|NCT03058289|537695030|FG003|Overall Study|Physician Decision|2|||
149058175|NCT03058289|537695031|FG004|Overall Study|Physician Decision|1|||
149058176|NCT03058289|537695032|FG005|Overall Study|Physician Decision|0|||
149058177|NCT03058289|537695033|FG006|Overall Study|Physician Decision|2|||
149058178|NCT03058289|537695034|FG007|Overall Study|Physician Decision|3|||
149058179|NCT03058289|537695035|FG008|Overall Study|Physician Decision|0|||
149058180|NCT03058289|537695027|FG000|Overall Study|Clinical Deterioration|2|||
149058181|NCT03058289|537695028|FG001|Overall Study|Clinical Deterioration|0|||
149058182|NCT03058289|537695029|FG002|Overall Study|Clinical Deterioration|0|||
149058183|NCT03058289|537695030|FG003|Overall Study|Clinical Deterioration|2|||
149058184|NCT03058289|537695031|FG004|Overall Study|Clinical Deterioration|1|||
149058185|NCT03058289|537695032|FG005|Overall Study|Clinical Deterioration|1|||
149058186|NCT03058289|537695033|FG006|Overall Study|Clinical Deterioration|0|||
149058187|NCT03058289|537695034|FG007|Overall Study|Clinical Deterioration|3|||
149058188|NCT03058289|537695035|FG008|Overall Study|Clinical Deterioration|2|||
149058189|NCT03058289|537695027|FG000|Overall Study|Lost to Follow-up|0|||
149058190|NCT03058289|537695028|FG001|Overall Study|Lost to Follow-up|0|||
149058191|NCT03058289|537695029|FG002|Overall Study|Lost to Follow-up|0|||
149058192|NCT03058289|537695030|FG003|Overall Study|Lost to Follow-up|0|||
149058193|NCT03058289|537695031|FG004|Overall Study|Lost to Follow-up|1|||
149058194|NCT03058289|537695032|FG005|Overall Study|Lost to Follow-up|0|||
149058195|NCT03058289|537695033|FG006|Overall Study|Lost to Follow-up|0|||
149058196|NCT03058289|537695034|FG007|Overall Study|Lost to Follow-up|0|||
149058197|NCT03058289|537695035|FG008|Overall Study|Lost to Follow-up|0|||
149058198|NCT03058289|537695027|FG000|Overall Study|Refused Further Treatment|0|||
149058199|NCT03058289|537695028|FG001|Overall Study|Refused Further Treatment|0|||
149058200|NCT03058289|537695029|FG002|Overall Study|Refused Further Treatment|1|||
149058201|NCT03058289|537695030|FG003|Overall Study|Refused Further Treatment|0|||
149058202|NCT03058289|537695031|FG004|Overall Study|Refused Further Treatment|1|||
149058203|NCT03058289|537695032|FG005|Overall Study|Refused Further Treatment|0|||
149058204|NCT03058289|537695033|FG006|Overall Study|Refused Further Treatment|0|||
149058205|NCT03058289|537695034|FG007|Overall Study|Refused Further Treatment|0|||
149058206|NCT03058289|537695035|FG008|Overall Study|Refused Further Treatment|0|||
149058207|NCT03058289|537695027|FG000|Overall Study|Rapid Progression of Disease|0|||
149058208|NCT03058289|537695028|FG001|Overall Study|Rapid Progression of Disease|0|||
149058209|NCT03058289|537695029|FG002|Overall Study|Rapid Progression of Disease|0|||
149058210|NCT03058289|537695030|FG003|Overall Study|Rapid Progression of Disease|1|||
149058211|NCT03058289|537695031|FG004|Overall Study|Rapid Progression of Disease|0|||
149058212|NCT03058289|537695032|FG005|Overall Study|Rapid Progression of Disease|0|||
149058213|NCT03058289|537695033|FG006|Overall Study|Rapid Progression of Disease|0|||
149058214|NCT03058289|537695034|FG007|Overall Study|Rapid Progression of Disease|0|||
149058215|NCT03058289|537695035|FG008|Overall Study|Rapid Progression of Disease|0|||
149058216|NCT04515849|537695040|FG000|Overall Study|Adverse Event|0|||
149058217|NCT04515849|537695041|FG001|Overall Study|Adverse Event|0|||
149058218|NCT04515849|537695042|FG002|Overall Study|Adverse Event|0|||
149058219|NCT04515849|537695043|FG003|Overall Study|Adverse Event|1|||
149058220|NCT04515849|537695044|FG004|Overall Study|Adverse Event|2|||
149058221|NCT04515849|537695040|FG000|Overall Study|Death|2|||
149058222|NCT04515849|537695041|FG001|Overall Study|Death|0|||
149058223|NCT04515849|537695042|FG002|Overall Study|Death|0|||
149058224|NCT04515849|537695043|FG003|Overall Study|Death|0|||
149058225|NCT04515849|537695044|FG004|Overall Study|Death|0|||
149058226|NCT04515849|537695040|FG000|Overall Study|Other:family emergency|0|||
149058227|NCT04515849|537695041|FG001|Overall Study|Other:family emergency|0|||
149058228|NCT04515849|537695042|FG002|Overall Study|Other:family emergency|0|||
149058229|NCT04515849|537695043|FG003|Overall Study|Other:family emergency|1|||
149058230|NCT04515849|537695044|FG004|Overall Study|Other:family emergency|0|||
149058231|NCT04515849|537695040|FG000|Overall Study|Other:randomised by error|0|||
149058232|NCT04515849|537695041|FG001|Overall Study|Other:randomised by error|1|||
149058233|NCT04515849|537695042|FG002|Overall Study|Other:randomised by error|0|||
149058234|NCT04515849|537695043|FG003|Overall Study|Other:randomised by error|0|||
149058235|NCT04515849|537695044|FG004|Overall Study|Other:randomised by error|0|||
149058236|NCT04515849|537695040|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
149058237|NCT04515849|537695041|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
149058238|NCT04515849|537695042|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
149058239|NCT04515849|537695043|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
149058240|NCT04515849|537695044|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
149058241|NCT04515849|537695040|FG000|Overall Study|Physician Decision|0|||
149058242|NCT04515849|537695041|FG001|Overall Study|Physician Decision|1|||
149058243|NCT04515849|537695042|FG002|Overall Study|Physician Decision|0|||
149058244|NCT04515849|537695043|FG003|Overall Study|Physician Decision|0|||
149058245|NCT04515849|537695044|FG004|Overall Study|Physician Decision|0|||
149058246|NCT04515849|537695040|FG000|Overall Study|Withdrawal by Subject|1|||
149058247|NCT04515849|537695041|FG001|Overall Study|Withdrawal by Subject|2|||
149058248|NCT04515849|537695042|FG002|Overall Study|Withdrawal by Subject|1|||
149058249|NCT04515849|537695043|FG003|Overall Study|Withdrawal by Subject|0|||
149058250|NCT04515849|537695044|FG004|Overall Study|Withdrawal by Subject|0|||
149058251|NCT04437615|537695049|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
149058252|NCT03869866|537696978|FG000|Overall Study|Protocol Violation|1|||
149058253|NCT03869866|537696978|FG000|Overall Study|Withdrawal by Subject|3|||
149058254|NCT06181227|537696979|FG000|Overall Study|Study terminated by sponsor|7|||
149058255|NCT06181227|537696980|FG001|Overall Study|Study terminated by sponsor|9|||
149058256|NCT06516705|537696981|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
149058257|NCT06516705|537696982|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
149058258|NCT06516705|537696981|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
149058259|NCT06516705|537696982|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
149058260|NCT06516705|537696981|FG000|T3 ( 3 Month After Education)|covid-19|1|||
149058261|NCT06516705|537696982|FG001|T3 ( 3 Month After Education)|covid-19|2|||
149058262|NCT06516705|537696981|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
149058263|NCT06516705|537696982|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
149058264|NCT06516705|537696981|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
149058265|NCT06516705|537696982|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
149058266|NCT06516705|537696981|FG000|T4 ( 6 Month After Education)|covid-19|3|||
149058267|NCT06516705|537696982|FG001|T4 ( 6 Month After Education)|covid-19|2|||
149058268|NCT06516705|537696981|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
149058269|NCT06516705|537696982|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
149058270|NCT05579899|537696983|FG000|Overall Study|Lost to Follow-up|3|||
149058271|NCT05579899|537696984|FG001|Overall Study|Lost to Follow-up|1|||
149058272|NCT05579899|537696983|FG000|Overall Study|Adverse Event|0|||
149058273|NCT05579899|537696984|FG001|Overall Study|Adverse Event|3|||
149058274|NCT05579899|537696983|FG000|Overall Study|Pregnancy|0|||
149058275|NCT05579899|537696984|FG001|Overall Study|Pregnancy|1|||
149058276|NCT05579899|537696983|FG000|Overall Study|Withdrawal by Subject|0|||
149058277|NCT05579899|537696984|FG001|Overall Study|Withdrawal by Subject|3|||
149058278|NCT03023410|537696985|FG000|Overall Study|study termination|0|||
149058279|NCT03023410|537696986|FG001|Overall Study|study termination|1|||
149058280|NCT03379675|537696989|FG000|Overall Study|Lost to Follow-up|0|||
149058281|NCT03379675|537696990|FG001|Overall Study|Lost to Follow-up|1|||
149058282|NCT03379675|537696991|FG002|Overall Study|Lost to Follow-up|0|||
149058283|NCT03379675|537696989|FG000|Overall Study|Adverse Event|2|||
149058284|NCT03379675|537696990|FG001|Overall Study|Adverse Event|0|||
149058285|NCT03379675|537696991|FG002|Overall Study|Adverse Event|0|||
149058286|NCT03379675|537696989|FG000|Overall Study|Withdrawal by Subject|2|||
149058287|NCT03379675|537696990|FG001|Overall Study|Withdrawal by Subject|1|||
149058288|NCT03379675|537696991|FG002|Overall Study|Withdrawal by Subject|2|||
149058289|NCT05540665|537696992|FG000|Overall Study|Study terminated by sponsor|6|||
149058290|NCT05540665|537696993|FG001|Overall Study|Study terminated by sponsor|6|||
149058291|NCT05540665|537696994|FG002|Overall Study|Study terminated by sponsor|7|||
149058292|NCT03381196|537696997|FG000|Overall Study|Withdrawal by Subject|7|||
149058293|NCT03381196|537696998|FG001|Overall Study|Withdrawal by Subject|7|||
149058294|NCT03381196|537696997|FG000|Overall Study|Other|0|||
149058295|NCT03381196|537696998|FG001|Overall Study|Other|1|||
149058296|NCT03381196|537696997|FG000|Overall Study|Lost to Follow-up|5|||
149058297|NCT03381196|537696998|FG001|Overall Study|Lost to Follow-up|4|||
149058298|NCT03381196|537696997|FG000|Overall Study|Death|0|||
149058299|NCT03381196|537696998|FG001|Overall Study|Death|1|||
149058300|NCT03381196|537696997|FG000|Overall Study|Adverse Event|1|||
149058301|NCT03381196|537696998|FG001|Overall Study|Adverse Event|0|||
149058302|NCT03381196|537696997|FG000|Overall Study|Randomized, not treated|3|||
149058303|NCT03381196|537696998|FG001|Overall Study|Randomized, not treated|6|||
149058304|NCT02675751|537696999|FG000|Overall Study|Lost to Follow-up|16|||
149058305|NCT03628924|537697000|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
149058306|NCT03628924|537697001|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
149058307|NCT03628924|537697002|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
149058308|NCT03628924|537697003|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
149058309|NCT03628924|537697004|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
149058310|NCT03628924|537697005|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
149058311|NCT03628924|537697006|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
149058312|NCT03628924|537697000|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149058313|NCT03628924|537697001|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149058314|NCT03628924|537697002|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
149058315|NCT03628924|537697003|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149058316|NCT03628924|537697004|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149058317|NCT03628924|537697005|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149058318|NCT03628924|537697006|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
149058319|NCT03628924|537697000|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
149058320|NCT03628924|537697001|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
149058321|NCT03628924|537697002|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
149058322|NCT03628924|537697003|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
149058323|NCT03628924|537697004|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
149058324|NCT03628924|537697005|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
149058325|NCT03628924|537697006|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
149058326|NCT03628924|537697000|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149058327|NCT03628924|537697001|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
149058328|NCT03628924|537697002|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149058329|NCT03628924|537697003|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149058330|NCT03628924|537697004|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149058331|NCT03628924|537697005|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149058332|NCT03628924|537697006|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149058333|NCT03628924|537697000|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
149058334|NCT03628924|537697001|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
149058335|NCT03628924|537697002|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
149058336|NCT03628924|537697003|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
149058337|NCT03628924|537697004|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
149058338|NCT03628924|537697005|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
149058339|NCT03628924|537697006|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
149058340|NCT03628924|537697000|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
149058341|NCT03628924|537697001|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
149058342|NCT03628924|537697002|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
149058343|NCT03628924|537697003|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
149058344|NCT03628924|537697004|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
149058345|NCT03628924|537697005|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
149058346|NCT03628924|537697006|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
149058347|NCT03628924|537697000|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
149058348|NCT03628924|537697001|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
149058349|NCT03628924|537697002|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
149058350|NCT03628924|537697003|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
149058351|NCT03628924|537697004|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
149058352|NCT03628924|537697005|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
149058353|NCT03628924|537697006|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
149058354|NCT03628924|537697000|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
149058355|NCT03628924|537697001|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
149058356|NCT03628924|537697002|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
149058357|NCT03628924|537697003|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
149058358|NCT03628924|537697004|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
149058359|NCT03628924|537697005|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
149058360|NCT03628924|537697006|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
149058361|NCT03628924|537697000|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
149058362|NCT03628924|537697001|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
149058363|NCT03628924|537697002|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
149058364|NCT03628924|537697003|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
149058365|NCT03628924|537697004|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
149058366|NCT03628924|537697005|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
149058367|NCT03628924|537697006|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
149058368|NCT03628924|537697000|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
149058369|NCT03628924|537697001|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
149058370|NCT03628924|537697002|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
149058371|NCT03628924|537697003|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
149058372|NCT03628924|537697004|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
149058373|NCT03628924|537697005|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
149058374|NCT03628924|537697006|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
149058375|NCT05672069|537697010|FG000|Overall Study|Implant removal|1|||
149058376|NCT05672069|537697010|FG000|Overall Study|Lost to Follow-up|2|||
149058377|NCT04032704|537697021|FG000|Part A|Withdrawal by Subject|0|||
149058378|NCT04032704|537697022|FG001|Part A|Withdrawal by Subject|0|||
149058379|NCT04032704|537697023|FG002|Part A|Withdrawal by Subject|3|||
149058380|NCT04032704|537697024|FG003|Part A|Withdrawal by Subject|0|||
149058381|NCT04032704|537697025|FG004|Part A|Withdrawal by Subject|1|||
149058382|NCT04032704|537697026|FG005|Part A|Withdrawal by Subject|7|||
149058383|NCT04032704|537697027|FG006|Part A|Withdrawal by Subject|0|||
149058384|NCT04032704|537697028|FG007|Part A|Withdrawal by Subject|0|||
149058385|NCT04032704|537697029|FG008|Part A|Withdrawal by Subject|0|||
149058386|NCT04032704|537697030|FG009|Part A|Withdrawal by Subject|0|||
149058387|NCT04032704|537697031|FG010|Part A|Withdrawal by Subject|0|||
149058388|NCT04032704|537697032|FG011|Part A|Withdrawal by Subject|0|||
149058389|NCT04032704|537697033|FG012|Part A|Withdrawal by Subject|0|||
149058390|NCT04032704|537697034|FG013|Part A|Withdrawal by Subject|0|||
149058391|NCT04032704|537697035|FG014|Part A|Withdrawal by Subject|0|||
149058392|NCT04032704|537697036|FG015|Part A|Withdrawal by Subject|0|||
149058393|NCT04032704|537697037|FG016|Part A|Withdrawal by Subject|0|||
149058394|NCT04032704|537697038|FG017|Part A|Withdrawal by Subject|0|||
149058395|NCT04032704|537697021|FG000|Part A|Lost to Follow-up|1|||
149058396|NCT04032704|537697022|FG001|Part A|Lost to Follow-up|0|||
149058397|NCT04032704|537697023|FG002|Part A|Lost to Follow-up|0|||
149058398|NCT04032704|537697024|FG003|Part A|Lost to Follow-up|0|||
149058399|NCT04032704|537697025|FG004|Part A|Lost to Follow-up|0|||
149058400|NCT04032704|537697026|FG005|Part A|Lost to Follow-up|0|||
149058401|NCT04032704|537697027|FG006|Part A|Lost to Follow-up|0|||
149058402|NCT04032704|537697028|FG007|Part A|Lost to Follow-up|0|||
149058403|NCT04032704|537697029|FG008|Part A|Lost to Follow-up|0|||
149058404|NCT04032704|537697030|FG009|Part A|Lost to Follow-up|0|||
149058405|NCT04032704|537697031|FG010|Part A|Lost to Follow-up|0|||
149058406|NCT04032704|537697032|FG011|Part A|Lost to Follow-up|0|||
149058407|NCT04032704|537697033|FG012|Part A|Lost to Follow-up|0|||
149058408|NCT04032704|537697034|FG013|Part A|Lost to Follow-up|0|||
149058409|NCT04032704|537697035|FG014|Part A|Lost to Follow-up|0|||
149058410|NCT04032704|537697036|FG015|Part A|Lost to Follow-up|0|||
149058411|NCT04032704|537697037|FG016|Part A|Lost to Follow-up|0|||
149058412|NCT04032704|537697038|FG017|Part A|Lost to Follow-up|0|||
149058413|NCT04032704|537697021|FG000|Part A|Death|9|||
149058414|NCT04032704|537697022|FG001|Part A|Death|2|||
149058415|NCT04032704|537697023|FG002|Part A|Death|10|||
149058416|NCT04032704|537697024|FG003|Part A|Death|7|||
149058417|NCT04032704|537697025|FG004|Part A|Death|4|||
149058418|NCT04032704|537697026|FG005|Part A|Death|5|||
149058419|NCT04032704|537697027|FG006|Part A|Death|0|||
149058420|NCT04032704|537697028|FG007|Part A|Death|0|||
149058421|NCT04032704|537697029|FG008|Part A|Death|0|||
149058422|NCT04032704|537697030|FG009|Part A|Death|0|||
149058423|NCT04032704|537697031|FG010|Part A|Death|0|||
149058424|NCT04032704|537697032|FG011|Part A|Death|0|||
149058425|NCT04032704|537697033|FG012|Part A|Death|0|||
148890131|NCT00453154|537077124|FG000|Double BIind Maintenance|Death|0|||
148890132|NCT00453154|537077125|FG001|Double BIind Maintenance|Death|0|||
148890133|NCT00453154|537077126|FG002|Double BIind Maintenance|Death|2|||
149058426|NCT04032704|537697034|FG013|Part A|Death|0|||
149058427|NCT04032704|537697035|FG014|Part A|Death|0|||
149058428|NCT04032704|537697036|FG015|Part A|Death|0|||
149058429|NCT04032704|537697037|FG016|Part A|Death|0|||
149058430|NCT04032704|537697038|FG017|Part A|Death|0|||
149058431|NCT04032704|537697021|FG000|Part B|Other|0|||
149058432|NCT04032704|537697022|FG001|Part B|Other|0|||
149058433|NCT04032704|537697023|FG002|Part B|Other|0|||
149058434|NCT04032704|537697024|FG003|Part B|Other|0|||
149058435|NCT04032704|537697025|FG004|Part B|Other|0|||
149058436|NCT04032704|537697026|FG005|Part B|Other|0|||
149058437|NCT04032704|537697027|FG006|Part B|Other|0|||
149058438|NCT04032704|537697028|FG007|Part B|Other|1|||
149058439|NCT04032704|537697029|FG008|Part B|Other|2|||
149058440|NCT04032704|537697030|FG009|Part B|Other|1|||
149058441|NCT04032704|537697031|FG010|Part B|Other|1|||
149058442|NCT04032704|537697032|FG011|Part B|Other|1|||
149058443|NCT04032704|537697033|FG012|Part B|Other|5|||
149058444|NCT04032704|537697034|FG013|Part B|Other|13|||
149058445|NCT04032704|537697035|FG014|Part B|Other|0|||
149058446|NCT04032704|537697036|FG015|Part B|Other|0|||
149058447|NCT04032704|537697037|FG016|Part B|Other|0|||
149058448|NCT04032704|537697038|FG017|Part B|Other|0|||
149058449|NCT04032704|537697021|FG000|Part B|Study termination by Sponsor|0|||
149058450|NCT04032704|537697022|FG001|Part B|Study termination by Sponsor|0|||
149058451|NCT04032704|537697023|FG002|Part B|Study termination by Sponsor|0|||
149058452|NCT04032704|537697024|FG003|Part B|Study termination by Sponsor|0|||
149058453|NCT04032704|537697025|FG004|Part B|Study termination by Sponsor|0|||
149058454|NCT04032704|537697026|FG005|Part B|Study termination by Sponsor|0|||
149058455|NCT04032704|537697027|FG006|Part B|Study termination by Sponsor|0|||
149058456|NCT04032704|537697028|FG007|Part B|Study termination by Sponsor|0|||
149058457|NCT04032704|537697029|FG008|Part B|Study termination by Sponsor|1|||
149058458|NCT04032704|537697030|FG009|Part B|Study termination by Sponsor|0|||
149058459|NCT04032704|537697031|FG010|Part B|Study termination by Sponsor|0|||
149058460|NCT04032704|537697032|FG011|Part B|Study termination by Sponsor|0|||
149058461|NCT04032704|537697033|FG012|Part B|Study termination by Sponsor|0|||
149058462|NCT04032704|537697034|FG013|Part B|Study termination by Sponsor|0|||
149058463|NCT04032704|537697035|FG014|Part B|Study termination by Sponsor|0|||
149058464|NCT04032704|537697036|FG015|Part B|Study termination by Sponsor|0|||
149058465|NCT04032704|537697037|FG016|Part B|Study termination by Sponsor|0|||
149058466|NCT04032704|537697038|FG017|Part B|Study termination by Sponsor|0|||
149058467|NCT04032704|537697021|FG000|Part B|Withdrawal by Subject|0|||
149058468|NCT04032704|537697022|FG001|Part B|Withdrawal by Subject|0|||
149058469|NCT04032704|537697023|FG002|Part B|Withdrawal by Subject|0|||
149058470|NCT04032704|537697024|FG003|Part B|Withdrawal by Subject|0|||
149058471|NCT04032704|537697025|FG004|Part B|Withdrawal by Subject|0|||
149058472|NCT04032704|537697026|FG005|Part B|Withdrawal by Subject|0|||
149058473|NCT04032704|537697027|FG006|Part B|Withdrawal by Subject|3|||
149058474|NCT04032704|537697028|FG007|Part B|Withdrawal by Subject|2|||
149058475|NCT04032704|537697029|FG008|Part B|Withdrawal by Subject|2|||
149058476|NCT04032704|537697030|FG009|Part B|Withdrawal by Subject|1|||
149058477|NCT04032704|537697031|FG010|Part B|Withdrawal by Subject|4|||
149058478|NCT04032704|537697032|FG011|Part B|Withdrawal by Subject|6|||
149058479|NCT04032704|537697033|FG012|Part B|Withdrawal by Subject|2|||
149058480|NCT04032704|537697034|FG013|Part B|Withdrawal by Subject|1|||
149058481|NCT04032704|537697035|FG014|Part B|Withdrawal by Subject|0|||
149058482|NCT04032704|537697036|FG015|Part B|Withdrawal by Subject|1|||
149058483|NCT04032704|537697037|FG016|Part B|Withdrawal by Subject|0|||
149058484|NCT04032704|537697038|FG017|Part B|Withdrawal by Subject|0|||
149058485|NCT04032704|537697021|FG000|Part B|Lost to Follow-up|0|||
149058486|NCT04032704|537697022|FG001|Part B|Lost to Follow-up|0|||
149058487|NCT04032704|537697023|FG002|Part B|Lost to Follow-up|0|||
149058488|NCT04032704|537697024|FG003|Part B|Lost to Follow-up|0|||
149058489|NCT04032704|537697025|FG004|Part B|Lost to Follow-up|0|||
149058490|NCT04032704|537697026|FG005|Part B|Lost to Follow-up|0|||
149058491|NCT04032704|537697027|FG006|Part B|Lost to Follow-up|0|||
149058492|NCT04032704|537697028|FG007|Part B|Lost to Follow-up|0|||
149058493|NCT04032704|537697029|FG008|Part B|Lost to Follow-up|0|||
149058494|NCT04032704|537697030|FG009|Part B|Lost to Follow-up|0|||
149058495|NCT04032704|537697031|FG010|Part B|Lost to Follow-up|0|||
149058496|NCT04032704|537697032|FG011|Part B|Lost to Follow-up|1|||
149058497|NCT04032704|537697033|FG012|Part B|Lost to Follow-up|0|||
149058498|NCT04032704|537697034|FG013|Part B|Lost to Follow-up|0|||
149058499|NCT04032704|537697035|FG014|Part B|Lost to Follow-up|0|||
149058500|NCT04032704|537697036|FG015|Part B|Lost to Follow-up|0|||
149058501|NCT04032704|537697037|FG016|Part B|Lost to Follow-up|0|||
149058502|NCT04032704|537697038|FG017|Part B|Lost to Follow-up|0|||
149058503|NCT04032704|537697021|FG000|Part B|Death|0|||
149058504|NCT04032704|537697022|FG001|Part B|Death|0|||
149058505|NCT04032704|537697023|FG002|Part B|Death|0|||
149058506|NCT04032704|537697024|FG003|Part B|Death|0|||
149058507|NCT04032704|537697025|FG004|Part B|Death|0|||
149058508|NCT04032704|537697026|FG005|Part B|Death|0|||
149058509|NCT04032704|537697027|FG006|Part B|Death|13|||
149058510|NCT04032704|537697028|FG007|Part B|Death|13|||
149058511|NCT04032704|537697029|FG008|Part B|Death|14|||
149058512|NCT04032704|537697030|FG009|Part B|Death|12|||
149058513|NCT04032704|537697031|FG010|Part B|Death|12|||
149058514|NCT04032704|537697032|FG011|Part B|Death|13|||
149058515|NCT04032704|537697033|FG012|Part B|Death|7|||
149058516|NCT04032704|537697034|FG013|Part B|Death|17|||
149058517|NCT04032704|537697035|FG014|Part B|Death|2|||
149058518|NCT04032704|537697036|FG015|Part B|Death|1|||
149058519|NCT04032704|537697037|FG016|Part B|Death|2|||
149058520|NCT04032704|537697038|FG017|Part B|Death|2|||
149058521|NCT05034328|537697039|FG000|Overall Study|Protocol Violation|1|||
149058522|NCT05034328|537697040|FG001|Overall Study|Protocol Violation|0|||
149058523|NCT05034328|537697039|FG000|Overall Study|Lost to Follow-up|0|||
149058524|NCT05034328|537697040|FG001|Overall Study|Lost to Follow-up|10|||
149058525|NCT02993159|537697041|FG000|Overall Study|Withdrawal by Subject|1|||
149058526|NCT02993159|537697042|FG001|Overall Study|Withdrawal by Subject|3|||
149058527|NCT02993159|537697041|FG000|Overall Study|Protocol Violation|1|||
149058528|NCT02993159|537697042|FG001|Overall Study|Protocol Violation|0|||
149058529|NCT02993159|537697041|FG000|Overall Study|Opted out of surgery|2|||
149058530|NCT02993159|537697042|FG001|Overall Study|Opted out of surgery|0|||
149058531|NCT02993159|537697041|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
149058532|NCT02993159|537697042|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
149058533|NCT02993159|537697041|FG000|Overall Study|Physician Decision|0|||
149058534|NCT02993159|537697042|FG001|Overall Study|Physician Decision|1|||
149058535|NCT04992520|537697045|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
149058536|NCT04992520|537697046|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
149058537|NCT04992520|537697047|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
149058538|NCT04992520|537697048|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
149058539|NCT04992520|537697049|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
149058540|NCT04992520|537697050|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
149058541|NCT04992520|537697045|FG000|Part A: First Challenge|Non-compliance|0|||
149058542|NCT04992520|537697046|FG001|Part A: First Challenge|Non-compliance|0|||
149058543|NCT04992520|537697047|FG002|Part A: First Challenge|Non-compliance|0|||
149058544|NCT04992520|537697048|FG003|Part A: First Challenge|Non-compliance|1|||
149058545|NCT04992520|537697049|FG004|Part A: First Challenge|Non-compliance|0|||
149058546|NCT04992520|537697050|FG005|Part A: First Challenge|Non-compliance|0|||
149058547|NCT04992520|537697045|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
149058548|NCT04992520|537697046|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
149058549|NCT04992520|537697047|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
149058550|NCT04992520|537697048|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
149058551|NCT04992520|537697049|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
149058552|NCT04992520|537697050|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
149058553|NCT04992520|537697045|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
149058554|NCT04992520|537697046|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
149058555|NCT04992520|537697047|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
149058556|NCT04992520|537697048|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
149058557|NCT04992520|537697049|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
149058558|NCT04992520|537697050|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
149058559|NCT02969707|537697054|FG000|Overall Study|Withdrawal by Subject|6|||
149058560|NCT02969707|537697055|FG001|Overall Study|Withdrawal by Subject|5|||
149058561|NCT02969707|537697054|FG000|Overall Study|Severe anxiety|0|||
149058562|NCT02969707|537697055|FG001|Overall Study|Severe anxiety|1|||
149058563|NCT02969707|537697054|FG000|Overall Study|Positive toxicology screen|0|||
149058564|NCT02969707|537697055|FG001|Overall Study|Positive toxicology screen|2|||
149058565|NCT02969707|537697054|FG000|Overall Study|Claustrophobia|2|||
149058566|NCT02969707|537697055|FG001|Overall Study|Claustrophobia|2|||
149058567|NCT02969707|537697054|FG000|Overall Study|Non-compliance|1|||
149058568|NCT02969707|537697055|FG001|Overall Study|Non-compliance|2|||
149058569|NCT05201079|537697056|FG000|Overall Study|Adverse Event|7|||
149058570|NCT05201079|537697057|FG001|Overall Study|Adverse Event|11|||
149058571|NCT05201079|537697056|FG000|Overall Study|Death|1|||
149058572|NCT05201079|537697057|FG001|Overall Study|Death|1|||
149058573|NCT05201079|537697056|FG000|Overall Study|Lack of Efficacy|0|||
149058574|NCT05201079|537697057|FG001|Overall Study|Lack of Efficacy|2|||
149058575|NCT05201079|537697056|FG000|Overall Study|Lost to Follow-up|0|||
149058576|NCT05201079|537697057|FG001|Overall Study|Lost to Follow-up|1|||
149058577|NCT05201079|537697056|FG000|Overall Study|Physician Decision|1|||
149058578|NCT05201079|537697057|FG001|Overall Study|Physician Decision|1|||
149058579|NCT05201079|537697056|FG000|Overall Study|Protocol Violation|1|||
149058580|NCT05201079|537697057|FG001|Overall Study|Protocol Violation|0|||
149058581|NCT05201079|537697056|FG000|Overall Study|Withdrawal by Subject|1|||
149058582|NCT05201079|537697057|FG001|Overall Study|Withdrawal by Subject|0|||
149058583|NCT05201079|537697056|FG000|Overall Study|Forbidden medication|9|||
149058584|NCT05201079|537697057|FG001|Overall Study|Forbidden medication|5|||
149058585|NCT05201079|537697056|FG000|Overall Study|Transfer to another hospital|0|||
149058586|NCT05201079|537697057|FG001|Overall Study|Transfer to another hospital|1|||
149058587|NCT05201079|537697056|FG000|Overall Study|Clinical condition|1|||
149058588|NCT05201079|537697057|FG001|Overall Study|Clinical condition|0|||
149058589|NCT05201079|537697056|FG000|Overall Study|SAE and sepsis|1|||
149058590|NCT05201079|537697057|FG001|Overall Study|SAE and sepsis|0|||
149058591|NCT04103580|537697060|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
149058592|NCT04103580|537697061|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
149058593|NCT04103580|537697060|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
149058594|NCT04103580|537697061|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
149058595|NCT04103580|537697060|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
149058596|NCT04103580|537697061|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
149058597|NCT04103580|537697060|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
149058598|NCT04103580|537697061|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
149058599|NCT04103580|537697060|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
149058600|NCT04103580|537697061|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
149058601|NCT04103580|537697060|FG000|Phase 1 Active Caregiving|Other|3|||
149058602|NCT04103580|537697061|FG001|Phase 1 Active Caregiving|Other|3|||
149058603|NCT04103580|537697060|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
149058604|NCT04103580|537697061|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
149058605|NCT04103580|537697060|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
149058606|NCT04103580|537697061|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
149058607|NCT04103580|537697060|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
149058608|NCT04103580|537697061|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
149058609|NCT04103580|537697060|FG000|Phase 2 Bereavement|Other|8|||
149058610|NCT04103580|537697061|FG001|Phase 2 Bereavement|Other|6|||
149058611|NCT04145440|537697062|FG000|Overall Study|Physician Decision|3|||
149058612|NCT04145440|537697063|FG001|Overall Study|Physician Decision|0|||
149058613|NCT04145440|537697062|FG000|Overall Study|Use of prohibited therapy|2|||
149058614|NCT04145440|537697063|FG001|Overall Study|Use of prohibited therapy|3|||
149058615|NCT05281562|537697066|FG000|Overall Study|Ineligible patient|1|||
149058616|NCT05281562|537697067|FG001|Overall Study|Ineligible patient|0|||
149058617|NCT04436276|537697068|FG000|Overall Study|Adverse Event|0|||
149058618|NCT04436276|537697069|FG001|Overall Study|Adverse Event|0|||
149058619|NCT04436276|537697070|FG002|Overall Study|Adverse Event|0|||
149058620|NCT04436276|537697071|FG003|Overall Study|Adverse Event|0|||
149058621|NCT04436276|537697072|FG004|Overall Study|Adverse Event|0|||
149058622|NCT04436276|537697073|FG005|Overall Study|Adverse Event|0|||
149058623|NCT04436276|537697074|FG006|Overall Study|Adverse Event|0|||
149058624|NCT04436276|537697075|FG007|Overall Study|Adverse Event|0|||
149058625|NCT04436276|537697076|FG008|Overall Study|Adverse Event|0|||
149058626|NCT04436276|537697077|FG009|Overall Study|Adverse Event|0|||
149058627|NCT04436276|537697078|FG010|Overall Study|Adverse Event|0|||
149058628|NCT04436276|537697079|FG011|Overall Study|Adverse Event|0|||
149058629|NCT04436276|537697080|FG012|Overall Study|Adverse Event|0|||
149058630|NCT04436276|537697081|FG013|Overall Study|Adverse Event|0|||
149058631|NCT04436276|537697082|FG014|Overall Study|Adverse Event|0|||
149058632|NCT04436276|537697083|FG015|Overall Study|Adverse Event|0|||
149058633|NCT04436276|537697084|FG016|Overall Study|Adverse Event|1|||
149058634|NCT04436276|537697085|FG017|Overall Study|Adverse Event|0|||
149058635|NCT04436276|537697086|FG018|Overall Study|Adverse Event|0|||
149058636|NCT04436276|537697087|FG019|Overall Study|Adverse Event|0|||
149058637|NCT04436276|537697088|FG020|Overall Study|Adverse Event|0|||
149058638|NCT04436276|537697089|FG021|Overall Study|Adverse Event|0|||
149058639|NCT04436276|537697090|FG022|Overall Study|Adverse Event|0|||
149058640|NCT04436276|537697068|FG000|Overall Study|Death|0|||
149058641|NCT04436276|537697069|FG001|Overall Study|Death|0|||
149058642|NCT04436276|537697070|FG002|Overall Study|Death|0|||
149058643|NCT04436276|537697071|FG003|Overall Study|Death|0|||
149058644|NCT04436276|537697072|FG004|Overall Study|Death|0|||
149058645|NCT04436276|537697073|FG005|Overall Study|Death|0|||
149058646|NCT04436276|537697074|FG006|Overall Study|Death|0|||
149058647|NCT04436276|537697075|FG007|Overall Study|Death|0|||
149058648|NCT04436276|537697076|FG008|Overall Study|Death|0|||
149058649|NCT04436276|537697077|FG009|Overall Study|Death|0|||
149058650|NCT04436276|537697078|FG010|Overall Study|Death|0|||
149058651|NCT04436276|537697079|FG011|Overall Study|Death|0|||
149058652|NCT04436276|537697080|FG012|Overall Study|Death|1|||
149058653|NCT04436276|537697081|FG013|Overall Study|Death|0|||
149058654|NCT04436276|537697082|FG014|Overall Study|Death|1|||
149058655|NCT04436276|537697083|FG015|Overall Study|Death|0|||
149058656|NCT04436276|537697084|FG016|Overall Study|Death|0|||
149058657|NCT04436276|537697085|FG017|Overall Study|Death|0|||
149058658|NCT04436276|537697086|FG018|Overall Study|Death|0|||
149058659|NCT04436276|537697087|FG019|Overall Study|Death|2|||
149058660|NCT04436276|537697088|FG020|Overall Study|Death|0|||
149058661|NCT04436276|537697089|FG021|Overall Study|Death|1|||
149058662|NCT04436276|537697090|FG022|Overall Study|Death|0|||
149058663|NCT04436276|537697068|FG000|Overall Study|Lost to Follow-up|0|||
149058664|NCT04436276|537697069|FG001|Overall Study|Lost to Follow-up|2|||
149058665|NCT04436276|537697070|FG002|Overall Study|Lost to Follow-up|2|||
149058666|NCT04436276|537697071|FG003|Overall Study|Lost to Follow-up|1|||
149058667|NCT04436276|537697072|FG004|Overall Study|Lost to Follow-up|4|||
149058668|NCT04436276|537697073|FG005|Overall Study|Lost to Follow-up|1|||
149058669|NCT04436276|537697074|FG006|Overall Study|Lost to Follow-up|0|||
149058670|NCT04436276|537697075|FG007|Overall Study|Lost to Follow-up|0|||
149058671|NCT04436276|537697076|FG008|Overall Study|Lost to Follow-up|1|||
149058672|NCT04436276|537697077|FG009|Overall Study|Lost to Follow-up|0|||
149058673|NCT04436276|537697078|FG010|Overall Study|Lost to Follow-up|5|||
149058674|NCT04436276|537697079|FG011|Overall Study|Lost to Follow-up|5|||
149058675|NCT04436276|537697080|FG012|Overall Study|Lost to Follow-up|4|||
149058676|NCT04436276|537697081|FG013|Overall Study|Lost to Follow-up|1|||
149058677|NCT04436276|537697082|FG014|Overall Study|Lost to Follow-up|7|||
149058678|NCT04436276|537697083|FG015|Overall Study|Lost to Follow-up|7|||
149058679|NCT04436276|537697084|FG016|Overall Study|Lost to Follow-up|1|||
149058680|NCT04436276|537697085|FG017|Overall Study|Lost to Follow-up|0|||
149058681|NCT04436276|537697086|FG018|Overall Study|Lost to Follow-up|1|||
149058682|NCT04436276|537697087|FG019|Overall Study|Lost to Follow-up|1|||
149058683|NCT04436276|537697088|FG020|Overall Study|Lost to Follow-up|2|||
149058684|NCT04436276|537697089|FG021|Overall Study|Lost to Follow-up|1|||
149058685|NCT04436276|537697090|FG022|Overall Study|Lost to Follow-up|1|||
149058686|NCT04436276|537697068|FG000|Overall Study|Physician Decision|1|||
149058687|NCT04436276|537697069|FG001|Overall Study|Physician Decision|0|||
149058688|NCT04436276|537697070|FG002|Overall Study|Physician Decision|2|||
149058689|NCT04436276|537697071|FG003|Overall Study|Physician Decision|1|||
149058690|NCT04436276|537697072|FG004|Overall Study|Physician Decision|0|||
149058691|NCT04436276|537697073|FG005|Overall Study|Physician Decision|0|||
149058692|NCT04436276|537697074|FG006|Overall Study|Physician Decision|0|||
149058693|NCT04436276|537697075|FG007|Overall Study|Physician Decision|0|||
149058694|NCT04436276|537697076|FG008|Overall Study|Physician Decision|0|||
149058695|NCT04436276|537697077|FG009|Overall Study|Physician Decision|0|||
149058696|NCT04436276|537697078|FG010|Overall Study|Physician Decision|0|||
149058697|NCT04436276|537697079|FG011|Overall Study|Physician Decision|1|||
149058698|NCT04436276|537697080|FG012|Overall Study|Physician Decision|2|||
149058699|NCT04436276|537697081|FG013|Overall Study|Physician Decision|0|||
149058700|NCT04436276|537697082|FG014|Overall Study|Physician Decision|0|||
149058701|NCT04436276|537697083|FG015|Overall Study|Physician Decision|0|||
149058702|NCT04436276|537697084|FG016|Overall Study|Physician Decision|0|||
149058703|NCT04436276|537697085|FG017|Overall Study|Physician Decision|0|||
149058704|NCT04436276|537697086|FG018|Overall Study|Physician Decision|0|||
149058705|NCT04436276|537697087|FG019|Overall Study|Physician Decision|0|||
149058706|NCT04436276|537697088|FG020|Overall Study|Physician Decision|1|||
149058707|NCT04436276|537697089|FG021|Overall Study|Physician Decision|2|||
149058708|NCT04436276|537697090|FG022|Overall Study|Physician Decision|0|||
149058709|NCT04436276|537697068|FG000|Overall Study|Protocol Violation|0|||
149058710|NCT04436276|537697069|FG001|Overall Study|Protocol Violation|0|||
149058711|NCT04436276|537697070|FG002|Overall Study|Protocol Violation|0|||
149058712|NCT04436276|537697071|FG003|Overall Study|Protocol Violation|0|||
149058713|NCT04436276|537697072|FG004|Overall Study|Protocol Violation|0|||
149058714|NCT04436276|537697073|FG005|Overall Study|Protocol Violation|0|||
149058715|NCT04436276|537697074|FG006|Overall Study|Protocol Violation|0|||
149058716|NCT04436276|537697075|FG007|Overall Study|Protocol Violation|0|||
149058717|NCT04436276|537697076|FG008|Overall Study|Protocol Violation|0|||
149058718|NCT04436276|537697077|FG009|Overall Study|Protocol Violation|0|||
149058719|NCT04436276|537697078|FG010|Overall Study|Protocol Violation|0|||
149058720|NCT04436276|537697079|FG011|Overall Study|Protocol Violation|0|||
149058721|NCT04436276|537697080|FG012|Overall Study|Protocol Violation|0|||
149058722|NCT04436276|537697081|FG013|Overall Study|Protocol Violation|1|||
149058723|NCT04436276|537697082|FG014|Overall Study|Protocol Violation|0|||
149058724|NCT04436276|537697083|FG015|Overall Study|Protocol Violation|1|||
149058725|NCT04436276|537697084|FG016|Overall Study|Protocol Violation|0|||
149058726|NCT04436276|537697085|FG017|Overall Study|Protocol Violation|0|||
149058727|NCT04436276|537697086|FG018|Overall Study|Protocol Violation|0|||
149058728|NCT04436276|537697087|FG019|Overall Study|Protocol Violation|0|||
149058729|NCT04436276|537697088|FG020|Overall Study|Protocol Violation|0|||
149058730|NCT04436276|537697089|FG021|Overall Study|Protocol Violation|0|||
149058731|NCT04436276|537697090|FG022|Overall Study|Protocol Violation|0|||
149058732|NCT04436276|537697068|FG000|Overall Study|Withdrawal by Subject|25|||
149058733|NCT04436276|537697069|FG001|Overall Study|Withdrawal by Subject|22|||
149058734|NCT04436276|537697070|FG002|Overall Study|Withdrawal by Subject|24|||
149058735|NCT04436276|537697071|FG003|Overall Study|Withdrawal by Subject|23|||
149058736|NCT04436276|537697072|FG004|Overall Study|Withdrawal by Subject|14|||
149058737|NCT04436276|537697073|FG005|Overall Study|Withdrawal by Subject|0|||
149058738|NCT04436276|537697074|FG006|Overall Study|Withdrawal by Subject|0|||
149058739|NCT04436276|537697075|FG007|Overall Study|Withdrawal by Subject|1|||
149058740|NCT04436276|537697076|FG008|Overall Study|Withdrawal by Subject|0|||
148890134|NCT00453154|537077127|FG003|Double BIind Maintenance|Death|1|||
149058741|NCT04436276|537697077|FG009|Overall Study|Withdrawal by Subject|1|||
149058742|NCT04436276|537697078|FG010|Overall Study|Withdrawal by Subject|17|||
149058743|NCT04436276|537697079|FG011|Overall Study|Withdrawal by Subject|7|||
149058744|NCT04436276|537697080|FG012|Overall Study|Withdrawal by Subject|10|||
149058745|NCT04436276|537697081|FG013|Overall Study|Withdrawal by Subject|6|||
149058746|NCT04436276|537697082|FG014|Overall Study|Withdrawal by Subject|20|||
149058747|NCT04436276|537697083|FG015|Overall Study|Withdrawal by Subject|6|||
149058748|NCT04436276|537697084|FG016|Overall Study|Withdrawal by Subject|11|||
149058749|NCT04436276|537697085|FG017|Overall Study|Withdrawal by Subject|4|||
149058750|NCT04436276|537697086|FG018|Overall Study|Withdrawal by Subject|14|||
149058751|NCT04436276|537697087|FG019|Overall Study|Withdrawal by Subject|24|||
149058752|NCT04436276|537697088|FG020|Overall Study|Withdrawal by Subject|24|||
149058753|NCT04436276|537697089|FG021|Overall Study|Withdrawal by Subject|16|||
149058754|NCT04436276|537697090|FG022|Overall Study|Withdrawal by Subject|14|||
149058755|NCT04436276|537697068|FG000|Overall Study|Other|3|||
149058756|NCT04436276|537697069|FG001|Overall Study|Other|2|||
149058757|NCT04436276|537697070|FG002|Overall Study|Other|5|||
149005511|NCT03217747|537497902|FG010|Overall Study|Stroke|0|||
149005512|NCT03217747|537497903|FG011|Overall Study|Stroke|1|||
149005513|NCT03217747|537497904|FG012|Overall Study|Stroke|0|||
149005514|NCT03217747|537497905|FG013|Overall Study|Stroke|0|||
149005515|NCT03996291|537497906|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
149005516|NCT03996291|537497907|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
149005517|NCT03996291|537497908|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
149005518|NCT03996291|537497909|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
149005519|NCT03996291|537497910|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
149005520|NCT03996291|537497911|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
149005521|NCT03996291|537497912|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
149005522|NCT03996291|537497913|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
149005523|NCT03996291|537497906|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
149005524|NCT03996291|537497907|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
149005525|NCT03996291|537497908|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
149005526|NCT03996291|537497909|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
149005527|NCT03996291|537497910|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
149005528|NCT03996291|537497911|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
149005529|NCT03996291|537497912|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
149005530|NCT03996291|537497913|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
149005531|NCT03996291|537497906|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
149005532|NCT03996291|537497907|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
149005533|NCT03996291|537497908|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
149005534|NCT03996291|537497909|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
149005535|NCT03996291|537497910|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
149005536|NCT03996291|537497911|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
149005537|NCT03996291|537497912|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
149005538|NCT03996291|537497913|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
149005539|NCT03996291|537497906|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
149005540|NCT03996291|537497907|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
149005541|NCT03996291|537497908|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
149005542|NCT03996291|537497909|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
149005543|NCT03996291|537497910|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
149005544|NCT03996291|537497911|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
149005545|NCT03996291|537497912|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
149005546|NCT03996291|537497913|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
149005547|NCT03996291|537497906|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005548|NCT03996291|537497907|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005549|NCT03996291|537497908|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005550|NCT03996291|537497909|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005551|NCT03996291|537497910|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
149005552|NCT03996291|537497911|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005553|NCT03996291|537497912|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005554|NCT03996291|537497913|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
149005555|NCT03248375|537497914|FG000|Overall Study|Lost to Follow-up|5|||
149005556|NCT00558064|537497919|FG000|Overall Study|Adverse Event|3|||
149005557|NCT00558064|537497920|FG001|Overall Study|Adverse Event|2|||
149005558|NCT00558064|537497919|FG000|Overall Study|Lack of Efficacy|0|||
149005559|NCT00558064|537497920|FG001|Overall Study|Lack of Efficacy|1|||
149005560|NCT00558064|537497919|FG000|Overall Study|Protocol Violation|1|||
149005561|NCT00558064|537497920|FG001|Overall Study|Protocol Violation|0|||
149005562|NCT00558064|537497919|FG000|Overall Study|Lost to Follow-up|0|||
149005563|NCT00558064|537497920|FG001|Overall Study|Lost to Follow-up|1|||
149005564|NCT00558064|537497919|FG000|Overall Study|Withdrawal by Subject|0|||
149005565|NCT00558064|537497920|FG001|Overall Study|Withdrawal by Subject|1|||
149005566|NCT00558064|537497919|FG000|Overall Study|No visit within allowance period|1|||
149005567|NCT00558064|537497920|FG001|Overall Study|No visit within allowance period|0|||
149005568|NCT02027402|537497924|FG000|Overall Study|Withdrawal by Subject|4|||
149005569|NCT02027402|537497925|FG001|Overall Study|Withdrawal by Subject|1|||
149005570|NCT00982930|537497928|FG000|Overall Study|Adverse Event|1|||
149005571|NCT00982930|537497928|FG000|Overall Study|Withdrawal by Subject|1|||
149005572|NCT00982930|537497928|FG000|Overall Study|Administrative Problems|2|||
149005573|NCT00941798|537497929|FG000|Overall Study|Withdrawal by Subject|72|||
149005574|NCT00941798|537497930|FG001|Overall Study|Withdrawal by Subject|74|||
149005575|NCT00941798|537497929|FG000|Overall Study|Adverse Event|43|||
149058758|NCT04436276|537697071|FG003|Overall Study|Other|9|||
149058759|NCT04436276|537697072|FG004|Overall Study|Other|23|||
149058760|NCT04436276|537697073|FG005|Overall Study|Other|1|||
149058761|NCT04436276|537697074|FG006|Overall Study|Other|0|||
149058762|NCT04436276|537697075|FG007|Overall Study|Other|0|||
149058763|NCT04436276|537697076|FG008|Overall Study|Other|0|||
149058764|NCT04436276|537697077|FG009|Overall Study|Other|0|||
149058765|NCT04436276|537697078|FG010|Overall Study|Other|3|||
149058766|NCT04436276|537697079|FG011|Overall Study|Other|1|||
149058767|NCT04436276|537697080|FG012|Overall Study|Other|1|||
149058768|NCT04436276|537697081|FG013|Overall Study|Other|2|||
149058769|NCT04436276|537697082|FG014|Overall Study|Other|3|||
149058770|NCT04436276|537697083|FG015|Overall Study|Other|0|||
149058771|NCT04436276|537697084|FG016|Overall Study|Other|0|||
149058772|NCT04436276|537697085|FG017|Overall Study|Other|6|||
149058773|NCT04436276|537697086|FG018|Overall Study|Other|1|||
149058774|NCT04436276|537697087|FG019|Overall Study|Other|0|||
149058775|NCT04436276|537697088|FG020|Overall Study|Other|2|||
149058776|NCT04436276|537697089|FG021|Overall Study|Other|2|||
149058777|NCT04436276|537697090|FG022|Overall Study|Other|60|||
149058778|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
149058779|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
149058780|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
149058781|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
149058782|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
149058783|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
149058784|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
149058785|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
149058786|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
149058787|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
149058788|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
149058789|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
149058790|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
149058791|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
149058792|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
149058793|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
149058794|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
149058795|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
149058796|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
149058797|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
149058798|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
149058799|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
149058800|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
149058801|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
149058802|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
149058803|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
149058804|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
149058805|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
149058806|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
149058807|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
149058808|NCT03852472|537697098|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
149058809|NCT03852472|537697099|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
149058810|NCT03852472|537697100|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
149058811|NCT03852472|537697101|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
149058812|NCT03852472|537697102|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
149058813|NCT03852472|537697098|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
149058814|NCT03852472|537697099|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
149058815|NCT03852472|537697100|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
149058816|NCT03852472|537697101|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
149058817|NCT03852472|537697102|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
149058818|NCT03852472|537697098|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
148890135|NCT00453154|537077124|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
148890136|NCT00453154|537077125|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
148890137|NCT00453154|537077126|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
148890138|NCT00453154|537077127|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
148890139|NCT00453154|537077124|FG000|Double BIind Maintenance|Progression|0|||
148890140|NCT00453154|537077125|FG001|Double BIind Maintenance|Progression|0|||
148890141|NCT00453154|537077126|FG002|Double BIind Maintenance|Progression|29|||
149058819|NCT03852472|537697099|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
149058820|NCT03852472|537697100|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
149058821|NCT03852472|537697101|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
149058822|NCT03852472|537697102|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
149058823|NCT03852472|537697098|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
149058824|NCT03852472|537697099|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
149058825|NCT03852472|537697100|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
149058826|NCT03852472|537697101|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
149058827|NCT03852472|537697102|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
149058828|NCT03852472|537697098|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
149058829|NCT03852472|537697099|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
149058830|NCT03852472|537697100|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
149058831|NCT03852472|537697101|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
149058832|NCT03852472|537697102|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
149058833|NCT03852472|537697098|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
149058834|NCT03852472|537697099|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
149058835|NCT03852472|537697100|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
149058836|NCT03852472|537697101|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
149058837|NCT03852472|537697102|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
149058838|NCT03852472|537697098|FG000|Period 2 - Week 44|Adverse Event|0|||
149058839|NCT03852472|537697099|FG001|Period 2 - Week 44|Adverse Event|3|||
149058840|NCT03852472|537697100|FG002|Period 2 - Week 44|Adverse Event|1|||
149058841|NCT03852472|537697101|FG003|Period 2 - Week 44|Adverse Event|2|||
149058842|NCT03852472|537697102|FG004|Period 2 - Week 44|Adverse Event|2|||
149058843|NCT03852472|537697098|FG000|Period 2 - Week 44|COVID-19 Related|0|||
149058844|NCT03852472|537697099|FG001|Period 2 - Week 44|COVID-19 Related|0|||
149058845|NCT03852472|537697100|FG002|Period 2 - Week 44|COVID-19 Related|0|||
149058846|NCT03852472|537697101|FG003|Period 2 - Week 44|COVID-19 Related|1|||
149058847|NCT03852472|537697102|FG004|Period 2 - Week 44|COVID-19 Related|0|||
149058848|NCT03852472|537697098|FG000|Period 2 - Week 44|Reason not stated|0|||
149058849|NCT03852472|537697099|FG001|Period 2 - Week 44|Reason not stated|0|||
149058850|NCT03852472|537697100|FG002|Period 2 - Week 44|Reason not stated|0|||
149058851|NCT03852472|537697101|FG003|Period 2 - Week 44|Reason not stated|0|||
149058852|NCT03852472|537697102|FG004|Period 2 - Week 44|Reason not stated|1|||
149058853|NCT01919554|537697103|FG000|Overall Study|Withdrawal by Subject|0|||
149058854|NCT01919554|537697104|FG001|Overall Study|Withdrawal by Subject|0|||
149058855|NCT01919554|537697105|FG002|Overall Study|Withdrawal by Subject|1|||
149058856|NCT01919554|537697106|FG003|Overall Study|Withdrawal by Subject|1|||
149058857|NCT04898673|537697108|FG000|Overall Study|Screenfail|1|||
149058858|NCT04898673|537697109|FG001|Overall Study|Screenfail|0|||
149058859|NCT03459729|537697112|FG000|Overall Study|Physician Decision|2|||
149058860|NCT06182033|537697113|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
149058861|NCT06182033|537697114|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
149058862|NCT06182033|537697113|FG000|Overall Study|Target child relocation|1|||
149058863|NCT06182033|537697114|FG001|Overall Study|Target child relocation|1|||
149058864|NCT06182033|537697113|FG000|Overall Study|Withdrawal by Subject|1|||
149058865|NCT06182033|537697114|FG001|Overall Study|Withdrawal by Subject|0|||
149058866|NCT05576155|537697121|FG000|Overall Study|Withdrawal by Subject|1|||
149058867|NCT05576155|537697122|FG001|Overall Study|Withdrawal by Subject|1|||
149058868|NCT04081103|537697125|FG000|Overall Study|Adverse Event|1|||
149058869|NCT04081103|537697126|FG001|Overall Study|Adverse Event|1|||
149058870|NCT04081103|537697127|FG002|Overall Study|Adverse Event|1|||
149058871|NCT04081103|537697125|FG000|Overall Study|Physician Decision|0|||
149058872|NCT04081103|537697126|FG001|Overall Study|Physician Decision|0|||
149058873|NCT04081103|537697127|FG002|Overall Study|Physician Decision|1|||
149058874|NCT03365882|537697132|FG000|Randomization|Still Receiving Protocol Treatment|2|||
149058875|NCT03365882|537697133|FG001|Randomization|Still Receiving Protocol Treatment|0|||
149058876|NCT03365882|537697132|FG000|Randomization|Adverse Event|1|||
149058877|NCT03365882|537697133|FG001|Randomization|Adverse Event|2|||
149058878|NCT03365882|537697132|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
149058879|NCT03365882|537697133|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
149058880|NCT03365882|537697132|FG000|Randomization|Progression/Relapse|21|||
149058881|NCT03365882|537697133|FG001|Randomization|Progression/Relapse|3|||
149058882|NCT03365882|537697132|FG000|Randomization|Death|1|||
149058883|NCT03365882|537697133|FG001|Randomization|Death|0|||
149058884|NCT03365882|537697132|FG000|Randomization|Other - Not Protocol Specified|1|||
149058885|NCT03365882|537697133|FG001|Randomization|Other - Not Protocol Specified|1|||
149058886|NCT03365882|537697132|FG000|Randomization|Major Protocol Deviation|0|||
149058887|NCT03365882|537697133|FG001|Randomization|Major Protocol Deviation|1|||
149058888|NCT03365882|537697132|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
149058889|NCT03365882|537697133|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
149058890|NCT03365882|537697132|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
149058891|NCT03365882|537697133|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
149058892|NCT03365882|537697132|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
149058893|NCT03365882|537697133|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
149058894|NCT03365882|537697132|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
149058895|NCT03365882|537697133|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
149058896|NCT04828005|537697134|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
149058897|NCT04828005|537697135|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
149058898|NCT04828005|537697136|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
149058899|NCT04828005|537697137|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
149058900|NCT04828005|537697134|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
149058901|NCT04828005|537697135|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
149058902|NCT04828005|537697136|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
149058903|NCT04828005|537697137|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
149058904|NCT04828005|537697134|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
149058905|NCT04828005|537697135|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
149058906|NCT04828005|537697136|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
149058907|NCT04828005|537697137|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
149058908|NCT04828005|537697134|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
149058909|NCT04828005|537697135|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
149058910|NCT04828005|537697136|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
149058911|NCT04828005|537697137|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
149058912|NCT04828005|537697134|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
149058913|NCT04828005|537697135|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
149058914|NCT04828005|537697136|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
149058915|NCT04828005|537697137|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
149058916|NCT04828005|537697134|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
149058917|NCT04828005|537697135|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
149058918|NCT04828005|537697136|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
149058919|NCT04828005|537697137|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
149058920|NCT04828005|537697134|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
149058921|NCT04828005|537697135|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
149058922|NCT04828005|537697136|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
149058923|NCT04828005|537697137|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
149058924|NCT04828005|537697134|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
149058925|NCT04828005|537697135|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
149058926|NCT04828005|537697136|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
149058927|NCT04828005|537697137|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
149058928|NCT04828005|537697134|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
149058929|NCT04828005|537697135|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
149058930|NCT04828005|537697136|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
149058931|NCT04828005|537697137|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
149058932|NCT03287817|537698794|FG000|Overall Study|Progressive disease|4|||
149058933|NCT03287817|537698795|FG001|Overall Study|Progressive disease|2|||
149058934|NCT03287817|537698796|FG002|Overall Study|Progressive disease|3|||
149058935|NCT03287817|537698797|FG003|Overall Study|Progressive disease|10|||
149058936|NCT03287817|537698798|FG004|Overall Study|Progressive disease|8|||
149058937|NCT03287817|537698794|FG000|Overall Study|Death|0|||
149058938|NCT03287817|537698795|FG001|Overall Study|Death|0|||
149058939|NCT03287817|537698796|FG002|Overall Study|Death|2|||
149058940|NCT03287817|537698797|FG003|Overall Study|Death|3|||
149058941|NCT03287817|537698798|FG004|Overall Study|Death|4|||
149058942|NCT03287817|537698794|FG000|Overall Study|Physician Decision|0|||
149058943|NCT03287817|537698795|FG001|Overall Study|Physician Decision|0|||
149058944|NCT03287817|537698796|FG002|Overall Study|Physician Decision|0|||
149058945|NCT03287817|537698797|FG003|Overall Study|Physician Decision|1|||
149058946|NCT03287817|537698798|FG004|Overall Study|Physician Decision|0|||
149058947|NCT03287817|537698794|FG000|Overall Study|Withdrawal by Subject|0|||
149058948|NCT03287817|537698795|FG001|Overall Study|Withdrawal by Subject|0|||
149058949|NCT03287817|537698796|FG002|Overall Study|Withdrawal by Subject|0|||
149058950|NCT03287817|537698797|FG003|Overall Study|Withdrawal by Subject|0|||
149058951|NCT03287817|537698798|FG004|Overall Study|Withdrawal by Subject|4|||
149058952|NCT05543915|537698799|FG000|Overall Study|Lost to Follow-up|0|||
149058953|NCT05543915|537698800|FG001|Overall Study|Lost to Follow-up|1|||
149058954|NCT00085735|537698802|FG000|Overall Study|Adverse Event|1|||
149058955|NCT00085735|537698803|FG001|Overall Study|Adverse Event|0|||
149058956|NCT00085735|537698804|FG002|Overall Study|Adverse Event|0|||
149058957|NCT00085735|537698805|FG003|Overall Study|Adverse Event|0|||
149058958|NCT00085735|537698806|FG004|Overall Study|Adverse Event|0|||
149058959|NCT00085735|537698807|FG005|Overall Study|Adverse Event|0|||
149058960|NCT00085735|537698802|FG000|Overall Study|Lack of Efficacy|2|||
149058961|NCT00085735|537698803|FG001|Overall Study|Lack of Efficacy|4|||
149058962|NCT00085735|537698804|FG002|Overall Study|Lack of Efficacy|6|||
149058963|NCT00085735|537698805|FG003|Overall Study|Lack of Efficacy|3|||
149058964|NCT00085735|537698806|FG004|Overall Study|Lack of Efficacy|4|||
149058965|NCT00085735|537698807|FG005|Overall Study|Lack of Efficacy|3|||
149058966|NCT00085735|537698802|FG000|Overall Study|Lost to Follow-up|0|||
149058967|NCT00085735|537698803|FG001|Overall Study|Lost to Follow-up|1|||
148890142|NCT00453154|537077127|FG003|Double BIind Maintenance|Progression|26|||
148890143|NCT00453154|537077124|FG000|Double BIind Maintenance|Medical Issues|0|||
148890144|NCT00453154|537077125|FG001|Double BIind Maintenance|Medical Issues|0|||
148890145|NCT00453154|537077126|FG002|Double BIind Maintenance|Medical Issues|3|||
148890146|NCT00453154|537077127|FG003|Double BIind Maintenance|Medical Issues|1|||
148890147|NCT00453154|537077124|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
148890148|NCT00453154|537077125|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
148890149|NCT00453154|537077126|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
148890150|NCT00453154|537077127|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
148890151|NCT03629886|537077128|FG000|Overall Study|Migrated / moved from the study area|0|||
148890152|NCT03629886|537077129|FG001|Overall Study|Migrated / moved from the study area|55|||
148890153|NCT03629886|537077128|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
148890154|NCT03629886|537077129|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
148890155|NCT03629886|537077128|FG000|Overall Study|Study vaccine not administrated|0|||
148890156|NCT03629886|537077129|FG001|Overall Study|Study vaccine not administrated|3|||
148890157|NCT03629886|537077128|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
148890158|NCT03629886|537077129|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
148890159|NCT03629886|537077128|FG000|Overall Study|Refused vaccination step of the study|0|||
148890160|NCT03629886|537077129|FG001|Overall Study|Refused vaccination step of the study|44|||
148890161|NCT05473026|537077131|FG000|Overall Study|Lost to Follow-up|5|||
148890162|NCT05473026|537077132|FG001|Overall Study|Lost to Follow-up|2|||
148890163|NCT00496015|537077133|FG000|Overall Study|Other|1|||
148890164|NCT00496015|537077134|FG001|Overall Study|Other|0|||
148890165|NCT00496015|537077135|FG002|Overall Study|Other|0|||
148890166|NCT00496015|537077136|FG003|Overall Study|Other|1|||
148890167|NCT00496015|537077137|FG004|Overall Study|Other|0|||
148890168|NCT01535807|537077139|FG000|Overall Study|Withdrawal by Subject|1|||
148890169|NCT01535807|537077140|FG001|Overall Study|Withdrawal by Subject|1|||
148890170|NCT01535807|537077139|FG000|Overall Study|Data collection error|1|||
148890171|NCT01535807|537077140|FG001|Overall Study|Data collection error|1|||
148890172|NCT02730728|537077143|FG000|Overall Study|Withdrawal by Subject|0|||
148890173|NCT02730728|537077144|FG001|Overall Study|Withdrawal by Subject|1|||
148890174|NCT02730728|537077145|FG002|Overall Study|Withdrawal by Subject|0|||
148890175|NCT02730728|537077143|FG000|Overall Study|Lack of Efficacy|0|||
148890176|NCT02730728|537077144|FG001|Overall Study|Lack of Efficacy|1|||
148890177|NCT02730728|537077145|FG002|Overall Study|Lack of Efficacy|1|||
148890178|NCT02193776|537077148|FG000|Overall Study|Consent withdrawn|1|||
148890179|NCT02193776|537077149|FG001|Overall Study|Consent withdrawn|0|||
148890180|NCT02193776|537077150|FG002|Overall Study|Consent withdrawn|0|||
148890181|NCT02193776|537077151|FG003|Overall Study|Consent withdrawn|0|||
148890182|NCT02193776|537077148|FG000|Overall Study|Failure to comply with protocol|0|||
148890183|NCT02193776|537077149|FG001|Overall Study|Failure to comply with protocol|1|||
148890184|NCT02193776|537077150|FG002|Overall Study|Failure to comply with protocol|0|||
148890185|NCT02193776|537077151|FG003|Overall Study|Failure to comply with protocol|0|||
148890186|NCT02193776|537077148|FG000|Overall Study|Investigator/Sponsor decision|1|||
148890187|NCT02193776|537077149|FG001|Overall Study|Investigator/Sponsor decision|1|||
148890188|NCT02193776|537077150|FG002|Overall Study|Investigator/Sponsor decision|0|||
148890189|NCT02193776|537077151|FG003|Overall Study|Investigator/Sponsor decision|0|||
148890190|NCT02193776|537077148|FG000|Overall Study|Death|1|||
148890191|NCT02193776|537077149|FG001|Overall Study|Death|0|||
148890192|NCT02193776|537077150|FG002|Overall Study|Death|0|||
148890193|NCT02193776|537077151|FG003|Overall Study|Death|0|||
148890194|NCT02193776|537077148|FG000|Overall Study|Adverse event/Specific toxicity|5|||
148890195|NCT02193776|537077149|FG001|Overall Study|Adverse event/Specific toxicity|5|||
148890196|NCT02193776|537077150|FG002|Overall Study|Adverse event/Specific toxicity|2|||
149058968|NCT00085735|537698804|FG002|Overall Study|Lost to Follow-up|0|||
149058969|NCT00085735|537698805|FG003|Overall Study|Lost to Follow-up|0|||
149058970|NCT00085735|537698806|FG004|Overall Study|Lost to Follow-up|1|||
149058971|NCT00085735|537698807|FG005|Overall Study|Lost to Follow-up|0|||
149058972|NCT00085735|537698802|FG000|Overall Study|Physician Decision|2|||
149058973|NCT00085735|537698803|FG001|Overall Study|Physician Decision|3|||
149058974|NCT00085735|537698804|FG002|Overall Study|Physician Decision|2|||
149058975|NCT00085735|537698805|FG003|Overall Study|Physician Decision|3|||
149058976|NCT00085735|537698806|FG004|Overall Study|Physician Decision|11|||
149058977|NCT00085735|537698807|FG005|Overall Study|Physician Decision|8|||
149058978|NCT00085735|537698802|FG000|Overall Study|Protocol Violation|1|||
149058979|NCT00085735|537698803|FG001|Overall Study|Protocol Violation|0|||
149058980|NCT00085735|537698804|FG002|Overall Study|Protocol Violation|0|||
149058981|NCT00085735|537698805|FG003|Overall Study|Protocol Violation|0|||
148890197|NCT02193776|537077151|FG003|Overall Study|Adverse event/Specific toxicity|2|||
148890198|NCT00248495|537077157|FG000|Overall Study|Withdrawal by Subject|1|||
148890199|NCT03812380|537077158|FG000|Overall Study|Protocol Violation|3|||
149058982|NCT00085735|537698806|FG004|Overall Study|Protocol Violation|0|||
149058983|NCT00085735|537698807|FG005|Overall Study|Protocol Violation|0|||
149058984|NCT00085735|537698802|FG000|Overall Study|Withdrawal by Subject|1|||
149058985|NCT00085735|537698803|FG001|Overall Study|Withdrawal by Subject|0|||
149058986|NCT00085735|537698804|FG002|Overall Study|Withdrawal by Subject|4|||
149058987|NCT00085735|537698805|FG003|Overall Study|Withdrawal by Subject|5|||
149058988|NCT00085735|537698806|FG004|Overall Study|Withdrawal by Subject|7|||
149058989|NCT00085735|537698807|FG005|Overall Study|Withdrawal by Subject|8|||
149058990|NCT00085735|537698802|FG000|Overall Study|Patient ineligible|1|||
149058991|NCT00085735|537698803|FG001|Overall Study|Patient ineligible|0|||
149058992|NCT00085735|537698804|FG002|Overall Study|Patient ineligible|3|||
149058993|NCT00085735|537698805|FG003|Overall Study|Patient ineligible|7|||
149058994|NCT00085735|537698806|FG004|Overall Study|Patient ineligible|17|||
149058995|NCT00085735|537698807|FG005|Overall Study|Patient ineligible|8|||
149058996|NCT00085735|537698802|FG000|Overall Study|Excess residual disease|2|||
149058997|NCT00085735|537698803|FG001|Overall Study|Excess residual disease|2|||
149058998|NCT00085735|537698804|FG002|Overall Study|Excess residual disease|1|||
149058999|NCT00085735|537698805|FG003|Overall Study|Excess residual disease|1|||
149059000|NCT00085735|537698806|FG004|Overall Study|Excess residual disease|1|||
149059001|NCT00085735|537698807|FG005|Overall Study|Excess residual disease|4|||
149059002|NCT00085735|537698802|FG000|Overall Study|Reason not documented|1|||
149059003|NCT00085735|537698803|FG001|Overall Study|Reason not documented|0|||
149059004|NCT00085735|537698804|FG002|Overall Study|Reason not documented|1|||
149059005|NCT00085735|537698805|FG003|Overall Study|Reason not documented|0|||
149059006|NCT00085735|537698806|FG004|Overall Study|Reason not documented|1|||
149059007|NCT00085735|537698807|FG005|Overall Study|Reason not documented|0|||
149059008|NCT00085735|537698802|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
149059009|NCT00085735|537698803|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
149059010|NCT00085735|537698804|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
149059011|NCT00085735|537698805|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
149059012|NCT00085735|537698806|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
149059013|NCT00085735|537698807|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
149059014|NCT02817776|537698808|FG000|Overall Study|Excluded|33|||
149059015|NCT02817776|537698808|FG000|Overall Study|Lost to Follow-up|20|||
149059016|NCT02817776|537698808|FG000|Overall Study|Withdrawal by Subject|33|||
149059017|NCT02817776|537698808|FG000|Overall Study|Death|2|||
149059018|NCT02359890|537698809|FG000|Overall Study|Not meeting eligibility|4|||
149059019|NCT02359890|537698809|FG000|Overall Study|Never treated with study catheter|6|||
149059020|NCT03907878|537698813|FG000|Treatment Period|Withdrawal by Subject|5|||
149059021|NCT03907878|537698813|FG000|Treatment Period|Adverse Event|4|||
149059022|NCT03907878|537698813|FG000|Treatment Period|Lack of Efficacy|1|||
149059023|NCT03907878|537698813|FG000|Treatment Period|Protocol Violation|1|||
149059024|NCT03907878|537698813|FG000|Follow-up Period|Adverse Event|3|||
149059025|NCT03907878|537698813|FG000|Follow-up Period|Withdrawal by Subject|3|||
149059026|NCT03904147|537698814|FG000|Overall Study|Death|15|||
149059027|NCT03904147|537698815|FG001|Overall Study|Death|13|||
149059028|NCT03904147|537698816|FG002|Overall Study|Death|15|||
149059029|NCT03904147|537698814|FG000|Overall Study|Withdrawal by Subject|7|||
149059030|NCT03904147|537698815|FG001|Overall Study|Withdrawal by Subject|12|||
149059031|NCT03904147|537698816|FG002|Overall Study|Withdrawal by Subject|1|||
149059032|NCT03904147|537698814|FG000|Overall Study|1Y visit completed after 365 days|1|||
149059033|NCT03904147|537698815|FG001|Overall Study|1Y visit completed after 365 days|1|||
149059034|NCT03904147|537698816|FG002|Overall Study|1Y visit completed after 365 days|0|||
149059035|NCT02815566|537698818|FG000|Overall Study|Adverse Event|1|||
149059036|NCT02815566|537698819|FG001|Overall Study|Adverse Event|1|||
149059037|NCT02815566|537698818|FG000|Overall Study|Withdrawal by Subject|1|||
149059038|NCT02815566|537698819|FG001|Overall Study|Withdrawal by Subject|0|||
149059039|NCT02815566|537698818|FG000|Overall Study|Lost to Follow-up|0|||
149059040|NCT02815566|537698819|FG001|Overall Study|Lost to Follow-up|1|||
149059041|NCT02861300|537698824|FG000|Overall Study|Death|0|||
149059042|NCT02861300|537698825|FG001|Overall Study|Death|0|||
149059043|NCT02861300|537698826|FG002|Overall Study|Death|0|||
149059044|NCT02861300|537698827|FG003|Overall Study|Death|0|||
149059045|NCT02861300|537698828|FG004|Overall Study|Death|0|||
149059046|NCT02861300|537698829|FG005|Overall Study|Death|0|||
149059047|NCT02861300|537698830|FG006|Overall Study|Death|24|||
149059048|NCT02861300|537698824|FG000|Overall Study|Delay in treatment|0|||
149059049|NCT02861300|537698825|FG001|Overall Study|Delay in treatment|0|||
149059050|NCT02861300|537698826|FG002|Overall Study|Delay in treatment|0|||
149059051|NCT02861300|537698827|FG003|Overall Study|Delay in treatment|0|||
149059052|NCT02861300|537698828|FG004|Overall Study|Delay in treatment|0|||
149059053|NCT02861300|537698829|FG005|Overall Study|Delay in treatment|1|||
149059054|NCT02861300|537698830|FG006|Overall Study|Delay in treatment|0|||
149059055|NCT02861300|537698824|FG000|Overall Study|Disease Progression|0|||
149059056|NCT02861300|537698825|FG001|Overall Study|Disease Progression|1|||
149059057|NCT02861300|537698826|FG002|Overall Study|Disease Progression|0|||
149059058|NCT02861300|537698827|FG003|Overall Study|Disease Progression|0|||
149059059|NCT02861300|537698828|FG004|Overall Study|Disease Progression|0|||
149059060|NCT02861300|537698829|FG005|Overall Study|Disease Progression|0|||
149059061|NCT02861300|537698830|FG006|Overall Study|Disease Progression|2|||
149059062|NCT02861300|537698824|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
149059063|NCT02861300|537698825|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
149059064|NCT02861300|537698826|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
149059065|NCT02861300|537698827|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
149059066|NCT02861300|537698828|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
149059067|NCT02861300|537698829|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
149059068|NCT02861300|537698830|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
149059069|NCT02861300|537698824|FG000|Overall Study|Clinical Complications|0|||
149059070|NCT02861300|537698825|FG001|Overall Study|Clinical Complications|0|||
149059071|NCT02861300|537698826|FG002|Overall Study|Clinical Complications|0|||
149059072|NCT02861300|537698827|FG003|Overall Study|Clinical Complications|0|||
149059073|NCT02861300|537698828|FG004|Overall Study|Clinical Complications|0|||
149059074|NCT02861300|537698829|FG005|Overall Study|Clinical Complications|0|||
149059075|NCT02861300|537698830|FG006|Overall Study|Clinical Complications|1|||
149059076|NCT01501955|537698835|FG000|Overall Study|Withdrawal by Subject|1|||
149059077|NCT01501955|537698836|FG001|Overall Study|Withdrawal by Subject|0|||
149059078|NCT01501955|537698835|FG000|Overall Study|Adverse Event|1|||
149059079|NCT01501955|537698836|FG001|Overall Study|Adverse Event|3|||
149059080|NCT05399459|537698838|FG000|Overall Study|Randomized but not treated|29|||
149059081|NCT05399459|537698839|FG001|Overall Study|Randomized but not treated|30|||
149059082|NCT05399459|537698840|FG002|Overall Study|Randomized but not treated|38|||
149059083|NCT05399459|537698838|FG000|Overall Study|Lost to Follow-up|1|||
149059084|NCT05399459|537698839|FG001|Overall Study|Lost to Follow-up|0|||
149059085|NCT05399459|537698840|FG002|Overall Study|Lost to Follow-up|0|||
149059086|NCT02231164|537698842|FG000|Overall Study|Adverse Event|1|||
149059087|NCT02231164|537698843|FG001|Overall Study|Adverse Event|1|||
149059088|NCT02231164|537698842|FG000|Overall Study|Lack of Efficacy|4|||
149059089|NCT02231164|537698843|FG001|Overall Study|Lack of Efficacy|3|||
149059090|NCT02231164|537698842|FG000|Overall Study|Withdrawal by Subject|1|||
149059091|NCT02231164|537698843|FG001|Overall Study|Withdrawal by Subject|2|||
149059092|NCT03625167|537698844|FG000|Overall Study|Protocol Violation|5|||
149059093|NCT06103188|537698845|FG000|Overall Study|Lost to Follow-up|1|||
149059094|NCT06103188|537698846|FG001|Overall Study|Lost to Follow-up|6|||
149059095|NCT06103188|537698847|FG002|Overall Study|Lost to Follow-up|4|||
149059096|NCT03020199|537698854|FG000|Treatment Period|Adverse Event|0|||
149059097|NCT03020199|537698855|FG001|Treatment Period|Adverse Event|2|||
149059098|NCT03020199|537698854|FG000|Treatment Period|Lack of Efficacy|1|||
149059099|NCT03020199|537698855|FG001|Treatment Period|Lack of Efficacy|6|||
149059100|NCT03020199|537698854|FG000|Treatment Period|Lost to Follow-up|1|||
149059101|NCT03020199|537698855|FG001|Treatment Period|Lost to Follow-up|6|||
149059102|NCT03020199|537698854|FG000|Treatment Period|Physician Decision|0|||
149059103|NCT03020199|537698855|FG001|Treatment Period|Physician Decision|1|||
149059104|NCT03020199|537698854|FG000|Treatment Period|Subject/guardian decision|8|||
149059105|NCT03020199|537698855|FG001|Treatment Period|Subject/guardian decision|15|||
149059106|NCT03020199|537698854|FG000|Treatment Period|Subjects not treated|3|||
149059107|NCT03020199|537698855|FG001|Treatment Period|Subjects not treated|4|||
149059108|NCT03020199|537698854|FG000|Follow-up Period|Disease relapse|32|||
149059109|NCT03020199|537698855|FG001|Follow-up Period|Disease relapse|7|||
149059110|NCT03020199|537698854|FG000|Follow-up Period|Lack of Efficacy|1|||
149059111|NCT03020199|537698855|FG001|Follow-up Period|Lack of Efficacy|2|||
149059112|NCT03020199|537698854|FG000|Follow-up Period|Lost to Follow-up|4|||
149059113|NCT03020199|537698855|FG001|Follow-up Period|Lost to Follow-up|6|||
149059114|NCT03020199|537698854|FG000|Follow-up Period|Physician Decision|2|||
149059115|NCT03020199|537698855|FG001|Follow-up Period|Physician Decision|2|||
149059116|NCT03020199|537698854|FG000|Follow-up Period|Protocol Violation|1|||
149059117|NCT03020199|537698855|FG001|Follow-up Period|Protocol Violation|2|||
149059118|NCT03020199|537698854|FG000|Follow-up Period|Study terminated by Sponsor|6|||
149059119|NCT03020199|537698855|FG001|Follow-up Period|Study terminated by Sponsor|3|||
149059120|NCT03020199|537698854|FG000|Follow-up Period|Subject/guardian decision|14|||
149059121|NCT03020199|537698855|FG001|Follow-up Period|Subject/guardian decision|9|||
149059122|NCT05583578|537698856|FG000|Overall Study|Withdrawal by Subject|2|||
149059123|NCT05583578|537698857|FG001|Overall Study|Withdrawal by Subject|0|||
149059124|NCT04313972|537698858|FG000|Overall Study|Withdrawal by Subject|0|||
149059125|NCT04313972|537698859|FG001|Overall Study|Withdrawal by Subject|1|||
149059126|NCT05877976|537698860|FG000|Overall Study|Lost to Follow-up|31|||
149059127|NCT04314713|537698862|FG000|Overall Study|Lost to Follow-up|0|||
149059128|NCT04314713|537698863|FG001|Overall Study|Lost to Follow-up|0|||
149059129|NCT04314713|537698864|FG002|Overall Study|Lost to Follow-up|0|||
149059130|NCT04314713|537698865|FG003|Overall Study|Lost to Follow-up|1|||
149059131|NCT04314713|537698866|FG004|Overall Study|Lost to Follow-up|0|||
149059132|NCT04314713|537698867|FG005|Overall Study|Lost to Follow-up|0|||
149059133|NCT00248287|537698869|FG000|Overall Study|Adverse Event|11|||
149059134|NCT00248287|537698870|FG001|Overall Study|Adverse Event|10|||
149059135|NCT00248287|537698869|FG000|Overall Study|Death|1|||
149059136|NCT00248287|537698870|FG001|Overall Study|Death|0|||
149059137|NCT00248287|537698869|FG000|Overall Study|Lost to Follow-up|0|||
149059138|NCT00248287|537698870|FG001|Overall Study|Lost to Follow-up|1|||
149059139|NCT00248287|537698869|FG000|Overall Study|Investigator Request|4|||
149059140|NCT00248287|537698870|FG001|Overall Study|Investigator Request|3|||
149059141|NCT00248287|537698869|FG000|Overall Study|Patient Request|5|||
149059142|NCT00248287|537698870|FG001|Overall Study|Patient Request|3|||
149059143|NCT00248287|537698869|FG000|Overall Study|Other|3|||
149059144|NCT00248287|537698870|FG001|Overall Study|Other|2|||
149059145|NCT04568486|537698877|FG000|Overall Study|Withdrawal by Subject|26|||
149059146|NCT04568486|537698877|FG000|Overall Study|Lost to Follow-up|7|||
149059147|NCT04248725|537698878|FG000|Post-Treatment|Lost to Follow-up|6|||
149059148|NCT04248725|537698879|FG001|Post-Treatment|Lost to Follow-up|5|||
149059149|NCT04248725|537698878|FG000|6-Month Follow Up|Lost to Follow-up|9|||
149059150|NCT04248725|537698879|FG001|6-Month Follow Up|Lost to Follow-up|8|||
149059151|NCT01210807|537698882|FG000|Overall Study|Lost to Follow-up|1|||
149059152|NCT01210807|537698883|FG001|Overall Study|Lost to Follow-up|2|||
149059153|NCT01210807|537698882|FG000|Overall Study|Not implanted bilaterally|2|||
149059154|NCT01210807|537698883|FG001|Overall Study|Not implanted bilaterally|1|||
149059155|NCT06457802|537698885|FG000|Overall Study|Early termination of study prior to participant completion|2|||
149059156|NCT06457802|537698886|FG001|Overall Study|Early termination of study prior to participant completion|2|||
149059157|NCT04524442|537698887|FG000|Overall Study|Subject Decision|1|||
149059158|NCT04880863|537698897|FG000|Overall Study|Adverse Event|1|||
149059159|NCT04880863|537698897|FG000|Overall Study|Patient decision|2|||
149059160|NCT04880863|537698897|FG000|Overall Study|Confirmed Disease Progression|15|||
149059161|NCT04880863|537698897|FG000|Overall Study|Death|3|||
149059162|NCT04880863|537698897|FG000|Overall Study|Physician Decision|4|||
149059163|NCT04880863|537698897|FG000|Overall Study|Unconfirmed Disease Progression|4|||
149059164|NCT04880863|537698897|FG000|Overall Study|Withdrawal by Subject|2|||
149059165|NCT04880863|537698897|FG000|Overall Study|Study discontinuation by the sponsor|4|||
149059166|NCT04880863|537698897|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
149059167|NCT04880863|537698897|FG000|Overall Study|Not received study drug NAP|2|||
149059168|NCT01152450|537698898|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
149059169|NCT01152450|537698899|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
149059170|NCT01152450|537698900|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
149059171|NCT01152450|537698901|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
149059172|NCT01152450|537698902|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
149059173|NCT01152450|537698903|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
149059174|NCT01152450|537698898|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
149059175|NCT01152450|537698899|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
149059176|NCT01152450|537698900|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
149059177|NCT01152450|537698901|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
149059178|NCT01152450|537698902|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
149059179|NCT01152450|537698903|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
149059180|NCT01152450|537698898|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149059181|NCT01152450|537698899|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
149059182|NCT01152450|537698900|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
149059183|NCT01152450|537698901|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149059184|NCT01152450|537698902|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149059185|NCT01152450|537698903|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
149059186|NCT01544114|537698907|FG000|Overall Study|Withdrawal by Subject|0|||
149059187|NCT01544114|537698908|FG001|Overall Study|Withdrawal by Subject|0|||
149059188|NCT01544114|537698909|FG002|Overall Study|Withdrawal by Subject|3|||
149059189|NCT01544114|537698907|FG000|Overall Study|Lost to Follow-up|0|||
149059190|NCT01544114|537698908|FG001|Overall Study|Lost to Follow-up|2|||
149059191|NCT01544114|537698909|FG002|Overall Study|Lost to Follow-up|0|||
149059192|NCT01544114|537698907|FG000|Overall Study|Adverse Event|1|||
149059193|NCT01544114|537698908|FG001|Overall Study|Adverse Event|1|||
149059194|NCT01544114|537698909|FG002|Overall Study|Adverse Event|2|||
149059195|NCT01544114|537698907|FG000|Overall Study|Protocol Violation|0|||
149059196|NCT01544114|537698908|FG001|Overall Study|Protocol Violation|1|||
149059197|NCT01544114|537698909|FG002|Overall Study|Protocol Violation|0|||
149059198|NCT05526430|537698912|FG000|Overall Study|Withdrawal by Subject|0|||
149059199|NCT05526430|537698913|FG001|Overall Study|Withdrawal by Subject|2|||
149059200|NCT05526430|537698914|FG002|Overall Study|Withdrawal by Subject|0|||
149059201|NCT05526430|537698915|FG003|Overall Study|Withdrawal by Subject|0|||
149059202|NCT03085810|537698920|FG000|Main Study|Withdrawal by Subject|77|||
149059203|NCT03085810|537698921|FG001|Main Study|Withdrawal by Subject|0|||
149059204|NCT03085810|537698922|FG002|Main Study|Withdrawal by Subject|0|||
149059205|NCT03085810|537698920|FG000|Main Study|Terminated By Sponsor|14|||
149059206|NCT03085810|537698921|FG001|Main Study|Terminated By Sponsor|0|||
149059207|NCT03085810|537698922|FG002|Main Study|Terminated By Sponsor|0|||
149059208|NCT03085810|537698920|FG000|Main Study|Protocol Violation|15|||
149059209|NCT03085810|537698921|FG001|Main Study|Protocol Violation|0|||
149059210|NCT03085810|537698922|FG002|Main Study|Protocol Violation|0|||
149059211|NCT03085810|537698920|FG000|Main Study|Physician Decision|13|||
149059212|NCT03085810|537698921|FG001|Main Study|Physician Decision|0|||
149059213|NCT03085810|537698922|FG002|Main Study|Physician Decision|0|||
149059214|NCT03085810|537698920|FG000|Main Study|Lost to Follow-up|17|||
149059215|NCT03085810|537698921|FG001|Main Study|Lost to Follow-up|0|||
149059216|NCT03085810|537698922|FG002|Main Study|Lost to Follow-up|0|||
149059217|NCT03085810|537698920|FG000|Main Study|Adverse Event|25|||
149059218|NCT03085810|537698921|FG001|Main Study|Adverse Event|0|||
149059219|NCT03085810|537698922|FG002|Main Study|Adverse Event|0|||
149059220|NCT03085810|537698920|FG000|Main Study|Pregnancy|7|||
149059221|NCT03085810|537698921|FG001|Main Study|Pregnancy|0|||
149059222|NCT03085810|537698922|FG002|Main Study|Pregnancy|0|||
149059223|NCT03085810|537698920|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
149059224|NCT03085810|537698921|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
149059225|NCT03085810|537698922|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
149059226|NCT03085810|537698920|FG000|Main Study|Lack of Efficacy|10|||
149059227|NCT03085810|537698921|FG001|Main Study|Lack of Efficacy|0|||
149059228|NCT03085810|537698922|FG002|Main Study|Lack of Efficacy|0|||
149059229|NCT03085810|537698920|FG000|Main Study|Death|12|||
149059230|NCT03085810|537698921|FG001|Main Study|Death|0|||
149059231|NCT03085810|537698922|FG002|Main Study|Death|0|||
149059232|NCT03085810|537698920|FG000|Main Study|Disease progression|1|||
149059233|NCT03085810|537698921|FG001|Main Study|Disease progression|0|||
149059234|NCT03085810|537698922|FG002|Main Study|Disease progression|0|||
149059235|NCT03085810|537698920|FG000|Main Study|Site Closure|3|||
149059236|NCT03085810|537698921|FG001|Main Study|Site Closure|0|||
149059237|NCT03085810|537698922|FG002|Main Study|Site Closure|0|||
149059238|NCT03085810|537698920|FG000|Main Study|Planned pregnancy|17|||
149059239|NCT03085810|537698921|FG001|Main Study|Planned pregnancy|0|||
149059240|NCT03085810|537698922|FG002|Main Study|Planned pregnancy|0|||
149059241|NCT03085810|537698920|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
149059242|NCT03085810|537698921|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
149059243|NCT03085810|537698922|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
149059244|NCT03085810|537698920|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
149059245|NCT03085810|537698921|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
149059246|NCT03085810|537698922|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
149059247|NCT03085810|537698920|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
149059248|NCT03085810|537698921|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
149059249|NCT03085810|537698922|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
149059250|NCT03085810|537698920|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
149059251|NCT03085810|537698921|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
149059252|NCT03085810|537698922|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
149059253|NCT02601313|537698923|FG000|Overall Study|Death|2|||
149059254|NCT02601313|537698924|FG001|Overall Study|Death|41|||
149059255|NCT02601313|537698925|FG002|Overall Study|Death|6|||
149059256|NCT02601313|537698923|FG000|Overall Study|Enrolled but never treated|0|||
149059257|NCT02601313|537698924|FG001|Overall Study|Enrolled but never treated|6|||
149059258|NCT02601313|537698925|FG002|Overall Study|Enrolled but never treated|3|||
149059259|NCT02601313|537698923|FG000|Overall Study|Enrolled, did not initiate AC|4|||
149059260|NCT02601313|537698924|FG001|Overall Study|Enrolled, did not initiate AC|0|||
149059261|NCT02601313|537698925|FG002|Overall Study|Enrolled, did not initiate AC|0|||
149059262|NCT02601313|537698923|FG000|Overall Study|Full consent withdrawal|0|||
149059263|NCT02601313|537698924|FG001|Overall Study|Full consent withdrawal|3|||
149059264|NCT02601313|537698925|FG002|Overall Study|Full consent withdrawal|2|||
149059265|NCT02601313|537698923|FG000|Overall Study|Lost to Follow-up|0|||
149059266|NCT02601313|537698924|FG001|Overall Study|Lost to Follow-up|1|||
149059267|NCT02601313|537698925|FG002|Overall Study|Lost to Follow-up|1|||
149059268|NCT05239455|537698926|FG000|Overall Study|Adverse Event|1|||
149059269|NCT05239455|537698926|FG000|Overall Study|Sponsor Decision|5|||
149059270|NCT05239455|537698926|FG000|Overall Study|Incomplete Blood Collection|1|||
149059271|NCT03800654|537698927|FG000|Overall Study|Time constraints|3|||
149059272|NCT03800654|537698928|FG001|Overall Study|Time constraints|3|||
149059273|NCT03800654|537698929|FG002|Overall Study|Time constraints|3|||
149059274|NCT03800654|537698927|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
148890200|NCT03812380|537077159|FG001|Overall Study|Protocol Violation|3|||
148890201|NCT03812380|537077158|FG000|Overall Study|Withdrawal by Subject|5|||
148890202|NCT03812380|537077159|FG001|Overall Study|Withdrawal by Subject|4|||
148890203|NCT03812380|537077158|FG000|Overall Study|Early termination of study|14|||
149059275|NCT03800654|537698928|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
149059276|NCT03800654|537698929|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
149059277|NCT03800654|537698927|FG000|Overall Study|Lost to Follow-up|2|||
149059278|NCT03800654|537698928|FG001|Overall Study|Lost to Follow-up|1|||
149059279|NCT03800654|537698929|FG002|Overall Study|Lost to Follow-up|6|||
149059280|NCT03800654|537698927|FG000|Overall Study|Medical Health Issue|0|||
149059281|NCT03800654|537698928|FG001|Overall Study|Medical Health Issue|0|||
149059282|NCT03800654|537698929|FG002|Overall Study|Medical Health Issue|1|||
149059283|NCT03800654|537698927|FG000|Overall Study|Personal Issues|0|||
149059284|NCT03800654|537698928|FG001|Overall Study|Personal Issues|2|||
149059285|NCT03800654|537698929|FG002|Overall Study|Personal Issues|0|||
149059286|NCT03800654|537698927|FG000|Overall Study|Protocol Violation|0|||
148890204|NCT03812380|537077159|FG001|Overall Study|Early termination of study|14|||
149059287|NCT03800654|537698928|FG001|Overall Study|Protocol Violation|1|||
149059288|NCT03800654|537698929|FG002|Overall Study|Protocol Violation|0|||
149059289|NCT05704543|537698931|FG000|Overall Study|Withdrawal by Subject|1|||
149059290|NCT05704543|537698932|FG001|Overall Study|Withdrawal by Subject|1|||
149059291|NCT05704543|537698933|FG002|Overall Study|Withdrawal by Subject|0|||
149059292|NCT05704543|537698934|FG003|Overall Study|Withdrawal by Subject|2|||
149059293|NCT05704543|537698931|FG000|Overall Study|Lost to Follow-up|1|||
149059294|NCT05704543|537698932|FG001|Overall Study|Lost to Follow-up|2|||
149059295|NCT05704543|537698933|FG002|Overall Study|Lost to Follow-up|0|||
149059296|NCT05704543|537698934|FG003|Overall Study|Lost to Follow-up|0|||
149059297|NCT04830800|537698941|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
149059298|NCT04830800|537698942|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
149059299|NCT04830800|537698943|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
149059300|NCT04830800|537698944|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
149059301|NCT04830800|537698945|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
149059302|NCT02626533|537698946|FG000|Overall Study|Protocol Violation|14|||
149059303|NCT02626533|537698946|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
149059304|NCT02626533|537698946|FG000|Overall Study|Withdrawal by Subject|1|||
149059305|NCT03701763|537698947|FG000|Placebo-controlled Phase|Adverse Event|1|||
149059306|NCT03701763|537698948|FG001|Placebo-controlled Phase|Adverse Event|5|||
149059307|NCT03701763|537698949|FG002|Placebo-controlled Phase|Adverse Event|0|||
149059308|NCT03701763|537698950|FG003|Placebo-controlled Phase|Adverse Event|0|||
149059309|NCT03701763|537698947|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
149059310|NCT03701763|537698948|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
149059311|NCT03701763|537698949|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
149059312|NCT03701763|537698950|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
149059313|NCT03701763|537698947|FG000|Placebo-controlled Phase|Miscellaneous|2|||
149059314|NCT03701763|537698948|FG001|Placebo-controlled Phase|Miscellaneous|0|||
149059315|NCT03701763|537698949|FG002|Placebo-controlled Phase|Miscellaneous|0|||
149059316|NCT03701763|537698950|FG003|Placebo-controlled Phase|Miscellaneous|0|||
149059317|NCT03701763|537698947|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
148890205|NCT00981149|537077160|FG000|Overall Study|Lost to Follow-up|1|||
148890206|NCT00981149|537077161|FG001|Overall Study|Lost to Follow-up|2|||
148890207|NCT00981149|537077160|FG000|Overall Study|Withdrawal by Subject|1|||
149059318|NCT03701763|537698948|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
149059319|NCT03701763|537698949|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
149059320|NCT03701763|537698950|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
149059321|NCT03701763|537698947|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
149059322|NCT03701763|537698948|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
149059323|NCT03701763|537698949|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
149059324|NCT03701763|537698950|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
149059325|NCT03701763|537698947|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
149059326|NCT03701763|537698948|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
149059327|NCT03701763|537698949|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
149059328|NCT03701763|537698950|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
149059329|NCT03701763|537698947|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
149059330|NCT03701763|537698948|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
149059331|NCT03701763|537698949|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
149059332|NCT03701763|537698950|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
149059333|NCT03701763|537698947|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
149059334|NCT03701763|537698948|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
149059335|NCT03701763|537698949|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
149059336|NCT03701763|537698950|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
149059337|NCT03701763|537698947|FG000|Apremilast Extension Phase|Adverse Event|0|||
149059338|NCT03701763|537698948|FG001|Apremilast Extension Phase|Adverse Event|0|||
149059339|NCT03701763|537698949|FG002|Apremilast Extension Phase|Adverse Event|3|||
149059340|NCT03701763|537698950|FG003|Apremilast Extension Phase|Adverse Event|1|||
149059341|NCT03701763|537698947|FG000|Apremilast Extension Phase|Miscellaneous|0|||
149059342|NCT03701763|537698948|FG001|Apremilast Extension Phase|Miscellaneous|0|||
149059343|NCT03701763|537698949|FG002|Apremilast Extension Phase|Miscellaneous|2|||
149059344|NCT03701763|537698950|FG003|Apremilast Extension Phase|Miscellaneous|1|||
149059345|NCT03701763|537698947|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
149059346|NCT03701763|537698948|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
149059347|NCT03701763|537698949|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
149059348|NCT03701763|537698950|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
149059349|NCT03701763|537698947|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
149059350|NCT03701763|537698948|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
149059351|NCT03701763|537698949|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
149059352|NCT03701763|537698950|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
149059353|NCT03701763|537698947|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
148890208|NCT00981149|537077161|FG001|Overall Study|Withdrawal by Subject|1|||
149059354|NCT03701763|537698948|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
149059355|NCT03701763|537698949|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
149059356|NCT03701763|537698950|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
149059357|NCT03701763|537698947|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
149059358|NCT03701763|537698948|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
149059359|NCT03701763|537698949|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
149059360|NCT03701763|537698950|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
149059361|NCT03701763|537698947|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
149059362|NCT03701763|537698948|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
149059363|NCT03701763|537698949|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
149059364|NCT03701763|537698950|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
149059365|NCT03701763|537698947|FG000|14-Week Observational Follow-up Phase|Other|0|||
149059366|NCT03701763|537698948|FG001|14-Week Observational Follow-up Phase|Other|0|||
149059367|NCT03701763|537698949|FG002|14-Week Observational Follow-up Phase|Other|1|||
149059368|NCT03701763|537698950|FG003|14-Week Observational Follow-up Phase|Other|0|||
149059369|NCT03701763|537698947|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
149059370|NCT03701763|537698948|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
149059371|NCT03701763|537698949|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
149059372|NCT03701763|537698950|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
149059373|NCT03701763|537698947|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
149059374|NCT03701763|537698948|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
149059375|NCT03701763|537698949|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
149059376|NCT03701763|537698950|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
149059377|NCT03785964|537698953|FG000|Overall Study|Adverse Event|14|||
149059378|NCT03785964|537698954|FG001|Overall Study|Adverse Event|1|||
149059379|NCT03785964|537698953|FG000|Overall Study|Unqualified Clinical Progression|1|||
149059380|NCT03785964|537698954|FG001|Overall Study|Unqualified Clinical Progression|1|||
149059381|NCT03785964|537698953|FG000|Overall Study|Participant non-compliance|1|||
149059382|NCT03785964|537698954|FG001|Overall Study|Participant non-compliance|1|||
149059383|NCT03785964|537698953|FG000|Overall Study|Not treated|1|||
149059384|NCT03785964|537698954|FG001|Overall Study|Not treated|0|||
149059385|NCT03785964|537698953|FG000|Overall Study|Other reason|5|||
149059386|NCT03785964|537698954|FG001|Overall Study|Other reason|11|||
149059387|NCT03785964|537698953|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
149059388|NCT03785964|537698954|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
149059389|NCT05070728|537698955|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
149059390|NCT05070728|537698956|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
149059391|NCT02151981|537698957|FG000|Overall Study|Death|184|||
149059392|NCT02151981|537698958|FG001|Overall Study|Death|88|||
149059393|NCT02151981|537698957|FG000|Overall Study|Lost to Follow-up|7|||
149059394|NCT02151981|537698958|FG001|Overall Study|Lost to Follow-up|1|||
149059395|NCT02151981|537698957|FG000|Overall Study|Withdrawal by Subject|27|||
149059396|NCT02151981|537698958|FG001|Overall Study|Withdrawal by Subject|21|||
149059397|NCT02151981|537698957|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149059398|NCT02151981|537698958|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
149059399|NCT02151981|537698957|FG000|Overall Study|Other reasons|1|||
149059400|NCT02151981|537698958|FG001|Overall Study|Other reasons|2|||
149059401|NCT05251909|537700731|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
149059402|NCT05251909|537700732|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
149059403|NCT04987320|537700733|FG000|Overall Study|Withdrawal by Subject|0|||
149059404|NCT04987320|537700734|FG001|Overall Study|Withdrawal by Subject|1|||
149059405|NCT01824875|537700735|FG000|Overall Study|Disease progression|22|||
149059406|NCT01824875|537700736|FG001|Overall Study|Disease progression|15|||
149059407|NCT01824875|537700735|FG000|Overall Study|Withdrawal by Subject|5|||
149059408|NCT01824875|537700736|FG001|Overall Study|Withdrawal by Subject|4|||
149059409|NCT01824875|537700735|FG000|Overall Study|Adverse Event|4|||
149059410|NCT01824875|537700736|FG001|Overall Study|Adverse Event|10|||
149059411|NCT01824875|537700735|FG000|Overall Study|Alternative therapy|3|||
149059412|NCT01824875|537700736|FG001|Overall Study|Alternative therapy|0|||
149059413|NCT01824875|537700735|FG000|Overall Study|Complicating disease|1|||
149059414|NCT01824875|537700736|FG001|Overall Study|Complicating disease|0|||
149059415|NCT01824875|537700735|FG000|Overall Study|Physician Decision|0|||
149059416|NCT01824875|537700736|FG001|Overall Study|Physician Decision|1|||
149059417|NCT01824875|537700735|FG000|Overall Study|Non-compliance|1|||
149059418|NCT01824875|537700736|FG001|Overall Study|Non-compliance|1|||
149059419|NCT01824875|537700735|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
149059420|NCT01824875|537700736|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
149059421|NCT01824875|537700735|FG000|Overall Study|Administrative issues|0|||
149059422|NCT01824875|537700736|FG001|Overall Study|Administrative issues|2|||
149059423|NCT01824875|537700735|FG000|Overall Study|Ineligible or never started treatment|9|||
149059424|NCT01824875|537700736|FG001|Overall Study|Ineligible or never started treatment|5|||
149059425|NCT01824875|537700735|FG000|Overall Study|Other|0|||
149059426|NCT01824875|537700736|FG001|Overall Study|Other|2|||
149059427|NCT00433329|537700739|FG000|Overall Study|Adverse Event|9|||
149059428|NCT00433329|537700739|FG000|Overall Study|Death|4|||
149059429|NCT00433329|537700739|FG000|Overall Study|Withdrew consent|3|||
149059430|NCT00433329|537700739|FG000|Overall Study|Discontinued sildenafil|2|||
149059431|NCT00433329|537700739|FG000|Overall Study|Moved out of state|1|||
149059432|NCT00433329|537700739|FG000|Overall Study|Lost to Follow-up|1|||
149059433|NCT00433329|537700739|FG000|Overall Study|Physician Decision|1|||
149059434|NCT04195698|537700740|FG000|Overall Study|Adverse Event|4|||
149059435|NCT04195698|537700741|FG001|Overall Study|Adverse Event|11|||
149059436|NCT04195698|537700740|FG000|Overall Study|Withdrawal by Subject|9|||
149059437|NCT04195698|537700741|FG001|Overall Study|Withdrawal by Subject|10|||
149059438|NCT04195698|537700740|FG000|Overall Study|Lost to Follow-up|5|||
149059439|NCT04195698|537700741|FG001|Overall Study|Lost to Follow-up|4|||
149059440|NCT04195698|537700740|FG000|Overall Study|Lack of Efficacy|2|||
149059441|NCT04195698|537700741|FG001|Overall Study|Lack of Efficacy|10|||
149059442|NCT04195698|537700740|FG000|Overall Study|Other|5|||
149059443|NCT04195698|537700741|FG001|Overall Study|Other|4|||
149059444|NCT05459688|537700742|FG000|Overall Study|Lost to Follow-up|6|||
149059445|NCT05459688|537700742|FG000|Overall Study|Physician Decision|1|||
149059446|NCT05459688|537700742|FG000|Overall Study|Withdrawal by Subject|19|||
149059447|NCT05459688|537700742|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
149059448|NCT01129102|537700743|FG000|Overall Study|No study drug treatment|2|||
149059449|NCT01129102|537700744|FG001|Overall Study|No study drug treatment|3|||
149059450|NCT01129102|537700745|FG002|Overall Study|No study drug treatment|1|||
149059451|NCT01129102|537700743|FG000|Overall Study|Withdrawal by Subject|2|||
149059452|NCT01129102|537700744|FG001|Overall Study|Withdrawal by Subject|0|||
149059453|NCT01129102|537700745|FG002|Overall Study|Withdrawal by Subject|3|||
149059454|NCT01129102|537700743|FG000|Overall Study|Protocol Violation|0|||
149059455|NCT01129102|537700744|FG001|Overall Study|Protocol Violation|1|||
149059456|NCT01129102|537700745|FG002|Overall Study|Protocol Violation|1|||
149059457|NCT01129102|537700743|FG000|Overall Study|Pregnancy|0|||
149059458|NCT01129102|537700744|FG001|Overall Study|Pregnancy|0|||
149059459|NCT01129102|537700745|FG002|Overall Study|Pregnancy|1|||
149059460|NCT01129102|537700743|FG000|Overall Study|Adverse Event|2|||
149059461|NCT01129102|537700744|FG001|Overall Study|Adverse Event|2|||
149059462|NCT01129102|537700745|FG002|Overall Study|Adverse Event|1|||
149059463|NCT01129102|537700743|FG000|Overall Study|Lost to Follow-up|2|||
149059464|NCT01129102|537700744|FG001|Overall Study|Lost to Follow-up|0|||
149059465|NCT01129102|537700745|FG002|Overall Study|Lost to Follow-up|0|||
149059466|NCT03462030|537700748|FG000|Overall Study|Withdrawal by Subject|1|||
149059467|NCT03462030|537700749|FG001|Overall Study|Withdrawal by Subject|1|||
149059468|NCT03371381|537700750|FG000|Overall Study|Death|5|||
149059469|NCT03371381|537700750|FG000|Overall Study|Study terminated by sponsor|3|||
149059470|NCT03371381|537700750|FG000|Overall Study|Other|4|||
149059471|NCT02276885|537700752|FG000|Overall Study|Withdrawal by Subject|2|||
149059472|NCT02276885|537700753|FG001|Overall Study|Withdrawal by Subject|0|||
149059473|NCT02276885|537700752|FG000|Overall Study|Lost to Follow-up|5|||
149059474|NCT02276885|537700753|FG001|Overall Study|Lost to Follow-up|2|||
149059475|NCT01574274|537700754|FG000|Overall Study|Ineligible|0|||
149059476|NCT01574274|537700755|FG001|Overall Study|Ineligible|1|||
149059477|NCT01574274|537700754|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
149059478|NCT01574274|537700755|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
149059479|NCT01574274|537700754|FG000|Overall Study|Ph+ B-ALL|3|||
149059480|NCT01574274|537700755|FG001|Overall Study|Ph+ B-ALL|4|||
149059481|NCT01574274|537700754|FG000|Overall Study|Induction Death|2|||
149059482|NCT01574274|537700755|FG001|Overall Study|Induction Death|0|||
149059483|NCT01574274|537700754|FG000|Overall Study|Induction Failure|4|||
149059484|NCT01574274|537700755|FG001|Overall Study|Induction Failure|1|||
149059485|NCT01574274|537700754|FG000|Overall Study|Adverse Event|16|||
149059486|NCT01574274|537700755|FG001|Overall Study|Adverse Event|13|||
149059487|NCT01574274|537700754|FG000|Overall Study|Remission Death|1|||
149059488|NCT01574274|537700755|FG001|Overall Study|Remission Death|0|||
149059489|NCT01574274|537700754|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
149059490|NCT01574274|537700755|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
149059491|NCT01574274|537700754|FG000|Overall Study|Other, unknown|3|||
149059492|NCT01574274|537700755|FG001|Overall Study|Other, unknown|2|||
149059493|NCT04676763|537700757|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
149059494|NCT04676763|537700758|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
149059495|NCT04676763|537700759|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
149059496|NCT04676763|537700757|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
149059497|NCT04676763|537700758|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
149059498|NCT04676763|537700759|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
149059499|NCT04676763|537700757|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
149059500|NCT04676763|537700758|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
149059501|NCT04676763|537700759|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
149059502|NCT01593917|537700769|FG000|Overall Study|Death|67|||
149059503|NCT01593917|537700769|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
149059504|NCT01593917|537700769|FG000|Overall Study|Withdrawal by Subject|23|||
149059505|NCT01593917|537700769|FG000|Overall Study|Lost to Follow-up|12|||
149059506|NCT01593917|537700769|FG000|Overall Study|Protocol Violation|5|||
149059507|NCT01593917|537700769|FG000|Overall Study|Physician Decision|3|||
149059508|NCT04663737|537700770|FG000|Overall Study|Withdrawal by Subject|2|||
149059509|NCT04663737|537700771|FG001|Overall Study|Withdrawal by Subject|0|||
149059510|NCT04016662|537700772|FG000|Run-In Phase|Death|1|||
149059511|NCT04016662|537700772|FG000|Run-In Phase|Withdrawal by Subject|11|||
149059512|NCT04016662|537700772|FG000|Run-In Phase|Not meeting screening eligibility|9|||
149059513|NCT04016662|537700772|FG000|Run-In Phase|Physician Decision|3|||
149059514|NCT04016662|537700772|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
149059515|NCT04016662|537700772|FG000|PLGS (12 Weeks)|Death|1|||
149059516|NCT04016662|537700772|FG000|SAP (12 Weeks)|Death|1|||
149059517|NCT04499924|537700773|FG000|Overall Study|Study termination by sponsor|4|||
149059518|NCT04499924|537700774|FG001|Overall Study|Study termination by sponsor|6|||
149059519|NCT04499924|537700773|FG000|Overall Study|Withdrawal by Subject|1|||
149059520|NCT04499924|537700774|FG001|Overall Study|Withdrawal by Subject|3|||
149059521|NCT02841579|537700782|FG000|Overall Study|Death|1|||
149059522|NCT02841579|537700782|FG000|Overall Study|Adverse Event|1|||
149059523|NCT02841579|537700782|FG000|Overall Study|Lack of Efficacy|9|||
149059524|NCT03011333|537700785|FG000|Overall Study|Lost to Follow-up|0|||
149059525|NCT03011333|537700786|FG001|Overall Study|Lost to Follow-up|1|||
149059526|NCT03011333|537700787|FG002|Overall Study|Lost to Follow-up|0|||
149059527|NCT03011333|537700788|FG003|Overall Study|Lost to Follow-up|1|||
149059528|NCT03011333|537700789|FG004|Overall Study|Lost to Follow-up|4|||
149059529|NCT03011333|537700790|FG005|Overall Study|Lost to Follow-up|4|||
149059530|NCT03011333|537700791|FG006|Overall Study|Lost to Follow-up|5|||
149059531|NCT02998268|537700792|FG000|Overall Study|Adverse Event|0|||
149059532|NCT02998268|537700793|FG001|Overall Study|Adverse Event|2|||
149059533|NCT02998268|537700792|FG000|Overall Study|Withdrawal by Subject|0|||
149059534|NCT02998268|537700793|FG001|Overall Study|Withdrawal by Subject|1|||
149059535|NCT04225273|537700794|FG000|Overall Study|Lost to Follow-up|3|||
149059536|NCT03652389|537700795|FG000|Overall Study|Lost to Follow-up|1|||
149059537|NCT03652389|537700796|FG001|Overall Study|Lost to Follow-up|5|||
149059538|NCT03652389|537700795|FG000|Overall Study|Withdrawal by Subject|5|||
149059539|NCT03652389|537700796|FG001|Overall Study|Withdrawal by Subject|1|||
149059540|NCT03652389|537700795|FG000|Overall Study|New diagnosis|2|||
149059541|NCT03652389|537700796|FG001|Overall Study|New diagnosis|0|||
149059542|NCT04413708|537700797|FG000|Overall Study|Lost to Follow-up|1|||
149059543|NCT04413708|537700798|FG001|Overall Study|Lost to Follow-up|2|||
149059544|NCT03133546|537700803|FG000|Overall Study|Death|46|||
149059545|NCT03133546|537700804|FG001|Overall Study|Death|43|||
149059546|NCT03133546|537700803|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
149059547|NCT03133546|537700804|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
149059548|NCT02714257|537700824|FG000|Overall Study|Withdrawal by Subject|6|||
149059549|NCT02714257|537700825|FG001|Overall Study|Withdrawal by Subject|11|||
149059550|NCT02714257|537700824|FG000|Overall Study|Death|3|||
149059551|NCT02714257|537700825|FG001|Overall Study|Death|4|||
149059552|NCT02714257|537700824|FG000|Overall Study|Lost to Follow-up|1|||
149059553|NCT02714257|537700825|FG001|Overall Study|Lost to Follow-up|6|||
149059554|NCT03656510|537700828|FG000|Overall Study|Lost to Follow-up|1|||
149059555|NCT03656510|537700829|FG001|Overall Study|Lost to Follow-up|0|||
149059556|NCT03656510|537700830|FG002|Overall Study|Lost to Follow-up|0|||
149059557|NCT03656510|537700831|FG003|Overall Study|Lost to Follow-up|0|||
149059558|NCT03656510|537700832|FG004|Overall Study|Lost to Follow-up|0|||
149059559|NCT03656510|537700833|FG005|Overall Study|Lost to Follow-up|0|||
149059560|NCT03656510|537700828|FG000|Overall Study|Withdrawal by Subject|1|||
149059561|NCT03656510|537700829|FG001|Overall Study|Withdrawal by Subject|1|||
149059562|NCT03656510|537700830|FG002|Overall Study|Withdrawal by Subject|0|||
149059563|NCT03656510|537700831|FG003|Overall Study|Withdrawal by Subject|1|||
149059564|NCT03656510|537700832|FG004|Overall Study|Withdrawal by Subject|0|||
148890209|NCT04244253|537077167|FG000|Overall Study|Adverse Event|2|||
148890210|NCT04244253|537077168|FG001|Overall Study|Adverse Event|2|||
149059565|NCT03656510|537700833|FG005|Overall Study|Withdrawal by Subject|0|||
149059566|NCT03974178|537700843|FG000|Overall Study|Death|0|||
149059567|NCT03974178|537700844|FG001|Overall Study|Death|1|||
149059568|NCT03899259|537700848|FG000|Overall Study|Adverse Event|5|||
149059569|NCT03899259|537700849|FG001|Overall Study|Adverse Event|4|||
149059570|NCT03899259|537700850|FG002|Overall Study|Adverse Event|6|||
149059571|NCT03899259|537700848|FG000|Overall Study|Lack of Efficacy|5|||
149059572|NCT03899259|537700849|FG001|Overall Study|Lack of Efficacy|0|||
149059573|NCT03899259|537700850|FG002|Overall Study|Lack of Efficacy|2|||
149059574|NCT03899259|537700848|FG000|Overall Study|Pregnancy|3|||
149059575|NCT03899259|537700849|FG001|Overall Study|Pregnancy|0|||
149059576|NCT03899259|537700850|FG002|Overall Study|Pregnancy|1|||
149059577|NCT03899259|537700848|FG000|Overall Study|Physician Decision|0|||
149059578|NCT03899259|537700849|FG001|Overall Study|Physician Decision|1|||
149059579|NCT03899259|537700850|FG002|Overall Study|Physician Decision|0|||
149059580|NCT03899259|537700848|FG000|Overall Study|Protocol Deviation|1|||
149059581|NCT03899259|537700849|FG001|Overall Study|Protocol Deviation|1|||
149059582|NCT03899259|537700850|FG002|Overall Study|Protocol Deviation|1|||
149059583|NCT03899259|537700848|FG000|Overall Study|Withdrawal by Subject|8|||
149059584|NCT03899259|537700849|FG001|Overall Study|Withdrawal by Subject|10|||
149059585|NCT03899259|537700850|FG002|Overall Study|Withdrawal by Subject|12|||
149059586|NCT03899259|537700848|FG000|Overall Study|Lost to Follow-up|5|||
149059587|NCT03899259|537700849|FG001|Overall Study|Lost to Follow-up|6|||
149059588|NCT03899259|537700850|FG002|Overall Study|Lost to Follow-up|2|||
149059589|NCT03899259|537700848|FG000|Overall Study|Lack of Adherence|1|||
149059590|NCT03899259|537700849|FG001|Overall Study|Lack of Adherence|0|||
149059591|NCT03899259|537700850|FG002|Overall Study|Lack of Adherence|0|||
149059592|NCT03899259|537700848|FG000|Overall Study|Screen Failure|1|||
149059593|NCT03899259|537700849|FG001|Overall Study|Screen Failure|0|||
149059594|NCT03899259|537700850|FG002|Overall Study|Screen Failure|0|||
149059595|NCT03899259|537700848|FG000|Overall Study|Ongoing Study Participation|127|||
149059596|NCT03899259|537700849|FG001|Overall Study|Ongoing Study Participation|134|||
149059597|NCT03899259|537700850|FG002|Overall Study|Ongoing Study Participation|210|||
149059598|NCT04625465|537700857|FG000|Overall Study|Lost to Follow-up|2|||
149059599|NCT04625465|537700858|FG001|Overall Study|Lost to Follow-up|2|||
149059600|NCT04625465|537700859|FG002|Overall Study|Lost to Follow-up|1|||
149059601|NCT04625465|537700860|FG003|Overall Study|Lost to Follow-up|0|||
149059602|NCT04625465|537700861|FG004|Overall Study|Lost to Follow-up|0|||
149059603|NCT04625465|537700862|FG005|Overall Study|Lost to Follow-up|2|||
149059604|NCT04625465|537700863|FG006|Overall Study|Lost to Follow-up|0|||
149059605|NCT04625465|537700864|FG007|Overall Study|Lost to Follow-up|0|||
149059606|NCT04625465|537700857|FG000|Overall Study|Death|1|||
149059607|NCT04625465|537700858|FG001|Overall Study|Death|0|||
149059608|NCT04625465|537700859|FG002|Overall Study|Death|0|||
149059609|NCT04625465|537700860|FG003|Overall Study|Death|0|||
149059610|NCT04625465|537700861|FG004|Overall Study|Death|0|||
149059611|NCT04625465|537700862|FG005|Overall Study|Death|0|||
149059612|NCT04625465|537700863|FG006|Overall Study|Death|0|||
149059613|NCT04625465|537700864|FG007|Overall Study|Death|0|||
149059614|NCT04625465|537700857|FG000|Overall Study|Withdrawal by Subject|1|||
149059615|NCT04625465|537700858|FG001|Overall Study|Withdrawal by Subject|0|||
149059616|NCT04625465|537700859|FG002|Overall Study|Withdrawal by Subject|4|||
149059617|NCT04625465|537700860|FG003|Overall Study|Withdrawal by Subject|4|||
149059618|NCT04625465|537700861|FG004|Overall Study|Withdrawal by Subject|4|||
149059619|NCT04625465|537700862|FG005|Overall Study|Withdrawal by Subject|0|||
149059620|NCT04625465|537700863|FG006|Overall Study|Withdrawal by Subject|0|||
149059621|NCT04625465|537700864|FG007|Overall Study|Withdrawal by Subject|0|||
149059622|NCT04054193|537700869|FG000|Cycle 1|Physician Decision|1|||
149059623|NCT04054193|537700869|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
149059624|NCT04054193|537700869|FG000|Cycle 1|Allocated but not treated|3|||
149059625|NCT04054193|537700869|FG000|Cycles 2-3|Physician Decision|2|||
149059626|NCT04054193|537700869|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
149059627|NCT04054193|537700869|FG000|Cycles 2-3|Various reasons|17|||
149059628|NCT04753697|537700870|FG000|Induction Phase|Withdrawal by Subject|12|||
149059629|NCT04753697|537700871|FG001|Induction Phase|Withdrawal by Subject|5|||
149059630|NCT04753697|537700872|FG002|Induction Phase|Withdrawal by Subject|6|||
149059631|NCT04753697|537700870|FG000|Induction Phase|Physician Decision|1|||
149059632|NCT04753697|537700871|FG001|Induction Phase|Physician Decision|0|||
149059633|NCT04753697|537700872|FG002|Induction Phase|Physician Decision|0|||
149059634|NCT04753697|537700870|FG000|Induction Phase|Lost to Follow-up|2|||
149059635|NCT04753697|537700871|FG001|Induction Phase|Lost to Follow-up|2|||
149059636|NCT04753697|537700872|FG002|Induction Phase|Lost to Follow-up|1|||
149059637|NCT04753697|537700870|FG000|Induction Phase|Lack of Efficacy|1|||
149059638|NCT04753697|537700871|FG001|Induction Phase|Lack of Efficacy|0|||
149059639|NCT04753697|537700872|FG002|Induction Phase|Lack of Efficacy|0|||
149059640|NCT04753697|537700870|FG000|Maintenance Phase|Physician Decision|0|||
148890211|NCT04244253|537077169|FG002|Overall Study|Adverse Event|4|||
148890212|NCT04244253|537077167|FG000|Overall Study|Protocol Violation|1|||
148890213|NCT04244253|537077168|FG001|Overall Study|Protocol Violation|2|||
149059641|NCT04753697|537700871|FG001|Maintenance Phase|Physician Decision|0|||
149059642|NCT04753697|537700872|FG002|Maintenance Phase|Physician Decision|1|||
149059643|NCT04753697|537700870|FG000|Maintenance Phase|Withdrawal by Subject|3|||
149059644|NCT04753697|537700871|FG001|Maintenance Phase|Withdrawal by Subject|4|||
149059645|NCT04753697|537700872|FG002|Maintenance Phase|Withdrawal by Subject|6|||
149059646|NCT04753697|537700870|FG000|Maintenance Phase|Lost to Follow-up|2|||
149059647|NCT04753697|537700871|FG001|Maintenance Phase|Lost to Follow-up|2|||
149059648|NCT04753697|537700872|FG002|Maintenance Phase|Lost to Follow-up|0|||
149059649|NCT04753697|537700870|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
149059650|NCT04753697|537700871|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
149059651|NCT04753697|537700872|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
149059652|NCT04753697|537700870|FG000|Maintenance Phase|Adverse Event|0|||
149059653|NCT04753697|537700871|FG001|Maintenance Phase|Adverse Event|1|||
149059654|NCT04753697|537700872|FG002|Maintenance Phase|Adverse Event|1|||
149059655|NCT04753697|537700870|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
149059656|NCT04753697|537700871|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
149059657|NCT04753697|537700872|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
149059658|NCT04200456|537700873|FG000|Overall Study|Physician Decision|0|||
149059659|NCT04200456|537700874|FG001|Overall Study|Physician Decision|1|||
149059660|NCT04200456|537700873|FG000|Overall Study|Withdrawal by Subject|2|||
149059661|NCT04200456|537700874|FG001|Overall Study|Withdrawal by Subject|2|||
149059662|NCT04200456|537700873|FG000|Overall Study|Lack of Efficacy|1|||
149059663|NCT04200456|537700874|FG001|Overall Study|Lack of Efficacy|1|||
149059664|NCT04200456|537700873|FG000|Overall Study|Adverse event, non-fatal|0|||
149059665|NCT04200456|537700874|FG001|Overall Study|Adverse event, non-fatal|1|||
149059666|NCT04200456|537700873|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
149059667|NCT04200456|537700874|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
149059668|NCT05446168|537700875|FG000|Overall Study|Physician Decision|0|||
149059669|NCT05446168|537700876|FG001|Overall Study|Physician Decision|1|||
149059670|NCT03257410|537702812|FG000|Overall Study|Adverse Event|2|||
149059671|NCT03257410|537702813|FG001|Overall Study|Adverse Event|3|||
149059672|NCT03257410|537702812|FG000|Overall Study|Protocol Violation|1|||
149059673|NCT03257410|537702813|FG001|Overall Study|Protocol Violation|2|||
149059674|NCT03257410|537702812|FG000|Overall Study|Lost to Follow-up|1|||
149059675|NCT03257410|537702813|FG001|Overall Study|Lost to Follow-up|0|||
149059676|NCT03257410|537702812|FG000|Overall Study|Withdrawal by Subject|1|||
149059677|NCT03257410|537702813|FG001|Overall Study|Withdrawal by Subject|2|||
149059678|NCT03257410|537702812|FG000|Overall Study|Physician Decision|1|||
149059679|NCT03257410|537702813|FG001|Overall Study|Physician Decision|1|||
149059680|NCT03257410|537702812|FG000|Overall Study|Renal transplantation|2|||
149059681|NCT03257410|537702813|FG001|Overall Study|Renal transplantation|0|||
149059682|NCT03257410|537702812|FG000|Overall Study|Switch to peritoneal dialysis|1|||
149059683|NCT03257410|537702813|FG001|Overall Study|Switch to peritoneal dialysis|0|||
149059684|NCT03257410|537702812|FG000|Overall Study|Death|3|||
149059685|NCT03257410|537702813|FG001|Overall Study|Death|2|||
149059686|NCT03257410|537702812|FG000|Overall Study|Change to another dialysis center|2|||
149059687|NCT03257410|537702813|FG001|Overall Study|Change to another dialysis center|2|||
149059688|NCT03257410|537702812|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
149059689|NCT03257410|537702813|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
149059690|NCT03257410|537702812|FG000|Overall Study|Miscellaneous|2|||
149059691|NCT03257410|537702813|FG001|Overall Study|Miscellaneous|2|||
149059692|NCT03257410|537702812|FG000|Overall Study|Other|0|||
149059693|NCT03257410|537702813|FG001|Overall Study|Other|1|||
149059694|NCT02598388|537702814|FG000|Overall Study|Lost to Follow-up|1|||
149059695|NCT02598388|537702815|FG001|Overall Study|Lost to Follow-up|0|||
149059696|NCT02598388|537702816|FG002|Overall Study|Lost to Follow-up|1|||
149059697|NCT02598388|537702817|FG003|Overall Study|Lost to Follow-up|0|||
149059698|NCT02598388|537702818|FG004|Overall Study|Lost to Follow-up|5|||
149059699|NCT02598388|537702819|FG005|Overall Study|Lost to Follow-up|1|||
149059700|NCT02598388|537702820|FG006|Overall Study|Lost to Follow-up|2|||
149059701|NCT02598388|537702821|FG007|Overall Study|Lost to Follow-up|1|||
149059702|NCT02598388|537702822|FG008|Overall Study|Lost to Follow-up|0|||
149059703|NCT02598388|537702823|FG009|Overall Study|Lost to Follow-up|0|||
149059704|NCT02598388|537702824|FG010|Overall Study|Lost to Follow-up|1|||
149059705|NCT02598388|537702825|FG011|Overall Study|Lost to Follow-up|0|||
149059706|NCT02598388|537702814|FG000|Overall Study|Withdrawal by Subject|0|||
149059707|NCT02598388|537702815|FG001|Overall Study|Withdrawal by Subject|0|||
149059708|NCT02598388|537702816|FG002|Overall Study|Withdrawal by Subject|0|||
149059709|NCT02598388|537702817|FG003|Overall Study|Withdrawal by Subject|0|||
149059710|NCT02598388|537702818|FG004|Overall Study|Withdrawal by Subject|2|||
149059711|NCT02598388|537702819|FG005|Overall Study|Withdrawal by Subject|0|||
149059712|NCT02598388|537702820|FG006|Overall Study|Withdrawal by Subject|2|||
149059713|NCT02598388|537702821|FG007|Overall Study|Withdrawal by Subject|0|||
149059714|NCT02598388|537702822|FG008|Overall Study|Withdrawal by Subject|0|||
149059715|NCT02598388|537702823|FG009|Overall Study|Withdrawal by Subject|1|||
149059716|NCT02598388|537702824|FG010|Overall Study|Withdrawal by Subject|0|||
149059717|NCT02598388|537702825|FG011|Overall Study|Withdrawal by Subject|0|||
149059718|NCT02598388|537702814|FG000|Overall Study|Other|0|||
149059719|NCT02598388|537702815|FG001|Overall Study|Other|0|||
149059720|NCT02598388|537702816|FG002|Overall Study|Other|1|||
149059721|NCT02598388|537702817|FG003|Overall Study|Other|0|||
148890214|NCT04244253|537077169|FG002|Overall Study|Protocol Violation|1|||
148890215|NCT04244253|537077167|FG000|Overall Study|Withdrawal by Subject|0|||
149059722|NCT02598388|537702818|FG004|Overall Study|Other|3|||
149059723|NCT02598388|537702819|FG005|Overall Study|Other|0|||
149059724|NCT02598388|537702820|FG006|Overall Study|Other|1|||
149059725|NCT02598388|537702821|FG007|Overall Study|Other|0|||
149059726|NCT02598388|537702822|FG008|Overall Study|Other|0|||
149059727|NCT02598388|537702823|FG009|Overall Study|Other|0|||
149059728|NCT02598388|537702824|FG010|Overall Study|Other|0|||
149059729|NCT02598388|537702825|FG011|Overall Study|Other|0|||
149119375|NCT00275262|537916292|FG000|Overall Study|Death|1|||
149059730|NCT05256017|537702828|FG000|Treatment Period|Withdrawal by Subject|1|||
149059731|NCT05256017|537702829|FG001|Treatment Period|Withdrawal by Subject|1|||
149059732|NCT05256017|537702828|FG000|Follow-up|Lost to Follow-up|7|||
149059733|NCT05256017|537702829|FG001|Follow-up|Lost to Follow-up|1|||
149059734|NCT05256017|537702828|FG000|Follow-up|Withdrawal by Subject|1|||
149059735|NCT05256017|537702829|FG001|Follow-up|Withdrawal by Subject|0|||
149059736|NCT05256017|537702828|FG000|Follow-up|Death|0|||
149059737|NCT05256017|537702829|FG001|Follow-up|Death|1|||
149059738|NCT03854227|537702832|FG000|Overall Study|Adverse Event|0|||
149059739|NCT03854227|537702833|FG001|Overall Study|Adverse Event|0|||
149059740|NCT03854227|537702834|FG002|Overall Study|Adverse Event|0|||
149059741|NCT03854227|537702835|FG003|Overall Study|Adverse Event|1|||
149059742|NCT03854227|537702836|FG004|Overall Study|Adverse Event|0|||
149059743|NCT03854227|537702837|FG005|Overall Study|Adverse Event|0|||
149059744|NCT03854227|537702838|FG006|Overall Study|Adverse Event|1|||
149059745|NCT03854227|537702839|FG007|Overall Study|Adverse Event|0|||
149059746|NCT03854227|537702840|FG008|Overall Study|Adverse Event|0|||
149059747|NCT03854227|537702841|FG009|Overall Study|Adverse Event|3|||
149059748|NCT03854227|537702842|FG010|Overall Study|Adverse Event|0|||
149059749|NCT03854227|537702843|FG011|Overall Study|Adverse Event|1|||
149059750|NCT03854227|537702832|FG000|Overall Study|Death|0|||
149059751|NCT03854227|537702833|FG001|Overall Study|Death|0|||
149059752|NCT03854227|537702834|FG002|Overall Study|Death|0|||
149059753|NCT03854227|537702835|FG003|Overall Study|Death|0|||
149059754|NCT03854227|537702836|FG004|Overall Study|Death|0|||
149059755|NCT03854227|537702837|FG005|Overall Study|Death|1|||
149059756|NCT03854227|537702838|FG006|Overall Study|Death|0|||
149059757|NCT03854227|537702839|FG007|Overall Study|Death|0|||
149059758|NCT03854227|537702840|FG008|Overall Study|Death|0|||
149059759|NCT03854227|537702841|FG009|Overall Study|Death|1|||
149059760|NCT03854227|537702842|FG010|Overall Study|Death|0|||
149059761|NCT03854227|537702843|FG011|Overall Study|Death|1|||
149059762|NCT03854227|537702832|FG000|Overall Study|Physician Decision|0|||
149059763|NCT03854227|537702833|FG001|Overall Study|Physician Decision|0|||
149059764|NCT03854227|537702834|FG002|Overall Study|Physician Decision|0|||
149059765|NCT03854227|537702835|FG003|Overall Study|Physician Decision|0|||
149059766|NCT03854227|537702836|FG004|Overall Study|Physician Decision|0|||
149059767|NCT03854227|537702837|FG005|Overall Study|Physician Decision|1|||
149059768|NCT03854227|537702838|FG006|Overall Study|Physician Decision|0|||
149059769|NCT03854227|537702839|FG007|Overall Study|Physician Decision|0|||
149059770|NCT03854227|537702840|FG008|Overall Study|Physician Decision|1|||
149059771|NCT03854227|537702841|FG009|Overall Study|Physician Decision|1|||
149059772|NCT03854227|537702842|FG010|Overall Study|Physician Decision|0|||
149059773|NCT03854227|537702843|FG011|Overall Study|Physician Decision|1|||
149059774|NCT03854227|537702832|FG000|Overall Study|Progressive disease|1|||
149059775|NCT03854227|537702833|FG001|Overall Study|Progressive disease|1|||
149059776|NCT03854227|537702834|FG002|Overall Study|Progressive disease|1|||
149059777|NCT03854227|537702835|FG003|Overall Study|Progressive disease|2|||
149059778|NCT03854227|537702836|FG004|Overall Study|Progressive disease|3|||
149059779|NCT03854227|537702837|FG005|Overall Study|Progressive disease|1|||
149059780|NCT03854227|537702838|FG006|Overall Study|Progressive disease|2|||
149059781|NCT03854227|537702839|FG007|Overall Study|Progressive disease|5|||
149059782|NCT03854227|537702840|FG008|Overall Study|Progressive disease|2|||
149059783|NCT03854227|537702841|FG009|Overall Study|Progressive disease|5|||
149059784|NCT03854227|537702842|FG010|Overall Study|Progressive disease|1|||
149059785|NCT03854227|537702843|FG011|Overall Study|Progressive disease|6|||
149059786|NCT03854227|537702832|FG000|Overall Study|Study terminated by sponsor|0|||
149059787|NCT03854227|537702833|FG001|Overall Study|Study terminated by sponsor|0|||
149059788|NCT03854227|537702834|FG002|Overall Study|Study terminated by sponsor|0|||
149059789|NCT03854227|537702835|FG003|Overall Study|Study terminated by sponsor|0|||
149059790|NCT03854227|537702836|FG004|Overall Study|Study terminated by sponsor|0|||
149059791|NCT03854227|537702837|FG005|Overall Study|Study terminated by sponsor|0|||
149059792|NCT03854227|537702838|FG006|Overall Study|Study terminated by sponsor|0|||
149059793|NCT03854227|537702839|FG007|Overall Study|Study terminated by sponsor|0|||
149059794|NCT03854227|537702840|FG008|Overall Study|Study terminated by sponsor|0|||
149059795|NCT03854227|537702841|FG009|Overall Study|Study terminated by sponsor|1|||
149059796|NCT03854227|537702842|FG010|Overall Study|Study terminated by sponsor|0|||
149059797|NCT03854227|537702843|FG011|Overall Study|Study terminated by sponsor|0|||
149059798|NCT03854227|537702832|FG000|Overall Study|Withdrawal by Subject|0|||
149059799|NCT03854227|537702833|FG001|Overall Study|Withdrawal by Subject|0|||
149059800|NCT03854227|537702834|FG002|Overall Study|Withdrawal by Subject|1|||
149059801|NCT03854227|537702835|FG003|Overall Study|Withdrawal by Subject|0|||
148890216|NCT04244253|537077168|FG001|Overall Study|Withdrawal by Subject|1|||
149059802|NCT03854227|537702836|FG004|Overall Study|Withdrawal by Subject|0|||
149059803|NCT03854227|537702837|FG005|Overall Study|Withdrawal by Subject|0|||
149059804|NCT03854227|537702838|FG006|Overall Study|Withdrawal by Subject|0|||
149059805|NCT03854227|537702839|FG007|Overall Study|Withdrawal by Subject|0|||
149059806|NCT03854227|537702840|FG008|Overall Study|Withdrawal by Subject|0|||
149059807|NCT03854227|537702841|FG009|Overall Study|Withdrawal by Subject|1|||
149059808|NCT03854227|537702842|FG010|Overall Study|Withdrawal by Subject|1|||
149059809|NCT03854227|537702843|FG011|Overall Study|Withdrawal by Subject|0|||
149059810|NCT03854227|537702832|FG000|Overall Study|Disease relapse|0|||
149059811|NCT03854227|537702833|FG001|Overall Study|Disease relapse|0|||
149059812|NCT03854227|537702834|FG002|Overall Study|Disease relapse|0|||
149059813|NCT03854227|537702835|FG003|Overall Study|Disease relapse|0|||
149059814|NCT03854227|537702836|FG004|Overall Study|Disease relapse|0|||
149059815|NCT03854227|537702837|FG005|Overall Study|Disease relapse|0|||
149059816|NCT03854227|537702838|FG006|Overall Study|Disease relapse|0|||
149059817|NCT03854227|537702839|FG007|Overall Study|Disease relapse|0|||
149059818|NCT03854227|537702840|FG008|Overall Study|Disease relapse|1|||
149059819|NCT03854227|537702841|FG009|Overall Study|Disease relapse|0|||
149059820|NCT03854227|537702842|FG010|Overall Study|Disease relapse|0|||
149059821|NCT03854227|537702843|FG011|Overall Study|Disease relapse|0|||
149059822|NCT03854227|537702832|FG000|Overall Study|Global deterioration of health status|0|||
149059823|NCT03854227|537702833|FG001|Overall Study|Global deterioration of health status|0|||
149059824|NCT03854227|537702834|FG002|Overall Study|Global deterioration of health status|0|||
149059825|NCT03854227|537702835|FG003|Overall Study|Global deterioration of health status|0|||
149059826|NCT03854227|537702836|FG004|Overall Study|Global deterioration of health status|0|||
149059827|NCT03854227|537702837|FG005|Overall Study|Global deterioration of health status|1|||
149059828|NCT03854227|537702838|FG006|Overall Study|Global deterioration of health status|0|||
149059829|NCT03854227|537702839|FG007|Overall Study|Global deterioration of health status|1|||
149059830|NCT03854227|537702840|FG008|Overall Study|Global deterioration of health status|0|||
149059831|NCT03854227|537702841|FG009|Overall Study|Global deterioration of health status|0|||
149059832|NCT03854227|537702842|FG010|Overall Study|Global deterioration of health status|0|||
149059833|NCT03854227|537702843|FG011|Overall Study|Global deterioration of health status|0|||
149059834|NCT03854227|537702832|FG000|Overall Study|Refused further treatment|0|||
149059835|NCT03854227|537702833|FG001|Overall Study|Refused further treatment|0|||
149059836|NCT03854227|537702834|FG002|Overall Study|Refused further treatment|0|||
149059837|NCT03854227|537702835|FG003|Overall Study|Refused further treatment|0|||
149059838|NCT03854227|537702836|FG004|Overall Study|Refused further treatment|0|||
149059839|NCT03854227|537702837|FG005|Overall Study|Refused further treatment|0|||
149059840|NCT03854227|537702838|FG006|Overall Study|Refused further treatment|0|||
149059841|NCT03854227|537702839|FG007|Overall Study|Refused further treatment|0|||
149059842|NCT03854227|537702840|FG008|Overall Study|Refused further treatment|0|||
149059843|NCT03854227|537702841|FG009|Overall Study|Refused further treatment|1|||
149059844|NCT03854227|537702842|FG010|Overall Study|Refused further treatment|0|||
149059845|NCT03854227|537702843|FG011|Overall Study|Refused further treatment|1|||
149059846|NCT03854227|537702832|FG000|Overall Study|Other|0|||
149059847|NCT03854227|537702833|FG001|Overall Study|Other|0|||
149059848|NCT03854227|537702834|FG002|Overall Study|Other|0|||
149059849|NCT03854227|537702835|FG003|Overall Study|Other|0|||
149059850|NCT03854227|537702836|FG004|Overall Study|Other|0|||
149059851|NCT03854227|537702837|FG005|Overall Study|Other|0|||
149059852|NCT03854227|537702838|FG006|Overall Study|Other|0|||
149059853|NCT03854227|537702839|FG007|Overall Study|Other|0|||
149059854|NCT03854227|537702840|FG008|Overall Study|Other|1|||
149059855|NCT03854227|537702841|FG009|Overall Study|Other|1|||
149059856|NCT03854227|537702842|FG010|Overall Study|Other|0|||
149059857|NCT03854227|537702843|FG011|Overall Study|Other|0|||
149059858|NCT03668236|537702844|FG000|90-day Follow-up|Withdrawal by Subject|3|||
149059859|NCT03668236|537702845|FG001|90-day Follow-up|Withdrawal by Subject|2|||
149059860|NCT03668236|537702844|FG000|90-day Follow-up|Lost to Follow-up|3|||
149059861|NCT03668236|537702845|FG001|90-day Follow-up|Lost to Follow-up|1|||
149059862|NCT03668236|537702844|FG000|Baseline Characteristics|Lost to Follow-up|9|||
149059863|NCT03668236|537702845|FG001|Baseline Characteristics|Lost to Follow-up|5|||
149059864|NCT03668236|537702844|FG000|1-year Follow-up|Withdrawal by Subject|17|||
149059865|NCT03668236|537702845|FG001|1-year Follow-up|Withdrawal by Subject|15|||
149059866|NCT06132282|537702846|FG000|Overall Study|Lost to Follow-up|31|||
149059867|NCT03748953|537702847|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
148890217|NCT04244253|537077169|FG002|Overall Study|Withdrawal by Subject|6|||
148890218|NCT04244253|537077167|FG000|Overall Study|Non-Compliance With Study Drug|0|||
148890219|NCT04244253|537077168|FG001|Overall Study|Non-Compliance With Study Drug|0|||
148890220|NCT04244253|537077169|FG002|Overall Study|Non-Compliance With Study Drug|1|||
148890221|NCT00619515|537077170|FG000|Overall Study|Study Termination by IRB|73|||
148890222|NCT03294590|537077171|FG000|Overall Study|Lost to Follow-up|105|||
148890223|NCT03294590|537077172|FG001|Overall Study|Lost to Follow-up|107|||
148890224|NCT00474955|537077174|FG000|Overall Study|Adverse Event|2|||
148890225|NCT00474955|537077174|FG000|Overall Study|Drug unavailability|1|||
148890226|NCT00474955|537077174|FG000|Overall Study|Personal reasons|5|||
148890227|NCT02576639|537077175|FG000|Overall Study|Withdrawal by Subject|1|||
148890228|NCT02576639|537077176|FG001|Overall Study|Withdrawal by Subject|2|||
148890229|NCT02576639|537077177|FG002|Overall Study|Withdrawal by Subject|1|||
148890230|NCT02576639|537077178|FG003|Overall Study|Withdrawal by Subject|0|||
149059868|NCT03748953|537702848|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
149059869|NCT03748953|537702847|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
149059870|NCT03748953|537702848|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
149059871|NCT03748953|537702847|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
149059872|NCT03748953|537702848|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
149059873|NCT03748953|537702847|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
149059874|NCT03748953|537702848|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
149059875|NCT03748953|537702847|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
149059876|NCT03748953|537702848|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
149059877|NCT04233216|537702852|FG000|Overall Study|Lost to Follow-up|1|||
149059878|NCT04233216|537702853|FG001|Overall Study|Lost to Follow-up|0|||
149059879|NCT04233216|537702854|FG002|Overall Study|Lost to Follow-up|2|||
149059880|NCT04233216|537702855|FG003|Overall Study|Lost to Follow-up|0|||
149059881|NCT04233216|537702852|FG000|Overall Study|Physician Decision|0|||
149059882|NCT04233216|537702853|FG001|Overall Study|Physician Decision|3|||
149059883|NCT04233216|537702854|FG002|Overall Study|Physician Decision|0|||
149059884|NCT04233216|537702855|FG003|Overall Study|Physician Decision|2|||
149059885|NCT04233216|537702852|FG000|Overall Study|Withdrawal by Subject|0|||
149059886|NCT04233216|537702853|FG001|Overall Study|Withdrawal by Subject|2|||
149059887|NCT04233216|537702854|FG002|Overall Study|Withdrawal by Subject|1|||
149059888|NCT04233216|537702855|FG003|Overall Study|Withdrawal by Subject|0|||
148890231|NCT02576639|537077179|FG004|Overall Study|Withdrawal by Subject|1|||
149059889|NCT04231149|537702856|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
149059890|NCT04231149|537702857|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
149059891|NCT04231149|537702858|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
149059892|NCT04231149|537702859|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
149059893|NCT04231149|537702860|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
149059894|NCT03252847|537702861|FG000|Overall Study|Withdrawal by Subject|0|||
149059895|NCT03252847|537702862|FG001|Overall Study|Withdrawal by Subject|0|||
149059896|NCT03252847|537702863|FG002|Overall Study|Withdrawal by Subject|1|||
149059897|NCT03252847|537702864|FG003|Overall Study|Withdrawal by Subject|0|||
149059898|NCT03252847|537702865|FG004|Overall Study|Withdrawal by Subject|0|||
149059899|NCT03252847|537702866|FG005|Overall Study|Withdrawal by Subject|0|||
149059900|NCT03252847|537702867|FG006|Overall Study|Withdrawal by Subject|0|||
149059901|NCT03252847|537702861|FG000|Overall Study|Other: Patient decision|0|||
149059902|NCT03252847|537702862|FG001|Overall Study|Other: Patient decision|0|||
149059903|NCT03252847|537702863|FG002|Overall Study|Other: Patient decision|0|||
149059904|NCT03252847|537702864|FG003|Overall Study|Other: Patient decision|0|||
149059905|NCT03252847|537702865|FG004|Overall Study|Other: Patient decision|1|||
149059906|NCT03252847|537702866|FG005|Overall Study|Other: Patient decision|0|||
149059907|NCT03252847|537702867|FG006|Overall Study|Other: Patient decision|0|||
149059908|NCT05808257|537702870|FG000|Overall Study|Lost to Follow-up|8|||
149059909|NCT05808257|537702871|FG001|Overall Study|Lost to Follow-up|8|||
149059910|NCT05477186|537702896|FG000|Overall Study|Vaccine not administered|0|||
149059911|NCT05477186|537702897|FG001|Overall Study|Vaccine not administered|2|||
149059912|NCT05477186|537702898|FG002|Overall Study|Vaccine not administered|1|||
149059913|NCT05477186|537702899|FG003|Overall Study|Vaccine not administered|0|||
149059914|NCT05477186|537702900|FG004|Overall Study|Vaccine not administered|1|||
149059915|NCT05477186|537702901|FG005|Overall Study|Vaccine not administered|0|||
149059916|NCT05477186|537702902|FG006|Overall Study|Vaccine not administered|0|||
149059917|NCT05477186|537702896|FG000|Overall Study|Withdrawal by Subject|1|||
149059918|NCT05477186|537702897|FG001|Overall Study|Withdrawal by Subject|0|||
149059919|NCT05477186|537702898|FG002|Overall Study|Withdrawal by Subject|0|||
149059920|NCT05477186|537702899|FG003|Overall Study|Withdrawal by Subject|0|||
149059921|NCT05477186|537702900|FG004|Overall Study|Withdrawal by Subject|0|||
149059922|NCT05477186|537702901|FG005|Overall Study|Withdrawal by Subject|1|||
149059923|NCT05477186|537702902|FG006|Overall Study|Withdrawal by Subject|0|||
149059924|NCT05477186|537702896|FG000|Overall Study|Lost to Follow-up|1|||
149059925|NCT05477186|537702897|FG001|Overall Study|Lost to Follow-up|0|||
149059926|NCT05477186|537702898|FG002|Overall Study|Lost to Follow-up|2|||
149059927|NCT05477186|537702899|FG003|Overall Study|Lost to Follow-up|1|||
149059928|NCT05477186|537702900|FG004|Overall Study|Lost to Follow-up|1|||
148890232|NCT02576639|537077175|FG000|Overall Study|Adverse Event|1|||
148890233|NCT02576639|537077176|FG001|Overall Study|Adverse Event|0|||
148890234|NCT02576639|537077177|FG002|Overall Study|Adverse Event|1|||
148890235|NCT02576639|537077178|FG003|Overall Study|Adverse Event|1|||
149059929|NCT05477186|537702901|FG005|Overall Study|Lost to Follow-up|0|||
149059930|NCT05477186|537702902|FG006|Overall Study|Lost to Follow-up|2|||
149059931|NCT05496231|537702903|FG000|Overall Study|Adverse Event|1|||
149059932|NCT05496231|537702904|FG001|Overall Study|Adverse Event|1|||
149059933|NCT05496231|537702905|FG002|Overall Study|Adverse Event|0|||
149059934|NCT05496231|537702906|FG003|Overall Study|Adverse Event|4|||
149059935|NCT05496231|537702903|FG000|Overall Study|Withdrawal by Subject|5|||
149059936|NCT05496231|537702904|FG001|Overall Study|Withdrawal by Subject|5|||
148890236|NCT02576639|537077179|FG004|Overall Study|Adverse Event|2|||
149059937|NCT05496231|537702905|FG002|Overall Study|Withdrawal by Subject|4|||
149059938|NCT05496231|537702906|FG003|Overall Study|Withdrawal by Subject|11|||
149059939|NCT05496231|537702903|FG000|Overall Study|Migrated/moved from the study area|3|||
149059940|NCT05496231|537702904|FG001|Overall Study|Migrated/moved from the study area|5|||
149059941|NCT05496231|537702905|FG002|Overall Study|Migrated/moved from the study area|3|||
149059942|NCT05496231|537702906|FG003|Overall Study|Migrated/moved from the study area|3|||
149059943|NCT05496231|537702903|FG000|Overall Study|Lost to Follow-up|13|||
149059944|NCT05496231|537702904|FG001|Overall Study|Lost to Follow-up|6|||
149059945|NCT05496231|537702905|FG002|Overall Study|Lost to Follow-up|11|||
149059946|NCT05496231|537702906|FG003|Overall Study|Lost to Follow-up|6|||
149059947|NCT05496231|537702903|FG000|Overall Study|Other|9|||
149059948|NCT05496231|537702904|FG001|Overall Study|Other|7|||
149059949|NCT05496231|537702905|FG002|Overall Study|Other|7|||
149059950|NCT05496231|537702906|FG003|Overall Study|Other|8|||
149059951|NCT03819153|537702911|FG000|Overall Study|Withdrawal by Subject|20|||
149059952|NCT03819153|537702912|FG001|Overall Study|Withdrawal by Subject|28|||
149059953|NCT03819153|537702911|FG000|Overall Study|Lost to Follow-up|23|||
149059954|NCT03819153|537702912|FG001|Overall Study|Lost to Follow-up|30|||
149059955|NCT05670587|537702918|FG000|Overall Study|Withdrawal by Subject|3|||
149059956|NCT01733316|537702920|FG000|RP103 Phase|Non-compliance|1|||
149059957|NCT01733316|537702920|FG000|Long Term Extension Phase|Adverse Event|1|||
149059958|NCT01733316|537702920|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
149059959|NCT01733316|537702920|FG000|Long Term Extension Phase|Sponsor Decision|2|||
149059960|NCT02305888|537702925|FG000|Overall Study|Lost to Follow-up|0|||
149059961|NCT02305888|537702926|FG001|Overall Study|Lost to Follow-up|0|||
149059962|NCT02305888|537702927|FG002|Overall Study|Lost to Follow-up|1|||
149059963|NCT02305888|537702925|FG000|Overall Study|Adverse Event|0|||
149059964|NCT02305888|537702926|FG001|Overall Study|Adverse Event|1|||
149059965|NCT02305888|537702927|FG002|Overall Study|Adverse Event|0|||
149059966|NCT05139810|537702928|FG000|Overall Study|Voluntary Withdrawal|2|||
149059967|NCT05139810|537702929|FG001|Overall Study|Voluntary Withdrawal|1|||
149059968|NCT05139810|537702930|FG002|Overall Study|Voluntary Withdrawal|0|||
149059969|NCT05139810|537702928|FG000|Overall Study|Pregnancy|1|||
149059970|NCT05139810|537702929|FG001|Overall Study|Pregnancy|0|||
149059971|NCT05139810|537702930|FG002|Overall Study|Pregnancy|0|||
149059972|NCT05139810|537702928|FG000|Overall Study|Roll Over to CS7|19|||
149059973|NCT05139810|537702929|FG001|Overall Study|Roll Over to CS7|44|||
149059974|NCT05139810|537702930|FG002|Overall Study|Roll Over to CS7|20|||
149059975|NCT05940194|537702931|FG000|Overall Study|Adverse Event|0|||
149059976|NCT05940194|537702932|FG001|Overall Study|Adverse Event|1|||
149059977|NCT05940194|537702933|FG002|Overall Study|Adverse Event|0|||
149059978|NCT05940194|537702931|FG000|Overall Study|Migrated/Moved from the study area|2|||
149059979|NCT05940194|537702932|FG001|Overall Study|Migrated/Moved from the study area|2|||
149059980|NCT05940194|537702933|FG002|Overall Study|Migrated/Moved from the study area|4|||
149059981|NCT04914676|537702934|FG000|Overall Study|Study termination|3|||
149059982|NCT04914676|537702935|FG001|Overall Study|Study termination|0|||
149059983|NCT03024437|537702936|FG000|Overall Study|Adverse Event|0|||
149059984|NCT03024437|537702937|FG001|Overall Study|Adverse Event|1|||
149059985|NCT03024437|537702938|FG002|Overall Study|Adverse Event|3|||
149059986|NCT03024437|537702939|FG003|Overall Study|Adverse Event|5|||
149059987|NCT03024437|537702940|FG004|Overall Study|Adverse Event|0|||
149059988|NCT03024437|537702936|FG000|Overall Study|Physician Decision|1|||
149059989|NCT03024437|537702937|FG001|Overall Study|Physician Decision|0|||
149059990|NCT03024437|537702938|FG002|Overall Study|Physician Decision|0|||
149059991|NCT03024437|537702939|FG003|Overall Study|Physician Decision|1|||
149059992|NCT03024437|537702940|FG004|Overall Study|Physician Decision|0|||
149059993|NCT03024437|537702936|FG000|Overall Study|Disease progression, relapse|1|||
149059994|NCT03024437|537702937|FG001|Overall Study|Disease progression, relapse|0|||
149059995|NCT03024437|537702938|FG002|Overall Study|Disease progression, relapse|0|||
149059996|NCT03024437|537702939|FG003|Overall Study|Disease progression, relapse|3|||
149059997|NCT03024437|537702940|FG004|Overall Study|Disease progression, relapse|0|||
149059998|NCT03024437|537702936|FG000|Overall Study|Disease progression, refractory disease|4|||
149059999|NCT03024437|537702937|FG001|Overall Study|Disease progression, refractory disease|4|||
149060000|NCT03024437|537702938|FG002|Overall Study|Disease progression, refractory disease|2|||
149060001|NCT03024437|537702939|FG003|Overall Study|Disease progression, refractory disease|2|||
149060002|NCT03024437|537702940|FG004|Overall Study|Disease progression, refractory disease|1|||
149060003|NCT03024437|537702936|FG000|Overall Study|Newly diagnosed cancer|0|||
149060004|NCT03024437|537702937|FG001|Overall Study|Newly diagnosed cancer|0|||
149060005|NCT03024437|537702938|FG002|Overall Study|Newly diagnosed cancer|0|||
149060006|NCT03024437|537702939|FG003|Overall Study|Newly diagnosed cancer|1|||
149060007|NCT03024437|537702940|FG004|Overall Study|Newly diagnosed cancer|0|||
149060008|NCT03024437|537702936|FG000|Overall Study|Moved out of state|0|||
149060009|NCT03024437|537702937|FG001|Overall Study|Moved out of state|1|||
149060010|NCT03024437|537702938|FG002|Overall Study|Moved out of state|0|||
149060011|NCT03024437|537702939|FG003|Overall Study|Moved out of state|0|||
149060012|NCT03024437|537702940|FG004|Overall Study|Moved out of state|0|||
149060013|NCT03024437|537702936|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
149060014|NCT03024437|537702937|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
149060015|NCT03024437|537702938|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
149060016|NCT03024437|537702939|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
149060017|NCT03024437|537702940|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
149060018|NCT03240016|537702943|FG000|Overall Study|Adverse Event|9|||
149060019|NCT03240016|537702943|FG000|Overall Study|Withdrawal by Subject|7|||
149060020|NCT03240016|537702943|FG000|Overall Study|Death|1|||
149060021|NCT03240016|537702943|FG000|Overall Study|Physician Decision|2|||
149060022|NCT05200403|537702944|FG000|Overall Study|Withdrawal by Subject|4|||
149060023|NCT05200403|537702945|FG001|Overall Study|Withdrawal by Subject|2|||
149060024|NCT05200403|537702946|FG002|Overall Study|Withdrawal by Subject|6|||
149060025|NCT05546411|537702947|FG000|Overall Study|Progressive Disease|1|||
149060026|NCT05546411|537702948|FG001|Overall Study|Progressive Disease|0|||
149060027|NCT05546411|537702947|FG000|Overall Study|Adverse Event|0|||
149060028|NCT05546411|537702948|FG001|Overall Study|Adverse Event|1|||
149060029|NCT05546411|537702947|FG000|Overall Study|Metastatic disease|1|||
149060030|NCT05546411|537702948|FG001|Overall Study|Metastatic disease|0|||
149060031|NCT02606422|537702949|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
149060032|NCT02606422|537702950|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
149060033|NCT02606422|537702949|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
149060034|NCT02606422|537702950|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
149060035|NCT02606422|537702949|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
149060036|NCT02606422|537702950|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
149060037|NCT02606422|537702949|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
149060038|NCT02606422|537702950|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
149060039|NCT05566639|537702954|FG000|Overall Study|Adverse Event|1|||
149060040|NCT05566639|537702955|FG001|Overall Study|Adverse Event|1|||
149060041|NCT05566639|537702954|FG000|Overall Study|Serious Adverse Event|1|||
149060042|NCT05566639|537702955|FG001|Overall Study|Serious Adverse Event|3|||
149060043|NCT05566639|537702954|FG000|Overall Study|Death|44|||
149060044|NCT05566639|537702955|FG001|Overall Study|Death|45|||
149060045|NCT05566639|537702954|FG000|Overall Study|Lost to Follow-up|467|||
149060046|NCT05566639|537702955|FG001|Overall Study|Lost to Follow-up|461|||
149060047|NCT05566639|537702954|FG000|Overall Study|Physician Decision|45|||
149060048|NCT05566639|537702955|FG001|Overall Study|Physician Decision|44|||
149060049|NCT05566639|537702954|FG000|Overall Study|Protocol Deviation|4|||
149060050|NCT05566639|537702955|FG001|Overall Study|Protocol Deviation|4|||
149060051|NCT05566639|537702954|FG000|Overall Study|Withdrawal by Subject|277|||
149060052|NCT05566639|537702955|FG001|Overall Study|Withdrawal by Subject|271|||
149060053|NCT05566639|537702954|FG000|Overall Study|Other Than Specified|52|||
149060054|NCT05566639|537702955|FG001|Overall Study|Other Than Specified|64|||
149060055|NCT02966873|537702964|FG000|Overall Study|Lost to Follow-up|16|||
149060056|NCT02966873|537702965|FG001|Overall Study|Lost to Follow-up|15|||
149060057|NCT03235544|537702968|FG000|Overall Study|Death|11|||
149060058|NCT03235544|537702969|FG001|Overall Study|Death|31|||
149060059|NCT03235544|537702970|FG002|Overall Study|Death|19|||
149060060|NCT03235544|537702971|FG003|Overall Study|Death|34|||
149060061|NCT03235544|537702968|FG000|Overall Study|Lost to Follow-up|0|||
149060062|NCT03235544|537702969|FG001|Overall Study|Lost to Follow-up|1|||
149060063|NCT03235544|537702970|FG002|Overall Study|Lost to Follow-up|1|||
149060064|NCT03235544|537702971|FG003|Overall Study|Lost to Follow-up|1|||
149060065|NCT03235544|537702968|FG000|Overall Study|Withdrawal by Subject|0|||
149060066|NCT03235544|537702969|FG001|Overall Study|Withdrawal by Subject|3|||
149060067|NCT03235544|537702970|FG002|Overall Study|Withdrawal by Subject|1|||
149060068|NCT03235544|537702971|FG003|Overall Study|Withdrawal by Subject|5|||
149060069|NCT03235544|537702968|FG000|Overall Study|Disease Progression|0|||
149060070|NCT03235544|537702969|FG001|Overall Study|Disease Progression|1|||
149060071|NCT03235544|537702970|FG002|Overall Study|Disease Progression|0|||
149060072|NCT03235544|537702971|FG003|Overall Study|Disease Progression|2|||
149060073|NCT03235544|537702968|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
149060074|NCT03235544|537702969|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
149060075|NCT03235544|537702970|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
149060076|NCT03235544|537702971|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
149060077|NCT03235544|537702968|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
149060078|NCT03235544|537702969|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
149060079|NCT03235544|537702970|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
149060080|NCT03235544|537702971|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
149060081|NCT00950742|537702972|FG000|Overall Study|Other Adverse Event|1|||
149060082|NCT00950742|537702973|FG001|Overall Study|Other Adverse Event|0|||
149060083|NCT00950742|537702972|FG000|Overall Study|Withdrawal by Subject|3|||
149060084|NCT00950742|537702973|FG001|Overall Study|Withdrawal by Subject|0|||
149060085|NCT00950742|537702972|FG000|Overall Study|Progressive Disease|6|||
149060086|NCT00950742|537702973|FG001|Overall Study|Progressive Disease|2|||
149060087|NCT00950742|537702972|FG000|Overall Study|Dose limiting toxicity|6|||
149060088|NCT00950742|537702973|FG001|Overall Study|Dose limiting toxicity|0|||
149060089|NCT01456949|537702975|FG000|Enrollment|PI death- incomplete data|6|||
149060090|NCT01456949|537702975|FG000|Enrollment|Death|1|||
149060091|NCT01456949|537702975|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
149060092|NCT01456949|537702975|FG000|Enrollment|Physician Decision|10|||
149060093|NCT01456949|537702975|FG000|Enrollment|Withdrawal by Subject|7|||
149060094|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
149060095|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
149060096|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
149060097|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
149060098|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
149060099|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
149060100|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
149060101|NCT01456949|537702975|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
149060102|NCT04471246|537702979|FG000|Overall Study|Lost to Follow-up|2|||
149060103|NCT04471246|537702980|FG001|Overall Study|Lost to Follow-up|2|||
149060104|NCT05764525|537702981|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
149060105|NCT05764525|537702982|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
149060106|NCT05764525|537702981|FG000|Overall Study|Withdrawal by Subject|4|||
149060107|NCT05764525|537702982|FG001|Overall Study|Withdrawal by Subject|8|||
149060108|NCT05764525|537702981|FG000|Overall Study|Physician Decision|1|||
149060109|NCT05764525|537702982|FG001|Overall Study|Physician Decision|0|||
149060110|NCT05907174|537702991|FG000|3-Month Assessment|Withdrawal by Subject|0|||
149060111|NCT05907174|537702992|FG001|3-Month Assessment|Withdrawal by Subject|0|||
149060112|NCT05907174|537702993|FG002|3-Month Assessment|Withdrawal by Subject|0|||
149060113|NCT05907174|537702994|FG003|3-Month Assessment|Withdrawal by Subject|1|||
149060114|NCT05907174|537702991|FG000|3-Month Assessment|Lost to Follow-up|1|||
149060115|NCT05907174|537702992|FG001|3-Month Assessment|Lost to Follow-up|1|||
149060116|NCT05907174|537702993|FG002|3-Month Assessment|Lost to Follow-up|1|||
149060117|NCT05907174|537702994|FG003|3-Month Assessment|Lost to Follow-up|1|||
149060118|NCT05907174|537702991|FG000|6-Month Assessment|Death|0|||
149060119|NCT05907174|537702992|FG001|6-Month Assessment|Death|0|||
149060120|NCT05907174|537702993|FG002|6-Month Assessment|Death|3|||
149060121|NCT05907174|537702994|FG003|6-Month Assessment|Death|0|||
149060122|NCT05907174|537702991|FG000|6-Month Assessment|Withdrawal by Subject|0|||
149060123|NCT05907174|537702992|FG001|6-Month Assessment|Withdrawal by Subject|0|||
149060124|NCT05907174|537702993|FG002|6-Month Assessment|Withdrawal by Subject|1|||
149060125|NCT05907174|537702994|FG003|6-Month Assessment|Withdrawal by Subject|1|||
149060126|NCT05907174|537702991|FG000|6-Month Assessment|Lost to Follow-up|0|||
149060127|NCT05907174|537702992|FG001|6-Month Assessment|Lost to Follow-up|1|||
149060128|NCT05907174|537702993|FG002|6-Month Assessment|Lost to Follow-up|1|||
149060129|NCT05907174|537702994|FG003|6-Month Assessment|Lost to Follow-up|1|||
149060130|NCT04498390|537702995|FG000|Overall Study|Adverse Event|0|||
149060131|NCT04498390|537702996|FG001|Overall Study|Adverse Event|0|||
149060132|NCT04498390|537702997|FG002|Overall Study|Adverse Event|1|||
149060133|NCT04498390|537702998|FG003|Overall Study|Adverse Event|0|||
149060134|NCT04498390|537702999|FG004|Overall Study|Adverse Event|0|||
149060135|NCT04498390|537702995|FG000|Overall Study|Withdrawal by Subject|0|||
149060136|NCT04498390|537702996|FG001|Overall Study|Withdrawal by Subject|0|||
149060137|NCT04498390|537702997|FG002|Overall Study|Withdrawal by Subject|0|||
149060138|NCT04498390|537702998|FG003|Overall Study|Withdrawal by Subject|1|||
149060139|NCT04498390|537702999|FG004|Overall Study|Withdrawal by Subject|0|||
149060140|NCT05093842|537703002|FG000|Overall Study|Pregnancy loss|1|||
149060141|NCT05093842|537703003|FG001|Overall Study|Pregnancy loss|1|||
149060142|NCT05093842|537703002|FG000|Overall Study|Lost to Follow-up|6|||
149060143|NCT05093842|537703003|FG001|Overall Study|Lost to Follow-up|0|||
149060144|NCT05093842|537703002|FG000|Overall Study|Physician Decision|0|||
149060145|NCT05093842|537703003|FG001|Overall Study|Physician Decision|1|||
149060146|NCT04858451|537704812|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
149060147|NCT04858451|537704813|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060148|NCT04858451|537704814|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060149|NCT04858451|537704815|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060150|NCT04858451|537704816|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060151|NCT04858451|537704817|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060152|NCT04858451|537704818|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060153|NCT04858451|537704819|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060154|NCT04858451|537704820|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
149060155|NCT04858451|537704812|FG000|Part 2|Discontinued|0|||
149060156|NCT04858451|537704813|FG001|Part 2|Discontinued|0|||
149060157|NCT04858451|537704814|FG002|Part 2|Discontinued|0|||
149060158|NCT04858451|537704815|FG003|Part 2|Discontinued|0|||
149060159|NCT04858451|537704816|FG004|Part 2|Discontinued|0|||
149060160|NCT04858451|537704817|FG005|Part 2|Discontinued|0|||
149060161|NCT04858451|537704818|FG006|Part 2|Discontinued|0|||
149060162|NCT04858451|537704819|FG007|Part 2|Discontinued|0|||
149060163|NCT04858451|537704820|FG008|Part 2|Discontinued|63|||
149060164|NCT03314454|537704821|FG000|Overall Study|Protocol Violation|1|||
149060165|NCT04119843|537704822|FG000|Overall Study|Adverse Event|3|||
149060166|NCT04119843|537704822|FG000|Overall Study|Death|1|||
149060167|NCT04298983|537704825|FG000|Overall Study|Adverse Event|4|||
149060168|NCT04298983|537704825|FG000|Overall Study|Lack of Efficacy|3|||
149060169|NCT04042233|537704826|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
149060170|NCT04042233|537704827|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
149060171|NCT04042233|537704826|FG000|Overall Study|Protocol Violation|0|||
149060172|NCT04042233|537704827|FG001|Overall Study|Protocol Violation|2|||
149060173|NCT04907851|537704828|FG000|Overall Study|Consent withdrawn|1|||
149060174|NCT04907851|537704829|FG001|Overall Study|Consent withdrawn|2|||
149060175|NCT04907851|537704830|FG002|Overall Study|Consent withdrawn|0|||
149060176|NCT04907851|537704828|FG000|Overall Study|Death|5|||
149060177|NCT04907851|537704829|FG001|Overall Study|Death|15|||
149060178|NCT04907851|537704830|FG002|Overall Study|Death|10|||
149060179|NCT04508309|537704831|FG000|Overall Study|Death|0|||
149060180|NCT04508309|537704832|FG001|Overall Study|Death|0|||
149060181|NCT04508309|537704833|FG002|Overall Study|Death|0|||
149060182|NCT04508309|537704834|FG003|Overall Study|Death|0|||
149060183|NCT04508309|537704835|FG004|Overall Study|Death|1|||
149060184|NCT04508309|537704831|FG000|Overall Study|Lost to Follow-up|0|||
149060185|NCT04508309|537704832|FG001|Overall Study|Lost to Follow-up|0|||
149060186|NCT04508309|537704833|FG002|Overall Study|Lost to Follow-up|1|||
149060187|NCT04508309|537704834|FG003|Overall Study|Lost to Follow-up|1|||
149060188|NCT04508309|537704835|FG004|Overall Study|Lost to Follow-up|0|||
149060189|NCT04508309|537704831|FG000|Overall Study|Withdrawal by Subject|0|||
149060190|NCT04508309|537704832|FG001|Overall Study|Withdrawal by Subject|0|||
149060191|NCT04508309|537704833|FG002|Overall Study|Withdrawal by Subject|0|||
149060192|NCT04508309|537704834|FG003|Overall Study|Withdrawal by Subject|0|||
149060193|NCT04508309|537704835|FG004|Overall Study|Withdrawal by Subject|1|||
149060194|NCT05436262|537704839|FG000|Pre-Randomization|Withdrawal by Subject|1|||
149060195|NCT05436262|537704840|FG001|Pre-Randomization|Withdrawal by Subject|0|||
149060196|NCT05436262|537704841|FG002|Pre-Randomization|Withdrawal by Subject|0|||
149060197|NCT05436262|537704839|FG000|Randomization|Withdrawal by Subject|0|||
149060198|NCT05436262|537704840|FG001|Randomization|Withdrawal by Subject|1|||
149060199|NCT05436262|537704841|FG002|Randomization|Withdrawal by Subject|0|||
149060200|NCT03710603|537704842|FG000|Overall Study|Adverse Event|1|||
149060201|NCT03710603|537704843|FG001|Overall Study|Adverse Event|0|||
149060202|NCT03710603|537704842|FG000|Overall Study|Death|44|||
149060203|NCT03710603|537704843|FG001|Overall Study|Death|34|||
149060204|NCT03710603|537704842|FG000|Overall Study|Lost to Follow-up|3|||
149060205|NCT03710603|537704843|FG001|Overall Study|Lost to Follow-up|5|||
149060206|NCT03710603|537704842|FG000|Overall Study|Withdrawal by Subject|11|||
149060207|NCT03710603|537704843|FG001|Overall Study|Withdrawal by Subject|10|||
149060208|NCT05002088|537704846|FG000|Overall Study|Withdrawal by Subject|9|||
149060209|NCT05002088|537704847|FG001|Overall Study|Withdrawal by Subject|0|||
149060210|NCT05002088|537704846|FG000|Overall Study|Lost to Follow-up|0|||
149060211|NCT05002088|537704847|FG001|Overall Study|Lost to Follow-up|1|||
149060212|NCT05002088|537704846|FG000|Overall Study|Death|16|||
149060213|NCT05002088|537704847|FG001|Overall Study|Death|2|||
149060214|NCT05002088|537704846|FG000|Overall Study|Protocol Violation|25|||
149060215|NCT05002088|537704847|FG001|Overall Study|Protocol Violation|7|||
149060216|NCT04068181|537704849|FG000|Overall Study|Death|17|||
149060217|NCT04068181|537704850|FG001|Overall Study|Death|12|||
148890237|NCT02576639|537077175|FG000|Overall Study|Physician Decision|0|||
148890238|NCT02576639|537077176|FG001|Overall Study|Physician Decision|0|||
148890239|NCT02576639|537077177|FG002|Overall Study|Physician Decision|0|||
148890240|NCT02576639|537077178|FG003|Overall Study|Physician Decision|0|||
148890241|NCT02576639|537077179|FG004|Overall Study|Physician Decision|1|||
148890242|NCT00628030|537077180|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
148890243|NCT00628030|537077181|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
148890244|NCT00628030|537077180|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
148890245|NCT00628030|537077181|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
148890246|NCT00628030|537077180|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
148890247|NCT00628030|537077181|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
148890248|NCT03827655|537077182|FG000|Overall Study|Death|0|||
149060218|NCT04068181|537704851|FG002|Overall Study|Death|4|||
149060219|NCT04068181|537704852|FG003|Overall Study|Death|7|||
149060220|NCT04068181|537704849|FG000|Overall Study|Lost to Follow-up|1|||
149060221|NCT04068181|537704850|FG001|Overall Study|Lost to Follow-up|0|||
149060222|NCT04068181|537704851|FG002|Overall Study|Lost to Follow-up|0|||
149060223|NCT04068181|537704852|FG003|Overall Study|Lost to Follow-up|0|||
149060224|NCT04068181|537704849|FG000|Overall Study|Withdrawal of consent from study|3|||
149060225|NCT04068181|537704850|FG001|Overall Study|Withdrawal of consent from study|0|||
149060226|NCT04068181|537704851|FG002|Overall Study|Withdrawal of consent from study|0|||
149060227|NCT04068181|537704852|FG003|Overall Study|Withdrawal of consent from study|0|||
149060228|NCT02723591|537704853|FG000|Overall Study|Adverse Event|48|||
149060229|NCT02723591|537704854|FG001|Overall Study|Adverse Event|40|||
149060230|NCT02723591|537704853|FG000|Overall Study|Death|2|||
148890249|NCT03827655|537077183|FG001|Overall Study|Death|0|||
149060231|NCT02723591|537704854|FG001|Overall Study|Death|2|||
149060232|NCT02723591|537704853|FG000|Overall Study|Lack of Efficacy|4|||
149060233|NCT02723591|537704854|FG001|Overall Study|Lack of Efficacy|3|||
149060234|NCT02723591|537704853|FG000|Overall Study|Lost to Follow-up|1|||
149060235|NCT02723591|537704854|FG001|Overall Study|Lost to Follow-up|7|||
149060236|NCT02723591|537704853|FG000|Overall Study|Protocol Violation|20|||
149060237|NCT02723591|537704854|FG001|Overall Study|Protocol Violation|23|||
149060238|NCT02723591|537704853|FG000|Overall Study|Withdrawal by Subject|4|||
149060239|NCT02723591|537704854|FG001|Overall Study|Withdrawal by Subject|8|||
149060240|NCT02723591|537704853|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
149060241|NCT02723591|537704854|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
149060242|NCT02723591|537704853|FG000|Overall Study|Miscellaneous|5|||
149060243|NCT02723591|537704854|FG001|Overall Study|Miscellaneous|6|||
149060244|NCT03599661|537704856|FG000|Overall Study|Lost to Follow-up|9|||
149060245|NCT04117347|537704857|FG000|Overall Study|Adverse Event|0|||
149060246|NCT04117347|537704858|FG001|Overall Study|Adverse Event|0|||
149060247|NCT04117347|537704859|FG002|Overall Study|Adverse Event|1|||
149060248|NCT04117347|537704857|FG000|Overall Study|No time for study|0|||
149060249|NCT04117347|537704858|FG001|Overall Study|No time for study|2|||
149060250|NCT04117347|537704859|FG002|Overall Study|No time for study|0|||
149060251|NCT04117347|537704857|FG000|Overall Study|Family emergency|1|||
149060252|NCT04117347|537704858|FG001|Overall Study|Family emergency|0|||
149060253|NCT04117347|537704859|FG002|Overall Study|Family emergency|0|||
149060254|NCT03691935|537704860|FG000|Overall Study|Physician Decision|2|||
149060255|NCT03691935|537704861|FG001|Overall Study|Physician Decision|1|||
149060256|NCT03691935|537704860|FG000|Overall Study|Adverse Event|3|||
149060257|NCT03691935|537704861|FG001|Overall Study|Adverse Event|0|||
149060258|NCT01946789|537704864|FG000|Overall Study|Death|0|||
149060259|NCT01946789|537704865|FG001|Overall Study|Death|2|||
149060260|NCT01946789|537704866|FG002|Overall Study|Death|1|||
149060261|NCT01946789|537704867|FG003|Overall Study|Death|1|||
149060262|NCT01946789|537704868|FG004|Overall Study|Death|1|||
149060263|NCT01946789|537704869|FG005|Overall Study|Death|1|||
149060264|NCT01946789|537704870|FG006|Overall Study|Death|3|||
149060265|NCT01946789|537704871|FG007|Overall Study|Death|1|||
149060266|NCT01946789|537704872|FG008|Overall Study|Death|2|||
149060267|NCT01946789|537704864|FG000|Overall Study|Progressive Disease|0|||
149060268|NCT01946789|537704865|FG001|Overall Study|Progressive Disease|0|||
149060269|NCT01946789|537704866|FG002|Overall Study|Progressive Disease|1|||
149060270|NCT01946789|537704867|FG003|Overall Study|Progressive Disease|0|||
149060271|NCT01946789|537704868|FG004|Overall Study|Progressive Disease|0|||
149060272|NCT01946789|537704869|FG005|Overall Study|Progressive Disease|2|||
149060273|NCT01946789|537704870|FG006|Overall Study|Progressive Disease|0|||
149060274|NCT01946789|537704871|FG007|Overall Study|Progressive Disease|0|||
149060275|NCT01946789|537704872|FG008|Overall Study|Progressive Disease|0|||
149060276|NCT01946789|537704864|FG000|Overall Study|Withdrawal by Subject|0|||
149060277|NCT01946789|537704865|FG001|Overall Study|Withdrawal by Subject|0|||
149060278|NCT01946789|537704866|FG002|Overall Study|Withdrawal by Subject|0|||
149060279|NCT01946789|537704867|FG003|Overall Study|Withdrawal by Subject|2|||
149060280|NCT01946789|537704868|FG004|Overall Study|Withdrawal by Subject|1|||
149060281|NCT01946789|537704869|FG005|Overall Study|Withdrawal by Subject|0|||
149060282|NCT01946789|537704870|FG006|Overall Study|Withdrawal by Subject|1|||
149060283|NCT01946789|537704871|FG007|Overall Study|Withdrawal by Subject|0|||
149060284|NCT01946789|537704872|FG008|Overall Study|Withdrawal by Subject|0|||
149060285|NCT03905798|537704877|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
149060286|NCT05374798|537704878|FG000|Overall Study|Lost to Follow-up|2|||
149060287|NCT05374798|537704878|FG000|Overall Study|Withdrawal by Subject|2|||
149060288|NCT05374798|537704878|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
149060289|NCT06473662|537704879|FG000|Overall Study|Withdrawal by Subject|1|||
149060290|NCT06473662|537704880|FG001|Overall Study|Withdrawal by Subject|6|||
149060291|NCT06473662|537704881|FG002|Overall Study|Withdrawal by Subject|5|||
149060292|NCT06473662|537704879|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
149060293|NCT06473662|537704880|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
149060294|NCT06473662|537704881|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
149060295|NCT06473662|537704879|FG000|Overall Study|Starting HbA1c below 7%|0|||
149060296|NCT06473662|537704880|FG001|Overall Study|Starting HbA1c below 7%|1|||
149060297|NCT06473662|537704881|FG002|Overall Study|Starting HbA1c below 7%|1|||
149060298|NCT06473662|537704879|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
149060299|NCT06473662|537704880|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
149060300|NCT06473662|537704881|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
149060301|NCT06473662|537704879|FG000|Overall Study|Did not take medication|2|||
149060302|NCT06473662|537704880|FG001|Overall Study|Did not take medication|3|||
149060303|NCT06473662|537704881|FG002|Overall Study|Did not take medication|2|||
149060304|NCT03463044|537704884|FG000|Overall Study|Lost to Follow-up|0|||
149060305|NCT03463044|537704885|FG001|Overall Study|Lost to Follow-up|0|||
149060306|NCT03463044|537704886|FG002|Overall Study|Lost to Follow-up|0|||
149060307|NCT03463044|537704887|FG003|Overall Study|Lost to Follow-up|0|||
149060308|NCT03463044|537704888|FG004|Overall Study|Lost to Follow-up|0|||
149060309|NCT03463044|537704889|FG005|Overall Study|Lost to Follow-up|0|||
149060310|NCT03463044|537704890|FG006|Overall Study|Lost to Follow-up|0|||
149060311|NCT03463044|537704891|FG007|Overall Study|Lost to Follow-up|1|||
149060312|NCT03463044|537704892|FG008|Overall Study|Lost to Follow-up|0|||
149060313|NCT03334630|537704893|FG000|Overall Study|Withdrawal by Subject|7|||
149060314|NCT03334630|537704894|FG001|Overall Study|Withdrawal by Subject|7|||
149060315|NCT03334630|537704893|FG000|Overall Study|Lost to Follow-up|3|||
149060316|NCT03334630|537704894|FG001|Overall Study|Lost to Follow-up|1|||
149060317|NCT03334630|537704893|FG000|Overall Study|Adverse Event|0|||
149060318|NCT03334630|537704894|FG001|Overall Study|Adverse Event|1|||
149060319|NCT03334630|537704893|FG000|Overall Study|Physician Decision|1|||
149060320|NCT03334630|537704894|FG001|Overall Study|Physician Decision|1|||
149060321|NCT03334630|537704893|FG000|Overall Study|Enrollment closed|2|||
149060322|NCT03334630|537704894|FG001|Overall Study|Enrollment closed|1|||
149060323|NCT03334630|537704893|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
149060324|NCT03334630|537704894|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
149060325|NCT03334630|537704893|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
149060326|NCT03334630|537704894|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
149060327|NCT03910478|537704903|FG000|Overall Study|Death|13|||
149060328|NCT03910478|537704904|FG001|Overall Study|Death|6|||
149060329|NCT03910478|537704903|FG000|Overall Study|Withdrawal by Subject|23|||
149060330|NCT03910478|537704904|FG001|Overall Study|Withdrawal by Subject|2|||
149060331|NCT03910478|537704903|FG000|Overall Study|Physician Decision|5|||
149060332|NCT03910478|537704904|FG001|Overall Study|Physician Decision|0|||
149060333|NCT03910478|537704903|FG000|Overall Study|Protocol Violation|1|||
149060334|NCT03910478|537704904|FG001|Overall Study|Protocol Violation|0|||
149060335|NCT03910478|537704903|FG000|Overall Study|Failure to meet continuation criteria|2|||
149060336|NCT03910478|537704904|FG001|Overall Study|Failure to meet continuation criteria|0|||
149060337|NCT03910478|537704903|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
149060338|NCT03910478|537704904|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
149060339|NCT01275677|537704910|FG000|Overall Study|Not at risk for recurrence.|1|||
149060340|NCT01275677|537704911|FG001|Overall Study|Not at risk for recurrence.|1|||
149060341|NCT01275677|537704910|FG000|Overall Study|No follow-up|26|||
149060342|NCT01275677|537704911|FG001|Overall Study|No follow-up|37|||
149060343|NCT01275677|537704910|FG000|Overall Study|No clinical follow up.|1|||
149060344|NCT01275677|537704911|FG001|Overall Study|No clinical follow up.|4|||
149060345|NCT03987022|537704912|FG000|Overall Study|Lost to Follow-up|2|||
149060346|NCT03987022|537704913|FG001|Overall Study|Lost to Follow-up|2|||
149060347|NCT03987022|537704912|FG000|Overall Study|Withdrawal by Subject|1|||
149060348|NCT03987022|537704913|FG001|Overall Study|Withdrawal by Subject|0|||
149060349|NCT03478956|537704914|FG000|Randomized Treatment Period|Adverse Event|1|||
149060350|NCT03478956|537704915|FG001|Randomized Treatment Period|Adverse Event|0|||
149060351|NCT03478956|537704916|FG002|Randomized Treatment Period|Adverse Event|0|||
149060352|NCT03478956|537704917|FG003|Randomized Treatment Period|Adverse Event|0|||
149060353|NCT03478956|537704914|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
149060354|NCT03478956|537704915|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
149060355|NCT03478956|537704916|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
149060356|NCT03478956|537704917|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
149060357|NCT03478956|537704914|FG000|Open Label Extension Period|Adverse Event|0|||
149060358|NCT03478956|537704915|FG001|Open Label Extension Period|Adverse Event|0|||
149060359|NCT03478956|537704916|FG002|Open Label Extension Period|Adverse Event|4|||
149060360|NCT03478956|537704917|FG003|Open Label Extension Period|Adverse Event|0|||
149060361|NCT03478956|537704914|FG000|Open Label Extension Period|Lack of Efficacy|0|||
149060362|NCT03478956|537704915|FG001|Open Label Extension Period|Lack of Efficacy|0|||
149060363|NCT03478956|537704916|FG002|Open Label Extension Period|Lack of Efficacy|8|||
149060364|NCT03478956|537704917|FG003|Open Label Extension Period|Lack of Efficacy|0|||
149060365|NCT03478956|537704914|FG000|Open Label Extension Period|Reason Not Provided|0|||
149060366|NCT03478956|537704915|FG001|Open Label Extension Period|Reason Not Provided|0|||
149060367|NCT03478956|537704916|FG002|Open Label Extension Period|Reason Not Provided|1|||
148890250|NCT03827655|537077184|FG002|Overall Study|Death|0|||
149060368|NCT03478956|537704917|FG003|Open Label Extension Period|Reason Not Provided|0|||
149060369|NCT03478956|537704914|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
149060370|NCT03478956|537704915|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
149060371|NCT03478956|537704916|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
149060372|NCT03478956|537704917|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
149060373|NCT03478956|537704914|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
149060374|NCT03478956|537704915|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
149060375|NCT03478956|537704916|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
149060376|NCT03478956|537704917|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
149060377|NCT03478956|537704914|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
149060378|NCT03478956|537704915|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
149060379|NCT03478956|537704916|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
149060380|NCT03478956|537704917|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
149119376|NCT00275262|537916293|FG001|Overall Study|Death|0|||
149060381|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
149060382|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
149060383|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
149060384|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
149060385|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
149060386|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
149060387|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
149060388|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
149060389|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
149060390|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
149060391|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
149060392|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
149060393|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
149060394|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
149060395|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
149060396|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
149060397|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
149060398|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
149060399|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
149060400|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
149060401|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
149060402|NCT04800211|537704918|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
149060403|NCT04800211|537704919|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
149060404|NCT04800211|537704920|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
149060405|NCT04800211|537704918|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
149060406|NCT04800211|537704919|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
149060407|NCT04800211|537704920|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
149060408|NCT04800211|537704918|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
149060409|NCT04800211|537704919|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
149060410|NCT04800211|537704920|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
149060411|NCT04800211|537704918|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
149060412|NCT04800211|537704919|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
149060413|NCT04800211|537704920|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
149060414|NCT05170841|537704923|FG000|Single Dose Phase|Adverse Event|1|||
149060415|NCT05170841|537704924|FG001|Single Dose Phase|Adverse Event|2|||
149060416|NCT05170841|537704925|FG002|Single Dose Phase|Adverse Event|0|||
149060417|NCT05170841|537704926|FG003|Single Dose Phase|Adverse Event|2|||
149060418|NCT05170841|537704923|FG000|Multiple Dose Phase|Adverse Event|1|||
149060419|NCT05170841|537704924|FG001|Multiple Dose Phase|Adverse Event|2|||
149060420|NCT05170841|537704925|FG002|Multiple Dose Phase|Adverse Event|1|||
149060421|NCT05170841|537704926|FG003|Multiple Dose Phase|Adverse Event|4|||
149060422|NCT05170841|537704923|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
149060423|NCT05170841|537704924|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
149060424|NCT05170841|537704925|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
149060425|NCT05170841|537704926|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
149060426|NCT02733159|537704936|FG000|Overall Study|Adverse Event|1|||
149060427|NCT02733159|537704936|FG000|Overall Study|Lack of disease progression|1|||
149060428|NCT03088878|537704937|FG000|Overall Study|Adverse Event|0|||
149060429|NCT03088878|537704938|FG001|Overall Study|Adverse Event|0|||
149060430|NCT03088878|537704939|FG002|Overall Study|Adverse Event|0|||
149060431|NCT03088878|537704940|FG003|Overall Study|Adverse Event|0|||
149060432|NCT03088878|537704941|FG004|Overall Study|Adverse Event|4|||
149060433|NCT03088878|537704942|FG005|Overall Study|Adverse Event|2|||
149060434|NCT03088878|537704943|FG006|Overall Study|Adverse Event|1|||
149060435|NCT03088878|537704944|FG007|Overall Study|Adverse Event|0|||
149060436|NCT03088878|537704945|FG008|Overall Study|Adverse Event|0|||
149060437|NCT03088878|537704946|FG009|Overall Study|Adverse Event|0|||
149060438|NCT03088878|537704947|FG010|Overall Study|Adverse Event|0|||
149060439|NCT03088878|537704948|FG011|Overall Study|Adverse Event|0|||
149060440|NCT03088878|537704949|FG012|Overall Study|Adverse Event|5|||
149060441|NCT03088878|537704950|FG013|Overall Study|Adverse Event|3|||
149060442|NCT03088878|537704937|FG000|Overall Study|Clinical Progression|0|||
149060443|NCT03088878|537704938|FG001|Overall Study|Clinical Progression|0|||
149060444|NCT03088878|537704939|FG002|Overall Study|Clinical Progression|0|||
149060445|NCT03088878|537704940|FG003|Overall Study|Clinical Progression|0|||
149060446|NCT03088878|537704941|FG004|Overall Study|Clinical Progression|2|||
149060447|NCT03088878|537704942|FG005|Overall Study|Clinical Progression|0|||
149060448|NCT03088878|537704943|FG006|Overall Study|Clinical Progression|0|||
149060449|NCT03088878|537704944|FG007|Overall Study|Clinical Progression|0|||
149060450|NCT03088878|537704945|FG008|Overall Study|Clinical Progression|0|||
149060451|NCT03088878|537704946|FG009|Overall Study|Clinical Progression|0|||
149060452|NCT03088878|537704947|FG010|Overall Study|Clinical Progression|0|||
149060453|NCT03088878|537704948|FG011|Overall Study|Clinical Progression|0|||
149060454|NCT03088878|537704949|FG012|Overall Study|Clinical Progression|0|||
149060455|NCT03088878|537704950|FG013|Overall Study|Clinical Progression|0|||
149060456|NCT03088878|537704937|FG000|Overall Study|Death|0|||
149060457|NCT03088878|537704938|FG001|Overall Study|Death|0|||
149060458|NCT03088878|537704939|FG002|Overall Study|Death|0|||
149060459|NCT03088878|537704940|FG003|Overall Study|Death|0|||
149060460|NCT03088878|537704941|FG004|Overall Study|Death|2|||
149060461|NCT03088878|537704942|FG005|Overall Study|Death|0|||
149060462|NCT03088878|537704943|FG006|Overall Study|Death|0|||
149060463|NCT03088878|537704944|FG007|Overall Study|Death|0|||
149060464|NCT03088878|537704945|FG008|Overall Study|Death|0|||
149060465|NCT03088878|537704946|FG009|Overall Study|Death|0|||
149060466|NCT03088878|537704947|FG010|Overall Study|Death|0|||
149060467|NCT03088878|537704948|FG011|Overall Study|Death|1|||
149060468|NCT03088878|537704949|FG012|Overall Study|Death|0|||
149060469|NCT03088878|537704950|FG013|Overall Study|Death|0|||
149060470|NCT03088878|537704937|FG000|Overall Study|Disease Progression|1|||
149060471|NCT03088878|537704938|FG001|Overall Study|Disease Progression|2|||
149060472|NCT03088878|537704939|FG002|Overall Study|Disease Progression|3|||
149060473|NCT03088878|537704940|FG003|Overall Study|Disease Progression|0|||
149060474|NCT03088878|537704941|FG004|Overall Study|Disease Progression|3|||
149060475|NCT03088878|537704942|FG005|Overall Study|Disease Progression|0|||
149060476|NCT03088878|537704943|FG006|Overall Study|Disease Progression|0|||
149060477|NCT03088878|537704944|FG007|Overall Study|Disease Progression|0|||
149060478|NCT03088878|537704945|FG008|Overall Study|Disease Progression|0|||
149060479|NCT03088878|537704946|FG009|Overall Study|Disease Progression|0|||
149060480|NCT03088878|537704947|FG010|Overall Study|Disease Progression|0|||
149060481|NCT03088878|537704948|FG011|Overall Study|Disease Progression|0|||
149060482|NCT03088878|537704949|FG012|Overall Study|Disease Progression|1|||
149060483|NCT03088878|537704950|FG013|Overall Study|Disease Progression|1|||
149060484|NCT03088878|537704937|FG000|Overall Study|Initiation of Alternative Treatment|0|||
149060485|NCT03088878|537704938|FG001|Overall Study|Initiation of Alternative Treatment|0|||
149060486|NCT03088878|537704939|FG002|Overall Study|Initiation of Alternative Treatment|0|||
149060487|NCT03088878|537704940|FG003|Overall Study|Initiation of Alternative Treatment|1|||
149060488|NCT03088878|537704941|FG004|Overall Study|Initiation of Alternative Treatment|0|||
149060489|NCT03088878|537704942|FG005|Overall Study|Initiation of Alternative Treatment|0|||
149060490|NCT03088878|537704943|FG006|Overall Study|Initiation of Alternative Treatment|0|||
149060491|NCT03088878|537704944|FG007|Overall Study|Initiation of Alternative Treatment|1|||
149060492|NCT03088878|537704945|FG008|Overall Study|Initiation of Alternative Treatment|1|||
149060493|NCT03088878|537704946|FG009|Overall Study|Initiation of Alternative Treatment|0|||
149060494|NCT03088878|537704947|FG010|Overall Study|Initiation of Alternative Treatment|0|||
149060495|NCT03088878|537704948|FG011|Overall Study|Initiation of Alternative Treatment|0|||
149060496|NCT03088878|537704949|FG012|Overall Study|Initiation of Alternative Treatment|0|||
149060497|NCT03088878|537704950|FG013|Overall Study|Initiation of Alternative Treatment|0|||
149060498|NCT03088878|537704937|FG000|Overall Study|Withdrawal by Subject|0|||
149060499|NCT03088878|537704938|FG001|Overall Study|Withdrawal by Subject|0|||
149060500|NCT03088878|537704939|FG002|Overall Study|Withdrawal by Subject|0|||
149060501|NCT03088878|537704940|FG003|Overall Study|Withdrawal by Subject|1|||
149060502|NCT03088878|537704941|FG004|Overall Study|Withdrawal by Subject|4|||
149060503|NCT03088878|537704942|FG005|Overall Study|Withdrawal by Subject|1|||
149060504|NCT03088878|537704943|FG006|Overall Study|Withdrawal by Subject|1|||
149060505|NCT03088878|537704944|FG007|Overall Study|Withdrawal by Subject|0|||
149060506|NCT03088878|537704945|FG008|Overall Study|Withdrawal by Subject|1|||
149060507|NCT03088878|537704946|FG009|Overall Study|Withdrawal by Subject|2|||
149060508|NCT03088878|537704947|FG010|Overall Study|Withdrawal by Subject|0|||
149060509|NCT03088878|537704948|FG011|Overall Study|Withdrawal by Subject|2|||
148890251|NCT03827655|537077185|FG003|Overall Study|Death|0|||
149060510|NCT03088878|537704949|FG012|Overall Study|Withdrawal by Subject|1|||
149060511|NCT03088878|537704950|FG013|Overall Study|Withdrawal by Subject|0|||
149060512|NCT03088878|537704937|FG000|Overall Study|Terminated by Sponsor|2|||
149060513|NCT03088878|537704938|FG001|Overall Study|Terminated by Sponsor|1|||
149060514|NCT03088878|537704939|FG002|Overall Study|Terminated by Sponsor|0|||
149060515|NCT03088878|537704940|FG003|Overall Study|Terminated by Sponsor|1|||
149060516|NCT03088878|537704941|FG004|Overall Study|Terminated by Sponsor|6|||
149060517|NCT03088878|537704942|FG005|Overall Study|Terminated by Sponsor|0|||
149060518|NCT03088878|537704943|FG006|Overall Study|Terminated by Sponsor|0|||
149060519|NCT03088878|537704944|FG007|Overall Study|Terminated by Sponsor|0|||
149060520|NCT03088878|537704945|FG008|Overall Study|Terminated by Sponsor|0|||
149060521|NCT03088878|537704946|FG009|Overall Study|Terminated by Sponsor|0|||
149060522|NCT03088878|537704947|FG010|Overall Study|Terminated by Sponsor|3|||
149060523|NCT03088878|537704948|FG011|Overall Study|Terminated by Sponsor|13|||
149060524|NCT03088878|537704949|FG012|Overall Study|Terminated by Sponsor|2|||
149060525|NCT03088878|537704950|FG013|Overall Study|Terminated by Sponsor|1|||
149060526|NCT03088878|537704937|FG000|Overall Study|Completed 2 years of Treatment|0|||
149060527|NCT03088878|537704938|FG001|Overall Study|Completed 2 years of Treatment|0|||
149060528|NCT03088878|537704939|FG002|Overall Study|Completed 2 years of Treatment|0|||
149060529|NCT03088878|537704940|FG003|Overall Study|Completed 2 years of Treatment|0|||
149060530|NCT03088878|537704941|FG004|Overall Study|Completed 2 years of Treatment|0|||
149060531|NCT03088878|537704942|FG005|Overall Study|Completed 2 years of Treatment|0|||
149060532|NCT03088878|537704943|FG006|Overall Study|Completed 2 years of Treatment|1|||
149060533|NCT03088878|537704944|FG007|Overall Study|Completed 2 years of Treatment|0|||
149060534|NCT03088878|537704945|FG008|Overall Study|Completed 2 years of Treatment|0|||
149060535|NCT03088878|537704946|FG009|Overall Study|Completed 2 years of Treatment|1|||
149060536|NCT03088878|537704947|FG010|Overall Study|Completed 2 years of Treatment|0|||
149060537|NCT03088878|537704948|FG011|Overall Study|Completed 2 years of Treatment|0|||
149060538|NCT03088878|537704949|FG012|Overall Study|Completed 2 years of Treatment|8|||
149060539|NCT03088878|537704950|FG013|Overall Study|Completed 2 years of Treatment|3|||
149060540|NCT03088878|537704937|FG000|Overall Study|Physician Decision|0|||
149060541|NCT03088878|537704938|FG001|Overall Study|Physician Decision|0|||
149060542|NCT03088878|537704939|FG002|Overall Study|Physician Decision|0|||
149060543|NCT03088878|537704940|FG003|Overall Study|Physician Decision|0|||
149060544|NCT03088878|537704941|FG004|Overall Study|Physician Decision|0|||
149060545|NCT03088878|537704942|FG005|Overall Study|Physician Decision|0|||
149060546|NCT03088878|537704943|FG006|Overall Study|Physician Decision|0|||
149060547|NCT03088878|537704944|FG007|Overall Study|Physician Decision|2|||
149060548|NCT03088878|537704945|FG008|Overall Study|Physician Decision|1|||
149060549|NCT03088878|537704946|FG009|Overall Study|Physician Decision|0|||
149060550|NCT03088878|537704947|FG010|Overall Study|Physician Decision|0|||
149060551|NCT03088878|537704948|FG011|Overall Study|Physician Decision|0|||
149060552|NCT03088878|537704949|FG012|Overall Study|Physician Decision|0|||
149060553|NCT03088878|537704950|FG013|Overall Study|Physician Decision|1|||
149060554|NCT03088878|537704937|FG000|Overall Study|COVID Related noncompliance|0|||
149060555|NCT03088878|537704938|FG001|Overall Study|COVID Related noncompliance|0|||
149060556|NCT03088878|537704939|FG002|Overall Study|COVID Related noncompliance|0|||
149060557|NCT03088878|537704940|FG003|Overall Study|COVID Related noncompliance|0|||
149060558|NCT03088878|537704941|FG004|Overall Study|COVID Related noncompliance|0|||
149060559|NCT03088878|537704942|FG005|Overall Study|COVID Related noncompliance|0|||
149060560|NCT03088878|537704943|FG006|Overall Study|COVID Related noncompliance|0|||
149060561|NCT03088878|537704944|FG007|Overall Study|COVID Related noncompliance|0|||
149060562|NCT03088878|537704945|FG008|Overall Study|COVID Related noncompliance|0|||
149060563|NCT03088878|537704946|FG009|Overall Study|COVID Related noncompliance|0|||
149060564|NCT03088878|537704947|FG010|Overall Study|COVID Related noncompliance|0|||
149060565|NCT03088878|537704948|FG011|Overall Study|COVID Related noncompliance|0|||
149060566|NCT03088878|537704949|FG012|Overall Study|COVID Related noncompliance|0|||
149060567|NCT03088878|537704950|FG013|Overall Study|COVID Related noncompliance|1|||
149060568|NCT03088878|537704937|FG000|Overall Study|Drug or Study Noncompliance|0|||
149060569|NCT03088878|537704938|FG001|Overall Study|Drug or Study Noncompliance|0|||
149060570|NCT03088878|537704939|FG002|Overall Study|Drug or Study Noncompliance|0|||
149060571|NCT03088878|537704940|FG003|Overall Study|Drug or Study Noncompliance|0|||
149060572|NCT03088878|537704941|FG004|Overall Study|Drug or Study Noncompliance|0|||
149060573|NCT03088878|537704942|FG005|Overall Study|Drug or Study Noncompliance|0|||
149060574|NCT03088878|537704943|FG006|Overall Study|Drug or Study Noncompliance|0|||
149060575|NCT03088878|537704944|FG007|Overall Study|Drug or Study Noncompliance|0|||
149060576|NCT03088878|537704945|FG008|Overall Study|Drug or Study Noncompliance|0|||
149060577|NCT03088878|537704946|FG009|Overall Study|Drug or Study Noncompliance|0|||
149060578|NCT03088878|537704947|FG010|Overall Study|Drug or Study Noncompliance|0|||
149060579|NCT03088878|537704948|FG011|Overall Study|Drug or Study Noncompliance|0|||
149060580|NCT03088878|537704949|FG012|Overall Study|Drug or Study Noncompliance|1|||
149060581|NCT03088878|537704950|FG013|Overall Study|Drug or Study Noncompliance|0|||
149060582|NCT04690582|537704962|FG000|Overall Study|Withdrawal by Subject|6|||
149060583|NCT04690582|537704963|FG001|Overall Study|Withdrawal by Subject|4|||
149060584|NCT04270942|537704964|FG000|Overall Study|Death|1|||
149060585|NCT04797195|537704971|FG000|Overall Study|Death|8|||
149060586|NCT04797195|537704972|FG001|Overall Study|Death|15|||
149060587|NCT04797195|537704971|FG000|Overall Study|Change from PD|15|||
149060588|NCT04797195|537704972|FG001|Overall Study|Change from PD|15|||
149060589|NCT04797195|537704971|FG000|Overall Study|Withdrawal by Subject|3|||
149060590|NCT04797195|537704972|FG001|Overall Study|Withdrawal by Subject|2|||
149060591|NCT02116530|537706855|FG000|Overall Study|Withdrawal by Subject|1|||
149060592|NCT02116530|537706856|FG001|Overall Study|Withdrawal by Subject|2|||
149060593|NCT02116530|537706855|FG000|Overall Study|Adverse Event|4|||
149060594|NCT02116530|537706856|FG001|Overall Study|Adverse Event|0|||
149060595|NCT02116530|537706855|FG000|Overall Study|Physician Decision|1|||
149060596|NCT02116530|537706856|FG001|Overall Study|Physician Decision|0|||
149060597|NCT02116530|537706855|FG000|Overall Study|Lost to Follow-up|1|||
149060598|NCT02116530|537706856|FG001|Overall Study|Lost to Follow-up|0|||
149060599|NCT02116530|537706855|FG000|Overall Study|Other Medical Problems|2|||
149060600|NCT02116530|537706856|FG001|Overall Study|Other Medical Problems|2|||
149060601|NCT05299723|537706858|FG000|Overall Study|Withdrawal by Subject|0|||
149060602|NCT05299723|537706859|FG001|Overall Study|Withdrawal by Subject|2|||
149060603|NCT05299723|537706860|FG002|Overall Study|Withdrawal by Subject|0|||
149060604|NCT01959607|537706861|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
149060605|NCT01959607|537706862|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
149060606|NCT01959607|537706863|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
149060607|NCT01959607|537706864|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
149060608|NCT03913442|537706865|FG000|Overall Study|Adverse Event|0|||
149060609|NCT03913442|537706866|FG001|Overall Study|Adverse Event|3|||
149060610|NCT03913442|537706865|FG000|Overall Study|Withdrawal by Subject|5|||
149060611|NCT03913442|537706866|FG001|Overall Study|Withdrawal by Subject|5|||
149060612|NCT03913442|537706865|FG000|Overall Study|Terminations|2|||
149060613|NCT03913442|537706866|FG001|Overall Study|Terminations|1|||
149060614|NCT03913442|537706865|FG000|Overall Study|Lost to Follow-up|2|||
149060615|NCT03913442|537706866|FG001|Overall Study|Lost to Follow-up|2|||
149060616|NCT05194956|537706867|FG000|Washout Period|Withdrawal by Subject|0|||
149060617|NCT05194956|537706868|FG001|Washout Period|Withdrawal by Subject|2|||
149060618|NCT03511664|537706871|FG000|Overall Study|Death|457|||
149060619|NCT03511664|537706872|FG001|Overall Study|Death|201|||
149060620|NCT03511664|537706873|FG002|Overall Study|Death|21|||
149060621|NCT03511664|537706871|FG000|Overall Study|Withdrew consent|40|||
149060622|NCT03511664|537706872|FG001|Overall Study|Withdrew consent|63|||
149060623|NCT03511664|537706873|FG002|Overall Study|Withdrew consent|3|||
149060624|NCT03511664|537706871|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
149060625|NCT03511664|537706872|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
149060626|NCT03511664|537706873|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
149060627|NCT03511664|537706871|FG000|Overall Study|Lost to Follow-up|8|||
149060628|NCT03511664|537706872|FG001|Overall Study|Lost to Follow-up|5|||
149060629|NCT03511664|537706873|FG002|Overall Study|Lost to Follow-up|0|||
149060630|NCT03511664|537706871|FG000|Overall Study|Physician Decision|2|||
149060631|NCT03511664|537706872|FG001|Overall Study|Physician Decision|1|||
149060632|NCT03511664|537706873|FG002|Overall Study|Physician Decision|0|||
149060633|NCT03511664|537706871|FG000|Overall Study|Patient non-compliance|1|||
149060634|NCT03511664|537706872|FG001|Overall Study|Patient non-compliance|0|||
149060635|NCT03511664|537706873|FG002|Overall Study|Patient non-compliance|0|||
149060636|NCT05934942|537706877|FG000|Run-in Period|Not treated|1|||
149060637|NCT05934942|537706877|FG000|Run-in Period|Withdrawal by Subject|1|||
149060638|NCT00539591|537706892|FG000|Overall Study|Toxicity|3|||
149060639|NCT00539591|537706893|FG001|Overall Study|Toxicity|0|||
149060640|NCT00539591|537706894|FG002|Overall Study|Toxicity|0|||
149060641|NCT00539591|537706892|FG000|Overall Study|Disease progression|2|||
149060642|NCT00539591|537706893|FG001|Overall Study|Disease progression|2|||
149060643|NCT00539591|537706894|FG002|Overall Study|Disease progression|3|||
149060644|NCT04568434|537706895|FG000|Overall Study|Voluntary Withdrawal|0|||
149060645|NCT04568434|537706896|FG001|Overall Study|Voluntary Withdrawal|1|||
149060646|NCT04568434|537706897|FG002|Overall Study|Voluntary Withdrawal|1|||
149060647|NCT04568434|537706895|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
149060648|NCT04568434|537706896|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
149060649|NCT04568434|537706897|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
149060650|NCT04568434|537706895|FG000|Overall Study|Investigator Judgement|1|||
149060651|NCT04568434|537706896|FG001|Overall Study|Investigator Judgement|0|||
149060652|NCT04568434|537706897|FG002|Overall Study|Investigator Judgement|0|||
149060653|NCT05469464|537706898|FG000|Overall Study|Withdrawal by Subject|8|||
149060654|NCT05469464|537706899|FG001|Overall Study|Withdrawal by Subject|7|||
149060655|NCT05469464|537706900|FG002|Overall Study|Withdrawal by Subject|4|||
149060656|NCT05469464|537706901|FG003|Overall Study|Withdrawal by Subject|5|||
149060657|NCT05469464|537706898|FG000|Overall Study|Adverse Event|8|||
149060658|NCT05469464|537706899|FG001|Overall Study|Adverse Event|14|||
149060659|NCT05469464|537706900|FG002|Overall Study|Adverse Event|13|||
149060660|NCT05469464|537706901|FG003|Overall Study|Adverse Event|2|||
149060661|NCT05469464|537706898|FG000|Overall Study|Lost to Follow-up|2|||
149060662|NCT05469464|537706899|FG001|Overall Study|Lost to Follow-up|5|||
149060663|NCT05469464|537706900|FG002|Overall Study|Lost to Follow-up|3|||
149060664|NCT05469464|537706901|FG003|Overall Study|Lost to Follow-up|3|||
148890252|NCT03827655|537077186|FG004|Overall Study|Death|1|||
148890253|NCT03827655|537077182|FG000|Overall Study|Protocol Deviation|1|||
148890254|NCT03827655|537077183|FG001|Overall Study|Protocol Deviation|0|||
149060665|NCT05469464|537706898|FG000|Overall Study|Lack of Efficacy|4|||
149060666|NCT05469464|537706899|FG001|Overall Study|Lack of Efficacy|1|||
149060667|NCT05469464|537706900|FG002|Overall Study|Lack of Efficacy|2|||
149060668|NCT05469464|537706901|FG003|Overall Study|Lack of Efficacy|2|||
149060669|NCT05469464|537706898|FG000|Overall Study|Physician Decision|0|||
149060670|NCT05469464|537706899|FG001|Overall Study|Physician Decision|0|||
149060671|NCT05469464|537706900|FG002|Overall Study|Physician Decision|0|||
149060672|NCT05469464|537706901|FG003|Overall Study|Physician Decision|1|||
149060673|NCT04707625|537706904|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
149060674|NCT05485779|537706907|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060675|NCT05485779|537706908|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060676|NCT05485779|537706909|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060677|NCT05485779|537706910|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060678|NCT05485779|537706911|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060679|NCT05485779|537706912|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060680|NCT05485779|537706913|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060681|NCT05485779|537706914|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
149060682|NCT05485779|537706915|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
149060683|NCT05485779|537706916|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060684|NCT05485779|537706917|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
149060685|NCT05485779|537706907|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060686|NCT05485779|537706908|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060687|NCT05485779|537706909|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060688|NCT05485779|537706910|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060689|NCT05485779|537706911|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060690|NCT05485779|537706912|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060691|NCT05485779|537706913|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060692|NCT05485779|537706914|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060693|NCT05485779|537706915|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060694|NCT05485779|537706916|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
149060695|NCT05485779|537706917|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
149060696|NCT05485779|537706907|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060697|NCT05485779|537706908|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060698|NCT05485779|537706909|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060699|NCT05485779|537706910|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
149060700|NCT05485779|537706911|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060701|NCT05485779|537706912|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060702|NCT05485779|537706913|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060703|NCT05485779|537706914|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060704|NCT05485779|537706915|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060705|NCT05485779|537706916|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060706|NCT05485779|537706917|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
149060707|NCT04826471|537706918|FG000|Overall Study|Lost to Follow-up|2|||
149060708|NCT04826471|537706918|FG000|Overall Study|Protocol Violation|3|||
149060709|NCT04826471|537706918|FG000|Overall Study|Withdrawal by Subject|1|||
149060710|NCT03030261|537706919|FG000|Overall Study|Still receiving continuation therapy|5|||
149060711|NCT04079218|537706920|FG000|Overall Study|Death|1|||
149060712|NCT04079218|537706921|FG001|Overall Study|Death|0|||
149060713|NCT04079218|537706920|FG000|Overall Study|Withdrawal by Subject|3|||
149060714|NCT04079218|537706921|FG001|Overall Study|Withdrawal by Subject|0|||
149060715|NCT04079218|537706920|FG000|Overall Study|Physician Decision|4|||
149060716|NCT04079218|537706921|FG001|Overall Study|Physician Decision|0|||
149060717|NCT04079218|537706920|FG000|Overall Study|Lost to Follow-up|0|||
149060718|NCT04079218|537706921|FG001|Overall Study|Lost to Follow-up|1|||
149060719|NCT05293171|537706922|FG000|Washout 5 to 7 Days|Adverse Event|1|||
149060720|NCT05293171|537706923|FG001|Washout 5 to 7 Days|Adverse Event|1|||
149060721|NCT05293171|537706924|FG002|Washout 5 to 7 Days|Adverse Event|0|||
149060722|NCT05293171|537706925|FG003|Washout 5 to 7 Days|Adverse Event|0|||
149060723|NCT05293171|537706926|FG004|Washout 5 to 7 Days|Adverse Event|0|||
149060724|NCT05293171|537706927|FG005|Washout 5 to 7 Days|Adverse Event|0|||
149060725|NCT05293171|537706928|FG006|Washout 5 to 7 Days|Adverse Event|0|||
149060726|NCT05293171|537706929|FG007|Washout 5 to 7 Days|Adverse Event|0|||
149060727|NCT05293171|537706930|FG008|Washout 5 to 7 Days|Adverse Event|0|||
149060728|NCT05293171|537706931|FG009|Washout 5 to 7 Days|Adverse Event|0|||
149060729|NCT05293171|537706932|FG010|Washout 5 to 7 Days|Adverse Event|0|||
149060730|NCT05293171|537706933|FG011|Washout 5 to 7 Days|Adverse Event|0|||
149060731|NCT05293171|537706922|FG000|Washout 5 to 7 Days|Adverse Event|0|||
149060732|NCT05293171|537706923|FG001|Washout 5 to 7 Days|Adverse Event|0|||
149060733|NCT05293171|537706924|FG002|Washout 5 to 7 Days|Adverse Event|0|||
149060734|NCT05293171|537706925|FG003|Washout 5 to 7 Days|Adverse Event|0|||
149060735|NCT05293171|537706926|FG004|Washout 5 to 7 Days|Adverse Event|0|||
149060736|NCT05293171|537706927|FG005|Washout 5 to 7 Days|Adverse Event|1|||
149060737|NCT05293171|537706928|FG006|Washout 5 to 7 Days|Adverse Event|0|||
149060738|NCT05293171|537706929|FG007|Washout 5 to 7 Days|Adverse Event|0|||
149060739|NCT05293171|537706930|FG008|Washout 5 to 7 Days|Adverse Event|0|||
149060740|NCT05293171|537706931|FG009|Washout 5 to 7 Days|Adverse Event|0|||
149060741|NCT05293171|537706932|FG010|Washout 5 to 7 Days|Adverse Event|0|||
149060742|NCT05293171|537706933|FG011|Washout 5 to 7 Days|Adverse Event|0|||
149060743|NCT02052882|537706934|FG000|Overall Study|Not treated|11|||
148890255|NCT03827655|537077184|FG002|Overall Study|Protocol Deviation|1|||
148890256|NCT03827655|537077185|FG003|Overall Study|Protocol Deviation|1|||
149060744|NCT02052882|537706934|FG000|Overall Study|Protocol Violation|1|||
149060745|NCT02052882|537706934|FG000|Overall Study|Inadequate testing|1|||
149060746|NCT03734679|537706945|FG000|Overall Study|Missed Visit|1|||
149060747|NCT02240238|537706956|FG000|Phase 1|Adverse Event|0|||
149060748|NCT02240238|537706957|FG001|Phase 1|Adverse Event|0|||
149060749|NCT02240238|537706958|FG002|Phase 1|Adverse Event|0|||
149060750|NCT02240238|537706959|FG003|Phase 1|Adverse Event|0|||
149060751|NCT02240238|537706960|FG004|Phase 1|Adverse Event|0|||
149060752|NCT02240238|537706961|FG005|Phase 1|Adverse Event|0|||
149060753|NCT02240238|537706962|FG006|Phase 1|Adverse Event|3|||
149060754|NCT02240238|537706963|FG007|Phase 1|Adverse Event|1|||
149060755|NCT02240238|537706964|FG008|Phase 1|Adverse Event|0|||
149060756|NCT02240238|537706965|FG009|Phase 1|Adverse Event|0|||
149060757|NCT02240238|537706966|FG010|Phase 1|Adverse Event|0|||
149060758|NCT02240238|537706967|FG011|Phase 1|Adverse Event|0|||
149060759|NCT02240238|537706956|FG000|Phase 1|Death|0|||
149060760|NCT02240238|537706957|FG001|Phase 1|Death|0|||
149060761|NCT02240238|537706958|FG002|Phase 1|Death|0|||
149060762|NCT02240238|537706959|FG003|Phase 1|Death|0|||
149060763|NCT02240238|537706960|FG004|Phase 1|Death|0|||
149060764|NCT02240238|537706961|FG005|Phase 1|Death|1|||
149060765|NCT02240238|537706962|FG006|Phase 1|Death|0|||
149060766|NCT02240238|537706963|FG007|Phase 1|Death|0|||
149060767|NCT02240238|537706964|FG008|Phase 1|Death|0|||
149060768|NCT02240238|537706965|FG009|Phase 1|Death|0|||
149060769|NCT02240238|537706966|FG010|Phase 1|Death|0|||
149060770|NCT02240238|537706967|FG011|Phase 1|Death|0|||
149060771|NCT02240238|537706956|FG000|Phase 1|Sponsor termination|0|||
149060772|NCT02240238|537706957|FG001|Phase 1|Sponsor termination|0|||
149060773|NCT02240238|537706958|FG002|Phase 1|Sponsor termination|0|||
149060774|NCT02240238|537706959|FG003|Phase 1|Sponsor termination|0|||
149060775|NCT02240238|537706960|FG004|Phase 1|Sponsor termination|0|||
149060776|NCT02240238|537706961|FG005|Phase 1|Sponsor termination|1|||
149060777|NCT02240238|537706962|FG006|Phase 1|Sponsor termination|0|||
149060778|NCT02240238|537706963|FG007|Phase 1|Sponsor termination|0|||
149060779|NCT02240238|537706964|FG008|Phase 1|Sponsor termination|0|||
149060780|NCT02240238|537706965|FG009|Phase 1|Sponsor termination|0|||
149060781|NCT02240238|537706966|FG010|Phase 1|Sponsor termination|0|||
149060782|NCT02240238|537706967|FG011|Phase 1|Sponsor termination|0|||
149060783|NCT02240238|537706956|FG000|Phase 1|Withdrawal by Subject|0|||
149060784|NCT02240238|537706957|FG001|Phase 1|Withdrawal by Subject|0|||
149060785|NCT02240238|537706958|FG002|Phase 1|Withdrawal by Subject|0|||
149060786|NCT02240238|537706959|FG003|Phase 1|Withdrawal by Subject|0|||
149060787|NCT02240238|537706960|FG004|Phase 1|Withdrawal by Subject|0|||
149060788|NCT02240238|537706961|FG005|Phase 1|Withdrawal by Subject|2|||
149060789|NCT02240238|537706962|FG006|Phase 1|Withdrawal by Subject|0|||
149060790|NCT02240238|537706963|FG007|Phase 1|Withdrawal by Subject|0|||
149060791|NCT02240238|537706964|FG008|Phase 1|Withdrawal by Subject|0|||
149060792|NCT02240238|537706965|FG009|Phase 1|Withdrawal by Subject|0|||
149060793|NCT02240238|537706966|FG010|Phase 1|Withdrawal by Subject|0|||
149060794|NCT02240238|537706967|FG011|Phase 1|Withdrawal by Subject|0|||
149060795|NCT02240238|537706956|FG000|Phase 1|Physician Decision|0|||
149060796|NCT02240238|537706957|FG001|Phase 1|Physician Decision|0|||
149060797|NCT02240238|537706958|FG002|Phase 1|Physician Decision|0|||
149060798|NCT02240238|537706959|FG003|Phase 1|Physician Decision|0|||
149060799|NCT02240238|537706960|FG004|Phase 1|Physician Decision|0|||
149060800|NCT02240238|537706961|FG005|Phase 1|Physician Decision|2|||
149060801|NCT02240238|537706962|FG006|Phase 1|Physician Decision|0|||
149060802|NCT02240238|537706963|FG007|Phase 1|Physician Decision|0|||
149060803|NCT02240238|537706964|FG008|Phase 1|Physician Decision|0|||
149060804|NCT02240238|537706965|FG009|Phase 1|Physician Decision|0|||
149060805|NCT02240238|537706966|FG010|Phase 1|Physician Decision|0|||
149060806|NCT02240238|537706967|FG011|Phase 1|Physician Decision|0|||
149060807|NCT02240238|537706956|FG000|Phase 2|Adverse Event|0|||
149060808|NCT02240238|537706957|FG001|Phase 2|Adverse Event|0|||
149060809|NCT02240238|537706958|FG002|Phase 2|Adverse Event|0|||
149060810|NCT02240238|537706959|FG003|Phase 2|Adverse Event|0|||
149060811|NCT02240238|537706960|FG004|Phase 2|Adverse Event|0|||
149060812|NCT02240238|537706961|FG005|Phase 2|Adverse Event|0|||
149060813|NCT02240238|537706962|FG006|Phase 2|Adverse Event|0|||
149060814|NCT02240238|537706963|FG007|Phase 2|Adverse Event|0|||
149060815|NCT02240238|537706964|FG008|Phase 2|Adverse Event|0|||
149060816|NCT02240238|537706965|FG009|Phase 2|Adverse Event|7|||
149060817|NCT02240238|537706966|FG010|Phase 2|Adverse Event|14|||
149060818|NCT02240238|537706967|FG011|Phase 2|Adverse Event|2|||
149060819|NCT02240238|537706956|FG000|Phase 2|Death|0|||
149060820|NCT02240238|537706957|FG001|Phase 2|Death|0|||
149060821|NCT02240238|537706958|FG002|Phase 2|Death|0|||
149060822|NCT02240238|537706959|FG003|Phase 2|Death|0|||
149060823|NCT02240238|537706960|FG004|Phase 2|Death|0|||
149060824|NCT02240238|537706961|FG005|Phase 2|Death|0|||
149060825|NCT02240238|537706962|FG006|Phase 2|Death|0|||
149060826|NCT02240238|537706963|FG007|Phase 2|Death|0|||
149060827|NCT02240238|537706964|FG008|Phase 2|Death|0|||
149060828|NCT02240238|537706965|FG009|Phase 2|Death|3|||
149060829|NCT02240238|537706966|FG010|Phase 2|Death|2|||
149060830|NCT02240238|537706967|FG011|Phase 2|Death|1|||
149060831|NCT02240238|537706956|FG000|Phase 2|Disease progression|0|||
149060832|NCT02240238|537706957|FG001|Phase 2|Disease progression|0|||
149060833|NCT02240238|537706958|FG002|Phase 2|Disease progression|0|||
149060834|NCT02240238|537706959|FG003|Phase 2|Disease progression|0|||
149060835|NCT02240238|537706960|FG004|Phase 2|Disease progression|0|||
149060836|NCT02240238|537706961|FG005|Phase 2|Disease progression|0|||
149060837|NCT02240238|537706962|FG006|Phase 2|Disease progression|0|||
149060838|NCT02240238|537706963|FG007|Phase 2|Disease progression|0|||
149060839|NCT02240238|537706964|FG008|Phase 2|Disease progression|0|||
149060840|NCT02240238|537706965|FG009|Phase 2|Disease progression|5|||
149060841|NCT02240238|537706966|FG010|Phase 2|Disease progression|11|||
149060842|NCT02240238|537706967|FG011|Phase 2|Disease progression|1|||
149060843|NCT02240238|537706956|FG000|Phase 2|Withdrawal by Subject|0|||
149060844|NCT02240238|537706957|FG001|Phase 2|Withdrawal by Subject|0|||
149060845|NCT02240238|537706958|FG002|Phase 2|Withdrawal by Subject|0|||
149060846|NCT02240238|537706959|FG003|Phase 2|Withdrawal by Subject|0|||
149060847|NCT02240238|537706960|FG004|Phase 2|Withdrawal by Subject|0|||
149060848|NCT02240238|537706961|FG005|Phase 2|Withdrawal by Subject|0|||
149060849|NCT02240238|537706962|FG006|Phase 2|Withdrawal by Subject|0|||
149060850|NCT02240238|537706963|FG007|Phase 2|Withdrawal by Subject|0|||
149060851|NCT02240238|537706964|FG008|Phase 2|Withdrawal by Subject|0|||
149060852|NCT02240238|537706965|FG009|Phase 2|Withdrawal by Subject|1|||
149060853|NCT02240238|537706966|FG010|Phase 2|Withdrawal by Subject|1|||
149060854|NCT02240238|537706967|FG011|Phase 2|Withdrawal by Subject|0|||
149060855|NCT02240238|537706956|FG000|Phase 2|Physician Decision|0|||
149060856|NCT02240238|537706957|FG001|Phase 2|Physician Decision|0|||
149060857|NCT02240238|537706958|FG002|Phase 2|Physician Decision|0|||
149060858|NCT02240238|537706959|FG003|Phase 2|Physician Decision|0|||
149060859|NCT02240238|537706960|FG004|Phase 2|Physician Decision|0|||
149060860|NCT02240238|537706961|FG005|Phase 2|Physician Decision|0|||
149060861|NCT02240238|537706962|FG006|Phase 2|Physician Decision|0|||
149060862|NCT02240238|537706963|FG007|Phase 2|Physician Decision|0|||
149060863|NCT02240238|537706964|FG008|Phase 2|Physician Decision|0|||
149060864|NCT02240238|537706965|FG009|Phase 2|Physician Decision|1|||
149060865|NCT02240238|537706966|FG010|Phase 2|Physician Decision|3|||
149060866|NCT02240238|537706967|FG011|Phase 2|Physician Decision|0|||
149060867|NCT02240238|537706956|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060868|NCT02240238|537706957|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060869|NCT02240238|537706958|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060870|NCT02240238|537706959|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060871|NCT02240238|537706960|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060872|NCT02240238|537706961|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060873|NCT02240238|537706962|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060874|NCT02240238|537706963|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060875|NCT02240238|537706964|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060876|NCT02240238|537706965|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
149060877|NCT02240238|537706966|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060878|NCT02240238|537706967|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
149060879|NCT02240238|537706956|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060880|NCT02240238|537706957|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060881|NCT02240238|537706958|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060882|NCT02240238|537706959|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060883|NCT02240238|537706960|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060884|NCT02240238|537706961|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060885|NCT02240238|537706962|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060886|NCT02240238|537706963|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060887|NCT02240238|537706964|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060888|NCT02240238|537706965|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
149060889|NCT02240238|537706966|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060890|NCT02240238|537706967|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
149060891|NCT02240238|537706956|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060892|NCT02240238|537706957|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060893|NCT02240238|537706958|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060894|NCT02240238|537706959|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060895|NCT02240238|537706960|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060896|NCT02240238|537706961|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060897|NCT02240238|537706962|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060898|NCT02240238|537706963|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060899|NCT02240238|537706964|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060900|NCT02240238|537706965|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060901|NCT02240238|537706966|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
149060902|NCT02240238|537706967|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
149060903|NCT02240238|537706956|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060904|NCT02240238|537706957|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060905|NCT02240238|537706958|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060906|NCT02240238|537706959|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060907|NCT02240238|537706960|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060908|NCT02240238|537706961|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060909|NCT02240238|537706962|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060910|NCT02240238|537706963|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060911|NCT02240238|537706964|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060912|NCT02240238|537706965|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060913|NCT02240238|537706966|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
149060914|NCT02240238|537706967|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
149060915|NCT02240238|537706956|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060916|NCT02240238|537706957|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060917|NCT02240238|537706958|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060918|NCT02240238|537706959|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060919|NCT02240238|537706960|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060920|NCT02240238|537706961|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060921|NCT02240238|537706962|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060922|NCT02240238|537706963|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060923|NCT02240238|537706964|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060924|NCT02240238|537706965|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060925|NCT02240238|537706966|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
149060926|NCT02240238|537706967|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
149060927|NCT02240238|537706956|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060928|NCT02240238|537706957|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060929|NCT02240238|537706958|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060930|NCT02240238|537706959|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060931|NCT02240238|537706960|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060932|NCT02240238|537706961|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060933|NCT02240238|537706962|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060934|NCT02240238|537706963|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060935|NCT02240238|537706964|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060936|NCT02240238|537706965|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060937|NCT02240238|537706966|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
149060938|NCT02240238|537706967|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
149060939|NCT02240238|537706956|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060940|NCT02240238|537706957|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060941|NCT02240238|537706958|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060942|NCT02240238|537706959|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060943|NCT02240238|537706960|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060944|NCT02240238|537706961|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
148890257|NCT03827655|537077186|FG004|Overall Study|Protocol Deviation|0|||
148890258|NCT03827655|537077182|FG000|Overall Study|Withdrawal by Subject|3|||
148890259|NCT03827655|537077183|FG001|Overall Study|Withdrawal by Subject|2|||
148890260|NCT03827655|537077184|FG002|Overall Study|Withdrawal by Subject|2|||
148890261|NCT03827655|537077185|FG003|Overall Study|Withdrawal by Subject|0|||
148890262|NCT03827655|537077186|FG004|Overall Study|Withdrawal by Subject|1|||
148890263|NCT03827655|537077182|FG000|Overall Study|Reason not Specified|3|||
148890264|NCT03827655|537077183|FG001|Overall Study|Reason not Specified|1|||
148890265|NCT03827655|537077184|FG002|Overall Study|Reason not Specified|1|||
148890266|NCT03827655|537077185|FG003|Overall Study|Reason not Specified|1|||
148890267|NCT03827655|537077186|FG004|Overall Study|Reason not Specified|1|||
148890268|NCT01092728|537077187|FG000|Overall Study|Withdrawal by Subject|2|||
148890269|NCT01092728|537077188|FG001|Overall Study|Withdrawal by Subject|0|||
148890270|NCT01092728|537077187|FG000|Overall Study|Adverse Event|0|||
148890271|NCT01092728|537077188|FG001|Overall Study|Adverse Event|1|||
148890272|NCT01092728|537077187|FG000|Overall Study|Disease Progression|1|||
148890273|NCT01092728|537077188|FG001|Overall Study|Disease Progression|13|||
148890274|NCT01092728|537077187|FG000|Overall Study|Prohibited Concomitant Medications|1|||
148890275|NCT01092728|537077188|FG001|Overall Study|Prohibited Concomitant Medications|0|||
149119799|NCT00006011|537917969|FG000|Overall Study|Other|4|||
149060945|NCT02240238|537706962|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060946|NCT02240238|537706963|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060947|NCT02240238|537706964|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060948|NCT02240238|537706965|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060949|NCT02240238|537706966|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
149060950|NCT02240238|537706967|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
149060951|NCT02240238|537706956|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060952|NCT02240238|537706957|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060953|NCT02240238|537706958|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060954|NCT02240238|537706959|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060955|NCT02240238|537706960|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060956|NCT02240238|537706961|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060957|NCT02240238|537706962|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060958|NCT02240238|537706963|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060959|NCT02240238|537706964|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060960|NCT02240238|537706965|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060961|NCT02240238|537706966|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
149060962|NCT02240238|537706967|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
149060963|NCT02724969|537706977|FG000|Overall Study|Lost to Follow-up|12|||
149060964|NCT02724969|537706978|FG001|Overall Study|Lost to Follow-up|6|||
149060965|NCT02724969|537706977|FG000|Overall Study|Withdrawal by Subject|3|||
149060966|NCT02724969|537706978|FG001|Overall Study|Withdrawal by Subject|3|||
149060967|NCT02724969|537706977|FG000|Overall Study|Infant demise|0|||
149060968|NCT02724969|537706978|FG001|Overall Study|Infant demise|2|||
149060969|NCT01346540|537706979|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
149060970|NCT01346540|537706980|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
149060971|NCT01346540|537706979|FG000|Overall Study|Adverse Event|0|||
149060972|NCT01346540|537706980|FG001|Overall Study|Adverse Event|4|||
149060973|NCT03362476|537706984|FG000|Overall Study|Withdrawal by Subject|0|||
149060974|NCT03362476|537706985|FG001|Overall Study|Withdrawal by Subject|1|||
149060975|NCT05216406|537706988|FG000|Overall Study|Lost to Follow-up|8|||
149060976|NCT05216406|537706989|FG001|Overall Study|Lost to Follow-up|9|||
149060977|NCT01236781|537706997|FG000|Overall Study|Ineligible|2|||
149060978|NCT01236781|537706998|FG001|Overall Study|Ineligible|1|||
149060979|NCT01236781|537706997|FG000|Overall Study|Did not complete study imaging|5|||
149060980|NCT01236781|537706998|FG001|Overall Study|Did not complete study imaging|0|||
149060981|NCT04577963|537706999|FG000|Part 2|Death|0|||
149060982|NCT04577963|537707000|FG001|Part 2|Death|1|||
149060983|NCT04577963|537707001|FG002|Part 2|Death|8|||
149060984|NCT04577963|537707002|FG003|Part 2|Death|0|||
149060985|NCT04577963|537707003|FG004|Part 2|Death|20|||
149060986|NCT04577963|537706999|FG000|Part 2|Lost to Follow-up|0|||
149060987|NCT04577963|537707000|FG001|Part 2|Lost to Follow-up|0|||
149060988|NCT04577963|537707001|FG002|Part 2|Lost to Follow-up|0|||
149060989|NCT04577963|537707002|FG003|Part 2|Lost to Follow-up|0|||
149060990|NCT04577963|537707003|FG004|Part 2|Lost to Follow-up|2|||
149060991|NCT04577963|537706999|FG000|Part 2|Withdrawal by Subject|0|||
149060992|NCT04577963|537707000|FG001|Part 2|Withdrawal by Subject|0|||
149060993|NCT04577963|537707001|FG002|Part 2|Withdrawal by Subject|0|||
149060994|NCT04577963|537707002|FG003|Part 2|Withdrawal by Subject|0|||
149060995|NCT04577963|537707003|FG004|Part 2|Withdrawal by Subject|10|||
149060996|NCT04577963|537706999|FG000|Part 2|Progressive disease|0|||
149060997|NCT04577963|537707000|FG001|Part 2|Progressive disease|0|||
149060998|NCT04577963|537707001|FG002|Part 2|Progressive disease|0|||
149060999|NCT04577963|537707002|FG003|Part 2|Progressive disease|0|||
149061000|NCT04577963|537707003|FG004|Part 2|Progressive disease|2|||
149061001|NCT04577963|537706999|FG000|Part 2|Investigator decision|0|||
149061002|NCT04577963|537707000|FG001|Part 2|Investigator decision|0|||
149061003|NCT04577963|537707001|FG002|Part 2|Investigator decision|0|||
149061004|NCT04577963|537707002|FG003|Part 2|Investigator decision|0|||
149061005|NCT04577963|537707003|FG004|Part 2|Investigator decision|1|||
149061006|NCT04577963|537706999|FG000|Part 2|Sponsor terminated study|0|||
149061007|NCT04577963|537707000|FG001|Part 2|Sponsor terminated study|0|||
149061008|NCT04577963|537707001|FG002|Part 2|Sponsor terminated study|3|||
149061009|NCT04577963|537707002|FG003|Part 2|Sponsor terminated study|1|||
149061010|NCT04577963|537707003|FG004|Part 2|Sponsor terminated study|4|||
149061011|NCT02709161|537707004|FG000|Overall Study|Withdrawal by Subject|1|||
149061012|NCT02709161|537707005|FG001|Overall Study|Withdrawal by Subject|0|||
149061013|NCT05167864|537707008|FG000|Overall Study|Lost to Follow-up|7|||
149061014|NCT05167864|537707009|FG001|Overall Study|Lost to Follow-up|6|||
149061015|NCT05167864|537707010|FG002|Overall Study|Lost to Follow-up|7|||
149061016|NCT05167864|537707011|FG003|Overall Study|Lost to Follow-up|9|||
149061017|NCT04059185|537707014|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
149061018|NCT04059185|537707015|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
149061019|NCT04059185|537707016|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
149061020|NCT04059185|537707014|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
149061021|NCT04059185|537707015|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
149061022|NCT04059185|537707016|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
149061023|NCT04059185|537707014|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
149061024|NCT04059185|537707015|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
149061025|NCT04059185|537707016|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
149061026|NCT04059185|537707014|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
149061027|NCT04059185|537707015|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
149061028|NCT04059185|537707016|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
149061029|NCT04059185|537707014|FG000|Longitudinal Assessment-Adults Only|Death|4|||
149061030|NCT04059185|537707015|FG001|Longitudinal Assessment-Adults Only|Death|4|||
149061031|NCT04059185|537707016|FG002|Longitudinal Assessment-Adults Only|Death|3|||
149061032|NCT04587453|537707024|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
149061033|NCT04587453|537707025|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
149061034|NCT05623228|537707028|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
149061035|NCT05623228|537707029|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061036|NCT05623228|537707030|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061037|NCT05623228|537707031|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061038|NCT05623228|537707032|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061039|NCT05623228|537707033|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061040|NCT05623228|537707034|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061041|NCT05623228|537707035|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
149061042|NCT05623228|537707028|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
149061043|NCT05623228|537707029|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
149061044|NCT05623228|537707030|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
149061045|NCT05623228|537707031|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
149061046|NCT05623228|537707032|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
149061047|NCT05623228|537707033|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
149061048|NCT05623228|537707034|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
149061049|NCT05623228|537707035|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
149061050|NCT04737330|537707037|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
149061051|NCT04737330|537707038|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
149061052|NCT04737330|537707037|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
149061053|NCT04737330|537707038|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
149061054|NCT04737330|537707037|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
149061055|NCT04737330|537707038|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
149061056|NCT04737330|537707037|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
149061057|NCT04737330|537707038|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
149061058|NCT04737330|537707037|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
149061059|NCT04737330|537707038|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
149061060|NCT04737330|537707037|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
149061061|NCT04737330|537707038|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
149061062|NCT03056573|537707046|FG000|Overall Study|Death|2|||
149061063|NCT03056573|537707047|FG001|Overall Study|Death|4|||
149061064|NCT03056573|537707046|FG000|Overall Study|Withdrawal by Subject|2|||
149061065|NCT03056573|537707047|FG001|Overall Study|Withdrawal by Subject|0|||
149061066|NCT03056573|537707046|FG000|Overall Study|Lost to Follow-up|1|||
149061067|NCT03056573|537707047|FG001|Overall Study|Lost to Follow-up|1|||
149061068|NCT02823145|537707048|FG000|Enrollment|Other|1|||
149061069|NCT02823145|537707049|FG001|Enrollment|Other|0|||
149061070|NCT02823145|537707048|FG000|Treatment|Adverse Event|0|||
149061071|NCT02823145|537707049|FG001|Treatment|Adverse Event|11|||
149061072|NCT02823145|537707048|FG000|Treatment|Death|0|||
149061073|NCT02823145|537707049|FG001|Treatment|Death|3|||
149061074|NCT02823145|537707048|FG000|Treatment|Family Decision|0|||
149061075|NCT02823145|537707049|FG001|Treatment|Family Decision|1|||
149061076|NCT02823145|537707048|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
149061077|NCT02823145|537707049|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
149061078|NCT02823145|537707048|FG000|Treatment|Lack of Efficacy|0|||
149061079|NCT02823145|537707049|FG001|Treatment|Lack of Efficacy|48|||
149061080|NCT02823145|537707048|FG000|Treatment|Non-Compliance With E-Diary|0|||
149061081|NCT02823145|537707049|FG001|Treatment|Non-Compliance With E-Diary|1|||
149061082|NCT02823145|537707048|FG000|Treatment|Physician Decision|0|||
149061083|NCT02823145|537707049|FG001|Treatment|Physician Decision|2|||
149061084|NCT02823145|537707048|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
149061085|NCT02823145|537707049|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
149061086|NCT02823145|537707048|FG000|Treatment|Subject needed to take prohibited medication|0|||
149061087|NCT02823145|537707049|FG001|Treatment|Subject needed to take prohibited medication|1|||
149061088|NCT02823145|537707048|FG000|Treatment|Subject transferred to direct access programme|0|||
149061089|NCT02823145|537707049|FG001|Treatment|Subject transferred to direct access programme|1|||
149061090|NCT02823145|537707048|FG000|Treatment|Switching to commercially available drug|0|||
149061091|NCT02823145|537707049|FG001|Treatment|Switching to commercially available drug|11|||
149061092|NCT02823145|537707048|FG000|Treatment|Transitioned to commercial supply of medication|0|||
149061093|NCT02823145|537707049|FG001|Treatment|Transitioned to commercial supply of medication|1|||
149061094|NCT02823145|537707048|FG000|Treatment|Withdrawal By Caregiver|0|||
149061095|NCT02823145|537707049|FG001|Treatment|Withdrawal By Caregiver|1|||
149061096|NCT02823145|537707048|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
149061097|NCT02823145|537707049|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
149061098|NCT02823145|537707048|FG000|Treatment|Withdrawal by Subject|0|||
149061099|NCT02823145|537707049|FG001|Treatment|Withdrawal by Subject|16|||
149061100|NCT02823145|537707048|FG000|Treatment|Reason unknown|0|||
149061101|NCT02823145|537707049|FG001|Treatment|Reason unknown|1|||
149061102|NCT04741776|537707050|FG000|Overall Study|Withdrawal by Subject|7|||
149061103|NCT04741776|537707051|FG001|Overall Study|Withdrawal by Subject|10|||
149061104|NCT04741776|537707052|FG002|Overall Study|Withdrawal by Subject|10|||
149061105|NCT04741776|537707053|FG003|Overall Study|Withdrawal by Subject|17|||
149061106|NCT04741776|537707050|FG000|Overall Study|Death|0|||
149061107|NCT04741776|537707051|FG001|Overall Study|Death|0|||
149061108|NCT04741776|537707052|FG002|Overall Study|Death|1|||
149061109|NCT04741776|537707053|FG003|Overall Study|Death|0|||
149061110|NCT02852655|537707059|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
149061111|NCT02852655|537707060|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
149061112|NCT02852655|537707061|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
149061113|NCT02852655|537707059|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
149061114|NCT02852655|537707060|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
149061115|NCT02852655|537707061|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
149061116|NCT02852655|537707059|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
149061117|NCT02852655|537707060|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
149061118|NCT02852655|537707061|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
149061119|NCT02852655|537707059|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
149061120|NCT02852655|537707060|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
149061121|NCT02852655|537707061|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
149061122|NCT02852655|537707059|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
149061123|NCT02852655|537707060|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
149061124|NCT02852655|537707061|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
149061125|NCT02852655|537707059|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
149061126|NCT02852655|537707060|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
149061127|NCT02852655|537707061|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
149061128|NCT02852655|537707059|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
149061129|NCT02852655|537707060|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
149061130|NCT02852655|537707061|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
149061131|NCT02852655|537707059|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
149061132|NCT02852655|537707060|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
149061133|NCT02852655|537707061|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
149061134|NCT02852655|537707059|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
149061135|NCT02852655|537707060|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
149061136|NCT02852655|537707061|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
149061137|NCT00323856|537707062|FG000|Overall Study|Withdrawal by Subject|1|||
149061138|NCT00323856|537707062|FG000|Overall Study|Was uncooperative and noncompliant|1|||
149061139|NCT00323856|537707062|FG000|Overall Study|Reason not specified|1|||
149061140|NCT00323856|537707062|FG000|Overall Study|Missing|2|||
149061141|NCT04171141|537709066|FG000|Overall Study|Adverse Event|0|||
149061142|NCT04171141|537709067|FG001|Overall Study|Adverse Event|0|||
149061143|NCT04171141|537709068|FG002|Overall Study|Adverse Event|2|||
149061144|NCT04171141|537709069|FG003|Overall Study|Adverse Event|0|||
149061145|NCT04171141|537709070|FG004|Overall Study|Adverse Event|0|||
149061146|NCT04171141|537709071|FG005|Overall Study|Adverse Event|0|||
149061147|NCT04171141|537709072|FG006|Overall Study|Adverse Event|0|||
149061148|NCT04171141|537709073|FG007|Overall Study|Adverse Event|0|||
149061149|NCT04171141|537709074|FG008|Overall Study|Adverse Event|0|||
149061150|NCT04171141|537709075|FG009|Overall Study|Adverse Event|0|||
149061151|NCT04171141|537709076|FG010|Overall Study|Adverse Event|0|||
149061152|NCT04171141|537709077|FG011|Overall Study|Adverse Event|0|||
149061153|NCT04171141|537709078|FG012|Overall Study|Adverse Event|0|||
149061154|NCT04171141|537709079|FG013|Overall Study|Adverse Event|2|||
149061155|NCT04171141|537709080|FG014|Overall Study|Adverse Event|0|||
149061156|NCT04171141|537709081|FG015|Overall Study|Adverse Event|0|||
149061157|NCT04171141|537709066|FG000|Overall Study|Physician Decision|0|||
149061158|NCT04171141|537709067|FG001|Overall Study|Physician Decision|0|||
149061159|NCT04171141|537709068|FG002|Overall Study|Physician Decision|0|||
149061160|NCT04171141|537709069|FG003|Overall Study|Physician Decision|0|||
149061161|NCT04171141|537709070|FG004|Overall Study|Physician Decision|1|||
149061162|NCT04171141|537709071|FG005|Overall Study|Physician Decision|0|||
149061163|NCT04171141|537709072|FG006|Overall Study|Physician Decision|0|||
149061164|NCT04171141|537709073|FG007|Overall Study|Physician Decision|0|||
149061165|NCT04171141|537709074|FG008|Overall Study|Physician Decision|0|||
149061166|NCT04171141|537709075|FG009|Overall Study|Physician Decision|0|||
149061167|NCT04171141|537709076|FG010|Overall Study|Physician Decision|0|||
149061168|NCT04171141|537709077|FG011|Overall Study|Physician Decision|0|||
149061169|NCT04171141|537709078|FG012|Overall Study|Physician Decision|0|||
149061170|NCT04171141|537709079|FG013|Overall Study|Physician Decision|0|||
149061171|NCT04171141|537709080|FG014|Overall Study|Physician Decision|0|||
149061172|NCT04171141|537709081|FG015|Overall Study|Physician Decision|1|||
149061173|NCT04171141|537709066|FG000|Overall Study|Progressive disease|2|||
149061174|NCT04171141|537709067|FG001|Overall Study|Progressive disease|3|||
149061175|NCT04171141|537709068|FG002|Overall Study|Progressive disease|4|||
149061176|NCT04171141|537709069|FG003|Overall Study|Progressive disease|7|||
149061177|NCT04171141|537709070|FG004|Overall Study|Progressive disease|1|||
149061178|NCT04171141|537709071|FG005|Overall Study|Progressive disease|8|||
149061179|NCT04171141|537709072|FG006|Overall Study|Progressive disease|4|||
149061180|NCT04171141|537709073|FG007|Overall Study|Progressive disease|6|||
149061181|NCT04171141|537709074|FG008|Overall Study|Progressive disease|7|||
149061182|NCT04171141|537709075|FG009|Overall Study|Progressive disease|3|||
149061183|NCT04171141|537709076|FG010|Overall Study|Progressive disease|4|||
149061184|NCT04171141|537709077|FG011|Overall Study|Progressive disease|3|||
149061185|NCT04171141|537709078|FG012|Overall Study|Progressive disease|4|||
149061186|NCT04171141|537709079|FG013|Overall Study|Progressive disease|2|||
149061187|NCT04171141|537709080|FG014|Overall Study|Progressive disease|4|||
149061188|NCT04171141|537709081|FG015|Overall Study|Progressive disease|1|||
149061189|NCT04171141|537709066|FG000|Overall Study|Withdrawal by Subject|0|||
149061190|NCT04171141|537709067|FG001|Overall Study|Withdrawal by Subject|0|||
149061191|NCT04171141|537709068|FG002|Overall Study|Withdrawal by Subject|0|||
149061192|NCT04171141|537709069|FG003|Overall Study|Withdrawal by Subject|1|||
149061193|NCT04171141|537709070|FG004|Overall Study|Withdrawal by Subject|0|||
149061194|NCT04171141|537709071|FG005|Overall Study|Withdrawal by Subject|0|||
149061195|NCT04171141|537709072|FG006|Overall Study|Withdrawal by Subject|1|||
149061196|NCT04171141|537709073|FG007|Overall Study|Withdrawal by Subject|0|||
149061197|NCT04171141|537709074|FG008|Overall Study|Withdrawal by Subject|0|||
149061198|NCT04171141|537709075|FG009|Overall Study|Withdrawal by Subject|1|||
149061199|NCT04171141|537709076|FG010|Overall Study|Withdrawal by Subject|0|||
149061200|NCT04171141|537709077|FG011|Overall Study|Withdrawal by Subject|0|||
149061201|NCT04171141|537709078|FG012|Overall Study|Withdrawal by Subject|0|||
149061202|NCT04171141|537709079|FG013|Overall Study|Withdrawal by Subject|0|||
149061203|NCT04171141|537709080|FG014|Overall Study|Withdrawal by Subject|0|||
149061204|NCT04171141|537709081|FG015|Overall Study|Withdrawal by Subject|0|||
149061205|NCT04171141|537709066|FG000|Overall Study|Global deterioration of health status|0|||
149061206|NCT04171141|537709067|FG001|Overall Study|Global deterioration of health status|0|||
149061207|NCT04171141|537709068|FG002|Overall Study|Global deterioration of health status|0|||
149061208|NCT04171141|537709069|FG003|Overall Study|Global deterioration of health status|1|||
149061209|NCT04171141|537709070|FG004|Overall Study|Global deterioration of health status|0|||
149061210|NCT04171141|537709071|FG005|Overall Study|Global deterioration of health status|2|||
149061211|NCT04171141|537709072|FG006|Overall Study|Global deterioration of health status|1|||
149061212|NCT04171141|537709073|FG007|Overall Study|Global deterioration of health status|0|||
149061213|NCT04171141|537709074|FG008|Overall Study|Global deterioration of health status|1|||
149061214|NCT04171141|537709075|FG009|Overall Study|Global deterioration of health status|0|||
149061215|NCT04171141|537709076|FG010|Overall Study|Global deterioration of health status|0|||
149061216|NCT04171141|537709077|FG011|Overall Study|Global deterioration of health status|0|||
149061217|NCT04171141|537709078|FG012|Overall Study|Global deterioration of health status|0|||
149061218|NCT04171141|537709079|FG013|Overall Study|Global deterioration of health status|0|||
149061219|NCT04171141|537709080|FG014|Overall Study|Global deterioration of health status|1|||
149061220|NCT04171141|537709081|FG015|Overall Study|Global deterioration of health status|1|||
149061221|NCT03663569|537709084|FG000|Overall Study|Discontinuation of study|11|||
149061222|NCT03663569|537709084|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
149061223|NCT03663569|537709084|FG000|Overall Study|Deceased patient|6|||
149061224|NCT03663569|537709084|FG000|Overall Study|Lost to Follow-up|18|||
149061225|NCT03663569|537709084|FG000|Overall Study|Withdrawal of consent|5|||
149061226|NCT03663569|537709084|FG000|Overall Study|Patient's request|11|||
149061227|NCT03663569|537709084|FG000|Overall Study|Adverse Event|4|||
149061228|NCT03663569|537709084|FG000|Overall Study|Not come to second visit|3|||
149061229|NCT03663569|537709084|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
149061230|NCT03663569|537709084|FG000|Overall Study|Serious adverse event|1|||
149061231|NCT04979442|537709085|FG000|Overall Study|Death|43|||
149061232|NCT04979442|537709086|FG001|Overall Study|Death|30|||
149061233|NCT04979442|537709085|FG000|Overall Study|Withdrawal by Subject|8|||
149061234|NCT04979442|537709086|FG001|Overall Study|Withdrawal by Subject|13|||
149061235|NCT04979442|537709085|FG000|Overall Study|Physician Decision|1|||
149061236|NCT04979442|537709086|FG001|Overall Study|Physician Decision|1|||
149061237|NCT04979442|537709085|FG000|Overall Study|Lost to Follow-up|0|||
149061238|NCT04979442|537709086|FG001|Overall Study|Lost to Follow-up|2|||
149061239|NCT04979442|537709085|FG000|Overall Study|do not want to continue|0|||
149061240|NCT04979442|537709086|FG001|Overall Study|do not want to continue|1|||
149061241|NCT04005794|537709088|FG000|Overall Study|Lost to Follow-up|0|||
149061242|NCT04005794|537709089|FG001|Overall Study|Lost to Follow-up|4|||
149061243|NCT04005794|537709090|FG002|Overall Study|Lost to Follow-up|0|||
149061244|NCT00104676|537709094|FG000|Overall Study|Death|3|||
149061245|NCT00104676|537709095|FG001|Overall Study|Death|2|||
149061246|NCT00104676|537709094|FG000|Overall Study|Withdrawal by Subject|0|||
149061247|NCT00104676|537709095|FG001|Overall Study|Withdrawal by Subject|2|||
149061248|NCT00104676|537709094|FG000|Overall Study|treatment interruption|4|||
149061249|NCT00104676|537709095|FG001|Overall Study|treatment interruption|10|||
149061250|NCT05622812|537709096|FG000|Overall Study|Withdrawal by Subject|1|||
149061251|NCT05622812|537709097|FG001|Overall Study|Withdrawal by Subject|4|||
149061252|NCT05622812|537709096|FG000|Overall Study|Lost to Follow-up|2|||
149061253|NCT05622812|537709097|FG001|Overall Study|Lost to Follow-up|1|||
149061254|NCT03766685|537709098|FG000|Overall Study|Lost to Follow-up|1|||
149061255|NCT03766685|537709099|FG001|Overall Study|Lost to Follow-up|1|||
149061256|NCT03766685|537709100|FG002|Overall Study|Lost to Follow-up|0|||
149061257|NCT03766685|537709101|FG003|Overall Study|Lost to Follow-up|0|||
149061258|NCT03766685|537709098|FG000|Overall Study|Adverse Event, not fatal|0|||
149061259|NCT03766685|537709099|FG001|Overall Study|Adverse Event, not fatal|1|||
149061260|NCT03766685|537709100|FG002|Overall Study|Adverse Event, not fatal|0|||
149061261|NCT03766685|537709101|FG003|Overall Study|Adverse Event, not fatal|1|||
149061262|NCT03766685|537709098|FG000|Overall Study|Withdrawal by Subject|0|||
149061263|NCT03766685|537709099|FG001|Overall Study|Withdrawal by Subject|2|||
149061264|NCT03766685|537709100|FG002|Overall Study|Withdrawal by Subject|0|||
149061265|NCT03766685|537709101|FG003|Overall Study|Withdrawal by Subject|0|||
149061266|NCT03766685|537709098|FG000|Overall Study|Protocol Violation|0|||
149061267|NCT03766685|537709099|FG001|Overall Study|Protocol Violation|1|||
149061268|NCT03766685|537709100|FG002|Overall Study|Protocol Violation|0|||
149061269|NCT03766685|537709101|FG003|Overall Study|Protocol Violation|0|||
149061270|NCT03766685|537709098|FG000|Overall Study|Non-compliance|0|||
149061271|NCT03766685|537709099|FG001|Overall Study|Non-compliance|2|||
149061272|NCT03766685|537709100|FG002|Overall Study|Non-compliance|0|||
149061273|NCT03766685|537709101|FG003|Overall Study|Non-compliance|0|||
149061274|NCT02927236|537709104|FG000|Characterization Phase|Physician Decision|0|||
149061275|NCT02927236|537709105|FG001|Characterization Phase|Physician Decision|3|||
149061276|NCT02927236|537709106|FG002|Characterization Phase|Physician Decision|0|||
149061277|NCT02927236|537709107|FG003|Characterization Phase|Physician Decision|2|||
149061278|NCT02927236|537709104|FG000|Characterization Phase|Lost to Follow-up|0|||
149061279|NCT02927236|537709105|FG001|Characterization Phase|Lost to Follow-up|0|||
149061280|NCT02927236|537709106|FG002|Characterization Phase|Lost to Follow-up|0|||
149061281|NCT02927236|537709107|FG003|Characterization Phase|Lost to Follow-up|3|||
149061282|NCT02927236|537709104|FG000|Characterization Phase|Withdrawal by Subject|1|||
149061283|NCT02927236|537709105|FG001|Characterization Phase|Withdrawal by Subject|0|||
149061284|NCT02927236|537709106|FG002|Characterization Phase|Withdrawal by Subject|0|||
149061285|NCT02927236|537709107|FG003|Characterization Phase|Withdrawal by Subject|1|||
149061286|NCT02927236|537709104|FG000|Treatment Phase|Adverse Event|1|||
149061287|NCT02927236|537709105|FG001|Treatment Phase|Adverse Event|0|||
149061288|NCT02927236|537709106|FG002|Treatment Phase|Adverse Event|1|||
149061289|NCT02927236|537709107|FG003|Treatment Phase|Adverse Event|1|||
149061290|NCT02927236|537709104|FG000|Treatment Phase|Protocol Violation|3|||
149061291|NCT02927236|537709105|FG001|Treatment Phase|Protocol Violation|0|||
149061292|NCT02927236|537709106|FG002|Treatment Phase|Protocol Violation|0|||
149061293|NCT02927236|537709107|FG003|Treatment Phase|Protocol Violation|1|||
149061294|NCT02927236|537709104|FG000|Treatment Phase|Lost to Follow-up|1|||
149061295|NCT02927236|537709105|FG001|Treatment Phase|Lost to Follow-up|0|||
149061296|NCT02927236|537709106|FG002|Treatment Phase|Lost to Follow-up|0|||
149061297|NCT02927236|537709107|FG003|Treatment Phase|Lost to Follow-up|0|||
149061298|NCT02927236|537709104|FG000|Follow-up Phase|Lost to Follow-up|1|||
149061299|NCT02927236|537709105|FG001|Follow-up Phase|Lost to Follow-up|0|||
149061300|NCT02927236|537709106|FG002|Follow-up Phase|Lost to Follow-up|1|||
149061301|NCT02927236|537709107|FG003|Follow-up Phase|Lost to Follow-up|0|||
149061302|NCT05297565|537709108|FG000|Overall Study|Other Reasons|0|||
149061303|NCT05297565|537709109|FG001|Overall Study|Other Reasons|1|||
149061304|NCT05297565|537709108|FG000|Overall Study|Physician Decision|0|||
149061305|NCT05297565|537709109|FG001|Overall Study|Physician Decision|1|||
149061306|NCT05297565|537709108|FG000|Overall Study|Disease recurrence|1|||
149061307|NCT05297565|537709109|FG001|Overall Study|Disease recurrence|0|||
149061308|NCT06232590|537709113|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
149061309|NCT06232590|537709114|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
149061310|NCT02433379|537709115|FG000|Overall Study|Screen Failures|55|||
149061311|NCT02433379|537709115|FG000|Overall Study|Death|57|||
149061312|NCT02433379|537709115|FG000|Overall Study|Total Withdrawals|209|||
149061313|NCT03952338|537709116|FG000|Overall Study|Lost to Follow-up|11|||
149061314|NCT03952338|537709117|FG001|Overall Study|Lost to Follow-up|17|||
149061315|NCT03952338|537709116|FG000|Overall Study|Withdrawal by Subject|1|||
149061316|NCT03952338|537709117|FG001|Overall Study|Withdrawal by Subject|1|||
149061317|NCT03952338|537709116|FG000|Overall Study|Protocol Violation|1|||
149061318|NCT03952338|537709117|FG001|Overall Study|Protocol Violation|0|||
149061319|NCT00592852|537709118|FG000|Overall Study|Non-compliance|1|||
149061320|NCT00592852|537709118|FG000|Overall Study|Adverse Event|3|||
149061321|NCT00592852|537709118|FG000|Overall Study|Found ineligible|1|||
149061322|NCT00592852|537709118|FG000|Overall Study|Withdrawal by Subject|1|||
149061323|NCT04770402|537709133|FG000|Overall Study|Lost to Follow-up|1|||
149061324|NCT04770402|537709134|FG001|Overall Study|Lost to Follow-up|2|||
149061325|NCT04770402|537709133|FG000|Overall Study|Non-compliance|1|||
149061326|NCT04770402|537709134|FG001|Overall Study|Non-compliance|0|||
149061327|NCT04770402|537709133|FG000|Overall Study|Withdrawal by Subject|0|||
149061328|NCT04770402|537709134|FG001|Overall Study|Withdrawal by Subject|1|||
149061329|NCT02589795|537709135|FG000|Overall Study|Lost to Follow-up|1|||
149061330|NCT02589795|537709136|FG001|Overall Study|Lost to Follow-up|0|||
149061331|NCT02589795|537709137|FG002|Overall Study|Lost to Follow-up|0|||
149061332|NCT02589795|537709135|FG000|Overall Study|Withdrawal by Subject|0|||
149061333|NCT02589795|537709136|FG001|Overall Study|Withdrawal by Subject|0|||
149061334|NCT02589795|537709137|FG002|Overall Study|Withdrawal by Subject|2|||
149061335|NCT02589795|537709135|FG000|Overall Study|Protocol Violation|0|||
149061336|NCT02589795|537709136|FG001|Overall Study|Protocol Violation|0|||
149061337|NCT02589795|537709137|FG002|Overall Study|Protocol Violation|1|||
149061338|NCT04909801|537709140|FG000|Overall Study|Lack of Efficacy|2|||
149061339|NCT04909801|537709141|FG001|Overall Study|Lack of Efficacy|1|||
149061340|NCT04909801|537709140|FG000|Overall Study|Adverse Event|1|||
149061341|NCT04909801|537709141|FG001|Overall Study|Adverse Event|2|||
149061342|NCT04909801|537709140|FG000|Overall Study|Participant request to discontinue study treatment|1|||
149061343|NCT04909801|537709141|FG001|Overall Study|Participant request to discontinue study treatment|2|||
149061344|NCT04909801|537709140|FG000|Overall Study|Withdrawal by Subject|2|||
149061345|NCT04909801|537709141|FG001|Overall Study|Withdrawal by Subject|1|||
149061346|NCT04909801|537709140|FG000|Overall Study|other reasons|1|||
149061347|NCT04909801|537709141|FG001|Overall Study|other reasons|1|||
149061348|NCT05274074|537709142|FG000|Overall Study|Lost to Follow-up|2|||
149061349|NCT05274074|537709143|FG001|Overall Study|Lost to Follow-up|3|||
149061350|NCT05274074|537709142|FG000|Overall Study|Withdrawal by Subject|1|||
149061351|NCT05274074|537709143|FG001|Overall Study|Withdrawal by Subject|2|||
149061352|NCT04811040|537709144|FG000|Overall Study|Lost to Follow-up|2|||
149061353|NCT04811040|537709145|FG001|Overall Study|Lost to Follow-up|0|||
149061354|NCT04811040|537709146|FG002|Overall Study|Lost to Follow-up|0|||
149061355|NCT04811040|537709147|FG003|Overall Study|Lost to Follow-up|0|||
149061356|NCT04811040|537709144|FG000|Overall Study|Withdrew consent|1|||
149061357|NCT04811040|537709145|FG001|Overall Study|Withdrew consent|1|||
149061358|NCT04811040|537709146|FG002|Overall Study|Withdrew consent|0|||
149061359|NCT04811040|537709147|FG003|Overall Study|Withdrew consent|0|||
149061360|NCT03687086|537709148|FG000|Overall Study|Withdrawal by Subject|3|||
149061361|NCT03687086|537709149|FG001|Overall Study|Withdrawal by Subject|4|||
149061362|NCT03687086|537709148|FG000|Overall Study|Lost to Follow-up|1|||
149061363|NCT03687086|537709149|FG001|Overall Study|Lost to Follow-up|1|||
149061364|NCT03687086|537709148|FG000|Overall Study|Death|1|||
149061365|NCT03687086|537709149|FG001|Overall Study|Death|0|||
149061366|NCT03687086|537709148|FG000|Overall Study|Incomplete assessment|0|||
149061367|NCT03687086|537709149|FG001|Overall Study|Incomplete assessment|2|||
149061368|NCT02505984|537709150|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
149061369|NCT02505984|537709151|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
149061370|NCT02505984|537709150|FG000|Overall Study|Unreliable self-report data|1|||
149061371|NCT02505984|537709151|FG001|Overall Study|Unreliable self-report data|0|||
149061372|NCT02505984|537709150|FG000|Overall Study|Study blind opened during assessment|0|||
149061373|NCT02505984|537709151|FG001|Overall Study|Study blind opened during assessment|1|||
149061374|NCT02505984|537709150|FG000|Overall Study|Noncompliance with study protocol|0|||
149061375|NCT02505984|537709151|FG001|Overall Study|Noncompliance with study protocol|1|||
149061376|NCT01828099|537709156|FG000|Treatment Period|Adverse Event|24|||
149061377|NCT01828099|537709157|FG001|Treatment Period|Adverse Event|23|||
149061378|NCT01828099|537709156|FG000|Treatment Period|Death|10|||
149061379|NCT01828099|537709157|FG001|Treatment Period|Death|12|||
149061380|NCT01828099|537709156|FG000|Treatment Period|Lost to Follow-up|2|||
149061381|NCT01828099|537709157|FG001|Treatment Period|Lost to Follow-up|1|||
149061382|NCT01828099|537709156|FG000|Treatment Period|Non-compliance with study treatment|1|||
149061383|NCT01828099|537709157|FG001|Treatment Period|Non-compliance with study treatment|0|||
149061384|NCT01828099|537709156|FG000|Treatment Period|Physician Decision|17|||
149061385|NCT01828099|537709157|FG001|Treatment Period|Physician Decision|16|||
149061386|NCT01828099|537709156|FG000|Treatment Period|Progressive disease|99|||
149061387|NCT01828099|537709157|FG001|Treatment Period|Progressive disease|107|||
149061388|NCT01828099|537709156|FG000|Treatment Period|Subject/guardian decision|22|||
149061389|NCT01828099|537709157|FG001|Treatment Period|Subject/guardian decision|26|||
149061390|NCT01828099|537709156|FG000|Treatment Period|Study terminated by Sponsor|13|||
149061391|NCT01828099|537709157|FG001|Treatment Period|Study terminated by Sponsor|1|||
149005576|NCT00941798|537497930|FG001|Overall Study|Adverse Event|23|||
149005577|NCT00941798|537497929|FG000|Overall Study|Lost to Follow-up|29|||
149005578|NCT00941798|537497930|FG001|Overall Study|Lost to Follow-up|23|||
149005579|NCT00941798|537497929|FG000|Overall Study|Protocol Violation|17|||
149005580|NCT00941798|537497930|FG001|Overall Study|Protocol Violation|20|||
149005581|NCT00941798|537497929|FG000|Overall Study|Administrative problems|13|||
149005582|NCT00941798|537497930|FG001|Overall Study|Administrative problems|23|||
149005583|NCT00941798|537497929|FG000|Overall Study|Lack of Efficacy|10|||
149005584|NCT00941798|537497930|FG001|Overall Study|Lack of Efficacy|17|||
149005585|NCT00941798|537497929|FG000|Overall Study|Patient's inability to use device|6|||
149005586|NCT00941798|537497930|FG001|Overall Study|Patient's inability to use device|1|||
149005587|NCT00941798|537497929|FG000|Overall Study|Abnormal test procedure results|3|||
149005588|NCT00941798|537497930|FG001|Overall Study|Abnormal test procedure results|1|||
149005589|NCT00941798|537497929|FG000|Overall Study|Abnormal laboratory values|1|||
149005590|NCT00941798|537497930|FG001|Overall Study|Abnormal laboratory values|2|||
149005591|NCT00941798|537497929|FG000|Overall Study|Death|0|||
149005592|NCT00941798|537497930|FG001|Overall Study|Death|1|||
149005593|NCT01489189|537497931|FG000|Overall Study|Withdrawal by Subject|20|||
149005594|NCT01489189|537497932|FG001|Overall Study|Withdrawal by Subject|23|||
149005595|NCT01489189|537497931|FG000|Overall Study|Death|10|||
149005596|NCT01489189|537497932|FG001|Overall Study|Death|8|||
149005597|NCT01489189|537497931|FG000|Overall Study|Missed Visit|1|||
149005598|NCT01489189|537497932|FG001|Overall Study|Missed Visit|4|||
149005599|NCT00112580|537497933|FG000|Overall Study|Adverse Event|1|||
149005600|NCT00112580|537497934|FG001|Overall Study|Adverse Event|2|||
149005601|NCT00112580|537497933|FG000|Overall Study|Disease progression|5|||
149005602|NCT00112580|537497934|FG001|Overall Study|Disease progression|16|||
149005603|NCT00112580|537497933|FG000|Overall Study|Participant withdrew consent|2|||
149005604|NCT00112580|537497934|FG001|Overall Study|Participant withdrew consent|1|||
149005605|NCT05597722|537497937|FG000|Overall Study|Study was terminated|6|||
149005606|NCT05597722|537497938|FG001|Overall Study|Study was terminated|1|||
149005607|NCT00404495|537497939|FG000|Overall Study|Death|37|||
149005608|NCT00404495|537497940|FG001|Overall Study|Death|11|||
149005609|NCT00404495|537497939|FG000|Overall Study|Lost to Follow-up|5|||
149005610|NCT00404495|537497940|FG001|Overall Study|Lost to Follow-up|0|||
149005611|NCT00404495|537497939|FG000|Overall Study|Other|1|||
149005612|NCT00404495|537497940|FG001|Overall Study|Other|0|||
149005613|NCT00404495|537497939|FG000|Overall Study|Withdrawal by Subject|1|||
149005614|NCT00404495|537497940|FG001|Overall Study|Withdrawal by Subject|0|||
149005615|NCT04108000|537497941|FG000|Overall Study|Death of patient|1|||
149005616|NCT04108000|537497942|FG001|Overall Study|Death of patient|0|||
149005617|NCT04108000|537497943|FG002|Overall Study|Death of patient|1|||
149005618|NCT04108000|537497944|FG003|Overall Study|Death of patient|0|||
149005619|NCT04108000|537497941|FG000|Overall Study|Withdrawal by Subject|2|||
149005620|NCT04108000|537497942|FG001|Overall Study|Withdrawal by Subject|2|||
149005621|NCT04108000|537497943|FG002|Overall Study|Withdrawal by Subject|0|||
149005622|NCT04108000|537497944|FG003|Overall Study|Withdrawal by Subject|0|||
149005623|NCT04108000|537497941|FG000|Overall Study|Death of surrogate partner|0|||
149005624|NCT04108000|537497942|FG001|Overall Study|Death of surrogate partner|1|||
149005625|NCT04108000|537497943|FG002|Overall Study|Death of surrogate partner|0|||
149005626|NCT04108000|537497944|FG003|Overall Study|Death of surrogate partner|1|||
149005627|NCT03904043|537497947|FG000|Overall Study|Adverse Event|1|||
149005628|NCT03904043|537497948|FG001|Overall Study|Adverse Event|1|||
149005629|NCT03904043|537497947|FG000|Overall Study|Withdrawal by Subject|1|||
149005630|NCT03904043|537497948|FG001|Overall Study|Withdrawal by Subject|0|||
149005631|NCT03904043|537497947|FG000|Overall Study|Non-compliance|1|||
149005632|NCT03904043|537497948|FG001|Overall Study|Non-compliance|0|||
149005633|NCT03904043|537497947|FG000|Overall Study|Did not start treatment|1|||
149005634|NCT03904043|537497948|FG001|Overall Study|Did not start treatment|0|||
149005635|NCT05559866|537497949|FG000|Overall Study|Withdrawal by Subject|1|||
149005636|NCT05559866|537497950|FG001|Overall Study|Withdrawal by Subject|0|||
149005637|NCT03750006|537497951|FG000|Overall Study|Withdrawal by Subject|8|||
149005638|NCT03750006|537497951|FG000|Overall Study|COVID PANDEMIC|11|||
149005639|NCT05619003|537497952|FG000|Overall Study|Adverse Event|1|||
149005640|NCT03538951|537497953|FG000|Overall Study|Withdrawal by Subject|1|||
149005641|NCT03538951|537497954|FG001|Overall Study|Withdrawal by Subject|2|||
149005642|NCT07018999|537497960|FG000|Overall Study|Protocol Violation|0|||
149005643|NCT07018999|537497961|FG001|Overall Study|Protocol Violation|1|||
149005644|NCT07018999|537497960|FG000|Overall Study|Incomplete data entry|4|||
149005645|NCT07018999|537497961|FG001|Overall Study|Incomplete data entry|7|||
149005646|NCT03444376|537497962|FG000|Part A|Disease relapse or Progression|1|||
149005647|NCT03444376|537497962|FG000|Part A|Withdrawal by Subject|2|||
149005648|NCT03444376|537497962|FG000|Part A|Adverse Event|1|||
149005649|NCT03444376|537497962|FG000|Part B|Disease relapse or Progression|18|||
149005650|NCT03444376|537497962|FG000|Part B|Withdrawal by Subject|2|||
149005651|NCT03444376|537497962|FG000|Part B|Adverse Event|2|||
149061392|NCT01828099|537709156|FG000|Treatment Period|Protocol deviation|1|||
149061393|NCT01828099|537709157|FG001|Treatment Period|Protocol deviation|0|||
149061394|NCT01828099|537709156|FG000|Treatment Period|No longer requires treatment|0|||
149061395|NCT01828099|537709157|FG001|Treatment Period|No longer requires treatment|1|||
149061396|NCT01828099|537709156|FG000|Extension-treatment Phase|Adverse Event|0|||
149061397|NCT01828099|537709157|FG001|Extension-treatment Phase|Adverse Event|17|||
149061398|NCT01828099|537709156|FG000|Extension-treatment Phase|Death|0|||
149061399|NCT01828099|537709157|FG001|Extension-treatment Phase|Death|11|||
149061400|NCT01828099|537709156|FG000|Extension-treatment Phase|Physician Decision|0|||
149061401|NCT01828099|537709157|FG001|Extension-treatment Phase|Physician Decision|5|||
149061402|NCT01828099|537709156|FG000|Extension-treatment Phase|Progressive disease|0|||
149061403|NCT01828099|537709157|FG001|Extension-treatment Phase|Progressive disease|54|||
149061404|NCT01828099|537709156|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
149061405|NCT01828099|537709157|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
149061406|NCT01828099|537709156|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
149061407|NCT01828099|537709157|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
149061408|NCT05645757|537709159|FG000|Overall Study|Enrolled but treatment not administered|0|||
149061409|NCT05645757|537709160|FG001|Overall Study|Enrolled but treatment not administered|0|||
149061410|NCT05645757|537709161|FG002|Overall Study|Enrolled but treatment not administered|0|||
149061411|NCT05645757|537709162|FG003|Overall Study|Enrolled but treatment not administered|0|||
149061412|NCT05645757|537709163|FG004|Overall Study|Enrolled but treatment not administered|1|||
149061413|NCT05645757|537709164|FG005|Overall Study|Enrolled but treatment not administered|1|||
149061414|NCT05645757|537709165|FG006|Overall Study|Enrolled but treatment not administered|0|||
149061415|NCT05645757|537709166|FG007|Overall Study|Enrolled but treatment not administered|0|||
149061416|NCT03924635|537709167|FG000|Overall Study|Withdrawal by Subject|2|||
149061417|NCT03924635|537709168|FG001|Overall Study|Withdrawal by Subject|4|||
149061418|NCT04362254|537709169|FG000|Overall Study|Adverse Event|1|||
149061419|NCT04362254|537709169|FG000|Overall Study|Protocol Violation|1|||
149061420|NCT04362254|537709169|FG000|Overall Study|Due to early termination of the trial|10|||
149061421|NCT00321048|537709170|FG000|Overall Study|Withdrawal by Subject|6|||
149061422|NCT00321048|537709171|FG001|Overall Study|Withdrawal by Subject|8|||
149061423|NCT04299464|537709172|FG000|Overall Study|Adverse Event|1|||
149061424|NCT04299464|537709173|FG001|Overall Study|Adverse Event|0|||
149061425|NCT04299464|537709174|FG002|Overall Study|Adverse Event|2|||
149061426|NCT04299464|537709172|FG000|Overall Study|Non-compliance with Study Drug|1|||
149061427|NCT04299464|537709173|FG001|Overall Study|Non-compliance with Study Drug|0|||
149061428|NCT04299464|537709174|FG002|Overall Study|Non-compliance with Study Drug|0|||
149061429|NCT04299464|537709172|FG000|Overall Study|Reason not Specified|0|||
149061430|NCT04299464|537709173|FG001|Overall Study|Reason not Specified|1|||
149061431|NCT04299464|537709174|FG002|Overall Study|Reason not Specified|3|||
149061432|NCT04299464|537709172|FG000|Overall Study|Physician Decision|0|||
149061433|NCT04299464|537709173|FG001|Overall Study|Physician Decision|1|||
149061434|NCT04299464|537709174|FG002|Overall Study|Physician Decision|1|||
149061435|NCT04299464|537709172|FG000|Overall Study|Withdrawal by Subject|0|||
149061436|NCT04299464|537709173|FG001|Overall Study|Withdrawal by Subject|2|||
149061437|NCT04299464|537709174|FG002|Overall Study|Withdrawal by Subject|1|||
149061438|NCT04971109|537709175|FG000|Overall Study|Adverse Event|4|||
149061439|NCT04971109|537709176|FG001|Overall Study|Adverse Event|3|||
149061440|NCT04971109|537709175|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
149061441|NCT04971109|537709176|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
149061442|NCT04971109|537709175|FG000|Overall Study|Lost to Follow-up|8|||
149061443|NCT04971109|537709176|FG001|Overall Study|Lost to Follow-up|2|||
149061444|NCT04971109|537709175|FG000|Overall Study|Physician Decision|5|||
149061445|NCT04971109|537709176|FG001|Overall Study|Physician Decision|0|||
149061446|NCT04971109|537709175|FG000|Overall Study|Protocol Violation|0|||
149061447|NCT04971109|537709176|FG001|Overall Study|Protocol Violation|1|||
149061448|NCT04971109|537709175|FG000|Overall Study|Withdrawal by Subject|18|||
149061449|NCT04971109|537709176|FG001|Overall Study|Withdrawal by Subject|3|||
149061450|NCT04971109|537709175|FG000|Overall Study|Subject was randomized in error|1|||
149061451|NCT04971109|537709176|FG001|Overall Study|Subject was randomized in error|0|||
149061452|NCT03672916|537709177|FG000|Overall Study|Death|6|||
149061453|NCT03672916|537709177|FG000|Overall Study|Lost to Follow-up|29|||
149061454|NCT03672916|537709177|FG000|Overall Study|Adverse Event|6|||
149061455|NCT03672916|537709177|FG000|Overall Study|Withdrawal by Subject|11|||
149061462|NCT03571581|537709181|FG000|Overall Study|Death|2|||
149061463|NCT03571581|537709181|FG000|Overall Study|Withdrawal by Subject|2|||
149061464|NCT01651403|537709182|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
149061465|NCT01651403|537709183|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
149005652|NCT03444376|537497962|FG000|Part B|Physician Decision|1|||
149005653|NCT03444376|537497962|FG000|Part C|Disease relapse or Progression|43|||
149005654|NCT03444376|537497962|FG000|Part C|Withdrawal by Subject|5|||
149005655|NCT03444376|537497962|FG000|Part C|Adverse Event|2|||
149005656|NCT03444376|537497962|FG000|Part C|Physician Decision|2|||
149005657|NCT03444376|537497962|FG000|Part C|Death|1|||
149005658|NCT00856167|537497964|FG000|Period 1|Withdrawal by Subject|1|||
149005659|NCT00856167|537497965|FG001|Period 1|Withdrawal by Subject|4|||
149005660|NCT00856167|537497966|FG002|Period 1|Withdrawal by Subject|0|||
149005661|NCT00856167|537497967|FG003|Period 1|Withdrawal by Subject|0|||
149005662|NCT00856167|537497964|FG000|Period 1|Lost to Follow-up|2|||
149005663|NCT00856167|537497965|FG001|Period 1|Lost to Follow-up|1|||
149005664|NCT00856167|537497966|FG002|Period 1|Lost to Follow-up|0|||
149005665|NCT00856167|537497967|FG003|Period 1|Lost to Follow-up|0|||
149005666|NCT00856167|537497964|FG000|Period 2|Lost to Follow-up|0|||
149005667|NCT00856167|537497965|FG001|Period 2|Lost to Follow-up|0|||
149005668|NCT00856167|537497966|FG002|Period 2|Lost to Follow-up|3|||
149005669|NCT00856167|537497967|FG003|Period 2|Lost to Follow-up|1|||
149005670|NCT00856167|537497964|FG000|Period 2|Withdrawal by Subject|0|||
149005671|NCT00856167|537497965|FG001|Period 2|Withdrawal by Subject|0|||
149005672|NCT00856167|537497966|FG002|Period 2|Withdrawal by Subject|2|||
149005673|NCT00856167|537497967|FG003|Period 2|Withdrawal by Subject|4|||
149005674|NCT04207840|537499630|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
149005675|NCT04207840|537499631|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
149005676|NCT04207840|537499632|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
149005677|NCT04207840|537499630|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
149005678|NCT04207840|537499631|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
149005679|NCT04207840|537499632|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
149005680|NCT03243422|537499633|FG000|Overall Study|Death|20|||
149005681|NCT03243422|537499634|FG001|Overall Study|Death|21|||
149005682|NCT03243422|537499633|FG000|Overall Study|Lost to Follow-up|9|||
149005683|NCT03243422|537499634|FG001|Overall Study|Lost to Follow-up|21|||
149005684|NCT03243422|537499633|FG000|Overall Study|Withdrawal by Subject|22|||
149005685|NCT03243422|537499634|FG001|Overall Study|Withdrawal by Subject|8|||
149005686|NCT02173054|537499635|FG000|Overall Study|lack of compliance|1|||
149005687|NCT02173054|537499636|FG001|Overall Study|lack of compliance|0|||
149005688|NCT02173054|537499637|FG002|Overall Study|lack of compliance|0|||
149005689|NCT02173054|537499635|FG000|Overall Study|Withdrawal by Subject|0|||
149005690|NCT02173054|537499636|FG001|Overall Study|Withdrawal by Subject|0|||
149005691|NCT02173054|537499637|FG002|Overall Study|Withdrawal by Subject|1|||
149005692|NCT03505476|537499640|FG000|Overall Study|Physician Decision|18|||
149005693|NCT03505476|537499640|FG000|Overall Study|Device Malfunctioned|101|||
149005694|NCT03505476|537499640|FG000|Overall Study|Data Corrupt|6|||
149005695|NCT03505476|537499640|FG000|Overall Study|Device application insufficiant|3|||
149005696|NCT02748694|537499641|FG000|Overall Study|Voluntary Withdrawal|0|||
149005697|NCT02748694|537499642|FG001|Overall Study|Voluntary Withdrawal|0|||
149005698|NCT02748694|537499643|FG002|Overall Study|Voluntary Withdrawal|0|||
149005699|NCT02748694|537499644|FG003|Overall Study|Voluntary Withdrawal|0|||
149005700|NCT02748694|537499645|FG004|Overall Study|Voluntary Withdrawal|0|||
149005701|NCT02748694|537499646|FG005|Overall Study|Voluntary Withdrawal|0|||
149005702|NCT02748694|537499647|FG006|Overall Study|Voluntary Withdrawal|0|||
149005703|NCT02748694|537499648|FG007|Overall Study|Voluntary Withdrawal|0|||
149005704|NCT02748694|537499649|FG008|Overall Study|Voluntary Withdrawal|0|||
149005705|NCT02748694|537499650|FG009|Overall Study|Voluntary Withdrawal|0|||
149005706|NCT02748694|537499651|FG010|Overall Study|Voluntary Withdrawal|0|||
149005707|NCT02748694|537499652|FG011|Overall Study|Voluntary Withdrawal|0|||
149005708|NCT02748694|537499653|FG012|Overall Study|Voluntary Withdrawal|0|||
149005709|NCT02748694|537499654|FG013|Overall Study|Voluntary Withdrawal|0|||
149005710|NCT02748694|537499655|FG014|Overall Study|Voluntary Withdrawal|2|||
149005711|NCT00659984|537499658|FG000|Overall Study|Adverse Event|1|||
149005712|NCT04026165|537499661|FG000|Run-in Placebo Period|Enrollment Error|13|||
149005713|NCT04026165|537499662|FG001|Run-in Placebo Period|Enrollment Error|0|||
149005714|NCT04026165|537499663|FG002|Run-in Placebo Period|Enrollment Error|0|||
149005715|NCT04026165|537499664|FG003|Run-in Placebo Period|Enrollment Error|0|||
149005716|NCT04026165|537499661|FG000|Run-in Placebo Period|Run-in Failure|4|||
149005717|NCT04026165|537499662|FG001|Run-in Placebo Period|Run-in Failure|0|||
149005718|NCT04026165|537499663|FG002|Run-in Placebo Period|Run-in Failure|0|||
149005719|NCT04026165|537499664|FG003|Run-in Placebo Period|Run-in Failure|0|||
149005720|NCT04026165|537499661|FG000|Run-in Placebo Period|Protocol Violation|2|||
149005721|NCT04026165|537499662|FG001|Run-in Placebo Period|Protocol Violation|0|||
149005722|NCT04026165|537499663|FG002|Run-in Placebo Period|Protocol Violation|0|||
149005723|NCT04026165|537499664|FG003|Run-in Placebo Period|Protocol Violation|0|||
149005724|NCT04026165|537499661|FG000|Run-in Placebo Period|Withdrew Consent|2|||
149005725|NCT04026165|537499662|FG001|Run-in Placebo Period|Withdrew Consent|0|||
149005726|NCT04026165|537499663|FG002|Run-in Placebo Period|Withdrew Consent|0|||
149061466|NCT01651403|537709182|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
149061467|NCT01651403|537709183|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
149061468|NCT01651403|537709182|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
149061469|NCT01651403|537709183|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
149061470|NCT01651403|537709182|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
149061471|NCT01651403|537709183|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
149061472|NCT01651403|537709182|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
149061473|NCT01651403|537709183|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
149061474|NCT01651403|537709182|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
149061475|NCT01651403|537709183|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
149061476|NCT05090683|537709184|FG000|Overall Study|Lost to Follow-up|10|||
149061477|NCT05090683|537709185|FG001|Overall Study|Lost to Follow-up|2|||
149061478|NCT05090683|537709184|FG000|Overall Study|Withdrawal by Subject|15|||
149061479|NCT05090683|537709185|FG001|Overall Study|Withdrawal by Subject|0|||
149061480|NCT04032847|537709186|FG000|Overall Study|Study termination by sponsor|8|||
149061481|NCT04032847|537709187|FG001|Overall Study|Study termination by sponsor|0|||
149061482|NCT04032847|537709188|FG002|Overall Study|Study termination by sponsor|4|||
149061483|NCT04032847|537709186|FG000|Overall Study|Death|12|||
149061484|NCT04032847|537709187|FG001|Overall Study|Death|0|||
149061485|NCT04032847|537709188|FG002|Overall Study|Death|0|||
149061486|NCT04032847|537709186|FG000|Overall Study|Progressive disease|2|||
149061487|NCT04032847|537709187|FG001|Overall Study|Progressive disease|0|||
149061488|NCT04032847|537709188|FG002|Overall Study|Progressive disease|1|||
149061489|NCT03325985|537709189|FG000|Overall Study|Lost to Follow-up|122|||
149061490|NCT03325985|537709190|FG001|Overall Study|Lost to Follow-up|26|||
149061491|NCT03325985|537709191|FG002|Overall Study|Lost to Follow-up|141|||
149061492|NCT03325985|537709192|FG003|Overall Study|Lost to Follow-up|28|||
149061493|NCT03325985|537709189|FG000|Overall Study|Death|99|||
149061494|NCT03325985|537709190|FG001|Overall Study|Death|36|||
149061495|NCT03325985|537709191|FG002|Overall Study|Death|94|||
149061496|NCT03325985|537709192|FG003|Overall Study|Death|32|||
149061497|NCT03213665|537709193|FG000|Overall Study|Adverse Event|1|||
149061498|NCT03213665|537709193|FG000|Overall Study|Physician Decision|2|||
149061499|NCT03213665|537709193|FG000|Overall Study|Withdrawal by Subject|3|||
149061500|NCT03213665|537709193|FG000|Overall Study|Progressive Disease|13|||
149061501|NCT04428203|537709194|FG000|Overall Study|Adverse Event|1|||
149061502|NCT04428203|537709195|FG001|Overall Study|Adverse Event|0|||
149061503|NCT04428203|537709196|FG002|Overall Study|Adverse Event|0|||
149061504|NCT04428203|537709194|FG000|Overall Study|Withdrawal by Subject|1|||
149061505|NCT04428203|537709195|FG001|Overall Study|Withdrawal by Subject|0|||
149061506|NCT04428203|537709196|FG002|Overall Study|Withdrawal by Subject|1|||
149061507|NCT02361216|537709197|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
149061508|NCT02361216|537709198|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
149061509|NCT02361216|537709197|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
149061510|NCT02361216|537709198|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
149061511|NCT02361216|537709197|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
149061512|NCT02361216|537709198|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
149061513|NCT02361216|537709197|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
149061514|NCT02361216|537709198|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
149061515|NCT02361216|537709197|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
149061516|NCT02361216|537709198|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
149061517|NCT02361216|537709197|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
149061518|NCT02361216|537709198|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
149061519|NCT04086121|537709209|FG000|Overall Study|Other than listed|8|||
149061520|NCT04086121|537709209|FG000|Overall Study|Withdrawal by Subject|3|||
149061521|NCT04086121|537709209|FG000|Overall Study|Lost to Follow-up|2|||
149061522|NCT04086121|537709209|FG000|Overall Study|Adverse Event|1|||
149061523|NCT05309291|537709214|FG000|Overall Study|Adverse Event|0|||
149061524|NCT05309291|537709215|FG001|Overall Study|Adverse Event|1|||
149061525|NCT05209152|537709216|FG000|Overall Study|Sponsor decision|1|||
149061526|NCT05209152|537709217|FG001|Overall Study|Sponsor decision|2|||
149061527|NCT05209152|537709216|FG000|Overall Study|Death|3|||
149061528|NCT05209152|537709217|FG001|Overall Study|Death|1|||
149061529|NCT05292391|537709220|FG000|Overall Study|Lost to Follow-up|0|||
149061530|NCT05292391|537709221|FG001|Overall Study|Lost to Follow-up|0|||
149061531|NCT05292391|537709222|FG002|Overall Study|Lost to Follow-up|0|||
149061532|NCT05292391|537709223|FG003|Overall Study|Lost to Follow-up|1|||
149061533|NCT05292391|537709224|FG004|Overall Study|Lost to Follow-up|0|||
149061534|NCT04857723|537709228|FG000|Overall Study|Withdrawal by Subject|2|||
149061535|NCT03221426|537709229|FG000|Overall Study|Ongoing in study|212|||
149061536|NCT03221426|537709230|FG001|Overall Study|Ongoing in study|193|||
149061537|NCT03221426|537709231|FG002|Overall Study|Ongoing in study|61|||
149061538|NCT03221426|537709232|FG003|Overall Study|Ongoing in study|55|||
149061539|NCT03221426|537709229|FG000|Overall Study|Withdrawal by Subject|12|||
149061540|NCT03221426|537709230|FG001|Overall Study|Withdrawal by Subject|4|||
149061541|NCT03221426|537709231|FG002|Overall Study|Withdrawal by Subject|2|||
149061542|NCT03221426|537709232|FG003|Overall Study|Withdrawal by Subject|3|||
149061543|NCT03221426|537709229|FG000|Overall Study|Lost to Follow-up|4|||
149061544|NCT03221426|537709230|FG001|Overall Study|Lost to Follow-up|1|||
149061545|NCT03221426|537709231|FG002|Overall Study|Lost to Follow-up|1|||
149061546|NCT03221426|537709232|FG003|Overall Study|Lost to Follow-up|0|||
149061547|NCT03221426|537709229|FG000|Overall Study|Death|174|||
149061548|NCT03221426|537709230|FG001|Overall Study|Death|204|||
149061549|NCT03221426|537709231|FG002|Overall Study|Death|36|||
149061550|NCT03221426|537709232|FG003|Overall Study|Death|45|||
149061551|NCT02844465|537710942|FG000|Overall Study|Screen Failure|36|||
149061552|NCT02844465|537710942|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
149061553|NCT02844465|537710942|FG000|Overall Study|Withdrawal by Subject|5|||
149061554|NCT02844465|537710942|FG000|Overall Study|Lost to Follow-up|1|||
149061555|NCT02844465|537710942|FG000|Overall Study|Retreatment|1|||
149061556|NCT05029622|537710946|FG000|Overall Study|Lost to Follow-up|1|||
149061557|NCT05671653|537710947|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
149061558|NCT05671653|537710948|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
149061559|NCT05671653|537710949|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
149061560|NCT05671653|537710950|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
149061561|NCT05671653|537710951|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
149061562|NCT05671653|537710952|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
149061563|NCT05671653|537710953|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
149061564|NCT05671653|537710954|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
149061565|NCT05671653|537710955|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
149061566|NCT05671653|537710956|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
149061567|NCT05671653|537710957|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
149061568|NCT05671653|537710958|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
149061569|NCT05671653|537710959|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
149061570|NCT05671653|537710947|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061571|NCT05671653|537710948|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061572|NCT05671653|537710949|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061573|NCT05671653|537710950|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061574|NCT05671653|537710951|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061575|NCT05671653|537710952|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
149061576|NCT05671653|537710953|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061577|NCT05671653|537710954|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061578|NCT05671653|537710955|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061579|NCT05671653|537710956|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061580|NCT05671653|537710957|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061581|NCT05671653|537710958|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
148890276|NCT03649217|537077189|FG000|Overall Study|subject had severe ataxia not initially found|1|||
148890277|NCT03649217|537077189|FG000|Overall Study|subject had cognitive issues not initially found|1|||
148890278|NCT02552966|537077190|FG000|Overall Study|Lost to Follow-up|2|||
148890279|NCT02552966|537077190|FG000|Overall Study|Withdrawal by Subject|3|||
148890280|NCT00721396|537077192|FG000|Overall Study|Adverse Event|4|||
148890281|NCT00721396|537077193|FG001|Overall Study|Adverse Event|7|||
148890282|NCT00721396|537077194|FG002|Overall Study|Adverse Event|2|||
148890283|NCT00721396|537077195|FG003|Overall Study|Adverse Event|0|||
148890284|NCT00721396|537077192|FG000|Overall Study|Withdrawal by Subject|12|||
148890285|NCT00721396|537077193|FG001|Overall Study|Withdrawal by Subject|15|||
148890286|NCT00721396|537077194|FG002|Overall Study|Withdrawal by Subject|3|||
148890287|NCT00721396|537077195|FG003|Overall Study|Withdrawal by Subject|7|||
148890288|NCT00721396|537077192|FG000|Overall Study|Lost to Follow-up|7|||
148890289|NCT00721396|537077193|FG001|Overall Study|Lost to Follow-up|9|||
148890290|NCT00721396|537077194|FG002|Overall Study|Lost to Follow-up|3|||
148890291|NCT00721396|537077195|FG003|Overall Study|Lost to Follow-up|3|||
148890292|NCT00721396|537077192|FG000|Overall Study|Protocol Violation|4|||
148890293|NCT00721396|537077193|FG001|Overall Study|Protocol Violation|3|||
148890294|NCT00721396|537077194|FG002|Overall Study|Protocol Violation|1|||
148890295|NCT00721396|537077195|FG003|Overall Study|Protocol Violation|0|||
148890296|NCT00721396|537077192|FG000|Overall Study|Inappropriate enrollment|0|||
148890297|NCT00721396|537077193|FG001|Overall Study|Inappropriate enrollment|2|||
148890298|NCT00721396|537077194|FG002|Overall Study|Inappropriate enrollment|0|||
148890299|NCT00721396|537077195|FG003|Overall Study|Inappropriate enrollment|0|||
148890300|NCT00721396|537077192|FG000|Overall Study|Administrative reason|3|||
148890301|NCT00721396|537077193|FG001|Overall Study|Administrative reason|0|||
149061582|NCT05671653|537710959|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
149061583|NCT05671653|537710947|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061584|NCT05671653|537710948|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061585|NCT05671653|537710949|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061586|NCT05671653|537710950|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061587|NCT05671653|537710951|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149119800|NCT00006011|537917970|FG001|Overall Study|Other|2|||
149061588|NCT05671653|537710952|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
149061589|NCT05671653|537710953|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061590|NCT05671653|537710954|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061591|NCT05671653|537710955|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061592|NCT05671653|537710956|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061593|NCT05671653|537710957|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061594|NCT05671653|537710958|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061595|NCT05671653|537710959|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
149061596|NCT05671653|537710947|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061597|NCT05671653|537710948|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061598|NCT05671653|537710949|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061599|NCT05671653|537710950|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061600|NCT05671653|537710951|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061601|NCT05671653|537710952|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061602|NCT05671653|537710953|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061603|NCT05671653|537710954|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061604|NCT05671653|537710955|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
149061605|NCT05671653|537710956|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061606|NCT05671653|537710957|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061607|NCT05671653|537710958|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061608|NCT05671653|537710959|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
149061609|NCT05671653|537710947|FG000|Cohort 2 Period 2|Adverse Event|0|||
149061610|NCT05671653|537710948|FG001|Cohort 2 Period 2|Adverse Event|0|||
149061611|NCT05671653|537710949|FG002|Cohort 2 Period 2|Adverse Event|0|||
149061612|NCT05671653|537710950|FG003|Cohort 2 Period 2|Adverse Event|0|||
149061613|NCT05671653|537710951|FG004|Cohort 2 Period 2|Adverse Event|0|||
149061614|NCT05671653|537710952|FG005|Cohort 2 Period 2|Adverse Event|0|||
149061615|NCT05671653|537710953|FG006|Cohort 2 Period 2|Adverse Event|0|||
149061616|NCT05671653|537710954|FG007|Cohort 2 Period 2|Adverse Event|0|||
149061617|NCT05671653|537710955|FG008|Cohort 2 Period 2|Adverse Event|0|||
149061618|NCT05671653|537710956|FG009|Cohort 2 Period 2|Adverse Event|0|||
149061619|NCT05671653|537710957|FG010|Cohort 2 Period 2|Adverse Event|1|||
149061620|NCT05671653|537710958|FG011|Cohort 2 Period 2|Adverse Event|0|||
149061621|NCT05671653|537710959|FG012|Cohort 2 Period 2|Adverse Event|0|||
149061622|NCT05671653|537710947|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
149061623|NCT05671653|537710948|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
149061624|NCT05671653|537710949|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
149061625|NCT05671653|537710950|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
149061626|NCT05671653|537710951|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
149061627|NCT05671653|537710952|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
149061628|NCT05671653|537710953|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
149061629|NCT05671653|537710954|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
149061630|NCT05671653|537710955|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
149061631|NCT05671653|537710956|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
149061632|NCT05671653|537710957|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
149061633|NCT05671653|537710958|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
149061634|NCT05671653|537710959|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
149061635|NCT05671653|537710947|FG000|Cohort 2 Period 2|Pregnancy|0|||
149061636|NCT05671653|537710948|FG001|Cohort 2 Period 2|Pregnancy|0|||
149061637|NCT05671653|537710949|FG002|Cohort 2 Period 2|Pregnancy|0|||
149061638|NCT05671653|537710950|FG003|Cohort 2 Period 2|Pregnancy|0|||
149061639|NCT05671653|537710951|FG004|Cohort 2 Period 2|Pregnancy|0|||
149061640|NCT05671653|537710952|FG005|Cohort 2 Period 2|Pregnancy|0|||
149061641|NCT05671653|537710953|FG006|Cohort 2 Period 2|Pregnancy|0|||
149061642|NCT05671653|537710954|FG007|Cohort 2 Period 2|Pregnancy|0|||
149061643|NCT05671653|537710955|FG008|Cohort 2 Period 2|Pregnancy|0|||
149061644|NCT05671653|537710956|FG009|Cohort 2 Period 2|Pregnancy|0|||
149061645|NCT05671653|537710957|FG010|Cohort 2 Period 2|Pregnancy|1|||
149061646|NCT05671653|537710958|FG011|Cohort 2 Period 2|Pregnancy|0|||
148890302|NCT00721396|537077194|FG002|Overall Study|Administrative reason|1|||
148890303|NCT00721396|537077195|FG003|Overall Study|Administrative reason|0|||
148890304|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
148890305|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
148890306|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
148890307|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
149061647|NCT05671653|537710959|FG012|Cohort 2 Period 2|Pregnancy|0|||
149061648|NCT05671653|537710947|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061649|NCT05671653|537710948|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061650|NCT05671653|537710949|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061651|NCT05671653|537710950|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061652|NCT05671653|537710951|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061653|NCT05671653|537710952|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061654|NCT05671653|537710953|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061655|NCT05671653|537710954|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061656|NCT05671653|537710955|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061657|NCT05671653|537710956|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061658|NCT05671653|537710957|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
149061659|NCT05671653|537710958|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061660|NCT05671653|537710959|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
149061661|NCT05671653|537710947|FG000|Cohort 2 Period 2|Other|0|||
149061662|NCT05671653|537710948|FG001|Cohort 2 Period 2|Other|0|||
149061663|NCT05671653|537710949|FG002|Cohort 2 Period 2|Other|0|||
149061664|NCT05671653|537710950|FG003|Cohort 2 Period 2|Other|0|||
149061665|NCT05671653|537710951|FG004|Cohort 2 Period 2|Other|0|||
149061666|NCT05671653|537710952|FG005|Cohort 2 Period 2|Other|0|||
149061667|NCT05671653|537710953|FG006|Cohort 2 Period 2|Other|0|||
149061668|NCT05671653|537710954|FG007|Cohort 2 Period 2|Other|0|||
149061669|NCT05671653|537710955|FG008|Cohort 2 Period 2|Other|0|||
149061670|NCT05671653|537710956|FG009|Cohort 2 Period 2|Other|0|||
149061671|NCT05671653|537710957|FG010|Cohort 2 Period 2|Other|1|||
149061672|NCT05671653|537710958|FG011|Cohort 2 Period 2|Other|0|||
149061673|NCT05671653|537710959|FG012|Cohort 2 Period 2|Other|0|||
149061674|NCT05671653|537710947|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061675|NCT05671653|537710948|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061676|NCT05671653|537710949|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061677|NCT05671653|537710950|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061678|NCT05671653|537710951|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061679|NCT05671653|537710952|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061680|NCT05671653|537710953|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061681|NCT05671653|537710954|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061682|NCT05671653|537710955|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061683|NCT05671653|537710956|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061684|NCT05671653|537710957|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061685|NCT05671653|537710958|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
149061686|NCT05671653|537710959|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
149061687|NCT01197378|537710963|FG000|Overall Study|Adverse Event|3|||
149061688|NCT01197378|537710963|FG000|Overall Study|Withdrawal by Subject|1|||
149061689|NCT01197378|537710963|FG000|Overall Study|Physician Decision|1|||
149061690|NCT01197378|537710963|FG000|Overall Study|Other|2|||
149061691|NCT04850898|537710967|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
149061692|NCT04850898|537710968|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
149061693|NCT04550221|537710969|FG000|Overall Study|Lost to Follow-up|0|||
149061694|NCT04550221|537710970|FG001|Overall Study|Lost to Follow-up|4|||
149061695|NCT04550221|537710969|FG000|Overall Study|Withdrawn|3|||
149061696|NCT04550221|537710970|FG001|Overall Study|Withdrawn|0|||
149061697|NCT04550221|537710969|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
149061698|NCT04550221|537710970|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
149061699|NCT02593773|537710978|FG000|Overall Study|Voluntary Withdrawal|3|||
149061700|NCT02593773|537710978|FG000|Overall Study|Study Terminated by Sponsor|31|||
149061701|NCT02593773|537710978|FG000|Overall Study|Death|1|||
149061702|NCT04447040|537710980|FG000|Overall Study|Lost to Follow-up|2|||
149061703|NCT04447040|537710981|FG001|Overall Study|Lost to Follow-up|1|||
149061704|NCT04447040|537710982|FG002|Overall Study|Lost to Follow-up|3|||
149061705|NCT04447040|537710983|FG003|Overall Study|Lost to Follow-up|3|||
149061706|NCT04447040|537710984|FG004|Overall Study|Lost to Follow-up|1|||
149061707|NCT04447040|537710985|FG005|Overall Study|Lost to Follow-up|3|||
149061708|NCT04447040|537710980|FG000|Overall Study|Withdrawal by Subject|0|||
149061709|NCT04447040|537710981|FG001|Overall Study|Withdrawal by Subject|1|||
149061710|NCT04447040|537710982|FG002|Overall Study|Withdrawal by Subject|1|||
149061711|NCT04447040|537710983|FG003|Overall Study|Withdrawal by Subject|1|||
149061712|NCT04447040|537710984|FG004|Overall Study|Withdrawal by Subject|0|||
149061713|NCT04447040|537710985|FG005|Overall Study|Withdrawal by Subject|0|||
149061714|NCT04076618|537710986|FG000|Overall Study|Lost to Follow-up|2|||
149061715|NCT04076618|537710987|FG001|Overall Study|Lost to Follow-up|1|||
149061716|NCT04076618|537710988|FG002|Overall Study|Lost to Follow-up|3|||
149061717|NCT04076618|537710986|FG000|Overall Study|Withdrawal by Subject|3|||
149061718|NCT04076618|537710987|FG001|Overall Study|Withdrawal by Subject|1|||
149061719|NCT04076618|537710988|FG002|Overall Study|Withdrawal by Subject|2|||
149061720|NCT04076618|537710986|FG000|Overall Study|Relocated out of state|0|||
149061721|NCT04076618|537710987|FG001|Overall Study|Relocated out of state|2|||
149061722|NCT04076618|537710988|FG002|Overall Study|Relocated out of state|0|||
149061723|NCT04076618|537710986|FG000|Overall Study|COVID concerns|0|||
149061724|NCT04076618|537710987|FG001|Overall Study|COVID concerns|1|||
149061725|NCT04076618|537710988|FG002|Overall Study|COVID concerns|0|||
148890308|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
149061726|NCT04076618|537710986|FG000|Overall Study|Adverse Event|0|||
149061727|NCT04076618|537710987|FG001|Overall Study|Adverse Event|0|||
149061728|NCT04076618|537710988|FG002|Overall Study|Adverse Event|2|||
149061729|NCT01928394|537710989|FG000|Treatment Period|Disease progression|17|||
149061730|NCT01928394|537710990|FG001|Treatment Period|Disease progression|2|||
149061731|NCT01928394|537710991|FG002|Treatment Period|Disease progression|12|||
149061732|NCT01928394|537710992|FG003|Treatment Period|Disease progression|48|||
149061733|NCT01928394|537710993|FG004|Treatment Period|Disease progression|3|||
149061734|NCT01928394|537710994|FG005|Treatment Period|Disease progression|25|||
149061735|NCT01928394|537710995|FG006|Treatment Period|Disease progression|38|||
149061736|NCT01928394|537710996|FG007|Treatment Period|Disease progression|16|||
149061737|NCT01928394|537710997|FG008|Treatment Period|Disease progression|3|||
149061738|NCT01928394|537710998|FG009|Treatment Period|Disease progression|11|||
149061739|NCT01928394|537710999|FG010|Treatment Period|Disease progression|22|||
149061740|NCT01928394|537711000|FG011|Treatment Period|Disease progression|73|||
149061741|NCT01928394|537711001|FG012|Treatment Period|Disease progression|38|||
149061742|NCT01928394|537711002|FG013|Treatment Period|Disease progression|118|||
149061743|NCT01928394|537711003|FG014|Treatment Period|Disease progression|59|||
149061744|NCT01928394|537711004|FG015|Treatment Period|Disease progression|1|||
149061745|NCT01928394|537711005|FG016|Treatment Period|Disease progression|43|||
149061746|NCT01928394|537711006|FG017|Treatment Period|Disease progression|56|||
149061747|NCT01928394|537711007|FG018|Treatment Period|Disease progression|50|||
149061748|NCT01928394|537711008|FG019|Treatment Period|Disease progression|71|||
149061749|NCT01928394|537711009|FG020|Treatment Period|Disease progression|30|||
149061750|NCT01928394|537711010|FG021|Treatment Period|Disease progression|31|||
149061751|NCT01928394|537711011|FG022|Treatment Period|Disease progression|31|||
149061752|NCT01928394|537710989|FG000|Treatment Period|Study drug toxicity|1|||
149061753|NCT01928394|537710990|FG001|Treatment Period|Study drug toxicity|1|||
149061754|NCT01928394|537710991|FG002|Treatment Period|Study drug toxicity|3|||
149061755|NCT01928394|537710992|FG003|Treatment Period|Study drug toxicity|3|||
149061756|NCT01928394|537710993|FG004|Treatment Period|Study drug toxicity|0|||
149061757|NCT01928394|537710994|FG005|Treatment Period|Study drug toxicity|9|||
149061758|NCT01928394|537710995|FG006|Treatment Period|Study drug toxicity|7|||
149061759|NCT01928394|537710996|FG007|Treatment Period|Study drug toxicity|1|||
149061760|NCT01928394|537710997|FG008|Treatment Period|Study drug toxicity|0|||
149061761|NCT01928394|537710998|FG009|Treatment Period|Study drug toxicity|5|||
149061762|NCT01928394|537710999|FG010|Treatment Period|Study drug toxicity|2|||
149061763|NCT01928394|537711000|FG011|Treatment Period|Study drug toxicity|3|||
149061764|NCT01928394|537711001|FG012|Treatment Period|Study drug toxicity|7|||
149061765|NCT01928394|537711002|FG013|Treatment Period|Study drug toxicity|5|||
149061766|NCT01928394|537711003|FG014|Treatment Period|Study drug toxicity|12|||
149061767|NCT01928394|537711004|FG015|Treatment Period|Study drug toxicity|0|||
149061768|NCT01928394|537711005|FG016|Treatment Period|Study drug toxicity|3|||
149061769|NCT01928394|537711006|FG017|Treatment Period|Study drug toxicity|3|||
149061770|NCT01928394|537711007|FG018|Treatment Period|Study drug toxicity|12|||
149061771|NCT01928394|537711008|FG019|Treatment Period|Study drug toxicity|15|||
149061772|NCT01928394|537711009|FG020|Treatment Period|Study drug toxicity|4|||
149061773|NCT01928394|537711010|FG021|Treatment Period|Study drug toxicity|7|||
149061774|NCT01928394|537711011|FG022|Treatment Period|Study drug toxicity|4|||
149061775|NCT01928394|537710989|FG000|Treatment Period|AE unrelated to study drug|0|||
149061776|NCT01928394|537710990|FG001|Treatment Period|AE unrelated to study drug|0|||
149061777|NCT01928394|537710991|FG002|Treatment Period|AE unrelated to study drug|2|||
149061778|NCT01928394|537710992|FG003|Treatment Period|AE unrelated to study drug|3|||
149061779|NCT01928394|537710993|FG004|Treatment Period|AE unrelated to study drug|0|||
149061780|NCT01928394|537710994|FG005|Treatment Period|AE unrelated to study drug|5|||
149061781|NCT01928394|537710995|FG006|Treatment Period|AE unrelated to study drug|1|||
149061782|NCT01928394|537710996|FG007|Treatment Period|AE unrelated to study drug|0|||
149061783|NCT01928394|537710997|FG008|Treatment Period|AE unrelated to study drug|0|||
149061784|NCT01928394|537710998|FG009|Treatment Period|AE unrelated to study drug|2|||
149061785|NCT01928394|537710999|FG010|Treatment Period|AE unrelated to study drug|0|||
149061786|NCT01928394|537711000|FG011|Treatment Period|AE unrelated to study drug|12|||
149061787|NCT01928394|537711001|FG012|Treatment Period|AE unrelated to study drug|6|||
149061788|NCT01928394|537711002|FG013|Treatment Period|AE unrelated to study drug|13|||
149061789|NCT01928394|537711003|FG014|Treatment Period|AE unrelated to study drug|6|||
149061790|NCT01928394|537711004|FG015|Treatment Period|AE unrelated to study drug|1|||
149061791|NCT01928394|537711005|FG016|Treatment Period|AE unrelated to study drug|1|||
149061792|NCT01928394|537711006|FG017|Treatment Period|AE unrelated to study drug|6|||
149061793|NCT01928394|537711007|FG018|Treatment Period|AE unrelated to study drug|3|||
149061794|NCT01928394|537711008|FG019|Treatment Period|AE unrelated to study drug|5|||
149061795|NCT01928394|537711009|FG020|Treatment Period|AE unrelated to study drug|1|||
149061796|NCT01928394|537711010|FG021|Treatment Period|AE unrelated to study drug|1|||
149061797|NCT01928394|537711011|FG022|Treatment Period|AE unrelated to study drug|0|||
149061798|NCT01928394|537710989|FG000|Treatment Period|Participant request to stop therapy|0|||
149061799|NCT01928394|537710990|FG001|Treatment Period|Participant request to stop therapy|0|||
149061800|NCT01928394|537710991|FG002|Treatment Period|Participant request to stop therapy|0|||
149061801|NCT01928394|537710992|FG003|Treatment Period|Participant request to stop therapy|0|||
149061802|NCT01928394|537710993|FG004|Treatment Period|Participant request to stop therapy|0|||
149061803|NCT01928394|537710994|FG005|Treatment Period|Participant request to stop therapy|3|||
149061804|NCT01928394|537710995|FG006|Treatment Period|Participant request to stop therapy|3|||
149061805|NCT01928394|537710996|FG007|Treatment Period|Participant request to stop therapy|0|||
149061806|NCT01928394|537710997|FG008|Treatment Period|Participant request to stop therapy|0|||
149061807|NCT01928394|537710998|FG009|Treatment Period|Participant request to stop therapy|0|||
149061808|NCT01928394|537710999|FG010|Treatment Period|Participant request to stop therapy|3|||
149061809|NCT01928394|537711000|FG011|Treatment Period|Participant request to stop therapy|2|||
149061810|NCT01928394|537711001|FG012|Treatment Period|Participant request to stop therapy|1|||
149061811|NCT01928394|537711002|FG013|Treatment Period|Participant request to stop therapy|2|||
149061812|NCT01928394|537711003|FG014|Treatment Period|Participant request to stop therapy|4|||
149061813|NCT01928394|537711004|FG015|Treatment Period|Participant request to stop therapy|0|||
149061814|NCT01928394|537711005|FG016|Treatment Period|Participant request to stop therapy|1|||
149061815|NCT01928394|537711006|FG017|Treatment Period|Participant request to stop therapy|3|||
149061816|NCT01928394|537711007|FG018|Treatment Period|Participant request to stop therapy|1|||
149061817|NCT01928394|537711008|FG019|Treatment Period|Participant request to stop therapy|1|||
149061818|NCT01928394|537711009|FG020|Treatment Period|Participant request to stop therapy|3|||
149061819|NCT01928394|537711010|FG021|Treatment Period|Participant request to stop therapy|1|||
149061820|NCT01928394|537711011|FG022|Treatment Period|Participant request to stop therapy|3|||
149061821|NCT01928394|537710989|FG000|Treatment Period|Participant withdrew consent|0|||
149061822|NCT01928394|537710990|FG001|Treatment Period|Participant withdrew consent|0|||
149061823|NCT01928394|537710991|FG002|Treatment Period|Participant withdrew consent|1|||
149061824|NCT01928394|537710992|FG003|Treatment Period|Participant withdrew consent|1|||
149061825|NCT01928394|537710993|FG004|Treatment Period|Participant withdrew consent|0|||
149005727|NCT04026165|537499664|FG003|Run-in Placebo Period|Withdrew Consent|0|||
149005728|NCT04026165|537499661|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
149061826|NCT01928394|537710994|FG005|Treatment Period|Participant withdrew consent|1|||
149061827|NCT01928394|537710995|FG006|Treatment Period|Participant withdrew consent|0|||
149061828|NCT01928394|537710996|FG007|Treatment Period|Participant withdrew consent|1|||
149061829|NCT01928394|537710997|FG008|Treatment Period|Participant withdrew consent|0|||
149061830|NCT01928394|537710998|FG009|Treatment Period|Participant withdrew consent|0|||
149061831|NCT01928394|537710999|FG010|Treatment Period|Participant withdrew consent|1|||
149061832|NCT01928394|537711000|FG011|Treatment Period|Participant withdrew consent|1|||
149061833|NCT01928394|537711001|FG012|Treatment Period|Participant withdrew consent|1|||
149061834|NCT01928394|537711002|FG013|Treatment Period|Participant withdrew consent|0|||
149061835|NCT01928394|537711003|FG014|Treatment Period|Participant withdrew consent|2|||
149061836|NCT01928394|537711004|FG015|Treatment Period|Participant withdrew consent|0|||
149061837|NCT01928394|537711005|FG016|Treatment Period|Participant withdrew consent|2|||
149061838|NCT01928394|537711006|FG017|Treatment Period|Participant withdrew consent|1|||
149061839|NCT01928394|537711007|FG018|Treatment Period|Participant withdrew consent|1|||
149061840|NCT01928394|537711008|FG019|Treatment Period|Participant withdrew consent|1|||
149061841|NCT01928394|537711009|FG020|Treatment Period|Participant withdrew consent|0|||
149061842|NCT01928394|537711010|FG021|Treatment Period|Participant withdrew consent|2|||
149061843|NCT01928394|537711011|FG022|Treatment Period|Participant withdrew consent|0|||
149061844|NCT01928394|537710989|FG000|Treatment Period|Poor/non-compliance|0|||
149061845|NCT01928394|537710990|FG001|Treatment Period|Poor/non-compliance|0|||
149061846|NCT01928394|537710991|FG002|Treatment Period|Poor/non-compliance|0|||
149061847|NCT01928394|537710992|FG003|Treatment Period|Poor/non-compliance|1|||
149061848|NCT01928394|537710993|FG004|Treatment Period|Poor/non-compliance|0|||
149061849|NCT01928394|537710994|FG005|Treatment Period|Poor/non-compliance|0|||
149061850|NCT01928394|537710995|FG006|Treatment Period|Poor/non-compliance|0|||
149061851|NCT01928394|537710996|FG007|Treatment Period|Poor/non-compliance|0|||
149061852|NCT01928394|537710997|FG008|Treatment Period|Poor/non-compliance|0|||
149061853|NCT01928394|537710998|FG009|Treatment Period|Poor/non-compliance|0|||
149061854|NCT01928394|537710999|FG010|Treatment Period|Poor/non-compliance|0|||
149061855|NCT01928394|537711000|FG011|Treatment Period|Poor/non-compliance|0|||
149061856|NCT01928394|537711001|FG012|Treatment Period|Poor/non-compliance|1|||
149061857|NCT01928394|537711002|FG013|Treatment Period|Poor/non-compliance|0|||
149061858|NCT01928394|537711003|FG014|Treatment Period|Poor/non-compliance|1|||
149005729|NCT04026165|537499662|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
149005730|NCT04026165|537499663|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
149005731|NCT04026165|537499664|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
149005732|NCT04026165|537499661|FG000|Run-in SEL Period|Run-in Failure|0|||
149005733|NCT04026165|537499662|FG001|Run-in SEL Period|Run-in Failure|26|||
149005734|NCT04026165|537499663|FG002|Run-in SEL Period|Run-in Failure|0|||
149005735|NCT04026165|537499664|FG003|Run-in SEL Period|Run-in Failure|0|||
149005736|NCT04026165|537499661|FG000|Run-in SEL Period|Withdrew Consent|0|||
149005737|NCT04026165|537499662|FG001|Run-in SEL Period|Withdrew Consent|10|||
149005738|NCT04026165|537499663|FG002|Run-in SEL Period|Withdrew Consent|0|||
149005739|NCT04026165|537499664|FG003|Run-in SEL Period|Withdrew Consent|0|||
149061859|NCT01928394|537711004|FG015|Treatment Period|Poor/non-compliance|0|||
149061860|NCT01928394|537711005|FG016|Treatment Period|Poor/non-compliance|0|||
149061861|NCT01928394|537711006|FG017|Treatment Period|Poor/non-compliance|1|||
149119801|NCT00006011|537917971|FG002|Overall Study|Other|5|||
149061862|NCT01928394|537711007|FG018|Treatment Period|Poor/non-compliance|0|||
149061863|NCT01928394|537711008|FG019|Treatment Period|Poor/non-compliance|1|||
149061864|NCT01928394|537711009|FG020|Treatment Period|Poor/non-compliance|0|||
149061865|NCT01928394|537711010|FG021|Treatment Period|Poor/non-compliance|0|||
149061866|NCT01928394|537711011|FG022|Treatment Period|Poor/non-compliance|0|||
149061867|NCT01928394|537710989|FG000|Treatment Period|other reason|0|||
149061868|NCT01928394|537710990|FG001|Treatment Period|other reason|0|||
149061869|NCT01928394|537710991|FG002|Treatment Period|other reason|0|||
149061870|NCT01928394|537710992|FG003|Treatment Period|other reason|0|||
149061871|NCT01928394|537710993|FG004|Treatment Period|other reason|0|||
149061872|NCT01928394|537710994|FG005|Treatment Period|other reason|0|||
149061873|NCT01928394|537710995|FG006|Treatment Period|other reason|0|||
149061874|NCT01928394|537710996|FG007|Treatment Period|other reason|0|||
149061875|NCT01928394|537710997|FG008|Treatment Period|other reason|0|||
149061876|NCT01928394|537710998|FG009|Treatment Period|other reason|0|||
149061877|NCT01928394|537710999|FG010|Treatment Period|other reason|1|||
149061878|NCT01928394|537711000|FG011|Treatment Period|other reason|1|||
149061879|NCT01928394|537711001|FG012|Treatment Period|other reason|1|||
149061880|NCT01928394|537711002|FG013|Treatment Period|other reason|0|||
149061881|NCT01928394|537711003|FG014|Treatment Period|other reason|1|||
149061882|NCT01928394|537711004|FG015|Treatment Period|other reason|0|||
149061883|NCT01928394|537711005|FG016|Treatment Period|other reason|0|||
149061884|NCT01928394|537711006|FG017|Treatment Period|other reason|0|||
149061885|NCT01928394|537711007|FG018|Treatment Period|other reason|2|||
149061886|NCT01928394|537711008|FG019|Treatment Period|other reason|2|||
149061887|NCT01928394|537711009|FG020|Treatment Period|other reason|0|||
149061888|NCT01928394|537711010|FG021|Treatment Period|other reason|0|||
149061889|NCT01928394|537711011|FG022|Treatment Period|other reason|0|||
149061890|NCT01928394|537710989|FG000|Treatment Period|Maximum clinical benefit|0|||
149061891|NCT01928394|537710990|FG001|Treatment Period|Maximum clinical benefit|0|||
149061892|NCT01928394|537710991|FG002|Treatment Period|Maximum clinical benefit|0|||
149061893|NCT01928394|537710992|FG003|Treatment Period|Maximum clinical benefit|0|||
149061894|NCT01928394|537710993|FG004|Treatment Period|Maximum clinical benefit|0|||
149061895|NCT01928394|537710994|FG005|Treatment Period|Maximum clinical benefit|0|||
149061896|NCT01928394|537710995|FG006|Treatment Period|Maximum clinical benefit|0|||
149061897|NCT01928394|537710996|FG007|Treatment Period|Maximum clinical benefit|0|||
149061898|NCT01928394|537710997|FG008|Treatment Period|Maximum clinical benefit|0|||
149061899|NCT01928394|537710998|FG009|Treatment Period|Maximum clinical benefit|0|||
149061900|NCT01928394|537710999|FG010|Treatment Period|Maximum clinical benefit|1|||
149061901|NCT01928394|537711000|FG011|Treatment Period|Maximum clinical benefit|1|||
149061902|NCT01928394|537711001|FG012|Treatment Period|Maximum clinical benefit|0|||
149061903|NCT01928394|537711002|FG013|Treatment Period|Maximum clinical benefit|0|||
149061904|NCT01928394|537711003|FG014|Treatment Period|Maximum clinical benefit|1|||
149061905|NCT01928394|537711004|FG015|Treatment Period|Maximum clinical benefit|0|||
149061906|NCT01928394|537711005|FG016|Treatment Period|Maximum clinical benefit|0|||
149061907|NCT01928394|537711006|FG017|Treatment Period|Maximum clinical benefit|1|||
149061908|NCT01928394|537711007|FG018|Treatment Period|Maximum clinical benefit|1|||
149061909|NCT01928394|537711008|FG019|Treatment Period|Maximum clinical benefit|0|||
149061910|NCT01928394|537711009|FG020|Treatment Period|Maximum clinical benefit|2|||
149061911|NCT01928394|537711010|FG021|Treatment Period|Maximum clinical benefit|0|||
149061912|NCT01928394|537711011|FG022|Treatment Period|Maximum clinical benefit|0|||
149061913|NCT01928394|537710989|FG000|Treatment Period|Lost to Follow-up|0|||
149061914|NCT01928394|537710990|FG001|Treatment Period|Lost to Follow-up|0|||
149061915|NCT01928394|537710991|FG002|Treatment Period|Lost to Follow-up|0|||
149061916|NCT01928394|537710992|FG003|Treatment Period|Lost to Follow-up|0|||
149061917|NCT01928394|537710993|FG004|Treatment Period|Lost to Follow-up|0|||
149061918|NCT01928394|537710994|FG005|Treatment Period|Lost to Follow-up|0|||
149061919|NCT01928394|537710995|FG006|Treatment Period|Lost to Follow-up|0|||
149061920|NCT01928394|537710996|FG007|Treatment Period|Lost to Follow-up|0|||
149061921|NCT01928394|537710997|FG008|Treatment Period|Lost to Follow-up|0|||
149061922|NCT01928394|537710998|FG009|Treatment Period|Lost to Follow-up|0|||
149061923|NCT01928394|537710999|FG010|Treatment Period|Lost to Follow-up|0|||
149061924|NCT01928394|537711000|FG011|Treatment Period|Lost to Follow-up|0|||
149061925|NCT01928394|537711001|FG012|Treatment Period|Lost to Follow-up|0|||
149061926|NCT01928394|537711002|FG013|Treatment Period|Lost to Follow-up|0|||
149061927|NCT01928394|537711003|FG014|Treatment Period|Lost to Follow-up|0|||
149061928|NCT01928394|537711004|FG015|Treatment Period|Lost to Follow-up|0|||
149061929|NCT01928394|537711005|FG016|Treatment Period|Lost to Follow-up|0|||
149061930|NCT01928394|537711006|FG017|Treatment Period|Lost to Follow-up|0|||
149061931|NCT01928394|537711007|FG018|Treatment Period|Lost to Follow-up|0|||
149061932|NCT01928394|537711008|FG019|Treatment Period|Lost to Follow-up|0|||
149061933|NCT01928394|537711009|FG020|Treatment Period|Lost to Follow-up|0|||
149061934|NCT01928394|537711010|FG021|Treatment Period|Lost to Follow-up|0|||
149061935|NCT01928394|537711011|FG022|Treatment Period|Lost to Follow-up|1|||
149061936|NCT01928394|537710989|FG000|Treatment Period|Death|0|||
149061937|NCT01928394|537710990|FG001|Treatment Period|Death|0|||
149061938|NCT01928394|537710991|FG002|Treatment Period|Death|0|||
149061939|NCT01928394|537710992|FG003|Treatment Period|Death|0|||
149061940|NCT01928394|537710993|FG004|Treatment Period|Death|0|||
149061941|NCT01928394|537710994|FG005|Treatment Period|Death|0|||
149061942|NCT01928394|537710995|FG006|Treatment Period|Death|0|||
149061943|NCT01928394|537710996|FG007|Treatment Period|Death|0|||
149061944|NCT01928394|537710997|FG008|Treatment Period|Death|0|||
149061945|NCT01928394|537710998|FG009|Treatment Period|Death|0|||
149061946|NCT01928394|537710999|FG010|Treatment Period|Death|0|||
149061947|NCT01928394|537711000|FG011|Treatment Period|Death|0|||
149061948|NCT01928394|537711001|FG012|Treatment Period|Death|0|||
149061949|NCT01928394|537711002|FG013|Treatment Period|Death|1|||
149061950|NCT01928394|537711003|FG014|Treatment Period|Death|2|||
149061951|NCT01928394|537711004|FG015|Treatment Period|Death|0|||
149061952|NCT01928394|537711005|FG016|Treatment Period|Death|0|||
149061953|NCT01928394|537711006|FG017|Treatment Period|Death|0|||
149061954|NCT01928394|537711007|FG018|Treatment Period|Death|0|||
149061955|NCT01928394|537711008|FG019|Treatment Period|Death|0|||
149061956|NCT01928394|537711009|FG020|Treatment Period|Death|0|||
149061957|NCT01928394|537711010|FG021|Treatment Period|Death|0|||
149061958|NCT01928394|537711011|FG022|Treatment Period|Death|0|||
149061959|NCT01928394|537710989|FG000|Follow-up Period|Participant withdrew consent|3|||
149061960|NCT01928394|537710990|FG001|Follow-up Period|Participant withdrew consent|0|||
149061961|NCT01928394|537710991|FG002|Follow-up Period|Participant withdrew consent|1|||
149061962|NCT01928394|537710992|FG003|Follow-up Period|Participant withdrew consent|4|||
149061963|NCT01928394|537710993|FG004|Follow-up Period|Participant withdrew consent|0|||
149061964|NCT01928394|537710994|FG005|Follow-up Period|Participant withdrew consent|2|||
149061965|NCT01928394|537710995|FG006|Follow-up Period|Participant withdrew consent|5|||
149061966|NCT01928394|537710996|FG007|Follow-up Period|Participant withdrew consent|1|||
149061967|NCT01928394|537710997|FG008|Follow-up Period|Participant withdrew consent|0|||
149061968|NCT01928394|537710998|FG009|Follow-up Period|Participant withdrew consent|0|||
149061969|NCT01928394|537710999|FG010|Follow-up Period|Participant withdrew consent|5|||
149061970|NCT01928394|537711000|FG011|Follow-up Period|Participant withdrew consent|8|||
149061971|NCT01928394|537711001|FG012|Follow-up Period|Participant withdrew consent|2|||
149061972|NCT01928394|537711002|FG013|Follow-up Period|Participant withdrew consent|12|||
149061973|NCT01928394|537711003|FG014|Follow-up Period|Participant withdrew consent|7|||
149061974|NCT01928394|537711004|FG015|Follow-up Period|Participant withdrew consent|0|||
149061975|NCT01928394|537711005|FG016|Follow-up Period|Participant withdrew consent|5|||
149061976|NCT01928394|537711006|FG017|Follow-up Period|Participant withdrew consent|3|||
149061977|NCT01928394|537711007|FG018|Follow-up Period|Participant withdrew consent|2|||
149061978|NCT01928394|537711008|FG019|Follow-up Period|Participant withdrew consent|7|||
149061979|NCT01928394|537711009|FG020|Follow-up Period|Participant withdrew consent|4|||
149061980|NCT01928394|537711010|FG021|Follow-up Period|Participant withdrew consent|6|||
149061981|NCT01928394|537711011|FG022|Follow-up Period|Participant withdrew consent|2|||
149061982|NCT01928394|537710989|FG000|Follow-up Period|Death|0|||
149061983|NCT01928394|537710990|FG001|Follow-up Period|Death|0|||
149061984|NCT01928394|537710991|FG002|Follow-up Period|Death|2|||
149061985|NCT01928394|537710992|FG003|Follow-up Period|Death|6|||
149061986|NCT01928394|537710993|FG004|Follow-up Period|Death|0|||
149061987|NCT01928394|537710994|FG005|Follow-up Period|Death|6|||
149061988|NCT01928394|537710995|FG006|Follow-up Period|Death|6|||
149061989|NCT01928394|537710996|FG007|Follow-up Period|Death|2|||
149061990|NCT01928394|537710997|FG008|Follow-up Period|Death|1|||
149061991|NCT01928394|537710998|FG009|Follow-up Period|Death|2|||
149061992|NCT01928394|537710999|FG010|Follow-up Period|Death|4|||
149061993|NCT01928394|537711000|FG011|Follow-up Period|Death|12|||
149061994|NCT01928394|537711001|FG012|Follow-up Period|Death|11|||
149061995|NCT01928394|537711002|FG013|Follow-up Period|Death|25|||
149061996|NCT01928394|537711003|FG014|Follow-up Period|Death|18|||
149061997|NCT01928394|537711004|FG015|Follow-up Period|Death|0|||
149061998|NCT01928394|537711005|FG016|Follow-up Period|Death|6|||
149061999|NCT01928394|537711006|FG017|Follow-up Period|Death|5|||
149062000|NCT01928394|537711007|FG018|Follow-up Period|Death|13|||
149062001|NCT01928394|537711008|FG019|Follow-up Period|Death|13|||
148890309|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
148890310|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
149062002|NCT01928394|537711009|FG020|Follow-up Period|Death|5|||
149062003|NCT01928394|537711010|FG021|Follow-up Period|Death|3|||
149062004|NCT01928394|537711011|FG022|Follow-up Period|Death|2|||
149062005|NCT01928394|537710989|FG000|Follow-up Period|other reason|0|||
149062006|NCT01928394|537710990|FG001|Follow-up Period|other reason|0|||
149062007|NCT01928394|537710991|FG002|Follow-up Period|other reason|0|||
149062008|NCT01928394|537710992|FG003|Follow-up Period|other reason|0|||
149062009|NCT01928394|537710993|FG004|Follow-up Period|other reason|0|||
149062010|NCT01928394|537710994|FG005|Follow-up Period|other reason|0|||
149062011|NCT01928394|537710995|FG006|Follow-up Period|other reason|1|||
149062012|NCT01928394|537710996|FG007|Follow-up Period|other reason|3|||
149062013|NCT01928394|537710997|FG008|Follow-up Period|other reason|0|||
149062014|NCT01928394|537710998|FG009|Follow-up Period|other reason|0|||
149062015|NCT01928394|537710999|FG010|Follow-up Period|other reason|2|||
149062016|NCT01928394|537711000|FG011|Follow-up Period|other reason|1|||
149062017|NCT01928394|537711001|FG012|Follow-up Period|other reason|0|||
149062018|NCT01928394|537711002|FG013|Follow-up Period|other reason|1|||
149062019|NCT01928394|537711003|FG014|Follow-up Period|other reason|4|||
149062020|NCT01928394|537711004|FG015|Follow-up Period|other reason|0|||
149062021|NCT01928394|537711005|FG016|Follow-up Period|other reason|2|||
149062022|NCT01928394|537711006|FG017|Follow-up Period|other reason|0|||
149062023|NCT01928394|537711007|FG018|Follow-up Period|other reason|1|||
149062024|NCT01928394|537711008|FG019|Follow-up Period|other reason|1|||
149062025|NCT01928394|537711009|FG020|Follow-up Period|other reason|0|||
149062026|NCT01928394|537711010|FG021|Follow-up Period|other reason|0|||
149062027|NCT01928394|537711011|FG022|Follow-up Period|other reason|1|||
149062028|NCT01928394|537710989|FG000|Follow-up Period|Lost to Follow-up|0|||
149062029|NCT01928394|537710990|FG001|Follow-up Period|Lost to Follow-up|0|||
149062030|NCT01928394|537710991|FG002|Follow-up Period|Lost to Follow-up|0|||
149005740|NCT04026165|537499661|FG000|Run-in SEL Period|Enrollment Error|0|||
149005741|NCT04026165|537499662|FG001|Run-in SEL Period|Enrollment Error|4|||
149005742|NCT04026165|537499663|FG002|Run-in SEL Period|Enrollment Error|0|||
149005743|NCT04026165|537499664|FG003|Run-in SEL Period|Enrollment Error|0|||
149005744|NCT04026165|537499661|FG000|Run-in SEL Period|Protocol Violation|0|||
149005745|NCT04026165|537499662|FG001|Run-in SEL Period|Protocol Violation|3|||
149005746|NCT04026165|537499663|FG002|Run-in SEL Period|Protocol Violation|0|||
149005747|NCT04026165|537499664|FG003|Run-in SEL Period|Protocol Violation|0|||
149005748|NCT04026165|537499661|FG000|Run-in SEL Period|Investigator's Discretion|0|||
149005749|NCT04026165|537499662|FG001|Run-in SEL Period|Investigator's Discretion|2|||
149005750|NCT04026165|537499663|FG002|Run-in SEL Period|Investigator's Discretion|0|||
149005751|NCT04026165|537499664|FG003|Run-in SEL Period|Investigator's Discretion|0|||
149005752|NCT04026165|537499661|FG000|Run-in SEL Period|Death|0|||
149005753|NCT04026165|537499662|FG001|Run-in SEL Period|Death|1|||
149005754|NCT04026165|537499663|FG002|Run-in SEL Period|Death|0|||
149005755|NCT04026165|537499664|FG003|Run-in SEL Period|Death|0|||
149005756|NCT04026165|537499661|FG000|Randomized Period|Withdrew Consent|0|||
149005757|NCT04026165|537499662|FG001|Randomized Period|Withdrew Consent|0|||
149005758|NCT04026165|537499663|FG002|Randomized Period|Withdrew Consent|5|||
149005759|NCT04026165|537499664|FG003|Randomized Period|Withdrew Consent|8|||
149005760|NCT04026165|537499661|FG000|Randomized Period|Death|0|||
149005761|NCT04026165|537499662|FG001|Randomized Period|Death|0|||
149005762|NCT04026165|537499663|FG002|Randomized Period|Death|5|||
149005763|NCT04026165|537499664|FG003|Randomized Period|Death|7|||
149005764|NCT04026165|537499661|FG000|Randomized Period|Investigator's Discretion|0|||
149005765|NCT04026165|537499662|FG001|Randomized Period|Investigator's Discretion|0|||
149005766|NCT04026165|537499663|FG002|Randomized Period|Investigator's Discretion|2|||
149005767|NCT04026165|537499664|FG003|Randomized Period|Investigator's Discretion|2|||
149005768|NCT04026165|537499661|FG000|Randomized Period|Lost to Follow-up|0|||
149005769|NCT04026165|537499662|FG001|Randomized Period|Lost to Follow-up|0|||
149005770|NCT04026165|537499663|FG002|Randomized Period|Lost to Follow-up|2|||
149005771|NCT04026165|537499664|FG003|Randomized Period|Lost to Follow-up|2|||
149005772|NCT01059630|537499665|FG000|Overall Study|Death|100|||
149005773|NCT01059630|537499666|FG001|Overall Study|Death|84|||
149005774|NCT01059630|537499665|FG000|Overall Study|Lost to Follow-up|4|||
149005775|NCT01059630|537499666|FG001|Overall Study|Lost to Follow-up|1|||
149005776|NCT01059630|537499665|FG000|Overall Study|Physician Decision|2|||
149005777|NCT01059630|537499666|FG001|Overall Study|Physician Decision|4|||
149005778|NCT01059630|537499665|FG000|Overall Study|Withdrawal by Subject|21|||
149005779|NCT01059630|537499666|FG001|Overall Study|Withdrawal by Subject|14|||
149005780|NCT03170375|537499667|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
149005781|NCT03170375|537499668|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
149005782|NCT03170375|537499669|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
149005783|NCT03170375|537499667|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
149005784|NCT03170375|537499668|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
149005785|NCT03170375|537499669|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
149005786|NCT00441701|537499670|FG000|Overall Study|Adverse Event|3|||
149005787|NCT00441701|537499671|FG001|Overall Study|Adverse Event|2|||
149005788|NCT00441701|537499672|FG002|Overall Study|Adverse Event|1|||
149005789|NCT00441701|537499673|FG003|Overall Study|Adverse Event|0|||
149005790|NCT00441701|537499674|FG004|Overall Study|Adverse Event|2|||
149005791|NCT00441701|537499675|FG005|Overall Study|Adverse Event|2|||
149005792|NCT00441701|537499676|FG006|Overall Study|Adverse Event|0|||
149005793|NCT00441701|537499677|FG007|Overall Study|Adverse Event|0|||
149005794|NCT00441701|537499678|FG008|Overall Study|Adverse Event|0|||
149005795|NCT00441701|537499679|FG009|Overall Study|Adverse Event|0|||
149005796|NCT00441701|537499670|FG000|Overall Study|Lack of Efficacy|2|||
149005797|NCT00441701|537499671|FG001|Overall Study|Lack of Efficacy|0|||
149005798|NCT00441701|537499672|FG002|Overall Study|Lack of Efficacy|2|||
149062031|NCT01928394|537710992|FG003|Follow-up Period|Lost to Follow-up|0|||
149005799|NCT00441701|537499673|FG003|Overall Study|Lack of Efficacy|2|||
149005800|NCT00441701|537499674|FG004|Overall Study|Lack of Efficacy|0|||
149062032|NCT01928394|537710993|FG004|Follow-up Period|Lost to Follow-up|0|||
149062033|NCT01928394|537710994|FG005|Follow-up Period|Lost to Follow-up|0|||
148890311|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
149005801|NCT00441701|537499675|FG005|Overall Study|Lack of Efficacy|1|||
149005802|NCT00441701|537499676|FG006|Overall Study|Lack of Efficacy|0|||
149005803|NCT00441701|537499677|FG007|Overall Study|Lack of Efficacy|0|||
149005804|NCT00441701|537499678|FG008|Overall Study|Lack of Efficacy|0|||
149005805|NCT00441701|537499679|FG009|Overall Study|Lack of Efficacy|0|||
149005806|NCT00441701|537499670|FG000|Overall Study|Withdrawal by Subject|0|||
149005807|NCT00441701|537499671|FG001|Overall Study|Withdrawal by Subject|2|||
149005808|NCT00441701|537499672|FG002|Overall Study|Withdrawal by Subject|1|||
149005809|NCT00441701|537499673|FG003|Overall Study|Withdrawal by Subject|1|||
149005810|NCT00441701|537499674|FG004|Overall Study|Withdrawal by Subject|0|||
149005811|NCT00441701|537499675|FG005|Overall Study|Withdrawal by Subject|0|||
149005812|NCT00441701|537499676|FG006|Overall Study|Withdrawal by Subject|0|||
149005813|NCT00441701|537499677|FG007|Overall Study|Withdrawal by Subject|0|||
149005814|NCT00441701|537499678|FG008|Overall Study|Withdrawal by Subject|0|||
149005815|NCT00441701|537499679|FG009|Overall Study|Withdrawal by Subject|0|||
149005816|NCT00621543|537499683|FG000|Overall Study|Lost to Follow-up|23|||
149005817|NCT01287611|537499688|FG000|Overall Study|Lost to Follow-up|29|||
149005818|NCT01287611|537499689|FG001|Overall Study|Lost to Follow-up|16|||
149005819|NCT01287611|537499688|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
149005820|NCT01287611|537499689|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
149005821|NCT00763958|537499690|FG000|Overall Study|did not meet final criteria|4|||
149005822|NCT00763958|537499691|FG001|Overall Study|did not meet final criteria|4|||
149005823|NCT00763958|537499690|FG000|Overall Study|Lost to Follow-up|10|||
149005824|NCT00763958|537499691|FG001|Overall Study|Lost to Follow-up|2|||
149005825|NCT00763958|537499690|FG000|Overall Study|Believed they were receiving placebo|0|||
149005826|NCT00763958|537499691|FG001|Overall Study|Believed they were receiving placebo|5|||
149005827|NCT02192970|537499692|FG000|Overall Study|Lost to Follow-up|6|||
149005828|NCT02192970|537499693|FG001|Overall Study|Lost to Follow-up|0|||
149005829|NCT04074590|537499694|FG000|Overall Study|Adverse Event|1|||
149005830|NCT04074590|537499695|FG001|Overall Study|Adverse Event|0|||
149005831|NCT04074590|537499694|FG000|Overall Study|Physician Decision|1|||
149005832|NCT04074590|537499695|FG001|Overall Study|Physician Decision|0|||
149005833|NCT04074590|537499694|FG000|Overall Study|Withdrawal by Subject|2|||
149005834|NCT04074590|537499695|FG001|Overall Study|Withdrawal by Subject|0|||
149005835|NCT00792103|537499697|FG000|Overall Study|Enrolled, not treated|15|||
149005836|NCT00792103|537499697|FG000|Overall Study|Lost to Follow-up|17|||
149005837|NCT00792103|537499697|FG000|Overall Study|Adverse Event|25|||
149005838|NCT00792103|537499697|FG000|Overall Study|Withdrawal by Subject|52|||
149005839|NCT00792103|537499697|FG000|Overall Study|Protocol Violation|10|||
149005840|NCT00792103|537499697|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
149005841|NCT03745222|537499698|FG000|Overall Study|Withdrawal by Subject|0|||
149005842|NCT03745222|537499699|FG001|Overall Study|Withdrawal by Subject|1|||
149005843|NCT03745222|537499700|FG002|Overall Study|Withdrawal by Subject|0|||
149005844|NCT03299686|537499701|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
149005845|NCT03299686|537499702|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
149005846|NCT03299686|537499701|FG000|Treatment Epoch|Physician Decision|1|||
149005847|NCT03299686|537499702|FG001|Treatment Epoch|Physician Decision|0|||
149005848|NCT03299686|537499701|FG000|Treatment Epoch|Adverse Event|8|||
149005849|NCT03299686|537499702|FG001|Treatment Epoch|Adverse Event|4|||
149005850|NCT03299686|537499701|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
149005851|NCT03299686|537499702|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
149005852|NCT02709005|537499703|FG000|Overall Study|Lost to Follow-up|1|||
149005853|NCT02709005|537499704|FG001|Overall Study|Lost to Follow-up|1|||
149005854|NCT02709005|537499703|FG000|Overall Study|Withdrawal by Subject|3|||
149005855|NCT02709005|537499704|FG001|Overall Study|Withdrawal by Subject|0|||
149005856|NCT00499863|537499710|FG000|Overall Study|Lack of Efficacy|21|||
149005857|NCT00499863|537499711|FG001|Overall Study|Lack of Efficacy|27|||
149005858|NCT00499863|537499710|FG000|Overall Study|Protocol Violation|12|||
149005859|NCT00499863|537499711|FG001|Overall Study|Protocol Violation|7|||
149005860|NCT00499863|537499710|FG000|Overall Study|Withdrawal by Subject|6|||
149005861|NCT00499863|537499711|FG001|Overall Study|Withdrawal by Subject|4|||
149005862|NCT00499863|537499710|FG000|Overall Study|Adverse Event|8|||
149005863|NCT00499863|537499711|FG001|Overall Study|Adverse Event|2|||
149005864|NCT00499863|537499710|FG000|Overall Study|Sponsor decision|2|||
149005865|NCT00499863|537499711|FG001|Overall Study|Sponsor decision|2|||
149005866|NCT00499863|537499710|FG000|Overall Study|Lost to Follow-up|1|||
149005867|NCT00499863|537499711|FG001|Overall Study|Lost to Follow-up|1|||
149005868|NCT02535364|537499712|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
149005869|NCT02535364|537499712|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
149005870|NCT02535364|537499712|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
149005871|NCT02535364|537499712|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
149005872|NCT02535364|537499712|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
149062034|NCT01928394|537710995|FG006|Follow-up Period|Lost to Follow-up|0|||
149062035|NCT01928394|537710996|FG007|Follow-up Period|Lost to Follow-up|0|||
149062036|NCT01928394|537710997|FG008|Follow-up Period|Lost to Follow-up|0|||
149062037|NCT01928394|537710998|FG009|Follow-up Period|Lost to Follow-up|0|||
149062038|NCT01928394|537710999|FG010|Follow-up Period|Lost to Follow-up|0|||
149062039|NCT01928394|537711000|FG011|Follow-up Period|Lost to Follow-up|1|||
149062040|NCT01928394|537711001|FG012|Follow-up Period|Lost to Follow-up|1|||
149062041|NCT01928394|537711002|FG013|Follow-up Period|Lost to Follow-up|0|||
149062042|NCT01928394|537711003|FG014|Follow-up Period|Lost to Follow-up|1|||
149062043|NCT01928394|537711004|FG015|Follow-up Period|Lost to Follow-up|0|||
149062044|NCT01928394|537711005|FG016|Follow-up Period|Lost to Follow-up|1|||
149062045|NCT01928394|537711006|FG017|Follow-up Period|Lost to Follow-up|0|||
149062046|NCT01928394|537711007|FG018|Follow-up Period|Lost to Follow-up|0|||
149062047|NCT01928394|537711008|FG019|Follow-up Period|Lost to Follow-up|0|||
149062048|NCT01928394|537711009|FG020|Follow-up Period|Lost to Follow-up|0|||
149062049|NCT01928394|537711010|FG021|Follow-up Period|Lost to Follow-up|0|||
149062050|NCT01928394|537711011|FG022|Follow-up Period|Lost to Follow-up|1|||
149062051|NCT02038777|537711012|FG000|Overall Study|Death|0|||
149062052|NCT02038777|537711013|FG001|Overall Study|Death|2|||
149062053|NCT02038777|537711014|FG002|Overall Study|Death|0|||
149062054|NCT02038777|537711015|FG003|Overall Study|Death|1|||
149062055|NCT02038777|537711016|FG004|Overall Study|Death|2|||
149062056|NCT02038777|537711017|FG005|Overall Study|Death|4|||
149062057|NCT02038777|537711018|FG006|Overall Study|Death|0|||
149062058|NCT02038777|537711019|FG007|Overall Study|Death|11|||
149062059|NCT02038777|537711012|FG000|Overall Study|Lost to Follow-up|0|||
149062060|NCT02038777|537711013|FG001|Overall Study|Lost to Follow-up|0|||
149062061|NCT02038777|537711014|FG002|Overall Study|Lost to Follow-up|0|||
149062062|NCT02038777|537711015|FG003|Overall Study|Lost to Follow-up|1|||
149062063|NCT02038777|537711016|FG004|Overall Study|Lost to Follow-up|0|||
149062064|NCT02038777|537711017|FG005|Overall Study|Lost to Follow-up|0|||
149062065|NCT02038777|537711018|FG006|Overall Study|Lost to Follow-up|0|||
149062066|NCT02038777|537711019|FG007|Overall Study|Lost to Follow-up|0|||
149062067|NCT02038777|537711012|FG000|Overall Study|Other|0|||
149062068|NCT02038777|537711013|FG001|Overall Study|Other|1|||
149062069|NCT02038777|537711014|FG002|Overall Study|Other|0|||
149062070|NCT02038777|537711015|FG003|Overall Study|Other|2|||
149062071|NCT02038777|537711016|FG004|Overall Study|Other|1|||
149062072|NCT02038777|537711017|FG005|Overall Study|Other|0|||
149062073|NCT02038777|537711018|FG006|Overall Study|Other|0|||
149062074|NCT02038777|537711019|FG007|Overall Study|Other|0|||
149062075|NCT02038777|537711012|FG000|Overall Study|Randomized but not treated|0|||
149062076|NCT02038777|537711013|FG001|Overall Study|Randomized but not treated|1|||
149062077|NCT02038777|537711014|FG002|Overall Study|Randomized but not treated|0|||
149062078|NCT02038777|537711015|FG003|Overall Study|Randomized but not treated|0|||
149062079|NCT02038777|537711016|FG004|Overall Study|Randomized but not treated|0|||
149062080|NCT02038777|537711017|FG005|Overall Study|Randomized but not treated|0|||
149062081|NCT02038777|537711018|FG006|Overall Study|Randomized but not treated|0|||
149062082|NCT02038777|537711019|FG007|Overall Study|Randomized but not treated|0|||
149062083|NCT02038777|537711012|FG000|Overall Study|Started Chemotherapy|1|||
149062084|NCT02038777|537711013|FG001|Overall Study|Started Chemotherapy|0|||
149062085|NCT02038777|537711014|FG002|Overall Study|Started Chemotherapy|3|||
149062086|NCT02038777|537711015|FG003|Overall Study|Started Chemotherapy|0|||
149062087|NCT02038777|537711016|FG004|Overall Study|Started Chemotherapy|0|||
149062088|NCT02038777|537711017|FG005|Overall Study|Started Chemotherapy|0|||
149062089|NCT02038777|537711018|FG006|Overall Study|Started Chemotherapy|0|||
149062090|NCT02038777|537711019|FG007|Overall Study|Started Chemotherapy|0|||
149062091|NCT02038777|537711012|FG000|Overall Study|participation terminated by sponsor|0|||
149062092|NCT02038777|537711013|FG001|Overall Study|participation terminated by sponsor|0|||
149062093|NCT02038777|537711014|FG002|Overall Study|participation terminated by sponsor|0|||
149062094|NCT02038777|537711015|FG003|Overall Study|participation terminated by sponsor|0|||
149062095|NCT02038777|537711016|FG004|Overall Study|participation terminated by sponsor|0|||
149062096|NCT02038777|537711017|FG005|Overall Study|participation terminated by sponsor|0|||
149062097|NCT02038777|537711018|FG006|Overall Study|participation terminated by sponsor|1|||
149062098|NCT02038777|537711019|FG007|Overall Study|participation terminated by sponsor|1|||
149062099|NCT05123586|537711033|FG000|Overall Study|Physician Decision|1|||
149062100|NCT05123586|537711034|FG001|Overall Study|Physician Decision|1|||
149062101|NCT05123586|537711033|FG000|Overall Study|Withdrawal by Subject|0|||
149062102|NCT05123586|537711034|FG001|Overall Study|Withdrawal by Subject|3|||
149062103|NCT03249090|537711044|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
149062104|NCT03249090|537711045|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
149062105|NCT03249090|537711044|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
149062106|NCT03249090|537711045|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
149062107|NCT03249090|537711044|FG000|3 Month Time Point|Voluntary withdrawal|6|||
149062108|NCT03249090|537711045|FG001|3 Month Time Point|Voluntary withdrawal|3|||
149062109|NCT03249090|537711044|FG000|3 Month Time Point|Changed oncology practice|4|||
149062110|NCT03249090|537711045|FG001|3 Month Time Point|Changed oncology practice|2|||
149062111|NCT03249090|537711044|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
149062112|NCT03249090|537711045|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
149062113|NCT03249090|537711044|FG000|12 Month Time Point|Voluntary withdrawal|35|||
149062114|NCT03249090|537711045|FG001|12 Month Time Point|Voluntary withdrawal|4|||
149062115|NCT03249090|537711044|FG000|12 Month Time Point|Changed oncology practice|20|||
149062116|NCT03249090|537711045|FG001|12 Month Time Point|Changed oncology practice|9|||
149062117|NCT04359654|537711051|FG000|Overall Study|Withdrawal by Subject|1|||
149062118|NCT04359654|537711052|FG001|Overall Study|Withdrawal by Subject|0|||
149062119|NCT04359654|537711051|FG000|Overall Study|Adverse Event|0|||
149062120|NCT04359654|537711052|FG001|Overall Study|Adverse Event|1|||
149062121|NCT06122194|537711053|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
149062122|NCT06122194|537711054|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
149062123|NCT06122194|537711055|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
149062124|NCT06122194|537711056|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
149062125|NCT04314778|537711057|FG000|Overall Study|Lost to Follow-up|5|||
149062126|NCT04314778|537711058|FG001|Overall Study|Lost to Follow-up|3|||
149062127|NCT05218096|537711059|FG000|Primary Evaluation|Withdrawal by Subject|0|||
149062128|NCT05218096|537711060|FG001|Primary Evaluation|Withdrawal by Subject|0|||
149062129|NCT05218096|537711061|FG002|Primary Evaluation|Withdrawal by Subject|2|||
149062130|NCT05218096|537711062|FG003|Primary Evaluation|Withdrawal by Subject|0|||
149062131|NCT05218096|537711063|FG004|Primary Evaluation|Withdrawal by Subject|0|||
149062132|NCT05218096|537711059|FG000|Primary Evaluation|Physician Decision|1|||
149062133|NCT05218096|537711060|FG001|Primary Evaluation|Physician Decision|0|||
149062134|NCT05218096|537711061|FG002|Primary Evaluation|Physician Decision|0|||
149062135|NCT05218096|537711062|FG003|Primary Evaluation|Physician Decision|0|||
149062136|NCT05218096|537711063|FG004|Primary Evaluation|Physician Decision|0|||
149062137|NCT05218096|537711059|FG000|Extended Treatment|Clinical Deterioration|1|||
149062138|NCT05218096|537711060|FG001|Extended Treatment|Clinical Deterioration|1|||
149062139|NCT05218096|537711061|FG002|Extended Treatment|Clinical Deterioration|0|||
149062140|NCT05218096|537711062|FG003|Extended Treatment|Clinical Deterioration|0|||
149062141|NCT05218096|537711063|FG004|Extended Treatment|Clinical Deterioration|0|||
149062142|NCT05218096|537711059|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
149062143|NCT05218096|537711060|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
149062144|NCT05218096|537711061|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
149062145|NCT05218096|537711062|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
149062146|NCT05218096|537711063|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
149062147|NCT05218096|537711059|FG000|Extended Treatment|Withdrawal by Subject|1|||
149062148|NCT05218096|537711060|FG001|Extended Treatment|Withdrawal by Subject|3|||
149062149|NCT05218096|537711061|FG002|Extended Treatment|Withdrawal by Subject|0|||
149062150|NCT05218096|537711062|FG003|Extended Treatment|Withdrawal by Subject|2|||
149062151|NCT05218096|537711063|FG004|Extended Treatment|Withdrawal by Subject|2|||
149062152|NCT05218096|537711059|FG000|Extended Treatment|Lack of Efficacy|3|||
149062153|NCT05218096|537711060|FG001|Extended Treatment|Lack of Efficacy|0|||
149062154|NCT05218096|537711061|FG002|Extended Treatment|Lack of Efficacy|0|||
149062155|NCT05218096|537711062|FG003|Extended Treatment|Lack of Efficacy|0|||
149062156|NCT05218096|537711063|FG004|Extended Treatment|Lack of Efficacy|0|||
149062157|NCT05218096|537711059|FG000|Extended Treatment|Physician Decision|0|||
149062158|NCT05218096|537711060|FG001|Extended Treatment|Physician Decision|1|||
149062159|NCT05218096|537711061|FG002|Extended Treatment|Physician Decision|0|||
149062160|NCT05218096|537711062|FG003|Extended Treatment|Physician Decision|0|||
149062161|NCT05218096|537711063|FG004|Extended Treatment|Physician Decision|0|||
149062162|NCT05218096|537711059|FG000|Open-label Extension|Adverse Event|1|||
149062163|NCT05218096|537711060|FG001|Open-label Extension|Adverse Event|0|||
149062164|NCT05218096|537711061|FG002|Open-label Extension|Adverse Event|0|||
149062165|NCT05218096|537711062|FG003|Open-label Extension|Adverse Event|0|||
149062166|NCT05218096|537711063|FG004|Open-label Extension|Adverse Event|1|||
149062167|NCT05218096|537711059|FG000|Open-label Extension|Pregnancy|0|||
149062168|NCT05218096|537711060|FG001|Open-label Extension|Pregnancy|0|||
149062169|NCT05218096|537711061|FG002|Open-label Extension|Pregnancy|0|||
149062170|NCT05218096|537711062|FG003|Open-label Extension|Pregnancy|0|||
149062171|NCT05218096|537711063|FG004|Open-label Extension|Pregnancy|1|||
148890312|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
148890313|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
149062172|NCT05218096|537711059|FG000|Open-label Extension|Lack of Efficacy|1|||
149062173|NCT05218096|537711060|FG001|Open-label Extension|Lack of Efficacy|2|||
149062174|NCT05218096|537711061|FG002|Open-label Extension|Lack of Efficacy|0|||
149062175|NCT05218096|537711062|FG003|Open-label Extension|Lack of Efficacy|0|||
149062176|NCT05218096|537711063|FG004|Open-label Extension|Lack of Efficacy|0|||
149062177|NCT05218096|537711059|FG000|Open-label Extension|Lost to Follow-up|1|||
149062178|NCT05218096|537711060|FG001|Open-label Extension|Lost to Follow-up|0|||
149062179|NCT05218096|537711061|FG002|Open-label Extension|Lost to Follow-up|0|||
149062180|NCT05218096|537711062|FG003|Open-label Extension|Lost to Follow-up|0|||
149062181|NCT05218096|537711063|FG004|Open-label Extension|Lost to Follow-up|0|||
149062182|NCT05218096|537711059|FG000|Open-label Extension|Death|0|||
149062183|NCT05218096|537711060|FG001|Open-label Extension|Death|0|||
149062184|NCT05218096|537711061|FG002|Open-label Extension|Death|0|||
149062185|NCT05218096|537711062|FG003|Open-label Extension|Death|1|||
149062186|NCT05218096|537711063|FG004|Open-label Extension|Death|0|||
149062187|NCT05218096|537711059|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
149062188|NCT05218096|537711060|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
149062189|NCT05218096|537711061|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
149062190|NCT05218096|537711062|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
149062191|NCT05218096|537711063|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
149062192|NCT04024020|537711066|FG000|Overall Study|Withdrawal by Subject|2|||
149062193|NCT04024020|537711067|FG001|Overall Study|Withdrawal by Subject|2|||
149062194|NCT05863156|537711074|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
149062195|NCT05863156|537711075|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
149062196|NCT05863156|537711076|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
149062197|NCT05256654|537711080|FG000|Overall Study|Adverse Event|0|||
149062198|NCT05256654|537711081|FG001|Overall Study|Adverse Event|0|||
149062199|NCT05256654|537711082|FG002|Overall Study|Adverse Event|1|||
149062200|NCT05256654|537711083|FG003|Overall Study|Adverse Event|0|||
149062201|NCT05256654|537711080|FG000|Overall Study|Lost to Follow-up|0|||
149062202|NCT05256654|537711081|FG001|Overall Study|Lost to Follow-up|0|||
149062203|NCT05256654|537711082|FG002|Overall Study|Lost to Follow-up|0|||
149062204|NCT05256654|537711083|FG003|Overall Study|Lost to Follow-up|1|||
149062205|NCT05256654|537711080|FG000|Overall Study|Withdrawal by Subject|1|||
149062206|NCT05256654|537711081|FG001|Overall Study|Withdrawal by Subject|2|||
149062207|NCT05256654|537711082|FG002|Overall Study|Withdrawal by Subject|1|||
149062208|NCT05256654|537711083|FG003|Overall Study|Withdrawal by Subject|3|||
149062209|NCT05256654|537711080|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
149062210|NCT05256654|537711081|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
149062211|NCT05256654|537711082|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
149062212|NCT05256654|537711083|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
149062213|NCT05256654|537711080|FG000|Overall Study|Other|0|||
149005873|NCT02535364|537499712|FG000|Part B Screening|Death|2|||
149005874|NCT02535364|537499712|FG000|Part B Screening|Physician Decision|1|||
149005875|NCT02535364|537499712|FG000|Part B Screening|Withdrawal by Subject|1|||
149005876|NCT02535364|537499712|FG000|Part B Screening|Adverse Event|1|||
149005877|NCT02535364|537499712|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
149005878|NCT02535364|537499712|FG000|Study Treatment|Death|1|||
149005879|NCT02535364|537499712|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
149005880|NCT02535364|537499712|FG000|12-Month Follow-up Period|Disease progression|22|||
149005881|NCT02535364|537499712|FG000|12-Month Follow-up Period|Death|5|||
149005882|NCT02535364|537499712|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
149005883|NCT02535364|537499712|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
149005884|NCT02535364|537499712|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
149005885|NCT00571701|537499713|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
149005886|NCT00571701|537499714|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
149005887|NCT00571701|537499713|FG000|First Intervention 12 Months|Death|1|||
149005888|NCT00571701|537499714|FG001|First Intervention 12 Months|Death|0|||
149005889|NCT00571701|537499713|FG000|Second Intervention 12 Months|Adverse Event|0|||
149005890|NCT00571701|537499714|FG001|Second Intervention 12 Months|Adverse Event|1|||
149005891|NCT00571701|537499713|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
149005892|NCT00571701|537499714|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
149005893|NCT00691132|537499715|FG000|Overall Study|Adverse Event|2|||
149005894|NCT00691132|537499716|FG001|Overall Study|Adverse Event|3|||
149005895|NCT00691132|537499715|FG000|Overall Study|Withdrawal by Subject|10|||
149005896|NCT00691132|537499716|FG001|Overall Study|Withdrawal by Subject|10|||
149005897|NCT00860067|537499719|FG000|Overall Study|Lost to Follow-up|46|||
149005898|NCT00860067|537499720|FG001|Overall Study|Lost to Follow-up|9|||
149005899|NCT00860067|537499721|FG002|Overall Study|Lost to Follow-up|9|||
149005900|NCT00860067|537499719|FG000|Overall Study|Withdrawal by Subject|4|||
149062214|NCT05256654|537711081|FG001|Overall Study|Other|0|||
149062215|NCT05256654|537711082|FG002|Overall Study|Other|0|||
149062216|NCT05256654|537711083|FG003|Overall Study|Other|1|||
149062217|NCT04862416|537711088|FG000|Overall Study|Withdrawal by Subject|0|||
149062218|NCT04862416|537711089|FG001|Overall Study|Withdrawal by Subject|1|||
149062219|NCT04862416|537711090|FG002|Overall Study|Withdrawal by Subject|0|||
149062220|NCT04862416|537711091|FG003|Overall Study|Withdrawal by Subject|1|||
149062221|NCT04862416|537711092|FG004|Overall Study|Withdrawal by Subject|0|||
149062222|NCT04862416|537711093|FG005|Overall Study|Withdrawal by Subject|0|||
149062223|NCT04862416|537711094|FG006|Overall Study|Withdrawal by Subject|0|||
149062224|NCT04862416|537711095|FG007|Overall Study|Withdrawal by Subject|0|||
149062225|NCT00746096|537711096|FG000|Overall Study|Adverse Event|1|||
149062226|NCT00746096|537711097|FG001|Overall Study|Adverse Event|0|||
149062227|NCT00746096|537711096|FG000|Overall Study|Withdrawal by Subject|5|||
149119802|NCT00006011|537917969|FG000|Overall Study|Ineligible|18|||
149005901|NCT00860067|537499720|FG001|Overall Study|Withdrawal by Subject|0|||
149005902|NCT00860067|537499721|FG002|Overall Study|Withdrawal by Subject|0|||
149005903|NCT00860067|537499719|FG000|Overall Study|Pregnancy|1|||
149005904|NCT00860067|537499720|FG001|Overall Study|Pregnancy|0|||
149005905|NCT00860067|537499721|FG002|Overall Study|Pregnancy|0|||
149005906|NCT01282801|537499722|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
149005907|NCT01282801|537499723|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
149005908|NCT01060553|537499726|FG000|Overall Study|Lost to Follow-up|3|||
149005909|NCT01060553|537499727|FG001|Overall Study|Lost to Follow-up|5|||
149005910|NCT01060553|537499726|FG000|Overall Study|Withdrawal by Subject|5|||
149005911|NCT01060553|537499727|FG001|Overall Study|Withdrawal by Subject|5|||
149005912|NCT01060553|537499726|FG000|Overall Study|Lack of Efficacy|1|||
149005913|NCT01060553|537499727|FG001|Overall Study|Lack of Efficacy|0|||
149005914|NCT01498822|537499729|FG000|Overall Study|Protocol Violation|8|||
149005915|NCT01498822|537499730|FG001|Overall Study|Protocol Violation|4|||
149005916|NCT01498822|537499729|FG000|Overall Study|Other Reason|5|||
149005917|NCT01498822|537499730|FG001|Overall Study|Other Reason|2|||
149005918|NCT01498822|537499729|FG000|Overall Study|Lack of Efficacy|7|||
149005919|NCT01498822|537499730|FG001|Overall Study|Lack of Efficacy|2|||
149005920|NCT01498822|537499729|FG000|Overall Study|AE, non-serious non-fatal|8|||
149005921|NCT01498822|537499730|FG001|Overall Study|AE, non-serious non-fatal|17|||
149005922|NCT01498822|537499729|FG000|Overall Study|SAE, non-fatal|2|||
149005923|NCT01498822|537499730|FG001|Overall Study|SAE, non-fatal|2|||
149005924|NCT01498822|537499729|FG000|Overall Study|Adverse Event, serious fatal|1|||
149005925|NCT01498822|537499730|FG001|Overall Study|Adverse Event, serious fatal|1|||
149005926|NCT01498822|537499729|FG000|Overall Study|Withdrawal by Subject|15|||
149005927|NCT01498822|537499730|FG001|Overall Study|Withdrawal by Subject|25|||
149005928|NCT01498822|537499729|FG000|Overall Study|Lost to Follow-up|8|||
149005929|NCT01498822|537499730|FG001|Overall Study|Lost to Follow-up|3|||
149005930|NCT04707196|537499731|FG000|Overall Study|Withdrawal by Subject|9|||
149005931|NCT04707196|537499732|FG001|Overall Study|Withdrawal by Subject|6|||
149005932|NCT04707196|537499731|FG000|Overall Study|Lost to Follow-up|1|||
149005933|NCT04707196|537499732|FG001|Overall Study|Lost to Follow-up|0|||
149005934|NCT04707196|537499731|FG000|Overall Study|Protocol Violation|4|||
149005935|NCT04707196|537499732|FG001|Overall Study|Protocol Violation|1|||
149005936|NCT04707196|537499731|FG000|Overall Study|Adverse Event|2|||
149005937|NCT04707196|537499732|FG001|Overall Study|Adverse Event|2|||
149005938|NCT04707196|537499731|FG000|Overall Study|Death|3|||
149005939|NCT04707196|537499732|FG001|Overall Study|Death|1|||
149005940|NCT04707196|537499731|FG000|Overall Study|Non-compliance with study drug|1|||
149005941|NCT04707196|537499732|FG001|Overall Study|Non-compliance with study drug|0|||
149005942|NCT04707196|537499731|FG000|Overall Study|Progressive disease|9|||
149005943|NCT04707196|537499732|FG001|Overall Study|Progressive disease|10|||
149005944|NCT01862796|537499733|FG000|Overall Study|Prohibited medications|0|||
149005945|NCT01862796|537499734|FG001|Overall Study|Prohibited medications|0|||
149005946|NCT01862796|537499735|FG002|Overall Study|Prohibited medications|1|||
149005947|NCT01462162|537499736|FG000|Overall Study|Adverse Event|5|||
149005948|NCT01462162|537499736|FG000|Overall Study|Lack of Efficacy|4|||
149005949|NCT01462162|537499736|FG000|Overall Study|Abnormal laboratory parameters|1|||
149005950|NCT01462162|537499736|FG000|Overall Study|Other|2|||
149005951|NCT03485911|537499737|FG000|Part 1|Perceived lack of efficacy|1|||
149005952|NCT03485911|537499738|FG001|Part 1|Perceived lack of efficacy|1|||
149005953|NCT03485911|537499739|FG002|Part 1|Perceived lack of efficacy|2|||
149005954|NCT03485911|537499740|FG003|Part 1|Perceived lack of efficacy|0|||
149005955|NCT03485911|537499737|FG000|Part 1|Subject withdrew consent|0|||
149005956|NCT03485911|537499738|FG001|Part 1|Subject withdrew consent|1|||
149005957|NCT03485911|537499739|FG002|Part 1|Subject withdrew consent|0|||
149005958|NCT03485911|537499740|FG003|Part 1|Subject withdrew consent|1|||
149005959|NCT03485911|537499737|FG000|Part 1|Lab abnormalities/AEs|3|||
149005960|NCT03485911|537499738|FG001|Part 1|Lab abnormalities/AEs|1|||
149005961|NCT03485911|537499739|FG002|Part 1|Lab abnormalities/AEs|1|||
149005962|NCT03485911|537499740|FG003|Part 1|Lab abnormalities/AEs|0|||
149005963|NCT03485911|537499737|FG000|Part 1|Withdrew Consent prior to dosing|0|||
149005964|NCT03485911|537499738|FG001|Part 1|Withdrew Consent prior to dosing|0|||
149005965|NCT03485911|537499739|FG002|Part 1|Withdrew Consent prior to dosing|0|||
149005966|NCT03485911|537499740|FG003|Part 1|Withdrew Consent prior to dosing|1|||
149005967|NCT03485911|537499737|FG000|Part 1|Other NOS|0|||
149005968|NCT03485911|537499738|FG001|Part 1|Other NOS|0|||
149005969|NCT03485911|537499739|FG002|Part 1|Other NOS|0|||
149005970|NCT03485911|537499740|FG003|Part 1|Other NOS|1|||
149005971|NCT03485911|537499737|FG000|Part 2|Perceived lack of efficacy|5|||
149005972|NCT03485911|537499738|FG001|Part 2|Perceived lack of efficacy|3|||
149005973|NCT03485911|537499739|FG002|Part 2|Perceived lack of efficacy|0|||
149005974|NCT03485911|537499740|FG003|Part 2|Perceived lack of efficacy|2|||
149005975|NCT03485911|537499737|FG000|Part 2|Subject withdrew consent|1|||
149005976|NCT03485911|537499738|FG001|Part 2|Subject withdrew consent|0|||
149005977|NCT03485911|537499739|FG002|Part 2|Subject withdrew consent|2|||
149005978|NCT03485911|537499740|FG003|Part 2|Subject withdrew consent|1|||
149005979|NCT03485911|537499737|FG000|Part 2|Lab abnormalities/AEs|1|||
149005980|NCT03485911|537499738|FG001|Part 2|Lab abnormalities/AEs|2|||
149062228|NCT00746096|537711097|FG001|Overall Study|Withdrawal by Subject|1|||
149062229|NCT00746096|537711096|FG000|Overall Study|Lost to Follow-up|2|||
149062230|NCT00746096|537711097|FG001|Overall Study|Lost to Follow-up|1|||
149062231|NCT00746096|537711096|FG000|Overall Study|Protocol Violation|1|||
149062232|NCT00746096|537711097|FG001|Overall Study|Protocol Violation|0|||
149062233|NCT00746096|537711096|FG000|Overall Study|No study drug treatment|1|||
149062234|NCT00746096|537711097|FG001|Overall Study|No study drug treatment|1|||
149062235|NCT01009788|537711104|FG000|Overall Study|Withdrawal by Subject|1|||
149062236|NCT01009788|537711105|FG001|Overall Study|Withdrawal by Subject|0|||
149062237|NCT01309672|537711107|FG000|Overall Study|Lack of Efficacy|20|||
149062238|NCT01309672|537711107|FG000|Overall Study|Other|9|||
149062239|NCT01309672|537711107|FG000|Overall Study|Adverse Event|5|||
149062240|NCT01309672|537711107|FG000|Overall Study|Withdrawal by Subject|3|||
149062241|NCT04141891|537711109|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
149062242|NCT04141891|537711110|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
149062243|NCT04141891|537711109|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
149062244|NCT04141891|537711110|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
149062245|NCT04141891|537711109|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
149062246|NCT04141891|537711110|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
149062247|NCT04141891|537711109|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
149062248|NCT04141891|537711110|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
149062249|NCT04141891|537711109|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
149062250|NCT04141891|537711110|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
149062251|NCT04141891|537711109|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
149062252|NCT04141891|537711110|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
149062253|NCT04141891|537711109|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
149062254|NCT04141891|537711110|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
149062255|NCT04141891|537711109|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
149062256|NCT04141891|537711110|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
149062257|NCT04141891|537711109|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
149062258|NCT04141891|537711110|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
149062259|NCT04141891|537711109|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
149062260|NCT04141891|537711110|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
149062261|NCT04141891|537711109|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
149062262|NCT04141891|537711110|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
149062263|NCT04141891|537711109|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
149062264|NCT04141891|537711110|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
149062265|NCT04141891|537711109|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
149062266|NCT04141891|537711110|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
149062267|NCT04141891|537711109|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
149062268|NCT04141891|537711110|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
149062269|NCT03295721|537711115|FG000|Overall Study|Adverse Event|1|||
149062270|NCT03295721|537711116|FG001|Overall Study|Adverse Event|0|||
149062271|NCT03295721|537711117|FG002|Overall Study|Adverse Event|0|||
149062272|NCT03295721|537711115|FG000|Overall Study|Lost to Follow-up|1|||
149062273|NCT03295721|537711116|FG001|Overall Study|Lost to Follow-up|1|||
149062274|NCT03295721|537711117|FG002|Overall Study|Lost to Follow-up|1|||
149062275|NCT03295721|537711115|FG000|Overall Study|Withdrawal by Subject|1|||
149062276|NCT03295721|537711116|FG001|Overall Study|Withdrawal by Subject|0|||
149062277|NCT03295721|537711117|FG002|Overall Study|Withdrawal by Subject|1|||
149062278|NCT03295721|537711115|FG000|Overall Study|Death|0|||
149062279|NCT03295721|537711116|FG001|Overall Study|Death|0|||
149062280|NCT03295721|537711117|FG002|Overall Study|Death|1|||
149062281|NCT03034356|537711119|FG000|Baseline|Lost to Follow-up|2|||
149062282|NCT03034356|537711120|FG001|Baseline|Lost to Follow-up|4|||
149062283|NCT03034356|537711119|FG000|Baseline|Withdrawal by Subject|2|||
149062284|NCT03034356|537711120|FG001|Baseline|Withdrawal by Subject|0|||
149062285|NCT03034356|537711119|FG000|Baseline|Physician Decision|0|||
149062286|NCT03034356|537711120|FG001|Baseline|Physician Decision|1|||
149062287|NCT03034356|537711119|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
149062288|NCT03034356|537711120|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
149062289|NCT03034356|537711119|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
149062290|NCT03034356|537711120|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
149062291|NCT03034356|537711119|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
149062292|NCT03034356|537711120|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
149062293|NCT03034356|537711119|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
149062294|NCT03034356|537711120|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
149062295|NCT02684227|537711121|FG000|Overall Study|Adverse Event|1|||
149062296|NCT02684227|537711122|FG001|Overall Study|Adverse Event|7|||
149062297|NCT02684227|537711121|FG000|Overall Study|Death|0|||
149062298|NCT02684227|537711122|FG001|Overall Study|Death|2|||
149062299|NCT02684227|537711121|FG000|Overall Study|Withdrawal by Subject|0|||
149005981|NCT03485911|537499739|FG002|Part 2|Lab abnormalities/AEs|0|||
149005982|NCT03485911|537499740|FG003|Part 2|Lab abnormalities/AEs|0|||
149005983|NCT03485911|537499737|FG000|Part 2|Other NOS|0|||
149005984|NCT03485911|537499738|FG001|Part 2|Other NOS|1|||
149005985|NCT03485911|537499739|FG002|Part 2|Other NOS|0|||
149005986|NCT03485911|537499740|FG003|Part 2|Other NOS|0|||
149005987|NCT03485911|537499737|FG000|Part 2|Intercurrent illness/new medical condition|1|||
149005988|NCT03485911|537499738|FG001|Part 2|Intercurrent illness/new medical condition|0|||
149005989|NCT03485911|537499739|FG002|Part 2|Intercurrent illness/new medical condition|0|||
149005990|NCT03485911|537499740|FG003|Part 2|Intercurrent illness/new medical condition|0|||
149005991|NCT03485911|537499737|FG000|Part 2|Investigator judgement|1|||
149005992|NCT03485911|537499738|FG001|Part 2|Investigator judgement|0|||
149005993|NCT03485911|537499739|FG002|Part 2|Investigator judgement|0|||
149005994|NCT03485911|537499740|FG003|Part 2|Investigator judgement|0|||
149005995|NCT03485911|537499737|FG000|Part 3|Perceived lack of efficacy|2|||
149005996|NCT03485911|537499738|FG001|Part 3|Perceived lack of efficacy|2|||
149005997|NCT03485911|537499739|FG002|Part 3|Perceived lack of efficacy|2|||
149005998|NCT03485911|537499740|FG003|Part 3|Perceived lack of efficacy|0|||
149005999|NCT03485911|537499737|FG000|Part 3|Subject withdrew consent|1|||
149006000|NCT03485911|537499738|FG001|Part 3|Subject withdrew consent|4|||
149006001|NCT03485911|537499739|FG002|Part 3|Subject withdrew consent|0|||
149006002|NCT03485911|537499740|FG003|Part 3|Subject withdrew consent|1|||
149006003|NCT03485911|537499737|FG000|Part 3|Lab abnormalities/AEs|1|||
149006004|NCT03485911|537499738|FG001|Part 3|Lab abnormalities/AEs|1|||
149006005|NCT03485911|537499739|FG002|Part 3|Lab abnormalities/AEs|0|||
149006006|NCT03485911|537499740|FG003|Part 3|Lab abnormalities/AEs|2|||
149006007|NCT03485911|537499737|FG000|Part 3|Other NOS|1|||
149006008|NCT03485911|537499738|FG001|Part 3|Other NOS|1|||
149006009|NCT03485911|537499739|FG002|Part 3|Other NOS|0|||
149006010|NCT03485911|537499740|FG003|Part 3|Other NOS|0|||
149006011|NCT03485911|537499737|FG000|Part 3|Intercurrent illness/new medical condition|0|||
149006012|NCT03485911|537499738|FG001|Part 3|Intercurrent illness/new medical condition|1|||
149006013|NCT03485911|537499739|FG002|Part 3|Intercurrent illness/new medical condition|1|||
149006014|NCT03485911|537499740|FG003|Part 3|Intercurrent illness/new medical condition|0|||
149006015|NCT03485911|537499737|FG000|Part 3|Sponsor discontinuation|1|||
149006016|NCT03485911|537499738|FG001|Part 3|Sponsor discontinuation|0|||
149006017|NCT03485911|537499739|FG002|Part 3|Sponsor discontinuation|0|||
149006018|NCT03485911|537499740|FG003|Part 3|Sponsor discontinuation|0|||
149006019|NCT03485911|537499737|FG000|Part 3|Berotralstat provided by alternative means|13|||
149006020|NCT03485911|537499738|FG001|Part 3|Berotralstat provided by alternative means|13|||
149006021|NCT03485911|537499739|FG002|Part 3|Berotralstat provided by alternative means|7|||
149006022|NCT03485911|537499740|FG003|Part 3|Berotralstat provided by alternative means|7|||
149006023|NCT03333928|537499741|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
149006024|NCT03333928|537499742|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
149006025|NCT03333928|537499743|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
149006026|NCT03333928|537499741|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
149006027|NCT03333928|537499742|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
149006028|NCT03333928|537499743|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
149006029|NCT03333928|537499741|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
149006030|NCT03333928|537499742|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
149006031|NCT03333928|537499743|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
149006032|NCT03333928|537499741|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
149006033|NCT03333928|537499742|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
149006034|NCT03333928|537499743|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
149006035|NCT03333928|537499741|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
149006036|NCT03333928|537499742|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
149006037|NCT03333928|537499743|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
149006038|NCT03333928|537499741|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
149006039|NCT03333928|537499742|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
149006040|NCT03333928|537499743|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
149006041|NCT03333928|537499741|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
149006042|NCT03333928|537499742|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
149006043|NCT03333928|537499743|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
149006044|NCT03333928|537499741|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
149006045|NCT03333928|537499742|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
149006046|NCT03333928|537499743|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
149006047|NCT01375205|537499754|FG000|Overall Study|Lost to Follow-up|15|||
149006048|NCT01375205|537499755|FG001|Overall Study|Lost to Follow-up|12|||
149006049|NCT01375205|537499754|FG000|Overall Study|Withdrawal by Subject|6|||
149006050|NCT01375205|537499755|FG001|Overall Study|Withdrawal by Subject|1|||
149006051|NCT01674621|537499756|FG000|Overall Study|Adverse Event|3|||
149006052|NCT01674621|537499757|FG001|Overall Study|Adverse Event|2|||
149006053|NCT01674621|537499758|FG002|Overall Study|Adverse Event|5|||
149062300|NCT02684227|537711122|FG001|Overall Study|Withdrawal by Subject|1|||
149062301|NCT02684227|537711121|FG000|Overall Study|Progressive Disease|0|||
149062302|NCT02684227|537711122|FG001|Overall Study|Progressive Disease|2|||
149062303|NCT05104463|537711123|FG000|Overall Study|Adverse Event|1|||
149062304|NCT05104463|537711124|FG001|Overall Study|Adverse Event|1|||
149062305|NCT05104463|537711123|FG000|Overall Study|Lost to Follow-up|1|||
149062306|NCT05104463|537711124|FG001|Overall Study|Lost to Follow-up|1|||
149062307|NCT05104463|537711123|FG000|Overall Study|Physician Decision|1|||
149062308|NCT05104463|537711124|FG001|Overall Study|Physician Decision|0|||
149062309|NCT05104463|537711123|FG000|Overall Study|Protocol Violation|0|||
149062310|NCT05104463|537711124|FG001|Overall Study|Protocol Violation|2|||
149062311|NCT05104463|537711123|FG000|Overall Study|Withdrawal by Subject|1|||
149062312|NCT05104463|537711124|FG001|Overall Study|Withdrawal by Subject|1|||
149062313|NCT05267470|537711125|FG000|Overall Study|Decision by sponsor|0|||
149062314|NCT05267470|537711126|FG001|Overall Study|Decision by sponsor|3|||
149062315|NCT05267470|537711127|FG002|Overall Study|Decision by sponsor|19|||
149062316|NCT05267470|537711128|FG003|Overall Study|Decision by sponsor|7|||
149062317|NCT05267470|537711129|FG004|Overall Study|Decision by sponsor|3|||
149062318|NCT05267470|537711125|FG000|Overall Study|Withdrawal by Subject|1|||
149062319|NCT05267470|537711126|FG001|Overall Study|Withdrawal by Subject|1|||
149062320|NCT05267470|537711127|FG002|Overall Study|Withdrawal by Subject|2|||
149062321|NCT05267470|537711128|FG003|Overall Study|Withdrawal by Subject|2|||
149062322|NCT05267470|537711129|FG004|Overall Study|Withdrawal by Subject|0|||
149062323|NCT05267470|537711125|FG000|Overall Study|Death|3|||
149062324|NCT05267470|537711126|FG001|Overall Study|Death|5|||
149062325|NCT05267470|537711127|FG002|Overall Study|Death|8|||
149062326|NCT05267470|537711128|FG003|Overall Study|Death|18|||
149062327|NCT05267470|537711129|FG004|Overall Study|Death|1|||
149062328|NCT05267470|537711125|FG000|Overall Study|Lost to Follow-up|0|||
149062329|NCT05267470|537711126|FG001|Overall Study|Lost to Follow-up|0|||
149062330|NCT05267470|537711127|FG002|Overall Study|Lost to Follow-up|0|||
149062331|NCT05267470|537711128|FG003|Overall Study|Lost to Follow-up|1|||
149062332|NCT05267470|537711129|FG004|Overall Study|Lost to Follow-up|0|||
149062333|NCT05809453|537712666|FG000|Overall Study|Withdrawal by Subject|1|||
149062334|NCT05809453|537712667|FG001|Overall Study|Withdrawal by Subject|0|||
149062335|NCT05809453|537712668|FG002|Overall Study|Withdrawal by Subject|0|||
149062336|NCT05809453|537712669|FG003|Overall Study|Withdrawal by Subject|0|||
149062337|NCT03916185|537712674|FG000|Overall Study|Lost to Follow-up|0|||
149062338|NCT03916185|537712675|FG001|Overall Study|Lost to Follow-up|1|||
149062339|NCT03916185|537712676|FG002|Overall Study|Lost to Follow-up|0|||
149062340|NCT03916185|537712677|FG003|Overall Study|Lost to Follow-up|0|||
149062341|NCT03916185|537712674|FG000|Overall Study|Moved|1|||
149062342|NCT03916185|537712675|FG001|Overall Study|Moved|0|||
149062343|NCT03916185|537712676|FG002|Overall Study|Moved|0|||
149062344|NCT03916185|537712677|FG003|Overall Study|Moved|1|||
149062345|NCT03916185|537712674|FG000|Overall Study|Not Able to Get to Clinic|1|||
149062346|NCT03916185|537712675|FG001|Overall Study|Not Able to Get to Clinic|0|||
149062347|NCT03916185|537712676|FG002|Overall Study|Not Able to Get to Clinic|0|||
149062348|NCT03916185|537712677|FG003|Overall Study|Not Able to Get to Clinic|0|||
149062349|NCT02460458|537712681|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
149062350|NCT02460458|537712681|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
149062351|NCT02460458|537712681|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
148890314|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
148890315|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
148890316|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
148890317|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
148890318|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
148890319|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
148890320|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
148890321|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
148890322|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
148890323|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
148890324|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
148890325|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
148890326|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
148890327|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
148890328|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
149062352|NCT02460458|537712681|FG000|First Prospective Phase|Lost to Follow-up|84|||
149062353|NCT02460458|537712681|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
149062354|NCT00696111|537712682|FG000|Overall Study|Withdrawal by Subject|17|||
148890329|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
149062355|NCT05299073|537712683|FG000|Overall Study|Withdrawal by Subject|0|||
149062356|NCT05299073|537712684|FG001|Overall Study|Withdrawal by Subject|0|||
149062357|NCT05299073|537712685|FG002|Overall Study|Withdrawal by Subject|1|||
149062358|NCT05299073|537712683|FG000|Overall Study|Adverse Event|0|||
149062359|NCT05299073|537712684|FG001|Overall Study|Adverse Event|1|||
149062360|NCT05299073|537712685|FG002|Overall Study|Adverse Event|0|||
149062361|NCT05299073|537712683|FG000|Overall Study|Lost to Follow-up|0|||
149062362|NCT05299073|537712684|FG001|Overall Study|Lost to Follow-up|1|||
149062363|NCT05299073|537712685|FG002|Overall Study|Lost to Follow-up|0|||
149062364|NCT01208662|537712689|FG000|Induction and Consolidation|Disease Progression|23|||
149062365|NCT01208662|537712690|FG001|Induction and Consolidation|Disease Progression|13|||
148890330|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
148890331|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
148890332|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
148890333|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
148890334|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
149062366|NCT01208662|537712691|FG002|Induction and Consolidation|Disease Progression|0|||
149062367|NCT01208662|537712689|FG000|Induction and Consolidation|Adverse Event|16|||
149062368|NCT01208662|537712690|FG001|Induction and Consolidation|Adverse Event|18|||
149062369|NCT01208662|537712691|FG002|Induction and Consolidation|Adverse Event|2|||
149062370|NCT01208662|537712689|FG000|Induction and Consolidation|MD or Participant Decision|16|||
149062371|NCT01208662|537712690|FG001|Induction and Consolidation|MD or Participant Decision|34|||
149062372|NCT01208662|537712691|FG002|Induction and Consolidation|MD or Participant Decision|4|||
149062373|NCT01208662|537712689|FG000|Induction and Consolidation|Death|1|||
149062374|NCT01208662|537712690|FG001|Induction and Consolidation|Death|3|||
149062375|NCT01208662|537712691|FG002|Induction and Consolidation|Death|1|||
149062376|NCT01208662|537712689|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
149062377|NCT01208662|537712690|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
149062378|NCT01208662|537712691|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
149062379|NCT01208662|537712689|FG000|Maintenance|Disease Progression|156|||
149062380|NCT01208662|537712690|FG001|Maintenance|Disease Progression|102|||
149062381|NCT01208662|537712691|FG002|Maintenance|Disease Progression|0|||
149062382|NCT01208662|537712689|FG000|Maintenance|Adverse Event|12|||
149062383|NCT01208662|537712690|FG001|Maintenance|Adverse Event|28|||
149062384|NCT01208662|537712691|FG002|Maintenance|Adverse Event|0|||
149062385|NCT01208662|537712689|FG000|Maintenance|MD or Participant Decision|24|||
149062386|NCT01208662|537712690|FG001|Maintenance|MD or Participant Decision|36|||
149062387|NCT01208662|537712691|FG002|Maintenance|MD or Participant Decision|0|||
149062388|NCT01208662|537712689|FG000|Maintenance|Death|0|||
149062389|NCT01208662|537712690|FG001|Maintenance|Death|3|||
149062390|NCT01208662|537712691|FG002|Maintenance|Death|0|||
149062391|NCT01208662|537712689|FG000|Maintenance|Discontinued for other reasons|21|||
149062392|NCT01208662|537712690|FG001|Maintenance|Discontinued for other reasons|31|||
149062393|NCT01208662|537712691|FG002|Maintenance|Discontinued for other reasons|0|||
149062394|NCT01208662|537712689|FG000|Maintenance|Still on Treatment|78|||
149062395|NCT01208662|537712690|FG001|Maintenance|Still on Treatment|89|||
149062396|NCT01208662|537712691|FG002|Maintenance|Still on Treatment|0|||
149062397|NCT05370040|537712692|FG000|Overall Study|Lost to Follow-up|0|||
149062398|NCT05370040|537712693|FG001|Overall Study|Lost to Follow-up|0|||
149062399|NCT05370040|537712694|FG002|Overall Study|Lost to Follow-up|1|||
149062400|NCT05370040|537712695|FG003|Overall Study|Lost to Follow-up|0|||
149062401|NCT05370040|537712696|FG004|Overall Study|Lost to Follow-up|1|||
149062402|NCT05370040|537712697|FG005|Overall Study|Lost to Follow-up|0|||
149062403|NCT03209973|537712698|FG000|Overall Study|Withdrawal by Subject|7|||
149062404|NCT03209973|537712698|FG000|Overall Study|Lost to Follow-up|2|||
149062405|NCT03209973|537712698|FG000|Overall Study|Death|8|||
149062406|NCT03209973|537712698|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
149062407|NCT03209973|537712698|FG000|Overall Study|Sponsor Decision|18|||
149062408|NCT03209973|537712698|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
149062409|NCT03209973|537712698|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
149062410|NCT04066205|537712699|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
149062411|NCT04066205|537712700|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
149062412|NCT04066205|537712699|FG000|T2 Immediate Post-Intervention|did not respond|5|||
149062413|NCT04066205|537712700|FG001|T2 Immediate Post-Intervention|did not respond|3|||
149062414|NCT04778397|537712702|FG000|Overall Study|Death|59|||
149062415|NCT04778397|537712703|FG001|Overall Study|Death|54|||
149062416|NCT04778397|537712704|FG002|Overall Study|Death|11|||
149062417|NCT04778397|537712705|FG003|Overall Study|Death|9|||
149062418|NCT04778397|537712702|FG000|Overall Study|Study Terminated by Sponsor|34|||
149062419|NCT04778397|537712703|FG001|Overall Study|Study Terminated by Sponsor|42|||
148890335|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
148890336|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
149062420|NCT04778397|537712704|FG002|Overall Study|Study Terminated by Sponsor|15|||
149062421|NCT04778397|537712705|FG003|Overall Study|Study Terminated by Sponsor|12|||
149062422|NCT04778397|537712702|FG000|Overall Study|Withdrew Consent|5|||
149062423|NCT04778397|537712703|FG001|Overall Study|Withdrew Consent|4|||
149062424|NCT04778397|537712704|FG002|Overall Study|Withdrew Consent|1|||
149062425|NCT04778397|537712705|FG003|Overall Study|Withdrew Consent|1|||
149062426|NCT04778397|537712702|FG000|Overall Study|Reason Not Specified|1|||
149062427|NCT04778397|537712703|FG001|Overall Study|Reason Not Specified|3|||
149062428|NCT04778397|537712704|FG002|Overall Study|Reason Not Specified|0|||
149062429|NCT04778397|537712705|FG003|Overall Study|Reason Not Specified|2|||
149062430|NCT04778397|537712702|FG000|Overall Study|Lost to Follow-up|2|||
149062431|NCT04778397|537712703|FG001|Overall Study|Lost to Follow-up|1|||
149062432|NCT04778397|537712704|FG002|Overall Study|Lost to Follow-up|0|||
149062433|NCT04778397|537712705|FG003|Overall Study|Lost to Follow-up|1|||
149062434|NCT04294641|537712706|FG000|Overall Study|Screen failure|4|||
149062435|NCT01627574|537712710|FG000|Overall Study|Withdrawal by Subject|8|||
149062436|NCT01627574|537712711|FG001|Overall Study|Withdrawal by Subject|5|||
149062437|NCT01627574|537712710|FG000|Overall Study|Lost to Follow-up|13|||
149062438|NCT01627574|537712711|FG001|Overall Study|Lost to Follow-up|13|||
149062439|NCT03513302|537712713|FG000|First Intervention (14 Days)|Screen failure|15|||
149062440|NCT03513302|537712714|FG001|First Intervention (14 Days)|Screen failure|16|||
149062441|NCT03756662|537712715|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
149062442|NCT04295512|537712718|FG000|Overall Study|Lack of family response to schedule assessment|0|||
149062443|NCT04295512|537712719|FG001|Overall Study|Lack of family response to schedule assessment|0|||
149062444|NCT04295512|537712720|FG002|Overall Study|Lack of family response to schedule assessment|0|||
149062445|NCT04295512|537712721|FG003|Overall Study|Lack of family response to schedule assessment|2|||
149062446|NCT04295512|537712718|FG000|Overall Study|Therapist did not refer eligible family|7|||
149062447|NCT04295512|537712719|FG001|Overall Study|Therapist did not refer eligible family|7|||
149062448|NCT04295512|537712720|FG002|Overall Study|Therapist did not refer eligible family|0|||
149062449|NCT04295512|537712721|FG003|Overall Study|Therapist did not refer eligible family|0|||
149062450|NCT05207956|537712727|FG000|Overall Study|Lost to follow up|1|||
149062451|NCT05207956|537712728|FG001|Overall Study|Lost to follow up|2|||
149062452|NCT01254864|537712729|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
149062453|NCT01254864|537712730|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
149062454|NCT01254864|537712731|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
149062455|NCT01254864|537712729|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
149062456|NCT01254864|537712730|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
149062457|NCT01254864|537712731|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
149062458|NCT01254864|537712729|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
149062459|NCT01254864|537712730|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
149062460|NCT01254864|537712731|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
149062461|NCT01254864|537712729|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
149062462|NCT01254864|537712730|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
149062463|NCT01254864|537712731|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
149062464|NCT01254864|537712729|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
149062465|NCT01254864|537712730|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
149062466|NCT01254864|537712731|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
149062467|NCT01254864|537712729|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
149062468|NCT01254864|537712730|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
149062469|NCT01254864|537712731|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
149062470|NCT01254864|537712729|FG000|Randomization Phase|Adverse Event|0|||
149062471|NCT01254864|537712730|FG001|Randomization Phase|Adverse Event|5|||
149062472|NCT01254864|537712731|FG002|Randomization Phase|Adverse Event|17|||
149062473|NCT01254864|537712729|FG000|Randomization Phase|Death|0|||
149062474|NCT01254864|537712730|FG001|Randomization Phase|Death|1|||
149062475|NCT01254864|537712731|FG002|Randomization Phase|Death|0|||
149062476|NCT01254864|537712729|FG000|Randomization Phase|Lost to Follow-up|0|||
149062477|NCT01254864|537712730|FG001|Randomization Phase|Lost to Follow-up|0|||
149062478|NCT01254864|537712731|FG002|Randomization Phase|Lost to Follow-up|1|||
149062479|NCT01254864|537712729|FG000|Randomization Phase|Physician Decision|0|||
149062480|NCT01254864|537712730|FG001|Randomization Phase|Physician Decision|20|||
149062481|NCT01254864|537712731|FG002|Randomization Phase|Physician Decision|25|||
149062482|NCT01254864|537712729|FG000|Randomization Phase|Withdrawal by Subject|0|||
149062483|NCT01254864|537712730|FG001|Randomization Phase|Withdrawal by Subject|4|||
149062484|NCT01254864|537712731|FG002|Randomization Phase|Withdrawal by Subject|2|||
149062485|NCT01254864|537712729|FG000|Randomization Phase|Non-Compliance|0|||
149062486|NCT01254864|537712730|FG001|Randomization Phase|Non-Compliance|1|||
149062487|NCT01254864|537712731|FG002|Randomization Phase|Non-Compliance|0|||
149062488|NCT01254864|537712729|FG000|Randomization Phase|Comorbidities|0|||
149062489|NCT01254864|537712730|FG001|Randomization Phase|Comorbidities|2|||
149062490|NCT01254864|537712731|FG002|Randomization Phase|Comorbidities|1|||
149062491|NCT03626220|537712734|FG000|Overall Study|Withdrawal by Subject|2|||
149062492|NCT03626220|537712735|FG001|Overall Study|Withdrawal by Subject|0|||
149062493|NCT04625725|537712736|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
149062494|NCT04625725|537712737|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
149062495|NCT04625725|537712738|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
149062496|NCT04625725|537712739|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
149062497|NCT04625725|537712740|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
149062498|NCT04625725|537712741|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
149062499|NCT04625725|537712736|FG000|Provent Main Study|Withdrawal by Subject|242|||
149062500|NCT04625725|537712737|FG001|Provent Main Study|Withdrawal by Subject|144|||
149062501|NCT04625725|537712738|FG002|Provent Main Study|Withdrawal by Subject|0|||
149062502|NCT04625725|537712739|FG003|Provent Main Study|Withdrawal by Subject|0|||
149062503|NCT04625725|537712740|FG004|Provent Main Study|Withdrawal by Subject|0|||
149062504|NCT04625725|537712741|FG005|Provent Main Study|Withdrawal by Subject|0|||
149062505|NCT04625725|537712736|FG000|Provent Main Study|Physician Decision|5|||
149062506|NCT04625725|537712737|FG001|Provent Main Study|Physician Decision|0|||
149062507|NCT04625725|537712738|FG002|Provent Main Study|Physician Decision|0|||
149062508|NCT04625725|537712739|FG003|Provent Main Study|Physician Decision|0|||
149062509|NCT04625725|537712740|FG004|Provent Main Study|Physician Decision|0|||
149062510|NCT04625725|537712741|FG005|Provent Main Study|Physician Decision|0|||
149062511|NCT04625725|537712736|FG000|Provent Main Study|Protocol Violation|1|||
149062512|NCT04625725|537712737|FG001|Provent Main Study|Protocol Violation|0|||
149062513|NCT04625725|537712738|FG002|Provent Main Study|Protocol Violation|0|||
149062514|NCT04625725|537712739|FG003|Provent Main Study|Protocol Violation|0|||
149062515|NCT04625725|537712740|FG004|Provent Main Study|Protocol Violation|0|||
149062516|NCT04625725|537712741|FG005|Provent Main Study|Protocol Violation|0|||
149062517|NCT04625725|537712736|FG000|Provent Main Study|Lost to Follow-up|357|||
149062518|NCT04625725|537712737|FG001|Provent Main Study|Lost to Follow-up|200|||
149062519|NCT04625725|537712738|FG002|Provent Main Study|Lost to Follow-up|0|||
149062520|NCT04625725|537712739|FG003|Provent Main Study|Lost to Follow-up|0|||
149062521|NCT04625725|537712740|FG004|Provent Main Study|Lost to Follow-up|0|||
149062522|NCT04625725|537712741|FG005|Provent Main Study|Lost to Follow-up|0|||
149062523|NCT04625725|537712736|FG000|Provent Main Study|Death|22|||
149062524|NCT04625725|537712737|FG001|Provent Main Study|Death|10|||
149062525|NCT04625725|537712738|FG002|Provent Main Study|Death|0|||
149062526|NCT04625725|537712739|FG003|Provent Main Study|Death|0|||
149062527|NCT04625725|537712740|FG004|Provent Main Study|Death|0|||
149062528|NCT04625725|537712741|FG005|Provent Main Study|Death|0|||
149062529|NCT04625725|537712736|FG000|Provent Main Study|Adverse Event|2|||
149062530|NCT04625725|537712737|FG001|Provent Main Study|Adverse Event|1|||
149062531|NCT04625725|537712738|FG002|Provent Main Study|Adverse Event|0|||
149062532|NCT04625725|537712739|FG003|Provent Main Study|Adverse Event|0|||
149062533|NCT04625725|537712740|FG004|Provent Main Study|Adverse Event|0|||
149062534|NCT04625725|537712741|FG005|Provent Main Study|Adverse Event|0|||
149062535|NCT04625725|537712736|FG000|Provent Main Study|Participants dosed in sub-study|310|||
149062536|NCT04625725|537712737|FG001|Provent Main Study|Participants dosed in sub-study|193|||
149062537|NCT04625725|537712738|FG002|Provent Main Study|Participants dosed in sub-study|0|||
149062538|NCT04625725|537712739|FG003|Provent Main Study|Participants dosed in sub-study|0|||
149062539|NCT04625725|537712740|FG004|Provent Main Study|Participants dosed in sub-study|0|||
149062540|NCT04625725|537712741|FG005|Provent Main Study|Participants dosed in sub-study|0|||
149062541|NCT04625725|537712736|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
149062542|NCT04625725|537712737|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
149062543|NCT04625725|537712738|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
149062544|NCT04625725|537712739|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
149062545|NCT04625725|537712740|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
149062546|NCT04625725|537712741|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
149062547|NCT04625725|537712736|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
149062548|NCT04625725|537712737|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
149062549|NCT04625725|537712738|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
149062550|NCT04625725|537712739|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
149062551|NCT04625725|537712740|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
149062552|NCT04625725|537712741|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
149062553|NCT04625725|537712736|FG000|Provent Main Study|INCARCERATION|3|||
149062554|NCT04625725|537712737|FG001|Provent Main Study|INCARCERATION|0|||
149062555|NCT04625725|537712738|FG002|Provent Main Study|INCARCERATION|0|||
149062556|NCT04625725|537712739|FG003|Provent Main Study|INCARCERATION|0|||
149062557|NCT04625725|537712740|FG004|Provent Main Study|INCARCERATION|0|||
149062558|NCT04625725|537712741|FG005|Provent Main Study|INCARCERATION|0|||
149062559|NCT04625725|537712736|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
149062560|NCT04625725|537712737|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
149062561|NCT04625725|537712738|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
149062562|NCT04625725|537712739|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
149062563|NCT04625725|537712740|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
149062564|NCT04625725|537712741|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
149062565|NCT04625725|537712736|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
149062566|NCT04625725|537712737|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
149062567|NCT04625725|537712738|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
149062568|NCT04625725|537712739|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
149062569|NCT04625725|537712740|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
149062570|NCT04625725|537712741|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
149119803|NCT00006011|537917970|FG001|Overall Study|Ineligible|16|||
149006054|NCT01674621|537499759|FG003|Overall Study|Adverse Event|5|||
149006055|NCT01674621|537499760|FG004|Overall Study|Adverse Event|1|||
149006056|NCT01674621|537499756|FG000|Overall Study|Inability to Complete Study Procedures|0|||
149006057|NCT01674621|537499757|FG001|Overall Study|Inability to Complete Study Procedures|0|||
149006058|NCT01674621|537499758|FG002|Overall Study|Inability to Complete Study Procedures|0|||
149006059|NCT01674621|537499759|FG003|Overall Study|Inability to Complete Study Procedures|0|||
149006060|NCT01674621|537499760|FG004|Overall Study|Inability to Complete Study Procedures|2|||
149006061|NCT01674621|537499756|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
149006062|NCT01674621|537499757|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
149006063|NCT01674621|537499758|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
149006064|NCT01674621|537499759|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
149006065|NCT01674621|537499760|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
149006066|NCT01674621|537499756|FG000|Overall Study|Withdrawal by Subject|2|||
149006067|NCT01674621|537499757|FG001|Overall Study|Withdrawal by Subject|5|||
149006068|NCT01674621|537499758|FG002|Overall Study|Withdrawal by Subject|2|||
149006069|NCT01674621|537499759|FG003|Overall Study|Withdrawal by Subject|0|||
149006070|NCT01674621|537499760|FG004|Overall Study|Withdrawal by Subject|1|||
149006071|NCT01674621|537499756|FG000|Overall Study|Other than specified|0|||
149006072|NCT01674621|537499757|FG001|Overall Study|Other than specified|1|||
149006073|NCT01674621|537499758|FG002|Overall Study|Other than specified|0|||
149006074|NCT01674621|537499759|FG003|Overall Study|Other than specified|0|||
149006075|NCT01674621|537499760|FG004|Overall Study|Other than specified|2|||
149006076|NCT01148862|537499761|FG000|Second Intervention|Withdrawal by Subject|0|||
149006077|NCT01148862|537499762|FG001|Second Intervention|Withdrawal by Subject|2|||
149006078|NCT05031078|537499763|FG000|Overall Study|Withdrawal by Subject|0|||
149006079|NCT05031078|537499764|FG001|Overall Study|Withdrawal by Subject|1|||
149006080|NCT05031078|537499765|FG002|Overall Study|Withdrawal by Subject|0|||
149006081|NCT03815019|537499766|FG000|Overall Study|Withdrawal by Subject|6|||
149006082|NCT03815019|537499767|FG001|Overall Study|Withdrawal by Subject|8|||
149006083|NCT05398796|537499768|FG000|Overall Study|Participant moved from the area|0|||
149006084|NCT05398796|537499769|FG001|Overall Study|Participant moved from the area|1|||
149006085|NCT05398796|537499770|FG002|Overall Study|Participant moved from the area|0|||
149006086|NCT05398796|537499771|FG003|Overall Study|Participant moved from the area|0|||
149006087|NCT04270747|537499773|FG000|Through Week 16|Adverse Event|1|||
149006088|NCT04270747|537499774|FG001|Through Week 16|Adverse Event|2|||
149006089|NCT04270747|537499775|FG002|Through Week 16|Adverse Event|0|||
149006090|NCT04270747|537499773|FG000|Through Week 16|Death|0|||
149006091|NCT04270747|537499774|FG001|Through Week 16|Death|2|||
149006092|NCT04270747|537499775|FG002|Through Week 16|Death|0|||
149006093|NCT04270747|537499773|FG000|Through Week 16|Consent Withdrawn|3|||
149006094|NCT04270747|537499774|FG001|Through Week 16|Consent Withdrawn|3|||
149006095|NCT04270747|537499775|FG002|Through Week 16|Consent Withdrawn|0|||
149006096|NCT04270747|537499773|FG000|Through Week 16|Physician Decision|1|||
149006097|NCT04270747|537499774|FG001|Through Week 16|Physician Decision|1|||
149006098|NCT04270747|537499775|FG002|Through Week 16|Physician Decision|0|||
149006099|NCT04270747|537499773|FG000|Through Week 16|Lost to Follow-up|2|||
149006100|NCT04270747|537499774|FG001|Through Week 16|Lost to Follow-up|0|||
149006101|NCT04270747|537499775|FG002|Through Week 16|Lost to Follow-up|0|||
149006102|NCT04270747|537499773|FG000|Through Week 16|Protocol Violation|1|||
149006103|NCT04270747|537499774|FG001|Through Week 16|Protocol Violation|2|||
149006104|NCT04270747|537499775|FG002|Through Week 16|Protocol Violation|0|||
149006105|NCT04270747|537499773|FG000|Through Week 16|Protocol Specified Criteria|6|||
149006106|NCT04270747|537499774|FG001|Through Week 16|Protocol Specified Criteria|7|||
149006107|NCT04270747|537499775|FG002|Through Week 16|Protocol Specified Criteria|0|||
149006108|NCT04270747|537499773|FG000|Through Week 16|Miscellaneous|1|||
149006109|NCT04270747|537499774|FG001|Through Week 16|Miscellaneous|1|||
149006110|NCT04270747|537499775|FG002|Through Week 16|Miscellaneous|0|||
149006111|NCT04270747|537499773|FG000|Post Week 16|Adverse Event|7|||
149006112|NCT04270747|537499774|FG001|Post Week 16|Adverse Event|5|||
149006113|NCT04270747|537499775|FG002|Post Week 16|Adverse Event|1|||
149006114|NCT04270747|537499773|FG000|Post Week 16|Death|2|||
149006115|NCT04270747|537499774|FG001|Post Week 16|Death|0|||
149006116|NCT04270747|537499775|FG002|Post Week 16|Death|2|||
149006117|NCT04270747|537499773|FG000|Post Week 16|Consent Withdrawn|4|||
149006118|NCT04270747|537499774|FG001|Post Week 16|Consent Withdrawn|3|||
149006119|NCT04270747|537499775|FG002|Post Week 16|Consent Withdrawn|6|||
149006120|NCT04270747|537499773|FG000|Post Week 16|Physician Decision|3|||
149006121|NCT04270747|537499774|FG001|Post Week 16|Physician Decision|1|||
149006122|NCT04270747|537499775|FG002|Post Week 16|Physician Decision|1|||
149006123|NCT04270747|537499773|FG000|Post Week 16|Lost to Follow-up|2|||
149006124|NCT04270747|537499774|FG001|Post Week 16|Lost to Follow-up|1|||
149006125|NCT04270747|537499775|FG002|Post Week 16|Lost to Follow-up|0|||
149006126|NCT04270747|537499773|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
149006127|NCT04270747|537499774|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
149006128|NCT04270747|537499775|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
149006129|NCT04270747|537499773|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
149006130|NCT04270747|537499774|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
149006131|NCT04270747|537499775|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
149006132|NCT04270747|537499773|FG000|Post Week 16|Miscellaneous|1|||
149006133|NCT04270747|537499774|FG001|Post Week 16|Miscellaneous|0|||
149006134|NCT04270747|537499775|FG002|Post Week 16|Miscellaneous|1|||
149006135|NCT05960097|537499777|FG000|Overall Study|Lost to Follow-up|3|||
149006136|NCT05960097|537499778|FG001|Overall Study|Lost to Follow-up|1|||
149006137|NCT05960097|537499779|FG002|Overall Study|Lost to Follow-up|1|||
149006138|NCT05960097|537499780|FG003|Overall Study|Lost to Follow-up|2|||
149006139|NCT05960097|537499781|FG004|Overall Study|Lost to Follow-up|1|||
149006140|NCT05960097|537499782|FG005|Overall Study|Lost to Follow-up|1|||
149006141|NCT05960097|537499783|FG006|Overall Study|Lost to Follow-up|2|||
149006142|NCT05960097|537499784|FG007|Overall Study|Lost to Follow-up|3|||
149006143|NCT05960097|537499777|FG000|Overall Study|Physician Decision|0|||
149006144|NCT05960097|537499778|FG001|Overall Study|Physician Decision|0|||
149006145|NCT05960097|537499779|FG002|Overall Study|Physician Decision|0|||
149006146|NCT05960097|537499780|FG003|Overall Study|Physician Decision|0|||
149006147|NCT05960097|537499781|FG004|Overall Study|Physician Decision|0|||
149006148|NCT05960097|537499782|FG005|Overall Study|Physician Decision|0|||
149006149|NCT05960097|537499783|FG006|Overall Study|Physician Decision|1|||
149006150|NCT05960097|537499784|FG007|Overall Study|Physician Decision|0|||
149006151|NCT05960097|537499777|FG000|Overall Study|Withdrawal by Subject|1|||
149006152|NCT05960097|537499778|FG001|Overall Study|Withdrawal by Subject|0|||
149006153|NCT05960097|537499779|FG002|Overall Study|Withdrawal by Subject|0|||
149006154|NCT05960097|537499780|FG003|Overall Study|Withdrawal by Subject|1|||
149006155|NCT05960097|537499781|FG004|Overall Study|Withdrawal by Subject|1|||
149006156|NCT05960097|537499782|FG005|Overall Study|Withdrawal by Subject|0|||
149006157|NCT05960097|537499783|FG006|Overall Study|Withdrawal by Subject|0|||
149006158|NCT05960097|537499784|FG007|Overall Study|Withdrawal by Subject|0|||
149006159|NCT05960097|537499777|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006160|NCT05960097|537499778|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006161|NCT05960097|537499779|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
149006162|NCT05960097|537499780|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006163|NCT05960097|537499781|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006164|NCT05960097|537499782|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006165|NCT05960097|537499783|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006166|NCT05960097|537499784|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
149006167|NCT01784068|537499785|FG000|NTCS Phase|Adverse Event|5|||
149006168|NCT01784068|537499786|FG001|NTCS Phase|Adverse Event|0|||
149006169|NCT01784068|537499785|FG000|NTCS Phase|Physician Decision|2|||
149006170|NCT01784068|537499786|FG001|NTCS Phase|Physician Decision|0|||
149006171|NCT01784068|537499785|FG000|NTCS Phase|Patient/guardian decision|3|||
149006172|NCT01784068|537499786|FG001|NTCS Phase|Patient/guardian decision|0|||
149006173|NCT01784068|537499785|FG000|NTCS Phase|Death|2|||
149006174|NCT01784068|537499786|FG001|NTCS Phase|Death|0|||
149006175|NCT01784068|537499785|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
149006176|NCT01784068|537499786|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
149006177|NCT01784068|537499785|FG000|TFR Phase|Physician Decision|0|||
149006178|NCT01784068|537499786|FG001|TFR Phase|Physician Decision|1|||
149006179|NCT01784068|537499785|FG000|TFR Phase|Patient/guardian decision|0|||
149006180|NCT01784068|537499786|FG001|TFR Phase|Patient/guardian decision|3|||
149006181|NCT01784068|537499785|FG000|TFR Phase|Death|0|||
149006182|NCT01784068|537499786|FG001|TFR Phase|Death|1|||
149006183|NCT01784068|537499785|FG000|TFR Phase|Lack of Efficacy|0|||
149006184|NCT01784068|537499786|FG001|TFR Phase|Lack of Efficacy|88|||
149006185|NCT06027619|537499787|FG000|Overall Study|Adverse Event|0|||
149006186|NCT06027619|537499788|FG001|Overall Study|Adverse Event|0|||
149006187|NCT06027619|537499789|FG002|Overall Study|Adverse Event|1|||
149006188|NCT01108458|537501776|FG000|Overall Study|Withdrawal by Subject|1|||
149006189|NCT01392300|537501791|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
149006190|NCT01392300|537501792|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
149006191|NCT01392300|537501793|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
149006192|NCT01392300|537501791|FG000|Main Period (MP)|Withdrawal by Subject|5|||
149006193|NCT01392300|537501792|FG001|Main Period (MP)|Withdrawal by Subject|1|||
149006194|NCT01392300|537501793|FG002|Main Period (MP)|Withdrawal by Subject|0|||
149006195|NCT01392300|537501791|FG000|Main Period (MP)|Lost to Follow-up|3|||
149006196|NCT01392300|537501792|FG001|Main Period (MP)|Lost to Follow-up|3|||
149006197|NCT01392300|537501793|FG002|Main Period (MP)|Lost to Follow-up|0|||
149006198|NCT01392300|537501791|FG000|Main Period (MP)|Non-compliance|1|||
149006199|NCT01392300|537501792|FG001|Main Period (MP)|Non-compliance|0|||
149006200|NCT01392300|537501793|FG002|Main Period (MP)|Non-compliance|0|||
149006201|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
149006202|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
149006203|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
149062571|NCT04625725|537712736|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
149062572|NCT04625725|537712737|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
149062573|NCT04625725|537712738|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
149062574|NCT04625725|537712739|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
149062575|NCT04625725|537712740|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
149062576|NCT04625725|537712741|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
149062577|NCT04625725|537712736|FG000|Provent Main Study|MISSING REASON|0|||
149062578|NCT04625725|537712737|FG001|Provent Main Study|MISSING REASON|1|||
149062579|NCT04625725|537712738|FG002|Provent Main Study|MISSING REASON|0|||
149062580|NCT04625725|537712739|FG003|Provent Main Study|MISSING REASON|0|||
149062581|NCT04625725|537712740|FG004|Provent Main Study|MISSING REASON|0|||
149062582|NCT04625725|537712741|FG005|Provent Main Study|MISSING REASON|0|||
149062583|NCT04625725|537712736|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
149062584|NCT04625725|537712737|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
149062585|NCT04625725|537712738|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
149062586|NCT04625725|537712739|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
149062587|NCT04625725|537712740|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
149062588|NCT04625725|537712741|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
149062589|NCT04625725|537712736|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
149062590|NCT04625725|537712737|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
149062591|NCT04625725|537712738|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
149062592|NCT04625725|537712739|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
149062593|NCT04625725|537712740|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
149062594|NCT04625725|537712741|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
149062595|NCT04625725|537712736|FG000|Provent Sub Study|Lost to Follow-up|0|||
149062596|NCT04625725|537712737|FG001|Provent Sub Study|Lost to Follow-up|0|||
149062597|NCT04625725|537712738|FG002|Provent Sub Study|Lost to Follow-up|20|||
149062598|NCT04625725|537712739|FG003|Provent Sub Study|Lost to Follow-up|10|||
149062599|NCT04625725|537712740|FG004|Provent Sub Study|Lost to Follow-up|6|||
149062600|NCT04625725|537712741|FG005|Provent Sub Study|Lost to Follow-up|4|||
149062601|NCT04625725|537712736|FG000|Provent Sub Study|Death|0|||
149062602|NCT04625725|537712737|FG001|Provent Sub Study|Death|0|||
149062603|NCT04625725|537712738|FG002|Provent Sub Study|Death|8|||
149062604|NCT04625725|537712739|FG003|Provent Sub Study|Death|5|||
149062605|NCT04625725|537712740|FG004|Provent Sub Study|Death|0|||
149062606|NCT04625725|537712741|FG005|Provent Sub Study|Death|1|||
149062607|NCT04625725|537712736|FG000|Provent Sub Study|Adverse Event|0|||
149062608|NCT04625725|537712737|FG001|Provent Sub Study|Adverse Event|0|||
149062609|NCT04625725|537712738|FG002|Provent Sub Study|Adverse Event|0|||
149062610|NCT04625725|537712739|FG003|Provent Sub Study|Adverse Event|0|||
149062611|NCT04625725|537712740|FG004|Provent Sub Study|Adverse Event|0|||
149062612|NCT04625725|537712741|FG005|Provent Sub Study|Adverse Event|1|||
149062613|NCT04625725|537712736|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
148890337|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
148890338|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
148890339|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
148890340|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
148890341|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
148890342|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
148890343|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
148890344|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
148890345|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890346|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
148890347|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890348|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
148890349|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890350|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890351|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890352|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890353|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
148890354|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
148890355|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
148890356|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
148890357|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
148890358|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
148890359|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
148890360|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
148890361|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
148890362|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
148890363|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
149062614|NCT04625725|537712737|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
149062615|NCT04625725|537712738|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
149062616|NCT04625725|537712739|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
149062617|NCT04625725|537712740|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
149062618|NCT04625725|537712741|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
149062619|NCT04625725|537712736|FG000|Provent Sub Study|Withdrawal by Subject|0|||
149062620|NCT04625725|537712737|FG001|Provent Sub Study|Withdrawal by Subject|0|||
149062621|NCT04625725|537712738|FG002|Provent Sub Study|Withdrawal by Subject|11|||
149062622|NCT04625725|537712739|FG003|Provent Sub Study|Withdrawal by Subject|13|||
149062623|NCT04625725|537712740|FG004|Provent Sub Study|Withdrawal by Subject|5|||
149062624|NCT04625725|537712741|FG005|Provent Sub Study|Withdrawal by Subject|6|||
149062625|NCT04625725|537712736|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
149062626|NCT04625725|537712737|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
149062627|NCT04625725|537712738|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
149062628|NCT04625725|537712739|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
149062629|NCT04625725|537712740|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
149062630|NCT04625725|537712741|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
149062631|NCT01828112|537712742|FG000|Treatment Phase|Adverse Event|7|||
149062632|NCT01828112|537712743|FG001|Treatment Phase|Adverse Event|8|||
149062633|NCT01828112|537712744|FG002|Treatment Phase|Adverse Event|0|||
149062634|NCT01828112|537712742|FG000|Treatment Phase|Death|9|||
149062635|NCT01828112|537712743|FG001|Treatment Phase|Death|5|||
149062636|NCT01828112|537712744|FG002|Treatment Phase|Death|0|||
149062637|NCT01828112|537712742|FG000|Treatment Phase|No longer required treatment|0|||
149062638|NCT01828112|537712743|FG001|Treatment Phase|No longer required treatment|1|||
149062639|NCT01828112|537712744|FG002|Treatment Phase|No longer required treatment|0|||
149062640|NCT01828112|537712742|FG000|Treatment Phase|Physician Decision|6|||
149062641|NCT01828112|537712743|FG001|Treatment Phase|Physician Decision|7|||
149062642|NCT01828112|537712744|FG002|Treatment Phase|Physician Decision|0|||
149062643|NCT01828112|537712742|FG000|Treatment Phase|Pregnancy|1|||
149062644|NCT01828112|537712743|FG001|Treatment Phase|Pregnancy|0|||
149062645|NCT01828112|537712744|FG002|Treatment Phase|Pregnancy|0|||
149062646|NCT01828112|537712742|FG000|Treatment Phase|Progressive disease|79|||
149062647|NCT01828112|537712743|FG001|Treatment Phase|Progressive disease|87|||
149062648|NCT01828112|537712744|FG002|Treatment Phase|Progressive disease|0|||
149062649|NCT01828112|537712742|FG000|Treatment Phase|Study terminated by sponsor|1|||
149062650|NCT01828112|537712743|FG001|Treatment Phase|Study terminated by sponsor|0|||
149062651|NCT01828112|537712744|FG002|Treatment Phase|Study terminated by sponsor|0|||
149062652|NCT01828112|537712742|FG000|Treatment Phase|Subject/guardian decision|12|||
149062653|NCT01828112|537712743|FG001|Treatment Phase|Subject/guardian decision|8|||
149062654|NCT01828112|537712744|FG002|Treatment Phase|Subject/guardian decision|0|||
149062655|NCT01828112|537712742|FG000|Extension Treatment Phase|Adverse Event|0|||
149062656|NCT01828112|537712743|FG001|Extension Treatment Phase|Adverse Event|0|||
149062657|NCT01828112|537712744|FG002|Extension Treatment Phase|Adverse Event|6|||
149062658|NCT01828112|537712742|FG000|Extension Treatment Phase|Death|0|||
149062659|NCT01828112|537712743|FG001|Extension Treatment Phase|Death|0|||
149062660|NCT01828112|537712744|FG002|Extension Treatment Phase|Death|17|||
149062661|NCT01828112|537712742|FG000|Extension Treatment Phase|Physician Decision|0|||
149062662|NCT01828112|537712743|FG001|Extension Treatment Phase|Physician Decision|0|||
149062663|NCT01828112|537712744|FG002|Extension Treatment Phase|Physician Decision|5|||
149062664|NCT01828112|537712742|FG000|Extension Treatment Phase|Progressive disease|0|||
149062665|NCT01828112|537712743|FG001|Extension Treatment Phase|Progressive disease|0|||
149062666|NCT01828112|537712744|FG002|Extension Treatment Phase|Progressive disease|46|||
149062667|NCT01828112|537712742|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
149062668|NCT01828112|537712743|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
149062669|NCT01828112|537712744|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
149062670|NCT01828112|537712742|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
149062671|NCT01828112|537712743|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
149062672|NCT01828112|537712744|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
149062673|NCT04308681|537712749|FG000|Pre-Treatment|Not reported|1|||
149062674|NCT04308681|537712750|FG001|Pre-Treatment|Not reported|1|||
149062675|NCT04308681|537712751|FG002|Pre-Treatment|Not reported|0|||
149062676|NCT04308681|537712752|FG003|Pre-Treatment|Not reported|0|||
149062677|NCT04308681|537712753|FG004|Pre-Treatment|Not reported|0|||
149062678|NCT04308681|537712754|FG005|Pre-Treatment|Not reported|2|||
149062679|NCT04308681|537712755|FG006|Pre-Treatment|Not reported|0|||
149062680|NCT04308681|537712756|FG007|Pre-Treatment|Not reported|0|||
149062681|NCT04308681|537712749|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
149062682|NCT04308681|537712750|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
149062683|NCT04308681|537712751|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
149062684|NCT04308681|537712752|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
149062685|NCT04308681|537712753|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
149062686|NCT04308681|537712754|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
149062687|NCT04308681|537712755|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
149062688|NCT04308681|537712756|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
149062689|NCT04308681|537712749|FG000|Treatment up to Week 26|Other reasons|2|||
149062690|NCT04308681|537712750|FG001|Treatment up to Week 26|Other reasons|0|||
149062691|NCT04308681|537712751|FG002|Treatment up to Week 26|Other reasons|0|||
149062692|NCT04308681|537712752|FG003|Treatment up to Week 26|Other reasons|0|||
148890364|NCT02365649|537077199|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890365|NCT02365649|537077200|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890366|NCT02365649|537077201|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
148890367|NCT02365649|537077202|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890368|NCT02365649|537077203|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890369|NCT02365649|537077204|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890370|NCT02365649|537077205|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890371|NCT02365649|537077206|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890372|NCT02365649|537077207|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890373|NCT02365649|537077208|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
148890374|NCT02365649|537077199|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890375|NCT02365649|537077200|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890376|NCT02365649|537077201|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890377|NCT02365649|537077202|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890378|NCT02365649|537077203|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890379|NCT02365649|537077204|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890380|NCT02365649|537077205|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
148890381|NCT02365649|537077206|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890382|NCT02365649|537077207|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890383|NCT02365649|537077208|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
148890384|NCT02365649|537077199|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890385|NCT02365649|537077200|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890386|NCT02365649|537077201|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890387|NCT02365649|537077202|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890388|NCT02365649|537077203|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890389|NCT02365649|537077204|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890390|NCT02365649|537077205|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
148890391|NCT02365649|537077206|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
148890392|NCT02365649|537077207|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
148890393|NCT02365649|537077208|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
148890394|NCT02365649|537077199|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
148890395|NCT02365649|537077200|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
148890396|NCT02365649|537077201|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
148890397|NCT02365649|537077202|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
148890398|NCT02365649|537077203|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
148890399|NCT02365649|537077204|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
148890400|NCT02365649|537077205|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
148890401|NCT02365649|537077206|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
148890402|NCT02365649|537077207|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
148890403|NCT02365649|537077208|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
148890404|NCT02365649|537077199|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
148890405|NCT02365649|537077200|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
149062693|NCT04308681|537712753|FG004|Treatment up to Week 26|Other reasons|1|||
149062694|NCT04308681|537712754|FG005|Treatment up to Week 26|Other reasons|1|||
149062695|NCT04308681|537712755|FG006|Treatment up to Week 26|Other reasons|0|||
149062696|NCT04308681|537712756|FG007|Treatment up to Week 26|Other reasons|0|||
149062697|NCT04308681|537712749|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
149062698|NCT04308681|537712750|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
149062699|NCT04308681|537712751|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
149062700|NCT04308681|537712752|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
149062701|NCT04308681|537712753|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
149062702|NCT04308681|537712754|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
149062703|NCT04308681|537712755|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
149062704|NCT04308681|537712756|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
149062705|NCT04308681|537712749|FG000|Treatment up to Week 26|Adverse Event|6|||
149062706|NCT04308681|537712750|FG001|Treatment up to Week 26|Adverse Event|5|||
149062707|NCT04308681|537712751|FG002|Treatment up to Week 26|Adverse Event|5|||
149062708|NCT04308681|537712752|FG003|Treatment up to Week 26|Adverse Event|0|||
149062709|NCT04308681|537712753|FG004|Treatment up to Week 26|Adverse Event|6|||
149062710|NCT04308681|537712754|FG005|Treatment up to Week 26|Adverse Event|1|||
149062711|NCT04308681|537712755|FG006|Treatment up to Week 26|Adverse Event|0|||
149062712|NCT04308681|537712756|FG007|Treatment up to Week 26|Adverse Event|0|||
149062713|NCT04308681|537712749|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
149062714|NCT04308681|537712750|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
149062715|NCT04308681|537712751|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
149062716|NCT04308681|537712752|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
149062717|NCT04308681|537712753|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
149062718|NCT04308681|537712754|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
149062719|NCT04308681|537712755|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
149062720|NCT04308681|537712756|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
149062721|NCT04308681|537712749|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
149062722|NCT04308681|537712750|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
149062723|NCT04308681|537712751|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
149062724|NCT04308681|537712752|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
149062725|NCT04308681|537712753|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
149062726|NCT04308681|537712754|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
149062727|NCT04308681|537712755|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
149062728|NCT04308681|537712756|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
149062729|NCT04308681|537712749|FG000|OTE - 26 Weeks|Death|0|||
149062730|NCT04308681|537712750|FG001|OTE - 26 Weeks|Death|1|||
149062731|NCT04308681|537712751|FG002|OTE - 26 Weeks|Death|0|||
149062732|NCT04308681|537712752|FG003|OTE - 26 Weeks|Death|0|||
149062733|NCT04308681|537712753|FG004|OTE - 26 Weeks|Death|0|||
149062734|NCT04308681|537712754|FG005|OTE - 26 Weeks|Death|0|||
149062735|NCT04308681|537712755|FG006|OTE - 26 Weeks|Death|1|||
149062736|NCT04308681|537712756|FG007|OTE - 26 Weeks|Death|0|||
149062737|NCT04308681|537712749|FG000|OTE - 26 Weeks|Adverse Event|0|||
149062738|NCT04308681|537712750|FG001|OTE - 26 Weeks|Adverse Event|2|||
149062739|NCT04308681|537712751|FG002|OTE - 26 Weeks|Adverse Event|8|||
149062740|NCT04308681|537712752|FG003|OTE - 26 Weeks|Adverse Event|3|||
149062741|NCT04308681|537712753|FG004|OTE - 26 Weeks|Adverse Event|0|||
149062742|NCT04308681|537712754|FG005|OTE - 26 Weeks|Adverse Event|1|||
149062743|NCT04308681|537712755|FG006|OTE - 26 Weeks|Adverse Event|2|||
149062744|NCT04308681|537712756|FG007|OTE - 26 Weeks|Adverse Event|0|||
149062745|NCT04308681|537712749|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
149062746|NCT04308681|537712750|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
149062747|NCT04308681|537712751|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
149062748|NCT04308681|537712752|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
149062749|NCT04308681|537712753|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
149062750|NCT04308681|537712754|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
149062751|NCT04308681|537712755|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
149062752|NCT04308681|537712756|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
149062753|NCT05565820|537712757|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
149062754|NCT05565820|537712758|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
149062755|NCT05565820|537712757|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
149062756|NCT05565820|537712758|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
149062757|NCT04689256|537712760|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
149062758|NCT04689256|537712761|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
149062759|NCT03556293|537712762|FG000|Overall Study|Ineligible for analysis|1904|||
149062760|NCT03556293|537712763|FG001|Overall Study|Ineligible for analysis|1471|||
149062761|NCT03556293|537712764|FG002|Overall Study|Ineligible for analysis|1091|||
149062762|NCT03556293|537712765|FG003|Overall Study|Ineligible for analysis|1269|||
149062763|NCT05828017|537712775|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
149062764|NCT04132518|537712776|FG000|Overall Study|Prematurely withdrawn from the study|0|||
149062765|NCT04132518|537712777|FG001|Overall Study|Prematurely withdrawn from the study|9|||
149062766|NCT04132518|537712778|FG002|Overall Study|Prematurely withdrawn from the study|1|||
149062767|NCT05425420|537712780|FG000|Overall Study|Physician Decision|1|||
149062768|NCT05425420|537712780|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
149062769|NCT04056611|537712783|FG000|Overall Study|Physician Decision|1|||
149062770|NCT02631746|537712784|FG000|Overall Study|Lack of Efficacy|3|||
149062771|NCT04571619|537712785|FG000|Phase 1|Death|22|||
149062772|NCT04571619|537712786|FG001|Phase 1|Death|18|||
149062773|NCT04571619|537712785|FG000|Phase 1|Withdrawal by Subject|7|||
149062774|NCT04571619|537712786|FG001|Phase 1|Withdrawal by Subject|2|||
149062775|NCT04571619|537712785|FG000|Phase 2|Death|13|||
149062776|NCT04571619|537712786|FG001|Phase 2|Death|16|||
149062777|NCT04571619|537712785|FG000|Phase 2|Withdrawal by Subject|6|||
149062778|NCT04571619|537712786|FG001|Phase 2|Withdrawal by Subject|4|||
148890406|NCT02365649|537077201|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
149062779|NCT04167553|537712787|FG000|Overall Study|Withdrawal by Subject|1|||
149062780|NCT04167553|537712788|FG001|Overall Study|Withdrawal by Subject|0|||
149062781|NCT04167553|537712789|FG002|Overall Study|Withdrawal by Subject|1|||
149062782|NCT04167553|537712790|FG003|Overall Study|Withdrawal by Subject|2|||
149062783|NCT04167553|537712791|FG004|Overall Study|Withdrawal by Subject|1|||
149062784|NCT04167553|537712792|FG005|Overall Study|Withdrawal by Subject|0|||
149062785|NCT04167553|537712793|FG006|Overall Study|Withdrawal by Subject|0|||
149062786|NCT04167553|537712787|FG000|Overall Study|Physician Decision|0|||
149062787|NCT04167553|537712788|FG001|Overall Study|Physician Decision|0|||
149062788|NCT04167553|537712789|FG002|Overall Study|Physician Decision|0|||
149062789|NCT04167553|537712790|FG003|Overall Study|Physician Decision|0|||
149062790|NCT04167553|537712791|FG004|Overall Study|Physician Decision|2|||
149062791|NCT04167553|537712792|FG005|Overall Study|Physician Decision|2|||
149062792|NCT04167553|537712793|FG006|Overall Study|Physician Decision|0|||
149062793|NCT04167553|537712787|FG000|Overall Study|Lost to Follow-up|0|||
149062794|NCT04167553|537712788|FG001|Overall Study|Lost to Follow-up|0|||
149062795|NCT04167553|537712789|FG002|Overall Study|Lost to Follow-up|2|||
149062796|NCT04167553|537712790|FG003|Overall Study|Lost to Follow-up|0|||
149062797|NCT04167553|537712791|FG004|Overall Study|Lost to Follow-up|0|||
149062798|NCT04167553|537712792|FG005|Overall Study|Lost to Follow-up|0|||
149062799|NCT04167553|537712793|FG006|Overall Study|Lost to Follow-up|0|||
149062800|NCT04479761|537712807|FG000|Overall Study|could not perform the balance tasks|1|||
149062801|NCT04479761|537712808|FG001|Overall Study|could not perform the balance tasks|0|||
149062802|NCT04479761|537712809|FG002|Overall Study|could not perform the balance tasks|0|||
149062803|NCT04479761|537712807|FG000|Overall Study|Adverse Event|1|||
149062804|NCT04479761|537712808|FG001|Overall Study|Adverse Event|0|||
149062805|NCT04479761|537712809|FG002|Overall Study|Adverse Event|0|||
149062806|NCT04479761|537712807|FG000|Overall Study|one control did not meet screening criteria|0|||
149062807|NCT04479761|537712808|FG001|Overall Study|one control did not meet screening criteria|0|||
149062808|NCT04479761|537712809|FG002|Overall Study|one control did not meet screening criteria|1|||
149062809|NCT04479761|537712807|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
149062810|NCT04479761|537712808|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
149062811|NCT04479761|537712809|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
149062812|NCT04183283|537714520|FG000|Period 1|Withdrawal by Subject|0|||
149062813|NCT04183283|537714521|FG001|Period 1|Withdrawal by Subject|1|||
149062814|NCT04183283|537714522|FG002|Period 1|Withdrawal by Subject|0|||
149062815|NCT04183283|537714523|FG003|Period 1|Withdrawal by Subject|0|||
149062816|NCT04183283|537714520|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
149062817|NCT04183283|537714521|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
149062818|NCT04183283|537714522|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
149062819|NCT04183283|537714523|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
149062820|NCT03220035|537714525|FG000|Overall Study|Adverse Event|1|||
149062821|NCT03220035|537714525|FG000|Overall Study|Protocol Violation|1|||
149062822|NCT03220035|537714525|FG000|Overall Study|Progressive Disease|2|||
149062823|NCT03386578|537714527|FG000|PK Component|Lost to Follow-up|0|||
149062824|NCT03386578|537714528|FG001|PK Component|Lost to Follow-up|1|||
149062825|NCT03386578|537714529|FG002|PK Component|Lost to Follow-up|0|||
149062826|NCT03386578|537714530|FG003|PK Component|Lost to Follow-up|0|||
149062827|NCT03386578|537714531|FG004|PK Component|Lost to Follow-up|0|||
149062828|NCT03386578|537714532|FG005|PK Component|Lost to Follow-up|0|||
149062829|NCT03386578|537714533|FG006|PK Component|Lost to Follow-up|1|||
149062830|NCT03386578|537714534|FG007|PK Component|Lost to Follow-up|0|||
149062831|NCT03386578|537714535|FG008|PK Component|Lost to Follow-up|0|||
149062832|NCT03386578|537714536|FG009|PK Component|Lost to Follow-up|0|||
149062833|NCT03386578|537714527|FG000|PK Component|Stillbirth/Abortion|0|||
149062834|NCT03386578|537714528|FG001|PK Component|Stillbirth/Abortion|0|||
149062835|NCT03386578|537714529|FG002|PK Component|Stillbirth/Abortion|0|||
149062836|NCT03386578|537714530|FG003|PK Component|Stillbirth/Abortion|0|||
149062837|NCT03386578|537714531|FG004|PK Component|Stillbirth/Abortion|0|||
149062838|NCT03386578|537714532|FG005|PK Component|Stillbirth/Abortion|2|||
149062839|NCT03386578|537714533|FG006|PK Component|Stillbirth/Abortion|0|||
149062840|NCT03386578|537714534|FG007|PK Component|Stillbirth/Abortion|0|||
149062841|NCT03386578|537714535|FG008|PK Component|Stillbirth/Abortion|0|||
149062842|NCT03386578|537714536|FG009|PK Component|Stillbirth/Abortion|0|||
149062843|NCT03386578|537714527|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
149062844|NCT03386578|537714528|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
149062845|NCT03386578|537714529|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
149062846|NCT03386578|537714530|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
149062847|NCT03386578|537714531|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
149062848|NCT03386578|537714532|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
149062849|NCT03386578|537714533|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
149062850|NCT03386578|537714534|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
149062851|NCT03386578|537714535|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
149062852|NCT03386578|537714536|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
149062853|NCT03386578|537714527|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
149062854|NCT03386578|537714528|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
149062855|NCT03386578|537714529|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
149062856|NCT03386578|537714530|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
149062857|NCT03386578|537714531|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
149062858|NCT03386578|537714532|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
149062859|NCT03386578|537714533|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
149062860|NCT03386578|537714534|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
149062861|NCT03386578|537714535|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
149062862|NCT03386578|537714536|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
149062863|NCT03386578|537714527|FG000|PrEP Comparison Component Step 1|Death|0|||
149062864|NCT03386578|537714528|FG001|PrEP Comparison Component Step 1|Death|0|||
149062865|NCT03386578|537714529|FG002|PrEP Comparison Component Step 1|Death|1|||
149062866|NCT03386578|537714530|FG003|PrEP Comparison Component Step 1|Death|0|||
149062867|NCT03386578|537714531|FG004|PrEP Comparison Component Step 1|Death|0|||
149062868|NCT03386578|537714532|FG005|PrEP Comparison Component Step 1|Death|0|||
149062869|NCT03386578|537714533|FG006|PrEP Comparison Component Step 1|Death|0|||
149062870|NCT03386578|537714534|FG007|PrEP Comparison Component Step 1|Death|9|||
149062871|NCT03386578|537714535|FG008|PrEP Comparison Component Step 1|Death|5|||
149062872|NCT03386578|537714536|FG009|PrEP Comparison Component Step 1|Death|0|||
149062873|NCT03386578|537714527|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062874|NCT03386578|537714528|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062875|NCT03386578|537714529|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062876|NCT03386578|537714530|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
149062877|NCT03386578|537714531|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062878|NCT03386578|537714532|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062879|NCT03386578|537714533|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062880|NCT03386578|537714534|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062881|NCT03386578|537714535|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
149062882|NCT03386578|537714536|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
149062883|NCT03386578|537714527|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062884|NCT03386578|537714528|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062885|NCT03386578|537714529|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062886|NCT03386578|537714530|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062887|NCT03386578|537714531|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062888|NCT03386578|537714532|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062889|NCT03386578|537714533|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062890|NCT03386578|537714534|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
149062891|NCT03386578|537714535|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
149062892|NCT03386578|537714536|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
149062893|NCT03386578|537714527|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062894|NCT03386578|537714528|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062895|NCT03386578|537714529|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062896|NCT03386578|537714530|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062897|NCT03386578|537714531|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062898|NCT03386578|537714532|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062899|NCT03386578|537714533|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062900|NCT03386578|537714534|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
149062901|NCT03386578|537714535|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
149062902|NCT03386578|537714536|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
149062903|NCT02424617|537714537|FG000|Overall Study|Adverse Event|0|||
149062904|NCT02424617|537714538|FG001|Overall Study|Adverse Event|1|||
149062905|NCT02424617|537714539|FG002|Overall Study|Adverse Event|0|||
149062906|NCT02424617|537714540|FG003|Overall Study|Adverse Event|0|||
149062907|NCT02424617|537714537|FG000|Overall Study|Investigator Decision|0|||
149062908|NCT02424617|537714538|FG001|Overall Study|Investigator Decision|0|||
149062909|NCT02424617|537714539|FG002|Overall Study|Investigator Decision|0|||
149062910|NCT02424617|537714540|FG003|Overall Study|Investigator Decision|1|||
149062911|NCT02424617|537714537|FG000|Overall Study|Withdrawal by Subject|1|||
149062912|NCT02424617|537714538|FG001|Overall Study|Withdrawal by Subject|1|||
149062913|NCT02424617|537714539|FG002|Overall Study|Withdrawal by Subject|0|||
149062914|NCT02424617|537714540|FG003|Overall Study|Withdrawal by Subject|1|||
149062915|NCT02424617|537714537|FG000|Overall Study|Progressive Disease|7|||
149062916|NCT02424617|537714538|FG001|Overall Study|Progressive Disease|6|||
149062917|NCT02424617|537714539|FG002|Overall Study|Progressive Disease|11|||
149062918|NCT02424617|537714540|FG003|Overall Study|Progressive Disease|10|||
149062919|NCT02424617|537714537|FG000|Overall Study|Other|0|||
149062920|NCT02424617|537714538|FG001|Overall Study|Other|0|||
149062921|NCT02424617|537714539|FG002|Overall Study|Other|0|||
149062922|NCT02424617|537714540|FG003|Overall Study|Other|1|||
149062923|NCT02694822|537714541|FG000|Phase 1|Death|2|||
149062924|NCT02694822|537714542|FG001|Phase 1|Death|1|||
149062925|NCT02694822|537714543|FG002|Phase 1|Death|6|||
149062926|NCT02694822|537714544|FG003|Phase 1|Death|6|||
149062927|NCT02694822|537714545|FG004|Phase 1|Death|3|||
149062928|NCT02694822|537714546|FG005|Phase 1|Death|0|||
149062929|NCT02694822|537714541|FG000|Phase 1|Withdrawal by Subject|2|||
149062930|NCT02694822|537714542|FG001|Phase 1|Withdrawal by Subject|2|||
149062931|NCT02694822|537714543|FG002|Phase 1|Withdrawal by Subject|4|||
149062932|NCT02694822|537714544|FG003|Phase 1|Withdrawal by Subject|8|||
149062933|NCT02694822|537714545|FG004|Phase 1|Withdrawal by Subject|1|||
149062934|NCT02694822|537714546|FG005|Phase 1|Withdrawal by Subject|0|||
149062935|NCT02694822|537714541|FG000|Phase 2|Death|0|||
149062936|NCT02694822|537714542|FG001|Phase 2|Death|0|||
149062937|NCT02694822|537714543|FG002|Phase 2|Death|0|||
149062938|NCT02694822|537714544|FG003|Phase 2|Death|0|||
149062939|NCT02694822|537714545|FG004|Phase 2|Death|0|||
149062940|NCT02694822|537714546|FG005|Phase 2|Death|26|||
149062941|NCT02694822|537714541|FG000|Phase 2|Withdrawal by Subject|0|||
149062942|NCT02694822|537714542|FG001|Phase 2|Withdrawal by Subject|0|||
149062943|NCT02694822|537714543|FG002|Phase 2|Withdrawal by Subject|0|||
149062944|NCT02694822|537714544|FG003|Phase 2|Withdrawal by Subject|0|||
149062945|NCT02694822|537714545|FG004|Phase 2|Withdrawal by Subject|0|||
149062946|NCT02694822|537714546|FG005|Phase 2|Withdrawal by Subject|13|||
149062947|NCT02694822|537714541|FG000|Phase 2|Administrative Study Closure|0|||
149062948|NCT02694822|537714542|FG001|Phase 2|Administrative Study Closure|0|||
149062949|NCT02694822|537714543|FG002|Phase 2|Administrative Study Closure|0|||
149062950|NCT02694822|537714544|FG003|Phase 2|Administrative Study Closure|0|||
149062951|NCT02694822|537714545|FG004|Phase 2|Administrative Study Closure|0|||
149062952|NCT02694822|537714546|FG005|Phase 2|Administrative Study Closure|2|||
149062953|NCT02694822|537714541|FG000|Phase 2|Lost to Follow-up|0|||
149062954|NCT02694822|537714542|FG001|Phase 2|Lost to Follow-up|0|||
149062955|NCT02694822|537714543|FG002|Phase 2|Lost to Follow-up|0|||
149062956|NCT02694822|537714544|FG003|Phase 2|Lost to Follow-up|0|||
149062957|NCT02694822|537714545|FG004|Phase 2|Lost to Follow-up|0|||
149062958|NCT02694822|537714546|FG005|Phase 2|Lost to Follow-up|1|||
149062959|NCT02694822|537714541|FG000|Phase 2|Participant Transferred to Another Site|0|||
149062960|NCT02694822|537714542|FG001|Phase 2|Participant Transferred to Another Site|0|||
149062961|NCT02694822|537714543|FG002|Phase 2|Participant Transferred to Another Site|0|||
149062962|NCT02694822|537714544|FG003|Phase 2|Participant Transferred to Another Site|0|||
149062963|NCT02694822|537714545|FG004|Phase 2|Participant Transferred to Another Site|0|||
149062964|NCT02694822|537714546|FG005|Phase 2|Participant Transferred to Another Site|1|||
149062965|NCT01868997|537714547|FG000|Overall Study|Adverse Event|2|||
149062966|NCT01868997|537714548|FG001|Overall Study|Adverse Event|5|||
149062967|NCT01868997|537714547|FG000|Overall Study|Lack of Efficacy|2|||
149062968|NCT01868997|537714548|FG001|Overall Study|Lack of Efficacy|0|||
149062969|NCT01868997|537714547|FG000|Overall Study|Other|3|||
149062970|NCT01868997|537714548|FG001|Overall Study|Other|1|||
149062971|NCT01960452|537714549|FG000|Overall Study|Withdrawal by Subject|2|||
149062972|NCT01960452|537714550|FG001|Overall Study|Withdrawal by Subject|1|||
149062973|NCT01960452|537714549|FG000|Overall Study|Sleep apnea in Night 1|1|||
149062974|NCT01960452|537714550|FG001|Overall Study|Sleep apnea in Night 1|0|||
149062975|NCT01960452|537714549|FG000|Overall Study|Poor Sleep in Night 1|0|||
149062976|NCT01960452|537714550|FG001|Overall Study|Poor Sleep in Night 1|2|||
149062977|NCT01960452|537714549|FG000|Overall Study|No Sex/Age Match Night 1|1|||
149062978|NCT01960452|537714550|FG001|Overall Study|No Sex/Age Match Night 1|0|||
149062979|NCT01960452|537714549|FG000|Overall Study|No Sex/Age Match Night 2|0|||
149062980|NCT01960452|537714550|FG001|Overall Study|No Sex/Age Match Night 2|2|||
149062981|NCT01960452|537714549|FG000|Overall Study|Technical Difficulties Night 2|2|||
149062982|NCT01960452|537714550|FG001|Overall Study|Technical Difficulties Night 2|0|||
149062983|NCT04730739|537714553|FG000|Overall Study|Death|1|||
149062984|NCT03308877|537714554|FG000|Overall Study|Lost to Follow-up|32|||
149062985|NCT03308877|537714555|FG001|Overall Study|Lost to Follow-up|28|||
149062986|NCT05646355|537714563|FG000|Overall Study|Lost to Follow-up|1|||
149062987|NCT05646355|537714564|FG001|Overall Study|Lost to Follow-up|0|||
149062988|NCT05646355|537714563|FG000|Overall Study|translated materials not available for pilot|2|||
149062989|NCT05646355|537714564|FG001|Overall Study|translated materials not available for pilot|0|||
149062990|NCT05646355|537714563|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
149062991|NCT05646355|537714564|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
149062992|NCT03523572|537714567|FG000|Dose Escalation|Progressive disease|1|||
149062993|NCT03523572|537714568|FG001|Dose Escalation|Progressive disease|0|||
149062994|NCT03523572|537714569|FG002|Dose Escalation|Progressive disease|0|||
149062995|NCT03523572|537714570|FG003|Dose Escalation|Progressive disease|0|||
149062996|NCT03523572|537714571|FG004|Dose Escalation|Progressive disease|0|||
149062997|NCT03523572|537714572|FG005|Dose Escalation|Progressive disease|0|||
149062998|NCT03523572|537714567|FG000|Dose Escalation|Clinical Progression|0|||
149062999|NCT03523572|537714568|FG001|Dose Escalation|Clinical Progression|1|||
149063000|NCT03523572|537714569|FG002|Dose Escalation|Clinical Progression|0|||
149063001|NCT03523572|537714570|FG003|Dose Escalation|Clinical Progression|0|||
149063002|NCT03523572|537714571|FG004|Dose Escalation|Clinical Progression|0|||
149063003|NCT03523572|537714572|FG005|Dose Escalation|Clinical Progression|0|||
149063004|NCT03523572|537714567|FG000|Dose Escalation|Adverse Event|2|||
149063005|NCT03523572|537714568|FG001|Dose Escalation|Adverse Event|0|||
149063006|NCT03523572|537714569|FG002|Dose Escalation|Adverse Event|0|||
149063007|NCT03523572|537714570|FG003|Dose Escalation|Adverse Event|0|||
149063008|NCT03523572|537714571|FG004|Dose Escalation|Adverse Event|0|||
149063009|NCT03523572|537714572|FG005|Dose Escalation|Adverse Event|0|||
149063010|NCT03523572|537714567|FG000|Dose Escalation|Physician Decision|1|||
149063011|NCT03523572|537714568|FG001|Dose Escalation|Physician Decision|1|||
149063012|NCT03523572|537714569|FG002|Dose Escalation|Physician Decision|0|||
149063013|NCT03523572|537714570|FG003|Dose Escalation|Physician Decision|0|||
149063014|NCT03523572|537714571|FG004|Dose Escalation|Physician Decision|0|||
149063015|NCT03523572|537714572|FG005|Dose Escalation|Physician Decision|0|||
149063016|NCT03523572|537714567|FG000|Dose Expansion|Progressive Disease|0|||
149063017|NCT03523572|537714568|FG001|Dose Expansion|Progressive Disease|0|||
149063018|NCT03523572|537714569|FG002|Dose Expansion|Progressive Disease|9|||
149063019|NCT03523572|537714570|FG003|Dose Expansion|Progressive Disease|11|||
149063020|NCT03523572|537714571|FG004|Dose Expansion|Progressive Disease|15|||
149063021|NCT03523572|537714572|FG005|Dose Expansion|Progressive Disease|2|||
149063022|NCT03523572|537714567|FG000|Dose Expansion|Clinical Progression|0|||
149063023|NCT03523572|537714568|FG001|Dose Expansion|Clinical Progression|0|||
149063024|NCT03523572|537714569|FG002|Dose Expansion|Clinical Progression|2|||
149063025|NCT03523572|537714570|FG003|Dose Expansion|Clinical Progression|2|||
149063026|NCT03523572|537714571|FG004|Dose Expansion|Clinical Progression|2|||
149063027|NCT03523572|537714572|FG005|Dose Expansion|Clinical Progression|0|||
149063028|NCT03523572|537714567|FG000|Dose Expansion|Adverse Event|0|||
149063029|NCT03523572|537714568|FG001|Dose Expansion|Adverse Event|0|||
149063030|NCT03523572|537714569|FG002|Dose Expansion|Adverse Event|10|||
149063031|NCT03523572|537714570|FG003|Dose Expansion|Adverse Event|1|||
149063032|NCT03523572|537714571|FG004|Dose Expansion|Adverse Event|5|||
149063033|NCT03523572|537714572|FG005|Dose Expansion|Adverse Event|2|||
149063034|NCT03523572|537714567|FG000|Dose Expansion|Withdrawal by Subject|0|||
149063035|NCT03523572|537714568|FG001|Dose Expansion|Withdrawal by Subject|0|||
149063036|NCT03523572|537714569|FG002|Dose Expansion|Withdrawal by Subject|1|||
149063037|NCT03523572|537714570|FG003|Dose Expansion|Withdrawal by Subject|1|||
149063038|NCT03523572|537714571|FG004|Dose Expansion|Withdrawal by Subject|0|||
149063039|NCT03523572|537714572|FG005|Dose Expansion|Withdrawal by Subject|0|||
149063040|NCT03523572|537714567|FG000|Dose Expansion|Physician Decision|0|||
149063041|NCT03523572|537714568|FG001|Dose Expansion|Physician Decision|0|||
149063042|NCT03523572|537714569|FG002|Dose Expansion|Physician Decision|1|||
149063043|NCT03523572|537714570|FG003|Dose Expansion|Physician Decision|0|||
149063044|NCT03523572|537714571|FG004|Dose Expansion|Physician Decision|1|||
149063045|NCT03523572|537714572|FG005|Dose Expansion|Physician Decision|0|||
149063046|NCT03523572|537714567|FG000|Dose Expansion|Miscellaneous|0|||
149063047|NCT03523572|537714568|FG001|Dose Expansion|Miscellaneous|0|||
149063048|NCT03523572|537714569|FG002|Dose Expansion|Miscellaneous|0|||
149063049|NCT03523572|537714570|FG003|Dose Expansion|Miscellaneous|0|||
149063050|NCT03523572|537714571|FG004|Dose Expansion|Miscellaneous|3|||
149063051|NCT03523572|537714572|FG005|Dose Expansion|Miscellaneous|0|||
149063052|NCT04685135|537714578|FG000|Overall Study|Death|126|||
149063053|NCT04685135|537714579|FG001|Overall Study|Death|53|||
149063054|NCT04685135|537714578|FG000|Overall Study|Withdrawal by Subject|12|||
149063055|NCT04685135|537714579|FG001|Overall Study|Withdrawal by Subject|16|||
149063056|NCT02315703|537714580|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
149063057|NCT02315703|537714581|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
149063058|NCT02315703|537714582|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
149063059|NCT02315703|537714583|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
149063060|NCT02315703|537714584|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
149063061|NCT02315703|537714585|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
149063062|NCT02315703|537714586|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
149063063|NCT02315703|537714587|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
149063064|NCT02315703|537714580|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
149063065|NCT02315703|537714581|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
149063066|NCT02315703|537714582|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
149063067|NCT02315703|537714583|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
149063068|NCT02315703|537714584|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
149063069|NCT02315703|537714585|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
149063070|NCT02315703|537714586|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
149063071|NCT02315703|537714587|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
149063072|NCT02315703|537714580|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
149063073|NCT02315703|537714581|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
149119804|NCT00006011|537917971|FG002|Overall Study|Ineligible|9|||
149063074|NCT02315703|537714582|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
149063075|NCT02315703|537714583|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
149063076|NCT02315703|537714584|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
149063077|NCT02315703|537714585|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
149063078|NCT02315703|537714586|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
149063079|NCT02315703|537714587|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
149063080|NCT02315703|537714580|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063081|NCT02315703|537714581|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063082|NCT02315703|537714582|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063083|NCT02315703|537714583|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063084|NCT02315703|537714584|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063085|NCT02315703|537714585|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063086|NCT02315703|537714586|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
149063087|NCT02315703|537714587|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
149063088|NCT02315703|537714580|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
149063089|NCT02315703|537714581|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
149063090|NCT02315703|537714582|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
149063091|NCT02315703|537714583|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
149063092|NCT02315703|537714584|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
149063093|NCT02315703|537714585|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
149063094|NCT02315703|537714586|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
149063095|NCT02315703|537714587|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
149063096|NCT02315703|537714580|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
149063097|NCT02315703|537714581|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
149063098|NCT02315703|537714582|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
149063099|NCT02315703|537714583|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
149063100|NCT02315703|537714584|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
149063101|NCT02315703|537714585|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
149063102|NCT02315703|537714586|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
149063103|NCT02315703|537714587|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
149063104|NCT02315703|537714580|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
149063105|NCT02315703|537714581|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
149063106|NCT02315703|537714582|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
149063107|NCT02315703|537714583|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
149063108|NCT02315703|537714584|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
149063109|NCT02315703|537714585|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
149063110|NCT02315703|537714586|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
149063111|NCT02315703|537714587|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
149063112|NCT02315703|537714580|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063113|NCT02315703|537714581|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
149063114|NCT02315703|537714582|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063115|NCT02315703|537714583|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063116|NCT02315703|537714584|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063117|NCT02315703|537714585|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063118|NCT02315703|537714586|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063119|NCT02315703|537714587|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
149063120|NCT02315703|537714580|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
149063121|NCT02315703|537714581|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
149063122|NCT02315703|537714582|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
149063123|NCT02315703|537714583|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
149063124|NCT02315703|537714584|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
149063125|NCT02315703|537714585|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
149063126|NCT02315703|537714586|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
149063127|NCT02315703|537714587|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
149063128|NCT05974501|537714588|FG000|Overall Study|Physician Decision|0|||
149063129|NCT05974501|537714589|FG001|Overall Study|Physician Decision|1|||
149063130|NCT03625115|537714590|FG000|Overall Study|Withdrawal by Subject|4|||
149063131|NCT03625115|537714591|FG001|Overall Study|Withdrawal by Subject|7|||
149063132|NCT03625115|537714590|FG000|Overall Study|Lost to Follow-up|17|||
149063133|NCT03625115|537714591|FG001|Overall Study|Lost to Follow-up|24|||
149063134|NCT04197336|537714592|FG000|Overall Study|Withdrawal by Subject|1|||
149063135|NCT04304144|537714593|FG000|DLT Observation Period|Physician Decision|0|||
149063136|NCT04304144|537714594|FG001|DLT Observation Period|Physician Decision|1|||
149063137|NCT04304144|537714595|FG002|DLT Observation Period|Physician Decision|0|||
149063138|NCT04304144|537714596|FG003|DLT Observation Period|Physician Decision|0|||
149063139|NCT04304144|537714593|FG000|Continued Treatment Period|Adverse Event|0|||
149063140|NCT04304144|537714594|FG001|Continued Treatment Period|Adverse Event|1|||
149063141|NCT04304144|537714595|FG002|Continued Treatment Period|Adverse Event|0|||
149063142|NCT04304144|537714596|FG003|Continued Treatment Period|Adverse Event|0|||
149063143|NCT04304144|537714593|FG000|Continued Treatment Period|Death|0|||
149063144|NCT04304144|537714594|FG001|Continued Treatment Period|Death|0|||
149063145|NCT04304144|537714595|FG002|Continued Treatment Period|Death|1|||
149063146|NCT04304144|537714596|FG003|Continued Treatment Period|Death|2|||
149063147|NCT04304144|537714593|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
149063148|NCT04304144|537714594|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
149063149|NCT04304144|537714595|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
149063150|NCT04304144|537714596|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
149063151|NCT04304144|537714593|FG000|Continued Treatment Period|Other than specified|2|||
149063152|NCT04304144|537714594|FG001|Continued Treatment Period|Other than specified|0|||
149063153|NCT04304144|537714595|FG002|Continued Treatment Period|Other than specified|1|||
149063154|NCT04304144|537714596|FG003|Continued Treatment Period|Other than specified|1|||
149063155|NCT05868382|537714597|FG000|Overall Study|Lost to Follow-up|5|||
149063156|NCT05868382|537714598|FG001|Overall Study|Lost to Follow-up|0|||
149063157|NCT05868382|537714599|FG002|Overall Study|Lost to Follow-up|6|||
149063158|NCT05868382|537714600|FG003|Overall Study|Lost to Follow-up|4|||
149063159|NCT05868382|537714601|FG004|Overall Study|Lost to Follow-up|2|||
149063160|NCT05868382|537714602|FG005|Overall Study|Lost to Follow-up|6|||
149063161|NCT05868382|537714597|FG000|Overall Study|Withdrawal by Subject|1|||
149063162|NCT05868382|537714598|FG001|Overall Study|Withdrawal by Subject|0|||
149063163|NCT05868382|537714599|FG002|Overall Study|Withdrawal by Subject|0|||
149063164|NCT05868382|537714600|FG003|Overall Study|Withdrawal by Subject|0|||
149063165|NCT05868382|537714601|FG004|Overall Study|Withdrawal by Subject|1|||
149063166|NCT05868382|537714602|FG005|Overall Study|Withdrawal by Subject|0|||
149063167|NCT04585815|537714603|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
149063168|NCT04585815|537714604|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
149063169|NCT04585815|537714605|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
149063170|NCT04585815|537714606|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
149063171|NCT04585815|537714607|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
149063172|NCT04585815|537714608|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
149063173|NCT04585815|537714609|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
149063174|NCT04585815|537714603|FG000|Sub-study A- Treatment Phase|Death|0|||
149063175|NCT04585815|537714604|FG001|Sub-study A- Treatment Phase|Death|1|||
149063176|NCT04585815|537714605|FG002|Sub-study A- Treatment Phase|Death|0|||
149063177|NCT04585815|537714606|FG003|Sub-study A- Treatment Phase|Death|0|||
149063178|NCT04585815|537714607|FG004|Sub-study A- Treatment Phase|Death|0|||
149063179|NCT04585815|537714608|FG005|Sub-study A- Treatment Phase|Death|0|||
149063180|NCT04585815|537714609|FG006|Sub-study A- Treatment Phase|Death|0|||
149063181|NCT04585815|537714603|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
149063182|NCT04585815|537714604|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
149063183|NCT04585815|537714605|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
149063184|NCT04585815|537714606|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
149063185|NCT04585815|537714607|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
149063186|NCT04585815|537714608|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
149063187|NCT04585815|537714609|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
149063188|NCT04585815|537714603|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
149063189|NCT04585815|537714604|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
149063190|NCT04585815|537714605|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
149063191|NCT04585815|537714606|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
149063192|NCT04585815|537714607|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
149063193|NCT04585815|537714608|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
149063194|NCT04585815|537714609|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
149063195|NCT04585815|537714603|FG000|Sub-study A- Treatment Phase|Other|1|||
149063196|NCT04585815|537714604|FG001|Sub-study A- Treatment Phase|Other|0|||
149063197|NCT04585815|537714605|FG002|Sub-study A- Treatment Phase|Other|0|||
149063198|NCT04585815|537714606|FG003|Sub-study A- Treatment Phase|Other|0|||
149063199|NCT04585815|537714607|FG004|Sub-study A- Treatment Phase|Other|0|||
149063200|NCT04585815|537714608|FG005|Sub-study A- Treatment Phase|Other|0|||
149063201|NCT04585815|537714609|FG006|Sub-study A- Treatment Phase|Other|0|||
149063202|NCT04585815|537714603|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
149063203|NCT04585815|537714604|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
149063204|NCT04585815|537714605|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
149063205|NCT04585815|537714606|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
149063206|NCT04585815|537714607|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
149063207|NCT04585815|537714608|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
149063208|NCT04585815|537714609|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
149063209|NCT04585815|537714603|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
149063210|NCT04585815|537714604|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
149063211|NCT04585815|537714605|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
149063212|NCT04585815|537714606|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
149063213|NCT04585815|537714607|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
149063214|NCT04585815|537714608|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
149063215|NCT04585815|537714609|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
149063216|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
149063217|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
149063218|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
149063219|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
149063220|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
149063221|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
149063222|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
149063223|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Death|0|||
149063224|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Death|0|||
149063225|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Death|0|||
149063226|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Death|1|||
149063227|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Death|0|||
149063228|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Death|0|||
149063229|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Death|0|||
149063230|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
149063231|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
149063232|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
149063233|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
149063234|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
149063235|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
149063236|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
149063237|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
149063238|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
149063239|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
149063240|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
149063241|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
149063242|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
149063243|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
149063244|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
149063245|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
149063246|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
149063247|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
149063248|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
149063249|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
149063250|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
149063251|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
149063252|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
149063253|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
149063254|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
149063255|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
149063256|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
149063257|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
149063258|NCT04585815|537714603|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
149063259|NCT04585815|537714604|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
149063260|NCT04585815|537714605|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
149063261|NCT04585815|537714606|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
149063262|NCT04585815|537714607|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
149063263|NCT04585815|537714608|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
149063264|NCT04585815|537714609|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
149063265|NCT04585815|537714603|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
149063266|NCT04585815|537714604|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
149063267|NCT04585815|537714605|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
149063268|NCT04585815|537714606|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
149063269|NCT04585815|537714607|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
149063270|NCT04585815|537714608|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
149063271|NCT04585815|537714609|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
149063272|NCT04585815|537714603|FG000|Sub-study B- Follow-up Phase|Death|0|||
149063273|NCT04585815|537714604|FG001|Sub-study B- Follow-up Phase|Death|0|||
149063274|NCT04585815|537714605|FG002|Sub-study B- Follow-up Phase|Death|1|||
149063275|NCT04585815|537714606|FG003|Sub-study B- Follow-up Phase|Death|3|||
149063276|NCT04585815|537714607|FG004|Sub-study B- Follow-up Phase|Death|0|||
149063277|NCT04585815|537714608|FG005|Sub-study B- Follow-up Phase|Death|0|||
149063278|NCT04585815|537714609|FG006|Sub-study B- Follow-up Phase|Death|1|||
149063279|NCT02497950|537714612|FG000|Overall Study|Death|209|||
149063280|NCT02497950|537714612|FG000|Overall Study|Transplanted|85|||
149063281|NCT02497950|537714612|FG000|Overall Study|Explanted|8|||
149063282|NCT02497950|537714612|FG000|Overall Study|Device Permanently Deactivated|4|||
149120211|NCT04602221|537918060|FG003|Overall Study|Other than listed|0|||
149063283|NCT02497950|537714612|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
149063284|NCT02497950|537714612|FG000|Overall Study|Lost to Follow-up|6|||
149063285|NCT02497950|537714612|FG000|Overall Study|Withdrawal by Subject|2|||
149063286|NCT02497950|537714612|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
149063287|NCT02497950|537714612|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
149063288|NCT04660539|537714613|FG000|Overall Study|Adverse Event|10|||
149063289|NCT04660539|537714613|FG000|Overall Study|Lack of Efficacy|4|||
149063290|NCT04660539|537714613|FG000|Overall Study|Lost to Follow-up|5|||
149063291|NCT04660539|537714613|FG000|Overall Study|Non-Compliance With Study Drug|3|||
149063292|NCT04660539|537714613|FG000|Overall Study|Reason not Specified|12|||
149063293|NCT04660539|537714613|FG000|Overall Study|Pregnancy|2|||
149063294|NCT04660539|537714613|FG000|Overall Study|Protocol Violation|2|||
149063295|NCT04660539|537714613|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
149063296|NCT04660539|537714613|FG000|Overall Study|Withdrawal by Subject|21|||
149063297|NCT03655028|537714616|FG000|12-weeks Follow up|Death|1|||
149063298|NCT03655028|537714617|FG001|12-weeks Follow up|Death|0|||
149063299|NCT03655028|537714616|FG000|12-weeks Follow up|Physician Decision|3|||
149063300|NCT03655028|537714617|FG001|12-weeks Follow up|Physician Decision|3|||
149063301|NCT03655028|537714616|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
149063302|NCT03655028|537714617|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
149063303|NCT03655028|537714616|FG000|12-weeks Follow up|Lost to Follow-up|4|||
149063304|NCT03655028|537714617|FG001|12-weeks Follow up|Lost to Follow-up|4|||
149063305|NCT03655028|537714616|FG000|24-weeks|Lost to Follow-up|1|||
149063306|NCT03655028|537714617|FG001|24-weeks|Lost to Follow-up|1|||
149063307|NCT03655028|537714616|FG000|24-weeks|Death|0|||
149063308|NCT03655028|537714617|FG001|24-weeks|Death|1|||
149063309|NCT03852550|537714625|FG000|Overall Study|Lost to Follow-up|4|||
149063310|NCT03852550|537714626|FG001|Overall Study|Lost to Follow-up|3|||
149063311|NCT03852550|537714625|FG000|Overall Study|Only parent outcomes completed|0|||
149063312|NCT03852550|537714626|FG001|Overall Study|Only parent outcomes completed|1|||
149063313|NCT03852550|537714625|FG000|Overall Study|Withdrawal by Subject|1|||
149063314|NCT03852550|537714626|FG001|Overall Study|Withdrawal by Subject|0|||
149063315|NCT00429364|537714647|FG000|Overall Study|Withdrawal by Subject|11|||
149063316|NCT00429364|537714648|FG001|Overall Study|Withdrawal by Subject|5|||
149063317|NCT00429364|537714647|FG000|Overall Study|Physician Decision|4|||
149063318|NCT00429364|537714648|FG001|Overall Study|Physician Decision|2|||
149063319|NCT00429364|537714647|FG000|Overall Study|Lost to Follow-up|7|||
149063320|NCT00429364|537714648|FG001|Overall Study|Lost to Follow-up|6|||
149063321|NCT00429364|537714647|FG000|Overall Study|Death|0|||
149063322|NCT00429364|537714648|FG001|Overall Study|Death|1|||
149063323|NCT00429364|537714647|FG000|Overall Study|Underwent aortic root surgery|10|||
149063324|NCT00429364|537714648|FG001|Overall Study|Underwent aortic root surgery|18|||
149063325|NCT00429364|537714647|FG000|Overall Study|Pregnancy|0|||
149063326|NCT00429364|537714648|FG001|Overall Study|Pregnancy|1|||
149063327|NCT04871529|537714649|FG000|Overall Study|Withdrawal by Subject|0|||
149063328|NCT04871529|537714650|FG001|Overall Study|Withdrawal by Subject|1|||
149063329|NCT04871529|537714649|FG000|Overall Study|Death|0|||
149063330|NCT04871529|537714650|FG001|Overall Study|Death|1|||
149063331|NCT04871529|537714649|FG000|Overall Study|Not protocol specified|0|||
149063332|NCT04871529|537714650|FG001|Overall Study|Not protocol specified|1|||
149063333|NCT05184452|537714651|FG000|Overall Study|Lost to Follow-up|0|||
149063334|NCT05184452|537714652|FG001|Overall Study|Lost to Follow-up|0|||
149063335|NCT05184452|537714653|FG002|Overall Study|Lost to Follow-up|0|||
149063336|NCT05184452|537714654|FG003|Overall Study|Lost to Follow-up|0|||
149063337|NCT05184452|537714655|FG004|Overall Study|Lost to Follow-up|0|||
149063338|NCT05184452|537714656|FG005|Overall Study|Lost to Follow-up|2|||
149063339|NCT05184452|537714657|FG006|Overall Study|Lost to Follow-up|0|||
149063340|NCT05184452|537714658|FG007|Overall Study|Lost to Follow-up|0|||
149063341|NCT05184452|537714659|FG008|Overall Study|Lost to Follow-up|0|||
149063342|NCT05184452|537714660|FG009|Overall Study|Lost to Follow-up|1|||
149063343|NCT05184452|537714651|FG000|Overall Study|Withdrawal by Subject|0|||
149063344|NCT05184452|537714652|FG001|Overall Study|Withdrawal by Subject|0|||
149063345|NCT05184452|537714653|FG002|Overall Study|Withdrawal by Subject|0|||
149063346|NCT05184452|537714654|FG003|Overall Study|Withdrawal by Subject|0|||
149063347|NCT05184452|537714655|FG004|Overall Study|Withdrawal by Subject|0|||
148890407|NCT02365649|537077202|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
149063348|NCT05184452|537714656|FG005|Overall Study|Withdrawal by Subject|1|||
149063349|NCT05184452|537714657|FG006|Overall Study|Withdrawal by Subject|0|||
149063350|NCT05184452|537714658|FG007|Overall Study|Withdrawal by Subject|0|||
149063351|NCT05184452|537714659|FG008|Overall Study|Withdrawal by Subject|0|||
149063352|NCT05184452|537714660|FG009|Overall Study|Withdrawal by Subject|1|||
149063353|NCT05586490|537714661|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
149063354|NCT05586490|537714662|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
149063355|NCT05586490|537714663|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
149063356|NCT05586490|537714664|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
149063357|NCT05586490|537714665|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
149063358|NCT05586490|537714661|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
149063359|NCT05586490|537714662|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
149063360|NCT05586490|537714663|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
149063361|NCT05586490|537714664|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
149063362|NCT05586490|537714665|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
149063363|NCT05586490|537714661|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
149063364|NCT05586490|537714662|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
149063365|NCT05586490|537714663|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
149063366|NCT05586490|537714664|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
149063367|NCT05586490|537714665|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
149063368|NCT05873556|537714666|FG000|Overall Study|Lost to Follow-up|4|||
149063369|NCT05873556|537714667|FG001|Overall Study|Lost to Follow-up|1|||
149063370|NCT03606408|537714668|FG000|Overall Study|Adverse Event|13|||
149063371|NCT03606408|537714668|FG000|Overall Study|Withdrawal by Subject|7|||
149063372|NCT03606408|537714668|FG000|Overall Study|Physician Decision|4|||
149063373|NCT03606408|537714668|FG000|Overall Study|Lack of Efficacy|2|||
149063374|NCT03606408|537714668|FG000|Overall Study|Death|1|||
149063375|NCT03606408|537714668|FG000|Overall Study|new therapy for study indication|1|||
149063376|NCT04862234|537714669|FG000|Overall Study|Surgery cancellation|1|||
149063377|NCT04862234|537714670|FG001|Overall Study|Surgery cancellation|2|||
149063378|NCT04862234|537714669|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
149063379|NCT04862234|537714670|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
149063380|NCT04862234|537714669|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
149063381|NCT04862234|537714670|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
149063382|NCT03292484|537714671|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
149063383|NCT03292484|537714671|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
148890408|NCT02365649|537077203|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
148890409|NCT02365649|537077204|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
149063384|NCT03292484|537714671|FG000|Overall Study|Protocol Violation|2|||
149063385|NCT03292484|537714671|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
149063386|NCT03292484|537714671|FG000|Overall Study|Sponsor decision|349|||
149063387|NCT03292484|537714671|FG000|Overall Study|Lost to Follow-up|7|||
149063388|NCT03292484|537714671|FG000|Overall Study|Coronavirus Disease 2019|1|||
149063389|NCT03292484|537714671|FG000|Overall Study|Other|20|||
149063390|NCT05290493|537714672|FG000|Overall Study|Withdrawal by Subject|2|||
149063391|NCT05290493|537714673|FG001|Overall Study|Withdrawal by Subject|2|||
149063392|NCT05290493|537714672|FG000|Overall Study|Adverse Event|1|||
149063393|NCT05290493|537714673|FG001|Overall Study|Adverse Event|0|||
149063394|NCT03673501|537714684|FG000|Overall Study|Participants ongoing.|36|||
149063395|NCT03673501|537714685|FG001|Overall Study|Participants ongoing.|24|||
149063396|NCT04599634|537714686|FG000|Overall Study|Dose limiting toxicity|0|||
149063397|NCT04599634|537714687|FG001|Overall Study|Dose limiting toxicity|0|||
149063398|NCT04599634|537714688|FG002|Overall Study|Dose limiting toxicity|2|||
149063399|NCT04599634|537714689|FG003|Overall Study|Dose limiting toxicity|0|||
149063400|NCT03714815|537714690|FG000|Overall Study|Physician Decision|2|||
149063401|NCT03714815|537714690|FG000|Overall Study|Withdrawal by Subject|2|||
149063402|NCT03714815|537714690|FG000|Overall Study|Death|11|||
149063403|NCT03733925|537714692|FG000|Overall Study|Lost to Follow-up|1|||
149063404|NCT03733925|537714692|FG000|Overall Study|Withdrawal by Subject|2|||
149063405|NCT03733925|537714692|FG000|Overall Study|Adverse Event|2|||
149063406|NCT03733925|537714692|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149063407|NCT03213873|537714693|FG000|Overall Study|Withdrawal by Subject|8|||
149063408|NCT03213873|537714694|FG001|Overall Study|Withdrawal by Subject|9|||
149063409|NCT03213873|537714693|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
149063410|NCT03213873|537714694|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
149063411|NCT03213873|537714693|FG000|Overall Study|Lost to Follow-up|0|||
149063412|NCT03213873|537714694|FG001|Overall Study|Lost to Follow-up|2|||
149063413|NCT03106740|537715805|FG000|Overall Study|Lost to Follow-up|2|||
149063414|NCT03106740|537715806|FG001|Overall Study|Lost to Follow-up|2|||
149063415|NCT03106740|537715805|FG000|Overall Study|Withdrawal by Subject|2|||
148890410|NCT02365649|537077205|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
149063416|NCT03106740|537715806|FG001|Overall Study|Withdrawal by Subject|4|||
149063417|NCT03106740|537715805|FG000|Overall Study|Physician Decision|0|||
149063418|NCT03106740|537715806|FG001|Overall Study|Physician Decision|1|||
149063419|NCT03106740|537715805|FG000|Overall Study|Partial data|1|||
149063420|NCT03106740|537715806|FG001|Overall Study|Partial data|0|||
149063421|NCT04565990|537715807|FG000|Overall Study|Death|5|||
149063422|NCT04565990|537715807|FG000|Overall Study|Lost to Follow-up|1|||
149063423|NCT04565990|537715807|FG000|Overall Study|Withdrawal by Subject|1|||
149063424|NCT04797858|537715808|FG000|Overall Study|Withdrawal by Subject|0|||
149063425|NCT04797858|537715809|FG001|Overall Study|Withdrawal by Subject|1|||
149063426|NCT04797858|537715808|FG000|Overall Study|Excluded due to administrative error|7|||
149063427|NCT04797858|537715809|FG001|Overall Study|Excluded due to administrative error|8|||
149063428|NCT05452460|537715813|FG000|Overall Study|Lost to Follow-up|3|||
149063429|NCT05452460|537715814|FG001|Overall Study|Lost to Follow-up|3|||
149063430|NCT05452460|537715813|FG000|Overall Study|Did not receive intervention|1|||
149063431|NCT05452460|537715814|FG001|Overall Study|Did not receive intervention|0|||
149063432|NCT04433208|537715815|FG000|Overall Study|Withdrawal by Subject|0|||
149063433|NCT04433208|537715816|FG001|Overall Study|Withdrawal by Subject|1|||
149063434|NCT04433208|537715817|FG002|Overall Study|Withdrawal by Subject|1|||
149063435|NCT04433208|537715818|FG003|Overall Study|Withdrawal by Subject|0|||
149063436|NCT04433208|537715819|FG004|Overall Study|Withdrawal by Subject|2|||
149063437|NCT04433208|537715820|FG005|Overall Study|Withdrawal by Subject|1|||
149063438|NCT04433208|537715815|FG000|Overall Study|Lost to Follow-up|0|||
149063439|NCT04433208|537715816|FG001|Overall Study|Lost to Follow-up|0|||
149063440|NCT04433208|537715817|FG002|Overall Study|Lost to Follow-up|0|||
149063441|NCT04433208|537715818|FG003|Overall Study|Lost to Follow-up|0|||
149063442|NCT04433208|537715819|FG004|Overall Study|Lost to Follow-up|0|||
149063443|NCT04433208|537715820|FG005|Overall Study|Lost to Follow-up|1|||
149063444|NCT03676192|537715825|FG000|Induction Study Period|Adverse Event|21|||
149063445|NCT03676192|537715826|FG001|Induction Study Period|Adverse Event|20|||
149063446|NCT03676192|537715825|FG000|Induction Study Period|Death|23|||
149063447|NCT03676192|537715826|FG001|Induction Study Period|Death|20|||
149063448|NCT03676192|537715825|FG000|Induction Study Period|Lost to Follow-up|3|||
149063449|NCT03676192|537715826|FG001|Induction Study Period|Lost to Follow-up|3|||
149063450|NCT03676192|537715825|FG000|Induction Study Period|Physician Decision|6|||
149063451|NCT03676192|537715826|FG001|Induction Study Period|Physician Decision|3|||
149063452|NCT03676192|537715825|FG000|Induction Study Period|Progressive Disease|32|||
149063453|NCT03676192|537715826|FG001|Induction Study Period|Progressive Disease|21|||
149063454|NCT03676192|537715825|FG000|Induction Study Period|Protocol Violation|1|||
149063455|NCT03676192|537715826|FG001|Induction Study Period|Protocol Violation|2|||
149063456|NCT03676192|537715825|FG000|Induction Study Period|Withdrawal by Subject|20|||
149063457|NCT03676192|537715826|FG001|Induction Study Period|Withdrawal by Subject|15|||
149063458|NCT04766892|537715829|FG000|Overall Study|Withdrawal by Subject|1|||
149063459|NCT04766892|537715829|FG000|Overall Study|Lost to Follow-up|1|||
149063460|NCT04766892|537715829|FG000|Overall Study|Adverse Event|3|||
149063461|NCT04766892|537715829|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
149063462|NCT03476343|537715835|FG000|Overall Study|Clinical exam moved to another scanner|7|||
149063463|NCT03476343|537715835|FG000|Overall Study|Clinical order cancelled|4|||
149063464|NCT03476343|537715835|FG000|Overall Study|Neonate did not settle down for the scan|1|||
149063465|NCT03711474|537715836|FG000|Overall Study|Physician Decision|2|||
149063466|NCT03711474|537715837|FG001|Overall Study|Physician Decision|0|||
149063467|NCT05147116|537715838|FG000|Overall Study|Withdrawal by Subject|0|||
149063468|NCT05147116|537715839|FG001|Overall Study|Withdrawal by Subject|1|||
149063469|NCT03381586|537715846|FG000|Overall Study|Adverse Event|1|||
149063470|NCT03381586|537715847|FG001|Overall Study|Adverse Event|1|||
149063471|NCT03381586|537715846|FG000|Overall Study|Protocol Violation|1|||
149063472|NCT03381586|537715847|FG001|Overall Study|Protocol Violation|0|||
149063473|NCT03381586|537715846|FG000|Overall Study|Withdrawal by Subject|1|||
149063474|NCT03381586|537715847|FG001|Overall Study|Withdrawal by Subject|2|||
149063475|NCT04709419|537715848|FG000|Overall Study|Physician Decision|1|||
149063476|NCT04709419|537715849|FG001|Overall Study|Physician Decision|0|||
149063477|NCT03824366|537715852|FG000|Overall Study|Death|1|||
149063478|NCT03824366|537715852|FG000|Overall Study|Previously unidentified metal artifact|1|||
149063479|NCT03824366|537715852|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
149063480|NCT03824366|537715852|FG000|Overall Study|Withdrawal by Subject|1|||
149063481|NCT05069896|537715855|FG000|Overall Study|Adverse Event|0|||
149063482|NCT05069896|537715856|FG001|Overall Study|Adverse Event|1|||
149063483|NCT05069896|537715857|FG002|Overall Study|Adverse Event|1|||
149063484|NCT05069896|537715858|FG003|Overall Study|Adverse Event|0|||
149063485|NCT05069896|537715859|FG004|Overall Study|Adverse Event|0|||
149063486|NCT05069896|537715860|FG005|Overall Study|Adverse Event|0|||
149063487|NCT05069896|537715855|FG000|Overall Study|Lost to Follow-up|0|||
149063488|NCT05069896|537715856|FG001|Overall Study|Lost to Follow-up|0|||
149063489|NCT05069896|537715857|FG002|Overall Study|Lost to Follow-up|1|||
149063490|NCT05069896|537715858|FG003|Overall Study|Lost to Follow-up|0|||
149063491|NCT05069896|537715859|FG004|Overall Study|Lost to Follow-up|1|||
149063492|NCT05069896|537715860|FG005|Overall Study|Lost to Follow-up|2|||
149063493|NCT04068831|537715861|FG000|Overall Study|Disease Progression|10|||
149063494|NCT04068831|537715862|FG001|Overall Study|Disease Progression|8|||
149063495|NCT02998528|537715868|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
149063496|NCT02998528|537715869|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
149063497|NCT02998528|537715870|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
149063498|NCT02998528|537715868|FG000|Randomization Period|Participant withdrew consent|0|||
149063499|NCT02998528|537715869|FG001|Randomization Period|Participant withdrew consent|3|||
149063500|NCT02998528|537715870|FG002|Randomization Period|Participant withdrew consent|0|||
149063501|NCT02998528|537715868|FG000|Randomization Period|Participant no longer meets study criteria|1|||
149063502|NCT02998528|537715869|FG001|Randomization Period|Participant no longer meets study criteria|3|||
149063503|NCT02998528|537715870|FG002|Randomization Period|Participant no longer meets study criteria|2|||
149063504|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
149063505|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
149063506|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
149063507|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
149063508|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
149063509|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
149063510|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
149063511|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
149063512|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
149063513|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
149063514|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
149063515|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
149063516|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
149063517|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
149063518|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
149063519|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Death|1|||
149063520|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Death|0|||
149063521|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Death|0|||
149063522|NCT02998528|537715868|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
149063523|NCT02998528|537715869|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
149063524|NCT02998528|537715870|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
149063525|NCT02998528|537715868|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
149063526|NCT02998528|537715869|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
149063527|NCT02998528|537715870|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
149063528|NCT02998528|537715868|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
149063529|NCT02998528|537715869|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
149063530|NCT02998528|537715870|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
149063531|NCT02998528|537715868|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
149063532|NCT02998528|537715869|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
149063533|NCT02998528|537715870|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
149063534|NCT02998528|537715868|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
149063535|NCT02998528|537715869|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
149063536|NCT02998528|537715870|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
149063537|NCT02998528|537715868|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
149063538|NCT02998528|537715869|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
149063539|NCT02998528|537715870|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
149063540|NCT05035654|537715873|FG000|Overall Study|Physician Decision|0|||
149063541|NCT05035654|537715874|FG001|Overall Study|Physician Decision|1|||
149063542|NCT05035654|537715875|FG002|Overall Study|Physician Decision|0|||
149063543|NCT05035654|537715873|FG000|Overall Study|Adverse Event|0|||
149063544|NCT05035654|537715874|FG001|Overall Study|Adverse Event|1|||
149063545|NCT05035654|537715875|FG002|Overall Study|Adverse Event|0|||
149063546|NCT05035654|537715873|FG000|Overall Study|Withdrawal by Subject|0|||
149063547|NCT05035654|537715874|FG001|Overall Study|Withdrawal by Subject|0|||
149063548|NCT05035654|537715875|FG002|Overall Study|Withdrawal by Subject|4|||
149063549|NCT05035654|537715873|FG000|Overall Study|Bilateral Dislodgement|1|||
149063550|NCT05035654|537715874|FG001|Overall Study|Bilateral Dislodgement|0|||
149063551|NCT05035654|537715875|FG002|Overall Study|Bilateral Dislodgement|0|||
149063552|NCT02988661|537715876|FG000|Overall Study|Death|2|||
149063553|NCT02988661|537715877|FG001|Overall Study|Death|18|||
149063554|NCT02988661|537715876|FG000|Overall Study|Lost to Follow-up|0|||
149063555|NCT02988661|537715877|FG001|Overall Study|Lost to Follow-up|33|||
149063556|NCT02988661|537715876|FG000|Overall Study|Withdrawal by Subject|0|||
149063557|NCT02988661|537715877|FG001|Overall Study|Withdrawal by Subject|6|||
149063558|NCT02988661|537715876|FG000|Overall Study|Unable to complete the 18-month survey|1|||
149063559|NCT02988661|537715877|FG001|Overall Study|Unable to complete the 18-month survey|27|||
149063560|NCT02839265|537715881|FG000|Overall Study|Screen Failure|2|||
149063561|NCT02839265|537715881|FG000|Overall Study|Death|1|||
149063562|NCT02839265|537715881|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
149063563|NCT05856435|537715886|FG000|Overall Study|Lost to Follow-up|6|||
149063564|NCT05660434|537715888|FG000|Overall Study|Never obtained study materials|2|||
149063565|NCT05660434|537715889|FG001|Overall Study|Never obtained study materials|1|||
149063566|NCT02828358|537715892|FG000|Overall Study|Physician Decision|7|||
149063567|NCT02828358|537715893|FG001|Overall Study|Physician Decision|1|||
148890411|NCT02365649|537077206|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
149063568|NCT02828358|537715892|FG000|Overall Study|Treatment Failure|6|||
149063569|NCT02828358|537715893|FG001|Overall Study|Treatment Failure|0|||
149120212|NCT04602221|537918061|FG004|Overall Study|Other than listed|0|||
149063570|NCT02828358|537715892|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
149063571|NCT02828358|537715893|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
149063572|NCT02828358|537715892|FG000|Overall Study|Refusal of further protocol therapy|2|||
149063573|NCT02828358|537715893|FG001|Overall Study|Refusal of further protocol therapy|0|||
149063574|NCT02828358|537715892|FG000|Overall Study|Relapse|25|||
149063575|NCT02828358|537715893|FG001|Overall Study|Relapse|0|||
149063576|NCT02828358|537715892|FG000|Overall Study|Still on therapy|5|||
149063577|NCT02828358|537715893|FG001|Overall Study|Still on therapy|0|||
149063578|NCT05285137|537715899|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
149063579|NCT05285137|537715900|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
149063580|NCT05285137|537715901|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
149063581|NCT05285137|537715902|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
149063582|NCT05285137|537715903|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
149063583|NCT05285137|537715904|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
149063584|NCT05285137|537715905|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
149063585|NCT05285137|537715906|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
149063586|NCT05285137|537715907|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
149063587|NCT05285137|537715899|FG000|Overall Study|Lost to Follow-up|0|||
149063588|NCT05285137|537715900|FG001|Overall Study|Lost to Follow-up|0|||
149063589|NCT05285137|537715901|FG002|Overall Study|Lost to Follow-up|1|||
149063590|NCT05285137|537715902|FG003|Overall Study|Lost to Follow-up|3|||
149063591|NCT05285137|537715903|FG004|Overall Study|Lost to Follow-up|0|||
149063592|NCT05285137|537715904|FG005|Overall Study|Lost to Follow-up|0|||
149063593|NCT05285137|537715905|FG006|Overall Study|Lost to Follow-up|1|||
149063594|NCT05285137|537715906|FG007|Overall Study|Lost to Follow-up|0|||
149063595|NCT05285137|537715907|FG008|Overall Study|Lost to Follow-up|0|||
149063596|NCT05285137|537715899|FG000|Overall Study|Physician Decision|0|||
149063597|NCT05285137|537715900|FG001|Overall Study|Physician Decision|1|||
149063598|NCT05285137|537715901|FG002|Overall Study|Physician Decision|0|||
149063599|NCT05285137|537715902|FG003|Overall Study|Physician Decision|0|||
149063600|NCT05285137|537715903|FG004|Overall Study|Physician Decision|0|||
149063601|NCT05285137|537715904|FG005|Overall Study|Physician Decision|0|||
149063602|NCT05285137|537715905|FG006|Overall Study|Physician Decision|0|||
149063603|NCT05285137|537715906|FG007|Overall Study|Physician Decision|0|||
149063604|NCT05285137|537715907|FG008|Overall Study|Physician Decision|0|||
149063605|NCT05285137|537715899|FG000|Overall Study|Pregnancy|0|||
149063606|NCT05285137|537715900|FG001|Overall Study|Pregnancy|0|||
149063607|NCT05285137|537715901|FG002|Overall Study|Pregnancy|0|||
149063608|NCT05285137|537715902|FG003|Overall Study|Pregnancy|0|||
149063609|NCT05285137|537715903|FG004|Overall Study|Pregnancy|0|||
149063610|NCT05285137|537715904|FG005|Overall Study|Pregnancy|0|||
149063611|NCT05285137|537715905|FG006|Overall Study|Pregnancy|1|||
149063612|NCT05285137|537715906|FG007|Overall Study|Pregnancy|0|||
149063613|NCT05285137|537715907|FG008|Overall Study|Pregnancy|0|||
149063614|NCT05285137|537715899|FG000|Overall Study|Withdrawal by Subject|0|||
149063615|NCT05285137|537715900|FG001|Overall Study|Withdrawal by Subject|1|||
149063616|NCT05285137|537715901|FG002|Overall Study|Withdrawal by Subject|2|||
149063617|NCT05285137|537715902|FG003|Overall Study|Withdrawal by Subject|1|||
149063618|NCT05285137|537715903|FG004|Overall Study|Withdrawal by Subject|0|||
149063619|NCT05285137|537715904|FG005|Overall Study|Withdrawal by Subject|0|||
149063620|NCT05285137|537715905|FG006|Overall Study|Withdrawal by Subject|0|||
149063621|NCT05285137|537715906|FG007|Overall Study|Withdrawal by Subject|0|||
149063622|NCT05285137|537715907|FG008|Overall Study|Withdrawal by Subject|1|||
149063623|NCT04230681|537715911|FG000|Overall Study|Physician Decision|2|||
149063624|NCT04230681|537715912|FG001|Overall Study|Physician Decision|3|||
149063625|NCT04230681|537715911|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
149063626|NCT04230681|537715912|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
149063627|NCT04230681|537715911|FG000|Overall Study|IV inadvertently removed|0|||
149063628|NCT04230681|537715912|FG001|Overall Study|IV inadvertently removed|1|||
149063629|NCT05906784|537717428|FG000|Overall Study|Lost to Follow-up|2|||
149063630|NCT05906784|537717429|FG001|Overall Study|Lost to Follow-up|1|||
149063631|NCT05906784|537717430|FG002|Overall Study|Lost to Follow-up|1|||
149063632|NCT05906784|537717431|FG003|Overall Study|Lost to Follow-up|1|||
149063633|NCT05269966|537717432|FG000|Overall Study|Adverse Event|4|||
149063634|NCT05269966|537717432|FG000|Overall Study|Withdrawal by Subject|1|||
149063635|NCT05269966|537717432|FG000|Overall Study|Lost to Follow-up|4|||
149063636|NCT05269966|537717432|FG000|Overall Study|Physician Decision|1|||
149063637|NCT04101357|537717446|FG000|Overall Study|Death|1|||
149063638|NCT04101357|537717447|FG001|Overall Study|Death|1|||
149063639|NCT04101357|537717448|FG002|Overall Study|Death|1|||
149063640|NCT04101357|537717449|FG003|Overall Study|Death|2|||
149063641|NCT04101357|537717450|FG004|Overall Study|Death|4|||
149063642|NCT04101357|537717451|FG005|Overall Study|Death|11|||
149063643|NCT04101357|537717452|FG006|Overall Study|Death|4|||
149063644|NCT04101357|537717453|FG007|Overall Study|Death|4|||
149063645|NCT04101357|537717454|FG008|Overall Study|Death|5|||
149063646|NCT04101357|537717455|FG009|Overall Study|Death|2|||
149063647|NCT04101357|537717456|FG010|Overall Study|Death|3|||
149063648|NCT04101357|537717446|FG000|Overall Study|Trial closure|0|||
149063649|NCT04101357|537717447|FG001|Overall Study|Trial closure|0|||
149063650|NCT04101357|537717448|FG002|Overall Study|Trial closure|0|||
149063651|NCT04101357|537717449|FG003|Overall Study|Trial closure|0|||
149063652|NCT04101357|537717450|FG004|Overall Study|Trial closure|0|||
149063653|NCT04101357|537717451|FG005|Overall Study|Trial closure|2|||
149063654|NCT04101357|537717452|FG006|Overall Study|Trial closure|2|||
149063655|NCT04101357|537717453|FG007|Overall Study|Trial closure|0|||
149063656|NCT04101357|537717454|FG008|Overall Study|Trial closure|0|||
149063657|NCT04101357|537717455|FG009|Overall Study|Trial closure|0|||
149063658|NCT04101357|537717456|FG010|Overall Study|Trial closure|1|||
149063659|NCT04101357|537717446|FG000|Overall Study|Lost to Follow-up|0|||
149063660|NCT04101357|537717447|FG001|Overall Study|Lost to Follow-up|0|||
149063661|NCT04101357|537717448|FG002|Overall Study|Lost to Follow-up|0|||
149063662|NCT04101357|537717449|FG003|Overall Study|Lost to Follow-up|1|||
149063663|NCT04101357|537717450|FG004|Overall Study|Lost to Follow-up|0|||
149063664|NCT04101357|537717451|FG005|Overall Study|Lost to Follow-up|0|||
149063665|NCT04101357|537717452|FG006|Overall Study|Lost to Follow-up|0|||
149063666|NCT04101357|537717453|FG007|Overall Study|Lost to Follow-up|1|||
149063667|NCT04101357|537717454|FG008|Overall Study|Lost to Follow-up|0|||
149063668|NCT04101357|537717455|FG009|Overall Study|Lost to Follow-up|0|||
149063669|NCT04101357|537717456|FG010|Overall Study|Lost to Follow-up|0|||
149063670|NCT04101357|537717446|FG000|Overall Study|Withdrawal by Subject|1|||
149063671|NCT04101357|537717447|FG001|Overall Study|Withdrawal by Subject|0|||
149063672|NCT04101357|537717448|FG002|Overall Study|Withdrawal by Subject|0|||
149063673|NCT04101357|537717449|FG003|Overall Study|Withdrawal by Subject|0|||
149063674|NCT04101357|537717450|FG004|Overall Study|Withdrawal by Subject|0|||
149063675|NCT04101357|537717451|FG005|Overall Study|Withdrawal by Subject|0|||
149063676|NCT04101357|537717452|FG006|Overall Study|Withdrawal by Subject|0|||
149063677|NCT04101357|537717453|FG007|Overall Study|Withdrawal by Subject|0|||
149063678|NCT04101357|537717454|FG008|Overall Study|Withdrawal by Subject|1|||
149063679|NCT04101357|537717455|FG009|Overall Study|Withdrawal by Subject|1|||
149063680|NCT04101357|537717456|FG010|Overall Study|Withdrawal by Subject|0|||
149063681|NCT04101357|537717446|FG000|Overall Study|Other|0|||
149063682|NCT04101357|537717447|FG001|Overall Study|Other|0|||
149063683|NCT04101357|537717448|FG002|Overall Study|Other|0|||
149063684|NCT04101357|537717449|FG003|Overall Study|Other|0|||
149063685|NCT04101357|537717450|FG004|Overall Study|Other|0|||
149063686|NCT04101357|537717451|FG005|Overall Study|Other|1|||
149063687|NCT04101357|537717452|FG006|Overall Study|Other|2|||
149063688|NCT04101357|537717453|FG007|Overall Study|Other|1|||
149063689|NCT04101357|537717454|FG008|Overall Study|Other|0|||
149063690|NCT04101357|537717455|FG009|Overall Study|Other|0|||
149063691|NCT04101357|537717456|FG010|Overall Study|Other|0|||
149063692|NCT04101357|537717446|FG000|Overall Study|Enrolled but not treated|0|||
149063693|NCT04101357|537717447|FG001|Overall Study|Enrolled but not treated|0|||
149063694|NCT04101357|537717448|FG002|Overall Study|Enrolled but not treated|0|||
149063695|NCT04101357|537717449|FG003|Overall Study|Enrolled but not treated|0|||
149063696|NCT04101357|537717450|FG004|Overall Study|Enrolled but not treated|0|||
149063697|NCT04101357|537717451|FG005|Overall Study|Enrolled but not treated|1|||
149063698|NCT04101357|537717452|FG006|Overall Study|Enrolled but not treated|1|||
149063699|NCT04101357|537717453|FG007|Overall Study|Enrolled but not treated|0|||
149063700|NCT04101357|537717454|FG008|Overall Study|Enrolled but not treated|0|||
149063701|NCT04101357|537717455|FG009|Overall Study|Enrolled but not treated|0|||
149063702|NCT04101357|537717456|FG010|Overall Study|Enrolled but not treated|0|||
149063703|NCT05618587|537717457|FG000|Overall Study|Lost to Follow-up|2|||
149063704|NCT05618587|537717458|FG001|Overall Study|Lost to Follow-up|0|||
149063705|NCT03442309|537717459|FG000|Overall Study|Lost to Follow-up|1676|||
149063706|NCT03442309|537717460|FG001|Overall Study|Lost to Follow-up|1642|||
149063707|NCT05204654|537717461|FG000|Overall Study|Study terminated due to time restraint|2|||
149063708|NCT05204654|537717462|FG001|Overall Study|Study terminated due to time restraint|2|||
149063709|NCT01221948|537717463|FG000|Overall Study|Physician Decision|5|||
149063710|NCT01221948|537717463|FG000|Overall Study|Withdrawal by Subject|2|||
149063711|NCT01221948|537717463|FG000|Overall Study|not disclosed|2|||
149063712|NCT01221948|537717463|FG000|Overall Study|Death|1|||
149063713|NCT01221948|537717463|FG000|Overall Study|Protocol Violation|4|||
148890412|NCT02365649|537077207|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
149063714|NCT02446236|537717466|FG000|Overall Study|Screen Failure|1|||
149063715|NCT02446236|537717467|FG001|Overall Study|Screen Failure|0|||
149063716|NCT02446236|537717468|FG002|Overall Study|Screen Failure|1|||
149063717|NCT02446236|537717466|FG000|Overall Study|Actively Receiving Therapy|0|||
149063718|NCT02446236|537717467|FG001|Overall Study|Actively Receiving Therapy|0|||
149063719|NCT02446236|537717468|FG002|Overall Study|Actively Receiving Therapy|1|||
149063720|NCT05012163|537717469|FG000|Overall Study|Protocol Violation|0|||
149063721|NCT05012163|537717470|FG001|Overall Study|Protocol Violation|0|||
149063722|NCT05012163|537717471|FG002|Overall Study|Protocol Violation|1|||
149063723|NCT05012163|537717472|FG003|Overall Study|Protocol Violation|1|||
149063724|NCT04003246|537717475|FG000|Overall Study|Death|9|||
149063725|NCT05280574|537717481|FG000|Overall Study|Withdrawal by Subject|0|||
149063726|NCT05280574|537717482|FG001|Overall Study|Withdrawal by Subject|2|||
149063727|NCT05280574|537717483|FG002|Overall Study|Withdrawal by Subject|0|||
149063728|NCT05363163|537717484|FG000|Overall Study|Withdrawal by Subject|13|||
149063729|NCT05838027|537717490|FG000|Overall Study|Lost to Follow-up|5|||
149063730|NCT05838027|537717491|FG001|Overall Study|Lost to Follow-up|1|||
149063731|NCT05838027|537717490|FG000|Overall Study|Withdrawal by Subject|1|||
149063732|NCT05838027|537717491|FG001|Overall Study|Withdrawal by Subject|0|||
149063733|NCT05683340|537717496|FG000|Overall Study|Adverse Event|1|||
149063734|NCT05683340|537717497|FG001|Overall Study|Adverse Event|1|||
149063735|NCT05683340|537717496|FG000|Overall Study|Protocol Violation|1|||
149063736|NCT05683340|537717497|FG001|Overall Study|Protocol Violation|0|||
149063737|NCT05683340|537717496|FG000|Overall Study|Withdrawal by Subject|0|||
149063738|NCT05683340|537717497|FG001|Overall Study|Withdrawal by Subject|2|||
149063739|NCT03505008|537717498|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
149063740|NCT03505008|537717499|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
149063741|NCT03505008|537717500|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
149063742|NCT03505008|537717501|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
149063743|NCT03505008|537717498|FG000|Before Week 24 Randomization|Adverse Event|10|||
149063744|NCT03505008|537717499|FG001|Before Week 24 Randomization|Adverse Event|0|||
149063745|NCT03505008|537717500|FG002|Before Week 24 Randomization|Adverse Event|0|||
149063746|NCT03505008|537717501|FG003|Before Week 24 Randomization|Adverse Event|0|||
149063747|NCT03505008|537717498|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
149063748|NCT03505008|537717499|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
149063749|NCT03505008|537717500|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
149063750|NCT03505008|537717501|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
149063751|NCT03505008|537717498|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
149063752|NCT03505008|537717499|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
149063753|NCT03505008|537717500|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
149063754|NCT03505008|537717501|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
149063755|NCT03505008|537717498|FG000|Before Week 24 Randomization|Physician Decision|2|||
149063756|NCT03505008|537717499|FG001|Before Week 24 Randomization|Physician Decision|0|||
149063757|NCT03505008|537717500|FG002|Before Week 24 Randomization|Physician Decision|0|||
149063758|NCT03505008|537717501|FG003|Before Week 24 Randomization|Physician Decision|0|||
149063759|NCT03505008|537717498|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
149063760|NCT03505008|537717499|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
149063761|NCT03505008|537717500|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
149063762|NCT03505008|537717501|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
149063763|NCT03505008|537717498|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
149063764|NCT03505008|537717499|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
149063765|NCT03505008|537717500|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
149063766|NCT03505008|537717501|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
149063767|NCT03505008|537717498|FG000|Before Week 24 Randomization|Complication|1|||
149063768|NCT03505008|537717499|FG001|Before Week 24 Randomization|Complication|0|||
149063769|NCT03505008|537717500|FG002|Before Week 24 Randomization|Complication|0|||
149063770|NCT03505008|537717501|FG003|Before Week 24 Randomization|Complication|0|||
149063771|NCT03505008|537717498|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
149063772|NCT03505008|537717499|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
149063773|NCT03505008|537717500|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
149063774|NCT03505008|537717501|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
149063775|NCT03505008|537717498|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
149063776|NCT03505008|537717499|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
149063777|NCT03505008|537717500|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
149063778|NCT03505008|537717501|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
149063779|NCT03505008|537717498|FG000|After Week 24 Randomization|Adverse Event|0|||
149063780|NCT03505008|537717499|FG001|After Week 24 Randomization|Adverse Event|1|||
149063781|NCT03505008|537717500|FG002|After Week 24 Randomization|Adverse Event|2|||
149063782|NCT03505008|537717501|FG003|After Week 24 Randomization|Adverse Event|2|||
149063783|NCT03505008|537717498|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
149063784|NCT03505008|537717499|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
149063785|NCT03505008|537717500|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
149063786|NCT03505008|537717501|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
149063787|NCT03505008|537717498|FG000|After Week 24 Randomization|Protocol Violation|0|||
149063788|NCT03505008|537717499|FG001|After Week 24 Randomization|Protocol Violation|0|||
149063789|NCT03505008|537717500|FG002|After Week 24 Randomization|Protocol Violation|1|||
149063790|NCT03505008|537717501|FG003|After Week 24 Randomization|Protocol Violation|0|||
149063791|NCT02962076|537717503|FG000|Overall Study|MHED tracer not available|5|||
149063792|NCT02962076|537717503|FG000|Overall Study|Protocol Violation|1|||
149063793|NCT02962076|537717503|FG000|Overall Study|Physician Decision|1|||
149063794|NCT02780700|537717504|FG000|Overall Study|Progressive disease|1|||
149063795|NCT03583333|537717505|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
149120213|NCT04602221|537918062|FG005|Overall Study|Other than listed|0|||
149063796|NCT03583333|537717506|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
149063797|NCT03583333|537717505|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
149063798|NCT03583333|537717506|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
149063799|NCT03583333|537717505|FG000|Overall Study|Withdrawal by Subject|9|||
149063800|NCT03583333|537717506|FG001|Overall Study|Withdrawal by Subject|5|||
148890413|NCT02365649|537077208|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
148890414|NCT02365649|537077199|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890415|NCT02365649|537077200|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890416|NCT02365649|537077201|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890417|NCT02365649|537077202|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890418|NCT02365649|537077203|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890419|NCT02365649|537077204|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890420|NCT02365649|537077205|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
148890421|NCT02365649|537077206|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890422|NCT02365649|537077207|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
148890423|NCT02365649|537077208|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
148890424|NCT00650767|537077226|FG000|Overall Study|Adverse Event|0|||
148890425|NCT00650767|537077227|FG001|Overall Study|Adverse Event|3|||
148890426|NCT00650767|537077228|FG002|Overall Study|Adverse Event|10|||
148890427|NCT00650767|537077229|FG003|Overall Study|Adverse Event|8|||
148890428|NCT00650767|537077226|FG000|Overall Study|Death|1|||
148890429|NCT00650767|537077227|FG001|Overall Study|Death|0|||
148890430|NCT00650767|537077228|FG002|Overall Study|Death|0|||
148890431|NCT00650767|537077229|FG003|Overall Study|Death|0|||
148890432|NCT00650767|537077226|FG000|Overall Study|Withdrawal by Subject|2|||
148890433|NCT00650767|537077227|FG001|Overall Study|Withdrawal by Subject|4|||
148890434|NCT00650767|537077228|FG002|Overall Study|Withdrawal by Subject|3|||
148890435|NCT00650767|537077229|FG003|Overall Study|Withdrawal by Subject|3|||
148890436|NCT00650767|537077226|FG000|Overall Study|Lost to Follow-up|1|||
148890437|NCT00650767|537077227|FG001|Overall Study|Lost to Follow-up|1|||
148890438|NCT00650767|537077228|FG002|Overall Study|Lost to Follow-up|1|||
148890439|NCT00650767|537077229|FG003|Overall Study|Lost to Follow-up|0|||
148890440|NCT00650767|537077226|FG000|Overall Study|Other|1|||
148890441|NCT00650767|537077227|FG001|Overall Study|Other|1|||
148890442|NCT00650767|537077228|FG002|Overall Study|Other|0|||
148890443|NCT00650767|537077229|FG003|Overall Study|Other|0|||
148890444|NCT01808196|537077233|FG000|Overall Study|Lost to Follow-up|1|||
148890445|NCT00479713|537077234|FG000|Overall Study|Adverse Event|8|||
148890446|NCT00479713|537077235|FG001|Overall Study|Adverse Event|6|||
148890447|NCT00479713|537077234|FG000|Overall Study|Death|1|||
148890448|NCT00479713|537077235|FG001|Overall Study|Death|0|||
148890449|NCT00479713|537077234|FG000|Overall Study|Lost to Follow-up|0|||
148890450|NCT00479713|537077235|FG001|Overall Study|Lost to Follow-up|1|||
148890451|NCT00479713|537077234|FG000|Overall Study|Protocol Violation|0|||
148890452|NCT00479713|537077235|FG001|Overall Study|Protocol Violation|1|||
148890453|NCT00479713|537077234|FG000|Overall Study|Withdrawal by Subject|4|||
148890454|NCT00479713|537077235|FG001|Overall Study|Withdrawal by Subject|1|||
148890455|NCT00141102|537077236|FG000|Overall Study|Adverse Event|233|||
148890456|NCT00141102|537077237|FG001|Overall Study|Adverse Event|305|||
148890457|NCT00141102|537077236|FG000|Overall Study|Laboratory Abnormality|9|||
148890458|NCT00141102|537077237|FG001|Overall Study|Laboratory Abnormality|33|||
148890459|NCT00141102|537077236|FG000|Overall Study|Lack of Efficacy|21|||
148890460|NCT00141102|537077237|FG001|Overall Study|Lack of Efficacy|26|||
148890461|NCT00141102|537077236|FG000|Overall Study|Lost to Follow-up|29|||
148890462|NCT00141102|537077237|FG001|Overall Study|Lost to Follow-up|32|||
148890463|NCT00141102|537077236|FG000|Overall Study|Other|87|||
148890464|NCT00141102|537077237|FG001|Overall Study|Other|76|||
148890465|NCT00141102|537077236|FG000|Overall Study|Withdrawal by Subject|112|||
148890466|NCT00141102|537077237|FG001|Overall Study|Withdrawal by Subject|142|||
148890467|NCT00141102|537077236|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
148890468|NCT00141102|537077237|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
148890469|NCT00141102|537077236|FG000|Overall Study|Death|2|||
148890470|NCT00141102|537077237|FG001|Overall Study|Death|2|||
148890471|NCT03061201|537077238|FG000|Overall Study|Participants Terminated at Month 36|0|||
148890472|NCT03061201|537077239|FG001|Overall Study|Participants Terminated at Month 36|1|||
148890473|NCT03061201|537077240|FG002|Overall Study|Participants Terminated at Month 36|0|||
148890474|NCT03061201|537077241|FG003|Overall Study|Participants Terminated at Month 36|1|||
148890475|NCT03061201|537077238|FG000|Overall Study|Lost to Follow-up|1|||
148890476|NCT03061201|537077239|FG001|Overall Study|Lost to Follow-up|0|||
149063801|NCT03583333|537717505|FG000|Overall Study|Physician Decision|3|||
148890477|NCT03061201|537077240|FG002|Overall Study|Lost to Follow-up|0|||
148890478|NCT03061201|537077241|FG003|Overall Study|Lost to Follow-up|0|||
148890479|NCT06172348|537077242|FG000|Treatment Period 2|Adverse Event|0|||
148890480|NCT06172348|537077243|FG001|Treatment Period 2|Adverse Event|0|||
148890481|NCT06172348|537077244|FG002|Treatment Period 2|Adverse Event|1|||
148890482|NCT06172348|537077245|FG003|Treatment Period 2|Adverse Event|0|||
149063802|NCT03583333|537717506|FG001|Overall Study|Physician Decision|2|||
149063803|NCT03583333|537717505|FG000|Overall Study|Death|12|||
149063804|NCT03583333|537717506|FG001|Overall Study|Death|7|||
149063805|NCT03926130|537717507|FG000|Overall Study|Adverse Event|9|||
149063806|NCT03926130|537717508|FG001|Overall Study|Adverse Event|11|||
149063807|NCT03926130|537717509|FG002|Overall Study|Adverse Event|2|||
149063808|NCT03926130|537717510|FG003|Overall Study|Adverse Event|0|||
149063809|NCT03926130|537717507|FG000|Overall Study|Death|2|||
149063810|NCT03926130|537717508|FG001|Overall Study|Death|0|||
149063811|NCT03926130|537717509|FG002|Overall Study|Death|1|||
149063812|NCT03926130|537717510|FG003|Overall Study|Death|0|||
149063813|NCT03926130|537717507|FG000|Overall Study|Lack of Efficacy|14|||
149063814|NCT03926130|537717508|FG001|Overall Study|Lack of Efficacy|11|||
149063815|NCT03926130|537717509|FG002|Overall Study|Lack of Efficacy|7|||
149063816|NCT03926130|537717510|FG003|Overall Study|Lack of Efficacy|1|||
149063817|NCT03926130|537717507|FG000|Overall Study|Lost to Follow-up|0|||
149063818|NCT03926130|537717508|FG001|Overall Study|Lost to Follow-up|7|||
149063819|NCT03926130|537717509|FG002|Overall Study|Lost to Follow-up|1|||
149063820|NCT03926130|537717510|FG003|Overall Study|Lost to Follow-up|0|||
149063821|NCT03926130|537717507|FG000|Overall Study|As Reported by Investigator|2|||
149063822|NCT03926130|537717508|FG001|Overall Study|As Reported by Investigator|6|||
149063823|NCT03926130|537717509|FG002|Overall Study|As Reported by Investigator|6|||
149063824|NCT03926130|537717510|FG003|Overall Study|As Reported by Investigator|0|||
149063825|NCT03926130|537717507|FG000|Overall Study|Physician Decision|3|||
149063826|NCT03926130|537717508|FG001|Overall Study|Physician Decision|2|||
149063827|NCT03926130|537717509|FG002|Overall Study|Physician Decision|1|||
149063828|NCT03926130|537717510|FG003|Overall Study|Physician Decision|0|||
149063829|NCT03926130|537717507|FG000|Overall Study|Pregnancy|2|||
149063830|NCT03926130|537717508|FG001|Overall Study|Pregnancy|2|||
149063831|NCT03926130|537717509|FG002|Overall Study|Pregnancy|1|||
149063832|NCT03926130|537717510|FG003|Overall Study|Pregnancy|0|||
149063833|NCT03926130|537717507|FG000|Overall Study|Withdrawal by Subject|20|||
149063834|NCT03926130|537717508|FG001|Overall Study|Withdrawal by Subject|28|||
149063835|NCT03926130|537717509|FG002|Overall Study|Withdrawal by Subject|18|||
149063836|NCT03926130|537717510|FG003|Overall Study|Withdrawal by Subject|1|||
149063837|NCT03926130|537717507|FG000|Overall Study|Non-Compliance|1|||
149063838|NCT03926130|537717508|FG001|Overall Study|Non-Compliance|1|||
149063839|NCT03926130|537717509|FG002|Overall Study|Non-Compliance|0|||
149063840|NCT03926130|537717510|FG003|Overall Study|Non-Compliance|0|||
149063841|NCT03926130|537717507|FG000|Overall Study|Disposition Not Captured|0|||
149063842|NCT03926130|537717508|FG001|Overall Study|Disposition Not Captured|2|||
149063843|NCT03926130|537717509|FG002|Overall Study|Disposition Not Captured|1|||
149063844|NCT03926130|537717510|FG003|Overall Study|Disposition Not Captured|0|||
149063845|NCT03640286|537717527|FG000|Overall Study|Adverse Event|6|||
149063846|NCT03640286|537717528|FG001|Overall Study|Adverse Event|6|||
149063847|NCT03640286|537717527|FG000|Overall Study|Lost to Follow-up|3|||
149063848|NCT03640286|537717528|FG001|Overall Study|Lost to Follow-up|6|||
149063849|NCT03640286|537717527|FG000|Overall Study|Pregnancy|1|||
149063850|NCT03640286|537717528|FG001|Overall Study|Pregnancy|0|||
149063851|NCT03640286|537717527|FG000|Overall Study|Withdrawal by Subject|10|||
149063852|NCT03640286|537717528|FG001|Overall Study|Withdrawal by Subject|10|||
149063853|NCT03640286|537717527|FG000|Overall Study|Non-compliance|4|||
149063854|NCT03640286|537717528|FG001|Overall Study|Non-compliance|10|||
149063855|NCT03640286|537717527|FG000|Overall Study|Medication change|1|||
149063856|NCT03640286|537717528|FG001|Overall Study|Medication change|0|||
149063857|NCT03640286|537717527|FG000|Overall Study|Other|1|||
149063858|NCT03640286|537717528|FG001|Overall Study|Other|2|||
149063859|NCT03640286|537717527|FG000|Overall Study|Joined another lifestyle program|0|||
149063860|NCT03640286|537717528|FG001|Overall Study|Joined another lifestyle program|1|||
149063861|NCT03181516|537717529|FG000|Overall Study|Withdrawal by Subject|14|||
149063862|NCT03181516|537717530|FG001|Overall Study|Withdrawal by Subject|7|||
149063863|NCT03181516|537717529|FG000|Overall Study|Lost to Follow-up|2|||
149063864|NCT03181516|537717530|FG001|Overall Study|Lost to Follow-up|2|||
149063865|NCT04580914|537717531|FG000|Overall Study|Withdrawal by Subject|6|||
149063866|NCT04580914|537717531|FG000|Overall Study|Lost to Follow-up|2|||
148890483|NCT06172348|537077246|FG004|Treatment Period 2|Adverse Event|0|||
148890484|NCT06172348|537077247|FG005|Treatment Period 2|Adverse Event|0|||
148890485|NCT04037891|537077248|FG000|Open-label Period|Withdrawal by Subject|1|||
148890486|NCT04037891|537077249|FG001|Open-label Period|Withdrawal by Subject|0|||
149063867|NCT05715528|537717532|FG000|Overall Study|Randomized but never treated|11|||
149063868|NCT05715528|537717533|FG001|Overall Study|Randomized but never treated|13|||
149063869|NCT05715528|537717532|FG000|Overall Study|Withdrew consent|7|||
149063870|NCT05715528|537717533|FG001|Overall Study|Withdrew consent|15|||
149063871|NCT05715528|537717532|FG000|Overall Study|Lost to Follow-up|5|||
149063872|NCT05715528|537717533|FG001|Overall Study|Lost to Follow-up|13|||
148890487|NCT04037891|537077250|FG002|Open-label Period|Withdrawal by Subject|0|||
149063873|NCT05715528|537717532|FG000|Overall Study|Investigator's discretion|3|||
149063874|NCT05715528|537717533|FG001|Overall Study|Investigator's discretion|1|||
149063875|NCT05715528|537717532|FG000|Overall Study|Protocol Violation|2|||
149063876|NCT05715528|537717533|FG001|Overall Study|Protocol Violation|0|||
149063877|NCT05715528|537717532|FG000|Overall Study|Non-compliance with study drug|0|||
149063878|NCT05715528|537717533|FG001|Overall Study|Non-compliance with study drug|1|||
149063879|NCT03118518|537717534|FG000|Overall Study|Early Exit after treatment|2|||
149063880|NCT03118518|537717535|FG001|Overall Study|Early Exit after treatment|8|||
149063881|NCT03118518|537717534|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
149063882|NCT03118518|537717535|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
149063883|NCT03485729|537717538|FG000|Overall Study|Withdrawal by Subject|0|||
149063884|NCT03485729|537717539|FG001|Overall Study|Withdrawal by Subject|0|||
149063885|NCT03485729|537717540|FG002|Overall Study|Withdrawal by Subject|1|||
149063886|NCT03485729|537717538|FG000|Overall Study|Disease progression|8|||
149063887|NCT03485729|537717539|FG001|Overall Study|Disease progression|13|||
149063888|NCT03485729|537717540|FG002|Overall Study|Disease progression|1|||
149063889|NCT03485729|537717538|FG000|Overall Study|Hospice care|1|||
149063890|NCT03485729|537717539|FG001|Overall Study|Hospice care|0|||
149063891|NCT03485729|537717540|FG002|Overall Study|Hospice care|0|||
149063892|NCT03485729|537717538|FG000|Overall Study|Poor performance status|1|||
149063893|NCT03485729|537717539|FG001|Overall Study|Poor performance status|0|||
149063894|NCT03485729|537717540|FG002|Overall Study|Poor performance status|0|||
149063895|NCT03485729|537717538|FG000|Overall Study|Illness|0|||
149063896|NCT03485729|537717539|FG001|Overall Study|Illness|1|||
149063897|NCT03485729|537717540|FG002|Overall Study|Illness|0|||
149063898|NCT04934072|537717541|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
149063899|NCT04934072|537717542|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
149063900|NCT04934072|537717543|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
149063901|NCT04934072|537717544|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
149063902|NCT04934072|537717545|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
149063903|NCT04934072|537717541|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
149063904|NCT04934072|537717542|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
149063905|NCT04934072|537717543|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
149063906|NCT04934072|537717544|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
149063907|NCT04934072|537717545|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
149063908|NCT04934072|537717541|FG000|Day 0 to Week 52|Other|3|||
149063909|NCT04934072|537717542|FG001|Day 0 to Week 52|Other|1|||
149063910|NCT04934072|537717543|FG002|Day 0 to Week 52|Other|0|||
149063911|NCT04934072|537717544|FG003|Day 0 to Week 52|Other|0|||
149063912|NCT04934072|537717545|FG004|Day 0 to Week 52|Other|0|||
149063913|NCT04934072|537717541|FG000|Day 0 to Week 52|Adverse Event|1|||
149063914|NCT04934072|537717542|FG001|Day 0 to Week 52|Adverse Event|3|||
149063915|NCT04934072|537717543|FG002|Day 0 to Week 52|Adverse Event|0|||
149063916|NCT04934072|537717544|FG003|Day 0 to Week 52|Adverse Event|0|||
149063917|NCT04934072|537717545|FG004|Day 0 to Week 52|Adverse Event|0|||
149063918|NCT04934072|537717541|FG000|Week 52 to Week 78|Adverse Event|0|||
149063919|NCT04934072|537717542|FG001|Week 52 to Week 78|Adverse Event|0|||
149063920|NCT04934072|537717543|FG002|Week 52 to Week 78|Adverse Event|0|||
149063921|NCT04934072|537717544|FG003|Week 52 to Week 78|Adverse Event|1|||
149063922|NCT04934072|537717545|FG004|Week 52 to Week 78|Adverse Event|1|||
149063923|NCT04934072|537717541|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
149063924|NCT04934072|537717542|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
149063925|NCT04934072|537717543|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
149063926|NCT04934072|537717544|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
149063927|NCT04934072|537717545|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
149063928|NCT04934072|537717541|FG000|Week 52 to Week 78|Other|0|||
149063929|NCT04934072|537717542|FG001|Week 52 to Week 78|Other|0|||
149063930|NCT04934072|537717543|FG002|Week 52 to Week 78|Other|1|||
149063931|NCT04934072|537717544|FG003|Week 52 to Week 78|Other|0|||
149063932|NCT04934072|537717545|FG004|Week 52 to Week 78|Other|0|||
149063933|NCT02413489|537717551|FG000|Overall Study|Death|11|||
149063934|NCT02413489|537717552|FG001|Overall Study|Death|3|||
149063935|NCT02413489|537717553|FG002|Overall Study|Death|4|||
149063936|NCT02413489|537717551|FG000|Overall Study|Withdrawal by Subject|2|||
149063937|NCT02413489|537717552|FG001|Overall Study|Withdrawal by Subject|0|||
149063938|NCT02413489|537717553|FG002|Overall Study|Withdrawal by Subject|0|||
148890488|NCT04037891|537077248|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
149063939|NCT02413489|537717551|FG000|Overall Study|Study Terminated By Sponsor|2|||
148890489|NCT04037891|537077249|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
149063940|NCT02413489|537717552|FG001|Overall Study|Study Terminated By Sponsor|13|||
149063941|NCT02413489|537717553|FG002|Overall Study|Study Terminated By Sponsor|1|||
149063942|NCT01199133|537717557|FG000|Year 1|Adverse Event|16|||
149063943|NCT01199133|537717558|FG001|Year 1|Adverse Event|4|||
149063944|NCT01199133|537717557|FG000|Year 1|Withdrawal by Subject|8|||
149063945|NCT01199133|537717558|FG001|Year 1|Withdrawal by Subject|4|||
149063946|NCT01199133|537717557|FG000|Year 1|Any other reason not above-mentioned|6|||
149063947|NCT01199133|537717558|FG001|Year 1|Any other reason not above-mentioned|7|||
149063948|NCT01199133|537717557|FG000|Year 2|Adverse Event|1|||
149063949|NCT01199133|537717558|FG001|Year 2|Adverse Event|0|||
149063950|NCT01199133|537717557|FG000|Year 2|Withdrawal by Subject|1|||
149063951|NCT01199133|537717558|FG001|Year 2|Withdrawal by Subject|1|||
149063952|NCT01199133|537717557|FG000|Year 2|Any other reason not above-mentioned|1|||
149063953|NCT01199133|537717558|FG001|Year 2|Any other reason not above-mentioned|2|||
149063954|NCT05100628|537717559|FG000|Overall Study|Progressive Disease|1|||
149063955|NCT05100628|537717560|FG001|Overall Study|Progressive Disease|0|||
149063956|NCT05100628|537717561|FG002|Overall Study|Progressive Disease|0|||
149063957|NCT05100628|537717562|FG003|Overall Study|Progressive Disease|0|||
149063958|NCT05100628|537717559|FG000|Overall Study|Study Terminated by Sponsor|0|||
149063959|NCT05100628|537717560|FG001|Overall Study|Study Terminated by Sponsor|0|||
149063960|NCT05100628|537717561|FG002|Overall Study|Study Terminated by Sponsor|3|||
149063961|NCT05100628|537717562|FG003|Overall Study|Study Terminated by Sponsor|0|||
149063962|NCT05100628|537717559|FG000|Overall Study|unkown|0|||
149063963|NCT05100628|537717560|FG001|Overall Study|unkown|1|||
149063964|NCT05100628|537717561|FG002|Overall Study|unkown|0|||
149063965|NCT05100628|537717562|FG003|Overall Study|unkown|0|||
149063966|NCT02575950|537717565|FG000|Overall Study|Withdrawal by Subject|0|||
149063967|NCT02575950|537717566|FG001|Overall Study|Withdrawal by Subject|0|||
149063968|NCT02575950|537717567|FG002|Overall Study|Withdrawal by Subject|0|||
149063969|NCT02575950|537717568|FG003|Overall Study|Withdrawal by Subject|2|||
149063970|NCT02575950|537717565|FG000|Overall Study|Lost to Follow-up|0|||
149063971|NCT02575950|537717566|FG001|Overall Study|Lost to Follow-up|1|||
149063972|NCT02575950|537717567|FG002|Overall Study|Lost to Follow-up|0|||
149063973|NCT02575950|537717568|FG003|Overall Study|Lost to Follow-up|3|||
149063974|NCT02641730|537717569|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
149063975|NCT02641730|537717570|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149063976|NCT02641730|537717571|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
149063977|NCT02641730|537717572|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
149063978|NCT02641730|537717573|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
149063979|NCT02641730|537717569|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
149063980|NCT02641730|537717570|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
149063981|NCT02641730|537717571|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
149063982|NCT02641730|537717572|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
149063983|NCT02641730|537717573|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
149063984|NCT02641730|537717569|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
149063985|NCT02641730|537717570|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
149063986|NCT02641730|537717571|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
149063987|NCT02641730|537717572|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
149063988|NCT02641730|537717573|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
149063989|NCT02641730|537717569|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149063990|NCT02641730|537717570|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149063991|NCT02641730|537717571|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
149063992|NCT02641730|537717572|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
149063993|NCT02641730|537717573|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
149063994|NCT02641730|537717569|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
149063995|NCT02641730|537717570|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
149063996|NCT02641730|537717571|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
149063997|NCT02641730|537717572|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
149063998|NCT02641730|537717573|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
149063999|NCT02641730|537717569|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
149064000|NCT02641730|537717570|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
149064001|NCT02641730|537717571|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
149064002|NCT02641730|537717572|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
149064003|NCT02641730|537717573|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
149064004|NCT05460871|537717574|FG000|Overall Study|Withdrawal by Subject|1|||
149064005|NCT05460871|537717575|FG001|Overall Study|Withdrawal by Subject|2|||
149064006|NCT00721149|537717576|FG000|Overall Study|Physician Decision|1|||
149064007|NCT04271046|537717577|FG000|Overall Study|Death|0|||
149064008|NCT04271046|537717578|FG001|Overall Study|Death|2|||
149064009|NCT04271046|537717579|FG002|Overall Study|Death|0|||
149064010|NCT04271046|537717580|FG003|Overall Study|Death|2|||
149064011|NCT04271046|537717577|FG000|Overall Study|Lost to Follow-up|12|||
149064012|NCT04271046|537717578|FG001|Overall Study|Lost to Follow-up|12|||
149064013|NCT04271046|537717579|FG002|Overall Study|Lost to Follow-up|11|||
149064014|NCT04271046|537717580|FG003|Overall Study|Lost to Follow-up|11|||
149064015|NCT04271046|537717577|FG000|Overall Study|Patient with Dementia Died|2|||
149064016|NCT04271046|537717578|FG001|Overall Study|Patient with Dementia Died|0|||
149064017|NCT04271046|537717579|FG002|Overall Study|Patient with Dementia Died|2|||
148890490|NCT04037891|537077250|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
148890491|NCT03446313|537077252|FG000|Overall Study|Lost to Follow-up|1|||
149064018|NCT04271046|537717580|FG003|Overall Study|Patient with Dementia Died|0|||
149064019|NCT04271046|537717577|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
149064020|NCT04271046|537717578|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
149064021|NCT04271046|537717579|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
149064022|NCT04271046|537717580|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
149064023|NCT05158504|537717581|FG000|Overall Study|Lost to Follow-up|2|||
149064024|NCT05158504|537717582|FG001|Overall Study|Lost to Follow-up|3|||
149064025|NCT03993392|537717585|FG000|Overall Study|Withdrawal by Subject|3|||
149064026|NCT03993392|537717585|FG000|Overall Study|Lost to Follow-up|2|||
149064027|NCT03993392|537717585|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
149064028|NCT03057054|537717586|FG000|Overall Study|Death|4|||
149064029|NCT03057054|537717587|FG001|Overall Study|Death|4|||
149064030|NCT03057054|537717586|FG000|Overall Study|Withdrawal by Subject|6|||
149064031|NCT03057054|537717587|FG001|Overall Study|Withdrawal by Subject|3|||
149064032|NCT03057054|537717586|FG000|Overall Study|Ineligible|1|||
149064033|NCT03057054|537717587|FG001|Overall Study|Ineligible|1|||
149064034|NCT06262477|537719467|FG000|Overall Study|Withdrawal by Subject|1|||
149064035|NCT06262477|537719468|FG001|Overall Study|Withdrawal by Subject|0|||
149064036|NCT06262477|537719467|FG000|Overall Study|Adverse Event|0|||
149064037|NCT06262477|537719468|FG001|Overall Study|Adverse Event|1|||
149064038|NCT06262477|537719467|FG000|Overall Study|Lost to Follow-up|0|||
149064039|NCT06262477|537719468|FG001|Overall Study|Lost to Follow-up|1|||
149064040|NCT01064440|537719469|FG000|Overall Study|Lost to Follow-up|1|||
149064041|NCT01064440|537719470|FG001|Overall Study|Lost to Follow-up|1|||
149064042|NCT01064440|537719471|FG002|Overall Study|Lost to Follow-up|1|||
149064043|NCT01064440|537719469|FG000|Overall Study|Non-compliance|0|||
149064044|NCT01064440|537719470|FG001|Overall Study|Non-compliance|1|||
149064045|NCT01064440|537719471|FG002|Overall Study|Non-compliance|0|||
149064046|NCT01064440|537719469|FG000|Overall Study|Death|1|||
149064047|NCT01064440|537719470|FG001|Overall Study|Death|0|||
149064048|NCT01064440|537719471|FG002|Overall Study|Death|1|||
149064049|NCT01064440|537719469|FG000|Overall Study|Withdrawal by Subject|0|||
149064050|NCT01064440|537719470|FG001|Overall Study|Withdrawal by Subject|1|||
149064051|NCT01064440|537719471|FG002|Overall Study|Withdrawal by Subject|1|||
149064052|NCT01064440|537719469|FG000|Overall Study|Other: amputation|1|||
149064053|NCT01064440|537719470|FG001|Overall Study|Other: amputation|0|||
149064054|NCT01064440|537719471|FG002|Overall Study|Other: amputation|0|||
149064055|NCT05247034|537719476|FG000|Overall Study|Lost to Follow-up|3|||
149064056|NCT05247034|537719477|FG001|Overall Study|Lost to Follow-up|2|||
149064057|NCT05247034|537719476|FG000|Overall Study|Organizational problems when attending appointments|1|||
149064058|NCT05247034|537719477|FG001|Overall Study|Organizational problems when attending appointments|0|||
149064059|NCT04414722|537719480|FG000|Overall Study|Lost to Follow-up|3|||
149064060|NCT04414722|537719481|FG001|Overall Study|Lost to Follow-up|4|||
149064061|NCT04414722|537719482|FG002|Overall Study|Lost to Follow-up|3|||
149064062|NCT04414722|537719483|FG003|Overall Study|Lost to Follow-up|2|||
149064063|NCT04414722|537719484|FG004|Overall Study|Lost to Follow-up|3|||
149064064|NCT04414722|537719480|FG000|Overall Study|Withdrawal by Subject|6|||
149064065|NCT04414722|537719481|FG001|Overall Study|Withdrawal by Subject|3|||
149064066|NCT04414722|537719482|FG002|Overall Study|Withdrawal by Subject|1|||
149064067|NCT04414722|537719483|FG003|Overall Study|Withdrawal by Subject|5|||
149064068|NCT04414722|537719484|FG004|Overall Study|Withdrawal by Subject|1|||
149064069|NCT04414722|537719480|FG000|Overall Study|Physician Decision|0|||
149064070|NCT04414722|537719481|FG001|Overall Study|Physician Decision|1|||
149064071|NCT04414722|537719482|FG002|Overall Study|Physician Decision|2|||
149064072|NCT04414722|537719483|FG003|Overall Study|Physician Decision|0|||
149064073|NCT04414722|537719484|FG004|Overall Study|Physician Decision|0|||
149064074|NCT04414722|537719480|FG000|Overall Study|Non-participatory|0|||
149064075|NCT04414722|537719481|FG001|Overall Study|Non-participatory|1|||
149064076|NCT04414722|537719482|FG002|Overall Study|Non-participatory|1|||
149064077|NCT04414722|537719483|FG003|Overall Study|Non-participatory|0|||
149064078|NCT04414722|537719484|FG004|Overall Study|Non-participatory|0|||
149064079|NCT02668692|537719485|FG000|Overall Study|Adverse Event|1|||
149064080|NCT02668692|537719486|FG001|Overall Study|Adverse Event|0|||
149064081|NCT04136912|537719491|FG000|Overall Study|Operational reasons|0|||
149064082|NCT04136912|537719492|FG001|Overall Study|Operational reasons|0|||
149064083|NCT04136912|537719493|FG002|Overall Study|Operational reasons|2|||
149064084|NCT04615273|537719500|FG000|Overall Study|Withdrawal by Subject|3|||
149064085|NCT04615273|537719501|FG001|Overall Study|Withdrawal by Subject|1|||
149064086|NCT04615273|537719502|FG002|Overall Study|Withdrawal by Subject|2|||
149064087|NCT04615273|537719500|FG000|Overall Study|Adverse Event|1|||
149064088|NCT04615273|537719501|FG001|Overall Study|Adverse Event|0|||
149064089|NCT04615273|537719502|FG002|Overall Study|Adverse Event|1|||
149064090|NCT04615273|537719500|FG000|Overall Study|Lost to Follow-up|0|||
149064091|NCT04615273|537719501|FG001|Overall Study|Lost to Follow-up|1|||
149064092|NCT04615273|537719502|FG002|Overall Study|Lost to Follow-up|0|||
149064093|NCT04615273|537719500|FG000|Overall Study|Physician Decision|0|||
149064094|NCT04615273|537719501|FG001|Overall Study|Physician Decision|0|||
149064095|NCT04615273|537719502|FG002|Overall Study|Physician Decision|1|||
149064096|NCT04615273|537719500|FG000|Overall Study|Other|0|||
149064097|NCT04615273|537719501|FG001|Overall Study|Other|1|||
149064098|NCT04615273|537719502|FG002|Overall Study|Other|0|||
149064099|NCT04615273|537719500|FG000|Overall Study|Randomized but not treated|1|||
149064100|NCT04615273|537719501|FG001|Overall Study|Randomized but not treated|3|||
149064101|NCT04615273|537719502|FG002|Overall Study|Randomized but not treated|1|||
149064102|NCT05524402|537719507|FG000|Overall Study|Withdrawal by Subject|3|||
149120214|NCT04602221|537918063|FG006|Overall Study|Other than listed|0|||
149064103|NCT05524402|537719508|FG001|Overall Study|Withdrawal by Subject|1|||
149064104|NCT05524402|537719507|FG000|Overall Study|Lost to Follow-up|2|||
149064105|NCT05524402|537719508|FG001|Overall Study|Lost to Follow-up|1|||
149064106|NCT05976334|537719509|FG000|Part B|Death|0|||
149064107|NCT05976334|537719510|FG001|Part B|Death|1|||
149064108|NCT05976334|537719509|FG000|Part B|Study Terminated by Sponsor|0|||
149064109|NCT05976334|537719510|FG001|Part B|Study Terminated by Sponsor|1|||
149064110|NCT05976334|537719509|FG000|Part B|Reason Not Specified|0|||
149064111|NCT05976334|537719510|FG001|Part B|Reason Not Specified|1|||
149064112|NCT05237284|537719511|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
149064113|NCT05237284|537719512|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
149064114|NCT05237284|537719513|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
149064115|NCT05237284|537719514|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
149064116|NCT05237284|537719511|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
149064117|NCT05237284|537719512|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
149064118|NCT05237284|537719513|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
149064119|NCT05237284|537719514|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
149064120|NCT05237284|537719511|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
149064121|NCT05237284|537719512|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
149064122|NCT05237284|537719513|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
149064123|NCT05237284|537719514|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
149064124|NCT05237284|537719511|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
149064125|NCT05237284|537719512|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
149064126|NCT05237284|537719513|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
149064127|NCT05237284|537719514|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
149064128|NCT05237284|537719511|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
149064129|NCT05237284|537719512|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
149064130|NCT05237284|537719513|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
149064131|NCT05237284|537719514|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
149064132|NCT05237284|537719511|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
149064133|NCT05237284|537719512|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
149064134|NCT05237284|537719513|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
149064135|NCT05237284|537719514|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
149064136|NCT05237284|537719511|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
149064137|NCT05237284|537719512|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
149064138|NCT05237284|537719513|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
149064139|NCT05237284|537719514|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
149064140|NCT05237284|537719511|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
149064141|NCT05237284|537719512|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
149064142|NCT05237284|537719513|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
149064143|NCT05237284|537719514|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
149064144|NCT05237284|537719511|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
149064145|NCT05237284|537719512|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
149064146|NCT05237284|537719513|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
149064147|NCT05237284|537719514|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
149064148|NCT04999111|537719515|FG000|Overall Study|Lost to Follow-up|21|||
149064149|NCT04999111|537719516|FG001|Overall Study|Lost to Follow-up|16|||
149064150|NCT04999111|537719517|FG002|Overall Study|Lost to Follow-up|2|||
149064151|NCT04999111|537719518|FG003|Overall Study|Lost to Follow-up|26|||
149064152|NCT04999111|537719519|FG004|Overall Study|Lost to Follow-up|30|||
149064153|NCT04999111|537719520|FG005|Overall Study|Lost to Follow-up|6|||
149064154|NCT04999111|537719515|FG000|Overall Study|Physician Decision|1|||
149064155|NCT04999111|537719516|FG001|Overall Study|Physician Decision|3|||
149064156|NCT04999111|537719517|FG002|Overall Study|Physician Decision|0|||
149064157|NCT04999111|537719518|FG003|Overall Study|Physician Decision|1|||
149064158|NCT04999111|537719519|FG004|Overall Study|Physician Decision|2|||
149064159|NCT04999111|537719520|FG005|Overall Study|Physician Decision|0|||
149064160|NCT04999111|537719515|FG000|Overall Study|Withdrawal by Subject|23|||
149064161|NCT04999111|537719516|FG001|Overall Study|Withdrawal by Subject|29|||
149064162|NCT04999111|537719517|FG002|Overall Study|Withdrawal by Subject|15|||
149064163|NCT04999111|537719518|FG003|Overall Study|Withdrawal by Subject|30|||
149064164|NCT04999111|537719519|FG004|Overall Study|Withdrawal by Subject|35|||
149064165|NCT04999111|537719520|FG005|Overall Study|Withdrawal by Subject|10|||
149064166|NCT04999111|537719515|FG000|Overall Study|Other|6|||
149064167|NCT04999111|537719516|FG001|Overall Study|Other|6|||
149064168|NCT04999111|537719517|FG002|Overall Study|Other|3|||
149064169|NCT04999111|537719518|FG003|Overall Study|Other|8|||
149064170|NCT04999111|537719519|FG004|Overall Study|Other|8|||
149064171|NCT04999111|537719520|FG005|Overall Study|Other|5|||
149064172|NCT04999111|537719515|FG000|Overall Study|Non-compliance with study schedule|1|||
149064173|NCT04999111|537719516|FG001|Overall Study|Non-compliance with study schedule|0|||
149064174|NCT04999111|537719517|FG002|Overall Study|Non-compliance with study schedule|0|||
149064175|NCT04999111|537719518|FG003|Overall Study|Non-compliance with study schedule|1|||
149064176|NCT04999111|537719519|FG004|Overall Study|Non-compliance with study schedule|1|||
149064177|NCT04999111|537719520|FG005|Overall Study|Non-compliance with study schedule|1|||
149064178|NCT04999111|537719515|FG000|Overall Study|Randomized but not vaccinated|1|||
149064179|NCT04999111|537719516|FG001|Overall Study|Randomized but not vaccinated|2|||
149064180|NCT04999111|537719517|FG002|Overall Study|Randomized but not vaccinated|0|||
149064181|NCT04999111|537719518|FG003|Overall Study|Randomized but not vaccinated|3|||
149064182|NCT04999111|537719519|FG004|Overall Study|Randomized but not vaccinated|3|||
149064183|NCT04999111|537719520|FG005|Overall Study|Randomized but not vaccinated|0|||
149064184|NCT04999111|537719515|FG000|Overall Study|Adverse Event|1|||
149064185|NCT04999111|537719516|FG001|Overall Study|Adverse Event|1|||
149064186|NCT04999111|537719517|FG002|Overall Study|Adverse Event|0|||
149064187|NCT04999111|537719518|FG003|Overall Study|Adverse Event|0|||
148890492|NCT03446313|537077253|FG001|Overall Study|Lost to Follow-up|2|||
148890493|NCT03446313|537077252|FG000|Overall Study|Failed primary screening|3|||
148890494|NCT03446313|537077253|FG001|Overall Study|Failed primary screening|0|||
148890495|NCT03446313|537077252|FG000|Overall Study|Diagnosed with terminal cancer|1|||
149064188|NCT04999111|537719519|FG004|Overall Study|Adverse Event|0|||
149064189|NCT04999111|537719520|FG005|Overall Study|Adverse Event|0|||
149064190|NCT04999111|537719515|FG000|Overall Study|Initiated prohibited medication|0|||
149064191|NCT04999111|537719516|FG001|Overall Study|Initiated prohibited medication|0|||
149064192|NCT04999111|537719517|FG002|Overall Study|Initiated prohibited medication|0|||
149064193|NCT04999111|537719518|FG003|Overall Study|Initiated prohibited medication|0|||
149064194|NCT04999111|537719519|FG004|Overall Study|Initiated prohibited medication|1|||
149064195|NCT04999111|537719520|FG005|Overall Study|Initiated prohibited medication|0|||
149064196|NCT02224144|537719526|FG000|Overall Study|Lost to Follow-up|3|||
149064197|NCT02224144|537719527|FG001|Overall Study|Lost to Follow-up|1|||
149064198|NCT02224144|537719526|FG000|Overall Study|Death|2|||
149064199|NCT02224144|537719527|FG001|Overall Study|Death|0|||
149064200|NCT02224144|537719526|FG000|Overall Study|Withdrawal by Subject|0|||
149064201|NCT02224144|537719527|FG001|Overall Study|Withdrawal by Subject|1|||
149064202|NCT02437136|537719528|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
149064203|NCT02437136|537719529|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
149064204|NCT02437136|537719530|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
149064205|NCT02437136|537719531|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
149064206|NCT02437136|537719532|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
149064207|NCT02437136|537719533|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
149064208|NCT02437136|537719534|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
149064209|NCT02437136|537719528|FG000|Expansion (Phase 2)|Death|0|||
149064210|NCT02437136|537719529|FG001|Expansion (Phase 2)|Death|0|||
149064211|NCT02437136|537719530|FG002|Expansion (Phase 2)|Death|0|||
149064212|NCT02437136|537719531|FG003|Expansion (Phase 2)|Death|6|||
149064213|NCT02437136|537719532|FG004|Expansion (Phase 2)|Death|37|||
149064214|NCT02437136|537719533|FG005|Expansion (Phase 2)|Death|29|||
149064215|NCT02437136|537719534|FG006|Expansion (Phase 2)|Death|24|||
149064216|NCT02437136|537719528|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
149064217|NCT02437136|537719529|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
149064218|NCT02437136|537719530|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
149064219|NCT02437136|537719531|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
149064220|NCT02437136|537719532|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
149064221|NCT02437136|537719533|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
149064222|NCT02437136|537719534|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
149064223|NCT02437136|537719528|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
149064224|NCT02437136|537719529|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
149064225|NCT02437136|537719530|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
149064226|NCT02437136|537719531|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
149064227|NCT02437136|537719532|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
149064228|NCT02437136|537719533|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
148890496|NCT03446313|537077253|FG001|Overall Study|Diagnosed with terminal cancer|0|||
148890497|NCT03446313|537077252|FG000|Overall Study|Excluded from analysis|1|||
149064229|NCT02437136|537719534|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
149064230|NCT01314105|537719535|FG000|Overall Study|Progressive Disease|6|||
149064231|NCT01314105|537719536|FG001|Overall Study|Progressive Disease|10|||
149064232|NCT01314105|537719535|FG000|Overall Study|Refused to continue taking medication|0|||
149064233|NCT01314105|537719536|FG001|Overall Study|Refused to continue taking medication|1|||
149064234|NCT01314105|537719535|FG000|Overall Study|Other Adverse Event|1|||
149064235|NCT01314105|537719536|FG001|Overall Study|Other Adverse Event|1|||
149064236|NCT02056834|537719539|FG000|Overall Study|Lost to Follow-up|7|||
149064237|NCT04526886|537719541|FG000|Overall Study|Physician Decision|4|||
148890498|NCT03446313|537077253|FG001|Overall Study|Excluded from analysis|1|||
148890499|NCT00866814|537077261|FG000|Overall Study|Lost to Follow-up|12|||
149064238|NCT03276676|537719542|FG000|Overall Study|Withdrawal by Subject|2|||
149064239|NCT03276676|537719543|FG001|Overall Study|Withdrawal by Subject|1|||
149064240|NCT04820322|537719554|FG000|Overall Study|Adverse Event|1|||
148890500|NCT00866814|537077261|FG000|Overall Study|Adverse Event|2|||
149064241|NCT04820322|537719555|FG001|Overall Study|Adverse Event|0|||
149064242|NCT03156465|537719556|FG000|Overall Study|Withdrawal by Subject|2|||
149064243|NCT04544007|537719560|FG000|Overall Study|Withdrawal by Subject|1|||
149064244|NCT04544007|537719560|FG000|Overall Study|Confirmed Progressive Disease|1|||
149064245|NCT04880733|537719567|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
149064246|NCT04880733|537719568|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
149064247|NCT04880733|537719569|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
149064248|NCT04880733|537719567|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
149064249|NCT04880733|537719568|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
149064250|NCT04880733|537719569|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
149064251|NCT04880733|537719567|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
149064252|NCT04880733|537719568|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
149064253|NCT04880733|537719569|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
149064254|NCT04880733|537719567|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
149064255|NCT04880733|537719568|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
149064256|NCT04880733|537719569|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
149064257|NCT04880733|537719567|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
149064258|NCT04880733|537719568|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
149064259|NCT04880733|537719569|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
149064260|NCT05533190|537719571|FG000|Overall Study|Lost to Follow-up|19|||
149064261|NCT05533190|537719572|FG001|Overall Study|Lost to Follow-up|7|||
149064262|NCT05533190|537719571|FG000|Overall Study|Failed to download app|1|||
149064263|NCT05533190|537719572|FG001|Overall Study|Failed to download app|0|||
149064264|NCT05533190|537719571|FG000|Overall Study|Thought app was a scam|1|||
149064265|NCT05533190|537719572|FG001|Overall Study|Thought app was a scam|0|||
149064266|NCT05533190|537719571|FG000|Overall Study|Withdrawal by Subject|2|||
149064267|NCT05533190|537719572|FG001|Overall Study|Withdrawal by Subject|0|||
149064268|NCT02323880|537719573|FG000|Overall Study|Adverse Event|2|||
149064269|NCT02323880|537719574|FG001|Overall Study|Adverse Event|0|||
149064270|NCT02323880|537719575|FG002|Overall Study|Adverse Event|1|||
149064271|NCT02323880|537719576|FG003|Overall Study|Adverse Event|1|||
149064272|NCT02323880|537719577|FG004|Overall Study|Adverse Event|1|||
149064273|NCT02323880|537719578|FG005|Overall Study|Adverse Event|0|||
149064274|NCT02323880|537719579|FG006|Overall Study|Adverse Event|1|||
149064275|NCT02323880|537719580|FG007|Overall Study|Adverse Event|0|||
149064276|NCT02323880|537719573|FG000|Overall Study|Death|0|||
149064277|NCT02323880|537719574|FG001|Overall Study|Death|0|||
149064278|NCT02323880|537719575|FG002|Overall Study|Death|0|||
149064279|NCT02323880|537719576|FG003|Overall Study|Death|0|||
149064280|NCT02323880|537719577|FG004|Overall Study|Death|0|||
149064281|NCT02323880|537719578|FG005|Overall Study|Death|1|||
149064282|NCT02323880|537719579|FG006|Overall Study|Death|0|||
149064283|NCT02323880|537719580|FG007|Overall Study|Death|0|||
149064284|NCT02323880|537719573|FG000|Overall Study|Lack of Efficacy|4|||
149064285|NCT02323880|537719574|FG001|Overall Study|Lack of Efficacy|11|||
149064286|NCT02323880|537719575|FG002|Overall Study|Lack of Efficacy|5|||
149064287|NCT02323880|537719576|FG003|Overall Study|Lack of Efficacy|5|||
149064288|NCT02323880|537719577|FG004|Overall Study|Lack of Efficacy|4|||
149064289|NCT02323880|537719578|FG005|Overall Study|Lack of Efficacy|8|||
149064290|NCT02323880|537719579|FG006|Overall Study|Lack of Efficacy|4|||
149064291|NCT02323880|537719580|FG007|Overall Study|Lack of Efficacy|6|||
149064292|NCT02323880|537719573|FG000|Overall Study|Physician Decision|0|||
149064293|NCT02323880|537719574|FG001|Overall Study|Physician Decision|0|||
149064294|NCT02323880|537719575|FG002|Overall Study|Physician Decision|0|||
149064295|NCT02323880|537719576|FG003|Overall Study|Physician Decision|0|||
149064296|NCT02323880|537719577|FG004|Overall Study|Physician Decision|1|||
149064297|NCT02323880|537719578|FG005|Overall Study|Physician Decision|1|||
149064298|NCT02323880|537719579|FG006|Overall Study|Physician Decision|1|||
149064299|NCT02323880|537719580|FG007|Overall Study|Physician Decision|0|||
149064300|NCT02323880|537719573|FG000|Overall Study|Withdrawal by Subject|0|||
149064301|NCT02323880|537719574|FG001|Overall Study|Withdrawal by Subject|2|||
149064302|NCT02323880|537719575|FG002|Overall Study|Withdrawal by Subject|0|||
149064303|NCT02323880|537719576|FG003|Overall Study|Withdrawal by Subject|0|||
148890501|NCT00866814|537077261|FG000|Overall Study|Physician Decision|1|||
149064304|NCT02323880|537719577|FG004|Overall Study|Withdrawal by Subject|0|||
149064305|NCT02323880|537719578|FG005|Overall Study|Withdrawal by Subject|0|||
149064306|NCT02323880|537719579|FG006|Overall Study|Withdrawal by Subject|0|||
149064307|NCT02323880|537719580|FG007|Overall Study|Withdrawal by Subject|0|||
149064308|NCT04218851|537719585|FG000|Overall Study|Death|1|||
149064309|NCT04218851|537719586|FG001|Overall Study|Death|3|||
149064310|NCT03717935|537719587|FG000|Overall Study|Withdrawal by Subject|0|||
149064311|NCT03717935|537719588|FG001|Overall Study|Withdrawal by Subject|2|||
149064312|NCT01820611|537719593|FG000|Overall Study|Death|8|||
149064313|NCT01820611|537719593|FG000|Overall Study|Adverse Event|1|||
148890502|NCT00866814|537077261|FG000|Overall Study|Death|1|||
148890503|NCT00866814|537077261|FG000|Overall Study|No longer wished to participate|1|||
149064314|NCT01820611|537719593|FG000|Overall Study|Withdrawal by Subject|9|||
149064315|NCT03484819|537719594|FG000|Overall Study|Death|2|||
149064316|NCT03484819|537719594|FG000|Overall Study|Adverse Event|2|||
149064317|NCT03484819|537719594|FG000|Overall Study|Physician Decision|1|||
149064318|NCT03484819|537719594|FG000|Overall Study|Withdrawal by Subject|2|||
149064319|NCT03484819|537719594|FG000|Overall Study|Disease Progression|4|||
149064320|NCT03484819|537719594|FG000|Overall Study|Complicating Condition|1|||
149064321|NCT05970861|537719595|FG000|Overall Study|Physician Decision|4|||
149064322|NCT05970861|537719596|FG001|Overall Study|Physician Decision|4|||
149064323|NCT05970861|537719595|FG000|Overall Study|Lost to Follow-up|4|||
149064324|NCT05970861|537719596|FG001|Overall Study|Lost to Follow-up|3|||
149064325|NCT04456296|537719597|FG000|Overall Study|Withdrawal by Subject|14|||
149064326|NCT04456296|537719598|FG001|Overall Study|Withdrawal by Subject|21|||
149064327|NCT04456296|537719599|FG002|Overall Study|Withdrawal by Subject|21|||
149064328|NCT04456296|537719597|FG000|Overall Study|Adverse Event|2|||
149064329|NCT04456296|537719598|FG001|Overall Study|Adverse Event|2|||
149064330|NCT04456296|537719599|FG002|Overall Study|Adverse Event|2|||
149064331|NCT04456296|537719597|FG000|Overall Study|Death|1|||
149064332|NCT04456296|537719598|FG001|Overall Study|Death|0|||
149064333|NCT04456296|537719599|FG002|Overall Study|Death|0|||
149064334|NCT04456296|537719597|FG000|Overall Study|Lost to Follow-up|3|||
149064335|NCT04456296|537719598|FG001|Overall Study|Lost to Follow-up|5|||
149064336|NCT04456296|537719599|FG002|Overall Study|Lost to Follow-up|6|||
149064337|NCT04456296|537719597|FG000|Overall Study|Other than specified|0|||
149064338|NCT04456296|537719598|FG001|Overall Study|Other than specified|1|||
149064339|NCT04456296|537719599|FG002|Overall Study|Other than specified|4|||
149064340|NCT04456296|537719597|FG000|Overall Study|Randomized, not treated|2|||
149064341|NCT04456296|537719598|FG001|Overall Study|Randomized, not treated|1|||
149064342|NCT04456296|537719599|FG002|Overall Study|Randomized, not treated|0|||
149064343|NCT05736458|537719600|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
149064344|NCT05736458|537719601|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
149064345|NCT05736458|537719602|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
149064346|NCT05736458|537719600|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
149064347|NCT05736458|537719601|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
149064348|NCT05736458|537719602|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
149064349|NCT05736458|537719600|FG000|TMS/fMRI #1|Physician Decision|0|||
149064350|NCT05736458|537719601|FG001|TMS/fMRI #1|Physician Decision|0|||
149064351|NCT05736458|537719602|FG002|TMS/fMRI #1|Physician Decision|2|||
149064352|NCT05736458|537719600|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
149064353|NCT05736458|537719601|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
149064354|NCT05736458|537719602|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
149064355|NCT02990338|537719603|FG000|Overall Study|Randomized and not treated|4|||
149064356|NCT02990338|537719604|FG001|Overall Study|Randomized and not treated|2|||
149064357|NCT02990338|537719603|FG000|Overall Study|Adverse Event|23|||
149064358|NCT02990338|537719604|FG001|Overall Study|Adverse Event|22|||
149064359|NCT02990338|537719603|FG000|Overall Study|Progressive disease|118|||
149064360|NCT02990338|537719604|FG001|Overall Study|Progressive disease|107|||
149064361|NCT02990338|537719603|FG000|Overall Study|Poor compliance to protocol|0|||
149064362|NCT02990338|537719604|FG001|Overall Study|Poor compliance to protocol|1|||
149064363|NCT02990338|537719603|FG000|Overall Study|Withdrawal by Subject|6|||
149064364|NCT02990338|537719604|FG001|Overall Study|Withdrawal by Subject|8|||
149064365|NCT02990338|537719603|FG000|Overall Study|Physician's decision|2|||
149064366|NCT02990338|537719604|FG001|Overall Study|Physician's decision|6|||
149064367|NCT02990338|537719603|FG000|Overall Study|Treatment extension study|0|||
149064368|NCT02990338|537719604|FG001|Overall Study|Treatment extension study|6|||
149064369|NCT02990338|537719603|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
149064370|NCT02990338|537719604|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
149064371|NCT02990338|537719603|FG000|Overall Study|Continue with therapy available commercially|0|||
149064372|NCT02990338|537719604|FG001|Overall Study|Continue with therapy available commercially|1|||
149064373|NCT04186819|537719606|FG000|Overall Study|Adverse Event|1|||
149064374|NCT04186819|537719606|FG000|Overall Study|Lost to Follow-up|1|||
149064375|NCT04186819|537719606|FG000|Overall Study|Opted for EBRT|1|||
149064376|NCT04186819|537719606|FG000|Overall Study|Opted SBRT|1|||
149064377|NCT04186819|537719606|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
149064378|NCT04186819|537719606|FG000|Overall Study|Physician Decision|1|||
149064379|NCT04186819|537719606|FG000|Overall Study|RP Delayed|1|||
149064380|NCT04186819|537719606|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
149064381|NCT04186819|537719606|FG000|Overall Study|Subject declined for financial reasons|1|||
149064382|NCT04186819|537719606|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
149064383|NCT04186819|537719606|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
149064384|NCT04186819|537719606|FG000|Overall Study|The subject opted for other treatment option|2|||
149064385|NCT04186819|537719606|FG000|Overall Study|The subject opted for other treatment options|1|||
149064386|NCT04186819|537719606|FG000|Overall Study|Withdrawal by Subject|3|||
149064387|NCT04186819|537719606|FG000|Overall Study|Reason not specified|1|||
149064388|NCT05900154|537719608|FG000|Follow-Up Period|Lost to Follow-up|1|||
149064389|NCT05900154|537719609|FG001|Follow-Up Period|Lost to Follow-up|2|||
149064390|NCT05900154|537719610|FG002|Follow-Up Period|Lost to Follow-up|1|||
149064391|NCT05900154|537719611|FG003|Follow-Up Period|Lost to Follow-up|0|||
149064392|NCT05900154|537719612|FG004|Follow-Up Period|Lost to Follow-up|1|||
149064393|NCT05900154|537719613|FG005|Follow-Up Period|Lost to Follow-up|1|||
149064394|NCT03606512|537719618|FG000|Overall Study|Lost to Follow-up|0|||
149064395|NCT03606512|537719619|FG001|Overall Study|Lost to Follow-up|1|||
149064396|NCT03606512|537719618|FG000|Overall Study|'moved from study area|0|||
149064397|NCT03606512|537719619|FG001|Overall Study|'moved from study area|1|||
149064398|NCT05513937|537719620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
149064399|NCT05513937|537719621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
149064400|NCT05513937|537719622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
149064401|NCT05513937|537719623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
149064402|NCT05513937|537719620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
149064403|NCT05513937|537719621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
149064404|NCT05513937|537719622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
149064405|NCT05513937|537719623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
149064406|NCT05513937|537719620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
149064407|NCT05513937|537719621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
149064408|NCT05513937|537719622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
149064409|NCT05513937|537719623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
149064410|NCT05513937|537719620|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
149064411|NCT05513937|537719621|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
149064412|NCT05513937|537719622|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
149064413|NCT05513937|537719623|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
149064414|NCT05513937|537719620|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
149064415|NCT05513937|537719621|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
149064416|NCT05513937|537719622|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
149064417|NCT05513937|537719623|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
149064418|NCT05513937|537719620|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
149064419|NCT05513937|537719621|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
149064420|NCT05513937|537719622|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
149064421|NCT05513937|537719623|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
149064422|NCT02846545|537719624|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
149064423|NCT02846545|537719625|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
149064424|NCT02846545|537719624|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
149064425|NCT02846545|537719625|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
149064426|NCT02846545|537719624|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
149064427|NCT02846545|537719625|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
149064428|NCT02846545|537719624|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
149064429|NCT02846545|537719625|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
149064430|NCT02846545|537719624|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
149064431|NCT02846545|537719625|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
149064432|NCT05654662|537719628|FG000|Overall Study|Withdrawal by Subject|1|||
149064433|NCT05654662|537719629|FG001|Overall Study|Withdrawal by Subject|0|||
149064434|NCT05654662|537719628|FG000|Overall Study|A death in the family|1|||
149064435|NCT05654662|537719629|FG001|Overall Study|A death in the family|0|||
149064436|NCT05962814|537719630|FG000|Overall Study|failed eligibility|1|||
149064437|NCT01880515|537720614|FG000|Overall Study|Lost to Follow-up|3|||
149064438|NCT01880515|537720615|FG001|Overall Study|Lost to Follow-up|2|||
149064439|NCT01880515|537720614|FG000|Overall Study|Disease Progression|5|||
149064440|NCT01880515|537720615|FG001|Overall Study|Disease Progression|7|||
149064441|NCT03505710|537720616|FG000|Overall Study|Progressive Disease|24|||
149064442|NCT03505710|537720617|FG001|Overall Study|Progressive Disease|17|||
149064443|NCT03505710|537720618|FG002|Overall Study|Progressive Disease|43|||
149064444|NCT03505710|537720616|FG000|Overall Study|Clinical Progression|6|||
149064445|NCT03505710|537720617|FG001|Overall Study|Clinical Progression|8|||
149064446|NCT03505710|537720618|FG002|Overall Study|Clinical Progression|3|||
149064447|NCT03505710|537720616|FG000|Overall Study|Adverse Event|12|||
149064448|NCT03505710|537720617|FG001|Overall Study|Adverse Event|6|||
149064449|NCT03505710|537720618|FG002|Overall Study|Adverse Event|28|||
148890504|NCT00866814|537077261|FG000|Overall Study|Unable to meet follow-up requirements|2|||
148890505|NCT00866814|537077261|FG000|Overall Study|Moved to area without study site|1|||
148890506|NCT04491136|537077262|FG000|Overall Study|Patient withdraw informed consent|9|||
149064450|NCT03505710|537720616|FG000|Overall Study|Withdrawal by Subject|1|||
149064451|NCT03505710|537720617|FG001|Overall Study|Withdrawal by Subject|3|||
149064452|NCT03505710|537720618|FG002|Overall Study|Withdrawal by Subject|7|||
149064453|NCT03505710|537720616|FG000|Overall Study|Physician Decision|1|||
149064454|NCT03505710|537720617|FG001|Overall Study|Physician Decision|1|||
149064455|NCT03505710|537720618|FG002|Overall Study|Physician Decision|2|||
149064456|NCT03505710|537720616|FG000|Overall Study|Death|4|||
149064457|NCT03505710|537720617|FG001|Overall Study|Death|5|||
149064458|NCT03505710|537720618|FG002|Overall Study|Death|6|||
149064459|NCT03505710|537720616|FG000|Overall Study|Other Reasons|1|||
149064460|NCT03505710|537720617|FG001|Overall Study|Other Reasons|1|||
149064461|NCT03505710|537720618|FG002|Overall Study|Other Reasons|1|||
149064462|NCT03505710|537720616|FG000|Overall Study|Study Terminated by Sponsor|0|||
149064463|NCT03505710|537720617|FG001|Overall Study|Study Terminated by Sponsor|0|||
149064464|NCT03505710|537720618|FG002|Overall Study|Study Terminated by Sponsor|1|||
149064465|NCT03981926|537720621|FG000|Overall Study|Lost to Follow-up|5|||
149064466|NCT03981926|537720622|FG001|Overall Study|Lost to Follow-up|9|||
149064467|NCT06262347|537720623|FG000|Overall Study|Lost to Follow-up|4|||
149064468|NCT06262347|537720624|FG001|Overall Study|Lost to Follow-up|3|||
149064469|NCT06262347|537720623|FG000|Overall Study|Withdrawal by Subject|0|||
149064470|NCT06262347|537720624|FG001|Overall Study|Withdrawal by Subject|1|||
149064471|NCT03580356|537720633|FG000|Treatment Period|Withdrawal by Subject|13|||
149064472|NCT03580356|537720634|FG001|Treatment Period|Withdrawal by Subject|0|||
149064473|NCT03580356|537720635|FG002|Treatment Period|Withdrawal by Subject|13|||
149064474|NCT03580356|537720636|FG003|Treatment Period|Withdrawal by Subject|1|||
149064475|NCT03580356|537720637|FG004|Treatment Period|Withdrawal by Subject|17|||
149064476|NCT03580356|537720638|FG005|Treatment Period|Withdrawal by Subject|0|||
149064477|NCT03580356|537720639|FG006|Treatment Period|Withdrawal by Subject|5|||
149064478|NCT03580356|537720640|FG007|Treatment Period|Withdrawal by Subject|0|||
149064479|NCT03580356|537720633|FG000|Treatment Period|Adverse Event|10|||
149064480|NCT03580356|537720634|FG001|Treatment Period|Adverse Event|0|||
149064481|NCT03580356|537720635|FG002|Treatment Period|Adverse Event|13|||
149064482|NCT03580356|537720636|FG003|Treatment Period|Adverse Event|0|||
149064483|NCT03580356|537720637|FG004|Treatment Period|Adverse Event|5|||
149064484|NCT03580356|537720638|FG005|Treatment Period|Adverse Event|0|||
149064485|NCT03580356|537720639|FG006|Treatment Period|Adverse Event|8|||
149064486|NCT03580356|537720640|FG007|Treatment Period|Adverse Event|0|||
149064487|NCT03580356|537720633|FG000|Treatment Period|Protocol Violation|5|||
149064488|NCT03580356|537720634|FG001|Treatment Period|Protocol Violation|0|||
149064489|NCT03580356|537720635|FG002|Treatment Period|Protocol Violation|6|||
149064490|NCT03580356|537720636|FG003|Treatment Period|Protocol Violation|1|||
149064491|NCT03580356|537720637|FG004|Treatment Period|Protocol Violation|9|||
149064492|NCT03580356|537720638|FG005|Treatment Period|Protocol Violation|1|||
149064493|NCT03580356|537720639|FG006|Treatment Period|Protocol Violation|1|||
149064494|NCT03580356|537720640|FG007|Treatment Period|Protocol Violation|0|||
149064495|NCT03580356|537720633|FG000|Treatment Period|Lack of Efficacy|6|||
149064496|NCT03580356|537720634|FG001|Treatment Period|Lack of Efficacy|0|||
149064497|NCT03580356|537720635|FG002|Treatment Period|Lack of Efficacy|2|||
149064498|NCT03580356|537720636|FG003|Treatment Period|Lack of Efficacy|0|||
149064499|NCT03580356|537720637|FG004|Treatment Period|Lack of Efficacy|3|||
149064500|NCT03580356|537720638|FG005|Treatment Period|Lack of Efficacy|0|||
149064501|NCT03580356|537720639|FG006|Treatment Period|Lack of Efficacy|3|||
149064502|NCT03580356|537720640|FG007|Treatment Period|Lack of Efficacy|0|||
149064503|NCT03580356|537720633|FG000|Treatment Period|Pregnancy|1|||
149064504|NCT03580356|537720634|FG001|Treatment Period|Pregnancy|0|||
149064505|NCT03580356|537720635|FG002|Treatment Period|Pregnancy|7|||
149064506|NCT03580356|537720636|FG003|Treatment Period|Pregnancy|0|||
149064507|NCT03580356|537720637|FG004|Treatment Period|Pregnancy|2|||
149064508|NCT03580356|537720638|FG005|Treatment Period|Pregnancy|0|||
149064509|NCT03580356|537720639|FG006|Treatment Period|Pregnancy|1|||
149064510|NCT03580356|537720640|FG007|Treatment Period|Pregnancy|0|||
149064511|NCT03580356|537720633|FG000|Treatment Period|Physician Decision|2|||
149064512|NCT03580356|537720634|FG001|Treatment Period|Physician Decision|0|||
149064513|NCT03580356|537720635|FG002|Treatment Period|Physician Decision|1|||
149064514|NCT03580356|537720636|FG003|Treatment Period|Physician Decision|0|||
149064515|NCT03580356|537720637|FG004|Treatment Period|Physician Decision|4|||
149064516|NCT03580356|537720638|FG005|Treatment Period|Physician Decision|0|||
149064517|NCT03580356|537720639|FG006|Treatment Period|Physician Decision|2|||
149064518|NCT03580356|537720640|FG007|Treatment Period|Physician Decision|0|||
149064519|NCT03580356|537720633|FG000|Treatment Period|Lost to Follow-up|1|||
149064520|NCT03580356|537720634|FG001|Treatment Period|Lost to Follow-up|1|||
149064521|NCT03580356|537720635|FG002|Treatment Period|Lost to Follow-up|1|||
149064522|NCT03580356|537720636|FG003|Treatment Period|Lost to Follow-up|0|||
149064523|NCT03580356|537720637|FG004|Treatment Period|Lost to Follow-up|3|||
149064524|NCT03580356|537720638|FG005|Treatment Period|Lost to Follow-up|0|||
149064525|NCT03580356|537720639|FG006|Treatment Period|Lost to Follow-up|1|||
149064526|NCT03580356|537720640|FG007|Treatment Period|Lost to Follow-up|0|||
149064527|NCT03580356|537720633|FG000|Treatment Period|Death|0|||
149064528|NCT03580356|537720634|FG001|Treatment Period|Death|0|||
149064529|NCT03580356|537720635|FG002|Treatment Period|Death|1|||
149064530|NCT03580356|537720636|FG003|Treatment Period|Death|0|||
149064531|NCT03580356|537720637|FG004|Treatment Period|Death|0|||
149064532|NCT03580356|537720638|FG005|Treatment Period|Death|0|||
149064533|NCT03580356|537720639|FG006|Treatment Period|Death|0|||
149064534|NCT03580356|537720640|FG007|Treatment Period|Death|0|||
149064535|NCT03580356|537720633|FG000|Treatment Period|Technical problems|0|||
149064536|NCT03580356|537720634|FG001|Treatment Period|Technical problems|0|||
149064537|NCT03580356|537720635|FG002|Treatment Period|Technical problems|0|||
149064538|NCT03580356|537720636|FG003|Treatment Period|Technical problems|0|||
149064539|NCT03580356|537720637|FG004|Treatment Period|Technical problems|1|||
149064540|NCT03580356|537720638|FG005|Treatment Period|Technical problems|0|||
149064541|NCT03580356|537720639|FG006|Treatment Period|Technical problems|0|||
149064542|NCT03580356|537720640|FG007|Treatment Period|Technical problems|0|||
149064543|NCT03580356|537720633|FG000|Treatment Period|Misrandomized, no treatment|0|||
149064544|NCT03580356|537720634|FG001|Treatment Period|Misrandomized, no treatment|0|||
149064545|NCT03580356|537720635|FG002|Treatment Period|Misrandomized, no treatment|1|||
149064546|NCT03580356|537720636|FG003|Treatment Period|Misrandomized, no treatment|0|||
149064547|NCT03580356|537720637|FG004|Treatment Period|Misrandomized, no treatment|2|||
149064548|NCT03580356|537720638|FG005|Treatment Period|Misrandomized, no treatment|0|||
149064549|NCT03580356|537720639|FG006|Treatment Period|Misrandomized, no treatment|0|||
149064550|NCT03580356|537720640|FG007|Treatment Period|Misrandomized, no treatment|0|||
149064551|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
149064552|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
149064553|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
149064554|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
149064555|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
149064556|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
149064557|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
149064558|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
149064559|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
149064560|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
149064561|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
149064562|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
149064563|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
149064564|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
149064565|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
149064566|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
149064567|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
149064568|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
149064569|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
149064570|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
149064571|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
149064572|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
149064573|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
149064574|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
149064575|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
149064576|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
149064577|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
149064578|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
149064579|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
149064580|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
149064581|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
149064582|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
149064583|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
149064584|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
149064585|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
149064586|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
149064587|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
149064588|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
149064589|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
149064590|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
149064591|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
149064592|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
149064593|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
149064594|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
149064595|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
149064596|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
149064597|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
149064598|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
149064599|NCT03580356|537720633|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
149064600|NCT03580356|537720634|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
149064601|NCT03580356|537720635|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
149064602|NCT03580356|537720636|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
149064603|NCT03580356|537720637|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
149064604|NCT03580356|537720638|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
149064605|NCT03580356|537720639|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
149064606|NCT03580356|537720640|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
149064607|NCT03536884|537720641|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
149064608|NCT03536884|537720642|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
149064609|NCT03536884|537720643|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064610|NCT03536884|537720644|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064611|NCT03536884|537720645|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064612|NCT03536884|537720646|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064613|NCT03536884|537720647|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064614|NCT03536884|537720648|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064615|NCT03536884|537720649|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064616|NCT03536884|537720650|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064617|NCT03536884|537720651|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064618|NCT03536884|537720652|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
149064619|NCT03536884|537720641|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064620|NCT03536884|537720642|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
149064621|NCT03536884|537720643|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064622|NCT03536884|537720644|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064623|NCT03536884|537720645|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064624|NCT03536884|537720646|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064625|NCT03536884|537720647|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064626|NCT03536884|537720648|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064627|NCT03536884|537720649|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064628|NCT03536884|537720650|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064629|NCT03536884|537720651|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064630|NCT03536884|537720652|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
149064631|NCT03536884|537720641|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
149064632|NCT03536884|537720642|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
149064633|NCT03536884|537720643|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064634|NCT03536884|537720644|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064635|NCT03536884|537720645|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064636|NCT03536884|537720646|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064637|NCT03536884|537720647|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064638|NCT03536884|537720648|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064639|NCT03536884|537720649|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064640|NCT03536884|537720650|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149120215|NCT04602221|537918064|FG007|Overall Study|Other than listed|0|||
148890507|NCT04491136|537077262|FG000|Overall Study|Adverse Event|2|||
148890508|NCT04491136|537077262|FG000|Overall Study|Death|3|||
148890509|NCT04491136|537077262|FG000|Overall Study|Lost to Follow-up|3|||
148890510|NCT04491136|537077262|FG000|Overall Study|Physician Decision|45|||
148890511|NCT04491136|537077262|FG000|Overall Study|sponsor terminated the study early|16|||
148890512|NCT04491136|537077262|FG000|Overall Study|Patient/guardian's decision|1|||
148890513|NCT01505374|537077266|FG000|Overall Study|Lost to Follow-up|1|||
148890514|NCT01505374|537077267|FG001|Overall Study|Lost to Follow-up|0|||
148890515|NCT01777776|537077270|FG000|Overall Study|Adverse Event|2|||
148890516|NCT01777776|537077271|FG001|Overall Study|Adverse Event|4|||
148890517|NCT01777776|537077272|FG002|Overall Study|Adverse Event|0|||
148890518|NCT01777776|537077273|FG003|Overall Study|Adverse Event|0|||
148890519|NCT01777776|537077270|FG000|Overall Study|Disease Progression|4|||
148890520|NCT01777776|537077271|FG001|Overall Study|Disease Progression|8|||
148890521|NCT01777776|537077272|FG002|Overall Study|Disease Progression|6|||
148890522|NCT01777776|537077273|FG003|Overall Study|Disease Progression|3|||
148890523|NCT01777776|537077270|FG000|Overall Study|Withdrawal by Subject|0|||
148890524|NCT01777776|537077271|FG001|Overall Study|Withdrawal by Subject|0|||
148890525|NCT01777776|537077272|FG002|Overall Study|Withdrawal by Subject|0|||
148890526|NCT01777776|537077273|FG003|Overall Study|Withdrawal by Subject|1|||
148890527|NCT00851786|537077276|FG000|Overall Study|Withdrawal by Subject|0|||
148890528|NCT00851786|537077277|FG001|Overall Study|Withdrawal by Subject|1|||
148890529|NCT00851786|537077276|FG000|Overall Study|Protocol Violation|0|||
148890530|NCT00851786|537077277|FG001|Overall Study|Protocol Violation|1|||
148890531|NCT00851786|537077276|FG000|Overall Study|Lost to Follow-up|1|||
148890532|NCT00851786|537077277|FG001|Overall Study|Lost to Follow-up|0|||
148890533|NCT00851786|537077276|FG000|Overall Study|Incarceration|1|||
148890534|NCT00851786|537077277|FG001|Overall Study|Incarceration|0|||
148890535|NCT00851786|537077276|FG000|Overall Study|Site Closure|1|||
148890536|NCT00851786|537077277|FG001|Overall Study|Site Closure|0|||
148890537|NCT00851786|537077276|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
149064641|NCT03536884|537720651|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064642|NCT03536884|537720652|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
149064643|NCT03536884|537720641|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064644|NCT03536884|537720642|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
149064645|NCT03536884|537720643|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064646|NCT03536884|537720644|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064647|NCT03536884|537720645|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064648|NCT03536884|537720646|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064649|NCT03536884|537720647|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064650|NCT03536884|537720648|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064651|NCT03536884|537720649|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064652|NCT03536884|537720650|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064653|NCT03536884|537720651|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064654|NCT03536884|537720652|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
149064655|NCT03536884|537720641|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064656|NCT03536884|537720642|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
149064657|NCT03536884|537720643|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064658|NCT03536884|537720644|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064659|NCT03536884|537720645|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064660|NCT03536884|537720646|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064661|NCT03536884|537720647|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064662|NCT03536884|537720648|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064663|NCT03536884|537720649|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064664|NCT03536884|537720650|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064665|NCT03536884|537720651|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064666|NCT03536884|537720652|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
149064667|NCT03536884|537720641|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064668|NCT03536884|537720642|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
149064669|NCT03536884|537720643|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064670|NCT03536884|537720644|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064671|NCT03536884|537720645|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064672|NCT03536884|537720646|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064673|NCT03536884|537720647|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064674|NCT03536884|537720648|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064675|NCT03536884|537720649|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064676|NCT03536884|537720650|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064677|NCT03536884|537720651|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064678|NCT03536884|537720652|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
149064679|NCT03536884|537720641|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064680|NCT03536884|537720642|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064681|NCT03536884|537720643|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
149064682|NCT03536884|537720644|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064683|NCT03536884|537720645|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
149064684|NCT03536884|537720646|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064685|NCT03536884|537720647|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064686|NCT03536884|537720648|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064687|NCT03536884|537720649|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064688|NCT03536884|537720650|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064689|NCT03536884|537720651|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064690|NCT03536884|537720652|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
149064691|NCT03536884|537720641|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064692|NCT03536884|537720642|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064693|NCT03536884|537720643|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
149064694|NCT03536884|537720644|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
149064695|NCT03536884|537720645|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
149064696|NCT03536884|537720646|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064697|NCT03536884|537720647|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064698|NCT03536884|537720648|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064699|NCT03536884|537720649|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064700|NCT03536884|537720650|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064701|NCT03536884|537720651|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064702|NCT03536884|537720652|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
149064703|NCT03536884|537720641|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064704|NCT03536884|537720642|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064705|NCT03536884|537720643|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064706|NCT03536884|537720644|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
149064707|NCT03536884|537720645|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
149064708|NCT03536884|537720646|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064709|NCT03536884|537720647|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064710|NCT03536884|537720648|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064711|NCT03536884|537720649|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064712|NCT03536884|537720650|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064713|NCT03536884|537720651|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064714|NCT03536884|537720652|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
149064715|NCT03536884|537720641|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064716|NCT03536884|537720642|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064717|NCT03536884|537720643|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
149064718|NCT03536884|537720644|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
149064719|NCT03536884|537720645|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
149064720|NCT03536884|537720646|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064721|NCT03536884|537720647|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064722|NCT03536884|537720648|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064723|NCT03536884|537720649|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064724|NCT03536884|537720650|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064725|NCT03536884|537720651|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064726|NCT03536884|537720652|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
149064727|NCT03536884|537720641|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064728|NCT03536884|537720642|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064729|NCT03536884|537720643|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
149064730|NCT03536884|537720644|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
149064731|NCT03536884|537720645|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
149064732|NCT03536884|537720646|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064733|NCT03536884|537720647|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064734|NCT03536884|537720648|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064735|NCT03536884|537720649|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064736|NCT03536884|537720650|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064737|NCT03536884|537720651|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064738|NCT03536884|537720652|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
149064739|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064740|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064741|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064742|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064743|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064744|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
149064745|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
149064746|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
149064747|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
149064748|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064749|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064750|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
149064751|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064752|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064753|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064754|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064755|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064756|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
149064757|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
149064758|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
149064759|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
149064760|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064761|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064762|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
149064763|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064764|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064765|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064766|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064767|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064768|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
149064769|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064770|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
149064771|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064772|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064773|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064774|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
149064775|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064776|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064777|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064778|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064779|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064780|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
149064781|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064782|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
149064783|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
149064784|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064785|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064786|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
149064787|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064788|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064789|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064790|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064791|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064792|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
149064793|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
149064794|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
149064795|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
149064796|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064797|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064798|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
149064799|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064800|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064801|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064802|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064803|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064804|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
149064805|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064806|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064807|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064808|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064809|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064810|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
149064811|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064812|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064813|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064814|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064815|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064816|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064817|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
149064818|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064819|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064820|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064821|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064822|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
149064823|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064824|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064825|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064826|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064827|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064828|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064829|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
149064830|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064831|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064832|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064833|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064834|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
149064835|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064836|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064837|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064838|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064839|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064840|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
149064841|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064842|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064843|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064844|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064845|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064846|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
149064847|NCT03536884|537720641|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064848|NCT03536884|537720642|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064849|NCT03536884|537720643|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064850|NCT03536884|537720644|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064851|NCT03536884|537720645|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064852|NCT03536884|537720646|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064853|NCT03536884|537720647|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064854|NCT03536884|537720648|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064855|NCT03536884|537720649|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
149064856|NCT03536884|537720650|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064857|NCT03536884|537720651|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064858|NCT03536884|537720652|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
149064859|NCT03536884|537720641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064860|NCT03536884|537720642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064861|NCT03536884|537720643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064862|NCT03536884|537720644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064863|NCT03536884|537720645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064864|NCT03536884|537720646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064865|NCT03536884|537720647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064866|NCT03536884|537720648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064867|NCT03536884|537720649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
149064868|NCT03536884|537720650|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
149064869|NCT03536884|537720651|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
149064870|NCT03536884|537720652|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
149064871|NCT03536884|537720641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064872|NCT03536884|537720642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064873|NCT03536884|537720643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064874|NCT03536884|537720644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064875|NCT03536884|537720645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064876|NCT03536884|537720646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064877|NCT03536884|537720647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064878|NCT03536884|537720648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064879|NCT03536884|537720649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
149064880|NCT03536884|537720650|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
149064881|NCT03536884|537720651|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
149064882|NCT03536884|537720652|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
149064883|NCT03536884|537720641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064884|NCT03536884|537720642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064885|NCT03536884|537720643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064886|NCT03536884|537720644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064887|NCT03536884|537720645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064888|NCT03536884|537720646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064889|NCT03536884|537720647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064890|NCT03536884|537720648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064891|NCT03536884|537720649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064892|NCT03536884|537720650|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064893|NCT03536884|537720651|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
149064894|NCT03536884|537720652|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
149064895|NCT03536884|537720641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064896|NCT03536884|537720642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064897|NCT03536884|537720643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064898|NCT03536884|537720644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064899|NCT03536884|537720645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064900|NCT03536884|537720646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149120216|NCT04602221|537918065|FG008|Overall Study|Other than listed|0|||
149064901|NCT03536884|537720647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064902|NCT03536884|537720648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064903|NCT03536884|537720649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064904|NCT03536884|537720650|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064905|NCT03536884|537720651|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
149064906|NCT03536884|537720652|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
149064907|NCT03536884|537720641|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064908|NCT03536884|537720642|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064909|NCT03536884|537720643|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064910|NCT03536884|537720644|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064911|NCT03536884|537720645|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064912|NCT03536884|537720646|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064913|NCT03536884|537720647|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064914|NCT03536884|537720648|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064915|NCT03536884|537720649|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064916|NCT03536884|537720650|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064917|NCT03536884|537720651|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
149064918|NCT03536884|537720652|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
149064919|NCT03213678|537720666|FG000|Overall Study|Death|1|||
149064920|NCT03213678|537720666|FG000|Overall Study|Physician Decision|1|||
149064921|NCT03213678|537720666|FG000|Overall Study|Progressive disease|16|||
149064922|NCT03174275|537720667|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
149064923|NCT03174275|537720667|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
149064924|NCT03174275|537720667|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
149064925|NCT03174275|537720667|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
149064926|NCT03174275|537720667|FG000|Adjuvant Chemotherapy|Progression|1|||
149064927|NCT03174275|537720667|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
149064928|NCT03174275|537720667|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
149064929|NCT03174275|537720667|FG000|Adjuvant Durvalumab|Progression|1|||
149064930|NCT03174275|537720667|FG000|Adjuvant Durvalumab|Adverse Event|3|||
149064931|NCT03174275|537720667|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
149064932|NCT03174275|537720667|FG000|Adjuvant Radiotherapy|Progression|1|||
149064933|NCT03174275|537720667|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
149064934|NCT03988621|537720672|FG000|Overall Study|Lost to Follow-up|16|||
149064935|NCT03988621|537720673|FG001|Overall Study|Lost to Follow-up|17|||
149064936|NCT03988621|537720672|FG000|Overall Study|Withdrawal by Subject|14|||
149064937|NCT03988621|537720673|FG001|Overall Study|Withdrawal by Subject|7|||
149064938|NCT03988621|537720672|FG000|Overall Study|Patient Lost to Follow Up|15|||
149064939|NCT03988621|537720673|FG001|Overall Study|Patient Lost to Follow Up|15|||
149064940|NCT03988621|537720672|FG000|Overall Study|Patient death|1|||
149064941|NCT03988621|537720673|FG001|Overall Study|Patient death|5|||
149064942|NCT05013385|537720674|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
149064943|NCT04247802|537720675|FG000|Overall Study|Withdrawal by Subject|1|||
149064944|NCT04247802|537720676|FG001|Overall Study|Withdrawal by Subject|3|||
149064945|NCT04247802|537720675|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
149064946|NCT04247802|537720676|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
149064947|NCT01447719|537720679|FG000|Overall Study|Image acquisition failure|2|||
149064948|NCT01447719|537720679|FG000|Overall Study|Invalid image or not imaged|3|||
148890538|NCT00851786|537077277|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
148890539|NCT01943591|537077280|FG000|Overall Study|Lost to Follow-up|3|||
148890540|NCT01943591|537077281|FG001|Overall Study|Lost to Follow-up|4|||
148890541|NCT01943591|537077280|FG000|Overall Study|Death|2|||
148890542|NCT01943591|537077281|FG001|Overall Study|Death|7|||
149064949|NCT01447719|537720679|FG000|Overall Study|Subject still living at end of study|79|||
149064950|NCT01447719|537720679|FG000|Overall Study|Withdrawal by Subject|2|||
149064951|NCT01447719|537720679|FG000|Overall Study|Family withdrew autopsy consent|7|||
149064952|NCT04778410|537720680|FG000|Safety Run-in Period|Death|5|||
149064953|NCT04778410|537720681|FG001|Safety Run-in Period|Death|6|||
149064954|NCT04778410|537720682|FG002|Safety Run-in Period|Death|0|||
149064955|NCT04778410|537720683|FG003|Safety Run-in Period|Death|0|||
149064956|NCT04778410|537720684|FG004|Safety Run-in Period|Death|0|||
149064957|NCT04778410|537720685|FG005|Safety Run-in Period|Death|0|||
149064958|NCT04778410|537720680|FG000|Phase 2 Period|Death|0|||
149064959|NCT04778410|537720681|FG001|Phase 2 Period|Death|0|||
149064960|NCT04778410|537720682|FG002|Phase 2 Period|Death|0|||
149064961|NCT04778410|537720683|FG003|Phase 2 Period|Death|5|||
149064962|NCT04778410|537720684|FG004|Phase 2 Period|Death|18|||
149064963|NCT04778410|537720685|FG005|Phase 2 Period|Death|0|||
149064964|NCT04778410|537720680|FG000|Phase 2 Period|Lost to Follow-up|0|||
149064965|NCT04778410|537720681|FG001|Phase 2 Period|Lost to Follow-up|0|||
149064966|NCT04778410|537720682|FG002|Phase 2 Period|Lost to Follow-up|0|||
149064967|NCT04778410|537720683|FG003|Phase 2 Period|Lost to Follow-up|1|||
149064968|NCT04778410|537720684|FG004|Phase 2 Period|Lost to Follow-up|1|||
149064969|NCT04778410|537720685|FG005|Phase 2 Period|Lost to Follow-up|0|||
149064970|NCT04778410|537720680|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
149064971|NCT04778410|537720681|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
149064972|NCT04778410|537720682|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
149064973|NCT04778410|537720683|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
149064974|NCT04778410|537720684|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
149064975|NCT04778410|537720685|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
149064976|NCT04778410|537720680|FG000|Phase 2 Period|Withdrew Consent|0|||
149064977|NCT04778410|537720681|FG001|Phase 2 Period|Withdrew Consent|0|||
149064978|NCT04778410|537720682|FG002|Phase 2 Period|Withdrew Consent|0|||
149064979|NCT04778410|537720683|FG003|Phase 2 Period|Withdrew Consent|0|||
149064980|NCT04778410|537720684|FG004|Phase 2 Period|Withdrew Consent|2|||
149064981|NCT04778410|537720685|FG005|Phase 2 Period|Withdrew Consent|0|||
149064982|NCT03252288|537720686|FG000|Overall Study|Death|1|||
149064983|NCT03252288|537720687|FG001|Overall Study|Death|0|||
149064984|NCT03252288|537720688|FG002|Overall Study|Death|0|||
149064985|NCT03252288|537720686|FG000|Overall Study|Death|11|||
149064986|NCT03252288|537720687|FG001|Overall Study|Death|0|||
149064987|NCT03252288|537720688|FG002|Overall Study|Death|0|||
149064988|NCT03252288|537720686|FG000|Overall Study|Withdrawal by Subject|2|||
149064989|NCT03252288|537720687|FG001|Overall Study|Withdrawal by Subject|0|||
149064990|NCT03252288|537720688|FG002|Overall Study|Withdrawal by Subject|0|||
149064991|NCT03252288|537720686|FG000|Overall Study|Lost to Follow-up|79|||
149064992|NCT03252288|537720687|FG001|Overall Study|Lost to Follow-up|0|||
149064993|NCT03252288|537720688|FG002|Overall Study|Lost to Follow-up|0|||
149064994|NCT03252288|537720686|FG000|Overall Study|Loss of baseline data on tablets|6|||
149064995|NCT03252288|537720687|FG001|Overall Study|Loss of baseline data on tablets|0|||
149064996|NCT03252288|537720688|FG002|Overall Study|Loss of baseline data on tablets|0|||
149064997|NCT02944968|537720689|FG000|Overall Study|Subject excluded before study procedure|1|||
149064998|NCT02944968|537720689|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
149064999|NCT02905331|537720690|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
149065000|NCT02905331|537720691|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
149065001|NCT02905331|537720692|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
149065002|NCT02905331|537720690|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
149065003|NCT02905331|537720691|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
149065004|NCT02905331|537720692|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
149065005|NCT02905331|537720690|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
149065006|NCT02905331|537720691|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
149065007|NCT02905331|537720692|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
149065008|NCT02905331|537720690|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
149065009|NCT02905331|537720691|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
149065010|NCT02905331|537720692|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
149065011|NCT02905331|537720690|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
149065012|NCT02905331|537720691|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
149065013|NCT02905331|537720692|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
149065014|NCT02492711|537720703|FG000|Overall Study|Adverse Event|9|||
149065015|NCT02492711|537720704|FG001|Overall Study|Adverse Event|9|||
149065016|NCT02492711|537720705|FG002|Overall Study|Adverse Event|2|||
149065017|NCT02492711|537720703|FG000|Overall Study|Death|3|||
149065018|NCT02492711|537720704|FG001|Overall Study|Death|3|||
149065019|NCT02492711|537720705|FG002|Overall Study|Death|0|||
149065020|NCT02492711|537720703|FG000|Overall Study|Withdrawal by Subject|10|||
149065021|NCT02492711|537720704|FG001|Overall Study|Withdrawal by Subject|16|||
149065022|NCT02492711|537720705|FG002|Overall Study|Withdrawal by Subject|5|||
149065023|NCT02492711|537720703|FG000|Overall Study|Physician Decision|10|||
149065024|NCT02492711|537720704|FG001|Overall Study|Physician Decision|6|||
149065025|NCT02492711|537720705|FG002|Overall Study|Physician Decision|4|||
149065026|NCT02492711|537720703|FG000|Overall Study|Lost to Follow-up|0|||
149065027|NCT02492711|537720704|FG001|Overall Study|Lost to Follow-up|0|||
149065028|NCT02492711|537720705|FG002|Overall Study|Lost to Follow-up|1|||
149065029|NCT02492711|537720703|FG000|Overall Study|study treatment delay|2|||
149065030|NCT02492711|537720704|FG001|Overall Study|study treatment delay|1|||
149065031|NCT02492711|537720705|FG002|Overall Study|study treatment delay|0|||
149065032|NCT02492711|537720703|FG000|Overall Study|change in chemotherapy|0|||
149065033|NCT02492711|537720704|FG001|Overall Study|change in chemotherapy|1|||
149065034|NCT02492711|537720705|FG002|Overall Study|change in chemotherapy|0|||
149065035|NCT02492711|537720703|FG000|Overall Study|never treated|2|||
149065036|NCT02492711|537720704|FG001|Overall Study|never treated|4|||
149065037|NCT02492711|537720705|FG002|Overall Study|never treated|0|||
149065038|NCT02492711|537720703|FG000|Overall Study|Other|0|||
149065039|NCT02492711|537720704|FG001|Overall Study|Other|0|||
149065040|NCT02492711|537720705|FG002|Overall Study|Other|1|||
149065041|NCT03663205|537720706|FG000|Overall Study|Death|144|||
149065042|NCT03663205|537720707|FG001|Overall Study|Death|69|||
149065043|NCT03663205|537720706|FG000|Overall Study|Sponsor decision|53|||
149065044|NCT03663205|537720707|FG001|Overall Study|Sponsor decision|19|||
149065045|NCT03663205|537720706|FG000|Overall Study|Withdrawal by Subject|8|||
149065046|NCT03663205|537720707|FG001|Overall Study|Withdrawal by Subject|11|||
149065047|NCT03663205|537720706|FG000|Overall Study|Lost to Follow-up|7|||
149065048|NCT03663205|537720707|FG001|Overall Study|Lost to Follow-up|9|||
149065049|NCT03663205|537720706|FG000|Overall Study|Transferred to long term extension study|11|||
149065050|NCT03663205|537720707|FG001|Overall Study|Transferred to long term extension study|3|||
149065051|NCT04633538|537720710|FG000|Overall Study|Death|1|||
149065052|NCT04633538|537720710|FG000|Overall Study|Lost to Follow-up|3|||
149065053|NCT04633538|537720710|FG000|Overall Study|Withdrawal by Subject|1|||
149065054|NCT02938520|537720711|FG000|Overall Study|On-going at the time of analysis|258|||
149065055|NCT02938520|537720712|FG001|Overall Study|On-going at the time of analysis|261|||
149065056|NCT02938520|537720711|FG000|Overall Study|Physician Decision|2|||
149065057|NCT02938520|537720712|FG001|Overall Study|Physician Decision|5|||
149065058|NCT02938520|537720711|FG000|Overall Study|Lost to Follow-up|2|||
149065059|NCT02938520|537720712|FG001|Overall Study|Lost to Follow-up|2|||
149065060|NCT02938520|537720711|FG000|Overall Study|Withdrawal by Subject|7|||
149065061|NCT02938520|537720712|FG001|Overall Study|Withdrawal by Subject|7|||
149065062|NCT02938520|537720711|FG000|Overall Study|Protocol Violation|0|||
149065063|NCT02938520|537720712|FG001|Overall Study|Protocol Violation|1|||
149065064|NCT02938520|537720711|FG000|Overall Study|Lack of Efficacy|5|||
149065065|NCT02938520|537720712|FG001|Overall Study|Lack of Efficacy|3|||
149065066|NCT02938520|537720711|FG000|Overall Study|Adverse Event|9|||
149065067|NCT02938520|537720712|FG001|Overall Study|Adverse Event|4|||
149065068|NCT03245840|537720713|FG000|Overall Study|Adverse Event|6|||
149065069|NCT03245840|537720714|FG001|Overall Study|Adverse Event|0|||
149065070|NCT03245840|537720713|FG000|Overall Study|Death|2|||
149065071|NCT03245840|537720714|FG001|Overall Study|Death|0|||
149065072|NCT03245840|537720713|FG000|Overall Study|Withdrawal by Subject|31|||
149065073|NCT03245840|537720714|FG001|Overall Study|Withdrawal by Subject|1|||
149065074|NCT03245840|537720713|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
149065075|NCT03245840|537720714|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149065076|NCT03245840|537720713|FG000|Overall Study|Physician Decision|4|||
149065077|NCT03245840|537720714|FG001|Overall Study|Physician Decision|1|||
149065078|NCT03245840|537720713|FG000|Overall Study|Study Terminated by Sponsor|56|||
149065079|NCT03245840|537720714|FG001|Overall Study|Study Terminated by Sponsor|6|||
149065080|NCT03245840|537720713|FG000|Overall Study|Site Terminated by Sponsor|4|||
149065081|NCT03245840|537720714|FG001|Overall Study|Site Terminated by Sponsor|0|||
149065082|NCT03245840|537720713|FG000|Overall Study|Lost to Follow-up|12|||
149065083|NCT03245840|537720714|FG001|Overall Study|Lost to Follow-up|2|||
149065084|NCT03245840|537720713|FG000|Overall Study|Pregnancy|2|||
149065085|NCT03245840|537720714|FG001|Overall Study|Pregnancy|0|||
149065086|NCT03245840|537720713|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149065087|NCT03245840|537720714|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149065088|NCT03245840|537720713|FG000|Overall Study|Not treated|1|||
149065089|NCT03245840|537720714|FG001|Overall Study|Not treated|1|||
149065090|NCT02518048|537720720|FG000|Overall Study|Withdrawal by Subject|1|||
149119377|NCT00275262|537916292|FG000|Overall Study|Started Chemotherapy|1|||
149119378|NCT00275262|537916293|FG001|Overall Study|Started Chemotherapy|0|||
149119379|NCT02217332|537916296|FG000|Overall Study|Adverse Event|3|||
149119380|NCT02217332|537916296|FG000|Overall Study|Dose interruption >1 month|1|||
149119381|NCT02217332|537916296|FG000|Overall Study|Protocol Violation (eligibility)|1|||
149119382|NCT02217332|537916296|FG000|Overall Study|Withdrawal by Subject|1|||
149119383|NCT02217332|537916296|FG000|Overall Study|Lost to Follow-up|1|||
149119384|NCT04343872|537916297|FG000|Overall Study|Lost to Follow-up|6|||
149119385|NCT04343872|537916298|FG001|Overall Study|Lost to Follow-up|3|||
149119386|NCT01850446|537916299|FG000|Overall Study|Lack of Efficacy|1|||
149119387|NCT01850446|537916300|FG001|Overall Study|Lack of Efficacy|0|||
149119388|NCT01850446|537916299|FG000|Overall Study|Withdrawal by Subject|4|||
149119389|NCT01850446|537916300|FG001|Overall Study|Withdrawal by Subject|0|||
149119390|NCT01850446|537916299|FG000|Overall Study|Protocol Violation|0|||
149119391|NCT01850446|537916300|FG001|Overall Study|Protocol Violation|2|||
149119392|NCT01290315|537916301|FG000|Overall Study|Adverse Event|0|||
149119393|NCT01290315|537916302|FG001|Overall Study|Adverse Event|0|||
149119394|NCT01290315|537916303|FG002|Overall Study|Adverse Event|0|||
149065091|NCT04108130|537722033|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
149065092|NCT04108130|537722034|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
149065093|NCT04108130|537722033|FG000|Overall Study|Consent Withdrawn|9|||
149065094|NCT04108130|537722034|FG001|Overall Study|Consent Withdrawn|6|||
149065095|NCT04108130|537722033|FG000|Overall Study|Surgery Cancelled|4|||
149065096|NCT04108130|537722034|FG001|Overall Study|Surgery Cancelled|4|||
149065097|NCT04108130|537722033|FG000|Overall Study|Found Ineligible for Study|4|||
149065098|NCT04108130|537722034|FG001|Overall Study|Found Ineligible for Study|3|||
149065099|NCT04108130|537722033|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
149065100|NCT04108130|537722034|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
149065101|NCT04108130|537722033|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
149065102|NCT04108130|537722034|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
149065103|NCT05507333|537722035|FG000|Overall Study|Protocol Violation|1|||
149065104|NCT01130883|537722036|FG000|Overall Study|Patient Noncompliance|6|||
149065105|NCT01130883|537722036|FG000|Overall Study|Reason Unknown|1|||
149065106|NCT01130883|537722036|FG000|Overall Study|Adverse Event|3|||
149065107|NCT03972150|537722039|FG000|Overall Study|Adverse Event|0|||
149065108|NCT03972150|537722040|FG001|Overall Study|Adverse Event|1|||
149065109|NCT03972150|537722041|FG002|Overall Study|Adverse Event|1|||
149065110|NCT03972150|537722042|FG003|Overall Study|Adverse Event|0|||
149065111|NCT03972150|537722043|FG004|Overall Study|Adverse Event|0|||
149065112|NCT03972150|537722039|FG000|Overall Study|Progressive disease|3|||
149065113|NCT03972150|537722040|FG001|Overall Study|Progressive disease|5|||
149065114|NCT03972150|537722041|FG002|Overall Study|Progressive disease|2|||
149065115|NCT03972150|537722042|FG003|Overall Study|Progressive disease|2|||
149065116|NCT03972150|537722043|FG004|Overall Study|Progressive disease|3|||
149065117|NCT00844415|537722062|FG000|Overall Study|Withdrawal by Subject|1|||
149065118|NCT03015532|537722063|FG000|Overall Study|Adverse Event|0|||
149065119|NCT03015532|537722064|FG001|Overall Study|Adverse Event|0|||
149065120|NCT03015532|537722065|FG002|Overall Study|Adverse Event|0|||
149065121|NCT03015532|537722066|FG003|Overall Study|Adverse Event|0|||
149065122|NCT03015532|537722067|FG004|Overall Study|Adverse Event|0|||
149065123|NCT03015532|537722068|FG005|Overall Study|Adverse Event|2|||
149065124|NCT03015532|537722069|FG006|Overall Study|Adverse Event|1|||
149065125|NCT03015532|537722070|FG007|Overall Study|Adverse Event|0|||
149065126|NCT03015532|537722063|FG000|Overall Study|Withdrawal by Subject|0|||
149065127|NCT03015532|537722064|FG001|Overall Study|Withdrawal by Subject|0|||
149065128|NCT03015532|537722065|FG002|Overall Study|Withdrawal by Subject|0|||
149065129|NCT03015532|537722066|FG003|Overall Study|Withdrawal by Subject|0|||
149065130|NCT03015532|537722067|FG004|Overall Study|Withdrawal by Subject|0|||
149065131|NCT03015532|537722068|FG005|Overall Study|Withdrawal by Subject|0|||
149065132|NCT03015532|537722069|FG006|Overall Study|Withdrawal by Subject|1|||
149065133|NCT03015532|537722070|FG007|Overall Study|Withdrawal by Subject|0|||
149065134|NCT03914469|537722071|FG000|Overall Study|Lost to Follow-up|1|||
149065135|NCT03914469|537722072|FG001|Overall Study|Lost to Follow-up|4|||
149065136|NCT04102111|537722076|FG000|Overall Study|Withdrawal by Subject|2|||
149065137|NCT04102111|537722077|FG001|Overall Study|Withdrawal by Subject|3|||
149065138|NCT04102111|537722076|FG000|Overall Study|Adverse Event|1|||
149065139|NCT04102111|537722077|FG001|Overall Study|Adverse Event|1|||
149065140|NCT04102111|537722076|FG000|Overall Study|Study terminated by sponsor|1|||
149065141|NCT04102111|537722077|FG001|Overall Study|Study terminated by sponsor|3|||
149065142|NCT03334695|537722078|FG000|Overall Study|Lost to Follow-up|3|||
149065143|NCT03334695|537722079|FG001|Overall Study|Lost to Follow-up|3|||
149065144|NCT03334695|537722078|FG000|Overall Study|Physician Decision|1|||
149065145|NCT03334695|537722079|FG001|Overall Study|Physician Decision|2|||
149065146|NCT03334695|537722078|FG000|Overall Study|Protocol Violation|0|||
149065147|NCT03334695|537722079|FG001|Overall Study|Protocol Violation|1|||
149065148|NCT02542631|537722080|FG000|Overall Study|Adverse Event|1|||
149065149|NCT02542631|537722081|FG001|Overall Study|Adverse Event|1|||
149065150|NCT02542631|537722080|FG000|Overall Study|Sponsor Termination|1|||
149065151|NCT02542631|537722081|FG001|Overall Study|Sponsor Termination|0|||
149065152|NCT02542631|537722080|FG000|Overall Study|Withdrawal by Subject|11|||
149065153|NCT02542631|537722081|FG001|Overall Study|Withdrawal by Subject|16|||
149065154|NCT02542631|537722080|FG000|Overall Study|Protocol Violation|1|||
149065155|NCT02542631|537722081|FG001|Overall Study|Protocol Violation|1|||
149065156|NCT02542631|537722080|FG000|Overall Study|Physician Decision|6|||
149065157|NCT02542631|537722081|FG001|Overall Study|Physician Decision|4|||
149065158|NCT02542631|537722080|FG000|Overall Study|Lost to Follow-up|6|||
149065159|NCT02542631|537722081|FG001|Overall Study|Lost to Follow-up|5|||
149065160|NCT02542631|537722080|FG000|Overall Study|Death|1|||
149065161|NCT02542631|537722081|FG001|Overall Study|Death|2|||
149065162|NCT02542631|537722080|FG000|Overall Study|Other|2|||
149065163|NCT02542631|537722081|FG001|Overall Study|Other|1|||
149065164|NCT02542631|537722080|FG000|Overall Study|Used Prohibited Medication|2|||
149065165|NCT02542631|537722081|FG001|Overall Study|Used Prohibited Medication|1|||
149065166|NCT02938923|537722082|FG000|Overall Study|Death|1|||
149065167|NCT02938923|537722083|FG001|Overall Study|Death|0|||
149065168|NCT02938923|537722084|FG002|Overall Study|Death|0|||
149065169|NCT02938923|537722082|FG000|Overall Study|Physician Decision|0|||
149065170|NCT02938923|537722083|FG001|Overall Study|Physician Decision|2|||
149065171|NCT02938923|537722084|FG002|Overall Study|Physician Decision|0|||
149065172|NCT02938923|537722082|FG000|Overall Study|Withdrawal by Subject|0|||
149065173|NCT02938923|537722083|FG001|Overall Study|Withdrawal by Subject|1|||
149065174|NCT02938923|537722084|FG002|Overall Study|Withdrawal by Subject|1|||
149065175|NCT04583280|537722086|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
149065176|NCT04583280|537722087|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
149065177|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
149065178|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
149065179|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
149065180|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
149065181|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
149065182|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
149065183|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
149065184|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
149065185|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
149065186|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
149065187|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
149065188|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
149065189|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
149065190|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
149065191|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
149065192|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
149065193|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
149065194|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
149065195|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
149065196|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
149065197|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
149065198|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
149065199|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
149065200|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
149065201|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
149065202|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
149065203|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
149065204|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
149065205|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
149065206|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
149065207|NCT04614948|537722088|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
149065208|NCT04614948|537722089|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
149065209|NCT04614948|537722090|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
149065210|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
149065211|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
149065212|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
149065213|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
149065214|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
149065215|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
149065216|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
149065217|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
149065218|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
149065219|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
149065220|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
149065221|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
149065222|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
149065223|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
149065224|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
149065225|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
149065226|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
149065227|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
149065228|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
149065229|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
149065230|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
149065231|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
149065232|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
149065233|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
149065234|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
149065235|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
149065236|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
149065237|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
149065238|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
149065239|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
149065240|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
149065241|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
149065242|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
149065243|NCT04614948|537722088|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
149065244|NCT04614948|537722089|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
149065245|NCT04614948|537722090|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
149065246|NCT04129554|537722091|FG000|Overall Study|Withdrawal by Subject|4|||
149065247|NCT04129554|537722092|FG001|Overall Study|Withdrawal by Subject|3|||
149065248|NCT04129554|537722091|FG000|Overall Study|Other|0|||
149065249|NCT04129554|537722092|FG001|Overall Study|Other|2|||
149065250|NCT01570361|537722093|FG000|Overall Study|Subject discontinued|1|||
149065251|NCT01570361|537722094|FG001|Overall Study|Subject discontinued|2|||
149065252|NCT01570361|537722093|FG000|Overall Study|Sponsor closing the study|51|||
149065253|NCT01570361|537722094|FG001|Overall Study|Sponsor closing the study|50|||
149065254|NCT01570361|537722093|FG000|Overall Study|Subject excluded|5|||
149065255|NCT01570361|537722094|FG001|Overall Study|Subject excluded|3|||
149065256|NCT01570361|537722093|FG000|Overall Study|Subject withdrew consent|14|||
149065257|NCT01570361|537722094|FG001|Overall Study|Subject withdrew consent|9|||
149065258|NCT01570361|537722093|FG000|Overall Study|Adverse Event|2|||
149065259|NCT01570361|537722094|FG001|Overall Study|Adverse Event|1|||
149065260|NCT01570361|537722093|FG000|Overall Study|Lost to Follow-up|4|||
149065261|NCT01570361|537722094|FG001|Overall Study|Lost to Follow-up|4|||
149065262|NCT01570361|537722093|FG000|Overall Study|Death|5|||
149065263|NCT01570361|537722094|FG001|Overall Study|Death|4|||
149065264|NCT01570361|537722093|FG000|Overall Study|Other|0|||
149065265|NCT01570361|537722094|FG001|Overall Study|Other|2|||
149065266|NCT03691298|537722097|FG000|Overall Study|Lost to Follow-up|8|||
149065267|NCT03691298|537722097|FG000|Overall Study|Sponsor terminated study|2|||
149065268|NCT05070741|537722103|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
149065269|NCT03582033|537722104|FG000|Part A|Other|0|||
149065270|NCT03582033|537722105|FG001|Part A|Other|0|||
149065271|NCT03582033|537722106|FG002|Part A|Other|0|||
149065272|NCT03582033|537722107|FG003|Part A|Other|0|||
149065273|NCT03582033|537722108|FG004|Part A|Other|2|||
149065274|NCT03582033|537722109|FG005|Part A|Other|0|||
149065275|NCT03582033|537722110|FG006|Part A|Other|0|||
149065276|NCT03582033|537722111|FG007|Part A|Other|0|||
149065277|NCT03582033|537722112|FG008|Part A|Other|0|||
149065278|NCT03582033|537722113|FG009|Part A|Other|0|||
149065279|NCT03582033|537722104|FG000|Part A|Death|1|||
149065280|NCT03582033|537722105|FG001|Part A|Death|1|||
149065281|NCT03582033|537722106|FG002|Part A|Death|2|||
149065282|NCT03582033|537722107|FG003|Part A|Death|4|||
149065283|NCT03582033|537722108|FG004|Part A|Death|11|||
149065284|NCT03582033|537722109|FG005|Part A|Death|0|||
149065285|NCT03582033|537722110|FG006|Part A|Death|0|||
149065286|NCT03582033|537722111|FG007|Part A|Death|0|||
149065287|NCT03582033|537722112|FG008|Part A|Death|0|||
149065288|NCT03582033|537722113|FG009|Part A|Death|0|||
149065289|NCT03582033|537722104|FG000|Part A|Lost to Follow-up|0|||
149065290|NCT03582033|537722105|FG001|Part A|Lost to Follow-up|0|||
149065291|NCT03582033|537722106|FG002|Part A|Lost to Follow-up|0|||
149065292|NCT03582033|537722107|FG003|Part A|Lost to Follow-up|0|||
149065293|NCT03582033|537722108|FG004|Part A|Lost to Follow-up|1|||
149065294|NCT03582033|537722109|FG005|Part A|Lost to Follow-up|0|||
149065295|NCT03582033|537722110|FG006|Part A|Lost to Follow-up|0|||
149065296|NCT03582033|537722111|FG007|Part A|Lost to Follow-up|0|||
149065297|NCT03582033|537722112|FG008|Part A|Lost to Follow-up|0|||
149065298|NCT03582033|537722113|FG009|Part A|Lost to Follow-up|0|||
149065299|NCT03582033|537722104|FG000|Part A|Study terminated by sponsor|0|||
149065300|NCT03582033|537722105|FG001|Part A|Study terminated by sponsor|0|||
149065301|NCT03582033|537722106|FG002|Part A|Study terminated by sponsor|0|||
149065302|NCT03582033|537722107|FG003|Part A|Study terminated by sponsor|2|||
149065303|NCT03582033|537722108|FG004|Part A|Study terminated by sponsor|1|||
149065304|NCT03582033|537722109|FG005|Part A|Study terminated by sponsor|0|||
149065305|NCT03582033|537722110|FG006|Part A|Study terminated by sponsor|0|||
149065306|NCT03582033|537722111|FG007|Part A|Study terminated by sponsor|0|||
149065307|NCT03582033|537722112|FG008|Part A|Study terminated by sponsor|0|||
149065308|NCT03582033|537722113|FG009|Part A|Study terminated by sponsor|0|||
149065309|NCT03582033|537722104|FG000|Part A|Withdrawal by Subject|1|||
149065310|NCT03582033|537722105|FG001|Part A|Withdrawal by Subject|1|||
149065311|NCT03582033|537722106|FG002|Part A|Withdrawal by Subject|0|||
149065312|NCT03582033|537722107|FG003|Part A|Withdrawal by Subject|1|||
149065313|NCT03582033|537722108|FG004|Part A|Withdrawal by Subject|7|||
149065314|NCT03582033|537722109|FG005|Part A|Withdrawal by Subject|0|||
149065315|NCT03582033|537722110|FG006|Part A|Withdrawal by Subject|0|||
149065316|NCT03582033|537722111|FG007|Part A|Withdrawal by Subject|0|||
149065317|NCT03582033|537722112|FG008|Part A|Withdrawal by Subject|0|||
149065318|NCT03582033|537722113|FG009|Part A|Withdrawal by Subject|0|||
149065319|NCT03582033|537722104|FG000|Part B|Death|0|||
149065320|NCT03582033|537722105|FG001|Part B|Death|0|||
149065321|NCT03582033|537722106|FG002|Part B|Death|0|||
149065322|NCT03582033|537722107|FG003|Part B|Death|0|||
149065323|NCT03582033|537722108|FG004|Part B|Death|0|||
149065324|NCT03582033|537722109|FG005|Part B|Death|2|||
149065325|NCT03582033|537722110|FG006|Part B|Death|0|||
149065326|NCT03582033|537722111|FG007|Part B|Death|0|||
149065327|NCT03582033|537722112|FG008|Part B|Death|0|||
149065328|NCT03582033|537722113|FG009|Part B|Death|0|||
149065329|NCT03582033|537722104|FG000|Part B|Study terminated by sponsor|0|||
149065330|NCT03582033|537722105|FG001|Part B|Study terminated by sponsor|0|||
149065331|NCT03582033|537722106|FG002|Part B|Study terminated by sponsor|0|||
149065332|NCT03582033|537722107|FG003|Part B|Study terminated by sponsor|0|||
149065333|NCT03582033|537722108|FG004|Part B|Study terminated by sponsor|0|||
149065334|NCT03582033|537722109|FG005|Part B|Study terminated by sponsor|12|||
149065335|NCT03582033|537722110|FG006|Part B|Study terminated by sponsor|0|||
149065336|NCT03582033|537722111|FG007|Part B|Study terminated by sponsor|0|||
149065337|NCT03582033|537722112|FG008|Part B|Study terminated by sponsor|0|||
149065338|NCT03582033|537722113|FG009|Part B|Study terminated by sponsor|0|||
149065339|NCT03582033|537722104|FG000|Part B|Withdrawal by Subject|0|||
149065340|NCT03582033|537722105|FG001|Part B|Withdrawal by Subject|0|||
149065341|NCT03582033|537722106|FG002|Part B|Withdrawal by Subject|0|||
149065342|NCT03582033|537722107|FG003|Part B|Withdrawal by Subject|0|||
149065343|NCT03582033|537722108|FG004|Part B|Withdrawal by Subject|0|||
149065344|NCT03582033|537722109|FG005|Part B|Withdrawal by Subject|6|||
149065345|NCT03582033|537722110|FG006|Part B|Withdrawal by Subject|0|||
149065346|NCT03582033|537722111|FG007|Part B|Withdrawal by Subject|0|||
149065347|NCT03582033|537722112|FG008|Part B|Withdrawal by Subject|0|||
149065348|NCT03582033|537722113|FG009|Part B|Withdrawal by Subject|0|||
149065349|NCT03582033|537722104|FG000|Part C|Other|0|||
149065350|NCT03582033|537722105|FG001|Part C|Other|0|||
149065351|NCT03582033|537722106|FG002|Part C|Other|0|||
149065352|NCT03582033|537722107|FG003|Part C|Other|0|||
149065353|NCT03582033|537722108|FG004|Part C|Other|0|||
149065354|NCT03582033|537722109|FG005|Part C|Other|0|||
149065355|NCT03582033|537722110|FG006|Part C|Other|2|||
149065356|NCT03582033|537722111|FG007|Part C|Other|0|||
149065357|NCT03582033|537722112|FG008|Part C|Other|0|||
149065358|NCT03582033|537722113|FG009|Part C|Other|0|||
149065359|NCT03582033|537722104|FG000|Part C|Death|0|||
149065360|NCT03582033|537722105|FG001|Part C|Death|0|||
149065361|NCT03582033|537722106|FG002|Part C|Death|0|||
149065362|NCT03582033|537722107|FG003|Part C|Death|0|||
149065363|NCT03582033|537722108|FG004|Part C|Death|0|||
149065364|NCT03582033|537722109|FG005|Part C|Death|0|||
149065365|NCT03582033|537722110|FG006|Part C|Death|6|||
149065366|NCT03582033|537722111|FG007|Part C|Death|1|||
149065367|NCT03582033|537722112|FG008|Part C|Death|2|||
149065368|NCT03582033|537722113|FG009|Part C|Death|0|||
149065369|NCT03582033|537722104|FG000|Part C|Study terminated by sponsor|0|||
149065370|NCT03582033|537722105|FG001|Part C|Study terminated by sponsor|0|||
149065371|NCT03582033|537722106|FG002|Part C|Study terminated by sponsor|0|||
149065372|NCT03582033|537722107|FG003|Part C|Study terminated by sponsor|0|||
149065373|NCT03582033|537722108|FG004|Part C|Study terminated by sponsor|0|||
149065374|NCT03582033|537722109|FG005|Part C|Study terminated by sponsor|0|||
149065375|NCT03582033|537722110|FG006|Part C|Study terminated by sponsor|3|||
149065376|NCT03582033|537722111|FG007|Part C|Study terminated by sponsor|3|||
149065377|NCT03582033|537722112|FG008|Part C|Study terminated by sponsor|2|||
149065378|NCT03582033|537722113|FG009|Part C|Study terminated by sponsor|0|||
149065379|NCT03582033|537722104|FG000|Part C|Withdrawal by Subject|0|||
149065380|NCT03582033|537722105|FG001|Part C|Withdrawal by Subject|0|||
149065381|NCT03582033|537722106|FG002|Part C|Withdrawal by Subject|0|||
149065382|NCT03582033|537722107|FG003|Part C|Withdrawal by Subject|0|||
149065383|NCT03582033|537722108|FG004|Part C|Withdrawal by Subject|0|||
149065384|NCT03582033|537722109|FG005|Part C|Withdrawal by Subject|0|||
149065385|NCT03582033|537722110|FG006|Part C|Withdrawal by Subject|1|||
149065386|NCT03582033|537722111|FG007|Part C|Withdrawal by Subject|2|||
149065387|NCT03582033|537722112|FG008|Part C|Withdrawal by Subject|1|||
149065388|NCT03582033|537722113|FG009|Part C|Withdrawal by Subject|0|||
149065389|NCT03582033|537722104|FG000|Part D|Death|0|||
149065390|NCT03582033|537722105|FG001|Part D|Death|0|||
149065391|NCT03582033|537722106|FG002|Part D|Death|0|||
149065392|NCT03582033|537722107|FG003|Part D|Death|0|||
149065393|NCT03582033|537722108|FG004|Part D|Death|0|||
149065394|NCT03582033|537722109|FG005|Part D|Death|0|||
149065395|NCT03582033|537722110|FG006|Part D|Death|0|||
149065396|NCT03582033|537722111|FG007|Part D|Death|0|||
149065397|NCT03582033|537722112|FG008|Part D|Death|0|||
149065398|NCT03582033|537722113|FG009|Part D|Death|1|||
149065399|NCT03582033|537722104|FG000|Part D|Study terminated by sponsor|0|||
149065400|NCT03582033|537722105|FG001|Part D|Study terminated by sponsor|0|||
149065401|NCT03582033|537722106|FG002|Part D|Study terminated by sponsor|0|||
149065402|NCT03582033|537722107|FG003|Part D|Study terminated by sponsor|0|||
149065403|NCT03582033|537722108|FG004|Part D|Study terminated by sponsor|0|||
149065404|NCT03582033|537722109|FG005|Part D|Study terminated by sponsor|0|||
149065405|NCT03582033|537722110|FG006|Part D|Study terminated by sponsor|0|||
149065406|NCT03582033|537722111|FG007|Part D|Study terminated by sponsor|0|||
149065407|NCT03582033|537722112|FG008|Part D|Study terminated by sponsor|0|||
149065408|NCT03582033|537722113|FG009|Part D|Study terminated by sponsor|4|||
149065409|NCT06010836|537722114|FG000|Overall Study|Lost to Follow-up|2|||
149065410|NCT06010836|537722115|FG001|Overall Study|Lost to Follow-up|2|||
149065411|NCT06010836|537722114|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
149065412|NCT06010836|537722115|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
149065413|NCT06010836|537722114|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
149065414|NCT06010836|537722115|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
149065415|NCT06010836|537722114|FG000|Overall Study|Did not receive intervention discussion|0|||
149065416|NCT06010836|537722115|FG001|Overall Study|Did not receive intervention discussion|4|||
149065417|NCT04206787|537722121|FG000|Overall Study|Other than listed|2|||
149065418|NCT04206787|537722121|FG000|Overall Study|Investigator decision|1|||
149065419|NCT04206787|537722121|FG000|Overall Study|Death|25|||
149065420|NCT04206787|537722121|FG000|Overall Study|Lost to Follow-up|9|||
149065421|NCT04206787|537722121|FG000|Overall Study|Withdrawal of consent|9|||
149065422|NCT04505410|537722122|FG000|Overall Study|Adverse Event|2|||
149065423|NCT04505410|537722123|FG001|Overall Study|Adverse Event|0|||
149065424|NCT04505410|537722122|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
149065425|NCT04505410|537722123|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
149065426|NCT04505410|537722122|FG000|Overall Study|did not want to follow diet|1|||
149065427|NCT04505410|537722123|FG001|Overall Study|did not want to follow diet|0|||
149065428|NCT04505410|537722122|FG000|Overall Study|flare up of ulcerative colitis|0|||
149065429|NCT04505410|537722123|FG001|Overall Study|flare up of ulcerative colitis|1|||
149065430|NCT04505410|537722122|FG000|Overall Study|Lost to Follow-up|0|||
149065431|NCT04505410|537722123|FG001|Overall Study|Lost to Follow-up|2|||
149065432|NCT04505410|537722122|FG000|Overall Study|Lost to Follow-up|1|||
149065433|NCT04505410|537722123|FG001|Overall Study|Lost to Follow-up|0|||
149065434|NCT04505410|537722122|FG000|Overall Study|initiated another diet on their own|0|||
149065435|NCT04505410|537722123|FG001|Overall Study|initiated another diet on their own|2|||
149065436|NCT05123027|537722128|FG000|Overall Study|Lost to Follow-up|17|||
149065437|NCT05123027|537722129|FG001|Overall Study|Lost to Follow-up|22|||
149065438|NCT05123027|537722128|FG000|Overall Study|Incarceration|3|||
149065439|NCT05123027|537722129|FG001|Overall Study|Incarceration|4|||
149065440|NCT05123027|537722128|FG000|Overall Study|Death|2|||
149065441|NCT05123027|537722129|FG001|Overall Study|Death|2|||
149065442|NCT05123027|537722128|FG000|Overall Study|Other|2|||
149065443|NCT05123027|537722129|FG001|Overall Study|Other|0|||
149065444|NCT02865538|537722131|FG000|Overall Study|Withdrawal by Subject|0|||
149065445|NCT02865538|537722132|FG001|Overall Study|Withdrawal by Subject|0|||
149065446|NCT02865538|537722133|FG002|Overall Study|Withdrawal by Subject|1|||
149065447|NCT02865538|537722134|FG003|Overall Study|Withdrawal by Subject|0|||
149065448|NCT02865538|537722135|FG004|Overall Study|Withdrawal by Subject|0|||
149065449|NCT02865538|537722131|FG000|Overall Study|Lost to Follow-up|1|||
149065450|NCT02865538|537722132|FG001|Overall Study|Lost to Follow-up|0|||
149065451|NCT02865538|537722133|FG002|Overall Study|Lost to Follow-up|0|||
149065452|NCT02865538|537722134|FG003|Overall Study|Lost to Follow-up|0|||
149065453|NCT02865538|537722135|FG004|Overall Study|Lost to Follow-up|0|||
149065454|NCT02585323|537724192|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
149065455|NCT02585323|537724193|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
149065456|NCT02585323|537724192|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
149065457|NCT02585323|537724193|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
149065458|NCT02585323|537724192|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
149065459|NCT02585323|537724193|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
149065460|NCT02585323|537724192|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
149065461|NCT02585323|537724193|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
149065462|NCT05311176|537724194|FG000|Overall Study|Death|6|||
149065463|NCT05311176|537724194|FG000|Overall Study|Sponsor discontinued the study|1|||
149065464|NCT05464069|537724195|FG000|Overall Study|Protocol Violation|3|||
149065465|NCT05464069|537724196|FG001|Overall Study|Protocol Violation|2|||
149065466|NCT03677141|537724200|FG000|Overall Study|Death|2|||
149065467|NCT03677141|537724201|FG001|Overall Study|Death|1|||
149065468|NCT03677141|537724202|FG002|Overall Study|Death|6|||
149065469|NCT03677141|537724203|FG003|Overall Study|Death|9|||
149065470|NCT03677141|537724204|FG004|Overall Study|Death|5|||
149065471|NCT03677141|537724205|FG005|Overall Study|Death|3|||
149065472|NCT03677141|537724200|FG000|Overall Study|Lost to Follow-up|0|||
149065473|NCT03677141|537724201|FG001|Overall Study|Lost to Follow-up|0|||
149065474|NCT03677141|537724202|FG002|Overall Study|Lost to Follow-up|0|||
149065475|NCT03677141|537724203|FG003|Overall Study|Lost to Follow-up|2|||
149065476|NCT03677141|537724204|FG004|Overall Study|Lost to Follow-up|0|||
149065477|NCT03677141|537724205|FG005|Overall Study|Lost to Follow-up|0|||
149065478|NCT03677141|537724200|FG000|Overall Study|Screen failure or enrolled in error|0|||
149065479|NCT03677141|537724201|FG001|Overall Study|Screen failure or enrolled in error|0|||
149065480|NCT03677141|537724202|FG002|Overall Study|Screen failure or enrolled in error|0|||
149065481|NCT03677141|537724203|FG003|Overall Study|Screen failure or enrolled in error|0|||
149065482|NCT03677141|537724204|FG004|Overall Study|Screen failure or enrolled in error|2|||
149065483|NCT03677141|537724205|FG005|Overall Study|Screen failure or enrolled in error|0|||
149065484|NCT03677141|537724200|FG000|Overall Study|Physician Decision|0|||
149065485|NCT03677141|537724201|FG001|Overall Study|Physician Decision|0|||
149065486|NCT03677141|537724202|FG002|Overall Study|Physician Decision|0|||
149065487|NCT03677141|537724203|FG003|Overall Study|Physician Decision|0|||
149065488|NCT03677141|537724204|FG004|Overall Study|Physician Decision|1|||
149065489|NCT03677141|537724205|FG005|Overall Study|Physician Decision|0|||
149065490|NCT03677141|537724200|FG000|Overall Study|Withdrawal by Subject|0|||
149065491|NCT03677141|537724201|FG001|Overall Study|Withdrawal by Subject|0|||
149065492|NCT03677141|537724202|FG002|Overall Study|Withdrawal by Subject|1|||
149065493|NCT03677141|537724203|FG003|Overall Study|Withdrawal by Subject|1|||
149065494|NCT03677141|537724204|FG004|Overall Study|Withdrawal by Subject|1|||
149065495|NCT03677141|537724205|FG005|Overall Study|Withdrawal by Subject|0|||
149065496|NCT06106022|537724211|FG000|Overall Study|Lost to Follow-up|1|||
149065497|NCT06106022|537724212|FG001|Overall Study|Lost to Follow-up|0|||
149065498|NCT06106022|537724211|FG000|Overall Study|Voluntary Withdrawal|0|||
149065499|NCT06106022|537724212|FG001|Overall Study|Voluntary Withdrawal|2|||
149065500|NCT04089865|537724213|FG000|Overall Study|Withdrawal by Subject|2|||
149065501|NCT04089865|537724214|FG001|Overall Study|Withdrawal by Subject|2|||
149065502|NCT04089865|537724215|FG002|Overall Study|Withdrawal by Subject|7|||
149065503|NCT04089865|537724216|FG003|Overall Study|Withdrawal by Subject|2|||
149065504|NCT05524116|537724219|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
149065505|NCT05524116|537724220|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
149065506|NCT05524116|537724219|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
149065507|NCT05524116|537724220|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
149065508|NCT05524116|537724219|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
149065509|NCT05524116|537724220|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
149065510|NCT05524116|537724219|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
149065511|NCT05524116|537724220|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
149065512|NCT05524116|537724219|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
149065513|NCT05524116|537724220|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
149065514|NCT02834390|537724229|FG000|Induction Phase|Progressive disease|0|||
149065515|NCT02834390|537724230|FG001|Induction Phase|Progressive disease|1|||
149065516|NCT02834390|537724229|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
149065517|NCT02834390|537724230|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
149065518|NCT02834390|537724229|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
149065519|NCT02834390|537724230|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
149065520|NCT02834390|537724229|FG000|Consolidation Phase|Physician Decision|1|||
149065521|NCT02834390|537724230|FG001|Consolidation Phase|Physician Decision|1|||
149065522|NCT05552508|537724237|FG000|Overall Study|Adverse Event|3|||
149065523|NCT04451772|537724241|FG000|Overall Study|Adverse Event|1|||
149065524|NCT04451772|537724242|FG001|Overall Study|Adverse Event|0|||
149065525|NCT04451772|537724243|FG002|Overall Study|Adverse Event|1|||
149065526|NCT04451772|537724244|FG003|Overall Study|Adverse Event|1|||
149065527|NCT04451772|537724245|FG004|Overall Study|Adverse Event|0|||
149065528|NCT04451772|537724246|FG005|Overall Study|Adverse Event|3|||
149065529|NCT04451772|537724241|FG000|Overall Study|Withdrawal by Subject|2|||
149065530|NCT04451772|537724242|FG001|Overall Study|Withdrawal by Subject|7|||
149065531|NCT04451772|537724243|FG002|Overall Study|Withdrawal by Subject|2|||
149065532|NCT04451772|537724244|FG003|Overall Study|Withdrawal by Subject|1|||
149065533|NCT04451772|537724245|FG004|Overall Study|Withdrawal by Subject|1|||
149065534|NCT04451772|537724246|FG005|Overall Study|Withdrawal by Subject|0|||
149065535|NCT04451772|537724241|FG000|Overall Study|Other, not specified|1|||
149065536|NCT04451772|537724242|FG001|Overall Study|Other, not specified|2|||
149065537|NCT04451772|537724243|FG002|Overall Study|Other, not specified|1|||
149065538|NCT04451772|537724244|FG003|Overall Study|Other, not specified|0|||
149065539|NCT04451772|537724245|FG004|Overall Study|Other, not specified|0|||
149065540|NCT04451772|537724246|FG005|Overall Study|Other, not specified|1|||
149065541|NCT04451772|537724241|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
149065542|NCT04451772|537724242|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
149065543|NCT04451772|537724243|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
149065544|NCT04451772|537724244|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
149065545|NCT04451772|537724245|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
149065546|NCT04451772|537724246|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
149065547|NCT04311632|537724247|FG000|Overall Study|Withdrawal by Subject|0|||
149065548|NCT04311632|537724248|FG001|Overall Study|Withdrawal by Subject|0|||
149065549|NCT04311632|537724249|FG002|Overall Study|Withdrawal by Subject|1|||
149065550|NCT04632225|537724250|FG000|Overall Study|Withdrawal by Subject|2|||
149065551|NCT04632225|537724251|FG001|Overall Study|Withdrawal by Subject|2|||
149065552|NCT04605159|537724252|FG000|Overall Study|Adverse Event|6|||
149065553|NCT04605159|537724253|FG001|Overall Study|Adverse Event|3|||
149065554|NCT04605159|537724254|FG002|Overall Study|Adverse Event|21|||
149065555|NCT04605159|537724255|FG003|Overall Study|Adverse Event|4|||
149065556|NCT04605159|537724252|FG000|Overall Study|Lost to Follow-up|74|||
149065557|NCT04605159|537724253|FG001|Overall Study|Lost to Follow-up|45|||
149065558|NCT04605159|537724254|FG002|Overall Study|Lost to Follow-up|119|||
149065559|NCT04605159|537724255|FG003|Overall Study|Lost to Follow-up|80|||
149065560|NCT04605159|537724252|FG000|Overall Study|Protocol Violation|4|||
149065561|NCT04605159|537724253|FG001|Overall Study|Protocol Violation|5|||
149065562|NCT04605159|537724254|FG002|Overall Study|Protocol Violation|2|||
149065563|NCT04605159|537724255|FG003|Overall Study|Protocol Violation|0|||
149065564|NCT04605159|537724252|FG000|Overall Study|Withdrawal by Subject|66|||
149065565|NCT04605159|537724253|FG001|Overall Study|Withdrawal by Subject|37|||
149065566|NCT04605159|537724254|FG002|Overall Study|Withdrawal by Subject|68|||
149065567|NCT04605159|537724255|FG003|Overall Study|Withdrawal by Subject|50|||
149065568|NCT04605159|537724252|FG000|Overall Study|Migrated / moved from the study area|32|||
149065569|NCT04605159|537724253|FG001|Overall Study|Migrated / moved from the study area|22|||
149065570|NCT04605159|537724254|FG002|Overall Study|Migrated / moved from the study area|41|||
149065571|NCT04605159|537724255|FG003|Overall Study|Migrated / moved from the study area|21|||
149065572|NCT04605159|537724252|FG000|Overall Study|Other|1|||
149065573|NCT04605159|537724253|FG001|Overall Study|Other|2|||
149065574|NCT04605159|537724254|FG002|Overall Study|Other|7|||
149065575|NCT04605159|537724255|FG003|Overall Study|Other|3|||
149065576|NCT05424380|537724260|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
149065577|NCT05424380|537724261|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
149065578|NCT05424380|537724262|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
149065579|NCT05424380|537724263|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
149065580|NCT05424380|537724264|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
149065581|NCT05424380|537724265|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
149065582|NCT05424380|537724260|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
149065583|NCT05424380|537724261|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
149065584|NCT05424380|537724262|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
149065585|NCT05424380|537724263|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
149065586|NCT05424380|537724264|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
149065587|NCT05424380|537724265|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
149065588|NCT05424380|537724260|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
149065589|NCT05424380|537724261|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
149065590|NCT05424380|537724262|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
149065591|NCT05424380|537724263|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
149065592|NCT05424380|537724264|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
149065593|NCT05424380|537724265|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
149065594|NCT05424380|537724260|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
149065595|NCT05424380|537724261|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
149065596|NCT05424380|537724262|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
149065597|NCT05424380|537724263|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
149065598|NCT05424380|537724264|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
149065599|NCT05424380|537724265|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
149065600|NCT05424380|537724260|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
149065601|NCT05424380|537724261|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
149065602|NCT05424380|537724262|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
149065603|NCT05424380|537724263|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
149065604|NCT05424380|537724264|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
149065605|NCT05424380|537724265|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
149065606|NCT05424380|537724260|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
149065607|NCT05424380|537724261|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
149065608|NCT05424380|537724262|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
149065609|NCT05424380|537724263|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
149065610|NCT05424380|537724264|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
149065611|NCT05424380|537724265|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
149065612|NCT05424380|537724260|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
149065613|NCT05424380|537724261|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
149065614|NCT05424380|537724262|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
149065615|NCT05424380|537724263|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
149065616|NCT05424380|537724264|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
149065617|NCT05424380|537724265|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
149065618|NCT05424380|537724260|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
149065619|NCT05424380|537724261|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
149065620|NCT05424380|537724262|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
149065621|NCT05424380|537724263|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
149065622|NCT05424380|537724264|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
149065623|NCT05424380|537724265|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
149065624|NCT05424380|537724260|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065625|NCT05424380|537724261|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065626|NCT05424380|537724262|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065627|NCT05424380|537724263|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
149065628|NCT05424380|537724264|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065629|NCT05424380|537724265|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065630|NCT05424380|537724260|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
149065631|NCT05424380|537724261|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
149065632|NCT05424380|537724262|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
149065633|NCT05424380|537724263|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
149065634|NCT05424380|537724264|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
149065635|NCT05424380|537724265|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
149065636|NCT05424380|537724260|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
149065637|NCT05424380|537724261|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
149065638|NCT05424380|537724262|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
149065639|NCT05424380|537724263|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
149065640|NCT05424380|537724264|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
149065641|NCT05424380|537724265|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
149065642|NCT05424380|537724260|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
149065643|NCT05424380|537724261|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
149065644|NCT05424380|537724262|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
149065645|NCT05424380|537724263|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
149065646|NCT05424380|537724264|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
149065647|NCT05424380|537724265|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
149065648|NCT05424380|537724260|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065649|NCT05424380|537724261|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065650|NCT05424380|537724262|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065651|NCT05424380|537724263|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065652|NCT05424380|537724264|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
149065653|NCT05424380|537724265|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
149065654|NCT05424380|537724260|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
149065655|NCT05424380|537724261|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
149065656|NCT05424380|537724262|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
149065657|NCT05424380|537724263|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
149065658|NCT05424380|537724264|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
149065659|NCT05424380|537724265|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
149065660|NCT03858517|537724270|FG000|Overall Study|Adverse Event|1|||
149065661|NCT03858517|537724270|FG000|Overall Study|Lost to Follow-up|1|||
149065662|NCT03858517|537724270|FG000|Overall Study|removed for being incarcerated|1|||
149065663|NCT03858517|537724270|FG000|Overall Study|Sponsor Closure|48|||
149065664|NCT05172232|537724271|FG000|Overall Study|Lost to Follow-up|3|||
149065665|NCT02473445|537724273|FG000|Overall Study|Withdrawal by Subject|2|||
149065666|NCT02473445|537724273|FG000|Overall Study|Sponsor Decision|20|||
149065667|NCT05422885|537724279|FG000|Overall Study|Lost to Follow-up|1|||
149065668|NCT05422885|537724279|FG000|Overall Study|Withdrawal by Subject|2|||
149065669|NCT04084574|537724280|FG000|Overall Study|Lost to Follow-up|1|||
149065670|NCT04084574|537724281|FG001|Overall Study|Lost to Follow-up|0|||
149065671|NCT04084574|537724280|FG000|Overall Study|Physician Decision|1|||
149065672|NCT04084574|537724281|FG001|Overall Study|Physician Decision|0|||
149065673|NCT04084574|537724280|FG000|Overall Study|Relocated out of state|1|||
149065674|NCT04084574|537724281|FG001|Overall Study|Relocated out of state|0|||
149065675|NCT01121588|537724282|FG000|Overall Study|Death|5|||
149065676|NCT01121588|537724283|FG001|Overall Study|Death|3|||
149065677|NCT01121588|537724284|FG002|Overall Study|Death|13|||
149065678|NCT01121588|537724282|FG000|Overall Study|Study Terminated by Sponsor|1|||
149065679|NCT01121588|537724283|FG001|Overall Study|Study Terminated by Sponsor|1|||
149065680|NCT01121588|537724284|FG002|Overall Study|Study Terminated by Sponsor|0|||
149065681|NCT01121588|537724282|FG000|Overall Study|Participant Refused Further Followup|2|||
149065682|NCT01121588|537724283|FG001|Overall Study|Participant Refused Further Followup|0|||
149065683|NCT01121588|537724284|FG002|Overall Study|Participant Refused Further Followup|2|||
149065684|NCT01121588|537724282|FG000|Overall Study|Lost to Follow-up|0|||
149065685|NCT01121588|537724283|FG001|Overall Study|Lost to Follow-up|1|||
149065686|NCT01121588|537724284|FG002|Overall Study|Lost to Follow-up|1|||
149065687|NCT01121588|537724282|FG000|Overall Study|Non-Specified Reasons|9|||
149065688|NCT01121588|537724283|FG001|Overall Study|Non-Specified Reasons|4|||
149065689|NCT01121588|537724284|FG002|Overall Study|Non-Specified Reasons|2|||
149065690|NCT00942877|537724285|FG000|Overall Study|Refused further treatment|1|||
149065691|NCT00942877|537724286|FG001|Overall Study|Refused further treatment|1|||
149065692|NCT00942877|537724285|FG000|Overall Study|Patient was not treated|1|||
149065693|NCT00942877|537724286|FG001|Overall Study|Patient was not treated|0|||
149065694|NCT00942877|537724285|FG000|Overall Study|Adverse Event|1|||
149065695|NCT00942877|537724286|FG001|Overall Study|Adverse Event|0|||
149065696|NCT00942877|537724285|FG000|Overall Study|Progressive disease|42|||
149065697|NCT00942877|537724286|FG001|Overall Study|Progressive disease|3|||
149065698|NCT01385202|537724287|FG000|Overall Study|Lost to Follow-up|6|||
149065699|NCT01385202|537724287|FG000|Overall Study|Not Eligible|11|||
149065700|NCT01385202|537724287|FG000|Overall Study|Withdrawn|1|||
149065701|NCT00964392|537724290|FG000|Overall Study|Withdrawal by Subject|4|||
149065702|NCT00964392|537724291|FG001|Overall Study|Withdrawal by Subject|6|||
149065703|NCT00964392|537724290|FG000|Overall Study|Lost to Follow-up|4|||
149065704|NCT00964392|537724291|FG001|Overall Study|Lost to Follow-up|10|||
149065705|NCT00964392|537724290|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
149065706|NCT00964392|537724291|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
149065707|NCT00964392|537724290|FG000|Overall Study|Not completed|44|||
149065708|NCT00964392|537724291|FG001|Overall Study|Not completed|168|||
149065709|NCT00303459|537724292|FG000|Overall Study|Death|33|||
149065710|NCT00303459|537724293|FG001|Overall Study|Death|44|||
149065711|NCT00303459|537724292|FG000|Overall Study|Withdrawal of consent|32|||
149065712|NCT00303459|537724293|FG001|Overall Study|Withdrawal of consent|26|||
149065713|NCT00303459|537724292|FG000|Overall Study|Lost to Follow-up|5|||
149065714|NCT00303459|537724293|FG001|Overall Study|Lost to Follow-up|4|||
149065715|NCT00303459|537724292|FG000|Overall Study|Administrative reason|7|||
149065716|NCT00303459|537724293|FG001|Overall Study|Administrative reason|7|||
149065717|NCT00303459|537724292|FG000|Overall Study|Decision by the investigator|5|||
149065718|NCT00303459|537724293|FG001|Overall Study|Decision by the investigator|7|||
149065719|NCT00303459|537724292|FG000|Overall Study|Lung transplantation|1|||
149065720|NCT00303459|537724293|FG001|Overall Study|Lung transplantation|1|||
149065721|NCT04424316|537724299|FG000|Overall Study|Adverse Event|0|||
149065722|NCT04424316|537724300|FG001|Overall Study|Adverse Event|1|||
149065723|NCT04424316|537724301|FG002|Overall Study|Adverse Event|0|||
149065724|NCT04424316|537724302|FG003|Overall Study|Adverse Event|0|||
149065725|NCT04424316|537724299|FG000|Overall Study|Death|1|||
149065726|NCT04424316|537724300|FG001|Overall Study|Death|0|||
149065727|NCT04424316|537724301|FG002|Overall Study|Death|8|||
149065728|NCT04424316|537724302|FG003|Overall Study|Death|14|||
149065729|NCT04424316|537724299|FG000|Overall Study|Lost to Follow-up|93|||
149065730|NCT04424316|537724300|FG001|Overall Study|Lost to Follow-up|88|||
149065731|NCT04424316|537724301|FG002|Overall Study|Lost to Follow-up|224|||
149065732|NCT04424316|537724302|FG003|Overall Study|Lost to Follow-up|211|||
149065733|NCT04424316|537724299|FG000|Overall Study|No longer met eligibility criteria|1|||
149065734|NCT04424316|537724300|FG001|Overall Study|No longer met eligibility criteria|0|||
149065735|NCT04424316|537724301|FG002|Overall Study|No longer met eligibility criteria|0|||
149065736|NCT04424316|537724302|FG003|Overall Study|No longer met eligibility criteria|0|||
149065737|NCT04424316|537724299|FG000|Overall Study|Other|15|||
149065738|NCT04424316|537724300|FG001|Overall Study|Other|11|||
149065739|NCT04424316|537724301|FG002|Overall Study|Other|34|||
149065740|NCT04424316|537724302|FG003|Overall Study|Other|45|||
149065741|NCT04424316|537724299|FG000|Overall Study|Physician Decision|1|||
149065742|NCT04424316|537724300|FG001|Overall Study|Physician Decision|0|||
149065743|NCT04424316|537724301|FG002|Overall Study|Physician Decision|1|||
149065744|NCT04424316|537724302|FG003|Overall Study|Physician Decision|1|||
149065745|NCT04424316|537724299|FG000|Overall Study|Protocol Violation|0|||
149065746|NCT04424316|537724300|FG001|Overall Study|Protocol Violation|1|||
149065747|NCT04424316|537724301|FG002|Overall Study|Protocol Violation|0|||
149065748|NCT04424316|537724302|FG003|Overall Study|Protocol Violation|0|||
149065749|NCT04424316|537724299|FG000|Overall Study|Withdrawal by Subject|71|||
149065750|NCT04424316|537724300|FG001|Overall Study|Withdrawal by Subject|77|||
149065751|NCT04424316|537724301|FG002|Overall Study|Withdrawal by Subject|0|||
149065752|NCT04424316|537724302|FG003|Overall Study|Withdrawal by Subject|0|||
149065753|NCT04424316|537724299|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149065754|NCT04424316|537724300|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149065755|NCT04424316|537724301|FG002|Overall Study|Withdrawal by parent/guardian|74|||
149065756|NCT04424316|537724302|FG003|Overall Study|Withdrawal by parent/guardian|81|||
149065757|NCT04424316|537724299|FG000|Overall Study|Randomized but not vaccinated|13|||
149065758|NCT04424316|537724300|FG001|Overall Study|Randomized but not vaccinated|21|||
149065759|NCT04424316|537724301|FG002|Overall Study|Randomized but not vaccinated|0|||
149065760|NCT04424316|537724302|FG003|Overall Study|Randomized but not vaccinated|0|||
149065761|NCT04424316|537724299|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
149065762|NCT04424316|537724300|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
149065763|NCT04424316|537724301|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
149065764|NCT04424316|537724302|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
149065765|NCT04109066|537724303|FG000|Pre-treatment|Participant withdrew consent|2|||
149065766|NCT04109066|537724304|FG001|Pre-treatment|Participant withdrew consent|0|||
149065767|NCT04109066|537724303|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
149065768|NCT04109066|537724304|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
149065769|NCT04109066|537724303|FG000|Treatment|Lack of Efficacy|2|||
149065770|NCT04109066|537724304|FG001|Treatment|Lack of Efficacy|4|||
149065771|NCT04109066|537724303|FG000|Treatment|Adverse Event|23|||
149065772|NCT04109066|537724304|FG001|Treatment|Adverse Event|7|||
149065773|NCT04109066|537724303|FG000|Treatment|Participant request to discontinue Study treatment|15|||
149065774|NCT04109066|537724304|FG001|Treatment|Participant request to discontinue Study treatment|14|||
149065775|NCT04109066|537724303|FG000|Treatment|Withdrawal by Subject|8|||
149065776|NCT04109066|537724304|FG001|Treatment|Withdrawal by Subject|8|||
149065777|NCT04109066|537724303|FG000|Treatment|Death|3|||
149065778|NCT04109066|537724304|FG001|Treatment|Death|0|||
149065779|NCT04109066|537724303|FG000|Treatment|Participant no longer meets study criteria|2|||
149065780|NCT04109066|537724304|FG001|Treatment|Participant no longer meets study criteria|2|||
149065781|NCT04109066|537724303|FG000|Treatment|Administrative reasons by sponsor|2|||
149065782|NCT04109066|537724304|FG001|Treatment|Administrative reasons by sponsor|3|||
149065783|NCT04109066|537724303|FG000|Treatment|Other reasons|17|||
149065784|NCT04109066|537724304|FG001|Treatment|Other reasons|23|||
149065785|NCT04109066|537724303|FG000|Treatment|Disease Progression|4|||
149065786|NCT04109066|537724304|FG001|Treatment|Disease Progression|7|||
149065787|NCT04109066|537724303|FG000|Treatment|Study drug toxicity|12|||
149065788|NCT04109066|537724304|FG001|Treatment|Study drug toxicity|5|||
149065789|NCT04109066|537724303|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
149065790|NCT04109066|537724304|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
149065791|NCT04109066|537724303|FG000|Treatment|Disease Recurrence|0|||
149065792|NCT04109066|537724304|FG001|Treatment|Disease Recurrence|2|||
149065793|NCT04109066|537724303|FG000|Treatment|Not reported|4|||
149065794|NCT04109066|537724304|FG001|Treatment|Not reported|8|||
149065795|NCT03812614|537724305|FG000|Intervention|Withdrawal by Subject|7|||
149065796|NCT03812614|537724306|FG001|Intervention|Withdrawal by Subject|2|||
149065797|NCT03812614|537724307|FG002|Intervention|Withdrawal by Subject|7|||
149065798|NCT03812614|537724308|FG003|Intervention|Withdrawal by Subject|2|||
149065799|NCT03812614|537724305|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
149065800|NCT03812614|537724306|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
149065801|NCT03812614|537724307|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
149065802|NCT03812614|537724308|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
149065803|NCT03812614|537724305|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
149065804|NCT03812614|537724306|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
149065805|NCT03812614|537724307|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
149065806|NCT03812614|537724308|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
149065807|NCT03812614|537724305|FG000|6-month Follow-up|Lost to Follow-up|0|||
149065808|NCT03812614|537724306|FG001|6-month Follow-up|Lost to Follow-up|0|||
149065809|NCT03812614|537724307|FG002|6-month Follow-up|Lost to Follow-up|12|||
149065810|NCT03812614|537724308|FG003|6-month Follow-up|Lost to Follow-up|8|||
149065811|NCT03812614|537724305|FG000|12-month Follow-up|Lost to Follow-up|18|||
149065812|NCT03812614|537724306|FG001|12-month Follow-up|Lost to Follow-up|17|||
149065813|NCT03812614|537724307|FG002|12-month Follow-up|Lost to Follow-up|5|||
149065814|NCT03812614|537724308|FG003|12-month Follow-up|Lost to Follow-up|2|||
149065815|NCT05652010|537724309|FG000|First Intervention|Withdrawal by Subject|0|||
149065816|NCT05652010|537724310|FG001|First Intervention|Withdrawal by Subject|1|||
149065817|NCT05652010|537724309|FG000|Second Intervention|Withdrawal by Subject|1|||
149065818|NCT05652010|537724310|FG001|Second Intervention|Withdrawal by Subject|0|||
149065819|NCT05451693|537724314|FG000|Overall Study|Withdrawal by Subject|1|||
149065820|NCT05451693|537724315|FG001|Overall Study|Withdrawal by Subject|1|||
149065821|NCT04707768|537724326|FG000|Overall Study|Adverse Event|9|||
149065822|NCT04707768|537724327|FG001|Overall Study|Adverse Event|18|||
149065823|NCT04707768|537724328|FG002|Overall Study|Adverse Event|3|||
149065824|NCT04707768|537724326|FG000|Overall Study|Investigator's Discretion|8|||
149065825|NCT04707768|537724327|FG001|Overall Study|Investigator's Discretion|4|||
149065826|NCT04707768|537724328|FG002|Overall Study|Investigator's Discretion|3|||
149065827|NCT04707768|537724326|FG000|Overall Study|Withdrawal by Subject|6|||
149065828|NCT04707768|537724327|FG001|Overall Study|Withdrawal by Subject|8|||
149065829|NCT04707768|537724328|FG002|Overall Study|Withdrawal by Subject|2|||
149065830|NCT04707768|537724326|FG000|Overall Study|Lack of Efficacy|1|||
149065831|NCT04707768|537724327|FG001|Overall Study|Lack of Efficacy|3|||
149065832|NCT04707768|537724328|FG002|Overall Study|Lack of Efficacy|0|||
149065833|NCT04707768|537724326|FG000|Overall Study|Lost to Follow-up|0|||
149065834|NCT04707768|537724327|FG001|Overall Study|Lost to Follow-up|0|||
149065835|NCT04707768|537724328|FG002|Overall Study|Lost to Follow-up|3|||
149065836|NCT04707768|537724326|FG000|Overall Study|Death|13|||
149065837|NCT04707768|537724327|FG001|Overall Study|Death|11|||
149065838|NCT04707768|537724328|FG002|Overall Study|Death|13|||
149065839|NCT04707768|537724326|FG000|Overall Study|Protocol Violation|2|||
149065840|NCT04707768|537724327|FG001|Overall Study|Protocol Violation|1|||
149065841|NCT04707768|537724328|FG002|Overall Study|Protocol Violation|0|||
149065842|NCT04707768|537724326|FG000|Overall Study|Non Compliance with Study Drug|1|||
149065843|NCT04707768|537724327|FG001|Overall Study|Non Compliance with Study Drug|0|||
149065844|NCT04707768|537724328|FG002|Overall Study|Non Compliance with Study Drug|0|||
149065845|NCT04707768|537724326|FG000|Overall Study|Transplant|4|||
149065846|NCT04707768|537724327|FG001|Overall Study|Transplant|4|||
149065847|NCT04707768|537724328|FG002|Overall Study|Transplant|8|||
149065848|NCT04707768|537724326|FG000|Overall Study|Other|9|||
149065849|NCT04707768|537724327|FG001|Overall Study|Other|5|||
149065850|NCT04707768|537724328|FG002|Overall Study|Other|2|||
149065851|NCT05953740|537724329|FG000|Period 1|Physician Decision|0|||
149065852|NCT05953740|537724330|FG001|Period 1|Physician Decision|1|||
149065853|NCT05953740|537724331|FG002|Period 1|Physician Decision|0|||
149065854|NCT05953740|537724332|FG003|Period 1|Physician Decision|0|||
149065855|NCT05953740|537724333|FG004|Period 1|Physician Decision|0|||
149065856|NCT05953740|537724334|FG005|Period 1|Physician Decision|0|||
149065857|NCT05953740|537724335|FG006|Period 1|Physician Decision|0|||
149065858|NCT05953740|537724336|FG007|Period 1|Physician Decision|0|||
149065859|NCT05953740|537724329|FG000|Period 2|Withdrawal by Subject|0|||
149065860|NCT05953740|537724330|FG001|Period 2|Withdrawal by Subject|1|||
149065861|NCT05953740|537724331|FG002|Period 2|Withdrawal by Subject|1|||
149065862|NCT05953740|537724332|FG003|Period 2|Withdrawal by Subject|0|||
149065863|NCT05953740|537724333|FG004|Period 2|Withdrawal by Subject|0|||
149065864|NCT05953740|537724334|FG005|Period 2|Withdrawal by Subject|0|||
149065865|NCT05953740|537724335|FG006|Period 2|Withdrawal by Subject|0|||
149065866|NCT05953740|537724336|FG007|Period 2|Withdrawal by Subject|0|||
149065867|NCT05890105|537724337|FG000|Overall Study|Adverse Event|1|||
149065868|NCT05890105|537724338|FG001|Overall Study|Adverse Event|0|||
149065869|NCT05890105|537724339|FG002|Overall Study|Adverse Event|0|||
149065870|NCT05890105|537724337|FG000|Overall Study|Other|1|||
149065871|NCT05890105|537724338|FG001|Overall Study|Other|2|||
149065872|NCT05890105|537724339|FG002|Overall Study|Other|0|||
149065873|NCT03735979|537724342|FG000|Overall Study|Lost to Follow-up|1|||
149065874|NCT03735979|537724343|FG001|Overall Study|Lost to Follow-up|12|||
149065875|NCT03735979|537724344|FG002|Overall Study|Lost to Follow-up|14|||
149065876|NCT03735979|537724342|FG000|Overall Study|Withdrawal by Subject|1|||
149065877|NCT03735979|537724343|FG001|Overall Study|Withdrawal by Subject|5|||
149065878|NCT03735979|537724344|FG002|Overall Study|Withdrawal by Subject|2|||
149065879|NCT03735979|537724342|FG000|Overall Study|Not due to the above reasons|1|||
149065880|NCT03735979|537724343|FG001|Overall Study|Not due to the above reasons|0|||
149065881|NCT03735979|537724344|FG002|Overall Study|Not due to the above reasons|0|||
149065882|NCT03165955|537724347|FG000|Treatment|Withdrawal by Subject|3|||
149065883|NCT03165955|537724347|FG000|Treatment|Death|1|||
149065884|NCT03165955|537724347|FG000|Treatment|Adverse Event|1|||
149065885|NCT03165955|537724347|FG000|Treatment|Progressive disease|3|||
149065886|NCT02994927|537724348|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149065887|NCT02994927|537724349|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149065888|NCT02994927|537724348|FG000|Overall Study|Did not meet eligibility criteria|0|||
149065889|NCT02994927|537724349|FG001|Overall Study|Did not meet eligibility criteria|1|||
149065890|NCT02994927|537724348|FG000|Overall Study|Physician Decision|4|||
149065891|NCT02994927|537724349|FG001|Overall Study|Physician Decision|3|||
149065892|NCT02994927|537724348|FG000|Overall Study|Death|4|||
149065893|NCT02994927|537724349|FG001|Overall Study|Death|2|||
149065894|NCT02994927|537724348|FG000|Overall Study|Adverse Event|2|||
149065895|NCT02994927|537724349|FG001|Overall Study|Adverse Event|1|||
149065896|NCT02994927|537724348|FG000|Overall Study|Withdrawal by Subject|3|||
149065897|NCT02994927|537724349|FG001|Overall Study|Withdrawal by Subject|6|||
149065898|NCT02994927|537724348|FG000|Overall Study|Lost to Follow-up|2|||
149065899|NCT02994927|537724349|FG001|Overall Study|Lost to Follow-up|1|||
149065900|NCT00626795|537724350|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
149065901|NCT00626795|537724351|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
149065902|NCT00626795|537724352|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
149065903|NCT00626795|537724350|FG000|Blinded Treatment|Lack of Efficacy|2|||
149065904|NCT00626795|537724351|FG001|Blinded Treatment|Lack of Efficacy|0|||
149065905|NCT00626795|537724352|FG002|Blinded Treatment|Lack of Efficacy|0|||
149065906|NCT00626795|537724350|FG000|Blinded Treatment|Unacceptable adverse event|0|||
149065907|NCT00626795|537724351|FG001|Blinded Treatment|Unacceptable adverse event|0|||
149065908|NCT00626795|537724352|FG002|Blinded Treatment|Unacceptable adverse event|1|||
149065909|NCT00626795|537724350|FG000|Blinded Treatment|Protocol Violation|0|||
149065910|NCT00626795|537724351|FG001|Blinded Treatment|Protocol Violation|1|||
149065911|NCT00626795|537724352|FG002|Blinded Treatment|Protocol Violation|1|||
149065912|NCT00626795|537724350|FG000|Blinded Treatment|Withdrawal by Subject|1|||
149065913|NCT00626795|537724351|FG001|Blinded Treatment|Withdrawal by Subject|1|||
149065914|NCT00626795|537724352|FG002|Blinded Treatment|Withdrawal by Subject|0|||
149065915|NCT00626795|537724350|FG000|Blinded Treatment|Other reasons|2|||
149065916|NCT00626795|537724351|FG001|Blinded Treatment|Other reasons|0|||
149065917|NCT00626795|537724352|FG002|Blinded Treatment|Other reasons|2|||
149065918|NCT00626795|537724350|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
149065919|NCT00626795|537724351|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
149065920|NCT00626795|537724352|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
149065921|NCT03533257|537724353|FG000|Overall Study|Adverse Event|4|||
149065922|NCT03533257|537724354|FG001|Overall Study|Adverse Event|2|||
149065923|NCT03533257|537724353|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
149065924|NCT03533257|537724354|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
149065925|NCT05405985|537725393|FG000|Overall Study|Withdrawal by Subject|1|||
149065926|NCT05405985|537725394|FG001|Overall Study|Withdrawal by Subject|0|||
149065927|NCT01917084|537725395|FG000|Overall Study|Withdrawal by Subject|1|||
149065928|NCT03571386|537725396|FG000|Overall Study|scheduling conflict|4|||
149065929|NCT03571386|537725397|FG001|Overall Study|scheduling conflict|0|||
149065930|NCT03571386|537725396|FG000|Overall Study|Withdrawal by Subject|15|||
149065931|NCT03571386|537725397|FG001|Overall Study|Withdrawal by Subject|5|||
149065932|NCT02278211|537725398|FG000|Overall Study|Unable to analyse PET scan|2|||
149065933|NCT02909686|537725399|FG000|Overall Study|Physician Decision|3|||
149065934|NCT02909686|537725399|FG000|Overall Study|Withdrawal by Subject|2|||
149065935|NCT06037668|537725402|FG000|Overall Study|Lost to Follow-up|1|||
149065936|NCT06037668|537725403|FG001|Overall Study|Lost to Follow-up|1|||
149065937|NCT06037668|537725402|FG000|Overall Study|Protocol Violation|1|||
149065938|NCT06037668|537725403|FG001|Overall Study|Protocol Violation|0|||
149065939|NCT06037668|537725402|FG000|Overall Study|Withdrawal by Subject|1|||
149065940|NCT06037668|537725403|FG001|Overall Study|Withdrawal by Subject|0|||
149065941|NCT06037668|537725402|FG000|Overall Study|Other Study Discontinuation Reason|1|||
149065942|NCT06037668|537725403|FG001|Overall Study|Other Study Discontinuation Reason|0|||
149065943|NCT05224544|537725404|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
149065944|NCT05224544|537725405|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
149065945|NCT04804540|537725406|FG000|Overall Study|Adverse Event|26|||
149065946|NCT04804540|537725407|FG001|Overall Study|Adverse Event|13|||
149065947|NCT01828021|537725408|FG000|Overall Study|Adverse Event|5|||
149065948|NCT01828021|537725408|FG000|Overall Study|Lack of Efficacy|17|||
149065949|NCT01828021|537725408|FG000|Overall Study|Withdrawal by Subject|2|||
149065950|NCT01828021|537725408|FG000|Overall Study|Ileal obstruction, unrelated|1|||
149065951|NCT02997202|537725409|FG000|Overall Study|Miscellaneous|2|||
149065952|NCT02997202|537725410|FG001|Overall Study|Miscellaneous|2|||
149065953|NCT02997202|537725409|FG000|Overall Study|Withdrawal by Subject|8|||
149065954|NCT02997202|537725410|FG001|Overall Study|Withdrawal by Subject|12|||
149065955|NCT02997202|537725409|FG000|Overall Study|Lost to Follow-up|5|||
149065956|NCT02997202|537725410|FG001|Overall Study|Lost to Follow-up|3|||
149065957|NCT02997202|537725409|FG000|Overall Study|Death|41|||
149065958|NCT02997202|537725410|FG001|Overall Study|Death|45|||
149065959|NCT04629339|537725414|FG000|Overall Study|Death|1|||
149065960|NCT04629339|537725415|FG001|Overall Study|Death|0|||
149065961|NCT04629339|537725416|FG002|Overall Study|Death|2|||
149065962|NCT04629339|537725417|FG003|Overall Study|Death|2|||
149065963|NCT04629339|537725418|FG004|Overall Study|Death|0|||
149065964|NCT04629339|537725414|FG000|Overall Study|Disease Progression|0|||
149065965|NCT04629339|537725415|FG001|Overall Study|Disease Progression|0|||
149065966|NCT04629339|537725416|FG002|Overall Study|Disease Progression|1|||
149065967|NCT04629339|537725417|FG003|Overall Study|Disease Progression|1|||
149065968|NCT04629339|537725418|FG004|Overall Study|Disease Progression|0|||
149065969|NCT04629339|537725414|FG000|Overall Study|Lost to Follow-up|0|||
149065970|NCT04629339|537725415|FG001|Overall Study|Lost to Follow-up|0|||
149065971|NCT04629339|537725416|FG002|Overall Study|Lost to Follow-up|0|||
149065972|NCT04629339|537725417|FG003|Overall Study|Lost to Follow-up|1|||
149065973|NCT04629339|537725418|FG004|Overall Study|Lost to Follow-up|0|||
149065974|NCT04629339|537725414|FG000|Overall Study|Physician Decision|0|||
149065975|NCT04629339|537725415|FG001|Overall Study|Physician Decision|1|||
149065976|NCT04629339|537725416|FG002|Overall Study|Physician Decision|0|||
149065977|NCT04629339|537725417|FG003|Overall Study|Physician Decision|0|||
149065978|NCT04629339|537725418|FG004|Overall Study|Physician Decision|0|||
149065979|NCT04629339|537725414|FG000|Overall Study|Study Terminated by Sponsor|0|||
149065980|NCT04629339|537725415|FG001|Overall Study|Study Terminated by Sponsor|0|||
149065981|NCT04629339|537725416|FG002|Overall Study|Study Terminated by Sponsor|0|||
149065982|NCT04629339|537725417|FG003|Overall Study|Study Terminated by Sponsor|1|||
149065983|NCT04629339|537725418|FG004|Overall Study|Study Terminated by Sponsor|0|||
149065984|NCT04629339|537725414|FG000|Overall Study|Withdrawal by Subject|0|||
149065985|NCT04629339|537725415|FG001|Overall Study|Withdrawal by Subject|0|||
149065986|NCT04629339|537725416|FG002|Overall Study|Withdrawal by Subject|2|||
149065987|NCT04629339|537725417|FG003|Overall Study|Withdrawal by Subject|2|||
149065988|NCT04629339|537725418|FG004|Overall Study|Withdrawal by Subject|0|||
149065989|NCT04158739|537725423|FG000|Overall Study|Adverse Event|1|||
149065990|NCT04158739|537725424|FG001|Overall Study|Adverse Event|0|||
149065991|NCT04158739|537725423|FG000|Overall Study|Death|0|||
149065992|NCT04158739|537725424|FG001|Overall Study|Death|1|||
149065993|NCT04158739|537725423|FG000|Overall Study|Lack of Efficacy|3|||
149065994|NCT04158739|537725424|FG001|Overall Study|Lack of Efficacy|7|||
149065995|NCT04158739|537725423|FG000|Overall Study|Physician Decision|0|||
149065996|NCT04158739|537725424|FG001|Overall Study|Physician Decision|1|||
149065997|NCT04158739|537725423|FG000|Overall Study|Withdrawal by Subject|3|||
149065998|NCT04158739|537725424|FG001|Overall Study|Withdrawal by Subject|0|||
149065999|NCT00677365|537725429|FG000|Overall Study|Adverse Event|2|||
149066000|NCT00677365|537725430|FG001|Overall Study|Adverse Event|1|||
149066001|NCT00677365|537725431|FG002|Overall Study|Adverse Event|1|||
149066002|NCT00677365|537725432|FG003|Overall Study|Adverse Event|2|||
149066003|NCT00677365|537725429|FG000|Overall Study|Withdrawal by Subject|0|||
149066004|NCT00677365|537725430|FG001|Overall Study|Withdrawal by Subject|0|||
149066005|NCT00677365|537725431|FG002|Overall Study|Withdrawal by Subject|1|||
149066006|NCT00677365|537725432|FG003|Overall Study|Withdrawal by Subject|0|||
149066007|NCT00677365|537725429|FG000|Overall Study|Other reason|0|||
149066008|NCT00677365|537725430|FG001|Overall Study|Other reason|0|||
149066009|NCT00677365|537725431|FG002|Overall Study|Other reason|0|||
149066010|NCT00677365|537725432|FG003|Overall Study|Other reason|1|||
149066011|NCT02782676|537725435|FG000|Overall Study|Lost to Follow-up|0|||
149066012|NCT02782676|537725436|FG001|Overall Study|Lost to Follow-up|1|||
149066013|NCT02874742|537725437|FG000|Overall Study|Death|0|||
149066014|NCT02874742|537725438|FG001|Overall Study|Death|1|||
149066015|NCT02874742|537725439|FG002|Overall Study|Death|0|||
149066016|NCT02874742|537725437|FG000|Overall Study|Lost to Follow-up|5|||
149066017|NCT02874742|537725438|FG001|Overall Study|Lost to Follow-up|4|||
149066018|NCT02874742|537725439|FG002|Overall Study|Lost to Follow-up|1|||
149066019|NCT02874742|537725437|FG000|Overall Study|Withdrawal by Subject|17|||
149066020|NCT02874742|537725438|FG001|Overall Study|Withdrawal by Subject|8|||
149066021|NCT02874742|537725439|FG002|Overall Study|Withdrawal by Subject|0|||
149066022|NCT02874742|537725437|FG000|Overall Study|Other|4|||
149066023|NCT02874742|537725438|FG001|Overall Study|Other|1|||
149066024|NCT02874742|537725439|FG002|Overall Study|Other|0|||
149066025|NCT02874742|537725437|FG000|Overall Study|Progressive Disease|1|||
149066026|NCT02874742|537725438|FG001|Overall Study|Progressive Disease|0|||
149066027|NCT02874742|537725439|FG002|Overall Study|Progressive Disease|0|||
149066028|NCT02874742|537725437|FG000|Overall Study|Screen Failure|0|||
149066029|NCT02874742|537725438|FG001|Overall Study|Screen Failure|2|||
149066030|NCT02874742|537725439|FG002|Overall Study|Screen Failure|0|||
149066031|NCT00631475|537725442|FG000|Overall Study|Death|18|||
149066032|NCT00631475|537725442|FG000|Overall Study|Adverse Event|14|||
149066033|NCT00631475|537725442|FG000|Overall Study|Withdrew consent|5|||
149066034|NCT00631475|537725442|FG000|Overall Study|Preparation for lung transplant|8|||
149066035|NCT03652272|537725443|FG000|3 Month|Withdrawal by Subject|1|||
149066036|NCT03652272|537725444|FG001|3 Month|Withdrawal by Subject|1|||
149066037|NCT03652272|537725443|FG000|3 Month|Lost to Follow-up|16|||
149066038|NCT03652272|537725444|FG001|3 Month|Lost to Follow-up|14|||
149066039|NCT04214834|537725447|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
149066040|NCT04214834|537725448|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
149066041|NCT04924400|537725449|FG000|Overall Study|Lost to Follow-up|3|||
149066042|NCT04924400|537725450|FG001|Overall Study|Lost to Follow-up|0|||
149066043|NCT05205161|537725453|FG000|Overall Study|Study terminated by sponsor|3|||
149066044|NCT05205161|537725454|FG001|Overall Study|Study terminated by sponsor|3|||
149066045|NCT05205161|537725455|FG002|Overall Study|Study terminated by sponsor|1|||
149066046|NCT05741294|537725456|FG000|Overall Study|Lost to Follow-up|3|||
149066047|NCT05741294|537725456|FG000|Overall Study|Protocol deviation|3|||
149066048|NCT05741294|537725456|FG000|Overall Study|Withdrawal by Subject|1|||
149066049|NCT05008055|537725459|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
149066050|NCT05008055|537725460|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
149066051|NCT05008055|537725461|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
149066052|NCT00319111|537725462|FG000|Overall Study|Adverse Event|20|||
149066053|NCT00319111|537725462|FG000|Overall Study|Withdrawal of consent|11|||
149066054|NCT00319111|537725462|FG000|Overall Study|Death|9|||
149066055|NCT00319111|537725462|FG000|Overall Study|Lack of clinical improvement|4|||
149066056|NCT00319111|537725462|FG000|Overall Study|Administrative|2|||
149066057|NCT00319111|537725462|FG000|Overall Study|Treatment failure|1|||
149066058|NCT01438853|537725463|FG000|Overall Study|Death|0|||
149066059|NCT01438853|537725464|FG001|Overall Study|Death|0|||
149066060|NCT01438853|537725465|FG002|Overall Study|Death|0|||
149066061|NCT01438853|537725466|FG003|Overall Study|Death|1|||
149066062|NCT01438853|537725463|FG000|Overall Study|Withdrawal by Subject|0|||
149066063|NCT01438853|537725464|FG001|Overall Study|Withdrawal by Subject|0|||
149066064|NCT01438853|537725465|FG002|Overall Study|Withdrawal by Subject|1|||
149066065|NCT01438853|537725466|FG003|Overall Study|Withdrawal by Subject|0|||
149066066|NCT04330040|537725468|FG000|Overall Study|Other: Adverse event|5|||
149066067|NCT04330040|537725469|FG001|Overall Study|Other: Adverse event|0|||
149066068|NCT04330040|537725470|FG002|Overall Study|Other: Adverse event|0|||
149066069|NCT04330040|537725468|FG000|Overall Study|Disease progression|38|||
149066070|NCT04330040|537725469|FG001|Overall Study|Disease progression|10|||
149066071|NCT04330040|537725470|FG002|Overall Study|Disease progression|0|||
149066072|NCT04330040|537725468|FG000|Overall Study|Physician Decision|5|||
149066073|NCT04330040|537725469|FG001|Overall Study|Physician Decision|3|||
149066074|NCT04330040|537725470|FG002|Overall Study|Physician Decision|0|||
149066075|NCT04330040|537725468|FG000|Overall Study|Lost to Follow-up|1|||
149066076|NCT04330040|537725469|FG001|Overall Study|Lost to Follow-up|1|||
149066077|NCT04330040|537725470|FG002|Overall Study|Lost to Follow-up|0|||
149066078|NCT04330040|537725468|FG000|Overall Study|Death|2|||
149066079|NCT04330040|537725469|FG001|Overall Study|Death|1|||
149066080|NCT04330040|537725470|FG002|Overall Study|Death|0|||
149066081|NCT04330040|537725468|FG000|Overall Study|Withdrawal by Subject|3|||
149066082|NCT04330040|537725469|FG001|Overall Study|Withdrawal by Subject|3|||
149066083|NCT04330040|537725470|FG002|Overall Study|Withdrawal by Subject|0|||
149066084|NCT04330040|537725468|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
149066085|NCT04330040|537725469|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
149066086|NCT04330040|537725470|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
149066087|NCT04330040|537725468|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
149066088|NCT04330040|537725469|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
149066089|NCT04330040|537725470|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
149066090|NCT04330040|537725468|FG000|Overall Study|Other: Disease progression|1|||
149066091|NCT04330040|537725469|FG001|Overall Study|Other: Disease progression|0|||
149066092|NCT04330040|537725470|FG002|Overall Study|Other: Disease progression|0|||
149066093|NCT04330040|537725468|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
149066094|NCT04330040|537725469|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
149066095|NCT04330040|537725470|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
149066096|NCT04330040|537725468|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
149066097|NCT04330040|537725469|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
149066098|NCT04330040|537725470|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
149066099|NCT04330040|537725468|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
149066100|NCT04330040|537725469|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
149066101|NCT04330040|537725470|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
149066102|NCT02461134|537725472|FG000|Overall Study|Adverse Event|1|||
149066103|NCT04499521|537725482|FG000|Overall Study|Disease Progression|1|||
149066104|NCT04499521|537725483|FG001|Overall Study|Disease Progression|0|||
149066105|NCT05525104|537725484|FG000|Overall Study|Failed caudal analgesia|1|||
149066106|NCT05525104|537725485|FG001|Overall Study|Failed caudal analgesia|3|||
149066107|NCT05525104|537725484|FG000|Overall Study|Premedication needed|0|||
149066108|NCT05525104|537725485|FG001|Overall Study|Premedication needed|1|||
149066109|NCT05525104|537725484|FG000|Overall Study|Protocol Violation|10|||
149066110|NCT05525104|537725485|FG001|Overall Study|Protocol Violation|0|||
149066111|NCT05525104|537725484|FG000|Overall Study|Cancelled operation|1|||
149066112|NCT05525104|537725485|FG001|Overall Study|Cancelled operation|0|||
149066113|NCT02039401|537725486|FG000|Overall Study|Adverse Event|0|||
149066114|NCT02039401|537725487|FG001|Overall Study|Adverse Event|1|||
149066115|NCT04427007|537726489|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
149066116|NCT04427007|537726490|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
149066117|NCT04165213|537726501|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
149066118|NCT04165213|537726502|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
149066119|NCT04165213|537726501|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
149066120|NCT04165213|537726502|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
149066121|NCT04165213|537726501|FG000|Clinician Enrollment|Termination from site|0|||
149066122|NCT04165213|537726502|FG001|Clinician Enrollment|Termination from site|1|||
149066123|NCT04165213|537726501|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
149066124|NCT04165213|537726502|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
149066125|NCT04165213|537726501|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
149066126|NCT04165213|537726502|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
149066127|NCT04165213|537726501|FG000|Caregiver Enrollment|Physician Decision|1|||
149066128|NCT04165213|537726502|FG001|Caregiver Enrollment|Physician Decision|0|||
149066129|NCT04165213|537726501|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
149066130|NCT04165213|537726502|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
149066131|NCT04165213|537726501|FG000|Caregiver Enrollment|PLWD death|2|||
149066132|NCT04165213|537726502|FG001|Caregiver Enrollment|PLWD death|0|||
149066133|NCT04165213|537726501|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
149066134|NCT04165213|537726502|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
149066135|NCT04165213|537726501|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
149066136|NCT04165213|537726502|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
149066137|NCT04165213|537726501|FG000|PLWD Enrollment|Lost to Follow-up|1|||
149066138|NCT04165213|537726502|FG001|PLWD Enrollment|Lost to Follow-up|1|||
149066139|NCT04165213|537726501|FG000|PLWD Enrollment|Physician Decision|1|||
149066140|NCT04165213|537726502|FG001|PLWD Enrollment|Physician Decision|0|||
149066141|NCT04165213|537726501|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
149066142|NCT04165213|537726502|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
149066143|NCT04165213|537726501|FG000|PLWD Enrollment|Death|2|||
149066144|NCT04165213|537726502|FG001|PLWD Enrollment|Death|0|||
149066145|NCT04165213|537726501|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
149066146|NCT04165213|537726502|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
149066147|NCT03681262|537726509|FG000|Overall Study|Continuing on study|3|||
149066148|NCT03681262|537726510|FG001|Overall Study|Continuing on study|3|||
149066149|NCT03681262|537726509|FG000|Overall Study|Lost to Follow-up|1|||
149066150|NCT03681262|537726510|FG001|Overall Study|Lost to Follow-up|0|||
149066151|NCT05007080|537726512|FG000|Overall Study|Lost to Follow-up|0|||
149066152|NCT05007080|537726513|FG001|Overall Study|Lost to Follow-up|1|||
149066153|NCT05007080|537726514|FG002|Overall Study|Lost to Follow-up|0|||
149066154|NCT05007080|537726515|FG003|Overall Study|Lost to Follow-up|1|||
149066155|NCT05007080|537726516|FG004|Overall Study|Lost to Follow-up|1|||
149066156|NCT05007080|537726517|FG005|Overall Study|Lost to Follow-up|1|||
149066157|NCT05007080|537726512|FG000|Overall Study|Death|0|||
149066158|NCT05007080|537726513|FG001|Overall Study|Death|1|||
149066159|NCT05007080|537726514|FG002|Overall Study|Death|0|||
149066160|NCT05007080|537726515|FG003|Overall Study|Death|0|||
149066161|NCT05007080|537726516|FG004|Overall Study|Death|0|||
149066162|NCT05007080|537726517|FG005|Overall Study|Death|0|||
149066163|NCT05007080|537726512|FG000|Overall Study|Withdrawal by Subject|1|||
149066164|NCT05007080|537726513|FG001|Overall Study|Withdrawal by Subject|2|||
149066165|NCT05007080|537726514|FG002|Overall Study|Withdrawal by Subject|0|||
149066166|NCT05007080|537726515|FG003|Overall Study|Withdrawal by Subject|2|||
149066167|NCT05007080|537726516|FG004|Overall Study|Withdrawal by Subject|1|||
149066168|NCT05007080|537726517|FG005|Overall Study|Withdrawal by Subject|1|||
149066169|NCT05007080|537726512|FG000|Overall Study|Other|1|||
149066170|NCT05007080|537726513|FG001|Overall Study|Other|0|||
149066171|NCT05007080|537726514|FG002|Overall Study|Other|1|||
149066172|NCT05007080|537726515|FG003|Overall Study|Other|1|||
149066173|NCT05007080|537726516|FG004|Overall Study|Other|0|||
149066174|NCT05007080|537726517|FG005|Overall Study|Other|2|||
149066175|NCT05007080|537726512|FG000|Overall Study|Randomized not vaccinated|0|||
149066176|NCT05007080|537726513|FG001|Overall Study|Randomized not vaccinated|0|||
149066177|NCT05007080|537726514|FG002|Overall Study|Randomized not vaccinated|0|||
149066178|NCT05007080|537726515|FG003|Overall Study|Randomized not vaccinated|0|||
149066179|NCT05007080|537726516|FG004|Overall Study|Randomized not vaccinated|0|||
149066180|NCT05007080|537726517|FG005|Overall Study|Randomized not vaccinated|1|||
149066181|NCT04055012|537726518|FG000|Overall Study|Withdrawal by Subject|1|||
149066182|NCT04055012|537726519|FG001|Overall Study|Withdrawal by Subject|3|||
149066183|NCT04055012|537726520|FG002|Overall Study|Withdrawal by Subject|1|||
149066184|NCT04055012|537726521|FG003|Overall Study|Withdrawal by Subject|0|||
149066185|NCT04055012|537726518|FG000|Overall Study|Metformin Recall|1|||
149066186|NCT04055012|537726519|FG001|Overall Study|Metformin Recall|1|||
149066187|NCT04055012|537726520|FG002|Overall Study|Metformin Recall|1|||
149066188|NCT04055012|537726521|FG003|Overall Study|Metformin Recall|0|||
149066189|NCT02326974|537726528|FG000|Overall Study|Withdrawal by Subject|2|||
149066190|NCT02326974|537726528|FG000|Overall Study|failed heterogenity evaluation|5|||
149066191|NCT02577354|537726529|FG000|Overall Study|Lack of Efficacy|4|||
149066192|NCT02577354|537726530|FG001|Overall Study|Lack of Efficacy|4|||
149066193|NCT02577354|537726529|FG000|Overall Study|Lost to Follow-up|3|||
149066194|NCT02577354|537726530|FG001|Overall Study|Lost to Follow-up|1|||
149066195|NCT02577354|537726529|FG000|Overall Study|Missed Visit|4|||
149066196|NCT02577354|537726530|FG001|Overall Study|Missed Visit|3|||
149066197|NCT02577354|537726529|FG000|Overall Study|Adverse Event|4|||
149066198|NCT02577354|537726530|FG001|Overall Study|Adverse Event|5|||
149066199|NCT03372057|537726541|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
149066200|NCT03372057|537726542|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
149066201|NCT03372057|537726543|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
149066202|NCT03372057|537726541|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
149066203|NCT03372057|537726542|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
149066204|NCT03372057|537726543|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
149066205|NCT03372057|537726541|FG000|Dose Optimization Phase|Death|16|||
149066206|NCT03372057|537726542|FG001|Dose Optimization Phase|Death|11|||
149066207|NCT03372057|537726543|FG002|Dose Optimization Phase|Death|0|||
149066208|NCT03372057|537726541|FG000|Expansion Phase|Withdrawal by Subject|0|||
149066209|NCT03372057|537726542|FG001|Expansion Phase|Withdrawal by Subject|0|||
149066210|NCT03372057|537726543|FG002|Expansion Phase|Withdrawal by Subject|4|||
149066211|NCT03372057|537726541|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
149066212|NCT03372057|537726542|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
149066213|NCT03372057|537726543|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
149066214|NCT03372057|537726541|FG000|Expansion Phase|Death|0|||
149066215|NCT03372057|537726542|FG001|Expansion Phase|Death|0|||
149066216|NCT03372057|537726543|FG002|Expansion Phase|Death|78|||
149066217|NCT03372057|537726541|FG000|Expansion Phase|Progressive Disease|0|||
149066218|NCT03372057|537726542|FG001|Expansion Phase|Progressive Disease|0|||
149066219|NCT03372057|537726543|FG002|Expansion Phase|Progressive Disease|1|||
149066220|NCT03372057|537726541|FG000|Expansion Phase|Adverse Event|0|||
149066221|NCT03372057|537726542|FG001|Expansion Phase|Adverse Event|0|||
149066222|NCT03372057|537726543|FG002|Expansion Phase|Adverse Event|1|||
149066223|NCT03880955|537726544|FG000|Overall Study|Adverse Event|1|||
149066224|NCT03880955|537726544|FG000|Overall Study|Death|1|||
149066225|NCT03880955|537726544|FG000|Overall Study|Lost to Follow-up|12|||
149066226|NCT03880955|537726544|FG000|Overall Study|Withdrawal by Subject|4|||
149066227|NCT03880955|537726544|FG000|Overall Study|Missing- Study Site Closed|27|||
149066228|NCT02510235|537726545|FG000|Overall Study|Withdrawal by Subject|1|||
149066229|NCT02510235|537726546|FG001|Overall Study|Withdrawal by Subject|0|||
149066230|NCT00450216|537726547|FG000|Overall Study|Adverse Event|38|||
149066231|NCT00450216|537726548|FG001|Overall Study|Adverse Event|23|||
149066232|NCT00450216|537726547|FG000|Overall Study|Withdrawal by Subject|48|||
149066233|NCT00450216|537726548|FG001|Overall Study|Withdrawal by Subject|26|||
149066234|NCT00450216|537726547|FG000|Overall Study|Lost to Follow-up|16|||
149066235|NCT00450216|537726548|FG001|Overall Study|Lost to Follow-up|9|||
149066236|NCT00450216|537726547|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
149066237|NCT00450216|537726548|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
149066238|NCT00450216|537726547|FG000|Overall Study|misc|21|||
149066239|NCT00450216|537726548|FG001|Overall Study|misc|20|||
149066240|NCT03011034|537726556|FG000|Overall Study|Adverse Event|1|||
149066241|NCT03011034|537726557|FG001|Overall Study|Adverse Event|0|||
149066242|NCT05112900|537726560|FG000|Overall Study|Withdrawal by Subject|960|||
149066243|NCT05112900|537726561|FG001|Overall Study|Withdrawal by Subject|921|||
149066244|NCT05112900|537726562|FG002|Overall Study|Withdrawal by Subject|968|||
149066245|NCT02919917|537726565|FG000|Overall Study|Withdrawal by Subject|4|||
149066246|NCT02919917|537726566|FG001|Overall Study|Withdrawal by Subject|8|||
149066247|NCT04743973|537726567|FG000|Overall Study|Withdrawal by Subject|5|||
149066248|NCT04761198|537726568|FG000|Overall Study|Progressive Disease|1|||
149066249|NCT04761198|537726569|FG001|Overall Study|Progressive Disease|0|||
149066250|NCT04761198|537726570|FG002|Overall Study|Progressive Disease|0|||
149066251|NCT04761198|537726571|FG003|Overall Study|Progressive Disease|1|||
149066252|NCT04761198|537726572|FG004|Overall Study|Progressive Disease|4|||
149066253|NCT04761198|537726573|FG005|Overall Study|Progressive Disease|1|||
149066254|NCT04761198|537726574|FG006|Overall Study|Progressive Disease|2|||
149066255|NCT04761198|537726568|FG000|Overall Study|Protocol Violation|0|||
149066256|NCT04761198|537726569|FG001|Overall Study|Protocol Violation|0|||
149066257|NCT04761198|537726570|FG002|Overall Study|Protocol Violation|0|||
149066258|NCT04761198|537726571|FG003|Overall Study|Protocol Violation|0|||
149066259|NCT04761198|537726572|FG004|Overall Study|Protocol Violation|1|||
149066260|NCT04761198|537726573|FG005|Overall Study|Protocol Violation|0|||
149066261|NCT04761198|537726574|FG006|Overall Study|Protocol Violation|0|||
149066262|NCT04761198|537726568|FG000|Overall Study|Death|2|||
149066263|NCT04761198|537726569|FG001|Overall Study|Death|1|||
149066264|NCT04761198|537726570|FG002|Overall Study|Death|2|||
149066265|NCT04761198|537726571|FG003|Overall Study|Death|5|||
149066266|NCT04761198|537726572|FG004|Overall Study|Death|14|||
149066267|NCT04761198|537726573|FG005|Overall Study|Death|2|||
149066268|NCT04761198|537726574|FG006|Overall Study|Death|5|||
149066269|NCT04761198|537726568|FG000|Overall Study|Lost to Follow-up|0|||
149066270|NCT04761198|537726569|FG001|Overall Study|Lost to Follow-up|0|||
149066271|NCT04761198|537726570|FG002|Overall Study|Lost to Follow-up|0|||
149066272|NCT04761198|537726571|FG003|Overall Study|Lost to Follow-up|0|||
149066273|NCT04761198|537726572|FG004|Overall Study|Lost to Follow-up|1|||
149066274|NCT04761198|537726573|FG005|Overall Study|Lost to Follow-up|0|||
149066275|NCT04761198|537726574|FG006|Overall Study|Lost to Follow-up|0|||
149066276|NCT04761198|537726568|FG000|Overall Study|Withdrawal by Subject|2|||
149066277|NCT04761198|537726569|FG001|Overall Study|Withdrawal by Subject|0|||
149066278|NCT04761198|537726570|FG002|Overall Study|Withdrawal by Subject|1|||
149066279|NCT04761198|537726571|FG003|Overall Study|Withdrawal by Subject|0|||
149066280|NCT04761198|537726572|FG004|Overall Study|Withdrawal by Subject|2|||
149066281|NCT04761198|537726573|FG005|Overall Study|Withdrawal by Subject|0|||
149066282|NCT04761198|537726574|FG006|Overall Study|Withdrawal by Subject|1|||
149066283|NCT04761198|537726568|FG000|Overall Study|Study Terminated by Sponsor|6|||
149066284|NCT04761198|537726569|FG001|Overall Study|Study Terminated by Sponsor|0|||
149066285|NCT04761198|537726570|FG002|Overall Study|Study Terminated by Sponsor|5|||
149066286|NCT04761198|537726571|FG003|Overall Study|Study Terminated by Sponsor|3|||
149066287|NCT04761198|537726572|FG004|Overall Study|Study Terminated by Sponsor|10|||
149066288|NCT04761198|537726573|FG005|Overall Study|Study Terminated by Sponsor|1|||
149066289|NCT04761198|537726574|FG006|Overall Study|Study Terminated by Sponsor|2|||
149066290|NCT03493542|537726577|FG000|Base Study|Withdrawal by Subject|0|||
149066291|NCT03493542|537726578|FG001|Base Study|Withdrawal by Subject|4|||
149066292|NCT03493542|537726579|FG002|Base Study|Withdrawal by Subject|0|||
149066293|NCT03493542|537726577|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
149066294|NCT03493542|537726578|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
149066295|NCT03493542|537726579|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
149066296|NCT03493542|537726577|FG000|Extension Study|Withdrawal by Subject|0|||
149066297|NCT03493542|537726578|FG001|Extension Study|Withdrawal by Subject|0|||
149066298|NCT03493542|537726579|FG002|Extension Study|Withdrawal by Subject|25|||
149066299|NCT01756300|537726585|FG000|Overall Study|Death|1|||
149066300|NCT01756300|537726585|FG000|Overall Study|Withdrawal by Subject|1|||
149066301|NCT04678856|537726586|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
149066302|NCT04678856|537726587|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
149066303|NCT04678856|537726586|FG000|Overall Study|Withdrawal by Subject|5|||
149066304|NCT04678856|537726587|FG001|Overall Study|Withdrawal by Subject|1|||
149066305|NCT04244175|537727535|FG000|Overall Study|Adverse Event|3|||
149066306|NCT04244175|537727536|FG001|Overall Study|Adverse Event|2|||
149066307|NCT04244175|537727537|FG002|Overall Study|Adverse Event|5|||
149066308|NCT04244175|537727535|FG000|Overall Study|Lack of Efficacy|1|||
149066309|NCT04244175|537727536|FG001|Overall Study|Lack of Efficacy|0|||
149066310|NCT04244175|537727537|FG002|Overall Study|Lack of Efficacy|1|||
149066311|NCT04244175|537727535|FG000|Overall Study|Lost to Follow-up|1|||
149066312|NCT04244175|537727536|FG001|Overall Study|Lost to Follow-up|0|||
149066313|NCT04244175|537727537|FG002|Overall Study|Lost to Follow-up|0|||
149066314|NCT04244175|537727535|FG000|Overall Study|Non-compliance with study drug|1|||
149066315|NCT04244175|537727536|FG001|Overall Study|Non-compliance with study drug|0|||
149066316|NCT04244175|537727537|FG002|Overall Study|Non-compliance with study drug|1|||
149066317|NCT04244175|537727535|FG000|Overall Study|Protocol deviation|0|||
149066318|NCT04244175|537727536|FG001|Overall Study|Protocol deviation|1|||
149066319|NCT04244175|537727537|FG002|Overall Study|Protocol deviation|0|||
149066320|NCT04244175|537727535|FG000|Overall Study|Withdrawal by Subject|1|||
149066321|NCT04244175|537727536|FG001|Overall Study|Withdrawal by Subject|3|||
149066322|NCT04244175|537727537|FG002|Overall Study|Withdrawal by Subject|1|||
149066323|NCT04244175|537727535|FG000|Overall Study|Other, not specified|0|||
149066324|NCT04244175|537727536|FG001|Overall Study|Other, not specified|1|||
149066325|NCT04244175|537727537|FG002|Overall Study|Other, not specified|2|||
149066326|NCT04464564|537727538|FG000|Period A (Placebo lead-in)|Other|5|||
149066327|NCT04464564|537727539|FG001|Period A (Placebo lead-in)|Other|0|||
149066328|NCT04464564|537727540|FG002|Period A (Placebo lead-in)|Other|0|||
149066329|NCT04464564|537727541|FG003|Period A (Placebo lead-in)|Other|0|||
149066330|NCT04464564|537727538|FG000|Period B (Randomization Period)|Adverse Event|0|||
149066331|NCT04464564|537727539|FG001|Period B (Randomization Period)|Adverse Event|1|||
149066332|NCT04464564|537727540|FG002|Period B (Randomization Period)|Adverse Event|2|||
149066333|NCT04464564|537727541|FG003|Period B (Randomization Period)|Adverse Event|8|||
149066334|NCT04464564|537727538|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
149066335|NCT04464564|537727539|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
149066336|NCT04464564|537727540|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
149066337|NCT04464564|537727541|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
149066338|NCT04464564|537727538|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
149066339|NCT04464564|537727539|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
149066340|NCT04464564|537727540|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
149066341|NCT04464564|537727541|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
149066342|NCT04464564|537727538|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
149066343|NCT04464564|537727539|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
149066344|NCT04464564|537727540|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
149066345|NCT04464564|537727541|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
149066346|NCT04464564|537727538|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
149066347|NCT04464564|537727539|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
149066348|NCT04464564|537727540|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
149066349|NCT04464564|537727541|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
149066350|NCT04464564|537727538|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
149066351|NCT04464564|537727539|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
149066352|NCT04464564|537727540|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
149066353|NCT04464564|537727541|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
149066354|NCT04464564|537727538|FG000|Period B (Randomization Period)|Reason not Specified|0|||
149066355|NCT04464564|537727539|FG001|Period B (Randomization Period)|Reason not Specified|3|||
149066356|NCT04464564|537727540|FG002|Period B (Randomization Period)|Reason not Specified|3|||
149066357|NCT04464564|537727541|FG003|Period B (Randomization Period)|Reason not Specified|3|||
149066358|NCT04389957|537727544|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
149066359|NCT04389957|537727545|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
149066360|NCT04389957|537727546|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
149066361|NCT04389957|537727547|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
149066362|NCT04389957|537727548|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
149066363|NCT04282980|537727549|FG000|Overall Study|Remained on treatment|6|||
149066364|NCT04282980|537727549|FG000|Overall Study|Survival follow-up|11|||
149066365|NCT04282980|537727549|FG000|Overall Study|Withdrawal of informed consent|1|||
149066366|NCT04282980|537727549|FG000|Overall Study|Lost to Follow-up|1|||
149066367|NCT04881461|537727556|FG000|Overall Study|Adverse Event|2|||
149066368|NCT04881461|537727557|FG001|Overall Study|Adverse Event|4|||
149066369|NCT04881461|537727556|FG000|Overall Study|Withdrawal by Subject|19|||
149066370|NCT04881461|537727557|FG001|Overall Study|Withdrawal by Subject|19|||
149066371|NCT04881461|537727556|FG000|Overall Study|Lost to Follow-up|4|||
149066372|NCT04881461|537727557|FG001|Overall Study|Lost to Follow-up|4|||
149066373|NCT04881461|537727556|FG000|Overall Study|Lack of Efficacy|1|||
149066374|NCT04881461|537727557|FG001|Overall Study|Lack of Efficacy|0|||
149066375|NCT04881461|537727556|FG000|Overall Study|"Reason stated as other in CRF"|1|||
149066376|NCT04881461|537727557|FG001|Overall Study|"Reason stated as other in CRF"|2|||
149066377|NCT02095691|537727560|FG000|Overall Study|Physician Decision|1|||
149066378|NCT00887198|537727561|FG000|Randomized Period|Ongoing|42|||
149066379|NCT00887198|537727562|FG001|Randomized Period|Ongoing|0|||
149066380|NCT00887198|537727563|FG002|Randomized Period|Ongoing|0|||
149066381|NCT00887198|537727561|FG000|Randomized Period|Adverse Event|50|||
149066382|NCT00887198|537727562|FG001|Randomized Period|Adverse Event|33|||
149066383|NCT00887198|537727563|FG002|Randomized Period|Adverse Event|0|||
149066384|NCT00887198|537727561|FG000|Randomized Period|Lost to Follow-up|1|||
149066385|NCT00887198|537727562|FG001|Randomized Period|Lost to Follow-up|0|||
149066386|NCT00887198|537727563|FG002|Randomized Period|Lost to Follow-up|0|||
149066387|NCT00887198|537727561|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
149066388|NCT00887198|537727562|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
149066389|NCT00887198|537727563|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
149066390|NCT00887198|537727561|FG000|Randomized Period|Withdrawal by Subject|41|||
149066391|NCT00887198|537727562|FG001|Randomized Period|Withdrawal by Subject|56|||
149066392|NCT00887198|537727563|FG002|Randomized Period|Withdrawal by Subject|0|||
149066393|NCT00887198|537727561|FG000|Randomized Period|Progressive disease|366|||
149066394|NCT00887198|537727562|FG001|Randomized Period|Progressive disease|370|||
149066395|NCT00887198|537727563|FG002|Randomized Period|Progressive disease|0|||
149066396|NCT00887198|537727561|FG000|Randomized Period|Other|42|||
149066397|NCT00887198|537727562|FG001|Randomized Period|Other|30|||
149066398|NCT00887198|537727563|FG002|Randomized Period|Other|0|||
149066399|NCT00887198|537727561|FG000|Randomized Period|Randomized, Not treated|4|||
149066400|NCT00887198|537727562|FG001|Randomized Period|Randomized, Not treated|2|||
149066401|NCT00887198|537727563|FG002|Randomized Period|Randomized, Not treated|0|||
149066402|NCT00887198|537727561|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
149066403|NCT00887198|537727562|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
149066404|NCT00887198|537727563|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
149066405|NCT00887198|537727561|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
149066406|NCT00887198|537727562|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
149066407|NCT00887198|537727563|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
149066408|NCT00887198|537727561|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
149066409|NCT00887198|537727562|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
149066410|NCT00887198|537727563|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
149066411|NCT00887198|537727561|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
149066412|NCT00887198|537727562|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
149066413|NCT00887198|537727563|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
149066414|NCT00887198|537727561|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
149066415|NCT00887198|537727562|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
149066416|NCT00887198|537727563|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
149066417|NCT00887198|537727561|FG000|Cross Over (Placebo to AA)|Other|0|||
149066418|NCT00887198|537727562|FG001|Cross Over (Placebo to AA)|Other|0|||
149066419|NCT00887198|537727563|FG002|Cross Over (Placebo to AA)|Other|19|||
149066420|NCT04173247|537727566|FG000|Overall Study|Withdrawal by Subject|0|||
149066421|NCT04173247|537727567|FG001|Overall Study|Withdrawal by Subject|2|||
149066422|NCT04173247|537727566|FG000|Overall Study|Death|1|||
149066423|NCT04173247|537727567|FG001|Overall Study|Death|0|||
149066424|NCT04173247|537727566|FG000|Overall Study|Physician Decision|1|||
149066425|NCT04173247|537727567|FG001|Overall Study|Physician Decision|0|||
149066426|NCT02163694|537727570|FG000|Overall Study|Adverse event- related to progression|4|||
149066427|NCT02163694|537727571|FG001|Overall Study|Adverse event- related to progression|10|||
149066428|NCT02163694|537727570|FG000|Overall Study|Adverse event- not related to progression|7|||
149066429|NCT02163694|537727571|FG001|Overall Study|Adverse event- not related to progression|22|||
149066430|NCT02163694|537727570|FG000|Overall Study|Withdrew consent|13|||
149066431|NCT02163694|537727571|FG001|Overall Study|Withdrew consent|28|||
149066432|NCT02163694|537727570|FG000|Overall Study|Lost to Follow-up|2|||
149066433|NCT02163694|537727571|FG001|Overall Study|Lost to Follow-up|2|||
149066434|NCT02163694|537727570|FG000|Overall Study|Sponsor discontinued study|3|||
149066435|NCT02163694|537727571|FG001|Overall Study|Sponsor discontinued study|29|||
149066436|NCT02163694|537727570|FG000|Overall Study|Progressive disease per protocol|125|||
149066437|NCT02163694|537727571|FG001|Overall Study|Progressive disease per protocol|224|||
149066438|NCT02163694|537727570|FG000|Overall Study|Other, not specified|17|||
149066439|NCT02163694|537727571|FG001|Overall Study|Other, not specified|22|||
149066440|NCT02163694|537727570|FG000|Overall Study|Randomized but Not Treated|1|||
149066441|NCT02163694|537727571|FG001|Overall Study|Randomized but Not Treated|0|||
149066442|NCT02163694|537727570|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
149066443|NCT02163694|537727571|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
149066444|NCT04369911|537727576|FG000|Overall Study|Lost to Follow-up|3|||
149066445|NCT04369911|537727577|FG001|Overall Study|Lost to Follow-up|3|||
149066446|NCT04369911|537727576|FG000|Overall Study|Withdrawal by Subject|1|||
149066447|NCT04369911|537727577|FG001|Overall Study|Withdrawal by Subject|2|||
149066448|NCT04490109|537727578|FG000|Overall Study|Lost to Follow-up|3|||
149066449|NCT04490109|537727579|FG001|Overall Study|Lost to Follow-up|10|||
149066450|NCT04490109|537727580|FG002|Overall Study|Lost to Follow-up|4|||
149066451|NCT04490109|537727578|FG000|Overall Study|Withdrawal by Subject|8|||
149066452|NCT04490109|537727579|FG001|Overall Study|Withdrawal by Subject|6|||
149066453|NCT04490109|537727580|FG002|Overall Study|Withdrawal by Subject|9|||
149066454|NCT04490109|537727578|FG000|Overall Study|Physician Decision|0|||
149066455|NCT04490109|537727579|FG001|Overall Study|Physician Decision|2|||
149066456|NCT04490109|537727580|FG002|Overall Study|Physician Decision|3|||
149066457|NCT04490109|537727578|FG000|Overall Study|Adverse Event|2|||
149066458|NCT04490109|537727579|FG001|Overall Study|Adverse Event|1|||
149066459|NCT04490109|537727580|FG002|Overall Study|Adverse Event|0|||
149066460|NCT04490109|537727578|FG000|Overall Study|Significant Non-Compliance|2|||
149066461|NCT04490109|537727579|FG001|Overall Study|Significant Non-Compliance|4|||
149066462|NCT04490109|537727580|FG002|Overall Study|Significant Non-Compliance|4|||
149066463|NCT04490109|537727578|FG000|Overall Study|Significant Clinical Event|0|||
149066464|NCT04490109|537727579|FG001|Overall Study|Significant Clinical Event|1|||
149066465|NCT04490109|537727580|FG002|Overall Study|Significant Clinical Event|0|||
149066466|NCT04490109|537727578|FG000|Overall Study|Other Reason|4|||
149066467|NCT04490109|537727579|FG001|Overall Study|Other Reason|1|||
149066468|NCT04490109|537727580|FG002|Overall Study|Other Reason|1|||
149066469|NCT03744676|537727581|FG000|Pre-Treatment Phase|Disease related complications|2|||
149066470|NCT03744676|537727581|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
149066471|NCT03744676|537727581|FG000|Pre-Treatment Phase|Death|7|||
149066472|NCT03744676|537727581|FG000|Pre-Treatment Phase|Other Reasons|7|||
149066473|NCT03744676|537727581|FG000|Treatment Phase|Participant withdrew consent|8|||
149066474|NCT03744676|537727581|FG000|Treatment Phase|Death|33|||
149066475|NCT03744676|537727581|FG000|Treatment Phase|other reasons|6|||
149066476|NCT04078152|537727582|FG000|Overall Study|Other|83|||
149066477|NCT04078152|537727583|FG001|Overall Study|Other|22|||
149066478|NCT04078152|537727584|FG002|Overall Study|Other|25|||
149066479|NCT04078152|537727582|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
149066480|NCT04078152|537727583|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
149066481|NCT04078152|537727584|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
149066482|NCT04078152|537727582|FG000|Overall Study|Withdrawal by Subject|5|||
149066483|NCT04078152|537727583|FG001|Overall Study|Withdrawal by Subject|0|||
149066484|NCT04078152|537727584|FG002|Overall Study|Withdrawal by Subject|1|||
149066485|NCT04078152|537727582|FG000|Overall Study|Death|10|||
149066486|NCT04078152|537727583|FG001|Overall Study|Death|2|||
149066487|NCT04078152|537727584|FG002|Overall Study|Death|12|||
149066488|NCT04078152|537727582|FG000|Overall Study|Adverse Event|1|||
149066489|NCT04078152|537727583|FG001|Overall Study|Adverse Event|0|||
149066490|NCT04078152|537727584|FG002|Overall Study|Adverse Event|0|||
149066491|NCT05541484|537727588|FG000|Overall Study|Withdrawal by Subject|1|||
149066492|NCT05541484|537727589|FG001|Overall Study|Withdrawal by Subject|0|||
149066493|NCT05785130|537727590|FG000|Overall Study|Withdrawal by Subject|1|||
149066494|NCT05785130|537727591|FG001|Overall Study|Withdrawal by Subject|0|||
149066495|NCT05785130|537727590|FG000|Overall Study|Lack of Efficacy|0|||
149066496|NCT05785130|537727591|FG001|Overall Study|Lack of Efficacy|1|||
149066497|NCT02624050|537727592|FG000|Overall Study|Physician Decision|4|||
149066498|NCT02624050|537727593|FG001|Overall Study|Physician Decision|0|||
149066499|NCT02624050|537727592|FG000|Overall Study|Protocol Violation|2|||
149066500|NCT02624050|537727593|FG001|Overall Study|Protocol Violation|0|||
149066501|NCT04157517|537727595|FG000|Overall Study|Death|1|||
149066502|NCT04157517|537727596|FG001|Overall Study|Death|2|||
149066503|NCT04157517|537727597|FG002|Overall Study|Death|2|||
149066504|NCT04157517|537727598|FG003|Overall Study|Death|3|||
149066505|NCT04157517|537727599|FG004|Overall Study|Death|3|||
149066506|NCT04157517|537727600|FG005|Overall Study|Death|4|||
149066507|NCT04157517|537727601|FG006|Overall Study|Death|1|||
149066508|NCT04157517|537727602|FG007|Overall Study|Death|2|||
149066509|NCT04157517|537727603|FG008|Overall Study|Death|4|||
149066510|NCT04157517|537727604|FG009|Overall Study|Death|0|||
149119395|NCT01290315|537916304|FG003|Overall Study|Adverse Event|3|||
149066511|NCT04157517|537727595|FG000|Overall Study|Withdrawal by Subject|1|||
149066512|NCT04157517|537727596|FG001|Overall Study|Withdrawal by Subject|1|||
149066513|NCT04157517|537727597|FG002|Overall Study|Withdrawal by Subject|1|||
149066514|NCT04157517|537727598|FG003|Overall Study|Withdrawal by Subject|0|||
149066515|NCT04157517|537727599|FG004|Overall Study|Withdrawal by Subject|0|||
149066516|NCT04157517|537727600|FG005|Overall Study|Withdrawal by Subject|1|||
149066517|NCT04157517|537727601|FG006|Overall Study|Withdrawal by Subject|0|||
149066518|NCT04157517|537727602|FG007|Overall Study|Withdrawal by Subject|0|||
149066519|NCT04157517|537727603|FG008|Overall Study|Withdrawal by Subject|1|||
149066520|NCT04157517|537727604|FG009|Overall Study|Withdrawal by Subject|0|||
149066521|NCT04157517|537727595|FG000|Overall Study|Other|1|||
149066522|NCT04157517|537727596|FG001|Overall Study|Other|0|||
149066523|NCT04157517|537727597|FG002|Overall Study|Other|0|||
149066524|NCT04157517|537727598|FG003|Overall Study|Other|0|||
149066525|NCT04157517|537727599|FG004|Overall Study|Other|0|||
149066526|NCT04157517|537727600|FG005|Overall Study|Other|1|||
149066527|NCT04157517|537727601|FG006|Overall Study|Other|2|||
149066528|NCT04157517|537727602|FG007|Overall Study|Other|7|||
149066529|NCT04157517|537727603|FG008|Overall Study|Other|7|||
149066530|NCT04157517|537727604|FG009|Overall Study|Other|0|||
149066531|NCT03279978|537727608|FG000|Overall Study|Withdrawal by Subject|0|||
149066532|NCT03279978|537727609|FG001|Overall Study|Withdrawal by Subject|1|||
149066533|NCT03279978|537727610|FG002|Overall Study|Withdrawal by Subject|0|||
149066534|NCT03279978|537727611|FG003|Overall Study|Withdrawal by Subject|0|||
149066535|NCT03279978|537727612|FG004|Overall Study|Withdrawal by Subject|0|||
149066536|NCT03279978|537727613|FG005|Overall Study|Withdrawal by Subject|0|||
149066537|NCT03279978|537727614|FG006|Overall Study|Withdrawal by Subject|0|||
149066538|NCT03279978|537727615|FG007|Overall Study|Withdrawal by Subject|0|||
149066539|NCT03279978|537727616|FG008|Overall Study|Withdrawal by Subject|0|||
149066540|NCT03279978|537727617|FG009|Overall Study|Withdrawal by Subject|1|||
149066541|NCT03279978|537727608|FG000|Overall Study|Lost to Follow-up|1|||
149066542|NCT03279978|537727609|FG001|Overall Study|Lost to Follow-up|0|||
149066543|NCT03279978|537727610|FG002|Overall Study|Lost to Follow-up|1|||
149066544|NCT03279978|537727611|FG003|Overall Study|Lost to Follow-up|0|||
149066545|NCT03279978|537727612|FG004|Overall Study|Lost to Follow-up|0|||
149066546|NCT03279978|537727613|FG005|Overall Study|Lost to Follow-up|0|||
149066547|NCT03279978|537727614|FG006|Overall Study|Lost to Follow-up|0|||
149066548|NCT03279978|537727615|FG007|Overall Study|Lost to Follow-up|0|||
149066549|NCT03279978|537727616|FG008|Overall Study|Lost to Follow-up|0|||
149066550|NCT03279978|537727617|FG009|Overall Study|Lost to Follow-up|0|||
149066551|NCT03279978|537727608|FG000|Overall Study|Other than stated above|0|||
149066552|NCT03279978|537727609|FG001|Overall Study|Other than stated above|0|||
149066553|NCT03279978|537727610|FG002|Overall Study|Other than stated above|0|||
149066554|NCT03279978|537727611|FG003|Overall Study|Other than stated above|0|||
149066555|NCT03279978|537727612|FG004|Overall Study|Other than stated above|0|||
149066556|NCT03279978|537727613|FG005|Overall Study|Other than stated above|0|||
149066557|NCT03279978|537727614|FG006|Overall Study|Other than stated above|1|||
149066558|NCT03279978|537727615|FG007|Overall Study|Other than stated above|0|||
149066559|NCT03279978|537727616|FG008|Overall Study|Other than stated above|0|||
149066560|NCT03279978|537727617|FG009|Overall Study|Other than stated above|0|||
149066561|NCT03734029|537727618|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
149066562|NCT03734029|537727619|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
149066563|NCT03734029|537727618|FG000|Overall Study|Adverse Event|60|||
149066564|NCT03734029|537727619|FG001|Overall Study|Adverse Event|14|||
149066565|NCT03734029|537727618|FG000|Overall Study|Withdrawal by Subject|12|||
149066566|NCT03734029|537727619|FG001|Overall Study|Withdrawal by Subject|11|||
149066567|NCT03734029|537727618|FG000|Overall Study|Clinical progression by investigator|10|||
149066568|NCT03734029|537727619|FG001|Overall Study|Clinical progression by investigator|8|||
149066569|NCT03734029|537727618|FG000|Overall Study|Death|5|||
149066570|NCT03734029|537727619|FG001|Overall Study|Death|2|||
149066571|NCT03734029|537727618|FG000|Overall Study|Physician Decision|4|||
149066572|NCT03734029|537727619|FG001|Overall Study|Physician Decision|3|||
149066573|NCT03734029|537727618|FG000|Overall Study|Other|2|||
149066574|NCT03734029|537727619|FG001|Overall Study|Other|0|||
149066575|NCT03734029|537727618|FG000|Overall Study|Lost to Follow-up|0|||
149066576|NCT03734029|537727619|FG001|Overall Study|Lost to Follow-up|1|||
149066577|NCT03734029|537727618|FG000|Overall Study|Randomized, but not treated|2|||
149066578|NCT03734029|537727619|FG001|Overall Study|Randomized, but not treated|12|||
149066579|NCT03417284|537728215|FG000|Overall Study|Inadequate supply on study drug|1|||
149066580|NCT03417284|537728216|FG001|Overall Study|Inadequate supply on study drug|0|||
149066581|NCT03417284|537728217|FG002|Overall Study|Inadequate supply on study drug|0|||
149066582|NCT03417284|537728218|FG003|Overall Study|Inadequate supply on study drug|0|||
149066583|NCT03417284|537728215|FG000|Overall Study|Disease Progression|0|||
149066584|NCT03417284|537728216|FG001|Overall Study|Disease Progression|0|||
149066585|NCT03417284|537728217|FG002|Overall Study|Disease Progression|1|||
149066586|NCT03417284|537728218|FG003|Overall Study|Disease Progression|0|||
149066587|NCT03636490|537728219|FG000|Overall Study|Dropped out or incomplete data|141|||
149066588|NCT05830799|537728225|FG000|Overall Study|Withdrawal by Subject|1|||
149066589|NCT04631016|537728228|FG000|Overall Study|Adverse Event|3|||
149066590|NCT04631016|537728229|FG001|Overall Study|Adverse Event|0|||
149066591|NCT04631016|537728228|FG000|Overall Study|Withdrawal by Subject|5|||
149066592|NCT04631016|537728229|FG001|Overall Study|Withdrawal by Subject|4|||
149066593|NCT04631016|537728228|FG000|Overall Study|Reason unspecified|1|||
149066594|NCT04631016|537728229|FG001|Overall Study|Reason unspecified|0|||
149066595|NCT04631016|537728228|FG000|Overall Study|Failure to meet randomization criteria|2|||
149066596|NCT04631016|537728229|FG001|Overall Study|Failure to meet randomization criteria|1|||
149066597|NCT04967599|537728232|FG000|Overall Study|Lost to Follow-up|35|||
149066598|NCT04967599|537728233|FG001|Overall Study|Lost to Follow-up|19|||
149066599|NCT04967599|537728234|FG002|Overall Study|Lost to Follow-up|23|||
149066600|NCT04163991|537728235|FG000|Overall Study|Adverse Event|0|||
149066601|NCT04163991|537728236|FG001|Overall Study|Adverse Event|0|||
149066602|NCT04163991|537728237|FG002|Overall Study|Adverse Event|0|||
149066603|NCT04163991|537728238|FG003|Overall Study|Adverse Event|1|||
149066604|NCT04163991|537728239|FG004|Overall Study|Adverse Event|0|||
149066605|NCT04163991|537728235|FG000|Overall Study|Death|0|||
149066606|NCT04163991|537728236|FG001|Overall Study|Death|0|||
149066607|NCT04163991|537728237|FG002|Overall Study|Death|1|||
149066608|NCT04163991|537728238|FG003|Overall Study|Death|0|||
149066609|NCT04163991|537728239|FG004|Overall Study|Death|0|||
149066610|NCT04163991|537728235|FG000|Overall Study|Lost to Follow-up|0|||
149066611|NCT04163991|537728236|FG001|Overall Study|Lost to Follow-up|1|||
149066612|NCT04163991|537728237|FG002|Overall Study|Lost to Follow-up|0|||
149066613|NCT04163991|537728238|FG003|Overall Study|Lost to Follow-up|0|||
149066614|NCT04163991|537728239|FG004|Overall Study|Lost to Follow-up|0|||
149066615|NCT04163991|537728235|FG000|Overall Study|Withdrawal by Subject|1|||
149066616|NCT04163991|537728236|FG001|Overall Study|Withdrawal by Subject|1|||
149066617|NCT04163991|537728237|FG002|Overall Study|Withdrawal by Subject|3|||
149066618|NCT04163991|537728238|FG003|Overall Study|Withdrawal by Subject|1|||
149066619|NCT04163991|537728239|FG004|Overall Study|Withdrawal by Subject|1|||
149066620|NCT04163991|537728235|FG000|Overall Study|Other, Not Specified|0|||
149066621|NCT04163991|537728236|FG001|Overall Study|Other, Not Specified|1|||
149066622|NCT04163991|537728237|FG002|Overall Study|Other, Not Specified|1|||
149066623|NCT04163991|537728238|FG003|Overall Study|Other, Not Specified|1|||
149066624|NCT04163991|537728239|FG004|Overall Study|Other, Not Specified|0|||
149066625|NCT03817983|537728240|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
149066626|NCT03817983|537728241|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
149066627|NCT03817983|537728242|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
149066628|NCT05454514|537728247|FG000|Overall Study|Withdrawal by Subject|4|||
149066629|NCT01897441|537728250|FG000|Overall Study|Lost to Follow-up|0|||
149066630|NCT01897441|537728251|FG001|Overall Study|Lost to Follow-up|0|||
149066631|NCT01897441|537728252|FG002|Overall Study|Lost to Follow-up|1|||
149066632|NCT01897441|537728253|FG003|Overall Study|Lost to Follow-up|0|||
149066633|NCT01897441|537728254|FG004|Overall Study|Lost to Follow-up|0|||
149066634|NCT01897441|537728255|FG005|Overall Study|Lost to Follow-up|0|||
149066635|NCT01897441|537728250|FG000|Overall Study|Withdrawal by Subject|0|||
149066636|NCT01897441|537728251|FG001|Overall Study|Withdrawal by Subject|0|||
149066637|NCT01897441|537728252|FG002|Overall Study|Withdrawal by Subject|0|||
149066638|NCT01897441|537728253|FG003|Overall Study|Withdrawal by Subject|0|||
149066639|NCT01897441|537728254|FG004|Overall Study|Withdrawal by Subject|1|||
149066640|NCT01897441|537728255|FG005|Overall Study|Withdrawal by Subject|0|||
149066641|NCT01897441|537728250|FG000|Overall Study|Withdrawn by Provider|0|||
149066642|NCT01897441|537728251|FG001|Overall Study|Withdrawn by Provider|2|||
149066643|NCT01897441|537728252|FG002|Overall Study|Withdrawn by Provider|0|||
149066644|NCT01897441|537728253|FG003|Overall Study|Withdrawn by Provider|0|||
149066645|NCT01897441|537728254|FG004|Overall Study|Withdrawn by Provider|0|||
149066646|NCT01897441|537728255|FG005|Overall Study|Withdrawn by Provider|0|||
149066647|NCT04159519|537728257|FG000|Overall Study|Adverse Event|1|||
149066648|NCT04159519|537728258|FG001|Overall Study|Adverse Event|1|||
149066649|NCT04159519|537728257|FG000|Overall Study|Lack of Efficacy|1|||
149066650|NCT04159519|537728258|FG001|Overall Study|Lack of Efficacy|0|||
149066651|NCT04159519|537728257|FG000|Overall Study|Discontinued from study|1|||
149066652|NCT04159519|537728258|FG001|Overall Study|Discontinued from study|0|||
149066653|NCT04159519|537728257|FG000|Overall Study|Protocol Violation|1|||
149066654|NCT04159519|537728258|FG001|Overall Study|Protocol Violation|1|||
149066655|NCT04159519|537728257|FG000|Overall Study|Withdrawal by Subject|4|||
149066656|NCT04159519|537728258|FG001|Overall Study|Withdrawal by Subject|4|||
149066657|NCT04780581|537728259|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
149066658|NCT04780581|537728260|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
149066659|NCT04780581|537728259|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
149066660|NCT04780581|537728260|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
149066661|NCT01651000|537728261|FG000|Overall Study|Adverse Event|2|||
149066662|NCT01651000|537728262|FG001|Overall Study|Adverse Event|8|||
149066663|NCT01651000|537728261|FG000|Overall Study|Lost to Follow-up|3|||
149066664|NCT01651000|537728262|FG001|Overall Study|Lost to Follow-up|2|||
149066665|NCT01651000|537728261|FG000|Overall Study|Protocol Violation|0|||
149066666|NCT01651000|537728262|FG001|Overall Study|Protocol Violation|3|||
149066667|NCT01651000|537728261|FG000|Overall Study|Withdrawal by Subject|2|||
149066668|NCT01651000|537728262|FG001|Overall Study|Withdrawal by Subject|10|||
149066669|NCT01651000|537728261|FG000|Overall Study|Subject noncompliance|0|||
149066670|NCT01651000|537728262|FG001|Overall Study|Subject noncompliance|3|||
149066671|NCT01651000|537728261|FG000|Overall Study|Lack of Efficacy|1|||
149066672|NCT01651000|537728262|FG001|Overall Study|Lack of Efficacy|1|||
149066673|NCT01651000|537728261|FG000|Overall Study|Physician Decision|1|||
149066674|NCT01651000|537728262|FG001|Overall Study|Physician Decision|0|||
149066675|NCT01651000|537728261|FG000|Overall Study|Administrative reason|1|||
149066676|NCT01651000|537728262|FG001|Overall Study|Administrative reason|0|||
149066677|NCT01651000|537728261|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
149066678|NCT01651000|537728262|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
149066679|NCT02765412|537728263|FG000|Overall Study|Death|482|||
149066680|NCT02765412|537728264|FG001|Overall Study|Death|855|||
149066681|NCT03781089|537728861|FG000|Overall Study|Constipation|1|||
149066682|NCT03781089|537728862|FG001|Overall Study|Constipation|0|||
149066683|NCT03781089|537728861|FG000|Overall Study|Positive pregnancy test|0|||
149066684|NCT03781089|537728862|FG001|Overall Study|Positive pregnancy test|1|||
149066685|NCT02246127|537728863|FG000|First Course Treatment|Adverse Event|9|||
149066686|NCT02246127|537728864|FG001|First Course Treatment|Adverse Event|7|||
149066687|NCT02246127|537728863|FG000|First Course Treatment|Withdrawal by Subject|6|||
149066688|NCT02246127|537728864|FG001|First Course Treatment|Withdrawal by Subject|7|||
149066689|NCT02246127|537728863|FG000|First Course Treatment|Physician Decision|9|||
149066690|NCT02246127|537728864|FG001|First Course Treatment|Physician Decision|9|||
149066691|NCT02246127|537728863|FG000|First Course Treatment|Death|3|||
149066692|NCT02246127|537728864|FG001|First Course Treatment|Death|3|||
149066693|NCT02246127|537728863|FG000|First Course Treatment|Not reported reasons|6|||
149066694|NCT02246127|537728864|FG001|First Course Treatment|Not reported reasons|7|||
149066695|NCT02246127|537728863|FG000|First Course Treatment|Not treated|3|||
149066696|NCT02246127|537728864|FG001|First Course Treatment|Not treated|3|||
149066697|NCT03635567|537728865|FG000|Overall Study|Lost to Follow-up|4|||
149066698|NCT03635567|537728866|FG001|Overall Study|Lost to Follow-up|1|||
149066699|NCT03635567|537728865|FG000|Overall Study|Withdrawal by Subject|11|||
149066700|NCT03635567|537728866|FG001|Overall Study|Withdrawal by Subject|16|||
149066701|NCT03635567|537728865|FG000|Overall Study|Sponsor Decision|99|||
149066702|NCT03635567|537728866|FG001|Overall Study|Sponsor Decision|57|||
149066703|NCT03635567|537728865|FG000|Overall Study|Death|194|||
149066704|NCT03635567|537728866|FG001|Overall Study|Death|235|||
149066705|NCT00942734|537728869|FG000|Overall Study|Adverse Event|2|||
149066706|NCT00942734|537728869|FG000|Overall Study|Protocol Violation|3|||
149066707|NCT00942734|537728869|FG000|Overall Study|Disease Progression|2|||
149066708|NCT00942734|537728869|FG000|Overall Study|Physician Decision|1|||
149066709|NCT05147584|537728870|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
149066710|NCT03884101|537728878|FG000|Overall Study|Participant Ongoing in Study|202|||
149066711|NCT03884101|537728879|FG001|Overall Study|Participant Ongoing in Study|186|||
149066712|NCT03884101|537728878|FG000|Overall Study|Death|212|||
149066713|NCT03884101|537728879|FG001|Overall Study|Death|224|||
149066714|NCT03884101|537728878|FG000|Overall Study|Lost to Follow-up|0|||
149066715|NCT03884101|537728879|FG001|Overall Study|Lost to Follow-up|1|||
149066716|NCT03884101|537728878|FG000|Overall Study|Withdrawal by Subject|6|||
149066717|NCT03884101|537728879|FG001|Overall Study|Withdrawal by Subject|11|||
149066718|NCT03370913|537728880|FG000|Overall Study|Death|1|||
149066719|NCT03370913|537728880|FG000|Overall Study|Lost to Follow-up|1|||
149066720|NCT04560179|537728883|FG000|Overall Study|Physician Decision|1|||
149066721|NCT04560179|537728884|FG001|Overall Study|Physician Decision|0|||
149066722|NCT04560179|537728885|FG002|Overall Study|Physician Decision|0|||
149066723|NCT04560179|537728886|FG003|Overall Study|Physician Decision|0|||
149066724|NCT04560179|537728887|FG004|Overall Study|Physician Decision|0|||
149066725|NCT04560179|537728883|FG000|Overall Study|Adverse Event|0|||
149066726|NCT04560179|537728884|FG001|Overall Study|Adverse Event|0|||
149066727|NCT04560179|537728885|FG002|Overall Study|Adverse Event|0|||
149066728|NCT04560179|537728886|FG003|Overall Study|Adverse Event|1|||
149066729|NCT04560179|537728887|FG004|Overall Study|Adverse Event|0|||
149066730|NCT03662022|537728888|FG000|Year 1 2019|prevalent case|83|||
149066731|NCT03662022|537728889|FG001|Year 1 2019|prevalent case|116|||
149066732|NCT03662022|537728890|FG002|Year 1 2019|prevalent case|158|||
149066733|NCT03662022|537728891|FG003|Year 1 2019|prevalent case|99|||
149066734|NCT03662022|537728888|FG000|Year 2 2020|incident case|18|||
149066735|NCT03662022|537728889|FG001|Year 2 2020|incident case|18|||
149066736|NCT03662022|537728890|FG002|Year 2 2020|incident case|16|||
149066737|NCT03662022|537728891|FG003|Year 2 2020|incident case|26|||
149066738|NCT03662022|537728888|FG000|Year 2 2020|other case|18|||
149066739|NCT03662022|537728889|FG001|Year 2 2020|other case|16|||
149066740|NCT03662022|537728890|FG002|Year 2 2020|other case|16|||
149066741|NCT03662022|537728891|FG003|Year 2 2020|other case|24|||
149066742|NCT03662022|537728888|FG000|Year 2 2020|Lost to Follow-up|1633|||
149066743|NCT03662022|537728889|FG001|Year 2 2020|Lost to Follow-up|1183|||
149066744|NCT03662022|537728890|FG002|Year 2 2020|Lost to Follow-up|1381|||
149066745|NCT03662022|537728891|FG003|Year 2 2020|Lost to Follow-up|2858|||
149066746|NCT03662022|537728888|FG000|Year 3 2021|incident case|24|||
149066747|NCT03662022|537728889|FG001|Year 3 2021|incident case|27|||
149066748|NCT03662022|537728890|FG002|Year 3 2021|incident case|24|||
149066749|NCT03662022|537728891|FG003|Year 3 2021|incident case|11|||
149066750|NCT03662022|537728888|FG000|Year 3 2021|other case|4|||
149066751|NCT03662022|537728889|FG001|Year 3 2021|other case|15|||
149066752|NCT03662022|537728890|FG002|Year 3 2021|other case|10|||
149066753|NCT03662022|537728891|FG003|Year 3 2021|other case|14|||
149066754|NCT03662022|537728888|FG000|Year 3 2021|Lost to Follow-up|179|||
149066755|NCT03662022|537728889|FG001|Year 3 2021|Lost to Follow-up|244|||
149066756|NCT03662022|537728890|FG002|Year 3 2021|Lost to Follow-up|480|||
149066757|NCT03662022|537728891|FG003|Year 3 2021|Lost to Follow-up|477|||
149066758|NCT03662022|537728888|FG000|Year 4 2022|incident case|25|||
149066759|NCT03662022|537728889|FG001|Year 4 2022|incident case|41|||
149066760|NCT03662022|537728890|FG002|Year 4 2022|incident case|28|||
149066761|NCT03662022|537728891|FG003|Year 4 2022|incident case|7|||
149066762|NCT03662022|537728888|FG000|Year 4 2022|other case|8|||
149066763|NCT03662022|537728889|FG001|Year 4 2022|other case|19|||
149066764|NCT03662022|537728890|FG002|Year 4 2022|other case|13|||
149066765|NCT03662022|537728891|FG003|Year 4 2022|other case|7|||
149066766|NCT03662022|537728888|FG000|Year 4 2022|Lost to Follow-up|986|||
149066767|NCT03662022|537728889|FG001|Year 4 2022|Lost to Follow-up|1079|||
149066768|NCT03662022|537728890|FG002|Year 4 2022|Lost to Follow-up|1236|||
149066769|NCT03662022|537728891|FG003|Year 4 2022|Lost to Follow-up|1826|||
149066770|NCT03248479|537728892|FG000|Overall Study|Death|12|||
149066771|NCT03248479|537728893|FG001|Overall Study|Death|44|||
149066772|NCT03248479|537728894|FG002|Overall Study|Death|1|||
149066773|NCT03248479|537728895|FG003|Overall Study|Death|72|||
149066774|NCT03248479|537728896|FG004|Overall Study|Death|17|||
149066775|NCT03248479|537728897|FG005|Overall Study|Death|6|||
149066776|NCT03248479|537728898|FG006|Overall Study|Death|1|||
149066777|NCT03248479|537728899|FG007|Overall Study|Death|14|||
149066778|NCT03248479|537728900|FG008|Overall Study|Death|3|||
149066779|NCT03248479|537728901|FG009|Overall Study|Death|7|||
149066780|NCT03248479|537728902|FG010|Overall Study|Death|3|||
149066781|NCT03248479|537728903|FG011|Overall Study|Death|1|||
149066782|NCT03248479|537728904|FG012|Overall Study|Death|1|||
149066783|NCT03248479|537728892|FG000|Overall Study|Study terminated by sponsor|12|||
149066784|NCT03248479|537728893|FG001|Overall Study|Study terminated by sponsor|15|||
149066785|NCT03248479|537728894|FG002|Overall Study|Study terminated by sponsor|0|||
149066786|NCT03248479|537728895|FG003|Overall Study|Study terminated by sponsor|5|||
149066787|NCT03248479|537728896|FG004|Overall Study|Study terminated by sponsor|0|||
149066788|NCT03248479|537728897|FG005|Overall Study|Study terminated by sponsor|0|||
149066789|NCT03248479|537728898|FG006|Overall Study|Study terminated by sponsor|0|||
149066790|NCT03248479|537728899|FG007|Overall Study|Study terminated by sponsor|1|||
149066791|NCT03248479|537728900|FG008|Overall Study|Study terminated by sponsor|1|||
149066792|NCT03248479|537728901|FG009|Overall Study|Study terminated by sponsor|0|||
149066793|NCT03248479|537728902|FG010|Overall Study|Study terminated by sponsor|5|||
149066794|NCT03248479|537728903|FG011|Overall Study|Study terminated by sponsor|4|||
149066795|NCT03248479|537728904|FG012|Overall Study|Study terminated by sponsor|0|||
149066796|NCT03248479|537728892|FG000|Overall Study|Consent withdrawn|6|||
149066797|NCT03248479|537728893|FG001|Overall Study|Consent withdrawn|3|||
149066798|NCT03248479|537728894|FG002|Overall Study|Consent withdrawn|0|||
149066799|NCT03248479|537728895|FG003|Overall Study|Consent withdrawn|9|||
149066800|NCT03248479|537728896|FG004|Overall Study|Consent withdrawn|1|||
149066801|NCT03248479|537728897|FG005|Overall Study|Consent withdrawn|0|||
149066802|NCT03248479|537728898|FG006|Overall Study|Consent withdrawn|0|||
149066803|NCT03248479|537728899|FG007|Overall Study|Consent withdrawn|1|||
149066804|NCT03248479|537728900|FG008|Overall Study|Consent withdrawn|0|||
149066805|NCT03248479|537728901|FG009|Overall Study|Consent withdrawn|3|||
149066806|NCT03248479|537728902|FG010|Overall Study|Consent withdrawn|1|||
149066807|NCT03248479|537728903|FG011|Overall Study|Consent withdrawn|0|||
149066808|NCT03248479|537728904|FG012|Overall Study|Consent withdrawn|1|||
149066809|NCT03248479|537728892|FG000|Overall Study|Lost to Follow-up|2|||
149066810|NCT03248479|537728893|FG001|Overall Study|Lost to Follow-up|1|||
149066811|NCT03248479|537728894|FG002|Overall Study|Lost to Follow-up|0|||
149066812|NCT03248479|537728895|FG003|Overall Study|Lost to Follow-up|0|||
149066813|NCT03248479|537728896|FG004|Overall Study|Lost to Follow-up|0|||
149066814|NCT03248479|537728897|FG005|Overall Study|Lost to Follow-up|0|||
149066815|NCT03248479|537728898|FG006|Overall Study|Lost to Follow-up|0|||
149066816|NCT03248479|537728899|FG007|Overall Study|Lost to Follow-up|0|||
149066817|NCT03248479|537728900|FG008|Overall Study|Lost to Follow-up|0|||
149066818|NCT03248479|537728901|FG009|Overall Study|Lost to Follow-up|0|||
149066819|NCT03248479|537728902|FG010|Overall Study|Lost to Follow-up|0|||
149066820|NCT03248479|537728903|FG011|Overall Study|Lost to Follow-up|0|||
149066821|NCT03248479|537728904|FG012|Overall Study|Lost to Follow-up|1|||
149066822|NCT03248479|537728892|FG000|Overall Study|Not reported|0|||
149066823|NCT03248479|537728893|FG001|Overall Study|Not reported|0|||
149066824|NCT03248479|537728894|FG002|Overall Study|Not reported|0|||
149066825|NCT03248479|537728895|FG003|Overall Study|Not reported|1|||
149066826|NCT03248479|537728896|FG004|Overall Study|Not reported|1|||
149066827|NCT03248479|537728897|FG005|Overall Study|Not reported|0|||
149066828|NCT03248479|537728898|FG006|Overall Study|Not reported|0|||
149066829|NCT03248479|537728899|FG007|Overall Study|Not reported|1|||
149066830|NCT03248479|537728900|FG008|Overall Study|Not reported|1|||
149066831|NCT03248479|537728901|FG009|Overall Study|Not reported|0|||
149066832|NCT03248479|537728902|FG010|Overall Study|Not reported|0|||
149066833|NCT03248479|537728903|FG011|Overall Study|Not reported|0|||
149066834|NCT03248479|537728904|FG012|Overall Study|Not reported|0|||
149066835|NCT04679389|537728905|FG000|Overall Study|Adverse Event|1|||
149066836|NCT04679389|537728906|FG001|Overall Study|Adverse Event|0|||
149066837|NCT04679389|537728905|FG000|Overall Study|Protocol Violation|2|||
149066838|NCT04679389|537728906|FG001|Overall Study|Protocol Violation|0|||
149066839|NCT04679389|537728905|FG000|Overall Study|Physician Decision|3|||
149066840|NCT04679389|537728906|FG001|Overall Study|Physician Decision|5|||
149066841|NCT04679389|537728905|FG000|Overall Study|Withdrawal by Subject|5|||
149066842|NCT04679389|537728906|FG001|Overall Study|Withdrawal by Subject|7|||
149066843|NCT03418740|537728918|FG000|Overall Study|Lost to Follow-up|13|||
149066844|NCT03418740|537728918|FG000|Overall Study|Scheduling Issues|7|||
149066845|NCT03418740|537728918|FG000|Overall Study|Withdrawal by Subject|2|||
149066846|NCT03418740|537728918|FG000|Overall Study|Unable to Continue Consent|1|||
149066847|NCT01475786|537728921|FG000|Overall Study|Adverse Event|0|||
149066848|NCT01475786|537728922|FG001|Overall Study|Adverse Event|1|||
149066849|NCT01475786|537728923|FG002|Overall Study|Adverse Event|0|||
149066850|NCT01475786|537728921|FG000|Overall Study|Lost to Follow-up|1|||
149066851|NCT01475786|537728922|FG001|Overall Study|Lost to Follow-up|2|||
149066852|NCT01475786|537728923|FG002|Overall Study|Lost to Follow-up|1|||
149066853|NCT01475786|537728921|FG000|Overall Study|Withdrawal by Subject|0|||
149066854|NCT01475786|537728922|FG001|Overall Study|Withdrawal by Subject|1|||
149066855|NCT01475786|537728923|FG002|Overall Study|Withdrawal by Subject|1|||
149066856|NCT01475786|537728921|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
149066857|NCT01475786|537728922|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
149066858|NCT01475786|537728923|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
149066859|NCT01499368|537728924|FG000|Overall Study|Did not meet I/E criteria|8|||
149066860|NCT01499368|537728925|FG001|Overall Study|Did not meet I/E criteria|4|||
149066861|NCT01499368|537728926|FG002|Overall Study|Did not meet I/E criteria|4|||
149066862|NCT01499368|537728924|FG000|Overall Study|Prohibited Concomitant medication|1|||
149066863|NCT01499368|537728925|FG001|Overall Study|Prohibited Concomitant medication|1|||
149066864|NCT01499368|537728926|FG002|Overall Study|Prohibited Concomitant medication|0|||
149066865|NCT01499368|537728924|FG000|Overall Study|Withdrawal by Subject|11|||
149066866|NCT01499368|537728925|FG001|Overall Study|Withdrawal by Subject|10|||
149066867|NCT01499368|537728926|FG002|Overall Study|Withdrawal by Subject|8|||
149066868|NCT01499368|537728924|FG000|Overall Study|Lost to Follow-up|3|||
149066869|NCT01499368|537728925|FG001|Overall Study|Lost to Follow-up|2|||
149066870|NCT01499368|537728926|FG002|Overall Study|Lost to Follow-up|5|||
149066871|NCT01499368|537728924|FG000|Overall Study|Adverse Event|4|||
149066872|NCT01499368|537728925|FG001|Overall Study|Adverse Event|0|||
149066873|NCT01499368|537728926|FG002|Overall Study|Adverse Event|2|||
149066874|NCT01499368|537728924|FG000|Overall Study|Physician Decision|0|||
149066875|NCT01499368|537728925|FG001|Overall Study|Physician Decision|1|||
149066876|NCT01499368|537728926|FG002|Overall Study|Physician Decision|0|||
149066877|NCT01499368|537728924|FG000|Overall Study|Deviation from visit window|0|||
149066878|NCT01499368|537728925|FG001|Overall Study|Deviation from visit window|0|||
149066879|NCT01499368|537728926|FG002|Overall Study|Deviation from visit window|1|||
149066880|NCT01499368|537728924|FG000|Overall Study|Error of Prescriptions|0|||
149066881|NCT01499368|537728925|FG001|Overall Study|Error of Prescriptions|0|||
149066882|NCT01499368|537728926|FG002|Overall Study|Error of Prescriptions|1|||
149066883|NCT04633278|537729500|FG000|Overall Study|Adverse Event|1|||
149066884|NCT04633278|537729501|FG001|Overall Study|Adverse Event|0|||
149066885|NCT04633278|537729500|FG000|Overall Study|Withdrawal by Subject|1|||
149066886|NCT04633278|537729501|FG001|Overall Study|Withdrawal by Subject|0|||
149066887|NCT04633278|537729500|FG000|Overall Study|Death|11|||
149066888|NCT04633278|537729501|FG001|Overall Study|Death|7|||
149066889|NCT04633278|537729500|FG000|Overall Study|Sponsor Decision|3|||
149066890|NCT04633278|537729501|FG001|Overall Study|Sponsor Decision|0|||
149066891|NCT04633278|537729500|FG000|Overall Study|Not Listed|1|||
149066892|NCT04633278|537729501|FG001|Overall Study|Not Listed|0|||
149066893|NCT05988398|537729504|FG000|Overall Study|Lack of time|21|||
149066894|NCT05988398|537729505|FG001|Overall Study|Lack of time|0|||
149066895|NCT05988398|537729504|FG000|Overall Study|Absent from school|0|||
149066896|NCT05988398|537729505|FG001|Overall Study|Absent from school|38|||
149066897|NCT05988398|537729504|FG000|Overall Study|Chose not to participate|0|||
149066898|NCT05988398|537729505|FG001|Overall Study|Chose not to participate|42|||
149066899|NCT05988398|537729504|FG000|Overall Study|Other commitments (e.g., sports)|0|||
149066900|NCT05988398|537729505|FG001|Overall Study|Other commitments (e.g., sports)|25|||
149066901|NCT00319046|537729507|FG000|Overall Study|withdrawal of subject's consent|7|||
149066902|NCT00319046|537729507|FG000|Overall Study|administrative reason|1|||
149066903|NCT04496752|537729511|FG000|Second Assessment|Lost to Follow-up|3|||
149066904|NCT04496752|537729512|FG001|Second Assessment|Lost to Follow-up|3|||
149066905|NCT04496752|537729511|FG000|Second Assessment|Adverse Event|2|||
149066906|NCT04496752|537729512|FG001|Second Assessment|Adverse Event|0|||
149066907|NCT04214418|537729517|FG000|Overall Study|Withdrawal by Subject|1|||
149066908|NCT04214418|537729518|FG001|Overall Study|Withdrawal by Subject|0|||
149066909|NCT04214418|537729519|FG002|Overall Study|Withdrawal by Subject|0|||
149066910|NCT04214418|537729520|FG003|Overall Study|Withdrawal by Subject|0|||
149066911|NCT04214418|537729521|FG004|Overall Study|Withdrawal by Subject|0|||
149066912|NCT04214418|537729522|FG005|Overall Study|Withdrawal by Subject|0|||
149066913|NCT04214418|537729517|FG000|Overall Study|Adverse Event|0|||
149066914|NCT04214418|537729518|FG001|Overall Study|Adverse Event|2|||
149066915|NCT04214418|537729519|FG002|Overall Study|Adverse Event|0|||
149066916|NCT04214418|537729520|FG003|Overall Study|Adverse Event|0|||
149066917|NCT04214418|537729521|FG004|Overall Study|Adverse Event|0|||
149066918|NCT04214418|537729522|FG005|Overall Study|Adverse Event|0|||
149066919|NCT04214418|537729517|FG000|Overall Study|Death|1|||
149066920|NCT04214418|537729518|FG001|Overall Study|Death|0|||
149066921|NCT04214418|537729519|FG002|Overall Study|Death|0|||
149066922|NCT04214418|537729520|FG003|Overall Study|Death|0|||
149066923|NCT04214418|537729521|FG004|Overall Study|Death|0|||
149066924|NCT04214418|537729522|FG005|Overall Study|Death|0|||
149066925|NCT04908930|537729525|FG000|Overall Study|Lost to Follow-up|1|||
149066926|NCT04908930|537729526|FG001|Overall Study|Lost to Follow-up|1|||
149066927|NCT04908930|537729527|FG002|Overall Study|Lost to Follow-up|0|||
149066928|NCT04908930|537729528|FG003|Overall Study|Lost to Follow-up|0|||
149066929|NCT04908930|537729529|FG004|Overall Study|Lost to Follow-up|0|||
149066930|NCT04908930|537729525|FG000|Overall Study|hardware in mouth|1|||
149066931|NCT04908930|537729526|FG001|Overall Study|hardware in mouth|1|||
149066932|NCT04908930|537729527|FG002|Overall Study|hardware in mouth|0|||
149066933|NCT04908930|537729528|FG003|Overall Study|hardware in mouth|0|||
149066934|NCT04908930|537729529|FG004|Overall Study|hardware in mouth|0|||
149066935|NCT04908930|537729525|FG000|Overall Study|wrong team|1|||
149066936|NCT04908930|537729526|FG001|Overall Study|wrong team|0|||
149066937|NCT04908930|537729527|FG002|Overall Study|wrong team|0|||
149066938|NCT04908930|537729528|FG003|Overall Study|wrong team|0|||
149066939|NCT04908930|537729529|FG004|Overall Study|wrong team|0|||
149066940|NCT04908930|537729525|FG000|Overall Study|quit team|2|||
149066941|NCT04908930|537729526|FG001|Overall Study|quit team|4|||
149066942|NCT04908930|537729527|FG002|Overall Study|quit team|0|||
149066943|NCT04908930|537729528|FG003|Overall Study|quit team|0|||
149066944|NCT04908930|537729529|FG004|Overall Study|quit team|0|||
149066945|NCT04908930|537729525|FG000|Overall Study|Withdrawal by Subject|1|||
149066946|NCT04908930|537729526|FG001|Overall Study|Withdrawal by Subject|2|||
149066947|NCT04908930|537729527|FG002|Overall Study|Withdrawal by Subject|0|||
149066948|NCT04908930|537729528|FG003|Overall Study|Withdrawal by Subject|0|||
149066949|NCT04908930|537729529|FG004|Overall Study|Withdrawal by Subject|0|||
149066950|NCT04908930|537729525|FG000|Overall Study|parent not liking program|0|||
149066951|NCT04908930|537729526|FG001|Overall Study|parent not liking program|1|||
149066952|NCT04908930|537729527|FG002|Overall Study|parent not liking program|0|||
149066953|NCT04908930|537729528|FG003|Overall Study|parent not liking program|0|||
149066954|NCT04908930|537729529|FG004|Overall Study|parent not liking program|0|||
149066955|NCT04795245|537729539|FG000|Overall Study|Unkown reason|7|||
149066956|NCT04795245|537729539|FG000|Overall Study|Death|17|||
149066957|NCT04795245|537729539|FG000|Overall Study|Other than listed|19|||
149066958|NCT04795245|537729539|FG000|Overall Study|Adverse Event|143|||
149066959|NCT04795245|537729539|FG000|Overall Study|Progressive disease|512|||
149066960|NCT04795245|537729539|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
149066961|NCT02933489|537729542|FG000|Overall Study|Ineligible|3|||
149066962|NCT02933489|537729543|FG001|Overall Study|Ineligible|3|||
149066963|NCT02933489|537729542|FG000|Overall Study|Withdrawal by Subject|27|||
149066964|NCT02933489|537729543|FG001|Overall Study|Withdrawal by Subject|18|||
149066965|NCT02933489|537729542|FG000|Overall Study|Unable to complete exams (other)|14|||
149066966|NCT02933489|537729543|FG001|Overall Study|Unable to complete exams (other)|7|||
149066967|NCT03250676|537729548|FG000|Overall Study|Adverse Event|0|||
149066968|NCT03250676|537729549|FG001|Overall Study|Adverse Event|0|||
149066969|NCT03250676|537729550|FG002|Overall Study|Adverse Event|0|||
149066970|NCT03250676|537729551|FG003|Overall Study|Adverse Event|1|||
149066971|NCT03250676|537729552|FG004|Overall Study|Adverse Event|2|||
149066972|NCT03250676|537729553|FG005|Overall Study|Adverse Event|9|||
149066973|NCT03250676|537729548|FG000|Overall Study|Withdrawal by Subject|1|||
149066974|NCT03250676|537729549|FG001|Overall Study|Withdrawal by Subject|0|||
149066975|NCT03250676|537729550|FG002|Overall Study|Withdrawal by Subject|0|||
149066976|NCT03250676|537729551|FG003|Overall Study|Withdrawal by Subject|1|||
149066977|NCT03250676|537729552|FG004|Overall Study|Withdrawal by Subject|1|||
149066978|NCT03250676|537729553|FG005|Overall Study|Withdrawal by Subject|2|||
149066979|NCT03250676|537729548|FG000|Overall Study|Physician Decision|0|||
149066980|NCT03250676|537729549|FG001|Overall Study|Physician Decision|0|||
149066981|NCT03250676|537729550|FG002|Overall Study|Physician Decision|0|||
149066982|NCT03250676|537729551|FG003|Overall Study|Physician Decision|2|||
149066983|NCT03250676|537729552|FG004|Overall Study|Physician Decision|0|||
149066984|NCT03250676|537729553|FG005|Overall Study|Physician Decision|3|||
149066985|NCT03250676|537729548|FG000|Overall Study|Withdrawal of consent|0|||
149066986|NCT03250676|537729549|FG001|Overall Study|Withdrawal of consent|0|||
149066987|NCT03250676|537729550|FG002|Overall Study|Withdrawal of consent|2|||
149066988|NCT03250676|537729551|FG003|Overall Study|Withdrawal of consent|0|||
149066989|NCT03250676|537729552|FG004|Overall Study|Withdrawal of consent|0|||
149066990|NCT03250676|537729553|FG005|Overall Study|Withdrawal of consent|2|||
149066991|NCT03250676|537729548|FG000|Overall Study|Other|1|||
149066992|NCT03250676|537729549|FG001|Overall Study|Other|0|||
149066993|NCT03250676|537729550|FG002|Overall Study|Other|0|||
149066994|NCT03250676|537729551|FG003|Overall Study|Other|0|||
149066995|NCT03250676|537729552|FG004|Overall Study|Other|0|||
149066996|NCT03250676|537729553|FG005|Overall Study|Other|0|||
149066997|NCT03250676|537729548|FG000|Overall Study|Disease progression|4|||
149066998|NCT03250676|537729549|FG001|Overall Study|Disease progression|12|||
149066999|NCT03250676|537729550|FG002|Overall Study|Disease progression|9|||
149067000|NCT03250676|537729551|FG003|Overall Study|Disease progression|7|||
149067001|NCT03250676|537729552|FG004|Overall Study|Disease progression|4|||
149067002|NCT03250676|537729553|FG005|Overall Study|Disease progression|88|||
149067003|NCT04626427|537729554|FG000|Overall Study|Death|1|||
149067004|NCT04626427|537729554|FG000|Overall Study|Withdrawal by Subject|1|||
149067005|NCT04626427|537729554|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
149067006|NCT04626427|537729554|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
149067007|NCT03990883|537729555|FG000|Blinded Treatment Phase|Adverse Event|1|||
149067008|NCT03990883|537729556|FG001|Blinded Treatment Phase|Adverse Event|1|||
149067009|NCT03990883|537729557|FG002|Blinded Treatment Phase|Adverse Event|0|||
149067010|NCT03990883|537729555|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
149067011|NCT03990883|537729556|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
149067012|NCT03990883|537729557|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
149067013|NCT03990883|537729555|FG000|Blinded Treatment Phase|Physician Decision|1|||
149067014|NCT03990883|537729556|FG001|Blinded Treatment Phase|Physician Decision|0|||
149067015|NCT03990883|537729557|FG002|Blinded Treatment Phase|Physician Decision|0|||
149067016|NCT03990883|537729555|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
149067017|NCT03990883|537729556|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
149067018|NCT03990883|537729557|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
149067019|NCT03990883|537729555|FG000|Blinded Treatment Phase|COVID-19|3|||
149067020|NCT03990883|537729556|FG001|Blinded Treatment Phase|COVID-19|2|||
149067021|NCT03990883|537729557|FG002|Blinded Treatment Phase|COVID-19|0|||
149067022|NCT03990883|537729555|FG000|Blinded Treatment Phase|Personal Reasons|6|||
149067023|NCT03990883|537729556|FG001|Blinded Treatment Phase|Personal Reasons|3|||
149067024|NCT03990883|537729557|FG002|Blinded Treatment Phase|Personal Reasons|0|||
149067025|NCT03990883|537729555|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
149067026|NCT03990883|537729556|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
149067027|NCT03990883|537729557|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
149067028|NCT03990883|537729555|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
149067029|NCT03990883|537729556|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
149067030|NCT03990883|537729557|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
149067031|NCT03990883|537729555|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
149067032|NCT03990883|537729556|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
149067033|NCT03990883|537729557|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
149067034|NCT04595331|537730571|FG000|Overall Study|Withdrawal by Subject|0|||
149067035|NCT04595331|537730572|FG001|Overall Study|Withdrawal by Subject|1|||
149067036|NCT04595331|537730571|FG000|Overall Study|Lost to Follow-up|0|||
149067037|NCT04595331|537730572|FG001|Overall Study|Lost to Follow-up|5|||
149067038|NCT04595331|537730571|FG000|Overall Study|Medical reason|0|||
149067039|NCT04595331|537730572|FG001|Overall Study|Medical reason|1|||
149067040|NCT05412004|537730574|FG000|Overall Study|Adverse Event|0|||
149067041|NCT05412004|537730575|FG001|Overall Study|Adverse Event|2|||
149067042|NCT05412004|537730576|FG002|Overall Study|Adverse Event|1|||
149067043|NCT05412004|537730577|FG003|Overall Study|Adverse Event|5|||
149067044|NCT05412004|537730574|FG000|Overall Study|Assigned Treatment by Mistake|5|||
149067045|NCT05412004|537730575|FG001|Overall Study|Assigned Treatment by Mistake|10|||
149067046|NCT05412004|537730576|FG002|Overall Study|Assigned Treatment by Mistake|2|||
149067047|NCT05412004|537730577|FG003|Overall Study|Assigned Treatment by Mistake|5|||
149067048|NCT05412004|537730574|FG000|Overall Study|Lost to Follow-up|3|||
149067049|NCT05412004|537730575|FG001|Overall Study|Lost to Follow-up|0|||
149067050|NCT05412004|537730576|FG002|Overall Study|Lost to Follow-up|0|||
149067051|NCT05412004|537730577|FG003|Overall Study|Lost to Follow-up|0|||
149067052|NCT05412004|537730574|FG000|Overall Study|Patient could not travel to site|0|||
149067053|NCT05412004|537730575|FG001|Overall Study|Patient could not travel to site|1|||
149067054|NCT05412004|537730576|FG002|Overall Study|Patient could not travel to site|0|||
149067055|NCT05412004|537730577|FG003|Overall Study|Patient could not travel to site|0|||
149067056|NCT05412004|537730574|FG000|Overall Study|Physician Decision|0|||
149067057|NCT05412004|537730575|FG001|Overall Study|Physician Decision|1|||
149067058|NCT05412004|537730576|FG002|Overall Study|Physician Decision|0|||
149067059|NCT05412004|537730577|FG003|Overall Study|Physician Decision|0|||
149067060|NCT05412004|537730574|FG000|Overall Study|Pregnancy|0|||
149067061|NCT05412004|537730575|FG001|Overall Study|Pregnancy|1|||
149067062|NCT05412004|537730576|FG002|Overall Study|Pregnancy|0|||
149067063|NCT05412004|537730577|FG003|Overall Study|Pregnancy|0|||
149067064|NCT05412004|537730574|FG000|Overall Study|Protocol Violation|1|||
149067065|NCT05412004|537730575|FG001|Overall Study|Protocol Violation|0|||
149067066|NCT05412004|537730576|FG002|Overall Study|Protocol Violation|0|||
149067067|NCT05412004|537730577|FG003|Overall Study|Protocol Violation|0|||
149067068|NCT05412004|537730574|FG000|Overall Study|Withdrawal by Subject|4|||
149067069|NCT05412004|537730575|FG001|Overall Study|Withdrawal by Subject|19|||
149067070|NCT05412004|537730576|FG002|Overall Study|Withdrawal by Subject|4|||
149067071|NCT05412004|537730577|FG003|Overall Study|Withdrawal by Subject|14|||
149067072|NCT05412004|537730574|FG000|Overall Study|Screen Failure|0|||
149067073|NCT05412004|537730575|FG001|Overall Study|Screen Failure|0|||
149067074|NCT05412004|537730576|FG002|Overall Study|Screen Failure|0|||
149067075|NCT05412004|537730577|FG003|Overall Study|Screen Failure|1|||
149067076|NCT05412004|537730574|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
149067077|NCT05412004|537730575|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
149067078|NCT05412004|537730576|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
149067079|NCT05412004|537730577|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
149067080|NCT04644029|537730578|FG000|Overall Study|Death|1|||
149067081|NCT04644029|537730579|FG001|Overall Study|Death|0|||
149067082|NCT04644029|537730578|FG000|Overall Study|Physician Decision|1|||
149067083|NCT04644029|537730579|FG001|Overall Study|Physician Decision|2|||
149067084|NCT04644029|537730578|FG000|Overall Study|Withdrawal by Subject|21|||
149067085|NCT04644029|537730579|FG001|Overall Study|Withdrawal by Subject|19|||
149067086|NCT04644029|537730578|FG000|Overall Study|Lost to Follow-up|31|||
149067087|NCT04644029|537730579|FG001|Overall Study|Lost to Follow-up|34|||
149067088|NCT04644029|537730578|FG000|Overall Study|Study Terminated by Sponsor|308|||
149067089|NCT04644029|537730579|FG001|Overall Study|Study Terminated by Sponsor|309|||
149067090|NCT04644029|537730578|FG000|Overall Study|Randomized in Error|2|||
149067091|NCT04644029|537730579|FG001|Overall Study|Randomized in Error|1|||
149067092|NCT04644029|537730578|FG000|Overall Study|Other|0|||
149067093|NCT04644029|537730579|FG001|Overall Study|Other|1|||
149067094|NCT05020353|537730580|FG000|Overall Study|Protocol Violation|7|||
149067095|NCT05020353|537730580|FG000|Overall Study|Withdrawal by Subject|33|||
149067096|NCT05132400|537730581|FG000|Overall Study|Withdrawal by Subject|14|||
149067097|NCT05132400|537730582|FG001|Overall Study|Withdrawal by Subject|8|||
149067098|NCT05132400|537730581|FG000|Overall Study|Lost to Follow-up|132|||
149067099|NCT05132400|537730582|FG001|Overall Study|Lost to Follow-up|121|||
149067100|NCT02611687|537730584|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
149067101|NCT02611687|537730585|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
149067102|NCT03934931|537730586|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
149067103|NCT03934931|537730587|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
149067104|NCT03934931|537730588|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
149067105|NCT02076009|537730592|FG000|Overall Study|Death|172|||
149067106|NCT02076009|537730593|FG001|Overall Study|Death|153|||
149067107|NCT02076009|537730592|FG000|Overall Study|Withdrawal by Subject|16|||
149067108|NCT02076009|537730593|FG001|Overall Study|Withdrawal by Subject|12|||
149067109|NCT02076009|537730592|FG000|Overall Study|Lost to Follow-up|4|||
149067110|NCT02076009|537730593|FG001|Overall Study|Lost to Follow-up|2|||
149067111|NCT02076009|537730592|FG000|Overall Study|Progressive Disease|1|||
149067112|NCT02076009|537730593|FG001|Overall Study|Progressive Disease|0|||
149067113|NCT02076009|537730592|FG000|Overall Study|Physician Decision|0|||
149067114|NCT02076009|537730593|FG001|Overall Study|Physician Decision|1|||
149067115|NCT02076009|537730592|FG000|Overall Study|End of data collection|90|||
149067116|NCT02076009|537730593|FG001|Overall Study|End of data collection|118|||
149067117|NCT03786926|537730601|FG000|Overall Study|Adverse Event|0|||
149067118|NCT03786926|537730602|FG001|Overall Study|Adverse Event|0|||
149067119|NCT03786926|537730603|FG002|Overall Study|Adverse Event|0|||
149067120|NCT03786926|537730604|FG003|Overall Study|Adverse Event|0|||
149067121|NCT03786926|537730605|FG004|Overall Study|Adverse Event|0|||
149067122|NCT03786926|537730606|FG005|Overall Study|Adverse Event|0|||
149067123|NCT03786926|537730607|FG006|Overall Study|Adverse Event|0|||
149067124|NCT03786926|537730608|FG007|Overall Study|Adverse Event|1|||
149067125|NCT03786926|537730609|FG008|Overall Study|Adverse Event|1|||
149067126|NCT03786926|537730610|FG009|Overall Study|Adverse Event|0|||
149067127|NCT03786926|537730611|FG010|Overall Study|Adverse Event|1|||
149067128|NCT03786926|537730601|FG000|Overall Study|Progressive disease|3|||
149067129|NCT03786926|537730602|FG001|Overall Study|Progressive disease|0|||
149067130|NCT03786926|537730603|FG002|Overall Study|Progressive disease|3|||
149067131|NCT03786926|537730604|FG003|Overall Study|Progressive disease|1|||
149067132|NCT03786926|537730605|FG004|Overall Study|Progressive disease|2|||
149067133|NCT03786926|537730606|FG005|Overall Study|Progressive disease|2|||
149067134|NCT03786926|537730607|FG006|Overall Study|Progressive disease|1|||
149067135|NCT03786926|537730608|FG007|Overall Study|Progressive disease|6|||
149067136|NCT03786926|537730609|FG008|Overall Study|Progressive disease|1|||
149067137|NCT03786926|537730610|FG009|Overall Study|Progressive disease|1|||
149067138|NCT03786926|537730611|FG010|Overall Study|Progressive disease|1|||
149067139|NCT03786926|537730601|FG000|Overall Study|Death|0|||
149067140|NCT03786926|537730602|FG001|Overall Study|Death|1|||
149067141|NCT03786926|537730603|FG002|Overall Study|Death|1|||
149067142|NCT03786926|537730604|FG003|Overall Study|Death|0|||
149067143|NCT03786926|537730605|FG004|Overall Study|Death|0|||
149067144|NCT03786926|537730606|FG005|Overall Study|Death|0|||
149067145|NCT03786926|537730607|FG006|Overall Study|Death|0|||
149067146|NCT03786926|537730608|FG007|Overall Study|Death|0|||
149067147|NCT03786926|537730609|FG008|Overall Study|Death|0|||
149067148|NCT03786926|537730610|FG009|Overall Study|Death|1|||
149067149|NCT03786926|537730611|FG010|Overall Study|Death|2|||
149067150|NCT03786926|537730601|FG000|Overall Study|Physician Decision|0|||
149067151|NCT03786926|537730602|FG001|Overall Study|Physician Decision|1|||
149067152|NCT03786926|537730603|FG002|Overall Study|Physician Decision|0|||
149067153|NCT03786926|537730604|FG003|Overall Study|Physician Decision|1|||
149067154|NCT03786926|537730605|FG004|Overall Study|Physician Decision|2|||
149067155|NCT03786926|537730606|FG005|Overall Study|Physician Decision|0|||
149067156|NCT03786926|537730607|FG006|Overall Study|Physician Decision|0|||
149067157|NCT03786926|537730608|FG007|Overall Study|Physician Decision|2|||
149067158|NCT03786926|537730609|FG008|Overall Study|Physician Decision|1|||
149067159|NCT03786926|537730610|FG009|Overall Study|Physician Decision|1|||
149067160|NCT03786926|537730611|FG010|Overall Study|Physician Decision|0|||
149067161|NCT03786926|537730601|FG000|Overall Study|Withdrawal by Subject|0|||
149067162|NCT03786926|537730602|FG001|Overall Study|Withdrawal by Subject|1|||
149067163|NCT03786926|537730603|FG002|Overall Study|Withdrawal by Subject|1|||
149067164|NCT03786926|537730604|FG003|Overall Study|Withdrawal by Subject|0|||
149067165|NCT03786926|537730605|FG004|Overall Study|Withdrawal by Subject|0|||
149067166|NCT03786926|537730606|FG005|Overall Study|Withdrawal by Subject|0|||
149067167|NCT03786926|537730607|FG006|Overall Study|Withdrawal by Subject|1|||
149067168|NCT03786926|537730608|FG007|Overall Study|Withdrawal by Subject|0|||
149067169|NCT03786926|537730609|FG008|Overall Study|Withdrawal by Subject|1|||
149067170|NCT03786926|537730610|FG009|Overall Study|Withdrawal by Subject|0|||
149067171|NCT03786926|537730611|FG010|Overall Study|Withdrawal by Subject|1|||
149067172|NCT03786926|537730601|FG000|Overall Study|Study terminated by Sponsor|0|||
149067173|NCT03786926|537730602|FG001|Overall Study|Study terminated by Sponsor|0|||
149067174|NCT03786926|537730603|FG002|Overall Study|Study terminated by Sponsor|0|||
149067175|NCT03786926|537730604|FG003|Overall Study|Study terminated by Sponsor|0|||
149067176|NCT03786926|537730605|FG004|Overall Study|Study terminated by Sponsor|1|||
149067177|NCT03786926|537730606|FG005|Overall Study|Study terminated by Sponsor|0|||
149067178|NCT03786926|537730607|FG006|Overall Study|Study terminated by Sponsor|0|||
149067179|NCT03786926|537730608|FG007|Overall Study|Study terminated by Sponsor|4|||
149067180|NCT03786926|537730609|FG008|Overall Study|Study terminated by Sponsor|0|||
149067181|NCT03786926|537730610|FG009|Overall Study|Study terminated by Sponsor|0|||
149067182|NCT03786926|537730611|FG010|Overall Study|Study terminated by Sponsor|0|||
149067183|NCT03786926|537730601|FG000|Overall Study|Anti-neoplasm treatment|0|||
149067184|NCT03786926|537730602|FG001|Overall Study|Anti-neoplasm treatment|0|||
149067185|NCT03786926|537730603|FG002|Overall Study|Anti-neoplasm treatment|0|||
149067186|NCT03786926|537730604|FG003|Overall Study|Anti-neoplasm treatment|0|||
149067187|NCT03786926|537730605|FG004|Overall Study|Anti-neoplasm treatment|1|||
149067188|NCT03786926|537730606|FG005|Overall Study|Anti-neoplasm treatment|0|||
149067189|NCT03786926|537730607|FG006|Overall Study|Anti-neoplasm treatment|1|||
149067190|NCT03786926|537730608|FG007|Overall Study|Anti-neoplasm treatment|0|||
149067191|NCT03786926|537730609|FG008|Overall Study|Anti-neoplasm treatment|0|||
149067192|NCT03786926|537730610|FG009|Overall Study|Anti-neoplasm treatment|0|||
149067193|NCT03786926|537730611|FG010|Overall Study|Anti-neoplasm treatment|0|||
149067194|NCT03786926|537730601|FG000|Overall Study|Other|0|||
149067195|NCT03786926|537730602|FG001|Overall Study|Other|0|||
149067196|NCT03786926|537730603|FG002|Overall Study|Other|0|||
149067197|NCT03786926|537730604|FG003|Overall Study|Other|1|||
149067198|NCT03786926|537730605|FG004|Overall Study|Other|0|||
149067199|NCT03786926|537730606|FG005|Overall Study|Other|1|||
149067200|NCT03786926|537730607|FG006|Overall Study|Other|0|||
149067201|NCT03786926|537730608|FG007|Overall Study|Other|0|||
149067202|NCT03786926|537730609|FG008|Overall Study|Other|2|||
149067203|NCT03786926|537730610|FG009|Overall Study|Other|0|||
149067204|NCT03786926|537730611|FG010|Overall Study|Other|0|||
149067205|NCT05875701|537730616|FG000|Overall Study|Lost to Follow-up|2|||
149067206|NCT05875701|537730617|FG001|Overall Study|Lost to Follow-up|0|||
149067207|NCT05875701|537730616|FG000|Overall Study|Withdrawal by Subject|1|||
149067208|NCT05875701|537730617|FG001|Overall Study|Withdrawal by Subject|1|||
149067209|NCT04408755|537730621|FG000|Period A (Placebo lead-in)|Other|11|||
149067210|NCT04408755|537730622|FG001|Period A (Placebo lead-in)|Other|0|||
149067211|NCT04408755|537730623|FG002|Period A (Placebo lead-in)|Other|0|||
149067212|NCT04408755|537730624|FG003|Period A (Placebo lead-in)|Other|0|||
149067213|NCT04408755|537730621|FG000|Period B (Randomization Period)|Adverse Event|0|||
149067214|NCT04408755|537730622|FG001|Period B (Randomization Period)|Adverse Event|3|||
149067215|NCT04408755|537730623|FG002|Period B (Randomization Period)|Adverse Event|0|||
149067216|NCT04408755|537730624|FG003|Period B (Randomization Period)|Adverse Event|1|||
149067217|NCT04408755|537730621|FG000|Period B (Randomization Period)|Death|0|||
149067218|NCT04408755|537730622|FG001|Period B (Randomization Period)|Death|0|||
149067219|NCT04408755|537730623|FG002|Period B (Randomization Period)|Death|1|||
149067220|NCT04408755|537730624|FG003|Period B (Randomization Period)|Death|0|||
149067221|NCT04408755|537730621|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
149067222|NCT04408755|537730622|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
149067223|NCT04408755|537730623|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
149067224|NCT04408755|537730624|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
149067225|NCT04408755|537730621|FG000|Period B (Randomization Period)|Physician Decision|0|||
149067226|NCT04408755|537730622|FG001|Period B (Randomization Period)|Physician Decision|0|||
149067227|NCT04408755|537730623|FG002|Period B (Randomization Period)|Physician Decision|1|||
149067228|NCT04408755|537730624|FG003|Period B (Randomization Period)|Physician Decision|0|||
149067229|NCT04408755|537730621|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
149067230|NCT04408755|537730622|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
149067231|NCT04408755|537730623|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
149067232|NCT04408755|537730624|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
149067233|NCT04408755|537730621|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
149067234|NCT04408755|537730622|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
149067235|NCT04408755|537730623|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
149067236|NCT04408755|537730624|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
149067237|NCT04408755|537730621|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
149067238|NCT04408755|537730622|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
149067239|NCT04408755|537730623|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
149067240|NCT04408755|537730624|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
149067241|NCT04408755|537730621|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
149067242|NCT04408755|537730622|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
149067243|NCT04408755|537730623|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
149067244|NCT04408755|537730624|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
149067245|NCT04408755|537730621|FG000|Period B (Randomization Period)|Reason not Specified|0|||
149067246|NCT04408755|537730622|FG001|Period B (Randomization Period)|Reason not Specified|1|||
149067247|NCT04408755|537730623|FG002|Period B (Randomization Period)|Reason not Specified|0|||
149067248|NCT04408755|537730624|FG003|Period B (Randomization Period)|Reason not Specified|2|||
149067249|NCT06655818|537730625|FG000|Overall Study|Withdrawal by Subject|1|||
149067250|NCT05836012|537730630|FG000|Overall Study|Lost to Follow-up|1|||
149067251|NCT05836012|537730631|FG001|Overall Study|Lost to Follow-up|0|||
149067252|NCT05836012|537730630|FG000|Overall Study|Withdrawal by Subject|1|||
149067253|NCT05836012|537730631|FG001|Overall Study|Withdrawal by Subject|3|||
149067254|NCT05836012|537730630|FG000|Overall Study|Reason not included in pre-specified categories|2|||
149067255|NCT05836012|537730631|FG001|Overall Study|Reason not included in pre-specified categories|1|||
149067260|NCT02777593|537730638|FG000|Overall Study|Still in study|1|||
149067261|NCT02777593|537730639|FG001|Overall Study|Still in study|32|||
149067262|NCT02777593|537730640|FG002|Overall Study|Still in study|3|||
149067263|NCT02777593|537730641|FG003|Overall Study|Still in study|6|||
149067264|NCT02777593|537730642|FG004|Overall Study|Still in study|5|||
149067265|NCT02777593|537730638|FG000|Overall Study|Death|21|||
149067266|NCT02777593|537730639|FG001|Overall Study|Death|28|||
149067267|NCT02777593|537730640|FG002|Overall Study|Death|0|||
149067268|NCT02777593|537730641|FG003|Overall Study|Death|5|||
149067269|NCT02777593|537730642|FG004|Overall Study|Death|0|||
149067270|NCT02777593|537730638|FG000|Overall Study|Withdrawal by Subject|8|||
149067271|NCT02777593|537730639|FG001|Overall Study|Withdrawal by Subject|4|||
149067272|NCT02777593|537730640|FG002|Overall Study|Withdrawal by Subject|1|||
149067273|NCT02777593|537730641|FG003|Overall Study|Withdrawal by Subject|1|||
149067274|NCT02777593|537730642|FG004|Overall Study|Withdrawal by Subject|0|||
149067275|NCT02777593|537730638|FG000|Overall Study|Lost to Follow-up|8|||
149067276|NCT02777593|537730639|FG001|Overall Study|Lost to Follow-up|16|||
149067277|NCT02777593|537730640|FG002|Overall Study|Lost to Follow-up|5|||
149067278|NCT02777593|537730641|FG003|Overall Study|Lost to Follow-up|0|||
149067279|NCT02777593|537730642|FG004|Overall Study|Lost to Follow-up|1|||
149067280|NCT02777593|537730638|FG000|Overall Study|Physician Decision|2|||
149067281|NCT02777593|537730639|FG001|Overall Study|Physician Decision|2|||
149067282|NCT02777593|537730640|FG002|Overall Study|Physician Decision|0|||
149067283|NCT02777593|537730641|FG003|Overall Study|Physician Decision|0|||
149067284|NCT02777593|537730642|FG004|Overall Study|Physician Decision|0|||
149067285|NCT02777593|537730638|FG000|Overall Study|Discontinued due to Other|1|||
149067286|NCT02777593|537730639|FG001|Overall Study|Discontinued due to Other|0|||
149067287|NCT02777593|537730640|FG002|Overall Study|Discontinued due to Other|0|||
149067288|NCT02777593|537730641|FG003|Overall Study|Discontinued due to Other|0|||
149067289|NCT02777593|537730642|FG004|Overall Study|Discontinued due to Other|0|||
149067290|NCT03547271|537730643|FG000|Overall Study|Adverse Event|1|||
149067291|NCT03547271|537730644|FG001|Overall Study|Adverse Event|1|||
149067292|NCT03547271|537730645|FG002|Overall Study|Adverse Event|0|||
149067293|NCT03547271|537730646|FG003|Overall Study|Adverse Event|0|||
149067294|NCT03547271|537730643|FG000|Overall Study|Protocol deviation|5|||
149067295|NCT03547271|537730644|FG001|Overall Study|Protocol deviation|7|||
149067296|NCT03547271|537730645|FG002|Overall Study|Protocol deviation|3|||
149067297|NCT03547271|537730646|FG003|Overall Study|Protocol deviation|0|||
149067298|NCT03547271|537730643|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
149067299|NCT03547271|537730644|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
149067300|NCT03547271|537730645|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
149067301|NCT03547271|537730646|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
149067302|NCT03547271|537730643|FG000|Overall Study|Lost to Follow-up|3|||
149067303|NCT03547271|537730644|FG001|Overall Study|Lost to Follow-up|3|||
149067304|NCT03547271|537730645|FG002|Overall Study|Lost to Follow-up|1|||
149067305|NCT03547271|537730646|FG003|Overall Study|Lost to Follow-up|0|||
149067306|NCT06065735|537730651|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
149067307|NCT06065735|537730652|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
149067308|NCT06065735|537730653|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
149067309|NCT06065735|537730651|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
149067310|NCT06065735|537730652|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
149067311|NCT06065735|537730653|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
149067312|NCT06065735|537730651|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
149067313|NCT06065735|537730652|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
149067314|NCT06065735|537730653|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
149067315|NCT06065735|537730651|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
149067316|NCT06065735|537730652|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
149067317|NCT06065735|537730653|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
149067318|NCT06065735|537730651|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
149067319|NCT06065735|537730652|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
149067320|NCT06065735|537730653|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
149067321|NCT02532621|537730654|FG000|Overall Study|Death|3|||
149067322|NCT02532621|537730654|FG000|Overall Study|Lost to Follow-up|3|||
149067323|NCT02532621|537730654|FG000|Overall Study|Withdrawal by Subject|6|||
149067324|NCT02532621|537730654|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
149067325|NCT02532621|537730654|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
149067326|NCT03522298|537730655|FG000|Overall Study|Adverse Event|1|||
149067327|NCT03522298|537730656|FG001|Overall Study|Adverse Event|0|||
149067328|NCT03522298|537730657|FG002|Overall Study|Adverse Event|0|||
149067329|NCT03522298|537730658|FG003|Overall Study|Adverse Event|1|||
149067330|NCT03522298|537730655|FG000|Overall Study|Death|2|||
149067331|NCT03522298|537730656|FG001|Overall Study|Death|4|||
149067332|NCT03522298|537730657|FG002|Overall Study|Death|8|||
149067333|NCT03522298|537730658|FG003|Overall Study|Death|8|||
149067334|NCT03522298|537730655|FG000|Overall Study|Patient decision|0|||
149067335|NCT03522298|537730656|FG001|Overall Study|Patient decision|2|||
149067336|NCT03522298|537730657|FG002|Overall Study|Patient decision|2|||
149067337|NCT03522298|537730658|FG003|Overall Study|Patient decision|2|||
149067338|NCT03904576|537730659|FG000|Washout Period|Protocol Violation|1|||
149067339|NCT03904576|537730660|FG001|Washout Period|Protocol Violation|1|||
149067340|NCT05718687|537730661|FG000|Overall Study|Withdrawal by Subject|3|||
149067341|NCT05215054|537730662|FG000|Overall Study|Lost to Follow-up|1|||
149067342|NCT05215054|537730663|FG001|Overall Study|Lost to Follow-up|1|||
149067343|NCT05215054|537730662|FG000|Overall Study|Protocol Violation|1|||
149067344|NCT05215054|537730663|FG001|Overall Study|Protocol Violation|1|||
149067345|NCT05215054|537730662|FG000|Overall Study|Withdrawal by Subject|4|||
149067346|NCT05215054|537730663|FG001|Overall Study|Withdrawal by Subject|4|||
149067347|NCT05485935|537730664|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
149067348|NCT05485935|537730665|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
149067349|NCT05485935|537730664|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
149067350|NCT05485935|537730665|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
149067351|NCT05485935|537730664|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
149067352|NCT05485935|537730665|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
149067353|NCT05485935|537730664|FG000|Period 2 (T2 and V3)|loss of contact|0|||
149067354|NCT05485935|537730665|FG001|Period 2 (T2 and V3)|loss of contact|1|||
149067355|NCT00739908|537731678|FG000|Overall Study|Adverse Event|5|||
149067356|NCT00739908|537731679|FG001|Overall Study|Adverse Event|6|||
149067357|NCT00739908|537731678|FG000|Overall Study|Withdrawal by Subject|4|||
149067358|NCT00739908|537731679|FG001|Overall Study|Withdrawal by Subject|2|||
149067359|NCT00739908|537731678|FG000|Overall Study|Lost to Follow-up|14|||
149067360|NCT00739908|537731679|FG001|Overall Study|Lost to Follow-up|9|||
149120217|NCT04602221|537918066|FG009|Overall Study|Other than listed|0|||
149067361|NCT00739908|537731678|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
149067362|NCT00739908|537731679|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
149067363|NCT00739908|537731678|FG000|Overall Study|Non-Compliance With Study Medication|0|||
149067364|NCT00739908|537731679|FG001|Overall Study|Non-Compliance With Study Medication|3|||
149067365|NCT00739908|537731678|FG000|Overall Study|Lack of Efficacy|0|||
149067366|NCT00739908|537731679|FG001|Overall Study|Lack of Efficacy|1|||
149067367|NCT00739908|537731678|FG000|Overall Study|Relocation|0|||
149067368|NCT00739908|537731679|FG001|Overall Study|Relocation|1|||
149067369|NCT05157841|537731680|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
149067370|NCT05157841|537731681|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
149067371|NCT05157841|537731682|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
149067372|NCT05157841|537731680|FG000|Part A (14 Days)|Adverse Event|1|||
149067373|NCT05157841|537731681|FG001|Part A (14 Days)|Adverse Event|0|||
149067374|NCT05157841|537731682|FG002|Part A (14 Days)|Adverse Event|0|||
149067375|NCT05157841|537731680|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
149067376|NCT05157841|537731681|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
149067377|NCT05157841|537731682|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
149067378|NCT02075554|537731686|FG000|Overall Study|Lost to Follow-up|7|||
149067379|NCT02075554|537731686|FG000|Overall Study|Withdrawal by Subject|5|||
149067380|NCT02075554|537731686|FG000|Overall Study|Physician Decision|3|||
149067381|NCT04933474|537731692|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
149067382|NCT04933474|537731693|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
149067383|NCT04933474|537731692|FG000|Overall Study|Lost to Follow-up|19|||
149067384|NCT04933474|537731693|FG001|Overall Study|Lost to Follow-up|9|||
149067385|NCT04933474|537731692|FG000|Overall Study|Life Burden - unable to participate|6|||
149067386|NCT04933474|537731693|FG001|Overall Study|Life Burden - unable to participate|2|||
149067387|NCT04933474|537731692|FG000|Overall Study|Disease Burden - unable to participate|4|||
149067388|NCT04933474|537731693|FG001|Overall Study|Disease Burden - unable to participate|1|||
149067389|NCT04933474|537731692|FG000|Overall Study|Surgery/Hospitalization|1|||
149067390|NCT04933474|537731693|FG001|Overall Study|Surgery/Hospitalization|2|||
149067391|NCT04933474|537731692|FG000|Overall Study|Dissatisfied with Intervention|1|||
149067392|NCT04933474|537731693|FG001|Overall Study|Dissatisfied with Intervention|1|||
149067393|NCT04933474|537731692|FG000|Overall Study|Withdrew interest in participation|1|||
149067394|NCT04933474|537731693|FG001|Overall Study|Withdrew interest in participation|0|||
149067395|NCT04933474|537731692|FG000|Overall Study|Had previously enrolled in the study|0|||
149067396|NCT04933474|537731693|FG001|Overall Study|Had previously enrolled in the study|1|||
149067397|NCT01773993|537731694|FG000|Overall Study|No Visit After Treatment|35|||
149067398|NCT04993677|537731695|FG000|Overall Study|Lost to Follow-up|1|||
149067399|NCT04993677|537731696|FG001|Overall Study|Lost to Follow-up|0|||
149067400|NCT04993677|537731697|FG002|Overall Study|Lost to Follow-up|0|||
149067401|NCT04993677|537731698|FG003|Overall Study|Lost to Follow-up|0|||
149067402|NCT04993677|537731695|FG000|Overall Study|Death|11|||
149067403|NCT04993677|537731696|FG001|Overall Study|Death|8|||
149067404|NCT04993677|537731697|FG002|Overall Study|Death|3|||
149067405|NCT04993677|537731698|FG003|Overall Study|Death|1|||
149067406|NCT04993677|537731695|FG000|Overall Study|Subject withdrawal of consent|4|||
149067407|NCT04993677|537731696|FG001|Overall Study|Subject withdrawal of consent|3|||
149067408|NCT04993677|537731697|FG002|Overall Study|Subject withdrawal of consent|0|||
149067409|NCT04993677|537731698|FG003|Overall Study|Subject withdrawal of consent|2|||
149067410|NCT04993677|537731695|FG000|Overall Study|Study termination by sponsor|3|||
149067411|NCT04993677|537731696|FG001|Overall Study|Study termination by sponsor|25|||
149067412|NCT04993677|537731697|FG002|Overall Study|Study termination by sponsor|3|||
149067413|NCT04993677|537731698|FG003|Overall Study|Study termination by sponsor|3|||
149067414|NCT04993677|537731695|FG000|Overall Study|Other|2|||
149067415|NCT04993677|537731696|FG001|Overall Study|Other|3|||
149067416|NCT04993677|537731697|FG002|Overall Study|Other|3|||
149067417|NCT04993677|537731698|FG003|Overall Study|Other|2|||
149067418|NCT04174170|537731699|FG000|Placebo Run-in Period|Not Randomized|38|||
149067419|NCT04174170|537731700|FG001|Placebo Run-in Period|Not Randomized|0|||
149067420|NCT04174170|537731701|FG002|Placebo Run-in Period|Not Randomized|0|||
149067421|NCT04174170|537731702|FG003|Placebo Run-in Period|Not Randomized|0|||
149067422|NCT04174170|537731699|FG000|Double Blind Treatment Period|Adverse Event|0|||
149067423|NCT04174170|537731700|FG001|Double Blind Treatment Period|Adverse Event|9|||
149067424|NCT04174170|537731701|FG002|Double Blind Treatment Period|Adverse Event|9|||
149067425|NCT04174170|537731702|FG003|Double Blind Treatment Period|Adverse Event|8|||
149067426|NCT04174170|537731699|FG000|Double Blind Treatment Period|Death|0|||
149067427|NCT04174170|537731700|FG001|Double Blind Treatment Period|Death|1|||
149067428|NCT04174170|537731701|FG002|Double Blind Treatment Period|Death|0|||
149067429|NCT04174170|537731702|FG003|Double Blind Treatment Period|Death|0|||
149067430|NCT04174170|537731699|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
149067431|NCT04174170|537731700|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
149067432|NCT04174170|537731701|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
149067433|NCT04174170|537731702|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
149067434|NCT04174170|537731699|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
149067435|NCT04174170|537731700|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
149067436|NCT04174170|537731701|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
149067437|NCT04174170|537731702|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
149067438|NCT04174170|537731699|FG000|Double Blind Treatment Period|Physician Decision|0|||
149067439|NCT04174170|537731700|FG001|Double Blind Treatment Period|Physician Decision|1|||
149067440|NCT04174170|537731701|FG002|Double Blind Treatment Period|Physician Decision|0|||
149067441|NCT04174170|537731702|FG003|Double Blind Treatment Period|Physician Decision|1|||
149067442|NCT04174170|537731699|FG000|Double Blind Treatment Period|Pregnancy|0|||
149067443|NCT04174170|537731700|FG001|Double Blind Treatment Period|Pregnancy|1|||
149067444|NCT04174170|537731701|FG002|Double Blind Treatment Period|Pregnancy|0|||
149067445|NCT04174170|537731702|FG003|Double Blind Treatment Period|Pregnancy|1|||
149067446|NCT04174170|537731699|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
149067447|NCT04174170|537731700|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
149067448|NCT04174170|537731701|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
149067449|NCT04174170|537731702|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
149067450|NCT04174170|537731699|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
149067451|NCT04174170|537731700|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
149067452|NCT04174170|537731701|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
149067453|NCT04174170|537731702|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
149067454|NCT04174170|537731699|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
149067455|NCT04174170|537731700|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
149067456|NCT04174170|537731701|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
149067457|NCT04174170|537731702|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
149067458|NCT00308997|537731706|FG000|Overall Study|Subject feigned clinical data|0|||
149067459|NCT00308997|537731707|FG001|Overall Study|Subject feigned clinical data|1|||
149067460|NCT00308997|537731706|FG000|Overall Study|Unable to tolerate intervention|1|||
149067461|NCT00308997|537731707|FG001|Overall Study|Unable to tolerate intervention|0|||
149067462|NCT04490356|537731708|FG000|Overall Study|Lost to Follow-up|1|||
149067463|NCT03733626|537731709|FG000|Overall Study|Physician Decision|4|||
149067464|NCT03733626|537731710|FG001|Overall Study|Physician Decision|4|||
149067465|NCT00412607|537731717|FG000|Overall Study|Withdrawal by Subject|9|||
149067466|NCT00412607|537731717|FG000|Overall Study|Lost to Follow-up|19|||
149067467|NCT00412607|537731717|FG000|Overall Study|Death|61|||
149067468|NCT00412607|537731717|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
149067469|NCT04675034|537731722|FG000|Overall Study|Lost to Follow-up|1|||
149067470|NCT04675034|537731723|FG001|Overall Study|Lost to Follow-up|1|||
149067471|NCT04675034|537731724|FG002|Overall Study|Lost to Follow-up|0|||
149067472|NCT04675034|537731725|FG003|Overall Study|Lost to Follow-up|2|||
149067473|NCT04675034|537731726|FG004|Overall Study|Lost to Follow-up|0|||
149067474|NCT04675034|537731722|FG000|Overall Study|Protocol Violation|1|||
149067475|NCT04675034|537731723|FG001|Overall Study|Protocol Violation|0|||
149067476|NCT04675034|537731724|FG002|Overall Study|Protocol Violation|0|||
149067477|NCT04675034|537731725|FG003|Overall Study|Protocol Violation|1|||
149067478|NCT04675034|537731726|FG004|Overall Study|Protocol Violation|3|||
149067479|NCT04675034|537731722|FG000|Overall Study|Withdrawal by Subject|9|||
149067480|NCT04675034|537731723|FG001|Overall Study|Withdrawal by Subject|3|||
149067481|NCT04675034|537731724|FG002|Overall Study|Withdrawal by Subject|4|||
149067482|NCT04675034|537731725|FG003|Overall Study|Withdrawal by Subject|8|||
149067483|NCT04675034|537731726|FG004|Overall Study|Withdrawal by Subject|6|||
149067484|NCT03884439|537731728|FG000|Overall Study|No informed consent for publication of study results|38|||
149067485|NCT03884439|537731728|FG000|Overall Study|Contract violation/deficiency|7|||
149067486|NCT02806726|537731731|FG000|Overall Study|Lost to Follow-up|1|||
149067487|NCT05129501|537731732|FG000|Overall Study|Lost to Follow-up|54|||
149067488|NCT05129501|537731733|FG001|Overall Study|Lost to Follow-up|41|||
149067489|NCT03092674|537731734|FG000|Overall Study|Adverse Event or Side Effects|1|||
149067490|NCT03092674|537731735|FG001|Overall Study|Adverse Event or Side Effects|4|||
149067491|NCT03092674|537731736|FG002|Overall Study|Adverse Event or Side Effects|4|||
149067492|NCT03092674|537731734|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
149067493|NCT03092674|537731735|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
149067494|NCT03092674|537731736|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
149067495|NCT03092674|537731734|FG000|Overall Study|Progression/Relapse|5|||
149067496|NCT03092674|537731735|FG001|Overall Study|Progression/Relapse|4|||
149067497|NCT03092674|537731736|FG002|Overall Study|Progression/Relapse|8|||
149067498|NCT03092674|537731734|FG000|Overall Study|Death|4|||
149067499|NCT03092674|537731735|FG001|Overall Study|Death|8|||
149067500|NCT03092674|537731736|FG002|Overall Study|Death|2|||
149067501|NCT03092674|537731734|FG000|Overall Study|Other - Not Protocol Specified|11|||
149067502|NCT03092674|537731735|FG001|Overall Study|Other - Not Protocol Specified|8|||
149067503|NCT03092674|537731736|FG002|Overall Study|Other - Not Protocol Specified|8|||
149067504|NCT01527188|537731737|FG000|Overall Study|Adverse Event|5|||
149067505|NCT01527188|537731738|FG001|Overall Study|Adverse Event|5|||
149067506|NCT01527188|537731739|FG002|Overall Study|Adverse Event|11|||
149067507|NCT01527188|537731740|FG003|Overall Study|Adverse Event|0|||
149067508|NCT01527188|537731737|FG000|Overall Study|Withdrawal by Subject|3|||
149067509|NCT01527188|537731738|FG001|Overall Study|Withdrawal by Subject|6|||
149067510|NCT01527188|537731739|FG002|Overall Study|Withdrawal by Subject|4|||
149067511|NCT01527188|537731740|FG003|Overall Study|Withdrawal by Subject|4|||
149067512|NCT01527188|537731737|FG000|Overall Study|Any other reason not above-mentioned|6|||
149067513|NCT01527188|537731738|FG001|Overall Study|Any other reason not above-mentioned|7|||
149067514|NCT01527188|537731739|FG002|Overall Study|Any other reason not above-mentioned|8|||
149067515|NCT01527188|537731740|FG003|Overall Study|Any other reason not above-mentioned|8|||
149067516|NCT03982186|537731743|FG000|Overall Study|Lost to Follow-up|0|||
149067517|NCT03982186|537731744|FG001|Overall Study|Lost to Follow-up|1|||
149067518|NCT03982186|537731745|FG002|Overall Study|Lost to Follow-up|2|||
149067519|NCT03982186|537731746|FG003|Overall Study|Lost to Follow-up|1|||
149067520|NCT03982186|537731747|FG004|Overall Study|Lost to Follow-up|1|||
149067521|NCT03982186|537731748|FG005|Overall Study|Lost to Follow-up|0|||
149067522|NCT03982186|537731743|FG000|Overall Study|Physician Decision|0|||
149067523|NCT03982186|537731744|FG001|Overall Study|Physician Decision|1|||
149067524|NCT03982186|537731745|FG002|Overall Study|Physician Decision|0|||
149067525|NCT03982186|537731746|FG003|Overall Study|Physician Decision|0|||
149067526|NCT03982186|537731747|FG004|Overall Study|Physician Decision|0|||
149067527|NCT03982186|537731748|FG005|Overall Study|Physician Decision|0|||
149067528|NCT03982186|537731743|FG000|Overall Study|Withdrawal by Subject|3|||
149067529|NCT03982186|537731744|FG001|Overall Study|Withdrawal by Subject|4|||
149067530|NCT03982186|537731745|FG002|Overall Study|Withdrawal by Subject|1|||
149067531|NCT03982186|537731746|FG003|Overall Study|Withdrawal by Subject|7|||
149067532|NCT03982186|537731747|FG004|Overall Study|Withdrawal by Subject|2|||
149067533|NCT03982186|537731748|FG005|Overall Study|Withdrawal by Subject|0|||
149067534|NCT03982186|537731743|FG000|Overall Study|Randomized and not treated|0|||
149067535|NCT03982186|537731744|FG001|Overall Study|Randomized and not treated|0|||
149067536|NCT03982186|537731745|FG002|Overall Study|Randomized and not treated|0|||
149067537|NCT03982186|537731746|FG003|Overall Study|Randomized and not treated|1|||
149067538|NCT03982186|537731747|FG004|Overall Study|Randomized and not treated|0|||
149067539|NCT03982186|537731748|FG005|Overall Study|Randomized and not treated|0|||
149067540|NCT02325154|537731749|FG000|Overall Study|Physician Decision|1|||
149067541|NCT01265537|537731750|FG000|Overall Study|Adverse Event|2|||
149067542|NCT01265537|537731751|FG001|Overall Study|Adverse Event|1|||
149067543|NCT01265537|537731750|FG000|Overall Study|Physician Decision|0|||
149067544|NCT01265537|537731751|FG001|Overall Study|Physician Decision|1|||
149067545|NCT03512301|537732358|FG000|Overall Study|Protocol Violation|2|||
149067546|NCT03512301|537732358|FG000|Overall Study|Did Not Qualify|3|||
149067547|NCT03512301|537732358|FG000|Overall Study|Age-ineligible|1|||
149067548|NCT03512301|537732358|FG000|Overall Study|Inadequate fluency with the English language|3|||
149067549|NCT02720068|537732359|FG000|Overall Study|Adverse Event|0|||
149067550|NCT02720068|537732360|FG001|Overall Study|Adverse Event|0|||
149067551|NCT02720068|537732361|FG002|Overall Study|Adverse Event|0|||
149067552|NCT02720068|537732362|FG003|Overall Study|Adverse Event|0|||
149067553|NCT02720068|537732363|FG004|Overall Study|Adverse Event|0|||
149067554|NCT02720068|537732364|FG005|Overall Study|Adverse Event|0|||
149067555|NCT02720068|537732365|FG006|Overall Study|Adverse Event|0|||
149067556|NCT02720068|537732366|FG007|Overall Study|Adverse Event|0|||
149067557|NCT02720068|537732367|FG008|Overall Study|Adverse Event|0|||
149067558|NCT02720068|537732368|FG009|Overall Study|Adverse Event|0|||
149067559|NCT02720068|537732369|FG010|Overall Study|Adverse Event|0|||
149067560|NCT02720068|537732370|FG011|Overall Study|Adverse Event|1|||
149067561|NCT02720068|537732371|FG012|Overall Study|Adverse Event|0|||
149067562|NCT02720068|537732372|FG013|Overall Study|Adverse Event|0|||
149067563|NCT02720068|537732373|FG014|Overall Study|Adverse Event|0|||
149067564|NCT02720068|537732374|FG015|Overall Study|Adverse Event|0|||
149067565|NCT02720068|537732375|FG016|Overall Study|Adverse Event|0|||
149067566|NCT02720068|537732376|FG017|Overall Study|Adverse Event|0|||
149067567|NCT02720068|537732359|FG000|Overall Study|Death|1|||
149067568|NCT02720068|537732360|FG001|Overall Study|Death|3|||
149067569|NCT02720068|537732361|FG002|Overall Study|Death|2|||
149067570|NCT02720068|537732362|FG003|Overall Study|Death|1|||
149067571|NCT02720068|537732363|FG004|Overall Study|Death|2|||
149067572|NCT02720068|537732364|FG005|Overall Study|Death|1|||
149067573|NCT02720068|537732365|FG006|Overall Study|Death|2|||
149067574|NCT02720068|537732366|FG007|Overall Study|Death|2|||
149067575|NCT02720068|537732367|FG008|Overall Study|Death|3|||
149067576|NCT02720068|537732368|FG009|Overall Study|Death|1|||
149067577|NCT02720068|537732369|FG010|Overall Study|Death|20|||
149067578|NCT02720068|537732370|FG011|Overall Study|Death|166|||
149067579|NCT02720068|537732371|FG012|Overall Study|Death|34|||
149067580|NCT02720068|537732372|FG013|Overall Study|Death|30|||
149067581|NCT02720068|537732373|FG014|Overall Study|Death|45|||
149067582|NCT02720068|537732374|FG015|Overall Study|Death|16|||
149067583|NCT02720068|537732375|FG016|Overall Study|Death|20|||
149067584|NCT02720068|537732376|FG017|Overall Study|Death|28|||
149067585|NCT02720068|537732359|FG000|Overall Study|Lost to Follow-up|0|||
149067586|NCT02720068|537732360|FG001|Overall Study|Lost to Follow-up|0|||
149067587|NCT02720068|537732361|FG002|Overall Study|Lost to Follow-up|0|||
149067588|NCT02720068|537732362|FG003|Overall Study|Lost to Follow-up|0|||
149067589|NCT02720068|537732363|FG004|Overall Study|Lost to Follow-up|0|||
149067590|NCT02720068|537732364|FG005|Overall Study|Lost to Follow-up|0|||
149067591|NCT02720068|537732365|FG006|Overall Study|Lost to Follow-up|0|||
149067592|NCT02720068|537732366|FG007|Overall Study|Lost to Follow-up|0|||
149067593|NCT02720068|537732367|FG008|Overall Study|Lost to Follow-up|0|||
149067594|NCT02720068|537732368|FG009|Overall Study|Lost to Follow-up|0|||
149067595|NCT02720068|537732369|FG010|Overall Study|Lost to Follow-up|0|||
149067596|NCT02720068|537732370|FG011|Overall Study|Lost to Follow-up|1|||
149067597|NCT02720068|537732371|FG012|Overall Study|Lost to Follow-up|0|||
149067598|NCT02720068|537732372|FG013|Overall Study|Lost to Follow-up|1|||
149067599|NCT02720068|537732373|FG014|Overall Study|Lost to Follow-up|2|||
149067600|NCT02720068|537732374|FG015|Overall Study|Lost to Follow-up|0|||
149067601|NCT02720068|537732375|FG016|Overall Study|Lost to Follow-up|0|||
149067602|NCT02720068|537732376|FG017|Overall Study|Lost to Follow-up|1|||
149067603|NCT02720068|537732359|FG000|Overall Study|Physician Decision|0|||
149067604|NCT02720068|537732360|FG001|Overall Study|Physician Decision|0|||
149067605|NCT02720068|537732361|FG002|Overall Study|Physician Decision|0|||
149067606|NCT02720068|537732362|FG003|Overall Study|Physician Decision|1|||
149067607|NCT02720068|537732363|FG004|Overall Study|Physician Decision|0|||
149067608|NCT02720068|537732364|FG005|Overall Study|Physician Decision|0|||
149067609|NCT02720068|537732365|FG006|Overall Study|Physician Decision|0|||
149067610|NCT02720068|537732366|FG007|Overall Study|Physician Decision|0|||
149067611|NCT02720068|537732367|FG008|Overall Study|Physician Decision|0|||
149067612|NCT02720068|537732368|FG009|Overall Study|Physician Decision|0|||
149067613|NCT02720068|537732369|FG010|Overall Study|Physician Decision|0|||
149067614|NCT02720068|537732370|FG011|Overall Study|Physician Decision|1|||
149067615|NCT02720068|537732371|FG012|Overall Study|Physician Decision|0|||
149067616|NCT02720068|537732372|FG013|Overall Study|Physician Decision|0|||
149067617|NCT02720068|537732373|FG014|Overall Study|Physician Decision|0|||
149067618|NCT02720068|537732374|FG015|Overall Study|Physician Decision|0|||
149067619|NCT02720068|537732375|FG016|Overall Study|Physician Decision|0|||
149067620|NCT02720068|537732376|FG017|Overall Study|Physician Decision|1|||
149067621|NCT02720068|537732359|FG000|Overall Study|Progressive Disease|2|||
149067622|NCT02720068|537732360|FG001|Overall Study|Progressive Disease|3|||
149067623|NCT02720068|537732361|FG002|Overall Study|Progressive Disease|1|||
149067624|NCT02720068|537732362|FG003|Overall Study|Progressive Disease|1|||
149067625|NCT02720068|537732363|FG004|Overall Study|Progressive Disease|1|||
149067626|NCT02720068|537732364|FG005|Overall Study|Progressive Disease|2|||
149067627|NCT02720068|537732365|FG006|Overall Study|Progressive Disease|1|||
149067628|NCT02720068|537732366|FG007|Overall Study|Progressive Disease|1|||
149067629|NCT02720068|537732367|FG008|Overall Study|Progressive Disease|0|||
149067630|NCT02720068|537732368|FG009|Overall Study|Progressive Disease|1|||
149067631|NCT02720068|537732369|FG010|Overall Study|Progressive Disease|0|||
149067632|NCT02720068|537732370|FG011|Overall Study|Progressive Disease|4|||
149067633|NCT02720068|537732371|FG012|Overall Study|Progressive Disease|1|||
149067634|NCT02720068|537732372|FG013|Overall Study|Progressive Disease|0|||
149067635|NCT02720068|537732373|FG014|Overall Study|Progressive Disease|0|||
149067636|NCT02720068|537732374|FG015|Overall Study|Progressive Disease|0|||
149067637|NCT02720068|537732375|FG016|Overall Study|Progressive Disease|0|||
149067638|NCT02720068|537732376|FG017|Overall Study|Progressive Disease|0|||
149067639|NCT02720068|537732359|FG000|Overall Study|Sponsor Decision|0|||
149067640|NCT02720068|537732360|FG001|Overall Study|Sponsor Decision|0|||
149067641|NCT02720068|537732361|FG002|Overall Study|Sponsor Decision|0|||
149067642|NCT02720068|537732362|FG003|Overall Study|Sponsor Decision|0|||
149067643|NCT02720068|537732363|FG004|Overall Study|Sponsor Decision|0|||
149067644|NCT02720068|537732364|FG005|Overall Study|Sponsor Decision|0|||
149067645|NCT02720068|537732365|FG006|Overall Study|Sponsor Decision|0|||
149067646|NCT02720068|537732366|FG007|Overall Study|Sponsor Decision|0|||
149067647|NCT02720068|537732367|FG008|Overall Study|Sponsor Decision|0|||
149067648|NCT02720068|537732368|FG009|Overall Study|Sponsor Decision|0|||
149067649|NCT02720068|537732369|FG010|Overall Study|Sponsor Decision|0|||
149067650|NCT02720068|537732370|FG011|Overall Study|Sponsor Decision|6|||
149067651|NCT02720068|537732371|FG012|Overall Study|Sponsor Decision|3|||
149067652|NCT02720068|537732372|FG013|Overall Study|Sponsor Decision|2|||
149067653|NCT02720068|537732373|FG014|Overall Study|Sponsor Decision|4|||
149067654|NCT02720068|537732374|FG015|Overall Study|Sponsor Decision|4|||
149067655|NCT02720068|537732375|FG016|Overall Study|Sponsor Decision|0|||
149067656|NCT02720068|537732376|FG017|Overall Study|Sponsor Decision|8|||
149067657|NCT02720068|537732359|FG000|Overall Study|Withdrawal by Subject|0|||
149067658|NCT02720068|537732360|FG001|Overall Study|Withdrawal by Subject|0|||
149067659|NCT02720068|537732361|FG002|Overall Study|Withdrawal by Subject|0|||
149067660|NCT02720068|537732362|FG003|Overall Study|Withdrawal by Subject|0|||
149067661|NCT02720068|537732363|FG004|Overall Study|Withdrawal by Subject|0|||
149067662|NCT02720068|537732364|FG005|Overall Study|Withdrawal by Subject|0|||
149067663|NCT02720068|537732365|FG006|Overall Study|Withdrawal by Subject|0|||
149067664|NCT02720068|537732366|FG007|Overall Study|Withdrawal by Subject|0|||
149120218|NCT04602221|537918067|FG010|Overall Study|Other than listed|0|||
149067665|NCT02720068|537732367|FG008|Overall Study|Withdrawal by Subject|0|||
149067666|NCT02720068|537732368|FG009|Overall Study|Withdrawal by Subject|1|||
149067667|NCT02720068|537732369|FG010|Overall Study|Withdrawal by Subject|0|||
149067668|NCT02720068|537732370|FG011|Overall Study|Withdrawal by Subject|27|||
149067669|NCT02720068|537732371|FG012|Overall Study|Withdrawal by Subject|2|||
149067670|NCT02720068|537732372|FG013|Overall Study|Withdrawal by Subject|8|||
149067671|NCT02720068|537732373|FG014|Overall Study|Withdrawal by Subject|7|||
149067672|NCT02720068|537732374|FG015|Overall Study|Withdrawal by Subject|0|||
149067673|NCT02720068|537732375|FG016|Overall Study|Withdrawal by Subject|0|||
149067674|NCT02720068|537732376|FG017|Overall Study|Withdrawal by Subject|2|||
149067675|NCT02720068|537732359|FG000|Overall Study|Protocol Violation|0|||
149067676|NCT02720068|537732360|FG001|Overall Study|Protocol Violation|0|||
149067677|NCT02720068|537732361|FG002|Overall Study|Protocol Violation|0|||
149067678|NCT02720068|537732362|FG003|Overall Study|Protocol Violation|0|||
149067679|NCT02720068|537732363|FG004|Overall Study|Protocol Violation|0|||
149067680|NCT02720068|537732364|FG005|Overall Study|Protocol Violation|0|||
149067681|NCT02720068|537732365|FG006|Overall Study|Protocol Violation|0|||
149067682|NCT02720068|537732366|FG007|Overall Study|Protocol Violation|0|||
149067683|NCT02720068|537732367|FG008|Overall Study|Protocol Violation|0|||
149067684|NCT02720068|537732368|FG009|Overall Study|Protocol Violation|0|||
149067685|NCT02720068|537732369|FG010|Overall Study|Protocol Violation|1|||
149067686|NCT02720068|537732370|FG011|Overall Study|Protocol Violation|0|||
149067687|NCT02720068|537732371|FG012|Overall Study|Protocol Violation|0|||
149067688|NCT02720068|537732372|FG013|Overall Study|Protocol Violation|0|||
149067689|NCT02720068|537732373|FG014|Overall Study|Protocol Violation|1|||
149067690|NCT02720068|537732374|FG015|Overall Study|Protocol Violation|0|||
149067691|NCT02720068|537732375|FG016|Overall Study|Protocol Violation|1|||
149067692|NCT02720068|537732376|FG017|Overall Study|Protocol Violation|0|||
149067693|NCT04664881|537732379|FG000|Overall Study|Withdrawal by Subject|1|||
149067694|NCT04664881|537732380|FG001|Overall Study|Withdrawal by Subject|8|||
149067695|NCT04664881|537732379|FG000|Overall Study|Physician Decision|0|||
149067696|NCT04664881|537732380|FG001|Overall Study|Physician Decision|5|||
149067697|NCT04664881|537732379|FG000|Overall Study|Lost to Follow-up|1|||
149067698|NCT04664881|537732380|FG001|Overall Study|Lost to Follow-up|0|||
149067699|NCT04772534|537732384|FG000|Overall Study|Physician Decision|1|||
149067700|NCT04772534|537732385|FG001|Overall Study|Physician Decision|0|||
149067701|NCT04772534|537732386|FG002|Overall Study|Physician Decision|0|||
149067702|NCT04772534|537732384|FG000|Overall Study|Withdrawal by Subject|3|||
149067703|NCT04772534|537732385|FG001|Overall Study|Withdrawal by Subject|0|||
149067704|NCT04772534|537732386|FG002|Overall Study|Withdrawal by Subject|1|||
149067705|NCT04194450|537732387|FG000|Overall Study|not eligible|1|||
149067706|NCT04194450|537732388|FG001|Overall Study|not eligible|0|||
149067707|NCT03816397|537732389|FG000|Overall Study|Censored at interim analysis date.|13|||
149067708|NCT03816397|537732390|FG001|Overall Study|Censored at interim analysis date.|6|||
149067709|NCT03816397|537732389|FG000|Overall Study|Withdrawal by Subject|1|||
149067710|NCT03816397|537732390|FG001|Overall Study|Withdrawal by Subject|1|||
149067711|NCT04093869|537732407|FG000|Overall Study|Death|0|||
149067712|NCT04093869|537732408|FG001|Overall Study|Death|1|||
149067713|NCT04093869|537732407|FG000|Overall Study|Withdrawal by Subject|1|||
149067714|NCT04093869|537732408|FG001|Overall Study|Withdrawal by Subject|0|||
149067715|NCT04281498|537732411|FG000|Overall Study|Progression of disease|1|||
149067716|NCT04281498|537732411|FG000|Overall Study|Planned SCT|1|||
149067717|NCT04281498|537732411|FG000|Overall Study|Alternative Treatment|1|||
149067718|NCT03587805|537732412|FG000|Overall Study|Adverse Event|72|||
149067719|NCT03587805|537732412|FG000|Overall Study|Death|1|||
149067720|NCT03587805|537732412|FG000|Overall Study|Lost to Follow-up|78|||
149067721|NCT03587805|537732412|FG000|Overall Study|Withdrawal by Subject|105|||
149067722|NCT03587805|537732412|FG000|Overall Study|Lack of Efficacy|119|||
149067723|NCT03587805|537732412|FG000|Overall Study|Reason unknown|26|||
149067724|NCT03587805|537732412|FG000|Overall Study|COVID_19 pandemic|4|||
149067725|NCT03587805|537732412|FG000|Overall Study|Various reasons|121|||
149067726|NCT03587805|537732412|FG000|Overall Study|Withdrawal by parent/guardian|3|||
149067727|NCT01220531|537732413|FG000|Overall Study|Death|7|||
149067728|NCT01220531|537732413|FG000|Overall Study|Lost to Follow-up|1|||
149067729|NCT01553149|537732414|FG000|Overall Study|Adverse Event|0|||
149067730|NCT01553149|537732415|FG001|Overall Study|Adverse Event|9|||
149067731|NCT01553149|537732414|FG000|Overall Study|Physician Decision|5|||
149067732|NCT01553149|537732415|FG001|Overall Study|Physician Decision|10|||
149067733|NCT01553149|537732414|FG000|Overall Study|Ineligible|0|||
149067734|NCT01553149|537732415|FG001|Overall Study|Ineligible|1|||
149067735|NCT05866926|537732416|FG000|Overall Study|Death|16|||
149067736|NCT05866926|537732417|FG001|Overall Study|Death|9|||
149067737|NCT05866926|537732416|FG000|Overall Study|Lost to Follow-up|0|||
149067738|NCT05866926|537732417|FG001|Overall Study|Lost to Follow-up|1|||
149067739|NCT05866926|537732416|FG000|Overall Study|Adverse Event|1|||
149067740|NCT05866926|537732417|FG001|Overall Study|Adverse Event|0|||
149067741|NCT05866926|537732416|FG000|Overall Study|Withdrawal by Subject|5|||
149067742|NCT05866926|537732417|FG001|Overall Study|Withdrawal by Subject|1|||
149067743|NCT05866926|537732416|FG000|Overall Study|Disease progression|1|||
149067744|NCT05866926|537732417|FG001|Overall Study|Disease progression|0|||
149067745|NCT05866926|537732416|FG000|Overall Study|other causes|2|||
149067746|NCT05866926|537732417|FG001|Overall Study|other causes|1|||
149067747|NCT00709956|537732418|FG000|Overall Study|Withdrawal by Subject|1|||
149067748|NCT00709956|537732419|FG001|Overall Study|Withdrawal by Subject|1|||
149067749|NCT00709956|537732418|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
149067750|NCT00709956|537732419|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
149067751|NCT01105091|537732420|FG000|Overall Study|Death|2|||
149067752|NCT01105091|537732421|FG001|Overall Study|Death|0|||
149067753|NCT04518943|537733226|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
149067754|NCT04518943|537733227|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
149067755|NCT04518943|537733228|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
149067756|NCT04518943|537733229|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
149067757|NCT04518943|537733230|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
149067758|NCT04518943|537733231|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
149067759|NCT04518943|537733232|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
149067760|NCT04518943|537733233|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
149067761|NCT04518943|537733234|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
149067762|NCT04518943|537733235|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
149067763|NCT04518943|537733236|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
149067764|NCT04518943|537733237|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
149067765|NCT04518943|537733238|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
149067766|NCT04518943|537733239|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
149067767|NCT04518943|537733240|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
149067768|NCT04518943|537733241|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
149067769|NCT03705793|537733245|FG000|Overall Study|Lost to Follow-up|3|||
149067770|NCT03705793|537733246|FG001|Overall Study|Lost to Follow-up|4|||
149067771|NCT03705793|537733245|FG000|Overall Study|Withdrawal by Subject|2|||
149067772|NCT03705793|537733246|FG001|Overall Study|Withdrawal by Subject|1|||
149067773|NCT02467270|537733257|FG000|Overall Study|Participants Never Treated|0|||
149067774|NCT02467270|537733258|FG001|Overall Study|Participants Never Treated|1|||
149067775|NCT02467270|537733259|FG002|Overall Study|Participants Never Treated|0|||
149067776|NCT02467270|537733257|FG000|Overall Study|Ongoing|50|||
149067777|NCT02467270|537733258|FG001|Overall Study|Ongoing|41|||
149067778|NCT02467270|537733259|FG002|Overall Study|Ongoing|43|||
149067779|NCT02467270|537733257|FG000|Overall Study|Adverse Event|16|||
149067780|NCT02467270|537733258|FG001|Overall Study|Adverse Event|15|||
149067781|NCT02467270|537733259|FG002|Overall Study|Adverse Event|14|||
149067782|NCT02467270|537733257|FG000|Overall Study|Progressive Disease|7|||
149067783|NCT02467270|537733258|FG001|Overall Study|Progressive Disease|7|||
149067784|NCT02467270|537733259|FG002|Overall Study|Progressive Disease|4|||
149067785|NCT02467270|537733257|FG000|Overall Study|Death|2|||
149067786|NCT02467270|537733258|FG001|Overall Study|Death|0|||
149067787|NCT02467270|537733259|FG002|Overall Study|Death|2|||
149067788|NCT02467270|537733257|FG000|Overall Study|Lack of Efficacy|12|||
149067789|NCT02467270|537733258|FG001|Overall Study|Lack of Efficacy|18|||
149067790|NCT02467270|537733259|FG002|Overall Study|Lack of Efficacy|23|||
149067791|NCT02467270|537733257|FG000|Overall Study|Non-compliance With Study Drug|0|||
149067792|NCT02467270|537733258|FG001|Overall Study|Non-compliance With Study Drug|2|||
149067793|NCT02467270|537733259|FG002|Overall Study|Non-compliance With Study Drug|1|||
149067794|NCT02467270|537733257|FG000|Overall Study|Lost to Follow-up|2|||
149067795|NCT02467270|537733258|FG001|Overall Study|Lost to Follow-up|1|||
149067796|NCT02467270|537733259|FG002|Overall Study|Lost to Follow-up|0|||
149067797|NCT02467270|537733257|FG000|Overall Study|Pregnancy|0|||
149067798|NCT02467270|537733258|FG001|Overall Study|Pregnancy|1|||
149067799|NCT02467270|537733259|FG002|Overall Study|Pregnancy|0|||
149067800|NCT02467270|537733257|FG000|Overall Study|Physician Decision|0|||
149067801|NCT02467270|537733258|FG001|Overall Study|Physician Decision|4|||
149067802|NCT02467270|537733259|FG002|Overall Study|Physician Decision|1|||
149067803|NCT02467270|537733257|FG000|Overall Study|Withdrawal by Subject|4|||
149067804|NCT02467270|537733258|FG001|Overall Study|Withdrawal by Subject|3|||
149067805|NCT02467270|537733259|FG002|Overall Study|Withdrawal by Subject|5|||
149067806|NCT02467270|537733257|FG000|Overall Study|Reason not Specified|1|||
149067807|NCT02467270|537733258|FG001|Overall Study|Reason not Specified|2|||
149067808|NCT02467270|537733259|FG002|Overall Study|Reason not Specified|1|||
149067809|NCT04757753|537733280|FG000|Overall Study|Lost to Follow-up|7|||
149067810|NCT04757753|537733281|FG001|Overall Study|Lost to Follow-up|7|||
149067811|NCT04757753|537733280|FG000|Overall Study|Withdrawal by Subject|0|||
149067812|NCT04757753|537733281|FG001|Overall Study|Withdrawal by Subject|3|||
149067813|NCT04757753|537733280|FG000|Overall Study|Endodontic treatment failure|1|||
149067814|NCT04757753|537733281|FG001|Overall Study|Endodontic treatment failure|2|||
149067815|NCT04757753|537733280|FG000|Overall Study|Tooth fracture/extraction|3|||
149067816|NCT04757753|537733281|FG001|Overall Study|Tooth fracture/extraction|0|||
149067817|NCT03142009|537733306|FG000|Overall Study|Lost to Follow-up|45|||
149067818|NCT03142009|537733307|FG001|Overall Study|Lost to Follow-up|30|||
149067819|NCT04940624|537733311|FG000|Overall Study|Adverse Event|4|||
149067820|NCT04940624|537733312|FG001|Overall Study|Adverse Event|11|||
149067821|NCT04940624|537733311|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
149067822|NCT04940624|537733312|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
149067823|NCT04940624|537733311|FG000|Overall Study|Physician Decision|1|||
149067824|NCT04940624|537733312|FG001|Overall Study|Physician Decision|0|||
149067825|NCT04940624|537733311|FG000|Overall Study|Lost to Follow-up|1|||
149067826|NCT04940624|537733312|FG001|Overall Study|Lost to Follow-up|0|||
149067827|NCT04940624|537733311|FG000|Overall Study|Reason Not Specified|1|||
149067828|NCT04940624|537733312|FG001|Overall Study|Reason Not Specified|0|||
149067829|NCT03008382|537733313|FG000|Overall Study|Withdrawal by Subject|2|||
149067830|NCT03008382|537733314|FG001|Overall Study|Withdrawal by Subject|5|||
149067831|NCT03008382|537733315|FG002|Overall Study|Withdrawal by Subject|2|||
149067832|NCT03008382|537733316|FG003|Overall Study|Withdrawal by Subject|0|||
149067833|NCT03008382|537733313|FG000|Overall Study|Protocol Violation|1|||
149067834|NCT03008382|537733314|FG001|Overall Study|Protocol Violation|0|||
149067835|NCT03008382|537733315|FG002|Overall Study|Protocol Violation|0|||
149067836|NCT03008382|537733316|FG003|Overall Study|Protocol Violation|0|||
149067837|NCT03008382|537733313|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
149067838|NCT03008382|537733314|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
149067839|NCT03008382|537733315|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
149067840|NCT03008382|537733316|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
149067841|NCT03008382|537733313|FG000|Overall Study|Lost to Follow-up|0|||
149067842|NCT03008382|537733314|FG001|Overall Study|Lost to Follow-up|0|||
149067843|NCT03008382|537733315|FG002|Overall Study|Lost to Follow-up|1|||
149067844|NCT03008382|537733316|FG003|Overall Study|Lost to Follow-up|0|||
149067845|NCT03008382|537733313|FG000|Overall Study|Screenfail|0|||
149067846|NCT03008382|537733314|FG001|Overall Study|Screenfail|0|||
149067847|NCT03008382|537733315|FG002|Overall Study|Screenfail|2|||
149067848|NCT03008382|537733316|FG003|Overall Study|Screenfail|0|||
149067849|NCT03215706|537733318|FG000|Randomization|Adverse Event unrelated to study drug|1|||
149067850|NCT03215706|537733319|FG001|Randomization|Adverse Event unrelated to study drug|0|||
149067851|NCT03215706|537733318|FG000|Randomization|participant withdrew consent|1|||
149067852|NCT03215706|537733319|FG001|Randomization|participant withdrew consent|3|||
149067853|NCT03215706|537733318|FG000|Randomization|no longer meets study criteria|1|||
149067854|NCT03215706|537733319|FG001|Randomization|no longer meets study criteria|4|||
149067855|NCT03215706|537733318|FG000|Randomization|other reasons|0|||
149067856|NCT03215706|537733319|FG001|Randomization|other reasons|2|||
149067857|NCT03215706|537733318|FG000|Treatment Period|Disease Progression|150|||
149067858|NCT03215706|537733319|FG001|Treatment Period|Disease Progression|142|||
149067859|NCT03215706|537733318|FG000|Treatment Period|Study Drug Toxicity|53|||
149067860|NCT03215706|537733319|FG001|Treatment Period|Study Drug Toxicity|21|||
149067861|NCT03215706|537733318|FG000|Treatment Period|Death|2|||
149067862|NCT03215706|537733319|FG001|Treatment Period|Death|1|||
149067863|NCT03215706|537733318|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
149067864|NCT03215706|537733319|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
149067865|NCT03215706|537733318|FG000|Treatment Period|Request to D/C treatment|1|||
149067866|NCT03215706|537733319|FG001|Treatment Period|Request to D/C treatment|6|||
149067867|NCT03215706|537733318|FG000|Treatment Period|Participant withdrew consent|3|||
149067868|NCT03215706|537733319|FG001|Treatment Period|Participant withdrew consent|4|||
149067869|NCT03215706|537733318|FG000|Treatment Period|Lost to Follow-up|0|||
149067870|NCT03215706|537733319|FG001|Treatment Period|Lost to Follow-up|1|||
149067871|NCT03215706|537733318|FG000|Treatment Period|Other Reasons|4|||
149067872|NCT03215706|537733319|FG001|Treatment Period|Other Reasons|5|||
149067873|NCT03215706|537733318|FG000|Treatment Period|Ongoing in the treatment period|105|||
149067874|NCT03215706|537733319|FG001|Treatment Period|Ongoing in the treatment period|43|||
149067875|NCT05267639|537734096|FG000|Overall Study|Withdrawal by Subject|1|||
149067876|NCT05267639|537734097|FG001|Overall Study|Withdrawal by Subject|0|||
149067877|NCT05180539|537734108|FG000|Overall Study|Lost to Follow-up|27|||
149067878|NCT05180539|537734109|FG001|Overall Study|Lost to Follow-up|30|||
149067879|NCT00994643|537734112|FG000|Overall Study|Withdrawal by Subject|1|||
149067880|NCT00968149|537734114|FG000|Overall Study|Adverse Event|5|||
149067881|NCT00968149|537734115|FG001|Overall Study|Adverse Event|1|||
149067882|NCT00968149|537734114|FG000|Overall Study|Lack of Efficacy|0|||
149067883|NCT00968149|537734115|FG001|Overall Study|Lack of Efficacy|4|||
149067884|NCT00968149|537734114|FG000|Overall Study|Lost to Follow-up|0|||
149067885|NCT00968149|537734115|FG001|Overall Study|Lost to Follow-up|1|||
149067886|NCT00968149|537734114|FG000|Overall Study|Protocol Violation|4|||
149067887|NCT00968149|537734115|FG001|Overall Study|Protocol Violation|0|||
149067888|NCT00968149|537734114|FG000|Overall Study|Withdrawal by Subject|2|||
149067889|NCT00968149|537734115|FG001|Overall Study|Withdrawal by Subject|0|||
149067890|NCT00447980|537734116|FG000|Overall Study|Withdrawal by Subject|1|||
149067891|NCT00447980|537734117|FG001|Overall Study|Withdrawal by Subject|1|||
149067892|NCT00447980|537734118|FG002|Overall Study|Withdrawal by Subject|4|||
149067893|NCT00447980|537734119|FG003|Overall Study|Withdrawal by Subject|4|||
149067894|NCT00447980|537734116|FG000|Overall Study|Lost to Follow-up|1|||
149067895|NCT00447980|537734117|FG001|Overall Study|Lost to Follow-up|1|||
149067896|NCT00447980|537734118|FG002|Overall Study|Lost to Follow-up|0|||
149067897|NCT00447980|537734119|FG003|Overall Study|Lost to Follow-up|0|||
149067898|NCT00447980|537734116|FG000|Overall Study|Did not proceed with surgery|3|||
149067899|NCT00447980|537734117|FG001|Overall Study|Did not proceed with surgery|3|||
149067900|NCT00447980|537734118|FG002|Overall Study|Did not proceed with surgery|2|||
149067901|NCT00447980|537734119|FG003|Overall Study|Did not proceed with surgery|2|||
149067902|NCT00113360|537734120|FG000|Overall Study|Adverse Event|3|||
149067903|NCT00113360|537734120|FG000|Overall Study|Subject required surgery|1|||
149067904|NCT00113360|537734120|FG000|Overall Study|Did not meet eligibility criteria|3|||
149067905|NCT02231749|537734126|FG000|Overall Study|Disease progression|229|||
149067906|NCT02231749|537734127|FG001|Overall Study|Disease progression|297|||
149067907|NCT02231749|537734126|FG000|Overall Study|Study Drug Toxicity|134|||
149067908|NCT02231749|537734127|FG001|Overall Study|Study Drug Toxicity|63|||
149067909|NCT02231749|537734126|FG000|Overall Study|Death|1|||
149067910|NCT02231749|537734127|FG001|Overall Study|Death|1|||
149067911|NCT02231749|537734126|FG000|Overall Study|AE unrelated to Study drug|32|||
149067912|NCT02231749|537734127|FG001|Overall Study|AE unrelated to Study drug|31|||
149067913|NCT02231749|537734126|FG000|Overall Study|Participant's request to discontinue|10|||
149067914|NCT02231749|537734127|FG001|Overall Study|Participant's request to discontinue|21|||
149067915|NCT02231749|537734126|FG000|Overall Study|Participant withdrew Consent|8|||
149067916|NCT02231749|537734127|FG001|Overall Study|Participant withdrew Consent|15|||
149067917|NCT02231749|537734126|FG000|Overall Study|Lost to Follow-up|1|||
149067918|NCT02231749|537734127|FG001|Overall Study|Lost to Follow-up|2|||
149067919|NCT02231749|537734126|FG000|Overall Study|Maximum Clinical Benefit|5|||
149067920|NCT02231749|537734127|FG001|Overall Study|Maximum Clinical Benefit|8|||
149067921|NCT02231749|537734126|FG000|Overall Study|Poor/Non-Compliance|0|||
149067922|NCT02231749|537734127|FG001|Overall Study|Poor/Non-Compliance|3|||
149067923|NCT02231749|537734126|FG000|Overall Study|Pregnancy|1|||
149067924|NCT02231749|537734127|FG001|Overall Study|Pregnancy|0|||
149067925|NCT02231749|537734126|FG000|Overall Study|other|0|||
149067926|NCT02231749|537734127|FG001|Overall Study|other|8|||
149067927|NCT02231749|537734126|FG000|Overall Study|No longer meets Study Criteria|1|||
149067928|NCT02231749|537734127|FG001|Overall Study|No longer meets Study Criteria|0|||
149067929|NCT03705390|537734128|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
149067930|NCT03705390|537734128|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
149067931|NCT02989662|537734130|FG000|Overall Study|Lost to Follow-up|0|||
149067932|NCT02989662|537734131|FG001|Overall Study|Lost to Follow-up|0|||
149067933|NCT02989662|537734132|FG002|Overall Study|Lost to Follow-up|0|||
149067934|NCT02989662|537734133|FG003|Overall Study|Lost to Follow-up|2|||
149067935|NCT02989662|537734130|FG000|Overall Study|Physician Decision|3|||
149067936|NCT02989662|537734131|FG001|Overall Study|Physician Decision|0|||
149067937|NCT02989662|537734132|FG002|Overall Study|Physician Decision|0|||
149067938|NCT02989662|537734133|FG003|Overall Study|Physician Decision|0|||
149067939|NCT02989662|537734130|FG000|Overall Study|Withdrawal by Subject|1|||
149067940|NCT02989662|537734131|FG001|Overall Study|Withdrawal by Subject|0|||
149067941|NCT02989662|537734132|FG002|Overall Study|Withdrawal by Subject|0|||
149067942|NCT02989662|537734133|FG003|Overall Study|Withdrawal by Subject|0|||
149067943|NCT00357682|537734134|FG000|Overall Study|Did not receive allocated Treatment|10|||
149067944|NCT00357682|537734135|FG001|Overall Study|Did not receive allocated Treatment|9|||
149067945|NCT00357682|537734136|FG002|Overall Study|Did not receive allocated Treatment|9|||
149067946|NCT00357682|537734137|FG003|Overall Study|Did not receive allocated Treatment|10|||
149067947|NCT00357682|537734134|FG000|Overall Study|Withdrew consent|6|||
149067948|NCT00357682|537734135|FG001|Overall Study|Withdrew consent|6|||
149067949|NCT00357682|537734136|FG002|Overall Study|Withdrew consent|5|||
149067950|NCT00357682|537734137|FG003|Overall Study|Withdrew consent|5|||
149067951|NCT00357682|537734134|FG000|Overall Study|Lost to Follow-up|39|||
149067952|NCT00357682|537734135|FG001|Overall Study|Lost to Follow-up|33|||
149067953|NCT00357682|537734136|FG002|Overall Study|Lost to Follow-up|26|||
149067954|NCT00357682|537734137|FG003|Overall Study|Lost to Follow-up|35|||
149067955|NCT00357682|537734134|FG000|Overall Study|Adverse Event|24|||
149067956|NCT00357682|537734135|FG001|Overall Study|Adverse Event|32|||
149067957|NCT00357682|537734136|FG002|Overall Study|Adverse Event|22|||
149067958|NCT00357682|537734137|FG003|Overall Study|Adverse Event|27|||
149067959|NCT00357682|537734134|FG000|Overall Study|Physician Decision|32|||
149067960|NCT00357682|537734135|FG001|Overall Study|Physician Decision|20|||
149067961|NCT00357682|537734136|FG002|Overall Study|Physician Decision|24|||
149067962|NCT00357682|537734137|FG003|Overall Study|Physician Decision|30|||
149067963|NCT00357682|537734134|FG000|Overall Study|Patient decision|73|||
149067964|NCT00357682|537734135|FG001|Overall Study|Patient decision|80|||
149067965|NCT00357682|537734136|FG002|Overall Study|Patient decision|51|||
149067966|NCT00357682|537734137|FG003|Overall Study|Patient decision|59|||
149067967|NCT00357682|537734134|FG000|Overall Study|Other reason|157|||
149067968|NCT00357682|537734135|FG001|Overall Study|Other reason|130|||
149067969|NCT00357682|537734136|FG002|Overall Study|Other reason|114|||
149067970|NCT00357682|537734137|FG003|Overall Study|Other reason|99|||
149067971|NCT03660930|537734139|FG000|Overall Study|Adverse Event|0|||
149067972|NCT03660930|537734140|FG001|Overall Study|Adverse Event|0|||
149067973|NCT03660930|537734141|FG002|Overall Study|Adverse Event|0|||
149067974|NCT03660930|537734142|FG003|Overall Study|Adverse Event|2|||
149067975|NCT03660930|537734143|FG004|Overall Study|Adverse Event|0|||
149067976|NCT03660930|537734144|FG005|Overall Study|Adverse Event|1|||
149067977|NCT03660930|537734145|FG006|Overall Study|Adverse Event|0|||
149067978|NCT03660930|537734146|FG007|Overall Study|Adverse Event|0|||
149067979|NCT03660930|537734139|FG000|Overall Study|Withdrawal by Subject|0|||
149067980|NCT03660930|537734140|FG001|Overall Study|Withdrawal by Subject|0|||
149067981|NCT03660930|537734141|FG002|Overall Study|Withdrawal by Subject|0|||
149067982|NCT03660930|537734142|FG003|Overall Study|Withdrawal by Subject|0|||
149067983|NCT03660930|537734143|FG004|Overall Study|Withdrawal by Subject|0|||
149067984|NCT03660930|537734144|FG005|Overall Study|Withdrawal by Subject|1|||
149067985|NCT03660930|537734145|FG006|Overall Study|Withdrawal by Subject|0|||
149067986|NCT03660930|537734146|FG007|Overall Study|Withdrawal by Subject|0|||
149067987|NCT02656706|537734149|FG000|Overall Study|Insurance Denial|1|||
149067988|NCT03725332|537734150|FG000|Overall Study|Adverse Event|5|||
149067989|NCT03725332|537734151|FG001|Overall Study|Adverse Event|10|||
149067990|NCT03725332|537734150|FG000|Overall Study|Death|1|||
149067991|NCT03725332|537734151|FG001|Overall Study|Death|3|||
149067992|NCT03725332|537734150|FG000|Overall Study|Lost to Follow-up|43|||
149067993|NCT03725332|537734151|FG001|Overall Study|Lost to Follow-up|122|||
149067994|NCT03725332|537734150|FG000|Overall Study|Withdrawal by Subject|0|||
149067995|NCT03725332|537734151|FG001|Overall Study|Withdrawal by Subject|1|||
149067996|NCT03725332|537734150|FG000|Overall Study|Duplicate enrollment|0|||
149067997|NCT03725332|537734151|FG001|Overall Study|Duplicate enrollment|1|||
149067998|NCT03725332|537734150|FG000|Overall Study|Did not consent|0|||
149067999|NCT03725332|537734151|FG001|Overall Study|Did not consent|1|||
149068000|NCT03201939|537734158|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
149068001|NCT03201939|537734159|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
149068002|NCT03333915|537734160|FG000|Overall Study|Lost to Follow-up|0|||
149068003|NCT03333915|537734161|FG001|Overall Study|Lost to Follow-up|0|||
149068004|NCT03333915|537734162|FG002|Overall Study|Lost to Follow-up|1|||
149068005|NCT03333915|537734163|FG003|Overall Study|Lost to Follow-up|0|||
149068006|NCT03333915|537734164|FG004|Overall Study|Lost to Follow-up|0|||
149068007|NCT03333915|537734160|FG000|Overall Study|Disease Progression|0|||
149068008|NCT03333915|537734161|FG001|Overall Study|Disease Progression|1|||
149068009|NCT03333915|537734162|FG002|Overall Study|Disease Progression|0|||
149068010|NCT03333915|537734163|FG003|Overall Study|Disease Progression|0|||
149068011|NCT03333915|537734164|FG004|Overall Study|Disease Progression|0|||
149068012|NCT03333915|537734160|FG000|Overall Study|Death|0|||
149068013|NCT03333915|537734161|FG001|Overall Study|Death|0|||
149068014|NCT03333915|537734162|FG002|Overall Study|Death|0|||
149068015|NCT03333915|537734163|FG003|Overall Study|Death|37|||
149068016|NCT03333915|537734164|FG004|Overall Study|Death|18|||
149068017|NCT03333915|537734160|FG000|Overall Study|Sponsor's Decision|0|||
149068018|NCT03333915|537734161|FG001|Overall Study|Sponsor's Decision|0|||
149068019|NCT03333915|537734162|FG002|Overall Study|Sponsor's Decision|0|||
149068020|NCT03333915|537734163|FG003|Overall Study|Sponsor's Decision|48|||
149068021|NCT03333915|537734164|FG004|Overall Study|Sponsor's Decision|4|||
149068022|NCT03333915|537734160|FG000|Overall Study|Withdrawal by Subject|0|||
149068023|NCT03333915|537734161|FG001|Overall Study|Withdrawal by Subject|0|||
149068024|NCT03333915|537734162|FG002|Overall Study|Withdrawal by Subject|0|||
149068025|NCT03333915|537734163|FG003|Overall Study|Withdrawal by Subject|5|||
149068026|NCT03333915|537734164|FG004|Overall Study|Withdrawal by Subject|1|||
149068027|NCT04046549|537734176|FG000|Overall Study|Adverse Event|1|||
149068028|NCT04046549|537734176|FG000|Overall Study|Physician Decision|1|||
149068029|NCT04046549|537734176|FG000|Overall Study|Withdrawal by Subject|3|||
149068030|NCT04046549|537734176|FG000|Overall Study|Other, Not Specified|5|||
149068031|NCT05771467|537734179|FG000|Overall Study|Lost to Follow-up|6|||
149068032|NCT05771467|537734180|FG001|Overall Study|Lost to Follow-up|3|||
149068033|NCT02206828|537734183|FG000|Overall Study|Lost to Follow-up|7|||
149068034|NCT04039113|537734184|FG000|Overall Study|Withdrawal by Subject|8|||
149068035|NCT04039113|537734185|FG001|Overall Study|Withdrawal by Subject|11|||
149068036|NCT04039113|537734184|FG000|Overall Study|Lost to Follow-up|1|||
149068037|NCT04039113|537734185|FG001|Overall Study|Lost to Follow-up|1|||
149068038|NCT04039113|537734184|FG000|Overall Study|Adverse Event|2|||
149068039|NCT04039113|537734185|FG001|Overall Study|Adverse Event|2|||
149068040|NCT04039113|537734184|FG000|Overall Study|Death|2|||
149068041|NCT04039113|537734185|FG001|Overall Study|Death|4|||
149068042|NCT04039113|537734184|FG000|Overall Study|Site Closure|6|||
149068043|NCT04039113|537734185|FG001|Overall Study|Site Closure|0|||
149068044|NCT04039113|537734184|FG000|Overall Study|Failure to meet randomisation criteria|4|||
149068045|NCT04039113|537734185|FG001|Overall Study|Failure to meet randomisation criteria|0|||
149068046|NCT04732871|537734764|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
149068047|NCT04732871|537734765|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
149068048|NCT04732871|537734766|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
149068049|NCT04732871|537734764|FG000|Overall Study|Lost to Follow-up|7|||
149068050|NCT04732871|537734765|FG001|Overall Study|Lost to Follow-up|4|||
149068051|NCT04732871|537734766|FG002|Overall Study|Lost to Follow-up|3|||
149068052|NCT04732871|537734764|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
149068053|NCT04732871|537734765|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
149068054|NCT04732871|537734766|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
149068055|NCT04732871|537734764|FG000|Overall Study|Migrated / moved from the study area|5|||
149068056|NCT04732871|537734765|FG001|Overall Study|Migrated / moved from the study area|0|||
149068057|NCT04732871|537734766|FG002|Overall Study|Migrated / moved from the study area|0|||
149068058|NCT04732871|537734764|FG000|Overall Study|Other|1|||
149068059|NCT04732871|537734765|FG001|Overall Study|Other|0|||
149068060|NCT04732871|537734766|FG002|Overall Study|Other|1|||
149068061|NCT04732871|537734764|FG000|Overall Study|Ongoing|6|||
149068062|NCT04732871|537734765|FG001|Overall Study|Ongoing|0|||
149068063|NCT04732871|537734766|FG002|Overall Study|Ongoing|1|||
149068064|NCT04732871|537734764|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
149068065|NCT04732871|537734765|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
149068066|NCT04732871|537734766|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
149068067|NCT02502266|537734768|FG000|Overall Study|Adverse Event|0|||
149068068|NCT02502266|537734769|FG001|Overall Study|Adverse Event|0|||
149068069|NCT02502266|537734770|FG002|Overall Study|Adverse Event|0|||
149068070|NCT02502266|537734771|FG003|Overall Study|Adverse Event|0|||
149068071|NCT02502266|537734772|FG004|Overall Study|Adverse Event|1|||
149068072|NCT02502266|537734773|FG005|Overall Study|Adverse Event|1|||
149068073|NCT02502266|537734774|FG006|Overall Study|Adverse Event|1|||
149068074|NCT02502266|537734768|FG000|Overall Study|Withdrawal by Subject|30|||
149068075|NCT02502266|537734769|FG001|Overall Study|Withdrawal by Subject|15|||
149068076|NCT02502266|537734770|FG002|Overall Study|Withdrawal by Subject|16|||
149068077|NCT02502266|537734771|FG003|Overall Study|Withdrawal by Subject|0|||
149068078|NCT02502266|537734772|FG004|Overall Study|Withdrawal by Subject|0|||
149068079|NCT02502266|537734773|FG005|Overall Study|Withdrawal by Subject|0|||
149068080|NCT02502266|537734774|FG006|Overall Study|Withdrawal by Subject|0|||
149068081|NCT02502266|537734768|FG000|Overall Study|Still on Treatment|0|||
149068082|NCT02502266|537734769|FG001|Overall Study|Still on Treatment|0|||
149068083|NCT02502266|537734770|FG002|Overall Study|Still on Treatment|1|||
149068084|NCT02502266|537734771|FG003|Overall Study|Still on Treatment|0|||
149068085|NCT02502266|537734772|FG004|Overall Study|Still on Treatment|0|||
149068086|NCT02502266|537734773|FG005|Overall Study|Still on Treatment|0|||
149068087|NCT02502266|537734774|FG006|Overall Study|Still on Treatment|0|||
149068088|NCT02502266|537734768|FG000|Overall Study|Other Reasons|19|||
149068089|NCT02502266|537734769|FG001|Overall Study|Other Reasons|6|||
149068090|NCT02502266|537734770|FG002|Overall Study|Other Reasons|14|||
149068091|NCT02502266|537734771|FG003|Overall Study|Other Reasons|0|||
149068092|NCT02502266|537734772|FG004|Overall Study|Other Reasons|1|||
149068093|NCT02502266|537734773|FG005|Overall Study|Other Reasons|1|||
149068094|NCT02502266|537734774|FG006|Overall Study|Other Reasons|0|||
149068095|NCT02502266|537734768|FG000|Overall Study|Arm 4 Discontinued|0|||
149068096|NCT02502266|537734769|FG001|Overall Study|Arm 4 Discontinued|0|||
149068097|NCT02502266|537734770|FG002|Overall Study|Arm 4 Discontinued|0|||
149068098|NCT02502266|537734771|FG003|Overall Study|Arm 4 Discontinued|52|||
149068099|NCT02502266|537734772|FG004|Overall Study|Arm 4 Discontinued|0|||
149068100|NCT02502266|537734773|FG005|Overall Study|Arm 4 Discontinued|0|||
149068101|NCT02502266|537734774|FG006|Overall Study|Arm 4 Discontinued|0|||
149068102|NCT02502266|537734768|FG000|Overall Study|Never treated|0|||
149068103|NCT02502266|537734769|FG001|Overall Study|Never treated|0|||
149068104|NCT02502266|537734770|FG002|Overall Study|Never treated|0|||
149068105|NCT02502266|537734771|FG003|Overall Study|Never treated|0|||
149068106|NCT02502266|537734772|FG004|Overall Study|Never treated|0|||
149068107|NCT02502266|537734773|FG005|Overall Study|Never treated|1|||
149068108|NCT02502266|537734774|FG006|Overall Study|Never treated|0|||
149068109|NCT01976936|537734775|FG000|Overall Study|Did not receive at least 9 doses|9|||
149068110|NCT01976936|537734776|FG001|Overall Study|Did not receive at least 9 doses|4|||
149068111|NCT06408870|537734777|FG000|Washout period|Withdrawal by Subject|1|||
149068112|NCT06408870|537734778|FG001|Washout period|Withdrawal by Subject|0|||
149068113|NCT06408870|537734777|FG000|Washout period|Adverse Event|2|||
149068114|NCT06408870|537734778|FG001|Washout period|Adverse Event|0|||
149068115|NCT05162586|537734782|FG000|Overall Study|Other|0|||
149068116|NCT05162586|537734783|FG001|Overall Study|Other|0|||
149068117|NCT05162586|537734784|FG002|Overall Study|Other|0|||
149068118|NCT05162586|537734785|FG003|Overall Study|Other|0|||
149068119|NCT05162586|537734786|FG004|Overall Study|Other|1|||
149068120|NCT05162586|537734787|FG005|Overall Study|Other|0|||
149068121|NCT05162586|537734788|FG006|Overall Study|Other|2|||
149068122|NCT05162586|537734789|FG007|Overall Study|Other|2|||
149068123|NCT05162586|537734782|FG000|Overall Study|Lack of Efficacy|0|||
149068124|NCT05162586|537734783|FG001|Overall Study|Lack of Efficacy|0|||
149068125|NCT05162586|537734784|FG002|Overall Study|Lack of Efficacy|0|||
149068126|NCT05162586|537734785|FG003|Overall Study|Lack of Efficacy|0|||
149068127|NCT05162586|537734786|FG004|Overall Study|Lack of Efficacy|1|||
149068128|NCT05162586|537734787|FG005|Overall Study|Lack of Efficacy|0|||
149068129|NCT05162586|537734788|FG006|Overall Study|Lack of Efficacy|0|||
149068130|NCT05162586|537734789|FG007|Overall Study|Lack of Efficacy|1|||
149068131|NCT05162586|537734782|FG000|Overall Study|Lost to Follow-up|0|||
149068132|NCT05162586|537734783|FG001|Overall Study|Lost to Follow-up|0|||
149068133|NCT05162586|537734784|FG002|Overall Study|Lost to Follow-up|0|||
149068134|NCT05162586|537734785|FG003|Overall Study|Lost to Follow-up|0|||
149068135|NCT05162586|537734786|FG004|Overall Study|Lost to Follow-up|2|||
149068136|NCT05162586|537734787|FG005|Overall Study|Lost to Follow-up|0|||
149068137|NCT05162586|537734788|FG006|Overall Study|Lost to Follow-up|0|||
149068138|NCT05162586|537734789|FG007|Overall Study|Lost to Follow-up|2|||
149068139|NCT05162586|537734782|FG000|Overall Study|Non-Compliance|0|||
149068140|NCT05162586|537734783|FG001|Overall Study|Non-Compliance|1|||
149068141|NCT05162586|537734784|FG002|Overall Study|Non-Compliance|0|||
149068142|NCT05162586|537734785|FG003|Overall Study|Non-Compliance|0|||
149068143|NCT05162586|537734786|FG004|Overall Study|Non-Compliance|1|||
149068144|NCT05162586|537734787|FG005|Overall Study|Non-Compliance|0|||
149068145|NCT05162586|537734788|FG006|Overall Study|Non-Compliance|0|||
149068146|NCT05162586|537734789|FG007|Overall Study|Non-Compliance|1|||
149068147|NCT05162586|537734782|FG000|Overall Study|Withdrawal by Subject|2|||
149068148|NCT05162586|537734783|FG001|Overall Study|Withdrawal by Subject|0|||
149068149|NCT05162586|537734784|FG002|Overall Study|Withdrawal by Subject|0|||
149068150|NCT05162586|537734785|FG003|Overall Study|Withdrawal by Subject|0|||
149068151|NCT05162586|537734786|FG004|Overall Study|Withdrawal by Subject|7|||
149068152|NCT05162586|537734787|FG005|Overall Study|Withdrawal by Subject|6|||
149068153|NCT05162586|537734788|FG006|Overall Study|Withdrawal by Subject|2|||
149068154|NCT05162586|537734789|FG007|Overall Study|Withdrawal by Subject|2|||
149068155|NCT05162586|537734782|FG000|Overall Study|Adverse Event|2|||
149068156|NCT05162586|537734783|FG001|Overall Study|Adverse Event|0|||
149068157|NCT05162586|537734784|FG002|Overall Study|Adverse Event|1|||
149068158|NCT05162586|537734785|FG003|Overall Study|Adverse Event|2|||
149068159|NCT05162586|537734786|FG004|Overall Study|Adverse Event|4|||
149068160|NCT05162586|537734787|FG005|Overall Study|Adverse Event|1|||
149068161|NCT05162586|537734788|FG006|Overall Study|Adverse Event|5|||
149068162|NCT05162586|537734789|FG007|Overall Study|Adverse Event|2|||
149068163|NCT02567435|537734790|FG000|Overall Study|Death|1|||
149068164|NCT02567435|537734791|FG001|Overall Study|Death|1|||
149068165|NCT02567435|537734792|FG002|Overall Study|Death|0|||
149068166|NCT02567435|537734793|FG003|Overall Study|Death|0|||
149068167|NCT02567435|537734790|FG000|Overall Study|Ineligible|1|||
149068168|NCT02567435|537734791|FG001|Overall Study|Ineligible|3|||
149068169|NCT02567435|537734792|FG002|Overall Study|Ineligible|0|||
149068170|NCT02567435|537734793|FG003|Overall Study|Ineligible|0|||
149068171|NCT02567435|537734790|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
149068172|NCT02567435|537734791|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
149068173|NCT02567435|537734792|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
149068174|NCT02567435|537734793|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
149068175|NCT05030584|537734795|FG000|Overall Study|Adverse Event|17|||
149068176|NCT05030584|537734796|FG001|Overall Study|Adverse Event|2|||
149068177|NCT05030584|537734795|FG000|Overall Study|Lack of Efficacy|0|||
149068178|NCT05030584|537734796|FG001|Overall Study|Lack of Efficacy|6|||
149068179|NCT05030584|537734795|FG000|Overall Study|Lost to Follow-up|5|||
149068180|NCT05030584|537734796|FG001|Overall Study|Lost to Follow-up|2|||
149068181|NCT05030584|537734795|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149068182|NCT05030584|537734796|FG001|Overall Study|Non-Compliance with Study Drug|3|||
149068183|NCT05030584|537734795|FG000|Overall Study|Other reason|4|||
149068184|NCT05030584|537734796|FG001|Overall Study|Other reason|3|||
149068185|NCT05030584|537734795|FG000|Overall Study|Physician Decision|1|||
149068186|NCT05030584|537734796|FG001|Overall Study|Physician Decision|4|||
149068187|NCT05030584|537734795|FG000|Overall Study|Protocol Violation|0|||
149068188|NCT05030584|537734796|FG001|Overall Study|Protocol Violation|2|||
149068189|NCT05030584|537734795|FG000|Overall Study|Randomized by Mistake|0|||
149068190|NCT05030584|537734796|FG001|Overall Study|Randomized by Mistake|2|||
149068191|NCT05030584|537734795|FG000|Overall Study|Withdrawal by Subject|21|||
149068192|NCT05030584|537734796|FG001|Overall Study|Withdrawal by Subject|28|||
149068193|NCT05030584|537734795|FG000|Overall Study|Technical Problems|0|||
149068194|NCT05030584|537734796|FG001|Overall Study|Technical Problems|1|||
149068195|NCT05030584|537734795|FG000|Overall Study|Completed post-treatment/FU visits|41|||
149068196|NCT05030584|537734796|FG001|Overall Study|Completed post-treatment/FU visits|31|||
149068197|NCT03047213|537734797|FG000|Overall Study|Withdrawal by Subject|2|||
149068198|NCT03047213|537734798|FG001|Overall Study|Withdrawal by Subject|0|||
149068199|NCT03047213|537734797|FG000|Overall Study|Adverse Event|2|||
149068200|NCT03047213|537734798|FG001|Overall Study|Adverse Event|0|||
149068201|NCT02446600|537734799|FG000|Overall Study|Never treated|20|||
149068202|NCT02446600|537734800|FG001|Overall Study|Never treated|2|||
149068203|NCT02446600|537734801|FG002|Overall Study|Never treated|6|||
149068204|NCT02446600|537734802|FG003|Overall Study|Never treated|0|||
149068205|NCT02446600|537734799|FG000|Overall Study|Withdrawal by Subject|19|||
149068206|NCT02446600|537734800|FG001|Overall Study|Withdrawal by Subject|5|||
149068207|NCT02446600|537734801|FG002|Overall Study|Withdrawal by Subject|17|||
149068208|NCT02446600|537734802|FG003|Overall Study|Withdrawal by Subject|0|||
149068209|NCT02446600|537734799|FG000|Overall Study|Ineligible|1|||
149068210|NCT02446600|537734800|FG001|Overall Study|Ineligible|4|||
149068211|NCT02446600|537734801|FG002|Overall Study|Ineligible|4|||
149068212|NCT02446600|537734802|FG003|Overall Study|Ineligible|1|||
149068213|NCT02446600|537734799|FG000|Overall Study|Duplicate Enrollment|0|||
149068214|NCT02446600|537734800|FG001|Overall Study|Duplicate Enrollment|1|||
149068215|NCT02446600|537734801|FG002|Overall Study|Duplicate Enrollment|0|||
149068216|NCT02446600|537734802|FG003|Overall Study|Duplicate Enrollment|0|||
149068217|NCT00328783|537734803|FG000|Overall Study|Could not tolerate ABC|21|||
149068218|NCT00328783|537734803|FG000|Overall Study|No heart in RT field|4|||
149068219|NCT00328783|537734803|FG000|Overall Study|Withdrawal by Subject|1|||
149068220|NCT03242915|537734804|FG000|Overall Study|Adverse Event|5|||
149068221|NCT03242915|537734805|FG001|Overall Study|Adverse Event|1|||
149068222|NCT03242915|537734804|FG000|Overall Study|Withdrawal by Subject|0|||
149068223|NCT03242915|537734805|FG001|Overall Study|Withdrawal by Subject|2|||
149068224|NCT03242915|537734804|FG000|Overall Study|Physician Decision|4|||
149068225|NCT03242915|537734805|FG001|Overall Study|Physician Decision|1|||
149068226|NCT02726386|537734806|FG000|Overall Study|Adverse Event|17|||
149068227|NCT02726386|537734807|FG001|Overall Study|Adverse Event|20|||
149068228|NCT02726386|537734806|FG000|Overall Study|Withdrawal by Subject|14|||
149068229|NCT02726386|537734807|FG001|Overall Study|Withdrawal by Subject|28|||
149068230|NCT02726386|537734806|FG000|Overall Study|Other reasons|7|||
149068231|NCT02726386|537734807|FG001|Overall Study|Other reasons|8|||
149068232|NCT03872466|537734812|FG000|Overall Study|Withdrawal by Subject|1|||
149068233|NCT03872466|537734813|FG001|Overall Study|Withdrawal by Subject|0|||
149068234|NCT03872466|537734812|FG000|Overall Study|Physician Decision|2|||
149068235|NCT03872466|537734813|FG001|Overall Study|Physician Decision|0|||
149068236|NCT01778686|537734814|FG000|Overall Study|Adverse Event|0|||
149068237|NCT01778686|537734815|FG001|Overall Study|Adverse Event|0|||
149068238|NCT01778686|537734816|FG002|Overall Study|Adverse Event|1|||
149068239|NCT04012567|537734817|FG000|Overall Study|Lost to Follow-up|0|||
149068240|NCT04012567|537734818|FG001|Overall Study|Lost to Follow-up|1|||
149068241|NCT04012567|537734817|FG000|Overall Study|Withdrawal by Subject|1|||
149068242|NCT04012567|537734818|FG001|Overall Study|Withdrawal by Subject|0|||
149068243|NCT06059443|537734819|FG000|Overall Study|Withdrawal by Subject|2|||
149068244|NCT06059443|537734820|FG001|Overall Study|Withdrawal by Subject|0|||
149068245|NCT06059443|537734819|FG000|Overall Study|Lost to Follow-up|2|||
149068246|NCT06059443|537734820|FG001|Overall Study|Lost to Follow-up|2|||
149068247|NCT00945724|537734822|FG000|Overall Study|Withdrawal by Subject|2|||
149068248|NCT00945724|537734822|FG000|Overall Study|Physician Decision|1|||
149068249|NCT00945724|537734822|FG000|Overall Study|Adverse Event|5|||
149068250|NCT00945724|537734822|FG000|Overall Study|Second malignancy|1|||
149068251|NCT04974047|537735247|FG000|Overall Study|Sponsor Ended Study|20|||
149068252|NCT04974047|537735248|FG001|Overall Study|Sponsor Ended Study|22|||
149068253|NCT04974047|537735247|FG000|Overall Study|Death|8|||
149068254|NCT04974047|537735248|FG001|Overall Study|Death|17|||
149068255|NCT04974047|537735247|FG000|Overall Study|Lost to Follow-up|2|||
149068256|NCT04974047|537735248|FG001|Overall Study|Lost to Follow-up|0|||
149068257|NCT04974047|537735247|FG000|Overall Study|Withdrawal by Subject|0|||
149068258|NCT04974047|537735248|FG001|Overall Study|Withdrawal by Subject|1|||
149068259|NCT03391466|537735249|FG000|Overall Study|Death|84|||
149068260|NCT03391466|537735250|FG001|Overall Study|Death|91|||
149068261|NCT03391466|537735249|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
149068262|NCT03391466|537735250|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
149068263|NCT03391466|537735249|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
149068264|NCT03391466|537735250|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
149068265|NCT03391466|537735249|FG000|Overall Study|Lost to Follow-up|9|||
149068266|NCT03391466|537735250|FG001|Overall Study|Lost to Follow-up|5|||
149068267|NCT03391466|537735249|FG000|Overall Study|Reason Not Specified|2|||
149068268|NCT03391466|537735250|FG001|Overall Study|Reason Not Specified|2|||
149068269|NCT03391466|537735249|FG000|Overall Study|Investigator Decision|0|||
149068270|NCT03391466|537735250|FG001|Overall Study|Investigator Decision|1|||
149068271|NCT04129164|537735251|FG000|Overall Study|Non-compliance with procedures|0|||
149068272|NCT04129164|537735252|FG001|Overall Study|Non-compliance with procedures|0|||
149068273|NCT04129164|537735253|FG002|Overall Study|Non-compliance with procedures|2|||
149068274|NCT04129164|537735254|FG003|Overall Study|Non-compliance with procedures|0|||
149068275|NCT04129164|537735251|FG000|Overall Study|Adverse Event|0|||
149068276|NCT04129164|537735252|FG001|Overall Study|Adverse Event|0|||
149068277|NCT04129164|537735253|FG002|Overall Study|Adverse Event|2|||
149068278|NCT04129164|537735254|FG003|Overall Study|Adverse Event|0|||
149068279|NCT04129164|537735251|FG000|Overall Study|Pregnancy|0|||
149068280|NCT04129164|537735252|FG001|Overall Study|Pregnancy|0|||
149068281|NCT04129164|537735253|FG002|Overall Study|Pregnancy|0|||
149068282|NCT04129164|537735254|FG003|Overall Study|Pregnancy|1|||
149068283|NCT04129164|537735251|FG000|Overall Study|Withdrawal by Subject|3|||
149068284|NCT04129164|537735252|FG001|Overall Study|Withdrawal by Subject|2|||
149068285|NCT04129164|537735253|FG002|Overall Study|Withdrawal by Subject|4|||
149068286|NCT04129164|537735254|FG003|Overall Study|Withdrawal by Subject|6|||
149068287|NCT04129164|537735251|FG000|Overall Study|Death|0|||
149068288|NCT04129164|537735252|FG001|Overall Study|Death|1|||
149068289|NCT04129164|537735253|FG002|Overall Study|Death|0|||
149068290|NCT04129164|537735254|FG003|Overall Study|Death|0|||
149068291|NCT04129164|537735251|FG000|Overall Study|Lost to Follow-up|0|||
149068292|NCT04129164|537735252|FG001|Overall Study|Lost to Follow-up|1|||
149068293|NCT04129164|537735253|FG002|Overall Study|Lost to Follow-up|0|||
149068294|NCT04129164|537735254|FG003|Overall Study|Lost to Follow-up|0|||
149068295|NCT02306161|537735255|FG000|Overall Study|Death|1|||
149068296|NCT02306161|537735256|FG001|Overall Study|Death|3|||
149068297|NCT02306161|537735255|FG000|Overall Study|Lack of Efficacy|20|||
149068298|NCT02306161|537735256|FG001|Overall Study|Lack of Efficacy|43|||
149068299|NCT02306161|537735255|FG000|Overall Study|Physician Decision|30|||
149068300|NCT02306161|537735256|FG001|Overall Study|Physician Decision|18|||
149068301|NCT02306161|537735255|FG000|Overall Study|Withdrawal by Subject|4|||
149068302|NCT02306161|537735256|FG001|Overall Study|Withdrawal by Subject|0|||
149068303|NCT02306161|537735255|FG000|Overall Study|Ineligible|9|||
149068304|NCT02306161|537735256|FG001|Overall Study|Ineligible|5|||
149068305|NCT02166463|537735257|FG000|Overall Study|Lost to Follow-up|0|||
149068306|NCT02166463|537735258|FG001|Overall Study|Lost to Follow-up|1|||
149068307|NCT02166463|537735257|FG000|Overall Study|Physician Decision|10|||
149068308|NCT02166463|537735258|FG001|Overall Study|Physician Decision|10|||
149068309|NCT02166463|537735257|FG000|Overall Study|Ineligible|11|||
149068310|NCT02166463|537735258|FG001|Overall Study|Ineligible|2|||
149068311|NCT02166463|537735257|FG000|Overall Study|Progressive Disease|9|||
149068312|NCT02166463|537735258|FG001|Overall Study|Progressive Disease|6|||
149068313|NCT02166463|537735257|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
149068314|NCT02166463|537735258|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
149068315|NCT02166463|537735257|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
149068316|NCT02166463|537735258|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
149068317|NCT02166463|537735257|FG000|Overall Study|Refusal of further protocol therapy|5|||
149068318|NCT02166463|537735258|FG001|Overall Study|Refusal of further protocol therapy|6|||
149068319|NCT06393127|537735263|FG000|Washout period|Withdrawal by Subject|1|||
149068320|NCT06393127|537735264|FG001|Washout period|Withdrawal by Subject|0|||
149068321|NCT06393127|537735263|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
149068322|NCT06393127|537735264|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
149068323|NCT02466971|537735265|FG000|Overall Study|eligible and never treated|14|||
149068324|NCT02466971|537735266|FG001|Overall Study|eligible and never treated|20|||
149068325|NCT02466971|537735265|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
149068326|NCT02466971|537735266|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
149068327|NCT02466971|537735265|FG000|Overall Study|ineligible and treated|1|||
149068328|NCT02466971|537735266|FG001|Overall Study|ineligible and treated|0|||
149068329|NCT02466971|537735265|FG000|Overall Study|ineligible and never treated|0|||
149068330|NCT02466971|537735266|FG001|Overall Study|ineligible and never treated|1|||
149068331|NCT05424718|537735272|FG000|Overall Study|Lost to Follow-up|5|||
149068332|NCT05424718|537735273|FG001|Overall Study|Lost to Follow-up|4|||
149068333|NCT02890355|537735280|FG000|Overall Study|Adverse Event|5|||
149068334|NCT02890355|537735281|FG001|Overall Study|Adverse Event|5|||
149068335|NCT02890355|537735280|FG000|Overall Study|Refusal unrelated to adverse event|5|||
149068336|NCT02890355|537735281|FG001|Overall Study|Refusal unrelated to adverse event|10|||
149068337|NCT02890355|537735280|FG000|Overall Study|Progression/relapse|46|||
149068338|NCT02890355|537735281|FG001|Overall Study|Progression/relapse|39|||
149068339|NCT02890355|537735280|FG000|Overall Study|Not protocol specified|3|||
149068340|NCT02890355|537735281|FG001|Overall Study|Not protocol specified|4|||
149068341|NCT00353496|537735286|FG000|Overall Study|Adverse Event|1|||
149068342|NCT00353496|537735287|FG001|Overall Study|Adverse Event|0|||
149068343|NCT00353496|537735286|FG000|Overall Study|Protocol Violation|2|||
149068344|NCT00353496|537735287|FG001|Overall Study|Protocol Violation|2|||
149068345|NCT00353496|537735286|FG000|Overall Study|Withdrawal by Subject|3|||
149068346|NCT00353496|537735287|FG001|Overall Study|Withdrawal by Subject|4|||
149068347|NCT00353496|537735286|FG000|Overall Study|Physician Decision|6|||
149068348|NCT00353496|537735287|FG001|Overall Study|Physician Decision|9|||
149068349|NCT00353496|537735286|FG000|Overall Study|Not otherwise specified|4|||
149068350|NCT00353496|537735287|FG001|Overall Study|Not otherwise specified|2|||
149068351|NCT02180867|537735289|FG000|Overall Study|Adverse Event|3|||
149068352|NCT02180867|537735290|FG001|Overall Study|Adverse Event|4|||
149068353|NCT02180867|537735291|FG002|Overall Study|Adverse Event|1|||
149068354|NCT02180867|537735292|FG003|Overall Study|Adverse Event|5|||
149068355|NCT02180867|537735293|FG004|Overall Study|Adverse Event|0|||
149068356|NCT02180867|537735294|FG005|Overall Study|Adverse Event|0|||
149068357|NCT02180867|537735295|FG006|Overall Study|Adverse Event|0|||
149068358|NCT02180867|537735289|FG000|Overall Study|Death|0|||
149068359|NCT02180867|537735290|FG001|Overall Study|Death|0|||
149068360|NCT02180867|537735291|FG002|Overall Study|Death|0|||
149068361|NCT02180867|537735292|FG003|Overall Study|Death|0|||
149068362|NCT02180867|537735293|FG004|Overall Study|Death|1|||
149068363|NCT02180867|537735294|FG005|Overall Study|Death|0|||
149068364|NCT02180867|537735295|FG006|Overall Study|Death|0|||
149068365|NCT02180867|537735289|FG000|Overall Study|Lack of Efficacy|0|||
149068366|NCT02180867|537735290|FG001|Overall Study|Lack of Efficacy|2|||
149068367|NCT02180867|537735291|FG002|Overall Study|Lack of Efficacy|0|||
149068368|NCT02180867|537735292|FG003|Overall Study|Lack of Efficacy|1|||
149068369|NCT02180867|537735293|FG004|Overall Study|Lack of Efficacy|6|||
149068370|NCT02180867|537735294|FG005|Overall Study|Lack of Efficacy|0|||
149068371|NCT02180867|537735295|FG006|Overall Study|Lack of Efficacy|1|||
149068372|NCT02180867|537735289|FG000|Overall Study|Physician Decision|1|||
149068373|NCT02180867|537735290|FG001|Overall Study|Physician Decision|3|||
149068374|NCT02180867|537735291|FG002|Overall Study|Physician Decision|1|||
149068375|NCT02180867|537735292|FG003|Overall Study|Physician Decision|10|||
149068376|NCT02180867|537735293|FG004|Overall Study|Physician Decision|9|||
149068377|NCT02180867|537735294|FG005|Overall Study|Physician Decision|3|||
149068378|NCT02180867|537735295|FG006|Overall Study|Physician Decision|4|||
149068379|NCT02180867|537735289|FG000|Overall Study|Withdrawal by Subject|0|||
149068380|NCT02180867|537735290|FG001|Overall Study|Withdrawal by Subject|0|||
149068381|NCT02180867|537735291|FG002|Overall Study|Withdrawal by Subject|0|||
149068382|NCT02180867|537735292|FG003|Overall Study|Withdrawal by Subject|1|||
149068383|NCT02180867|537735293|FG004|Overall Study|Withdrawal by Subject|1|||
149068384|NCT02180867|537735294|FG005|Overall Study|Withdrawal by Subject|0|||
149068385|NCT02180867|537735295|FG006|Overall Study|Withdrawal by Subject|0|||
149068386|NCT02180867|537735289|FG000|Overall Study|Ineligible|1|||
149068387|NCT02180867|537735290|FG001|Overall Study|Ineligible|2|||
149068388|NCT02180867|537735291|FG002|Overall Study|Ineligible|0|||
149068389|NCT02180867|537735292|FG003|Overall Study|Ineligible|3|||
149068390|NCT02180867|537735293|FG004|Overall Study|Ineligible|5|||
149068391|NCT02180867|537735294|FG005|Overall Study|Ineligible|0|||
149068392|NCT02180867|537735295|FG006|Overall Study|Ineligible|0|||
149068393|NCT02180867|537735289|FG000|Overall Study|Repeat Eligibility Studies|0|||
149068394|NCT02180867|537735290|FG001|Overall Study|Repeat Eligibility Studies|0|||
149068395|NCT02180867|537735291|FG002|Overall Study|Repeat Eligibility Studies|0|||
149068396|NCT02180867|537735292|FG003|Overall Study|Repeat Eligibility Studies|0|||
149068397|NCT02180867|537735293|FG004|Overall Study|Repeat Eligibility Studies|1|||
149068398|NCT02180867|537735294|FG005|Overall Study|Repeat Eligibility Studies|0|||
149068399|NCT02180867|537735295|FG006|Overall Study|Repeat Eligibility Studies|0|||
149068400|NCT02180867|537735289|FG000|Overall Study|Refusal of further protocol therapy|1|||
149068401|NCT02180867|537735290|FG001|Overall Study|Refusal of further protocol therapy|0|||
149068402|NCT02180867|537735291|FG002|Overall Study|Refusal of further protocol therapy|2|||
149068403|NCT02180867|537735292|FG003|Overall Study|Refusal of further protocol therapy|6|||
149068404|NCT02180867|537735293|FG004|Overall Study|Refusal of further protocol therapy|4|||
149068405|NCT02180867|537735294|FG005|Overall Study|Refusal of further protocol therapy|0|||
149068406|NCT02180867|537735295|FG006|Overall Study|Refusal of further protocol therapy|0|||
149068407|NCT04129450|537735296|FG000|Overall Study|Lost to Follow-up|20|||
149068408|NCT04129450|537735297|FG001|Overall Study|Lost to Follow-up|10|||
149068409|NCT04129450|537735296|FG000|Overall Study|Withdrawal by Subject|9|||
149068410|NCT04129450|537735297|FG001|Overall Study|Withdrawal by Subject|5|||
149068411|NCT04129450|537735296|FG000|Overall Study|Work Family Obligations|2|||
149068412|NCT04129450|537735297|FG001|Overall Study|Work Family Obligations|0|||
149068413|NCT04129450|537735296|FG000|Overall Study|Other|3|||
149068414|NCT04129450|537735297|FG001|Overall Study|Other|0|||
149068415|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|Other|0|||
149068416|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|Other|2|||
149068417|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|Other|1|||
149068418|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|Other|2|||
149068419|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|Other|2|||
149068420|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|Other|0|||
149068421|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|Other|0|||
149068422|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|Other|0|||
149068423|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|Other|0|||
149068424|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|Other|0|||
149068425|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|Other|0|||
149068426|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|Other|0|||
149068427|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|Other|0|||
149068428|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|Other|0|||
149068429|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|Other|0|||
149068430|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|Other|0|||
149068431|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|Other|0|||
149068432|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
149068433|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
149068434|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
149068435|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
149068436|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
149068437|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
149068438|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068439|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068440|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068441|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068442|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068443|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068444|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068445|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068446|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068447|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068448|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
149068449|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068450|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
149068451|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
149068452|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068453|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
149068454|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
149068455|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068456|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068457|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068458|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068459|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068460|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068461|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068462|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068463|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068464|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068465|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
149068466|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|Death|2|||
149068467|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|Death|1|||
149068468|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|Death|1|||
149068469|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|Death|0|||
149068470|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|Death|0|||
149068471|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|Death|0|||
149068472|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|Death|0|||
149068473|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|Death|0|||
149068474|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|Death|0|||
149068475|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|Death|0|||
149068476|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|Death|0|||
149068477|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|Death|0|||
149068478|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|Death|0|||
149068479|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|Death|0|||
149068480|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|Death|0|||
149068481|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|Death|0|||
149068482|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|Death|0|||
149068483|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068484|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
149068485|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068486|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068487|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
149068488|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
149068489|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068490|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068491|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068492|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068493|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068494|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068495|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068496|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068497|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068498|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068499|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
149068500|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068501|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068502|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068503|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068504|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
149068505|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
149068506|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068507|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068508|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068509|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068510|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068511|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068512|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068513|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068514|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068515|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068516|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
149068517|NCT02719574|537735997|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068518|NCT02719574|537735998|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068519|NCT02719574|537735999|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
149068520|NCT02719574|537736000|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068521|NCT02719574|537736001|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068522|NCT02719574|537736002|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068523|NCT02719574|537736003|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068524|NCT02719574|537736004|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068525|NCT02719574|537736005|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068526|NCT02719574|537736006|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068527|NCT02719574|537736007|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068528|NCT02719574|537736008|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068529|NCT02719574|537736009|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068530|NCT02719574|537736010|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068531|NCT02719574|537736011|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068532|NCT02719574|537736012|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068533|NCT02719574|537736013|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
149068534|NCT02719574|537735997|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068535|NCT02719574|537735998|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068536|NCT02719574|537735999|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068537|NCT02719574|537736000|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068538|NCT02719574|537736001|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068539|NCT02719574|537736002|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068540|NCT02719574|537736003|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
149068541|NCT02719574|537736004|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
149068542|NCT02719574|537736005|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
149068543|NCT02719574|537736006|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068544|NCT02719574|537736007|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068545|NCT02719574|537736008|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068546|NCT02719574|537736009|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068547|NCT02719574|537736010|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068548|NCT02719574|537736011|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068549|NCT02719574|537736012|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068550|NCT02719574|537736013|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
149068551|NCT02719574|537735997|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068552|NCT02719574|537735998|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068553|NCT02719574|537735999|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068554|NCT02719574|537736000|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068555|NCT02719574|537736001|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068556|NCT02719574|537736002|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068557|NCT02719574|537736003|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
149068558|NCT02719574|537736004|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
149068559|NCT02719574|537736005|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068560|NCT02719574|537736006|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068561|NCT02719574|537736007|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068562|NCT02719574|537736008|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068563|NCT02719574|537736009|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068564|NCT02719574|537736010|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068565|NCT02719574|537736011|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068566|NCT02719574|537736012|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068567|NCT02719574|537736013|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
149068568|NCT02719574|537735997|FG000|Phase 1 (Dose Expansion)|Death|0|||
149068569|NCT02719574|537735998|FG001|Phase 1 (Dose Expansion)|Death|0|||
149068570|NCT02719574|537735999|FG002|Phase 1 (Dose Expansion)|Death|0|||
149068571|NCT02719574|537736000|FG003|Phase 1 (Dose Expansion)|Death|0|||
149068572|NCT02719574|537736001|FG004|Phase 1 (Dose Expansion)|Death|0|||
149068573|NCT02719574|537736002|FG005|Phase 1 (Dose Expansion)|Death|0|||
149068574|NCT02719574|537736003|FG006|Phase 1 (Dose Expansion)|Death|1|||
149068575|NCT02719574|537736004|FG007|Phase 1 (Dose Expansion)|Death|6|||
149068576|NCT02719574|537736005|FG008|Phase 1 (Dose Expansion)|Death|0|||
149068577|NCT02719574|537736006|FG009|Phase 1 (Dose Expansion)|Death|0|||
149068578|NCT02719574|537736007|FG010|Phase 1 (Dose Expansion)|Death|0|||
149068579|NCT02719574|537736008|FG011|Phase 1 (Dose Expansion)|Death|0|||
149068580|NCT02719574|537736009|FG012|Phase 1 (Dose Expansion)|Death|0|||
149068581|NCT02719574|537736010|FG013|Phase 1 (Dose Expansion)|Death|0|||
149068582|NCT02719574|537736011|FG014|Phase 1 (Dose Expansion)|Death|0|||
149068583|NCT02719574|537736012|FG015|Phase 1 (Dose Expansion)|Death|0|||
149068584|NCT02719574|537736013|FG016|Phase 1 (Dose Expansion)|Death|0|||
149068585|NCT02719574|537735997|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068586|NCT02719574|537735998|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068587|NCT02719574|537735999|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068588|NCT02719574|537736000|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068589|NCT02719574|537736001|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068590|NCT02719574|537736002|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068591|NCT02719574|537736003|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
149068592|NCT02719574|537736004|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
149068593|NCT02719574|537736005|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068594|NCT02719574|537736006|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068595|NCT02719574|537736007|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068596|NCT02719574|537736008|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068597|NCT02719574|537736009|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068598|NCT02719574|537736010|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068599|NCT02719574|537736011|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068600|NCT02719574|537736012|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068601|NCT02719574|537736013|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
149068602|NCT02719574|537735997|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068603|NCT02719574|537735998|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068604|NCT02719574|537735999|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068605|NCT02719574|537736000|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068606|NCT02719574|537736001|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068607|NCT02719574|537736002|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068608|NCT02719574|537736003|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
149068609|NCT02719574|537736004|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
149068610|NCT02719574|537736005|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068611|NCT02719574|537736006|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068612|NCT02719574|537736007|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068613|NCT02719574|537736008|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068614|NCT02719574|537736009|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068615|NCT02719574|537736010|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068616|NCT02719574|537736011|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068617|NCT02719574|537736012|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068618|NCT02719574|537736013|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
149068619|NCT02719574|537735997|FG000|Phase 1 (Dose Expansion)|Other|0|||
149068620|NCT02719574|537735998|FG001|Phase 1 (Dose Expansion)|Other|0|||
149068621|NCT02719574|537735999|FG002|Phase 1 (Dose Expansion)|Other|0|||
149068622|NCT02719574|537736000|FG003|Phase 1 (Dose Expansion)|Other|0|||
149068623|NCT02719574|537736001|FG004|Phase 1 (Dose Expansion)|Other|0|||
149068624|NCT02719574|537736002|FG005|Phase 1 (Dose Expansion)|Other|0|||
149068625|NCT02719574|537736003|FG006|Phase 1 (Dose Expansion)|Other|1|||
149068626|NCT02719574|537736004|FG007|Phase 1 (Dose Expansion)|Other|7|||
149068627|NCT02719574|537736005|FG008|Phase 1 (Dose Expansion)|Other|0|||
149068628|NCT02719574|537736006|FG009|Phase 1 (Dose Expansion)|Other|0|||
149068629|NCT02719574|537736007|FG010|Phase 1 (Dose Expansion)|Other|0|||
149068630|NCT02719574|537736008|FG011|Phase 1 (Dose Expansion)|Other|0|||
149068631|NCT02719574|537736009|FG012|Phase 1 (Dose Expansion)|Other|0|||
149068632|NCT02719574|537736010|FG013|Phase 1 (Dose Expansion)|Other|0|||
149068633|NCT02719574|537736011|FG014|Phase 1 (Dose Expansion)|Other|0|||
149068634|NCT02719574|537736012|FG015|Phase 1 (Dose Expansion)|Other|0|||
149068635|NCT02719574|537736013|FG016|Phase 1 (Dose Expansion)|Other|0|||
149068636|NCT02719574|537735997|FG000|Phase 2|Protocol Defined Disease Progression|0|||
149068637|NCT02719574|537735998|FG001|Phase 2|Protocol Defined Disease Progression|0|||
149068638|NCT02719574|537735999|FG002|Phase 2|Protocol Defined Disease Progression|0|||
149068639|NCT02719574|537736000|FG003|Phase 2|Protocol Defined Disease Progression|0|||
149068640|NCT02719574|537736001|FG004|Phase 2|Protocol Defined Disease Progression|0|||
149068641|NCT02719574|537736002|FG005|Phase 2|Protocol Defined Disease Progression|0|||
149068642|NCT02719574|537736003|FG006|Phase 2|Protocol Defined Disease Progression|0|||
149068643|NCT02719574|537736004|FG007|Phase 2|Protocol Defined Disease Progression|0|||
149068644|NCT02719574|537736005|FG008|Phase 2|Protocol Defined Disease Progression|0|||
149068645|NCT02719574|537736006|FG009|Phase 2|Protocol Defined Disease Progression|65|||
149068646|NCT02719574|537736007|FG010|Phase 2|Protocol Defined Disease Progression|8|||
149068647|NCT02719574|537736008|FG011|Phase 2|Protocol Defined Disease Progression|2|||
149068648|NCT02719574|537736009|FG012|Phase 2|Protocol Defined Disease Progression|4|||
149068649|NCT02719574|537736010|FG013|Phase 2|Protocol Defined Disease Progression|9|||
149068650|NCT02719574|537736011|FG014|Phase 2|Protocol Defined Disease Progression|11|||
149068651|NCT02719574|537736012|FG015|Phase 2|Protocol Defined Disease Progression|3|||
149068652|NCT02719574|537736013|FG016|Phase 2|Protocol Defined Disease Progression|4|||
149068653|NCT02719574|537735997|FG000|Phase 2|Adverse Event|0|||
149068654|NCT02719574|537735998|FG001|Phase 2|Adverse Event|0|||
149068655|NCT02719574|537735999|FG002|Phase 2|Adverse Event|0|||
149068656|NCT02719574|537736000|FG003|Phase 2|Adverse Event|0|||
149068657|NCT02719574|537736001|FG004|Phase 2|Adverse Event|0|||
149068658|NCT02719574|537736002|FG005|Phase 2|Adverse Event|0|||
149068659|NCT02719574|537736003|FG006|Phase 2|Adverse Event|0|||
149068660|NCT02719574|537736004|FG007|Phase 2|Adverse Event|0|||
149068661|NCT02719574|537736005|FG008|Phase 2|Adverse Event|0|||
149068662|NCT02719574|537736006|FG009|Phase 2|Adverse Event|27|||
149068663|NCT02719574|537736007|FG010|Phase 2|Adverse Event|0|||
149068664|NCT02719574|537736008|FG011|Phase 2|Adverse Event|1|||
149068665|NCT02719574|537736009|FG012|Phase 2|Adverse Event|1|||
149068666|NCT02719574|537736010|FG013|Phase 2|Adverse Event|1|||
149068667|NCT02719574|537736011|FG014|Phase 2|Adverse Event|2|||
149068668|NCT02719574|537736012|FG015|Phase 2|Adverse Event|2|||
149068669|NCT02719574|537736013|FG016|Phase 2|Adverse Event|3|||
149068670|NCT02719574|537735997|FG000|Phase 2|Other|0|||
149068671|NCT02719574|537735998|FG001|Phase 2|Other|0|||
149068672|NCT02719574|537735999|FG002|Phase 2|Other|0|||
149068673|NCT02719574|537736000|FG003|Phase 2|Other|0|||
149068674|NCT02719574|537736001|FG004|Phase 2|Other|0|||
149068675|NCT02719574|537736002|FG005|Phase 2|Other|0|||
149068676|NCT02719574|537736003|FG006|Phase 2|Other|0|||
149068677|NCT02719574|537736004|FG007|Phase 2|Other|0|||
149068678|NCT02719574|537736005|FG008|Phase 2|Other|0|||
149068679|NCT02719574|537736006|FG009|Phase 2|Other|20|||
149068680|NCT02719574|537736007|FG010|Phase 2|Other|7|||
149068681|NCT02719574|537736008|FG011|Phase 2|Other|0|||
149068682|NCT02719574|537736009|FG012|Phase 2|Other|5|||
149068683|NCT02719574|537736010|FG013|Phase 2|Other|7|||
149068684|NCT02719574|537736011|FG014|Phase 2|Other|0|||
149068685|NCT02719574|537736012|FG015|Phase 2|Other|1|||
149068686|NCT02719574|537736013|FG016|Phase 2|Other|4|||
149068687|NCT02719574|537735997|FG000|Phase 2|Transplant|0|||
149068688|NCT02719574|537735998|FG001|Phase 2|Transplant|0|||
149068689|NCT02719574|537735999|FG002|Phase 2|Transplant|0|||
149068690|NCT02719574|537736000|FG003|Phase 2|Transplant|0|||
149068691|NCT02719574|537736001|FG004|Phase 2|Transplant|0|||
149068692|NCT02719574|537736002|FG005|Phase 2|Transplant|0|||
149068693|NCT02719574|537736003|FG006|Phase 2|Transplant|0|||
149068694|NCT02719574|537736004|FG007|Phase 2|Transplant|0|||
149068695|NCT02719574|537736005|FG008|Phase 2|Transplant|0|||
149068696|NCT02719574|537736006|FG009|Phase 2|Transplant|15|||
149068697|NCT02719574|537736007|FG010|Phase 2|Transplant|2|||
149068698|NCT02719574|537736008|FG011|Phase 2|Transplant|0|||
149068699|NCT02719574|537736009|FG012|Phase 2|Transplant|6|||
149068700|NCT02719574|537736010|FG013|Phase 2|Transplant|1|||
149068701|NCT02719574|537736011|FG014|Phase 2|Transplant|1|||
149068702|NCT02719574|537736012|FG015|Phase 2|Transplant|0|||
149068703|NCT02719574|537736013|FG016|Phase 2|Transplant|0|||
149068704|NCT02719574|537735997|FG000|Phase 2|Death|0|||
149068705|NCT02719574|537735998|FG001|Phase 2|Death|0|||
149068706|NCT02719574|537735999|FG002|Phase 2|Death|0|||
149068707|NCT02719574|537736000|FG003|Phase 2|Death|0|||
149068708|NCT02719574|537736001|FG004|Phase 2|Death|0|||
149068709|NCT02719574|537736002|FG005|Phase 2|Death|0|||
149068710|NCT02719574|537736003|FG006|Phase 2|Death|0|||
149068711|NCT02719574|537736004|FG007|Phase 2|Death|0|||
149068712|NCT02719574|537736005|FG008|Phase 2|Death|0|||
149068713|NCT02719574|537736006|FG009|Phase 2|Death|14|||
149068714|NCT02719574|537736007|FG010|Phase 2|Death|0|||
149068715|NCT02719574|537736008|FG011|Phase 2|Death|0|||
149068716|NCT02719574|537736009|FG012|Phase 2|Death|1|||
149068717|NCT02719574|537736010|FG013|Phase 2|Death|1|||
149068718|NCT02719574|537736011|FG014|Phase 2|Death|2|||
149068719|NCT02719574|537736012|FG015|Phase 2|Death|0|||
149068720|NCT02719574|537736013|FG016|Phase 2|Death|0|||
149068721|NCT02719574|537735997|FG000|Phase 2|Investigator Decision|0|||
149068722|NCT02719574|537735998|FG001|Phase 2|Investigator Decision|0|||
149068723|NCT02719574|537735999|FG002|Phase 2|Investigator Decision|0|||
149068724|NCT02719574|537736000|FG003|Phase 2|Investigator Decision|0|||
149068725|NCT02719574|537736001|FG004|Phase 2|Investigator Decision|0|||
149068726|NCT02719574|537736002|FG005|Phase 2|Investigator Decision|0|||
149068727|NCT02719574|537736003|FG006|Phase 2|Investigator Decision|0|||
149068728|NCT02719574|537736004|FG007|Phase 2|Investigator Decision|0|||
149068729|NCT02719574|537736005|FG008|Phase 2|Investigator Decision|0|||
149068730|NCT02719574|537736006|FG009|Phase 2|Investigator Decision|6|||
149068731|NCT02719574|537736007|FG010|Phase 2|Investigator Decision|1|||
149068732|NCT02719574|537736008|FG011|Phase 2|Investigator Decision|2|||
149068733|NCT02719574|537736009|FG012|Phase 2|Investigator Decision|3|||
149068734|NCT02719574|537736010|FG013|Phase 2|Investigator Decision|1|||
149068735|NCT02719574|537736011|FG014|Phase 2|Investigator Decision|3|||
149068736|NCT02719574|537736012|FG015|Phase 2|Investigator Decision|2|||
149068737|NCT02719574|537736013|FG016|Phase 2|Investigator Decision|0|||
149068738|NCT02719574|537735997|FG000|Phase 2|Withdrawal by Subject|0|||
149068739|NCT02719574|537735998|FG001|Phase 2|Withdrawal by Subject|0|||
149068740|NCT02719574|537735999|FG002|Phase 2|Withdrawal by Subject|0|||
149068741|NCT02719574|537736000|FG003|Phase 2|Withdrawal by Subject|0|||
149068742|NCT02719574|537736001|FG004|Phase 2|Withdrawal by Subject|0|||
149068743|NCT02719574|537736002|FG005|Phase 2|Withdrawal by Subject|0|||
149068744|NCT02719574|537736003|FG006|Phase 2|Withdrawal by Subject|0|||
149068745|NCT02719574|537736004|FG007|Phase 2|Withdrawal by Subject|0|||
149068746|NCT02719574|537736005|FG008|Phase 2|Withdrawal by Subject|0|||
149068747|NCT02719574|537736006|FG009|Phase 2|Withdrawal by Subject|5|||
149068748|NCT02719574|537736007|FG010|Phase 2|Withdrawal by Subject|0|||
149068749|NCT02719574|537736008|FG011|Phase 2|Withdrawal by Subject|0|||
149068750|NCT02719574|537736009|FG012|Phase 2|Withdrawal by Subject|0|||
149068751|NCT02719574|537736010|FG013|Phase 2|Withdrawal by Subject|1|||
149068752|NCT02719574|537736011|FG014|Phase 2|Withdrawal by Subject|1|||
149068753|NCT02719574|537736012|FG015|Phase 2|Withdrawal by Subject|2|||
149068754|NCT02719574|537736013|FG016|Phase 2|Withdrawal by Subject|0|||
149068755|NCT02719574|537735997|FG000|Phase 2|Protocol Violation|0|||
149068756|NCT02719574|537735998|FG001|Phase 2|Protocol Violation|0|||
149068757|NCT02719574|537735999|FG002|Phase 2|Protocol Violation|0|||
149068758|NCT02719574|537736000|FG003|Phase 2|Protocol Violation|0|||
149068759|NCT02719574|537736001|FG004|Phase 2|Protocol Violation|0|||
149068760|NCT02719574|537736002|FG005|Phase 2|Protocol Violation|0|||
149068761|NCT02719574|537736003|FG006|Phase 2|Protocol Violation|0|||
149068762|NCT02719574|537736004|FG007|Phase 2|Protocol Violation|0|||
149068763|NCT02719574|537736005|FG008|Phase 2|Protocol Violation|0|||
149068764|NCT02719574|537736006|FG009|Phase 2|Protocol Violation|1|||
149068765|NCT02719574|537736007|FG010|Phase 2|Protocol Violation|0|||
149068766|NCT02719574|537736008|FG011|Phase 2|Protocol Violation|0|||
149068767|NCT02719574|537736009|FG012|Phase 2|Protocol Violation|0|||
149068768|NCT02719574|537736010|FG013|Phase 2|Protocol Violation|0|||
149068769|NCT02719574|537736011|FG014|Phase 2|Protocol Violation|0|||
149068770|NCT02719574|537736012|FG015|Phase 2|Protocol Violation|0|||
149068771|NCT02719574|537736013|FG016|Phase 2|Protocol Violation|0|||
149068772|NCT00495677|537736018|FG000|Stage 1 (25 Days)|Adverse Event|0|||
149068773|NCT00495677|537736019|FG001|Stage 1 (25 Days)|Adverse Event|0|||
149068774|NCT00495677|537736020|FG002|Stage 1 (25 Days)|Adverse Event|1|||
149068775|NCT00495677|537736021|FG003|Stage 1 (25 Days)|Adverse Event|0|||
149068776|NCT00495677|537736022|FG004|Stage 1 (25 Days)|Adverse Event|0|||
149068777|NCT00495677|537736023|FG005|Stage 1 (25 Days)|Adverse Event|0|||
149068778|NCT00495677|537736024|FG006|Stage 1 (25 Days)|Adverse Event|0|||
149068779|NCT03653364|537736029|FG000|Overall Study|Withdrawal by Subject|1|||
149068780|NCT03653364|537736029|FG000|Overall Study|Enrolled in Error|1|||
149068781|NCT03653364|537736029|FG000|Overall Study|Death|1|||
149068782|NCT03983382|537736036|FG000|Overall Study|Death|1|||
149068783|NCT03983382|537736036|FG000|Overall Study|Lost to Follow-up|3|||
149068784|NCT03983382|537736036|FG000|Overall Study|Physician Decision|2|||
149068785|NCT03983382|537736036|FG000|Overall Study|Withdrawal by Subject|10|||
149068786|NCT03983382|537736036|FG000|Overall Study|Change in cancer treatment|2|||
149068787|NCT02115282|537736046|FG000|Overall Study|Disease progression during treatment|216|||
149068788|NCT02115282|537736047|FG001|Overall Study|Disease progression during treatment|229|||
149068789|NCT02115282|537736046|FG000|Overall Study|Adverse Event|49|||
149068790|NCT02115282|537736047|FG001|Overall Study|Adverse Event|23|||
149068791|NCT02115282|537736046|FG000|Overall Study|Death|1|||
149068792|NCT02115282|537736047|FG001|Overall Study|Death|3|||
149068793|NCT02115282|537736046|FG000|Overall Study|Alternative therapy|1|||
149068794|NCT02115282|537736047|FG001|Overall Study|Alternative therapy|1|||
149068795|NCT02115282|537736046|FG000|Overall Study|Complicating disease|0|||
149068796|NCT02115282|537736047|FG001|Overall Study|Complicating disease|3|||
149068797|NCT02115282|537736046|FG000|Overall Study|Withdrawal by Subject|12|||
149068798|NCT02115282|537736047|FG001|Overall Study|Withdrawal by Subject|10|||
149068799|NCT02115282|537736046|FG000|Overall Study|Symptomatic progression/deterioration|7|||
149068800|NCT02115282|537736047|FG001|Overall Study|Symptomatic progression/deterioration|18|||
149068801|NCT02115282|537736046|FG000|Overall Study|Non-compliance|5|||
149068802|NCT02115282|537736047|FG001|Overall Study|Non-compliance|1|||
149068803|NCT02115282|537736046|FG000|Overall Study|Protocol Violation|2|||
149068804|NCT02115282|537736047|FG001|Overall Study|Protocol Violation|2|||
149068805|NCT02115282|537736046|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
149068806|NCT02115282|537736047|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
149068807|NCT02115282|537736046|FG000|Overall Study|Not start protocol therapy|9|||
149068808|NCT02115282|537736047|FG001|Overall Study|Not start protocol therapy|10|||
149068809|NCT02101853|537736050|FG000|Block 1 Induction|Adverse Event|11|||
149068810|NCT02101853|537736051|FG001|Block 1 Induction|Adverse Event|0|||
149068811|NCT02101853|537736052|FG002|Block 1 Induction|Adverse Event|0|||
149068812|NCT02101853|537736053|FG003|Block 1 Induction|Adverse Event|0|||
149068813|NCT02101853|537736054|FG004|Block 1 Induction|Adverse Event|0|||
149068814|NCT02101853|537736055|FG005|Block 1 Induction|Adverse Event|0|||
149068815|NCT02101853|537736050|FG000|Block 1 Induction|Death|20|||
149068816|NCT02101853|537736051|FG001|Block 1 Induction|Death|0|||
149068817|NCT02101853|537736052|FG002|Block 1 Induction|Death|0|||
149068818|NCT02101853|537736053|FG003|Block 1 Induction|Death|0|||
149068819|NCT02101853|537736054|FG004|Block 1 Induction|Death|0|||
149068820|NCT02101853|537736055|FG005|Block 1 Induction|Death|0|||
149068821|NCT02101853|537736050|FG000|Block 1 Induction|Lack of Efficacy|6|||
149068822|NCT02101853|537736051|FG001|Block 1 Induction|Lack of Efficacy|0|||
149068823|NCT02101853|537736052|FG002|Block 1 Induction|Lack of Efficacy|0|||
149068824|NCT02101853|537736053|FG003|Block 1 Induction|Lack of Efficacy|0|||
149068825|NCT02101853|537736054|FG004|Block 1 Induction|Lack of Efficacy|0|||
149068826|NCT02101853|537736055|FG005|Block 1 Induction|Lack of Efficacy|0|||
149068827|NCT02101853|537736050|FG000|Block 1 Induction|Physician Decision|61|||
149068828|NCT02101853|537736051|FG001|Block 1 Induction|Physician Decision|0|||
149068829|NCT02101853|537736052|FG002|Block 1 Induction|Physician Decision|0|||
149068830|NCT02101853|537736053|FG003|Block 1 Induction|Physician Decision|0|||
149068831|NCT02101853|537736054|FG004|Block 1 Induction|Physician Decision|0|||
149068832|NCT02101853|537736055|FG005|Block 1 Induction|Physician Decision|0|||
149068833|NCT02101853|537736050|FG000|Block 1 Induction|Protocol Violation|2|||
149068834|NCT02101853|537736051|FG001|Block 1 Induction|Protocol Violation|0|||
149068835|NCT02101853|537736052|FG002|Block 1 Induction|Protocol Violation|0|||
149068836|NCT02101853|537736053|FG003|Block 1 Induction|Protocol Violation|0|||
149068837|NCT02101853|537736054|FG004|Block 1 Induction|Protocol Violation|0|||
149068838|NCT02101853|537736055|FG005|Block 1 Induction|Protocol Violation|0|||
149068839|NCT02101853|537736050|FG000|Block 1 Induction|Withdrawal by Subject|65|||
149068840|NCT02101853|537736051|FG001|Block 1 Induction|Withdrawal by Subject|0|||
149068841|NCT02101853|537736052|FG002|Block 1 Induction|Withdrawal by Subject|0|||
149068842|NCT02101853|537736053|FG003|Block 1 Induction|Withdrawal by Subject|0|||
149068843|NCT02101853|537736054|FG004|Block 1 Induction|Withdrawal by Subject|0|||
149068844|NCT02101853|537736055|FG005|Block 1 Induction|Withdrawal by Subject|0|||
149068845|NCT02101853|537736050|FG000|Block 1 Induction|Ineligible|8|||
149068846|NCT02101853|537736051|FG001|Block 1 Induction|Ineligible|0|||
149068847|NCT02101853|537736052|FG002|Block 1 Induction|Ineligible|0|||
149068848|NCT02101853|537736053|FG003|Block 1 Induction|Ineligible|0|||
149068849|NCT02101853|537736054|FG004|Block 1 Induction|Ineligible|0|||
149068850|NCT02101853|537736055|FG005|Block 1 Induction|Ineligible|0|||
149068851|NCT02101853|537736050|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
149068852|NCT02101853|537736051|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
149068853|NCT02101853|537736052|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
149068854|NCT02101853|537736053|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
149068855|NCT02101853|537736054|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
149068856|NCT02101853|537736055|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
149068857|NCT02101853|537736050|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
149068858|NCT02101853|537736051|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068859|NCT02101853|537736052|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068860|NCT02101853|537736053|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068861|NCT02101853|537736054|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068862|NCT02101853|537736055|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068863|NCT02101853|537736050|FG000|Post Induction Randomization|Adverse Event|0|||
149068864|NCT02101853|537736051|FG001|Post Induction Randomization|Adverse Event|3|||
149068865|NCT02101853|537736052|FG002|Post Induction Randomization|Adverse Event|8|||
149068866|NCT02101853|537736053|FG003|Post Induction Randomization|Adverse Event|4|||
149068867|NCT02101853|537736054|FG004|Post Induction Randomization|Adverse Event|4|||
149068868|NCT02101853|537736055|FG005|Post Induction Randomization|Adverse Event|0|||
149068869|NCT02101853|537736050|FG000|Post Induction Randomization|Death|0|||
149068870|NCT02101853|537736051|FG001|Post Induction Randomization|Death|9|||
149068871|NCT02101853|537736052|FG002|Post Induction Randomization|Death|2|||
149068872|NCT02101853|537736053|FG003|Post Induction Randomization|Death|2|||
149068873|NCT02101853|537736054|FG004|Post Induction Randomization|Death|0|||
149068874|NCT02101853|537736055|FG005|Post Induction Randomization|Death|0|||
149068875|NCT02101853|537736050|FG000|Post Induction Randomization|Lack of Efficacy|0|||
149068876|NCT02101853|537736051|FG001|Post Induction Randomization|Lack of Efficacy|14|||
149068877|NCT02101853|537736052|FG002|Post Induction Randomization|Lack of Efficacy|23|||
149068878|NCT02101853|537736053|FG003|Post Induction Randomization|Lack of Efficacy|18|||
149068879|NCT02101853|537736054|FG004|Post Induction Randomization|Lack of Efficacy|21|||
149068880|NCT02101853|537736055|FG005|Post Induction Randomization|Lack of Efficacy|0|||
149068881|NCT02101853|537736050|FG000|Post Induction Randomization|Physician Decision|0|||
149068882|NCT02101853|537736051|FG001|Post Induction Randomization|Physician Decision|43|||
149068883|NCT02101853|537736052|FG002|Post Induction Randomization|Physician Decision|23|||
149068884|NCT02101853|537736053|FG003|Post Induction Randomization|Physician Decision|14|||
149068885|NCT02101853|537736054|FG004|Post Induction Randomization|Physician Decision|14|||
149068886|NCT02101853|537736055|FG005|Post Induction Randomization|Physician Decision|0|||
149068887|NCT02101853|537736050|FG000|Post Induction Randomization|Protocol Violation|0|||
149068888|NCT02101853|537736051|FG001|Post Induction Randomization|Protocol Violation|3|||
149068889|NCT02101853|537736052|FG002|Post Induction Randomization|Protocol Violation|0|||
149068890|NCT02101853|537736053|FG003|Post Induction Randomization|Protocol Violation|0|||
149068891|NCT02101853|537736054|FG004|Post Induction Randomization|Protocol Violation|0|||
149068892|NCT02101853|537736055|FG005|Post Induction Randomization|Protocol Violation|0|||
149068893|NCT02101853|537736050|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
149068894|NCT02101853|537736051|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
149068895|NCT02101853|537736052|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
149068896|NCT02101853|537736053|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
149068897|NCT02101853|537736054|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
149068898|NCT02101853|537736055|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
149068899|NCT02101853|537736050|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068900|NCT02101853|537736051|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068901|NCT02101853|537736052|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068902|NCT02101853|537736053|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
149068903|NCT02101853|537736054|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068904|NCT02101853|537736055|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
149068905|NCT02101853|537736050|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
149068906|NCT02101853|537736051|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
149068907|NCT02101853|537736052|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
149068908|NCT02101853|537736053|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
149068909|NCT02101853|537736054|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
149068910|NCT02101853|537736055|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
149068911|NCT02101853|537736050|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
149068912|NCT02101853|537736051|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
149068913|NCT02101853|537736052|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
149068914|NCT02101853|537736053|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
149068915|NCT02101853|537736054|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
149068916|NCT02101853|537736055|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
149068917|NCT02101853|537736050|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
149068918|NCT02101853|537736051|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
149068919|NCT02101853|537736052|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
149068920|NCT02101853|537736053|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
149068921|NCT02101853|537736054|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
149068922|NCT02101853|537736055|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
149068923|NCT02101853|537736050|FG000|Blinatumomab Salvage Therapy|Death|0|||
149068924|NCT02101853|537736051|FG001|Blinatumomab Salvage Therapy|Death|0|||
149068925|NCT02101853|537736052|FG002|Blinatumomab Salvage Therapy|Death|0|||
149068926|NCT02101853|537736053|FG003|Blinatumomab Salvage Therapy|Death|0|||
149068927|NCT02101853|537736054|FG004|Blinatumomab Salvage Therapy|Death|0|||
149068928|NCT02101853|537736055|FG005|Blinatumomab Salvage Therapy|Death|2|||
149068929|NCT02101853|537736050|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
149068930|NCT02101853|537736051|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
149068931|NCT02101853|537736052|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
149068932|NCT02101853|537736053|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
149068933|NCT02101853|537736054|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
149068934|NCT02101853|537736055|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
149068935|NCT02101853|537736050|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
149068936|NCT02101853|537736051|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
149068937|NCT02101853|537736052|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
149068938|NCT02101853|537736053|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
149068939|NCT02101853|537736054|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
149068940|NCT02101853|537736055|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
149068941|NCT02101853|537736050|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
149068942|NCT02101853|537736051|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
149068943|NCT02101853|537736052|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
149068944|NCT02101853|537736053|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
149068945|NCT02101853|537736054|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
149120219|NCT04602221|537918068|FG011|Overall Study|Other than listed|0|||
149068946|NCT02101853|537736055|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
149068947|NCT02112916|537736059|FG000|Overall Study|Adverse Event|6|||
149068948|NCT02112916|537736060|FG001|Overall Study|Adverse Event|9|||
149068949|NCT02112916|537736061|FG002|Overall Study|Adverse Event|3|||
149068950|NCT02112916|537736062|FG003|Overall Study|Adverse Event|2|||
149068951|NCT02112916|537736059|FG000|Overall Study|Death|9|||
149068952|NCT02112916|537736060|FG001|Overall Study|Death|9|||
149068953|NCT02112916|537736061|FG002|Overall Study|Death|3|||
149068954|NCT02112916|537736062|FG003|Overall Study|Death|4|||
149068955|NCT02112916|537736059|FG000|Overall Study|Lost to Follow-up|1|||
149068956|NCT02112916|537736060|FG001|Overall Study|Lost to Follow-up|0|||
149068957|NCT02112916|537736061|FG002|Overall Study|Lost to Follow-up|0|||
149068958|NCT02112916|537736062|FG003|Overall Study|Lost to Follow-up|0|||
149068959|NCT02112916|537736059|FG000|Overall Study|Physician Decision|94|||
149068960|NCT02112916|537736060|FG001|Overall Study|Physician Decision|72|||
149068961|NCT02112916|537736061|FG002|Overall Study|Physician Decision|24|||
149068962|NCT02112916|537736062|FG003|Overall Study|Physician Decision|15|||
149068963|NCT02112916|537736059|FG000|Overall Study|Withdrawal by Subject|5|||
149068964|NCT02112916|537736060|FG001|Overall Study|Withdrawal by Subject|3|||
149068965|NCT02112916|537736061|FG002|Overall Study|Withdrawal by Subject|1|||
149068966|NCT02112916|537736062|FG003|Overall Study|Withdrawal by Subject|1|||
149068967|NCT02112916|537736059|FG000|Overall Study|Ineligible|4|||
149068968|NCT02112916|537736060|FG001|Overall Study|Ineligible|8|||
149068969|NCT02112916|537736061|FG002|Overall Study|Ineligible|3|||
149068970|NCT02112916|537736062|FG003|Overall Study|Ineligible|8|||
149068971|NCT02112916|537736059|FG000|Overall Study|Inevaluable|6|||
149068972|NCT02112916|537736060|FG001|Overall Study|Inevaluable|4|||
149068973|NCT02112916|537736061|FG002|Overall Study|Inevaluable|5|||
149068974|NCT02112916|537736062|FG003|Overall Study|Inevaluable|5|||
149068975|NCT02112916|537736059|FG000|Overall Study|Refusal of further protocol therapy|19|||
149068976|NCT02112916|537736060|FG001|Overall Study|Refusal of further protocol therapy|16|||
149068977|NCT02112916|537736061|FG002|Overall Study|Refusal of further protocol therapy|1|||
149068978|NCT02112916|537736062|FG003|Overall Study|Refusal of further protocol therapy|7|||
149068979|NCT02112916|537736059|FG000|Overall Study|Development of SMN|1|||
149068980|NCT02112916|537736060|FG001|Overall Study|Development of SMN|0|||
149068981|NCT02112916|537736061|FG002|Overall Study|Development of SMN|0|||
149068982|NCT02112916|537736062|FG003|Overall Study|Development of SMN|1|||
149068983|NCT02112916|537736059|FG000|Overall Study|Relapse/Progression|10|||
149068984|NCT02112916|537736060|FG001|Overall Study|Relapse/Progression|18|||
149068985|NCT02112916|537736061|FG002|Overall Study|Relapse/Progression|15|||
149068986|NCT02112916|537736062|FG003|Overall Study|Relapse/Progression|2|||
149068987|NCT02112916|537736059|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
149068988|NCT02112916|537736060|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
149068989|NCT02112916|537736061|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
149068990|NCT02112916|537736062|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
149068991|NCT02112916|537736059|FG000|Overall Study|Still on Therapy|44|||
149068992|NCT02112916|537736060|FG001|Overall Study|Still on Therapy|47|||
149068993|NCT02112916|537736061|FG002|Overall Study|Still on Therapy|3|||
149068994|NCT02112916|537736062|FG003|Overall Study|Still on Therapy|2|||
149068995|NCT02112916|537736059|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
149068996|NCT02112916|537736060|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
149068997|NCT02112916|537736061|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
149068998|NCT02112916|537736062|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
149068999|NCT02112916|537736059|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
149069000|NCT02112916|537736060|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
149069001|NCT02112916|537736061|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
149069002|NCT02112916|537736062|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
149069003|NCT04174560|537736063|FG000|Overall Study|Lost to Follow-up|1|||
149069004|NCT04174560|537736064|FG001|Overall Study|Lost to Follow-up|0|||
149069005|NCT04174560|537736065|FG002|Overall Study|Lost to Follow-up|0|||
149069006|NCT04174560|537736066|FG003|Overall Study|Lost to Follow-up|0|||
149069007|NCT04174560|537736063|FG000|Overall Study|Withdrawal by Subject|0|||
149069008|NCT04174560|537736064|FG001|Overall Study|Withdrawal by Subject|0|||
149069009|NCT04174560|537736065|FG002|Overall Study|Withdrawal by Subject|2|||
149069010|NCT04174560|537736066|FG003|Overall Study|Withdrawal by Subject|0|||
149069011|NCT04479787|537736073|FG000|Through 6 Months|Withdrawal by Subject|16|||
149069012|NCT04479787|537736074|FG001|Through 6 Months|Withdrawal by Subject|14|||
149069013|NCT04479787|537736073|FG000|Through 6 Months|Unsuccessful Trial|17|||
149069014|NCT04479787|537736074|FG001|Through 6 Months|Unsuccessful Trial|0|||
149069015|NCT04479787|537736073|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
149069016|NCT04479787|537736074|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
149069017|NCT04479787|537736073|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
149120220|NCT04602221|537918069|FG012|Overall Study|Other than listed|0|||
149069018|NCT04479787|537736074|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
149069019|NCT04479787|537736073|FG000|Through 6 Months|Lost to Follow-up|3|||
149069020|NCT04479787|537736074|FG001|Through 6 Months|Lost to Follow-up|2|||
149069021|NCT04479787|537736073|FG000|Through 6 Months|Death|3|||
149069022|NCT04479787|537736074|FG001|Through 6 Months|Death|0|||
149069023|NCT04479787|537736073|FG000|Through 6 Months|Inclusion/Exclusion|2|||
149069024|NCT04479787|537736074|FG001|Through 6 Months|Inclusion/Exclusion|1|||
149069025|NCT04479787|537736073|FG000|Through 6 Months|Subject Became Pregnant|1|||
149069026|NCT04479787|537736074|FG001|Through 6 Months|Subject Became Pregnant|1|||
149069027|NCT04479787|537736073|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
149069028|NCT04479787|537736074|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
149069029|NCT04479787|537736073|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
149069030|NCT04479787|537736074|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
149069031|NCT04479787|537736073|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
149069032|NCT04479787|537736074|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
149069033|NCT04479787|537736073|FG000|After 6 Months|Withdrawal by Subject|3|||
149069034|NCT04479787|537736074|FG001|After 6 Months|Withdrawal by Subject|13|||
149069035|NCT04479787|537736073|FG000|After 6 Months|Unsuccessful Trial|0|||
149069036|NCT04479787|537736074|FG001|After 6 Months|Unsuccessful Trial|7|||
149069037|NCT04479787|537736073|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
149069038|NCT04479787|537736074|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
149069039|NCT04479787|537736073|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
149069040|NCT04479787|537736074|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
149069041|NCT04479787|537736073|FG000|After 6 Months|Death|2|||
149069042|NCT04479787|537736074|FG001|After 6 Months|Death|0|||
149069043|NCT04479787|537736073|FG000|After 6 Months|Lost to Follow-up|1|||
149069044|NCT04479787|537736074|FG001|After 6 Months|Lost to Follow-up|1|||
149069045|NCT04479787|537736073|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
149069046|NCT04479787|537736074|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
149069047|NCT04479787|537736073|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
149069048|NCT04479787|537736074|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
149069049|NCT04479787|537736073|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
149069050|NCT04479787|537736074|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
149069051|NCT04479787|537736073|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
149069052|NCT04479787|537736074|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
149069053|NCT05714059|537736077|FG000|Overall Study|Withdrawal by Subject|2|||
149069054|NCT05714059|537736078|FG001|Overall Study|Withdrawal by Subject|2|||
149069055|NCT05714059|537736077|FG000|Overall Study|Adverse Event|0|||
149069056|NCT05714059|537736078|FG001|Overall Study|Adverse Event|1|||
149069057|NCT05714059|537736077|FG000|Overall Study|Lost to Follow-up|0|||
149069058|NCT05714059|537736078|FG001|Overall Study|Lost to Follow-up|1|||
149069059|NCT05714059|537736077|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
149069060|NCT05714059|537736078|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
149069061|NCT05714059|537736077|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
149069062|NCT05714059|537736078|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
149069063|NCT04899674|537736079|FG000|Test|Adverse Event|1|||
149069064|NCT03774472|537736080|FG000|Overall Study|Physician Decision|1|||
149069065|NCT03774472|537736081|FG001|Overall Study|Physician Decision|0|||
149069066|NCT03774472|537736082|FG002|Overall Study|Physician Decision|0|||
149069067|NCT03774472|537736080|FG000|Overall Study|Progression prior to 4 weeks|0|||
149069068|NCT03774472|537736081|FG001|Overall Study|Progression prior to 4 weeks|1|||
149069069|NCT03774472|537736082|FG002|Overall Study|Progression prior to 4 weeks|0|||
149069070|NCT03774472|537736080|FG000|Overall Study|Withdrawal by Subject|0|||
149069071|NCT03774472|537736081|FG001|Overall Study|Withdrawal by Subject|1|||
149069072|NCT03774472|537736082|FG002|Overall Study|Withdrawal by Subject|0|||
149069073|NCT03150862|537736084|FG000|Overall Study|Death|2|||
149069074|NCT03150862|537736085|FG001|Overall Study|Death|7|||
149069075|NCT03150862|537736086|FG002|Overall Study|Death|8|||
149069076|NCT03150862|537736087|FG003|Overall Study|Death|27|||
149069077|NCT03150862|537736088|FG004|Overall Study|Death|4|||
149069078|NCT03150862|537736089|FG005|Overall Study|Death|8|||
149069079|NCT03150862|537736090|FG006|Overall Study|Death|6|||
149069080|NCT03150862|537736091|FG007|Overall Study|Death|21|||
149069081|NCT03150862|537736084|FG000|Overall Study|Withdrawal by Subject|1|||
149069082|NCT03150862|537736085|FG001|Overall Study|Withdrawal by Subject|1|||
149069083|NCT03150862|537736086|FG002|Overall Study|Withdrawal by Subject|0|||
149069084|NCT03150862|537736087|FG003|Overall Study|Withdrawal by Subject|3|||
149069085|NCT03150862|537736088|FG004|Overall Study|Withdrawal by Subject|1|||
149069086|NCT03150862|537736089|FG005|Overall Study|Withdrawal by Subject|1|||
149069087|NCT03150862|537736090|FG006|Overall Study|Withdrawal by Subject|1|||
149069088|NCT03150862|537736091|FG007|Overall Study|Withdrawal by Subject|3|||
149069089|NCT03150862|537736084|FG000|Overall Study|Lost to Follow-up|0|||
149069090|NCT03150862|537736085|FG001|Overall Study|Lost to Follow-up|0|||
149069091|NCT03150862|537736086|FG002|Overall Study|Lost to Follow-up|1|||
149069092|NCT03150862|537736087|FG003|Overall Study|Lost to Follow-up|0|||
149069093|NCT03150862|537736088|FG004|Overall Study|Lost to Follow-up|0|||
149069094|NCT03150862|537736089|FG005|Overall Study|Lost to Follow-up|0|||
149069095|NCT03150862|537736090|FG006|Overall Study|Lost to Follow-up|0|||
149069096|NCT03150862|537736091|FG007|Overall Study|Lost to Follow-up|2|||
149069097|NCT03150862|537736084|FG000|Overall Study|Sponsor's decision|0|||
149069098|NCT03150862|537736085|FG001|Overall Study|Sponsor's decision|0|||
149069099|NCT03150862|537736086|FG002|Overall Study|Sponsor's decision|0|||
149069100|NCT03150862|537736087|FG003|Overall Study|Sponsor's decision|10|||
149069101|NCT03150862|537736088|FG004|Overall Study|Sponsor's decision|3|||
149069102|NCT03150862|537736089|FG005|Overall Study|Sponsor's decision|0|||
149069103|NCT03150862|537736090|FG006|Overall Study|Sponsor's decision|1|||
149069104|NCT03150862|537736091|FG007|Overall Study|Sponsor's decision|1|||
149069105|NCT03150862|537736084|FG000|Overall Study|Change in Methylation status|0|||
149069106|NCT03150862|537736085|FG001|Overall Study|Change in Methylation status|0|||
149069107|NCT03150862|537736086|FG002|Overall Study|Change in Methylation status|0|||
149069108|NCT03150862|537736087|FG003|Overall Study|Change in Methylation status|0|||
149069109|NCT03150862|537736088|FG004|Overall Study|Change in Methylation status|1|||
149069110|NCT03150862|537736089|FG005|Overall Study|Change in Methylation status|0|||
149069111|NCT03150862|537736090|FG006|Overall Study|Change in Methylation status|0|||
149069112|NCT03150862|537736091|FG007|Overall Study|Change in Methylation status|0|||
149069113|NCT03150862|537736084|FG000|Overall Study|Roll over in to Long Term Extension|0|||
149069114|NCT03150862|537736085|FG001|Overall Study|Roll over in to Long Term Extension|0|||
149069115|NCT03150862|537736086|FG002|Overall Study|Roll over in to Long Term Extension|0|||
149069116|NCT03150862|537736087|FG003|Overall Study|Roll over in to Long Term Extension|0|||
149069117|NCT03150862|537736088|FG004|Overall Study|Roll over in to Long Term Extension|0|||
149069118|NCT03150862|537736089|FG005|Overall Study|Roll over in to Long Term Extension|0|||
149069119|NCT03150862|537736090|FG006|Overall Study|Roll over in to Long Term Extension|0|||
149069120|NCT03150862|537736091|FG007|Overall Study|Roll over in to Long Term Extension|1|||
149069121|NCT03150862|537736084|FG000|Overall Study|Progressive Disease|0|||
149069122|NCT03150862|537736085|FG001|Overall Study|Progressive Disease|0|||
149069123|NCT03150862|537736086|FG002|Overall Study|Progressive Disease|0|||
149069124|NCT03150862|537736087|FG003|Overall Study|Progressive Disease|0|||
149069125|NCT03150862|537736088|FG004|Overall Study|Progressive Disease|0|||
149069126|NCT03150862|537736089|FG005|Overall Study|Progressive Disease|0|||
149069127|NCT03150862|537736090|FG006|Overall Study|Progressive Disease|0|||
149069128|NCT03150862|537736091|FG007|Overall Study|Progressive Disease|2|||
149069129|NCT01171976|537736551|FG000|Overall Study|Protocol Violation|0|||
149069130|NCT01171976|537736552|FG001|Overall Study|Protocol Violation|0|||
149069131|NCT01171976|537736553|FG002|Overall Study|Protocol Violation|1|||
149069132|NCT01171976|537736551|FG000|Overall Study|Death|2|||
149069133|NCT01171976|537736552|FG001|Overall Study|Death|4|||
149069134|NCT01171976|537736553|FG002|Overall Study|Death|1|||
149069135|NCT01171976|537736551|FG000|Overall Study|Lost to Follow-up|4|||
149069136|NCT01171976|537736552|FG001|Overall Study|Lost to Follow-up|0|||
149069137|NCT01171976|537736553|FG002|Overall Study|Lost to Follow-up|2|||
149069138|NCT01171976|537736551|FG000|Overall Study|Withdrawal by Subject|1|||
149069139|NCT01171976|537736552|FG001|Overall Study|Withdrawal by Subject|5|||
149069140|NCT01171976|537736553|FG002|Overall Study|Withdrawal by Subject|6|||
149069141|NCT01171976|537736551|FG000|Overall Study|Abnormal test result|1|||
149069142|NCT01171976|537736552|FG001|Overall Study|Abnormal test result|0|||
149069143|NCT01171976|537736553|FG002|Overall Study|Abnormal test result|0|||
149069144|NCT01171976|537736551|FG000|Overall Study|Adverse Event|6|||
149069145|NCT01171976|537736552|FG001|Overall Study|Adverse Event|2|||
149069146|NCT01171976|537736553|FG002|Overall Study|Adverse Event|5|||
149069147|NCT00003222|537736558|FG000|Overall Study|Physician Decision|0|||
149069148|NCT00003222|537736559|FG001|Overall Study|Physician Decision|1|||
149069149|NCT03767335|537736571|FG000|Overall Study|Physician Decision|1|||
149069150|NCT03767335|537736572|FG001|Overall Study|Physician Decision|1|||
149069151|NCT03767335|537736573|FG002|Overall Study|Physician Decision|0|||
149069152|NCT03767335|537736571|FG000|Overall Study|Withdrawal by Subject|0|||
149069153|NCT03767335|537736572|FG001|Overall Study|Withdrawal by Subject|0|||
149069154|NCT03767335|537736573|FG002|Overall Study|Withdrawal by Subject|6|||
149069155|NCT03767335|537736571|FG000|Overall Study|Participant excluded from efficacy population|0|||
149069156|NCT03767335|537736572|FG001|Overall Study|Participant excluded from efficacy population|0|||
149069157|NCT03767335|537736573|FG002|Overall Study|Participant excluded from efficacy population|1|||
149069158|NCT03767335|537736571|FG000|Overall Study|Death|0|||
149069159|NCT03767335|537736572|FG001|Overall Study|Death|0|||
149069160|NCT03767335|537736573|FG002|Overall Study|Death|2|||
149069161|NCT03767335|537736571|FG000|Overall Study|Progressive Disease|2|||
149069162|NCT03767335|537736572|FG001|Overall Study|Progressive Disease|2|||
149069163|NCT03767335|537736573|FG002|Overall Study|Progressive Disease|2|||
149069164|NCT03767335|537736571|FG000|Overall Study|Disease progression needing additional medication|0|||
149069165|NCT03767335|537736572|FG001|Overall Study|Disease progression needing additional medication|0|||
149069166|NCT03767335|537736573|FG002|Overall Study|Disease progression needing additional medication|17|||
149069167|NCT03767335|537736571|FG000|Overall Study|Sponsor decision|0|||
149069168|NCT03767335|537736572|FG001|Overall Study|Sponsor decision|0|||
149069169|NCT03767335|537736573|FG002|Overall Study|Sponsor decision|2|||
149069170|NCT03767335|537736571|FG000|Overall Study|Other Medical Reasons|0|||
149069171|NCT03767335|537736572|FG001|Overall Study|Other Medical Reasons|0|||
149069172|NCT03767335|537736573|FG002|Overall Study|Other Medical Reasons|3|||
149069173|NCT01313559|537736574|FG000|Overall Study|Withdrawal by Subject|1|||
149069174|NCT01313559|537736575|FG001|Overall Study|Withdrawal by Subject|2|||
149069175|NCT01313559|537736574|FG000|Overall Study|Disease progression|1|||
149069176|NCT01313559|537736575|FG001|Overall Study|Disease progression|0|||
149069177|NCT01313559|537736574|FG000|Overall Study|Rising PSA|2|||
149069178|NCT01313559|537736575|FG001|Overall Study|Rising PSA|0|||
149069179|NCT02754596|537736576|FG000|Overall Study|Withdrawal by Subject|3|||
149069180|NCT02754596|537736577|FG001|Overall Study|Withdrawal by Subject|4|||
149069181|NCT02754596|537736578|FG002|Overall Study|Withdrawal by Subject|0|||
149069182|NCT02754596|537736576|FG000|Overall Study|Physician Decision|1|||
149069183|NCT02754596|537736577|FG001|Overall Study|Physician Decision|1|||
149069184|NCT02754596|537736578|FG002|Overall Study|Physician Decision|1|||
149069185|NCT02754596|537736576|FG000|Overall Study|Lost to Follow-up|1|||
149069186|NCT02754596|537736577|FG001|Overall Study|Lost to Follow-up|1|||
149069187|NCT02754596|537736578|FG002|Overall Study|Lost to Follow-up|2|||
149069188|NCT02754596|537736576|FG000|Overall Study|Death|0|||
149069189|NCT02754596|537736577|FG001|Overall Study|Death|2|||
149069190|NCT02754596|537736578|FG002|Overall Study|Death|0|||
149069191|NCT02754596|537736576|FG000|Overall Study|Adverse Event|1|||
149069192|NCT02754596|537736577|FG001|Overall Study|Adverse Event|0|||
149069193|NCT02754596|537736578|FG002|Overall Study|Adverse Event|1|||
149069194|NCT02754596|537736576|FG000|Overall Study|Other|1|||
149069195|NCT02754596|537736577|FG001|Overall Study|Other|0|||
149069196|NCT02754596|537736578|FG002|Overall Study|Other|0|||
149069197|NCT03782116|537736581|FG000|Completed Intervetion|Lost to Follow-up|11|||
149069198|NCT03782116|537736582|FG001|Completed Intervetion|Lost to Follow-up|7|||
149069199|NCT03782116|537736581|FG000|Completed Intervetion|Withdrawal by Subject|6|||
149069200|NCT03782116|537736582|FG001|Completed Intervetion|Withdrawal by Subject|5|||
149069201|NCT03782116|537736581|FG000|Included in Analysis|Protocol Violation|5|||
149069202|NCT03782116|537736582|FG001|Included in Analysis|Protocol Violation|5|||
149069203|NCT05934292|537736584|FG000|Overall Study|Lost to Follow-up|0|||
149069204|NCT05934292|537736585|FG001|Overall Study|Lost to Follow-up|0|||
149069205|NCT05934292|537736586|FG002|Overall Study|Lost to Follow-up|1|||
149069206|NCT05934292|537736587|FG003|Overall Study|Lost to Follow-up|0|||
149069207|NCT05039021|537737374|FG000|Overall Study|Death|1|||
149069208|NCT05039021|537737374|FG000|Overall Study|Lost to Follow-up|3|||
149069209|NCT02566889|537737377|FG000|Overall Study|Withdrawal by Subject|3|||
149069210|NCT02566889|537737378|FG001|Overall Study|Withdrawal by Subject|1|||
149069211|NCT02566889|537737377|FG000|Overall Study|Adverse Event|4|||
149069212|NCT02566889|537737378|FG001|Overall Study|Adverse Event|2|||
149069213|NCT02566889|537737377|FG000|Overall Study|Other|6|||
149069214|NCT02566889|537737378|FG001|Overall Study|Other|2|||
149069215|NCT03140670|537737379|FG000|Overall Study|Withdrawal by Subject|2|||
149069216|NCT03140670|537737379|FG000|Overall Study|Lost to Follow-up|1|||
149069217|NCT03140670|537737379|FG000|Overall Study|Physician Decision|1|||
149069218|NCT00220805|537737380|FG000|Overall Study|Adverse Event|1|||
149069219|NCT00220805|537737381|FG001|Overall Study|Adverse Event|3|||
149069220|NCT00220805|537737380|FG000|Overall Study|Withdrawal by Subject|3|||
149069221|NCT00220805|537737381|FG001|Overall Study|Withdrawal by Subject|0|||
149069222|NCT00220805|537737380|FG000|Overall Study|Lack of Efficacy|1|||
149069223|NCT00220805|537737381|FG001|Overall Study|Lack of Efficacy|0|||
149069224|NCT00220805|537737380|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
149069225|NCT00220805|537737381|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
149069226|NCT02325466|537737382|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
149069227|NCT02325466|537737383|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
149069228|NCT02325466|537737384|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
149069229|NCT02325466|537737382|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
149069230|NCT02325466|537737383|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
149069231|NCT02325466|537737384|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
149069232|NCT02325466|537737382|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
149069233|NCT02325466|537737383|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
149069234|NCT02325466|537737384|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
149069235|NCT02325466|537737382|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
149069236|NCT02325466|537737383|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
149069237|NCT02325466|537737384|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
149069238|NCT02325466|537737382|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
149069239|NCT02325466|537737383|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
149069240|NCT02325466|537737384|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
149069241|NCT02325466|537737382|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
149069242|NCT02325466|537737383|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
149069243|NCT02325466|537737384|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
149069244|NCT02325466|537737382|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
149069245|NCT02325466|537737383|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
149069246|NCT02325466|537737384|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
149069247|NCT02325466|537737382|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
149069248|NCT02325466|537737383|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
149069249|NCT02325466|537737384|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
149069250|NCT02325466|537737382|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
149069251|NCT02325466|537737383|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
149069252|NCT02325466|537737384|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
149069253|NCT03699163|537737385|FG000|Overall Study|Physician Decision|12|||
149069254|NCT03699163|537737386|FG001|Overall Study|Physician Decision|0|||
149069255|NCT03699163|537737385|FG000|Overall Study|failed QC measures|205|||
149069256|NCT03699163|537737386|FG001|Overall Study|failed QC measures|206|||
149069257|NCT01260896|537737393|FG000|First Intervention|Withdrawn Due to Emesis|2|||
149069258|NCT01260896|537737394|FG001|First Intervention|Withdrawn Due to Emesis|0|||
149069259|NCT00982644|537737395|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
149069260|NCT00982644|537737396|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
149069261|NCT00982644|537737395|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
149069262|NCT00982644|537737396|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
149069263|NCT00982644|537737395|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
149069264|NCT00982644|537737396|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
149069265|NCT00982644|537737395|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
149069266|NCT00982644|537737396|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
149069267|NCT00982644|537737395|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
149069268|NCT00982644|537737396|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
149069269|NCT00982644|537737395|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
149069270|NCT00982644|537737396|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
149069271|NCT00982644|537737395|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
149069272|NCT00982644|537737396|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
149069273|NCT00982644|537737395|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
149069274|NCT00982644|537737396|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
149069275|NCT00982644|537737395|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
149069276|NCT00982644|537737396|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
149069277|NCT00982644|537737395|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
149069278|NCT00982644|537737396|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
149069279|NCT03213457|537737397|FG000|Screening Period|Withdrawal by Subject|0|||
149069280|NCT03213457|537737398|FG001|Screening Period|Withdrawal by Subject|1|||
149069281|NCT03213457|537737399|FG002|Screening Period|Withdrawal by Subject|0|||
149069282|NCT03213457|537737397|FG000|Screening Period|Other|1|||
149069283|NCT03213457|537737398|FG001|Screening Period|Other|0|||
149069284|NCT03213457|537737399|FG002|Screening Period|Other|0|||
149069285|NCT03213457|537737397|FG000|Double-Blind Period|Adverse Event|3|||
149069286|NCT03213457|537737398|FG001|Double-Blind Period|Adverse Event|2|||
149069287|NCT03213457|537737399|FG002|Double-Blind Period|Adverse Event|7|||
149069288|NCT03213457|537737397|FG000|Double-Blind Period|Withdrawal by Subject|14|||
149069289|NCT03213457|537737398|FG001|Double-Blind Period|Withdrawal by Subject|2|||
149069290|NCT03213457|537737399|FG002|Double-Blind Period|Withdrawal by Subject|14|||
149069291|NCT03213457|537737397|FG000|Double-Blind Period|Lost to Follow-up|2|||
149069292|NCT03213457|537737398|FG001|Double-Blind Period|Lost to Follow-up|3|||
149069293|NCT03213457|537737399|FG002|Double-Blind Period|Lost to Follow-up|9|||
149069294|NCT03213457|537737397|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
149069295|NCT03213457|537737398|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
149069296|NCT03213457|537737399|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
149069297|NCT03213457|537737397|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
149069298|NCT03213457|537737398|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
149069299|NCT03213457|537737399|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
149069300|NCT03213457|537737397|FG000|Double-Blind Period|Pregnancy|5|||
149069301|NCT03213457|537737398|FG001|Double-Blind Period|Pregnancy|0|||
149069302|NCT03213457|537737399|FG002|Double-Blind Period|Pregnancy|0|||
149069303|NCT03213457|537737397|FG000|Double-Blind Period|Other|10|||
149069304|NCT03213457|537737398|FG001|Double-Blind Period|Other|3|||
149069305|NCT03213457|537737399|FG002|Double-Blind Period|Other|17|||
149069306|NCT03213457|537737397|FG000|Open-Label Period|Adverse Event|1|||
149069307|NCT03213457|537737398|FG001|Open-Label Period|Adverse Event|2|||
149069308|NCT03213457|537737399|FG002|Open-Label Period|Adverse Event|2|||
149069309|NCT03213457|537737397|FG000|Open-Label Period|Withdrawal by Subject|12|||
149069310|NCT03213457|537737398|FG001|Open-Label Period|Withdrawal by Subject|5|||
149069311|NCT03213457|537737399|FG002|Open-Label Period|Withdrawal by Subject|24|||
149069312|NCT03213457|537737397|FG000|Open-Label Period|Lost to Follow-up|1|||
149069313|NCT03213457|537737398|FG001|Open-Label Period|Lost to Follow-up|2|||
149069314|NCT03213457|537737399|FG002|Open-Label Period|Lost to Follow-up|8|||
149069315|NCT03213457|537737397|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
149069316|NCT03213457|537737398|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
149069317|NCT03213457|537737399|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
149069318|NCT03213457|537737397|FG000|Open-Label Period|Non-compliance with study procedures|1|||
149069319|NCT03213457|537737398|FG001|Open-Label Period|Non-compliance with study procedures|1|||
149069320|NCT03213457|537737399|FG002|Open-Label Period|Non-compliance with study procedures|2|||
149069321|NCT03213457|537737397|FG000|Open-Label Period|Exclusionary medications|0|||
149069322|NCT03213457|537737398|FG001|Open-Label Period|Exclusionary medications|0|||
149069323|NCT03213457|537737399|FG002|Open-Label Period|Exclusionary medications|1|||
149069324|NCT03213457|537737397|FG000|Open-Label Period|Other|1|||
149069325|NCT03213457|537737398|FG001|Open-Label Period|Other|1|||
149069326|NCT03213457|537737399|FG002|Open-Label Period|Other|6|||
149069327|NCT03213457|537737397|FG000|Follow-Up Period|Adverse Event|16|||
149069328|NCT03213457|537737398|FG001|Follow-Up Period|Adverse Event|8|||
149069329|NCT03213457|537737399|FG002|Follow-Up Period|Adverse Event|37|||
149069330|NCT03213457|537737397|FG000|Follow-Up Period|Withdrawal by Subject|18|||
149069331|NCT03213457|537737398|FG001|Follow-Up Period|Withdrawal by Subject|11|||
149069332|NCT03213457|537737399|FG002|Follow-Up Period|Withdrawal by Subject|55|||
149069333|NCT03213457|537737397|FG000|Follow-Up Period|Lost to Follow-up|28|||
149069334|NCT03213457|537737398|FG001|Follow-Up Period|Lost to Follow-up|15|||
149069335|NCT03213457|537737399|FG002|Follow-Up Period|Lost to Follow-up|50|||
149069336|NCT03213457|537737397|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
149069337|NCT03213457|537737398|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
149069338|NCT03213457|537737399|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
149069339|NCT03213457|537737397|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
149069340|NCT03213457|537737398|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
149069341|NCT03213457|537737399|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
149069342|NCT03213457|537737397|FG000|Follow-Up Period|Pregnancy|7|||
149069343|NCT03213457|537737398|FG001|Follow-Up Period|Pregnancy|0|||
149069344|NCT03213457|537737399|FG002|Follow-Up Period|Pregnancy|18|||
149069345|NCT03213457|537737397|FG000|Follow-Up Period|Exclusionary medications|1|||
149069346|NCT03213457|537737398|FG001|Follow-Up Period|Exclusionary medications|1|||
149069347|NCT03213457|537737399|FG002|Follow-Up Period|Exclusionary medications|5|||
149069348|NCT03213457|537737397|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
149069349|NCT03213457|537737398|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
149069350|NCT03213457|537737399|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
149069351|NCT03213457|537737397|FG000|Follow-Up Period|Other|14|||
149069352|NCT03213457|537737398|FG001|Follow-Up Period|Other|10|||
149069353|NCT03213457|537737399|FG002|Follow-Up Period|Other|31|||
149069354|NCT02951052|537737400|FG000|Overall Study|Adverse Event|13|||
149069355|NCT02951052|537737401|FG001|Overall Study|Adverse Event|5|||
149069356|NCT02951052|537737400|FG000|Overall Study|Withdrawal by Subject|1|||
149069357|NCT02951052|537737401|FG001|Overall Study|Withdrawal by Subject|5|||
149069358|NCT02951052|537737400|FG000|Overall Study|Physician Decision|2|||
149069359|NCT02951052|537737401|FG001|Overall Study|Physician Decision|0|||
149069360|NCT02951052|537737400|FG000|Overall Study|Lost to Follow-up|1|||
149069361|NCT02951052|537737401|FG001|Overall Study|Lost to Follow-up|1|||
149069362|NCT02951052|537737400|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
149069363|NCT02951052|537737401|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
149069364|NCT02951052|537737400|FG000|Overall Study|Protocol Violation|5|||
149069365|NCT02951052|537737401|FG001|Overall Study|Protocol Violation|3|||
149069366|NCT02951052|537737400|FG000|Overall Study|Lack of Efficacy|3|||
149069367|NCT02951052|537737401|FG001|Overall Study|Lack of Efficacy|4|||
149069368|NCT02951052|537737400|FG000|Overall Study|Ongoing|1|||
149069369|NCT02951052|537737401|FG001|Overall Study|Ongoing|0|||
149069370|NCT04908514|537737410|FG000|Overall Study|Lost to Follow-up|2|||
149069371|NCT04908514|537737410|FG000|Overall Study|Withdrawal by Subject|1|||
149069372|NCT04059406|537737413|FG000|Overall Study|Early Treatment Termination|5|||
149069373|NCT04059406|537737414|FG001|Overall Study|Early Treatment Termination|5|||
149069374|NCT04059406|537737415|FG002|Overall Study|Early Treatment Termination|15|||
149069375|NCT05155306|537737416|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
149069376|NCT05155306|537737417|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
149069377|NCT05155306|537737418|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
149069378|NCT05155306|537737419|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
149069379|NCT05155306|537737416|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
149069380|NCT05155306|537737417|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
149069381|NCT05155306|537737418|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
149069382|NCT05155306|537737419|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
149069383|NCT04158141|537737420|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
149069384|NCT04158141|537737421|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
149069385|NCT04158141|537737422|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
149069386|NCT04158141|537737420|FG000|Step 1: Registration|Adverse Event|1|||
149069387|NCT04158141|537737421|FG001|Step 1: Registration|Adverse Event|0|||
149069388|NCT04158141|537737422|FG002|Step 1: Registration|Adverse Event|0|||
149069389|NCT04158141|537737420|FG000|Step 1: Registration|Withdrawal by Subject|1|||
149069390|NCT04158141|537737421|FG001|Step 1: Registration|Withdrawal by Subject|0|||
149069391|NCT04158141|537737422|FG002|Step 1: Registration|Withdrawal by Subject|0|||
149069392|NCT04158141|537737420|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
149069393|NCT04158141|537737421|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
149069394|NCT04158141|537737422|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
149069395|NCT04121741|537737423|FG000|Overall Study|Protocol Violation|1|||
149069396|NCT04121741|537737424|FG001|Overall Study|Protocol Violation|0|||
149069397|NCT04121741|537737425|FG002|Overall Study|Protocol Violation|0|||
149069398|NCT04121741|537737426|FG003|Overall Study|Protocol Violation|0|||
149069399|NCT04121741|537737427|FG004|Overall Study|Protocol Violation|0|||
149069400|NCT04121741|537737428|FG005|Overall Study|Protocol Violation|0|||
149069401|NCT01084863|537737430|FG000|Main Study Treatment Period|Disease progression|11|||
149069402|NCT01084863|537737431|FG001|Main Study Treatment Period|Disease progression|7|||
149069403|NCT01084863|537737430|FG000|Main Study Treatment Period|Adverse Event|5|||
149069404|NCT01084863|537737431|FG001|Main Study Treatment Period|Adverse Event|3|||
149069405|NCT01084863|537737430|FG000|Main Study Treatment Period|Other Reason|0|||
149069406|NCT01084863|537737431|FG001|Main Study Treatment Period|Other Reason|1|||
149069407|NCT01084863|537737430|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
149069408|NCT01084863|537737431|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
149069409|NCT01084863|537737430|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
149069410|NCT01084863|537737431|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
149069411|NCT01084863|537737430|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
149069412|NCT01084863|537737431|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
149069413|NCT01084863|537737430|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
149069414|NCT01084863|537737431|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
149069415|NCT01084863|537737430|FG000|Treatment Period Beyond Cycle 8|Other|0|||
149069416|NCT01084863|537737431|FG001|Treatment Period Beyond Cycle 8|Other|1|||
149069417|NCT01084863|537737430|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
149069418|NCT01084863|537737431|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
149069419|NCT03473223|537737432|FG000|Overall Study|Lost to Follow-up|1|||
149069420|NCT03473223|537737433|FG001|Overall Study|Lost to Follow-up|1|||
149069421|NCT03473223|537737432|FG000|Overall Study|Withdrawal by Subject|47|||
149069422|NCT03473223|537737433|FG001|Overall Study|Withdrawal by Subject|42|||
149069423|NCT03473223|537737432|FG000|Overall Study|Indirect contact|32|||
149069424|NCT03473223|537737433|FG001|Overall Study|Indirect contact|29|||
149069425|NCT03473223|537737432|FG000|Overall Study|Other (Not specified)|32|||
149069426|NCT03473223|537737433|FG001|Overall Study|Other (Not specified)|20|||
149069427|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
149069428|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
149069429|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
149069430|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
149069431|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
149069432|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
149069433|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
149069434|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
149069435|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
149069436|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
149069437|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
149069438|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
149069439|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
149069440|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
149069441|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
149069442|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
149069443|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
149069444|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
149069445|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
149069446|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
149069447|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
149069448|NCT04505722|537737434|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
149069449|NCT04505722|537737435|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
149069450|NCT04505722|537737436|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
149069451|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
149069452|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
149069453|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
149069454|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
149069455|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
149069456|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
149069457|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
149069458|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
149069459|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
149069460|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
149069461|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
149069462|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
149069463|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
149069464|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
149069465|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
149069466|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
149069467|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
149069468|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
149069469|NCT04505722|537737434|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
149069470|NCT04505722|537737435|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
149069471|NCT04505722|537737436|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
149069472|NCT04755595|537737437|FG000|Overall Study|Lost to Follow-up|1|||
149069473|NCT00319696|537737438|FG000|Overall Study|Adverse Event|36|||
149069474|NCT00319696|537737438|FG000|Overall Study|withdrawal of consent|14|||
149069475|NCT00319696|537737438|FG000|Overall Study|administrative|7|||
149069476|NCT00319696|537737438|FG000|Overall Study|Lost to Follow-up|3|||
149069477|NCT01596972|537738128|FG000|Overall Study|Physician Decision|1|||
149069478|NCT01596972|537738129|FG001|Overall Study|Physician Decision|9|||
149069479|NCT01596972|537738128|FG000|Overall Study|Lost to Follow-up|0|||
149069480|NCT01596972|537738129|FG001|Overall Study|Lost to Follow-up|4|||
149069481|NCT01596972|537738128|FG000|Overall Study|Withdrawal by Subject|0|||
149069482|NCT01596972|537738129|FG001|Overall Study|Withdrawal by Subject|1|||
149069483|NCT01639131|537738131|FG000|Overall Study|Disease Progression|6|||
149069484|NCT01964300|537738133|FG000|Overall Study|Ineligible after enrollment|0|||
149069485|NCT01964300|537738134|FG001|Overall Study|Ineligible after enrollment|1|||
149069486|NCT01964300|537738133|FG000|Overall Study|Adverse Event|1|||
149069487|NCT01964300|537738134|FG001|Overall Study|Adverse Event|1|||
149069488|NCT01964300|537738133|FG000|Overall Study|Lack of Efficacy|3|||
149069489|NCT01964300|537738134|FG001|Overall Study|Lack of Efficacy|5|||
149069490|NCT01964300|537738133|FG000|Overall Study|Withdrawal by Subject|0|||
149069491|NCT01964300|537738134|FG001|Overall Study|Withdrawal by Subject|1|||
149069492|NCT01964300|537738133|FG000|Overall Study|To receive alternative therapy|1|||
149069493|NCT01964300|537738134|FG001|Overall Study|To receive alternative therapy|2|||
149069494|NCT01964300|537738133|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
149069495|NCT01964300|537738134|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
149069496|NCT01964300|537738133|FG000|Overall Study|Weight criteria not met|0|||
149069497|NCT01964300|537738134|FG001|Overall Study|Weight criteria not met|1|||
149069498|NCT00557492|537738135|FG000|Overall Study|Change in health insurance|1|||
149069499|NCT02285270|537738137|FG000|Overall Study|Lost to Follow-up|1|||
149069500|NCT02285270|537738137|FG000|Overall Study|Physician Decision|3|||
149069501|NCT02285270|537738137|FG000|Overall Study|Determined to be ineligible|1|||
149069502|NCT02111096|537738138|FG000|Overall Study|Adverse Event|4|||
149069503|NCT02111096|537738139|FG001|Overall Study|Adverse Event|1|||
149069504|NCT02111096|537738140|FG002|Overall Study|Adverse Event|2|||
149069505|NCT02111096|537738138|FG000|Overall Study|Non-Compliance with Study Drug|1|||
149069506|NCT02111096|537738139|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149069507|NCT02111096|537738140|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149069508|NCT02111096|537738138|FG000|Overall Study|Lost to Follow Up|1|||
149069509|NCT02111096|537738139|FG001|Overall Study|Lost to Follow Up|1|||
149069510|NCT02111096|537738140|FG002|Overall Study|Lost to Follow Up|1|||
149069511|NCT02111096|537738138|FG000|Overall Study|Physician Decision|0|||
149069512|NCT02111096|537738139|FG001|Overall Study|Physician Decision|1|||
149069513|NCT02111096|537738140|FG002|Overall Study|Physician Decision|0|||
149069514|NCT02111096|537738138|FG000|Overall Study|Protocol Violation|1|||
149069515|NCT02111096|537738139|FG001|Overall Study|Protocol Violation|0|||
149069516|NCT02111096|537738140|FG002|Overall Study|Protocol Violation|1|||
149069517|NCT02111096|537738138|FG000|Overall Study|Terminated by Sponsor|53|||
149069518|NCT02111096|537738139|FG001|Overall Study|Terminated by Sponsor|35|||
149069519|NCT02111096|537738140|FG002|Overall Study|Terminated by Sponsor|54|||
149069520|NCT02111096|537738138|FG000|Overall Study|Withdrawal by Subject|4|||
149069521|NCT02111096|537738139|FG001|Overall Study|Withdrawal by Subject|2|||
149069522|NCT02111096|537738140|FG002|Overall Study|Withdrawal by Subject|8|||
149069523|NCT00439270|537738141|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
149069524|NCT00439270|537738142|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
149120221|NCT04602221|537918070|FG013|Overall Study|Other than listed|0|||
149069525|NCT00439270|537738143|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
149069526|NCT00439270|537738144|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
149069527|NCT00439270|537738145|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
149069528|NCT00439270|537738141|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
149069529|NCT00439270|537738142|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
149069530|NCT00439270|537738143|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
149069531|NCT00439270|537738144|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
149069532|NCT00439270|537738145|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
149069533|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
149069534|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
149069535|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
149069536|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
149069537|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
149069538|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
149069539|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
149069540|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
149069541|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
149069542|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
149069543|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
149069544|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
149069545|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
149069546|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
149069547|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
149069548|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
149069549|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
149069550|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
149069551|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
149069552|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
149069553|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
149069554|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
149069555|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
149069556|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
149069557|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
149069558|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
149069559|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
149069560|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
149069561|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
149069562|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
149069563|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
149069564|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
149069565|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
149069566|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
149069567|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
149069568|NCT00439270|537738141|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
149069569|NCT00439270|537738142|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
149069570|NCT00439270|537738143|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
149069571|NCT00439270|537738144|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
149069572|NCT00439270|537738145|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
149069573|NCT03621735|537738146|FG000|Overall Study|Withdrawal by Subject|13|||
149069574|NCT03621735|537738147|FG001|Overall Study|Withdrawal by Subject|13|||
149069575|NCT04334317|537738148|FG000|Overall Study|Adverse Event|1|||
149069576|NCT04334317|537738149|FG001|Overall Study|Adverse Event|2|||
149069577|NCT04334317|537738150|FG002|Overall Study|Adverse Event|0|||
149069578|NCT04334317|537738151|FG003|Overall Study|Adverse Event|0|||
149069579|NCT04334317|537738148|FG000|Overall Study|Protocol Deviation|0|||
149069580|NCT04334317|537738149|FG001|Overall Study|Protocol Deviation|1|||
149069581|NCT04334317|537738150|FG002|Overall Study|Protocol Deviation|0|||
149069582|NCT04334317|537738151|FG003|Overall Study|Protocol Deviation|0|||
149069583|NCT04334317|537738148|FG000|Overall Study|Withdrawal by Subject|2|||
149069584|NCT04334317|537738149|FG001|Overall Study|Withdrawal by Subject|2|||
149069585|NCT04334317|537738150|FG002|Overall Study|Withdrawal by Subject|0|||
149069586|NCT04334317|537738151|FG003|Overall Study|Withdrawal by Subject|0|||
149069587|NCT03875313|537738157|FG000|Overall Study|Withdrawal by Subject|1|||
149069588|NCT03875313|537738158|FG001|Overall Study|Withdrawal by Subject|3|||
149069589|NCT03875313|537738159|FG002|Overall Study|Withdrawal by Subject|0|||
149069590|NCT03875313|537738160|FG003|Overall Study|Withdrawal by Subject|0|||
149069591|NCT03875313|537738161|FG004|Overall Study|Withdrawal by Subject|0|||
149069592|NCT03875313|537738157|FG000|Overall Study|Death|0|||
149069593|NCT03875313|537738158|FG001|Overall Study|Death|0|||
149069594|NCT03875313|537738159|FG002|Overall Study|Death|0|||
149069595|NCT03875313|537738160|FG003|Overall Study|Death|0|||
149069596|NCT03875313|537738161|FG004|Overall Study|Death|1|||
149069597|NCT03875313|537738157|FG000|Overall Study|Lost to Follow-up|0|||
149069598|NCT03875313|537738158|FG001|Overall Study|Lost to Follow-up|0|||
149069599|NCT03875313|537738159|FG002|Overall Study|Lost to Follow-up|0|||
149069600|NCT03875313|537738160|FG003|Overall Study|Lost to Follow-up|0|||
149069601|NCT03875313|537738161|FG004|Overall Study|Lost to Follow-up|1|||
149069602|NCT03875313|537738157|FG000|Overall Study|Study Termination by Sponsor|0|||
149069603|NCT03875313|537738158|FG001|Overall Study|Study Termination by Sponsor|1|||
149069604|NCT03875313|537738159|FG002|Overall Study|Study Termination by Sponsor|1|||
149069605|NCT03875313|537738160|FG003|Overall Study|Study Termination by Sponsor|0|||
149069606|NCT03875313|537738161|FG004|Overall Study|Study Termination by Sponsor|1|||
149069607|NCT03875313|537738157|FG000|Overall Study|New Anticancer Treatment|0|||
149069608|NCT03875313|537738158|FG001|Overall Study|New Anticancer Treatment|1|||
149069609|NCT03875313|537738159|FG002|Overall Study|New Anticancer Treatment|2|||
149069610|NCT03875313|537738160|FG003|Overall Study|New Anticancer Treatment|1|||
149069611|NCT03875313|537738161|FG004|Overall Study|New Anticancer Treatment|0|||
149069612|NCT03875313|537738157|FG000|Overall Study|Other, Not Specified|2|||
149069613|NCT03875313|537738158|FG001|Overall Study|Other, Not Specified|11|||
149069614|NCT03875313|537738159|FG002|Overall Study|Other, Not Specified|3|||
149069615|NCT03875313|537738160|FG003|Overall Study|Other, Not Specified|3|||
149069616|NCT03875313|537738161|FG004|Overall Study|Other, Not Specified|1|||
149069617|NCT04121546|537738163|FG000|Overall Study|Lost to Follow-up|1|||
149069618|NCT04121546|537738164|FG001|Overall Study|Lost to Follow-up|3|||
149069619|NCT00686595|537738167|FG000|Overall Study|Adverse Event|3|||
149069620|NCT00686595|537738167|FG000|Overall Study|Protocol Violation|1|||
149069621|NCT00686595|537738167|FG000|Overall Study|Lost to Follow-up|1|||
149069622|NCT00686595|537738167|FG000|Overall Study|Lack of Efficacy|1|||
149069623|NCT00686595|537738167|FG000|Overall Study|Poor Compliance|1|||
149069624|NCT03286114|537738170|FG000|Overall Study|Adverse Event|6|||
149069625|NCT03286114|537738170|FG000|Overall Study|Death|3|||
149069626|NCT00943917|537738174|FG000|Stage I|Adverse Event|1|||
149069627|NCT00943917|537738175|FG001|Stage I|Adverse Event|2|||
149069628|NCT00943917|537738176|FG002|Stage I|Adverse Event|2|||
149069629|NCT00943917|537738177|FG003|Stage I|Adverse Event|0|||
149069630|NCT00943917|537738178|FG004|Stage I|Adverse Event|0|||
149069631|NCT00943917|537738179|FG005|Stage I|Adverse Event|0|||
149069632|NCT00943917|537738180|FG006|Stage I|Adverse Event|0|||
149069633|NCT00943917|537738181|FG007|Stage I|Adverse Event|0|||
149069634|NCT00943917|537738182|FG008|Stage I|Adverse Event|0|||
149069635|NCT00943917|537738183|FG009|Stage I|Adverse Event|0|||
149069636|NCT00943917|537738184|FG010|Stage I|Adverse Event|0|||
149069637|NCT00943917|537738185|FG011|Stage I|Adverse Event|0|||
149069638|NCT00943917|537738186|FG012|Stage I|Adverse Event|0|||
149069639|NCT00943917|537738187|FG013|Stage I|Adverse Event|0|||
149069640|NCT00943917|537738188|FG014|Stage I|Adverse Event|0|||
149069641|NCT00943917|537738174|FG000|Stage I|Lost to Follow-up|0|||
149069642|NCT00943917|537738175|FG001|Stage I|Lost to Follow-up|0|||
149069643|NCT00943917|537738176|FG002|Stage I|Lost to Follow-up|1|||
149069644|NCT00943917|537738177|FG003|Stage I|Lost to Follow-up|0|||
149069645|NCT00943917|537738178|FG004|Stage I|Lost to Follow-up|0|||
149069646|NCT00943917|537738179|FG005|Stage I|Lost to Follow-up|0|||
149069647|NCT00943917|537738180|FG006|Stage I|Lost to Follow-up|0|||
149069648|NCT00943917|537738181|FG007|Stage I|Lost to Follow-up|0|||
149069649|NCT00943917|537738182|FG008|Stage I|Lost to Follow-up|0|||
149069650|NCT00943917|537738183|FG009|Stage I|Lost to Follow-up|0|||
149069651|NCT00943917|537738184|FG010|Stage I|Lost to Follow-up|0|||
149069652|NCT00943917|537738185|FG011|Stage I|Lost to Follow-up|0|||
149069653|NCT00943917|537738186|FG012|Stage I|Lost to Follow-up|0|||
149069654|NCT00943917|537738187|FG013|Stage I|Lost to Follow-up|0|||
149069655|NCT00943917|537738188|FG014|Stage I|Lost to Follow-up|0|||
149069656|NCT00943917|537738174|FG000|Stage I|hyperglycemia|0|||
149069657|NCT00943917|537738175|FG001|Stage I|hyperglycemia|0|||
149069658|NCT00943917|537738176|FG002|Stage I|hyperglycemia|1|||
149069659|NCT00943917|537738177|FG003|Stage I|hyperglycemia|0|||
149069660|NCT00943917|537738178|FG004|Stage I|hyperglycemia|0|||
149069661|NCT00943917|537738179|FG005|Stage I|hyperglycemia|0|||
149069662|NCT00943917|537738180|FG006|Stage I|hyperglycemia|0|||
149069663|NCT00943917|537738181|FG007|Stage I|hyperglycemia|0|||
149069664|NCT00943917|537738182|FG008|Stage I|hyperglycemia|0|||
149069665|NCT00943917|537738183|FG009|Stage I|hyperglycemia|0|||
149069666|NCT00943917|537738184|FG010|Stage I|hyperglycemia|0|||
149069667|NCT00943917|537738185|FG011|Stage I|hyperglycemia|0|||
149069668|NCT00943917|537738186|FG012|Stage I|hyperglycemia|0|||
149069669|NCT00943917|537738187|FG013|Stage I|hyperglycemia|0|||
149069670|NCT00943917|537738188|FG014|Stage I|hyperglycemia|0|||
149069671|NCT00943917|537738174|FG000|Stage I|A1C elevation|1|||
149069672|NCT00943917|537738175|FG001|Stage I|A1C elevation|0|||
149069673|NCT00943917|537738176|FG002|Stage I|A1C elevation|0|||
149069674|NCT00943917|537738177|FG003|Stage I|A1C elevation|0|||
149069675|NCT00943917|537738178|FG004|Stage I|A1C elevation|0|||
149069676|NCT00943917|537738179|FG005|Stage I|A1C elevation|0|||
149069677|NCT00943917|537738180|FG006|Stage I|A1C elevation|0|||
149069678|NCT00943917|537738181|FG007|Stage I|A1C elevation|0|||
149069679|NCT00943917|537738182|FG008|Stage I|A1C elevation|0|||
149069680|NCT00943917|537738183|FG009|Stage I|A1C elevation|0|||
149069681|NCT00943917|537738184|FG010|Stage I|A1C elevation|0|||
149069682|NCT00943917|537738185|FG011|Stage I|A1C elevation|0|||
149069683|NCT00943917|537738186|FG012|Stage I|A1C elevation|0|||
149069684|NCT00943917|537738187|FG013|Stage I|A1C elevation|0|||
149069685|NCT00943917|537738188|FG014|Stage I|A1C elevation|0|||
149069686|NCT00943917|537738174|FG000|Stage I|Withdrawal by Subject|2|||
149069687|NCT00943917|537738175|FG001|Stage I|Withdrawal by Subject|1|||
149069688|NCT00943917|537738176|FG002|Stage I|Withdrawal by Subject|2|||
149069689|NCT00943917|537738177|FG003|Stage I|Withdrawal by Subject|0|||
149069690|NCT00943917|537738178|FG004|Stage I|Withdrawal by Subject|0|||
149069691|NCT00943917|537738179|FG005|Stage I|Withdrawal by Subject|0|||
149069692|NCT00943917|537738180|FG006|Stage I|Withdrawal by Subject|0|||
149069693|NCT00943917|537738181|FG007|Stage I|Withdrawal by Subject|0|||
149069694|NCT00943917|537738182|FG008|Stage I|Withdrawal by Subject|0|||
149069695|NCT00943917|537738183|FG009|Stage I|Withdrawal by Subject|0|||
149069696|NCT00943917|537738184|FG010|Stage I|Withdrawal by Subject|0|||
149069697|NCT00943917|537738185|FG011|Stage I|Withdrawal by Subject|0|||
149069698|NCT00943917|537738186|FG012|Stage I|Withdrawal by Subject|0|||
149069699|NCT00943917|537738187|FG013|Stage I|Withdrawal by Subject|0|||
149069700|NCT00943917|537738188|FG014|Stage I|Withdrawal by Subject|0|||
149069701|NCT00943917|537738174|FG000|Stage II|Adverse Event|0|||
149069702|NCT00943917|537738175|FG001|Stage II|Adverse Event|0|||
149069703|NCT00943917|537738176|FG002|Stage II|Adverse Event|0|||
149069704|NCT00943917|537738177|FG003|Stage II|Adverse Event|0|||
149069705|NCT00943917|537738178|FG004|Stage II|Adverse Event|0|||
149069706|NCT00943917|537738179|FG005|Stage II|Adverse Event|1|||
149069707|NCT00943917|537738180|FG006|Stage II|Adverse Event|3|||
149069708|NCT00943917|537738181|FG007|Stage II|Adverse Event|0|||
149069709|NCT00943917|537738182|FG008|Stage II|Adverse Event|1|||
149069710|NCT00943917|537738183|FG009|Stage II|Adverse Event|0|||
149069711|NCT00943917|537738184|FG010|Stage II|Adverse Event|0|||
149069712|NCT00943917|537738185|FG011|Stage II|Adverse Event|0|||
149069713|NCT00943917|537738186|FG012|Stage II|Adverse Event|0|||
149069714|NCT00943917|537738187|FG013|Stage II|Adverse Event|0|||
149069715|NCT00943917|537738188|FG014|Stage II|Adverse Event|0|||
149069716|NCT00943917|537738174|FG000|Stage II|Withdrawal by Subject|0|||
149069717|NCT00943917|537738175|FG001|Stage II|Withdrawal by Subject|0|||
149069718|NCT00943917|537738176|FG002|Stage II|Withdrawal by Subject|0|||
149069719|NCT00943917|537738177|FG003|Stage II|Withdrawal by Subject|0|||
149069720|NCT00943917|537738178|FG004|Stage II|Withdrawal by Subject|0|||
149069721|NCT00943917|537738179|FG005|Stage II|Withdrawal by Subject|1|||
149069722|NCT00943917|537738180|FG006|Stage II|Withdrawal by Subject|0|||
149069723|NCT00943917|537738181|FG007|Stage II|Withdrawal by Subject|0|||
149069724|NCT00943917|537738182|FG008|Stage II|Withdrawal by Subject|0|||
149069725|NCT00943917|537738183|FG009|Stage II|Withdrawal by Subject|0|||
149069726|NCT00943917|537738184|FG010|Stage II|Withdrawal by Subject|0|||
149069727|NCT00943917|537738185|FG011|Stage II|Withdrawal by Subject|0|||
149069728|NCT00943917|537738186|FG012|Stage II|Withdrawal by Subject|0|||
149069729|NCT00943917|537738187|FG013|Stage II|Withdrawal by Subject|0|||
149069730|NCT00943917|537738188|FG014|Stage II|Withdrawal by Subject|0|||
149069731|NCT00943917|537738174|FG000|Stage II|Pregnancy|0|||
149069732|NCT00943917|537738175|FG001|Stage II|Pregnancy|0|||
149069733|NCT00943917|537738176|FG002|Stage II|Pregnancy|0|||
149069734|NCT00943917|537738177|FG003|Stage II|Pregnancy|0|||
149069735|NCT00943917|537738178|FG004|Stage II|Pregnancy|0|||
149069736|NCT00943917|537738179|FG005|Stage II|Pregnancy|1|||
149069737|NCT00943917|537738180|FG006|Stage II|Pregnancy|0|||
149069738|NCT00943917|537738181|FG007|Stage II|Pregnancy|0|||
149069739|NCT00943917|537738182|FG008|Stage II|Pregnancy|0|||
149069740|NCT00943917|537738183|FG009|Stage II|Pregnancy|0|||
149069741|NCT00943917|537738184|FG010|Stage II|Pregnancy|0|||
149069742|NCT00943917|537738185|FG011|Stage II|Pregnancy|0|||
149069743|NCT00943917|537738186|FG012|Stage II|Pregnancy|0|||
149069744|NCT00943917|537738187|FG013|Stage II|Pregnancy|0|||
149069745|NCT00943917|537738188|FG014|Stage II|Pregnancy|0|||
149069746|NCT00943917|537738174|FG000|Stage II Continuation|Adverse Event|0|||
149069747|NCT00943917|537738175|FG001|Stage II Continuation|Adverse Event|0|||
149069748|NCT00943917|537738176|FG002|Stage II Continuation|Adverse Event|0|||
149069749|NCT00943917|537738177|FG003|Stage II Continuation|Adverse Event|0|||
149069750|NCT00943917|537738178|FG004|Stage II Continuation|Adverse Event|0|||
149069751|NCT00943917|537738179|FG005|Stage II Continuation|Adverse Event|0|||
149069752|NCT00943917|537738180|FG006|Stage II Continuation|Adverse Event|0|||
149069753|NCT00943917|537738181|FG007|Stage II Continuation|Adverse Event|0|||
149069754|NCT00943917|537738182|FG008|Stage II Continuation|Adverse Event|0|||
149069755|NCT00943917|537738183|FG009|Stage II Continuation|Adverse Event|0|||
149069756|NCT00943917|537738184|FG010|Stage II Continuation|Adverse Event|0|||
149069757|NCT00943917|537738185|FG011|Stage II Continuation|Adverse Event|1|||
149069758|NCT00943917|537738186|FG012|Stage II Continuation|Adverse Event|2|||
149069759|NCT00943917|537738187|FG013|Stage II Continuation|Adverse Event|1|||
149069760|NCT00943917|537738188|FG014|Stage II Continuation|Adverse Event|1|||
149069761|NCT00943917|537738174|FG000|Stage II Continuation|Withdrawal by Subject|0|||
149069762|NCT00943917|537738175|FG001|Stage II Continuation|Withdrawal by Subject|0|||
149069763|NCT00943917|537738176|FG002|Stage II Continuation|Withdrawal by Subject|0|||
149069764|NCT00943917|537738177|FG003|Stage II Continuation|Withdrawal by Subject|0|||
149069765|NCT00943917|537738178|FG004|Stage II Continuation|Withdrawal by Subject|0|||
149069766|NCT00943917|537738179|FG005|Stage II Continuation|Withdrawal by Subject|0|||
149069767|NCT00943917|537738180|FG006|Stage II Continuation|Withdrawal by Subject|0|||
149069768|NCT00943917|537738181|FG007|Stage II Continuation|Withdrawal by Subject|0|||
149069769|NCT00943917|537738182|FG008|Stage II Continuation|Withdrawal by Subject|0|||
149069770|NCT00943917|537738183|FG009|Stage II Continuation|Withdrawal by Subject|0|||
149069771|NCT00943917|537738184|FG010|Stage II Continuation|Withdrawal by Subject|0|||
149069772|NCT00943917|537738185|FG011|Stage II Continuation|Withdrawal by Subject|0|||
149069773|NCT00943917|537738186|FG012|Stage II Continuation|Withdrawal by Subject|0|||
149069774|NCT00943917|537738187|FG013|Stage II Continuation|Withdrawal by Subject|1|||
149069775|NCT00943917|537738188|FG014|Stage II Continuation|Withdrawal by Subject|3|||
149069776|NCT00943917|537738174|FG000|Stage II Continuation|Protocol Violation|0|||
149069777|NCT00943917|537738175|FG001|Stage II Continuation|Protocol Violation|0|||
149069778|NCT00943917|537738176|FG002|Stage II Continuation|Protocol Violation|0|||
149069779|NCT00943917|537738177|FG003|Stage II Continuation|Protocol Violation|0|||
149069780|NCT00943917|537738178|FG004|Stage II Continuation|Protocol Violation|0|||
149069781|NCT00943917|537738179|FG005|Stage II Continuation|Protocol Violation|0|||
149069782|NCT00943917|537738180|FG006|Stage II Continuation|Protocol Violation|0|||
149069783|NCT00943917|537738181|FG007|Stage II Continuation|Protocol Violation|0|||
149069784|NCT00943917|537738182|FG008|Stage II Continuation|Protocol Violation|0|||
149069785|NCT00943917|537738183|FG009|Stage II Continuation|Protocol Violation|1|||
149069786|NCT00943917|537738184|FG010|Stage II Continuation|Protocol Violation|0|||
149069787|NCT00943917|537738185|FG011|Stage II Continuation|Protocol Violation|1|||
149069788|NCT00943917|537738186|FG012|Stage II Continuation|Protocol Violation|0|||
149069789|NCT00943917|537738187|FG013|Stage II Continuation|Protocol Violation|0|||
149069790|NCT00943917|537738188|FG014|Stage II Continuation|Protocol Violation|0|||
149069791|NCT00943917|537738174|FG000|Stage II Continuation|hypoglycemia|0|||
149069792|NCT00943917|537738175|FG001|Stage II Continuation|hypoglycemia|0|||
149069793|NCT00943917|537738176|FG002|Stage II Continuation|hypoglycemia|0|||
149069794|NCT00943917|537738177|FG003|Stage II Continuation|hypoglycemia|0|||
149069795|NCT00943917|537738178|FG004|Stage II Continuation|hypoglycemia|0|||
149069796|NCT00943917|537738179|FG005|Stage II Continuation|hypoglycemia|0|||
149069797|NCT00943917|537738180|FG006|Stage II Continuation|hypoglycemia|0|||
149069798|NCT00943917|537738181|FG007|Stage II Continuation|hypoglycemia|0|||
149069799|NCT00943917|537738182|FG008|Stage II Continuation|hypoglycemia|0|||
149069800|NCT00943917|537738183|FG009|Stage II Continuation|hypoglycemia|0|||
149069801|NCT00943917|537738184|FG010|Stage II Continuation|hypoglycemia|0|||
149069802|NCT00943917|537738185|FG011|Stage II Continuation|hypoglycemia|0|||
149069803|NCT00943917|537738186|FG012|Stage II Continuation|hypoglycemia|1|||
149069804|NCT00943917|537738187|FG013|Stage II Continuation|hypoglycemia|0|||
149069805|NCT00943917|537738188|FG014|Stage II Continuation|hypoglycemia|0|||
149069806|NCT00943917|537738174|FG000|Stage II Continuation|A1C elevation|0|||
149069807|NCT00943917|537738175|FG001|Stage II Continuation|A1C elevation|0|||
149069808|NCT00943917|537738176|FG002|Stage II Continuation|A1C elevation|0|||
149069809|NCT00943917|537738177|FG003|Stage II Continuation|A1C elevation|0|||
149069810|NCT00943917|537738178|FG004|Stage II Continuation|A1C elevation|0|||
149069811|NCT00943917|537738179|FG005|Stage II Continuation|A1C elevation|0|||
149069812|NCT00943917|537738180|FG006|Stage II Continuation|A1C elevation|0|||
149069813|NCT00943917|537738181|FG007|Stage II Continuation|A1C elevation|0|||
149069814|NCT00943917|537738182|FG008|Stage II Continuation|A1C elevation|0|||
149069815|NCT00943917|537738183|FG009|Stage II Continuation|A1C elevation|0|||
149069816|NCT00943917|537738184|FG010|Stage II Continuation|A1C elevation|0|||
149069817|NCT00943917|537738185|FG011|Stage II Continuation|A1C elevation|0|||
149069818|NCT00943917|537738186|FG012|Stage II Continuation|A1C elevation|0|||
149069819|NCT00943917|537738187|FG013|Stage II Continuation|A1C elevation|1|||
149069820|NCT00943917|537738188|FG014|Stage II Continuation|A1C elevation|0|||
149069821|NCT03248492|537738189|FG000|Overall Study|Progressive Disease|24|||
149069822|NCT03248492|537738190|FG001|Overall Study|Progressive Disease|23|||
149069823|NCT03248492|537738191|FG002|Overall Study|Progressive Disease|11|||
149069824|NCT03248492|537738192|FG003|Overall Study|Progressive Disease|66|||
149069825|NCT03248492|537738193|FG004|Overall Study|Progressive Disease|1|||
149069826|NCT03248492|537738189|FG000|Overall Study|Adverse Event|14|||
149069827|NCT03248492|537738190|FG001|Overall Study|Adverse Event|13|||
149069828|NCT03248492|537738191|FG002|Overall Study|Adverse Event|9|||
149069829|NCT03248492|537738192|FG003|Overall Study|Adverse Event|22|||
149069830|NCT03248492|537738193|FG004|Overall Study|Adverse Event|2|||
149069831|NCT03248492|537738189|FG000|Overall Study|Withdrawal by Subject|5|||
149069832|NCT03248492|537738190|FG001|Overall Study|Withdrawal by Subject|4|||
149069833|NCT03248492|537738191|FG002|Overall Study|Withdrawal by Subject|0|||
149069834|NCT03248492|537738192|FG003|Overall Study|Withdrawal by Subject|8|||
149069835|NCT03248492|537738193|FG004|Overall Study|Withdrawal by Subject|1|||
149069836|NCT03248492|537738189|FG000|Overall Study|Physician Decision|1|||
149069837|NCT03248492|537738190|FG001|Overall Study|Physician Decision|1|||
149069838|NCT03248492|537738191|FG002|Overall Study|Physician Decision|1|||
149069839|NCT03248492|537738192|FG003|Overall Study|Physician Decision|7|||
149069840|NCT03248492|537738193|FG004|Overall Study|Physician Decision|0|||
149069841|NCT03248492|537738189|FG000|Overall Study|Death|1|||
149069842|NCT03248492|537738190|FG001|Overall Study|Death|1|||
149069843|NCT03248492|537738191|FG002|Overall Study|Death|0|||
149069844|NCT03248492|537738192|FG003|Overall Study|Death|6|||
149069845|NCT03248492|537738193|FG004|Overall Study|Death|0|||
149069846|NCT03248492|537738189|FG000|Overall Study|Study Terminated by Sponsor|3|||
149069847|NCT03248492|537738190|FG001|Overall Study|Study Terminated by Sponsor|1|||
149069848|NCT03248492|537738191|FG002|Overall Study|Study Terminated by Sponsor|0|||
149069849|NCT03248492|537738192|FG003|Overall Study|Study Terminated by Sponsor|7|||
149069850|NCT03248492|537738193|FG004|Overall Study|Study Terminated by Sponsor|0|||
149069851|NCT03248492|537738189|FG000|Overall Study|Other|2|||
149069852|NCT03248492|537738190|FG001|Overall Study|Other|5|||
149069853|NCT03248492|537738191|FG002|Overall Study|Other|0|||
149069854|NCT03248492|537738192|FG003|Overall Study|Other|14|||
149069855|NCT03248492|537738193|FG004|Overall Study|Other|0|||
149069856|NCT04495621|537738194|FG000|Overall Study|Withdrawal by Subject|0|||
149069857|NCT04495621|537738195|FG001|Overall Study|Withdrawal by Subject|3|||
149069858|NCT04495621|537738194|FG000|Overall Study|Death|7|||
149069859|NCT04495621|537738195|FG001|Overall Study|Death|11|||
149069860|NCT04495621|537738194|FG000|Overall Study|Investigator Decision|0|||
149069861|NCT04495621|537738195|FG001|Overall Study|Investigator Decision|7|||
149069862|NCT04495621|537738194|FG000|Overall Study|Lost to Follow-up|0|||
149069863|NCT04495621|537738195|FG001|Overall Study|Lost to Follow-up|1|||
149069864|NCT04018495|537738198|FG000|Overall Study|Physician Decision|1|||
149069865|NCT01983683|537738206|FG000|Overall Study|Withdrawal by Subject|14|||
149069866|NCT01983683|537738207|FG001|Overall Study|Withdrawal by Subject|18|||
149069867|NCT01983683|537738206|FG000|Overall Study|Death|11|||
149069868|NCT01983683|537738207|FG001|Overall Study|Death|15|||
149069869|NCT01983683|537738206|FG000|Overall Study|Physician Decision|8|||
149069870|NCT01983683|537738207|FG001|Overall Study|Physician Decision|9|||
149069871|NCT01983683|537738206|FG000|Overall Study|Lost to Follow-up|4|||
149069872|NCT01983683|537738207|FG001|Overall Study|Lost to Follow-up|8|||
149069873|NCT01983683|537738206|FG000|Overall Study|Sponsor Decision|1|||
149069874|NCT01983683|537738207|FG001|Overall Study|Sponsor Decision|1|||
149069875|NCT00319020|537738210|FG000|Overall Study|Death|2|||
149069876|NCT00319020|537738211|FG001|Overall Study|Death|2|||
149069877|NCT00319020|537738210|FG000|Overall Study|Withdrawal by Subject|4|||
149069878|NCT00319020|537738211|FG001|Overall Study|Withdrawal by Subject|1|||
149069879|NCT00319020|537738210|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
149069880|NCT00319020|537738211|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
149069881|NCT00319020|537738210|FG000|Overall Study|Administrative reason|0|||
149069882|NCT00319020|537738211|FG001|Overall Study|Administrative reason|5|||
149069883|NCT00319020|537738210|FG000|Overall Study|Disease progression|0|||
149069884|NCT00319020|537738211|FG001|Overall Study|Disease progression|2|||
149069885|NCT00319020|537738210|FG000|Overall Study|Transplant|0|||
149069886|NCT00319020|537738211|FG001|Overall Study|Transplant|1|||
149069887|NCT00319020|537738210|FG000|Overall Study|Treatment failure|0|||
149069888|NCT00319020|537738211|FG001|Overall Study|Treatment failure|1|||
149069889|NCT00319020|537738210|FG000|Overall Study|Adverse Event|0|||
149069890|NCT00319020|537738211|FG001|Overall Study|Adverse Event|1|||
149069891|NCT00655499|537739178|FG000|Overall Study|not eligible|4|||
149069892|NCT01288443|537739189|FG000|Overall Study|Adverse Event|0|||
149069893|NCT01288443|537739190|FG001|Overall Study|Adverse Event|0|||
149069894|NCT01288443|537739191|FG002|Overall Study|Adverse Event|1|||
149069895|NCT01288443|537739192|FG003|Overall Study|Adverse Event|1|||
149069896|NCT01288443|537739193|FG004|Overall Study|Adverse Event|3|||
149069897|NCT01288443|537739194|FG005|Overall Study|Adverse Event|1|||
149069898|NCT01288443|537739189|FG000|Overall Study|Poor compliance to protocol|0|||
149069899|NCT01288443|537739190|FG001|Overall Study|Poor compliance to protocol|0|||
149069900|NCT01288443|537739191|FG002|Overall Study|Poor compliance to protocol|0|||
149069901|NCT01288443|537739192|FG003|Overall Study|Poor compliance to protocol|0|||
149069902|NCT01288443|537739193|FG004|Overall Study|Poor compliance to protocol|0|||
149069903|NCT01288443|537739194|FG005|Overall Study|Poor compliance to protocol|1|||
149069904|NCT01288443|537739189|FG000|Overall Study|Participant Moved|0|||
149069905|NCT01288443|537739190|FG001|Overall Study|Participant Moved|0|||
149069906|NCT01288443|537739191|FG002|Overall Study|Participant Moved|0|||
149069907|NCT01288443|537739192|FG003|Overall Study|Participant Moved|1|||
149069908|NCT01288443|537739193|FG004|Overall Study|Participant Moved|2|||
149069909|NCT01288443|537739194|FG005|Overall Study|Participant Moved|1|||
149069910|NCT01288443|537739189|FG000|Overall Study|Consent withdrawn by Participant|0|||
149069911|NCT01288443|537739190|FG001|Overall Study|Consent withdrawn by Participant|0|||
149069912|NCT01288443|537739191|FG002|Overall Study|Consent withdrawn by Participant|0|||
149069913|NCT01288443|537739192|FG003|Overall Study|Consent withdrawn by Participant|0|||
149069914|NCT01288443|537739193|FG004|Overall Study|Consent withdrawn by Participant|0|||
149069915|NCT01288443|537739194|FG005|Overall Study|Consent withdrawn by Participant|1|||
149069916|NCT01288443|537739189|FG000|Overall Study|Lost to Follow-up|0|||
149069917|NCT01288443|537739190|FG001|Overall Study|Lost to Follow-up|1|||
149069918|NCT01288443|537739191|FG002|Overall Study|Lost to Follow-up|0|||
149069919|NCT01288443|537739192|FG003|Overall Study|Lost to Follow-up|0|||
149069920|NCT01288443|537739193|FG004|Overall Study|Lost to Follow-up|0|||
149069921|NCT01288443|537739194|FG005|Overall Study|Lost to Follow-up|0|||
149069922|NCT01288443|537739189|FG000|Overall Study|Study drug auto-injector administration|0|||
149069923|NCT01288443|537739190|FG001|Overall Study|Study drug auto-injector administration|0|||
149069924|NCT01288443|537739191|FG002|Overall Study|Study drug auto-injector administration|0|||
149069925|NCT01288443|537739192|FG003|Overall Study|Study drug auto-injector administration|0|||
149069926|NCT01288443|537739193|FG004|Overall Study|Study drug auto-injector administration|1|||
149069927|NCT01288443|537739194|FG005|Overall Study|Study drug auto-injector administration|1|||
149069928|NCT01288443|537739189|FG000|Overall Study|Other than above|0|||
149069929|NCT01288443|537739190|FG001|Overall Study|Other than above|0|||
149069930|NCT01288443|537739191|FG002|Overall Study|Other than above|0|||
149069931|NCT01288443|537739192|FG003|Overall Study|Other than above|2|||
149069932|NCT01288443|537739193|FG004|Overall Study|Other than above|1|||
149069933|NCT01288443|537739194|FG005|Overall Study|Other than above|0|||
149069934|NCT03183050|537739195|FG000|Overall Study|Lost to Follow-up|23|||
149069935|NCT01315132|537739196|FG000|Overall Study|not treated due to disease progression|1|||
149069936|NCT05707351|537739200|FG000|Overall Study|Withdrawal by Subject|2|||
149069937|NCT05707351|537739200|FG000|Overall Study|Reason Not Specified|1|||
149069944|NCT05521516|537739223|FG000|Overall Study|Withdrawal by Subject|1|||
149069945|NCT05521516|537739224|FG001|Overall Study|Withdrawal by Subject|1|||
149069946|NCT04305327|537739225|FG000|Overall Study|Study early termination|2|||
149069947|NCT04305327|537739226|FG001|Overall Study|Study early termination|5|||
149069948|NCT04305327|537739227|FG002|Overall Study|Study early termination|2|||
149069949|NCT04305327|537739228|FG003|Overall Study|Study early termination|2|||
149069950|NCT04305327|537739225|FG000|Overall Study|Withdrawal by Subject|0|||
149069951|NCT04305327|537739226|FG001|Overall Study|Withdrawal by Subject|1|||
149069952|NCT04305327|537739227|FG002|Overall Study|Withdrawal by Subject|0|||
149069953|NCT04305327|537739228|FG003|Overall Study|Withdrawal by Subject|0|||
149069954|NCT02500576|537739229|FG000|Overall Study|Adverse Event|0|||
149069955|NCT02500576|537739230|FG001|Overall Study|Adverse Event|1|||
149069956|NCT02500576|537739229|FG000|Overall Study|Death|2|||
149069957|NCT02500576|537739230|FG001|Overall Study|Death|1|||
149069958|NCT02500576|537739229|FG000|Overall Study|Lack of Efficacy|5|||
149069959|NCT02500576|537739230|FG001|Overall Study|Lack of Efficacy|5|||
149069960|NCT02500576|537739229|FG000|Overall Study|Withdrawal by Subject|1|||
149069961|NCT02500576|537739230|FG001|Overall Study|Withdrawal by Subject|1|||
149069962|NCT05827068|537739231|FG000|Overall Study|Lost to Follow-up|1|||
149069963|NCT05827068|537739232|FG001|Overall Study|Lost to Follow-up|4|||
149069964|NCT05827068|537739233|FG002|Overall Study|Lost to Follow-up|1|||
149069965|NCT05827068|537739234|FG003|Overall Study|Lost to Follow-up|1|||
149069966|NCT05827068|537739235|FG004|Overall Study|Lost to Follow-up|2|||
149069967|NCT05827068|537739236|FG005|Overall Study|Lost to Follow-up|4|||
149069968|NCT05827068|537739237|FG006|Overall Study|Lost to Follow-up|1|||
149069969|NCT05827068|537739231|FG000|Overall Study|Withdrawal by Subject|4|||
149069970|NCT05827068|537739232|FG001|Overall Study|Withdrawal by Subject|0|||
149069971|NCT05827068|537739233|FG002|Overall Study|Withdrawal by Subject|1|||
149069972|NCT05827068|537739234|FG003|Overall Study|Withdrawal by Subject|2|||
149069973|NCT05827068|537739235|FG004|Overall Study|Withdrawal by Subject|3|||
149069974|NCT05827068|537739236|FG005|Overall Study|Withdrawal by Subject|0|||
149069975|NCT05827068|537739237|FG006|Overall Study|Withdrawal by Subject|1|||
149069976|NCT05827068|537739231|FG000|Overall Study|Physician Decision|0|||
149069977|NCT05827068|537739232|FG001|Overall Study|Physician Decision|0|||
149069978|NCT05827068|537739233|FG002|Overall Study|Physician Decision|0|||
149069979|NCT05827068|537739234|FG003|Overall Study|Physician Decision|0|||
149069980|NCT05827068|537739235|FG004|Overall Study|Physician Decision|1|||
149069981|NCT05827068|537739236|FG005|Overall Study|Physician Decision|0|||
149069982|NCT05827068|537739237|FG006|Overall Study|Physician Decision|1|||
149069983|NCT05827068|537739231|FG000|Overall Study|Other Than Specified|0|||
149069984|NCT05827068|537739232|FG001|Overall Study|Other Than Specified|1|||
149069985|NCT05827068|537739233|FG002|Overall Study|Other Than Specified|0|||
149069986|NCT05827068|537739234|FG003|Overall Study|Other Than Specified|0|||
149069987|NCT05827068|537739235|FG004|Overall Study|Other Than Specified|0|||
149069988|NCT05827068|537739236|FG005|Overall Study|Other Than Specified|0|||
149069989|NCT05827068|537739237|FG006|Overall Study|Other Than Specified|0|||
149069990|NCT04882917|537739243|FG000|Overall Study|Adverse Event|0|||
149069991|NCT04882917|537739244|FG001|Overall Study|Adverse Event|1|||
149069992|NCT04882917|537739245|FG002|Overall Study|Adverse Event|2|||
149069993|NCT04882917|537739246|FG003|Overall Study|Adverse Event|2|||
149069994|NCT04882917|537739243|FG000|Overall Study|Withdrawal by Subject|1|||
149069995|NCT04882917|537739244|FG001|Overall Study|Withdrawal by Subject|0|||
149069996|NCT04882917|537739245|FG002|Overall Study|Withdrawal by Subject|2|||
149069997|NCT04882917|537739246|FG003|Overall Study|Withdrawal by Subject|1|||
149069998|NCT04882917|537739243|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
149069999|NCT04882917|537739244|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
149070000|NCT04882917|537739245|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
149070001|NCT04882917|537739246|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
149070002|NCT04926740|537739250|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
149070003|NCT04926740|537739251|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
149070004|NCT04926740|537739250|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
149070005|NCT04926740|537739251|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
149070006|NCT04980300|537739252|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
149070007|NCT04980300|537739253|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
149070008|NCT04980300|537739252|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
149070009|NCT04980300|537739253|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
149070010|NCT04980300|537739252|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
149070011|NCT04980300|537739253|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
149070012|NCT04980300|537739252|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
149070013|NCT04980300|537739253|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
149070014|NCT04530487|537740447|FG000|Overall Study|Death|1|||
149070015|NCT04977583|537740448|FG000|Overall Study|Lost to Follow-up|8|||
149070016|NCT04977583|537740449|FG001|Overall Study|Lost to Follow-up|4|||
149070017|NCT04977583|537740450|FG002|Overall Study|Lost to Follow-up|13|||
149070018|NCT04977583|537740448|FG000|Overall Study|Withdrawal by Subject|3|||
149070019|NCT04977583|537740449|FG001|Overall Study|Withdrawal by Subject|2|||
149070020|NCT04977583|537740450|FG002|Overall Study|Withdrawal by Subject|1|||
149070021|NCT02422615|537740467|FG000|Treatment Period|Progressive disease|314|||
149070022|NCT02422615|537740468|FG001|Treatment Period|Progressive disease|200|||
149070023|NCT02422615|537740467|FG000|Treatment Period|Adverse Event|51|||
149070024|NCT02422615|537740468|FG001|Treatment Period|Adverse Event|9|||
149070025|NCT02422615|537740467|FG000|Treatment Period|Physician Decision|32|||
149070026|NCT02422615|537740468|FG001|Treatment Period|Physician Decision|8|||
149070027|NCT02422615|537740467|FG000|Treatment Period|Subject/guardian decision|38|||
149070028|NCT02422615|537740468|FG001|Treatment Period|Subject/guardian decision|8|||
149070029|NCT02422615|537740467|FG000|Treatment Period|Death|2|||
149070030|NCT02422615|537740468|FG001|Treatment Period|Death|1|||
149070031|NCT02422615|537740467|FG000|Treatment Period|Technical problems|0|||
149070032|NCT02422615|537740468|FG001|Treatment Period|Technical problems|1|||
149070033|NCT02422615|537740467|FG000|Treatment Period|Protocol deviation|1|||
149070034|NCT02422615|537740468|FG001|Treatment Period|Protocol deviation|1|||
149070035|NCT02422615|537740467|FG000|Treatment Period|Study terminated as per protocol|46|||
149070036|NCT02422615|537740468|FG001|Treatment Period|Study terminated as per protocol|14|||
149070037|NCT02422615|537740467|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
149070038|NCT02422615|537740468|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
149070039|NCT02422615|537740467|FG000|Post-treatment Efficacy Follow-up|Death|2|||
149070040|NCT02422615|537740468|FG001|Post-treatment Efficacy Follow-up|Death|1|||
149070041|NCT02422615|537740467|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
149070042|NCT02422615|537740468|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
149070043|NCT02422615|537740467|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
149070044|NCT02422615|537740468|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
149070045|NCT02422615|537740467|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
149070046|NCT02422615|537740468|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
149070047|NCT02422615|537740467|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
149070048|NCT02422615|537740468|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
149070049|NCT01036724|537740469|FG000|Overall Study|Adverse Event|1|||
149070050|NCT01036724|537740470|FG001|Overall Study|Adverse Event|2|||
149070051|NCT01036724|537740469|FG000|Overall Study|Lack of Efficacy|1|||
149070052|NCT01036724|537740470|FG001|Overall Study|Lack of Efficacy|1|||
149070053|NCT01036724|537740469|FG000|Overall Study|Protocol Violation|4|||
149070054|NCT01036724|537740470|FG001|Overall Study|Protocol Violation|5|||
149070055|NCT01574716|537740474|FG000|Part 1|Death|3|||
149070056|NCT01574716|537740475|FG001|Part 1|Death|1|||
149070057|NCT01574716|537740476|FG002|Part 1|Death|8|||
149070058|NCT01574716|537740477|FG003|Part 1|Death|0|||
149070059|NCT01574716|537740478|FG004|Part 1|Death|0|||
149070060|NCT01574716|537740474|FG000|Part 1|Discontinuation of study by sponsor|0|||
149070061|NCT01574716|537740475|FG001|Part 1|Discontinuation of study by sponsor|0|||
149070062|NCT01574716|537740476|FG002|Part 1|Discontinuation of study by sponsor|1|||
149070063|NCT01574716|537740477|FG003|Part 1|Discontinuation of study by sponsor|0|||
149070064|NCT01574716|537740478|FG004|Part 1|Discontinuation of study by sponsor|0|||
149070065|NCT01574716|537740474|FG000|Part 1|Withdrawal by Subject|0|||
149070066|NCT01574716|537740475|FG001|Part 1|Withdrawal by Subject|2|||
149070067|NCT01574716|537740476|FG002|Part 1|Withdrawal by Subject|0|||
149070068|NCT01574716|537740477|FG003|Part 1|Withdrawal by Subject|0|||
149070069|NCT01574716|537740478|FG004|Part 1|Withdrawal by Subject|0|||
149070070|NCT01574716|537740474|FG000|Part 1|Lost to Follow-up|0|||
149070071|NCT01574716|537740475|FG001|Part 1|Lost to Follow-up|1|||
149070072|NCT01574716|537740476|FG002|Part 1|Lost to Follow-up|0|||
149070073|NCT01574716|537740477|FG003|Part 1|Lost to Follow-up|0|||
149070074|NCT01574716|537740478|FG004|Part 1|Lost to Follow-up|0|||
149070075|NCT01574716|537740474|FG000|Part 2|Progressive disease|0|||
149070076|NCT01574716|537740475|FG001|Part 2|Progressive disease|0|||
149070077|NCT01574716|537740476|FG002|Part 2|Progressive disease|0|||
149070078|NCT01574716|537740477|FG003|Part 2|Progressive disease|1|||
149070079|NCT01574716|537740478|FG004|Part 2|Progressive disease|0|||
149070080|NCT01574716|537740474|FG000|Part 2|Death|0|||
149070081|NCT01574716|537740475|FG001|Part 2|Death|0|||
149070082|NCT01574716|537740476|FG002|Part 2|Death|0|||
149070083|NCT01574716|537740477|FG003|Part 2|Death|76|||
149070084|NCT01574716|537740478|FG004|Part 2|Death|35|||
149070085|NCT01574716|537740474|FG000|Part 2|Discontinuation of study by sponsor|0|||
149070086|NCT01574716|537740475|FG001|Part 2|Discontinuation of study by sponsor|0|||
149070087|NCT01574716|537740476|FG002|Part 2|Discontinuation of study by sponsor|0|||
149070088|NCT01574716|537740477|FG003|Part 2|Discontinuation of study by sponsor|51|||
149070089|NCT01574716|537740478|FG004|Part 2|Discontinuation of study by sponsor|31|||
149070090|NCT01574716|537740474|FG000|Part 2|Withdrawal by Subject|0|||
149070091|NCT01574716|537740475|FG001|Part 2|Withdrawal by Subject|0|||
149070092|NCT01574716|537740476|FG002|Part 2|Withdrawal by Subject|0|||
149070093|NCT01574716|537740477|FG003|Part 2|Withdrawal by Subject|5|||
149070094|NCT01574716|537740478|FG004|Part 2|Withdrawal by Subject|4|||
149070095|NCT01574716|537740474|FG000|Part 2|Brain metastases|0|||
149070096|NCT01574716|537740475|FG001|Part 2|Brain metastases|0|||
149070097|NCT01574716|537740476|FG002|Part 2|Brain metastases|0|||
149070098|NCT01574716|537740477|FG003|Part 2|Brain metastases|1|||
149070099|NCT01574716|537740478|FG004|Part 2|Brain metastases|0|||
149070100|NCT01574716|537740474|FG000|Part 2|Lost to Follow-up|0|||
149070101|NCT01574716|537740475|FG001|Part 2|Lost to Follow-up|0|||
149070102|NCT01574716|537740476|FG002|Part 2|Lost to Follow-up|0|||
149070103|NCT01574716|537740477|FG003|Part 2|Lost to Follow-up|3|||
149070104|NCT01574716|537740478|FG004|Part 2|Lost to Follow-up|0|||
149070105|NCT00692913|537740480|FG000|Overall Study|Adverse Event|8|||
149070106|NCT00692913|537740481|FG001|Overall Study|Adverse Event|4|||
149070107|NCT00692913|537740480|FG000|Overall Study|Lost to Follow-up|3|||
149070108|NCT00692913|537740481|FG001|Overall Study|Lost to Follow-up|5|||
149070109|NCT00692913|537740480|FG000|Overall Study|Physician Decision|2|||
149070110|NCT00692913|537740481|FG001|Overall Study|Physician Decision|0|||
149070111|NCT00692913|537740480|FG000|Overall Study|Protocol Violation|1|||
149070112|NCT00692913|537740481|FG001|Overall Study|Protocol Violation|1|||
149070113|NCT00692913|537740480|FG000|Overall Study|Withdrawal by Subject|15|||
149070114|NCT00692913|537740481|FG001|Overall Study|Withdrawal by Subject|20|||
149070115|NCT02291913|537740482|FG000|Overall Study|Progressive Disease|32|||
149070116|NCT02291913|537740482|FG000|Overall Study|Adverse Event|11|||
149070117|NCT02291913|537740482|FG000|Overall Study|Death|2|||
149070118|NCT02291913|537740482|FG000|Overall Study|Physician Decision|1|||
149070119|NCT02291913|537740482|FG000|Overall Study|Withdrawal by Subject|1|||
149070120|NCT02291913|537740482|FG000|Overall Study|Protocol Violation|1|||
149070121|NCT01637402|537740483|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
149070122|NCT01637402|537740484|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
149070123|NCT01637402|537740483|FG000|Standard Dose Regimen|Adverse Event|1|||
149070124|NCT01637402|537740484|FG001|Standard Dose Regimen|Adverse Event|0|||
149070125|NCT01637402|537740483|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
149070126|NCT01637402|537740484|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
149070127|NCT01637402|537740483|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
149070128|NCT01637402|537740484|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
149070129|NCT01637402|537740483|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
149070130|NCT01637402|537740484|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
149070131|NCT01637402|537740483|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
149070132|NCT01637402|537740484|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
149070133|NCT04876417|537740487|FG000|Overall Study|Lost to Follow-up|5|||
149070134|NCT04876417|537740488|FG001|Overall Study|Lost to Follow-up|8|||
149070135|NCT04876417|537740489|FG002|Overall Study|Lost to Follow-up|0|||
149070136|NCT04876417|537740490|FG003|Overall Study|Lost to Follow-up|0|||
149070137|NCT01268306|537740493|FG000|Overall Study|Lost to Follow-up|1|||
149070138|NCT03709706|537740494|FG000|Overall Study|Adverse Event|0|||
149070139|NCT03709706|537740495|FG001|Overall Study|Adverse Event|1|||
149070140|NCT03709706|537740494|FG000|Overall Study|Physician Decision|14|||
149070141|NCT03709706|537740495|FG001|Overall Study|Physician Decision|8|||
149070142|NCT03709706|537740494|FG000|Overall Study|Withdrawal by Subject|2|||
149070143|NCT03709706|537740495|FG001|Overall Study|Withdrawal by Subject|1|||
149070144|NCT03709706|537740494|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
149070145|NCT03709706|537740495|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
149070146|NCT01105975|537740496|FG000|Overall Study|Adverse Event|2|||
149070147|NCT01105975|537740497|FG001|Overall Study|Adverse Event|1|||
149070148|NCT01105975|537740498|FG002|Overall Study|Adverse Event|5|||
149070149|NCT01105975|537740499|FG003|Overall Study|Adverse Event|1|||
149070150|NCT01105975|537740500|FG004|Overall Study|Adverse Event|0|||
149070151|NCT01105975|537740501|FG005|Overall Study|Adverse Event|1|||
149070152|NCT01105975|537740502|FG006|Overall Study|Adverse Event|2|||
149070153|NCT01105975|537740503|FG007|Overall Study|Adverse Event|4|||
149070154|NCT01105975|537740504|FG008|Overall Study|Adverse Event|1|||
149070155|NCT01105975|537740505|FG009|Overall Study|Adverse Event|4|||
149070156|NCT01105975|537740496|FG000|Overall Study|Withdrawal by Subject|2|||
149070157|NCT01105975|537740497|FG001|Overall Study|Withdrawal by Subject|2|||
149070158|NCT01105975|537740498|FG002|Overall Study|Withdrawal by Subject|2|||
149070159|NCT01105975|537740499|FG003|Overall Study|Withdrawal by Subject|0|||
149070160|NCT01105975|537740500|FG004|Overall Study|Withdrawal by Subject|4|||
149070161|NCT01105975|537740501|FG005|Overall Study|Withdrawal by Subject|1|||
149070162|NCT01105975|537740502|FG006|Overall Study|Withdrawal by Subject|2|||
149070163|NCT01105975|537740503|FG007|Overall Study|Withdrawal by Subject|1|||
149070164|NCT01105975|537740504|FG008|Overall Study|Withdrawal by Subject|0|||
149070165|NCT01105975|537740505|FG009|Overall Study|Withdrawal by Subject|3|||
149070166|NCT01105975|537740496|FG000|Overall Study|Lost to Follow-up|1|||
149070167|NCT01105975|537740497|FG001|Overall Study|Lost to Follow-up|0|||
149070168|NCT01105975|537740498|FG002|Overall Study|Lost to Follow-up|0|||
149070169|NCT01105975|537740499|FG003|Overall Study|Lost to Follow-up|1|||
149070170|NCT01105975|537740500|FG004|Overall Study|Lost to Follow-up|1|||
149070171|NCT01105975|537740501|FG005|Overall Study|Lost to Follow-up|0|||
149070172|NCT01105975|537740502|FG006|Overall Study|Lost to Follow-up|0|||
149070173|NCT01105975|537740503|FG007|Overall Study|Lost to Follow-up|0|||
149070174|NCT01105975|537740504|FG008|Overall Study|Lost to Follow-up|1|||
149070175|NCT01105975|537740505|FG009|Overall Study|Lost to Follow-up|0|||
149070176|NCT01105975|537740496|FG000|Overall Study|Physician Decision|0|||
149070177|NCT01105975|537740497|FG001|Overall Study|Physician Decision|0|||
149070178|NCT01105975|537740498|FG002|Overall Study|Physician Decision|0|||
149070179|NCT01105975|537740499|FG003|Overall Study|Physician Decision|0|||
149070180|NCT01105975|537740500|FG004|Overall Study|Physician Decision|0|||
149070181|NCT01105975|537740501|FG005|Overall Study|Physician Decision|0|||
149070182|NCT01105975|537740502|FG006|Overall Study|Physician Decision|2|||
149070183|NCT01105975|537740503|FG007|Overall Study|Physician Decision|0|||
149070184|NCT01105975|537740504|FG008|Overall Study|Physician Decision|0|||
149070185|NCT01105975|537740505|FG009|Overall Study|Physician Decision|0|||
149070186|NCT01105975|537740496|FG000|Overall Study|Protocol Violation|0|||
149070187|NCT01105975|537740497|FG001|Overall Study|Protocol Violation|2|||
149070188|NCT01105975|537740498|FG002|Overall Study|Protocol Violation|2|||
149070189|NCT01105975|537740499|FG003|Overall Study|Protocol Violation|0|||
149070190|NCT01105975|537740500|FG004|Overall Study|Protocol Violation|1|||
149070191|NCT01105975|537740501|FG005|Overall Study|Protocol Violation|1|||
149070192|NCT01105975|537740502|FG006|Overall Study|Protocol Violation|1|||
149070193|NCT01105975|537740503|FG007|Overall Study|Protocol Violation|1|||
149070194|NCT01105975|537740504|FG008|Overall Study|Protocol Violation|2|||
149070195|NCT01105975|537740505|FG009|Overall Study|Protocol Violation|2|||
149070196|NCT01105975|537740496|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149070197|NCT01105975|537740497|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149070198|NCT01105975|537740498|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
149070199|NCT01105975|537740499|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149070200|NCT01105975|537740500|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149070201|NCT01105975|537740501|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
149070202|NCT01105975|537740502|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
149070203|NCT01105975|537740503|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
149070204|NCT01105975|537740504|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
149070205|NCT01105975|537740505|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
149070206|NCT04868617|537740506|FG000|Overall Study|Death|1|||
149070207|NCT04868617|537740507|FG001|Overall Study|Death|0|||
149070208|NCT04868617|537740506|FG000|Overall Study|Adverse Event|1|||
149070209|NCT04868617|537740507|FG001|Overall Study|Adverse Event|0|||
149070210|NCT04868617|537740506|FG000|Overall Study|Withdrawal by Subject|1|||
149070211|NCT04868617|537740507|FG001|Overall Study|Withdrawal by Subject|0|||
149070212|NCT04868617|537740506|FG000|Overall Study|Device deficiency|1|||
149070213|NCT04868617|537740507|FG001|Overall Study|Device deficiency|0|||
149070214|NCT02797132|537740509|FG000|Part A (15 Days)|Adverse Event|1|||
149070215|NCT02797132|537740509|FG000|Part B (24 Weeks)|Adverse Event|3|||
149070216|NCT02502526|537740510|FG000|Overall Study|Lost to Follow-up|2|||
149070217|NCT02502526|537740511|FG001|Overall Study|Lost to Follow-up|2|||
149070218|NCT02502526|537740512|FG002|Overall Study|Lost to Follow-up|3|||
149070219|NCT02502526|537740510|FG000|Overall Study|Withdrawal by Subject|0|||
149070220|NCT02502526|537740511|FG001|Overall Study|Withdrawal by Subject|1|||
149070221|NCT02502526|537740512|FG002|Overall Study|Withdrawal by Subject|1|||
149070222|NCT02502526|537740510|FG000|Overall Study|Disqualified due to cataract grading|0|||
149070223|NCT02502526|537740511|FG001|Overall Study|Disqualified due to cataract grading|0|||
149070224|NCT02502526|537740512|FG002|Overall Study|Disqualified due to cataract grading|1|||
149070225|NCT02502526|537740510|FG000|Overall Study|Enrollment suspension|4|||
149070226|NCT02502526|537740511|FG001|Overall Study|Enrollment suspension|1|||
149070227|NCT02502526|537740512|FG002|Overall Study|Enrollment suspension|1|||
149070228|NCT01342367|537740515|FG000|Overall Study|Death|1|||
149070229|NCT01342367|537740516|FG001|Overall Study|Death|0|||
149070230|NCT01342367|537740515|FG000|Overall Study|Withdrawal by Subject|1|||
149070231|NCT01342367|537740516|FG001|Overall Study|Withdrawal by Subject|2|||
149070232|NCT02964741|537740517|FG000|Overall Study|Protocol Violation|1|||
149070233|NCT02964741|537740518|FG001|Overall Study|Protocol Violation|0|||
149070234|NCT02964741|537740519|FG002|Overall Study|Protocol Violation|0|||
149070235|NCT02964741|537740517|FG000|Overall Study|Withdrawal by Subject|0|||
149070236|NCT02964741|537740518|FG001|Overall Study|Withdrawal by Subject|1|||
149070237|NCT02964741|537740519|FG002|Overall Study|Withdrawal by Subject|0|||
149070238|NCT02964741|537740517|FG000|Overall Study|claustrophobia|1|||
149070239|NCT02964741|537740518|FG001|Overall Study|claustrophobia|0|||
149070240|NCT02964741|537740519|FG002|Overall Study|claustrophobia|0|||
149070241|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
149070242|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
149070243|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
149070244|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
149070245|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
149070246|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
149070247|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
149070248|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
149070249|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
149070250|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
149070251|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
149070252|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
149070253|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
149070254|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
149070255|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
149070256|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
149070257|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
149070258|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
149070259|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
149070260|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
149070261|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
149070262|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
149070263|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
149070264|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
149070265|NCT01074294|537740523|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
149070266|NCT01074294|537740524|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
149070267|NCT01074294|537740525|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
149070268|NCT01074294|537740526|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
149070269|NCT01074294|537740523|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
149070270|NCT01074294|537740524|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
149070271|NCT01074294|537740525|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
149070272|NCT01074294|537740526|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
149070273|NCT01074294|537740523|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
149070274|NCT01074294|537740524|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
149070275|NCT01074294|537740525|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
149070276|NCT01074294|537740526|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
149070277|NCT01074294|537740523|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
149070278|NCT01074294|537740524|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
149070279|NCT01074294|537740525|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
149070280|NCT01074294|537740526|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
149070281|NCT01074294|537740523|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
149070282|NCT01074294|537740524|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
149070283|NCT01074294|537740525|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
149070284|NCT01074294|537740526|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
149070285|NCT01074294|537740523|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
149070286|NCT01074294|537740524|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
149070287|NCT01074294|537740525|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
149070288|NCT01074294|537740526|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
149070289|NCT01074294|537740523|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
149070290|NCT01074294|537740524|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
149070291|NCT01074294|537740525|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
149070292|NCT01074294|537740526|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
149070293|NCT00640159|537740527|FG000|Overall Study|Lost to Follow-up|2|||
149070294|NCT00112359|537740528|FG000|Overall Study|Unrelated adverse event|16|||
149070295|NCT00112359|537740529|FG001|Overall Study|Unrelated adverse event|8|||
149070296|NCT00112359|537740528|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
149070297|NCT00112359|537740529|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
149070298|NCT00112359|537740528|FG000|Overall Study|Related adverse event|5|||
149070299|NCT00112359|537740529|FG001|Overall Study|Related adverse event|3|||
149070300|NCT00112359|537740528|FG000|Overall Study|Lost to Follow-up|0|||
149070301|NCT00112359|537740529|FG001|Overall Study|Lost to Follow-up|1|||
149070302|NCT00112359|537740528|FG000|Overall Study|Personal/administrative|1|||
149070303|NCT00112359|537740529|FG001|Overall Study|Personal/administrative|1|||
149070304|NCT00112359|537740528|FG000|Overall Study|Other|3|||
149070305|NCT00112359|537740529|FG001|Overall Study|Other|0|||
149070306|NCT00312208|537740530|FG000|Overall Study|Adverse Event|97|||
149070307|NCT00312208|537740531|FG001|Overall Study|Adverse Event|61|||
149070308|NCT00312208|537740530|FG000|Overall Study|Protocol Violation|5|||
149070309|NCT00312208|537740531|FG001|Overall Study|Protocol Violation|3|||
149070310|NCT00312208|537740530|FG000|Overall Study|Death|2|||
149070311|NCT00312208|537740531|FG001|Overall Study|Death|1|||
149070312|NCT00312208|537740530|FG000|Overall Study|Lack of Efficacy|7|||
149070313|NCT00312208|537740531|FG001|Overall Study|Lack of Efficacy|4|||
149070314|NCT00312208|537740530|FG000|Overall Study|Lost to Follow-up|3|||
149070315|NCT00312208|537740531|FG001|Overall Study|Lost to Follow-up|5|||
149070316|NCT00312208|537740530|FG000|Overall Study|Withdrawal by Subject|53|||
149070317|NCT00312208|537740531|FG001|Overall Study|Withdrawal by Subject|42|||
149070318|NCT00312208|537740530|FG000|Overall Study|Other|5|||
149070319|NCT00312208|537740531|FG001|Overall Study|Other|7|||
149070320|NCT03170882|537740538|FG000|Overall Study|Death|17|||
149070321|NCT03170882|537740539|FG001|Overall Study|Death|29|||
149070322|NCT03170882|537740538|FG000|Overall Study|Lost to Follow-up|0|||
149070323|NCT03170882|537740539|FG001|Overall Study|Lost to Follow-up|1|||
149070324|NCT03170882|537740538|FG000|Overall Study|Withdrawal by Subject|4|||
149070325|NCT03170882|537740539|FG001|Overall Study|Withdrawal by Subject|7|||
149070326|NCT03170882|537740538|FG000|Overall Study|Reason not Specified|28|||
149070327|NCT03170882|537740539|FG001|Overall Study|Reason not Specified|36|||
149070328|NCT01371994|537740561|FG000|Overall Study|Adverse Event|3|||
149070329|NCT01371994|537740562|FG001|Overall Study|Adverse Event|6|||
149070330|NCT01371994|537740561|FG000|Overall Study|Lack of Efficacy|3|||
149070331|NCT01371994|537740562|FG001|Overall Study|Lack of Efficacy|0|||
149070332|NCT01371994|537740561|FG000|Overall Study|Withdrawal by Subject|13|||
149070333|NCT01371994|537740562|FG001|Overall Study|Withdrawal by Subject|7|||
149070334|NCT01371994|537740561|FG000|Overall Study|Lost to Follow-up|1|||
149070335|NCT01371994|537740562|FG001|Overall Study|Lost to Follow-up|1|||
149070336|NCT01371994|537740561|FG000|Overall Study|Protocol Violation|24|||
149070337|NCT01371994|537740562|FG001|Overall Study|Protocol Violation|17|||
149070338|NCT01371994|537740561|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
149070339|NCT01371994|537740562|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
149070340|NCT01371994|537740561|FG000|Overall Study|Physician Decision|1|||
149070341|NCT01371994|537740562|FG001|Overall Study|Physician Decision|1|||
149070342|NCT01371994|537740561|FG000|Overall Study|Miscellaneous Reasons|6|||
149070343|NCT01371994|537740562|FG001|Overall Study|Miscellaneous Reasons|4|||
149070344|NCT00087685|537740563|FG000|Overall Study|Adverse Event|5|||
149070345|NCT00087685|537740563|FG000|Overall Study|Non-Compliance|1|||
149070346|NCT00087685|537740563|FG000|Overall Study|Progressive Disease|5|||
149070347|NCT00087685|537740563|FG000|Overall Study|Withdrawal by Subject|3|||
149070348|NCT03275285|537740565|FG000|Overall Study|Ongoing|45|||
149070349|NCT03275285|537740566|FG001|Overall Study|Ongoing|69|||
149070350|NCT00115934|537740567|FG000|Overall Study|Lost to Follow-up|1|||
149070351|NCT00115934|537740568|FG001|Overall Study|Lost to Follow-up|0|||
149070352|NCT00115934|537740567|FG000|Overall Study|Did not receive intervention|3|||
149070353|NCT00115934|537740568|FG001|Overall Study|Did not receive intervention|2|||
149070354|NCT00747565|537740569|FG000|Overall Study|Withdrawal by Subject|10|||
149070355|NCT00747565|537740570|FG001|Overall Study|Withdrawal by Subject|6|||
149070356|NCT00747565|537740569|FG000|Overall Study|Lost to Follow-up|4|||
149070357|NCT00747565|537740570|FG001|Overall Study|Lost to Follow-up|1|||
149070358|NCT00227266|537740573|FG000|Overall Study|Withdrawal by Subject|0|||
149070359|NCT00227266|537740574|FG001|Overall Study|Withdrawal by Subject|0|||
149070360|NCT00227266|537740575|FG002|Overall Study|Withdrawal by Subject|1|||
149070361|NCT00227266|537740573|FG000|Overall Study|Protocol Violation|1|||
149070362|NCT00227266|537740574|FG001|Overall Study|Protocol Violation|0|||
149070363|NCT00227266|537740575|FG002|Overall Study|Protocol Violation|1|||
149070364|NCT00227266|537740573|FG000|Overall Study|Excessive weight gain|0|||
149070365|NCT00227266|537740574|FG001|Overall Study|Excessive weight gain|0|||
149070366|NCT00227266|537740575|FG002|Overall Study|Excessive weight gain|2|||
149070367|NCT00210106|537741256|FG000|Overall Study|Death|1|||
149070368|NCT00210106|537741256|FG000|Overall Study|Protocol Violation|13|||
149070369|NCT00786864|537741257|FG000|Overall Study|Lost to Follow-up|0|||
149070370|NCT00786864|537741258|FG001|Overall Study|Lost to Follow-up|1|||
149070371|NCT00786864|537741257|FG000|Overall Study|Sustained serious back injury|1|||
149070372|NCT00786864|537741258|FG001|Overall Study|Sustained serious back injury|0|||
149070373|NCT03876457|537741260|FG000|Overall Study|Lost to Follow-up|1|||
149070374|NCT03876457|537741261|FG001|Overall Study|Lost to Follow-up|3|||
149070375|NCT02438137|537741266|FG000|Overall Study|Lost to Follow-up|3|||
149070376|NCT02438137|537741267|FG001|Overall Study|Lost to Follow-up|2|||
149070377|NCT02438137|537741266|FG000|Overall Study|Adverse Event|1|||
149070378|NCT02438137|537741267|FG001|Overall Study|Adverse Event|0|||
149070379|NCT02438137|537741266|FG000|Overall Study|Withdrawal by Subject|4|||
149070380|NCT02438137|537741267|FG001|Overall Study|Withdrawal by Subject|3|||
149070381|NCT02438137|537741266|FG000|Overall Study|Physician Decision|0|||
149070382|NCT02438137|537741267|FG001|Overall Study|Physician Decision|1|||
149070383|NCT00945321|537741268|FG000|Period 1|Adverse Event|0|||
149070384|NCT00945321|537741269|FG001|Period 1|Adverse Event|0|||
149070385|NCT00945321|537741270|FG002|Period 1|Adverse Event|0|||
149070386|NCT00945321|537741271|FG003|Period 1|Adverse Event|0|||
149070387|NCT00945321|537741272|FG004|Period 1|Adverse Event|1|||
149070388|NCT00945321|537741273|FG005|Period 1|Adverse Event|0|||
149070389|NCT00945321|537741268|FG000|Period 4|Lost to Follow-up|0|||
149070390|NCT00945321|537741269|FG001|Period 4|Lost to Follow-up|0|||
149070391|NCT00945321|537741270|FG002|Period 4|Lost to Follow-up|0|||
149070392|NCT00945321|537741271|FG003|Period 4|Lost to Follow-up|0|||
149070393|NCT00945321|537741272|FG004|Period 4|Lost to Follow-up|0|||
149070394|NCT00945321|537741273|FG005|Period 4|Lost to Follow-up|1|||
149070395|NCT04017611|537741274|FG000|Overall Study|Withdrawn prior to completion|1|||
149070396|NCT02284113|537741285|FG000|Overall Study|Adverse Event|1|||
149070397|NCT02284113|537741286|FG001|Overall Study|Adverse Event|0|||
149070398|NCT02284113|537741285|FG000|Overall Study|non-compliance|0|||
149070399|NCT02284113|537741286|FG001|Overall Study|non-compliance|1|||
149070400|NCT02284113|537741285|FG000|Overall Study|Withdrawal by Subject|0|||
149070401|NCT02284113|537741286|FG001|Overall Study|Withdrawal by Subject|1|||
149070402|NCT02284113|537741285|FG000|Overall Study|not provided|0|||
149070403|NCT02284113|537741286|FG001|Overall Study|not provided|1|||
149070404|NCT02284113|537741285|FG000|Overall Study|surgery cancelled|2|||
149070405|NCT02284113|537741286|FG001|Overall Study|surgery cancelled|0|||
149070406|NCT04191824|537741287|FG000|Overall Study|Death|13|||
149070407|NCT04191824|537741288|FG001|Overall Study|Death|12|||
149070408|NCT04191824|537741287|FG000|Overall Study|Lost to Follow-up|456|||
149070409|NCT04191824|537741288|FG001|Overall Study|Lost to Follow-up|435|||
149070410|NCT04191824|537741287|FG000|Overall Study|Physician Decision|2|||
149070411|NCT04191824|537741288|FG001|Overall Study|Physician Decision|1|||
149070412|NCT04191824|537741287|FG000|Overall Study|Protocol Violation|0|||
149070413|NCT04191824|537741288|FG001|Overall Study|Protocol Violation|2|||
149070414|NCT04191824|537741287|FG000|Overall Study|Withdrawal by Subject|16|||
149070415|NCT04191824|537741288|FG001|Overall Study|Withdrawal by Subject|18|||
149070416|NCT04191824|537741287|FG000|Overall Study|Early site closure|24|||
149070417|NCT04191824|537741288|FG001|Overall Study|Early site closure|22|||
149070418|NCT01218009|537741289|FG000|Overall Study|Protocol Violation|2|||
149070419|NCT01218009|537741290|FG001|Overall Study|Protocol Violation|1|||
149070420|NCT01218009|537741289|FG000|Overall Study|Withdrawal by Subject|3|||
149070421|NCT01218009|537741290|FG001|Overall Study|Withdrawal by Subject|1|||
149070422|NCT01218009|537741289|FG000|Overall Study|Sponsor terminated study|161|||
149070423|NCT01218009|537741290|FG001|Overall Study|Sponsor terminated study|163|||
149070424|NCT01324310|537741291|FG000|Overall Study|Adverse Event|1|||
149070425|NCT01324310|537741291|FG000|Overall Study|Disease Progression|1|||
149070426|NCT01830595|537741292|FG000|First Period|Withdrawal by Subject|1|||
149070427|NCT01830595|537741293|FG001|First Period|Withdrawal by Subject|3|||
149070428|NCT01830595|537741292|FG000|Washout|Withdrawal by Subject|2|||
149070429|NCT01830595|537741293|FG001|Washout|Withdrawal by Subject|2|||
149070430|NCT05018143|537741294|FG000|Overall Study|Lost to Follow-up|5|||
149070431|NCT05018143|537741295|FG001|Overall Study|Lost to Follow-up|4|||
149070432|NCT05018143|537741294|FG000|Overall Study|Withdrawal by Subject|0|||
149070433|NCT05018143|537741295|FG001|Overall Study|Withdrawal by Subject|1|||
149070434|NCT05116774|537741296|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
149070435|NCT05116774|537741297|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
149070436|NCT05116774|537741296|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
149070437|NCT05116774|537741297|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
149070438|NCT05116774|537741296|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
149070439|NCT05116774|537741297|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
149070440|NCT05116774|537741296|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
149070441|NCT05116774|537741297|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
149070442|NCT05601882|537741298|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
149070443|NCT05601882|537741299|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
149070444|NCT05601882|537741300|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
149070445|NCT05601882|537741301|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
149070446|NCT05601882|537741298|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
149070447|NCT05601882|537741299|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
149070448|NCT05601882|537741300|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
149070449|NCT05601882|537741301|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
149070450|NCT05601882|537741298|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
149070451|NCT05601882|537741299|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
149070452|NCT05601882|537741300|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
149070453|NCT05601882|537741301|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
149070454|NCT05601882|537741298|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
149070455|NCT05601882|537741299|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
149070456|NCT05601882|537741300|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
149070457|NCT05601882|537741301|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
149070458|NCT05601882|537741298|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
149070459|NCT05601882|537741299|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
149070460|NCT05601882|537741300|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
149070461|NCT05601882|537741301|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
149070462|NCT05601882|537741298|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
149070463|NCT05601882|537741299|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
149070464|NCT05601882|537741300|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
149070465|NCT05601882|537741301|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
149070466|NCT03777657|537741302|FG000|Overall Study|Death|397|||
149070467|NCT03777657|537741303|FG001|Overall Study|Death|431|||
149070468|NCT03777657|537741302|FG000|Overall Study|Study Closed by Sponsor|77|||
149070469|NCT03777657|537741303|FG001|Overall Study|Study Closed by Sponsor|38|||
149070470|NCT03777657|537741302|FG000|Overall Study|Withdrawal by Subject|20|||
149070471|NCT03777657|537741303|FG001|Overall Study|Withdrawal by Subject|17|||
149070472|NCT03777657|537741302|FG000|Overall Study|Lost to Follow-up|6|||
149070473|NCT03777657|537741303|FG001|Overall Study|Lost to Follow-up|10|||
149070474|NCT03789110|537741304|FG000|Overall Study|Adverse Event|2|||
149070475|NCT03789110|537741304|FG000|Overall Study|Physician Decision|1|||
149070476|NCT03789110|537741304|FG000|Overall Study|Withdrawal by Subject|2|||
149070477|NCT03789110|537741304|FG000|Overall Study|Lack of Efficacy|22|||
149070478|NCT03789110|537741304|FG000|Overall Study|still on treatment|3|||
149070479|NCT03691493|537741305|FG000|Overall Study|Withdrawal by Subject|1|||
149070480|NCT05464732|537741315|FG000|Overall Study|Lost to Follow-up|0|||
149070481|NCT05464732|537741316|FG001|Overall Study|Lost to Follow-up|1|||
149070482|NCT05464732|537741315|FG000|Overall Study|Adverse Event|1|||
149070483|NCT05464732|537741316|FG001|Overall Study|Adverse Event|0|||
149070484|NCT02549352|537741317|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
149070485|NCT02549352|537741318|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
149070486|NCT02549352|537741317|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
149070487|NCT02549352|537741318|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
149070488|NCT02549352|537741317|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
149070489|NCT02549352|537741318|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
149070490|NCT02549352|537741317|FG000|12-month Follow-up|Withdrawal by Subject|4|||
149070491|NCT02549352|537741318|FG001|12-month Follow-up|Withdrawal by Subject|5|||
149070492|NCT02549352|537741317|FG000|12-month Follow-up|Lost to Follow-up|3|||
149070493|NCT02549352|537741318|FG001|12-month Follow-up|Lost to Follow-up|2|||
149070494|NCT02549352|537741317|FG000|12-month Follow-up|Death|0|||
149070495|NCT02549352|537741318|FG001|12-month Follow-up|Death|1|||
149070496|NCT02549352|537741317|FG000|12-month Follow-up|Protocol Violation|0|||
149070497|NCT02549352|537741318|FG001|12-month Follow-up|Protocol Violation|1|||
149070498|NCT02549352|537741317|FG000|12-month Follow-up|Other|1|||
149070499|NCT02549352|537741318|FG001|12-month Follow-up|Other|3|||
149070500|NCT01470144|537741319|FG000|Overall Study|Adverse Event|2|||
149070501|NCT01470144|537741319|FG000|Overall Study|Death|1|||
149070502|NCT01470144|537741319|FG000|Overall Study|Lung transplant|6|||
149070503|NCT01470144|537741319|FG000|Overall Study|Patient's and investigator's decision|1|||
149070504|NCT00593840|537741320|FG000|Overall Study|Withdrawal by Subject|1|||
149070505|NCT05864209|537742142|FG000|Overall Study|Lost to Follow-up|2|||
149070506|NCT05864209|537742143|FG001|Overall Study|Lost to Follow-up|3|||
149070507|NCT02722434|537742146|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
149070508|NCT02722434|537742147|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
149070509|NCT02722434|537742146|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
149070510|NCT02722434|537742147|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
149070511|NCT04559698|537742148|FG000|Overall Study|Lost to Follow-up|14|||
149070512|NCT04559698|537742149|FG001|Overall Study|Lost to Follow-up|15|||
149070513|NCT04559698|537742148|FG000|Overall Study|Withdrawal by Subject|0|||
149070514|NCT04559698|537742149|FG001|Overall Study|Withdrawal by Subject|1|||
149070515|NCT03437733|537742150|FG000|Overall Study|Eligibility criteria not met|0|||
149070516|NCT03437733|537742151|FG001|Overall Study|Eligibility criteria not met|3|||
149070517|NCT01982682|537742152|FG000|Overall Study|Physician Decision|1|||
149070518|NCT02760654|537742153|FG000|Overall Study|Lost to Follow-up|3|||
149070519|NCT02760654|537742154|FG001|Overall Study|Lost to Follow-up|3|||
149070520|NCT02760654|537742153|FG000|Overall Study|Withdrawal by Subject|4|||
149070521|NCT02760654|537742154|FG001|Overall Study|Withdrawal by Subject|3|||
149070522|NCT00146172|537742155|FG000|Overall Study|Adverse Event|0|||
149070523|NCT00146172|537742156|FG001|Overall Study|Adverse Event|0|||
149070524|NCT00146172|537742157|FG002|Overall Study|Adverse Event|1|||
149070525|NCT00146172|537742158|FG003|Overall Study|Adverse Event|1|||
149070526|NCT00146172|537742159|FG004|Overall Study|Adverse Event|0|||
149070527|NCT00146172|537742160|FG005|Overall Study|Adverse Event|2|||
149070528|NCT00146172|537742161|FG006|Overall Study|Adverse Event|3|||
149070529|NCT00146172|537742162|FG007|Overall Study|Adverse Event|10|||
149070530|NCT00146172|537742155|FG000|Overall Study|Lost to Follow-up|0|||
149070531|NCT00146172|537742156|FG001|Overall Study|Lost to Follow-up|0|||
149070532|NCT00146172|537742157|FG002|Overall Study|Lost to Follow-up|0|||
149070533|NCT00146172|537742158|FG003|Overall Study|Lost to Follow-up|0|||
149070534|NCT00146172|537742159|FG004|Overall Study|Lost to Follow-up|0|||
149070535|NCT00146172|537742160|FG005|Overall Study|Lost to Follow-up|0|||
149070536|NCT00146172|537742161|FG006|Overall Study|Lost to Follow-up|0|||
149070537|NCT00146172|537742162|FG007|Overall Study|Lost to Follow-up|1|||
149070538|NCT00146172|537742155|FG000|Overall Study|Disease Progression|2|||
149070539|NCT00146172|537742156|FG001|Overall Study|Disease Progression|4|||
149070540|NCT00146172|537742157|FG002|Overall Study|Disease Progression|2|||
149070541|NCT00146172|537742158|FG003|Overall Study|Disease Progression|5|||
149070542|NCT00146172|537742159|FG004|Overall Study|Disease Progression|2|||
149070543|NCT00146172|537742160|FG005|Overall Study|Disease Progression|2|||
149070544|NCT00146172|537742161|FG006|Overall Study|Disease Progression|1|||
149070545|NCT00146172|537742162|FG007|Overall Study|Disease Progression|22|||
149070546|NCT00146172|537742155|FG000|Overall Study|Death|0|||
149070547|NCT00146172|537742156|FG001|Overall Study|Death|0|||
149070548|NCT00146172|537742157|FG002|Overall Study|Death|0|||
149070549|NCT00146172|537742158|FG003|Overall Study|Death|0|||
149070550|NCT00146172|537742159|FG004|Overall Study|Death|0|||
149070551|NCT00146172|537742160|FG005|Overall Study|Death|0|||
149070552|NCT00146172|537742161|FG006|Overall Study|Death|1|||
149070553|NCT00146172|537742162|FG007|Overall Study|Death|0|||
149070554|NCT00146172|537742155|FG000|Overall Study|Physician Decision|0|||
149070555|NCT00146172|537742156|FG001|Overall Study|Physician Decision|0|||
149070556|NCT00146172|537742157|FG002|Overall Study|Physician Decision|0|||
149070557|NCT00146172|537742158|FG003|Overall Study|Physician Decision|0|||
149070558|NCT00146172|537742159|FG004|Overall Study|Physician Decision|0|||
149070559|NCT00146172|537742160|FG005|Overall Study|Physician Decision|0|||
149070560|NCT00146172|537742161|FG006|Overall Study|Physician Decision|0|||
149070561|NCT00146172|537742162|FG007|Overall Study|Physician Decision|1|||
149070562|NCT00146172|537742155|FG000|Overall Study|Withdrawal by Subject|0|||
149070563|NCT00146172|537742156|FG001|Overall Study|Withdrawal by Subject|0|||
149070564|NCT00146172|537742157|FG002|Overall Study|Withdrawal by Subject|0|||
149070565|NCT00146172|537742158|FG003|Overall Study|Withdrawal by Subject|0|||
149070566|NCT00146172|537742159|FG004|Overall Study|Withdrawal by Subject|0|||
149070567|NCT00146172|537742160|FG005|Overall Study|Withdrawal by Subject|1|||
149070568|NCT00146172|537742161|FG006|Overall Study|Withdrawal by Subject|1|||
149070569|NCT00146172|537742162|FG007|Overall Study|Withdrawal by Subject|4|||
149070570|NCT00146172|537742155|FG000|Overall Study|Symptomatic Deterioration|1|||
149070571|NCT00146172|537742156|FG001|Overall Study|Symptomatic Deterioration|0|||
149070572|NCT00146172|537742157|FG002|Overall Study|Symptomatic Deterioration|1|||
149070573|NCT00146172|537742158|FG003|Overall Study|Symptomatic Deterioration|0|||
149070574|NCT00146172|537742159|FG004|Overall Study|Symptomatic Deterioration|1|||
149070575|NCT00146172|537742160|FG005|Overall Study|Symptomatic Deterioration|2|||
149070576|NCT00146172|537742161|FG006|Overall Study|Symptomatic Deterioration|0|||
149070577|NCT00146172|537742162|FG007|Overall Study|Symptomatic Deterioration|2|||
149070578|NCT01184326|537742166|FG000|Overall Study|Adverse Event|1|||
149070579|NCT01184326|537742167|FG001|Overall Study|Adverse Event|2|||
149070580|NCT01184326|537742168|FG002|Overall Study|Adverse Event|0|||
149070581|NCT01184326|537742166|FG000|Overall Study|Death|0|||
149070582|NCT01184326|537742167|FG001|Overall Study|Death|0|||
149070583|NCT01184326|537742168|FG002|Overall Study|Death|1|||
149070584|NCT01184326|537742166|FG000|Overall Study|Withdrawal by Subject|0|||
149070585|NCT01184326|537742167|FG001|Overall Study|Withdrawal by Subject|0|||
149070586|NCT01184326|537742168|FG002|Overall Study|Withdrawal by Subject|1|||
149070587|NCT01184326|537742166|FG000|Overall Study|Physician Decision|1|||
149070588|NCT01184326|537742167|FG001|Overall Study|Physician Decision|1|||
149070589|NCT01184326|537742168|FG002|Overall Study|Physician Decision|0|||
149070590|NCT01184326|537742166|FG000|Overall Study|Disease Progression|1|||
149070591|NCT01184326|537742167|FG001|Overall Study|Disease Progression|3|||
149070592|NCT01184326|537742168|FG002|Overall Study|Disease Progression|12|||
149070593|NCT01084694|537742169|FG000|Overall Study|Withdrawal by Subject|2|||
149070594|NCT01084694|537742170|FG001|Overall Study|Withdrawal by Subject|1|||
149070595|NCT01084694|537742169|FG000|Overall Study|Death|2|||
149070596|NCT01084694|537742170|FG001|Overall Study|Death|12|||
149070597|NCT01084694|537742169|FG000|Overall Study|eligibility not maintained|2|||
149070598|NCT01084694|537742170|FG001|Overall Study|eligibility not maintained|7|||
149070599|NCT00605306|537742174|FG000|Overall Study|Adverse Event|0|||
149070600|NCT00605306|537742175|FG001|Overall Study|Adverse Event|1|||
149070601|NCT01750684|537742176|FG000|Overall Study|Death|1|||
149070602|NCT01750684|537742177|FG001|Overall Study|Death|0|||
149070603|NCT01750684|537742176|FG000|Overall Study|Non-compliance with Study Drug|0|||
149070604|NCT01750684|537742177|FG001|Overall Study|Non-compliance with Study Drug|1|||
149070605|NCT01750684|537742176|FG000|Overall Study|Withdrawn by Sponsor|0|||
149070606|NCT01750684|537742177|FG001|Overall Study|Withdrawn by Sponsor|1|||
149070607|NCT01750684|537742176|FG000|Overall Study|Protocol Violation|1|||
149070608|NCT01750684|537742177|FG001|Overall Study|Protocol Violation|0|||
149070609|NCT02185794|537742180|FG000|Overall Study|Enrolled but Never Dosed|1|||
149070610|NCT02185794|537742181|FG001|Overall Study|Enrolled but Never Dosed|6|||
149070611|NCT02185794|537742182|FG002|Overall Study|Enrolled but Never Dosed|3|||
149070612|NCT02185794|537742183|FG003|Overall Study|Enrolled but Never Dosed|1|||
149070613|NCT02185794|537742184|FG004|Overall Study|Enrolled but Never Dosed|1|||
149070614|NCT02185794|537742185|FG005|Overall Study|Enrolled but Never Dosed|0|||
149070615|NCT02185794|537742180|FG000|Overall Study|Investigator's Discretion|1|||
149070616|NCT02185794|537742181|FG001|Overall Study|Investigator's Discretion|0|||
149070617|NCT02185794|537742182|FG002|Overall Study|Investigator's Discretion|1|||
149070618|NCT02185794|537742183|FG003|Overall Study|Investigator's Discretion|2|||
149070619|NCT02185794|537742184|FG004|Overall Study|Investigator's Discretion|2|||
149070620|NCT02185794|537742185|FG005|Overall Study|Investigator's Discretion|15|||
149070621|NCT02185794|537742180|FG000|Overall Study|Withdrew Consent|2|||
149070622|NCT02185794|537742181|FG001|Overall Study|Withdrew Consent|5|||
149070623|NCT02185794|537742182|FG002|Overall Study|Withdrew Consent|10|||
149070624|NCT02185794|537742183|FG003|Overall Study|Withdrew Consent|2|||
149070625|NCT02185794|537742184|FG004|Overall Study|Withdrew Consent|0|||
149070626|NCT02185794|537742185|FG005|Overall Study|Withdrew Consent|0|||
149070627|NCT02185794|537742180|FG000|Overall Study|Lost to Follow-up|1|||
149070628|NCT02185794|537742181|FG001|Overall Study|Lost to Follow-up|2|||
149070629|NCT02185794|537742182|FG002|Overall Study|Lost to Follow-up|2|||
149070630|NCT02185794|537742183|FG003|Overall Study|Lost to Follow-up|3|||
149070631|NCT02185794|537742184|FG004|Overall Study|Lost to Follow-up|0|||
149070632|NCT02185794|537742185|FG005|Overall Study|Lost to Follow-up|1|||
149070633|NCT00336505|537742186|FG000|Overall Study|Adverse Event|10|||
149070634|NCT00336505|537742187|FG001|Overall Study|Adverse Event|9|||
149070635|NCT00336505|537742186|FG000|Overall Study|Lack of Efficacy|8|||
149070636|NCT00336505|537742187|FG001|Overall Study|Lack of Efficacy|4|||
149070637|NCT00336505|537742186|FG000|Overall Study|Lost to Follow-up|7|||
149070638|NCT00336505|537742187|FG001|Overall Study|Lost to Follow-up|4|||
149070639|NCT00336505|537742186|FG000|Overall Study|Withdrawal by Subject|5|||
149070640|NCT00336505|537742187|FG001|Overall Study|Withdrawal by Subject|3|||
149070641|NCT00336505|537742186|FG000|Overall Study|Other|7|||
149070642|NCT00336505|537742187|FG001|Overall Study|Other|7|||
149070643|NCT01092416|537742188|FG000|Enrollment|Atherectomy device not inserted|3|||
149070644|NCT01092416|537742188|FG000|30-Day Follow-up|Death|2|||
149070645|NCT01092416|537742188|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
149070646|NCT01092416|537742188|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
149070647|NCT01092416|537742188|FG000|12-Month Follow-up|Death|16|||
149070648|NCT01092416|537742188|FG000|12-Month Follow-up|Lost to Follow-up|4|||
149070649|NCT01092416|537742188|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
149070650|NCT01092416|537742188|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
149070651|NCT01092416|537742188|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
149070652|NCT00246805|537742189|FG000|Phase 1|Lost to Follow-up|1|||
149070653|NCT00246805|537742190|FG001|Phase 1|Lost to Follow-up|0|||
149070654|NCT03478969|537742191|FG000|Overall Study|Withdrawal by Subject|4|||
149070655|NCT03478969|537742192|FG001|Overall Study|Withdrawal by Subject|7|||
149070656|NCT03478969|537742193|FG002|Overall Study|Withdrawal by Subject|6|||
149070657|NCT03478969|537742191|FG000|Overall Study|Adverse Event|2|||
149070658|NCT03478969|537742192|FG001|Overall Study|Adverse Event|0|||
149070659|NCT03478969|537742193|FG002|Overall Study|Adverse Event|1|||
149070660|NCT03478969|537742191|FG000|Overall Study|Pregnancy|1|||
149070661|NCT03478969|537742192|FG001|Overall Study|Pregnancy|0|||
149070662|NCT03478969|537742193|FG002|Overall Study|Pregnancy|0|||
149070663|NCT03478969|537742191|FG000|Overall Study|Personal Reasons|1|||
149070664|NCT03478969|537742192|FG001|Overall Study|Personal Reasons|0|||
149070665|NCT03478969|537742193|FG002|Overall Study|Personal Reasons|1|||
149070666|NCT03478969|537742191|FG000|Overall Study|Covid-19|1|||
149070667|NCT03478969|537742192|FG001|Overall Study|Covid-19|4|||
149070668|NCT03478969|537742193|FG002|Overall Study|Covid-19|3|||
149070669|NCT03478969|537742191|FG000|Overall Study|Multiple Reasons|0|||
149070670|NCT03478969|537742192|FG001|Overall Study|Multiple Reasons|1|||
149070671|NCT03478969|537742193|FG002|Overall Study|Multiple Reasons|1|||
149070672|NCT03478969|537742191|FG000|Overall Study|Eligibility Criteria|0|||
149070673|NCT03478969|537742192|FG001|Overall Study|Eligibility Criteria|0|||
149070674|NCT03478969|537742193|FG002|Overall Study|Eligibility Criteria|5|||
149070675|NCT03478969|537742191|FG000|Overall Study|Lost to Follow-up|0|||
149070676|NCT03478969|537742192|FG001|Overall Study|Lost to Follow-up|0|||
149070677|NCT03478969|537742193|FG002|Overall Study|Lost to Follow-up|1|||
149070678|NCT00739934|537742194|FG000|Voriconazole IV|Adverse Event|6|||
149070679|NCT00739934|537742194|FG000|Voriconazole Oral|Other|3|||
149070680|NCT01952366|537742195|FG000|Overall Study|Death|22|||
149070681|NCT01952366|537742195|FG000|Overall Study|Withdrawal by Subject|9|||
149070682|NCT00857766|537742196|FG000|Overall Study|Adverse Event|13|||
149070683|NCT00857766|537742197|FG001|Overall Study|Adverse Event|12|||
149070684|NCT00857766|537742196|FG000|Overall Study|Protocol Violation|11|||
149070685|NCT00857766|537742197|FG001|Overall Study|Protocol Violation|11|||
149070686|NCT00857766|537742196|FG000|Overall Study|Lost to Follow-up|1|||
149070687|NCT00857766|537742197|FG001|Overall Study|Lost to Follow-up|0|||
149070688|NCT00857766|537742196|FG000|Overall Study|Investigator Discretion|2|||
149070689|NCT00857766|537742197|FG001|Overall Study|Investigator Discretion|3|||
149070690|NCT00857766|537742196|FG000|Overall Study|Participant Withdrew Consent|4|||
149070691|NCT00857766|537742197|FG001|Overall Study|Participant Withdrew Consent|4|||
149070692|NCT01212744|537742198|FG000|Overall Study|Withdrawal by Subject|1|||
149070693|NCT02167451|537742200|FG000|Overall Study|Withdrawal by Subject|1|||
149070694|NCT03355573|537742205|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
149070695|NCT03355573|537742205|FG000|Overall Study|Sponsor's decision|1|||
149070696|NCT03355573|537742205|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
149070697|NCT03355573|537742205|FG000|Overall Study|PI's decision|2|||
149070698|NCT03355573|537742205|FG000|Overall Study|Withdrawal by Subject|23|||
149070699|NCT03355573|537742205|FG000|Overall Study|Lost to Follow-up|4|||
149070700|NCT03355573|537742205|FG000|Overall Study|Lack of Efficacy|2|||
149070701|NCT03355573|537742205|FG000|Overall Study|Adverse Event, non-fatal|17|||
149070702|NCT03355573|537742205|FG000|Overall Study|Adverse Event, serious fatal|2|||
149070703|NCT00811941|537742206|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
149070704|NCT00811941|537742207|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
149070705|NCT00811941|537742206|FG000|All Treated Patients|Adverse Event|2|||
149070706|NCT00811941|537742207|FG001|All Treated Patients|Adverse Event|43|||
149070707|NCT00811941|537742206|FG000|All Treated Patients|Lack of Efficacy|2|||
149070708|NCT00811941|537742207|FG001|All Treated Patients|Lack of Efficacy|3|||
149070709|NCT00811941|537742206|FG000|All Treated Patients|Non-compliance|1|||
149070710|NCT00811941|537742207|FG001|All Treated Patients|Non-compliance|8|||
149070711|NCT00811941|537742206|FG000|All Treated Patients|Protocol Violation|5|||
149070712|NCT00811941|537742207|FG001|All Treated Patients|Protocol Violation|17|||
149070713|NCT00811941|537742206|FG000|All Treated Patients|Withdrawal by Subject|35|||
149070714|NCT00811941|537742207|FG001|All Treated Patients|Withdrawal by Subject|94|||
149070715|NCT00811941|537742206|FG000|All Treated Patients|Lost to Follow-up|3|||
149070716|NCT00811941|537742207|FG001|All Treated Patients|Lost to Follow-up|12|||
149070717|NCT00811941|537742206|FG000|All Treated Patients|Other Reason|4|||
149070718|NCT00811941|537742207|FG001|All Treated Patients|Other Reason|14|||
149070719|NCT03885232|537742208|FG000|Overall Study|Lost to Follow-up|74|||
149070720|NCT03885232|537742209|FG001|Overall Study|Lost to Follow-up|32|||
149070721|NCT03885232|537742208|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
149070722|NCT03885232|537742209|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
149070723|NCT02397096|537742210|FG000|Day 1 to Week 24|Adverse Event|7|||
149070724|NCT02397096|537742211|FG001|Day 1 to Week 24|Adverse Event|1|||
149070725|NCT02397096|537742210|FG000|Day 1 to Week 24|Death|1|||
149070726|NCT02397096|537742211|FG001|Day 1 to Week 24|Death|0|||
149070727|NCT02397096|537742210|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
149070728|NCT02397096|537742211|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
149070729|NCT02397096|537742210|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
149070730|NCT02397096|537742211|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
149070731|NCT02397096|537742210|FG000|Day 1 to Week 24|Physician Decision|2|||
149070732|NCT02397096|537742211|FG001|Day 1 to Week 24|Physician Decision|3|||
149070733|NCT02397096|537742210|FG000|Day 1 to Week 24|Protocol Violation|1|||
149070734|NCT02397096|537742211|FG001|Day 1 to Week 24|Protocol Violation|4|||
149070735|NCT02397096|537742210|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
149070736|NCT02397096|537742211|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
149070737|NCT02397096|537742210|FG000|Day 1 to Week 24|Randomized, not treated|3|||
149070738|NCT02397096|537742211|FG001|Day 1 to Week 24|Randomized, not treated|0|||
149070739|NCT02397096|537742210|FG000|Week 24 to Week 48|Adverse Event|6|||
149070740|NCT02397096|537742211|FG001|Week 24 to Week 48|Adverse Event|2|||
149070741|NCT02397096|537742210|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
149070742|NCT02397096|537742211|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
149070743|NCT02397096|537742210|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
149070744|NCT02397096|537742211|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
149070745|NCT02397096|537742210|FG000|Week 24 to Week 48|Physician Decision|2|||
149070746|NCT02397096|537742211|FG001|Week 24 to Week 48|Physician Decision|1|||
149070747|NCT02397096|537742210|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
149070748|NCT02397096|537742211|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
149070749|NCT02397096|537742210|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
149070750|NCT02397096|537742211|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
149070751|NCT02397096|537742210|FG000|Study Extension 1|Adverse Event|7|||
149070752|NCT02397096|537742211|FG001|Study Extension 1|Adverse Event|5|||
149070753|NCT02397096|537742210|FG000|Study Extension 1|Death|1|||
149070754|NCT02397096|537742211|FG001|Study Extension 1|Death|0|||
149070755|NCT02397096|537742210|FG000|Study Extension 1|Lack of Efficacy|2|||
149070756|NCT02397096|537742211|FG001|Study Extension 1|Lack of Efficacy|5|||
149070757|NCT02397096|537742210|FG000|Study Extension 1|Lost to Follow-up|2|||
149070758|NCT02397096|537742211|FG001|Study Extension 1|Lost to Follow-up|3|||
149070759|NCT02397096|537742210|FG000|Study Extension 1|Non-compliance with study drug|3|||
149070760|NCT02397096|537742211|FG001|Study Extension 1|Non-compliance with study drug|0|||
149070761|NCT02397096|537742210|FG000|Study Extension 1|Physician Decision|4|||
149070762|NCT02397096|537742211|FG001|Study Extension 1|Physician Decision|2|||
149070763|NCT02397096|537742210|FG000|Study Extension 1|Pregnancy|1|||
149070764|NCT02397096|537742211|FG001|Study Extension 1|Pregnancy|0|||
149070765|NCT02397096|537742210|FG000|Study Extension 1|Protocol Violation|0|||
149070766|NCT02397096|537742211|FG001|Study Extension 1|Protocol Violation|1|||
149070767|NCT02397096|537742210|FG000|Study Extension 1|Withdrawal by Subject|21|||
149070768|NCT02397096|537742211|FG001|Study Extension 1|Withdrawal by Subject|7|||
149070769|NCT02397096|537742210|FG000|Study Extension 2|Adverse Event|3|||
149070770|NCT02397096|537742211|FG001|Study Extension 2|Adverse Event|3|||
149070771|NCT02397096|537742210|FG000|Study Extension 2|Availability of study medication locally|152|||
149070772|NCT02397096|537742211|FG001|Study Extension 2|Availability of study medication locally|64|||
149070773|NCT02397096|537742210|FG000|Study Extension 2|Death|2|||
149070774|NCT02397096|537742211|FG001|Study Extension 2|Death|0|||
149070775|NCT02397096|537742210|FG000|Study Extension 2|Lack of Efficacy|1|||
149070776|NCT02397096|537742211|FG001|Study Extension 2|Lack of Efficacy|0|||
149070777|NCT02397096|537742210|FG000|Study Extension 2|Lost to Follow-up|2|||
149070778|NCT02397096|537742211|FG001|Study Extension 2|Lost to Follow-up|1|||
149070779|NCT02397096|537742210|FG000|Study Extension 2|Non-compliance with study drug|1|||
149070780|NCT02397096|537742211|FG001|Study Extension 2|Non-compliance with study drug|0|||
149070781|NCT02397096|537742210|FG000|Study Extension 2|Physician Decision|2|||
149070782|NCT02397096|537742211|FG001|Study Extension 2|Physician Decision|5|||
149070783|NCT02397096|537742210|FG000|Study Extension 2|Pregnancy|1|||
149070784|NCT02397096|537742211|FG001|Study Extension 2|Pregnancy|0|||
149070785|NCT02397096|537742210|FG000|Study Extension 2|Withdrawal by Subject|10|||
149070786|NCT02397096|537742211|FG001|Study Extension 2|Withdrawal by Subject|3|||
149070787|NCT02397096|537742210|FG000|Study Extension 3|Adverse Event|1|||
149070788|NCT02397096|537742211|FG001|Study Extension 3|Adverse Event|0|||
149070789|NCT02397096|537742210|FG000|Study Extension 3|Availability of study medication locally|11|||
149070790|NCT02397096|537742211|FG001|Study Extension 3|Availability of study medication locally|3|||
149070791|NCT02397096|537742210|FG000|Study Extension 3|Lost to Follow-up|1|||
149070792|NCT02397096|537742211|FG001|Study Extension 3|Lost to Follow-up|0|||
149070793|NCT02397096|537742210|FG000|Study Extension 3|Withdrawal by Subject|2|||
149070794|NCT02397096|537742211|FG001|Study Extension 3|Withdrawal by Subject|1|||
149070795|NCT03840902|537742212|FG000|Overall Study|Randomized but not treated|1|||
149070796|NCT03840902|537742213|FG001|Overall Study|Randomized but not treated|1|||
149070797|NCT05139992|537742219|FG000|Overall Study|Withdrawal by Subject|12|||
149070798|NCT05139992|537742219|FG000|Overall Study|Lost to Follow-up|6|||
149070799|NCT03834740|537742220|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
149070800|NCT03834740|537742221|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
149070801|NCT03834740|537742222|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
149070802|NCT01208974|537742223|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
149070803|NCT01208974|537742224|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
149070804|NCT01208974|537742225|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
149070805|NCT01208974|537742226|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
149070806|NCT01208974|537742223|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
149070807|NCT01208974|537742224|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
149070808|NCT01208974|537742225|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
149070809|NCT01208974|537742226|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
149070810|NCT01208974|537742223|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
149070811|NCT01208974|537742224|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
149070812|NCT01208974|537742225|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
149070813|NCT01208974|537742226|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
149070814|NCT03593226|537742227|FG000|Overall Study|Disease progression|6|||
149070815|NCT03593226|537742228|FG001|Overall Study|Disease progression|13|||
149070816|NCT03593226|537742229|FG002|Overall Study|Disease progression|5|||
149070817|NCT03593226|537742230|FG003|Overall Study|Disease progression|6|||
149070818|NCT03593226|537742227|FG000|Overall Study|Adverse Event|0|||
149070819|NCT03593226|537742228|FG001|Overall Study|Adverse Event|1|||
149070820|NCT03593226|537742229|FG002|Overall Study|Adverse Event|0|||
149070821|NCT03593226|537742230|FG003|Overall Study|Adverse Event|0|||
149070822|NCT03593226|537742227|FG000|Overall Study|Withdrawal by Subject|0|||
149070823|NCT03593226|537742228|FG001|Overall Study|Withdrawal by Subject|4|||
149070824|NCT03593226|537742229|FG002|Overall Study|Withdrawal by Subject|1|||
149070825|NCT03593226|537742230|FG003|Overall Study|Withdrawal by Subject|0|||
149070826|NCT03593226|537742227|FG000|Overall Study|Physician Decision|0|||
149070827|NCT03593226|537742228|FG001|Overall Study|Physician Decision|1|||
149070828|NCT03593226|537742229|FG002|Overall Study|Physician Decision|0|||
149070829|NCT03593226|537742230|FG003|Overall Study|Physician Decision|0|||
149070830|NCT03593226|537742227|FG000|Overall Study|Clinical disease progression|0|||
149070831|NCT03593226|537742228|FG001|Overall Study|Clinical disease progression|0|||
149070832|NCT03593226|537742229|FG002|Overall Study|Clinical disease progression|1|||
149070833|NCT03593226|537742230|FG003|Overall Study|Clinical disease progression|0|||
149070834|NCT03891758|537742231|FG000|Overall Study|Adverse Event|2|||
149070835|NCT03891758|537742232|FG001|Overall Study|Adverse Event|0|||
149070836|NCT03891758|537742231|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149070837|NCT03891758|537742232|FG001|Overall Study|Withdrawal by parent/guardian|2|||
149070838|NCT03959423|537742237|FG000|Overall Study|Withdrawal by Subject|2|||
149070839|NCT03959423|537742238|FG001|Overall Study|Withdrawal by Subject|3|||
149070840|NCT03959423|537742237|FG000|Overall Study|Physician Decision|0|||
149070841|NCT03959423|537742238|FG001|Overall Study|Physician Decision|1|||
149070842|NCT03959423|537742237|FG000|Overall Study|Lost to Follow-up|1|||
149070843|NCT03959423|537742238|FG001|Overall Study|Lost to Follow-up|0|||
149070844|NCT03959423|537742237|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
149070845|NCT03959423|537742238|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
149070846|NCT05704725|537742240|FG000|Overall Study|Lost to Follow-up|0|||
149070847|NCT05704725|537742241|FG001|Overall Study|Lost to Follow-up|1|||
149070848|NCT05704725|537742240|FG000|Overall Study|Withdrawal by Subject|1|||
149070849|NCT05704725|537742241|FG001|Overall Study|Withdrawal by Subject|0|||
149070850|NCT04503681|537743391|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
149070851|NCT04503681|537743392|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
149070852|NCT01812759|537743395|FG000|Overall Study|Physician Decision|0|||
149070853|NCT01812759|537743396|FG001|Overall Study|Physician Decision|0|||
149070854|NCT01812759|537743397|FG002|Overall Study|Physician Decision|1|||
149070855|NCT00536120|537743398|FG000|Overall Study|Lost to Follow-up|1|||
149070856|NCT00536120|537743399|FG001|Overall Study|Lost to Follow-up|0|||
149070857|NCT00536120|537743398|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
149070858|NCT00536120|537743399|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
149070859|NCT00536120|537743398|FG000|Overall Study|Non-compliance|1|||
149070860|NCT00536120|537743399|FG001|Overall Study|Non-compliance|0|||
149070861|NCT00536120|537743398|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
149070862|NCT00536120|537743399|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
149070863|NCT00536120|537743398|FG000|Overall Study|Steroid Use|0|||
149070864|NCT00536120|537743399|FG001|Overall Study|Steroid Use|2|||
149070865|NCT00536120|537743398|FG000|Overall Study|Missed Study Visit|0|||
149070866|NCT00536120|537743399|FG001|Overall Study|Missed Study Visit|1|||
149070867|NCT04213807|537743400|FG000|Overall Study|Physician Decision|0|||
149070868|NCT04213807|537743401|FG001|Overall Study|Physician Decision|0|||
149070869|NCT04213807|537743402|FG002|Overall Study|Physician Decision|1|||
149070870|NCT00366249|537743403|FG000|Overall Study|Adverse Event|53|||
149070871|NCT00366249|537743404|FG001|Overall Study|Adverse Event|28|||
149070872|NCT00366249|537743403|FG000|Overall Study|Death|0|||
149070873|NCT00366249|537743404|FG001|Overall Study|Death|1|||
149070874|NCT00366249|537743403|FG000|Overall Study|Physician Decision|5|||
149070875|NCT00366249|537743404|FG001|Overall Study|Physician Decision|2|||
149070876|NCT00366249|537743403|FG000|Overall Study|Lost to Follow-up|2|||
149070877|NCT00366249|537743404|FG001|Overall Study|Lost to Follow-up|0|||
149070878|NCT00366249|537743403|FG000|Overall Study|Protocol Violation|1|||
149070879|NCT00366249|537743404|FG001|Overall Study|Protocol Violation|2|||
149070880|NCT00366249|537743403|FG000|Overall Study|Withdrawal by Subject|18|||
149070881|NCT00366249|537743404|FG001|Overall Study|Withdrawal by Subject|4|||
149070882|NCT00366249|537743403|FG000|Overall Study|Lack of Efficacy|21|||
149070883|NCT00366249|537743404|FG001|Overall Study|Lack of Efficacy|21|||
149070884|NCT00366249|537743403|FG000|Overall Study|Most due to osteomylitis status|31|||
149070885|NCT00366249|537743404|FG001|Overall Study|Most due to osteomylitis status|20|||
149070886|NCT01561300|537743405|FG000|Run in on Placebo|Adverse Event|1|||
149070887|NCT01561300|537743406|FG001|Run in on Placebo|Adverse Event|0|||
149070888|NCT00777049|537743407|FG000|Overall Study|Withdrawal by Subject|1|||
149070889|NCT00777049|537743408|FG001|Overall Study|Withdrawal by Subject|0|||
149070890|NCT00777049|537743407|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
149070891|NCT00777049|537743408|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
149070892|NCT01185600|537743409|FG000|Overall Study|Adverse Event|1|||
149070893|NCT01185600|537743410|FG001|Overall Study|Adverse Event|1|||
149070894|NCT01185600|537743409|FG000|Overall Study|Death|0|||
149070895|NCT01185600|537743410|FG001|Overall Study|Death|1|||
149070896|NCT01185600|537743409|FG000|Overall Study|Lost to Follow-up|0|||
149070897|NCT01185600|537743410|FG001|Overall Study|Lost to Follow-up|5|||
149070898|NCT01185600|537743409|FG000|Overall Study|Physician Decision|29|||
149070899|NCT01185600|537743410|FG001|Overall Study|Physician Decision|35|||
149070900|NCT01185600|537743409|FG000|Overall Study|Withdrawal by Subject|1|||
149070901|NCT01185600|537743410|FG001|Overall Study|Withdrawal by Subject|1|||
149070902|NCT01185600|537743409|FG000|Overall Study|Hold by DSMB|1|||
149070903|NCT01185600|537743410|FG001|Overall Study|Hold by DSMB|2|||
149070904|NCT01436175|537743411|FG000|Overall Study|Adverse Event|111|||
149070905|NCT01436175|537743411|FG000|Overall Study|Protocol Violation|49|||
149070906|NCT01436175|537743411|FG000|Overall Study|Withdrawal by Subject|108|||
149070907|NCT01436175|537743411|FG000|Overall Study|Lost to Follow-up|89|||
149070908|NCT01436175|537743411|FG000|Overall Study|Lack of Efficacy|24|||
149070909|NCT01436175|537743411|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
149070910|NCT01436175|537743411|FG000|Overall Study|Other|826|||
149070911|NCT00724126|537743412|FG000|Overall Study|Adverse Event|2|||
149070912|NCT00724126|537743413|FG001|Overall Study|Adverse Event|0|||
149070913|NCT00724126|537743412|FG000|Overall Study|Withdrawal by Subject|8|||
149070914|NCT00724126|537743413|FG001|Overall Study|Withdrawal by Subject|6|||
149070915|NCT00724126|537743412|FG000|Overall Study|Lost to Follow-up|6|||
149070916|NCT00724126|537743413|FG001|Overall Study|Lost to Follow-up|6|||
149070917|NCT00724126|537743412|FG000|Overall Study|Noncompliance|2|||
149070918|NCT00724126|537743413|FG001|Overall Study|Noncompliance|1|||
149070919|NCT00724126|537743412|FG000|Overall Study|Subject randomized although ineligible|1|||
149070920|NCT00724126|537743413|FG001|Overall Study|Subject randomized although ineligible|1|||
149070921|NCT00724126|537743412|FG000|Overall Study|Subject had to leave vicinity of site|0|||
149070922|NCT00724126|537743413|FG001|Overall Study|Subject had to leave vicinity of site|1|||
149070923|NCT01579318|537743417|FG000|Overall Study|Disease Progression|1|||
149070924|NCT01500200|537743418|FG000|Stage 1|Adverse Event|1|||
149070925|NCT01500200|537743419|FG001|Stage 1|Adverse Event|4|||
149070926|NCT01500200|537743420|FG002|Stage 1|Adverse Event|5|||
149070927|NCT01500200|537743421|FG003|Stage 1|Adverse Event|0|||
149070928|NCT01500200|537743422|FG004|Stage 1|Adverse Event|0|||
149070929|NCT01500200|537743423|FG005|Stage 1|Adverse Event|0|||
149070930|NCT01500200|537743418|FG000|Stage 1|Lost to Follow-up|2|||
149070931|NCT01500200|537743419|FG001|Stage 1|Lost to Follow-up|2|||
149070932|NCT01500200|537743420|FG002|Stage 1|Lost to Follow-up|1|||
149070933|NCT01500200|537743421|FG003|Stage 1|Lost to Follow-up|0|||
149070934|NCT01500200|537743422|FG004|Stage 1|Lost to Follow-up|0|||
149070935|NCT01500200|537743423|FG005|Stage 1|Lost to Follow-up|0|||
149070936|NCT01500200|537743418|FG000|Stage 1|Withdrawal by Subject|3|||
149070937|NCT01500200|537743419|FG001|Stage 1|Withdrawal by Subject|0|||
149070938|NCT01500200|537743420|FG002|Stage 1|Withdrawal by Subject|0|||
149070939|NCT01500200|537743421|FG003|Stage 1|Withdrawal by Subject|0|||
149070940|NCT01500200|537743422|FG004|Stage 1|Withdrawal by Subject|0|||
149070941|NCT01500200|537743423|FG005|Stage 1|Withdrawal by Subject|0|||
149070942|NCT01500200|537743418|FG000|Stage 1|Noncompliance with Study Drug|1|||
149070943|NCT01500200|537743419|FG001|Stage 1|Noncompliance with Study Drug|0|||
149070944|NCT01500200|537743420|FG002|Stage 1|Noncompliance with Study Drug|0|||
149070945|NCT01500200|537743421|FG003|Stage 1|Noncompliance with Study Drug|0|||
149070946|NCT01500200|537743422|FG004|Stage 1|Noncompliance with Study Drug|0|||
149070947|NCT01500200|537743423|FG005|Stage 1|Noncompliance with Study Drug|0|||
149070948|NCT01500200|537743418|FG000|Stage 1|Physician Decision|1|||
149070949|NCT01500200|537743419|FG001|Stage 1|Physician Decision|0|||
149070950|NCT01500200|537743420|FG002|Stage 1|Physician Decision|0|||
149070951|NCT01500200|537743421|FG003|Stage 1|Physician Decision|0|||
149070952|NCT01500200|537743422|FG004|Stage 1|Physician Decision|0|||
149070953|NCT01500200|537743423|FG005|Stage 1|Physician Decision|0|||
149070954|NCT01500200|537743418|FG000|Stage 2|Adverse Event|0|||
149070955|NCT01500200|537743419|FG001|Stage 2|Adverse Event|0|||
149070956|NCT01500200|537743420|FG002|Stage 2|Adverse Event|0|||
149070957|NCT01500200|537743421|FG003|Stage 2|Adverse Event|0|||
149070958|NCT01500200|537743422|FG004|Stage 2|Adverse Event|5|||
149070959|NCT01500200|537743423|FG005|Stage 2|Adverse Event|4|||
149070960|NCT00623194|537743424|FG000|Overall Study|Lack of Efficacy|1|||
149070961|NCT00623194|537743424|FG000|Overall Study|Protocol Violation|3|||
149070962|NCT00623194|537743424|FG000|Overall Study|Unclassified|1|||
149070963|NCT04860505|537743425|FG000|Overall Study|Lost to Follow-up|2|||
149070964|NCT01961609|537743426|FG000|Initiation|Missing|3|||
149070965|NCT01961609|537743427|FG001|Initiation|Missing|2|||
149070966|NCT01961609|537743428|FG002|Initiation|Missing|0|||
149070967|NCT01961609|537743429|FG003|Initiation|Missing|0|||
149070968|NCT01961609|537743426|FG000|Initiation|Protocol deviation|1|||
149070969|NCT01961609|537743427|FG001|Initiation|Protocol deviation|0|||
149070970|NCT01961609|537743428|FG002|Initiation|Protocol deviation|0|||
149070971|NCT01961609|537743429|FG003|Initiation|Protocol deviation|0|||
149070972|NCT01961609|537743426|FG000|Initiation|Death|0|||
149070973|NCT01961609|537743427|FG001|Initiation|Death|1|||
149070974|NCT01961609|537743428|FG002|Initiation|Death|0|||
149070975|NCT01961609|537743429|FG003|Initiation|Death|0|||
149070976|NCT01961609|537743426|FG000|Initiation|Administrative problems|1|||
149070977|NCT01961609|537743427|FG001|Initiation|Administrative problems|0|||
149070978|NCT01961609|537743428|FG002|Initiation|Administrative problems|0|||
149070979|NCT01961609|537743429|FG003|Initiation|Administrative problems|0|||
149070980|NCT01961609|537743426|FG000|Initiation|Withdrawal by Subject|1|||
149070981|NCT01961609|537743427|FG001|Initiation|Withdrawal by Subject|2|||
149070982|NCT01961609|537743428|FG002|Initiation|Withdrawal by Subject|0|||
149070983|NCT01961609|537743429|FG003|Initiation|Withdrawal by Subject|0|||
149070984|NCT01961609|537743426|FG000|Initiation|Lack of Efficacy|2|||
149070985|NCT01961609|537743427|FG001|Initiation|Lack of Efficacy|1|||
149070986|NCT01961609|537743428|FG002|Initiation|Lack of Efficacy|0|||
149070987|NCT01961609|537743429|FG003|Initiation|Lack of Efficacy|0|||
149070988|NCT01961609|537743426|FG000|Initiation|Abnormal lab values|0|||
149070989|NCT01961609|537743427|FG001|Initiation|Abnormal lab values|1|||
149070990|NCT01961609|537743428|FG002|Initiation|Abnormal lab values|0|||
149070991|NCT01961609|537743429|FG003|Initiation|Abnormal lab values|0|||
149070992|NCT01961609|537743426|FG000|Initiation|Adverse Event|3|||
149070993|NCT01961609|537743427|FG001|Initiation|Adverse Event|5|||
149070994|NCT01961609|537743428|FG002|Initiation|Adverse Event|0|||
149070995|NCT01961609|537743429|FG003|Initiation|Adverse Event|0|||
149070996|NCT01961609|537743426|FG000|Initiation|Randomized but not treated|1|||
149070997|NCT01961609|537743427|FG001|Initiation|Randomized but not treated|1|||
149070998|NCT01961609|537743428|FG002|Initiation|Randomized but not treated|0|||
149070999|NCT01961609|537743429|FG003|Initiation|Randomized but not treated|0|||
149071000|NCT01961609|537743426|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
149071001|NCT01961609|537743427|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
149071002|NCT01961609|537743428|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
149071003|NCT01961609|537743429|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
149071004|NCT01961609|537743426|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
149071005|NCT01961609|537743427|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
149071006|NCT01961609|537743428|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
149071007|NCT01961609|537743429|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
149071008|NCT01961609|537743426|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
149071009|NCT01961609|537743427|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
149071010|NCT01961609|537743428|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
149071011|NCT01961609|537743429|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
149071012|NCT01961609|537743426|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
149071013|NCT01961609|537743427|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
149071014|NCT01961609|537743428|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
149071015|NCT01961609|537743429|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
149071016|NCT01961609|537743426|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
149071017|NCT01961609|537743427|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
149071018|NCT01961609|537743428|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
149071019|NCT01961609|537743429|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
149071020|NCT01961609|537743426|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
149071021|NCT01961609|537743427|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
149071022|NCT01961609|537743428|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
149071023|NCT01961609|537743429|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
149071024|NCT01961609|537743426|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
149071025|NCT01961609|537743427|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
149071026|NCT01961609|537743428|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
149071027|NCT01961609|537743429|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
149071028|NCT01961609|537743426|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
149071029|NCT01961609|537743427|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
149071030|NCT01961609|537743428|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
149071031|NCT01961609|537743429|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
149071032|NCT01961609|537743426|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
149071033|NCT01961609|537743427|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
149071034|NCT01961609|537743428|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
149071035|NCT01961609|537743429|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
149071036|NCT01961609|537743426|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
149071037|NCT01961609|537743427|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
149071038|NCT01961609|537743428|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
149071039|NCT01961609|537743429|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
149071040|NCT01961609|537743426|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
149071041|NCT01961609|537743427|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
149071042|NCT01961609|537743428|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
149071043|NCT01961609|537743429|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
149071044|NCT01961609|537743426|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
149071045|NCT01961609|537743427|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
149071046|NCT01961609|537743428|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
149071047|NCT01961609|537743429|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
149071048|NCT01988402|537743430|FG000|Overall Study|Adverse Event|1|||
149071049|NCT01988402|537743431|FG001|Overall Study|Adverse Event|2|||
149071050|NCT01988402|537743430|FG000|Overall Study|Withdrawal by Subject|1|||
149071051|NCT01988402|537743431|FG001|Overall Study|Withdrawal by Subject|0|||
149071052|NCT00571649|537743434|FG000|Treatment Period|Adverse Event|438|||
149071053|NCT00571649|537743435|FG001|Treatment Period|Adverse Event|385|||
149071054|NCT00571649|537743434|FG000|Treatment Period|Clinical endpoint reached|50|||
149071055|NCT00571649|537743435|FG001|Treatment Period|Clinical endpoint reached|56|||
149071056|NCT00571649|537743434|FG000|Treatment Period|Withdrawal by Subject|285|||
149071057|NCT00571649|537743435|FG001|Treatment Period|Withdrawal by Subject|255|||
149071058|NCT00571649|537743434|FG000|Treatment Period|Death|76|||
149071059|NCT00571649|537743435|FG001|Treatment Period|Death|59|||
149071060|NCT00571649|537743434|FG000|Treatment Period|Physician Decision|8|||
149071061|NCT00571649|537743435|FG001|Treatment Period|Physician Decision|9|||
149071062|NCT00571649|537743434|FG000|Treatment Period|Lost to Follow-up|43|||
149071063|NCT00571649|537743435|FG001|Treatment Period|Lost to Follow-up|41|||
149071064|NCT00571649|537743434|FG000|Treatment Period|Non-compliant with study medication|88|||
149071065|NCT00571649|537743435|FG001|Treatment Period|Non-compliant with study medication|89|||
149071066|NCT00571649|537743434|FG000|Treatment Period|Patient convenience|11|||
149071067|NCT00571649|537743435|FG001|Treatment Period|Patient convenience|13|||
149071068|NCT00571649|537743434|FG000|Treatment Period|Protocol Violation|90|||
149071069|NCT00571649|537743435|FG001|Treatment Period|Protocol Violation|92|||
149071070|NCT00571649|537743434|FG000|Treatment Period|Technical problems|3|||
149071071|NCT00571649|537743435|FG001|Treatment Period|Technical problems|5|||
149071072|NCT00571649|537743434|FG000|Follow-up Period|Adverse Event|46|||
149071073|NCT00571649|537743435|FG001|Follow-up Period|Adverse Event|40|||
149071074|NCT00571649|537743434|FG000|Follow-up Period|Clinical endpoint reached|5|||
149071075|NCT00571649|537743435|FG001|Follow-up Period|Clinical endpoint reached|2|||
149071076|NCT00571649|537743434|FG000|Follow-up Period|Withdrawal by Subject|119|||
149071077|NCT00571649|537743435|FG001|Follow-up Period|Withdrawal by Subject|115|||
149071078|NCT00571649|537743434|FG000|Follow-up Period|Death|132|||
149071079|NCT00571649|537743435|FG001|Follow-up Period|Death|133|||
149071080|NCT00571649|537743434|FG000|Follow-up Period|Physician Decision|7|||
149071081|NCT00571649|537743435|FG001|Follow-up Period|Physician Decision|13|||
149071082|NCT00571649|537743434|FG000|Follow-up Period|Lost to Follow-up|95|||
149071083|NCT00571649|537743435|FG001|Follow-up Period|Lost to Follow-up|92|||
149071084|NCT00571649|537743434|FG000|Follow-up Period|Patient convenience|136|||
149071085|NCT00571649|537743435|FG001|Follow-up Period|Patient convenience|121|||
149071086|NCT00571649|537743434|FG000|Follow-up Period|Protocol Violation|5|||
149071087|NCT00571649|537743435|FG001|Follow-up Period|Protocol Violation|12|||
149071088|NCT01218659|537743436|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
149071089|NCT01218659|537743437|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
149071090|NCT01218659|537743438|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
149071091|NCT01218659|537743436|FG000|18-Month Randomized Period|Did not receive study drug|0|||
149071092|NCT01218659|537743437|FG001|18-Month Randomized Period|Did not receive study drug|3|||
149071093|NCT01218659|537743438|FG002|18-Month Randomized Period|Did not receive study drug|0|||
149071094|NCT01218659|537743436|FG000|12-Month OLE|Withdrawal by Subject|0|||
149071095|NCT01218659|537743437|FG001|12-Month OLE|Withdrawal by Subject|0|||
149071096|NCT01218659|537743438|FG002|12-Month OLE|Withdrawal by Subject|2|||
149071097|NCT01218659|537743436|FG000|12-Month OLE|Physician Decision|0|||
149071098|NCT01218659|537743437|FG001|12-Month OLE|Physician Decision|0|||
149071099|NCT01218659|537743438|FG002|12-Month OLE|Physician Decision|1|||
149071100|NCT01218659|537743436|FG000|12-Month OLE|Lost to Follow-up|0|||
149071101|NCT01218659|537743437|FG001|12-Month OLE|Lost to Follow-up|0|||
149071102|NCT01218659|537743438|FG002|12-Month OLE|Lost to Follow-up|1|||
149071103|NCT01218659|537743436|FG000|12-Month OLE|Pregnancy|0|||
149071104|NCT01218659|537743437|FG001|12-Month OLE|Pregnancy|0|||
149071105|NCT01218659|537743438|FG002|12-Month OLE|Pregnancy|1|||
149071106|NCT01218659|537743436|FG000|12-Month OLE|Lack of Efficacy|0|||
149071107|NCT01218659|537743437|FG001|12-Month OLE|Lack of Efficacy|0|||
149071108|NCT01218659|537743438|FG002|12-Month OLE|Lack of Efficacy|1|||
149071109|NCT01218659|537743436|FG000|12-Month OLE|Declined to participate in the OLE|0|||
149071110|NCT01218659|537743437|FG001|12-Month OLE|Declined to participate in the OLE|0|||
149071111|NCT01218659|537743438|FG002|12-Month OLE|Declined to participate in the OLE|4|||
149071112|NCT03066609|537743441|FG000|INDUCTION|Pregnancy|0|||
149071113|NCT03066609|537743442|FG001|INDUCTION|Pregnancy|0|||
149071114|NCT03066609|537743443|FG002|INDUCTION|Pregnancy|1|||
149071115|NCT03066609|537743444|FG003|INDUCTION|Pregnancy|0|||
149071116|NCT03066609|537743441|FG000|INDUCTION|Lack of Efficacy|0|||
149071117|NCT03066609|537743442|FG001|INDUCTION|Lack of Efficacy|0|||
149071118|NCT03066609|537743443|FG002|INDUCTION|Lack of Efficacy|1|||
149071119|NCT03066609|537743444|FG003|INDUCTION|Lack of Efficacy|0|||
149071120|NCT03066609|537743441|FG000|INDUCTION|Adverse Event|2|||
149071121|NCT03066609|537743442|FG001|INDUCTION|Adverse Event|2|||
149071122|NCT03066609|537743443|FG002|INDUCTION|Adverse Event|0|||
149071123|NCT03066609|537743444|FG003|INDUCTION|Adverse Event|0|||
149071124|NCT03066609|537743441|FG000|MAINTENANCE|Adverse Event|0|||
149071125|NCT03066609|537743442|FG001|MAINTENANCE|Adverse Event|0|||
149071126|NCT03066609|537743443|FG002|MAINTENANCE|Adverse Event|0|||
149071127|NCT03066609|537743444|FG003|MAINTENANCE|Adverse Event|1|||
149071128|NCT03066609|537743441|FG000|MAINTENANCE|Withdrawal by Subject|4|||
149071129|NCT03066609|537743442|FG001|MAINTENANCE|Withdrawal by Subject|2|||
149071130|NCT03066609|537743443|FG002|MAINTENANCE|Withdrawal by Subject|1|||
149071131|NCT03066609|537743444|FG003|MAINTENANCE|Withdrawal by Subject|1|||
149071132|NCT03066609|537743441|FG000|MAINTENANCE|Lost to Follow-up|0|||
149071133|NCT03066609|537743442|FG001|MAINTENANCE|Lost to Follow-up|1|||
149071134|NCT03066609|537743443|FG002|MAINTENANCE|Lost to Follow-up|1|||
149071135|NCT03066609|537743444|FG003|MAINTENANCE|Lost to Follow-up|0|||
149071136|NCT03066609|537743441|FG000|MAINTENANCE|Pregnancy|1|||
149071137|NCT03066609|537743442|FG001|MAINTENANCE|Pregnancy|0|||
149071138|NCT03066609|537743443|FG002|MAINTENANCE|Pregnancy|0|||
149071139|NCT03066609|537743444|FG003|MAINTENANCE|Pregnancy|0|||
149071140|NCT03066609|537743441|FG000|MAINTENANCE|Lack of Efficacy|2|||
149071141|NCT03066609|537743442|FG001|MAINTENANCE|Lack of Efficacy|1|||
149071142|NCT03066609|537743443|FG002|MAINTENANCE|Lack of Efficacy|0|||
149071143|NCT03066609|537743444|FG003|MAINTENANCE|Lack of Efficacy|1|||
149071144|NCT03066609|537743441|FG000|OVERALL STUDY|Adverse Event|2|||
149071145|NCT03066609|537743442|FG001|OVERALL STUDY|Adverse Event|2|||
149071146|NCT03066609|537743443|FG002|OVERALL STUDY|Adverse Event|0|||
149071147|NCT03066609|537743444|FG003|OVERALL STUDY|Adverse Event|1|||
149071148|NCT03066609|537743441|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
149071149|NCT03066609|537743442|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
149071150|NCT03066609|537743443|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
149071151|NCT03066609|537743444|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
149071152|NCT03066609|537743441|FG000|OVERALL STUDY|Lost to Follow-up|1|||
149071153|NCT03066609|537743442|FG001|OVERALL STUDY|Lost to Follow-up|1|||
149071154|NCT03066609|537743443|FG002|OVERALL STUDY|Lost to Follow-up|1|||
149071155|NCT03066609|537743444|FG003|OVERALL STUDY|Lost to Follow-up|1|||
149071156|NCT03066609|537743441|FG000|OVERALL STUDY|Pregnancy|1|||
149071157|NCT03066609|537743442|FG001|OVERALL STUDY|Pregnancy|0|||
149071158|NCT03066609|537743443|FG002|OVERALL STUDY|Pregnancy|1|||
149071159|NCT03066609|537743444|FG003|OVERALL STUDY|Pregnancy|0|||
149071160|NCT03066609|537743441|FG000|OVERALL STUDY|Lack of Efficacy|2|||
149071161|NCT03066609|537743442|FG001|OVERALL STUDY|Lack of Efficacy|1|||
149071162|NCT03066609|537743443|FG002|OVERALL STUDY|Lack of Efficacy|1|||
149071163|NCT03066609|537743444|FG003|OVERALL STUDY|Lack of Efficacy|1|||
149071164|NCT03066609|537743441|FG000|OVERALL STUDY|discontinued follow up|0|||
149071165|NCT03066609|537743442|FG001|OVERALL STUDY|discontinued follow up|2|||
149071166|NCT03066609|537743443|FG002|OVERALL STUDY|discontinued follow up|0|||
149071167|NCT03066609|537743444|FG003|OVERALL STUDY|discontinued follow up|0|||
149071168|NCT01566890|537743445|FG000|Overall Study|Adverse Event|1|||
149071169|NCT01566890|537743446|FG001|Overall Study|Adverse Event|0|||
149071170|NCT01566890|537743447|FG002|Overall Study|Adverse Event|0|||
149071171|NCT01566890|537743448|FG003|Overall Study|Adverse Event|0|||
149071172|NCT01566890|537743449|FG004|Overall Study|Adverse Event|0|||
149071173|NCT01566890|537743445|FG000|Overall Study|Withdrawal by Subject|3|||
149071174|NCT01566890|537743446|FG001|Overall Study|Withdrawal by Subject|1|||
149071175|NCT01566890|537743447|FG002|Overall Study|Withdrawal by Subject|1|||
149071176|NCT01566890|537743448|FG003|Overall Study|Withdrawal by Subject|1|||
149071177|NCT01566890|537743449|FG004|Overall Study|Withdrawal by Subject|0|||
149071178|NCT01566890|537743445|FG000|Overall Study|Screen failure|6|||
149071179|NCT01566890|537743446|FG001|Overall Study|Screen failure|0|||
149071180|NCT01566890|537743447|FG002|Overall Study|Screen failure|1|||
149071181|NCT01566890|537743448|FG003|Overall Study|Screen failure|1|||
149071182|NCT01566890|537743449|FG004|Overall Study|Screen failure|0|||
149071183|NCT01566890|537743445|FG000|Overall Study|Incomplete CEU data|1|||
149071184|NCT01566890|537743446|FG001|Overall Study|Incomplete CEU data|3|||
149071185|NCT01566890|537743447|FG002|Overall Study|Incomplete CEU data|5|||
149071186|NCT01566890|537743448|FG003|Overall Study|Incomplete CEU data|8|||
149071187|NCT01566890|537743449|FG004|Overall Study|Incomplete CEU data|0|||
149071188|NCT01566890|537743445|FG000|Overall Study|Lost to Follow-up|0|||
149071189|NCT01566890|537743446|FG001|Overall Study|Lost to Follow-up|0|||
149071190|NCT01566890|537743447|FG002|Overall Study|Lost to Follow-up|4|||
149071191|NCT01566890|537743448|FG003|Overall Study|Lost to Follow-up|4|||
149071192|NCT01566890|537743449|FG004|Overall Study|Lost to Follow-up|0|||
149071193|NCT01566890|537743445|FG000|Overall Study|Other|0|||
149071194|NCT01566890|537743446|FG001|Overall Study|Other|0|||
149071195|NCT01566890|537743447|FG002|Overall Study|Other|0|||
149071196|NCT01566890|537743448|FG003|Overall Study|Other|0|||
149071197|NCT01566890|537743449|FG004|Overall Study|Other|7|||
149071198|NCT00523419|537743460|FG000|Overall Study|Adverse Event|1|||
149071199|NCT00523419|537743460|FG000|Overall Study|Withdrawal by Subject|1|||
149071200|NCT00523419|537743460|FG000|Overall Study|Physician Decision|2|||
149071201|NCT00523419|537743460|FG000|Overall Study|Progressive Disease|22|||
149071202|NCT00523419|537743460|FG000|Overall Study|Death due to Study Disease|4|||
149071203|NCT00523419|537743460|FG000|Overall Study|Death due to Adverse Event|2|||
149071204|NCT00822120|537743461|FG000|Initial Registration|Adverse Event|1|||
149071205|NCT00822120|537743462|FG001|Initial Registration|Adverse Event|0|||
149071206|NCT00822120|537743463|FG002|Initial Registration|Adverse Event|0|||
149071207|NCT00822120|537743464|FG003|Initial Registration|Adverse Event|0|||
149071208|NCT00822120|537743465|FG004|Initial Registration|Adverse Event|0|||
149071209|NCT00822120|537743466|FG005|Initial Registration|Adverse Event|0|||
149071210|NCT00822120|537743461|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
149071211|NCT00822120|537743462|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149071212|NCT00822120|537743463|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149071213|NCT00822120|537743464|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149071214|NCT00822120|537743465|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149071215|NCT00822120|537743466|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
149071216|NCT00822120|537743461|FG000|Initial Registration|Reasons not Protocol Specified|2|||
149071217|NCT00822120|537743462|FG001|Initial Registration|Reasons not Protocol Specified|0|||
149071218|NCT00822120|537743463|FG002|Initial Registration|Reasons not Protocol Specified|0|||
149071219|NCT00822120|537743464|FG003|Initial Registration|Reasons not Protocol Specified|0|||
149071220|NCT00822120|537743465|FG004|Initial Registration|Reasons not Protocol Specified|0|||
149071221|NCT00822120|537743466|FG005|Initial Registration|Reasons not Protocol Specified|0|||
149071222|NCT00822120|537743461|FG000|Initial Registration|Ineligible|22|||
149071223|NCT00822120|537743462|FG001|Initial Registration|Ineligible|1|||
149071224|NCT00822120|537743463|FG002|Initial Registration|Ineligible|0|||
149071225|NCT00822120|537743464|FG003|Initial Registration|Ineligible|0|||
149071226|NCT00822120|537743465|FG004|Initial Registration|Ineligible|0|||
149071227|NCT00822120|537743466|FG005|Initial Registration|Ineligible|0|||
149071228|NCT00822120|537743461|FG000|PET-directed Therapy|Adverse Event|0|||
149071229|NCT00822120|537743462|FG001|PET-directed Therapy|Adverse Event|0|||
149071230|NCT00822120|537743463|FG002|PET-directed Therapy|Adverse Event|0|||
149071231|NCT00822120|537743464|FG003|PET-directed Therapy|Adverse Event|1|||
149071232|NCT00822120|537743465|FG004|PET-directed Therapy|Adverse Event|0|||
149071233|NCT00822120|537743466|FG005|PET-directed Therapy|Adverse Event|0|||
149071234|NCT00822120|537743461|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
149071235|NCT00822120|537743462|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
149071236|NCT00822120|537743463|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
149071237|NCT00822120|537743464|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
149071238|NCT00822120|537743465|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
149071239|NCT00822120|537743466|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
149071240|NCT00822120|537743461|FG000|PET-directed Therapy|Death|0|||
149071241|NCT00822120|537743462|FG001|PET-directed Therapy|Death|0|||
149071242|NCT00822120|537743463|FG002|PET-directed Therapy|Death|0|||
149071243|NCT00822120|537743464|FG003|PET-directed Therapy|Death|2|||
149071244|NCT00822120|537743465|FG004|PET-directed Therapy|Death|0|||
149071245|NCT00822120|537743466|FG005|PET-directed Therapy|Death|0|||
149071246|NCT00822120|537743461|FG000|PET-directed Therapy|Protocol Violation|0|||
149071247|NCT00822120|537743462|FG001|PET-directed Therapy|Protocol Violation|0|||
149071248|NCT00822120|537743463|FG002|PET-directed Therapy|Protocol Violation|0|||
149071249|NCT00822120|537743464|FG003|PET-directed Therapy|Protocol Violation|6|||
149071250|NCT00822120|537743465|FG004|PET-directed Therapy|Protocol Violation|0|||
149071251|NCT00822120|537743466|FG005|PET-directed Therapy|Protocol Violation|0|||
149071252|NCT03802994|537743471|FG000|Overall Study|Lost to Follow-up|0|||
149071253|NCT03802994|537743472|FG001|Overall Study|Lost to Follow-up|2|||
149071254|NCT03802994|537743473|FG002|Overall Study|Lost to Follow-up|3|||
149071255|NCT03802994|537743474|FG003|Overall Study|Lost to Follow-up|2|||
149071256|NCT03802994|537743475|FG004|Overall Study|Lost to Follow-up|2|||
149071257|NCT02646618|537743478|FG000|Overall Study|Lost to Follow-up|10|||
149071258|NCT02646618|537743479|FG001|Overall Study|Lost to Follow-up|14|||
149071259|NCT00918203|537743482|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
149071260|NCT00918203|537743483|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
149071261|NCT00918203|537743484|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
149071262|NCT00918203|537743482|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
149071263|NCT00918203|537743483|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
149071264|NCT00918203|537743484|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
149071265|NCT00918203|537743482|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
149071266|NCT00918203|537743483|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
149071267|NCT00918203|537743484|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
149071268|NCT00918203|537743482|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
149071269|NCT00918203|537743483|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
149071270|NCT00918203|537743484|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
149071271|NCT00701701|537743485|FG000|Overall Study|Withdrawal by Subject|0|||
149071272|NCT00701701|537743486|FG001|Overall Study|Withdrawal by Subject|1|||
149071273|NCT00701701|537743485|FG000|Overall Study|Adverse Event|0|||
149071274|NCT00701701|537743486|FG001|Overall Study|Adverse Event|1|||
149071275|NCT03357952|537743487|FG000|Overall Study|Withdrawal by Subject|0|||
149071276|NCT03357952|537743488|FG001|Overall Study|Withdrawal by Subject|1|||
149071277|NCT03357952|537743487|FG000|Overall Study|Sponsor Decision|9|||
149071278|NCT03357952|537743488|FG001|Overall Study|Sponsor Decision|0|||
149071279|NCT02016872|537743489|FG000|Overall Study|Withdrawal by Subject|10|||
149071280|NCT02016872|537743489|FG000|Overall Study|Death Progression|2|||
149071281|NCT02016872|537743489|FG000|Overall Study|No FMISO scan|1|||
149071282|NCT02016872|537743489|FG000|Overall Study|Ineligible|2|||
149071283|NCT06688357|537743490|FG000|Overall Study|Adverse Event|0|||
149071284|NCT06688357|537743491|FG001|Overall Study|Adverse Event|1|||
149071285|NCT03222609|537743492|FG000|Overall Study|Withdrew consent|2|||
149071286|NCT03222609|537743493|FG001|Overall Study|Withdrew consent|3|||
149071287|NCT03222609|537743494|FG002|Overall Study|Withdrew consent|4|||
149071288|NCT03222609|537743495|FG003|Overall Study|Withdrew consent|2|||
149071289|NCT03222609|537743492|FG000|Overall Study|Lost to Follow-up|1|||
149071290|NCT03222609|537743493|FG001|Overall Study|Lost to Follow-up|0|||
149071291|NCT03222609|537743494|FG002|Overall Study|Lost to Follow-up|0|||
149071292|NCT03222609|537743495|FG003|Overall Study|Lost to Follow-up|0|||
149071293|NCT03222609|537743492|FG000|Overall Study|Death|16|||
149071294|NCT03222609|537743493|FG001|Overall Study|Death|13|||
149071295|NCT03222609|537743494|FG002|Overall Study|Death|9|||
149071296|NCT03222609|537743495|FG003|Overall Study|Death|6|||
149071297|NCT03222609|537743492|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
149071298|NCT03222609|537743493|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
149071299|NCT03222609|537743494|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
149071300|NCT03222609|537743495|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
149071301|NCT04517435|537743512|FG000|Overall Study|Withdrawal by Subject|0|||
149071302|NCT04517435|537743513|FG001|Overall Study|Withdrawal by Subject|0|||
149071303|NCT04517435|537743514|FG002|Overall Study|Withdrawal by Subject|1|||
149071304|NCT04517435|537743512|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
149071305|NCT04517435|537743513|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
149071306|NCT04517435|537743514|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
149071307|NCT03211247|537743515|FG000|Overall Study|Adverse Event|8|||
149071308|NCT03211247|537743516|FG001|Overall Study|Adverse Event|0|||
149071309|NCT03211247|537743517|FG002|Overall Study|Adverse Event|1|||
149071310|NCT03211247|537743518|FG003|Overall Study|Adverse Event|0|||
149071311|NCT03211247|537743519|FG004|Overall Study|Adverse Event|0|||
149071312|NCT03211247|537743515|FG000|Overall Study|Lost to Follow-up|2|||
149071313|NCT03211247|537743516|FG001|Overall Study|Lost to Follow-up|1|||
149071314|NCT03211247|537743517|FG002|Overall Study|Lost to Follow-up|0|||
149071315|NCT03211247|537743518|FG003|Overall Study|Lost to Follow-up|0|||
149071316|NCT03211247|537743519|FG004|Overall Study|Lost to Follow-up|0|||
149071317|NCT03211247|537743515|FG000|Overall Study|Physician Decision|1|||
149071318|NCT03211247|537743516|FG001|Overall Study|Physician Decision|2|||
149071319|NCT03211247|537743517|FG002|Overall Study|Physician Decision|0|||
149071320|NCT03211247|537743518|FG003|Overall Study|Physician Decision|0|||
149071321|NCT03211247|537743519|FG004|Overall Study|Physician Decision|0|||
149071322|NCT03211247|537743515|FG000|Overall Study|Non-compliance with study drug|2|||
149071323|NCT03211247|537743516|FG001|Overall Study|Non-compliance with study drug|0|||
149071324|NCT03211247|537743517|FG002|Overall Study|Non-compliance with study drug|0|||
149071325|NCT03211247|537743518|FG003|Overall Study|Non-compliance with study drug|0|||
149071326|NCT03211247|537743519|FG004|Overall Study|Non-compliance with study drug|0|||
149071327|NCT03211247|537743515|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
149071328|NCT03211247|537743516|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
149071329|NCT03211247|537743517|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
149071330|NCT03211247|537743518|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
149071331|NCT03211247|537743519|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
149071332|NCT03211247|537743515|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
149071333|NCT03211247|537743516|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
149071334|NCT03211247|537743517|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
149071335|NCT03211247|537743518|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
149071336|NCT03211247|537743519|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
149071337|NCT03211247|537743515|FG000|Overall Study|Protocol Violation|0|||
149071338|NCT03211247|537743516|FG001|Overall Study|Protocol Violation|1|||
149071339|NCT03211247|537743517|FG002|Overall Study|Protocol Violation|0|||
149071340|NCT03211247|537743518|FG003|Overall Study|Protocol Violation|0|||
149071341|NCT03211247|537743519|FG004|Overall Study|Protocol Violation|0|||
149071342|NCT00545545|537743520|FG000|Overall Study|Progressive Neoplastic Disease|1|||
149071343|NCT00545545|537743521|FG001|Overall Study|Progressive Neoplastic Disease|5|||
149071344|NCT00545545|537743522|FG002|Overall Study|Progressive Neoplastic Disease|0|||
149071345|NCT00545545|537743523|FG003|Overall Study|Progressive Neoplastic Disease|4|||
149071346|NCT00545545|537743524|FG004|Overall Study|Progressive Neoplastic Disease|8|||
149071347|NCT00545545|537743525|FG005|Overall Study|Progressive Neoplastic Disease|7|||
149071348|NCT00545545|537743520|FG000|Overall Study|Withdrawal by Subject|0|||
149071349|NCT00545545|537743521|FG001|Overall Study|Withdrawal by Subject|1|||
149071350|NCT00545545|537743522|FG002|Overall Study|Withdrawal by Subject|0|||
149071351|NCT00545545|537743523|FG003|Overall Study|Withdrawal by Subject|0|||
149071352|NCT00545545|537743524|FG004|Overall Study|Withdrawal by Subject|0|||
149071353|NCT00545545|537743525|FG005|Overall Study|Withdrawal by Subject|0|||
149071354|NCT00545545|537743520|FG000|Overall Study|Physician Decision|1|||
149071355|NCT00545545|537743521|FG001|Overall Study|Physician Decision|0|||
149071356|NCT00545545|537743522|FG002|Overall Study|Physician Decision|0|||
149071357|NCT00545545|537743523|FG003|Overall Study|Physician Decision|0|||
149071358|NCT00545545|537743524|FG004|Overall Study|Physician Decision|0|||
149071359|NCT00545545|537743525|FG005|Overall Study|Physician Decision|1|||
149071360|NCT00545545|537743520|FG000|Overall Study|Irinotecan intolerance|1|||
149071361|NCT00545545|537743521|FG001|Overall Study|Irinotecan intolerance|1|||
149071362|NCT00545545|537743522|FG002|Overall Study|Irinotecan intolerance|0|||
149071363|NCT00545545|537743523|FG003|Overall Study|Irinotecan intolerance|0|||
149071364|NCT00545545|537743524|FG004|Overall Study|Irinotecan intolerance|0|||
149071365|NCT00545545|537743525|FG005|Overall Study|Irinotecan intolerance|0|||
149071366|NCT00545545|537743520|FG000|Overall Study|No target lesions to track post surgery|0|||
149071367|NCT00545545|537743521|FG001|Overall Study|No target lesions to track post surgery|0|||
149071368|NCT00545545|537743522|FG002|Overall Study|No target lesions to track post surgery|0|||
149071369|NCT00545545|537743523|FG003|Overall Study|No target lesions to track post surgery|0|||
149071370|NCT00545545|537743524|FG004|Overall Study|No target lesions to track post surgery|1|||
149071371|NCT00545545|537743525|FG005|Overall Study|No target lesions to track post surgery|1|||
149071372|NCT02678689|537743526|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
149071373|NCT02678689|537743527|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
149071374|NCT04153890|537743528|FG000|Overall Study|Lost to Follow-up|9|||
149071375|NCT04153890|537743529|FG001|Overall Study|Lost to Follow-up|0|||
149071376|NCT04153890|537743530|FG002|Overall Study|Lost to Follow-up|9|||
149071377|NCT04153890|537743531|FG003|Overall Study|Lost to Follow-up|0|||
149071378|NCT04153890|537743528|FG000|Overall Study|Death|0|||
149071379|NCT04153890|537743529|FG001|Overall Study|Death|2|||
149071380|NCT04153890|537743530|FG002|Overall Study|Death|0|||
149071381|NCT04153890|537743531|FG003|Overall Study|Death|0|||
149071382|NCT04153890|537743528|FG000|Overall Study|Withdrawal by Subject|0|||
149071383|NCT04153890|537743529|FG001|Overall Study|Withdrawal by Subject|0|||
149071384|NCT04153890|537743530|FG002|Overall Study|Withdrawal by Subject|0|||
149071385|NCT04153890|537743531|FG003|Overall Study|Withdrawal by Subject|2|||
149071386|NCT02798471|537743536|FG000|Overall Study|Adverse Event|7|||
149071387|NCT02798471|537743537|FG001|Overall Study|Adverse Event|2|||
149071388|NCT02798471|537743536|FG000|Overall Study|Physician Decision|3|||
149071389|NCT02798471|537743537|FG001|Overall Study|Physician Decision|7|||
149071390|NCT02798471|537743536|FG000|Overall Study|Death|2|||
149071391|NCT02798471|537743537|FG001|Overall Study|Death|3|||
149071392|NCT02798471|537743536|FG000|Overall Study|Lost to Follow-up|0|||
149071393|NCT02798471|537743537|FG001|Overall Study|Lost to Follow-up|1|||
149071394|NCT02798471|537743536|FG000|Overall Study|Other|5|||
149071395|NCT02798471|537743537|FG001|Overall Study|Other|3|||
149071396|NCT02798471|537743536|FG000|Overall Study|Subject withdrew consent|0|||
149071397|NCT02798471|537743537|FG001|Overall Study|Subject withdrew consent|6|||
149071398|NCT02798471|537743536|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
149071399|NCT02798471|537743537|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
149071400|NCT02798471|537743536|FG000|Overall Study|Randomized, but not treated|0|||
149071401|NCT02798471|537743537|FG001|Overall Study|Randomized, but not treated|2|||
149071402|NCT03752684|537745392|FG000|Overall Study|Lost to Follow-up|4|||
149071403|NCT03352713|537745393|FG000|Overall Study|Lost to Follow-up|8|||
149071404|NCT03352713|537745393|FG000|Overall Study|Withdrawn by investigator|5|||
149071405|NCT03352713|537745393|FG000|Overall Study|Completed 0 EMAs|8|||
149071406|NCT03352713|537745393|FG000|Overall Study|Device incompatible/stolen|5|||
149071407|NCT04989816|537745394|FG000|Overall Study|Death|77|||
149071408|NCT04989816|537745394|FG000|Overall Study|Lost to Follow-up|3|||
149071409|NCT01128595|537745402|FG000|Treatment Period 3|Withdrawal by Subject|0|||
149071410|NCT01128595|537745403|FG001|Treatment Period 3|Withdrawal by Subject|1|||
149071411|NCT01128595|537745404|FG002|Treatment Period 3|Withdrawal by Subject|0|||
149071412|NCT01128595|537745405|FG003|Treatment Period 3|Withdrawal by Subject|0|||
149071413|NCT00372775|537745406|FG000|Overall Study|Adverse Event|8|||
149071414|NCT00372775|537745406|FG000|Overall Study|Death|15|||
149071415|NCT00372775|537745406|FG000|Overall Study|Objective progression or relapse|30|||
149071416|NCT00372775|537745406|FG000|Overall Study|Global deterioration of health status|6|||
149071417|NCT00372775|537745406|FG000|Overall Study|Withdrawal by Subject|1|||
149071418|NCT00372775|537745406|FG000|Overall Study|Other|1|||
149071419|NCT00372775|537745406|FG000|Overall Study|Not Treated|2|||
149071420|NCT00609869|537745407|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
149071421|NCT00609869|537745407|FG000|Overall Study|Severe hematologic toxicity|1|||
149071422|NCT00609869|537745407|FG000|Overall Study|Withdrawal by Subject|1|||
149071423|NCT00609869|537745407|FG000|Overall Study|Seizures|1|||
149071424|NCT00609869|537745407|FG000|Overall Study|Severe tumor flare reaction|1|||
149071425|NCT00609869|537745407|FG000|Overall Study|Hepatitis B infection|1|||
149071426|NCT00609869|537745407|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
149071427|NCT00609869|537745407|FG000|Overall Study|Mantle cell: not evaluable|4|||
149071428|NCT05405244|537745409|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
149071429|NCT05405244|537745410|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
149071430|NCT05405244|537745409|FG000|Washout (2 Weeks)|Adverse Event|2|||
149071431|NCT05405244|537745410|FG001|Washout (2 Weeks)|Adverse Event|0|||
149071432|NCT05405244|537745409|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
149071433|NCT05405244|537745410|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
149071434|NCT03418922|537745411|FG000|Overall Study|Withdrawal by Subject|0|||
149071435|NCT03418922|537745412|FG001|Overall Study|Withdrawal by Subject|2|||
149071436|NCT03418922|537745411|FG000|Overall Study|Adverse Event|2|||
149071437|NCT03418922|537745412|FG001|Overall Study|Adverse Event|2|||
149071438|NCT03418922|537745411|FG000|Overall Study|Death|0|||
149071439|NCT03418922|537745412|FG001|Overall Study|Death|1|||
149071440|NCT03418922|537745411|FG000|Overall Study|Physician Decision|0|||
149071441|NCT03418922|537745412|FG001|Overall Study|Physician Decision|1|||
149071442|NCT03577106|537745413|FG000|Overall Study|Withdrawal by Subject|3|||
149071443|NCT03601715|537745416|FG000|Second Intervention|Lost to Follow-up|1|||
149071444|NCT03601715|537745417|FG001|Second Intervention|Lost to Follow-up|1|||
149071445|NCT03601715|537745418|FG002|Second Intervention|Lost to Follow-up|0|||
149071446|NCT02347332|537745419|FG000|Overall Study|Not treated|5|||
149071447|NCT02347332|537745420|FG001|Overall Study|Not treated|2|||
149071448|NCT02347332|537745419|FG000|Overall Study|Progressive disease|141|||
149071449|NCT02347332|537745420|FG001|Overall Study|Progressive disease|159|||
149071450|NCT02347332|537745419|FG000|Overall Study|Adverse Event|50|||
149071451|NCT02347332|537745420|FG001|Overall Study|Adverse Event|41|||
149071452|NCT02347332|537745419|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
149071453|NCT02347332|537745420|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
149071454|NCT02347332|537745419|FG000|Overall Study|Protocol Violation|1|||
149071455|NCT02347332|537745420|FG001|Overall Study|Protocol Violation|1|||
149071456|NCT02347332|537745419|FG000|Overall Study|Lost to Follow-up|2|||
149071457|NCT02347332|537745420|FG001|Overall Study|Lost to Follow-up|1|||
149071458|NCT02347332|537745419|FG000|Overall Study|Physician Decision|4|||
149071459|NCT02347332|537745420|FG001|Overall Study|Physician Decision|3|||
149071460|NCT02347332|537745419|FG000|Overall Study|Withdrawal by Subject|20|||
149071461|NCT02347332|537745420|FG001|Overall Study|Withdrawal by Subject|14|||
149071462|NCT02347332|537745419|FG000|Overall Study|Protocol requirement|1|||
149071463|NCT02347332|537745420|FG001|Overall Study|Protocol requirement|1|||
149071464|NCT02347332|537745419|FG000|Overall Study|Switch Post-Trial program|0|||
149071465|NCT02347332|537745420|FG001|Overall Study|Switch Post-Trial program|1|||
149071466|NCT01478594|537745422|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
149071467|NCT01478594|537745423|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
149071468|NCT01478594|537745422|FG000|Overall Study|Death|45|||
149071469|NCT01478594|537745423|FG001|Overall Study|Death|18|||
149071470|NCT01478594|537745422|FG000|Overall Study|Lost to Follow-up|3|||
149071471|NCT01478594|537745423|FG001|Overall Study|Lost to Follow-up|1|||
149071472|NCT01478594|537745422|FG000|Overall Study|Withdrawal by Subject|9|||
149071473|NCT01478594|537745423|FG001|Overall Study|Withdrawal by Subject|3|||
149071474|NCT01478594|537745422|FG000|Overall Study|Study Closed by Sponsor|8|||
149071475|NCT01478594|537745423|FG001|Overall Study|Study Closed by Sponsor|5|||
149071476|NCT01313884|537745425|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
149071477|NCT01970007|537745426|FG000|Overall Study|Death|5|||
149071478|NCT01970007|537745426|FG000|Overall Study|Withdrawal by Subject|23|||
149071479|NCT01970007|537745426|FG000|Overall Study|Lost to Follow-up|24|||
149071480|NCT01970007|537745426|FG000|Overall Study|"Other endpoint"|3|||
149071481|NCT02854436|537745427|FG000|Overall Study|Adverse Event|1|||
149071482|NCT02854436|537745427|FG000|Overall Study|Death|208|||
149071483|NCT02854436|537745427|FG000|Overall Study|Lost to Follow-up|5|||
149071484|NCT02854436|537745427|FG000|Overall Study|Withdrawal by Subject|24|||
149071485|NCT02854436|537745427|FG000|Overall Study|Other|45|||
149071486|NCT02854436|537745427|FG000|Overall Study|Physician Decision|6|||
149071487|NCT00754065|537745429|FG000|Overall Study|Never received treatment|12|||
149071488|NCT00754065|537745430|FG001|Overall Study|Never received treatment|2|||
149071489|NCT00754065|537745429|FG000|Overall Study|Adverse Event|19|||
149071490|NCT00754065|537745430|FG001|Overall Study|Adverse Event|25|||
149071491|NCT00754065|537745429|FG000|Overall Study|Lost to Follow-up|7|||
149071492|NCT00754065|537745430|FG001|Overall Study|Lost to Follow-up|11|||
149071493|NCT00754065|537745429|FG000|Overall Study|Protocol Violation|12|||
149071494|NCT00754065|537745430|FG001|Overall Study|Protocol Violation|10|||
149071495|NCT00754065|537745429|FG000|Overall Study|Withdrawal by Subject|4|||
149071496|NCT00754065|537745430|FG001|Overall Study|Withdrawal by Subject|5|||
149071497|NCT00754065|537745429|FG000|Overall Study|Pregnancy|6|||
149071498|NCT00754065|537745430|FG001|Overall Study|Pregnancy|0|||
149071499|NCT00754065|537745429|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
149071500|NCT00754065|537745430|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
149071501|NCT04353492|537745433|FG000|Overall Study|Subject decision|24|||
149071502|NCT04353492|537745433|FG000|Overall Study|Physician Decision|5|||
149071503|NCT04353492|537745433|FG000|Overall Study|Adverse Event|3|||
149071504|NCT04353492|537745433|FG000|Overall Study|Pregnancy|3|||
149071505|NCT04353492|537745433|FG000|Overall Study|Lost to Follow-up|2|||
149071506|NCT04353492|537745433|FG000|Overall Study|Protocol deviation|1|||
149071507|NCT04353492|537745433|FG000|Overall Study|Technical problems|1|||
149071508|NCT04250194|537745434|FG000|Overall Study|Declined to schedule biopsy|6|||
149071509|NCT04250194|537745435|FG001|Overall Study|Declined to schedule biopsy|10|||
149071510|NCT04250194|537745434|FG000|Overall Study|Medically Unfit for Biopsy|2|||
149071511|NCT04250194|537745435|FG001|Overall Study|Medically Unfit for Biopsy|1|||
149071512|NCT04250194|537745434|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
149071513|NCT04250194|537745435|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
149071514|NCT04250194|537745434|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
149071515|NCT04250194|537745435|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
149071516|NCT04250194|537745434|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
149071517|NCT04250194|537745435|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
149071518|NCT00582972|537745438|FG000|Overall Study|Protocol Violation|2|||
149071519|NCT02101775|537745443|FG000|Overall Study|Adverse Event|4|||
149071520|NCT02101775|537745444|FG001|Overall Study|Adverse Event|0|||
149071521|NCT02101775|537745445|FG002|Overall Study|Adverse Event|0|||
149071522|NCT02101775|537745443|FG000|Overall Study|Admission to Hospital|0|||
149071523|NCT02101775|537745444|FG001|Overall Study|Admission to Hospital|1|||
149071524|NCT02101775|537745445|FG002|Overall Study|Admission to Hospital|0|||
149071525|NCT01211184|537745448|FG000|Overall Study|Withdrawal by Subject|0|||
149071526|NCT01211184|537745449|FG001|Overall Study|Withdrawal by Subject|2|||
149071527|NCT01211184|537745450|FG002|Overall Study|Withdrawal by Subject|1|||
149071528|NCT01421667|537745451|FG000|Overall Study|Withdrawal by Subject|0|||
149071529|NCT01421667|537745452|FG001|Overall Study|Withdrawal by Subject|1|||
149071530|NCT01421667|537745453|FG002|Overall Study|Withdrawal by Subject|2|||
149071531|NCT01421667|537745454|FG003|Overall Study|Withdrawal by Subject|1|||
149071532|NCT01421667|537745451|FG000|Overall Study|Lost to Follow-up|0|||
149071533|NCT01421667|537745452|FG001|Overall Study|Lost to Follow-up|1|||
149071534|NCT01421667|537745453|FG002|Overall Study|Lost to Follow-up|0|||
149071535|NCT01421667|537745454|FG003|Overall Study|Lost to Follow-up|0|||
149071536|NCT00503906|537745455|FG000|Overall Study|Withdrawal by Subject|1|||
149071537|NCT04060212|537745456|FG000|Overall Study|Withdrawal by Subject|7|||
149071538|NCT01499849|537745457|FG000|Overall Study|Adverse Event|28|||
149071539|NCT01499849|537745458|FG001|Overall Study|Adverse Event|32|||
149071540|NCT01499849|537745457|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
149071541|NCT01499849|537745458|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
149071542|NCT01499849|537745457|FG000|Overall Study|Withdrawal by Subject|43|||
149071543|NCT01499849|537745458|FG001|Overall Study|Withdrawal by Subject|43|||
149071544|NCT01499849|537745457|FG000|Overall Study|Death|5|||
149071545|NCT01499849|537745458|FG001|Overall Study|Death|7|||
149071546|NCT01499849|537745457|FG000|Overall Study|Disease Progression|11|||
149071547|NCT01499849|537745458|FG001|Overall Study|Disease Progression|10|||
149071548|NCT01499849|537745457|FG000|Overall Study|Protocol Violation|11|||
149071549|NCT01499849|537745458|FG001|Overall Study|Protocol Violation|11|||
149071550|NCT01499849|537745457|FG000|Overall Study|Physician Decision|20|||
149071551|NCT01499849|537745458|FG001|Overall Study|Physician Decision|19|||
149071552|NCT01499849|537745457|FG000|Overall Study|Lack of Efficacy|3|||
149071553|NCT01499849|537745458|FG001|Overall Study|Lack of Efficacy|4|||
149071554|NCT01499849|537745457|FG000|Overall Study|Lost to Follow-up|6|||
149071555|NCT01499849|537745458|FG001|Overall Study|Lost to Follow-up|3|||
149071556|NCT01499849|537745457|FG000|Overall Study|Other Reasons|27|||
149071557|NCT01499849|537745458|FG001|Overall Study|Other Reasons|30|||
149071558|NCT00174252|537745459|FG000|Overall Study|Protocol Violation|2|||
149071559|NCT03611556|537745465|FG000|Overall Study|Death|7|||
149071560|NCT03611556|537745466|FG001|Overall Study|Death|7|||
149071561|NCT03611556|537745467|FG002|Overall Study|Death|3|||
149071562|NCT03611556|537745468|FG003|Overall Study|Death|8|||
149071563|NCT03611556|537745469|FG004|Overall Study|Death|47|||
149071564|NCT03611556|537745470|FG005|Overall Study|Death|32|||
149071565|NCT03611556|537745471|FG006|Overall Study|Death|53|||
149071566|NCT03611556|537745465|FG000|Overall Study|Withdrawal by Subject|0|||
149071567|NCT03611556|537745466|FG001|Overall Study|Withdrawal by Subject|0|||
149071568|NCT03611556|537745467|FG002|Overall Study|Withdrawal by Subject|0|||
149071569|NCT03611556|537745468|FG003|Overall Study|Withdrawal by Subject|0|||
149071570|NCT03611556|537745469|FG004|Overall Study|Withdrawal by Subject|4|||
149071571|NCT03611556|537745470|FG005|Overall Study|Withdrawal by Subject|2|||
149071572|NCT03611556|537745471|FG006|Overall Study|Withdrawal by Subject|4|||
149071573|NCT03611556|537745465|FG000|Overall Study|Sponsor decision|0|||
149071574|NCT03611556|537745466|FG001|Overall Study|Sponsor decision|0|||
149071575|NCT03611556|537745467|FG002|Overall Study|Sponsor decision|0|||
149071576|NCT03611556|537745468|FG003|Overall Study|Sponsor decision|0|||
149071577|NCT03611556|537745469|FG004|Overall Study|Sponsor decision|9|||
149071578|NCT03611556|537745470|FG005|Overall Study|Sponsor decision|4|||
149071579|NCT03611556|537745471|FG006|Overall Study|Sponsor decision|12|||
149071580|NCT03611556|537745465|FG000|Overall Study|Reasons|0|||
149071581|NCT03611556|537745466|FG001|Overall Study|Reasons|0|||
149071582|NCT03611556|537745467|FG002|Overall Study|Reasons|0|||
149071583|NCT03611556|537745468|FG003|Overall Study|Reasons|0|||
149071584|NCT03611556|537745469|FG004|Overall Study|Reasons|2|||
149071585|NCT03611556|537745470|FG005|Overall Study|Reasons|0|||
149071586|NCT03611556|537745471|FG006|Overall Study|Reasons|1|||
149071587|NCT02844439|537745475|FG000|Overall Study|Withdrawal by Subject|1|||
149071588|NCT02844439|537745475|FG000|Overall Study|Lost to Follow-up|2|||
149071589|NCT02844439|537745475|FG000|Overall Study|Termination by Sponsor|4|||
149071590|NCT02844439|537745475|FG000|Overall Study|Death|28|||
149071591|NCT02844439|537745475|FG000|Overall Study|Other|5|||
149071592|NCT03500549|537745478|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
149071593|NCT03500549|537745479|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
149071594|NCT03500549|537745478|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
149071595|NCT03500549|537745479|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
149071596|NCT02107261|537745482|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
149071597|NCT02107261|537745483|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
149071598|NCT02107261|537745482|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
149071599|NCT02107261|537745483|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
149071600|NCT04337931|537745486|FG000|Overall Study|Death|4|||
149071601|NCT04337931|537745487|FG001|Overall Study|Death|1|||
149071602|NCT04337931|537745488|FG002|Overall Study|Death|7|||
149071603|NCT04337931|537745486|FG000|Overall Study|Withdrawal by Subject|0|||
149071604|NCT04337931|537745487|FG001|Overall Study|Withdrawal by Subject|1|||
149071605|NCT04337931|537745488|FG002|Overall Study|Withdrawal by Subject|0|||
149071606|NCT04337931|537745486|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
149071607|NCT04337931|537745487|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
149071608|NCT04337931|537745488|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
149071609|NCT04337931|537745486|FG000|Overall Study|Study terminated by sponsor|3|||
149071610|NCT04337931|537745487|FG001|Overall Study|Study terminated by sponsor|6|||
149071611|NCT04337931|537745488|FG002|Overall Study|Study terminated by sponsor|2|||
149071612|NCT04337931|537745486|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
149071613|NCT04337931|537745487|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
149071614|NCT04337931|537745488|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
149071615|NCT04337931|537745486|FG000|Overall Study|Colorectal cancer treatment|1|||
149071616|NCT04337931|537745487|FG001|Overall Study|Colorectal cancer treatment|0|||
149071617|NCT04337931|537745488|FG002|Overall Study|Colorectal cancer treatment|0|||
149071618|NCT04337931|537745486|FG000|Overall Study|Participant decision|0|||
149071619|NCT04337931|537745487|FG001|Overall Study|Participant decision|1|||
149071620|NCT04337931|537745488|FG002|Overall Study|Participant decision|0|||
149071621|NCT01738438|537745489|FG000|Overall Study|Disease Progression|32|||
149071622|NCT01738438|537745489|FG000|Overall Study|Adverse Event|3|||
149071623|NCT01532999|537745491|FG000|Overall Study|Lost to Follow-up|14|||
149071624|NCT01532999|537745492|FG001|Overall Study|Lost to Follow-up|8|||
149071625|NCT01532999|537745491|FG000|Overall Study|Physician Decision|1|||
149071626|NCT01532999|537745492|FG001|Overall Study|Physician Decision|2|||
149071627|NCT01532999|537745491|FG000|Overall Study|Withdrawal by Subject|5|||
149071628|NCT01532999|537745492|FG001|Overall Study|Withdrawal by Subject|0|||
149071629|NCT01532999|537745491|FG000|Overall Study|Relocated|2|||
149071630|NCT01532999|537745492|FG001|Overall Study|Relocated|0|||
149071631|NCT01532999|537745491|FG000|Overall Study|should not have been randomized|1|||
149071632|NCT01532999|537745492|FG001|Overall Study|should not have been randomized|0|||
149071633|NCT01532999|537745491|FG000|Overall Study|substantial noncompliance|2|||
149071634|NCT01532999|537745492|FG001|Overall Study|substantial noncompliance|0|||
149071635|NCT01532999|537745491|FG000|Overall Study|no show for week 9 assessments|6|||
149071636|NCT01532999|537745492|FG001|Overall Study|no show for week 9 assessments|4|||
149071637|NCT01532999|537745491|FG000|Overall Study|Adverse Event|0|||
149071638|NCT01532999|537745492|FG001|Overall Study|Adverse Event|1|||
149071639|NCT01532999|537745491|FG000|Overall Study|incarcerated|0|||
149071640|NCT01532999|537745492|FG001|Overall Study|incarcerated|1|||
149071641|NCT01532999|537745491|FG000|Overall Study|New job|0|||
149071642|NCT01532999|537745492|FG001|Overall Study|New job|2|||
149071643|NCT02928172|537745493|FG000|Overall Study|Device did not record data|1|||
149071644|NCT02408887|537745494|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
149071645|NCT02408887|537745495|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
149071646|NCT02408887|537745494|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
149071647|NCT02408887|537745495|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
149071648|NCT03333109|537745497|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
149071649|NCT03333109|537745498|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
149071650|NCT03333109|537745499|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
149071651|NCT03333109|537745497|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
149071652|NCT03333109|537745498|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
149071653|NCT03333109|537745499|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
149071654|NCT03333109|537745497|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
149071655|NCT03333109|537745498|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
149071656|NCT03333109|537745499|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
149071657|NCT03333109|537745497|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
149071658|NCT03333109|537745498|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
149071659|NCT03333109|537745499|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
149071660|NCT03333109|537745497|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
149071661|NCT03333109|537745498|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
149071662|NCT03333109|537745499|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
149071663|NCT03333109|537745497|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
149071664|NCT03333109|537745498|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
149071665|NCT03333109|537745499|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
149071666|NCT03333109|537745497|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
149071667|NCT03333109|537745498|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
149071668|NCT03333109|537745499|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
149071669|NCT03333109|537745497|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
149071670|NCT03333109|537745498|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
149071671|NCT03333109|537745499|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
149071672|NCT00589875|537745500|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
149071673|NCT00589875|537745500|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
149071674|NCT02415127|537745503|FG000|Overall Study|Adverse Event|1|||
149071675|NCT02415127|537745504|FG001|Overall Study|Adverse Event|0|||
149071676|NCT02761187|537745505|FG000|Overall Study|Too ill to Participate|13|||
149071677|NCT02761187|537745506|FG001|Overall Study|Too ill to Participate|8|||
149071678|NCT02761187|537745505|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
149071679|NCT02761187|537745506|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
149071680|NCT02761187|537745505|FG000|Overall Study|Patient withdrew consent|64|||
149071681|NCT02761187|537745506|FG001|Overall Study|Patient withdrew consent|58|||
149071682|NCT02761187|537745505|FG000|Overall Study|Physician discretion|4|||
149071683|NCT02761187|537745506|FG001|Overall Study|Physician discretion|8|||
149071684|NCT02761187|537745505|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
149071685|NCT02761187|537745506|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
149071686|NCT02761187|537745505|FG000|Overall Study|On Hospice|20|||
149071687|NCT02761187|537745506|FG001|Overall Study|On Hospice|26|||
149071688|NCT02761187|537745505|FG000|Overall Study|Deceased|474|||
149071689|NCT02761187|537745506|FG001|Overall Study|Deceased|642|||
149071690|NCT02761187|537745505|FG000|Overall Study|Lost to Follow-up|73|||
149071691|NCT02761187|537745506|FG001|Overall Study|Lost to Follow-up|63|||
149071692|NCT02761187|537745505|FG000|Overall Study|Due to study discontinued at site|100|||
149071693|NCT02761187|537745506|FG001|Overall Study|Due to study discontinued at site|85|||
149071694|NCT02761187|537745505|FG000|Overall Study|Reason not Specified|1484|||
149071695|NCT02761187|537745506|FG001|Overall Study|Reason not Specified|937|||
149071696|NCT03997474|537745507|FG000|Overall Study|Death|6|||
149071697|NCT03997474|537745508|FG001|Overall Study|Death|2|||
149071698|NCT03997474|537745509|FG002|Overall Study|Death|1|||
149071699|NCT03997474|537745507|FG000|Overall Study|Physician Decision|2|||
149071700|NCT03997474|537745508|FG001|Overall Study|Physician Decision|0|||
149071701|NCT03997474|537745509|FG002|Overall Study|Physician Decision|0|||
149071702|NCT03997474|537745507|FG000|Overall Study|study terminated by sponsor|1|||
149071703|NCT03997474|537745508|FG001|Overall Study|study terminated by sponsor|0|||
149071704|NCT03997474|537745509|FG002|Overall Study|study terminated by sponsor|1|||
149071705|NCT05630833|537745510|FG000|Overall Study|Adverse Event|3|||
149071706|NCT05630833|537745511|FG001|Overall Study|Adverse Event|0|||
149071707|NCT05630833|537745510|FG000|Overall Study|Lack of Efficacy|0|||
149071708|NCT05630833|537745511|FG001|Overall Study|Lack of Efficacy|1|||
149071709|NCT05630833|537745510|FG000|Overall Study|Lost to Follow-up|1|||
149071710|NCT05630833|537745511|FG001|Overall Study|Lost to Follow-up|0|||
149071711|NCT05630833|537745510|FG000|Overall Study|Withdrawal by Subject|3|||
149071712|NCT05630833|537745511|FG001|Overall Study|Withdrawal by Subject|1|||
149071713|NCT00490139|537745512|FG000|Overall Study|Lost to Follow-up|249|||
149071714|NCT00490139|537745513|FG001|Overall Study|Lost to Follow-up|216|||
149071715|NCT00490139|537745514|FG002|Overall Study|Lost to Follow-up|205|||
149071716|NCT00490139|537745515|FG003|Overall Study|Lost to Follow-up|229|||
149071717|NCT00490139|537745512|FG000|Overall Study|Withdrawal by Subject|333|||
149071718|NCT00490139|537745513|FG001|Overall Study|Withdrawal by Subject|322|||
149071719|NCT00490139|537745514|FG002|Overall Study|Withdrawal by Subject|396|||
149071720|NCT00490139|537745515|FG003|Overall Study|Withdrawal by Subject|295|||
149071721|NCT00490139|537745512|FG000|Overall Study|Patient did not sign ICF 12|169|||
149071722|NCT00490139|537745513|FG001|Overall Study|Patient did not sign ICF 12|176|||
149071723|NCT00490139|537745514|FG002|Overall Study|Patient did not sign ICF 12|139|||
149071724|NCT00490139|537745515|FG003|Overall Study|Patient did not sign ICF 12|167|||
149071725|NCT00490139|537745512|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
149071726|NCT00490139|537745513|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
149071727|NCT00490139|537745514|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
149071728|NCT00490139|537745515|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
149071729|NCT00490139|537745512|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
149071730|NCT00490139|537745513|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
149071731|NCT00490139|537745514|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
149071732|NCT00490139|537745515|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
149071733|NCT00490139|537745512|FG000|Overall Study|Other reasons as defined per protocol|98|||
149071734|NCT00490139|537745513|FG001|Overall Study|Other reasons as defined per protocol|84|||
149071735|NCT00490139|537745514|FG002|Overall Study|Other reasons as defined per protocol|82|||
149071736|NCT00490139|537745515|FG003|Overall Study|Other reasons as defined per protocol|105|||
149071737|NCT03664804|537745517|FG000|Overall Study|Withdrawal by Subject|7|||
149071738|NCT05529992|537745518|FG000|Overall Study|Withdrawal by Subject|1|||
149071739|NCT06140290|537745519|FG000|Period 1|Adverse Event|1|||
149071740|NCT06140290|537745520|FG001|Period 1|Adverse Event|0|||
149071741|NCT06140290|537745519|FG000|Period 2|Assigned but not treated|0|||
149071742|NCT06140290|537745520|FG001|Period 2|Assigned but not treated|1|||
149071743|NCT06140290|537745519|FG000|Period 2|Withdrawal by Subject|0|||
149071744|NCT06140290|537745520|FG001|Period 2|Withdrawal by Subject|1|||
149071745|NCT03459196|537747136|FG000|Overall Study|Subject didn't receive study catheter|2|||
149071746|NCT03083366|537747139|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
149071747|NCT03083366|537747140|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
149071748|NCT03083366|537747139|FG000|Enrollment Period|Lack of Efficacy|1|||
149071749|NCT03083366|537747140|FG001|Enrollment Period|Lack of Efficacy|0|||
149071750|NCT05250115|537747142|FG000|Overall Study|Premature study end|40|||
149071751|NCT05250115|537747142|FG000|Overall Study|Adverse Event|8|||
149071752|NCT05250115|537747142|FG000|Overall Study|Lost to Follow-up|7|||
149071753|NCT05250115|537747142|FG000|Overall Study|Withdrawal by Subject|6|||
149071754|NCT05250115|537747142|FG000|Overall Study|Withdrawal of informed consent|1|||
149071755|NCT05250115|537747142|FG000|Overall Study|Other|7|||
149071756|NCT03758638|537747143|FG000|Overall Study|Pregnancy|17|||
149071757|NCT03758638|537747144|FG001|Overall Study|Pregnancy|25|||
149071758|NCT03758638|537747143|FG000|Overall Study|Lost to Follow-up|60|||
149071759|NCT03758638|537747144|FG001|Overall Study|Lost to Follow-up|54|||
149071760|NCT03758638|537747143|FG000|Overall Study|Protocol Violation|2|||
149071761|NCT03758638|537747144|FG001|Overall Study|Protocol Violation|0|||
149071762|NCT03758638|537747143|FG000|Overall Study|Withdrawal by Subject|8|||
149071763|NCT03758638|537747144|FG001|Overall Study|Withdrawal by Subject|2|||
149071764|NCT03758638|537747143|FG000|Overall Study|Providers not included in the primary outcome.|183|||
149071765|NCT03758638|537747144|FG001|Overall Study|Providers not included in the primary outcome.|128|||
149071766|NCT01314118|537747145|FG000|Overall Study|Adverse Event|9|||
149071767|NCT01314118|537747145|FG000|Overall Study|Progressive disease|27|||
149071768|NCT01314118|537747145|FG000|Overall Study|Physician Decision|11|||
149071769|NCT01314118|537747145|FG000|Overall Study|Death|4|||
149071770|NCT01314118|537747145|FG000|Overall Study|Protocol Violation|5|||
149071771|NCT01314118|537747145|FG000|Overall Study|Withdrawal by Subject|11|||
149071772|NCT01314118|537747145|FG000|Overall Study|Other|2|||
149071773|NCT01314118|537747145|FG000|Overall Study|Ongoing|62|||
149071774|NCT00065182|537747152|FG000|Overall Study|Adverse Event|24|||
149071775|NCT00065182|537747153|FG001|Overall Study|Adverse Event|17|||
149071776|NCT00065182|537747152|FG000|Overall Study|Lost to Follow-up|0|||
149071777|NCT00065182|537747153|FG001|Overall Study|Lost to Follow-up|4|||
149071778|NCT00065182|537747152|FG000|Overall Study|Protocol Violation|3|||
149071779|NCT00065182|537747153|FG001|Overall Study|Protocol Violation|4|||
149071780|NCT00065182|537747152|FG000|Overall Study|Serious adverse events (SAE)|1|||
149071781|NCT00065182|537747153|FG001|Overall Study|Serious adverse events (SAE)|0|||
149071782|NCT00065182|537747152|FG000|Overall Study|Sponsor Decision|11|||
149071783|NCT00065182|537747153|FG001|Overall Study|Sponsor Decision|7|||
149071784|NCT00065182|537747152|FG000|Overall Study|Withdrawal by Subject|8|||
149071785|NCT00065182|537747153|FG001|Overall Study|Withdrawal by Subject|3|||
149071786|NCT00065182|537747152|FG000|Overall Study|No clinical benefit|1|||
149071787|NCT00065182|537747153|FG001|Overall Study|No clinical benefit|0|||
149071788|NCT00065182|537747152|FG000|Overall Study|Death|0|||
149071789|NCT00065182|537747153|FG001|Overall Study|Death|1|||
149071790|NCT00065182|537747152|FG000|Overall Study|Decline in Status|0|||
149071791|NCT00065182|537747153|FG001|Overall Study|Decline in Status|1|||
149071792|NCT02633215|537747154|FG000|Overall Study|Lost to Follow-up|2|||
149071793|NCT02633215|537747155|FG001|Overall Study|Lost to Follow-up|3|||
149071794|NCT03442777|537747156|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
149071795|NCT03442777|537747157|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
149071796|NCT03442777|537747158|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
149071797|NCT03801148|537747159|FG000|Period 1 (2 Days)|Adverse Event|1|||
149071798|NCT03801148|537747160|FG001|Period 1 (2 Days)|Adverse Event|1|||
149071799|NCT03801148|537747161|FG002|Period 1 (2 Days)|Adverse Event|0|||
149071800|NCT03801148|537747162|FG003|Period 1 (2 Days)|Adverse Event|0|||
149071801|NCT03801148|537747159|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
149071802|NCT03801148|537747160|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
149071803|NCT03801148|537747161|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
149071804|NCT03801148|537747162|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
149071805|NCT03801148|537747159|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149071806|NCT03801148|537747160|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149071807|NCT03801148|537747161|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
149071808|NCT03801148|537747162|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
149071809|NCT03801148|537747159|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
149071810|NCT03801148|537747160|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
149071811|NCT03801148|537747161|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
149071812|NCT03801148|537747162|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
149071813|NCT00790569|537747163|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
149071814|NCT00790569|537747164|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
149071815|NCT00790569|537747165|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
149071816|NCT00790569|537747163|FG000|End of Treatment (6 Month Interview)|Death|0|||
149071817|NCT00790569|537747164|FG001|End of Treatment (6 Month Interview)|Death|2|||
149071818|NCT00790569|537747165|FG002|End of Treatment (6 Month Interview)|Death|1|||
149071819|NCT00790569|537747163|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
149071820|NCT00790569|537747164|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
149071821|NCT00790569|537747165|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
149071822|NCT00790569|537747163|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
149071823|NCT00790569|537747164|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
149071824|NCT00790569|537747165|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
149071825|NCT00790569|537747163|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
149071826|NCT00790569|537747164|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
149071827|NCT00790569|537747165|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
149120222|NCT04602221|537918071|FG014|Overall Study|Other than listed|0|||
149071828|NCT00790569|537747163|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
149071829|NCT00790569|537747164|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
149071830|NCT00790569|537747165|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
149071831|NCT01627561|537747166|FG000|Overall Study|Lost to Follow-up|1|||
149071832|NCT01627561|537747167|FG001|Overall Study|Lost to Follow-up|0|||
149071833|NCT01627561|537747166|FG000|Overall Study|Withdrawal by Subject|0|||
149071834|NCT01627561|537747167|FG001|Overall Study|Withdrawal by Subject|1|||
149071835|NCT01627561|537747166|FG000|Overall Study|Migrated/moved from study area|0|||
149071836|NCT01627561|537747167|FG001|Overall Study|Migrated/moved from study area|2|||
149071837|NCT03244800|537747168|FG000|Overall Study|Adverse Event|0|||
149071838|NCT03244800|537747169|FG001|Overall Study|Adverse Event|1|||
149071839|NCT03244800|537747170|FG002|Overall Study|Adverse Event|0|||
149071840|NCT03244800|537747171|FG003|Overall Study|Adverse Event|1|||
149071841|NCT03244800|537747168|FG000|Overall Study|Withdrew treatment|0|||
149071842|NCT03244800|537747169|FG001|Overall Study|Withdrew treatment|0|||
149071843|NCT03244800|537747170|FG002|Overall Study|Withdrew treatment|0|||
149071844|NCT03244800|537747171|FG003|Overall Study|Withdrew treatment|1|||
149071845|NCT00890591|537747179|FG000|Overall Study|Lack of Efficacy|20|||
149071846|NCT02941549|537747182|FG000|Overall Study|Adverse Event|1|||
149071847|NCT02941549|537747183|FG001|Overall Study|Adverse Event|0|||
149071848|NCT02941549|537747184|FG002|Overall Study|Adverse Event|0|||
149071849|NCT02941549|537747182|FG000|Overall Study|Withdrawal by Subject|2|||
149071850|NCT02941549|537747183|FG001|Overall Study|Withdrawal by Subject|1|||
149071851|NCT02941549|537747184|FG002|Overall Study|Withdrawal by Subject|2|||
149071852|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
149071853|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
149071854|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071855|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071856|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071857|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
149071858|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
149071859|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071860|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071861|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071862|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071863|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071864|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071865|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
149071866|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071867|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071868|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071869|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071870|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071871|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
149071872|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
149071873|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071874|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071875|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071876|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071877|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071878|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071879|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
149071880|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
149071881|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071882|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071883|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071884|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071885|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071886|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
149071887|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071888|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071889|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071890|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071891|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071892|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071893|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
149071894|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071895|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071896|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071897|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071898|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071899|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
149071900|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
149071901|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071902|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071903|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071904|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071905|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071906|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071907|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
149071908|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071909|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071910|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071911|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071912|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071913|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071914|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
149071915|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071916|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071917|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071918|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071919|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071920|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071921|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
149071922|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
149071923|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
149071924|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
149071925|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071926|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071927|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
149071928|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
149071929|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071930|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071931|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071932|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071933|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071934|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071935|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
149071936|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071937|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
149071938|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071939|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071940|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071941|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
149071942|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071943|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071944|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071945|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071946|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071947|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071948|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071949|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
149071950|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
149071951|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071952|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071953|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071954|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071955|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
149071956|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071957|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071958|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071959|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071960|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071961|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071962|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071963|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
149071964|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071965|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071966|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071967|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
149071968|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
149071969|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071970|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071971|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
149071972|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
149071973|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071974|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071975|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071976|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071977|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
149071978|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071979|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071980|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071981|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071982|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071983|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071984|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071985|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
149071986|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
149071987|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071988|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071989|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071990|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071991|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
149071992|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071993|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071994|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071995|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071996|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071997|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071998|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149071999|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149072000|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
149072001|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149072002|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149072003|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149072004|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149072005|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
149072006|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072007|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072008|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072009|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
149072010|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072011|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072012|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072013|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072014|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072015|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072016|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072017|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072018|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072019|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
149072020|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072021|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072022|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072023|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072024|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072025|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072026|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072027|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
149072028|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
149072029|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072030|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072031|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072032|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072033|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
149072034|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072035|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072036|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072037|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072038|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072039|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072040|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072041|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
149072042|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072043|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072044|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072045|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072046|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072047|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
149072048|NCT04033445|537747191|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072049|NCT04033445|537747192|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072050|NCT04033445|537747193|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072051|NCT04033445|537747194|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072052|NCT04033445|537747195|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072053|NCT04033445|537747196|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072054|NCT04033445|537747197|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072055|NCT04033445|537747198|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
149072056|NCT04033445|537747199|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072057|NCT04033445|537747200|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072058|NCT04033445|537747201|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072059|NCT04033445|537747202|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072060|NCT04033445|537747203|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072061|NCT04033445|537747204|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
149072062|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072063|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072064|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072065|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072066|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072067|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072068|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072069|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072070|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
149072071|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
149072072|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
149072073|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
149072074|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
149072075|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
149072076|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072077|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072078|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072079|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072080|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072081|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072082|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072083|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072084|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
149072085|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
149072086|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
149072087|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
149072088|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
149072089|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
149072090|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072091|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072092|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072093|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072094|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072095|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072096|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072097|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072098|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072099|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072100|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
149072101|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
149072102|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
149072103|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
149072104|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072105|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072106|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072107|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072108|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072109|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072110|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072111|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072112|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072113|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
149072114|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
149072115|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
149072116|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
149072117|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
149072118|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072119|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072120|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072121|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072122|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072123|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072124|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072125|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072126|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
149072127|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
149072128|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
149072129|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
149072130|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
149072131|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
149072132|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072133|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072134|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072135|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072136|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072137|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072138|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072139|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072140|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072141|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072142|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072143|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072144|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
149072145|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
149072146|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072147|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072148|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072149|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072150|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072151|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072152|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072153|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072154|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
149072155|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
149072156|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
149072157|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
149072158|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
149072159|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
149072160|NCT04033445|537747191|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072161|NCT04033445|537747192|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072162|NCT04033445|537747193|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072163|NCT04033445|537747194|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072164|NCT04033445|537747195|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072165|NCT04033445|537747196|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072166|NCT04033445|537747197|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072167|NCT04033445|537747198|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072168|NCT04033445|537747199|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072169|NCT04033445|537747200|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
149072170|NCT04033445|537747201|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072171|NCT04033445|537747202|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
149072172|NCT04033445|537747203|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
149072173|NCT04033445|537747204|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
149072174|NCT00776009|537747205|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
149072175|NCT00776009|537747206|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
149072176|NCT00776009|537747207|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
149072177|NCT00776009|537747208|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
149072178|NCT00776009|537747209|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
149072179|NCT00776009|537747210|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
149072180|NCT00776009|537747205|FG000|Period 1: First Intervention|Protocol Violation|0|||
149072181|NCT00776009|537747206|FG001|Period 1: First Intervention|Protocol Violation|1|||
149072182|NCT00776009|537747207|FG002|Period 1: First Intervention|Protocol Violation|0|||
149072183|NCT00776009|537747208|FG003|Period 1: First Intervention|Protocol Violation|0|||
149072184|NCT00776009|537747209|FG004|Period 1: First Intervention|Protocol Violation|1|||
149072185|NCT00776009|537747210|FG005|Period 1: First Intervention|Protocol Violation|0|||
149072186|NCT00776009|537747205|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
149072187|NCT00776009|537747206|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
149072188|NCT00776009|537747207|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
149072189|NCT00776009|537747208|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
149072190|NCT00776009|537747209|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
149072191|NCT00776009|537747210|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
149072192|NCT00776009|537747205|FG000|Period 2: Second Intervention|Protocol Violation|1|||
149072193|NCT00776009|537747206|FG001|Period 2: Second Intervention|Protocol Violation|0|||
149072194|NCT00776009|537747207|FG002|Period 2: Second Intervention|Protocol Violation|1|||
149072195|NCT00776009|537747208|FG003|Period 2: Second Intervention|Protocol Violation|0|||
149072196|NCT00776009|537747209|FG004|Period 2: Second Intervention|Protocol Violation|0|||
149072197|NCT00776009|537747210|FG005|Period 2: Second Intervention|Protocol Violation|0|||
149072198|NCT00776009|537747205|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
149072199|NCT00776009|537747206|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
149072200|NCT00776009|537747207|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
149072201|NCT00776009|537747208|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
149072202|NCT00776009|537747209|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
149072203|NCT00776009|537747210|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
149072204|NCT00293397|537747212|FG000|Overall Study|Death|2|||
149072205|NCT03631407|537747213|FG000|Overall Study|Withdrawal by Subject|3|||
149072206|NCT03631407|537747214|FG001|Overall Study|Withdrawal by Subject|2|||
149072207|NCT03631407|537747213|FG000|Overall Study|Sponsor Decision|0|||
149072208|NCT03631407|537747214|FG001|Overall Study|Sponsor Decision|2|||
149072209|NCT03631407|537747213|FG000|Overall Study|Death|16|||
149072210|NCT03631407|537747214|FG001|Overall Study|Death|16|||
149072211|NCT03631407|537747213|FG000|Overall Study|Randomized by mistake without study treatment|1|||
149072212|NCT03631407|537747214|FG001|Overall Study|Randomized by mistake without study treatment|0|||
149072213|NCT01437319|537747215|FG000|Phase I|Lost to Follow-up|2|||
149072214|NCT01437319|537747216|FG001|Phase I|Lost to Follow-up|0|||
149072215|NCT01437319|537747217|FG002|Phase I|Lost to Follow-up|0|||
149072216|NCT01437319|537747215|FG000|Phase I|Protocol Violation|1|||
149072217|NCT01437319|537747216|FG001|Phase I|Protocol Violation|0|||
149072218|NCT01437319|537747217|FG002|Phase I|Protocol Violation|0|||
149072219|NCT01437319|537747215|FG000|Phase I|Study related symptoms/complaints|27|||
149072220|NCT01437319|537747216|FG001|Phase I|Study related symptoms/complaints|0|||
149072221|NCT01437319|537747217|FG002|Phase I|Study related symptoms/complaints|0|||
149072222|NCT01437319|537747215|FG000|Phase I|Withdrawal by Subject|25|||
149072223|NCT01437319|537747216|FG001|Phase I|Withdrawal by Subject|0|||
149072224|NCT01437319|537747217|FG002|Phase I|Withdrawal by Subject|0|||
149072225|NCT01437319|537747215|FG000|Phase II|Withdrawal by Subject|0|||
149072226|NCT01437319|537747216|FG001|Phase II|Withdrawal by Subject|8|||
149072227|NCT01437319|537747217|FG002|Phase II|Withdrawal by Subject|16|||
149072228|NCT01437319|537747215|FG000|Phase II|Lost to Follow-up|0|||
149072229|NCT01437319|537747216|FG001|Phase II|Lost to Follow-up|7|||
149072230|NCT01437319|537747217|FG002|Phase II|Lost to Follow-up|2|||
149072231|NCT01437319|537747215|FG000|Phase II|Study related symptoms/complaints|0|||
149072232|NCT01437319|537747216|FG001|Phase II|Study related symptoms/complaints|28|||
149072233|NCT01437319|537747217|FG002|Phase II|Study related symptoms/complaints|19|||
149072234|NCT01437319|537747215|FG000|Phase II|Protocol Violation|0|||
149072235|NCT01437319|537747216|FG001|Phase II|Protocol Violation|1|||
149072236|NCT01437319|537747217|FG002|Phase II|Protocol Violation|0|||
149072237|NCT00983294|537747218|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
149072238|NCT00983294|537747218|FG000|Colchicine With Azithromycin|Adverse Event|1|||
149072239|NCT00622700|537747219|FG000|Core Treatment Period|Randomized but Not Treated|0|||
149072240|NCT00622700|537747220|FG001|Core Treatment Period|Randomized but Not Treated|2|||
149072241|NCT00622700|537747221|FG002|Core Treatment Period|Randomized but Not Treated|2|||
149072242|NCT00622700|537747222|FG003|Core Treatment Period|Randomized but Not Treated|0|||
149072243|NCT00622700|537747223|FG004|Core Treatment Period|Randomized but Not Treated|0|||
149072244|NCT00622700|537747224|FG005|Core Treatment Period|Randomized but Not Treated|0|||
149072245|NCT00622700|537747225|FG006|Core Treatment Period|Randomized but Not Treated|0|||
149072246|NCT00622700|537747219|FG000|Core Treatment Period|Adverse Event|18|||
149072247|NCT00622700|537747220|FG001|Core Treatment Period|Adverse Event|25|||
149072248|NCT00622700|537747221|FG002|Core Treatment Period|Adverse Event|18|||
149072249|NCT00622700|537747222|FG003|Core Treatment Period|Adverse Event|0|||
149072250|NCT00622700|537747223|FG004|Core Treatment Period|Adverse Event|0|||
149072251|NCT00622700|537747224|FG005|Core Treatment Period|Adverse Event|0|||
149072252|NCT00622700|537747225|FG006|Core Treatment Period|Adverse Event|0|||
149072253|NCT00622700|537747219|FG000|Core Treatment Period|Lack of Efficacy|19|||
149072254|NCT00622700|537747220|FG001|Core Treatment Period|Lack of Efficacy|6|||
149072255|NCT00622700|537747221|FG002|Core Treatment Period|Lack of Efficacy|12|||
149072256|NCT00622700|537747222|FG003|Core Treatment Period|Lack of Efficacy|0|||
149072257|NCT00622700|537747223|FG004|Core Treatment Period|Lack of Efficacy|0|||
149072258|NCT00622700|537747224|FG005|Core Treatment Period|Lack of Efficacy|0|||
149072259|NCT00622700|537747225|FG006|Core Treatment Period|Lack of Efficacy|0|||
149072260|NCT00622700|537747219|FG000|Core Treatment Period|Lost to Follow-up|1|||
149072261|NCT00622700|537747220|FG001|Core Treatment Period|Lost to Follow-up|1|||
149072262|NCT00622700|537747221|FG002|Core Treatment Period|Lost to Follow-up|1|||
149072263|NCT00622700|537747222|FG003|Core Treatment Period|Lost to Follow-up|0|||
149072264|NCT00622700|537747223|FG004|Core Treatment Period|Lost to Follow-up|0|||
149072265|NCT00622700|537747224|FG005|Core Treatment Period|Lost to Follow-up|0|||
149072266|NCT00622700|537747225|FG006|Core Treatment Period|Lost to Follow-up|0|||
149072267|NCT00622700|537747219|FG000|Core Treatment Period|Death|1|||
149072268|NCT00622700|537747220|FG001|Core Treatment Period|Death|0|||
149072269|NCT00622700|537747221|FG002|Core Treatment Period|Death|0|||
149072270|NCT00622700|537747222|FG003|Core Treatment Period|Death|0|||
149072271|NCT00622700|537747223|FG004|Core Treatment Period|Death|0|||
149072272|NCT00622700|537747224|FG005|Core Treatment Period|Death|0|||
149072273|NCT00622700|537747225|FG006|Core Treatment Period|Death|0|||
149072274|NCT00622700|537747219|FG000|Core Treatment Period|Progressive Disease|3|||
149072275|NCT00622700|537747220|FG001|Core Treatment Period|Progressive Disease|1|||
149072276|NCT00622700|537747221|FG002|Core Treatment Period|Progressive Disease|0|||
149072277|NCT00622700|537747222|FG003|Core Treatment Period|Progressive Disease|0|||
149072278|NCT00622700|537747223|FG004|Core Treatment Period|Progressive Disease|0|||
149072279|NCT00622700|537747224|FG005|Core Treatment Period|Progressive Disease|0|||
149072280|NCT00622700|537747225|FG006|Core Treatment Period|Progressive Disease|0|||
149072281|NCT00622700|537747219|FG000|Core Treatment Period|Withdrawal by Subject|12|||
149072282|NCT00622700|537747220|FG001|Core Treatment Period|Withdrawal by Subject|18|||
149072283|NCT00622700|537747221|FG002|Core Treatment Period|Withdrawal by Subject|15|||
149072284|NCT00622700|537747222|FG003|Core Treatment Period|Withdrawal by Subject|0|||
149072285|NCT00622700|537747223|FG004|Core Treatment Period|Withdrawal by Subject|0|||
149072286|NCT00622700|537747224|FG005|Core Treatment Period|Withdrawal by Subject|0|||
149072287|NCT00622700|537747225|FG006|Core Treatment Period|Withdrawal by Subject|0|||
149072288|NCT00622700|537747219|FG000|Core Treatment Period|Other than specified above|2|||
149072289|NCT00622700|537747220|FG001|Core Treatment Period|Other than specified above|2|||
149072290|NCT00622700|537747221|FG002|Core Treatment Period|Other than specified above|5|||
149072291|NCT00622700|537747222|FG003|Core Treatment Period|Other than specified above|0|||
149072292|NCT00622700|537747223|FG004|Core Treatment Period|Other than specified above|0|||
149072293|NCT00622700|537747224|FG005|Core Treatment Period|Other than specified above|0|||
149072294|NCT00622700|537747225|FG006|Core Treatment Period|Other than specified above|0|||
149072295|NCT00622700|537747219|FG000|Extension Treatment Period|Adverse Event|0|||
149072296|NCT00622700|537747220|FG001|Extension Treatment Period|Adverse Event|0|||
149072297|NCT00622700|537747221|FG002|Extension Treatment Period|Adverse Event|0|||
149072298|NCT00622700|537747222|FG003|Extension Treatment Period|Adverse Event|5|||
149072299|NCT00622700|537747223|FG004|Extension Treatment Period|Adverse Event|9|||
149072300|NCT00622700|537747224|FG005|Extension Treatment Period|Adverse Event|6|||
149072301|NCT00622700|537747225|FG006|Extension Treatment Period|Adverse Event|8|||
149072302|NCT00622700|537747219|FG000|Extension Treatment Period|Lack of Efficacy|0|||
149072303|NCT00622700|537747220|FG001|Extension Treatment Period|Lack of Efficacy|0|||
149072304|NCT00622700|537747221|FG002|Extension Treatment Period|Lack of Efficacy|0|||
149072305|NCT00622700|537747222|FG003|Extension Treatment Period|Lack of Efficacy|2|||
149072306|NCT00622700|537747223|FG004|Extension Treatment Period|Lack of Efficacy|8|||
149072307|NCT00622700|537747224|FG005|Extension Treatment Period|Lack of Efficacy|1|||
149072308|NCT00622700|537747225|FG006|Extension Treatment Period|Lack of Efficacy|9|||
149072309|NCT00622700|537747219|FG000|Extension Treatment Period|Protocol Violation|0|||
149072310|NCT00622700|537747220|FG001|Extension Treatment Period|Protocol Violation|0|||
149072311|NCT00622700|537747221|FG002|Extension Treatment Period|Protocol Violation|0|||
149072312|NCT00622700|537747222|FG003|Extension Treatment Period|Protocol Violation|0|||
149072313|NCT00622700|537747223|FG004|Extension Treatment Period|Protocol Violation|0|||
149072314|NCT00622700|537747224|FG005|Extension Treatment Period|Protocol Violation|2|||
149072315|NCT00622700|537747225|FG006|Extension Treatment Period|Protocol Violation|0|||
149072316|NCT00622700|537747219|FG000|Extension Treatment Period|Lost to Follow-up|0|||
149072317|NCT00622700|537747220|FG001|Extension Treatment Period|Lost to Follow-up|0|||
149072318|NCT00622700|537747221|FG002|Extension Treatment Period|Lost to Follow-up|0|||
149072319|NCT00622700|537747222|FG003|Extension Treatment Period|Lost to Follow-up|0|||
149072320|NCT00622700|537747223|FG004|Extension Treatment Period|Lost to Follow-up|1|||
149072321|NCT00622700|537747224|FG005|Extension Treatment Period|Lost to Follow-up|0|||
149072322|NCT00622700|537747225|FG006|Extension Treatment Period|Lost to Follow-up|0|||
149072323|NCT00622700|537747219|FG000|Extension Treatment Period|Progressive Disease|0|||
149072324|NCT00622700|537747220|FG001|Extension Treatment Period|Progressive Disease|0|||
149072325|NCT00622700|537747221|FG002|Extension Treatment Period|Progressive Disease|0|||
149072326|NCT00622700|537747222|FG003|Extension Treatment Period|Progressive Disease|1|||
149072327|NCT00622700|537747223|FG004|Extension Treatment Period|Progressive Disease|2|||
149072328|NCT00622700|537747224|FG005|Extension Treatment Period|Progressive Disease|0|||
149072329|NCT00622700|537747225|FG006|Extension Treatment Period|Progressive Disease|2|||
149072330|NCT00622700|537747219|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
149072331|NCT00622700|537747220|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
149072332|NCT00622700|537747221|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
149072333|NCT00622700|537747222|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
149072334|NCT00622700|537747223|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
149072335|NCT00622700|537747224|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
149072336|NCT00622700|537747225|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
149072337|NCT00622700|537747219|FG000|Extension Treatment Period|Missing|0|||
149072338|NCT00622700|537747220|FG001|Extension Treatment Period|Missing|0|||
149072339|NCT00622700|537747221|FG002|Extension Treatment Period|Missing|0|||
149072340|NCT00622700|537747222|FG003|Extension Treatment Period|Missing|2|||
149072341|NCT00622700|537747223|FG004|Extension Treatment Period|Missing|3|||
149072342|NCT00622700|537747224|FG005|Extension Treatment Period|Missing|1|||
149072343|NCT00622700|537747225|FG006|Extension Treatment Period|Missing|0|||
149072344|NCT00622700|537747219|FG000|Extension Treatment Period|Other than specified above|0|||
149072345|NCT00622700|537747220|FG001|Extension Treatment Period|Other than specified above|0|||
149072346|NCT00622700|537747221|FG002|Extension Treatment Period|Other than specified above|0|||
149072347|NCT00622700|537747222|FG003|Extension Treatment Period|Other than specified above|0|||
149072348|NCT00622700|537747223|FG004|Extension Treatment Period|Other than specified above|0|||
149072349|NCT00622700|537747224|FG005|Extension Treatment Period|Other than specified above|1|||
149072350|NCT00622700|537747225|FG006|Extension Treatment Period|Other than specified above|1|||
149072351|NCT00942266|537747226|FG000|Overall Study|Withdrawal by Subject|1|||
149072352|NCT00942266|537747227|FG001|Overall Study|Withdrawal by Subject|0|||
149072353|NCT00942266|537747226|FG000|Overall Study|Adverse Event|2|||
149072354|NCT00942266|537747227|FG001|Overall Study|Adverse Event|1|||
149072355|NCT00942266|537747226|FG000|Overall Study|Disease Progression|38|||
149072356|NCT00942266|537747227|FG001|Overall Study|Disease Progression|11|||
149072357|NCT00942266|537747226|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
149072358|NCT00942266|537747227|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
149072359|NCT00942266|537747226|FG000|Overall Study|Intercurrent illness|0|||
149072360|NCT00942266|537747227|FG001|Overall Study|Intercurrent illness|1|||
149072361|NCT00942266|537747226|FG000|Overall Study|Physician Decision|2|||
149072362|NCT00942266|537747227|FG001|Overall Study|Physician Decision|0|||
149072363|NCT00942266|537747226|FG000|Overall Study|medical deterioration (pneumonia)|0|||
149072364|NCT00942266|537747227|FG001|Overall Study|medical deterioration (pneumonia)|1|||
149072365|NCT04035447|537747228|FG000|Treatment Period|Lost to Follow-up|6|||
149072366|NCT04035447|537747229|FG001|Treatment Period|Lost to Follow-up|5|||
149072367|NCT04035447|537747228|FG000|Treatment Period|Physician Decision|0|||
149072368|NCT04035447|537747229|FG001|Treatment Period|Physician Decision|2|||
149072369|NCT03473743|537747230|FG000|Overall Study|Withdrawal by Subject|0|||
149072370|NCT03473743|537747231|FG001|Overall Study|Withdrawal by Subject|0|||
149072371|NCT03473743|537747232|FG002|Overall Study|Withdrawal by Subject|0|||
149072372|NCT03473743|537747233|FG003|Overall Study|Withdrawal by Subject|0|||
149072373|NCT03473743|537747234|FG004|Overall Study|Withdrawal by Subject|0|||
149072374|NCT03473743|537747235|FG005|Overall Study|Withdrawal by Subject|0|||
149072375|NCT03473743|537747236|FG006|Overall Study|Withdrawal by Subject|0|||
149072376|NCT03473743|537747237|FG007|Overall Study|Withdrawal by Subject|3|||
149072377|NCT03473743|537747230|FG000|Overall Study|Other|0|||
149072378|NCT03473743|537747231|FG001|Overall Study|Other|0|||
149072379|NCT03473743|537747232|FG002|Overall Study|Other|0|||
149072380|NCT03473743|537747233|FG003|Overall Study|Other|1|||
149072381|NCT03473743|537747234|FG004|Overall Study|Other|0|||
149072382|NCT03473743|537747235|FG005|Overall Study|Other|0|||
149072383|NCT03473743|537747236|FG006|Overall Study|Other|0|||
149072384|NCT03473743|537747237|FG007|Overall Study|Other|0|||
149072385|NCT03473743|537747230|FG000|Overall Study|Ongoing|0|||
149072386|NCT03473743|537747231|FG001|Overall Study|Ongoing|0|||
149072387|NCT03473743|537747232|FG002|Overall Study|Ongoing|6|||
149072388|NCT03473743|537747233|FG003|Overall Study|Ongoing|8|||
149072389|NCT03473743|537747234|FG004|Overall Study|Ongoing|1|||
149072390|NCT03473743|537747235|FG005|Overall Study|Ongoing|1|||
149072391|NCT03473743|537747236|FG006|Overall Study|Ongoing|22|||
149072392|NCT03473743|537747237|FG007|Overall Study|Ongoing|24|||
149072393|NCT03473743|537747230|FG000|Overall Study|Randomized but not treated|0|||
149072394|NCT03473743|537747231|FG001|Overall Study|Randomized but not treated|0|||
149072395|NCT03473743|537747232|FG002|Overall Study|Randomized but not treated|0|||
149072396|NCT03473743|537747233|FG003|Overall Study|Randomized but not treated|0|||
149072397|NCT03473743|537747234|FG004|Overall Study|Randomized but not treated|0|||
149072398|NCT03473743|537747235|FG005|Overall Study|Randomized but not treated|0|||
149072399|NCT03473743|537747236|FG006|Overall Study|Randomized but not treated|1|||
149072400|NCT03473743|537747237|FG007|Overall Study|Randomized but not treated|1|||
149072401|NCT00980954|537747238|FG000|Overall Study|Protocol Violation|9|||
149072402|NCT00980954|537747239|FG001|Overall Study|Protocol Violation|15|||
149072403|NCT03304587|537747243|FG000|Overall Study|Headache after intervention|0|||
149072404|NCT03304587|537747244|FG001|Overall Study|Headache after intervention|1|||
149072405|NCT03304587|537747243|FG000|Overall Study|Withdrawal by Subject|1|||
149072406|NCT03304587|537747244|FG001|Overall Study|Withdrawal by Subject|0|||
149072407|NCT01458366|537747248|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
149072408|NCT01458366|537747249|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
149120223|NCT04602221|537918072|FG015|Overall Study|Other than listed|1|||
149072409|NCT01458366|537747250|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
149072410|NCT01458366|537747251|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
149072411|NCT01458366|537747252|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
149072412|NCT01458366|537747248|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
149072413|NCT01458366|537747249|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
149072414|NCT01458366|537747250|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
149072415|NCT01458366|537747251|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
149072416|NCT01458366|537747252|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
149072417|NCT04647487|537747255|FG000|Overall Study|Protocol Deviation|0|||
149072418|NCT04647487|537747256|FG001|Overall Study|Protocol Deviation|0|||
149072419|NCT04647487|537747257|FG002|Overall Study|Protocol Deviation|1|||
149072420|NCT04647487|537747255|FG000|Overall Study|Withdrawal by Subject|1|||
149072421|NCT04647487|537747256|FG001|Overall Study|Withdrawal by Subject|0|||
149072422|NCT04647487|537747257|FG002|Overall Study|Withdrawal by Subject|2|||
149072423|NCT05580003|537747258|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072424|NCT05580003|537747259|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072425|NCT05580003|537747260|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072426|NCT05580003|537747261|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072427|NCT05580003|537747262|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072428|NCT05580003|537747263|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072429|NCT05580003|537747264|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
149072430|NCT05580003|537747265|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072431|NCT05580003|537747266|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072432|NCT05580003|537747267|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072433|NCT05580003|537747268|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072434|NCT05580003|537747269|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072435|NCT05580003|537747270|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072436|NCT05580003|537747271|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072437|NCT05580003|537747272|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072438|NCT05580003|537747273|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072439|NCT05580003|537747274|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072440|NCT05580003|537747275|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072441|NCT05580003|537747276|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072442|NCT05580003|537747277|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072443|NCT05580003|537747278|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072444|NCT05580003|537747279|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072445|NCT05580003|537747280|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072446|NCT05580003|537747281|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072447|NCT05580003|537747282|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072448|NCT05580003|537747283|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072449|NCT05580003|537747284|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072450|NCT05580003|537747285|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
149072451|NCT05580003|537747258|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072452|NCT05580003|537747259|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072453|NCT05580003|537747260|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072454|NCT05580003|537747261|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072455|NCT05580003|537747262|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072456|NCT05580003|537747263|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
149072457|NCT05580003|537747264|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072458|NCT05580003|537747265|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072459|NCT05580003|537747266|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072460|NCT05580003|537747267|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072461|NCT05580003|537747268|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072462|NCT05580003|537747269|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072463|NCT05580003|537747270|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072464|NCT05580003|537747271|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072465|NCT05580003|537747272|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072466|NCT05580003|537747273|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072467|NCT05580003|537747274|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072468|NCT05580003|537747275|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072469|NCT05580003|537747276|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072470|NCT05580003|537747277|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072471|NCT05580003|537747278|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072472|NCT05580003|537747279|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072473|NCT05580003|537747280|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072474|NCT05580003|537747281|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072475|NCT05580003|537747282|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072476|NCT05580003|537747283|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072477|NCT05580003|537747284|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072478|NCT05580003|537747285|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
149072479|NCT05580003|537747258|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072480|NCT05580003|537747259|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072481|NCT05580003|537747260|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072482|NCT05580003|537747261|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
149072483|NCT05580003|537747262|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072484|NCT05580003|537747263|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072485|NCT05580003|537747264|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072486|NCT05580003|537747265|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072487|NCT05580003|537747266|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072488|NCT05580003|537747267|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072489|NCT05580003|537747268|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072490|NCT05580003|537747269|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072491|NCT05580003|537747270|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072492|NCT05580003|537747271|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072493|NCT05580003|537747272|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072494|NCT05580003|537747273|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072495|NCT05580003|537747274|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072496|NCT05580003|537747275|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072497|NCT05580003|537747276|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072498|NCT05580003|537747277|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072499|NCT05580003|537747278|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072500|NCT05580003|537747279|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072501|NCT05580003|537747280|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072502|NCT05580003|537747281|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072503|NCT05580003|537747282|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072504|NCT05580003|537747283|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072505|NCT05580003|537747284|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072506|NCT05580003|537747285|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
149072507|NCT05580003|537747258|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072508|NCT05580003|537747259|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
149072509|NCT05580003|537747260|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072510|NCT05580003|537747261|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072511|NCT05580003|537747262|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072512|NCT05580003|537747263|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072513|NCT05580003|537747264|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072514|NCT05580003|537747265|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072515|NCT05580003|537747266|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072516|NCT05580003|537747267|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072517|NCT05580003|537747268|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072518|NCT05580003|537747269|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072519|NCT05580003|537747270|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072520|NCT05580003|537747271|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072521|NCT05580003|537747272|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072522|NCT05580003|537747273|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072523|NCT05580003|537747274|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072524|NCT05580003|537747275|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072525|NCT05580003|537747276|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072526|NCT05580003|537747277|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072527|NCT05580003|537747278|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072528|NCT05580003|537747279|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072529|NCT05580003|537747280|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072530|NCT05580003|537747281|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072531|NCT05580003|537747282|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072532|NCT05580003|537747283|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072533|NCT05580003|537747284|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072534|NCT05580003|537747285|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
149072535|NCT05580003|537747258|FG000|Part 2 (up to 10 Days)|Other|0|||
149072536|NCT05580003|537747259|FG001|Part 2 (up to 10 Days)|Other|0|||
149072537|NCT05580003|537747260|FG002|Part 2 (up to 10 Days)|Other|0|||
149072538|NCT05580003|537747261|FG003|Part 2 (up to 10 Days)|Other|0|||
149072539|NCT05580003|537747262|FG004|Part 2 (up to 10 Days)|Other|0|||
149072540|NCT05580003|537747263|FG005|Part 2 (up to 10 Days)|Other|0|||
149072541|NCT05580003|537747264|FG006|Part 2 (up to 10 Days)|Other|0|||
149072542|NCT05580003|537747265|FG007|Part 2 (up to 10 Days)|Other|0|||
149072543|NCT05580003|537747266|FG008|Part 2 (up to 10 Days)|Other|0|||
149072544|NCT05580003|537747267|FG009|Part 2 (up to 10 Days)|Other|1|||
149072545|NCT05580003|537747268|FG010|Part 2 (up to 10 Days)|Other|0|||
149072546|NCT05580003|537747269|FG011|Part 2 (up to 10 Days)|Other|0|||
149072547|NCT05580003|537747270|FG012|Part 2 (up to 10 Days)|Other|0|||
149072548|NCT05580003|537747271|FG013|Part 2 (up to 10 Days)|Other|0|||
149072549|NCT05580003|537747272|FG014|Part 2 (up to 10 Days)|Other|0|||
149072550|NCT05580003|537747273|FG015|Part 2 (up to 10 Days)|Other|0|||
149072551|NCT05580003|537747274|FG016|Part 2 (up to 10 Days)|Other|0|||
149072552|NCT05580003|537747275|FG017|Part 2 (up to 10 Days)|Other|0|||
149072553|NCT05580003|537747276|FG018|Part 2 (up to 10 Days)|Other|0|||
149072554|NCT05580003|537747277|FG019|Part 2 (up to 10 Days)|Other|0|||
149072555|NCT05580003|537747278|FG020|Part 2 (up to 10 Days)|Other|0|||
149072556|NCT05580003|537747279|FG021|Part 2 (up to 10 Days)|Other|0|||
149072557|NCT05580003|537747280|FG022|Part 2 (up to 10 Days)|Other|0|||
149072558|NCT05580003|537747281|FG023|Part 2 (up to 10 Days)|Other|0|||
149072559|NCT05580003|537747282|FG024|Part 2 (up to 10 Days)|Other|0|||
149072560|NCT05580003|537747283|FG025|Part 2 (up to 10 Days)|Other|0|||
149072561|NCT05580003|537747284|FG026|Part 2 (up to 10 Days)|Other|0|||
149072562|NCT05580003|537747285|FG027|Part 2 (up to 10 Days)|Other|0|||
149072563|NCT05580003|537747258|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072564|NCT05580003|537747259|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072565|NCT05580003|537747260|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072566|NCT05580003|537747261|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072567|NCT05580003|537747262|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072568|NCT05580003|537747263|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072569|NCT05580003|537747264|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072570|NCT05580003|537747265|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072571|NCT05580003|537747266|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072572|NCT05580003|537747267|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072573|NCT05580003|537747268|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072574|NCT05580003|537747269|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072575|NCT05580003|537747270|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072576|NCT05580003|537747271|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072577|NCT05580003|537747272|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072578|NCT05580003|537747273|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072579|NCT05580003|537747274|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072580|NCT05580003|537747275|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072581|NCT05580003|537747276|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072582|NCT05580003|537747277|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
149072583|NCT05580003|537747278|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072584|NCT05580003|537747279|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072585|NCT05580003|537747280|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072586|NCT05580003|537747281|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072587|NCT05580003|537747282|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072588|NCT05580003|537747283|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072589|NCT05580003|537747284|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072590|NCT05580003|537747285|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
149072591|NCT05580003|537747258|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072592|NCT05580003|537747259|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072593|NCT05580003|537747260|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072594|NCT05580003|537747261|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072595|NCT05580003|537747262|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072596|NCT05580003|537747263|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072597|NCT05580003|537747264|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072598|NCT05580003|537747265|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072599|NCT05580003|537747266|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072600|NCT05580003|537747267|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072601|NCT05580003|537747268|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072602|NCT05580003|537747269|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072603|NCT05580003|537747270|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072604|NCT05580003|537747271|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072605|NCT05580003|537747272|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072606|NCT05580003|537747273|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072607|NCT05580003|537747274|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072608|NCT05580003|537747275|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072609|NCT05580003|537747276|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072610|NCT05580003|537747277|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072611|NCT05580003|537747278|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
149072612|NCT05580003|537747279|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072613|NCT05580003|537747280|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072614|NCT05580003|537747281|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072615|NCT05580003|537747282|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072616|NCT05580003|537747283|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072617|NCT05580003|537747284|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072618|NCT05580003|537747285|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
149072619|NCT05580003|537747258|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072620|NCT05580003|537747259|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072621|NCT05580003|537747260|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072622|NCT05580003|537747261|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072623|NCT05580003|537747262|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072624|NCT05580003|537747263|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072625|NCT05580003|537747264|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072626|NCT05580003|537747265|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072627|NCT05580003|537747266|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072628|NCT05580003|537747267|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072629|NCT05580003|537747268|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072630|NCT05580003|537747269|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072631|NCT05580003|537747270|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072632|NCT05580003|537747271|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072633|NCT05580003|537747272|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072634|NCT05580003|537747273|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072635|NCT05580003|537747274|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072636|NCT05580003|537747275|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072637|NCT05580003|537747276|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072638|NCT05580003|537747277|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072639|NCT05580003|537747278|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072640|NCT05580003|537747279|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
149072641|NCT05580003|537747280|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072642|NCT05580003|537747281|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072643|NCT05580003|537747282|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072644|NCT05580003|537747283|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072645|NCT05580003|537747284|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072646|NCT05580003|537747285|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
149072647|NCT05580003|537747258|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072648|NCT05580003|537747259|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072649|NCT05580003|537747260|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072650|NCT05580003|537747261|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072651|NCT05580003|537747262|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072652|NCT05580003|537747263|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072653|NCT05580003|537747264|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072654|NCT05580003|537747265|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072655|NCT05580003|537747266|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072656|NCT05580003|537747267|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072657|NCT05580003|537747268|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072658|NCT05580003|537747269|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072659|NCT05580003|537747270|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072660|NCT05580003|537747271|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072661|NCT05580003|537747272|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072662|NCT05580003|537747273|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072663|NCT05580003|537747274|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072664|NCT05580003|537747275|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072665|NCT05580003|537747276|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072666|NCT05580003|537747277|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072667|NCT05580003|537747278|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072668|NCT05580003|537747279|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072669|NCT05580003|537747280|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072670|NCT05580003|537747281|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072671|NCT05580003|537747282|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072672|NCT05580003|537747283|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072673|NCT05580003|537747284|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
149072674|NCT05580003|537747285|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
149072675|NCT05580003|537747258|FG000|Part 6 Period 2 (Day 1)|Other|0|||
149072676|NCT05580003|537747259|FG001|Part 6 Period 2 (Day 1)|Other|0|||
149072677|NCT05580003|537747260|FG002|Part 6 Period 2 (Day 1)|Other|0|||
149072678|NCT05580003|537747261|FG003|Part 6 Period 2 (Day 1)|Other|0|||
149072679|NCT05580003|537747262|FG004|Part 6 Period 2 (Day 1)|Other|0|||
149072680|NCT05580003|537747263|FG005|Part 6 Period 2 (Day 1)|Other|0|||
149072681|NCT05580003|537747264|FG006|Part 6 Period 2 (Day 1)|Other|0|||
149072682|NCT05580003|537747265|FG007|Part 6 Period 2 (Day 1)|Other|0|||
149072683|NCT05580003|537747266|FG008|Part 6 Period 2 (Day 1)|Other|0|||
149072684|NCT05580003|537747267|FG009|Part 6 Period 2 (Day 1)|Other|0|||
149072685|NCT05580003|537747268|FG010|Part 6 Period 2 (Day 1)|Other|0|||
149072686|NCT05580003|537747269|FG011|Part 6 Period 2 (Day 1)|Other|0|||
149072687|NCT05580003|537747270|FG012|Part 6 Period 2 (Day 1)|Other|0|||
149072688|NCT05580003|537747271|FG013|Part 6 Period 2 (Day 1)|Other|0|||
149072689|NCT05580003|537747272|FG014|Part 6 Period 2 (Day 1)|Other|0|||
149072690|NCT05580003|537747273|FG015|Part 6 Period 2 (Day 1)|Other|0|||
149072691|NCT05580003|537747274|FG016|Part 6 Period 2 (Day 1)|Other|0|||
149072692|NCT05580003|537747275|FG017|Part 6 Period 2 (Day 1)|Other|0|||
149072693|NCT05580003|537747276|FG018|Part 6 Period 2 (Day 1)|Other|0|||
149072694|NCT05580003|537747277|FG019|Part 6 Period 2 (Day 1)|Other|0|||
149072695|NCT05580003|537747278|FG020|Part 6 Period 2 (Day 1)|Other|0|||
149072696|NCT05580003|537747279|FG021|Part 6 Period 2 (Day 1)|Other|0|||
149072697|NCT05580003|537747280|FG022|Part 6 Period 2 (Day 1)|Other|0|||
149072698|NCT05580003|537747281|FG023|Part 6 Period 2 (Day 1)|Other|0|||
149072699|NCT05580003|537747282|FG024|Part 6 Period 2 (Day 1)|Other|1|||
149072700|NCT05580003|537747283|FG025|Part 6 Period 2 (Day 1)|Other|0|||
149072701|NCT05580003|537747284|FG026|Part 6 Period 2 (Day 1)|Other|0|||
149072702|NCT05580003|537747285|FG027|Part 6 Period 2 (Day 1)|Other|0|||
149072703|NCT01753999|537747286|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
149072704|NCT01753999|537747287|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
149072705|NCT01753999|537747286|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
149072706|NCT01753999|537747287|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
149072707|NCT01753999|537747286|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
149072708|NCT01753999|537747287|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
149072709|NCT01753999|537747286|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
149072710|NCT01753999|537747287|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
149072711|NCT01753999|537747286|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
149072712|NCT01753999|537747287|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
149072713|NCT01753999|537747286|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
149072714|NCT01753999|537747287|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
149072715|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
149072716|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
149072717|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
149072718|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
149072719|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
149072720|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
149072721|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
149072722|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
149072723|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
149072724|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
149072725|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
149072726|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
149072727|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149072728|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149072729|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149072730|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149072731|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
149072732|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
149072733|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
149072734|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
149072735|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
149072736|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
149072737|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
149072738|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
149072739|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
149072740|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
149072741|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
149072742|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
149072743|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
149072744|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
149072745|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
149072746|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
149072747|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
149072748|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
149072749|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
149072750|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
149072751|NCT02392234|537747288|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
149072752|NCT02392234|537747289|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
149072753|NCT02392234|537747290|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
149072754|NCT02392234|537747291|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
149072755|NCT02392234|537747292|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
149072756|NCT02392234|537747293|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
149072757|NCT02392234|537747288|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
149072758|NCT02392234|537747289|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
149072759|NCT02392234|537747290|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
149072760|NCT02392234|537747291|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
149072761|NCT02392234|537747292|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
149072762|NCT02392234|537747293|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
149072763|NCT02029235|537747294|FG000|Overall Study|Non-compliance with study meds or diary|4|||
149072764|NCT02029235|537747295|FG001|Overall Study|Non-compliance with study meds or diary|1|||
149072765|NCT01387516|537747296|FG000|Overall Study|Lost to Follow-up|4|||
149072766|NCT01387516|537747297|FG001|Overall Study|Lost to Follow-up|4|||
149072767|NCT01387516|537747298|FG002|Overall Study|Lost to Follow-up|2|||
149072768|NCT01387516|537747299|FG003|Overall Study|Lost to Follow-up|3|||
149072769|NCT01387516|537747296|FG000|Overall Study|Withdrawal by Subject|1|||
149072770|NCT01387516|537747297|FG001|Overall Study|Withdrawal by Subject|1|||
149072771|NCT01387516|537747298|FG002|Overall Study|Withdrawal by Subject|2|||
149072772|NCT01387516|537747299|FG003|Overall Study|Withdrawal by Subject|0|||
149072773|NCT01387516|537747296|FG000|Overall Study|Death|0|||
149072774|NCT01387516|537747297|FG001|Overall Study|Death|0|||
149072775|NCT01387516|537747298|FG002|Overall Study|Death|0|||
149072776|NCT01387516|537747299|FG003|Overall Study|Death|1|||
149072777|NCT04436289|537747302|FG000|Overall Study|Death prior to hospital discharge|8|||
149072778|NCT04436289|537747303|FG001|Overall Study|Death prior to hospital discharge|5|||
149072779|NCT04436289|537747304|FG002|Overall Study|Death prior to hospital discharge|0|||
149072780|NCT04436289|537747305|FG003|Overall Study|Death prior to hospital discharge|1|||
149072781|NCT04436289|537747302|FG000|Overall Study|Withdrawal by Subject|0|||
149072782|NCT04436289|537747303|FG001|Overall Study|Withdrawal by Subject|1|||
149072783|NCT04436289|537747304|FG002|Overall Study|Withdrawal by Subject|4|||
149072784|NCT04436289|537747305|FG003|Overall Study|Withdrawal by Subject|0|||
149072785|NCT04436289|537747302|FG000|Overall Study|Extended hospital stay|0|||
149072786|NCT04436289|537747303|FG001|Overall Study|Extended hospital stay|1|||
149072787|NCT04436289|537747304|FG002|Overall Study|Extended hospital stay|0|||
149072788|NCT04436289|537747305|FG003|Overall Study|Extended hospital stay|0|||
149072789|NCT04436289|537747302|FG000|Overall Study|Lost to Follow-up|0|||
149072790|NCT04436289|537747303|FG001|Overall Study|Lost to Follow-up|4|||
149072791|NCT04436289|537747304|FG002|Overall Study|Lost to Follow-up|1|||
149072792|NCT04436289|537747305|FG003|Overall Study|Lost to Follow-up|3|||
149072793|NCT02130557|537747306|FG000|Overall Study|Withdrawal by Subject|12|||
149072794|NCT02130557|537747307|FG001|Overall Study|Withdrawal by Subject|12|||
149072795|NCT02130557|537747306|FG000|Overall Study|Investigator Request|0|||
149072796|NCT02130557|537747307|FG001|Overall Study|Investigator Request|2|||
149072797|NCT02130557|537747306|FG000|Overall Study|Deceased|14|||
149072798|NCT02130557|537747307|FG001|Overall Study|Deceased|14|||
149072799|NCT02130557|537747306|FG000|Overall Study|Lost to Follow-up|6|||
149072800|NCT02130557|537747307|FG001|Overall Study|Lost to Follow-up|7|||
149072801|NCT02130557|537747306|FG000|Overall Study|Other|2|||
149072802|NCT02130557|537747307|FG001|Overall Study|Other|1|||
149072803|NCT02130557|537747306|FG000|Overall Study|Missing|2|||
149072804|NCT02130557|537747307|FG001|Overall Study|Missing|1|||
149072805|NCT00309166|537747308|FG000|Overall Study|Adverse event, non-fatal|1|||
149072806|NCT00309166|537747309|FG001|Overall Study|Adverse event, non-fatal|0|||
149072807|NCT00309166|537747308|FG000|Overall Study|Withdrawal by Subject|4|||
149072808|NCT00309166|537747309|FG001|Overall Study|Withdrawal by Subject|3|||
149072809|NCT03280030|537747310|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
149072810|NCT03280030|537747311|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
149072811|NCT03280030|537747312|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
149072812|NCT03280030|537747310|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
149072813|NCT03280030|537747311|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
149072814|NCT03280030|537747312|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
149072815|NCT03280030|537747310|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
149072816|NCT03280030|537747311|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
149072817|NCT03280030|537747312|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
149072818|NCT03280030|537747310|FG000|Part 2 - Efficacy|Adverse Event|0|||
149072819|NCT03280030|537747311|FG001|Part 2 - Efficacy|Adverse Event|4|||
149072820|NCT03280030|537747312|FG002|Part 2 - Efficacy|Adverse Event|6|||
149072821|NCT03280030|537747310|FG000|Part 2 - Efficacy|Death|0|||
149072822|NCT03280030|537747311|FG001|Part 2 - Efficacy|Death|3|||
149072823|NCT03280030|537747312|FG002|Part 2 - Efficacy|Death|0|||
149072824|NCT03280030|537747310|FG000|Part 2 - Efficacy|Physician Decision|0|||
149072825|NCT03280030|537747311|FG001|Part 2 - Efficacy|Physician Decision|10|||
149072826|NCT03280030|537747312|FG002|Part 2 - Efficacy|Physician Decision|16|||
149072827|NCT03280030|537747310|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
149072828|NCT03280030|537747311|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
149072829|NCT03280030|537747312|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
149072830|NCT03280030|537747310|FG000|Part 2 - Efficacy|Progressive disease|0|||
149072831|NCT03280030|537747311|FG001|Part 2 - Efficacy|Progressive disease|7|||
149072832|NCT03280030|537747312|FG002|Part 2 - Efficacy|Progressive disease|5|||
149072833|NCT06191679|537747313|FG000|Baseline|Lost to Follow-up|1|||
149072834|NCT06191679|537747314|FG001|Baseline|Lost to Follow-up|0|||
149072835|NCT06191679|537747315|FG002|Baseline|Lost to Follow-up|1|||
149072836|NCT06191679|537747316|FG003|Baseline|Lost to Follow-up|0|||
149072837|NCT06191679|537747313|FG000|Allocation to Group|Withdrawal by Subject|0|||
149072838|NCT06191679|537747314|FG001|Allocation to Group|Withdrawal by Subject|1|||
149072839|NCT06191679|537747315|FG002|Allocation to Group|Withdrawal by Subject|2|||
149072840|NCT06191679|537747316|FG003|Allocation to Group|Withdrawal by Subject|0|||
149072841|NCT06191679|537747313|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
149072842|NCT06191679|537747314|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
149072843|NCT06191679|537747315|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
149072844|NCT06191679|537747316|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
149072845|NCT06191679|537747313|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
149072846|NCT06191679|537747314|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
149072847|NCT06191679|537747315|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
149072848|NCT06191679|537747316|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
149072849|NCT06191679|537747313|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
149072850|NCT06191679|537747314|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
149072851|NCT06191679|537747315|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
149072852|NCT06191679|537747316|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
149072853|NCT05786612|537747318|FG000|Overall Study|Adverse Event|1|||
149072854|NCT05786612|537747319|FG001|Overall Study|Adverse Event|2|||
149072855|NCT05786612|537747318|FG000|Overall Study|one screening failure|0|||
149072856|NCT05786612|537747319|FG001|Overall Study|one screening failure|2|||
149072857|NCT03277989|537747325|FG000|Overall Study|Lost to Follow-up|6|||
149072858|NCT03277989|537747325|FG000|Overall Study|Adverse Event|6|||
149072859|NCT03277989|537747325|FG000|Overall Study|Withdrawal by Subject|3|||
149072860|NCT03277989|537747325|FG000|Overall Study|Didn't Receive Study Device|7|||
149072861|NCT03277989|537747325|FG000|Overall Study|Site Closure|26|||
149072862|NCT03277989|537747325|FG000|Overall Study|Sponsor Closure|107|||
149072863|NCT06056310|537748557|FG000|Overall Study|Other Reasons|2|||
149072864|NCT06056310|537748557|FG000|Overall Study|Sponsor Request|16|||
149072865|NCT02702843|537748559|FG000|Overall Study|Insufficient data to analyze|15|||
149072866|NCT02702843|537748560|FG001|Overall Study|Insufficient data to analyze|23|||
149072867|NCT01171898|537748563|FG000|Overall Study|Death|0|||
149072868|NCT01171898|537748564|FG001|Overall Study|Death|0|||
149072869|NCT01171898|537748565|FG002|Overall Study|Death|2|||
149072870|NCT01171898|537748566|FG003|Overall Study|Death|0|||
149072871|NCT01171898|537748563|FG000|Overall Study|Lost to Follow-up|0|||
149072872|NCT01171898|537748564|FG001|Overall Study|Lost to Follow-up|1|||
149072873|NCT01171898|537748565|FG002|Overall Study|Lost to Follow-up|1|||
149072874|NCT01171898|537748566|FG003|Overall Study|Lost to Follow-up|1|||
149072875|NCT01171898|537748563|FG000|Overall Study|Withdrawal by Subject|1|||
149072876|NCT01171898|537748564|FG001|Overall Study|Withdrawal by Subject|4|||
149072877|NCT01171898|537748565|FG002|Overall Study|Withdrawal by Subject|6|||
149072878|NCT01171898|537748566|FG003|Overall Study|Withdrawal by Subject|3|||
149072879|NCT01171898|537748563|FG000|Overall Study|Terminated by Sponsor|1|||
149072880|NCT01171898|537748564|FG001|Overall Study|Terminated by Sponsor|0|||
149072881|NCT01171898|537748565|FG002|Overall Study|Terminated by Sponsor|0|||
149072882|NCT01171898|537748566|FG003|Overall Study|Terminated by Sponsor|0|||
149072883|NCT01171898|537748563|FG000|Overall Study|Ongoing|1|||
149072884|NCT01171898|537748564|FG001|Overall Study|Ongoing|9|||
149072885|NCT01171898|537748565|FG002|Overall Study|Ongoing|3|||
149072886|NCT01171898|537748566|FG003|Overall Study|Ongoing|0|||
149072887|NCT01171898|537748563|FG000|Overall Study|Other|1|||
149072888|NCT01171898|537748564|FG001|Overall Study|Other|5|||
149072889|NCT01171898|537748565|FG002|Overall Study|Other|0|||
149072890|NCT01171898|537748566|FG003|Overall Study|Other|2|||
149072891|NCT05802173|537748567|FG000|Overall Study|Withdrawal by Subject|2|||
149072892|NCT05802173|537748568|FG001|Overall Study|Withdrawal by Subject|0|||
149072893|NCT05802173|537748569|FG002|Overall Study|Withdrawal by Subject|0|||
149072894|NCT05802173|537748567|FG000|Overall Study|Protocol Violation|1|||
149072895|NCT05802173|537748568|FG001|Overall Study|Protocol Violation|0|||
149072896|NCT05802173|537748569|FG002|Overall Study|Protocol Violation|0|||
149072897|NCT05802173|537748567|FG000|Overall Study|Lost to Follow-up|0|||
149072898|NCT05802173|537748568|FG001|Overall Study|Lost to Follow-up|6|||
149072899|NCT05802173|537748569|FG002|Overall Study|Lost to Follow-up|4|||
149072900|NCT05802173|537748567|FG000|Overall Study|non-compliance|0|||
149072901|NCT05802173|537748568|FG001|Overall Study|non-compliance|1|||
149072902|NCT05802173|537748569|FG002|Overall Study|non-compliance|0|||
149072903|NCT02932410|537748570|FG000|Overall Study|Death|7|||
149072904|NCT02932410|537748571|FG001|Overall Study|Death|6|||
149072905|NCT02932410|537748572|FG002|Overall Study|Death|0|||
149072906|NCT02932410|537748573|FG003|Overall Study|Death|0|||
149072907|NCT02932410|537748570|FG000|Overall Study|Lost to Follow-up|1|||
149072908|NCT02932410|537748571|FG001|Overall Study|Lost to Follow-up|2|||
149072909|NCT02932410|537748572|FG002|Overall Study|Lost to Follow-up|0|||
149072910|NCT02932410|537748573|FG003|Overall Study|Lost to Follow-up|0|||
149072911|NCT02932410|537748570|FG000|Overall Study|Parent/Subjects decision|6|||
149072912|NCT02932410|537748571|FG001|Overall Study|Parent/Subjects decision|6|||
149072913|NCT02932410|537748572|FG002|Overall Study|Parent/Subjects decision|1|||
149072914|NCT02932410|537748573|FG003|Overall Study|Parent/Subjects decision|0|||
149072915|NCT02932410|537748570|FG000|Overall Study|Physician Decision|0|||
149072916|NCT02932410|537748571|FG001|Overall Study|Physician Decision|1|||
149072917|NCT02932410|537748572|FG002|Overall Study|Physician Decision|0|||
149072918|NCT02932410|537748573|FG003|Overall Study|Physician Decision|0|||
149072919|NCT00360269|537748574|FG000|Overall Study|Lost to Follow-up|7|||
149072920|NCT00360269|537748575|FG001|Overall Study|Lost to Follow-up|9|||
149072921|NCT00360269|537748574|FG000|Overall Study|Physician Decision|1|||
149072922|NCT00360269|537748575|FG001|Overall Study|Physician Decision|2|||
149072923|NCT00360269|537748574|FG000|Overall Study|Adverse Event|1|||
149072924|NCT00360269|537748575|FG001|Overall Study|Adverse Event|0|||
149072925|NCT00360269|537748574|FG000|Overall Study|Withdrawal by Subject|1|||
149072926|NCT00360269|537748575|FG001|Overall Study|Withdrawal by Subject|1|||
149072927|NCT00048932|537748578|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
149072928|NCT00048932|537748579|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
149072929|NCT00048932|537748580|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
149072930|NCT00048932|537748578|FG000|Double Blind Period (DB)|Adverse Event|51|||
149072931|NCT00048932|537748579|FG001|Double Blind Period (DB)|Adverse Event|19|||
149072932|NCT00048932|537748580|FG002|Double Blind Period (DB)|Adverse Event|0|||
149072933|NCT00048932|537748578|FG000|Double Blind Period (DB)|Death|5|||
149072934|NCT00048932|537748579|FG001|Double Blind Period (DB)|Death|3|||
149072935|NCT00048932|537748580|FG002|Double Blind Period (DB)|Death|0|||
149072936|NCT00048932|537748578|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
149072937|NCT00048932|537748579|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
149072938|NCT00048932|537748580|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
149072939|NCT00048932|537748578|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
149072940|NCT00048932|537748579|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
149072941|NCT00048932|537748580|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
149072942|NCT00048932|537748578|FG000|Double Blind Period (DB)|Relocation|1|||
149072943|NCT00048932|537748579|FG001|Double Blind Period (DB)|Relocation|0|||
149072944|NCT00048932|537748580|FG002|Double Blind Period (DB)|Relocation|0|||
149072945|NCT00048932|537748578|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
149072946|NCT00048932|537748579|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
149072947|NCT00048932|537748580|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
149072948|NCT00048932|537748578|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
149072949|NCT00048932|537748579|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
149072950|NCT00048932|537748580|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
149072951|NCT00048932|537748578|FG000|Double Blind Period (DB)|Pregnancy|1|||
149072952|NCT00048932|537748579|FG001|Double Blind Period (DB)|Pregnancy|0|||
149072953|NCT00048932|537748580|FG002|Double Blind Period (DB)|Pregnancy|0|||
149072954|NCT00048932|537748578|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
149072955|NCT00048932|537748579|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
149072956|NCT00048932|537748580|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
149072957|NCT00048932|537748578|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
149072958|NCT00048932|537748579|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
149072959|NCT00048932|537748580|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
149072960|NCT00048932|537748578|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
149072961|NCT00048932|537748579|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
149072962|NCT00048932|537748580|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
149072963|NCT00048932|537748578|FG000|Open Label Period (OL)|Death|0|||
149072964|NCT00048932|537748579|FG001|Open Label Period (OL)|Death|0|||
149072965|NCT00048932|537748580|FG002|Open Label Period (OL)|Death|25|||
149072966|NCT00048932|537748578|FG000|Open Label Period (OL)|Adverse Event|0|||
149072967|NCT00048932|537748579|FG001|Open Label Period (OL)|Adverse Event|0|||
149072968|NCT00048932|537748580|FG002|Open Label Period (OL)|Adverse Event|103|||
149072969|NCT00048932|537748578|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
149072970|NCT00048932|537748579|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
149006204|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
149006205|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
149006206|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
149006207|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
149006208|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
149006209|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
149006210|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Death|0|||
149006211|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Death|0|||
149006212|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Death|4|||
149072971|NCT00048932|537748580|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
149072972|NCT00048932|537748578|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
149072973|NCT00048932|537748579|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
149072974|NCT00048932|537748580|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
149072975|NCT00048932|537748578|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
149072976|NCT00048932|537748579|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
149072977|NCT00048932|537748580|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
149072978|NCT00048932|537748578|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
149072979|NCT00048932|537748579|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
149072980|NCT00048932|537748580|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
149072981|NCT00048932|537748578|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
149072982|NCT00048932|537748579|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
149072983|NCT00048932|537748580|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
149072984|NCT00048932|537748578|FG000|Open Label Period (OL)|Pregnancy|0|||
149072985|NCT00048932|537748579|FG001|Open Label Period (OL)|Pregnancy|0|||
149072986|NCT00048932|537748580|FG002|Open Label Period (OL)|Pregnancy|6|||
149072987|NCT00048932|537748578|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
149072988|NCT00048932|537748579|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
149072989|NCT00048932|537748580|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
149072990|NCT00048932|537748578|FG000|Open Label Period (OL)|Investigator Retiring|0|||
149072991|NCT00048932|537748579|FG001|Open Label Period (OL)|Investigator Retiring|0|||
149072992|NCT00048932|537748580|FG002|Open Label Period (OL)|Investigator Retiring|2|||
149072993|NCT00048932|537748578|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
149072994|NCT00048932|537748579|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
149072995|NCT00048932|537748580|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
149072996|NCT00048932|537748578|FG000|Open Label Period (OL)|Participant Relocated|0|||
149072997|NCT00048932|537748579|FG001|Open Label Period (OL)|Participant Relocated|0|||
149072998|NCT00048932|537748580|FG002|Open Label Period (OL)|Participant Relocated|6|||
149072999|NCT00048932|537748578|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
149073000|NCT00048932|537748579|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
149073001|NCT00048932|537748580|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
149073002|NCT00048932|537748578|FG000|Open Label Period (OL)|Site Closure|0|||
149073003|NCT00048932|537748579|FG001|Open Label Period (OL)|Site Closure|0|||
149073004|NCT00048932|537748580|FG002|Open Label Period (OL)|Site Closure|3|||
149073005|NCT00048932|537748578|FG000|Open Label Period (OL)|Trial Terminated|0|||
149073006|NCT00048932|537748579|FG001|Open Label Period (OL)|Trial Terminated|0|||
149073007|NCT00048932|537748580|FG002|Open Label Period (OL)|Trial Terminated|1|||
149073008|NCT00048932|537748578|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
149073009|NCT00048932|537748579|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
149073010|NCT00048932|537748580|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
149073011|NCT00048932|537748578|FG000|Open Label Period (OL)|Patient Decision|0|||
149073012|NCT00048932|537748579|FG001|Open Label Period (OL)|Patient Decision|0|||
149073013|NCT00048932|537748580|FG002|Open Label Period (OL)|Patient Decision|4|||
149073014|NCT00048932|537748578|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
149073015|NCT00048932|537748579|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
149073016|NCT00048932|537748580|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
149073017|NCT00048932|537748578|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
149073018|NCT00048932|537748579|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
149073019|NCT00048932|537748580|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
149073020|NCT00048932|537748578|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
149073021|NCT00048932|537748579|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
149073022|NCT00048932|537748580|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
149073023|NCT00048932|537748578|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
149073024|NCT00048932|537748579|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
149073025|NCT00048932|537748580|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
149073026|NCT00048932|537748578|FG000|Open Label Period (OL)|Investigator Decision|0|||
149073027|NCT00048932|537748579|FG001|Open Label Period (OL)|Investigator Decision|0|||
149073028|NCT00048932|537748580|FG002|Open Label Period (OL)|Investigator Decision|4|||
149073029|NCT00048932|537748578|FG000|Open Label Period (OL)|Site Staff Issues|0|||
149073030|NCT00048932|537748579|FG001|Open Label Period (OL)|Site Staff Issues|0|||
149073031|NCT00048932|537748580|FG002|Open Label Period (OL)|Site Staff Issues|2|||
149073032|NCT00048932|537748578|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
149073033|NCT00048932|537748579|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
149073034|NCT00048932|537748580|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
149073035|NCT00048932|537748578|FG000|Open Label Period (OL)|Participant Surgery|0|||
149073036|NCT00048932|537748579|FG001|Open Label Period (OL)|Participant Surgery|0|||
149073037|NCT00048932|537748580|FG002|Open Label Period (OL)|Participant Surgery|1|||
149073038|NCT00754325|537748581|FG000|Initial Treatment|Continuing Active Treatment|4|||
149073039|NCT00754325|537748582|FG001|Initial Treatment|Continuing Active Treatment|5|||
149073040|NCT00754325|537748581|FG000|Initial Treatment|Adverse Event|7|||
149073041|NCT00754325|537748582|FG001|Initial Treatment|Adverse Event|6|||
149073042|NCT00754325|537748581|FG000|Initial Treatment|Withdrawal by Subject|2|||
149073043|NCT00754325|537748582|FG001|Initial Treatment|Withdrawal by Subject|2|||
149073044|NCT00754325|537748581|FG000|Initial Treatment|Physician Decision|2|||
149073045|NCT00754325|537748582|FG001|Initial Treatment|Physician Decision|0|||
149073046|NCT00754325|537748581|FG000|Initial Treatment|Sponsor Request|0|||
149073047|NCT00754325|537748582|FG001|Initial Treatment|Sponsor Request|1|||
149073048|NCT00754325|537748581|FG000|Initial Treatment|Disease Progression|35|||
149073049|NCT00754325|537748582|FG001|Initial Treatment|Disease Progression|35|||
149073050|NCT03451422|537748583|FG000|Overall Study|Lost to Follow-up|0|||
149073051|NCT03451422|537748584|FG001|Overall Study|Lost to Follow-up|0|||
149073052|NCT03451422|537748585|FG002|Overall Study|Lost to Follow-up|0|||
149073053|NCT03451422|537748586|FG003|Overall Study|Lost to Follow-up|0|||
149073054|NCT03451422|537748587|FG004|Overall Study|Lost to Follow-up|0|||
149073055|NCT03451422|537748588|FG005|Overall Study|Lost to Follow-up|1|||
149073056|NCT03451422|537748583|FG000|Overall Study|Decision by sponsor|1|||
149073057|NCT03451422|537748584|FG001|Overall Study|Decision by sponsor|0|||
149073058|NCT03451422|537748585|FG002|Overall Study|Decision by sponsor|1|||
149073059|NCT03451422|537748586|FG003|Overall Study|Decision by sponsor|0|||
149073060|NCT03451422|537748587|FG004|Overall Study|Decision by sponsor|0|||
149073061|NCT03451422|537748588|FG005|Overall Study|Decision by sponsor|0|||
149073062|NCT03451422|537748583|FG000|Overall Study|Withdrawal by Subject|0|||
149073063|NCT03451422|537748584|FG001|Overall Study|Withdrawal by Subject|0|||
149073064|NCT03451422|537748585|FG002|Overall Study|Withdrawal by Subject|2|||
149073065|NCT03451422|537748586|FG003|Overall Study|Withdrawal by Subject|3|||
149073066|NCT03451422|537748587|FG004|Overall Study|Withdrawal by Subject|2|||
149073067|NCT03451422|537748588|FG005|Overall Study|Withdrawal by Subject|1|||
149073068|NCT00918333|537748589|FG000|Overall Study|Drug not taken per protocol|1|||
149073069|NCT00918333|537748590|FG001|Overall Study|Drug not taken per protocol|0|||
149073070|NCT00918333|537748589|FG000|Overall Study|Inadequate amount of drugs provided|1|||
149073071|NCT00918333|537748590|FG001|Overall Study|Inadequate amount of drugs provided|4|||
149073072|NCT00918333|537748589|FG000|Overall Study|Ineligible|1|||
149073073|NCT00918333|537748590|FG001|Overall Study|Ineligible|0|||
149073074|NCT00918333|537748589|FG000|Overall Study|Withdrawal by Subject|0|||
149073075|NCT00918333|537748590|FG001|Overall Study|Withdrawal by Subject|1|||
149073076|NCT00263757|537748591|FG000|Overall Study|Withdrawal by Subject|5|||
149073077|NCT00263757|537748592|FG001|Overall Study|Withdrawal by Subject|4|||
149073078|NCT00263757|537748591|FG000|Overall Study|Screen failure|0|||
149073079|NCT00263757|537748592|FG001|Overall Study|Screen failure|1|||
149073080|NCT00263757|537748591|FG000|Overall Study|Adverse Event|3|||
149073081|NCT00263757|537748592|FG001|Overall Study|Adverse Event|3|||
149073082|NCT00713596|537748593|FG000|Overall Study|Study was terminated|2|||
149073083|NCT00713596|537748594|FG001|Overall Study|Study was terminated|3|||
149073084|NCT00713596|537748595|FG002|Overall Study|Study was terminated|2|||
149073085|NCT04545619|537748596|FG000|Overall Study|due to equipment challenges|1|||
149073086|NCT04384172|537748597|FG000|Overall Study|Lost to Follow-up|0|||
149073087|NCT04384172|537748598|FG001|Overall Study|Lost to Follow-up|2|||
149073088|NCT04384172|537748597|FG000|Overall Study|Pregnancy|1|||
149073089|NCT04384172|537748598|FG001|Overall Study|Pregnancy|0|||
149073090|NCT04384172|537748597|FG000|Overall Study|Withdrawal by Subject|0|||
149073091|NCT04384172|537748598|FG001|Overall Study|Withdrawal by Subject|1|||
149073092|NCT01640951|537748599|FG000|Overall Study|Adverse Event|8|||
149073093|NCT01640951|537748600|FG001|Overall Study|Adverse Event|3|||
149073094|NCT01640951|537748601|FG002|Overall Study|Adverse Event|10|||
149073095|NCT01640951|537748602|FG003|Overall Study|Adverse Event|6|||
149073096|NCT01640951|537748603|FG004|Overall Study|Adverse Event|1|||
149073097|NCT01640951|537748604|FG005|Overall Study|Adverse Event|11|||
149073098|NCT01640951|537748605|FG006|Overall Study|Adverse Event|1|||
149073099|NCT01640951|537748606|FG007|Overall Study|Adverse Event|3|||
149073100|NCT01640951|537748599|FG000|Overall Study|Lack of Efficacy|20|||
149073101|NCT01640951|537748600|FG001|Overall Study|Lack of Efficacy|1|||
149073102|NCT01640951|537748601|FG002|Overall Study|Lack of Efficacy|7|||
149073103|NCT01640951|537748602|FG003|Overall Study|Lack of Efficacy|14|||
149073104|NCT01640951|537748603|FG004|Overall Study|Lack of Efficacy|0|||
149073105|NCT01640951|537748604|FG005|Overall Study|Lack of Efficacy|6|||
149073106|NCT01640951|537748605|FG006|Overall Study|Lack of Efficacy|5|||
149073107|NCT01640951|537748606|FG007|Overall Study|Lack of Efficacy|6|||
149073108|NCT01640951|537748599|FG000|Overall Study|Lost to Follow-up|1|||
149073109|NCT01640951|537748600|FG001|Overall Study|Lost to Follow-up|0|||
149073110|NCT01640951|537748601|FG002|Overall Study|Lost to Follow-up|6|||
149073111|NCT01640951|537748602|FG003|Overall Study|Lost to Follow-up|2|||
149073112|NCT01640951|537748603|FG004|Overall Study|Lost to Follow-up|2|||
149073113|NCT01640951|537748604|FG005|Overall Study|Lost to Follow-up|3|||
149073114|NCT01640951|537748605|FG006|Overall Study|Lost to Follow-up|1|||
149073115|NCT01640951|537748606|FG007|Overall Study|Lost to Follow-up|1|||
149073116|NCT01640951|537748599|FG000|Overall Study|Non-compliance with study treatment|0|||
149073117|NCT01640951|537748600|FG001|Overall Study|Non-compliance with study treatment|0|||
149073118|NCT01640951|537748601|FG002|Overall Study|Non-compliance with study treatment|1|||
149073119|NCT01640951|537748602|FG003|Overall Study|Non-compliance with study treatment|1|||
149073120|NCT01640951|537748603|FG004|Overall Study|Non-compliance with study treatment|1|||
149073121|NCT01640951|537748604|FG005|Overall Study|Non-compliance with study treatment|4|||
149073122|NCT01640951|537748605|FG006|Overall Study|Non-compliance with study treatment|1|||
149073123|NCT01640951|537748606|FG007|Overall Study|Non-compliance with study treatment|0|||
149073124|NCT01640951|537748599|FG000|Overall Study|Physician Decision|2|||
149073125|NCT01640951|537748600|FG001|Overall Study|Physician Decision|5|||
149073126|NCT01640951|537748601|FG002|Overall Study|Physician Decision|2|||
149073127|NCT01640951|537748602|FG003|Overall Study|Physician Decision|2|||
149073128|NCT01640951|537748603|FG004|Overall Study|Physician Decision|2|||
149073129|NCT01640951|537748604|FG005|Overall Study|Physician Decision|3|||
149073130|NCT01640951|537748605|FG006|Overall Study|Physician Decision|3|||
149073131|NCT01640951|537748606|FG007|Overall Study|Physician Decision|0|||
149073132|NCT01640951|537748599|FG000|Overall Study|Pregnancy|3|||
149073133|NCT01640951|537748600|FG001|Overall Study|Pregnancy|0|||
149073134|NCT01640951|537748601|FG002|Overall Study|Pregnancy|0|||
149073135|NCT01640951|537748602|FG003|Overall Study|Pregnancy|4|||
149073136|NCT01640951|537748603|FG004|Overall Study|Pregnancy|0|||
149073137|NCT01640951|537748604|FG005|Overall Study|Pregnancy|0|||
149073138|NCT01640951|537748605|FG006|Overall Study|Pregnancy|2|||
149073139|NCT01640951|537748606|FG007|Overall Study|Pregnancy|0|||
149073140|NCT01640951|537748599|FG000|Overall Study|Protocol Deviation|0|||
149073141|NCT01640951|537748600|FG001|Overall Study|Protocol Deviation|1|||
149073142|NCT01640951|537748601|FG002|Overall Study|Protocol Deviation|2|||
149073143|NCT01640951|537748602|FG003|Overall Study|Protocol Deviation|1|||
149073144|NCT01640951|537748603|FG004|Overall Study|Protocol Deviation|0|||
149073145|NCT01640951|537748604|FG005|Overall Study|Protocol Deviation|1|||
149073146|NCT01640951|537748605|FG006|Overall Study|Protocol Deviation|0|||
149073147|NCT01640951|537748606|FG007|Overall Study|Protocol Deviation|0|||
149073148|NCT01640951|537748599|FG000|Overall Study|Subject/Guardian decision|12|||
149073149|NCT01640951|537748600|FG001|Overall Study|Subject/Guardian decision|4|||
149073150|NCT01640951|537748601|FG002|Overall Study|Subject/Guardian decision|13|||
149073151|NCT01640951|537748602|FG003|Overall Study|Subject/Guardian decision|15|||
149073152|NCT01640951|537748603|FG004|Overall Study|Subject/Guardian decision|7|||
149073153|NCT01640951|537748604|FG005|Overall Study|Subject/Guardian decision|19|||
149073154|NCT01640951|537748605|FG006|Overall Study|Subject/Guardian decision|5|||
149073155|NCT01640951|537748606|FG007|Overall Study|Subject/Guardian decision|4|||
149073156|NCT01640951|537748599|FG000|Overall Study|Death|0|||
149073157|NCT01640951|537748600|FG001|Overall Study|Death|1|||
149073158|NCT01640951|537748601|FG002|Overall Study|Death|1|||
149073159|NCT01640951|537748602|FG003|Overall Study|Death|0|||
149073160|NCT01640951|537748603|FG004|Overall Study|Death|0|||
149073161|NCT01640951|537748604|FG005|Overall Study|Death|0|||
149073162|NCT01640951|537748605|FG006|Overall Study|Death|0|||
149073163|NCT01640951|537748606|FG007|Overall Study|Death|2|||
149073164|NCT04949542|537748607|FG000|Overall Study|Lost to Follow-up|4|||
149073165|NCT04949542|537748608|FG001|Overall Study|Lost to Follow-up|1|||
149073166|NCT01536093|537748609|FG000|Overall Study|Death|1|||
149073167|NCT01536093|537748610|FG001|Overall Study|Death|2|||
149073168|NCT01536093|537748609|FG000|Overall Study|absence of maternal colostrum|2|||
149073169|NCT01536093|537748610|FG001|Overall Study|absence of maternal colostrum|0|||
149073170|NCT01536093|537748609|FG000|Overall Study|Withdrawal by Subject|0|||
149073171|NCT01536093|537748610|FG001|Overall Study|Withdrawal by Subject|1|||
149073172|NCT02365597|537748611|FG000|Overall Study|Lost to Follow-up|0|||
149073173|NCT02365597|537748612|FG001|Overall Study|Lost to Follow-up|1|||
149073174|NCT02365597|537748613|FG002|Overall Study|Lost to Follow-up|0|||
149073175|NCT02365597|537748614|FG003|Overall Study|Lost to Follow-up|1|||
149073176|NCT02365597|537748611|FG000|Overall Study|Withdrawal by Subject|1|||
149073177|NCT02365597|537748612|FG001|Overall Study|Withdrawal by Subject|8|||
149073178|NCT02365597|537748613|FG002|Overall Study|Withdrawal by Subject|5|||
149073179|NCT02365597|537748614|FG003|Overall Study|Withdrawal by Subject|1|||
149073180|NCT02365597|537748611|FG000|Overall Study|Sponsor's decision|1|||
149073181|NCT02365597|537748612|FG001|Overall Study|Sponsor's decision|3|||
149073182|NCT02365597|537748613|FG002|Overall Study|Sponsor's decision|13|||
149073183|NCT02365597|537748614|FG003|Overall Study|Sponsor's decision|0|||
149073184|NCT02365597|537748611|FG000|Overall Study|Other|0|||
149073185|NCT02365597|537748612|FG001|Overall Study|Other|4|||
149073186|NCT02365597|537748613|FG002|Overall Study|Other|0|||
149073187|NCT02365597|537748614|FG003|Overall Study|Other|0|||
149073188|NCT02365597|537748611|FG000|Overall Study|Enrolled but not treated|0|||
149073189|NCT02365597|537748612|FG001|Overall Study|Enrolled but not treated|1|||
149073190|NCT02365597|537748613|FG002|Overall Study|Enrolled but not treated|1|||
149073191|NCT02365597|537748614|FG003|Overall Study|Enrolled but not treated|0|||
149073192|NCT02365597|537748611|FG000|Overall Study|Ongoing|0|||
149073193|NCT02365597|537748612|FG001|Overall Study|Ongoing|0|||
149073194|NCT02365597|537748613|FG002|Overall Study|Ongoing|0|||
149073195|NCT02365597|537748614|FG003|Overall Study|Ongoing|17|||
149073196|NCT02275611|537748615|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
149073197|NCT02275611|537748616|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
149073198|NCT02275611|537748617|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
149073199|NCT02275611|537748618|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
149073200|NCT01759862|537748624|FG000|Overall Study|Physician Decision|3|||
149073201|NCT01759862|537748625|FG001|Overall Study|Physician Decision|1|||
149073202|NCT01759862|537748624|FG000|Overall Study|Adverse Event|0|||
149073203|NCT01759862|537748625|FG001|Overall Study|Adverse Event|1|||
149073204|NCT00390884|537748628|FG000|Overall Study|Withdrawal by Subject|2|||
149073205|NCT00390884|537748629|FG001|Overall Study|Withdrawal by Subject|2|||
149073206|NCT05036278|537748630|FG000|Overall Study|Withdrawal by Subject|1|||
149073207|NCT05036278|537748630|FG000|Overall Study|Adverse Event|1|||
149073208|NCT01946204|537748633|FG000|Overall Study|Death|38|||
149073209|NCT01946204|537748634|FG001|Overall Study|Death|59|||
149073210|NCT01946204|537748633|FG000|Overall Study|Withdrawal by Subject|37|||
149073211|NCT01946204|537748634|FG001|Overall Study|Withdrawal by Subject|50|||
149073212|NCT01946204|537748633|FG000|Overall Study|Lost to Follow-up|3|||
149073213|NCT01946204|537748634|FG001|Overall Study|Lost to Follow-up|7|||
149073214|NCT01946204|537748633|FG000|Overall Study|Ongoing|316|||
149073215|NCT01946204|537748634|FG001|Overall Study|Ongoing|687|||
149073216|NCT01946204|537748633|FG000|Overall Study|Other|7|||
149073217|NCT01946204|537748634|FG001|Overall Study|Other|3|||
149073218|NCT02787005|537748635|FG000|Overall Study|Adverse Event|24|||
149073219|NCT02787005|537748636|FG001|Overall Study|Adverse Event|9|||
149073220|NCT02787005|537748637|FG002|Overall Study|Adverse Event|9|||
149073221|NCT02787005|537748638|FG003|Overall Study|Adverse Event|7|||
149073222|NCT02787005|537748639|FG004|Overall Study|Adverse Event|2|||
149073223|NCT02787005|537748635|FG000|Overall Study|Death|100|||
149073224|NCT02787005|537748636|FG001|Overall Study|Death|53|||
149073225|NCT02787005|537748637|FG002|Overall Study|Death|48|||
149073226|NCT02787005|537748638|FG003|Overall Study|Death|69|||
149073227|NCT02787005|537748639|FG004|Overall Study|Death|38|||
149073228|NCT02787005|537748635|FG000|Overall Study|Sponsor Decision|7|||
149073229|NCT02787005|537748636|FG001|Overall Study|Sponsor Decision|4|||
149073230|NCT02787005|537748637|FG002|Overall Study|Sponsor Decision|0|||
149073231|NCT02787005|537748638|FG003|Overall Study|Sponsor Decision|4|||
149073232|NCT02787005|537748639|FG004|Overall Study|Sponsor Decision|5|||
149073233|NCT02787005|537748635|FG000|Overall Study|Withdrawal by Subject|2|||
149073234|NCT02787005|537748636|FG001|Overall Study|Withdrawal by Subject|1|||
149073235|NCT02787005|537748637|FG002|Overall Study|Withdrawal by Subject|1|||
149073236|NCT02787005|537748638|FG003|Overall Study|Withdrawal by Subject|0|||
149073237|NCT02787005|537748639|FG004|Overall Study|Withdrawal by Subject|1|||
149073238|NCT02787005|537748635|FG000|Overall Study|Screen Failure|0|||
149073239|NCT02787005|537748636|FG001|Overall Study|Screen Failure|2|||
149073240|NCT02787005|537748637|FG002|Overall Study|Screen Failure|0|||
149073241|NCT02787005|537748638|FG003|Overall Study|Screen Failure|0|||
149073242|NCT02787005|537748639|FG004|Overall Study|Screen Failure|1|||
149073243|NCT02787005|537748635|FG000|Overall Study|Lost to Follow-up|0|||
149073244|NCT02787005|537748636|FG001|Overall Study|Lost to Follow-up|0|||
149073245|NCT02787005|537748637|FG002|Overall Study|Lost to Follow-up|0|||
149073246|NCT02787005|537748638|FG003|Overall Study|Lost to Follow-up|1|||
149073247|NCT02787005|537748639|FG004|Overall Study|Lost to Follow-up|0|||
149073248|NCT03466411|537748640|FG000|Overall Study|Lost to Follow-up|0|||
149073249|NCT03466411|537748641|FG001|Overall Study|Lost to Follow-up|1|||
149073250|NCT03466411|537748642|FG002|Overall Study|Lost to Follow-up|1|||
149073251|NCT03466411|537748643|FG003|Overall Study|Lost to Follow-up|0|||
149073252|NCT03466411|537748644|FG004|Overall Study|Lost to Follow-up|0|||
149073253|NCT03466411|537748645|FG005|Overall Study|Lost to Follow-up|0|||
149073254|NCT03466411|537748646|FG006|Overall Study|Lost to Follow-up|1|||
149073255|NCT03466411|537748647|FG007|Overall Study|Lost to Follow-up|1|||
149073256|NCT03466411|537748648|FG008|Overall Study|Lost to Follow-up|0|||
149073257|NCT03466411|537748649|FG009|Overall Study|Lost to Follow-up|1|||
149073258|NCT03466411|537748650|FG010|Overall Study|Lost to Follow-up|1|||
149073259|NCT03466411|537748651|FG011|Overall Study|Lost to Follow-up|1|||
149073260|NCT03466411|537748652|FG012|Overall Study|Lost to Follow-up|0|||
149073261|NCT03466411|537748640|FG000|Overall Study|Withdrawal by Subject|14|||
149073262|NCT03466411|537748641|FG001|Overall Study|Withdrawal by Subject|7|||
149073263|NCT03466411|537748642|FG002|Overall Study|Withdrawal by Subject|8|||
149073264|NCT03466411|537748643|FG003|Overall Study|Withdrawal by Subject|4|||
149073265|NCT03466411|537748644|FG004|Overall Study|Withdrawal by Subject|6|||
149073266|NCT03466411|537748645|FG005|Overall Study|Withdrawal by Subject|3|||
149073267|NCT03466411|537748646|FG006|Overall Study|Withdrawal by Subject|6|||
149073268|NCT03466411|537748647|FG007|Overall Study|Withdrawal by Subject|9|||
149073269|NCT03466411|537748648|FG008|Overall Study|Withdrawal by Subject|6|||
149073270|NCT03466411|537748649|FG009|Overall Study|Withdrawal by Subject|11|||
149073271|NCT03466411|537748650|FG010|Overall Study|Withdrawal by Subject|14|||
149073272|NCT03466411|537748651|FG011|Overall Study|Withdrawal by Subject|12|||
149073273|NCT03466411|537748652|FG012|Overall Study|Withdrawal by Subject|7|||
149073274|NCT03466411|537748640|FG000|Overall Study|Other|1|||
149073275|NCT03466411|537748641|FG001|Overall Study|Other|1|||
149073276|NCT03466411|537748642|FG002|Overall Study|Other|0|||
149073277|NCT03466411|537748643|FG003|Overall Study|Other|1|||
149073278|NCT03466411|537748644|FG004|Overall Study|Other|2|||
149073279|NCT03466411|537748645|FG005|Overall Study|Other|0|||
149073280|NCT03466411|537748646|FG006|Overall Study|Other|0|||
149073281|NCT03466411|537748647|FG007|Overall Study|Other|0|||
149073282|NCT03466411|537748648|FG008|Overall Study|Other|0|||
149073283|NCT03466411|537748649|FG009|Overall Study|Other|1|||
149073284|NCT03466411|537748650|FG010|Overall Study|Other|2|||
149073285|NCT03466411|537748651|FG011|Overall Study|Other|0|||
149073286|NCT03466411|537748652|FG012|Overall Study|Other|0|||
149073287|NCT03466411|537748640|FG000|Overall Study|Randomized but not Treated|0|||
149073288|NCT03466411|537748641|FG001|Overall Study|Randomized but not Treated|0|||
149073289|NCT03466411|537748642|FG002|Overall Study|Randomized but not Treated|0|||
149073290|NCT03466411|537748643|FG003|Overall Study|Randomized but not Treated|0|||
149073291|NCT03466411|537748644|FG004|Overall Study|Randomized but not Treated|0|||
149073292|NCT03466411|537748645|FG005|Overall Study|Randomized but not Treated|0|||
149073293|NCT03466411|537748646|FG006|Overall Study|Randomized but not Treated|1|||
149073294|NCT03466411|537748647|FG007|Overall Study|Randomized but not Treated|0|||
149073295|NCT03466411|537748648|FG008|Overall Study|Randomized but not Treated|0|||
149073296|NCT03466411|537748649|FG009|Overall Study|Randomized but not Treated|0|||
149073297|NCT03466411|537748650|FG010|Overall Study|Randomized but not Treated|0|||
149073298|NCT03466411|537748651|FG011|Overall Study|Randomized but not Treated|0|||
149073299|NCT03466411|537748652|FG012|Overall Study|Randomized but not Treated|0|||
149073300|NCT00274261|537748665|FG000|Overall Study|Adverse Event|19|||
149073301|NCT00274261|537748666|FG001|Overall Study|Adverse Event|11|||
149073302|NCT00274261|537748665|FG000|Overall Study|Pregnancy|114|||
149073303|NCT00274261|537748666|FG001|Overall Study|Pregnancy|83|||
149073304|NCT00274261|537748665|FG000|Overall Study|Withdrawal by Subject|179|||
149073305|NCT00274261|537748666|FG001|Overall Study|Withdrawal by Subject|126|||
149073306|NCT00274261|537748665|FG000|Overall Study|Protocol Violation|71|||
149073307|NCT00274261|537748666|FG001|Overall Study|Protocol Violation|42|||
149073308|NCT00274261|537748665|FG000|Overall Study|Lost to Follow-up|106|||
149073309|NCT00274261|537748666|FG001|Overall Study|Lost to Follow-up|75|||
149073310|NCT03582475|537748667|FG000|Treatment Period|Withdrawal by Subject|0|||
149073311|NCT03582475|537748668|FG001|Treatment Period|Withdrawal by Subject|1|||
149073312|NCT03582475|537748667|FG000|Follow-up Period|Withdrawal by Subject|0|||
149073313|NCT03582475|537748668|FG001|Follow-up Period|Withdrawal by Subject|1|||
149073314|NCT03170648|537748669|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
149073315|NCT03170648|537748669|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
149073316|NCT02052440|537748670|FG000|Overall Study|Withdrawal by Subject|0|||
149073317|NCT02052440|537748671|FG001|Overall Study|Withdrawal by Subject|1|||
149073318|NCT03509909|537748672|FG000|Overall Study|Withdrawal by Subject|16|||
149073319|NCT03509909|537748673|FG001|Overall Study|Withdrawal by Subject|9|||
149073320|NCT03509909|537748672|FG000|Overall Study|Lost to Follow-up|3|||
149073321|NCT03509909|537748673|FG001|Overall Study|Lost to Follow-up|4|||
149073322|NCT03509909|537748672|FG000|Overall Study|Adverse Event|2|||
149073323|NCT03509909|537748673|FG001|Overall Study|Adverse Event|0|||
149073324|NCT04325828|537748674|FG000|Overall Study|Ongoing|26|||
149073325|NCT05509816|537748675|FG000|Overall Study|Lost to Follow-up|1|||
149073326|NCT04066075|537748676|FG000|Overall Study|Lost to Follow-up|3|||
149073327|NCT04066075|537748677|FG001|Overall Study|Lost to Follow-up|3|||
149073328|NCT04066075|537748676|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
149073329|NCT04066075|537748677|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
149073330|NCT04066075|537748676|FG000|Overall Study|Withdrawal by Subject|2|||
149073331|NCT04066075|537748677|FG001|Overall Study|Withdrawal by Subject|2|||
149073332|NCT04088227|537748680|FG000|Overall Study|Withdrawal by Subject|1|||
149073333|NCT04088227|537748681|FG001|Overall Study|Withdrawal by Subject|0|||
149073334|NCT04088227|537748680|FG000|Overall Study|Surgery postponed >5weeks|1|||
149073335|NCT04088227|537748681|FG001|Overall Study|Surgery postponed >5weeks|0|||
149073336|NCT03160885|537748684|FG000|Initial Treatment Period|Not dosed|2|||
149073337|NCT03160885|537748685|FG001|Initial Treatment Period|Not dosed|0|||
149073338|NCT03160885|537748686|FG002|Initial Treatment Period|Not dosed|0|||
149073339|NCT03160885|537748687|FG003|Initial Treatment Period|Not dosed|0|||
149073340|NCT03160885|537748688|FG004|Initial Treatment Period|Not dosed|0|||
149073341|NCT03160885|537748689|FG005|Initial Treatment Period|Not dosed|0|||
149073342|NCT03160885|537748690|FG006|Initial Treatment Period|Not dosed|0|||
149073343|NCT03160885|537748684|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
149073344|NCT03160885|537748685|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
149073345|NCT03160885|537748686|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149073346|NCT03160885|537748687|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149073347|NCT03160885|537748688|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149073348|NCT03160885|537748689|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149073349|NCT03160885|537748690|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
149073350|NCT03160885|537748684|FG000|Open-label Treatment|Not dosed|0|||
149073351|NCT03160885|537748685|FG001|Open-label Treatment|Not dosed|0|||
149073352|NCT03160885|537748686|FG002|Open-label Treatment|Not dosed|0|||
149073353|NCT03160885|537748687|FG003|Open-label Treatment|Not dosed|0|||
149073354|NCT03160885|537748688|FG004|Open-label Treatment|Not dosed|0|||
149073355|NCT03160885|537748689|FG005|Open-label Treatment|Not dosed|0|||
149073356|NCT03160885|537748690|FG006|Open-label Treatment|Not dosed|2|||
149073357|NCT03160885|537748684|FG000|Open-label Treatment|Discontinued IMP|0|||
149073358|NCT03160885|537748685|FG001|Open-label Treatment|Discontinued IMP|0|||
149073359|NCT03160885|537748686|FG002|Open-label Treatment|Discontinued IMP|0|||
149073360|NCT03160885|537748687|FG003|Open-label Treatment|Discontinued IMP|0|||
149073361|NCT03160885|537748688|FG004|Open-label Treatment|Discontinued IMP|0|||
149073362|NCT03160885|537748689|FG005|Open-label Treatment|Discontinued IMP|0|||
149073363|NCT03160885|537748690|FG006|Open-label Treatment|Discontinued IMP|131|||
149073364|NCT03160885|537748684|FG000|Open-label Treatment|Completed Week 50|0|||
149073365|NCT03160885|537748685|FG001|Open-label Treatment|Completed Week 50|0|||
149073366|NCT03160885|537748686|FG002|Open-label Treatment|Completed Week 50|0|||
149073367|NCT03160885|537748687|FG003|Open-label Treatment|Completed Week 50|0|||
149073368|NCT03160885|537748688|FG004|Open-label Treatment|Completed Week 50|0|||
149073369|NCT03160885|537748689|FG005|Open-label Treatment|Completed Week 50|0|||
149073370|NCT03160885|537748690|FG006|Open-label Treatment|Completed Week 50|4|||
149073371|NCT03160885|537748684|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
149073372|NCT03160885|537748685|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
149073373|NCT03160885|537748686|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
149073374|NCT03160885|537748687|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
149073375|NCT03160885|537748688|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
149073376|NCT03160885|537748689|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
149073377|NCT03160885|537748690|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
149073378|NCT03160885|537748684|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
149073379|NCT03160885|537748685|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
149073380|NCT03160885|537748686|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
149073381|NCT03160885|537748687|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
149073382|NCT03160885|537748688|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
149073383|NCT03160885|537748689|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
149073384|NCT03160885|537748690|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
149073385|NCT03160885|537748684|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149073386|NCT03160885|537748685|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149073387|NCT03160885|537748686|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
149073388|NCT03160885|537748687|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
149073389|NCT03160885|537748688|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
149073390|NCT03160885|537748689|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
149073391|NCT03160885|537748690|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
149073392|NCT03160885|537748684|FG000|Maintenance Treatment Period|Completed Week 50|0|||
149073393|NCT03160885|537748685|FG001|Maintenance Treatment Period|Completed Week 50|0|||
149073394|NCT03160885|537748686|FG002|Maintenance Treatment Period|Completed Week 50|1|||
149073395|NCT03160885|537748687|FG003|Maintenance Treatment Period|Completed Week 50|0|||
149073396|NCT03160885|537748688|FG004|Maintenance Treatment Period|Completed Week 50|0|||
149073397|NCT03160885|537748689|FG005|Maintenance Treatment Period|Completed Week 50|0|||
149073398|NCT03160885|537748690|FG006|Maintenance Treatment Period|Completed Week 50|0|||
149073399|NCT02751528|537748691|FG000|Overall Study|Withdrawal by Subject|1|||
149073400|NCT02751528|537748691|FG000|Overall Study|Adverse Event|1|||
149073401|NCT05485805|537748692|FG000|Overall Study|Withdrawal by Subject|1|||
149073402|NCT05485805|537748693|FG001|Overall Study|Withdrawal by Subject|2|||
149073403|NCT05485805|537748694|FG002|Overall Study|Withdrawal by Subject|2|||
149073404|NCT05485805|537748695|FG003|Overall Study|Withdrawal by Subject|0|||
149073405|NCT05485805|537748696|FG004|Overall Study|Withdrawal by Subject|2|||
149073406|NCT05485805|537748692|FG000|Overall Study|Adverse Event|0|||
149073407|NCT05485805|537748693|FG001|Overall Study|Adverse Event|1|||
149073408|NCT05485805|537748694|FG002|Overall Study|Adverse Event|0|||
149073409|NCT05485805|537748695|FG003|Overall Study|Adverse Event|0|||
149073410|NCT05485805|537748696|FG004|Overall Study|Adverse Event|0|||
149073411|NCT05485805|537748692|FG000|Overall Study|Lost to Follow-up|1|||
149073412|NCT05485805|537748693|FG001|Overall Study|Lost to Follow-up|1|||
149073413|NCT05485805|537748694|FG002|Overall Study|Lost to Follow-up|3|||
149073414|NCT05485805|537748695|FG003|Overall Study|Lost to Follow-up|1|||
149073415|NCT05485805|537748696|FG004|Overall Study|Lost to Follow-up|0|||
149073416|NCT04484623|537748698|FG000|Overall Study|Lost to Follow-up|0|||
149073417|NCT04484623|537748699|FG001|Overall Study|Lost to Follow-up|1|||
149073418|NCT04484623|537748698|FG000|Overall Study|Protocol Deviation|1|||
149073419|NCT04484623|537748699|FG001|Overall Study|Protocol Deviation|0|||
149073420|NCT04484623|537748698|FG000|Overall Study|Physician Decision|1|||
149073421|NCT04484623|537748699|FG001|Overall Study|Physician Decision|0|||
149073422|NCT04484623|537748698|FG000|Overall Study|Withdrawal by Subject|11|||
149073423|NCT04484623|537748699|FG001|Overall Study|Withdrawal by Subject|8|||
149073424|NCT04484623|537748698|FG000|Overall Study|Ongoing|94|||
149073425|NCT04484623|537748699|FG001|Overall Study|Ongoing|84|||
149073426|NCT03367156|537750060|FG000|Overall Study|Lack of interest|3|||
149073427|NCT03367156|537750061|FG001|Overall Study|Lack of interest|1|||
149073428|NCT03367156|537750060|FG000|Overall Study|Death|2|||
149073429|NCT03367156|537750061|FG001|Overall Study|Death|0|||
149073430|NCT03367156|537750060|FG000|Overall Study|Lost to Follow-up|2|||
149073431|NCT03367156|537750061|FG001|Overall Study|Lost to Follow-up|1|||
149073432|NCT03367156|537750060|FG000|Overall Study|Became ineligible|1|||
149073433|NCT03367156|537750061|FG001|Overall Study|Became ineligible|2|||
149073434|NCT03367156|537750060|FG000|Overall Study|Hospitalization|1|||
149073435|NCT03367156|537750061|FG001|Overall Study|Hospitalization|0|||
149073436|NCT03367156|537750060|FG000|Overall Study|Concerned about Treatment|11|||
149073437|NCT03367156|537750061|FG001|Overall Study|Concerned about Treatment|3|||
149073438|NCT03367156|537750060|FG000|Overall Study|Started new treatment|4|||
149073439|NCT03367156|537750061|FG001|Overall Study|Started new treatment|1|||
149073440|NCT00092534|537750062|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
149073441|NCT00092534|537750063|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
149073442|NCT00092534|537750064|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
149073443|NCT00092534|537750065|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
149073444|NCT00092534|537750066|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
149073445|NCT00092534|537750062|FG000|Base Study Vaccination Period|Adverse Event|3|||
149073446|NCT00092534|537750063|FG001|Base Study Vaccination Period|Adverse Event|1|||
149073447|NCT00092534|537750064|FG002|Base Study Vaccination Period|Adverse Event|0|||
149073448|NCT00092534|537750065|FG003|Base Study Vaccination Period|Adverse Event|0|||
149073449|NCT00092534|537750066|FG004|Base Study Vaccination Period|Adverse Event|0|||
149073450|NCT00092534|537750062|FG000|Base Study Vaccination Period|Death|5|||
149073451|NCT00092534|537750063|FG001|Base Study Vaccination Period|Death|4|||
149073452|NCT00092534|537750064|FG002|Base Study Vaccination Period|Death|0|||
149073453|NCT00092534|537750065|FG003|Base Study Vaccination Period|Death|0|||
149073454|NCT00092534|537750066|FG004|Base Study Vaccination Period|Death|0|||
149073455|NCT00092534|537750062|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
149073456|NCT00092534|537750063|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
149073457|NCT00092534|537750064|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
149073458|NCT00092534|537750065|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
149073459|NCT00092534|537750066|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
149073460|NCT00092534|537750062|FG000|Base Study Vaccination Period|Physician Decision|1|||
149073461|NCT00092534|537750063|FG001|Base Study Vaccination Period|Physician Decision|0|||
149073462|NCT00092534|537750064|FG002|Base Study Vaccination Period|Physician Decision|0|||
149073463|NCT00092534|537750065|FG003|Base Study Vaccination Period|Physician Decision|0|||
149073464|NCT00092534|537750066|FG004|Base Study Vaccination Period|Physician Decision|0|||
149073465|NCT00092534|537750062|FG000|Base Study Vaccination Period|Pregnancy|9|||
149073466|NCT00092534|537750063|FG001|Base Study Vaccination Period|Pregnancy|7|||
149073467|NCT00092534|537750064|FG002|Base Study Vaccination Period|Pregnancy|0|||
149073468|NCT00092534|537750065|FG003|Base Study Vaccination Period|Pregnancy|0|||
149073469|NCT00092534|537750066|FG004|Base Study Vaccination Period|Pregnancy|0|||
149073470|NCT00092534|537750062|FG000|Base Study Vaccination Period|Protocol Violation|2|||
149073471|NCT00092534|537750063|FG001|Base Study Vaccination Period|Protocol Violation|1|||
149073472|NCT00092534|537750064|FG002|Base Study Vaccination Period|Protocol Violation|0|||
149073473|NCT00092534|537750065|FG003|Base Study Vaccination Period|Protocol Violation|0|||
149073474|NCT00092534|537750066|FG004|Base Study Vaccination Period|Protocol Violation|0|||
149073475|NCT00092534|537750062|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
149073476|NCT00092534|537750063|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
149073477|NCT00092534|537750064|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
149073478|NCT00092534|537750065|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
149073479|NCT00092534|537750066|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
149073480|NCT00092534|537750062|FG000|Base Study Vaccination Period|Moved|14|||
149073481|NCT00092534|537750063|FG001|Base Study Vaccination Period|Moved|12|||
149073482|NCT00092534|537750064|FG002|Base Study Vaccination Period|Moved|0|||
149073483|NCT00092534|537750065|FG003|Base Study Vaccination Period|Moved|0|||
149073484|NCT00092534|537750066|FG004|Base Study Vaccination Period|Moved|0|||
149073485|NCT00092534|537750062|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
149073486|NCT00092534|537750063|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
149073487|NCT00092534|537750064|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
149073488|NCT00092534|537750065|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
149073489|NCT00092534|537750066|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
149073490|NCT00092534|537750062|FG000|Base Study Vaccination Period|Travel|1|||
149073491|NCT00092534|537750063|FG001|Base Study Vaccination Period|Travel|0|||
149073492|NCT00092534|537750064|FG002|Base Study Vaccination Period|Travel|0|||
149073493|NCT00092534|537750065|FG003|Base Study Vaccination Period|Travel|0|||
149073494|NCT00092534|537750066|FG004|Base Study Vaccination Period|Travel|0|||
149073495|NCT00092534|537750062|FG000|Base Study Vaccination Period|Site Closed|0|||
149073496|NCT00092534|537750063|FG001|Base Study Vaccination Period|Site Closed|1|||
149073497|NCT00092534|537750064|FG002|Base Study Vaccination Period|Site Closed|0|||
149073498|NCT00092534|537750065|FG003|Base Study Vaccination Period|Site Closed|0|||
149073499|NCT00092534|537750066|FG004|Base Study Vaccination Period|Site Closed|0|||
149073500|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Adverse Event|2|||
149073501|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Adverse Event|4|||
149073502|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Adverse Event|0|||
149073503|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Adverse Event|0|||
149073504|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Adverse Event|0|||
149073505|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Death|2|||
149073506|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Death|1|||
149073507|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Death|0|||
149073508|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Death|0|||
149073509|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Death|0|||
149073510|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
149073511|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
149073512|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
149073513|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
149073514|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
149073515|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Pregnancy|6|||
149073516|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Pregnancy|10|||
149073517|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Pregnancy|0|||
149073518|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Pregnancy|0|||
149073519|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Pregnancy|0|||
149073520|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
149073521|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
149073522|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
149073523|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
149073524|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
149073525|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
149073526|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
149073527|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
149073528|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
149073529|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
149073530|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Moved|62|||
149073531|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Moved|58|||
149073532|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Moved|0|||
149073533|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Moved|0|||
149073534|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Moved|0|||
149073535|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Travel|10|||
149073536|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Travel|7|||
149073537|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Travel|0|||
149073538|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Travel|0|||
149073539|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Travel|0|||
149073540|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Site Closed|0|||
149073541|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Site Closed|2|||
149073542|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Site Closed|0|||
149073543|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Site Closed|0|||
149073544|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Site Closed|0|||
149073545|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
149073546|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
149073547|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
149073548|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
149073549|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
149073550|NCT00092534|537750062|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
149073551|NCT00092534|537750063|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
149073552|NCT00092534|537750064|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
149073553|NCT00092534|537750065|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
149073554|NCT00092534|537750066|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
149073555|NCT00092534|537750062|FG000|Base Study EXT|Lost to Follow-up|0|||
149073556|NCT00092534|537750063|FG001|Base Study EXT|Lost to Follow-up|0|||
149073557|NCT00092534|537750064|FG002|Base Study EXT|Lost to Follow-up|41|||
149073558|NCT00092534|537750065|FG003|Base Study EXT|Lost to Follow-up|0|||
149073559|NCT00092534|537750066|FG004|Base Study EXT|Lost to Follow-up|0|||
149073560|NCT00092534|537750062|FG000|Base Study EXT|Physician Decision|0|||
149073561|NCT00092534|537750063|FG001|Base Study EXT|Physician Decision|0|||
149073562|NCT00092534|537750064|FG002|Base Study EXT|Physician Decision|1|||
149073563|NCT00092534|537750065|FG003|Base Study EXT|Physician Decision|0|||
149073564|NCT00092534|537750066|FG004|Base Study EXT|Physician Decision|0|||
149073565|NCT00092534|537750062|FG000|Base Study EXT|Pregnancy|0|||
149073566|NCT00092534|537750063|FG001|Base Study EXT|Pregnancy|0|||
149073567|NCT00092534|537750064|FG002|Base Study EXT|Pregnancy|12|||
149006213|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
149006214|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
149006215|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
149006216|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
149006217|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
149006218|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
149006219|NCT01392300|537501791|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
149006220|NCT01392300|537501792|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
149006221|NCT01392300|537501793|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
149006222|NCT00710606|537501798|FG000|Overall Study|Adverse Event|0|||
149006223|NCT00710606|537501799|FG001|Overall Study|Adverse Event|2|||
149006224|NCT05056870|537501800|FG000|Period 1|Site COVID-19 Related|3|||
149006225|NCT05056870|537501801|FG001|Period 1|Site COVID-19 Related|3|||
149006226|NCT05056870|537501800|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
149006227|NCT05056870|537501801|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
149006228|NCT05056870|537501800|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
149006229|NCT05056870|537501801|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
149006230|NCT05056870|537501800|FG000|Period 2|COVID-19 Related|1|||
149006231|NCT05056870|537501801|FG001|Period 2|COVID-19 Related|0|||
149006232|NCT05056870|537501800|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
149006233|NCT05056870|537501801|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
149006234|NCT05044325|537501802|FG000|Part A:Treatment Period 1|Adverse Event|0|||
149006235|NCT05044325|537501803|FG001|Part A:Treatment Period 1|Adverse Event|0|||
149006236|NCT05044325|537501804|FG002|Part A:Treatment Period 1|Adverse Event|0|||
149006237|NCT05044325|537501805|FG003|Part A:Treatment Period 1|Adverse Event|0|||
149006238|NCT05044325|537501806|FG004|Part A:Treatment Period 1|Adverse Event|0|||
149006239|NCT05044325|537501807|FG005|Part A:Treatment Period 1|Adverse Event|1|||
149006240|NCT05044325|537501808|FG006|Part A:Treatment Period 1|Adverse Event|0|||
149006241|NCT05044325|537501809|FG007|Part A:Treatment Period 1|Adverse Event|1|||
149006242|NCT05044325|537501810|FG008|Part A:Treatment Period 1|Adverse Event|0|||
149006243|NCT05044325|537501811|FG009|Part A:Treatment Period 1|Adverse Event|0|||
149006244|NCT05044325|537501802|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006245|NCT05044325|537501803|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006246|NCT05044325|537501804|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006247|NCT05044325|537501805|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
149006248|NCT05044325|537501806|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
149006249|NCT05044325|537501807|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
149006250|NCT05044325|537501808|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006251|NCT05044325|537501809|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006252|NCT05044325|537501810|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006253|NCT05044325|537501811|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
149006254|NCT05044325|537501802|FG000|Part A:Treatment Period 1|Physician Decision|0|||
149006255|NCT05044325|537501803|FG001|Part A:Treatment Period 1|Physician Decision|0|||
149006256|NCT05044325|537501804|FG002|Part A:Treatment Period 1|Physician Decision|0|||
149006257|NCT05044325|537501805|FG003|Part A:Treatment Period 1|Physician Decision|0|||
149006258|NCT05044325|537501806|FG004|Part A:Treatment Period 1|Physician Decision|0|||
149006259|NCT05044325|537501807|FG005|Part A:Treatment Period 1|Physician Decision|0|||
149006260|NCT05044325|537501808|FG006|Part A:Treatment Period 1|Physician Decision|1|||
149006261|NCT05044325|537501809|FG007|Part A:Treatment Period 1|Physician Decision|0|||
149006262|NCT05044325|537501810|FG008|Part A:Treatment Period 1|Physician Decision|0|||
149006263|NCT05044325|537501811|FG009|Part A:Treatment Period 1|Physician Decision|0|||
149006264|NCT05044325|537501802|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006265|NCT05044325|537501803|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149073568|NCT00092534|537750065|FG003|Base Study EXT|Pregnancy|0|||
149073569|NCT00092534|537750066|FG004|Base Study EXT|Pregnancy|0|||
149073570|NCT00092534|537750062|FG000|Base Study EXT|Withdrawal by Subject|0|||
149073571|NCT00092534|537750063|FG001|Base Study EXT|Withdrawal by Subject|0|||
149073572|NCT00092534|537750064|FG002|Base Study EXT|Withdrawal by Subject|18|||
149073573|NCT00092534|537750065|FG003|Base Study EXT|Withdrawal by Subject|0|||
149073574|NCT00092534|537750066|FG004|Base Study EXT|Withdrawal by Subject|0|||
149073575|NCT00092534|537750062|FG000|Base Study EXT|Participant moved|0|||
149073576|NCT00092534|537750063|FG001|Base Study EXT|Participant moved|0|||
149073577|NCT00092534|537750064|FG002|Base Study EXT|Participant moved|6|||
149073578|NCT00092534|537750065|FG003|Base Study EXT|Participant moved|0|||
149073579|NCT00092534|537750066|FG004|Base Study EXT|Participant moved|0|||
149073580|NCT00092534|537750062|FG000|Base Study EXT|Travel|0|||
149073581|NCT00092534|537750063|FG001|Base Study EXT|Travel|0|||
149073582|NCT00092534|537750064|FG002|Base Study EXT|Travel|2|||
149073583|NCT00092534|537750065|FG003|Base Study EXT|Travel|0|||
149073584|NCT00092534|537750066|FG004|Base Study EXT|Travel|0|||
149073585|NCT00092534|537750062|FG000|Base Study EXT|Site closed|0|||
149073586|NCT00092534|537750063|FG001|Base Study EXT|Site closed|0|||
149073587|NCT00092534|537750064|FG002|Base Study EXT|Site closed|21|||
149073588|NCT00092534|537750065|FG003|Base Study EXT|Site closed|0|||
149073589|NCT00092534|537750066|FG004|Base Study EXT|Site closed|0|||
149073590|NCT00092534|537750062|FG000|Base Study EXT|Study ended|0|||
149073591|NCT00092534|537750063|FG001|Base Study EXT|Study ended|0|||
149073592|NCT00092534|537750064|FG002|Base Study EXT|Study ended|29|||
149073593|NCT00092534|537750065|FG003|Base Study EXT|Study ended|0|||
149073594|NCT00092534|537750066|FG004|Base Study EXT|Study ended|0|||
149073595|NCT00092534|537750062|FG000|Base Study EXT|Protocol Violation|0|||
149073596|NCT00092534|537750063|FG001|Base Study EXT|Protocol Violation|0|||
149073597|NCT00092534|537750064|FG002|Base Study EXT|Protocol Violation|15|||
149073598|NCT00092534|537750065|FG003|Base Study EXT|Protocol Violation|0|||
149073599|NCT00092534|537750066|FG004|Base Study EXT|Protocol Violation|0|||
149073600|NCT00092534|537750062|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
149073601|NCT00092534|537750063|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
149073602|NCT00092534|537750064|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
149073603|NCT00092534|537750065|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
149073604|NCT00092534|537750066|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
149073605|NCT02232737|537750071|FG000|Overall Study|Lost to Follow-up|18|||
149073606|NCT02232737|537750072|FG001|Overall Study|Lost to Follow-up|28|||
149073607|NCT02232737|537750073|FG002|Overall Study|Lost to Follow-up|33|||
149073608|NCT02232737|537750071|FG000|Overall Study|Personal reasons|7|||
149073609|NCT02232737|537750072|FG001|Overall Study|Personal reasons|8|||
149073610|NCT02232737|537750073|FG002|Overall Study|Personal reasons|14|||
149073611|NCT02232737|537750071|FG000|Overall Study|Adverse Event|6|||
149073612|NCT02232737|537750072|FG001|Overall Study|Adverse Event|3|||
149073613|NCT02232737|537750073|FG002|Overall Study|Adverse Event|8|||
149073614|NCT02232737|537750071|FG000|Overall Study|Incarcerated|2|||
149073615|NCT02232737|537750072|FG001|Overall Study|Incarcerated|1|||
149073616|NCT02232737|537750073|FG002|Overall Study|Incarcerated|2|||
149073617|NCT02232737|537750071|FG000|Overall Study|Withdrawal by Subject|0|||
149073618|NCT02232737|537750072|FG001|Overall Study|Withdrawal by Subject|1|||
149073619|NCT02232737|537750073|FG002|Overall Study|Withdrawal by Subject|2|||
149073620|NCT02232737|537750071|FG000|Overall Study|Death|0|||
149073621|NCT02232737|537750072|FG001|Overall Study|Death|1|||
149073622|NCT02232737|537750073|FG002|Overall Study|Death|1|||
149073623|NCT02232737|537750071|FG000|Overall Study|Physician Decision|1|||
149073624|NCT02232737|537750072|FG001|Overall Study|Physician Decision|3|||
149073625|NCT02232737|537750073|FG002|Overall Study|Physician Decision|1|||
149073626|NCT02232737|537750071|FG000|Overall Study|Protocol Violation|1|||
149073627|NCT02232737|537750072|FG001|Overall Study|Protocol Violation|0|||
149073628|NCT02232737|537750073|FG002|Overall Study|Protocol Violation|1|||
149073629|NCT02232737|537750071|FG000|Overall Study|Reason unknown|1|||
149073630|NCT02232737|537750072|FG001|Overall Study|Reason unknown|0|||
149073631|NCT02232737|537750073|FG002|Overall Study|Reason unknown|0|||
149073632|NCT02866942|537750075|FG000|Overall Study|Invalid consent|1|||
149073633|NCT06212752|537750076|FG000|Overall Study|Death|5|||
149073634|NCT06212752|537750077|FG001|Overall Study|Death|3|||
149073635|NCT06212752|537750076|FG000|Overall Study|Participants ongoing|23|||
149073636|NCT06212752|537750077|FG001|Overall Study|Participants ongoing|8|||
149073637|NCT00756574|537750078|FG000|Overall Study|Withdrawal by Subject|9|||
149073638|NCT00756574|537750079|FG001|Overall Study|Withdrawal by Subject|7|||
149073639|NCT00756574|537750078|FG000|Overall Study|Lost to Follow-up|4|||
149073640|NCT00756574|537750079|FG001|Overall Study|Lost to Follow-up|4|||
149073641|NCT04622332|537750080|FG000|Overall Study|Withdrawal by Subject|4|||
149073642|NCT04622332|537750081|FG001|Overall Study|Withdrawal by Subject|2|||
149073643|NCT04622332|537750080|FG000|Overall Study|Physician Decision|1|||
149073644|NCT04622332|537750081|FG001|Overall Study|Physician Decision|1|||
149073645|NCT04622332|537750080|FG000|Overall Study|Adverse Event|0|||
149073646|NCT04622332|537750081|FG001|Overall Study|Adverse Event|2|||
149073647|NCT04622332|537750080|FG000|Overall Study|Protocol Violation|0|||
149073648|NCT04622332|537750081|FG001|Overall Study|Protocol Violation|1|||
149073649|NCT05966155|537750082|FG000|Overall Study|Death|1|||
149073650|NCT05966155|537750083|FG001|Overall Study|Death|2|||
149073651|NCT05966155|537750082|FG000|Overall Study|Lost to Follow-up|63|||
149073652|NCT05966155|537750083|FG001|Overall Study|Lost to Follow-up|67|||
149073653|NCT05966155|537750082|FG000|Overall Study|Protocol Violation|1|||
149073654|NCT05966155|537750083|FG001|Overall Study|Protocol Violation|0|||
149073655|NCT05966155|537750082|FG000|Overall Study|Withdrawal by Subject|8|||
149073656|NCT05966155|537750083|FG001|Overall Study|Withdrawal by Subject|9|||
149073657|NCT05966155|537750082|FG000|Overall Study|Enrolled Erroneously|0|||
149073658|NCT05966155|537750083|FG001|Overall Study|Enrolled Erroneously|1|||
149073659|NCT05966155|537750082|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
149073660|NCT05966155|537750083|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
149073661|NCT03516812|537750086|FG000|Overall Study|Adverse Event|4|||
149073662|NCT03516812|537750086|FG000|Overall Study|Lack of Efficacy|2|||
149073663|NCT04795167|537750087|FG000|Overall Study|Death|1|||
149073664|NCT04795167|537750088|FG001|Overall Study|Death|18|||
149073665|NCT04795167|537750089|FG002|Overall Study|Death|1|||
149073666|NCT04795167|537750087|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
149073667|NCT04795167|537750088|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
149073668|NCT04795167|537750089|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
149073669|NCT02257736|537750095|FG000|Overall Study|Progressive disease|365|||
149073670|NCT02257736|537750096|FG001|Overall Study|Progressive disease|327|||
149073671|NCT02257736|537750095|FG000|Overall Study|Adverse Event|45|||
149073672|NCT02257736|537750096|FG001|Overall Study|Adverse Event|56|||
149073673|NCT02257736|537750095|FG000|Overall Study|Withdrawal by Subject|21|||
149073674|NCT02257736|537750096|FG001|Overall Study|Withdrawal by Subject|38|||
149073675|NCT02257736|537750095|FG000|Overall Study|Death|11|||
149073676|NCT02257736|537750096|FG001|Overall Study|Death|6|||
149073677|NCT02257736|537750095|FG000|Overall Study|Physician Decision|5|||
149073678|NCT02257736|537750096|FG001|Overall Study|Physician Decision|9|||
149073679|NCT02257736|537750095|FG000|Overall Study|Non-Compliance with study drug|1|||
149073680|NCT02257736|537750096|FG001|Overall Study|Non-Compliance with study drug|2|||
149073681|NCT02257736|537750095|FG000|Overall Study|Protocol Violation|1|||
149073682|NCT02257736|537750096|FG001|Overall Study|Protocol Violation|0|||
149073683|NCT02257736|537750095|FG000|Overall Study|Other|1|||
149073684|NCT02257736|537750096|FG001|Overall Study|Other|7|||
149073685|NCT02257736|537750095|FG000|Overall Study|Randomized, not treated|1|||
149073686|NCT02257736|537750096|FG001|Overall Study|Randomized, not treated|2|||
149073687|NCT03431350|537750097|FG000|Overall Study|ONGOING|0|||
149073688|NCT03431350|537750098|FG001|Overall Study|ONGOING|0|||
149073689|NCT03431350|537750099|FG002|Overall Study|ONGOING|2|||
149073690|NCT03431350|537750100|FG003|Overall Study|ONGOING|0|||
149073691|NCT03431350|537750101|FG004|Overall Study|ONGOING|1|||
149073692|NCT03431350|537750102|FG005|Overall Study|ONGOING|3|||
149073693|NCT03431350|537750103|FG006|Overall Study|ONGOING|0|||
149073694|NCT03431350|537750104|FG007|Overall Study|ONGOING|1|||
149073695|NCT03431350|537750105|FG008|Overall Study|ONGOING|3|||
149073696|NCT03431350|537750106|FG009|Overall Study|ONGOING|4|||
149073697|NCT03431350|537750107|FG010|Overall Study|ONGOING|2|||
149073698|NCT03431350|537750108|FG011|Overall Study|ONGOING|1|||
149073699|NCT03431350|537750097|FG000|Overall Study|Death|6|||
149073700|NCT03431350|537750098|FG001|Overall Study|Death|5|||
149073701|NCT03431350|537750099|FG002|Overall Study|Death|18|||
149073702|NCT03431350|537750100|FG003|Overall Study|Death|7|||
149073703|NCT03431350|537750101|FG004|Overall Study|Death|4|||
149073704|NCT03431350|537750102|FG005|Overall Study|Death|3|||
149073705|NCT03431350|537750103|FG006|Overall Study|Death|2|||
149073706|NCT03431350|537750104|FG007|Overall Study|Death|0|||
149073707|NCT03431350|537750105|FG008|Overall Study|Death|0|||
149073708|NCT03431350|537750106|FG009|Overall Study|Death|0|||
149073709|NCT03431350|537750107|FG010|Overall Study|Death|4|||
149073710|NCT03431350|537750108|FG011|Overall Study|Death|0|||
149073711|NCT03431350|537750097|FG000|Overall Study|Lost to Follow-up|0|||
149073712|NCT03431350|537750098|FG001|Overall Study|Lost to Follow-up|1|||
149073713|NCT03431350|537750099|FG002|Overall Study|Lost to Follow-up|0|||
149073714|NCT03431350|537750100|FG003|Overall Study|Lost to Follow-up|0|||
149073715|NCT03431350|537750101|FG004|Overall Study|Lost to Follow-up|0|||
149073716|NCT03431350|537750102|FG005|Overall Study|Lost to Follow-up|0|||
149073717|NCT03431350|537750103|FG006|Overall Study|Lost to Follow-up|0|||
149073718|NCT03431350|537750104|FG007|Overall Study|Lost to Follow-up|0|||
149073719|NCT03431350|537750105|FG008|Overall Study|Lost to Follow-up|0|||
149073720|NCT03431350|537750106|FG009|Overall Study|Lost to Follow-up|0|||
149073721|NCT03431350|537750107|FG010|Overall Study|Lost to Follow-up|0|||
149073722|NCT03431350|537750108|FG011|Overall Study|Lost to Follow-up|0|||
149073723|NCT03431350|537750097|FG000|Overall Study|Withdrawal by Subject|0|||
149073724|NCT03431350|537750098|FG001|Overall Study|Withdrawal by Subject|0|||
149073725|NCT03431350|537750099|FG002|Overall Study|Withdrawal by Subject|0|||
149073726|NCT03431350|537750100|FG003|Overall Study|Withdrawal by Subject|1|||
149073727|NCT03431350|537750101|FG004|Overall Study|Withdrawal by Subject|1|||
149073728|NCT03431350|537750102|FG005|Overall Study|Withdrawal by Subject|1|||
149073729|NCT03431350|537750103|FG006|Overall Study|Withdrawal by Subject|0|||
149073730|NCT03431350|537750104|FG007|Overall Study|Withdrawal by Subject|0|||
149073731|NCT03431350|537750105|FG008|Overall Study|Withdrawal by Subject|0|||
149073732|NCT03431350|537750106|FG009|Overall Study|Withdrawal by Subject|2|||
149073733|NCT03431350|537750107|FG010|Overall Study|Withdrawal by Subject|0|||
149073734|NCT03431350|537750108|FG011|Overall Study|Withdrawal by Subject|1|||
149073735|NCT03431350|537750097|FG000|Overall Study|Other|0|||
149073736|NCT03431350|537750098|FG001|Overall Study|Other|0|||
149073737|NCT03431350|537750099|FG002|Overall Study|Other|1|||
149073738|NCT03431350|537750100|FG003|Overall Study|Other|3|||
149073739|NCT03431350|537750101|FG004|Overall Study|Other|2|||
149073740|NCT03431350|537750102|FG005|Overall Study|Other|2|||
149073741|NCT03431350|537750103|FG006|Overall Study|Other|4|||
149073742|NCT03431350|537750104|FG007|Overall Study|Other|0|||
149073743|NCT03431350|537750105|FG008|Overall Study|Other|14|||
149073744|NCT03431350|537750106|FG009|Overall Study|Other|11|||
149073745|NCT03431350|537750107|FG010|Overall Study|Other|11|||
149073746|NCT03431350|537750108|FG011|Overall Study|Other|15|||
149073747|NCT05663866|537750111|FG000|Overall Study|Adverse Event|0|||
149073748|NCT05663866|537750112|FG001|Overall Study|Adverse Event|0|||
149073749|NCT05663866|537750113|FG002|Overall Study|Adverse Event|1|||
149073750|NCT05663866|537750114|FG003|Overall Study|Adverse Event|0|||
149073751|NCT05663866|537750111|FG000|Overall Study|Physician Decision|0|||
149073752|NCT05663866|537750112|FG001|Overall Study|Physician Decision|0|||
149073753|NCT05663866|537750113|FG002|Overall Study|Physician Decision|0|||
149073754|NCT05663866|537750114|FG003|Overall Study|Physician Decision|1|||
149073755|NCT05663866|537750111|FG000|Overall Study|Withdrawal by Subject|0|||
149073756|NCT05663866|537750112|FG001|Overall Study|Withdrawal by Subject|2|||
149073757|NCT05663866|537750113|FG002|Overall Study|Withdrawal by Subject|1|||
149073758|NCT05663866|537750114|FG003|Overall Study|Withdrawal by Subject|2|||
149073759|NCT05663866|537750111|FG000|Overall Study|Progressive disease|4|||
149073760|NCT05663866|537750112|FG001|Overall Study|Progressive disease|8|||
149073761|NCT05663866|537750113|FG002|Overall Study|Progressive disease|5|||
149073762|NCT05663866|537750114|FG003|Overall Study|Progressive disease|2|||
149073763|NCT05663866|537750111|FG000|Overall Study|Other|1|||
149073764|NCT05663866|537750112|FG001|Overall Study|Other|0|||
149073765|NCT05663866|537750113|FG002|Overall Study|Other|0|||
149073766|NCT05663866|537750114|FG003|Overall Study|Other|0|||
149073767|NCT05663866|537750111|FG000|Overall Study|Ongoing|1|||
149073768|NCT05663866|537750112|FG001|Overall Study|Ongoing|27|||
149073769|NCT05663866|537750113|FG002|Overall Study|Ongoing|6|||
149073770|NCT05663866|537750114|FG003|Overall Study|Ongoing|1|||
149073771|NCT04801420|537750119|FG000|Overall Study|Other|1|||
149073772|NCT04801420|537750120|FG001|Overall Study|Other|2|||
149073773|NCT04801420|537750121|FG002|Overall Study|Other|1|||
149073774|NCT04801420|537750119|FG000|Overall Study|Lost to Follow-up|7|||
149073775|NCT04801420|537750120|FG001|Overall Study|Lost to Follow-up|9|||
149073776|NCT04801420|537750121|FG002|Overall Study|Lost to Follow-up|10|||
149073777|NCT04801420|537750119|FG000|Overall Study|Moved from study area|0|||
149073778|NCT04801420|537750120|FG001|Overall Study|Moved from study area|1|||
149073779|NCT04801420|537750121|FG002|Overall Study|Moved from study area|1|||
149073780|NCT04801420|537750119|FG000|Overall Study|Withdrawal by Subject|5|||
149073781|NCT04801420|537750120|FG001|Overall Study|Withdrawal by Subject|1|||
149073782|NCT04801420|537750121|FG002|Overall Study|Withdrawal by Subject|4|||
149073783|NCT04801420|537750119|FG000|Overall Study|Individual stopping criteria reached|0|||
149073784|NCT04801420|537750120|FG001|Overall Study|Individual stopping criteria reached|1|||
149073785|NCT04801420|537750121|FG002|Overall Study|Individual stopping criteria reached|0|||
149073786|NCT04801420|537750119|FG000|Overall Study|Ongoing in the study|195|||
149073787|NCT04801420|537750120|FG001|Overall Study|Ongoing in the study|195|||
149073788|NCT04801420|537750121|FG002|Overall Study|Ongoing in the study|192|||
149073789|NCT03598907|537750122|FG000|Overall Study|Physician Decision|14|||
149073790|NCT03598907|537750123|FG001|Overall Study|Physician Decision|19|||
149073796|NCT03414684|537750125|FG000|First-course Treatment|Complete response|0|||
149073797|NCT03414684|537750126|FG001|First-course Treatment|Complete response|1|||
149073798|NCT03414684|537750125|FG000|First-course Treatment|Intercurrent illness|1|||
149073799|NCT03414684|537750126|FG001|First-course Treatment|Intercurrent illness|0|||
149073800|NCT03414684|537750125|FG000|First-course Treatment|Progressive Disease|31|||
149073801|NCT03414684|537750126|FG001|First-course Treatment|Progressive Disease|32|||
149073802|NCT03414684|537750125|FG000|First-course Treatment|Adverse Event|1|||
149073803|NCT03414684|537750126|FG001|First-course Treatment|Adverse Event|2|||
149073804|NCT03414684|537750125|FG000|First-course Treatment|Physician Decision|0|||
149073805|NCT03414684|537750126|FG001|First-course Treatment|Physician Decision|1|||
149073806|NCT03414684|537750125|FG000|First-course Treatment|Withdrawal by Subject|0|||
149073807|NCT03414684|537750126|FG001|First-course Treatment|Withdrawal by Subject|1|||
149073808|NCT03414684|537750125|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
149073809|NCT03414684|537750126|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
149073810|NCT03414684|537750125|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
149073811|NCT03414684|537750126|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
149073812|NCT03414684|537750125|FG000|First-course Treatment|Still on treatment|3|||
149073813|NCT03414684|537750126|FG001|First-course Treatment|Still on treatment|0|||
149073814|NCT03414684|537750125|FG000|First-course Treatment|Never started protocol therapy|2|||
149073815|NCT03414684|537750126|FG001|First-course Treatment|Never started protocol therapy|1|||
149073816|NCT03414684|537750125|FG000|Crossover Treatment|Progressive disease|0|||
149073817|NCT03414684|537750126|FG001|Crossover Treatment|Progressive disease|12|||
149073818|NCT03414684|537750125|FG000|Crossover Treatment|Adverse Event|0|||
149073819|NCT03414684|537750126|FG001|Crossover Treatment|Adverse Event|3|||
149073820|NCT03414684|537750125|FG000|Crossover Treatment|Physician Decision|0|||
149073821|NCT03414684|537750126|FG001|Crossover Treatment|Physician Decision|1|||
149073822|NCT03414684|537750125|FG000|Crossover Treatment|Still on treatment|0|||
149073823|NCT03414684|537750126|FG001|Crossover Treatment|Still on treatment|2|||
149073824|NCT02078648|537750127|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
149073825|NCT02078648|537750128|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
149073826|NCT02078648|537750127|FG000|Overall Study|Adverse Event|0|||
149073827|NCT02078648|537750128|FG001|Overall Study|Adverse Event|1|||
149073828|NCT02078648|537750127|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
149073829|NCT02078648|537750128|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
149073830|NCT02078648|537750127|FG000|Overall Study|Withdrawal by Subject|3|||
149073831|NCT02078648|537750128|FG001|Overall Study|Withdrawal by Subject|1|||
149073832|NCT02078648|537750127|FG000|Overall Study|Investigator Decision|5|||
149073833|NCT02078648|537750128|FG001|Overall Study|Investigator Decision|7|||
149073834|NCT02078648|537750127|FG000|Overall Study|Death|1|||
149073835|NCT02078648|537750128|FG001|Overall Study|Death|1|||
149073836|NCT02078648|537750127|FG000|Overall Study|Undefined|0|||
149073837|NCT02078648|537750128|FG001|Overall Study|Undefined|1|||
149073838|NCT01675492|537750129|FG000|Overall Study|study completed early - product approval|42|||
149073839|NCT05379270|537750130|FG000|Overall Study|Withdrawal by Subject|1|||
149073840|NCT05379270|537750131|FG001|Overall Study|Withdrawal by Subject|1|||
149073841|NCT00489307|537750134|FG000|Overall Study|Death|1|||
149073842|NCT00489307|537750135|FG001|Overall Study|Death|1|||
149073843|NCT00489307|537750134|FG000|Overall Study|Lost to Follow-up|2|||
149073844|NCT00489307|537750135|FG001|Overall Study|Lost to Follow-up|2|||
149073845|NCT00489307|537750134|FG000|Overall Study|Physician Decision|1|||
149073846|NCT00489307|537750135|FG001|Overall Study|Physician Decision|0|||
149073847|NCT00489307|537750134|FG000|Overall Study|Withdrawal by Subject|2|||
149073848|NCT00489307|537750135|FG001|Overall Study|Withdrawal by Subject|4|||
149073849|NCT00489307|537750134|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
149073850|NCT00489307|537750135|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
149073851|NCT00489307|537750134|FG000|Overall Study|Surgery after assignment|1|||
149073852|NCT00489307|537750135|FG001|Overall Study|Surgery after assignment|0|||
149073853|NCT00489307|537750134|FG000|Overall Study|Did not fill up the forms|2|||
149073854|NCT00489307|537750135|FG001|Overall Study|Did not fill up the forms|1|||
149073855|NCT00489307|537750134|FG000|Overall Study|Patient or family refusal|5|||
149073856|NCT00489307|537750135|FG001|Overall Study|Patient or family refusal|9|||
149073857|NCT02307682|537750136|FG000|Overall Study|Adverse Event|9|||
149073858|NCT02307682|537750137|FG001|Overall Study|Adverse Event|8|||
149073859|NCT02307682|537750138|FG002|Overall Study|Adverse Event|12|||
149073860|NCT02307682|537750136|FG000|Overall Study|Lack of Efficacy|1|||
149073861|NCT02307682|537750137|FG001|Overall Study|Lack of Efficacy|0|||
149073862|NCT02307682|537750138|FG002|Overall Study|Lack of Efficacy|1|||
149073863|NCT02307682|537750136|FG000|Overall Study|Physician Decision|2|||
149073864|NCT02307682|537750137|FG001|Overall Study|Physician Decision|2|||
149073865|NCT02307682|537750138|FG002|Overall Study|Physician Decision|8|||
149073866|NCT02307682|537750136|FG000|Overall Study|Progressive Disease|1|||
149073867|NCT02307682|537750137|FG001|Overall Study|Progressive Disease|0|||
149073868|NCT02307682|537750138|FG002|Overall Study|Progressive Disease|0|||
149073869|NCT02307682|537750136|FG000|Overall Study|Withdrawal by Subject|26|||
149073870|NCT02307682|537750137|FG001|Overall Study|Withdrawal by Subject|34|||
149073871|NCT02307682|537750138|FG002|Overall Study|Withdrawal by Subject|23|||
149073872|NCT02307682|537750136|FG000|Overall Study|Death|9|||
149073873|NCT02307682|537750137|FG001|Overall Study|Death|7|||
149073874|NCT02307682|537750138|FG002|Overall Study|Death|12|||
149073875|NCT02307682|537750136|FG000|Overall Study|Lost to Follow-up|1|||
149073876|NCT02307682|537750137|FG001|Overall Study|Lost to Follow-up|5|||
149073877|NCT02307682|537750138|FG002|Overall Study|Lost to Follow-up|6|||
149073878|NCT02307682|537750136|FG000|Overall Study|Protocol Deviation|0|||
149073879|NCT02307682|537750137|FG001|Overall Study|Protocol Deviation|0|||
149073880|NCT02307682|537750138|FG002|Overall Study|Protocol Deviation|2|||
149073881|NCT02307682|537750136|FG000|Overall Study|Other|1|||
149073882|NCT02307682|537750137|FG001|Overall Study|Other|1|||
149073883|NCT02307682|537750138|FG002|Overall Study|Other|0|||
149073884|NCT04306367|537750144|FG000|Overall Study|Progression of Disease|9|||
149073885|NCT04306367|537750144|FG000|Overall Study|Adverse Event|3|||
149073886|NCT04306367|537750144|FG000|Overall Study|Withdrawal by Subject|1|||
149073887|NCT02401815|537750147|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073888|NCT02401815|537750148|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073889|NCT02401815|537750149|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073890|NCT02401815|537750150|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
149073891|NCT02401815|537750151|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073892|NCT02401815|537750152|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073893|NCT02401815|537750153|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073894|NCT02401815|537750154|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073895|NCT02401815|537750155|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073896|NCT02401815|537750156|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
149073897|NCT02401815|537750147|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
149073898|NCT02401815|537750148|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073899|NCT02401815|537750149|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073900|NCT02401815|537750150|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
149073901|NCT02401815|537750151|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073902|NCT02401815|537750152|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073903|NCT02401815|537750153|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073904|NCT02401815|537750154|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073905|NCT02401815|537750155|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073906|NCT02401815|537750156|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
149073907|NCT02401815|537750147|FG000|Dose Escalation (up to 670 Days)|Death|1|||
149073908|NCT02401815|537750148|FG001|Dose Escalation (up to 670 Days)|Death|2|||
149073909|NCT02401815|537750149|FG002|Dose Escalation (up to 670 Days)|Death|3|||
149073910|NCT02401815|537750150|FG003|Dose Escalation (up to 670 Days)|Death|5|||
149073911|NCT02401815|537750151|FG004|Dose Escalation (up to 670 Days)|Death|4|||
149073912|NCT02401815|537750152|FG005|Dose Escalation (up to 670 Days)|Death|0|||
149073913|NCT02401815|537750153|FG006|Dose Escalation (up to 670 Days)|Death|0|||
149073914|NCT02401815|537750154|FG007|Dose Escalation (up to 670 Days)|Death|0|||
149073915|NCT02401815|537750155|FG008|Dose Escalation (up to 670 Days)|Death|0|||
149073916|NCT02401815|537750156|FG009|Dose Escalation (up to 670 Days)|Death|0|||
149073917|NCT02401815|537750147|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073918|NCT02401815|537750148|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
149073919|NCT02401815|537750149|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073920|NCT02401815|537750150|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073921|NCT02401815|537750151|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
149073922|NCT02401815|537750152|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073923|NCT02401815|537750153|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073924|NCT02401815|537750154|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073925|NCT02401815|537750155|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073926|NCT02401815|537750156|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
149073927|NCT02401815|537750147|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
149073928|NCT02401815|537750148|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073929|NCT02401815|537750149|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073930|NCT02401815|537750150|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073931|NCT02401815|537750151|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
149073932|NCT02401815|537750152|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073933|NCT02401815|537750153|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073934|NCT02401815|537750154|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073935|NCT02401815|537750155|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073936|NCT02401815|537750156|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
149073937|NCT02401815|537750147|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073938|NCT02401815|537750148|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073939|NCT02401815|537750149|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073940|NCT02401815|537750150|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073941|NCT02401815|537750151|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073942|NCT02401815|537750152|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
149073943|NCT02401815|537750153|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073944|NCT02401815|537750154|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073945|NCT02401815|537750155|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073946|NCT02401815|537750156|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
149073947|NCT02401815|537750147|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073948|NCT02401815|537750148|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073949|NCT02401815|537750149|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073950|NCT02401815|537750150|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073951|NCT02401815|537750151|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073952|NCT02401815|537750152|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073953|NCT02401815|537750153|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
149073954|NCT02401815|537750154|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073955|NCT02401815|537750155|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073956|NCT02401815|537750156|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073957|NCT02401815|537750147|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073958|NCT02401815|537750148|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073959|NCT02401815|537750149|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073960|NCT02401815|537750150|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073961|NCT02401815|537750151|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073962|NCT02401815|537750152|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
149073963|NCT02401815|537750153|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
149073964|NCT02401815|537750154|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073965|NCT02401815|537750155|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073966|NCT02401815|537750156|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
149073967|NCT02401815|537750147|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073968|NCT02401815|537750148|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073969|NCT02401815|537750149|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073970|NCT02401815|537750150|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073971|NCT02401815|537750151|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073972|NCT02401815|537750152|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
149073973|NCT02401815|537750153|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073974|NCT02401815|537750154|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073975|NCT02401815|537750155|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073976|NCT02401815|537750156|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
149073977|NCT02401815|537750147|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073978|NCT02401815|537750148|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073979|NCT02401815|537750149|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073980|NCT02401815|537750150|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073981|NCT02401815|537750151|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073982|NCT02401815|537750152|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073983|NCT02401815|537750153|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
149073984|NCT02401815|537750154|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
149073985|NCT02401815|537750155|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
149073986|NCT02401815|537750156|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
149073987|NCT02401815|537750147|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073988|NCT02401815|537750148|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073989|NCT02401815|537750149|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073990|NCT02401815|537750150|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073991|NCT02401815|537750151|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073992|NCT02401815|537750152|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073993|NCT02401815|537750153|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073994|NCT02401815|537750154|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
149073995|NCT02401815|537750155|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
149073996|NCT02401815|537750156|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
149073997|NCT02401815|537750147|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149073998|NCT02401815|537750148|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149073999|NCT02401815|537750149|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074000|NCT02401815|537750150|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074001|NCT02401815|537750151|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074002|NCT02401815|537750152|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074003|NCT02401815|537750153|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074004|NCT02401815|537750154|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074005|NCT02401815|537750155|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
149074006|NCT02401815|537750156|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
149074007|NCT02401815|537750147|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074008|NCT02401815|537750148|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074009|NCT02401815|537750149|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074010|NCT02401815|537750150|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074011|NCT02401815|537750151|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074012|NCT02401815|537750152|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074013|NCT02401815|537750153|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074014|NCT02401815|537750154|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074015|NCT02401815|537750155|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
149074016|NCT02401815|537750156|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
149074017|NCT02401815|537750147|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074018|NCT02401815|537750148|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074019|NCT02401815|537750149|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074020|NCT02401815|537750150|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074021|NCT02401815|537750151|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074022|NCT02401815|537750152|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074023|NCT02401815|537750153|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074024|NCT02401815|537750154|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
149074025|NCT02401815|537750155|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
149074026|NCT02401815|537750156|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
149074027|NCT00748709|537750157|FG000|Overall Study|Progressive disease|15|||
149074028|NCT00748709|537750157|FG000|Overall Study|Drug reducing Toxity|2|||
149074029|NCT00748709|537750157|FG000|Overall Study|Other Adverse Event|1|||
149074030|NCT00748709|537750157|FG000|Overall Study|Withdrawal by Subject|1|||
149074031|NCT00748709|537750157|FG000|Overall Study|Other Reasons|1|||
149074032|NCT04218357|537750162|FG000|1st Allocation|Withdrawal by Subject|1|||
149074033|NCT04218357|537750163|FG001|1st Allocation|Withdrawal by Subject|0|||
149074034|NCT05349838|537750164|FG000|Overall Study|Virological Failure|1|||
149074035|NCT05349838|537750165|FG001|Overall Study|Virological Failure|2|||
149074036|NCT05349838|537750164|FG000|Overall Study|Withdrawal by Subject|2|||
149074037|NCT05349838|537750165|FG001|Overall Study|Withdrawal by Subject|3|||
149074038|NCT05349838|537750164|FG000|Overall Study|Adverse Event|3|||
149074039|NCT05349838|537750165|FG001|Overall Study|Adverse Event|1|||
149074040|NCT05349838|537750164|FG000|Overall Study|Lost to Follow-up|1|||
149074041|NCT05349838|537750165|FG001|Overall Study|Lost to Follow-up|2|||
149074042|NCT05349838|537750164|FG000|Overall Study|Other reasons|5|||
149074043|NCT05349838|537750165|FG001|Overall Study|Other reasons|1|||
149074044|NCT05037513|537750166|FG000|Intervention Period|Lost to Follow-up|1|||
149074045|NCT05037513|537750167|FG001|Intervention Period|Lost to Follow-up|2|||
149074046|NCT05037513|537750166|FG000|Follow Up Period|Lost to Follow-up|16|||
149074047|NCT05037513|537750167|FG001|Follow Up Period|Lost to Follow-up|21|||
149074048|NCT05037513|537750166|FG000|Follow Up Period|Death|0|||
149074049|NCT05037513|537750167|FG001|Follow Up Period|Death|1|||
149074050|NCT05037513|537750166|FG000|Follow Up Period|Incarcerated|4|||
149074051|NCT05037513|537750167|FG001|Follow Up Period|Incarcerated|2|||
149074052|NCT05886777|537750168|FG000|Overall Study|Lost to Follow-up|1|||
149074053|NCT05886777|537750169|FG001|Overall Study|Lost to Follow-up|0|||
149074054|NCT05886777|537750170|FG002|Overall Study|Lost to Follow-up|2|||
149074055|NCT05886777|537750171|FG003|Overall Study|Lost to Follow-up|1|||
149074056|NCT05886777|537750172|FG004|Overall Study|Lost to Follow-up|0|||
149074057|NCT05886777|537750173|FG005|Overall Study|Lost to Follow-up|2|||
149074058|NCT05886777|537750174|FG006|Overall Study|Lost to Follow-up|0|||
149074059|NCT05886777|537750168|FG000|Overall Study|Other|0|||
149074060|NCT05886777|537750169|FG001|Overall Study|Other|2|||
149074061|NCT05886777|537750170|FG002|Overall Study|Other|1|||
149074062|NCT05886777|537750171|FG003|Overall Study|Other|0|||
149074063|NCT05886777|537750172|FG004|Overall Study|Other|0|||
149074064|NCT05886777|537750173|FG005|Overall Study|Other|0|||
149074065|NCT05886777|537750174|FG006|Overall Study|Other|0|||
149074066|NCT05886777|537750168|FG000|Overall Study|Withdrawal by Subject|1|||
149074067|NCT05886777|537750169|FG001|Overall Study|Withdrawal by Subject|0|||
149074068|NCT05886777|537750170|FG002|Overall Study|Withdrawal by Subject|1|||
149074069|NCT05886777|537750171|FG003|Overall Study|Withdrawal by Subject|4|||
149074070|NCT05886777|537750172|FG004|Overall Study|Withdrawal by Subject|3|||
149074071|NCT05886777|537750173|FG005|Overall Study|Withdrawal by Subject|1|||
149074072|NCT05886777|537750174|FG006|Overall Study|Withdrawal by Subject|1|||
149074073|NCT05886777|537750168|FG000|Overall Study|Protocol Violation|0|||
149074074|NCT05886777|537750169|FG001|Overall Study|Protocol Violation|0|||
149074075|NCT05886777|537750170|FG002|Overall Study|Protocol Violation|1|||
149074076|NCT05886777|537750171|FG003|Overall Study|Protocol Violation|0|||
149074077|NCT05886777|537750172|FG004|Overall Study|Protocol Violation|0|||
149074078|NCT05886777|537750173|FG005|Overall Study|Protocol Violation|0|||
149074079|NCT05886777|537750174|FG006|Overall Study|Protocol Violation|0|||
149074080|NCT05886777|537750168|FG000|Overall Study|No longer met eligibility criteria|0|||
149074081|NCT05886777|537750169|FG001|Overall Study|No longer met eligibility criteria|1|||
149074082|NCT05886777|537750170|FG002|Overall Study|No longer met eligibility criteria|0|||
149074083|NCT05886777|537750171|FG003|Overall Study|No longer met eligibility criteria|0|||
149074084|NCT05886777|537750172|FG004|Overall Study|No longer met eligibility criteria|0|||
149074085|NCT05886777|537750173|FG005|Overall Study|No longer met eligibility criteria|0|||
149074086|NCT05886777|537750174|FG006|Overall Study|No longer met eligibility criteria|0|||
149074087|NCT03773107|537750175|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
149074088|NCT03773107|537750176|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
149074089|NCT03773107|537750177|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
149074090|NCT03773107|537750178|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
149074091|NCT07204444|537750181|FG000|Overall Study|Medical/Hospitalization|6|||
149074092|NCT07204444|537750182|FG001|Overall Study|Medical/Hospitalization|9|||
149074093|NCT07204444|537750183|FG002|Overall Study|Medical/Hospitalization|6|||
149074094|NCT07204444|537750181|FG000|Overall Study|Treatment Provider Issue|1|||
149074095|NCT07204444|537750182|FG001|Overall Study|Treatment Provider Issue|3|||
149074096|NCT07204444|537750183|FG002|Overall Study|Treatment Provider Issue|0|||
149074097|NCT07204444|537750181|FG000|Overall Study|Withdrawal by Subject|11|||
149074098|NCT07204444|537750182|FG001|Overall Study|Withdrawal by Subject|5|||
149074099|NCT07204444|537750183|FG002|Overall Study|Withdrawal by Subject|5|||
149074100|NCT07204444|537750181|FG000|Overall Study|Death|3|||
149074101|NCT07204444|537750182|FG001|Overall Study|Death|6|||
149074102|NCT07204444|537750183|FG002|Overall Study|Death|1|||
149074103|NCT07204444|537750181|FG000|Overall Study|Unable To Reach|29|||
149074104|NCT07204444|537750182|FG001|Overall Study|Unable To Reach|26|||
149074105|NCT07204444|537750183|FG002|Overall Study|Unable To Reach|17|||
149074106|NCT07204444|537750181|FG000|Overall Study|Protocol Deviation|3|||
149074107|NCT07204444|537750182|FG001|Overall Study|Protocol Deviation|2|||
149074108|NCT07204444|537750183|FG002|Overall Study|Protocol Deviation|0|||
149074109|NCT02036970|537751227|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
149074110|NCT02036970|537751228|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
149074111|NCT02036970|537751229|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
149074112|NCT02036970|537751230|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
149074113|NCT02036970|537751231|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
149074114|NCT02036970|537751232|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
149074115|NCT02036970|537751233|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
149074116|NCT02036970|537751234|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
149074117|NCT02036970|537751235|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
149074118|NCT02036970|537751236|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
149074119|NCT02036970|537751227|FG000|Part 1: Day 1 Through Week 16|Death|0|||
149074120|NCT02036970|537751228|FG001|Part 1: Day 1 Through Week 16|Death|0|||
149074121|NCT02036970|537751229|FG002|Part 1: Day 1 Through Week 16|Death|0|||
149074122|NCT02036970|537751230|FG003|Part 1: Day 1 Through Week 16|Death|0|||
149074123|NCT02036970|537751231|FG004|Part 1: Day 1 Through Week 16|Death|0|||
149074124|NCT02036970|537751232|FG005|Part 1: Day 1 Through Week 16|Death|0|||
149074125|NCT02036970|537751233|FG006|Part 1: Day 1 Through Week 16|Death|0|||
149074126|NCT02036970|537751234|FG007|Part 1: Day 1 Through Week 16|Death|0|||
149074127|NCT02036970|537751235|FG008|Part 1: Day 1 Through Week 16|Death|1|||
149074128|NCT02036970|537751236|FG009|Part 1: Day 1 Through Week 16|Death|0|||
149074129|NCT02036970|537751227|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
149074130|NCT02036970|537751228|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074131|NCT02036970|537751229|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
149074132|NCT02036970|537751230|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074133|NCT02036970|537751231|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074134|NCT02036970|537751232|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074135|NCT02036970|537751233|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074136|NCT02036970|537751234|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074137|NCT02036970|537751235|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
149074138|NCT02036970|537751236|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
149074139|NCT02036970|537751227|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074140|NCT02036970|537751228|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074141|NCT02036970|537751229|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074142|NCT02036970|537751230|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074143|NCT02036970|537751231|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
149074144|NCT02036970|537751232|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074145|NCT02036970|537751233|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074146|NCT02036970|537751234|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
149074147|NCT02036970|537751235|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
149074148|NCT02036970|537751236|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
149074149|NCT02036970|537751227|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074150|NCT02036970|537751228|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074151|NCT02036970|537751229|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074152|NCT02036970|537751230|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
149074153|NCT02036970|537751231|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074154|NCT02036970|537751232|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074155|NCT02036970|537751233|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074156|NCT02036970|537751234|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074157|NCT02036970|537751235|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074158|NCT02036970|537751236|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
149074159|NCT02036970|537751227|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
149074160|NCT02036970|537751228|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
149074161|NCT02036970|537751229|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
149074162|NCT02036970|537751230|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
149074163|NCT02036970|537751231|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
149074164|NCT02036970|537751232|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
149074165|NCT02036970|537751233|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
149074166|NCT02036970|537751234|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
149074167|NCT02036970|537751235|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
149074168|NCT02036970|537751236|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
149074169|NCT02036970|537751227|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074170|NCT02036970|537751228|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074171|NCT02036970|537751229|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074172|NCT02036970|537751230|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074173|NCT02036970|537751231|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074174|NCT02036970|537751232|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074175|NCT02036970|537751233|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074176|NCT02036970|537751234|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
149074177|NCT02036970|537751235|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074178|NCT02036970|537751236|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
149074179|NCT02036970|537751227|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074180|NCT02036970|537751228|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
149074181|NCT02036970|537751229|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
149074182|NCT02036970|537751230|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074183|NCT02036970|537751231|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074184|NCT02036970|537751232|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074185|NCT02036970|537751233|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074186|NCT02036970|537751234|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074187|NCT02036970|537751235|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
149074188|NCT02036970|537751236|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
149074189|NCT02036970|537751227|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
149074190|NCT02036970|537751228|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
149074191|NCT02036970|537751229|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
149074192|NCT02036970|537751230|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
149074193|NCT02036970|537751231|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
149074194|NCT02036970|537751232|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
149074195|NCT02036970|537751233|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
149074196|NCT02036970|537751234|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
149074197|NCT02036970|537751235|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
149074198|NCT02036970|537751236|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
149074199|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
149074200|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
149074201|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
149074202|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
149074203|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
149074204|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
149074205|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
149074206|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
149074207|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
149074208|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
149074209|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
149074210|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
149074211|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
149074212|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
149074213|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
149074214|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
149074215|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
149074216|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
149074217|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
149074218|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
149074219|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
149074220|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
149074221|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
149074222|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
149074223|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
149074224|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Other|1|||
149074225|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Other|0|||
149074226|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Other|0|||
149074227|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Other|0|||
149074228|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Other|0|||
149074229|NCT02386098|537751237|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
149074230|NCT02386098|537751238|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
149074231|NCT02386098|537751239|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
149074232|NCT02386098|537751240|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
149074233|NCT02386098|537751241|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
149074234|NCT03002194|537751244|FG000|Overall Study|Lost to Follow-up|6|||
149074235|NCT03002194|537751244|FG000|Overall Study|Adverse Event|1|||
149074236|NCT03002194|537751244|FG000|Overall Study|Lack of Efficacy|1|||
149074237|NCT03002194|537751244|FG000|Overall Study|Withdrawal by Subject|2|||
149074238|NCT02200705|537751249|FG000|Overall Study|Excluded|12|||
149074239|NCT02200705|537751249|FG000|Overall Study|Death|21|||
149074240|NCT02200705|537751249|FG000|Overall Study|Withdrawal by Subject|22|||
149074241|NCT02200705|537751249|FG000|Overall Study|Lost to Follow-up|13|||
149074242|NCT02200705|537751249|FG000|Overall Study|Physician Decision|5|||
149074243|NCT02200705|537751249|FG000|Overall Study|Adverse Event|2|||
149074244|NCT03738228|537751250|FG000|Overall Study|Never received study treatment|2|||
149074245|NCT03738228|537751251|FG001|Overall Study|Never received study treatment|2|||
149074246|NCT04162210|537751252|FG000|Overall Study|Lost to Follow-up|4|||
149074247|NCT04162210|537751253|FG001|Overall Study|Lost to Follow-up|1|||
149074248|NCT04162210|537751252|FG000|Overall Study|Withdrawal by Subject|17|||
149074249|NCT04162210|537751253|FG001|Overall Study|Withdrawal by Subject|9|||
149074250|NCT04162210|537751252|FG000|Overall Study|Ongoing|113|||
149074251|NCT04162210|537751253|FG001|Overall Study|Ongoing|59|||
149074252|NCT01641900|537751254|FG000|Overall Study|Withdrawal by Subject|2|||
149074253|NCT01641900|537751255|FG001|Overall Study|Withdrawal by Subject|2|||
149074254|NCT02568215|537751256|FG000|Overall Study|Death|1|||
149074255|NCT02568215|537751257|FG001|Overall Study|Death|2|||
149074256|NCT02568215|537751258|FG002|Overall Study|Death|0|||
149074257|NCT02568215|537751256|FG000|Overall Study|Physician Decision|2|||
149074258|NCT02568215|537751257|FG001|Overall Study|Physician Decision|2|||
149074259|NCT02568215|537751258|FG002|Overall Study|Physician Decision|2|||
149074260|NCT02568215|537751256|FG000|Overall Study|Lost to Follow-up|29|||
149074261|NCT02568215|537751257|FG001|Overall Study|Lost to Follow-up|32|||
149074262|NCT02568215|537751258|FG002|Overall Study|Lost to Follow-up|41|||
149074263|NCT02568215|537751256|FG000|Overall Study|Withdrawal by Subject|21|||
149074264|NCT02568215|537751257|FG001|Overall Study|Withdrawal by Subject|19|||
149074265|NCT02568215|537751258|FG002|Overall Study|Withdrawal by Subject|22|||
149074266|NCT02568215|537751256|FG000|Overall Study|Protocol Violation|1|||
149074267|NCT02568215|537751257|FG001|Overall Study|Protocol Violation|1|||
149074268|NCT02568215|537751258|FG002|Overall Study|Protocol Violation|0|||
149074269|NCT02568215|537751256|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
149074270|NCT02568215|537751257|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
149074271|NCT02568215|537751258|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
149074272|NCT02568215|537751256|FG000|Overall Study|Other|0|||
149074273|NCT02568215|537751257|FG001|Overall Study|Other|1|||
149074274|NCT02568215|537751258|FG002|Overall Study|Other|4|||
149074275|NCT00371345|537751259|FG000|Overall Study|Disease Progression|21|||
149074276|NCT00371345|537751260|FG001|Overall Study|Disease Progression|35|||
149074277|NCT00371345|537751259|FG000|Overall Study|Study Drug Toxicity|1|||
149074278|NCT00371345|537751260|FG001|Overall Study|Study Drug Toxicity|7|||
149074279|NCT00371345|537751259|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
149074280|NCT00371345|537751260|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
149074281|NCT00371345|537751259|FG000|Overall Study|Participant Request|1|||
149074282|NCT00371345|537751260|FG001|Overall Study|Participant Request|1|||
149074283|NCT00371345|537751259|FG000|Overall Study|Participant Withdrew Consent|0|||
149074284|NCT00371345|537751260|FG001|Overall Study|Participant Withdrew Consent|1|||
149074285|NCT00442104|537751261|FG000|Overall Study|Adverse Event|5|||
149074286|NCT00442104|537751261|FG000|Overall Study|Death|2|||
149074287|NCT00442104|537751261|FG000|Overall Study|Lost to Follow-up|3|||
149074288|NCT00442104|537751261|FG000|Overall Study|Withdrawal by Subject|5|||
149074289|NCT00442104|537751261|FG000|Overall Study|Insufficient Clinical Response|10|||
149074290|NCT00442104|537751261|FG000|Overall Study|Other|21|||
149074291|NCT00442104|537751261|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
149074292|NCT04497415|537751264|FG000|Overall Study|Lost to Follow-up|43|||
149074293|NCT04497415|537751265|FG001|Overall Study|Lost to Follow-up|27|||
149074294|NCT02463448|537751269|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
149074295|NCT02463448|537751269|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
149074296|NCT02463448|537751269|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
149074297|NCT02463448|537751269|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
149074298|NCT03021993|537751270|FG000|Overall Study|Withdrawal by Subject|4|||
149074299|NCT03021993|537751270|FG000|Overall Study|Physician Decision|1|||
149074300|NCT03021993|537751270|FG000|Overall Study|enrolled but were not treated|1|||
149074301|NCT03021993|537751270|FG000|Overall Study|Death|3|||
149074302|NCT03683576|537751273|FG000|Overall Study|Withdrawal by Subject|2|||
149074303|NCT03683576|537751274|FG001|Overall Study|Withdrawal by Subject|0|||
149074304|NCT03683576|537751275|FG002|Overall Study|Withdrawal by Subject|8|||
149074305|NCT03683576|537751276|FG003|Overall Study|Withdrawal by Subject|3|||
149074306|NCT03683576|537751273|FG000|Overall Study|Adverse Event|3|||
149074307|NCT03683576|537751274|FG001|Overall Study|Adverse Event|0|||
149074308|NCT03683576|537751275|FG002|Overall Study|Adverse Event|0|||
149074309|NCT03683576|537751276|FG003|Overall Study|Adverse Event|4|||
149074310|NCT03683576|537751273|FG000|Overall Study|Lack of Efficacy|1|||
149074311|NCT03683576|537751274|FG001|Overall Study|Lack of Efficacy|0|||
149074312|NCT03683576|537751275|FG002|Overall Study|Lack of Efficacy|1|||
149074313|NCT03683576|537751276|FG003|Overall Study|Lack of Efficacy|1|||
149074314|NCT03683576|537751273|FG000|Overall Study|Lost to Follow-up|0|||
149074315|NCT03683576|537751274|FG001|Overall Study|Lost to Follow-up|1|||
149074316|NCT03683576|537751275|FG002|Overall Study|Lost to Follow-up|2|||
149074317|NCT03683576|537751276|FG003|Overall Study|Lost to Follow-up|0|||
149074318|NCT03683576|537751273|FG000|Overall Study|Other, Not Specified|0|||
149074319|NCT03683576|537751274|FG001|Overall Study|Other, Not Specified|2|||
149074320|NCT03683576|537751275|FG002|Overall Study|Other, Not Specified|0|||
149074321|NCT03683576|537751276|FG003|Overall Study|Other, Not Specified|0|||
149074322|NCT03683576|537751273|FG000|Overall Study|Protocol Violation|0|||
149074323|NCT03683576|537751274|FG001|Overall Study|Protocol Violation|1|||
149074324|NCT03683576|537751275|FG002|Overall Study|Protocol Violation|1|||
149074325|NCT03683576|537751276|FG003|Overall Study|Protocol Violation|0|||
149074326|NCT02628626|537751278|FG000|Overall Study|Withdrawal by Subject|2|||
149074327|NCT02628626|537751279|FG001|Overall Study|Withdrawal by Subject|2|||
149074328|NCT02744066|537751280|FG000|Overall Study|Withdrawal by parent|0|||
149074329|NCT02744066|537751281|FG001|Overall Study|Withdrawal by parent|1|||
149074330|NCT02744066|537751280|FG000|Overall Study|Discharged from NICU prior to completion|0|||
149074331|NCT02744066|537751281|FG001|Overall Study|Discharged from NICU prior to completion|4|||
149074332|NCT03492177|537751285|FG000|Overall Study|Adverse Event|1|||
149074333|NCT03492177|537751286|FG001|Overall Study|Adverse Event|0|||
149074334|NCT03492177|537751287|FG002|Overall Study|Adverse Event|0|||
149074335|NCT03492177|537751285|FG000|Overall Study|Death|3|||
149074336|NCT03492177|537751286|FG001|Overall Study|Death|0|||
149074337|NCT03492177|537751287|FG002|Overall Study|Death|3|||
149074338|NCT03492177|537751285|FG000|Overall Study|Lack of Efficacy|1|||
149074339|NCT03492177|537751286|FG001|Overall Study|Lack of Efficacy|2|||
149074340|NCT03492177|537751287|FG002|Overall Study|Lack of Efficacy|0|||
149074341|NCT03492177|537751285|FG000|Overall Study|Other|1|||
149074342|NCT03492177|537751286|FG001|Overall Study|Other|0|||
149074343|NCT03492177|537751287|FG002|Overall Study|Other|0|||
149074344|NCT03492177|537751285|FG000|Overall Study|Ongoing|16|||
149074345|NCT03492177|537751286|FG001|Overall Study|Ongoing|19|||
149074346|NCT03492177|537751287|FG002|Overall Study|Ongoing|17|||
149074347|NCT01400958|537751290|FG000|Overall Study|Physician Decision|0|||
149074348|NCT01400958|537751291|FG001|Overall Study|Physician Decision|1|||
149074349|NCT01400958|537751290|FG000|Overall Study|Withdrawal by Subject|0|||
149074350|NCT01400958|537751291|FG001|Overall Study|Withdrawal by Subject|1|||
149074351|NCT01400958|537751290|FG000|Overall Study|Adverse Event|1|||
149074352|NCT01400958|537751291|FG001|Overall Study|Adverse Event|0|||
149074353|NCT03102034|537751292|FG000|Overall Study|Withdrawal by Subject|1|||
149074354|NCT03102034|537751293|FG001|Overall Study|Withdrawal by Subject|0|||
149074355|NCT03488719|537751294|FG000|Overall Study|Adverse Event|0|||
149074356|NCT03488719|537751295|FG001|Overall Study|Adverse Event|4|||
149074357|NCT03488719|537751296|FG002|Overall Study|Adverse Event|2|||
149074358|NCT03488719|537751294|FG000|Overall Study|Other|0|||
149074359|NCT03488719|537751295|FG001|Overall Study|Other|0|||
149074360|NCT03488719|537751296|FG002|Overall Study|Other|5|||
149074361|NCT03656718|537751299|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
149074362|NCT03656718|537751300|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
149074363|NCT03656718|537751301|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
149074364|NCT03656718|537751302|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
149074365|NCT03656718|537751303|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
149074366|NCT03656718|537751304|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
149074367|NCT03656718|537751305|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
149074368|NCT03656718|537751299|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
149074369|NCT03656718|537751300|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
149074370|NCT03656718|537751301|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
149074371|NCT03656718|537751302|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
149074372|NCT03656718|537751303|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
149074373|NCT03656718|537751304|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
149074374|NCT03656718|537751305|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
149074375|NCT03656718|537751299|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
149074376|NCT03656718|537751300|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
149074377|NCT03656718|537751301|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
149074378|NCT03656718|537751302|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
149074379|NCT03656718|537751303|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
149074380|NCT03656718|537751304|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
149074381|NCT03656718|537751305|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
149074382|NCT03656718|537751299|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
149074383|NCT03656718|537751300|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
149074384|NCT03656718|537751301|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
149074385|NCT03656718|537751302|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
149074386|NCT03656718|537751303|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
149074387|NCT03656718|537751304|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
149074388|NCT03656718|537751305|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
149074389|NCT03656718|537751299|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
149074390|NCT03656718|537751300|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
149074391|NCT03656718|537751301|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
149074392|NCT03656718|537751302|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
149074393|NCT03656718|537751303|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
149074394|NCT03656718|537751304|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
149074395|NCT03656718|537751305|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
149074396|NCT03656718|537751299|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
149074397|NCT03656718|537751300|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
149074398|NCT03656718|537751301|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
149074399|NCT03656718|537751302|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
149074400|NCT03656718|537751303|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
149074401|NCT03656718|537751304|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
149074402|NCT03656718|537751305|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
149074403|NCT03656718|537751299|FG000|Treatment Period Part C|Disease progression|0|||
149074404|NCT03656718|537751300|FG001|Treatment Period Part C|Disease progression|0|||
149074405|NCT03656718|537751301|FG002|Treatment Period Part C|Disease progression|0|||
149074406|NCT03656718|537751302|FG003|Treatment Period Part C|Disease progression|0|||
149074407|NCT03656718|537751303|FG004|Treatment Period Part C|Disease progression|12|||
149074408|NCT03656718|537751304|FG005|Treatment Period Part C|Disease progression|0|||
149074409|NCT03656718|537751305|FG006|Treatment Period Part C|Disease progression|0|||
149074410|NCT03656718|537751299|FG000|Treatment Period Part C|Death|0|||
149074411|NCT03656718|537751300|FG001|Treatment Period Part C|Death|0|||
149074412|NCT03656718|537751301|FG002|Treatment Period Part C|Death|0|||
149074413|NCT03656718|537751302|FG003|Treatment Period Part C|Death|0|||
149074414|NCT03656718|537751303|FG004|Treatment Period Part C|Death|1|||
149074415|NCT03656718|537751304|FG005|Treatment Period Part C|Death|0|||
149074416|NCT03656718|537751305|FG006|Treatment Period Part C|Death|0|||
149074417|NCT03656718|537751299|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
149074418|NCT03656718|537751300|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
149074419|NCT03656718|537751301|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
149074420|NCT03656718|537751302|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
149074421|NCT03656718|537751303|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
149074422|NCT03656718|537751304|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
149074423|NCT03656718|537751305|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
149074424|NCT03656718|537751299|FG000|Treatment Period Part C|Other reasons|0|||
149074425|NCT03656718|537751300|FG001|Treatment Period Part C|Other reasons|0|||
149074426|NCT03656718|537751301|FG002|Treatment Period Part C|Other reasons|0|||
149074427|NCT03656718|537751302|FG003|Treatment Period Part C|Other reasons|0|||
149074428|NCT03656718|537751303|FG004|Treatment Period Part C|Other reasons|1|||
149074429|NCT03656718|537751304|FG005|Treatment Period Part C|Other reasons|0|||
149074430|NCT03656718|537751305|FG006|Treatment Period Part C|Other reasons|0|||
149074431|NCT03656718|537751299|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
149074432|NCT03656718|537751300|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
149074433|NCT03656718|537751301|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
149074434|NCT03656718|537751302|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
149074435|NCT03656718|537751303|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
149074436|NCT03656718|537751304|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
149074437|NCT03656718|537751305|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
149074438|NCT01855750|537751306|FG000|Overall Study|Death|78|||
149074439|NCT01855750|537751307|FG001|Overall Study|Death|78|||
149074440|NCT01855750|537751306|FG000|Overall Study|Lost to Follow-up|9|||
149074441|NCT01855750|537751307|FG001|Overall Study|Lost to Follow-up|23|||
149074442|NCT01855750|537751306|FG000|Overall Study|Withdrawal by Subject|35|||
149074443|NCT01855750|537751307|FG001|Overall Study|Withdrawal by Subject|28|||
149074444|NCT01855750|537751306|FG000|Overall Study|Sponsor ends the study|297|||
149074445|NCT01855750|537751307|FG001|Overall Study|Sponsor ends the study|290|||
149074446|NCT03425682|537751308|FG000|Overall Study|Lost to Follow-up|2|||
149074447|NCT03425682|537751309|FG001|Overall Study|Lost to Follow-up|4|||
149074448|NCT03425682|537751308|FG000|Overall Study|Withdrawal by Subject|0|||
149074449|NCT03425682|537751309|FG001|Overall Study|Withdrawal by Subject|3|||
149074450|NCT03425682|537751308|FG000|Overall Study|Subject did not meet I/E|4|||
149074451|NCT03425682|537751309|FG001|Overall Study|Subject did not meet I/E|10|||
149074452|NCT03610581|537751310|FG000|Overall Study|Study terminated by sponsor|2|||
149074453|NCT03610581|537751311|FG001|Overall Study|Study terminated by sponsor|0|||
149074454|NCT03610581|537751310|FG000|Overall Study|Other|0|||
149074455|NCT03610581|537751311|FG001|Overall Study|Other|1|||
149074456|NCT03610581|537751310|FG000|Overall Study|Withdrawal by Subject|1|||
149074457|NCT03610581|537751311|FG001|Overall Study|Withdrawal by Subject|0|||
149074458|NCT02517268|537751314|FG000|Overall Study|Withdrawal by Subject|1|||
149074459|NCT02517268|537751315|FG001|Overall Study|Withdrawal by Subject|0|||
149074460|NCT04686266|537751316|FG000|Overall Study|Withdrawal by Subject|0|||
149074461|NCT04686266|537751317|FG001|Overall Study|Withdrawal by Subject|1|||
149074462|NCT03227861|537751320|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
149074463|NCT03227861|537751320|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
149074464|NCT03227861|537751320|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
149074465|NCT03227861|537751320|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
149074466|NCT03227861|537751320|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
149074467|NCT03227861|537751320|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
149074468|NCT03227861|537751320|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
149074469|NCT03227861|537751320|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
149074470|NCT03227861|537751320|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
149074471|NCT03227861|537751320|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
149074472|NCT05071430|537751322|FG000|Overall Study|Adverse Event|1|||
149074473|NCT05071430|537751323|FG001|Overall Study|Adverse Event|2|||
149074474|NCT05071430|537751322|FG000|Overall Study|Lost to Follow-up|4|||
149074475|NCT05071430|537751323|FG001|Overall Study|Lost to Follow-up|4|||
149074476|NCT05071430|537751322|FG000|Overall Study|Protocol Violation|1|||
149074477|NCT05071430|537751323|FG001|Overall Study|Protocol Violation|0|||
149074478|NCT05071430|537751322|FG000|Overall Study|Withdrawal by Subject|3|||
149074479|NCT05071430|537751323|FG001|Overall Study|Withdrawal by Subject|2|||
149074480|NCT05071430|537751322|FG000|Overall Study|Other|1|||
149074481|NCT05071430|537751323|FG001|Overall Study|Other|1|||
149074482|NCT01958021|537751324|FG000|Treatment|Progressive disease|206|||
149074483|NCT01958021|537751325|FG001|Treatment|Progressive disease|265|||
149074484|NCT01958021|537751324|FG000|Treatment|Adverse Event|38|||
149074485|NCT01958021|537751325|FG001|Treatment|Adverse Event|10|||
149074486|NCT01958021|537751324|FG000|Treatment|Subject/guardian decision|29|||
149074487|NCT01958021|537751325|FG001|Treatment|Subject/guardian decision|25|||
149074488|NCT01958021|537751324|FG000|Treatment|Physician Decision|28|||
149074489|NCT01958021|537751325|FG001|Treatment|Physician Decision|21|||
149074490|NCT01958021|537751324|FG000|Treatment|Death|6|||
149074491|NCT01958021|537751325|FG001|Treatment|Death|1|||
149074492|NCT01958021|537751324|FG000|Treatment|Protocol deviation|3|||
149074493|NCT01958021|537751325|FG001|Treatment|Protocol deviation|1|||
149074494|NCT01958021|537751324|FG000|Treatment|Sponsor decision|24|||
149074495|NCT01958021|537751325|FG001|Treatment|Sponsor decision|11|||
149074496|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
149074497|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
149074498|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Death|1|||
149074499|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Death|0|||
149074500|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
149074501|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
149074502|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
149074503|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
149074504|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
149074505|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
149074506|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
149074507|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
149074508|NCT01958021|537751324|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
149074509|NCT01958021|537751325|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
149074510|NCT05199571|537752778|FG000|Treatment Period|Participant decision|3|||
149074511|NCT05199571|537752778|FG000|Treatment Period|Physician Decision|1|||
149074512|NCT05199571|537752778|FG000|Post-treatment Follow up Period|Participant decision|3|||
149074513|NCT03762850|537752779|FG000|Overall Study|Death|0|||
149074514|NCT03762850|537752780|FG001|Overall Study|Death|1|||
149074515|NCT03762850|537752779|FG000|Overall Study|Lost to Follow-up|0|||
149074516|NCT03762850|537752780|FG001|Overall Study|Lost to Follow-up|1|||
149074517|NCT03762850|537752779|FG000|Overall Study|Physician Decision|0|||
149074518|NCT03762850|537752780|FG001|Overall Study|Physician Decision|1|||
149074519|NCT03762850|537752779|FG000|Overall Study|Withdrawal by Subject|4|||
149074520|NCT03762850|537752780|FG001|Overall Study|Withdrawal by Subject|9|||
149074521|NCT04083976|537752781|FG000|Overall Study|Lost to Follow-up|3|||
149074522|NCT04083976|537752782|FG001|Overall Study|Lost to Follow-up|0|||
149074523|NCT04083976|537752783|FG002|Overall Study|Lost to Follow-up|0|||
149074524|NCT04083976|537752784|FG003|Overall Study|Lost to Follow-up|1|||
149074525|NCT04083976|537752781|FG000|Overall Study|Withdrawal by Subject|16|||
149074526|NCT04083976|537752782|FG001|Overall Study|Withdrawal by Subject|1|||
149074527|NCT04083976|537752783|FG002|Overall Study|Withdrawal by Subject|9|||
149074528|NCT04083976|537752784|FG003|Overall Study|Withdrawal by Subject|0|||
149074529|NCT04083976|537752781|FG000|Overall Study|Sponsor Decision|14|||
149074530|NCT04083976|537752782|FG001|Overall Study|Sponsor Decision|0|||
149074531|NCT04083976|537752783|FG002|Overall Study|Sponsor Decision|0|||
149074532|NCT04083976|537752784|FG003|Overall Study|Sponsor Decision|7|||
149074533|NCT04083976|537752781|FG000|Overall Study|Other|1|||
149074534|NCT04083976|537752782|FG001|Overall Study|Other|0|||
149074535|NCT04083976|537752783|FG002|Overall Study|Other|1|||
149074536|NCT04083976|537752784|FG003|Overall Study|Other|0|||
149074537|NCT00512252|537752792|FG000|Overall Study|Lost to Follow-up|0|||
149074538|NCT00512252|537752793|FG001|Overall Study|Lost to Follow-up|0|||
149074539|NCT00512252|537752794|FG002|Overall Study|Lost to Follow-up|1|||
149074540|NCT00512252|537752792|FG000|Overall Study|Protocol Violation|0|||
149074541|NCT00512252|537752793|FG001|Overall Study|Protocol Violation|0|||
149074542|NCT00512252|537752794|FG002|Overall Study|Protocol Violation|1|||
149074543|NCT00512252|537752792|FG000|Overall Study|Death|0|||
149074544|NCT00512252|537752793|FG001|Overall Study|Death|0|||
149074545|NCT00512252|537752794|FG002|Overall Study|Death|1|||
149074546|NCT02357966|537752795|FG000|Overall Study|Death|0|||
149074547|NCT02357966|537752796|FG001|Overall Study|Death|0|||
149074548|NCT02357966|537752797|FG002|Overall Study|Death|1|||
149074549|NCT02357966|537752798|FG003|Overall Study|Death|0|||
149074550|NCT02357966|537752799|FG004|Overall Study|Death|2|||
149074551|NCT02357966|537752800|FG005|Overall Study|Death|0|||
149074552|NCT02357966|537752795|FG000|Overall Study|Physician Decision|1|||
149074553|NCT02357966|537752796|FG001|Overall Study|Physician Decision|0|||
149074554|NCT02357966|537752797|FG002|Overall Study|Physician Decision|0|||
149074555|NCT02357966|537752798|FG003|Overall Study|Physician Decision|0|||
149074556|NCT02357966|537752799|FG004|Overall Study|Physician Decision|1|||
149074557|NCT02357966|537752800|FG005|Overall Study|Physician Decision|0|||
149074558|NCT01779700|537752801|FG000|Overall Study|Adverse Event|4|||
149074559|NCT01779700|537752802|FG001|Overall Study|Adverse Event|3|||
149074560|NCT01779700|537752801|FG000|Overall Study|Withdrawal by Subject|0|||
149074561|NCT01779700|537752802|FG001|Overall Study|Withdrawal by Subject|2|||
149074562|NCT04608409|537752806|FG000|Overall Study|Physician Decision|1|||
149074563|NCT04608409|537752807|FG001|Overall Study|Physician Decision|1|||
149074564|NCT04608409|537752808|FG002|Overall Study|Physician Decision|2|||
149074565|NCT00229658|537752811|FG000|Overall Study|Administrative|2|||
149074566|NCT00229658|537752812|FG001|Overall Study|Administrative|1|||
149074567|NCT00229658|537752811|FG000|Overall Study|Investigator decision|13|||
149074568|NCT00229658|537752812|FG001|Overall Study|Investigator decision|10|||
149074569|NCT00229658|537752811|FG000|Overall Study|Other|80|||
149074570|NCT00229658|537752812|FG001|Overall Study|Other|60|||
149074571|NCT00229658|537752811|FG000|Overall Study|Lost to Follow-up|82|||
149074572|NCT00229658|537752812|FG001|Overall Study|Lost to Follow-up|55|||
149074573|NCT00229658|537752811|FG000|Overall Study|Serious Adverse Event|2|||
149074574|NCT00229658|537752812|FG001|Overall Study|Serious Adverse Event|2|||
149074575|NCT00229658|537752811|FG000|Overall Study|Withdrawal of consent|46|||
149074576|NCT00229658|537752812|FG001|Overall Study|Withdrawal of consent|39|||
149074577|NCT02157116|537752813|FG000|Overall Study|Withdrawal by Subject|4|||
149074578|NCT02157116|537752813|FG000|Overall Study|Physician Decision|3|||
149074579|NCT02157116|537752813|FG000|Overall Study|Failed Screening|2|||
149074580|NCT00975585|537752814|FG000|Overall Study|Adverse Event|0|||
149074581|NCT00975585|537752815|FG001|Overall Study|Adverse Event|4|||
149074582|NCT00975585|537752814|FG000|Overall Study|Lost to Follow-up|3|||
149074583|NCT00975585|537752815|FG001|Overall Study|Lost to Follow-up|5|||
149074584|NCT00975585|537752814|FG000|Overall Study|Withdrawal by Subject|2|||
149074585|NCT00975585|537752815|FG001|Overall Study|Withdrawal by Subject|1|||
149074586|NCT00975585|537752814|FG000|Overall Study|Lens issue|2|||
149074587|NCT00975585|537752815|FG001|Overall Study|Lens issue|2|||
149074588|NCT01953224|537752816|FG000|Overall Study|Lost to Follow-up|1|||
149074589|NCT01953224|537752817|FG001|Overall Study|Lost to Follow-up|1|||
149074590|NCT01953224|537752816|FG000|Overall Study|Withdrawal by Subject|1|||
149074591|NCT01953224|537752817|FG001|Overall Study|Withdrawal by Subject|2|||
149074592|NCT00683800|537752819|FG000|Overall Study|Adverse Event|195|||
149074593|NCT00683800|537752820|FG001|Overall Study|Adverse Event|102|||
149074594|NCT00683800|537752819|FG000|Overall Study|Death|0|||
149074595|NCT00683800|537752820|FG001|Overall Study|Death|1|||
149074596|NCT00683800|537752819|FG000|Overall Study|Lost to Follow-up|57|||
149074597|NCT00683800|537752820|FG001|Overall Study|Lost to Follow-up|44|||
149074598|NCT00683800|537752819|FG000|Overall Study|Other|5|||
149074599|NCT00683800|537752820|FG001|Overall Study|Other|2|||
149074600|NCT00683800|537752819|FG000|Overall Study|Protocol Violation|13|||
149074601|NCT00683800|537752820|FG001|Overall Study|Protocol Violation|16|||
149074602|NCT00683800|537752819|FG000|Overall Study|Withdrawal by Subject|66|||
149074603|NCT00683800|537752820|FG001|Overall Study|Withdrawal by Subject|64|||
149074604|NCT00683800|537752819|FG000|Overall Study|Lack of Efficacy|61|||
149074605|NCT00683800|537752820|FG001|Overall Study|Lack of Efficacy|104|||
149074606|NCT00683800|537752819|FG000|Overall Study|Randomized, not treated|35|||
149074607|NCT00683800|537752820|FG001|Overall Study|Randomized, not treated|33|||
149074608|NCT00463229|537752825|FG000|Overall Study|Lost to Follow-up|5|||
149074609|NCT00463229|537752826|FG001|Overall Study|Lost to Follow-up|7|||
149074610|NCT00463229|537752825|FG000|Overall Study|Death|4|||
149074611|NCT00463229|537752826|FG001|Overall Study|Death|3|||
149074612|NCT02406092|537752841|FG000|Overall Study|Screen failure|10|||
149074613|NCT02406092|537752842|FG001|Overall Study|Screen failure|7|||
149074614|NCT02406092|537752841|FG000|Overall Study|Death|22|||
149074615|NCT02406092|537752842|FG001|Overall Study|Death|5|||
149074616|NCT02406092|537752841|FG000|Overall Study|Lost to Follow-up|4|||
149074617|NCT02406092|537752842|FG001|Overall Study|Lost to Follow-up|1|||
149074618|NCT02406092|537752841|FG000|Overall Study|Adverse Event|1|||
149074619|NCT02406092|537752842|FG001|Overall Study|Adverse Event|0|||
149074620|NCT02406092|537752841|FG000|Overall Study|Withdrawal by Subject|1|||
149074621|NCT02406092|537752842|FG001|Overall Study|Withdrawal by Subject|0|||
149074622|NCT03041233|537752843|FG000|Overall Study|Death|5|||
149074623|NCT03041233|537752843|FG000|Overall Study|Physician Decision|1|||
149074624|NCT03041233|537752843|FG000|Overall Study|Lost to Follow-up|16|||
149074625|NCT03041233|537752843|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
149074626|NCT03041233|537752843|FG000|Overall Study|Sponsor Request|1|||
149074627|NCT03041233|537752843|FG000|Overall Study|Duplicate subject|1|||
149074628|NCT03041233|537752843|FG000|Overall Study|Re-ablation|1|||
149074629|NCT00853593|537752844|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
149074630|NCT00853593|537752844|FG000|Overall Study|Model 4396 lead not attempted|29|||
149074631|NCT00853593|537752844|FG000|Overall Study|Implant not attempted|4|||
149074632|NCT03890289|537752847|FG000|Overall Study|Adverse Event|1|||
149074633|NCT03890289|537752847|FG000|Overall Study|Physician Decision|1|||
149074634|NCT03890289|537752847|FG000|Overall Study|Lack of Efficacy|2|||
149074635|NCT02816398|537752852|FG000|Overall Study|Death|5|||
149074636|NCT02816398|537752852|FG000|Overall Study|Lack of Efficacy|8|||
149074637|NCT02816398|537752852|FG000|Overall Study|Lost to Follow-up|1|||
149074638|NCT03362190|537752856|FG000|Overall Study|Adverse Event|0|||
149074639|NCT03362190|537752857|FG001|Overall Study|Adverse Event|0|||
149074640|NCT03362190|537752858|FG002|Overall Study|Adverse Event|0|||
149074641|NCT03362190|537752859|FG003|Overall Study|Adverse Event|1|||
149074642|NCT03362190|537752856|FG000|Overall Study|Withdrawal by Subject|0|||
149074643|NCT03362190|537752857|FG001|Overall Study|Withdrawal by Subject|0|||
149074644|NCT03362190|537752858|FG002|Overall Study|Withdrawal by Subject|0|||
149074645|NCT03362190|537752859|FG003|Overall Study|Withdrawal by Subject|1|||
149074646|NCT00687219|537752860|FG000|Overall Study|Adverse Event|8|||
149074647|NCT00687219|537752860|FG000|Overall Study|Discontinuance criteria met|7|||
149074648|NCT00687219|537752860|FG000|Overall Study|HCV-RNA positive conversion|34|||
149074649|NCT00687219|537752860|FG000|Overall Study|Withdrawal by Subject|1|||
149074650|NCT00687219|537752860|FG000|Overall Study|Lack of Efficacy|1|||
149074651|NCT01367236|537752865|FG000|Overall Study|Withdrawal by Subject|3|||
149074652|NCT01367236|537752866|FG001|Overall Study|Withdrawal by Subject|1|||
149074653|NCT02235298|537752867|FG000|Overall Study|Lost to Follow-up|6|||
149074654|NCT02235298|537752868|FG001|Overall Study|Lost to Follow-up|5|||
149074655|NCT02235298|537752867|FG000|Overall Study|Adverse Event|2|||
149074656|NCT02235298|537752868|FG001|Overall Study|Adverse Event|2|||
149074657|NCT02235298|537752867|FG000|Overall Study|Withdrawal by Subject|0|||
149074658|NCT02235298|537752868|FG001|Overall Study|Withdrawal by Subject|1|||
149074659|NCT01588951|537752872|FG000|Overall Study|Ineligible in retrospect|0|||
149074660|NCT01588951|537752873|FG001|Overall Study|Ineligible in retrospect|0|||
149074661|NCT01588951|537752874|FG002|Overall Study|Ineligible in retrospect|1|||
149074662|NCT01593020|537752877|FG000|Overall Study|Adverse Event|1|||
149074663|NCT01593020|537752878|FG001|Overall Study|Adverse Event|1|||
149074664|NCT01593020|537752877|FG000|Overall Study|Death|0|||
149074665|NCT01593020|537752878|FG001|Overall Study|Death|1|||
149074666|NCT01593020|537752877|FG000|Overall Study|Ineligible|1|||
149074667|NCT01593020|537752878|FG001|Overall Study|Ineligible|0|||
149074668|NCT02350634|537752879|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
149074674|NCT02499328|537752889|FG000|Overall Study|Withdrawal by Subject|1|||
149074675|NCT02499328|537752890|FG001|Overall Study|Withdrawal by Subject|1|||
149074676|NCT02499328|537752891|FG002|Overall Study|Withdrawal by Subject|5|||
149074677|NCT02499328|537752892|FG003|Overall Study|Withdrawal by Subject|3|||
149074678|NCT02499328|537752893|FG004|Overall Study|Withdrawal by Subject|5|||
149074679|NCT02499328|537752894|FG005|Overall Study|Withdrawal by Subject|0|||
149074680|NCT02499328|537752895|FG006|Overall Study|Withdrawal by Subject|0|||
149074681|NCT02499328|537752896|FG007|Overall Study|Withdrawal by Subject|0|||
149074682|NCT02499328|537752897|FG008|Overall Study|Withdrawal by Subject|2|||
149074683|NCT02499328|537752898|FG009|Overall Study|Withdrawal by Subject|2|||
149074684|NCT02499328|537752899|FG010|Overall Study|Withdrawal by Subject|0|||
149074685|NCT02499328|537752900|FG011|Overall Study|Withdrawal by Subject|3|||
149074686|NCT02499328|537752901|FG012|Overall Study|Withdrawal by Subject|7|||
149074687|NCT02499328|537752902|FG013|Overall Study|Withdrawal by Subject|3|||
149074688|NCT02499328|537752903|FG014|Overall Study|Withdrawal by Subject|1|||
149074689|NCT02499328|537752904|FG015|Overall Study|Withdrawal by Subject|0|||
149074690|NCT02499328|537752905|FG016|Overall Study|Withdrawal by Subject|0|||
149074691|NCT02499328|537752906|FG017|Overall Study|Withdrawal by Subject|3|||
149074692|NCT02499328|537752907|FG018|Overall Study|Withdrawal by Subject|0|||
149074693|NCT02499328|537752889|FG000|Overall Study|Lost to Follow-up|0|||
149074694|NCT02499328|537752890|FG001|Overall Study|Lost to Follow-up|1|||
149074695|NCT02499328|537752891|FG002|Overall Study|Lost to Follow-up|1|||
149074696|NCT02499328|537752892|FG003|Overall Study|Lost to Follow-up|2|||
149074697|NCT02499328|537752893|FG004|Overall Study|Lost to Follow-up|0|||
149074698|NCT02499328|537752894|FG005|Overall Study|Lost to Follow-up|0|||
149074699|NCT02499328|537752895|FG006|Overall Study|Lost to Follow-up|0|||
149074700|NCT02499328|537752896|FG007|Overall Study|Lost to Follow-up|2|||
149074701|NCT02499328|537752897|FG008|Overall Study|Lost to Follow-up|3|||
149074702|NCT02499328|537752898|FG009|Overall Study|Lost to Follow-up|0|||
149074703|NCT02499328|537752899|FG010|Overall Study|Lost to Follow-up|0|||
149074704|NCT02499328|537752900|FG011|Overall Study|Lost to Follow-up|0|||
149074705|NCT02499328|537752901|FG012|Overall Study|Lost to Follow-up|0|||
149074706|NCT02499328|537752902|FG013|Overall Study|Lost to Follow-up|0|||
149074707|NCT02499328|537752903|FG014|Overall Study|Lost to Follow-up|0|||
149074708|NCT02499328|537752904|FG015|Overall Study|Lost to Follow-up|0|||
149074709|NCT02499328|537752905|FG016|Overall Study|Lost to Follow-up|0|||
149074710|NCT02499328|537752906|FG017|Overall Study|Lost to Follow-up|0|||
149074711|NCT02499328|537752907|FG018|Overall Study|Lost to Follow-up|1|||
149074712|NCT02499328|537752889|FG000|Overall Study|Death|0|||
149074713|NCT02499328|537752890|FG001|Overall Study|Death|3|||
149074714|NCT02499328|537752891|FG002|Overall Study|Death|3|||
149074715|NCT02499328|537752892|FG003|Overall Study|Death|2|||
149074716|NCT02499328|537752893|FG004|Overall Study|Death|4|||
149074717|NCT02499328|537752894|FG005|Overall Study|Death|7|||
149074718|NCT02499328|537752895|FG006|Overall Study|Death|3|||
149074719|NCT02499328|537752896|FG007|Overall Study|Death|0|||
149074720|NCT02499328|537752897|FG008|Overall Study|Death|2|||
149074721|NCT02499328|537752898|FG009|Overall Study|Death|6|||
149074722|NCT02499328|537752899|FG010|Overall Study|Death|6|||
149074723|NCT02499328|537752900|FG011|Overall Study|Death|20|||
149074724|NCT02499328|537752901|FG012|Overall Study|Death|9|||
149074725|NCT02499328|537752902|FG013|Overall Study|Death|7|||
149074726|NCT02499328|537752903|FG014|Overall Study|Death|3|||
149074727|NCT02499328|537752904|FG015|Overall Study|Death|1|||
149074728|NCT02499328|537752905|FG016|Overall Study|Death|1|||
149074729|NCT02499328|537752906|FG017|Overall Study|Death|16|||
149074730|NCT02499328|537752907|FG018|Overall Study|Death|5|||
149074731|NCT02499328|537752889|FG000|Overall Study|"Other"|2|||
149074732|NCT02499328|537752890|FG001|Overall Study|"Other"|2|||
149074733|NCT02499328|537752891|FG002|Overall Study|"Other"|1|||
149074734|NCT02499328|537752892|FG003|Overall Study|"Other"|3|||
149074735|NCT02499328|537752893|FG004|Overall Study|"Other"|6|||
149006266|NCT05044325|537501804|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
149006267|NCT05044325|537501805|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006268|NCT05044325|537501806|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006269|NCT05044325|537501807|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006270|NCT05044325|537501808|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006271|NCT05044325|537501809|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006272|NCT05044325|537501810|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006273|NCT05044325|537501811|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
149006274|NCT05044325|537501802|FG000|Part A:Treatment Period 2|Adverse Event|0|||
149006275|NCT05044325|537501803|FG001|Part A:Treatment Period 2|Adverse Event|1|||
149006276|NCT05044325|537501804|FG002|Part A:Treatment Period 2|Adverse Event|0|||
149006277|NCT05044325|537501805|FG003|Part A:Treatment Period 2|Adverse Event|0|||
149006278|NCT05044325|537501806|FG004|Part A:Treatment Period 2|Adverse Event|1|||
149006279|NCT05044325|537501807|FG005|Part A:Treatment Period 2|Adverse Event|1|||
149006280|NCT05044325|537501808|FG006|Part A:Treatment Period 2|Adverse Event|0|||
149006281|NCT05044325|537501809|FG007|Part A:Treatment Period 2|Adverse Event|0|||
149006282|NCT05044325|537501810|FG008|Part A:Treatment Period 2|Adverse Event|0|||
149006283|NCT05044325|537501811|FG009|Part A:Treatment Period 2|Adverse Event|0|||
149006284|NCT05044325|537501802|FG000|Part A:Treatment Period 2|Physician Decision|0|||
149006285|NCT05044325|537501803|FG001|Part A:Treatment Period 2|Physician Decision|0|||
149006286|NCT05044325|537501804|FG002|Part A:Treatment Period 2|Physician Decision|0|||
149006287|NCT05044325|537501805|FG003|Part A:Treatment Period 2|Physician Decision|0|||
149006288|NCT05044325|537501806|FG004|Part A:Treatment Period 2|Physician Decision|0|||
149006289|NCT05044325|537501807|FG005|Part A:Treatment Period 2|Physician Decision|1|||
149006290|NCT05044325|537501808|FG006|Part A:Treatment Period 2|Physician Decision|0|||
149006291|NCT05044325|537501809|FG007|Part A:Treatment Period 2|Physician Decision|0|||
149006292|NCT05044325|537501810|FG008|Part A:Treatment Period 2|Physician Decision|0|||
149006293|NCT05044325|537501811|FG009|Part A:Treatment Period 2|Physician Decision|0|||
149006294|NCT05044325|537501802|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006295|NCT05044325|537501803|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006296|NCT05044325|537501804|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006297|NCT05044325|537501805|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
149006298|NCT05044325|537501806|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
149006299|NCT05044325|537501807|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006300|NCT05044325|537501808|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006301|NCT05044325|537501809|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006302|NCT05044325|537501810|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149074736|NCT02499328|537752894|FG005|Overall Study|"Other"|2|||
149074737|NCT02499328|537752895|FG006|Overall Study|"Other"|3|||
149074738|NCT02499328|537752896|FG007|Overall Study|"Other"|4|||
149074739|NCT02499328|537752897|FG008|Overall Study|"Other"|6|||
149074740|NCT02499328|537752898|FG009|Overall Study|"Other"|16|||
149074741|NCT02499328|537752899|FG010|Overall Study|"Other"|13|||
149074742|NCT02499328|537752900|FG011|Overall Study|"Other"|31|||
149074743|NCT02499328|537752901|FG012|Overall Study|"Other"|8|||
149074744|NCT02499328|537752902|FG013|Overall Study|"Other"|7|||
149074745|NCT02499328|537752903|FG014|Overall Study|"Other"|6|||
149074746|NCT02499328|537752904|FG015|Overall Study|"Other"|0|||
149074747|NCT02499328|537752905|FG016|Overall Study|"Other"|0|||
149074748|NCT02499328|537752906|FG017|Overall Study|"Other"|34|||
149074749|NCT02499328|537752907|FG018|Overall Study|"Other"|43|||
149074750|NCT02499328|537752889|FG000|Overall Study|Disease Progression|0|||
149074751|NCT02499328|537752890|FG001|Overall Study|Disease Progression|0|||
149074752|NCT02499328|537752891|FG002|Overall Study|Disease Progression|0|||
149074753|NCT02499328|537752892|FG003|Overall Study|Disease Progression|0|||
149074754|NCT02499328|537752893|FG004|Overall Study|Disease Progression|0|||
149074755|NCT02499328|537752894|FG005|Overall Study|Disease Progression|0|||
149074756|NCT02499328|537752895|FG006|Overall Study|Disease Progression|1|||
149074757|NCT02499328|537752896|FG007|Overall Study|Disease Progression|0|||
149074758|NCT02499328|537752897|FG008|Overall Study|Disease Progression|1|||
149074759|NCT02499328|537752898|FG009|Overall Study|Disease Progression|0|||
149074760|NCT02499328|537752899|FG010|Overall Study|Disease Progression|1|||
149074761|NCT02499328|537752900|FG011|Overall Study|Disease Progression|0|||
149074762|NCT02499328|537752901|FG012|Overall Study|Disease Progression|0|||
149074763|NCT02499328|537752902|FG013|Overall Study|Disease Progression|0|||
149074764|NCT02499328|537752903|FG014|Overall Study|Disease Progression|0|||
149074765|NCT02499328|537752904|FG015|Overall Study|Disease Progression|0|||
149074766|NCT02499328|537752905|FG016|Overall Study|Disease Progression|0|||
149074767|NCT02499328|537752906|FG017|Overall Study|Disease Progression|2|||
149074768|NCT02499328|537752907|FG018|Overall Study|Disease Progression|0|||
149074769|NCT02499328|537752889|FG000|Overall Study|Adverse Event|1|||
149074770|NCT02499328|537752890|FG001|Overall Study|Adverse Event|0|||
149074771|NCT02499328|537752891|FG002|Overall Study|Adverse Event|0|||
149074772|NCT02499328|537752892|FG003|Overall Study|Adverse Event|1|||
149074773|NCT02499328|537752893|FG004|Overall Study|Adverse Event|0|||
149074774|NCT02499328|537752894|FG005|Overall Study|Adverse Event|0|||
149074775|NCT02499328|537752895|FG006|Overall Study|Adverse Event|0|||
149074776|NCT02499328|537752896|FG007|Overall Study|Adverse Event|0|||
149074777|NCT02499328|537752897|FG008|Overall Study|Adverse Event|0|||
149074778|NCT02499328|537752898|FG009|Overall Study|Adverse Event|0|||
149074779|NCT02499328|537752899|FG010|Overall Study|Adverse Event|0|||
149074780|NCT02499328|537752900|FG011|Overall Study|Adverse Event|0|||
149074781|NCT02499328|537752901|FG012|Overall Study|Adverse Event|1|||
149074782|NCT02499328|537752902|FG013|Overall Study|Adverse Event|0|||
149074783|NCT02499328|537752903|FG014|Overall Study|Adverse Event|0|||
149074784|NCT02499328|537752904|FG015|Overall Study|Adverse Event|0|||
149074785|NCT02499328|537752905|FG016|Overall Study|Adverse Event|0|||
149074786|NCT02499328|537752906|FG017|Overall Study|Adverse Event|0|||
149074787|NCT02499328|537752907|FG018|Overall Study|Adverse Event|0|||
149074788|NCT02972359|537752911|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
149074789|NCT02972359|537752911|FG000|Overall Study|Lack of Efficacy|1|||
149074790|NCT02972359|537752911|FG000|Overall Study|Adverse Event|4|||
149074791|NCT02972359|537752911|FG000|Overall Study|Death|1|||
149074792|NCT02972359|537752911|FG000|Overall Study|Withdrawal by Subject|30|||
149074793|NCT02972359|537752911|FG000|Overall Study|Protocol Violation|1|||
149074794|NCT02972359|537752911|FG000|Overall Study|Lost to Follow-up|26|||
149074795|NCT02972359|537752911|FG000|Overall Study|Other reasons|5|||
149074796|NCT02972359|537752911|FG000|Overall Study|Missing|1|||
149074797|NCT02063659|537752912|FG000|Double-Blind Treatment Period|Adverse Event|1|||
149074798|NCT02063659|537752913|FG001|Double-Blind Treatment Period|Adverse Event|2|||
149074799|NCT02063659|537752914|FG002|Double-Blind Treatment Period|Adverse Event|0|||
149074800|NCT02063659|537752915|FG003|Double-Blind Treatment Period|Adverse Event|0|||
149074801|NCT02063659|537752912|FG000|Double-Blind Treatment Period|Physician Decision|1|||
149074802|NCT02063659|537752913|FG001|Double-Blind Treatment Period|Physician Decision|0|||
149074803|NCT02063659|537752914|FG002|Double-Blind Treatment Period|Physician Decision|0|||
149074804|NCT02063659|537752915|FG003|Double-Blind Treatment Period|Physician Decision|0|||
149074805|NCT02063659|537752912|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
149074806|NCT02063659|537752913|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
149074807|NCT02063659|537752914|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
149074808|NCT02063659|537752915|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
149074809|NCT02063659|537752912|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
149074810|NCT02063659|537752913|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
149074811|NCT02063659|537752914|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
149074812|NCT02063659|537752915|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
149074813|NCT02063659|537752912|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
149074814|NCT02063659|537752913|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
149074815|NCT02063659|537752914|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
149074816|NCT02063659|537752915|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
149074817|NCT02063659|537752912|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
149074818|NCT02063659|537752913|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
149074819|NCT02063659|537752914|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
149074820|NCT02063659|537752915|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
149074821|NCT02063659|537752912|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
149074822|NCT02063659|537752913|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
149074823|NCT02063659|537752914|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
149074824|NCT02063659|537752915|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
149074825|NCT02063659|537752912|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
149074826|NCT02063659|537752913|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
149074827|NCT02063659|537752914|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
149074828|NCT02063659|537752915|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
149074829|NCT00914966|537752916|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
149074830|NCT00914966|537752916|FG000|Step 1: 1500 Units|Physician Decision|1|||
149074831|NCT00914966|537752916|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
149074832|NCT03477175|537752921|FG000|Overall Study|Unable to travel due to COVID-19|0|||
149074833|NCT03477175|537752922|FG001|Overall Study|Unable to travel due to COVID-19|1|||
149074834|NCT03477175|537752921|FG000|Overall Study|Physician Decision|1|||
149074835|NCT03477175|537752922|FG001|Overall Study|Physician Decision|0|||
149074836|NCT03477175|537752921|FG000|Overall Study|Transitioned to commercial drug|6|||
149074837|NCT03477175|537752922|FG001|Overall Study|Transitioned to commercial drug|6|||
149074838|NCT03477175|537752921|FG000|Overall Study|Lost to Follow-up|1|||
149074839|NCT03477175|537752922|FG001|Overall Study|Lost to Follow-up|1|||
149074840|NCT03477175|537752921|FG000|Overall Study|Withdrawal by Subject|3|||
149074841|NCT03477175|537752922|FG001|Overall Study|Withdrawal by Subject|1|||
149074842|NCT03477175|537752921|FG000|Overall Study|Adverse Event|1|||
149074843|NCT03477175|537752922|FG001|Overall Study|Adverse Event|5|||
149074844|NCT03477175|537752921|FG000|Overall Study|Disease Progression|7|||
149074845|NCT03477175|537752922|FG001|Overall Study|Disease Progression|7|||
149074846|NCT03371017|537752923|FG000|Overall Study|Physician Decision|0|||
149074847|NCT03371017|537752924|FG001|Overall Study|Physician Decision|1|||
149074848|NCT03371017|537752923|FG000|Overall Study|Reason not Specified|0|||
149074849|NCT03371017|537752924|FG001|Overall Study|Reason not Specified|1|||
149074850|NCT03371017|537752923|FG000|Overall Study|Lost to Follow-up|13|||
149074851|NCT03371017|537752924|FG001|Overall Study|Lost to Follow-up|16|||
149074852|NCT03371017|537752923|FG000|Overall Study|Death|228|||
149074853|NCT03371017|537752924|FG001|Overall Study|Death|215|||
149074854|NCT03371017|537752923|FG000|Overall Study|Withdrawal by Subject|20|||
149074855|NCT03371017|537752924|FG001|Overall Study|Withdrawal by Subject|25|||
149074856|NCT03371017|537752923|FG000|Overall Study|Study Ended by Sponsor|37|||
149074857|NCT03371017|537752924|FG001|Overall Study|Study Ended by Sponsor|38|||
149074858|NCT03371017|537752923|FG000|Overall Study|Protocol Deviation|0|||
149074859|NCT03371017|537752924|FG001|Overall Study|Protocol Deviation|1|||
149074860|NCT05525572|537752925|FG000|Overall Study|Lost to Follow-up|2|||
149074861|NCT05025384|537752932|FG000|Overall Study|Physician Decision|5|||
149074862|NCT05025384|537752933|FG001|Overall Study|Physician Decision|6|||
149074863|NCT05810285|537752936|FG000|Overall Study|Death|4|||
149074864|NCT05810285|537752937|FG001|Overall Study|Death|21|||
149074865|NCT05810285|537752936|FG000|Overall Study|Adverse Event|18|||
149074866|NCT05810285|537752937|FG001|Overall Study|Adverse Event|16|||
149074867|NCT05470114|537752938|FG000|Overall Study|Withdrawal by Subject|1|||
149074868|NCT05470114|537752939|FG001|Overall Study|Withdrawal by Subject|0|||
149074869|NCT05470114|537752938|FG000|Overall Study|Lost to Follow-up|1|||
149074870|NCT05470114|537752939|FG001|Overall Study|Lost to Follow-up|0|||
149074871|NCT04649047|537752940|FG000|Overall Study|Withdrawal by Subject|3|||
149074872|NCT02488408|537752941|FG000|Part A|Adverse Event|2|||
149074873|NCT02488408|537752942|FG001|Part A|Adverse Event|0|||
149074874|NCT02488408|537752943|FG002|Part A|Adverse Event|0|||
149074875|NCT02488408|537752944|FG003|Part A|Adverse Event|0|||
149074876|NCT02488408|537752945|FG004|Part A|Adverse Event|0|||
149074877|NCT02488408|537752946|FG005|Part A|Adverse Event|0|||
149074878|NCT02488408|537752947|FG006|Part A|Adverse Event|0|||
149074879|NCT02488408|537752948|FG007|Part A|Adverse Event|0|||
149074880|NCT02488408|537752949|FG008|Part A|Adverse Event|0|||
149074881|NCT02488408|537752950|FG009|Part A|Adverse Event|0|||
149074882|NCT02488408|537752941|FG000|Part A|Death|1|||
149074883|NCT02488408|537752942|FG001|Part A|Death|5|||
149074884|NCT02488408|537752943|FG002|Part A|Death|0|||
149074885|NCT02488408|537752944|FG003|Part A|Death|0|||
149074886|NCT02488408|537752945|FG004|Part A|Death|3|||
149074887|NCT02488408|537752946|FG005|Part A|Death|0|||
149074888|NCT02488408|537752947|FG006|Part A|Death|0|||
149074889|NCT02488408|537752948|FG007|Part A|Death|0|||
149074890|NCT02488408|537752949|FG008|Part A|Death|0|||
149074891|NCT02488408|537752950|FG009|Part A|Death|0|||
149074892|NCT02488408|537752941|FG000|Part A|Disease Progression|2|||
149074893|NCT02488408|537752942|FG001|Part A|Disease Progression|8|||
149074894|NCT02488408|537752943|FG002|Part A|Disease Progression|2|||
149074895|NCT02488408|537752944|FG003|Part A|Disease Progression|3|||
149074896|NCT02488408|537752945|FG004|Part A|Disease Progression|4|||
149074897|NCT02488408|537752946|FG005|Part A|Disease Progression|0|||
149074898|NCT02488408|537752947|FG006|Part A|Disease Progression|0|||
149074899|NCT02488408|537752948|FG007|Part A|Disease Progression|0|||
149074900|NCT02488408|537752949|FG008|Part A|Disease Progression|0|||
149074901|NCT02488408|537752950|FG009|Part A|Disease Progression|0|||
149074902|NCT02488408|537752941|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
149074903|NCT02488408|537752942|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
149074904|NCT02488408|537752943|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
149074905|NCT02488408|537752944|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
149074906|NCT02488408|537752945|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
149074907|NCT02488408|537752946|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
149074908|NCT02488408|537752947|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
149074909|NCT02488408|537752948|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
149074910|NCT02488408|537752949|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
149074911|NCT02488408|537752950|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
149074912|NCT02488408|537752941|FG000|Part A|Investigator Decision|0|||
149074913|NCT02488408|537752942|FG001|Part A|Investigator Decision|1|||
149074914|NCT02488408|537752943|FG002|Part A|Investigator Decision|1|||
149074915|NCT02488408|537752944|FG003|Part A|Investigator Decision|0|||
149074916|NCT02488408|537752945|FG004|Part A|Investigator Decision|0|||
149074917|NCT02488408|537752946|FG005|Part A|Investigator Decision|0|||
149074918|NCT02488408|537752947|FG006|Part A|Investigator Decision|0|||
149074919|NCT02488408|537752948|FG007|Part A|Investigator Decision|0|||
149074920|NCT02488408|537752949|FG008|Part A|Investigator Decision|0|||
149074921|NCT02488408|537752950|FG009|Part A|Investigator Decision|0|||
149074922|NCT02488408|537752941|FG000|Part A|Withdrawal by Subject|0|||
149074923|NCT02488408|537752942|FG001|Part A|Withdrawal by Subject|0|||
149074924|NCT02488408|537752943|FG002|Part A|Withdrawal by Subject|2|||
149074925|NCT02488408|537752944|FG003|Part A|Withdrawal by Subject|0|||
149074926|NCT02488408|537752945|FG004|Part A|Withdrawal by Subject|0|||
149074927|NCT02488408|537752946|FG005|Part A|Withdrawal by Subject|0|||
149074928|NCT02488408|537752947|FG006|Part A|Withdrawal by Subject|0|||
149074929|NCT02488408|537752948|FG007|Part A|Withdrawal by Subject|0|||
149074930|NCT02488408|537752949|FG008|Part A|Withdrawal by Subject|0|||
149074931|NCT02488408|537752950|FG009|Part A|Withdrawal by Subject|0|||
149074932|NCT02488408|537752941|FG000|Part A|Other|1|||
149074933|NCT02488408|537752942|FG001|Part A|Other|0|||
149074934|NCT02488408|537752943|FG002|Part A|Other|0|||
149074935|NCT02488408|537752944|FG003|Part A|Other|0|||
149074936|NCT02488408|537752945|FG004|Part A|Other|0|||
149074937|NCT02488408|537752946|FG005|Part A|Other|0|||
149074938|NCT02488408|537752947|FG006|Part A|Other|0|||
149074939|NCT02488408|537752948|FG007|Part A|Other|0|||
149074940|NCT02488408|537752949|FG008|Part A|Other|0|||
149074941|NCT02488408|537752950|FG009|Part A|Other|0|||
149074942|NCT02488408|537752941|FG000|Part B|Adverse Event|0|||
149074943|NCT02488408|537752942|FG001|Part B|Adverse Event|0|||
149074944|NCT02488408|537752943|FG002|Part B|Adverse Event|0|||
149074945|NCT02488408|537752944|FG003|Part B|Adverse Event|0|||
149074946|NCT02488408|537752945|FG004|Part B|Adverse Event|0|||
149074947|NCT02488408|537752946|FG005|Part B|Adverse Event|2|||
149074948|NCT02488408|537752947|FG006|Part B|Adverse Event|2|||
149074949|NCT02488408|537752948|FG007|Part B|Adverse Event|7|||
149074950|NCT02488408|537752949|FG008|Part B|Adverse Event|2|||
149074951|NCT02488408|537752950|FG009|Part B|Adverse Event|2|||
149074952|NCT02488408|537752941|FG000|Part B|Death|0|||
149074953|NCT02488408|537752942|FG001|Part B|Death|0|||
149074954|NCT02488408|537752943|FG002|Part B|Death|0|||
149074955|NCT02488408|537752944|FG003|Part B|Death|0|||
149074956|NCT02488408|537752945|FG004|Part B|Death|0|||
149074957|NCT02488408|537752946|FG005|Part B|Death|3|||
149074958|NCT02488408|537752947|FG006|Part B|Death|1|||
149074959|NCT02488408|537752948|FG007|Part B|Death|2|||
149074960|NCT02488408|537752949|FG008|Part B|Death|2|||
149074961|NCT02488408|537752950|FG009|Part B|Death|2|||
149074962|NCT02488408|537752941|FG000|Part B|Death due to Disease Progression|0|||
149074963|NCT02488408|537752942|FG001|Part B|Death due to Disease Progression|0|||
149074964|NCT02488408|537752943|FG002|Part B|Death due to Disease Progression|0|||
149074965|NCT02488408|537752944|FG003|Part B|Death due to Disease Progression|0|||
149074966|NCT02488408|537752945|FG004|Part B|Death due to Disease Progression|0|||
149074967|NCT02488408|537752946|FG005|Part B|Death due to Disease Progression|2|||
149074968|NCT02488408|537752947|FG006|Part B|Death due to Disease Progression|2|||
149074969|NCT02488408|537752948|FG007|Part B|Death due to Disease Progression|1|||
149074970|NCT02488408|537752949|FG008|Part B|Death due to Disease Progression|1|||
149074971|NCT02488408|537752950|FG009|Part B|Death due to Disease Progression|1|||
149074972|NCT02488408|537752941|FG000|Part B|Disease Progression|0|||
149074973|NCT02488408|537752942|FG001|Part B|Disease Progression|0|||
149074974|NCT02488408|537752943|FG002|Part B|Disease Progression|0|||
149074975|NCT02488408|537752944|FG003|Part B|Disease Progression|0|||
149074976|NCT02488408|537752945|FG004|Part B|Disease Progression|0|||
149074977|NCT02488408|537752946|FG005|Part B|Disease Progression|6|||
149074978|NCT02488408|537752947|FG006|Part B|Disease Progression|9|||
149074979|NCT02488408|537752948|FG007|Part B|Disease Progression|7|||
149074980|NCT02488408|537752949|FG008|Part B|Disease Progression|9|||
149074981|NCT02488408|537752950|FG009|Part B|Disease Progression|11|||
149074982|NCT02488408|537752941|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
149074983|NCT02488408|537752942|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
149074984|NCT02488408|537752943|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
149074985|NCT02488408|537752944|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
149074986|NCT02488408|537752945|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
149074987|NCT02488408|537752946|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
149074988|NCT02488408|537752947|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
149074989|NCT02488408|537752948|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
149074990|NCT02488408|537752949|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
149074991|NCT02488408|537752950|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
149074992|NCT02488408|537752941|FG000|Part B|Investigator Decision|0|||
149074993|NCT02488408|537752942|FG001|Part B|Investigator Decision|0|||
149074994|NCT02488408|537752943|FG002|Part B|Investigator Decision|0|||
149074995|NCT02488408|537752944|FG003|Part B|Investigator Decision|0|||
149074996|NCT02488408|537752945|FG004|Part B|Investigator Decision|0|||
149074997|NCT02488408|537752946|FG005|Part B|Investigator Decision|0|||
149074998|NCT02488408|537752947|FG006|Part B|Investigator Decision|1|||
149074999|NCT02488408|537752948|FG007|Part B|Investigator Decision|0|||
149075000|NCT02488408|537752949|FG008|Part B|Investigator Decision|2|||
149075001|NCT02488408|537752950|FG009|Part B|Investigator Decision|1|||
149075002|NCT00719888|537752951|FG000|Overall Study|Death|24|||
149075003|NCT00719888|537752952|FG001|Overall Study|Death|9|||
149075004|NCT00719888|537752951|FG000|Overall Study|Relapse|8|||
149075005|NCT00719888|537752952|FG001|Overall Study|Relapse|3|||
149075006|NCT00719888|537752951|FG000|Overall Study|Physician Decision|1|||
149075007|NCT00719888|537752952|FG001|Overall Study|Physician Decision|0|||
149075008|NCT00719888|537752951|FG000|Overall Study|Withdrawal by Subject|1|||
149075009|NCT00719888|537752952|FG001|Overall Study|Withdrawal by Subject|0|||
149075010|NCT03861052|537754190|FG000|Overall Study|Adverse Event|1|||
149075011|NCT03861052|537754191|FG001|Overall Study|Adverse Event|1|||
149075012|NCT03861052|537754192|FG002|Overall Study|Adverse Event|2|||
149075013|NCT03861052|537754193|FG003|Overall Study|Adverse Event|4|||
149075014|NCT03861052|537754190|FG000|Overall Study|Lost to Follow-up|0|||
149075015|NCT03861052|537754191|FG001|Overall Study|Lost to Follow-up|0|||
149075016|NCT03861052|537754192|FG002|Overall Study|Lost to Follow-up|0|||
149075017|NCT03861052|537754193|FG003|Overall Study|Lost to Follow-up|1|||
149075018|NCT03861052|537754190|FG000|Overall Study|Physician Decision|0|||
149075019|NCT03861052|537754191|FG001|Overall Study|Physician Decision|1|||
149075020|NCT03861052|537754192|FG002|Overall Study|Physician Decision|0|||
149075021|NCT03861052|537754193|FG003|Overall Study|Physician Decision|0|||
149075022|NCT03861052|537754190|FG000|Overall Study|Withdrawal by Subject|2|||
149075023|NCT03861052|537754191|FG001|Overall Study|Withdrawal by Subject|5|||
149075024|NCT03861052|537754192|FG002|Overall Study|Withdrawal by Subject|3|||
149075025|NCT03861052|537754193|FG003|Overall Study|Withdrawal by Subject|0|||
149075026|NCT03861052|537754190|FG000|Overall Study|Relocation to other city|1|||
149075027|NCT03861052|537754191|FG001|Overall Study|Relocation to other city|0|||
149075028|NCT03861052|537754192|FG002|Overall Study|Relocation to other city|0|||
149075029|NCT03861052|537754193|FG003|Overall Study|Relocation to other city|0|||
149075030|NCT00705406|537754194|FG000|Overall Study|Lost to Follow-up|3|||
149075031|NCT00705406|537754195|FG001|Overall Study|Lost to Follow-up|3|||
149075032|NCT00705406|537754194|FG000|Overall Study|Did not receive study drug|1|||
149075033|NCT00705406|537754195|FG001|Overall Study|Did not receive study drug|2|||
149075034|NCT03712371|537754198|FG000|Overall Study|Lack of Efficacy|0|||
149075035|NCT03712371|537754199|FG001|Overall Study|Lack of Efficacy|0|||
149075036|NCT03712371|537754200|FG002|Overall Study|Lack of Efficacy|0|||
149075037|NCT03712371|537754201|FG003|Overall Study|Lack of Efficacy|1|||
149075048|NCT00205179|537754213|FG000|Overall Study|Death|0|||
149075049|NCT00205179|537754214|FG001|Overall Study|Death|2|||
149075050|NCT00205179|537754213|FG000|Overall Study|Physician Decision|1|||
149075051|NCT00205179|537754214|FG001|Overall Study|Physician Decision|1|||
149075052|NCT00205179|537754213|FG000|Overall Study|Adverse Event|1|||
149075053|NCT00205179|537754214|FG001|Overall Study|Adverse Event|1|||
149075054|NCT01767467|537754215|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
149075055|NCT01767467|537754216|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
149075056|NCT01767467|537754215|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
149075057|NCT01767467|537754216|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
149075058|NCT01767467|537754215|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
149075059|NCT01767467|537754216|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
149075060|NCT01767467|537754215|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
149075061|NCT01767467|537754216|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
149075062|NCT01767467|537754215|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
149075063|NCT01767467|537754216|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
149075064|NCT01767467|537754215|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
149075065|NCT01767467|537754216|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
149075066|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
149075067|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
149075068|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
149075069|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
149075070|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
149075071|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
149075072|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
149075073|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
149075074|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
149075075|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
149075076|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
149075077|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
149075078|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
149075079|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
149075080|NCT01767467|537754215|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
149075081|NCT01767467|537754216|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
149075082|NCT01359150|537754217|FG000|Overall Study|Lack of Efficacy|1|||
149075083|NCT01359150|537754218|FG001|Overall Study|Lack of Efficacy|1|||
149075084|NCT01359150|537754217|FG000|Overall Study|Withdrawal by Subject|1|||
149075085|NCT01359150|537754218|FG001|Overall Study|Withdrawal by Subject|1|||
149075086|NCT01359150|537754217|FG000|Overall Study|Adverse Event|4|||
149075087|NCT01359150|537754218|FG001|Overall Study|Adverse Event|3|||
149075088|NCT01359150|537754217|FG000|Overall Study|Other|1|||
149075089|NCT01359150|537754218|FG001|Overall Study|Other|0|||
149075090|NCT01787032|537754221|FG000|Overall Study|Protocol Violation|0|||
149075091|NCT01787032|537754222|FG001|Overall Study|Protocol Violation|0|||
149075092|NCT01787032|537754223|FG002|Overall Study|Protocol Violation|0|||
149075093|NCT01787032|537754224|FG003|Overall Study|Protocol Violation|0|||
149075094|NCT01787032|537754225|FG004|Overall Study|Protocol Violation|1|||
149075095|NCT01787032|537754226|FG005|Overall Study|Protocol Violation|1|||
149075096|NCT02040870|537754227|FG000|Overall Study|Completed treatment phase|6|||
149075097|NCT02040870|537754227|FG000|Overall Study|Adverse Event|7|||
149075098|NCT02040870|537754227|FG000|Overall Study|Progressive disease|58|||
149075099|NCT02040870|537754227|FG000|Overall Study|Physician Decision|6|||
149075100|NCT02040870|537754227|FG000|Overall Study|Subject/guardian decision|10|||
149075101|NCT02040870|537754227|FG000|Overall Study|Lost to Follow-up|3|||
149075102|NCT02040870|537754227|FG000|Overall Study|Death|13|||
149075103|NCT04971733|537754228|FG000|Overall Study|Adverse Event|1|||
149075104|NCT04971733|537754229|FG001|Overall Study|Adverse Event|1|||
149075105|NCT04971733|537754228|FG000|Overall Study|Subject choice|2|||
149075106|NCT04971733|537754229|FG001|Overall Study|Subject choice|0|||
149075107|NCT04971733|537754228|FG000|Overall Study|Withdrawal by Subject|1|||
149075108|NCT04971733|537754229|FG001|Overall Study|Withdrawal by Subject|0|||
149075109|NCT04971733|537754228|FG000|Overall Study|Other|1|||
149075110|NCT04971733|537754229|FG001|Overall Study|Other|0|||
149075111|NCT04200664|537754233|FG000|Overall Study|Withdrawal by Subject|1|||
149075112|NCT04200664|537754234|FG001|Overall Study|Withdrawal by Subject|0|||
149075113|NCT04200664|537754235|FG002|Overall Study|Withdrawal by Subject|0|||
149075114|NCT04038580|537754258|FG000|Washout 1|Death|0|||
149075115|NCT04038580|537754259|FG001|Washout 1|Death|0|||
149075116|NCT04038580|537754260|FG002|Washout 1|Death|0|||
149075117|NCT04038580|537754261|FG003|Washout 1|Death|1|||
149075118|NCT04038580|537754262|FG004|Washout 1|Death|0|||
149075119|NCT04038580|537754263|FG005|Washout 1|Death|0|||
149075120|NCT04038580|537754258|FG000|Washout 1|Withdrawal by Subject|0|||
149075121|NCT04038580|537754259|FG001|Washout 1|Withdrawal by Subject|0|||
149075122|NCT04038580|537754260|FG002|Washout 1|Withdrawal by Subject|0|||
149075123|NCT04038580|537754261|FG003|Washout 1|Withdrawal by Subject|0|||
149075124|NCT04038580|537754262|FG004|Washout 1|Withdrawal by Subject|1|||
149075125|NCT04038580|537754263|FG005|Washout 1|Withdrawal by Subject|0|||
149075126|NCT04038580|537754258|FG000|Wash-out 2|Withdrawal by Subject|1|||
149075127|NCT04038580|537754259|FG001|Wash-out 2|Withdrawal by Subject|0|||
149075128|NCT04038580|537754260|FG002|Wash-out 2|Withdrawal by Subject|0|||
149075129|NCT04038580|537754261|FG003|Wash-out 2|Withdrawal by Subject|2|||
149075130|NCT04038580|537754262|FG004|Wash-out 2|Withdrawal by Subject|0|||
149075131|NCT04038580|537754263|FG005|Wash-out 2|Withdrawal by Subject|1|||
149075132|NCT04038580|537754258|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
149075133|NCT04038580|537754259|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
149075134|NCT04038580|537754260|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
149075135|NCT04038580|537754261|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
149075136|NCT04038580|537754262|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
149075137|NCT04038580|537754263|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
149075138|NCT04038580|537754258|FG000|Wash-out 3|Withdrawal by Subject|1|||
149075139|NCT04038580|537754259|FG001|Wash-out 3|Withdrawal by Subject|0|||
149075140|NCT04038580|537754260|FG002|Wash-out 3|Withdrawal by Subject|2|||
149075141|NCT04038580|537754261|FG003|Wash-out 3|Withdrawal by Subject|0|||
149075142|NCT04038580|537754262|FG004|Wash-out 3|Withdrawal by Subject|0|||
149075143|NCT04038580|537754263|FG005|Wash-out 3|Withdrawal by Subject|0|||
149075144|NCT04021862|537754264|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
149075145|NCT04021862|537754265|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
149075146|NCT04021862|537754266|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
149075147|NCT04021862|537754267|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
149075148|NCT04021862|537754268|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
149075149|NCT04021862|537754269|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
149075150|NCT04021862|537754264|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
149075151|NCT04021862|537754265|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
149075152|NCT04021862|537754266|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
149075153|NCT04021862|537754267|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
149075154|NCT04021862|537754268|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
149075155|NCT04021862|537754269|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
149075156|NCT04021862|537754264|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
149075157|NCT04021862|537754265|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
149075158|NCT04021862|537754266|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
149075159|NCT04021862|537754267|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
149075160|NCT04021862|537754268|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
149075161|NCT04021862|537754269|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
149075162|NCT04021862|537754264|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
149075163|NCT04021862|537754265|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
149075164|NCT04021862|537754266|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
149075165|NCT04021862|537754267|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
149075166|NCT04021862|537754268|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
149075167|NCT04021862|537754269|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
149075168|NCT04021862|537754264|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
149075169|NCT04021862|537754265|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
149075170|NCT04021862|537754266|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
149075171|NCT04021862|537754267|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
149075172|NCT04021862|537754268|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
149075173|NCT04021862|537754269|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
149075174|NCT04300023|537754270|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
149075175|NCT04300023|537754271|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
149075176|NCT04057131|537754272|FG000|Overall Study|Protocol Violation|24|||
149075177|NCT05251363|537754273|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
149075178|NCT05251363|537754273|FG000|Overall Study After Implant Period|Death|9|||
149075179|NCT05251363|537754273|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
149075180|NCT05251363|537754273|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
149075181|NCT05251363|537754273|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
149075182|NCT05251363|537754273|FG000|Overall Study After Implant Period|Physician Decision|1|||
149075183|NCT05251363|537754273|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
149075184|NCT03835754|537754274|FG000|Overall Study|Death|4|||
149075185|NCT02830204|537754275|FG000|Overall Study|Death|9|||
149075186|NCT02830204|537754275|FG000|Overall Study|Withdrawal by Subject|1|||
149075187|NCT04445831|537754278|FG000|Overall Study|Withdrawal by Subject|2|||
149075188|NCT04445831|537754279|FG001|Overall Study|Withdrawal by Subject|1|||
149075189|NCT04445831|537754280|FG002|Overall Study|Withdrawal by Subject|1|||
149075190|NCT04445831|537754281|FG003|Overall Study|Withdrawal by Subject|0|||
149075191|NCT04445831|537754282|FG004|Overall Study|Withdrawal by Subject|0|||
149075192|NCT04445831|537754283|FG005|Overall Study|Withdrawal by Subject|0|||
149075193|NCT04445831|537754284|FG006|Overall Study|Withdrawal by Subject|0|||
149075194|NCT04445831|537754278|FG000|Overall Study|Subject withdrawal by caregiver|0|||
149075195|NCT04445831|537754279|FG001|Overall Study|Subject withdrawal by caregiver|1|||
149075196|NCT04445831|537754280|FG002|Overall Study|Subject withdrawal by caregiver|0|||
149075197|NCT04445831|537754281|FG003|Overall Study|Subject withdrawal by caregiver|0|||
149075198|NCT04445831|537754282|FG004|Overall Study|Subject withdrawal by caregiver|0|||
149075199|NCT04445831|537754283|FG005|Overall Study|Subject withdrawal by caregiver|0|||
149075200|NCT04445831|537754284|FG006|Overall Study|Subject withdrawal by caregiver|0|||
149075201|NCT05613907|537754288|FG000|Overall Study|Lost to Follow-up|5|||
149075202|NCT05613907|537754288|FG000|Overall Study|Death|3|||
149075203|NCT05613907|537754288|FG000|Overall Study|Withdrawal by Subject|2|||
149075204|NCT00093496|537755438|FG000|Overall Study|Protocol Violation|1|||
149075205|NCT00093496|537755439|FG001|Overall Study|Protocol Violation|3|||
149075206|NCT00586313|537755440|FG000|Overall Study|Lack of Efficacy|2|||
149075207|NCT01932970|537755441|FG000|Overall Study|Withdrawal by Subject|5|||
149075208|NCT01932970|537755441|FG000|Overall Study|Death|1|||
149075209|NCT01932970|537755441|FG000|Overall Study|Lost to Follow-up|2|||
149075210|NCT01932970|537755441|FG000|Overall Study|Protocol Specified Criteria|10|||
149075211|NCT03205566|537755442|FG000|Phase 1|Protocol Violation|1|||
149075212|NCT03205566|537755443|FG001|Phase 1|Protocol Violation|1|||
149075213|NCT03184987|537755444|FG000|Overall Study|Withdrawal by Subject|0|||
149075214|NCT03184987|537755445|FG001|Overall Study|Withdrawal by Subject|1|||
149075215|NCT03184987|537755446|FG002|Overall Study|Withdrawal by Subject|2|||
149075216|NCT03184987|537755444|FG000|Overall Study|Physician Decision|0|||
149075217|NCT03184987|537755445|FG001|Overall Study|Physician Decision|0|||
149075218|NCT03184987|537755446|FG002|Overall Study|Physician Decision|1|||
149075219|NCT03184987|537755444|FG000|Overall Study|Adverse Event|1|||
149075220|NCT03184987|537755445|FG001|Overall Study|Adverse Event|0|||
149075221|NCT03184987|537755446|FG002|Overall Study|Adverse Event|1|||
149075222|NCT00853580|537755447|FG000|Overall Study|Lost to Follow-up|3|||
149075223|NCT00853580|537755448|FG001|Overall Study|Lost to Follow-up|5|||
149075224|NCT00853580|537755447|FG000|Overall Study|Protocol Violation|2|||
149075225|NCT00853580|537755448|FG001|Overall Study|Protocol Violation|1|||
149075226|NCT00853580|537755447|FG000|Overall Study|Withdrawal by Subject|2|||
149075227|NCT00853580|537755448|FG001|Overall Study|Withdrawal by Subject|8|||
149075228|NCT00853580|537755447|FG000|Overall Study|Commenced contraindicated therapy|0|||
149075229|NCT00853580|537755448|FG001|Overall Study|Commenced contraindicated therapy|2|||
149075230|NCT01700205|537755449|FG000|Overall Study|Withdrawal by Subject|13|||
149075231|NCT01700205|537755450|FG001|Overall Study|Withdrawal by Subject|13|||
149075232|NCT01700205|537755449|FG000|Overall Study|Protocol Violation|2|||
149075233|NCT01700205|537755450|FG001|Overall Study|Protocol Violation|2|||
149075234|NCT01728324|537755451|FG000|Termination of DBV|Adverse Event|14|||
149075235|NCT01728324|537755452|FG001|Termination of DBV|Adverse Event|13|||
149075236|NCT01728324|537755453|FG002|Termination of DBV|Adverse Event|4|||
149075237|NCT01728324|537755451|FG000|Termination of DBV|Lack of Efficacy|14|||
149075238|NCT01728324|537755452|FG001|Termination of DBV|Lack of Efficacy|12|||
149075239|NCT01728324|537755453|FG002|Termination of DBV|Lack of Efficacy|8|||
149075240|NCT01728324|537755451|FG000|Termination of DBV|Withdrawal by Subject|9|||
149075241|NCT01728324|537755452|FG001|Termination of DBV|Withdrawal by Subject|6|||
149075242|NCT01728324|537755453|FG002|Termination of DBV|Withdrawal by Subject|2|||
149075243|NCT01728324|537755451|FG000|Termination of DBV|Other than stated|1|||
149075244|NCT01728324|537755452|FG001|Termination of DBV|Other than stated|3|||
149075245|NCT01728324|537755453|FG002|Termination of DBV|Other than stated|0|||
149075246|NCT01728324|537755451|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
149075247|NCT01728324|537755452|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
149075248|NCT01728324|537755453|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
149075249|NCT01728324|537755451|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
149075250|NCT01728324|537755452|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
149075251|NCT01728324|537755453|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
149075252|NCT01728324|537755451|FG000|Termination of FDV|Adverse Event|14|||
149075253|NCT01728324|537755452|FG001|Termination of FDV|Adverse Event|13|||
149075254|NCT01728324|537755453|FG002|Termination of FDV|Adverse Event|4|||
149075255|NCT01728324|537755451|FG000|Termination of FDV|Lack of Efficacy|14|||
149075256|NCT01728324|537755452|FG001|Termination of FDV|Lack of Efficacy|12|||
149075257|NCT01728324|537755453|FG002|Termination of FDV|Lack of Efficacy|8|||
149075258|NCT01728324|537755451|FG000|Termination of FDV|Withdrawal by Subject|9|||
149075259|NCT01728324|537755452|FG001|Termination of FDV|Withdrawal by Subject|6|||
149075260|NCT01728324|537755453|FG002|Termination of FDV|Withdrawal by Subject|2|||
149075261|NCT01728324|537755451|FG000|Termination of FDV|Other than stated|1|||
149075262|NCT01728324|537755452|FG001|Termination of FDV|Other than stated|3|||
149075263|NCT01728324|537755453|FG002|Termination of FDV|Other than stated|0|||
149075264|NCT01728324|537755451|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
149075265|NCT01728324|537755452|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
149075266|NCT01728324|537755453|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
149075267|NCT01728324|537755451|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
149075268|NCT01728324|537755452|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
149075269|NCT01728324|537755453|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
149075270|NCT01728324|537755451|FG000|Termination of RBV|Adverse Event|15|||
149075271|NCT01728324|537755452|FG001|Termination of RBV|Adverse Event|16|||
149075272|NCT01728324|537755453|FG002|Termination of RBV|Adverse Event|5|||
149075273|NCT01728324|537755451|FG000|Termination of RBV|Lack of Efficacy|14|||
149075274|NCT01728324|537755452|FG001|Termination of RBV|Lack of Efficacy|11|||
149075275|NCT01728324|537755453|FG002|Termination of RBV|Lack of Efficacy|7|||
149075276|NCT01728324|537755451|FG000|Termination of RBV|Withdrawal by Subject|9|||
149075277|NCT01728324|537755452|FG001|Termination of RBV|Withdrawal by Subject|5|||
149075278|NCT01728324|537755453|FG002|Termination of RBV|Withdrawal by Subject|2|||
149075279|NCT01728324|537755451|FG000|Termination of RBV|Other than stated|1|||
149075280|NCT01728324|537755452|FG001|Termination of RBV|Other than stated|3|||
149075281|NCT01728324|537755453|FG002|Termination of RBV|Other than stated|1|||
149075282|NCT01728324|537755451|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
149075283|NCT01728324|537755452|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
149075284|NCT01728324|537755453|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
149075285|NCT01728324|537755451|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
149075286|NCT01728324|537755452|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
149075287|NCT01728324|537755453|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
149075288|NCT01619059|537755454|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
149075289|NCT01619059|537755455|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
149075290|NCT01619059|537755454|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
149075291|NCT01619059|537755455|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
149075292|NCT01619059|537755454|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
149075293|NCT01619059|537755455|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
149075294|NCT01619059|537755454|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
149075295|NCT01619059|537755455|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
149075296|NCT01619059|537755454|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
149075297|NCT01619059|537755455|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
149075298|NCT01619059|537755454|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
149075299|NCT01619059|537755455|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
149075300|NCT01619059|537755454|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
149075301|NCT01619059|537755455|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
149075302|NCT01619059|537755454|FG000|Long-Term (LT) Treatment Period|Death|1|||
149075303|NCT01619059|537755455|FG001|Long-Term (LT) Treatment Period|Death|0|||
149075304|NCT01619059|537755454|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
149075305|NCT01619059|537755455|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
149075306|NCT01619059|537755454|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
149075307|NCT01619059|537755455|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
149075308|NCT03113409|537755458|FG000|Overall Study|Withdrawal by Subject|5|||
149075309|NCT03113409|537755459|FG001|Overall Study|Withdrawal by Subject|0|||
149075310|NCT03113409|537755460|FG002|Overall Study|Withdrawal by Subject|0|||
149075311|NCT00388726|537755463|FG000|Overall Study|Adverse Event|50|||
149075312|NCT00388726|537755464|FG001|Overall Study|Adverse Event|24|||
149075313|NCT00388726|537755463|FG000|Overall Study|Progressive Disease|336|||
149075314|NCT00388726|537755464|FG001|Overall Study|Progressive Disease|153|||
149075315|NCT00388726|537755463|FG000|Overall Study|Clinical Progression|61|||
149075316|NCT00388726|537755464|FG001|Overall Study|Clinical Progression|36|||
149075317|NCT00388726|537755463|FG000|Overall Study|Withdrawal by Subject|10|||
149075318|NCT00388726|537755464|FG001|Overall Study|Withdrawal by Subject|7|||
149075319|NCT00388726|537755463|FG000|Overall Study|Administrative|6|||
149075320|NCT00388726|537755464|FG001|Overall Study|Administrative|9|||
149075321|NCT00388726|537755463|FG000|Overall Study|Physician Decision|18|||
149075322|NCT00388726|537755464|FG001|Overall Study|Physician Decision|13|||
149075323|NCT00388726|537755463|FG000|Overall Study|Death|3|||
149075324|NCT00388726|537755464|FG001|Overall Study|Death|2|||
149075325|NCT00600353|537755465|FG000|Overall Study|history of malignancy within 5 years|1|||
149075326|NCT00600353|537755466|FG001|Overall Study|history of malignancy within 5 years|0|||
149075327|NCT00600353|537755465|FG000|Overall Study|History of prepartive regimen|0|||
149075328|NCT00600353|537755466|FG001|Overall Study|History of prepartive regimen|1|||
149075329|NCT04941482|537755467|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
149075330|NCT04941482|537755468|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
149075331|NCT03229408|537755469|FG000|Overall Study|Withdrawal by Subject|4|||
149075332|NCT03229408|537755470|FG001|Overall Study|Withdrawal by Subject|1|||
149075333|NCT03229408|537755469|FG000|Overall Study|Adverse Event|2|||
149075334|NCT03229408|537755470|FG001|Overall Study|Adverse Event|0|||
149075335|NCT03229408|537755469|FG000|Overall Study|Pregnancy|0|||
149075336|NCT03229408|537755470|FG001|Overall Study|Pregnancy|1|||
149075337|NCT03229408|537755469|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
149075338|NCT03229408|537755470|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
149075339|NCT03745313|537755471|FG000|At 30 Days Follow-up|Death|2|||
149075340|NCT03745313|537755471|FG000|At 6 Months Follow-up|Death|1|||
149075341|NCT03745313|537755471|FG000|At 6 Months Follow-up|Missed Visit|1|||
149075342|NCT03745313|537755471|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
149075343|NCT03745313|537755471|FG000|At 1 Year Follow-up|Death|2|||
149075344|NCT03745313|537755471|FG000|At 1 Year Follow-up|Missed Visit|2|||
149075345|NCT03745313|537755471|FG000|At 2 Year Follow-up|Missed Visit|1|||
149075346|NCT01706159|537755473|FG000|Overall Study|Withdrawal Criteria|2|||
149075347|NCT01706159|537755474|FG001|Overall Study|Withdrawal Criteria|1|||
149075348|NCT01706159|537755473|FG000|Overall Study|Unclassified|6|||
149075349|NCT01706159|537755474|FG001|Overall Study|Unclassified|1|||
149075350|NCT02454959|537755475|FG000|Overall Study|Protocol-Specified Criteria|3|||
149075351|NCT02454959|537755475|FG000|Overall Study|Physician Decision|1|||
149075352|NCT02454959|537755475|FG000|Overall Study|Withdrawal by Subject|3|||
149075353|NCT02454959|537755475|FG000|Overall Study|Adverse Event|2|||
149075354|NCT03611075|537755476|FG000|Overall Study|Physician Decision|0|||
149075355|NCT03611075|537755477|FG001|Overall Study|Physician Decision|1|||
149075356|NCT03611075|537755478|FG002|Overall Study|Physician Decision|1|||
149075357|NCT03611075|537755479|FG003|Overall Study|Physician Decision|0|||
149075358|NCT03611075|537755480|FG004|Overall Study|Physician Decision|0|||
149075359|NCT03611075|537755481|FG005|Overall Study|Physician Decision|0|||
149075360|NCT03611075|537755482|FG006|Overall Study|Physician Decision|0|||
149075361|NCT03611075|537755483|FG007|Overall Study|Physician Decision|0|||
149075362|NCT03611075|537755484|FG008|Overall Study|Physician Decision|0|||
149075363|NCT03611075|537755476|FG000|Overall Study|Lost to Follow-up|1|||
149075364|NCT03611075|537755477|FG001|Overall Study|Lost to Follow-up|0|||
149075365|NCT03611075|537755478|FG002|Overall Study|Lost to Follow-up|0|||
149075366|NCT03611075|537755479|FG003|Overall Study|Lost to Follow-up|2|||
149075367|NCT03611075|537755480|FG004|Overall Study|Lost to Follow-up|0|||
149075368|NCT03611075|537755481|FG005|Overall Study|Lost to Follow-up|0|||
149075369|NCT03611075|537755482|FG006|Overall Study|Lost to Follow-up|0|||
149075370|NCT03611075|537755483|FG007|Overall Study|Lost to Follow-up|0|||
149075371|NCT03611075|537755484|FG008|Overall Study|Lost to Follow-up|0|||
149075372|NCT03611075|537755476|FG000|Overall Study|Withdrawal by Subject|0|||
149075373|NCT03611075|537755477|FG001|Overall Study|Withdrawal by Subject|1|||
149075374|NCT03611075|537755478|FG002|Overall Study|Withdrawal by Subject|1|||
149075375|NCT03611075|537755479|FG003|Overall Study|Withdrawal by Subject|1|||
149075376|NCT03611075|537755480|FG004|Overall Study|Withdrawal by Subject|0|||
149075377|NCT03611075|537755481|FG005|Overall Study|Withdrawal by Subject|0|||
149075378|NCT03611075|537755482|FG006|Overall Study|Withdrawal by Subject|1|||
149075379|NCT03611075|537755483|FG007|Overall Study|Withdrawal by Subject|0|||
149075380|NCT03611075|537755484|FG008|Overall Study|Withdrawal by Subject|0|||
149075381|NCT03611075|537755476|FG000|Overall Study|Reason unknown|0|||
149075382|NCT03611075|537755477|FG001|Overall Study|Reason unknown|0|||
149075383|NCT03611075|537755478|FG002|Overall Study|Reason unknown|0|||
149075384|NCT03611075|537755479|FG003|Overall Study|Reason unknown|1|||
149075385|NCT03611075|537755480|FG004|Overall Study|Reason unknown|0|||
149075386|NCT03611075|537755481|FG005|Overall Study|Reason unknown|0|||
149075387|NCT03611075|537755482|FG006|Overall Study|Reason unknown|1|||
149075388|NCT03611075|537755483|FG007|Overall Study|Reason unknown|0|||
149075389|NCT03611075|537755484|FG008|Overall Study|Reason unknown|0|||
149075390|NCT01701401|537755485|FG000|Overall Study|Randomized But Not Treated|3|||
149075391|NCT01701401|537755486|FG001|Overall Study|Randomized But Not Treated|1|||
149075392|NCT01701401|537755487|FG002|Overall Study|Randomized But Not Treated|0|||
149075393|NCT01701401|537755488|FG003|Overall Study|Randomized But Not Treated|1|||
149075394|NCT01701401|537755485|FG000|Overall Study|Lost to Follow-up|5|||
149075395|NCT01701401|537755486|FG001|Overall Study|Lost to Follow-up|5|||
149075396|NCT01701401|537755487|FG002|Overall Study|Lost to Follow-up|1|||
149075397|NCT01701401|537755488|FG003|Overall Study|Lost to Follow-up|3|||
149075398|NCT01701401|537755485|FG000|Overall Study|Withdrew Consent|0|||
149075399|NCT01701401|537755486|FG001|Overall Study|Withdrew Consent|3|||
149075400|NCT01701401|537755487|FG002|Overall Study|Withdrew Consent|1|||
149075401|NCT01701401|537755488|FG003|Overall Study|Withdrew Consent|2|||
149075402|NCT01701401|537755485|FG000|Overall Study|Lack of Efficacy|1|||
149075403|NCT01701401|537755486|FG001|Overall Study|Lack of Efficacy|0|||
149075404|NCT01701401|537755487|FG002|Overall Study|Lack of Efficacy|2|||
149075405|NCT01701401|537755488|FG003|Overall Study|Lack of Efficacy|0|||
149075406|NCT01701401|537755485|FG000|Overall Study|Adverse Event|1|||
149075407|NCT01701401|537755486|FG001|Overall Study|Adverse Event|0|||
149075408|NCT01701401|537755487|FG002|Overall Study|Adverse Event|0|||
149075409|NCT01701401|537755488|FG003|Overall Study|Adverse Event|0|||
149075410|NCT01701401|537755485|FG000|Overall Study|Protocol Violation|0|||
149075411|NCT01701401|537755486|FG001|Overall Study|Protocol Violation|0|||
149075412|NCT01701401|537755487|FG002|Overall Study|Protocol Violation|1|||
149075413|NCT01701401|537755488|FG003|Overall Study|Protocol Violation|0|||
149075414|NCT04827732|537755489|FG000|Overall Study|Did not start treatment|0|||
149075415|NCT04827732|537755490|FG001|Overall Study|Did not start treatment|1|||
149075416|NCT04827732|537755491|FG002|Overall Study|Did not start treatment|0|||
149075417|NCT04827732|537755492|FG003|Overall Study|Did not start treatment|1|||
149075418|NCT03789656|537755504|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
149075419|NCT03789656|537755505|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
149075420|NCT03789656|537755506|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
149075421|NCT03789656|537755507|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
149075422|NCT03789656|537755508|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
149075423|NCT03789656|537755504|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
149075424|NCT03789656|537755505|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
149075425|NCT03789656|537755506|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
149075426|NCT03789656|537755507|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
149075427|NCT03789656|537755508|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
149075428|NCT03789656|537755504|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
149075429|NCT03789656|537755505|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
149075430|NCT03789656|537755506|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
149075431|NCT03789656|537755507|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
149075432|NCT03789656|537755508|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
149075433|NCT03789656|537755504|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
149075434|NCT03789656|537755505|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
149075435|NCT03789656|537755506|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
149075436|NCT03789656|537755507|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
149075437|NCT03789656|537755508|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
149075438|NCT05325294|537755518|FG000|Overall Study|Adverse Event|3|||
149075439|NCT05325294|537755519|FG001|Overall Study|Adverse Event|3|||
149075440|NCT05325294|537755518|FG000|Overall Study|Physician Decision|0|||
149075441|NCT05325294|537755519|FG001|Overall Study|Physician Decision|1|||
149075442|NCT05325294|537755518|FG000|Overall Study|Withdrawal by Subject|0|||
149075443|NCT05325294|537755519|FG001|Overall Study|Withdrawal by Subject|3|||
149075444|NCT05325294|537755518|FG000|Overall Study|Lost to Follow-up|1|||
149075445|NCT05325294|537755519|FG001|Overall Study|Lost to Follow-up|0|||
149075446|NCT05325294|537755518|FG000|Overall Study|Sponsor Request|0|||
149075447|NCT05325294|537755519|FG001|Overall Study|Sponsor Request|2|||
149075448|NCT04701203|537755522|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
149075449|NCT04701203|537755523|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
149075450|NCT04701203|537755524|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
149075451|NCT04701203|537755522|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
149075452|NCT04701203|537755523|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
149075453|NCT04701203|537755524|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
149075454|NCT04701203|537755522|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
149075455|NCT04701203|537755523|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
149075456|NCT04701203|537755524|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
149075457|NCT04701203|537755522|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
149075458|NCT04701203|537755523|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
149075459|NCT04701203|537755524|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
149075460|NCT02434328|537755526|FG000|Overall Study|Adverse Event|9|||
149075461|NCT02434328|537755527|FG001|Overall Study|Adverse Event|4|||
149075462|NCT02434328|537755526|FG000|Overall Study|Lack of Efficacy|0|||
149075463|NCT02434328|537755527|FG001|Overall Study|Lack of Efficacy|2|||
149075464|NCT02434328|537755526|FG000|Overall Study|Physician Decision|0|||
149075465|NCT02434328|537755527|FG001|Overall Study|Physician Decision|1|||
149075466|NCT02434328|537755526|FG000|Overall Study|Withdrawal by Subject|12|||
149075467|NCT02434328|537755527|FG001|Overall Study|Withdrawal by Subject|21|||
149075468|NCT02434328|537755526|FG000|Overall Study|Death|4|||
149075469|NCT02434328|537755527|FG001|Overall Study|Death|7|||
149075470|NCT02434328|537755526|FG000|Overall Study|Lost to Follow-up|1|||
149075471|NCT02434328|537755527|FG001|Overall Study|Lost to Follow-up|6|||
149075472|NCT02434328|537755526|FG000|Overall Study|Other|4|||
149075473|NCT02434328|537755527|FG001|Overall Study|Other|1|||
149075474|NCT00491894|537755528|FG000|Overall Study|Adverse Event|14|||
149075475|NCT00491894|537755528|FG000|Overall Study|Withdrawal by Subject|5|||
149075476|NCT00491894|537755528|FG000|Overall Study|Death|3|||
149075477|NCT00491894|537755528|FG000|Overall Study|Lost to Follow-up|3|||
149075478|NCT00491894|537755528|FG000|Overall Study|Lack of Efficacy|2|||
149075479|NCT00491894|537755528|FG000|Overall Study|Other-Failed to meet any criteria|2|||
149075480|NCT00491894|537755528|FG000|Overall Study|Physician Decision|2|||
149075481|NCT00491894|537755528|FG000|Overall Study|Protocol Violation|2|||
149075482|NCT00491894|537755528|FG000|Overall Study|Other-Intake of prohibited medication|1|||
149075483|NCT01563185|537755529|FG000|Overall Study|Withdrawal by Subject|1|||
149075484|NCT01563185|537755529|FG000|Overall Study|Non-Compliance with study drug|1|||
149075485|NCT04577651|537755530|FG000|Overall Study|Screen Failure|7|||
149075486|NCT04577651|537755530|FG000|Overall Study|Adverse Event|1|||
149075487|NCT04577651|537755530|FG000|Overall Study|Death|1|||
149075488|NCT04577651|537755530|FG000|Overall Study|Physician Decision|1|||
149075489|NCT04577651|537755530|FG000|Overall Study|Withdrawal by Subject|3|||
149075490|NCT05293717|537755534|FG000|Overall Study|Physician Decision|1|||
149075491|NCT05422339|537756865|FG000|Overall Study|Withdrawal by Subject|17|||
149075492|NCT05422339|537756866|FG001|Overall Study|Withdrawal by Subject|15|||
149075493|NCT04172675|537756867|FG000|Overall Study|Withdrawal by Subject|7|||
149075494|NCT04172675|537756868|FG001|Overall Study|Withdrawal by Subject|5|||
149075495|NCT04172675|537756869|FG002|Overall Study|Withdrawal by Subject|1|||
149075496|NCT04172675|537756870|FG003|Overall Study|Withdrawal by Subject|4|||
149075497|NCT05029284|537756871|FG000|Overall Study|Lost to Follow-up|1|||
149075498|NCT03070392|537756872|FG000|Overall Study|Not Treated|7|||
149075499|NCT03070392|537756873|FG001|Overall Study|Not Treated|0|||
149075500|NCT03070392|537756874|FG002|Overall Study|Not Treated|3|||
149075501|NCT03070392|537756875|FG003|Overall Study|Not Treated|12|||
149075502|NCT03070392|537756872|FG000|Overall Study|Death|3|||
149075503|NCT03070392|537756873|FG001|Overall Study|Death|0|||
149075504|NCT03070392|537756874|FG002|Overall Study|Death|0|||
149075505|NCT03070392|537756875|FG003|Overall Study|Death|1|||
149075506|NCT03070392|537756872|FG000|Overall Study|Withdrawal by Subject|7|||
149075507|NCT03070392|537756873|FG001|Overall Study|Withdrawal by Subject|0|||
149075508|NCT03070392|537756874|FG002|Overall Study|Withdrawal by Subject|0|||
149075509|NCT03070392|537756875|FG003|Overall Study|Withdrawal by Subject|3|||
149075510|NCT03070392|537756872|FG000|Overall Study|Physician Decision|1|||
149075511|NCT03070392|537756873|FG001|Overall Study|Physician Decision|0|||
149075512|NCT03070392|537756874|FG002|Overall Study|Physician Decision|0|||
149075513|NCT03070392|537756875|FG003|Overall Study|Physician Decision|2|||
149075514|NCT03070392|537756872|FG000|Overall Study|Progressive Disease|154|||
149075515|NCT03070392|537756873|FG001|Overall Study|Progressive Disease|6|||
149075516|NCT03070392|537756874|FG002|Overall Study|Progressive Disease|2|||
149075517|NCT03070392|537756875|FG003|Overall Study|Progressive Disease|70|||
149075518|NCT03070392|537756872|FG000|Overall Study|Adverse Event|6|||
149075519|NCT03070392|537756873|FG001|Overall Study|Adverse Event|1|||
149075520|NCT03070392|537756874|FG002|Overall Study|Adverse Event|1|||
149075521|NCT03070392|537756875|FG003|Overall Study|Adverse Event|3|||
149075522|NCT03070392|537756872|FG000|Overall Study|Alternate anticancer treatment|1|||
149075523|NCT03070392|537756873|FG001|Overall Study|Alternate anticancer treatment|0|||
149075524|NCT03070392|537756874|FG002|Overall Study|Alternate anticancer treatment|0|||
149075525|NCT03070392|537756875|FG003|Overall Study|Alternate anticancer treatment|1|||
149075526|NCT03070392|537756872|FG000|Overall Study|Ongoing|73|||
149075527|NCT03070392|537756873|FG001|Overall Study|Ongoing|0|||
149075528|NCT03070392|537756874|FG002|Overall Study|Ongoing|0|||
149075529|NCT03070392|537756875|FG003|Overall Study|Ongoing|11|||
149075530|NCT02972034|537756876|FG000|Overall Study|Death|11|||
149075531|NCT02972034|537756877|FG001|Overall Study|Death|1|||
149075532|NCT02972034|537756878|FG002|Overall Study|Death|3|||
149075533|NCT02972034|537756879|FG003|Overall Study|Death|3|||
149075534|NCT02972034|537756880|FG004|Overall Study|Death|2|||
149075535|NCT02972034|537756881|FG005|Overall Study|Death|2|||
149075536|NCT02972034|537756882|FG006|Overall Study|Death|3|||
149075537|NCT02972034|537756883|FG007|Overall Study|Death|4|||
149075538|NCT02972034|537756884|FG008|Overall Study|Death|8|||
149075539|NCT02972034|537756885|FG009|Overall Study|Death|11|||
149075540|NCT02972034|537756886|FG010|Overall Study|Death|3|||
149075541|NCT02972034|537756887|FG011|Overall Study|Death|2|||
149075542|NCT02972034|537756888|FG012|Overall Study|Death|11|||
149075543|NCT02972034|537756889|FG013|Overall Study|Death|10|||
149075544|NCT02972034|537756890|FG014|Overall Study|Death|9|||
149075545|NCT02972034|537756876|FG000|Overall Study|Lost to Follow-up|0|||
149075546|NCT02972034|537756877|FG001|Overall Study|Lost to Follow-up|0|||
149075547|NCT02972034|537756878|FG002|Overall Study|Lost to Follow-up|0|||
149075548|NCT02972034|537756879|FG003|Overall Study|Lost to Follow-up|0|||
149075549|NCT02972034|537756880|FG004|Overall Study|Lost to Follow-up|1|||
149075550|NCT02972034|537756881|FG005|Overall Study|Lost to Follow-up|0|||
149075551|NCT02972034|537756882|FG006|Overall Study|Lost to Follow-up|0|||
149075552|NCT02972034|537756883|FG007|Overall Study|Lost to Follow-up|1|||
149075553|NCT02972034|537756884|FG008|Overall Study|Lost to Follow-up|0|||
149075554|NCT02972034|537756885|FG009|Overall Study|Lost to Follow-up|0|||
149075555|NCT02972034|537756886|FG010|Overall Study|Lost to Follow-up|0|||
149075556|NCT02972034|537756887|FG011|Overall Study|Lost to Follow-up|0|||
149075557|NCT02972034|537756888|FG012|Overall Study|Lost to Follow-up|0|||
149075558|NCT02972034|537756889|FG013|Overall Study|Lost to Follow-up|0|||
149075559|NCT02972034|537756890|FG014|Overall Study|Lost to Follow-up|1|||
149075560|NCT02972034|537756876|FG000|Overall Study|Physician Decision|0|||
149075561|NCT02972034|537756877|FG001|Overall Study|Physician Decision|0|||
149075562|NCT02972034|537756878|FG002|Overall Study|Physician Decision|0|||
149075563|NCT02972034|537756879|FG003|Overall Study|Physician Decision|0|||
149075564|NCT02972034|537756880|FG004|Overall Study|Physician Decision|0|||
149075565|NCT02972034|537756881|FG005|Overall Study|Physician Decision|0|||
149075566|NCT02972034|537756882|FG006|Overall Study|Physician Decision|0|||
149075567|NCT02972034|537756883|FG007|Overall Study|Physician Decision|1|||
149075568|NCT02972034|537756884|FG008|Overall Study|Physician Decision|0|||
149075569|NCT02972034|537756885|FG009|Overall Study|Physician Decision|0|||
149075570|NCT02972034|537756886|FG010|Overall Study|Physician Decision|1|||
149075571|NCT02972034|537756887|FG011|Overall Study|Physician Decision|0|||
149075572|NCT02972034|537756888|FG012|Overall Study|Physician Decision|0|||
149075573|NCT02972034|537756889|FG013|Overall Study|Physician Decision|0|||
149075574|NCT02972034|537756890|FG014|Overall Study|Physician Decision|0|||
149075575|NCT02972034|537756876|FG000|Overall Study|Sponsor Decision|0|||
149075576|NCT02972034|537756877|FG001|Overall Study|Sponsor Decision|0|||
149075577|NCT02972034|537756878|FG002|Overall Study|Sponsor Decision|0|||
149075578|NCT02972034|537756879|FG003|Overall Study|Sponsor Decision|1|||
149075579|NCT02972034|537756880|FG004|Overall Study|Sponsor Decision|0|||
149075580|NCT02972034|537756881|FG005|Overall Study|Sponsor Decision|0|||
149075581|NCT02972034|537756882|FG006|Overall Study|Sponsor Decision|1|||
149075582|NCT02972034|537756883|FG007|Overall Study|Sponsor Decision|1|||
149075583|NCT02972034|537756884|FG008|Overall Study|Sponsor Decision|1|||
149075584|NCT02972034|537756885|FG009|Overall Study|Sponsor Decision|2|||
149075585|NCT02972034|537756886|FG010|Overall Study|Sponsor Decision|2|||
149075586|NCT02972034|537756887|FG011|Overall Study|Sponsor Decision|0|||
149075587|NCT02972034|537756888|FG012|Overall Study|Sponsor Decision|1|||
149075588|NCT02972034|537756889|FG013|Overall Study|Sponsor Decision|0|||
149075589|NCT02972034|537756890|FG014|Overall Study|Sponsor Decision|1|||
149075590|NCT02972034|537756876|FG000|Overall Study|Withdrawal by Subject|3|||
149075591|NCT02972034|537756877|FG001|Overall Study|Withdrawal by Subject|0|||
149075592|NCT02972034|537756878|FG002|Overall Study|Withdrawal by Subject|0|||
149075593|NCT02972034|537756879|FG003|Overall Study|Withdrawal by Subject|0|||
149075594|NCT02972034|537756880|FG004|Overall Study|Withdrawal by Subject|1|||
149075595|NCT02972034|537756881|FG005|Overall Study|Withdrawal by Subject|1|||
149075596|NCT02972034|537756882|FG006|Overall Study|Withdrawal by Subject|0|||
149075597|NCT02972034|537756883|FG007|Overall Study|Withdrawal by Subject|0|||
149075598|NCT02972034|537756884|FG008|Overall Study|Withdrawal by Subject|1|||
149075599|NCT02972034|537756885|FG009|Overall Study|Withdrawal by Subject|1|||
149075600|NCT02972034|537756886|FG010|Overall Study|Withdrawal by Subject|2|||
149075601|NCT02972034|537756887|FG011|Overall Study|Withdrawal by Subject|1|||
149075602|NCT02972034|537756888|FG012|Overall Study|Withdrawal by Subject|1|||
149075603|NCT02972034|537756889|FG013|Overall Study|Withdrawal by Subject|1|||
149075604|NCT02972034|537756890|FG014|Overall Study|Withdrawal by Subject|0|||
149075605|NCT02972034|537756876|FG000|Overall Study|Screen Failure|0|||
149075606|NCT02972034|537756877|FG001|Overall Study|Screen Failure|0|||
149075607|NCT02972034|537756878|FG002|Overall Study|Screen Failure|0|||
149075608|NCT02972034|537756879|FG003|Overall Study|Screen Failure|0|||
149075609|NCT02972034|537756880|FG004|Overall Study|Screen Failure|0|||
149075610|NCT02972034|537756881|FG005|Overall Study|Screen Failure|0|||
149075611|NCT02972034|537756882|FG006|Overall Study|Screen Failure|0|||
149075612|NCT02972034|537756883|FG007|Overall Study|Screen Failure|0|||
149075613|NCT02972034|537756884|FG008|Overall Study|Screen Failure|0|||
149075614|NCT02972034|537756885|FG009|Overall Study|Screen Failure|0|||
149075615|NCT02972034|537756886|FG010|Overall Study|Screen Failure|0|||
149075616|NCT02972034|537756887|FG011|Overall Study|Screen Failure|0|||
149075617|NCT02972034|537756888|FG012|Overall Study|Screen Failure|1|||
149075618|NCT02972034|537756889|FG013|Overall Study|Screen Failure|0|||
149075619|NCT02972034|537756890|FG014|Overall Study|Screen Failure|0|||
149075620|NCT03009344|537756891|FG000|Overall Study|Lack of Efficacy|5|||
149075621|NCT03009344|537756891|FG000|Overall Study|Withdrawal by Subject|1|||
149075622|NCT03009344|537756891|FG000|Overall Study|Adverse Event|1|||
149075623|NCT00378898|537756892|FG000|Overall Study|Withdrawal by Subject|10|||
149075624|NCT00378898|537756893|FG001|Overall Study|Withdrawal by Subject|5|||
149075625|NCT00378898|537756892|FG000|Overall Study|Protocol Violation|1|||
149075626|NCT00378898|537756893|FG001|Overall Study|Protocol Violation|1|||
149075627|NCT01278030|537756902|FG000|Overall Study|Withdrawal by Subject|8|||
149075628|NCT01278030|537756903|FG001|Overall Study|Withdrawal by Subject|4|||
149075629|NCT00458783|537756905|FG000|Overall Study|Protocol Violation|1228|||
149075630|NCT00458783|537756906|FG001|Overall Study|Protocol Violation|1220|||
149075631|NCT01737398|537756907|FG000|Overall Study|Adverse event or SAE|16|||
149075632|NCT01737398|537756908|FG001|Overall Study|Adverse event or SAE|1|||
149075633|NCT01737398|537756907|FG000|Overall Study|Stopping rule met|2|||
149075634|NCT01737398|537756908|FG001|Overall Study|Stopping rule met|1|||
149075635|NCT01737398|537756907|FG000|Overall Study|Voluntary withdrawal|2|||
149075636|NCT01737398|537756908|FG001|Overall Study|Voluntary withdrawal|3|||
149075637|NCT01737398|537756907|FG000|Overall Study|Ineligibility|1|||
149075638|NCT01737398|537756908|FG001|Overall Study|Ineligibility|0|||
149075639|NCT01737398|537756907|FG000|Overall Study|Liver transplant|1|||
149075640|NCT01737398|537756908|FG001|Overall Study|Liver transplant|0|||
149075641|NCT01737398|537756907|FG000|Overall Study|Disease progression|2|||
149075642|NCT01737398|537756908|FG001|Overall Study|Disease progression|3|||
149075643|NCT01737398|537756907|FG000|Overall Study|Sponsor's decision|2|||
149075644|NCT01737398|537756908|FG001|Overall Study|Sponsor's decision|0|||
149075645|NCT02372799|537756910|FG000|Treatment Period|Adverse Event|3|||
149075646|NCT02372799|537756911|FG001|Treatment Period|Adverse Event|10|||
149075647|NCT02372799|537756912|FG002|Treatment Period|Adverse Event|6|||
149075648|NCT02372799|537756910|FG000|Treatment Period|Insufficient therapeutic response|2|||
149075649|NCT02372799|537756911|FG001|Treatment Period|Insufficient therapeutic response|2|||
149075650|NCT02372799|537756912|FG002|Treatment Period|Insufficient therapeutic response|0|||
149075651|NCT02372799|537756910|FG000|Treatment Period|Withdrawal by Subject|10|||
149075652|NCT02372799|537756911|FG001|Treatment Period|Withdrawal by Subject|10|||
149075653|NCT02372799|537756912|FG002|Treatment Period|Withdrawal by Subject|2|||
149075654|NCT02372799|537756910|FG000|Treatment Period|Lost to Follow-up|11|||
149075655|NCT02372799|537756911|FG001|Treatment Period|Lost to Follow-up|5|||
149075656|NCT02372799|537756912|FG002|Treatment Period|Lost to Follow-up|3|||
149075657|NCT02372799|537756910|FG000|Treatment Period|Protocol Violation|3|||
149075658|NCT02372799|537756911|FG001|Treatment Period|Protocol Violation|0|||
149075659|NCT02372799|537756912|FG002|Treatment Period|Protocol Violation|0|||
149075660|NCT02372799|537756910|FG000|Treatment Period|Non-compliance with study drug|4|||
149075661|NCT02372799|537756911|FG001|Treatment Period|Non-compliance with study drug|4|||
149075662|NCT02372799|537756912|FG002|Treatment Period|Non-compliance with study drug|4|||
149075663|NCT02372799|537756910|FG000|Treatment Period|Miscellaneous Reasons|1|||
149075664|NCT02372799|537756911|FG001|Treatment Period|Miscellaneous Reasons|1|||
149075665|NCT02372799|537756912|FG002|Treatment Period|Miscellaneous Reasons|0|||
149075666|NCT02372799|537756910|FG000|Down-taper Period|Lost to Follow-up|1|||
149075667|NCT02372799|537756911|FG001|Down-taper Period|Lost to Follow-up|2|||
149075668|NCT02372799|537756912|FG002|Down-taper Period|Lost to Follow-up|2|||
149075669|NCT00089609|537756913|FG000|Overall Study|Withdrawal by Subject|3|||
149075670|NCT00089609|537756914|FG001|Overall Study|Withdrawal by Subject|1|||
149075671|NCT05815342|537756915|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
149075672|NCT05815342|537756915|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
149075673|NCT05815342|537756915|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
149075674|NCT05815342|537756915|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
149075675|NCT05815342|537756915|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
149075676|NCT03116464|537756916|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
149075677|NCT00747006|537756917|FG000|Overall Study|Adverse Event|1|||
149075678|NCT00747006|537756918|FG001|Overall Study|Adverse Event|0|||
149075679|NCT00747006|537756919|FG002|Overall Study|Adverse Event|0|||
149075680|NCT00747006|537756917|FG000|Overall Study|Lost to Follow-up|0|||
149075681|NCT00747006|537756918|FG001|Overall Study|Lost to Follow-up|1|||
149075682|NCT00747006|537756919|FG002|Overall Study|Lost to Follow-up|0|||
149075683|NCT00747006|537756917|FG000|Overall Study|Physician Decision|2|||
149075684|NCT00747006|537756918|FG001|Overall Study|Physician Decision|0|||
149075685|NCT00747006|537756919|FG002|Overall Study|Physician Decision|1|||
149075686|NCT00357994|537756920|FG000|Overall Study|Adverse Event|1|||
149075687|NCT00357994|537756921|FG001|Overall Study|Adverse Event|2|||
149075688|NCT00357994|537756920|FG000|Overall Study|Lack of Efficacy|0|||
149075689|NCT00357994|537756921|FG001|Overall Study|Lack of Efficacy|1|||
149075690|NCT00357994|537756920|FG000|Overall Study|Protocol Violation|1|||
149075691|NCT00357994|537756921|FG001|Overall Study|Protocol Violation|0|||
149075692|NCT00345046|537756926|FG000|Overall Study|Protocol Violation|1|||
149075693|NCT00345046|537756927|FG001|Overall Study|Protocol Violation|1|||
149075694|NCT00345046|537756928|FG002|Overall Study|Protocol Violation|2|||
149075695|NCT04652869|537756931|FG000|Overall Study|Withdrawal by Subject|0|||
149075696|NCT04652869|537756932|FG001|Overall Study|Withdrawal by Subject|2|||
149075697|NCT04652869|537756933|FG002|Overall Study|Withdrawal by Subject|0|||
149075698|NCT00562094|537756934|FG000|Overall Study|Lost to Follow-up|62|||
149075699|NCT01613417|537756935|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
149075700|NCT01613417|537756936|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
149075701|NCT00019604|537756937|FG000|Overall Study|Death|1|||
149075702|NCT00019604|537756937|FG000|Overall Study|Progressive disease|23|||
149075703|NCT00019604|537756937|FG000|Overall Study|Refused treatment|1|||
149075704|NCT00019604|537756937|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
149075705|NCT00019604|537756937|FG000|Overall Study|Going to have liver transplant|1|||
149075706|NCT00019604|537756937|FG000|Overall Study|Move to a different study|1|||
149075707|NCT00019604|537756937|FG000|Overall Study|Non compliant on systemic CH|1|||
149075708|NCT00019604|537756937|FG000|Overall Study|Non compliant|1|||
149075709|NCT00019604|537756937|FG000|Overall Study|Resectable disease|1|||
149075710|NCT00019604|537756937|FG000|Overall Study|Started new chemo regimen|1|||
149075711|NCT00019604|537756937|FG000|Overall Study|Pt going to immunotherapy study|1|||
149075712|NCT00019604|537756937|FG000|Overall Study|Too much disease|1|||
149075713|NCT00019604|537756937|FG000|Overall Study|Unable to evaluate|1|||
149075714|NCT00019604|537756937|FG000|Overall Study|Details for other not available|4|||
149075715|NCT00454194|537756952|FG000|Overall Study|Adverse Event|7|||
149075716|NCT00454194|537756953|FG001|Overall Study|Adverse Event|2|||
149075717|NCT00454194|537756952|FG000|Overall Study|Withdrawal by Subject|12|||
149075718|NCT00454194|537756953|FG001|Overall Study|Withdrawal by Subject|8|||
149075719|NCT00454194|537756952|FG000|Overall Study|Other Medical Problems|1|||
149075720|NCT00454194|537756953|FG001|Overall Study|Other Medical Problems|2|||
149075721|NCT00454194|537756952|FG000|Overall Study|Other Unspecified Reason|2|||
149075722|NCT00454194|537756953|FG001|Overall Study|Other Unspecified Reason|2|||
149075723|NCT01170208|537756971|FG000|Overall Study|Withdrawal by Subject|5|||
149075724|NCT01170208|537756972|FG001|Overall Study|Withdrawal by Subject|0|||
149075725|NCT01170208|537756973|FG002|Overall Study|Withdrawal by Subject|1|||
149075726|NCT01170208|537756971|FG000|Overall Study|Protocol Violation|1|||
149075727|NCT01170208|537756972|FG001|Overall Study|Protocol Violation|0|||
149075728|NCT01170208|537756973|FG002|Overall Study|Protocol Violation|1|||
149075729|NCT03335488|537756976|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
149075730|NCT03335488|537756977|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
149075731|NCT03335488|537756976|FG000|Safety Extension Period|Adverse Event|1|||
149075732|NCT03335488|537756977|FG001|Safety Extension Period|Adverse Event|0|||
149075733|NCT03335488|537756976|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
149075734|NCT03335488|537756977|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
149075735|NCT01160354|537756982|FG000|Overall Study|Death|0|||
149075736|NCT01160354|537756983|FG001|Overall Study|Death|1|||
149075737|NCT01160354|537756984|FG002|Overall Study|Death|1|||
149075738|NCT00641537|537756990|FG000|96-week Period|Adverse Event|0|||
149075739|NCT00641537|537756991|FG001|96-week Period|Adverse Event|1|||
149075740|NCT00641537|537756992|FG002|96-week Period|Adverse Event|3|||
149075741|NCT00641537|537756993|FG003|96-week Period|Adverse Event|0|||
149075742|NCT00641537|537756994|FG004|96-week Period|Adverse Event|2|||
149075743|NCT00641537|537756995|FG005|96-week Period|Adverse Event|0|||
149075744|NCT00641537|537756996|FG006|96-week Period|Adverse Event|0|||
149075745|NCT00641537|537756997|FG007|96-week Period|Adverse Event|0|||
149075746|NCT00641537|537756990|FG000|96-week Period|Lost to Follow-up|3|||
149075747|NCT00641537|537756991|FG001|96-week Period|Lost to Follow-up|1|||
149075748|NCT00641537|537756992|FG002|96-week Period|Lost to Follow-up|2|||
149075749|NCT00641537|537756993|FG003|96-week Period|Lost to Follow-up|2|||
149075750|NCT00641537|537756994|FG004|96-week Period|Lost to Follow-up|4|||
149075751|NCT00641537|537756995|FG005|96-week Period|Lost to Follow-up|0|||
149075752|NCT00641537|537756996|FG006|96-week Period|Lost to Follow-up|1|||
149075753|NCT00641537|537756997|FG007|96-week Period|Lost to Follow-up|0|||
149075754|NCT00641537|537756990|FG000|96-week Period|Protocol Violation|0|||
149075755|NCT00641537|537756991|FG001|96-week Period|Protocol Violation|1|||
149075756|NCT00641537|537756992|FG002|96-week Period|Protocol Violation|0|||
149075757|NCT00641537|537756993|FG003|96-week Period|Protocol Violation|1|||
149075758|NCT00641537|537756994|FG004|96-week Period|Protocol Violation|0|||
149075759|NCT00641537|537756995|FG005|96-week Period|Protocol Violation|1|||
149075760|NCT00641537|537756996|FG006|96-week Period|Protocol Violation|0|||
149075761|NCT00641537|537756997|FG007|96-week Period|Protocol Violation|0|||
149075762|NCT00641537|537756990|FG000|96-week Period|Death|2|||
149075763|NCT00641537|537756991|FG001|96-week Period|Death|0|||
149075764|NCT00641537|537756992|FG002|96-week Period|Death|1|||
149075765|NCT00641537|537756993|FG003|96-week Period|Death|0|||
149075766|NCT00641537|537756994|FG004|96-week Period|Death|0|||
149075767|NCT00641537|537756995|FG005|96-week Period|Death|0|||
149075768|NCT00641537|537756996|FG006|96-week Period|Death|0|||
149075769|NCT00641537|537756997|FG007|96-week Period|Death|0|||
149075770|NCT00641537|537756990|FG000|96-week Period|Other|4|||
149075771|NCT00641537|537756991|FG001|96-week Period|Other|7|||
149075772|NCT00641537|537756992|FG002|96-week Period|Other|14|||
149075773|NCT00641537|537756993|FG003|96-week Period|Other|9|||
149075774|NCT00641537|537756994|FG004|96-week Period|Other|11|||
149075775|NCT00641537|537756995|FG005|96-week Period|Other|6|||
149075776|NCT00641537|537756996|FG006|96-week Period|Other|4|||
149075777|NCT00641537|537756997|FG007|96-week Period|Other|6|||
149075778|NCT00641537|537756990|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
149075779|NCT00641537|537756991|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
149075780|NCT00641537|537756992|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
149075781|NCT00641537|537756993|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
149075782|NCT00641537|537756994|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
149075783|NCT00641537|537756995|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
149075784|NCT00641537|537756996|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
149075785|NCT00641537|537756997|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
149075786|NCT00641537|537756990|FG000|24-Week Supplemental Follow-up Period|Other|0|||
149075787|NCT00641537|537756991|FG001|24-Week Supplemental Follow-up Period|Other|2|||
149075788|NCT00641537|537756992|FG002|24-Week Supplemental Follow-up Period|Other|2|||
149075789|NCT00641537|537756993|FG003|24-Week Supplemental Follow-up Period|Other|1|||
149075790|NCT00641537|537756994|FG004|24-Week Supplemental Follow-up Period|Other|3|||
149075791|NCT00641537|537756995|FG005|24-Week Supplemental Follow-up Period|Other|0|||
149075792|NCT00641537|537756996|FG006|24-Week Supplemental Follow-up Period|Other|1|||
149075793|NCT00641537|537756997|FG007|24-Week Supplemental Follow-up Period|Other|1|||
149075794|NCT02743819|537756999|FG000|Overall Study|Lack of Efficacy|5|||
149075795|NCT02743819|537756999|FG000|Overall Study|Death|2|||
149075796|NCT02743819|537756999|FG000|Overall Study|Adverse Event|1|||
149075797|NCT04762277|537757000|FG000|Overall Study|Withdrawal by Subject|0|||
149075798|NCT04762277|537757001|FG001|Overall Study|Withdrawal by Subject|2|||
149075799|NCT04762277|537757000|FG000|Overall Study|Protocol Violation|0|||
149075800|NCT04762277|537757001|FG001|Overall Study|Protocol Violation|1|||
149075801|NCT04762277|537757000|FG000|Overall Study|Adverse Event|1|||
149075802|NCT04762277|537757001|FG001|Overall Study|Adverse Event|0|||
149075803|NCT01690624|537757002|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
149075804|NCT01690624|537757003|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
149075805|NCT01690624|537757004|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
149075806|NCT01690624|537757005|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
149075807|NCT01690624|537757002|FG000|Overall Study|Adverse event (other than DLT)|3|||
149075808|NCT01690624|537757003|FG001|Overall Study|Adverse event (other than DLT)|1|||
149075809|NCT01690624|537757004|FG002|Overall Study|Adverse event (other than DLT)|1|||
149075810|NCT01690624|537757005|FG003|Overall Study|Adverse event (other than DLT)|1|||
149075811|NCT01690624|537757002|FG000|Overall Study|Withdrawal by Subject|0|||
149075812|NCT01690624|537757003|FG001|Overall Study|Withdrawal by Subject|0|||
149075813|NCT01690624|537757004|FG002|Overall Study|Withdrawal by Subject|1|||
149075814|NCT01690624|537757005|FG003|Overall Study|Withdrawal by Subject|0|||
149075815|NCT01690624|537757002|FG000|Overall Study|Sponsor is ending trial|0|||
149075816|NCT01690624|537757003|FG001|Overall Study|Sponsor is ending trial|0|||
149075817|NCT01690624|537757004|FG002|Overall Study|Sponsor is ending trial|0|||
149075818|NCT01690624|537757005|FG003|Overall Study|Sponsor is ending trial|1|||
149075819|NCT01690624|537757002|FG000|Overall Study|Physician Decision|0|||
149075820|NCT01690624|537757003|FG001|Overall Study|Physician Decision|0|||
149075821|NCT01690624|537757004|FG002|Overall Study|Physician Decision|0|||
149075822|NCT01690624|537757005|FG003|Overall Study|Physician Decision|1|||
149075823|NCT01690624|537757002|FG000|Overall Study|Withdrawal by Subject|0|||
149075824|NCT01690624|537757003|FG001|Overall Study|Withdrawal by Subject|1|||
149075825|NCT01690624|537757004|FG002|Overall Study|Withdrawal by Subject|0|||
149075826|NCT01690624|537757005|FG003|Overall Study|Withdrawal by Subject|0|||
149075827|NCT01690624|537757002|FG000|Overall Study|Lack of Efficacy|1|||
149075828|NCT01690624|537757003|FG001|Overall Study|Lack of Efficacy|1|||
149075829|NCT01690624|537757004|FG002|Overall Study|Lack of Efficacy|3|||
149075830|NCT01690624|537757005|FG003|Overall Study|Lack of Efficacy|0|||
149075831|NCT03147287|537757010|FG000|Overall Study|Randomized Not Treated|2|||
149075832|NCT03147287|537757011|FG001|Overall Study|Randomized Not Treated|1|||
149075833|NCT03147287|537757012|FG002|Overall Study|Randomized Not Treated|1|||
149075834|NCT03147287|537757010|FG000|Overall Study|Progressive Disease RECIST|31|||
149075835|NCT03147287|537757011|FG001|Overall Study|Progressive Disease RECIST|72|||
149075836|NCT03147287|537757012|FG002|Overall Study|Progressive Disease RECIST|32|||
149075837|NCT03147287|537757010|FG000|Overall Study|Progressive Disease not RECIST|13|||
149075838|NCT03147287|537757011|FG001|Overall Study|Progressive Disease not RECIST|21|||
149075839|NCT03147287|537757012|FG002|Overall Study|Progressive Disease not RECIST|13|||
149075840|NCT03147287|537757010|FG000|Overall Study|Physician Decision|1|||
149075841|NCT03147287|537757011|FG001|Overall Study|Physician Decision|2|||
149075842|NCT03147287|537757012|FG002|Overall Study|Physician Decision|1|||
149075843|NCT03147287|537757010|FG000|Overall Study|Intercurrent illness|0|||
149075844|NCT03147287|537757011|FG001|Overall Study|Intercurrent illness|1|||
149075845|NCT03147287|537757012|FG002|Overall Study|Intercurrent illness|0|||
149075846|NCT03147287|537757010|FG000|Overall Study|Withdrawal by Subject|2|||
149075847|NCT03147287|537757011|FG001|Overall Study|Withdrawal by Subject|3|||
149075848|NCT03147287|537757012|FG002|Overall Study|Withdrawal by Subject|2|||
149075849|NCT03147287|537757010|FG000|Overall Study|Patient Non-Compliance|0|||
149075850|NCT03147287|537757011|FG001|Overall Study|Patient Non-Compliance|2|||
149075851|NCT03147287|537757012|FG002|Overall Study|Patient Non-Compliance|0|||
149075852|NCT03147287|537757010|FG000|Overall Study|Patient moved|0|||
149075853|NCT03147287|537757011|FG001|Overall Study|Patient moved|1|||
149075854|NCT03147287|537757012|FG002|Overall Study|Patient moved|0|||
149075855|NCT03147287|537757010|FG000|Overall Study|Arm A crossover without PD|1|||
149075856|NCT03147287|537757011|FG001|Overall Study|Arm A crossover without PD|0|||
149075857|NCT03147287|537757012|FG002|Overall Study|Arm A crossover without PD|0|||
149075858|NCT03147287|537757010|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
149075859|NCT03147287|537757011|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
149075860|NCT03147287|537757012|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
149075861|NCT02534233|537758628|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
149075862|NCT01372085|537758632|FG000|Washout Period 2|Physician Decision|0|||
149075863|NCT01372085|537758633|FG001|Washout Period 2|Physician Decision|0|||
149075864|NCT01372085|537758634|FG002|Washout Period 2|Physician Decision|0|||
149075865|NCT01372085|537758635|FG003|Washout Period 2|Physician Decision|0|||
149075866|NCT01372085|537758636|FG004|Washout Period 2|Physician Decision|1|||
149075867|NCT01372085|537758637|FG005|Washout Period 2|Physician Decision|0|||
149075868|NCT01372085|537758638|FG006|Washout Period 2|Physician Decision|0|||
149075869|NCT01372085|537758639|FG007|Washout Period 2|Physician Decision|0|||
149075870|NCT01372085|537758640|FG008|Washout Period 2|Physician Decision|0|||
149075871|NCT01372085|537758641|FG009|Washout Period 2|Physician Decision|0|||
149075872|NCT01372085|537758632|FG000|Washout Period 3|Withdrawal by Subject|0|||
149075873|NCT01372085|537758633|FG001|Washout Period 3|Withdrawal by Subject|0|||
149075874|NCT01372085|537758634|FG002|Washout Period 3|Withdrawal by Subject|0|||
149075875|NCT01372085|537758635|FG003|Washout Period 3|Withdrawal by Subject|0|||
149075876|NCT01372085|537758636|FG004|Washout Period 3|Withdrawal by Subject|0|||
149075877|NCT01372085|537758637|FG005|Washout Period 3|Withdrawal by Subject|2|||
149075878|NCT01372085|537758638|FG006|Washout Period 3|Withdrawal by Subject|0|||
149075879|NCT01372085|537758639|FG007|Washout Period 3|Withdrawal by Subject|0|||
149075880|NCT01372085|537758640|FG008|Washout Period 3|Withdrawal by Subject|0|||
149075881|NCT01372085|537758641|FG009|Washout Period 3|Withdrawal by Subject|0|||
149075882|NCT03689946|537758642|FG000|Overall Study|Withdrawal by Subject|3|||
149075883|NCT03689946|537758642|FG000|Overall Study|Lost to Follow-up|3|||
149075884|NCT03689946|537758642|FG000|Overall Study|Data corruption|2|||
149075885|NCT01555138|537758643|FG000|Overall Study|Death|0|||
149075886|NCT01555138|537758644|FG001|Overall Study|Death|1|||
149075887|NCT01555138|537758643|FG000|Overall Study|Lost to Follow-up|1|||
149075888|NCT01555138|537758644|FG001|Overall Study|Lost to Follow-up|0|||
149075889|NCT01555138|537758643|FG000|Overall Study|Abnormal Lab reults|1|||
149075890|NCT01555138|537758644|FG001|Overall Study|Abnormal Lab reults|3|||
149075891|NCT01555138|537758643|FG000|Overall Study|Lack of Efficacy|2|||
149075892|NCT01555138|537758644|FG001|Overall Study|Lack of Efficacy|2|||
149075893|NCT01555138|537758643|FG000|Overall Study|Protocol Violation|5|||
149075894|NCT01555138|537758644|FG001|Overall Study|Protocol Violation|3|||
149075895|NCT01555138|537758643|FG000|Overall Study|Administrative problems|8|||
149075896|NCT01555138|537758644|FG001|Overall Study|Administrative problems|0|||
149075897|NCT01555138|537758643|FG000|Overall Study|Withdrawal by Subject|16|||
149075898|NCT01555138|537758644|FG001|Overall Study|Withdrawal by Subject|15|||
149075899|NCT01555138|537758643|FG000|Overall Study|Adverse Event|14|||
149075900|NCT01555138|537758644|FG001|Overall Study|Adverse Event|14|||
149075901|NCT03220724|537758645|FG000|Overall Study|Lost to Follow-up|2|||
149075902|NCT03220724|537758646|FG001|Overall Study|Lost to Follow-up|2|||
149075903|NCT03220724|537758647|FG002|Overall Study|Lost to Follow-up|0|||
149075904|NCT03220724|537758648|FG003|Overall Study|Lost to Follow-up|3|||
149075905|NCT03220724|537758649|FG004|Overall Study|Lost to Follow-up|1|||
149075906|NCT03220724|537758650|FG005|Overall Study|Lost to Follow-up|0|||
149075907|NCT03220724|537758651|FG006|Overall Study|Lost to Follow-up|2|||
149075908|NCT03220724|537758652|FG007|Overall Study|Lost to Follow-up|1|||
149075909|NCT03220724|537758653|FG008|Overall Study|Lost to Follow-up|0|||
149075910|NCT03220724|537758645|FG000|Overall Study|Withdrawal by Subject|1|||
149075911|NCT03220724|537758646|FG001|Overall Study|Withdrawal by Subject|0|||
149075912|NCT03220724|537758647|FG002|Overall Study|Withdrawal by Subject|1|||
149075913|NCT03220724|537758648|FG003|Overall Study|Withdrawal by Subject|0|||
149075914|NCT03220724|537758649|FG004|Overall Study|Withdrawal by Subject|0|||
149075915|NCT03220724|537758650|FG005|Overall Study|Withdrawal by Subject|0|||
149075916|NCT03220724|537758651|FG006|Overall Study|Withdrawal by Subject|0|||
149075917|NCT03220724|537758652|FG007|Overall Study|Withdrawal by Subject|0|||
149075918|NCT03220724|537758653|FG008|Overall Study|Withdrawal by Subject|0|||
149075919|NCT00599196|537758656|FG000|Overall Study|Lack of Efficacy|22|||
149075920|NCT00599196|537758656|FG000|Overall Study|Adverse Event|93|||
149075921|NCT00599196|537758656|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
149075922|NCT00599196|537758656|FG000|Overall Study|Subject withdrew consent|43|||
149075923|NCT00599196|537758656|FG000|Overall Study|Study ended per sponsor|197|||
149075924|NCT00599196|537758656|FG000|Overall Study|Lost to Follow-up|17|||
149075925|NCT00599196|537758656|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
149075926|NCT00599196|537758656|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
149075927|NCT00599196|537758656|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
149075928|NCT00599196|537758656|FG000|Overall Study|Other: Pt Moved To Australia|1|||
149075929|NCT00599196|537758656|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
149075930|NCT00599196|537758656|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
149075931|NCT00047385|537758658|FG000|Overall Study|Death before any screening|2|||
149075932|NCT00047385|537758659|FG001|Overall Study|Death before any screening|5|||
149075933|NCT00047385|537758658|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
149075934|NCT00047385|537758659|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
149075935|NCT00047385|537758658|FG000|Overall Study|Eligible for screening but had no screen|260|||
149075936|NCT00047385|537758659|FG001|Overall Study|Eligible for screening but had no screen|492|||
149075937|NCT03865732|537758660|FG000|Overall Study|Adverse Event|0|||
149075938|NCT03865732|537758661|FG001|Overall Study|Adverse Event|1|||
149075939|NCT03392194|537758662|FG000|Overall Study|Withdrawal by Subject|1|||
149075940|NCT03392194|537758663|FG001|Overall Study|Withdrawal by Subject|2|||
149075941|NCT03392194|537758662|FG000|Overall Study|Conflicts with personal schedule|1|||
149075942|NCT03392194|537758663|FG001|Overall Study|Conflicts with personal schedule|0|||
149075943|NCT01009645|537758668|FG000|Overall Study|Lost to Follow-up|2|||
149075944|NCT01009645|537758669|FG001|Overall Study|Lost to Follow-up|8|||
149075945|NCT01009645|537758670|FG002|Overall Study|Lost to Follow-up|4|||
149075946|NCT01009645|537758671|FG003|Overall Study|Lost to Follow-up|5|||
149075947|NCT00620854|537758672|FG000|Washout 1|Withdrawal by Subject|0|||
149075948|NCT00620854|537758673|FG001|Washout 1|Withdrawal by Subject|0|||
149075949|NCT00620854|537758674|FG002|Washout 1|Withdrawal by Subject|1|||
149075950|NCT00620854|537758675|FG003|Washout 1|Withdrawal by Subject|1|||
149075951|NCT00620854|537758676|FG004|Washout 1|Withdrawal by Subject|0|||
149075952|NCT00620854|537758677|FG005|Washout 1|Withdrawal by Subject|0|||
149075953|NCT03345979|537758679|FG000|Overall Study|Withdrawal by Subject|20|||
149075954|NCT03345979|537758680|FG001|Overall Study|Withdrawal by Subject|31|||
149075955|NCT03345979|537758679|FG000|Overall Study|Adverse Event|10|||
149075956|NCT03345979|537758680|FG001|Overall Study|Adverse Event|11|||
149075957|NCT03345979|537758679|FG000|Overall Study|Lost to Follow-up|8|||
149075958|NCT03345979|537758680|FG001|Overall Study|Lost to Follow-up|9|||
149075959|NCT03345979|537758679|FG000|Overall Study|Lack of Efficacy|4|||
149075960|NCT03345979|537758680|FG001|Overall Study|Lack of Efficacy|2|||
149075961|NCT03345979|537758679|FG000|Overall Study|Protocol Violation|1|||
149075962|NCT03345979|537758680|FG001|Overall Study|Protocol Violation|3|||
149075963|NCT03345979|537758679|FG000|Overall Study|Physician Decision|0|||
149075964|NCT03345979|537758680|FG001|Overall Study|Physician Decision|2|||
149075965|NCT00734578|537758681|FG000|Overall Study|Adverse Event|4|||
149075966|NCT00734578|537758682|FG001|Overall Study|Adverse Event|6|||
149075967|NCT00734578|537758683|FG002|Overall Study|Adverse Event|1|||
149075968|NCT00734578|537758681|FG000|Overall Study|Protocol Violation|8|||
149075969|NCT00734578|537758682|FG001|Overall Study|Protocol Violation|6|||
149075970|NCT00734578|537758683|FG002|Overall Study|Protocol Violation|3|||
149075971|NCT00734578|537758681|FG000|Overall Study|Withdrawal by Subject|7|||
149075972|NCT00734578|537758682|FG001|Overall Study|Withdrawal by Subject|8|||
149075973|NCT00734578|537758683|FG002|Overall Study|Withdrawal by Subject|11|||
149075974|NCT00734578|537758681|FG000|Overall Study|Lost to Follow-up|9|||
149075975|NCT00734578|537758682|FG001|Overall Study|Lost to Follow-up|3|||
149075976|NCT00734578|537758683|FG002|Overall Study|Lost to Follow-up|5|||
149075977|NCT00734578|537758681|FG000|Overall Study|Lack of Efficacy|3|||
149075978|NCT00734578|537758682|FG001|Overall Study|Lack of Efficacy|2|||
149075979|NCT00734578|537758683|FG002|Overall Study|Lack of Efficacy|5|||
149075980|NCT00734578|537758681|FG000|Overall Study|Randomized in error|1|||
149075981|NCT00734578|537758682|FG001|Overall Study|Randomized in error|0|||
149075982|NCT00734578|537758683|FG002|Overall Study|Randomized in error|0|||
149075983|NCT00734578|537758681|FG000|Overall Study|Exclusion criteria|1|||
149075984|NCT00734578|537758682|FG001|Overall Study|Exclusion criteria|0|||
149075985|NCT00734578|537758683|FG002|Overall Study|Exclusion criteria|0|||
149075986|NCT00999596|537758684|FG000|Overall Study|Statistical population not required|101|||
149075987|NCT02095145|537758685|FG000|Overall Study|Withdrawal by Subject|1|||
149075988|NCT02095145|537758686|FG001|Overall Study|Withdrawal by Subject|0|||
149075989|NCT02085941|537758687|FG000|Overall Study|Lack of Efficacy|1|||
149075990|NCT02085941|537758688|FG001|Overall Study|Lack of Efficacy|0|||
149075991|NCT02085941|537758687|FG000|Overall Study|Death|6|||
149075992|NCT02085941|537758688|FG001|Overall Study|Death|1|||
149075993|NCT02085941|537758687|FG000|Overall Study|Lost to Follow-up|1|||
149075994|NCT02085941|537758688|FG001|Overall Study|Lost to Follow-up|0|||
149075995|NCT02085941|537758687|FG000|Overall Study|Physician Decision|0|||
149075996|NCT02085941|537758688|FG001|Overall Study|Physician Decision|2|||
149075997|NCT03274076|537758694|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
149075998|NCT03274076|537758695|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
149075999|NCT03274076|537758696|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
149076000|NCT03274076|537758697|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
149076001|NCT03274076|537758694|FG000|24 Weeks Open Label|Adverse Event|0|||
149076002|NCT03274076|537758695|FG001|24 Weeks Open Label|Adverse Event|0|||
149076003|NCT03274076|537758696|FG002|24 Weeks Open Label|Adverse Event|2|||
149076004|NCT03274076|537758697|FG003|24 Weeks Open Label|Adverse Event|0|||
149076005|NCT03274076|537758694|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
149076006|NCT03274076|537758695|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
149076007|NCT03274076|537758696|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
149076008|NCT03274076|537758697|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
149076009|NCT02630966|537758717|FG000|Overall Study|Adverse Event|1|||
149076010|NCT02630966|537758718|FG001|Overall Study|Adverse Event|3|||
149076011|NCT02630966|537758717|FG000|Overall Study|Significant Protocol Deviation|0|||
149076012|NCT02630966|537758718|FG001|Overall Study|Significant Protocol Deviation|2|||
149076013|NCT02630966|537758717|FG000|Overall Study|Voluntary Withdrawal|1|||
149076014|NCT02630966|537758718|FG001|Overall Study|Voluntary Withdrawal|1|||
149076015|NCT02630966|537758717|FG000|Overall Study|Lack of Efficacy|0|||
149076016|NCT02630966|537758718|FG001|Overall Study|Lack of Efficacy|2|||
149076017|NCT01801007|537758719|FG000|Overall Study|Adverse Event|2|||
149076018|NCT01801007|537758719|FG000|Overall Study|Lost to Follow-up|4|||
149076019|NCT01801007|537758719|FG000|Overall Study|Withdrawal by Subject|5|||
149076020|NCT00665392|537758720|FG000|Overall Study|not treated|1|||
149076021|NCT03389802|537758721|FG000|Overall Study|Lack of Efficacy|3|||
149076022|NCT03389802|537758722|FG001|Overall Study|Lack of Efficacy|3|||
149076023|NCT03389802|537758723|FG002|Overall Study|Lack of Efficacy|13|||
149076024|NCT03389802|537758724|FG003|Overall Study|Lack of Efficacy|6|||
149076025|NCT03389802|537758725|FG004|Overall Study|Lack of Efficacy|1|||
149076026|NCT03389802|537758721|FG000|Overall Study|Adverse Event|0|||
149076027|NCT03389802|537758722|FG001|Overall Study|Adverse Event|0|||
149076028|NCT03389802|537758723|FG002|Overall Study|Adverse Event|1|||
149076029|NCT03389802|537758724|FG003|Overall Study|Adverse Event|0|||
149076030|NCT03389802|537758725|FG004|Overall Study|Adverse Event|4|||
149076031|NCT03389802|537758721|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
149076032|NCT03389802|537758722|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
149076033|NCT03389802|537758723|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
149076034|NCT03389802|537758724|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
149076035|NCT03389802|537758725|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
149076036|NCT02426138|537758726|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
149076037|NCT02426138|537758727|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
149076038|NCT04677738|537758732|FG000|Overall Study|Withdrawal by Subject|4|||
149076039|NCT04677738|537758733|FG001|Overall Study|Withdrawal by Subject|2|||
149076040|NCT03697603|537758736|FG000|Overall Study|Adverse Event|3|||
149076041|NCT03697603|537758737|FG001|Overall Study|Adverse Event|18|||
149076042|NCT03697603|537758738|FG002|Overall Study|Adverse Event|3|||
149076043|NCT03697603|537758736|FG000|Overall Study|Physician Decision|1|||
149076044|NCT03697603|537758737|FG001|Overall Study|Physician Decision|0|||
149076045|NCT03697603|537758738|FG002|Overall Study|Physician Decision|2|||
149076046|NCT03697603|537758736|FG000|Overall Study|Protocol Violation|3|||
149076047|NCT03697603|537758737|FG001|Overall Study|Protocol Violation|8|||
149076048|NCT03697603|537758738|FG002|Overall Study|Protocol Violation|5|||
149076049|NCT03697603|537758736|FG000|Overall Study|Withdrawal by Subject|5|||
149076050|NCT03697603|537758737|FG001|Overall Study|Withdrawal by Subject|1|||
149076051|NCT03697603|537758738|FG002|Overall Study|Withdrawal by Subject|1|||
149076052|NCT03697603|537758736|FG000|Overall Study|Protocol Violation|0|||
149076053|NCT03697603|537758737|FG001|Overall Study|Protocol Violation|0|||
149076054|NCT03697603|537758738|FG002|Overall Study|Protocol Violation|1|||
149076055|NCT00553332|537758739|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
149076056|NCT03520036|537758741|FG000|Overall Study|Adverse Event|1|||
149076057|NCT03520036|537758742|FG001|Overall Study|Adverse Event|2|||
149076058|NCT03520036|537758743|FG002|Overall Study|Adverse Event|0|||
149076059|NCT03520036|537758741|FG000|Overall Study|Protocol Violation|1|||
149076060|NCT03520036|537758742|FG001|Overall Study|Protocol Violation|0|||
149076061|NCT03520036|537758743|FG002|Overall Study|Protocol Violation|0|||
149076062|NCT03520036|537758741|FG000|Overall Study|Withdrawal by Subject|0|||
149076063|NCT03520036|537758742|FG001|Overall Study|Withdrawal by Subject|1|||
149076064|NCT03520036|537758743|FG002|Overall Study|Withdrawal by Subject|4|||
149076065|NCT03520036|537758741|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
149076066|NCT03520036|537758742|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
149076067|NCT03520036|537758743|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
149076068|NCT00467272|537758747|FG000|Overall Study|Pneumonia|2|||
149076069|NCT00467272|537758747|FG000|Overall Study|Thrombophlebitis|1|||
149076070|NCT00145470|537758750|FG000|Overall Study|Adverse Event|19|||
149076071|NCT00145470|537758751|FG001|Overall Study|Adverse Event|25|||
149076072|NCT00145470|537758750|FG000|Overall Study|Lack of Efficacy|27|||
149076073|NCT00145470|537758751|FG001|Overall Study|Lack of Efficacy|13|||
149076074|NCT00145470|537758750|FG000|Overall Study|Withdrawal by Subject|36|||
149076075|NCT00145470|537758751|FG001|Overall Study|Withdrawal by Subject|34|||
149076076|NCT00145470|537758750|FG000|Overall Study|Lost to Follow-up|21|||
149076077|NCT00145470|537758751|FG001|Overall Study|Lost to Follow-up|17|||
149076078|NCT00145470|537758750|FG000|Overall Study|Reason Not Reported|9|||
149076079|NCT00145470|537758751|FG001|Overall Study|Reason Not Reported|9|||
149076080|NCT00676091|537758753|FG000|Infant Series|Parent or legal guardian request|10|||
149076081|NCT00676091|537758754|FG001|Infant Series|Parent or legal guardian request|8|||
149076082|NCT00676091|537758753|FG000|Infant Series|Protocol Violation|6|||
149076083|NCT00676091|537758754|FG001|Infant Series|Protocol Violation|3|||
149076084|NCT00676091|537758753|FG000|Infant Series|Adverse Event|2|||
149076085|NCT00676091|537758754|FG001|Infant Series|Adverse Event|3|||
149076086|NCT00676091|537758753|FG000|Infant Series|Failed to return|1|||
149076087|NCT00676091|537758754|FG001|Infant Series|Failed to return|3|||
149076088|NCT00676091|537758753|FG000|Infant Series|Lost to Follow-up|1|||
149076089|NCT00676091|537758754|FG001|Infant Series|Lost to Follow-up|0|||
149076090|NCT00676091|537758753|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
149076091|NCT00676091|537758754|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
149076092|NCT00676091|537758753|FG000|After Infant Series|Adverse Event|0|||
149076093|NCT00676091|537758754|FG001|After Infant Series|Adverse Event|1|||
149076094|NCT00676091|537758753|FG000|After Infant Series|Protocol Violation|0|||
149076095|NCT00676091|537758754|FG001|After Infant Series|Protocol Violation|1|||
149076096|NCT00676091|537758753|FG000|After Infant Series|Failed to return|1|||
149076097|NCT00676091|537758754|FG001|After Infant Series|Failed to return|1|||
149076098|NCT00676091|537758753|FG000|Toddler Dose|Failed to return|2|||
149076099|NCT00676091|537758754|FG001|Toddler Dose|Failed to return|0|||
149076100|NCT00676091|537758753|FG000|Toddler Dose|Parent or legal guardian request|1|||
149076101|NCT00676091|537758754|FG001|Toddler Dose|Parent or legal guardian request|0|||
149076102|NCT00933270|537758760|FG000|Overall Study|Withdrawal by Subject|26|||
149076103|NCT00933270|537758760|FG000|Overall Study|Insufficient Follow-up|10|||
149076104|NCT00933270|537758760|FG000|Overall Study|Lost to Follow-up|14|||
149076105|NCT00933270|537758760|FG000|Overall Study|Adverse Event|1|||
149076106|NCT00933270|537758760|FG000|Overall Study|Missed Visit|2|||
149076107|NCT00933270|537758760|FG000|Overall Study|Death|24|||
149076108|NCT00933270|537758760|FG000|Overall Study|Moved or would not return|10|||
149076109|NCT00989196|537758761|FG000|Treatment Period|Lost to Follow-up|1|||
149076110|NCT00989196|537758762|FG001|Treatment Period|Lost to Follow-up|0|||
149076121|NCT05824559|537758770|FG000|Overall Study|Adverse Event|2|||
149076122|NCT05824559|537758770|FG000|Overall Study|Physician Decision|2|||
149076123|NCT05824559|537758770|FG000|Overall Study|Progressive Disease|16|||
149076124|NCT05824559|537758770|FG000|Overall Study|Study Terminated by Sponsor|1|||
149076125|NCT05824559|537758770|FG000|Overall Study|Withdrawal by Subject|2|||
149076126|NCT02409680|537758771|FG000|Overall Study|Lost to Follow-up|15|||
149076127|NCT02409680|537758772|FG001|Overall Study|Lost to Follow-up|30|||
149076128|NCT05366751|537758773|FG000|Overall Study|Adverse Event|25|||
149076129|NCT05366751|537758773|FG000|Overall Study|Physician Decision|3|||
149076130|NCT05366751|537758773|FG000|Overall Study|Lost to Follow-up|2|||
149076131|NCT05366751|537758773|FG000|Overall Study|Withdrawal by Subject|14|||
149076132|NCT05366751|537758773|FG000|Overall Study|Study Terminated by Sponsor|50|||
149076133|NCT05366751|537758773|FG000|Overall Study|Site Terminated by Sponsor|3|||
149076134|NCT04912856|537758776|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
149076135|NCT04912856|537758777|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
149076136|NCT04912856|537758776|FG000|Overall Study|Not reported in synoptic CSR.|0|||
149076137|NCT04912856|537758777|FG001|Overall Study|Not reported in synoptic CSR.|1|||
149076138|NCT00647387|537758778|FG000|Overall Study|Lost to Follow-up|6|||
149076139|NCT00647387|537758778|FG000|Overall Study|Unsuccessful implant|5|||
149076140|NCT00647387|537758778|FG000|Overall Study|Device explanted|3|||
149076141|NCT00647387|537758778|FG000|Overall Study|Other Reason|3|||
149076142|NCT00647387|537758778|FG000|Overall Study|Death|2|||
149076143|NCT00925548|537760248|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
149076144|NCT00925548|537760249|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
149076145|NCT02278796|537760250|FG000|Overall Study|Death|2|||
149076146|NCT02278796|537760251|FG001|Overall Study|Death|3|||
149076147|NCT03214081|537760252|FG000|Overall Study|Case Report Forms Uncollected|9|||
149076148|NCT03214081|537760252|FG000|Overall Study|Protocol Deviation|54|||
149076149|NCT02962284|537760253|FG000|Overall Study|Death|2|||
149076150|NCT02962284|537760254|FG001|Overall Study|Death|0|||
149076151|NCT02962284|537760253|FG000|Overall Study|Progressive disease|2|||
149076152|NCT02962284|537760254|FG001|Overall Study|Progressive disease|3|||
149076153|NCT02962284|537760253|FG000|Overall Study|Withdrawal by Subject|1|||
149076154|NCT02962284|537760254|FG001|Overall Study|Withdrawal by Subject|0|||
149076155|NCT02000752|537760261|FG000|Overall Study|Dystocic delivery|19|||
149076156|NCT02000752|537760262|FG001|Overall Study|Dystocic delivery|8|||
149076157|NCT02000752|537760261|FG000|Overall Study|Shift Changes|12|||
149076158|NCT02000752|537760262|FG001|Overall Study|Shift Changes|5|||
149076159|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
149076160|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
149076161|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
149076162|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
149076163|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
149076164|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
149076165|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
149076166|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
149076167|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
149076168|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
149076169|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
149076170|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
149076171|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
149076172|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
149076173|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
149076174|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
149120224|NCT04602221|537918073|FG016|Overall Study|Other than listed|0|||
149076175|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
149076176|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
149076177|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
149076178|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
149076179|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
149076180|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
149076181|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
149076182|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
149076183|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
149076184|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
149076185|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
149076186|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
149076187|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
149076188|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
149076189|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
149076190|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
149076191|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
149076192|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
149076193|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
149076194|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
149076195|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
149076196|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
149076197|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
149076198|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
149076199|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
149076200|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
149076201|NCT03732807|537760268|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
149076202|NCT03732807|537760269|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
149076203|NCT03732807|537760270|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
149076204|NCT03732807|537760271|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
149076205|NCT03732807|537760272|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
149076206|NCT03732807|537760273|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
149076207|NCT03732807|537760274|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
149076208|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
149076209|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
149076210|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
149076211|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
149076212|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
149076213|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
149076214|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
149076215|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
149076216|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
149076217|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
149076218|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
149076219|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
149076220|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
149076221|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
149076222|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
149076223|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
149076224|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
149076225|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
149076226|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
149076227|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
149076228|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
149076229|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
149076230|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
149076231|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
149076232|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
149076233|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
149076234|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
149076235|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
149076236|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
149076237|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
149076238|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
149076239|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
149120225|NCT04602221|537918074|FG017|Overall Study|Other than listed|1|||
149076240|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
149076241|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
149076242|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
149076243|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
149076244|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
149076245|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
149076246|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
149076247|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
149076248|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
149076249|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
149076250|NCT03732807|537760268|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
149076251|NCT03732807|537760269|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
149076252|NCT03732807|537760270|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
149076253|NCT03732807|537760271|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
149076254|NCT03732807|537760272|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
149076255|NCT03732807|537760273|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
149076256|NCT03732807|537760274|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
149076257|NCT01079806|537760275|FG000|Day 1 to Week 96|Adverse Event|0|||
149076258|NCT01079806|537760276|FG001|Day 1 to Week 96|Adverse Event|3|||
149076259|NCT01079806|537760275|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
149076260|NCT01079806|537760276|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
149076261|NCT01079806|537760275|FG000|Day 1 to Week 96|Pregnancy|0|||
149076262|NCT01079806|537760276|FG001|Day 1 to Week 96|Pregnancy|1|||
149076263|NCT01079806|537760275|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
149076264|NCT01079806|537760276|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
149076265|NCT01079806|537760275|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
149076266|NCT01079806|537760276|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
149076267|NCT01079806|537760275|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
149076268|NCT01079806|537760276|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
149076269|NCT01079806|537760275|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
149076270|NCT01079806|537760276|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
149076271|NCT01079806|537760275|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
149076272|NCT01079806|537760276|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
149076273|NCT01079806|537760275|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
149076274|NCT01079806|537760276|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
149076275|NCT01079806|537760275|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
149076276|NCT01079806|537760276|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
149076277|NCT02788981|537760279|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
149076278|NCT02788981|537760280|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
149076279|NCT00249769|537760281|FG000|Overall Study|Withdrawal by Subject|1|||
149076280|NCT00249769|537760282|FG001|Overall Study|Withdrawal by Subject|10|||
149076281|NCT00249769|537760283|FG002|Overall Study|Withdrawal by Subject|6|||
149076282|NCT00249769|537760281|FG000|Overall Study|Migration from Study Area|1|||
149076283|NCT00249769|537760282|FG001|Overall Study|Migration from Study Area|3|||
149076284|NCT00249769|537760283|FG002|Overall Study|Migration from Study Area|14|||
149076285|NCT00249769|537760281|FG000|Overall Study|Miscellaneous|0|||
149076286|NCT00249769|537760282|FG001|Overall Study|Miscellaneous|2|||
149076287|NCT00249769|537760283|FG002|Overall Study|Miscellaneous|2|||
149076288|NCT00249769|537760281|FG000|Overall Study|Adverse Event|0|||
149076289|NCT00249769|537760282|FG001|Overall Study|Adverse Event|0|||
149076290|NCT00249769|537760283|FG002|Overall Study|Adverse Event|1|||
149076291|NCT00249769|537760281|FG000|Overall Study|Physician Decision|0|||
149076292|NCT00249769|537760282|FG001|Overall Study|Physician Decision|0|||
149076293|NCT00249769|537760283|FG002|Overall Study|Physician Decision|2|||
149076294|NCT00249769|537760281|FG000|Overall Study|Lost to Follow-up|0|||
149076295|NCT00249769|537760282|FG001|Overall Study|Lost to Follow-up|0|||
149076296|NCT00249769|537760283|FG002|Overall Study|Lost to Follow-up|3|||
149076297|NCT02022657|537760288|FG000|Overall Study|Withdrawal by Subject|2|||
149076298|NCT02022657|537760289|FG001|Overall Study|Withdrawal by Subject|0|||
149076299|NCT02022657|537760290|FG002|Overall Study|Withdrawal by Subject|1|||
149076300|NCT02022657|537760291|FG003|Overall Study|Withdrawal by Subject|0|||
149076301|NCT02022657|537760292|FG004|Overall Study|Withdrawal by Subject|0|||
149076302|NCT02022657|537760293|FG005|Overall Study|Withdrawal by Subject|0|||
149076303|NCT02022657|537760288|FG000|Overall Study|Physician Decision|0|||
149076304|NCT02022657|537760289|FG001|Overall Study|Physician Decision|0|||
149076305|NCT02022657|537760290|FG002|Overall Study|Physician Decision|0|||
149076306|NCT02022657|537760291|FG003|Overall Study|Physician Decision|0|||
149076307|NCT02022657|537760292|FG004|Overall Study|Physician Decision|0|||
149076308|NCT02022657|537760293|FG005|Overall Study|Physician Decision|1|||
149076309|NCT00795184|537760295|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
149076310|NCT00795184|537760296|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
149076311|NCT03781375|537760297|FG000|Double-blind Phase|Adverse Event|0|||
149076312|NCT03781375|537760298|FG001|Double-blind Phase|Adverse Event|1|||
149076313|NCT03781375|537760297|FG000|Double-blind Phase|Lack of Response|6|||
149076314|NCT03781375|537760298|FG001|Double-blind Phase|Lack of Response|2|||
149076315|NCT03781375|537760297|FG000|Double-blind Phase|Other|1|||
149076316|NCT03781375|537760298|FG001|Double-blind Phase|Other|3|||
149076317|NCT03781375|537760297|FG000|Open-label Phase|Protocol Issues|0|||
149076318|NCT03781375|537760298|FG001|Open-label Phase|Protocol Issues|1|||
149076319|NCT03781375|537760297|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
149076320|NCT03781375|537760298|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
149076321|NCT03781375|537760297|FG000|Open-label Phase|Other|2|||
149076322|NCT03781375|537760298|FG001|Open-label Phase|Other|2|||
149076323|NCT02079649|537760299|FG000|Overall Study|Lost to Follow-up|0|||
149076324|NCT02079649|537760300|FG001|Overall Study|Lost to Follow-up|0|||
149076325|NCT02079649|537760301|FG002|Overall Study|Lost to Follow-up|0|||
149076326|NCT02079649|537760302|FG003|Overall Study|Lost to Follow-up|1|||
149076327|NCT02079649|537760299|FG000|Overall Study|Withdrawal by Subject|0|||
149076328|NCT02079649|537760300|FG001|Overall Study|Withdrawal by Subject|0|||
149076329|NCT02079649|537760301|FG002|Overall Study|Withdrawal by Subject|0|||
149076330|NCT02079649|537760302|FG003|Overall Study|Withdrawal by Subject|1|||
149076331|NCT02079649|537760299|FG000|Overall Study|Randomization error (prior to treatment)|1|||
149076332|NCT02079649|537760300|FG001|Overall Study|Randomization error (prior to treatment)|0|||
149076333|NCT02079649|537760301|FG002|Overall Study|Randomization error (prior to treatment)|1|||
149076334|NCT02079649|537760302|FG003|Overall Study|Randomization error (prior to treatment)|0|||
149076335|NCT03739866|537760309|FG000|Overall Study|Lost to Follow-up|0|||
149076336|NCT03739866|537760310|FG001|Overall Study|Lost to Follow-up|0|||
149076337|NCT03739866|537760311|FG002|Overall Study|Lost to Follow-up|0|||
149076338|NCT03739866|537760312|FG003|Overall Study|Lost to Follow-up|1|||
149076339|NCT03739866|537760313|FG004|Overall Study|Lost to Follow-up|0|||
149076340|NCT03739866|537760314|FG005|Overall Study|Lost to Follow-up|0|||
149076341|NCT03739866|537760315|FG006|Overall Study|Lost to Follow-up|0|||
149076342|NCT03739866|537760316|FG007|Overall Study|Lost to Follow-up|0|||
149076343|NCT03739866|537760309|FG000|Overall Study|Enrolled but not treated|0|||
149076344|NCT03739866|537760310|FG001|Overall Study|Enrolled but not treated|0|||
149076345|NCT03739866|537760311|FG002|Overall Study|Enrolled but not treated|1|||
149076346|NCT03739866|537760312|FG003|Overall Study|Enrolled but not treated|0|||
149076347|NCT03739866|537760313|FG004|Overall Study|Enrolled but not treated|1|||
149076348|NCT03739866|537760314|FG005|Overall Study|Enrolled but not treated|0|||
149076349|NCT03739866|537760315|FG006|Overall Study|Enrolled but not treated|0|||
149076350|NCT03739866|537760316|FG007|Overall Study|Enrolled but not treated|0|||
149076351|NCT01034306|537760317|FG000|Overall Study|Adverse Event|1|||
149076352|NCT01034306|537760318|FG001|Overall Study|Adverse Event|0|||
149076353|NCT01034306|537760317|FG000|Overall Study|Lost to Follow-up|0|||
149076354|NCT01034306|537760318|FG001|Overall Study|Lost to Follow-up|1|||
149076355|NCT01034306|537760317|FG000|Overall Study|Withdrawal by Subject|2|||
149076356|NCT01034306|537760318|FG001|Overall Study|Withdrawal by Subject|2|||
149076357|NCT01034306|537760317|FG000|Overall Study|hospitalized and decided to stop|1|||
149076358|NCT01034306|537760318|FG001|Overall Study|hospitalized and decided to stop|0|||
149076359|NCT01034306|537760317|FG000|Overall Study|Noncomplience|1|||
149076360|NCT01034306|537760318|FG001|Overall Study|Noncomplience|0|||
149076361|NCT03489369|537760319|FG000|Overall Study|Documented Progressive Disease|3|||
149076362|NCT03489369|537760320|FG001|Overall Study|Documented Progressive Disease|2|||
149076363|NCT03489369|537760321|FG002|Overall Study|Documented Progressive Disease|3|||
149076364|NCT03489369|537760322|FG003|Overall Study|Documented Progressive Disease|6|||
149076365|NCT03489369|537760319|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
149076366|NCT03489369|537760320|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
149076367|NCT03489369|537760321|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
149076368|NCT03489369|537760322|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
149076369|NCT01968967|537760323|FG000|Treatment Period|Other|22|||
149076370|NCT01968967|537760324|FG001|Treatment Period|Other|22|||
149076371|NCT01968967|537760325|FG002|Treatment Period|Other|0|||
149076372|NCT01968967|537760326|FG003|Treatment Period|Other|0|||
149076373|NCT01968967|537760327|FG004|Treatment Period|Other|0|||
149076374|NCT01968967|537760323|FG000|Treatment Period|Withdrawal by Subject|71|||
149076375|NCT01968967|537760324|FG001|Treatment Period|Withdrawal by Subject|61|||
149076376|NCT01968967|537760325|FG002|Treatment Period|Withdrawal by Subject|0|||
149076377|NCT01968967|537760326|FG003|Treatment Period|Withdrawal by Subject|0|||
149076378|NCT01968967|537760327|FG004|Treatment Period|Withdrawal by Subject|0|||
149076379|NCT01968967|537760323|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
149076380|NCT01968967|537760324|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
149076381|NCT01968967|537760325|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
149076382|NCT01968967|537760326|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
149076383|NCT01968967|537760327|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
149076384|NCT01968967|537760323|FG000|Treatment Period|Lost to Follow-up|26|||
149076385|NCT01968967|537760324|FG001|Treatment Period|Lost to Follow-up|31|||
149076386|NCT01968967|537760325|FG002|Treatment Period|Lost to Follow-up|0|||
149076387|NCT01968967|537760326|FG003|Treatment Period|Lost to Follow-up|0|||
149076388|NCT01968967|537760327|FG004|Treatment Period|Lost to Follow-up|0|||
149076389|NCT01968967|537760323|FG000|Treatment Period|Protocol Violation|1|||
149076390|NCT01968967|537760324|FG001|Treatment Period|Protocol Violation|2|||
149076391|NCT01968967|537760325|FG002|Treatment Period|Protocol Violation|0|||
149076392|NCT01968967|537760326|FG003|Treatment Period|Protocol Violation|0|||
149076393|NCT01968967|537760327|FG004|Treatment Period|Protocol Violation|0|||
149076394|NCT01968967|537760323|FG000|Treatment Period|Adverse Event|9|||
149076395|NCT01968967|537760324|FG001|Treatment Period|Adverse Event|8|||
149076396|NCT01968967|537760325|FG002|Treatment Period|Adverse Event|0|||
149076397|NCT01968967|537760326|FG003|Treatment Period|Adverse Event|0|||
149076398|NCT01968967|537760327|FG004|Treatment Period|Adverse Event|0|||
149076399|NCT01968967|537760323|FG000|Treatment Period|Death|9|||
149076400|NCT01968967|537760324|FG001|Treatment Period|Death|2|||
149076401|NCT01968967|537760325|FG002|Treatment Period|Death|0|||
149076402|NCT01968967|537760326|FG003|Treatment Period|Death|0|||
149076403|NCT01968967|537760327|FG004|Treatment Period|Death|0|||
149076404|NCT01968967|537760323|FG000|Treatment Period|Randomized Not Treated|6|||
149076405|NCT01968967|537760324|FG001|Treatment Period|Randomized Not Treated|5|||
149076406|NCT01968967|537760325|FG002|Treatment Period|Randomized Not Treated|0|||
149076407|NCT01968967|537760326|FG003|Treatment Period|Randomized Not Treated|0|||
149076408|NCT01968967|537760327|FG004|Treatment Period|Randomized Not Treated|0|||
149076409|NCT01968967|537760323|FG000|Extension Period|Withdrew Consent|0|||
149076410|NCT01968967|537760324|FG001|Extension Period|Withdrew Consent|0|||
149076411|NCT01968967|537760325|FG002|Extension Period|Withdrew Consent|2|||
149076412|NCT01968967|537760326|FG003|Extension Period|Withdrew Consent|0|||
149076413|NCT01968967|537760327|FG004|Extension Period|Withdrew Consent|5|||
149076414|NCT02203799|537760332|FG000|Overall Study|Withdrawal by Subject|3|||
149076415|NCT01953692|537760335|FG000|Overall Study|Adverse Event|5|||
149076416|NCT01953692|537760336|FG001|Overall Study|Adverse Event|2|||
149076417|NCT01953692|537760337|FG002|Overall Study|Adverse Event|4|||
149076418|NCT01953692|537760338|FG003|Overall Study|Adverse Event|2|||
149076419|NCT01953692|537760339|FG004|Overall Study|Adverse Event|1|||
149076420|NCT01953692|537760340|FG005|Overall Study|Adverse Event|2|||
149076421|NCT01953692|537760341|FG006|Overall Study|Adverse Event|0|||
149076422|NCT01953692|537760342|FG007|Overall Study|Adverse Event|0|||
149076423|NCT01953692|537760343|FG008|Overall Study|Adverse Event|0|||
149076424|NCT01953692|537760335|FG000|Overall Study|Clinical Progression|0|||
149076425|NCT01953692|537760336|FG001|Overall Study|Clinical Progression|15|||
149076426|NCT01953692|537760337|FG002|Overall Study|Clinical Progression|7|||
149076427|NCT01953692|537760338|FG003|Overall Study|Clinical Progression|5|||
149076428|NCT01953692|537760339|FG004|Overall Study|Clinical Progression|0|||
149076429|NCT01953692|537760340|FG005|Overall Study|Clinical Progression|7|||
149076430|NCT01953692|537760341|FG006|Overall Study|Clinical Progression|20|||
149076431|NCT01953692|537760342|FG007|Overall Study|Clinical Progression|3|||
149076432|NCT01953692|537760343|FG008|Overall Study|Clinical Progression|3|||
149076433|NCT01953692|537760335|FG000|Overall Study|Death|5|||
149076434|NCT01953692|537760336|FG001|Overall Study|Death|0|||
149076435|NCT01953692|537760337|FG002|Overall Study|Death|2|||
149076436|NCT01953692|537760338|FG003|Overall Study|Death|2|||
149076437|NCT01953692|537760339|FG004|Overall Study|Death|1|||
149076438|NCT01953692|537760340|FG005|Overall Study|Death|3|||
149076439|NCT01953692|537760341|FG006|Overall Study|Death|6|||
149076440|NCT01953692|537760342|FG007|Overall Study|Death|2|||
149076441|NCT01953692|537760343|FG008|Overall Study|Death|1|||
149076442|NCT01953692|537760335|FG000|Overall Study|Excluded Medication|1|||
149076443|NCT01953692|537760336|FG001|Overall Study|Excluded Medication|0|||
149076444|NCT01953692|537760337|FG002|Overall Study|Excluded Medication|0|||
149076445|NCT01953692|537760338|FG003|Overall Study|Excluded Medication|0|||
149076446|NCT01953692|537760339|FG004|Overall Study|Excluded Medication|0|||
149076447|NCT01953692|537760340|FG005|Overall Study|Excluded Medication|0|||
149076448|NCT01953692|537760341|FG006|Overall Study|Excluded Medication|0|||
149076449|NCT01953692|537760342|FG007|Overall Study|Excluded Medication|0|||
149076450|NCT01953692|537760343|FG008|Overall Study|Excluded Medication|0|||
149076451|NCT01953692|537760335|FG000|Overall Study|Lost to Follow-up|1|||
149076452|NCT01953692|537760336|FG001|Overall Study|Lost to Follow-up|0|||
149076453|NCT01953692|537760337|FG002|Overall Study|Lost to Follow-up|3|||
149076454|NCT01953692|537760338|FG003|Overall Study|Lost to Follow-up|1|||
149076455|NCT01953692|537760339|FG004|Overall Study|Lost to Follow-up|0|||
149076456|NCT01953692|537760340|FG005|Overall Study|Lost to Follow-up|1|||
149076457|NCT01953692|537760341|FG006|Overall Study|Lost to Follow-up|0|||
149076458|NCT01953692|537760342|FG007|Overall Study|Lost to Follow-up|0|||
149076459|NCT01953692|537760343|FG008|Overall Study|Lost to Follow-up|0|||
149076460|NCT01953692|537760335|FG000|Overall Study|Physician Decision|11|||
149076461|NCT01953692|537760336|FG001|Overall Study|Physician Decision|4|||
149076462|NCT01953692|537760337|FG002|Overall Study|Physician Decision|2|||
149076463|NCT01953692|537760338|FG003|Overall Study|Physician Decision|2|||
149076464|NCT01953692|537760339|FG004|Overall Study|Physician Decision|1|||
149076465|NCT01953692|537760340|FG005|Overall Study|Physician Decision|2|||
149076466|NCT01953692|537760341|FG006|Overall Study|Physician Decision|4|||
149076467|NCT01953692|537760342|FG007|Overall Study|Physician Decision|1|||
149076468|NCT01953692|537760343|FG008|Overall Study|Physician Decision|0|||
149076469|NCT01953692|537760335|FG000|Overall Study|Protocol Violation|0|||
149076470|NCT01953692|537760336|FG001|Overall Study|Protocol Violation|2|||
149076471|NCT01953692|537760337|FG002|Overall Study|Protocol Violation|1|||
149076472|NCT01953692|537760338|FG003|Overall Study|Protocol Violation|0|||
149076473|NCT01953692|537760339|FG004|Overall Study|Protocol Violation|0|||
149076474|NCT01953692|537760340|FG005|Overall Study|Protocol Violation|0|||
149076475|NCT01953692|537760341|FG006|Overall Study|Protocol Violation|0|||
149076476|NCT01953692|537760342|FG007|Overall Study|Protocol Violation|1|||
149076477|NCT01953692|537760343|FG008|Overall Study|Protocol Violation|0|||
149076478|NCT01953692|537760335|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076479|NCT01953692|537760336|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076480|NCT01953692|537760337|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076481|NCT01953692|537760338|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076482|NCT01953692|537760339|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076483|NCT01953692|537760340|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076484|NCT01953692|537760341|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076485|NCT01953692|537760342|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
149076486|NCT01953692|537760343|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
149076487|NCT01953692|537760335|FG000|Overall Study|Withdrawal by Subject|4|||
149076488|NCT01953692|537760336|FG001|Overall Study|Withdrawal by Subject|2|||
149076489|NCT01953692|537760337|FG002|Overall Study|Withdrawal by Subject|1|||
149076490|NCT01953692|537760338|FG003|Overall Study|Withdrawal by Subject|2|||
149076491|NCT01953692|537760339|FG004|Overall Study|Withdrawal by Subject|0|||
149076492|NCT01953692|537760340|FG005|Overall Study|Withdrawal by Subject|3|||
149076493|NCT01953692|537760341|FG006|Overall Study|Withdrawal by Subject|2|||
149076494|NCT01953692|537760342|FG007|Overall Study|Withdrawal by Subject|1|||
149076495|NCT01953692|537760343|FG008|Overall Study|Withdrawal by Subject|1|||
149076496|NCT02022670|537760344|FG000|Overall Study|Adverse Event|1|||
149076497|NCT02022670|537760345|FG001|Overall Study|Adverse Event|0|||
149076498|NCT02022670|537760346|FG002|Overall Study|Adverse Event|1|||
149076499|NCT01328496|537760349|FG000|Overall Study|Significant Change in Health Status|1|||
149076500|NCT01328496|537760350|FG001|Overall Study|Significant Change in Health Status|0|||
149076501|NCT02091752|537760353|FG000|Overall Study|Study terminated by Sponsor|2|||
149076502|NCT02091752|537760353|FG000|Overall Study|Adverse Event|1|||
149076503|NCT04029090|537760360|FG000|Overall Study|Protocol Violation|1|||
149076504|NCT04029090|537760361|FG001|Overall Study|Protocol Violation|0|||
149076505|NCT04029090|537760362|FG002|Overall Study|Protocol Violation|0|||
149076506|NCT04029090|537760360|FG000|Overall Study|Withdrawal by Subject|0|||
149076507|NCT04029090|537760361|FG001|Overall Study|Withdrawal by Subject|1|||
149076508|NCT04029090|537760362|FG002|Overall Study|Withdrawal by Subject|0|||
149076509|NCT01065779|537760363|FG000|Overall Study|Duplicate Investigation|1|||
149076510|NCT01065779|537760363|FG000|Overall Study|Investigation Before Contract Date|37|||
149076511|NCT01065779|537760363|FG000|Overall Study|Non-enrollment Period Administration|10|||
149076512|NCT01065779|537760363|FG000|Overall Study|Not Administered With Study Drug|17|||
149076513|NCT01065779|537760363|FG000|Overall Study|Failed to Follow-up|10|||
149076514|NCT01065779|537760363|FG000|Overall Study|Inclusion Criteria Violation|7|||
149076515|NCT02157948|537760364|FG000|Overall Study|Withdrawal by Subject|4|||
149076516|NCT02157948|537760365|FG001|Overall Study|Withdrawal by Subject|5|||
149076517|NCT02157948|537760364|FG000|Overall Study|Lost to Follow-up|3|||
149076518|NCT02157948|537760365|FG001|Overall Study|Lost to Follow-up|2|||
149076519|NCT02157948|537760364|FG000|Overall Study|Protocol Specified Criteria|2|||
149076520|NCT02157948|537760365|FG001|Overall Study|Protocol Specified Criteria|1|||
149076521|NCT02157948|537760364|FG000|Overall Study|Decision by Sponsor|0|||
149076522|NCT02157948|537760365|FG001|Overall Study|Decision by Sponsor|1|||
149076523|NCT01604824|537760367|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
149076524|NCT01604824|537760368|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
149076525|NCT01604824|537760369|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
149076526|NCT01604824|537760370|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
149076527|NCT01604824|537760371|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
149076528|NCT01604824|537760372|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
149076529|NCT01604824|537760367|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
149076530|NCT01604824|537760368|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
149076531|NCT01604824|537760369|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
149076532|NCT01604824|537760370|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
149076533|NCT01604824|537760371|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
149076534|NCT01604824|537760372|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
149076535|NCT01683409|537760377|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
149076536|NCT01683409|537760378|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
149076537|NCT01683409|537760379|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
149076538|NCT01683409|537760380|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
149076539|NCT01683409|537760381|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
149076540|NCT01683409|537760377|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
149076541|NCT01683409|537760378|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
149076542|NCT01683409|537760379|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
149076543|NCT01683409|537760380|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
149076544|NCT01683409|537760381|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
149076545|NCT01683409|537760377|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
149076546|NCT01683409|537760378|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
149076547|NCT01683409|537760379|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
149076548|NCT01683409|537760380|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
149076549|NCT01683409|537760381|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
149076550|NCT01683409|537760377|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
149076551|NCT01683409|537760378|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
149076552|NCT01683409|537760379|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
149076553|NCT01683409|537760380|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
149076554|NCT01683409|537760381|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
149076555|NCT01683409|537760377|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
149076556|NCT01683409|537760378|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
149076557|NCT01683409|537760379|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
149076558|NCT01683409|537760380|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
149076559|NCT01683409|537760381|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
149076560|NCT01683409|537760377|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
149076561|NCT01683409|537760378|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
149076562|NCT01683409|537760379|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
149076563|NCT01683409|537760380|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
149076564|NCT01683409|537760381|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
149076565|NCT01683409|537760377|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
149076566|NCT01683409|537760378|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
149076567|NCT01683409|537760379|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
149076568|NCT01683409|537760380|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
149076569|NCT01683409|537760381|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
149076570|NCT01683409|537760377|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
149076571|NCT01683409|537760378|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
149076572|NCT01683409|537760379|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
149076573|NCT01683409|537760380|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
149076574|NCT01683409|537760381|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
149076575|NCT01683409|537760377|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
149076576|NCT01683409|537760378|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
149076577|NCT01683409|537760379|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
149076578|NCT01683409|537760380|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
149076579|NCT01683409|537760381|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
149076580|NCT01683409|537760377|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
149076581|NCT01683409|537760378|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
149076582|NCT01683409|537760379|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
149076583|NCT01683409|537760380|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
149076584|NCT01683409|537760381|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
149076585|NCT01683409|537760377|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
149076586|NCT01683409|537760378|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
149076587|NCT01683409|537760379|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
149076588|NCT01683409|537760380|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
149076589|NCT01683409|537760381|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
149076590|NCT04218864|537760383|FG000|Overall Study|Lost to Follow-up|8|||
149076591|NCT04218864|537760384|FG001|Overall Study|Lost to Follow-up|4|||
149076592|NCT04218864|537760383|FG000|Overall Study|Withdrawal by Subject|1|||
149076593|NCT04218864|537760384|FG001|Overall Study|Withdrawal by Subject|3|||
149076594|NCT04745676|537760387|FG000|Overall Study|Death|1|||
149076595|NCT04745676|537760388|FG001|Overall Study|Death|0|||
149076596|NCT04745676|537760389|FG002|Overall Study|Death|0|||
149076597|NCT03683030|537760390|FG000|Overall Study|Enrolled but screen failures|12|||
149076598|NCT03683030|537760391|FG001|Overall Study|Enrolled but screen failures|7|||
149076599|NCT03683030|537760390|FG000|Overall Study|Enrolled but no catheter inserted|11|||
149076600|NCT03683030|537760391|FG001|Overall Study|Enrolled but no catheter inserted|13|||
149076601|NCT03683030|537760390|FG000|Overall Study|Withdrawal by Subject|0|||
149076602|NCT03683030|537760391|FG001|Overall Study|Withdrawal by Subject|2|||
149076603|NCT03683030|537760390|FG000|Overall Study|Early termination by subject|1|||
149076604|NCT03683030|537760391|FG001|Overall Study|Early termination by subject|0|||
149076605|NCT03683030|537760390|FG000|Overall Study|Lost to Follow-up|0|||
149076606|NCT03683030|537760391|FG001|Overall Study|Lost to Follow-up|6|||
149076607|NCT03683030|537760390|FG000|Overall Study|Death|0|||
149076608|NCT03683030|537760391|FG001|Overall Study|Death|2|||
149076609|NCT03683030|537760390|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
149076610|NCT03683030|537760391|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
149076611|NCT00302211|537760396|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
149076612|NCT00302211|537760397|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
149076613|NCT00302211|537760398|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
149076614|NCT00302211|537760399|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
149076615|NCT00302211|537760400|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
149076616|NCT00302211|537760396|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
149076617|NCT00302211|537760397|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
149076618|NCT00302211|537760398|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
149076619|NCT00302211|537760399|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
149076620|NCT00302211|537760400|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
149076621|NCT00302211|537760396|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
149076622|NCT00302211|537760397|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
149076623|NCT00302211|537760398|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
149076624|NCT00302211|537760399|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
149076625|NCT00302211|537760400|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
149076626|NCT00302211|537760396|FG000|Double Blind Period (New Patients)|Disease progression|0|||
149076627|NCT00302211|537760397|FG001|Double Blind Period (New Patients)|Disease progression|1|||
149076628|NCT00302211|537760398|FG002|Double Blind Period (New Patients)|Disease progression|1|||
149076629|NCT00302211|537760399|FG003|Double Blind Period (New Patients)|Disease progression|0|||
149076630|NCT00302211|537760400|FG004|Double Blind Period (New Patients)|Disease progression|0|||
149076631|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
149076632|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
149076633|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
149076634|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
149076635|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
149076636|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
149076637|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
149076638|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
149076639|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
149076640|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
149076641|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
149076642|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
149076643|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
149076644|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
149076645|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
149076646|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
149076647|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
149076648|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
149076649|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
149076650|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
149076651|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Death|0|||
149076652|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Death|0|||
149076653|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Death|0|||
149076654|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Death|1|||
149076655|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Death|1|||
149076656|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
149076657|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
149076658|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
149076659|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
149076660|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
149076661|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
149076662|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
149076663|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
149076664|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
149076665|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
149076666|NCT00302211|537760396|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
149076667|NCT00302211|537760397|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
149076668|NCT00302211|537760398|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
149076669|NCT00302211|537760399|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
149076670|NCT00302211|537760400|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
149076671|NCT05349721|537761885|FG000|Part A (24 Weeks)|Adverse Event|9|||
149076672|NCT05349721|537761886|FG001|Part A (24 Weeks)|Adverse Event|2|||
149076673|NCT05349721|537761885|FG000|Part A (24 Weeks)|Death|8|||
149076674|NCT05349721|537761886|FG001|Part A (24 Weeks)|Death|3|||
149076675|NCT05349721|537761885|FG000|Part A (24 Weeks)|Disease Progression|1|||
149076676|NCT05349721|537761886|FG001|Part A (24 Weeks)|Disease Progression|1|||
149076677|NCT05349721|537761885|FG000|Part A (24 Weeks)|Screen Failure|2|||
149076678|NCT05349721|537761886|FG001|Part A (24 Weeks)|Screen Failure|0|||
149076679|NCT05349721|537761885|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
149076680|NCT05349721|537761886|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
149076681|NCT05349721|537761885|FG000|Part A (24 Weeks)|Other Than Specified|5|||
149076682|NCT05349721|537761886|FG001|Part A (24 Weeks)|Other Than Specified|1|||
149076683|NCT05349721|537761885|FG000|Part B (28 Weeks)|Adverse Event|3|||
149076684|NCT05349721|537761886|FG001|Part B (28 Weeks)|Adverse Event|0|||
149076685|NCT05349721|537761885|FG000|Part B (28 Weeks)|Death|21|||
149076686|NCT05349721|537761886|FG001|Part B (28 Weeks)|Death|11|||
149076687|NCT05349721|537761885|FG000|Part B (28 Weeks)|Disease Progression|2|||
149076688|NCT05349721|537761886|FG001|Part B (28 Weeks)|Disease Progression|1|||
149076689|NCT05349721|537761885|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
149076690|NCT05349721|537761886|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
149076691|NCT05349721|537761885|FG000|Part B (28 Weeks)|Physician Decision|1|||
149076692|NCT05349721|537761886|FG001|Part B (28 Weeks)|Physician Decision|0|||
149076693|NCT05349721|537761885|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
149076694|NCT05349721|537761886|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
149076695|NCT05349721|537761885|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
149076696|NCT05349721|537761886|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
149076697|NCT05349721|537761885|FG000|Part B (28 Weeks)|Other Than Specified|4|||
149076698|NCT05349721|537761886|FG001|Part B (28 Weeks)|Other Than Specified|2|||
149076699|NCT05349721|537761885|FG000|Part C (108 Weeks)|Death|0|||
149076700|NCT05349721|537761886|FG001|Part C (108 Weeks)|Death|1|||
149076701|NCT05349721|537761885|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
149076702|NCT05349721|537761886|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
149076703|NCT05349721|537761885|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
149076704|NCT05349721|537761886|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
149076705|NCT05349721|537761885|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
149076706|NCT05349721|537761886|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
149076707|NCT03678688|537761887|FG000|Overall Study|Reason not Specified|0|||
149076708|NCT03678688|537761888|FG001|Overall Study|Reason not Specified|0|||
149076709|NCT03678688|537761889|FG002|Overall Study|Reason not Specified|3|||
149076710|NCT03678688|537761890|FG003|Overall Study|Reason not Specified|0|||
149076711|NCT03678688|537761891|FG004|Overall Study|Reason not Specified|1|||
149076712|NCT03678688|537761892|FG005|Overall Study|Reason not Specified|0|||
149076713|NCT03678688|537761893|FG006|Overall Study|Reason not Specified|0|||
149076714|NCT03678688|537761894|FG007|Overall Study|Reason not Specified|0|||
149076715|NCT03678688|537761895|FG008|Overall Study|Reason not Specified|0|||
149076716|NCT03678688|537761887|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
149076717|NCT03678688|537761888|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
149076718|NCT03678688|537761889|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
149076719|NCT03678688|537761890|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
149076720|NCT03678688|537761891|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
149076721|NCT03678688|537761892|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
149076722|NCT03678688|537761893|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
149076723|NCT03678688|537761894|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
149076724|NCT03678688|537761895|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
149076725|NCT03678688|537761887|FG000|Overall Study|Covid Related Adverse Event|0|||
149076726|NCT03678688|537761888|FG001|Overall Study|Covid Related Adverse Event|0|||
149076727|NCT03678688|537761889|FG002|Overall Study|Covid Related Adverse Event|0|||
149076728|NCT03678688|537761890|FG003|Overall Study|Covid Related Adverse Event|0|||
149076729|NCT03678688|537761891|FG004|Overall Study|Covid Related Adverse Event|0|||
149076730|NCT03678688|537761892|FG005|Overall Study|Covid Related Adverse Event|3|||
149076731|NCT03678688|537761893|FG006|Overall Study|Covid Related Adverse Event|1|||
149076732|NCT03678688|537761894|FG007|Overall Study|Covid Related Adverse Event|1|||
149076733|NCT03678688|537761895|FG008|Overall Study|Covid Related Adverse Event|0|||
149076734|NCT03678688|537761887|FG000|Overall Study|Physician Decision|0|||
149076735|NCT03678688|537761888|FG001|Overall Study|Physician Decision|0|||
149076736|NCT03678688|537761889|FG002|Overall Study|Physician Decision|0|||
149076737|NCT03678688|537761890|FG003|Overall Study|Physician Decision|0|||
149076738|NCT03678688|537761891|FG004|Overall Study|Physician Decision|0|||
149076739|NCT03678688|537761892|FG005|Overall Study|Physician Decision|1|||
149076740|NCT03678688|537761893|FG006|Overall Study|Physician Decision|0|||
149076741|NCT03678688|537761894|FG007|Overall Study|Physician Decision|0|||
149076742|NCT03678688|537761895|FG008|Overall Study|Physician Decision|0|||
149076743|NCT03678688|537761887|FG000|Overall Study|Withdrawal by Subject|0|||
149076744|NCT03678688|537761888|FG001|Overall Study|Withdrawal by Subject|0|||
149076745|NCT03678688|537761889|FG002|Overall Study|Withdrawal by Subject|0|||
149076746|NCT03678688|537761890|FG003|Overall Study|Withdrawal by Subject|0|||
149076747|NCT03678688|537761891|FG004|Overall Study|Withdrawal by Subject|0|||
149076748|NCT03678688|537761892|FG005|Overall Study|Withdrawal by Subject|0|||
149076749|NCT03678688|537761893|FG006|Overall Study|Withdrawal by Subject|2|||
149076750|NCT03678688|537761894|FG007|Overall Study|Withdrawal by Subject|1|||
149076751|NCT03678688|537761895|FG008|Overall Study|Withdrawal by Subject|0|||
149076752|NCT03136159|537761896|FG000|Overall Study|chorioamnionitis|2|||
149076753|NCT03136159|537761897|FG001|Overall Study|chorioamnionitis|0|||
149076754|NCT03136159|537761896|FG000|Overall Study|vertical skin incision|1|||
149076755|NCT03136159|537761897|FG001|Overall Study|vertical skin incision|0|||
149076756|NCT03136159|537761896|FG000|Overall Study|additional dressing|1|||
149076757|NCT03136159|537761897|FG001|Overall Study|additional dressing|0|||
149076758|NCT03136159|537761896|FG000|Overall Study|never got dressing placed|1|||
149076759|NCT03136159|537761897|FG001|Overall Study|never got dressing placed|0|||
149076760|NCT04323800|537761898|FG000|Overall Study|Withdrawal by Subject|4|||
149076761|NCT04323800|537761899|FG001|Overall Study|Withdrawal by Subject|4|||
149076762|NCT04323800|537761898|FG000|Overall Study|Incomplete transfusion|1|||
149076763|NCT04323800|537761899|FG001|Overall Study|Incomplete transfusion|0|||
149076764|NCT04323800|537761898|FG000|Overall Study|Other|0|||
149076765|NCT04323800|537761899|FG001|Overall Study|Other|1|||
149076766|NCT04323800|537761898|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
149076767|NCT04323800|537761899|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
149076768|NCT00489554|537761900|FG000|Overall Study|Adverse Event|2|||
149076769|NCT00489554|537761900|FG000|Overall Study|Withdrawal by Subject|1|||
149076770|NCT00489554|537761900|FG000|Overall Study|Lost to Follow-up|1|||
149076771|NCT01732757|537761901|FG000|Overall Study|Lost to Follow-up|1|||
149076772|NCT01732757|537761902|FG001|Overall Study|Lost to Follow-up|0|||
149076773|NCT01732757|537761903|FG002|Overall Study|Lost to Follow-up|0|||
149076774|NCT02132949|537761908|FG000|Overall Study|Death|7|||
149076775|NCT02132949|537761909|FG001|Overall Study|Death|13|||
149076776|NCT02132949|537761908|FG000|Overall Study|Lost to Follow-up|14|||
149076777|NCT02132949|537761909|FG001|Overall Study|Lost to Follow-up|4|||
149076778|NCT02132949|537761908|FG000|Overall Study|Withdrawal by Subject|6|||
149076779|NCT02132949|537761909|FG001|Overall Study|Withdrawal by Subject|5|||
149076780|NCT02132949|537761908|FG000|Overall Study|Noncompliance|5|||
149076781|NCT02132949|537761909|FG001|Overall Study|Noncompliance|1|||
149076782|NCT02132949|537761908|FG000|Overall Study|Physician Decision|3|||
149076783|NCT02132949|537761909|FG001|Overall Study|Physician Decision|1|||
149076784|NCT02132949|537761908|FG000|Overall Study|Disease Progression|3|||
149076785|NCT02132949|537761909|FG001|Overall Study|Disease Progression|0|||
149076786|NCT02132949|537761908|FG000|Overall Study|Adverse Event|2|||
149076787|NCT02132949|537761909|FG001|Overall Study|Adverse Event|1|||
149076788|NCT02132949|537761908|FG000|Overall Study|Withdrew Prior to Treatment|1|||
149076789|NCT02132949|537761909|FG001|Overall Study|Withdrew Prior to Treatment|2|||
149076790|NCT02132949|537761908|FG000|Overall Study|Reason Unspecified|0|||
149076791|NCT02132949|537761909|FG001|Overall Study|Reason Unspecified|1|||
149076792|NCT01583166|537761912|FG000|Overall Study|Withdrawal by Subject|4|||
149076793|NCT01583166|537761913|FG001|Overall Study|Withdrawal by Subject|6|||
149076794|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
149076795|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
149076796|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
149076797|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
149076798|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
149076799|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
149076800|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
149076801|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
149076802|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
149076803|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
149076804|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
149076805|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
149076806|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Other|1|||
149076807|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Other|0|||
149076808|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Other|0|||
149076809|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
149076810|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
149076811|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
149076812|NCT00887224|537761914|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
149076813|NCT00887224|537761915|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
149076814|NCT00887224|537761916|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
149076815|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
149076816|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
149076817|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
149076818|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
149076819|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
149076820|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
149076821|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
149076822|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
149076823|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
149076824|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
149076825|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
149076826|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
149076827|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Other|1|||
149076828|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Other|0|||
149076829|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Other|0|||
149076830|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
149076831|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
149076832|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
149076833|NCT00887224|537761914|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
149076834|NCT00887224|537761915|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
149076835|NCT00887224|537761916|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
149076836|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
149076837|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
149076838|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
149076839|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
149076840|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
149076841|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
149076842|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
149076843|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
149076844|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
149076845|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
149076846|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
149076847|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
149076848|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Other|30|||
149076849|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Other|0|||
149076850|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Other|0|||
149076851|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
149076852|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
149076853|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
149076854|NCT00887224|537761914|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
149076855|NCT00887224|537761915|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
149076856|NCT00887224|537761916|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
149076857|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Adverse Event|0|||
149076858|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Adverse Event|7|||
149076859|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Adverse Event|2|||
149076860|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Failed to return|0|||
149076861|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Failed to return|2|||
149076862|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Failed to return|2|||
149076863|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
149076864|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
149076865|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
149076866|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
149076867|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
149076868|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
149076869|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Other|0|||
149076870|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Other|2|||
149076871|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Other|0|||
149076872|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
149076873|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
149076874|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
149076875|NCT00887224|537761914|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
149076876|NCT00887224|537761915|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
149076877|NCT00887224|537761916|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
149076878|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
149076879|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
149076880|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
149076881|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
149076882|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
149076883|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
149076884|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
149076885|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
149076886|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
149076887|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
149076888|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
149076889|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
149076890|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
149076891|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
149076892|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
149076893|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
149076894|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
149076895|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
149076896|NCT00887224|537761914|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
149076897|NCT00887224|537761915|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
149076898|NCT00887224|537761916|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
149076899|NCT01698918|537761919|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
149076900|NCT01698918|537761919|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
149076901|NCT01698918|537761919|FG000|First Line Treatment (Core+Extension)|Death|2|||
149076902|NCT01698918|537761919|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
149076903|NCT01698918|537761919|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
149076904|NCT01698918|537761919|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
149076905|NCT01698918|537761919|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
149076906|NCT01698918|537761919|FG000|Second Line Treatment (Core+Extension)|Death|1|||
149076907|NCT01698918|537761919|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
149076908|NCT01698918|537761919|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
149076909|NCT04693637|537761923|FG000|Overall Study|Death|4|||
149076910|NCT04693637|537761923|FG000|Overall Study|Withdrawal by Subject|3|||
149076911|NCT04693637|537761923|FG000|Overall Study|Physician Decision|2|||
149076912|NCT04693637|537761923|FG000|Overall Study|Lost to Follow-up|1|||
149076913|NCT05553366|537761926|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
149076914|NCT05553366|537761927|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
149076915|NCT05553366|537761928|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
149076916|NCT05553366|537761926|FG000|Overall Study|Lost to Follow-up|3|||
149076917|NCT05553366|537761927|FG001|Overall Study|Lost to Follow-up|3|||
149076918|NCT05553366|537761928|FG002|Overall Study|Lost to Follow-up|3|||
149076919|NCT05553366|537761926|FG000|Overall Study|Other non-compliance|1|||
149076920|NCT05553366|537761927|FG001|Overall Study|Other non-compliance|1|||
149076921|NCT05553366|537761928|FG002|Overall Study|Other non-compliance|0|||
149076922|NCT05553366|537761926|FG000|Overall Study|Randomized but not dosed|0|||
149076923|NCT05553366|537761927|FG001|Overall Study|Randomized but not dosed|0|||
149076924|NCT05553366|537761928|FG002|Overall Study|Randomized but not dosed|2|||
149076925|NCT00836498|537761929|FG000|Overall Study|Adverse Event|1|||
149076926|NCT00836498|537761930|FG001|Overall Study|Adverse Event|0|||
149076927|NCT00836498|537761929|FG000|Overall Study|Lost to Follow-up|1|||
149076928|NCT00836498|537761930|FG001|Overall Study|Lost to Follow-up|0|||
149076929|NCT00836498|537761929|FG000|Overall Study|Withdrawal by Subject|2|||
149076930|NCT00836498|537761930|FG001|Overall Study|Withdrawal by Subject|1|||
149076931|NCT02384382|537761933|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
149076932|NCT02384382|537761933|FG000|Overall Study|Death|1|||
149076933|NCT02384382|537761933|FG000|Overall Study|Adverse Event|1|||
149076934|NCT02384382|537761933|FG000|Overall Study|Disease progression|16|||
149076935|NCT02113449|537761934|FG000|Overall Study|Adverse Event|4|||
149076936|NCT04248803|537761958|FG000|Overall Study|Lost to Follow-up|7|||
149076937|NCT04248803|537761959|FG001|Overall Study|Lost to Follow-up|7|||
149076938|NCT04248803|537761960|FG002|Overall Study|Lost to Follow-up|7|||
149076939|NCT04248803|537761961|FG003|Overall Study|Lost to Follow-up|7|||
149076940|NCT04248803|537761962|FG004|Overall Study|Lost to Follow-up|7|||
149076941|NCT04248803|537761963|FG005|Overall Study|Lost to Follow-up|7|||
149076942|NCT05352230|537761964|FG000|First Intervention (3 Months)|study terminated|2|||
149076943|NCT05352230|537761965|FG001|First Intervention (3 Months)|study terminated|2|||
149076944|NCT04399837|537761966|FG000|Overall Study|Other than listed|0|||
149076945|NCT04399837|537761967|FG001|Overall Study|Other than listed|2|||
149076946|NCT04399837|537761968|FG002|Overall Study|Other than listed|2|||
149076947|NCT04399837|537761969|FG003|Overall Study|Other than listed|3|||
149076948|NCT04399837|537761966|FG000|Overall Study|Withdrawal by Subject|1|||
149076949|NCT04399837|537761967|FG001|Overall Study|Withdrawal by Subject|2|||
149076950|NCT04399837|537761968|FG002|Overall Study|Withdrawal by Subject|1|||
149076951|NCT04399837|537761969|FG003|Overall Study|Withdrawal by Subject|1|||
149076952|NCT00614614|537761975|FG000|Primary Vaccination Phase|Adverse Event|6|||
149076953|NCT00614614|537761976|FG001|Primary Vaccination Phase|Adverse Event|0|||
149076954|NCT00614614|537761977|FG002|Primary Vaccination Phase|Adverse Event|0|||
149076955|NCT00614614|537761978|FG003|Primary Vaccination Phase|Adverse Event|0|||
149076956|NCT00614614|537761979|FG004|Primary Vaccination Phase|Adverse Event|0|||
149076957|NCT00614614|537761975|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
149076958|NCT00614614|537761976|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
149076959|NCT00614614|537761977|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
149076960|NCT00614614|537761978|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
149076961|NCT00614614|537761979|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
149076962|NCT00614614|537761975|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
149076963|NCT00614614|537761976|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
149076964|NCT00614614|537761977|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
149076965|NCT00614614|537761978|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
149076966|NCT00614614|537761979|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
149076967|NCT00614614|537761975|FG000|Primary Vaccination Phase|Protocol Violation|9|||
149076968|NCT00614614|537761976|FG001|Primary Vaccination Phase|Protocol Violation|3|||
149076969|NCT00614614|537761977|FG002|Primary Vaccination Phase|Protocol Violation|0|||
149076970|NCT00614614|537761978|FG003|Primary Vaccination Phase|Protocol Violation|0|||
149076971|NCT00614614|537761979|FG004|Primary Vaccination Phase|Protocol Violation|0|||
149076972|NCT00614614|537761975|FG000|Primary Vaccination Phase|Other|4|||
149076973|NCT00614614|537761976|FG001|Primary Vaccination Phase|Other|0|||
149076974|NCT00614614|537761977|FG002|Primary Vaccination Phase|Other|0|||
149076975|NCT00614614|537761978|FG003|Primary Vaccination Phase|Other|0|||
149076976|NCT00614614|537761979|FG004|Primary Vaccination Phase|Other|0|||
149076977|NCT00614614|537761975|FG000|Booster Vaccination Phase|Adverse Event|0|||
149076978|NCT00614614|537761976|FG001|Booster Vaccination Phase|Adverse Event|0|||
149076979|NCT00614614|537761977|FG002|Booster Vaccination Phase|Adverse Event|1|||
149076980|NCT00614614|537761978|FG003|Booster Vaccination Phase|Adverse Event|1|||
149076981|NCT00614614|537761979|FG004|Booster Vaccination Phase|Adverse Event|0|||
149076982|NCT00614614|537761975|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
149076983|NCT00614614|537761976|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
149076984|NCT00614614|537761977|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
149076985|NCT00614614|537761978|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
149076986|NCT00614614|537761979|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
149076987|NCT00614614|537761975|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
149076988|NCT00614614|537761976|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
149076989|NCT00614614|537761977|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
149076990|NCT00614614|537761978|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
149076991|NCT00614614|537761979|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
149076992|NCT00614614|537761975|FG000|Booster Vaccination Phase|Protocol Violation|0|||
149076993|NCT00614614|537761976|FG001|Booster Vaccination Phase|Protocol Violation|0|||
149076994|NCT00614614|537761977|FG002|Booster Vaccination Phase|Protocol Violation|2|||
149076995|NCT00614614|537761978|FG003|Booster Vaccination Phase|Protocol Violation|3|||
149076996|NCT00614614|537761979|FG004|Booster Vaccination Phase|Protocol Violation|0|||
149076997|NCT00614614|537761975|FG000|Booster Vaccination Phase|Other|0|||
149076998|NCT00614614|537761976|FG001|Booster Vaccination Phase|Other|1|||
149076999|NCT00614614|537761977|FG002|Booster Vaccination Phase|Other|3|||
149077000|NCT00614614|537761978|FG003|Booster Vaccination Phase|Other|2|||
149077001|NCT00614614|537761979|FG004|Booster Vaccination Phase|Other|1|||
149077002|NCT05426109|537761980|FG000|Overall Study|Withdrawal by Subject|0|||
149077003|NCT05426109|537761981|FG001|Overall Study|Withdrawal by Subject|1|||
149077004|NCT05212285|537761982|FG000|Overall Study|Lack of Efficacy|12|||
149077005|NCT05212285|537761983|FG001|Overall Study|Lack of Efficacy|8|||
149077006|NCT05212285|537761982|FG000|Overall Study|Withdrawal by Subject|8|||
149077007|NCT05212285|537761983|FG001|Overall Study|Withdrawal by Subject|1|||
149077008|NCT05212285|537761982|FG000|Overall Study|Lost to Follow-up|13|||
149077009|NCT05212285|537761983|FG001|Overall Study|Lost to Follow-up|1|||
149077010|NCT05212285|537761982|FG000|Overall Study|miss data|21|||
149077011|NCT05212285|537761983|FG001|Overall Study|miss data|2|||
149077012|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
149077013|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
149077014|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
149077015|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
149077016|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
149077017|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
149077018|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
149077019|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
149077020|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
149077021|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
149077022|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
149077023|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
149077024|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
149077025|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
149077026|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
149077027|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
149077028|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
149077029|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
149077030|NCT02222493|537761984|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
149077031|NCT02222493|537761985|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
149077032|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
149077033|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
149077034|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
149077035|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
149077036|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
149077037|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
149077038|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
149077039|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
149077040|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
149077041|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
149077042|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
149077043|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
149077044|NCT02222493|537761984|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
149077045|NCT02222493|537761985|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
149077046|NCT02222493|537761984|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
149077047|NCT02222493|537761985|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
149077048|NCT02222493|537761984|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
149077049|NCT02222493|537761985|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
149077050|NCT02222493|537761984|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
149077051|NCT02222493|537761985|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
149077052|NCT02222493|537761984|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
149077053|NCT02222493|537761985|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
149077054|NCT02222493|537761984|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
149077055|NCT02222493|537761985|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
149077056|NCT01000805|537761989|FG000|Overall Study|Adverse Event|21|||
149077057|NCT01000805|537761990|FG001|Overall Study|Adverse Event|9|||
149077058|NCT01000805|537761989|FG000|Overall Study|Lack of Efficacy|5|||
149077059|NCT01000805|537761990|FG001|Overall Study|Lack of Efficacy|16|||
149077060|NCT01000805|537761989|FG000|Overall Study|Lost to Follow-up|16|||
149077061|NCT01000805|537761990|FG001|Overall Study|Lost to Follow-up|21|||
149077062|NCT01000805|537761989|FG000|Overall Study|Physician Decision|0|||
149077063|NCT01000805|537761990|FG001|Overall Study|Physician Decision|1|||
149077064|NCT01000805|537761989|FG000|Overall Study|Protocol Violation|12|||
149077065|NCT01000805|537761990|FG001|Overall Study|Protocol Violation|8|||
149077066|NCT01000805|537761989|FG000|Overall Study|Withdrawal by Subject|16|||
149077067|NCT01000805|537761990|FG001|Overall Study|Withdrawal by Subject|6|||
149077068|NCT01000805|537761989|FG000|Overall Study|Sponsor Decision|0|||
149077069|NCT01000805|537761990|FG001|Overall Study|Sponsor Decision|1|||
149077070|NCT02542943|537761991|FG000|Overall Study|Lost to Follow-up|1|||
149077071|NCT02542943|537761992|FG001|Overall Study|Lost to Follow-up|0|||
149077072|NCT02542943|537761993|FG002|Overall Study|Lost to Follow-up|0|||
149077073|NCT02542943|537761991|FG000|Overall Study|Withdrawal by Subject|0|||
149077074|NCT02542943|537761992|FG001|Overall Study|Withdrawal by Subject|1|||
149077075|NCT02542943|537761993|FG002|Overall Study|Withdrawal by Subject|0|||
149077076|NCT03476798|537761994|FG000|Overall Study|Death|1|||
149077077|NCT03476798|537761994|FG000|Overall Study|Withdrawal by Subject|2|||
149077078|NCT03476798|537761994|FG000|Overall Study|Protocol Violation|2|||
149077079|NCT06269003|537761995|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
149077080|NCT06269003|537761996|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
149077081|NCT06269003|537761997|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
149077082|NCT06269003|537761998|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
149077083|NCT05865392|537762002|FG000|Overall Study|Withdrawal by Subject|4|||
149077084|NCT05865392|537762003|FG001|Overall Study|Withdrawal by Subject|0|||
149077085|NCT05865392|537762002|FG000|Overall Study|Didn't meet inclusion criteria|4|||
149077086|NCT05865392|537762003|FG001|Overall Study|Didn't meet inclusion criteria|0|||
149077087|NCT03343704|537762004|FG000|Overall Study|Refused to complete follow up|0|||
149077088|NCT03343704|537762005|FG001|Overall Study|Refused to complete follow up|1|||
149077089|NCT03343704|537762004|FG000|Overall Study|Death|0|||
149077090|NCT03343704|537762005|FG001|Overall Study|Death|1|||
149077091|NCT03343704|537762004|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
149077092|NCT03343704|537762005|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
149077093|NCT05432986|537762013|FG000|Overall Study|Withdrawal by Subject|2|||
149077094|NCT05432986|537762013|FG000|Overall Study|incomplete measurement|7|||
149077095|NCT00551421|537763702|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
149077096|NCT03823703|537763704|FG000|Overall Study|Sponsor request|0|||
149077097|NCT03823703|537763705|FG001|Overall Study|Sponsor request|3|||
149077098|NCT03823703|537763706|FG002|Overall Study|Sponsor request|4|||
149077099|NCT03823703|537763704|FG000|Overall Study|Adverse Event|3|||
149077100|NCT03823703|537763705|FG001|Overall Study|Adverse Event|1|||
149077101|NCT03823703|537763706|FG002|Overall Study|Adverse Event|0|||
149077102|NCT03823703|537763704|FG000|Overall Study|Withdrawal by Subject|0|||
149077103|NCT03823703|537763705|FG001|Overall Study|Withdrawal by Subject|1|||
149077104|NCT03823703|537763706|FG002|Overall Study|Withdrawal by Subject|0|||
149077105|NCT00799409|537763707|FG000|Overall Study|Withdrawal by Subject|1|||
149077106|NCT00799409|537763708|FG001|Overall Study|Withdrawal by Subject|0|||
149077107|NCT00799409|537763709|FG002|Overall Study|Withdrawal by Subject|0|||
149077108|NCT00799409|537763707|FG000|Overall Study|Lost to Follow-up|1|||
149077109|NCT00799409|537763708|FG001|Overall Study|Lost to Follow-up|0|||
149077110|NCT00799409|537763709|FG002|Overall Study|Lost to Follow-up|0|||
149077111|NCT00799409|537763707|FG000|Overall Study|Optimal Dose Not Achieved|2|||
149077112|NCT00799409|537763708|FG001|Overall Study|Optimal Dose Not Achieved|0|||
149077113|NCT00799409|537763709|FG002|Overall Study|Optimal Dose Not Achieved|0|||
149077114|NCT00799409|537763707|FG000|Overall Study|Failure to follow study protocol)|1|||
149077115|NCT00799409|537763708|FG001|Overall Study|Failure to follow study protocol)|0|||
149077116|NCT00799409|537763709|FG002|Overall Study|Failure to follow study protocol)|0|||
149077117|NCT00799409|537763707|FG000|Overall Study|Did not attend lab school day 1|1|||
149077118|NCT00799409|537763708|FG001|Overall Study|Did not attend lab school day 1|0|||
149077119|NCT00799409|537763709|FG002|Overall Study|Did not attend lab school day 1|0|||
149077120|NCT00799409|537763707|FG000|Overall Study|medication compliance|1|||
149077121|NCT00799409|537763708|FG001|Overall Study|medication compliance|0|||
149077122|NCT00799409|537763709|FG002|Overall Study|medication compliance|0|||
149077123|NCT03137459|537763710|FG000|2-month Assessment|Withdrawal by Subject|13|||
149077124|NCT03137459|537763711|FG001|2-month Assessment|Withdrawal by Subject|3|||
149077125|NCT03137459|537763710|FG000|2-month Assessment|Unable to reach|42|||
149077126|NCT03137459|537763711|FG001|2-month Assessment|Unable to reach|32|||
149077127|NCT03137459|537763710|FG000|2-month Assessment|Refused assessment|7|||
149077128|NCT03137459|537763711|FG001|2-month Assessment|Refused assessment|5|||
149077129|NCT03137459|537763710|FG000|2-month Assessment|Acutely ill|6|||
149077130|NCT03137459|537763711|FG001|2-month Assessment|Acutely ill|2|||
149077131|NCT03137459|537763710|FG000|4-month Assessment|Death|4|||
149077132|NCT03137459|537763711|FG001|4-month Assessment|Death|2|||
149077133|NCT03137459|537763710|FG000|4-month Assessment|Withdrawal by Subject|4|||
149077134|NCT03137459|537763711|FG001|4-month Assessment|Withdrawal by Subject|2|||
149077135|NCT03137459|537763710|FG000|4-month Assessment|Unable to reach|44|||
149077136|NCT03137459|537763711|FG001|4-month Assessment|Unable to reach|29|||
149077137|NCT03137459|537763710|FG000|4-month Assessment|Refused assessment|24|||
149077138|NCT03137459|537763711|FG001|4-month Assessment|Refused assessment|10|||
149077139|NCT03137459|537763710|FG000|4-month Assessment|Acutely ill|2|||
149077140|NCT03137459|537763711|FG001|4-month Assessment|Acutely ill|3|||
149077141|NCT03137459|537763710|FG000|6-months|Lost to Follow-up|14|||
149077142|NCT03137459|537763711|FG001|6-months|Lost to Follow-up|11|||
149077143|NCT03137459|537763710|FG000|6-months|Death|0|||
149077144|NCT03137459|537763711|FG001|6-months|Death|2|||
149077145|NCT03137459|537763710|FG000|6-months|Refused assessment|6|||
149077146|NCT03137459|537763711|FG001|6-months|Refused assessment|3|||
149077147|NCT03137459|537763710|FG000|6-months|Acutely ill|1|||
149077148|NCT03137459|537763711|FG001|6-months|Acutely ill|1|||
149077149|NCT00985088|537763712|FG000|Overall Study|Serious Adverse Event|1|||
149077150|NCT00985088|537763713|FG001|Overall Study|Serious Adverse Event|1|||
149077151|NCT00985088|537763714|FG002|Overall Study|Serious Adverse Event|0|||
149077152|NCT00985088|537763715|FG003|Overall Study|Serious Adverse Event|0|||
149077153|NCT00985088|537763716|FG004|Overall Study|Serious Adverse Event|0|||
149077154|NCT00985088|537763717|FG005|Overall Study|Serious Adverse Event|0|||
149077155|NCT00985088|537763718|FG006|Overall Study|Serious Adverse Event|0|||
149077156|NCT00985088|537763719|FG007|Overall Study|Serious Adverse Event|1|||
149077157|NCT00985088|537763712|FG000|Overall Study|Adverse Event|0|||
149077158|NCT00985088|537763713|FG001|Overall Study|Adverse Event|0|||
149077159|NCT00985088|537763714|FG002|Overall Study|Adverse Event|1|||
149077160|NCT00985088|537763715|FG003|Overall Study|Adverse Event|0|||
149077161|NCT00985088|537763716|FG004|Overall Study|Adverse Event|0|||
149077162|NCT00985088|537763717|FG005|Overall Study|Adverse Event|0|||
149077163|NCT00985088|537763718|FG006|Overall Study|Adverse Event|0|||
149077164|NCT00985088|537763719|FG007|Overall Study|Adverse Event|0|||
149077165|NCT00985088|537763712|FG000|Overall Study|Withdrawal by Subject|4|||
149077166|NCT00985088|537763713|FG001|Overall Study|Withdrawal by Subject|0|||
149077167|NCT00985088|537763714|FG002|Overall Study|Withdrawal by Subject|0|||
149077168|NCT00985088|537763715|FG003|Overall Study|Withdrawal by Subject|1|||
149077169|NCT00985088|537763716|FG004|Overall Study|Withdrawal by Subject|3|||
149077170|NCT00985088|537763717|FG005|Overall Study|Withdrawal by Subject|2|||
149077171|NCT00985088|537763718|FG006|Overall Study|Withdrawal by Subject|1|||
149077172|NCT00985088|537763719|FG007|Overall Study|Withdrawal by Subject|2|||
149077173|NCT00985088|537763712|FG000|Overall Study|Migrated/moved from study area|0|||
149077174|NCT00985088|537763713|FG001|Overall Study|Migrated/moved from study area|0|||
149077175|NCT00985088|537763714|FG002|Overall Study|Migrated/moved from study area|1|||
149077176|NCT00985088|537763715|FG003|Overall Study|Migrated/moved from study area|0|||
149077177|NCT00985088|537763716|FG004|Overall Study|Migrated/moved from study area|0|||
149077178|NCT00985088|537763717|FG005|Overall Study|Migrated/moved from study area|0|||
149077179|NCT00985088|537763718|FG006|Overall Study|Migrated/moved from study area|0|||
149077180|NCT00985088|537763719|FG007|Overall Study|Migrated/moved from study area|1|||
149077181|NCT00985088|537763712|FG000|Overall Study|Lost to Follow-up|6|||
149077182|NCT00985088|537763713|FG001|Overall Study|Lost to Follow-up|1|||
149077183|NCT00985088|537763714|FG002|Overall Study|Lost to Follow-up|2|||
149077184|NCT00985088|537763715|FG003|Overall Study|Lost to Follow-up|6|||
149077185|NCT00985088|537763716|FG004|Overall Study|Lost to Follow-up|6|||
149077186|NCT00985088|537763717|FG005|Overall Study|Lost to Follow-up|5|||
149077187|NCT00985088|537763718|FG006|Overall Study|Lost to Follow-up|3|||
149077188|NCT00985088|537763719|FG007|Overall Study|Lost to Follow-up|2|||
149077189|NCT01970878|537763720|FG000|Overall Study|Withdrawal by Subject|11|||
149077190|NCT01970878|537763721|FG001|Overall Study|Withdrawal by Subject|10|||
149077191|NCT01970878|537763722|FG002|Overall Study|Withdrawal by Subject|14|||
149077192|NCT01970878|537763723|FG003|Overall Study|Withdrawal by Subject|7|||
149077193|NCT01970878|537763720|FG000|Overall Study|Lost to Follow-up|1|||
149077194|NCT01970878|537763721|FG001|Overall Study|Lost to Follow-up|3|||
149077195|NCT01970878|537763722|FG002|Overall Study|Lost to Follow-up|2|||
149077196|NCT01970878|537763723|FG003|Overall Study|Lost to Follow-up|4|||
149077197|NCT01970878|537763720|FG000|Overall Study|Administrative Reasons|1|||
149077198|NCT01970878|537763721|FG001|Overall Study|Administrative Reasons|0|||
149077199|NCT01970878|537763722|FG002|Overall Study|Administrative Reasons|0|||
149077200|NCT01970878|537763723|FG003|Overall Study|Administrative Reasons|4|||
149077201|NCT01970878|537763720|FG000|Overall Study|Lack of Efficacy|2|||
149077202|NCT01970878|537763721|FG001|Overall Study|Lack of Efficacy|1|||
149077203|NCT01970878|537763722|FG002|Overall Study|Lack of Efficacy|2|||
149077204|NCT01970878|537763723|FG003|Overall Study|Lack of Efficacy|0|||
149077205|NCT01970878|537763720|FG000|Overall Study|Adverse Event|12|||
149077206|NCT01970878|537763721|FG001|Overall Study|Adverse Event|7|||
149077207|NCT01970878|537763722|FG002|Overall Study|Adverse Event|4|||
149077208|NCT01970878|537763723|FG003|Overall Study|Adverse Event|3|||
149077209|NCT01970878|537763720|FG000|Overall Study|Protocol Specified Criteria|10|||
149077210|NCT01970878|537763721|FG001|Overall Study|Protocol Specified Criteria|4|||
149077211|NCT01970878|537763722|FG002|Overall Study|Protocol Specified Criteria|3|||
149077212|NCT01970878|537763723|FG003|Overall Study|Protocol Specified Criteria|6|||
149077213|NCT01970878|537763720|FG000|Overall Study|Physician Decision|0|||
149077214|NCT01970878|537763721|FG001|Overall Study|Physician Decision|1|||
149077215|NCT01970878|537763722|FG002|Overall Study|Physician Decision|1|||
149077216|NCT01970878|537763723|FG003|Overall Study|Physician Decision|0|||
149077217|NCT01970878|537763720|FG000|Overall Study|No Completion Status|0|||
149077218|NCT01970878|537763721|FG001|Overall Study|No Completion Status|1|||
149077219|NCT01970878|537763722|FG002|Overall Study|No Completion Status|0|||
149077220|NCT01970878|537763723|FG003|Overall Study|No Completion Status|0|||
149077221|NCT00731692|537763725|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
149077222|NCT00731692|537763726|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
149077223|NCT00731692|537763727|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
149077224|NCT00731692|537763725|FG000|Core Study (36 Months)|Physician Decision|1|||
149077225|NCT00731692|537763726|FG001|Core Study (36 Months)|Physician Decision|0|||
149077226|NCT00731692|537763727|FG002|Core Study (36 Months)|Physician Decision|2|||
149077227|NCT00731692|537763725|FG000|Core Study (36 Months)|Death|2|||
149077228|NCT00731692|537763726|FG001|Core Study (36 Months)|Death|1|||
149077229|NCT00731692|537763727|FG002|Core Study (36 Months)|Death|2|||
149077230|NCT00731692|537763725|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
149077231|NCT00731692|537763726|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
149077232|NCT00731692|537763727|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
149077233|NCT00731692|537763725|FG000|Core Study (36 Months)|Administrative|2|||
149077234|NCT00731692|537763726|FG001|Core Study (36 Months)|Administrative|2|||
149077235|NCT00731692|537763727|FG002|Core Study (36 Months)|Administrative|6|||
149077236|NCT00731692|537763725|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
149077237|NCT00731692|537763726|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
149077238|NCT00731692|537763727|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
149077239|NCT00731692|537763725|FG000|Core Study (36 Months)|Protocol Violation|4|||
149077240|NCT00731692|537763726|FG001|Core Study (36 Months)|Protocol Violation|5|||
149077241|NCT00731692|537763727|FG002|Core Study (36 Months)|Protocol Violation|8|||
149077242|NCT00731692|537763725|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
149077243|NCT00731692|537763726|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
149077244|NCT00731692|537763727|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
149077245|NCT00731692|537763725|FG000|Core Study (36 Months)|Adverse Event|25|||
149077246|NCT00731692|537763726|FG001|Core Study (36 Months)|Adverse Event|28|||
149077247|NCT00731692|537763727|FG002|Core Study (36 Months)|Adverse Event|29|||
149077248|NCT00731692|537763725|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
149077249|NCT00731692|537763726|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
149077250|NCT00731692|537763727|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
149077251|NCT00731692|537763725|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
149077252|NCT00731692|537763726|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
149077253|NCT00731692|537763727|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
149077254|NCT00731692|537763725|FG000|Extension Phase|Abnormal test procedure|0|||
149077255|NCT00731692|537763726|FG001|Extension Phase|Abnormal test procedure|0|||
149077256|NCT00731692|537763727|FG002|Extension Phase|Abnormal test procedure|1|||
149077257|NCT00731692|537763725|FG000|Extension Phase|Abnormal lab values|0|||
149077258|NCT00731692|537763726|FG001|Extension Phase|Abnormal lab values|0|||
149077259|NCT00731692|537763727|FG002|Extension Phase|Abnormal lab values|1|||
149077260|NCT00731692|537763725|FG000|Extension Phase|Lost to Follow-up|0|||
149077261|NCT00731692|537763726|FG001|Extension Phase|Lost to Follow-up|1|||
149077262|NCT00731692|537763727|FG002|Extension Phase|Lost to Follow-up|4|||
149077263|NCT00731692|537763725|FG000|Extension Phase|Withdrawal by Subject|4|||
149077264|NCT00731692|537763726|FG001|Extension Phase|Withdrawal by Subject|5|||
149077265|NCT00731692|537763727|FG002|Extension Phase|Withdrawal by Subject|3|||
149077266|NCT00731692|537763725|FG000|Extension Phase|Adverse Event|1|||
149077267|NCT00731692|537763726|FG001|Extension Phase|Adverse Event|1|||
149077268|NCT00731692|537763727|FG002|Extension Phase|Adverse Event|15|||
149077269|NCT06571695|537763728|FG000|Overall Study|Lost to Follow-up|1|||
149077270|NCT06571695|537763729|FG001|Overall Study|Lost to Follow-up|6|||
149077271|NCT04921358|537763730|FG000|Overall Study|Withdrawal by Subject|6|||
149077272|NCT04921358|537763731|FG001|Overall Study|Withdrawal by Subject|13|||
149077273|NCT04921358|537763730|FG000|Overall Study|Lost to Follow-up|3|||
149077274|NCT04921358|537763731|FG001|Overall Study|Lost to Follow-up|6|||
149077275|NCT04921358|537763730|FG000|Overall Study|Study Terminated by Sponsor|86|||
149077276|NCT04921358|537763731|FG001|Overall Study|Study Terminated by Sponsor|89|||
149077277|NCT04921358|537763730|FG000|Overall Study|Death|92|||
149077278|NCT04921358|537763731|FG001|Overall Study|Death|82|||
149077279|NCT04926857|537763732|FG000|Overall Study|Withdrawal by Subject|40|||
149077280|NCT04926857|537763732|FG000|Overall Study|Death|9|||
149077281|NCT04926857|537763732|FG000|Overall Study|Study product no longer in use|44|||
149077282|NCT04926857|537763732|FG000|Overall Study|Inadequate data to address primary objective|16|||
149077283|NCT02637063|537763733|FG000|Overall Study|Lost to Follow-up|3|||
149077284|NCT02637063|537763734|FG001|Overall Study|Lost to Follow-up|2|||
149077285|NCT02637063|537763735|FG002|Overall Study|Lost to Follow-up|3|||
149077286|NCT02637063|537763733|FG000|Overall Study|Withdrawal by Subject|2|||
149077287|NCT02637063|537763734|FG001|Overall Study|Withdrawal by Subject|2|||
149077288|NCT02637063|537763735|FG002|Overall Study|Withdrawal by Subject|3|||
149077289|NCT00491400|537763736|FG000|Overall Study|Withdrawal by Subject|5|||
149077290|NCT00491400|537763737|FG001|Overall Study|Withdrawal by Subject|4|||
149077291|NCT00745875|537763741|FG000|Overall Study|Continuing study treatment|4|||
149077292|NCT00745875|537763742|FG001|Overall Study|Continuing study treatment|4|||
149077293|NCT02310581|537763743|FG000|Overall Study|Adverse Event|1|||
149077294|NCT02310581|537763744|FG001|Overall Study|Adverse Event|1|||
149077295|NCT02310581|537763745|FG002|Overall Study|Adverse Event|1|||
149077296|NCT02310581|537763746|FG003|Overall Study|Adverse Event|0|||
149077297|NCT02310581|537763743|FG000|Overall Study|Withdrawal by Subject|2|||
149077298|NCT02310581|537763744|FG001|Overall Study|Withdrawal by Subject|1|||
149077299|NCT02310581|537763745|FG002|Overall Study|Withdrawal by Subject|0|||
149077300|NCT02310581|537763746|FG003|Overall Study|Withdrawal by Subject|1|||
149077301|NCT02824198|537763747|FG000|Overall Study|Non-compliance with the protocol|5|||
149077302|NCT02824198|537763748|FG001|Overall Study|Non-compliance with the protocol|1|||
149077303|NCT02824198|537763747|FG000|Overall Study|Lost to Follow-up|5|||
149077304|NCT02824198|537763748|FG001|Overall Study|Lost to Follow-up|2|||
149077305|NCT02824198|537763747|FG000|Overall Study|Withdrawal by Subject|5|||
149077306|NCT02824198|537763748|FG001|Overall Study|Withdrawal by Subject|0|||
149077307|NCT01833455|537763749|FG000|Overall Study|Withdrawal by Subject|1|||
149077308|NCT01833455|537763750|FG001|Overall Study|Withdrawal by Subject|0|||
149077309|NCT03883828|537763751|FG000|Overall Study|Did not start radiotherapy|1|||
149077310|NCT03883828|537763752|FG001|Overall Study|Did not start radiotherapy|2|||
149077311|NCT01256359|537763753|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
149077312|NCT01256359|537763754|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
149077313|NCT01256359|537763753|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
149077314|NCT01256359|537763754|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
149077315|NCT03960645|537763755|FG000|Overall Study|Protocol Violation|1|||
149077316|NCT03960645|537763756|FG001|Overall Study|Protocol Violation|0|||
149077317|NCT04938453|537763757|FG000|Washout Period 1|Adverse Event|1|||
149077318|NCT04938453|537763758|FG001|Washout Period 1|Adverse Event|0|||
149077319|NCT04938453|537763757|FG000|Washout Period 1|Physician Decision|0|||
149077320|NCT04938453|537763758|FG001|Washout Period 1|Physician Decision|1|||
149077321|NCT03292406|537763761|FG000|Overall Study|Progressive Disease|6|||
149077322|NCT03292406|537763762|FG001|Overall Study|Progressive Disease|3|||
149077323|NCT03292406|537763763|FG002|Overall Study|Progressive Disease|4|||
149077324|NCT03292406|537763761|FG000|Overall Study|Adverse Event|7|||
149077325|NCT03292406|537763762|FG001|Overall Study|Adverse Event|1|||
149077326|NCT03292406|537763763|FG002|Overall Study|Adverse Event|4|||
149077327|NCT03292406|537763761|FG000|Overall Study|Withdrawal by Subject|0|||
149077328|NCT03292406|537763762|FG001|Overall Study|Withdrawal by Subject|7|||
149077329|NCT03292406|537763763|FG002|Overall Study|Withdrawal by Subject|2|||
149077330|NCT03292406|537763761|FG000|Overall Study|Protocol Violation|0|||
149077331|NCT03292406|537763762|FG001|Overall Study|Protocol Violation|1|||
149077332|NCT03292406|537763763|FG002|Overall Study|Protocol Violation|1|||
149077333|NCT03292406|537763761|FG000|Overall Study|Other|0|||
149077334|NCT03292406|537763762|FG001|Overall Study|Other|1|||
149077335|NCT03292406|537763763|FG002|Overall Study|Other|2|||
149077336|NCT02575365|537763768|FG000|Overall Study|Lost to Follow-up|4|||
149077337|NCT00487240|537763770|FG000|Overall Study|Withdrawal by Subject|12|||
149077338|NCT00487240|537763771|FG001|Overall Study|Withdrawal by Subject|6|||
149077339|NCT00487240|537763770|FG000|Overall Study|Lost to Follow-up|7|||
149077340|NCT00487240|537763771|FG001|Overall Study|Lost to Follow-up|6|||
149077341|NCT00487240|537763770|FG000|Overall Study|Adverse Event|0|||
149077342|NCT00487240|537763771|FG001|Overall Study|Adverse Event|4|||
149077343|NCT00487240|537763770|FG000|Overall Study|Protocol Violation|5|||
149077344|NCT00487240|537763771|FG001|Overall Study|Protocol Violation|5|||
149077345|NCT00487240|537763770|FG000|Overall Study|Entry Criteria Not Met|3|||
149077346|NCT00487240|537763771|FG001|Overall Study|Entry Criteria Not Met|4|||
149077347|NCT00487240|537763770|FG000|Overall Study|Sponsor Decision|2|||
149077348|NCT00487240|537763771|FG001|Overall Study|Sponsor Decision|1|||
149077349|NCT00487240|537763770|FG000|Overall Study|Physician Decision|2|||
149077350|NCT00487240|537763771|FG001|Overall Study|Physician Decision|0|||
149077351|NCT01019135|537763772|FG000|Overall Study|Did not receive allocated intervention|12|||
149077352|NCT01019135|537763773|FG001|Overall Study|Did not receive allocated intervention|6|||
149077353|NCT01019135|537763774|FG002|Overall Study|Did not receive allocated intervention|25|||
149077354|NCT01019135|537763772|FG000|Overall Study|Did not attend CR|8|||
149077355|NCT01019135|537763773|FG001|Overall Study|Did not attend CR|13|||
149077356|NCT01019135|537763774|FG002|Overall Study|Did not attend CR|6|||
149077357|NCT04237792|537763776|FG000|Treatment (Day 1)|Adverse Event|1|||
149077358|NCT04237792|537763777|FG001|Treatment (Day 1)|Adverse Event|0|||
149077359|NCT04237792|537763778|FG002|Treatment (Day 1)|Adverse Event|0|||
149077360|NCT04237792|537763779|FG003|Treatment (Day 1)|Adverse Event|0|||
149077361|NCT04237792|537763780|FG004|Treatment (Day 1)|Adverse Event|1|||
149077362|NCT04237792|537763781|FG005|Treatment (Day 1)|Adverse Event|1|||
149077363|NCT04237792|537763776|FG000|Treatment (Day 1)|Other|0|||
149077364|NCT04237792|537763777|FG001|Treatment (Day 1)|Other|0|||
149077365|NCT04237792|537763778|FG002|Treatment (Day 1)|Other|1|||
149077366|NCT04237792|537763779|FG003|Treatment (Day 1)|Other|0|||
149077367|NCT04237792|537763780|FG004|Treatment (Day 1)|Other|0|||
149077368|NCT04237792|537763781|FG005|Treatment (Day 1)|Other|1|||
149077369|NCT04237792|537763776|FG000|Treatment (Day 1)|Not treated|1|||
149077370|NCT04237792|537763777|FG001|Treatment (Day 1)|Not treated|1|||
149077371|NCT04237792|537763778|FG002|Treatment (Day 1)|Not treated|2|||
149077372|NCT04237792|537763779|FG003|Treatment (Day 1)|Not treated|1|||
149077373|NCT04237792|537763780|FG004|Treatment (Day 1)|Not treated|0|||
149077374|NCT04237792|537763781|FG005|Treatment (Day 1)|Not treated|1|||
149077375|NCT04885998|537763782|FG000|Overall Study|Withdrawal by Subject|0|||
149077376|NCT04885998|537763783|FG001|Overall Study|Withdrawal by Subject|2|||
149077377|NCT04885998|537763784|FG002|Overall Study|Withdrawal by Subject|0|||
149077378|NCT04885998|537763785|FG003|Overall Study|Withdrawal by Subject|3|||
149077379|NCT04885998|537763782|FG000|Overall Study|Lost to Follow-up|1|||
149077380|NCT04885998|537763783|FG001|Overall Study|Lost to Follow-up|1|||
149077381|NCT04885998|537763784|FG002|Overall Study|Lost to Follow-up|0|||
149077382|NCT04885998|537763785|FG003|Overall Study|Lost to Follow-up|0|||
149077383|NCT04885998|537763782|FG000|Overall Study|Death|2|||
149077384|NCT04885998|537763783|FG001|Overall Study|Death|1|||
149077385|NCT04885998|537763784|FG002|Overall Study|Death|2|||
149077386|NCT04885998|537763785|FG003|Overall Study|Death|2|||
149077387|NCT04885998|537763782|FG000|Overall Study|Decision by sponsor|1|||
149077388|NCT04885998|537763783|FG001|Overall Study|Decision by sponsor|1|||
149077389|NCT04885998|537763784|FG002|Overall Study|Decision by sponsor|0|||
149077390|NCT04885998|537763785|FG003|Overall Study|Decision by sponsor|0|||
149077391|NCT00910962|537763786|FG000|Overall Study|Adverse Event|5|||
149077392|NCT00910962|537763787|FG001|Overall Study|Adverse Event|20|||
149077393|NCT00910962|537763788|FG002|Overall Study|Adverse Event|17|||
149077394|NCT00910962|537763786|FG000|Overall Study|Protocol Violation|1|||
149077395|NCT00910962|537763787|FG001|Overall Study|Protocol Violation|3|||
149077396|NCT00910962|537763788|FG002|Overall Study|Protocol Violation|3|||
149077397|NCT00910962|537763786|FG000|Overall Study|Lost to Follow-up|0|||
149077398|NCT00910962|537763787|FG001|Overall Study|Lost to Follow-up|3|||
149077399|NCT00910962|537763788|FG002|Overall Study|Lost to Follow-up|1|||
149077400|NCT00910962|537763786|FG000|Overall Study|Physician Decision|0|||
149077401|NCT00910962|537763787|FG001|Overall Study|Physician Decision|6|||
149077402|NCT00910962|537763788|FG002|Overall Study|Physician Decision|6|||
149077403|NCT00910962|537763786|FG000|Overall Study|Withdrawal by Subject|25|||
149077404|NCT00910962|537763787|FG001|Overall Study|Withdrawal by Subject|32|||
149077405|NCT00910962|537763788|FG002|Overall Study|Withdrawal by Subject|32|||
149077406|NCT00910962|537763786|FG000|Overall Study|Reached defined stopping criteria|12|||
149077407|NCT00910962|537763787|FG001|Overall Study|Reached defined stopping criteria|14|||
149077408|NCT00910962|537763788|FG002|Overall Study|Reached defined stopping criteria|17|||
149077409|NCT01629589|537763789|FG000|Overall Study|Protocol Violation|4|||
149077410|NCT01629589|537763790|FG001|Overall Study|Protocol Violation|2|||
149077411|NCT01629589|537763789|FG000|Overall Study|Lost to Follow-up|2|||
149077412|NCT01629589|537763790|FG001|Overall Study|Lost to Follow-up|1|||
149077413|NCT01629589|537763789|FG000|Overall Study|Withdrawal by Subject|2|||
149077414|NCT01629589|537763790|FG001|Overall Study|Withdrawal by Subject|3|||
149077415|NCT01629589|537763789|FG000|Overall Study|Did not receive study vaccine|0|||
149077416|NCT01629589|537763790|FG001|Overall Study|Did not receive study vaccine|1|||
149077417|NCT03057600|537763794|FG000|Overall Study|Adverse Event|0|||
149077418|NCT03057600|537763795|FG001|Overall Study|Adverse Event|0|||
149077419|NCT03057600|537763796|FG002|Overall Study|Adverse Event|4|||
149077420|NCT03057600|537763797|FG003|Overall Study|Adverse Event|0|||
149077421|NCT03057600|537763794|FG000|Overall Study|Radiologic Disease Progression|8|||
149077422|NCT03057600|537763795|FG001|Overall Study|Radiologic Disease Progression|7|||
149077423|NCT03057600|537763796|FG002|Overall Study|Radiologic Disease Progression|13|||
149077424|NCT03057600|537763797|FG003|Overall Study|Radiologic Disease Progression|10|||
149077425|NCT03057600|537763794|FG000|Overall Study|Symptomatic Deterioration|0|||
149077426|NCT03057600|537763795|FG001|Overall Study|Symptomatic Deterioration|1|||
149077427|NCT03057600|537763796|FG002|Overall Study|Symptomatic Deterioration|1|||
149077428|NCT03057600|537763797|FG003|Overall Study|Symptomatic Deterioration|0|||
149077429|NCT03057600|537763794|FG000|Overall Study|Investigator Decision|0|||
149077430|NCT03057600|537763795|FG001|Overall Study|Investigator Decision|0|||
149077431|NCT03057600|537763796|FG002|Overall Study|Investigator Decision|1|||
149077432|NCT03057600|537763797|FG003|Overall Study|Investigator Decision|0|||
149077433|NCT03057600|537763794|FG000|Overall Study|Study Termination by Sponsor|0|||
149077434|NCT03057600|537763795|FG001|Overall Study|Study Termination by Sponsor|0|||
149077435|NCT03057600|537763796|FG002|Overall Study|Study Termination by Sponsor|0|||
149077436|NCT03057600|537763797|FG003|Overall Study|Study Termination by Sponsor|2|||
149077437|NCT03057600|537763794|FG000|Overall Study|Withdrawal by Subject|0|||
149077438|NCT03057600|537763795|FG001|Overall Study|Withdrawal by Subject|1|||
149077439|NCT03057600|537763796|FG002|Overall Study|Withdrawal by Subject|0|||
149077440|NCT03057600|537763797|FG003|Overall Study|Withdrawal by Subject|0|||
149077441|NCT03057600|537763794|FG000|Overall Study|Other, Not Specified|1|||
149077442|NCT03057600|537763795|FG001|Overall Study|Other, Not Specified|1|||
149077443|NCT03057600|537763796|FG002|Overall Study|Other, Not Specified|1|||
149077444|NCT03057600|537763797|FG003|Overall Study|Other, Not Specified|1|||
149077445|NCT03822832|537763798|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
149077446|NCT03822832|537763799|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
149077447|NCT03822832|537763798|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
149077448|NCT03822832|537763799|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
149077449|NCT03822832|537763798|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
149077450|NCT03822832|537763799|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
149077451|NCT03822832|537763798|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
149077452|NCT03822832|537763799|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
149077453|NCT03822832|537763798|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
149077454|NCT03822832|537763799|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
149077455|NCT03822832|537763798|FG000|Re-allocation|Not re-allocated to open label period|2|||
149077456|NCT03822832|537763799|FG001|Re-allocation|Not re-allocated to open label period|6|||
149077457|NCT03822832|537763798|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
149077458|NCT03822832|537763799|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
149077459|NCT03822832|537763798|FG000|Period 2 - Open Label Period|Adverse Event|0|||
149077460|NCT03822832|537763799|FG001|Period 2 - Open Label Period|Adverse Event|3|||
149077461|NCT00243867|537763800|FG000|Overall Study|Adverse Event|24|||
149077462|NCT00243867|537763801|FG001|Overall Study|Adverse Event|34|||
149077463|NCT00243867|537763800|FG000|Overall Study|Lack of Efficacy|115|||
149077464|NCT00243867|537763801|FG001|Overall Study|Lack of Efficacy|78|||
149077465|NCT00243867|537763800|FG000|Overall Study|Withdrawal by Subject|11|||
149077466|NCT00243867|537763801|FG001|Overall Study|Withdrawal by Subject|23|||
149077467|NCT00243867|537763800|FG000|Overall Study|Lost to Follow-up|2|||
149077468|NCT00243867|537763801|FG001|Overall Study|Lost to Follow-up|1|||
149077469|NCT00243867|537763800|FG000|Overall Study|Physician Decision|2|||
149077470|NCT00243867|537763801|FG001|Overall Study|Physician Decision|7|||
149077471|NCT00243867|537763800|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
149077472|NCT00243867|537763801|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
149077473|NCT02060487|537763802|FG000|Overall Study|Other|1|||
149077474|NCT02060487|537763803|FG001|Overall Study|Other|2|||
149077475|NCT02060487|537763804|FG002|Overall Study|Other|1|||
149077476|NCT02060487|537763802|FG000|Overall Study|Lack of Efficacy|0|||
149077477|NCT02060487|537763803|FG001|Overall Study|Lack of Efficacy|1|||
149077478|NCT02060487|537763804|FG002|Overall Study|Lack of Efficacy|0|||
149077479|NCT02060487|537763802|FG000|Overall Study|Withdrawal by Subject|3|||
149077480|NCT02060487|537763803|FG001|Overall Study|Withdrawal by Subject|10|||
149077481|NCT02060487|537763804|FG002|Overall Study|Withdrawal by Subject|4|||
149077482|NCT02060487|537763802|FG000|Overall Study|Study Terminated By Sponsor|87|||
149077483|NCT02060487|537763803|FG001|Overall Study|Study Terminated By Sponsor|89|||
149077484|NCT02060487|537763804|FG002|Overall Study|Study Terminated By Sponsor|100|||
149077485|NCT02060487|537763802|FG000|Overall Study|Randomized in error|1|||
149077486|NCT02060487|537763803|FG001|Overall Study|Randomized in error|0|||
149077487|NCT02060487|537763804|FG002|Overall Study|Randomized in error|0|||
149077488|NCT02060487|537763802|FG000|Overall Study|Protocol Violation|0|||
149077489|NCT02060487|537763803|FG001|Overall Study|Protocol Violation|1|||
149077490|NCT02060487|537763804|FG002|Overall Study|Protocol Violation|1|||
149077491|NCT02060487|537763802|FG000|Overall Study|Lost to Follow-up|3|||
149077492|NCT02060487|537763803|FG001|Overall Study|Lost to Follow-up|0|||
149077493|NCT02060487|537763804|FG002|Overall Study|Lost to Follow-up|2|||
149077494|NCT02060487|537763802|FG000|Overall Study|Death|34|||
149077495|NCT02060487|537763803|FG001|Overall Study|Death|25|||
149077496|NCT02060487|537763804|FG002|Overall Study|Death|19|||
149077497|NCT02060487|537763802|FG000|Overall Study|Adverse Event|0|||
149077498|NCT02060487|537763803|FG001|Overall Study|Adverse Event|0|||
149077499|NCT02060487|537763804|FG002|Overall Study|Adverse Event|1|||
149077500|NCT05182606|537763810|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
149077501|NCT02686658|537763812|FG000|Overall Study|Adverse Event|0|||
149077502|NCT02686658|537763813|FG001|Overall Study|Adverse Event|0|||
149077503|NCT02686658|537763814|FG002|Overall Study|Adverse Event|1|||
149077504|NCT02686658|537763815|FG003|Overall Study|Adverse Event|1|||
149077505|NCT02686658|537763816|FG004|Overall Study|Adverse Event|2|||
149077506|NCT02686658|537763817|FG005|Overall Study|Adverse Event|1|||
149077507|NCT02686658|537763812|FG000|Overall Study|Investigator decision|0|||
149077508|NCT02686658|537763813|FG001|Overall Study|Investigator decision|0|||
149077509|NCT02686658|537763814|FG002|Overall Study|Investigator decision|0|||
149077510|NCT02686658|537763815|FG003|Overall Study|Investigator decision|1|||
149077511|NCT02686658|537763816|FG004|Overall Study|Investigator decision|2|||
149077512|NCT02686658|537763817|FG005|Overall Study|Investigator decision|1|||
149077513|NCT02686658|537763812|FG000|Overall Study|Sponsor decision|1|||
149077514|NCT02686658|537763813|FG001|Overall Study|Sponsor decision|2|||
149077515|NCT02686658|537763814|FG002|Overall Study|Sponsor decision|1|||
149077516|NCT02686658|537763815|FG003|Overall Study|Sponsor decision|5|||
149077517|NCT02686658|537763816|FG004|Overall Study|Sponsor decision|13|||
149077518|NCT02686658|537763817|FG005|Overall Study|Sponsor decision|2|||
149077519|NCT02686658|537763812|FG000|Overall Study|Lost to Follow-up|0|||
149077520|NCT02686658|537763813|FG001|Overall Study|Lost to Follow-up|0|||
149077521|NCT02686658|537763814|FG002|Overall Study|Lost to Follow-up|2|||
149077522|NCT02686658|537763815|FG003|Overall Study|Lost to Follow-up|0|||
149077523|NCT02686658|537763816|FG004|Overall Study|Lost to Follow-up|0|||
149077524|NCT02686658|537763817|FG005|Overall Study|Lost to Follow-up|1|||
149077525|NCT02686658|537763812|FG000|Overall Study|Death|1|||
149077526|NCT02686658|537763813|FG001|Overall Study|Death|0|||
149077527|NCT02686658|537763814|FG002|Overall Study|Death|0|||
149077528|NCT02686658|537763815|FG003|Overall Study|Death|1|||
149077529|NCT02686658|537763816|FG004|Overall Study|Death|1|||
149077530|NCT02686658|537763817|FG005|Overall Study|Death|1|||
149077531|NCT02686658|537763812|FG000|Overall Study|Withdrawal by Subject|2|||
149077532|NCT02686658|537763813|FG001|Overall Study|Withdrawal by Subject|5|||
149077533|NCT02686658|537763814|FG002|Overall Study|Withdrawal by Subject|4|||
149077534|NCT02686658|537763815|FG003|Overall Study|Withdrawal by Subject|4|||
149077535|NCT02686658|537763816|FG004|Overall Study|Withdrawal by Subject|17|||
149077536|NCT02686658|537763817|FG005|Overall Study|Withdrawal by Subject|8|||
149077537|NCT02686658|537763812|FG000|Overall Study|Placed in hospice care|0|||
149077538|NCT02686658|537763813|FG001|Overall Study|Placed in hospice care|0|||
149077539|NCT02686658|537763814|FG002|Overall Study|Placed in hospice care|1|||
149077540|NCT02686658|537763815|FG003|Overall Study|Placed in hospice care|0|||
149077541|NCT02686658|537763816|FG004|Overall Study|Placed in hospice care|0|||
149077542|NCT02686658|537763817|FG005|Overall Study|Placed in hospice care|0|||
149077543|NCT02686658|537763812|FG000|Overall Study|Participant non-compliance|0|||
149077544|NCT02686658|537763813|FG001|Overall Study|Participant non-compliance|0|||
149077545|NCT02686658|537763814|FG002|Overall Study|Participant non-compliance|0|||
149077546|NCT02686658|537763815|FG003|Overall Study|Participant non-compliance|0|||
149077547|NCT02686658|537763816|FG004|Overall Study|Participant non-compliance|0|||
149077548|NCT02686658|537763817|FG005|Overall Study|Participant non-compliance|1|||
149077549|NCT02686658|537763812|FG000|Overall Study|Concern over coronavirus disease care|0|||
149077550|NCT02686658|537763813|FG001|Overall Study|Concern over coronavirus disease care|0|||
149077551|NCT02686658|537763814|FG002|Overall Study|Concern over coronavirus disease care|0|||
149077552|NCT02686658|537763815|FG003|Overall Study|Concern over coronavirus disease care|0|||
149077553|NCT02686658|537763816|FG004|Overall Study|Concern over coronavirus disease care|2|||
149077554|NCT02686658|537763817|FG005|Overall Study|Concern over coronavirus disease care|1|||
149077555|NCT02309294|537763820|FG000|Overall Study|Withdrawal by Subject|2|||
149077556|NCT01227421|537763821|FG000|Overall Study|Lost to Follow-up|6|||
149077557|NCT01227421|537763822|FG001|Overall Study|Lost to Follow-up|7|||
149077558|NCT01227421|537763823|FG002|Overall Study|Lost to Follow-up|5|||
149077559|NCT01227421|537763821|FG000|Overall Study|Adverse Event|2|||
149077560|NCT01227421|537763822|FG001|Overall Study|Adverse Event|7|||
149077561|NCT01227421|537763823|FG002|Overall Study|Adverse Event|2|||
149077562|NCT01227421|537763821|FG000|Overall Study|Withdrawal by Subject|1|||
149077563|NCT01227421|537763822|FG001|Overall Study|Withdrawal by Subject|2|||
149077564|NCT01227421|537763823|FG002|Overall Study|Withdrawal by Subject|1|||
149077565|NCT01227421|537763821|FG000|Overall Study|Protocol Violation|1|||
149077566|NCT01227421|537763822|FG001|Overall Study|Protocol Violation|1|||
149077567|NCT01227421|537763823|FG002|Overall Study|Protocol Violation|2|||
149077568|NCT01227421|537763821|FG000|Overall Study|Randomized in error|1|||
149077569|NCT01227421|537763822|FG001|Overall Study|Randomized in error|1|||
149077570|NCT01227421|537763823|FG002|Overall Study|Randomized in error|0|||
149077571|NCT01827839|537763826|FG000|Overall Study|Adverse Event|1|||
149077572|NCT01827839|537763826|FG000|Overall Study|Consent Withdrawal|2|||
149077573|NCT04447027|537763832|FG000|Dose Escalation|Withdrawal by Subject|1|||
149077574|NCT04447027|537763833|FG001|Dose Escalation|Withdrawal by Subject|4|||
149077575|NCT04447027|537763834|FG002|Dose Escalation|Withdrawal by Subject|3|||
149077576|NCT04447027|537763835|FG003|Dose Escalation|Withdrawal by Subject|3|||
149077577|NCT04447027|537763836|FG004|Dose Escalation|Withdrawal by Subject|1|||
149077578|NCT04447027|537763837|FG005|Dose Escalation|Withdrawal by Subject|0|||
149077579|NCT04447027|537763838|FG006|Dose Escalation|Withdrawal by Subject|0|||
149077580|NCT04447027|537763839|FG007|Dose Escalation|Withdrawal by Subject|0|||
149077581|NCT04447027|537763840|FG008|Dose Escalation|Withdrawal by Subject|0|||
149077582|NCT04447027|537763832|FG000|Dose Escalation|Refused further treatment|0|||
149077583|NCT04447027|537763833|FG001|Dose Escalation|Refused further treatment|1|||
149077584|NCT04447027|537763834|FG002|Dose Escalation|Refused further treatment|1|||
149077585|NCT04447027|537763835|FG003|Dose Escalation|Refused further treatment|0|||
149077586|NCT04447027|537763836|FG004|Dose Escalation|Refused further treatment|0|||
149077587|NCT04447027|537763837|FG005|Dose Escalation|Refused further treatment|0|||
149077588|NCT04447027|537763838|FG006|Dose Escalation|Refused further treatment|0|||
149077589|NCT04447027|537763839|FG007|Dose Escalation|Refused further treatment|0|||
149077590|NCT04447027|537763840|FG008|Dose Escalation|Refused further treatment|0|||
149077591|NCT04447027|537763832|FG000|Dose Expansion|Withdrawal by Subject|0|||
149077592|NCT04447027|537763833|FG001|Dose Expansion|Withdrawal by Subject|0|||
149077593|NCT04447027|537763834|FG002|Dose Expansion|Withdrawal by Subject|0|||
149077594|NCT04447027|537763835|FG003|Dose Expansion|Withdrawal by Subject|0|||
149077595|NCT04447027|537763836|FG004|Dose Expansion|Withdrawal by Subject|0|||
149077596|NCT04447027|537763837|FG005|Dose Expansion|Withdrawal by Subject|2|||
149077597|NCT04447027|537763838|FG006|Dose Expansion|Withdrawal by Subject|0|||
149077598|NCT04447027|537763839|FG007|Dose Expansion|Withdrawal by Subject|2|||
149077599|NCT04447027|537763840|FG008|Dose Expansion|Withdrawal by Subject|0|||
149077600|NCT04118894|537763841|FG000|Overall Study|Lost to Follow-up|21|||
149077601|NCT04118894|537763841|FG000|Overall Study|Withdrawal by Subject|10|||
149077602|NCT04118894|537763841|FG000|Overall Study|Adverse Event|4|||
149077603|NCT02556918|537765522|FG000|Overall Study|Protocol Violation|5|||
149077604|NCT02556918|537765523|FG001|Overall Study|Protocol Violation|6|||
149077605|NCT02556918|537765522|FG000|Overall Study|Withdrawal by Subject|4|||
149077606|NCT02556918|537765523|FG001|Overall Study|Withdrawal by Subject|4|||
149077607|NCT04511702|537765531|FG000|Overall Study|Lost to Follow-up|3|||
149077608|NCT04511702|537765532|FG001|Overall Study|Lost to Follow-up|0|||
149077609|NCT04511702|537765533|FG002|Overall Study|Lost to Follow-up|4|||
149077610|NCT04511702|537765531|FG000|Overall Study|Withdrawal by Subject|17|||
149077611|NCT04511702|537765532|FG001|Overall Study|Withdrawal by Subject|1|||
149077612|NCT04511702|537765533|FG002|Overall Study|Withdrawal by Subject|8|||
149077613|NCT00597376|537765535|FG000|Overall Study|Withdrawal by Subject|4|||
149077614|NCT00597376|537765536|FG001|Overall Study|Withdrawal by Subject|3|||
149077615|NCT00597376|537765535|FG000|Overall Study|Adverse Event|4|||
149077616|NCT00597376|537765536|FG001|Overall Study|Adverse Event|1|||
149077617|NCT02634307|537765537|FG000|Overall Study|Adverse Event|50|||
149077618|NCT02634307|537765538|FG001|Overall Study|Adverse Event|24|||
149077619|NCT02634307|537765539|FG002|Overall Study|Adverse Event|14|||
149077620|NCT02634307|537765537|FG000|Overall Study|Lost to Follow-up|21|||
149077621|NCT02634307|537765538|FG001|Overall Study|Lost to Follow-up|5|||
149077622|NCT02634307|537765539|FG002|Overall Study|Lost to Follow-up|6|||
149077623|NCT02634307|537765537|FG000|Overall Study|Pregnancy|5|||
149077624|NCT02634307|537765538|FG001|Overall Study|Pregnancy|1|||
149077625|NCT02634307|537765539|FG002|Overall Study|Pregnancy|3|||
149077626|NCT02634307|537765537|FG000|Overall Study|Withdrawal by Subject|38|||
149077627|NCT02634307|537765538|FG001|Overall Study|Withdrawal by Subject|24|||
149077628|NCT02634307|537765539|FG002|Overall Study|Withdrawal by Subject|18|||
149077629|NCT02634307|537765537|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149077630|NCT02634307|537765538|FG001|Overall Study|Non-Compliance with Study Drug|2|||
149077631|NCT02634307|537765539|FG002|Overall Study|Non-Compliance with Study Drug|2|||
149077632|NCT02634307|537765537|FG000|Overall Study|Lack of Efficacy|1|||
149077633|NCT02634307|537765538|FG001|Overall Study|Lack of Efficacy|5|||
149077634|NCT02634307|537765539|FG002|Overall Study|Lack of Efficacy|3|||
149077635|NCT02634307|537765537|FG000|Overall Study|Physician Decision|7|||
149077636|NCT02634307|537765538|FG001|Overall Study|Physician Decision|5|||
149077637|NCT02634307|537765539|FG002|Overall Study|Physician Decision|5|||
149077638|NCT02634307|537765537|FG000|Overall Study|Reason not Specified|3|||
149077639|NCT02634307|537765538|FG001|Overall Study|Reason not Specified|5|||
149077640|NCT02634307|537765539|FG002|Overall Study|Reason not Specified|10|||
149077641|NCT01214200|537765544|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
149077642|NCT01214200|537765544|FG000|Overall Study|Withdrawal by Subject|2|||
149077643|NCT00667017|537765545|FG000|Overall Study|Withdrawal by Subject|1|||
149077644|NCT01823224|537765546|FG000|Overall Study|Lost to Follow-up|5|||
149077645|NCT01823224|537765547|FG001|Overall Study|Lost to Follow-up|6|||
149077646|NCT01823224|537765546|FG000|Overall Study|didn't qualify|1|||
149077647|NCT01823224|537765547|FG001|Overall Study|didn't qualify|2|||
149077648|NCT01823224|537765546|FG000|Overall Study|pharmacy error|0|||
149077649|NCT01823224|537765547|FG001|Overall Study|pharmacy error|1|||
149077650|NCT01823224|537765546|FG000|Overall Study|missed med dose|0|||
149077651|NCT01823224|537765547|FG001|Overall Study|missed med dose|1|||
149077652|NCT01823224|537765546|FG000|Overall Study|Withdrawal by Subject|0|||
149077653|NCT01823224|537765547|FG001|Overall Study|Withdrawal by Subject|1|||
149077654|NCT01532648|537765548|FG000|Overall Study|Lost to Follow-up|3|||
149077655|NCT01532648|537765549|FG001|Overall Study|Lost to Follow-up|4|||
149077656|NCT01532648|537765548|FG000|Overall Study|Lack of Efficacy|4|||
149077657|NCT01532648|537765549|FG001|Overall Study|Lack of Efficacy|1|||
149077658|NCT01532648|537765548|FG000|Overall Study|Protocol Violation|1|||
149077659|NCT01532648|537765549|FG001|Overall Study|Protocol Violation|1|||
149077660|NCT01532648|537765548|FG000|Overall Study|Adverse Event|12|||
149077661|NCT01532648|537765549|FG001|Overall Study|Adverse Event|9|||
149077662|NCT01532648|537765548|FG000|Overall Study|Withdrawal by Subject|16|||
149077663|NCT01532648|537765549|FG001|Overall Study|Withdrawal by Subject|2|||
149077664|NCT01779050|537765550|FG000|Overall Study|Withdrawal by Subject|1|||
149077665|NCT01779050|537765551|FG001|Overall Study|Withdrawal by Subject|0|||
149077666|NCT01353274|537765552|FG000|Overall Study|No case report form (CRF) collected|28|||
149077667|NCT03737110|537765556|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
149077668|NCT03737110|537765557|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
149077669|NCT03737110|537765558|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
149077670|NCT03737110|537765559|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
149077671|NCT03737110|537765560|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
149077672|NCT03737110|537765561|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
149077673|NCT03737110|537765556|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
149077674|NCT03737110|537765557|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
149077675|NCT03737110|537765558|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
149077676|NCT03737110|537765559|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
149077677|NCT03737110|537765560|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
149077678|NCT03737110|537765561|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
149077679|NCT03737110|537765556|FG000|Run-in (RI) Period|Adverse Event|4|||
149077680|NCT03737110|537765557|FG001|Run-in (RI) Period|Adverse Event|0|||
149077681|NCT03737110|537765558|FG002|Run-in (RI) Period|Adverse Event|0|||
149077682|NCT03737110|537765559|FG003|Run-in (RI) Period|Adverse Event|0|||
149077683|NCT03737110|537765560|FG004|Run-in (RI) Period|Adverse Event|0|||
149077684|NCT03737110|537765561|FG005|Run-in (RI) Period|Adverse Event|0|||
149077685|NCT03737110|537765556|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
149077686|NCT03737110|537765557|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
149077687|NCT03737110|537765558|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
149077688|NCT03737110|537765559|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
149077689|NCT03737110|537765560|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
149077690|NCT03737110|537765561|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
149077691|NCT03737110|537765556|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
149077692|NCT03737110|537765557|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
149077693|NCT03737110|537765558|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
149077694|NCT03737110|537765559|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
149077695|NCT03737110|537765560|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
149077696|NCT03737110|537765561|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
149077697|NCT03737110|537765556|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
149077698|NCT03737110|537765557|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
149077699|NCT03737110|537765558|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
149077700|NCT03737110|537765559|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
149077701|NCT03737110|537765560|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
149077702|NCT03737110|537765561|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
149077703|NCT03737110|537765556|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
149077704|NCT03737110|537765557|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
149077705|NCT03737110|537765558|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
149077706|NCT03737110|537765559|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
149077707|NCT03737110|537765560|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
149077708|NCT03737110|537765561|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
149077709|NCT03737110|537765556|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
149077710|NCT03737110|537765557|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
149077711|NCT03737110|537765558|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
149077712|NCT03737110|537765559|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
149077713|NCT03737110|537765560|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
149077714|NCT03737110|537765561|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
149077715|NCT00670488|537765564|FG000|Overall Study|Adverse Event|0|||
149077716|NCT00670488|537765565|FG001|Overall Study|Adverse Event|7|||
149077717|NCT00670488|537765566|FG002|Overall Study|Adverse Event|0|||
149077718|NCT00670488|537765567|FG003|Overall Study|Adverse Event|3|||
149077719|NCT00670488|537765568|FG004|Overall Study|Adverse Event|1|||
149077720|NCT00670488|537765569|FG005|Overall Study|Adverse Event|1|||
149077721|NCT00670488|537765570|FG006|Overall Study|Adverse Event|5|||
149077722|NCT00670488|537765571|FG007|Overall Study|Adverse Event|1|||
149077723|NCT00670488|537765572|FG008|Overall Study|Adverse Event|0|||
149077724|NCT00670488|537765573|FG009|Overall Study|Adverse Event|1|||
149077725|NCT00670488|537765564|FG000|Overall Study|Physician Decision|1|||
149077726|NCT00670488|537765565|FG001|Overall Study|Physician Decision|9|||
149077727|NCT00670488|537765566|FG002|Overall Study|Physician Decision|0|||
149077728|NCT00670488|537765567|FG003|Overall Study|Physician Decision|1|||
149077729|NCT00670488|537765568|FG004|Overall Study|Physician Decision|0|||
149077730|NCT00670488|537765569|FG005|Overall Study|Physician Decision|0|||
149077731|NCT00670488|537765570|FG006|Overall Study|Physician Decision|0|||
149077732|NCT00670488|537765571|FG007|Overall Study|Physician Decision|0|||
149077733|NCT00670488|537765572|FG008|Overall Study|Physician Decision|0|||
149077734|NCT00670488|537765573|FG009|Overall Study|Physician Decision|0|||
149077735|NCT00670488|537765564|FG000|Overall Study|Progressive Disease|2|||
149077736|NCT00670488|537765565|FG001|Overall Study|Progressive Disease|41|||
149077737|NCT00670488|537765566|FG002|Overall Study|Progressive Disease|3|||
149077738|NCT00670488|537765567|FG003|Overall Study|Progressive Disease|2|||
149077739|NCT00670488|537765568|FG004|Overall Study|Progressive Disease|2|||
149077740|NCT00670488|537765569|FG005|Overall Study|Progressive Disease|4|||
149077741|NCT00670488|537765570|FG006|Overall Study|Progressive Disease|11|||
149077742|NCT00670488|537765571|FG007|Overall Study|Progressive Disease|2|||
149077743|NCT00670488|537765572|FG008|Overall Study|Progressive Disease|2|||
149077744|NCT00670488|537765573|FG009|Overall Study|Progressive Disease|1|||
149077745|NCT00670488|537765564|FG000|Overall Study|Withdrawal by Subject|0|||
149077746|NCT00670488|537765565|FG001|Overall Study|Withdrawal by Subject|1|||
149077747|NCT00670488|537765566|FG002|Overall Study|Withdrawal by Subject|0|||
149077748|NCT00670488|537765567|FG003|Overall Study|Withdrawal by Subject|1|||
149077749|NCT00670488|537765568|FG004|Overall Study|Withdrawal by Subject|0|||
149077750|NCT00670488|537765569|FG005|Overall Study|Withdrawal by Subject|0|||
149077751|NCT00670488|537765570|FG006|Overall Study|Withdrawal by Subject|1|||
149077752|NCT00670488|537765571|FG007|Overall Study|Withdrawal by Subject|0|||
149077753|NCT00670488|537765572|FG008|Overall Study|Withdrawal by Subject|1|||
149077754|NCT00670488|537765573|FG009|Overall Study|Withdrawal by Subject|0|||
149077755|NCT02708498|537765574|FG000|Overall Study|Death|20|||
149077756|NCT02708498|537765575|FG001|Overall Study|Death|19|||
149077757|NCT02708498|537765576|FG002|Overall Study|Death|0|||
149077758|NCT02708498|537765577|FG003|Overall Study|Death|0|||
149077759|NCT02708498|537765578|FG004|Overall Study|Death|1|||
149077760|NCT02708498|537765579|FG005|Overall Study|Death|0|||
149077761|NCT02708498|537765580|FG006|Overall Study|Death|0|||
149077762|NCT02708498|537765581|FG007|Overall Study|Death|0|||
149077763|NCT02708498|537765574|FG000|Overall Study|Unknown reason, missing data|0|||
149077764|NCT02708498|537765575|FG001|Overall Study|Unknown reason, missing data|0|||
149077765|NCT02708498|537765576|FG002|Overall Study|Unknown reason, missing data|62|||
149077766|NCT02708498|537765577|FG003|Overall Study|Unknown reason, missing data|51|||
149077767|NCT02708498|537765578|FG004|Overall Study|Unknown reason, missing data|195|||
149077768|NCT02708498|537765579|FG005|Overall Study|Unknown reason, missing data|132|||
149077769|NCT02708498|537765580|FG006|Overall Study|Unknown reason, missing data|0|||
149077770|NCT02708498|537765581|FG007|Overall Study|Unknown reason, missing data|0|||
149077771|NCT03052517|537765584|FG000|Overall Study|Study Terminated By Sponsor|928|||
149077772|NCT03052517|537765585|FG001|Overall Study|Study Terminated By Sponsor|938|||
149077773|NCT03052517|537765586|FG002|Overall Study|Study Terminated By Sponsor|296|||
149077774|NCT03052517|537765584|FG000|Overall Study|Subject/Guardian Decision|50|||
149077775|NCT03052517|537765585|FG001|Overall Study|Subject/Guardian Decision|45|||
149077776|NCT03052517|537765586|FG002|Overall Study|Subject/Guardian Decision|22|||
149077777|NCT03052517|537765584|FG000|Overall Study|Lack of Efficacy|23|||
149077778|NCT03052517|537765585|FG001|Overall Study|Lack of Efficacy|14|||
149077779|NCT03052517|537765586|FG002|Overall Study|Lack of Efficacy|7|||
149077780|NCT03052517|537765584|FG000|Overall Study|Adverse Event|6|||
149077781|NCT03052517|537765585|FG001|Overall Study|Adverse Event|5|||
149077782|NCT03052517|537765586|FG002|Overall Study|Adverse Event|0|||
149077783|NCT03052517|537765584|FG000|Overall Study|Physician Decision|4|||
149077784|NCT03052517|537765585|FG001|Overall Study|Physician Decision|5|||
149077785|NCT03052517|537765586|FG002|Overall Study|Physician Decision|1|||
149077786|NCT03052517|537765584|FG000|Overall Study|Death|3|||
149077787|NCT03052517|537765585|FG001|Overall Study|Death|0|||
149077788|NCT03052517|537765586|FG002|Overall Study|Death|1|||
149077789|NCT03052517|537765584|FG000|Overall Study|Lost to Follow-up|2|||
149077790|NCT03052517|537765585|FG001|Overall Study|Lost to Follow-up|4|||
149077791|NCT03052517|537765586|FG002|Overall Study|Lost to Follow-up|0|||
149077792|NCT03052517|537765584|FG000|Overall Study|Pregnancy|1|||
149077793|NCT03052517|537765585|FG001|Overall Study|Pregnancy|0|||
149077794|NCT03052517|537765586|FG002|Overall Study|Pregnancy|1|||
149077795|NCT03052517|537765584|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
149077796|NCT03052517|537765585|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
149077797|NCT03052517|537765586|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
149077798|NCT03052517|537765584|FG000|Overall Study|Technical Problems|0|||
149077799|NCT03052517|537765585|FG001|Overall Study|Technical Problems|1|||
149077800|NCT03052517|537765586|FG002|Overall Study|Technical Problems|0|||
149077801|NCT05260437|537765589|FG000|Overall Study|Lost to Follow-up|5|||
149077802|NCT05260437|537765590|FG001|Overall Study|Lost to Follow-up|2|||
149077803|NCT05260437|537765591|FG002|Overall Study|Lost to Follow-up|1|||
149077804|NCT05260437|537765592|FG003|Overall Study|Lost to Follow-up|2|||
149077805|NCT05260437|537765593|FG004|Overall Study|Lost to Follow-up|2|||
149077806|NCT05260437|537765589|FG000|Overall Study|Withdrawal by Subject|3|||
149077807|NCT05260437|537765590|FG001|Overall Study|Withdrawal by Subject|0|||
149077808|NCT05260437|537765591|FG002|Overall Study|Withdrawal by Subject|4|||
149077809|NCT05260437|537765592|FG003|Overall Study|Withdrawal by Subject|5|||
149077810|NCT05260437|537765593|FG004|Overall Study|Withdrawal by Subject|0|||
149077811|NCT05260437|537765589|FG000|Overall Study|Vaccine Not Administered|0|||
149077812|NCT05260437|537765590|FG001|Overall Study|Vaccine Not Administered|1|||
149077813|NCT05260437|537765591|FG002|Overall Study|Vaccine Not Administered|0|||
149077814|NCT05260437|537765592|FG003|Overall Study|Vaccine Not Administered|0|||
149077815|NCT05260437|537765593|FG004|Overall Study|Vaccine Not Administered|0|||
149077816|NCT01858688|537765594|FG000|Overall Study|Withdrawal by Subject|8|||
149077817|NCT01858688|537765594|FG000|Overall Study|Participant began another therapy|3|||
149077818|NCT01858688|537765594|FG000|Overall Study|Physician Decision|2|||
149077819|NCT01858688|537765594|FG000|Overall Study|Progressive Disease|2|||
149077820|NCT01858688|537765594|FG000|Overall Study|Reason not reproted|5|||
149077821|NCT00195819|537765595|FG000|Double-Blind|Withdrawal by Subject|1|||
149077822|NCT00195819|537765596|FG001|Double-Blind|Withdrawal by Subject|0|||
149077823|NCT00195819|537765595|FG000|Double-Blind|Moved|1|||
149077824|NCT00195819|537765596|FG001|Double-Blind|Moved|0|||
149077825|NCT00195819|537765595|FG000|Open-label|Adverse Event|0|||
149077826|NCT00195819|537765596|FG001|Open-label|Adverse Event|9|||
149077827|NCT00195819|537765595|FG000|Open-label|Lack of Efficacy|0|||
149077828|NCT00195819|537765596|FG001|Open-label|Lack of Efficacy|2|||
149077829|NCT00195819|537765595|FG000|Open-label|Pregnancy|0|||
149077830|NCT00195819|537765596|FG001|Open-label|Pregnancy|1|||
149077831|NCT00195819|537765595|FG000|Open-label|Protocol Violation|0|||
149077832|NCT00195819|537765596|FG001|Open-label|Protocol Violation|2|||
149077833|NCT00195819|537765595|FG000|Open-label|Moved|0|||
149077834|NCT00195819|537765596|FG001|Open-label|Moved|1|||
149077835|NCT00195819|537765595|FG000|Open-label|Withdrawal by Subject|0|||
149077836|NCT00195819|537765596|FG001|Open-label|Withdrawal by Subject|5|||
149077837|NCT01124045|537765597|FG000|Overall Study|Lost to Follow-up|0|||
149077838|NCT01124045|537765598|FG001|Overall Study|Lost to Follow-up|1|||
149077839|NCT01124045|537765597|FG000|Overall Study|Physician Decision|0|||
149077840|NCT01124045|537765598|FG001|Overall Study|Physician Decision|2|||
149077841|NCT03298087|537765600|FG000|Overall Study|Withdrawal by Subject|4|||
149077842|NCT01530334|537765601|FG000|Overall Study|Adverse Event|3|||
149077843|NCT01530334|537765601|FG000|Overall Study|unknown reason|1|||
149077844|NCT01530334|537765601|FG000|Overall Study|Progressive disease|47|||
149077845|NCT01303510|537765602|FG000|Overall Study|Lost to Follow-up|1|||
149077846|NCT01303510|537765603|FG001|Overall Study|Lost to Follow-up|0|||
149077847|NCT01485887|537765604|FG000|Overall Study|Withdrawal by Subject|2|||
149077848|NCT01485887|537765604|FG000|Overall Study|Adverse Event|8|||
149077849|NCT01485887|537765604|FG000|Overall Study|Deterioration of primary disease|1|||
149077850|NCT01485887|537765604|FG000|Overall Study|Primary disease markedly improved|1|||
149077851|NCT00822900|537765607|FG000|Overall Study|Withdrawal by Subject|14|||
149077852|NCT00822900|537765608|FG001|Overall Study|Withdrawal by Subject|14|||
149077853|NCT00822900|537765607|FG000|Overall Study|Lost to Follow-up|9|||
149077854|NCT00822900|537765608|FG001|Overall Study|Lost to Follow-up|9|||
149077855|NCT00822900|537765607|FG000|Overall Study|Death|83|||
149077856|NCT00822900|537765608|FG001|Overall Study|Death|69|||
149077857|NCT00822900|537765607|FG000|Overall Study|Became a ward of the state|2|||
149077858|NCT00822900|537765608|FG001|Overall Study|Became a ward of the state|1|||
149077859|NCT03418545|537765609|FG000|Overall Study|Withdrawal by Participant|2|||
149077860|NCT03418545|537765610|FG001|Overall Study|Withdrawal by Participant|4|||
149077861|NCT03418545|537765609|FG000|Overall Study|Lost to Follow-up|3|||
149077862|NCT03418545|537765610|FG001|Overall Study|Lost to Follow-up|5|||
149077863|NCT03418545|537765609|FG000|Overall Study|Reason Not Specified|0|||
149077864|NCT03418545|537765610|FG001|Overall Study|Reason Not Specified|1|||
149077865|NCT03418545|537765609|FG000|Overall Study|Missing Completion Status|0|||
149077866|NCT03418545|537765610|FG001|Overall Study|Missing Completion Status|1|||
149077867|NCT00701415|537765613|FG000|Overall Study|Adverse Event|0|||
149077868|NCT00701415|537765614|FG001|Overall Study|Adverse Event|1|||
149077869|NCT00701415|537765613|FG000|Overall Study|Social/family issues and needle phobia|1|||
149077870|NCT00701415|537765614|FG001|Overall Study|Social/family issues and needle phobia|0|||
149077871|NCT01972776|537765623|FG000|Part 1|Withdrawal by Subject|0|||
149077872|NCT01972776|537765624|FG001|Part 1|Withdrawal by Subject|0|||
149077873|NCT01972776|537765625|FG002|Part 1|Withdrawal by Subject|1|||
149077874|NCT01972776|537765626|FG003|Part 1|Withdrawal by Subject|0|||
149077875|NCT01972776|537765627|FG004|Part 1|Withdrawal by Subject|0|||
149077876|NCT01972776|537765628|FG005|Part 1|Withdrawal by Subject|0|||
149077877|NCT01972776|537765623|FG000|Part 1|Adverse Event|0|||
149077878|NCT01972776|537765624|FG001|Part 1|Adverse Event|0|||
149077879|NCT01972776|537765625|FG002|Part 1|Adverse Event|1|||
149077880|NCT01972776|537765626|FG003|Part 1|Adverse Event|1|||
149077881|NCT01972776|537765627|FG004|Part 1|Adverse Event|0|||
149077882|NCT01972776|537765628|FG005|Part 1|Adverse Event|0|||
149077883|NCT01972776|537765623|FG000|Part 2|Adverse Event|0|||
149077884|NCT01972776|537765624|FG001|Part 2|Adverse Event|0|||
149077885|NCT01972776|537765625|FG002|Part 2|Adverse Event|0|||
149077886|NCT01972776|537765626|FG003|Part 2|Adverse Event|0|||
149077887|NCT01972776|537765627|FG004|Part 2|Adverse Event|3|||
149077888|NCT01972776|537765628|FG005|Part 2|Adverse Event|0|||
149077889|NCT01972776|537765623|FG000|Part 2|Administrative problems|0|||
149077890|NCT01972776|537765624|FG001|Part 2|Administrative problems|0|||
149077891|NCT01972776|537765625|FG002|Part 2|Administrative problems|0|||
149077892|NCT01972776|537765626|FG003|Part 2|Administrative problems|0|||
149077893|NCT01972776|537765627|FG004|Part 2|Administrative problems|10|||
149077894|NCT01972776|537765628|FG005|Part 2|Administrative problems|7|||
149077895|NCT02106884|537765629|FG000|Overall Study|Change of diagnosis/exclusion|0|||
149077896|NCT02106884|537765630|FG001|Overall Study|Change of diagnosis/exclusion|1|||
149077897|NCT03162614|537765638|FG000|Overall Study|Lost to Follow-up|2|||
149077898|NCT03162614|537765639|FG001|Overall Study|Lost to Follow-up|1|||
149077899|NCT03162614|537765640|FG002|Overall Study|Lost to Follow-up|1|||
149077900|NCT03162614|537765641|FG003|Overall Study|Lost to Follow-up|1|||
149077901|NCT03162614|537765642|FG004|Overall Study|Lost to Follow-up|2|||
149077902|NCT03162614|537765643|FG005|Overall Study|Lost to Follow-up|0|||
149077903|NCT03162614|537765638|FG000|Overall Study|Protocol Violation|0|||
149077904|NCT03162614|537765639|FG001|Overall Study|Protocol Violation|1|||
149077905|NCT03162614|537765640|FG002|Overall Study|Protocol Violation|0|||
149077906|NCT03162614|537765641|FG003|Overall Study|Protocol Violation|1|||
149077907|NCT03162614|537765642|FG004|Overall Study|Protocol Violation|0|||
149077908|NCT03162614|537765643|FG005|Overall Study|Protocol Violation|0|||
149077909|NCT03162614|537765638|FG000|Overall Study|Withdrawal by Subject|2|||
149077910|NCT03162614|537765639|FG001|Overall Study|Withdrawal by Subject|1|||
149077911|NCT03162614|537765640|FG002|Overall Study|Withdrawal by Subject|1|||
149077912|NCT03162614|537765641|FG003|Overall Study|Withdrawal by Subject|1|||
149077913|NCT03162614|537765642|FG004|Overall Study|Withdrawal by Subject|0|||
149077914|NCT03162614|537765643|FG005|Overall Study|Withdrawal by Subject|0|||
149077915|NCT03162614|537765638|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
149077916|NCT03162614|537765639|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
149077917|NCT03162614|537765640|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
149077918|NCT03162614|537765641|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
149077919|NCT03162614|537765642|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
149077920|NCT03162614|537765643|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
149077921|NCT04638816|537765644|FG000|Overall Study|Withdrawal by Subject|0|||
149077922|NCT04638816|537765645|FG001|Overall Study|Withdrawal by Subject|1|||
149077923|NCT04638816|537765644|FG000|Overall Study|Lost to Follow-up|0|||
149077924|NCT04638816|537765645|FG001|Overall Study|Lost to Follow-up|1|||
149077925|NCT02251652|537765646|FG000|Overall Study|Withdrawal by Subject|1|||
149077926|NCT00109031|537765649|FG000|Overall Study|Adverse Event|0|||
149077927|NCT00109031|537765650|FG001|Overall Study|Adverse Event|0|||
149077928|NCT00109031|537765651|FG002|Overall Study|Adverse Event|1|||
149077929|NCT00109031|537765652|FG003|Overall Study|Adverse Event|0|||
149077930|NCT00109031|537765649|FG000|Overall Study|Withdrawal by Subject|0|||
149077931|NCT00109031|537765650|FG001|Overall Study|Withdrawal by Subject|1|||
149077932|NCT00109031|537765651|FG002|Overall Study|Withdrawal by Subject|0|||
149077933|NCT00109031|537765652|FG003|Overall Study|Withdrawal by Subject|0|||
149077934|NCT00109031|537765649|FG000|Overall Study|Physician Decision|0|||
149077935|NCT00109031|537765650|FG001|Overall Study|Physician Decision|1|||
149077936|NCT00109031|537765651|FG002|Overall Study|Physician Decision|0|||
149077937|NCT00109031|537765652|FG003|Overall Study|Physician Decision|0|||
149077938|NCT00109031|537765649|FG000|Overall Study|Protocol Violation|0|||
149077939|NCT00109031|537765650|FG001|Overall Study|Protocol Violation|0|||
149077940|NCT00109031|537765651|FG002|Overall Study|Protocol Violation|1|||
149077941|NCT00109031|537765652|FG003|Overall Study|Protocol Violation|0|||
149077942|NCT01822756|537765653|FG000|Overall Study|Adverse Event|0|||
149077943|NCT01822756|537765654|FG001|Overall Study|Adverse Event|0|||
149077944|NCT01822756|537765655|FG002|Overall Study|Adverse Event|0|||
149077945|NCT01822756|537765656|FG003|Overall Study|Adverse Event|2|||
149077946|NCT01822756|537765657|FG004|Overall Study|Adverse Event|0|||
149077947|NCT01822756|537765653|FG000|Overall Study|Disease progression|11|||
149077948|NCT01822756|537765654|FG001|Overall Study|Disease progression|1|||
149077949|NCT01822756|537765655|FG002|Overall Study|Disease progression|7|||
149077950|NCT01822756|537765656|FG003|Overall Study|Disease progression|2|||
149077951|NCT01822756|537765657|FG004|Overall Study|Disease progression|6|||
149077952|NCT01822756|537765653|FG000|Overall Study|Death|2|||
149077953|NCT01822756|537765654|FG001|Overall Study|Death|2|||
149077954|NCT01822756|537765655|FG002|Overall Study|Death|1|||
149077955|NCT01822756|537765656|FG003|Overall Study|Death|0|||
149077956|NCT01822756|537765657|FG004|Overall Study|Death|0|||
149077957|NCT01822756|537765653|FG000|Overall Study|Lost to Follow-up|1|||
149077958|NCT01822756|537765654|FG001|Overall Study|Lost to Follow-up|0|||
149077959|NCT01822756|537765655|FG002|Overall Study|Lost to Follow-up|1|||
149077960|NCT01822756|537765656|FG003|Overall Study|Lost to Follow-up|0|||
149077961|NCT01822756|537765657|FG004|Overall Study|Lost to Follow-up|1|||
149077962|NCT01822756|537765653|FG000|Overall Study|Physician Decision|0|||
149077963|NCT01822756|537765654|FG001|Overall Study|Physician Decision|1|||
149077964|NCT01822756|537765655|FG002|Overall Study|Physician Decision|0|||
149077965|NCT01822756|537765656|FG003|Overall Study|Physician Decision|0|||
149077966|NCT01822756|537765657|FG004|Overall Study|Physician Decision|0|||
149077967|NCT01822756|537765653|FG000|Overall Study|disease progression & patient preference|2|||
149077968|NCT01822756|537765654|FG001|Overall Study|disease progression & patient preference|0|||
149077969|NCT01822756|537765655|FG002|Overall Study|disease progression & patient preference|1|||
149077970|NCT01822756|537765656|FG003|Overall Study|disease progression & patient preference|0|||
149077971|NCT01822756|537765657|FG004|Overall Study|disease progression & patient preference|0|||
149077972|NCT02208843|537765658|FG000|Overall Study|Clinical symptoms of progression|2|||
149077973|NCT02208843|537765658|FG000|Overall Study|Progression disease according to RECIST|24|||
149077974|NCT02208843|537765658|FG000|Overall Study|Adverse Event|12|||
149077975|NCT02208843|537765658|FG000|Overall Study|Protocol Violation|1|||
149077976|NCT02208843|537765658|FG000|Overall Study|Withdrawal by Subject|1|||
149077977|NCT02208843|537765658|FG000|Overall Study|Switched to commercial afatinib|20|||
149077978|NCT01321073|537765663|FG000|Overall Study|Did not attempt implant|4|||
149077979|NCT01321073|537765663|FG000|Overall Study|Death|3|||
149077980|NCT02969356|537765674|FG000|Overall Study|Adverse Event|7|||
149077981|NCT02969356|537765674|FG000|Overall Study|Consent withdrawn|2|||
149077982|NCT02969356|537765674|FG000|Overall Study|Lost to Follow-up|3|||
149077983|NCT02969356|537765674|FG000|Overall Study|Did not need to be reinjected|6|||
149077984|NCT02969356|537765674|FG000|Overall Study|Personal reasons|5|||
149077985|NCT00108355|537767265|FG000|Overall Study|Peritonitis at index paracentesis|1|||
149077986|NCT00108355|537767266|FG001|Overall Study|Peritonitis at index paracentesis|1|||
149077987|NCT00108355|537767265|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
149077988|NCT00108355|537767266|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
149077989|NCT04992273|537767267|FG000|Overall Study|Lost to Follow-up|0|||
149077990|NCT04992273|537767268|FG001|Overall Study|Lost to Follow-up|1|||
149077991|NCT01364597|537767269|FG000|Overall Study|Adverse Event|4|||
149077992|NCT01364597|537767270|FG001|Overall Study|Adverse Event|5|||
149077993|NCT01364597|537767271|FG002|Overall Study|Adverse Event|16|||
149077994|NCT01364597|537767272|FG003|Overall Study|Adverse Event|7|||
149077995|NCT01364597|537767269|FG000|Overall Study|Lack of Efficacy|4|||
149077996|NCT01364597|537767270|FG001|Overall Study|Lack of Efficacy|4|||
149077997|NCT01364597|537767271|FG002|Overall Study|Lack of Efficacy|23|||
149077998|NCT01364597|537767272|FG003|Overall Study|Lack of Efficacy|8|||
149077999|NCT01364597|537767269|FG000|Overall Study|Protocol Violation|0|||
149078000|NCT01364597|537767270|FG001|Overall Study|Protocol Violation|0|||
149078001|NCT01364597|537767271|FG002|Overall Study|Protocol Violation|2|||
149078002|NCT01364597|537767272|FG003|Overall Study|Protocol Violation|0|||
149078003|NCT01364597|537767269|FG000|Overall Study|Lost to Follow-up|0|||
149078004|NCT01364597|537767270|FG001|Overall Study|Lost to Follow-up|0|||
149078005|NCT01364597|537767271|FG002|Overall Study|Lost to Follow-up|5|||
149078006|NCT01364597|537767272|FG003|Overall Study|Lost to Follow-up|3|||
149078007|NCT01364597|537767269|FG000|Overall Study|Withdrawal by Subject|4|||
149078008|NCT01364597|537767270|FG001|Overall Study|Withdrawal by Subject|1|||
149078009|NCT01364597|537767271|FG002|Overall Study|Withdrawal by Subject|18|||
149078010|NCT01364597|537767272|FG003|Overall Study|Withdrawal by Subject|6|||
149078011|NCT01364597|537767269|FG000|Overall Study|Non compliance|1|||
149078012|NCT01364597|537767270|FG001|Overall Study|Non compliance|0|||
149078013|NCT01364597|537767271|FG002|Overall Study|Non compliance|1|||
149078014|NCT01364597|537767272|FG003|Overall Study|Non compliance|0|||
149078015|NCT01364597|537767269|FG000|Overall Study|Lack of compliance|1|||
149078016|NCT01364597|537767270|FG001|Overall Study|Lack of compliance|0|||
149078017|NCT01364597|537767271|FG002|Overall Study|Lack of compliance|0|||
149078018|NCT01364597|537767272|FG003|Overall Study|Lack of compliance|0|||
149078019|NCT01364597|537767269|FG000|Overall Study|End of treatment epilepsy|1|||
149078020|NCT01364597|537767270|FG001|Overall Study|End of treatment epilepsy|0|||
149078021|NCT01364597|537767271|FG002|Overall Study|End of treatment epilepsy|0|||
149078022|NCT01364597|537767272|FG003|Overall Study|End of treatment epilepsy|0|||
149078023|NCT01364597|537767269|FG000|Overall Study|No Seizures|1|||
149078024|NCT01364597|537767270|FG001|Overall Study|No Seizures|0|||
149078025|NCT01364597|537767271|FG002|Overall Study|No Seizures|0|||
149078026|NCT01364597|537767272|FG003|Overall Study|No Seizures|0|||
149078027|NCT01364597|537767269|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
149078028|NCT01364597|537767270|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
149078029|NCT01364597|537767271|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
149078030|NCT01364597|537767272|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
149078031|NCT01364597|537767269|FG000|Overall Study|Cure|1|||
149078032|NCT01364597|537767270|FG001|Overall Study|Cure|0|||
149078033|NCT01364597|537767271|FG002|Overall Study|Cure|0|||
149078034|NCT01364597|537767272|FG003|Overall Study|Cure|0|||
149078035|NCT01364597|537767269|FG000|Overall Study|Patient was moving|0|||
149078036|NCT01364597|537767270|FG001|Overall Study|Patient was moving|1|||
149078037|NCT01364597|537767271|FG002|Overall Study|Patient was moving|0|||
149078038|NCT01364597|537767272|FG003|Overall Study|Patient was moving|0|||
149078039|NCT01364597|537767269|FG000|Overall Study|Seizures resolved|0|||
149078040|NCT01364597|537767270|FG001|Overall Study|Seizures resolved|0|||
149078041|NCT01364597|537767271|FG002|Overall Study|Seizures resolved|1|||
149078042|NCT01364597|537767272|FG003|Overall Study|Seizures resolved|0|||
149078043|NCT01364597|537767269|FG000|Overall Study|Patient became seizure-free after surgery|0|||
149078044|NCT01364597|537767270|FG001|Overall Study|Patient became seizure-free after surgery|0|||
149078045|NCT01364597|537767271|FG002|Overall Study|Patient became seizure-free after surgery|1|||
149078046|NCT01364597|537767272|FG003|Overall Study|Patient became seizure-free after surgery|0|||
149078047|NCT01364597|537767269|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
149078048|NCT01364597|537767270|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
149078049|NCT01364597|537767271|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
149078050|NCT01364597|537767272|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
149078051|NCT01364597|537767269|FG000|Overall Study|Patient cured from Epilepsy|0|||
149078052|NCT01364597|537767270|FG001|Overall Study|Patient cured from Epilepsy|0|||
149078053|NCT01364597|537767271|FG002|Overall Study|Patient cured from Epilepsy|1|||
149078054|NCT01364597|537767272|FG003|Overall Study|Patient cured from Epilepsy|0|||
149078055|NCT01364597|537767269|FG000|Overall Study|Investigator decision|0|||
149078056|NCT01364597|537767270|FG001|Overall Study|Investigator decision|0|||
149078057|NCT01364597|537767271|FG002|Overall Study|Investigator decision|1|||
149078058|NCT01364597|537767272|FG003|Overall Study|Investigator decision|0|||
149078059|NCT01364597|537767269|FG000|Overall Study|Sponsor recommended discontinuation|0|||
149078060|NCT01364597|537767270|FG001|Overall Study|Sponsor recommended discontinuation|0|||
149078061|NCT01364597|537767271|FG002|Overall Study|Sponsor recommended discontinuation|0|||
149078062|NCT01364597|537767272|FG003|Overall Study|Sponsor recommended discontinuation|1|||
149078063|NCT01364597|537767269|FG000|Overall Study|Parents went abroad with the patient|0|||
149078064|NCT01364597|537767270|FG001|Overall Study|Parents went abroad with the patient|0|||
149078065|NCT01364597|537767271|FG002|Overall Study|Parents went abroad with the patient|1|||
149078066|NCT01364597|537767272|FG003|Overall Study|Parents went abroad with the patient|0|||
149078067|NCT01364597|537767269|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
149078068|NCT01364597|537767270|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
149078069|NCT01364597|537767271|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
149078070|NCT01364597|537767272|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
149078071|NCT01364597|537767269|FG000|Overall Study|BRV administration dropout|0|||
149078072|NCT01364597|537767270|FG001|Overall Study|BRV administration dropout|0|||
149078073|NCT01364597|537767271|FG002|Overall Study|BRV administration dropout|1|||
149078074|NCT01364597|537767272|FG003|Overall Study|BRV administration dropout|0|||
149078075|NCT01364597|537767269|FG000|Overall Study|Dropout|0|||
149078076|NCT01364597|537767270|FG001|Overall Study|Dropout|0|||
149078077|NCT01364597|537767271|FG002|Overall Study|Dropout|3|||
149078078|NCT01364597|537767272|FG003|Overall Study|Dropout|1|||
149078079|NCT01364597|537767269|FG000|Overall Study|Unreliable subject|0|||
149078080|NCT01364597|537767270|FG001|Overall Study|Unreliable subject|0|||
149078081|NCT01364597|537767271|FG002|Overall Study|Unreliable subject|0|||
149078082|NCT01364597|537767272|FG003|Overall Study|Unreliable subject|1|||
149078083|NCT01364597|537767269|FG000|Overall Study|Other|0|||
149078084|NCT01364597|537767270|FG001|Overall Study|Other|0|||
149078085|NCT01364597|537767271|FG002|Overall Study|Other|0|||
149078086|NCT01364597|537767272|FG003|Overall Study|Other|1|||
149078087|NCT03493282|537767276|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
149078088|NCT03493282|537767277|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
149078089|NCT03493282|537767278|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
149078090|NCT03493282|537767276|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
149078091|NCT03493282|537767277|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
149078092|NCT03493282|537767278|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
149078093|NCT01380145|537767279|FG000|Overall Study|Progressive disease|4|||
149078094|NCT02698475|537767280|FG000|Main Study Period|Lack of Efficacy|1|||
149078095|NCT02698475|537767280|FG000|Main Study Period|Protocol Violation|2|||
149078096|NCT02698475|537767280|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
149078097|NCT02698475|537767280|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
149120380|NCT02559895|537918092|FG002|Overall Study|Study Burden|12|||
149078098|NCT02698475|537767280|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
149078099|NCT02698475|537767280|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
149078100|NCT02698475|537767280|FG000|Long-Term Extension Period|Other|1|||
149078101|NCT02038049|537767281|FG000|Overall Study|Lost to Follow-up|1|||
149078102|NCT02038049|537767282|FG001|Overall Study|Lost to Follow-up|0|||
149078103|NCT02771366|537767283|FG000|Period 1|Withdrawal by Subject|0|||
149078104|NCT02771366|537767284|FG001|Period 1|Withdrawal by Subject|2|||
149078105|NCT02771366|537767283|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
149078106|NCT02771366|537767284|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
149078107|NCT00587171|537767287|FG000|Overall Study|Lost to Follow-up|1|||
149078108|NCT00587171|537767288|FG001|Overall Study|Lost to Follow-up|1|||
149078109|NCT02148705|537767292|FG000|Overall Study|Death|2|||
149078110|NCT02148705|537767293|FG001|Overall Study|Death|0|||
149078111|NCT02148705|537767294|FG002|Overall Study|Death|0|||
149078112|NCT02148705|537767292|FG000|Overall Study|Lost to Follow-up|13|||
149078113|NCT02148705|537767293|FG001|Overall Study|Lost to Follow-up|4|||
149078114|NCT02148705|537767294|FG002|Overall Study|Lost to Follow-up|10|||
149078115|NCT02148705|537767292|FG000|Overall Study|Withdrawal by Subject|3|||
149078116|NCT02148705|537767293|FG001|Overall Study|Withdrawal by Subject|0|||
149078117|NCT02148705|537767294|FG002|Overall Study|Withdrawal by Subject|2|||
149078118|NCT02148705|537767292|FG000|Overall Study|Not Treated|0|||
149078119|NCT02148705|537767293|FG001|Overall Study|Not Treated|1|||
149078120|NCT02148705|537767294|FG002|Overall Study|Not Treated|5|||
149078121|NCT01737021|537767297|FG000|Overall Study|Lost to Follow-up|5|||
149078122|NCT01737021|537767298|FG001|Overall Study|Lost to Follow-up|3|||
149078123|NCT01673594|537767299|FG000|Overall Study|Adverse Event|3|||
149078124|NCT01673594|537767300|FG001|Overall Study|Adverse Event|1|||
149078125|NCT01673594|537767299|FG000|Overall Study|Lost to Follow-up|1|||
149078126|NCT01673594|537767300|FG001|Overall Study|Lost to Follow-up|0|||
149078127|NCT01673594|537767299|FG000|Overall Study|Physician Decision|2|||
149078128|NCT01673594|537767300|FG001|Overall Study|Physician Decision|4|||
149078129|NCT01673594|537767299|FG000|Overall Study|Withdrawal by Subject|0|||
149078130|NCT01673594|537767300|FG001|Overall Study|Withdrawal by Subject|1|||
149078131|NCT02605174|537767304|FG000|Overall Study|Adverse Event|0|||
149078132|NCT02605174|537767305|FG001|Overall Study|Adverse Event|0|||
149078133|NCT02605174|537767306|FG002|Overall Study|Adverse Event|1|||
149078134|NCT02605174|537767307|FG003|Overall Study|Adverse Event|0|||
149006303|NCT05044325|537501811|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
149006304|NCT00755222|537501812|FG000|Overall Study|Withdrawal by Subject|4|||
149006305|NCT00755222|537501813|FG001|Overall Study|Withdrawal by Subject|2|||
149006306|NCT00755222|537501812|FG000|Overall Study|Adverse Event|2|||
149006307|NCT00755222|537501813|FG001|Overall Study|Adverse Event|0|||
149006308|NCT00755222|537501812|FG000|Overall Study|Protocol Violation|2|||
149006309|NCT00755222|537501813|FG001|Overall Study|Protocol Violation|0|||
149006310|NCT00742079|537501824|FG000|Overall Study|Lost to Follow-up|0|||
149006311|NCT00742079|537501825|FG001|Overall Study|Lost to Follow-up|1|||
149006312|NCT02243202|537501826|FG000|Overall Study|Adverse Event|5|||
149006313|NCT02243202|537501827|FG001|Overall Study|Adverse Event|6|||
149006314|NCT02243202|537501828|FG002|Overall Study|Adverse Event|10|||
149006315|NCT02243202|537501829|FG003|Overall Study|Adverse Event|4|||
149006316|NCT02243202|537501826|FG000|Overall Study|Lost to Follow-up|9|||
149006317|NCT02243202|537501827|FG001|Overall Study|Lost to Follow-up|9|||
149006318|NCT02243202|537501828|FG002|Overall Study|Lost to Follow-up|14|||
149006319|NCT02243202|537501829|FG003|Overall Study|Lost to Follow-up|11|||
149006320|NCT02243202|537501826|FG000|Overall Study|Protocol Violation|3|||
149006321|NCT02243202|537501827|FG001|Overall Study|Protocol Violation|1|||
149006322|NCT02243202|537501828|FG002|Overall Study|Protocol Violation|2|||
149006323|NCT02243202|537501829|FG003|Overall Study|Protocol Violation|1|||
149006324|NCT02243202|537501826|FG000|Overall Study|Withdrawal by Subject|7|||
149006325|NCT02243202|537501827|FG001|Overall Study|Withdrawal by Subject|6|||
149006326|NCT02243202|537501828|FG002|Overall Study|Withdrawal by Subject|4|||
149006327|NCT02243202|537501829|FG003|Overall Study|Withdrawal by Subject|4|||
149006328|NCT02243202|537501826|FG000|Overall Study|Other|1|||
149006329|NCT02243202|537501827|FG001|Overall Study|Other|3|||
149006330|NCT02243202|537501828|FG002|Overall Study|Other|1|||
149006331|NCT02243202|537501829|FG003|Overall Study|Other|2|||
149006332|NCT02243202|537501826|FG000|Overall Study|Randomized but not received treatment|0|||
149006333|NCT02243202|537501827|FG001|Overall Study|Randomized but not received treatment|0|||
149006334|NCT02243202|537501828|FG002|Overall Study|Randomized but not received treatment|0|||
149006335|NCT02243202|537501829|FG003|Overall Study|Randomized but not received treatment|1|||
149006336|NCT04382924|537501831|FG000|Overall Study|Death|2|||
149006337|NCT04382924|537501832|FG001|Overall Study|Death|5|||
149006338|NCT04382924|537501833|FG002|Overall Study|Death|4|||
149006339|NCT04382924|537501831|FG000|Overall Study|Protocol Violation|0|||
149006340|NCT04382924|537501832|FG001|Overall Study|Protocol Violation|1|||
149006341|NCT04382924|537501833|FG002|Overall Study|Protocol Violation|1|||
149006342|NCT04382924|537501831|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
149078135|NCT02605174|537767308|FG004|Overall Study|Adverse Event|4|||
149078136|NCT02605174|537767309|FG005|Overall Study|Adverse Event|0|||
149078137|NCT02605174|537767310|FG006|Overall Study|Adverse Event|0|||
149078138|NCT02605174|537767304|FG000|Overall Study|Lost to Follow-up|20|||
149078139|NCT02605174|537767305|FG001|Overall Study|Lost to Follow-up|7|||
149078140|NCT02605174|537767306|FG002|Overall Study|Lost to Follow-up|27|||
149078141|NCT02605174|537767307|FG003|Overall Study|Lost to Follow-up|10|||
149078142|NCT02605174|537767308|FG004|Overall Study|Lost to Follow-up|20|||
149078143|NCT02605174|537767309|FG005|Overall Study|Lost to Follow-up|10|||
149078144|NCT02605174|537767310|FG006|Overall Study|Lost to Follow-up|29|||
149078145|NCT02605174|537767304|FG000|Overall Study|Protocol Violation|10|||
149078146|NCT02605174|537767305|FG001|Overall Study|Protocol Violation|4|||
149078147|NCT02605174|537767306|FG002|Overall Study|Protocol Violation|14|||
149078148|NCT02605174|537767307|FG003|Overall Study|Protocol Violation|6|||
149078149|NCT02605174|537767308|FG004|Overall Study|Protocol Violation|7|||
149078150|NCT02605174|537767309|FG005|Overall Study|Protocol Violation|7|||
149078151|NCT02605174|537767310|FG006|Overall Study|Protocol Violation|12|||
149078152|NCT02605174|537767304|FG000|Overall Study|Pregnancy|1|||
149078153|NCT02605174|537767305|FG001|Overall Study|Pregnancy|0|||
149078154|NCT02605174|537767306|FG002|Overall Study|Pregnancy|0|||
149078155|NCT02605174|537767307|FG003|Overall Study|Pregnancy|2|||
149078156|NCT02605174|537767308|FG004|Overall Study|Pregnancy|0|||
149078157|NCT02605174|537767309|FG005|Overall Study|Pregnancy|0|||
149078158|NCT02605174|537767310|FG006|Overall Study|Pregnancy|0|||
149078159|NCT02605174|537767304|FG000|Overall Study|Withdrawal by Subject|9|||
149078160|NCT02605174|537767305|FG001|Overall Study|Withdrawal by Subject|6|||
149078161|NCT02605174|537767306|FG002|Overall Study|Withdrawal by Subject|14|||
149078162|NCT02605174|537767307|FG003|Overall Study|Withdrawal by Subject|11|||
149078163|NCT02605174|537767308|FG004|Overall Study|Withdrawal by Subject|6|||
149078164|NCT02605174|537767309|FG005|Overall Study|Withdrawal by Subject|4|||
149078165|NCT02605174|537767310|FG006|Overall Study|Withdrawal by Subject|15|||
149078166|NCT02605174|537767304|FG000|Overall Study|Physician Decision|2|||
149078167|NCT02605174|537767305|FG001|Overall Study|Physician Decision|0|||
149078168|NCT02605174|537767306|FG002|Overall Study|Physician Decision|0|||
149078169|NCT02605174|537767307|FG003|Overall Study|Physician Decision|0|||
149078170|NCT02605174|537767308|FG004|Overall Study|Physician Decision|0|||
149078171|NCT02605174|537767309|FG005|Overall Study|Physician Decision|0|||
149078172|NCT02605174|537767310|FG006|Overall Study|Physician Decision|3|||
149078173|NCT02605174|537767304|FG000|Overall Study|Randomization Failure|22|||
149078174|NCT02605174|537767305|FG001|Overall Study|Randomization Failure|6|||
149078175|NCT02605174|537767306|FG002|Overall Study|Randomization Failure|20|||
149078176|NCT02605174|537767307|FG003|Overall Study|Randomization Failure|7|||
149078177|NCT02605174|537767308|FG004|Overall Study|Randomization Failure|16|||
149078178|NCT02605174|537767309|FG005|Overall Study|Randomization Failure|11|||
149078179|NCT02605174|537767310|FG006|Overall Study|Randomization Failure|30|||
149078180|NCT04250636|537767311|FG000|Overall Study|Lost to Follow-up|2|||
149078181|NCT00022672|537767313|FG000|Main Phase: 24 Months|Adverse Event|6|||
149078182|NCT00022672|537767314|FG001|Main Phase: 24 Months|Adverse Event|0|||
149078183|NCT00022672|537767313|FG000|Main Phase: 24 Months|Death|0|||
149078184|NCT00022672|537767314|FG001|Main Phase: 24 Months|Death|3|||
149078185|NCT00022672|537767313|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
149078186|NCT00022672|537767314|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
149078187|NCT00022672|537767313|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
149078188|NCT00022672|537767314|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
149078189|NCT00022672|537767313|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
149078190|NCT00022672|537767314|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
149078191|NCT00022672|537767313|FG000|Main Phase: 24 Months|Refused Treatment|3|||
149078192|NCT00022672|537767314|FG001|Main Phase: 24 Months|Refused Treatment|4|||
149078193|NCT00022672|537767313|FG000|Main Phase: 24 Months|Failure to Return|1|||
149078194|NCT00022672|537767314|FG001|Main Phase: 24 Months|Failure to Return|1|||
149078195|NCT00022672|537767313|FG000|Main Phase: 24 Months|Other|1|||
149078196|NCT00022672|537767314|FG001|Main Phase: 24 Months|Other|0|||
149078197|NCT00022672|537767313|FG000|Extension Phase|Adverse Event|1|||
149078198|NCT00022672|537767314|FG001|Extension Phase|Adverse Event|3|||
149078199|NCT00022672|537767313|FG000|Extension Phase|Death|0|||
149078200|NCT00022672|537767314|FG001|Extension Phase|Death|1|||
149078201|NCT00022672|537767313|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
149078202|NCT00022672|537767314|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
149078203|NCT00022672|537767313|FG000|Extension Phase|Refused Treatment|0|||
149078204|NCT00022672|537767314|FG001|Extension Phase|Refused Treatment|2|||
149078205|NCT00022672|537767313|FG000|Extension Phase|Other|1|||
149078206|NCT00022672|537767314|FG001|Extension Phase|Other|1|||
149078207|NCT00403494|537767315|FG000|Overall Study|Adverse Event|10|||
149078208|NCT00403494|537767316|FG001|Overall Study|Adverse Event|8|||
149078209|NCT00403494|537767315|FG000|Overall Study|Withdrew Consent|3|||
149078210|NCT00403494|537767316|FG001|Overall Study|Withdrew Consent|2|||
149078211|NCT00403494|537767315|FG000|Overall Study|Inappropriately enrolled|0|||
149078212|NCT00403494|537767316|FG001|Overall Study|Inappropriately enrolled|1|||
149078213|NCT00403494|537767315|FG000|Overall Study|Lost to Follow-up|0|||
149078214|NCT00403494|537767316|FG001|Overall Study|Lost to Follow-up|2|||
149078215|NCT00403494|537767315|FG000|Overall Study|Protocol noncompliance|0|||
149078216|NCT00403494|537767316|FG001|Overall Study|Protocol noncompliance|1|||
149078217|NCT00403494|537767315|FG000|Overall Study|Death|1|||
149078218|NCT00403494|537767316|FG001|Overall Study|Death|0|||
149078219|NCT00403494|537767315|FG000|Overall Study|Sponsor Request|1|||
149078220|NCT00403494|537767316|FG001|Overall Study|Sponsor Request|0|||
149078221|NCT03648541|537767317|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
149078222|NCT03648541|537767318|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
149078223|NCT03648541|537767317|FG000|Re-induction Period Only|Lack of Efficacy|7|||
149078224|NCT03648541|537767318|FG001|Re-induction Period Only|Lack of Efficacy|0|||
149078225|NCT03648541|537767317|FG000|Maintenance Period Only|Missing|0|||
149078226|NCT03648541|537767318|FG001|Maintenance Period Only|Missing|1|||
149078227|NCT03648541|537767317|FG000|Maintenance Period Only|Other not listed below|0|||
149078228|NCT03648541|537767318|FG001|Maintenance Period Only|Other not listed below|4|||
149078229|NCT03648541|537767317|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
149078230|NCT03648541|537767318|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
149078231|NCT03648541|537767317|FG000|Maintenance Period Only|Protocol Violation|0|||
149078232|NCT03648541|537767318|FG001|Maintenance Period Only|Protocol Violation|1|||
149078233|NCT03648541|537767317|FG000|Maintenance Period Only|Lack of Efficacy|0|||
149078234|NCT03648541|537767318|FG001|Maintenance Period Only|Lack of Efficacy|18|||
149078235|NCT03648541|537767317|FG000|Maintenance Period Only|Adverse Event|0|||
149078236|NCT03648541|537767318|FG001|Maintenance Period Only|Adverse Event|4|||
149078237|NCT03648541|537767317|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
149078238|NCT03648541|537767318|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
149078239|NCT04658784|537767319|FG000|6-month Follow-up|Lost to Follow-up|2|||
149078240|NCT04658784|537767320|FG001|6-month Follow-up|Lost to Follow-up|5|||
149078241|NCT02958553|537767321|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
149078242|NCT02958553|537767321|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
149078243|NCT00273052|537767329|FG000|Overall Study|Withdrawal by Subject|16|||
149078244|NCT00273052|537767330|FG001|Overall Study|Withdrawal by Subject|19|||
149078245|NCT00273052|537767329|FG000|Overall Study|Adverse Event|21|||
149078246|NCT00273052|537767330|FG001|Overall Study|Adverse Event|19|||
149078247|NCT00273052|537767329|FG000|Overall Study|Protocol Violation|14|||
149078248|NCT00273052|537767330|FG001|Overall Study|Protocol Violation|18|||
149078249|NCT00273052|537767329|FG000|Overall Study|Lost to Follow-up|7|||
149078250|NCT00273052|537767330|FG001|Overall Study|Lost to Follow-up|25|||
149078251|NCT00273052|537767329|FG000|Overall Study|Lack of Efficacy|6|||
149078252|NCT00273052|537767330|FG001|Overall Study|Lack of Efficacy|4|||
149078253|NCT00273052|537767329|FG000|Overall Study|Non-Compliance|3|||
149078254|NCT00273052|537767330|FG001|Overall Study|Non-Compliance|1|||
149078255|NCT00273052|537767329|FG000|Overall Study|Other|2|||
149078256|NCT00273052|537767330|FG001|Overall Study|Other|0|||
149078257|NCT00273052|537767329|FG000|Overall Study|Worsening serum lipid levels|0|||
149078258|NCT00273052|537767330|FG001|Overall Study|Worsening serum lipid levels|2|||
149078259|NCT01852045|537767333|FG000|Overall Study|Adverse Event|1|||
149078260|NCT01852045|537767334|FG001|Overall Study|Adverse Event|0|||
149078261|NCT01852045|537767335|FG002|Overall Study|Adverse Event|0|||
149078262|NCT01852045|537767333|FG000|Overall Study|Lack of Efficacy|3|||
149078263|NCT01852045|537767334|FG001|Overall Study|Lack of Efficacy|0|||
149078264|NCT01852045|537767335|FG002|Overall Study|Lack of Efficacy|0|||
149078265|NCT01852045|537767333|FG000|Overall Study|Lost to Follow-up|0|||
149078266|NCT01852045|537767334|FG001|Overall Study|Lost to Follow-up|1|||
149078267|NCT01852045|537767335|FG002|Overall Study|Lost to Follow-up|1|||
149078268|NCT01852045|537767333|FG000|Overall Study|Withdrawal by Subject|1|||
149078269|NCT01852045|537767334|FG001|Overall Study|Withdrawal by Subject|0|||
149078270|NCT01852045|537767335|FG002|Overall Study|Withdrawal by Subject|1|||
149078271|NCT01852045|537767333|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149078272|NCT01852045|537767334|FG001|Overall Study|Other Miscellaneous Reasons|3|||
149078273|NCT01852045|537767335|FG002|Overall Study|Other Miscellaneous Reasons|2|||
149078274|NCT02827201|537767336|FG000|Overall Study|Death|1|||
149078275|NCT02827201|537767337|FG001|Overall Study|Death|2|||
149078276|NCT02827201|537767336|FG000|Overall Study|Patients not treated|1|||
149078277|NCT02827201|537767337|FG001|Overall Study|Patients not treated|1|||
149078278|NCT02736188|537767338|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
149078279|NCT02736188|537767338|FG000|Overall Study|Adverse Event|1|||
149078280|NCT02736188|537767338|FG000|Overall Study|Withdrawal by Subject|1|||
149078281|NCT02736188|537767338|FG000|Overall Study|Other|6|||
149078282|NCT02630186|537767339|FG000|Overall Study|Withdrawal by Subject|1|||
149078283|NCT00439218|537767340|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
149078284|NCT03176407|537767341|FG000|Overall Study|Protocol Violation|1|||
149078285|NCT03176407|537767341|FG000|Overall Study|human failure|1|||
149078286|NCT03176407|537767341|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
149078287|NCT01428583|537767343|FG000|Overall Study|Adverse Event|75|||
149078288|NCT01428583|537767343|FG000|Overall Study|Withdrawal by Subject|51|||
149078289|NCT01428583|537767343|FG000|Overall Study|Lack of Efficacy|37|||
149078290|NCT01428583|537767343|FG000|Overall Study|Lost to Follow-up|17|||
149078291|NCT01428583|537767343|FG000|Overall Study|Death|1|||
149078292|NCT01428583|537767343|FG000|Overall Study|Pregnancy|1|||
149078293|NCT01428583|537767343|FG000|Overall Study|Protocol Violation|1|||
149078294|NCT01428583|537767343|FG000|Overall Study|Physician Decision|12|||
149078295|NCT01428583|537767343|FG000|Overall Study|Non-compliant|25|||
149078296|NCT01428583|537767343|FG000|Overall Study|Confirmed positive urine drug test|8|||
149078297|NCT01428583|537767343|FG000|Overall Study|Sponsor's request|3|||
149078298|NCT01428583|537767343|FG000|Overall Study|Other|6|||
149078299|NCT00768755|537767346|FG000|Phase 1|Death|6|||
149078300|NCT00768755|537767347|FG001|Phase 1|Death|0|||
149078301|NCT00768755|537767348|FG002|Phase 1|Death|0|||
149078302|NCT00768755|537767349|FG003|Phase 1|Death|0|||
149078303|NCT00768755|537767346|FG000|Phase 1|Other|4|||
149078304|NCT00768755|537767347|FG001|Phase 1|Other|0|||
149078305|NCT00768755|537767348|FG002|Phase 1|Other|0|||
149078306|NCT00768755|537767349|FG003|Phase 1|Other|0|||
149078307|NCT00768755|537767346|FG000|Phase 2|Death|0|||
149078308|NCT00768755|537767347|FG001|Phase 2|Death|37|||
149078309|NCT00768755|537767348|FG002|Phase 2|Death|48|||
149078310|NCT00768755|537767349|FG003|Phase 2|Death|31|||
149078311|NCT00768755|537767346|FG000|Phase 2|Protocol Violation|0|||
149078312|NCT00768755|537767347|FG001|Phase 2|Protocol Violation|2|||
149078313|NCT00768755|537767348|FG002|Phase 2|Protocol Violation|0|||
149078314|NCT00768755|537767349|FG003|Phase 2|Protocol Violation|1|||
149078315|NCT00768755|537767346|FG000|Phase 2|Lost to Follow-up|0|||
149078316|NCT00768755|537767347|FG001|Phase 2|Lost to Follow-up|1|||
149078317|NCT00768755|537767348|FG002|Phase 2|Lost to Follow-up|1|||
149078318|NCT00768755|537767349|FG003|Phase 2|Lost to Follow-up|4|||
149078319|NCT00768755|537767346|FG000|Phase 2|Withdrawal by Subject|0|||
149078320|NCT00768755|537767347|FG001|Phase 2|Withdrawal by Subject|1|||
149078321|NCT00768755|537767348|FG002|Phase 2|Withdrawal by Subject|0|||
149078322|NCT00768755|537767349|FG003|Phase 2|Withdrawal by Subject|1|||
149078323|NCT00768755|537767346|FG000|Phase 2|Other|0|||
149078324|NCT00768755|537767347|FG001|Phase 2|Other|1|||
149078325|NCT00768755|537767348|FG002|Phase 2|Other|2|||
149078326|NCT00768755|537767349|FG003|Phase 2|Other|4|||
149078327|NCT00768755|537767346|FG000|Phase 2|Study Terminated by Sponsor|0|||
149078328|NCT00768755|537767347|FG001|Phase 2|Study Terminated by Sponsor|13|||
149078329|NCT00768755|537767348|FG002|Phase 2|Study Terminated by Sponsor|7|||
149078330|NCT00768755|537767349|FG003|Phase 2|Study Terminated by Sponsor|14|||
149078331|NCT00768755|537767346|FG000|Phase 2|Randomized but not treated|0|||
149078332|NCT00768755|537767347|FG001|Phase 2|Randomized but not treated|0|||
149078333|NCT00768755|537767348|FG002|Phase 2|Randomized but not treated|0|||
149078334|NCT00768755|537767349|FG003|Phase 2|Randomized but not treated|2|||
149078335|NCT03142932|537767352|FG000|Overall Study|Lost to Follow-up|2|||
149078336|NCT03142932|537767353|FG001|Overall Study|Lost to Follow-up|11|||
149078337|NCT02128269|537767354|FG000|Treatment Period|Adverse Event|1|||
149078338|NCT02128269|537767354|FG000|Treatment Period|Physician Decision|1|||
149078339|NCT00878189|537767355|FG000|Overall Study|Death|0|||
149078340|NCT00878189|537767356|FG001|Overall Study|Death|1|||
149078341|NCT00878189|537767357|FG002|Overall Study|Death|0|||
149078342|NCT00878189|537767358|FG003|Overall Study|Death|1|||
149078343|NCT00878189|537767359|FG004|Overall Study|Death|0|||
149078344|NCT00878189|537767360|FG005|Overall Study|Death|0|||
149078345|NCT00878189|537767361|FG006|Overall Study|Death|0|||
149078346|NCT00878189|537767362|FG007|Overall Study|Death|0|||
149078347|NCT00878189|537767363|FG008|Overall Study|Death|1|||
149078348|NCT00878189|537767355|FG000|Overall Study|Participant Refused to Follow-up|0|||
149078349|NCT00878189|537767356|FG001|Overall Study|Participant Refused to Follow-up|0|||
149078350|NCT00878189|537767357|FG002|Overall Study|Participant Refused to Follow-up|0|||
149078351|NCT00878189|537767358|FG003|Overall Study|Participant Refused to Follow-up|0|||
149078352|NCT00878189|537767359|FG004|Overall Study|Participant Refused to Follow-up|0|||
149078353|NCT00878189|537767360|FG005|Overall Study|Participant Refused to Follow-up|4|||
149078354|NCT00878189|537767361|FG006|Overall Study|Participant Refused to Follow-up|0|||
149078355|NCT00878189|537767362|FG007|Overall Study|Participant Refused to Follow-up|0|||
149078356|NCT00878189|537767363|FG008|Overall Study|Participant Refused to Follow-up|0|||
149078357|NCT00878189|537767355|FG000|Overall Study|Other|3|||
149078358|NCT00878189|537767356|FG001|Overall Study|Other|2|||
149078359|NCT00878189|537767357|FG002|Overall Study|Other|4|||
149078360|NCT00878189|537767358|FG003|Overall Study|Other|7|||
149078361|NCT00878189|537767359|FG004|Overall Study|Other|4|||
149078362|NCT00878189|537767360|FG005|Overall Study|Other|18|||
149078363|NCT00878189|537767361|FG006|Overall Study|Other|15|||
149078364|NCT00878189|537767362|FG007|Overall Study|Other|3|||
149078365|NCT00878189|537767363|FG008|Overall Study|Other|4|||
149078366|NCT00878189|537767355|FG000|Overall Study|Lost to Follow-up|0|||
149078367|NCT00878189|537767356|FG001|Overall Study|Lost to Follow-up|0|||
149078368|NCT00878189|537767357|FG002|Overall Study|Lost to Follow-up|0|||
149078369|NCT00878189|537767358|FG003|Overall Study|Lost to Follow-up|0|||
149078370|NCT00878189|537767359|FG004|Overall Study|Lost to Follow-up|0|||
149078371|NCT00878189|537767360|FG005|Overall Study|Lost to Follow-up|1|||
149078372|NCT00878189|537767361|FG006|Overall Study|Lost to Follow-up|1|||
149078373|NCT00878189|537767362|FG007|Overall Study|Lost to Follow-up|0|||
149078374|NCT00878189|537767363|FG008|Overall Study|Lost to Follow-up|0|||
149078375|NCT00878189|537767355|FG000|Overall Study|Objection Progression or Relapse|0|||
149078376|NCT00878189|537767356|FG001|Overall Study|Objection Progression or Relapse|0|||
149078377|NCT00878189|537767357|FG002|Overall Study|Objection Progression or Relapse|0|||
149078378|NCT00878189|537767358|FG003|Overall Study|Objection Progression or Relapse|0|||
149078379|NCT00878189|537767359|FG004|Overall Study|Objection Progression or Relapse|0|||
149078380|NCT00878189|537767360|FG005|Overall Study|Objection Progression or Relapse|0|||
149078381|NCT00878189|537767361|FG006|Overall Study|Objection Progression or Relapse|0|||
149078382|NCT00878189|537767362|FG007|Overall Study|Objection Progression or Relapse|0|||
149078383|NCT00878189|537767363|FG008|Overall Study|Objection Progression or Relapse|3|||
149078384|NCT00638456|537767364|FG000|Overall Study|Withdrawal by Subject|6|||
149078385|NCT00638456|537767365|FG001|Overall Study|Withdrawal by Subject|2|||
149078386|NCT01640288|537767366|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
149078387|NCT01640288|537767367|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
149078388|NCT01640288|537767366|FG000|Overall Study|Screen Failure|20|||
149078389|NCT01640288|537767367|FG001|Overall Study|Screen Failure|18|||
149078390|NCT01640288|537767366|FG000|Overall Study|Withdrawn by PI|5|||
149078391|NCT01640288|537767367|FG001|Overall Study|Withdrawn by PI|0|||
149078392|NCT01640288|537767366|FG000|Overall Study|Withdrawal by Subject|1|||
149078393|NCT01640288|537767367|FG001|Overall Study|Withdrawal by Subject|0|||
149078394|NCT00787176|537767369|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
149078395|NCT00787176|537767370|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
149078396|NCT00787176|537767371|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
149078397|NCT00787176|537767372|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
149078398|NCT02234141|537767378|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
149078399|NCT02234141|537767379|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
149078400|NCT02234141|537767380|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
149078401|NCT02234141|537767381|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
149078402|NCT02234141|537767382|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
149078403|NCT02234141|537767383|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
149078404|NCT02234141|537767384|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
149078405|NCT02234141|537767378|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
149078406|NCT02234141|537767379|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
149078407|NCT02234141|537767380|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
149078408|NCT02234141|537767381|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
149078409|NCT02234141|537767382|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
149078410|NCT02234141|537767383|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
149078411|NCT02234141|537767384|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
149078412|NCT02234141|537767378|FG000|Treatment Period (24 Weeks)|Death|1|||
149078413|NCT02234141|537767379|FG001|Treatment Period (24 Weeks)|Death|2|||
149078414|NCT02234141|537767380|FG002|Treatment Period (24 Weeks)|Death|0|||
149078415|NCT02234141|537767381|FG003|Treatment Period (24 Weeks)|Death|1|||
149078416|NCT02234141|537767382|FG004|Treatment Period (24 Weeks)|Death|0|||
149078417|NCT02234141|537767383|FG005|Treatment Period (24 Weeks)|Death|0|||
149078418|NCT02234141|537767384|FG006|Treatment Period (24 Weeks)|Death|0|||
149078419|NCT02234141|537767378|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
149078420|NCT02234141|537767379|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
149078421|NCT02234141|537767380|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
149078422|NCT02234141|537767381|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
149078423|NCT02234141|537767382|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
149078424|NCT02234141|537767383|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
149078425|NCT02234141|537767384|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
149078426|NCT02234141|537767378|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
149078427|NCT02234141|537767379|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
149078428|NCT02234141|537767380|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
149078429|NCT02234141|537767381|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
149078430|NCT02234141|537767382|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
149078431|NCT02234141|537767383|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
149078432|NCT02234141|537767384|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
149078433|NCT02234141|537767378|FG000|Long-Term Treatment Period|Death|0|||
149078434|NCT02234141|537767379|FG001|Long-Term Treatment Period|Death|0|||
149078435|NCT02234141|537767380|FG002|Long-Term Treatment Period|Death|0|||
149078436|NCT02234141|537767381|FG003|Long-Term Treatment Period|Death|0|||
149078437|NCT02234141|537767382|FG004|Long-Term Treatment Period|Death|0|||
149078438|NCT02234141|537767383|FG005|Long-Term Treatment Period|Death|1|||
149078439|NCT02234141|537767384|FG006|Long-Term Treatment Period|Death|0|||
149078440|NCT02234141|537767378|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
149078441|NCT02234141|537767379|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
149078442|NCT02234141|537767380|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
149078443|NCT02234141|537767381|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
149078444|NCT02234141|537767382|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
149078445|NCT02234141|537767383|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
149078446|NCT02234141|537767384|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
149078447|NCT02234141|537767378|FG000|Long-Term Treatment Period|Adverse Event|4|||
149078448|NCT02234141|537767379|FG001|Long-Term Treatment Period|Adverse Event|0|||
149078449|NCT02234141|537767380|FG002|Long-Term Treatment Period|Adverse Event|5|||
149078450|NCT02234141|537767381|FG003|Long-Term Treatment Period|Adverse Event|0|||
149078451|NCT02234141|537767382|FG004|Long-Term Treatment Period|Adverse Event|1|||
149078452|NCT02234141|537767383|FG005|Long-Term Treatment Period|Adverse Event|1|||
149078453|NCT02234141|537767384|FG006|Long-Term Treatment Period|Adverse Event|1|||
149078454|NCT02234141|537767378|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
149078455|NCT02234141|537767379|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
149078456|NCT02234141|537767380|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
149078457|NCT02234141|537767381|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
149078458|NCT02234141|537767382|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
149078459|NCT02234141|537767383|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
149078460|NCT02234141|537767384|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
149078461|NCT02234141|537767378|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
149078462|NCT02234141|537767379|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
149078463|NCT02234141|537767380|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
149078464|NCT02234141|537767381|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
149078465|NCT02234141|537767382|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
149078466|NCT02234141|537767383|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
149078467|NCT02234141|537767384|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
149078468|NCT00895245|537767385|FG000|Overall Study|Lack of Efficacy|6|||
149078469|NCT02095678|537767386|FG000|Overall Study|Withdrawal by Subject|0|||
149078470|NCT02095678|537767387|FG001|Overall Study|Withdrawal by Subject|1|||
149078471|NCT02095678|537767386|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
149078472|NCT02095678|537767387|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
149078473|NCT02095678|537767386|FG000|Overall Study|lesion impacted by previous treatment|1|||
149078474|NCT02095678|537767387|FG001|Overall Study|lesion impacted by previous treatment|1|||
149078475|NCT02095678|537767386|FG000|Overall Study|No Confirmed Diagnosis|0|||
149078476|NCT02095678|537767387|FG001|Overall Study|No Confirmed Diagnosis|3|||
149078477|NCT02095678|537767386|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
149078478|NCT02095678|537767387|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
149078479|NCT02095678|537767386|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
149078480|NCT02095678|537767387|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
149078481|NCT01074242|537767390|FG000|Overall Study|Case report before date of contract|40|||
149078482|NCT01074242|537767390|FG000|Overall Study|Lost to Follow-up|1|||
149078483|NCT01074242|537767390|FG000|Overall Study|Case report unclear|6|||
149078484|NCT01074242|537767390|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
149078485|NCT01074242|537767390|FG000|Overall Study|Duplicate Case Report Form|5|||
149078486|NCT01957163|537767391|FG000|Overall Study|Adverse Event|5|||
149078487|NCT01957163|537767392|FG001|Overall Study|Adverse Event|2|||
149078488|NCT01957163|537767393|FG002|Overall Study|Adverse Event|4|||
149078489|NCT01957163|537767391|FG000|Overall Study|Lack of Efficacy|5|||
149078490|NCT01957163|537767392|FG001|Overall Study|Lack of Efficacy|4|||
149078491|NCT01957163|537767393|FG002|Overall Study|Lack of Efficacy|9|||
149078492|NCT01957163|537767391|FG000|Overall Study|Protocol Violation|1|||
149078493|NCT01957163|537767392|FG001|Overall Study|Protocol Violation|2|||
149078494|NCT01957163|537767393|FG002|Overall Study|Protocol Violation|0|||
149078495|NCT01957163|537767391|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
149078496|NCT01957163|537767392|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
149078497|NCT01957163|537767393|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
149078498|NCT01957163|537767391|FG000|Overall Study|Lost to Follow-up|0|||
149078499|NCT01957163|537767392|FG001|Overall Study|Lost to Follow-up|1|||
149078500|NCT01957163|537767393|FG002|Overall Study|Lost to Follow-up|0|||
149078501|NCT01957163|537767391|FG000|Overall Study|Withdrawal by Subject|4|||
149078502|NCT01957163|537767392|FG001|Overall Study|Withdrawal by Subject|2|||
149078503|NCT01957163|537767393|FG002|Overall Study|Withdrawal by Subject|4|||
149078504|NCT04224272|537767400|FG000|Part 1 - Dose Finding|Death|4|||
149078505|NCT04224272|537767400|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
149078506|NCT04224272|537767400|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
149078507|NCT04224272|537767400|FG000|Part 2 - Dose Expansion|Death|10|||
149078508|NCT04224272|537767400|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
149078509|NCT02609048|537767401|FG000|Overall Study|Adverse Event|3|||
149078510|NCT02609048|537767402|FG001|Overall Study|Adverse Event|0|||
149078511|NCT02609048|537767403|FG002|Overall Study|Adverse Event|0|||
149078512|NCT02609048|537767401|FG000|Overall Study|Randomized but never treated|1|||
149078513|NCT02609048|537767402|FG001|Overall Study|Randomized but never treated|1|||
149078514|NCT02609048|537767403|FG002|Overall Study|Randomized but never treated|1|||
149078515|NCT02609048|537767401|FG000|Overall Study|Withdrawal of informed consent|1|||
149078516|NCT02609048|537767402|FG001|Overall Study|Withdrawal of informed consent|0|||
149078517|NCT02609048|537767403|FG002|Overall Study|Withdrawal of informed consent|0|||
149078518|NCT02609048|537767401|FG000|Overall Study|Reason not specified|6|||
149078519|NCT02609048|537767402|FG001|Overall Study|Reason not specified|9|||
149078520|NCT02609048|537767403|FG002|Overall Study|Reason not specified|9|||
149078521|NCT04924608|537768762|FG000|Overall Study|Adverse Event|10|||
149078522|NCT04924608|537768763|FG001|Overall Study|Adverse Event|6|||
149078523|NCT04924608|537768762|FG000|Overall Study|Lost to Follow-up|1|||
149078524|NCT04924608|537768763|FG001|Overall Study|Lost to Follow-up|1|||
149078525|NCT04924608|537768762|FG000|Overall Study|Ongoing at the data cut-off date|54|||
149078526|NCT04924608|537768763|FG001|Overall Study|Ongoing at the data cut-off date|60|||
149078527|NCT04924608|537768762|FG000|Overall Study|Progressive Disease|2|||
149078528|NCT04924608|537768763|FG001|Overall Study|Progressive Disease|0|||
149078529|NCT04924608|537768762|FG000|Overall Study|Withdrawal by Subject|3|||
149078530|NCT04924608|537768763|FG001|Overall Study|Withdrawal by Subject|6|||
149078531|NCT04924608|537768762|FG000|Overall Study|Other reason|1|||
149078532|NCT04924608|537768763|FG001|Overall Study|Other reason|1|||
149078533|NCT04493424|537768764|FG000|Overall Study|Termination of the trial by the sponsor|89|||
149078534|NCT04493424|537768764|FG000|Overall Study|Withdrawal by Subject|9|||
149078535|NCT04493424|537768764|FG000|Overall Study|Lost to Follow-up|2|||
149078536|NCT04493424|537768764|FG000|Overall Study|Lack of Efficacy|3|||
149078537|NCT04493424|537768764|FG000|Overall Study|Adverse Event|5|||
149078538|NCT00949117|537768765|FG000|Overall Study|Lack of Efficacy|2|||
149078539|NCT00949117|537768766|FG001|Overall Study|Lack of Efficacy|3|||
149078540|NCT00949117|537768765|FG000|Overall Study|Protocol Violation|1|||
149078541|NCT00949117|537768766|FG001|Overall Study|Protocol Violation|1|||
149078542|NCT00949117|537768765|FG000|Overall Study|Adverse Event|0|||
149078543|NCT00949117|537768766|FG001|Overall Study|Adverse Event|1|||
149078544|NCT03769090|537768767|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
149078545|NCT03769090|537768768|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
149078546|NCT03769090|537768769|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
149078547|NCT03769090|537768767|FG000|Overall Study|Withdrawal by Subject|52|||
149078548|NCT03769090|537768768|FG001|Overall Study|Withdrawal by Subject|62|||
149078549|NCT03769090|537768769|FG002|Overall Study|Withdrawal by Subject|74|||
149078550|NCT03769090|537768767|FG000|Overall Study|Death|4|||
149078551|NCT03769090|537768768|FG001|Overall Study|Death|2|||
149078552|NCT03769090|537768769|FG002|Overall Study|Death|2|||
149078553|NCT03769090|537768767|FG000|Overall Study|Adverse Event|7|||
149078554|NCT03769090|537768768|FG001|Overall Study|Adverse Event|7|||
149078555|NCT03769090|537768769|FG002|Overall Study|Adverse Event|8|||
149078556|NCT03769090|537768767|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
149078557|NCT03769090|537768768|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
149078558|NCT03769090|537768769|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
149078559|NCT03769090|537768767|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
149078560|NCT03769090|537768768|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
149078561|NCT03769090|537768769|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
149078562|NCT03769090|537768767|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
149078563|NCT03769090|537768768|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
149078564|NCT03769090|537768769|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
149078565|NCT03769090|537768767|FG000|Overall Study|Protocol Violation|5|||
149078566|NCT03769090|537768768|FG001|Overall Study|Protocol Violation|6|||
149078567|NCT03769090|537768769|FG002|Overall Study|Protocol Violation|8|||
149078568|NCT03769090|537768767|FG000|Overall Study|Pregnancy|1|||
149078569|NCT03769090|537768768|FG001|Overall Study|Pregnancy|0|||
149078570|NCT03769090|537768769|FG002|Overall Study|Pregnancy|3|||
149078571|NCT03769090|537768767|FG000|Overall Study|Lost to Follow-up|19|||
149078572|NCT03769090|537768768|FG001|Overall Study|Lost to Follow-up|25|||
149078573|NCT03769090|537768769|FG002|Overall Study|Lost to Follow-up|21|||
149078574|NCT03769090|537768767|FG000|Overall Study|Condition under investigation worsened|2|||
149078575|NCT03769090|537768768|FG001|Overall Study|Condition under investigation worsened|0|||
149078576|NCT03769090|537768769|FG002|Overall Study|Condition under investigation worsened|1|||
149078577|NCT03769090|537768767|FG000|Overall Study|Lack of Efficacy|1|||
149078578|NCT03769090|537768768|FG001|Overall Study|Lack of Efficacy|2|||
149078579|NCT03769090|537768769|FG002|Overall Study|Lack of Efficacy|2|||
149078580|NCT03769090|537768767|FG000|Overall Study|Other reasons|8|||
149078581|NCT03769090|537768768|FG001|Overall Study|Other reasons|12|||
149078582|NCT03769090|537768769|FG002|Overall Study|Other reasons|15|||
149078583|NCT03964974|537768770|FG000|Overall Study|Lost to Follow-up|3|||
149078584|NCT03964974|537768771|FG001|Overall Study|Lost to Follow-up|2|||
149078585|NCT03964974|537768770|FG000|Overall Study|Withdrawal by Subject|0|||
149078586|NCT03964974|537768771|FG001|Overall Study|Withdrawal by Subject|3|||
149078587|NCT02014402|537768772|FG000|Overall Study|Adverse Event|1|||
149078588|NCT02014402|537768773|FG001|Overall Study|Adverse Event|0|||
149078589|NCT02014402|537768774|FG002|Overall Study|Adverse Event|0|||
149078590|NCT02014402|537768775|FG003|Overall Study|Adverse Event|0|||
149078591|NCT02014402|537768772|FG000|Overall Study|Withdrawal by Subject|1|||
149078592|NCT02014402|537768773|FG001|Overall Study|Withdrawal by Subject|2|||
149078593|NCT02014402|537768774|FG002|Overall Study|Withdrawal by Subject|2|||
149078594|NCT02014402|537768775|FG003|Overall Study|Withdrawal by Subject|1|||
149078595|NCT02014402|537768772|FG000|Overall Study|Subject did not have transportation|0|||
149078596|NCT02014402|537768773|FG001|Overall Study|Subject did not have transportation|1|||
149078597|NCT02014402|537768774|FG002|Overall Study|Subject did not have transportation|0|||
149078598|NCT02014402|537768775|FG003|Overall Study|Subject did not have transportation|0|||
149078599|NCT02014402|537768772|FG000|Overall Study|Lost to Follow-up|0|||
149078600|NCT02014402|537768773|FG001|Overall Study|Lost to Follow-up|0|||
149078601|NCT02014402|537768774|FG002|Overall Study|Lost to Follow-up|1|||
149078602|NCT02014402|537768775|FG003|Overall Study|Lost to Follow-up|2|||
149078603|NCT02713594|537768779|FG000|Overall Study|Withdrawal by Subject|32|||
149078604|NCT02713594|537768780|FG001|Overall Study|Withdrawal by Subject|22|||
149078605|NCT02713594|537768779|FG000|Overall Study|Lost to Follow-up|358|||
149078606|NCT02713594|537768780|FG001|Overall Study|Lost to Follow-up|374|||
149078607|NCT00670449|537768781|FG000|Overall Study|Adverse Event|6|||
149078608|NCT00670449|537768782|FG001|Overall Study|Adverse Event|2|||
149078609|NCT00670449|537768783|FG002|Overall Study|Adverse Event|8|||
149078610|NCT00670449|537768784|FG003|Overall Study|Adverse Event|5|||
149078611|NCT00670449|537768781|FG000|Overall Study|Protocol Deviation|1|||
149078612|NCT00670449|537768782|FG001|Overall Study|Protocol Deviation|2|||
149078613|NCT00670449|537768783|FG002|Overall Study|Protocol Deviation|0|||
149078614|NCT00670449|537768784|FG003|Overall Study|Protocol Deviation|1|||
149078615|NCT00670449|537768781|FG000|Overall Study|Administrative Problems|0|||
149078616|NCT00670449|537768782|FG001|Overall Study|Administrative Problems|2|||
149078617|NCT00670449|537768783|FG002|Overall Study|Administrative Problems|0|||
149078618|NCT00670449|537768784|FG003|Overall Study|Administrative Problems|1|||
149078619|NCT00670449|537768781|FG000|Overall Study|Subject Withdrew Consent|0|||
149078620|NCT00670449|537768782|FG001|Overall Study|Subject Withdrew Consent|2|||
149078621|NCT00670449|537768783|FG002|Overall Study|Subject Withdrew Consent|0|||
149078622|NCT00670449|537768784|FG003|Overall Study|Subject Withdrew Consent|1|||
149078623|NCT00670449|537768781|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
149078624|NCT00670449|537768782|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149078625|NCT00670449|537768783|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
149078626|NCT00670449|537768784|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
149078627|NCT00670449|537768781|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
149078628|NCT00670449|537768782|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
149078629|NCT00670449|537768783|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
149078630|NCT00670449|537768784|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
149078631|NCT00413283|537768785|FG000|Overall Study|Withdrawal by Subject|1|||
149078632|NCT00413283|537768786|FG001|Overall Study|Withdrawal by Subject|0|||
149078633|NCT00413283|537768787|FG002|Overall Study|Withdrawal by Subject|0|||
149078634|NCT00413283|537768788|FG003|Overall Study|Withdrawal by Subject|1|||
149078635|NCT00413283|537768785|FG000|Overall Study|Death|0|||
149078636|NCT00413283|537768786|FG001|Overall Study|Death|0|||
149078637|NCT00413283|537768787|FG002|Overall Study|Death|1|||
149078638|NCT00413283|537768788|FG003|Overall Study|Death|1|||
149078639|NCT00413283|537768785|FG000|Overall Study|Adverse Event|0|||
149078640|NCT00413283|537768786|FG001|Overall Study|Adverse Event|0|||
149078641|NCT00413283|537768787|FG002|Overall Study|Adverse Event|0|||
149078642|NCT00413283|537768788|FG003|Overall Study|Adverse Event|1|||
149078643|NCT00413283|537768785|FG000|Overall Study|Ineligibility determined|0|||
149078644|NCT00413283|537768786|FG001|Overall Study|Ineligibility determined|0|||
149078645|NCT00413283|537768787|FG002|Overall Study|Ineligibility determined|0|||
149078646|NCT00413283|537768788|FG003|Overall Study|Ineligibility determined|1|||
149078647|NCT00413283|537768785|FG000|Overall Study|Protocol deviation|0|||
149078648|NCT00413283|537768786|FG001|Overall Study|Protocol deviation|1|||
149078649|NCT00413283|537768787|FG002|Overall Study|Protocol deviation|0|||
149078650|NCT00413283|537768788|FG003|Overall Study|Protocol deviation|0|||
149078651|NCT00413283|537768785|FG000|Overall Study|Requirement for alternative therapy|0|||
149078652|NCT00413283|537768786|FG001|Overall Study|Requirement for alternative therapy|2|||
149078653|NCT00413283|537768787|FG002|Overall Study|Requirement for alternative therapy|0|||
149078654|NCT00413283|537768788|FG003|Overall Study|Requirement for alternative therapy|0|||
149078655|NCT00413283|537768785|FG000|Overall Study|Other|0|||
149078656|NCT00413283|537768786|FG001|Overall Study|Other|0|||
149078657|NCT00413283|537768787|FG002|Overall Study|Other|1|||
149078658|NCT00413283|537768788|FG003|Overall Study|Other|0|||
149078659|NCT02002689|537768789|FG000|Overall Study|Disease Progression|7|||
149078660|NCT02002689|537768789|FG000|Overall Study|Adverse Event|3|||
149078661|NCT00671853|537768790|FG000|Overall Study|Lack of Efficacy|3|||
149078662|NCT00671853|537768791|FG001|Overall Study|Lack of Efficacy|7|||
149078663|NCT00671853|537768790|FG000|Overall Study|Adverse Event|7|||
149078664|NCT00671853|537768791|FG001|Overall Study|Adverse Event|1|||
149078665|NCT00671853|537768790|FG000|Overall Study|Withdrawal by Subject|1|||
149078666|NCT00671853|537768791|FG001|Overall Study|Withdrawal by Subject|5|||
149078667|NCT00671853|537768790|FG000|Overall Study|Lost to Follow-up|8|||
149078668|NCT00671853|537768791|FG001|Overall Study|Lost to Follow-up|8|||
149078669|NCT00671853|537768790|FG000|Overall Study|Physician Decision|0|||
149078670|NCT00671853|537768791|FG001|Overall Study|Physician Decision|2|||
149078671|NCT00671853|537768790|FG000|Overall Study|Non-adherence with study procedures|1|||
149078672|NCT00671853|537768791|FG001|Overall Study|Non-adherence with study procedures|4|||
149078673|NCT02660086|537768792|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
149078674|NCT02660086|537768793|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
149078675|NCT02660086|537768792|FG000|Overall Study- 12-month|Left full-time employment|12|||
149078676|NCT02660086|537768793|FG001|Overall Study- 12-month|Left full-time employment|20|||
149078677|NCT02660086|537768792|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
149078678|NCT02660086|537768793|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
149078679|NCT02660086|537768792|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
149078680|NCT02660086|537768793|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
149078681|NCT02660086|537768792|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
149078682|NCT02660086|537768793|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
149078683|NCT02660086|537768792|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
149078684|NCT02660086|537768793|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
149078685|NCT03928743|537768799|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
149078686|NCT03928743|537768800|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
149078687|NCT03928743|537768801|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
149078688|NCT03928743|537768799|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
149078689|NCT03928743|537768800|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
149078690|NCT03928743|537768801|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
149078691|NCT03928743|537768799|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
149078692|NCT03928743|537768800|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
149078693|NCT03928743|537768801|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
149078694|NCT03928743|537768799|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
149078695|NCT03928743|537768800|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
149078696|NCT03928743|537768801|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
149078697|NCT03928743|537768799|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
149078698|NCT03928743|537768800|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
149078699|NCT03928743|537768801|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
149078700|NCT03928743|537768799|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
149078701|NCT03928743|537768800|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
149078702|NCT03928743|537768801|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
149078703|NCT03928743|537768799|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
149078704|NCT03928743|537768800|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
149078705|NCT03928743|537768801|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
149078706|NCT03928743|537768799|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
149078707|NCT03928743|537768800|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
149078708|NCT03928743|537768801|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
149078709|NCT03928743|537768799|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
149078710|NCT03928743|537768800|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
149078711|NCT03928743|537768801|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
149078712|NCT03928743|537768799|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
149078713|NCT03928743|537768800|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
149078714|NCT03928743|537768801|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
149078715|NCT03928743|537768799|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
149078716|NCT03928743|537768800|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
149078717|NCT03928743|537768801|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
149078718|NCT05005247|537768802|FG000|Overall Study|Withdrawal by Subject|0|||
149078719|NCT05005247|537768803|FG001|Overall Study|Withdrawal by Subject|1|||
149078720|NCT05005247|537768804|FG002|Overall Study|Withdrawal by Subject|0|||
149078721|NCT01450007|537768805|FG000|Overall Study|Late exclusion before treatment|2|||
149078722|NCT01450007|537768806|FG001|Overall Study|Late exclusion before treatment|3|||
149078723|NCT01450007|537768807|FG002|Overall Study|Late exclusion before treatment|2|||
149078724|NCT01450007|537768805|FG000|Overall Study|Protocol Violation|0|||
149078725|NCT01450007|537768806|FG001|Overall Study|Protocol Violation|1|||
149078726|NCT01450007|537768807|FG002|Overall Study|Protocol Violation|1|||
149078727|NCT01450007|537768805|FG000|Overall Study|Adverse Event|0|||
149078728|NCT01450007|537768806|FG001|Overall Study|Adverse Event|1|||
149078729|NCT01450007|537768807|FG002|Overall Study|Adverse Event|0|||
149120381|NCT02559895|537918093|FG003|Overall Study|Study Burden|22|||
149078730|NCT02224755|537768814|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
149078731|NCT02224755|537768815|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
149078732|NCT02224755|537768814|FG000|Two Year Follow up Post-implant|Death|103|||
149078733|NCT02224755|537768815|FG001|Two Year Follow up Post-implant|Death|98|||
149078734|NCT02224755|537768814|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
149078735|NCT02224755|537768815|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
149078736|NCT02224755|537768814|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
149078737|NCT02224755|537768815|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
149078738|NCT02224755|537768814|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
149078739|NCT02224755|537768815|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
149078740|NCT01951703|537768816|FG000|First Intervention|Withdrawal by Subject|1|||
149078741|NCT01951703|537768817|FG001|First Intervention|Withdrawal by Subject|0|||
149078742|NCT01951703|537768816|FG000|First Intervention|Subject was not compliant|1|||
149078743|NCT01951703|537768817|FG001|First Intervention|Subject was not compliant|1|||
149078744|NCT01951703|537768816|FG000|First Intervention|Physician Decision|1|||
149078745|NCT01951703|537768817|FG001|First Intervention|Physician Decision|0|||
149078746|NCT01951703|537768816|FG000|Second Intervention|Protocol Violation|0|||
149078747|NCT01951703|537768817|FG001|Second Intervention|Protocol Violation|1|||
149078748|NCT01951703|537768816|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
149078749|NCT01951703|537768817|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
149078750|NCT00240994|537768820|FG000|Overall Study|Lost to Follow-up|1|||
149078751|NCT00240994|537768820|FG000|Overall Study|Protocol Violation|1|||
149078752|NCT00240994|537768820|FG000|Overall Study|Graft failure|1|||
149078753|NCT05124210|537768821|FG000|Overall Study|Lost to Follow-up|1|||
149078754|NCT05124210|537768822|FG001|Overall Study|Lost to Follow-up|0|||
149078755|NCT05124210|537768821|FG000|Overall Study|Withdrawal by Subject|1|||
149078756|NCT05124210|537768822|FG001|Overall Study|Withdrawal by Subject|0|||
149078757|NCT02007070|537768824|FG000|Overall Study|Adverse Event|4|||
149078758|NCT02007070|537768824|FG000|Overall Study|Clinical Progression|4|||
149078759|NCT02007070|537768824|FG000|Overall Study|Death|1|||
149078760|NCT02007070|537768824|FG000|Overall Study|Protocol Violation|2|||
149078761|NCT02007070|537768824|FG000|Overall Study|Physician Decision|1|||
149078762|NCT02007070|537768824|FG000|Overall Study|Progressive Disease|21|||
149078763|NCT00703092|537768825|FG000|Overall Study|Withdrawal by Subject|2|||
149078764|NCT00681109|537768826|FG000|Overall Study|Lost to Follow-up|2|||
149078765|NCT00681109|537768827|FG001|Overall Study|Lost to Follow-up|6|||
149078766|NCT00681109|537768828|FG002|Overall Study|Lost to Follow-up|0|||
149078767|NCT02706483|537768829|FG000|Overall Study|Adverse Event|97|||
149078768|NCT02706483|537768829|FG000|Overall Study|Death|1|||
149078769|NCT02706483|537768829|FG000|Overall Study|Lack of Efficacy|39|||
149078770|NCT02706483|537768829|FG000|Overall Study|Lost to Follow-up|101|||
149078771|NCT02706483|537768829|FG000|Overall Study|Non-compliance with study drug|15|||
149078772|NCT02706483|537768829|FG000|Overall Study|Physician Decision|6|||
149078773|NCT02706483|537768829|FG000|Overall Study|Pregnancy|6|||
149078774|NCT02706483|537768829|FG000|Overall Study|Protocol Violation|18|||
149078775|NCT02706483|537768829|FG000|Overall Study|Withdrawal by Subject|136|||
149078776|NCT02706483|537768829|FG000|Overall Study|Non-compliance with visits|6|||
149078777|NCT02706483|537768829|FG000|Overall Study|Site closure|4|||
149078778|NCT02706483|537768829|FG000|Overall Study|Subject moved|1|||
149078779|NCT04660799|537768830|FG000|Overall Study|Progressive Disease|1|||
149078780|NCT04660799|537768831|FG001|Overall Study|Progressive Disease|1|||
149078781|NCT04660799|537768830|FG000|Overall Study|Death|2|||
149078782|NCT04660799|537768831|FG001|Overall Study|Death|1|||
149078783|NCT04660799|537768830|FG000|Overall Study|Adverse Event|2|||
149078784|NCT04660799|537768831|FG001|Overall Study|Adverse Event|1|||
149078785|NCT04660799|537768830|FG000|Overall Study|Withdrawal by Subject|2|||
149078786|NCT04660799|537768831|FG001|Overall Study|Withdrawal by Subject|5|||
149078787|NCT03131713|537768832|FG000|Overall Study|Lost to Follow-up|5|||
149078788|NCT03131713|537768833|FG001|Overall Study|Lost to Follow-up|0|||
149078789|NCT01228734|537768840|FG000|Overall Study|Randomized, but not treated|0|||
149078790|NCT01228734|537768841|FG001|Overall Study|Randomized, but not treated|4|||
149078791|NCT00659373|537768846|FG000|Overall Study|Withdrawal by Subject|3|||
149078792|NCT00659373|537768847|FG001|Overall Study|Withdrawal by Subject|5|||
149078793|NCT00659373|537768846|FG000|Overall Study|Assessment Missed|2|||
149078794|NCT00659373|537768847|FG001|Overall Study|Assessment Missed|2|||
149078795|NCT03042767|537768848|FG000|Overall Study|Lost to Follow-up|1|||
149078796|NCT03042767|537768849|FG001|Overall Study|Lost to Follow-up|2|||
149078797|NCT02382640|537768852|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
149078798|NCT02382640|537768853|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
149078799|NCT02382640|537768854|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
149078800|NCT02382640|537768855|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
149078801|NCT01543204|537768856|FG000|Overall Study|Non-compliance|1|||
149078802|NCT01543204|537768856|FG000|Overall Study|Adverse Event|1|||
149078803|NCT01543204|537768856|FG000|Overall Study|Withdrawal by Subject|4|||
149078804|NCT01543204|537768856|FG000|Overall Study|Requirement for Alternative Therapy|1|||
149078805|NCT01543204|537768856|FG000|Overall Study|Lost to Follow-up|1|||
149078806|NCT01220999|537768857|FG000|Overall Study|Progressive disease|0|||
149078807|NCT01220999|537768858|FG001|Overall Study|Progressive disease|0|||
149078808|NCT01220999|537768859|FG002|Overall Study|Progressive disease|1|||
149078809|NCT01220999|537768860|FG003|Overall Study|Progressive disease|0|||
149078810|NCT01220999|537768861|FG004|Overall Study|Progressive disease|0|||
149078811|NCT01560429|537768863|FG000|Overall Study|Protocol Violation|3|||
149078812|NCT01560429|537768864|FG001|Overall Study|Protocol Violation|6|||
149078813|NCT02449902|537768865|FG000|Overall Study|Adverse Event|0|||
149078814|NCT02449902|537768866|FG001|Overall Study|Adverse Event|1|||
149078815|NCT02449902|537768865|FG000|Overall Study|Withdrawal by Subject|0|||
149078816|NCT02449902|537768866|FG001|Overall Study|Withdrawal by Subject|1|||
149078817|NCT01365546|537768867|FG000|Overall Study|Withdrawal by Subject|1|||
149078818|NCT01365546|537768867|FG000|Overall Study|Screen failure|9|||
149078819|NCT01365546|537768867|FG000|Overall Study|Study termination|1|||
149078820|NCT03326856|537768868|FG000|Overall Study|Lost to Follow-up|1|||
149078821|NCT03326856|537768869|FG001|Overall Study|Lost to Follow-up|1|||
149078822|NCT03326856|537768870|FG002|Overall Study|Lost to Follow-up|0|||
149078823|NCT03326856|537768871|FG003|Overall Study|Lost to Follow-up|0|||
149078824|NCT03326856|537768872|FG004|Overall Study|Lost to Follow-up|0|||
149078825|NCT02037568|537768873|FG000|Overall Study|Withdrawal by Subject|17|||
149078826|NCT02037568|537768874|FG001|Overall Study|Withdrawal by Subject|24|||
149078827|NCT02037568|537768873|FG000|Overall Study|Lost to Follow-up|16|||
149078828|NCT02037568|537768874|FG001|Overall Study|Lost to Follow-up|13|||
149078829|NCT02037568|537768873|FG000|Overall Study|Screen Failure|3|||
149078830|NCT02037568|537768874|FG001|Overall Study|Screen Failure|1|||
149078831|NCT02037568|537768873|FG000|Overall Study|Patient did not receive transplant|0|||
149078832|NCT02037568|537768874|FG001|Overall Study|Patient did not receive transplant|1|||
149078833|NCT00721734|537768875|FG000|Overall Study|Progressive Disease|3|||
149078834|NCT00721734|537768876|FG001|Overall Study|Progressive Disease|10|||
149078835|NCT00721734|537768877|FG002|Overall Study|Progressive Disease|4|||
149078836|NCT00721734|537768878|FG003|Overall Study|Progressive Disease|5|||
149078837|NCT00721734|537768879|FG004|Overall Study|Progressive Disease|2|||
149078838|NCT00721734|537768875|FG000|Overall Study|Adverse Event|3|||
149078839|NCT00721734|537768876|FG001|Overall Study|Adverse Event|1|||
149078840|NCT00721734|537768877|FG002|Overall Study|Adverse Event|4|||
149078841|NCT00721734|537768878|FG003|Overall Study|Adverse Event|0|||
149078842|NCT00721734|537768879|FG004|Overall Study|Adverse Event|3|||
149078843|NCT00721734|537768875|FG000|Overall Study|Withdrawal by Subject|2|||
149078844|NCT00721734|537768876|FG001|Overall Study|Withdrawal by Subject|1|||
149078845|NCT00721734|537768877|FG002|Overall Study|Withdrawal by Subject|0|||
149078846|NCT00721734|537768878|FG003|Overall Study|Withdrawal by Subject|0|||
149078847|NCT00721734|537768879|FG004|Overall Study|Withdrawal by Subject|1|||
149078848|NCT00721734|537768875|FG000|Overall Study|Other|0|||
149078849|NCT00721734|537768876|FG001|Overall Study|Other|0|||
149078850|NCT00721734|537768877|FG002|Overall Study|Other|0|||
149078851|NCT00721734|537768878|FG003|Overall Study|Other|1|||
149078852|NCT00721734|537768879|FG004|Overall Study|Other|0|||
149078853|NCT05484661|537768885|FG000|Overall Study|Withdrawal by Subject|1|||
149078854|NCT05484661|537768886|FG001|Overall Study|Withdrawal by Subject|0|||
149078855|NCT00570505|537768889|FG000|Overall Study|Adverse Event|7|||
149078856|NCT00570505|537768889|FG000|Overall Study|Withdrawal by Subject|7|||
149078857|NCT00570505|537768889|FG000|Overall Study|Lost to Follow-up|23|||
149078858|NCT00570505|537768889|FG000|Overall Study|Other loss to follow-up|4|||
149078859|NCT03905642|537768893|FG000|Overall Study|Withdrawal by Subject|3|||
149078860|NCT03905642|537768893|FG000|Overall Study|Pregnancy|1|||
149078861|NCT03905642|537768893|FG000|Overall Study|Adverse Event|1|||
149078862|NCT03905642|537768893|FG000|Overall Study|Lack of Efficacy|1|||
149078863|NCT03905642|537768893|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
149078864|NCT02159989|537768894|FG000|Overall Study|Adverse Event|1|||
149078865|NCT02159989|537768895|FG001|Overall Study|Adverse Event|0|||
149078866|NCT02159989|537768896|FG002|Overall Study|Adverse Event|0|||
149078867|NCT02159989|537768897|FG003|Overall Study|Adverse Event|0|||
149078868|NCT02159989|537768898|FG004|Overall Study|Adverse Event|1|||
149078869|NCT02159989|537768899|FG005|Overall Study|Adverse Event|0|||
149078870|NCT02159989|537768900|FG006|Overall Study|Adverse Event|1|||
149078871|NCT02159989|537768901|FG007|Overall Study|Adverse Event|2|||
149078872|NCT02159989|537768902|FG008|Overall Study|Adverse Event|0|||
149078873|NCT02159989|537768903|FG009|Overall Study|Adverse Event|2|||
149078874|NCT02159989|537768904|FG010|Overall Study|Adverse Event|1|||
149078875|NCT02159989|537768894|FG000|Overall Study|Death|0|||
149078876|NCT02159989|537768895|FG001|Overall Study|Death|0|||
149078877|NCT02159989|537768896|FG002|Overall Study|Death|0|||
149078878|NCT02159989|537768897|FG003|Overall Study|Death|0|||
149078879|NCT02159989|537768898|FG004|Overall Study|Death|0|||
149078880|NCT02159989|537768899|FG005|Overall Study|Death|0|||
149078881|NCT02159989|537768900|FG006|Overall Study|Death|0|||
149078882|NCT02159989|537768901|FG007|Overall Study|Death|0|||
149078883|NCT02159989|537768902|FG008|Overall Study|Death|0|||
149078884|NCT02159989|537768903|FG009|Overall Study|Death|0|||
149078885|NCT02159989|537768904|FG010|Overall Study|Death|1|||
149078886|NCT02159989|537768894|FG000|Overall Study|Lack of Efficacy|2|||
149078887|NCT02159989|537768895|FG001|Overall Study|Lack of Efficacy|3|||
149078888|NCT02159989|537768896|FG002|Overall Study|Lack of Efficacy|3|||
149078889|NCT02159989|537768897|FG003|Overall Study|Lack of Efficacy|0|||
149078890|NCT02159989|537768898|FG004|Overall Study|Lack of Efficacy|2|||
149078891|NCT02159989|537768899|FG005|Overall Study|Lack of Efficacy|3|||
149078892|NCT02159989|537768900|FG006|Overall Study|Lack of Efficacy|3|||
149078893|NCT02159989|537768901|FG007|Overall Study|Lack of Efficacy|1|||
149078894|NCT02159989|537768902|FG008|Overall Study|Lack of Efficacy|3|||
149078895|NCT02159989|537768903|FG009|Overall Study|Lack of Efficacy|6|||
149078896|NCT02159989|537768904|FG010|Overall Study|Lack of Efficacy|7|||
149078897|NCT02159989|537768894|FG000|Overall Study|Lost to Follow-up|0|||
149078898|NCT02159989|537768895|FG001|Overall Study|Lost to Follow-up|0|||
149078899|NCT02159989|537768896|FG002|Overall Study|Lost to Follow-up|0|||
149078900|NCT02159989|537768897|FG003|Overall Study|Lost to Follow-up|1|||
149078901|NCT02159989|537768898|FG004|Overall Study|Lost to Follow-up|0|||
149078902|NCT02159989|537768899|FG005|Overall Study|Lost to Follow-up|0|||
149078903|NCT02159989|537768900|FG006|Overall Study|Lost to Follow-up|0|||
149078904|NCT02159989|537768901|FG007|Overall Study|Lost to Follow-up|0|||
149078905|NCT02159989|537768902|FG008|Overall Study|Lost to Follow-up|0|||
149078906|NCT02159989|537768903|FG009|Overall Study|Lost to Follow-up|0|||
149078907|NCT02159989|537768904|FG010|Overall Study|Lost to Follow-up|1|||
149078908|NCT02159989|537768894|FG000|Overall Study|Withdrawal by Subject|2|||
149078909|NCT02159989|537768895|FG001|Overall Study|Withdrawal by Subject|0|||
149078910|NCT02159989|537768896|FG002|Overall Study|Withdrawal by Subject|0|||
149078911|NCT02159989|537768897|FG003|Overall Study|Withdrawal by Subject|2|||
149078912|NCT02159989|537768898|FG004|Overall Study|Withdrawal by Subject|1|||
149078913|NCT02159989|537768899|FG005|Overall Study|Withdrawal by Subject|0|||
149078914|NCT02159989|537768900|FG006|Overall Study|Withdrawal by Subject|3|||
149078915|NCT02159989|537768901|FG007|Overall Study|Withdrawal by Subject|1|||
149078916|NCT02159989|537768902|FG008|Overall Study|Withdrawal by Subject|0|||
149078917|NCT02159989|537768903|FG009|Overall Study|Withdrawal by Subject|0|||
149078918|NCT02159989|537768904|FG010|Overall Study|Withdrawal by Subject|0|||
149078919|NCT02159989|537768894|FG000|Overall Study|New treatment|0|||
149078920|NCT02159989|537768895|FG001|Overall Study|New treatment|1|||
149078921|NCT02159989|537768896|FG002|Overall Study|New treatment|0|||
149078922|NCT02159989|537768897|FG003|Overall Study|New treatment|0|||
149078923|NCT02159989|537768898|FG004|Overall Study|New treatment|0|||
149078924|NCT02159989|537768899|FG005|Overall Study|New treatment|0|||
149078925|NCT02159989|537768900|FG006|Overall Study|New treatment|0|||
149078926|NCT02159989|537768901|FG007|Overall Study|New treatment|0|||
149078927|NCT02159989|537768902|FG008|Overall Study|New treatment|0|||
149078928|NCT02159989|537768903|FG009|Overall Study|New treatment|0|||
149078929|NCT02159989|537768904|FG010|Overall Study|New treatment|0|||
149078930|NCT02159989|537768894|FG000|Overall Study|Insurance Issues|0|||
149078931|NCT02159989|537768895|FG001|Overall Study|Insurance Issues|0|||
149078932|NCT02159989|537768896|FG002|Overall Study|Insurance Issues|0|||
149078933|NCT02159989|537768897|FG003|Overall Study|Insurance Issues|0|||
149078934|NCT02159989|537768898|FG004|Overall Study|Insurance Issues|0|||
149078935|NCT02159989|537768899|FG005|Overall Study|Insurance Issues|0|||
149078936|NCT02159989|537768900|FG006|Overall Study|Insurance Issues|0|||
149078937|NCT02159989|537768901|FG007|Overall Study|Insurance Issues|0|||
149078938|NCT02159989|537768902|FG008|Overall Study|Insurance Issues|0|||
149078939|NCT02159989|537768903|FG009|Overall Study|Insurance Issues|1|||
149078940|NCT02159989|537768904|FG010|Overall Study|Insurance Issues|0|||
149078941|NCT05338476|537768906|FG000|Period 2|Adverse Event|0|||
149078942|NCT05338476|537768907|FG001|Period 2|Adverse Event|1|||
149078943|NCT02485925|537768908|FG000|Overall Study|Withdrawal by Subject|3|||
149078944|NCT02485925|537768908|FG000|Overall Study|Death|1|||
149078945|NCT02485925|537768908|FG000|Overall Study|Lost to Follow-up|11|||
149078946|NCT04186247|537768909|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
149078947|NCT04186247|537768910|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
149078948|NCT04186247|537768911|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
149078949|NCT04186247|537768912|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
149078950|NCT04186247|537768913|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
149078951|NCT01480258|537770851|FG000|Infant Series|Protocol Violation|2|||
149078952|NCT01480258|537770852|FG001|Infant Series|Protocol Violation|0|||
149078953|NCT01480258|537770851|FG000|Infant Series|Physician Decision|0|||
149078954|NCT01480258|537770852|FG001|Infant Series|Physician Decision|1|||
149078955|NCT01480258|537770851|FG000|Infant Series|Not Vaccinated|3|||
149078956|NCT01480258|537770852|FG001|Infant Series|Not Vaccinated|0|||
149078957|NCT01480258|537770851|FG000|Infant Series|Adverse Event|1|||
149078958|NCT01480258|537770852|FG001|Infant Series|Adverse Event|1|||
149078959|NCT01480258|537770851|FG000|Infant Series|Withdrawal by Subject|1|||
149078960|NCT01480258|537770852|FG001|Infant Series|Withdrawal by Subject|6|||
149078961|NCT01480258|537770851|FG000|Interim Period|Lost to Follow-up|0|||
149078962|NCT01480258|537770852|FG001|Interim Period|Lost to Follow-up|2|||
149078963|NCT01480258|537770851|FG000|Interim Period|Physician Decision|1|||
149078964|NCT01480258|537770852|FG001|Interim Period|Physician Decision|0|||
149078965|NCT01480258|537770851|FG000|Interim Period|Protocol Violation|0|||
149078966|NCT01480258|537770852|FG001|Interim Period|Protocol Violation|1|||
149078967|NCT01480258|537770851|FG000|Interim Period|Withdrawal by Subject|9|||
149078968|NCT01480258|537770852|FG001|Interim Period|Withdrawal by Subject|6|||
149078969|NCT02362789|537770860|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
149078970|NCT02362789|537770861|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
149078971|NCT02362789|537770862|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
149078972|NCT02362789|537770860|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
149078973|NCT02362789|537770861|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
149078974|NCT02362789|537770862|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
149078975|NCT02362789|537770860|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
149078976|NCT02362789|537770861|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
149078977|NCT02362789|537770862|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
149078978|NCT02362789|537770860|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
149078979|NCT02362789|537770861|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
149078980|NCT02362789|537770862|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
149078981|NCT02362789|537770860|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
149078982|NCT02362789|537770861|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
149078983|NCT02362789|537770862|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
149078984|NCT03861234|537770866|FG000|Overall Study|Not treated|0|||
149078985|NCT03861234|537770867|FG001|Overall Study|Not treated|0|||
149078986|NCT03861234|537770868|FG002|Overall Study|Not treated|0|||
149078987|NCT03861234|537770869|FG003|Overall Study|Not treated|0|||
149078988|NCT03861234|537770870|FG004|Overall Study|Not treated|0|||
149078989|NCT03861234|537770871|FG005|Overall Study|Not treated|1|||
149078990|NCT03861234|537770872|FG006|Overall Study|Not treated|0|||
149078991|NCT03861234|537770873|FG007|Overall Study|Not treated|0|||
149078992|NCT03861234|537770866|FG000|Overall Study|Adverse Event|0|||
149078993|NCT03861234|537770867|FG001|Overall Study|Adverse Event|0|||
149078994|NCT03861234|537770868|FG002|Overall Study|Adverse Event|0|||
149078995|NCT03861234|537770869|FG003|Overall Study|Adverse Event|0|||
149078996|NCT03861234|537770870|FG004|Overall Study|Adverse Event|0|||
149078997|NCT03861234|537770871|FG005|Overall Study|Adverse Event|1|||
149078998|NCT03861234|537770872|FG006|Overall Study|Adverse Event|0|||
149078999|NCT03861234|537770873|FG007|Overall Study|Adverse Event|0|||
149079000|NCT03861234|537770866|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
149079001|NCT03861234|537770867|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
149079002|NCT03861234|537770868|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
149006343|NCT04382924|537501832|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
149006344|NCT04382924|537501833|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
149006345|NCT04382924|537501831|FG000|Overall Study|Withdrawal by Subject|6|||
149006346|NCT04382924|537501832|FG001|Overall Study|Withdrawal by Subject|3|||
149006347|NCT04382924|537501833|FG002|Overall Study|Withdrawal by Subject|6|||
149006348|NCT01114204|537501839|FG000|Overall Study|Adverse Event|3|||
149006349|NCT01114204|537501840|FG001|Overall Study|Adverse Event|2|||
149006350|NCT01114204|537501839|FG000|Overall Study|Lost to Follow-up|1|||
149006351|NCT01114204|537501840|FG001|Overall Study|Lost to Follow-up|0|||
149006352|NCT01114204|537501839|FG000|Overall Study|Withdrawal by Subject|10|||
149006353|NCT01114204|537501840|FG001|Overall Study|Withdrawal by Subject|6|||
149006354|NCT01114204|537501839|FG000|Overall Study|Death|1|||
149006355|NCT01114204|537501840|FG001|Overall Study|Death|0|||
149006356|NCT01114204|537501839|FG000|Overall Study|Other-Personal reasons|2|||
149006357|NCT01114204|537501840|FG001|Overall Study|Other-Personal reasons|0|||
149006358|NCT01114204|537501839|FG000|Overall Study|Other-Medical monitor request|1|||
149006359|NCT01114204|537501840|FG001|Overall Study|Other-Medical monitor request|0|||
149006360|NCT01114204|537501839|FG000|Overall Study|Other-Participant request|2|||
149006361|NCT01114204|537501840|FG001|Overall Study|Other-Participant request|0|||
149006362|NCT01114204|537501839|FG000|Overall Study|Other-Protocol Violation|1|||
149006363|NCT01114204|537501840|FG001|Overall Study|Other-Protocol Violation|0|||
149006364|NCT00991341|537501845|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
149006365|NCT00991341|537501846|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
149006366|NCT00991341|537501845|FG000|Overall Study|Death|3|||
149006367|NCT00991341|537501846|FG001|Overall Study|Death|0|||
149006368|NCT00991341|537501845|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
149006369|NCT00991341|537501846|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
149006370|NCT00991341|537501845|FG000|Overall Study|Physician Decision|1|||
149006371|NCT00991341|537501846|FG001|Overall Study|Physician Decision|2|||
149006372|NCT00991341|537501845|FG000|Overall Study|Withdrawal by Subject|3|||
149006373|NCT00991341|537501846|FG001|Overall Study|Withdrawal by Subject|4|||
149006374|NCT00215540|537501862|FG000|Overall Study|Withdrew from study medication|1|||
149006375|NCT00215540|537501863|FG001|Overall Study|Withdrew from study medication|0|||
149006376|NCT00215540|537501864|FG002|Overall Study|Withdrew from study medication|0|||
149006377|NCT03010462|537501865|FG000|Overall Study|Withdrawal by Subject|3|||
149006378|NCT03010462|537501866|FG001|Overall Study|Withdrawal by Subject|1|||
149006379|NCT02799472|537501868|FG000|Overall Study|Withdrawal by Subject|2|||
149006380|NCT02799472|537501869|FG001|Overall Study|Withdrawal by Subject|4|||
149006381|NCT02799472|537501868|FG000|Overall Study|Lack of Efficacy|2|||
149079003|NCT03861234|537770869|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
149079004|NCT03861234|537770870|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
149079005|NCT03861234|537770871|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
149079006|NCT03861234|537770872|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
149079007|NCT03861234|537770873|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
149079008|NCT03861234|537770866|FG000|Overall Study|As per sponsor decision|0|||
149079009|NCT03861234|537770867|FG001|Overall Study|As per sponsor decision|0|||
149079010|NCT03861234|537770868|FG002|Overall Study|As per sponsor decision|0|||
149079011|NCT03861234|537770869|FG003|Overall Study|As per sponsor decision|0|||
149079012|NCT03861234|537770870|FG004|Overall Study|As per sponsor decision|0|||
149079013|NCT03861234|537770871|FG005|Overall Study|As per sponsor decision|0|||
149079014|NCT03861234|537770872|FG006|Overall Study|As per sponsor decision|1|||
149079015|NCT03861234|537770873|FG007|Overall Study|As per sponsor decision|0|||
149079016|NCT03861234|537770866|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
149079017|NCT03861234|537770867|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
149079018|NCT03861234|537770868|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
149079019|NCT03861234|537770869|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
149079020|NCT03861234|537770870|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
149079021|NCT03861234|537770871|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
149079022|NCT03861234|537770872|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
149079023|NCT03861234|537770873|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
149079024|NCT00621842|537770874|FG000|Overall Study|Adverse Event|6|||
149079025|NCT00621842|537770874|FG000|Overall Study|Withdrawal by Subject|7|||
149079026|NCT00621842|537770874|FG000|Overall Study|Protocol Violation|4|||
149079027|NCT00621842|537770874|FG000|Overall Study|Lack of Efficacy|2|||
149079028|NCT05074433|537770875|FG000|Overall Study|Adverse Event|0|||
149079029|NCT05074433|537770876|FG001|Overall Study|Adverse Event|2|||
149079030|NCT05074433|537770877|FG002|Overall Study|Adverse Event|0|||
149006382|NCT02799472|537501869|FG001|Overall Study|Lack of Efficacy|0|||
149006383|NCT02799472|537501868|FG000|Overall Study|Lost to Follow-up|0|||
149006384|NCT02799472|537501869|FG001|Overall Study|Lost to Follow-up|1|||
149006385|NCT02007434|537501870|FG000|Overall Study|Lost to Follow-up|0|||
149006386|NCT02007434|537501871|FG001|Overall Study|Lost to Follow-up|1|||
149006387|NCT02007434|537501872|FG002|Overall Study|Lost to Follow-up|0|||
149006388|NCT02007434|537501873|FG003|Overall Study|Lost to Follow-up|0|||
149006389|NCT02007434|537501874|FG004|Overall Study|Lost to Follow-up|0|||
149006390|NCT02007434|537501875|FG005|Overall Study|Lost to Follow-up|0|||
149006391|NCT02007434|537501876|FG006|Overall Study|Lost to Follow-up|0|||
149006392|NCT02007434|537501877|FG007|Overall Study|Lost to Follow-up|0|||
149006393|NCT02007434|537501870|FG000|Overall Study|Non-compliance|1|||
149006394|NCT02007434|537501871|FG001|Overall Study|Non-compliance|0|||
149006395|NCT02007434|537501872|FG002|Overall Study|Non-compliance|1|||
149006396|NCT02007434|537501873|FG003|Overall Study|Non-compliance|0|||
149006397|NCT02007434|537501874|FG004|Overall Study|Non-compliance|0|||
149006398|NCT02007434|537501875|FG005|Overall Study|Non-compliance|0|||
149006399|NCT02007434|537501876|FG006|Overall Study|Non-compliance|0|||
149006400|NCT02007434|537501877|FG007|Overall Study|Non-compliance|0|||
149006401|NCT04766086|537501894|FG000|Overall Study|Lost to Follow-up|3|||
149006402|NCT04766086|537501895|FG001|Overall Study|Lost to Follow-up|5|||
149006403|NCT04766086|537501896|FG002|Overall Study|Lost to Follow-up|3|||
149006404|NCT04766086|537501894|FG000|Overall Study|Withdrawal by Subject|1|||
149006405|NCT04766086|537501895|FG001|Overall Study|Withdrawal by Subject|1|||
149006406|NCT04766086|537501896|FG002|Overall Study|Withdrawal by Subject|2|||
149006407|NCT04766086|537501894|FG000|Overall Study|Other|0|||
149006408|NCT04766086|537501895|FG001|Overall Study|Other|0|||
149006409|NCT04766086|537501896|FG002|Overall Study|Other|1|||
149006410|NCT01959347|537501897|FG000|Overall Study|Protocol Violation|9|||
149006411|NCT01959347|537501898|FG001|Overall Study|Protocol Violation|7|||
149006412|NCT03541044|537501899|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
149006413|NCT03541044|537501900|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
149006414|NCT03541044|537501899|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
149006415|NCT03541044|537501900|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
149006416|NCT04581200|537501901|FG000|Overall Study|Lost to Follow-up|6|||
149006417|NCT04581200|537501902|FG001|Overall Study|Lost to Follow-up|5|||
149006418|NCT03131960|537501903|FG000|Overall Study|Adverse Event|0|||
149006419|NCT03131960|537501904|FG001|Overall Study|Adverse Event|1|||
149079031|NCT05074433|537770878|FG003|Overall Study|Adverse Event|1|||
149079032|NCT05074433|537770875|FG000|Overall Study|Sponsor Request|0|||
149079033|NCT05074433|537770876|FG001|Overall Study|Sponsor Request|1|||
149079034|NCT05074433|537770877|FG002|Overall Study|Sponsor Request|1|||
149079035|NCT05074433|537770878|FG003|Overall Study|Sponsor Request|0|||
149079036|NCT05074433|537770875|FG000|Overall Study|Death|1|||
149079037|NCT05074433|537770876|FG001|Overall Study|Death|0|||
149079038|NCT05074433|537770877|FG002|Overall Study|Death|0|||
149079039|NCT05074433|537770878|FG003|Overall Study|Death|0|||
149079040|NCT05074433|537770875|FG000|Overall Study|Lost to Follow-up|0|||
149079041|NCT05074433|537770876|FG001|Overall Study|Lost to Follow-up|0|||
149079042|NCT05074433|537770877|FG002|Overall Study|Lost to Follow-up|2|||
149079043|NCT05074433|537770878|FG003|Overall Study|Lost to Follow-up|0|||
149079044|NCT05074433|537770875|FG000|Overall Study|Subject Decision|8|||
149079045|NCT05074433|537770876|FG001|Overall Study|Subject Decision|6|||
149079046|NCT05074433|537770877|FG002|Overall Study|Subject Decision|4|||
149079047|NCT05074433|537770878|FG003|Overall Study|Subject Decision|5|||
149079048|NCT04397263|537770879|FG000|Overall Study|Withdrawal by Subject|2|||
149079049|NCT01989689|537770880|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
149079050|NCT01989689|537770881|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
149079051|NCT01989689|537770880|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
149079052|NCT01989689|537770881|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
149079053|NCT02066636|537770882|FG000|Overall Study|Disease progression|51|||
149079054|NCT02066636|537770883|FG001|Overall Study|Disease progression|60|||
149079055|NCT02066636|537770884|FG002|Overall Study|Disease progression|700|||
149079056|NCT02066636|537770882|FG000|Overall Study|Study drug toxicity|13|||
149079057|NCT02066636|537770883|FG001|Overall Study|Study drug toxicity|2|||
149079058|NCT02066636|537770884|FG002|Overall Study|Study drug toxicity|58|||
149079059|NCT02066636|537770882|FG000|Overall Study|Death|4|||
149079060|NCT02066636|537770883|FG001|Overall Study|Death|2|||
149079061|NCT02066636|537770884|FG002|Overall Study|Death|158|||
149079062|NCT02066636|537770882|FG000|Overall Study|Adverse event unrelated to study drug|6|||
149079063|NCT02066636|537770883|FG001|Overall Study|Adverse event unrelated to study drug|4|||
149079064|NCT02066636|537770884|FG002|Overall Study|Adverse event unrelated to study drug|45|||
149079065|NCT02066636|537770882|FG000|Overall Study|Participant request to discontinue treatment|12|||
149079066|NCT02066636|537770883|FG001|Overall Study|Participant request to discontinue treatment|12|||
149079067|NCT02066636|537770884|FG002|Overall Study|Participant request to discontinue treatment|70|||
149079068|NCT02066636|537770882|FG000|Overall Study|Participant withdrew consent|10|||
149079069|NCT02066636|537770883|FG001|Overall Study|Participant withdrew consent|18|||
149079070|NCT02066636|537770884|FG002|Overall Study|Participant withdrew consent|61|||
149079071|NCT02066636|537770882|FG000|Overall Study|Lost to Follow-up|0|||
149079072|NCT02066636|537770883|FG001|Overall Study|Lost to Follow-up|2|||
149079073|NCT02066636|537770884|FG002|Overall Study|Lost to Follow-up|2|||
149079074|NCT02066636|537770882|FG000|Overall Study|Maximum clinical benefit|2|||
149079075|NCT02066636|537770883|FG001|Overall Study|Maximum clinical benefit|2|||
149079076|NCT02066636|537770884|FG002|Overall Study|Maximum clinical benefit|3|||
149079077|NCT02066636|537770882|FG000|Overall Study|Poor/non-compliance|2|||
149079078|NCT02066636|537770883|FG001|Overall Study|Poor/non-compliance|1|||
149079079|NCT02066636|537770884|FG002|Overall Study|Poor/non-compliance|1|||
149079080|NCT02066636|537770882|FG000|Overall Study|Participant no loner meets study criteria|3|||
149079081|NCT02066636|537770883|FG001|Overall Study|Participant no loner meets study criteria|2|||
149079082|NCT02066636|537770884|FG002|Overall Study|Participant no loner meets study criteria|28|||
149079083|NCT02066636|537770882|FG000|Overall Study|Administrative reasons by sponsor|8|||
149079084|NCT02066636|537770883|FG001|Overall Study|Administrative reasons by sponsor|5|||
149079085|NCT02066636|537770884|FG002|Overall Study|Administrative reasons by sponsor|0|||
149079086|NCT02066636|537770882|FG000|Overall Study|Other reasons|16|||
149079087|NCT02066636|537770883|FG001|Overall Study|Other reasons|15|||
149079088|NCT02066636|537770884|FG002|Overall Study|Other reasons|50|||
149079089|NCT00391170|537770893|FG000|Overall Study|Withdrawal by Subject|1|||
149079090|NCT00391170|537770894|FG001|Overall Study|Withdrawal by Subject|0|||
149079091|NCT00391170|537770893|FG000|Overall Study|Adverse Event|3|||
149079092|NCT00391170|537770894|FG001|Overall Study|Adverse Event|2|||
149079093|NCT00391170|537770893|FG000|Overall Study|Physician Decision|2|||
149079094|NCT00391170|537770894|FG001|Overall Study|Physician Decision|2|||
149079095|NCT03567616|537770899|FG000|Overall Study|Disease progression|4|||
149079096|NCT03567616|537770899|FG000|Overall Study|Withdrawal by Subject|1|||
149079097|NCT03567616|537770899|FG000|Overall Study|Physician Decision|1|||
149079098|NCT03567616|537770899|FG000|Overall Study|Death|1|||
149079099|NCT03567616|537770899|FG000|Overall Study|Adverse Event|1|||
149079100|NCT00705159|537770908|FG000|Overall Study|Withdrawal by Subject|0|||
149079101|NCT00705159|537770909|FG001|Overall Study|Withdrawal by Subject|1|||
149079102|NCT00705159|537770910|FG002|Overall Study|Withdrawal by Subject|1|||
149079103|NCT00705159|537770911|FG003|Overall Study|Withdrawal by Subject|1|||
149079104|NCT00705159|537770908|FG000|Overall Study|Protocol Violation|0|||
149079105|NCT00705159|537770909|FG001|Overall Study|Protocol Violation|1|||
149079106|NCT00705159|537770910|FG002|Overall Study|Protocol Violation|0|||
149079107|NCT00705159|537770911|FG003|Overall Study|Protocol Violation|0|||
149079108|NCT00705159|537770908|FG000|Overall Study|Adverse Event|0|||
149079109|NCT00705159|537770909|FG001|Overall Study|Adverse Event|0|||
149079110|NCT00705159|537770910|FG002|Overall Study|Adverse Event|1|||
149079111|NCT00705159|537770911|FG003|Overall Study|Adverse Event|0|||
149079112|NCT00705159|537770908|FG000|Overall Study|Lost to Follow-up|0|||
149079113|NCT00705159|537770909|FG001|Overall Study|Lost to Follow-up|0|||
149079114|NCT00705159|537770910|FG002|Overall Study|Lost to Follow-up|3|||
149079115|NCT00705159|537770911|FG003|Overall Study|Lost to Follow-up|2|||
149079116|NCT00705159|537770908|FG000|Overall Study|Screen Failure|0|||
149079117|NCT00705159|537770909|FG001|Overall Study|Screen Failure|0|||
149079118|NCT00705159|537770910|FG002|Overall Study|Screen Failure|0|||
149079119|NCT00705159|537770911|FG003|Overall Study|Screen Failure|1|||
149079120|NCT00526994|537770912|FG000|Overall Study|Lost to Follow-up|98|||
149079121|NCT00526994|537770913|FG001|Overall Study|Lost to Follow-up|108|||
149079122|NCT00526994|537770914|FG002|Overall Study|Lost to Follow-up|96|||
149079123|NCT00526994|537770912|FG000|Overall Study|Death|4|||
149079124|NCT00526994|537770913|FG001|Overall Study|Death|3|||
149079125|NCT00526994|537770914|FG002|Overall Study|Death|3|||
149079126|NCT00526994|537770912|FG000|Overall Study|Withdrawal by Subject|2|||
149079127|NCT00526994|537770913|FG001|Overall Study|Withdrawal by Subject|7|||
149079128|NCT00526994|537770914|FG002|Overall Study|Withdrawal by Subject|5|||
149079129|NCT00526994|537770912|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
149079130|NCT00526994|537770913|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
149079131|NCT00526994|537770914|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
149079132|NCT03026166|537770915|FG000|Overall Study|Death|22|||
149079133|NCT03026166|537770916|FG001|Overall Study|Death|7|||
149079134|NCT03026166|537770915|FG000|Overall Study|Physician Decision|2|||
149079135|NCT03026166|537770916|FG001|Overall Study|Physician Decision|0|||
149079136|NCT03026166|537770915|FG000|Overall Study|Withdrawal by Subject|1|||
149079137|NCT03026166|537770916|FG001|Overall Study|Withdrawal by Subject|2|||
149079138|NCT03026166|537770915|FG000|Overall Study|Lost to Follow-up|1|||
149079139|NCT03026166|537770916|FG001|Overall Study|Lost to Follow-up|0|||
149079140|NCT03026166|537770915|FG000|Overall Study|Study Terminated by Sponsor|3|||
149079141|NCT03026166|537770916|FG001|Overall Study|Study Terminated by Sponsor|3|||
149079142|NCT03026166|537770915|FG000|Overall Study|Other|1|||
149079143|NCT03026166|537770916|FG001|Overall Study|Other|0|||
149079144|NCT05270460|537770917|FG000|Overall Study|Adverse Event|0|||
149079145|NCT05270460|537770918|FG001|Overall Study|Adverse Event|1|||
149079146|NCT05270460|537770919|FG002|Overall Study|Adverse Event|0|||
149079147|NCT05270460|537770917|FG000|Overall Study|Early Termination|0|||
149079148|NCT05270460|537770918|FG001|Overall Study|Early Termination|1|||
149079149|NCT05270460|537770919|FG002|Overall Study|Early Termination|0|||
149079150|NCT00380250|537770920|FG000|Overall Study|Withdrawal by Subject|39|||
149079151|NCT00380250|537770921|FG001|Overall Study|Withdrawal by Subject|28|||
149079152|NCT00380250|537770920|FG000|Overall Study|Adverse Event|20|||
149079153|NCT00380250|537770921|FG001|Overall Study|Adverse Event|9|||
149079154|NCT00380250|537770920|FG000|Overall Study|Lack of Efficacy|10|||
149079155|NCT00380250|537770921|FG001|Overall Study|Lack of Efficacy|8|||
149079156|NCT00380250|537770920|FG000|Overall Study|Protocol Violation|15|||
149079157|NCT00380250|537770921|FG001|Overall Study|Protocol Violation|5|||
149079158|NCT00380250|537770920|FG000|Overall Study|Lost to Follow-up|14|||
149079159|NCT00380250|537770921|FG001|Overall Study|Lost to Follow-up|5|||
149079160|NCT00380250|537770920|FG000|Overall Study|Physician Decision|1|||
149079161|NCT00380250|537770921|FG001|Overall Study|Physician Decision|0|||
149079162|NCT02833948|537770924|FG000|Overall Study|Death|2|||
149079163|NCT02833948|537770925|FG001|Overall Study|Death|3|||
149079164|NCT02833948|537770924|FG000|Overall Study|were not scanned|8|||
149079165|NCT02833948|537770925|FG001|Overall Study|were not scanned|13|||
149079166|NCT02833948|537770924|FG000|Overall Study|scans could not be evaluated|5|||
149079167|NCT02833948|537770925|FG001|Overall Study|scans could not be evaluated|2|||
149079168|NCT00680771|537770931|FG000|Overall Study|Withdrawal by Subject|1|||
149079169|NCT00680771|537770932|FG001|Overall Study|Withdrawal by Subject|0|||
149079170|NCT00680771|537770931|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
149079171|NCT00680771|537770932|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
149079172|NCT00680771|537770931|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
149079173|NCT00680771|537770932|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
149079174|NCT02691702|537770933|FG000|Overall Study|Adverse Event|1|||
149079175|NCT02691702|537770934|FG001|Overall Study|Adverse Event|0|||
149079176|NCT02691702|537770935|FG002|Overall Study|Adverse Event|0|||
149079177|NCT02691702|537770936|FG003|Overall Study|Adverse Event|0|||
149079178|NCT02691702|537770937|FG004|Overall Study|Adverse Event|0|||
149079179|NCT02691702|537770938|FG005|Overall Study|Adverse Event|0|||
149079180|NCT02691702|537770939|FG006|Overall Study|Adverse Event|0|||
149079181|NCT02691702|537770940|FG007|Overall Study|Adverse Event|0|||
149079182|NCT02691702|537770941|FG008|Overall Study|Adverse Event|1|||
149079183|NCT02691702|537770942|FG009|Overall Study|Adverse Event|0|||
149079184|NCT02691702|537770943|FG010|Overall Study|Adverse Event|1|||
149079185|NCT02691702|537770933|FG000|Overall Study|Lost to Follow-up|0|||
149079186|NCT02691702|537770934|FG001|Overall Study|Lost to Follow-up|0|||
149079187|NCT02691702|537770935|FG002|Overall Study|Lost to Follow-up|1|||
149079188|NCT02691702|537770936|FG003|Overall Study|Lost to Follow-up|0|||
149079189|NCT02691702|537770937|FG004|Overall Study|Lost to Follow-up|0|||
149079190|NCT02691702|537770938|FG005|Overall Study|Lost to Follow-up|2|||
149079191|NCT02691702|537770939|FG006|Overall Study|Lost to Follow-up|0|||
149079192|NCT02691702|537770940|FG007|Overall Study|Lost to Follow-up|0|||
149079193|NCT02691702|537770941|FG008|Overall Study|Lost to Follow-up|0|||
149079194|NCT02691702|537770942|FG009|Overall Study|Lost to Follow-up|0|||
149079195|NCT02691702|537770943|FG010|Overall Study|Lost to Follow-up|1|||
149079196|NCT02691702|537770933|FG000|Overall Study|Withdrawal by Subject|1|||
149079197|NCT02691702|537770934|FG001|Overall Study|Withdrawal by Subject|1|||
149079198|NCT02691702|537770935|FG002|Overall Study|Withdrawal by Subject|0|||
149079199|NCT02691702|537770936|FG003|Overall Study|Withdrawal by Subject|0|||
149079200|NCT02691702|537770937|FG004|Overall Study|Withdrawal by Subject|0|||
149079201|NCT02691702|537770938|FG005|Overall Study|Withdrawal by Subject|1|||
149079202|NCT02691702|537770939|FG006|Overall Study|Withdrawal by Subject|2|||
149079203|NCT02691702|537770940|FG007|Overall Study|Withdrawal by Subject|0|||
149079204|NCT02691702|537770941|FG008|Overall Study|Withdrawal by Subject|0|||
149079205|NCT02691702|537770942|FG009|Overall Study|Withdrawal by Subject|0|||
149079206|NCT02691702|537770943|FG010|Overall Study|Withdrawal by Subject|0|||
149079207|NCT02691702|537770933|FG000|Overall Study|Other|0|||
149079208|NCT02691702|537770934|FG001|Overall Study|Other|0|||
149079209|NCT02691702|537770935|FG002|Overall Study|Other|0|||
149079210|NCT02691702|537770936|FG003|Overall Study|Other|0|||
149079211|NCT02691702|537770937|FG004|Overall Study|Other|0|||
149079212|NCT02691702|537770938|FG005|Overall Study|Other|0|||
149079213|NCT02691702|537770939|FG006|Overall Study|Other|1|||
149079214|NCT02691702|537770940|FG007|Overall Study|Other|0|||
149079215|NCT02691702|537770941|FG008|Overall Study|Other|1|||
149079216|NCT02691702|537770942|FG009|Overall Study|Other|0|||
149079217|NCT02691702|537770943|FG010|Overall Study|Other|0|||
149079218|NCT02691702|537770933|FG000|Overall Study|Protocol Violation|0|||
149079219|NCT02691702|537770934|FG001|Overall Study|Protocol Violation|0|||
149079220|NCT02691702|537770935|FG002|Overall Study|Protocol Violation|0|||
149079221|NCT02691702|537770936|FG003|Overall Study|Protocol Violation|0|||
149079222|NCT02691702|537770937|FG004|Overall Study|Protocol Violation|0|||
149079223|NCT02691702|537770938|FG005|Overall Study|Protocol Violation|0|||
149079224|NCT02691702|537770939|FG006|Overall Study|Protocol Violation|0|||
149079225|NCT02691702|537770940|FG007|Overall Study|Protocol Violation|0|||
149079226|NCT02691702|537770941|FG008|Overall Study|Protocol Violation|0|||
149079227|NCT02691702|537770942|FG009|Overall Study|Protocol Violation|2|||
149079228|NCT02691702|537770943|FG010|Overall Study|Protocol Violation|0|||
149079229|NCT05613088|537770944|FG000|Treatment|Ongoing Study Treatment|9|||
149079230|NCT05613088|537770945|FG001|Treatment|Ongoing Study Treatment|2|||
149079231|NCT05613088|537770944|FG000|Treatment|Adverse Event|3|||
149079232|NCT05613088|537770945|FG001|Treatment|Adverse Event|1|||
149079233|NCT05613088|537770944|FG000|Treatment|Other Reasons|0|||
149079234|NCT05613088|537770945|FG001|Treatment|Other Reasons|1|||
149079235|NCT05613088|537770944|FG000|Treatment|Progressive Disease|58|||
149079236|NCT05613088|537770945|FG001|Treatment|Progressive Disease|26|||
149079237|NCT05613088|537770944|FG000|Treatment|Withdrawal by Subject|0|||
149079238|NCT05613088|537770945|FG001|Treatment|Withdrawal by Subject|4|||
149079239|NCT05169684|537770946|FG000|Overall Study|Adverse Event|1|||
149079240|NCT05169684|537770947|FG001|Overall Study|Adverse Event|3|||
149079241|NCT05169684|537770946|FG000|Overall Study|Physician Decision|0|||
149079242|NCT05169684|537770947|FG001|Overall Study|Physician Decision|1|||
149079243|NCT05169684|537770946|FG000|Overall Study|Progressive Disease|1|||
149079244|NCT05169684|537770947|FG001|Overall Study|Progressive Disease|1|||
149079245|NCT05169684|537770946|FG000|Overall Study|Participant request to discontinue treatment|0|||
149079246|NCT05169684|537770947|FG001|Overall Study|Participant request to discontinue treatment|1|||
149079247|NCT05169684|537770946|FG000|Overall Study|Other Reason|0|||
149079248|NCT05169684|537770947|FG001|Overall Study|Other Reason|1|||
149079249|NCT01668719|537770948|FG000|Phase I|On treatment|1|||
149079250|NCT01668719|537770949|FG001|Phase I|On treatment|0|||
149079251|NCT01668719|537770950|FG002|Phase I|On treatment|0|||
149079252|NCT01668719|537770948|FG000|Phase I|Adverse Event|2|||
149079253|NCT01668719|537770949|FG001|Phase I|Adverse Event|0|||
149079254|NCT01668719|537770950|FG002|Phase I|Adverse Event|0|||
149079255|NCT01668719|537770948|FG000|Phase I|Progression/relapse|1|||
149079256|NCT01668719|537770949|FG001|Phase I|Progression/relapse|0|||
149079257|NCT01668719|537770950|FG002|Phase I|Progression/relapse|0|||
149079258|NCT01668719|537770948|FG000|Phase I|not protocol specified|2|||
149079259|NCT01668719|537770949|FG001|Phase I|not protocol specified|0|||
149079260|NCT01668719|537770950|FG002|Phase I|not protocol specified|0|||
149079261|NCT01668719|537770948|FG000|Phase II|On treatment|0|||
149079262|NCT01668719|537770949|FG001|Phase II|On treatment|4|||
149079263|NCT01668719|537770950|FG002|Phase II|On treatment|3|||
149079264|NCT01668719|537770948|FG000|Phase II|Adverse Event|0|||
149079265|NCT01668719|537770949|FG001|Phase II|Adverse Event|18|||
149079266|NCT01668719|537770950|FG002|Phase II|Adverse Event|18|||
149079267|NCT01668719|537770948|FG000|Phase II|Refusal unrelated to adverse event|0|||
149079268|NCT01668719|537770949|FG001|Phase II|Refusal unrelated to adverse event|4|||
149079269|NCT01668719|537770950|FG002|Phase II|Refusal unrelated to adverse event|1|||
149079270|NCT01668719|537770948|FG000|Phase II|Progression/relapse|0|||
149079271|NCT01668719|537770949|FG001|Phase II|Progression/relapse|13|||
149079272|NCT01668719|537770950|FG002|Phase II|Progression/relapse|17|||
149079273|NCT01668719|537770948|FG000|Phase II|Death|0|||
149079274|NCT01668719|537770949|FG001|Phase II|Death|0|||
149079275|NCT01668719|537770950|FG002|Phase II|Death|2|||
149079276|NCT01668719|537770948|FG000|Phase II|not protocol specified|0|||
149079277|NCT01668719|537770949|FG001|Phase II|not protocol specified|13|||
149079278|NCT01668719|537770950|FG002|Phase II|not protocol specified|7|||
149079279|NCT03539055|537770951|FG000|Overall Study|Death|4|||
149079280|NCT03539055|537770951|FG000|Overall Study|Lost to Follow-up|1|||
149079281|NCT03539055|537770951|FG000|Overall Study|Withdrawal by Subject|2|||
149079282|NCT03539055|537770951|FG000|Overall Study|Screen Fail|7|||
149079283|NCT03539055|537770951|FG000|Overall Study|Drug Intolerance|2|||
149079284|NCT01638000|537770958|FG000|Overall Study|Randomized but Never Received Drug|7|||
149079285|NCT01638000|537770959|FG001|Overall Study|Randomized but Never Received Drug|10|||
149079286|NCT01638000|537770958|FG000|Overall Study|Adverse Event|14|||
149079287|NCT01638000|537770959|FG001|Overall Study|Adverse Event|16|||
149079288|NCT01638000|537770958|FG000|Overall Study|Lack of Efficacy|5|||
149079289|NCT01638000|537770959|FG001|Overall Study|Lack of Efficacy|6|||
149079290|NCT01638000|537770958|FG000|Overall Study|Protocol Violation|11|||
149079291|NCT01638000|537770959|FG001|Overall Study|Protocol Violation|13|||
149079292|NCT01638000|537770958|FG000|Overall Study|Withdrawal by Subject|21|||
149079293|NCT01638000|537770959|FG001|Overall Study|Withdrawal by Subject|24|||
149079294|NCT01638000|537770958|FG000|Overall Study|Miscellaneous|2|||
149079295|NCT01638000|537770959|FG001|Overall Study|Miscellaneous|2|||
149079296|NCT00875706|537770960|FG000|Overall Study|Withdrawal by Subject|1|||
149079297|NCT00875706|537770961|FG001|Overall Study|Withdrawal by Subject|0|||
149079298|NCT00875706|537770962|FG002|Overall Study|Withdrawal by Subject|0|||
149079299|NCT03652610|537770963|FG000|Overall Study|Lost to Follow-up|1|||
149079300|NCT03652610|537770964|FG001|Overall Study|Lost to Follow-up|0|||
149079301|NCT03652610|537770963|FG000|Overall Study|Withdrawal by Subject|3|||
149079302|NCT03652610|537770964|FG001|Overall Study|Withdrawal by Subject|5|||
149079303|NCT03775213|537770965|FG000|Overall Study|Withdrawal by Subject|51|||
149079304|NCT03775213|537770966|FG001|Overall Study|Withdrawal by Subject|53|||
149079305|NCT03775213|537770965|FG000|Overall Study|Incomplete Survey|7|||
149079306|NCT03775213|537770966|FG001|Overall Study|Incomplete Survey|7|||
149079307|NCT00786188|537770967|FG000|Overall Study|Adverse Event|3|||
149079308|NCT00786188|537770968|FG001|Overall Study|Adverse Event|1|||
149079309|NCT00786188|537770967|FG000|Overall Study|Withdrawal by Subject|2|||
149079310|NCT00786188|537770968|FG001|Overall Study|Withdrawal by Subject|0|||
149079311|NCT00326183|537770969|FG000|Overall Study|Lost to Follow-up|104|||
149079312|NCT00326183|537770970|FG001|Overall Study|Lost to Follow-up|56|||
149079313|NCT00326183|537770969|FG000|Overall Study|Protocol Violation|6|||
149079314|NCT00326183|537770970|FG001|Overall Study|Protocol Violation|3|||
149079315|NCT00326183|537770969|FG000|Overall Study|Withdrawal by Subject|35|||
149079316|NCT00326183|537770970|FG001|Overall Study|Withdrawal by Subject|7|||
149079317|NCT00326183|537770969|FG000|Overall Study|Subject Moved|7|||
149079318|NCT00326183|537770970|FG001|Overall Study|Subject Moved|4|||
149079319|NCT00326183|537770969|FG000|Overall Study|Other|47|||
149079320|NCT00326183|537770970|FG001|Overall Study|Other|13|||
149079321|NCT00326183|537770969|FG000|Overall Study|Adverse Event|1|||
149079322|NCT00326183|537770970|FG001|Overall Study|Adverse Event|0|||
149079323|NCT00824408|537770974|FG000|Run-in Phase|Progressive disease|4|||
149079324|NCT00824408|537770975|FG001|Run-in Phase|Progressive disease|4|||
149079325|NCT00824408|537770976|FG002|Run-in Phase|Progressive disease|0|||
149079326|NCT00824408|537770977|FG003|Run-in Phase|Progressive disease|0|||
149079327|NCT00824408|537770978|FG004|Run-in Phase|Progressive disease|0|||
149079328|NCT00824408|537770974|FG000|Run-in Phase|Adverse Event|1|||
149079329|NCT00824408|537770975|FG001|Run-in Phase|Adverse Event|1|||
149079330|NCT00824408|537770976|FG002|Run-in Phase|Adverse Event|0|||
149079331|NCT00824408|537770977|FG003|Run-in Phase|Adverse Event|0|||
149079332|NCT00824408|537770978|FG004|Run-in Phase|Adverse Event|0|||
149079333|NCT00824408|537770974|FG000|Run-in Phase|Refused to continue medication|1|||
149079334|NCT00824408|537770975|FG001|Run-in Phase|Refused to continue medication|0|||
149079335|NCT00824408|537770976|FG002|Run-in Phase|Refused to continue medication|0|||
149079336|NCT00824408|537770977|FG003|Run-in Phase|Refused to continue medication|0|||
149079337|NCT00824408|537770978|FG004|Run-in Phase|Refused to continue medication|0|||
149079338|NCT00824408|537770974|FG000|Run-in Phase|Other reason not defined above|0|||
149079339|NCT00824408|537770975|FG001|Run-in Phase|Other reason not defined above|1|||
149079340|NCT00824408|537770976|FG002|Run-in Phase|Other reason not defined above|0|||
149079341|NCT00824408|537770977|FG003|Run-in Phase|Other reason not defined above|0|||
149079342|NCT00824408|537770978|FG004|Run-in Phase|Other reason not defined above|0|||
149079343|NCT00824408|537770974|FG000|Randomized Phase|Not treated|0|||
149079344|NCT00824408|537770975|FG001|Randomized Phase|Not treated|0|||
149079345|NCT00824408|537770976|FG002|Randomized Phase|Not treated|1|||
149079346|NCT00824408|537770977|FG003|Randomized Phase|Not treated|1|||
149079347|NCT00824408|537770978|FG004|Randomized Phase|Not treated|1|||
149079348|NCT00824408|537770974|FG000|Randomized Phase|Progressive disease|0|||
149079349|NCT00824408|537770975|FG001|Randomized Phase|Progressive disease|0|||
149079350|NCT00824408|537770976|FG002|Randomized Phase|Progressive disease|25|||
149079351|NCT00824408|537770977|FG003|Randomized Phase|Progressive disease|36|||
149079352|NCT00824408|537770978|FG004|Randomized Phase|Progressive disease|34|||
149079353|NCT00824408|537770974|FG000|Randomized Phase|Adverse Event|0|||
149079354|NCT00824408|537770975|FG001|Randomized Phase|Adverse Event|0|||
149079355|NCT00824408|537770976|FG002|Randomized Phase|Adverse Event|4|||
149079356|NCT00824408|537770977|FG003|Randomized Phase|Adverse Event|5|||
149079357|NCT00824408|537770978|FG004|Randomized Phase|Adverse Event|5|||
149079358|NCT00824408|537770974|FG000|Randomized Phase|Refused to continue medication|0|||
149079359|NCT00824408|537770975|FG001|Randomized Phase|Refused to continue medication|0|||
149079360|NCT00824408|537770976|FG002|Randomized Phase|Refused to continue medication|2|||
149079361|NCT00824408|537770977|FG003|Randomized Phase|Refused to continue medication|2|||
149079362|NCT00824408|537770978|FG004|Randomized Phase|Refused to continue medication|2|||
149079363|NCT00824408|537770974|FG000|Randomized Phase|Other reason not defined above|0|||
149079364|NCT00824408|537770975|FG001|Randomized Phase|Other reason not defined above|0|||
149079365|NCT00824408|537770976|FG002|Randomized Phase|Other reason not defined above|4|||
149079366|NCT00824408|537770977|FG003|Randomized Phase|Other reason not defined above|2|||
149079367|NCT00824408|537770978|FG004|Randomized Phase|Other reason not defined above|4|||
149079368|NCT04821271|537770981|FG000|Period 1|Withdrawal by Subject|2|||
149079369|NCT04821271|537770982|FG001|Period 1|Withdrawal by Subject|0|||
149079370|NCT02521493|537770983|FG000|Overall Study|Death|3|||
149079371|NCT02521493|537770984|FG001|Overall Study|Death|4|||
149079372|NCT02521493|537770985|FG002|Overall Study|Death|1|||
149079373|NCT02521493|537770983|FG000|Overall Study|Physician Decision|19|||
149079374|NCT02521493|537770984|FG001|Overall Study|Physician Decision|1|||
149079375|NCT02521493|537770985|FG002|Overall Study|Physician Decision|2|||
149079376|NCT02521493|537770983|FG000|Overall Study|Withdrawal by Subject|3|||
149079377|NCT02521493|537770984|FG001|Overall Study|Withdrawal by Subject|0|||
149079378|NCT02521493|537770985|FG002|Overall Study|Withdrawal by Subject|0|||
149079379|NCT02521493|537770983|FG000|Overall Study|Ineligible|0|||
149079380|NCT02521493|537770984|FG001|Overall Study|Ineligible|1|||
149079381|NCT02521493|537770985|FG002|Overall Study|Ineligible|0|||
149079382|NCT02521493|537770983|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
149079383|NCT02521493|537770984|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
149079384|NCT02521493|537770985|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
149079385|NCT02521493|537770983|FG000|Overall Study|No MRD result|0|||
149079386|NCT02521493|537770984|FG001|Overall Study|No MRD result|0|||
149079387|NCT02521493|537770985|FG002|Overall Study|No MRD result|4|||
149079388|NCT01218594|537770986|FG000|Overall Study|Death|1|||
149079389|NCT01218594|537770986|FG000|Overall Study|Withdrawal by Subject|3|||
149079390|NCT01218594|537770986|FG000|Overall Study|Adverse Event|2|||
149079391|NCT01218594|537770986|FG000|Overall Study|Physician Decision|6|||
149079392|NCT02334215|537770990|FG000|Overall Study|Death|1|||
149079393|NCT02334215|537770991|FG001|Overall Study|Death|1|||
149079394|NCT02334215|537770992|FG002|Overall Study|Death|0|||
149079395|NCT02334215|537770990|FG000|Overall Study|Lost to Follow-up|1|||
149079396|NCT02334215|537770991|FG001|Overall Study|Lost to Follow-up|0|||
149079397|NCT02334215|537770992|FG002|Overall Study|Lost to Follow-up|4|||
149079398|NCT02334215|537770990|FG000|Overall Study|Withdrawal by Subject|2|||
149079399|NCT02334215|537770991|FG001|Overall Study|Withdrawal by Subject|2|||
149079400|NCT02334215|537770992|FG002|Overall Study|Withdrawal by Subject|1|||
149079401|NCT02334215|537770990|FG000|Overall Study|Not released from incarceration on time|3|||
149079402|NCT02334215|537770991|FG001|Overall Study|Not released from incarceration on time|3|||
149079403|NCT02334215|537770992|FG002|Overall Study|Not released from incarceration on time|3|||
149079404|NCT02334215|537770990|FG000|Overall Study|Incarcerated|0|||
149079405|NCT02334215|537770991|FG001|Overall Study|Incarcerated|0|||
149079406|NCT02334215|537770992|FG002|Overall Study|Incarcerated|7|||
149079407|NCT05615363|537770993|FG000|Overall Study|Adverse Event|0|||
149079408|NCT05615363|537770994|FG001|Overall Study|Adverse Event|4|||
149079409|NCT05615363|537770995|FG002|Overall Study|Adverse Event|4|||
149079410|NCT05615363|537770996|FG003|Overall Study|Adverse Event|3|||
149079411|NCT05615363|537770997|FG004|Overall Study|Adverse Event|1|||
149079412|NCT05615363|537770993|FG000|Overall Study|Physician Decision|2|||
149079413|NCT05615363|537770994|FG001|Overall Study|Physician Decision|0|||
149079414|NCT05615363|537770995|FG002|Overall Study|Physician Decision|4|||
149079415|NCT05615363|537770996|FG003|Overall Study|Physician Decision|1|||
149079416|NCT05615363|537770997|FG004|Overall Study|Physician Decision|3|||
149079417|NCT05615363|537770993|FG000|Overall Study|Protocol Violation|2|||
149079418|NCT05615363|537770994|FG001|Overall Study|Protocol Violation|0|||
149079419|NCT05615363|537770995|FG002|Overall Study|Protocol Violation|0|||
149079420|NCT05615363|537770996|FG003|Overall Study|Protocol Violation|0|||
149079421|NCT05615363|537770997|FG004|Overall Study|Protocol Violation|1|||
149079422|NCT05615363|537770993|FG000|Overall Study|Withdrawal by Subject|0|||
149079423|NCT05615363|537770994|FG001|Overall Study|Withdrawal by Subject|0|||
149079424|NCT05615363|537770995|FG002|Overall Study|Withdrawal by Subject|1|||
149079425|NCT05615363|537770996|FG003|Overall Study|Withdrawal by Subject|0|||
149079426|NCT05615363|537770997|FG004|Overall Study|Withdrawal by Subject|0|||
149079427|NCT04602728|537771000|FG000|Overall Study|Lost to Follow-up|4|||
149079428|NCT04602728|537771001|FG001|Overall Study|Lost to Follow-up|4|||
149079429|NCT04937504|537771006|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
149079430|NCT04937504|537771007|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
149079431|NCT04937504|537771006|FG000|9 Months Assessment|Lost to Follow-up|3|||
149079432|NCT04937504|537771007|FG001|9 Months Assessment|Lost to Follow-up|2|||
149079433|NCT01668355|537773087|FG000|Overall Study|Death|3|||
149079434|NCT01668355|537773088|FG001|Overall Study|Death|1|||
149079435|NCT01668355|537773087|FG000|Overall Study|Withdrawal by Subject|6|||
149079436|NCT01668355|537773088|FG001|Overall Study|Withdrawal by Subject|1|||
149079437|NCT01190124|537773093|FG000|Overall Study|Death|3|||
149079438|NCT01190124|537773094|FG001|Overall Study|Death|0|||
149079439|NCT01190124|537773095|FG002|Overall Study|Death|0|||
149079440|NCT01190124|537773093|FG000|Overall Study|Therapeutic Failure|12|||
149079441|NCT01190124|537773094|FG001|Overall Study|Therapeutic Failure|0|||
149079442|NCT01190124|537773095|FG002|Overall Study|Therapeutic Failure|1|||
149079443|NCT01190124|537773093|FG000|Overall Study|Lost to Follow-up|2|||
149079444|NCT01190124|537773094|FG001|Overall Study|Lost to Follow-up|0|||
149079445|NCT01190124|537773095|FG002|Overall Study|Lost to Follow-up|0|||
149079446|NCT00070707|537773096|FG000|Overall Study|Adverse Event|1|||
149079447|NCT00070707|537773097|FG001|Overall Study|Adverse Event|2|||
149079448|NCT00070707|537773096|FG000|Overall Study|Lack of Efficacy|4|||
149079449|NCT00070707|537773097|FG001|Overall Study|Lack of Efficacy|1|||
149079450|NCT00070707|537773096|FG000|Overall Study|Protocol Violation|8|||
149079451|NCT00070707|537773097|FG001|Overall Study|Protocol Violation|4|||
149079452|NCT00070707|537773096|FG000|Overall Study|Unrelated to Study Medication|1|||
149079453|NCT00070707|537773097|FG001|Overall Study|Unrelated to Study Medication|0|||
149079454|NCT03690219|537773098|FG000|Overall Study|no injuries|9|||
149079455|NCT03690219|537773099|FG001|Overall Study|no injuries|20|||
149079456|NCT03690219|537773098|FG000|Overall Study|missing information|7|||
149079457|NCT03690219|537773099|FG001|Overall Study|missing information|7|||
149079458|NCT01523392|537773100|FG000|Treatment Period 1|Withdrawal by Subject|2|||
149079459|NCT01523392|537773101|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149079460|NCT01523392|537773100|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
149079461|NCT01523392|537773101|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
149079462|NCT01523392|537773100|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
149079463|NCT01523392|537773101|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
149079464|NCT04809623|537773102|FG000|Overall Study|Study Terminated by Sponsor|1|||
149079465|NCT04809623|537773103|FG001|Overall Study|Study Terminated by Sponsor|0|||
149079466|NCT02354417|537773104|FG000|Overall Study|Physician Decision|1|||
149079467|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
149079468|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149079469|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149079470|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149079471|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
149079472|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149079473|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149079474|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149079475|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
149079476|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149079477|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149079478|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149079479|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
149079480|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149079481|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149079482|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149079483|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
149079484|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149079485|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149079486|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149079487|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
149079488|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149079489|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149079490|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149079491|NCT01185340|537773107|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
149079492|NCT01185340|537773108|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149079493|NCT01185340|537773109|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149079494|NCT01185340|537773110|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149079495|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
149079496|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
149079497|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
149079498|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
149079499|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
149079500|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
149079501|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
149079502|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
149079503|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
149079504|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
149079505|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
149079506|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
149079507|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
149079508|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
149079509|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
149079510|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
149079511|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
149079512|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
149079513|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
149079514|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
149079515|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
149079516|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
149079517|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
149079518|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
149079519|NCT01185340|537773107|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
149079520|NCT01185340|537773108|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
149079521|NCT01185340|537773109|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
149079522|NCT01185340|537773110|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
149079523|NCT01719172|537773111|FG000|Overall Study|Lost to Follow-up|1|||
149079524|NCT01719172|537773111|FG000|Overall Study|Death|1|||
149079525|NCT01148017|537773112|FG000|Overall Study|Withdrawal by Subject|31|||
149079526|NCT01148017|537773113|FG001|Overall Study|Withdrawal by Subject|14|||
149079527|NCT01148017|537773114|FG002|Overall Study|Withdrawal by Subject|0|||
149079528|NCT01148017|537773115|FG003|Overall Study|Withdrawal by Subject|0|||
149079529|NCT01148017|537773112|FG000|Overall Study|Lost to Follow-up|23|||
149079530|NCT01148017|537773113|FG001|Overall Study|Lost to Follow-up|10|||
149079531|NCT01148017|537773114|FG002|Overall Study|Lost to Follow-up|0|||
149079532|NCT01148017|537773115|FG003|Overall Study|Lost to Follow-up|0|||
149079533|NCT01148017|537773112|FG000|Overall Study|Inappropriate enrollment|1|||
149079534|NCT01148017|537773113|FG001|Overall Study|Inappropriate enrollment|0|||
149079535|NCT01148017|537773114|FG002|Overall Study|Inappropriate enrollment|0|||
149079536|NCT01148017|537773115|FG003|Overall Study|Inappropriate enrollment|0|||
149079537|NCT01148017|537773112|FG000|Overall Study|Administrative reason|22|||
149079538|NCT01148017|537773113|FG001|Overall Study|Administrative reason|9|||
149079539|NCT01148017|537773114|FG002|Overall Study|Administrative reason|0|||
149079540|NCT01148017|537773115|FG003|Overall Study|Administrative reason|0|||
149079541|NCT01148017|537773112|FG000|Overall Study|Unable to classify|3|||
149079542|NCT01148017|537773113|FG001|Overall Study|Unable to classify|1|||
149079543|NCT01148017|537773114|FG002|Overall Study|Unable to classify|0|||
149079544|NCT01148017|537773115|FG003|Overall Study|Unable to classify|0|||
149079545|NCT01848483|537773116|FG000|Overall Study|Death|2|||
149079546|NCT01848483|537773117|FG001|Overall Study|Death|1|||
149079547|NCT01848483|537773116|FG000|Overall Study|Lost to Follow-up|6|||
149079548|NCT01848483|537773117|FG001|Overall Study|Lost to Follow-up|8|||
149079549|NCT01848483|537773116|FG000|Overall Study|Withdrawal by Subject|1|||
149079550|NCT01848483|537773117|FG001|Overall Study|Withdrawal by Subject|0|||
149079551|NCT01848483|537773116|FG000|Overall Study|Incarceration|2|||
149079552|NCT01848483|537773117|FG001|Overall Study|Incarceration|2|||
149079553|NCT00246129|537773122|FG000|Overall Study|Lost to Follow-up|1|||
149079554|NCT00246129|537773123|FG001|Overall Study|Lost to Follow-up|0|||
149079555|NCT00246129|537773122|FG000|Overall Study|Death|2|||
149079556|NCT00246129|537773123|FG001|Overall Study|Death|1|||
149079557|NCT00246129|537773122|FG000|Overall Study|suffered primary non-function|1|||
149079558|NCT00246129|537773123|FG001|Overall Study|suffered primary non-function|0|||
149079559|NCT00246129|537773122|FG000|Overall Study|grafts failed|3|||
149079560|NCT00246129|537773123|FG001|Overall Study|grafts failed|1|||
149079561|NCT03740737|537773124|FG000|Overall Study|Protocol deviation|13|||
149079562|NCT03740737|537773125|FG001|Overall Study|Protocol deviation|0|||
149079563|NCT03740737|537773124|FG000|Overall Study|Adverse Event|2|||
149079564|NCT03740737|537773125|FG001|Overall Study|Adverse Event|0|||
149079565|NCT03740737|537773124|FG000|Overall Study|Lost to Follow-up|1|||
149079566|NCT03740737|537773125|FG001|Overall Study|Lost to Follow-up|0|||
149079567|NCT03740737|537773124|FG000|Overall Study|Randomization failure|1|||
149079568|NCT03740737|537773125|FG001|Overall Study|Randomization failure|0|||
149079569|NCT03740737|537773124|FG000|Overall Study|Participant withdrew consent|1|||
149079570|NCT03740737|537773125|FG001|Overall Study|Participant withdrew consent|0|||
149079571|NCT03740737|537773124|FG000|Overall Study|Participant withdrew from trial|2|||
149079572|NCT03740737|537773125|FG001|Overall Study|Participant withdrew from trial|1|||
149079573|NCT03469258|537773126|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
149079574|NCT02236611|537773128|FG000|Overall Study|Adverse Event|10|||
149079575|NCT02236611|537773129|FG001|Overall Study|Adverse Event|16|||
149079576|NCT02236611|537773128|FG000|Overall Study|Lack of Efficacy|4|||
149079577|NCT02236611|537773129|FG001|Overall Study|Lack of Efficacy|7|||
149079578|NCT02236611|537773128|FG000|Overall Study|Lost to Follow-up|0|||
149079579|NCT02236611|537773129|FG001|Overall Study|Lost to Follow-up|2|||
149079580|NCT02236611|537773128|FG000|Overall Study|Protocol deviation|3|||
149079581|NCT02236611|537773129|FG001|Overall Study|Protocol deviation|5|||
149079582|NCT02236611|537773128|FG000|Overall Study|Withdrew consent|9|||
149079583|NCT02236611|537773129|FG001|Overall Study|Withdrew consent|4|||
149079584|NCT03041090|537773130|FG000|Overall Study|technical error|0|||
149079585|NCT03041090|537773131|FG001|Overall Study|technical error|3|||
149079586|NCT03403036|537773132|FG000|Overall Study|Lack of Efficacy|5|||
149079587|NCT02701296|537773133|FG000|Overall Study|Incomplete Data|0|||
149079588|NCT02701296|537773134|FG001|Overall Study|Incomplete Data|2|||
149079589|NCT01409837|537773135|FG000|Overall Study|Withdrawal by Subject|2|||
149079590|NCT01409837|537773136|FG001|Overall Study|Withdrawal by Subject|1|||
149079591|NCT01409837|537773135|FG000|Overall Study|Lost to Follow-up|1|||
149079592|NCT01409837|537773136|FG001|Overall Study|Lost to Follow-up|0|||
149079593|NCT01409837|537773135|FG000|Overall Study|Physician Decision|0|||
149079594|NCT01409837|537773136|FG001|Overall Study|Physician Decision|1|||
149079595|NCT03851094|537773140|FG000|Overall Study|Withdrawal by Subject|0|||
149079596|NCT03851094|537773141|FG001|Overall Study|Withdrawal by Subject|1|||
149079597|NCT03851094|537773140|FG000|Overall Study|Participant lost device|0|||
149079598|NCT03851094|537773141|FG001|Overall Study|Participant lost device|1|||
149079599|NCT03851094|537773140|FG000|Overall Study|Participant returned device|0|||
149079600|NCT03851094|537773141|FG001|Overall Study|Participant returned device|2|||
149079601|NCT00484198|537773142|FG000|Overall Study|Participant Withdrew Consent|12|||
149079602|NCT00484198|537773143|FG001|Overall Study|Participant Withdrew Consent|21|||
149079603|NCT00484198|537773144|FG002|Overall Study|Participant Withdrew Consent|47|||
149079604|NCT00484198|537773145|FG003|Overall Study|Participant Withdrew Consent|59|||
149079605|NCT00484198|537773142|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
149079606|NCT00484198|537773143|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
149079607|NCT00484198|537773144|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
149079608|NCT00484198|537773145|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
149079609|NCT00484198|537773142|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
149079610|NCT00484198|537773143|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
149079611|NCT00484198|537773144|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
149079612|NCT00484198|537773145|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
149079613|NCT00484198|537773142|FG000|Overall Study|Adverse Event|3|||
149079614|NCT00484198|537773143|FG001|Overall Study|Adverse Event|11|||
149079615|NCT00484198|537773144|FG002|Overall Study|Adverse Event|32|||
149079616|NCT00484198|537773145|FG003|Overall Study|Adverse Event|31|||
149079617|NCT00484198|537773142|FG000|Overall Study|Protocol Violation|0|||
149079618|NCT00484198|537773143|FG001|Overall Study|Protocol Violation|5|||
149079619|NCT00484198|537773144|FG002|Overall Study|Protocol Violation|6|||
149079620|NCT00484198|537773145|FG003|Overall Study|Protocol Violation|8|||
149079621|NCT00484198|537773142|FG000|Overall Study|Other|7|||
149079622|NCT00484198|537773143|FG001|Overall Study|Other|10|||
149079623|NCT00484198|537773144|FG002|Overall Study|Other|31|||
149079624|NCT00484198|537773145|FG003|Overall Study|Other|28|||
149079625|NCT01536704|537773148|FG000|Washout Period 1|Withdrawal by Subject|1|||
149079626|NCT01536704|537773149|FG001|Washout Period 1|Withdrawal by Subject|2|||
149079627|NCT01536704|537773150|FG002|Washout Period 1|Withdrawal by Subject|0|||
149079628|NCT01536704|537773151|FG003|Washout Period 1|Withdrawal by Subject|0|||
149079629|NCT01536704|537773148|FG000|Washout Period 2|Adverse Event|1|||
149079630|NCT01536704|537773149|FG001|Washout Period 2|Adverse Event|0|||
149079631|NCT01536704|537773150|FG002|Washout Period 2|Adverse Event|0|||
149079632|NCT01536704|537773151|FG003|Washout Period 2|Adverse Event|0|||
149079633|NCT01536704|537773148|FG000|Washout Period 2|Withdrawal by Subject|0|||
149079634|NCT01536704|537773149|FG001|Washout Period 2|Withdrawal by Subject|0|||
149079635|NCT01536704|537773150|FG002|Washout Period 2|Withdrawal by Subject|0|||
149079636|NCT01536704|537773151|FG003|Washout Period 2|Withdrawal by Subject|1|||
149079637|NCT01536704|537773148|FG000|Period 3|Adverse Event|0|||
149079638|NCT01536704|537773149|FG001|Period 3|Adverse Event|0|||
149079639|NCT01536704|537773150|FG002|Period 3|Adverse Event|0|||
149079640|NCT01536704|537773151|FG003|Period 3|Adverse Event|1|||
149079641|NCT01536704|537773148|FG000|Washout Period 3|Adverse Event|0|||
149079642|NCT01536704|537773149|FG001|Washout Period 3|Adverse Event|0|||
149079643|NCT01536704|537773150|FG002|Washout Period 3|Adverse Event|1|||
149079644|NCT01536704|537773151|FG003|Washout Period 3|Adverse Event|0|||
149079645|NCT03490032|537773152|FG000|Overall Study|family issue (child custody)|1|||
149079646|NCT03490032|537773153|FG001|Overall Study|family issue (child custody)|0|||
149079647|NCT03490032|537773154|FG002|Overall Study|family issue (child custody)|0|||
149079648|NCT00308308|537773155|FG000|Overall Study|Adverse Event|17|||
149079649|NCT00308308|537773156|FG001|Overall Study|Adverse Event|2|||
149079650|NCT00308308|537773155|FG000|Overall Study|Lost to Follow-up|5|||
149079651|NCT00308308|537773156|FG001|Overall Study|Lost to Follow-up|5|||
149079652|NCT00308308|537773155|FG000|Overall Study|Physician Decision|15|||
149079653|NCT00308308|537773156|FG001|Overall Study|Physician Decision|7|||
149079654|NCT00308308|537773155|FG000|Overall Study|Protocol Violation|3|||
149079655|NCT00308308|537773156|FG001|Overall Study|Protocol Violation|14|||
149079656|NCT00308308|537773155|FG000|Overall Study|Withdrawal by Subject|47|||
149079657|NCT00308308|537773156|FG001|Overall Study|Withdrawal by Subject|19|||
149079658|NCT00308308|537773155|FG000|Overall Study|Various|7|||
149079659|NCT00308308|537773156|FG001|Overall Study|Various|5|||
149079660|NCT00308308|537773155|FG000|Overall Study|Randomized but not dosed|8|||
149079661|NCT00308308|537773156|FG001|Overall Study|Randomized but not dosed|16|||
149079662|NCT00308308|537773155|FG000|Overall Study|Other|1|||
149079663|NCT00308308|537773156|FG001|Overall Study|Other|0|||
149079664|NCT02392507|537773157|FG000|Induction Regimen|Death|3|||
149079665|NCT02392507|537773157|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
149079666|NCT02392507|537773157|FG000|Induction Regimen|Physician Decision|1|||
149079667|NCT02392507|537773157|FG000|Induction Regimen|Withdrawal by Subject|2|||
149079668|NCT02392507|537773157|FG000|Maintenance Regimen|Death|1|||
149079669|NCT02392507|537773157|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
149079670|NCT01802333|537773158|FG000|Overall Study|Ineligible|2|||
149079671|NCT01802333|537773159|FG001|Overall Study|Ineligible|6|||
149079672|NCT01802333|537773160|FG002|Overall Study|Ineligible|8|||
149079673|NCT01802333|537773158|FG000|Overall Study|Adverse Event|1|||
149079674|NCT01802333|537773159|FG001|Overall Study|Adverse Event|8|||
149079675|NCT01802333|537773160|FG002|Overall Study|Adverse Event|8|||
149079676|NCT01802333|537773158|FG000|Overall Study|Withdrawal by Subject|6|||
149079677|NCT01802333|537773159|FG001|Overall Study|Withdrawal by Subject|6|||
149079678|NCT01802333|537773160|FG002|Overall Study|Withdrawal by Subject|5|||
149079679|NCT01802333|537773158|FG000|Overall Study|Progression/relapse|1|||
149079680|NCT01802333|537773159|FG001|Overall Study|Progression/relapse|3|||
149079681|NCT01802333|537773160|FG002|Overall Study|Progression/relapse|0|||
149079682|NCT01802333|537773158|FG000|Overall Study|Death|7|||
149079683|NCT01802333|537773159|FG001|Overall Study|Death|14|||
149079684|NCT01802333|537773160|FG002|Overall Study|Death|13|||
149079685|NCT01802333|537773158|FG000|Overall Study|Other - not protocol specified|32|||
149079686|NCT01802333|537773159|FG001|Overall Study|Other - not protocol specified|22|||
149079687|NCT01802333|537773160|FG002|Overall Study|Other - not protocol specified|24|||
149079688|NCT01802333|537773158|FG000|Overall Study|Did not start treatment|0|||
149079689|NCT01802333|537773159|FG001|Overall Study|Did not start treatment|2|||
149079690|NCT01802333|537773160|FG002|Overall Study|Did not start treatment|5|||
149079691|NCT01021748|537773167|FG000|Overall Study|Adverse Event|2|||
149079692|NCT01021748|537773168|FG001|Overall Study|Adverse Event|1|||
149079693|NCT01021748|537773169|FG002|Overall Study|Adverse Event|2|||
149079694|NCT01021748|537773170|FG003|Overall Study|Adverse Event|0|||
149079695|NCT01021748|537773171|FG004|Overall Study|Adverse Event|2|||
149079696|NCT01021748|537773172|FG005|Overall Study|Adverse Event|0|||
149079697|NCT01021748|537773173|FG006|Overall Study|Adverse Event|1|||
149079698|NCT01021748|537773174|FG007|Overall Study|Adverse Event|0|||
149079699|NCT01021748|537773175|FG008|Overall Study|Adverse Event|7|||
149079700|NCT01021748|537773167|FG000|Overall Study|Physician Decision|1|||
149079701|NCT01021748|537773168|FG001|Overall Study|Physician Decision|0|||
149079702|NCT01021748|537773169|FG002|Overall Study|Physician Decision|1|||
149079703|NCT01021748|537773170|FG003|Overall Study|Physician Decision|1|||
149079704|NCT01021748|537773171|FG004|Overall Study|Physician Decision|0|||
149079705|NCT01021748|537773172|FG005|Overall Study|Physician Decision|0|||
149079706|NCT01021748|537773173|FG006|Overall Study|Physician Decision|1|||
149079707|NCT01021748|537773174|FG007|Overall Study|Physician Decision|1|||
149079708|NCT01021748|537773175|FG008|Overall Study|Physician Decision|2|||
149079709|NCT01021748|537773167|FG000|Overall Study|Progressive Disease|3|||
149079710|NCT01021748|537773168|FG001|Overall Study|Progressive Disease|3|||
149079711|NCT01021748|537773169|FG002|Overall Study|Progressive Disease|4|||
149079712|NCT01021748|537773170|FG003|Overall Study|Progressive Disease|6|||
149079713|NCT01021748|537773171|FG004|Overall Study|Progressive Disease|7|||
149079714|NCT01021748|537773172|FG005|Overall Study|Progressive Disease|3|||
149079715|NCT01021748|537773173|FG006|Overall Study|Progressive Disease|0|||
149079716|NCT01021748|537773174|FG007|Overall Study|Progressive Disease|5|||
149079717|NCT01021748|537773175|FG008|Overall Study|Progressive Disease|6|||
149079718|NCT01021748|537773167|FG000|Overall Study|Withdrawal by Subject|0|||
149079719|NCT01021748|537773168|FG001|Overall Study|Withdrawal by Subject|0|||
149079720|NCT01021748|537773169|FG002|Overall Study|Withdrawal by Subject|0|||
149079721|NCT01021748|537773170|FG003|Overall Study|Withdrawal by Subject|0|||
149079722|NCT01021748|537773171|FG004|Overall Study|Withdrawal by Subject|0|||
149079723|NCT01021748|537773172|FG005|Overall Study|Withdrawal by Subject|0|||
149079724|NCT01021748|537773173|FG006|Overall Study|Withdrawal by Subject|1|||
149079725|NCT01021748|537773174|FG007|Overall Study|Withdrawal by Subject|0|||
149079726|NCT01021748|537773175|FG008|Overall Study|Withdrawal by Subject|1|||
149079727|NCT01021748|537773167|FG000|Overall Study|Not Treated|0|||
149079728|NCT01021748|537773168|FG001|Overall Study|Not Treated|1|||
149079729|NCT01021748|537773169|FG002|Overall Study|Not Treated|0|||
149079730|NCT01021748|537773170|FG003|Overall Study|Not Treated|0|||
149079731|NCT01021748|537773171|FG004|Overall Study|Not Treated|0|||
149079732|NCT01021748|537773172|FG005|Overall Study|Not Treated|0|||
149079733|NCT01021748|537773173|FG006|Overall Study|Not Treated|0|||
149079734|NCT01021748|537773174|FG007|Overall Study|Not Treated|0|||
149079735|NCT01021748|537773175|FG008|Overall Study|Not Treated|0|||
149079736|NCT01829711|537773176|FG000|Overall Study|Lost to Follow-up|2|||
149079737|NCT01829711|537773176|FG000|Overall Study|Withdrawal by Subject|3|||
149079738|NCT01829711|537773176|FG000|Overall Study|Death|4|||
149079739|NCT01829711|537773176|FG000|Overall Study|Started new therapies|17|||
149079740|NCT01829711|537773176|FG000|Overall Study|Adverse Event|3|||
149079741|NCT01829711|537773176|FG000|Overall Study|Due to progression of disease|13|||
149079742|NCT01829711|537773176|FG000|Overall Study|Due to lack of response|1|||
149079743|NCT03259568|537773177|FG000|Overall Study|Participant performance was low|3|||
149079744|NCT04248868|537773178|FG000|Overall Study|Death|1|||
149079745|NCT04248868|537773178|FG000|Overall Study|Lost to Follow-up|3|||
149079746|NCT04248868|537773178|FG000|Overall Study|Protocol Violation|2|||
149079747|NCT03128099|537773179|FG000|Overall Study|High dose task was too long|0|||
149079748|NCT03128099|537773180|FG001|Overall Study|High dose task was too long|4|||
149079749|NCT03128099|537773181|FG002|Overall Study|High dose task was too long|0|||
149079750|NCT03128099|537773179|FG000|Overall Study|Participant got a full time job.|1|||
149079751|NCT03128099|537773180|FG001|Overall Study|Participant got a full time job.|0|||
149079752|NCT03128099|537773181|FG002|Overall Study|Participant got a full time job.|0|||
149079753|NCT03128099|537773179|FG000|Overall Study|Became homeless and lost contact|1|||
149079754|NCT03128099|537773180|FG001|Overall Study|Became homeless and lost contact|0|||
149079755|NCT03128099|537773181|FG002|Overall Study|Became homeless and lost contact|0|||
149079756|NCT03128099|537773179|FG000|Overall Study|Did not complete all the assessments|0|||
149079757|NCT03128099|537773180|FG001|Overall Study|Did not complete all the assessments|0|||
149079758|NCT03128099|537773181|FG002|Overall Study|Did not complete all the assessments|1|||
149079759|NCT00089791|537773182|FG000|Overall Study|Physician Decision|6|||
149079760|NCT00089791|537773183|FG001|Overall Study|Physician Decision|3|||
149079761|NCT00089791|537773182|FG000|Overall Study|Adverse Event|81|||
149079762|NCT00089791|537773183|FG001|Overall Study|Adverse Event|93|||
149079763|NCT00089791|537773182|FG000|Overall Study|Withdrawal by Subject|403|||
149079764|NCT00089791|537773183|FG001|Overall Study|Withdrawal by Subject|344|||
149079765|NCT00089791|537773182|FG000|Overall Study|Death|78|||
149079766|NCT00089791|537773183|FG001|Overall Study|Death|62|||
149079767|NCT00089791|537773182|FG000|Overall Study|Disease progression|7|||
149079768|NCT00089791|537773183|FG001|Overall Study|Disease progression|3|||
149079769|NCT00089791|537773182|FG000|Overall Study|Ineligibility determined|12|||
149079770|NCT00089791|537773183|FG001|Overall Study|Ineligibility determined|9|||
149079771|NCT00089791|537773182|FG000|Overall Study|Lost to Follow-up|57|||
149079772|NCT00089791|537773183|FG001|Overall Study|Lost to Follow-up|57|||
149079773|NCT00089791|537773182|FG000|Overall Study|Noncompliance|17|||
149079774|NCT00089791|537773183|FG001|Overall Study|Noncompliance|13|||
149079775|NCT00089791|537773182|FG000|Overall Study|Other|20|||
149079776|NCT00089791|537773183|FG001|Overall Study|Other|32|||
149079777|NCT00089791|537773182|FG000|Overall Study|Protocol deviation|12|||
149079778|NCT00089791|537773183|FG001|Overall Study|Protocol deviation|10|||
149079779|NCT00089791|537773182|FG000|Overall Study|Requirement for alternative therapy|7|||
149079780|NCT00089791|537773183|FG001|Overall Study|Requirement for alternative therapy|4|||
149079781|NCT03205488|537773186|FG000|Overall Study|Adverse Event|1|||
149079782|NCT03205488|537773187|FG001|Overall Study|Adverse Event|2|||
149079783|NCT03205488|537773188|FG002|Overall Study|Adverse Event|4|||
149079784|NCT03205488|537773186|FG000|Overall Study|Protocol Violation|0|||
149079785|NCT03205488|537773187|FG001|Overall Study|Protocol Violation|0|||
149079786|NCT03205488|537773188|FG002|Overall Study|Protocol Violation|1|||
149079787|NCT05163353|537773189|FG000|Overall Study|Adverse Event|1|||
149079788|NCT05163353|537773190|FG001|Overall Study|Adverse Event|0|||
149079789|NCT05163353|537773189|FG000|Overall Study|Withdrawal by Subject|21|||
149079790|NCT05163353|537773190|FG001|Overall Study|Withdrawal by Subject|6|||
149079791|NCT05163353|537773189|FG000|Overall Study|Protocol Violation|0|||
149079792|NCT05163353|537773190|FG001|Overall Study|Protocol Violation|1|||
149079793|NCT05163353|537773189|FG000|Overall Study|Lost to Follow-up|13|||
149079794|NCT05163353|537773190|FG001|Overall Study|Lost to Follow-up|2|||
149079795|NCT06086028|537773192|FG000|Overall Study|Withdrawal by Subject|1|||
149079796|NCT06086028|537773193|FG001|Overall Study|Withdrawal by Subject|1|||
149079797|NCT06086028|537773192|FG000|Overall Study|Lost to Follow-up|2|||
149079798|NCT06086028|537773193|FG001|Overall Study|Lost to Follow-up|3|||
149079799|NCT04083781|537773199|FG000|Main Part|Physician Decision|0|||
149079800|NCT04083781|537773200|FG001|Main Part|Physician Decision|1|||
149079801|NCT04083781|537773201|FG002|Main Part|Physician Decision|2|||
149079802|NCT04083781|537773202|FG003|Main Part|Physician Decision|0|||
149079803|NCT04083781|537773199|FG000|Main Part|Death|1|||
149079804|NCT04083781|537773200|FG001|Main Part|Death|3|||
149079805|NCT04083781|537773201|FG002|Main Part|Death|1|||
149079806|NCT04083781|537773202|FG003|Main Part|Death|0|||
149079807|NCT04083781|537773199|FG000|Main Part|Withdrawal by Subject|5|||
149079808|NCT04083781|537773200|FG001|Main Part|Withdrawal by Subject|2|||
149079809|NCT04083781|537773201|FG002|Main Part|Withdrawal by Subject|3|||
149079810|NCT04083781|537773202|FG003|Main Part|Withdrawal by Subject|7|||
149079811|NCT04083781|537773199|FG000|Extension Part|Physician Decision|0|||
149079812|NCT04083781|537773200|FG001|Extension Part|Physician Decision|0|||
149079813|NCT04083781|537773201|FG002|Extension Part|Physician Decision|0|||
149079814|NCT04083781|537773202|FG003|Extension Part|Physician Decision|1|||
149079815|NCT04083781|537773199|FG000|Extension Part|Death|0|||
149079816|NCT04083781|537773200|FG001|Extension Part|Death|1|||
149079817|NCT04083781|537773201|FG002|Extension Part|Death|0|||
149079818|NCT04083781|537773202|FG003|Extension Part|Death|1|||
149079819|NCT04083781|537773199|FG000|Extension Part|Withdrawal by Subject|0|||
149079820|NCT04083781|537773200|FG001|Extension Part|Withdrawal by Subject|1|||
149079821|NCT04083781|537773201|FG002|Extension Part|Withdrawal by Subject|0|||
149079822|NCT04083781|537773202|FG003|Extension Part|Withdrawal by Subject|0|||
149079823|NCT04083781|537773199|FG000|Extension Part|Ongoing|13|||
149079824|NCT04083781|537773200|FG001|Extension Part|Ongoing|25|||
149079825|NCT04083781|537773201|FG002|Extension Part|Ongoing|15|||
149079826|NCT04083781|537773202|FG003|Extension Part|Ongoing|51|||
149079827|NCT03803475|537773203|FG000|Overall Study|Physician Decision|1|||
149079828|NCT01880736|537773204|FG000|Overall Study|Adverse Event|0|||
149079829|NCT01880736|537773205|FG001|Overall Study|Adverse Event|0|||
149079830|NCT01880736|537773206|FG002|Overall Study|Adverse Event|0|||
149079831|NCT01880736|537773207|FG003|Overall Study|Adverse Event|1|||
149079832|NCT01880736|537773204|FG000|Overall Study|Withdrawal Criteria|1|||
149079833|NCT01880736|537773205|FG001|Overall Study|Withdrawal Criteria|2|||
149079834|NCT01880736|537773206|FG002|Overall Study|Withdrawal Criteria|1|||
149079835|NCT01880736|537773207|FG003|Overall Study|Withdrawal Criteria|5|||
149079836|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
149079837|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
149079838|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
149079839|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
149079840|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
149079841|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
149079842|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
149079843|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
149079844|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
149079845|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
149079846|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
149079847|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
149079848|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
149079849|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
149079850|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
149079851|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
149079852|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
149079853|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
149079854|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
149079855|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
149079856|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
149079857|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
149079858|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
149079859|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
149079860|NCT02203032|537773211|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
149079861|NCT02203032|537773212|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
149079862|NCT02203032|537773213|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
149079863|NCT02203032|537773214|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
149079864|NCT02203032|537773211|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
149079865|NCT02203032|537773212|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
149079866|NCT02203032|537773213|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
149079867|NCT02203032|537773214|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
149079868|NCT02203032|537773211|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
149079869|NCT02203032|537773212|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
149079870|NCT02203032|537773213|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
149079871|NCT02203032|537773214|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
149079872|NCT02203032|537773211|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
149079873|NCT02203032|537773212|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
149079874|NCT02203032|537773213|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
149079875|NCT02203032|537773214|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
149079876|NCT02203032|537773211|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
149079877|NCT02203032|537773212|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
149079878|NCT02203032|537773213|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
149079879|NCT02203032|537773214|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
149079880|NCT02203032|537773211|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
149079881|NCT02203032|537773212|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
149079882|NCT02203032|537773213|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
149079883|NCT02203032|537773214|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
149079884|NCT02241785|537773215|FG000|Overall Study|Sponsor Termination|43|||
149079885|NCT02241785|537773215|FG000|Overall Study|Withdrawal by Subject|1|||
149079886|NCT02241785|537773215|FG000|Overall Study|Lost to Follow-up|2|||
149079887|NCT02241785|537773215|FG000|Overall Study|Adverse Event|1|||
149079888|NCT04748341|537773218|FG000|Overall Study|Lost to Follow-up|1|||
149079889|NCT04748341|537773219|FG001|Overall Study|Lost to Follow-up|1|||
149079890|NCT00452114|537773220|FG000|Overall Study|Physician Decision|3|||
149079891|NCT00452114|537773221|FG001|Overall Study|Physician Decision|3|||
149079892|NCT04197713|537773222|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
149079893|NCT04197713|537773223|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
149079894|NCT05289037|537773235|FG000|Overall Study|Withdrawal by Subject|7|||
149079895|NCT05289037|537773236|FG001|Overall Study|Withdrawal by Subject|0|||
149079896|NCT05289037|537773237|FG002|Overall Study|Withdrawal by Subject|3|||
149079897|NCT05289037|537773238|FG003|Overall Study|Withdrawal by Subject|3|||
149079898|NCT05289037|537773239|FG004|Overall Study|Withdrawal by Subject|1|||
149079899|NCT05289037|537773240|FG005|Overall Study|Withdrawal by Subject|5|||
149079900|NCT05289037|537773241|FG006|Overall Study|Withdrawal by Subject|2|||
149079901|NCT05289037|537773242|FG007|Overall Study|Withdrawal by Subject|1|||
149079902|NCT05289037|537773243|FG008|Overall Study|Withdrawal by Subject|2|||
149079903|NCT05289037|537773244|FG009|Overall Study|Withdrawal by Subject|2|||
149079904|NCT05289037|537773245|FG010|Overall Study|Withdrawal by Subject|1|||
149079905|NCT05289037|537773246|FG011|Overall Study|Withdrawal by Subject|0|||
149079906|NCT05289037|537773247|FG012|Overall Study|Withdrawal by Subject|1|||
149079907|NCT05289037|537773248|FG013|Overall Study|Withdrawal by Subject|2|||
149079908|NCT05289037|537773249|FG014|Overall Study|Withdrawal by Subject|0|||
149079909|NCT05289037|537773250|FG015|Overall Study|Withdrawal by Subject|3|||
149079910|NCT05289037|537773251|FG016|Overall Study|Withdrawal by Subject|3|||
149079911|NCT05289037|537773235|FG000|Overall Study|Lost to Follow-up|1|||
149079912|NCT05289037|537773236|FG001|Overall Study|Lost to Follow-up|4|||
149079913|NCT05289037|537773237|FG002|Overall Study|Lost to Follow-up|3|||
149079914|NCT05289037|537773238|FG003|Overall Study|Lost to Follow-up|3|||
149079915|NCT05289037|537773239|FG004|Overall Study|Lost to Follow-up|3|||
149079916|NCT05289037|537773240|FG005|Overall Study|Lost to Follow-up|2|||
149079917|NCT05289037|537773241|FG006|Overall Study|Lost to Follow-up|3|||
149079918|NCT05289037|537773242|FG007|Overall Study|Lost to Follow-up|2|||
149079919|NCT05289037|537773243|FG008|Overall Study|Lost to Follow-up|2|||
149079920|NCT05289037|537773244|FG009|Overall Study|Lost to Follow-up|1|||
149079921|NCT05289037|537773245|FG010|Overall Study|Lost to Follow-up|3|||
149079922|NCT05289037|537773246|FG011|Overall Study|Lost to Follow-up|4|||
149079923|NCT05289037|537773247|FG012|Overall Study|Lost to Follow-up|2|||
149079924|NCT05289037|537773248|FG013|Overall Study|Lost to Follow-up|7|||
149079925|NCT05289037|537773249|FG014|Overall Study|Lost to Follow-up|4|||
149079926|NCT05289037|537773250|FG015|Overall Study|Lost to Follow-up|6|||
149079927|NCT05289037|537773251|FG016|Overall Study|Lost to Follow-up|4|||
149079928|NCT05289037|537773235|FG000|Overall Study|Death|0|||
149079929|NCT05289037|537773236|FG001|Overall Study|Death|0|||
149079930|NCT05289037|537773237|FG002|Overall Study|Death|0|||
149079931|NCT05289037|537773238|FG003|Overall Study|Death|0|||
149079932|NCT05289037|537773239|FG004|Overall Study|Death|0|||
149079933|NCT05289037|537773240|FG005|Overall Study|Death|1|||
149079934|NCT05289037|537773241|FG006|Overall Study|Death|0|||
149079935|NCT05289037|537773242|FG007|Overall Study|Death|0|||
149079936|NCT05289037|537773243|FG008|Overall Study|Death|0|||
149079937|NCT05289037|537773244|FG009|Overall Study|Death|0|||
149079938|NCT05289037|537773245|FG010|Overall Study|Death|0|||
149079939|NCT05289037|537773246|FG011|Overall Study|Death|0|||
149079940|NCT05289037|537773247|FG012|Overall Study|Death|0|||
149079941|NCT05289037|537773248|FG013|Overall Study|Death|0|||
149079942|NCT05289037|537773249|FG014|Overall Study|Death|1|||
149079943|NCT05289037|537773250|FG015|Overall Study|Death|0|||
149079944|NCT05289037|537773251|FG016|Overall Study|Death|0|||
149079945|NCT05289037|537773235|FG000|Overall Study|Did not receive vaccine|0|||
149079946|NCT05289037|537773236|FG001|Overall Study|Did not receive vaccine|3|||
149079947|NCT05289037|537773237|FG002|Overall Study|Did not receive vaccine|0|||
149079948|NCT05289037|537773238|FG003|Overall Study|Did not receive vaccine|0|||
149079949|NCT05289037|537773239|FG004|Overall Study|Did not receive vaccine|1|||
149079950|NCT05289037|537773240|FG005|Overall Study|Did not receive vaccine|1|||
149079951|NCT05289037|537773241|FG006|Overall Study|Did not receive vaccine|1|||
149079952|NCT05289037|537773242|FG007|Overall Study|Did not receive vaccine|0|||
149079953|NCT05289037|537773243|FG008|Overall Study|Did not receive vaccine|0|||
149079954|NCT05289037|537773244|FG009|Overall Study|Did not receive vaccine|0|||
149079955|NCT05289037|537773245|FG010|Overall Study|Did not receive vaccine|0|||
149079956|NCT05289037|537773246|FG011|Overall Study|Did not receive vaccine|0|||
149079957|NCT05289037|537773247|FG012|Overall Study|Did not receive vaccine|0|||
149079958|NCT05289037|537773248|FG013|Overall Study|Did not receive vaccine|0|||
149079959|NCT05289037|537773249|FG014|Overall Study|Did not receive vaccine|1|||
149079960|NCT05289037|537773250|FG015|Overall Study|Did not receive vaccine|0|||
149079961|NCT05289037|537773251|FG016|Overall Study|Did not receive vaccine|0|||
149079962|NCT05289037|537773235|FG000|Overall Study|Unable to make last visit|0|||
149079963|NCT05289037|537773236|FG001|Overall Study|Unable to make last visit|0|||
149079964|NCT05289037|537773237|FG002|Overall Study|Unable to make last visit|1|||
149079965|NCT05289037|537773238|FG003|Overall Study|Unable to make last visit|0|||
149079966|NCT05289037|537773239|FG004|Overall Study|Unable to make last visit|0|||
149079967|NCT05289037|537773240|FG005|Overall Study|Unable to make last visit|0|||
149079968|NCT05289037|537773241|FG006|Overall Study|Unable to make last visit|0|||
149079969|NCT05289037|537773242|FG007|Overall Study|Unable to make last visit|0|||
149079970|NCT05289037|537773243|FG008|Overall Study|Unable to make last visit|0|||
149079971|NCT05289037|537773244|FG009|Overall Study|Unable to make last visit|0|||
149079972|NCT05289037|537773245|FG010|Overall Study|Unable to make last visit|0|||
149079973|NCT05289037|537773246|FG011|Overall Study|Unable to make last visit|0|||
149079974|NCT05289037|537773247|FG012|Overall Study|Unable to make last visit|0|||
149079975|NCT05289037|537773248|FG013|Overall Study|Unable to make last visit|0|||
149079976|NCT05289037|537773249|FG014|Overall Study|Unable to make last visit|0|||
149079977|NCT05289037|537773250|FG015|Overall Study|Unable to make last visit|0|||
149079978|NCT05289037|537773251|FG016|Overall Study|Unable to make last visit|0|||
149079979|NCT05289037|537773235|FG000|Overall Study|Protocol deviation|0|||
149079980|NCT05289037|537773236|FG001|Overall Study|Protocol deviation|0|||
149079981|NCT05289037|537773237|FG002|Overall Study|Protocol deviation|0|||
149079982|NCT05289037|537773238|FG003|Overall Study|Protocol deviation|0|||
149079983|NCT05289037|537773239|FG004|Overall Study|Protocol deviation|0|||
149079984|NCT05289037|537773240|FG005|Overall Study|Protocol deviation|0|||
149079985|NCT05289037|537773241|FG006|Overall Study|Protocol deviation|0|||
149079986|NCT05289037|537773242|FG007|Overall Study|Protocol deviation|0|||
149079987|NCT05289037|537773243|FG008|Overall Study|Protocol deviation|0|||
149079988|NCT05289037|537773244|FG009|Overall Study|Protocol deviation|0|||
149079989|NCT05289037|537773245|FG010|Overall Study|Protocol deviation|0|||
149079990|NCT05289037|537773246|FG011|Overall Study|Protocol deviation|0|||
149079991|NCT05289037|537773247|FG012|Overall Study|Protocol deviation|0|||
149079992|NCT05289037|537773248|FG013|Overall Study|Protocol deviation|0|||
149079993|NCT05289037|537773249|FG014|Overall Study|Protocol deviation|0|||
149079994|NCT05289037|537773250|FG015|Overall Study|Protocol deviation|1|||
149079995|NCT05289037|537773251|FG016|Overall Study|Protocol deviation|0|||
149079996|NCT02831049|537773252|FG000|Overall Study|Lost to Follow-up|0|||
149079997|NCT02831049|537773253|FG001|Overall Study|Lost to Follow-up|0|||
149079998|NCT02831049|537773254|FG002|Overall Study|Lost to Follow-up|1|||
149079999|NCT02831049|537773252|FG000|Overall Study|Withdrawal by Subject|0|||
149080000|NCT02831049|537773253|FG001|Overall Study|Withdrawal by Subject|1|||
149080001|NCT02831049|537773254|FG002|Overall Study|Withdrawal by Subject|1|||
149080002|NCT02831049|537773252|FG000|Overall Study|Pandemic shutdown|1|||
149080003|NCT02831049|537773253|FG001|Overall Study|Pandemic shutdown|0|||
149080004|NCT02831049|537773254|FG002|Overall Study|Pandemic shutdown|0|||
149080005|NCT05995977|537773255|FG000|Overall Study|Withdrawal by Subject|1|||
149080006|NCT05995977|537773256|FG001|Overall Study|Withdrawal by Subject|4|||
149080007|NCT05995977|537773255|FG000|Overall Study|Lost to Follow-up|2|||
149080008|NCT05995977|537773256|FG001|Overall Study|Lost to Follow-up|0|||
149080009|NCT04181788|537773257|FG000|TREATMENT|Adverse Event|0|||
149080010|NCT04181788|537773258|FG001|TREATMENT|Adverse Event|2|||
149080011|NCT04181788|537773259|FG002|TREATMENT|Adverse Event|1|||
149080012|NCT04181788|537773260|FG003|TREATMENT|Adverse Event|0|||
149080013|NCT04181788|537773261|FG004|TREATMENT|Adverse Event|1|||
149080014|NCT04181788|537773262|FG005|TREATMENT|Adverse Event|3|||
149080015|NCT04181788|537773257|FG000|TREATMENT|Death|0|||
149080016|NCT04181788|537773258|FG001|TREATMENT|Death|0|||
149080017|NCT04181788|537773259|FG002|TREATMENT|Death|0|||
149080018|NCT04181788|537773260|FG003|TREATMENT|Death|0|||
149080019|NCT04181788|537773261|FG004|TREATMENT|Death|8|||
149080020|NCT04181788|537773262|FG005|TREATMENT|Death|8|||
149080021|NCT04181788|537773257|FG000|TREATMENT|Physician Decision|0|||
149080022|NCT04181788|537773258|FG001|TREATMENT|Physician Decision|0|||
149080023|NCT04181788|537773259|FG002|TREATMENT|Physician Decision|0|||
149080024|NCT04181788|537773260|FG003|TREATMENT|Physician Decision|0|||
149080025|NCT04181788|537773261|FG004|TREATMENT|Physician Decision|0|||
149080026|NCT04181788|537773262|FG005|TREATMENT|Physician Decision|1|||
149080027|NCT04181788|537773257|FG000|TREATMENT|Progressive disease|3|||
149080028|NCT04181788|537773258|FG001|TREATMENT|Progressive disease|3|||
149080029|NCT04181788|537773259|FG002|TREATMENT|Progressive disease|5|||
149080030|NCT04181788|537773260|FG003|TREATMENT|Progressive disease|7|||
149080031|NCT04181788|537773261|FG004|TREATMENT|Progressive disease|20|||
149080032|NCT04181788|537773262|FG005|TREATMENT|Progressive disease|38|||
149080033|NCT04181788|537773257|FG000|TREATMENT|Global deterioration of health status|0|||
149080034|NCT04181788|537773258|FG001|TREATMENT|Global deterioration of health status|2|||
149080035|NCT04181788|537773259|FG002|TREATMENT|Global deterioration of health status|0|||
149080036|NCT04181788|537773260|FG003|TREATMENT|Global deterioration of health status|0|||
149080037|NCT04181788|537773261|FG004|TREATMENT|Global deterioration of health status|2|||
149080038|NCT04181788|537773262|FG005|TREATMENT|Global deterioration of health status|8|||
149080039|NCT04181788|537773257|FG000|TREATMENT|Withdrawal by Subject|1|||
149080040|NCT04181788|537773258|FG001|TREATMENT|Withdrawal by Subject|2|||
149080041|NCT04181788|537773259|FG002|TREATMENT|Withdrawal by Subject|0|||
149080042|NCT04181788|537773260|FG003|TREATMENT|Withdrawal by Subject|0|||
149080043|NCT04181788|537773261|FG004|TREATMENT|Withdrawal by Subject|3|||
149080044|NCT04181788|537773262|FG005|TREATMENT|Withdrawal by Subject|5|||
149080045|NCT04181788|537773257|FG000|TREATMENT|Other unspecified|0|||
149080046|NCT04181788|537773258|FG001|TREATMENT|Other unspecified|0|||
149080047|NCT04181788|537773259|FG002|TREATMENT|Other unspecified|0|||
149080048|NCT04181788|537773260|FG003|TREATMENT|Other unspecified|0|||
149080049|NCT04181788|537773261|FG004|TREATMENT|Other unspecified|0|||
149080050|NCT04181788|537773262|FG005|TREATMENT|Other unspecified|2|||
149080051|NCT04181788|537773257|FG000|TREATMENT|Ongoing|0|||
149080052|NCT04181788|537773258|FG001|TREATMENT|Ongoing|3|||
149080053|NCT04181788|537773259|FG002|TREATMENT|Ongoing|0|||
149080054|NCT04181788|537773260|FG003|TREATMENT|Ongoing|5|||
149080055|NCT04181788|537773261|FG004|TREATMENT|Ongoing|7|||
149080056|NCT04181788|537773262|FG005|TREATMENT|Ongoing|15|||
149080057|NCT04181788|537773257|FG000|FOLLOW-UP|Death|0|||
149080058|NCT04181788|537773258|FG001|FOLLOW-UP|Death|0|||
149080059|NCT04181788|537773259|FG002|FOLLOW-UP|Death|1|||
149080060|NCT04181788|537773260|FG003|FOLLOW-UP|Death|2|||
149080061|NCT04181788|537773261|FG004|FOLLOW-UP|Death|8|||
149080062|NCT04181788|537773262|FG005|FOLLOW-UP|Death|20|||
149080063|NCT04181788|537773257|FG000|FOLLOW-UP|Lost to Follow-up|0|||
149080064|NCT04181788|537773258|FG001|FOLLOW-UP|Lost to Follow-up|0|||
149080065|NCT04181788|537773259|FG002|FOLLOW-UP|Lost to Follow-up|0|||
149080066|NCT04181788|537773260|FG003|FOLLOW-UP|Lost to Follow-up|0|||
149080067|NCT04181788|537773261|FG004|FOLLOW-UP|Lost to Follow-up|0|||
149080068|NCT04181788|537773262|FG005|FOLLOW-UP|Lost to Follow-up|2|||
149080069|NCT04181788|537773257|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
149080070|NCT04181788|537773258|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
149080071|NCT04181788|537773259|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
149080072|NCT04181788|537773260|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
149080073|NCT04181788|537773261|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
149080074|NCT04181788|537773262|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
149080075|NCT04181788|537773257|FG000|FOLLOW-UP|Other unspecified|0|||
149080076|NCT04181788|537773258|FG001|FOLLOW-UP|Other unspecified|1|||
149080077|NCT04181788|537773259|FG002|FOLLOW-UP|Other unspecified|0|||
149080078|NCT04181788|537773260|FG003|FOLLOW-UP|Other unspecified|0|||
149080079|NCT04181788|537773261|FG004|FOLLOW-UP|Other unspecified|0|||
149080080|NCT04181788|537773262|FG005|FOLLOW-UP|Other unspecified|3|||
149080081|NCT04181788|537773257|FG000|FOLLOW-UP|Ongoing|0|||
149080082|NCT04181788|537773258|FG001|FOLLOW-UP|Ongoing|0|||
149080083|NCT04181788|537773259|FG002|FOLLOW-UP|Ongoing|1|||
149080084|NCT04181788|537773260|FG003|FOLLOW-UP|Ongoing|3|||
149080085|NCT04181788|537773261|FG004|FOLLOW-UP|Ongoing|2|||
149080086|NCT04181788|537773262|FG005|FOLLOW-UP|Ongoing|2|||
149080087|NCT04535414|537773264|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
149080088|NCT04535414|537773265|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
149080089|NCT04535414|537773264|FG000|Overall Study|Cancelled appointment|1|||
149080090|NCT04535414|537773265|FG001|Overall Study|Cancelled appointment|0|||
149080091|NCT04535414|537773264|FG000|Overall Study|cancelled - food in stomach|2|||
149080092|NCT04535414|537773265|FG001|Overall Study|cancelled - food in stomach|0|||
149080093|NCT04535414|537773264|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
149080094|NCT04535414|537773265|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
149080095|NCT04535414|537773264|FG000|Overall Study|Withdrawal by Subject|0|||
149080096|NCT04535414|537773265|FG001|Overall Study|Withdrawal by Subject|1|||
149080097|NCT03662659|537773266|FG000|Pre-treatment|Participant no longer met study criteria|1|||
149080098|NCT03662659|537773267|FG001|Pre-treatment|Participant no longer met study criteria|1|||
149080099|NCT03662659|537773266|FG000|Pre-treatment|Other reasons|1|||
149080100|NCT03662659|537773267|FG001|Pre-treatment|Other reasons|0|||
149080101|NCT03662659|537773266|FG000|Treatment|Completed Treatment|0|||
149080102|NCT03662659|537773267|FG001|Treatment|Completed Treatment|2|||
149080103|NCT03662659|537773266|FG000|Treatment|Disease Progression|85|||
149080104|NCT03662659|537773267|FG001|Treatment|Disease Progression|97|||
149080105|NCT03662659|537773266|FG000|Treatment|Study Drug Toxicity|19|||
149080106|NCT03662659|537773267|FG001|Treatment|Study Drug Toxicity|9|||
149080107|NCT03662659|537773266|FG000|Treatment|Death|11|||
149080108|NCT03662659|537773267|FG001|Treatment|Death|9|||
149080109|NCT03662659|537773266|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
149080110|NCT03662659|537773267|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
149080111|NCT03662659|537773266|FG000|Treatment|Withdrawal by Subject|1|||
149080112|NCT03662659|537773267|FG001|Treatment|Withdrawal by Subject|1|||
149080113|NCT03662659|537773266|FG000|Treatment|Poor/Non-compliance|1|||
149080114|NCT03662659|537773267|FG001|Treatment|Poor/Non-compliance|0|||
149080115|NCT03662659|537773266|FG000|Treatment|Participant no longer meets study criteria|1|||
149080116|NCT03662659|537773267|FG001|Treatment|Participant no longer meets study criteria|0|||
149080117|NCT03662659|537773266|FG000|Treatment|Other reasons|10|||
149080118|NCT03662659|537773267|FG001|Treatment|Other reasons|8|||
149080119|NCT03662659|537773266|FG000|Treatment|Administrative reasons by sponsor|1|||
149080120|NCT03662659|537773267|FG001|Treatment|Administrative reasons by sponsor|0|||
149080121|NCT03662659|537773266|FG000|Treatment|maximum clinical benefit|0|||
149080122|NCT03662659|537773267|FG001|Treatment|maximum clinical benefit|2|||
149080123|NCT01276509|537775312|FG000|Overall Study|Adverse Event|9|||
149080124|NCT01276509|537775313|FG001|Overall Study|Adverse Event|8|||
149080125|NCT01276509|537775314|FG002|Overall Study|Adverse Event|4|||
149080126|NCT01276509|537775315|FG003|Overall Study|Adverse Event|3|||
149080127|NCT01276509|537775312|FG000|Overall Study|Lack of Efficacy|2|||
149080128|NCT01276509|537775313|FG001|Overall Study|Lack of Efficacy|1|||
149080129|NCT01276509|537775314|FG002|Overall Study|Lack of Efficacy|1|||
149080130|NCT01276509|537775315|FG003|Overall Study|Lack of Efficacy|2|||
149080131|NCT01276509|537775312|FG000|Overall Study|Pregnancy|1|||
149080132|NCT01276509|537775313|FG001|Overall Study|Pregnancy|0|||
149080133|NCT01276509|537775314|FG002|Overall Study|Pregnancy|0|||
149080134|NCT01276509|537775315|FG003|Overall Study|Pregnancy|0|||
149080135|NCT01276509|537775312|FG000|Overall Study|Withdrawal by Subject|1|||
149080136|NCT01276509|537775313|FG001|Overall Study|Withdrawal by Subject|2|||
149080137|NCT01276509|537775314|FG002|Overall Study|Withdrawal by Subject|0|||
149080138|NCT01276509|537775315|FG003|Overall Study|Withdrawal by Subject|0|||
149080139|NCT01276509|537775312|FG000|Overall Study|Other|0|||
149080140|NCT01276509|537775313|FG001|Overall Study|Other|1|||
149080141|NCT01276509|537775314|FG002|Overall Study|Other|0|||
149080142|NCT01276509|537775315|FG003|Overall Study|Other|0|||
149080143|NCT01277302|537775318|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
149080144|NCT01277302|537775319|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
149080145|NCT01277302|537775320|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
149080146|NCT01277302|537775318|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
149080147|NCT01277302|537775319|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
149080148|NCT01277302|537775320|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
149080149|NCT01277302|537775318|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
149080150|NCT01277302|537775319|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
149080151|NCT01277302|537775320|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
149080152|NCT01277302|537775318|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
149080153|NCT01277302|537775319|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
149080154|NCT01277302|537775320|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
149080155|NCT01277302|537775318|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
149080156|NCT01277302|537775319|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
149080157|NCT01277302|537775320|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
149080158|NCT01277302|537775318|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
149080159|NCT01277302|537775319|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
149080160|NCT01277302|537775320|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
149080161|NCT01277302|537775318|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
149080162|NCT01277302|537775319|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
149080163|NCT01277302|537775320|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
149080164|NCT01277302|537775318|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
149080165|NCT01277302|537775319|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
149080166|NCT01277302|537775320|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
149080167|NCT01277302|537775318|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
149080168|NCT01277302|537775319|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
149080169|NCT01277302|537775320|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
149080170|NCT02710669|537775321|FG000|Overall Study|Physician Decision|2|||
149080171|NCT02710669|537775322|FG001|Overall Study|Physician Decision|1|||
149080172|NCT02710669|537775323|FG002|Overall Study|Physician Decision|0|||
149080173|NCT02710669|537775321|FG000|Overall Study|Institutional delays (including COVID)|2|||
149080174|NCT02710669|537775322|FG001|Overall Study|Institutional delays (including COVID)|2|||
149080175|NCT02710669|537775323|FG002|Overall Study|Institutional delays (including COVID)|0|||
149080176|NCT02710669|537775321|FG000|Overall Study|arrived in afib/aflutter|10|||
149080177|NCT02710669|537775322|FG001|Overall Study|arrived in afib/aflutter|8|||
149080178|NCT02710669|537775323|FG002|Overall Study|arrived in afib/aflutter|2|||
149080179|NCT01128959|537775329|FG000|Lead in Period|Adverse Event|3|||
149080180|NCT01128959|537775329|FG000|Treatment Period|Adverse Event|3|||
149080181|NCT01128959|537775329|FG000|Treatment Period|Withdrawal by Subject|1|||
149080182|NCT02338999|537775330|FG000|First Intervention|Withdrawal by Subject|3|||
149080183|NCT02338999|537775331|FG001|First Intervention|Withdrawal by Subject|1|||
149080184|NCT02338999|537775330|FG000|Washout Period|Withdrawal by Subject|0|||
149080185|NCT02338999|537775331|FG001|Washout Period|Withdrawal by Subject|2|||
149080186|NCT02338999|537775330|FG000|Second Intervention|Withdrawal by Subject|0|||
149080187|NCT02338999|537775331|FG001|Second Intervention|Withdrawal by Subject|2|||
149080188|NCT01332266|537775332|FG000|Phase 1b|Death|3|||
149080189|NCT01332266|537775333|FG001|Phase 1b|Death|3|||
149080190|NCT01332266|537775334|FG002|Phase 1b|Death|2|||
149080191|NCT01332266|537775335|FG003|Phase 1b|Death|0|||
149080192|NCT01332266|537775336|FG004|Phase 1b|Death|0|||
149080193|NCT01332266|537775332|FG000|Phase 1b|Lost to Follow-up|0|||
149080194|NCT01332266|537775333|FG001|Phase 1b|Lost to Follow-up|1|||
149080195|NCT01332266|537775334|FG002|Phase 1b|Lost to Follow-up|0|||
149080196|NCT01332266|537775335|FG003|Phase 1b|Lost to Follow-up|0|||
149080197|NCT01332266|537775336|FG004|Phase 1b|Lost to Follow-up|0|||
149080198|NCT01332266|537775332|FG000|Phase 1b|Withdrawal by Subject|1|||
149080199|NCT01332266|537775333|FG001|Phase 1b|Withdrawal by Subject|1|||
149080200|NCT01332266|537775334|FG002|Phase 1b|Withdrawal by Subject|1|||
149080201|NCT01332266|537775335|FG003|Phase 1b|Withdrawal by Subject|0|||
149080202|NCT01332266|537775336|FG004|Phase 1b|Withdrawal by Subject|0|||
149080203|NCT01332266|537775332|FG000|Phase 2|Death|0|||
149080204|NCT01332266|537775333|FG001|Phase 2|Death|0|||
149080205|NCT01332266|537775334|FG002|Phase 2|Death|0|||
149080206|NCT01332266|537775335|FG003|Phase 2|Death|33|||
149080207|NCT01332266|537775336|FG004|Phase 2|Death|36|||
149080208|NCT01332266|537775332|FG000|Phase 2|Lost to Follow-up|0|||
149080209|NCT01332266|537775333|FG001|Phase 2|Lost to Follow-up|0|||
149080210|NCT01332266|537775334|FG002|Phase 2|Lost to Follow-up|0|||
149080211|NCT01332266|537775335|FG003|Phase 2|Lost to Follow-up|2|||
149080212|NCT01332266|537775336|FG004|Phase 2|Lost to Follow-up|0|||
149080213|NCT01332266|537775332|FG000|Phase 2|Physician Decision|0|||
149080214|NCT01332266|537775333|FG001|Phase 2|Physician Decision|0|||
149080215|NCT01332266|537775334|FG002|Phase 2|Physician Decision|0|||
149080216|NCT01332266|537775335|FG003|Phase 2|Physician Decision|3|||
149080217|NCT01332266|537775336|FG004|Phase 2|Physician Decision|1|||
149080218|NCT01332266|537775332|FG000|Phase 2|Symptomatic deterioration|0|||
149080219|NCT01332266|537775333|FG001|Phase 2|Symptomatic deterioration|0|||
149080220|NCT01332266|537775334|FG002|Phase 2|Symptomatic deterioration|0|||
149080221|NCT01332266|537775335|FG003|Phase 2|Symptomatic deterioration|0|||
149080222|NCT01332266|537775336|FG004|Phase 2|Symptomatic deterioration|1|||
149080223|NCT01332266|537775332|FG000|Phase 2|Progression Disease|0|||
149080224|NCT01332266|537775333|FG001|Phase 2|Progression Disease|0|||
149080225|NCT01332266|537775334|FG002|Phase 2|Progression Disease|0|||
149080226|NCT01332266|537775335|FG003|Phase 2|Progression Disease|2|||
149080227|NCT01332266|537775336|FG004|Phase 2|Progression Disease|1|||
149080228|NCT01332266|537775332|FG000|Phase 2|Withdrawal by Subject|0|||
149080229|NCT01332266|537775333|FG001|Phase 2|Withdrawal by Subject|0|||
149080230|NCT01332266|537775334|FG002|Phase 2|Withdrawal by Subject|0|||
149080231|NCT01332266|537775335|FG003|Phase 2|Withdrawal by Subject|2|||
149080232|NCT01332266|537775336|FG004|Phase 2|Withdrawal by Subject|2|||
149080233|NCT01947491|537775338|FG000|Overall Study|Lost to Follow-up|5|||
149080234|NCT01947491|537775339|FG001|Overall Study|Lost to Follow-up|3|||
149080235|NCT01947491|537775340|FG002|Overall Study|Lost to Follow-up|1|||
149080236|NCT01947491|537775341|FG003|Overall Study|Lost to Follow-up|2|||
149080237|NCT01947491|537775338|FG000|Overall Study|Lack of Efficacy|1|||
149080238|NCT01947491|537775339|FG001|Overall Study|Lack of Efficacy|0|||
149080239|NCT01947491|537775340|FG002|Overall Study|Lack of Efficacy|0|||
149080240|NCT01947491|537775341|FG003|Overall Study|Lack of Efficacy|1|||
149080241|NCT01947491|537775338|FG000|Overall Study|Protocol Violation|1|||
149080242|NCT01947491|537775339|FG001|Overall Study|Protocol Violation|0|||
149080243|NCT01947491|537775340|FG002|Overall Study|Protocol Violation|0|||
149080244|NCT01947491|537775341|FG003|Overall Study|Protocol Violation|0|||
149080245|NCT01947491|537775338|FG000|Overall Study|Withdrawal by Subject|1|||
149080246|NCT01947491|537775339|FG001|Overall Study|Withdrawal by Subject|1|||
149080247|NCT01947491|537775340|FG002|Overall Study|Withdrawal by Subject|1|||
149080248|NCT01947491|537775341|FG003|Overall Study|Withdrawal by Subject|0|||
149080249|NCT01947491|537775338|FG000|Overall Study|Worsening of condition|0|||
149080250|NCT01947491|537775339|FG001|Overall Study|Worsening of condition|1|||
149080251|NCT01947491|537775340|FG002|Overall Study|Worsening of condition|0|||
149080252|NCT01947491|537775341|FG003|Overall Study|Worsening of condition|0|||
149080253|NCT01947491|537775338|FG000|Overall Study|Adverse Event|0|||
149080254|NCT01947491|537775339|FG001|Overall Study|Adverse Event|1|||
149080255|NCT01947491|537775340|FG002|Overall Study|Adverse Event|0|||
149080256|NCT01947491|537775341|FG003|Overall Study|Adverse Event|2|||
149080257|NCT02067663|537775342|FG000|Overall Study|Lost to Follow-up|13|||
149080258|NCT02067663|537775343|FG001|Overall Study|Lost to Follow-up|14|||
149080259|NCT00486954|537775344|FG000|Pilot Part|Adverse Event|4|||
149080260|NCT00486954|537775345|FG001|Pilot Part|Adverse Event|0|||
149080261|NCT00486954|537775346|FG002|Pilot Part|Adverse Event|5|||
149080262|NCT00486954|537775347|FG003|Pilot Part|Adverse Event|0|||
149080263|NCT00486954|537775348|FG004|Pilot Part|Adverse Event|0|||
149080264|NCT00486954|537775344|FG000|Pilot Part|Disease Progression|2|||
149080265|NCT00486954|537775345|FG001|Pilot Part|Disease Progression|0|||
149080266|NCT00486954|537775346|FG002|Pilot Part|Disease Progression|1|||
149080267|NCT00486954|537775347|FG003|Pilot Part|Disease Progression|0|||
149080268|NCT00486954|537775348|FG004|Pilot Part|Disease Progression|0|||
149080269|NCT00486954|537775344|FG000|Randomized Part|Lost to Follow-up|0|||
149080270|NCT00486954|537775345|FG001|Randomized Part|Lost to Follow-up|0|||
149080271|NCT00486954|537775346|FG002|Randomized Part|Lost to Follow-up|0|||
149080272|NCT00486954|537775347|FG003|Randomized Part|Lost to Follow-up|0|||
149080273|NCT00486954|537775348|FG004|Randomized Part|Lost to Follow-up|1|||
149080274|NCT00486954|537775344|FG000|Randomized Part|Withdrawal by Subject|0|||
149080275|NCT00486954|537775345|FG001|Randomized Part|Withdrawal by Subject|0|||
149080276|NCT00486954|537775346|FG002|Randomized Part|Withdrawal by Subject|0|||
149080277|NCT00486954|537775347|FG003|Randomized Part|Withdrawal by Subject|1|||
149080278|NCT00486954|537775348|FG004|Randomized Part|Withdrawal by Subject|0|||
149080279|NCT00486954|537775344|FG000|Randomized Part|Sponsor Terminated Study|0|||
149080280|NCT00486954|537775345|FG001|Randomized Part|Sponsor Terminated Study|0|||
149080281|NCT00486954|537775346|FG002|Randomized Part|Sponsor Terminated Study|0|||
149080282|NCT00486954|537775347|FG003|Randomized Part|Sponsor Terminated Study|19|||
149080283|NCT00486954|537775348|FG004|Randomized Part|Sponsor Terminated Study|13|||
149080284|NCT03236779|537775349|FG000|Overall Study|Lost to Follow-up|13|||
149080285|NCT03236779|537775350|FG001|Overall Study|Lost to Follow-up|21|||
149080286|NCT01836523|537775355|FG000|Overall Study|Adverse Event|15|||
149080287|NCT01836523|537775356|FG001|Overall Study|Adverse Event|41|||
149080288|NCT01836523|537775357|FG002|Overall Study|Adverse Event|49|||
149080289|NCT01836523|537775358|FG003|Overall Study|Adverse Event|14|||
149080290|NCT01836523|537775355|FG000|Overall Study|Protocol Violation|6|||
149080291|NCT01836523|537775356|FG001|Overall Study|Protocol Violation|3|||
149080292|NCT01836523|537775357|FG002|Overall Study|Protocol Violation|2|||
149080293|NCT01836523|537775358|FG003|Overall Study|Protocol Violation|4|||
149080294|NCT01836523|537775355|FG000|Overall Study|Met Withdrawal Criteria|13|||
149080295|NCT01836523|537775356|FG001|Overall Study|Met Withdrawal Criteria|13|||
149080296|NCT01836523|537775357|FG002|Overall Study|Met Withdrawal Criteria|21|||
149080297|NCT01836523|537775358|FG003|Overall Study|Met Withdrawal Criteria|27|||
149080298|NCT01836523|537775355|FG000|Overall Study|Unclassified|17|||
149080299|NCT01836523|537775356|FG001|Overall Study|Unclassified|28|||
149080300|NCT01836523|537775357|FG002|Overall Study|Unclassified|19|||
149080301|NCT01836523|537775358|FG003|Overall Study|Unclassified|29|||
149080302|NCT02935673|537775359|FG000|Overall Study|Adverse Event|0|||
149080303|NCT02935673|537775360|FG001|Overall Study|Adverse Event|1|||
149080304|NCT02935673|537775361|FG002|Overall Study|Adverse Event|0|||
149080305|NCT02935673|537775359|FG000|Overall Study|Withdrawal by Subject|1|||
149080306|NCT02935673|537775360|FG001|Overall Study|Withdrawal by Subject|2|||
149080307|NCT02935673|537775361|FG002|Overall Study|Withdrawal by Subject|0|||
149080308|NCT02309515|537775362|FG000|Overall Study|Withdrawal by Subject|0|||
149080309|NCT02309515|537775363|FG001|Overall Study|Withdrawal by Subject|1|||
149080310|NCT04070105|537775367|FG000|Overall Study|Lost to Follow-up|0|||
149080311|NCT04070105|537775368|FG001|Overall Study|Lost to Follow-up|0|||
149080312|NCT04070105|537775369|FG002|Overall Study|Lost to Follow-up|0|||
149080313|NCT04070105|537775370|FG003|Overall Study|Lost to Follow-up|0|||
149080314|NCT04070105|537775371|FG004|Overall Study|Lost to Follow-up|0|||
149080315|NCT04070105|537775372|FG005|Overall Study|Lost to Follow-up|1|||
149080316|NCT00624377|537775378|FG000|Overall Study|Lost to Follow-up|355|||
149080317|NCT00624377|537775378|FG000|Overall Study|Withdrawal by Subject|100|||
149080318|NCT00624377|537775378|FG000|Overall Study|Adverse Event|14|||
149080319|NCT00624377|537775378|FG000|Overall Study|Other|91|||
149080320|NCT00624377|537775378|FG000|Overall Study|Non-evaluable population|84|||
149080321|NCT01102426|537775382|FG000|Overall Study|Randomized but not treated|4|||
149080322|NCT01102426|537775383|FG001|Overall Study|Randomized but not treated|1|||
149080323|NCT01102426|537775382|FG000|Overall Study|Adverse Events (treatment-related)|15|||
149080324|NCT01102426|537775383|FG001|Overall Study|Adverse Events (treatment-related)|8|||
149080325|NCT01102426|537775382|FG000|Overall Study|Physician Decision|9|||
149080326|NCT01102426|537775383|FG001|Overall Study|Physician Decision|6|||
149080327|NCT01102426|537775382|FG000|Overall Study|Progressive Disease|85|||
149080328|NCT01102426|537775383|FG001|Overall Study|Progressive Disease|44|||
149080329|NCT01102426|537775382|FG000|Overall Study|Adverse Events (unrelated to|9|||
149080330|NCT01102426|537775383|FG001|Overall Study|Adverse Events (unrelated to|1|||
149080331|NCT01102426|537775382|FG000|Overall Study|Patient Refusal|24|||
149080332|NCT01102426|537775383|FG001|Overall Study|Patient Refusal|12|||
149080333|NCT01102426|537775382|FG000|Overall Study|Death (due to adverse events|0|||
149080334|NCT01102426|537775383|FG001|Overall Study|Death (due to adverse events|1|||
149080335|NCT01102426|537775382|FG000|Overall Study|Death (non-related to the study|19|||
149080336|NCT01102426|537775383|FG001|Overall Study|Death (non-related to the study|8|||
149080337|NCT01393964|537775384|FG000|Overall Study|Disease Progression|4|||
149080338|NCT01393964|537775385|FG001|Overall Study|Disease Progression|3|||
149080339|NCT01393964|537775386|FG002|Overall Study|Disease Progression|5|||
149080340|NCT01393964|537775384|FG000|Overall Study|Study drug toxicity|1|||
149080341|NCT01393964|537775385|FG001|Overall Study|Study drug toxicity|0|||
149080342|NCT01393964|537775386|FG002|Overall Study|Study drug toxicity|0|||
149080343|NCT01393964|537775384|FG000|Overall Study|Withdrawal by Subject|0|||
149080344|NCT01393964|537775385|FG001|Overall Study|Withdrawal by Subject|0|||
149080345|NCT01393964|537775386|FG002|Overall Study|Withdrawal by Subject|1|||
149080346|NCT01393964|537775384|FG000|Overall Study|Adverse event unrelated to study drug|0|||
149080347|NCT01393964|537775385|FG001|Overall Study|Adverse event unrelated to study drug|3|||
149080348|NCT01393964|537775386|FG002|Overall Study|Adverse event unrelated to study drug|0|||
149080349|NCT01393964|537775384|FG000|Overall Study|Subject request stop study treatment|0|||
149080350|NCT01393964|537775385|FG001|Overall Study|Subject request stop study treatment|1|||
149080351|NCT01393964|537775386|FG002|Overall Study|Subject request stop study treatment|0|||
149080352|NCT01393964|537775384|FG000|Overall Study|Subject decided to move to transplant|1|||
149080353|NCT01393964|537775385|FG001|Overall Study|Subject decided to move to transplant|0|||
149080354|NCT01393964|537775386|FG002|Overall Study|Subject decided to move to transplant|0|||
149080355|NCT01393964|537775384|FG000|Overall Study|Subject switched to commercial supply|1|||
149080356|NCT01393964|537775385|FG001|Overall Study|Subject switched to commercial supply|0|||
149080357|NCT01393964|537775386|FG002|Overall Study|Subject switched to commercial supply|2|||
149080358|NCT01393964|537775384|FG000|Overall Study|Subject plateaued in terms of effect|1|||
149080359|NCT01393964|537775385|FG001|Overall Study|Subject plateaued in terms of effect|0|||
149080360|NCT01393964|537775386|FG002|Overall Study|Subject plateaued in terms of effect|0|||
149080361|NCT01393964|537775384|FG000|Overall Study|Investigator removed subject from study|0|||
149080362|NCT01393964|537775385|FG001|Overall Study|Investigator removed subject from study|1|||
149080363|NCT01393964|537775386|FG002|Overall Study|Investigator removed subject from study|0|||
149080364|NCT01393964|537775384|FG000|Overall Study|Subject converted to roll-over study|0|||
149080365|NCT01393964|537775385|FG001|Overall Study|Subject converted to roll-over study|1|||
149080366|NCT01393964|537775386|FG002|Overall Study|Subject converted to roll-over study|0|||
149080367|NCT01393964|537775384|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
149080368|NCT01393964|537775385|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
149080369|NCT01393964|537775386|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
149080370|NCT02988713|537775387|FG000|Overall Study|Withdrawal by Subject|1|||
149080371|NCT02988713|537775387|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
149080372|NCT04679675|537775388|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
149080373|NCT04679675|537775389|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
149080374|NCT04679675|537775390|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
149080375|NCT04679675|537775391|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
149080376|NCT04679675|537775388|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
149080377|NCT04679675|537775389|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
149080378|NCT04679675|537775390|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
149080379|NCT04679675|537775391|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
149080380|NCT03265132|537775393|FG000|Overall Study|Adverse Event|0|||
149080381|NCT03265132|537775394|FG001|Overall Study|Adverse Event|1|||
149080382|NCT03265132|537775393|FG000|Overall Study|Lack of Efficacy|0|||
149080383|NCT03265132|537775394|FG001|Overall Study|Lack of Efficacy|2|||
149080384|NCT03265132|537775393|FG000|Overall Study|Progressive disease|0|||
149080385|NCT03265132|537775394|FG001|Overall Study|Progressive disease|2|||
149080386|NCT03265132|537775393|FG000|Overall Study|Withdrawal by Subject|0|||
149080387|NCT03265132|537775394|FG001|Overall Study|Withdrawal by Subject|1|||
149080388|NCT03909100|537775397|FG000|Overall Study|Protocol Deviation|2|||
149080389|NCT03909100|537775397|FG000|Overall Study|Technical Problems|4|||
149080390|NCT03909100|537775397|FG000|Overall Study|Withdrawal by Subject|4|||
149080391|NCT03909100|537775397|FG000|Overall Study|Lost to Follow-up|1|||
149080392|NCT03909100|537775397|FG000|Overall Study|Reason not Specified|4|||
149080393|NCT00148122|537775398|FG000|Overall Study|Withdrawal by Subject|2|||
149080394|NCT00274287|537775399|FG000|Overall Study|Withdrawal by Subject|1|||
149080395|NCT00274287|537775399|FG000|Overall Study|subject non-compliance|1|||
149080396|NCT04492475|537775400|FG000|Overall Study|Enrolled but not treated|8|||
149080397|NCT04492475|537775401|FG001|Overall Study|Enrolled but not treated|8|||
149080398|NCT04492475|537775400|FG000|Overall Study|Withdrawal by Subject|4|||
149080399|NCT04492475|537775401|FG001|Overall Study|Withdrawal by Subject|0|||
149080400|NCT04492475|537775400|FG000|Overall Study|Became ineligible after enrollment|2|||
149080401|NCT04492475|537775401|FG001|Overall Study|Became ineligible after enrollment|0|||
149080402|NCT03200574|537775410|FG000|Overall Study|Death|4|||
149080403|NCT03200574|537775410|FG000|Overall Study|Withdrawal by Subject|8|||
149080404|NCT03200574|537775410|FG000|Overall Study|Long-Term need for anticoagulation|1|||
149080405|NCT03200574|537775410|FG000|Overall Study|Relocation|2|||
149080406|NCT03200574|537775410|FG000|Overall Study|Lost to Follow-up|2|||
149080407|NCT03035942|537775411|FG000|Overall Study|Adverse Event|8|||
149080408|NCT03035942|537775412|FG001|Overall Study|Adverse Event|4|||
149080409|NCT03035942|537775413|FG002|Overall Study|Adverse Event|5|||
149080410|NCT01989104|537775414|FG000|Overall Study|Withdrawal by Subject|3|||
149080411|NCT01989104|537775415|FG001|Overall Study|Withdrawal by Subject|0|||
149080412|NCT01989104|537775416|FG002|Overall Study|Withdrawal by Subject|0|||
149080413|NCT01989104|537775417|FG003|Overall Study|Withdrawal by Subject|0|||
149080414|NCT01989104|537775418|FG004|Overall Study|Withdrawal by Subject|0|||
149080415|NCT01263496|537775424|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
149080416|NCT01263496|537775425|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080417|NCT01263496|537775426|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080418|NCT01263496|537775427|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080419|NCT01263496|537775428|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080420|NCT01263496|537775429|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080421|NCT01263496|537775430|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080422|NCT01263496|537775431|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080423|NCT01263496|537775432|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
149080424|NCT01263496|537775424|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080425|NCT01263496|537775425|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080426|NCT01263496|537775426|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080427|NCT01263496|537775427|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
149080428|NCT01263496|537775428|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
149080429|NCT01263496|537775429|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080430|NCT01263496|537775430|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080431|NCT01263496|537775431|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080432|NCT01263496|537775432|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
149080433|NCT01263496|537775424|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
149080434|NCT01263496|537775425|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
149080435|NCT01263496|537775426|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
149080436|NCT01263496|537775427|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
149080437|NCT01263496|537775428|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
149080438|NCT01263496|537775429|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
149080439|NCT01263496|537775430|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
149080440|NCT01263496|537775431|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
149080441|NCT01263496|537775432|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
149080442|NCT01263496|537775424|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080443|NCT01263496|537775425|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
149080444|NCT01263496|537775426|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080445|NCT01263496|537775427|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080446|NCT01263496|537775428|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080447|NCT01263496|537775429|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080448|NCT01263496|537775430|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080449|NCT01263496|537775431|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080450|NCT01263496|537775432|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
149080451|NCT01263496|537775424|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149080452|NCT01263496|537775425|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149080453|NCT01263496|537775426|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149080454|NCT01263496|537775427|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149080455|NCT01263496|537775428|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
149080456|NCT01263496|537775429|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149080457|NCT01263496|537775430|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149080458|NCT01263496|537775431|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149080459|NCT01263496|537775432|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149080460|NCT01263496|537775424|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
149080461|NCT01263496|537775425|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
149080462|NCT01263496|537775426|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
149080463|NCT01263496|537775427|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
149080464|NCT01263496|537775428|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
149080465|NCT01263496|537775429|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149080466|NCT01263496|537775430|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149080467|NCT01263496|537775431|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149080468|NCT01263496|537775432|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
149080469|NCT01263496|537775424|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080470|NCT01263496|537775425|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080471|NCT01263496|537775426|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080472|NCT01263496|537775427|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080473|NCT01263496|537775428|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080474|NCT01263496|537775429|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080475|NCT01263496|537775430|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080476|NCT01263496|537775431|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
149080477|NCT01263496|537775432|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149080478|NCT00266656|537775439|FG000|Overall Study|Death|1|||
149080479|NCT00266656|537775440|FG001|Overall Study|Death|0|||
149080480|NCT00266656|537775439|FG000|Overall Study|Lost to Follow-up|4|||
149080481|NCT00266656|537775440|FG001|Overall Study|Lost to Follow-up|1|||
149080482|NCT00266656|537775439|FG000|Overall Study|Withdrawal by Subject|4|||
149080483|NCT00266656|537775440|FG001|Overall Study|Withdrawal by Subject|2|||
149080484|NCT00266656|537775439|FG000|Overall Study|Did Not Reach Final Height|4|||
149080485|NCT00266656|537775440|FG001|Overall Study|Did Not Reach Final Height|8|||
149080486|NCT00266656|537775439|FG000|Overall Study|Parent/Caregiver Decision|1|||
149080487|NCT00266656|537775440|FG001|Overall Study|Parent/Caregiver Decision|2|||
149080488|NCT02106325|537775443|FG000|Phase 1|Lost to Follow-up|2|||
149080489|NCT02106325|537775444|FG001|Phase 1|Lost to Follow-up|2|||
149080490|NCT02106325|537775443|FG000|Phase 2|Lost to Follow-up|2|||
149080491|NCT02106325|537775444|FG001|Phase 2|Lost to Follow-up|3|||
149080492|NCT02106325|537775443|FG000|Phase 3|Lost to Follow-up|2|||
149080493|NCT02106325|537775444|FG001|Phase 3|Lost to Follow-up|1|||
149080494|NCT03242863|537775446|FG000|Study Week 1|Withdrawal by Subject|0|||
149080495|NCT03242863|537775447|FG001|Study Week 1|Withdrawal by Subject|1|||
149080496|NCT03242863|537775448|FG002|Study Week 1|Withdrawal by Subject|0|||
149080497|NCT03242863|537775449|FG003|Study Week 1|Withdrawal by Subject|0|||
149080498|NCT03242863|537775450|FG004|Study Week 1|Withdrawal by Subject|3|||
149080499|NCT03242863|537775451|FG005|Study Week 1|Withdrawal by Subject|0|||
149080500|NCT04852978|537775452|FG000|Overall Study|Physician Decision|0|||
149080501|NCT04852978|537775453|FG001|Overall Study|Physician Decision|1|||
149080502|NCT04852978|537775454|FG002|Overall Study|Physician Decision|0|||
149080503|NCT04852978|537775455|FG003|Overall Study|Physician Decision|0|||
149080504|NCT04852978|537775456|FG004|Overall Study|Physician Decision|0|||
149080505|NCT04852978|537775457|FG005|Overall Study|Physician Decision|0|||
149080506|NCT04852978|537775458|FG006|Overall Study|Physician Decision|0|||
149080507|NCT04852978|537775459|FG007|Overall Study|Physician Decision|2|||
149080508|NCT04852978|537775460|FG008|Overall Study|Physician Decision|0|||
149080509|NCT04852978|537775452|FG000|Overall Study|Sponsor request|0|||
149080510|NCT04852978|537775453|FG001|Overall Study|Sponsor request|0|||
149080511|NCT04852978|537775454|FG002|Overall Study|Sponsor request|1|||
149080512|NCT04852978|537775455|FG003|Overall Study|Sponsor request|0|||
149080513|NCT04852978|537775456|FG004|Overall Study|Sponsor request|0|||
149080514|NCT04852978|537775457|FG005|Overall Study|Sponsor request|0|||
149080515|NCT04852978|537775458|FG006|Overall Study|Sponsor request|0|||
149080516|NCT04852978|537775459|FG007|Overall Study|Sponsor request|0|||
149080517|NCT04852978|537775460|FG008|Overall Study|Sponsor request|0|||
149080518|NCT04852978|537775452|FG000|Overall Study|Death|0|||
149080519|NCT04852978|537775453|FG001|Overall Study|Death|0|||
149080520|NCT04852978|537775454|FG002|Overall Study|Death|0|||
149080521|NCT04852978|537775455|FG003|Overall Study|Death|0|||
149080522|NCT04852978|537775456|FG004|Overall Study|Death|0|||
149080523|NCT04852978|537775457|FG005|Overall Study|Death|0|||
149080524|NCT04852978|537775458|FG006|Overall Study|Death|1|||
149080525|NCT04852978|537775459|FG007|Overall Study|Death|0|||
149080526|NCT04852978|537775460|FG008|Overall Study|Death|0|||
149080527|NCT04852978|537775452|FG000|Overall Study|Lost to Follow-up|3|||
149080528|NCT04852978|537775453|FG001|Overall Study|Lost to Follow-up|2|||
149080529|NCT04852978|537775454|FG002|Overall Study|Lost to Follow-up|2|||
149080530|NCT04852978|537775455|FG003|Overall Study|Lost to Follow-up|0|||
149080531|NCT04852978|537775456|FG004|Overall Study|Lost to Follow-up|2|||
149080532|NCT04852978|537775457|FG005|Overall Study|Lost to Follow-up|4|||
149080533|NCT04852978|537775458|FG006|Overall Study|Lost to Follow-up|1|||
149080534|NCT04852978|537775459|FG007|Overall Study|Lost to Follow-up|2|||
149080535|NCT04852978|537775460|FG008|Overall Study|Lost to Follow-up|2|||
149120382|NCT02559895|537918090|FG000|Overall Study|Other|1|||
149080536|NCT04852978|537775452|FG000|Overall Study|Withdrawal by Subject|4|||
149080537|NCT04852978|537775453|FG001|Overall Study|Withdrawal by Subject|2|||
149080538|NCT04852978|537775454|FG002|Overall Study|Withdrawal by Subject|2|||
149080539|NCT04852978|537775455|FG003|Overall Study|Withdrawal by Subject|1|||
149080540|NCT04852978|537775456|FG004|Overall Study|Withdrawal by Subject|5|||
149080541|NCT04852978|537775457|FG005|Overall Study|Withdrawal by Subject|3|||
149080542|NCT04852978|537775458|FG006|Overall Study|Withdrawal by Subject|2|||
149080543|NCT04852978|537775459|FG007|Overall Study|Withdrawal by Subject|2|||
149080544|NCT04852978|537775460|FG008|Overall Study|Withdrawal by Subject|1|||
149080545|NCT04369664|537776936|FG000|Overall Study|Physician Decision|1|||
149080546|NCT04369664|537776937|FG001|Overall Study|Physician Decision|0|||
149080547|NCT00535626|537776943|FG000|Overall Study|Death|15|||
149080548|NCT00535626|537776943|FG000|Overall Study|Lost to Follow-up|29|||
149080549|NCT00535626|537776943|FG000|Overall Study|Withdrawal by Subject|20|||
149080550|NCT00535626|537776943|FG000|Overall Study|Removal/revision of study component|8|||
149080551|NCT00535626|537776943|FG000|Overall Study|Subject terminated|31|||
149080552|NCT00535626|537776943|FG000|Overall Study|Unable to return|2|||
149080553|NCT02830893|537776944|FG000|Overall Study|Relocation to out of the country|1|||
149080554|NCT02830893|537776945|FG001|Overall Study|Relocation to out of the country|0|||
149080555|NCT02830893|537776944|FG000|Overall Study|Lost to Follow-up|0|||
149080556|NCT02830893|537776945|FG001|Overall Study|Lost to Follow-up|2|||
149080557|NCT02830893|537776944|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
149080558|NCT02830893|537776945|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
149080559|NCT01567852|537776946|FG000|Overall Study|Withdrawal by Subject|3|||
149080560|NCT01567852|537776947|FG001|Overall Study|Withdrawal by Subject|6|||
149080561|NCT01567852|537776946|FG000|Overall Study|ECT discontinued|1|||
149080562|NCT01567852|537776947|FG001|Overall Study|ECT discontinued|1|||
149080563|NCT00215943|537776948|FG000|Overall Study|Disease Progression|3|||
149080564|NCT00215943|537776949|FG001|Overall Study|Disease Progression|5|||
149080565|NCT00215943|537776948|FG000|Overall Study|Alternate therapy|0|||
149080566|NCT00215943|537776949|FG001|Overall Study|Alternate therapy|1|||
149080567|NCT00215943|537776948|FG000|Overall Study|Adverse Event|3|||
149080568|NCT00215943|537776949|FG001|Overall Study|Adverse Event|6|||
149080569|NCT00215943|537776948|FG000|Overall Study|Other disease|0|||
149080570|NCT00215943|537776949|FG001|Overall Study|Other disease|1|||
149080571|NCT00215943|537776948|FG000|Overall Study|Other complications|3|||
149080572|NCT00215943|537776949|FG001|Overall Study|Other complications|1|||
149080573|NCT03332589|537776950|FG000|Overall Study|Lack of Efficacy|2|||
149080574|NCT03332589|537776951|FG001|Overall Study|Lack of Efficacy|0|||
149080575|NCT03332589|537776952|FG002|Overall Study|Lack of Efficacy|0|||
149080576|NCT03332589|537776950|FG000|Overall Study|Adverse Event|1|||
149080577|NCT03332589|537776951|FG001|Overall Study|Adverse Event|0|||
149080578|NCT03332589|537776952|FG002|Overall Study|Adverse Event|0|||
149080579|NCT03332589|537776950|FG000|Overall Study|Death|1|||
149080580|NCT03332589|537776951|FG001|Overall Study|Death|0|||
149080581|NCT03332589|537776952|FG002|Overall Study|Death|0|||
149080582|NCT00443820|537776953|FG000|Overall Study|Adverse Event|1|||
149080583|NCT00443820|537776954|FG001|Overall Study|Adverse Event|1|||
149080584|NCT00443820|537776955|FG002|Overall Study|Adverse Event|0|||
149080585|NCT00443820|537776956|FG003|Overall Study|Adverse Event|0|||
149080586|NCT00443820|537776953|FG000|Overall Study|Lack of Efficacy|3|||
149080587|NCT00443820|537776954|FG001|Overall Study|Lack of Efficacy|2|||
149080588|NCT00443820|537776955|FG002|Overall Study|Lack of Efficacy|1|||
149080589|NCT00443820|537776956|FG003|Overall Study|Lack of Efficacy|1|||
149080590|NCT00443820|537776953|FG000|Overall Study|Protocol Violation|2|||
149080591|NCT00443820|537776954|FG001|Overall Study|Protocol Violation|1|||
149080592|NCT00443820|537776955|FG002|Overall Study|Protocol Violation|2|||
149080593|NCT00443820|537776956|FG003|Overall Study|Protocol Violation|1|||
149080594|NCT00443820|537776953|FG000|Overall Study|Withdrawal by Subject|6|||
149080595|NCT00443820|537776954|FG001|Overall Study|Withdrawal by Subject|7|||
149080596|NCT00443820|537776955|FG002|Overall Study|Withdrawal by Subject|8|||
149080597|NCT00443820|537776956|FG003|Overall Study|Withdrawal by Subject|9|||
149080598|NCT00443820|537776953|FG000|Overall Study|Lost to Follow-up|9|||
149080599|NCT00443820|537776954|FG001|Overall Study|Lost to Follow-up|8|||
149080600|NCT00443820|537776955|FG002|Overall Study|Lost to Follow-up|6|||
149080601|NCT00443820|537776956|FG003|Overall Study|Lost to Follow-up|5|||
149080602|NCT00443820|537776953|FG000|Overall Study|Administrative problems|0|||
149080603|NCT00443820|537776954|FG001|Overall Study|Administrative problems|0|||
149080604|NCT00443820|537776955|FG002|Overall Study|Administrative problems|0|||
149080605|NCT00443820|537776956|FG003|Overall Study|Administrative problems|1|||
149080606|NCT00443820|537776953|FG000|Overall Study|Death|0|||
149080607|NCT00443820|537776954|FG001|Overall Study|Death|0|||
149080608|NCT00443820|537776955|FG002|Overall Study|Death|1|||
149080609|NCT00443820|537776956|FG003|Overall Study|Death|0|||
149080610|NCT04633200|537776957|FG000|Overall Study|Lost to Follow-up|3|||
149080611|NCT04633200|537776958|FG001|Overall Study|Lost to Follow-up|5|||
149080612|NCT02507297|537776959|FG000|Overall Study|Withdrawal by Subject|1|||
149080613|NCT02507297|537776960|FG001|Overall Study|Withdrawal by Subject|0|||
149080614|NCT02507297|537776959|FG000|Overall Study|Lost to Follow-up|0|||
149080615|NCT02507297|537776960|FG001|Overall Study|Lost to Follow-up|1|||
149080616|NCT02489799|537776961|FG000|Overall Study|Lost to Follow-up|4|||
149080617|NCT02489799|537776962|FG001|Overall Study|Lost to Follow-up|1|||
149080618|NCT02489799|537776961|FG000|Overall Study|Failure to Maintain Eligibility|4|||
149080619|NCT02489799|537776962|FG001|Overall Study|Failure to Maintain Eligibility|6|||
149080620|NCT02489799|537776961|FG000|Overall Study|Withdrawal by Subject|1|||
149080621|NCT02489799|537776962|FG001|Overall Study|Withdrawal by Subject|1|||
149080622|NCT02489799|537776961|FG000|Overall Study|Death|0|||
149080623|NCT02489799|537776962|FG001|Overall Study|Death|1|||
149080624|NCT01808534|537776972|FG000|Overall Study|Disease progression|3|||
149080625|NCT01808534|537776972|FG000|Overall Study|Physician Decision|1|||
149080626|NCT01377844|537776973|FG000|Overall Study|Withdrawal by Subject|25|||
149080627|NCT01377844|537776974|FG001|Overall Study|Withdrawal by Subject|28|||
149080628|NCT01377844|537776973|FG000|Overall Study|Protocol Violation|2|||
149080629|NCT01377844|537776974|FG001|Overall Study|Protocol Violation|3|||
149080630|NCT01377844|537776973|FG000|Overall Study|Adverse Event|3|||
149080631|NCT01377844|537776974|FG001|Overall Study|Adverse Event|0|||
149080632|NCT01377844|537776973|FG000|Overall Study|Physician Decision|6|||
149080633|NCT01377844|537776974|FG001|Overall Study|Physician Decision|3|||
149080634|NCT01377844|537776973|FG000|Overall Study|Study terminated by Sponsor|0|||
149080635|NCT01377844|537776974|FG001|Overall Study|Study terminated by Sponsor|1|||
149080636|NCT02092285|537776975|FG000|Induction Phase|Adverse Event|7|||
149080637|NCT02092285|537776975|FG000|Induction Phase|Physician Decision|4|||
149080638|NCT02092285|537776975|FG000|Induction Phase|Pregnancy|1|||
149080639|NCT02092285|537776975|FG000|Induction Phase|Relapse/Recurrence|7|||
149080640|NCT02092285|537776975|FG000|Induction Phase|Withdrawal by Subject|2|||
149080641|NCT02092285|537776975|FG000|Induction Phase|Lack of Efficacy|14|||
149080642|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
149080643|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
149080644|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
149080645|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
149080646|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
149080647|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
149080648|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
149080649|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
149080650|NCT02092285|537776975|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
149080651|NCT00087516|537776976|FG000|Overall Study|Adverse Event|10|||
149080652|NCT00087516|537776977|FG001|Overall Study|Adverse Event|10|||
149080653|NCT00087516|537776978|FG002|Overall Study|Adverse Event|3|||
149080654|NCT00087516|537776979|FG003|Overall Study|Adverse Event|6|||
149080655|NCT00087516|537776976|FG000|Overall Study|Lack of Efficacy|82|||
149080656|NCT00087516|537776977|FG001|Overall Study|Lack of Efficacy|80|||
149080657|NCT00087516|537776978|FG002|Overall Study|Lack of Efficacy|39|||
149080658|NCT00087516|537776979|FG003|Overall Study|Lack of Efficacy|29|||
149080659|NCT00087516|537776976|FG000|Overall Study|Lost to Follow-up|8|||
149080660|NCT00087516|537776977|FG001|Overall Study|Lost to Follow-up|6|||
149080661|NCT00087516|537776978|FG002|Overall Study|Lost to Follow-up|5|||
149080662|NCT00087516|537776979|FG003|Overall Study|Lost to Follow-up|5|||
149080663|NCT00087516|537776976|FG000|Overall Study|Protocol Violation|4|||
149080664|NCT00087516|537776977|FG001|Overall Study|Protocol Violation|8|||
149080665|NCT00087516|537776978|FG002|Overall Study|Protocol Violation|3|||
149080666|NCT00087516|537776979|FG003|Overall Study|Protocol Violation|6|||
149080667|NCT00087516|537776976|FG000|Overall Study|Withdrawal by Subject|16|||
149080668|NCT00087516|537776977|FG001|Overall Study|Withdrawal by Subject|27|||
149080669|NCT00087516|537776978|FG002|Overall Study|Withdrawal by Subject|11|||
149080670|NCT00087516|537776979|FG003|Overall Study|Withdrawal by Subject|12|||
149080671|NCT00087516|537776976|FG000|Overall Study|Site terminated|0|||
149080672|NCT00087516|537776977|FG001|Overall Study|Site terminated|2|||
149080673|NCT00087516|537776978|FG002|Overall Study|Site terminated|1|||
149080674|NCT00087516|537776979|FG003|Overall Study|Site terminated|0|||
149080675|NCT00087516|537776976|FG000|Overall Study|Protocol specified discontinuation|35|||
149080676|NCT00087516|537776977|FG001|Overall Study|Protocol specified discontinuation|33|||
149080677|NCT00087516|537776978|FG002|Overall Study|Protocol specified discontinuation|33|||
149080678|NCT00087516|537776979|FG003|Overall Study|Protocol specified discontinuation|26|||
149080679|NCT00087516|537776976|FG000|Overall Study|Patient moved|3|||
149080680|NCT00087516|537776977|FG001|Overall Study|Patient moved|2|||
149080681|NCT00087516|537776978|FG002|Overall Study|Patient moved|1|||
149080682|NCT00087516|537776979|FG003|Overall Study|Patient moved|0|||
149080683|NCT00087516|537776976|FG000|Overall Study|Patient was non-compliant|3|||
149080684|NCT00087516|537776977|FG001|Overall Study|Patient was non-compliant|1|||
149080685|NCT00087516|537776978|FG002|Overall Study|Patient was non-compliant|0|||
149080686|NCT00087516|537776979|FG003|Overall Study|Patient was non-compliant|0|||
149080687|NCT00087516|537776976|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
149080688|NCT00087516|537776977|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
149080689|NCT00087516|537776978|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
149080690|NCT00087516|537776979|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
149080691|NCT00087516|537776976|FG000|Overall Study|Other|0|||
149080692|NCT00087516|537776977|FG001|Overall Study|Other|0|||
149080693|NCT00087516|537776978|FG002|Overall Study|Other|1|||
149080694|NCT00087516|537776979|FG003|Overall Study|Other|0|||
149080695|NCT00278395|537776982|FG000|Overall Study|Adverse Event|2|||
149080696|NCT00278395|537776982|FG000|Overall Study|Nonevaluable|1|||
149080697|NCT02202317|537776986|FG000|Overall Study|Lost to Follow-up|1|||
149080698|NCT00569166|537776988|FG000|Overall Study|Withdrawal by Subject|7|||
149080699|NCT00569166|537776989|FG001|Overall Study|Withdrawal by Subject|5|||
149080700|NCT00569166|537776990|FG002|Overall Study|Withdrawal by Subject|3|||
149080701|NCT00569166|537776988|FG000|Overall Study|Lost to Follow-up|2|||
149080702|NCT00569166|537776989|FG001|Overall Study|Lost to Follow-up|1|||
149080703|NCT00569166|537776990|FG002|Overall Study|Lost to Follow-up|1|||
149080704|NCT01686152|537776992|FG000|Overall Study|Withdrawal by Subject|11|||
149080705|NCT01686152|537776993|FG001|Overall Study|Withdrawal by Subject|11|||
149080706|NCT01686152|537776994|FG002|Overall Study|Withdrawal by Subject|3|||
149080707|NCT01686152|537776992|FG000|Overall Study|Drug Code Unblinded|0|||
149080708|NCT01686152|537776993|FG001|Overall Study|Drug Code Unblinded|1|||
149080709|NCT01686152|537776994|FG002|Overall Study|Drug Code Unblinded|0|||
149080710|NCT01686152|537776992|FG000|Overall Study|Protocol Violation|6|||
149080711|NCT01686152|537776993|FG001|Overall Study|Protocol Violation|1|||
149080712|NCT01686152|537776994|FG002|Overall Study|Protocol Violation|0|||
149080713|NCT01686152|537776992|FG000|Overall Study|Adverse Event|12|||
149080714|NCT01686152|537776993|FG001|Overall Study|Adverse Event|11|||
149080715|NCT01686152|537776994|FG002|Overall Study|Adverse Event|0|||
149080716|NCT01686152|537776992|FG000|Overall Study|Lack of Efficacy|0|||
149080717|NCT01686152|537776993|FG001|Overall Study|Lack of Efficacy|0|||
149080718|NCT01686152|537776994|FG002|Overall Study|Lack of Efficacy|1|||
149080719|NCT01686152|537776992|FG000|Overall Study|IP Non-compliance|5|||
149080720|NCT01686152|537776993|FG001|Overall Study|IP Non-compliance|5|||
149080721|NCT01686152|537776994|FG002|Overall Study|IP Non-compliance|0|||
149080722|NCT01686152|537776992|FG000|Overall Study|Lost to Follow-up|7|||
149080723|NCT01686152|537776993|FG001|Overall Study|Lost to Follow-up|6|||
149080724|NCT01686152|537776994|FG002|Overall Study|Lost to Follow-up|5|||
149080725|NCT01853384|537776995|FG000|Randomized|Adverse Event|5|||
149080726|NCT01853384|537776996|FG001|Randomized|Adverse Event|3|||
149080727|NCT01853384|537776995|FG000|Randomized|Death|1|||
149080728|NCT01853384|537776996|FG001|Randomized|Death|2|||
149080729|NCT01853384|537776995|FG000|Randomized|Lost to Follow-up|1|||
149080730|NCT01853384|537776996|FG001|Randomized|Lost to Follow-up|1|||
149080731|NCT01853384|537776995|FG000|Randomized|Withdrawal by Subject|5|||
149080732|NCT01853384|537776996|FG001|Randomized|Withdrawal by Subject|3|||
149080733|NCT01853384|537776995|FG000|Randomized|Sponsor Decision|47|||
149080734|NCT01853384|537776996|FG001|Randomized|Sponsor Decision|34|||
149080735|NCT01853384|537776995|FG000|Randomized|Other|3|||
149080736|NCT01853384|537776996|FG001|Randomized|Other|3|||
149080737|NCT01853384|537776995|FG000|Completed Follow up Visit 1|Early Termination|13|||
149080738|NCT01853384|537776996|FG001|Completed Follow up Visit 1|Early Termination|9|||
149080739|NCT01853384|537776995|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
149080740|NCT01853384|537776996|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
149080741|NCT01853384|537776995|FG000|Completed Follow up Visit 2|Adverse Event|1|||
149080742|NCT01853384|537776996|FG001|Completed Follow up Visit 2|Adverse Event|0|||
149080743|NCT01853384|537776995|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
149080744|NCT01853384|537776996|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
149080745|NCT01853384|537776995|FG000|Completed Follow up Visit 2|Death|1|||
149080746|NCT01853384|537776996|FG001|Completed Follow up Visit 2|Death|0|||
149080747|NCT01853384|537776995|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
149080748|NCT01853384|537776996|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
149080749|NCT00704340|537776997|FG000|Overall Study|Lost to Follow-up|2|||
149080750|NCT00704340|537776998|FG001|Overall Study|Lost to Follow-up|1|||
149080751|NCT00704340|537776997|FG000|Overall Study|Death|0|||
149080752|NCT00704340|537776998|FG001|Overall Study|Death|1|||
149080753|NCT00929526|537776999|FG000|Overall Study|Withdrawal by Subject|1|||
149080754|NCT00929526|537777000|FG001|Overall Study|Withdrawal by Subject|11|||
149080755|NCT00929526|537776999|FG000|Overall Study|Lost to Follow-up|8|||
149080756|NCT00929526|537777000|FG001|Overall Study|Lost to Follow-up|12|||
149080757|NCT00929526|537776999|FG000|Overall Study|Other|8|||
149080758|NCT00929526|537777000|FG001|Overall Study|Other|6|||
149080759|NCT00403845|537777001|FG000|Treatment Period 1|Subject withdrew consent|1|||
149080760|NCT00403845|537777002|FG001|Treatment Period 1|Subject withdrew consent|0|||
149080761|NCT00403845|537777003|FG002|Treatment Period 1|Subject withdrew consent|0|||
149080762|NCT00403845|537777004|FG003|Treatment Period 1|Subject withdrew consent|0|||
149080763|NCT00403845|537777001|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
149080764|NCT00403845|537777002|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
149080765|NCT00403845|537777003|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
149080766|NCT00403845|537777004|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
149080767|NCT00403845|537777001|FG000|Treatment Period 2|Subject withdrew consent|1|||
149080768|NCT00403845|537777002|FG001|Treatment Period 2|Subject withdrew consent|0|||
149080769|NCT00403845|537777003|FG002|Treatment Period 2|Subject withdrew consent|0|||
149080770|NCT00403845|537777004|FG003|Treatment Period 2|Subject withdrew consent|0|||
149080771|NCT00403845|537777001|FG000|Treatment Period 3|Subject withdrew consent|0|||
149080772|NCT00403845|537777002|FG001|Treatment Period 3|Subject withdrew consent|0|||
149080773|NCT00403845|537777003|FG002|Treatment Period 3|Subject withdrew consent|0|||
149080774|NCT00403845|537777004|FG003|Treatment Period 3|Subject withdrew consent|1|||
149080775|NCT00403845|537777001|FG000|Treatment Period 3|Adverse Event|0|||
149080776|NCT00403845|537777002|FG001|Treatment Period 3|Adverse Event|0|||
149080777|NCT00403845|537777003|FG002|Treatment Period 3|Adverse Event|0|||
149080778|NCT00403845|537777004|FG003|Treatment Period 3|Adverse Event|1|||
149080779|NCT03316170|537777005|FG000|Overall Study|Death|1|||
149080780|NCT03316170|537777006|FG001|Overall Study|Death|0|||
149080781|NCT03316170|537777005|FG000|Overall Study|Lost to Follow-up|6|||
149080782|NCT03316170|537777006|FG001|Overall Study|Lost to Follow-up|7|||
149080783|NCT00578344|537777007|FG000|Overall Study|Insurance problems|1|||
149080784|NCT00578344|537777007|FG000|Overall Study|Graft failure|1|||
149080785|NCT02169414|537777008|FG000|Overall Study|Withdrawal by Subject|1|||
149080786|NCT02169414|537777009|FG001|Overall Study|Withdrawal by Subject|0|||
149080787|NCT02169414|537777010|FG002|Overall Study|Withdrawal by Subject|0|||
149080788|NCT02169414|537777011|FG003|Overall Study|Withdrawal by Subject|0|||
149080789|NCT02169414|537777008|FG000|Overall Study|Adverse Event|0|||
149080790|NCT02169414|537777009|FG001|Overall Study|Adverse Event|1|||
149080791|NCT02169414|537777010|FG002|Overall Study|Adverse Event|0|||
149080792|NCT02169414|537777011|FG003|Overall Study|Adverse Event|0|||
149080793|NCT03374254|537777014|FG000|Overall Study|Death|5|||
149080794|NCT03374254|537777015|FG001|Overall Study|Death|16|||
149080795|NCT03374254|537777016|FG002|Overall Study|Death|13|||
149080796|NCT03374254|537777017|FG003|Overall Study|Death|11|||
149080797|NCT03374254|537777018|FG004|Overall Study|Death|9|||
149080798|NCT03374254|537777019|FG005|Overall Study|Death|12|||
149080799|NCT03374254|537777020|FG006|Overall Study|Death|11|||
149080800|NCT03374254|537777021|FG007|Overall Study|Death|6|||
149080801|NCT03374254|537777022|FG008|Overall Study|Death|7|||
149080802|NCT03374254|537777014|FG000|Overall Study|Lost to Follow-up|0|||
149080803|NCT03374254|537777015|FG001|Overall Study|Lost to Follow-up|0|||
149080804|NCT03374254|537777016|FG002|Overall Study|Lost to Follow-up|0|||
149080805|NCT03374254|537777017|FG003|Overall Study|Lost to Follow-up|0|||
149080806|NCT03374254|537777018|FG004|Overall Study|Lost to Follow-up|0|||
149080807|NCT03374254|537777019|FG005|Overall Study|Lost to Follow-up|0|||
149080808|NCT03374254|537777020|FG006|Overall Study|Lost to Follow-up|2|||
149080809|NCT03374254|537777021|FG007|Overall Study|Lost to Follow-up|0|||
149080810|NCT03374254|537777022|FG008|Overall Study|Lost to Follow-up|0|||
149080811|NCT03374254|537777014|FG000|Overall Study|Sponsor Decision|1|||
149080812|NCT03374254|537777015|FG001|Overall Study|Sponsor Decision|0|||
149080813|NCT03374254|537777016|FG002|Overall Study|Sponsor Decision|2|||
149080814|NCT03374254|537777017|FG003|Overall Study|Sponsor Decision|3|||
149080815|NCT03374254|537777018|FG004|Overall Study|Sponsor Decision|2|||
149080816|NCT03374254|537777019|FG005|Overall Study|Sponsor Decision|3|||
149080817|NCT03374254|537777020|FG006|Overall Study|Sponsor Decision|3|||
149080818|NCT03374254|537777021|FG007|Overall Study|Sponsor Decision|3|||
149080819|NCT03374254|537777022|FG008|Overall Study|Sponsor Decision|4|||
149080820|NCT03374254|537777014|FG000|Overall Study|Withdrawal by Subject|0|||
149080821|NCT03374254|537777015|FG001|Overall Study|Withdrawal by Subject|0|||
149080822|NCT03374254|537777016|FG002|Overall Study|Withdrawal by Subject|0|||
149080823|NCT03374254|537777017|FG003|Overall Study|Withdrawal by Subject|2|||
149080824|NCT03374254|537777018|FG004|Overall Study|Withdrawal by Subject|0|||
149080825|NCT03374254|537777019|FG005|Overall Study|Withdrawal by Subject|1|||
149080826|NCT03374254|537777020|FG006|Overall Study|Withdrawal by Subject|0|||
149080827|NCT03374254|537777021|FG007|Overall Study|Withdrawal by Subject|0|||
149080828|NCT03374254|537777022|FG008|Overall Study|Withdrawal by Subject|0|||
149080829|NCT04803734|537777023|FG000|Overall Study|Withdrawal by Subject|0|||
149080830|NCT04803734|537777024|FG001|Overall Study|Withdrawal by Subject|1|||
149080831|NCT04803734|537777023|FG000|Overall Study|Protocol Violation|0|||
149080832|NCT04803734|537777024|FG001|Overall Study|Protocol Violation|1|||
149080833|NCT00749944|537777033|FG000|Overall Study|Lost to Follow-up|2|||
149080834|NCT00749944|537777034|FG001|Overall Study|Lost to Follow-up|1|||
149080835|NCT00749944|537777033|FG000|Overall Study|Other|1|||
149080836|NCT00749944|537777034|FG001|Overall Study|Other|0|||
149080837|NCT00749944|537777033|FG000|Overall Study|Withdrawal by Subject|2|||
149080838|NCT00749944|537777034|FG001|Overall Study|Withdrawal by Subject|0|||
149080839|NCT02547974|537777035|FG000|Overall Study|Withdrawal by Subject|1|||
149080840|NCT02547974|537777036|FG001|Overall Study|Withdrawal by Subject|0|||
149080841|NCT02547974|537777037|FG002|Overall Study|Withdrawal by Subject|0|||
149080842|NCT02547974|537777038|FG003|Overall Study|Withdrawal by Subject|0|||
149080843|NCT00923078|537777042|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
149080844|NCT00923078|537777043|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
149080845|NCT00923078|537777044|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
149080846|NCT00923078|537777042|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
149080847|NCT00923078|537777043|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
149080848|NCT00923078|537777044|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
149080849|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
149080850|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
149080851|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
149080852|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
149080853|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Adverse Event|7|||
149080854|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Adverse Event|8|||
149080855|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Adverse Event|8|||
149080856|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Adverse Event|9|||
149080857|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
149080858|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
149080859|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
149080860|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
149080861|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
149080862|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
149080863|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
149080864|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
149080865|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Pregnancy|0|||
149080866|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Pregnancy|2|||
149080867|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Pregnancy|2|||
149080868|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Pregnancy|0|||
149080869|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Non-compliance|1|||
149080870|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Non-compliance|0|||
149080871|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Non-compliance|0|||
149080872|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Non-compliance|3|||
149080873|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Other|3|||
149080874|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Other|0|||
149080875|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Other|3|||
149080876|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Other|2|||
149080877|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
149080878|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
149080879|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
149080880|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
149080881|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
149080882|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
149080883|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
149080884|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
149080885|NCT02143713|537777045|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
149080886|NCT02143713|537777046|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
149080887|NCT02143713|537777047|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
149080888|NCT02143713|537777048|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
149080889|NCT02143713|537777045|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
149080890|NCT02143713|537777046|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
149080891|NCT02143713|537777047|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
149080892|NCT02143713|537777048|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
149080893|NCT02143713|537777045|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
149080894|NCT02143713|537777046|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
149080895|NCT02143713|537777047|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
149080896|NCT02143713|537777048|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
149080897|NCT02143713|537777045|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
149080898|NCT02143713|537777046|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
149080899|NCT02143713|537777047|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
149120383|NCT02559895|537918091|FG001|Overall Study|Other|5|||
149080900|NCT02143713|537777048|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
149080901|NCT02143713|537777045|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
149080902|NCT02143713|537777046|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
149080903|NCT02143713|537777047|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
149080904|NCT02143713|537777048|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
149080905|NCT02143713|537777045|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
149080906|NCT02143713|537777046|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
149080907|NCT02143713|537777047|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
149080908|NCT02143713|537777048|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
149080909|NCT02143713|537777045|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
149080910|NCT02143713|537777046|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
149080911|NCT02143713|537777047|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
149080912|NCT02143713|537777048|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
149080913|NCT01768572|537777051|FG000|Overall Study|Adverse Event|7|||
149080914|NCT01768572|537777052|FG001|Overall Study|Adverse Event|8|||
149080915|NCT01768572|537777053|FG002|Overall Study|Adverse Event|4|||
149080916|NCT01768572|537777051|FG000|Overall Study|Lack of Efficacy|1|||
149080917|NCT01768572|537777052|FG001|Overall Study|Lack of Efficacy|3|||
149080918|NCT01768572|537777053|FG002|Overall Study|Lack of Efficacy|1|||
149080919|NCT01768572|537777051|FG000|Overall Study|Other, Not due to an adverse event|1|||
149080920|NCT01768572|537777052|FG001|Overall Study|Other, Not due to an adverse event|1|||
149080921|NCT01768572|537777053|FG002|Overall Study|Other, Not due to an adverse event|1|||
149080922|NCT02245620|537777054|FG000|Overall Study|Physician Decision|1|||
149080923|NCT02245620|537777055|FG001|Overall Study|Physician Decision|1|||
149080924|NCT01999335|537777056|FG000|Overall Study|Discontinued before receiving treatment|0|||
149080925|NCT01999335|537777057|FG001|Overall Study|Discontinued before receiving treatment|0|||
149080926|NCT01999335|537777058|FG002|Overall Study|Discontinued before receiving treatment|0|||
149080927|NCT01999335|537777059|FG003|Overall Study|Discontinued before receiving treatment|0|||
149080928|NCT01999335|537777060|FG004|Overall Study|Discontinued before receiving treatment|2|||
149080929|NCT00080119|537777061|FG000|Overall Study|Discontinued because of study closure|0|||
149080930|NCT00080119|537777062|FG001|Overall Study|Discontinued because of study closure|0|||
149080931|NCT00080119|537777063|FG002|Overall Study|Discontinued because of study closure|130|||
149080932|NCT00080119|537777064|FG003|Overall Study|Discontinued because of study closure|141|||
149080933|NCT00080119|537777061|FG000|Overall Study|Unable to get to clinic|24|||
149080934|NCT00080119|537777062|FG001|Overall Study|Unable to get to clinic|24|||
149080935|NCT00080119|537777063|FG002|Overall Study|Unable to get to clinic|7|||
149080936|NCT00080119|537777064|FG003|Overall Study|Unable to get to clinic|1|||
149080937|NCT00080119|537777061|FG000|Overall Study|Consent withdrawn|13|||
149080938|NCT00080119|537777062|FG001|Overall Study|Consent withdrawn|17|||
149080939|NCT00080119|537777063|FG002|Overall Study|Consent withdrawn|4|||
149080940|NCT00080119|537777064|FG003|Overall Study|Consent withdrawn|6|||
149080941|NCT00080119|537777061|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
149080942|NCT00080119|537777062|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
149080943|NCT00080119|537777063|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
149080944|NCT00080119|537777064|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
149080945|NCT00080119|537777061|FG000|Overall Study|Lost to Follow-up|16|||
149080946|NCT00080119|537777062|FG001|Overall Study|Lost to Follow-up|19|||
149080947|NCT00080119|537777063|FG002|Overall Study|Lost to Follow-up|19|||
149080948|NCT00080119|537777064|FG003|Overall Study|Lost to Follow-up|14|||
149080949|NCT04766996|537777065|FG000|Overall Study|Withdrawal by Subject|1|||
149080950|NCT04766996|537777066|FG001|Overall Study|Withdrawal by Subject|0|||
149080951|NCT04766996|537777067|FG002|Overall Study|Withdrawal by Subject|13|||
149080952|NCT01322386|537777068|FG000|Overall Study|Protocol Violation|0|||
149080953|NCT01322386|537777069|FG001|Overall Study|Protocol Violation|1|||
149080954|NCT01322386|537777068|FG000|Overall Study|Physician Decision|0|||
149080955|NCT01322386|537777069|FG001|Overall Study|Physician Decision|1|||
149080956|NCT00871494|537777077|FG000|Overall Study|Protocol Violation|5|||
149080957|NCT00871494|537777077|FG000|Overall Study|Lack of Efficacy|4|||
149080958|NCT00871494|537777077|FG000|Overall Study|Adverse Event|4|||
149080959|NCT00871494|537777077|FG000|Overall Study|Lost to Follow-up|1|||
149080960|NCT03938272|537777078|FG000|Overall Study|Withdrawal by Subject|1|||
149080961|NCT03938272|537777079|FG001|Overall Study|Withdrawal by Subject|0|||
149080962|NCT03938272|537777078|FG000|Overall Study|Physician Decision|0|||
149080963|NCT03938272|537777079|FG001|Overall Study|Physician Decision|2|||
149080964|NCT03938272|537777078|FG000|Overall Study|Study termination by sponsor|10|||
149080965|NCT03938272|537777079|FG001|Overall Study|Study termination by sponsor|8|||
149080966|NCT02538094|537777080|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
149080967|NCT02538094|537777081|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
149080968|NCT02538094|537777080|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
149080969|NCT02538094|537777081|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
149080970|NCT01860079|537777084|FG000|Overall Study|Physician Decision|14|||
149080971|NCT01860079|537777085|FG001|Overall Study|Physician Decision|22|||
149080972|NCT01323790|537777086|FG000|Overall Study|Other|3|||
149080973|NCT01323790|537777087|FG001|Overall Study|Other|2|||
149080974|NCT01323790|537777088|FG002|Overall Study|Other|1|||
149080975|NCT01323790|537777086|FG000|Overall Study|Lost to Follow-up|11|||
149080976|NCT01323790|537777087|FG001|Overall Study|Lost to Follow-up|9|||
149080977|NCT01323790|537777088|FG002|Overall Study|Lost to Follow-up|9|||
149080978|NCT01323790|537777086|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
149080979|NCT01323790|537777087|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
149080980|NCT01323790|537777088|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
149080981|NCT01323790|537777086|FG000|Overall Study|Lack of Efficacy|3|||
149080982|NCT01323790|537777087|FG001|Overall Study|Lack of Efficacy|0|||
149080983|NCT01323790|537777088|FG002|Overall Study|Lack of Efficacy|3|||
149080984|NCT01323790|537777086|FG000|Overall Study|Adverse Event|11|||
149080985|NCT01323790|537777087|FG001|Overall Study|Adverse Event|24|||
149080986|NCT01323790|537777088|FG002|Overall Study|Adverse Event|12|||
149080987|NCT01323790|537777086|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149080988|NCT01323790|537777087|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
149080989|NCT01323790|537777088|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
149080990|NCT01323790|537777086|FG000|Overall Study|Withdrawal by Subject|23|||
149080991|NCT01323790|537777087|FG001|Overall Study|Withdrawal by Subject|20|||
149080992|NCT01323790|537777088|FG002|Overall Study|Withdrawal by Subject|13|||
149080993|NCT01323790|537777086|FG000|Overall Study|Did Not Receive Treatment|2|||
149080994|NCT01323790|537777087|FG001|Overall Study|Did Not Receive Treatment|0|||
149080995|NCT01323790|537777088|FG002|Overall Study|Did Not Receive Treatment|1|||
149080996|NCT01323790|537777086|FG000|Overall Study|Severe non-compliance with protocol|2|||
149080997|NCT01323790|537777087|FG001|Overall Study|Severe non-compliance with protocol|2|||
149080998|NCT01323790|537777088|FG002|Overall Study|Severe non-compliance with protocol|2|||
149080999|NCT02915783|537777090|FG000|Overall Study|Death|21|||
149081000|NCT02915783|537777090|FG000|Overall Study|Lost to Follow-up|1|||
149081001|NCT02915783|537777090|FG000|Overall Study|Withdrawal by Subject|2|||
149081002|NCT02950961|537777091|FG000|Overall Study|Study had to stop due to COVID.|7|||
149081003|NCT02114515|537777094|FG000|Overall Study|Lost to Follow-up|52|||
149081004|NCT02114515|537777095|FG001|Overall Study|Lost to Follow-up|55|||
149081005|NCT02114515|537777094|FG000|Overall Study|Death|12|||
149081006|NCT02114515|537777095|FG001|Overall Study|Death|12|||
149081007|NCT02114515|537777094|FG000|Overall Study|Withdrawal by Subject|4|||
149081008|NCT02114515|537777095|FG001|Overall Study|Withdrawal by Subject|22|||
149081009|NCT02114515|537777094|FG000|Overall Study|Other|65|||
149081010|NCT02114515|537777095|FG001|Overall Study|Other|61|||
149081011|NCT00667732|537777096|FG000|Run -In (8 Weeks)|Adverse Event|4|||
149081012|NCT00667732|537777097|FG001|Run -In (8 Weeks)|Adverse Event|0|||
149081013|NCT00667732|537777098|FG002|Run -In (8 Weeks)|Adverse Event|0|||
149081014|NCT00667732|537777096|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
149081015|NCT00667732|537777097|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
149081016|NCT00667732|537777098|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
149081017|NCT00667732|537777096|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
149081018|NCT00667732|537777097|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
149081019|NCT00667732|537777098|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
149081020|NCT05522777|537778629|FG000|Overall Study|Lack of Efficacy|1|||
149081021|NCT05522777|537778629|FG000|Overall Study|Withdrawal by Subject|1|||
149081022|NCT04909593|537778630|FG000|Overall Study|Withdrawal by Subject|1|||
149081023|NCT01018992|537778631|FG000|Overall Study|Adverse Event|8|||
149081024|NCT01018992|537778632|FG001|Overall Study|Adverse Event|3|||
149081025|NCT01018992|537778631|FG000|Overall Study|Withdrawal by Subject|3|||
149081026|NCT01018992|537778632|FG001|Overall Study|Withdrawal by Subject|8|||
149081027|NCT01018992|537778631|FG000|Overall Study|Protocol Violation|0|||
149081028|NCT01018992|537778632|FG001|Overall Study|Protocol Violation|4|||
149081029|NCT01018992|537778631|FG000|Overall Study|Lost to Follow-up|5|||
149081030|NCT01018992|537778632|FG001|Overall Study|Lost to Follow-up|1|||
149081031|NCT01825785|537778633|FG000|Overall Study|Adverse Event|0|||
149081032|NCT01825785|537778634|FG001|Overall Study|Adverse Event|0|||
149081033|NCT01825785|537778635|FG002|Overall Study|Adverse Event|0|||
149081034|NCT01825785|537778636|FG003|Overall Study|Adverse Event|0|||
149081035|NCT01825785|537778637|FG004|Overall Study|Adverse Event|1|||
149081036|NCT01825785|537778638|FG005|Overall Study|Adverse Event|0|||
149081037|NCT01825785|537778639|FG006|Overall Study|Adverse Event|0|||
149081038|NCT01825785|537778633|FG000|Overall Study|Withdrawal by Subject|0|||
149081039|NCT01825785|537778634|FG001|Overall Study|Withdrawal by Subject|0|||
149081040|NCT01825785|537778635|FG002|Overall Study|Withdrawal by Subject|0|||
149081041|NCT01825785|537778636|FG003|Overall Study|Withdrawal by Subject|0|||
149081042|NCT01825785|537778637|FG004|Overall Study|Withdrawal by Subject|1|||
149081043|NCT01825785|537778638|FG005|Overall Study|Withdrawal by Subject|1|||
149081044|NCT01825785|537778639|FG006|Overall Study|Withdrawal by Subject|0|||
149081045|NCT02784834|537778644|FG000|Overall Study|Lack of Efficacy|1|||
149081046|NCT00889863|537778649|FG000|Part I: Open Label|Death|1|||
149081047|NCT00889863|537778650|FG001|Part I: Open Label|Death|0|||
149081048|NCT00889863|537778649|FG000|Part I: Open Label|Adverse Event|4|||
149081049|NCT00889863|537778650|FG001|Part I: Open Label|Adverse Event|0|||
149081050|NCT00889863|537778649|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
149081051|NCT00889863|537778650|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
149081052|NCT00889863|537778649|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
149081053|NCT00889863|537778650|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
149081054|NCT00889863|537778649|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
149081055|NCT00889863|537778650|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
149081056|NCT00889863|537778649|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
149081057|NCT00889863|537778650|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
149081058|NCT00889863|537778649|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
149081059|NCT00889863|537778650|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
149081060|NCT04410445|537778659|FG000|Overall Study|Lost to Follow-up|3|||
149081061|NCT04410445|537778660|FG001|Overall Study|Lost to Follow-up|9|||
149081062|NCT04410445|537778659|FG000|Overall Study|Withdrawal by Subject|27|||
149081063|NCT04410445|537778660|FG001|Overall Study|Withdrawal by Subject|15|||
149081064|NCT01320683|537778661|FG000|Overall Study|Positive antibody response|1|||
149081065|NCT02291861|537778662|FG000|Overall Study|Adverse Event|2|||
149081066|NCT02291861|537778663|FG001|Overall Study|Adverse Event|4|||
149081067|NCT02291861|537778664|FG002|Overall Study|Adverse Event|1|||
149081068|NCT02291861|537778665|FG003|Overall Study|Adverse Event|2|||
149081069|NCT02291861|537778662|FG000|Overall Study|Death|0|||
149081070|NCT02291861|537778663|FG001|Overall Study|Death|0|||
149081071|NCT02291861|537778664|FG002|Overall Study|Death|1|||
149081072|NCT02291861|537778665|FG003|Overall Study|Death|1|||
149081073|NCT02291861|537778662|FG000|Overall Study|Protocol Violation|1|||
149081074|NCT02291861|537778663|FG001|Overall Study|Protocol Violation|0|||
149081075|NCT02291861|537778664|FG002|Overall Study|Protocol Violation|0|||
149081076|NCT02291861|537778665|FG003|Overall Study|Protocol Violation|1|||
149081077|NCT02291861|537778662|FG000|Overall Study|Withdrawal by Subject|1|||
149081078|NCT02291861|537778663|FG001|Overall Study|Withdrawal by Subject|2|||
149081079|NCT02291861|537778664|FG002|Overall Study|Withdrawal by Subject|1|||
149081080|NCT02291861|537778665|FG003|Overall Study|Withdrawal by Subject|4|||
149081081|NCT02291861|537778662|FG000|Overall Study|Noncompliance|1|||
149081082|NCT02291861|537778663|FG001|Overall Study|Noncompliance|1|||
149081083|NCT02291861|537778664|FG002|Overall Study|Noncompliance|2|||
149081084|NCT02291861|537778665|FG003|Overall Study|Noncompliance|1|||
149081085|NCT02291861|537778662|FG000|Overall Study|Lost to Follow-up|2|||
149081086|NCT02291861|537778663|FG001|Overall Study|Lost to Follow-up|1|||
149081087|NCT02291861|537778664|FG002|Overall Study|Lost to Follow-up|4|||
149081088|NCT02291861|537778665|FG003|Overall Study|Lost to Follow-up|0|||
149081089|NCT02291861|537778662|FG000|Overall Study|Other|0|||
149081090|NCT02291861|537778663|FG001|Overall Study|Other|0|||
149081091|NCT02291861|537778664|FG002|Overall Study|Other|0|||
149081092|NCT02291861|537778665|FG003|Overall Study|Other|1|||
149081093|NCT03547154|537778675|FG000|Overall Study|Disease Progression/Recurrence|6|||
149081094|NCT03547154|537778676|FG001|Overall Study|Disease Progression/Recurrence|14|||
149081095|NCT03547154|537778675|FG000|Overall Study|Adverse Event|26|||
149081096|NCT03547154|537778676|FG001|Overall Study|Adverse Event|31|||
149081097|NCT03547154|537778675|FG000|Overall Study|Protocol Violation|6|||
149081098|NCT03547154|537778676|FG001|Overall Study|Protocol Violation|1|||
149081099|NCT03547154|537778675|FG000|Overall Study|Physician Decision|4|||
149081100|NCT03547154|537778676|FG001|Overall Study|Physician Decision|3|||
149081101|NCT03547154|537778675|FG000|Overall Study|Insufficient Therapeutic Response|13|||
149081102|NCT03547154|537778676|FG001|Overall Study|Insufficient Therapeutic Response|10|||
149081103|NCT03547154|537778675|FG000|Overall Study|Withdrawal by Subject|10|||
149081104|NCT03547154|537778676|FG001|Overall Study|Withdrawal by Subject|6|||
149081105|NCT03547154|537778675|FG000|Overall Study|Not Selected|0|||
149081106|NCT03547154|537778676|FG001|Overall Study|Not Selected|1|||
149081107|NCT03547154|537778675|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
149081108|NCT03547154|537778676|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
149081109|NCT02404441|537778677|FG000|Phase 1 Part|Adverse Event|1|||
149081110|NCT02404441|537778678|FG001|Phase 1 Part|Adverse Event|0|||
149081111|NCT02404441|537778679|FG002|Phase 1 Part|Adverse Event|0|||
149081112|NCT02404441|537778680|FG003|Phase 1 Part|Adverse Event|0|||
149081113|NCT02404441|537778681|FG004|Phase 1 Part|Adverse Event|0|||
149081114|NCT02404441|537778682|FG005|Phase 1 Part|Adverse Event|0|||
149081115|NCT02404441|537778683|FG006|Phase 1 Part|Adverse Event|0|||
149081116|NCT02404441|537778684|FG007|Phase 1 Part|Adverse Event|0|||
149081117|NCT02404441|537778685|FG008|Phase 1 Part|Adverse Event|0|||
149081118|NCT02404441|537778686|FG009|Phase 1 Part|Adverse Event|0|||
149081119|NCT02404441|537778677|FG000|Phase 1 Part|Physician Decision|0|||
149081120|NCT02404441|537778678|FG001|Phase 1 Part|Physician Decision|1|||
149081121|NCT02404441|537778679|FG002|Phase 1 Part|Physician Decision|0|||
149081122|NCT02404441|537778680|FG003|Phase 1 Part|Physician Decision|0|||
149081123|NCT02404441|537778681|FG004|Phase 1 Part|Physician Decision|0|||
149081124|NCT02404441|537778682|FG005|Phase 1 Part|Physician Decision|0|||
149081125|NCT02404441|537778683|FG006|Phase 1 Part|Physician Decision|0|||
149081126|NCT02404441|537778684|FG007|Phase 1 Part|Physician Decision|0|||
149081127|NCT02404441|537778685|FG008|Phase 1 Part|Physician Decision|0|||
149081128|NCT02404441|537778686|FG009|Phase 1 Part|Physician Decision|0|||
149081129|NCT02404441|537778677|FG000|Phase 1 Part|Progressive Disease|14|||
149081130|NCT02404441|537778678|FG001|Phase 1 Part|Progressive Disease|11|||
149081131|NCT02404441|537778679|FG002|Phase 1 Part|Progressive Disease|7|||
149081132|NCT02404441|537778680|FG003|Phase 1 Part|Progressive Disease|6|||
149081133|NCT02404441|537778681|FG004|Phase 1 Part|Progressive Disease|9|||
149081134|NCT02404441|537778682|FG005|Phase 1 Part|Progressive Disease|0|||
149081135|NCT02404441|537778683|FG006|Phase 1 Part|Progressive Disease|0|||
149081136|NCT02404441|537778684|FG007|Phase 1 Part|Progressive Disease|0|||
149081137|NCT02404441|537778685|FG008|Phase 1 Part|Progressive Disease|0|||
149081138|NCT02404441|537778686|FG009|Phase 1 Part|Progressive Disease|0|||
149081139|NCT02404441|537778677|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
149081140|NCT02404441|537778678|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
149081141|NCT02404441|537778679|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
149081142|NCT02404441|537778680|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
149081143|NCT02404441|537778681|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
149081144|NCT02404441|537778682|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
149081145|NCT02404441|537778683|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
149081146|NCT02404441|537778684|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
149081147|NCT02404441|537778685|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
149081148|NCT02404441|537778686|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
149081149|NCT02404441|537778677|FG000|Phase 1 Part|Death|1|||
149081150|NCT02404441|537778678|FG001|Phase 1 Part|Death|1|||
149081151|NCT02404441|537778679|FG002|Phase 1 Part|Death|1|||
149081152|NCT02404441|537778680|FG003|Phase 1 Part|Death|0|||
149081153|NCT02404441|537778681|FG004|Phase 1 Part|Death|1|||
149081154|NCT02404441|537778682|FG005|Phase 1 Part|Death|0|||
149081155|NCT02404441|537778683|FG006|Phase 1 Part|Death|0|||
149081156|NCT02404441|537778684|FG007|Phase 1 Part|Death|0|||
149081157|NCT02404441|537778685|FG008|Phase 1 Part|Death|0|||
149081158|NCT02404441|537778686|FG009|Phase 1 Part|Death|0|||
149081159|NCT02404441|537778677|FG000|Phase 2 Part|Adverse Event|0|||
149081160|NCT02404441|537778678|FG001|Phase 2 Part|Adverse Event|0|||
149081161|NCT02404441|537778679|FG002|Phase 2 Part|Adverse Event|0|||
149081162|NCT02404441|537778680|FG003|Phase 2 Part|Adverse Event|0|||
149081163|NCT02404441|537778681|FG004|Phase 2 Part|Adverse Event|0|||
149081164|NCT02404441|537778682|FG005|Phase 2 Part|Adverse Event|2|||
149081165|NCT02404441|537778683|FG006|Phase 2 Part|Adverse Event|3|||
149081166|NCT02404441|537778684|FG007|Phase 2 Part|Adverse Event|3|||
149081167|NCT02404441|537778685|FG008|Phase 2 Part|Adverse Event|6|||
149081168|NCT02404441|537778686|FG009|Phase 2 Part|Adverse Event|1|||
149081169|NCT02404441|537778677|FG000|Phase 2 Part|Physician Decision|0|||
149081170|NCT02404441|537778678|FG001|Phase 2 Part|Physician Decision|0|||
149081171|NCT02404441|537778679|FG002|Phase 2 Part|Physician Decision|0|||
149081172|NCT02404441|537778680|FG003|Phase 2 Part|Physician Decision|0|||
149081173|NCT02404441|537778681|FG004|Phase 2 Part|Physician Decision|0|||
149081174|NCT02404441|537778682|FG005|Phase 2 Part|Physician Decision|7|||
149081175|NCT02404441|537778683|FG006|Phase 2 Part|Physician Decision|9|||
149081176|NCT02404441|537778684|FG007|Phase 2 Part|Physician Decision|2|||
149081177|NCT02404441|537778685|FG008|Phase 2 Part|Physician Decision|1|||
149081178|NCT02404441|537778686|FG009|Phase 2 Part|Physician Decision|3|||
149081179|NCT02404441|537778677|FG000|Phase 2 Part|Progressive disease|0|||
149081180|NCT02404441|537778678|FG001|Phase 2 Part|Progressive disease|0|||
149081181|NCT02404441|537778679|FG002|Phase 2 Part|Progressive disease|0|||
149081182|NCT02404441|537778680|FG003|Phase 2 Part|Progressive disease|0|||
149081183|NCT02404441|537778681|FG004|Phase 2 Part|Progressive disease|0|||
149081184|NCT02404441|537778682|FG005|Phase 2 Part|Progressive disease|43|||
149081185|NCT02404441|537778683|FG006|Phase 2 Part|Progressive disease|32|||
149081186|NCT02404441|537778684|FG007|Phase 2 Part|Progressive disease|31|||
149081187|NCT02404441|537778685|FG008|Phase 2 Part|Progressive disease|39|||
149081188|NCT02404441|537778686|FG009|Phase 2 Part|Progressive disease|27|||
149081189|NCT02404441|537778677|FG000|Phase 2 Part|Subject/guardian decision|0|||
149081190|NCT02404441|537778678|FG001|Phase 2 Part|Subject/guardian decision|0|||
149081191|NCT02404441|537778679|FG002|Phase 2 Part|Subject/guardian decision|0|||
149081192|NCT02404441|537778680|FG003|Phase 2 Part|Subject/guardian decision|0|||
149081193|NCT02404441|537778681|FG004|Phase 2 Part|Subject/guardian decision|0|||
149081194|NCT02404441|537778682|FG005|Phase 2 Part|Subject/guardian decision|3|||
149081195|NCT02404441|537778683|FG006|Phase 2 Part|Subject/guardian decision|9|||
149081196|NCT02404441|537778684|FG007|Phase 2 Part|Subject/guardian decision|0|||
149081197|NCT02404441|537778685|FG008|Phase 2 Part|Subject/guardian decision|3|||
149081198|NCT02404441|537778686|FG009|Phase 2 Part|Subject/guardian decision|2|||
149081199|NCT02404441|537778677|FG000|Phase 2 Part|Death|0|||
149081200|NCT02404441|537778678|FG001|Phase 2 Part|Death|0|||
149081201|NCT02404441|537778679|FG002|Phase 2 Part|Death|0|||
149081202|NCT02404441|537778680|FG003|Phase 2 Part|Death|0|||
149081203|NCT02404441|537778681|FG004|Phase 2 Part|Death|0|||
149081204|NCT02404441|537778682|FG005|Phase 2 Part|Death|4|||
149081205|NCT02404441|537778683|FG006|Phase 2 Part|Death|8|||
149081206|NCT02404441|537778684|FG007|Phase 2 Part|Death|4|||
149081207|NCT02404441|537778685|FG008|Phase 2 Part|Death|10|||
149081208|NCT02404441|537778686|FG009|Phase 2 Part|Death|9|||
149081209|NCT01918033|537778687|FG000|Overall Study|Adverse Event|1|||
149081210|NCT01918033|537778688|FG001|Overall Study|Adverse Event|0|||
149081211|NCT01918033|537778689|FG002|Overall Study|Adverse Event|2|||
149081212|NCT01918033|537778687|FG000|Overall Study|Lost to Follow-up|0|||
149081213|NCT01918033|537778688|FG001|Overall Study|Lost to Follow-up|1|||
149081214|NCT01918033|537778689|FG002|Overall Study|Lost to Follow-up|0|||
149081215|NCT01918033|537778687|FG000|Overall Study|Protocol Violation|2|||
149081216|NCT01918033|537778688|FG001|Overall Study|Protocol Violation|0|||
149081217|NCT01918033|537778689|FG002|Overall Study|Protocol Violation|1|||
149081218|NCT01918033|537778687|FG000|Overall Study|Withdrawal by Subject|2|||
149081219|NCT01918033|537778688|FG001|Overall Study|Withdrawal by Subject|1|||
149081220|NCT01918033|537778689|FG002|Overall Study|Withdrawal by Subject|0|||
149081221|NCT00088166|537778697|FG000|Overall Study|Adverse Event|11|||
149081222|NCT00088166|537778698|FG001|Overall Study|Adverse Event|9|||
149081223|NCT00088166|537778697|FG000|Overall Study|Death|3|||
149081224|NCT00088166|537778698|FG001|Overall Study|Death|1|||
149081225|NCT00088166|537778697|FG000|Overall Study|Lost to Follow-up|0|||
149081226|NCT00088166|537778698|FG001|Overall Study|Lost to Follow-up|1|||
149081227|NCT00088166|537778697|FG000|Overall Study|Physician Decision|4|||
149081228|NCT00088166|537778698|FG001|Overall Study|Physician Decision|1|||
149081229|NCT00088166|537778697|FG000|Overall Study|Protocol Violation|1|||
149081230|NCT00088166|537778698|FG001|Overall Study|Protocol Violation|5|||
149081231|NCT00088166|537778697|FG000|Overall Study|Patient deterioration|29|||
149081232|NCT00088166|537778698|FG001|Overall Study|Patient deterioration|39|||
149081233|NCT00088166|537778697|FG000|Overall Study|Withdrawal by Subject|5|||
149081234|NCT00088166|537778698|FG001|Overall Study|Withdrawal by Subject|5|||
149081235|NCT02671266|537778699|FG000|Overall Study|Withdrawal by Subject|1|||
149081236|NCT02671266|537778700|FG001|Overall Study|Withdrawal by Subject|1|||
149081237|NCT00666705|537778704|FG000|Overall Study|Withdrawal by Subject|1|||
149081238|NCT01976507|537778707|FG000|Overall Study|Adverse Event|6|||
149081239|NCT01976507|537778707|FG000|Overall Study|ablation not done, drug not given|1|||
149081240|NCT01794299|537778709|FG000|Overall Study|ATIR manufacturing not possible|1|||
149081241|NCT01794299|537778709|FG000|Overall Study|Death|14|||
149081242|NCT01794299|537778709|FG000|Overall Study|Graft failure|1|||
149081243|NCT01794299|537778709|FG000|Overall Study|ATIR batch rejected|2|||
149081244|NCT01794299|537778709|FG000|Overall Study|Relapse|2|||
149081245|NCT01794299|537778709|FG000|Overall Study|Discontinued from active follow-up|1|||
149081246|NCT01794299|537778709|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
149081247|NCT01029704|537778711|FG000|Overall Study|Adverse Event|0|||
149081248|NCT01029704|537778712|FG001|Overall Study|Adverse Event|0|||
149081249|NCT01029704|537778713|FG002|Overall Study|Adverse Event|0|||
149081250|NCT01029704|537778714|FG003|Overall Study|Adverse Event|0|||
149081251|NCT01029704|537778715|FG004|Overall Study|Adverse Event|0|||
149081252|NCT01029704|537778716|FG005|Overall Study|Adverse Event|0|||
149081253|NCT01029704|537778717|FG006|Overall Study|Adverse Event|1|||
149081254|NCT01029704|537778718|FG007|Overall Study|Adverse Event|1|||
149081255|NCT01029704|537778719|FG008|Overall Study|Adverse Event|0|||
149081256|NCT01029704|537778711|FG000|Overall Study|Withdrawal by Subject|0|||
149081257|NCT01029704|537778712|FG001|Overall Study|Withdrawal by Subject|0|||
149081258|NCT01029704|537778713|FG002|Overall Study|Withdrawal by Subject|0|||
149081259|NCT01029704|537778714|FG003|Overall Study|Withdrawal by Subject|0|||
149081260|NCT01029704|537778715|FG004|Overall Study|Withdrawal by Subject|2|||
149081261|NCT01029704|537778716|FG005|Overall Study|Withdrawal by Subject|1|||
149081262|NCT01029704|537778717|FG006|Overall Study|Withdrawal by Subject|1|||
149081263|NCT01029704|537778718|FG007|Overall Study|Withdrawal by Subject|1|||
149081264|NCT01029704|537778719|FG008|Overall Study|Withdrawal by Subject|0|||
149081265|NCT01029704|537778711|FG000|Overall Study|Lost to Follow-up|0|||
149081266|NCT01029704|537778712|FG001|Overall Study|Lost to Follow-up|0|||
149081267|NCT01029704|537778713|FG002|Overall Study|Lost to Follow-up|0|||
149081268|NCT01029704|537778714|FG003|Overall Study|Lost to Follow-up|0|||
149081269|NCT01029704|537778715|FG004|Overall Study|Lost to Follow-up|0|||
149081270|NCT01029704|537778716|FG005|Overall Study|Lost to Follow-up|0|||
149081271|NCT01029704|537778717|FG006|Overall Study|Lost to Follow-up|1|||
149081272|NCT01029704|537778718|FG007|Overall Study|Lost to Follow-up|1|||
149081273|NCT01029704|537778719|FG008|Overall Study|Lost to Follow-up|1|||
149081274|NCT01029704|537778711|FG000|Overall Study|Lack of Efficacy|0|||
149081275|NCT01029704|537778712|FG001|Overall Study|Lack of Efficacy|0|||
149081276|NCT01029704|537778713|FG002|Overall Study|Lack of Efficacy|0|||
149081277|NCT01029704|537778714|FG003|Overall Study|Lack of Efficacy|0|||
149081278|NCT01029704|537778715|FG004|Overall Study|Lack of Efficacy|2|||
149081279|NCT01029704|537778716|FG005|Overall Study|Lack of Efficacy|3|||
149081280|NCT01029704|537778717|FG006|Overall Study|Lack of Efficacy|1|||
149081281|NCT01029704|537778718|FG007|Overall Study|Lack of Efficacy|2|||
149081282|NCT01029704|537778719|FG008|Overall Study|Lack of Efficacy|0|||
149081283|NCT01029704|537778711|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
149081284|NCT01029704|537778712|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
149081285|NCT01029704|537778713|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
149081286|NCT01029704|537778714|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
149081287|NCT01029704|537778715|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
149081288|NCT01029704|537778716|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
149081289|NCT01029704|537778717|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
149081290|NCT01029704|537778718|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
149081291|NCT01029704|537778719|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
149081292|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
149081293|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
149081294|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
149081295|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
149081296|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Death|0|||
149081297|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Death|0|||
149081298|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Death|1|||
149081299|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Death|0|||
149081300|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
149081301|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
149081302|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
149081303|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
149081304|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
149081305|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
149081306|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
149081307|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
149081308|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
149081309|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
149081310|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
149081311|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
149081312|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
149081313|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
149081314|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
149081315|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
149081316|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
149081317|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
149081318|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
149081319|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
149081320|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Other|2|||
149081321|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Other|0|||
149081322|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Other|0|||
149081323|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Other|0|||
149081324|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
149081325|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
149081326|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
149081327|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
149081328|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
149081329|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
149081330|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
149081331|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
149081332|NCT03845517|537778720|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
149081333|NCT03845517|537778721|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
149081334|NCT03845517|537778722|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
149081335|NCT03845517|537778723|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
149081336|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
149081337|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
149081338|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
149081339|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
149081340|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Death|0|||
149081341|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Death|0|||
149081342|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Death|1|||
149081343|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Death|1|||
149081344|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
149081345|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
149081346|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
149081347|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
149081348|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
149081349|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
149081350|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
149081351|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
149081352|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
149081353|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
149081354|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
149081355|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
149081356|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Other|1|||
149081357|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Other|0|||
149081358|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Other|1|||
149081359|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Other|0|||
149081360|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
149081361|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
149081362|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
149081363|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
149081364|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
149081365|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
149081366|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
149081367|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
149081368|NCT03845517|537778720|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
149081369|NCT03845517|537778721|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
149081370|NCT03845517|537778722|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
149081371|NCT03845517|537778723|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
149081372|NCT03006393|537778724|FG000|Overall Study|Withdrawal by Subject|1|||
149081373|NCT03006393|537778725|FG001|Overall Study|Withdrawal by Subject|1|||
149081374|NCT03006393|537778724|FG000|Overall Study|Pregnancy|0|||
149081375|NCT03006393|537778725|FG001|Overall Study|Pregnancy|1|||
149081376|NCT03006393|537778724|FG000|Overall Study|Lost to Follow-up|0|||
149081377|NCT03006393|537778725|FG001|Overall Study|Lost to Follow-up|1|||
149081378|NCT01109979|537778726|FG000|Overall Study|Physician Decision|2|||
149081379|NCT01109979|537778727|FG001|Overall Study|Physician Decision|0|||
149081380|NCT01109979|537778726|FG000|Overall Study|Withdrawal by Subject|0|||
149081381|NCT01109979|537778727|FG001|Overall Study|Withdrawal by Subject|1|||
149081382|NCT00807599|537778730|FG000|Overall Study|Not treated on protocol study|0|||
149081383|NCT00807599|537778731|FG001|Overall Study|Not treated on protocol study|0|||
149081384|NCT00807599|537778732|FG002|Overall Study|Not treated on protocol study|2|||
149081385|NCT00807599|537778730|FG000|Overall Study|Adverse Event|0|||
149081386|NCT00807599|537778731|FG001|Overall Study|Adverse Event|0|||
149081387|NCT00807599|537778732|FG002|Overall Study|Adverse Event|5|||
149081388|NCT00807599|537778730|FG000|Overall Study|Inadequate response to induction|0|||
149081389|NCT00807599|537778731|FG001|Overall Study|Inadequate response to induction|0|||
149081390|NCT00807599|537778732|FG002|Overall Study|Inadequate response to induction|9|||
149081391|NCT00807599|537778730|FG000|Overall Study|Withdrawal by Subject|0|||
149081392|NCT00807599|537778731|FG001|Overall Study|Withdrawal by Subject|0|||
149081393|NCT00807599|537778732|FG002|Overall Study|Withdrawal by Subject|1|||
149081394|NCT02161458|537778734|FG000|Overall Study|Withdrawal by Subject|0|||
149081395|NCT02161458|537778735|FG001|Overall Study|Withdrawal by Subject|4|||
149081396|NCT02161458|537778736|FG002|Overall Study|Withdrawal by Subject|4|||
149081397|NCT02161458|537778737|FG003|Overall Study|Withdrawal by Subject|0|||
149081398|NCT02161458|537778734|FG000|Overall Study|Lost to Follow-up|0|||
149081399|NCT02161458|537778735|FG001|Overall Study|Lost to Follow-up|2|||
149081400|NCT02161458|537778736|FG002|Overall Study|Lost to Follow-up|1|||
149081401|NCT02161458|537778737|FG003|Overall Study|Lost to Follow-up|0|||
149081402|NCT03136861|537778741|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
149081403|NCT03136861|537778742|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
149081404|NCT03136861|537778743|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
149081405|NCT03136861|537778744|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
149081406|NCT03136861|537778745|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
149081407|NCT03136861|537778746|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
149081408|NCT03136861|537778747|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
149081409|NCT03136861|537778741|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
149081410|NCT03136861|537778742|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
149081411|NCT03136861|537778743|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
149081412|NCT03136861|537778744|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
149081413|NCT03136861|537778745|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
149081414|NCT03136861|537778746|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
149081415|NCT03136861|537778747|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
149081416|NCT03136861|537778741|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
149081417|NCT03136861|537778742|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
149081418|NCT03136861|537778743|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
149081419|NCT03136861|537778744|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
149081420|NCT03136861|537778745|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
149081421|NCT03136861|537778746|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
149081422|NCT03136861|537778747|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
149081423|NCT03136861|537778741|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
149081424|NCT03136861|537778742|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
149081425|NCT03136861|537778743|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
149081426|NCT03136861|537778744|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
149081427|NCT03136861|537778745|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
149081428|NCT03136861|537778746|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
149081429|NCT03136861|537778747|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
149081430|NCT03136861|537778741|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
149081431|NCT03136861|537778742|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
149081432|NCT03136861|537778743|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
149081433|NCT03136861|537778744|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
149081434|NCT03136861|537778745|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
149081435|NCT03136861|537778746|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
149081436|NCT03136861|537778747|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
149081437|NCT03136861|537778741|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
149081438|NCT03136861|537778742|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
149081439|NCT03136861|537778743|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
149081440|NCT03136861|537778744|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
149081441|NCT03136861|537778745|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
149081442|NCT03136861|537778746|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
149081443|NCT03136861|537778747|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
149081444|NCT03136861|537778741|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
149081445|NCT03136861|537778742|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
149081446|NCT03136861|537778743|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
149081447|NCT03136861|537778744|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
149081448|NCT03136861|537778745|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
149081449|NCT03136861|537778746|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
149081450|NCT03136861|537778747|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
149081451|NCT03136861|537778741|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
149081452|NCT03136861|537778742|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
149081453|NCT03136861|537778743|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
149081454|NCT03136861|537778744|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
149081455|NCT03136861|537778745|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
149081456|NCT03136861|537778746|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
149081457|NCT03136861|537778747|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
149081458|NCT03390166|537778748|FG000|Overall Study|Death|0|||
149081459|NCT03390166|537778749|FG001|Overall Study|Death|1|||
149081460|NCT03390166|537778748|FG000|Overall Study|Lost to Follow-up|6|||
149081461|NCT03390166|537778749|FG001|Overall Study|Lost to Follow-up|4|||
149081462|NCT03390166|537778748|FG000|Overall Study|Physician Decision|2|||
149081463|NCT03390166|537778749|FG001|Overall Study|Physician Decision|1|||
149081464|NCT03390166|537778748|FG000|Overall Study|Move from study area|3|||
149081465|NCT03390166|537778749|FG001|Overall Study|Move from study area|2|||
149081466|NCT03390166|537778748|FG000|Overall Study|To militarycamp for conscript|1|||
149081467|NCT03390166|537778749|FG001|Overall Study|To militarycamp for conscript|0|||
149081468|NCT03390166|537778748|FG000|Overall Study|To drug therapy course|0|||
149081469|NCT03390166|537778749|FG001|Overall Study|To drug therapy course|1|||
149081470|NCT03390166|537778748|FG000|Overall Study|Move to work oversea|0|||
149081471|NCT03390166|537778749|FG001|Overall Study|Move to work oversea|1|||
149081472|NCT01328756|537778753|FG000|Overall Study|Protocol Violation|4|||
149081473|NCT01328756|537778753|FG000|Overall Study|Adverse Event|39|||
149081474|NCT01328756|537778753|FG000|Overall Study|Lack of Efficacy|5|||
149081475|NCT01328756|537778753|FG000|Overall Study|Withdrawal by Subject|41|||
149081476|NCT01328756|537778753|FG000|Overall Study|Lost to Follow-up|5|||
149081477|NCT01328756|537778753|FG000|Overall Study|Other|29|||
149081478|NCT01262456|537778757|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
149081479|NCT01262456|537778758|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
149081480|NCT01262456|537778759|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
149081481|NCT01262456|537778757|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
149081482|NCT01262456|537778758|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
149081483|NCT01262456|537778759|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
149081484|NCT01262456|537778757|FG000|3-Month Double-Blind Period|Adverse Event|6|||
149081485|NCT01262456|537778758|FG001|3-Month Double-Blind Period|Adverse Event|4|||
149081486|NCT01262456|537778759|FG002|3-Month Double-Blind Period|Adverse Event|8|||
149081487|NCT01262456|537778757|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
149081488|NCT01262456|537778758|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
149081489|NCT01262456|537778759|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
149081490|NCT01262456|537778757|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
149081491|NCT01262456|537778758|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
149081492|NCT01262456|537778759|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
149081493|NCT01262456|537778757|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
149081494|NCT01262456|537778758|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
149081495|NCT01262456|537778759|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
149081496|NCT01262456|537778757|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
149081497|NCT01262456|537778758|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
149081498|NCT01262456|537778759|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
149081499|NCT01262456|537778757|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
149081500|NCT01262456|537778758|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
149081501|NCT01262456|537778759|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
149081502|NCT01262456|537778757|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
149081503|NCT01262456|537778758|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
149081504|NCT01262456|537778759|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
149081505|NCT03692871|537778760|FG000|Overall Study|Death|1|||
149081506|NCT03692871|537778761|FG001|Overall Study|Death|1|||
149081507|NCT03692871|537778760|FG000|Overall Study|Lost to Follow-up|24|||
149081508|NCT03692871|537778761|FG001|Overall Study|Lost to Follow-up|9|||
149081509|NCT03692871|537778760|FG000|Overall Study|Physician Decision|22|||
149081510|NCT03692871|537778761|FG001|Overall Study|Physician Decision|7|||
149081511|NCT03692871|537778760|FG000|Overall Study|Protocol Deviation|1|||
149081512|NCT03692871|537778761|FG001|Overall Study|Protocol Deviation|0|||
149081513|NCT03692871|537778760|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
149081514|NCT03692871|537778761|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
149081515|NCT02852824|537778764|FG000|Overall Study|Withdrawal by Subject|1|||
149081516|NCT02852824|537778765|FG001|Overall Study|Withdrawal by Subject|0|||
149081517|NCT02852824|537778766|FG002|Overall Study|Withdrawal by Subject|0|||
149081518|NCT02852824|537778767|FG003|Overall Study|Withdrawal by Subject|0|||
149081519|NCT02852824|537778768|FG004|Overall Study|Withdrawal by Subject|0|||
149081520|NCT02852824|537778769|FG005|Overall Study|Withdrawal by Subject|0|||
149081521|NCT02852824|537778770|FG006|Overall Study|Withdrawal by Subject|0|||
149081522|NCT02852824|537778764|FG000|Overall Study|Adverse Event|0|||
149081523|NCT02852824|537778765|FG001|Overall Study|Adverse Event|0|||
149081524|NCT02852824|537778766|FG002|Overall Study|Adverse Event|0|||
149081525|NCT02852824|537778767|FG003|Overall Study|Adverse Event|0|||
149081526|NCT02852824|537778768|FG004|Overall Study|Adverse Event|2|||
149081527|NCT02852824|537778769|FG005|Overall Study|Adverse Event|0|||
149081528|NCT02852824|537778770|FG006|Overall Study|Adverse Event|0|||
149081529|NCT01316913|537778771|FG000|Overall Study|Adverse Event|17|||
149081530|NCT01316913|537778772|FG001|Overall Study|Adverse Event|20|||
149081531|NCT01316913|537778773|FG002|Overall Study|Adverse Event|15|||
149081532|NCT01316913|537778774|FG003|Overall Study|Adverse Event|11|||
149081533|NCT01316913|537778771|FG000|Overall Study|Lack of Efficacy|22|||
149081534|NCT01316913|537778772|FG001|Overall Study|Lack of Efficacy|12|||
149081535|NCT01316913|537778773|FG002|Overall Study|Lack of Efficacy|9|||
149081536|NCT01316913|537778774|FG003|Overall Study|Lack of Efficacy|13|||
149081537|NCT01316913|537778771|FG000|Overall Study|Protocol Violation|1|||
149081538|NCT01316913|537778772|FG001|Overall Study|Protocol Violation|4|||
149081539|NCT01316913|537778773|FG002|Overall Study|Protocol Violation|4|||
149081540|NCT01316913|537778774|FG003|Overall Study|Protocol Violation|1|||
149081541|NCT01316913|537778771|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
149081542|NCT01316913|537778772|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
149081543|NCT01316913|537778773|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
149081544|NCT01316913|537778774|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
149081545|NCT01316913|537778771|FG000|Overall Study|Lost to Follow-up|0|||
149081546|NCT01316913|537778772|FG001|Overall Study|Lost to Follow-up|1|||
149081547|NCT01316913|537778773|FG002|Overall Study|Lost to Follow-up|0|||
149081548|NCT01316913|537778774|FG003|Overall Study|Lost to Follow-up|2|||
149081549|NCT01316913|537778771|FG000|Overall Study|Withdrawal by Subject|10|||
149081550|NCT01316913|537778772|FG001|Overall Study|Withdrawal by Subject|9|||
149081551|NCT01316913|537778773|FG002|Overall Study|Withdrawal by Subject|10|||
149081552|NCT01316913|537778774|FG003|Overall Study|Withdrawal by Subject|6|||
149081553|NCT05445557|537778775|FG000|Double Blind Part|Lost to Follow-up|1|||
149081554|NCT03055988|537778776|FG000|Period 1|Adverse Event|0|||
149081555|NCT03055988|537778777|FG001|Period 1|Adverse Event|1|||
149081556|NCT03055988|537778776|FG000|Period 1|Lost to Follow-up|1|||
149081557|NCT03055988|537778777|FG001|Period 1|Lost to Follow-up|0|||
149081558|NCT03055988|537778776|FG000|Period 1|Withdrawal by Subject|0|||
149081559|NCT03055988|537778777|FG001|Period 1|Withdrawal by Subject|4|||
149081560|NCT03055988|537778776|FG000|Period 2|Adverse Event|0|||
149081561|NCT03055988|537778777|FG001|Period 2|Adverse Event|1|||
149081562|NCT03055988|537778776|FG000|Period 2|Other than listed|1|||
149081563|NCT03055988|537778777|FG001|Period 2|Other than listed|1|||
149081564|NCT01915914|537778780|FG000|Acute Phase|Withdrawal by Subject|4|||
149081565|NCT01915914|537778781|FG001|Acute Phase|Withdrawal by Subject|0|||
149081566|NCT01915914|537778782|FG002|Acute Phase|Withdrawal by Subject|0|||
149081567|NCT01915914|537778783|FG003|Acute Phase|Withdrawal by Subject|0|||
149081568|NCT01915914|537778780|FG000|Acute Phase|Lost to Follow-up|4|||
149081569|NCT01915914|537778781|FG001|Acute Phase|Lost to Follow-up|0|||
149081570|NCT01915914|537778782|FG002|Acute Phase|Lost to Follow-up|0|||
149081571|NCT01915914|537778783|FG003|Acute Phase|Lost to Follow-up|0|||
149081572|NCT01915914|537778780|FG000|Acute Phase|Physician Decision|1|||
149081573|NCT01915914|537778781|FG001|Acute Phase|Physician Decision|0|||
149081574|NCT01915914|537778782|FG002|Acute Phase|Physician Decision|0|||
149081575|NCT01915914|537778783|FG003|Acute Phase|Physician Decision|0|||
149081576|NCT01915914|537778780|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
149081577|NCT01915914|537778781|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
149081578|NCT01915914|537778782|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
149081579|NCT01915914|537778783|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
149081580|NCT01915914|537778780|FG000|Acute Phase|"Not Achieved treatment success"|1|||
149081581|NCT01915914|537778781|FG001|Acute Phase|"Not Achieved treatment success"|0|||
149081582|NCT01915914|537778782|FG002|Acute Phase|"Not Achieved treatment success"|0|||
149081583|NCT01915914|537778783|FG003|Acute Phase|"Not Achieved treatment success"|0|||
149081584|NCT01915914|537778780|FG000|Acute Phase|Missing|1|||
149081585|NCT01915914|537778781|FG001|Acute Phase|Missing|0|||
149081586|NCT01915914|537778782|FG002|Acute Phase|Missing|0|||
149081587|NCT01915914|537778783|FG003|Acute Phase|Missing|0|||
149081588|NCT01915914|537778780|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149081589|NCT01915914|537778781|FG001|Maintenance Phase|Withdrawal by Subject|1|||
149081590|NCT01915914|537778782|FG002|Maintenance Phase|Withdrawal by Subject|1|||
149081591|NCT01915914|537778783|FG003|Maintenance Phase|Withdrawal by Subject|0|||
149081592|NCT01915914|537778780|FG000|Maintenance Phase|Lost to Follow-up|0|||
149081593|NCT01915914|537778781|FG001|Maintenance Phase|Lost to Follow-up|4|||
149081594|NCT01915914|537778782|FG002|Maintenance Phase|Lost to Follow-up|1|||
149081595|NCT01915914|537778783|FG003|Maintenance Phase|Lost to Follow-up|0|||
149081596|NCT01915914|537778780|FG000|Maintenance Phase|Missing|0|||
149081597|NCT01915914|537778781|FG001|Maintenance Phase|Missing|1|||
149081598|NCT01915914|537778782|FG002|Maintenance Phase|Missing|0|||
149081599|NCT01915914|537778783|FG003|Maintenance Phase|Missing|0|||
149081600|NCT01915914|537778780|FG000|Follow-up Phase|Withdrawal by Subject|0|||
149081601|NCT01915914|537778781|FG001|Follow-up Phase|Withdrawal by Subject|0|||
149081602|NCT01915914|537778782|FG002|Follow-up Phase|Withdrawal by Subject|0|||
149081603|NCT01915914|537778783|FG003|Follow-up Phase|Withdrawal by Subject|1|||
149081604|NCT01915914|537778780|FG000|Follow-up Phase|Physician Decision|0|||
149081605|NCT01915914|537778781|FG001|Follow-up Phase|Physician Decision|0|||
149081606|NCT01915914|537778782|FG002|Follow-up Phase|Physician Decision|0|||
149081607|NCT01915914|537778783|FG003|Follow-up Phase|Physician Decision|1|||
149081608|NCT00428714|537778785|FG000|Overall Study|Progressive Disease|28|||
149081609|NCT00428714|537778786|FG001|Overall Study|Progressive Disease|36|||
149081610|NCT00428714|537778785|FG000|Overall Study|Withdrawal by Subject|0|||
149081611|NCT00428714|537778786|FG001|Overall Study|Withdrawal by Subject|3|||
149081612|NCT00428714|537778785|FG000|Overall Study|Adverse Event|0|||
149081613|NCT00428714|537778786|FG001|Overall Study|Adverse Event|2|||
149081614|NCT00428714|537778785|FG000|Overall Study|Physician Decision|1|||
149081615|NCT00428714|537778786|FG001|Overall Study|Physician Decision|1|||
149081616|NCT00428714|537778785|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
149081617|NCT00428714|537778786|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
149081618|NCT00428714|537778785|FG000|Overall Study|Death due to other then PD|1|||
149081619|NCT00428714|537778786|FG001|Overall Study|Death due to other then PD|0|||
149081620|NCT01736475|537778789|FG000|Overall Study|Adverse Event|4|||
149081621|NCT01736475|537778790|FG001|Overall Study|Adverse Event|0|||
149081622|NCT01736475|537778789|FG000|Overall Study|Withdrawal by Subject|2|||
149081623|NCT01736475|537778790|FG001|Overall Study|Withdrawal by Subject|0|||
149081624|NCT01736475|537778789|FG000|Overall Study|Protocol Violation|4|||
149081625|NCT01736475|537778790|FG001|Overall Study|Protocol Violation|0|||
149081626|NCT01736475|537778789|FG000|Overall Study|Other - Screen failure|1|||
149081627|NCT01736475|537778790|FG001|Overall Study|Other - Screen failure|0|||
149081628|NCT01736475|537778789|FG000|Overall Study|Other - Surgical procedure|1|||
149081629|NCT01736475|537778790|FG001|Overall Study|Other - Surgical procedure|0|||
149081630|NCT00513071|537778791|FG000|Overall Study|Adverse Event|1|||
149081631|NCT00513071|537778791|FG000|Overall Study|Withdrawal by Subject|1|||
149081632|NCT00513071|537778791|FG000|Overall Study|Physician Decision|3|||
149081633|NCT00747149|537780014|FG000|Overall Study|Adverse Event|0|||
149081634|NCT00747149|537780015|FG001|Overall Study|Adverse Event|15|||
149081635|NCT00747149|537780014|FG000|Overall Study|Lost to Follow-up|0|||
149081636|NCT00747149|537780015|FG001|Overall Study|Lost to Follow-up|10|||
149081637|NCT00747149|537780014|FG000|Overall Study|Withdrawal by Subject|0|||
149081638|NCT00747149|537780015|FG001|Overall Study|Withdrawal by Subject|6|||
149081639|NCT00747149|537780014|FG000|Overall Study|Did not receive treatment|0|||
149081640|NCT00747149|537780015|FG001|Overall Study|Did not receive treatment|1|||
149081641|NCT00747149|537780014|FG000|Overall Study|Incorrect enrollment|0|||
149081642|NCT00747149|537780015|FG001|Overall Study|Incorrect enrollment|6|||
149081643|NCT00747149|537780014|FG000|Overall Study|Severe non-compliance to protocol|0|||
149081644|NCT00747149|537780015|FG001|Overall Study|Severe non-compliance to protocol|1|||
149081645|NCT00747149|537780014|FG000|Overall Study|Not reported|1|||
149081646|NCT00747149|537780015|FG001|Overall Study|Not reported|4|||
149081647|NCT03840200|537780020|FG000|Overall Study|Death|6|||
149081648|NCT03840200|537780021|FG001|Overall Study|Death|3|||
149081649|NCT03840200|537780022|FG002|Overall Study|Death|6|||
149081650|NCT03840200|537780023|FG003|Overall Study|Death|10|||
149081651|NCT03840200|537780020|FG000|Overall Study|Reason Not Specified|2|||
149081652|NCT03840200|537780021|FG001|Overall Study|Reason Not Specified|2|||
149081653|NCT03840200|537780022|FG002|Overall Study|Reason Not Specified|1|||
149081654|NCT03840200|537780023|FG003|Overall Study|Reason Not Specified|15|||
149081655|NCT03840200|537780020|FG000|Overall Study|Physician Decision|0|||
149081656|NCT03840200|537780021|FG001|Overall Study|Physician Decision|0|||
149081657|NCT03840200|537780022|FG002|Overall Study|Physician Decision|0|||
149081658|NCT03840200|537780023|FG003|Overall Study|Physician Decision|2|||
149081659|NCT03840200|537780020|FG000|Overall Study|Progressive Disease|0|||
149081660|NCT03840200|537780021|FG001|Overall Study|Progressive Disease|0|||
149081661|NCT03840200|537780022|FG002|Overall Study|Progressive Disease|0|||
149081662|NCT03840200|537780023|FG003|Overall Study|Progressive Disease|1|||
149081663|NCT03840200|537780020|FG000|Overall Study|Withdrawal by Subject|0|||
149081664|NCT03840200|537780021|FG001|Overall Study|Withdrawal by Subject|1|||
149081665|NCT03840200|537780022|FG002|Overall Study|Withdrawal by Subject|0|||
149081666|NCT03840200|537780023|FG003|Overall Study|Withdrawal by Subject|2|||
149081667|NCT05487300|537780026|FG000|Overall Study|Withdrawal by Subject|1|||
149081668|NCT05487300|537780027|FG001|Overall Study|Withdrawal by Subject|0|||
149081669|NCT03141177|537780028|FG000|Overall Study|Death|62|||
149081670|NCT03141177|537780029|FG001|Overall Study|Death|13|||
149081671|NCT03141177|537780030|FG002|Overall Study|Death|84|||
149081672|NCT03141177|537780028|FG000|Overall Study|Participant withdrew consent|9|||
149081673|NCT03141177|537780029|FG001|Overall Study|Participant withdrew consent|2|||
149081674|NCT03141177|537780030|FG002|Overall Study|Participant withdrew consent|13|||
149081675|NCT03141177|537780028|FG000|Overall Study|Not reported|1|||
149081676|NCT03141177|537780029|FG001|Overall Study|Not reported|0|||
149081677|NCT03141177|537780030|FG002|Overall Study|Not reported|1|||
149081678|NCT03141177|537780028|FG000|Overall Study|Lost to Follow-up|2|||
149081679|NCT03141177|537780029|FG001|Overall Study|Lost to Follow-up|1|||
149081680|NCT03141177|537780030|FG002|Overall Study|Lost to Follow-up|1|||
149081681|NCT03141177|537780028|FG000|Overall Study|Other reasons|4|||
149081682|NCT03141177|537780029|FG001|Overall Study|Other reasons|0|||
149081683|NCT03141177|537780030|FG002|Overall Study|Other reasons|11|||
149081684|NCT03141177|537780028|FG000|Overall Study|Participants did not start treatment period|3|||
149081685|NCT03141177|537780029|FG001|Overall Study|Participants did not start treatment period|0|||
149081686|NCT03141177|537780030|FG002|Overall Study|Participants did not start treatment period|8|||
149081687|NCT05006703|537780031|FG000|Overall Study|Withdrawal by Subject|1|||
149081688|NCT05006703|537780032|FG001|Overall Study|Withdrawal by Subject|0|||
149081689|NCT05006703|537780031|FG000|Overall Study|Lost to Follow-up|13|||
149081690|NCT05006703|537780032|FG001|Overall Study|Lost to Follow-up|5|||
149081691|NCT02196259|537780037|FG000|Overall Study|Researcher choice|0|||
149081692|NCT02196259|537780038|FG001|Overall Study|Researcher choice|0|||
149081693|NCT02196259|537780039|FG002|Overall Study|Researcher choice|1|||
149081694|NCT02196259|537780037|FG000|Overall Study|Partial data analysis|0|||
149081695|NCT02196259|537780038|FG001|Overall Study|Partial data analysis|3|||
149081696|NCT02196259|537780039|FG002|Overall Study|Partial data analysis|0|||
149081697|NCT01304940|537780041|FG000|Overall Study|not meet symptom severity requirement|3|||
149081698|NCT01304940|537780042|FG001|Overall Study|not meet symptom severity requirement|0|||
149081699|NCT02065895|537780043|FG000|Overall Study|Protocol Violation|1|||
149081700|NCT02065895|537780044|FG001|Overall Study|Protocol Violation|0|||
149081701|NCT02065895|537780045|FG002|Overall Study|Protocol Violation|0|||
149081702|NCT02065895|537780046|FG003|Overall Study|Protocol Violation|1|||
149081703|NCT02065895|537780047|FG004|Overall Study|Protocol Violation|0|||
149081704|NCT02065895|537780048|FG005|Overall Study|Protocol Violation|0|||
149081705|NCT02065895|537780043|FG000|Overall Study|Scheduling conflicts|0|||
149081706|NCT02065895|537780044|FG001|Overall Study|Scheduling conflicts|1|||
149081707|NCT02065895|537780045|FG002|Overall Study|Scheduling conflicts|0|||
149081708|NCT02065895|537780046|FG003|Overall Study|Scheduling conflicts|0|||
149081709|NCT02065895|537780047|FG004|Overall Study|Scheduling conflicts|0|||
149081710|NCT02065895|537780048|FG005|Overall Study|Scheduling conflicts|0|||
149081711|NCT01205126|537780049|FG000|Titration Phase|Adverse Event|5|||
149081712|NCT01205126|537780050|FG001|Titration Phase|Adverse Event|3|||
149081713|NCT01205126|537780049|FG000|Titration Phase|Withdrawal by Subject|5|||
149081714|NCT01205126|537780050|FG001|Titration Phase|Withdrawal by Subject|5|||
149081715|NCT01205126|537780049|FG000|Titration Phase|Lost to Follow-up|2|||
149081716|NCT01205126|537780050|FG001|Titration Phase|Lost to Follow-up|2|||
149081717|NCT01205126|537780049|FG000|Titration Phase|No stable titration dose|1|||
149081718|NCT01205126|537780050|FG001|Titration Phase|No stable titration dose|0|||
149081719|NCT01205126|537780049|FG000|Titration Phase|More than maximum dosage required|2|||
149081720|NCT01205126|537780050|FG001|Titration Phase|More than maximum dosage required|3|||
149081721|NCT01205126|537780049|FG000|Titration Phase|Other|8|||
149081722|NCT01205126|537780050|FG001|Titration Phase|Other|6|||
149081723|NCT01205126|537780049|FG000|Between Titration & Maintenance Phase|Other|0|||
149081724|NCT01205126|537780050|FG001|Between Titration & Maintenance Phase|Other|4|||
149081725|NCT01205126|537780049|FG000|Maintenance Phase|Adverse Event|3|||
149081726|NCT01205126|537780050|FG001|Maintenance Phase|Adverse Event|7|||
149081727|NCT01205126|537780049|FG000|Maintenance Phase|Death|4|||
149081728|NCT01205126|537780050|FG001|Maintenance Phase|Death|4|||
149081729|NCT01205126|537780049|FG000|Maintenance Phase|More than the maximum dosage required|5|||
149081730|NCT01205126|537780050|FG001|Maintenance Phase|More than the maximum dosage required|5|||
149081731|NCT01205126|537780049|FG000|Maintenance Phase|Prohibited drugs used|1|||
149081732|NCT01205126|537780050|FG001|Maintenance Phase|Prohibited drugs used|0|||
149081733|NCT01205126|537780049|FG000|Maintenance Phase|Other|11|||
149081734|NCT01205126|537780050|FG001|Maintenance Phase|Other|8|||
149081735|NCT01205126|537780049|FG000|Maintenance Phase|Lost to Follow-up|5|||
149081736|NCT01205126|537780050|FG001|Maintenance Phase|Lost to Follow-up|5|||
149081737|NCT01205126|537780049|FG000|Maintenance Phase|Withdrawal by Subject|8|||
149081738|NCT01205126|537780050|FG001|Maintenance Phase|Withdrawal by Subject|11|||
149081739|NCT00805792|537780051|FG000|Overall Study|Death|3|||
149081740|NCT00805792|537780051|FG000|Overall Study|Lost to Follow-up|2|||
149081741|NCT02753075|537780054|FG000|Overall Study|Adverse Event|2|||
149081742|NCT02753075|537780055|FG001|Overall Study|Adverse Event|1|||
149081743|NCT02753075|537780056|FG002|Overall Study|Adverse Event|0|||
149081744|NCT02753075|537780054|FG000|Overall Study|Lost to Follow-up|2|||
149081745|NCT02753075|537780055|FG001|Overall Study|Lost to Follow-up|0|||
149081746|NCT02753075|537780056|FG002|Overall Study|Lost to Follow-up|0|||
149081747|NCT02753075|537780054|FG000|Overall Study|Withdrawal of Consent|1|||
149081748|NCT02753075|537780055|FG001|Overall Study|Withdrawal of Consent|1|||
149081749|NCT02753075|537780056|FG002|Overall Study|Withdrawal of Consent|3|||
149081750|NCT02753075|537780054|FG000|Overall Study|Physician Decision|3|||
149081751|NCT02753075|537780055|FG001|Overall Study|Physician Decision|1|||
149081752|NCT02753075|537780056|FG002|Overall Study|Physician Decision|0|||
149081753|NCT01393600|537780058|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
149081754|NCT01393600|537780059|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
149081755|NCT01393600|537780060|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
149081756|NCT01393600|537780061|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
149081757|NCT01393600|537780058|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
149081758|NCT01393600|537780059|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
149081759|NCT01393600|537780060|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
149081760|NCT01393600|537780061|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
149081761|NCT01393600|537780058|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
149081762|NCT01393600|537780059|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
149081763|NCT01393600|537780060|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
149081764|NCT01393600|537780061|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
149081765|NCT01393600|537780058|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
149081766|NCT01393600|537780059|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
149081767|NCT01393600|537780060|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
149081768|NCT01393600|537780061|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
149081769|NCT01393600|537780058|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
149081770|NCT01393600|537780059|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
149081771|NCT01393600|537780060|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
149081772|NCT01393600|537780061|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
149081773|NCT01393600|537780058|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
149081774|NCT01393600|537780059|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
149081775|NCT01393600|537780060|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
149081776|NCT01393600|537780061|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
149081777|NCT01393600|537780058|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
149081778|NCT01393600|537780059|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
149081779|NCT01393600|537780060|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
149081780|NCT01393600|537780061|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
149081781|NCT01072149|537780062|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081782|NCT01072149|537780063|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081783|NCT01072149|537780064|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
149081784|NCT01072149|537780065|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081785|NCT01072149|537780066|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081786|NCT01072149|537780067|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081787|NCT01072149|537780068|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081788|NCT01072149|537780069|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081789|NCT01072149|537780070|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081790|NCT01072149|537780071|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081791|NCT01072149|537780072|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081792|NCT01072149|537780073|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081793|NCT01072149|537780074|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081794|NCT01072149|537780075|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081795|NCT01072149|537780076|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081796|NCT01072149|537780077|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081797|NCT01072149|537780078|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081798|NCT01072149|537780079|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
149081799|NCT01072149|537780062|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081800|NCT01072149|537780063|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081801|NCT01072149|537780064|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081802|NCT01072149|537780065|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081803|NCT01072149|537780066|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081804|NCT01072149|537780067|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081805|NCT01072149|537780068|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081806|NCT01072149|537780069|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081807|NCT01072149|537780070|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081808|NCT01072149|537780071|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081809|NCT01072149|537780072|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081810|NCT01072149|537780073|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081811|NCT01072149|537780074|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081812|NCT01072149|537780075|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081813|NCT01072149|537780076|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081814|NCT01072149|537780077|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081815|NCT01072149|537780078|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
149081816|NCT01072149|537780079|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
149081817|NCT01072149|537780062|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081818|NCT01072149|537780063|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081819|NCT01072149|537780064|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081820|NCT01072149|537780065|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081821|NCT01072149|537780066|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081822|NCT01072149|537780067|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081823|NCT01072149|537780068|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081824|NCT01072149|537780069|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081825|NCT01072149|537780070|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081826|NCT01072149|537780071|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081827|NCT01072149|537780072|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
149081828|NCT01072149|537780073|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081829|NCT01072149|537780074|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081830|NCT01072149|537780075|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081831|NCT01072149|537780076|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081832|NCT01072149|537780077|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081833|NCT01072149|537780078|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081834|NCT01072149|537780079|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
149081835|NCT01072149|537780062|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081836|NCT01072149|537780063|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
149081837|NCT01072149|537780064|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081838|NCT01072149|537780065|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081839|NCT01072149|537780066|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081840|NCT01072149|537780067|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081841|NCT01072149|537780068|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081842|NCT01072149|537780069|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081843|NCT01072149|537780070|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081844|NCT01072149|537780071|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081845|NCT01072149|537780072|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081846|NCT01072149|537780073|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081847|NCT01072149|537780074|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081848|NCT01072149|537780075|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081849|NCT01072149|537780076|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081850|NCT01072149|537780077|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081851|NCT01072149|537780078|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081852|NCT01072149|537780079|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
149081853|NCT01072149|537780062|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081854|NCT01072149|537780063|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081855|NCT01072149|537780064|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
149081856|NCT01072149|537780065|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081857|NCT01072149|537780066|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081858|NCT01072149|537780067|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081859|NCT01072149|537780068|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081860|NCT01072149|537780069|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081861|NCT01072149|537780070|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081862|NCT01072149|537780071|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081863|NCT01072149|537780072|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081864|NCT01072149|537780073|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081865|NCT01072149|537780074|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081866|NCT01072149|537780075|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081867|NCT01072149|537780076|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081868|NCT01072149|537780077|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081869|NCT01072149|537780078|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081870|NCT01072149|537780079|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
149081871|NCT01072149|537780062|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081872|NCT01072149|537780063|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081873|NCT01072149|537780064|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081874|NCT01072149|537780065|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081875|NCT01072149|537780066|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081876|NCT01072149|537780067|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081877|NCT01072149|537780068|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081878|NCT01072149|537780069|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
149081879|NCT01072149|537780070|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081880|NCT01072149|537780071|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081881|NCT01072149|537780072|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081882|NCT01072149|537780073|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081883|NCT01072149|537780074|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081884|NCT01072149|537780075|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081885|NCT01072149|537780076|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081886|NCT01072149|537780077|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081887|NCT01072149|537780078|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081888|NCT01072149|537780079|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
149081889|NCT01072149|537780062|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
149081890|NCT01072149|537780063|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
149081891|NCT01072149|537780064|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
149081892|NCT01072149|537780065|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
149081893|NCT01072149|537780066|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
149081894|NCT01072149|537780067|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
149081895|NCT01072149|537780068|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
149081896|NCT01072149|537780069|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
149081897|NCT01072149|537780070|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
149081898|NCT01072149|537780071|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
149081899|NCT01072149|537780072|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
149081900|NCT01072149|537780073|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
149081901|NCT01072149|537780074|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
149081902|NCT01072149|537780075|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
149081903|NCT01072149|537780076|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
149081904|NCT01072149|537780077|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
149081905|NCT01072149|537780078|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
149081906|NCT01072149|537780079|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
149081907|NCT01072149|537780062|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081908|NCT01072149|537780063|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081909|NCT01072149|537780064|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081910|NCT01072149|537780065|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081911|NCT01072149|537780066|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081912|NCT01072149|537780067|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081913|NCT01072149|537780068|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081914|NCT01072149|537780069|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081915|NCT01072149|537780070|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081916|NCT01072149|537780071|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081917|NCT01072149|537780072|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081918|NCT01072149|537780073|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081919|NCT01072149|537780074|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081920|NCT01072149|537780075|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081921|NCT01072149|537780076|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081922|NCT01072149|537780077|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
149081923|NCT01072149|537780078|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081924|NCT01072149|537780079|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
149081925|NCT01072149|537780062|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
149081926|NCT01072149|537780063|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
149081927|NCT01072149|537780064|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
149081928|NCT01072149|537780065|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
149081929|NCT01072149|537780066|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
149081930|NCT01072149|537780067|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
149081931|NCT01072149|537780068|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
149081932|NCT01072149|537780069|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
149081933|NCT01072149|537780070|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
149081934|NCT01072149|537780071|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
149081935|NCT01072149|537780072|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
149081936|NCT01072149|537780073|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
149081937|NCT01072149|537780074|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
149081938|NCT01072149|537780075|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
149081939|NCT01072149|537780076|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
149081940|NCT01072149|537780077|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
149081941|NCT01072149|537780078|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
149081942|NCT01072149|537780079|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
149081943|NCT01072149|537780062|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081944|NCT01072149|537780063|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081945|NCT01072149|537780064|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081946|NCT01072149|537780065|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081947|NCT01072149|537780066|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081948|NCT01072149|537780067|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081949|NCT01072149|537780068|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081950|NCT01072149|537780069|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081951|NCT01072149|537780070|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081952|NCT01072149|537780071|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081953|NCT01072149|537780072|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081954|NCT01072149|537780073|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081955|NCT01072149|537780074|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
149081956|NCT01072149|537780075|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081957|NCT01072149|537780076|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081958|NCT01072149|537780077|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081959|NCT01072149|537780078|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081960|NCT01072149|537780079|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
149081961|NCT01072149|537780062|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081962|NCT01072149|537780063|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081963|NCT01072149|537780064|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
149081964|NCT01072149|537780065|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081965|NCT01072149|537780066|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081966|NCT01072149|537780067|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081967|NCT01072149|537780068|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081968|NCT01072149|537780069|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081969|NCT01072149|537780070|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081970|NCT01072149|537780071|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081971|NCT01072149|537780072|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081972|NCT01072149|537780073|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081973|NCT01072149|537780074|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081974|NCT01072149|537780075|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
149081975|NCT01072149|537780076|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081976|NCT01072149|537780077|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081977|NCT01072149|537780078|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081978|NCT01072149|537780079|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
149081979|NCT01090739|537780085|FG000|Enrollment|Withdrawal by Subject|24|||
149081980|NCT01090739|537780085|FG000|Enrollment|Protocol Violation|14|||
149081981|NCT01090739|537780085|FG000|Enrollment|Lost to Follow-up|5|||
149081982|NCT01090739|537780085|FG000|Enrollment|Physician Decision|5|||
149081983|NCT01090739|537780085|FG000|Enrollment|Sponsor termination of site|4|||
149081984|NCT01090739|537780085|FG000|Enrollment|Study implant limit reached|2|||
149081985|NCT01090739|537780085|FG000|Enrollment|Adverse Event|1|||
149081986|NCT01090739|537780085|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
149081987|NCT01090739|537780085|FG000|12 Month Follow-up|Lost to Follow-up|1|||
149081988|NCT01090739|537780085|FG000|12 Month Follow-up|Physician Decision|1|||
149081989|NCT01090739|537780085|FG000|12 Month Follow-up|Death|1|||
149081990|NCT01090739|537780085|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
149081991|NCT01090739|537780085|FG000|24 Month Follow-up|Lost to Follow-up|1|||
149081992|NCT01090739|537780085|FG000|24 Month Follow-up|Death|1|||
149081993|NCT01090739|537780085|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
149081994|NCT01090739|537780085|FG000|36 Month Follow-up|Visit still pending|17|||
149081995|NCT00441168|537780086|FG000|Treatment Period|Death|3|||
149081996|NCT00441168|537780087|FG001|Treatment Period|Death|0|||
149081997|NCT00441168|537780086|FG000|Treatment Period|Adverse Event|1|||
149081998|NCT00441168|537780087|FG001|Treatment Period|Adverse Event|2|||
149081999|NCT00441168|537780086|FG000|Treatment Period|Progressive Disease|0|||
149082000|NCT00441168|537780087|FG001|Treatment Period|Progressive Disease|2|||
149082001|NCT00441168|537780086|FG000|Treatment Period|Protocol Violation|0|||
149082002|NCT00441168|537780087|FG001|Treatment Period|Protocol Violation|1|||
149082003|NCT00441168|537780086|FG000|Treatment Period|Lost to Follow-up|0|||
149082004|NCT00441168|537780087|FG001|Treatment Period|Lost to Follow-up|1|||
149082005|NCT00441168|537780086|FG000|Treatment Period|Withdrawal by Subject|3|||
149082006|NCT00441168|537780087|FG001|Treatment Period|Withdrawal by Subject|0|||
149082007|NCT00441168|537780086|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
149082008|NCT00441168|537780087|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
149082009|NCT00441168|537780086|FG000|Treatment Period|refractory disease|1|||
149082010|NCT00441168|537780087|FG001|Treatment Period|refractory disease|0|||
149082011|NCT00441168|537780086|FG000|Follow-up Period|Death|3|||
149082012|NCT00441168|537780087|FG001|Follow-up Period|Death|0|||
149082013|NCT00441168|537780086|FG000|Follow-up Period|Lost to Follow-up|5|||
149082014|NCT00441168|537780087|FG001|Follow-up Period|Lost to Follow-up|6|||
149082015|NCT00441168|537780086|FG000|Follow-up Period|Withdrawal by Subject|3|||
149082016|NCT00441168|537780087|FG001|Follow-up Period|Withdrawal by Subject|0|||
149082017|NCT00441168|537780086|FG000|Follow-up Period|Other|1|||
149082018|NCT00441168|537780087|FG001|Follow-up Period|Other|3|||
149082019|NCT00988429|537780088|FG000|Overall Study|Adverse Event|9|||
149082020|NCT00988429|537780089|FG001|Overall Study|Adverse Event|21|||
149082021|NCT00988429|537780090|FG002|Overall Study|Adverse Event|45|||
149082022|NCT00988429|537780088|FG000|Overall Study|Lack of Efficacy|0|||
149082023|NCT00988429|537780089|FG001|Overall Study|Lack of Efficacy|0|||
149082024|NCT00988429|537780090|FG002|Overall Study|Lack of Efficacy|1|||
149082025|NCT00988429|537780088|FG000|Overall Study|Non-Compliance with Study Drug|5|||
149082026|NCT00988429|537780089|FG001|Overall Study|Non-Compliance with Study Drug|1|||
149082027|NCT00988429|537780090|FG002|Overall Study|Non-Compliance with Study Drug|3|||
149082028|NCT00988429|537780088|FG000|Overall Study|Physician Decision|1|||
149082029|NCT00988429|537780089|FG001|Overall Study|Physician Decision|0|||
149082030|NCT00988429|537780090|FG002|Overall Study|Physician Decision|3|||
149082031|NCT00988429|537780088|FG000|Overall Study|Pregnancy|2|||
149082032|NCT00988429|537780089|FG001|Overall Study|Pregnancy|1|||
149082033|NCT00988429|537780090|FG002|Overall Study|Pregnancy|0|||
149082034|NCT00988429|537780088|FG000|Overall Study|Protocol Violation|4|||
149082035|NCT00988429|537780089|FG001|Overall Study|Protocol Violation|3|||
149082036|NCT00988429|537780090|FG002|Overall Study|Protocol Violation|3|||
149082037|NCT00988429|537780088|FG000|Overall Study|Withdrawal by Subject|7|||
149082038|NCT00988429|537780089|FG001|Overall Study|Withdrawal by Subject|7|||
149082039|NCT00988429|537780090|FG002|Overall Study|Withdrawal by Subject|12|||
149082040|NCT00988429|537780088|FG000|Overall Study|Administrative Reasons|1|||
149082041|NCT00988429|537780089|FG001|Overall Study|Administrative Reasons|2|||
149082042|NCT00988429|537780090|FG002|Overall Study|Administrative Reasons|1|||
149082043|NCT00988429|537780088|FG000|Overall Study|other reasons|8|||
149082044|NCT00988429|537780089|FG001|Overall Study|other reasons|8|||
149082045|NCT00988429|537780090|FG002|Overall Study|other reasons|1|||
149082046|NCT02964234|537780091|FG000|Overall Study|Lost to Follow-up|22|||
149082047|NCT02964234|537780092|FG001|Overall Study|Lost to Follow-up|13|||
149082048|NCT01799993|537780094|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
149082049|NCT01799993|537780095|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
149082050|NCT01799993|537780094|FG000|Overall Study|Death|61|||
149082051|NCT01799993|537780095|FG001|Overall Study|Death|45|||
149082052|NCT01799993|537780094|FG000|Overall Study|Withdrawal by Subject|23|||
149082053|NCT01799993|537780095|FG001|Overall Study|Withdrawal by Subject|24|||
149082054|NCT01799993|537780094|FG000|Overall Study|Lost to Follow-up|5|||
149082055|NCT01799993|537780095|FG001|Overall Study|Lost to Follow-up|8|||
149082056|NCT01799993|537780094|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
149082057|NCT01799993|537780095|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
149082058|NCT01799993|537780094|FG000|Overall Study|Protocol driven decision point|0|||
149082059|NCT01799993|537780095|FG001|Overall Study|Protocol driven decision point|3|||
149082060|NCT01799993|537780094|FG000|Overall Study|Protocol Violation|1|||
149082061|NCT01799993|537780095|FG001|Overall Study|Protocol Violation|1|||
149082062|NCT01799993|537780094|FG000|Overall Study|Deterioration of general conditions|2|||
149082063|NCT01799993|537780095|FG001|Overall Study|Deterioration of general conditions|0|||
149082064|NCT01799993|537780094|FG000|Overall Study|Screen failure|0|||
149082065|NCT01799993|537780095|FG001|Overall Study|Screen failure|1|||
149082066|NCT01799993|537780094|FG000|Overall Study|Adverse Event|1|||
149082067|NCT01799993|537780095|FG001|Overall Study|Adverse Event|0|||
149082068|NCT01799993|537780094|FG000|Overall Study|Lack of Efficacy|1|||
149082069|NCT01799993|537780095|FG001|Overall Study|Lack of Efficacy|0|||
149082070|NCT01799993|537780094|FG000|Overall Study|Recovery|0|||
149082071|NCT01799993|537780095|FG001|Overall Study|Recovery|1|||
149082072|NCT01799993|537780094|FG000|Overall Study|Logistical difficulties|1|||
149082073|NCT01799993|537780095|FG001|Overall Study|Logistical difficulties|0|||
149082074|NCT01799993|537780094|FG000|Overall Study|Protocol deviation|1|||
149082075|NCT01799993|537780095|FG001|Overall Study|Protocol deviation|0|||
149082076|NCT01799993|537780094|FG000|Overall Study|Non-compliance with medical device|1|||
149082077|NCT01799993|537780095|FG001|Overall Study|Non-compliance with medical device|0|||
149082078|NCT01799993|537780094|FG000|Overall Study|Withdrawal by parent/guardian|0|||
149082079|NCT01799993|537780095|FG001|Overall Study|Withdrawal by parent/guardian|1|||
149082080|NCT01799993|537780094|FG000|Overall Study|Other|1|||
149082081|NCT01799993|537780095|FG001|Overall Study|Other|0|||
149082082|NCT01799993|537780094|FG000|Overall Study|Subject didn't return for follow-up|0|||
149082083|NCT01799993|537780095|FG001|Overall Study|Subject didn't return for follow-up|1|||
149082084|NCT04867382|537780096|FG000|Overall Study|Did not complete the survey|2|||
149082085|NCT04867382|537780097|FG001|Overall Study|Did not complete the survey|1|||
149082086|NCT02102724|537780102|FG000|Overall Study|Lost to Follow-up|1|||
149082087|NCT02102724|537780103|FG001|Overall Study|Lost to Follow-up|0|||
149082088|NCT02102724|537780102|FG000|Overall Study|surgery for brain aneurysm|1|||
149082089|NCT02102724|537780103|FG001|Overall Study|surgery for brain aneurysm|1|||
149082090|NCT02008916|537780104|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
149082091|NCT02008916|537780105|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
149082092|NCT02008916|537780106|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
149082093|NCT02008916|537780104|FG000|Week 16 - 156|Adverse Event|4|||
149082094|NCT02008916|537780105|FG001|Week 16 - 156|Adverse Event|2|||
149082095|NCT02008916|537780106|FG002|Week 16 - 156|Adverse Event|3|||
149082096|NCT02008916|537780104|FG000|Week 16 - 156|Withdrawal by Subject|7|||
149082097|NCT02008916|537780105|FG001|Week 16 - 156|Withdrawal by Subject|3|||
149082098|NCT02008916|537780106|FG002|Week 16 - 156|Withdrawal by Subject|5|||
149082099|NCT02008916|537780104|FG000|Week 16 - 156|No longer requires treatment|0|||
149082100|NCT02008916|537780105|FG001|Week 16 - 156|No longer requires treatment|1|||
149082101|NCT02008916|537780106|FG002|Week 16 - 156|No longer requires treatment|0|||
149082102|NCT02008916|537780104|FG000|Week 16 - 156|Lost to Follow-up|5|||
149082103|NCT02008916|537780105|FG001|Week 16 - 156|Lost to Follow-up|0|||
149082104|NCT02008916|537780106|FG002|Week 16 - 156|Lost to Follow-up|0|||
149082105|NCT02008916|537780104|FG000|Week 16 - 156|Lack of Efficacy|3|||
149082106|NCT02008916|537780105|FG001|Week 16 - 156|Lack of Efficacy|5|||
149082107|NCT02008916|537780106|FG002|Week 16 - 156|Lack of Efficacy|2|||
149082108|NCT02008916|537780104|FG000|Week 16 - 156|Pregnancy|0|||
149082109|NCT02008916|537780105|FG001|Week 16 - 156|Pregnancy|1|||
149082110|NCT02008916|537780106|FG002|Week 16 - 156|Pregnancy|0|||
149082111|NCT02008916|537780104|FG000|Week 16 - 156|Physician Decision|0|||
149082112|NCT02008916|537780105|FG001|Week 16 - 156|Physician Decision|1|||
149082113|NCT02008916|537780106|FG002|Week 16 - 156|Physician Decision|0|||
149082114|NCT02432274|537780107|FG000|Overall Study|Death|2|||
149082115|NCT02432274|537780108|FG001|Overall Study|Death|6|||
149082116|NCT02432274|537780109|FG002|Overall Study|Death|7|||
149082117|NCT02432274|537780110|FG003|Overall Study|Death|0|||
149082118|NCT02432274|537780111|FG004|Overall Study|Death|27|||
149082119|NCT02432274|537780112|FG005|Overall Study|Death|7|||
149082120|NCT02432274|537780113|FG006|Overall Study|Death|9|||
149082121|NCT02432274|537780114|FG007|Overall Study|Death|14|||
149082122|NCT02432274|537780107|FG000|Overall Study|Withdrawal of Consent|0|||
149082123|NCT02432274|537780108|FG001|Overall Study|Withdrawal of Consent|0|||
149082124|NCT02432274|537780109|FG002|Overall Study|Withdrawal of Consent|0|||
149082125|NCT02432274|537780110|FG003|Overall Study|Withdrawal of Consent|0|||
149082126|NCT02432274|537780111|FG004|Overall Study|Withdrawal of Consent|2|||
149082127|NCT02432274|537780112|FG005|Overall Study|Withdrawal of Consent|0|||
149082128|NCT02432274|537780113|FG006|Overall Study|Withdrawal of Consent|1|||
149082129|NCT02432274|537780114|FG007|Overall Study|Withdrawal of Consent|2|||
149082130|NCT02807857|537780115|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
149082131|NCT02807857|537780115|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
149082132|NCT02807857|537780115|FG000|Follow-Up Set|Withdrawal by Subject|8|||
149082133|NCT02807857|537780115|FG000|Follow-Up Set|Lost to Follow-up|7|||
149082134|NCT02807857|537780115|FG000|Follow-Up Set|Physician Decision|6|||
149082135|NCT02807857|537780115|FG000|Follow-Up Set|Adverse Event|3|||
149082136|NCT02807857|537780115|FG000|Follow-Up Set|Death|27|||
149082137|NCT02807857|537780115|FG000|Follow-Up Set|Relocation|2|||
149082138|NCT00800176|537780116|FG000|Overall Study|Adverse Event|2|||
149082139|NCT00800176|537780117|FG001|Overall Study|Adverse Event|1|||
149082140|NCT00800176|537780118|FG002|Overall Study|Adverse Event|0|||
149082141|NCT00800176|537780119|FG003|Overall Study|Adverse Event|2|||
149082142|NCT00800176|537780120|FG004|Overall Study|Adverse Event|1|||
149082143|NCT00800176|537780121|FG005|Overall Study|Adverse Event|1|||
149082144|NCT00800176|537780116|FG000|Overall Study|Refused treatment|3|||
149082145|NCT00800176|537780117|FG001|Overall Study|Refused treatment|2|||
149082146|NCT00800176|537780118|FG002|Overall Study|Refused treatment|0|||
149082147|NCT00800176|537780119|FG003|Overall Study|Refused treatment|0|||
149082148|NCT00800176|537780120|FG004|Overall Study|Refused treatment|1|||
149082149|NCT00800176|537780121|FG005|Overall Study|Refused treatment|4|||
149082150|NCT00800176|537780116|FG000|Overall Study|Failure to return|3|||
149082151|NCT00800176|537780117|FG001|Overall Study|Failure to return|3|||
149082152|NCT00800176|537780118|FG002|Overall Study|Failure to return|0|||
149082153|NCT00800176|537780119|FG003|Overall Study|Failure to return|2|||
149082154|NCT00800176|537780120|FG004|Overall Study|Failure to return|0|||
149082155|NCT00800176|537780121|FG005|Overall Study|Failure to return|0|||
149082156|NCT00800176|537780116|FG000|Overall Study|Other|1|||
149082157|NCT00800176|537780117|FG001|Overall Study|Other|0|||
149082158|NCT00800176|537780118|FG002|Overall Study|Other|0|||
149082159|NCT00800176|537780119|FG003|Overall Study|Other|0|||
149082160|NCT00800176|537780120|FG004|Overall Study|Other|2|||
149082161|NCT00800176|537780121|FG005|Overall Study|Other|0|||
149082162|NCT02326220|537780124|FG000|Double-blind Treatment Period|Adverse Event|1|||
149082163|NCT02326220|537780125|FG001|Double-blind Treatment Period|Adverse Event|2|||
149082164|NCT02326220|537780126|FG002|Double-blind Treatment Period|Adverse Event|0|||
149082165|NCT02326220|537780124|FG000|Double-blind Treatment Period|Protocol Violation|0|||
149082166|NCT02326220|537780125|FG001|Double-blind Treatment Period|Protocol Violation|1|||
149082167|NCT02326220|537780126|FG002|Double-blind Treatment Period|Protocol Violation|0|||
149082168|NCT02326220|537780124|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
149082169|NCT02326220|537780125|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
149082170|NCT02326220|537780126|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149082171|NCT02326220|537780124|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
149082172|NCT02326220|537780125|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
149082173|NCT02326220|537780126|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
149082174|NCT02326220|537780124|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
149082175|NCT02326220|537780125|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
149082176|NCT02326220|537780126|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
149082177|NCT02659540|537780127|FG000|Overall Study|Adverse Event|3|||
149082178|NCT02659540|537780128|FG001|Overall Study|Adverse Event|2|||
149082179|NCT02659540|537780127|FG000|Overall Study|Death|1|||
149082180|NCT02659540|537780128|FG001|Overall Study|Death|0|||
149082181|NCT02659540|537780127|FG000|Overall Study|Progressive disease|2|||
149082182|NCT02659540|537780128|FG001|Overall Study|Progressive disease|6|||
149082183|NCT00824850|537780129|FG000|Overall Study|Withdrawal by Subject|0|||
149082184|NCT00824850|537780130|FG001|Overall Study|Withdrawal by Subject|1|||
149082185|NCT01075152|537780131|FG000|Overall Study|Withdrawal by Subject|1|||
149082186|NCT01075152|537780132|FG001|Overall Study|Withdrawal by Subject|0|||
149082187|NCT04820491|537780133|FG000|Overall Study|Withdrawal by Subject|1|||
149082188|NCT04820491|537780134|FG001|Overall Study|Withdrawal by Subject|0|||
149082189|NCT02144285|537780137|FG000|Overall Study|Withdrawal by Subject|0|||
149082190|NCT02144285|537780138|FG001|Overall Study|Withdrawal by Subject|0|||
149082191|NCT02144285|537780139|FG002|Overall Study|Withdrawal by Subject|0|||
149082192|NCT02144285|537780140|FG003|Overall Study|Withdrawal by Subject|0|||
149082193|NCT02144285|537780141|FG004|Overall Study|Withdrawal by Subject|1|||
149082194|NCT02144285|537780142|FG005|Overall Study|Withdrawal by Subject|0|||
149082195|NCT02144285|537780143|FG006|Overall Study|Withdrawal by Subject|0|||
149082196|NCT02144285|537780144|FG007|Overall Study|Withdrawal by Subject|0|||
149082197|NCT02144285|537780145|FG008|Overall Study|Withdrawal by Subject|0|||
149082198|NCT02144285|537780146|FG009|Overall Study|Withdrawal by Subject|0|||
149082199|NCT05184062|537780148|FG000|Overall Study|Lost to Follow-up|5|||
149082200|NCT05184062|537780149|FG001|Overall Study|Lost to Follow-up|1|||
149082201|NCT05184062|537780148|FG000|Overall Study|Withdrawal by Subject|1|||
149082202|NCT05184062|537780149|FG001|Overall Study|Withdrawal by Subject|0|||
149082203|NCT03786471|537780152|FG000|Overall Study|Death|254|||
149082204|NCT03786471|537780153|FG001|Overall Study|Death|223|||
149082205|NCT03786471|537780154|FG002|Overall Study|Death|37|||
149082206|NCT03786471|537780152|FG000|Overall Study|Lost to Follow-up|63|||
149082207|NCT03786471|537780153|FG001|Overall Study|Lost to Follow-up|50|||
149082208|NCT03786471|537780154|FG002|Overall Study|Lost to Follow-up|15|||
149082209|NCT03786471|537780152|FG000|Overall Study|Withdrawal by Subject|99|||
149082210|NCT03786471|537780153|FG001|Overall Study|Withdrawal by Subject|81|||
149082211|NCT03786471|537780154|FG002|Overall Study|Withdrawal by Subject|11|||
149082212|NCT00264576|537781801|FG000|Overall Study|Lost to Follow-up|1|||
149082213|NCT00264576|537781802|FG001|Overall Study|Lost to Follow-up|1|||
149082214|NCT02659059|537781803|FG000|Overall Study|Other reasons|6|||
149082215|NCT02659059|537781804|FG001|Overall Study|Other reasons|1|||
149082216|NCT02659059|537781803|FG000|Overall Study|Disease Progression|143|||
149082217|NCT02659059|537781804|FG001|Overall Study|Disease Progression|16|||
149082218|NCT02659059|537781803|FG000|Overall Study|Study Drug toxicity|56|||
149082219|NCT02659059|537781804|FG001|Overall Study|Study Drug toxicity|9|||
149082220|NCT02659059|537781803|FG000|Overall Study|Death|3|||
149082221|NCT02659059|537781804|FG001|Overall Study|Death|1|||
149082222|NCT02659059|537781803|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
149082223|NCT02659059|537781804|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
149082224|NCT02659059|537781803|FG000|Overall Study|Participant request to discontinue study treatment|5|||
149082225|NCT02659059|537781804|FG001|Overall Study|Participant request to discontinue study treatment|0|||
149082226|NCT02659059|537781803|FG000|Overall Study|Participant withdrew consent|6|||
149082227|NCT02659059|537781804|FG001|Overall Study|Participant withdrew consent|1|||
149082228|NCT00092456|537781805|FG000|Overall Study|Adverse Event|0|||
149082229|NCT00092456|537781806|FG001|Overall Study|Adverse Event|0|||
149082230|NCT00092456|537781807|FG002|Overall Study|Adverse Event|1|||
149082231|NCT00092456|537781808|FG003|Overall Study|Adverse Event|1|||
149082232|NCT00092456|537781805|FG000|Overall Study|Lost to Follow-up|2|||
149082233|NCT00092456|537781806|FG001|Overall Study|Lost to Follow-up|2|||
149082234|NCT00092456|537781807|FG002|Overall Study|Lost to Follow-up|1|||
149082235|NCT00092456|537781808|FG003|Overall Study|Lost to Follow-up|2|||
149082236|NCT00092456|537781805|FG000|Overall Study|Protocol Violation|5|||
149082237|NCT00092456|537781806|FG001|Overall Study|Protocol Violation|7|||
149082238|NCT00092456|537781807|FG002|Overall Study|Protocol Violation|8|||
149082239|NCT00092456|537781808|FG003|Overall Study|Protocol Violation|6|||
149082240|NCT00092456|537781805|FG000|Overall Study|Withdrawal by Subject|13|||
149082241|NCT00092456|537781806|FG001|Overall Study|Withdrawal by Subject|5|||
149082242|NCT00092456|537781807|FG002|Overall Study|Withdrawal by Subject|16|||
149082243|NCT00092456|537781808|FG003|Overall Study|Withdrawal by Subject|6|||
149082244|NCT00092456|537781805|FG000|Overall Study|Moved|1|||
149082245|NCT00092456|537781806|FG001|Overall Study|Moved|1|||
149082246|NCT00092456|537781807|FG002|Overall Study|Moved|0|||
149082247|NCT00092456|537781808|FG003|Overall Study|Moved|1|||
149082248|NCT00092456|537781805|FG000|Overall Study|Other|4|||
149082249|NCT00092456|537781806|FG001|Overall Study|Other|2|||
149082250|NCT00092456|537781807|FG002|Overall Study|Other|3|||
149082251|NCT00092456|537781808|FG003|Overall Study|Other|0|||
149082252|NCT04783389|537781809|FG000|Overall Study|Withdrawal by Subject|2|||
149082253|NCT04783389|537781810|FG001|Overall Study|Withdrawal by Subject|0|||
149082254|NCT04783389|537781811|FG002|Overall Study|Withdrawal by Subject|0|||
149082255|NCT04783389|537781809|FG000|Overall Study|Termination of Study by Sponsor|10|||
149082256|NCT04783389|537781810|FG001|Overall Study|Termination of Study by Sponsor|12|||
149082257|NCT04783389|537781811|FG002|Overall Study|Termination of Study by Sponsor|14|||
149082258|NCT01241448|537781812|FG000|Overall Study|Adverse Event|1|||
149082259|NCT01241448|537781813|FG001|Overall Study|Adverse Event|0|||
149082260|NCT01241448|537781814|FG002|Overall Study|Adverse Event|2|||
149082261|NCT01241448|537781815|FG003|Overall Study|Adverse Event|2|||
149082262|NCT01241448|537781812|FG000|Overall Study|Lost to Follow-up|2|||
149082263|NCT01241448|537781813|FG001|Overall Study|Lost to Follow-up|1|||
149082264|NCT01241448|537781814|FG002|Overall Study|Lost to Follow-up|1|||
149082265|NCT01241448|537781815|FG003|Overall Study|Lost to Follow-up|1|||
149082266|NCT01241448|537781812|FG000|Overall Study|Physician Decision|0|||
149082267|NCT01241448|537781813|FG001|Overall Study|Physician Decision|2|||
149082268|NCT01241448|537781814|FG002|Overall Study|Physician Decision|0|||
149082269|NCT01241448|537781815|FG003|Overall Study|Physician Decision|0|||
149082270|NCT01241448|537781812|FG000|Overall Study|Protocol Violation|10|||
149082271|NCT01241448|537781813|FG001|Overall Study|Protocol Violation|5|||
149082272|NCT01241448|537781814|FG002|Overall Study|Protocol Violation|3|||
149082273|NCT01241448|537781815|FG003|Overall Study|Protocol Violation|6|||
149082274|NCT01241448|537781812|FG000|Overall Study|Sponsor Decision|17|||
149082275|NCT01241448|537781813|FG001|Overall Study|Sponsor Decision|14|||
149082276|NCT01241448|537781814|FG002|Overall Study|Sponsor Decision|12|||
149082277|NCT01241448|537781815|FG003|Overall Study|Sponsor Decision|6|||
149082278|NCT01241448|537781812|FG000|Overall Study|Withdrawal by Subject|4|||
149082279|NCT01241448|537781813|FG001|Overall Study|Withdrawal by Subject|5|||
149082280|NCT01241448|537781814|FG002|Overall Study|Withdrawal by Subject|3|||
149082281|NCT01241448|537781815|FG003|Overall Study|Withdrawal by Subject|6|||
149082282|NCT01241448|537781812|FG000|Overall Study|Excluded due to data integrity issues|3|||
149082283|NCT01241448|537781813|FG001|Overall Study|Excluded due to data integrity issues|2|||
149082284|NCT01241448|537781814|FG002|Overall Study|Excluded due to data integrity issues|2|||
149082285|NCT01241448|537781815|FG003|Overall Study|Excluded due to data integrity issues|2|||
149082286|NCT03137784|537781816|FG000|Overall Study|Adverse Event|1|||
149082287|NCT03137784|537781817|FG001|Overall Study|Adverse Event|1|||
149082288|NCT03137784|537781818|FG002|Overall Study|Adverse Event|0|||
149082289|NCT03137784|537781819|FG003|Overall Study|Adverse Event|0|||
149082290|NCT03137784|537781820|FG004|Overall Study|Adverse Event|0|||
149082291|NCT03137784|537781821|FG005|Overall Study|Adverse Event|0|||
149082292|NCT03137784|537781816|FG000|Overall Study|Subject/guardian decision|1|||
149082293|NCT03137784|537781817|FG001|Overall Study|Subject/guardian decision|0|||
149082294|NCT03137784|537781818|FG002|Overall Study|Subject/guardian decision|0|||
149082295|NCT03137784|537781819|FG003|Overall Study|Subject/guardian decision|0|||
149082296|NCT03137784|537781820|FG004|Overall Study|Subject/guardian decision|0|||
149082297|NCT03137784|537781821|FG005|Overall Study|Subject/guardian decision|0|||
149082298|NCT03137784|537781816|FG000|Overall Study|Non-compliance with study treatment|0|||
149082299|NCT03137784|537781817|FG001|Overall Study|Non-compliance with study treatment|0|||
149082300|NCT03137784|537781818|FG002|Overall Study|Non-compliance with study treatment|0|||
149082301|NCT03137784|537781819|FG003|Overall Study|Non-compliance with study treatment|0|||
149082302|NCT03137784|537781820|FG004|Overall Study|Non-compliance with study treatment|1|||
149082303|NCT03137784|537781821|FG005|Overall Study|Non-compliance with study treatment|0|||
149082304|NCT04311983|537781822|FG000|Overall Study|Lost to Follow-up|421|||
149082305|NCT04311983|537781823|FG001|Overall Study|Lost to Follow-up|456|||
149082306|NCT04311983|537781822|FG000|Overall Study|Incomplete survey|7|||
149082307|NCT04311983|537781823|FG001|Overall Study|Incomplete survey|9|||
149082308|NCT04311983|537781822|FG000|Overall Study|Death|1|||
149082309|NCT04311983|537781823|FG001|Overall Study|Death|0|||
149082310|NCT02165202|537781829|FG000|Oral Phase|Refused further participation|5|||
149082311|NCT02165202|537781830|FG001|Oral Phase|Refused further participation|1|||
149082312|NCT02165202|537781829|FG000|Oral Phase|Study product Related Toxicity|1|||
149082313|NCT02165202|537781830|FG001|Oral Phase|Study product Related Toxicity|0|||
149082314|NCT02165202|537781829|FG000|Oral Phase|Unable to contact Participant|1|||
149082315|NCT02165202|537781830|FG001|Oral Phase|Unable to contact Participant|1|||
149082316|NCT02165202|537781829|FG000|Oral Phase|Clinical reasons|1|||
149082317|NCT02165202|537781830|FG001|Oral Phase|Clinical reasons|0|||
149082318|NCT02165202|537781829|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
149082319|NCT02165202|537781830|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
149082320|NCT02165202|537781829|FG000|Oral Phase|CMC advised termination|1|||
149082321|NCT02165202|537781830|FG001|Oral Phase|CMC advised termination|0|||
149082322|NCT02165202|537781829|FG000|Oral Phase|Relocated, no follow-up planned|1|||
149082323|NCT02165202|537781830|FG001|Oral Phase|Relocated, no follow-up planned|0|||
149082324|NCT02165202|537781829|FG000|Oral Phase|Abnormal EKG|0|||
149082325|NCT02165202|537781830|FG001|Oral Phase|Abnormal EKG|1|||
149082326|NCT02165202|537781829|FG000|Injection Phase|Abnormal Lab Value|5|||
149082327|NCT02165202|537781830|FG001|Injection Phase|Abnormal Lab Value|1|||
149082328|NCT02165202|537781829|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
149082329|NCT02165202|537781830|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
149082330|NCT02165202|537781829|FG000|Injection Phase|Unable to attend within Visit Window|1|||
149082331|NCT02165202|537781830|FG001|Injection Phase|Unable to attend within Visit Window|0|||
149082332|NCT02165202|537781829|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
149082333|NCT02165202|537781830|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
149082334|NCT02165202|537781829|FG000|Injection Phase|End of Study|2|||
149082335|NCT02165202|537781830|FG001|Injection Phase|End of Study|1|||
149082336|NCT02165202|537781829|FG000|Injection Phase|Study Product related Toxicity|1|||
149082337|NCT02165202|537781830|FG001|Injection Phase|Study Product related Toxicity|0|||
149082338|NCT02165202|537781829|FG000|Injection Phase|No longer interested|0|||
149082339|NCT02165202|537781830|FG001|Injection Phase|No longer interested|1|||
149082340|NCT02165202|537781829|FG000|Injection Phase|Participant unwilling to comply|1|||
149082341|NCT02165202|537781830|FG001|Injection Phase|Participant unwilling to comply|0|||
149082342|NCT04328467|537781836|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
149082343|NCT04328467|537781837|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
149082344|NCT04328467|537781838|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
149082345|NCT00990184|537781839|FG000|Overall Study|Physician Decision|1|||
149082346|NCT01975701|537781842|FG000|Overall Study|Lost to Follow-up|1|||
149082347|NCT01975701|537781842|FG000|Overall Study|Death|23|||
149082348|NCT01975701|537781842|FG000|Overall Study|Physician Decision|1|||
149082349|NCT01655498|537781843|FG000|Overall Study|Unrelated health issue|2|||
149082350|NCT01655498|537781843|FG000|Overall Study|Protocol Violation|2|||
149082351|NCT01655498|537781843|FG000|Overall Study|Withdrawal by Subject|1|||
149082352|NCT02152384|537781846|FG000|Period 1|Withdrawal by Subject|0|||
149082353|NCT02152384|537781847|FG001|Period 1|Withdrawal by Subject|1|||
149082354|NCT02152384|537781846|FG000|Period 1|Adverse Event|1|||
149082355|NCT02152384|537781847|FG001|Period 1|Adverse Event|1|||
149082356|NCT02446015|537781848|FG000|Overall Study|Adverse Event|0|||
149082357|NCT02446015|537781849|FG001|Overall Study|Adverse Event|1|||
149082358|NCT02446015|537781848|FG000|Overall Study|Withdrawal by Subject|1|||
149082359|NCT02446015|537781849|FG001|Overall Study|Withdrawal by Subject|0|||
149082360|NCT00603798|537781853|FG000|Overall Study|Adverse Event|4|||
149082361|NCT00603798|537781854|FG001|Overall Study|Adverse Event|2|||
149082362|NCT00603798|537781855|FG002|Overall Study|Adverse Event|1|||
149082363|NCT00603798|537781853|FG000|Overall Study|Withdrawal by Subject|4|||
149082364|NCT00603798|537781854|FG001|Overall Study|Withdrawal by Subject|3|||
149082365|NCT00603798|537781855|FG002|Overall Study|Withdrawal by Subject|4|||
149082366|NCT00603798|537781853|FG000|Overall Study|Lost to Follow-up|1|||
149082367|NCT00603798|537781854|FG001|Overall Study|Lost to Follow-up|0|||
149082368|NCT00603798|537781855|FG002|Overall Study|Lost to Follow-up|1|||
149082369|NCT00603798|537781853|FG000|Overall Study|Non-compliance with study procedures|0|||
149082370|NCT00603798|537781854|FG001|Overall Study|Non-compliance with study procedures|1|||
149082371|NCT00603798|537781855|FG002|Overall Study|Non-compliance with study procedures|0|||
149082372|NCT00603798|537781853|FG000|Overall Study|Not due to AE|1|||
149082373|NCT00603798|537781854|FG001|Overall Study|Not due to AE|1|||
149082374|NCT00603798|537781855|FG002|Overall Study|Not due to AE|4|||
149082375|NCT04361617|537781859|FG000|Overall Study|Withdrawal by Subject|0|||
149082376|NCT04361617|537781860|FG001|Overall Study|Withdrawal by Subject|1|||
149082377|NCT02005484|537781862|FG000|Overall Study|Death|1|||
149082378|NCT02005484|537781862|FG000|Overall Study|Disease progression|1|||
149082379|NCT02005484|537781862|FG000|Overall Study|Changed to a Different Study|1|||
149082380|NCT02005484|537781862|FG000|Overall Study|Sponsor decision|1|||
149082381|NCT00687297|537781866|FG000|Randomization|Withdrawal by Subject|2|||
149082382|NCT00687297|537781867|FG001|Randomization|Withdrawal by Subject|0|||
149082383|NCT00687297|537781866|FG000|Randomization|Withdrew before treatment, ineligible|1|||
149082384|NCT00687297|537781867|FG001|Randomization|Withdrew before treatment, ineligible|1|||
149082385|NCT00687297|537781866|FG000|Induction|Withdrawal by Subject|4|||
149082386|NCT00687297|537781867|FG001|Induction|Withdrawal by Subject|4|||
149082387|NCT00687297|537781866|FG000|Induction|Adverse Event|16|||
149082388|NCT00687297|537781867|FG001|Induction|Adverse Event|15|||
149082389|NCT00687297|537781866|FG000|Induction|Death|7|||
149082390|NCT00687297|537781867|FG001|Induction|Death|11|||
149082391|NCT00687297|537781866|FG000|Induction|Lack of Efficacy|17|||
149082392|NCT00687297|537781867|FG001|Induction|Lack of Efficacy|21|||
149082393|NCT00687297|537781866|FG000|Induction|Ineligible|0|||
149082394|NCT00687297|537781867|FG001|Induction|Ineligible|1|||
149082395|NCT00687297|537781866|FG000|Induction|Patient Noncompliance|1|||
149082396|NCT00687297|537781867|FG001|Induction|Patient Noncompliance|0|||
149082397|NCT00687297|537781866|FG000|Induction|Physician Decision|0|||
149082398|NCT00687297|537781867|FG001|Induction|Physician Decision|2|||
149082399|NCT00687297|537781866|FG000|Induction|Other|0|||
149082400|NCT00687297|537781867|FG001|Induction|Other|1|||
149082401|NCT03695185|537781870|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
149082402|NCT03695185|537781870|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
149082403|NCT03695185|537781870|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
149082404|NCT03695185|537781870|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
149082405|NCT03695185|537781870|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
149082406|NCT03695185|537781870|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
149082407|NCT02584257|537781871|FG000|Period 1|Withdrawal by Subject|0|||
149082408|NCT02584257|537781872|FG001|Period 1|Withdrawal by Subject|0|||
149082409|NCT02584257|537781873|FG002|Period 1|Withdrawal by Subject|0|||
149082410|NCT02584257|537781874|FG003|Period 1|Withdrawal by Subject|0|||
149082411|NCT02584257|537781875|FG004|Period 1|Withdrawal by Subject|0|||
149082412|NCT02584257|537781876|FG005|Period 1|Withdrawal by Subject|0|||
149082413|NCT02584257|537781877|FG006|Period 1|Withdrawal by Subject|1|||
149082414|NCT02584257|537781878|FG007|Period 1|Withdrawal by Subject|0|||
149082415|NCT02584257|537781879|FG008|Period 1|Withdrawal by Subject|0|||
149082416|NCT02584257|537781871|FG000|Period 2|Physician Decision|1|||
149082417|NCT02584257|537781872|FG001|Period 2|Physician Decision|0|||
149082418|NCT02584257|537781873|FG002|Period 2|Physician Decision|0|||
149082419|NCT02584257|537781874|FG003|Period 2|Physician Decision|0|||
149082420|NCT02584257|537781875|FG004|Period 2|Physician Decision|0|||
149082421|NCT02584257|537781876|FG005|Period 2|Physician Decision|0|||
149082422|NCT02584257|537781877|FG006|Period 2|Physician Decision|0|||
149082423|NCT02584257|537781878|FG007|Period 2|Physician Decision|0|||
149082424|NCT02584257|537781879|FG008|Period 2|Physician Decision|0|||
149082425|NCT02584257|537781871|FG000|Period 2|Adverse Event|0|||
149082426|NCT02584257|537781872|FG001|Period 2|Adverse Event|1|||
149082427|NCT02584257|537781873|FG002|Period 2|Adverse Event|0|||
149082428|NCT02584257|537781874|FG003|Period 2|Adverse Event|0|||
149082429|NCT02584257|537781875|FG004|Period 2|Adverse Event|0|||
149082430|NCT02584257|537781876|FG005|Period 2|Adverse Event|0|||
149082431|NCT02584257|537781877|FG006|Period 2|Adverse Event|0|||
149082432|NCT02584257|537781878|FG007|Period 2|Adverse Event|0|||
149082433|NCT02584257|537781879|FG008|Period 2|Adverse Event|0|||
149082434|NCT01670877|537781880|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
149082435|NCT01670877|537781881|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
149082436|NCT01670877|537781882|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
149082437|NCT01670877|537781883|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
149082438|NCT01670877|537781884|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
149082439|NCT01670877|537781885|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
149082440|NCT01670877|537781880|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
149082441|NCT01670877|537781881|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
149082442|NCT01670877|537781882|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
149082443|NCT01670877|537781883|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
149082444|NCT01670877|537781884|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
149082445|NCT01670877|537781885|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
149082446|NCT01670877|537781880|FG000|Part I and Part 2|Grade 2 vomiting|0|||
149082447|NCT01670877|537781881|FG001|Part I and Part 2|Grade 2 vomiting|0|||
149082448|NCT01670877|537781882|FG002|Part I and Part 2|Grade 2 vomiting|0|||
149082449|NCT01670877|537781883|FG003|Part I and Part 2|Grade 2 vomiting|1|||
149082450|NCT01670877|537781884|FG004|Part I and Part 2|Grade 2 vomiting|0|||
149082451|NCT01670877|537781885|FG005|Part I and Part 2|Grade 2 vomiting|0|||
149082452|NCT01670877|537781880|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
149082453|NCT01670877|537781881|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
149082454|NCT01670877|537781882|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
149082455|NCT01670877|537781883|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
149082456|NCT01670877|537781884|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
149082457|NCT01670877|537781885|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
149082458|NCT01670877|537781880|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
149082459|NCT01670877|537781881|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
149082460|NCT01670877|537781882|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
149082461|NCT01670877|537781883|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
149082462|NCT01670877|537781884|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
149082463|NCT01670877|537781885|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
149082464|NCT02309892|537781886|FG000|Overall Study|Physician Decision|1|||
149082465|NCT02309892|537781887|FG001|Overall Study|Physician Decision|0|||
149082466|NCT02309892|537781888|FG002|Overall Study|Physician Decision|0|||
149082467|NCT02309892|537781889|FG003|Overall Study|Physician Decision|0|||
149082468|NCT02309892|537781890|FG004|Overall Study|Physician Decision|0|||
149082469|NCT02309892|537781891|FG005|Overall Study|Physician Decision|0|||
149082470|NCT02309892|537781892|FG006|Overall Study|Physician Decision|0|||
149082471|NCT02309892|537781886|FG000|Overall Study|Adverse Event|1|||
149082472|NCT02309892|537781887|FG001|Overall Study|Adverse Event|0|||
149082473|NCT02309892|537781888|FG002|Overall Study|Adverse Event|1|||
149082474|NCT02309892|537781889|FG003|Overall Study|Adverse Event|0|||
149082475|NCT02309892|537781890|FG004|Overall Study|Adverse Event|0|||
149082476|NCT02309892|537781891|FG005|Overall Study|Adverse Event|0|||
149082477|NCT02309892|537781892|FG006|Overall Study|Adverse Event|0|||
149082478|NCT02309892|537781886|FG000|Overall Study|Progressive Disease|0|||
149082479|NCT02309892|537781887|FG001|Overall Study|Progressive Disease|1|||
149082480|NCT02309892|537781888|FG002|Overall Study|Progressive Disease|0|||
149082481|NCT02309892|537781889|FG003|Overall Study|Progressive Disease|0|||
149082482|NCT02309892|537781890|FG004|Overall Study|Progressive Disease|1|||
149082483|NCT02309892|537781891|FG005|Overall Study|Progressive Disease|0|||
149082484|NCT02309892|537781892|FG006|Overall Study|Progressive Disease|0|||
149082485|NCT02309892|537781886|FG000|Overall Study|Death|0|||
149082486|NCT02309892|537781887|FG001|Overall Study|Death|0|||
149082487|NCT02309892|537781888|FG002|Overall Study|Death|0|||
149082488|NCT02309892|537781889|FG003|Overall Study|Death|0|||
149082489|NCT02309892|537781890|FG004|Overall Study|Death|0|||
149082490|NCT02309892|537781891|FG005|Overall Study|Death|1|||
149082491|NCT02309892|537781892|FG006|Overall Study|Death|0|||
149082492|NCT05376397|537781895|FG000|Overall Study|Lost to Follow-up|1|||
149082493|NCT01535261|537781898|FG000|Overall Study|Physician Decision|8|||
149082494|NCT01535261|537781898|FG000|Overall Study|Protocol Violation|3|||
149082495|NCT01535261|537781898|FG000|Overall Study|Death|5|||
149082496|NCT01535261|537781898|FG000|Overall Study|Lost to Follow-up|8|||
149082497|NCT01535261|537781898|FG000|Overall Study|Withdrawal by Subject|14|||
149082498|NCT01535261|537781898|FG000|Overall Study|Adverse Event|12|||
149082499|NCT01137682|537781899|FG000|Overall Study|Adverse Event-CORE|2|||
149082500|NCT01137682|537781900|FG001|Overall Study|Adverse Event-CORE|4|||
149082501|NCT01137682|537781901|FG002|Overall Study|Adverse Event-CORE|0|||
149082502|NCT01137682|537781899|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
149082503|NCT01137682|537781900|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
149082504|NCT01137682|537781901|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
149082505|NCT01137682|537781899|FG000|Overall Study|Administrative problems-CORE|2|||
149082506|NCT01137682|537781900|FG001|Overall Study|Administrative problems-CORE|1|||
149082507|NCT01137682|537781901|FG002|Overall Study|Administrative problems-CORE|0|||
149082508|NCT01137682|537781899|FG000|Overall Study|Protocol Violation-CORE|0|||
149082509|NCT01137682|537781900|FG001|Overall Study|Protocol Violation-CORE|1|||
149082510|NCT01137682|537781901|FG002|Overall Study|Protocol Violation-CORE|1|||
149082511|NCT01137682|537781899|FG000|Overall Study|Adverse Event-Extension|4|||
149082512|NCT01137682|537781900|FG001|Overall Study|Adverse Event-Extension|8|||
149082513|NCT01137682|537781901|FG002|Overall Study|Adverse Event-Extension|7|||
149082514|NCT01137682|537781899|FG000|Overall Study|Lack of Efficacy-Extension|15|||
149082515|NCT01137682|537781900|FG001|Overall Study|Lack of Efficacy-Extension|9|||
149082516|NCT01137682|537781901|FG002|Overall Study|Lack of Efficacy-Extension|13|||
149082517|NCT01137682|537781899|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
149082518|NCT01137682|537781900|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
149082519|NCT01137682|537781901|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
149082520|NCT01137682|537781899|FG000|Overall Study|Lost to Follow Up-Extension|0|||
149082521|NCT01137682|537781900|FG001|Overall Study|Lost to Follow Up-Extension|1|||
149082522|NCT01137682|537781901|FG002|Overall Study|Lost to Follow Up-Extension|0|||
149082523|NCT01137682|537781899|FG000|Overall Study|Administrative problems-Extension|0|||
149082524|NCT01137682|537781900|FG001|Overall Study|Administrative problems-Extension|2|||
149082525|NCT01137682|537781901|FG002|Overall Study|Administrative problems-Extension|0|||
149082526|NCT01137682|537781899|FG000|Overall Study|Death-Extension|2|||
149082527|NCT01137682|537781900|FG001|Overall Study|Death-Extension|0|||
149082528|NCT01137682|537781901|FG002|Overall Study|Death-Extension|0|||
149082529|NCT01137682|537781899|FG000|Overall Study|Protocol Violation-Extension|2|||
149082530|NCT01137682|537781900|FG001|Overall Study|Protocol Violation-Extension|1|||
149082531|NCT01137682|537781901|FG002|Overall Study|Protocol Violation-Extension|0|||
149082532|NCT01137682|537781899|FG000|Overall Study|Did not enter extension|2|||
149082533|NCT01137682|537781900|FG001|Overall Study|Did not enter extension|3|||
149082534|NCT01137682|537781901|FG002|Overall Study|Did not enter extension|2|||
149082535|NCT01137682|537781899|FG000|Overall Study|Did not receive treatment in extension|0|||
149082536|NCT01137682|537781900|FG001|Overall Study|Did not receive treatment in extension|0|||
149082537|NCT01137682|537781901|FG002|Overall Study|Did not receive treatment in extension|1|||
149082538|NCT02525744|537781902|FG000|Period 1|Physician Decision|0|||
149082539|NCT02525744|537781903|FG001|Period 1|Physician Decision|0|||
149082540|NCT02525744|537781904|FG002|Period 1|Physician Decision|1|||
149082541|NCT02525744|537781905|FG003|Period 1|Physician Decision|0|||
149082542|NCT02525744|537781902|FG000|Period 3|Adverse Event|0|||
149082543|NCT02525744|537781903|FG001|Period 3|Adverse Event|1|||
149082544|NCT02525744|537781904|FG002|Period 3|Adverse Event|0|||
149082545|NCT02525744|537781905|FG003|Period 3|Adverse Event|0|||
149082546|NCT02525744|537781902|FG000|Period 4|Withdrawal by Subject|1|||
149082547|NCT02525744|537781903|FG001|Period 4|Withdrawal by Subject|0|||
149082548|NCT02525744|537781904|FG002|Period 4|Withdrawal by Subject|0|||
149082549|NCT02525744|537781905|FG003|Period 4|Withdrawal by Subject|0|||
149082550|NCT02525744|537781902|FG000|Period 5|Physician Decision|1|||
149082551|NCT02525744|537781903|FG001|Period 5|Physician Decision|0|||
149082552|NCT02525744|537781904|FG002|Period 5|Physician Decision|0|||
149082553|NCT02525744|537781905|FG003|Period 5|Physician Decision|0|||
149082554|NCT02069379|537781906|FG000|Baseline Measurements|Lost to Follow-up|1|||
149082555|NCT02069379|537781907|FG001|Baseline Measurements|Lost to Follow-up|0|||
149082556|NCT02069379|537781908|FG002|Baseline Measurements|Lost to Follow-up|0|||
149082557|NCT02069379|537781909|FG003|Baseline Measurements|Lost to Follow-up|0|||
149082558|NCT02069379|537781906|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
149082559|NCT02069379|537781907|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
149082560|NCT02069379|537781908|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
149082561|NCT02069379|537781909|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
149082562|NCT02069379|537781906|FG000|First Treatment Arm|Lost to Follow-up|0|||
149082563|NCT02069379|537781907|FG001|First Treatment Arm|Lost to Follow-up|1|||
149082564|NCT02069379|537781908|FG002|First Treatment Arm|Lost to Follow-up|1|||
149082565|NCT02069379|537781909|FG003|First Treatment Arm|Lost to Follow-up|0|||
149082566|NCT02069379|537781906|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
149082567|NCT02069379|537781907|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
149082568|NCT02069379|537781908|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
149082569|NCT02069379|537781909|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
149082570|NCT02069379|537781906|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
149082571|NCT02069379|537781907|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
149082572|NCT02069379|537781908|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
149082573|NCT02069379|537781909|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
149082574|NCT02069379|537781906|FG000|Second Treatment Arm|Lost to Follow-up|0|||
149082575|NCT02069379|537781907|FG001|Second Treatment Arm|Lost to Follow-up|0|||
149082576|NCT02069379|537781908|FG002|Second Treatment Arm|Lost to Follow-up|1|||
149082577|NCT02069379|537781909|FG003|Second Treatment Arm|Lost to Follow-up|0|||
149082578|NCT04617847|537781910|FG000|Overall Study|Withdrawal by Subject|1|||
149082579|NCT04617847|537781911|FG001|Overall Study|Withdrawal by Subject|0|||
149082580|NCT04617847|537781910|FG000|Overall Study|Adverse Event|0|||
149082581|NCT04617847|537781911|FG001|Overall Study|Adverse Event|2|||
149082582|NCT04617847|537781910|FG000|Overall Study|Death|0|||
149082583|NCT04617847|537781911|FG001|Overall Study|Death|1|||
149082584|NCT04617847|537781910|FG000|Overall Study|Termination of Study by Sponsor|2|||
149082585|NCT04617847|537781911|FG001|Overall Study|Termination of Study by Sponsor|21|||
149082586|NCT02206607|537781912|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
149082587|NCT02206607|537781913|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
149082588|NCT02206607|537781914|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
149082589|NCT02206607|537781915|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
149082590|NCT02206607|537781916|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
149082591|NCT02206607|537781912|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
149082592|NCT02206607|537781913|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
149082593|NCT02206607|537781914|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
149082594|NCT02206607|537781915|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
149082595|NCT02206607|537781916|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
149082596|NCT04183491|537781921|FG000|Overall Study|Withdrawal by Subject|0|||
149082597|NCT04183491|537781922|FG001|Overall Study|Withdrawal by Subject|0|||
149082598|NCT04183491|537781923|FG002|Overall Study|Withdrawal by Subject|1|||
149082599|NCT04183491|537781924|FG003|Overall Study|Withdrawal by Subject|0|||
149082600|NCT04183491|537781925|FG004|Overall Study|Withdrawal by Subject|0|||
149082601|NCT04183491|537781926|FG005|Overall Study|Withdrawal by Subject|1|||
149082602|NCT04183491|537781927|FG006|Overall Study|Withdrawal by Subject|0|||
149082603|NCT03288506|537781931|FG000|Overall Study|Withdrawal by Subject|52|||
149082604|NCT03989232|537781932|FG000|Overall Study|Lost to Follow-up|3|||
149082605|NCT03989232|537781933|FG001|Overall Study|Lost to Follow-up|10|||
149082606|NCT03989232|537781932|FG000|Overall Study|Withdrawal by Subject|6|||
149082607|NCT03989232|537781933|FG001|Overall Study|Withdrawal by Subject|6|||
149082608|NCT03989232|537781932|FG000|Overall Study|Death|1|||
149082609|NCT03989232|537781933|FG001|Overall Study|Death|2|||
149082610|NCT01930188|537781934|FG000|Overall Study|unclassified|4|||
149082611|NCT01930188|537781935|FG001|Overall Study|unclassified|5|||
149082612|NCT01930188|537781936|FG002|Overall Study|unclassified|3|||
149082613|NCT01930188|537781934|FG000|Overall Study|Missing follow-up information|2|||
149082614|NCT01930188|537781935|FG001|Overall Study|Missing follow-up information|2|||
149082615|NCT01930188|537781936|FG002|Overall Study|Missing follow-up information|3|||
149082616|NCT01930188|537781934|FG000|Overall Study|Lost to Follow-up|5|||
149082617|NCT01930188|537781935|FG001|Overall Study|Lost to Follow-up|2|||
149082618|NCT01930188|537781936|FG002|Overall Study|Lost to Follow-up|2|||
149082619|NCT01930188|537781934|FG000|Overall Study|Death|2|||
149082620|NCT01930188|537781935|FG001|Overall Study|Death|1|||
149082621|NCT01930188|537781936|FG002|Overall Study|Death|3|||
149082622|NCT01930188|537781934|FG000|Overall Study|Withdrawal by Subject|9|||
149082623|NCT01930188|537781935|FG001|Overall Study|Withdrawal by Subject|11|||
149082624|NCT01930188|537781936|FG002|Overall Study|Withdrawal by Subject|8|||
149082625|NCT00337610|537781939|FG000|Overall Study|Adverse Event|2|||
149082626|NCT00337610|537781940|FG001|Overall Study|Adverse Event|2|||
149082627|NCT00337610|537781939|FG000|Overall Study|Death|0|||
149082628|NCT00337610|537781940|FG001|Overall Study|Death|1|||
149082629|NCT00337610|537781939|FG000|Overall Study|Lack of Efficacy|6|||
149082630|NCT00337610|537781940|FG001|Overall Study|Lack of Efficacy|3|||
149082631|NCT00337610|537781939|FG000|Overall Study|Lost to Follow-up|3|||
149082632|NCT00337610|537781940|FG001|Overall Study|Lost to Follow-up|3|||
149082633|NCT00337610|537781939|FG000|Overall Study|Withdrawal by Subject|6|||
149082634|NCT00337610|537781940|FG001|Overall Study|Withdrawal by Subject|5|||
149082635|NCT02203513|537781946|FG000|Overall Study|Refused further treatment|2|||
149082636|NCT02203513|537781947|FG001|Overall Study|Refused further treatment|0|||
149082637|NCT02203513|537781948|FG002|Overall Study|Refused further treatment|1|||
149082638|NCT02203513|537781949|FG003|Overall Study|Refused further treatment|0|||
149082639|NCT02203513|537781950|FG004|Overall Study|Refused further treatment|0|||
149082640|NCT02203513|537781946|FG000|Overall Study|Switched to alternative treatment|3|||
149082641|NCT02203513|537781947|FG001|Overall Study|Switched to alternative treatment|4|||
149082642|NCT02203513|537781948|FG002|Overall Study|Switched to alternative treatment|0|||
149082643|NCT02203513|537781949|FG003|Overall Study|Switched to alternative treatment|0|||
149082644|NCT02203513|537781950|FG004|Overall Study|Switched to alternative treatment|4|||
149082645|NCT02203513|537781946|FG000|Overall Study|Did not receive investigational product (IP)|0|||
149082646|NCT02203513|537781947|FG001|Overall Study|Did not receive investigational product (IP)|1|||
149082647|NCT02203513|537781948|FG002|Overall Study|Did not receive investigational product (IP)|0|||
149082648|NCT02203513|537781949|FG003|Overall Study|Did not receive investigational product (IP)|0|||
149082649|NCT02203513|537781950|FG004|Overall Study|Did not receive investigational product (IP)|0|||
149082650|NCT02203513|537781946|FG000|Overall Study|Death (unrelated to study therapy)|1|||
149082651|NCT02203513|537781947|FG001|Overall Study|Death (unrelated to study therapy)|3|||
149082652|NCT02203513|537781948|FG002|Overall Study|Death (unrelated to study therapy)|1|||
149082653|NCT02203513|537781949|FG003|Overall Study|Death (unrelated to study therapy)|0|||
149082654|NCT02203513|537781950|FG004|Overall Study|Death (unrelated to study therapy)|2|||
149082655|NCT02203513|537781946|FG000|Overall Study|Lost to Follow-up|0|||
149082656|NCT02203513|537781947|FG001|Overall Study|Lost to Follow-up|0|||
149082657|NCT02203513|537781948|FG002|Overall Study|Lost to Follow-up|1|||
149082658|NCT02203513|537781949|FG003|Overall Study|Lost to Follow-up|1|||
149082659|NCT02203513|537781950|FG004|Overall Study|Lost to Follow-up|0|||
149082660|NCT01441596|537781951|FG000|Overall Study|Other reason not defined below|0|||
149082661|NCT01441596|537781952|FG001|Overall Study|Other reason not defined below|2|||
149082662|NCT01441596|537781953|FG002|Overall Study|Other reason not defined below|1|||
149082663|NCT01441596|537781951|FG000|Overall Study|Withdrawal by Subject|4|||
149082664|NCT01441596|537781952|FG001|Overall Study|Withdrawal by Subject|0|||
149082665|NCT01441596|537781953|FG002|Overall Study|Withdrawal by Subject|2|||
149082666|NCT01441596|537781951|FG000|Overall Study|Not treated|0|||
149082667|NCT01441596|537781952|FG001|Overall Study|Not treated|1|||
149082668|NCT01441596|537781953|FG002|Overall Study|Not treated|1|||
149082669|NCT01528605|537781954|FG000|Overall Study|Lost to Follow-up|1|||
149082670|NCT01528605|537781955|FG001|Overall Study|Lost to Follow-up|0|||
149082671|NCT01528605|537781956|FG002|Overall Study|Lost to Follow-up|1|||
149082672|NCT01528605|537781957|FG003|Overall Study|Lost to Follow-up|1|||
149082673|NCT01528605|537781958|FG004|Overall Study|Lost to Follow-up|0|||
149082674|NCT01528605|537781959|FG005|Overall Study|Lost to Follow-up|0|||
149082675|NCT01528605|537781954|FG000|Overall Study|Death|1|||
149082676|NCT01528605|537781955|FG001|Overall Study|Death|0|||
149082677|NCT01528605|537781956|FG002|Overall Study|Death|0|||
149082678|NCT01528605|537781957|FG003|Overall Study|Death|0|||
149082679|NCT01528605|537781958|FG004|Overall Study|Death|0|||
149082680|NCT01528605|537781959|FG005|Overall Study|Death|0|||
149082681|NCT01681511|537781960|FG000|Overall Study|No Treatment Received|1|||
149082682|NCT01681511|537781961|FG001|Overall Study|No Treatment Received|3|||
149082683|NCT01681511|537781960|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
149082684|NCT01681511|537781961|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
149082685|NCT01681511|537781960|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
149082686|NCT01681511|537781961|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
149082687|NCT01681511|537781960|FG000|Overall Study|No Daily Urine Sample Collected|0|||
149082688|NCT01681511|537781961|FG001|Overall Study|No Daily Urine Sample Collected|1|||
149082689|NCT01681511|537781960|FG000|Overall Study|No post-catheter sample collected|11|||
149082690|NCT01681511|537781961|FG001|Overall Study|No post-catheter sample collected|4|||
149082691|NCT01156675|537781962|FG000|Overall Study|Death|5|||
149082692|NCT01156675|537781963|FG001|Overall Study|Death|3|||
149082693|NCT01156675|537781964|FG002|Overall Study|Death|0|||
149082694|NCT01156675|537781962|FG000|Overall Study|No data|29|||
149082695|NCT01156675|537781963|FG001|Overall Study|No data|22|||
149082696|NCT01156675|537781964|FG002|Overall Study|No data|2|||
149082697|NCT00090519|537781978|FG000|Overall Study|Adverse Event|5|||
149082698|NCT00090519|537781979|FG001|Overall Study|Adverse Event|4|||
149082699|NCT00090519|537781978|FG000|Overall Study|Death|9|||
149082700|NCT00090519|537781979|FG001|Overall Study|Death|9|||
149082701|NCT00090519|537781978|FG000|Overall Study|Lost to Follow-up|26|||
149082702|NCT00090519|537781979|FG001|Overall Study|Lost to Follow-up|29|||
149082703|NCT00090519|537781978|FG000|Overall Study|Withdrawal by Subject|28|||
149082704|NCT00090519|537781979|FG001|Overall Study|Withdrawal by Subject|29|||
149082705|NCT00090519|537781978|FG000|Overall Study|Physician Decision|2|||
149082706|NCT00090519|537781979|FG001|Overall Study|Physician Decision|3|||
149082707|NCT00090519|537781978|FG000|Overall Study|Sponsor Decision|3|||
149082708|NCT00090519|537781979|FG001|Overall Study|Sponsor Decision|1|||
149082709|NCT00116649|537781980|FG000|Overall Study|Adverse Event|20|||
149082710|NCT00116649|537781980|FG000|Overall Study|Lack of Efficacy|1|||
149082711|NCT00116649|537781980|FG000|Overall Study|Lost to Follow-up|32|||
149082712|NCT00116649|537781980|FG000|Overall Study|Withdrawal by Subject|68|||
149082713|NCT00116649|537781980|FG000|Overall Study|Local Skin Reaction|9|||
149082714|NCT00116649|537781980|FG000|Overall Study|Various Reasons|18|||
149082715|NCT00116649|537781980|FG000|Overall Study|Protocol Specified|7|||
149082716|NCT02161146|537781981|FG000|Overall Study|Adverse Event|1|||
149082717|NCT02161146|537781982|FG001|Overall Study|Adverse Event|1|||
149082718|NCT02161146|537781983|FG002|Overall Study|Adverse Event|0|||
149082719|NCT02161146|537781984|FG003|Overall Study|Adverse Event|1|||
149082720|NCT02161146|537781985|FG004|Overall Study|Adverse Event|0|||
149082721|NCT02161146|537781981|FG000|Overall Study|Lost to Follow-up|0|||
149082722|NCT02161146|537781982|FG001|Overall Study|Lost to Follow-up|1|||
149082723|NCT02161146|537781983|FG002|Overall Study|Lost to Follow-up|0|||
149082724|NCT02161146|537781984|FG003|Overall Study|Lost to Follow-up|0|||
149082725|NCT02161146|537781985|FG004|Overall Study|Lost to Follow-up|0|||
149082726|NCT02161146|537781981|FG000|Overall Study|Personal Reasons|0|||
149082727|NCT02161146|537781982|FG001|Overall Study|Personal Reasons|1|||
149082728|NCT02161146|537781983|FG002|Overall Study|Personal Reasons|0|||
149082729|NCT02161146|537781984|FG003|Overall Study|Personal Reasons|2|||
149082730|NCT02161146|537781985|FG004|Overall Study|Personal Reasons|1|||
149082731|NCT02161146|537781981|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149082732|NCT02161146|537781982|FG001|Overall Study|Other Miscellaneous Reasons|1|||
149082733|NCT02161146|537781983|FG002|Overall Study|Other Miscellaneous Reasons|0|||
149082734|NCT02161146|537781984|FG003|Overall Study|Other Miscellaneous Reasons|0|||
149082735|NCT02161146|537781985|FG004|Overall Study|Other Miscellaneous Reasons|0|||
149082736|NCT00845520|537781986|FG000|Overall Study|Death|1|||
149082737|NCT00845520|537781987|FG001|Overall Study|Death|2|||
149082738|NCT00845520|537781988|FG002|Overall Study|Death|0|||
149082739|NCT00845520|537781986|FG000|Overall Study|Lost to Follow-up|1|||
149082740|NCT00845520|537781987|FG001|Overall Study|Lost to Follow-up|0|||
149082741|NCT00845520|537781988|FG002|Overall Study|Lost to Follow-up|0|||
149082742|NCT00845520|537781986|FG000|Overall Study|Adverse Event|0|||
149082743|NCT00845520|537781987|FG001|Overall Study|Adverse Event|0|||
149082744|NCT00845520|537781988|FG002|Overall Study|Adverse Event|1|||
149082745|NCT02613403|537781989|FG000|Overall Study|Lost to Follow-up|0|||
149082746|NCT02613403|537781990|FG001|Overall Study|Lost to Follow-up|1|||
149082747|NCT02613403|537781991|FG002|Overall Study|Lost to Follow-up|0|||
149082748|NCT02613403|537781992|FG003|Overall Study|Lost to Follow-up|0|||
149082749|NCT02613403|537781993|FG004|Overall Study|Lost to Follow-up|0|||
149082750|NCT02613403|537781989|FG000|Overall Study|Withdrawal by Subject|2|||
149082751|NCT02613403|537781990|FG001|Overall Study|Withdrawal by Subject|0|||
149082752|NCT02613403|537781991|FG002|Overall Study|Withdrawal by Subject|0|||
149082753|NCT02613403|537781992|FG003|Overall Study|Withdrawal by Subject|0|||
149082754|NCT02613403|537781993|FG004|Overall Study|Withdrawal by Subject|0|||
149082755|NCT02699099|537781994|FG000|Overall Study|Adverse Event|1|||
149082756|NCT02699099|537781995|FG001|Overall Study|Adverse Event|0|||
149082757|NCT02699099|537781996|FG002|Overall Study|Adverse Event|2|||
149082758|NCT02699099|537781994|FG000|Overall Study|Lost to Follow-up|0|||
149082759|NCT02699099|537781995|FG001|Overall Study|Lost to Follow-up|1|||
149082760|NCT02699099|537781996|FG002|Overall Study|Lost to Follow-up|0|||
149082761|NCT02699099|537781994|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
149082762|NCT02699099|537781995|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
149082763|NCT02699099|537781996|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
149082764|NCT01240590|537781999|FG000|Phase I|Refused further treatment|0|||
149082765|NCT01240590|537782000|FG001|Phase I|Refused further treatment|0|||
149082766|NCT01240590|537782001|FG002|Phase I|Refused further treatment|3|||
149082767|NCT01240590|537782002|FG003|Phase I|Refused further treatment|0|||
149082768|NCT01240590|537782003|FG004|Phase I|Refused further treatment|0|||
149082769|NCT01240590|537781999|FG000|Phase II|Refused further treatment|0|||
149082770|NCT01240590|537782000|FG001|Phase II|Refused further treatment|0|||
149082771|NCT01240590|537782001|FG002|Phase II|Refused further treatment|0|||
149082772|NCT01240590|537782002|FG003|Phase II|Refused further treatment|2|||
149082773|NCT01240590|537782003|FG004|Phase II|Refused further treatment|1|||
149082774|NCT01529632|537782005|FG000|Overall Study|Administrative problem|2|||
149082775|NCT01529632|537782006|FG001|Overall Study|Administrative problem|1|||
149082776|NCT01529632|537782005|FG000|Overall Study|Protocol Violation|0|||
149082777|NCT01529632|537782006|FG001|Overall Study|Protocol Violation|1|||
149082778|NCT01529632|537782005|FG000|Overall Study|Adverse Event|1|||
149082779|NCT01529632|537782006|FG001|Overall Study|Adverse Event|1|||
149082780|NCT00452452|537782007|FG000|Overall Study|Protocol Violation|0|||
149082781|NCT00452452|537782008|FG001|Overall Study|Protocol Violation|0|||
149082782|NCT00452452|537782009|FG002|Overall Study|Protocol Violation|1|||
149082783|NCT00452452|537782007|FG000|Overall Study|Withdrawal by Subject|1|||
149082784|NCT00452452|537782008|FG001|Overall Study|Withdrawal by Subject|0|||
149082785|NCT00452452|537782009|FG002|Overall Study|Withdrawal by Subject|0|||
149082786|NCT00452452|537782007|FG000|Overall Study|Lost to Follow-up|1|||
149082787|NCT00452452|537782008|FG001|Overall Study|Lost to Follow-up|0|||
149082788|NCT00452452|537782009|FG002|Overall Study|Lost to Follow-up|0|||
149082789|NCT03659136|537782012|FG000|Overall Study|Not treated|2|||
149082790|NCT03659136|537782013|FG001|Overall Study|Not treated|0|||
149082791|NCT03659136|537782012|FG000|Overall Study|Covid-19 related|1|||
149006420|NCT04404478|537501908|FG000|Overall Study|Withdrawal by Subject|1|||
149006421|NCT04404478|537501909|FG001|Overall Study|Withdrawal by Subject|3|||
149006422|NCT01215357|537501910|FG000|Overall Study|Withdrawal by Subject|3|||
149006423|NCT01215357|537501910|FG000|Overall Study|Protocol Violation|9|||
149006424|NCT01859793|537501911|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
149006425|NCT01859793|537501912|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
149006426|NCT01859793|537501911|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
149006427|NCT01859793|537501912|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
149006428|NCT01859793|537501911|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
149006429|NCT01859793|537501912|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
149006430|NCT01859793|537501911|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
149006431|NCT01859793|537501912|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
149006432|NCT03056534|537501920|FG000|Overall Study|Participant withdrew consent|8|||
149006433|NCT03056534|537501920|FG000|Overall Study|Participant not able to return|6|||
149006434|NCT03056534|537501920|FG000|Overall Study|Lost to Follow-up|37|||
149006435|NCT03056534|537501920|FG000|Overall Study|Investigator judgment|1|||
149006436|NCT03056534|537501920|FG000|Overall Study|Death|4|||
149006437|NCT03056534|537501920|FG000|Overall Study|Adverse Event|1|||
149006438|NCT03056534|537501920|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
149006439|NCT02675465|537501923|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
149006440|NCT02675465|537501924|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
149006441|NCT02675465|537501925|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
149006442|NCT02675465|537501926|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
149006443|NCT02675465|537501927|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
149006444|NCT02675465|537501928|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
149006445|NCT02675465|537501923|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
149006446|NCT02675465|537501924|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
149006447|NCT02675465|537501925|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
149006448|NCT02675465|537501926|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
149006449|NCT02675465|537501927|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
149006450|NCT02675465|537501928|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
149006451|NCT02675465|537501923|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
149006452|NCT02675465|537501924|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
149006453|NCT02675465|537501925|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
149006454|NCT02675465|537501926|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
149006455|NCT02675465|537501927|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
149006456|NCT02675465|537501928|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
149006457|NCT02675465|537501923|FG000|Stage 4: Long Term Extension|Death|0|||
149006458|NCT02675465|537501924|FG001|Stage 4: Long Term Extension|Death|0|||
149006459|NCT02675465|537501925|FG002|Stage 4: Long Term Extension|Death|0|||
149006460|NCT02675465|537501926|FG003|Stage 4: Long Term Extension|Death|1|||
149006461|NCT02675465|537501927|FG004|Stage 4: Long Term Extension|Death|0|||
149006462|NCT02675465|537501928|FG005|Stage 4: Long Term Extension|Death|0|||
149006463|NCT00728962|537501931|FG000|Implant Placement Surgery|Adverse Event|8|||
149006464|NCT00728962|537501931|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
149006465|NCT00728962|537501931|FG000|Implant Placement Surgery|Protocol Violation|1|||
149006466|NCT00728962|537501931|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
149006467|NCT00728962|537501931|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
149006468|NCT04954586|537501932|FG000|Overall Study|Withdrawal by Subject|5|||
149006469|NCT00532155|537501933|FG000|Overall Study|Adverse Event|66|||
149006470|NCT00532155|537501934|FG001|Overall Study|Adverse Event|123|||
149006471|NCT00532155|537501933|FG000|Overall Study|Lack of Efficacy|332|||
149006472|NCT00532155|537501934|FG001|Overall Study|Lack of Efficacy|255|||
149006473|NCT00532155|537501933|FG000|Overall Study|Protocol Violation|1|||
149006474|NCT00532155|537501934|FG001|Overall Study|Protocol Violation|3|||
149006475|NCT00532155|537501933|FG000|Overall Study|Lost to Follow-up|2|||
149006476|NCT00532155|537501934|FG001|Overall Study|Lost to Follow-up|0|||
149006477|NCT00532155|537501933|FG000|Overall Study|Physician Decision|16|||
149006478|NCT00532155|537501934|FG001|Overall Study|Physician Decision|15|||
149006479|NCT00532155|537501933|FG000|Overall Study|Withdrawal by Subject|23|||
149006480|NCT00532155|537501934|FG001|Overall Study|Withdrawal by Subject|44|||
149006481|NCT00532155|537501933|FG000|Overall Study|Consent withdrawn|5|||
149006482|NCT00532155|537501934|FG001|Overall Study|Consent withdrawn|7|||
149006483|NCT00532155|537501933|FG000|Overall Study|Moved|1|||
149006484|NCT00532155|537501934|FG001|Overall Study|Moved|0|||
149006485|NCT00532155|537501933|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
149006486|NCT00532155|537501934|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
149006487|NCT00532155|537501933|FG000|Overall Study|Occurence of a second cancer|0|||
149006488|NCT00532155|537501934|FG001|Overall Study|Occurence of a second cancer|1|||
149006489|NCT00532155|537501933|FG000|Overall Study|Occurence of a secondary cancer|0|||
149006490|NCT00532155|537501934|FG001|Overall Study|Occurence of a secondary cancer|1|||
149082792|NCT03659136|537782013|FG001|Overall Study|Covid-19 related|1|||
149082793|NCT03659136|537782012|FG000|Overall Study|Withdrawal by Subject|1|||
149082794|NCT03659136|537782013|FG001|Overall Study|Withdrawal by Subject|6|||
149082795|NCT03659136|537782012|FG000|Overall Study|Adverse Event|4|||
149082796|NCT03659136|537782013|FG001|Overall Study|Adverse Event|6|||
149082797|NCT03659136|537782012|FG000|Overall Study|Progressive disease|37|||
149082798|NCT03659136|537782013|FG001|Overall Study|Progressive disease|31|||
149082799|NCT03659136|537782012|FG000|Overall Study|Study closure|2|||
149082800|NCT03659136|537782013|FG001|Overall Study|Study closure|2|||
149082801|NCT03659136|537782012|FG000|Overall Study|Sponsor decision/recommendation|3|||
149082802|NCT03659136|537782013|FG001|Overall Study|Sponsor decision/recommendation|2|||
149082803|NCT03659136|537782012|FG000|Overall Study|Switched to other drug/therapy|2|||
149082804|NCT03659136|537782013|FG001|Overall Study|Switched to other drug/therapy|2|||
149082805|NCT03659136|537782012|FG000|Overall Study|Lack of clinical benefit|0|||
149082806|NCT03659136|537782013|FG001|Overall Study|Lack of clinical benefit|1|||
149082807|NCT04620733|537783432|FG000|Overall Study|Adverse Event|4|||
149082808|NCT04620733|537783433|FG001|Overall Study|Adverse Event|3|||
149082809|NCT04620733|537783432|FG000|Overall Study|Withdrawal by Subject|2|||
149082810|NCT04620733|537783433|FG001|Overall Study|Withdrawal by Subject|5|||
149082811|NCT04620733|537783432|FG000|Overall Study|Lost to Follow-up|1|||
149082812|NCT04620733|537783433|FG001|Overall Study|Lost to Follow-up|1|||
149082813|NCT04620733|537783432|FG000|Overall Study|Protocol Deviation|1|||
149082814|NCT04620733|537783433|FG001|Overall Study|Protocol Deviation|1|||
149082815|NCT04620733|537783432|FG000|Overall Study|Reason Not Specified|0|||
149082816|NCT04620733|537783433|FG001|Overall Study|Reason Not Specified|1|||
149082817|NCT00451906|537783444|FG000|Overall Study|Adverse Event|515|||
149082818|NCT00451906|537783444|FG000|Overall Study|Lost to Follow-up|31|||
149082819|NCT00451906|537783444|FG000|Overall Study|Withdrawal by Subject|111|||
149082820|NCT00451906|537783444|FG000|Overall Study|Protocol Violation|21|||
149082821|NCT00451906|537783444|FG000|Overall Study|Progressive disease|1328|||
149082822|NCT00451906|537783444|FG000|Overall Study|Termination of the study|108|||
149082823|NCT00451906|537783444|FG000|Overall Study|Other Reasons|121|||
149082824|NCT00451906|537783444|FG000|Overall Study|Did not complete final visit|4|||
149082825|NCT02121808|537783446|FG000|Overall Study|Technical problem|3|||
149082826|NCT02164578|537783451|FG000|Treatment Period|Withdrawal by Subject|3|||
149082827|NCT02164578|537783452|FG001|Treatment Period|Withdrawal by Subject|3|||
149082828|NCT02164578|537783451|FG000|Treatment Period|Adverse Event|13|||
149082829|NCT02164578|537783452|FG001|Treatment Period|Adverse Event|6|||
149082830|NCT02164578|537783451|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
149082831|NCT02164578|537783452|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
149082832|NCT02164578|537783451|FG000|Treatment Period|Protocol Violation|0|||
149082833|NCT02164578|537783452|FG001|Treatment Period|Protocol Violation|2|||
149082834|NCT02164578|537783451|FG000|Extension Period|Withdrawal by Subject|2|||
149082835|NCT02164578|537783452|FG001|Extension Period|Withdrawal by Subject|0|||
149082836|NCT02164578|537783451|FG000|Extension Period|Adverse Event|4|||
149082837|NCT02164578|537783452|FG001|Extension Period|Adverse Event|0|||
149082838|NCT02164578|537783451|FG000|Extension Period|Expiry of study medication|1|||
149082839|NCT02164578|537783452|FG001|Extension Period|Expiry of study medication|0|||
149082840|NCT02164578|537783451|FG000|Extension Period|Protocol Violation|0|||
149082841|NCT02164578|537783452|FG001|Extension Period|Protocol Violation|1|||
149082842|NCT03924193|537783453|FG000|Overall Study|Adverse Event|10|||
149082843|NCT03924193|537783454|FG001|Overall Study|Adverse Event|0|||
149082844|NCT03924193|537783455|FG002|Overall Study|Adverse Event|10|||
149082845|NCT03924193|537783453|FG000|Overall Study|Withdrawal by Subject|5|||
149082846|NCT03924193|537783454|FG001|Overall Study|Withdrawal by Subject|10|||
149082847|NCT03924193|537783455|FG002|Overall Study|Withdrawal by Subject|2|||
149082848|NCT03029585|537783456|FG000|Overall Study|Death|1|||
149082849|NCT03029585|537783457|FG001|Overall Study|Death|1|||
149082850|NCT03029585|537783456|FG000|Overall Study|Withdrawal by Subject|1|||
149082851|NCT03029585|537783457|FG001|Overall Study|Withdrawal by Subject|0|||
149082852|NCT03340961|537783458|FG000|Overall Study|Adverse Event|1|||
149082853|NCT03340961|537783459|FG001|Overall Study|Adverse Event|3|||
149082854|NCT03340961|537783460|FG002|Overall Study|Adverse Event|2|||
149082855|NCT03340961|537783461|FG003|Overall Study|Adverse Event|4|||
149082856|NCT03340961|537783458|FG000|Overall Study|Lost to Follow-up|0|||
149082857|NCT03340961|537783459|FG001|Overall Study|Lost to Follow-up|1|||
149082858|NCT03340961|537783460|FG002|Overall Study|Lost to Follow-up|0|||
149082859|NCT03340961|537783461|FG003|Overall Study|Lost to Follow-up|1|||
149082860|NCT03340961|537783458|FG000|Overall Study|Withdrawal by Subject|3|||
149082861|NCT03340961|537783459|FG001|Overall Study|Withdrawal by Subject|2|||
149082862|NCT03340961|537783460|FG002|Overall Study|Withdrawal by Subject|4|||
149082863|NCT03340961|537783461|FG003|Overall Study|Withdrawal by Subject|7|||
149082864|NCT03340961|537783458|FG000|Overall Study|Use of prohibited treatment|0|||
149082865|NCT03340961|537783459|FG001|Overall Study|Use of prohibited treatment|3|||
149082866|NCT03340961|537783460|FG002|Overall Study|Use of prohibited treatment|2|||
149082867|NCT03340961|537783461|FG003|Overall Study|Use of prohibited treatment|4|||
149082868|NCT03340961|537783458|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
149082869|NCT03340961|537783459|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
149082870|NCT03340961|537783460|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
149082871|NCT03340961|537783461|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
149082872|NCT03340961|537783458|FG000|Overall Study|Subject developed an exclusion criterion|0|||
149082873|NCT03340961|537783459|FG001|Overall Study|Subject developed an exclusion criterion|1|||
149082874|NCT03340961|537783460|FG002|Overall Study|Subject developed an exclusion criterion|0|||
149082875|NCT03340961|537783461|FG003|Overall Study|Subject developed an exclusion criterion|0|||
149082876|NCT03340961|537783458|FG000|Overall Study|Protocol Violation|1|||
149082877|NCT03340961|537783459|FG001|Overall Study|Protocol Violation|0|||
149082878|NCT03340961|537783460|FG002|Overall Study|Protocol Violation|1|||
149082879|NCT03340961|537783461|FG003|Overall Study|Protocol Violation|0|||
149082880|NCT03340961|537783458|FG000|Overall Study|Adverse Event|1|||
149082881|NCT03340961|537783459|FG001|Overall Study|Adverse Event|1|||
149082882|NCT03340961|537783460|FG002|Overall Study|Adverse Event|0|||
149082883|NCT03340961|537783461|FG003|Overall Study|Adverse Event|0|||
149082884|NCT03340961|537783458|FG000|Overall Study|Lack of Efficacy|0|||
149082885|NCT03340961|537783459|FG001|Overall Study|Lack of Efficacy|0|||
149082886|NCT03340961|537783460|FG002|Overall Study|Lack of Efficacy|0|||
149082887|NCT03340961|537783461|FG003|Overall Study|Lack of Efficacy|1|||
149082888|NCT01215253|537783466|FG000|Overall Study|Withdrawal by Subject|57|||
149082889|NCT01215253|537783467|FG001|Overall Study|Withdrawal by Subject|35|||
149082890|NCT01215253|537783466|FG000|Overall Study|Physician Decision|9|||
149082891|NCT01215253|537783467|FG001|Overall Study|Physician Decision|12|||
149082892|NCT01215253|537783466|FG000|Overall Study|Lost to Follow-up|6|||
149082893|NCT01215253|537783467|FG001|Overall Study|Lost to Follow-up|4|||
149082894|NCT01215253|537783466|FG000|Overall Study|Other|14|||
149082895|NCT01215253|537783467|FG001|Overall Study|Other|12|||
149082896|NCT02137785|537783468|FG000|Overall Study|Lost to Follow-up|1|||
149082897|NCT02137785|537783469|FG001|Overall Study|Lost to Follow-up|0|||
149082898|NCT02137785|537783468|FG000|Overall Study|Withdrawal by Subject|1|||
149082899|NCT02137785|537783469|FG001|Overall Study|Withdrawal by Subject|4|||
149082900|NCT02137785|537783468|FG000|Overall Study|subject moved out of state|1|||
149082901|NCT02137785|537783469|FG001|Overall Study|subject moved out of state|0|||
149082902|NCT00417885|537783470|FG000|Overall Study|Adverse Event|1|||
149082903|NCT00417885|537783470|FG000|Overall Study|Objective Progression or Relapse|3|||
149082904|NCT00417885|537783470|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
149082905|NCT03146845|537783471|FG000|Overall Study|Reference ulcer healed|1|||
149082906|NCT03146845|537783472|FG001|Overall Study|Reference ulcer healed|0|||
149082907|NCT03146845|537783471|FG000|Overall Study|Physician Decision|1|||
149082908|NCT03146845|537783472|FG001|Overall Study|Physician Decision|0|||
149082909|NCT03146845|537783471|FG000|Overall Study|Adverse Event|1|||
149082910|NCT03146845|537783472|FG001|Overall Study|Adverse Event|0|||
149082911|NCT03146845|537783471|FG000|Overall Study|Withdrawal by Subject|2|||
149082912|NCT03146845|537783472|FG001|Overall Study|Withdrawal by Subject|0|||
149082913|NCT03146845|537783471|FG000|Overall Study|Noncompliance|0|||
149082914|NCT03146845|537783472|FG001|Overall Study|Noncompliance|1|||
149082915|NCT03146845|537783471|FG000|Overall Study|Protocol Violation|0|||
149082916|NCT03146845|537783472|FG001|Overall Study|Protocol Violation|2|||
149082917|NCT03146845|537783471|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
149082918|NCT03146845|537783472|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
149082919|NCT02721147|537783473|FG000|Overall Study|Lost to Follow-up|2|||
149082920|NCT02721147|537783474|FG001|Overall Study|Lost to Follow-up|0|||
149082921|NCT02721147|537783475|FG002|Overall Study|Lost to Follow-up|0|||
149082922|NCT01722097|537783478|FG000|Overall Study|Patient sheets not returned|6|||
149082923|NCT01722097|537783479|FG001|Overall Study|Patient sheets not returned|5|||
149082924|NCT02009332|537783483|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
149082925|NCT02009332|537783484|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
149082926|NCT02009332|537783485|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
149082927|NCT02009332|537783486|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
149082928|NCT02009332|537783487|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
149082929|NCT02009332|537783488|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
149082930|NCT02009332|537783483|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
149082931|NCT02009332|537783484|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
149082932|NCT02009332|537783485|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
149082933|NCT02009332|537783486|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
149082934|NCT02009332|537783487|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
149082935|NCT02009332|537783488|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
149082936|NCT02009332|537783483|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
149082937|NCT02009332|537783484|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
149082938|NCT02009332|537783485|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
149082939|NCT02009332|537783486|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
149082940|NCT02009332|537783487|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
149082941|NCT02009332|537783488|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
149082942|NCT01912599|537783489|FG000|Overall Study|Withdrawal by Subject|0|||
149082943|NCT01912599|537783490|FG001|Overall Study|Withdrawal by Subject|1|||
149082944|NCT01757288|537783493|FG000|Overall Study|Consent withdrawal|0|||
149082945|NCT01757288|537783494|FG001|Overall Study|Consent withdrawal|4|||
149082946|NCT01757288|537783495|FG002|Overall Study|Consent withdrawal|4|||
149082947|NCT01757288|537783493|FG000|Overall Study|Patient off study, IRB hold.|0|||
149082948|NCT01757288|537783494|FG001|Overall Study|Patient off study, IRB hold.|0|||
149082949|NCT01757288|537783495|FG002|Overall Study|Patient off study, IRB hold.|1|||
149082950|NCT01757288|537783493|FG000|Overall Study|Patient death prior to starting treatment|0|||
149082951|NCT01757288|537783494|FG001|Overall Study|Patient death prior to starting treatment|0|||
149082952|NCT01757288|537783495|FG002|Overall Study|Patient death prior to starting treatment|1|||
149082953|NCT01757288|537783493|FG000|Overall Study|Wrong medication administered|0|||
149082954|NCT01757288|537783494|FG001|Overall Study|Wrong medication administered|1|||
149082955|NCT01757288|537783495|FG002|Overall Study|Wrong medication administered|0|||
149082956|NCT01757288|537783493|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
149082957|NCT01757288|537783494|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
149082958|NCT01757288|537783495|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
149082959|NCT01757288|537783493|FG000|Overall Study|Not meeting protocol constraints|0|||
149082960|NCT01757288|537783494|FG001|Overall Study|Not meeting protocol constraints|1|||
149082961|NCT01757288|537783495|FG002|Overall Study|Not meeting protocol constraints|1|||
149082962|NCT01757288|537783493|FG000|Overall Study|Multiple missed appointments|0|||
149082963|NCT01757288|537783494|FG001|Overall Study|Multiple missed appointments|1|||
149082964|NCT01757288|537783495|FG002|Overall Study|Multiple missed appointments|0|||
149082965|NCT01757288|537783493|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
149082966|NCT01757288|537783494|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
149082967|NCT01757288|537783495|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
149082968|NCT01757288|537783493|FG000|Overall Study|>2 weeks treatment break|0|||
149082969|NCT01757288|537783494|FG001|Overall Study|>2 weeks treatment break|0|||
149082970|NCT01757288|537783495|FG002|Overall Study|>2 weeks treatment break|1|||
149082971|NCT02825550|537783496|FG000|Overall Study|Physician Decision|1|||
149082972|NCT00042939|537783500|FG000|Overall Study|Adverse Event|6|||
149082973|NCT00042939|537783501|FG001|Overall Study|Adverse Event|7|||
149082974|NCT00042939|537783500|FG000|Overall Study|Death|3|||
149082975|NCT00042939|537783501|FG001|Overall Study|Death|2|||
149082976|NCT00042939|537783500|FG000|Overall Study|Withdrawal by Subject|3|||
149082977|NCT00042939|537783501|FG001|Overall Study|Withdrawal by Subject|4|||
149082978|NCT00042939|537783500|FG000|Overall Study|Other disease|1|||
149082979|NCT00042939|537783501|FG001|Overall Study|Other disease|0|||
149082980|NCT00042939|537783500|FG000|Overall Study|Ineligible|2|||
149082981|NCT00042939|537783501|FG001|Overall Study|Ineligible|2|||
149082982|NCT00042939|537783500|FG000|Overall Study|Deterioration of health|3|||
149082983|NCT00042939|537783501|FG001|Overall Study|Deterioration of health|4|||
149082984|NCT00042939|537783500|FG000|Overall Study|QOL diminished|1|||
149082985|NCT00042939|537783501|FG001|Overall Study|QOL diminished|0|||
149082986|NCT00042939|537783500|FG000|Overall Study|Rising ca 19-9|1|||
149082987|NCT00042939|537783501|FG001|Overall Study|Rising ca 19-9|0|||
149082988|NCT00042939|537783500|FG000|Overall Study|Patient non-compliance|1|||
149082989|NCT00042939|537783501|FG001|Overall Study|Patient non-compliance|0|||
149082990|NCT00042939|537783500|FG000|Overall Study|Still on treatment|1|||
149082991|NCT00042939|537783501|FG001|Overall Study|Still on treatment|0|||
149082992|NCT00042939|537783500|FG000|Overall Study|Treatment break > 4 weeks|0|||
149082993|NCT00042939|537783501|FG001|Overall Study|Treatment break > 4 weeks|1|||
149082994|NCT00042939|537783500|FG000|Overall Study|Did not start treatment|2|||
149082995|NCT00042939|537783501|FG001|Overall Study|Did not start treatment|1|||
149082996|NCT00795639|537783502|FG000|Overall Study|Death|1|||
149082997|NCT00795639|537783503|FG001|Overall Study|Death|6|||
149082998|NCT00795639|537783502|FG000|Overall Study|Withdrawal by Subject|1|||
149082999|NCT00795639|537783503|FG001|Overall Study|Withdrawal by Subject|3|||
149083000|NCT00795639|537783502|FG000|Overall Study|Pregnancy|1|||
149083001|NCT00795639|537783503|FG001|Overall Study|Pregnancy|0|||
149083002|NCT00795639|537783502|FG000|Overall Study|Adverse Event|5|||
149083003|NCT00795639|537783503|FG001|Overall Study|Adverse Event|2|||
149083004|NCT00795639|537783502|FG000|Overall Study|Other|0|||
149083005|NCT00795639|537783503|FG001|Overall Study|Other|2|||
149083006|NCT00795639|537783502|FG000|Overall Study|Terminated by sponsor|13|||
149083007|NCT00795639|537783503|FG001|Overall Study|Terminated by sponsor|12|||
149083008|NCT00795639|537783502|FG000|Overall Study|Randomized and not treated|0|||
149083009|NCT00795639|537783503|FG001|Overall Study|Randomized and not treated|1|||
149083010|NCT03349476|537783504|FG000|Overall Study|Physician Decision|3|||
149083011|NCT00472082|537783509|FG000|Overall Study|Study prematurely terminated|5|||
149083012|NCT00248794|537783512|FG000|Overall Study|Lost to Follow-up|6|||
149083013|NCT00248794|537783513|FG001|Overall Study|Lost to Follow-up|8|||
149083014|NCT00248794|537783514|FG002|Overall Study|Lost to Follow-up|3|||
149083015|NCT03449979|537783515|FG000|Overall Study|Technical difficulty|0|||
149083016|NCT03449979|537783516|FG001|Overall Study|Technical difficulty|0|||
149083017|NCT03449979|537783517|FG002|Overall Study|Technical difficulty|0|||
149083018|NCT03449979|537783518|FG003|Overall Study|Technical difficulty|1|||
149083019|NCT04421456|537783521|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
149083020|NCT04421456|537783522|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
149083021|NCT04421456|537783523|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
149083022|NCT04421456|537783521|FG000|Randomized Treatment Period|Adverse Event|0|||
149083023|NCT04421456|537783522|FG001|Randomized Treatment Period|Adverse Event|1|||
149083024|NCT04421456|537783523|FG002|Randomized Treatment Period|Adverse Event|0|||
149083025|NCT04421456|537783521|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
149083026|NCT04421456|537783522|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
149083027|NCT04421456|537783523|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
149083028|NCT04421456|537783521|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
149083029|NCT04421456|537783522|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
149083030|NCT04421456|537783523|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
149083031|NCT04421456|537783521|FG000|Randomized Treatment Period|Participant non-compliance|1|||
149083032|NCT04421456|537783522|FG001|Randomized Treatment Period|Participant non-compliance|1|||
149083033|NCT04421456|537783523|FG002|Randomized Treatment Period|Participant non-compliance|2|||
149083034|NCT04421456|537783521|FG000|Randomized Treatment Period|Other|0|||
149083035|NCT04421456|537783522|FG001|Randomized Treatment Period|Other|1|||
149083036|NCT04421456|537783523|FG002|Randomized Treatment Period|Other|3|||
149083037|NCT01762345|537783524|FG000|Overall Study|Adverse Event|5|||
149083038|NCT01762345|537783524|FG000|Overall Study|Protocol Violation|2|||
149083039|NCT00700999|537783525|FG000|Overall Study|Lost to Follow-up|7|||
149083040|NCT00700999|537783526|FG001|Overall Study|Lost to Follow-up|7|||
149083041|NCT00700999|537783525|FG000|Overall Study|Excluded - did not meet study criteria|0|||
149083042|NCT00700999|537783526|FG001|Overall Study|Excluded - did not meet study criteria|1|||
149083043|NCT00700999|537783525|FG000|Overall Study|Withdrawal by Subject|8|||
149083044|NCT00700999|537783526|FG001|Overall Study|Withdrawal by Subject|1|||
149083045|NCT02379078|537783527|FG000|Overall Study|Lost to Follow-up|33|||
149083046|NCT02379078|537783528|FG001|Overall Study|Lost to Follow-up|30|||
149083047|NCT02379078|537783527|FG000|Overall Study|Withdrawal by Subject|6|||
149083048|NCT02379078|537783528|FG001|Overall Study|Withdrawal by Subject|5|||
149083049|NCT00244751|537783529|FG000|Overall Study|Adverse Event|7|||
149083050|NCT00244751|537783530|FG001|Overall Study|Adverse Event|7|||
149083051|NCT00244751|537783531|FG002|Overall Study|Adverse Event|5|||
149083052|NCT00244751|537783529|FG000|Overall Study|Lost to Follow-up|0|||
149083053|NCT00244751|537783530|FG001|Overall Study|Lost to Follow-up|1|||
149083054|NCT00244751|537783531|FG002|Overall Study|Lost to Follow-up|0|||
149083055|NCT00244751|537783529|FG000|Overall Study|Protocol Violation|1|||
149083056|NCT00244751|537783530|FG001|Overall Study|Protocol Violation|0|||
149083057|NCT00244751|537783531|FG002|Overall Study|Protocol Violation|1|||
149083058|NCT00244751|537783529|FG000|Overall Study|Withdrawal by Subject|7|||
149083059|NCT00244751|537783530|FG001|Overall Study|Withdrawal by Subject|5|||
149083060|NCT00244751|537783531|FG002|Overall Study|Withdrawal by Subject|3|||
149083061|NCT00244751|537783529|FG000|Overall Study|Elevated liver enzymes|1|||
149083062|NCT00244751|537783530|FG001|Overall Study|Elevated liver enzymes|0|||
149083063|NCT00244751|537783531|FG002|Overall Study|Elevated liver enzymes|0|||
149083064|NCT00244751|537783529|FG000|Overall Study|Lack of compliance with protocol|0|||
149083065|NCT00244751|537783530|FG001|Overall Study|Lack of compliance with protocol|1|||
149083066|NCT00244751|537783531|FG002|Overall Study|Lack of compliance with protocol|0|||
149083067|NCT00244751|537783529|FG000|Overall Study|Safety reasons|0|||
149083068|NCT00244751|537783530|FG001|Overall Study|Safety reasons|1|||
149083069|NCT00244751|537783531|FG002|Overall Study|Safety reasons|0|||
149083070|NCT00244751|537783529|FG000|Overall Study|Participant randomized by mistake|0|||
149083071|NCT00244751|537783530|FG001|Overall Study|Participant randomized by mistake|0|||
149083072|NCT00244751|537783531|FG002|Overall Study|Participant randomized by mistake|1|||
149083073|NCT00761267|537783532|FG000|Overall Study|Death|1|||
149083074|NCT00761267|537783533|FG001|Overall Study|Death|2|||
149083075|NCT00761267|537783534|FG002|Overall Study|Death|5|||
149083076|NCT00761267|537783532|FG000|Overall Study|Lost to Follow-up|0|||
149083077|NCT00761267|537783533|FG001|Overall Study|Lost to Follow-up|0|||
149083078|NCT00761267|537783534|FG002|Overall Study|Lost to Follow-up|1|||
149083079|NCT00761267|537783532|FG000|Overall Study|Randomized but not treated|1|||
149083080|NCT00761267|537783533|FG001|Overall Study|Randomized but not treated|1|||
149083081|NCT00761267|537783534|FG002|Overall Study|Randomized but not treated|0|||
149083082|NCT00761267|537783532|FG000|Overall Study|Withdrawal by Subject|0|||
149083083|NCT00761267|537783533|FG001|Overall Study|Withdrawal by Subject|1|||
149083084|NCT00761267|537783534|FG002|Overall Study|Withdrawal by Subject|0|||
149083085|NCT01777932|537783538|FG000|Overall Study|Disease progression|136|||
149083086|NCT01777932|537783538|FG000|Overall Study|Death|3|||
149083087|NCT01777932|537783538|FG000|Overall Study|Adverse Event|34|||
149083088|NCT01777932|537783538|FG000|Overall Study|Lost to Follow-up|3|||
149083089|NCT01777932|537783538|FG000|Overall Study|Investigator decision|10|||
149083090|NCT01777932|537783538|FG000|Overall Study|Reimbursement limit|9|||
149083091|NCT01777932|537783538|FG000|Overall Study|Patient refused further treatment|10|||
149083092|NCT00068107|537783541|FG000|Overall Study|end-stage renal disease|6|||
149083093|NCT00068107|537783541|FG000|Overall Study|Death|2|||
149083094|NCT00068107|537783541|FG000|Overall Study|Withdrawal by Subject|1|||
149083095|NCT01419184|537783542|FG000|Overall Study|Site data not available|3|||
149083096|NCT01419184|537783543|FG001|Overall Study|Site data not available|2|||
149083097|NCT01419184|537783542|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
149083098|NCT01419184|537783543|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
149083099|NCT01419184|537783542|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
149083100|NCT01419184|537783543|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
149083101|NCT01419184|537783542|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
149083102|NCT01419184|537783543|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
149083103|NCT01419184|537783542|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
149083104|NCT01419184|537783543|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
149083105|NCT01419184|537783542|FG000|Overall Study|Participant randomized, not treated|1|||
149083106|NCT01419184|537783543|FG001|Overall Study|Participant randomized, not treated|0|||
149083107|NCT02644122|537783551|FG000|Overall Study|Withdrawal by Subject|1|||
149083108|NCT03031782|537783554|FG000|Treatment Period 1|Lack of Efficacy|3|||
149083109|NCT03031782|537783555|FG001|Treatment Period 1|Lack of Efficacy|0|||
149083110|NCT03031782|537783556|FG002|Treatment Period 1|Lack of Efficacy|0|||
149083111|NCT03031782|537783557|FG003|Treatment Period 1|Lack of Efficacy|0|||
149083112|NCT03031782|537783558|FG004|Treatment Period 1|Lack of Efficacy|0|||
149083113|NCT03031782|537783554|FG000|Treatment Period 2|Physician Decision|0|||
149083114|NCT03031782|537783555|FG001|Treatment Period 2|Physician Decision|1|||
149083115|NCT03031782|537783556|FG002|Treatment Period 2|Physician Decision|0|||
149083116|NCT03031782|537783557|FG003|Treatment Period 2|Physician Decision|0|||
149083117|NCT03031782|537783558|FG004|Treatment Period 2|Physician Decision|3|||
149083118|NCT03031782|537783554|FG000|Treatment Period 2|Lack of Efficacy|0|||
149083119|NCT03031782|537783555|FG001|Treatment Period 2|Lack of Efficacy|1|||
149083120|NCT03031782|537783556|FG002|Treatment Period 2|Lack of Efficacy|0|||
149083121|NCT03031782|537783557|FG003|Treatment Period 2|Lack of Efficacy|0|||
149083122|NCT03031782|537783558|FG004|Treatment Period 2|Lack of Efficacy|1|||
149083123|NCT03031782|537783554|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149083124|NCT03031782|537783555|FG001|Treatment Period 2|Withdrawal by Subject|3|||
149083125|NCT03031782|537783556|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149083126|NCT03031782|537783557|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149083127|NCT03031782|537783558|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149083128|NCT03031782|537783554|FG000|Treatment Period 2|Adverse Event|0|||
149083129|NCT03031782|537783555|FG001|Treatment Period 2|Adverse Event|1|||
149083130|NCT03031782|537783556|FG002|Treatment Period 2|Adverse Event|2|||
149083131|NCT03031782|537783557|FG003|Treatment Period 2|Adverse Event|0|||
149083132|NCT03031782|537783558|FG004|Treatment Period 2|Adverse Event|0|||
149083133|NCT03031782|537783554|FG000|Treatment Period 3|Withdrawal by Subject|0|||
149083134|NCT03031782|537783555|FG001|Treatment Period 3|Withdrawal by Subject|0|||
149083135|NCT03031782|537783556|FG002|Treatment Period 3|Withdrawal by Subject|0|||
149083136|NCT03031782|537783557|FG003|Treatment Period 3|Withdrawal by Subject|1|||
149083137|NCT03031782|537783558|FG004|Treatment Period 3|Withdrawal by Subject|0|||
149083138|NCT03122860|537783559|FG000|Overall Study|Discontinued Before Treatment|1|||
149083139|NCT03122860|537783560|FG001|Overall Study|Discontinued Before Treatment|1|||
149083140|NCT03122860|537783561|FG002|Overall Study|Discontinued Before Treatment|2|||
149083141|NCT03122860|537783562|FG003|Overall Study|Discontinued Before Treatment|0|||
149083142|NCT03122860|537783563|FG004|Overall Study|Discontinued Before Treatment|1|||
149083143|NCT03122860|537783564|FG005|Overall Study|Discontinued Before Treatment|0|||
149083144|NCT03122860|537783559|FG000|Overall Study|Adverse Event|1|||
149083145|NCT03122860|537783560|FG001|Overall Study|Adverse Event|0|||
149083146|NCT03122860|537783561|FG002|Overall Study|Adverse Event|1|||
149083147|NCT03122860|537783562|FG003|Overall Study|Adverse Event|1|||
149083148|NCT03122860|537783563|FG004|Overall Study|Adverse Event|0|||
149083149|NCT03122860|537783564|FG005|Overall Study|Adverse Event|0|||
149083150|NCT03122860|537783559|FG000|Overall Study|Lost to Follow-up|5|||
149083151|NCT03122860|537783560|FG001|Overall Study|Lost to Follow-up|2|||
149083152|NCT03122860|537783561|FG002|Overall Study|Lost to Follow-up|3|||
149083153|NCT03122860|537783562|FG003|Overall Study|Lost to Follow-up|3|||
149083154|NCT03122860|537783563|FG004|Overall Study|Lost to Follow-up|5|||
149083155|NCT03122860|537783564|FG005|Overall Study|Lost to Follow-up|4|||
149083156|NCT03122860|537783559|FG000|Overall Study|Subject Non-Compliance|0|||
149083157|NCT03122860|537783560|FG001|Overall Study|Subject Non-Compliance|0|||
149083158|NCT03122860|537783561|FG002|Overall Study|Subject Non-Compliance|1|||
149083159|NCT03122860|537783562|FG003|Overall Study|Subject Non-Compliance|0|||
149083160|NCT03122860|537783563|FG004|Overall Study|Subject Non-Compliance|0|||
149083161|NCT03122860|537783564|FG005|Overall Study|Subject Non-Compliance|0|||
149083162|NCT03122860|537783559|FG000|Overall Study|Withdrawal by Subject|3|||
149083163|NCT03122860|537783560|FG001|Overall Study|Withdrawal by Subject|2|||
149083164|NCT03122860|537783561|FG002|Overall Study|Withdrawal by Subject|5|||
149083165|NCT03122860|537783562|FG003|Overall Study|Withdrawal by Subject|7|||
149083166|NCT03122860|537783563|FG004|Overall Study|Withdrawal by Subject|9|||
149083167|NCT03122860|537783564|FG005|Overall Study|Withdrawal by Subject|8|||
149083168|NCT01138657|537783565|FG000|Overall Study|Adverse Event|3|||
149083169|NCT01138657|537783566|FG001|Overall Study|Adverse Event|10|||
149083170|NCT01138657|537783565|FG000|Overall Study|Lack of Efficacy|2|||
149083171|NCT01138657|537783566|FG001|Overall Study|Lack of Efficacy|1|||
149083172|NCT01138657|537783565|FG000|Overall Study|Lost to Follow-up|0|||
149083173|NCT01138657|537783566|FG001|Overall Study|Lost to Follow-up|3|||
149083174|NCT01138657|537783565|FG000|Overall Study|Miscellaneous Reasons|3|||
149083175|NCT01138657|537783566|FG001|Overall Study|Miscellaneous Reasons|4|||
149083176|NCT00805441|537783573|FG000|Overall Study|Adverse Event|5|||
149083177|NCT00805441|537783574|FG001|Overall Study|Adverse Event|2|||
149083178|NCT00805441|537783573|FG000|Overall Study|Lack of Efficacy|0|||
149083179|NCT00805441|537783574|FG001|Overall Study|Lack of Efficacy|2|||
149083180|NCT00805441|537783573|FG000|Overall Study|Protocol Violation|4|||
149083181|NCT00805441|537783574|FG001|Overall Study|Protocol Violation|8|||
149083182|NCT00805441|537783573|FG000|Overall Study|Lost to Follow-up|10|||
149083183|NCT00805441|537783574|FG001|Overall Study|Lost to Follow-up|13|||
149083184|NCT00805441|537783573|FG000|Overall Study|Withdrawal by Subject|15|||
149083185|NCT00805441|537783574|FG001|Overall Study|Withdrawal by Subject|9|||
149083186|NCT00805441|537783573|FG000|Overall Study|Physician Decision|0|||
149083187|NCT00805441|537783574|FG001|Overall Study|Physician Decision|1|||
149083188|NCT00805441|537783573|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
149083189|NCT00805441|537783574|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
149083190|NCT02935894|537783576|FG000|Overall Study|Subject dismissed|1|||
149083191|NCT01079949|537783579|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
149083192|NCT01079949|537783580|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
149083193|NCT01079949|537783579|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
149083194|NCT01079949|537783580|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
149083195|NCT01079949|537783579|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
149083196|NCT01079949|537783580|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
149083197|NCT01079949|537783579|FG000|Overall Study|Randomized but not treated|1|||
149083198|NCT01079949|537783580|FG001|Overall Study|Randomized but not treated|0|||
149083199|NCT03976102|537785319|FG000|Overall Study|Withdrawal by Subject|4|||
149083200|NCT03976102|537785320|FG001|Overall Study|Withdrawal by Subject|4|||
149083201|NCT03976102|537785319|FG000|Overall Study|Adverse Event|2|||
149083202|NCT03976102|537785320|FG001|Overall Study|Adverse Event|4|||
149083203|NCT03976102|537785319|FG000|Overall Study|Not related to Covid-19|9|||
149083204|NCT03976102|537785320|FG001|Overall Study|Not related to Covid-19|13|||
149083205|NCT03976102|537785319|FG000|Overall Study|Lost to Follow-up|0|||
149083206|NCT03976102|537785320|FG001|Overall Study|Lost to Follow-up|2|||
149083207|NCT03976102|537785319|FG000|Overall Study|Death|3|||
149083208|NCT03976102|537785320|FG001|Overall Study|Death|2|||
149083209|NCT03976102|537785319|FG000|Overall Study|Physician Decision|1|||
149083210|NCT03976102|537785320|FG001|Overall Study|Physician Decision|1|||
149083211|NCT05066230|537785323|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
149083212|NCT05066230|537785324|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
149083213|NCT05066230|537785323|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
149083214|NCT05066230|537785324|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
149083215|NCT05066230|537785323|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
149083216|NCT05066230|537785324|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
149083217|NCT05066230|537785323|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
149083218|NCT05066230|537785324|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
149083219|NCT05066230|537785323|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
149083220|NCT05066230|537785324|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
149083221|NCT05066230|537785323|FG000|After Week 48|Adverse Event|1|||
149083222|NCT05066230|537785324|FG001|After Week 48|Adverse Event|0|||
149083223|NCT05066230|537785323|FG000|After Week 48|Non-compliance with study schedule|1|||
149083224|NCT05066230|537785324|FG001|After Week 48|Non-compliance with study schedule|0|||
149083225|NCT05066230|537785323|FG000|After Week 48|Withdrawal by Subject|0|||
149083226|NCT05066230|537785324|FG001|After Week 48|Withdrawal by Subject|1|||
149083227|NCT05066230|537785323|FG000|After Week 48|Lost to Follow-up|3|||
149083228|NCT05066230|537785324|FG001|After Week 48|Lost to Follow-up|3|||
149083229|NCT05066230|537785323|FG000|After Week 48|Sponsor Request|115|||
149083230|NCT05066230|537785324|FG001|After Week 48|Sponsor Request|111|||
149083231|NCT03072238|537785325|FG000|Overall Study|Withdrawal by Subject|44|||
149083232|NCT03072238|537785326|FG001|Overall Study|Withdrawal by Subject|64|||
149083233|NCT03072238|537785325|FG000|Overall Study|Lost to Follow-up|14|||
149083234|NCT03072238|537785326|FG001|Overall Study|Lost to Follow-up|5|||
149083235|NCT03072238|537785325|FG000|Overall Study|Physician Decision|4|||
149083236|NCT03072238|537785326|FG001|Overall Study|Physician Decision|6|||
149083237|NCT03072238|537785325|FG000|Overall Study|Death|351|||
149083238|NCT03072238|537785326|FG001|Overall Study|Death|318|||
149083239|NCT03072238|537785325|FG000|Overall Study|Progressive Disease|3|||
149083240|NCT03072238|537785326|FG001|Overall Study|Progressive Disease|4|||
149083241|NCT03072238|537785325|FG000|Overall Study|Reason Not Specified|138|||
149083242|NCT03072238|537785326|FG001|Overall Study|Reason Not Specified|150|||
149083243|NCT01562275|537785332|FG000|Stage 1|Adverse Event|0|||
149083244|NCT01562275|537785333|FG001|Stage 1|Adverse Event|0|||
149083245|NCT01562275|537785334|FG002|Stage 1|Adverse Event|0|||
149083246|NCT01562275|537785335|FG003|Stage 1|Adverse Event|1|||
149083247|NCT01562275|537785336|FG004|Stage 1|Adverse Event|1|||
149083248|NCT01562275|537785337|FG005|Stage 1|Adverse Event|0|||
149083249|NCT01562275|537785338|FG006|Stage 1|Adverse Event|0|||
149083250|NCT01562275|537785339|FG007|Stage 1|Adverse Event|0|||
149083251|NCT01562275|537785340|FG008|Stage 1|Adverse Event|0|||
149083252|NCT01562275|537785341|FG009|Stage 1|Adverse Event|1|||
149083253|NCT01562275|537785342|FG010|Stage 1|Adverse Event|0|||
149083254|NCT01562275|537785343|FG011|Stage 1|Adverse Event|0|||
149083255|NCT01562275|537785344|FG012|Stage 1|Adverse Event|0|||
149083256|NCT01562275|537785332|FG000|Stage 1|Death|1|||
149083257|NCT01562275|537785333|FG001|Stage 1|Death|0|||
149083258|NCT01562275|537785334|FG002|Stage 1|Death|0|||
149083259|NCT01562275|537785335|FG003|Stage 1|Death|0|||
149083260|NCT01562275|537785336|FG004|Stage 1|Death|0|||
149083261|NCT01562275|537785337|FG005|Stage 1|Death|0|||
149083262|NCT01562275|537785338|FG006|Stage 1|Death|0|||
149083263|NCT01562275|537785339|FG007|Stage 1|Death|0|||
149083264|NCT01562275|537785340|FG008|Stage 1|Death|0|||
149083265|NCT01562275|537785341|FG009|Stage 1|Death|0|||
149083266|NCT01562275|537785342|FG010|Stage 1|Death|0|||
149083267|NCT01562275|537785343|FG011|Stage 1|Death|0|||
149083268|NCT01562275|537785344|FG012|Stage 1|Death|0|||
149083269|NCT01562275|537785332|FG000|Stage 1|Non Compliance|0|||
149083270|NCT01562275|537785333|FG001|Stage 1|Non Compliance|0|||
149083271|NCT01562275|537785334|FG002|Stage 1|Non Compliance|1|||
149083272|NCT01562275|537785335|FG003|Stage 1|Non Compliance|0|||
149083273|NCT01562275|537785336|FG004|Stage 1|Non Compliance|0|||
149083274|NCT01562275|537785337|FG005|Stage 1|Non Compliance|0|||
149083275|NCT01562275|537785338|FG006|Stage 1|Non Compliance|0|||
149083276|NCT01562275|537785339|FG007|Stage 1|Non Compliance|0|||
149083277|NCT01562275|537785340|FG008|Stage 1|Non Compliance|0|||
149083278|NCT01562275|537785341|FG009|Stage 1|Non Compliance|0|||
149083279|NCT01562275|537785342|FG010|Stage 1|Non Compliance|0|||
149083280|NCT01562275|537785343|FG011|Stage 1|Non Compliance|0|||
149083281|NCT01562275|537785344|FG012|Stage 1|Non Compliance|0|||
149083282|NCT01562275|537785332|FG000|Stage 1|Physician Decision|0|||
149083283|NCT01562275|537785333|FG001|Stage 1|Physician Decision|0|||
149083284|NCT01562275|537785334|FG002|Stage 1|Physician Decision|0|||
149083285|NCT01562275|537785335|FG003|Stage 1|Physician Decision|0|||
149083286|NCT01562275|537785336|FG004|Stage 1|Physician Decision|1|||
149083287|NCT01562275|537785337|FG005|Stage 1|Physician Decision|0|||
149083288|NCT01562275|537785338|FG006|Stage 1|Physician Decision|1|||
149083289|NCT01562275|537785339|FG007|Stage 1|Physician Decision|0|||
149083290|NCT01562275|537785340|FG008|Stage 1|Physician Decision|1|||
149083291|NCT01562275|537785341|FG009|Stage 1|Physician Decision|0|||
149083292|NCT01562275|537785342|FG010|Stage 1|Physician Decision|0|||
149083293|NCT01562275|537785343|FG011|Stage 1|Physician Decision|0|||
149083294|NCT01562275|537785344|FG012|Stage 1|Physician Decision|0|||
149083295|NCT01562275|537785332|FG000|Stage 1|Progression of Disease|2|||
149083296|NCT01562275|537785333|FG001|Stage 1|Progression of Disease|6|||
149083297|NCT01562275|537785334|FG002|Stage 1|Progression of Disease|2|||
149083298|NCT01562275|537785335|FG003|Stage 1|Progression of Disease|1|||
149083299|NCT01562275|537785336|FG004|Stage 1|Progression of Disease|2|||
149083300|NCT01562275|537785337|FG005|Stage 1|Progression of Disease|4|||
149083301|NCT01562275|537785338|FG006|Stage 1|Progression of Disease|1|||
149083302|NCT01562275|537785339|FG007|Stage 1|Progression of Disease|7|||
149083303|NCT01562275|537785340|FG008|Stage 1|Progression of Disease|2|||
149083304|NCT01562275|537785341|FG009|Stage 1|Progression of Disease|5|||
149083305|NCT01562275|537785342|FG010|Stage 1|Progression of Disease|3|||
149083306|NCT01562275|537785343|FG011|Stage 1|Progression of Disease|0|||
149083307|NCT01562275|537785344|FG012|Stage 1|Progression of Disease|0|||
149083308|NCT01562275|537785332|FG000|Stage 1|Withdrawal by Subject|0|||
149083309|NCT01562275|537785333|FG001|Stage 1|Withdrawal by Subject|1|||
149083310|NCT01562275|537785334|FG002|Stage 1|Withdrawal by Subject|0|||
149083311|NCT01562275|537785335|FG003|Stage 1|Withdrawal by Subject|2|||
149083312|NCT01562275|537785336|FG004|Stage 1|Withdrawal by Subject|0|||
149083313|NCT01562275|537785337|FG005|Stage 1|Withdrawal by Subject|0|||
149083314|NCT01562275|537785338|FG006|Stage 1|Withdrawal by Subject|1|||
149083315|NCT01562275|537785339|FG007|Stage 1|Withdrawal by Subject|0|||
149083316|NCT01562275|537785340|FG008|Stage 1|Withdrawal by Subject|0|||
149083317|NCT01562275|537785341|FG009|Stage 1|Withdrawal by Subject|1|||
149083318|NCT01562275|537785342|FG010|Stage 1|Withdrawal by Subject|0|||
149083319|NCT01562275|537785343|FG011|Stage 1|Withdrawal by Subject|0|||
149083320|NCT01562275|537785344|FG012|Stage 1|Withdrawal by Subject|0|||
149083321|NCT01562275|537785332|FG000|Stage 2|Death|0|||
149083322|NCT01562275|537785333|FG001|Stage 2|Death|0|||
149083323|NCT01562275|537785334|FG002|Stage 2|Death|0|||
149083324|NCT01562275|537785335|FG003|Stage 2|Death|0|||
149083325|NCT01562275|537785336|FG004|Stage 2|Death|0|||
149083326|NCT01562275|537785337|FG005|Stage 2|Death|0|||
149083327|NCT01562275|537785338|FG006|Stage 2|Death|0|||
149083328|NCT01562275|537785339|FG007|Stage 2|Death|0|||
149083329|NCT01562275|537785340|FG008|Stage 2|Death|0|||
149083330|NCT01562275|537785341|FG009|Stage 2|Death|0|||
149083331|NCT01562275|537785342|FG010|Stage 2|Death|0|||
149083332|NCT01562275|537785343|FG011|Stage 2|Death|2|||
149083333|NCT01562275|537785344|FG012|Stage 2|Death|1|||
149083334|NCT01562275|537785332|FG000|Stage 2|Progression of Disease|0|||
149083335|NCT01562275|537785333|FG001|Stage 2|Progression of Disease|0|||
149083336|NCT01562275|537785334|FG002|Stage 2|Progression of Disease|0|||
149083337|NCT01562275|537785335|FG003|Stage 2|Progression of Disease|0|||
149083338|NCT01562275|537785336|FG004|Stage 2|Progression of Disease|0|||
149083339|NCT01562275|537785337|FG005|Stage 2|Progression of Disease|0|||
149083340|NCT01562275|537785338|FG006|Stage 2|Progression of Disease|0|||
149083341|NCT01562275|537785339|FG007|Stage 2|Progression of Disease|0|||
149083342|NCT01562275|537785340|FG008|Stage 2|Progression of Disease|0|||
149083343|NCT01562275|537785341|FG009|Stage 2|Progression of Disease|0|||
149083344|NCT01562275|537785342|FG010|Stage 2|Progression of Disease|0|||
149083345|NCT01562275|537785343|FG011|Stage 2|Progression of Disease|12|||
149083346|NCT01562275|537785344|FG012|Stage 2|Progression of Disease|4|||
149083347|NCT01863368|537785345|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
149083348|NCT01863368|537785346|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
149083349|NCT01863368|537785345|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
149083350|NCT01863368|537785346|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
149083351|NCT01863368|537785345|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
149083352|NCT01863368|537785346|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
149083353|NCT01863368|537785345|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
149083354|NCT01863368|537785346|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
149083355|NCT01863368|537785345|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
149083356|NCT01863368|537785346|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
149083357|NCT01863368|537785345|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
149083358|NCT01863368|537785346|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
149083359|NCT00647699|537785347|FG000|Overall Study|Lost to Follow-up|5|||
149083360|NCT00647699|537785348|FG001|Overall Study|Lost to Follow-up|4|||
149083361|NCT00647699|537785347|FG000|Overall Study|Withdrawal by Subject|3|||
149083362|NCT00647699|537785348|FG001|Overall Study|Withdrawal by Subject|8|||
149083363|NCT00515112|537785350|FG000|Overall Study|Death|0|||
149083364|NCT00515112|537785351|FG001|Overall Study|Death|1|||
149083365|NCT00515112|537785350|FG000|Overall Study|The study was terminated|3|||
149083366|NCT00515112|537785351|FG001|Overall Study|The study was terminated|2|||
149083367|NCT04425252|537785354|FG000|Overall Study|Withdrawal by Subject|2|||
149083368|NCT04425252|537785355|FG001|Overall Study|Withdrawal by Subject|1|||
149083369|NCT04425252|537785354|FG000|Overall Study|Lost to Follow-up|1|||
149083370|NCT04425252|537785355|FG001|Overall Study|Lost to Follow-up|0|||
149083371|NCT04425252|537785354|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
149083372|NCT04425252|537785355|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
149083373|NCT00307489|537785356|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
149083374|NCT00307489|537785357|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
149083375|NCT00307489|537785356|FG000|Baseline Through Week 48|Physician Decision|1|||
149083376|NCT00307489|537785357|FG001|Baseline Through Week 48|Physician Decision|0|||
149083377|NCT00307489|537785356|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
149083378|NCT00307489|537785357|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
149083379|NCT00307489|537785356|FG000|Week 48 Through Week 168|Adverse Event|1|||
149083380|NCT00307489|537785357|FG001|Week 48 Through Week 168|Adverse Event|0|||
149083381|NCT00307489|537785356|FG000|Week 48 Through Week 168|Physician Decision|1|||
149083382|NCT00307489|537785357|FG001|Week 48 Through Week 168|Physician Decision|0|||
149083383|NCT00307489|537785356|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
149083384|NCT00307489|537785357|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
149083385|NCT00307489|537785356|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
149083386|NCT00307489|537785357|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
149083387|NCT00307489|537785356|FG000|Week 48 Through Week 168|Death|0|||
149083388|NCT00307489|537785357|FG001|Week 48 Through Week 168|Death|1|||
149083389|NCT00307489|537785356|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
149083390|NCT00307489|537785357|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
149083391|NCT00307489|537785356|FG000|Week 48 Through Week 168|Seroconversion|1|||
149083392|NCT00307489|537785357|FG001|Week 48 Through Week 168|Seroconversion|0|||
149083393|NCT00304278|537785359|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
149083394|NCT00304278|537785359|FG000|Overall Study|PT had medical condition preventing TX|1|||
149083395|NCT04025762|537785362|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
149083396|NCT04025762|537785363|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
149083397|NCT01286311|537785365|FG000|Overall Study|Physician did not want outreach sent|14|||
149083398|NCT01286311|537785366|FG001|Overall Study|Physician did not want outreach sent|0|||
149083399|NCT01381549|537785369|FG000|Overall Study|Ineligible: No organisms isolated|0|||
149083400|NCT01381549|537785370|FG001|Overall Study|Ineligible: No organisms isolated|0|||
149083401|NCT01381549|537785371|FG002|Overall Study|Ineligible: No organisms isolated|1|||
149083402|NCT02981953|537785372|FG000|Overall Study|Death|9|||
149083403|NCT02981953|537785372|FG000|Overall Study|Withdrawal by Subject|1|||
149083404|NCT02981953|537785372|FG000|Overall Study|Withdrawal to non-compliance|1|||
149083405|NCT02889900|537785373|FG000|Overall Study|Adverse Event|11|||
149083406|NCT02889900|537785373|FG000|Overall Study|Condition under investigation worsened|32|||
149083407|NCT02889900|537785373|FG000|Overall Study|Other|5|||
149083408|NCT02889900|537785373|FG000|Overall Study|Withdrawal by Subject|7|||
149083409|NCT02889900|537785373|FG000|Overall Study|Not treated|2|||
149083410|NCT00813709|537785380|FG000|Double Blind Period|Adverse Event|4|||
149083411|NCT00813709|537785381|FG001|Double Blind Period|Adverse Event|1|||
149083412|NCT00813709|537785382|FG002|Double Blind Period|Adverse Event|4|||
149083413|NCT00813709|537785383|FG003|Double Blind Period|Adverse Event|0|||
149083414|NCT00813709|537785384|FG004|Double Blind Period|Adverse Event|0|||
149083415|NCT00813709|537785385|FG005|Double Blind Period|Adverse Event|0|||
149083416|NCT00813709|537785380|FG000|Double Blind Period|Lost to Follow-up|3|||
149083417|NCT00813709|537785381|FG001|Double Blind Period|Lost to Follow-up|2|||
149083418|NCT00813709|537785382|FG002|Double Blind Period|Lost to Follow-up|2|||
149083419|NCT00813709|537785383|FG003|Double Blind Period|Lost to Follow-up|0|||
149083420|NCT00813709|537785384|FG004|Double Blind Period|Lost to Follow-up|0|||
149083421|NCT00813709|537785385|FG005|Double Blind Period|Lost to Follow-up|0|||
149083422|NCT00813709|537785380|FG000|Double Blind Period|Switched to open label phase|9|||
149083423|NCT00813709|537785381|FG001|Double Blind Period|Switched to open label phase|26|||
149083424|NCT00813709|537785382|FG002|Double Blind Period|Switched to open label phase|18|||
149083425|NCT00813709|537785383|FG003|Double Blind Period|Switched to open label phase|0|||
149083426|NCT00813709|537785384|FG004|Double Blind Period|Switched to open label phase|0|||
149083427|NCT00813709|537785385|FG005|Double Blind Period|Switched to open label phase|0|||
149083428|NCT00813709|537785380|FG000|Double Blind Period|Randomized but not treated|1|||
149083429|NCT00813709|537785381|FG001|Double Blind Period|Randomized but not treated|3|||
149083430|NCT00813709|537785382|FG002|Double Blind Period|Randomized but not treated|1|||
149083431|NCT00813709|537785383|FG003|Double Blind Period|Randomized but not treated|0|||
149083432|NCT00813709|537785384|FG004|Double Blind Period|Randomized but not treated|0|||
149083433|NCT00813709|537785385|FG005|Double Blind Period|Randomized but not treated|0|||
149083434|NCT00813709|537785380|FG000|Double Blind Period|Other|14|||
149083435|NCT00813709|537785381|FG001|Double Blind Period|Other|9|||
149083436|NCT00813709|537785382|FG002|Double Blind Period|Other|6|||
149083437|NCT00813709|537785383|FG003|Double Blind Period|Other|0|||
149083438|NCT00813709|537785384|FG004|Double Blind Period|Other|0|||
149083439|NCT00813709|537785385|FG005|Double Blind Period|Other|0|||
149083440|NCT00813709|537785380|FG000|Open Label Period|Adverse Event|0|||
149083441|NCT00813709|537785381|FG001|Open Label Period|Adverse Event|0|||
149083442|NCT00813709|537785382|FG002|Open Label Period|Adverse Event|0|||
149083443|NCT00813709|537785383|FG003|Open Label Period|Adverse Event|5|||
149083444|NCT00813709|537785384|FG004|Open Label Period|Adverse Event|4|||
149083445|NCT00813709|537785385|FG005|Open Label Period|Adverse Event|3|||
149083446|NCT00813709|537785380|FG000|Open Label Period|Lack of Efficacy|0|||
149083447|NCT00813709|537785381|FG001|Open Label Period|Lack of Efficacy|0|||
149083448|NCT00813709|537785382|FG002|Open Label Period|Lack of Efficacy|0|||
149083449|NCT00813709|537785383|FG003|Open Label Period|Lack of Efficacy|3|||
149083450|NCT00813709|537785384|FG004|Open Label Period|Lack of Efficacy|1|||
149083451|NCT00813709|537785385|FG005|Open Label Period|Lack of Efficacy|1|||
149083452|NCT00813709|537785380|FG000|Open Label Period|Randomized but not treated|0|||
149083453|NCT00813709|537785381|FG001|Open Label Period|Randomized but not treated|0|||
149083454|NCT00813709|537785382|FG002|Open Label Period|Randomized but not treated|0|||
149083455|NCT00813709|537785383|FG003|Open Label Period|Randomized but not treated|1|||
149083456|NCT00813709|537785384|FG004|Open Label Period|Randomized but not treated|0|||
149083457|NCT00813709|537785385|FG005|Open Label Period|Randomized but not treated|1|||
149083458|NCT00813709|537785380|FG000|Open Label Period|Other|0|||
149083459|NCT00813709|537785381|FG001|Open Label Period|Other|0|||
149083460|NCT00813709|537785382|FG002|Open Label Period|Other|0|||
149083461|NCT00813709|537785383|FG003|Open Label Period|Other|11|||
149083462|NCT00813709|537785384|FG004|Open Label Period|Other|5|||
149083463|NCT00813709|537785385|FG005|Open Label Period|Other|6|||
149083464|NCT03840993|537785386|FG000|Overall Study|Adverse Event|1|||
149083465|NCT03840993|537785387|FG001|Overall Study|Adverse Event|0|||
149083466|NCT03840993|537785386|FG000|Overall Study|Lost to Follow-up|4|||
149083467|NCT03840993|537785387|FG001|Overall Study|Lost to Follow-up|0|||
149083468|NCT03840993|537785386|FG000|Overall Study|Physician Decision|0|||
149083469|NCT03840993|537785387|FG001|Overall Study|Physician Decision|1|||
149083470|NCT03840993|537785386|FG000|Overall Study|Pregnancy|0|||
149083471|NCT03840993|537785387|FG001|Overall Study|Pregnancy|1|||
149083472|NCT03840993|537785386|FG000|Overall Study|Withdrawal by Subject|1|||
149083473|NCT03840993|537785387|FG001|Overall Study|Withdrawal by Subject|3|||
149083474|NCT03840993|537785386|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
149083475|NCT03840993|537785387|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
149083476|NCT00759681|537785388|FG000|Overall Study|Death|2|||
149083477|NCT00759681|537785389|FG001|Overall Study|Death|5|||
149083478|NCT00759681|537785388|FG000|Overall Study|Lost to Follow-up|8|||
149083479|NCT00759681|537785389|FG001|Overall Study|Lost to Follow-up|5|||
149083480|NCT00473512|537785390|FG000|Period 1 (Phase 1)|Adverse Event|0|||
149083481|NCT00473512|537785391|FG001|Period 1 (Phase 1)|Adverse Event|0|||
149083482|NCT00473512|537785392|FG002|Period 1 (Phase 1)|Adverse Event|0|||
149083483|NCT00473512|537785393|FG003|Period 1 (Phase 1)|Adverse Event|5|||
149083484|NCT00473512|537785394|FG004|Period 1 (Phase 1)|Adverse Event|0|||
149083485|NCT00473512|537785390|FG000|Period 1 (Phase 1)|Death|0|||
149083486|NCT00473512|537785391|FG001|Period 1 (Phase 1)|Death|0|||
149083487|NCT00473512|537785392|FG002|Period 1 (Phase 1)|Death|0|||
149083488|NCT00473512|537785393|FG003|Period 1 (Phase 1)|Death|1|||
149083489|NCT00473512|537785394|FG004|Period 1 (Phase 1)|Death|0|||
149083490|NCT00473512|537785390|FG000|Period 1 (Phase 1)|Disease Progression|1|||
149083491|NCT00473512|537785391|FG001|Period 1 (Phase 1)|Disease Progression|1|||
149083492|NCT00473512|537785392|FG002|Period 1 (Phase 1)|Disease Progression|0|||
149083493|NCT00473512|537785393|FG003|Period 1 (Phase 1)|Disease Progression|10|||
149083494|NCT00473512|537785394|FG004|Period 1 (Phase 1)|Disease Progression|1|||
149083495|NCT00473512|537785390|FG000|Period 1 (Phase 1)|Other|0|||
149083496|NCT00473512|537785391|FG001|Period 1 (Phase 1)|Other|0|||
149083497|NCT00473512|537785392|FG002|Period 1 (Phase 1)|Other|0|||
149083498|NCT00473512|537785393|FG003|Period 1 (Phase 1)|Other|1|||
149083499|NCT00473512|537785394|FG004|Period 1 (Phase 1)|Other|0|||
149083500|NCT00473512|537785390|FG000|Period 2 (Phase 2)|Adverse Event|0|||
149083501|NCT00473512|537785391|FG001|Period 2 (Phase 2)|Adverse Event|0|||
149083502|NCT00473512|537785392|FG002|Period 2 (Phase 2)|Adverse Event|0|||
149083503|NCT00473512|537785393|FG003|Period 2 (Phase 2)|Adverse Event|1|||
149083504|NCT00473512|537785394|FG004|Period 2 (Phase 2)|Adverse Event|0|||
149083505|NCT00473512|537785390|FG000|Period 2 (Phase 2)|Death|0|||
149083506|NCT00473512|537785391|FG001|Period 2 (Phase 2)|Death|0|||
149083507|NCT00473512|537785392|FG002|Period 2 (Phase 2)|Death|0|||
149083508|NCT00473512|537785393|FG003|Period 2 (Phase 2)|Death|1|||
149083509|NCT00473512|537785394|FG004|Period 2 (Phase 2)|Death|1|||
149083510|NCT00473512|537785390|FG000|Period 2 (Phase 2)|Disease Progression|0|||
149083511|NCT00473512|537785391|FG001|Period 2 (Phase 2)|Disease Progression|2|||
149083512|NCT00473512|537785392|FG002|Period 2 (Phase 2)|Disease Progression|2|||
149083513|NCT00473512|537785393|FG003|Period 2 (Phase 2)|Disease Progression|17|||
149083514|NCT00473512|537785394|FG004|Period 2 (Phase 2)|Disease Progression|1|||
149083515|NCT00473512|537785390|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
149083516|NCT00473512|537785391|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
149083517|NCT00473512|537785392|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
149083518|NCT00473512|537785393|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
149083519|NCT00473512|537785394|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
149083520|NCT00473512|537785390|FG000|Period 2 (Phase 2)|Other|1|||
149083521|NCT00473512|537785391|FG001|Period 2 (Phase 2)|Other|0|||
149083522|NCT00473512|537785392|FG002|Period 2 (Phase 2)|Other|0|||
149083523|NCT00473512|537785393|FG003|Period 2 (Phase 2)|Other|3|||
149083524|NCT00473512|537785394|FG004|Period 2 (Phase 2)|Other|0|||
149083525|NCT00267956|537785399|FG000|Controlled Period|Adverse Event|4|||
149083526|NCT00267956|537785400|FG001|Controlled Period|Adverse Event|1|||
149083527|NCT00267956|537785401|FG002|Controlled Period|Adverse Event|0|||
149083528|NCT00267956|537785402|FG003|Controlled Period|Adverse Event|0|||
149083529|NCT00267956|537785399|FG000|Controlled Period|Lack of Efficacy|4|||
149083530|NCT00267956|537785400|FG001|Controlled Period|Lack of Efficacy|2|||
149083531|NCT00267956|537785401|FG002|Controlled Period|Lack of Efficacy|0|||
149083532|NCT00267956|537785402|FG003|Controlled Period|Lack of Efficacy|0|||
149083533|NCT00267956|537785399|FG000|Controlled Period|Lost to Follow-up|2|||
149083534|NCT00267956|537785400|FG001|Controlled Period|Lost to Follow-up|0|||
149083535|NCT00267956|537785401|FG002|Controlled Period|Lost to Follow-up|0|||
149083536|NCT00267956|537785402|FG003|Controlled Period|Lost to Follow-up|0|||
149083537|NCT00267956|537785399|FG000|Controlled Period|Withdrew consent|3|||
149083538|NCT00267956|537785400|FG001|Controlled Period|Withdrew consent|1|||
149083539|NCT00267956|537785401|FG002|Controlled Period|Withdrew consent|0|||
149083540|NCT00267956|537785402|FG003|Controlled Period|Withdrew consent|0|||
149083541|NCT00267956|537785399|FG000|After Controlled Period|Adverse Event|0|||
149083542|NCT00267956|537785400|FG001|After Controlled Period|Adverse Event|0|||
149083543|NCT00267956|537785401|FG002|After Controlled Period|Adverse Event|2|||
149083544|NCT00267956|537785402|FG003|After Controlled Period|Adverse Event|1|||
149083545|NCT00267956|537785399|FG000|After Controlled Period|Lack of Efficacy|0|||
149083546|NCT00267956|537785400|FG001|After Controlled Period|Lack of Efficacy|0|||
149083547|NCT00267956|537785401|FG002|After Controlled Period|Lack of Efficacy|1|||
149083548|NCT00267956|537785402|FG003|After Controlled Period|Lack of Efficacy|1|||
149083549|NCT00267956|537785399|FG000|After Controlled Period|Lost to Follow-up|0|||
149083550|NCT00267956|537785400|FG001|After Controlled Period|Lost to Follow-up|0|||
149083551|NCT00267956|537785401|FG002|After Controlled Period|Lost to Follow-up|1|||
149083552|NCT00267956|537785402|FG003|After Controlled Period|Lost to Follow-up|0|||
149083553|NCT00267956|537785399|FG000|After Controlled Period|Withdrew consent|0|||
149083554|NCT00267956|537785400|FG001|After Controlled Period|Withdrew consent|0|||
149083555|NCT00267956|537785401|FG002|After Controlled Period|Withdrew consent|1|||
149083556|NCT00267956|537785402|FG003|After Controlled Period|Withdrew consent|0|||
149083557|NCT01263223|537785403|FG000|Period 2|Withdrawal by Subject|0|||
149083558|NCT01263223|537785404|FG001|Period 2|Withdrawal by Subject|1|||
149083559|NCT01263223|537785403|FG000|7-day Follow-up|Withdrawal by Subject|0|||
149083560|NCT01263223|537785404|FG001|7-day Follow-up|Withdrawal by Subject|1|||
149083561|NCT01263223|537785403|FG000|7-day Follow-up|Lost to Follow-up|1|||
149083562|NCT01263223|537785404|FG001|7-day Follow-up|Lost to Follow-up|0|||
149083563|NCT02246647|537785408|FG000|Overall Study|Withdrawal by Subject|1|||
149083564|NCT02246647|537785409|FG001|Overall Study|Withdrawal by Subject|1|||
149083565|NCT01113541|537785411|FG000|Overall Study|Withdrawal by Subject|1|||
149083566|NCT01113541|537785411|FG000|Overall Study|Protocol Violation|1|||
149083567|NCT01113541|537785411|FG000|Overall Study|Study Terminated by Sponsor|7|||
149083568|NCT01113541|537785411|FG000|Overall Study|Adverse Event|4|||
149083569|NCT01584648|537785414|FG000|Overall Study|Death|136|||
149083570|NCT01584648|537785415|FG001|Overall Study|Death|146|||
149083571|NCT01584648|537785414|FG000|Overall Study|Lost to Follow-up|9|||
149083572|NCT01584648|537785415|FG001|Overall Study|Lost to Follow-up|9|||
149083573|NCT01584648|537785414|FG000|Overall Study|Investigator discretion|3|||
149083574|NCT01584648|537785415|FG001|Overall Study|Investigator discretion|2|||
149083575|NCT01584648|537785414|FG000|Overall Study|Withdrew consent|13|||
149083576|NCT01584648|537785415|FG001|Overall Study|Withdrew consent|4|||
149083577|NCT01584648|537785414|FG000|Overall Study|Study closed/terminated|50|||
149083578|NCT01584648|537785415|FG001|Overall Study|Study closed/terminated|23|||
149083579|NCT01584648|537785414|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
149083580|NCT01584648|537785415|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
149083581|NCT03386344|537785419|FG000|Overall Study|Adverse Event|6|||
149083582|NCT03386344|537785420|FG001|Overall Study|Adverse Event|3|||
149083583|NCT03386344|537785421|FG002|Overall Study|Adverse Event|1|||
149083584|NCT03386344|537785419|FG000|Overall Study|Poor Compliance to Protocol|0|||
149083585|NCT03386344|537785420|FG001|Overall Study|Poor Compliance to Protocol|1|||
149083586|NCT03386344|537785421|FG002|Overall Study|Poor Compliance to Protocol|0|||
149083587|NCT03386344|537785419|FG000|Overall Study|Study Terminated by Sponsor|101|||
149083588|NCT03386344|537785420|FG001|Overall Study|Study Terminated by Sponsor|102|||
149083589|NCT03386344|537785421|FG002|Overall Study|Study Terminated by Sponsor|106|||
149083590|NCT03386344|537785419|FG000|Overall Study|Lost to Follow-up|3|||
149083591|NCT03386344|537785420|FG001|Overall Study|Lost to Follow-up|2|||
149083592|NCT03386344|537785421|FG002|Overall Study|Lost to Follow-up|1|||
149083593|NCT03386344|537785419|FG000|Overall Study|At the Participant's own Request|7|||
149083594|NCT03386344|537785420|FG001|Overall Study|At the Participant's own Request|7|||
149083595|NCT03386344|537785421|FG002|Overall Study|At the Participant's own Request|8|||
149083596|NCT03386344|537785419|FG000|Overall Study|Reason not Specified|0|||
149083597|NCT03386344|537785420|FG001|Overall Study|Reason not Specified|1|||
149083598|NCT03386344|537785421|FG002|Overall Study|Reason not Specified|0|||
149083599|NCT03481725|537785422|FG000|Overall Study|Withdrawal by Subject|1|||
149083600|NCT03481725|537785423|FG001|Overall Study|Withdrawal by Subject|0|||
149083601|NCT01894620|537785426|FG000|Overall Study|Withdrawal by Subject|0|||
149083602|NCT01894620|537785427|FG001|Overall Study|Withdrawal by Subject|1|||
149083603|NCT01133678|537785428|FG000|Overall Study|Death|1|||
149083604|NCT01133678|537785429|FG001|Overall Study|Death|1|||
149083605|NCT00879710|537785430|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
149083606|NCT00879710|537785431|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
149083607|NCT00879710|537785432|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
149083608|NCT00879710|537785433|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
149083609|NCT00879710|537785430|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
149083610|NCT00879710|537785431|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
149083611|NCT00879710|537785432|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
149083612|NCT00879710|537785433|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
149083613|NCT02514824|537785434|FG000|Overall Study|Withdrawal by Subject|1|||
149083614|NCT02514824|537785435|FG001|Overall Study|Withdrawal by Subject|0|||
149083615|NCT02514824|537785436|FG002|Overall Study|Withdrawal by Subject|0|||
149083616|NCT02514824|537785437|FG003|Overall Study|Withdrawal by Subject|0|||
149083617|NCT02514824|537785434|FG000|Overall Study|Dose-Limiting Toxicity|0|||
149083618|NCT02514824|537785435|FG001|Overall Study|Dose-Limiting Toxicity|1|||
149083619|NCT02514824|537785436|FG002|Overall Study|Dose-Limiting Toxicity|0|||
149083620|NCT02514824|537785437|FG003|Overall Study|Dose-Limiting Toxicity|0|||
149083621|NCT02170207|537785440|FG000|Overall Study|Case report forms unavailable|5|||
149083622|NCT00346398|537785441|FG000|Overall Study|Lost to Follow-up|3|||
149083623|NCT00346398|537785442|FG001|Overall Study|Lost to Follow-up|0|||
149083624|NCT00346398|537785441|FG000|Overall Study|Withdrawal by Subject|0|||
149083625|NCT00346398|537785442|FG001|Overall Study|Withdrawal by Subject|2|||
149083626|NCT03979040|537785443|FG000|Overall Study|Withdrawal by Subject|24|||
149083627|NCT03979040|537785444|FG001|Overall Study|Withdrawal by Subject|32|||
149083628|NCT03979040|537785443|FG000|Overall Study|randomized but never started treatment|32|||
149083629|NCT03979040|537785444|FG001|Overall Study|randomized but never started treatment|39|||
149083630|NCT03979040|537785443|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
149083631|NCT03979040|537785444|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
149083632|NCT02607956|537785445|FG000|Double-Blinded Phase|Withdrew Consent|17|||
149083633|NCT02607956|537785446|FG001|Double-Blinded Phase|Withdrew Consent|19|||
149083634|NCT02607956|537785447|FG002|Double-Blinded Phase|Withdrew Consent|0|||
149083635|NCT02607956|537785448|FG003|Double-Blinded Phase|Withdrew Consent|0|||
149083636|NCT02607956|537785445|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
149083637|NCT02607956|537785446|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
149083638|NCT02607956|537785447|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
149083639|NCT02607956|537785448|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
149083640|NCT02607956|537785445|FG000|Double-Blinded Phase|Randomized but never treated|7|||
149083641|NCT02607956|537785446|FG001|Double-Blinded Phase|Randomized but never treated|5|||
149083642|NCT02607956|537785447|FG002|Double-Blinded Phase|Randomized but never treated|0|||
149083643|NCT02607956|537785448|FG003|Double-Blinded Phase|Randomized but never treated|0|||
149083644|NCT02607956|537785445|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
149083645|NCT02607956|537785446|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
149083646|NCT02607956|537785447|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
149083647|NCT02607956|537785448|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
149083648|NCT02607956|537785445|FG000|Double-Blinded Phase|Death|4|||
149083649|NCT02607956|537785446|FG001|Double-Blinded Phase|Death|4|||
149083650|NCT02607956|537785447|FG002|Double-Blinded Phase|Death|0|||
149083651|NCT02607956|537785448|FG003|Double-Blinded Phase|Death|0|||
149083652|NCT02607956|537785445|FG000|Double-Blinded Phase|Adverse Event|4|||
149083653|NCT02607956|537785446|FG001|Double-Blinded Phase|Adverse Event|3|||
149083654|NCT02607956|537785447|FG002|Double-Blinded Phase|Adverse Event|0|||
149083655|NCT02607956|537785448|FG003|Double-Blinded Phase|Adverse Event|0|||
149083656|NCT02607956|537785445|FG000|Double-Blinded Phase|Protocol Violation|3|||
149083657|NCT02607956|537785446|FG001|Double-Blinded Phase|Protocol Violation|1|||
149083658|NCT02607956|537785447|FG002|Double-Blinded Phase|Protocol Violation|0|||
149083659|NCT02607956|537785448|FG003|Double-Blinded Phase|Protocol Violation|0|||
149083660|NCT02607956|537785445|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
149083661|NCT02607956|537785446|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
149083662|NCT02607956|537785447|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
149083663|NCT02607956|537785448|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
149083664|NCT02607956|537785445|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
149083665|NCT02607956|537785446|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
149083666|NCT02607956|537785447|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
149083667|NCT02607956|537785448|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
149083668|NCT02607956|537785445|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
149083669|NCT02607956|537785446|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
149083670|NCT02607956|537785447|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
149083671|NCT02607956|537785448|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
149083672|NCT02607956|537785445|FG000|Open-Label Extension Phase|Death|0|||
149083673|NCT02607956|537785446|FG001|Open-Label Extension Phase|Death|0|||
149083674|NCT02607956|537785447|FG002|Open-Label Extension Phase|Death|1|||
149083675|NCT02607956|537785448|FG003|Open-Label Extension Phase|Death|3|||
149083676|NCT02607956|537785445|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
149083677|NCT02607956|537785446|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
149083678|NCT02607956|537785447|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
149083679|NCT02607956|537785448|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
149083680|NCT02607956|537785445|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
149083681|NCT02607956|537785446|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
149083682|NCT02607956|537785447|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
149083683|NCT02607956|537785448|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
149083684|NCT02607956|537785445|FG000|Open-Label Extension Phase|Protocol Violation|0|||
149083685|NCT02607956|537785446|FG001|Open-Label Extension Phase|Protocol Violation|0|||
149083686|NCT02607956|537785447|FG002|Open-Label Extension Phase|Protocol Violation|0|||
149083687|NCT02607956|537785448|FG003|Open-Label Extension Phase|Protocol Violation|2|||
149083688|NCT02607956|537785445|FG000|Open-Label Extension Phase|Pregnancy|0|||
149083689|NCT02607956|537785446|FG001|Open-Label Extension Phase|Pregnancy|0|||
149083690|NCT02607956|537785447|FG002|Open-Label Extension Phase|Pregnancy|0|||
149083691|NCT02607956|537785448|FG003|Open-Label Extension Phase|Pregnancy|1|||
149083692|NCT03541369|537785453|FG000|Overall Study|Death|0|||
149083693|NCT03541369|537785454|FG001|Overall Study|Death|0|||
149083694|NCT03541369|537785455|FG002|Overall Study|Death|0|||
149083695|NCT03541369|537785456|FG003|Overall Study|Death|0|||
149083696|NCT03541369|537785457|FG004|Overall Study|Death|1|||
149083697|NCT03541369|537785458|FG005|Overall Study|Death|1|||
149083698|NCT03541369|537785459|FG006|Overall Study|Death|0|||
149083699|NCT03541369|537785460|FG007|Overall Study|Death|2|||
149083700|NCT03541369|537785461|FG008|Overall Study|Death|1|||
149083701|NCT03541369|537785462|FG009|Overall Study|Death|2|||
149083702|NCT03541369|537785463|FG010|Overall Study|Death|1|||
149083703|NCT03541369|537785464|FG011|Overall Study|Death|0|||
149083704|NCT03541369|537785465|FG012|Overall Study|Death|2|||
149083705|NCT03541369|537785466|FG013|Overall Study|Death|1|||
149083706|NCT03541369|537785467|FG014|Overall Study|Death|1|||
149083707|NCT03541369|537785468|FG015|Overall Study|Death|1|||
149083708|NCT03541369|537785469|FG016|Overall Study|Death|0|||
149083709|NCT03541369|537785470|FG017|Overall Study|Death|1|||
149083710|NCT03541369|537785453|FG000|Overall Study|Decision by sponsor|0|||
149083711|NCT03541369|537785454|FG001|Overall Study|Decision by sponsor|0|||
149083712|NCT03541369|537785455|FG002|Overall Study|Decision by sponsor|0|||
149083713|NCT03541369|537785456|FG003|Overall Study|Decision by sponsor|1|||
149083714|NCT03541369|537785457|FG004|Overall Study|Decision by sponsor|0|||
149083715|NCT03541369|537785458|FG005|Overall Study|Decision by sponsor|2|||
149083716|NCT03541369|537785459|FG006|Overall Study|Decision by sponsor|0|||
149083717|NCT03541369|537785460|FG007|Overall Study|Decision by sponsor|1|||
149083718|NCT03541369|537785461|FG008|Overall Study|Decision by sponsor|2|||
149083719|NCT03541369|537785462|FG009|Overall Study|Decision by sponsor|0|||
149083720|NCT03541369|537785463|FG010|Overall Study|Decision by sponsor|0|||
149083721|NCT03541369|537785464|FG011|Overall Study|Decision by sponsor|0|||
149083722|NCT03541369|537785465|FG012|Overall Study|Decision by sponsor|2|||
149083723|NCT03541369|537785466|FG013|Overall Study|Decision by sponsor|2|||
149083724|NCT03541369|537785467|FG014|Overall Study|Decision by sponsor|0|||
149083725|NCT03541369|537785468|FG015|Overall Study|Decision by sponsor|1|||
149083726|NCT03541369|537785469|FG016|Overall Study|Decision by sponsor|1|||
149083727|NCT03541369|537785470|FG017|Overall Study|Decision by sponsor|1|||
149083728|NCT03541369|537785453|FG000|Overall Study|Withdrawal by Subject|0|||
149083729|NCT03541369|537785454|FG001|Overall Study|Withdrawal by Subject|0|||
149083730|NCT03541369|537785455|FG002|Overall Study|Withdrawal by Subject|0|||
149083731|NCT03541369|537785456|FG003|Overall Study|Withdrawal by Subject|0|||
149083732|NCT03541369|537785457|FG004|Overall Study|Withdrawal by Subject|0|||
149083733|NCT03541369|537785458|FG005|Overall Study|Withdrawal by Subject|0|||
149083734|NCT03541369|537785459|FG006|Overall Study|Withdrawal by Subject|1|||
149083735|NCT03541369|537785460|FG007|Overall Study|Withdrawal by Subject|0|||
149083736|NCT03541369|537785461|FG008|Overall Study|Withdrawal by Subject|0|||
149083737|NCT03541369|537785462|FG009|Overall Study|Withdrawal by Subject|0|||
149083738|NCT03541369|537785463|FG010|Overall Study|Withdrawal by Subject|0|||
149083739|NCT03541369|537785464|FG011|Overall Study|Withdrawal by Subject|1|||
149083740|NCT03541369|537785465|FG012|Overall Study|Withdrawal by Subject|0|||
149083741|NCT03541369|537785466|FG013|Overall Study|Withdrawal by Subject|0|||
149083742|NCT03541369|537785467|FG014|Overall Study|Withdrawal by Subject|3|||
149083743|NCT03541369|537785468|FG015|Overall Study|Withdrawal by Subject|0|||
149083744|NCT03541369|537785469|FG016|Overall Study|Withdrawal by Subject|4|||
149083745|NCT03541369|537785470|FG017|Overall Study|Withdrawal by Subject|2|||
149083746|NCT03541369|537785453|FG000|Overall Study|Lost to Follow-up|0|||
149083747|NCT03541369|537785454|FG001|Overall Study|Lost to Follow-up|0|||
149083748|NCT03541369|537785455|FG002|Overall Study|Lost to Follow-up|0|||
149083749|NCT03541369|537785456|FG003|Overall Study|Lost to Follow-up|0|||
149083750|NCT03541369|537785457|FG004|Overall Study|Lost to Follow-up|1|||
149083751|NCT03541369|537785458|FG005|Overall Study|Lost to Follow-up|0|||
149083752|NCT03541369|537785459|FG006|Overall Study|Lost to Follow-up|0|||
149083753|NCT03541369|537785460|FG007|Overall Study|Lost to Follow-up|0|||
149083754|NCT03541369|537785461|FG008|Overall Study|Lost to Follow-up|1|||
149083755|NCT03541369|537785462|FG009|Overall Study|Lost to Follow-up|0|||
149083756|NCT03541369|537785463|FG010|Overall Study|Lost to Follow-up|0|||
149083757|NCT03541369|537785464|FG011|Overall Study|Lost to Follow-up|0|||
149083758|NCT03541369|537785465|FG012|Overall Study|Lost to Follow-up|1|||
149083759|NCT03541369|537785466|FG013|Overall Study|Lost to Follow-up|0|||
149083760|NCT03541369|537785467|FG014|Overall Study|Lost to Follow-up|0|||
149083761|NCT03541369|537785468|FG015|Overall Study|Lost to Follow-up|0|||
149083762|NCT03541369|537785469|FG016|Overall Study|Lost to Follow-up|0|||
149083763|NCT03541369|537785470|FG017|Overall Study|Lost to Follow-up|0|||
149083764|NCT02279732|537785473|FG000|Overall Study|Death|23|||
149083765|NCT02279732|537785474|FG001|Overall Study|Death|20|||
149083766|NCT02279732|537785473|FG000|Overall Study|Disease Progression|13|||
149083767|NCT02279732|537785474|FG001|Overall Study|Disease Progression|3|||
149083768|NCT02279732|537785473|FG000|Overall Study|Withdrawal by Subject|2|||
149083769|NCT02279732|537785474|FG001|Overall Study|Withdrawal by Subject|7|||
149083770|NCT02279732|537785473|FG000|Overall Study|Adverse Event|1|||
149083771|NCT02279732|537785474|FG001|Overall Study|Adverse Event|2|||
149083772|NCT02279732|537785473|FG000|Overall Study|Administrative Reason By Sponsor|0|||
149083773|NCT02279732|537785474|FG001|Overall Study|Administrative Reason By Sponsor|2|||
149083774|NCT02279732|537785473|FG000|Overall Study|Study Drug Toxicity|2|||
149083775|NCT02279732|537785474|FG001|Overall Study|Study Drug Toxicity|0|||
149083776|NCT02279732|537785473|FG000|Overall Study|Lost to Follow-up|0|||
149083777|NCT02279732|537785474|FG001|Overall Study|Lost to Follow-up|1|||
149083778|NCT02279732|537785473|FG000|Overall Study|Maximum Clinical Benefit|1|||
149083779|NCT02279732|537785474|FG001|Overall Study|Maximum Clinical Benefit|0|||
149083780|NCT02279732|537785473|FG000|Overall Study|Subject Requested to Discontinue|0|||
149083781|NCT02279732|537785474|FG001|Overall Study|Subject Requested to Discontinue|1|||
149083782|NCT02279732|537785473|FG000|Overall Study|Other|53|||
149083783|NCT02279732|537785474|FG001|Overall Study|Other|67|||
149083784|NCT02279732|537785473|FG000|Overall Study|Other|3|||
149083785|NCT02279732|537785474|FG001|Overall Study|Other|3|||
149083786|NCT03072862|537785478|FG000|Overall Study|Withdrawal by Subject|4|||
149083787|NCT03072862|537785478|FG000|Overall Study|Lost to Follow-up|6|||
149083788|NCT03072862|537785478|FG000|Overall Study|Protocol Violation|4|||
149083789|NCT03072862|537785478|FG000|Overall Study|Physician Decision|2|||
149083790|NCT03072862|537785478|FG000|Overall Study|Death|1|||
149083791|NCT03072862|537785478|FG000|Overall Study|Adverse Event|1|||
149083792|NCT02513667|537785479|FG000|Overall Study|Withdrawal by Subject|0|||
149083793|NCT02513667|537785480|FG001|Overall Study|Withdrawal by Subject|1|||
149083794|NCT03347396|537785481|FG000|Part A (26 Weeks)|Adverse Event|1|||
149083795|NCT03347396|537785482|FG001|Part A (26 Weeks)|Adverse Event|0|||
149083796|NCT03347396|537785481|FG000|Part A (26 Weeks)|Death|0|||
149083797|NCT03347396|537785482|FG001|Part A (26 Weeks)|Death|1|||
149083798|NCT03347396|537785481|FG000|Part B (149 Weeks)|Adverse Event|1|||
149083799|NCT03347396|537785482|FG001|Part B (149 Weeks)|Adverse Event|1|||
149083800|NCT03347396|537785481|FG000|Part B (149 Weeks)|Death|1|||
149083801|NCT03347396|537785482|FG001|Part B (149 Weeks)|Death|0|||
149083802|NCT01670526|537785489|FG000|Overall Study|Withdrawal by Subject|3|||
149083803|NCT01670526|537785490|FG001|Overall Study|Withdrawal by Subject|1|||
149083804|NCT01670526|537785489|FG000|Overall Study|Lost to Follow-up|9|||
149083805|NCT01670526|537785490|FG001|Overall Study|Lost to Follow-up|5|||
149083806|NCT00392197|537785491|FG000|Overall Study|Adverse Event|4|||
149083807|NCT00392197|537785492|FG001|Overall Study|Adverse Event|12|||
149083808|NCT00392197|537785491|FG000|Overall Study|Lack of Efficacy|3|||
149083809|NCT00392197|537785492|FG001|Overall Study|Lack of Efficacy|4|||
149083810|NCT00392197|537785491|FG000|Overall Study|Lost to Follow-up|0|||
149083811|NCT00392197|537785492|FG001|Overall Study|Lost to Follow-up|1|||
149083812|NCT00392197|537785491|FG000|Overall Study|Physician Decision|3|||
149083813|NCT00392197|537785492|FG001|Overall Study|Physician Decision|2|||
149083814|NCT00392197|537785491|FG000|Overall Study|Protocol Violation|7|||
149083815|NCT00392197|537785492|FG001|Overall Study|Protocol Violation|5|||
149083816|NCT00392197|537785491|FG000|Overall Study|Withdrawal by Subject|4|||
149083817|NCT00392197|537785492|FG001|Overall Study|Withdrawal by Subject|6|||
149083818|NCT01970527|537785494|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
149083819|NCT01970527|537785495|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
149083820|NCT01970527|537785494|FG000|Treatment|Disease progression|0|||
149083821|NCT01970527|537785495|FG001|Treatment|Disease progression|1|||
149083822|NCT01970527|537785494|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
149083823|NCT01970527|537785495|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
149083824|NCT01970527|537785494|FG000|Treatment|Death|0|||
149083825|NCT01970527|537785495|FG001|Treatment|Death|1|||
149083826|NCT01970527|537785494|FG000|Follow-up Clinic Visit|Disease progression|1|||
149083827|NCT01970527|537785495|FG001|Follow-up Clinic Visit|Disease progression|1|||
149083828|NCT01970527|537785494|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
149083829|NCT01970527|537785495|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
149083830|NCT01970527|537785494|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
149083831|NCT01970527|537785495|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
149083832|NCT04914897|537787817|FG000|Overall Study|Withdrawal by Subject|3|||
149083833|NCT04914897|537787818|FG001|Overall Study|Withdrawal by Subject|1|||
149083834|NCT04914897|537787819|FG002|Overall Study|Withdrawal by Subject|1|||
149083835|NCT04914897|537787820|FG003|Overall Study|Withdrawal by Subject|1|||
149083836|NCT04914897|537787817|FG000|Overall Study|Poor compliance to protocol|0|||
149083837|NCT04914897|537787818|FG001|Overall Study|Poor compliance to protocol|0|||
149083838|NCT04914897|537787819|FG002|Overall Study|Poor compliance to protocol|1|||
149083839|NCT04914897|537787820|FG003|Overall Study|Poor compliance to protocol|0|||
149083840|NCT04914897|537787817|FG000|Overall Study|Progressive disease|5|||
149083841|NCT04914897|537787818|FG001|Overall Study|Progressive disease|14|||
149083842|NCT04914897|537787819|FG002|Overall Study|Progressive disease|30|||
149083843|NCT04914897|537787820|FG003|Overall Study|Progressive disease|21|||
149083844|NCT04914897|537787817|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
149083845|NCT04914897|537787818|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
149083846|NCT04914897|537787819|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
149083847|NCT04914897|537787820|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
149083848|NCT04914897|537787817|FG000|Overall Study|Other|1|||
149083849|NCT04914897|537787818|FG001|Overall Study|Other|0|||
149083850|NCT04914897|537787819|FG002|Overall Study|Other|0|||
149083851|NCT04914897|537787820|FG003|Overall Study|Other|1|||
149083852|NCT03020914|537787821|FG000|Overall Study|Surgery Cancelled|1|||
149083853|NCT03020914|537787822|FG001|Overall Study|Surgery Cancelled|0|||
149083854|NCT01437540|537787824|FG000|Overall Study|Not listed below|7|||
149083855|NCT01437540|537787825|FG001|Overall Study|Not listed below|6|||
149083856|NCT01437540|537787824|FG000|Overall Study|COPD exacerbation|13|||
149083857|NCT01437540|537787825|FG001|Overall Study|COPD exacerbation|3|||
149083858|NCT01437540|537787824|FG000|Overall Study|Lost to Follow-up|3|||
149083859|NCT01437540|537787825|FG001|Overall Study|Lost to Follow-up|5|||
149083860|NCT01437540|537787824|FG000|Overall Study|Lack of Efficacy|23|||
149083861|NCT01437540|537787825|FG001|Overall Study|Lack of Efficacy|11|||
149083862|NCT01437540|537787824|FG000|Overall Study|Protocol Violation|24|||
149083863|NCT01437540|537787825|FG001|Overall Study|Protocol Violation|12|||
149083864|NCT01437540|537787824|FG000|Overall Study|Adverse Event|26|||
149083865|NCT01437540|537787825|FG001|Overall Study|Adverse Event|13|||
149083866|NCT01437540|537787824|FG000|Overall Study|Withdrawal by Subject|31|||
149083867|NCT01437540|537787825|FG001|Overall Study|Withdrawal by Subject|15|||
149083868|NCT00608959|537787831|FG000|Part 1|Did not meet eligibility criteria|1|||
149083869|NCT01416285|537787832|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
149083870|NCT01416285|537787833|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
149083871|NCT01005602|537787834|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
149083872|NCT01005602|537787835|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
149083873|NCT01248715|537787836|FG000|Overall Study|Not influenza positive|501|||
149083874|NCT01248715|537787837|FG001|Overall Study|Not influenza positive|510|||
149083875|NCT01919489|537787841|FG000|Overall Study|Rejected the need of injections|4|||
149083876|NCT01919489|537787842|FG001|Overall Study|Rejected the need of injections|7|||
149083877|NCT01919489|537787841|FG000|Overall Study|Adverse Event|10|||
149083878|NCT01919489|537787842|FG001|Overall Study|Adverse Event|0|||
149083879|NCT01919489|537787841|FG000|Overall Study|Hospital readmission|2|||
149083880|NCT01919489|537787842|FG001|Overall Study|Hospital readmission|9|||
149083881|NCT01919489|537787841|FG000|Overall Study|Death|2|||
149083882|NCT01919489|537787842|FG001|Overall Study|Death|1|||
149083883|NCT01919489|537787841|FG000|Overall Study|Lost to Follow-up|38|||
149083884|NCT01919489|537787842|FG001|Overall Study|Lost to Follow-up|27|||
149083885|NCT01131325|537787843|FG000|Overall Study|Adverse Event|1|||
149083886|NCT01131325|537787843|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
149083887|NCT03761849|537787844|FG000|Overall Study|transferred to OpenLabelExtension|35|||
149083888|NCT03761849|537787845|FG001|Overall Study|transferred to OpenLabelExtension|34|||
149083889|NCT03761849|537787846|FG002|Overall Study|transferred to OpenLabelExtension|36|||
149083890|NCT03761849|537787847|FG003|Overall Study|transferred to OpenLabelExtension|0|||
149083891|NCT03761849|537787848|FG004|Overall Study|transferred to OpenLabelExtension|0|||
149083892|NCT03761849|537787849|FG005|Overall Study|transferred to OpenLabelExtension|0|||
149083893|NCT03761849|537787844|FG000|Overall Study|Adverse Event|1|||
149083894|NCT03761849|537787845|FG001|Overall Study|Adverse Event|0|||
149083895|NCT03761849|537787846|FG002|Overall Study|Adverse Event|0|||
149083896|NCT03761849|537787847|FG003|Overall Study|Adverse Event|0|||
149083897|NCT03761849|537787848|FG004|Overall Study|Adverse Event|2|||
149083898|NCT03761849|537787849|FG005|Overall Study|Adverse Event|3|||
149083899|NCT03761849|537787844|FG000|Overall Study|Withdrawal by Subject|0|||
149083900|NCT03761849|537787845|FG001|Overall Study|Withdrawal by Subject|0|||
149083901|NCT03761849|537787846|FG002|Overall Study|Withdrawal by Subject|0|||
149083902|NCT03761849|537787847|FG003|Overall Study|Withdrawal by Subject|41|||
149083903|NCT03761849|537787848|FG004|Overall Study|Withdrawal by Subject|43|||
149083904|NCT03761849|537787849|FG005|Overall Study|Withdrawal by Subject|35|||
149083905|NCT03761849|537787844|FG000|Overall Study|Lost to Follow-up|0|||
149083906|NCT03761849|537787845|FG001|Overall Study|Lost to Follow-up|1|||
149083907|NCT03761849|537787846|FG002|Overall Study|Lost to Follow-up|0|||
149083908|NCT03761849|537787847|FG003|Overall Study|Lost to Follow-up|2|||
149083909|NCT03761849|537787848|FG004|Overall Study|Lost to Follow-up|4|||
149083910|NCT03761849|537787849|FG005|Overall Study|Lost to Follow-up|5|||
149083911|NCT03761849|537787844|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
149083912|NCT03761849|537787845|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
149083913|NCT03761849|537787846|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
149083914|NCT03761849|537787847|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
149083915|NCT03761849|537787848|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
149083916|NCT03761849|537787849|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
149083917|NCT03761849|537787844|FG000|Overall Study|Physician Decision|0|||
149083918|NCT03761849|537787845|FG001|Overall Study|Physician Decision|0|||
149083919|NCT03761849|537787846|FG002|Overall Study|Physician Decision|0|||
149083920|NCT03761849|537787847|FG003|Overall Study|Physician Decision|1|||
149083921|NCT03761849|537787848|FG004|Overall Study|Physician Decision|4|||
149083922|NCT03761849|537787849|FG005|Overall Study|Physician Decision|4|||
149083923|NCT03761849|537787844|FG000|Overall Study|Death|0|||
149083924|NCT03761849|537787845|FG001|Overall Study|Death|0|||
149083925|NCT03761849|537787846|FG002|Overall Study|Death|0|||
149083926|NCT03761849|537787847|FG003|Overall Study|Death|1|||
149083927|NCT03761849|537787848|FG004|Overall Study|Death|1|||
149083928|NCT03761849|537787849|FG005|Overall Study|Death|3|||
149083929|NCT03761849|537787844|FG000|Overall Study|Protocol Violation|0|||
149083930|NCT03761849|537787845|FG001|Overall Study|Protocol Violation|0|||
149083931|NCT03761849|537787846|FG002|Overall Study|Protocol Violation|0|||
149083932|NCT03761849|537787847|FG003|Overall Study|Protocol Violation|2|||
149083933|NCT03761849|537787848|FG004|Overall Study|Protocol Violation|2|||
149083934|NCT03761849|537787849|FG005|Overall Study|Protocol Violation|1|||
149083935|NCT03761849|537787844|FG000|Overall Study|Participant could not come to site|0|||
149083936|NCT03761849|537787845|FG001|Overall Study|Participant could not come to site|0|||
149083937|NCT03761849|537787846|FG002|Overall Study|Participant could not come to site|0|||
149083938|NCT03761849|537787847|FG003|Overall Study|Participant could not come to site|0|||
149083939|NCT03761849|537787848|FG004|Overall Study|Participant could not come to site|1|||
149083940|NCT03761849|537787849|FG005|Overall Study|Participant could not come to site|0|||
149083941|NCT03761849|537787844|FG000|Overall Study|SF- safety Finding|0|||
149083942|NCT03761849|537787845|FG001|Overall Study|SF- safety Finding|0|||
149083943|NCT03761849|537787846|FG002|Overall Study|SF- safety Finding|0|||
149083944|NCT03761849|537787847|FG003|Overall Study|SF- safety Finding|0|||
149083945|NCT03761849|537787848|FG004|Overall Study|SF- safety Finding|0|||
149083946|NCT03761849|537787849|FG005|Overall Study|SF- safety Finding|1|||
149083947|NCT03761849|537787844|FG000|Overall Study|Patient did not attend visit|0|||
149083948|NCT03761849|537787845|FG001|Overall Study|Patient did not attend visit|0|||
149083949|NCT03761849|537787846|FG002|Overall Study|Patient did not attend visit|0|||
149083950|NCT03761849|537787847|FG003|Overall Study|Patient did not attend visit|0|||
149083951|NCT03761849|537787848|FG004|Overall Study|Patient did not attend visit|0|||
149083952|NCT03761849|537787849|FG005|Overall Study|Patient did not attend visit|1|||
149083953|NCT01540474|537787850|FG000|Vaccination Period|Lost to Follow-up|0|||
149083954|NCT01540474|537787851|FG001|Vaccination Period|Lost to Follow-up|1|||
149083955|NCT01540474|537787852|FG002|Vaccination Period|Lost to Follow-up|0|||
149083956|NCT01540474|537787853|FG003|Vaccination Period|Lost to Follow-up|0|||
149083957|NCT00857311|537787854|FG000|Overall Study|Lost to Follow-up|1|||
149083958|NCT00857311|537787855|FG001|Overall Study|Lost to Follow-up|0|||
149083959|NCT00857311|537787856|FG002|Overall Study|Lost to Follow-up|0|||
149083960|NCT00857311|537787857|FG003|Overall Study|Lost to Follow-up|0|||
149083961|NCT01587703|537787858|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
149083962|NCT01587703|537787859|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083963|NCT01587703|537787860|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083964|NCT01587703|537787861|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083965|NCT01587703|537787862|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083966|NCT01587703|537787863|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083967|NCT01587703|537787864|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083968|NCT01587703|537787865|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083969|NCT01587703|537787866|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083970|NCT01587703|537787867|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083971|NCT01587703|537787868|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083972|NCT01587703|537787869|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083973|NCT01587703|537787870|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083974|NCT01587703|537787871|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083975|NCT01587703|537787872|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083976|NCT01587703|537787873|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083977|NCT01587703|537787874|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083978|NCT01587703|537787875|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083979|NCT01587703|537787876|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
149083980|NCT01587703|537787858|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083981|NCT01587703|537787859|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083982|NCT01587703|537787860|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083983|NCT01587703|537787861|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083984|NCT01587703|537787862|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083985|NCT01587703|537787863|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
149083986|NCT01587703|537787864|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083987|NCT01587703|537787865|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
149083988|NCT01587703|537787866|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083989|NCT01587703|537787867|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083990|NCT01587703|537787868|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083991|NCT01587703|537787869|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083992|NCT01587703|537787870|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083993|NCT01587703|537787871|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083994|NCT01587703|537787872|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083995|NCT01587703|537787873|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083996|NCT01587703|537787874|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083997|NCT01587703|537787875|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149120384|NCT02559895|537918092|FG002|Overall Study|Other|3|||
149083998|NCT01587703|537787876|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
149083999|NCT01587703|537787858|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084000|NCT01587703|537787859|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084001|NCT01587703|537787860|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084002|NCT01587703|537787861|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084003|NCT01587703|537787862|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084004|NCT01587703|537787863|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084005|NCT01587703|537787864|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
149084006|NCT01587703|537787865|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084007|NCT01587703|537787866|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084008|NCT01587703|537787867|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084009|NCT01587703|537787868|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084010|NCT01587703|537787869|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084011|NCT01587703|537787870|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084012|NCT01587703|537787871|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084013|NCT01587703|537787872|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084014|NCT01587703|537787873|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084015|NCT01587703|537787874|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084016|NCT01587703|537787875|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084017|NCT01587703|537787876|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
149084018|NCT01587703|537787858|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
149084019|NCT01587703|537787859|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
149084020|NCT01587703|537787860|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
149084021|NCT01587703|537787861|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
149084022|NCT01587703|537787862|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
149084023|NCT01587703|537787863|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
149084024|NCT01587703|537787864|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
149084025|NCT01587703|537787865|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
149084026|NCT01587703|537787866|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084027|NCT01587703|537787867|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084028|NCT01587703|537787868|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084029|NCT01587703|537787869|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084030|NCT01587703|537787870|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084031|NCT01587703|537787871|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084032|NCT01587703|537787872|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084033|NCT01587703|537787873|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084034|NCT01587703|537787874|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084035|NCT01587703|537787875|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084036|NCT01587703|537787876|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
149084037|NCT01587703|537787858|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084038|NCT01587703|537787859|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084039|NCT01587703|537787860|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084040|NCT01587703|537787861|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084041|NCT01587703|537787862|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084042|NCT01587703|537787863|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084043|NCT01587703|537787864|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084044|NCT01587703|537787865|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084045|NCT01587703|537787866|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
149084046|NCT01587703|537787867|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
149084047|NCT01587703|537787868|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
149084048|NCT01587703|537787869|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084049|NCT01587703|537787870|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084050|NCT01587703|537787871|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084051|NCT01587703|537787872|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084052|NCT01587703|537787873|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084053|NCT01587703|537787874|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084054|NCT01587703|537787875|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084055|NCT01587703|537787876|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
149084056|NCT01587703|537787858|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084057|NCT01587703|537787859|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084058|NCT01587703|537787860|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084059|NCT01587703|537787861|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084060|NCT01587703|537787862|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084061|NCT01587703|537787863|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084062|NCT01587703|537787864|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084063|NCT01587703|537787865|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084064|NCT01587703|537787866|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
149084065|NCT01587703|537787867|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084066|NCT01587703|537787868|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
149084067|NCT01587703|537787869|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084068|NCT01587703|537787870|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084069|NCT01587703|537787871|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084070|NCT01587703|537787872|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084071|NCT01587703|537787873|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084072|NCT01587703|537787874|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084073|NCT01587703|537787875|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084074|NCT01587703|537787876|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
149084075|NCT01587703|537787858|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084076|NCT01587703|537787859|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084077|NCT01587703|537787860|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084078|NCT01587703|537787861|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084079|NCT01587703|537787862|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084080|NCT01587703|537787863|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084081|NCT01587703|537787864|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084082|NCT01587703|537787865|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084083|NCT01587703|537787866|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084084|NCT01587703|537787867|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
149084085|NCT01587703|537787868|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
149084086|NCT01587703|537787869|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084087|NCT01587703|537787870|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084088|NCT01587703|537787871|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084089|NCT01587703|537787872|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084090|NCT01587703|537787873|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084091|NCT01587703|537787874|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084092|NCT01587703|537787875|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084093|NCT01587703|537787876|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
149084094|NCT01587703|537787858|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084095|NCT01587703|537787859|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084096|NCT01587703|537787860|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084097|NCT01587703|537787861|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084098|NCT01587703|537787862|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084099|NCT01587703|537787863|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084100|NCT01587703|537787864|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084101|NCT01587703|537787865|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084102|NCT01587703|537787866|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
149084103|NCT01587703|537787867|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084104|NCT01587703|537787868|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084105|NCT01587703|537787869|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084106|NCT01587703|537787870|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084107|NCT01587703|537787871|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084108|NCT01587703|537787872|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084109|NCT01587703|537787873|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084110|NCT01587703|537787874|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084111|NCT01587703|537787875|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084112|NCT01587703|537787876|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
149084113|NCT01587703|537787858|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084114|NCT01587703|537787859|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084115|NCT01587703|537787860|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084116|NCT01587703|537787861|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084117|NCT01587703|537787862|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084118|NCT01587703|537787863|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084119|NCT01587703|537787864|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084120|NCT01587703|537787865|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084121|NCT01587703|537787866|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084122|NCT01587703|537787867|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084123|NCT01587703|537787868|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084124|NCT01587703|537787869|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084125|NCT01587703|537787870|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084126|NCT01587703|537787871|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084127|NCT01587703|537787872|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084128|NCT01587703|537787873|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084129|NCT01587703|537787874|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084130|NCT01587703|537787875|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
149084131|NCT01587703|537787876|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
149084132|NCT01587703|537787858|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084133|NCT01587703|537787859|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084134|NCT01587703|537787860|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084135|NCT01587703|537787861|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084136|NCT01587703|537787862|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084137|NCT01587703|537787863|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084138|NCT01587703|537787864|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084139|NCT01587703|537787865|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084140|NCT01587703|537787866|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084141|NCT01587703|537787867|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084142|NCT01587703|537787868|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084143|NCT01587703|537787869|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084144|NCT01587703|537787870|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084145|NCT01587703|537787871|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084146|NCT01587703|537787872|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084147|NCT01587703|537787873|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084148|NCT01587703|537787874|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
149084149|NCT01587703|537787875|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
149084150|NCT01587703|537787876|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
149084151|NCT01587703|537787858|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084152|NCT01587703|537787859|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084153|NCT01587703|537787860|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084154|NCT01587703|537787861|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084155|NCT01587703|537787862|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084156|NCT01587703|537787863|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084157|NCT01587703|537787864|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084158|NCT01587703|537787865|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084159|NCT01587703|537787866|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084160|NCT01587703|537787867|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084161|NCT01587703|537787868|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084162|NCT01587703|537787869|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084163|NCT01587703|537787870|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084164|NCT01587703|537787871|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084165|NCT01587703|537787872|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084166|NCT01587703|537787873|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
149084167|NCT01587703|537787874|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084168|NCT01587703|537787875|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084169|NCT01587703|537787876|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
149084170|NCT01587703|537787858|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084171|NCT01587703|537787859|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084172|NCT01587703|537787860|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084173|NCT01587703|537787861|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084174|NCT01587703|537787862|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084175|NCT01587703|537787863|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084176|NCT01587703|537787864|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084177|NCT01587703|537787865|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084178|NCT01587703|537787866|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084179|NCT01587703|537787867|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084180|NCT01587703|537787868|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084181|NCT01587703|537787869|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
149084182|NCT01587703|537787870|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084183|NCT01587703|537787871|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084184|NCT01587703|537787872|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
149084185|NCT01587703|537787873|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084186|NCT01587703|537787874|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084187|NCT01587703|537787875|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084188|NCT01587703|537787876|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
149084189|NCT01587703|537787858|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084190|NCT01587703|537787859|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084191|NCT01587703|537787860|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084192|NCT01587703|537787861|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084193|NCT01587703|537787862|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084194|NCT01587703|537787863|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084195|NCT01587703|537787864|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084196|NCT01587703|537787865|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084197|NCT01587703|537787866|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084198|NCT01587703|537787867|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084199|NCT01587703|537787868|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084200|NCT01587703|537787869|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
149084201|NCT01587703|537787870|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
149084202|NCT01587703|537787871|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
149084203|NCT01587703|537787872|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
149084204|NCT01587703|537787873|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
149084205|NCT01587703|537787874|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
149084206|NCT01587703|537787875|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084207|NCT01587703|537787876|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
149084208|NCT01587703|537787858|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084209|NCT01587703|537787859|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084210|NCT01587703|537787860|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084211|NCT01587703|537787861|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084212|NCT01587703|537787862|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084213|NCT01587703|537787863|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084214|NCT01587703|537787864|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084215|NCT01587703|537787865|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084216|NCT01587703|537787866|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084217|NCT01587703|537787867|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084218|NCT01587703|537787868|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084219|NCT01587703|537787869|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
149084220|NCT01587703|537787870|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
149084221|NCT01587703|537787871|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
149084222|NCT01587703|537787872|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
149084223|NCT01587703|537787873|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
149084224|NCT01587703|537787874|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
149084225|NCT01587703|537787875|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084226|NCT01587703|537787876|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
149084227|NCT01587703|537787858|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084228|NCT01587703|537787859|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084229|NCT01587703|537787860|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084230|NCT01587703|537787861|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084231|NCT01587703|537787862|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084232|NCT01587703|537787863|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084233|NCT01587703|537787864|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084234|NCT01587703|537787865|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084235|NCT01587703|537787866|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084236|NCT01587703|537787867|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084237|NCT01587703|537787868|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084238|NCT01587703|537787869|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
149084239|NCT01587703|537787870|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084240|NCT01587703|537787871|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084241|NCT01587703|537787872|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084242|NCT01587703|537787873|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084243|NCT01587703|537787874|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084244|NCT01587703|537787875|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084245|NCT01587703|537787876|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
149084246|NCT00828139|537787877|FG000|Overall Study|Adverse Event|8|||
149084247|NCT00828139|537787878|FG001|Overall Study|Adverse Event|1|||
149084248|NCT00828139|537787879|FG002|Overall Study|Adverse Event|10|||
149084249|NCT00828139|537787880|FG003|Overall Study|Adverse Event|5|||
149084250|NCT00828139|537787877|FG000|Overall Study|Death|2|||
149084251|NCT00828139|537787878|FG001|Overall Study|Death|1|||
149084252|NCT00828139|537787879|FG002|Overall Study|Death|0|||
149084253|NCT00828139|537787880|FG003|Overall Study|Death|2|||
149084254|NCT00828139|537787877|FG000|Overall Study|Refusal unrelated to toxicity|3|||
149084255|NCT00828139|537787878|FG001|Overall Study|Refusal unrelated to toxicity|4|||
149084256|NCT00828139|537787879|FG002|Overall Study|Refusal unrelated to toxicity|5|||
149084257|NCT00828139|537787880|FG003|Overall Study|Refusal unrelated to toxicity|3|||
149084258|NCT00828139|537787877|FG000|Overall Study|Disease Progression|24|||
149084259|NCT00828139|537787878|FG001|Overall Study|Disease Progression|33|||
149084260|NCT00828139|537787879|FG002|Overall Study|Disease Progression|35|||
149084261|NCT00828139|537787880|FG003|Overall Study|Disease Progression|39|||
149084262|NCT00828139|537787877|FG000|Overall Study|Other|4|||
149084263|NCT00828139|537787878|FG001|Overall Study|Other|2|||
149084264|NCT00828139|537787879|FG002|Overall Study|Other|5|||
149084265|NCT00828139|537787880|FG003|Overall Study|Other|2|||
149084266|NCT01714947|537787881|FG000|Part B|Progressive Disease|3|||
149084267|NCT04271254|537787882|FG000|Overall Study|Withdrawal by Subject|3|||
149084268|NCT04751929|537787883|FG000|Overall Study|Withdrawal by Subject|2|||
149084269|NCT04751929|537787884|FG001|Overall Study|Withdrawal by Subject|0|||
149084270|NCT04751929|537787885|FG002|Overall Study|Withdrawal by Subject|0|||
149084271|NCT04751929|537787886|FG003|Overall Study|Withdrawal by Subject|0|||
149084272|NCT04751929|537787883|FG000|Overall Study|Rising PSA|0|||
149084273|NCT04751929|537787884|FG001|Overall Study|Rising PSA|1|||
149084274|NCT04751929|537787885|FG002|Overall Study|Rising PSA|0|||
149084275|NCT04751929|537787886|FG003|Overall Study|Rising PSA|0|||
149084276|NCT04751929|537787883|FG000|Overall Study|Adverse Event|1|||
149084277|NCT04751929|537787884|FG001|Overall Study|Adverse Event|2|||
149084278|NCT04751929|537787885|FG002|Overall Study|Adverse Event|0|||
149084279|NCT04751929|537787886|FG003|Overall Study|Adverse Event|0|||
149084280|NCT04751929|537787883|FG000|Overall Study|Progressive Disease|3|||
149084281|NCT04751929|537787884|FG001|Overall Study|Progressive Disease|4|||
149084282|NCT04751929|537787885|FG002|Overall Study|Progressive Disease|4|||
149084283|NCT04751929|537787886|FG003|Overall Study|Progressive Disease|0|||
149084284|NCT04751929|537787883|FG000|Overall Study|Death|1|||
149084285|NCT04751929|537787884|FG001|Overall Study|Death|1|||
149084286|NCT04751929|537787885|FG002|Overall Study|Death|0|||
149084287|NCT04751929|537787886|FG003|Overall Study|Death|0|||
149084288|NCT01123356|537787887|FG000|Overall Study|Adverse Event|2|||
149084289|NCT01123356|537787887|FG000|Overall Study|Lack of Efficacy|4|||
149084290|NCT01123356|537787887|FG000|Overall Study|Withdrawal by Subject|1|||
149084291|NCT00376259|537787890|FG000|Overall Study|Sponsor request - study termination|21|||
149084292|NCT00376259|537787891|FG001|Overall Study|Sponsor request - study termination|21|||
149084293|NCT00376259|537787890|FG000|Overall Study|Patient request|1|||
149084294|NCT00376259|537787891|FG001|Overall Study|Patient request|0|||
149084295|NCT00930644|537787893|FG000|Overall Study|Withdrawal by Subject|4|||
149084296|NCT00930644|537787893|FG000|Overall Study|Physician Decision|2|||
149084297|NCT00930644|537787893|FG000|Overall Study|Death|1|||
149084298|NCT00930644|537787893|FG000|Overall Study|Adverse Event|16|||
149084299|NCT01877720|537787894|FG000|Overall Study|Adverse Event|1|||
149084300|NCT01877720|537787895|FG001|Overall Study|Adverse Event|0|||
149084301|NCT01129011|537787898|FG000|Overall Study|Adverse Event|20|||
149084302|NCT01129011|537787899|FG001|Overall Study|Adverse Event|30|||
149084303|NCT01129011|537787898|FG000|Overall Study|Withdrawal by Subject|24|||
149084304|NCT01129011|537787899|FG001|Overall Study|Withdrawal by Subject|8|||
149084305|NCT01129011|537787898|FG000|Overall Study|Lost to Follow-up|6|||
149084306|NCT01129011|537787899|FG001|Overall Study|Lost to Follow-up|7|||
149084307|NCT01129011|537787898|FG000|Overall Study|Duodenal Ulcer|2|||
149084308|NCT01129011|537787899|FG001|Overall Study|Duodenal Ulcer|8|||
149084309|NCT01129011|537787898|FG000|Overall Study|misc|7|||
149084310|NCT01129011|537787899|FG001|Overall Study|misc|4|||
149084311|NCT01012999|537787900|FG000|Overall Study|Protocol Violation|1|||
149084312|NCT01369147|537787901|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
149084313|NCT01369147|537787902|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
149084314|NCT01369147|537787903|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
149084315|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
149084316|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
149084317|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
149084318|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
149084319|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
149084320|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
149084321|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
149084322|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
149084323|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
149084324|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
149084325|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
149084326|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
149084327|NCT01494467|537787906|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
149084328|NCT01494467|537787907|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
149084329|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
149084330|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
149084331|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
149084332|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
149084333|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
149084334|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
149084335|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
149084336|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
149084337|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
149084338|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
149084339|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
149084340|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
149084341|NCT01494467|537787906|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
149084342|NCT01494467|537787907|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
149084343|NCT02410278|537787910|FG000|Run-in Period|Adverse Event|5|||
149084344|NCT02410278|537787911|FG001|Run-in Period|Adverse Event|0|||
149084345|NCT02410278|537787912|FG002|Run-in Period|Adverse Event|0|||
149084346|NCT02410278|537787910|FG000|Run-in Period|GSRS Threshold Not Met|30|||
149084347|NCT02410278|537787911|FG001|Run-in Period|GSRS Threshold Not Met|0|||
149084348|NCT02410278|537787912|FG002|Run-in Period|GSRS Threshold Not Met|0|||
149084349|NCT02410278|537787910|FG000|Run-in Period|Lost to Follow-up|1|||
149084350|NCT02410278|537787911|FG001|Run-in Period|Lost to Follow-up|0|||
149084351|NCT02410278|537787912|FG002|Run-in Period|Lost to Follow-up|0|||
149084352|NCT02410278|537787910|FG000|Run-in Period|Withdrawal by Subject|1|||
149084353|NCT02410278|537787911|FG001|Run-in Period|Withdrawal by Subject|0|||
149084354|NCT02410278|537787912|FG002|Run-in Period|Withdrawal by Subject|0|||
149084355|NCT02410278|537787910|FG000|Run-in Period|Pregnancy|1|||
149084356|NCT02410278|537787911|FG001|Run-in Period|Pregnancy|0|||
149084357|NCT02410278|537787912|FG002|Run-in Period|Pregnancy|0|||
149084358|NCT02410278|537787910|FG000|Study Treatment Period|Adverse Event|0|||
149084359|NCT02410278|537787911|FG001|Study Treatment Period|Adverse Event|6|||
149084360|NCT02410278|537787912|FG002|Study Treatment Period|Adverse Event|3|||
149084361|NCT02410278|537787910|FG000|Study Treatment Period|Physician Decision|0|||
149084362|NCT02410278|537787911|FG001|Study Treatment Period|Physician Decision|0|||
149084363|NCT02410278|537787912|FG002|Study Treatment Period|Physician Decision|1|||
149084364|NCT02410278|537787910|FG000|Study Treatment Period|Withdrawal by Subject|0|||
149084365|NCT02410278|537787911|FG001|Study Treatment Period|Withdrawal by Subject|1|||
149084366|NCT02410278|537787912|FG002|Study Treatment Period|Withdrawal by Subject|0|||
149084367|NCT02410278|537787910|FG000|Study Treatment Period|Other|0|||
149084368|NCT02410278|537787911|FG001|Study Treatment Period|Other|3|||
149084369|NCT02410278|537787912|FG002|Study Treatment Period|Other|0|||
149084370|NCT02410278|537787910|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
149084371|NCT02410278|537787911|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
149084372|NCT02410278|537787912|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
149084373|NCT01280721|537787915|FG000|Overall Study|Adverse Event|4|||
149084374|NCT01280721|537787915|FG000|Overall Study|Physician Decision|3|||
149084375|NCT01280721|537787915|FG000|Overall Study|Withdrawal by Subject|6|||
149084376|NCT01280721|537787915|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
149084377|NCT01280721|537787915|FG000|Overall Study|No tolerability for the lowest dose|2|||
149084378|NCT01180400|537787916|FG000|Overall Study|Withdrawal by Subject|5|||
149084379|NCT01180400|537787917|FG001|Overall Study|Withdrawal by Subject|6|||
149084380|NCT01180400|537787916|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
149084381|NCT01180400|537787917|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
149084382|NCT01180400|537787916|FG000|Overall Study|Adverse Event|12|||
149084383|NCT01180400|537787917|FG001|Overall Study|Adverse Event|10|||
149084384|NCT01180400|537787916|FG000|Overall Study|Severe non-compliance to protocol|1|||
149084385|NCT01180400|537787917|FG001|Overall Study|Severe non-compliance to protocol|2|||
149084386|NCT01180400|537787916|FG000|Overall Study|Condition under investigation worsened|2|||
149084387|NCT01180400|537787917|FG001|Overall Study|Condition under investigation worsened|1|||
149084388|NCT01180400|537787916|FG000|Overall Study|Lack of Efficacy|2|||
149084389|NCT01180400|537787917|FG001|Overall Study|Lack of Efficacy|0|||
149084390|NCT01180400|537787916|FG000|Overall Study|Study-specific withdrawal criteria|1|||
149084391|NCT01180400|537787917|FG001|Overall Study|Study-specific withdrawal criteria|2|||
149084392|NCT01180400|537787916|FG000|Overall Study|Lost to Follow-up|2|||
149084393|NCT01180400|537787917|FG001|Overall Study|Lost to Follow-up|3|||
149084394|NCT01180400|537787916|FG000|Overall Study|Other|0|||
149084395|NCT01180400|537787917|FG001|Overall Study|Other|1|||
149084396|NCT01182285|537787919|FG000|First Intervention Week 1-10|Disease progression|1|||
149084397|NCT01182285|537787920|FG001|First Intervention Week 1-10|Disease progression|0|||
149084398|NCT01182285|537787921|FG002|First Intervention Week 1-10|Disease progression|0|||
149084399|NCT01182285|537787919|FG000|First Intervention Week 1-10|Adverse Event|1|||
149084400|NCT01182285|537787920|FG001|First Intervention Week 1-10|Adverse Event|0|||
149084401|NCT01182285|537787921|FG002|First Intervention Week 1-10|Adverse Event|0|||
149084402|NCT01182285|537787919|FG000|First Intervention Week 1-10|Non-compliance|1|||
149084403|NCT01182285|537787920|FG001|First Intervention Week 1-10|Non-compliance|0|||
149084404|NCT01182285|537787921|FG002|First Intervention Week 1-10|Non-compliance|0|||
149084405|NCT01182285|537787919|FG000|Third Intervention Week 11-52|Disease Progression|0|||
149084406|NCT01182285|537787920|FG001|Third Intervention Week 11-52|Disease Progression|0|||
149084407|NCT01182285|537787921|FG002|Third Intervention Week 11-52|Disease Progression|6|||
149084408|NCT01182285|537787919|FG000|Third Intervention Week 11-52|Other|0|||
149084409|NCT01182285|537787920|FG001|Third Intervention Week 11-52|Other|0|||
149084410|NCT01182285|537787921|FG002|Third Intervention Week 11-52|Other|2|||
149084411|NCT03209492|537787922|FG000|Overall Study|Case Report Forms Uncollected|5|||
149084412|NCT01525875|537787923|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
149084413|NCT01525875|537787924|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
149084414|NCT01525875|537787923|FG000|Open-label Period|Lost to Follow-up|0|||
149084415|NCT01525875|537787924|FG001|Open-label Period|Lost to Follow-up|2|||
149084416|NCT02877680|537787927|FG000|Overall Study|Lost to Follow-up|1|||
149084417|NCT02877680|537787928|FG001|Overall Study|Lost to Follow-up|1|||
149084418|NCT01864200|537787935|FG000|Overall Study|Lost to Follow-up|1|||
149084419|NCT01864200|537787936|FG001|Overall Study|Lost to Follow-up|3|||
149084420|NCT01864200|537787935|FG000|Overall Study|Protocol Violation|1|||
149084421|NCT01864200|537787936|FG001|Overall Study|Protocol Violation|0|||
149084422|NCT02077374|537787937|FG000|Overall Study|Withdrawal by Subject|0|||
149084423|NCT02077374|537787938|FG001|Overall Study|Withdrawal by Subject|1|||
149084424|NCT02077374|537787937|FG000|Overall Study|Protocol Violation|0|||
149084425|NCT02077374|537787938|FG001|Overall Study|Protocol Violation|1|||
149084426|NCT00424476|537787942|FG000|Overall Study|Withdrawal by Subject|7|||
149084427|NCT00424476|537787943|FG001|Overall Study|Withdrawal by Subject|6|||
149084428|NCT00424476|537787944|FG002|Overall Study|Withdrawal by Subject|3|||
149084429|NCT00424476|537787942|FG000|Overall Study|Adverse Event|19|||
149084430|NCT00424476|537787943|FG001|Overall Study|Adverse Event|16|||
149084431|NCT00424476|537787944|FG002|Overall Study|Adverse Event|15|||
149084432|NCT00424476|537787942|FG000|Overall Study|Lack of Efficacy|16|||
149084433|NCT00424476|537787943|FG001|Overall Study|Lack of Efficacy|12|||
149084434|NCT00424476|537787944|FG002|Overall Study|Lack of Efficacy|12|||
149084435|NCT00424476|537787942|FG000|Overall Study|Lack of Compliance|1|||
149084436|NCT00424476|537787943|FG001|Overall Study|Lack of Compliance|1|||
149084437|NCT00424476|537787944|FG002|Overall Study|Lack of Compliance|1|||
149084438|NCT00424476|537787942|FG000|Overall Study|Lost to Follow-up|4|||
149084439|NCT00424476|537787943|FG001|Overall Study|Lost to Follow-up|6|||
149084440|NCT00424476|537787944|FG002|Overall Study|Lost to Follow-up|3|||
149084441|NCT00424476|537787942|FG000|Overall Study|Protocol Violation|7|||
149084442|NCT00424476|537787943|FG001|Overall Study|Protocol Violation|2|||
149084443|NCT00424476|537787944|FG002|Overall Study|Protocol Violation|3|||
149084444|NCT00424476|537787942|FG000|Overall Study|Physician Decision|3|||
149084445|NCT00424476|537787943|FG001|Overall Study|Physician Decision|2|||
149084446|NCT00424476|537787944|FG002|Overall Study|Physician Decision|3|||
149084447|NCT00424476|537787942|FG000|Overall Study|Other|4|||
149084448|NCT00424476|537787943|FG001|Overall Study|Other|3|||
149084449|NCT00424476|537787944|FG002|Overall Study|Other|9|||
149084450|NCT00529529|537787947|FG000|Overall Study|Adverse Event|12|||
149084451|NCT00529529|537787948|FG001|Overall Study|Adverse Event|17|||
149084452|NCT00529529|537787949|FG002|Overall Study|Adverse Event|8|||
149084453|NCT00529529|537787947|FG000|Overall Study|Subject withdrew consent|12|||
149084454|NCT00529529|537787948|FG001|Overall Study|Subject withdrew consent|9|||
149084455|NCT00529529|537787949|FG002|Overall Study|Subject withdrew consent|12|||
149084456|NCT00529529|537787947|FG000|Overall Study|Protocol deviation|8|||
149084457|NCT00529529|537787948|FG001|Overall Study|Protocol deviation|12|||
149084458|NCT00529529|537787949|FG002|Overall Study|Protocol deviation|5|||
149084459|NCT00529529|537787947|FG000|Overall Study|Lost to Follow-up|5|||
149084460|NCT00529529|537787948|FG001|Overall Study|Lost to Follow-up|3|||
149084461|NCT00529529|537787949|FG002|Overall Study|Lost to Follow-up|1|||
149084462|NCT00529529|537787947|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
149084463|NCT00529529|537787948|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149084464|NCT00529529|537787949|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
149084465|NCT00529529|537787947|FG000|Overall Study|Death|2|||
149084466|NCT00529529|537787948|FG001|Overall Study|Death|0|||
149084467|NCT00529529|537787949|FG002|Overall Study|Death|0|||
149084468|NCT00529529|537787947|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149084469|NCT00529529|537787948|FG001|Overall Study|Abnormal test procedure result(s)|0|||
149084470|NCT00529529|537787949|FG002|Overall Study|Abnormal test procedure result(s)|0|||
149084471|NCT00529529|537787947|FG000|Overall Study|Administrative problems|1|||
149084472|NCT00529529|537787948|FG001|Overall Study|Administrative problems|0|||
149084473|NCT00529529|537787949|FG002|Overall Study|Administrative problems|3|||
149084474|NCT01020435|537787954|FG000|Overall Study|Lost to Follow-up|0|||
149084475|NCT01020435|537787955|FG001|Overall Study|Lost to Follow-up|1|||
149084476|NCT01000649|537787956|FG000|Overall Study|Adverse Event|5|||
149084477|NCT01000649|537787957|FG001|Overall Study|Adverse Event|1|||
149084478|NCT01000649|537787958|FG002|Overall Study|Adverse Event|2|||
149084479|NCT01000649|537787959|FG003|Overall Study|Adverse Event|4|||
149084480|NCT01000649|537787956|FG000|Overall Study|Lost to Follow-up|0|||
149084481|NCT01000649|537787957|FG001|Overall Study|Lost to Follow-up|2|||
149084482|NCT01000649|537787958|FG002|Overall Study|Lost to Follow-up|0|||
149084483|NCT01000649|537787959|FG003|Overall Study|Lost to Follow-up|2|||
149084484|NCT01916109|537787960|FG000|Overall Study|Withdrawal by Subject|1|||
149084485|NCT00103857|537787961|FG000|54-Week Base Study|Adverse Event|12|||
149084486|NCT00103857|537787962|FG001|54-Week Base Study|Adverse Event|9|||
149084487|NCT00103857|537787963|FG002|54-Week Base Study|Adverse Event|11|||
149084488|NCT00103857|537787964|FG003|54-Week Base Study|Adverse Event|6|||
149084489|NCT00103857|537787965|FG004|54-Week Base Study|Adverse Event|5|||
149084490|NCT00103857|537787966|FG005|54-Week Base Study|Adverse Event|11|||
149084491|NCT00103857|537787967|FG006|54-Week Base Study|Adverse Event|3|||
149084492|NCT00103857|537787961|FG000|54-Week Base Study|Death|0|||
149084493|NCT00103857|537787962|FG001|54-Week Base Study|Death|0|||
149084494|NCT00103857|537787963|FG002|54-Week Base Study|Death|0|||
149084495|NCT00103857|537787964|FG003|54-Week Base Study|Death|0|||
149084496|NCT00103857|537787965|FG004|54-Week Base Study|Death|1|||
149084497|NCT00103857|537787966|FG005|54-Week Base Study|Death|1|||
149084498|NCT00103857|537787967|FG006|54-Week Base Study|Death|0|||
149084499|NCT00103857|537787961|FG000|54-Week Base Study|Lack of Efficacy|11|||
149084500|NCT00103857|537787962|FG001|54-Week Base Study|Lack of Efficacy|14|||
149084501|NCT00103857|537787963|FG002|54-Week Base Study|Lack of Efficacy|8|||
149084502|NCT00103857|537787964|FG003|54-Week Base Study|Lack of Efficacy|4|||
149084503|NCT00103857|537787965|FG004|54-Week Base Study|Lack of Efficacy|3|||
149084504|NCT00103857|537787966|FG005|54-Week Base Study|Lack of Efficacy|14|||
149084505|NCT00103857|537787967|FG006|54-Week Base Study|Lack of Efficacy|19|||
149084506|NCT00103857|537787961|FG000|54-Week Base Study|Lost to Follow-up|5|||
149084507|NCT00103857|537787962|FG001|54-Week Base Study|Lost to Follow-up|4|||
149084508|NCT00103857|537787963|FG002|54-Week Base Study|Lost to Follow-up|7|||
149084509|NCT00103857|537787964|FG003|54-Week Base Study|Lost to Follow-up|5|||
149084510|NCT00103857|537787965|FG004|54-Week Base Study|Lost to Follow-up|10|||
149084511|NCT00103857|537787966|FG005|54-Week Base Study|Lost to Follow-up|9|||
149084512|NCT00103857|537787967|FG006|54-Week Base Study|Lost to Follow-up|3|||
149084513|NCT00103857|537787961|FG000|54-Week Base Study|Physician Decision|1|||
149084514|NCT00103857|537787962|FG001|54-Week Base Study|Physician Decision|1|||
149084515|NCT00103857|537787963|FG002|54-Week Base Study|Physician Decision|0|||
149084516|NCT00103857|537787964|FG003|54-Week Base Study|Physician Decision|0|||
149084517|NCT00103857|537787965|FG004|54-Week Base Study|Physician Decision|1|||
149084518|NCT00103857|537787966|FG005|54-Week Base Study|Physician Decision|0|||
149084519|NCT00103857|537787967|FG006|54-Week Base Study|Physician Decision|0|||
149084520|NCT00103857|537787961|FG000|54-Week Base Study|Pregnancy|1|||
149084521|NCT00103857|537787962|FG001|54-Week Base Study|Pregnancy|0|||
149084522|NCT00103857|537787963|FG002|54-Week Base Study|Pregnancy|0|||
149084523|NCT00103857|537787964|FG003|54-Week Base Study|Pregnancy|0|||
149084524|NCT00103857|537787965|FG004|54-Week Base Study|Pregnancy|1|||
149084525|NCT00103857|537787966|FG005|54-Week Base Study|Pregnancy|0|||
149084526|NCT00103857|537787967|FG006|54-Week Base Study|Pregnancy|1|||
149084527|NCT00103857|537787961|FG000|54-Week Base Study|Protocol Violation|6|||
149084528|NCT00103857|537787962|FG001|54-Week Base Study|Protocol Violation|4|||
149084529|NCT00103857|537787963|FG002|54-Week Base Study|Protocol Violation|2|||
149084530|NCT00103857|537787964|FG003|54-Week Base Study|Protocol Violation|4|||
149084531|NCT00103857|537787965|FG004|54-Week Base Study|Protocol Violation|0|||
149084532|NCT00103857|537787966|FG005|54-Week Base Study|Protocol Violation|3|||
149084533|NCT00103857|537787967|FG006|54-Week Base Study|Protocol Violation|3|||
149084534|NCT00103857|537787961|FG000|54-Week Base Study|Withdrawal by Subject|17|||
149084535|NCT00103857|537787962|FG001|54-Week Base Study|Withdrawal by Subject|16|||
149084536|NCT00103857|537787963|FG002|54-Week Base Study|Withdrawal by Subject|16|||
149084537|NCT00103857|537787964|FG003|54-Week Base Study|Withdrawal by Subject|15|||
149084538|NCT00103857|537787965|FG004|54-Week Base Study|Withdrawal by Subject|10|||
149084539|NCT00103857|537787966|FG005|54-Week Base Study|Withdrawal by Subject|15|||
149084540|NCT00103857|537787967|FG006|54-Week Base Study|Withdrawal by Subject|4|||
149084541|NCT00103857|537787961|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
149084542|NCT00103857|537787962|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
149084543|NCT00103857|537787963|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
149084544|NCT00103857|537787964|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
149084545|NCT00103857|537787965|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
149084546|NCT00103857|537787966|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
149084547|NCT00103857|537787967|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
149084548|NCT00103857|537787961|FG000|54-Week Base Study|patient moved|0|||
149084549|NCT00103857|537787962|FG001|54-Week Base Study|patient moved|1|||
149084550|NCT00103857|537787963|FG002|54-Week Base Study|patient moved|1|||
149084551|NCT00103857|537787964|FG003|54-Week Base Study|patient moved|2|||
149084552|NCT00103857|537787965|FG004|54-Week Base Study|patient moved|3|||
149084553|NCT00103857|537787966|FG005|54-Week Base Study|patient moved|1|||
149084554|NCT00103857|537787967|FG006|54-Week Base Study|patient moved|0|||
149084555|NCT00103857|537787961|FG000|54-Week Base Study|non-compliance with study procedures|1|||
149084556|NCT00103857|537787962|FG001|54-Week Base Study|non-compliance with study procedures|2|||
149084557|NCT00103857|537787963|FG002|54-Week Base Study|non-compliance with study procedures|0|||
149084558|NCT00103857|537787964|FG003|54-Week Base Study|non-compliance with study procedures|0|||
149084559|NCT00103857|537787965|FG004|54-Week Base Study|non-compliance with study procedures|0|||
149084560|NCT00103857|537787966|FG005|54-Week Base Study|non-compliance with study procedures|2|||
149084561|NCT00103857|537787967|FG006|54-Week Base Study|non-compliance with study procedures|0|||
149084562|NCT00103857|537787961|FG000|54-Week Base Study|patient incarcerated|0|||
149084563|NCT00103857|537787962|FG001|54-Week Base Study|patient incarcerated|0|||
149084564|NCT00103857|537787963|FG002|54-Week Base Study|patient incarcerated|0|||
149084565|NCT00103857|537787964|FG003|54-Week Base Study|patient incarcerated|0|||
149084566|NCT00103857|537787965|FG004|54-Week Base Study|patient incarcerated|1|||
149084567|NCT00103857|537787966|FG005|54-Week Base Study|patient incarcerated|1|||
149084568|NCT00103857|537787967|FG006|54-Week Base Study|patient incarcerated|0|||
149084569|NCT00103857|537787961|FG000|54-Week Base Study|laboratory reporting error|0|||
149084570|NCT00103857|537787962|FG001|54-Week Base Study|laboratory reporting error|0|||
149084571|NCT00103857|537787963|FG002|54-Week Base Study|laboratory reporting error|0|||
149084572|NCT00103857|537787964|FG003|54-Week Base Study|laboratory reporting error|0|||
149084573|NCT00103857|537787965|FG004|54-Week Base Study|laboratory reporting error|1|||
149084574|NCT00103857|537787966|FG005|54-Week Base Study|laboratory reporting error|0|||
149084575|NCT00103857|537787967|FG006|54-Week Base Study|laboratory reporting error|0|||
149084576|NCT00103857|537787961|FG000|54-Week Base Study|site error|0|||
149084577|NCT00103857|537787962|FG001|54-Week Base Study|site error|0|||
149084578|NCT00103857|537787963|FG002|54-Week Base Study|site error|0|||
149084579|NCT00103857|537787964|FG003|54-Week Base Study|site error|0|||
149084580|NCT00103857|537787965|FG004|54-Week Base Study|site error|0|||
149084581|NCT00103857|537787966|FG005|54-Week Base Study|site error|1|||
149084582|NCT00103857|537787967|FG006|54-Week Base Study|site error|0|||
149084583|NCT00103857|537787961|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
149084584|NCT00103857|537787962|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
149084585|NCT00103857|537787963|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
149084586|NCT00103857|537787964|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
149084587|NCT00103857|537787965|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
149084588|NCT00103857|537787966|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
149084589|NCT00103857|537787967|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
149084590|NCT00103857|537787961|FG000|50-Week Extension Study|Adverse Event|2|||
149084591|NCT00103857|537787962|FG001|50-Week Extension Study|Adverse Event|3|||
149084592|NCT00103857|537787963|FG002|50-Week Extension Study|Adverse Event|2|||
149084593|NCT00103857|537787964|FG003|50-Week Extension Study|Adverse Event|0|||
149084594|NCT00103857|537787965|FG004|50-Week Extension Study|Adverse Event|1|||
149084595|NCT00103857|537787966|FG005|50-Week Extension Study|Adverse Event|1|||
149084596|NCT00103857|537787967|FG006|50-Week Extension Study|Adverse Event|0|||
149084597|NCT00103857|537787961|FG000|50-Week Extension Study|Death|0|||
149084598|NCT00103857|537787962|FG001|50-Week Extension Study|Death|0|||
149084599|NCT00103857|537787963|FG002|50-Week Extension Study|Death|0|||
149084600|NCT00103857|537787964|FG003|50-Week Extension Study|Death|1|||
149084601|NCT00103857|537787965|FG004|50-Week Extension Study|Death|0|||
149084602|NCT00103857|537787966|FG005|50-Week Extension Study|Death|1|||
149084603|NCT00103857|537787967|FG006|50-Week Extension Study|Death|0|||
149084604|NCT00103857|537787961|FG000|50-Week Extension Study|Lack of Efficacy|26|||
149084605|NCT00103857|537787962|FG001|50-Week Extension Study|Lack of Efficacy|15|||
149084606|NCT00103857|537787963|FG002|50-Week Extension Study|Lack of Efficacy|13|||
149084607|NCT00103857|537787964|FG003|50-Week Extension Study|Lack of Efficacy|16|||
149084608|NCT00103857|537787965|FG004|50-Week Extension Study|Lack of Efficacy|8|||
149084609|NCT00103857|537787966|FG005|50-Week Extension Study|Lack of Efficacy|8|||
149084610|NCT00103857|537787967|FG006|50-Week Extension Study|Lack of Efficacy|0|||
149084611|NCT00103857|537787961|FG000|50-Week Extension Study|Lost to Follow-up|4|||
149084612|NCT00103857|537787962|FG001|50-Week Extension Study|Lost to Follow-up|0|||
149084613|NCT00103857|537787963|FG002|50-Week Extension Study|Lost to Follow-up|1|||
149084614|NCT00103857|537787964|FG003|50-Week Extension Study|Lost to Follow-up|4|||
149084615|NCT00103857|537787965|FG004|50-Week Extension Study|Lost to Follow-up|3|||
149084616|NCT00103857|537787966|FG005|50-Week Extension Study|Lost to Follow-up|3|||
149084617|NCT00103857|537787967|FG006|50-Week Extension Study|Lost to Follow-up|0|||
149084618|NCT00103857|537787961|FG000|50-Week Extension Study|Physician Decision|0|||
149084619|NCT00103857|537787962|FG001|50-Week Extension Study|Physician Decision|1|||
149084620|NCT00103857|537787963|FG002|50-Week Extension Study|Physician Decision|1|||
149084621|NCT00103857|537787964|FG003|50-Week Extension Study|Physician Decision|0|||
149084622|NCT00103857|537787965|FG004|50-Week Extension Study|Physician Decision|0|||
149084623|NCT00103857|537787966|FG005|50-Week Extension Study|Physician Decision|0|||
149084624|NCT00103857|537787967|FG006|50-Week Extension Study|Physician Decision|0|||
149084625|NCT00103857|537787961|FG000|50-Week Extension Study|Pregnancy|0|||
149084626|NCT00103857|537787962|FG001|50-Week Extension Study|Pregnancy|0|||
149084627|NCT00103857|537787963|FG002|50-Week Extension Study|Pregnancy|1|||
149084628|NCT00103857|537787964|FG003|50-Week Extension Study|Pregnancy|0|||
149084629|NCT00103857|537787965|FG004|50-Week Extension Study|Pregnancy|1|||
149084630|NCT00103857|537787966|FG005|50-Week Extension Study|Pregnancy|0|||
149084631|NCT00103857|537787967|FG006|50-Week Extension Study|Pregnancy|0|||
149084632|NCT00103857|537787961|FG000|50-Week Extension Study|Protocol Violation|1|||
149084633|NCT00103857|537787962|FG001|50-Week Extension Study|Protocol Violation|1|||
149084634|NCT00103857|537787963|FG002|50-Week Extension Study|Protocol Violation|1|||
149084635|NCT00103857|537787964|FG003|50-Week Extension Study|Protocol Violation|2|||
149084636|NCT00103857|537787965|FG004|50-Week Extension Study|Protocol Violation|0|||
149084637|NCT00103857|537787966|FG005|50-Week Extension Study|Protocol Violation|1|||
149084638|NCT00103857|537787967|FG006|50-Week Extension Study|Protocol Violation|0|||
149084639|NCT00103857|537787961|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
149084640|NCT00103857|537787962|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
149084641|NCT00103857|537787963|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
149084642|NCT00103857|537787964|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
149084643|NCT00103857|537787965|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
149084644|NCT00103857|537787966|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
149084645|NCT00103857|537787967|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
149084646|NCT00103857|537787961|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
149084647|NCT00103857|537787962|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
149084648|NCT00103857|537787963|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
149084649|NCT00103857|537787964|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
149084650|NCT00103857|537787965|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
149084651|NCT00103857|537787966|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
149084652|NCT00103857|537787967|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
149084653|NCT00103857|537787961|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
149084654|NCT00103857|537787962|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
149084655|NCT00103857|537787963|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
149084656|NCT00103857|537787964|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
149084657|NCT00103857|537787965|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
149084658|NCT00103857|537787966|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
149084659|NCT00103857|537787967|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
149084660|NCT00103857|537787961|FG000|50-Week Extension Study|patient moved|0|||
149084661|NCT00103857|537787962|FG001|50-Week Extension Study|patient moved|0|||
149084662|NCT00103857|537787963|FG002|50-Week Extension Study|patient moved|1|||
149084663|NCT00103857|537787964|FG003|50-Week Extension Study|patient moved|2|||
149084664|NCT00103857|537787965|FG004|50-Week Extension Study|patient moved|0|||
149084665|NCT00103857|537787966|FG005|50-Week Extension Study|patient moved|0|||
149084666|NCT00103857|537787967|FG006|50-Week Extension Study|patient moved|0|||
149084667|NCT00103857|537787961|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
149084668|NCT00103857|537787962|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
149084669|NCT00103857|537787963|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
149084670|NCT00103857|537787964|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
149084671|NCT00103857|537787965|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
149084672|NCT00103857|537787966|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
149084673|NCT00103857|537787967|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
149084674|NCT00103857|537787961|FG000|50-Week Extension Study|reason unspecified|0|||
149084675|NCT00103857|537787962|FG001|50-Week Extension Study|reason unspecified|0|||
149084676|NCT00103857|537787963|FG002|50-Week Extension Study|reason unspecified|0|||
149084677|NCT00103857|537787964|FG003|50-Week Extension Study|reason unspecified|0|||
149084678|NCT00103857|537787965|FG004|50-Week Extension Study|reason unspecified|1|||
149084679|NCT00103857|537787966|FG005|50-Week Extension Study|reason unspecified|0|||
149084680|NCT00103857|537787967|FG006|50-Week Extension Study|reason unspecified|0|||
149084681|NCT01856569|537787968|FG000|Overall Study|Other|1|||
149084682|NCT01856569|537787968|FG000|Overall Study|Changed Site/Structure|1|||
149084683|NCT01856569|537787968|FG000|Overall Study|Lost to Follow-up|3|||
149084684|NCT01856569|537787968|FG000|Overall Study|Did not met inclusion criteria|8|||
149084685|NCT02707952|537787969|FG000|Overall Study|Adverse Event|1|||
149084686|NCT02707952|537787970|FG001|Overall Study|Adverse Event|0|||
149084687|NCT02707952|537787971|FG002|Overall Study|Adverse Event|0|||
149084688|NCT02707952|537787972|FG003|Overall Study|Adverse Event|0|||
149084689|NCT02707952|537787969|FG000|Overall Study|Lost to Follow-up|1|||
149084690|NCT02707952|537787970|FG001|Overall Study|Lost to Follow-up|0|||
149084691|NCT02707952|537787971|FG002|Overall Study|Lost to Follow-up|0|||
149084692|NCT02707952|537787972|FG003|Overall Study|Lost to Follow-up|0|||
149084693|NCT02707952|537787969|FG000|Overall Study|Withdrawal by Subject|0|||
149084694|NCT02707952|537787970|FG001|Overall Study|Withdrawal by Subject|1|||
149084695|NCT02707952|537787971|FG002|Overall Study|Withdrawal by Subject|2|||
149084696|NCT02707952|537787972|FG003|Overall Study|Withdrawal by Subject|0|||
149084697|NCT00696241|537787973|FG000|Overall Study|Adverse Event|11|||
149084698|NCT00696241|537787974|FG001|Overall Study|Adverse Event|3|||
149084699|NCT00696241|537787975|FG002|Overall Study|Adverse Event|6|||
149084700|NCT00696241|537787976|FG003|Overall Study|Adverse Event|4|||
149084701|NCT00696241|537787977|FG004|Overall Study|Adverse Event|5|||
149084702|NCT00696241|537787973|FG000|Overall Study|Protocol Violation|1|||
149084703|NCT00696241|537787974|FG001|Overall Study|Protocol Violation|1|||
149084704|NCT00696241|537787975|FG002|Overall Study|Protocol Violation|2|||
149084705|NCT00696241|537787976|FG003|Overall Study|Protocol Violation|0|||
149084706|NCT00696241|537787977|FG004|Overall Study|Protocol Violation|3|||
149084707|NCT00696241|537787973|FG000|Overall Study|Lost to Follow-up|1|||
149084708|NCT00696241|537787974|FG001|Overall Study|Lost to Follow-up|4|||
149084709|NCT00696241|537787975|FG002|Overall Study|Lost to Follow-up|1|||
149084710|NCT00696241|537787976|FG003|Overall Study|Lost to Follow-up|2|||
149084711|NCT00696241|537787977|FG004|Overall Study|Lost to Follow-up|0|||
149084712|NCT00696241|537787973|FG000|Overall Study|Withdrawal by Subject|4|||
149084713|NCT00696241|537787974|FG001|Overall Study|Withdrawal by Subject|8|||
149084714|NCT00696241|537787975|FG002|Overall Study|Withdrawal by Subject|6|||
149084715|NCT00696241|537787976|FG003|Overall Study|Withdrawal by Subject|1|||
149084716|NCT00696241|537787977|FG004|Overall Study|Withdrawal by Subject|0|||
149084717|NCT00696241|537787973|FG000|Overall Study|Lack of Efficacy|1|||
149084718|NCT00696241|537787974|FG001|Overall Study|Lack of Efficacy|5|||
149084719|NCT00696241|537787975|FG002|Overall Study|Lack of Efficacy|4|||
149084720|NCT00696241|537787976|FG003|Overall Study|Lack of Efficacy|5|||
149084721|NCT00696241|537787977|FG004|Overall Study|Lack of Efficacy|3|||
149084722|NCT00696241|537787973|FG000|Overall Study|Other|6|||
149084723|NCT00696241|537787974|FG001|Overall Study|Other|1|||
149084724|NCT00696241|537787975|FG002|Overall Study|Other|5|||
149084725|NCT00696241|537787976|FG003|Overall Study|Other|2|||
149084726|NCT00696241|537787977|FG004|Overall Study|Other|1|||
149084727|NCT03065400|537787978|FG000|Overall Study|Adverse Event|1|||
149084728|NCT03065400|537787978|FG000|Overall Study|Physician Decision|3|||
149084729|NCT03065400|537787978|FG000|Overall Study|Withdrawal by Subject|1|||
149084730|NCT03065400|537787978|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
149084731|NCT03060525|537787979|FG000|Overall Study|moved out of state|1|||
149084732|NCT03060525|537787980|FG001|Overall Study|moved out of state|1|||
149084733|NCT03060525|537787981|FG002|Overall Study|moved out of state|1|||
149084734|NCT03060525|537787982|FG003|Overall Study|moved out of state|1|||
149084735|NCT03060525|537787979|FG000|Overall Study|unable to meet time commitment required of study|2|||
149084736|NCT03060525|537787980|FG001|Overall Study|unable to meet time commitment required of study|3|||
149084737|NCT03060525|537787981|FG002|Overall Study|unable to meet time commitment required of study|3|||
149084738|NCT03060525|537787982|FG003|Overall Study|unable to meet time commitment required of study|1|||
149084739|NCT03060525|537787979|FG000|Overall Study|no longer interested in doing intervention|0|||
149084740|NCT03060525|537787980|FG001|Overall Study|no longer interested in doing intervention|0|||
149084741|NCT03060525|537787981|FG002|Overall Study|no longer interested in doing intervention|0|||
149084742|NCT03060525|537787982|FG003|Overall Study|no longer interested in doing intervention|1|||
149084743|NCT02147093|537787983|FG000|Period 1|Lost to Follow-up|0|||
149084744|NCT02147093|537787984|FG001|Period 1|Lost to Follow-up|1|||
149084745|NCT02147093|537787983|FG000|Period 2|Protocol Violation|2|||
149084746|NCT02147093|537787984|FG001|Period 2|Protocol Violation|0|||
149084747|NCT02189759|537787990|FG000|Overall Study|Lost to Follow-up|0|||
149084748|NCT02189759|537787991|FG001|Overall Study|Lost to Follow-up|0|||
149084749|NCT02189759|537787992|FG002|Overall Study|Lost to Follow-up|2|||
149084750|NCT02189759|537787993|FG003|Overall Study|Lost to Follow-up|5|||
149084751|NCT01147471|537787994|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
149084752|NCT01147471|537787995|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
149084753|NCT01147471|537787994|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
149084754|NCT01147471|537787995|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
149084755|NCT01147471|537787994|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
149084756|NCT01147471|537787995|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
149084757|NCT01147471|537787994|FG000|3 Month Follow Up|Lost to Follow-up|1|||
149084758|NCT01147471|537787995|FG001|3 Month Follow Up|Lost to Follow-up|1|||
149084759|NCT01147471|537787994|FG000|3 Month Follow Up|Physician Decision|0|||
149084760|NCT01147471|537787995|FG001|3 Month Follow Up|Physician Decision|1|||
149084761|NCT01147471|537787994|FG000|6 Month Follow Up|Lost to Follow-up|4|||
149084762|NCT01147471|537787995|FG001|6 Month Follow Up|Lost to Follow-up|2|||
149084763|NCT03890484|537788001|FG000|Overall Study|Lost to Follow-up|1|||
149084764|NCT03890484|537788002|FG001|Overall Study|Lost to Follow-up|1|||
149084765|NCT00518206|537788003|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
149084766|NCT00518206|537788004|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
149084767|NCT00518206|537788003|FG000|Overall Study|Withdrawal by Subject|2|||
149084768|NCT00518206|537788004|FG001|Overall Study|Withdrawal by Subject|0|||
149084769|NCT00518206|537788003|FG000|Overall Study|Drug Supply Issue|1|||
149084770|NCT00518206|537788004|FG001|Overall Study|Drug Supply Issue|0|||
149084771|NCT00518206|537788003|FG000|Overall Study|Reason Unknown|1|||
149084772|NCT00518206|537788004|FG001|Overall Study|Reason Unknown|0|||
149084773|NCT00518206|537788003|FG000|Overall Study|Completion Status Unknown|1|||
149084774|NCT00518206|537788004|FG001|Overall Study|Completion Status Unknown|0|||
149084775|NCT01294644|537788005|FG000|Overall Study|Adverse Event|2|||
149084776|NCT01294644|537788006|FG001|Overall Study|Adverse Event|0|||
149084777|NCT01294644|537788007|FG002|Overall Study|Adverse Event|1|||
149084778|NCT01294644|537788005|FG000|Overall Study|Withdrawal by Subject|3|||
149084779|NCT01294644|537788006|FG001|Overall Study|Withdrawal by Subject|7|||
149084780|NCT01294644|537788007|FG002|Overall Study|Withdrawal by Subject|4|||
149084781|NCT01294644|537788005|FG000|Overall Study|Lost to Follow-up|3|||
149084782|NCT01294644|537788006|FG001|Overall Study|Lost to Follow-up|2|||
149084783|NCT01294644|537788007|FG002|Overall Study|Lost to Follow-up|5|||
149084784|NCT01294644|537788005|FG000|Overall Study|Miscellaneous Reason|2|||
149084785|NCT01294644|537788006|FG001|Overall Study|Miscellaneous Reason|1|||
149084786|NCT01294644|537788007|FG002|Overall Study|Miscellaneous Reason|4|||
149084787|NCT02188459|537788008|FG000|Overall Study|Lost to Follow-up|3|||
149084788|NCT02188459|537788009|FG001|Overall Study|Lost to Follow-up|4|||
149084789|NCT02188459|537788008|FG000|Overall Study|Early Termination|0|||
149084790|NCT02188459|537788009|FG001|Overall Study|Early Termination|3|||
149084791|NCT02548585|537788010|FG000|Overall Study|Withdrawal by Subject|0|||
149084792|NCT02548585|537788011|FG001|Overall Study|Withdrawal by Subject|0|||
149084793|NCT02548585|537788012|FG002|Overall Study|Withdrawal by Subject|0|||
149084794|NCT02548585|537788013|FG003|Overall Study|Withdrawal by Subject|0|||
149084795|NCT02548585|537788014|FG004|Overall Study|Withdrawal by Subject|0|||
149084796|NCT02548585|537788015|FG005|Overall Study|Withdrawal by Subject|1|||
149084797|NCT02548585|537788016|FG006|Overall Study|Withdrawal by Subject|0|||
149084798|NCT02548585|537788010|FG000|Overall Study|Lost to Follow-up|1|||
149084799|NCT02548585|537788011|FG001|Overall Study|Lost to Follow-up|0|||
149084800|NCT02548585|537788012|FG002|Overall Study|Lost to Follow-up|0|||
149084801|NCT02548585|537788013|FG003|Overall Study|Lost to Follow-up|0|||
149084802|NCT02548585|537788014|FG004|Overall Study|Lost to Follow-up|0|||
149084803|NCT02548585|537788015|FG005|Overall Study|Lost to Follow-up|0|||
149084804|NCT02548585|537788016|FG006|Overall Study|Lost to Follow-up|0|||
149084805|NCT02548585|537788010|FG000|Overall Study|Other|1|||
149084806|NCT02548585|537788011|FG001|Overall Study|Other|0|||
149084807|NCT02548585|537788012|FG002|Overall Study|Other|0|||
149084808|NCT02548585|537788013|FG003|Overall Study|Other|2|||
149084809|NCT02548585|537788014|FG004|Overall Study|Other|3|||
149084810|NCT02548585|537788015|FG005|Overall Study|Other|0|||
149084811|NCT02548585|537788016|FG006|Overall Study|Other|1|||
149084812|NCT02548585|537788010|FG000|Overall Study|Randomized but not treated|0|||
149084813|NCT02548585|537788011|FG001|Overall Study|Randomized but not treated|0|||
149084814|NCT02548585|537788012|FG002|Overall Study|Randomized but not treated|0|||
149084815|NCT02548585|537788013|FG003|Overall Study|Randomized but not treated|0|||
149084816|NCT02548585|537788014|FG004|Overall Study|Randomized but not treated|0|||
149084817|NCT02548585|537788015|FG005|Overall Study|Randomized but not treated|1|||
149084818|NCT02548585|537788016|FG006|Overall Study|Randomized but not treated|0|||
149084819|NCT02612285|537788017|FG000|Overall Study|Withdrawal by Subject|1|||
149084820|NCT00853957|537788022|FG000|Overall Study|Adverse Event|9|||
149084821|NCT00853957|537788023|FG001|Overall Study|Adverse Event|3|||
149084822|NCT00853957|537788022|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149084823|NCT00853957|537788023|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149084824|NCT00853957|537788022|FG000|Overall Study|Subject withdrew consent|4|||
149084825|NCT00853957|537788023|FG001|Overall Study|Subject withdrew consent|5|||
149084826|NCT00853957|537788022|FG000|Overall Study|Lost to Follow-up|1|||
149084827|NCT00853957|537788023|FG001|Overall Study|Lost to Follow-up|6|||
149084828|NCT00853957|537788022|FG000|Overall Study|Protocol deviation|0|||
149084829|NCT00853957|537788023|FG001|Overall Study|Protocol deviation|3|||
149084830|NCT02942771|537788024|FG000|Overall Study|Adverse Event|1|||
149084831|NCT02942771|537788025|FG001|Overall Study|Adverse Event|0|||
149084832|NCT02942771|537788026|FG002|Overall Study|Adverse Event|0|||
149084833|NCT02942771|537788027|FG003|Overall Study|Adverse Event|0|||
149084834|NCT02942771|537788028|FG004|Overall Study|Adverse Event|2|||
149084835|NCT02942771|537788024|FG000|Overall Study|Lost to Follow-up|1|||
149084836|NCT02942771|537788025|FG001|Overall Study|Lost to Follow-up|0|||
149084837|NCT02942771|537788026|FG002|Overall Study|Lost to Follow-up|0|||
149084838|NCT02942771|537788027|FG003|Overall Study|Lost to Follow-up|0|||
149084839|NCT02942771|537788028|FG004|Overall Study|Lost to Follow-up|0|||
149084840|NCT02942771|537788024|FG000|Overall Study|Withdrawal by Subject|1|||
149084841|NCT02942771|537788025|FG001|Overall Study|Withdrawal by Subject|0|||
149084842|NCT02942771|537788026|FG002|Overall Study|Withdrawal by Subject|0|||
149084843|NCT02942771|537788027|FG003|Overall Study|Withdrawal by Subject|0|||
149084844|NCT02942771|537788028|FG004|Overall Study|Withdrawal by Subject|2|||
149084845|NCT04919499|537788029|FG000|Overall Study|Adverse Event|0|||
149084846|NCT04919499|537788030|FG001|Overall Study|Adverse Event|0|||
149084847|NCT04919499|537788031|FG002|Overall Study|Adverse Event|0|||
149084848|NCT04919499|537788032|FG003|Overall Study|Adverse Event|0|||
149084849|NCT04919499|537788033|FG004|Overall Study|Adverse Event|2|||
149084850|NCT04919499|537788029|FG000|Overall Study|Not treated|0|||
149084851|NCT04919499|537788030|FG001|Overall Study|Not treated|0|||
149084852|NCT04919499|537788031|FG002|Overall Study|Not treated|0|||
149084853|NCT04919499|537788032|FG003|Overall Study|Not treated|1|||
149084854|NCT04919499|537788033|FG004|Overall Study|Not treated|0|||
149084855|NCT03884478|537789533|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
149084856|NCT03884478|537789534|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
149084857|NCT03884478|537789535|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
149084858|NCT03884478|537789533|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
149084859|NCT03884478|537789534|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
149084860|NCT03884478|537789535|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
149084861|NCT03884478|537789533|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
149084862|NCT03884478|537789534|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
149084863|NCT03884478|537789535|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
149084864|NCT03884478|537789533|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
149084865|NCT03884478|537789534|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
149084866|NCT03884478|537789535|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
149084867|NCT01807234|537789536|FG000|Overall Study|Lost to Follow-up|2|||
149084868|NCT01807234|537789537|FG001|Overall Study|Lost to Follow-up|5|||
149084869|NCT01807234|537789538|FG002|Overall Study|Lost to Follow-up|1|||
149084870|NCT01807234|537789539|FG003|Overall Study|Lost to Follow-up|1|||
149084871|NCT01807234|537789540|FG004|Overall Study|Lost to Follow-up|1|||
149084872|NCT01807234|537789541|FG005|Overall Study|Lost to Follow-up|2|||
149084873|NCT01807234|537789536|FG000|Overall Study|Withdrawal by Subject|3|||
149084874|NCT01807234|537789537|FG001|Overall Study|Withdrawal by Subject|1|||
149084875|NCT01807234|537789538|FG002|Overall Study|Withdrawal by Subject|1|||
149084876|NCT01807234|537789539|FG003|Overall Study|Withdrawal by Subject|1|||
149084877|NCT01807234|537789540|FG004|Overall Study|Withdrawal by Subject|2|||
149084878|NCT01807234|537789541|FG005|Overall Study|Withdrawal by Subject|1|||
149084879|NCT01807234|537789536|FG000|Overall Study|Lack of Efficacy|0|||
149084880|NCT01807234|537789537|FG001|Overall Study|Lack of Efficacy|0|||
149084881|NCT01807234|537789538|FG002|Overall Study|Lack of Efficacy|0|||
149084882|NCT01807234|537789539|FG003|Overall Study|Lack of Efficacy|0|||
149084883|NCT01807234|537789540|FG004|Overall Study|Lack of Efficacy|1|||
149084884|NCT01807234|537789541|FG005|Overall Study|Lack of Efficacy|1|||
149084885|NCT02068352|537789542|FG000|Overall Study|Lost to Follow-up|0|||
149084886|NCT02068352|537789543|FG001|Overall Study|Lost to Follow-up|2|||
149084887|NCT02068352|537789544|FG002|Overall Study|Lost to Follow-up|0|||
149084888|NCT02068352|537789542|FG000|Overall Study|Adverse Event|4|||
149084889|NCT02068352|537789543|FG001|Overall Study|Adverse Event|2|||
149084890|NCT02068352|537789544|FG002|Overall Study|Adverse Event|7|||
149084891|NCT02068352|537789542|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
149084892|NCT02068352|537789543|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
149084893|NCT02068352|537789544|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
149084894|NCT02068352|537789542|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
149084895|NCT02068352|537789543|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
149084896|NCT02068352|537789544|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
149084897|NCT02068352|537789542|FG000|Overall Study|Protocol Deviation|0|||
149084898|NCT02068352|537789543|FG001|Overall Study|Protocol Deviation|0|||
149084899|NCT02068352|537789544|FG002|Overall Study|Protocol Deviation|1|||
149084900|NCT03745651|537789550|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
149084901|NCT03745651|537789551|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
149084902|NCT03745651|537789552|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149084903|NCT03745651|537789553|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149084904|NCT03745651|537789554|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149084905|NCT03745651|537789555|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149084906|NCT03745651|537789556|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
149084907|NCT03745651|537789550|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
149084908|NCT03745651|537789551|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
149084909|NCT03745651|537789552|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
149084910|NCT03745651|537789553|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149084911|NCT03745651|537789554|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149084912|NCT03745651|537789555|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149084913|NCT03745651|537789556|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
149084914|NCT03745651|537789550|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
149084915|NCT03745651|537789551|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149084916|NCT03745651|537789552|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
149084917|NCT03745651|537789553|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149084918|NCT03745651|537789554|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149084919|NCT03745651|537789555|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149084920|NCT03745651|537789556|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
149120385|NCT02559895|537918093|FG003|Overall Study|Other|3|||
149084921|NCT03745651|537789550|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149084922|NCT03745651|537789551|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
149084923|NCT03745651|537789552|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149084924|NCT03745651|537789553|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149084925|NCT03745651|537789554|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149084926|NCT03745651|537789555|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149084927|NCT03745651|537789556|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
149084928|NCT03745651|537789550|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
149084929|NCT03745651|537789551|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
149084930|NCT03745651|537789552|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
149084931|NCT03745651|537789553|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149084932|NCT03745651|537789554|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149084933|NCT03745651|537789555|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149084934|NCT03745651|537789556|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
149084935|NCT03745651|537789550|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
149084936|NCT03745651|537789551|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
149084937|NCT03745651|537789552|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
149084938|NCT03745651|537789553|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
149084939|NCT03745651|537789554|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
149084940|NCT03745651|537789555|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
149084941|NCT03745651|537789556|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
149084942|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149084943|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149084944|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149084945|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149084946|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149084947|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
149084948|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
149084949|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149084950|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149084951|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149084952|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
149084953|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
149084954|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
149084955|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
149084956|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149084957|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149084958|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
149084959|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
149084960|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
149084961|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
149084962|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
149084963|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149084964|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149084965|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149084966|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
149084967|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
149084968|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
149084969|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
149084970|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
149084971|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
149084972|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
149084973|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
149084974|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
149084975|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
149084976|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
149084977|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149084978|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149084979|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149084980|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149084981|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149084982|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
149084983|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
149084984|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149084985|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149084986|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
149084987|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
149084988|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
149084989|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
149084990|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
149084991|NCT03745651|537789550|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
149084992|NCT03745651|537789551|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
149084993|NCT03745651|537789552|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
149084994|NCT03745651|537789553|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
149084995|NCT03745651|537789554|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
149084996|NCT03745651|537789555|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
149084997|NCT03745651|537789556|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
149084998|NCT04175834|537789557|FG000|Overall Study|Withdrawal by Subject|1|||
149084999|NCT04175834|537789558|FG001|Overall Study|Withdrawal by Subject|0|||
149085000|NCT01322347|537789559|FG000|Overall Study|Adverse Event|7|||
149085001|NCT01322347|537789560|FG001|Overall Study|Adverse Event|2|||
149085002|NCT01322347|537789559|FG000|Overall Study|Death|5|||
149085003|NCT01322347|537789560|FG001|Overall Study|Death|3|||
149085004|NCT01322347|537789559|FG000|Overall Study|Physician Decision|2|||
149085005|NCT01322347|537789560|FG001|Overall Study|Physician Decision|1|||
149085006|NCT01322347|537789559|FG000|Overall Study|Protocol Violation|5|||
149085007|NCT01322347|537789560|FG001|Overall Study|Protocol Violation|2|||
149085008|NCT01322347|537789559|FG000|Overall Study|Withdrawal by Subject|1|||
149085009|NCT01322347|537789560|FG001|Overall Study|Withdrawal by Subject|4|||
149085010|NCT01322347|537789559|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
149085011|NCT01322347|537789560|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
149085012|NCT01322347|537789559|FG000|Overall Study|blood transfusion|5|||
149085013|NCT01322347|537789560|FG001|Overall Study|blood transfusion|5|||
149085014|NCT01322347|537789559|FG000|Overall Study|sponsor decision|1|||
149085015|NCT01322347|537789560|FG001|Overall Study|sponsor decision|3|||
149085016|NCT01322347|537789559|FG000|Overall Study|ineligible|6|||
149085017|NCT01322347|537789560|FG001|Overall Study|ineligible|3|||
149085018|NCT01322347|537789559|FG000|Overall Study|kidney transplant|3|||
149085019|NCT01322347|537789560|FG001|Overall Study|kidney transplant|1|||
149085020|NCT01322347|537789559|FG000|Overall Study|study drug withheld > 12 wks|0|||
149085021|NCT01322347|537789560|FG001|Overall Study|study drug withheld > 12 wks|1|||
149085022|NCT01322347|537789559|FG000|Overall Study|moved/changed dialysis|2|||
149085023|NCT01322347|537789560|FG001|Overall Study|moved/changed dialysis|4|||
149085024|NCT04883541|537789561|FG000|Overall Study|Not attending regular yoga class|16|||
149085025|NCT04883541|537789562|FG001|Overall Study|Not attending regular yoga class|0|||
149085026|NCT04883541|537789561|FG000|Overall Study|Not attending the pregnancy school|0|||
149085027|NCT04883541|537789562|FG001|Overall Study|Not attending the pregnancy school|9|||
149085028|NCT02823574|537789563|FG000|Randomization|Disease Progression|0|||
149085029|NCT02823574|537789564|FG001|Randomization|Disease Progression|0|||
149085030|NCT02823574|537789565|FG002|Randomization|Disease Progression|1|||
149085031|NCT02823574|537789566|FG003|Randomization|Disease Progression|0|||
149085032|NCT02823574|537789563|FG000|Randomization|AE unrelated to Study Drug|1|||
149085033|NCT02823574|537789564|FG001|Randomization|AE unrelated to Study Drug|0|||
149085034|NCT02823574|537789565|FG002|Randomization|AE unrelated to Study Drug|0|||
149085035|NCT02823574|537789566|FG003|Randomization|AE unrelated to Study Drug|0|||
149085036|NCT02823574|537789563|FG000|Treatment Period|Poor/Non Compliance|1|||
149085037|NCT02823574|537789564|FG001|Treatment Period|Poor/Non Compliance|0|||
149085038|NCT02823574|537789565|FG002|Treatment Period|Poor/Non Compliance|0|||
149085039|NCT02823574|537789566|FG003|Treatment Period|Poor/Non Compliance|1|||
149085040|NCT02823574|537789563|FG000|Treatment Period|Maximum Clinical Benefit|8|||
149085041|NCT02823574|537789564|FG001|Treatment Period|Maximum Clinical Benefit|4|||
149085042|NCT02823574|537789565|FG002|Treatment Period|Maximum Clinical Benefit|7|||
149085043|NCT02823574|537789566|FG003|Treatment Period|Maximum Clinical Benefit|1|||
149085044|NCT02823574|537789563|FG000|Treatment Period|Lost to Follow-up|1|||
149085045|NCT02823574|537789564|FG001|Treatment Period|Lost to Follow-up|1|||
149085046|NCT02823574|537789565|FG002|Treatment Period|Lost to Follow-up|0|||
149085047|NCT02823574|537789566|FG003|Treatment Period|Lost to Follow-up|0|||
149085048|NCT02823574|537789563|FG000|Treatment Period|Participant withdrew consent|4|||
149085049|NCT02823574|537789564|FG001|Treatment Period|Participant withdrew consent|0|||
149085050|NCT02823574|537789565|FG002|Treatment Period|Participant withdrew consent|0|||
149085051|NCT02823574|537789566|FG003|Treatment Period|Participant withdrew consent|1|||
149085052|NCT02823574|537789563|FG000|Treatment Period|Participant request to discontinue|5|||
149085053|NCT02823574|537789564|FG001|Treatment Period|Participant request to discontinue|0|||
149085054|NCT02823574|537789565|FG002|Treatment Period|Participant request to discontinue|3|||
149085055|NCT02823574|537789566|FG003|Treatment Period|Participant request to discontinue|2|||
149085056|NCT02823574|537789563|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
149085057|NCT02823574|537789564|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
149085058|NCT02823574|537789565|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
149085059|NCT02823574|537789566|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
149085060|NCT02823574|537789563|FG000|Treatment Period|Study Drug Toxicity|11|||
149085061|NCT02823574|537789564|FG001|Treatment Period|Study Drug Toxicity|2|||
149085062|NCT02823574|537789565|FG002|Treatment Period|Study Drug Toxicity|14|||
149085063|NCT02823574|537789566|FG003|Treatment Period|Study Drug Toxicity|4|||
149085064|NCT02823574|537789563|FG000|Treatment Period|Disease Progression|113|||
149085065|NCT02823574|537789564|FG001|Treatment Period|Disease Progression|64|||
149085066|NCT02823574|537789565|FG002|Treatment Period|Disease Progression|82|||
149085067|NCT02823574|537789566|FG003|Treatment Period|Disease Progression|43|||
149085068|NCT02823574|537789563|FG000|Treatment Period|Other reasons|5|||
149085069|NCT02823574|537789564|FG001|Treatment Period|Other reasons|9|||
149085070|NCT02823574|537789565|FG002|Treatment Period|Other reasons|3|||
149085071|NCT02823574|537789566|FG003|Treatment Period|Other reasons|6|||
149085072|NCT02823574|537789563|FG000|Treatment Period|Participant no longer meets study criteria|0|||
149085073|NCT02823574|537789564|FG001|Treatment Period|Participant no longer meets study criteria|0|||
149085074|NCT02823574|537789565|FG002|Treatment Period|Participant no longer meets study criteria|1|||
149085075|NCT02823574|537789566|FG003|Treatment Period|Participant no longer meets study criteria|0|||
149085076|NCT02823574|537789563|FG000|Treatment Period|Death|0|||
149085077|NCT02823574|537789564|FG001|Treatment Period|Death|0|||
149085078|NCT02823574|537789565|FG002|Treatment Period|Death|3|||
149085079|NCT02823574|537789566|FG003|Treatment Period|Death|1|||
149085080|NCT00590759|537789567|FG000|Overall Study|Death|52|||
149085081|NCT00590759|537789567|FG000|Overall Study|Lost to Follow-up|28|||
149085082|NCT02542696|537789572|FG000|Overall Study|Adverse Event|167|||
149085083|NCT02542696|537789572|FG000|Overall Study|Lack of Efficacy|26|||
149085084|NCT02542696|537789572|FG000|Overall Study|Lost to Follow-up|6|||
149085085|NCT02542696|537789572|FG000|Overall Study|Withdrawal by Subject|104|||
149085086|NCT02542696|537789572|FG000|Overall Study|Protocol Violation|5|||
149085087|NCT02542696|537789572|FG000|Overall Study|Death|8|||
149085088|NCT02542696|537789572|FG000|Overall Study|DECREASED OFF TIME|1|||
149085089|NCT02542696|537789572|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
149085090|NCT02542696|537789572|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
149085091|NCT02542696|537789572|FG000|Overall Study|MEDICAL HISTORY|1|||
149085092|NCT02542696|537789572|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
149085093|NCT02542696|537789572|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
149085094|NCT02542696|537789572|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
149085095|NCT02542696|537789572|FG000|Overall Study|SPONSOR DECISION|3|||
149085096|NCT02542696|537789572|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
149085097|NCT02542696|537789572|FG000|Overall Study|SUBJECT DECISION|2|||
149085098|NCT03693989|537789573|FG000|Overall Study|Protocol Violation|3|||
149085099|NCT03693989|537789574|FG001|Overall Study|Protocol Violation|4|||
149085100|NCT01190436|537789575|FG000|Overall Study|Lost to Follow-up|35|||
149085101|NCT01190436|537789575|FG000|Overall Study|Other|4|||
149085102|NCT00113529|537789576|FG000|Overall Study|Adverse Event|4|||
149085103|NCT00113529|537789576|FG000|Overall Study|Lack of Efficacy|20|||
149085104|NCT00113529|537789576|FG000|Overall Study|Decision of sponsor|6|||
149085105|NCT00113529|537789576|FG000|Overall Study|Withdrawal by Subject|4|||
149085106|NCT00648895|537789577|FG000|Overall Study|Lack of Efficacy|0|||
149085107|NCT00648895|537789578|FG001|Overall Study|Lack of Efficacy|1|||
149085108|NCT01077284|537789579|FG000|Overall Study|Adverse Event|2|||
149085109|NCT01077284|537789580|FG001|Overall Study|Adverse Event|0|||
149085110|NCT01077284|537789581|FG002|Overall Study|Adverse Event|1|||
149085111|NCT01077284|537789579|FG000|Overall Study|Lost to Follow-up|1|||
149085112|NCT01077284|537789580|FG001|Overall Study|Lost to Follow-up|2|||
149085113|NCT01077284|537789581|FG002|Overall Study|Lost to Follow-up|0|||
149085114|NCT01077284|537789579|FG000|Overall Study|Withdrawal by Subject|2|||
149085115|NCT01077284|537789580|FG001|Overall Study|Withdrawal by Subject|3|||
149085116|NCT01077284|537789581|FG002|Overall Study|Withdrawal by Subject|1|||
149085117|NCT01077284|537789579|FG000|Overall Study|Other|0|||
149085118|NCT01077284|537789580|FG001|Overall Study|Other|0|||
149085119|NCT01077284|537789581|FG002|Overall Study|Other|1|||
149085120|NCT04626128|537789582|FG000|Overall Study|Withdrawal by Subject|0|||
149085121|NCT04626128|537789583|FG001|Overall Study|Withdrawal by Subject|1|||
149085122|NCT04626128|537789584|FG002|Overall Study|Withdrawal by Subject|0|||
149085123|NCT04626128|537789585|FG003|Overall Study|Withdrawal by Subject|0|||
149085124|NCT00841321|537789586|FG000|Overall Study|Lost to Follow-up|1|||
149085125|NCT00841321|537789587|FG001|Overall Study|Lost to Follow-up|1|||
149085126|NCT00841321|537789586|FG000|Overall Study|Adverse Event|0|||
149085127|NCT00841321|537789587|FG001|Overall Study|Adverse Event|2|||
149085128|NCT02632747|537789590|FG000|Wash-out Period|Adverse Event|1|||
149085129|NCT02632747|537789591|FG001|Wash-out Period|Adverse Event|0|||
149085130|NCT00379210|537789592|FG000|Overall Study|Withdrawal by Subject|10|||
149085131|NCT00379210|537789593|FG001|Overall Study|Withdrawal by Subject|7|||
149085132|NCT03444155|537789594|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
149085133|NCT03444155|537789595|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
149085134|NCT02991118|537789596|FG000|Overall Study|Death|3|||
149085135|NCT02991118|537789597|FG001|Overall Study|Death|8|||
149085136|NCT02991118|537789596|FG000|Overall Study|Protocol Violation|0|||
149085137|NCT02991118|537789597|FG001|Overall Study|Protocol Violation|3|||
149085138|NCT02991118|537789596|FG000|Overall Study|Physician Decision|0|||
149085139|NCT02991118|537789597|FG001|Overall Study|Physician Decision|1|||
149085140|NCT02991118|537789596|FG000|Overall Study|Moved out of the country|0|||
149085141|NCT02991118|537789597|FG001|Overall Study|Moved out of the country|1|||
149085142|NCT02991118|537789596|FG000|Overall Study|Adverse Event|2|||
149085143|NCT02991118|537789597|FG001|Overall Study|Adverse Event|2|||
149085144|NCT02991118|537789596|FG000|Overall Study|Withdrawal by Subject|1|||
149085145|NCT02991118|537789597|FG001|Overall Study|Withdrawal by Subject|7|||
149085146|NCT02991118|537789596|FG000|Overall Study|Could not attend study visits|0|||
149085147|NCT02991118|537789597|FG001|Overall Study|Could not attend study visits|1|||
149085148|NCT02991118|537789596|FG000|Overall Study|Lost to Follow-up|1|||
149085149|NCT02991118|537789597|FG001|Overall Study|Lost to Follow-up|9|||
149085150|NCT00446095|537789598|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
149085151|NCT00446095|537789599|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
149085152|NCT00446095|537789600|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
149085153|NCT00446095|537789601|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
149085154|NCT00446095|537789602|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
149085155|NCT00446095|537789598|FG000|Phase II (8 Weeks)|Adverse Event|0|||
149085156|NCT00446095|537789599|FG001|Phase II (8 Weeks)|Adverse Event|1|||
149085157|NCT00446095|537789600|FG002|Phase II (8 Weeks)|Adverse Event|1|||
149085158|NCT00446095|537789601|FG003|Phase II (8 Weeks)|Adverse Event|0|||
149085159|NCT00446095|537789602|FG004|Phase II (8 Weeks)|Adverse Event|0|||
149085160|NCT00446095|537789598|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
149085161|NCT00446095|537789599|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
149085162|NCT00446095|537789600|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
149085163|NCT00446095|537789601|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
149085164|NCT00446095|537789602|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
149085165|NCT00446095|537789598|FG000|Phase II (8 Weeks)|Physician Decision|1|||
149085166|NCT00446095|537789599|FG001|Phase II (8 Weeks)|Physician Decision|0|||
149085167|NCT00446095|537789600|FG002|Phase II (8 Weeks)|Physician Decision|0|||
149085168|NCT00446095|537789601|FG003|Phase II (8 Weeks)|Physician Decision|0|||
149085169|NCT00446095|537789602|FG004|Phase II (8 Weeks)|Physician Decision|0|||
149085170|NCT00446095|537789598|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
149085171|NCT00446095|537789599|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
149085172|NCT00446095|537789600|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
149085173|NCT00446095|537789601|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
149085174|NCT00446095|537789602|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
149085175|NCT00446095|537789598|FG000|Phase II (8 Weeks)|Ongoing|0|||
149085176|NCT00446095|537789599|FG001|Phase II (8 Weeks)|Ongoing|0|||
149085177|NCT00446095|537789600|FG002|Phase II (8 Weeks)|Ongoing|1|||
149085178|NCT00446095|537789601|FG003|Phase II (8 Weeks)|Ongoing|0|||
149085179|NCT00446095|537789602|FG004|Phase II (8 Weeks)|Ongoing|0|||
149085180|NCT00446095|537789598|FG000|Phase I (28 Days)|Adverse Event|0|||
149085181|NCT00446095|537789599|FG001|Phase I (28 Days)|Adverse Event|0|||
149085182|NCT00446095|537789600|FG002|Phase I (28 Days)|Adverse Event|0|||
149085183|NCT00446095|537789601|FG003|Phase I (28 Days)|Adverse Event|1|||
149085184|NCT00446095|537789602|FG004|Phase I (28 Days)|Adverse Event|0|||
149085185|NCT00446095|537789598|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
149085186|NCT00446095|537789599|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
149085187|NCT00446095|537789600|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
149085188|NCT00446095|537789601|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
149085189|NCT00446095|537789602|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
149085190|NCT00886834|537789604|FG000|Overall Study|Protocol Violation|0|||
149085191|NCT00886834|537789605|FG001|Overall Study|Protocol Violation|3|||
149085192|NCT00657709|537789606|FG000|Overall Study|AE or Death|7|||
149085193|NCT00657709|537789607|FG001|Overall Study|AE or Death|7|||
149085194|NCT00657709|537789608|FG002|Overall Study|AE or Death|6|||
149085195|NCT00657709|537789609|FG003|Overall Study|AE or Death|7|||
149085196|NCT00657709|537789610|FG004|Overall Study|AE or Death|1|||
149085197|NCT00657709|537789606|FG000|Overall Study|Withdrawal by Subject|7|||
149085198|NCT00657709|537789607|FG001|Overall Study|Withdrawal by Subject|15|||
149085199|NCT00657709|537789608|FG002|Overall Study|Withdrawal by Subject|15|||
149085200|NCT00657709|537789609|FG003|Overall Study|Withdrawal by Subject|5|||
149085201|NCT00657709|537789610|FG004|Overall Study|Withdrawal by Subject|9|||
149085202|NCT00657709|537789606|FG000|Overall Study|Lost to Follow-up|9|||
149085203|NCT00657709|537789607|FG001|Overall Study|Lost to Follow-up|9|||
149085204|NCT00657709|537789608|FG002|Overall Study|Lost to Follow-up|7|||
149085205|NCT00657709|537789609|FG003|Overall Study|Lost to Follow-up|1|||
149085206|NCT00657709|537789610|FG004|Overall Study|Lost to Follow-up|21|||
149085207|NCT00657709|537789606|FG000|Overall Study|Protocol Violation|0|||
149085208|NCT00657709|537789607|FG001|Overall Study|Protocol Violation|2|||
149085209|NCT00657709|537789608|FG002|Overall Study|Protocol Violation|0|||
149085210|NCT00657709|537789609|FG003|Overall Study|Protocol Violation|1|||
149085211|NCT00657709|537789610|FG004|Overall Study|Protocol Violation|2|||
149085212|NCT02574286|537789611|FG000|Overall Study|Adverse Event|3|||
149085213|NCT02574286|537789611|FG000|Overall Study|Withdrawal by Subject|2|||
149085214|NCT03875729|537789612|FG000|Overall Study|Adverse Event|0|||
149085215|NCT03875729|537789613|FG001|Overall Study|Adverse Event|5|||
149085216|NCT03875729|537789612|FG000|Overall Study|Withdrawal by Subject|8|||
149085217|NCT03875729|537789613|FG001|Overall Study|Withdrawal by Subject|11|||
149085218|NCT03875729|537789612|FG000|Overall Study|Pregnancy|0|||
149085219|NCT03875729|537789613|FG001|Overall Study|Pregnancy|1|||
149085220|NCT03875729|537789612|FG000|Overall Study|Lost to Follow-up|0|||
149085221|NCT03875729|537789613|FG001|Overall Study|Lost to Follow-up|5|||
149085222|NCT03875729|537789612|FG000|Overall Study|Personal reasons|2|||
149085223|NCT03875729|537789613|FG001|Overall Study|Personal reasons|0|||
149085224|NCT02764320|537789614|FG000|Overall Study|Withdrawal by Subject|35|||
149085225|NCT02764320|537789615|FG001|Overall Study|Withdrawal by Subject|38|||
149085226|NCT02764320|537789614|FG000|Overall Study|Protocol Violation|11|||
149085227|NCT02764320|537789615|FG001|Overall Study|Protocol Violation|6|||
149085228|NCT02764320|537789614|FG000|Overall Study|Adverse Event|2|||
149085229|NCT02764320|537789615|FG001|Overall Study|Adverse Event|0|||
149085230|NCT02764320|537789614|FG000|Overall Study|Health Issues unable to continue|2|||
149085231|NCT02764320|537789615|FG001|Overall Study|Health Issues unable to continue|0|||
149085232|NCT02764320|537789614|FG000|Overall Study|Did not meet inclusion criteria|1|||
149085233|NCT02764320|537789615|FG001|Overall Study|Did not meet inclusion criteria|0|||
149085234|NCT02764320|537789614|FG000|Overall Study|Subject moved|0|||
149085235|NCT02764320|537789615|FG001|Overall Study|Subject moved|2|||
149085236|NCT02764320|537789614|FG000|Overall Study|Overused medication unavailable|0|||
149085237|NCT02764320|537789615|FG001|Overall Study|Overused medication unavailable|1|||
149085238|NCT02764320|537789614|FG000|Overall Study|Seeking care outside site|0|||
149085239|NCT02764320|537789615|FG001|Overall Study|Seeking care outside site|1|||
149085240|NCT02764320|537789614|FG000|Overall Study|Technology barriers|0|||
149085241|NCT02764320|537789615|FG001|Overall Study|Technology barriers|1|||
149085242|NCT00753896|537789618|FG000|Overall Study|Adverse Event|4|||
149085243|NCT00753896|537789618|FG000|Overall Study|Death|1|||
149085244|NCT00753896|537789618|FG000|Overall Study|Lost to Follow-up|2|||
149085245|NCT00753896|537789618|FG000|Overall Study|Protocol Violation|1|||
149085246|NCT00753896|537789618|FG000|Overall Study|Withdrawal by Subject|4|||
149085247|NCT00753896|537789618|FG000|Overall Study|Entry Criteria Not Met|4|||
149085248|NCT01280656|537789619|FG000|Overall Study|Adverse Event|1|||
149085249|NCT01280656|537789620|FG001|Overall Study|Adverse Event|14|||
149085250|NCT01280656|537789621|FG002|Overall Study|Adverse Event|13|||
149085251|NCT01280656|537789619|FG000|Overall Study|Lack of Efficacy|1|||
149085252|NCT01280656|537789620|FG001|Overall Study|Lack of Efficacy|22|||
149085253|NCT01280656|537789621|FG002|Overall Study|Lack of Efficacy|38|||
149085254|NCT01280656|537789619|FG000|Overall Study|Treatment shortening (RGT)|0|||
149085255|NCT01280656|537789620|FG001|Overall Study|Treatment shortening (RGT)|4|||
149085256|NCT01280656|537789621|FG002|Overall Study|Treatment shortening (RGT)|5|||
149085257|NCT01280656|537789619|FG000|Overall Study|Other|1|||
149085258|NCT01280656|537789620|FG001|Overall Study|Other|7|||
149085259|NCT01280656|537789621|FG002|Overall Study|Other|7|||
149085260|NCT04085614|537789622|FG000|Overall Study|Protocol Violation|9|||
149085261|NCT04085614|537789623|FG001|Overall Study|Protocol Violation|6|||
149085262|NCT00952523|537789624|FG000|Overall Study|Withdrawal by Subject|7|||
149085263|NCT01029925|537789625|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
149085264|NCT01029925|537789625|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
149085265|NCT01029925|537789625|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
149085266|NCT05265247|537789626|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
149085267|NCT05265247|537789627|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
149085268|NCT05265247|537789626|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
149085269|NCT05265247|537789627|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
149085270|NCT05265247|537789626|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
149085271|NCT05265247|537789627|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
149085272|NCT02399449|537789628|FG000|Overall Study|Withdrawal by Subject|3|||
149085273|NCT02399449|537789629|FG001|Overall Study|Withdrawal by Subject|9|||
149085274|NCT02399449|537789628|FG000|Overall Study|Physician Decision|0|||
149085275|NCT02399449|537789629|FG001|Overall Study|Physician Decision|1|||
149085276|NCT02516202|537789630|FG000|Overall Study|Withdrawal by Subject|1|||
149085277|NCT02516202|537789631|FG001|Overall Study|Withdrawal by Subject|0|||
149085278|NCT02516202|537789632|FG002|Overall Study|Withdrawal by Subject|1|||
149085279|NCT02516202|537789630|FG000|Overall Study|Lost to Follow-up|1|||
149085280|NCT02516202|537789631|FG001|Overall Study|Lost to Follow-up|1|||
149085281|NCT02516202|537789632|FG002|Overall Study|Lost to Follow-up|1|||
149085282|NCT02516202|537789630|FG000|Overall Study|Stopped Follow-up|0|||
149085283|NCT02516202|537789631|FG001|Overall Study|Stopped Follow-up|0|||
149085284|NCT02516202|537789632|FG002|Overall Study|Stopped Follow-up|1|||
149085285|NCT02159352|537789633|FG000|Overall Study|Adverse Event|3|||
149085286|NCT02159352|537789634|FG001|Overall Study|Adverse Event|1|||
149085287|NCT02159352|537789633|FG000|Overall Study|Withdrawal by Subject|0|||
149085288|NCT02159352|537789634|FG001|Overall Study|Withdrawal by Subject|1|||
149085289|NCT01287832|537789637|FG000|Overall Study|Adverse Event|1|||
149085290|NCT01287832|537789638|FG001|Overall Study|Adverse Event|0|||
149085291|NCT01287832|537789637|FG000|Overall Study|Death|0|||
149085292|NCT01287832|537789638|FG001|Overall Study|Death|1|||
149085293|NCT04749797|537789639|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
149085294|NCT04749797|537789640|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
149085295|NCT04749797|537789641|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
149085296|NCT00632736|537789642|FG000|Overall Study|Adverse Event|104|||
149085297|NCT00632736|537789642|FG000|Overall Study|Lost to Follow-up|15|||
149085298|NCT00632736|537789642|FG000|Overall Study|Protocol Violation|14|||
149085299|NCT00632736|537789642|FG000|Overall Study|Withdrawal by Subject|99|||
149085300|NCT00632736|537789642|FG000|Overall Study|Lack of Efficacy|5|||
149085301|NCT00632736|537789642|FG000|Overall Study|Sponsor terminated study|5|||
149085302|NCT00632736|537789642|FG000|Overall Study|Non-compliance|10|||
149085303|NCT00632736|537789642|FG000|Overall Study|Other|16|||
149085304|NCT00871715|537789643|FG000|Overall Study|Withdrawal by Subject|6|||
149085305|NCT00871715|537789644|FG001|Overall Study|Withdrawal by Subject|10|||
149085306|NCT00871715|537789645|FG002|Overall Study|Withdrawal by Subject|15|||
149085307|NCT00871715|537789643|FG000|Overall Study|Physician Decision|6|||
149085308|NCT00871715|537789644|FG001|Overall Study|Physician Decision|0|||
149085309|NCT00871715|537789645|FG002|Overall Study|Physician Decision|2|||
149085310|NCT00871715|537789643|FG000|Overall Study|Lost to Follow-up|3|||
149085311|NCT00871715|537789644|FG001|Overall Study|Lost to Follow-up|6|||
149085312|NCT00871715|537789645|FG002|Overall Study|Lost to Follow-up|9|||
149085313|NCT01794689|537789646|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
149085314|NCT01794689|537789647|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
149085315|NCT01794689|537789648|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
149085316|NCT01794689|537789649|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
149085317|NCT01794689|537789646|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
149085318|NCT01794689|537789647|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
149085319|NCT01794689|537789648|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
149085320|NCT01794689|537789649|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
149085321|NCT01794689|537789646|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
149085322|NCT01794689|537789647|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
149085323|NCT01794689|537789648|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
149085324|NCT01794689|537789649|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
149085325|NCT01794689|537789646|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
149085326|NCT01794689|537789647|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
149085327|NCT01794689|537789648|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
149085328|NCT01794689|537789649|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
149085329|NCT02312258|537789650|FG000|Overall Study|Lost to Follow-up|8|||
149085330|NCT02312258|537789651|FG001|Overall Study|Lost to Follow-up|8|||
149085331|NCT02312258|537789650|FG000|Overall Study|Withdrawal by Patient|49|||
149085332|NCT02312258|537789651|FG001|Overall Study|Withdrawal by Patient|76|||
149085333|NCT02312258|537789650|FG000|Overall Study|Reason not Specified|107|||
149085334|NCT02312258|537789651|FG001|Overall Study|Reason not Specified|159|||
149085335|NCT02312258|537789650|FG000|Overall Study|Missing|2|||
149085336|NCT02312258|537789651|FG001|Overall Study|Missing|1|||
149085337|NCT02312258|537789650|FG000|Overall Study|Death|115|||
149085338|NCT02312258|537789651|FG001|Overall Study|Death|181|||
149085339|NCT01697956|537789652|FG000|Overall Study|Protocol Violation|1|||
149085340|NCT01697956|537789653|FG001|Overall Study|Protocol Violation|1|||
149085341|NCT03075878|537789654|FG000|Overall Study|Physician Decision|1|||
149085342|NCT00882050|537789657|FG000|Overall Study|Physician Decision|1|||
149085343|NCT00882050|537789658|FG001|Overall Study|Physician Decision|0|||
149085344|NCT00882050|537789659|FG002|Overall Study|Physician Decision|0|||
149085345|NCT01986348|537789660|FG000|Overall Study|Death|8|||
149085346|NCT01986348|537789661|FG001|Overall Study|Death|22|||
149085347|NCT01986348|537789662|FG002|Overall Study|Death|10|||
149085348|NCT01986348|537789663|FG003|Overall Study|Death|21|||
149085349|NCT01986348|537789660|FG000|Overall Study|Lost to Follow-up|0|||
149085350|NCT01986348|537789661|FG001|Overall Study|Lost to Follow-up|0|||
149085351|NCT01986348|537789662|FG002|Overall Study|Lost to Follow-up|0|||
149085352|NCT01986348|537789663|FG003|Overall Study|Lost to Follow-up|2|||
149085353|NCT01986348|537789660|FG000|Overall Study|Physician Decision|0|||
149085354|NCT01986348|537789661|FG001|Overall Study|Physician Decision|0|||
149085355|NCT01986348|537789662|FG002|Overall Study|Physician Decision|0|||
149085356|NCT01986348|537789663|FG003|Overall Study|Physician Decision|1|||
149085357|NCT01986348|537789660|FG000|Overall Study|Progressive Disease|0|||
149085358|NCT01986348|537789661|FG001|Overall Study|Progressive Disease|0|||
149085359|NCT01986348|537789662|FG002|Overall Study|Progressive Disease|2|||
149085360|NCT01986348|537789663|FG003|Overall Study|Progressive Disease|0|||
149085361|NCT01986348|537789660|FG000|Overall Study|Withdrawal by Participant|0|||
149085362|NCT01986348|537789661|FG001|Overall Study|Withdrawal by Participant|1|||
149085363|NCT01986348|537789662|FG002|Overall Study|Withdrawal by Participant|2|||
149085364|NCT01986348|537789663|FG003|Overall Study|Withdrawal by Participant|1|||
149085365|NCT01986348|537789660|FG000|Overall Study|Study Terminated by Sponsor|0|||
149085366|NCT01986348|537789661|FG001|Overall Study|Study Terminated by Sponsor|0|||
149085367|NCT01986348|537789662|FG002|Overall Study|Study Terminated by Sponsor|0|||
149085368|NCT01986348|537789663|FG003|Overall Study|Study Terminated by Sponsor|3|||
149085369|NCT01986348|537789660|FG000|Overall Study|Other-unspecified|0|||
149085370|NCT01986348|537789661|FG001|Overall Study|Other-unspecified|1|||
149085371|NCT01986348|537789662|FG002|Overall Study|Other-unspecified|0|||
149085372|NCT01986348|537789663|FG003|Overall Study|Other-unspecified|2|||
149085373|NCT01898299|537789665|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
149085374|NCT01898299|537789666|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
149085375|NCT01186809|537789667|FG000|Overall Study|Death|30|||
149085376|NCT04895085|537789668|FG000|Overall Study|Death|1|||
149085377|NCT04895085|537789668|FG000|Overall Study|Withdrawal by Subject|1|||
149085378|NCT04895085|537789668|FG000|Overall Study|No longer eligible: Moved from area|1|||
149085379|NCT00760877|537790967|FG000|Overall Study|Protocol Violation|1|||
149085380|NCT00760877|537790968|FG001|Overall Study|Protocol Violation|0|||
149085381|NCT00760877|537790967|FG000|Overall Study|Non-compliance with protocol treatment|2|||
149085382|NCT00760877|537790968|FG001|Overall Study|Non-compliance with protocol treatment|1|||
149085383|NCT00760877|537790967|FG000|Overall Study|Pregnancy|1|||
149085384|NCT00760877|537790968|FG001|Overall Study|Pregnancy|4|||
149085385|NCT00760877|537790967|FG000|Overall Study|Death|2|||
149085386|NCT00760877|537790968|FG001|Overall Study|Death|1|||
149085387|NCT00760877|537790967|FG000|Overall Study|Withdrawal by Subject|7|||
149085388|NCT00760877|537790968|FG001|Overall Study|Withdrawal by Subject|3|||
149085389|NCT00760877|537790967|FG000|Overall Study|Adverse Event|19|||
149085390|NCT00760877|537790968|FG001|Overall Study|Adverse Event|12|||
149085391|NCT00760877|537790967|FG000|Overall Study|Participant diagnosed with AML|0|||
149085392|NCT00760877|537790968|FG001|Overall Study|Participant diagnosed with AML|1|||
149085393|NCT00760877|537790967|FG000|Overall Study|Participant not eligible to cross-over|0|||
149085394|NCT00760877|537790968|FG001|Overall Study|Participant not eligible to cross-over|1|||
149085395|NCT00760877|537790967|FG000|Overall Study|Physician Decision|1|||
149085396|NCT00760877|537790968|FG001|Overall Study|Physician Decision|2|||
149085397|NCT00760877|537790967|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
149085398|NCT00760877|537790968|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
149085399|NCT00760877|537790967|FG000|Overall Study|Treatment failure|1|||
149085400|NCT00760877|537790968|FG001|Overall Study|Treatment failure|0|||
149085401|NCT00711555|537790971|FG000|Overall Study|Adverse Event|3|||
149085402|NCT04820023|537790978|FG000|Overall Study|Death|0|||
149085403|NCT04820023|537790979|FG001|Overall Study|Death|0|||
149085404|NCT04820023|537790980|FG002|Overall Study|Death|0|||
149085405|NCT04820023|537790981|FG003|Overall Study|Death|0|||
149085406|NCT04820023|537790982|FG004|Overall Study|Death|0|||
149085407|NCT04820023|537790983|FG005|Overall Study|Death|0|||
149085408|NCT04820023|537790984|FG006|Overall Study|Death|1|||
149085409|NCT04820023|537790985|FG007|Overall Study|Death|0|||
149085410|NCT04820023|537790986|FG008|Overall Study|Death|1|||
149085411|NCT04820023|537790978|FG000|Overall Study|Withdrawal by Subject|1|||
149085412|NCT04820023|537790979|FG001|Overall Study|Withdrawal by Subject|2|||
149085413|NCT04820023|537790980|FG002|Overall Study|Withdrawal by Subject|2|||
149085414|NCT04820023|537790981|FG003|Overall Study|Withdrawal by Subject|1|||
149085415|NCT04820023|537790982|FG004|Overall Study|Withdrawal by Subject|4|||
149085416|NCT04820023|537790983|FG005|Overall Study|Withdrawal by Subject|3|||
149085417|NCT04820023|537790984|FG006|Overall Study|Withdrawal by Subject|3|||
149085418|NCT04820023|537790985|FG007|Overall Study|Withdrawal by Subject|6|||
149085419|NCT04820023|537790986|FG008|Overall Study|Withdrawal by Subject|5|||
149085420|NCT04820023|537790978|FG000|Overall Study|Progressive Disease|3|||
149085421|NCT04820023|537790979|FG001|Overall Study|Progressive Disease|0|||
149085422|NCT04820023|537790980|FG002|Overall Study|Progressive Disease|2|||
149085423|NCT04820023|537790981|FG003|Overall Study|Progressive Disease|2|||
149085424|NCT04820023|537790982|FG004|Overall Study|Progressive Disease|2|||
149085425|NCT04820023|537790983|FG005|Overall Study|Progressive Disease|0|||
149085426|NCT04820023|537790984|FG006|Overall Study|Progressive Disease|1|||
149085427|NCT04820023|537790985|FG007|Overall Study|Progressive Disease|1|||
149085428|NCT04820023|537790986|FG008|Overall Study|Progressive Disease|0|||
149085429|NCT04820023|537790978|FG000|Overall Study|New anti-cancer therapy|0|||
149085430|NCT04820023|537790979|FG001|Overall Study|New anti-cancer therapy|0|||
149085431|NCT04820023|537790980|FG002|Overall Study|New anti-cancer therapy|0|||
149085432|NCT04820023|537790981|FG003|Overall Study|New anti-cancer therapy|0|||
149085433|NCT04820023|537790982|FG004|Overall Study|New anti-cancer therapy|2|||
149085434|NCT04820023|537790983|FG005|Overall Study|New anti-cancer therapy|0|||
149085435|NCT04820023|537790984|FG006|Overall Study|New anti-cancer therapy|0|||
149085436|NCT04820023|537790985|FG007|Overall Study|New anti-cancer therapy|0|||
149085437|NCT04820023|537790986|FG008|Overall Study|New anti-cancer therapy|0|||
149085438|NCT04820023|537790978|FG000|Overall Study|Other|0|||
149085439|NCT04820023|537790979|FG001|Overall Study|Other|1|||
149085440|NCT04820023|537790980|FG002|Overall Study|Other|0|||
149085441|NCT04820023|537790981|FG003|Overall Study|Other|0|||
149085442|NCT04820023|537790982|FG004|Overall Study|Other|0|||
149085443|NCT04820023|537790983|FG005|Overall Study|Other|0|||
149085444|NCT04820023|537790984|FG006|Overall Study|Other|0|||
149085445|NCT04820023|537790985|FG007|Overall Study|Other|2|||
149085446|NCT04820023|537790986|FG008|Overall Study|Other|0|||
149085447|NCT02400749|537790987|FG000|Week 0 -16|Withdrawal by Subject|5|||
149085448|NCT02400749|537790988|FG001|Week 0 -16|Withdrawal by Subject|5|||
149085449|NCT02400749|537790987|FG000|Week 0 -16|Adverse Event|3|||
149085450|NCT02400749|537790988|FG001|Week 0 -16|Adverse Event|1|||
149085451|NCT02400749|537790987|FG000|Week 0 -16|Lost to Follow-up|2|||
149085452|NCT02400749|537790988|FG001|Week 0 -16|Lost to Follow-up|0|||
149085453|NCT02400749|537790987|FG000|Week 0 -16|Protocol Violation|1|||
149085454|NCT02400749|537790988|FG001|Week 0 -16|Protocol Violation|0|||
149085455|NCT02400749|537790987|FG000|Week 17 - 32|Withdrawal by Subject|3|||
149085456|NCT02400749|537790988|FG001|Week 17 - 32|Withdrawal by Subject|2|||
149085457|NCT02400749|537790987|FG000|Week 17 - 32|Adverse Event|2|||
149085458|NCT02400749|537790988|FG001|Week 17 - 32|Adverse Event|1|||
149085459|NCT01945593|537790989|FG000|Overall Study|Adverse Event|0|||
149085460|NCT01945593|537790990|FG001|Overall Study|Adverse Event|0|||
149085461|NCT01945593|537790991|FG002|Overall Study|Adverse Event|0|||
149085462|NCT01945593|537790992|FG003|Overall Study|Adverse Event|5|||
149085463|NCT01945593|537790989|FG000|Overall Study|Physician Decision|0|||
149085464|NCT01945593|537790990|FG001|Overall Study|Physician Decision|0|||
149085465|NCT01945593|537790991|FG002|Overall Study|Physician Decision|1|||
149085466|NCT01945593|537790992|FG003|Overall Study|Physician Decision|1|||
149085467|NCT01945593|537790989|FG000|Overall Study|Withdrawal by Subject|0|||
149085468|NCT01945593|537790990|FG001|Overall Study|Withdrawal by Subject|2|||
149085469|NCT01945593|537790991|FG002|Overall Study|Withdrawal by Subject|0|||
149085470|NCT01945593|537790992|FG003|Overall Study|Withdrawal by Subject|4|||
149085471|NCT01945593|537790989|FG000|Overall Study|Protocol Violation|0|||
149085472|NCT01945593|537790990|FG001|Overall Study|Protocol Violation|2|||
149085473|NCT01945593|537790991|FG002|Overall Study|Protocol Violation|1|||
149085474|NCT01945593|537790992|FG003|Overall Study|Protocol Violation|3|||
149085475|NCT01945593|537790989|FG000|Overall Study|Death|0|||
149085476|NCT01945593|537790990|FG001|Overall Study|Death|0|||
149085477|NCT01945593|537790991|FG002|Overall Study|Death|1|||
149085478|NCT01945593|537790992|FG003|Overall Study|Death|0|||
149085479|NCT01945593|537790989|FG000|Overall Study|Other: Terminated|0|||
149085480|NCT01945593|537790990|FG001|Overall Study|Other: Terminated|0|||
149085481|NCT01945593|537790991|FG002|Overall Study|Other: Terminated|0|||
149085482|NCT01945593|537790992|FG003|Overall Study|Other: Terminated|1|||
149085483|NCT01945593|537790989|FG000|Overall Study|Other: Surgical Procedure|0|||
149085484|NCT01945593|537790990|FG001|Overall Study|Other: Surgical Procedure|2|||
149085485|NCT01945593|537790991|FG002|Overall Study|Other: Surgical Procedure|0|||
149085486|NCT01945593|537790992|FG003|Overall Study|Other: Surgical Procedure|6|||
149085487|NCT01945593|537790989|FG000|Overall Study|Other: Screen Failure|0|||
149085488|NCT01945593|537790990|FG001|Overall Study|Other: Screen Failure|2|||
149085489|NCT01945593|537790991|FG002|Overall Study|Other: Screen Failure|0|||
149085490|NCT01945593|537790992|FG003|Overall Study|Other: Screen Failure|0|||
149085491|NCT00228813|537790993|FG000|Overall Study|Death|4|||
149085492|NCT00507429|537790994|FG000|Treatment Phase|Disease Progression|12|||
149085493|NCT00507429|537790995|FG001|Treatment Phase|Disease Progression|5|||
149085494|NCT00507429|537790994|FG000|Treatment Phase|Adverse Event|12|||
149085495|NCT00507429|537790995|FG001|Treatment Phase|Adverse Event|5|||
149085496|NCT00507429|537790994|FG000|Treatment Phase|Withdrawal by Subject|3|||
149085497|NCT00507429|537790995|FG001|Treatment Phase|Withdrawal by Subject|3|||
149085498|NCT00507429|537790994|FG000|Treatment Phase|Physician Decision|4|||
149085499|NCT00507429|537790995|FG001|Treatment Phase|Physician Decision|2|||
149085500|NCT00507429|537790994|FG000|Treatment Phase|Other|6|||
149085501|NCT00507429|537790995|FG001|Treatment Phase|Other|3|||
149085502|NCT00507429|537790994|FG000|Maintenance Phase|Progressive Disease|14|||
149085503|NCT00507429|537790995|FG001|Maintenance Phase|Progressive Disease|0|||
149085504|NCT01279447|537790997|FG000|Overall Study|Lost to Follow-up|3|||
149085505|NCT01279447|537790998|FG001|Overall Study|Lost to Follow-up|1|||
149085506|NCT02213094|537790999|FG000|Overall Study|Adverse Event|1|||
149085507|NCT02213094|537791000|FG001|Overall Study|Adverse Event|0|||
149085508|NCT01074229|537791001|FG000|Overall Study|Lost to Follow-up|1|||
149085509|NCT01074229|537791002|FG001|Overall Study|Lost to Follow-up|0|||
149085510|NCT01074229|537791003|FG002|Overall Study|Lost to Follow-up|0|||
149085511|NCT01074229|537791001|FG000|Overall Study|Change to open surgical procedure|1|||
149085512|NCT01074229|537791002|FG001|Overall Study|Change to open surgical procedure|3|||
149085513|NCT01074229|537791003|FG002|Overall Study|Change to open surgical procedure|4|||
149085514|NCT02163499|537791004|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
149085515|NCT02163499|537791004|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
149085516|NCT02163499|537791004|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
149085517|NCT02163499|537791004|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
149085518|NCT02163499|537791004|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
149085519|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
149085520|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
149085521|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
149085522|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
149085523|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
149085524|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
149085525|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
149085526|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
149085527|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
149085528|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Death|8|||
149085529|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
149085530|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
149085531|NCT02163499|537791004|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
149085532|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
149085533|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
149085534|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
149085535|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
149085536|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
149085537|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
149085538|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
149085539|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
149085540|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
149085541|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
149085542|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
149085543|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
149085544|NCT01345253|537791009|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
149085545|NCT01345253|537791010|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
149085546|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
149085547|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
149085548|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
149085549|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
149085550|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
149085551|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
149085552|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
149085553|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
149085554|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
149085555|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
149085556|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
149085557|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
149085558|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
149085559|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
149085560|NCT01345253|537791009|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
149085561|NCT01345253|537791010|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
149085562|NCT05361304|537791013|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
149085563|NCT05361304|537791014|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
149085564|NCT05361304|537791013|FG000|Overall Study|COVID-19 Related|1|||
149085565|NCT05361304|537791014|FG001|Overall Study|COVID-19 Related|2|||
149085566|NCT05361304|537791013|FG000|Overall Study|Withdrawal by Subject|1|||
149085567|NCT05361304|537791014|FG001|Overall Study|Withdrawal by Subject|0|||
149085568|NCT00476151|537791015|FG000|Overall Study|Adverse Event|0|||
149085569|NCT00476151|537791016|FG001|Overall Study|Adverse Event|2|||
149085570|NCT00476151|537791015|FG000|Overall Study|Protocol Violation|1|||
149085571|NCT00476151|537791016|FG001|Overall Study|Protocol Violation|3|||
149085572|NCT00476151|537791015|FG000|Overall Study|Withdrawal by Subject|2|||
149085573|NCT00476151|537791016|FG001|Overall Study|Withdrawal by Subject|0|||
149085574|NCT00476151|537791015|FG000|Overall Study|Physician Decision|0|||
149085575|NCT00476151|537791016|FG001|Overall Study|Physician Decision|2|||
149085576|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
149085577|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
149085578|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
149085579|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
149085580|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
149085581|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
149085582|NCT03557307|537791020|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
149085583|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
149085584|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|Death|3|||
149085585|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
149085586|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
149085587|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
149085588|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
149085589|NCT03557307|537791020|FG000|Period 2: Maintenance Phase|other|3|||
149085590|NCT04239911|537791024|FG000|Overall Study|Lost to Follow-up|2|||
149085591|NCT04239911|537791025|FG001|Overall Study|Lost to Follow-up|1|||
149085592|NCT03456856|537791026|FG000|Overall Study|Lost to Follow-up|2|||
149085593|NCT03456856|537791026|FG000|Overall Study|Withdrawal by Subject|1|||
149085594|NCT00096278|537791029|FG000|Overall Study|No follow-up data|15|||
149085595|NCT00096278|537791030|FG001|Overall Study|No follow-up data|18|||
149085596|NCT00096278|537791029|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
149085597|NCT00096278|537791030|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
149085598|NCT02959866|537791033|FG000|Overall Study|Withdrawal by Subject|1|||
149085599|NCT03150589|537791034|FG000|Overall Study|Withdrawal by Subject|16|||
149085600|NCT03150589|537791035|FG001|Overall Study|Withdrawal by Subject|9|||
149085601|NCT03150589|537791034|FG000|Overall Study|Adverse Event|7|||
149085602|NCT03150589|537791035|FG001|Overall Study|Adverse Event|6|||
149085603|NCT03150589|537791034|FG000|Overall Study|Protocol Violation|4|||
149085604|NCT03150589|537791035|FG001|Overall Study|Protocol Violation|3|||
149085605|NCT03150589|537791034|FG000|Overall Study|Lost to Follow-up|3|||
149085606|NCT03150589|537791035|FG001|Overall Study|Lost to Follow-up|3|||
149085607|NCT03150589|537791034|FG000|Overall Study|Death|2|||
149085608|NCT03150589|537791035|FG001|Overall Study|Death|3|||
149085609|NCT03150589|537791034|FG000|Overall Study|IP non-compliance and other reasons|12|||
149085610|NCT03150589|537791035|FG001|Overall Study|IP non-compliance and other reasons|3|||
149085611|NCT01405508|537791036|FG000|Overall Study|AE, non-serious non-fatal|1|||
149085612|NCT01405508|537791037|FG001|Overall Study|AE, non-serious non-fatal|1|||
149085613|NCT01405508|537791038|FG002|Overall Study|AE, non-serious non-fatal|0|||
149085614|NCT01405508|537791039|FG003|Overall Study|AE, non-serious non-fatal|0|||
149085615|NCT00476957|537791044|FG000|Overall Study|Lost to Follow-up|176|||
149085616|NCT00476957|537791045|FG001|Overall Study|Lost to Follow-up|193|||
149085617|NCT00409747|537791046|FG000|Overall Study|Withdrawal by Subject|1|||
149085618|NCT02006641|537791048|FG000|Overall Study|Withdrawal before treatment|2|||
149085619|NCT02006641|537791049|FG001|Overall Study|Withdrawal before treatment|5|||
149085620|NCT02006641|537791050|FG002|Overall Study|Withdrawal before treatment|3|||
149085621|NCT02006641|537791048|FG000|Overall Study|Adverse Event|15|||
149085622|NCT02006641|537791049|FG001|Overall Study|Adverse Event|11|||
149085623|NCT02006641|537791050|FG002|Overall Study|Adverse Event|15|||
149085624|NCT02006641|537791048|FG000|Overall Study|Protocol Violation|0|||
149085625|NCT02006641|537791049|FG001|Overall Study|Protocol Violation|2|||
149085626|NCT02006641|537791050|FG002|Overall Study|Protocol Violation|2|||
149085627|NCT02006641|537791048|FG000|Overall Study|Lost to Follow-up|0|||
149085628|NCT02006641|537791049|FG001|Overall Study|Lost to Follow-up|1|||
149085629|NCT02006641|537791050|FG002|Overall Study|Lost to Follow-up|0|||
149085630|NCT02006641|537791048|FG000|Overall Study|Withdrawal by Subject|7|||
149085631|NCT02006641|537791049|FG001|Overall Study|Withdrawal by Subject|12|||
149085632|NCT02006641|537791050|FG002|Overall Study|Withdrawal by Subject|11|||
149085633|NCT02006641|537791048|FG000|Overall Study|Other reason: patient didn't show up|1|||
149085634|NCT02006641|537791049|FG001|Overall Study|Other reason: patient didn't show up|0|||
149085635|NCT02006641|537791050|FG002|Overall Study|Other reason: patient didn't show up|0|||
149085636|NCT02006641|537791048|FG000|Overall Study|Other reason:patient didn't want to come|0|||
149085637|NCT02006641|537791049|FG001|Overall Study|Other reason:patient didn't want to come|0|||
149085638|NCT02006641|537791050|FG002|Overall Study|Other reason:patient didn't want to come|1|||
149085639|NCT02006641|537791048|FG000|Overall Study|Other reason: patient has moved|1|||
149085640|NCT02006641|537791049|FG001|Overall Study|Other reason: patient has moved|0|||
149085641|NCT02006641|537791050|FG002|Overall Study|Other reason: patient has moved|1|||
149085642|NCT02006641|537791048|FG000|Overall Study|Other reason: caregiver in hospital|0|||
149085643|NCT02006641|537791049|FG001|Overall Study|Other reason: caregiver in hospital|1|||
149085644|NCT02006641|537791050|FG002|Overall Study|Other reason: caregiver in hospital|0|||
149085645|NCT02006641|537791048|FG000|Overall Study|Other reason: patient's wife has died|0|||
149085646|NCT02006641|537791049|FG001|Overall Study|Other reason: patient's wife has died|0|||
149085647|NCT02006641|537791050|FG002|Overall Study|Other reason: patient's wife has died|1|||
149085648|NCT02006641|537791048|FG000|Overall Study|Other reason: hospitalisation|0|||
149085649|NCT02006641|537791049|FG001|Overall Study|Other reason: hospitalisation|1|||
149085650|NCT02006641|537791050|FG002|Overall Study|Other reason: hospitalisation|0|||
149085651|NCT02006641|537791048|FG000|Overall Study|Other reason: caregiver impossibility|0|||
149085652|NCT02006641|537791049|FG001|Overall Study|Other reason: caregiver impossibility|0|||
149085653|NCT02006641|537791050|FG002|Overall Study|Other reason: caregiver impossibility|1|||
149085654|NCT02006641|537791048|FG000|Overall Study|Other reason: protocol non-compliance|0|||
149085655|NCT02006641|537791049|FG001|Overall Study|Other reason: protocol non-compliance|0|||
149085656|NCT02006641|537791050|FG002|Overall Study|Other reason: protocol non-compliance|1|||
149085657|NCT02132195|537791051|FG000|Initial Assignment|Relapsed|14|||
149085658|NCT02132195|537791052|FG001|Initial Assignment|Relapsed|0|||
149085659|NCT02132195|537791053|FG002|Initial Assignment|Relapsed|0|||
149085660|NCT02132195|537791051|FG000|Rescue Therapy|Relapsed|0|||
149085661|NCT02132195|537791052|FG001|Rescue Therapy|Relapsed|0|||
149085662|NCT02132195|537791053|FG002|Rescue Therapy|Relapsed|7|||
149085663|NCT02132195|537791051|FG000|Rescue Therapy|Physician Decision|0|||
149085664|NCT02132195|537791052|FG001|Rescue Therapy|Physician Decision|0|||
149085665|NCT02132195|537791053|FG002|Rescue Therapy|Physician Decision|1|||
149085666|NCT02132195|537791051|FG000|Rescue Therapy|Withdrawal by Subject|0|||
149085667|NCT02132195|537791052|FG001|Rescue Therapy|Withdrawal by Subject|0|||
149085668|NCT02132195|537791053|FG002|Rescue Therapy|Withdrawal by Subject|1|||
149085669|NCT02132195|537791051|FG000|Rescue Therapy|Adverse Event|0|||
149085670|NCT02132195|537791052|FG001|Rescue Therapy|Adverse Event|0|||
149085671|NCT02132195|537791053|FG002|Rescue Therapy|Adverse Event|2|||
149085672|NCT00537914|537791054|FG000|Overall Study|Death|1|||
149085673|NCT00537914|537791054|FG000|Overall Study|Adverse Event|7|||
149085674|NCT00537914|537791054|FG000|Overall Study|Treatment failure|10|||
149085675|NCT00537914|537791054|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
149085676|NCT00537914|537791054|FG000|Overall Study|Lost to Follow-up|19|||
149085677|NCT00537914|537791054|FG000|Overall Study|Withdrawal of informed consent|59|||
149085678|NCT01964547|537791055|FG000|Overall Study|Adverse Event|8|||
149085679|NCT01964547|537791056|FG001|Overall Study|Adverse Event|2|||
149085680|NCT01964547|537791055|FG000|Overall Study|Withdrawal by Subject|4|||
149085681|NCT01964547|537791056|FG001|Overall Study|Withdrawal by Subject|7|||
149085682|NCT01964547|537791055|FG000|Overall Study|Lost to Follow-up|0|||
149085683|NCT01964547|537791056|FG001|Overall Study|Lost to Follow-up|1|||
149085684|NCT01964547|537791055|FG000|Overall Study|Withdrawal by Investigator|0|||
149085685|NCT01964547|537791056|FG001|Overall Study|Withdrawal by Investigator|1|||
149085686|NCT01115309|537791057|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
149085687|NCT01115309|537791057|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
149085688|NCT01115309|537791057|FG000|Long-term Follow-up|Lost to Follow-up|6|||
149085689|NCT05700851|537791058|FG000|Overall Study|Received a kidney transplant|1|||
149085690|NCT05700851|537791058|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
149085691|NCT05700851|537791058|FG000|Overall Study|Withdrawal by Subject|1|||
149085692|NCT03246724|537791059|FG000|Overall Study|Withdrawal by Subject|5|||
149085693|NCT03246724|537791060|FG001|Overall Study|Withdrawal by Subject|2|||
149085694|NCT03246724|537791061|FG002|Overall Study|Withdrawal by Subject|4|||
149085695|NCT03246724|537791062|FG003|Overall Study|Withdrawal by Subject|2|||
149085696|NCT03246724|537791059|FG000|Overall Study|Ineligible on day of surgery|7|||
149085697|NCT03246724|537791060|FG001|Overall Study|Ineligible on day of surgery|2|||
149085698|NCT03246724|537791061|FG002|Overall Study|Ineligible on day of surgery|0|||
149085699|NCT03246724|537791062|FG003|Overall Study|Ineligible on day of surgery|3|||
149085700|NCT03246724|537791059|FG000|Overall Study|Study completed before surgical date|2|||
149085701|NCT03246724|537791060|FG001|Overall Study|Study completed before surgical date|1|||
149085702|NCT03246724|537791061|FG002|Overall Study|Study completed before surgical date|8|||
149085703|NCT03246724|537791062|FG003|Overall Study|Study completed before surgical date|1|||
149085704|NCT03246724|537791059|FG000|Overall Study|Transferred to other arm|0|||
149085705|NCT03246724|537791060|FG001|Overall Study|Transferred to other arm|0|||
149085706|NCT03246724|537791061|FG002|Overall Study|Transferred to other arm|1|||
149085707|NCT03246724|537791062|FG003|Overall Study|Transferred to other arm|0|||
149085708|NCT03246724|537791059|FG000|Overall Study|Unable to obtain medication timely|0|||
149085709|NCT03246724|537791060|FG001|Overall Study|Unable to obtain medication timely|2|||
149085710|NCT03246724|537791061|FG002|Overall Study|Unable to obtain medication timely|2|||
149085711|NCT03246724|537791062|FG003|Overall Study|Unable to obtain medication timely|1|||
149085712|NCT03246724|537791059|FG000|Overall Study|Re-consented to participate|0|||
149085713|NCT03246724|537791060|FG001|Overall Study|Re-consented to participate|0|||
149085714|NCT03246724|537791061|FG002|Overall Study|Re-consented to participate|0|||
149085715|NCT03246724|537791062|FG003|Overall Study|Re-consented to participate|1|||
149085716|NCT02978716|537791063|FG000|Overall Study|Death|25|||
149085717|NCT02978716|537791064|FG001|Overall Study|Death|13|||
149085718|NCT02978716|537791065|FG002|Overall Study|Death|20|||
149085719|NCT02978716|537791063|FG000|Overall Study|Lost to Follow-up|0|||
149085720|NCT02978716|537791064|FG001|Overall Study|Lost to Follow-up|0|||
149085721|NCT02978716|537791065|FG002|Overall Study|Lost to Follow-up|1|||
149085722|NCT02978716|537791063|FG000|Overall Study|Withdrawal by Subject|6|||
149085723|NCT02978716|537791064|FG001|Overall Study|Withdrawal by Subject|4|||
149085724|NCT02978716|537791065|FG002|Overall Study|Withdrawal by Subject|5|||
149085725|NCT02978716|537791063|FG000|Overall Study|Sponsor terminated|2|||
149085726|NCT02978716|537791064|FG001|Overall Study|Sponsor terminated|13|||
149085727|NCT02978716|537791065|FG002|Overall Study|Sponsor terminated|9|||
149085728|NCT02978716|537791063|FG000|Overall Study|Other|1|||
149085729|NCT02978716|537791064|FG001|Overall Study|Other|3|||
149085730|NCT02978716|537791065|FG002|Overall Study|Other|0|||
149085731|NCT00589628|537791066|FG000|Overall Study|Lost to Follow-up|0|||
149085732|NCT00589628|537791067|FG001|Overall Study|Lost to Follow-up|1|||
149085733|NCT00689351|537791071|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
149085734|NCT00689351|537791072|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
149085735|NCT00689351|537791071|FG000|Infant Series of Dosing|Adverse Event|1|||
149085736|NCT00689351|537791072|FG001|Infant Series of Dosing|Adverse Event|0|||
149085737|NCT00689351|537791071|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
149085738|NCT00689351|537791072|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
149085739|NCT00689351|537791071|FG000|After Infant Series|Parent/legal guardian request|1|||
149085740|NCT00689351|537791072|FG001|After Infant Series|Parent/legal guardian request|0|||
149085741|NCT01766206|537791073|FG000|Overall Study|Withdrawal by Subject|22|||
149085742|NCT01766206|537791073|FG000|Overall Study|Lost to Follow-up|10|||
149085743|NCT01766206|537791073|FG000|Overall Study|Inappropriate enrollment|18|||
149085744|NCT01766206|537791073|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
149085745|NCT01662505|537791074|FG000|Overall Study|Progressive disease|6|||
149085746|NCT01662505|537791075|FG001|Overall Study|Progressive disease|1|||
149085747|NCT01662505|537791076|FG002|Overall Study|Progressive disease|5|||
149085748|NCT01662505|537791074|FG000|Overall Study|Refused cont. medication|0|||
149085749|NCT01662505|537791075|FG001|Overall Study|Refused cont. medication|0|||
149085750|NCT01662505|537791076|FG002|Overall Study|Refused cont. medication|1|||
149085751|NCT01662505|537791074|FG000|Overall Study|Not specified above|1|||
149085752|NCT01662505|537791075|FG001|Overall Study|Not specified above|3|||
149085753|NCT01662505|537791076|FG002|Overall Study|Not specified above|2|||
149085754|NCT01313663|537791077|FG000|Overall Study|Study Closed/Terminated|2|||
149085755|NCT01313663|537791078|FG001|Overall Study|Study Closed/Terminated|4|||
149085756|NCT01313663|537791077|FG000|Overall Study|Lost to Follow-up|0|||
149085757|NCT01313663|537791078|FG001|Overall Study|Lost to Follow-up|1|||
149085758|NCT01313663|537791077|FG000|Overall Study|Physician Decision|0|||
149085759|NCT01313663|537791078|FG001|Overall Study|Physician Decision|2|||
149085760|NCT01313663|537791077|FG000|Overall Study|Withdrawal by Subject|2|||
149085761|NCT01313663|537791078|FG001|Overall Study|Withdrawal by Subject|1|||
149085762|NCT01661972|537791081|FG000|Overall Study|Adverse Event|1|||
149085763|NCT01661972|537791082|FG001|Overall Study|Adverse Event|2|||
149085764|NCT01661972|537791081|FG000|Overall Study|Death during Treatment period|1|||
149085765|NCT01661972|537791082|FG001|Overall Study|Death during Treatment period|1|||
149085766|NCT01661972|537791081|FG000|Overall Study|Withdrawal by Subject|0|||
149085767|NCT01661972|537791082|FG001|Overall Study|Withdrawal by Subject|1|||
149085768|NCT01229176|537791083|FG000|Overall Study|Withdrawal by Subject|0|||
149085769|NCT01229176|537791084|FG001|Overall Study|Withdrawal by Subject|0|||
149085770|NCT01229176|537791085|FG002|Overall Study|Withdrawal by Subject|0|||
149085771|NCT01229176|537791086|FG003|Overall Study|Withdrawal by Subject|1|||
149085772|NCT01229176|537791087|FG004|Overall Study|Withdrawal by Subject|1|||
149085773|NCT01229176|537791088|FG005|Overall Study|Withdrawal by Subject|1|||
149085774|NCT01229176|537791089|FG006|Overall Study|Withdrawal by Subject|0|||
149085775|NCT01229176|537791090|FG007|Overall Study|Withdrawal by Subject|1|||
149085776|NCT01229176|537791083|FG000|Overall Study|Lost to Follow-up|0|||
149085777|NCT01229176|537791084|FG001|Overall Study|Lost to Follow-up|3|||
149085778|NCT01229176|537791085|FG002|Overall Study|Lost to Follow-up|0|||
149085779|NCT01229176|537791086|FG003|Overall Study|Lost to Follow-up|0|||
149085780|NCT01229176|537791087|FG004|Overall Study|Lost to Follow-up|1|||
149085781|NCT01229176|537791088|FG005|Overall Study|Lost to Follow-up|1|||
149085782|NCT01229176|537791089|FG006|Overall Study|Lost to Follow-up|0|||
149085783|NCT01229176|537791090|FG007|Overall Study|Lost to Follow-up|2|||
149085784|NCT02367794|537791093|FG000|Overall Study|Death|252|||
149085785|NCT02367794|537791094|FG001|Overall Study|Death|245|||
149085786|NCT02367794|537791095|FG002|Overall Study|Death|243|||
149085787|NCT02367794|537791093|FG000|Overall Study|Lost to Follow-up|1|||
149085788|NCT02367794|537791094|FG001|Overall Study|Lost to Follow-up|2|||
149085789|NCT02367794|537791095|FG002|Overall Study|Lost to Follow-up|2|||
149085790|NCT02367794|537791093|FG000|Overall Study|Physician Decision|0|||
149085791|NCT02367794|537791094|FG001|Overall Study|Physician Decision|5|||
149085792|NCT02367794|537791095|FG002|Overall Study|Physician Decision|3|||
149085793|NCT02367794|537791093|FG000|Overall Study|Protocol Violation|1|||
149085794|NCT02367794|537791094|FG001|Overall Study|Protocol Violation|0|||
149085795|NCT02367794|537791095|FG002|Overall Study|Protocol Violation|1|||
149085796|NCT02367794|537791093|FG000|Overall Study|Withdrawal by Subject|25|||
149085797|NCT02367794|537791094|FG001|Overall Study|Withdrawal by Subject|12|||
149085798|NCT02367794|537791095|FG002|Overall Study|Withdrawal by Subject|20|||
149085799|NCT02367794|537791093|FG000|Overall Study|Brain metastasis|1|||
149085800|NCT02367794|537791094|FG001|Overall Study|Brain metastasis|0|||
149085801|NCT02367794|537791095|FG002|Overall Study|Brain metastasis|0|||
149085802|NCT02367794|537791093|FG000|Overall Study|Randomized in error|0|||
149085803|NCT02367794|537791094|FG001|Overall Study|Randomized in error|0|||
149085804|NCT02367794|537791095|FG002|Overall Study|Randomized in error|1|||
149085805|NCT02367794|537791093|FG000|Overall Study|Patient unable to receive carboplatin|0|||
149085806|NCT02367794|537791094|FG001|Overall Study|Patient unable to receive carboplatin|0|||
149085807|NCT02367794|537791095|FG002|Overall Study|Patient unable to receive carboplatin|1|||
149085808|NCT02367794|537791093|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
149085809|NCT02367794|537791094|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
149085810|NCT02367794|537791095|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
149085811|NCT02367794|537791093|FG000|Overall Study|Adverse Event|0|||
149085812|NCT02367794|537791094|FG001|Overall Study|Adverse Event|0|||
149085813|NCT02367794|537791095|FG002|Overall Study|Adverse Event|2|||
149085814|NCT02367794|537791093|FG000|Overall Study|Study Terminated By Sponsor|0|||
149085815|NCT02367794|537791094|FG001|Overall Study|Study Terminated By Sponsor|1|||
149085816|NCT02367794|537791095|FG002|Overall Study|Study Terminated By Sponsor|1|||
149085817|NCT02367794|537791093|FG000|Overall Study|Moved to Roll-Over Study|0|||
149085818|NCT02367794|537791094|FG001|Overall Study|Moved to Roll-Over Study|15|||
149085819|NCT02367794|537791095|FG002|Overall Study|Moved to Roll-Over Study|13|||
149085820|NCT02367794|537791093|FG000|Overall Study|Sponsor Request|60|||
149085821|NCT02367794|537791094|FG001|Overall Study|Sponsor Request|57|||
149085822|NCT02367794|537791095|FG002|Overall Study|Sponsor Request|45|||
149085823|NCT02367794|537791093|FG000|Overall Study|Moved into PTAP Study|0|||
149085824|NCT02367794|537791094|FG001|Overall Study|Moved into PTAP Study|2|||
149085825|NCT02367794|537791095|FG002|Overall Study|Moved into PTAP Study|3|||
149085826|NCT02367794|537791093|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
149085827|NCT02367794|537791094|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
149085828|NCT02367794|537791095|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
149085829|NCT02367794|537791093|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
149085830|NCT02367794|537791094|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
149085831|NCT02367794|537791095|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
149085832|NCT02367794|537791093|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
149085833|NCT02367794|537791094|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
149085834|NCT02367794|537791095|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
149085835|NCT02367794|537791093|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
149085836|NCT02367794|537791094|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
149085837|NCT02367794|537791095|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
149085838|NCT02158806|537791096|FG000|Overall Study|Death|2|||
149085839|NCT02158806|537791097|FG001|Overall Study|Death|0|||
149085840|NCT02158806|537791096|FG000|Overall Study|Withdrawal by Subject|2|||
149085841|NCT02158806|537791097|FG001|Overall Study|Withdrawal by Subject|0|||
149085842|NCT02158806|537791096|FG000|Overall Study|Lost to Follow-up|0|||
149085843|NCT02158806|537791097|FG001|Overall Study|Lost to Follow-up|3|||
149085844|NCT02158806|537791096|FG000|Overall Study|Moved out of area|0|||
149085845|NCT02158806|537791097|FG001|Overall Study|Moved out of area|1|||
149085846|NCT02158806|537791096|FG000|Overall Study|Transferred to palliative care|0|||
149085847|NCT02158806|537791097|FG001|Overall Study|Transferred to palliative care|1|||
149085848|NCT02340806|537791101|FG000|Overall Study|Protocol Violation|2|||
149085849|NCT02340806|537791102|FG001|Overall Study|Protocol Violation|0|||
149085850|NCT02340806|537791101|FG000|Overall Study|epidural catheter replaced|2|||
149085851|NCT02340806|537791102|FG001|Overall Study|epidural catheter replaced|1|||
149085852|NCT02340806|537791101|FG000|Overall Study|history of chronic pain medication|1|||
149085853|NCT02340806|537791102|FG001|Overall Study|history of chronic pain medication|0|||
149085854|NCT02340806|537791101|FG000|Overall Study|re-dose < 90 min of CSE|1|||
149085855|NCT02340806|537791102|FG001|Overall Study|re-dose < 90 min of CSE|3|||
149085856|NCT01159600|537791104|FG000|Overall Study|Not treated|0|||
149085857|NCT01159600|537791105|FG001|Overall Study|Not treated|0|||
149085858|NCT01159600|537791106|FG002|Overall Study|Not treated|1|||
149085859|NCT01159600|537791107|FG003|Overall Study|Not treated|0|||
149085860|NCT01159600|537791108|FG004|Overall Study|Not treated|0|||
149085861|NCT01159600|537791109|FG005|Overall Study|Not treated|1|||
149085862|NCT01159600|537791110|FG006|Overall Study|Not treated|2|||
149085863|NCT01159600|537791111|FG007|Overall Study|Not treated|2|||
149085864|NCT01159600|537791104|FG000|Overall Study|Adverse Event|7|||
149085865|NCT01159600|537791105|FG001|Overall Study|Adverse Event|2|||
149085866|NCT01159600|537791106|FG002|Overall Study|Adverse Event|5|||
149085867|NCT01159600|537791107|FG003|Overall Study|Adverse Event|1|||
149085868|NCT01159600|537791108|FG004|Overall Study|Adverse Event|8|||
149085869|NCT01159600|537791109|FG005|Overall Study|Adverse Event|6|||
149085870|NCT01159600|537791110|FG006|Overall Study|Adverse Event|7|||
149085871|NCT01159600|537791111|FG007|Overall Study|Adverse Event|5|||
149085872|NCT01159600|537791104|FG000|Overall Study|Lack of Efficacy|0|||
149085873|NCT01159600|537791105|FG001|Overall Study|Lack of Efficacy|0|||
149085874|NCT01159600|537791106|FG002|Overall Study|Lack of Efficacy|0|||
149085875|NCT01159600|537791107|FG003|Overall Study|Lack of Efficacy|0|||
149085876|NCT01159600|537791108|FG004|Overall Study|Lack of Efficacy|2|||
149085877|NCT01159600|537791109|FG005|Overall Study|Lack of Efficacy|0|||
149085878|NCT01159600|537791110|FG006|Overall Study|Lack of Efficacy|0|||
149085879|NCT01159600|537791111|FG007|Overall Study|Lack of Efficacy|1|||
149085880|NCT01159600|537791104|FG000|Overall Study|Non compliant with protocol|2|||
149085881|NCT01159600|537791105|FG001|Overall Study|Non compliant with protocol|1|||
149085882|NCT01159600|537791106|FG002|Overall Study|Non compliant with protocol|0|||
149085883|NCT01159600|537791107|FG003|Overall Study|Non compliant with protocol|0|||
149085884|NCT01159600|537791108|FG004|Overall Study|Non compliant with protocol|2|||
149085885|NCT01159600|537791109|FG005|Overall Study|Non compliant with protocol|0|||
149085886|NCT01159600|537791110|FG006|Overall Study|Non compliant with protocol|2|||
149085887|NCT01159600|537791111|FG007|Overall Study|Non compliant with protocol|0|||
149085888|NCT01159600|537791104|FG000|Overall Study|Lost to Follow-up|2|||
149085889|NCT01159600|537791105|FG001|Overall Study|Lost to Follow-up|3|||
149085890|NCT01159600|537791106|FG002|Overall Study|Lost to Follow-up|4|||
149085891|NCT01159600|537791107|FG003|Overall Study|Lost to Follow-up|3|||
149085892|NCT01159600|537791108|FG004|Overall Study|Lost to Follow-up|3|||
149085893|NCT01159600|537791109|FG005|Overall Study|Lost to Follow-up|0|||
149085894|NCT01159600|537791110|FG006|Overall Study|Lost to Follow-up|3|||
149085895|NCT01159600|537791111|FG007|Overall Study|Lost to Follow-up|2|||
149085896|NCT01159600|537791104|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
149085897|NCT01159600|537791105|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
149085898|NCT01159600|537791106|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
149085899|NCT01159600|537791107|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
149085900|NCT01159600|537791108|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
149085901|NCT01159600|537791109|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
149085902|NCT01159600|537791110|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
149085903|NCT01159600|537791111|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
149085904|NCT01159600|537791104|FG000|Overall Study|Other reason not defined above|3|||
149085905|NCT01159600|537791105|FG001|Overall Study|Other reason not defined above|0|||
149085906|NCT01159600|537791106|FG002|Overall Study|Other reason not defined above|4|||
149085907|NCT01159600|537791107|FG003|Overall Study|Other reason not defined above|2|||
149085908|NCT01159600|537791108|FG004|Overall Study|Other reason not defined above|5|||
149085909|NCT01159600|537791109|FG005|Overall Study|Other reason not defined above|7|||
149085910|NCT01159600|537791110|FG006|Overall Study|Other reason not defined above|3|||
149085911|NCT01159600|537791111|FG007|Overall Study|Other reason not defined above|3|||
149085912|NCT00946998|537792950|FG000|Overall Study|Exited prior to first outcome assessment|5|||
149085913|NCT00946998|537792951|FG001|Overall Study|Exited prior to first outcome assessment|3|||
149085914|NCT05379400|537792955|FG000|Overall Study|Lost to Follow-up|1|||
149085915|NCT05379400|537792956|FG001|Overall Study|Lost to Follow-up|1|||
149085916|NCT01020487|537792957|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
149085917|NCT01020487|537792958|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
149085918|NCT01020487|537792959|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
149085919|NCT01020487|537792957|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
149085920|NCT01020487|537792958|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
149085921|NCT01020487|537792959|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
149085922|NCT01020487|537792957|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
149085923|NCT01020487|537792958|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
149085924|NCT01020487|537792959|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
149085925|NCT01020487|537792957|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
149085926|NCT01020487|537792958|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
149085927|NCT01020487|537792959|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
149085928|NCT01020487|537792957|FG000|Part 2 Open-label Period|Adverse Event|0|||
149085929|NCT01020487|537792958|FG001|Part 2 Open-label Period|Adverse Event|4|||
149085930|NCT01020487|537792959|FG002|Part 2 Open-label Period|Adverse Event|1|||
149085931|NCT04049578|537792960|FG000|Overall Study|Physician Decision|1|||
149085932|NCT00555620|537792970|FG000|Overall Study|Death|0|||
149085933|NCT00555620|537792971|FG001|Overall Study|Death|1|||
149085934|NCT00555620|537792972|FG002|Overall Study|Death|0|||
149085935|NCT00555620|537792973|FG003|Overall Study|Death|0|||
149085936|NCT00555620|537792974|FG004|Overall Study|Death|0|||
149085937|NCT00555620|537792975|FG005|Overall Study|Death|1|||
149085938|NCT00555620|537792970|FG000|Overall Study|Study terminated by sponsor|0|||
149085939|NCT00555620|537792971|FG001|Overall Study|Study terminated by sponsor|0|||
149085940|NCT00555620|537792972|FG002|Overall Study|Study terminated by sponsor|1|||
149085941|NCT00555620|537792973|FG003|Overall Study|Study terminated by sponsor|0|||
149085942|NCT00555620|537792974|FG004|Overall Study|Study terminated by sponsor|0|||
149085943|NCT00555620|537792975|FG005|Overall Study|Study terminated by sponsor|0|||
149085944|NCT00555620|537792970|FG000|Overall Study|Adverse Event|0|||
149085945|NCT00555620|537792971|FG001|Overall Study|Adverse Event|0|||
149085946|NCT00555620|537792972|FG002|Overall Study|Adverse Event|1|||
149085947|NCT00555620|537792973|FG003|Overall Study|Adverse Event|5|||
149085948|NCT00555620|537792974|FG004|Overall Study|Adverse Event|0|||
149085949|NCT00555620|537792975|FG005|Overall Study|Adverse Event|1|||
149085950|NCT00555620|537792970|FG000|Overall Study|Objective progression or relapse|6|||
149085951|NCT00555620|537792971|FG001|Overall Study|Objective progression or relapse|5|||
149085952|NCT00555620|537792972|FG002|Overall Study|Objective progression or relapse|12|||
149085953|NCT00555620|537792973|FG003|Overall Study|Objective progression or relapse|17|||
149085954|NCT00555620|537792974|FG004|Overall Study|Objective progression or relapse|3|||
149085955|NCT00555620|537792975|FG005|Overall Study|Objective progression or relapse|16|||
149085956|NCT00555620|537792970|FG000|Overall Study|Participant refused treatment|0|||
149085957|NCT00555620|537792971|FG001|Overall Study|Participant refused treatment|1|||
149085958|NCT00555620|537792972|FG002|Overall Study|Participant refused treatment|1|||
149085959|NCT00555620|537792973|FG003|Overall Study|Participant refused treatment|0|||
149085960|NCT00555620|537792974|FG004|Overall Study|Participant refused treatment|0|||
149085961|NCT00555620|537792975|FG005|Overall Study|Participant refused treatment|1|||
149085962|NCT00555620|537792970|FG000|Overall Study|Other|0|||
149085963|NCT00555620|537792971|FG001|Overall Study|Other|0|||
149085964|NCT00555620|537792972|FG002|Overall Study|Other|0|||
149085965|NCT00555620|537792973|FG003|Overall Study|Other|1|||
149085966|NCT00555620|537792974|FG004|Overall Study|Other|0|||
149085967|NCT00555620|537792975|FG005|Overall Study|Other|3|||
149085968|NCT01922102|537792976|FG000|Overall Study|Withdrawal by Subject|7|||
149085969|NCT01922102|537792977|FG001|Overall Study|Withdrawal by Subject|3|||
149085970|NCT01922102|537792978|FG002|Overall Study|Withdrawal by Subject|7|||
149085971|NCT01922102|537792976|FG000|Overall Study|Physician Decision|0|||
149085972|NCT01922102|537792977|FG001|Overall Study|Physician Decision|2|||
149085973|NCT01922102|537792978|FG002|Overall Study|Physician Decision|1|||
149085974|NCT01922102|537792976|FG000|Overall Study|Adverse Event|1|||
149085975|NCT01922102|537792977|FG001|Overall Study|Adverse Event|2|||
149085976|NCT01922102|537792978|FG002|Overall Study|Adverse Event|0|||
149085977|NCT01922102|537792976|FG000|Overall Study|Lost to Follow-up|1|||
149085978|NCT01922102|537792977|FG001|Overall Study|Lost to Follow-up|0|||
149085979|NCT01922102|537792978|FG002|Overall Study|Lost to Follow-up|0|||
149085980|NCT01922102|537792976|FG000|Overall Study|Administrative problems|0|||
149085981|NCT01922102|537792977|FG001|Overall Study|Administrative problems|2|||
149085982|NCT01922102|537792978|FG002|Overall Study|Administrative problems|0|||
149085983|NCT05203822|537792979|FG000|Overall Study|Adverse Event|1|||
149085984|NCT05203822|537792979|FG000|Overall Study|Withdrawal by Subject|1|||
149085985|NCT03320941|537792983|FG000|Overall Study|subject/guardian decision|0|||
149085986|NCT03320941|537792984|FG001|Overall Study|subject/guardian decision|0|||
149085987|NCT03320941|537792985|FG002|Overall Study|subject/guardian decision|0|||
149085988|NCT03320941|537792986|FG003|Overall Study|subject/guardian decision|1|||
149085989|NCT03320941|537792987|FG004|Overall Study|subject/guardian decision|0|||
149085990|NCT00447499|537792988|FG000|Overall Study|Adverse Event|1|||
149085991|NCT00447499|537792988|FG000|Overall Study|Patient Decision|4|||
149085992|NCT00447499|537792988|FG000|Overall Study|Sponsor Decision|1|||
149085993|NCT00447499|537792988|FG000|Overall Study|Physician Decision|1|||
149085994|NCT01767376|537792990|FG000|Overall Study|Lost to Follow-up|3|||
149085995|NCT01767376|537792991|FG001|Overall Study|Lost to Follow-up|2|||
149085996|NCT01767376|537792992|FG002|Overall Study|Lost to Follow-up|0|||
149085997|NCT01767376|537792990|FG000|Overall Study|Withdrawal by Subject|1|||
149085998|NCT01767376|537792991|FG001|Overall Study|Withdrawal by Subject|1|||
149085999|NCT01767376|537792992|FG002|Overall Study|Withdrawal by Subject|0|||
149086000|NCT03360071|537792993|FG000|Overall Study|Lost to Follow-up|1|||
149086001|NCT03360071|537792994|FG001|Overall Study|Lost to Follow-up|0|||
149086002|NCT00946088|537792995|FG000|Overall Study|Withdrawal by Subject|0|||
149086003|NCT00946088|537792996|FG001|Overall Study|Withdrawal by Subject|1|||
149086004|NCT03184519|537793000|FG000|Overall Study|Lost to Follow-up|6|||
149086005|NCT03184519|537793000|FG000|Overall Study|Physician Decision|21|||
149086006|NCT03262389|537793003|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
149086007|NCT03262389|537793003|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
149086008|NCT03262389|537793003|FG000|Overall Study|opted out of PET/MR|1|||
149086009|NCT01052272|537793004|FG000|Overall Study|Death|0|||
149086010|NCT01052272|537793005|FG001|Overall Study|Death|0|||
149086011|NCT01052272|537793006|FG002|Overall Study|Death|1|||
149086012|NCT01052272|537793007|FG003|Overall Study|Death|1|||
149086013|NCT01052272|537793004|FG000|Overall Study|Physician Decision|0|||
149086014|NCT01052272|537793005|FG001|Overall Study|Physician Decision|1|||
149086015|NCT01052272|537793006|FG002|Overall Study|Physician Decision|0|||
149086016|NCT01052272|537793007|FG003|Overall Study|Physician Decision|0|||
149086017|NCT01052272|537793004|FG000|Overall Study|patient refuses follow-up|5|||
149086018|NCT01052272|537793005|FG001|Overall Study|patient refuses follow-up|4|||
149086019|NCT01052272|537793006|FG002|Overall Study|patient refuses follow-up|2|||
149086020|NCT01052272|537793007|FG003|Overall Study|patient refuses follow-up|4|||
149086021|NCT01052272|537793004|FG000|Overall Study|Withdrawal by Subject|0|||
149086022|NCT01052272|537793005|FG001|Overall Study|Withdrawal by Subject|2|||
149086023|NCT01052272|537793006|FG002|Overall Study|Withdrawal by Subject|3|||
149086024|NCT01052272|537793007|FG003|Overall Study|Withdrawal by Subject|2|||
149086025|NCT01052272|537793004|FG000|Overall Study|placed in long-term care|0|||
149086026|NCT01052272|537793005|FG001|Overall Study|placed in long-term care|0|||
149086027|NCT01052272|537793006|FG002|Overall Study|placed in long-term care|1|||
149086028|NCT01052272|537793007|FG003|Overall Study|placed in long-term care|0|||
149086029|NCT01052272|537793004|FG000|Overall Study|decline in health|0|||
149086030|NCT01052272|537793005|FG001|Overall Study|decline in health|0|||
149086031|NCT01052272|537793006|FG002|Overall Study|decline in health|1|||
149086032|NCT01052272|537793007|FG003|Overall Study|decline in health|0|||
149086033|NCT02865083|537793010|FG000|Overall Study|Early Termination|3|||
149086034|NCT02865083|537793011|FG001|Overall Study|Early Termination|1|||
149086035|NCT02105688|537793012|FG000|Part A: Double-Blind|Adverse Event|1|||
149086036|NCT02105688|537793013|FG001|Part A: Double-Blind|Adverse Event|0|||
149086037|NCT02105688|537793012|FG000|Part A: Double-Blind|Death|0|||
149086038|NCT02105688|537793013|FG001|Part A: Double-Blind|Death|1|||
149086039|NCT02105688|537793012|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
149086040|NCT02105688|537793013|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
149086041|NCT02105688|537793012|FG000|Part A: Double-Blind|Physician Decision|0|||
149086042|NCT02105688|537793013|FG001|Part A: Double-Blind|Physician Decision|1|||
149086043|NCT02105688|537793012|FG000|Part A: Double-Blind|Status Unknown|0|||
149086044|NCT02105688|537793013|FG001|Part A: Double-Blind|Status Unknown|2|||
149086045|NCT02105688|537793012|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
149086046|NCT02105688|537793013|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
149086047|NCT02105688|537793012|FG000|Part B: Observational Follow-up|Death|2|||
149086048|NCT02105688|537793013|FG001|Part B: Observational Follow-up|Death|1|||
149086049|NCT02105688|537793012|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
149086050|NCT02105688|537793013|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
149086051|NCT02105688|537793012|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
149086052|NCT02105688|537793013|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
149086053|NCT02105688|537793012|FG000|Part B: Observational Follow-up|Physician Decision|3|||
149086054|NCT02105688|537793013|FG001|Part B: Observational Follow-up|Physician Decision|1|||
149086055|NCT01358175|537793014|FG000|Overall Study|Death|1|||
149086056|NCT01358175|537793015|FG001|Overall Study|Death|0|||
149086057|NCT01358175|537793016|FG002|Overall Study|Death|1|||
149086058|NCT01358175|537793014|FG000|Overall Study|Withdrawal by Subject|9|||
149086059|NCT01358175|537793015|FG001|Overall Study|Withdrawal by Subject|5|||
149086060|NCT01358175|537793016|FG002|Overall Study|Withdrawal by Subject|10|||
149086061|NCT01358175|537793014|FG000|Overall Study|Technical issues|0|||
149086062|NCT01358175|537793015|FG001|Overall Study|Technical issues|1|||
149086063|NCT01358175|537793016|FG002|Overall Study|Technical issues|0|||
149086064|NCT01358175|537793014|FG000|Overall Study|Pregnancy|0|||
149086065|NCT01358175|537793015|FG001|Overall Study|Pregnancy|1|||
149086066|NCT01358175|537793016|FG002|Overall Study|Pregnancy|0|||
149086067|NCT01358175|537793014|FG000|Overall Study|Physician Decision|1|||
149086068|NCT01358175|537793015|FG001|Overall Study|Physician Decision|0|||
149086069|NCT01358175|537793016|FG002|Overall Study|Physician Decision|0|||
149086070|NCT01358175|537793014|FG000|Overall Study|Non Compliance with Study Treatment|0|||
149086071|NCT01358175|537793015|FG001|Overall Study|Non Compliance with Study Treatment|1|||
149086072|NCT01358175|537793016|FG002|Overall Study|Non Compliance with Study Treatment|1|||
149086073|NCT01358175|537793014|FG000|Overall Study|Lost to Follow-up|1|||
149086074|NCT01358175|537793015|FG001|Overall Study|Lost to Follow-up|1|||
149086075|NCT01358175|537793016|FG002|Overall Study|Lost to Follow-up|3|||
149086076|NCT01358175|537793014|FG000|Overall Study|Lack of Efficacy|3|||
149086077|NCT01358175|537793015|FG001|Overall Study|Lack of Efficacy|8|||
149086078|NCT01358175|537793016|FG002|Overall Study|Lack of Efficacy|6|||
149086079|NCT01358175|537793014|FG000|Overall Study|Adverse Event|6|||
149086080|NCT01358175|537793015|FG001|Overall Study|Adverse Event|11|||
149086081|NCT01358175|537793016|FG002|Overall Study|Adverse Event|11|||
149086082|NCT04908488|537793019|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
149086083|NCT04908488|537793020|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
149086084|NCT04908488|537793019|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
149086085|NCT04908488|537793020|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
149086086|NCT01107912|537793022|FG000|Period 1|Adverse Event|0|||
149086087|NCT01107912|537793023|FG001|Period 1|Adverse Event|0|||
149086088|NCT01107912|537793024|FG002|Period 1|Adverse Event|0|||
149086089|NCT01107912|537793025|FG003|Period 1|Adverse Event|0|||
149086090|NCT01107912|537793026|FG004|Period 1|Adverse Event|2|||
149086091|NCT01107912|537793027|FG005|Period 1|Adverse Event|0|||
149086092|NCT01107912|537793022|FG000|Period 1|Physician Decision|0|||
149086093|NCT01107912|537793023|FG001|Period 1|Physician Decision|0|||
149086094|NCT01107912|537793024|FG002|Period 1|Physician Decision|0|||
149086095|NCT01107912|537793025|FG003|Period 1|Physician Decision|0|||
149086096|NCT01107912|537793026|FG004|Period 1|Physician Decision|1|||
149086097|NCT01107912|537793027|FG005|Period 1|Physician Decision|0|||
149086098|NCT01107912|537793022|FG000|Period 1|Withdrawal by Subject|1|||
149086099|NCT01107912|537793023|FG001|Period 1|Withdrawal by Subject|0|||
149086100|NCT01107912|537793024|FG002|Period 1|Withdrawal by Subject|0|||
149086101|NCT01107912|537793025|FG003|Period 1|Withdrawal by Subject|0|||
149086102|NCT01107912|537793026|FG004|Period 1|Withdrawal by Subject|0|||
149086103|NCT01107912|537793027|FG005|Period 1|Withdrawal by Subject|0|||
149086104|NCT01107912|537793022|FG000|Period 2|Physician Decision|0|||
149086105|NCT01107912|537793023|FG001|Period 2|Physician Decision|0|||
149086106|NCT01107912|537793024|FG002|Period 2|Physician Decision|1|||
149086107|NCT01107912|537793025|FG003|Period 2|Physician Decision|0|||
149086108|NCT01107912|537793026|FG004|Period 2|Physician Decision|0|||
149086109|NCT01107912|537793027|FG005|Period 2|Physician Decision|0|||
149086110|NCT01107912|537793022|FG000|Period 3|Adverse Event|0|||
149086111|NCT01107912|537793023|FG001|Period 3|Adverse Event|1|||
149086112|NCT01107912|537793024|FG002|Period 3|Adverse Event|1|||
149086113|NCT01107912|537793025|FG003|Period 3|Adverse Event|0|||
149086114|NCT01107912|537793026|FG004|Period 3|Adverse Event|0|||
149086115|NCT01107912|537793027|FG005|Period 3|Adverse Event|0|||
149086116|NCT01107912|537793022|FG000|Period 3|Withdrawal by Subject|0|||
149086117|NCT01107912|537793023|FG001|Period 3|Withdrawal by Subject|0|||
149086118|NCT01107912|537793024|FG002|Period 3|Withdrawal by Subject|0|||
149086119|NCT01107912|537793025|FG003|Period 3|Withdrawal by Subject|1|||
149086120|NCT01107912|537793026|FG004|Period 3|Withdrawal by Subject|0|||
149086121|NCT01107912|537793027|FG005|Period 3|Withdrawal by Subject|0|||
149086122|NCT01124916|537793032|FG000|Overall Study|Lost to Follow-up|3|||
149086123|NCT01124916|537793033|FG001|Overall Study|Lost to Follow-up|2|||
149086124|NCT00595959|537793040|FG000|Overall Study|Withdrawal by Subject|1|||
149086125|NCT00595959|537793040|FG000|Overall Study|Lost to Follow-up|1|||
149086126|NCT00963924|537793043|FG000|Overall Study|Adverse Event|1|||
149086127|NCT00963924|537793044|FG001|Overall Study|Adverse Event|0|||
149086128|NCT00963924|537793043|FG000|Overall Study|Withdrawal by Subject|0|||
149086129|NCT00963924|537793044|FG001|Overall Study|Withdrawal by Subject|1|||
149086130|NCT00963924|537793043|FG000|Overall Study|Changed antipsychotic|0|||
149086131|NCT00963924|537793044|FG001|Overall Study|Changed antipsychotic|1|||
149086132|NCT00963924|537793043|FG000|Overall Study|Lost to Follow-up|0|||
149086133|NCT00963924|537793044|FG001|Overall Study|Lost to Follow-up|1|||
149086134|NCT00901459|537793047|FG000|Overall Study|Withdrawal by Subject|6|||
149086135|NCT04765046|537793048|FG000|Overall Study|Screen Failure|2|||
149086136|NCT04765046|537793048|FG000|Overall Study|Withdrawal by Subject|4|||
149086137|NCT04765046|537793048|FG000|Overall Study|Physician Decision|4|||
149086138|NCT04765046|537793048|FG000|Overall Study|Surgery Cancelled|8|||
149086139|NCT03529942|537793049|FG000|Overall Study|Withdrawal by Subject|13|||
149086140|NCT03529942|537793049|FG000|Overall Study|Physician Decision|1|||
149086141|NCT03529942|537793049|FG000|Overall Study|Lost to Follow-up|7|||
149086142|NCT03529942|537793049|FG000|Overall Study|Needle inserted but no drug administered|1|||
149086143|NCT03529942|537793049|FG000|Overall Study|Personal reasons|1|||
149086144|NCT00636168|537793052|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
149086145|NCT00636168|537793053|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
149086146|NCT00636168|537793052|FG000|Randomized to Study Drug|Adverse Event|1|||
149086147|NCT00636168|537793053|FG001|Randomized to Study Drug|Adverse Event|0|||
149086148|NCT00636168|537793052|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
149086149|NCT00636168|537793053|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
149086150|NCT00636168|537793052|FG000|Treated With Study Drug|Recurrence of disease|135|||
149086151|NCT00636168|537793053|FG001|Treated With Study Drug|Recurrence of disease|282|||
149086152|NCT00636168|537793052|FG000|Treated With Study Drug|Adverse Event|250|||
149086153|NCT00636168|537793053|FG001|Treated With Study Drug|Adverse Event|22|||
149086154|NCT00636168|537793052|FG000|Treated With Study Drug|Participant withdrew consent|16|||
149086155|NCT00636168|537793053|FG001|Treated With Study Drug|Participant withdrew consent|21|||
149086156|NCT00636168|537793052|FG000|Treated With Study Drug|Poor/non-compliance|1|||
149086157|NCT00636168|537793053|FG001|Treated With Study Drug|Poor/non-compliance|3|||
149086158|NCT00636168|537793052|FG000|Treated With Study Drug|Death|3|||
149086159|NCT00636168|537793053|FG001|Treated With Study Drug|Death|0|||
149086160|NCT00636168|537793052|FG000|Treated With Study Drug|Pregnancy|1|||
149086161|NCT00636168|537793053|FG001|Treated With Study Drug|Pregnancy|0|||
149086162|NCT00636168|537793052|FG000|Treated With Study Drug|No longer meets study criteria|1|||
149086163|NCT00636168|537793053|FG001|Treated With Study Drug|No longer meets study criteria|0|||
149086164|NCT00636168|537793052|FG000|Treated With Study Drug|Other reason|1|||
149086165|NCT00636168|537793053|FG001|Treated With Study Drug|Other reason|3|||
149086166|NCT00636168|537793052|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
149086167|NCT00636168|537793053|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
149086168|NCT00636168|537793052|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
149086169|NCT00636168|537793053|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
149086170|NCT00636168|537793052|FG000|Long Term Follow-Up|Death|8|||
149086171|NCT00636168|537793053|FG001|Long Term Follow-Up|Death|9|||
149086172|NCT01240785|537793058|FG000|Overall Study|Lost to Follow-up|1|||
149086173|NCT01240785|537793059|FG001|Overall Study|Lost to Follow-up|0|||
149086174|NCT01240785|537793058|FG000|Overall Study|Protocol Violation|0|||
149086175|NCT01240785|537793059|FG001|Overall Study|Protocol Violation|3|||
149086176|NCT03015220|537793060|FG000|Overall Study|Withdrawal by Subject|3|||
149086177|NCT03015220|537793061|FG001|Overall Study|Withdrawal by Subject|2|||
149086178|NCT03015220|537793062|FG002|Overall Study|Withdrawal by Subject|2|||
149086179|NCT03015220|537793063|FG003|Overall Study|Withdrawal by Subject|2|||
149086180|NCT03015220|537793060|FG000|Overall Study|Lost to Follow-up|0|||
149086181|NCT03015220|537793061|FG001|Overall Study|Lost to Follow-up|0|||
149086182|NCT03015220|537793062|FG002|Overall Study|Lost to Follow-up|1|||
149086183|NCT03015220|537793063|FG003|Overall Study|Lost to Follow-up|0|||
149086184|NCT00912964|537793064|FG000|Overall Study|Eligibility criterion not met|1|||
149086185|NCT00912964|537793065|FG001|Overall Study|Eligibility criterion not met|1|||
149086186|NCT00912964|537793066|FG002|Overall Study|Eligibility criterion not met|0|||
149086187|NCT00912964|537793064|FG000|Overall Study|Adverse Event|15|||
149086188|NCT00912964|537793065|FG001|Overall Study|Adverse Event|18|||
149086189|NCT00912964|537793066|FG002|Overall Study|Adverse Event|12|||
149086190|NCT00912964|537793064|FG000|Overall Study|Lack of Efficacy|11|||
149086191|NCT00912964|537793065|FG001|Overall Study|Lack of Efficacy|4|||
149086192|NCT00912964|537793066|FG002|Overall Study|Lack of Efficacy|3|||
149086193|NCT00912964|537793064|FG000|Overall Study|Withdrawal by Subject|20|||
149086194|NCT00912964|537793065|FG001|Overall Study|Withdrawal by Subject|12|||
149086195|NCT00912964|537793066|FG002|Overall Study|Withdrawal by Subject|18|||
149086196|NCT00912964|537793064|FG000|Overall Study|Lost to Follow-up|4|||
149086197|NCT00912964|537793065|FG001|Overall Study|Lost to Follow-up|3|||
149086198|NCT00912964|537793066|FG002|Overall Study|Lost to Follow-up|3|||
149086199|NCT00912964|537793064|FG000|Overall Study|Protocol Violation|5|||
149086200|NCT00912964|537793065|FG001|Overall Study|Protocol Violation|3|||
149086201|NCT00912964|537793066|FG002|Overall Study|Protocol Violation|8|||
149086202|NCT00912964|537793064|FG000|Overall Study|Taking exclusionary medications|7|||
149086203|NCT00912964|537793065|FG001|Overall Study|Taking exclusionary medications|4|||
149086204|NCT00912964|537793066|FG002|Overall Study|Taking exclusionary medications|8|||
149086205|NCT00912964|537793064|FG000|Overall Study|Medical History|1|||
149086206|NCT00912964|537793065|FG001|Overall Study|Medical History|0|||
149086207|NCT00912964|537793066|FG002|Overall Study|Medical History|0|||
149086208|NCT00912964|537793064|FG000|Overall Study|Non-compliance with study procedures|2|||
149086209|NCT00912964|537793065|FG001|Overall Study|Non-compliance with study procedures|0|||
149086210|NCT00912964|537793066|FG002|Overall Study|Non-compliance with study procedures|0|||
149086211|NCT00912964|537793064|FG000|Overall Study|Violation of exclusion criterion|0|||
149086212|NCT00912964|537793065|FG001|Overall Study|Violation of exclusion criterion|0|||
149086213|NCT00912964|537793066|FG002|Overall Study|Violation of exclusion criterion|2|||
149086214|NCT00912964|537793064|FG000|Overall Study|Randomized but never received study drug|0|||
149086215|NCT00912964|537793065|FG001|Overall Study|Randomized but never received study drug|1|||
149086216|NCT00912964|537793066|FG002|Overall Study|Randomized but never received study drug|0|||
149086217|NCT04447287|537793067|FG000|Period 1: Run-in Period|Adverse Event|3|||
149086218|NCT04447287|537793068|FG001|Period 1: Run-in Period|Adverse Event|0|||
149086219|NCT04447287|537793069|FG002|Period 1: Run-in Period|Adverse Event|0|||
149086220|NCT04447287|537793067|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
149086221|NCT04447287|537793068|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
149086222|NCT04447287|537793069|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
149086223|NCT04447287|537793067|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
149086224|NCT04447287|537793068|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
149086225|NCT04447287|537793069|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
149086226|NCT00655824|537793072|FG000|Overall Study|Adverse Event|3|||
149086227|NCT00655824|537793072|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
149086228|NCT00655824|537793072|FG000|Overall Study|Protocol Violation|1|||
149086229|NCT00655824|537793072|FG000|Overall Study|Withdrawal by Subject|4|||
149086230|NCT00655824|537793072|FG000|Overall Study|Deterioration of Trial Disease|2|||
149086231|NCT00960206|537793073|FG000|Overall Study|Death|7|||
149086232|NCT00960206|537793074|FG001|Overall Study|Death|4|||
149086233|NCT00960206|537793075|FG002|Overall Study|Death|1|||
149086234|NCT00960206|537793073|FG000|Overall Study|Unwilling/Unable to return|1|||
149086235|NCT00960206|537793074|FG001|Overall Study|Unwilling/Unable to return|2|||
149086236|NCT00960206|537793075|FG002|Overall Study|Unwilling/Unable to return|0|||
149086237|NCT00960206|537793073|FG000|Overall Study|Lost to Follow-up|8|||
149086238|NCT00960206|537793074|FG001|Overall Study|Lost to Follow-up|14|||
149086239|NCT00960206|537793075|FG002|Overall Study|Lost to Follow-up|8|||
149086240|NCT00960206|537793073|FG000|Overall Study|Withdrawal by Subject|2|||
149086241|NCT00960206|537793074|FG001|Overall Study|Withdrawal by Subject|4|||
149086242|NCT00960206|537793075|FG002|Overall Study|Withdrawal by Subject|0|||
149086243|NCT00960206|537793073|FG000|Overall Study|Revision of study component|2|||
149086244|NCT00960206|537793074|FG001|Overall Study|Revision of study component|2|||
149086245|NCT00960206|537793075|FG002|Overall Study|Revision of study component|2|||
149086246|NCT00960206|537793073|FG000|Overall Study|Missing 10 year data|20|||
149086247|NCT00960206|537793074|FG001|Overall Study|Missing 10 year data|1|||
149086248|NCT00960206|537793075|FG002|Overall Study|Missing 10 year data|1|||
149086249|NCT02470806|537793082|FG000|Overall Study|Lost to Follow-up|1|||
149086250|NCT02470806|537793083|FG001|Overall Study|Lost to Follow-up|1|||
149086251|NCT02470806|537793082|FG000|Overall Study|Adverse Event|5|||
149086252|NCT02470806|537793083|FG001|Overall Study|Adverse Event|2|||
149086253|NCT02470806|537793082|FG000|Overall Study|Protocol Violation|4|||
149086254|NCT02470806|537793083|FG001|Overall Study|Protocol Violation|11|||
149086255|NCT02470806|537793082|FG000|Overall Study|Physician Decision|0|||
149086256|NCT02470806|537793083|FG001|Overall Study|Physician Decision|3|||
149086257|NCT02470806|537793082|FG000|Overall Study|Withdrawal by Subject|3|||
149086258|NCT02470806|537793083|FG001|Overall Study|Withdrawal by Subject|10|||
149086259|NCT02470806|537793082|FG000|Overall Study|Lack of Efficacy|5|||
149086260|NCT02470806|537793083|FG001|Overall Study|Lack of Efficacy|15|||
149086261|NCT03032198|537793084|FG000|Overall Study|Screen Fail|1|||
149086262|NCT00866619|537793085|FG000|Overall Study|Adverse Event|112|||
149086263|NCT00866619|537793086|FG001|Overall Study|Adverse Event|106|||
149086264|NCT00866619|537793087|FG002|Overall Study|Adverse Event|47|||
149086265|NCT00866619|537793088|FG003|Overall Study|Adverse Event|44|||
149086266|NCT00866619|537793085|FG000|Overall Study|Protocol Violation|2|||
149086267|NCT00866619|537793086|FG001|Overall Study|Protocol Violation|39|||
149086268|NCT00866619|537793087|FG002|Overall Study|Protocol Violation|2|||
149086269|NCT00866619|537793088|FG003|Overall Study|Protocol Violation|17|||
149086270|NCT00866619|537793085|FG000|Overall Study|Withdrawal by Subject|587|||
149086271|NCT00866619|537793086|FG001|Overall Study|Withdrawal by Subject|295|||
149086272|NCT00866619|537793087|FG002|Overall Study|Withdrawal by Subject|272|||
149086273|NCT00866619|537793088|FG003|Overall Study|Withdrawal by Subject|144|||
149086274|NCT00866619|537793085|FG000|Overall Study|Lost to Follow-up|1145|||
149086275|NCT00866619|537793086|FG001|Overall Study|Lost to Follow-up|830|||
149086276|NCT00866619|537793087|FG002|Overall Study|Lost to Follow-up|568|||
149086277|NCT00866619|537793088|FG003|Overall Study|Lost to Follow-up|425|||
149086278|NCT02892019|537793090|FG000|Overall Study|randomized but not treated|0|||
149086279|NCT02892019|537793091|FG001|Overall Study|randomized but not treated|1|||
149086280|NCT02892019|537793090|FG000|Overall Study|Withdrawal by Subject|0|||
149086281|NCT02892019|537793091|FG001|Overall Study|Withdrawal by Subject|1|||
149086282|NCT02892019|537793090|FG000|Overall Study|Adverse Event|1|||
149086283|NCT02892019|537793091|FG001|Overall Study|Adverse Event|1|||
149086284|NCT05356130|537794014|FG000|Overall Study|Withdrawal by Subject|0|||
149086285|NCT05356130|537794015|FG001|Overall Study|Withdrawal by Subject|0|||
149086286|NCT05356130|537794016|FG002|Overall Study|Withdrawal by Subject|3|||
149086287|NCT04851587|537794017|FG000|Overall Study|Lost to Follow-up|18|||
149086288|NCT00538629|537794028|FG000|Overall Study|At subject's request|1|||
149086289|NCT00538629|537794028|FG000|Overall Study|Adverse Event|2|||
149086290|NCT00538629|537794028|FG000|Overall Study|Lack of Efficacy|12|||
149086291|NCT00538629|537794028|FG000|Overall Study|Lost to Follow-up|6|||
149086292|NCT00538629|537794028|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
149086293|NCT01193283|537794035|FG000|Overall Study|Death|1|||
149086294|NCT01183013|537794036|FG000|Overall Study|Adverse Event|6|||
149086295|NCT01183013|537794037|FG001|Overall Study|Adverse Event|8|||
149086296|NCT01183013|537794038|FG002|Overall Study|Adverse Event|5|||
149086297|NCT01183013|537794039|FG003|Overall Study|Adverse Event|5|||
149086298|NCT01183013|537794040|FG004|Overall Study|Adverse Event|10|||
149086299|NCT01183013|537794041|FG005|Overall Study|Adverse Event|10|||
149086300|NCT01183013|537794042|FG006|Overall Study|Adverse Event|6|||
149086301|NCT01183013|537794036|FG000|Overall Study|Lack of Efficacy|3|||
149086302|NCT01183013|537794037|FG001|Overall Study|Lack of Efficacy|2|||
149086303|NCT01183013|537794038|FG002|Overall Study|Lack of Efficacy|1|||
149086304|NCT01183013|537794039|FG003|Overall Study|Lack of Efficacy|2|||
149086305|NCT01183013|537794040|FG004|Overall Study|Lack of Efficacy|1|||
149086306|NCT01183013|537794041|FG005|Overall Study|Lack of Efficacy|2|||
149086307|NCT01183013|537794042|FG006|Overall Study|Lack of Efficacy|0|||
149086308|NCT01183013|537794036|FG000|Overall Study|Protocol Violation|5|||
149086309|NCT01183013|537794037|FG001|Overall Study|Protocol Violation|2|||
149086310|NCT01183013|537794038|FG002|Overall Study|Protocol Violation|4|||
149086311|NCT01183013|537794039|FG003|Overall Study|Protocol Violation|0|||
149086312|NCT01183013|537794040|FG004|Overall Study|Protocol Violation|4|||
149086313|NCT01183013|537794041|FG005|Overall Study|Protocol Violation|3|||
149086314|NCT01183013|537794042|FG006|Overall Study|Protocol Violation|3|||
149086315|NCT01183013|537794036|FG000|Overall Study|Lost to Follow-up|7|||
149086316|NCT01183013|537794037|FG001|Overall Study|Lost to Follow-up|3|||
149086317|NCT01183013|537794038|FG002|Overall Study|Lost to Follow-up|4|||
149086318|NCT01183013|537794039|FG003|Overall Study|Lost to Follow-up|3|||
149086319|NCT01183013|537794040|FG004|Overall Study|Lost to Follow-up|2|||
149086320|NCT01183013|537794041|FG005|Overall Study|Lost to Follow-up|6|||
149086321|NCT01183013|537794042|FG006|Overall Study|Lost to Follow-up|5|||
149086322|NCT01183013|537794036|FG000|Overall Study|Withdrawal by Subject|9|||
149086323|NCT01183013|537794037|FG001|Overall Study|Withdrawal by Subject|13|||
149086324|NCT01183013|537794038|FG002|Overall Study|Withdrawal by Subject|10|||
149086325|NCT01183013|537794039|FG003|Overall Study|Withdrawal by Subject|8|||
149086326|NCT01183013|537794040|FG004|Overall Study|Withdrawal by Subject|7|||
149086327|NCT01183013|537794041|FG005|Overall Study|Withdrawal by Subject|9|||
149086328|NCT01183013|537794042|FG006|Overall Study|Withdrawal by Subject|10|||
149086329|NCT01183013|537794036|FG000|Overall Study|Reasons other than stated above|15|||
149086330|NCT01183013|537794037|FG001|Overall Study|Reasons other than stated above|11|||
149086331|NCT01183013|537794038|FG002|Overall Study|Reasons other than stated above|17|||
149086332|NCT01183013|537794039|FG003|Overall Study|Reasons other than stated above|12|||
149086333|NCT01183013|537794040|FG004|Overall Study|Reasons other than stated above|12|||
149086334|NCT01183013|537794041|FG005|Overall Study|Reasons other than stated above|15|||
149086335|NCT01183013|537794042|FG006|Overall Study|Reasons other than stated above|13|||
149086336|NCT00584909|537794043|FG000|Overall Study|Adverse Event|4|||
149086337|NCT02469155|537794044|FG000|Overall Study|Adverse Event|6|||
149086338|NCT02469155|537794045|FG001|Overall Study|Adverse Event|0|||
149086339|NCT02469155|537794046|FG002|Overall Study|Adverse Event|1|||
149086340|NCT02469155|537794047|FG003|Overall Study|Adverse Event|10|||
149086341|NCT02469155|537794044|FG000|Overall Study|Lack of Efficacy|13|||
149086342|NCT02469155|537794045|FG001|Overall Study|Lack of Efficacy|10|||
149086343|NCT02469155|537794046|FG002|Overall Study|Lack of Efficacy|10|||
149086344|NCT02469155|537794047|FG003|Overall Study|Lack of Efficacy|8|||
149086345|NCT02469155|537794044|FG000|Overall Study|Death|0|||
149086346|NCT02469155|537794045|FG001|Overall Study|Death|0|||
149086347|NCT02469155|537794046|FG002|Overall Study|Death|0|||
149086348|NCT02469155|537794047|FG003|Overall Study|Death|1|||
149086349|NCT02469155|537794044|FG000|Overall Study|Lost to Follow-up|5|||
149086350|NCT02469155|537794045|FG001|Overall Study|Lost to Follow-up|2|||
149086351|NCT02469155|537794046|FG002|Overall Study|Lost to Follow-up|7|||
149086352|NCT02469155|537794047|FG003|Overall Study|Lost to Follow-up|2|||
149086353|NCT02469155|537794044|FG000|Overall Study|Physician Decision|0|||
149086354|NCT02469155|537794045|FG001|Overall Study|Physician Decision|0|||
149086355|NCT02469155|537794046|FG002|Overall Study|Physician Decision|1|||
149086356|NCT02469155|537794047|FG003|Overall Study|Physician Decision|0|||
149086357|NCT02469155|537794044|FG000|Overall Study|Withdrawal by Subject|34|||
149086358|NCT02469155|537794045|FG001|Overall Study|Withdrawal by Subject|30|||
149086359|NCT02469155|537794046|FG002|Overall Study|Withdrawal by Subject|20|||
149086360|NCT02469155|537794047|FG003|Overall Study|Withdrawal by Subject|37|||
149086361|NCT02469155|537794044|FG000|Overall Study|Other|3|||
149086362|NCT02469155|537794045|FG001|Overall Study|Other|3|||
149086363|NCT02469155|537794046|FG002|Overall Study|Other|2|||
149086364|NCT02469155|537794047|FG003|Overall Study|Other|10|||
149086365|NCT02469155|537794044|FG000|Overall Study|Protocol Violation|0|||
149086366|NCT02469155|537794045|FG001|Overall Study|Protocol Violation|1|||
149086367|NCT02469155|537794046|FG002|Overall Study|Protocol Violation|0|||
149086368|NCT02469155|537794047|FG003|Overall Study|Protocol Violation|1|||
149086369|NCT04930263|537794055|FG000|Overall Study|Withdrawal by Subject|3|||
149086370|NCT04930263|537794056|FG001|Overall Study|Withdrawal by Subject|5|||
149086371|NCT01989156|537794057|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
149086372|NCT01989156|537794058|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
149086373|NCT01989156|537794059|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
149086374|NCT01989156|537794057|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
149086375|NCT01989156|537794058|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
149086376|NCT01989156|537794059|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
149086377|NCT01989156|537794057|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
149086378|NCT01989156|537794058|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
149086379|NCT01989156|537794059|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
149086380|NCT01989156|537794057|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
149086381|NCT01989156|537794058|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
149086382|NCT01989156|537794059|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
149086383|NCT01989156|537794057|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
149086384|NCT01989156|537794058|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
149086385|NCT01989156|537794059|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
149086386|NCT01989156|537794057|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
149086387|NCT01989156|537794058|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
149086388|NCT01989156|537794059|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
149086389|NCT01989156|537794057|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
149086390|NCT01989156|537794058|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
149086391|NCT01989156|537794059|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
149086392|NCT01989156|537794057|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
149086393|NCT01989156|537794058|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
149086394|NCT01989156|537794059|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
149086395|NCT00850993|537794060|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
149086396|NCT00850993|537794061|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
149086397|NCT00850993|537794062|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
149086398|NCT00850993|537794063|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
149086399|NCT03839355|537794064|FG000|Overall Study|Withdrawal by Subject|1|||
149086400|NCT03839355|537794065|FG001|Overall Study|Withdrawal by Subject|0|||
149086401|NCT04501614|537794068|FG000|Overall Study|Study Terminated by Sponsor|6|||
149086402|NCT04501614|537794069|FG001|Overall Study|Study Terminated by Sponsor|3|||
149086403|NCT04501614|537794068|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
149086404|NCT04501614|537794069|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
149086405|NCT02555397|537794070|FG000|Overall Study|Withdrawal by Subject|1|||
149086406|NCT02555397|537794071|FG001|Overall Study|Withdrawal by Subject|0|||
149086407|NCT02555397|537794072|FG002|Overall Study|Withdrawal by Subject|0|||
149086408|NCT02555397|537794073|FG003|Overall Study|Withdrawal by Subject|0|||
149086409|NCT02555397|537794074|FG004|Overall Study|Withdrawal by Subject|0|||
149086410|NCT04529941|537794075|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
149086411|NCT04529941|537794076|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
149086412|NCT00237809|537794077|FG000|Overall Study|Lost to Follow-up|11|||
149086413|NCT00237809|537794078|FG001|Overall Study|Lost to Follow-up|10|||
149086414|NCT00237809|537794079|FG002|Overall Study|Lost to Follow-up|9|||
149086415|NCT00237809|537794080|FG003|Overall Study|Lost to Follow-up|9|||
149086416|NCT02291549|537794087|FG000|Overall Study|Lost to Follow-up|1|||
149086417|NCT02291549|537794088|FG001|Overall Study|Lost to Follow-up|0|||
149086418|NCT02291549|537794087|FG000|Overall Study|Withdrawal by Subject|0|||
149086419|NCT02291549|537794088|FG001|Overall Study|Withdrawal by Subject|1|||
149086420|NCT01468597|537794090|FG000|Overall Study|Found ineligible|17|||
149086421|NCT01468597|537794090|FG000|Overall Study|concomitant valves|12|||
149086422|NCT01468597|537794090|FG000|Overall Study|off-pump CABG|1|||
149086423|NCT01468597|537794090|FG000|Overall Study|no platelet function data|5|||
149086424|NCT02138838|537794091|FG000|Overall Study|Study Closure|7|||
149086425|NCT02138838|537794092|FG001|Overall Study|Study Closure|6|||
149086426|NCT02138838|537794091|FG000|Overall Study|Withdrawal by Subject|1|||
149086427|NCT02138838|537794092|FG001|Overall Study|Withdrawal by Subject|5|||
149086428|NCT02010684|537794094|FG000|Overall Study|Lost to Follow-up|8|||
149086429|NCT02010684|537794095|FG001|Overall Study|Lost to Follow-up|18|||
149086430|NCT02010684|537794094|FG000|Overall Study|Withdrawal by Subject|4|||
149086431|NCT02010684|537794095|FG001|Overall Study|Withdrawal by Subject|5|||
149086432|NCT01517282|537794100|FG000|Overall Study|Consent withdrawn|0|||
149086433|NCT01517282|537794101|FG001|Overall Study|Consent withdrawn|1|||
149086434|NCT01517282|537794102|FG002|Overall Study|Consent withdrawn|1|||
149086435|NCT01517282|537794103|FG003|Overall Study|Consent withdrawn|1|||
149086436|NCT01517282|537794100|FG000|Overall Study|Physician Decision|1|||
149086437|NCT01517282|537794101|FG001|Overall Study|Physician Decision|0|||
149086438|NCT01517282|537794102|FG002|Overall Study|Physician Decision|0|||
149086439|NCT01517282|537794103|FG003|Overall Study|Physician Decision|0|||
149086440|NCT01884571|537794104|FG000|Overall Study|Adverse Event|1|||
149086441|NCT01884571|537794104|FG000|Overall Study|Death|2|||
149086442|NCT01884571|537794104|FG000|Overall Study|Withdrawal by Subject|2|||
149086443|NCT01884571|537794104|FG000|Overall Study|Disease progression|3|||
149086444|NCT00091572|537794106|FG000|Overall Study|Lost to Follow-up|1|||
149086445|NCT00091572|537794107|FG001|Overall Study|Lost to Follow-up|1|||
149086446|NCT00091572|537794106|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
149086447|NCT00091572|537794107|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
149086448|NCT00091572|537794106|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
149086449|NCT00091572|537794107|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
149086450|NCT00091572|537794106|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
149086451|NCT00091572|537794107|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
149086452|NCT00091572|537794106|FG000|Overall Study|Other Reason|6|||
149086453|NCT00091572|537794107|FG001|Overall Study|Other Reason|13|||
149086454|NCT00091572|537794106|FG000|Overall Study|Ongoing (still on treatment)|8|||
149086455|NCT00091572|537794107|FG001|Overall Study|Ongoing (still on treatment)|12|||
149086456|NCT00091572|537794106|FG000|Overall Study|Major Protocol Violation|2|||
149086457|NCT00091572|537794107|FG001|Overall Study|Major Protocol Violation|0|||
149086458|NCT00091572|537794106|FG000|Overall Study|Toxicity (Related AE)|53|||
149086459|NCT00091572|537794107|FG001|Overall Study|Toxicity (Related AE)|9|||
149086460|NCT01199302|537794111|FG000|Overall Study|Adverse Event|1|||
149086461|NCT01199302|537794112|FG001|Overall Study|Adverse Event|1|||
149086462|NCT01199302|537794113|FG002|Overall Study|Adverse Event|2|||
149086463|NCT01199302|537794114|FG003|Overall Study|Adverse Event|0|||
149086464|NCT01199302|537794111|FG000|Overall Study|Withdrawal by Subject|2|||
149086465|NCT01199302|537794112|FG001|Overall Study|Withdrawal by Subject|2|||
149086466|NCT01199302|537794113|FG002|Overall Study|Withdrawal by Subject|3|||
149086467|NCT01199302|537794114|FG003|Overall Study|Withdrawal by Subject|0|||
149086468|NCT01199302|537794111|FG000|Overall Study|Disease Progression|3|||
149086469|NCT01199302|537794112|FG001|Overall Study|Disease Progression|4|||
149086470|NCT01199302|537794113|FG002|Overall Study|Disease Progression|4|||
149086471|NCT01199302|537794114|FG003|Overall Study|Disease Progression|2|||
149086472|NCT01199302|537794111|FG000|Overall Study|Study Termination|13|||
149086473|NCT01199302|537794112|FG001|Overall Study|Study Termination|8|||
149086474|NCT01199302|537794113|FG002|Overall Study|Study Termination|11|||
149086475|NCT01199302|537794114|FG003|Overall Study|Study Termination|9|||
149086476|NCT01199302|537794111|FG000|Overall Study|Lost to Follow-up|0|||
149086477|NCT01199302|537794112|FG001|Overall Study|Lost to Follow-up|1|||
149086478|NCT01199302|537794113|FG002|Overall Study|Lost to Follow-up|0|||
149086479|NCT01199302|537794114|FG003|Overall Study|Lost to Follow-up|0|||
149086480|NCT01199302|537794111|FG000|Overall Study|Other|1|||
149086481|NCT01199302|537794112|FG001|Overall Study|Other|0|||
149086482|NCT01199302|537794113|FG002|Overall Study|Other|0|||
149086483|NCT01199302|537794114|FG003|Overall Study|Other|0|||
149086484|NCT04433091|537794115|FG000|Overall Study|Lost to Follow-up|1|||
149086485|NCT04433091|537794116|FG001|Overall Study|Lost to Follow-up|0|||
149086486|NCT04433091|537794115|FG000|Overall Study|Withdrawn .|2|||
149086487|NCT04433091|537794116|FG001|Overall Study|Withdrawn .|4|||
149086488|NCT04520256|537794118|FG000|Overall Study|Lost to Follow-up|6|||
149086489|NCT04520256|537794119|FG001|Overall Study|Lost to Follow-up|4|||
149086490|NCT04520256|537794120|FG002|Overall Study|Lost to Follow-up|2|||
149086491|NCT04520256|537794121|FG003|Overall Study|Lost to Follow-up|3|||
149086492|NCT04520256|537794122|FG004|Overall Study|Lost to Follow-up|6|||
149086493|NCT04520256|537794123|FG005|Overall Study|Lost to Follow-up|6|||
149086494|NCT04520256|537794124|FG006|Overall Study|Lost to Follow-up|4|||
149086495|NCT04520256|537794125|FG007|Overall Study|Lost to Follow-up|6|||
149086496|NCT04520256|537794126|FG008|Overall Study|Lost to Follow-up|1|||
149086497|NCT04520256|537794127|FG009|Overall Study|Lost to Follow-up|3|||
149086498|NCT04520256|537794128|FG010|Overall Study|Lost to Follow-up|3|||
149086499|NCT04520256|537794129|FG011|Overall Study|Lost to Follow-up|2|||
149086500|NCT04520256|537794130|FG012|Overall Study|Lost to Follow-up|5|||
149086501|NCT04520256|537794131|FG013|Overall Study|Lost to Follow-up|3|||
149086502|NCT04520256|537794132|FG014|Overall Study|Lost to Follow-up|3|||
149086503|NCT04520256|537794133|FG015|Overall Study|Lost to Follow-up|6|||
149086504|NCT04520256|537794134|FG016|Overall Study|Lost to Follow-up|6|||
149086505|NCT04520256|537794135|FG017|Overall Study|Lost to Follow-up|4|||
149086506|NCT04520256|537794136|FG018|Overall Study|Lost to Follow-up|3|||
149086507|NCT04520256|537794137|FG019|Overall Study|Lost to Follow-up|3|||
149086508|NCT04520256|537794138|FG020|Overall Study|Lost to Follow-up|7|||
149086509|NCT04520256|537794139|FG021|Overall Study|Lost to Follow-up|3|||
149086510|NCT04520256|537794140|FG022|Overall Study|Lost to Follow-up|3|||
149086511|NCT04520256|537794141|FG023|Overall Study|Lost to Follow-up|8|||
149086512|NCT04520256|537794142|FG024|Overall Study|Lost to Follow-up|5|||
149086513|NCT04520256|537794143|FG025|Overall Study|Lost to Follow-up|4|||
149086514|NCT04520256|537794144|FG026|Overall Study|Lost to Follow-up|3|||
149086515|NCT04520256|537794145|FG027|Overall Study|Lost to Follow-up|4|||
149086516|NCT04520256|537794146|FG028|Overall Study|Lost to Follow-up|3|||
149086517|NCT04520256|537794147|FG029|Overall Study|Lost to Follow-up|4|||
149086518|NCT04520256|537794148|FG030|Overall Study|Lost to Follow-up|4|||
149086519|NCT04520256|537794149|FG031|Overall Study|Lost to Follow-up|4|||
149086520|NCT01730118|537795631|FG000|Dose Escalation|Death on study|5|||
149086521|NCT01730118|537795632|FG001|Dose Escalation|Death on study|7|||
149086522|NCT01730118|537795633|FG002|Dose Escalation|Death on study|2|||
149086523|NCT01730118|537795634|FG003|Dose Escalation|Death on study|6|||
149086524|NCT01730118|537795635|FG004|Dose Escalation|Death on study|0|||
149086525|NCT01730118|537795636|FG005|Dose Escalation|Death on study|0|||
149086526|NCT01730118|537795637|FG006|Dose Escalation|Death on study|0|||
149086527|NCT01730118|537795631|FG000|Dose Escalation|Died before treatment|0|||
149086528|NCT01730118|537795632|FG001|Dose Escalation|Died before treatment|0|||
149086529|NCT01730118|537795633|FG002|Dose Escalation|Died before treatment|0|||
149086530|NCT01730118|537795634|FG003|Dose Escalation|Died before treatment|0|||
149086531|NCT01730118|537795635|FG004|Dose Escalation|Died before treatment|0|||
149086532|NCT01730118|537795636|FG005|Dose Escalation|Died before treatment|0|||
149086533|NCT01730118|537795637|FG006|Dose Escalation|Died before treatment|1|||
149086534|NCT01730118|537795631|FG000|Dose Escalation|Chose to start a different treatment|1|||
149086535|NCT01730118|537795632|FG001|Dose Escalation|Chose to start a different treatment|0|||
149086536|NCT01730118|537795633|FG002|Dose Escalation|Chose to start a different treatment|0|||
149086537|NCT01730118|537795634|FG003|Dose Escalation|Chose to start a different treatment|0|||
149086538|NCT01730118|537795635|FG004|Dose Escalation|Chose to start a different treatment|0|||
149086539|NCT01730118|537795636|FG005|Dose Escalation|Chose to start a different treatment|0|||
149086540|NCT01730118|537795637|FG006|Dose Escalation|Chose to start a different treatment|0|||
149086541|NCT01730118|537795631|FG000|Dose Escalation|Withdrawal by Subject|0|||
149086542|NCT01730118|537795632|FG001|Dose Escalation|Withdrawal by Subject|0|||
149086543|NCT01730118|537795633|FG002|Dose Escalation|Withdrawal by Subject|1|||
149086544|NCT01730118|537795634|FG003|Dose Escalation|Withdrawal by Subject|0|||
149086545|NCT01730118|537795635|FG004|Dose Escalation|Withdrawal by Subject|0|||
149086546|NCT01730118|537795636|FG005|Dose Escalation|Withdrawal by Subject|0|||
149086547|NCT01730118|537795637|FG006|Dose Escalation|Withdrawal by Subject|0|||
149086548|NCT01730118|537795631|FG000|Dose Escalation|Disease progression prior to treatment|0|||
149086549|NCT01730118|537795632|FG001|Dose Escalation|Disease progression prior to treatment|0|||
149086550|NCT01730118|537795633|FG002|Dose Escalation|Disease progression prior to treatment|0|||
149086551|NCT01730118|537795634|FG003|Dose Escalation|Disease progression prior to treatment|0|||
149086552|NCT01730118|537795635|FG004|Dose Escalation|Disease progression prior to treatment|0|||
149086553|NCT01730118|537795636|FG005|Dose Escalation|Disease progression prior to treatment|0|||
149086554|NCT01730118|537795637|FG006|Dose Escalation|Disease progression prior to treatment|1|||
149086555|NCT01730118|537795631|FG000|Dose Expansion|Death|0|||
149086556|NCT01730118|537795632|FG001|Dose Expansion|Death|0|||
149086557|NCT01730118|537795633|FG002|Dose Expansion|Death|0|||
149086558|NCT01730118|537795634|FG003|Dose Expansion|Death|0|||
149086559|NCT01730118|537795635|FG004|Dose Expansion|Death|1|||
149086560|NCT01730118|537795636|FG005|Dose Expansion|Death|0|||
149086561|NCT01730118|537795637|FG006|Dose Expansion|Death|0|||
149086562|NCT01730118|537795631|FG000|Dose Expansion|Other medical condition|0|||
149086563|NCT01730118|537795632|FG001|Dose Expansion|Other medical condition|0|||
149086564|NCT01730118|537795633|FG002|Dose Expansion|Other medical condition|0|||
149086565|NCT01730118|537795634|FG003|Dose Expansion|Other medical condition|0|||
149086566|NCT01730118|537795635|FG004|Dose Expansion|Other medical condition|1|||
149086567|NCT01730118|537795636|FG005|Dose Expansion|Other medical condition|0|||
149086568|NCT01730118|537795637|FG006|Dose Expansion|Other medical condition|0|||
149086569|NCT01730118|537795631|FG000|Dose Expansion|Withdrawal by Subject|0|||
149086570|NCT01730118|537795632|FG001|Dose Expansion|Withdrawal by Subject|0|||
149086571|NCT01730118|537795633|FG002|Dose Expansion|Withdrawal by Subject|0|||
149086572|NCT01730118|537795634|FG003|Dose Expansion|Withdrawal by Subject|0|||
149086573|NCT01730118|537795635|FG004|Dose Expansion|Withdrawal by Subject|1|||
149086574|NCT01730118|537795636|FG005|Dose Expansion|Withdrawal by Subject|0|||
149086575|NCT01730118|537795637|FG006|Dose Expansion|Withdrawal by Subject|0|||
149086576|NCT01730118|537795631|FG000|Dose Expansion|Disease progression|0|||
149086577|NCT01730118|537795632|FG001|Dose Expansion|Disease progression|0|||
149086578|NCT01730118|537795633|FG002|Dose Expansion|Disease progression|0|||
149086579|NCT01730118|537795634|FG003|Dose Expansion|Disease progression|0|||
149086580|NCT01730118|537795635|FG004|Dose Expansion|Disease progression|0|||
149086581|NCT01730118|537795636|FG005|Dose Expansion|Disease progression|1|||
149086582|NCT01730118|537795637|FG006|Dose Expansion|Disease progression|0|||
149086583|NCT01730118|537795631|FG000|Dose Expansion|Inability to return|0|||
149086584|NCT01730118|537795632|FG001|Dose Expansion|Inability to return|0|||
149086585|NCT01730118|537795633|FG002|Dose Expansion|Inability to return|0|||
149086586|NCT01730118|537795634|FG003|Dose Expansion|Inability to return|0|||
149086587|NCT01730118|537795635|FG004|Dose Expansion|Inability to return|0|||
149086588|NCT01730118|537795636|FG005|Dose Expansion|Inability to return|1|||
149086589|NCT01730118|537795637|FG006|Dose Expansion|Inability to return|0|||
149086590|NCT01730118|537795631|FG000|Dose Expansion|Physician Decision|0|||
149086591|NCT01730118|537795632|FG001|Dose Expansion|Physician Decision|0|||
149086592|NCT01730118|537795633|FG002|Dose Expansion|Physician Decision|0|||
149086593|NCT01730118|537795634|FG003|Dose Expansion|Physician Decision|0|||
149086594|NCT01730118|537795635|FG004|Dose Expansion|Physician Decision|0|||
149086595|NCT01730118|537795636|FG005|Dose Expansion|Physician Decision|1|||
149086596|NCT01730118|537795637|FG006|Dose Expansion|Physician Decision|0|||
149086597|NCT02101554|537795640|FG000|Overall Study|Protocol Violation|0|||
149086598|NCT02101554|537795641|FG001|Overall Study|Protocol Violation|1|||
149086599|NCT02101554|537795642|FG002|Overall Study|Protocol Violation|0|||
149086600|NCT02101554|537795640|FG000|Overall Study|Insufficient Clinical Response|0|||
149086601|NCT02101554|537795641|FG001|Overall Study|Insufficient Clinical Response|2|||
149086602|NCT02101554|537795642|FG002|Overall Study|Insufficient Clinical Response|0|||
149086603|NCT02101554|537795640|FG000|Overall Study|Adverse Event|2|||
149086604|NCT02101554|537795641|FG001|Overall Study|Adverse Event|1|||
149086605|NCT02101554|537795642|FG002|Overall Study|Adverse Event|1|||
149086606|NCT02101554|537795640|FG000|Overall Study|Lost to Follow-up|0|||
149086607|NCT02101554|537795641|FG001|Overall Study|Lost to Follow-up|1|||
149086608|NCT02101554|537795642|FG002|Overall Study|Lost to Follow-up|0|||
149086609|NCT02101554|537795640|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
149086610|NCT02101554|537795641|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
149086611|NCT02101554|537795642|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
149086612|NCT03409276|537795643|FG000|Overall Study|Withdrawal by Subject|0|||
149086613|NCT03409276|537795644|FG001|Overall Study|Withdrawal by Subject|0|||
149086614|NCT03409276|537795645|FG002|Overall Study|Withdrawal by Subject|0|||
149086615|NCT03409276|537795646|FG003|Overall Study|Withdrawal by Subject|0|||
149086616|NCT03409276|537795647|FG004|Overall Study|Withdrawal by Subject|1|||
149086617|NCT03409276|537795643|FG000|Overall Study|Lost to Follow-up|0|||
149086618|NCT03409276|537795644|FG001|Overall Study|Lost to Follow-up|0|||
149086619|NCT03409276|537795645|FG002|Overall Study|Lost to Follow-up|0|||
149086620|NCT03409276|537795646|FG003|Overall Study|Lost to Follow-up|2|||
149086621|NCT03409276|537795647|FG004|Overall Study|Lost to Follow-up|2|||
149086622|NCT03605745|537795648|FG000|Overall Study|Study was terminated for business reasons|47|||
149086623|NCT04454125|537795649|FG000|Overall Study|Lost to Follow-up|0|||
149086624|NCT04454125|537795650|FG001|Overall Study|Lost to Follow-up|1|||
149086625|NCT03345407|537795655|FG000|Overall Study|Withdrawal by Subject|11|||
149086626|NCT03345407|537795656|FG001|Overall Study|Withdrawal by Subject|1|||
149086627|NCT03345407|537795657|FG002|Overall Study|Withdrawal by Subject|5|||
149086628|NCT03345407|537795658|FG003|Overall Study|Withdrawal by Subject|6|||
149086629|NCT03345407|537795659|FG004|Overall Study|Withdrawal by Subject|3|||
149086630|NCT03345407|537795660|FG005|Overall Study|Withdrawal by Subject|6|||
149086631|NCT03345407|537795661|FG006|Overall Study|Withdrawal by Subject|16|||
149086632|NCT03345407|537795655|FG000|Overall Study|Physician Decision|3|||
149086633|NCT03345407|537795656|FG001|Overall Study|Physician Decision|1|||
149086634|NCT03345407|537795657|FG002|Overall Study|Physician Decision|0|||
149086635|NCT03345407|537795658|FG003|Overall Study|Physician Decision|0|||
149086636|NCT03345407|537795659|FG004|Overall Study|Physician Decision|1|||
149086637|NCT03345407|537795660|FG005|Overall Study|Physician Decision|2|||
149086638|NCT03345407|537795661|FG006|Overall Study|Physician Decision|3|||
149086639|NCT03345407|537795655|FG000|Overall Study|Lost to Follow-up|2|||
149086640|NCT03345407|537795656|FG001|Overall Study|Lost to Follow-up|0|||
149086641|NCT03345407|537795657|FG002|Overall Study|Lost to Follow-up|1|||
149086642|NCT03345407|537795658|FG003|Overall Study|Lost to Follow-up|0|||
149086643|NCT03345407|537795659|FG004|Overall Study|Lost to Follow-up|1|||
149086644|NCT03345407|537795660|FG005|Overall Study|Lost to Follow-up|2|||
149086645|NCT03345407|537795661|FG006|Overall Study|Lost to Follow-up|3|||
149086646|NCT03345407|537795655|FG000|Overall Study|Protocol-defined stopping criteria|9|||
149086647|NCT03345407|537795656|FG001|Overall Study|Protocol-defined stopping criteria|0|||
149086648|NCT03345407|537795657|FG002|Overall Study|Protocol-defined stopping criteria|0|||
149086649|NCT03345407|537795658|FG003|Overall Study|Protocol-defined stopping criteria|0|||
149086650|NCT03345407|537795659|FG004|Overall Study|Protocol-defined stopping criteria|2|||
149086651|NCT03345407|537795660|FG005|Overall Study|Protocol-defined stopping criteria|1|||
149086652|NCT03345407|537795661|FG006|Overall Study|Protocol-defined stopping criteria|1|||
149086653|NCT03345407|537795655|FG000|Overall Study|Protocol Violation|2|||
149086654|NCT03345407|537795656|FG001|Overall Study|Protocol Violation|0|||
149086655|NCT03345407|537795657|FG002|Overall Study|Protocol Violation|0|||
149086656|NCT03345407|537795658|FG003|Overall Study|Protocol Violation|0|||
149086657|NCT03345407|537795659|FG004|Overall Study|Protocol Violation|1|||
149086658|NCT03345407|537795660|FG005|Overall Study|Protocol Violation|0|||
149086659|NCT03345407|537795661|FG006|Overall Study|Protocol Violation|3|||
149086660|NCT03345407|537795655|FG000|Overall Study|Lack of Efficacy|1|||
149086661|NCT03345407|537795656|FG001|Overall Study|Lack of Efficacy|1|||
149086662|NCT03345407|537795657|FG002|Overall Study|Lack of Efficacy|1|||
149086663|NCT03345407|537795658|FG003|Overall Study|Lack of Efficacy|1|||
149086664|NCT03345407|537795659|FG004|Overall Study|Lack of Efficacy|1|||
149086665|NCT03345407|537795660|FG005|Overall Study|Lack of Efficacy|0|||
149086666|NCT03345407|537795661|FG006|Overall Study|Lack of Efficacy|3|||
149086667|NCT03345407|537795655|FG000|Overall Study|Adverse Event|4|||
149086668|NCT03345407|537795656|FG001|Overall Study|Adverse Event|0|||
149086669|NCT03345407|537795657|FG002|Overall Study|Adverse Event|5|||
149086670|NCT03345407|537795658|FG003|Overall Study|Adverse Event|4|||
149086671|NCT03345407|537795659|FG004|Overall Study|Adverse Event|6|||
149086672|NCT03345407|537795660|FG005|Overall Study|Adverse Event|5|||
149086673|NCT03345407|537795661|FG006|Overall Study|Adverse Event|16|||
149086674|NCT02256553|537795665|FG000|Period I|Adverse Event|5|||
149086675|NCT02256553|537795665|FG000|Period I|Protocol Violation|1|||
149086676|NCT02256553|537795665|FG000|Period II|Adverse Event|1|||
149086677|NCT02256553|537795665|FG000|Period II|Subject Moved|1|||
149086678|NCT02256553|537795665|FG000|Period III|Adverse Event|3|||
149086679|NCT02092909|537795666|FG000|Overall Study|Adverse Event|0|||
149086680|NCT02092909|537795667|FG001|Overall Study|Adverse Event|0|||
149086681|NCT02092909|537795668|FG002|Overall Study|Adverse Event|4|||
149086682|NCT02092909|537795669|FG003|Overall Study|Adverse Event|2|||
149086683|NCT02092909|537795666|FG000|Overall Study|Lack of Efficacy|0|||
149086684|NCT02092909|537795667|FG001|Overall Study|Lack of Efficacy|2|||
149086685|NCT02092909|537795668|FG002|Overall Study|Lack of Efficacy|1|||
149086686|NCT02092909|537795669|FG003|Overall Study|Lack of Efficacy|0|||
149086687|NCT02092909|537795666|FG000|Overall Study|Withdrawal by Subject|0|||
149086688|NCT02092909|537795667|FG001|Overall Study|Withdrawal by Subject|0|||
149086689|NCT02092909|537795668|FG002|Overall Study|Withdrawal by Subject|2|||
149086690|NCT02092909|537795669|FG003|Overall Study|Withdrawal by Subject|1|||
149086691|NCT02092909|537795666|FG000|Overall Study|Study terminated by Sponsor|0|||
149086692|NCT02092909|537795667|FG001|Overall Study|Study terminated by Sponsor|0|||
149086693|NCT02092909|537795668|FG002|Overall Study|Study terminated by Sponsor|0|||
149086694|NCT02092909|537795669|FG003|Overall Study|Study terminated by Sponsor|2|||
149086695|NCT02092909|537795666|FG000|Overall Study|Miscellaneous|1|||
149086696|NCT02092909|537795667|FG001|Overall Study|Miscellaneous|1|||
149086697|NCT02092909|537795668|FG002|Overall Study|Miscellaneous|2|||
149086698|NCT02092909|537795669|FG003|Overall Study|Miscellaneous|1|||
149086699|NCT03436797|537795670|FG000|Main Study|Withdrawal by Subject|2|||
149086700|NCT03436797|537795670|FG000|Main Study|Adverse Event|4|||
149086701|NCT03436797|537795670|FG000|Main Study|Lost to Follow-up|1|||
149086702|NCT03436797|537795670|FG000|Main Study|Death|1|||
149086703|NCT03436797|537795670|FG000|Main Study|Non-Specific|2|||
149086704|NCT03436797|537795670|FG000|Extended Dosing|Patient decision|1|||
149086705|NCT04739306|537795671|FG000|Main Study Period|Adverse Event|6|||
149086706|NCT04739306|537795672|FG001|Main Study Period|Adverse Event|7|||
149086707|NCT04739306|537795671|FG000|Main Study Period|Lost to Follow-up|4|||
149086708|NCT04739306|537795672|FG001|Main Study Period|Lost to Follow-up|6|||
149086709|NCT04739306|537795671|FG000|Main Study Period|Physician Decision|1|||
149086710|NCT04739306|537795672|FG001|Main Study Period|Physician Decision|1|||
149086711|NCT04739306|537795671|FG000|Main Study Period|Withdrawal by Subject|8|||
149086712|NCT04739306|537795672|FG001|Main Study Period|Withdrawal by Subject|6|||
149086713|NCT04739306|537795671|FG000|Main Study Period|Protocol Violation|0|||
149086714|NCT04739306|537795672|FG001|Main Study Period|Protocol Violation|1|||
149086715|NCT04739306|537795671|FG000|Main Study Period|War in Ukraine|1|||
149086716|NCT04739306|537795672|FG001|Main Study Period|War in Ukraine|1|||
149086717|NCT01951105|537795673|FG000|Overall Study|Adverse Event|0|||
149086718|NCT01951105|537795674|FG001|Overall Study|Adverse Event|5|||
149086719|NCT01951105|537795675|FG002|Overall Study|Adverse Event|0|||
149086720|NCT01951105|537795673|FG000|Overall Study|Lost to Follow-up|0|||
149086721|NCT01951105|537795674|FG001|Overall Study|Lost to Follow-up|1|||
149086722|NCT01951105|537795675|FG002|Overall Study|Lost to Follow-up|0|||
149086723|NCT01951105|537795673|FG000|Overall Study|Protocol Violation|1|||
149086724|NCT01951105|537795674|FG001|Overall Study|Protocol Violation|1|||
149086725|NCT01951105|537795675|FG002|Overall Study|Protocol Violation|1|||
149086726|NCT01951105|537795673|FG000|Overall Study|Withdrawal by Subject|0|||
149086727|NCT01951105|537795674|FG001|Overall Study|Withdrawal by Subject|3|||
149086728|NCT01951105|537795675|FG002|Overall Study|Withdrawal by Subject|1|||
149086729|NCT02727998|537795676|FG000|Overall Study|Lost to Follow-up|3|||
149086730|NCT02727998|537795677|FG001|Overall Study|Lost to Follow-up|3|||
149086731|NCT02727998|537795676|FG000|Overall Study|Withdrawal by Subject|0|||
149086732|NCT02727998|537795677|FG001|Overall Study|Withdrawal by Subject|1|||
149086733|NCT03651271|537795678|FG000|Overall Study|Death|4|||
149086734|NCT03651271|537795679|FG001|Overall Study|Death|37|||
149086735|NCT03651271|537795680|FG002|Overall Study|Death|0|||
149086736|NCT03651271|537795681|FG003|Overall Study|Death|2|||
149086737|NCT03651271|537795682|FG004|Overall Study|Death|6|||
149086738|NCT03651271|537795678|FG000|Overall Study|Lost to Follow-up|1|||
149086739|NCT03651271|537795679|FG001|Overall Study|Lost to Follow-up|5|||
149086740|NCT03651271|537795680|FG002|Overall Study|Lost to Follow-up|0|||
149086741|NCT03651271|537795681|FG003|Overall Study|Lost to Follow-up|1|||
149086742|NCT03651271|537795682|FG004|Overall Study|Lost to Follow-up|0|||
149086743|NCT03651271|537795678|FG000|Overall Study|Physician Decision|0|||
149086744|NCT03651271|537795679|FG001|Overall Study|Physician Decision|2|||
149086745|NCT03651271|537795680|FG002|Overall Study|Physician Decision|0|||
149086746|NCT03651271|537795681|FG003|Overall Study|Physician Decision|0|||
149086747|NCT03651271|537795682|FG004|Overall Study|Physician Decision|0|||
149086748|NCT03651271|537795678|FG000|Overall Study|Withdrawal by Subject|1|||
149086749|NCT03651271|537795679|FG001|Overall Study|Withdrawal by Subject|15|||
149086750|NCT03651271|537795680|FG002|Overall Study|Withdrawal by Subject|0|||
149086751|NCT03651271|537795681|FG003|Overall Study|Withdrawal by Subject|0|||
149086752|NCT03651271|537795682|FG004|Overall Study|Withdrawal by Subject|1|||
149086753|NCT03651271|537795678|FG000|Overall Study|Patient medically unable to continue|0|||
149086754|NCT03651271|537795679|FG001|Overall Study|Patient medically unable to continue|0|||
149086755|NCT03651271|537795680|FG002|Overall Study|Patient medically unable to continue|0|||
149086756|NCT03651271|537795681|FG003|Overall Study|Patient medically unable to continue|1|||
149086757|NCT03651271|537795682|FG004|Overall Study|Patient medically unable to continue|0|||
149086758|NCT05072795|537795683|FG000|Overall Study|Lost to Follow-up|5|||
149086759|NCT00821093|537795684|FG000|Overall Study|Adverse Event|20|||
149086760|NCT00821093|537795685|FG001|Overall Study|Adverse Event|12|||
149086761|NCT00821093|537795684|FG000|Overall Study|Withdrawal by Subject|9|||
149086762|NCT00821093|537795685|FG001|Overall Study|Withdrawal by Subject|13|||
149086763|NCT00821093|537795684|FG000|Overall Study|Lost to Follow-up|9|||
149086764|NCT00821093|537795685|FG001|Overall Study|Lost to Follow-up|3|||
149086765|NCT00821093|537795684|FG000|Overall Study|Protocol deviation|3|||
149086766|NCT00821093|537795685|FG001|Overall Study|Protocol deviation|6|||
149086767|NCT00821093|537795684|FG000|Overall Study|Abnormal laboratory value(s)|2|||
149086768|NCT00821093|537795685|FG001|Overall Study|Abnormal laboratory value(s)|0|||
149086769|NCT00821093|537795684|FG000|Overall Study|Lack of Efficacy|2|||
149086770|NCT00821093|537795685|FG001|Overall Study|Lack of Efficacy|2|||
149086771|NCT00821093|537795684|FG000|Overall Study|Death|2|||
149086772|NCT00821093|537795685|FG001|Overall Study|Death|1|||
149086773|NCT00821093|537795684|FG000|Overall Study|Abnormal test procedure result(s)|1|||
149086774|NCT00821093|537795685|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149086775|NCT00821093|537795684|FG000|Overall Study|Administrative problems|1|||
149086776|NCT00821093|537795685|FG001|Overall Study|Administrative problems|2|||
149086777|NCT01901302|537795689|FG000|Overall Study|Adverse Event|2|||
149086778|NCT01901302|537795690|FG001|Overall Study|Adverse Event|1|||
149086779|NCT01901302|537795689|FG000|Overall Study|Lack of Efficacy|0|||
149086780|NCT01901302|537795690|FG001|Overall Study|Lack of Efficacy|2|||
149086781|NCT01901302|537795689|FG000|Overall Study|Study Terminated by Sponsor|23|||
149086782|NCT01901302|537795690|FG001|Overall Study|Study Terminated by Sponsor|20|||
149086783|NCT01901302|537795689|FG000|Overall Study|Withdrawal by Subject|2|||
149086784|NCT01901302|537795690|FG001|Overall Study|Withdrawal by Subject|0|||
149086785|NCT05104242|537795695|FG000|Overall Study|Withdrawal by Subject|1|||
149086786|NCT05104242|537795696|FG001|Overall Study|Withdrawal by Subject|5|||
149086787|NCT05104242|537795695|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
149086788|NCT05104242|537795696|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
149086789|NCT02812706|537795697|FG000|Phase 1|Adverse Event|0|||
149086790|NCT02812706|537795698|FG001|Phase 1|Adverse Event|2|||
149086791|NCT02812706|537795699|FG002|Phase 1|Adverse Event|0|||
149086792|NCT02812706|537795697|FG000|Phase 1|Progressive disease|3|||
149086793|NCT02812706|537795698|FG001|Phase 1|Progressive disease|3|||
149086794|NCT02812706|537795699|FG002|Phase 1|Progressive disease|0|||
149086795|NCT02812706|537795697|FG000|Phase 2|Adverse Event|0|||
149086796|NCT02812706|537795698|FG001|Phase 2|Adverse Event|0|||
149086797|NCT02812706|537795699|FG002|Phase 2|Adverse Event|2|||
149086798|NCT02812706|537795697|FG000|Phase 2|Progressive disease|0|||
149086799|NCT02812706|537795698|FG001|Phase 2|Progressive disease|0|||
149086800|NCT02812706|537795699|FG002|Phase 2|Progressive disease|22|||
149086801|NCT02812706|537795697|FG000|Phase 2|Other-Unspecified|0|||
149086802|NCT02812706|537795698|FG001|Phase 2|Other-Unspecified|0|||
149086803|NCT02812706|537795699|FG002|Phase 2|Other-Unspecified|4|||
149086804|NCT00910871|537795705|FG000|Overall Study|Adverse Event|5|||
149086805|NCT00910871|537795705|FG000|Overall Study|Death|12|||
149086806|NCT00910871|537795705|FG000|Overall Study|Lost to Follow-up|8|||
149086807|NCT00910871|537795705|FG000|Overall Study|Protocol Violation|11|||
149086808|NCT00910871|537795705|FG000|Overall Study|Withdrawal by Subject|12|||
149086809|NCT00910871|537795705|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
149086810|NCT00910871|537795705|FG000|Overall Study|Undefined|1|||
149086811|NCT01005914|537795709|FG000|Overall Study|Adverse Event|4|||
149086812|NCT01005914|537795709|FG000|Overall Study|Death|4|||
149086813|NCT01005914|537795709|FG000|Overall Study|Lack of Efficacy|1|||
149086814|NCT01005914|537795709|FG000|Overall Study|Withdrawal by Subject|1|||
149086815|NCT01613599|537795710|FG000|Overall Study|Death|9|||
149086816|NCT01613599|537795710|FG000|Overall Study|Lost to Follow-up|5|||
149086817|NCT01613599|537795710|FG000|Overall Study|Withdrawal by Subject|8|||
149086818|NCT01613599|537795710|FG000|Overall Study|Reason not specified|3|||
149086819|NCT00321555|537795711|FG000|Overall Study|Developed antibodies|1|||
149086820|NCT00321555|537795711|FG000|Overall Study|Switched to alternative treatment|3|||
149086821|NCT00321555|537795711|FG000|Overall Study|Physician Decision|1|||
149086822|NCT00321555|537795711|FG000|Overall Study|Disease progression on study|1|||
149086823|NCT02066389|537795713|FG000|Overall Study|Adverse Event|1|||
149086824|NCT02066389|537795714|FG001|Overall Study|Adverse Event|1|||
149086825|NCT02066389|537795715|FG002|Overall Study|Adverse Event|1|||
149086826|NCT02066389|537795716|FG003|Overall Study|Adverse Event|1|||
149086827|NCT02066389|537795717|FG004|Overall Study|Adverse Event|5|||
149086828|NCT02066389|537795718|FG005|Overall Study|Adverse Event|1|||
149086829|NCT02066389|537795713|FG000|Overall Study|Withdrawal by Subject|4|||
149086830|NCT02066389|537795714|FG001|Overall Study|Withdrawal by Subject|0|||
149086831|NCT02066389|537795715|FG002|Overall Study|Withdrawal by Subject|5|||
149086832|NCT02066389|537795716|FG003|Overall Study|Withdrawal by Subject|1|||
149086833|NCT02066389|537795717|FG004|Overall Study|Withdrawal by Subject|1|||
149086834|NCT02066389|537795718|FG005|Overall Study|Withdrawal by Subject|2|||
149086835|NCT02066389|537795713|FG000|Overall Study|Lost to Follow-up|0|||
149086836|NCT02066389|537795714|FG001|Overall Study|Lost to Follow-up|0|||
149086837|NCT02066389|537795715|FG002|Overall Study|Lost to Follow-up|0|||
149086838|NCT02066389|537795716|FG003|Overall Study|Lost to Follow-up|1|||
149086839|NCT02066389|537795717|FG004|Overall Study|Lost to Follow-up|1|||
149086840|NCT02066389|537795718|FG005|Overall Study|Lost to Follow-up|1|||
149086841|NCT02066389|537795713|FG000|Overall Study|Randomized in Error|0|||
149086842|NCT02066389|537795714|FG001|Overall Study|Randomized in Error|0|||
149086843|NCT02066389|537795715|FG002|Overall Study|Randomized in Error|0|||
149086844|NCT02066389|537795716|FG003|Overall Study|Randomized in Error|0|||
149086845|NCT02066389|537795717|FG004|Overall Study|Randomized in Error|0|||
149086846|NCT02066389|537795718|FG005|Overall Study|Randomized in Error|1|||
149086847|NCT01755598|537795719|FG000|Overall Study|Other|109|||
149086848|NCT01755598|537795720|FG001|Overall Study|Other|109|||
149086849|NCT01755598|537795719|FG000|Overall Study|Lost to Follow-up|32|||
149086850|NCT01755598|537795720|FG001|Overall Study|Lost to Follow-up|43|||
149086851|NCT01755598|537795719|FG000|Overall Study|Migrated/moved from study area|76|||
149086852|NCT01755598|537795720|FG001|Overall Study|Migrated/moved from study area|65|||
149086853|NCT01755598|537795719|FG000|Overall Study|Withdrawal by Subject|22|||
149086854|NCT01755598|537795720|FG001|Overall Study|Withdrawal by Subject|31|||
149086855|NCT01755598|537795719|FG000|Overall Study|Protocol Violation|7|||
149086856|NCT01755598|537795720|FG001|Overall Study|Protocol Violation|7|||
149086857|NCT01755598|537795719|FG000|Overall Study|Adverse Event|19|||
149086858|NCT01755598|537795720|FG001|Overall Study|Adverse Event|28|||
149086859|NCT04016415|537795721|FG000|Overall Study|Adverse Event|2|||
149086860|NCT04016415|537795722|FG001|Overall Study|Adverse Event|1|||
149086861|NCT04016415|537795721|FG000|Overall Study|Lost to Follow-up|6|||
149086862|NCT04016415|537795722|FG001|Overall Study|Lost to Follow-up|2|||
149086863|NCT04016415|537795721|FG000|Overall Study|Physician Decision|5|||
149086864|NCT04016415|537795722|FG001|Overall Study|Physician Decision|1|||
149086865|NCT04016415|537795721|FG000|Overall Study|Pregnancy|0|||
149086866|NCT04016415|537795722|FG001|Overall Study|Pregnancy|1|||
149086867|NCT04016415|537795721|FG000|Overall Study|Withdrawal by Subject|24|||
149086868|NCT04016415|537795722|FG001|Overall Study|Withdrawal by Subject|27|||
149086869|NCT04016415|537795721|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
149086870|NCT04016415|537795722|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
149086871|NCT02260154|537795731|FG000|Overall Study|Screening failure|2|||
149086872|NCT03547167|537795736|FG000|Overall Study|Withdrawal by Subject|34|||
149086873|NCT03547167|537795737|FG001|Overall Study|Withdrawal by Subject|12|||
149086874|NCT03547167|537795736|FG000|Overall Study|Screen Failure|0|||
149086875|NCT03547167|537795737|FG001|Overall Study|Screen Failure|1|||
149086876|NCT03547167|537795736|FG000|Overall Study|Lost to Follow-up|59|||
149086877|NCT03547167|537795737|FG001|Overall Study|Lost to Follow-up|15|||
149086878|NCT03547167|537795736|FG000|Overall Study|Death|4|||
149086879|NCT03547167|537795737|FG001|Overall Study|Death|2|||
149086880|NCT00736502|537795738|FG000|Overall Study|Adverse Event|22|||
149086881|NCT00736502|537795738|FG000|Overall Study|Lack of Efficacy|16|||
149086882|NCT00736502|537795738|FG000|Overall Study|Lost to Follow-up|27|||
149086883|NCT00645411|537795739|FG000|Overall Study|Adverse Event|0|||
149086884|NCT00645411|537795740|FG001|Overall Study|Adverse Event|0|||
149086885|NCT00645411|537795741|FG002|Overall Study|Adverse Event|0|||
149086886|NCT00645411|537795742|FG003|Overall Study|Adverse Event|2|||
149086887|NCT00645411|537795739|FG000|Overall Study|Withdrawal by Subject|2|||
149086888|NCT00645411|537795740|FG001|Overall Study|Withdrawal by Subject|1|||
149086889|NCT00645411|537795741|FG002|Overall Study|Withdrawal by Subject|19|||
149086890|NCT00645411|537795742|FG003|Overall Study|Withdrawal by Subject|21|||
149086891|NCT00645411|537795739|FG000|Overall Study|Lost to Follow-up|10|||
149086892|NCT00645411|537795740|FG001|Overall Study|Lost to Follow-up|5|||
149086893|NCT00645411|537795741|FG002|Overall Study|Lost to Follow-up|124|||
149086894|NCT00645411|537795742|FG003|Overall Study|Lost to Follow-up|75|||
149086895|NCT00645411|537795739|FG000|Overall Study|Protocol Violation|1|||
149086896|NCT00645411|537795740|FG001|Overall Study|Protocol Violation|0|||
149086897|NCT00645411|537795741|FG002|Overall Study|Protocol Violation|1|||
149086898|NCT00645411|537795742|FG003|Overall Study|Protocol Violation|0|||
149086899|NCT00645411|537795739|FG000|Overall Study|Inappropriate enrollment|0|||
149086900|NCT00645411|537795740|FG001|Overall Study|Inappropriate enrollment|0|||
149086901|NCT00645411|537795741|FG002|Overall Study|Inappropriate enrollment|4|||
149086902|NCT00645411|537795742|FG003|Overall Study|Inappropriate enrollment|1|||
149086903|NCT00645411|537795739|FG000|Overall Study|Unable to classify|0|||
149086904|NCT00645411|537795740|FG001|Overall Study|Unable to classify|0|||
149086905|NCT00645411|537795741|FG002|Overall Study|Unable to classify|3|||
149086906|NCT00645411|537795742|FG003|Overall Study|Unable to classify|4|||
149086907|NCT01307800|537795743|FG000|Overall Study|Adverse Event|9|||
149086908|NCT01307800|537795744|FG001|Overall Study|Adverse Event|8|||
149086909|NCT01307800|537795745|FG002|Overall Study|Adverse Event|10|||
149086910|NCT01307800|537795746|FG003|Overall Study|Adverse Event|14|||
149086911|NCT01307800|537795743|FG000|Overall Study|Entry Criteria Not Met|0|||
149086912|NCT01307800|537795744|FG001|Overall Study|Entry Criteria Not Met|0|||
149086913|NCT01307800|537795745|FG002|Overall Study|Entry Criteria Not Met|0|||
149086914|NCT01307800|537795746|FG003|Overall Study|Entry Criteria Not Met|2|||
149086915|NCT01307800|537795743|FG000|Overall Study|Lost to Follow-up|5|||
149086916|NCT01307800|537795744|FG001|Overall Study|Lost to Follow-up|6|||
149086917|NCT01307800|537795745|FG002|Overall Study|Lost to Follow-up|2|||
149086918|NCT01307800|537795746|FG003|Overall Study|Lost to Follow-up|8|||
149086919|NCT01307800|537795743|FG000|Overall Study|Perceived Lack of Efficacy|24|||
149086920|NCT01307800|537795744|FG001|Overall Study|Perceived Lack of Efficacy|23|||
149086921|NCT01307800|537795745|FG002|Overall Study|Perceived Lack of Efficacy|20|||
149086922|NCT01307800|537795746|FG003|Overall Study|Perceived Lack of Efficacy|33|||
149086923|NCT01307800|537795743|FG000|Overall Study|Protocol Violation|0|||
149086924|NCT01307800|537795744|FG001|Overall Study|Protocol Violation|3|||
149086925|NCT01307800|537795745|FG002|Overall Study|Protocol Violation|4|||
149086926|NCT01307800|537795746|FG003|Overall Study|Protocol Violation|5|||
149086927|NCT01307800|537795743|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
149086928|NCT01307800|537795744|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
149086929|NCT01307800|537795745|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
149086930|NCT01307800|537795746|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
149086931|NCT01307800|537795743|FG000|Overall Study|Sponsor Decision|6|||
149086932|NCT01307800|537795744|FG001|Overall Study|Sponsor Decision|9|||
149086933|NCT01307800|537795745|FG002|Overall Study|Sponsor Decision|12|||
149086934|NCT01307800|537795746|FG003|Overall Study|Sponsor Decision|28|||
149086935|NCT01307800|537795743|FG000|Overall Study|Withdrawal by Subject|10|||
149086936|NCT01307800|537795744|FG001|Overall Study|Withdrawal by Subject|11|||
149086937|NCT01307800|537795745|FG002|Overall Study|Withdrawal by Subject|8|||
149086938|NCT01307800|537795746|FG003|Overall Study|Withdrawal by Subject|15|||
149086939|NCT01307800|537795743|FG000|Overall Study|Participant Moved|0|||
149086940|NCT01307800|537795744|FG001|Overall Study|Participant Moved|2|||
149086941|NCT01307800|537795745|FG002|Overall Study|Participant Moved|1|||
149086942|NCT01307800|537795746|FG003|Overall Study|Participant Moved|3|||
149086943|NCT02674399|537795749|FG000|Overall Study|Lost to Follow-up|2|||
149086944|NCT02674399|537795750|FG001|Overall Study|Lost to Follow-up|0|||
149086945|NCT02255474|537795751|FG000|Overall Study|Lost to Follow-up|1|||
149086946|NCT02255474|537795752|FG001|Overall Study|Lost to Follow-up|1|||
149086947|NCT02255474|537795753|FG002|Overall Study|Lost to Follow-up|3|||
149086948|NCT02255474|537795751|FG000|Overall Study|Withdrawal by Subject|1|||
149086949|NCT02255474|537795752|FG001|Overall Study|Withdrawal by Subject|1|||
149086950|NCT02255474|537795753|FG002|Overall Study|Withdrawal by Subject|0|||
149086951|NCT02332889|537795771|FG000|Overall Study|Physician Decision|1|||
149086952|NCT01634165|537795774|FG000|Period 2|Adverse Event|0|||
149086953|NCT01634165|537795775|FG001|Period 2|Adverse Event|1|||
149086954|NCT01634165|537795776|FG002|Period 2|Adverse Event|0|||
149086955|NCT01634165|537795777|FG003|Period 2|Adverse Event|0|||
149086956|NCT04097535|537795780|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
149086957|NCT03070301|537795781|FG000|Overall Study|Progression of disease|16|||
149086958|NCT03070301|537795781|FG000|Overall Study|Physician Decision|3|||
149086959|NCT03070301|537795781|FG000|Overall Study|Withdrawal by Subject|1|||
149086960|NCT02880293|537797045|FG000|Overall Study|Inevaluable|5|||
149086961|NCT00668746|537797046|FG000|Overall Study|Lost to Follow-up|2|||
149086962|NCT00668746|537797047|FG001|Overall Study|Lost to Follow-up|1|||
149086963|NCT02109172|537797048|FG000|Overall Study|Withdrawal by Subject|1|||
149086964|NCT02109172|537797049|FG001|Overall Study|Withdrawal by Subject|0|||
149086965|NCT02109172|537797050|FG002|Overall Study|Withdrawal by Subject|0|||
149086966|NCT02109172|537797051|FG003|Overall Study|Withdrawal by Subject|1|||
149086967|NCT02109172|537797052|FG004|Overall Study|Withdrawal by Subject|0|||
149086968|NCT02109172|537797053|FG005|Overall Study|Withdrawal by Subject|0|||
149086969|NCT02109172|537797048|FG000|Overall Study|Adverse Event|0|||
149086970|NCT02109172|537797049|FG001|Overall Study|Adverse Event|0|||
149086971|NCT02109172|537797050|FG002|Overall Study|Adverse Event|1|||
149086972|NCT02109172|537797051|FG003|Overall Study|Adverse Event|0|||
149086973|NCT02109172|537797052|FG004|Overall Study|Adverse Event|0|||
149086974|NCT02109172|537797053|FG005|Overall Study|Adverse Event|1|||
149086975|NCT02109172|537797048|FG000|Overall Study|Death|0|||
149086976|NCT02109172|537797049|FG001|Overall Study|Death|0|||
149086977|NCT02109172|537797050|FG002|Overall Study|Death|0|||
149086978|NCT02109172|537797051|FG003|Overall Study|Death|0|||
149086979|NCT02109172|537797052|FG004|Overall Study|Death|1|||
149086980|NCT02109172|537797053|FG005|Overall Study|Death|0|||
149086981|NCT01816165|537797060|FG000|Overall Study|Adverse Event|1|||
149086982|NCT01816165|537797061|FG001|Overall Study|Adverse Event|0|||
149086983|NCT01816165|537797062|FG002|Overall Study|Adverse Event|0|||
149086984|NCT01816165|537797063|FG003|Overall Study|Adverse Event|0|||
149086985|NCT02409732|537797064|FG000|Overall Study|Withdrawal by Subject|4|||
149086986|NCT02409732|537797064|FG000|Overall Study|Lost to Follow-up|2|||
149086987|NCT03960437|537797066|FG000|Overall Study|Removed by PI|4|||
149086988|NCT03960437|537797066|FG000|Overall Study|Lost to Follow-up|2|||
149086989|NCT03960437|537797066|FG000|Overall Study|Withdrawal by Subject|1|||
149086990|NCT03960437|537797066|FG000|Overall Study|Death|2|||
149086991|NCT03614923|537797067|FG000|Overall Study|Withdrawal by Subject|2|||
149086992|NCT03614923|537797068|FG001|Overall Study|Withdrawal by Subject|1|||
149086993|NCT03614923|537797069|FG002|Overall Study|Withdrawal by Subject|1|||
149086994|NCT03614923|537797067|FG000|Overall Study|Adverse Event|0|||
149086995|NCT03614923|537797068|FG001|Overall Study|Adverse Event|2|||
149086996|NCT03614923|537797069|FG002|Overall Study|Adverse Event|1|||
149086997|NCT03614923|537797067|FG000|Overall Study|Lost to Follow-up|1|||
149086998|NCT03614923|537797068|FG001|Overall Study|Lost to Follow-up|0|||
149086999|NCT03614923|537797069|FG002|Overall Study|Lost to Follow-up|1|||
149087000|NCT03614923|537797067|FG000|Overall Study|Lack of Efficacy|2|||
149087001|NCT03614923|537797068|FG001|Overall Study|Lack of Efficacy|0|||
149087002|NCT03614923|537797069|FG002|Overall Study|Lack of Efficacy|1|||
149087003|NCT03614923|537797067|FG000|Overall Study|Non-compliance|0|||
149087004|NCT03614923|537797068|FG001|Overall Study|Non-compliance|1|||
149087005|NCT03614923|537797069|FG002|Overall Study|Non-compliance|0|||
149087006|NCT03614923|537797067|FG000|Overall Study|Other|0|||
149087007|NCT03614923|537797068|FG001|Overall Study|Other|1|||
149087008|NCT03614923|537797069|FG002|Overall Study|Other|1|||
149087009|NCT01882088|537797071|FG000|Overall Study|Intolerance of esophageal manometry|1|||
149087010|NCT01882088|537797071|FG000|Overall Study|no possibility to place the catheter|1|||
149087011|NCT01882088|537797071|FG000|Overall Study|Protocol Violation|1|||
149087012|NCT01882088|537797071|FG000|Overall Study|inadequate pH-impedance tracings|2|||
149087013|NCT02030847|537797077|FG000|Overall Study|Death|10|||
149087014|NCT02030847|537797077|FG000|Overall Study|Disease Progression|15|||
149087015|NCT02030847|537797077|FG000|Overall Study|New Cancer Therapy|8|||
149087016|NCT02030847|537797077|FG000|Overall Study|Physician Decision|3|||
149087017|NCT02030847|537797077|FG000|Overall Study|Withdrawal by Subject|1|||
149087018|NCT00168805|537797078|FG000|Overall Study|Adverse Event|7|||
149087019|NCT00168805|537797079|FG001|Overall Study|Adverse Event|11|||
149087020|NCT00168805|537797080|FG002|Overall Study|Adverse Event|16|||
149087021|NCT00168805|537797078|FG000|Overall Study|Protocol Violation|12|||
149087022|NCT00168805|537797079|FG001|Overall Study|Protocol Violation|11|||
149087023|NCT00168805|537797080|FG002|Overall Study|Protocol Violation|8|||
149087024|NCT00168805|537797078|FG000|Overall Study|Lost to Follow-up|12|||
149087025|NCT00168805|537797079|FG001|Overall Study|Lost to Follow-up|17|||
149087026|NCT00168805|537797080|FG002|Overall Study|Lost to Follow-up|11|||
149087027|NCT00168805|537797078|FG000|Overall Study|Withdrawal by Subject|16|||
149087028|NCT00168805|537797079|FG001|Overall Study|Withdrawal by Subject|18|||
149087029|NCT00168805|537797080|FG002|Overall Study|Withdrawal by Subject|21|||
149087030|NCT00168805|537797078|FG000|Overall Study|Other|24|||
149087031|NCT00168805|537797079|FG001|Overall Study|Other|21|||
149087032|NCT00168805|537797080|FG002|Overall Study|Other|22|||
149087033|NCT00168805|537797078|FG000|Treatment|Adverse Event|25|||
149087034|NCT00168805|537797079|FG001|Treatment|Adverse Event|26|||
149087035|NCT00168805|537797080|FG002|Treatment|Adverse Event|32|||
149087036|NCT00168805|537797078|FG000|Treatment|Protocol Violation|3|||
149087037|NCT00168805|537797079|FG001|Treatment|Protocol Violation|5|||
149087038|NCT00168805|537797080|FG002|Treatment|Protocol Violation|5|||
149087039|NCT00168805|537797078|FG000|Treatment|Withdrawal by Subject|3|||
149087040|NCT00168805|537797079|FG001|Treatment|Withdrawal by Subject|7|||
149087041|NCT00168805|537797080|FG002|Treatment|Withdrawal by Subject|8|||
149087042|NCT00168805|537797078|FG000|Treatment|Other|18|||
149087043|NCT00168805|537797079|FG001|Treatment|Other|18|||
149087044|NCT00168805|537797080|FG002|Treatment|Other|17|||
149087045|NCT04175392|537797086|FG000|Overall Study|Withdrawal by Subject|3|||
149087046|NCT04175392|537797087|FG001|Overall Study|Withdrawal by Subject|2|||
149087047|NCT01103141|537797088|FG000|Overall Study|Death|0|||
149087048|NCT01103141|537797089|FG001|Overall Study|Death|1|||
149087049|NCT01103141|537797088|FG000|Overall Study|Lost to Follow-up|2|||
149087050|NCT01103141|537797089|FG001|Overall Study|Lost to Follow-up|1|||
149087051|NCT01601821|537797092|FG000|Overall Study|Death|2|||
149087052|NCT01601821|537797093|FG001|Overall Study|Death|5|||
149087053|NCT01601821|537797092|FG000|Overall Study|Protocol Violation|2|||
149087054|NCT01601821|537797093|FG001|Overall Study|Protocol Violation|2|||
149087055|NCT01601821|537797092|FG000|Overall Study|Lost to Follow-up|6|||
149087056|NCT01601821|537797093|FG001|Overall Study|Lost to Follow-up|14|||
149087057|NCT01601821|537797092|FG000|Overall Study|Withdrawal by Subject|1|||
149087058|NCT01601821|537797093|FG001|Overall Study|Withdrawal by Subject|0|||
149087059|NCT01601821|537797092|FG000|Overall Study|Graft Loss|6|||
149087060|NCT01601821|537797093|FG001|Overall Study|Graft Loss|6|||
149087061|NCT01601821|537797092|FG000|Overall Study|Study Events|7|||
149087062|NCT01601821|537797093|FG001|Overall Study|Study Events|1|||
149087063|NCT01601821|537797092|FG000|Overall Study|Other|5|||
149087064|NCT01601821|537797093|FG001|Overall Study|Other|1|||
149087065|NCT00422162|537797094|FG000|Overall Study|Adverse Event|11|||
149087066|NCT00422162|537797095|FG001|Overall Study|Adverse Event|9|||
149087067|NCT00422162|537797094|FG000|Overall Study|Lack of Efficacy|4|||
149087068|NCT00422162|537797095|FG001|Overall Study|Lack of Efficacy|10|||
149087069|NCT00422162|537797094|FG000|Overall Study|Withdrawal by Subject|7|||
149087070|NCT00422162|537797095|FG001|Overall Study|Withdrawal by Subject|6|||
149087071|NCT00422162|537797094|FG000|Overall Study|Lost to Follow-up|1|||
149087072|NCT00422162|537797095|FG001|Overall Study|Lost to Follow-up|2|||
149087073|NCT00422162|537797094|FG000|Overall Study|Non-Compliant with Protocol|1|||
149087074|NCT00422162|537797095|FG001|Overall Study|Non-Compliant with Protocol|1|||
149087075|NCT00422162|537797094|FG000|Overall Study|Other|0|||
149087076|NCT00422162|537797095|FG001|Overall Study|Other|1|||
149087077|NCT00422162|537797094|FG000|Overall Study|Didn't Receive Treatment|0|||
149087078|NCT00422162|537797095|FG001|Overall Study|Didn't Receive Treatment|1|||
149087079|NCT05274906|537797096|FG000|Overall Study|Withdrawal by Subject|2|||
149087080|NCT05274906|537797097|FG001|Overall Study|Withdrawal by Subject|1|||
149087081|NCT02062827|537797098|FG000|Overall Study|Death|1|||
149087082|NCT02062827|537797099|FG001|Overall Study|Death|0|||
149087083|NCT02062827|537797100|FG002|Overall Study|Death|0|||
149087084|NCT02062827|537797101|FG003|Overall Study|Death|0|||
149087085|NCT02062827|537797102|FG004|Overall Study|Death|0|||
149087086|NCT02062827|537797103|FG005|Overall Study|Death|0|||
149087087|NCT02062827|537797104|FG006|Overall Study|Death|0|||
149087088|NCT02062827|537797105|FG007|Overall Study|Death|0|||
149087089|NCT02062827|537797098|FG000|Overall Study|Withdrawal by Subject|3|||
149087090|NCT02062827|537797099|FG001|Overall Study|Withdrawal by Subject|1|||
149087091|NCT02062827|537797100|FG002|Overall Study|Withdrawal by Subject|1|||
149087092|NCT02062827|537797101|FG003|Overall Study|Withdrawal by Subject|2|||
149087093|NCT02062827|537797102|FG004|Overall Study|Withdrawal by Subject|6|||
149087094|NCT02062827|537797103|FG005|Overall Study|Withdrawal by Subject|0|||
149087095|NCT02062827|537797104|FG006|Overall Study|Withdrawal by Subject|5|||
149087096|NCT02062827|537797105|FG007|Overall Study|Withdrawal by Subject|0|||
149087097|NCT02062827|537797098|FG000|Overall Study|Screen Fail|0|||
149087098|NCT02062827|537797099|FG001|Overall Study|Screen Fail|0|||
149087099|NCT02062827|537797100|FG002|Overall Study|Screen Fail|0|||
149087100|NCT02062827|537797101|FG003|Overall Study|Screen Fail|0|||
149087101|NCT02062827|537797102|FG004|Overall Study|Screen Fail|0|||
149087102|NCT02062827|537797103|FG005|Overall Study|Screen Fail|0|||
149087103|NCT02062827|537797104|FG006|Overall Study|Screen Fail|0|||
149087104|NCT02062827|537797105|FG007|Overall Study|Screen Fail|8|||
149087105|NCT02991456|537797110|FG000|Overall Study|Adverse Event|2|||
149087106|NCT02991456|537797111|FG001|Overall Study|Adverse Event|0|||
149087107|NCT02991456|537797110|FG000|Overall Study|Lost to Follow-up|0|||
149087108|NCT02991456|537797111|FG001|Overall Study|Lost to Follow-up|2|||
149087109|NCT02991456|537797110|FG000|Overall Study|Withdrawal by Subject|1|||
149087110|NCT02991456|537797111|FG001|Overall Study|Withdrawal by Subject|0|||
149087111|NCT03503188|537797112|FG000|Overall Study|Non eligible in the sub study|0|||
149087112|NCT03503188|537797113|FG001|Overall Study|Non eligible in the sub study|1|||
149087113|NCT01699178|537797114|FG000|Overall Study|Adverse Event|1|||
149087114|NCT01699178|537797115|FG001|Overall Study|Adverse Event|5|||
149087115|NCT01699178|537797114|FG000|Overall Study|Lost to Follow-up|1|||
149087116|NCT01699178|537797115|FG001|Overall Study|Lost to Follow-up|6|||
149087117|NCT01699178|537797114|FG000|Overall Study|Non-compliance with Study Drug|3|||
149087118|NCT01699178|537797115|FG001|Overall Study|Non-compliance with Study Drug|1|||
149087119|NCT01699178|537797114|FG000|Overall Study|Physician Decision|1|||
149087120|NCT01699178|537797115|FG001|Overall Study|Physician Decision|0|||
149087121|NCT01699178|537797114|FG000|Overall Study|Withdrawal by Subject|4|||
149087122|NCT01699178|537797115|FG001|Overall Study|Withdrawal by Subject|12|||
149087123|NCT01699178|537797114|FG000|Overall Study|Hematocrit >54%|1|||
149087124|NCT01699178|537797115|FG001|Overall Study|Hematocrit >54%|1|||
149087125|NCT01699178|537797114|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
149087126|NCT01699178|537797115|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
149087127|NCT01699178|537797114|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
149087128|NCT01699178|537797115|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
149087129|NCT02561195|537797121|FG000|Vaccination 1 to 3|Adverse Event|4|||
149087130|NCT02561195|537797122|FG001|Vaccination 1 to 3|Adverse Event|5|||
149087131|NCT02561195|537797123|FG002|Vaccination 1 to 3|Adverse Event|0|||
149087132|NCT02561195|537797124|FG003|Vaccination 1 to 3|Adverse Event|3|||
149087133|NCT02561195|537797125|FG004|Vaccination 1 to 3|Adverse Event|4|||
149087134|NCT02561195|537797126|FG005|Vaccination 1 to 3|Adverse Event|0|||
149087135|NCT02561195|537797127|FG006|Vaccination 1 to 3|Adverse Event|0|||
149087136|NCT02561195|537797128|FG007|Vaccination 1 to 3|Adverse Event|0|||
149087137|NCT02561195|537797129|FG008|Vaccination 1 to 3|Adverse Event|0|||
149087138|NCT02561195|537797130|FG009|Vaccination 1 to 3|Adverse Event|0|||
149087139|NCT02561195|537797131|FG010|Vaccination 1 to 3|Adverse Event|0|||
149087140|NCT02561195|537797132|FG011|Vaccination 1 to 3|Adverse Event|0|||
149087141|NCT02561195|537797133|FG012|Vaccination 1 to 3|Adverse Event|0|||
149087142|NCT02561195|537797134|FG013|Vaccination 1 to 3|Adverse Event|0|||
149087143|NCT02561195|537797121|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
149087144|NCT02561195|537797122|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
149087145|NCT02561195|537797123|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
149087146|NCT02561195|537797124|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
149087147|NCT02561195|537797125|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
149087148|NCT02561195|537797126|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
149087149|NCT02561195|537797127|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
149087150|NCT02561195|537797128|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
149087151|NCT02561195|537797129|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
149087152|NCT02561195|537797130|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
149087153|NCT02561195|537797131|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
149087154|NCT02561195|537797132|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
149087155|NCT02561195|537797133|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
149087156|NCT02561195|537797134|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
149087157|NCT02561195|537797121|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087158|NCT02561195|537797122|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
149087159|NCT02561195|537797123|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087160|NCT02561195|537797124|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
149087161|NCT02561195|537797125|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
149087162|NCT02561195|537797126|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
149087163|NCT02561195|537797127|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087164|NCT02561195|537797128|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087165|NCT02561195|537797129|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087166|NCT02561195|537797130|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087167|NCT02561195|537797131|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087168|NCT02561195|537797132|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087169|NCT02561195|537797133|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087170|NCT02561195|537797134|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
149087171|NCT02561195|537797121|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
149087172|NCT02561195|537797122|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
149087173|NCT02561195|537797123|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
149087174|NCT02561195|537797124|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
149087175|NCT02561195|537797125|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
149087176|NCT02561195|537797126|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
149087177|NCT02561195|537797127|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
149087178|NCT02561195|537797128|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
149087179|NCT02561195|537797129|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
149087180|NCT02561195|537797130|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
149087181|NCT02561195|537797131|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
149087182|NCT02561195|537797132|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
149087183|NCT02561195|537797133|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
149087184|NCT02561195|537797134|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
149087185|NCT02561195|537797121|FG000|Vaccination 1 to 3|Other|7|||
149087186|NCT02561195|537797122|FG001|Vaccination 1 to 3|Other|3|||
149087187|NCT02561195|537797123|FG002|Vaccination 1 to 3|Other|1|||
149087188|NCT02561195|537797124|FG003|Vaccination 1 to 3|Other|7|||
149087189|NCT02561195|537797125|FG004|Vaccination 1 to 3|Other|5|||
149087190|NCT02561195|537797126|FG005|Vaccination 1 to 3|Other|1|||
149087191|NCT02561195|537797127|FG006|Vaccination 1 to 3|Other|0|||
149087192|NCT02561195|537797128|FG007|Vaccination 1 to 3|Other|0|||
149087193|NCT02561195|537797129|FG008|Vaccination 1 to 3|Other|0|||
149087194|NCT02561195|537797130|FG009|Vaccination 1 to 3|Other|0|||
149087195|NCT02561195|537797131|FG010|Vaccination 1 to 3|Other|0|||
149087196|NCT02561195|537797132|FG011|Vaccination 1 to 3|Other|0|||
149087197|NCT02561195|537797133|FG012|Vaccination 1 to 3|Other|0|||
149087198|NCT02561195|537797134|FG013|Vaccination 1 to 3|Other|0|||
149087199|NCT02561195|537797121|FG000|Vaccination 1 to 3|Protocol Violation|1|||
149087200|NCT02561195|537797122|FG001|Vaccination 1 to 3|Protocol Violation|0|||
149087201|NCT02561195|537797123|FG002|Vaccination 1 to 3|Protocol Violation|1|||
149087202|NCT02561195|537797124|FG003|Vaccination 1 to 3|Protocol Violation|2|||
149087203|NCT02561195|537797125|FG004|Vaccination 1 to 3|Protocol Violation|5|||
149087204|NCT02561195|537797126|FG005|Vaccination 1 to 3|Protocol Violation|2|||
149087205|NCT02561195|537797127|FG006|Vaccination 1 to 3|Protocol Violation|0|||
149087206|NCT02561195|537797128|FG007|Vaccination 1 to 3|Protocol Violation|0|||
149087207|NCT02561195|537797129|FG008|Vaccination 1 to 3|Protocol Violation|0|||
149087208|NCT02561195|537797130|FG009|Vaccination 1 to 3|Protocol Violation|0|||
149087209|NCT02561195|537797131|FG010|Vaccination 1 to 3|Protocol Violation|0|||
149087210|NCT02561195|537797132|FG011|Vaccination 1 to 3|Protocol Violation|0|||
149087211|NCT02561195|537797133|FG012|Vaccination 1 to 3|Protocol Violation|0|||
149087212|NCT02561195|537797134|FG013|Vaccination 1 to 3|Protocol Violation|0|||
149087213|NCT02561195|537797121|FG000|Vaccination 1 to 3|Death|2|||
149087214|NCT02561195|537797122|FG001|Vaccination 1 to 3|Death|1|||
149087215|NCT02561195|537797123|FG002|Vaccination 1 to 3|Death|0|||
149087216|NCT02561195|537797124|FG003|Vaccination 1 to 3|Death|2|||
149087217|NCT02561195|537797125|FG004|Vaccination 1 to 3|Death|0|||
149087218|NCT02561195|537797126|FG005|Vaccination 1 to 3|Death|0|||
149087219|NCT02561195|537797127|FG006|Vaccination 1 to 3|Death|0|||
149087220|NCT02561195|537797128|FG007|Vaccination 1 to 3|Death|0|||
149087221|NCT02561195|537797129|FG008|Vaccination 1 to 3|Death|0|||
149087222|NCT02561195|537797130|FG009|Vaccination 1 to 3|Death|0|||
149087223|NCT02561195|537797131|FG010|Vaccination 1 to 3|Death|0|||
149087224|NCT02561195|537797132|FG011|Vaccination 1 to 3|Death|0|||
149087225|NCT02561195|537797133|FG012|Vaccination 1 to 3|Death|0|||
149087226|NCT02561195|537797134|FG013|Vaccination 1 to 3|Death|0|||
149087227|NCT02561195|537797121|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
149087228|NCT02561195|537797122|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
149087229|NCT02561195|537797123|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
149087230|NCT02561195|537797124|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
149087231|NCT02561195|537797125|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
149087232|NCT02561195|537797126|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087233|NCT02561195|537797127|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087234|NCT02561195|537797128|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087235|NCT02561195|537797129|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087236|NCT02561195|537797130|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087237|NCT02561195|537797131|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087238|NCT02561195|537797132|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087239|NCT02561195|537797133|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087240|NCT02561195|537797134|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
149087241|NCT02561195|537797121|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
149087242|NCT02561195|537797122|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
149087243|NCT02561195|537797123|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
149087244|NCT02561195|537797124|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
149087245|NCT02561195|537797125|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
149087246|NCT02561195|537797126|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
149087247|NCT02561195|537797127|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
149087248|NCT02561195|537797128|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
149087249|NCT02561195|537797129|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
149087250|NCT02561195|537797130|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
149087251|NCT02561195|537797131|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
149087252|NCT02561195|537797132|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
149087253|NCT02561195|537797133|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
149087254|NCT02561195|537797134|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
149087255|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087256|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087257|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087258|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087259|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087260|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087261|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087262|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087263|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
149087264|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
149087265|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
149087266|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
149087267|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
149087268|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
149087269|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087270|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087271|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087272|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087273|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087274|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087275|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087276|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087277|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087278|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087279|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087280|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087281|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
149087282|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
149087283|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|Death|0|||
149087284|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|Death|0|||
149087285|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|Death|0|||
149087286|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|Death|0|||
149087287|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|Death|0|||
149087288|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|Death|0|||
149087289|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|Death|0|||
149087290|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|Death|0|||
149087291|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|Death|0|||
149087292|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|Death|1|||
149087293|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|Death|0|||
149087294|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|Death|0|||
149087295|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|Death|0|||
149087296|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|Death|0|||
149087297|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087298|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087299|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087300|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087301|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087302|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087303|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
149087304|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
149087305|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087306|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
149087307|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
149087308|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
149087309|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
149087310|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
149087311|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087312|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087313|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087314|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087315|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087316|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087317|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087318|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087319|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087320|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087321|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
149087322|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
149087323|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
149087324|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
149087325|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|Other|0|||
149087326|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|Other|0|||
149087327|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|Other|0|||
149087328|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|Other|0|||
149087329|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|Other|0|||
149087330|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|Other|0|||
149087331|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|Other|0|||
149087332|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|Other|0|||
149087333|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|Other|0|||
149087334|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|Other|0|||
149087335|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|Other|2|||
149087336|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|Other|2|||
149087337|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|Other|1|||
149087338|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|Other|0|||
149087339|NCT02561195|537797121|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087340|NCT02561195|537797122|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087341|NCT02561195|537797123|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087342|NCT02561195|537797124|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087343|NCT02561195|537797125|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087344|NCT02561195|537797126|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087345|NCT02561195|537797127|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
149087346|NCT02561195|537797128|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087347|NCT02561195|537797129|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087348|NCT02561195|537797130|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087349|NCT02561195|537797131|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
149087350|NCT02561195|537797132|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
149087351|NCT02561195|537797133|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
149087352|NCT02561195|537797134|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
149087353|NCT03905512|537797137|FG000|Overall Study|Withdrawal by Subject|9|||
149087354|NCT03905512|537797138|FG001|Overall Study|Withdrawal by Subject|8|||
149087355|NCT03905512|537797137|FG000|Overall Study|Adverse Event|1|||
149087356|NCT03905512|537797138|FG001|Overall Study|Adverse Event|2|||
149087357|NCT03905512|537797137|FG000|Overall Study|Lost to Follow-up|4|||
149087358|NCT03905512|537797138|FG001|Overall Study|Lost to Follow-up|3|||
149087359|NCT03905512|537797137|FG000|Overall Study|Other than Specified|7|||
149087360|NCT03905512|537797138|FG001|Overall Study|Other than Specified|4|||
149087361|NCT00070317|537797141|FG000|Overall Study|Inevaluable (Never Treated)|1|||
149087362|NCT00070317|537797141|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
149087363|NCT00070317|537797141|FG000|Overall Study|Ineligible required test not done|1|||
149087364|NCT00070317|537797141|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
149087365|NCT00070317|537797141|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
149087366|NCT01885559|537797142|FG000|Overall Study|Lost to Follow-up|15|||
149087367|NCT01885559|537797143|FG001|Overall Study|Lost to Follow-up|16|||
149087368|NCT01885559|537797142|FG000|Overall Study|Less than full participation|9|||
149087369|NCT01885559|537797143|FG001|Overall Study|Less than full participation|19|||
149087370|NCT01885559|537797142|FG000|Overall Study|Protocol Violation|0|||
149087371|NCT01885559|537797143|FG001|Overall Study|Protocol Violation|1|||
149087372|NCT03560206|537797145|FG000|Overall Study|Lost to Follow-up|19|||
149087373|NCT03560206|537797146|FG001|Overall Study|Lost to Follow-up|11|||
149087374|NCT03560206|537797145|FG000|Overall Study|Withdrawal by Subject|2|||
149087375|NCT03560206|537797146|FG001|Overall Study|Withdrawal by Subject|4|||
149087376|NCT03560206|537797145|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
149087377|NCT03560206|537797146|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
149087378|NCT03560206|537797145|FG000|Overall Study|Busy schedule|14|||
149087379|NCT03560206|537797146|FG001|Overall Study|Busy schedule|2|||
149087380|NCT03560206|537797145|FG000|Overall Study|patients' new health condition such as cancer|10|||
149087381|NCT03560206|537797146|FG001|Overall Study|patients' new health condition such as cancer|1|||
149087382|NCT03987074|537797147|FG000|Overall Study|Withdrew Consent|1|||
149087383|NCT03987074|537797148|FG001|Overall Study|Withdrew Consent|1|||
149087384|NCT03987074|537797149|FG002|Overall Study|Withdrew Consent|0|||
149087385|NCT03987074|537797150|FG003|Overall Study|Withdrew Consent|2|||
149087386|NCT03987074|537797151|FG004|Overall Study|Withdrew Consent|1|||
149087387|NCT03987074|537797147|FG000|Overall Study|Adverse Event|2|||
149087388|NCT03987074|537797148|FG001|Overall Study|Adverse Event|1|||
149087389|NCT03987074|537797149|FG002|Overall Study|Adverse Event|0|||
149087390|NCT03987074|537797150|FG003|Overall Study|Adverse Event|0|||
149087391|NCT03987074|537797151|FG004|Overall Study|Adverse Event|1|||
149087392|NCT03987074|537797147|FG000|Overall Study|Lost to Follow-up|0|||
149087393|NCT03987074|537797148|FG001|Overall Study|Lost to Follow-up|0|||
149087394|NCT03987074|537797149|FG002|Overall Study|Lost to Follow-up|1|||
149087395|NCT03987074|537797150|FG003|Overall Study|Lost to Follow-up|1|||
149087396|NCT03987074|537797151|FG004|Overall Study|Lost to Follow-up|0|||
149087397|NCT03987074|537797147|FG000|Overall Study|Investigator's Discretion|0|||
149087398|NCT03987074|537797148|FG001|Overall Study|Investigator's Discretion|0|||
149087399|NCT03987074|537797149|FG002|Overall Study|Investigator's Discretion|0|||
149087400|NCT03987074|537797150|FG003|Overall Study|Investigator's Discretion|1|||
149087401|NCT03987074|537797151|FG004|Overall Study|Investigator's Discretion|0|||
149087402|NCT03100370|537797152|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149087403|NCT03100370|537797153|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149087404|NCT03100370|537797154|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149087405|NCT03100370|537797155|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
149087406|NCT03100370|537797156|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149087407|NCT03100370|537797157|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
149087408|NCT00508144|537797158|FG000|Overall Study|Not eligible|6|||
149087409|NCT00508144|537797158|FG000|Overall Study|Death|5|||
149087410|NCT01084772|537797162|FG000|Baseline|Withdrawal by Subject|7|||
149087411|NCT01084772|537797163|FG001|Baseline|Withdrawal by Subject|6|||
149087412|NCT01084772|537797162|FG000|3 Months|Death|1|||
149087413|NCT01084772|537797163|FG001|3 Months|Death|0|||
149087414|NCT01084772|537797162|FG000|3 Months|Study Termination|2|||
149087415|NCT01084772|537797163|FG001|3 Months|Study Termination|2|||
149087416|NCT01084772|537797162|FG000|1 Year|Withdrawal by Subject|0|||
149087417|NCT01084772|537797163|FG001|1 Year|Withdrawal by Subject|1|||
149087418|NCT01084772|537797162|FG000|1 Year|Lost to Follow-up|3|||
149087419|NCT01084772|537797163|FG001|1 Year|Lost to Follow-up|0|||
149087420|NCT01084772|537797162|FG000|1 Year|Study Termination|0|||
149087421|NCT01084772|537797163|FG001|1 Year|Study Termination|7|||
149087422|NCT01084772|537797162|FG000|2 Years|Withdrawal by Subject|1|||
149087423|NCT01084772|537797163|FG001|2 Years|Withdrawal by Subject|0|||
149087424|NCT01084772|537797162|FG000|2 Years|Lost to Follow-up|5|||
149087425|NCT01084772|537797163|FG001|2 Years|Lost to Follow-up|2|||
149087426|NCT01084772|537797162|FG000|2 Years|Study Termination|3|||
149087427|NCT01084772|537797163|FG001|2 Years|Study Termination|2|||
149087428|NCT01867307|537797164|FG000|Overall Study|Protocol Violation|2|||
149087429|NCT01867307|537797165|FG001|Overall Study|Protocol Violation|0|||
149087430|NCT01867307|537797164|FG000|Overall Study|Other Adverse Event|1|||
149087431|NCT01867307|537797165|FG001|Overall Study|Other Adverse Event|3|||
149087432|NCT02009865|537797166|FG000|Overall Study|Adverse Event|0|||
149087433|NCT02009865|537797167|FG001|Overall Study|Adverse Event|2|||
149087434|NCT02009865|537797166|FG000|Overall Study|Protocol Violation|0|||
149087435|NCT02009865|537797167|FG001|Overall Study|Protocol Violation|2|||
149087436|NCT02009865|537797166|FG000|Overall Study|Withdrawal by Subject|1|||
149087437|NCT02009865|537797167|FG001|Overall Study|Withdrawal by Subject|1|||
149087438|NCT00525915|537797168|FG000|Overall Study|Non-Compliance|0|||
149087439|NCT00525915|537797169|FG001|Overall Study|Non-Compliance|1|||
149087440|NCT00525915|537797168|FG000|Overall Study|Disease Progression|5|||
149087441|NCT00525915|537797169|FG001|Overall Study|Disease Progression|6|||
149087442|NCT00525915|537797168|FG000|Overall Study|Withdrawal by Subject|1|||
149087443|NCT00525915|537797169|FG001|Overall Study|Withdrawal by Subject|0|||
149087444|NCT00525915|537797168|FG000|Overall Study|Refused Surgery|1|||
149087445|NCT00525915|537797169|FG001|Overall Study|Refused Surgery|2|||
149087446|NCT00525915|537797168|FG000|Overall Study|Unrelated illness|1|||
149087447|NCT00525915|537797169|FG001|Overall Study|Unrelated illness|0|||
149087448|NCT02135445|537797171|FG000|Overall Study|Lost to Follow-up|1|||
149087449|NCT02135445|537797172|FG001|Overall Study|Lost to Follow-up|0|||
149087450|NCT02135445|537797171|FG000|Overall Study|Withdrawal by Subject|1|||
149087451|NCT02135445|537797172|FG001|Overall Study|Withdrawal by Subject|0|||
149087452|NCT03556891|537797173|FG000|Initial Pivotal Study|Adverse Event|4|||
149087453|NCT03556891|537797173|FG000|Initial Pivotal Study|MRI Need|3|||
149087454|NCT03556891|537797173|FG000|Initial Pivotal Study|Device Failure|1|||
149087455|NCT03556891|537797173|FG000|Initial Pivotal Study|Death|1|||
149087456|NCT03556891|537797173|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
149087457|NCT03556891|537797173|FG000|Initial Pivotal Study|Missing at random|1|||
149087458|NCT03556891|537797173|FG000|Initial Pivotal Study|Missing due to COVID|1|||
149087459|NCT03556891|537797173|FG000|Initial Pivotal Study|Protocol Violation|1|||
149087460|NCT00489489|537798022|FG000|Overall Study|Not treated due to protocol violation|0|||
149087461|NCT00489489|537798023|FG001|Overall Study|Not treated due to protocol violation|1|||
149087462|NCT00489489|537798024|FG002|Overall Study|Not treated due to protocol violation|1|||
149087463|NCT00489489|537798022|FG000|Overall Study|Adverse Event|1|||
149087464|NCT00489489|537798023|FG001|Overall Study|Adverse Event|1|||
149087465|NCT00489489|537798024|FG002|Overall Study|Adverse Event|1|||
149087466|NCT00489489|537798022|FG000|Overall Study|Protocol Violation|1|||
149087467|NCT00489489|537798023|FG001|Overall Study|Protocol Violation|0|||
149087468|NCT00489489|537798024|FG002|Overall Study|Protocol Violation|1|||
149087469|NCT00489489|537798022|FG000|Overall Study|Progressive disease|0|||
149087470|NCT00489489|537798023|FG001|Overall Study|Progressive disease|1|||
149087471|NCT00489489|537798024|FG002|Overall Study|Progressive disease|0|||
149087472|NCT00489489|537798022|FG000|Overall Study|Participant did not wish to continue|1|||
149087473|NCT00489489|537798023|FG001|Overall Study|Participant did not wish to continue|1|||
149087474|NCT00489489|537798024|FG002|Overall Study|Participant did not wish to continue|0|||
149087475|NCT00489489|537798022|FG000|Overall Study|Other than above|0|||
149087476|NCT00489489|537798023|FG001|Overall Study|Other than above|1|||
149087477|NCT00489489|537798024|FG002|Overall Study|Other than above|0|||
149087478|NCT03978130|537798027|FG000|Overall Study|Lost to Follow-up|13|||
149087479|NCT03978130|537798028|FG001|Overall Study|Lost to Follow-up|14|||
149087480|NCT03978130|537798027|FG000|Overall Study|Withdrawal by Subject|12|||
149087481|NCT03978130|537798028|FG001|Overall Study|Withdrawal by Subject|2|||
149087482|NCT03978130|537798027|FG000|Overall Study|Adverse Event|2|||
149087483|NCT03978130|537798028|FG001|Overall Study|Adverse Event|1|||
149087484|NCT02136797|537798033|FG000|Overall Study|Not Treated|8|||
149087485|NCT04523571|537798034|FG000|Received 2 Doses|Withdrawal by Subject|0|||
149087486|NCT04523571|537798035|FG001|Received 2 Doses|Withdrawal by Subject|0|||
149087487|NCT04523571|537798036|FG002|Received 2 Doses|Withdrawal by Subject|0|||
149087488|NCT04523571|537798037|FG003|Received 2 Doses|Withdrawal by Subject|1|||
149087489|NCT04523571|537798038|FG004|Received 2 Doses|Withdrawal by Subject|1|||
149087490|NCT04523571|537798039|FG005|Received 2 Doses|Withdrawal by Subject|0|||
149087491|NCT04523571|537798034|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
149087492|NCT04523571|537798035|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
149087493|NCT04523571|537798036|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
149087494|NCT04523571|537798037|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
149087495|NCT04523571|537798038|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
149087496|NCT04523571|537798039|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
149087497|NCT04523571|537798034|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
149087498|NCT04523571|537798035|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
149087499|NCT04523571|537798036|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
149087500|NCT04523571|537798037|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
149087501|NCT04523571|537798038|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
149087502|NCT04523571|537798039|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
149087503|NCT04523571|537798034|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
149087504|NCT04523571|537798035|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
149087505|NCT04523571|537798036|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
149087506|NCT04523571|537798037|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
149087507|NCT04523571|537798038|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
149087508|NCT04523571|537798039|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
149087509|NCT04198428|537798040|FG000|Overall Study|Withdrawal by Subject|150|||
149087510|NCT04198428|537798041|FG001|Overall Study|Withdrawal by Subject|156|||
149087511|NCT03344458|537798046|FG000|Overall Study|Physician Decision|1|||
149087512|NCT03344458|537798046|FG000|Overall Study|Withdrawal by Subject|16|||
149087513|NCT03344458|537798046|FG000|Overall Study|Other reasons|10|||
149087514|NCT03344458|537798046|FG000|Overall Study|Lost to Follow-up|9|||
149087515|NCT03344458|537798046|FG000|Overall Study|Protocol Violation|3|||
149087516|NCT03696342|537798047|FG000|Overall Study|Lost to Follow-up|1|||
149087517|NCT03696342|537798048|FG001|Overall Study|Lost to Follow-up|0|||
149087518|NCT01838499|537798052|FG000|Overall Study|Protocol Violation|0|||
149087519|NCT01838499|537798053|FG001|Overall Study|Protocol Violation|1|||
149087520|NCT01838499|537798052|FG000|Overall Study|Lost to Follow-up|2|||
149087521|NCT01838499|537798053|FG001|Overall Study|Lost to Follow-up|4|||
149087522|NCT01838499|537798052|FG000|Overall Study|Lack of Efficacy|1|||
149087523|NCT01838499|537798053|FG001|Overall Study|Lack of Efficacy|2|||
149087524|NCT01838499|537798052|FG000|Overall Study|Adverse Event|2|||
149087525|NCT01838499|537798053|FG001|Overall Study|Adverse Event|1|||
149087526|NCT01838499|537798052|FG000|Overall Study|Withdrawal by Subject|19|||
149087527|NCT01838499|537798053|FG001|Overall Study|Withdrawal by Subject|9|||
149087528|NCT03314233|537798055|FG000|Overall Study|No longer eligible at time of delivery|1|||
149087529|NCT01797705|537798056|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
149087530|NCT01797705|537798056|FG000|Overall Study|Withdrawal by Subject|1|||
149087531|NCT01838447|537798057|FG000|Overall Study|Change in surgical plan|1|||
149087532|NCT01838447|537798058|FG001|Overall Study|Change in surgical plan|2|||
149087533|NCT01838447|537798057|FG000|Overall Study|Withdrawal by Subject|1|||
149087534|NCT01838447|537798058|FG001|Overall Study|Withdrawal by Subject|1|||
149087535|NCT01114217|537798060|FG000|Overall Study|Adverse Event|5|||
149087536|NCT01114217|537798061|FG001|Overall Study|Adverse Event|3|||
149087537|NCT01114217|537798060|FG000|Overall Study|Lost to Follow-up|17|||
149087538|NCT01114217|537798061|FG001|Overall Study|Lost to Follow-up|33|||
149087539|NCT01114217|537798060|FG000|Overall Study|Withdrawal by Subject|21|||
149087540|NCT01114217|537798061|FG001|Overall Study|Withdrawal by Subject|28|||
149087541|NCT01114217|537798060|FG000|Overall Study|Other-Clerical Error|3|||
149087542|NCT01114217|537798061|FG001|Overall Study|Other-Clerical Error|0|||
149087543|NCT01114217|537798060|FG000|Overall Study|Other-Early termination|6|||
149087544|NCT01114217|537798061|FG001|Overall Study|Other-Early termination|10|||
149087545|NCT01114217|537798060|FG000|Overall Study|Other-Procedure|1|||
149087546|NCT01114217|537798061|FG001|Overall Study|Other-Procedure|1|||
149087547|NCT01114217|537798060|FG000|Overall Study|Other-Pregnancy|2|||
149087548|NCT01114217|537798061|FG001|Overall Study|Other-Pregnancy|4|||
149087549|NCT01114217|537798060|FG000|Overall Study|Other-Protocol Violation|1|||
149087550|NCT01114217|537798061|FG001|Overall Study|Other-Protocol Violation|3|||
149087551|NCT01114217|537798060|FG000|Overall Study|Other-Lack of Efficacy|1|||
149087552|NCT01114217|537798061|FG001|Overall Study|Other-Lack of Efficacy|0|||
149087553|NCT01114217|537798060|FG000|Overall Study|Other-Non Compliance|2|||
149087554|NCT01114217|537798061|FG001|Overall Study|Other-Non Compliance|0|||
149087555|NCT01114217|537798060|FG000|Overall Study|Other-Physician Decision|1|||
149087556|NCT01114217|537798061|FG001|Overall Study|Other-Physician Decision|1|||
149087557|NCT01114217|537798060|FG000|Overall Study|Other-Sponsor Decision|10|||
149087558|NCT01114217|537798061|FG001|Overall Study|Other-Sponsor Decision|12|||
149087559|NCT01114217|537798060|FG000|Overall Study|Other-Study Termination|0|||
149087560|NCT01114217|537798061|FG001|Overall Study|Other-Study Termination|1|||
149087561|NCT01114217|537798060|FG000|Overall Study|Other-Study Withdrawn|1|||
149087562|NCT01114217|537798061|FG001|Overall Study|Other-Study Withdrawn|1|||
149087563|NCT01114217|537798060|FG000|Overall Study|Other-Site Stopped Communicating|2|||
149087564|NCT01114217|537798061|FG001|Overall Study|Other-Site Stopped Communicating|0|||
149087565|NCT01114217|537798060|FG000|Overall Study|Other-Lost to Follow-up|1|||
149087566|NCT01114217|537798061|FG001|Overall Study|Other-Lost to Follow-up|0|||
149087567|NCT01114217|537798060|FG000|Overall Study|Other-Withdrawal by Subject|1|||
149087568|NCT01114217|537798061|FG001|Overall Study|Other-Withdrawal by Subject|1|||
149087569|NCT06247488|537798062|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
149087570|NCT06247488|537798063|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
149087571|NCT06247488|537798064|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
149087572|NCT06247488|537798065|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
149087573|NCT06247488|537798066|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
149087574|NCT06247488|537798067|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
149087575|NCT06247488|537798062|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
149087576|NCT06247488|537798063|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
149087577|NCT06247488|537798064|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
149087578|NCT06247488|537798065|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
149087579|NCT06247488|537798066|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
149087580|NCT06247488|537798067|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
149087581|NCT06247488|537798062|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
149087582|NCT06247488|537798063|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
149087583|NCT06247488|537798064|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
149087584|NCT06247488|537798065|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
149087585|NCT06247488|537798066|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
149087586|NCT06247488|537798067|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
149087587|NCT06247488|537798062|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
149087588|NCT06247488|537798063|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
149087589|NCT06247488|537798064|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
149087590|NCT06247488|537798065|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
149087591|NCT06247488|537798066|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
149087592|NCT06247488|537798067|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
149087593|NCT06247488|537798062|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
149087594|NCT06247488|537798063|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
149087595|NCT06247488|537798064|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
149087596|NCT06247488|537798065|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
149087597|NCT06247488|537798066|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
149087598|NCT06247488|537798067|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
149087599|NCT06247488|537798062|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
149087600|NCT06247488|537798063|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
149087601|NCT06247488|537798064|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
149087602|NCT06247488|537798065|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
149087603|NCT06247488|537798066|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
149087604|NCT06247488|537798067|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
149087605|NCT06247488|537798062|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
149087606|NCT06247488|537798063|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
149087607|NCT06247488|537798064|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
149087608|NCT06247488|537798065|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
149087609|NCT06247488|537798066|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
149087610|NCT06247488|537798067|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
149087611|NCT03785210|537798070|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
149087612|NCT03785210|537798071|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
149087613|NCT00561678|537798072|FG000|Overall Study|Withdrawal by Subject|4|||
149087614|NCT00561678|537798073|FG001|Overall Study|Withdrawal by Subject|3|||
149087615|NCT00561678|537798072|FG000|Overall Study|surgery cancelled|1|||
149087616|NCT00561678|537798073|FG001|Overall Study|surgery cancelled|1|||
149087617|NCT00561678|537798072|FG000|Overall Study|surgery rescheduled to different site|2|||
149087618|NCT00561678|537798073|FG001|Overall Study|surgery rescheduled to different site|2|||
149087619|NCT00561678|537798072|FG000|Overall Study|anesthesia provider refusal|1|||
149087620|NCT00561678|537798073|FG001|Overall Study|anesthesia provider refusal|0|||
149087621|NCT00848198|537798077|FG000|Overall Study|Incomplete Case Report Forms|15|||
149087622|NCT03708744|537798078|FG000|Overall Study|Withdrawal by Subject|0|||
149087623|NCT03708744|537798079|FG001|Overall Study|Withdrawal by Subject|0|||
149087624|NCT03708744|537798080|FG002|Overall Study|Withdrawal by Subject|1|||
149087625|NCT03708744|537798081|FG003|Overall Study|Withdrawal by Subject|0|||
149087626|NCT02604199|537798082|FG000|Overall Study|Pregnancy|0|||
149087627|NCT02604199|537798083|FG001|Overall Study|Pregnancy|0|||
149087628|NCT02604199|537798084|FG002|Overall Study|Pregnancy|0|||
149087629|NCT02604199|537798085|FG003|Overall Study|Pregnancy|1|||
149087630|NCT02604199|537798082|FG000|Overall Study|Study terminated by sponsor|0|||
149087631|NCT02604199|537798083|FG001|Overall Study|Study terminated by sponsor|2|||
149087632|NCT02604199|537798084|FG002|Overall Study|Study terminated by sponsor|0|||
149087633|NCT02604199|537798085|FG003|Overall Study|Study terminated by sponsor|2|||
149087634|NCT02604199|537798082|FG000|Overall Study|Withdrawal by Subject|0|||
149087635|NCT02604199|537798083|FG001|Overall Study|Withdrawal by Subject|1|||
149087636|NCT02604199|537798084|FG002|Overall Study|Withdrawal by Subject|0|||
149087637|NCT02604199|537798085|FG003|Overall Study|Withdrawal by Subject|0|||
149087638|NCT02213458|537798090|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
149087639|NCT02213458|537798091|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
149087640|NCT02213458|537798090|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
149087641|NCT02213458|537798091|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
149087642|NCT02213458|537798090|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
149087643|NCT02213458|537798091|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
149087644|NCT02213458|537798090|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
149087645|NCT02213458|537798091|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
149087646|NCT02213458|537798090|FG000|Overall Study|Refused re-consent|6|||
149087647|NCT02213458|537798091|FG001|Overall Study|Refused re-consent|0|||
149087648|NCT02213458|537798090|FG000|Overall Study|Lost to Follow-up|2|||
149087649|NCT02213458|537798091|FG001|Overall Study|Lost to Follow-up|2|||
149087650|NCT02213458|537798090|FG000|Overall Study|Withdrawal by Subject|26|||
149087651|NCT02213458|537798091|FG001|Overall Study|Withdrawal by Subject|8|||
149087652|NCT04362176|537798094|FG000|Overall Study|Lost to Follow-up|5|||
149087653|NCT04362176|537798095|FG001|Overall Study|Lost to Follow-up|8|||
149087654|NCT04362176|537798094|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
149087655|NCT04362176|537798095|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
149087656|NCT05740371|537798098|FG000|Overall Study|Death|1|||
149087657|NCT00617708|537798101|FG000|Overall Study|Adverse Event|0|||
149087658|NCT00617708|537798102|FG001|Overall Study|Adverse Event|6|||
149087659|NCT00617708|537798103|FG002|Overall Study|Adverse Event|9|||
149087660|NCT00617708|537798101|FG000|Overall Study|Withdrawal by Subject|1|||
149087661|NCT00617708|537798102|FG001|Overall Study|Withdrawal by Subject|1|||
149087662|NCT00617708|537798103|FG002|Overall Study|Withdrawal by Subject|7|||
149087663|NCT00617708|537798101|FG000|Overall Study|Death|0|||
149087664|NCT00617708|537798102|FG001|Overall Study|Death|6|||
149087665|NCT00617708|537798103|FG002|Overall Study|Death|5|||
149087666|NCT00617708|537798101|FG000|Overall Study|Progression/Relapse|7|||
149087667|NCT00617708|537798102|FG001|Overall Study|Progression/Relapse|40|||
149087668|NCT00617708|537798103|FG002|Overall Study|Progression/Relapse|36|||
149087669|NCT00617708|537798101|FG000|Overall Study|Not protocol specified|1|||
149087670|NCT00617708|537798102|FG001|Overall Study|Not protocol specified|4|||
149087671|NCT00617708|537798103|FG002|Overall Study|Not protocol specified|2|||
149087672|NCT00617708|537798101|FG000|Overall Study|Not eligible|1|||
149087673|NCT00617708|537798102|FG001|Overall Study|Not eligible|3|||
149087674|NCT00617708|537798103|FG002|Overall Study|Not eligible|5|||
149087675|NCT03122548|537798104|FG000|Overall Study|Death|2|||
149087676|NCT03122548|537798104|FG000|Overall Study|Progression - subject went into hospice|1|||
149087677|NCT03122548|537798104|FG000|Overall Study|Study Terminated by Sponsor|2|||
149087678|NCT03820024|537798105|FG000|Overall Study|Physician Decision|1|||
149087679|NCT03820024|537798106|FG001|Overall Study|Physician Decision|2|||
149087680|NCT00676195|537799352|FG000|Overall Study|Lost to Follow-up|1|||
149087681|NCT00676195|537799352|FG000|Overall Study|Adverse Event|1|||
149087682|NCT00676195|537799352|FG000|Overall Study|Physician Decision|1|||
149087683|NCT02388932|537799357|FG000|Overall Study|Death|1|||
149087684|NCT05927753|537799360|FG000|Overall Study|Withdrawal by Subject|0|||
149087685|NCT05927753|537799361|FG001|Overall Study|Withdrawal by Subject|2|||
149087686|NCT05927753|537799360|FG000|Overall Study|Physician Decision|0|||
149087687|NCT05927753|537799361|FG001|Overall Study|Physician Decision|1|||
149087688|NCT02123797|537799363|FG000|Baseline Intervention|Death|9|||
149087689|NCT02123797|537799364|FG001|Baseline Intervention|Death|16|||
149087690|NCT02123797|537799365|FG002|Baseline Intervention|Death|0|||
149087691|NCT02123797|537799366|FG003|Baseline Intervention|Death|0|||
149087692|NCT02123797|537799367|FG004|Baseline Intervention|Death|0|||
149087693|NCT02123797|537799363|FG000|Baseline Intervention|Withdrawal by Subject|2|||
149087694|NCT02123797|537799364|FG001|Baseline Intervention|Withdrawal by Subject|8|||
149087695|NCT02123797|537799365|FG002|Baseline Intervention|Withdrawal by Subject|0|||
149087696|NCT02123797|537799366|FG003|Baseline Intervention|Withdrawal by Subject|0|||
149087697|NCT02123797|537799367|FG004|Baseline Intervention|Withdrawal by Subject|0|||
149087698|NCT02123797|537799363|FG000|Baseline Intervention|Relocation|2|||
149087699|NCT02123797|537799364|FG001|Baseline Intervention|Relocation|0|||
149087700|NCT02123797|537799365|FG002|Baseline Intervention|Relocation|0|||
149087701|NCT02123797|537799366|FG003|Baseline Intervention|Relocation|0|||
149087702|NCT02123797|537799367|FG004|Baseline Intervention|Relocation|0|||
149087703|NCT02123797|537799363|FG000|Baseline Intervention|Out of window for initial survey|6|||
149087704|NCT02123797|537799364|FG001|Baseline Intervention|Out of window for initial survey|13|||
149087705|NCT02123797|537799365|FG002|Baseline Intervention|Out of window for initial survey|0|||
149087706|NCT02123797|537799366|FG003|Baseline Intervention|Out of window for initial survey|0|||
149087707|NCT02123797|537799367|FG004|Baseline Intervention|Out of window for initial survey|0|||
149087708|NCT02123797|537799363|FG000|Baseline Intervention|Lost to Follow-up|0|||
149087709|NCT02123797|537799364|FG001|Baseline Intervention|Lost to Follow-up|5|||
149087710|NCT02123797|537799365|FG002|Baseline Intervention|Lost to Follow-up|0|||
149087711|NCT02123797|537799366|FG003|Baseline Intervention|Lost to Follow-up|0|||
149087712|NCT02123797|537799367|FG004|Baseline Intervention|Lost to Follow-up|0|||
149087713|NCT02123797|537799363|FG000|Baseline Intervention|Other Disease|3|||
149087714|NCT02123797|537799364|FG001|Baseline Intervention|Other Disease|0|||
149087715|NCT02123797|537799365|FG002|Baseline Intervention|Other Disease|0|||
149087716|NCT02123797|537799366|FG003|Baseline Intervention|Other Disease|0|||
149087717|NCT02123797|537799367|FG004|Baseline Intervention|Other Disease|0|||
149087718|NCT02123797|537799363|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
149087719|NCT02123797|537799364|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
149087720|NCT02123797|537799365|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
149087721|NCT02123797|537799366|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
149087722|NCT02123797|537799367|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
149087723|NCT02123797|537799363|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
149087724|NCT02123797|537799364|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
149087725|NCT02123797|537799365|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
149087726|NCT02123797|537799366|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
149087727|NCT02123797|537799367|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
149087728|NCT02123797|537799363|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
149087729|NCT02123797|537799364|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
149087730|NCT02123797|537799365|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
149087731|NCT02123797|537799366|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
149087732|NCT02123797|537799367|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
149087733|NCT02123797|537799363|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
149087734|NCT02123797|537799364|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
149087735|NCT02123797|537799365|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
149087736|NCT02123797|537799366|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
149087737|NCT02123797|537799367|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
149087738|NCT02123797|537799363|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
149087739|NCT02123797|537799364|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
149087740|NCT02123797|537799365|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
149087741|NCT02123797|537799366|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
149087742|NCT02123797|537799367|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
149087743|NCT02123797|537799363|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
149087744|NCT02123797|537799364|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
149087745|NCT02123797|537799365|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
149087746|NCT02123797|537799366|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
149087747|NCT02123797|537799367|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
149087748|NCT02123797|537799363|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
149087749|NCT02123797|537799364|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
149087750|NCT02123797|537799365|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
149087751|NCT02123797|537799366|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
149087752|NCT02123797|537799367|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
149087753|NCT02123797|537799363|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
149087754|NCT02123797|537799364|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
149087755|NCT02123797|537799365|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
149087756|NCT02123797|537799366|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
149087757|NCT02123797|537799367|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
149087758|NCT02123797|537799363|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
149087759|NCT02123797|537799364|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
149087760|NCT02123797|537799365|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
149087761|NCT02123797|537799366|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
149087762|NCT02123797|537799367|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
149087763|NCT05878990|537799370|FG000|Overall Study|Lost to Follow-up|7|||
149087764|NCT05878990|537799370|FG000|Overall Study|Withdrawal by Subject|1|||
149087765|NCT02011568|537799373|FG000|Overall Study|Withdrawal by Subject|8|||
149087766|NCT02011568|537799374|FG001|Overall Study|Withdrawal by Subject|10|||
149087767|NCT02011568|537799373|FG000|Overall Study|Physician Decision|1|||
149087768|NCT02011568|537799374|FG001|Overall Study|Physician Decision|3|||
149087769|NCT00396409|537799375|FG000|Period 1 - 2007|Adverse Event|0|||
149087770|NCT00396409|537799376|FG001|Period 1 - 2007|Adverse Event|1|||
149087771|NCT00396409|537799375|FG000|Period 1 - 2007|Lack of Efficacy|0|||
149087772|NCT00396409|537799376|FG001|Period 1 - 2007|Lack of Efficacy|1|||
149087773|NCT00396409|537799375|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
149087774|NCT00396409|537799376|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
149087775|NCT00396409|537799375|FG000|Period 1 - 2007|Lost to Follow-up|2|||
149087776|NCT00396409|537799376|FG001|Period 1 - 2007|Lost to Follow-up|3|||
149087777|NCT00396409|537799375|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
149087778|NCT00396409|537799376|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
149087779|NCT00396409|537799375|FG000|Period 2 - 2008|Protocol Violation|1|||
149087780|NCT00396409|537799376|FG001|Period 2 - 2008|Protocol Violation|0|||
149087781|NCT00396409|537799375|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
149087782|NCT00396409|537799376|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
149087783|NCT00396409|537799375|FG000|Period 2 - 2008|Lost to Follow-up|3|||
149087784|NCT00396409|537799376|FG001|Period 2 - 2008|Lost to Follow-up|1|||
149087785|NCT00331799|537799377|FG000|Overall Study|Withdrawal by Subject|2|||
149087786|NCT00331799|537799377|FG000|Overall Study|Sedation|1|||
149087787|NCT02889809|537799378|FG000|Overall Study|Withdrawal by Subject|30|||
149087788|NCT02889809|537799379|FG001|Overall Study|Withdrawal by Subject|21|||
149087789|NCT02889809|537799378|FG000|Overall Study|Lost to Follow-up|1|||
149087790|NCT02889809|537799379|FG001|Overall Study|Lost to Follow-up|1|||
149087791|NCT02889809|537799378|FG000|Overall Study|Site Closed|12|||
149087792|NCT02889809|537799379|FG001|Overall Study|Site Closed|11|||
149087793|NCT04203199|537799380|FG000|First Intervention Period|Lost to Follow-up|0|||
149087794|NCT04203199|537799381|FG001|First Intervention Period|Lost to Follow-up|1|||
149087795|NCT04203199|537799380|FG000|Second Intervention Period|Medication change|1|||
149087796|NCT04203199|537799381|FG001|Second Intervention Period|Medication change|0|||
149087797|NCT01136733|537799385|FG000|Phase 1b|Adverse Event|0|||
149087798|NCT01136733|537799386|FG001|Phase 1b|Adverse Event|3|||
149087799|NCT01136733|537799387|FG002|Phase 1b|Adverse Event|1|||
149087800|NCT01136733|537799388|FG003|Phase 1b|Adverse Event|0|||
149087801|NCT01136733|537799389|FG004|Phase 1b|Adverse Event|0|||
149087802|NCT01136733|537799390|FG005|Phase 1b|Adverse Event|0|||
149087803|NCT01136733|537799391|FG006|Phase 1b|Adverse Event|0|||
149087804|NCT01136733|537799385|FG000|Phase 1b|Participant Choice|0|||
149087805|NCT01136733|537799386|FG001|Phase 1b|Participant Choice|0|||
149087806|NCT01136733|537799387|FG002|Phase 1b|Participant Choice|1|||
149087807|NCT01136733|537799388|FG003|Phase 1b|Participant Choice|0|||
149087808|NCT01136733|537799389|FG004|Phase 1b|Participant Choice|0|||
149087809|NCT01136733|537799390|FG005|Phase 1b|Participant Choice|0|||
149087810|NCT01136733|537799391|FG006|Phase 1b|Participant Choice|0|||
149087811|NCT01136733|537799385|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
149087812|NCT01136733|537799386|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
149087813|NCT01136733|537799387|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
149087814|NCT01136733|537799388|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
149087815|NCT01136733|537799389|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
149087816|NCT01136733|537799390|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
149087817|NCT01136733|537799391|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
149087818|NCT01136733|537799385|FG000|Phase 1b|Clinical Progression|1|||
149087819|NCT01136733|537799386|FG001|Phase 1b|Clinical Progression|1|||
149087820|NCT01136733|537799387|FG002|Phase 1b|Clinical Progression|0|||
149087821|NCT01136733|537799388|FG003|Phase 1b|Clinical Progression|0|||
149087822|NCT01136733|537799389|FG004|Phase 1b|Clinical Progression|0|||
149087823|NCT01136733|537799390|FG005|Phase 1b|Clinical Progression|0|||
149087824|NCT01136733|537799391|FG006|Phase 1b|Clinical Progression|0|||
149087825|NCT01136733|537799385|FG000|Phase 2|Disease Progression|0|||
149087826|NCT01136733|537799386|FG001|Phase 2|Disease Progression|0|||
149087827|NCT01136733|537799387|FG002|Phase 2|Disease Progression|0|||
149087828|NCT01136733|537799388|FG003|Phase 2|Disease Progression|0|||
149087829|NCT01136733|537799389|FG004|Phase 2|Disease Progression|30|||
149087830|NCT01136733|537799390|FG005|Phase 2|Disease Progression|32|||
149087831|NCT01136733|537799391|FG006|Phase 2|Disease Progression|38|||
149087832|NCT01136733|537799385|FG000|Phase 2|Adverse Event|0|||
149087833|NCT01136733|537799386|FG001|Phase 2|Adverse Event|0|||
149087834|NCT01136733|537799387|FG002|Phase 2|Adverse Event|0|||
149087835|NCT01136733|537799388|FG003|Phase 2|Adverse Event|0|||
149087836|NCT01136733|537799389|FG004|Phase 2|Adverse Event|11|||
149087837|NCT01136733|537799390|FG005|Phase 2|Adverse Event|13|||
149087838|NCT01136733|537799391|FG006|Phase 2|Adverse Event|5|||
149087839|NCT01136733|537799385|FG000|Phase 2|Participant Choice|0|||
149087840|NCT01136733|537799386|FG001|Phase 2|Participant Choice|0|||
149087841|NCT01136733|537799387|FG002|Phase 2|Participant Choice|0|||
149087842|NCT01136733|537799388|FG003|Phase 2|Participant Choice|0|||
149087843|NCT01136733|537799389|FG004|Phase 2|Participant Choice|3|||
149087844|NCT01136733|537799390|FG005|Phase 2|Participant Choice|0|||
149087845|NCT01136733|537799391|FG006|Phase 2|Participant Choice|1|||
149087846|NCT01136733|537799385|FG000|Phase 2|Administrative-Withdrew Consent|0|||
149087847|NCT01136733|537799386|FG001|Phase 2|Administrative-Withdrew Consent|0|||
149087848|NCT01136733|537799387|FG002|Phase 2|Administrative-Withdrew Consent|0|||
149087849|NCT01136733|537799388|FG003|Phase 2|Administrative-Withdrew Consent|0|||
149087850|NCT01136733|537799389|FG004|Phase 2|Administrative-Withdrew Consent|1|||
149087851|NCT01136733|537799390|FG005|Phase 2|Administrative-Withdrew Consent|0|||
149087852|NCT01136733|537799391|FG006|Phase 2|Administrative-Withdrew Consent|0|||
149087853|NCT01136733|537799385|FG000|Phase 2|Other|0|||
149087854|NCT01136733|537799386|FG001|Phase 2|Other|0|||
149087855|NCT01136733|537799387|FG002|Phase 2|Other|0|||
149087856|NCT01136733|537799388|FG003|Phase 2|Other|0|||
149087857|NCT01136733|537799389|FG004|Phase 2|Other|6|||
149087858|NCT01136733|537799390|FG005|Phase 2|Other|7|||
149087859|NCT01136733|537799391|FG006|Phase 2|Other|6|||
149087860|NCT01745380|537799392|FG000|Overall Study|Lost to Follow-up|1|||
149087861|NCT01745380|537799393|FG001|Overall Study|Lost to Follow-up|0|||
149087862|NCT01745380|537799392|FG000|Overall Study|Lack of Efficacy|0|||
149087863|NCT01745380|537799393|FG001|Overall Study|Lack of Efficacy|1|||
149087864|NCT02368691|537799394|FG000|Overall Study|Death|13|||
149087865|NCT02368691|537799394|FG000|Overall Study|Lack of Efficacy|15|||
149087866|NCT02368691|537799394|FG000|Overall Study|Physician Decision|4|||
149087867|NCT02069366|537799397|FG000|Overall Study|Lost to Follow-up|0|||
149087868|NCT02069366|537799398|FG001|Overall Study|Lost to Follow-up|0|||
149087869|NCT02069366|537799399|FG002|Overall Study|Lost to Follow-up|1|||
149087870|NCT02069366|537799400|FG003|Overall Study|Lost to Follow-up|0|||
149087871|NCT02069366|537799401|FG004|Overall Study|Lost to Follow-up|0|||
149087872|NCT02069366|537799402|FG005|Overall Study|Lost to Follow-up|2|||
149087873|NCT02069366|537799397|FG000|Overall Study|Protocol Violation|0|||
149087874|NCT02069366|537799398|FG001|Overall Study|Protocol Violation|0|||
149087875|NCT02069366|537799399|FG002|Overall Study|Protocol Violation|1|||
149087876|NCT02069366|537799400|FG003|Overall Study|Protocol Violation|0|||
149087877|NCT02069366|537799401|FG004|Overall Study|Protocol Violation|0|||
149087878|NCT02069366|537799402|FG005|Overall Study|Protocol Violation|0|||
149087879|NCT02069366|537799397|FG000|Overall Study|Withdrawal by Subject|1|||
149087880|NCT02069366|537799398|FG001|Overall Study|Withdrawal by Subject|0|||
149087881|NCT02069366|537799399|FG002|Overall Study|Withdrawal by Subject|1|||
149087882|NCT02069366|537799400|FG003|Overall Study|Withdrawal by Subject|2|||
149087883|NCT02069366|537799401|FG004|Overall Study|Withdrawal by Subject|0|||
149087884|NCT02069366|537799402|FG005|Overall Study|Withdrawal by Subject|0|||
149087885|NCT00460434|537799403|FG000|Overall Study|Lost to Follow-up|3|||
149087886|NCT00460434|537799404|FG001|Overall Study|Lost to Follow-up|7|||
149087887|NCT02722278|537799405|FG000|Overall Study|Withdrawal by Subject|5|||
149087888|NCT02722278|537799406|FG001|Overall Study|Withdrawal by Subject|3|||
149087889|NCT02722278|537799405|FG000|Overall Study|Adverse Event|4|||
149087890|NCT02722278|537799406|FG001|Overall Study|Adverse Event|1|||
149087891|NCT02722278|537799405|FG000|Overall Study|Lost to Follow-up|2|||
149087892|NCT02722278|537799406|FG001|Overall Study|Lost to Follow-up|0|||
149087893|NCT02722278|537799405|FG000|Overall Study|Protocol Violation|1|||
149087894|NCT02722278|537799406|FG001|Overall Study|Protocol Violation|0|||
149087895|NCT02722278|537799405|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
149087896|NCT02722278|537799406|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
149087897|NCT02722278|537799405|FG000|Overall Study|Subject declined after tx assignment|0|||
149087898|NCT02722278|537799406|FG001|Overall Study|Subject declined after tx assignment|1|||
149087899|NCT02722278|537799405|FG000|Overall Study|Site closure not study related|0|||
149087900|NCT02722278|537799406|FG001|Overall Study|Site closure not study related|1|||
149087901|NCT00510783|537799409|FG000|Overall Study|Lost to Follow-up|29|||
149087902|NCT00510783|537799410|FG001|Overall Study|Lost to Follow-up|25|||
149087903|NCT00510783|537799409|FG000|Overall Study|Withdrawal by Subject|2|||
149087904|NCT00510783|537799410|FG001|Overall Study|Withdrawal by Subject|3|||
149087905|NCT00510783|537799409|FG000|Overall Study|Protocol Violation|0|||
149087906|NCT00510783|537799410|FG001|Overall Study|Protocol Violation|1|||
149087907|NCT00316121|537799411|FG000|Overall Study|Death|1|||
149087908|NCT00316121|537799412|FG001|Overall Study|Death|0|||
149087909|NCT00316121|537799411|FG000|Overall Study|Lost to Follow-up|14|||
149087910|NCT00316121|537799412|FG001|Overall Study|Lost to Follow-up|8|||
149087911|NCT00316121|537799411|FG000|Overall Study|Withdrawal by Subject|2|||
149087912|NCT00316121|537799412|FG001|Overall Study|Withdrawal by Subject|0|||
149087913|NCT00316121|537799411|FG000|Overall Study|Reason is missing|1|||
149087914|NCT00316121|537799412|FG001|Overall Study|Reason is missing|0|||
149087915|NCT00316121|537799411|FG000|Overall Study|Subject relocated|1|||
149087916|NCT00316121|537799412|FG001|Overall Study|Subject relocated|1|||
149087917|NCT00316121|537799411|FG000|Overall Study|Subject refused to return|1|||
149087918|NCT00316121|537799412|FG001|Overall Study|Subject refused to return|0|||
149087919|NCT00316121|537799411|FG000|Overall Study|Subject no show for visit x 3|1|||
149087920|NCT00316121|537799412|FG001|Overall Study|Subject no show for visit x 3|0|||
149087921|NCT00316121|537799411|FG000|Overall Study|Subject did not have 24 month visit|1|||
149087922|NCT00316121|537799412|FG001|Overall Study|Subject did not have 24 month visit|0|||
149087923|NCT00460577|537799417|FG000|Overall Study|Protocol Violation|2|||
149087924|NCT00460577|537799418|FG001|Overall Study|Protocol Violation|6|||
149087925|NCT04043806|537799419|FG000|Overall Study|Commercial drug is available for participants|13|||
149087926|NCT04043806|537799419|FG000|Overall Study|Physician Decision|2|||
149087927|NCT04043806|537799419|FG000|Overall Study|Other|12|||
149087928|NCT04043806|537799419|FG000|Overall Study|Adverse Event|2|||
149087929|NCT04043806|537799419|FG000|Overall Study|Lost to Follow-up|6|||
149087930|NCT04043806|537799419|FG000|Overall Study|Other non-compliance|2|||
149087931|NCT04043806|537799419|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
149087932|NCT04043806|537799419|FG000|Overall Study|Never Dosed|1|||
149087933|NCT01622088|537799422|FG000|Overall Study|Adverse Event|20|||
149087934|NCT01622088|537799422|FG000|Overall Study|Lost to Follow-up|1|||
149087935|NCT01622088|537799422|FG000|Overall Study|Withdrawal by Subject|20|||
149087936|NCT01622088|537799422|FG000|Overall Study|Investigator Decision|1|||
149087937|NCT01622088|537799422|FG000|Overall Study|Death|53|||
149087938|NCT01622088|537799422|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
149087939|NCT01721109|537799428|FG000|Overall Study|Lack of Efficacy|1|||
149087940|NCT01721109|537799428|FG000|Overall Study|Non- Compliance with Study Drug|3|||
149087941|NCT01721109|537799428|FG000|Overall Study|Withdrew Consent|1|||
149087942|NCT01721109|537799428|FG000|Overall Study|Lost to Follow-up|2|||
149087943|NCT03166215|537799429|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
149087944|NCT03166215|537799430|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
149087945|NCT03166215|537799431|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
149087946|NCT03166215|537799429|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
149087947|NCT03166215|537799430|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
149087948|NCT03166215|537799431|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
149087949|NCT00658632|537799433|FG000|Overall Study|Adverse Event|13|||
149087950|NCT00658632|537799434|FG001|Overall Study|Adverse Event|11|||
149087951|NCT00658632|537799433|FG000|Overall Study|Lost to Follow-up|25|||
149087952|NCT00658632|537799434|FG001|Overall Study|Lost to Follow-up|23|||
149087953|NCT00658632|537799433|FG000|Overall Study|Withdrawal by Subject|10|||
149087954|NCT00658632|537799434|FG001|Overall Study|Withdrawal by Subject|7|||
149087955|NCT00658632|537799433|FG000|Overall Study|Lack of Efficacy|0|||
149087956|NCT00658632|537799434|FG001|Overall Study|Lack of Efficacy|1|||
149087957|NCT00658632|537799433|FG000|Overall Study|Withdrawal of consent|8|||
149087958|NCT00658632|537799434|FG001|Overall Study|Withdrawal of consent|14|||
149087959|NCT00658632|537799433|FG000|Overall Study|Pregnancy|1|||
149087960|NCT00658632|537799434|FG001|Overall Study|Pregnancy|1|||
149087961|NCT00658632|537799433|FG000|Overall Study|Other|7|||
149087962|NCT00658632|537799434|FG001|Overall Study|Other|8|||
149087963|NCT02632045|537799438|FG000|Overall Study|Withdrawal by Subject|1|||
149087964|NCT02632045|537799439|FG001|Overall Study|Withdrawal by Subject|2|||
149087965|NCT05878522|537799440|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087966|NCT05878522|537799441|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087967|NCT05878522|537799442|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087968|NCT05878522|537799443|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087969|NCT05878522|537799444|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087970|NCT05878522|537799445|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087971|NCT05878522|537799446|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087972|NCT05878522|537799447|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087973|NCT05878522|537799448|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
149087974|NCT05878522|537799449|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087975|NCT05878522|537799450|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087976|NCT05878522|537799451|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
149087977|NCT05878522|537799440|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
149087978|NCT05878522|537799441|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087979|NCT05878522|537799442|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087980|NCT05878522|537799443|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087981|NCT05878522|537799444|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087982|NCT05878522|537799445|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087983|NCT05878522|537799446|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087984|NCT05878522|537799447|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087985|NCT05878522|537799448|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087986|NCT05878522|537799449|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
149087987|NCT05878522|537799450|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087988|NCT05878522|537799451|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
149087989|NCT05878522|537799440|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087990|NCT05878522|537799441|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
149087991|NCT05878522|537799442|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087992|NCT05878522|537799443|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
149087993|NCT05878522|537799444|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087994|NCT05878522|537799445|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087995|NCT05878522|537799446|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087996|NCT05878522|537799447|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087997|NCT05878522|537799448|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087998|NCT05878522|537799449|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149087999|NCT05878522|537799450|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149088000|NCT05878522|537799451|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
149088001|NCT05878522|537799440|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088002|NCT05878522|537799441|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088003|NCT05878522|537799442|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088004|NCT05878522|537799443|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088005|NCT05878522|537799444|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
149088006|NCT05878522|537799445|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088007|NCT05878522|537799446|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088008|NCT05878522|537799447|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088009|NCT05878522|537799448|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088010|NCT05878522|537799449|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088011|NCT05878522|537799450|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088012|NCT05878522|537799451|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
149088013|NCT04551053|537799452|FG000|Overall Study|Death|10|||
149088014|NCT04551053|537799453|FG001|Overall Study|Death|9|||
149088015|NCT04551053|537799452|FG000|Overall Study|Lost to Follow-up|0|||
149088016|NCT04551053|537799453|FG001|Overall Study|Lost to Follow-up|2|||
149088017|NCT04551053|537799452|FG000|Overall Study|Study Terminated by Sponsor|57|||
149088018|NCT04551053|537799453|FG001|Overall Study|Study Terminated by Sponsor|65|||
149088019|NCT04551053|537799452|FG000|Overall Study|Withdrawal by Subject|12|||
149088020|NCT04551053|537799453|FG001|Overall Study|Withdrawal by Subject|5|||
149088021|NCT04551053|537799452|FG000|Overall Study|Adverse Event|2|||
149088022|NCT04551053|537799453|FG001|Overall Study|Adverse Event|0|||
149088023|NCT04551053|537799452|FG000|Overall Study|Lack of Efficacy|2|||
149088024|NCT04551053|537799453|FG001|Overall Study|Lack of Efficacy|1|||
149088025|NCT04551053|537799452|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
149088026|NCT04551053|537799453|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
149088027|NCT04551053|537799452|FG000|Overall Study|Splenapendectomi|1|||
149088028|NCT04551053|537799453|FG001|Overall Study|Splenapendectomi|0|||
149088029|NCT04551053|537799452|FG000|Overall Study|Medical Decision|1|||
149088030|NCT04551053|537799453|FG001|Overall Study|Medical Decision|1|||
149088031|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
149088032|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
149088033|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
149088034|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
149088035|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
149088036|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
149088037|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
149088038|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
149088039|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
149088040|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
149088041|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
149088042|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
149088043|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
149088044|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
149088045|NCT02971683|537799454|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
149088046|NCT02971683|537799455|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
149088047|NCT02971683|537799454|FG000|Open-Label|Lost to Follow-up|1|||
149088048|NCT02971683|537799455|FG001|Open-Label|Lost to Follow-up|0|||
149088049|NCT02971683|537799454|FG000|Open-Label|Participants withdrew consent|0|||
149088050|NCT02971683|537799455|FG001|Open-Label|Participants withdrew consent|2|||
149088051|NCT02971683|537799454|FG000|Open-Label|Participant request to discontinue study treatment|1|||
149088052|NCT02971683|537799455|FG001|Open-Label|Participant request to discontinue study treatment|0|||
149088053|NCT02971683|537799454|FG000|Open-Label|Lack of Efficacy|2|||
149088054|NCT02971683|537799455|FG001|Open-Label|Lack of Efficacy|0|||
149088055|NCT02971683|537799454|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
149088056|NCT02971683|537799455|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
149088057|NCT02971683|537799454|FG000|Long-Term Open Label|Participant withdrew consent|1|||
149088058|NCT02971683|537799455|FG001|Long-Term Open Label|Participant withdrew consent|0|||
149088059|NCT02971683|537799454|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
149088060|NCT02971683|537799455|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
149088061|NCT02971683|537799454|FG000|Long-Term Open Label|Adverse Event|1|||
149088062|NCT02971683|537799455|FG001|Long-Term Open Label|Adverse Event|2|||
149088063|NCT02971683|537799454|FG000|Long-Term Open Label|Lack of Efficacy|1|||
149088064|NCT02971683|537799455|FG001|Long-Term Open Label|Lack of Efficacy|1|||
149088065|NCT05615870|537799463|FG000|Overall Study|Lost to Follow-up|10|||
149088066|NCT05615870|537799464|FG001|Overall Study|Lost to Follow-up|13|||
149088067|NCT05615870|537799463|FG000|Overall Study|Physician Decision|2|||
149088068|NCT05615870|537799464|FG001|Overall Study|Physician Decision|0|||
149088069|NCT05615870|537799463|FG000|Overall Study|Withdrawal by Subject|0|||
149088070|NCT05615870|537799464|FG001|Overall Study|Withdrawal by Subject|2|||
149088071|NCT05615870|537799463|FG000|Overall Study|Protocol Violation|0|||
149088072|NCT05615870|537799464|FG001|Overall Study|Protocol Violation|3|||
149088073|NCT05615870|537799463|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
149088074|NCT05615870|537799464|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
149088075|NCT05615870|537799463|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
149088076|NCT05615870|537799464|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
149088077|NCT05615870|537799463|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
149088078|NCT05615870|537799464|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
149088079|NCT02993926|537799470|FG000|Enantone Treatment Phase|Adverse Event|1|||
149088080|NCT02993926|537799471|FG001|Enantone Treatment Phase|Adverse Event|0|||
149088081|NCT02993926|537799472|FG002|Enantone Treatment Phase|Adverse Event|0|||
149088082|NCT02993926|537799470|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
149088083|NCT02993926|537799471|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
149088084|NCT02993926|537799472|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
149088085|NCT02993926|537799470|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
149088086|NCT02993926|537799471|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
149088087|NCT02993926|537799472|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
149088088|NCT02993926|537799470|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
149088089|NCT02993926|537799471|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
149088090|NCT02993926|537799472|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
149088091|NCT01760876|537799473|FG000|Overall Study|Non-cardiac death (head injury)|1|||
149088092|NCT01760876|537799473|FG000|Overall Study|Carcinoma of prostate|1|||
149088093|NCT01760876|537799473|FG000|Overall Study|Impaired renal function|1|||
149088094|NCT01760876|537799473|FG000|Overall Study|Major depression|1|||
149088095|NCT01760876|537799473|FG000|Overall Study|Very poor baseline OCT quality|2|||
149088096|NCT00732498|537799477|FG000|Overall Study|Ineligible|1|||
149088097|NCT00732498|537799477|FG000|Overall Study|Adverse Event|2|||
149088098|NCT00732498|537799477|FG000|Overall Study|Physician Decision|3|||
149088099|NCT03394508|537799481|FG000|Overall Study|Protocol Violation|0|||
149088100|NCT03394508|537799482|FG001|Overall Study|Protocol Violation|3|||
149088101|NCT03394508|537799481|FG000|Overall Study|Lost to Follow-up|1|||
149088102|NCT03394508|537799482|FG001|Overall Study|Lost to Follow-up|0|||
149088103|NCT00267865|537799483|FG000|Induction Treatment|Died before completing.|2|||
149088104|NCT00267865|537799483|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
149088105|NCT04295499|537799487|FG000|Overall Study|moving out of state|1|||
149088106|NCT04295499|537799488|FG001|Overall Study|moving out of state|0|||
149088107|NCT04295499|537799487|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
149088108|NCT04295499|537799488|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
149088109|NCT00308113|537799489|FG000|Overall Study|Protocol closure|0|||
149088110|NCT00308113|537799490|FG001|Overall Study|Protocol closure|0|||
149088111|NCT00308113|537799491|FG002|Overall Study|Protocol closure|0|||
149088112|NCT00308113|537799492|FG003|Overall Study|Protocol closure|1|||
149088113|NCT02819141|537799493|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
149088114|NCT02819141|537799494|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
149088115|NCT04413149|537801289|FG000|Overall Study|Death|10|||
149088116|NCT04413149|537801290|FG001|Overall Study|Death|5|||
149088117|NCT04413149|537801289|FG000|Overall Study|Lung transplantation|1|||
149088118|NCT04413149|537801290|FG001|Overall Study|Lung transplantation|0|||
149088119|NCT02661490|537801293|FG000|Overall Study|Lost to Follow-up|0|||
149088120|NCT02661490|537801294|FG001|Overall Study|Lost to Follow-up|1|||
149088121|NCT02661490|537801295|FG002|Overall Study|Lost to Follow-up|0|||
149088122|NCT02661490|537801296|FG003|Overall Study|Lost to Follow-up|0|||
149088123|NCT02661490|537801297|FG004|Overall Study|Lost to Follow-up|2|||
149088124|NCT02661490|537801293|FG000|Overall Study|Withdrawal by Subject|2|||
149088125|NCT02661490|537801294|FG001|Overall Study|Withdrawal by Subject|0|||
149088126|NCT02661490|537801295|FG002|Overall Study|Withdrawal by Subject|2|||
149088127|NCT02661490|537801296|FG003|Overall Study|Withdrawal by Subject|0|||
149088128|NCT02661490|537801297|FG004|Overall Study|Withdrawal by Subject|0|||
149088129|NCT02661490|537801293|FG000|Overall Study|Death|1|||
149088130|NCT02661490|537801294|FG001|Overall Study|Death|1|||
149088131|NCT02661490|537801295|FG002|Overall Study|Death|0|||
149088132|NCT02661490|537801296|FG003|Overall Study|Death|1|||
149088133|NCT02661490|537801297|FG004|Overall Study|Death|0|||
149088134|NCT02661490|537801293|FG000|Overall Study|Reason not Specified|0|||
149088135|NCT02661490|537801294|FG001|Overall Study|Reason not Specified|0|||
149088136|NCT02661490|537801295|FG002|Overall Study|Reason not Specified|0|||
149088137|NCT02661490|537801296|FG003|Overall Study|Reason not Specified|0|||
149088138|NCT02661490|537801297|FG004|Overall Study|Reason not Specified|1|||
149088139|NCT02878590|537801298|FG000|Overall Study|Withdrawal by Subject|2|||
149088140|NCT03322514|537801299|FG000|Overall Study|Withdrawal by Subject|1|||
149088141|NCT03322514|537801300|FG001|Overall Study|Withdrawal by Subject|1|||
149088142|NCT01184859|537801301|FG000|Period 1: Single Dose|Insufficient urine production|0|||
149088143|NCT01184859|537801302|FG001|Period 1: Single Dose|Insufficient urine production|1|||
149088144|NCT01184859|537801303|FG002|Period 1: Single Dose|Insufficient urine production|0|||
149088145|NCT01184859|537801304|FG003|Period 1: Single Dose|Insufficient urine production|0|||
149088146|NCT01184859|537801305|FG004|Period 1: Single Dose|Insufficient urine production|0|||
149088147|NCT01184859|537801301|FG000|Period 1: Single Dose|Protocol Violation|0|||
149088148|NCT01184859|537801302|FG001|Period 1: Single Dose|Protocol Violation|1|||
149088149|NCT01184859|537801303|FG002|Period 1: Single Dose|Protocol Violation|0|||
149088150|NCT01184859|537801304|FG003|Period 1: Single Dose|Protocol Violation|0|||
149088151|NCT01184859|537801305|FG004|Period 1: Single Dose|Protocol Violation|0|||
149088152|NCT01184859|537801301|FG000|Period 1: Single Dose|Adverse Event|0|||
149088153|NCT01184859|537801302|FG001|Period 1: Single Dose|Adverse Event|0|||
149088154|NCT01184859|537801303|FG002|Period 1: Single Dose|Adverse Event|0|||
149088155|NCT01184859|537801304|FG003|Period 1: Single Dose|Adverse Event|0|||
149088156|NCT01184859|537801305|FG004|Period 1: Single Dose|Adverse Event|1|||
149088157|NCT01184859|537801301|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
149088158|NCT01184859|537801302|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
149088159|NCT01184859|537801303|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
149088160|NCT01184859|537801304|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
149088161|NCT01184859|537801305|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
149088162|NCT01184859|537801301|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
149088163|NCT01184859|537801302|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
149088164|NCT01184859|537801303|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
149088165|NCT01184859|537801304|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
149088166|NCT01184859|537801305|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
149088167|NCT00961298|537801306|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
149088168|NCT00961298|537801306|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
149088169|NCT00961298|537801306|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
149088170|NCT00814632|537801307|FG000|Overall Study|Lack of Efficacy|2|||
149088171|NCT02514577|537801308|FG000|Overall Study|Lost to Follow-up|6|||
149088172|NCT02514577|537801309|FG001|Overall Study|Lost to Follow-up|6|||
149088173|NCT02514577|537801308|FG000|Overall Study|Protocol Violation|1|||
149088174|NCT02514577|537801309|FG001|Overall Study|Protocol Violation|0|||
149088175|NCT02514577|537801308|FG000|Overall Study|Withdrawal by Subject|6|||
149088176|NCT02514577|537801309|FG001|Overall Study|Withdrawal by Subject|6|||
149088177|NCT02514577|537801308|FG000|Overall Study|Adverse Event|1|||
149088178|NCT02514577|537801309|FG001|Overall Study|Adverse Event|1|||
149088179|NCT00409006|537801310|FG000|Overall Study|Death|15|||
149088180|NCT00409006|537801311|FG001|Overall Study|Death|6|||
149088181|NCT00409006|537801310|FG000|Overall Study|Lost to Follow-up|1|||
149088182|NCT00409006|537801311|FG001|Overall Study|Lost to Follow-up|2|||
149088183|NCT00409006|537801310|FG000|Overall Study|Withdrawal by Subject|3|||
149088184|NCT00409006|537801311|FG001|Overall Study|Withdrawal by Subject|2|||
149088185|NCT00409006|537801310|FG000|Overall Study|Physician Decision|1|||
149088186|NCT00409006|537801311|FG001|Overall Study|Physician Decision|2|||
149088187|NCT03050372|537801314|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
149088188|NCT03050372|537801315|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
149088189|NCT03050372|537801314|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
149088190|NCT03050372|537801315|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
149088191|NCT00627523|537801317|FG000|Overall Study|Lack of Efficacy|1|||
149088192|NCT00627523|537801318|FG001|Overall Study|Lack of Efficacy|0|||
149088193|NCT00627523|537801317|FG000|Overall Study|Withdrawal by Subject|0|||
149088194|NCT00627523|537801318|FG001|Overall Study|Withdrawal by Subject|2|||
149088195|NCT00627523|537801317|FG000|Overall Study|Other|1|||
149088196|NCT00627523|537801318|FG001|Overall Study|Other|0|||
149088197|NCT01038128|537801324|FG000|Overall Study|Lack of Efficacy|1|||
149088198|NCT01038128|537801324|FG000|Overall Study|Lost to Follow-up|1|||
149088199|NCT01038128|537801324|FG000|Overall Study|Withdrawal by Subject|2|||
149088200|NCT01234675|537801325|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
149088201|NCT01234675|537801326|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
149088202|NCT01234675|537801325|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
149088203|NCT01234675|537801326|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
149088204|NCT01107353|537801336|FG000|Overall Study|Positive Drug Screen|1|||
149088205|NCT01107353|537801337|FG001|Overall Study|Positive Drug Screen|0|||
149088206|NCT02186015|537801338|FG000|Overall Study|Physician Decision|1|||
149088207|NCT02186015|537801339|FG001|Overall Study|Physician Decision|0|||
149088208|NCT02660034|537801340|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
149088209|NCT02660034|537801341|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
149088210|NCT02660034|537801342|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
149088211|NCT02660034|537801343|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
149088212|NCT02660034|537801344|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
149088213|NCT02660034|537801345|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
149088214|NCT02660034|537801346|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
149088215|NCT02660034|537801347|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
149088216|NCT02660034|537801348|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
149088217|NCT02660034|537801349|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
149088218|NCT02660034|537801350|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
149088219|NCT02660034|537801351|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
149088220|NCT02660034|537801352|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
149088221|NCT02660034|537801353|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
149088222|NCT02660034|537801340|FG000|Overall Study|Progressive Disease (Clinical)|7|||
149088223|NCT02660034|537801341|FG001|Overall Study|Progressive Disease (Clinical)|8|||
149088224|NCT02660034|537801342|FG002|Overall Study|Progressive Disease (Clinical)|3|||
149088225|NCT02660034|537801343|FG003|Overall Study|Progressive Disease (Clinical)|9|||
149088226|NCT02660034|537801344|FG004|Overall Study|Progressive Disease (Clinical)|3|||
149088227|NCT02660034|537801345|FG005|Overall Study|Progressive Disease (Clinical)|0|||
149088228|NCT02660034|537801346|FG006|Overall Study|Progressive Disease (Clinical)|0|||
149088229|NCT02660034|537801347|FG007|Overall Study|Progressive Disease (Clinical)|0|||
149088230|NCT02660034|537801348|FG008|Overall Study|Progressive Disease (Clinical)|0|||
149088231|NCT02660034|537801349|FG009|Overall Study|Progressive Disease (Clinical)|0|||
149088232|NCT02660034|537801350|FG010|Overall Study|Progressive Disease (Clinical)|0|||
149088233|NCT02660034|537801351|FG011|Overall Study|Progressive Disease (Clinical)|0|||
149088234|NCT02660034|537801352|FG012|Overall Study|Progressive Disease (Clinical)|0|||
149088235|NCT02660034|537801353|FG013|Overall Study|Progressive Disease (Clinical)|0|||
149088236|NCT02660034|537801340|FG000|Overall Study|Lost to Follow-up|0|||
149088237|NCT02660034|537801341|FG001|Overall Study|Lost to Follow-up|0|||
149088238|NCT02660034|537801342|FG002|Overall Study|Lost to Follow-up|1|||
149088239|NCT02660034|537801343|FG003|Overall Study|Lost to Follow-up|1|||
149088240|NCT02660034|537801344|FG004|Overall Study|Lost to Follow-up|0|||
149088241|NCT02660034|537801345|FG005|Overall Study|Lost to Follow-up|0|||
149088242|NCT02660034|537801346|FG006|Overall Study|Lost to Follow-up|0|||
149088243|NCT02660034|537801347|FG007|Overall Study|Lost to Follow-up|0|||
149088244|NCT02660034|537801348|FG008|Overall Study|Lost to Follow-up|0|||
149088245|NCT02660034|537801349|FG009|Overall Study|Lost to Follow-up|1|||
149088246|NCT02660034|537801350|FG010|Overall Study|Lost to Follow-up|1|||
149088247|NCT02660034|537801351|FG011|Overall Study|Lost to Follow-up|1|||
149088248|NCT02660034|537801352|FG012|Overall Study|Lost to Follow-up|0|||
149088249|NCT02660034|537801353|FG013|Overall Study|Lost to Follow-up|0|||
149088250|NCT02660034|537801340|FG000|Overall Study|Participant moved into special access scheme|1|||
149088251|NCT02660034|537801341|FG001|Overall Study|Participant moved into special access scheme|2|||
149088252|NCT02660034|537801342|FG002|Overall Study|Participant moved into special access scheme|0|||
149088253|NCT02660034|537801343|FG003|Overall Study|Participant moved into special access scheme|0|||
149088254|NCT02660034|537801344|FG004|Overall Study|Participant moved into special access scheme|0|||
149088255|NCT02660034|537801345|FG005|Overall Study|Participant moved into special access scheme|0|||
149088256|NCT02660034|537801346|FG006|Overall Study|Participant moved into special access scheme|0|||
149088257|NCT02660034|537801347|FG007|Overall Study|Participant moved into special access scheme|0|||
149088258|NCT02660034|537801348|FG008|Overall Study|Participant moved into special access scheme|0|||
149088259|NCT02660034|537801349|FG009|Overall Study|Participant moved into special access scheme|0|||
149088260|NCT02660034|537801350|FG010|Overall Study|Participant moved into special access scheme|0|||
149088261|NCT02660034|537801351|FG011|Overall Study|Participant moved into special access scheme|0|||
149088262|NCT02660034|537801352|FG012|Overall Study|Participant moved into special access scheme|0|||
149088263|NCT02660034|537801353|FG013|Overall Study|Participant moved into special access scheme|0|||
149088264|NCT02660034|537801340|FG000|Overall Study|Adverse Event|1|||
149088265|NCT02660034|537801341|FG001|Overall Study|Adverse Event|0|||
149088266|NCT02660034|537801342|FG002|Overall Study|Adverse Event|0|||
149088267|NCT02660034|537801343|FG003|Overall Study|Adverse Event|0|||
149088268|NCT02660034|537801344|FG004|Overall Study|Adverse Event|0|||
149088269|NCT02660034|537801345|FG005|Overall Study|Adverse Event|0|||
149088270|NCT02660034|537801346|FG006|Overall Study|Adverse Event|0|||
149088271|NCT02660034|537801347|FG007|Overall Study|Adverse Event|0|||
149088272|NCT02660034|537801348|FG008|Overall Study|Adverse Event|0|||
149088273|NCT02660034|537801349|FG009|Overall Study|Adverse Event|0|||
149088274|NCT02660034|537801350|FG010|Overall Study|Adverse Event|0|||
149088275|NCT02660034|537801351|FG011|Overall Study|Adverse Event|0|||
149088276|NCT02660034|537801352|FG012|Overall Study|Adverse Event|0|||
149088277|NCT02660034|537801353|FG013|Overall Study|Adverse Event|0|||
149006491|NCT00532155|537501933|FG000|Overall Study|Promotor ended study|1|||
149006492|NCT00532155|537501934|FG001|Overall Study|Promotor ended study|0|||
149006493|NCT00532155|537501933|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
149006494|NCT00532155|537501934|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
149006495|NCT00532155|537501933|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
149006496|NCT00532155|537501934|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
149006497|NCT00532155|537501933|FG000|Overall Study|Study stopped|1|||
149006498|NCT00532155|537501934|FG001|Overall Study|Study stopped|0|||
149006499|NCT00532155|537501933|FG000|Overall Study|Study terminated by sponsor|1|||
149006500|NCT00532155|537501934|FG001|Overall Study|Study terminated by sponsor|0|||
149006501|NCT00532155|537501933|FG000|Overall Study|Study termination stop further treatment|4|||
149006502|NCT00532155|537501934|FG001|Overall Study|Study termination stop further treatment|0|||
149006503|NCT00532155|537501933|FG000|Overall Study|Did not receive study medication|2|||
149006504|NCT00532155|537501934|FG001|Overall Study|Did not receive study medication|6|||
149006505|NCT02134925|537501935|FG000|Overall Study|Withdrawal by Subject|1|||
149006506|NCT02134925|537501936|FG001|Overall Study|Withdrawal by Subject|0|||
149006507|NCT02134925|537501935|FG000|Overall Study|Cancel|1|||
149006508|NCT02134925|537501936|FG001|Overall Study|Cancel|6|||
149006509|NCT04027348|537501937|FG000|Overall Study|Adverse Event|2|||
149006510|NCT02158884|537501938|FG000|Baseline Assessment|Missed performance assessment|3|||
149088278|NCT02660034|537801340|FG000|Overall Study|Sponsor Decision|0|||
149088279|NCT02660034|537801341|FG001|Overall Study|Sponsor Decision|1|||
149088280|NCT02660034|537801342|FG002|Overall Study|Sponsor Decision|2|||
149088281|NCT02660034|537801343|FG003|Overall Study|Sponsor Decision|2|||
149088282|NCT02660034|537801344|FG004|Overall Study|Sponsor Decision|3|||
149088283|NCT02660034|537801345|FG005|Overall Study|Sponsor Decision|0|||
149088284|NCT02660034|537801346|FG006|Overall Study|Sponsor Decision|0|||
149088285|NCT02660034|537801347|FG007|Overall Study|Sponsor Decision|0|||
149088286|NCT02660034|537801348|FG008|Overall Study|Sponsor Decision|0|||
149088287|NCT02660034|537801349|FG009|Overall Study|Sponsor Decision|0|||
149088288|NCT02660034|537801350|FG010|Overall Study|Sponsor Decision|0|||
149088289|NCT02660034|537801351|FG011|Overall Study|Sponsor Decision|0|||
149088290|NCT02660034|537801352|FG012|Overall Study|Sponsor Decision|0|||
149088291|NCT02660034|537801353|FG013|Overall Study|Sponsor Decision|1|||
149088292|NCT02660034|537801340|FG000|Overall Study|Withdrawal by Subject|0|||
149088293|NCT02660034|537801341|FG001|Overall Study|Withdrawal by Subject|0|||
149088294|NCT02660034|537801342|FG002|Overall Study|Withdrawal by Subject|0|||
149088295|NCT02660034|537801343|FG003|Overall Study|Withdrawal by Subject|0|||
149088296|NCT02660034|537801344|FG004|Overall Study|Withdrawal by Subject|0|||
149088297|NCT02660034|537801345|FG005|Overall Study|Withdrawal by Subject|0|||
149088298|NCT02660034|537801346|FG006|Overall Study|Withdrawal by Subject|1|||
149088299|NCT02660034|537801347|FG007|Overall Study|Withdrawal by Subject|1|||
149088300|NCT02660034|537801348|FG008|Overall Study|Withdrawal by Subject|1|||
149088301|NCT02660034|537801349|FG009|Overall Study|Withdrawal by Subject|0|||
149088302|NCT02660034|537801350|FG010|Overall Study|Withdrawal by Subject|0|||
149088303|NCT02660034|537801351|FG011|Overall Study|Withdrawal by Subject|1|||
149088304|NCT02660034|537801352|FG012|Overall Study|Withdrawal by Subject|2|||
149088305|NCT02660034|537801353|FG013|Overall Study|Withdrawal by Subject|0|||
149088306|NCT02660034|537801340|FG000|Overall Study|Death|0|||
149088307|NCT02660034|537801341|FG001|Overall Study|Death|0|||
149088308|NCT02660034|537801342|FG002|Overall Study|Death|0|||
149088309|NCT02660034|537801343|FG003|Overall Study|Death|0|||
149088310|NCT02660034|537801344|FG004|Overall Study|Death|0|||
149088311|NCT02660034|537801345|FG005|Overall Study|Death|13|||
149088312|NCT02660034|537801346|FG006|Overall Study|Death|14|||
149088313|NCT02660034|537801347|FG007|Overall Study|Death|10|||
149088314|NCT02660034|537801348|FG008|Overall Study|Death|9|||
149088315|NCT02660034|537801349|FG009|Overall Study|Death|21|||
149088316|NCT02660034|537801350|FG010|Overall Study|Death|17|||
149088317|NCT02660034|537801351|FG011|Overall Study|Death|15|||
149088318|NCT02660034|537801352|FG012|Overall Study|Death|18|||
149088319|NCT02660034|537801353|FG013|Overall Study|Death|7|||
149088320|NCT02660034|537801340|FG000|Overall Study|Physician Decision|0|||
149088321|NCT02660034|537801341|FG001|Overall Study|Physician Decision|0|||
149088322|NCT02660034|537801342|FG002|Overall Study|Physician Decision|0|||
149088323|NCT02660034|537801343|FG003|Overall Study|Physician Decision|0|||
149088324|NCT02660034|537801344|FG004|Overall Study|Physician Decision|0|||
149088325|NCT02660034|537801345|FG005|Overall Study|Physician Decision|0|||
149088326|NCT02660034|537801346|FG006|Overall Study|Physician Decision|0|||
149088327|NCT02660034|537801347|FG007|Overall Study|Physician Decision|0|||
149088328|NCT02660034|537801348|FG008|Overall Study|Physician Decision|0|||
149088329|NCT02660034|537801349|FG009|Overall Study|Physician Decision|0|||
149088330|NCT02660034|537801350|FG010|Overall Study|Physician Decision|0|||
149088331|NCT02660034|537801351|FG011|Overall Study|Physician Decision|0|||
149088332|NCT02660034|537801352|FG012|Overall Study|Physician Decision|0|||
149088333|NCT02660034|537801353|FG013|Overall Study|Physician Decision|1|||
149088334|NCT02660034|537801340|FG000|Overall Study|Participants transferred to LTE|0|||
149088335|NCT02660034|537801341|FG001|Overall Study|Participants transferred to LTE|0|||
149088336|NCT02660034|537801342|FG002|Overall Study|Participants transferred to LTE|0|||
149088337|NCT02660034|537801343|FG003|Overall Study|Participants transferred to LTE|0|||
149088338|NCT02660034|537801344|FG004|Overall Study|Participants transferred to LTE|0|||
149088339|NCT02660034|537801345|FG005|Overall Study|Participants transferred to LTE|10|||
149088340|NCT02660034|537801346|FG006|Overall Study|Participants transferred to LTE|8|||
149088341|NCT02660034|537801347|FG007|Overall Study|Participants transferred to LTE|8|||
149088342|NCT02660034|537801348|FG008|Overall Study|Participants transferred to LTE|10|||
149088343|NCT02660034|537801349|FG009|Overall Study|Participants transferred to LTE|1|||
149088344|NCT02660034|537801350|FG010|Overall Study|Participants transferred to LTE|2|||
149088345|NCT02660034|537801351|FG011|Overall Study|Participants transferred to LTE|4|||
149088346|NCT02660034|537801352|FG012|Overall Study|Participants transferred to LTE|1|||
149088347|NCT02660034|537801353|FG013|Overall Study|Participants transferred to LTE|1|||
149088348|NCT01533181|537801356|FG000|Overall Study|Disease progression pre-active treatment|0|||
149088349|NCT01533181|537801357|FG001|Overall Study|Disease progression pre-active treatment|1|||
149088350|NCT01533181|537801356|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
149088351|NCT01533181|537801357|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
149088352|NCT01837719|537801358|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
149088353|NCT01837719|537801358|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
149088354|NCT01703988|537801359|FG000|Overall Study|Investigator Judgment|0|||
149088355|NCT01703988|537801360|FG001|Overall Study|Investigator Judgment|0|||
149088356|NCT01703988|537801361|FG002|Overall Study|Investigator Judgment|0|||
149088357|NCT01703988|537801362|FG003|Overall Study|Investigator Judgment|1|||
149088358|NCT02995733|537801363|FG000|Overall Study|Study site closed|9|||
149088359|NCT02995733|537801364|FG001|Overall Study|Study site closed|10|||
149088360|NCT02995733|537801363|FG000|Overall Study|Death|3|||
149088361|NCT02995733|537801364|FG001|Overall Study|Death|4|||
149088362|NCT02995733|537801363|FG000|Overall Study|Withdrawal by Subject|6|||
149088363|NCT02995733|537801364|FG001|Overall Study|Withdrawal by Subject|2|||
149088364|NCT02995733|537801363|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
149088365|NCT02995733|537801364|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
149088366|NCT02995733|537801363|FG000|Overall Study|Lost to Follow-up|48|||
149088367|NCT02995733|537801364|FG001|Overall Study|Lost to Follow-up|37|||
149088368|NCT02995733|537801363|FG000|Overall Study|Other|0|||
149088369|NCT02995733|537801364|FG001|Overall Study|Other|1|||
149088370|NCT02720198|537801365|FG000|Overall Study|Withdrawal by Subject|0|||
149088371|NCT02720198|537801366|FG001|Overall Study|Withdrawal by Subject|1|||
149088372|NCT04879823|537801367|FG000|Overall Study|Physician Decision|3|||
149088373|NCT04879823|537801368|FG001|Overall Study|Physician Decision|1|||
149088374|NCT04879823|537801367|FG000|Overall Study|Protocol Violation|2|||
149088375|NCT04879823|537801368|FG001|Overall Study|Protocol Violation|3|||
149088376|NCT04879823|537801367|FG000|Overall Study|Lost to Follow-up|43|||
149088377|NCT04879823|537801368|FG001|Overall Study|Lost to Follow-up|35|||
149088378|NCT04468633|537801371|FG000|Overall Study|Withdrawal by Subject|4|||
149088379|NCT04468633|537801372|FG001|Overall Study|Withdrawal by Subject|0|||
149088380|NCT01403805|537801373|FG000|Overall Study|Withdrawal by Subject|0|||
149088381|NCT01403805|537801374|FG001|Overall Study|Withdrawal by Subject|4|||
149088382|NCT01403805|537801373|FG000|Overall Study|Lost to Follow-up|0|||
149088383|NCT01403805|537801374|FG001|Overall Study|Lost to Follow-up|2|||
149088384|NCT01403805|537801373|FG000|Overall Study|Death|0|||
149088385|NCT01403805|537801374|FG001|Overall Study|Death|1|||
149088386|NCT00147745|537801375|FG000|Overall Study|Withdrawal by Subject|1|||
149088387|NCT00147745|537801376|FG001|Overall Study|Withdrawal by Subject|0|||
149088388|NCT00147745|537801377|FG002|Overall Study|Withdrawal by Subject|0|||
149088389|NCT03045302|537801379|FG000|Overall Study|Pre-treatment adverse event|1|||
149088390|NCT00134056|537801380|FG000|Randomization|Not eligible for assigned treatment|22|||
149088391|NCT00134056|537801381|FG001|Randomization|Not eligible for assigned treatment|20|||
149088392|NCT00134056|537801380|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
149088393|NCT00134056|537801381|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
149088394|NCT00134056|537801380|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
149088395|NCT00134056|537801381|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
149088396|NCT00134056|537801380|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
149088397|NCT00134056|537801381|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
149088398|NCT00134056|537801380|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
149088399|NCT00134056|537801381|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
149088400|NCT00742560|537801383|FG000|Overall Study|Adverse Event|0|||
149088401|NCT00742560|537801384|FG001|Overall Study|Adverse Event|0|||
149088402|NCT00742560|537801385|FG002|Overall Study|Adverse Event|1|||
149088403|NCT00742560|537801386|FG003|Overall Study|Adverse Event|1|||
149088404|NCT00742560|537801387|FG004|Overall Study|Adverse Event|1|||
149088405|NCT00742560|537801383|FG000|Overall Study|Death|0|||
149088406|NCT00742560|537801384|FG001|Overall Study|Death|2|||
149088407|NCT00742560|537801385|FG002|Overall Study|Death|0|||
149088408|NCT00742560|537801386|FG003|Overall Study|Death|2|||
149088409|NCT00742560|537801387|FG004|Overall Study|Death|3|||
149088410|NCT00742560|537801383|FG000|Overall Study|Subject's Decision|1|||
149088411|NCT00742560|537801384|FG001|Overall Study|Subject's Decision|0|||
149088412|NCT00742560|537801385|FG002|Overall Study|Subject's Decision|2|||
149088413|NCT00742560|537801386|FG003|Overall Study|Subject's Decision|3|||
149088414|NCT00742560|537801387|FG004|Overall Study|Subject's Decision|3|||
149088415|NCT00742560|537801383|FG000|Overall Study|Investigator's Decision|0|||
149088416|NCT00742560|537801384|FG001|Overall Study|Investigator's Decision|0|||
149088417|NCT00742560|537801385|FG002|Overall Study|Investigator's Decision|4|||
149088418|NCT00742560|537801386|FG003|Overall Study|Investigator's Decision|1|||
149088419|NCT00742560|537801387|FG004|Overall Study|Investigator's Decision|0|||
149088420|NCT00742560|537801383|FG000|Overall Study|Disease Progression|1|||
149088421|NCT00742560|537801384|FG001|Overall Study|Disease Progression|0|||
149088422|NCT00742560|537801385|FG002|Overall Study|Disease Progression|5|||
149088423|NCT00742560|537801386|FG003|Overall Study|Disease Progression|17|||
149088424|NCT00742560|537801387|FG004|Overall Study|Disease Progression|16|||
149088425|NCT00742560|537801383|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
149088426|NCT00742560|537801384|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
149088427|NCT00742560|537801385|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
149088428|NCT00742560|537801386|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
149088429|NCT00742560|537801387|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
149088430|NCT00742560|537801383|FG000|Overall Study|Other|0|||
149088431|NCT00742560|537801384|FG001|Overall Study|Other|1|||
149088432|NCT00742560|537801385|FG002|Overall Study|Other|8|||
149088433|NCT00742560|537801386|FG003|Overall Study|Other|9|||
149088434|NCT00742560|537801387|FG004|Overall Study|Other|9|||
149088435|NCT00742560|537801383|FG000|Overall Study|MIssing|0|||
149088436|NCT00742560|537801384|FG001|Overall Study|MIssing|0|||
149088437|NCT00742560|537801385|FG002|Overall Study|MIssing|0|||
149088438|NCT00742560|537801386|FG003|Overall Study|MIssing|0|||
149088439|NCT00742560|537801387|FG004|Overall Study|MIssing|1|||
149088440|NCT04985604|537801388|FG000|Overall Study|Death|4|||
149088441|NCT04985604|537801389|FG001|Overall Study|Death|6|||
149088442|NCT04985604|537801388|FG000|Overall Study|Withdrawal by Subject|0|||
149088443|NCT04985604|537801389|FG001|Overall Study|Withdrawal by Subject|1|||
149088444|NCT04598776|537801390|FG000|Overall Study|Protocol Violation|5|||
149088445|NCT04598776|537801390|FG000|Overall Study|Physician Decision|4|||
149088446|NCT00348283|537801391|FG000|Induction|Adverse Event|0|||
149088447|NCT00348283|537801392|FG001|Induction|Adverse Event|2|||
149088448|NCT00348283|537801391|FG000|Induction|Protocol Violation|0|||
149088449|NCT00348283|537801392|FG001|Induction|Protocol Violation|4|||
149088450|NCT00348283|537801391|FG000|Double Blind|Adverse Event|2|||
149088451|NCT00348283|537801392|FG001|Double Blind|Adverse Event|5|||
149088452|NCT00348283|537801391|FG000|Double Blind|Withdrawal by Subject|1|||
149088453|NCT00348283|537801392|FG001|Double Blind|Withdrawal by Subject|1|||
149088454|NCT00348283|537801391|FG000|Double Blind|Protocol Violation|0|||
149088455|NCT00348283|537801392|FG001|Double Blind|Protocol Violation|1|||
149088456|NCT00348283|537801391|FG000|Double Blind|Lack of Efficacy|2|||
149088457|NCT00348283|537801392|FG001|Double Blind|Lack of Efficacy|2|||
149088458|NCT00348283|537801391|FG000|Double Blind|Pregnancy|0|||
149088459|NCT00348283|537801392|FG001|Double Blind|Pregnancy|1|||
149088460|NCT00348283|537801391|FG000|Open Label|Adverse Event|0|||
149088461|NCT00348283|537801392|FG001|Open Label|Adverse Event|8|||
149088462|NCT00348283|537801391|FG000|Open Label|Withdrawal by Subject|0|||
149088463|NCT00348283|537801392|FG001|Open Label|Withdrawal by Subject|4|||
149088464|NCT00348283|537801391|FG000|Open Label|Lost to Follow-up|0|||
149088465|NCT00348283|537801392|FG001|Open Label|Lost to Follow-up|1|||
149088466|NCT00348283|537801391|FG000|Open Label|Lack of Efficacy|0|||
149088467|NCT00348283|537801392|FG001|Open Label|Lack of Efficacy|13|||
149088468|NCT00348283|537801391|FG000|Open Label|Administrative reasons|0|||
149088469|NCT00348283|537801392|FG001|Open Label|Administrative reasons|5|||
149088470|NCT00348283|537801391|FG000|Open Label|Subject moved to the United States|0|||
149088471|NCT00348283|537801392|FG001|Open Label|Subject moved to the United States|1|||
149088472|NCT00348283|537801391|FG000|Open Label|Pregnancy|0|||
149088473|NCT00348283|537801392|FG001|Open Label|Pregnancy|1|||
149088474|NCT00348283|537801391|FG000|Open Label|Sponsor decision|0|||
149088475|NCT00348283|537801392|FG001|Open Label|Sponsor decision|1|||
149088476|NCT02282761|537801395|FG000|Overall Study|Death|0|||
149088477|NCT02282761|537801396|FG001|Overall Study|Death|0|||
149088478|NCT02282761|537801397|FG002|Overall Study|Death|1|||
149088479|NCT02282761|537801395|FG000|Overall Study|Adverse Event|6|||
149088480|NCT02282761|537801396|FG001|Overall Study|Adverse Event|2|||
149088481|NCT02282761|537801397|FG002|Overall Study|Adverse Event|0|||
149088482|NCT02282761|537801395|FG000|Overall Study|Lack of Efficacy|11|||
149088483|NCT02282761|537801396|FG001|Overall Study|Lack of Efficacy|6|||
149088484|NCT02282761|537801397|FG002|Overall Study|Lack of Efficacy|17|||
149088485|NCT02282761|537801395|FG000|Overall Study|Lost to Follow-up|2|||
149088486|NCT02282761|537801396|FG001|Overall Study|Lost to Follow-up|2|||
149088487|NCT02282761|537801397|FG002|Overall Study|Lost to Follow-up|1|||
149088488|NCT02282761|537801395|FG000|Overall Study|Physician Decision|0|||
149088489|NCT02282761|537801396|FG001|Overall Study|Physician Decision|0|||
149088490|NCT02282761|537801397|FG002|Overall Study|Physician Decision|2|||
149088491|NCT02282761|537801395|FG000|Overall Study|Withdrawal by Subject|8|||
149088492|NCT02282761|537801396|FG001|Overall Study|Withdrawal by Subject|10|||
149088493|NCT02282761|537801397|FG002|Overall Study|Withdrawal by Subject|16|||
149088494|NCT02282761|537801395|FG000|Overall Study|Other|3|||
149088495|NCT02282761|537801396|FG001|Overall Study|Other|2|||
149088496|NCT02282761|537801397|FG002|Overall Study|Other|1|||
149088497|NCT06312566|537801401|FG000|Overall Study|Protocol Violation|0|||
149088498|NCT06312566|537801402|FG001|Overall Study|Protocol Violation|1|||
149088499|NCT03747575|537801403|FG000|Overall Study|Withdrawal by Subject|6|||
149088500|NCT03747575|537801404|FG001|Overall Study|Withdrawal by Subject|3|||
149088501|NCT03747575|537801403|FG000|Overall Study|Lost to Follow-up|3|||
149088502|NCT03747575|537801404|FG001|Overall Study|Lost to Follow-up|3|||
149088503|NCT03747575|537801403|FG000|Overall Study|Adverse Event|0|||
149088504|NCT03747575|537801404|FG001|Overall Study|Adverse Event|1|||
149088505|NCT02924051|537801407|FG000|Overall Study|Withdrawal by Subject|1|||
149088506|NCT02924051|537801408|FG001|Overall Study|Withdrawal by Subject|9|||
149088507|NCT00914732|537801412|FG000|Overall Study|Lost to Follow-up|6|||
149088508|NCT00914732|537801413|FG001|Overall Study|Lost to Follow-up|7|||
149088509|NCT00914732|537801414|FG002|Overall Study|Lost to Follow-up|9|||
149088510|NCT00914732|537801412|FG000|Overall Study|Withdrawal by Subject|3|||
149088511|NCT00914732|537801413|FG001|Overall Study|Withdrawal by Subject|0|||
149088512|NCT00914732|537801414|FG002|Overall Study|Withdrawal by Subject|2|||
149088513|NCT00914732|537801412|FG000|Overall Study|Adverse Event|1|||
149088514|NCT00914732|537801413|FG001|Overall Study|Adverse Event|0|||
149088515|NCT00914732|537801414|FG002|Overall Study|Adverse Event|0|||
149088516|NCT02130401|537801415|FG000|Overall Study|Poor enrollment|6|||
149088517|NCT00321672|537801418|FG000|Overall Study|Withdrawal by Subject|5|||
149088518|NCT00321672|537801419|FG001|Overall Study|Withdrawal by Subject|1|||
149088519|NCT00321672|537801420|FG002|Overall Study|Withdrawal by Subject|2|||
149088520|NCT00321672|537801421|FG003|Overall Study|Withdrawal by Subject|0|||
149088521|NCT00321672|537801418|FG000|Overall Study|Noncompliance|1|||
149088522|NCT00321672|537801419|FG001|Overall Study|Noncompliance|2|||
149088523|NCT00321672|537801420|FG002|Overall Study|Noncompliance|1|||
149088524|NCT00321672|537801421|FG003|Overall Study|Noncompliance|0|||
149006511|NCT02158884|537501938|FG000|Baseline Assessment|Missed SMFA|1|||
149006512|NCT02158884|537501938|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
149006513|NCT02158884|537501938|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
149006514|NCT02158884|537501938|FG000|6 Month Assessment|Missed SMFA|20|||
149006515|NCT02158884|537501938|FG000|12 Month Assessment|Missed SMFA|17|||
149006516|NCT02487472|537501939|FG000|Overall Study|Did not complete telephonic interviews|9|||
149006517|NCT02487472|537501939|FG000|Overall Study|Other|2|||
149006518|NCT04843930|537501944|FG000|Randomization|Withdrawal by Subject|6|||
149006519|NCT04843930|537501945|FG001|Randomization|Withdrawal by Subject|6|||
149006520|NCT04843930|537501946|FG002|Randomization|Withdrawal by Subject|0|||
149006521|NCT04843930|537501947|FG003|Randomization|Withdrawal by Subject|0|||
149006522|NCT04843930|537501944|FG000|Week 6 Assessment|Adverse Event|3|||
149006523|NCT04843930|537501945|FG001|Week 6 Assessment|Adverse Event|0|||
149006524|NCT04843930|537501946|FG002|Week 6 Assessment|Adverse Event|0|||
149006525|NCT04843930|537501947|FG003|Week 6 Assessment|Adverse Event|0|||
149006526|NCT04843930|537501944|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
149006527|NCT04843930|537501945|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
149006528|NCT04843930|537501946|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
149006529|NCT04843930|537501947|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
149006530|NCT04843930|537501944|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
149006531|NCT04843930|537501945|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
149006532|NCT04843930|537501946|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
149006533|NCT04843930|537501947|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
149006534|NCT02010632|537501950|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
149006535|NCT02010632|537501951|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
149006536|NCT04241094|537501952|FG000|Overall Study|Dropped out of treatment|4|||
149006537|NCT04241094|537501952|FG000|Overall Study|Ineligible after clinical assessment|2|||
149006538|NCT04241094|537501952|FG000|Overall Study|Lost to Follow-up|2|||
149006539|NCT01669798|537501953|FG000|Overall Study|Physician Decision|5|||
149006540|NCT05918978|537501957|FG000|Overall Study|Study Terminated by Sponsor|17|||
149006541|NCT05918978|537501958|FG001|Overall Study|Study Terminated by Sponsor|11|||
149006542|NCT05918978|537501957|FG000|Overall Study|Withdrawal by Subject|1|||
149006543|NCT05918978|537501958|FG001|Overall Study|Withdrawal by Subject|1|||
149006544|NCT05918978|537501957|FG000|Overall Study|Adverse Event|1|||
149006545|NCT05918978|537501958|FG001|Overall Study|Adverse Event|0|||
149006546|NCT05918978|537501957|FG000|Overall Study|Other|0|||
149006547|NCT05918978|537501958|FG001|Overall Study|Other|1|||
149006548|NCT00622180|537501959|FG000|Overall Study|Lost to Follow-up|1|||
149006549|NCT00622180|537501960|FG001|Overall Study|Lost to Follow-up|2|||
149006550|NCT06387472|537501963|FG000|Overall Study|Withdrawal by Subject|1|||
149006551|NCT06387472|537501963|FG000|Overall Study|Lost to Follow-up|2|||
149006552|NCT06387472|537501963|FG000|Overall Study|Physician Decision|1|||
149006553|NCT02332590|537501964|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
149006554|NCT02332590|537501965|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
149006555|NCT02332590|537501964|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
149006556|NCT02332590|537501965|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
149006557|NCT02332590|537501964|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
149006558|NCT02332590|537501965|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
149006559|NCT02332590|537501964|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
149006560|NCT02332590|537501965|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
149006561|NCT02332590|537501964|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
149006562|NCT02332590|537501965|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
149006563|NCT02332590|537501964|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
149006564|NCT02332590|537501965|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
149006565|NCT02332590|537501964|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
149006566|NCT02332590|537501965|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
149006567|NCT02332590|537501964|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
149006568|NCT02332590|537501965|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
149006569|NCT02332590|537501964|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
149006570|NCT02332590|537501965|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
149006571|NCT00279201|537501966|FG000|Initiation|Death|1|||
149006572|NCT00279201|537501967|FG001|Initiation|Death|5|||
149006573|NCT00279201|537501968|FG002|Initiation|Death|0|||
149006574|NCT00279201|537501969|FG003|Initiation|Death|0|||
149006575|NCT00279201|537501970|FG004|Initiation|Death|0|||
149006576|NCT00279201|537501971|FG005|Initiation|Death|0|||
149006577|NCT00279201|537501966|FG000|Initiation|Adverse Event|6|||
149006578|NCT00279201|537501967|FG001|Initiation|Adverse Event|15|||
149006579|NCT00279201|537501968|FG002|Initiation|Adverse Event|0|||
149006580|NCT00279201|537501969|FG003|Initiation|Adverse Event|0|||
149006581|NCT00279201|537501970|FG004|Initiation|Adverse Event|0|||
149006582|NCT00279201|537501971|FG005|Initiation|Adverse Event|0|||
149006583|NCT00279201|537501966|FG000|Initiation|Lost to Follow-up|42|||
149006584|NCT00279201|537501967|FG001|Initiation|Lost to Follow-up|41|||
149006585|NCT00279201|537501968|FG002|Initiation|Lost to Follow-up|0|||
149006586|NCT00279201|537501969|FG003|Initiation|Lost to Follow-up|0|||
149088525|NCT00321672|537801418|FG000|Overall Study|Adverse Event|1|||
149088526|NCT00321672|537801419|FG001|Overall Study|Adverse Event|1|||
149088527|NCT00321672|537801420|FG002|Overall Study|Adverse Event|0|||
149088528|NCT00321672|537801421|FG003|Overall Study|Adverse Event|0|||
149088529|NCT00321672|537801418|FG000|Overall Study|Lack of Efficacy|1|||
149088530|NCT00321672|537801419|FG001|Overall Study|Lack of Efficacy|1|||
149088531|NCT00321672|537801420|FG002|Overall Study|Lack of Efficacy|0|||
149088532|NCT00321672|537801421|FG003|Overall Study|Lack of Efficacy|0|||
149088533|NCT00321672|537801418|FG000|Overall Study|Lost to Follow-up|2|||
149088534|NCT00321672|537801419|FG001|Overall Study|Lost to Follow-up|0|||
149088535|NCT00321672|537801420|FG002|Overall Study|Lost to Follow-up|4|||
149088536|NCT00321672|537801421|FG003|Overall Study|Lost to Follow-up|2|||
149088537|NCT00321672|537801418|FG000|Overall Study|Death|1|||
149088538|NCT00321672|537801419|FG001|Overall Study|Death|0|||
149088539|NCT00321672|537801420|FG002|Overall Study|Death|0|||
149088540|NCT00321672|537801421|FG003|Overall Study|Death|0|||
149088541|NCT00321672|537801418|FG000|Overall Study|Too far to travel for visits|1|||
149088542|NCT00321672|537801419|FG001|Overall Study|Too far to travel for visits|0|||
149088543|NCT00321672|537801420|FG002|Overall Study|Too far to travel for visits|0|||
149088544|NCT00321672|537801421|FG003|Overall Study|Too far to travel for visits|0|||
149088545|NCT00321672|537801418|FG000|Overall Study|Incarcerated|0|||
149088546|NCT00321672|537801419|FG001|Overall Study|Incarcerated|0|||
149088547|NCT00321672|537801420|FG002|Overall Study|Incarcerated|2|||
149088548|NCT00321672|537801421|FG003|Overall Study|Incarcerated|0|||
149088549|NCT00321672|537801418|FG000|Overall Study|Moved out of state|0|||
149088550|NCT00321672|537801419|FG001|Overall Study|Moved out of state|1|||
149088551|NCT00321672|537801420|FG002|Overall Study|Moved out of state|1|||
149088552|NCT00321672|537801421|FG003|Overall Study|Moved out of state|0|||
149088553|NCT00321672|537801418|FG000|Overall Study|Protocol Violation|0|||
149088554|NCT00321672|537801419|FG001|Overall Study|Protocol Violation|0|||
149088555|NCT00321672|537801420|FG002|Overall Study|Protocol Violation|1|||
149088556|NCT00321672|537801421|FG003|Overall Study|Protocol Violation|0|||
149088557|NCT00321672|537801418|FG000|Overall Study|Diagnosis of testicular cancer|0|||
149088558|NCT00321672|537801419|FG001|Overall Study|Diagnosis of testicular cancer|1|||
149088559|NCT00321672|537801420|FG002|Overall Study|Diagnosis of testicular cancer|0|||
149088560|NCT00321672|537801421|FG003|Overall Study|Diagnosis of testicular cancer|0|||
149088561|NCT00321672|537801418|FG000|Overall Study|Extensive travel required for new job|0|||
149088562|NCT00321672|537801419|FG001|Overall Study|Extensive travel required for new job|1|||
149088563|NCT00321672|537801420|FG002|Overall Study|Extensive travel required for new job|0|||
149088564|NCT00321672|537801421|FG003|Overall Study|Extensive travel required for new job|0|||
149088565|NCT00512902|537801422|FG000|Overall Study|Adverse Event|7|||
149088566|NCT00512902|537801422|FG000|Overall Study|Lost to Follow-up|1|||
149088567|NCT01549951|537801423|FG000|Overall Study|Adverse Event|15|||
149088568|NCT01549951|537801423|FG000|Overall Study|Withdrawal by Subject|2|||
149088569|NCT01549951|537801423|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
149088570|NCT01549951|537801423|FG000|Overall Study|Progressive disease|29|||
149088571|NCT01549951|537801423|FG000|Overall Study|Symptomatic deterioration|1|||
149088572|NCT01549951|537801423|FG000|Overall Study|Other|2|||
149088573|NCT00738400|537801424|FG000|Overall Study|Adverse Event|3|||
149088574|NCT00738400|537801425|FG001|Overall Study|Adverse Event|1|||
149088575|NCT00738400|537801424|FG000|Overall Study|Withdrawal by Subject|0|||
149088576|NCT00738400|537801425|FG001|Overall Study|Withdrawal by Subject|1|||
149088577|NCT00738400|537801424|FG000|Overall Study|Lack of Efficacy|0|||
149088578|NCT00738400|537801425|FG001|Overall Study|Lack of Efficacy|1|||
149088579|NCT00738400|537801424|FG000|Overall Study|Lost to Follow-up|0|||
149088580|NCT00738400|537801425|FG001|Overall Study|Lost to Follow-up|3|||
149088581|NCT00738400|537801424|FG000|Overall Study|Protocol Violation|1|||
149088582|NCT00738400|537801425|FG001|Overall Study|Protocol Violation|0|||
149088583|NCT00738400|537801424|FG000|Overall Study|Non-compliant with study medication|0|||
149088584|NCT00738400|537801425|FG001|Overall Study|Non-compliant with study medication|1|||
149088585|NCT01052714|537801430|FG000|Overall Study|Adverse Event|6|||
149088586|NCT01052714|537801431|FG001|Overall Study|Adverse Event|3|||
149088587|NCT01052714|537801432|FG002|Overall Study|Adverse Event|0|||
149088588|NCT01052714|537801430|FG000|Overall Study|Death|1|||
149088589|NCT01052714|537801431|FG001|Overall Study|Death|2|||
149088590|NCT01052714|537801432|FG002|Overall Study|Death|0|||
149088591|NCT01052714|537801430|FG000|Overall Study|Lost to Follow-up|2|||
149088592|NCT01052714|537801431|FG001|Overall Study|Lost to Follow-up|3|||
149088593|NCT01052714|537801432|FG002|Overall Study|Lost to Follow-up|0|||
149088594|NCT01052714|537801430|FG000|Overall Study|Physician Decision|9|||
149088595|NCT01052714|537801431|FG001|Overall Study|Physician Decision|9|||
149088596|NCT01052714|537801432|FG002|Overall Study|Physician Decision|1|||
149088597|NCT01052714|537801430|FG000|Overall Study|Withdrawal by Subject|7|||
149088598|NCT01052714|537801431|FG001|Overall Study|Withdrawal by Subject|12|||
149088599|NCT01052714|537801432|FG002|Overall Study|Withdrawal by Subject|1|||
149088600|NCT00990314|537801433|FG000|Overall Study|Death|2|||
149088601|NCT00990314|537801433|FG000|Overall Study|Adverse Event|2|||
149088602|NCT00990314|537801433|FG000|Overall Study|Withdrawal by Subject|3|||
149088603|NCT00990314|537801433|FG000|Overall Study|Non-Compliance|1|||
149088604|NCT00990314|537801433|FG000|Overall Study|Physician Decision|3|||
149088605|NCT00990314|537801433|FG000|Overall Study|Lack of Efficacy|1|||
149088606|NCT03689452|537801441|FG000|Overall Study|Lost to Follow-up|1|||
149088607|NCT03689452|537801442|FG001|Overall Study|Lost to Follow-up|1|||
149088608|NCT02676778|537801443|FG000|Overall Study|Disease Progression|7|||
149088609|NCT02676778|537801444|FG001|Overall Study|Disease Progression|3|||
149088610|NCT02676778|537801445|FG002|Overall Study|Disease Progression|1|||
149088611|NCT02676778|537801443|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
149088612|NCT02676778|537801444|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
149088613|NCT02676778|537801445|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
149088614|NCT02676778|537801443|FG000|Overall Study|Withdrawal by Subject|3|||
149088615|NCT02676778|537801444|FG001|Overall Study|Withdrawal by Subject|2|||
149088616|NCT02676778|537801445|FG002|Overall Study|Withdrawal by Subject|0|||
149088617|NCT02676778|537801443|FG000|Overall Study|Other|4|||
149088618|NCT02676778|537801444|FG001|Overall Study|Other|3|||
149088619|NCT02676778|537801445|FG002|Overall Study|Other|0|||
149088620|NCT02676778|537801443|FG000|Overall Study|Adverse Event|2|||
149088621|NCT02676778|537801444|FG001|Overall Study|Adverse Event|3|||
149088622|NCT02676778|537801445|FG002|Overall Study|Adverse Event|0|||
149088623|NCT03214198|537801452|FG000|Overall Study|Case Report Forms Uncollected|18|||
149088624|NCT03214198|537801452|FG000|Overall Study|Protocol Deviation|18|||
149088625|NCT03686176|537801453|FG000|Overall Study|Procedure cancelled|1|||
149088626|NCT03686176|537801454|FG001|Overall Study|Procedure cancelled|0|||
149088627|NCT03686176|537801455|FG002|Overall Study|Procedure cancelled|0|||
149088628|NCT03686176|537801453|FG000|Overall Study|VR Malfunction|1|||
149088629|NCT03686176|537801454|FG001|Overall Study|VR Malfunction|0|||
149088630|NCT03686176|537801455|FG002|Overall Study|VR Malfunction|0|||
149088631|NCT04448561|537801462|FG000|Overall Study|Noncompliance|1|||
149088632|NCT04448561|537801463|FG001|Overall Study|Noncompliance|0|||
149088633|NCT03602053|537803260|FG000|Overall Study|Withdrawal by Subject|7|||
149088634|NCT03602053|537803261|FG001|Overall Study|Withdrawal by Subject|9|||
149088635|NCT03602053|537803262|FG002|Overall Study|Withdrawal by Subject|7|||
149088636|NCT03602053|537803260|FG000|Overall Study|Lost to Follow-up|5|||
149088637|NCT03602053|537803261|FG001|Overall Study|Lost to Follow-up|6|||
149088638|NCT03602053|537803262|FG002|Overall Study|Lost to Follow-up|0|||
149088639|NCT03602053|537803260|FG000|Overall Study|Protocol Violation|3|||
149088640|NCT03602053|537803261|FG001|Overall Study|Protocol Violation|0|||
149088641|NCT03602053|537803262|FG002|Overall Study|Protocol Violation|4|||
149088642|NCT03602053|537803260|FG000|Overall Study|Physician Decision|1|||
149088643|NCT03602053|537803261|FG001|Overall Study|Physician Decision|0|||
149088644|NCT03602053|537803262|FG002|Overall Study|Physician Decision|0|||
149088645|NCT03602053|537803260|FG000|Overall Study|migration|2|||
149088646|NCT03602053|537803261|FG001|Overall Study|migration|3|||
149088647|NCT03602053|537803262|FG002|Overall Study|migration|0|||
149088648|NCT03602053|537803260|FG000|Overall Study|Other|1|||
149088649|NCT03602053|537803261|FG001|Overall Study|Other|0|||
149088650|NCT03602053|537803262|FG002|Overall Study|Other|0|||
149088651|NCT03672188|537803273|FG000|Overall Study|Withdrawal by Subject|0|||
149088652|NCT03672188|537803274|FG001|Overall Study|Withdrawal by Subject|0|||
149088653|NCT03672188|537803275|FG002|Overall Study|Withdrawal by Subject|0|||
149088654|NCT03672188|537803276|FG003|Overall Study|Withdrawal by Subject|3|||
149088655|NCT03672188|537803277|FG004|Overall Study|Withdrawal by Subject|0|||
149088656|NCT03672188|537803278|FG005|Overall Study|Withdrawal by Subject|0|||
149088657|NCT03672188|537803279|FG006|Overall Study|Withdrawal by Subject|0|||
149088658|NCT03672188|537803280|FG007|Overall Study|Withdrawal by Subject|0|||
149088659|NCT03672188|537803281|FG008|Overall Study|Withdrawal by Subject|0|||
149088660|NCT03672188|537803282|FG009|Overall Study|Withdrawal by Subject|0|||
149088661|NCT03672188|537803283|FG010|Overall Study|Withdrawal by Subject|0|||
149088662|NCT03672188|537803284|FG011|Overall Study|Withdrawal by Subject|0|||
149088663|NCT03672188|537803285|FG012|Overall Study|Withdrawal by Subject|0|||
149088664|NCT03672188|537803286|FG013|Overall Study|Withdrawal by Subject|0|||
149088665|NCT03672188|537803287|FG014|Overall Study|Withdrawal by Subject|0|||
149088666|NCT03672188|537803273|FG000|Overall Study|Death|0|||
149088667|NCT03672188|537803274|FG001|Overall Study|Death|0|||
149088668|NCT03672188|537803275|FG002|Overall Study|Death|0|||
149088669|NCT03672188|537803276|FG003|Overall Study|Death|0|||
149088670|NCT03672188|537803277|FG004|Overall Study|Death|0|||
149088671|NCT03672188|537803278|FG005|Overall Study|Death|0|||
149088672|NCT03672188|537803279|FG006|Overall Study|Death|0|||
149088673|NCT03672188|537803280|FG007|Overall Study|Death|0|||
149088674|NCT03672188|537803281|FG008|Overall Study|Death|0|||
149088675|NCT03672188|537803282|FG009|Overall Study|Death|0|||
149088676|NCT03672188|537803283|FG010|Overall Study|Death|0|||
149088677|NCT03672188|537803284|FG011|Overall Study|Death|0|||
149088678|NCT03672188|537803285|FG012|Overall Study|Death|1|||
149088679|NCT03672188|537803286|FG013|Overall Study|Death|0|||
149088680|NCT03672188|537803287|FG014|Overall Study|Death|0|||
149088681|NCT03672188|537803273|FG000|Overall Study|Lost to Follow-up|0|||
149088682|NCT03672188|537803274|FG001|Overall Study|Lost to Follow-up|0|||
149088683|NCT03672188|537803275|FG002|Overall Study|Lost to Follow-up|1|||
149088684|NCT03672188|537803276|FG003|Overall Study|Lost to Follow-up|0|||
149088685|NCT03672188|537803277|FG004|Overall Study|Lost to Follow-up|0|||
149088686|NCT03672188|537803278|FG005|Overall Study|Lost to Follow-up|0|||
149088687|NCT03672188|537803279|FG006|Overall Study|Lost to Follow-up|0|||
149088688|NCT03672188|537803280|FG007|Overall Study|Lost to Follow-up|0|||
149088689|NCT03672188|537803281|FG008|Overall Study|Lost to Follow-up|0|||
149088690|NCT03672188|537803282|FG009|Overall Study|Lost to Follow-up|0|||
149088691|NCT03672188|537803283|FG010|Overall Study|Lost to Follow-up|0|||
149088692|NCT03672188|537803284|FG011|Overall Study|Lost to Follow-up|0|||
149088693|NCT03672188|537803285|FG012|Overall Study|Lost to Follow-up|0|||
149088694|NCT03672188|537803286|FG013|Overall Study|Lost to Follow-up|0|||
149088695|NCT03672188|537803287|FG014|Overall Study|Lost to Follow-up|0|||
149088696|NCT03997409|537803288|FG000|Overall Study|Protocol Violation|1|||
149088697|NCT03997409|537803289|FG001|Overall Study|Protocol Violation|1|||
149088698|NCT03997409|537803290|FG002|Overall Study|Protocol Violation|0|||
149088699|NCT03997409|537803288|FG000|Overall Study|Withdrawal by Subject|3|||
149088700|NCT03997409|537803289|FG001|Overall Study|Withdrawal by Subject|0|||
149088701|NCT03997409|537803290|FG002|Overall Study|Withdrawal by Subject|0|||
149088702|NCT03997409|537803288|FG000|Overall Study|Lost to Follow-up|0|||
149088703|NCT03997409|537803289|FG001|Overall Study|Lost to Follow-up|0|||
149088704|NCT03997409|537803290|FG002|Overall Study|Lost to Follow-up|1|||
149088705|NCT01753323|537803291|FG000|Overall Study|Lack of Efficacy|0|||
149088706|NCT01753323|537803292|FG001|Overall Study|Lack of Efficacy|0|||
149088707|NCT01753323|537803293|FG002|Overall Study|Lack of Efficacy|8|||
149088708|NCT01753323|537803291|FG000|Overall Study|Protocol deviation|1|||
149088709|NCT01753323|537803292|FG001|Overall Study|Protocol deviation|0|||
149088710|NCT01753323|537803293|FG002|Overall Study|Protocol deviation|0|||
149088711|NCT01753323|537803291|FG000|Overall Study|Adverse Event|0|||
149088712|NCT01753323|537803292|FG001|Overall Study|Adverse Event|0|||
149088713|NCT01753323|537803293|FG002|Overall Study|Adverse Event|1|||
149088714|NCT01870999|537803295|FG000|Overall Study|Adverse Event|0|||
149088715|NCT01870999|537803296|FG001|Overall Study|Adverse Event|4|||
149088716|NCT01870999|537803297|FG002|Overall Study|Adverse Event|1|||
149088717|NCT01870999|537803295|FG000|Overall Study|Subject met withdrawal criteria|3|||
149088718|NCT01870999|537803296|FG001|Overall Study|Subject met withdrawal criteria|2|||
149088719|NCT01870999|537803297|FG002|Overall Study|Subject met withdrawal criteria|0|||
149088720|NCT01870999|537803295|FG000|Overall Study|Subject withdrawn by Investigator|1|||
149088721|NCT01870999|537803296|FG001|Overall Study|Subject withdrawn by Investigator|0|||
149088722|NCT01870999|537803297|FG002|Overall Study|Subject withdrawn by Investigator|0|||
149088723|NCT01870999|537803295|FG000|Overall Study|Withdrawal by Subject|0|||
149088724|NCT01870999|537803296|FG001|Overall Study|Withdrawal by Subject|2|||
149088725|NCT01870999|537803297|FG002|Overall Study|Withdrawal by Subject|5|||
149088726|NCT01870999|537803295|FG000|Overall Study|Protocol Violation|0|||
149088727|NCT01870999|537803296|FG001|Overall Study|Protocol Violation|0|||
149088728|NCT01870999|537803297|FG002|Overall Study|Protocol Violation|1|||
149088729|NCT01636258|537803298|FG000|Overall Study|Lost to Follow-up|1|||
149088730|NCT01636258|537803299|FG001|Overall Study|Lost to Follow-up|0|||
149088731|NCT00116584|537803310|FG000|Overall Study|Withdrawal by Subject|1|||
149088732|NCT00116584|537803311|FG001|Overall Study|Withdrawal by Subject|0|||
149088733|NCT00116584|537803310|FG000|Overall Study|Protocol Violation|1|||
149088734|NCT00116584|537803311|FG001|Overall Study|Protocol Violation|1|||
149088735|NCT03034772|537803312|FG000|Overall Study|Adverse Event|0|||
149088736|NCT03034772|537803313|FG001|Overall Study|Adverse Event|1|||
149088737|NCT03034772|537803312|FG000|Overall Study|Withdrawal by Subject|0|||
149088738|NCT03034772|537803313|FG001|Overall Study|Withdrawal by Subject|1|||
149088739|NCT02798861|537803316|FG000|Overall Study|Lost to Follow-up|22|||
149088740|NCT02798861|537803316|FG000|Overall Study|Withdrawal by Subject|1|||
149088741|NCT00907517|537803317|FG000|Overall Study|Progressive Disease|3|||
149088742|NCT00907517|537803318|FG001|Overall Study|Progressive Disease|3|||
149088743|NCT00907517|537803319|FG002|Overall Study|Progressive Disease|4|||
149088744|NCT00907517|537803320|FG003|Overall Study|Progressive Disease|4|||
149088745|NCT00907517|537803321|FG004|Overall Study|Progressive Disease|4|||
149088746|NCT00907517|537803317|FG000|Overall Study|Symptomatic Deterioration|0|||
149088747|NCT00907517|537803318|FG001|Overall Study|Symptomatic Deterioration|0|||
149088748|NCT00907517|537803319|FG002|Overall Study|Symptomatic Deterioration|0|||
149088749|NCT00907517|537803320|FG003|Overall Study|Symptomatic Deterioration|0|||
149088750|NCT00907517|537803321|FG004|Overall Study|Symptomatic Deterioration|1|||
149088751|NCT01498445|537803331|FG000|Overall Study|Lack of Efficacy|0|||
149088752|NCT01498445|537803332|FG001|Overall Study|Lack of Efficacy|0|||
149088753|NCT01498445|537803333|FG002|Overall Study|Lack of Efficacy|1|||
149088754|NCT01498445|537803334|FG003|Overall Study|Lack of Efficacy|2|||
149088755|NCT01498445|537803335|FG004|Overall Study|Lack of Efficacy|0|||
149088756|NCT01498445|537803336|FG005|Overall Study|Lack of Efficacy|0|||
149088757|NCT01498445|537803331|FG000|Overall Study|Screen Failure|0|||
149088758|NCT01498445|537803332|FG001|Overall Study|Screen Failure|0|||
149088759|NCT01498445|537803333|FG002|Overall Study|Screen Failure|0|||
149088760|NCT01498445|537803334|FG003|Overall Study|Screen Failure|0|||
149088761|NCT01498445|537803335|FG004|Overall Study|Screen Failure|1|||
149088762|NCT01498445|537803336|FG005|Overall Study|Screen Failure|1|||
149088763|NCT02465866|537803337|FG000|Period 3|Withdrawal by Subject|0|||
149088764|NCT02465866|537803338|FG001|Period 3|Withdrawal by Subject|1|||
149088765|NCT02465866|537803339|FG002|Period 3|Withdrawal by Subject|0|||
149088766|NCT02465866|537803340|FG003|Period 3|Withdrawal by Subject|0|||
149088767|NCT02023099|537803341|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
149088768|NCT02023099|537803342|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
149088769|NCT02023099|537803343|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
149088770|NCT02023099|537803341|FG000|Overall Study|Withdrawn Consent|3|||
149088771|NCT02023099|537803342|FG001|Overall Study|Withdrawn Consent|0|||
149088772|NCT02023099|537803343|FG002|Overall Study|Withdrawn Consent|1|||
149088773|NCT02023099|537803341|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
149088774|NCT02023099|537803342|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
149088775|NCT02023099|537803343|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
149088776|NCT00203502|537803344|FG000|Overall Study|Death|1|||
149088777|NCT02592434|537803345|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
149088778|NCT02592434|537803346|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
149088779|NCT02592434|537803347|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
149088780|NCT02592434|537803345|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
149088781|NCT02592434|537803346|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
149088782|NCT02592434|537803347|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
149088783|NCT02592434|537803345|FG000|Open-Label Phase (18 Weeks)|Other|3|||
149088784|NCT02592434|537803346|FG001|Open-Label Phase (18 Weeks)|Other|0|||
149088785|NCT02592434|537803347|FG002|Open-Label Phase (18 Weeks)|Other|0|||
149088786|NCT02592434|537803345|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
149088787|NCT02592434|537803346|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
149088788|NCT02592434|537803347|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
149088789|NCT02592434|537803345|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
149088790|NCT02592434|537803346|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
149088791|NCT02592434|537803347|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
149088792|NCT02592434|537803345|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
149088793|NCT02592434|537803346|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
149088794|NCT02592434|537803347|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
149088795|NCT02592434|537803345|FG000|Double Blind Phase (26 Weeks)|Other|0|||
149088796|NCT02592434|537803346|FG001|Double Blind Phase (26 Weeks)|Other|1|||
149088797|NCT02592434|537803347|FG002|Double Blind Phase (26 Weeks)|Other|0|||
149088798|NCT02592434|537803345|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
149088799|NCT02592434|537803346|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
149088800|NCT02592434|537803347|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
149088801|NCT02592434|537803345|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
149088802|NCT02592434|537803346|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
149088803|NCT02592434|537803347|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
149088804|NCT02592434|537803345|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
149088805|NCT02592434|537803346|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
149088806|NCT02592434|537803347|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
149088807|NCT01469819|537803348|FG000|Overall Study|Withdrawal by Subject|1|||
149088808|NCT01469819|537803348|FG000|Overall Study|Did not meet inclusionary criteria|2|||
149088809|NCT01469819|537803348|FG000|Overall Study|Could not swallow SmartPill|2|||
149088810|NCT01469819|537803348|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
149088811|NCT01695993|537803351|FG000|Overall Study|Lost to Follow-up|2|||
149088812|NCT01695993|537803352|FG001|Overall Study|Lost to Follow-up|1|||
149088813|NCT01695993|537803353|FG002|Overall Study|Lost to Follow-up|3|||
149088814|NCT01695993|537803351|FG000|Overall Study|Withdrawal by Subject|2|||
149088815|NCT01695993|537803352|FG001|Overall Study|Withdrawal by Subject|2|||
149088816|NCT01695993|537803353|FG002|Overall Study|Withdrawal by Subject|2|||
149088817|NCT01695993|537803351|FG000|Overall Study|To ill to continue|1|||
149088818|NCT01695993|537803352|FG001|Overall Study|To ill to continue|2|||
149088819|NCT01695993|537803353|FG002|Overall Study|To ill to continue|0|||
149088820|NCT01695993|537803351|FG000|Overall Study|Changed Medical Facility|0|||
149088821|NCT01695993|537803352|FG001|Overall Study|Changed Medical Facility|0|||
149088822|NCT01695993|537803353|FG002|Overall Study|Changed Medical Facility|1|||
149088823|NCT00105521|537803355|FG000|Overall Study|Other|1|||
149088824|NCT00105521|537803356|FG001|Overall Study|Other|1|||
149088825|NCT00105521|537803357|FG002|Overall Study|Other|2|||
149088826|NCT00105521|537803358|FG003|Overall Study|Other|0|||
149088827|NCT00105521|537803355|FG000|Overall Study|Adverse Event|10|||
149088828|NCT00105521|537803356|FG001|Overall Study|Adverse Event|4|||
149088829|NCT00105521|537803357|FG002|Overall Study|Adverse Event|10|||
149088830|NCT00105521|537803358|FG003|Overall Study|Adverse Event|8|||
149088831|NCT00105521|537803355|FG000|Overall Study|Withdrawal by Subject|1|||
149088832|NCT00105521|537803356|FG001|Overall Study|Withdrawal by Subject|0|||
149088833|NCT00105521|537803357|FG002|Overall Study|Withdrawal by Subject|1|||
149088834|NCT00105521|537803358|FG003|Overall Study|Withdrawal by Subject|4|||
149088835|NCT00105521|537803355|FG000|Overall Study|Lack of Efficacy|0|||
149088836|NCT00105521|537803356|FG001|Overall Study|Lack of Efficacy|0|||
149006587|NCT00279201|537501970|FG004|Initiation|Lost to Follow-up|0|||
149006588|NCT00279201|537501971|FG005|Initiation|Lost to Follow-up|0|||
149006589|NCT00279201|537501966|FG000|Initiation|Entry Criteria Exclusion|7|||
149006590|NCT00279201|537501967|FG001|Initiation|Entry Criteria Exclusion|9|||
149006591|NCT00279201|537501968|FG002|Initiation|Entry Criteria Exclusion|0|||
149006592|NCT00279201|537501969|FG003|Initiation|Entry Criteria Exclusion|0|||
149006593|NCT00279201|537501970|FG004|Initiation|Entry Criteria Exclusion|0|||
149006594|NCT00279201|537501971|FG005|Initiation|Entry Criteria Exclusion|0|||
149006595|NCT00279201|537501966|FG000|Initiation|Protocol Violation|9|||
149006596|NCT00279201|537501967|FG001|Initiation|Protocol Violation|10|||
149006597|NCT00279201|537501968|FG002|Initiation|Protocol Violation|0|||
149006598|NCT00279201|537501969|FG003|Initiation|Protocol Violation|0|||
149006599|NCT00279201|537501970|FG004|Initiation|Protocol Violation|0|||
149006600|NCT00279201|537501971|FG005|Initiation|Protocol Violation|0|||
149006601|NCT00279201|537501966|FG000|Initiation|Withdrawal by Subject|35|||
149006602|NCT00279201|537501967|FG001|Initiation|Withdrawal by Subject|41|||
149006603|NCT00279201|537501968|FG002|Initiation|Withdrawal by Subject|0|||
149006604|NCT00279201|537501969|FG003|Initiation|Withdrawal by Subject|0|||
149006605|NCT00279201|537501970|FG004|Initiation|Withdrawal by Subject|0|||
149006606|NCT00279201|537501971|FG005|Initiation|Withdrawal by Subject|0|||
149006607|NCT00279201|537501966|FG000|Initiation|Physician Decision|15|||
149006608|NCT00279201|537501967|FG001|Initiation|Physician Decision|18|||
149006609|NCT00279201|537501968|FG002|Initiation|Physician Decision|0|||
149006610|NCT00279201|537501969|FG003|Initiation|Physician Decision|0|||
149006611|NCT00279201|537501970|FG004|Initiation|Physician Decision|0|||
149006612|NCT00279201|537501971|FG005|Initiation|Physician Decision|0|||
149006613|NCT00279201|537501966|FG000|Initiation|Sponsor Decision|13|||
149006614|NCT00279201|537501967|FG001|Initiation|Sponsor Decision|5|||
149006615|NCT00279201|537501968|FG002|Initiation|Sponsor Decision|0|||
149006616|NCT00279201|537501969|FG003|Initiation|Sponsor Decision|0|||
149006617|NCT00279201|537501970|FG004|Initiation|Sponsor Decision|0|||
149006618|NCT00279201|537501971|FG005|Initiation|Sponsor Decision|0|||
149006619|NCT00279201|537501966|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
149006620|NCT00279201|537501967|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
149006621|NCT00279201|537501968|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
149006622|NCT00279201|537501969|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
149006623|NCT00279201|537501970|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
149006624|NCT00279201|537501971|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
149006625|NCT00279201|537501966|FG000|Maintenance|Lack of Efficacy|32|||
149006626|NCT00279201|537501967|FG001|Maintenance|Lack of Efficacy|30|||
149006627|NCT00279201|537501968|FG002|Maintenance|Lack of Efficacy|0|||
149006628|NCT00279201|537501969|FG003|Maintenance|Lack of Efficacy|0|||
149006629|NCT00279201|537501970|FG004|Maintenance|Lack of Efficacy|0|||
149006630|NCT00279201|537501971|FG005|Maintenance|Lack of Efficacy|0|||
149006631|NCT00279201|537501966|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
149006632|NCT00279201|537501967|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
149006633|NCT00279201|537501968|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
149006634|NCT00279201|537501969|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
149006635|NCT00279201|537501970|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
149006636|NCT00279201|537501971|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
149006637|NCT00279201|537501966|FG000|Maintenance|Adverse Event|4|||
149006638|NCT00279201|537501967|FG001|Maintenance|Adverse Event|4|||
149006639|NCT00279201|537501968|FG002|Maintenance|Adverse Event|0|||
149006640|NCT00279201|537501969|FG003|Maintenance|Adverse Event|0|||
149006641|NCT00279201|537501970|FG004|Maintenance|Adverse Event|0|||
149006642|NCT00279201|537501971|FG005|Maintenance|Adverse Event|0|||
149006643|NCT00279201|537501966|FG000|Maintenance|Death|4|||
149006644|NCT00279201|537501967|FG001|Maintenance|Death|4|||
149006645|NCT00279201|537501968|FG002|Maintenance|Death|0|||
149006646|NCT00279201|537501969|FG003|Maintenance|Death|0|||
149006647|NCT00279201|537501970|FG004|Maintenance|Death|0|||
149006648|NCT00279201|537501971|FG005|Maintenance|Death|0|||
149088837|NCT00105521|537803357|FG002|Overall Study|Lack of Efficacy|0|||
149006649|NCT00279201|537501966|FG000|Maintenance|Lost to Follow-up|17|||
149006650|NCT00279201|537501967|FG001|Maintenance|Lost to Follow-up|13|||
149006651|NCT00279201|537501968|FG002|Maintenance|Lost to Follow-up|0|||
149006652|NCT00279201|537501969|FG003|Maintenance|Lost to Follow-up|0|||
149006653|NCT00279201|537501970|FG004|Maintenance|Lost to Follow-up|0|||
149006654|NCT00279201|537501971|FG005|Maintenance|Lost to Follow-up|0|||
149006655|NCT00279201|537501966|FG000|Maintenance|Entry Criteria Exclusion|1|||
149006656|NCT00279201|537501967|FG001|Maintenance|Entry Criteria Exclusion|4|||
149006657|NCT00279201|537501968|FG002|Maintenance|Entry Criteria Exclusion|0|||
149006658|NCT00279201|537501969|FG003|Maintenance|Entry Criteria Exclusion|0|||
149006659|NCT00279201|537501970|FG004|Maintenance|Entry Criteria Exclusion|0|||
149006660|NCT00279201|537501971|FG005|Maintenance|Entry Criteria Exclusion|0|||
149006661|NCT00279201|537501966|FG000|Maintenance|Protocol Violation|16|||
149006662|NCT00279201|537501967|FG001|Maintenance|Protocol Violation|24|||
149006663|NCT00279201|537501968|FG002|Maintenance|Protocol Violation|0|||
149006664|NCT00279201|537501969|FG003|Maintenance|Protocol Violation|0|||
149088838|NCT00105521|537803358|FG003|Overall Study|Lack of Efficacy|1|||
149088839|NCT00105521|537803355|FG000|Overall Study|Protocol Violation|3|||
149088840|NCT00105521|537803356|FG001|Overall Study|Protocol Violation|5|||
149088841|NCT00105521|537803357|FG002|Overall Study|Protocol Violation|4|||
149088842|NCT00105521|537803358|FG003|Overall Study|Protocol Violation|4|||
149088843|NCT00105521|537803355|FG000|Overall Study|Lost to Follow-up|0|||
149088844|NCT00105521|537803356|FG001|Overall Study|Lost to Follow-up|1|||
149088845|NCT00105521|537803357|FG002|Overall Study|Lost to Follow-up|0|||
149088846|NCT00105521|537803358|FG003|Overall Study|Lost to Follow-up|0|||
149088847|NCT00385697|537803359|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
149088848|NCT00385697|537803360|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
149088849|NCT00385697|537803361|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
149088850|NCT00385697|537803362|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
149088851|NCT00385697|537803363|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
149088852|NCT00385697|537803359|FG000|Open-label Segment 1|Lost to Follow-up|1|||
149088853|NCT00385697|537803360|FG001|Open-label Segment 1|Lost to Follow-up|0|||
149088854|NCT00385697|537803361|FG002|Open-label Segment 1|Lost to Follow-up|0|||
149088855|NCT00385697|537803362|FG003|Open-label Segment 1|Lost to Follow-up|0|||
149088856|NCT00385697|537803363|FG004|Open-label Segment 1|Lost to Follow-up|0|||
149088857|NCT00385697|537803359|FG000|Double-blind Segment 2|Adverse Event|0|||
149088858|NCT00385697|537803360|FG001|Double-blind Segment 2|Adverse Event|3|||
149088859|NCT00385697|537803361|FG002|Double-blind Segment 2|Adverse Event|1|||
149088860|NCT00385697|537803362|FG003|Double-blind Segment 2|Adverse Event|0|||
149088861|NCT00385697|537803363|FG004|Double-blind Segment 2|Adverse Event|0|||
149088862|NCT00385697|537803359|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
149088863|NCT00385697|537803360|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
149088864|NCT00385697|537803361|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
149088865|NCT00385697|537803362|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
149088866|NCT00385697|537803363|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
149088867|NCT00385697|537803359|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
149088868|NCT00385697|537803360|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
149088869|NCT00385697|537803361|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
149088870|NCT00385697|537803362|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
149088871|NCT00385697|537803363|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
149088872|NCT00385697|537803359|FG000|Double-blind Segment 2|Other|0|||
149088873|NCT00385697|537803360|FG001|Double-blind Segment 2|Other|2|||
149088874|NCT00385697|537803361|FG002|Double-blind Segment 2|Other|0|||
149088875|NCT00385697|537803362|FG003|Double-blind Segment 2|Other|0|||
149088876|NCT00385697|537803363|FG004|Double-blind Segment 2|Other|0|||
149088877|NCT00442559|537803365|FG000|Overall Study|Lost to Follow-up|32|||
149088878|NCT00442559|537803366|FG001|Overall Study|Lost to Follow-up|34|||
149088879|NCT00442559|537803365|FG000|Overall Study|Protocol Violation|1|||
149088880|NCT00442559|537803366|FG001|Overall Study|Protocol Violation|1|||
149088881|NCT00442559|537803365|FG000|Overall Study|Withdrawal by Subject|1|||
149088882|NCT00442559|537803366|FG001|Overall Study|Withdrawal by Subject|0|||
149088883|NCT02305797|537803367|FG000|Overall Study|Adverse Event|11|||
149088884|NCT02305797|537803368|FG001|Overall Study|Adverse Event|2|||
149088885|NCT02305797|537803367|FG000|Overall Study|Withdrawal by Subject|9|||
149088886|NCT02305797|537803368|FG001|Overall Study|Withdrawal by Subject|10|||
149088887|NCT02305797|537803367|FG000|Overall Study|Lack of Efficacy|6|||
149088888|NCT02305797|537803368|FG001|Overall Study|Lack of Efficacy|0|||
149088889|NCT02305797|537803367|FG000|Overall Study|Lost to Follow-up|5|||
149088890|NCT02305797|537803368|FG001|Overall Study|Lost to Follow-up|11|||
149088891|NCT02305797|537803367|FG000|Overall Study|Pregnancy|0|||
149088892|NCT02305797|537803368|FG001|Overall Study|Pregnancy|2|||
149088893|NCT02305797|537803367|FG000|Overall Study|Noncompliance|14|||
149088894|NCT02305797|537803368|FG001|Overall Study|Noncompliance|12|||
149088895|NCT02305797|537803367|FG000|Overall Study|Reason not collected|0|||
149088896|NCT02305797|537803368|FG001|Overall Study|Reason not collected|1|||
149088897|NCT01426217|537803379|FG000|Overall Study|lost sample|8|||
149088898|NCT01426217|537803380|FG001|Overall Study|lost sample|14|||
149088899|NCT01648699|537803381|FG000|Overall Study|Death|1|||
149088900|NCT01648699|537803381|FG000|Overall Study|Lost to Follow-up|2|||
149088901|NCT01648699|537803381|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
149088902|NCT01536795|537803382|FG000|Overall Study|Lost to Follow-up|0|||
149088903|NCT01536795|537803383|FG001|Overall Study|Lost to Follow-up|2|||
149088904|NCT01536795|537803382|FG000|Overall Study|Lack of Efficacy|1|||
149088905|NCT01536795|537803383|FG001|Overall Study|Lack of Efficacy|0|||
149088906|NCT02267746|537803384|FG000|Overall Study|Adverse Event|0|||
149088907|NCT02267746|537803385|FG001|Overall Study|Adverse Event|2|||
149088908|NCT02267746|537803386|FG002|Overall Study|Adverse Event|1|||
149088909|NCT02267746|537803384|FG000|Overall Study|Protocol Violation|8|||
149088910|NCT02267746|537803385|FG001|Overall Study|Protocol Violation|7|||
149088911|NCT02267746|537803386|FG002|Overall Study|Protocol Violation|3|||
149088912|NCT02267746|537803384|FG000|Overall Study|Lack of Efficacy|11|||
149088913|NCT02267746|537803385|FG001|Overall Study|Lack of Efficacy|11|||
149088914|NCT02267746|537803386|FG002|Overall Study|Lack of Efficacy|15|||
149088915|NCT02267746|537803384|FG000|Overall Study|Protocol Violation|1|||
149006665|NCT00279201|537501970|FG004|Maintenance|Protocol Violation|0|||
149006666|NCT00279201|537501971|FG005|Maintenance|Protocol Violation|0|||
149006667|NCT00279201|537501966|FG000|Maintenance|Withdrawal by Subject|18|||
149006668|NCT00279201|537501967|FG001|Maintenance|Withdrawal by Subject|18|||
149006669|NCT00279201|537501968|FG002|Maintenance|Withdrawal by Subject|0|||
149006670|NCT00279201|537501969|FG003|Maintenance|Withdrawal by Subject|0|||
149006671|NCT00279201|537501970|FG004|Maintenance|Withdrawal by Subject|0|||
149006672|NCT00279201|537501971|FG005|Maintenance|Withdrawal by Subject|0|||
149006673|NCT00279201|537501966|FG000|Maintenance|Physician Decision|9|||
149006674|NCT00279201|537501967|FG001|Maintenance|Physician Decision|9|||
149006675|NCT00279201|537501968|FG002|Maintenance|Physician Decision|0|||
149006676|NCT00279201|537501969|FG003|Maintenance|Physician Decision|0|||
149006677|NCT00279201|537501970|FG004|Maintenance|Physician Decision|0|||
149006678|NCT00279201|537501971|FG005|Maintenance|Physician Decision|0|||
149006679|NCT00279201|537501966|FG000|Maintenance|Sponsor Decision|4|||
149006680|NCT00279201|537501967|FG001|Maintenance|Sponsor Decision|0|||
149006681|NCT00279201|537501968|FG002|Maintenance|Sponsor Decision|0|||
149006682|NCT00279201|537501969|FG003|Maintenance|Sponsor Decision|0|||
149006683|NCT00279201|537501970|FG004|Maintenance|Sponsor Decision|0|||
149006684|NCT00279201|537501971|FG005|Maintenance|Sponsor Decision|0|||
149006685|NCT00279201|537501966|FG000|Maintenance|HbA1c>7.5%|123|||
149006686|NCT00279201|537501967|FG001|Maintenance|HbA1c>7.5%|126|||
149006687|NCT00279201|537501968|FG002|Maintenance|HbA1c>7.5%|0|||
149006688|NCT00279201|537501969|FG003|Maintenance|HbA1c>7.5%|0|||
149006689|NCT00279201|537501970|FG004|Maintenance|HbA1c>7.5%|0|||
149006690|NCT00279201|537501971|FG005|Maintenance|HbA1c>7.5%|0|||
149006691|NCT00279201|537501966|FG000|Intensification Addendum|Withdrawal by Subject|0|||
149006692|NCT00279201|537501967|FG001|Intensification Addendum|Withdrawal by Subject|0|||
149006693|NCT00279201|537501968|FG002|Intensification Addendum|Withdrawal by Subject|12|||
149006694|NCT00279201|537501969|FG003|Intensification Addendum|Withdrawal by Subject|14|||
149006695|NCT00279201|537501970|FG004|Intensification Addendum|Withdrawal by Subject|9|||
149006696|NCT00279201|537501971|FG005|Intensification Addendum|Withdrawal by Subject|18|||
149006697|NCT00279201|537501966|FG000|Intensification Addendum|Lost to Follow-up|0|||
149006698|NCT00279201|537501967|FG001|Intensification Addendum|Lost to Follow-up|0|||
149006699|NCT00279201|537501968|FG002|Intensification Addendum|Lost to Follow-up|4|||
149006700|NCT00279201|537501969|FG003|Intensification Addendum|Lost to Follow-up|6|||
149006701|NCT00279201|537501970|FG004|Intensification Addendum|Lost to Follow-up|7|||
149006702|NCT00279201|537501971|FG005|Intensification Addendum|Lost to Follow-up|7|||
149006703|NCT00279201|537501966|FG000|Intensification Addendum|Protocol Violation|0|||
149006704|NCT00279201|537501967|FG001|Intensification Addendum|Protocol Violation|0|||
149006705|NCT00279201|537501968|FG002|Intensification Addendum|Protocol Violation|2|||
149006706|NCT00279201|537501969|FG003|Intensification Addendum|Protocol Violation|2|||
149006707|NCT00279201|537501970|FG004|Intensification Addendum|Protocol Violation|6|||
149006708|NCT00279201|537501971|FG005|Intensification Addendum|Protocol Violation|6|||
149006709|NCT00279201|537501966|FG000|Intensification Addendum|Adverse Event|0|||
149006710|NCT00279201|537501967|FG001|Intensification Addendum|Adverse Event|0|||
149006711|NCT00279201|537501968|FG002|Intensification Addendum|Adverse Event|0|||
149006712|NCT00279201|537501969|FG003|Intensification Addendum|Adverse Event|4|||
149006713|NCT00279201|537501970|FG004|Intensification Addendum|Adverse Event|1|||
149006714|NCT00279201|537501971|FG005|Intensification Addendum|Adverse Event|3|||
149006715|NCT00279201|537501966|FG000|Intensification Addendum|Physician Decision|0|||
149006716|NCT00279201|537501967|FG001|Intensification Addendum|Physician Decision|0|||
149006717|NCT00279201|537501968|FG002|Intensification Addendum|Physician Decision|4|||
149006718|NCT00279201|537501969|FG003|Intensification Addendum|Physician Decision|1|||
149006719|NCT00279201|537501970|FG004|Intensification Addendum|Physician Decision|3|||
149006720|NCT00279201|537501971|FG005|Intensification Addendum|Physician Decision|2|||
149006721|NCT00279201|537501966|FG000|Intensification Addendum|Sponsor Decision|0|||
149006722|NCT00279201|537501967|FG001|Intensification Addendum|Sponsor Decision|0|||
149006723|NCT00279201|537501968|FG002|Intensification Addendum|Sponsor Decision|0|||
149006724|NCT00279201|537501969|FG003|Intensification Addendum|Sponsor Decision|0|||
149006725|NCT00279201|537501970|FG004|Intensification Addendum|Sponsor Decision|1|||
149006726|NCT00279201|537501971|FG005|Intensification Addendum|Sponsor Decision|1|||
149006727|NCT00279201|537501966|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
149006728|NCT00279201|537501967|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
149006729|NCT00279201|537501968|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
149006730|NCT00279201|537501969|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
149006731|NCT00279201|537501970|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
149006732|NCT00279201|537501971|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
149006733|NCT00279201|537501966|FG000|Intensification Addendum|Lack of Efficacy|0|||
149006734|NCT00279201|537501967|FG001|Intensification Addendum|Lack of Efficacy|0|||
149006735|NCT00279201|537501968|FG002|Intensification Addendum|Lack of Efficacy|0|||
149006736|NCT00279201|537501969|FG003|Intensification Addendum|Lack of Efficacy|1|||
149006737|NCT00279201|537501970|FG004|Intensification Addendum|Lack of Efficacy|1|||
149006738|NCT00279201|537501971|FG005|Intensification Addendum|Lack of Efficacy|0|||
149006739|NCT00279201|537501966|FG000|Intensification Addendum|Death|0|||
149088916|NCT02267746|537803385|FG001|Overall Study|Protocol Violation|2|||
149088917|NCT02267746|537803386|FG002|Overall Study|Protocol Violation|1|||
149088918|NCT02267746|537803384|FG000|Overall Study|Miscellaneous|1|||
149088919|NCT02267746|537803385|FG001|Overall Study|Miscellaneous|0|||
149088920|NCT02267746|537803386|FG002|Overall Study|Miscellaneous|1|||
149088921|NCT01812837|537803387|FG000|Overall Study|Lost to Follow-up|1|||
149088922|NCT01812837|537803388|FG001|Overall Study|Lost to Follow-up|1|||
149088923|NCT01812837|537803389|FG002|Overall Study|Lost to Follow-up|0|||
149088924|NCT01812837|537803387|FG000|Overall Study|Protocol Violation|1|||
149088925|NCT01812837|537803388|FG001|Overall Study|Protocol Violation|0|||
149088926|NCT01812837|537803389|FG002|Overall Study|Protocol Violation|0|||
149088927|NCT05008224|537803394|FG000|Overall Study|Death|3|||
149088928|NCT05008224|537803394|FG000|Overall Study|Lost to Follow-up|2|||
149088929|NCT05008224|537803394|FG000|Overall Study|Did Not Continue on Extension Study|39|||
149088930|NCT05008224|537803394|FG000|Overall Study|Transferred to Extension Study|100|||
149088931|NCT05008224|537803394|FG000|Overall Study|Withdrawal by Subject|2|||
149088932|NCT05234632|537803395|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
149088933|NCT05234632|537803396|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
149088934|NCT05234632|537803395|FG000|Overall Study|Withdrawal by Subject|2|||
149088935|NCT05234632|537803396|FG001|Overall Study|Withdrawal by Subject|0|||
149088936|NCT05234632|537803395|FG000|Overall Study|Adverse Event|0|||
149088937|NCT05234632|537803396|FG001|Overall Study|Adverse Event|4|||
149088938|NCT05234632|537803395|FG000|Overall Study|Physician Decision|1|||
149088939|NCT05234632|537803396|FG001|Overall Study|Physician Decision|1|||
149088940|NCT05234632|537803395|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
149088941|NCT05234632|537803396|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
149088942|NCT05234632|537803395|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
149088943|NCT05234632|537803396|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
149088944|NCT04799587|537803397|FG000|Overall Study|Withdrawal by Subject|0|||
149088945|NCT04799587|537803398|FG001|Overall Study|Withdrawal by Subject|1|||
149088946|NCT00728884|537803399|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
149088947|NCT00728884|537803399|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
149088948|NCT05263492|537803400|FG000|Overall Study|Adverse Event|1|||
149088949|NCT05263492|537803400|FG000|Overall Study|Disease progression during active treatment|3|||
149088950|NCT03345420|537803403|FG000|Overall Study|Withdrawal by Subject|1|||
149088951|NCT05216835|537803404|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
149088952|NCT05216835|537803405|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
149088953|NCT05216835|537803406|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
149088954|NCT05216835|537803407|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
149088955|NCT05216835|537803408|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
149088956|NCT05216835|537803409|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
149088957|NCT05216835|537803410|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
149088958|NCT05216835|537803411|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
149088959|NCT05216835|537803404|FG000|Overall Study|Death|0|||
149088960|NCT05216835|537803405|FG001|Overall Study|Death|0|||
149088961|NCT05216835|537803406|FG002|Overall Study|Death|0|||
149088962|NCT05216835|537803407|FG003|Overall Study|Death|1|||
149088963|NCT05216835|537803408|FG004|Overall Study|Death|1|||
149088964|NCT05216835|537803409|FG005|Overall Study|Death|1|||
149088965|NCT05216835|537803410|FG006|Overall Study|Death|1|||
149088966|NCT05216835|537803411|FG007|Overall Study|Death|1|||
149088967|NCT05216835|537803404|FG000|Overall Study|Physician Decision|0|||
149088968|NCT05216835|537803405|FG001|Overall Study|Physician Decision|0|||
149088969|NCT05216835|537803406|FG002|Overall Study|Physician Decision|0|||
149088970|NCT05216835|537803407|FG003|Overall Study|Physician Decision|0|||
149088971|NCT05216835|537803408|FG004|Overall Study|Physician Decision|0|||
149088972|NCT05216835|537803409|FG005|Overall Study|Physician Decision|1|||
149088973|NCT05216835|537803410|FG006|Overall Study|Physician Decision|1|||
149088974|NCT05216835|537803411|FG007|Overall Study|Physician Decision|0|||
149088975|NCT05216835|537803404|FG000|Overall Study|Study terminated by Sponsor|0|||
149088976|NCT05216835|537803405|FG001|Overall Study|Study terminated by Sponsor|0|||
149088977|NCT05216835|537803406|FG002|Overall Study|Study terminated by Sponsor|0|||
149088978|NCT05216835|537803407|FG003|Overall Study|Study terminated by Sponsor|0|||
149088979|NCT05216835|537803408|FG004|Overall Study|Study terminated by Sponsor|0|||
149088980|NCT05216835|537803409|FG005|Overall Study|Study terminated by Sponsor|0|||
149088981|NCT05216835|537803410|FG006|Overall Study|Study terminated by Sponsor|0|||
149088982|NCT05216835|537803411|FG007|Overall Study|Study terminated by Sponsor|1|||
149088983|NCT05216835|537803404|FG000|Overall Study|Withdrawal by Subject|1|||
149088984|NCT05216835|537803405|FG001|Overall Study|Withdrawal by Subject|0|||
149088985|NCT05216835|537803406|FG002|Overall Study|Withdrawal by Subject|1|||
149088986|NCT05216835|537803407|FG003|Overall Study|Withdrawal by Subject|0|||
149088987|NCT05216835|537803408|FG004|Overall Study|Withdrawal by Subject|1|||
149088988|NCT05216835|537803409|FG005|Overall Study|Withdrawal by Subject|0|||
149088989|NCT05216835|537803410|FG006|Overall Study|Withdrawal by Subject|0|||
149088990|NCT05216835|537803411|FG007|Overall Study|Withdrawal by Subject|1|||
149088991|NCT05216835|537803404|FG000|Overall Study|Other|0|||
149088992|NCT05216835|537803405|FG001|Overall Study|Other|1|||
149088993|NCT05216835|537803406|FG002|Overall Study|Other|0|||
149088994|NCT05216835|537803407|FG003|Overall Study|Other|0|||
149088995|NCT05216835|537803408|FG004|Overall Study|Other|0|||
149088996|NCT05216835|537803409|FG005|Overall Study|Other|0|||
149088997|NCT05216835|537803410|FG006|Overall Study|Other|0|||
149088998|NCT05216835|537803411|FG007|Overall Study|Other|0|||
149088999|NCT05179603|537803412|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
149089000|NCT05179603|537803412|FG000|Overall Study|Withdrawal by Subject|1|||
149089001|NCT05179603|537803412|FG000|Overall Study|Progressive disease|4|||
149089002|NCT05179603|537803412|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
149089003|NCT03861078|537803413|FG000|Overall Study|COVID-19 shut down|4|||
149089004|NCT03861078|537803413|FG000|Overall Study|Lost to Follow-up|1|||
149089005|NCT03861078|537803413|FG000|Overall Study|Protocol Violation|2|||
149089006|NCT03861078|537803413|FG000|Overall Study|lack of venous access|1|||
149089007|NCT01075815|537803414|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
149089008|NCT01075815|537803415|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
149089009|NCT01075815|537803414|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
149089010|NCT01075815|537803415|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
149089011|NCT01075815|537803414|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
149089012|NCT01075815|537803415|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
149089013|NCT00596960|537803416|FG000|Overall Study|Death|1|||
149089014|NCT00596960|537803417|FG001|Overall Study|Death|2|||
149089015|NCT00596960|537803416|FG000|Overall Study|Lost to Follow-up|6|||
149089016|NCT00596960|537803417|FG001|Overall Study|Lost to Follow-up|5|||
149089017|NCT00596960|537803416|FG000|Overall Study|Withdrawal by Subject|1|||
149089018|NCT00596960|537803417|FG001|Overall Study|Withdrawal by Subject|0|||
149089019|NCT00596960|537803416|FG000|Overall Study|Incarcerated|2|||
149089020|NCT00596960|537803417|FG001|Overall Study|Incarcerated|0|||
149089021|NCT00596960|537803416|FG000|Overall Study|Physician Decision|1|||
149089022|NCT00596960|537803417|FG001|Overall Study|Physician Decision|0|||
149089023|NCT00596960|537803416|FG000|Overall Study|Protocol Violation|0|||
149089024|NCT00596960|537803417|FG001|Overall Study|Protocol Violation|1|||
149089025|NCT00596960|537803416|FG000|Overall Study|No alcohol use data|0|||
149089026|NCT00596960|537803417|FG001|Overall Study|No alcohol use data|1|||
149089027|NCT02058992|537803418|FG000|Overall Study|Lost to Follow-up|4|||
149089028|NCT02058992|537803418|FG000|Overall Study|Protocol Violation|92|||
149089029|NCT02058992|537803418|FG000|Overall Study|CRF Uncollected|20|||
149089030|NCT03005106|537803422|FG000|Overall Study|Lost to Follow-up|16|||
149089031|NCT03005106|537803422|FG000|Overall Study|Adverse Event|1|||
149089032|NCT03005106|537803422|FG000|Overall Study|Physician Decision|1|||
149089033|NCT03005106|537803422|FG000|Overall Study|Death|2|||
149089034|NCT01855399|537803423|FG000|6 Month|Lost to Follow-up|12|||
149089035|NCT01855399|537803424|FG001|6 Month|Lost to Follow-up|9|||
149089036|NCT01855399|537803423|FG000|6 Month|Withdrawal by Subject|8|||
149089037|NCT01855399|537803424|FG001|6 Month|Withdrawal by Subject|6|||
149089038|NCT01855399|537803423|FG000|12 Month|Lost to Follow-up|7|||
149089039|NCT01855399|537803424|FG001|12 Month|Lost to Follow-up|11|||
149089040|NCT03019289|537803425|FG000|Overall Study|Adverse Event|1|||
149089041|NCT03019289|537803426|FG001|Overall Study|Adverse Event|0|||
149089042|NCT03019289|537803427|FG002|Overall Study|Adverse Event|0|||
149089043|NCT03019289|537803428|FG003|Overall Study|Adverse Event|0|||
149089044|NCT03019289|537803429|FG004|Overall Study|Adverse Event|0|||
149089045|NCT03019289|537803430|FG005|Overall Study|Adverse Event|0|||
149089046|NCT03019289|537803431|FG006|Overall Study|Adverse Event|0|||
149089047|NCT03019289|537803432|FG007|Overall Study|Adverse Event|0|||
149089048|NCT03019289|537803433|FG008|Overall Study|Adverse Event|1|||
149089049|NCT03019289|537803425|FG000|Overall Study|Other|1|||
149089050|NCT03019289|537803426|FG001|Overall Study|Other|0|||
149089051|NCT03019289|537803427|FG002|Overall Study|Other|0|||
149089052|NCT03019289|537803428|FG003|Overall Study|Other|0|||
149089053|NCT03019289|537803429|FG004|Overall Study|Other|0|||
149089054|NCT03019289|537803430|FG005|Overall Study|Other|0|||
149089055|NCT03019289|537803431|FG006|Overall Study|Other|0|||
149089056|NCT03019289|537803432|FG007|Overall Study|Other|0|||
149089057|NCT03019289|537803433|FG008|Overall Study|Other|0|||
149089058|NCT00936065|537803434|FG000|Overall Study|Adverse Event|1|||
149089059|NCT00936065|537803435|FG001|Overall Study|Adverse Event|0|||
149089060|NCT00936065|537803436|FG002|Overall Study|Adverse Event|1|||
149089061|NCT00936065|537803434|FG000|Overall Study|Lack of Efficacy|1|||
149089062|NCT00936065|537803435|FG001|Overall Study|Lack of Efficacy|0|||
149089063|NCT00936065|537803436|FG002|Overall Study|Lack of Efficacy|1|||
149089064|NCT00936065|537803434|FG000|Overall Study|Lost to Follow-up|1|||
149089065|NCT00936065|537803435|FG001|Overall Study|Lost to Follow-up|0|||
149089066|NCT00936065|537803436|FG002|Overall Study|Lost to Follow-up|0|||
149089067|NCT00936065|537803434|FG000|Overall Study|Protocol Violation|1|||
149089068|NCT00936065|537803435|FG001|Overall Study|Protocol Violation|2|||
149089069|NCT00936065|537803436|FG002|Overall Study|Protocol Violation|1|||
149089070|NCT00936065|537803434|FG000|Overall Study|Withdrawal by Subject|0|||
149089071|NCT00936065|537803435|FG001|Overall Study|Withdrawal by Subject|2|||
149089072|NCT00936065|537803436|FG002|Overall Study|Withdrawal by Subject|4|||
149089073|NCT01288729|537803437|FG000|Overall Study|Withdrawal by Subject|1|||
149089074|NCT01288729|537803438|FG001|Overall Study|Withdrawal by Subject|0|||
149089075|NCT01232569|537805049|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
149089076|NCT01232569|537805050|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
149089077|NCT01232569|537805051|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149089078|NCT01232569|537805052|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
149089079|NCT01232569|537805049|FG000|Double-blind Treatment Period|Escape|2|||
149089080|NCT01232569|537805050|FG001|Double-blind Treatment Period|Escape|2|||
149089081|NCT01232569|537805051|FG002|Double-blind Treatment Period|Escape|0|||
149089082|NCT01232569|537805052|FG003|Double-blind Treatment Period|Escape|0|||
149089083|NCT01232569|537805049|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
149089084|NCT01232569|537805050|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
149089085|NCT01232569|537805051|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
149089086|NCT01232569|537805052|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
149089087|NCT01232569|537805049|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
149089088|NCT01232569|537805050|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
149089089|NCT01232569|537805051|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
149089090|NCT01232569|537805052|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
149089091|NCT01232569|537805049|FG000|Double-blind Treatment Period|Physician Decision|1|||
149089092|NCT01232569|537805050|FG001|Double-blind Treatment Period|Physician Decision|0|||
149089093|NCT01232569|537805051|FG002|Double-blind Treatment Period|Physician Decision|0|||
149089094|NCT01232569|537805052|FG003|Double-blind Treatment Period|Physician Decision|0|||
149089095|NCT01232569|537805049|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
149089096|NCT01232569|537805050|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
149089097|NCT01232569|537805051|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
149089098|NCT01232569|537805052|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
149089099|NCT01232569|537805049|FG000|Double-blind Treatment Period|Death|2|||
149089100|NCT01232569|537805050|FG001|Double-blind Treatment Period|Death|0|||
149089101|NCT01232569|537805051|FG002|Double-blind Treatment Period|Death|0|||
149089102|NCT01232569|537805052|FG003|Double-blind Treatment Period|Death|0|||
149089103|NCT05335005|537805058|FG000|Overall Study|Lost to Follow-up|1|||
149089104|NCT00644332|537805059|FG000|Overall Study|Adverse Event|11|||
149089105|NCT00644332|537805059|FG000|Overall Study|Withdrawal by Subject|6|||
149089106|NCT00644332|537805059|FG000|Overall Study|Completion Status Unknown|2|||
149089107|NCT00644332|537805059|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
149089108|NCT00644332|537805059|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
149089109|NCT03694210|537805060|FG000|Overall Study|Death|1|||
149089110|NCT03694210|537805060|FG000|Overall Study|Screen Failure|7|||
149089111|NCT02706834|537805064|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149089112|NCT02706834|537805065|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
149089113|NCT02706834|537805066|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
149089114|NCT02706834|537805067|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
149089115|NCT02706834|537805068|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
149089116|NCT02706834|537805069|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
149089117|NCT02706834|537805070|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
149089118|NCT02706834|537805071|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
149089119|NCT02706834|537805072|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
149089120|NCT02706834|537805073|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
149089121|NCT02706834|537805074|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
149089122|NCT02706834|537805064|FG000|Overall Study|Lost to Follow-up|0|||
149089123|NCT02706834|537805065|FG001|Overall Study|Lost to Follow-up|0|||
149089124|NCT02706834|537805066|FG002|Overall Study|Lost to Follow-up|1|||
149089125|NCT02706834|537805067|FG003|Overall Study|Lost to Follow-up|0|||
149089126|NCT02706834|537805068|FG004|Overall Study|Lost to Follow-up|0|||
149089127|NCT02706834|537805069|FG005|Overall Study|Lost to Follow-up|0|||
149089128|NCT02706834|537805070|FG006|Overall Study|Lost to Follow-up|0|||
149089129|NCT02706834|537805071|FG007|Overall Study|Lost to Follow-up|0|||
149089130|NCT02706834|537805072|FG008|Overall Study|Lost to Follow-up|0|||
149089131|NCT02706834|537805073|FG009|Overall Study|Lost to Follow-up|0|||
149089132|NCT02706834|537805074|FG010|Overall Study|Lost to Follow-up|0|||
149089133|NCT02706834|537805064|FG000|Overall Study|Voluntary Withdrawal|1|||
149089134|NCT02706834|537805065|FG001|Overall Study|Voluntary Withdrawal|0|||
149089135|NCT02706834|537805066|FG002|Overall Study|Voluntary Withdrawal|0|||
149089136|NCT02706834|537805067|FG003|Overall Study|Voluntary Withdrawal|0|||
149089137|NCT02706834|537805068|FG004|Overall Study|Voluntary Withdrawal|0|||
149089138|NCT02706834|537805069|FG005|Overall Study|Voluntary Withdrawal|0|||
149089139|NCT02706834|537805070|FG006|Overall Study|Voluntary Withdrawal|0|||
149089140|NCT02706834|537805071|FG007|Overall Study|Voluntary Withdrawal|0|||
149089141|NCT02706834|537805072|FG008|Overall Study|Voluntary Withdrawal|0|||
149089142|NCT02706834|537805073|FG009|Overall Study|Voluntary Withdrawal|1|||
149089143|NCT02706834|537805074|FG010|Overall Study|Voluntary Withdrawal|0|||
149089144|NCT02706834|537805064|FG000|Overall Study|Other Reason Not Specified|1|||
149089145|NCT02706834|537805065|FG001|Overall Study|Other Reason Not Specified|0|||
149089146|NCT02706834|537805066|FG002|Overall Study|Other Reason Not Specified|0|||
149089147|NCT02706834|537805067|FG003|Overall Study|Other Reason Not Specified|0|||
149089148|NCT02706834|537805068|FG004|Overall Study|Other Reason Not Specified|1|||
149089149|NCT02706834|537805069|FG005|Overall Study|Other Reason Not Specified|0|||
149089150|NCT02706834|537805070|FG006|Overall Study|Other Reason Not Specified|0|||
149089151|NCT02706834|537805071|FG007|Overall Study|Other Reason Not Specified|0|||
149089152|NCT02706834|537805072|FG008|Overall Study|Other Reason Not Specified|0|||
149089153|NCT02706834|537805073|FG009|Overall Study|Other Reason Not Specified|0|||
149089154|NCT02706834|537805074|FG010|Overall Study|Other Reason Not Specified|0|||
149089155|NCT00678899|537805079|FG000|Overall Study|Adverse Event|1|||
149089156|NCT04057937|537805102|FG000|Placebo-controlled Phase|Adverse Event|3|||
149089157|NCT04057937|537805103|FG001|Placebo-controlled Phase|Adverse Event|0|||
149089158|NCT04057937|537805102|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
149089159|NCT04057937|537805103|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
149089160|NCT04057937|537805102|FG000|Active-treatment Phase|Pregnancy|0|||
149089161|NCT04057937|537805103|FG001|Active-treatment Phase|Pregnancy|1|||
149006740|NCT00279201|537501967|FG001|Intensification Addendum|Death|0|||
149006741|NCT00279201|537501968|FG002|Intensification Addendum|Death|0|||
149006742|NCT00279201|537501969|FG003|Intensification Addendum|Death|0|||
149006743|NCT00279201|537501970|FG004|Intensification Addendum|Death|1|||
149006744|NCT00279201|537501971|FG005|Intensification Addendum|Death|0|||
149089162|NCT04057937|537805102|FG000|Active-treatment Phase|Physician Decision|0|||
149089163|NCT04057937|537805103|FG001|Active-treatment Phase|Physician Decision|1|||
149089164|NCT02029521|537805104|FG000|Overall Study|Protocol Violation|1|||
149089165|NCT02029521|537805105|FG001|Overall Study|Protocol Violation|0|||
149089166|NCT02029521|537805104|FG000|Overall Study|Withdrawal by Subject|1|||
149089167|NCT02029521|537805105|FG001|Overall Study|Withdrawal by Subject|1|||
149089168|NCT01072396|537805106|FG000|Period One|Adverse Event|1|||
149089169|NCT01072396|537805107|FG001|Period One|Adverse Event|1|||
149089170|NCT01072396|537805106|FG000|Period One|Protocol Violation|2|||
149089171|NCT01072396|537805107|FG001|Period One|Protocol Violation|1|||
149089172|NCT01072396|537805106|FG000|Period One|Withdrawal by Subject|2|||
149089173|NCT01072396|537805107|FG001|Period One|Withdrawal by Subject|0|||
149089174|NCT01072396|537805106|FG000|Washout Period|Missing termination information|0|||
149089175|NCT01072396|537805107|FG001|Washout Period|Missing termination information|1|||
149089176|NCT01072396|537805106|FG000|Period Two|Adverse Event|0|||
149089177|NCT01072396|537805107|FG001|Period Two|Adverse Event|3|||
149089178|NCT01072396|537805106|FG000|Period Two|Lost to Follow-up|1|||
149089179|NCT01072396|537805107|FG001|Period Two|Lost to Follow-up|0|||
149089180|NCT00472199|537805108|FG000|Overall Study|Adverse Event|19|||
149089181|NCT00472199|537805109|FG001|Overall Study|Adverse Event|23|||
149089182|NCT00472199|537805108|FG000|Overall Study|Lack of Efficacy|4|||
149089183|NCT00472199|537805109|FG001|Overall Study|Lack of Efficacy|25|||
149089184|NCT00472199|537805108|FG000|Overall Study|Lost to Follow-up|2|||
149089185|NCT00472199|537805109|FG001|Overall Study|Lost to Follow-up|4|||
149089186|NCT00472199|537805108|FG000|Overall Study|Protocol Violation|3|||
149089187|NCT00472199|537805109|FG001|Overall Study|Protocol Violation|2|||
149089188|NCT00472199|537805108|FG000|Overall Study|Withdrawal by Subject|6|||
149089189|NCT00472199|537805109|FG001|Overall Study|Withdrawal by Subject|5|||
149089190|NCT00472199|537805108|FG000|Overall Study|personal reason|0|||
149089191|NCT00472199|537805109|FG001|Overall Study|personal reason|1|||
149089192|NCT00472199|537805108|FG000|Overall Study|patient was asymptomatic|1|||
149089193|NCT00472199|537805109|FG001|Overall Study|patient was asymptomatic|0|||
149089194|NCT02446912|537805111|FG000|Overall Study|Adverse Event|3|||
149089195|NCT02446912|537805112|FG001|Overall Study|Adverse Event|13|||
149089196|NCT02446912|537805113|FG002|Overall Study|Adverse Event|5|||
149089197|NCT02446912|537805111|FG000|Overall Study|Condition under investigation worsened|0|||
149089198|NCT02446912|537805112|FG001|Overall Study|Condition under investigation worsened|1|||
149089199|NCT02446912|537805113|FG002|Overall Study|Condition under investigation worsened|1|||
149089200|NCT02446912|537805111|FG000|Overall Study|Study-specific withdrawal criteria|1|||
149089201|NCT02446912|537805112|FG001|Overall Study|Study-specific withdrawal criteria|0|||
149089202|NCT02446912|537805113|FG002|Overall Study|Study-specific withdrawal criteria|0|||
149089203|NCT02446912|537805111|FG000|Overall Study|Lack of Efficacy|1|||
149089204|NCT02446912|537805112|FG001|Overall Study|Lack of Efficacy|4|||
149089205|NCT02446912|537805113|FG002|Overall Study|Lack of Efficacy|7|||
149089206|NCT02446912|537805111|FG000|Overall Study|Lost to Follow-up|0|||
149089207|NCT02446912|537805112|FG001|Overall Study|Lost to Follow-up|0|||
149089208|NCT02446912|537805113|FG002|Overall Study|Lost to Follow-up|2|||
149089209|NCT02446912|537805111|FG000|Overall Study|Severe non-compliance to protocol|1|||
149089210|NCT02446912|537805112|FG001|Overall Study|Severe non-compliance to protocol|0|||
149089211|NCT02446912|537805113|FG002|Overall Study|Severe non-compliance to protocol|1|||
149089212|NCT02446912|537805111|FG000|Overall Study|Withdrawal by Subject|10|||
149089213|NCT02446912|537805112|FG001|Overall Study|Withdrawal by Subject|15|||
149089214|NCT02446912|537805113|FG002|Overall Study|Withdrawal by Subject|15|||
149089215|NCT02446912|537805111|FG000|Overall Study|Miscellaneous|2|||
149089216|NCT02446912|537805112|FG001|Overall Study|Miscellaneous|2|||
149089217|NCT02446912|537805113|FG002|Overall Study|Miscellaneous|4|||
149089218|NCT01268488|537805114|FG000|Overall Study|Adverse Event|3|||
149089219|NCT01268488|537805114|FG000|Overall Study|Physician Decision|2|||
149089220|NCT01106586|537805117|FG000|Overall Study|Adverse Event|9|||
149089221|NCT01106586|537805118|FG001|Overall Study|Adverse Event|15|||
149089222|NCT01106586|537805117|FG000|Overall Study|Death|1|||
149089223|NCT01106586|537805118|FG001|Overall Study|Death|3|||
149089224|NCT01106586|537805117|FG000|Overall Study|Pregnancy|2|||
149089225|NCT01106586|537805118|FG001|Overall Study|Pregnancy|2|||
149089226|NCT01106586|537805117|FG000|Overall Study|Lack of Efficacy|1|||
149089227|NCT01106586|537805118|FG001|Overall Study|Lack of Efficacy|0|||
149089228|NCT01106586|537805117|FG000|Overall Study|Investigator's Discretion|5|||
149089229|NCT01106586|537805118|FG001|Overall Study|Investigator's Discretion|8|||
149089230|NCT01106586|537805117|FG000|Overall Study|Withdrew Consent|18|||
149089231|NCT01106586|537805118|FG001|Overall Study|Withdrew Consent|30|||
149089232|NCT01106586|537805117|FG000|Overall Study|Lost to Follow-up|24|||
149089233|NCT01106586|537805118|FG001|Overall Study|Lost to Follow-up|20|||
149089234|NCT01106586|537805117|FG000|Overall Study|Participant Noncompliance|12|||
149089235|NCT01106586|537805118|FG001|Overall Study|Participant Noncompliance|10|||
149089236|NCT01106586|537805117|FG000|Overall Study|Protocol Violation|1|||
149089237|NCT01106586|537805118|FG001|Overall Study|Protocol Violation|0|||
149089238|NCT01106586|537805117|FG000|Overall Study|Participant Transferred to Another Study|212|||
149089239|NCT01106586|537805118|FG001|Overall Study|Participant Transferred to Another Study|197|||
149089240|NCT01757171|537805119|FG000|Overall Study|Adverse Event|5|||
149089241|NCT01757171|537805120|FG001|Overall Study|Adverse Event|1|||
149089242|NCT01757171|537805119|FG000|Overall Study|Disease Progression|1|||
149089243|NCT01757171|537805120|FG001|Overall Study|Disease Progression|0|||
149089244|NCT01757171|537805119|FG000|Overall Study|Hospitalization|1|||
149089245|NCT01757171|537805120|FG001|Overall Study|Hospitalization|0|||
149089246|NCT01757171|537805119|FG000|Overall Study|ECOG decline|1|||
149089247|NCT01757171|537805120|FG001|Overall Study|ECOG decline|0|||
149089248|NCT00428441|537805121|FG000|Overall Study|Lost to Follow-up|1|||
149089249|NCT01014013|537805125|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
149089250|NCT01014013|537805126|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
149089251|NCT01014013|537805125|FG000|Overall Study|Clinical adverse experience|4|||
149089252|NCT01014013|537805126|FG001|Overall Study|Clinical adverse experience|2|||
149089253|NCT01014013|537805125|FG000|Overall Study|Laboratory adverse experience|1|||
149089254|NCT01014013|537805126|FG001|Overall Study|Laboratory adverse experience|1|||
149089255|NCT01014013|537805125|FG000|Overall Study|Protocol Violation|1|||
149089256|NCT01014013|537805126|FG001|Overall Study|Protocol Violation|3|||
149089257|NCT01014013|537805125|FG000|Overall Study|Withdrawal by Subject|7|||
149089258|NCT01014013|537805126|FG001|Overall Study|Withdrawal by Subject|4|||
149089259|NCT01014013|537805125|FG000|Overall Study|Clinical/microbiologic failure|1|||
149089260|NCT01014013|537805126|FG001|Overall Study|Clinical/microbiologic failure|2|||
149089261|NCT01014013|537805125|FG000|Overall Study|Pathogen culture = no growth|26|||
149089262|NCT01014013|537805126|FG001|Overall Study|Pathogen culture = no growth|34|||
149089263|NCT01014013|537805125|FG000|Overall Study|Negative urine culture|2|||
149089264|NCT01014013|537805126|FG001|Overall Study|Negative urine culture|0|||
149089265|NCT01014013|537805125|FG000|Overall Study|Pathogen resistant|7|||
149089266|NCT01014013|537805126|FG001|Overall Study|Pathogen resistant|4|||
149089267|NCT01014013|537805125|FG000|Overall Study|Physician Decision|0|||
149089268|NCT01014013|537805126|FG001|Overall Study|Physician Decision|1|||
149089269|NCT01014013|537805125|FG000|Overall Study|Another antibiotic therapy required|0|||
149089270|NCT01014013|537805126|FG001|Overall Study|Another antibiotic therapy required|1|||
149089271|NCT01014013|537805125|FG000|Overall Study|Appendectomy|1|||
149089272|NCT01014013|537805126|FG001|Overall Study|Appendectomy|0|||
149089273|NCT01014013|537805125|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
149089274|NCT01014013|537805126|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
149089275|NCT03508830|537805127|FG000|Overall Study|Withdrawal by Subject|3|||
149089276|NCT03508830|537805128|FG001|Overall Study|Withdrawal by Subject|4|||
149089277|NCT03508830|537805127|FG000|Overall Study|Physician Decision|2|||
149089278|NCT03508830|537805128|FG001|Overall Study|Physician Decision|2|||
149089279|NCT02097056|537805131|FG000|Overall Study|Protocol Violation|2|||
149089280|NCT02097056|537805131|FG000|Overall Study|Withdrawal by Subject|15|||
149089281|NCT02097056|537805131|FG000|Overall Study|Lost to Follow-up|2|||
149089282|NCT02097056|537805131|FG000|Overall Study|Adverse Event|37|||
149089283|NCT02097056|537805131|FG000|Overall Study|Other|2|||
149089284|NCT03906240|537805132|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
149089285|NCT03906240|537805133|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
149089286|NCT03906240|537805132|FG000|Overall Study|Lost to Follow-up|1|||
149089287|NCT03906240|537805133|FG001|Overall Study|Lost to Follow-up|0|||
149089288|NCT03906240|537805132|FG000|Overall Study|Withdrawal by Subject|0|||
149089289|NCT03906240|537805133|FG001|Overall Study|Withdrawal by Subject|1|||
149089290|NCT01446042|537805134|FG000|Overall Study|Withdrawal by Subject|12|||
149089291|NCT01446042|537805135|FG001|Overall Study|Withdrawal by Subject|2|||
149089292|NCT01446042|537805136|FG002|Overall Study|Withdrawal by Subject|4|||
149089293|NCT01446042|537805134|FG000|Overall Study|Adverse Event|1|||
149089294|NCT01446042|537805135|FG001|Overall Study|Adverse Event|0|||
149089295|NCT01446042|537805136|FG002|Overall Study|Adverse Event|4|||
149089296|NCT01446042|537805134|FG000|Overall Study|Lost to Follow-up|5|||
149089297|NCT01446042|537805135|FG001|Overall Study|Lost to Follow-up|0|||
149089298|NCT01446042|537805136|FG002|Overall Study|Lost to Follow-up|0|||
149089299|NCT01446042|537805134|FG000|Overall Study|Other reasons|2|||
149089300|NCT01446042|537805135|FG001|Overall Study|Other reasons|1|||
149089301|NCT01446042|537805136|FG002|Overall Study|Other reasons|1|||
149089302|NCT00274846|537805148|FG000|Overall Study|Did not receive adequate NK cells|1|||
149089303|NCT01395914|537805154|FG000|Overall Study|Unrelated to study drug AE|6|||
149089304|NCT01395914|537805155|FG001|Overall Study|Unrelated to study drug AE|1|||
149089305|NCT01395914|537805154|FG000|Overall Study|Death|23|||
149089306|NCT01395914|537805155|FG001|Overall Study|Death|17|||
149089307|NCT01395914|537805154|FG000|Overall Study|Other|9|||
149089308|NCT01395914|537805155|FG001|Overall Study|Other|3|||
149089309|NCT01395914|537805154|FG000|Overall Study|Withdrawal by patient|27|||
149089310|NCT01395914|537805155|FG001|Overall Study|Withdrawal by patient|14|||
149089311|NCT01395914|537805154|FG000|Overall Study|Study drug-related AE|1|||
149089312|NCT01395914|537805155|FG001|Overall Study|Study drug-related AE|0|||
149089313|NCT01395914|537805154|FG000|Overall Study|Lost to Follow-up|6|||
149089314|NCT01395914|537805155|FG001|Overall Study|Lost to Follow-up|2|||
149089315|NCT05287178|537805156|FG000|Overall Study|Lost to Follow-up|2|||
149089316|NCT01920178|537805157|FG000|Overall Study|Lost to Follow-up|2|||
149089317|NCT01920178|537805158|FG001|Overall Study|Lost to Follow-up|1|||
149089318|NCT03023878|537805159|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
149089319|NCT03023878|537805159|FG000|Pre-Study Run-In Period|Death|1|||
149089320|NCT03023878|537805159|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
149089321|NCT03023878|537805159|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
149089322|NCT03023878|537805159|FG000|Treatment Period|Disease Progression|1|||
149089323|NCT03023878|537805159|FG000|Treatment Period|Withdrawal by Subject|1|||
149089324|NCT03023878|537805159|FG000|Treatment Period|Adverse Event|1|||
149089325|NCT03023878|537805159|FG000|Long Term Follow-Up Period|Death|2|||
149089326|NCT00288353|537805160|FG000|Overall Study|Lack of Efficacy|2|||
149089327|NCT00288353|537805161|FG001|Overall Study|Lack of Efficacy|2|||
149089328|NCT00288353|537805160|FG000|Overall Study|Withdrawal by Subject|5|||
149089329|NCT00288353|537805161|FG001|Overall Study|Withdrawal by Subject|5|||
149089330|NCT02849509|537805162|FG000|Overall Study|Worsening of disease under study|1|||
149089331|NCT02849509|537805163|FG001|Overall Study|Worsening of disease under study|1|||
149089332|NCT02849509|537805164|FG002|Overall Study|Worsening of disease under study|1|||
149089333|NCT02849509|537805162|FG000|Overall Study|Worsening of other pre-existing disease|0|||
149089334|NCT02849509|537805163|FG001|Overall Study|Worsening of other pre-existing disease|1|||
149089335|NCT02849509|537805164|FG002|Overall Study|Worsening of other pre-existing disease|2|||
149089336|NCT02849509|537805162|FG000|Overall Study|Other adverse event|36|||
149089337|NCT02849509|537805163|FG001|Overall Study|Other adverse event|41|||
149089338|NCT02849509|537805164|FG002|Overall Study|Other adverse event|8|||
149089339|NCT02849509|537805162|FG000|Overall Study|Withdrawal by Subject|6|||
149089340|NCT02849509|537805163|FG001|Overall Study|Withdrawal by Subject|17|||
149089341|NCT02849509|537805164|FG002|Overall Study|Withdrawal by Subject|12|||
149089342|NCT02849509|537805162|FG000|Overall Study|Lost to Follow-up|27|||
149089343|NCT02849509|537805163|FG001|Overall Study|Lost to Follow-up|67|||
149089344|NCT02849509|537805164|FG002|Overall Study|Lost to Follow-up|36|||
149089345|NCT02849509|537805162|FG000|Overall Study|Other, reason not specified|14|||
149089346|NCT02849509|537805163|FG001|Overall Study|Other, reason not specified|29|||
149089347|NCT02849509|537805164|FG002|Overall Study|Other, reason not specified|25|||
149089348|NCT02849509|537805162|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
149089349|NCT02849509|537805163|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
149089350|NCT02849509|537805164|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
149089351|NCT02374476|537805172|FG000|VT Induced Ablation|Screening Failures|36|||
149089352|NCT02374476|537805173|FG001|VT Induced Ablation|Screening Failures|0|||
149089353|NCT02374476|537805174|FG002|VT Induced Ablation|Screening Failures|0|||
149089354|NCT02374476|537805172|FG000|Arm Assignment|Withdrawal by Subject|0|||
149089355|NCT02374476|537805173|FG001|Arm Assignment|Withdrawal by Subject|0|||
149089356|NCT02374476|537805174|FG002|Arm Assignment|Withdrawal by Subject|1|||
149089357|NCT05431543|537805175|FG000|Overall Study|Medical History|1|||
149089358|NCT05431543|537805176|FG001|Overall Study|Medical History|0|||
149089359|NCT05431543|537805177|FG002|Overall Study|Medical History|0|||
149089360|NCT02389894|537805178|FG000|Overall Study|Death|4|||
149089361|NCT02389894|537805179|FG001|Overall Study|Death|5|||
149089362|NCT02389894|537805180|FG002|Overall Study|Death|3|||
149089363|NCT02389894|537805178|FG000|Overall Study|Withdrawal by Subject|2|||
149089364|NCT02389894|537805179|FG001|Overall Study|Withdrawal by Subject|4|||
149089365|NCT02389894|537805180|FG002|Overall Study|Withdrawal by Subject|5|||
149089366|NCT02389894|537805178|FG000|Overall Study|Lost to Follow-up|2|||
149089367|NCT02389894|537805179|FG001|Overall Study|Lost to Follow-up|1|||
149089368|NCT02389894|537805180|FG002|Overall Study|Lost to Follow-up|1|||
149089369|NCT00145496|537805183|FG000|Overall Study|Adverse Event|42|||
149089370|NCT00145496|537805184|FG001|Overall Study|Adverse Event|30|||
149089371|NCT00145496|537805183|FG000|Overall Study|Lack of Efficacy|12|||
149089372|NCT00145496|537805184|FG001|Overall Study|Lack of Efficacy|7|||
149089373|NCT00145496|537805183|FG000|Overall Study|Withdrawal by Subject|32|||
149089374|NCT00145496|537805184|FG001|Overall Study|Withdrawal by Subject|26|||
149089375|NCT00145496|537805183|FG000|Overall Study|Lost to Follow-up|12|||
149089376|NCT00145496|537805184|FG001|Overall Study|Lost to Follow-up|5|||
149089377|NCT00145496|537805183|FG000|Overall Study|Other|25|||
149089378|NCT00145496|537805184|FG001|Overall Study|Other|13|||
149089379|NCT01429285|537805188|FG000|Overall Study|Protocol Violation|9|||
149089380|NCT01429285|537805189|FG001|Overall Study|Protocol Violation|4|||
149089381|NCT01429285|537805188|FG000|Overall Study|Missing Data|5|||
149089382|NCT01429285|537805189|FG001|Overall Study|Missing Data|3|||
149089383|NCT01429285|537805188|FG000|Overall Study|Erroneously Enrolled Twice|8|||
149089384|NCT01429285|537805189|FG001|Overall Study|Erroneously Enrolled Twice|2|||
149089385|NCT03138499|537805190|FG000|Overall Study|Lost to Follow-up|1|||
149089386|NCT03138499|537805191|FG001|Overall Study|Lost to Follow-up|0|||
149089387|NCT03138499|537805190|FG000|Overall Study|Participants withdrew consent|1|||
149089388|NCT03138499|537805191|FG001|Overall Study|Participants withdrew consent|0|||
149089389|NCT03138499|537805190|FG000|Overall Study|Participant discontinued study before treatment|0|||
149089390|NCT03138499|537805191|FG001|Overall Study|Participant discontinued study before treatment|1|||
149089391|NCT03138499|537805190|FG000|Overall Study|Disease Progression|2|||
149089392|NCT03138499|537805191|FG001|Overall Study|Disease Progression|6|||
149089393|NCT03138499|537805190|FG000|Overall Study|Study drug toxicity|2|||
149089394|NCT03138499|537805191|FG001|Overall Study|Study drug toxicity|2|||
149089395|NCT03138499|537805190|FG000|Overall Study|Participant request to discontinue study treatment|1|||
149089396|NCT03138499|537805191|FG001|Overall Study|Participant request to discontinue study treatment|1|||
149089397|NCT03138499|537805190|FG000|Overall Study|Other reasons|2|||
149089398|NCT03138499|537805191|FG001|Overall Study|Other reasons|0|||
149089399|NCT01334606|537805192|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
149089400|NCT02312245|537805193|FG000|Overall Study|Death|0|||
149089401|NCT02312245|537805194|FG001|Overall Study|Death|0|||
149089402|NCT02312245|537805195|FG002|Overall Study|Death|0|||
149089403|NCT02312245|537805196|FG003|Overall Study|Death|1|||
149089404|NCT02312245|537805193|FG000|Overall Study|Withdrawal by Subject|1|||
149089405|NCT02312245|537805194|FG001|Overall Study|Withdrawal by Subject|1|||
149089406|NCT02312245|537805195|FG002|Overall Study|Withdrawal by Subject|0|||
149089407|NCT02312245|537805196|FG003|Overall Study|Withdrawal by Subject|2|||
149089408|NCT02312245|537805193|FG000|Overall Study|Alternative Therapy|1|||
149089409|NCT02312245|537805194|FG001|Overall Study|Alternative Therapy|0|||
149089410|NCT02312245|537805195|FG002|Overall Study|Alternative Therapy|0|||
149089411|NCT02312245|537805196|FG003|Overall Study|Alternative Therapy|0|||
149089412|NCT02312245|537805193|FG000|Overall Study|Progression|0|||
149089413|NCT02312245|537805194|FG001|Overall Study|Progression|0|||
149089414|NCT02312245|537805195|FG002|Overall Study|Progression|0|||
149089415|NCT02312245|537805196|FG003|Overall Study|Progression|5|||
149089416|NCT02312245|537805193|FG000|Overall Study|Patient went to hospice|0|||
149089417|NCT02312245|537805194|FG001|Overall Study|Patient went to hospice|0|||
149089418|NCT02312245|537805195|FG002|Overall Study|Patient went to hospice|0|||
149089419|NCT02312245|537805196|FG003|Overall Study|Patient went to hospice|1|||
149089420|NCT02312245|537805193|FG000|Overall Study|Ineligible|1|||
149089421|NCT02312245|537805194|FG001|Overall Study|Ineligible|0|||
149089422|NCT02312245|537805195|FG002|Overall Study|Ineligible|0|||
149089423|NCT02312245|537805196|FG003|Overall Study|Ineligible|0|||
149089424|NCT00448344|537805197|FG000|Overall Study|Lost to Follow-up|20|||
149089425|NCT00448344|537805198|FG001|Overall Study|Lost to Follow-up|22|||
149089426|NCT00448344|537805197|FG000|Overall Study|Withdrawal by Subject|6|||
149089427|NCT00448344|537805198|FG001|Overall Study|Withdrawal by Subject|8|||
149089428|NCT00448344|537805197|FG000|Overall Study|Death|3|||
149089429|NCT00448344|537805198|FG001|Overall Study|Death|4|||
149089430|NCT00448344|537805197|FG000|Overall Study|Physician Decision|1|||
149089431|NCT00448344|537805198|FG001|Overall Study|Physician Decision|2|||
149089432|NCT01123200|537805202|FG000|Overall Study|Withdrawal by Subject|1|||
149089433|NCT02577315|537805209|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
149089434|NCT02577315|537805210|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
149089435|NCT04044352|537806922|FG000|Overall Study|Lost to Follow-up|9|||
149089436|NCT04044352|537806922|FG000|Overall Study|Withdrawal by Subject|2|||
149089437|NCT02176356|537806923|FG000|Overall Study|Screen Failure|14|||
149089438|NCT02176356|537806923|FG000|Overall Study|Lost to Follow-up|4|||
149089439|NCT02176356|537806923|FG000|Overall Study|Personal Reasons|3|||
149089440|NCT02176356|537806923|FG000|Overall Study|Other Miscellaneous Reasons|2|||
149089441|NCT01537120|537806927|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
149089442|NCT01537120|537806927|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
149089443|NCT03087851|537806929|FG000|Overall Study|Withdraw on medical grounds|0|||
149089444|NCT03087851|537806930|FG001|Overall Study|Withdraw on medical grounds|1|||
149089445|NCT03087851|537806931|FG002|Overall Study|Withdraw on medical grounds|2|||
149089446|NCT00443755|537806934|FG000|Overall Study|Withdrawal by Subject|2|||
149089447|NCT00443755|537806935|FG001|Overall Study|Withdrawal by Subject|1|||
149089448|NCT02775214|537806936|FG000|Overall Study|Withdrawal by Subject|2|||
149089449|NCT02775214|537806937|FG001|Overall Study|Withdrawal by Subject|0|||
149089450|NCT03451292|537806938|FG000|Overall Study|Death|44|||
149089451|NCT03451292|537806939|FG001|Overall Study|Death|59|||
149089452|NCT03451292|537806938|FG000|Overall Study|Withdrawal by Subject|18|||
149089453|NCT03451292|537806939|FG001|Overall Study|Withdrawal by Subject|13|||
149089454|NCT03451292|537806938|FG000|Overall Study|Transplantation|18|||
149089455|NCT03451292|537806939|FG001|Overall Study|Transplantation|12|||
149089456|NCT03451292|537806938|FG000|Overall Study|Lost to Follow-up|4|||
149089457|NCT03451292|537806939|FG001|Overall Study|Lost to Follow-up|12|||
149089458|NCT03451292|537806938|FG000|Overall Study|Physician Decision|4|||
149089459|NCT03451292|537806939|FG001|Overall Study|Physician Decision|3|||
149089460|NCT03451292|537806938|FG000|Overall Study|Adverse Event|3|||
149089461|NCT03451292|537806939|FG001|Overall Study|Adverse Event|3|||
149089462|NCT03451292|537806938|FG000|Overall Study|Non-compliance with Study Drug|2|||
149089463|NCT03451292|537806939|FG001|Overall Study|Non-compliance with Study Drug|0|||
149089464|NCT04385849|537806940|FG000|Overall Study|Lost to Follow-up|1|||
149089465|NCT04385849|537806941|FG001|Overall Study|Lost to Follow-up|0|||
149089466|NCT00355784|537806942|FG000|Overall Study|Withdrawal by Subject|0|||
149089467|NCT00355784|537806943|FG001|Overall Study|Withdrawal by Subject|0|||
149089468|NCT00355784|537806944|FG002|Overall Study|Withdrawal by Subject|2|||
149089469|NCT02543294|537806945|FG000|Overall Study|Lost to Follow-up|3|||
149089470|NCT02543294|537806945|FG000|Overall Study|Physician Decision|2|||
149089471|NCT02543294|537806945|FG000|Overall Study|Withdrawal by Subject|7|||
149089472|NCT00730925|537806946|FG000|Overall Study|Progressive Disease|21|||
149089473|NCT00730925|537806946|FG000|Overall Study|Dose reducing Event|2|||
149089474|NCT00730925|537806946|FG000|Overall Study|Other Averse Event|7|||
149089475|NCT00730925|537806946|FG000|Overall Study|Protocol Violation|1|||
149089476|NCT00730925|537806946|FG000|Overall Study|Withdrawal by Subject|1|||
149089477|NCT00730925|537806946|FG000|Overall Study|Switch to combination therapy|8|||
149089478|NCT00730925|537806946|FG000|Overall Study|Other|1|||
149089479|NCT02137239|537806947|FG000|Overall Study|Discontinued Study Treatment|0|||
149089480|NCT02137239|537806948|FG001|Overall Study|Discontinued Study Treatment|3|||
149089481|NCT02137239|537806947|FG000|Overall Study|Withdrew Consent|1|||
149089482|NCT02137239|537806948|FG001|Overall Study|Withdrew Consent|1|||
149089483|NCT02137239|537806947|FG000|Overall Study|Adverse Event|2|||
149089484|NCT02137239|537806948|FG001|Overall Study|Adverse Event|2|||
149089485|NCT02475733|537806953|FG000|Overall Study|Withdrawal by Subject|1|||
149089486|NCT02475733|537806954|FG001|Overall Study|Withdrawal by Subject|0|||
149089487|NCT02475733|537806953|FG000|Overall Study|Physician Decision|1|||
149089488|NCT02475733|537806954|FG001|Overall Study|Physician Decision|0|||
149089489|NCT02131155|537806957|FG000|Overall Study|Adverse Event|1|||
149089490|NCT02131155|537806958|FG001|Overall Study|Adverse Event|0|||
149089491|NCT02131155|537806957|FG000|Overall Study|Treatment completed|1|||
149089492|NCT02131155|537806958|FG001|Overall Study|Treatment completed|0|||
149089493|NCT02131155|537806957|FG000|Overall Study|Primary tumour recurrence|2|||
149089494|NCT02131155|537806958|FG001|Overall Study|Primary tumour recurrence|1|||
149089495|NCT02131155|537806957|FG000|Overall Study|Refused to continue study medication|1|||
149089496|NCT02131155|537806958|FG001|Overall Study|Refused to continue study medication|0|||
149089497|NCT02131155|537806957|FG000|Overall Study|Study early termination|20|||
149089498|NCT02131155|537806958|FG001|Overall Study|Study early termination|10|||
149089499|NCT01887418|537806959|FG000|Overall Study|Travelling difficulties|0|||
149089500|NCT01887418|537806960|FG001|Overall Study|Travelling difficulties|0|||
149089501|NCT01887418|537806961|FG002|Overall Study|Travelling difficulties|1|||
149089502|NCT03132753|537806962|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
149089503|NCT03132753|537806963|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
149089504|NCT03132753|537806962|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
149089505|NCT03132753|537806963|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
149089506|NCT02744898|537806964|FG000|Overall Study|Progressive Disease|2|||
149089507|NCT02744898|537806964|FG000|Overall Study|Physician Decision|1|||
149089508|NCT02744898|537806964|FG000|Overall Study|Toxicity|1|||
149089509|NCT04908800|537806966|FG000|Overall Study|Adverse Event|0|||
149089510|NCT04908800|537806967|FG001|Overall Study|Adverse Event|0|||
149089511|NCT04908800|537806968|FG002|Overall Study|Adverse Event|0|||
149089512|NCT04908800|537806969|FG003|Overall Study|Adverse Event|0|||
149089513|NCT04908800|537806970|FG004|Overall Study|Adverse Event|0|||
149089514|NCT04908800|537806971|FG005|Overall Study|Adverse Event|0|||
149089515|NCT04908800|537806972|FG006|Overall Study|Adverse Event|0|||
149089516|NCT04908800|537806973|FG007|Overall Study|Adverse Event|0|||
149089517|NCT04908800|537806974|FG008|Overall Study|Adverse Event|0|||
149089518|NCT04908800|537806975|FG009|Overall Study|Adverse Event|0|||
149089519|NCT04908800|537806976|FG010|Overall Study|Adverse Event|1|||
149089520|NCT04908800|537806977|FG011|Overall Study|Adverse Event|0|||
149089521|NCT04908800|537806978|FG012|Overall Study|Adverse Event|0|||
149089522|NCT00157209|537806979|FG000|Overall Study|Ongoing at data cut-off|10|||
149089523|NCT00157209|537806980|FG001|Overall Study|Ongoing at data cut-off|0|||
149089524|NCT03751280|537806981|FG000|Overall Study|Adverse Event|0|||
149089525|NCT03751280|537806982|FG001|Overall Study|Adverse Event|1|||
149089526|NCT03751280|537806981|FG000|Overall Study|Lost to Follow-up|3|||
149089527|NCT03751280|537806982|FG001|Overall Study|Lost to Follow-up|5|||
149089528|NCT03751280|537806981|FG000|Overall Study|Physician Decision|0|||
149089529|NCT03751280|537806982|FG001|Overall Study|Physician Decision|2|||
149089530|NCT03751280|537806981|FG000|Overall Study|Protocol Violation|0|||
149089531|NCT03751280|537806982|FG001|Overall Study|Protocol Violation|2|||
149089532|NCT03751280|537806981|FG000|Overall Study|Withdrawal by Subject|5|||
149089533|NCT03751280|537806982|FG001|Overall Study|Withdrawal by Subject|2|||
149089534|NCT00296504|537806983|FG000|Interim Analysis|Withdrawal by Subject|8|||
149089535|NCT00296504|537806984|FG001|Interim Analysis|Withdrawal by Subject|0|||
149089536|NCT00296504|537806985|FG002|Interim Analysis|Withdrawal by Subject|12|||
149089537|NCT00296504|537806986|FG003|Interim Analysis|Withdrawal by Subject|0|||
149089538|NCT00296504|537806987|FG004|Interim Analysis|Withdrawal by Subject|5|||
149089539|NCT00296504|537806988|FG005|Interim Analysis|Withdrawal by Subject|5|||
149089540|NCT00296504|537806989|FG006|Interim Analysis|Withdrawal by Subject|9|||
149089541|NCT00296504|537806990|FG007|Interim Analysis|Withdrawal by Subject|3|||
149089542|NCT00296504|537806991|FG008|Interim Analysis|Withdrawal by Subject|0|||
149089543|NCT00296504|537806983|FG000|Interim Analysis|Lost to Follow-up|13|||
149089544|NCT00296504|537806984|FG001|Interim Analysis|Lost to Follow-up|3|||
149089545|NCT00296504|537806985|FG002|Interim Analysis|Lost to Follow-up|26|||
149089546|NCT00296504|537806986|FG003|Interim Analysis|Lost to Follow-up|8|||
149089547|NCT00296504|537806987|FG004|Interim Analysis|Lost to Follow-up|14|||
149089548|NCT00296504|537806988|FG005|Interim Analysis|Lost to Follow-up|4|||
149089549|NCT00296504|537806989|FG006|Interim Analysis|Lost to Follow-up|11|||
149089550|NCT00296504|537806990|FG007|Interim Analysis|Lost to Follow-up|4|||
149089551|NCT00296504|537806991|FG008|Interim Analysis|Lost to Follow-up|0|||
149089552|NCT00296504|537806983|FG000|Interim Analysis|Clinical Progression|1|||
149089553|NCT00296504|537806984|FG001|Interim Analysis|Clinical Progression|0|||
149089554|NCT00296504|537806985|FG002|Interim Analysis|Clinical Progression|1|||
149089555|NCT00296504|537806986|FG003|Interim Analysis|Clinical Progression|1|||
149089556|NCT00296504|537806987|FG004|Interim Analysis|Clinical Progression|0|||
149089557|NCT00296504|537806988|FG005|Interim Analysis|Clinical Progression|2|||
149089558|NCT00296504|537806989|FG006|Interim Analysis|Clinical Progression|1|||
149089559|NCT00296504|537806990|FG007|Interim Analysis|Clinical Progression|2|||
149089560|NCT00296504|537806991|FG008|Interim Analysis|Clinical Progression|0|||
149089561|NCT00296504|537806983|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
149089562|NCT00296504|537806984|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
149089563|NCT00296504|537806985|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
149089564|NCT00296504|537806986|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
149089565|NCT00296504|537806987|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
149089566|NCT00296504|537806988|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
149089567|NCT00296504|537806989|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
149089568|NCT00296504|537806990|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
149089569|NCT00296504|537806991|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
149089570|NCT00296504|537806983|FG000|Interim Analysis|Adverse Event|0|||
149089571|NCT00296504|537806984|FG001|Interim Analysis|Adverse Event|0|||
149089572|NCT00296504|537806985|FG002|Interim Analysis|Adverse Event|13|||
149089573|NCT00296504|537806986|FG003|Interim Analysis|Adverse Event|4|||
149089574|NCT00296504|537806987|FG004|Interim Analysis|Adverse Event|6|||
149089575|NCT00296504|537806988|FG005|Interim Analysis|Adverse Event|3|||
149089576|NCT00296504|537806989|FG006|Interim Analysis|Adverse Event|4|||
149089577|NCT00296504|537806990|FG007|Interim Analysis|Adverse Event|5|||
149089578|NCT00296504|537806991|FG008|Interim Analysis|Adverse Event|0|||
149089579|NCT00296504|537806983|FG000|Interim Analysis|Protocol Violation|0|||
149089580|NCT00296504|537806984|FG001|Interim Analysis|Protocol Violation|0|||
149089581|NCT00296504|537806985|FG002|Interim Analysis|Protocol Violation|2|||
149089582|NCT00296504|537806986|FG003|Interim Analysis|Protocol Violation|0|||
149089583|NCT00296504|537806987|FG004|Interim Analysis|Protocol Violation|1|||
149089584|NCT00296504|537806988|FG005|Interim Analysis|Protocol Violation|0|||
149089585|NCT00296504|537806989|FG006|Interim Analysis|Protocol Violation|0|||
149089586|NCT00296504|537806990|FG007|Interim Analysis|Protocol Violation|1|||
149089587|NCT00296504|537806991|FG008|Interim Analysis|Protocol Violation|0|||
149089588|NCT00296504|537806983|FG000|Interim Analysis|Insufficient CD4 Response|0|||
149089589|NCT00296504|537806984|FG001|Interim Analysis|Insufficient CD4 Response|0|||
149089590|NCT00296504|537806985|FG002|Interim Analysis|Insufficient CD4 Response|0|||
149089591|NCT00296504|537806986|FG003|Interim Analysis|Insufficient CD4 Response|0|||
149089592|NCT00296504|537806987|FG004|Interim Analysis|Insufficient CD4 Response|1|||
149089593|NCT00296504|537806988|FG005|Interim Analysis|Insufficient CD4 Response|1|||
149089594|NCT00296504|537806989|FG006|Interim Analysis|Insufficient CD4 Response|0|||
149089595|NCT00296504|537806990|FG007|Interim Analysis|Insufficient CD4 Response|0|||
149089596|NCT00296504|537806991|FG008|Interim Analysis|Insufficient CD4 Response|0|||
149089597|NCT00296504|537806983|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
149089598|NCT00296504|537806984|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
149089599|NCT00296504|537806985|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
149089600|NCT00296504|537806986|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
149089601|NCT00296504|537806987|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
149089602|NCT00296504|537806988|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
149089603|NCT00296504|537806989|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
149089604|NCT00296504|537806990|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
149089605|NCT00296504|537806991|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
149089606|NCT00296504|537806983|FG000|Interim Analysis|Pregnancy|4|||
149089607|NCT00296504|537806984|FG001|Interim Analysis|Pregnancy|1|||
149089608|NCT00296504|537806985|FG002|Interim Analysis|Pregnancy|4|||
149089609|NCT00296504|537806986|FG003|Interim Analysis|Pregnancy|2|||
149089610|NCT00296504|537806987|FG004|Interim Analysis|Pregnancy|0|||
149089611|NCT00296504|537806988|FG005|Interim Analysis|Pregnancy|1|||
149089612|NCT00296504|537806989|FG006|Interim Analysis|Pregnancy|1|||
149089613|NCT00296504|537806990|FG007|Interim Analysis|Pregnancy|1|||
149089614|NCT00296504|537806991|FG008|Interim Analysis|Pregnancy|0|||
149089615|NCT00296504|537806983|FG000|Interim Analysis|Death|1|||
149089616|NCT00296504|537806984|FG001|Interim Analysis|Death|0|||
149089617|NCT00296504|537806985|FG002|Interim Analysis|Death|3|||
149089618|NCT00296504|537806986|FG003|Interim Analysis|Death|0|||
149089619|NCT00296504|537806987|FG004|Interim Analysis|Death|0|||
149089620|NCT00296504|537806988|FG005|Interim Analysis|Death|0|||
149089621|NCT00296504|537806989|FG006|Interim Analysis|Death|0|||
149089622|NCT00296504|537806990|FG007|Interim Analysis|Death|0|||
149089623|NCT00296504|537806991|FG008|Interim Analysis|Death|0|||
149089624|NCT00296504|537806983|FG000|Interim Analysis|Participant Non-compliant|0|||
149089625|NCT00296504|537806984|FG001|Interim Analysis|Participant Non-compliant|1|||
149089626|NCT00296504|537806985|FG002|Interim Analysis|Participant Non-compliant|2|||
149089627|NCT00296504|537806986|FG003|Interim Analysis|Participant Non-compliant|1|||
149089628|NCT00296504|537806987|FG004|Interim Analysis|Participant Non-compliant|1|||
149089629|NCT00296504|537806988|FG005|Interim Analysis|Participant Non-compliant|3|||
149089630|NCT00296504|537806989|FG006|Interim Analysis|Participant Non-compliant|6|||
149089631|NCT00296504|537806990|FG007|Interim Analysis|Participant Non-compliant|2|||
149089632|NCT00296504|537806991|FG008|Interim Analysis|Participant Non-compliant|0|||
149089633|NCT00296504|537806983|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089634|NCT00296504|537806984|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089635|NCT00296504|537806985|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
149089636|NCT00296504|537806986|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089637|NCT00296504|537806987|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089638|NCT00296504|537806988|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
149089639|NCT00296504|537806989|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089640|NCT00296504|537806990|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089641|NCT00296504|537806991|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
149089642|NCT00296504|537806983|FG000|Interim Analysis|To Simplify Treatment|0|||
149089643|NCT00296504|537806984|FG001|Interim Analysis|To Simplify Treatment|0|||
149089644|NCT00296504|537806985|FG002|Interim Analysis|To Simplify Treatment|1|||
149089645|NCT00296504|537806986|FG003|Interim Analysis|To Simplify Treatment|0|||
149089646|NCT00296504|537806987|FG004|Interim Analysis|To Simplify Treatment|0|||
149089647|NCT00296504|537806988|FG005|Interim Analysis|To Simplify Treatment|0|||
149089648|NCT00296504|537806989|FG006|Interim Analysis|To Simplify Treatment|2|||
149089649|NCT00296504|537806990|FG007|Interim Analysis|To Simplify Treatment|0|||
149089650|NCT00296504|537806991|FG008|Interim Analysis|To Simplify Treatment|0|||
149089651|NCT00296504|537806983|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089652|NCT00296504|537806984|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089653|NCT00296504|537806985|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
149089654|NCT00296504|537806986|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089655|NCT00296504|537806987|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089656|NCT00296504|537806988|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089657|NCT00296504|537806989|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089658|NCT00296504|537806990|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089659|NCT00296504|537806991|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
149089660|NCT00296504|537806983|FG000|Interim Analysis|Participant Moved|1|||
149089661|NCT00296504|537806984|FG001|Interim Analysis|Participant Moved|0|||
149089662|NCT00296504|537806985|FG002|Interim Analysis|Participant Moved|1|||
149089663|NCT00296504|537806986|FG003|Interim Analysis|Participant Moved|0|||
149089664|NCT00296504|537806987|FG004|Interim Analysis|Participant Moved|0|||
149089665|NCT00296504|537806988|FG005|Interim Analysis|Participant Moved|1|||
149089666|NCT00296504|537806989|FG006|Interim Analysis|Participant Moved|1|||
149089667|NCT00296504|537806990|FG007|Interim Analysis|Participant Moved|0|||
149089668|NCT00296504|537806991|FG008|Interim Analysis|Participant Moved|0|||
149089669|NCT00296504|537806983|FG000|Interim Analysis|Participant Was Incarcerated|2|||
149089670|NCT00296504|537806984|FG001|Interim Analysis|Participant Was Incarcerated|0|||
149089671|NCT00296504|537806985|FG002|Interim Analysis|Participant Was Incarcerated|1|||
149089672|NCT00296504|537806986|FG003|Interim Analysis|Participant Was Incarcerated|0|||
149089673|NCT00296504|537806987|FG004|Interim Analysis|Participant Was Incarcerated|0|||
149089674|NCT00296504|537806988|FG005|Interim Analysis|Participant Was Incarcerated|0|||
149089675|NCT00296504|537806989|FG006|Interim Analysis|Participant Was Incarcerated|0|||
149089676|NCT00296504|537806990|FG007|Interim Analysis|Participant Was Incarcerated|0|||
149089677|NCT00296504|537806991|FG008|Interim Analysis|Participant Was Incarcerated|0|||
149089678|NCT00296504|537806983|FG000|Interim Analysis|Resistance to FPV|0|||
149089679|NCT00296504|537806984|FG001|Interim Analysis|Resistance to FPV|0|||
149089680|NCT00296504|537806985|FG002|Interim Analysis|Resistance to FPV|1|||
149089681|NCT00296504|537806986|FG003|Interim Analysis|Resistance to FPV|0|||
149089682|NCT00296504|537806987|FG004|Interim Analysis|Resistance to FPV|0|||
149089683|NCT00296504|537806988|FG005|Interim Analysis|Resistance to FPV|0|||
149089684|NCT00296504|537806989|FG006|Interim Analysis|Resistance to FPV|0|||
149089685|NCT00296504|537806990|FG007|Interim Analysis|Resistance to FPV|0|||
149089686|NCT00296504|537806991|FG008|Interim Analysis|Resistance to FPV|0|||
149089687|NCT00296504|537806983|FG000|Interim Analysis|Physician Decision|0|||
149089688|NCT00296504|537806984|FG001|Interim Analysis|Physician Decision|0|||
149089689|NCT00296504|537806985|FG002|Interim Analysis|Physician Decision|1|||
149089690|NCT00296504|537806986|FG003|Interim Analysis|Physician Decision|0|||
149089691|NCT00296504|537806987|FG004|Interim Analysis|Physician Decision|0|||
149089692|NCT00296504|537806988|FG005|Interim Analysis|Physician Decision|0|||
149089693|NCT00296504|537806989|FG006|Interim Analysis|Physician Decision|0|||
149089694|NCT00296504|537806990|FG007|Interim Analysis|Physician Decision|0|||
149089695|NCT00296504|537806991|FG008|Interim Analysis|Physician Decision|0|||
149089696|NCT00296504|537806983|FG000|Interim Analysis|Principle Investigator Discretion|2|||
149089697|NCT00296504|537806984|FG001|Interim Analysis|Principle Investigator Discretion|0|||
149089698|NCT00296504|537806985|FG002|Interim Analysis|Principle Investigator Discretion|1|||
149089699|NCT00296504|537806986|FG003|Interim Analysis|Principle Investigator Discretion|1|||
149089700|NCT00296504|537806987|FG004|Interim Analysis|Principle Investigator Discretion|0|||
149089701|NCT00296504|537806988|FG005|Interim Analysis|Principle Investigator Discretion|0|||
149089702|NCT00296504|537806989|FG006|Interim Analysis|Principle Investigator Discretion|0|||
149089703|NCT00296504|537806990|FG007|Interim Analysis|Principle Investigator Discretion|0|||
149089704|NCT00296504|537806991|FG008|Interim Analysis|Principle Investigator Discretion|0|||
149089705|NCT00296504|537806983|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
149089706|NCT00296504|537806984|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
149089707|NCT00296504|537806985|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
149089708|NCT00296504|537806986|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
149089709|NCT00296504|537806987|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
149089710|NCT00296504|537806988|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
149089711|NCT00296504|537806989|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
149089712|NCT00296504|537806990|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
149089713|NCT00296504|537806991|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
149089714|NCT00296504|537806983|FG000|Interim Analysis|Non-adherence|2|||
149089715|NCT00296504|537806984|FG001|Interim Analysis|Non-adherence|0|||
149089716|NCT00296504|537806985|FG002|Interim Analysis|Non-adherence|0|||
149089717|NCT00296504|537806986|FG003|Interim Analysis|Non-adherence|0|||
149089718|NCT00296504|537806987|FG004|Interim Analysis|Non-adherence|1|||
149089719|NCT00296504|537806988|FG005|Interim Analysis|Non-adherence|0|||
149089720|NCT00296504|537806989|FG006|Interim Analysis|Non-adherence|0|||
149089721|NCT00296504|537806990|FG007|Interim Analysis|Non-adherence|1|||
149089722|NCT00296504|537806991|FG008|Interim Analysis|Non-adherence|0|||
149089723|NCT00296504|537806983|FG000|Interim Analysis|Site Closing|1|||
149089724|NCT00296504|537806984|FG001|Interim Analysis|Site Closing|0|||
149089725|NCT00296504|537806985|FG002|Interim Analysis|Site Closing|0|||
149089726|NCT00296504|537806986|FG003|Interim Analysis|Site Closing|0|||
149089727|NCT00296504|537806987|FG004|Interim Analysis|Site Closing|0|||
149089728|NCT00296504|537806988|FG005|Interim Analysis|Site Closing|1|||
149089729|NCT00296504|537806989|FG006|Interim Analysis|Site Closing|2|||
149089730|NCT00296504|537806990|FG007|Interim Analysis|Site Closing|0|||
149089731|NCT00296504|537806991|FG008|Interim Analysis|Site Closing|0|||
149089732|NCT00296504|537806983|FG000|Interim Analysis|Lack of Personnel at Site|1|||
149089733|NCT00296504|537806984|FG001|Interim Analysis|Lack of Personnel at Site|0|||
149089734|NCT00296504|537806985|FG002|Interim Analysis|Lack of Personnel at Site|0|||
149089735|NCT00296504|537806986|FG003|Interim Analysis|Lack of Personnel at Site|0|||
149089736|NCT00296504|537806987|FG004|Interim Analysis|Lack of Personnel at Site|0|||
149089737|NCT00296504|537806988|FG005|Interim Analysis|Lack of Personnel at Site|0|||
149089738|NCT00296504|537806989|FG006|Interim Analysis|Lack of Personnel at Site|0|||
149089739|NCT00296504|537806990|FG007|Interim Analysis|Lack of Personnel at Site|0|||
149089740|NCT00296504|537806991|FG008|Interim Analysis|Lack of Personnel at Site|0|||
149089741|NCT00296504|537806983|FG000|Interim Analysis|Missed Schedule Date|1|||
149089742|NCT00296504|537806984|FG001|Interim Analysis|Missed Schedule Date|0|||
149089743|NCT00296504|537806985|FG002|Interim Analysis|Missed Schedule Date|0|||
149089744|NCT00296504|537806986|FG003|Interim Analysis|Missed Schedule Date|0|||
149089745|NCT00296504|537806987|FG004|Interim Analysis|Missed Schedule Date|0|||
149089746|NCT00296504|537806988|FG005|Interim Analysis|Missed Schedule Date|0|||
149089747|NCT00296504|537806989|FG006|Interim Analysis|Missed Schedule Date|0|||
149089748|NCT00296504|537806990|FG007|Interim Analysis|Missed Schedule Date|0|||
149089749|NCT00296504|537806991|FG008|Interim Analysis|Missed Schedule Date|0|||
149089750|NCT00296504|537806983|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
149089751|NCT00296504|537806984|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
149089752|NCT00296504|537806985|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
149089753|NCT00296504|537806986|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
149089754|NCT00296504|537806987|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
149089755|NCT00296504|537806988|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
149089756|NCT00296504|537806989|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
149089757|NCT00296504|537806990|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
149089758|NCT00296504|537806991|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
149089759|NCT00296504|537806983|FG000|Interim Analysis|Participant Stopped|0|||
149089760|NCT00296504|537806984|FG001|Interim Analysis|Participant Stopped|0|||
149089761|NCT00296504|537806985|FG002|Interim Analysis|Participant Stopped|0|||
149089762|NCT00296504|537806986|FG003|Interim Analysis|Participant Stopped|0|||
149089763|NCT00296504|537806987|FG004|Interim Analysis|Participant Stopped|1|||
149089764|NCT00296504|537806988|FG005|Interim Analysis|Participant Stopped|0|||
149089765|NCT00296504|537806989|FG006|Interim Analysis|Participant Stopped|0|||
149089766|NCT00296504|537806990|FG007|Interim Analysis|Participant Stopped|0|||
149089767|NCT00296504|537806991|FG008|Interim Analysis|Participant Stopped|0|||
149089768|NCT00296504|537806983|FG000|Interim Analysis|Physician and Participant Decision|0|||
149089769|NCT00296504|537806984|FG001|Interim Analysis|Physician and Participant Decision|0|||
149089770|NCT00296504|537806985|FG002|Interim Analysis|Physician and Participant Decision|0|||
149089771|NCT00296504|537806986|FG003|Interim Analysis|Physician and Participant Decision|0|||
149089772|NCT00296504|537806987|FG004|Interim Analysis|Physician and Participant Decision|0|||
149089773|NCT00296504|537806988|FG005|Interim Analysis|Physician and Participant Decision|1|||
149089774|NCT00296504|537806989|FG006|Interim Analysis|Physician and Participant Decision|0|||
149089775|NCT00296504|537806990|FG007|Interim Analysis|Physician and Participant Decision|0|||
149089776|NCT00296504|537806991|FG008|Interim Analysis|Physician and Participant Decision|0|||
149089777|NCT00296504|537806983|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
149089778|NCT00296504|537806984|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
149089779|NCT00296504|537806985|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
149089780|NCT00296504|537806986|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
149089781|NCT00296504|537806987|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
149089782|NCT00296504|537806988|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
149089783|NCT00296504|537806989|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
149089784|NCT00296504|537806990|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
149089785|NCT00296504|537806991|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
149089786|NCT00296504|537806983|FG000|Interim Analysis|Study Ended|0|||
149089787|NCT00296504|537806984|FG001|Interim Analysis|Study Ended|0|||
149089788|NCT00296504|537806985|FG002|Interim Analysis|Study Ended|0|||
149089789|NCT00296504|537806986|FG003|Interim Analysis|Study Ended|0|||
149089790|NCT00296504|537806987|FG004|Interim Analysis|Study Ended|0|||
149089791|NCT00296504|537806988|FG005|Interim Analysis|Study Ended|0|||
149089792|NCT00296504|537806989|FG006|Interim Analysis|Study Ended|1|||
149089793|NCT00296504|537806990|FG007|Interim Analysis|Study Ended|0|||
149089794|NCT00296504|537806991|FG008|Interim Analysis|Study Ended|0|||
149089795|NCT00296504|537806983|FG000|Interim Analysis|Participant Needed Interferon|0|||
149089796|NCT00296504|537806984|FG001|Interim Analysis|Participant Needed Interferon|0|||
149089797|NCT00296504|537806985|FG002|Interim Analysis|Participant Needed Interferon|0|||
149089798|NCT00296504|537806986|FG003|Interim Analysis|Participant Needed Interferon|0|||
149089799|NCT00296504|537806987|FG004|Interim Analysis|Participant Needed Interferon|0|||
149089800|NCT00296504|537806988|FG005|Interim Analysis|Participant Needed Interferon|0|||
149089801|NCT00296504|537806989|FG006|Interim Analysis|Participant Needed Interferon|0|||
149089802|NCT00296504|537806990|FG007|Interim Analysis|Participant Needed Interferon|1|||
149089803|NCT00296504|537806991|FG008|Interim Analysis|Participant Needed Interferon|0|||
149089804|NCT00296504|537806983|FG000|Interim Analysis|Ongoing|32|||
149089805|NCT00296504|537806984|FG001|Interim Analysis|Ongoing|12|||
149089806|NCT00296504|537806985|FG002|Interim Analysis|Ongoing|16|||
149089807|NCT00296504|537806986|FG003|Interim Analysis|Ongoing|22|||
149089808|NCT00296504|537806987|FG004|Interim Analysis|Ongoing|0|||
149089809|NCT00296504|537806988|FG005|Interim Analysis|Ongoing|0|||
149089810|NCT00296504|537806989|FG006|Interim Analysis|Ongoing|30|||
149089811|NCT00296504|537806990|FG007|Interim Analysis|Ongoing|1|||
149089812|NCT00296504|537806991|FG008|Interim Analysis|Ongoing|0|||
149089813|NCT00296504|537806983|FG000|Final Analysis|Withdrawal by Subject|0|||
149089814|NCT00296504|537806984|FG001|Final Analysis|Withdrawal by Subject|0|||
149089815|NCT00296504|537806985|FG002|Final Analysis|Withdrawal by Subject|0|||
149089816|NCT00296504|537806986|FG003|Final Analysis|Withdrawal by Subject|0|||
149089817|NCT00296504|537806987|FG004|Final Analysis|Withdrawal by Subject|0|||
149089818|NCT00296504|537806988|FG005|Final Analysis|Withdrawal by Subject|0|||
149089819|NCT00296504|537806989|FG006|Final Analysis|Withdrawal by Subject|0|||
149089820|NCT00296504|537806990|FG007|Final Analysis|Withdrawal by Subject|0|||
149089821|NCT00296504|537806991|FG008|Final Analysis|Withdrawal by Subject|1|||
149089822|NCT00296504|537806983|FG000|Final Analysis|Lost to Follow-up|0|||
149089823|NCT00296504|537806984|FG001|Final Analysis|Lost to Follow-up|0|||
149089824|NCT00296504|537806985|FG002|Final Analysis|Lost to Follow-up|0|||
149089825|NCT00296504|537806986|FG003|Final Analysis|Lost to Follow-up|0|||
149089826|NCT00296504|537806987|FG004|Final Analysis|Lost to Follow-up|0|||
149089827|NCT00296504|537806988|FG005|Final Analysis|Lost to Follow-up|0|||
149089828|NCT00296504|537806989|FG006|Final Analysis|Lost to Follow-up|0|||
149089829|NCT00296504|537806990|FG007|Final Analysis|Lost to Follow-up|0|||
149089830|NCT00296504|537806991|FG008|Final Analysis|Lost to Follow-up|5|||
149089831|NCT00296504|537806983|FG000|Final Analysis|Insufficient Viral Load Response|0|||
149089832|NCT00296504|537806984|FG001|Final Analysis|Insufficient Viral Load Response|0|||
149089833|NCT00296504|537806985|FG002|Final Analysis|Insufficient Viral Load Response|0|||
149089834|NCT00296504|537806986|FG003|Final Analysis|Insufficient Viral Load Response|0|||
149089835|NCT00296504|537806987|FG004|Final Analysis|Insufficient Viral Load Response|0|||
149089836|NCT00296504|537806988|FG005|Final Analysis|Insufficient Viral Load Response|0|||
149089837|NCT00296504|537806989|FG006|Final Analysis|Insufficient Viral Load Response|0|||
149089838|NCT00296504|537806990|FG007|Final Analysis|Insufficient Viral Load Response|0|||
149089839|NCT00296504|537806991|FG008|Final Analysis|Insufficient Viral Load Response|6|||
149089840|NCT00296504|537806983|FG000|Final Analysis|Adverse Event|0|||
149089841|NCT00296504|537806984|FG001|Final Analysis|Adverse Event|0|||
149089842|NCT00296504|537806985|FG002|Final Analysis|Adverse Event|0|||
149089843|NCT00296504|537806986|FG003|Final Analysis|Adverse Event|0|||
149089844|NCT00296504|537806987|FG004|Final Analysis|Adverse Event|0|||
149089845|NCT00296504|537806988|FG005|Final Analysis|Adverse Event|0|||
149089846|NCT00296504|537806989|FG006|Final Analysis|Adverse Event|0|||
149089847|NCT00296504|537806990|FG007|Final Analysis|Adverse Event|0|||
149089848|NCT00296504|537806991|FG008|Final Analysis|Adverse Event|2|||
149089849|NCT00296504|537806983|FG000|Final Analysis|Pregnancy|0|||
149089850|NCT00296504|537806984|FG001|Final Analysis|Pregnancy|0|||
149089851|NCT00296504|537806985|FG002|Final Analysis|Pregnancy|0|||
149089852|NCT00296504|537806986|FG003|Final Analysis|Pregnancy|0|||
149089853|NCT00296504|537806987|FG004|Final Analysis|Pregnancy|0|||
149089854|NCT00296504|537806988|FG005|Final Analysis|Pregnancy|0|||
149089855|NCT00296504|537806989|FG006|Final Analysis|Pregnancy|0|||
149089856|NCT00296504|537806990|FG007|Final Analysis|Pregnancy|0|||
149089857|NCT00296504|537806991|FG008|Final Analysis|Pregnancy|4|||
149089858|NCT00296504|537806983|FG000|Final Analysis|Tuberculosis|0|||
149089859|NCT00296504|537806984|FG001|Final Analysis|Tuberculosis|0|||
149089860|NCT00296504|537806985|FG002|Final Analysis|Tuberculosis|0|||
149089861|NCT00296504|537806986|FG003|Final Analysis|Tuberculosis|0|||
149089862|NCT00296504|537806987|FG004|Final Analysis|Tuberculosis|0|||
149089863|NCT00296504|537806988|FG005|Final Analysis|Tuberculosis|0|||
149089864|NCT00296504|537806989|FG006|Final Analysis|Tuberculosis|0|||
149089865|NCT00296504|537806990|FG007|Final Analysis|Tuberculosis|0|||
149089866|NCT00296504|537806991|FG008|Final Analysis|Tuberculosis|1|||
149089867|NCT00296504|537806983|FG000|Final Analysis|Participant Moved to Another Country|0|||
149089868|NCT00296504|537806984|FG001|Final Analysis|Participant Moved to Another Country|0|||
149089869|NCT00296504|537806985|FG002|Final Analysis|Participant Moved to Another Country|0|||
149089870|NCT00296504|537806986|FG003|Final Analysis|Participant Moved to Another Country|0|||
149089871|NCT00296504|537806987|FG004|Final Analysis|Participant Moved to Another Country|0|||
149089872|NCT00296504|537806988|FG005|Final Analysis|Participant Moved to Another Country|0|||
149089873|NCT00296504|537806989|FG006|Final Analysis|Participant Moved to Another Country|0|||
149089874|NCT00296504|537806990|FG007|Final Analysis|Participant Moved to Another Country|0|||
149089875|NCT00296504|537806991|FG008|Final Analysis|Participant Moved to Another Country|1|||
149089876|NCT00296504|537806983|FG000|Final Analysis|Poor Adherence|0|||
149089877|NCT00296504|537806984|FG001|Final Analysis|Poor Adherence|0|||
149089878|NCT00296504|537806985|FG002|Final Analysis|Poor Adherence|0|||
149089879|NCT00296504|537806986|FG003|Final Analysis|Poor Adherence|0|||
149089880|NCT00296504|537806987|FG004|Final Analysis|Poor Adherence|0|||
149089881|NCT00296504|537806988|FG005|Final Analysis|Poor Adherence|0|||
149089882|NCT00296504|537806989|FG006|Final Analysis|Poor Adherence|0|||
149089883|NCT00296504|537806990|FG007|Final Analysis|Poor Adherence|0|||
149089884|NCT00296504|537806991|FG008|Final Analysis|Poor Adherence|1|||
149089885|NCT01323309|537806992|FG000|Overall Study|Death|9|||
149089886|NCT01323309|537806993|FG001|Overall Study|Death|15|||
149089887|NCT01323309|537806994|FG002|Overall Study|Death|5|||
149089888|NCT01323309|537806992|FG000|Overall Study|Lost to Follow-up|11|||
149089889|NCT01323309|537806993|FG001|Overall Study|Lost to Follow-up|14|||
149089890|NCT01323309|537806994|FG002|Overall Study|Lost to Follow-up|24|||
149089891|NCT01323309|537806992|FG000|Overall Study|Withdrawal by Subject|14|||
149089892|NCT01323309|537806993|FG001|Overall Study|Withdrawal by Subject|14|||
149089893|NCT01323309|537806994|FG002|Overall Study|Withdrawal by Subject|18|||
149089894|NCT01323309|537806992|FG000|Overall Study|Disease progression|5|||
149089895|NCT01323309|537806993|FG001|Overall Study|Disease progression|11|||
149089896|NCT01323309|537806994|FG002|Overall Study|Disease progression|4|||
149089897|NCT02162771|537806996|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
149089898|NCT02162771|537806997|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
149089899|NCT02162771|537806996|FG000|Core Study Period (Part 2)|Adverse Event|4|||
149089900|NCT02162771|537806997|FG001|Core Study Period (Part 2)|Adverse Event|1|||
149089901|NCT02162771|537806996|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
149089902|NCT02162771|537806997|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
149089903|NCT02162771|537806996|FG000|Core Study Period (Part 2)|Physician Decision|0|||
149089904|NCT02162771|537806997|FG001|Core Study Period (Part 2)|Physician Decision|2|||
149089905|NCT02162771|537806996|FG000|Core Study Period (Part 2)|Death|1|||
149089906|NCT02162771|537806997|FG001|Core Study Period (Part 2)|Death|0|||
149089907|NCT02162771|537806996|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
149089908|NCT02162771|537806997|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
149089909|NCT02162771|537806996|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
149089910|NCT02162771|537806997|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
149089911|NCT02162771|537806996|FG000|Maintenance Study Period (Part 2)|Death|2|||
149089912|NCT02162771|537806997|FG001|Maintenance Study Period (Part 2)|Death|1|||
149089913|NCT02162771|537806996|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
149089914|NCT02162771|537806997|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
149089915|NCT02162771|537806996|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
149089916|NCT02162771|537806997|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
149089917|NCT02162771|537806996|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
149089918|NCT02162771|537806997|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
149089919|NCT01348763|537807001|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
149089920|NCT01348763|537807001|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
149089921|NCT01078571|537807002|FG000|Overall Study|Adverse Event|36|||
149089922|NCT01078571|537807002|FG000|Overall Study|Lack of effectiveness|36|||
149089923|NCT01078571|537807002|FG000|Overall Study|Reason not reported|21|||
149089924|NCT01078571|537807002|FG000|Overall Study|Withdrawal by Subject|12|||
149089925|NCT01078571|537807002|FG000|Overall Study|Lost to Follow-up|8|||
149089926|NCT01078571|537807002|FG000|Overall Study|Protocol Violation|2|||
149089927|NCT01047306|537807015|FG000|Overall Study|Withdrawal by Subject|2|||
149089928|NCT01047306|537807016|FG001|Overall Study|Withdrawal by Subject|0|||
149089929|NCT01047306|537807015|FG000|Overall Study|Lost to Follow-up|1|||
149089930|NCT01047306|537807016|FG001|Overall Study|Lost to Follow-up|0|||
149089931|NCT01878253|537807017|FG000|Overall Study|Death|1|||
149089932|NCT01878253|537807017|FG000|Overall Study|SIdus System Removal|3|||
149089933|NCT01878253|537807017|FG000|Overall Study|Withdrawal by Subject|1|||
149089934|NCT01878253|537807017|FG000|Overall Study|Lost to Follow-up|2|||
149089935|NCT01878253|537807017|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
149089936|NCT03647709|537807018|FG000|Overall Study|Lost to Follow-up|5|||
149089937|NCT03647709|537807018|FG000|Overall Study|Physician Decision|6|||
149089938|NCT03647709|537807018|FG000|Overall Study|Withdrawal by Subject|3|||
149089939|NCT00449033|537807023|FG000|Treatment Period|Adverse Event|117|||
149089940|NCT00449033|537807024|FG001|Treatment Period|Adverse Event|83|||
149089941|NCT00449033|537807023|FG000|Treatment Period|Death|21|||
149089942|NCT00449033|537807024|FG001|Treatment Period|Death|12|||
149089943|NCT00449033|537807023|FG000|Treatment Period|Lost to Follow-up|0|||
149089944|NCT00449033|537807024|FG001|Treatment Period|Lost to Follow-up|2|||
149089945|NCT00449033|537807023|FG000|Treatment Period|Physician Decision|4|||
149089946|NCT00449033|537807024|FG001|Treatment Period|Physician Decision|5|||
149089947|NCT00449033|537807023|FG000|Treatment Period|Protocol Violation|8|||
149089948|NCT00449033|537807024|FG001|Treatment Period|Protocol Violation|7|||
149089949|NCT00449033|537807023|FG000|Treatment Period|Disease Progression|231|||
149089950|NCT00449033|537807024|FG001|Treatment Period|Disease Progression|288|||
149089951|NCT00449033|537807023|FG000|Treatment Period|Consent Withdrawn|36|||
149089952|NCT00449033|537807024|FG001|Treatment Period|Consent Withdrawn|20|||
149089953|NCT00449033|537807023|FG000|Treatment Period|Amended Protocol Criteria|22|||
149089954|NCT00449033|537807024|FG001|Treatment Period|Amended Protocol Criteria|18|||
149089955|NCT00449033|537807023|FG000|Treatment Period|Non-compliance|7|||
149089956|NCT00449033|537807024|FG001|Treatment Period|Non-compliance|8|||
149089957|NCT00449033|537807023|FG000|Treatment Period|Second Malignancy|0|||
149089958|NCT00449033|537807024|FG001|Treatment Period|Second Malignancy|1|||
149089959|NCT00449033|537807023|FG000|Treatment Period|Reason Missing|0|||
149089960|NCT00449033|537807024|FG001|Treatment Period|Reason Missing|4|||
149089961|NCT00449033|537807023|FG000|Treatment Period|Treatment Ongoing|6|||
149089962|NCT00449033|537807024|FG001|Treatment Period|Treatment Ongoing|4|||
149089963|NCT00449033|537807023|FG000|Follow-up Period|Death|299|||
149089964|NCT00449033|537807024|FG001|Follow-up Period|Death|311|||
149089965|NCT00449033|537807023|FG000|Follow-up Period|Lost to Follow-up|6|||
149089966|NCT00449033|537807024|FG001|Follow-up Period|Lost to Follow-up|10|||
149089967|NCT00449033|537807023|FG000|Follow-up Period|Reason Missing|120|||
149089968|NCT00449033|537807024|FG001|Follow-up Period|Reason Missing|113|||
149089969|NCT04393779|537807027|FG000|Overall Study|Death|1|||
149089970|NCT04393779|537807027|FG000|Overall Study|Device reintervention or explant|4|||
149089971|NCT03802513|537807029|FG000|Overall Study|Lost to Follow-up|1|||
149089972|NCT01190228|537807033|FG000|Overall Study|Protocol Violation|4|||
149089973|NCT01190228|537807034|FG001|Overall Study|Protocol Violation|0|||
149089974|NCT01190228|537807035|FG002|Overall Study|Protocol Violation|0|||
149089975|NCT01190228|537807033|FG000|Overall Study|Withdrawal by Subject|1|||
149089976|NCT01190228|537807034|FG001|Overall Study|Withdrawal by Subject|0|||
149089977|NCT01190228|537807035|FG002|Overall Study|Withdrawal by Subject|0|||
149089978|NCT01945086|537807045|FG000|Overall Study|Withdrawal by Subject|1|||
149089979|NCT01945086|537807046|FG001|Overall Study|Withdrawal by Subject|0|||
149089980|NCT01945086|537807047|FG002|Overall Study|Withdrawal by Subject|1|||
149089981|NCT01945086|537807045|FG000|Overall Study|Adverse Event|0|||
149089982|NCT01945086|537807046|FG001|Overall Study|Adverse Event|0|||
149089983|NCT01945086|537807047|FG002|Overall Study|Adverse Event|1|||
149089984|NCT04853394|537807051|FG000|Follow-up Interviews|Lost to Follow-up|22|||
149089985|NCT04853394|537807052|FG001|Follow-up Interviews|Lost to Follow-up|15|||
149089986|NCT00748098|537807053|FG000|First Treatment Intervention Period|Adverse Event|1|||
149089987|NCT00748098|537807054|FG001|First Treatment Intervention Period|Adverse Event|1|||
149089988|NCT00748098|537807053|FG000|First Treatment Intervention Period|Protocol Violation|1|||
149089989|NCT00748098|537807054|FG001|First Treatment Intervention Period|Protocol Violation|0|||
149089990|NCT00748098|537807053|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
149089991|NCT00748098|537807054|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
149089992|NCT00748098|537807053|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
149089993|NCT00748098|537807054|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
149089994|NCT00748098|537807053|FG000|First Taper Period|Protocol Violation|1|||
149089995|NCT00748098|537807054|FG001|First Taper Period|Protocol Violation|0|||
149089996|NCT00748098|537807053|FG000|First Taper Period|Withdrawal by Subject|2|||
149089997|NCT00748098|537807054|FG001|First Taper Period|Withdrawal by Subject|0|||
149089998|NCT00748098|537807053|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
149089999|NCT00748098|537807054|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
149090000|NCT00748098|537807053|FG000|1-Week Washout Period|Adverse Event|0|||
149090001|NCT00748098|537807054|FG001|1-Week Washout Period|Adverse Event|1|||
149090002|NCT00748098|537807053|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
149090003|NCT00748098|537807054|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
149090004|NCT00748098|537807053|FG000|Second Treatment Intervention Period|Adverse Event|4|||
149090005|NCT00748098|537807054|FG001|Second Treatment Intervention Period|Adverse Event|1|||
149090006|NCT00748098|537807053|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
149090007|NCT00748098|537807054|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
149090008|NCT00748098|537807053|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
149090009|NCT00748098|537807054|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
149090010|NCT04212299|537807055|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
149090011|NCT01002547|537809076|FG000|Overall Study|Withdrawal by Subject|4|||
149090012|NCT01002547|537809077|FG001|Overall Study|Withdrawal by Subject|0|||
149090013|NCT01002547|537809078|FG002|Overall Study|Withdrawal by Subject|5|||
149090014|NCT01002547|537809076|FG000|Overall Study|Lost to Follow-up|2|||
149090015|NCT01002547|537809077|FG001|Overall Study|Lost to Follow-up|1|||
149090016|NCT01002547|537809078|FG002|Overall Study|Lost to Follow-up|1|||
149090017|NCT01002547|537809076|FG000|Overall Study|Physician Decision|1|||
149090018|NCT01002547|537809077|FG001|Overall Study|Physician Decision|0|||
149090019|NCT01002547|537809078|FG002|Overall Study|Physician Decision|0|||
149090020|NCT01002547|537809076|FG000|Overall Study|Death|0|||
149090021|NCT01002547|537809077|FG001|Overall Study|Death|2|||
149090022|NCT01002547|537809078|FG002|Overall Study|Death|2|||
149090023|NCT01002547|537809076|FG000|Overall Study|Adverse Event|1|||
149090024|NCT01002547|537809077|FG001|Overall Study|Adverse Event|0|||
149090025|NCT01002547|537809078|FG002|Overall Study|Adverse Event|0|||
149090026|NCT00705614|537809083|FG000|Initial Intervention|Adverse Event|40|||
149090027|NCT00705614|537809084|FG001|Initial Intervention|Adverse Event|21|||
149090028|NCT00705614|537809083|FG000|Initial Intervention|Lost to Follow-up|310|||
149090029|NCT00705614|537809084|FG001|Initial Intervention|Lost to Follow-up|191|||
149090030|NCT00705614|537809083|FG000|Initial Intervention|Withdrawal by Subject|114|||
149090031|NCT00705614|537809084|FG001|Initial Intervention|Withdrawal by Subject|71|||
149090032|NCT00705614|537809083|FG000|Initial Intervention|Administrative Reason|51|||
149090033|NCT00705614|537809084|FG001|Initial Intervention|Administrative Reason|38|||
149090034|NCT00705614|537809083|FG000|Initial Intervention|Status completion unknown|3|||
149090035|NCT00705614|537809084|FG001|Initial Intervention|Status completion unknown|0|||
149090036|NCT00705614|537809083|FG000|Switch to Remicade|Adverse Event|0|||
149090037|NCT00705614|537809084|FG001|Switch to Remicade|Adverse Event|5|||
149090038|NCT00705614|537809083|FG000|Switch to Remicade|Lost to Follow-up|0|||
149090039|NCT00705614|537809084|FG001|Switch to Remicade|Lost to Follow-up|23|||
149090040|NCT00705614|537809083|FG000|Switch to Remicade|Withdrawal by Subject|0|||
149090041|NCT00705614|537809084|FG001|Switch to Remicade|Withdrawal by Subject|12|||
149090042|NCT00705614|537809083|FG000|Switch to Remicade|Administrative Reason|0|||
149090043|NCT00705614|537809084|FG001|Switch to Remicade|Administrative Reason|9|||
149090044|NCT00925288|537809085|FG000|Overall Study|Lost to Follow-up|9|||
149090045|NCT00925288|537809086|FG001|Overall Study|Lost to Follow-up|7|||
149090046|NCT00088452|537809087|FG000|Overall Study|Did not receive intervention|1|||
149090047|NCT00088452|537809088|FG001|Overall Study|Did not receive intervention|0|||
149090048|NCT00088452|537809089|FG002|Overall Study|Did not receive intervention|1|||
149090049|NCT02081196|537809091|FG000|Overall Study|Lost to Follow-up|1|||
149090050|NCT00434577|537809096|FG000|Months 0-3|Serious Adverse Event|0|||
149090051|NCT00434577|537809097|FG001|Months 0-3|Serious Adverse Event|0|||
149090052|NCT00434577|537809098|FG002|Months 0-3|Serious Adverse Event|1|||
149090053|NCT00434577|537809099|FG003|Months 0-3|Serious Adverse Event|0|||
149090054|NCT00434577|537809100|FG004|Months 0-3|Serious Adverse Event|0|||
149090055|NCT00434577|537809096|FG000|Months 0-3|Adverse Event|0|||
149090056|NCT00434577|537809097|FG001|Months 0-3|Adverse Event|1|||
149090057|NCT00434577|537809098|FG002|Months 0-3|Adverse Event|1|||
149090058|NCT00434577|537809099|FG003|Months 0-3|Adverse Event|0|||
149090059|NCT00434577|537809100|FG004|Months 0-3|Adverse Event|0|||
149090060|NCT00434577|537809096|FG000|Months 0-3|Lost to Follow-up|0|||
149090061|NCT00434577|537809097|FG001|Months 0-3|Lost to Follow-up|0|||
149090062|NCT00434577|537809098|FG002|Months 0-3|Lost to Follow-up|0|||
149090063|NCT00434577|537809099|FG003|Months 0-3|Lost to Follow-up|0|||
149090064|NCT00434577|537809100|FG004|Months 0-3|Lost to Follow-up|2|||
149090065|NCT00434577|537809096|FG000|Months 0-3|Protocol Violation|1|||
149090066|NCT00434577|537809097|FG001|Months 0-3|Protocol Violation|0|||
149090067|NCT00434577|537809098|FG002|Months 0-3|Protocol Violation|1|||
149090068|NCT00434577|537809099|FG003|Months 0-3|Protocol Violation|0|||
149090069|NCT00434577|537809100|FG004|Months 0-3|Protocol Violation|0|||
149090070|NCT00434577|537809096|FG000|Months 0-3|Withdrawal by Subject|2|||
149090071|NCT00434577|537809097|FG001|Months 0-3|Withdrawal by Subject|1|||
149090072|NCT00434577|537809098|FG002|Months 0-3|Withdrawal by Subject|1|||
149090073|NCT00434577|537809099|FG003|Months 0-3|Withdrawal by Subject|1|||
149090074|NCT00434577|537809100|FG004|Months 0-3|Withdrawal by Subject|1|||
149090075|NCT01904019|537809107|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
149090076|NCT01904019|537809107|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
149090077|NCT01904019|537809107|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
149090078|NCT01904019|537809107|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
149090079|NCT01904019|537809107|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
149090080|NCT01904019|537809107|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
149090081|NCT00635570|537809108|FG000|Overall Study|Lost to Follow-up|8|||
149090082|NCT00635570|537809109|FG001|Overall Study|Lost to Follow-up|8|||
149090083|NCT00635570|537809108|FG000|Overall Study|Withdrawal by Subject|1|||
149090084|NCT00635570|537809109|FG001|Overall Study|Withdrawal by Subject|1|||
149090085|NCT00635570|537809108|FG000|Overall Study|Adverse Event|2|||
149090086|NCT00635570|537809109|FG001|Overall Study|Adverse Event|0|||
149090087|NCT00635570|537809108|FG000|Overall Study|Physician Decision|1|||
149090088|NCT00635570|537809109|FG001|Overall Study|Physician Decision|0|||
149090089|NCT00635570|537809108|FG000|Overall Study|Did not complete survey|2|||
149090090|NCT00635570|537809109|FG001|Overall Study|Did not complete survey|1|||
149090091|NCT00635570|537809108|FG000|Overall Study|Early termination(No sexual activity)|1|||
149090092|NCT00635570|537809109|FG001|Overall Study|Early termination(No sexual activity)|1|||
149090093|NCT00332488|537809113|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
149090094|NCT00332488|537809114|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
149090095|NCT00332488|537809115|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
149090096|NCT00332488|537809113|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
149090097|NCT00332488|537809114|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
149090098|NCT00332488|537809115|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
149090099|NCT00332488|537809113|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
149090100|NCT00332488|537809114|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
149090101|NCT00332488|537809115|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
149090102|NCT00332488|537809113|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
149090103|NCT00332488|537809114|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
149090104|NCT00332488|537809115|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
149090105|NCT00332488|537809113|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
149090106|NCT00332488|537809114|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
149090107|NCT00332488|537809115|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
149090108|NCT00332488|537809113|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
149090109|NCT00332488|537809114|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
149090110|NCT00332488|537809115|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
149090111|NCT00332488|537809113|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
149090112|NCT00332488|537809114|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
149090113|NCT00332488|537809115|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
149090114|NCT00332488|537809113|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
149090115|NCT00332488|537809114|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
149090116|NCT00332488|537809115|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
149090117|NCT00332488|537809113|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
149090118|NCT00332488|537809114|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
149090119|NCT00332488|537809115|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
149090120|NCT00332488|537809113|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
149090121|NCT00332488|537809114|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
149090122|NCT00332488|537809115|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
149090123|NCT00332488|537809113|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
149090124|NCT00332488|537809114|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
149090125|NCT00332488|537809115|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
149090126|NCT00332488|537809113|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
149090127|NCT00332488|537809114|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
149090128|NCT00332488|537809115|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
149090129|NCT04816708|537809118|FG000|Overall Study|Lost to Follow-up|10|||
149090130|NCT04816708|537809119|FG001|Overall Study|Lost to Follow-up|4|||
149090131|NCT01350102|537809123|FG000|Overall Study|Adverse Event|0|||
149090132|NCT01350102|537809124|FG001|Overall Study|Adverse Event|0|||
149090133|NCT01350102|537809125|FG002|Overall Study|Adverse Event|1|||
149090134|NCT01350102|537809126|FG003|Overall Study|Adverse Event|0|||
149090135|NCT01375777|537809130|FG000|Overall Study|Withdrawal by Subject|0|||
149090136|NCT01375777|537809131|FG001|Overall Study|Withdrawal by Subject|2|||
149090137|NCT01375777|537809132|FG002|Overall Study|Withdrawal by Subject|1|||
149090138|NCT01375777|537809133|FG003|Overall Study|Withdrawal by Subject|0|||
149090139|NCT01375777|537809134|FG004|Overall Study|Withdrawal by Subject|1|||
149090140|NCT01375777|537809135|FG005|Overall Study|Withdrawal by Subject|1|||
149090141|NCT01375777|537809136|FG006|Overall Study|Withdrawal by Subject|1|||
149090142|NCT01375777|537809137|FG007|Overall Study|Withdrawal by Subject|2|||
149090143|NCT01375777|537809138|FG008|Overall Study|Withdrawal by Subject|1|||
149090144|NCT01375777|537809130|FG000|Overall Study|Lost to Follow-up|1|||
149090145|NCT01375777|537809131|FG001|Overall Study|Lost to Follow-up|0|||
149090146|NCT01375777|537809132|FG002|Overall Study|Lost to Follow-up|0|||
149090147|NCT01375777|537809133|FG003|Overall Study|Lost to Follow-up|0|||
149090148|NCT01375777|537809134|FG004|Overall Study|Lost to Follow-up|0|||
149090149|NCT01375777|537809135|FG005|Overall Study|Lost to Follow-up|0|||
149090150|NCT01375777|537809136|FG006|Overall Study|Lost to Follow-up|1|||
149090151|NCT01375777|537809137|FG007|Overall Study|Lost to Follow-up|0|||
149090152|NCT01375777|537809138|FG008|Overall Study|Lost to Follow-up|0|||
149090153|NCT01375777|537809130|FG000|Overall Study|Other|1|||
149090154|NCT01375777|537809131|FG001|Overall Study|Other|1|||
149090155|NCT01375777|537809132|FG002|Overall Study|Other|0|||
149090156|NCT01375777|537809133|FG003|Overall Study|Other|0|||
149090157|NCT01375777|537809134|FG004|Overall Study|Other|0|||
149090158|NCT01375777|537809135|FG005|Overall Study|Other|0|||
149090159|NCT01375777|537809136|FG006|Overall Study|Other|0|||
149090160|NCT01375777|537809137|FG007|Overall Study|Other|0|||
149090161|NCT01375777|537809138|FG008|Overall Study|Other|1|||
149090162|NCT01572493|537809139|FG000|Overall Study|Physician Decision|1|||
149090163|NCT01572493|537809140|FG001|Overall Study|Physician Decision|0|||
149090164|NCT01572493|537809141|FG002|Overall Study|Physician Decision|0|||
149090165|NCT01572493|537809142|FG003|Overall Study|Physician Decision|0|||
149090166|NCT01572493|537809143|FG004|Overall Study|Physician Decision|0|||
149090167|NCT01572493|537809144|FG005|Overall Study|Physician Decision|0|||
149090168|NCT01572493|537809145|FG006|Overall Study|Physician Decision|0|||
149090169|NCT01572493|537809146|FG007|Overall Study|Physician Decision|0|||
149090170|NCT01572493|537809147|FG008|Overall Study|Physician Decision|0|||
149090171|NCT01572493|537809139|FG000|Overall Study|Switched to alternative treatment|0|||
149090172|NCT01572493|537809140|FG001|Overall Study|Switched to alternative treatment|1|||
149090173|NCT01572493|537809141|FG002|Overall Study|Switched to alternative treatment|2|||
149090174|NCT01572493|537809142|FG003|Overall Study|Switched to alternative treatment|1|||
149090175|NCT01572493|537809143|FG004|Overall Study|Switched to alternative treatment|2|||
149090176|NCT01572493|537809144|FG005|Overall Study|Switched to alternative treatment|0|||
149090177|NCT01572493|537809145|FG006|Overall Study|Switched to alternative treatment|2|||
149090178|NCT01572493|537809146|FG007|Overall Study|Switched to alternative treatment|0|||
149090179|NCT01572493|537809147|FG008|Overall Study|Switched to alternative treatment|2|||
149090180|NCT01572493|537809139|FG000|Overall Study|Death|0|||
149090181|NCT01572493|537809140|FG001|Overall Study|Death|0|||
149090182|NCT01572493|537809141|FG002|Overall Study|Death|0|||
149090183|NCT01572493|537809142|FG003|Overall Study|Death|1|||
149090184|NCT01572493|537809143|FG004|Overall Study|Death|0|||
149090185|NCT01572493|537809144|FG005|Overall Study|Death|1|||
149090186|NCT01572493|537809145|FG006|Overall Study|Death|0|||
149090187|NCT01572493|537809146|FG007|Overall Study|Death|0|||
149090188|NCT01572493|537809147|FG008|Overall Study|Death|0|||
149090189|NCT01572493|537809139|FG000|Overall Study|Adverse Event|0|||
149090190|NCT01572493|537809140|FG001|Overall Study|Adverse Event|0|||
149090191|NCT01572493|537809141|FG002|Overall Study|Adverse Event|0|||
149090192|NCT01572493|537809142|FG003|Overall Study|Adverse Event|0|||
149090193|NCT01572493|537809143|FG004|Overall Study|Adverse Event|0|||
149090194|NCT01572493|537809144|FG005|Overall Study|Adverse Event|0|||
149090195|NCT01572493|537809145|FG006|Overall Study|Adverse Event|1|||
149090196|NCT01572493|537809146|FG007|Overall Study|Adverse Event|0|||
149090197|NCT01572493|537809147|FG008|Overall Study|Adverse Event|0|||
149090198|NCT00609245|537809148|FG000|Overall Study|Adverse Event|1|||
149090199|NCT01090076|537809149|FG000|Overall Study|Death|1|||
149090200|NCT01090076|537809150|FG001|Overall Study|Death|1|||
149090201|NCT01090076|537809149|FG000|Overall Study|Withdrawal by Subject|0|||
149090202|NCT01090076|537809150|FG001|Overall Study|Withdrawal by Subject|1|||
149090203|NCT01654289|537809154|FG000|Overall Study|Withdrawal by Subject|10|||
149090204|NCT01654289|537809155|FG001|Overall Study|Withdrawal by Subject|8|||
149090205|NCT01654289|537809156|FG002|Overall Study|Withdrawal by Subject|5|||
149090206|NCT01654289|537809154|FG000|Overall Study|Withdrew from intervention only|17|||
149090207|NCT01654289|537809155|FG001|Overall Study|Withdrew from intervention only|20|||
149090208|NCT01654289|537809156|FG002|Overall Study|Withdrew from intervention only|0|||
149090209|NCT01732627|537809157|FG000|Overall Study|Withdrawal by Subject|1|||
149090210|NCT01732627|537809158|FG001|Overall Study|Withdrawal by Subject|0|||
149090211|NCT02504502|537809160|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
149090212|NCT02504502|537809161|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
149090213|NCT02504502|537809160|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
149090214|NCT02504502|537809161|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
149090215|NCT00475735|537809165|FG000|Treatment Period 1|Adverse Event|2|||
149090216|NCT00475735|537809166|FG001|Treatment Period 1|Adverse Event|0|||
149090217|NCT00475735|537809167|FG002|Treatment Period 1|Adverse Event|0|||
149090218|NCT00475735|537809168|FG003|Treatment Period 1|Adverse Event|0|||
149090219|NCT00475735|537809169|FG004|Treatment Period 1|Adverse Event|0|||
149090220|NCT00475735|537809170|FG005|Treatment Period 1|Adverse Event|0|||
149090221|NCT00475735|537809165|FG000|Treatment Period 1|Lack of Efficacy|1|||
149090222|NCT00475735|537809166|FG001|Treatment Period 1|Lack of Efficacy|0|||
149090223|NCT00475735|537809167|FG002|Treatment Period 1|Lack of Efficacy|0|||
149090224|NCT00475735|537809168|FG003|Treatment Period 1|Lack of Efficacy|0|||
149090225|NCT00475735|537809169|FG004|Treatment Period 1|Lack of Efficacy|0|||
149090226|NCT00475735|537809170|FG005|Treatment Period 1|Lack of Efficacy|0|||
149090227|NCT00475735|537809165|FG000|Treatment Period 1|Lost to Follow-up|0|||
149090228|NCT00475735|537809166|FG001|Treatment Period 1|Lost to Follow-up|0|||
149090229|NCT00475735|537809167|FG002|Treatment Period 1|Lost to Follow-up|0|||
149090230|NCT00475735|537809168|FG003|Treatment Period 1|Lost to Follow-up|0|||
149090231|NCT00475735|537809169|FG004|Treatment Period 1|Lost to Follow-up|0|||
149090232|NCT00475735|537809170|FG005|Treatment Period 1|Lost to Follow-up|1|||
149090233|NCT00475735|537809165|FG000|Treatment Period 1|Protocol Violation|0|||
149090234|NCT00475735|537809166|FG001|Treatment Period 1|Protocol Violation|0|||
149090235|NCT00475735|537809167|FG002|Treatment Period 1|Protocol Violation|0|||
149090236|NCT00475735|537809168|FG003|Treatment Period 1|Protocol Violation|1|||
149090237|NCT00475735|537809169|FG004|Treatment Period 1|Protocol Violation|0|||
149090238|NCT00475735|537809170|FG005|Treatment Period 1|Protocol Violation|0|||
149090239|NCT00475735|537809165|FG000|Treatment Period 1|Withdrawal by Subject|1|||
149090240|NCT00475735|537809166|FG001|Treatment Period 1|Withdrawal by Subject|1|||
149090241|NCT00475735|537809167|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149090242|NCT00475735|537809168|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149090243|NCT00475735|537809169|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149090244|NCT00475735|537809170|FG005|Treatment Period 1|Withdrawal by Subject|0|||
149090245|NCT00475735|537809165|FG000|Treatment Period 1|DC due to AE but continuing|0|||
149090246|NCT00475735|537809166|FG001|Treatment Period 1|DC due to AE but continuing|0|||
149090247|NCT00475735|537809167|FG002|Treatment Period 1|DC due to AE but continuing|0|||
149090248|NCT00475735|537809168|FG003|Treatment Period 1|DC due to AE but continuing|1|||
149090249|NCT00475735|537809169|FG004|Treatment Period 1|DC due to AE but continuing|2|||
149090250|NCT00475735|537809170|FG005|Treatment Period 1|DC due to AE but continuing|2|||
149090251|NCT00475735|537809165|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
149090252|NCT00475735|537809166|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
149090253|NCT00475735|537809167|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
149090254|NCT00475735|537809168|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
149090255|NCT00475735|537809169|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
149090256|NCT00475735|537809170|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
149090257|NCT00475735|537809165|FG000|Treatment Washout|Lost to Follow-up|0|||
149090258|NCT00475735|537809166|FG001|Treatment Washout|Lost to Follow-up|1|||
149090259|NCT00475735|537809167|FG002|Treatment Washout|Lost to Follow-up|0|||
149090260|NCT00475735|537809168|FG003|Treatment Washout|Lost to Follow-up|0|||
149090261|NCT00475735|537809169|FG004|Treatment Washout|Lost to Follow-up|0|||
149090262|NCT00475735|537809170|FG005|Treatment Washout|Lost to Follow-up|0|||
149090263|NCT00475735|537809165|FG000|Treatment Washout|Protocol Violation|0|||
149090264|NCT00475735|537809166|FG001|Treatment Washout|Protocol Violation|1|||
149090265|NCT00475735|537809167|FG002|Treatment Washout|Protocol Violation|0|||
149090266|NCT00475735|537809168|FG003|Treatment Washout|Protocol Violation|0|||
149090267|NCT00475735|537809169|FG004|Treatment Washout|Protocol Violation|0|||
149090268|NCT00475735|537809170|FG005|Treatment Washout|Protocol Violation|0|||
149090269|NCT00475735|537809165|FG000|Treatment Period 2|Adverse Event|0|||
149090270|NCT00475735|537809166|FG001|Treatment Period 2|Adverse Event|1|||
149090271|NCT00475735|537809167|FG002|Treatment Period 2|Adverse Event|0|||
149090272|NCT00475735|537809168|FG003|Treatment Period 2|Adverse Event|2|||
149090273|NCT00475735|537809169|FG004|Treatment Period 2|Adverse Event|0|||
149090274|NCT00475735|537809170|FG005|Treatment Period 2|Adverse Event|0|||
149090275|NCT00475735|537809165|FG000|Treatment Period 2|Lack of Efficacy|0|||
149090276|NCT00475735|537809166|FG001|Treatment Period 2|Lack of Efficacy|0|||
149090277|NCT00475735|537809167|FG002|Treatment Period 2|Lack of Efficacy|0|||
149090278|NCT00475735|537809168|FG003|Treatment Period 2|Lack of Efficacy|0|||
149090279|NCT00475735|537809169|FG004|Treatment Period 2|Lack of Efficacy|0|||
149090280|NCT00475735|537809170|FG005|Treatment Period 2|Lack of Efficacy|1|||
149090281|NCT00475735|537809165|FG000|Treatment Period 2|Withdrawal by Subject|0|||
149090282|NCT00475735|537809166|FG001|Treatment Period 2|Withdrawal by Subject|0|||
149090283|NCT00475735|537809167|FG002|Treatment Period 2|Withdrawal by Subject|0|||
149090284|NCT00475735|537809168|FG003|Treatment Period 2|Withdrawal by Subject|0|||
149090285|NCT00475735|537809169|FG004|Treatment Period 2|Withdrawal by Subject|1|||
149090286|NCT00475735|537809170|FG005|Treatment Period 2|Withdrawal by Subject|0|||
149090287|NCT00084747|537809171|FG000|Overall Study|Relapsed|8|||
149090288|NCT00084747|537809171|FG000|Overall Study|Death|3|||
149090289|NCT00084747|537809171|FG000|Overall Study|Withdrawal by Subject|2|||
149090290|NCT04474691|537809179|FG000|Overall Study|Withdrawal by Subject|9|||
149090291|NCT00832650|537809184|FG000|Overall Study|Randomized but not treated|0|||
149090292|NCT00832650|537809185|FG001|Overall Study|Randomized but not treated|0|||
149090293|NCT00832650|537809186|FG002|Overall Study|Randomized but not treated|1|||
149090294|NCT03219216|537809187|FG000|Overall Study|Lost to Follow-up|0|||
149090295|NCT03219216|537809188|FG001|Overall Study|Lost to Follow-up|1|||
149090296|NCT02332824|537809189|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
149090297|NCT02332824|537809190|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
149090298|NCT02332824|537809191|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
149090299|NCT02332824|537809192|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
149090300|NCT02332824|537809193|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
149090301|NCT02332824|537809194|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
149090302|NCT02332824|537809189|FG000|Overall Study|Voluntary Withdrawal|1|||
149090303|NCT02332824|537809190|FG001|Overall Study|Voluntary Withdrawal|0|||
149090304|NCT02332824|537809191|FG002|Overall Study|Voluntary Withdrawal|0|||
149090305|NCT02332824|537809192|FG003|Overall Study|Voluntary Withdrawal|0|||
149090306|NCT02332824|537809193|FG004|Overall Study|Voluntary Withdrawal|0|||
149090307|NCT02332824|537809194|FG005|Overall Study|Voluntary Withdrawal|0|||
149090308|NCT02332824|537809189|FG000|Overall Study|Inconvenient schedule|1|||
149090309|NCT02332824|537809190|FG001|Overall Study|Inconvenient schedule|1|||
149090310|NCT02332824|537809191|FG002|Overall Study|Inconvenient schedule|0|||
149090311|NCT02332824|537809192|FG003|Overall Study|Inconvenient schedule|0|||
149090312|NCT02332824|537809193|FG004|Overall Study|Inconvenient schedule|0|||
149090313|NCT02332824|537809194|FG005|Overall Study|Inconvenient schedule|0|||
149090314|NCT02332824|537809189|FG000|Overall Study|Transfer|0|||
149090315|NCT02332824|537809190|FG001|Overall Study|Transfer|0|||
149090316|NCT02332824|537809191|FG002|Overall Study|Transfer|1|||
149090317|NCT02332824|537809192|FG003|Overall Study|Transfer|1|||
149090318|NCT02332824|537809193|FG004|Overall Study|Transfer|0|||
149090319|NCT02332824|537809194|FG005|Overall Study|Transfer|0|||
149090320|NCT00440037|537809195|FG000|Overall Study|Withdrawal by Subject|6|||
149090321|NCT00440037|537809195|FG000|Overall Study|Administrative decision|3|||
149090322|NCT00498797|537809196|FG000|Overall Study|Withdrawal by Subject|4|||
149090323|NCT00498797|537809197|FG001|Overall Study|Withdrawal by Subject|2|||
149090324|NCT00498797|537809196|FG000|Overall Study|Adverse Event|12|||
149090325|NCT00498797|537809197|FG001|Overall Study|Adverse Event|5|||
149090326|NCT00498797|537809196|FG000|Overall Study|Condition under investigation worsened|19|||
149090327|NCT00498797|537809197|FG001|Overall Study|Condition under investigation worsened|21|||
149090328|NCT00498797|537809196|FG000|Overall Study|Other|3|||
149090329|NCT00498797|537809197|FG001|Overall Study|Other|1|||
149090330|NCT03928821|537809198|FG000|Overall Study|Death|0|||
149090331|NCT03928821|537809199|FG001|Overall Study|Death|1|||
149090332|NCT03928821|537809200|FG002|Overall Study|Death|0|||
149090333|NCT03928821|537809201|FG003|Overall Study|Death|0|||
149090334|NCT03928821|537809198|FG000|Overall Study|Lost to Follow-up|0|||
149090335|NCT03928821|537809199|FG001|Overall Study|Lost to Follow-up|2|||
149090336|NCT03928821|537809200|FG002|Overall Study|Lost to Follow-up|3|||
149090337|NCT03928821|537809201|FG003|Overall Study|Lost to Follow-up|0|||
149090338|NCT03928821|537809198|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
149090339|NCT03928821|537809199|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
149090340|NCT03928821|537809200|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
149090341|NCT03928821|537809201|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
149090342|NCT02784535|537809202|FG000|Overall Study|Adverse Event|1|||
149090343|NCT02784535|537809203|FG001|Overall Study|Adverse Event|0|||
149090344|NCT02784535|537809202|FG000|Overall Study|Withdrawal by Subject|0|||
149090345|NCT02784535|537809203|FG001|Overall Study|Withdrawal by Subject|1|||
149090346|NCT02784535|537809202|FG000|Overall Study|Physician Decision|0|||
149090347|NCT02784535|537809203|FG001|Overall Study|Physician Decision|1|||
149090348|NCT03740919|537809204|FG000|Lead-in Period|Lost to Follow-up|1|||
149090349|NCT03740919|537809205|FG001|Lead-in Period|Lost to Follow-up|0|||
149090350|NCT03740919|537809206|FG002|Lead-in Period|Lost to Follow-up|0|||
149090351|NCT03740919|537809207|FG003|Lead-in Period|Lost to Follow-up|0|||
149090352|NCT03740919|537809204|FG000|Lead-in Period|Physician Decision|2|||
149090353|NCT03740919|537809205|FG001|Lead-in Period|Physician Decision|0|||
149090354|NCT03740919|537809206|FG002|Lead-in Period|Physician Decision|0|||
149090355|NCT03740919|537809207|FG003|Lead-in Period|Physician Decision|0|||
149090356|NCT03740919|537809204|FG000|Lead-in Period|Protocol Violation|1|||
149090357|NCT03740919|537809205|FG001|Lead-in Period|Protocol Violation|0|||
149090358|NCT03740919|537809206|FG002|Lead-in Period|Protocol Violation|0|||
149090359|NCT03740919|537809207|FG003|Lead-in Period|Protocol Violation|0|||
149090360|NCT03740919|537809204|FG000|Lead-in Period|Withdrawal by Subject|10|||
149090361|NCT03740919|537809205|FG001|Lead-in Period|Withdrawal by Subject|0|||
149090362|NCT03740919|537809206|FG002|Lead-in Period|Withdrawal by Subject|0|||
149090363|NCT03740919|537809207|FG003|Lead-in Period|Withdrawal by Subject|0|||
149090364|NCT03740919|537809204|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
149090365|NCT03740919|537809205|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
149090366|NCT03740919|537809206|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
149090367|NCT03740919|537809207|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
149090368|NCT03740919|537809204|FG000|Lead-in Period|Study Task Too Burdensome|1|||
149090369|NCT03740919|537809205|FG001|Lead-in Period|Study Task Too Burdensome|0|||
149090370|NCT03740919|537809206|FG002|Lead-in Period|Study Task Too Burdensome|0|||
149090371|NCT03740919|537809207|FG003|Lead-in Period|Study Task Too Burdensome|0|||
149090372|NCT03740919|537809204|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
149090373|NCT03740919|537809205|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
149090374|NCT03740919|537809206|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
149090375|NCT03740919|537809207|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
149090376|NCT03740919|537809204|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
149090377|NCT03740919|537809205|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
149090378|NCT03740919|537809206|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
149090379|NCT03740919|537809207|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
149090380|NCT03740919|537809204|FG000|Treatment Period|Adverse Event|0|||
149090381|NCT03740919|537809205|FG001|Treatment Period|Adverse Event|0|||
149090382|NCT03740919|537809206|FG002|Treatment Period|Adverse Event|2|||
149090383|NCT03740919|537809207|FG003|Treatment Period|Adverse Event|0|||
149090384|NCT03740919|537809204|FG000|Treatment Period|Protocol Violation|0|||
149090385|NCT03740919|537809205|FG001|Treatment Period|Protocol Violation|1|||
149090386|NCT03740919|537809206|FG002|Treatment Period|Protocol Violation|0|||
149090387|NCT03740919|537809207|FG003|Treatment Period|Protocol Violation|0|||
149090388|NCT03740919|537809204|FG000|Treatment Period|Withdrawal by Subject|0|||
149090389|NCT03740919|537809205|FG001|Treatment Period|Withdrawal by Subject|7|||
149090390|NCT03740919|537809206|FG002|Treatment Period|Withdrawal by Subject|6|||
149090391|NCT03740919|537809207|FG003|Treatment Period|Withdrawal by Subject|2|||
149090392|NCT03740919|537809204|FG000|Treatment Period|Terminated by Sponsor|0|||
149090393|NCT03740919|537809205|FG001|Treatment Period|Terminated by Sponsor|1|||
149090394|NCT03740919|537809206|FG002|Treatment Period|Terminated by Sponsor|0|||
149090395|NCT03740919|537809207|FG003|Treatment Period|Terminated by Sponsor|0|||
149090396|NCT03740919|537809204|FG000|Treatment Period|Issue with Insulin Pump|0|||
149090397|NCT03740919|537809205|FG001|Treatment Period|Issue with Insulin Pump|1|||
149090398|NCT03740919|537809206|FG002|Treatment Period|Issue with Insulin Pump|0|||
149090399|NCT03740919|537809207|FG003|Treatment Period|Issue with Insulin Pump|0|||
149090400|NCT03740919|537809204|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
149090401|NCT03740919|537809205|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
149090402|NCT03740919|537809206|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
149090403|NCT03740919|537809207|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
149090404|NCT03740919|537809204|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
149090405|NCT03740919|537809205|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
149090406|NCT03740919|537809206|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
149090407|NCT03740919|537809207|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
149090408|NCT03740919|537809204|FG000|Treatment Period|Not Completing Diary|0|||
149090409|NCT03740919|537809205|FG001|Treatment Period|Not Completing Diary|0|||
149090410|NCT03740919|537809206|FG002|Treatment Period|Not Completing Diary|1|||
149090411|NCT03740919|537809207|FG003|Treatment Period|Not Completing Diary|0|||
149090412|NCT03740919|537809204|FG000|Treatment Period|Insulin Painful to Participant|0|||
149090413|NCT03740919|537809205|FG001|Treatment Period|Insulin Painful to Participant|0|||
149090414|NCT03740919|537809206|FG002|Treatment Period|Insulin Painful to Participant|1|||
149090415|NCT03740919|537809207|FG003|Treatment Period|Insulin Painful to Participant|0|||
149090416|NCT00985621|537809210|FG000|Overall Study|Adverse Event|2|||
149090417|NCT00985621|537809211|FG001|Overall Study|Adverse Event|3|||
149090418|NCT00985621|537809212|FG002|Overall Study|Adverse Event|4|||
149090419|NCT00985621|537809213|FG003|Overall Study|Adverse Event|16|||
149090420|NCT00985621|537809210|FG000|Overall Study|Lack of Efficacy|10|||
149090421|NCT00985621|537809211|FG001|Overall Study|Lack of Efficacy|6|||
149090422|NCT00985621|537809212|FG002|Overall Study|Lack of Efficacy|5|||
149090423|NCT00985621|537809213|FG003|Overall Study|Lack of Efficacy|12|||
149090424|NCT00985621|537809210|FG000|Overall Study|Lost to Follow-up|2|||
149090425|NCT00985621|537809211|FG001|Overall Study|Lost to Follow-up|3|||
149090426|NCT00985621|537809212|FG002|Overall Study|Lost to Follow-up|4|||
149090427|NCT00985621|537809213|FG003|Overall Study|Lost to Follow-up|4|||
149090428|NCT00985621|537809210|FG000|Overall Study|Study Terminated by Sponsor|89|||
149090429|NCT00985621|537809211|FG001|Overall Study|Study Terminated by Sponsor|108|||
149090430|NCT00985621|537809212|FG002|Overall Study|Study Terminated by Sponsor|99|||
149090431|NCT00985621|537809213|FG003|Overall Study|Study Terminated by Sponsor|92|||
149090432|NCT00985621|537809210|FG000|Overall Study|Protocol Violation|1|||
149090433|NCT00985621|537809211|FG001|Overall Study|Protocol Violation|1|||
149090434|NCT00985621|537809212|FG002|Overall Study|Protocol Violation|1|||
149090435|NCT00985621|537809213|FG003|Overall Study|Protocol Violation|0|||
149090436|NCT00985621|537809210|FG000|Overall Study|Withdrawal by Subject|8|||
149090437|NCT00985621|537809211|FG001|Overall Study|Withdrawal by Subject|10|||
149090438|NCT00985621|537809212|FG002|Overall Study|Withdrawal by Subject|8|||
149090439|NCT00985621|537809213|FG003|Overall Study|Withdrawal by Subject|12|||
149090440|NCT00985621|537809210|FG000|Overall Study|Other|1|||
149090441|NCT00985621|537809211|FG001|Overall Study|Other|0|||
149090442|NCT00985621|537809212|FG002|Overall Study|Other|0|||
149090443|NCT00985621|537809213|FG003|Overall Study|Other|0|||
149090444|NCT00985621|537809210|FG000|Overall Study|Randomized but not Treated|1|||
149090445|NCT00985621|537809211|FG001|Overall Study|Randomized but not Treated|0|||
149090446|NCT00985621|537809212|FG002|Overall Study|Randomized but not Treated|2|||
149090447|NCT00985621|537809213|FG003|Overall Study|Randomized but not Treated|1|||
149090448|NCT01911819|537809214|FG000|Overall Study|Adverse Event|0|||
149090449|NCT01911819|537809215|FG001|Overall Study|Adverse Event|1|||
149090450|NCT01911819|537809216|FG002|Overall Study|Adverse Event|0|||
149090451|NCT01911819|537809214|FG000|Overall Study|Withdrawal by Subject|1|||
149090452|NCT01911819|537809215|FG001|Overall Study|Withdrawal by Subject|1|||
149090453|NCT01911819|537809216|FG002|Overall Study|Withdrawal by Subject|0|||
149090454|NCT03953079|537809217|FG000|Core Study|Withdrawal by Subject|1|||
149090455|NCT03953079|537809218|FG001|Core Study|Withdrawal by Subject|2|||
149090456|NCT03953079|537809219|FG002|Core Study|Withdrawal by Subject|1|||
149090457|NCT03953079|537809217|FG000|Core Study|COVID-19|0|||
149090458|NCT03953079|537809218|FG001|Core Study|COVID-19|1|||
149090459|NCT03953079|537809219|FG002|Core Study|COVID-19|0|||
149090460|NCT03953079|537809217|FG000|Core Study|Difficulties leaving the house|0|||
149090461|NCT03953079|537809218|FG001|Core Study|Difficulties leaving the house|1|||
149090462|NCT03953079|537809219|FG002|Core Study|Difficulties leaving the house|0|||
149090463|NCT03953079|537809217|FG000|Extension Study|Withdrawal by Subject|1|||
149090464|NCT03953079|537809218|FG001|Extension Study|Withdrawal by Subject|0|||
149090465|NCT03953079|537809219|FG002|Extension Study|Withdrawal by Subject|0|||
149090466|NCT03953079|537809217|FG000|Extension Study|Received Rescue Treatment|5|||
149090467|NCT03953079|537809218|FG001|Extension Study|Received Rescue Treatment|6|||
149090468|NCT03953079|537809219|FG002|Extension Study|Received Rescue Treatment|5|||
149090469|NCT04394624|537809223|FG000|Overall Study|Adverse Event|6|||
149090470|NCT04394624|537809224|FG001|Overall Study|Adverse Event|0|||
149090471|NCT04394624|537809223|FG000|Overall Study|Progressive disease|24|||
149090472|NCT04394624|537809224|FG001|Overall Study|Progressive disease|0|||
149090473|NCT04394624|537809223|FG000|Overall Study|Not related to COVID-19|1|||
149090474|NCT04394624|537809224|FG001|Overall Study|Not related to COVID-19|0|||
149090475|NCT00603278|537809225|FG000|Overall Study|Lack of Efficacy|35|||
149090476|NCT00603278|537809226|FG001|Overall Study|Lack of Efficacy|10|||
149090477|NCT00603278|537809227|FG002|Overall Study|Lack of Efficacy|11|||
149090478|NCT00603278|537809228|FG003|Overall Study|Lack of Efficacy|8|||
149090479|NCT00603278|537809229|FG004|Overall Study|Lack of Efficacy|7|||
149090480|NCT00603278|537809230|FG005|Overall Study|Lack of Efficacy|14|||
149090481|NCT00603278|537809225|FG000|Overall Study|Adverse Event|0|||
149090482|NCT00603278|537809226|FG001|Overall Study|Adverse Event|3|||
149090483|NCT00603278|537809227|FG002|Overall Study|Adverse Event|1|||
149090484|NCT00603278|537809228|FG003|Overall Study|Adverse Event|0|||
149090485|NCT00603278|537809229|FG004|Overall Study|Adverse Event|2|||
149090486|NCT00603278|537809230|FG005|Overall Study|Adverse Event|1|||
149090487|NCT00603278|537809225|FG000|Overall Study|Withdrawal by Subject|2|||
149090488|NCT00603278|537809226|FG001|Overall Study|Withdrawal by Subject|3|||
149090489|NCT00603278|537809227|FG002|Overall Study|Withdrawal by Subject|1|||
149090490|NCT00603278|537809228|FG003|Overall Study|Withdrawal by Subject|2|||
149090491|NCT00603278|537809229|FG004|Overall Study|Withdrawal by Subject|1|||
149090492|NCT00603278|537809230|FG005|Overall Study|Withdrawal by Subject|2|||
149090493|NCT00603278|537809225|FG000|Overall Study|Protocol Violation|3|||
149090494|NCT00603278|537809226|FG001|Overall Study|Protocol Violation|0|||
149090495|NCT00603278|537809227|FG002|Overall Study|Protocol Violation|1|||
149090496|NCT00603278|537809228|FG003|Overall Study|Protocol Violation|1|||
149090497|NCT00603278|537809229|FG004|Overall Study|Protocol Violation|0|||
149090498|NCT00603278|537809230|FG005|Overall Study|Protocol Violation|1|||
149090499|NCT00603278|537809225|FG000|Overall Study|Physician Decision|0|||
149090500|NCT00603278|537809226|FG001|Overall Study|Physician Decision|1|||
149090501|NCT00603278|537809227|FG002|Overall Study|Physician Decision|0|||
149090502|NCT00603278|537809228|FG003|Overall Study|Physician Decision|0|||
149090503|NCT00603278|537809229|FG004|Overall Study|Physician Decision|2|||
149090504|NCT00603278|537809230|FG005|Overall Study|Physician Decision|1|||
149090505|NCT00603278|537809225|FG000|Overall Study|Lost to Follow-up|1|||
149090506|NCT00603278|537809226|FG001|Overall Study|Lost to Follow-up|0|||
149090507|NCT00603278|537809227|FG002|Overall Study|Lost to Follow-up|0|||
149090508|NCT00603278|537809228|FG003|Overall Study|Lost to Follow-up|0|||
149090509|NCT00603278|537809229|FG004|Overall Study|Lost to Follow-up|1|||
149090510|NCT00603278|537809230|FG005|Overall Study|Lost to Follow-up|0|||
149090511|NCT04743999|537809232|FG000|3-month Questionnaire|Death|1|||
149090512|NCT04743999|537809232|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
149090513|NCT04743999|537809232|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
149090514|NCT04743999|537809232|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
149090515|NCT01721759|537809233|FG000|Treatment Period|Disease Progression|85|||
149090516|NCT01721759|537809233|FG000|Treatment Period|Study drug toxicity|14|||
149090517|NCT01721759|537809233|FG000|Treatment Period|Death|1|||
149090518|NCT01721759|537809233|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
149090519|NCT01721759|537809233|FG000|Treatment Period|Participant request to withdraw|3|||
149090520|NCT01721759|537809233|FG000|Treatment Period|Other Reasons|3|||
149090521|NCT01721759|537809233|FG000|End of Study Period|Participant Withdrew Consent|5|||
149090522|NCT01721759|537809233|FG000|End of Study Period|Death|101|||
149090523|NCT01721759|537809233|FG000|End of Study Period|Lost to Follow-up|1|||
149090524|NCT01721759|537809233|FG000|End of Study Period|Other Reasons|10|||
149090525|NCT00417989|537809234|FG000|Overall Study|Withdrawal by Subject|13|||
149090526|NCT00417989|537809235|FG001|Overall Study|Withdrawal by Subject|13|||
149090527|NCT00417989|537809234|FG000|Overall Study|Lost to Follow-up|1|||
149090528|NCT00417989|537809235|FG001|Overall Study|Lost to Follow-up|6|||
149090529|NCT00417989|537809234|FG000|Overall Study|Protocol Violation|1|||
149090530|NCT00417989|537809235|FG001|Overall Study|Protocol Violation|0|||
149090531|NCT00417989|537809234|FG000|Overall Study|Death|0|||
149090532|NCT00417989|537809235|FG001|Overall Study|Death|1|||
149090533|NCT00417989|537809234|FG000|Overall Study|Physician Decision|5|||
149090534|NCT00417989|537809235|FG001|Overall Study|Physician Decision|2|||
149090535|NCT01636778|537809236|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
149090536|NCT01636778|537809237|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
149090537|NCT01636778|537809238|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
149090538|NCT01636778|537809236|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
149090539|NCT01636778|537809237|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
149090540|NCT01636778|537809238|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
149090541|NCT01636778|537809236|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
149090542|NCT01636778|537809237|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
149090543|NCT01636778|537809238|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
149090544|NCT01636778|537809236|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
149090545|NCT01636778|537809237|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
149090546|NCT01636778|537809238|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
149090547|NCT01636778|537809236|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
149090548|NCT01636778|537809237|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
149090549|NCT01636778|537809238|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
149090550|NCT01636778|537809236|FG000|Follow-up Period After Part 2|Other|0|||
149090551|NCT01636778|537809237|FG001|Follow-up Period After Part 2|Other|0|||
149090552|NCT01636778|537809238|FG002|Follow-up Period After Part 2|Other|1|||
149090553|NCT01636778|537809236|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
149090554|NCT01636778|537809237|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
149090555|NCT01636778|537809238|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
149090556|NCT01636778|537809236|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
149090557|NCT01636778|537809237|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
149090558|NCT01636778|537809238|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
149090559|NCT00990821|537809244|FG000|Overall Study|Withdrawal by Subject|0|||
149090560|NCT00990821|537809245|FG001|Overall Study|Withdrawal by Subject|2|||
149090561|NCT00990821|537809246|FG002|Overall Study|Withdrawal by Subject|0|||
149090562|NCT00990821|537809247|FG003|Overall Study|Withdrawal by Subject|0|||
149090563|NCT00990821|537809248|FG004|Overall Study|Withdrawal by Subject|3|||
149090564|NCT00990821|537809249|FG005|Overall Study|Withdrawal by Subject|3|||
149090565|NCT00990821|537809250|FG006|Overall Study|Withdrawal by Subject|1|||
149090566|NCT00990821|537809251|FG007|Overall Study|Withdrawal by Subject|0|||
149090567|NCT00990821|537809252|FG008|Overall Study|Withdrawal by Subject|0|||
149090568|NCT00990821|537809253|FG009|Overall Study|Withdrawal by Subject|1|||
149090569|NCT00990821|537809254|FG010|Overall Study|Withdrawal by Subject|3|||
149090570|NCT00990821|537809255|FG011|Overall Study|Withdrawal by Subject|5|||
149090571|NCT00990821|537809256|FG012|Overall Study|Withdrawal by Subject|2|||
149090572|NCT00990821|537809257|FG013|Overall Study|Withdrawal by Subject|1|||
149090573|NCT03530345|537809258|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
149090574|NCT03530345|537809259|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
149090575|NCT03530345|537809258|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
149090576|NCT03530345|537809259|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
149090577|NCT03530345|537809258|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
149090578|NCT03530345|537809259|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
149090579|NCT03530345|537809258|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
149090580|NCT03530345|537809259|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
149090581|NCT04150250|537809260|FG000|Overall Study|Lost to Follow-up|0|||
149090582|NCT04150250|537809261|FG001|Overall Study|Lost to Follow-up|2|||
149090583|NCT02442622|537809267|FG000|Overall Study|Withdrawal by Subject|3|||
149090584|NCT02442622|537809268|FG001|Overall Study|Withdrawal by Subject|1|||
149090585|NCT04357964|537811432|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
149090586|NCT04357964|537811433|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
149090587|NCT04357964|537811432|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
149090588|NCT04357964|537811433|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
149090589|NCT04357964|537811432|FG000|Overall Study|Adipose sample was insufficient quality|0|||
149090590|NCT04357964|537811433|FG001|Overall Study|Adipose sample was insufficient quality|1|||
149090591|NCT00733226|537811434|FG000|Overall Study|Withdrawal by Subject|1|||
149090592|NCT00733226|537811435|FG001|Overall Study|Withdrawal by Subject|0|||
149090593|NCT00733226|537811434|FG000|Overall Study|Lost to Follow-up|2|||
149090594|NCT00733226|537811435|FG001|Overall Study|Lost to Follow-up|0|||
149090595|NCT00733226|537811434|FG000|Overall Study|moved to another place|2|||
149090596|NCT00733226|537811435|FG001|Overall Study|moved to another place|0|||
149090597|NCT02561078|537811436|FG000|Overall Study|Adverse Event|5|||
149090598|NCT02561078|537811437|FG001|Overall Study|Adverse Event|2|||
149090599|NCT02561078|537811436|FG000|Overall Study|Death|2|||
149090600|NCT02561078|537811437|FG001|Overall Study|Death|1|||
149090601|NCT02561078|537811436|FG000|Overall Study|Lost to Follow-up|2|||
149090602|NCT02561078|537811437|FG001|Overall Study|Lost to Follow-up|6|||
149090603|NCT02561078|537811436|FG000|Overall Study|Non-Compliance with Study Drug|6|||
149090604|NCT02561078|537811437|FG001|Overall Study|Non-Compliance with Study Drug|3|||
149090605|NCT02561078|537811436|FG000|Overall Study|Physician Decision|2|||
149090606|NCT02561078|537811437|FG001|Overall Study|Physician Decision|3|||
149090607|NCT02561078|537811436|FG000|Overall Study|Withdrawal by Subject|13|||
149090608|NCT02561078|537811437|FG001|Overall Study|Withdrawal by Subject|10|||
149090609|NCT00043186|537811438|FG000|Overall Study|Physician Decision|0|||
149090610|NCT00043186|537811439|FG001|Overall Study|Physician Decision|0|||
149090611|NCT00043186|537811440|FG002|Overall Study|Physician Decision|3|||
149090612|NCT00043186|537811441|FG003|Overall Study|Physician Decision|0|||
149090613|NCT00043186|537811442|FG004|Overall Study|Physician Decision|1|||
149090614|NCT00043186|537811443|FG005|Overall Study|Physician Decision|0|||
149090615|NCT00043186|537811444|FG006|Overall Study|Physician Decision|0|||
149090616|NCT00043186|537811445|FG007|Overall Study|Physician Decision|1|||
149090617|NCT00043186|537811446|FG008|Overall Study|Physician Decision|1|||
149090618|NCT00043186|537811438|FG000|Overall Study|Adverse Event|2|||
149090619|NCT00043186|537811439|FG001|Overall Study|Adverse Event|2|||
149090620|NCT00043186|537811440|FG002|Overall Study|Adverse Event|2|||
149090621|NCT00043186|537811441|FG003|Overall Study|Adverse Event|3|||
149090622|NCT00043186|537811442|FG004|Overall Study|Adverse Event|2|||
149090623|NCT00043186|537811443|FG005|Overall Study|Adverse Event|1|||
149090624|NCT00043186|537811444|FG006|Overall Study|Adverse Event|2|||
149090625|NCT00043186|537811445|FG007|Overall Study|Adverse Event|1|||
149090626|NCT00043186|537811446|FG008|Overall Study|Adverse Event|3|||
149090627|NCT00043186|537811438|FG000|Overall Study|Withdrawal by Subject|11|||
149090628|NCT00043186|537811439|FG001|Overall Study|Withdrawal by Subject|8|||
149090629|NCT00043186|537811440|FG002|Overall Study|Withdrawal by Subject|11|||
149090630|NCT00043186|537811441|FG003|Overall Study|Withdrawal by Subject|13|||
149090631|NCT00043186|537811442|FG004|Overall Study|Withdrawal by Subject|14|||
149090632|NCT00043186|537811443|FG005|Overall Study|Withdrawal by Subject|6|||
149090633|NCT00043186|537811444|FG006|Overall Study|Withdrawal by Subject|12|||
149090634|NCT00043186|537811445|FG007|Overall Study|Withdrawal by Subject|9|||
149090635|NCT00043186|537811446|FG008|Overall Study|Withdrawal by Subject|10|||
149090636|NCT00043186|537811438|FG000|Overall Study|Death|0|||
149090637|NCT00043186|537811439|FG001|Overall Study|Death|0|||
149090638|NCT00043186|537811440|FG002|Overall Study|Death|1|||
149090639|NCT00043186|537811441|FG003|Overall Study|Death|0|||
149090640|NCT00043186|537811442|FG004|Overall Study|Death|0|||
149090641|NCT00043186|537811443|FG005|Overall Study|Death|0|||
149090642|NCT00043186|537811444|FG006|Overall Study|Death|2|||
149090643|NCT00043186|537811445|FG007|Overall Study|Death|0|||
149090644|NCT00043186|537811446|FG008|Overall Study|Death|0|||
149090645|NCT00043186|537811438|FG000|Overall Study|Disease progression|1|||
149090646|NCT00043186|537811439|FG001|Overall Study|Disease progression|0|||
149090647|NCT00043186|537811440|FG002|Overall Study|Disease progression|0|||
149090648|NCT00043186|537811441|FG003|Overall Study|Disease progression|3|||
149090649|NCT00043186|537811442|FG004|Overall Study|Disease progression|0|||
149090650|NCT00043186|537811443|FG005|Overall Study|Disease progression|0|||
149090651|NCT00043186|537811444|FG006|Overall Study|Disease progression|0|||
149090652|NCT00043186|537811445|FG007|Overall Study|Disease progression|4|||
149090653|NCT00043186|537811446|FG008|Overall Study|Disease progression|0|||
149090654|NCT00043186|537811438|FG000|Overall Study|Ineligibility determined|0|||
149090655|NCT00043186|537811439|FG001|Overall Study|Ineligibility determined|0|||
149090656|NCT00043186|537811440|FG002|Overall Study|Ineligibility determined|0|||
149090657|NCT00043186|537811441|FG003|Overall Study|Ineligibility determined|0|||
149090658|NCT00043186|537811442|FG004|Overall Study|Ineligibility determined|0|||
149090659|NCT00043186|537811443|FG005|Overall Study|Ineligibility determined|0|||
149090660|NCT00043186|537811444|FG006|Overall Study|Ineligibility determined|0|||
149090661|NCT00043186|537811445|FG007|Overall Study|Ineligibility determined|0|||
149090662|NCT00043186|537811446|FG008|Overall Study|Ineligibility determined|1|||
149090663|NCT00043186|537811438|FG000|Overall Study|Lost to Follow-up|3|||
149090664|NCT00043186|537811439|FG001|Overall Study|Lost to Follow-up|5|||
149090665|NCT00043186|537811440|FG002|Overall Study|Lost to Follow-up|1|||
149090666|NCT00043186|537811441|FG003|Overall Study|Lost to Follow-up|1|||
149090667|NCT00043186|537811442|FG004|Overall Study|Lost to Follow-up|1|||
149090668|NCT00043186|537811443|FG005|Overall Study|Lost to Follow-up|1|||
149090669|NCT00043186|537811444|FG006|Overall Study|Lost to Follow-up|1|||
149090670|NCT00043186|537811445|FG007|Overall Study|Lost to Follow-up|1|||
149090671|NCT00043186|537811446|FG008|Overall Study|Lost to Follow-up|2|||
149090672|NCT00043186|537811438|FG000|Overall Study|Noncompliance|0|||
149090673|NCT00043186|537811439|FG001|Overall Study|Noncompliance|0|||
149090674|NCT00043186|537811440|FG002|Overall Study|Noncompliance|1|||
149090675|NCT00043186|537811441|FG003|Overall Study|Noncompliance|1|||
149090676|NCT00043186|537811442|FG004|Overall Study|Noncompliance|0|||
149090677|NCT00043186|537811443|FG005|Overall Study|Noncompliance|0|||
149090678|NCT00043186|537811444|FG006|Overall Study|Noncompliance|0|||
149090679|NCT00043186|537811445|FG007|Overall Study|Noncompliance|0|||
149090680|NCT00043186|537811446|FG008|Overall Study|Noncompliance|0|||
149090681|NCT00043186|537811438|FG000|Overall Study|Other|0|||
149090682|NCT00043186|537811439|FG001|Overall Study|Other|0|||
149090683|NCT00043186|537811440|FG002|Overall Study|Other|1|||
149090684|NCT00043186|537811441|FG003|Overall Study|Other|1|||
149090685|NCT00043186|537811442|FG004|Overall Study|Other|0|||
149090686|NCT00043186|537811443|FG005|Overall Study|Other|0|||
149090687|NCT00043186|537811444|FG006|Overall Study|Other|0|||
149090688|NCT00043186|537811445|FG007|Overall Study|Other|0|||
149090689|NCT00043186|537811446|FG008|Overall Study|Other|0|||
149090690|NCT00958711|537811447|FG000|Overall Study|Withdrawal by Subject|0|||
149090691|NCT00958711|537811448|FG001|Overall Study|Withdrawal by Subject|4|||
149090692|NCT00958711|537811447|FG000|Overall Study|Physician Decision|5|||
149090693|NCT00958711|537811448|FG001|Overall Study|Physician Decision|7|||
149090694|NCT00958711|537811447|FG000|Overall Study|Lost to Follow-up|4|||
149090695|NCT00958711|537811448|FG001|Overall Study|Lost to Follow-up|1|||
149090696|NCT00958711|537811447|FG000|Overall Study|Other|2|||
149090697|NCT00958711|537811448|FG001|Overall Study|Other|5|||
149090698|NCT00958711|537811447|FG000|Overall Study|Death|1|||
149090699|NCT00958711|537811448|FG001|Overall Study|Death|2|||
149090700|NCT00958711|537811447|FG000|Overall Study|Adverse Event|1|||
149090701|NCT00958711|537811448|FG001|Overall Study|Adverse Event|2|||
149090702|NCT03722485|537811449|FG000|Overall Study|Withdrawal by Subject|1|||
149090703|NCT03722485|537811450|FG001|Overall Study|Withdrawal by Subject|0|||
149090704|NCT03722485|537811449|FG000|Overall Study|Adverse Event|0|||
149090705|NCT03722485|537811450|FG001|Overall Study|Adverse Event|2|||
149090706|NCT03722485|537811449|FG000|Overall Study|subject discharged prior to study completion|1|||
149090707|NCT03722485|537811450|FG001|Overall Study|subject discharged prior to study completion|5|||
149090708|NCT03722485|537811449|FG000|Overall Study|eligibility criteria not met|2|||
149090709|NCT03722485|537811450|FG001|Overall Study|eligibility criteria not met|0|||
149090710|NCT02151643|537811451|FG000|Overall Study|Adverse Event|2|||
149090711|NCT02151643|537811452|FG001|Overall Study|Adverse Event|0|||
149090712|NCT02151643|537811453|FG002|Overall Study|Adverse Event|1|||
149090713|NCT02151643|537811454|FG003|Overall Study|Adverse Event|4|||
149090714|NCT02151643|537811455|FG004|Overall Study|Adverse Event|0|||
149090715|NCT02151643|537811451|FG000|Overall Study|Withdrawal by Subject|0|||
149090716|NCT02151643|537811452|FG001|Overall Study|Withdrawal by Subject|1|||
149090717|NCT02151643|537811453|FG002|Overall Study|Withdrawal by Subject|1|||
149090718|NCT02151643|537811454|FG003|Overall Study|Withdrawal by Subject|1|||
149090719|NCT02151643|537811455|FG004|Overall Study|Withdrawal by Subject|1|||
149090720|NCT02151643|537811451|FG000|Overall Study|Hyperphosphataemia|1|||
149090721|NCT02151643|537811452|FG001|Overall Study|Hyperphosphataemia|0|||
149090722|NCT02151643|537811453|FG002|Overall Study|Hyperphosphataemia|0|||
149090723|NCT02151643|537811454|FG003|Overall Study|Hyperphosphataemia|0|||
149090724|NCT02151643|537811455|FG004|Overall Study|Hyperphosphataemia|1|||
149090725|NCT02151643|537811451|FG000|Overall Study|High Ferritin levels|3|||
149090726|NCT02151643|537811452|FG001|Overall Study|High Ferritin levels|3|||
149090727|NCT02151643|537811453|FG002|Overall Study|High Ferritin levels|2|||
149090728|NCT02151643|537811454|FG003|Overall Study|High Ferritin levels|2|||
149090729|NCT02151643|537811455|FG004|Overall Study|High Ferritin levels|1|||
149090730|NCT00197106|537811456|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
149090731|NCT00197106|537811457|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
149090732|NCT00197106|537811458|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
149090733|NCT00197106|537811456|FG000|Overall Treatment Period|Lack of Efficacy|0|||
149090734|NCT00197106|537811457|FG001|Overall Treatment Period|Lack of Efficacy|1|||
149090735|NCT00197106|537811458|FG002|Overall Treatment Period|Lack of Efficacy|0|||
149090736|NCT00197106|537811456|FG000|Overall Treatment Period|Lost to Follow-up|0|||
149090737|NCT00197106|537811457|FG001|Overall Treatment Period|Lost to Follow-up|0|||
149090738|NCT00197106|537811458|FG002|Overall Treatment Period|Lost to Follow-up|2|||
149090739|NCT00197106|537811456|FG000|Overall Treatment Period|Protocol Violation|0|||
149090740|NCT00197106|537811457|FG001|Overall Treatment Period|Protocol Violation|0|||
149090741|NCT00197106|537811458|FG002|Overall Treatment Period|Protocol Violation|2|||
149090742|NCT00197106|537811456|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
149090743|NCT00197106|537811457|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
149090744|NCT00197106|537811458|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
149090745|NCT01503515|537811459|FG000|Overall Study|Adverse Event|4|||
149090746|NCT01503515|537811460|FG001|Overall Study|Adverse Event|5|||
149090747|NCT01503515|537811459|FG000|Overall Study|Death|0|||
149090748|NCT01503515|537811460|FG001|Overall Study|Death|1|||
149090749|NCT01503515|537811459|FG000|Overall Study|Physician Decision|14|||
149090750|NCT01503515|537811460|FG001|Overall Study|Physician Decision|23|||
149090751|NCT01503515|537811459|FG000|Overall Study|Withdrawal by Subject|0|||
149090752|NCT01503515|537811460|FG001|Overall Study|Withdrawal by Subject|1|||
149090753|NCT01503515|537811459|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
149090754|NCT01503515|537811460|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
149090755|NCT01503515|537811459|FG000|Overall Study|Ineligible|1|||
149090756|NCT01503515|537811460|FG001|Overall Study|Ineligible|1|||
149090757|NCT04050722|537811461|FG000|Overall Study|Withdrawal by Subject|1|||
149090758|NCT04050722|537811462|FG001|Overall Study|Withdrawal by Subject|0|||
149090759|NCT00377312|537811463|FG000|Overall Study|Adverse Event|1|||
149090760|NCT00377312|537811464|FG001|Overall Study|Adverse Event|1|||
149090761|NCT00762723|537811465|FG000|Overall Study|Study Terminated slow enrollement|5|||
149090762|NCT00762723|537811466|FG001|Overall Study|Study Terminated slow enrollement|5|||
149090763|NCT00762723|537811467|FG002|Overall Study|Study Terminated slow enrollement|3|||
149090764|NCT01116440|537811472|FG000|Treatment|Withdrawal by Subject|2|||
149090765|NCT01116440|537811473|FG001|Treatment|Withdrawal by Subject|2|||
149090766|NCT01116440|537811472|FG000|Treatment|Lost to Follow-up|1|||
149090767|NCT01116440|537811473|FG001|Treatment|Lost to Follow-up|1|||
149090768|NCT01116440|537811472|FG000|Treatment|Protocol Violation|0|||
149090769|NCT01116440|537811473|FG001|Treatment|Protocol Violation|2|||
149090770|NCT01116440|537811472|FG000|Treatment|Lack of Efficacy|0|||
149090771|NCT01116440|537811473|FG001|Treatment|Lack of Efficacy|1|||
149090772|NCT01116440|537811472|FG000|Treatment|Adverse Event|0|||
149090773|NCT01116440|537811473|FG001|Treatment|Adverse Event|1|||
149090774|NCT01116440|537811472|FG000|Withdrawal|Withdrawal by Subject|0|||
149090775|NCT01116440|537811473|FG001|Withdrawal|Withdrawal by Subject|1|||
149090776|NCT01116440|537811472|FG000|Withdrawal|Lost to Follow-up|0|||
149090777|NCT01116440|537811473|FG001|Withdrawal|Lost to Follow-up|1|||
149090778|NCT01116440|537811472|FG000|Follow-up|Lost to Follow-up|0|||
149090779|NCT01116440|537811473|FG001|Follow-up|Lost to Follow-up|1|||
149090780|NCT01116440|537811472|FG000|Follow-up|Withdrawal by Subject|0|||
149090781|NCT01116440|537811473|FG001|Follow-up|Withdrawal by Subject|1|||
149090782|NCT02402465|537811484|FG000|Overall Study|Withdrawal by Subject|0|||
149090783|NCT02402465|537811485|FG001|Overall Study|Withdrawal by Subject|0|||
149090784|NCT02402465|537811486|FG002|Overall Study|Withdrawal by Subject|0|||
149090785|NCT02402465|537811487|FG003|Overall Study|Withdrawal by Subject|0|||
149090786|NCT02402465|537811488|FG004|Overall Study|Withdrawal by Subject|0|||
149090787|NCT02402465|537811489|FG005|Overall Study|Withdrawal by Subject|1|||
149090788|NCT02402465|537811484|FG000|Overall Study|Lost to Follow-up|0|||
149090789|NCT02402465|537811485|FG001|Overall Study|Lost to Follow-up|1|||
149090790|NCT02402465|537811486|FG002|Overall Study|Lost to Follow-up|0|||
149090791|NCT02402465|537811487|FG003|Overall Study|Lost to Follow-up|0|||
149090792|NCT02402465|537811488|FG004|Overall Study|Lost to Follow-up|1|||
149090793|NCT02402465|537811489|FG005|Overall Study|Lost to Follow-up|0|||
149090794|NCT01284634|537811490|FG000|Overall Study|Adverse Event|1|||
149090795|NCT01284634|537811491|FG001|Overall Study|Adverse Event|0|||
149090796|NCT01284634|537811492|FG002|Overall Study|Adverse Event|2|||
149090797|NCT01284634|537811493|FG003|Overall Study|Adverse Event|1|||
149090798|NCT02236598|537811494|FG000|Overall Study|Adverse Event|0|||
149090799|NCT02236598|537811495|FG001|Overall Study|Adverse Event|1|||
149090800|NCT02236598|537811494|FG000|Overall Study|Withdrawal by Subject|0|||
149090801|NCT02236598|537811495|FG001|Overall Study|Withdrawal by Subject|1|||
149090802|NCT03334747|537811499|FG000|Treatment Phase|Technical problems|0|||
149090803|NCT03334747|537811500|FG001|Treatment Phase|Technical problems|0|||
149090804|NCT03334747|537811501|FG002|Treatment Phase|Technical problems|0|||
149090805|NCT03334747|537811502|FG003|Treatment Phase|Technical problems|0|||
149090806|NCT03334747|537811503|FG004|Treatment Phase|Technical problems|1|||
149090807|NCT03334747|537811504|FG005|Treatment Phase|Technical problems|0|||
149090808|NCT03334747|537811505|FG006|Treatment Phase|Technical problems|0|||
149090809|NCT03334747|537811506|FG007|Treatment Phase|Technical problems|0|||
149090810|NCT03334747|537811507|FG008|Treatment Phase|Technical problems|0|||
149090811|NCT03334747|537811499|FG000|Treatment Phase|Subject/guardian decision|1|||
149090812|NCT03334747|537811500|FG001|Treatment Phase|Subject/guardian decision|0|||
149090813|NCT03334747|537811501|FG002|Treatment Phase|Subject/guardian decision|0|||
149090814|NCT03334747|537811502|FG003|Treatment Phase|Subject/guardian decision|0|||
149090815|NCT03334747|537811503|FG004|Treatment Phase|Subject/guardian decision|0|||
149090816|NCT03334747|537811504|FG005|Treatment Phase|Subject/guardian decision|1|||
149090817|NCT03334747|537811505|FG006|Treatment Phase|Subject/guardian decision|0|||
149090818|NCT03334747|537811506|FG007|Treatment Phase|Subject/guardian decision|0|||
149090819|NCT03334747|537811507|FG008|Treatment Phase|Subject/guardian decision|0|||
149090820|NCT03334747|537811499|FG000|Follow-Up Phase|Subject/guardian decision|0|||
149090821|NCT03334747|537811500|FG001|Follow-Up Phase|Subject/guardian decision|0|||
149090822|NCT03334747|537811501|FG002|Follow-Up Phase|Subject/guardian decision|0|||
149090823|NCT03334747|537811502|FG003|Follow-Up Phase|Subject/guardian decision|0|||
149090824|NCT03334747|537811503|FG004|Follow-Up Phase|Subject/guardian decision|0|||
149090825|NCT03334747|537811504|FG005|Follow-Up Phase|Subject/guardian decision|0|||
149090826|NCT03334747|537811505|FG006|Follow-Up Phase|Subject/guardian decision|1|||
149090827|NCT03334747|537811506|FG007|Follow-Up Phase|Subject/guardian decision|0|||
149090828|NCT03334747|537811507|FG008|Follow-Up Phase|Subject/guardian decision|1|||
149090829|NCT00191984|537811514|FG000|Overall Study|Disease Progression|21|||
149090830|NCT00191984|537811514|FG000|Overall Study|Adverse Event|4|||
149090831|NCT00191984|537811514|FG000|Overall Study|Death|2|||
149090832|NCT00191984|537811514|FG000|Overall Study|Entry Criteria Exclusion|1|||
149090833|NCT00191984|537811514|FG000|Overall Study|Withdrawal by Subject|7|||
149090834|NCT00191984|537811514|FG000|Overall Study|Physician Decision|4|||
149090835|NCT03303521|537811515|FG000|Overall Study|Withdrawal by Subject|2|||
149090836|NCT03303521|537811516|FG001|Overall Study|Withdrawal by Subject|0|||
149090837|NCT03303521|537811515|FG000|Overall Study|Death|1|||
149090838|NCT03303521|537811516|FG001|Overall Study|Death|0|||
149090839|NCT03303521|537811515|FG000|Overall Study|Kidney transplantation|0|||
149090840|NCT03303521|537811516|FG001|Overall Study|Kidney transplantation|1|||
149090841|NCT03303521|537811515|FG000|Overall Study|Investigational product discontinuation|0|||
149090842|NCT03303521|537811516|FG001|Overall Study|Investigational product discontinuation|1|||
149090843|NCT03303521|537811515|FG000|Overall Study|Transferred to non-study dialysis center|1|||
149090844|NCT03303521|537811516|FG001|Overall Study|Transferred to non-study dialysis center|0|||
149090845|NCT03303521|537811515|FG000|Overall Study|Non-comliance to study protocol|0|||
149090846|NCT03303521|537811516|FG001|Overall Study|Non-comliance to study protocol|1|||
149090847|NCT03303521|537811515|FG000|Overall Study|Adverse Event|1|||
149090848|NCT03303521|537811516|FG001|Overall Study|Adverse Event|0|||
149090849|NCT00005908|537811519|FG000|Overall Study|Withdrawal by Subject|1|||
149090850|NCT00005908|537811520|FG001|Overall Study|Withdrawal by Subject|0|||
149090851|NCT04736602|537811525|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
149090852|NCT04736602|537811525|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
149090853|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Adverse Event|3|||
149090854|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Adverse Event|0|||
149090855|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
149090856|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
149090857|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Disease Progression|23|||
149090858|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Disease Progression|22|||
149090859|NCT01379521|537811526|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
149090860|NCT01379521|537811527|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
149090861|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
149090862|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
149090863|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
149090864|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
149090865|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
149090866|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
149090867|NCT01379521|537811526|FG000|Overall Study -Treatment Period|Death|2|||
149090868|NCT01379521|537811527|FG001|Overall Study -Treatment Period|Death|1|||
149090869|NCT01379521|537811526|FG000|Post-Treatment Evaluations|Disease Progression|22|||
149090870|NCT01379521|537811527|FG001|Post-Treatment Evaluations|Disease Progression|20|||
149090871|NCT01379521|537811526|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
149090872|NCT01379521|537811527|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
149090873|NCT01379521|537811526|FG000|Post-Treatment Evaluations|Death|1|||
149090874|NCT01379521|537811527|FG001|Post-Treatment Evaluations|Death|0|||
149090875|NCT00938041|537811528|FG000|Overall Study|Lost to Follow-up|6|||
149090876|NCT00938041|537811528|FG000|Overall Study|Received Alternative Therapy|1|||
149090877|NCT00938041|537811528|FG000|Overall Study|Progressive Disease|5|||
149090878|NCT00938041|537811528|FG000|Overall Study|Death|12|||
149090879|NCT00938041|537811528|FG000|Overall Study|Adrenal Insufficiency|3|||
149090880|NCT03042559|537811529|FG000|Overall Study|drop out|1|||
149090881|NCT03042559|537811530|FG001|Overall Study|drop out|1|||
149090882|NCT01536535|537811532|FG000|Overall Study|Withdrawal by Subject|10|||
149090883|NCT01536535|537811533|FG001|Overall Study|Withdrawal by Subject|5|||
149090884|NCT01536535|537811532|FG000|Overall Study|Lost to Follow-up|4|||
149090885|NCT01536535|537811533|FG001|Overall Study|Lost to Follow-up|6|||
149090886|NCT01536535|537811532|FG000|Overall Study|Physician Decision|1|||
149090887|NCT01536535|537811533|FG001|Overall Study|Physician Decision|1|||
149090888|NCT01536535|537811532|FG000|Overall Study|Participant moved|0|||
149090889|NCT01536535|537811533|FG001|Overall Study|Participant moved|1|||
149090890|NCT01485991|537811537|FG000|Overall Study|Adverse Event|0|||
149090891|NCT01485991|537811538|FG001|Overall Study|Adverse Event|4|||
149090892|NCT01485991|537811537|FG000|Overall Study|Lost to Follow-up|13|||
149090893|NCT01485991|537811538|FG001|Overall Study|Lost to Follow-up|10|||
149090894|NCT01485991|537811537|FG000|Overall Study|Withdrawal by Subject|13|||
149090895|NCT01485991|537811538|FG001|Overall Study|Withdrawal by Subject|20|||
149090896|NCT01485991|537811537|FG000|Overall Study|randomized but not treated|6|||
149090897|NCT01485991|537811538|FG001|Overall Study|randomized but not treated|2|||
149090898|NCT02538471|537811539|FG000|Overall Study|Progression of disease|2|||
149090899|NCT01475370|537811540|FG000|Overall Study|Exacerbation of primary disease|2|||
149090900|NCT01475370|537811541|FG001|Overall Study|Exacerbation of primary disease|2|||
149090901|NCT01475370|537811542|FG002|Overall Study|Exacerbation of primary disease|2|||
149090902|NCT01475370|537811540|FG000|Overall Study|Study drug administration difficult|0|||
149090903|NCT01475370|537811541|FG001|Overall Study|Study drug administration difficult|1|||
149090904|NCT01475370|537811542|FG002|Overall Study|Study drug administration difficult|1|||
149090905|NCT01475370|537811540|FG000|Overall Study|Other than specified|1|||
149090906|NCT01475370|537811541|FG001|Overall Study|Other than specified|0|||
149090907|NCT01475370|537811542|FG002|Overall Study|Other than specified|0|||
149090908|NCT00125853|537811543|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
149090909|NCT00125853|537811544|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
149090910|NCT02522299|537811547|FG000|Overall Study|Adverse Event|2|||
149090911|NCT02522299|537811548|FG001|Overall Study|Adverse Event|0|||
149090912|NCT02522299|537811547|FG000|Overall Study|Physician Decision|0|||
149090913|NCT02522299|537811548|FG001|Overall Study|Physician Decision|1|||
149090914|NCT02522299|537811547|FG000|Overall Study|Withdrawal by Subject|2|||
149090915|NCT02522299|537811548|FG001|Overall Study|Withdrawal by Subject|0|||
149090916|NCT03575572|537811551|FG000|Overall Study|Withdrawal by Subject|2|||
149090917|NCT03575572|537811551|FG000|Overall Study|Physician Decision|2|||
149090918|NCT01257698|537811552|FG000|Overall Study|Protocol Violation|4|||
149090919|NCT01257698|537811553|FG001|Overall Study|Protocol Violation|0|||
149090920|NCT00050167|537811555|FG000|Overall Study|not eligible not invasive|1|||
149090921|NCT00050167|537811556|FG001|Overall Study|not eligible not invasive|1|||
149090922|NCT02038803|537811560|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
149090923|NCT02038803|537811560|FG000|Overall Study|Lost to Follow-up|1|||
149090924|NCT04754594|537811561|FG000|Blinded Period|Withdrawal by Subject|4|||
149090925|NCT04754594|537811562|FG001|Blinded Period|Withdrawal by Subject|9|||
149090926|NCT04754594|537811563|FG002|Blinded Period|Withdrawal by Subject|0|||
149090927|NCT04754594|537811564|FG003|Blinded Period|Withdrawal by Subject|0|||
149090928|NCT04754594|537811561|FG000|Blinded Period|Protocol Violation|2|||
149090929|NCT04754594|537811562|FG001|Blinded Period|Protocol Violation|2|||
149090930|NCT04754594|537811563|FG002|Blinded Period|Protocol Violation|0|||
149090931|NCT04754594|537811564|FG003|Blinded Period|Protocol Violation|0|||
149090932|NCT04754594|537811561|FG000|Blinded Period|Lost to Follow-up|1|||
149090933|NCT04754594|537811562|FG001|Blinded Period|Lost to Follow-up|1|||
149090934|NCT04754594|537811563|FG002|Blinded Period|Lost to Follow-up|0|||
149090935|NCT04754594|537811564|FG003|Blinded Period|Lost to Follow-up|0|||
149090936|NCT04754594|537811561|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
149090937|NCT04754594|537811562|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
149090938|NCT04754594|537811563|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
149090939|NCT04754594|537811564|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
149090940|NCT04754594|537811561|FG000|Unblinded Period|Withdrawal by Subject|6|||
149090941|NCT04754594|537811562|FG001|Unblinded Period|Withdrawal by Subject|8|||
149090942|NCT04754594|537811563|FG002|Unblinded Period|Withdrawal by Subject|0|||
149090943|NCT04754594|537811564|FG003|Unblinded Period|Withdrawal by Subject|0|||
149090944|NCT04754594|537811561|FG000|Unblinded Period|Lost to Follow-up|5|||
149090945|NCT04754594|537811562|FG001|Unblinded Period|Lost to Follow-up|3|||
149090946|NCT04754594|537811563|FG002|Unblinded Period|Lost to Follow-up|0|||
149090947|NCT04754594|537811564|FG003|Unblinded Period|Lost to Follow-up|0|||
149090948|NCT04754594|537811561|FG000|Unblinded Period|Protocol Violation|2|||
149090949|NCT04754594|537811562|FG001|Unblinded Period|Protocol Violation|4|||
149090950|NCT04754594|537811563|FG002|Unblinded Period|Protocol Violation|0|||
149090951|NCT04754594|537811564|FG003|Unblinded Period|Protocol Violation|0|||
149090952|NCT04754594|537811561|FG000|Unblinded Period|Other|3|||
149090953|NCT04754594|537811562|FG001|Unblinded Period|Other|0|||
149090954|NCT04754594|537811563|FG002|Unblinded Period|Other|0|||
149090955|NCT04754594|537811564|FG003|Unblinded Period|Other|0|||
149090956|NCT04754594|537811561|FG000|Infant Participants|Withdrawal by Subject|0|||
149090957|NCT04754594|537811562|FG001|Infant Participants|Withdrawal by Subject|0|||
149090958|NCT04754594|537811563|FG002|Infant Participants|Withdrawal by Subject|9|||
149090959|NCT04754594|537811564|FG003|Infant Participants|Withdrawal by Subject|17|||
149090960|NCT04754594|537811561|FG000|Infant Participants|Lost to Follow-up|0|||
149090961|NCT04754594|537811562|FG001|Infant Participants|Lost to Follow-up|0|||
149090962|NCT04754594|537811563|FG002|Infant Participants|Lost to Follow-up|4|||
149090963|NCT04754594|537811564|FG003|Infant Participants|Lost to Follow-up|10|||
149090964|NCT04754594|537811561|FG000|Infant Participants|Death|0|||
149090965|NCT04754594|537811562|FG001|Infant Participants|Death|0|||
149090966|NCT04754594|537811563|FG002|Infant Participants|Death|1|||
149090967|NCT04754594|537811564|FG003|Infant Participants|Death|1|||
149090968|NCT04754594|537811561|FG000|Infant Participants|Other|0|||
149090969|NCT04754594|537811562|FG001|Infant Participants|Other|0|||
149090970|NCT04754594|537811563|FG002|Infant Participants|Other|1|||
149090971|NCT04754594|537811564|FG003|Infant Participants|Other|1|||
149090972|NCT02588027|537811565|FG000|Overall Study|Withdrawal by Subject|1|||
149090973|NCT02588027|537811566|FG001|Overall Study|Withdrawal by Subject|3|||
149090974|NCT02588027|537811565|FG000|Overall Study|Protocol Violation|4|||
149090975|NCT02588027|537811566|FG001|Overall Study|Protocol Violation|1|||
149090976|NCT04372186|537811567|FG000|Overall Study|Death|24|||
149090977|NCT04372186|537811568|FG001|Overall Study|Death|11|||
149090978|NCT04372186|537811567|FG000|Overall Study|Transferred to a different facility for care|0|||
149090979|NCT04372186|537811568|FG001|Overall Study|Transferred to a different facility for care|2|||
149090980|NCT04736472|537811569|FG000|Overall Study|Lost to Follow-up|1|||
149090981|NCT04736472|537811570|FG001|Overall Study|Lost to Follow-up|0|||
149090982|NCT04736472|537811571|FG002|Overall Study|Lost to Follow-up|0|||
149090983|NCT04736472|537811569|FG000|Overall Study|Withdrawal by Subject|2|||
149090984|NCT04736472|537811570|FG001|Overall Study|Withdrawal by Subject|0|||
149090985|NCT04736472|537811571|FG002|Overall Study|Withdrawal by Subject|0|||
149090986|NCT04736472|537811569|FG000|Overall Study|Protocol Violation|48|||
149090987|NCT04736472|537811570|FG001|Overall Study|Protocol Violation|0|||
149090988|NCT04736472|537811571|FG002|Overall Study|Protocol Violation|6|||
149090989|NCT02116582|537811572|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
149090990|NCT02116582|537811572|FG000|Overall Study|Adverse Event|22|||
149090991|NCT02116582|537811572|FG000|Overall Study|Death|9|||
149090992|NCT02116582|537811572|FG000|Overall Study|Progressive Disease|148|||
149090993|NCT02116582|537811572|FG000|Overall Study|Protocol Violation|3|||
149090994|NCT02116582|537811572|FG000|Overall Study|Withdrawal by Subject|8|||
149090995|NCT02116582|537811572|FG000|Overall Study|Other: Miscellaneous|11|||
149090996|NCT02116582|537811572|FG000|Overall Study|Lost to Follow-up|1|||
149090997|NCT02116582|537811572|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
149090998|NCT01876823|537811573|FG000|Overall Study|Withdrawal by Subject|5|||
149090999|NCT01876823|537811573|FG000|Overall Study|Physician Decision|2|||
149091000|NCT01876823|537811573|FG000|Overall Study|Patients moved|2|||
149091001|NCT02256488|537811574|FG000|Overall Study|Lost to Follow-up|6|||
149091002|NCT02256488|537811575|FG001|Overall Study|Lost to Follow-up|6|||
149091003|NCT02256488|537811576|FG002|Overall Study|Lost to Follow-up|9|||
149091004|NCT02256488|537811577|FG003|Overall Study|Lost to Follow-up|3|||
149091005|NCT02256488|537811574|FG000|Overall Study|OTHER|1|||
149091006|NCT02256488|537811575|FG001|Overall Study|OTHER|0|||
149091007|NCT02256488|537811576|FG002|Overall Study|OTHER|1|||
149091008|NCT02256488|537811577|FG003|Overall Study|OTHER|1|||
149091009|NCT02256488|537811574|FG000|Overall Study|Withdrawal by Subject|1|||
149091010|NCT02256488|537811575|FG001|Overall Study|Withdrawal by Subject|0|||
149091011|NCT02256488|537811576|FG002|Overall Study|Withdrawal by Subject|0|||
149091012|NCT02256488|537811577|FG003|Overall Study|Withdrawal by Subject|2|||
149091013|NCT02268526|537811578|FG000|Overall Study|Adverse Event|0|||
149091014|NCT02268526|537811579|FG001|Overall Study|Adverse Event|2|||
149091015|NCT02268526|537811580|FG002|Overall Study|Adverse Event|1|||
149091016|NCT02268526|537811578|FG000|Overall Study|Death|1|||
149091017|NCT02268526|537811579|FG001|Overall Study|Death|11|||
149091018|NCT02268526|537811580|FG002|Overall Study|Death|0|||
149091019|NCT02268526|537811578|FG000|Overall Study|protocol deviation|0|||
149091020|NCT02268526|537811579|FG001|Overall Study|protocol deviation|1|||
149091021|NCT02268526|537811580|FG002|Overall Study|protocol deviation|0|||
149091022|NCT02268526|537811578|FG000|Overall Study|Physician Decision|0|||
149091023|NCT02268526|537811579|FG001|Overall Study|Physician Decision|0|||
149091024|NCT02268526|537811580|FG002|Overall Study|Physician Decision|1|||
149091025|NCT02268526|537811578|FG000|Overall Study|Subject/guardian decision|0|||
149091026|NCT02268526|537811579|FG001|Overall Study|Subject/guardian decision|7|||
149091027|NCT02268526|537811580|FG002|Overall Study|Subject/guardian decision|3|||
149091028|NCT00975130|537811581|FG000|Study Part 1|Adverse Event|150|||
149091029|NCT00975130|537811582|FG001|Study Part 1|Adverse Event|0|||
149091030|NCT00975130|537811583|FG002|Study Part 1|Adverse Event|0|||
149091031|NCT00975130|537811581|FG000|Study Part 1|Lost to Follow-up|19|||
149091032|NCT00975130|537811582|FG001|Study Part 1|Lost to Follow-up|0|||
149091033|NCT00975130|537811583|FG002|Study Part 1|Lost to Follow-up|0|||
149091034|NCT00975130|537811581|FG000|Study Part 1|Withdrawal by Subject|61|||
149091035|NCT00975130|537811582|FG001|Study Part 1|Withdrawal by Subject|0|||
149091036|NCT00975130|537811583|FG002|Study Part 1|Withdrawal by Subject|0|||
149091037|NCT00975130|537811581|FG000|Study Part 1|Protocol Violation|13|||
149091038|NCT00975130|537811582|FG001|Study Part 1|Protocol Violation|0|||
149091039|NCT00975130|537811583|FG002|Study Part 1|Protocol Violation|0|||
149091040|NCT00975130|537811581|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
149091041|NCT00975130|537811582|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
149091042|NCT00975130|537811583|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
149091043|NCT00975130|537811581|FG000|Study Part 1|Administrative|4|||
149091044|NCT00975130|537811582|FG001|Study Part 1|Administrative|0|||
149091045|NCT00975130|537811583|FG002|Study Part 1|Administrative|0|||
149091046|NCT00975130|537811581|FG000|Study Part 1|Withdrew Consent|24|||
149091047|NCT00975130|537811582|FG001|Study Part 1|Withdrew Consent|0|||
149091048|NCT00975130|537811583|FG002|Study Part 1|Withdrew Consent|0|||
149091049|NCT00975130|537811581|FG000|Study Part 2|Adverse Event|0|||
149091050|NCT00975130|537811582|FG001|Study Part 2|Adverse Event|14|||
149091051|NCT00975130|537811583|FG002|Study Part 2|Adverse Event|7|||
149091052|NCT00975130|537811581|FG000|Study Part 2|Lost to Follow-up|0|||
149091053|NCT00975130|537811582|FG001|Study Part 2|Lost to Follow-up|0|||
149091054|NCT00975130|537811583|FG002|Study Part 2|Lost to Follow-up|1|||
149091055|NCT00975130|537811581|FG000|Study Part 2|Withdrawal by Subject|0|||
149091056|NCT00975130|537811582|FG001|Study Part 2|Withdrawal by Subject|13|||
149091057|NCT00975130|537811583|FG002|Study Part 2|Withdrawal by Subject|5|||
149091058|NCT00975130|537811581|FG000|Study Part 2|Withdrew Consent|0|||
149091059|NCT00975130|537811582|FG001|Study Part 2|Withdrew Consent|6|||
149091060|NCT00975130|537811583|FG002|Study Part 2|Withdrew Consent|2|||
149091061|NCT00975130|537811581|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
149091062|NCT00975130|537811582|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
149091063|NCT00975130|537811583|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
149091064|NCT00975130|537811581|FG000|Study Part 2|Administrative|0|||
149091065|NCT00975130|537811582|FG001|Study Part 2|Administrative|1|||
149091066|NCT00975130|537811583|FG002|Study Part 2|Administrative|0|||
149091067|NCT00975130|537811581|FG000|Study Part 2|Protocol Violation|0|||
149091068|NCT00975130|537811582|FG001|Study Part 2|Protocol Violation|0|||
149091069|NCT00975130|537811583|FG002|Study Part 2|Protocol Violation|1|||
149091070|NCT01261793|537811584|FG000|Overall Study|Lack of Efficacy|44|||
149091071|NCT01261793|537811585|FG001|Overall Study|Lack of Efficacy|37|||
149091072|NCT01261793|537811586|FG002|Overall Study|Lack of Efficacy|32|||
149091073|NCT01261793|537811584|FG000|Overall Study|Protocol Violation|3|||
149091074|NCT01261793|537811585|FG001|Overall Study|Protocol Violation|5|||
149091075|NCT01261793|537811586|FG002|Overall Study|Protocol Violation|6|||
149091076|NCT01261793|537811584|FG000|Overall Study|Lost to Follow-up|10|||
149091077|NCT01261793|537811585|FG001|Overall Study|Lost to Follow-up|3|||
149091078|NCT01261793|537811586|FG002|Overall Study|Lost to Follow-up|7|||
149091079|NCT01261793|537811584|FG000|Overall Study|Withdrawal by Subject|12|||
149091080|NCT01261793|537811585|FG001|Overall Study|Withdrawal by Subject|14|||
149091081|NCT01261793|537811586|FG002|Overall Study|Withdrawal by Subject|14|||
149091082|NCT01261793|537811584|FG000|Overall Study|Death|3|||
149091083|NCT01261793|537811585|FG001|Overall Study|Death|1|||
149091084|NCT01261793|537811586|FG002|Overall Study|Death|0|||
149091085|NCT01261793|537811584|FG000|Overall Study|Adverse Event|9|||
149091086|NCT01261793|537811585|FG001|Overall Study|Adverse Event|24|||
149091087|NCT01261793|537811586|FG002|Overall Study|Adverse Event|19|||
149091088|NCT01261793|537811584|FG000|Overall Study|Patient non-availability|1|||
149091089|NCT01261793|537811585|FG001|Overall Study|Patient non-availability|1|||
149091090|NCT01261793|537811586|FG002|Overall Study|Patient non-availability|1|||
149091091|NCT01261793|537811584|FG000|Overall Study|Suspected pregnancy|1|||
149091092|NCT01261793|537811585|FG001|Overall Study|Suspected pregnancy|1|||
149091093|NCT01261793|537811586|FG002|Overall Study|Suspected pregnancy|0|||
149091094|NCT01261793|537811584|FG000|Overall Study|Patient non-compliance|1|||
149091095|NCT01261793|537811585|FG001|Overall Study|Patient non-compliance|0|||
149091096|NCT01261793|537811586|FG002|Overall Study|Patient non-compliance|1|||
149091097|NCT01261793|537811584|FG000|Overall Study|Patient pregnant|1|||
149091098|NCT01261793|537811585|FG001|Overall Study|Patient pregnant|0|||
149091099|NCT01261793|537811586|FG002|Overall Study|Patient pregnant|0|||
149091100|NCT01261793|537811584|FG000|Overall Study|Outside the study area|0|||
149091101|NCT01261793|537811585|FG001|Overall Study|Outside the study area|2|||
149091102|NCT01261793|537811586|FG002|Overall Study|Outside the study area|1|||
149091103|NCT01261793|537811584|FG000|Overall Study|Lack of efficacy & patient not available|0|||
149091104|NCT01261793|537811585|FG001|Overall Study|Lack of efficacy & patient not available|1|||
149091105|NCT01261793|537811586|FG002|Overall Study|Lack of efficacy & patient not available|0|||
149091106|NCT01261793|537811584|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
149091107|NCT01261793|537811585|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
149091108|NCT01261793|537811586|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
149091109|NCT01261793|537811584|FG000|Overall Study|Randomization error|0|||
149091110|NCT01261793|537811585|FG001|Overall Study|Randomization error|1|||
149091111|NCT01261793|537811586|FG002|Overall Study|Randomization error|0|||
149091112|NCT01261793|537811584|FG000|Overall Study|Patient unable to start IV line|0|||
149091113|NCT01261793|537811585|FG001|Overall Study|Patient unable to start IV line|0|||
149091114|NCT01261793|537811586|FG002|Overall Study|Patient unable to start IV line|1|||
149091115|NCT00577096|537811587|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
149091116|NCT00577096|537811588|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
149091117|NCT00577096|537811587|FG000|Short Term Participation|Withdrawal by Subject|3|||
149091118|NCT00577096|537811588|FG001|Short Term Participation|Withdrawal by Subject|5|||
149091119|NCT00577096|537811587|FG000|Short Term Participation|Death|1|||
149091120|NCT00577096|537811588|FG001|Short Term Participation|Death|1|||
149091121|NCT03305458|537811589|FG000|Overall Study|Withdrawal by Subject|50|||
149091122|NCT03305458|537811590|FG001|Overall Study|Withdrawal by Subject|46|||
149091123|NCT03305458|537811591|FG002|Overall Study|Withdrawal by Subject|93|||
149091124|NCT03305458|537811589|FG000|Overall Study|Lost to Follow-up|85|||
149091125|NCT03305458|537811590|FG001|Overall Study|Lost to Follow-up|85|||
149091126|NCT03305458|537811591|FG002|Overall Study|Lost to Follow-up|35|||
149091127|NCT03562117|537811593|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
149091128|NCT03562117|537811594|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
149091129|NCT03562117|537811595|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
149091130|NCT02418819|537811604|FG000|Overall Study|Adverse Event|0|||
149091131|NCT02418819|537811605|FG001|Overall Study|Adverse Event|0|||
149091132|NCT02418819|537811606|FG002|Overall Study|Adverse Event|1|||
149091133|NCT02418819|537811607|FG003|Overall Study|Adverse Event|0|||
149091134|NCT02418819|537811604|FG000|Overall Study|Lost to Follow-up|1|||
149091135|NCT02418819|537811605|FG001|Overall Study|Lost to Follow-up|0|||
149091136|NCT02418819|537811606|FG002|Overall Study|Lost to Follow-up|0|||
149091137|NCT02418819|537811607|FG003|Overall Study|Lost to Follow-up|0|||
149091138|NCT02418819|537811604|FG000|Overall Study|No longer meets eligibility criteria|0|||
149091139|NCT02418819|537811605|FG001|Overall Study|No longer meets eligibility criteria|0|||
149091140|NCT02418819|537811606|FG002|Overall Study|No longer meets eligibility criteria|1|||
149091141|NCT02418819|537811607|FG003|Overall Study|No longer meets eligibility criteria|0|||
149091142|NCT02418819|537811604|FG000|Overall Study|No longer willing to participate|0|||
149091143|NCT02418819|537811605|FG001|Overall Study|No longer willing to participate|0|||
149091144|NCT02418819|537811606|FG002|Overall Study|No longer willing to participate|2|||
149091145|NCT02418819|537811607|FG003|Overall Study|No longer willing to participate|1|||
149091146|NCT04374253|537811611|FG000|Overall Study|Adverse Event|0|||
149091147|NCT04374253|537811612|FG001|Overall Study|Adverse Event|26|||
149091148|NCT04374253|537811613|FG002|Overall Study|Adverse Event|2|||
149091149|NCT04374253|537811614|FG003|Overall Study|Adverse Event|12|||
149091150|NCT04374253|537811611|FG000|Overall Study|Study terminated by sponsor|13|||
149091151|NCT04374253|537811612|FG001|Overall Study|Study terminated by sponsor|593|||
149091152|NCT04374253|537811613|FG002|Overall Study|Study terminated by sponsor|21|||
149091153|NCT04374253|537811614|FG003|Overall Study|Study terminated by sponsor|567|||
149091154|NCT04374253|537811611|FG000|Overall Study|Withdrawal by Subject|0|||
149091155|NCT04374253|537811612|FG001|Overall Study|Withdrawal by Subject|55|||
149091156|NCT04374253|537811613|FG002|Overall Study|Withdrawal by Subject|3|||
149091157|NCT04374253|537811614|FG003|Overall Study|Withdrawal by Subject|40|||
149091158|NCT04374253|537811611|FG000|Overall Study|Physician Decision|1|||
149091159|NCT04374253|537811612|FG001|Overall Study|Physician Decision|10|||
149091160|NCT04374253|537811613|FG002|Overall Study|Physician Decision|1|||
149091161|NCT04374253|537811614|FG003|Overall Study|Physician Decision|10|||
149091162|NCT04374253|537811611|FG000|Overall Study|Protocol Violation|0|||
149091163|NCT04374253|537811612|FG001|Overall Study|Protocol Violation|0|||
149091164|NCT04374253|537811613|FG002|Overall Study|Protocol Violation|0|||
149091165|NCT04374253|537811614|FG003|Overall Study|Protocol Violation|2|||
149091166|NCT04374253|537811611|FG000|Overall Study|Death|0|||
149091167|NCT04374253|537811612|FG001|Overall Study|Death|3|||
149091168|NCT04374253|537811613|FG002|Overall Study|Death|1|||
149091169|NCT04374253|537811614|FG003|Overall Study|Death|1|||
149091170|NCT04374253|537811611|FG000|Overall Study|Lack of Efficacy|0|||
149091171|NCT04374253|537811612|FG001|Overall Study|Lack of Efficacy|0|||
149091172|NCT04374253|537811613|FG002|Overall Study|Lack of Efficacy|0|||
149091173|NCT04374253|537811614|FG003|Overall Study|Lack of Efficacy|1|||
149091174|NCT04374253|537811611|FG000|Overall Study|Lost to Follow-up|1|||
149091175|NCT04374253|537811612|FG001|Overall Study|Lost to Follow-up|1|||
149091176|NCT04374253|537811613|FG002|Overall Study|Lost to Follow-up|0|||
149091177|NCT04374253|537811614|FG003|Overall Study|Lost to Follow-up|2|||
149091178|NCT04374253|537811611|FG000|Overall Study|Reason Not Specified|0|||
149091179|NCT04374253|537811612|FG001|Overall Study|Reason Not Specified|8|||
149091180|NCT04374253|537811613|FG002|Overall Study|Reason Not Specified|0|||
149091181|NCT04374253|537811614|FG003|Overall Study|Reason Not Specified|8|||
149091182|NCT00383500|537811615|FG000|Overall Study|Withdrawal by Subject|8|||
149091183|NCT00383500|537811616|FG001|Overall Study|Withdrawal by Subject|3|||
149091184|NCT00383500|537811617|FG002|Overall Study|Withdrawal by Subject|0|||
149091185|NCT00383500|537811615|FG000|Overall Study|Lost to Follow-up|0|||
149091186|NCT00383500|537811616|FG001|Overall Study|Lost to Follow-up|0|||
149091187|NCT00383500|537811617|FG002|Overall Study|Lost to Follow-up|2|||
149091188|NCT00651937|537812696|FG000|Overall Study|Withdrawal by Subject|4|||
149091189|NCT00651937|537812697|FG001|Overall Study|Withdrawal by Subject|1|||
149091190|NCT00848393|537812704|FG000|Overall Study|Protocol Violation|0|||
149091191|NCT00848393|537812705|FG001|Overall Study|Protocol Violation|0|||
149091192|NCT00848393|537812706|FG002|Overall Study|Protocol Violation|1|||
149091193|NCT00848393|537812704|FG000|Overall Study|surgical complications unrelated to stud|0|||
149091194|NCT00848393|537812705|FG001|Overall Study|surgical complications unrelated to stud|0|||
149091195|NCT00848393|537812706|FG002|Overall Study|surgical complications unrelated to stud|2|||
149091196|NCT00443898|537812711|FG000|Overall Study|Adverse Event|0|||
149091197|NCT00443898|537812712|FG001|Overall Study|Adverse Event|0|||
149091198|NCT00443898|537812713|FG002|Overall Study|Adverse Event|1|||
149091199|NCT00443898|537812714|FG003|Overall Study|Adverse Event|1|||
149091200|NCT00443898|537812711|FG000|Overall Study|Lack of Efficacy|2|||
149091201|NCT00443898|537812712|FG001|Overall Study|Lack of Efficacy|3|||
149091202|NCT00443898|537812713|FG002|Overall Study|Lack of Efficacy|3|||
149091203|NCT00443898|537812714|FG003|Overall Study|Lack of Efficacy|1|||
149091204|NCT00443898|537812711|FG000|Overall Study|Protocol Violation|1|||
149091205|NCT00443898|537812712|FG001|Overall Study|Protocol Violation|1|||
149091206|NCT00443898|537812713|FG002|Overall Study|Protocol Violation|1|||
149091207|NCT00443898|537812714|FG003|Overall Study|Protocol Violation|0|||
149091208|NCT00443898|537812711|FG000|Overall Study|Withdrawal by Subject|11|||
149091209|NCT00443898|537812712|FG001|Overall Study|Withdrawal by Subject|10|||
149091210|NCT00443898|537812713|FG002|Overall Study|Withdrawal by Subject|10|||
149091211|NCT00443898|537812714|FG003|Overall Study|Withdrawal by Subject|6|||
149091212|NCT00443898|537812711|FG000|Overall Study|Lost to Follow-up|10|||
149091213|NCT00443898|537812712|FG001|Overall Study|Lost to Follow-up|10|||
149091214|NCT00443898|537812713|FG002|Overall Study|Lost to Follow-up|14|||
149091215|NCT00443898|537812714|FG003|Overall Study|Lost to Follow-up|10|||
149091216|NCT00443898|537812711|FG000|Overall Study|Death|0|||
149091217|NCT00443898|537812712|FG001|Overall Study|Death|1|||
149091218|NCT00443898|537812713|FG002|Overall Study|Death|0|||
149091219|NCT00443898|537812714|FG003|Overall Study|Death|0|||
149091220|NCT00755716|537812715|FG000|Overall Study|Adverse Event|1|||
149091221|NCT00755716|537812716|FG001|Overall Study|Adverse Event|4|||
149091222|NCT00755716|537812717|FG002|Overall Study|Adverse Event|1|||
149091223|NCT00755716|537812715|FG000|Overall Study|Lack of Efficacy|2|||
149091224|NCT00755716|537812716|FG001|Overall Study|Lack of Efficacy|0|||
149091225|NCT00755716|537812717|FG002|Overall Study|Lack of Efficacy|0|||
149091226|NCT00755716|537812715|FG000|Overall Study|Lost to Follow-up|5|||
149091227|NCT00755716|537812716|FG001|Overall Study|Lost to Follow-up|3|||
149091228|NCT00755716|537812717|FG002|Overall Study|Lost to Follow-up|1|||
149091229|NCT00755716|537812715|FG000|Overall Study|work schedule issues|0|||
149091230|NCT00755716|537812716|FG001|Overall Study|work schedule issues|1|||
149091231|NCT00755716|537812717|FG002|Overall Study|work schedule issues|1|||
149091232|NCT03681353|537812718|FG000|Overall Study|Lost to Follow-up|2|||
149091233|NCT03681353|537812718|FG000|Overall Study|Withdrawal by Subject|3|||
149091234|NCT03681353|537812718|FG000|Overall Study|withdrawn by PI|2|||
149091235|NCT00726388|537812724|FG000|Overall Study|Withdrawal by Subject|5|||
149091236|NCT00726388|537812724|FG000|Overall Study|Adverse Event|3|||
149091237|NCT00726388|537812724|FG000|Overall Study|Lost to Follow-up|10|||
149091238|NCT00726388|537812724|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
149091239|NCT00726388|537812724|FG000|Overall Study|Other|5|||
149091240|NCT00726388|537812724|FG000|Overall Study|Enrolled, Not Treated|79|||
149091241|NCT00382408|537812728|FG000|Overall Study|Did not meet protocol requirement|3|||
149091242|NCT00382408|537812729|FG001|Overall Study|Did not meet protocol requirement|3|||
149091243|NCT00382408|537812728|FG000|Overall Study|Protocol Violation|2|||
149091244|NCT00382408|537812729|FG001|Overall Study|Protocol Violation|2|||
149091245|NCT00382408|537812728|FG000|Overall Study|Physician Decision|1|||
149091246|NCT00382408|537812729|FG001|Overall Study|Physician Decision|0|||
149091247|NCT00382408|537812728|FG000|Overall Study|Withdrawal by Subject|17|||
149091248|NCT00382408|537812729|FG001|Overall Study|Withdrawal by Subject|6|||
149091249|NCT00382408|537812728|FG000|Overall Study|Pregnancy|2|||
149091250|NCT00382408|537812729|FG001|Overall Study|Pregnancy|0|||
149091251|NCT00382408|537812728|FG000|Overall Study|Lost to Follow-up|19|||
149091252|NCT00382408|537812729|FG001|Overall Study|Lost to Follow-up|8|||
149091253|NCT00382408|537812728|FG000|Overall Study|Other|100|||
149091254|NCT00382408|537812729|FG001|Overall Study|Other|35|||
149091255|NCT00520403|537812730|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
149091256|NCT00520403|537812730|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
149091257|NCT00520403|537812730|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
149091258|NCT00520403|537812730|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
149091259|NCT00520403|537812730|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
149091260|NCT00520403|537812730|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
149091261|NCT00520403|537812730|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
149091262|NCT00520403|537812730|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
149091263|NCT01145417|537812731|FG000|Overall Study|Death|1|||
149091264|NCT01145417|537812732|FG001|Overall Study|Death|0|||
149091265|NCT01145417|537812731|FG000|Overall Study|Lost to Follow-up|2|||
149091266|NCT01145417|537812732|FG001|Overall Study|Lost to Follow-up|1|||
149091267|NCT01145417|537812731|FG000|Overall Study|Withdrawal by Subject|1|||
149091268|NCT01145417|537812732|FG001|Overall Study|Withdrawal by Subject|2|||
149091269|NCT01145417|537812731|FG000|Overall Study|Pregnancy|1|||
149091270|NCT01145417|537812732|FG001|Overall Study|Pregnancy|0|||
149091271|NCT01145417|537812731|FG000|Overall Study|Adverse Event|0|||
149091272|NCT01145417|537812732|FG001|Overall Study|Adverse Event|1|||
149091273|NCT01145417|537812731|FG000|Overall Study|Study terminated by sponsor|35|||
149091274|NCT01145417|537812732|FG001|Overall Study|Study terminated by sponsor|43|||
149091275|NCT01145417|537812731|FG000|Overall Study|Other|1|||
149091276|NCT01145417|537812732|FG001|Overall Study|Other|0|||
149091277|NCT01797562|537812733|FG000|Overall Study|Protocol Violation|5|||
149091278|NCT00917462|537812736|FG000|Overall Study|Clinical Deterioration|1|||
149091279|NCT03341312|537812743|FG000|Period 1|Withdrawal by Subject|0|||
149091280|NCT03341312|537812744|FG001|Period 1|Withdrawal by Subject|1|||
149091281|NCT03341312|537812745|FG002|Period 1|Withdrawal by Subject|0|||
149091282|NCT03341312|537812746|FG003|Period 1|Withdrawal by Subject|0|||
149091283|NCT01812707|537812747|FG000|Overall Study|Adverse Event|0|||
149091284|NCT01812707|537812748|FG001|Overall Study|Adverse Event|0|||
149091285|NCT01812707|537812749|FG002|Overall Study|Adverse Event|0|||
149091286|NCT01812707|537812750|FG003|Overall Study|Adverse Event|2|||
149091287|NCT01812707|537812747|FG000|Overall Study|Poor compliance to protocol|1|||
149091288|NCT01812707|537812748|FG001|Overall Study|Poor compliance to protocol|0|||
149091289|NCT01812707|537812749|FG002|Overall Study|Poor compliance to protocol|0|||
149091290|NCT01812707|537812750|FG003|Overall Study|Poor compliance to protocol|0|||
149091291|NCT01812707|537812747|FG000|Overall Study|Consent withdrawn by participant|1|||
149091292|NCT01812707|537812748|FG001|Overall Study|Consent withdrawn by participant|0|||
149091293|NCT01812707|537812749|FG002|Overall Study|Consent withdrawn by participant|0|||
149091294|NCT01812707|537812750|FG003|Overall Study|Consent withdrawn by participant|0|||
149091295|NCT01631825|537812751|FG000|Overall Study|Adverse Event|42|||
149091296|NCT01631825|537812751|FG000|Overall Study|Lack of Efficacy|7|||
149091297|NCT01631825|537812751|FG000|Overall Study|Withdrawal by Subject|9|||
149091298|NCT01631825|537812751|FG000|Overall Study|Protocol Violation|4|||
149091299|NCT01631825|537812751|FG000|Overall Study|Discontinuation criteria|1|||
149091300|NCT01631825|537812751|FG000|Overall Study|Physician Decision|2|||
149091301|NCT03193216|537812753|FG000|Overall Study|Lost to Follow-up|1|||
149091302|NCT03193216|537812754|FG001|Overall Study|Lost to Follow-up|0|||
149091303|NCT03193216|537812753|FG000|Overall Study|Withdrawal by Subject|5|||
149091304|NCT03193216|537812754|FG001|Overall Study|Withdrawal by Subject|0|||
149091305|NCT03193216|537812753|FG000|Overall Study|Physician Decision|4|||
149091306|NCT03193216|537812754|FG001|Overall Study|Physician Decision|0|||
149091307|NCT01514864|537812755|FG000|Overall Study|Disease progression|7|||
149091308|NCT01514864|537812756|FG001|Overall Study|Disease progression|5|||
149091309|NCT01514864|537812755|FG000|Overall Study|Study drug toxicity|2|||
149091310|NCT01514864|537812756|FG001|Overall Study|Study drug toxicity|0|||
149091311|NCT05135156|537812757|FG000|Overall Study|Lost to Follow-up|0|||
149091312|NCT05135156|537812758|FG001|Overall Study|Lost to Follow-up|0|||
149091313|NCT05135156|537812759|FG002|Overall Study|Lost to Follow-up|2|||
149091314|NCT01370018|537812760|FG000|Overall Study|Did not meet criteria for analysis|1|||
149091315|NCT03772041|537812762|FG000|Overall Study|Adverse Event|8|||
149091316|NCT03772041|537812763|FG001|Overall Study|Adverse Event|3|||
149091317|NCT03772041|537812762|FG000|Overall Study|Withdrawal by Subject|0|||
149091318|NCT03772041|537812763|FG001|Overall Study|Withdrawal by Subject|2|||
149091319|NCT03772041|537812762|FG000|Overall Study|Protocol Violation|4|||
149091320|NCT03772041|537812763|FG001|Overall Study|Protocol Violation|2|||
149091321|NCT03772041|537812762|FG000|Overall Study|Physician Decision|2|||
149091322|NCT03772041|537812763|FG001|Overall Study|Physician Decision|3|||
149091323|NCT01525641|537812764|FG000|Overall Study|Case report form not collected|25|||
149091324|NCT01525641|537812764|FG000|Overall Study|No visit since the first visit|16|||
149091325|NCT01525641|537812764|FG000|Overall Study|Adverse Event|73|||
149091326|NCT01525641|537812764|FG000|Overall Study|Lack of Efficacy|24|||
149091327|NCT01525641|537812764|FG000|Overall Study|Improvement|5|||
149091328|NCT01525641|537812764|FG000|Overall Study|Lost to follow-up (relocation)|1|||
149091329|NCT01525641|537812764|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
149091330|NCT01525641|537812764|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
149091331|NCT01525641|537812764|FG000|Overall Study|Other than stated above|7|||
149091332|NCT02204319|537812765|FG000|Overall Study|Pregnancy|1|||
149091333|NCT02204319|537812765|FG000|Overall Study|Withdrawal by Subject|2|||
149091334|NCT03544229|537812770|FG000|Overall Study|Adverse Event|1|||
149091335|NCT03544229|537812771|FG001|Overall Study|Adverse Event|0|||
149091336|NCT03544229|537812772|FG002|Overall Study|Adverse Event|1|||
149091337|NCT03544229|537812773|FG003|Overall Study|Adverse Event|0|||
149091338|NCT03544229|537812770|FG000|Overall Study|Protocol Deviation|0|||
149091339|NCT03544229|537812771|FG001|Overall Study|Protocol Deviation|0|||
149091340|NCT03544229|537812772|FG002|Overall Study|Protocol Deviation|1|||
149091341|NCT03544229|537812773|FG003|Overall Study|Protocol Deviation|0|||
149091342|NCT03544229|537812770|FG000|Overall Study|Lost to Follow-up|3|||
149091343|NCT03544229|537812771|FG001|Overall Study|Lost to Follow-up|0|||
149091344|NCT03544229|537812772|FG002|Overall Study|Lost to Follow-up|0|||
149091345|NCT03544229|537812773|FG003|Overall Study|Lost to Follow-up|2|||
149091346|NCT03544229|537812770|FG000|Overall Study|Voluntary Withdrawal|2|||
149091347|NCT03544229|537812771|FG001|Overall Study|Voluntary Withdrawal|1|||
149091348|NCT03544229|537812772|FG002|Overall Study|Voluntary Withdrawal|3|||
149091349|NCT03544229|537812773|FG003|Overall Study|Voluntary Withdrawal|0|||
149091350|NCT03544229|537812770|FG000|Overall Study|Lack of Efficacy|0|||
149091351|NCT03544229|537812771|FG001|Overall Study|Lack of Efficacy|1|||
149091352|NCT03544229|537812772|FG002|Overall Study|Lack of Efficacy|0|||
149091353|NCT03544229|537812773|FG003|Overall Study|Lack of Efficacy|0|||
149091354|NCT05012397|537812775|FG000|Overall Study|Death|10|||
149091355|NCT05012397|537812775|FG000|Overall Study|Physician Decision|9|||
149091356|NCT05012397|537812775|FG000|Overall Study|Withdrawal by Subject|5|||
149091357|NCT05012397|537812775|FG000|Overall Study|Lost to Follow-up|2|||
149091358|NCT00404547|537812776|FG000|Overall Study|Adverse Event|39|||
149091359|NCT00404547|537812777|FG001|Overall Study|Adverse Event|6|||
149091360|NCT00404547|537812776|FG000|Overall Study|Withdrawal by Subject|19|||
149091361|NCT00404547|537812777|FG001|Overall Study|Withdrawal by Subject|2|||
149091362|NCT00404547|537812776|FG000|Overall Study|Protocol Violation|0|||
149091363|NCT00404547|537812777|FG001|Overall Study|Protocol Violation|1|||
149091364|NCT00404547|537812776|FG000|Overall Study|Lost to Follow-up|20|||
149091365|NCT00404547|537812777|FG001|Overall Study|Lost to Follow-up|9|||
149091366|NCT00404547|537812776|FG000|Overall Study|Lack of compliance|5|||
149091367|NCT00404547|537812777|FG001|Overall Study|Lack of compliance|1|||
149091368|NCT00404547|537812776|FG000|Overall Study|Other|4|||
149091369|NCT00404547|537812777|FG001|Overall Study|Other|0|||
149091370|NCT00404547|537812776|FG000|Overall Study|Reason not stated|3|||
149091371|NCT00404547|537812777|FG001|Overall Study|Reason not stated|6|||
149091372|NCT00679549|537812778|FG000|Overall Study|dropout|2|||
149091373|NCT00679549|537812779|FG001|Overall Study|dropout|4|||
149091374|NCT00679549|537812778|FG000|Overall Study|missing outcome echocardiograms|4|||
149091375|NCT00679549|537812779|FG001|Overall Study|missing outcome echocardiograms|5|||
149091376|NCT02350127|537812785|FG000|4-Month Assessment|Withdrawal by Subject|10|||
149091377|NCT02350127|537812786|FG001|4-Month Assessment|Withdrawal by Subject|9|||
149091378|NCT02350127|537812785|FG000|4-Month Assessment|Death|1|||
149091379|NCT02350127|537812786|FG001|4-Month Assessment|Death|0|||
149091380|NCT02350127|537812785|FG000|8-Month Assessment|Death|1|||
149091381|NCT02350127|537812786|FG001|8-Month Assessment|Death|1|||
149091382|NCT02350127|537812785|FG000|8-Month Assessment|Withdrawal by Subject|5|||
149091383|NCT02350127|537812786|FG001|8-Month Assessment|Withdrawal by Subject|8|||
149091384|NCT03048058|537812789|FG000|Overall Study|Lost to Follow-up|4|||
149091385|NCT03048058|537812790|FG001|Overall Study|Lost to Follow-up|0|||
149091386|NCT03048058|537812789|FG000|Overall Study|Withdrawal by Subject|0|||
149091387|NCT03048058|537812790|FG001|Overall Study|Withdrawal by Subject|4|||
149091388|NCT01247922|537812791|FG000|Overall Study|Disease progression|4|||
149091389|NCT01207453|537812792|FG000|First Intervention|Adverse Event|2|||
149091390|NCT01207453|537812793|FG001|First Intervention|Adverse Event|1|||
149091391|NCT01207453|537812792|FG000|Washout|Adverse Event|1|||
149091392|NCT01207453|537812793|FG001|Washout|Adverse Event|0|||
149091393|NCT01207453|537812792|FG000|Washout|Lost to Follow-up|1|||
149091394|NCT01207453|537812793|FG001|Washout|Lost to Follow-up|0|||
149091395|NCT01207453|537812792|FG000|2nd Intervention|Adverse Event|1|||
149091396|NCT01207453|537812793|FG001|2nd Intervention|Adverse Event|2|||
149091397|NCT01207453|537812792|FG000|2nd Intervention|Lost to Follow-up|1|||
149091398|NCT01207453|537812793|FG001|2nd Intervention|Lost to Follow-up|0|||
149091399|NCT00676663|537812796|FG000|Overall Study|Death|43|||
149091400|NCT00676663|537812797|FG001|Overall Study|Death|27|||
149091401|NCT00676663|537812796|FG000|Overall Study|Withdrew Consent|1|||
149091402|NCT00676663|537812797|FG001|Overall Study|Withdrew Consent|8|||
149091403|NCT00676663|537812796|FG000|Overall Study|Lost to Follow-up|1|||
149091404|NCT00676663|537812797|FG001|Overall Study|Lost to Follow-up|3|||
149091405|NCT04382053|537812803|FG000|Overall Study|Death|6|||
149091406|NCT04382053|537812804|FG001|Overall Study|Death|8|||
149091407|NCT04382053|537812803|FG000|Overall Study|Lost to Follow-up|0|||
149091408|NCT04382053|537812804|FG001|Overall Study|Lost to Follow-up|2|||
149091409|NCT04382053|537812803|FG000|Overall Study|Protocol Deviation|1|||
149091410|NCT04382053|537812804|FG001|Overall Study|Protocol Deviation|2|||
149091411|NCT04382053|537812803|FG000|Overall Study|Withdrawal by Subject|2|||
149091412|NCT04382053|537812804|FG001|Overall Study|Withdrawal by Subject|1|||
149091413|NCT01399905|537812807|FG000|Overall Study|Withdrawal by Subject|1|||
149091414|NCT01399905|537812808|FG001|Overall Study|Withdrawal by Subject|1|||
149091415|NCT00714688|537812816|FG000|Overall Study|Lack of Efficacy|14|||
149091416|NCT00714688|537812817|FG001|Overall Study|Lack of Efficacy|1|||
149091417|NCT00714688|537812818|FG002|Overall Study|Lack of Efficacy|4|||
149091418|NCT00714688|537812816|FG000|Overall Study|Withdrawal by Subject|4|||
149091419|NCT00714688|537812817|FG001|Overall Study|Withdrawal by Subject|3|||
149091420|NCT00714688|537812818|FG002|Overall Study|Withdrawal by Subject|3|||
149091421|NCT00714688|537812816|FG000|Overall Study|Lost to Follow-up|5|||
149091422|NCT00714688|537812817|FG001|Overall Study|Lost to Follow-up|2|||
149091423|NCT00714688|537812818|FG002|Overall Study|Lost to Follow-up|0|||
149091424|NCT00714688|537812816|FG000|Overall Study|Adverse Event|2|||
149091425|NCT00714688|537812817|FG001|Overall Study|Adverse Event|15|||
149091426|NCT00714688|537812818|FG002|Overall Study|Adverse Event|19|||
149091427|NCT00714688|537812816|FG000|Overall Study|Subject Non-compliant|3|||
149091428|NCT00714688|537812817|FG001|Overall Study|Subject Non-compliant|5|||
149091429|NCT00714688|537812818|FG002|Overall Study|Subject Non-compliant|5|||
149091430|NCT00714688|537812816|FG000|Overall Study|Ineligible to Continue the Study|0|||
149091431|NCT00714688|537812817|FG001|Overall Study|Ineligible to Continue the Study|1|||
149091432|NCT00714688|537812818|FG002|Overall Study|Ineligible to Continue the Study|1|||
149091433|NCT00714688|537812816|FG000|Overall Study|Sponsor's Decision|0|||
149091434|NCT00714688|537812817|FG001|Overall Study|Sponsor's Decision|2|||
149091435|NCT00714688|537812818|FG002|Overall Study|Sponsor's Decision|0|||
149091436|NCT00714688|537812816|FG000|Overall Study|Other|1|||
149091437|NCT00714688|537812817|FG001|Overall Study|Other|6|||
149091438|NCT00714688|537812818|FG002|Overall Study|Other|5|||
149091439|NCT01786551|537812819|FG000|Overall Study|Participant withdrew consent|2|||
149091440|NCT01524887|537812820|FG000|Overall Study|Withdrawal by Subject|6|||
149091441|NCT01524887|537812821|FG001|Overall Study|Withdrawal by Subject|2|||
149091442|NCT01524887|537812822|FG002|Overall Study|Withdrawal by Subject|3|||
149091443|NCT01524887|537812820|FG000|Overall Study|Adverse Event|5|||
149091444|NCT01524887|537812821|FG001|Overall Study|Adverse Event|1|||
149091445|NCT01524887|537812822|FG002|Overall Study|Adverse Event|1|||
149091446|NCT01524887|537812820|FG000|Overall Study|Protocol Violation|0|||
149091447|NCT01524887|537812821|FG001|Overall Study|Protocol Violation|0|||
149091448|NCT01524887|537812822|FG002|Overall Study|Protocol Violation|1|||
149091449|NCT01524887|537812820|FG000|Overall Study|Study termination|73|||
149091450|NCT01524887|537812821|FG001|Overall Study|Study termination|87|||
149091451|NCT01524887|537812822|FG002|Overall Study|Study termination|79|||
149091452|NCT01524887|537812820|FG000|Overall Study|Withdrawal by Caregiver|0|||
149091453|NCT01524887|537812821|FG001|Overall Study|Withdrawal by Caregiver|0|||
149091454|NCT01524887|537812822|FG002|Overall Study|Withdrawal by Caregiver|2|||
149091455|NCT01524887|537812820|FG000|Overall Study|Use of prohibited medication|1|||
149091456|NCT01524887|537812821|FG001|Overall Study|Use of prohibited medication|0|||
149091457|NCT01524887|537812822|FG002|Overall Study|Use of prohibited medication|0|||
149091458|NCT01123642|537812826|FG000|Overall Study|Lost to Follow-up|23|||
149091459|NCT01123642|537812826|FG000|Overall Study|Withdrawal by Subject|9|||
149091460|NCT01123642|537812826|FG000|Overall Study|ineligible at baseline assessment|36|||
149091461|NCT01816685|537814383|FG000|Overall Study|Lost to Follow-up|7|||
149091462|NCT01816685|537814384|FG001|Overall Study|Lost to Follow-up|9|||
149091463|NCT01816685|537814383|FG000|Overall Study|Surgery Cancelled|3|||
149091464|NCT01816685|537814384|FG001|Overall Study|Surgery Cancelled|2|||
149091465|NCT02720185|537814385|FG000|Overall Study|Lost to Follow-up|1|||
149091466|NCT00381888|537814386|FG000|Overall Study|Death|1|||
149091467|NCT00381888|537814386|FG000|Overall Study|Withdrawal by Subject|1|||
149091468|NCT00381888|537814386|FG000|Overall Study|Physician Decision|1|||
149091469|NCT00381888|537814386|FG000|Overall Study|Protocol Violation|9|||
149091470|NCT00381888|537814386|FG000|Overall Study|Had laparoscopic surgery|2|||
149091471|NCT00381888|537814386|FG000|Overall Study|Surgery was cancelled|2|||
149091472|NCT00381888|537814386|FG000|Overall Study|Adverse Event|1|||
149091473|NCT02507687|537814392|FG000|Overall Study|Adverse Event|3|||
149091474|NCT02507687|537814393|FG001|Overall Study|Adverse Event|2|||
149091475|NCT02507687|537814394|FG002|Overall Study|Adverse Event|2|||
149091476|NCT02507687|537814395|FG003|Overall Study|Adverse Event|2|||
149091477|NCT02507687|537814392|FG000|Overall Study|Withdrawal by Subject|1|||
149091478|NCT02507687|537814393|FG001|Overall Study|Withdrawal by Subject|4|||
149091479|NCT02507687|537814394|FG002|Overall Study|Withdrawal by Subject|6|||
149091480|NCT02507687|537814395|FG003|Overall Study|Withdrawal by Subject|6|||
149091481|NCT02507687|537814392|FG000|Overall Study|Protocol Violation|1|||
149091482|NCT02507687|537814393|FG001|Overall Study|Protocol Violation|0|||
149091483|NCT02507687|537814394|FG002|Overall Study|Protocol Violation|2|||
149091484|NCT02507687|537814395|FG003|Overall Study|Protocol Violation|0|||
149091485|NCT02507687|537814392|FG000|Overall Study|Lost to Follow-up|0|||
149091486|NCT02507687|537814393|FG001|Overall Study|Lost to Follow-up|0|||
149091487|NCT02507687|537814394|FG002|Overall Study|Lost to Follow-up|2|||
149091488|NCT02507687|537814395|FG003|Overall Study|Lost to Follow-up|1|||
149091489|NCT02507687|537814392|FG000|Overall Study|Screen Failure|0|||
149091490|NCT02507687|537814393|FG001|Overall Study|Screen Failure|0|||
149091491|NCT02507687|537814394|FG002|Overall Study|Screen Failure|1|||
149091492|NCT02507687|537814395|FG003|Overall Study|Screen Failure|0|||
149091493|NCT02507687|537814392|FG000|Overall Study|Other, Not Specified|0|||
149091494|NCT02507687|537814393|FG001|Overall Study|Other, Not Specified|0|||
149091495|NCT02507687|537814394|FG002|Overall Study|Other, Not Specified|2|||
149091496|NCT02507687|537814395|FG003|Overall Study|Other, Not Specified|4|||
149091497|NCT00598871|537814396|FG000|Overall Study|Adverse Event|0|||
149091498|NCT00598871|537814397|FG001|Overall Study|Adverse Event|1|||
149091499|NCT01983462|537814400|FG000|Overall Study|Adverse Event|1|||
149091500|NCT01983462|537814401|FG001|Overall Study|Adverse Event|0|||
149091501|NCT01983462|537814402|FG002|Overall Study|Adverse Event|0|||
149091502|NCT00349622|537814403|FG000|Overall Study|Death|168|||
149091503|NCT00349622|537814404|FG001|Overall Study|Death|86|||
149091504|NCT00349622|537814403|FG000|Overall Study|Lost to Follow-up|5|||
149091505|NCT00349622|537814404|FG001|Overall Study|Lost to Follow-up|1|||
149091506|NCT00349622|537814403|FG000|Overall Study|Withdrawal by Subject|5|||
149091507|NCT00349622|537814404|FG001|Overall Study|Withdrawal by Subject|9|||
149091508|NCT00805285|537814409|FG000|Overall Study|Lack of Efficacy|1|||
149091509|NCT00839306|537814410|FG000|Overall Study|Adverse Event|3|||
149091510|NCT00839306|537814411|FG001|Overall Study|Adverse Event|5|||
149091511|NCT00839306|537814410|FG000|Overall Study|Lost to Follow-up|6|||
149091512|NCT00839306|537814411|FG001|Overall Study|Lost to Follow-up|9|||
149091513|NCT00839306|537814410|FG000|Overall Study|Withdrawal by Subject|5|||
149091514|NCT00839306|537814411|FG001|Overall Study|Withdrawal by Subject|7|||
149091515|NCT00839306|537814410|FG000|Overall Study|Lack of Efficacy|5|||
149091516|NCT00839306|537814411|FG001|Overall Study|Lack of Efficacy|4|||
149091517|NCT00839306|537814410|FG000|Overall Study|Other|6|||
149091518|NCT00839306|537814411|FG001|Overall Study|Other|18|||
149091519|NCT02396758|537814414|FG000|Overall Study|Withdrawal by Subject|2|||
149091520|NCT02396758|537814415|FG001|Overall Study|Withdrawal by Subject|0|||
149091521|NCT02396758|537814416|FG002|Overall Study|Withdrawal by Subject|0|||
149091522|NCT02396758|537814417|FG003|Overall Study|Withdrawal by Subject|1|||
149091523|NCT02396758|537814414|FG000|Overall Study|Lost to Follow-up|8|||
149091524|NCT02396758|537814415|FG001|Overall Study|Lost to Follow-up|5|||
149091525|NCT02396758|537814416|FG002|Overall Study|Lost to Follow-up|3|||
149091526|NCT02396758|537814417|FG003|Overall Study|Lost to Follow-up|3|||
149091527|NCT02396758|537814414|FG000|Overall Study|Death|1|||
149091528|NCT02396758|537814415|FG001|Overall Study|Death|1|||
149091529|NCT02396758|537814416|FG002|Overall Study|Death|0|||
149091530|NCT02396758|537814417|FG003|Overall Study|Death|1|||
149091531|NCT02396758|537814414|FG000|Overall Study|Randomized but not treated|1|||
149091532|NCT02396758|537814415|FG001|Overall Study|Randomized but not treated|0|||
149091533|NCT02396758|537814416|FG002|Overall Study|Randomized but not treated|1|||
149091534|NCT02396758|537814417|FG003|Overall Study|Randomized but not treated|0|||
149091535|NCT03022045|537814418|FG000|Overall Study|Adverse Event|0|||
149091536|NCT03022045|537814419|FG001|Overall Study|Adverse Event|1|||
149091537|NCT03022045|537814418|FG000|Overall Study|Withdrawal by Subject|1|||
149091538|NCT03022045|537814419|FG001|Overall Study|Withdrawal by Subject|1|||
149091539|NCT03568708|537814420|FG000|Overall Study|Withdrawal by Subject|1|||
149091540|NCT03568708|537814421|FG001|Overall Study|Withdrawal by Subject|1|||
149091541|NCT03568708|537814420|FG000|Overall Study|Lost to Follow-up|0|||
149091542|NCT03568708|537814421|FG001|Overall Study|Lost to Follow-up|1|||
149091543|NCT01126879|537814422|FG000|Overall Study|Progressive Disease|3|||
149091544|NCT01126879|537814423|FG001|Overall Study|Progressive Disease|1|||
149091545|NCT01126879|537814422|FG000|Overall Study|Withdrawal by Subject|1|||
149091546|NCT01126879|537814423|FG001|Overall Study|Withdrawal by Subject|0|||
149091547|NCT01126879|537814422|FG000|Overall Study|Adverse Event|0|||
149091548|NCT01126879|537814423|FG001|Overall Study|Adverse Event|1|||
149091549|NCT01126879|537814422|FG000|Overall Study|Physician Decision|1|||
149091550|NCT01126879|537814423|FG001|Overall Study|Physician Decision|0|||
149091551|NCT00511147|537814426|FG000|Overall Study|Withdrawal by Subject|1|||
149091552|NCT00511147|537814426|FG000|Overall Study|Disease progression|5|||
149091553|NCT00511147|537814426|FG000|Overall Study|Required platelet transfusion|1|||
149091554|NCT00809783|537814427|FG000|Overall Study|Death|1|||
149091555|NCT00809783|537814428|FG001|Overall Study|Death|0|||
149091556|NCT00809783|537814429|FG002|Overall Study|Death|0|||
149091557|NCT00809783|537814427|FG000|Overall Study|Adverse Event|34|||
149091558|NCT00809783|537814428|FG001|Overall Study|Adverse Event|52|||
149091559|NCT00809783|537814429|FG002|Overall Study|Adverse Event|71|||
149091560|NCT00809783|537814427|FG000|Overall Study|Lack of Efficacy|39|||
149091561|NCT00809783|537814428|FG001|Overall Study|Lack of Efficacy|52|||
149091562|NCT00809783|537814429|FG002|Overall Study|Lack of Efficacy|63|||
149091563|NCT00809783|537814427|FG000|Overall Study|Lost to Follow-up|0|||
149091564|NCT00809783|537814428|FG001|Overall Study|Lost to Follow-up|3|||
149091565|NCT00809783|537814429|FG002|Overall Study|Lost to Follow-up|4|||
149091566|NCT00809783|537814427|FG000|Overall Study|Withdrawal by Subject|47|||
149091567|NCT00809783|537814428|FG001|Overall Study|Withdrawal by Subject|72|||
149091568|NCT00809783|537814429|FG002|Overall Study|Withdrawal by Subject|64|||
149091569|NCT00809783|537814427|FG000|Overall Study|Protocol Violation|2|||
149091570|NCT00809783|537814428|FG001|Overall Study|Protocol Violation|6|||
149091571|NCT00809783|537814429|FG002|Overall Study|Protocol Violation|5|||
149091572|NCT00809783|537814427|FG000|Overall Study|Randomized, but not treated|3|||
149091573|NCT00809783|537814428|FG001|Overall Study|Randomized, but not treated|0|||
149091574|NCT00809783|537814429|FG002|Overall Study|Randomized, but not treated|2|||
149091575|NCT00809783|537814427|FG000|Overall Study|Study Terminated by Sponsor|378|||
149091576|NCT00809783|537814428|FG001|Overall Study|Study Terminated by Sponsor|626|||
149091577|NCT00809783|537814429|FG002|Overall Study|Study Terminated by Sponsor|565|||
149091578|NCT00809783|537814427|FG000|Overall Study|Other|21|||
149091579|NCT00809783|537814428|FG001|Overall Study|Other|21|||
149091580|NCT00809783|537814429|FG002|Overall Study|Other|16|||
149091581|NCT00126555|537814430|FG000|Overall Study|Withdrawal by Subject|1|||
149091582|NCT00126555|537814430|FG000|Overall Study|Adverse Event|2|||
149091583|NCT00126555|537814430|FG000|Overall Study|Progressive Disease|3|||
149091584|NCT01780545|537814436|FG000|Overall Study|Withdrawal by Subject|3|||
149091585|NCT01780545|537814437|FG001|Overall Study|Withdrawal by Subject|1|||
149091586|NCT01780545|537814436|FG000|Overall Study|Lost to Follow-up|1|||
149091587|NCT01780545|537814437|FG001|Overall Study|Lost to Follow-up|1|||
149091588|NCT05372913|537814445|FG000|Overall Study|Withdrawal by Subject|0|||
149091589|NCT05372913|537814446|FG001|Overall Study|Withdrawal by Subject|2|||
149091590|NCT05372913|537814445|FG000|Overall Study|Protocol Violation|2|||
149091591|NCT05372913|537814446|FG001|Overall Study|Protocol Violation|2|||
149091592|NCT05372913|537814445|FG000|Overall Study|Adverse Event|0|||
149091593|NCT05372913|537814446|FG001|Overall Study|Adverse Event|1|||
149091594|NCT03275402|537814447|FG000|Overall Study|Death|17|||
149091595|NCT03275402|537814447|FG000|Overall Study|Study terminated by sponsor|21|||
149091596|NCT03275402|537814447|FG000|Overall Study|Withdrawal by Subject|1|||
149091597|NCT02986659|537814448|FG000|First Intervention Period|Adverse Event|3|||
149091598|NCT02986659|537814449|FG001|First Intervention Period|Adverse Event|1|||
149091599|NCT02986659|537814448|FG000|First Intervention Period|Lost to Follow-up|1|||
149091600|NCT02986659|537814449|FG001|First Intervention Period|Lost to Follow-up|0|||
149091601|NCT02986659|537814448|FG000|First Intervention Period|Withdrawal by Subject|0|||
149091602|NCT02986659|537814449|FG001|First Intervention Period|Withdrawal by Subject|1|||
149091603|NCT02986659|537814448|FG000|Second Intervention Period|Adverse Event|0|||
149091604|NCT02986659|537814449|FG001|Second Intervention Period|Adverse Event|6|||
149091605|NCT02254681|537814455|FG000|Overall Study|Lack of Efficacy|6|||
149091606|NCT02469077|537814456|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
149091607|NCT02469077|537814457|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
149091608|NCT02469077|537814456|FG000|Post Randomization/Intervention Period|Relocated|1|||
149091609|NCT02469077|537814457|FG001|Post Randomization/Intervention Period|Relocated|1|||
149091610|NCT02469077|537814456|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
149091611|NCT02469077|537814457|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
149091612|NCT02469077|537814456|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
149091613|NCT02469077|537814457|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
149091614|NCT01059526|537814458|FG000|Overall Study|Patient enrolled but not treated|20|||
149091615|NCT01059526|537814459|FG001|Overall Study|Patient enrolled but not treated|17|||
149091616|NCT01059526|537814458|FG000|Overall Study|Adverse Event|2|||
149091617|NCT01059526|537814459|FG001|Overall Study|Adverse Event|2|||
149091618|NCT01059526|537814458|FG000|Overall Study|Protocol Violation|0|||
149091619|NCT01059526|537814459|FG001|Overall Study|Protocol Violation|1|||
149091620|NCT01059526|537814458|FG000|Overall Study|Withdrawal by Subject|3|||
149091621|NCT01059526|537814459|FG001|Overall Study|Withdrawal by Subject|1|||
149091622|NCT01059526|537814458|FG000|Overall Study|Lost to Follow-up|4|||
149091623|NCT01059526|537814459|FG001|Overall Study|Lost to Follow-up|1|||
149091624|NCT01059526|537814458|FG000|Overall Study|Patient found to be dermatographic|1|||
149091625|NCT01059526|537814459|FG001|Overall Study|Patient found to be dermatographic|0|||
149091626|NCT01732588|537814460|FG000|First Intervention (7 Days)|Adverse Event|0|||
149091627|NCT01732588|537814461|FG001|First Intervention (7 Days)|Adverse Event|1|||
149091628|NCT01732588|537814462|FG002|First Intervention (7 Days)|Adverse Event|0|||
149091629|NCT02005029|537814463|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
149091630|NCT02005029|537814464|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
149091631|NCT04748445|537814466|FG000|Overall Study|No longer met eligibility criteria|12|||
149091632|NCT04748445|537814466|FG000|Overall Study|Other|36|||
149091633|NCT04748445|537814466|FG000|Overall Study|Withdrawal by Subject|553|||
149091634|NCT04748445|537814466|FG000|Overall Study|Lost to Follow-up|30|||
149091635|NCT00139659|537814471|FG000|Overall Study|Adverse Event|12|||
149091636|NCT00139659|537814472|FG001|Overall Study|Adverse Event|1|||
149091637|NCT00139659|537814471|FG000|Overall Study|Lack of Efficacy|1|||
149091638|NCT00139659|537814472|FG001|Overall Study|Lack of Efficacy|1|||
149091639|NCT00139659|537814471|FG000|Overall Study|Lost to Follow-up|7|||
149091640|NCT00139659|537814472|FG001|Overall Study|Lost to Follow-up|3|||
149091641|NCT00139659|537814471|FG000|Overall Study|Reason not Specified|6|||
149091642|NCT00139659|537814472|FG001|Overall Study|Reason not Specified|3|||
149091643|NCT00139659|537814471|FG000|Overall Study|Withdrawal by Subject|14|||
149091644|NCT00139659|537814472|FG001|Overall Study|Withdrawal by Subject|10|||
149091645|NCT00794573|537814508|FG000|Overall Study|Death|3|||
149091646|NCT00794573|537814509|FG001|Overall Study|Death|0|||
149091647|NCT00794573|537814508|FG000|Overall Study|Withdrawal by Subject|9|||
149091648|NCT00794573|537814509|FG001|Overall Study|Withdrawal by Subject|12|||
149091649|NCT00794573|537814508|FG000|Overall Study|Lost to Follow-up|26|||
149091650|NCT00794573|537814509|FG001|Overall Study|Lost to Follow-up|33|||
149091651|NCT03356145|537814510|FG000|Overall Study|Withdrawal by Subject|2|||
149091652|NCT03356145|537814511|FG001|Overall Study|Withdrawal by Subject|1|||
149091653|NCT03356145|537814510|FG000|Overall Study|Did not meet inclusion criteria|1|||
149091654|NCT03356145|537814511|FG001|Overall Study|Did not meet inclusion criteria|0|||
149091655|NCT00905255|537814514|FG000|Overall Study|Adverse Event|7|||
149091656|NCT00905255|537814515|FG001|Overall Study|Adverse Event|5|||
149091657|NCT00905255|537814514|FG000|Overall Study|Withdrawal by Subject|5|||
149091658|NCT00905255|537814515|FG001|Overall Study|Withdrawal by Subject|4|||
149091659|NCT00905255|537814514|FG000|Overall Study|Familial and Personal Reasons|1|||
149091660|NCT00905255|537814515|FG001|Overall Study|Familial and Personal Reasons|0|||
149091661|NCT01332318|537814518|FG000|Overall Study|Adverse Event|0|||
149091662|NCT01332318|537814519|FG001|Overall Study|Adverse Event|3|||
149091663|NCT01332318|537814520|FG002|Overall Study|Adverse Event|0|||
149091664|NCT01332318|537814521|FG003|Overall Study|Adverse Event|0|||
149091665|NCT01332318|537814518|FG000|Overall Study|Withdrawal by Subject|1|||
149091666|NCT01332318|537814519|FG001|Overall Study|Withdrawal by Subject|1|||
149091667|NCT01332318|537814520|FG002|Overall Study|Withdrawal by Subject|0|||
149091668|NCT01332318|537814521|FG003|Overall Study|Withdrawal by Subject|1|||
149091669|NCT01332318|537814518|FG000|Overall Study|Protocol Violation|1|||
149091670|NCT01332318|537814519|FG001|Overall Study|Protocol Violation|0|||
149091671|NCT01332318|537814520|FG002|Overall Study|Protocol Violation|1|||
149091672|NCT01332318|537814521|FG003|Overall Study|Protocol Violation|1|||
149091673|NCT02040532|537814522|FG000|Overall Study|Lost to Follow-up|1|||
149091674|NCT02040532|537814522|FG000|Overall Study|Physician Decision|4|||
149091675|NCT02040532|537814522|FG000|Overall Study|Adverse Event|4|||
149091676|NCT02040532|537814522|FG000|Overall Study|Withdrawal by Subject|3|||
149091677|NCT00500539|537814523|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
149091678|NCT00500539|537814523|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
149091679|NCT00500539|537814523|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
149091680|NCT00500539|537814523|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
149091681|NCT00500539|537814523|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
149091682|NCT00500539|537814523|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
149091683|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
149091684|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
149091685|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
149091686|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
149091687|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Death|1|||
149091688|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
149091689|NCT00500539|537814523|FG000|Follow-up Period (16 Weeks)|Missing|3|||
149091690|NCT00170950|537814524|FG000|Overall Study|Death|236|||
149091691|NCT00170950|537814525|FG001|Overall Study|Death|274|||
149091692|NCT00170950|537814524|FG000|Overall Study|Withdrawal by Subject|496|||
149091693|NCT00170950|537814525|FG001|Overall Study|Withdrawal by Subject|498|||
149091694|NCT00170950|537814524|FG000|Overall Study|Lost to Follow-up|134|||
149091695|NCT00170950|537814525|FG001|Overall Study|Lost to Follow-up|115|||
149091696|NCT00170950|537814524|FG000|Overall Study|Missing|2|||
149091697|NCT00170950|537814525|FG001|Overall Study|Missing|1|||
149091698|NCT00170950|537814524|FG000|Overall Study|Termination Data Not Recorded|17|||
149091699|NCT00170950|537814525|FG001|Overall Study|Termination Data Not Recorded|22|||
149091700|NCT01808144|537814526|FG000|Overall Study|Death|1|||
149091701|NCT01808144|537814527|FG001|Overall Study|Death|0|||
149091702|NCT01808144|537814526|FG000|Overall Study|Withdrawal by Subject|16|||
149091703|NCT01808144|537814527|FG001|Overall Study|Withdrawal by Subject|23|||
149091704|NCT01808144|537814526|FG000|Overall Study|Lost to Follow-up|6|||
149091705|NCT01808144|537814527|FG001|Overall Study|Lost to Follow-up|3|||
149091706|NCT01808144|537814526|FG000|Overall Study|Protocol Violation|6|||
149091707|NCT01808144|537814527|FG001|Overall Study|Protocol Violation|6|||
149091708|NCT01808144|537814526|FG000|Overall Study|Gout flare|0|||
149091709|NCT01808144|537814527|FG001|Overall Study|Gout flare|1|||
149091710|NCT01808144|537814526|FG000|Overall Study|Adverse Event|11|||
149091711|NCT01808144|537814527|FG001|Overall Study|Adverse Event|15|||
149091712|NCT03993054|537814528|FG000|Overall Study|PI Decision|1|||
149091713|NCT00497198|537814532|FG000|Overall Study|Adverse Event|4|||
149091714|NCT00497198|537814533|FG001|Overall Study|Adverse Event|2|||
149091715|NCT00497198|537814532|FG000|Overall Study|Physician Decision|1|||
149091716|NCT00497198|537814533|FG001|Overall Study|Physician Decision|2|||
149091717|NCT00497198|537814532|FG000|Overall Study|Withdrawal by Subject|0|||
149091718|NCT00497198|537814533|FG001|Overall Study|Withdrawal by Subject|1|||
149091719|NCT03098797|537816515|FG000|Part 2 Open Label Extension|Adverse Event|2|||
149091720|NCT03098797|537816516|FG001|Part 2 Open Label Extension|Adverse Event|0|||
149091721|NCT00509821|537816517|FG000|Study Period 1 (Induction)|Death|0|||
149091722|NCT00509821|537816518|FG001|Study Period 1 (Induction)|Death|1|||
149091723|NCT00509821|537816517|FG000|Study Period 1 (Induction)|Adverse Event|0|||
149091724|NCT00509821|537816518|FG001|Study Period 1 (Induction)|Adverse Event|2|||
149091725|NCT00509821|537816517|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
149091726|NCT00509821|537816518|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
149091727|NCT00552513|537816521|FG000|Overall Study|Lost to Follow-up|5|||
149091728|NCT00552513|537816522|FG001|Overall Study|Lost to Follow-up|1|||
149091729|NCT01589523|537816523|FG000|Overall Study|Withdrawal by Subject|1|||
149091730|NCT00961896|537816524|FG000|Overall Study|Abnormal laboratory value|0|||
149091731|NCT00961896|537816525|FG001|Overall Study|Abnormal laboratory value|0|||
149091732|NCT00961896|537816526|FG002|Overall Study|Abnormal laboratory value|1|||
149091733|NCT00506922|537816527|FG000|Overall Study|Physician Decision|0|||
149091734|NCT00506922|537816528|FG001|Overall Study|Physician Decision|0|||
149091735|NCT00506922|537816529|FG002|Overall Study|Physician Decision|0|||
149091736|NCT00506922|537816530|FG003|Overall Study|Physician Decision|2|||
149091737|NCT00506922|537816531|FG004|Overall Study|Physician Decision|0|||
149091738|NCT00506922|537816527|FG000|Overall Study|Withdrawal by Subject|0|||
149091739|NCT00506922|537816528|FG001|Overall Study|Withdrawal by Subject|0|||
149091740|NCT00506922|537816529|FG002|Overall Study|Withdrawal by Subject|0|||
149091741|NCT00506922|537816530|FG003|Overall Study|Withdrawal by Subject|0|||
149091742|NCT00506922|537816531|FG004|Overall Study|Withdrawal by Subject|1|||
149091743|NCT00792259|537816532|FG000|Overall Study|Poor Quality Scans|1|||
149091744|NCT00792259|537816533|FG001|Overall Study|Poor Quality Scans|0|||
149091745|NCT00792259|537816534|FG002|Overall Study|Poor Quality Scans|0|||
149091746|NCT00371462|537816535|FG000|Overall Study|Withdrawal by Subject|1|||
149091747|NCT00371462|537816536|FG001|Overall Study|Withdrawal by Subject|0|||
149091748|NCT00371462|537816535|FG000|Overall Study|Other|7|||
149091749|NCT00371462|537816536|FG001|Overall Study|Other|8|||
149091750|NCT03721978|537816537|FG000|Overall Study|Withdrawal by Subject|6|||
149091751|NCT03721978|537816538|FG001|Overall Study|Withdrawal by Subject|1|||
149091752|NCT03721978|537816537|FG000|Overall Study|Adverse Event|1|||
149091753|NCT03721978|537816538|FG001|Overall Study|Adverse Event|1|||
149091754|NCT03721978|537816537|FG000|Overall Study|Progressive Disease|1|||
149091755|NCT03721978|537816538|FG001|Overall Study|Progressive Disease|0|||
149091756|NCT03721978|537816537|FG000|Overall Study|Lost to Follow-up|5|||
149091757|NCT03721978|537816538|FG001|Overall Study|Lost to Follow-up|1|||
149091758|NCT03721978|537816537|FG000|Overall Study|Reason not Specified|0|||
149091759|NCT03721978|537816538|FG001|Overall Study|Reason not Specified|2|||
149091760|NCT05244226|537816539|FG000|Overall Study|Adverse Event|1|||
149091761|NCT05244226|537816540|FG001|Overall Study|Adverse Event|0|||
149091762|NCT05244226|537816541|FG002|Overall Study|Adverse Event|0|||
149091763|NCT05244226|537816539|FG000|Overall Study|Lost to Follow-up|0|||
149091764|NCT05244226|537816540|FG001|Overall Study|Lost to Follow-up|0|||
149091765|NCT05244226|537816541|FG002|Overall Study|Lost to Follow-up|1|||
149091766|NCT05244226|537816539|FG000|Overall Study|Protocol Violation|0|||
149091767|NCT05244226|537816540|FG001|Overall Study|Protocol Violation|2|||
149091768|NCT05244226|537816541|FG002|Overall Study|Protocol Violation|2|||
149091769|NCT02675998|537816546|FG000|8-Week Treatment Period|Adverse Event|6|||
149091770|NCT02675998|537816547|FG001|8-Week Treatment Period|Adverse Event|5|||
149091771|NCT02675998|537816548|FG002|8-Week Treatment Period|Adverse Event|6|||
149091772|NCT02675998|537816549|FG003|8-Week Treatment Period|Adverse Event|0|||
149091773|NCT02675998|537816546|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
149091774|NCT02675998|537816547|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
149091775|NCT02675998|537816548|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
149091776|NCT02675998|537816549|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
149091777|NCT02675998|537816546|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
149091778|NCT02675998|537816547|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
149091779|NCT02675998|537816548|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
149091780|NCT02675998|537816549|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
149091781|NCT02675998|537816546|FG000|8-Week Treatment Period|Physician Decision|1|||
149091782|NCT02675998|537816547|FG001|8-Week Treatment Period|Physician Decision|0|||
149091783|NCT02675998|537816548|FG002|8-Week Treatment Period|Physician Decision|2|||
149091784|NCT02675998|537816549|FG003|8-Week Treatment Period|Physician Decision|0|||
149091785|NCT02675998|537816546|FG000|8-Week Treatment Period|GI side Effects|1|||
149091786|NCT02675998|537816547|FG001|8-Week Treatment Period|GI side Effects|4|||
149091787|NCT02675998|537816548|FG002|8-Week Treatment Period|GI side Effects|2|||
149091788|NCT02675998|537816549|FG003|8-Week Treatment Period|GI side Effects|0|||
149091789|NCT02675998|537816546|FG000|8-Week Treatment Period|Protocol Violation|1|||
149091790|NCT02675998|537816547|FG001|8-Week Treatment Period|Protocol Violation|1|||
149091791|NCT02675998|537816548|FG002|8-Week Treatment Period|Protocol Violation|1|||
149091792|NCT02675998|537816549|FG003|8-Week Treatment Period|Protocol Violation|0|||
149091793|NCT02675998|537816546|FG000|8-Week Treatment Period|Other|3|||
149091794|NCT02675998|537816547|FG001|8-Week Treatment Period|Other|1|||
149091795|NCT02675998|537816548|FG002|8-Week Treatment Period|Other|2|||
149091796|NCT02675998|537816549|FG003|8-Week Treatment Period|Other|0|||
149091797|NCT02675998|537816546|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
149091798|NCT02675998|537816547|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
149091799|NCT02675998|537816548|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
149091800|NCT02675998|537816549|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
149091801|NCT02675998|537816546|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
149091802|NCT02675998|537816547|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
149091803|NCT02675998|537816548|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
149091804|NCT02675998|537816549|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
149091805|NCT02675998|537816546|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
149091806|NCT02675998|537816547|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
149091807|NCT02675998|537816548|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
149091808|NCT02675998|537816549|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
149091809|NCT02675998|537816546|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
149091810|NCT02675998|537816547|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
149091811|NCT02675998|537816548|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
149091812|NCT02675998|537816549|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
149091813|NCT02675998|537816546|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
149091814|NCT02675998|537816547|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
149091815|NCT02675998|537816548|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
149091816|NCT02675998|537816549|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
149091817|NCT00275301|537816550|FG000|Overall Study|Adverse Event|5|||
149091818|NCT01194271|537816555|FG000|Overall Study|Withdrawal by Subject|1|||
149091819|NCT01194271|537816555|FG000|Overall Study|Ineligible, Screen Failure|1|||
149091820|NCT01194271|537816555|FG000|Overall Study|Death|1|||
149091821|NCT00508274|537816556|FG000|Overall Study|Adverse Event|5|||
149091822|NCT00508274|537816556|FG000|Overall Study|Death|7|||
149091823|NCT00508274|537816556|FG000|Overall Study|Disease progression|32|||
149091824|NCT00508274|537816556|FG000|Overall Study|Withdrawal by Subject|1|||
149091825|NCT00508274|537816556|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
149091826|NCT00508274|537816556|FG000|Overall Study|Missing|3|||
149091827|NCT03296566|537816557|FG000|Overall Study|Lost to Follow-up|19|||
149091828|NCT03296566|537816558|FG001|Overall Study|Lost to Follow-up|46|||
149091829|NCT03296566|537816557|FG000|Overall Study|Withdrawal by Subject|0|||
149091830|NCT03296566|537816558|FG001|Overall Study|Withdrawal by Subject|3|||
149091831|NCT00550771|537816564|FG000|Overall Study|Adverse Event|11|||
149091832|NCT00550771|537816565|FG001|Overall Study|Adverse Event|3|||
149091833|NCT00550771|537816564|FG000|Overall Study|Discontinued for study-related reasons|0|||
149091834|NCT00550771|537816565|FG001|Overall Study|Discontinued for study-related reasons|1|||
149091835|NCT00550771|537816564|FG000|Overall Study|Physician Decision|2|||
149091836|NCT00550771|537816565|FG001|Overall Study|Physician Decision|0|||
149091837|NCT00550771|537816564|FG000|Overall Study|Withdrawal by Subject|0|||
149091838|NCT00550771|537816565|FG001|Overall Study|Withdrawal by Subject|1|||
149091839|NCT00550771|537816564|FG000|Overall Study|Protocol Violation|4|||
149091840|NCT00550771|537816565|FG001|Overall Study|Protocol Violation|5|||
149091841|NCT02229396|537816566|FG000|Overall Study|Adverse Event|6|||
149091842|NCT02229396|537816567|FG001|Overall Study|Adverse Event|12|||
149091843|NCT02229396|537816568|FG002|Overall Study|Adverse Event|12|||
149091844|NCT02229396|537816566|FG000|Overall Study|Death|2|||
149091845|NCT02229396|537816567|FG001|Overall Study|Death|3|||
149091846|NCT02229396|537816568|FG002|Overall Study|Death|1|||
149091847|NCT02229396|537816566|FG000|Overall Study|Lost to Follow-up|14|||
149091848|NCT02229396|537816567|FG001|Overall Study|Lost to Follow-up|14|||
149091849|NCT02229396|537816568|FG002|Overall Study|Lost to Follow-up|21|||
149091850|NCT02229396|537816566|FG000|Overall Study|Protocol Violation|2|||
149091851|NCT02229396|537816567|FG001|Overall Study|Protocol Violation|1|||
149091852|NCT02229396|537816568|FG002|Overall Study|Protocol Violation|0|||
149091853|NCT02229396|537816566|FG000|Overall Study|Patient Incorrectly Randomized|0|||
149091854|NCT02229396|537816567|FG001|Overall Study|Patient Incorrectly Randomized|0|||
149091855|NCT02229396|537816568|FG002|Overall Study|Patient Incorrectly Randomized|1|||
149091856|NCT02229396|537816566|FG000|Overall Study|Other|10|||
149091857|NCT02229396|537816567|FG001|Overall Study|Other|18|||
149091858|NCT02229396|537816568|FG002|Overall Study|Other|15|||
149091859|NCT02229396|537816566|FG000|Overall Study|Withdrawal by Subject|42|||
149091860|NCT02229396|537816567|FG001|Overall Study|Withdrawal by Subject|28|||
149091861|NCT02229396|537816568|FG002|Overall Study|Withdrawal by Subject|41|||
149091862|NCT02229396|537816566|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
149091863|NCT02229396|537816567|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
149091864|NCT02229396|537816568|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
149091865|NCT02229396|537816566|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
149091866|NCT02229396|537816567|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
149091867|NCT02229396|537816568|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
149091868|NCT02679079|537816569|FG000|Overall Study|Adverse Event|2|||
149091869|NCT02679079|537816570|FG001|Overall Study|Adverse Event|0|||
149091870|NCT02679079|537816571|FG002|Overall Study|Adverse Event|2|||
149091871|NCT02679079|537816569|FG000|Overall Study|Protocol Violation|0|||
149091872|NCT02679079|537816570|FG001|Overall Study|Protocol Violation|1|||
149091873|NCT02679079|537816571|FG002|Overall Study|Protocol Violation|0|||
149091874|NCT02679079|537816569|FG000|Overall Study|Withdrawal by Subject|2|||
149091875|NCT02679079|537816570|FG001|Overall Study|Withdrawal by Subject|1|||
149091876|NCT02679079|537816571|FG002|Overall Study|Withdrawal by Subject|0|||
149091877|NCT03924947|537816572|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
149091878|NCT03924947|537816573|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
149091879|NCT03924947|537816574|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
149091880|NCT03924947|537816575|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
149091881|NCT03924947|537816576|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
149091882|NCT03924947|537816577|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
149091883|NCT01441583|537816580|FG000|Overall Study|Withdrawal by Subject|1|||
149091884|NCT01441583|537816581|FG001|Overall Study|Withdrawal by Subject|1|||
149091885|NCT01441583|537816582|FG002|Overall Study|Withdrawal by Subject|1|||
149091886|NCT01441583|537816580|FG000|Overall Study|Death|1|||
149091887|NCT01441583|537816581|FG001|Overall Study|Death|0|||
149091888|NCT01441583|537816582|FG002|Overall Study|Death|4|||
149091889|NCT01441583|537816580|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
149091890|NCT01441583|537816581|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
149091891|NCT01441583|537816582|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
149091892|NCT05060237|537816584|FG000|Overall Study|Withdrawal by Subject|4|||
149091893|NCT05060237|537816584|FG000|Overall Study|Screening failure|8|||
149091894|NCT01066897|537816585|FG000|Overall Study|Withdrawal by Subject|1|||
149091895|NCT01066897|537816586|FG001|Overall Study|Withdrawal by Subject|0|||
149091896|NCT01066897|537816585|FG000|Overall Study|stopped study after developing the flu.|1|||
149091897|NCT01066897|537816586|FG001|Overall Study|stopped study after developing the flu.|0|||
149091898|NCT01697592|537816587|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
149091899|NCT01697592|537816588|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091900|NCT01697592|537816589|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091901|NCT01697592|537816590|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091902|NCT01697592|537816591|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091903|NCT01697592|537816592|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091904|NCT01697592|537816593|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091905|NCT01697592|537816594|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091906|NCT01697592|537816595|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091907|NCT01697592|537816596|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
149091908|NCT01697592|537816587|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091909|NCT01697592|537816588|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091910|NCT01697592|537816589|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091911|NCT01697592|537816590|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091912|NCT01697592|537816591|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091913|NCT01697592|537816592|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
149091914|NCT01697592|537816593|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091915|NCT01697592|537816594|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091916|NCT01697592|537816595|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091917|NCT01697592|537816596|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
149091918|NCT01697592|537816587|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
149091919|NCT01697592|537816588|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091920|NCT01697592|537816589|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091921|NCT01697592|537816590|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091922|NCT01697592|537816591|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091923|NCT01697592|537816592|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091924|NCT01697592|537816593|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091925|NCT01697592|537816594|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091926|NCT01697592|537816595|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091927|NCT01697592|537816596|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
149091928|NCT01697592|537816587|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
149091929|NCT01697592|537816588|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
149091930|NCT01697592|537816589|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149091931|NCT01697592|537816590|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149091932|NCT01697592|537816591|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149091933|NCT01697592|537816592|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149091934|NCT01697592|537816593|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
149091935|NCT01697592|537816594|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149091936|NCT01697592|537816595|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
149091937|NCT01697592|537816596|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
149091938|NCT01697592|537816587|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
149091939|NCT01697592|537816588|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
149091940|NCT01697592|537816589|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
149091941|NCT01697592|537816590|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
149091942|NCT01697592|537816591|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
149091943|NCT01697592|537816592|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
149091944|NCT01697592|537816593|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
149091945|NCT01697592|537816594|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
149091946|NCT01697592|537816595|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
149091947|NCT01697592|537816596|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
149091948|NCT01697592|537816587|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
149091949|NCT01697592|537816588|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091950|NCT01697592|537816589|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091951|NCT01697592|537816590|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
149091952|NCT01697592|537816591|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091953|NCT01697592|537816592|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091954|NCT01697592|537816593|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091955|NCT01697592|537816594|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091956|NCT01697592|537816595|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091957|NCT01697592|537816596|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
149091958|NCT01697592|537816587|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
149091959|NCT01697592|537816588|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091960|NCT01697592|537816589|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091961|NCT01697592|537816590|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091962|NCT01697592|537816591|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091963|NCT01697592|537816592|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
149091964|NCT01697592|537816593|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091965|NCT01697592|537816594|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
149091966|NCT01697592|537816595|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091967|NCT01697592|537816596|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
149091968|NCT01697592|537816587|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
149091969|NCT01697592|537816588|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
149091970|NCT01697592|537816589|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
149091971|NCT01697592|537816590|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
149091972|NCT01697592|537816591|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
149091973|NCT01697592|537816592|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
149091974|NCT01697592|537816593|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
149091975|NCT01697592|537816594|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
149091976|NCT01697592|537816595|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
149091977|NCT01697592|537816596|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
149091978|NCT02110225|537816597|FG000|Overall Study|Lost to Follow-up|0|||
149091979|NCT02110225|537816598|FG001|Overall Study|Lost to Follow-up|1|||
149091980|NCT02110225|537816599|FG002|Overall Study|Lost to Follow-up|0|||
149091981|NCT02176018|537816600|FG000|Overall Study|Adverse Event|0|||
149091982|NCT02176018|537816601|FG001|Overall Study|Adverse Event|2|||
149091983|NCT02176018|537816600|FG000|Overall Study|Lost to Follow-up|3|||
149091984|NCT02176018|537816601|FG001|Overall Study|Lost to Follow-up|1|||
149091985|NCT02176018|537816600|FG000|Overall Study|Protocol Violation|1|||
149091986|NCT02176018|537816601|FG001|Overall Study|Protocol Violation|1|||
149091987|NCT02176018|537816600|FG000|Overall Study|Withdrawal by Subject|1|||
149091988|NCT02176018|537816601|FG001|Overall Study|Withdrawal by Subject|2|||
149091989|NCT00265096|537816602|FG000|Overall Study|Adverse Event|14|||
149091990|NCT00265096|537816603|FG001|Overall Study|Adverse Event|18|||
149091991|NCT00265096|537816604|FG002|Overall Study|Adverse Event|18|||
149091992|NCT00265096|537816602|FG000|Overall Study|Lost to Follow-up|2|||
149091993|NCT00265096|537816603|FG001|Overall Study|Lost to Follow-up|5|||
149091994|NCT00265096|537816604|FG002|Overall Study|Lost to Follow-up|3|||
149091995|NCT00265096|537816602|FG000|Overall Study|Death|0|||
149091996|NCT00265096|537816603|FG001|Overall Study|Death|1|||
149091997|NCT00265096|537816604|FG002|Overall Study|Death|2|||
149091998|NCT00265096|537816602|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
149091999|NCT00265096|537816603|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
149092000|NCT00265096|537816604|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
149092001|NCT00265096|537816602|FG000|Overall Study|Other|11|||
149092002|NCT00265096|537816603|FG001|Overall Study|Other|19|||
149092003|NCT00265096|537816604|FG002|Overall Study|Other|10|||
149092004|NCT00774306|537816605|FG000|Overall Study|Adverse Event|3|||
149092005|NCT00774306|537816606|FG001|Overall Study|Adverse Event|0|||
149092006|NCT00774306|537816607|FG002|Overall Study|Adverse Event|0|||
149092007|NCT00774306|537816608|FG003|Overall Study|Adverse Event|0|||
149092008|NCT00774306|537816605|FG000|Overall Study|Protocol Violation|2|||
149092009|NCT00774306|537816606|FG001|Overall Study|Protocol Violation|0|||
149092010|NCT00774306|537816607|FG002|Overall Study|Protocol Violation|3|||
149092011|NCT00774306|537816608|FG003|Overall Study|Protocol Violation|0|||
149092012|NCT00774306|537816605|FG000|Overall Study|Withdrawal by Subject|6|||
149092013|NCT00774306|537816606|FG001|Overall Study|Withdrawal by Subject|1|||
149092014|NCT00774306|537816607|FG002|Overall Study|Withdrawal by Subject|1|||
149092015|NCT00774306|537816608|FG003|Overall Study|Withdrawal by Subject|0|||
149092016|NCT00774306|537816605|FG000|Overall Study|Lost to Follow-up|6|||
149092017|NCT00774306|537816606|FG001|Overall Study|Lost to Follow-up|0|||
149092018|NCT00774306|537816607|FG002|Overall Study|Lost to Follow-up|4|||
149092019|NCT00774306|537816608|FG003|Overall Study|Lost to Follow-up|5|||
149092020|NCT00774306|537816605|FG000|Overall Study|Death|1|||
149092021|NCT00774306|537816606|FG001|Overall Study|Death|1|||
149092022|NCT00774306|537816607|FG002|Overall Study|Death|0|||
149092023|NCT00774306|537816608|FG003|Overall Study|Death|0|||
149092024|NCT00666835|537816612|FG000|Overall Study|Withdrawal by Subject|5|||
149092025|NCT00666835|537816613|FG001|Overall Study|Withdrawal by Subject|2|||
149092026|NCT00666835|537816612|FG000|Overall Study|Lack of Efficacy|0|||
149092027|NCT00666835|537816613|FG001|Overall Study|Lack of Efficacy|1|||
149092028|NCT00666835|537816612|FG000|Overall Study|Incl./excl. not fulfilled|7|||
149092029|NCT00666835|537816613|FG001|Overall Study|Incl./excl. not fulfilled|2|||
149092030|NCT00666835|537816612|FG000|Overall Study|Adverse Event|7|||
149092031|NCT00666835|537816613|FG001|Overall Study|Adverse Event|6|||
149092032|NCT00666835|537816612|FG000|Overall Study|Protocol Violation|2|||
149092033|NCT00666835|537816613|FG001|Overall Study|Protocol Violation|0|||
149092034|NCT00666835|537816612|FG000|Overall Study|Death|15|||
149092035|NCT00666835|537816613|FG001|Overall Study|Death|4|||
149092036|NCT00666835|537816612|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
149092037|NCT00666835|537816613|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
149092038|NCT00666835|537816612|FG000|Overall Study|Hemoglobulin concentration|4|||
149092039|NCT00666835|537816613|FG001|Overall Study|Hemoglobulin concentration|3|||
149092040|NCT00666835|537816612|FG000|Overall Study|Planned operation|2|||
149092041|NCT00666835|537816613|FG001|Overall Study|Planned operation|0|||
149092042|NCT00666835|537816612|FG000|Overall Study|Physician Decision|1|||
149092043|NCT00666835|537816613|FG001|Overall Study|Physician Decision|2|||
149092044|NCT00899379|537816614|FG000|Overall Study|Adverse Event|2|||
149092045|NCT00899379|537816615|FG001|Overall Study|Adverse Event|2|||
149092046|NCT00899379|537816616|FG002|Overall Study|Adverse Event|1|||
149092047|NCT00899379|537816617|FG003|Overall Study|Adverse Event|1|||
149092048|NCT00899379|537816618|FG004|Overall Study|Adverse Event|2|||
149092049|NCT00899379|537816614|FG000|Overall Study|Lack of Efficacy|0|||
149092050|NCT00899379|537816615|FG001|Overall Study|Lack of Efficacy|4|||
149092051|NCT00899379|537816616|FG002|Overall Study|Lack of Efficacy|3|||
149092052|NCT00899379|537816617|FG003|Overall Study|Lack of Efficacy|0|||
149092053|NCT00899379|537816618|FG004|Overall Study|Lack of Efficacy|1|||
149092054|NCT00899379|537816614|FG000|Overall Study|Lost to Follow-up|9|||
149092055|NCT00899379|537816615|FG001|Overall Study|Lost to Follow-up|3|||
149092056|NCT00899379|537816616|FG002|Overall Study|Lost to Follow-up|0|||
149092057|NCT00899379|537816617|FG003|Overall Study|Lost to Follow-up|6|||
149092058|NCT00899379|537816618|FG004|Overall Study|Lost to Follow-up|2|||
149092059|NCT00899379|537816614|FG000|Overall Study|Protocol Violation|0|||
149092060|NCT00899379|537816615|FG001|Overall Study|Protocol Violation|0|||
149092061|NCT00899379|537816616|FG002|Overall Study|Protocol Violation|1|||
149092062|NCT00899379|537816617|FG003|Overall Study|Protocol Violation|1|||
149092063|NCT00899379|537816618|FG004|Overall Study|Protocol Violation|0|||
149092064|NCT00899379|537816614|FG000|Overall Study|Withdrawal by Subject|2|||
149092065|NCT00899379|537816615|FG001|Overall Study|Withdrawal by Subject|4|||
149092066|NCT00899379|537816616|FG002|Overall Study|Withdrawal by Subject|2|||
149092067|NCT00899379|537816617|FG003|Overall Study|Withdrawal by Subject|3|||
149092068|NCT00899379|537816618|FG004|Overall Study|Withdrawal by Subject|6|||
149092069|NCT00899379|537816614|FG000|Overall Study|Pregnancy|0|||
149092070|NCT00899379|537816615|FG001|Overall Study|Pregnancy|0|||
149092071|NCT00899379|537816616|FG002|Overall Study|Pregnancy|1|||
149092072|NCT00899379|537816617|FG003|Overall Study|Pregnancy|0|||
149092073|NCT00899379|537816618|FG004|Overall Study|Pregnancy|1|||
149092074|NCT00899379|537816614|FG000|Overall Study|Patient Uncooperative|0|||
149092075|NCT00899379|537816615|FG001|Overall Study|Patient Uncooperative|1|||
149092076|NCT00899379|537816616|FG002|Overall Study|Patient Uncooperative|0|||
149092077|NCT00899379|537816617|FG003|Overall Study|Patient Uncooperative|1|||
149092078|NCT00899379|537816618|FG004|Overall Study|Patient Uncooperative|2|||
149092079|NCT00899379|537816614|FG000|Overall Study|Abnormal Baseline ECG|0|||
149092080|NCT00899379|537816615|FG001|Overall Study|Abnormal Baseline ECG|0|||
149092081|NCT00899379|537816616|FG002|Overall Study|Abnormal Baseline ECG|0|||
149092082|NCT00899379|537816617|FG003|Overall Study|Abnormal Baseline ECG|1|||
149092083|NCT00899379|537816618|FG004|Overall Study|Abnormal Baseline ECG|0|||
149092084|NCT00899379|537816614|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
149092085|NCT00899379|537816615|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
149092086|NCT00899379|537816616|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
149092087|NCT00899379|537816617|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
149092088|NCT00899379|537816618|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
149092089|NCT00899379|537816614|FG000|Overall Study|Not Completed/Entered Extn|5|||
149092090|NCT00899379|537816615|FG001|Overall Study|Not Completed/Entered Extn|1|||
149092091|NCT00899379|537816616|FG002|Overall Study|Not Completed/Entered Extn|6|||
149092092|NCT00899379|537816617|FG003|Overall Study|Not Completed/Entered Extn|4|||
149092093|NCT00899379|537816618|FG004|Overall Study|Not Completed/Entered Extn|3|||
149092094|NCT00899379|537816614|FG000|Overall Study|Study Terminated|3|||
149092095|NCT00899379|537816615|FG001|Overall Study|Study Terminated|0|||
149092096|NCT00899379|537816616|FG002|Overall Study|Study Terminated|3|||
149092097|NCT00899379|537816617|FG003|Overall Study|Study Terminated|3|||
149092098|NCT00899379|537816618|FG004|Overall Study|Study Terminated|1|||
149092099|NCT00899379|537816614|FG000|Overall Study|Lost to Follow-up|3|||
149092100|NCT00899379|537816615|FG001|Overall Study|Lost to Follow-up|1|||
149092101|NCT00899379|537816616|FG002|Overall Study|Lost to Follow-up|0|||
149092102|NCT00899379|537816617|FG003|Overall Study|Lost to Follow-up|2|||
149092103|NCT00899379|537816618|FG004|Overall Study|Lost to Follow-up|5|||
149092104|NCT00899379|537816614|FG000|Overall Study|Withdrawal by Subject|4|||
149092105|NCT00899379|537816615|FG001|Overall Study|Withdrawal by Subject|7|||
149092106|NCT00899379|537816616|FG002|Overall Study|Withdrawal by Subject|4|||
149092107|NCT00899379|537816617|FG003|Overall Study|Withdrawal by Subject|7|||
149092108|NCT00899379|537816618|FG004|Overall Study|Withdrawal by Subject|2|||
149092109|NCT00899379|537816614|FG000|Overall Study|Pregnancy|1|||
149092110|NCT00899379|537816615|FG001|Overall Study|Pregnancy|0|||
149092111|NCT00899379|537816616|FG002|Overall Study|Pregnancy|0|||
149092112|NCT00899379|537816617|FG003|Overall Study|Pregnancy|0|||
149092113|NCT00899379|537816618|FG004|Overall Study|Pregnancy|0|||
149092114|NCT00899379|537816614|FG000|Overall Study|Patient Uncooperative|0|||
149092115|NCT00899379|537816615|FG001|Overall Study|Patient Uncooperative|0|||
149092116|NCT00899379|537816616|FG002|Overall Study|Patient Uncooperative|0|||
149092117|NCT00899379|537816617|FG003|Overall Study|Patient Uncooperative|1|||
149092118|NCT00899379|537816618|FG004|Overall Study|Patient Uncooperative|0|||
149092119|NCT00899379|537816614|FG000|Overall Study|Abnormal Prestudy Labs|0|||
149092120|NCT00899379|537816615|FG001|Overall Study|Abnormal Prestudy Labs|0|||
149092121|NCT00899379|537816616|FG002|Overall Study|Abnormal Prestudy Labs|0|||
149092122|NCT00899379|537816617|FG003|Overall Study|Abnormal Prestudy Labs|0|||
149092123|NCT00899379|537816618|FG004|Overall Study|Abnormal Prestudy Labs|2|||
149092124|NCT00899379|537816614|FG000|Overall Study|Abnormal Baseline ECG|0|||
149092125|NCT00899379|537816615|FG001|Overall Study|Abnormal Baseline ECG|0|||
149092126|NCT00899379|537816616|FG002|Overall Study|Abnormal Baseline ECG|1|||
149092127|NCT00899379|537816617|FG003|Overall Study|Abnormal Baseline ECG|1|||
149092128|NCT00899379|537816618|FG004|Overall Study|Abnormal Baseline ECG|0|||
149092129|NCT00899379|537816614|FG000|Overall Study|No Attack Pretreatment|3|||
149092130|NCT00899379|537816615|FG001|Overall Study|No Attack Pretreatment|5|||
149092131|NCT00899379|537816616|FG002|Overall Study|No Attack Pretreatment|5|||
149092132|NCT00899379|537816617|FG003|Overall Study|No Attack Pretreatment|6|||
149092133|NCT00899379|537816618|FG004|Overall Study|No Attack Pretreatment|4|||
149092134|NCT00899379|537816614|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
149092135|NCT00899379|537816615|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
149092136|NCT00899379|537816616|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
149092137|NCT00899379|537816617|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
149092138|NCT00899379|537816618|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
149092139|NCT00899379|537816614|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
149092140|NCT00899379|537816615|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
149092141|NCT00899379|537816616|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
149092142|NCT00899379|537816617|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
149092143|NCT00899379|537816618|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
149092144|NCT02253147|537816621|FG000|Overall Study|Protocol Violation|30|||
149092145|NCT02253147|537816621|FG000|Overall Study|Did not consent to study extension|9|||
149092146|NCT02253147|537816621|FG000|Overall Study|Conditional re-treatment at W52|5|||
149092147|NCT02253147|537816621|FG000|Overall Study|Lost to Follow-up|2|||
149092148|NCT02253147|537816621|FG000|Overall Study|Withdrawal by Subject|1|||
149092149|NCT00396097|537816624|FG000|Overall Study|Withdrawal by Subject|17|||
149092150|NCT00396097|537816625|FG001|Overall Study|Withdrawal by Subject|17|||
149092151|NCT00396097|537816624|FG000|Overall Study|Lost to Follow-up|4|||
149092152|NCT00396097|537816625|FG001|Overall Study|Lost to Follow-up|9|||
149092153|NCT00396097|537816624|FG000|Overall Study|Other|3|||
149092154|NCT00396097|537816625|FG001|Overall Study|Other|5|||
149092155|NCT00396097|537816624|FG000|Overall Study|Protocol Violation|0|||
149092156|NCT00396097|537816625|FG001|Overall Study|Protocol Violation|6|||
149092157|NCT00396097|537816624|FG000|Overall Study|Adverse Event|1|||
149092158|NCT00396097|537816625|FG001|Overall Study|Adverse Event|5|||
149092159|NCT00396097|537816624|FG000|Overall Study|Insufficient Clinical Response|1|||
149092160|NCT00396097|537816625|FG001|Overall Study|Insufficient Clinical Response|4|||
149092161|NCT02973477|537816626|FG000|First Intervention|Lost to Follow-up|0|||
149092162|NCT02973477|537816627|FG001|First Intervention|Lost to Follow-up|2|||
149092163|NCT02973477|537816626|FG000|Washout|Withdrawal by Subject|1|||
149092164|NCT02973477|537816627|FG001|Washout|Withdrawal by Subject|0|||
149092165|NCT02973477|537816626|FG000|Second Intervention|Lost to Follow-up|1|||
149092166|NCT02973477|537816627|FG001|Second Intervention|Lost to Follow-up|0|||
149092167|NCT03461211|537816628|FG000|Overall Study|Adverse Event|1|||
149092168|NCT03461211|537816629|FG001|Overall Study|Adverse Event|1|||
149092169|NCT03461211|537816628|FG000|Overall Study|Lack of Efficacy|0|||
149092170|NCT03461211|537816629|FG001|Overall Study|Lack of Efficacy|1|||
149092171|NCT03807700|537816630|FG000|Overall Study|Withdrawal by Subject|2|||
149092172|NCT03807700|537816631|FG001|Overall Study|Withdrawal by Subject|1|||
149092173|NCT02621047|537816633|FG000|Overall Study|Adverse Event|0|||
149092174|NCT02621047|537816634|FG001|Overall Study|Adverse Event|0|||
149092175|NCT02621047|537816635|FG002|Overall Study|Adverse Event|1|||
149092176|NCT01264887|537816639|FG000|Overall Study|Adverse Event|5|||
149092177|NCT01264887|537816639|FG000|Overall Study|Death|7|||
149092178|NCT01264887|537816639|FG000|Overall Study|Lack of Efficacy|5|||
149092179|NCT01264887|537816639|FG000|Overall Study|Physician Decision|4|||
149092180|NCT01264887|537816639|FG000|Overall Study|Withdrawal by Subject|6|||
149092181|NCT01264887|537816639|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
149092182|NCT01264887|537816639|FG000|Overall Study|Other|2|||
149092183|NCT02171130|537816640|FG000|Overall Study|Death|1|||
149092184|NCT02171130|537816640|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
149092185|NCT02171130|537816640|FG000|Overall Study|Discontinued; Site Termination|5|||
149092186|NCT02171130|537816640|FG000|Overall Study|Withdrawal by Subject|3|||
149092187|NCT02171130|537816640|FG000|Overall Study|Physician Decision|1|||
149092188|NCT02171130|537816640|FG000|Overall Study|Lost to Follow-up|1|||
149092189|NCT02171130|537816640|FG000|Overall Study|Met Exclusion Criteria|1|||
149092190|NCT04531813|537816641|FG000|Overall Study|Protocol Violation|1|||
149092191|NCT04531813|537816641|FG000|Overall Study|Withdrawal by Subject|1|||
149092192|NCT00591409|537816642|FG000|Overall Study|Not Treated|0|||
149092193|NCT00591409|537816643|FG001|Overall Study|Not Treated|0|||
149092194|NCT00591409|537816644|FG002|Overall Study|Not Treated|0|||
149092195|NCT00591409|537816645|FG003|Overall Study|Not Treated|0|||
149092196|NCT00591409|537816646|FG004|Overall Study|Not Treated|1|||
149092197|NCT00591409|537816647|FG005|Overall Study|Not Treated|0|||
149092198|NCT00591409|537816648|FG006|Overall Study|Not Treated|0|||
149092199|NCT00591409|537816649|FG007|Overall Study|Not Treated|0|||
149092200|NCT00591409|537816650|FG008|Overall Study|Not Treated|0|||
149092201|NCT00591409|537816651|FG009|Overall Study|Not Treated|1|||
149092202|NCT02853305|537816654|FG000|Overall Study|Death|287|||
149092203|NCT02853305|537816655|FG001|Overall Study|Death|249|||
149092204|NCT02853305|537816656|FG002|Overall Study|Death|300|||
149092205|NCT02853305|537816654|FG000|Overall Study|Withdrawal by Subject|2|||
149092206|NCT02853305|537816655|FG001|Overall Study|Withdrawal by Subject|8|||
149092207|NCT02853305|537816656|FG002|Overall Study|Withdrawal by Subject|3|||
149092208|NCT02853305|537816654|FG000|Overall Study|Transferred to Extension Study|46|||
149092209|NCT02853305|537816655|FG001|Overall Study|Transferred to Extension Study|30|||
149092210|NCT02853305|537816656|FG002|Overall Study|Transferred to Extension Study|25|||
149092211|NCT02853305|537816654|FG000|Overall Study|Did Not Continue on Extension Study|16|||
149092212|NCT02853305|537816655|FG001|Overall Study|Did Not Continue on Extension Study|20|||
149092213|NCT02853305|537816656|FG002|Overall Study|Did Not Continue on Extension Study|24|||
149092214|NCT04772313|537816657|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
149092215|NCT04772313|537816657|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
149092216|NCT01836198|537816658|FG000|Part A, Period 2|Protocol Violation|0|||
149092217|NCT01836198|537816659|FG001|Part A, Period 2|Protocol Violation|1|||
149092218|NCT01836198|537816660|FG002|Part A, Period 2|Protocol Violation|0|||
149092219|NCT03187353|537816661|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
149092220|NCT03187353|537816662|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
149092221|NCT03187353|537816661|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
149092222|NCT03187353|537816662|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
149092223|NCT03187353|537816661|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
149092224|NCT03187353|537816662|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
149092225|NCT03187353|537816661|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
149092226|NCT03187353|537816662|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
149092227|NCT03187353|537816661|FG000|Washout (2 Weeks)|Adverse Event|2|||
149092228|NCT03187353|537816662|FG001|Washout (2 Weeks)|Adverse Event|0|||
149092229|NCT03187353|537816661|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
149092230|NCT03187353|537816662|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
149092231|NCT03794609|537816670|FG000|Overall Study|Other|10|||
149092232|NCT03794609|537816670|FG000|Overall Study|Withdrawal by Subject|66|||
149092233|NCT03794609|537816670|FG000|Overall Study|The child is enrolled in an interventional study|70|||
149092234|NCT03794609|537816670|FG000|Overall Study|Inclusion/exclusion criteria|8|||
149092235|NCT03794609|537816670|FG000|Overall Study|At sponsor's request|151|||
149092236|NCT03794609|537816670|FG000|Overall Study|Physician Decision|1|||
149092237|NCT03794609|537816670|FG000|Overall Study|Lost to Follow-up|5|||
149092238|NCT02359552|537816671|FG000|Overall Study|Lost to Follow-up|3|||
149092239|NCT02359552|537816672|FG001|Overall Study|Lost to Follow-up|4|||
149092240|NCT01747629|537816673|FG000|Overall Study|Adverse Event|1|||
149092241|NCT01747629|537816674|FG001|Overall Study|Adverse Event|2|||
149092242|NCT01747629|537816673|FG000|Overall Study|Withdrawal by Subject|2|||
149092243|NCT01747629|537816674|FG001|Overall Study|Withdrawal by Subject|2|||
149092244|NCT01747629|537816673|FG000|Overall Study|Noncompliance|1|||
149092245|NCT01747629|537816674|FG001|Overall Study|Noncompliance|1|||
149092246|NCT01747629|537816673|FG000|Overall Study|Inclusion criteria not met|1|||
149092247|NCT01747629|537816674|FG001|Overall Study|Inclusion criteria not met|0|||
149092248|NCT01747629|537816673|FG000|Overall Study|Not treated|1|||
149092249|NCT01747629|537816674|FG001|Overall Study|Not treated|0|||
149092250|NCT01747629|537816673|FG000|Overall Study|Other|2|||
149092251|NCT01747629|537816674|FG001|Overall Study|Other|1|||
149092252|NCT04089332|537816680|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
149092253|NCT04089332|537816680|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
149092254|NCT04089332|537816680|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
149092255|NCT06016127|537816685|FG000|Overall Study|Withdrawal by Subject|4|||
149092256|NCT06016127|537816686|FG001|Overall Study|Withdrawal by Subject|3|||
149092257|NCT00734851|537816687|FG000|Overall Study|Withdrawal by Subject|2|||
149092258|NCT00734851|537816687|FG000|Overall Study|Lost to Follow-up|1|||
149092259|NCT00734851|537816687|FG000|Overall Study|Physician Decision|18|||
149092260|NCT01770509|537816688|FG000|Overall Study|Injury|0|||
149092261|NCT01770509|537816689|FG001|Overall Study|Injury|1|||
149092262|NCT01770509|537816688|FG000|Overall Study|Lost to Follow-up|1|||
149092263|NCT01770509|537816689|FG001|Overall Study|Lost to Follow-up|2|||
149092264|NCT01294358|537816690|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
149092265|NCT01294358|537816691|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
149092266|NCT01294358|537816692|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
149092267|NCT01294358|537816693|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
149092268|NCT01294358|537816694|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
149092269|NCT01294358|537816690|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
149092270|NCT01294358|537816691|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
149092271|NCT01294358|537816692|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
149092272|NCT01294358|537816693|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
149092273|NCT01294358|537816694|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
149092274|NCT01294358|537816690|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
149092275|NCT01294358|537816691|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
149092276|NCT01294358|537816692|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
149092277|NCT01294358|537816693|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
149092278|NCT01294358|537816694|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
149092279|NCT01294358|537816690|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
149092280|NCT01294358|537816691|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
149092281|NCT01294358|537816692|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
149092282|NCT01294358|537816693|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
149092283|NCT01294358|537816694|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
149092284|NCT02963922|537816695|FG000|Overall Study|Adverse Event|15|||
149092285|NCT02963922|537816696|FG001|Overall Study|Adverse Event|6|||
149092286|NCT02963922|537816695|FG000|Overall Study|Protocol deviation|6|||
149092287|NCT02963922|537816696|FG001|Overall Study|Protocol deviation|6|||
149092288|NCT02963922|537816695|FG000|Overall Study|Lack of Efficacy|1|||
149092289|NCT02963922|537816696|FG001|Overall Study|Lack of Efficacy|1|||
149092290|NCT02963922|537816695|FG000|Overall Study|Lost to Follow-up|2|||
149092291|NCT02963922|537816696|FG001|Overall Study|Lost to Follow-up|3|||
149092292|NCT02963922|537816695|FG000|Overall Study|Other|8|||
149092293|NCT02963922|537816696|FG001|Overall Study|Other|14|||
149092294|NCT04341584|537816704|FG000|Overall Study|Withdrew consent|0|||
149092295|NCT04341584|537816705|FG001|Overall Study|Withdrew consent|2|||
149092296|NCT04341584|537816706|FG002|Overall Study|Withdrew consent|2|||
149092297|NCT04341584|537816707|FG003|Overall Study|Withdrew consent|1|||
149092298|NCT04853238|537816708|FG000|Overall Study|Death|4|||
149092299|NCT04853238|537816709|FG001|Overall Study|Death|0|||
149092300|NCT04853238|537816710|FG002|Overall Study|Death|2|||
149092301|NCT04853238|537816708|FG000|Overall Study|Lost to Follow-up|16|||
149092302|NCT04853238|537816709|FG001|Overall Study|Lost to Follow-up|2|||
149092303|NCT04853238|537816710|FG002|Overall Study|Lost to Follow-up|37|||
149092304|NCT04853238|537816708|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
149092305|NCT04853238|537816709|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
149092306|NCT04853238|537816710|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
149092307|NCT04853238|537816708|FG000|Overall Study|Withdrawal by Subject|6|||
149092308|NCT04853238|537816709|FG001|Overall Study|Withdrawal by Subject|0|||
149092309|NCT04853238|537816710|FG002|Overall Study|Withdrawal by Subject|21|||
149092310|NCT04853238|537816708|FG000|Overall Study|Physician Decision|0|||
149092311|NCT04853238|537816709|FG001|Overall Study|Physician Decision|0|||
149092312|NCT04853238|537816710|FG002|Overall Study|Physician Decision|2|||
149092313|NCT04853238|537816708|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
149092314|NCT04853238|537816709|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
149092315|NCT04853238|537816710|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
149092316|NCT02972242|537818326|FG000|Overall Study|Withdrawal by Subject|1|||
149092317|NCT02972242|537818327|FG001|Overall Study|Withdrawal by Subject|0|||
149092318|NCT01243411|537818330|FG000|Overall Study|Withdrawal by Subject|18|||
149092319|NCT01243411|537818330|FG000|Overall Study|Lost to Follow-up|10|||
149092320|NCT01243411|537818330|FG000|Overall Study|Adverse Event|5|||
149092321|NCT01243411|537818330|FG000|Overall Study|Other|8|||
149092322|NCT03022578|537818333|FG000|Overall Study|Adverse Event|1|||
149092323|NCT03022578|537818333|FG000|Overall Study|Lack of Efficacy|2|||
149092324|NCT03022578|537818333|FG000|Overall Study|Withdrawal by Subject|1|||
149092325|NCT03319719|537818352|FG000|Overall Study|Lost to Follow-up|1|||
149092326|NCT00498433|537818353|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
149092327|NCT00498433|537818354|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
149092328|NCT00498433|537818355|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
149092329|NCT00498433|537818353|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
149092330|NCT00498433|537818354|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
149092331|NCT00498433|537818355|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
149092332|NCT00498433|537818353|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
149092333|NCT00498433|537818354|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
149092334|NCT00498433|537818355|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
149092335|NCT00498433|537818353|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
149092336|NCT00498433|537818354|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
149092337|NCT00498433|537818355|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
149092338|NCT00744796|537818356|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
149092339|NCT02581189|537818360|FG000|Overall Study|Failure to return|36|||
149092340|NCT02581189|537818360|FG000|Overall Study|Withdrew consent|5|||
149092341|NCT02581189|537818360|FG000|Overall Study|Death|3|||
149092342|NCT02581189|537818360|FG000|Overall Study|Insufficient virological response|2|||
149092343|NCT02581189|537818360|FG000|Overall Study|Other, not specified|7|||
149092344|NCT02720081|537818361|FG000|Overall Study|Adverse Event|0|||
149092345|NCT02720081|537818362|FG001|Overall Study|Adverse Event|3|||
149092346|NCT02720081|537818361|FG000|Overall Study|Protocol Violation|4|||
149092347|NCT02720081|537818362|FG001|Overall Study|Protocol Violation|1|||
149092348|NCT02316847|537818363|FG000|Overall Study|Adverse Event|0|||
149092349|NCT02316847|537818364|FG001|Overall Study|Adverse Event|3|||
149092350|NCT02316847|537818363|FG000|Overall Study|Lost to Follow-up|0|||
149092351|NCT02316847|537818364|FG001|Overall Study|Lost to Follow-up|2|||
149092352|NCT02316847|537818363|FG000|Overall Study|Physician Decision|0|||
149092353|NCT02316847|537818364|FG001|Overall Study|Physician Decision|1|||
149092354|NCT02316847|537818363|FG000|Overall Study|Pregnancy|0|||
149092355|NCT02316847|537818364|FG001|Overall Study|Pregnancy|1|||
149092356|NCT02316847|537818363|FG000|Overall Study|Withdrawal by Subject|2|||
149092357|NCT02316847|537818364|FG001|Overall Study|Withdrawal by Subject|9|||
149092358|NCT02316847|537818363|FG000|Overall Study|Noncompliance with study drug|0|||
149092359|NCT02316847|537818364|FG001|Overall Study|Noncompliance with study drug|3|||
149092360|NCT02316847|537818363|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
149092361|NCT02316847|537818364|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
149092362|NCT03371485|537818369|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
149092363|NCT03371485|537818369|FG000|2-year Follow-up|Death|5|||
149092364|NCT02381652|537818376|FG000|Overall Study|Withdrawal by Subject|0|||
149092365|NCT02381652|537818377|FG001|Overall Study|Withdrawal by Subject|0|||
149092366|NCT02381652|537818378|FG002|Overall Study|Withdrawal by Subject|1|||
149092367|NCT01340300|537818379|FG000|Overall Study|Lost to Follow-up|3|||
149092368|NCT01340300|537818380|FG001|Overall Study|Lost to Follow-up|0|||
149092369|NCT01340300|537818381|FG002|Overall Study|Lost to Follow-up|5|||
149092370|NCT01340300|537818382|FG003|Overall Study|Lost to Follow-up|10|||
149092371|NCT01340300|537818379|FG000|Overall Study|Withdrawal by Subject|5|||
149092372|NCT01340300|537818380|FG001|Overall Study|Withdrawal by Subject|6|||
149092373|NCT01340300|537818381|FG002|Overall Study|Withdrawal by Subject|6|||
149092374|NCT01340300|537818382|FG003|Overall Study|Withdrawal by Subject|3|||
149092375|NCT01340300|537818379|FG000|Overall Study|Adverse Event|1|||
149092376|NCT01340300|537818380|FG001|Overall Study|Adverse Event|0|||
149092377|NCT01340300|537818381|FG002|Overall Study|Adverse Event|4|||
149092378|NCT01340300|537818382|FG003|Overall Study|Adverse Event|0|||
149092379|NCT01340300|537818379|FG000|Overall Study|Physician Decision|0|||
149092380|NCT01340300|537818380|FG001|Overall Study|Physician Decision|1|||
149092381|NCT01340300|537818381|FG002|Overall Study|Physician Decision|0|||
149092382|NCT01340300|537818382|FG003|Overall Study|Physician Decision|0|||
149092383|NCT01340300|537818379|FG000|Overall Study|Unrelated sickness|0|||
149092384|NCT01340300|537818380|FG001|Overall Study|Unrelated sickness|2|||
149092385|NCT01340300|537818381|FG002|Overall Study|Unrelated sickness|0|||
149092386|NCT01340300|537818382|FG003|Overall Study|Unrelated sickness|1|||
149092387|NCT01061775|537818384|FG000|Overall Study|Physician Decision|2|||
149092388|NCT01061775|537818384|FG000|Overall Study|Lost to Follow-up|1|||
149092389|NCT00588341|537818385|FG000|Overall Study|Withdrawal by Subject|3|||
149092390|NCT00588341|537818385|FG000|Overall Study|Not treated due to metastatic disease|1|||
149092391|NCT00588341|537818385|FG000|Overall Study|Patient ineligible|1|||
149092392|NCT02567227|537818386|FG000|9 Weeks|Adverse Event|5|||
149092393|NCT02567227|537818387|FG001|9 Weeks|Adverse Event|5|||
149092394|NCT02567227|537818386|FG000|9 Weeks|Withdrawal by Subject|18|||
149092395|NCT02567227|537818387|FG001|9 Weeks|Withdrawal by Subject|8|||
149092396|NCT02567227|537818386|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
149092397|NCT02567227|537818387|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
149092398|NCT02567227|537818386|FG000|6 Month|Death|2|||
149092399|NCT02567227|537818387|FG001|6 Month|Death|0|||
149092400|NCT02567227|537818386|FG000|6 Month|Lost to Follow-up|43|||
149092401|NCT02567227|537818387|FG001|6 Month|Lost to Follow-up|40|||
149092402|NCT02567227|537818386|FG000|12 Months|Lost to Follow-up|31|||
149092403|NCT02567227|537818387|FG001|12 Months|Lost to Follow-up|32|||
149092404|NCT02567227|537818386|FG000|12 Months|Death|0|||
149092405|NCT02567227|537818387|FG001|12 Months|Death|2|||
149092406|NCT03746483|537818388|FG000|Overall Study|Adverse Event|0|||
149092407|NCT03746483|537818389|FG001|Overall Study|Adverse Event|1|||
149092408|NCT03746483|537818388|FG000|Overall Study|Lack of Efficacy|3|||
149092409|NCT03746483|537818389|FG001|Overall Study|Lack of Efficacy|2|||
149092410|NCT03746483|537818388|FG000|Overall Study|Lost to Follow-up|1|||
149092411|NCT03746483|537818389|FG001|Overall Study|Lost to Follow-up|0|||
149092412|NCT03746483|537818388|FG000|Overall Study|Protocol Violation|2|||
149092413|NCT03746483|537818389|FG001|Overall Study|Protocol Violation|0|||
149092414|NCT01954771|537818392|FG000|Overall Study|Missing HbA1c of end-point|1|||
149092415|NCT01954771|537818393|FG001|Overall Study|Missing HbA1c of end-point|1|||
149092416|NCT01954771|537818394|FG002|Overall Study|Missing HbA1c of end-point|0|||
149092417|NCT01954771|537818392|FG000|Overall Study|Missing CGMS of end-point|1|||
149092418|NCT01954771|537818393|FG001|Overall Study|Missing CGMS of end-point|1|||
149092419|NCT01954771|537818394|FG002|Overall Study|Missing CGMS of end-point|0|||
149092420|NCT01954771|537818392|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
149092421|NCT01954771|537818393|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
149092422|NCT01954771|537818394|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
149092423|NCT02498418|537818397|FG000|Overall Study|Lack of Efficacy|0|||
149092424|NCT02498418|537818398|FG001|Overall Study|Lack of Efficacy|0|||
149092425|NCT02498418|537818399|FG002|Overall Study|Lack of Efficacy|1|||
149092426|NCT02498418|537818397|FG000|Overall Study|Withdrawal by Subject|2|||
149092427|NCT02498418|537818398|FG001|Overall Study|Withdrawal by Subject|0|||
149092428|NCT02498418|537818399|FG002|Overall Study|Withdrawal by Subject|3|||
149092429|NCT02498418|537818397|FG000|Overall Study|Lost to Follow-up|0|||
149092430|NCT02498418|537818398|FG001|Overall Study|Lost to Follow-up|1|||
149092431|NCT02498418|537818399|FG002|Overall Study|Lost to Follow-up|1|||
149092432|NCT02498418|537818397|FG000|Overall Study|Participant taken prohibited medication|0|||
149092433|NCT02498418|537818398|FG001|Overall Study|Participant taken prohibited medication|1|||
149092434|NCT02498418|537818399|FG002|Overall Study|Participant taken prohibited medication|1|||
149092435|NCT01026103|537818400|FG000|Overall Study|Physician Decision|1|||
149092436|NCT01026103|537818400|FG000|Overall Study|did not receive study device bc of error|1|||
149092437|NCT03635775|537818402|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
149092438|NCT03635775|537818403|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
149092439|NCT03635775|537818404|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
149092440|NCT03635775|537818405|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
149092441|NCT00762502|537818406|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
149092442|NCT00762502|537818407|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
149092443|NCT00762502|537818408|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
149092444|NCT00762502|537818406|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
149092445|NCT00762502|537818407|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
149092446|NCT00762502|537818408|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
149092447|NCT00762502|537818406|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
149092448|NCT00762502|537818407|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
149092449|NCT00762502|537818408|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
149092450|NCT01675050|537818410|FG000|Period One Treatment|Withdrawal by Subject|1|||
149092451|NCT01675050|537818411|FG001|Period One Treatment|Withdrawal by Subject|0|||
149092452|NCT00264498|537818412|FG000|Randomized Treatment|Death|0|||
149092453|NCT00264498|537818413|FG001|Randomized Treatment|Death|3|||
149092454|NCT00264498|537818412|FG000|Randomized Treatment|Withdrawal by Subject|0|||
149092455|NCT00264498|537818413|FG001|Randomized Treatment|Withdrawal by Subject|1|||
149092456|NCT00264498|537818412|FG000|Randomized Treatment|Objective disease Progression|13|||
149092457|NCT00264498|537818413|FG001|Randomized Treatment|Objective disease Progression|14|||
149092458|NCT00264498|537818412|FG000|Randomized Treatment|Physician Decision|1|||
149092459|NCT00264498|537818413|FG001|Randomized Treatment|Physician Decision|0|||
149092460|NCT00264498|537818412|FG000|Randomized Treatment|Incorrectly randomized|1|||
149092461|NCT00264498|537818413|FG001|Randomized Treatment|Incorrectly randomized|0|||
149092462|NCT00264498|537818412|FG000|Randomized Treatment|Study Closure|1|||
149092463|NCT00264498|537818413|FG001|Randomized Treatment|Study Closure|0|||
149092464|NCT00264498|537818412|FG000|Randomized Treatment|Protocol Violation|1|||
149092465|NCT00264498|537818413|FG001|Randomized Treatment|Protocol Violation|0|||
149092466|NCT00264498|537818412|FG000|Crossover Treatment|Death|1|||
149092467|NCT00264498|537818413|FG001|Crossover Treatment|Death|3|||
149092468|NCT00264498|537818412|FG000|Crossover Treatment|Objective disease progression|4|||
149092469|NCT00264498|537818413|FG001|Crossover Treatment|Objective disease progression|5|||
149092470|NCT00264498|537818412|FG000|Crossover Treatment|Study closure|0|||
149092471|NCT00264498|537818413|FG001|Crossover Treatment|Study closure|1|||
149092472|NCT00264498|537818412|FG000|Crossover Treatment|Withdrawal by Subject|1|||
149092473|NCT00264498|537818413|FG001|Crossover Treatment|Withdrawal by Subject|0|||
149092474|NCT04543942|537818414|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
149092475|NCT04543942|537818415|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
149092476|NCT04543942|537818414|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
149092477|NCT04543942|537818415|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
149092478|NCT02205476|537818416|FG000|Overall Study|Study termination by Sponsor|7|||
149092479|NCT02205476|537818417|FG001|Overall Study|Study termination by Sponsor|3|||
149092480|NCT02625922|537818423|FG000|Overall Study|Non-availability of IMP|1|||
149092481|NCT02625922|537818424|FG001|Overall Study|Non-availability of IMP|1|||
149092482|NCT02625922|537818423|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
149092483|NCT02625922|537818424|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
149092484|NCT02391116|537818425|FG000|Treatment|Withdrawal by Subject|1|||
149092485|NCT02391116|537818425|FG000|Treatment|Protocol Violation|1|||
149092486|NCT02391116|537818425|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
149092487|NCT02391116|537818425|FG000|Treatment|AE with Clinical PD|3|||
149092488|NCT02391116|537818425|FG000|Safety Follow-up|Adverse Event|1|||
149092489|NCT02391116|537818425|FG000|Safety Follow-up|Withdrawal by Subject|4|||
149092490|NCT02391116|537818425|FG000|Safety Follow-up|Switching to Other Therapy|4|||
149092491|NCT02391116|537818425|FG000|Safety Follow-up|No Follow Up|1|||
149092492|NCT02391116|537818425|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
149092493|NCT02391116|537818425|FG000|Active Follow-up|Withdrawal by Subject|1|||
149092494|NCT02391116|537818425|FG000|Active Follow-up|Switching to Other Therapy|2|||
149092495|NCT02391116|537818425|FG000|Survival Follow-up|Withdrawal by Subject|3|||
149092496|NCT02391116|537818425|FG000|Survival Follow-up|Switching to Other Therapy|1|||
149092497|NCT02391545|537818427|FG000|Overall Study|Death|0|||
149092498|NCT02391545|537818428|FG001|Overall Study|Death|2|||
149092499|NCT02391545|537818427|FG000|Overall Study|Lost to Follow-up|0|||
149092500|NCT02391545|537818428|FG001|Overall Study|Lost to Follow-up|1|||
149092501|NCT02391545|537818427|FG000|Overall Study|Termination of study by sponsor|20|||
149092502|NCT02391545|537818428|FG001|Overall Study|Termination of study by sponsor|20|||
149092503|NCT02391545|537818427|FG000|Overall Study|Withdrawal by Subject|0|||
149092504|NCT02391545|537818428|FG001|Overall Study|Withdrawal by Subject|1|||
149092505|NCT02391545|537818427|FG000|Overall Study|Other Reasons|6|||
149092506|NCT02391545|537818428|FG001|Overall Study|Other Reasons|4|||
149092507|NCT01222078|537818429|FG000|Overall Study|Early termination of the study|1|||
149092508|NCT01363297|537818431|FG000|Overall Study|Other|0|||
149092509|NCT01363297|537818432|FG001|Overall Study|Other|0|||
149092510|NCT01363297|537818433|FG002|Overall Study|Other|0|||
149092511|NCT01363297|537818434|FG003|Overall Study|Other|0|||
149092512|NCT01363297|537818435|FG004|Overall Study|Other|1|||
149092513|NCT01363297|537818431|FG000|Overall Study|Death|3|||
149092514|NCT01363297|537818432|FG001|Overall Study|Death|6|||
149092515|NCT01363297|537818433|FG002|Overall Study|Death|6|||
149092516|NCT01363297|537818434|FG003|Overall Study|Death|10|||
149092517|NCT01363297|537818435|FG004|Overall Study|Death|30|||
149092518|NCT00495612|537818436|FG000|Overall Study|Lost to Follow-up|1|||
149092519|NCT00495612|537818437|FG001|Overall Study|Lost to Follow-up|0|||
149092520|NCT00495612|537818436|FG000|Overall Study|Subject's Decision to Withdraw|3|||
149092521|NCT00495612|537818437|FG001|Overall Study|Subject's Decision to Withdraw|0|||
149092522|NCT02864147|537818444|FG000|Overall Study|Withdrawal by Subject|3|||
149092523|NCT02864147|537818445|FG001|Overall Study|Withdrawal by Subject|2|||
149092524|NCT02864147|537818446|FG002|Overall Study|Withdrawal by Subject|1|||
149092525|NCT02864147|537818444|FG000|Overall Study|Lost to Follow-up|0|||
149092526|NCT02864147|537818445|FG001|Overall Study|Lost to Follow-up|4|||
149092527|NCT02864147|537818446|FG002|Overall Study|Lost to Follow-up|0|||
149092528|NCT02864147|537818444|FG000|Overall Study|Adverse Event|0|||
149092529|NCT02864147|537818445|FG001|Overall Study|Adverse Event|1|||
149092530|NCT02864147|537818446|FG002|Overall Study|Adverse Event|0|||
149092531|NCT02864147|537818444|FG000|Overall Study|Pregnancy|4|||
149092532|NCT02864147|537818445|FG001|Overall Study|Pregnancy|0|||
149092533|NCT02864147|537818446|FG002|Overall Study|Pregnancy|0|||
149092534|NCT02864147|537818444|FG000|Overall Study|Physician Decision|0|||
149092535|NCT02864147|537818445|FG001|Overall Study|Physician Decision|0|||
149092536|NCT02864147|537818446|FG002|Overall Study|Physician Decision|1|||
149092537|NCT02864147|537818444|FG000|Overall Study|Opted for excisional procedures|0|||
149092538|NCT02864147|537818445|FG001|Overall Study|Opted for excisional procedures|0|||
149092539|NCT02864147|537818446|FG002|Overall Study|Opted for excisional procedures|3|||
149092540|NCT00981578|537818450|FG000|Overall Study|Death|1|||
149092541|NCT00981578|537818450|FG000|Overall Study|Withdrawal by Subject|2|||
149092542|NCT02865135|537818451|FG000|Overall Study|Death|0|||
149092543|NCT02865135|537818452|FG001|Overall Study|Death|1|||
149092544|NCT02865135|537818453|FG002|Overall Study|Death|0|||
149092545|NCT02865135|537818451|FG000|Overall Study|Progression|6|||
149092546|NCT02865135|537818452|FG001|Overall Study|Progression|2|||
149092547|NCT02865135|537818453|FG002|Overall Study|Progression|2|||
149092548|NCT01180790|537818455|FG000|Overall Study|Adverse Event|1|||
149092549|NCT01180790|537818456|FG001|Overall Study|Adverse Event|1|||
149092550|NCT01180790|537818457|FG002|Overall Study|Adverse Event|2|||
149092551|NCT01180790|537818458|FG003|Overall Study|Adverse Event|0|||
149092552|NCT01180790|537818459|FG004|Overall Study|Adverse Event|1|||
149092553|NCT01180790|537818460|FG005|Overall Study|Adverse Event|3|||
149092554|NCT01180790|537818461|FG006|Overall Study|Adverse Event|0|||
149092555|NCT01180790|537818455|FG000|Overall Study|Withdrawal by Subject|3|||
149092556|NCT01180790|537818456|FG001|Overall Study|Withdrawal by Subject|0|||
149092557|NCT01180790|537818457|FG002|Overall Study|Withdrawal by Subject|5|||
149092558|NCT01180790|537818458|FG003|Overall Study|Withdrawal by Subject|0|||
149092559|NCT01180790|537818459|FG004|Overall Study|Withdrawal by Subject|2|||
149092560|NCT01180790|537818460|FG005|Overall Study|Withdrawal by Subject|1|||
149092561|NCT01180790|537818461|FG006|Overall Study|Withdrawal by Subject|0|||
149092562|NCT01180790|537818455|FG000|Overall Study|Lost to Follow-up|3|||
149092563|NCT01180790|537818456|FG001|Overall Study|Lost to Follow-up|1|||
149092564|NCT01180790|537818457|FG002|Overall Study|Lost to Follow-up|0|||
149092565|NCT01180790|537818458|FG003|Overall Study|Lost to Follow-up|2|||
149092566|NCT01180790|537818459|FG004|Overall Study|Lost to Follow-up|1|||
149092567|NCT01180790|537818460|FG005|Overall Study|Lost to Follow-up|0|||
149092568|NCT01180790|537818461|FG006|Overall Study|Lost to Follow-up|1|||
149092569|NCT01180790|537818455|FG000|Overall Study|Physician Decision|1|||
149092570|NCT01180790|537818456|FG001|Overall Study|Physician Decision|0|||
149092571|NCT01180790|537818457|FG002|Overall Study|Physician Decision|0|||
149092572|NCT01180790|537818458|FG003|Overall Study|Physician Decision|1|||
149092573|NCT01180790|537818459|FG004|Overall Study|Physician Decision|0|||
149092574|NCT01180790|537818460|FG005|Overall Study|Physician Decision|0|||
149092575|NCT01180790|537818461|FG006|Overall Study|Physician Decision|0|||
149092576|NCT01180790|537818455|FG000|Overall Study|Lack of Efficacy|1|||
149092577|NCT01180790|537818456|FG001|Overall Study|Lack of Efficacy|2|||
149092578|NCT01180790|537818457|FG002|Overall Study|Lack of Efficacy|5|||
149092579|NCT01180790|537818458|FG003|Overall Study|Lack of Efficacy|6|||
149092580|NCT01180790|537818459|FG004|Overall Study|Lack of Efficacy|1|||
149092581|NCT01180790|537818460|FG005|Overall Study|Lack of Efficacy|3|||
149092582|NCT01180790|537818461|FG006|Overall Study|Lack of Efficacy|0|||
149092583|NCT01180790|537818455|FG000|Overall Study|compliance|0|||
149092584|NCT01180790|537818456|FG001|Overall Study|compliance|1|||
149092585|NCT01180790|537818457|FG002|Overall Study|compliance|0|||
149092586|NCT01180790|537818458|FG003|Overall Study|compliance|0|||
149092587|NCT01180790|537818459|FG004|Overall Study|compliance|0|||
149092588|NCT01180790|537818460|FG005|Overall Study|compliance|0|||
149092589|NCT01180790|537818461|FG006|Overall Study|compliance|0|||
149092590|NCT01180790|537818455|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
149092591|NCT01180790|537818456|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
149092592|NCT01180790|537818457|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
149092593|NCT01180790|537818458|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
149092594|NCT01180790|537818459|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
149092595|NCT01180790|537818460|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
149092596|NCT01180790|537818461|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
149092597|NCT00655668|537818462|FG000|Overall Study|Adverse Event|6|||
149092598|NCT00655668|537818462|FG000|Overall Study|Death|5|||
149092599|NCT00655668|537818462|FG000|Overall Study|Disease Progression|27|||
149092600|NCT00655668|537818462|FG000|Overall Study|Study Terminated|9|||
149092601|NCT00655668|537818462|FG000|Overall Study|Other|1|||
149092602|NCT00655668|537818462|FG000|Overall Study|New Lymphoma Treatment Started|4|||
149092603|NCT00655668|537818462|FG000|Overall Study|Withdrawal by Subject|2|||
149092604|NCT03840148|537818463|FG000|Study Drug Disposition|Adverse Event|13|||
149092605|NCT03840148|537818464|FG001|Study Drug Disposition|Adverse Event|2|||
149092606|NCT03840148|537818463|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
149092607|NCT03840148|537818464|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
149092608|NCT03840148|537818463|FG000|Study Drug Disposition|Lack of Efficacy|3|||
149092609|NCT03840148|537818464|FG001|Study Drug Disposition|Lack of Efficacy|0|||
149092610|NCT03840148|537818463|FG000|Study Drug Disposition|Physician Decision|2|||
149092611|NCT03840148|537818464|FG001|Study Drug Disposition|Physician Decision|0|||
149092612|NCT03840148|537818463|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
149092613|NCT03840148|537818464|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
149092614|NCT03840148|537818463|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
149092615|NCT03840148|537818464|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
149092616|NCT03840148|537818463|FG000|Study Completion Disposition|Physician Decision|2|||
149092617|NCT03840148|537818464|FG001|Study Completion Disposition|Physician Decision|0|||
149092618|NCT03840148|537818463|FG000|Study Completion Disposition|Covid-19 related|2|||
149092619|NCT03840148|537818464|FG001|Study Completion Disposition|Covid-19 related|0|||
149092620|NCT03840148|537818463|FG000|Study Completion Disposition|Lost to Follow-up|1|||
149092621|NCT03840148|537818464|FG001|Study Completion Disposition|Lost to Follow-up|1|||
149092622|NCT03840148|537818463|FG000|Study Completion Disposition|Death|1|||
149092623|NCT03840148|537818464|FG001|Study Completion Disposition|Death|0|||
149092624|NCT03840148|537818463|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
149092625|NCT03840148|537818464|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
149092626|NCT03615404|537818465|FG000|Overall Study|Death|1|||
149092627|NCT03615404|537818465|FG000|Overall Study|vaccine did not pass quality assurance|1|||
149092628|NCT00257556|537818466|FG000|Overall Study|Adverse Event|1|||
149092629|NCT00257556|537818467|FG001|Overall Study|Adverse Event|4|||
149092630|NCT00257556|537818466|FG000|Overall Study|Physician Decision|6|||
149092631|NCT00257556|537818467|FG001|Overall Study|Physician Decision|0|||
149092632|NCT00257556|537818466|FG000|Overall Study|Did not meet hCG criterion|3|||
149092633|NCT00257556|537818467|FG001|Overall Study|Did not meet hCG criterion|0|||
149092634|NCT00257556|537818466|FG000|Overall Study|other reason|4|||
149092635|NCT00257556|537818467|FG001|Overall Study|other reason|6|||
149092636|NCT03849300|537818469|FG000|Overall Study|move out to different area|1|||
149092637|NCT03849300|537818470|FG001|Overall Study|move out to different area|3|||
149092638|NCT03849300|537818471|FG002|Overall Study|move out to different area|1|||
149092639|NCT03849300|537818472|FG003|Overall Study|move out to different area|4|||
149092640|NCT03849300|537818469|FG000|Overall Study|scheduling/transportation conflict|4|||
149092641|NCT03849300|537818470|FG001|Overall Study|scheduling/transportation conflict|4|||
149092642|NCT03849300|537818471|FG002|Overall Study|scheduling/transportation conflict|3|||
149092643|NCT03849300|537818472|FG003|Overall Study|scheduling/transportation conflict|2|||
149092644|NCT01774929|537818473|FG000|Overall Study|Adverse Event|3|||
149092645|NCT04839289|537818474|FG000|Overall Study|Withdrawal by Subject|1|||
149092646|NCT04839289|537818475|FG001|Overall Study|Withdrawal by Subject|0|||
149092647|NCT00884793|537818476|FG000|Overall Study|Withdrawal by Subject|1|||
149092648|NCT00663923|537818477|FG000|Overall Study|Lost to Follow-up|2|||
149092649|NCT02785900|537818478|FG000|Overall Study|Study Termination by Sponsor|64|||
149092650|NCT02785900|537818479|FG001|Overall Study|Study Termination by Sponsor|81|||
149092651|NCT02785900|537818478|FG000|Overall Study|Death|46|||
149092652|NCT02785900|537818479|FG001|Overall Study|Death|32|||
149092653|NCT02785900|537818478|FG000|Overall Study|Withdrawal by Subject|4|||
149092654|NCT02785900|537818479|FG001|Overall Study|Withdrawal by Subject|8|||
149092655|NCT02785900|537818478|FG000|Overall Study|Physician Decision|3|||
149092656|NCT02785900|537818479|FG001|Overall Study|Physician Decision|2|||
149092657|NCT02093897|537820139|FG000|Overall Study|Physician Decision|1|||
149092658|NCT02093897|537820139|FG000|Overall Study|Planned age group closure - no's reached|17|||
149092659|NCT02093897|537820139|FG000|Overall Study|Adverse event, non-fatal|1|||
149092660|NCT02956278|537820140|FG000|Overall Study|Withdrawal by Subject|6|||
149092661|NCT02956278|537820141|FG001|Overall Study|Withdrawal by Subject|2|||
149092662|NCT02956278|537820142|FG002|Overall Study|Withdrawal by Subject|0|||
149092663|NCT02329223|537820143|FG000|Overall Study|Withdrawal by Subject|1|||
149092664|NCT02329223|537820144|FG001|Overall Study|Withdrawal by Subject|2|||
149092665|NCT02329223|537820145|FG002|Overall Study|Withdrawal by Subject|5|||
149092666|NCT02329223|537820143|FG000|Overall Study|Physician Decision|0|||
149092667|NCT02329223|537820144|FG001|Overall Study|Physician Decision|0|||
149092668|NCT02329223|537820145|FG002|Overall Study|Physician Decision|1|||
149092669|NCT02329223|537820143|FG000|Overall Study|Adverse Event|0|||
149092670|NCT02329223|537820144|FG001|Overall Study|Adverse Event|1|||
149092671|NCT02329223|537820145|FG002|Overall Study|Adverse Event|0|||
149092672|NCT01157351|537820146|FG000|Overall Study|Adverse Event|5|||
149092673|NCT01157351|537820147|FG001|Overall Study|Adverse Event|4|||
149092674|NCT01157351|537820146|FG000|Overall Study|Death|1|||
149092675|NCT01157351|537820147|FG001|Overall Study|Death|0|||
149092676|NCT01157351|537820146|FG000|Overall Study|Lost to Follow-up|53|||
149092677|NCT01157351|537820147|FG001|Overall Study|Lost to Follow-up|55|||
149092678|NCT01157351|537820146|FG000|Overall Study|Withdrawal by Subject|37|||
149092679|NCT01157351|537820147|FG001|Overall Study|Withdrawal by Subject|27|||
149092680|NCT01157351|537820146|FG000|Overall Study|Physician Decision|5|||
149092681|NCT01157351|537820147|FG001|Overall Study|Physician Decision|4|||
149092682|NCT01157351|537820146|FG000|Overall Study|Protocol Violation|0|||
149092683|NCT01157351|537820147|FG001|Overall Study|Protocol Violation|1|||
149092684|NCT01157351|537820146|FG000|Overall Study|Other|32|||
149092685|NCT01157351|537820147|FG001|Overall Study|Other|36|||
149092686|NCT01157351|537820146|FG000|Overall Study|Noncompliance with Study Drug|0|||
149092687|NCT01157351|537820147|FG001|Overall Study|Noncompliance with Study Drug|3|||
149092688|NCT01157351|537820146|FG000|Overall Study|Randomized but not Treated|4|||
149092689|NCT01157351|537820147|FG001|Overall Study|Randomized but not Treated|2|||
149092690|NCT00684203|537820148|FG000|Overall Study|Adverse Event|6|||
149092691|NCT00684203|537820149|FG001|Overall Study|Adverse Event|4|||
149092692|NCT00684203|537820150|FG002|Overall Study|Adverse Event|8|||
149092693|NCT00684203|537820151|FG003|Overall Study|Adverse Event|0|||
149092694|NCT00684203|537820152|FG004|Overall Study|Adverse Event|0|||
149092695|NCT00684203|537820153|FG005|Overall Study|Adverse Event|0|||
149092696|NCT00684203|537820148|FG000|Overall Study|Protocol-defined clinical event|3|||
149092697|NCT00684203|537820149|FG001|Overall Study|Protocol-defined clinical event|1|||
149092698|NCT00684203|537820150|FG002|Overall Study|Protocol-defined clinical event|0|||
149092699|NCT00684203|537820151|FG003|Overall Study|Protocol-defined clinical event|0|||
149092700|NCT00684203|537820152|FG004|Overall Study|Protocol-defined clinical event|0|||
149092701|NCT00684203|537820153|FG005|Overall Study|Protocol-defined clinical event|0|||
149092702|NCT00684203|537820148|FG000|Overall Study|Withdrawal by Subject|0|||
149092703|NCT00684203|537820149|FG001|Overall Study|Withdrawal by Subject|2|||
149092704|NCT00684203|537820150|FG002|Overall Study|Withdrawal by Subject|1|||
149092705|NCT00684203|537820151|FG003|Overall Study|Withdrawal by Subject|0|||
149092706|NCT00684203|537820152|FG004|Overall Study|Withdrawal by Subject|0|||
149092707|NCT00684203|537820153|FG005|Overall Study|Withdrawal by Subject|0|||
149092708|NCT00684203|537820148|FG000|Overall Study|Did not meet protocol eligibility|0|||
149092709|NCT00684203|537820149|FG001|Overall Study|Did not meet protocol eligibility|1|||
149092710|NCT00684203|537820150|FG002|Overall Study|Did not meet protocol eligibility|0|||
149092711|NCT00684203|537820151|FG003|Overall Study|Did not meet protocol eligibility|0|||
149092712|NCT00684203|537820152|FG004|Overall Study|Did not meet protocol eligibility|0|||
149092713|NCT00684203|537820153|FG005|Overall Study|Did not meet protocol eligibility|0|||
149092714|NCT04140266|537820154|FG000|Overall Study|Physician Decision|2|||
149092715|NCT04140266|537820155|FG001|Overall Study|Physician Decision|0|||
149092716|NCT04140266|537820154|FG000|Overall Study|Withdrawal by Subject|4|||
149092717|NCT04140266|537820155|FG001|Overall Study|Withdrawal by Subject|2|||
149092718|NCT03511378|537820158|FG000|Overall Study|Withdrawal by Subject|2|||
149092719|NCT03511378|537820159|FG001|Overall Study|Withdrawal by Subject|2|||
149092720|NCT03511378|537820158|FG000|Overall Study|Patient not coming or schedule visit|1|||
149092721|NCT03511378|537820159|FG001|Overall Study|Patient not coming or schedule visit|0|||
149092722|NCT00730847|537820161|FG000|Overall Study|Adverse Event|1|||
149092723|NCT00730847|537820161|FG000|Overall Study|Protocol Violation|2|||
149092724|NCT00730847|537820161|FG000|Overall Study|Withdrawal by Subject|16|||
149092725|NCT00730847|537820161|FG000|Overall Study|Lost to Follow-up|67|||
149092726|NCT00730847|537820161|FG000|Overall Study|Unknown completion status|21|||
149092727|NCT00730847|537820161|FG000|Overall Study|Other|24|||
149092728|NCT00280683|537820162|FG000|Overall Study|Withdrawal by Subject|1|||
149092729|NCT00280683|537820163|FG001|Overall Study|Withdrawal by Subject|2|||
149092730|NCT00280683|537820162|FG000|Overall Study|Adverse Event|1|||
149092731|NCT00280683|537820163|FG001|Overall Study|Adverse Event|1|||
149092732|NCT00111839|537820169|FG000|Overall Study|Disease Progression|30|||
149092733|NCT00111839|537820170|FG001|Overall Study|Disease Progression|33|||
149092734|NCT00111839|537820171|FG002|Overall Study|Disease Progression|33|||
149092735|NCT00111839|537820169|FG000|Overall Study|Adverse Event|5|||
149092736|NCT00111839|537820170|FG001|Overall Study|Adverse Event|3|||
149092737|NCT00111839|537820171|FG002|Overall Study|Adverse Event|1|||
149092738|NCT00111839|537820169|FG000|Overall Study|Protocol Violation|2|||
149092739|NCT00111839|537820170|FG001|Overall Study|Protocol Violation|4|||
149092740|NCT00111839|537820171|FG002|Overall Study|Protocol Violation|2|||
149092741|NCT00111839|537820169|FG000|Overall Study|Death|1|||
149092742|NCT00111839|537820170|FG001|Overall Study|Death|1|||
149092743|NCT00111839|537820171|FG002|Overall Study|Death|6|||
149092744|NCT00111839|537820169|FG000|Overall Study|Withdrawal by Subject|2|||
149092745|NCT00111839|537820170|FG001|Overall Study|Withdrawal by Subject|2|||
149092746|NCT00111839|537820171|FG002|Overall Study|Withdrawal by Subject|2|||
149092747|NCT00111839|537820169|FG000|Overall Study|Lost to Follow-up|1|||
149092748|NCT00111839|537820170|FG001|Overall Study|Lost to Follow-up|0|||
149092749|NCT00111839|537820171|FG002|Overall Study|Lost to Follow-up|0|||
149092750|NCT00111839|537820169|FG000|Overall Study|Logistical Constraint|1|||
149092751|NCT00111839|537820170|FG001|Overall Study|Logistical Constraint|0|||
149092752|NCT00111839|537820171|FG002|Overall Study|Logistical Constraint|0|||
149092753|NCT00111839|537820169|FG000|Overall Study|Other|6|||
149092754|NCT00111839|537820170|FG001|Overall Study|Other|3|||
149092755|NCT00111839|537820171|FG002|Overall Study|Other|3|||
149092756|NCT00111839|537820169|FG000|Overall Study|Randomized but Not Treated|0|||
149092757|NCT00111839|537820170|FG001|Overall Study|Randomized but Not Treated|0|||
149092758|NCT00111839|537820171|FG002|Overall Study|Randomized but Not Treated|2|||
149092759|NCT02499835|537820174|FG000|Overall Study|Withdrawal by Subject|1|||
149092760|NCT02499835|537820175|FG001|Overall Study|Withdrawal by Subject|0|||
149092761|NCT02499835|537820176|FG002|Overall Study|Withdrawal by Subject|0|||
149092762|NCT02499835|537820177|FG003|Overall Study|Withdrawal by Subject|1|||
149092763|NCT02499835|537820174|FG000|Overall Study|Physician Decision|0|||
149092764|NCT02499835|537820175|FG001|Overall Study|Physician Decision|3|||
149092765|NCT02499835|537820176|FG002|Overall Study|Physician Decision|18|||
149092766|NCT02499835|537820177|FG003|Overall Study|Physician Decision|7|||
149092767|NCT02499835|537820174|FG000|Overall Study|Adverse Event|0|||
149092768|NCT02499835|537820175|FG001|Overall Study|Adverse Event|0|||
149092769|NCT02499835|537820176|FG002|Overall Study|Adverse Event|0|||
149092770|NCT02499835|537820177|FG003|Overall Study|Adverse Event|1|||
149092771|NCT02499835|537820174|FG000|Overall Study|Disease progression|2|||
149092772|NCT02499835|537820175|FG001|Overall Study|Disease progression|1|||
149092773|NCT02499835|537820176|FG002|Overall Study|Disease progression|0|||
149092774|NCT02499835|537820177|FG003|Overall Study|Disease progression|7|||
149092775|NCT05109117|537820178|FG000|Overall Study|Lost to Follow-up|1|||
149092776|NCT05109117|537820178|FG000|Overall Study|Discontinued for non-compliance|1|||
149092777|NCT03972137|537820179|FG000|Overall Study|Lost to Follow-up|2|||
149092778|NCT03972137|537820179|FG000|Overall Study|Withdrawal by Subject|4|||
149092779|NCT03220776|537820180|FG000|Overall Study|Claustrophobia|0|||
149092780|NCT03220776|537820181|FG001|Overall Study|Claustrophobia|1|||
149092781|NCT03220776|537820182|FG002|Overall Study|Claustrophobia|1|||
149092782|NCT03220776|537820183|FG003|Overall Study|Claustrophobia|0|||
149092783|NCT03220776|537820184|FG004|Overall Study|Claustrophobia|1|||
149092784|NCT03220776|537820185|FG005|Overall Study|Claustrophobia|0|||
149092785|NCT03220776|537820180|FG000|Overall Study|MRI Equipment Failure|1|||
149092786|NCT03220776|537820181|FG001|Overall Study|MRI Equipment Failure|0|||
149092787|NCT03220776|537820182|FG002|Overall Study|MRI Equipment Failure|0|||
149092788|NCT03220776|537820183|FG003|Overall Study|MRI Equipment Failure|0|||
149092789|NCT03220776|537820184|FG004|Overall Study|MRI Equipment Failure|0|||
149092790|NCT03220776|537820185|FG005|Overall Study|MRI Equipment Failure|0|||
149092791|NCT03220776|537820180|FG000|Overall Study|Inclimate Weather|0|||
149092792|NCT03220776|537820181|FG001|Overall Study|Inclimate Weather|0|||
149092793|NCT03220776|537820182|FG002|Overall Study|Inclimate Weather|0|||
149092794|NCT03220776|537820183|FG003|Overall Study|Inclimate Weather|0|||
149092795|NCT03220776|537820184|FG004|Overall Study|Inclimate Weather|0|||
149092796|NCT03220776|537820185|FG005|Overall Study|Inclimate Weather|1|||
149092797|NCT03220776|537820180|FG000|Overall Study|Physician Decision|0|||
149092798|NCT03220776|537820181|FG001|Overall Study|Physician Decision|0|||
149092799|NCT03220776|537820182|FG002|Overall Study|Physician Decision|0|||
149092800|NCT03220776|537820183|FG003|Overall Study|Physician Decision|1|||
149092801|NCT03220776|537820184|FG004|Overall Study|Physician Decision|0|||
149092802|NCT03220776|537820185|FG005|Overall Study|Physician Decision|0|||
149092803|NCT03220776|537820180|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
149092804|NCT03220776|537820181|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
149092805|NCT03220776|537820182|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
149092806|NCT03220776|537820183|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
149092807|NCT03220776|537820184|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
149092808|NCT03220776|537820185|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
149092809|NCT03220776|537820180|FG000|Overall Study|Protocol Violation|0|||
149092810|NCT03220776|537820181|FG001|Overall Study|Protocol Violation|0|||
149092811|NCT03220776|537820182|FG002|Overall Study|Protocol Violation|0|||
149092812|NCT03220776|537820183|FG003|Overall Study|Protocol Violation|2|||
149092813|NCT03220776|537820184|FG004|Overall Study|Protocol Violation|0|||
149092814|NCT03220776|537820185|FG005|Overall Study|Protocol Violation|1|||
149092815|NCT03220776|537820180|FG000|Overall Study|Withdrawal by Subject|1|||
149092816|NCT03220776|537820181|FG001|Overall Study|Withdrawal by Subject|0|||
149092817|NCT03220776|537820182|FG002|Overall Study|Withdrawal by Subject|0|||
149092818|NCT03220776|537820183|FG003|Overall Study|Withdrawal by Subject|0|||
149092819|NCT03220776|537820184|FG004|Overall Study|Withdrawal by Subject|0|||
149092820|NCT03220776|537820185|FG005|Overall Study|Withdrawal by Subject|0|||
149092821|NCT02490878|537820187|FG000|Overall Study|deemed ineligible|0|||
149092822|NCT02490878|537820188|FG001|Overall Study|deemed ineligible|1|||
149092823|NCT02490878|537820187|FG000|Overall Study|progression prior to treatment|0|||
149092824|NCT02490878|537820188|FG001|Overall Study|progression prior to treatment|1|||
149092825|NCT02490878|537820187|FG000|Overall Study|only submitted baseline QOL|0|||
149092826|NCT02490878|537820188|FG001|Overall Study|only submitted baseline QOL|1|||
149092827|NCT04194541|537820189|FG000|Day 1 Through 13|Lost to Follow-up|3|||
149092828|NCT04194541|537820189|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
149092829|NCT04194541|537820189|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
149092830|NCT02642159|537820190|FG000|Overall Study|Randomized but not treated|1|||
149092831|NCT02642159|537820191|FG001|Overall Study|Randomized but not treated|0|||
149092832|NCT02642159|537820190|FG000|Overall Study|Adverse Event|10|||
149092833|NCT02642159|537820191|FG001|Overall Study|Adverse Event|4|||
149092834|NCT02642159|537820190|FG000|Overall Study|Withdrawal by Subject|9|||
149092835|NCT02642159|537820191|FG001|Overall Study|Withdrawal by Subject|1|||
149092836|NCT02642159|537820190|FG000|Overall Study|Poor compliance to study protocol|1|||
149092837|NCT02642159|537820191|FG001|Overall Study|Poor compliance to study protocol|0|||
149092838|NCT02642159|537820190|FG000|Overall Study|Other than specified above|10|||
149092839|NCT02642159|537820191|FG001|Overall Study|Other than specified above|3|||
149092840|NCT03280108|537820193|FG000|Overall Study|Lost to Follow-up|2|||
149092841|NCT03280108|537820194|FG001|Overall Study|Lost to Follow-up|0|||
149092842|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
149092843|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149092844|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149092845|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149092846|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
149092847|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
149092848|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149092849|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149092850|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149092851|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
149092852|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
149092853|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149092854|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149092855|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149092856|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
149092857|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
149092858|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149092859|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149092860|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149092861|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
149092862|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
149092863|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149092864|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149092865|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149092866|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
149092867|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
149092868|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149092869|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149092870|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149092871|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
149092872|NCT01187407|537820195|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
149092873|NCT01187407|537820196|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149092874|NCT01187407|537820197|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149092875|NCT01187407|537820198|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149092876|NCT01187407|537820199|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
149092877|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
149092878|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
149092879|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
149092880|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
149092881|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
149092882|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
149092883|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
149092884|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
149092885|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
149092886|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
149092887|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
149092888|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
149092889|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
149092890|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
149092891|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
149092892|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
149092893|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
149092894|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
149092895|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
149092896|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
149092897|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
149092898|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
149092899|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
149092900|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
149092901|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
149092902|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
149092903|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
149092904|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
149092905|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
149092906|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
149092907|NCT01187407|537820195|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
149092908|NCT01187407|537820196|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
149092909|NCT01187407|537820197|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
149092910|NCT01187407|537820198|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
149092911|NCT01187407|537820199|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
149092912|NCT01820637|537820200|FG000|Overall Study|Death|2|||
149092913|NCT01820637|537820200|FG000|Overall Study|Withdrawal by Subject|1|||
149092914|NCT00583115|537820201|FG000|Overall Study|Death|1|||
149092915|NCT02382406|537820202|FG000|Study Treatment|Disease Progression|8|||
149092916|NCT02382406|537820203|FG001|Study Treatment|Disease Progression|0|||
149092917|NCT02382406|537820204|FG002|Study Treatment|Disease Progression|20|||
149092918|NCT02382406|537820202|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
149092919|NCT02382406|537820203|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
149092920|NCT02382406|537820204|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
149092921|NCT02382406|537820202|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
149092922|NCT02382406|537820203|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
149092923|NCT02382406|537820204|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
149092924|NCT02382406|537820202|FG000|Study Treatment|symptomatic deterioration|1|||
149092925|NCT02382406|537820203|FG001|Study Treatment|symptomatic deterioration|0|||
149092926|NCT02382406|537820204|FG002|Study Treatment|symptomatic deterioration|1|||
149092927|NCT02382406|537820202|FG000|Study Treatment|Death|0|||
149092928|NCT02382406|537820203|FG001|Study Treatment|Death|0|||
149092929|NCT02382406|537820204|FG002|Study Treatment|Death|2|||
149092930|NCT02382406|537820202|FG000|Follow up|Death|11|||
149092931|NCT02382406|537820203|FG001|Follow up|Death|0|||
149092932|NCT02382406|537820204|FG002|Follow up|Death|19|||
149092933|NCT02382406|537820202|FG000|Follow up|Symptomatic deterioration|1|||
149092934|NCT02382406|537820203|FG001|Follow up|Symptomatic deterioration|0|||
149092935|NCT02382406|537820204|FG002|Follow up|Symptomatic deterioration|1|||
149092936|NCT02382406|537820202|FG000|Follow up|Patient Refused Follow-up|1|||
149092937|NCT02382406|537820203|FG001|Follow up|Patient Refused Follow-up|0|||
149092938|NCT02382406|537820204|FG002|Follow up|Patient Refused Follow-up|0|||
149092939|NCT02382406|537820202|FG000|Follow up|Study Terminated|1|||
149092940|NCT02382406|537820203|FG001|Follow up|Study Terminated|0|||
149092941|NCT02382406|537820204|FG002|Follow up|Study Terminated|8|||
149092942|NCT02382406|537820202|FG000|Follow up|Withdrawal by Subject|0|||
149092943|NCT02382406|537820203|FG001|Follow up|Withdrawal by Subject|0|||
149092944|NCT02382406|537820204|FG002|Follow up|Withdrawal by Subject|2|||
149092945|NCT01713998|537820205|FG000|Overall Study|Lost to Follow-up|2|||
149092946|NCT01713998|537820206|FG001|Overall Study|Lost to Follow-up|0|||
149092947|NCT01713998|537820207|FG002|Overall Study|Lost to Follow-up|2|||
149092948|NCT01713998|537820205|FG000|Overall Study|Withdrawal by Subject|1|||
149092949|NCT01713998|537820206|FG001|Overall Study|Withdrawal by Subject|0|||
149092950|NCT01713998|537820207|FG002|Overall Study|Withdrawal by Subject|0|||
149092951|NCT03638258|537820208|FG000|Overall Study|Adverse Event|1|||
149092952|NCT03638258|537820209|FG001|Overall Study|Adverse Event|0|||
149092953|NCT03638258|537820210|FG002|Overall Study|Adverse Event|2|||
149092954|NCT03638258|537820208|FG000|Overall Study|Lost to Follow-up|2|||
149092955|NCT03638258|537820209|FG001|Overall Study|Lost to Follow-up|4|||
149092956|NCT03638258|537820210|FG002|Overall Study|Lost to Follow-up|5|||
149092957|NCT03638258|537820208|FG000|Overall Study|Pregnancy|0|||
149092958|NCT03638258|537820209|FG001|Overall Study|Pregnancy|0|||
149092959|NCT03638258|537820210|FG002|Overall Study|Pregnancy|1|||
149092960|NCT03638258|537820208|FG000|Overall Study|Protocol Violation|0|||
149092961|NCT03638258|537820209|FG001|Overall Study|Protocol Violation|0|||
149092962|NCT03638258|537820210|FG002|Overall Study|Protocol Violation|1|||
149092963|NCT03638258|537820208|FG000|Overall Study|Withdrawal by Subject|4|||
149092964|NCT03638258|537820209|FG001|Overall Study|Withdrawal by Subject|5|||
149092965|NCT03638258|537820210|FG002|Overall Study|Withdrawal by Subject|12|||
149092966|NCT03638258|537820208|FG000|Overall Study|Lack of Efficacy|0|||
149092967|NCT03638258|537820209|FG001|Overall Study|Lack of Efficacy|0|||
149092968|NCT03638258|537820210|FG002|Overall Study|Lack of Efficacy|2|||
149092969|NCT00607789|537820212|FG000|Overall Study|Adverse Event|3|||
149092970|NCT00607789|537820213|FG001|Overall Study|Adverse Event|0|||
149092971|NCT00607789|537820212|FG000|Overall Study|Lack of Efficacy|0|||
149092972|NCT00607789|537820213|FG001|Overall Study|Lack of Efficacy|1|||
149092973|NCT00607789|537820212|FG000|Overall Study|Inadequate adherence|3|||
149092974|NCT00607789|537820213|FG001|Overall Study|Inadequate adherence|0|||
149092975|NCT00607789|537820212|FG000|Overall Study|Lost to Follow-up|0|||
149092976|NCT00607789|537820213|FG001|Overall Study|Lost to Follow-up|5|||
149092977|NCT00607789|537820212|FG000|Overall Study|Withdrawal by Subject|1|||
149092978|NCT00607789|537820213|FG001|Overall Study|Withdrawal by Subject|0|||
149092979|NCT01313299|537820214|FG000|Overall Study|Adverse Event|3|||
149092980|NCT01313299|537820215|FG001|Overall Study|Adverse Event|1|||
149092981|NCT01313299|537820216|FG002|Overall Study|Adverse Event|1|||
149092982|NCT01313299|537820214|FG000|Overall Study|Lost to Follow-up|1|||
149092983|NCT01313299|537820215|FG001|Overall Study|Lost to Follow-up|0|||
149092984|NCT01313299|537820216|FG002|Overall Study|Lost to Follow-up|0|||
149092985|NCT01313299|537820214|FG000|Overall Study|Protocol Violation|2|||
149092986|NCT01313299|537820215|FG001|Overall Study|Protocol Violation|0|||
149092987|NCT01313299|537820216|FG002|Overall Study|Protocol Violation|0|||
149092988|NCT01313299|537820214|FG000|Overall Study|Withdrawal by Subject|1|||
149092989|NCT01313299|537820215|FG001|Overall Study|Withdrawal by Subject|0|||
149092990|NCT01313299|537820216|FG002|Overall Study|Withdrawal by Subject|2|||
149092991|NCT01313299|537820214|FG000|Overall Study|Family reason and moved out of state|0|||
149092992|NCT01313299|537820215|FG001|Overall Study|Family reason and moved out of state|2|||
149092993|NCT01313299|537820216|FG002|Overall Study|Family reason and moved out of state|0|||
149092994|NCT01313299|537820214|FG000|Overall Study|Lack of subject compliance|0|||
149092995|NCT01313299|537820215|FG001|Overall Study|Lack of subject compliance|0|||
149092996|NCT01313299|537820216|FG002|Overall Study|Lack of subject compliance|1|||
149092997|NCT02506881|537820217|FG000|First Intervention (Day 1)|Protocol Violation|0|||
149092998|NCT02506881|537820218|FG001|First Intervention (Day 1)|Protocol Violation|0|||
149092999|NCT02506881|537820219|FG002|First Intervention (Day 1)|Protocol Violation|1|||
149093000|NCT02506881|537820220|FG003|First Intervention (Day 1)|Protocol Violation|0|||
149093001|NCT02506881|537820217|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
149093002|NCT02506881|537820218|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
149093003|NCT02506881|537820219|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
149093004|NCT02506881|537820220|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
149093005|NCT02506881|537820217|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
149093006|NCT02506881|537820218|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
149093007|NCT02506881|537820219|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
149093008|NCT02506881|537820220|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
149093009|NCT01919398|537820221|FG000|Overall Study|Progressive Disease|0|||
149093010|NCT01919398|537820222|FG001|Overall Study|Progressive Disease|0|||
149093011|NCT01919398|537820223|FG002|Overall Study|Progressive Disease|4|||
149093012|NCT02016690|537820225|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
149093013|NCT02016690|537820225|FG000|Overall Study|Excluded from SAS: Duplication|2|||
149093014|NCT02016690|537820225|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
149093015|NCT02016690|537820225|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
149093016|NCT02016690|537820225|FG000|Overall Study|Did not meet inclusion criteria|13|||
149093017|NCT02016690|537820225|FG000|Overall Study|Hospitalized for RSV at study start|3|||
149093018|NCT03340766|537820230|FG000|Overall Study|Withdrawal by Subject|2|||
149093019|NCT03340766|537820231|FG001|Overall Study|Withdrawal by Subject|1|||
149093020|NCT03340766|537820232|FG002|Overall Study|Withdrawal by Subject|3|||
149093021|NCT03340766|537820230|FG000|Overall Study|Lost to Follow-up|0|||
149093022|NCT03340766|537820231|FG001|Overall Study|Lost to Follow-up|0|||
149093023|NCT03340766|537820232|FG002|Overall Study|Lost to Follow-up|1|||
149093024|NCT03340766|537820230|FG000|Overall Study|Death|6|||
149093025|NCT03340766|537820231|FG001|Overall Study|Death|7|||
149093026|NCT03340766|537820232|FG002|Overall Study|Death|4|||
149093027|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
149093028|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
149093029|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
149093030|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
149093031|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
149093032|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
149093033|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
149093034|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
149093035|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
149093036|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
149093037|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
149093038|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
149093039|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
149093040|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
149093041|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
149093042|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
149093043|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
149093044|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
149093045|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
149093046|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
149093047|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
149093048|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
149093049|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
149093050|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
149093051|NCT02269917|537820233|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
149093052|NCT02269917|537820234|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
149093053|NCT02269917|537820235|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
149093054|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
149093055|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
149093056|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
149093057|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
149093058|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
149093059|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
149093060|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
149093061|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
149093062|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
149093063|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
149093064|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
149093065|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
149093066|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
149093067|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
149093068|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
149093069|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
149093070|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
149093071|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
149093072|NCT02269917|537820233|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
149093073|NCT02269917|537820234|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
149093074|NCT02269917|537820235|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
149093075|NCT00240097|537820236|FG000|Part I|Adverse Event|1|||
149093076|NCT00240097|537820236|FG000|Part I|Death|1|||
149093077|NCT00240097|537820236|FG000|Part I|histology|1|||
149093078|NCT00240097|537820236|FG000|Part I|unevaluable|1|||
149093079|NCT00240097|537820236|FG000|Part II|did not continue from Part I|23|||
149093080|NCT02383927|537820237|FG000|Overall Study|Disease Progression|8|||
149093081|NCT02383927|537820238|FG001|Overall Study|Disease Progression|8|||
149093082|NCT02383927|537820239|FG002|Overall Study|Disease Progression|15|||
149093083|NCT02383927|537820240|FG003|Overall Study|Disease Progression|4|||
149093084|NCT02383927|537820237|FG000|Overall Study|Physician Decision|0|||
149093085|NCT02383927|537820238|FG001|Overall Study|Physician Decision|0|||
149093086|NCT02383927|537820239|FG002|Overall Study|Physician Decision|2|||
149093087|NCT02383927|537820240|FG003|Overall Study|Physician Decision|0|||
149093088|NCT02383927|537820237|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
149093089|NCT02383927|537820238|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
149093090|NCT02383927|537820239|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
149093091|NCT02383927|537820240|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
149093092|NCT02383927|537820237|FG000|Overall Study|Adverse Event|4|||
149093093|NCT02383927|537820238|FG001|Overall Study|Adverse Event|1|||
149093094|NCT02383927|537820239|FG002|Overall Study|Adverse Event|3|||
149093095|NCT02383927|537820240|FG003|Overall Study|Adverse Event|5|||
149093096|NCT02383927|537820237|FG000|Overall Study|Miscellaneous|1|||
149093097|NCT02383927|537820238|FG001|Overall Study|Miscellaneous|0|||
149093098|NCT02383927|537820239|FG002|Overall Study|Miscellaneous|0|||
149093099|NCT02383927|537820240|FG003|Overall Study|Miscellaneous|1|||
149093100|NCT02383927|537820237|FG000|Overall Study|Withdrawal by Subject|0|||
149093101|NCT02383927|537820238|FG001|Overall Study|Withdrawal by Subject|1|||
149093102|NCT02383927|537820239|FG002|Overall Study|Withdrawal by Subject|4|||
149093103|NCT02383927|537820240|FG003|Overall Study|Withdrawal by Subject|0|||
149093104|NCT00818519|537820241|FG000|Overall Study|Adverse Event|2|||
149093105|NCT00818519|537820242|FG001|Overall Study|Adverse Event|2|||
149093106|NCT00818519|537820241|FG000|Overall Study|Lost to Follow-up|4|||
149093107|NCT00818519|537820242|FG001|Overall Study|Lost to Follow-up|6|||
149093108|NCT00818519|537820241|FG000|Overall Study|Protocol Violation|2|||
149093109|NCT00818519|537820242|FG001|Overall Study|Protocol Violation|1|||
149093110|NCT00818519|537820241|FG000|Overall Study|Pregnancy|0|||
149093111|NCT00818519|537820242|FG001|Overall Study|Pregnancy|1|||
149093112|NCT00818519|537820241|FG000|Overall Study|Withdrawal by Subject|4|||
149093113|NCT00818519|537820242|FG001|Overall Study|Withdrawal by Subject|9|||
149093114|NCT00818519|537820241|FG000|Overall Study|participant recovered completely|1|||
149093115|NCT00818519|537820242|FG001|Overall Study|participant recovered completely|0|||
149093116|NCT00818519|537820241|FG000|Overall Study|participant will leave for long tme|1|||
149093117|NCT00818519|537820242|FG001|Overall Study|participant will leave for long tme|0|||
149093118|NCT02335242|537820249|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
149093119|NCT02335242|537820250|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
149093120|NCT02335242|537820249|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
149093121|NCT02335242|537820250|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
149093122|NCT02335242|537820249|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
149093123|NCT02335242|537820250|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
149093124|NCT03873038|537820251|FG000|Part 2|Withdrawal by Subject|0|||
149093125|NCT03873038|537820252|FG001|Part 2|Withdrawal by Subject|0|||
149093126|NCT03873038|537820253|FG002|Part 2|Withdrawal by Subject|0|||
149093127|NCT03873038|537820254|FG003|Part 2|Withdrawal by Subject|0|||
149093128|NCT03873038|537820255|FG004|Part 2|Withdrawal by Subject|0|||
149093129|NCT03873038|537820256|FG005|Part 2|Withdrawal by Subject|1|||
149093130|NCT03873038|537820251|FG000|Part 2|Unknon|0|||
149093131|NCT03873038|537820252|FG001|Part 2|Unknon|0|||
149093132|NCT03873038|537820253|FG002|Part 2|Unknon|0|||
149093133|NCT03873038|537820254|FG003|Part 2|Unknon|0|||
149093134|NCT03873038|537820255|FG004|Part 2|Unknon|1|||
149093135|NCT03873038|537820256|FG005|Part 2|Unknon|0|||
149093136|NCT00595764|537820257|FG000|Overall Study|Protocol Violation|24|||
149093137|NCT00595764|537820258|FG001|Overall Study|Protocol Violation|19|||
149093138|NCT00595764|537820257|FG000|Overall Study|Missed Medication >1 week|10|||
149093139|NCT00595764|537820258|FG001|Overall Study|Missed Medication >1 week|17|||
149093140|NCT00595764|537820257|FG000|Overall Study|Missed 3 PM visits|1|||
149093141|NCT00595764|537820258|FG001|Overall Study|Missed 3 PM visits|7|||
149093142|NCT00595764|537820257|FG000|Overall Study|Withdrawal by Subject|4|||
149093143|NCT00595764|537820258|FG001|Overall Study|Withdrawal by Subject|0|||
149093144|NCT04222088|537820259|FG000|Overall Study|Lost to Follow-up|5|||
149093145|NCT04222088|537820260|FG001|Overall Study|Lost to Follow-up|1|||
149093146|NCT04222088|537820259|FG000|Overall Study|Withdrawal by Subject|4|||
149093147|NCT04222088|537820260|FG001|Overall Study|Withdrawal by Subject|0|||
149093148|NCT00464737|537820262|FG000|Overall Study|Adverse Event|12|||
149093149|NCT00464737|537820263|FG001|Overall Study|Adverse Event|17|||
149093150|NCT00464737|537820264|FG002|Overall Study|Adverse Event|33|||
149093151|NCT00464737|537820262|FG000|Overall Study|Lack of Efficacy|7|||
149093152|NCT00464737|537820263|FG001|Overall Study|Lack of Efficacy|7|||
149093153|NCT00464737|537820264|FG002|Overall Study|Lack of Efficacy|4|||
149093154|NCT00464737|537820262|FG000|Overall Study|Withdrawal by Subject|5|||
149093155|NCT00464737|537820263|FG001|Overall Study|Withdrawal by Subject|3|||
149093156|NCT00464737|537820264|FG002|Overall Study|Withdrawal by Subject|5|||
149093157|NCT00464737|537820262|FG000|Overall Study|Protocol Violation|1|||
149093158|NCT00464737|537820263|FG001|Overall Study|Protocol Violation|1|||
149093159|NCT00464737|537820264|FG002|Overall Study|Protocol Violation|5|||
149093160|NCT00464737|537820262|FG000|Overall Study|Non-compliance|0|||
149093161|NCT00464737|537820263|FG001|Overall Study|Non-compliance|1|||
149093162|NCT00464737|537820264|FG002|Overall Study|Non-compliance|1|||
149093163|NCT00464737|537820262|FG000|Overall Study|Lost to Follow-up|5|||
149093164|NCT00464737|537820263|FG001|Overall Study|Lost to Follow-up|2|||
149093165|NCT00464737|537820264|FG002|Overall Study|Lost to Follow-up|5|||
149093166|NCT00464737|537820262|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
149093167|NCT00464737|537820263|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
149093168|NCT00464737|537820264|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
149093169|NCT00464737|537820262|FG000|Overall Study|Other: Subject left town; family illness|1|||
149093170|NCT00464737|537820263|FG001|Overall Study|Other: Subject left town; family illness|0|||
149093171|NCT00464737|537820264|FG002|Overall Study|Other: Subject left town; family illness|0|||
149093172|NCT00464737|537820262|FG000|Overall Study|Other: Study demands too great|0|||
149093173|NCT00464737|537820263|FG001|Overall Study|Other: Study demands too great|1|||
149093174|NCT00464737|537820264|FG002|Overall Study|Other: Study demands too great|0|||
149093175|NCT00464737|537820262|FG000|Overall Study|Other: Personal family reasons|0|||
149093176|NCT00464737|537820263|FG001|Overall Study|Other: Personal family reasons|0|||
149093177|NCT00464737|537820264|FG002|Overall Study|Other: Personal family reasons|1|||
149093178|NCT00464737|537820262|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
149093179|NCT00464737|537820263|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
149093180|NCT00464737|537820264|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
149093181|NCT01544153|537820265|FG000|Overall Study|Under 18|0|||
149093182|NCT01544153|537820266|FG001|Overall Study|Under 18|1|||
149093183|NCT01544153|537820267|FG002|Overall Study|Under 18|0|||
149093184|NCT01544153|537820268|FG003|Overall Study|Under 18|0|||
149093185|NCT01544153|537820265|FG000|Overall Study|Non-smoker|0|||
149093186|NCT01544153|537820266|FG001|Overall Study|Non-smoker|0|||
149093187|NCT01544153|537820267|FG002|Overall Study|Non-smoker|1|||
149093188|NCT01544153|537820268|FG003|Overall Study|Non-smoker|0|||
149093189|NCT00390806|537820273|FG000|Overall Study|Lost to Follow-up|7|||
149093190|NCT00390806|537820274|FG001|Overall Study|Lost to Follow-up|6|||
149093191|NCT00390806|537820273|FG000|Overall Study|Protocol Violation|2|||
149093192|NCT00390806|537820274|FG001|Overall Study|Protocol Violation|2|||
149093193|NCT00390806|537820273|FG000|Overall Study|Withdrawal by Subject|12|||
149093194|NCT00390806|537820274|FG001|Overall Study|Withdrawal by Subject|15|||
149093195|NCT00390806|537820273|FG000|Overall Study|Investigator Decision|4|||
149093196|NCT00390806|537820274|FG001|Overall Study|Investigator Decision|6|||
149093197|NCT00390806|537820273|FG000|Overall Study|Death|1|||
149093198|NCT00390806|537820274|FG001|Overall Study|Death|0|||
149093199|NCT00390806|537820273|FG000|Overall Study|Physician Decision|0|||
149093200|NCT00390806|537820274|FG001|Overall Study|Physician Decision|1|||
149093201|NCT00390806|537820273|FG000|Overall Study|Ongoing|4|||
149093202|NCT00390806|537820274|FG001|Overall Study|Ongoing|2|||
149093203|NCT03169530|537820277|FG000|Overall Study|Study ended by NIH|15|||
149093204|NCT03169530|537820278|FG001|Overall Study|Study ended by NIH|17|||
149093205|NCT01032200|537820279|FG000|Overall Study|Death|1|||
149093206|NCT01032200|537820280|FG001|Overall Study|Death|1|||
149093207|NCT01032200|537820279|FG000|Overall Study|Withdrawal by Subject|1|||
149093208|NCT01032200|537820280|FG001|Overall Study|Withdrawal by Subject|3|||
149093209|NCT01032200|537820279|FG000|Overall Study|Toxicity|0|||
149093210|NCT01032200|537820280|FG001|Overall Study|Toxicity|2|||
149093211|NCT01032200|537820279|FG000|Overall Study|Progression|1|||
149093212|NCT01032200|537820280|FG001|Overall Study|Progression|0|||
149093213|NCT01032200|537820279|FG000|Overall Study|Multiple|1|||
149093214|NCT01032200|537820280|FG001|Overall Study|Multiple|1|||
149093215|NCT00727259|537820284|FG000|Overall Study|Not all questionnaires completed|1055|||
149093216|NCT01021683|537820285|FG000|Overall Study|Lack of Efficacy|12|||
149093217|NCT01021683|537820285|FG000|Overall Study|Recovery of neutrophil count|51|||
149093218|NCT01021683|537820285|FG000|Overall Study|Other|8|||
149093219|NCT01804140|537820287|FG000|Overall Study|No sampling or biopsy procedures done|114|||
149093220|NCT00547300|537820288|FG000|Overall Study|Study was Administratively Terminated|25|||
149093221|NCT00547300|537820289|FG001|Overall Study|Study was Administratively Terminated|24|||
149093222|NCT00547300|537820288|FG000|Overall Study|Did not Meet Entry Criteria|0|||
149093223|NCT00547300|537820289|FG001|Overall Study|Did not Meet Entry Criteria|2|||
149093224|NCT04130061|537820292|FG000|Overall Study|OR team forgot to request membrane|1|||
149093225|NCT04130061|537820293|FG001|Overall Study|OR team forgot to request membrane|0|||
149119396|NCT01290315|537916301|FG000|Overall Study|Selection criteria/compliance|2|||
149119397|NCT01290315|537916302|FG001|Overall Study|Selection criteria/compliance|1|||
149119398|NCT01290315|537916303|FG002|Overall Study|Selection criteria/compliance|0|||
149119399|NCT01290315|537916304|FG003|Overall Study|Selection criteria/compliance|2|||
149119400|NCT01290315|537916301|FG000|Overall Study|Lost to Follow-up|0|||
149119401|NCT01290315|537916302|FG001|Overall Study|Lost to Follow-up|1|||
149119402|NCT01290315|537916303|FG002|Overall Study|Lost to Follow-up|0|||
149119403|NCT01290315|537916304|FG003|Overall Study|Lost to Follow-up|0|||
149119404|NCT01290315|537916301|FG000|Overall Study|Withdrawal by Subject|1|||
149119405|NCT01290315|537916302|FG001|Overall Study|Withdrawal by Subject|1|||
149119406|NCT01290315|537916303|FG002|Overall Study|Withdrawal by Subject|0|||
149119407|NCT01290315|537916304|FG003|Overall Study|Withdrawal by Subject|0|||
149119408|NCT03725085|537916309|FG000|Overall Study|Lost to Follow-up|2|||
149119409|NCT02704754|537916310|FG000|Overall Study|Lost to Follow-up|1|||
149119410|NCT02704754|537916311|FG001|Overall Study|Lost to Follow-up|1|||
149119411|NCT02704754|537916310|FG000|Overall Study|Lack of Efficacy|1|||
149119412|NCT02704754|537916311|FG001|Overall Study|Lack of Efficacy|0|||
149119413|NCT02704754|537916310|FG000|Overall Study|Withdrawal by Subject|1|||
149119414|NCT02704754|537916311|FG001|Overall Study|Withdrawal by Subject|0|||
149119415|NCT00423943|537916312|FG000|Overall Study|Withdrawal by Subject|3|||
149119416|NCT00423943|537916313|FG001|Overall Study|Withdrawal by Subject|1|||
149119417|NCT02134977|537916314|FG000|Overall Study|Protocol Deviation|102|||
149119418|NCT00901186|537916321|FG000|Overall Study|Lack of Efficacy|0|||
149119419|NCT00901186|537916322|FG001|Overall Study|Lack of Efficacy|1|||
149119420|NCT00901186|537916321|FG000|Overall Study|Abnormal laboratory values|0|||
149119421|NCT00901186|537916322|FG001|Overall Study|Abnormal laboratory values|1|||
149119422|NCT00901186|537916321|FG000|Overall Study|Lost to Follow-up|2|||
149119423|NCT00901186|537916322|FG001|Overall Study|Lost to Follow-up|0|||
149119424|NCT00901186|537916321|FG000|Overall Study|Adverse Event|2|||
149119425|NCT00901186|537916322|FG001|Overall Study|Adverse Event|4|||
149119426|NCT00901186|537916321|FG000|Overall Study|Administration problems|0|||
149119427|NCT00901186|537916322|FG001|Overall Study|Administration problems|1|||
149119428|NCT00901186|537916321|FG000|Overall Study|Protocol deviations|5|||
149119429|NCT00901186|537916322|FG001|Overall Study|Protocol deviations|4|||
149119430|NCT01658150|537916323|FG000|Overall Study|Withdrawal by Subject|1|||
149119431|NCT04187989|537916324|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
149119432|NCT04187989|537916325|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
149119433|NCT04187989|537916324|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
149119434|NCT04187989|537916325|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
149119435|NCT03646656|537916326|FG000|Overall Study|Lost to Follow-up|1|||
149119436|NCT03646656|537916327|FG001|Overall Study|Lost to Follow-up|0|||
149119437|NCT03646656|537916326|FG000|Overall Study|Withdrawal by Subject|2|||
149119438|NCT03646656|537916327|FG001|Overall Study|Withdrawal by Subject|0|||
149119439|NCT03602066|537916328|FG000|Overall Study|Withdrawal by Subject|2|||
149119440|NCT03602066|537916329|FG001|Overall Study|Withdrawal by Subject|0|||
149119441|NCT03602066|537916328|FG000|Overall Study|Physician Decision|1|||
149119442|NCT03602066|537916329|FG001|Overall Study|Physician Decision|0|||
149119443|NCT00446043|537916332|FG000|Overall Study|Adverse Event|9|||
149119444|NCT00446043|537916332|FG000|Overall Study|Withdrawal by Subject|70|||
149119445|NCT00446043|537916332|FG000|Overall Study|Protocol Violation|2|||
149119446|NCT00446043|537916332|FG000|Overall Study|Lost to Follow-up|42|||
149119447|NCT00446043|537916332|FG000|Overall Study|Pregnancy|2|||
149119448|NCT01879722|537916338|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
149119449|NCT01879722|537916339|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
149119450|NCT01879722|537916340|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
149119451|NCT01879722|537916341|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
149119452|NCT01879722|537916342|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
149119453|NCT01879722|537916343|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
149119454|NCT01879722|537916344|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
149119455|NCT01879722|537916345|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
149119456|NCT01879722|537916346|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
149119457|NCT01879722|537916347|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
149119458|NCT01879722|537916338|FG000|Overall Study|Voluntary Withdrawal|0|||
149119459|NCT01879722|537916339|FG001|Overall Study|Voluntary Withdrawal|0|||
149119460|NCT01879722|537916340|FG002|Overall Study|Voluntary Withdrawal|0|||
149119461|NCT01879722|537916341|FG003|Overall Study|Voluntary Withdrawal|0|||
149119462|NCT01879722|537916342|FG004|Overall Study|Voluntary Withdrawal|0|||
149119463|NCT01879722|537916343|FG005|Overall Study|Voluntary Withdrawal|0|||
149119464|NCT01879722|537916344|FG006|Overall Study|Voluntary Withdrawal|0|||
149119465|NCT01879722|537916345|FG007|Overall Study|Voluntary Withdrawal|0|||
149119466|NCT01879722|537916346|FG008|Overall Study|Voluntary Withdrawal|1|||
149119467|NCT01879722|537916347|FG009|Overall Study|Voluntary Withdrawal|0|||
149119468|NCT04988867|537916350|FG000|Overall Study|Study terminated by Sponsor|12|||
149093226|NCT01772147|537822399|FG000|Overall Study|Adverse Event|13|||
149093227|NCT01772147|537822400|FG001|Overall Study|Adverse Event|10|||
149093228|NCT01772147|537822401|FG002|Overall Study|Adverse Event|6|||
149093229|NCT01772147|537822399|FG000|Overall Study|Withdrew Consent|7|||
149093230|NCT01772147|537822400|FG001|Overall Study|Withdrew Consent|8|||
149093231|NCT01772147|537822401|FG002|Overall Study|Withdrew Consent|4|||
149093232|NCT01772147|537822399|FG000|Overall Study|Lost to Follow-up|1|||
149093233|NCT01772147|537822400|FG001|Overall Study|Lost to Follow-up|0|||
149093234|NCT01772147|537822401|FG002|Overall Study|Lost to Follow-up|1|||
149093235|NCT01772147|537822399|FG000|Overall Study|Protocol Deviation|2|||
149093236|NCT01772147|537822400|FG001|Overall Study|Protocol Deviation|1|||
149093237|NCT01772147|537822401|FG002|Overall Study|Protocol Deviation|1|||
149093238|NCT01772147|537822399|FG000|Overall Study|Lack of Efficacy|8|||
149093239|NCT01772147|537822400|FG001|Overall Study|Lack of Efficacy|6|||
149093240|NCT01772147|537822401|FG002|Overall Study|Lack of Efficacy|6|||
149093241|NCT04572997|537822406|FG000|Overall Study|Adverse Event|1|||
149093242|NCT01967719|537822407|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
149093243|NCT01967719|537822408|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
149093244|NCT01967719|537822409|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
149093245|NCT01967719|537822410|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
149093246|NCT01967719|537822407|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
149093247|NCT01967719|537822408|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
149093248|NCT01967719|537822409|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
149093249|NCT01967719|537822410|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
149093250|NCT00796614|537822420|FG000|Overall Study|Adverse Event|1|||
149093251|NCT00796614|537822421|FG001|Overall Study|Adverse Event|2|||
149093252|NCT00796614|537822422|FG002|Overall Study|Adverse Event|0|||
149093253|NCT00796614|537822423|FG003|Overall Study|Adverse Event|0|||
149093254|NCT00796614|537822420|FG000|Overall Study|Protocol Violation|0|||
149093255|NCT00796614|537822421|FG001|Overall Study|Protocol Violation|0|||
149093256|NCT00796614|537822422|FG002|Overall Study|Protocol Violation|2|||
149093257|NCT00796614|537822423|FG003|Overall Study|Protocol Violation|0|||
149093258|NCT00796614|537822420|FG000|Overall Study|Lost to Follow-up|2|||
149093259|NCT00796614|537822421|FG001|Overall Study|Lost to Follow-up|2|||
149093260|NCT00796614|537822422|FG002|Overall Study|Lost to Follow-up|1|||
149093261|NCT00796614|537822423|FG003|Overall Study|Lost to Follow-up|0|||
149093262|NCT00796614|537822420|FG000|Overall Study|Withdrawal by Subject|1|||
149093263|NCT00796614|537822421|FG001|Overall Study|Withdrawal by Subject|0|||
149093264|NCT00796614|537822422|FG002|Overall Study|Withdrawal by Subject|0|||
149093265|NCT00796614|537822423|FG003|Overall Study|Withdrawal by Subject|1|||
149093266|NCT00796614|537822420|FG000|Overall Study|Other than stated|1|||
149093267|NCT00796614|537822421|FG001|Overall Study|Other than stated|0|||
149093268|NCT00796614|537822422|FG002|Overall Study|Other than stated|0|||
149093269|NCT00796614|537822423|FG003|Overall Study|Other than stated|0|||
149093270|NCT00740597|537822424|FG000|Overall Study|insurance would not cover treatment|1|||
149093271|NCT00746785|537822426|FG000|Overall Study|Lost to Follow-up|29|||
149093272|NCT00746785|537822427|FG001|Overall Study|Lost to Follow-up|25|||
149093273|NCT00746785|537822428|FG002|Overall Study|Lost to Follow-up|27|||
149093274|NCT01231464|537822429|FG000|Overall Study|Adverse Event|0|||
149093275|NCT01231464|537822430|FG001|Overall Study|Adverse Event|1|||
149093276|NCT01231464|537822429|FG000|Overall Study|Protocol Violation|1|||
149093277|NCT01231464|537822430|FG001|Overall Study|Protocol Violation|2|||
149093278|NCT01231464|537822429|FG000|Overall Study|Lost to Follow-up|1|||
149093279|NCT01231464|537822430|FG001|Overall Study|Lost to Follow-up|2|||
149093280|NCT01231464|537822429|FG000|Overall Study|Withdrawal by Subject|3|||
149093281|NCT01231464|537822430|FG001|Overall Study|Withdrawal by Subject|2|||
149093282|NCT03449134|537822431|FG000|52-Week Treatment Period|Death|2|||
149093283|NCT03449134|537822432|FG001|52-Week Treatment Period|Death|1|||
149093284|NCT03449134|537822433|FG002|52-Week Treatment Period|Death|0|||
149093285|NCT03449134|537822431|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
149093286|NCT03449134|537822432|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
149093287|NCT03449134|537822433|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
149093288|NCT03449134|537822431|FG000|52-Week Treatment Period|Physician Decision|2|||
149093289|NCT03449134|537822432|FG001|52-Week Treatment Period|Physician Decision|3|||
149093290|NCT03449134|537822433|FG002|52-Week Treatment Period|Physician Decision|3|||
149093291|NCT03449134|537822431|FG000|52-Week Treatment Period|Screen Failure|1|||
149093292|NCT03449134|537822432|FG001|52-Week Treatment Period|Screen Failure|0|||
149093293|NCT03449134|537822433|FG002|52-Week Treatment Period|Screen Failure|1|||
149093294|NCT03449134|537822431|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
149093295|NCT03449134|537822432|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
149093296|NCT03449134|537822433|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
149093297|NCT03449134|537822431|FG000|52-Week Treatment Period|Site Closure|1|||
149093298|NCT03449134|537822432|FG001|52-Week Treatment Period|Site Closure|0|||
149093299|NCT03449134|537822433|FG002|52-Week Treatment Period|Site Closure|0|||
149093300|NCT00957996|537822439|FG000|Overall Study|Death|4|||
149093301|NCT00957996|537822440|FG001|Overall Study|Death|10|||
149093302|NCT00957996|537822439|FG000|Overall Study|Lost to Follow-up|4|||
149093303|NCT00957996|537822440|FG001|Overall Study|Lost to Follow-up|7|||
149093304|NCT00957996|537822439|FG000|Overall Study|Withdrawal by Subject|9|||
149093305|NCT00957996|537822440|FG001|Overall Study|Withdrawal by Subject|2|||
149093306|NCT00957996|537822439|FG000|Overall Study|Adverse Event|2|||
149093307|NCT00957996|537822440|FG001|Overall Study|Adverse Event|1|||
149093308|NCT00957996|537822439|FG000|Overall Study|Physician Decision|1|||
149093309|NCT00957996|537822440|FG001|Overall Study|Physician Decision|1|||
149093310|NCT00957996|537822439|FG000|Overall Study|Influenza-related complication|0|||
149093311|NCT00957996|537822440|FG001|Overall Study|Influenza-related complication|1|||
149093312|NCT00957996|537822439|FG000|Overall Study|Missing|1|||
149093313|NCT00957996|537822440|FG001|Overall Study|Missing|0|||
149093314|NCT00957996|537822439|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
149093315|NCT00957996|537822440|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
149093316|NCT01960348|537822446|FG000|Overall Study|Adverse event, not serious|2|||
149093317|NCT01960348|537822447|FG001|Overall Study|Adverse event, not serious|2|||
149093318|NCT01960348|537822446|FG000|Overall Study|Adverse event, serious fatal|6|||
149093319|NCT01960348|537822447|FG001|Overall Study|Adverse event, serious fatal|5|||
149093320|NCT01960348|537822446|FG000|Overall Study|Adverse event, serious non-fatal|0|||
149093321|NCT01960348|537822447|FG001|Overall Study|Adverse event, serious non-fatal|3|||
149093322|NCT01960348|537822446|FG000|Overall Study|Withdrawal by Subject|1|||
149093323|NCT01960348|537822447|FG001|Overall Study|Withdrawal by Subject|11|||
149093324|NCT01960348|537822446|FG000|Overall Study|Physician Decision|0|||
149093325|NCT01960348|537822447|FG001|Overall Study|Physician Decision|1|||
149093326|NCT01960348|537822446|FG000|Overall Study|Protocol Violation|1|||
149093327|NCT01960348|537822447|FG001|Overall Study|Protocol Violation|0|||
149093328|NCT01580995|537822448|FG000|Overall Study|Lost to Follow-up|2|||
149093329|NCT01580995|537822449|FG001|Overall Study|Lost to Follow-up|2|||
149093330|NCT01821729|537822450|FG000|Overall Study|Withdrawal by Subject|1|||
149093331|NCT02916706|537822451|FG000|Overall Study|Adverse Event|0|||
149093332|NCT02916706|537822452|FG001|Overall Study|Adverse Event|1|||
149093333|NCT02916706|537822451|FG000|Overall Study|Lost to Follow-up|0|||
149093334|NCT02916706|537822452|FG001|Overall Study|Lost to Follow-up|1|||
149093335|NCT02916706|537822451|FG000|Overall Study|Physician Decision|1|||
149093336|NCT02916706|537822452|FG001|Overall Study|Physician Decision|0|||
149093337|NCT02916706|537822451|FG000|Overall Study|Protocol Violation|3|||
149093338|NCT02916706|537822452|FG001|Overall Study|Protocol Violation|1|||
149093339|NCT02916706|537822451|FG000|Overall Study|Withdrawal by Subject|6|||
149093340|NCT02916706|537822452|FG001|Overall Study|Withdrawal by Subject|9|||
149093341|NCT02916706|537822451|FG000|Overall Study|Other|5|||
149093342|NCT02916706|537822452|FG001|Overall Study|Other|19|||
149093343|NCT00381797|537822458|FG000|Overall Study|Withdrawal by Subject|1|||
149093344|NCT00381797|537822459|FG001|Overall Study|Withdrawal by Subject|1|||
149093345|NCT00381797|537822460|FG002|Overall Study|Withdrawal by Subject|0|||
149093346|NCT00381797|537822461|FG003|Overall Study|Withdrawal by Subject|0|||
149093347|NCT00381797|537822462|FG004|Overall Study|Withdrawal by Subject|2|||
149093348|NCT00381797|537822458|FG000|Overall Study|Ineligible|0|||
149093349|NCT00381797|537822459|FG001|Overall Study|Ineligible|0|||
149093350|NCT00381797|537822460|FG002|Overall Study|Ineligible|0|||
149093351|NCT00381797|537822461|FG003|Overall Study|Ineligible|1|||
149093352|NCT00381797|537822462|FG004|Overall Study|Ineligible|0|||
149093353|NCT01902381|537822465|FG000|Overall Study|Withdrawal by Subject|1|||
149093354|NCT02762500|537822466|FG000|Overall Study|Lack of Efficacy|1|||
149093355|NCT02762500|537822467|FG001|Overall Study|Lack of Efficacy|0|||
149093356|NCT02762500|537822466|FG000|Overall Study|Withdrawal by Subject|1|||
149093357|NCT02762500|537822467|FG001|Overall Study|Withdrawal by Subject|1|||
149093358|NCT02762500|537822466|FG000|Overall Study|Adverse Event|0|||
149093359|NCT02762500|537822467|FG001|Overall Study|Adverse Event|2|||
149093360|NCT00329550|537822468|FG000|Overall Study|Adverse Event|3|||
149093361|NCT00329550|537822469|FG001|Overall Study|Adverse Event|4|||
149093362|NCT00329550|537822470|FG002|Overall Study|Adverse Event|2|||
149093363|NCT00329550|537822468|FG000|Overall Study|Withdrawal of Consent|1|||
149093364|NCT00329550|537822469|FG001|Overall Study|Withdrawal of Consent|0|||
149093365|NCT00329550|537822470|FG002|Overall Study|Withdrawal of Consent|1|||
149093366|NCT00329550|537822468|FG000|Overall Study|Due to Relocation|0|||
149093367|NCT00329550|537822469|FG001|Overall Study|Due to Relocation|0|||
149093368|NCT00329550|537822470|FG002|Overall Study|Due to Relocation|1|||
149093369|NCT00488319|537822471|FG000|Overall Study|Adverse Event|1|||
149093370|NCT00488319|537822472|FG001|Overall Study|Adverse Event|2|||
149093371|NCT00488319|537822473|FG002|Overall Study|Adverse Event|23|||
149093372|NCT00488319|537822471|FG000|Overall Study|Lack of Efficacy|6|||
149093373|NCT00488319|537822472|FG001|Overall Study|Lack of Efficacy|12|||
149093374|NCT00488319|537822473|FG002|Overall Study|Lack of Efficacy|27|||
149093375|NCT00488319|537822471|FG000|Overall Study|Lost to Follow-up|3|||
149093376|NCT00488319|537822472|FG001|Overall Study|Lost to Follow-up|5|||
149093377|NCT00488319|537822473|FG002|Overall Study|Lost to Follow-up|16|||
149093378|NCT00488319|537822471|FG000|Overall Study|Withdrawal by Subject|5|||
149093379|NCT00488319|537822472|FG001|Overall Study|Withdrawal by Subject|20|||
149093380|NCT00488319|537822473|FG002|Overall Study|Withdrawal by Subject|44|||
149093381|NCT00488319|537822471|FG000|Overall Study|Other reasons for withdrawal|0|||
149119469|NCT04988867|537916350|FG000|Overall Study|Adverse Event|2|||
149093382|NCT00488319|537822472|FG001|Overall Study|Other reasons for withdrawal|4|||
149093383|NCT00488319|537822473|FG002|Overall Study|Other reasons for withdrawal|12|||
149093384|NCT01011049|537822476|FG000|Overall Study|Protocol Violation|0|||
149093385|NCT01011049|537822477|FG001|Overall Study|Protocol Violation|0|||
149093386|NCT01011049|537822478|FG002|Overall Study|Protocol Violation|2|||
149093387|NCT01011049|537822479|FG003|Overall Study|Protocol Violation|0|||
149093388|NCT01011049|537822476|FG000|Overall Study|Lost to Follow-up|1|||
149093389|NCT01011049|537822477|FG001|Overall Study|Lost to Follow-up|2|||
149093390|NCT01011049|537822478|FG002|Overall Study|Lost to Follow-up|1|||
149093391|NCT01011049|537822479|FG003|Overall Study|Lost to Follow-up|0|||
149093392|NCT01011049|537822476|FG000|Overall Study|Withdrawal by Subject|0|||
149093393|NCT01011049|537822477|FG001|Overall Study|Withdrawal by Subject|0|||
149093394|NCT01011049|537822478|FG002|Overall Study|Withdrawal by Subject|1|||
149093395|NCT01011049|537822479|FG003|Overall Study|Withdrawal by Subject|0|||
149093396|NCT00352053|537822480|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
149093397|NCT00352053|537822481|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
149093398|NCT00352053|537822480|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
149093399|NCT00352053|537822481|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
149093400|NCT00352053|537822480|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
149093401|NCT00352053|537822481|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
149093402|NCT00352053|537822480|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
149093403|NCT00352053|537822481|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
149093404|NCT00352053|537822480|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
149093405|NCT00352053|537822481|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
149093406|NCT00352053|537822480|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
149093407|NCT00352053|537822481|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
149093408|NCT00352053|537822480|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
149093409|NCT00352053|537822481|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
149093410|NCT00352053|537822480|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
149093411|NCT00352053|537822481|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
149093412|NCT00352053|537822480|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
149093413|NCT00352053|537822481|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
149093414|NCT00352053|537822480|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
149093415|NCT00352053|537822481|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
149093416|NCT00352053|537822480|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
149093417|NCT00352053|537822481|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
149093418|NCT00352053|537822480|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
149093419|NCT00352053|537822481|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
149093420|NCT00352053|537822480|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
149093421|NCT00352053|537822481|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
149093422|NCT02435381|537822482|FG000|Overall Study|Lost to Follow-up|2|||
149093423|NCT02435381|537822483|FG001|Overall Study|Lost to Follow-up|1|||
149093424|NCT04150341|537822486|FG000|Overall Study|Physician Decision|0|||
149093425|NCT04150341|537822487|FG001|Overall Study|Physician Decision|0|||
149093426|NCT04150341|537822488|FG002|Overall Study|Physician Decision|1|||
149093427|NCT04150341|537822489|FG003|Overall Study|Physician Decision|0|||
149093428|NCT04150341|537822490|FG004|Overall Study|Physician Decision|0|||
149093429|NCT04150341|537822491|FG005|Overall Study|Physician Decision|0|||
149093430|NCT04150341|537822486|FG000|Overall Study|Adverse Event|0|||
149093431|NCT04150341|537822487|FG001|Overall Study|Adverse Event|0|||
149093432|NCT04150341|537822488|FG002|Overall Study|Adverse Event|0|||
149093433|NCT04150341|537822489|FG003|Overall Study|Adverse Event|0|||
149093434|NCT04150341|537822490|FG004|Overall Study|Adverse Event|1|||
149093435|NCT04150341|537822491|FG005|Overall Study|Adverse Event|0|||
149093436|NCT00833898|537822492|FG000|Overall Study|Withdrawal by Subject|33|||
149093437|NCT00833898|537822493|FG001|Overall Study|Withdrawal by Subject|27|||
149093438|NCT00833898|537822492|FG000|Overall Study|Lost to Follow-up|7|||
149093439|NCT00833898|537822493|FG001|Overall Study|Lost to Follow-up|7|||
149093440|NCT00833898|537822492|FG000|Overall Study|Patient did not receive transplant|0|||
149093441|NCT00833898|537822493|FG001|Overall Study|Patient did not receive transplant|2|||
149093442|NCT00666198|537822495|FG000|Overall Study|Protocol Violation|10|||
149093443|NCT00666198|537822495|FG000|Overall Study|No Visit After First Day of Treatment|13|||
149093444|NCT00666198|537822495|FG000|Overall Study|Safety Not Assessable|6|||
149093445|NCT00666198|537822495|FG000|Overall Study|No Drug Administration|4|||
149093446|NCT05153499|537822496|FG000|Overall Study|Withdrawal by Subject|1|||
149093447|NCT05153499|537822497|FG001|Overall Study|Withdrawal by Subject|0|||
149093448|NCT05153499|537822496|FG000|Overall Study|Clinical Hold|1|||
149093449|NCT05153499|537822497|FG001|Overall Study|Clinical Hold|0|||
149093450|NCT05153499|537822496|FG000|Overall Study|Study Termination|6|||
149093451|NCT05153499|537822497|FG001|Overall Study|Study Termination|5|||
149093452|NCT03226353|537822502|FG000|Overall Study|Withdrawal by Subject|1|||
149093453|NCT03226353|537822502|FG000|Overall Study|Screen Failure|5|||
149093454|NCT03441789|537822503|FG000|Overall Study|Withdrawal by Subject|1|||
149093455|NCT03441789|537822504|FG001|Overall Study|Withdrawal by Subject|1|||
149093456|NCT03441789|537822503|FG000|Overall Study|Adverse Event|0|||
149093457|NCT03441789|537822504|FG001|Overall Study|Adverse Event|1|||
149093458|NCT03441789|537822503|FG000|Overall Study|Protocol Violation|0|||
149093459|NCT03441789|537822504|FG001|Overall Study|Protocol Violation|1|||
149093460|NCT03441789|537822503|FG000|Overall Study|Lost to Follow-up|0|||
149093461|NCT03441789|537822504|FG001|Overall Study|Lost to Follow-up|1|||
149093462|NCT03168425|537822507|FG000|Overall Study|Lost to Follow-up|5|||
149093463|NCT03168425|537822508|FG001|Overall Study|Lost to Follow-up|8|||
149093464|NCT03168425|537822507|FG000|Overall Study|unable to confirm post op opioids|2|||
149093465|NCT03168425|537822508|FG001|Overall Study|unable to confirm post op opioids|3|||
149093466|NCT02166047|537822509|FG000|Overall Study|Withdrawal by Participant|0|||
149093467|NCT02166047|537822510|FG001|Overall Study|Withdrawal by Participant|1|||
149093468|NCT02166047|537822511|FG002|Overall Study|Withdrawal by Participant|2|||
149093469|NCT02166047|537822512|FG003|Overall Study|Withdrawal by Participant|0|||
149093470|NCT02166047|537822513|FG004|Overall Study|Withdrawal by Participant|0|||
149093471|NCT02166047|537822514|FG005|Overall Study|Withdrawal by Participant|0|||
149093472|NCT02166047|537822515|FG006|Overall Study|Withdrawal by Participant|1|||
149093473|NCT02166047|537822516|FG007|Overall Study|Withdrawal by Participant|0|||
149093474|NCT02166047|537822517|FG008|Overall Study|Withdrawal by Participant|0|||
149093475|NCT02166047|537822518|FG009|Overall Study|Withdrawal by Participant|0|||
149093476|NCT02166047|537822519|FG010|Overall Study|Withdrawal by Participant|0|||
149093477|NCT02166047|537822520|FG011|Overall Study|Withdrawal by Participant|0|||
149093478|NCT02166047|537822509|FG000|Overall Study|Adverse Event|0|||
149093479|NCT02166047|537822510|FG001|Overall Study|Adverse Event|0|||
149093480|NCT02166047|537822511|FG002|Overall Study|Adverse Event|0|||
149093481|NCT02166047|537822512|FG003|Overall Study|Adverse Event|0|||
149093482|NCT02166047|537822513|FG004|Overall Study|Adverse Event|1|||
149093483|NCT02166047|537822514|FG005|Overall Study|Adverse Event|0|||
149093484|NCT02166047|537822515|FG006|Overall Study|Adverse Event|1|||
149093485|NCT02166047|537822516|FG007|Overall Study|Adverse Event|0|||
149093486|NCT02166047|537822517|FG008|Overall Study|Adverse Event|0|||
149093487|NCT02166047|537822518|FG009|Overall Study|Adverse Event|0|||
149093488|NCT02166047|537822519|FG010|Overall Study|Adverse Event|2|||
149093489|NCT02166047|537822520|FG011|Overall Study|Adverse Event|0|||
149093490|NCT01960114|537822521|FG000|Overall Study|Adverse Event|1|||
149093491|NCT01960114|537822522|FG001|Overall Study|Adverse Event|0|||
149093492|NCT01960114|537822521|FG000|Overall Study|Could not swallow study medication|0|||
149093493|NCT01960114|537822522|FG001|Overall Study|Could not swallow study medication|1|||
149093494|NCT02845375|537822527|FG000|Overall Study|upper airway obstruction|1|||
149093495|NCT02845375|537822528|FG001|Overall Study|upper airway obstruction|2|||
149093496|NCT02845375|537822529|FG002|Overall Study|upper airway obstruction|1|||
149093497|NCT02959177|537822530|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
149093498|NCT02959177|537822531|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
149093499|NCT02959177|537822532|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
149093500|NCT02959177|537822530|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
149093501|NCT02959177|537822531|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
149093502|NCT02959177|537822532|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
149093503|NCT02959177|537822530|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
149093504|NCT02959177|537822531|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
149093505|NCT02959177|537822532|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
149093506|NCT02959177|537822530|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
149093507|NCT02959177|537822531|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
149093508|NCT02959177|537822532|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
149093509|NCT02959177|537822530|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
149093510|NCT02959177|537822531|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
149093511|NCT02959177|537822532|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
149093512|NCT02959177|537822530|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
149093513|NCT02959177|537822531|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
149093514|NCT02959177|537822532|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
149093515|NCT02959177|537822530|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
149093516|NCT02959177|537822531|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
149093517|NCT02959177|537822532|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
149093518|NCT02215954|537822534|FG000|Overall Study|Adverse Event|0|||
149093519|NCT02215954|537822535|FG001|Overall Study|Adverse Event|0|||
149093520|NCT02215954|537822536|FG002|Overall Study|Adverse Event|1|||
149093521|NCT02215954|537822534|FG000|Overall Study|Withdrawal by Subject|0|||
149093522|NCT02215954|537822535|FG001|Overall Study|Withdrawal by Subject|0|||
149093523|NCT02215954|537822536|FG002|Overall Study|Withdrawal by Subject|2|||
149093524|NCT02215954|537822534|FG000|Overall Study|Not exposed|1|||
149093525|NCT02215954|537822535|FG001|Overall Study|Not exposed|1|||
149093526|NCT02215954|537822536|FG002|Overall Study|Not exposed|3|||
149093527|NCT01287416|537822537|FG000|Pre-post Training|Withdrawal by Subject|17|||
149093528|NCT01287416|537822538|FG001|Pre-post Training|Withdrawal by Subject|24|||
149093529|NCT01287416|537822537|FG000|Pre-post Training|Lost to Follow-up|5|||
149093530|NCT01287416|537822538|FG001|Pre-post Training|Lost to Follow-up|1|||
149093531|NCT01287416|537822537|FG000|6 Month Follow-up|Lost to Follow-up|3|||
149093532|NCT01287416|537822538|FG001|6 Month Follow-up|Lost to Follow-up|2|||
149093533|NCT00853021|537822540|FG000|Overall Study|Adverse Event|2|||
149093534|NCT00853021|537822540|FG000|Overall Study|Withdrawal by Subject|2|||
149093535|NCT00853021|537822540|FG000|Overall Study|Death|1|||
149093536|NCT00580047|537822547|FG000|Overall Study|Lost to Follow-up|1|||
149093537|NCT00580047|537822548|FG001|Overall Study|Lost to Follow-up|1|||
149093538|NCT00580047|537822549|FG002|Overall Study|Lost to Follow-up|0|||
149093539|NCT00580047|537822547|FG000|Overall Study|Withdrawal by Subject|1|||
149093540|NCT00580047|537822548|FG001|Overall Study|Withdrawal by Subject|1|||
149093541|NCT00580047|537822549|FG002|Overall Study|Withdrawal by Subject|2|||
149093542|NCT00580047|537822547|FG000|Overall Study|Withdrawal by Subject|1|||
149093543|NCT00580047|537822548|FG001|Overall Study|Withdrawal by Subject|0|||
149093544|NCT00580047|537822549|FG002|Overall Study|Withdrawal by Subject|0|||
149093545|NCT02820298|537822552|FG000|Overall Study|Withdrawal by Subject|0|||
149093546|NCT02820298|537822553|FG001|Overall Study|Withdrawal by Subject|1|||
149093547|NCT02820298|537822552|FG000|Overall Study|Physician Decision|1|||
149093548|NCT02820298|537822553|FG001|Overall Study|Physician Decision|0|||
149093549|NCT02820298|537822552|FG000|Overall Study|Protocol Violation|0|||
149093550|NCT02820298|537822553|FG001|Overall Study|Protocol Violation|1|||
149093551|NCT01064856|537822554|FG000|Double-blind (DB) Period|Adverse Event|1|||
149093552|NCT01064856|537822555|FG001|Double-blind (DB) Period|Adverse Event|0|||
149093553|NCT01064856|537822556|FG002|Double-blind (DB) Period|Adverse Event|0|||
149093554|NCT01064856|537822557|FG003|Double-blind (DB) Period|Adverse Event|0|||
149093555|NCT01064856|537822554|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
149093556|NCT01064856|537822555|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
149093557|NCT01064856|537822556|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
149093558|NCT01064856|537822557|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
149093559|NCT01064856|537822554|FG000|Open-label (OL) Period|Adverse Event|0|||
149093560|NCT01064856|537822555|FG001|Open-label (OL) Period|Adverse Event|0|||
149093561|NCT01064856|537822556|FG002|Open-label (OL) Period|Adverse Event|12|||
149093562|NCT01064856|537822557|FG003|Open-label (OL) Period|Adverse Event|6|||
149093563|NCT01064856|537822554|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
149093564|NCT01064856|537822555|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
149093565|NCT01064856|537822556|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
149093566|NCT01064856|537822557|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
149093567|NCT01064856|537822554|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
149093568|NCT01064856|537822555|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
149093569|NCT01064856|537822556|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
149093570|NCT01064856|537822557|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
149093571|NCT01064856|537822554|FG000|Open-label (OL) Period|Other|0|||
149093572|NCT01064856|537822555|FG001|Open-label (OL) Period|Other|0|||
149093573|NCT01064856|537822556|FG002|Open-label (OL) Period|Other|7|||
149093574|NCT01064856|537822557|FG003|Open-label (OL) Period|Other|7|||
149093575|NCT01894256|537822558|FG000|Part A|Adverse Event|0|||
149093576|NCT01894256|537822559|FG001|Part A|Adverse Event|1|||
149093577|NCT01894256|537822560|FG002|Part A|Adverse Event|0|||
149093578|NCT01894256|537822558|FG000|Part B|Death|0|||
149093579|NCT01894256|537822559|FG001|Part B|Death|1|||
149093580|NCT01894256|537822560|FG002|Part B|Death|1|||
149093581|NCT01894256|537822558|FG000|Part B|Withdrawal by Subject|0|||
149093582|NCT01894256|537822559|FG001|Part B|Withdrawal by Subject|1|||
149093583|NCT01894256|537822560|FG002|Part B|Withdrawal by Subject|0|||
149093584|NCT01894256|537822558|FG000|Part B|Lack of Efficacy|15|||
149093585|NCT01894256|537822559|FG001|Part B|Lack of Efficacy|12|||
149093586|NCT01894256|537822560|FG002|Part B|Lack of Efficacy|13|||
149093587|NCT01780584|537822561|FG000|Overall Study|Death|1|||
149093588|NCT01780584|537822562|FG001|Overall Study|Death|0|||
149093589|NCT01780584|537822563|FG002|Overall Study|Death|1|||
149093590|NCT01780584|537822561|FG000|Overall Study|Adverse Event|0|||
149093591|NCT01780584|537822562|FG001|Overall Study|Adverse Event|1|||
149093592|NCT01780584|537822563|FG002|Overall Study|Adverse Event|0|||
149093593|NCT01780584|537822561|FG000|Overall Study|Protocol Violation|0|||
149093594|NCT01780584|537822562|FG001|Overall Study|Protocol Violation|0|||
149093595|NCT01780584|537822563|FG002|Overall Study|Protocol Violation|1|||
149093596|NCT00141271|537822566|FG000|Overall Study|Adverse Event|31|||
149093597|NCT00141271|537822567|FG001|Overall Study|Adverse Event|19|||
149093598|NCT00141271|537822568|FG002|Overall Study|Adverse Event|17|||
149093599|NCT00141271|537822566|FG000|Overall Study|Laboratory Abnormality|2|||
149093600|NCT00141271|537822567|FG001|Overall Study|Laboratory Abnormality|1|||
149093601|NCT00141271|537822568|FG002|Overall Study|Laboratory Abnormality|1|||
149093602|NCT00141271|537822566|FG000|Overall Study|Lack of Efficacy|7|||
149093603|NCT00141271|537822567|FG001|Overall Study|Lack of Efficacy|7|||
149093604|NCT00141271|537822568|FG002|Overall Study|Lack of Efficacy|3|||
149093605|NCT00141271|537822566|FG000|Overall Study|Lost to Follow-up|15|||
149093606|NCT00141271|537822567|FG001|Overall Study|Lost to Follow-up|15|||
149093607|NCT00141271|537822568|FG002|Overall Study|Lost to Follow-up|21|||
149093608|NCT00141271|537822566|FG000|Overall Study|Withdrawal by Subject|14|||
149093609|NCT00141271|537822567|FG001|Overall Study|Withdrawal by Subject|9|||
149093610|NCT00141271|537822568|FG002|Overall Study|Withdrawal by Subject|10|||
149093611|NCT00141271|537822566|FG000|Overall Study|Other|11|||
149093612|NCT00141271|537822567|FG001|Overall Study|Other|12|||
149093613|NCT00141271|537822568|FG002|Overall Study|Other|5|||
149093614|NCT02133131|537822569|FG000|Overall Study|Adverse Event|0|||
149093615|NCT02133131|537822570|FG001|Overall Study|Adverse Event|0|||
149093616|NCT02133131|537822571|FG002|Overall Study|Adverse Event|0|||
149093617|NCT02133131|537822572|FG003|Overall Study|Adverse Event|1|||
149093618|NCT02133131|537822573|FG004|Overall Study|Adverse Event|0|||
149093619|NCT02133131|537822574|FG005|Overall Study|Adverse Event|0|||
149093620|NCT02133131|537822575|FG006|Overall Study|Adverse Event|0|||
149093621|NCT02133131|537822569|FG000|Overall Study|Lost to Follow-up|1|||
149093622|NCT02133131|537822570|FG001|Overall Study|Lost to Follow-up|0|||
149093623|NCT02133131|537822571|FG002|Overall Study|Lost to Follow-up|0|||
149093624|NCT02133131|537822572|FG003|Overall Study|Lost to Follow-up|1|||
149093625|NCT02133131|537822573|FG004|Overall Study|Lost to Follow-up|0|||
149093626|NCT02133131|537822574|FG005|Overall Study|Lost to Follow-up|0|||
149093627|NCT02133131|537822575|FG006|Overall Study|Lost to Follow-up|0|||
149093628|NCT02133131|537822569|FG000|Overall Study|Status not recorded|4|||
149093629|NCT02133131|537822570|FG001|Overall Study|Status not recorded|5|||
149093630|NCT02133131|537822571|FG002|Overall Study|Status not recorded|1|||
149093631|NCT02133131|537822572|FG003|Overall Study|Status not recorded|4|||
149093632|NCT02133131|537822573|FG004|Overall Study|Status not recorded|0|||
149093633|NCT02133131|537822574|FG005|Overall Study|Status not recorded|0|||
149093634|NCT02133131|537822575|FG006|Overall Study|Status not recorded|0|||
149093635|NCT02133131|537822569|FG000|Overall Study|Ongoing in study|0|||
149093636|NCT02133131|537822570|FG001|Overall Study|Ongoing in study|0|||
149093637|NCT02133131|537822571|FG002|Overall Study|Ongoing in study|0|||
149093638|NCT02133131|537822572|FG003|Overall Study|Ongoing in study|0|||
149093639|NCT02133131|537822573|FG004|Overall Study|Ongoing in study|15|||
149093640|NCT02133131|537822574|FG005|Overall Study|Ongoing in study|14|||
149093641|NCT02133131|537822575|FG006|Overall Study|Ongoing in study|11|||
149093642|NCT02133131|537822569|FG000|Overall Study|Protocol Violation|0|||
149093643|NCT02133131|537822570|FG001|Overall Study|Protocol Violation|0|||
149093644|NCT02133131|537822571|FG002|Overall Study|Protocol Violation|0|||
149093645|NCT02133131|537822572|FG003|Overall Study|Protocol Violation|0|||
149093646|NCT02133131|537822573|FG004|Overall Study|Protocol Violation|0|||
149093647|NCT02133131|537822574|FG005|Overall Study|Protocol Violation|0|||
149093648|NCT02133131|537822575|FG006|Overall Study|Protocol Violation|1|||
149093649|NCT04783519|537822576|FG000|Overall Study|Withdrawal by Subject|2|||
149093650|NCT04783519|537822577|FG001|Overall Study|Withdrawal by Subject|7|||
149093651|NCT04783519|537822578|FG002|Overall Study|Withdrawal by Subject|3|||
149093652|NCT04783519|537822576|FG000|Overall Study|Lost to Follow-up|9|||
149093653|NCT04783519|537822577|FG001|Overall Study|Lost to Follow-up|7|||
149093654|NCT04783519|537822578|FG002|Overall Study|Lost to Follow-up|6|||
149093655|NCT00645099|537822579|FG000|Overall Study|Lack of Efficacy|15|||
149093656|NCT00645099|537822580|FG001|Overall Study|Lack of Efficacy|6|||
149093657|NCT00645099|537822579|FG000|Overall Study|Withdrawal by Subject|30|||
149093658|NCT00645099|537822580|FG001|Overall Study|Withdrawal by Subject|22|||
149093659|NCT00645099|537822579|FG000|Overall Study|Lost to Follow-up|6|||
149093660|NCT00645099|537822580|FG001|Overall Study|Lost to Follow-up|4|||
149093661|NCT00645099|537822579|FG000|Overall Study|Adverse Event|11|||
149093662|NCT00645099|537822580|FG001|Overall Study|Adverse Event|5|||
149093663|NCT00645099|537822579|FG000|Overall Study|Other|9|||
149093664|NCT00645099|537822580|FG001|Overall Study|Other|5|||
149093665|NCT01201915|537822581|FG000|Overall Study|Adverse Event|2|||
149093666|NCT01201915|537822582|FG001|Overall Study|Adverse Event|1|||
149093667|NCT01201915|537822583|FG002|Overall Study|Adverse Event|1|||
149093668|NCT01201915|537822581|FG000|Overall Study|Lost to Follow-up|0|||
149093669|NCT01201915|537822582|FG001|Overall Study|Lost to Follow-up|4|||
149093670|NCT01201915|537822583|FG002|Overall Study|Lost to Follow-up|0|||
149093671|NCT01201915|537822581|FG000|Overall Study|Physician Decision|3|||
149093672|NCT01201915|537822582|FG001|Overall Study|Physician Decision|0|||
149093673|NCT01201915|537822583|FG002|Overall Study|Physician Decision|0|||
149093674|NCT01201915|537822581|FG000|Overall Study|Subject Decision|3|||
149093675|NCT01201915|537822582|FG001|Overall Study|Subject Decision|3|||
149093676|NCT01201915|537822583|FG002|Overall Study|Subject Decision|5|||
149093677|NCT01201915|537822581|FG000|Overall Study|Target Lesion Progression|0|||
149093678|NCT01201915|537822582|FG001|Overall Study|Target Lesion Progression|3|||
149093679|NCT01201915|537822583|FG002|Overall Study|Target Lesion Progression|0|||
149093680|NCT03406507|537822584|FG000|Extension Period|Lack of Efficacy|0|||
149093681|NCT03406507|537822585|FG001|Extension Period|Lack of Efficacy|1|||
149093682|NCT02316171|537822586|FG000|Overall Study|difficulties with urinary catheter|1|||
149093683|NCT02316171|537822587|FG001|Overall Study|difficulties with urinary catheter|0|||
149093684|NCT02316171|537822588|FG002|Overall Study|difficulties with urinary catheter|0|||
149093685|NCT02316171|537822589|FG003|Overall Study|difficulties with urinary catheter|0|||
149093686|NCT04435522|537822590|FG000|Overall Study|Withdrawal by Subject|2|||
149093687|NCT00719212|537824205|FG000|Overall Study|Death|41|||
149093688|NCT00719212|537824205|FG000|Overall Study|Lost to Follow-up|2|||
149093689|NCT00719212|537824205|FG000|Overall Study|Withdrawal by Subject|1|||
149093690|NCT00837096|537824206|FG000|Overall Study|Physician Decision|1|||
149093691|NCT00837096|537824207|FG001|Overall Study|Physician Decision|1|||
149093692|NCT00837096|537824206|FG000|Overall Study|Not reported|9|||
149093693|NCT00837096|537824207|FG001|Overall Study|Not reported|8|||
149093694|NCT00494026|537824208|FG000|Overall Study|Sponsor Decision|4|||
149093695|NCT02466243|537824209|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
149093696|NCT02466243|537824210|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
149093697|NCT02466243|537824209|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
149093698|NCT02466243|537824210|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
149093699|NCT02466243|537824209|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
149093700|NCT02466243|537824210|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
149093701|NCT02466243|537824209|FG000|Part B Open-label Treatment Period|Missing|2|||
149093702|NCT02466243|537824210|FG001|Part B Open-label Treatment Period|Missing|2|||
149093703|NCT00875615|537824211|FG000|Overall Study|Withdrawal by Subject|1|||
149093704|NCT00405912|537824213|FG000|Overall Study|Withdrawal by Subject|12|||
149093705|NCT00405912|537824214|FG001|Overall Study|Withdrawal by Subject|11|||
149093706|NCT00405912|537824215|FG002|Overall Study|Withdrawal by Subject|12|||
149093707|NCT00405912|537824213|FG000|Overall Study|Lost to Follow-up|4|||
149093708|NCT00405912|537824214|FG001|Overall Study|Lost to Follow-up|8|||
149093709|NCT00405912|537824215|FG002|Overall Study|Lost to Follow-up|4|||
149093710|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
149093711|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
149093712|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
149093713|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
149093714|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
149093715|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
149093716|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
149093717|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
149093718|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Death|6|||
149093719|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Death|2|||
149093720|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Death|2|||
149093721|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Death|9|||
149093722|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
149093723|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
149093724|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
149093725|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
149093726|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
149093727|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
149093728|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
149093729|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
149093730|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
149093731|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
149093732|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
149093733|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
149093734|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
149093735|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
149093736|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
149093737|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
149093738|NCT03730662|537824221|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
149093739|NCT03730662|537824222|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
149093740|NCT03730662|537824223|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
149093741|NCT03730662|537824224|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
149093742|NCT03730662|537824221|FG000|Variable Treatment Period|Adverse Event|1|||
149093743|NCT03730662|537824222|FG001|Variable Treatment Period|Adverse Event|2|||
149093744|NCT03730662|537824223|FG002|Variable Treatment Period|Adverse Event|0|||
149093745|NCT03730662|537824224|FG003|Variable Treatment Period|Adverse Event|7|||
149093746|NCT03730662|537824221|FG000|Variable Treatment Period|Death|9|||
149093747|NCT03730662|537824222|FG001|Variable Treatment Period|Death|0|||
149093748|NCT03730662|537824223|FG002|Variable Treatment Period|Death|6|||
149093749|NCT03730662|537824224|FG003|Variable Treatment Period|Death|26|||
149093750|NCT03730662|537824221|FG000|Variable Treatment Period|Lost to Follow-up|2|||
149093751|NCT03730662|537824222|FG001|Variable Treatment Period|Lost to Follow-up|1|||
149093752|NCT03730662|537824223|FG002|Variable Treatment Period|Lost to Follow-up|4|||
149093753|NCT03730662|537824224|FG003|Variable Treatment Period|Lost to Follow-up|11|||
149093754|NCT03730662|537824221|FG000|Variable Treatment Period|Personal Reason|0|||
149093755|NCT03730662|537824222|FG001|Variable Treatment Period|Personal Reason|2|||
149093756|NCT03730662|537824223|FG002|Variable Treatment Period|Personal Reason|1|||
149093757|NCT03730662|537824224|FG003|Variable Treatment Period|Personal Reason|6|||
149093758|NCT03730662|537824221|FG000|Variable Treatment Period|Physician Decision|0|||
149093759|NCT03730662|537824222|FG001|Variable Treatment Period|Physician Decision|0|||
149093760|NCT03730662|537824223|FG002|Variable Treatment Period|Physician Decision|0|||
149093761|NCT03730662|537824224|FG003|Variable Treatment Period|Physician Decision|3|||
149093762|NCT03730662|537824221|FG000|Variable Treatment Period|Protocol Violation|0|||
149093763|NCT03730662|537824222|FG001|Variable Treatment Period|Protocol Violation|1|||
149093764|NCT03730662|537824223|FG002|Variable Treatment Period|Protocol Violation|1|||
149093765|NCT03730662|537824224|FG003|Variable Treatment Period|Protocol Violation|1|||
149093766|NCT03730662|537824221|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
149093767|NCT03730662|537824222|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
149093768|NCT03730662|537824223|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
149093769|NCT03730662|537824224|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
149093770|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
149093771|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
149093772|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
149093773|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
149093774|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Death|0|||
149093775|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Death|1|||
149093776|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
149093777|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
149093778|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
149093779|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
149093780|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
149093781|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
149093782|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
149093783|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
149093784|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
149093785|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
149093786|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
149093787|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
149093788|NCT01309243|537824225|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
149093789|NCT01309243|537824226|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
149093790|NCT01309243|537824225|FG000|Extension Phase|Lost to Follow-up|6|||
149093791|NCT01309243|537824226|FG001|Extension Phase|Lost to Follow-up|0|||
149093792|NCT00632931|537824227|FG000|Part 1, Period 1|Protocol Violation|1|||
149093793|NCT00632931|537824228|FG001|Part 1, Period 1|Protocol Violation|0|||
149093794|NCT00632931|537824229|FG002|Part 1, Period 1|Protocol Violation|0|||
149093795|NCT00632931|537824227|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
149093796|NCT00632931|537824228|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
149093797|NCT00632931|537824229|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
149093798|NCT00632931|537824227|FG000|Part 2|Adverse Event|0|||
149093799|NCT00632931|537824228|FG001|Part 2|Adverse Event|0|||
149093800|NCT00632931|537824229|FG002|Part 2|Adverse Event|3|||
149093801|NCT00632931|537824227|FG000|Part 2|Death|0|||
149093802|NCT00632931|537824228|FG001|Part 2|Death|0|||
149093803|NCT00632931|537824229|FG002|Part 2|Death|1|||
149093804|NCT00632931|537824227|FG000|Part 2|Lack of Efficacy|0|||
149093805|NCT00632931|537824228|FG001|Part 2|Lack of Efficacy|0|||
149093806|NCT00632931|537824229|FG002|Part 2|Lack of Efficacy|17|||
149093807|NCT00632931|537824227|FG000|Part 2|Withdrawal by Subject|0|||
149093808|NCT00632931|537824228|FG001|Part 2|Withdrawal by Subject|0|||
149093809|NCT00632931|537824229|FG002|Part 2|Withdrawal by Subject|3|||
149093810|NCT01402063|537824232|FG000|Overall Study|Withdrawal by Subject|3|||
149093811|NCT01402063|537824233|FG001|Overall Study|Withdrawal by Subject|3|||
149093812|NCT03712449|537824236|FG000|Overall Study|Withdraw Consent|0|||
149093813|NCT03712449|537824237|FG001|Overall Study|Withdraw Consent|1|||
149093814|NCT04491006|537824241|FG000|Overall Study|Adverse Event|0|||
149093815|NCT04491006|537824242|FG001|Overall Study|Adverse Event|3|||
149093816|NCT04491006|537824243|FG002|Overall Study|Adverse Event|5|||
149093817|NCT04491006|537824241|FG000|Overall Study|Withdrawal by Subject|1|||
149093818|NCT04491006|537824242|FG001|Overall Study|Withdrawal by Subject|0|||
149093819|NCT04491006|537824243|FG002|Overall Study|Withdrawal by Subject|2|||
149093820|NCT00451555|537824250|FG000|Overall Study|Protocol Violation|2|||
149093821|NCT00451555|537824251|FG001|Overall Study|Protocol Violation|2|||
149093822|NCT00451555|537824250|FG000|Overall Study|Adverse Event|3|||
149093823|NCT00451555|537824251|FG001|Overall Study|Adverse Event|1|||
149093824|NCT00451555|537824250|FG000|Overall Study|Withdrawal by Subject|6|||
149093825|NCT00451555|537824251|FG001|Overall Study|Withdrawal by Subject|0|||
149093826|NCT00451555|537824250|FG000|Overall Study|Physician Decision|2|||
149093827|NCT00451555|537824251|FG001|Overall Study|Physician Decision|1|||
149093828|NCT00922441|537824252|FG000|Overall Study|Protocol Violation|0|||
149093829|NCT00922441|537824253|FG001|Overall Study|Protocol Violation|0|||
149093830|NCT00922441|537824254|FG002|Overall Study|Protocol Violation|2|||
149093831|NCT00922441|537824252|FG000|Overall Study|Withdrawal by Subject|0|||
149093832|NCT00922441|537824253|FG001|Overall Study|Withdrawal by Subject|0|||
149093833|NCT00922441|537824254|FG002|Overall Study|Withdrawal by Subject|1|||
149093834|NCT00468858|537824260|FG000|Overall Study|Adverse Event|0|||
149093835|NCT00468858|537824261|FG001|Overall Study|Adverse Event|1|||
149093836|NCT00468858|537824262|FG002|Overall Study|Adverse Event|0|||
149093837|NCT00468858|537824260|FG000|Overall Study|Withdrawal by Subject|7|||
149093838|NCT00468858|537824261|FG001|Overall Study|Withdrawal by Subject|4|||
149093839|NCT00468858|537824262|FG002|Overall Study|Withdrawal by Subject|5|||
149093840|NCT00468858|537824260|FG000|Overall Study|Relocation|1|||
149093841|NCT00468858|537824261|FG001|Overall Study|Relocation|3|||
149093842|NCT00468858|537824262|FG002|Overall Study|Relocation|3|||
149093843|NCT00468858|537824260|FG000|Overall Study|Lost to Follow-up|1|||
149093844|NCT00468858|537824261|FG001|Overall Study|Lost to Follow-up|2|||
149093845|NCT00468858|537824262|FG002|Overall Study|Lost to Follow-up|5|||
149093846|NCT00468858|537824260|FG000|Overall Study|Other|0|||
149093847|NCT00468858|537824261|FG001|Overall Study|Other|0|||
149093848|NCT00468858|537824262|FG002|Overall Study|Other|1|||
149093849|NCT01885936|537824265|FG000|Overall Study|Withdrawal by Subject|1|||
149093850|NCT01885936|537824266|FG001|Overall Study|Withdrawal by Subject|0|||
149093851|NCT00317603|537824269|FG000|Overall Study|Progressive Disease|3|||
149093852|NCT00523549|537824270|FG000|Overall Study|Adverse Event|6|||
149093853|NCT00523549|537824271|FG001|Overall Study|Adverse Event|3|||
149093854|NCT00523549|537824270|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149093855|NCT00523549|537824271|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149093856|NCT00523549|537824270|FG000|Overall Study|Protocol Deviation|3|||
149093857|NCT00523549|537824271|FG001|Overall Study|Protocol Deviation|1|||
149093858|NCT00523549|537824270|FG000|Overall Study|Patient withdrew consent|7|||
149093859|NCT00523549|537824271|FG001|Overall Study|Patient withdrew consent|6|||
149093860|NCT00523549|537824270|FG000|Overall Study|Lost to Follow-up|3|||
149093861|NCT00523549|537824271|FG001|Overall Study|Lost to Follow-up|5|||
149093862|NCT00427778|537824276|FG000|First Intervention (4 Weeks)|no longer interested|1|||
149093863|NCT00427778|537824277|FG001|First Intervention (4 Weeks)|no longer interested|0|||
149093864|NCT00427778|537824276|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
149093865|NCT00427778|537824277|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
149093866|NCT00427778|537824276|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
149093867|NCT00427778|537824277|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
149093868|NCT00427778|537824276|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
149093869|NCT00427778|537824277|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
149093870|NCT00439647|537824278|FG000|Overall Study|Withdrawal by Subject|25|||
149093871|NCT00439647|537824279|FG001|Overall Study|Withdrawal by Subject|22|||
149093872|NCT00439647|537824278|FG000|Overall Study|Death|15|||
149093873|NCT00439647|537824279|FG001|Overall Study|Death|18|||
149093874|NCT00439647|537824278|FG000|Overall Study|Adverse Event|11|||
149093875|NCT00439647|537824279|FG001|Overall Study|Adverse Event|11|||
149093876|NCT00439647|537824278|FG000|Overall Study|Lost to Follow-up|4|||
149093877|NCT00439647|537824279|FG001|Overall Study|Lost to Follow-up|12|||
149093878|NCT00439647|537824278|FG000|Overall Study|Protocol Violation|3|||
149093879|NCT00439647|537824279|FG001|Overall Study|Protocol Violation|4|||
149093880|NCT00439647|537824278|FG000|Overall Study|Lack of Efficacy|0|||
149093881|NCT00439647|537824279|FG001|Overall Study|Lack of Efficacy|4|||
149093882|NCT00843115|537824281|FG000|Overall Study|Death|4|||
149093883|NCT00843115|537824281|FG000|Overall Study|Adverse Event|30|||
149093884|NCT00843115|537824281|FG000|Overall Study|Lost to Follow-up|4|||
149093885|NCT00843115|537824281|FG000|Overall Study|Withdrawal by Subject|17|||
149093886|NCT00843115|537824281|FG000|Overall Study|Family wanted meds stopped|1|||
149093887|NCT00843115|537824281|FG000|Overall Study|Family does not want continuation|1|||
149093888|NCT00843115|537824281|FG000|Overall Study|Patient forgot to take meds|1|||
149093889|NCT00843115|537824281|FG000|Overall Study|Does not meet entrance criteria|1|||
149093890|NCT00843115|537824281|FG000|Overall Study|Physician Decision|1|||
149093891|NCT00843115|537824281|FG000|Overall Study|Family discontinued meds|1|||
149093892|NCT00843115|537824281|FG000|Overall Study|patient took for 2 days then stopped|1|||
149093893|NCT00843115|537824281|FG000|Overall Study|patient never took the medication|1|||
149093894|NCT00843115|537824281|FG000|Overall Study|hospitalized due to deterioration|1|||
149093895|NCT00843115|537824281|FG000|Overall Study|week 12 not done|1|||
149093896|NCT00843115|537824281|FG000|Overall Study|Syndrome De Glissement|1|||
149093897|NCT00225277|537824282|FG000|Overall Study|Adverse Event|30|||
149093898|NCT00225277|537824283|FG001|Overall Study|Adverse Event|34|||
149093899|NCT00225277|537824282|FG000|Overall Study|Lack of Efficacy|4|||
149093900|NCT00225277|537824283|FG001|Overall Study|Lack of Efficacy|1|||
149093901|NCT00225277|537824282|FG000|Overall Study|Lost to Follow-up|4|||
149093902|NCT00225277|537824283|FG001|Overall Study|Lost to Follow-up|6|||
149093903|NCT00225277|537824282|FG000|Overall Study|Physician Decision|6|||
149093904|NCT00225277|537824283|FG001|Overall Study|Physician Decision|8|||
149093905|NCT00225277|537824282|FG000|Overall Study|Protocol Violation|6|||
149093906|NCT00225277|537824283|FG001|Overall Study|Protocol Violation|3|||
149093907|NCT00225277|537824282|FG000|Overall Study|Withdrawal by Subject|40|||
149093908|NCT00225277|537824283|FG001|Overall Study|Withdrawal by Subject|34|||
149093909|NCT00225277|537824282|FG000|Overall Study|Other|7|||
149093910|NCT00225277|537824283|FG001|Overall Study|Other|9|||
149093911|NCT01177137|537824286|FG000|Overall Study|Withdrawal by Subject|10|||
149093912|NCT01177137|537824287|FG001|Overall Study|Withdrawal by Subject|10|||
149093913|NCT01177137|537824288|FG002|Overall Study|Withdrawal by Subject|2|||
149093914|NCT00677092|537824290|FG000|Overall Study|Adverse Event|1|||
149093915|NCT00677092|537824290|FG000|Overall Study|Lost to Follow-up|1|||
149093916|NCT00677092|537824290|FG000|Overall Study|Withdrawal by Subject|3|||
149093917|NCT00677092|537824290|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
149093918|NCT02460562|537824293|FG000|Overall Study|Lost to Follow-up|15|||
149093919|NCT02460562|537824294|FG001|Overall Study|Lost to Follow-up|16|||
149093920|NCT00784277|537824295|FG000|IR Treatment|Adverse Event|4|||
149093921|NCT00784277|537824296|FG001|IR Treatment|Adverse Event|8|||
149093922|NCT00784277|537824297|FG002|IR Treatment|Adverse Event|19|||
149093923|NCT00784277|537824298|FG003|IR Treatment|Adverse Event|35|||
149093924|NCT00784277|537824299|FG004|IR Treatment|Adverse Event|0|||
149093925|NCT00784277|537824300|FG005|IR Treatment|Adverse Event|0|||
149093926|NCT00784277|537824301|FG006|IR Treatment|Adverse Event|0|||
149093927|NCT00784277|537824295|FG000|IR Treatment|Lack of Efficacy|4|||
149093928|NCT00784277|537824296|FG001|IR Treatment|Lack of Efficacy|4|||
149093929|NCT00784277|537824297|FG002|IR Treatment|Lack of Efficacy|1|||
149093930|NCT00784277|537824298|FG003|IR Treatment|Lack of Efficacy|0|||
149093931|NCT00784277|537824299|FG004|IR Treatment|Lack of Efficacy|0|||
149093932|NCT00784277|537824300|FG005|IR Treatment|Lack of Efficacy|0|||
149093933|NCT00784277|537824301|FG006|IR Treatment|Lack of Efficacy|0|||
149093934|NCT00784277|537824295|FG000|IR Treatment|Lost to Follow-up|1|||
149093935|NCT00784277|537824296|FG001|IR Treatment|Lost to Follow-up|0|||
149093936|NCT00784277|537824297|FG002|IR Treatment|Lost to Follow-up|1|||
149093937|NCT00784277|537824298|FG003|IR Treatment|Lost to Follow-up|0|||
149093938|NCT00784277|537824299|FG004|IR Treatment|Lost to Follow-up|0|||
149093939|NCT00784277|537824300|FG005|IR Treatment|Lost to Follow-up|0|||
149093940|NCT00784277|537824301|FG006|IR Treatment|Lost to Follow-up|0|||
149093941|NCT00784277|537824295|FG000|IR Treatment|Withdrawal by Subject|5|||
149093942|NCT00784277|537824296|FG001|IR Treatment|Withdrawal by Subject|1|||
149093943|NCT00784277|537824297|FG002|IR Treatment|Withdrawal by Subject|4|||
149093944|NCT00784277|537824298|FG003|IR Treatment|Withdrawal by Subject|6|||
149093945|NCT00784277|537824299|FG004|IR Treatment|Withdrawal by Subject|0|||
149093946|NCT00784277|537824300|FG005|IR Treatment|Withdrawal by Subject|0|||
149093947|NCT00784277|537824301|FG006|IR Treatment|Withdrawal by Subject|0|||
149093948|NCT00784277|537824295|FG000|IR Treatment|Resolution Of Pain|0|||
149093949|NCT00784277|537824296|FG001|IR Treatment|Resolution Of Pain|1|||
149093950|NCT00784277|537824297|FG002|IR Treatment|Resolution Of Pain|0|||
149093951|NCT00784277|537824298|FG003|IR Treatment|Resolution Of Pain|0|||
149093952|NCT00784277|537824299|FG004|IR Treatment|Resolution Of Pain|0|||
149093953|NCT00784277|537824300|FG005|IR Treatment|Resolution Of Pain|0|||
149093954|NCT00784277|537824301|FG006|IR Treatment|Resolution Of Pain|0|||
149093955|NCT00784277|537824295|FG000|IR Treatment|Other|2|||
149093956|NCT00784277|537824296|FG001|IR Treatment|Other|3|||
149093957|NCT00784277|537824297|FG002|IR Treatment|Other|3|||
149093958|NCT00784277|537824298|FG003|IR Treatment|Other|2|||
149093959|NCT00784277|537824299|FG004|IR Treatment|Other|0|||
149093960|NCT00784277|537824300|FG005|IR Treatment|Other|0|||
149093961|NCT00784277|537824301|FG006|IR Treatment|Other|0|||
149093962|NCT00784277|537824295|FG000|ER Treatment|Adverse Event|0|||
149093963|NCT00784277|537824296|FG001|ER Treatment|Adverse Event|0|||
149093964|NCT00784277|537824297|FG002|ER Treatment|Adverse Event|0|||
149093965|NCT00784277|537824298|FG003|ER Treatment|Adverse Event|0|||
149093966|NCT00784277|537824299|FG004|ER Treatment|Adverse Event|1|||
149093967|NCT00784277|537824300|FG005|ER Treatment|Adverse Event|7|||
149093968|NCT00784277|537824301|FG006|ER Treatment|Adverse Event|7|||
149093969|NCT00784277|537824295|FG000|ER Treatment|Lack of Efficacy|0|||
149093970|NCT00784277|537824296|FG001|ER Treatment|Lack of Efficacy|0|||
149093971|NCT00784277|537824297|FG002|ER Treatment|Lack of Efficacy|0|||
149093972|NCT00784277|537824298|FG003|ER Treatment|Lack of Efficacy|0|||
149093973|NCT00784277|537824299|FG004|ER Treatment|Lack of Efficacy|3|||
149093974|NCT00784277|537824300|FG005|ER Treatment|Lack of Efficacy|4|||
149093975|NCT00784277|537824301|FG006|ER Treatment|Lack of Efficacy|0|||
149093976|NCT00784277|537824295|FG000|ER Treatment|Lost to Follow-up|0|||
149093977|NCT00784277|537824296|FG001|ER Treatment|Lost to Follow-up|0|||
149093978|NCT00784277|537824297|FG002|ER Treatment|Lost to Follow-up|0|||
149093979|NCT00784277|537824298|FG003|ER Treatment|Lost to Follow-up|0|||
149093980|NCT00784277|537824299|FG004|ER Treatment|Lost to Follow-up|0|||
149093981|NCT00784277|537824300|FG005|ER Treatment|Lost to Follow-up|2|||
149093982|NCT00784277|537824301|FG006|ER Treatment|Lost to Follow-up|0|||
149093983|NCT00784277|537824295|FG000|ER Treatment|Withdrawal by Subject|0|||
149093984|NCT00784277|537824296|FG001|ER Treatment|Withdrawal by Subject|0|||
149093985|NCT00784277|537824297|FG002|ER Treatment|Withdrawal by Subject|0|||
149093986|NCT00784277|537824298|FG003|ER Treatment|Withdrawal by Subject|0|||
149093987|NCT00784277|537824299|FG004|ER Treatment|Withdrawal by Subject|2|||
149093988|NCT00784277|537824300|FG005|ER Treatment|Withdrawal by Subject|5|||
149093989|NCT00784277|537824301|FG006|ER Treatment|Withdrawal by Subject|3|||
149093990|NCT00784277|537824295|FG000|ER Treatment|Study Medication Non-Compliant|0|||
149093991|NCT00784277|537824296|FG001|ER Treatment|Study Medication Non-Compliant|0|||
149093992|NCT00784277|537824297|FG002|ER Treatment|Study Medication Non-Compliant|0|||
149093993|NCT00784277|537824298|FG003|ER Treatment|Study Medication Non-Compliant|0|||
149093994|NCT00784277|537824299|FG004|ER Treatment|Study Medication Non-Compliant|2|||
149093995|NCT00784277|537824300|FG005|ER Treatment|Study Medication Non-Compliant|3|||
149093996|NCT00784277|537824301|FG006|ER Treatment|Study Medication Non-Compliant|3|||
149093997|NCT00784277|537824295|FG000|ER Treatment|Other|0|||
149093998|NCT00784277|537824296|FG001|ER Treatment|Other|0|||
149093999|NCT00784277|537824297|FG002|ER Treatment|Other|0|||
149094000|NCT00784277|537824298|FG003|ER Treatment|Other|0|||
149094001|NCT00784277|537824299|FG004|ER Treatment|Other|1|||
149094002|NCT00784277|537824300|FG005|ER Treatment|Other|3|||
149094003|NCT00784277|537824301|FG006|ER Treatment|Other|2|||
149094004|NCT01093222|537824302|FG000|Overall Study|Ineligible|6|||
149094005|NCT01093222|537824302|FG000|Overall Study|Adverse Event|7|||
149094006|NCT01093222|537824302|FG000|Overall Study|Progression/relapse|24|||
149094007|NCT01093222|537824302|FG000|Overall Study|Death|2|||
149094008|NCT01093222|537824302|FG000|Overall Study|Not protocol specified|1|||
149094009|NCT00187135|537824305|FG000|Visit One|Withdrawal by Subject|1|||
149094010|NCT00187135|537824306|FG001|Visit One|Withdrawal by Subject|0|||
149094011|NCT00187135|537824307|FG002|Visit One|Withdrawal by Subject|0|||
149094012|NCT00187135|537824308|FG003|Visit One|Withdrawal by Subject|0|||
149094013|NCT00187135|537824309|FG004|Visit One|Withdrawal by Subject|0|||
149094014|NCT00187135|537824310|FG005|Visit One|Withdrawal by Subject|1|||
149094015|NCT00187135|537824305|FG000|Visit One|Physician Decision|3|||
149094016|NCT00187135|537824306|FG001|Visit One|Physician Decision|1|||
149094017|NCT00187135|537824307|FG002|Visit One|Physician Decision|0|||
149094018|NCT00187135|537824308|FG003|Visit One|Physician Decision|0|||
149094019|NCT00187135|537824309|FG004|Visit One|Physician Decision|0|||
149094020|NCT00187135|537824310|FG005|Visit One|Physician Decision|1|||
149094021|NCT00187135|537824305|FG000|Visit Two|Death|0|||
149094022|NCT00187135|537824306|FG001|Visit Two|Death|0|||
149094023|NCT00187135|537824307|FG002|Visit Two|Death|0|||
149094024|NCT00187135|537824308|FG003|Visit Two|Death|1|||
149094025|NCT00187135|537824309|FG004|Visit Two|Death|0|||
149094026|NCT00187135|537824310|FG005|Visit Two|Death|1|||
149094027|NCT00187135|537824305|FG000|Visit Two|Physician Decision|1|||
149094028|NCT00187135|537824306|FG001|Visit Two|Physician Decision|0|||
149094029|NCT00187135|537824307|FG002|Visit Two|Physician Decision|0|||
149094030|NCT00187135|537824308|FG003|Visit Two|Physician Decision|0|||
149094031|NCT00187135|537824309|FG004|Visit Two|Physician Decision|0|||
149094032|NCT00187135|537824310|FG005|Visit Two|Physician Decision|0|||
149094033|NCT00187135|537824305|FG000|Visit Two|Withdrawal by Subject|1|||
149094034|NCT00187135|537824306|FG001|Visit Two|Withdrawal by Subject|1|||
149094035|NCT00187135|537824307|FG002|Visit Two|Withdrawal by Subject|1|||
149094036|NCT00187135|537824308|FG003|Visit Two|Withdrawal by Subject|0|||
149094037|NCT00187135|537824309|FG004|Visit Two|Withdrawal by Subject|1|||
149094038|NCT00187135|537824310|FG005|Visit Two|Withdrawal by Subject|1|||
149094039|NCT00187135|537824305|FG000|Visit Two|Study Discontinued|3|||
149094040|NCT00187135|537824306|FG001|Visit Two|Study Discontinued|2|||
149094041|NCT00187135|537824307|FG002|Visit Two|Study Discontinued|1|||
149094042|NCT00187135|537824308|FG003|Visit Two|Study Discontinued|7|||
149094043|NCT00187135|537824309|FG004|Visit Two|Study Discontinued|5|||
149094044|NCT00187135|537824310|FG005|Visit Two|Study Discontinued|6|||
149094045|NCT00187135|537824305|FG000|Visit Three|Death|0|||
149094046|NCT00187135|537824306|FG001|Visit Three|Death|0|||
149094047|NCT00187135|537824307|FG002|Visit Three|Death|1|||
149094048|NCT00187135|537824308|FG003|Visit Three|Death|0|||
149094049|NCT00187135|537824309|FG004|Visit Three|Death|1|||
149094050|NCT00187135|537824310|FG005|Visit Three|Death|0|||
149094051|NCT00187135|537824305|FG000|Visit Three|Withdrawal by Subject|0|||
149094052|NCT00187135|537824306|FG001|Visit Three|Withdrawal by Subject|1|||
149094053|NCT00187135|537824307|FG002|Visit Three|Withdrawal by Subject|1|||
149094054|NCT00187135|537824308|FG003|Visit Three|Withdrawal by Subject|2|||
149094055|NCT00187135|537824309|FG004|Visit Three|Withdrawal by Subject|0|||
149094056|NCT00187135|537824310|FG005|Visit Three|Withdrawal by Subject|0|||
149094057|NCT00187135|537824305|FG000|Visit Three|Study Discontinued|7|||
149094058|NCT00187135|537824306|FG001|Visit Three|Study Discontinued|6|||
149094059|NCT00187135|537824307|FG002|Visit Three|Study Discontinued|7|||
149094060|NCT00187135|537824308|FG003|Visit Three|Study Discontinued|7|||
149094061|NCT00187135|537824309|FG004|Visit Three|Study Discontinued|7|||
149094062|NCT00187135|537824310|FG005|Visit Three|Study Discontinued|6|||
149094063|NCT01951261|537824311|FG000|Overall Study|Death|1|||
149094064|NCT01951261|537824312|FG001|Overall Study|Death|0|||
149094065|NCT01951261|537824311|FG000|Overall Study|Lost to Follow-up|4|||
149094066|NCT01951261|537824312|FG001|Overall Study|Lost to Follow-up|3|||
149094067|NCT01951261|537824311|FG000|Overall Study|Protocol Violation|4|||
149094068|NCT01951261|537824312|FG001|Overall Study|Protocol Violation|3|||
149094069|NCT01924806|537824313|FG000|Overall Study|Physician Decision|2|||
149094070|NCT01924806|537824314|FG001|Overall Study|Physician Decision|1|||
149094071|NCT00297778|537824322|FG000|Overall Study|Adverse Event|16|||
149094072|NCT00297778|537824323|FG001|Overall Study|Adverse Event|10|||
149094073|NCT00297778|537824322|FG000|Overall Study|Withdrawal by Subject|1|||
149094074|NCT00297778|537824323|FG001|Overall Study|Withdrawal by Subject|5|||
149094075|NCT00297778|537824322|FG000|Overall Study|Lack of Efficacy|2|||
149094076|NCT00297778|537824323|FG001|Overall Study|Lack of Efficacy|1|||
149094077|NCT00297778|537824322|FG000|Overall Study|Non-compliant with trial protocol|0|||
149094078|NCT00297778|537824323|FG001|Overall Study|Non-compliant with trial protocol|3|||
149094079|NCT00297778|537824322|FG000|Overall Study|Other|0|||
149094080|NCT00297778|537824323|FG001|Overall Study|Other|1|||
149094081|NCT02996097|537824324|FG000|Overall Study|Lost to Follow-up|11|||
149094082|NCT02996097|537824325|FG001|Overall Study|Lost to Follow-up|11|||
149094083|NCT02201771|537824326|FG000|Overall Study|Death|3|||
149094084|NCT02201771|537824327|FG001|Overall Study|Death|2|||
149094085|NCT02201771|537824328|FG002|Overall Study|Death|0|||
149094086|NCT02201771|537824326|FG000|Overall Study|Protocol Violation|10|||
149094087|NCT02201771|537824327|FG001|Overall Study|Protocol Violation|8|||
149094088|NCT02201771|537824328|FG002|Overall Study|Protocol Violation|10|||
149094089|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
149094090|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
149094091|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
149094092|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
149094093|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
149094094|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
149094095|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
149094096|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
149094097|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
149094098|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
149094099|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
149094100|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
149094101|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
149094102|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
149094103|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
149094104|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
149094105|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
149094106|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
149094107|NCT03569475|537824329|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
149094108|NCT03569475|537824330|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
149094109|NCT03569475|537824331|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
149094110|NCT03569475|537824329|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
149094111|NCT03569475|537824330|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
149094112|NCT03569475|537824331|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
149094113|NCT03569475|537824329|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
149094114|NCT03569475|537824330|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
149094115|NCT03569475|537824331|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
149094116|NCT02109107|537824332|FG000|Overall Study|Lost to Follow-up|2|||
149094117|NCT03078751|537824337|FG000|Overall Study|Adverse Event|4|||
149094118|NCT03078751|537824338|FG001|Overall Study|Adverse Event|0|||
149094119|NCT03078751|537824337|FG000|Overall Study|Physician Decision|1|||
149094120|NCT03078751|537824338|FG001|Overall Study|Physician Decision|0|||
149094121|NCT03078751|537824337|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
149094122|NCT03078751|537824338|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
149094123|NCT03078751|537824337|FG000|Overall Study|Subject/guardian decision|8|||
149094124|NCT03078751|537824338|FG001|Overall Study|Subject/guardian decision|1|||
149094125|NCT03078751|537824337|FG000|Overall Study|Untreated|0|||
149094126|NCT03078751|537824338|FG001|Overall Study|Untreated|4|||
149094127|NCT02515097|537824339|FG000|Overall Study|Lost to Follow-up|4|||
149094128|NCT02515097|537824340|FG001|Overall Study|Lost to Follow-up|2|||
149094129|NCT02515097|537824339|FG000|Overall Study|Withdrawal by Subject|1|||
149094130|NCT02515097|537824340|FG001|Overall Study|Withdrawal by Subject|3|||
149094131|NCT02515097|537824339|FG000|Overall Study|Adverse Event|2|||
149094132|NCT02515097|537824340|FG001|Overall Study|Adverse Event|1|||
149094133|NCT03613454|537824341|FG000|Overall Study|Protocol Violation|1|||
149094134|NCT03613454|537824342|FG001|Overall Study|Protocol Violation|0|||
149094135|NCT03613454|537824341|FG000|Overall Study|Protocol Violation|0|||
149094136|NCT03613454|537824342|FG001|Overall Study|Protocol Violation|1|||
149094137|NCT04167085|537824343|FG000|Baseline|Withdrawal by Subject|2|||
149094138|NCT04167085|537824344|FG001|Baseline|Withdrawal by Subject|1|||
149094139|NCT04167085|537824343|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
149094140|NCT04167085|537824344|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
149094141|NCT02273180|537824348|FG000|Overall Study|Adverse Event|2|||
149094142|NCT02273180|537824349|FG001|Overall Study|Adverse Event|2|||
149094143|NCT02273180|537824348|FG000|Overall Study|Lack of Efficacy|1|||
149094144|NCT02273180|537824349|FG001|Overall Study|Lack of Efficacy|0|||
149094145|NCT02273180|537824348|FG000|Overall Study|Protocol Violation|1|||
149094146|NCT02273180|537824349|FG001|Overall Study|Protocol Violation|7|||
149094147|NCT02273180|537824348|FG000|Overall Study|Randomized but not treated|1|||
149094148|NCT02273180|537824349|FG001|Overall Study|Randomized but not treated|0|||
149094149|NCT02273180|537824348|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
149094150|NCT02273180|537824349|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
149094151|NCT02273180|537824348|FG000|Overall Study|Other than specified above|21|||
149094152|NCT02273180|537824349|FG001|Overall Study|Other than specified above|10|||
149094153|NCT02154516|537824350|FG000|Overall Study|Withdrawal by Subject|0|||
149094154|NCT02154516|537824351|FG001|Overall Study|Withdrawal by Subject|1|||
149094155|NCT02154516|537824350|FG000|Overall Study|Lost to Follow-up|1|||
149094156|NCT02154516|537824351|FG001|Overall Study|Lost to Follow-up|0|||
149094157|NCT02154516|537824350|FG000|Overall Study|Removal/revision of device|1|||
149094158|NCT02154516|537824351|FG001|Overall Study|Removal/revision of device|0|||
149094159|NCT02154516|537824350|FG000|Overall Study|Death|2|||
149094160|NCT02154516|537824351|FG001|Overall Study|Death|1|||
149094161|NCT02965599|537824352|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
149094162|NCT02965599|537824353|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
149094163|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
149094164|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
149094165|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
149094166|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
149094167|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
149094168|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
149094169|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
149094170|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
149094171|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
149094172|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
149094173|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
149094174|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
149094175|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
149094176|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
149094177|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
149094178|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
149094179|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
149094180|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
149094181|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
149094182|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
149094183|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
149094184|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
149094185|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
149094186|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
149094187|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
149094188|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
149094189|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
149094190|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
149094191|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
149094192|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
149094193|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
149094194|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
149094195|NCT00092521|537825959|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
149094196|NCT00092521|537825960|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
149094197|NCT00092521|537825961|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
149094198|NCT00092521|537825962|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
149094199|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
149094200|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
149094201|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
149094202|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
149094203|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
149094204|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
149094205|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
149094206|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
149094207|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
149094208|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
149094209|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
149094210|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
149094211|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Death|2|||
149094212|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Death|0|||
149094213|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Death|1|||
149094214|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Death|0|||
149094215|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
149094216|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
149094217|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
149094218|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
149094219|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
149094220|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
149094221|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
149094222|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
149094223|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
149094224|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
149094225|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
149094226|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
149094227|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Moved|32|||
149094228|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Moved|2|||
149094229|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Moved|28|||
149094230|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Moved|0|||
149094231|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
149094232|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
149094233|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
149094234|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
149094235|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Travel|2|||
149094236|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Travel|0|||
149094237|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Travel|0|||
149094238|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Travel|0|||
149094239|NCT00092521|537825959|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
149094240|NCT00092521|537825960|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
149094241|NCT00092521|537825961|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
149094242|NCT00092521|537825962|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
149094243|NCT00092521|537825959|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
149094244|NCT00092521|537825960|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
149094245|NCT00092521|537825961|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
149094246|NCT00092521|537825962|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
149094247|NCT00092521|537825959|FG000|Extension Study (Group 4)|Adverse Event|0|||
149094248|NCT00092521|537825960|FG001|Extension Study (Group 4)|Adverse Event|0|||
149094249|NCT00092521|537825961|FG002|Extension Study (Group 4)|Adverse Event|0|||
149094250|NCT00092521|537825962|FG003|Extension Study (Group 4)|Adverse Event|2|||
149094251|NCT00092521|537825959|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
149094252|NCT00092521|537825960|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
149094253|NCT00092521|537825961|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
149094254|NCT00092521|537825962|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
149094255|NCT00092521|537825959|FG000|Extension Study (Group 4)|Pregnancy|0|||
149094256|NCT00092521|537825960|FG001|Extension Study (Group 4)|Pregnancy|0|||
149094257|NCT00092521|537825961|FG002|Extension Study (Group 4)|Pregnancy|0|||
149094258|NCT00092521|537825962|FG003|Extension Study (Group 4)|Pregnancy|4|||
149094259|NCT00092521|537825959|FG000|Extension Study (Group 4)|Protocol Violation|0|||
149094260|NCT00092521|537825960|FG001|Extension Study (Group 4)|Protocol Violation|0|||
149094261|NCT00092521|537825961|FG002|Extension Study (Group 4)|Protocol Violation|0|||
149094262|NCT00092521|537825962|FG003|Extension Study (Group 4)|Protocol Violation|2|||
149094263|NCT00092521|537825959|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
149094264|NCT00092521|537825960|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
149094265|NCT00092521|537825961|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
149094266|NCT00092521|537825962|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
149094267|NCT00092521|537825959|FG000|Extension Study (Group 4)|Moved|0|||
149094268|NCT00092521|537825960|FG001|Extension Study (Group 4)|Moved|0|||
149094269|NCT00092521|537825961|FG002|Extension Study (Group 4)|Moved|0|||
149094270|NCT00092521|537825962|FG003|Extension Study (Group 4)|Moved|16|||
149094271|NCT00092521|537825959|FG000|Extension Study (Group 4)|Site Terminated|0|||
149094272|NCT00092521|537825960|FG001|Extension Study (Group 4)|Site Terminated|0|||
149094273|NCT00092521|537825961|FG002|Extension Study (Group 4)|Site Terminated|0|||
149094274|NCT00092521|537825962|FG003|Extension Study (Group 4)|Site Terminated|4|||
149094275|NCT00092521|537825959|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
149094276|NCT00092521|537825960|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
149094277|NCT00092521|537825961|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
149094278|NCT00092521|537825962|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
149094279|NCT01878383|537825963|FG000|Overall Study|Lost to Follow-up|0|||
149094280|NCT01878383|537825964|FG001|Overall Study|Lost to Follow-up|1499|||
149094281|NCT03464383|537825965|FG000|Overall Study|Lost to Follow-up|1|||
149094282|NCT03464383|537825966|FG001|Overall Study|Lost to Follow-up|0|||
149094283|NCT03464383|537825967|FG002|Overall Study|Lost to Follow-up|0|||
149094284|NCT03464383|537825965|FG000|Overall Study|Withdrawal by Subject|0|||
149094285|NCT03464383|537825966|FG001|Overall Study|Withdrawal by Subject|1|||
149094286|NCT03464383|537825967|FG002|Overall Study|Withdrawal by Subject|0|||
149094287|NCT00560313|537825968|FG000|Overall Study|Adverse Events or Death|2|||
149094288|NCT00560313|537825968|FG000|Overall Study|Withdrawal by Subject|2|||
149094289|NCT00560313|537825968|FG000|Overall Study|Lost to Follow-up|1|||
149094290|NCT00560313|537825968|FG000|Overall Study|Protocol Violation|1|||
149094291|NCT03475056|537825969|FG000|Overall Study|Lost to Follow-up|0|||
149094292|NCT03475056|537825970|FG001|Overall Study|Lost to Follow-up|1|||
149094293|NCT03475056|537825969|FG000|Overall Study|Moved from Area|0|||
149094294|NCT03475056|537825970|FG001|Overall Study|Moved from Area|2|||
149094295|NCT00113269|537825973|FG000|Overall Study|Not transplanted, donor issues|4|||
149094296|NCT00113269|537825974|FG001|Overall Study|Not transplanted, donor issues|0|||
149094297|NCT00113269|537825975|FG002|Overall Study|Not transplanted, donor issues|2|||
149094298|NCT00113269|537825976|FG003|Overall Study|Not transplanted, donor issues|2|||
149094299|NCT00113269|537825973|FG000|Overall Study|Not transplanted, recipient issues|2|||
149094300|NCT00113269|537825974|FG001|Overall Study|Not transplanted, recipient issues|1|||
149094301|NCT00113269|537825975|FG002|Overall Study|Not transplanted, recipient issues|7|||
149094302|NCT00113269|537825976|FG003|Overall Study|Not transplanted, recipient issues|4|||
149094303|NCT00113269|537825973|FG000|Overall Study|Early graft loss, technical|0|||
149094304|NCT00113269|537825974|FG001|Overall Study|Early graft loss, technical|0|||
149094305|NCT00113269|537825975|FG002|Overall Study|Early graft loss, technical|2|||
149094306|NCT00113269|537825976|FG003|Overall Study|Early graft loss, technical|0|||
149094307|NCT00113269|537825973|FG000|Overall Study|Death in operating room|0|||
149094308|NCT00113269|537825974|FG001|Overall Study|Death in operating room|0|||
149094309|NCT00113269|537825975|FG002|Overall Study|Death in operating room|0|||
149094310|NCT00113269|537825976|FG003|Overall Study|Death in operating room|1|||
149094311|NCT00113269|537825973|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
149094312|NCT00113269|537825974|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
149094313|NCT00113269|537825975|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
149094314|NCT00113269|537825976|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
149094315|NCT00113269|537825973|FG000|Overall Study|Adverse Event|2|||
149094316|NCT00113269|537825974|FG001|Overall Study|Adverse Event|7|||
149094317|NCT00113269|537825975|FG002|Overall Study|Adverse Event|11|||
149094318|NCT00113269|537825976|FG003|Overall Study|Adverse Event|7|||
149094319|NCT00113269|537825973|FG000|Overall Study|Withdrawal by Subject|4|||
149094320|NCT00113269|537825974|FG001|Overall Study|Withdrawal by Subject|3|||
149094321|NCT00113269|537825975|FG002|Overall Study|Withdrawal by Subject|4|||
149094322|NCT00113269|537825976|FG003|Overall Study|Withdrawal by Subject|2|||
149094323|NCT00113269|537825973|FG000|Overall Study|Graft loss|6|||
149094324|NCT00113269|537825974|FG001|Overall Study|Graft loss|6|||
149094325|NCT00113269|537825975|FG002|Overall Study|Graft loss|4|||
149094326|NCT00113269|537825976|FG003|Overall Study|Graft loss|9|||
149094327|NCT00113269|537825973|FG000|Overall Study|Protocol Violation|1|||
149094328|NCT00113269|537825974|FG001|Overall Study|Protocol Violation|0|||
149094329|NCT00113269|537825975|FG002|Overall Study|Protocol Violation|4|||
149094330|NCT00113269|537825976|FG003|Overall Study|Protocol Violation|2|||
149094331|NCT00113269|537825973|FG000|Overall Study|Lost to Follow-up|2|||
149094332|NCT00113269|537825974|FG001|Overall Study|Lost to Follow-up|3|||
149094333|NCT00113269|537825975|FG002|Overall Study|Lost to Follow-up|6|||
149094334|NCT00113269|537825976|FG003|Overall Study|Lost to Follow-up|3|||
149094335|NCT00113269|537825973|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
149094336|NCT00113269|537825974|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
149094337|NCT00113269|537825975|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
149094338|NCT00113269|537825976|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
149094339|NCT00113269|537825973|FG000|Overall Study|Discontinued due to rejection|0|||
149094340|NCT00113269|537825974|FG001|Overall Study|Discontinued due to rejection|0|||
149094341|NCT00113269|537825975|FG002|Overall Study|Discontinued due to rejection|1|||
149094342|NCT00113269|537825976|FG003|Overall Study|Discontinued due to rejection|0|||
149094343|NCT00113269|537825973|FG000|Overall Study|Moved|0|||
149094344|NCT00113269|537825974|FG001|Overall Study|Moved|1|||
149094345|NCT00113269|537825975|FG002|Overall Study|Moved|0|||
149094346|NCT00113269|537825976|FG003|Overall Study|Moved|3|||
149094347|NCT00113269|537825973|FG000|Overall Study|Received pancreas transplant|0|||
149094348|NCT00113269|537825974|FG001|Overall Study|Received pancreas transplant|0|||
149094349|NCT00113269|537825975|FG002|Overall Study|Received pancreas transplant|0|||
149094350|NCT00113269|537825976|FG003|Overall Study|Received pancreas transplant|2|||
149094351|NCT00113269|537825973|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
149094352|NCT00113269|537825974|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
149094353|NCT00113269|537825975|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
149094354|NCT00113269|537825976|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
149094355|NCT00113269|537825973|FG000|Overall Study|Did not meet eligibility criteria|1|||
149094356|NCT00113269|537825974|FG001|Overall Study|Did not meet eligibility criteria|0|||
149094357|NCT00113269|537825975|FG002|Overall Study|Did not meet eligibility criteria|0|||
149094358|NCT00113269|537825976|FG003|Overall Study|Did not meet eligibility criteria|1|||
149094359|NCT00113269|537825973|FG000|Overall Study|Unable to return for follow up|2|||
149094360|NCT00113269|537825974|FG001|Overall Study|Unable to return for follow up|1|||
149094361|NCT00113269|537825975|FG002|Overall Study|Unable to return for follow up|0|||
149094362|NCT00113269|537825976|FG003|Overall Study|Unable to return for follow up|0|||
149094363|NCT02517528|537825977|FG000|Overall Study|Withdrawal by Subject|1|||
149094364|NCT01268098|537825980|FG000|Overall Study|Adverse Event|1|||
149094365|NCT01268098|537825981|FG001|Overall Study|Adverse Event|0|||
149094366|NCT01093599|537825983|FG000|Overall Study|Lost to Follow-up|32|||
149094367|NCT01093599|537825984|FG001|Overall Study|Lost to Follow-up|46|||
149094368|NCT01703845|537825985|FG000|Overall Study|Adverse Event|1|||
149094369|NCT01703845|537825986|FG001|Overall Study|Adverse Event|0|||
149094370|NCT01703845|537825985|FG000|Overall Study|Protocol Violation|1|||
149094371|NCT01703845|537825986|FG001|Overall Study|Protocol Violation|0|||
149094372|NCT01703845|537825985|FG000|Overall Study|other than stated above|1|||
149094373|NCT01703845|537825986|FG001|Overall Study|other than stated above|0|||
149094374|NCT01845649|537825989|FG000|Overall Study|Adverse Event|7|||
149094375|NCT01845649|537825990|FG001|Overall Study|Adverse Event|10|||
149094376|NCT01845649|537825989|FG000|Overall Study|Lack of Efficacy|1|||
149094377|NCT01845649|537825990|FG001|Overall Study|Lack of Efficacy|1|||
149094378|NCT01845649|537825989|FG000|Overall Study|Lost to Follow-up|2|||
149094379|NCT01845649|537825990|FG001|Overall Study|Lost to Follow-up|2|||
149094380|NCT01845649|537825989|FG000|Overall Study|Withdrew Consent|12|||
149094381|NCT01845649|537825990|FG001|Overall Study|Withdrew Consent|4|||
149094382|NCT01845649|537825989|FG000|Overall Study|Protocol Deviation|7|||
149094383|NCT01845649|537825990|FG001|Overall Study|Protocol Deviation|4|||
149094384|NCT01845649|537825989|FG000|Overall Study|Reason not Specified|2|||
149094385|NCT01845649|537825990|FG001|Overall Study|Reason not Specified|1|||
149094386|NCT01222533|537825992|FG000|Overall Study|Adverse Event|5|||
149094387|NCT01222533|537825992|FG000|Overall Study|Withdrawal by Subject|5|||
149094388|NCT01222533|537825992|FG000|Overall Study|Other|4|||
149094389|NCT03418493|537825993|FG000|Overall Study|Adverse Event|1|||
149094390|NCT03418493|537825994|FG001|Overall Study|Adverse Event|0|||
149094391|NCT03418493|537825995|FG002|Overall Study|Adverse Event|0|||
149094392|NCT03418493|537825996|FG003|Overall Study|Adverse Event|0|||
149094393|NCT03418493|537825997|FG004|Overall Study|Adverse Event|0|||
149094394|NCT03418493|537825998|FG005|Overall Study|Adverse Event|0|||
149094395|NCT03418493|537825999|FG006|Overall Study|Adverse Event|0|||
149094396|NCT03418493|537826000|FG007|Overall Study|Adverse Event|0|||
149094397|NCT03418493|537826001|FG008|Overall Study|Adverse Event|0|||
149094398|NCT03418493|537826002|FG009|Overall Study|Adverse Event|0|||
149094399|NCT03418493|537826003|FG010|Overall Study|Adverse Event|0|||
149094400|NCT03418493|537825993|FG000|Overall Study|Protocol Violation|0|||
149094401|NCT03418493|537825994|FG001|Overall Study|Protocol Violation|0|||
149094402|NCT03418493|537825995|FG002|Overall Study|Protocol Violation|0|||
149094403|NCT03418493|537825996|FG003|Overall Study|Protocol Violation|0|||
149094404|NCT03418493|537825997|FG004|Overall Study|Protocol Violation|0|||
149094405|NCT03418493|537825998|FG005|Overall Study|Protocol Violation|0|||
149094406|NCT03418493|537825999|FG006|Overall Study|Protocol Violation|0|||
149094407|NCT03418493|537826000|FG007|Overall Study|Protocol Violation|0|||
149094408|NCT03418493|537826001|FG008|Overall Study|Protocol Violation|0|||
149094409|NCT03418493|537826002|FG009|Overall Study|Protocol Violation|1|||
149094410|NCT03418493|537826003|FG010|Overall Study|Protocol Violation|0|||
149094411|NCT00526097|537826007|FG000|Overall Study|Adverse Event|6|||
149094412|NCT00526097|537826008|FG001|Overall Study|Adverse Event|44|||
149094413|NCT00526097|537826007|FG000|Overall Study|Protocol Violation|4|||
149094414|NCT00526097|537826008|FG001|Overall Study|Protocol Violation|10|||
149094415|NCT00526097|537826007|FG000|Overall Study|Withdrawal by Subject|3|||
149094416|NCT00526097|537826008|FG001|Overall Study|Withdrawal by Subject|1|||
149094417|NCT00526097|537826007|FG000|Overall Study|Other|2|||
149094418|NCT00526097|537826008|FG001|Overall Study|Other|1|||
149094419|NCT00966979|537826009|FG000|Overall Study|Death|1|||
149094420|NCT00966979|537826009|FG000|Overall Study|Lost to Follow-up|6|||
149094421|NCT00966979|537826009|FG000|Overall Study|Withdrawal by Subject|14|||
149094422|NCT00966979|537826009|FG000|Overall Study|Adverse Event|5|||
149094423|NCT00966979|537826009|FG000|Overall Study|Sponsor terminated early|49|||
149094424|NCT00966979|537826009|FG000|Overall Study|Censored because surgery not done|2|||
149094425|NCT00966979|537826009|FG000|Overall Study|Censored because study device was not implanted|14|||
149094426|NCT00966979|537826009|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
149094427|NCT03713281|537826013|FG000|Overall Study|Lens handling difficuluties|2|||
149094428|NCT03713281|537826013|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
149094429|NCT00630552|537826015|FG000|Overall Study|Adverse Event|0|||
149094430|NCT00630552|537826016|FG001|Overall Study|Adverse Event|1|||
149094431|NCT00630552|537826017|FG002|Overall Study|Adverse Event|5|||
149094432|NCT00630552|537826018|FG003|Overall Study|Adverse Event|4|||
149094433|NCT00630552|537826019|FG004|Overall Study|Adverse Event|2|||
149094434|NCT00630552|537826015|FG000|Overall Study|Disease progression|5|||
149094435|NCT00630552|537826016|FG001|Overall Study|Disease progression|6|||
149094436|NCT00630552|537826017|FG002|Overall Study|Disease progression|27|||
149094437|NCT00630552|537826018|FG003|Overall Study|Disease progression|22|||
149094438|NCT00630552|537826019|FG004|Overall Study|Disease progression|31|||
149094439|NCT00630552|537826015|FG000|Overall Study|Never received IP|0|||
149094440|NCT00630552|537826016|FG001|Overall Study|Never received IP|0|||
149094441|NCT00630552|537826017|FG002|Overall Study|Never received IP|0|||
149094442|NCT00630552|537826018|FG003|Overall Study|Never received IP|2|||
149094443|NCT00630552|537826019|FG004|Overall Study|Never received IP|2|||
149094444|NCT00630552|537826015|FG000|Overall Study|Ineligibility determined|0|||
149094445|NCT00630552|537826016|FG001|Overall Study|Ineligibility determined|0|||
149094446|NCT00630552|537826017|FG002|Overall Study|Ineligibility determined|0|||
149094447|NCT00630552|537826018|FG003|Overall Study|Ineligibility determined|0|||
149094448|NCT00630552|537826019|FG004|Overall Study|Ineligibility determined|1|||
149094449|NCT00630552|537826015|FG000|Overall Study|Protocol Violation|0|||
149094450|NCT00630552|537826016|FG001|Overall Study|Protocol Violation|0|||
149094451|NCT00630552|537826017|FG002|Overall Study|Protocol Violation|0|||
149094452|NCT00630552|537826018|FG003|Overall Study|Protocol Violation|1|||
149094453|NCT00630552|537826019|FG004|Overall Study|Protocol Violation|0|||
149094454|NCT00630552|537826015|FG000|Overall Study|Physician Decision|0|||
149094455|NCT00630552|537826016|FG001|Overall Study|Physician Decision|0|||
149094456|NCT00630552|537826017|FG002|Overall Study|Physician Decision|0|||
149094457|NCT00630552|537826018|FG003|Overall Study|Physician Decision|0|||
149094458|NCT00630552|537826019|FG004|Overall Study|Physician Decision|1|||
149094459|NCT00630552|537826015|FG000|Overall Study|Death|0|||
149094460|NCT00630552|537826016|FG001|Overall Study|Death|0|||
149094461|NCT00630552|537826017|FG002|Overall Study|Death|1|||
149094462|NCT00630552|537826018|FG003|Overall Study|Death|2|||
149094463|NCT00630552|537826019|FG004|Overall Study|Death|2|||
149094464|NCT00630552|537826015|FG000|Overall Study|Withdrawal by Subject|0|||
149094465|NCT00630552|537826016|FG001|Overall Study|Withdrawal by Subject|0|||
149094466|NCT00630552|537826017|FG002|Overall Study|Withdrawal by Subject|0|||
149094467|NCT00630552|537826018|FG003|Overall Study|Withdrawal by Subject|1|||
149094468|NCT00630552|537826019|FG004|Overall Study|Withdrawal by Subject|0|||
149094469|NCT00630552|537826015|FG000|Overall Study|Other|0|||
149094470|NCT00630552|537826016|FG001|Overall Study|Other|0|||
149094471|NCT00630552|537826017|FG002|Overall Study|Other|4|||
149094472|NCT00630552|537826018|FG003|Overall Study|Other|2|||
149094473|NCT00630552|537826019|FG004|Overall Study|Other|0|||
149094474|NCT03226106|537826020|FG000|Overall Study|Withdrawal by Subject|2|||
149094475|NCT03226106|537826021|FG001|Overall Study|Withdrawal by Subject|0|||
149094476|NCT03226106|537826020|FG000|Overall Study|Adverse Event|1|||
149094477|NCT03226106|537826021|FG001|Overall Study|Adverse Event|0|||
149094478|NCT03226106|537826020|FG000|Overall Study|Lost to Follow-up|2|||
149094479|NCT03226106|537826021|FG001|Overall Study|Lost to Follow-up|0|||
149094480|NCT01084239|537826022|FG000|28-Day Follow-up|Lost to Follow-up|4|||
149094481|NCT01084239|537826023|FG001|28-Day Follow-up|Lost to Follow-up|9|||
149094482|NCT00721214|537826024|FG000|Overall Study|Chose another center for transplant|1|||
149094483|NCT00721214|537826024|FG000|Overall Study|Death|3|||
149094484|NCT00983905|537826025|FG000|Theophylline Alone|Adverse Event|1|||
149094485|NCT00983905|537826025|FG000|Colchicine Alone|Adverse Event|2|||
149094486|NCT02847637|537826029|FG000|Overall Study|Withdrawal by Subject|0|||
149094487|NCT02847637|537826030|FG001|Overall Study|Withdrawal by Subject|1|||
149094488|NCT02847637|537826031|FG002|Overall Study|Withdrawal by Subject|1|||
149094489|NCT02847637|537826032|FG003|Overall Study|Withdrawal by Subject|0|||
149094490|NCT02847637|537826029|FG000|Overall Study|Lost to Follow-up|1|||
149094491|NCT02847637|537826030|FG001|Overall Study|Lost to Follow-up|1|||
149094492|NCT02847637|537826031|FG002|Overall Study|Lost to Follow-up|0|||
149094493|NCT02847637|537826032|FG003|Overall Study|Lost to Follow-up|0|||
149094494|NCT01746108|537826035|FG000|Overall Study|Migrated /moved from study area|0|||
149094495|NCT01746108|537826036|FG001|Overall Study|Migrated /moved from study area|1|||
149094496|NCT01746108|537826037|FG002|Overall Study|Migrated /moved from study area|0|||
149094497|NCT01746108|537826035|FG000|Overall Study|Adverse event, non-fatal|0|||
149094498|NCT01746108|537826036|FG001|Overall Study|Adverse event, non-fatal|1|||
149094499|NCT01746108|537826037|FG002|Overall Study|Adverse event, non-fatal|0|||
149094500|NCT01746108|537826035|FG000|Overall Study|Withdrawal by Subject|0|||
149094501|NCT01746108|537826036|FG001|Overall Study|Withdrawal by Subject|1|||
149094502|NCT01746108|537826037|FG002|Overall Study|Withdrawal by Subject|0|||
149094503|NCT01746108|537826035|FG000|Overall Study|Lost to Follow-up|0|||
149094504|NCT01746108|537826036|FG001|Overall Study|Lost to Follow-up|1|||
149094505|NCT01746108|537826037|FG002|Overall Study|Lost to Follow-up|0|||
149094506|NCT03036150|537826040|FG000|Overall Study|Withdrawal by Subject|8|||
149094507|NCT03036150|537826041|FG001|Overall Study|Withdrawal by Subject|3|||
149094508|NCT03036150|537826040|FG000|Overall Study|Lost to Follow-up|2|||
149094509|NCT03036150|537826041|FG001|Overall Study|Lost to Follow-up|2|||
149094510|NCT01990664|537826042|FG000|Overall Study|Lost to Follow-up|2|||
149094511|NCT01990664|537826043|FG001|Overall Study|Lost to Follow-up|6|||
149094512|NCT01990664|537826042|FG000|Overall Study|Withdrawal by Subject|2|||
149094513|NCT01990664|537826043|FG001|Overall Study|Withdrawal by Subject|3|||
149094514|NCT01990664|537826042|FG000|Overall Study|Protocol Violation|1|||
149094515|NCT01990664|537826043|FG001|Overall Study|Protocol Violation|0|||
149094516|NCT01990664|537826042|FG000|Overall Study|Lens Discomfort|1|||
149094517|NCT01990664|537826043|FG001|Overall Study|Lens Discomfort|1|||
149094518|NCT01990664|537826042|FG000|Overall Study|Lens Handling Difficulties|1|||
149094519|NCT01990664|537826043|FG001|Overall Study|Lens Handling Difficulties|0|||
149094520|NCT01990664|537826042|FG000|Overall Study|Unsatisfactory Visual Response|0|||
149094521|NCT01990664|537826043|FG001|Overall Study|Unsatisfactory Visual Response|1|||
149094522|NCT00809341|537826044|FG000|Overall Study|Physician Decision|0|||
149094523|NCT00809341|537826045|FG001|Overall Study|Physician Decision|1|||
149094524|NCT00570921|537826047|FG000|Overall Study|Protocol Violation|1|||
149094525|NCT00570921|537826047|FG000|Overall Study|Physician Decision|1|||
149094526|NCT03891641|537826057|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
149094527|NCT03891641|537826058|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
149094528|NCT03927222|537826062|FG000|Overall Study|Progression|3|||
149094529|NCT03927222|537826062|FG000|Overall Study|CMV testing results inconclusive|1|||
149094530|NCT03927222|537826062|FG000|Overall Study|Unable to generate enough vaccines|1|||
149094531|NCT03927222|537826062|FG000|Overall Study|Early study termination|1|||
149094532|NCT00745121|537826063|FG000|Overall Study|Death|3|||
149094533|NCT00745121|537826064|FG001|Overall Study|Death|0|||
149094534|NCT00745121|537826063|FG000|Overall Study|Adverse Event|1|||
149094535|NCT00745121|537826064|FG001|Overall Study|Adverse Event|0|||
149094536|NCT00745121|537826063|FG000|Overall Study|Lost to Follow-up|1|||
149094537|NCT00745121|537826064|FG001|Overall Study|Lost to Follow-up|0|||
149094538|NCT00745121|537826063|FG000|Overall Study|Withdrawal by Subject|4|||
149094539|NCT00745121|537826064|FG001|Overall Study|Withdrawal by Subject|2|||
149094540|NCT03723915|537826066|FG000|Screening|Failed to meet screening requirements.|2|||
149094541|NCT03723915|537826066|FG000|On Treatment|Failed to meet treatment requirements|2|||
149094542|NCT04016805|537826067|FG000|Overall Study|Sponsor's Discretion|30|||
149094543|NCT04016805|537826068|FG001|Overall Study|Sponsor's Discretion|6|||
149094544|NCT04016805|537826069|FG002|Overall Study|Sponsor's Discretion|5|||
149094545|NCT00740870|537826070|FG000|Overall Study|Not Catheterized|4|||
149094546|NCT00740870|537826070|FG000|Overall Study|Further testing contraindicated implant|17|||
149094547|NCT00640042|537826074|FG000|Enrollment|Did not receive study drug|83|||
149094548|NCT01592383|537826091|FG000|Overall Study|Adverse Event|1|||
149094549|NCT02799745|537826098|FG000|Overall Study|Participant moved out of state|1|||
149094550|NCT02799745|537826099|FG001|Overall Study|Participant moved out of state|0|||
149094551|NCT02799745|537826098|FG000|Overall Study|Discontinued due to planned surgery|1|||
149094552|NCT02799745|537826099|FG001|Overall Study|Discontinued due to planned surgery|0|||
149094553|NCT02799745|537826098|FG000|Overall Study|Withdrawal by Subject|16|||
149094554|NCT02799745|537826099|FG001|Overall Study|Withdrawal by Subject|25|||
149094555|NCT02799745|537826098|FG000|Overall Study|Protocol Deviation|4|||
149094556|NCT02799745|537826099|FG001|Overall Study|Protocol Deviation|5|||
149094557|NCT02799745|537826098|FG000|Overall Study|Progressive Disease|28|||
149094558|NCT02799745|537826099|FG001|Overall Study|Progressive Disease|38|||
149094559|NCT02799745|537826098|FG000|Overall Study|Lost to Follow-up|3|||
149094560|NCT02799745|537826099|FG001|Overall Study|Lost to Follow-up|2|||
149094561|NCT02799745|537826098|FG000|Overall Study|Death|3|||
149094562|NCT02799745|537826099|FG001|Overall Study|Death|0|||
149094563|NCT02799745|537826098|FG000|Overall Study|Adverse Event|0|||
149094564|NCT02799745|537826099|FG001|Overall Study|Adverse Event|1|||
149094565|NCT00853372|537827461|FG000|Overall Study|Death|30|||
149094566|NCT00853372|537827462|FG001|Overall Study|Death|26|||
149094567|NCT00853372|537827461|FG000|Overall Study|Lost to Follow-up|1|||
149094568|NCT00853372|537827462|FG001|Overall Study|Lost to Follow-up|2|||
149094569|NCT00853372|537827461|FG000|Overall Study|Full Consent Withdrawn|1|||
149094570|NCT00853372|537827462|FG001|Overall Study|Full Consent Withdrawn|1|||
149094571|NCT01644188|537827465|FG000|Overall Study|Adverse Event|44|||
149094572|NCT01644188|537827466|FG001|Overall Study|Adverse Event|20|||
149094573|NCT01644188|537827465|FG000|Overall Study|Poor compliance to protocol|26|||
149094574|NCT01644188|537827466|FG001|Overall Study|Poor compliance to protocol|14|||
149094575|NCT01644188|537827465|FG000|Overall Study|Physician Decision|1|||
149094576|NCT01644188|537827466|FG001|Overall Study|Physician Decision|3|||
149094577|NCT01644188|537827465|FG000|Overall Study|Participant moved|7|||
149094578|NCT01644188|537827466|FG001|Overall Study|Participant moved|2|||
149094579|NCT01644188|537827465|FG000|Overall Study|Related to auto-injector administration|2|||
149094580|NCT01644188|537827466|FG001|Overall Study|Related to auto-injector administration|2|||
149094581|NCT01644188|537827465|FG000|Overall Study|Consent withdrawn by participant|14|||
149094582|NCT01644188|537827466|FG001|Overall Study|Consent withdrawn by participant|7|||
149094583|NCT01644188|537827465|FG000|Overall Study|Selection criteria finally not met|2|||
149094584|NCT01644188|537827466|FG001|Overall Study|Selection criteria finally not met|0|||
149094585|NCT01644188|537827465|FG000|Overall Study|Lost to Follow-up|1|||
149094586|NCT01644188|537827466|FG001|Overall Study|Lost to Follow-up|0|||
149094587|NCT01644188|537827465|FG000|Overall Study|Death|4|||
149094588|NCT01644188|537827466|FG001|Overall Study|Death|3|||
149094589|NCT01644188|537827465|FG000|Overall Study|Last visit outside protocol visit window|14|||
149094590|NCT01644188|537827466|FG001|Overall Study|Last visit outside protocol visit window|16|||
149094591|NCT01644188|537827465|FG000|Overall Study|Site closure|1|||
149094592|NCT01644188|537827466|FG001|Overall Study|Site closure|1|||
149094593|NCT01644188|537827465|FG000|Overall Study|Other than specified above|6|||
149094594|NCT01644188|537827466|FG001|Overall Study|Other than specified above|7|||
149094595|NCT01929876|537827468|FG000|Period 2|Non-Compliance|1|||
149094596|NCT03991988|537827471|FG000|Overall Study|Withdrawal by Subject|2|||
149094597|NCT03991988|537827472|FG001|Overall Study|Withdrawal by Subject|2|||
149094598|NCT01947517|537827473|FG000|Overall Study|Withdrawal by Subject|1|||
149094599|NCT01947517|537827474|FG001|Overall Study|Withdrawal by Subject|1|||
149094600|NCT05446714|537827475|FG000|Overall Study|Lost to Follow-up|1|||
149094601|NCT05446714|537827476|FG001|Overall Study|Lost to Follow-up|3|||
149094602|NCT05446714|537827477|FG002|Overall Study|Lost to Follow-up|2|||
149094603|NCT05446714|537827475|FG000|Overall Study|Protocol Violation|2|||
149094604|NCT05446714|537827476|FG001|Overall Study|Protocol Violation|0|||
149094605|NCT05446714|537827477|FG002|Overall Study|Protocol Violation|0|||
149094606|NCT00943618|537827480|FG000|Overall Study|Lost to Follow-up|38|||
149094607|NCT00943618|537827481|FG001|Overall Study|Lost to Follow-up|48|||
149094608|NCT00943618|537827482|FG002|Overall Study|Lost to Follow-up|20|||
149094609|NCT00943618|537827480|FG000|Overall Study|Discontinued Medication|17|||
149094610|NCT00943618|537827481|FG001|Overall Study|Discontinued Medication|29|||
149094611|NCT00943618|537827482|FG002|Overall Study|Discontinued Medication|11|||
149094612|NCT01990313|537827487|FG000|Overall Study|Lost to Follow-up|1|||
149094613|NCT02412111|537827488|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
149094614|NCT02412111|537827489|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
149094615|NCT02412111|537827490|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
149094616|NCT02412111|537827488|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
149094617|NCT02412111|537827489|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
149094618|NCT02412111|537827490|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
149094619|NCT02412111|537827488|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
149094620|NCT02412111|537827489|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
149094621|NCT02412111|537827490|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
149094622|NCT02412111|537827488|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
149094623|NCT02412111|537827489|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
149094624|NCT02412111|537827490|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
149094625|NCT02412111|537827488|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
149094626|NCT02412111|537827489|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
149094627|NCT02412111|537827490|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
149094628|NCT02412111|537827488|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
149094629|NCT02412111|537827489|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
149094630|NCT02412111|537827490|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
149094631|NCT02412111|537827488|FG000|Active Comparator Period (8 Weeks)|Other|0|||
149094632|NCT02412111|537827489|FG001|Active Comparator Period (8 Weeks)|Other|0|||
149094633|NCT02412111|537827490|FG002|Active Comparator Period (8 Weeks)|Other|2|||
149094634|NCT04349644|537827492|FG000|Allocation/Pretest|Lost to pretest|0|||
149094635|NCT04349644|537827493|FG001|Allocation/Pretest|Lost to pretest|3|||
149094636|NCT04349644|537827492|FG000|Posttest|Lost to posttest|0|||
149094637|NCT04349644|537827493|FG001|Posttest|Lost to posttest|8|||
149094638|NCT04349644|537827492|FG000|Posttest|Discontinued intervention|6|||
149094639|NCT04349644|537827493|FG001|Posttest|Discontinued intervention|0|||
149094640|NCT04349644|537827492|FG000|Follow-up|Lost to Follow-up|0|||
149094641|NCT04349644|537827493|FG001|Follow-up|Lost to Follow-up|2|||
149094642|NCT05006417|537827494|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
149094643|NCT01169636|537827495|FG000|Overall Study|Adverse Event|0|||
149094644|NCT01169636|537827496|FG001|Overall Study|Adverse Event|0|||
149094645|NCT01169636|537827497|FG002|Overall Study|Adverse Event|1|||
149094646|NCT01169636|537827498|FG003|Overall Study|Adverse Event|1|||
149094647|NCT01169636|537827499|FG004|Overall Study|Adverse Event|0|||
149094648|NCT01169636|537827495|FG000|Overall Study|Screen failure|0|||
149094649|NCT01169636|537827496|FG001|Overall Study|Screen failure|0|||
149094650|NCT01169636|537827497|FG002|Overall Study|Screen failure|2|||
149094651|NCT01169636|537827498|FG003|Overall Study|Screen failure|0|||
149094652|NCT01169636|537827499|FG004|Overall Study|Screen failure|0|||
149094653|NCT01169636|537827495|FG000|Overall Study|Withdrawal by Subject|0|||
149094654|NCT01169636|537827496|FG001|Overall Study|Withdrawal by Subject|0|||
149094655|NCT01169636|537827497|FG002|Overall Study|Withdrawal by Subject|0|||
149094656|NCT01169636|537827498|FG003|Overall Study|Withdrawal by Subject|0|||
149094657|NCT01169636|537827499|FG004|Overall Study|Withdrawal by Subject|3|||
149094658|NCT02396953|537827500|FG000|Overall Study|Withdrawal by Subject|0|||
149094659|NCT02396953|537827501|FG001|Overall Study|Withdrawal by Subject|0|||
149094660|NCT02396953|537827502|FG002|Overall Study|Withdrawal by Subject|1|||
149094661|NCT02396953|537827500|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
149094662|NCT02396953|537827501|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
149094663|NCT02396953|537827502|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
149094664|NCT02396953|537827500|FG000|Overall Study|Personal Reasons|1|||
149094665|NCT02396953|537827501|FG001|Overall Study|Personal Reasons|1|||
149094666|NCT02396953|537827502|FG002|Overall Study|Personal Reasons|0|||
149094667|NCT02624869|537827503|FG000|Overall Study|Lost to Follow-up|0|||
149094668|NCT02624869|537827504|FG001|Overall Study|Lost to Follow-up|0|||
149094669|NCT02624869|537827505|FG002|Overall Study|Lost to Follow-up|1|||
149094670|NCT02624869|537827503|FG000|Overall Study|Withdrawal by Subject|1|||
149094671|NCT02624869|537827504|FG001|Overall Study|Withdrawal by Subject|3|||
149094672|NCT02624869|537827505|FG002|Overall Study|Withdrawal by Subject|1|||
149094673|NCT00510198|537827506|FG000|Overall Study|Withdrawal by Subject|5|||
149094674|NCT00510198|537827507|FG001|Overall Study|Withdrawal by Subject|4|||
149094675|NCT02994784|537827508|FG000|6 Months Follow-up|Lost to Follow-up|3|||
149094676|NCT01917006|537827509|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
149094677|NCT01917006|537827510|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
149094678|NCT01917006|537827511|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
149094679|NCT01917006|537827512|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
149094680|NCT01917006|537827513|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
149094681|NCT01917006|537827514|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
149094682|NCT01917006|537827515|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
149094683|NCT01917006|537827516|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
149094684|NCT01917006|537827509|FG000|Randomized-treatment Period|Personal Reasons|0|||
149094685|NCT01917006|537827510|FG001|Randomized-treatment Period|Personal Reasons|0|||
149094686|NCT01917006|537827511|FG002|Randomized-treatment Period|Personal Reasons|0|||
149094687|NCT01917006|537827512|FG003|Randomized-treatment Period|Personal Reasons|0|||
149094688|NCT01917006|537827513|FG004|Randomized-treatment Period|Personal Reasons|0|||
149094689|NCT01917006|537827514|FG005|Randomized-treatment Period|Personal Reasons|1|||
149094690|NCT01917006|537827515|FG006|Randomized-treatment Period|Personal Reasons|0|||
149094691|NCT01917006|537827516|FG007|Randomized-treatment Period|Personal Reasons|0|||
149094692|NCT01917006|537827509|FG000|Randomized-treatment Period|Protocol Violation|1|||
149094693|NCT01917006|537827510|FG001|Randomized-treatment Period|Protocol Violation|0|||
149094694|NCT01917006|537827511|FG002|Randomized-treatment Period|Protocol Violation|0|||
149094695|NCT01917006|537827512|FG003|Randomized-treatment Period|Protocol Violation|0|||
149094696|NCT01917006|537827513|FG004|Randomized-treatment Period|Protocol Violation|0|||
149094697|NCT01917006|537827514|FG005|Randomized-treatment Period|Protocol Violation|0|||
149094698|NCT01917006|537827515|FG006|Randomized-treatment Period|Protocol Violation|0|||
149094699|NCT01917006|537827516|FG007|Randomized-treatment Period|Protocol Violation|0|||
149094700|NCT01917006|537827509|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094701|NCT01917006|537827510|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094702|NCT01917006|537827511|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094703|NCT01917006|537827512|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094704|NCT01917006|537827513|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094705|NCT01917006|537827514|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094706|NCT01917006|537827515|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
149094707|NCT01917006|537827516|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
149094708|NCT01917006|537827509|FG000|Open-label Period|Adverse Event|0|||
149094709|NCT01917006|537827510|FG001|Open-label Period|Adverse Event|0|||
149094710|NCT01917006|537827511|FG002|Open-label Period|Adverse Event|0|||
149094711|NCT01917006|537827512|FG003|Open-label Period|Adverse Event|0|||
149094712|NCT01917006|537827513|FG004|Open-label Period|Adverse Event|0|||
149094713|NCT01917006|537827514|FG005|Open-label Period|Adverse Event|0|||
149094714|NCT01917006|537827515|FG006|Open-label Period|Adverse Event|0|||
149094715|NCT01917006|537827516|FG007|Open-label Period|Adverse Event|1|||
149094716|NCT01917006|537827509|FG000|Open-label Period|Lost to Follow-up|0|||
149094717|NCT01917006|537827510|FG001|Open-label Period|Lost to Follow-up|0|||
149094718|NCT01917006|537827511|FG002|Open-label Period|Lost to Follow-up|0|||
149094719|NCT01917006|537827512|FG003|Open-label Period|Lost to Follow-up|0|||
149094720|NCT01917006|537827513|FG004|Open-label Period|Lost to Follow-up|0|||
149094721|NCT01917006|537827514|FG005|Open-label Period|Lost to Follow-up|0|||
149094722|NCT01917006|537827515|FG006|Open-label Period|Lost to Follow-up|0|||
149094723|NCT01917006|537827516|FG007|Open-label Period|Lost to Follow-up|1|||
149094724|NCT02158247|537827517|FG000|Overall Study|Invisible vocal cords|5|||
149094725|NCT01649557|537827518|FG000|Overall Study|Lost to Follow-up|5|||
149094726|NCT01649557|537827519|FG001|Overall Study|Lost to Follow-up|0|||
149094727|NCT01649557|537827520|FG002|Overall Study|Lost to Follow-up|3|||
149094728|NCT01649557|537827518|FG000|Overall Study|Adverse Event|7|||
149094729|NCT01649557|537827519|FG001|Overall Study|Adverse Event|5|||
149094730|NCT01649557|537827520|FG002|Overall Study|Adverse Event|1|||
149094731|NCT01649557|537827518|FG000|Overall Study|Met withdrawal criteria|4|||
149094732|NCT01649557|537827519|FG001|Overall Study|Met withdrawal criteria|0|||
149094733|NCT01649557|537827520|FG002|Overall Study|Met withdrawal criteria|0|||
149094734|NCT01649557|537827518|FG000|Overall Study|Physician Decision|8|||
149094735|NCT01649557|537827519|FG001|Overall Study|Physician Decision|2|||
149094736|NCT01649557|537827520|FG002|Overall Study|Physician Decision|1|||
149094737|NCT01649557|537827518|FG000|Overall Study|Withdrawal by Subject|15|||
149094738|NCT01649557|537827519|FG001|Overall Study|Withdrawal by Subject|5|||
149094739|NCT01649557|537827520|FG002|Overall Study|Withdrawal by Subject|4|||
149094740|NCT01649557|537827518|FG000|Overall Study|Protocol deviation|0|||
149094741|NCT01649557|537827519|FG001|Overall Study|Protocol deviation|2|||
149094742|NCT01649557|537827520|FG002|Overall Study|Protocol deviation|0|||
149094743|NCT01649557|537827518|FG000|Overall Study|Lack of Efficacy|5|||
149094744|NCT01649557|537827519|FG001|Overall Study|Lack of Efficacy|0|||
149094745|NCT01649557|537827520|FG002|Overall Study|Lack of Efficacy|0|||
149094746|NCT03029234|537827522|FG000|Overall Study|Sponsor Decision|1|||
149094747|NCT03029234|537827522|FG000|Overall Study|Withdrawal by Subject|5|||
149094748|NCT03029234|537827522|FG000|Overall Study|Death|91|||
149094749|NCT03029234|537827522|FG000|Overall Study|Lost to Follow-up|2|||
149094750|NCT02544113|537827523|FG000|Overall Study|Death|3|||
149094751|NCT02544113|537827524|FG001|Overall Study|Death|4|||
149094752|NCT00797511|537827526|FG000|Overall Study|Withdrawal by Subject|1|||
149094753|NCT00931918|537827529|FG000|Overall Study|Adverse Event|4|||
149094754|NCT00931918|537827530|FG001|Overall Study|Adverse Event|6|||
149094755|NCT00931918|537827529|FG000|Overall Study|Progressive Disease|2|||
149094756|NCT00931918|537827530|FG001|Overall Study|Progressive Disease|1|||
149094757|NCT00931918|537827529|FG000|Overall Study|Symptomatic Deterioration|1|||
149094758|NCT00931918|537827530|FG001|Overall Study|Symptomatic Deterioration|0|||
149094759|NCT00931918|537827529|FG000|Overall Study|Withdrawal by Patient|3|||
149094760|NCT00931918|537827530|FG001|Overall Study|Withdrawal by Patient|4|||
149094761|NCT00931918|537827529|FG000|Overall Study|Other Reason not Specified|4|||
149094762|NCT00931918|537827530|FG001|Overall Study|Other Reason not Specified|4|||
149094763|NCT00931918|537827529|FG000|Overall Study|Did not receive study drug|3|||
149094764|NCT00931918|537827530|FG001|Overall Study|Did not receive study drug|2|||
149094765|NCT01281917|537827544|FG000|Overall Study|Withdrawal by Subject|1|||
149094766|NCT02101268|537827547|FG000|Randomized Treatment Phase|Subject Decision|8|||
149094767|NCT02101268|537827548|FG001|Randomized Treatment Phase|Subject Decision|4|||
149094768|NCT02101268|537827549|FG002|Randomized Treatment Phase|Subject Decision|0|||
149094769|NCT02101268|537827550|FG003|Randomized Treatment Phase|Subject Decision|0|||
149094770|NCT02101268|537827547|FG000|Randomized Treatment Phase|Physician Decision|4|||
149094771|NCT02101268|537827548|FG001|Randomized Treatment Phase|Physician Decision|1|||
149094772|NCT02101268|537827549|FG002|Randomized Treatment Phase|Physician Decision|0|||
149094773|NCT02101268|537827550|FG003|Randomized Treatment Phase|Physician Decision|0|||
149094774|NCT02101268|537827547|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
149094775|NCT02101268|537827548|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
149094776|NCT02101268|537827549|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
149094777|NCT02101268|537827550|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
149094778|NCT02101268|537827547|FG000|Randomized Treatment Phase|Adverse Event|6|||
149094779|NCT02101268|537827548|FG001|Randomized Treatment Phase|Adverse Event|0|||
149094780|NCT02101268|537827549|FG002|Randomized Treatment Phase|Adverse Event|0|||
149094781|NCT02101268|537827550|FG003|Randomized Treatment Phase|Adverse Event|0|||
149094782|NCT02101268|537827547|FG000|Randomized Treatment Phase|Death|5|||
149094783|NCT02101268|537827548|FG001|Randomized Treatment Phase|Death|4|||
149094784|NCT02101268|537827549|FG002|Randomized Treatment Phase|Death|0|||
149094785|NCT02101268|537827550|FG003|Randomized Treatment Phase|Death|0|||
149094786|NCT02101268|537827547|FG000|Randomized Treatment Phase|Disease Progression|4|||
149094787|NCT02101268|537827548|FG001|Randomized Treatment Phase|Disease Progression|1|||
149094788|NCT02101268|537827549|FG002|Randomized Treatment Phase|Disease Progression|0|||
149094789|NCT02101268|537827550|FG003|Randomized Treatment Phase|Disease Progression|0|||
149094790|NCT02101268|537827547|FG000|Extended Treatment Phase|Subject Decision|0|||
149094791|NCT02101268|537827548|FG001|Extended Treatment Phase|Subject Decision|0|||
149094792|NCT02101268|537827549|FG002|Extended Treatment Phase|Subject Decision|3|||
149094793|NCT02101268|537827550|FG003|Extended Treatment Phase|Subject Decision|2|||
149094794|NCT02101268|537827547|FG000|Extended Treatment Phase|Physician Decision|0|||
149094795|NCT02101268|537827548|FG001|Extended Treatment Phase|Physician Decision|0|||
149094796|NCT02101268|537827549|FG002|Extended Treatment Phase|Physician Decision|5|||
149094797|NCT02101268|537827550|FG003|Extended Treatment Phase|Physician Decision|2|||
149094798|NCT02101268|537827547|FG000|Extended Treatment Phase|Adverse Event|0|||
149094799|NCT02101268|537827548|FG001|Extended Treatment Phase|Adverse Event|0|||
149094800|NCT02101268|537827549|FG002|Extended Treatment Phase|Adverse Event|14|||
149094801|NCT02101268|537827550|FG003|Extended Treatment Phase|Adverse Event|18|||
149094802|NCT02101268|537827547|FG000|Extended Treatment Phase|Death|0|||
149094803|NCT02101268|537827548|FG001|Extended Treatment Phase|Death|0|||
149094804|NCT02101268|537827549|FG002|Extended Treatment Phase|Death|5|||
149094805|NCT02101268|537827550|FG003|Extended Treatment Phase|Death|1|||
149094806|NCT02101268|537827547|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
149094807|NCT02101268|537827548|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
149094808|NCT02101268|537827549|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
149094809|NCT02101268|537827550|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
149094810|NCT02101268|537827547|FG000|Extended Treatment Phase|Disease Progression|0|||
149094811|NCT02101268|537827548|FG001|Extended Treatment Phase|Disease Progression|0|||
149094812|NCT02101268|537827549|FG002|Extended Treatment Phase|Disease Progression|13|||
149094813|NCT02101268|537827550|FG003|Extended Treatment Phase|Disease Progression|6|||
149094814|NCT02101268|537827547|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
149094815|NCT02101268|537827548|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
149094816|NCT02101268|537827549|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
149094817|NCT02101268|537827550|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
149094818|NCT00819013|537827552|FG000|Overall Study|Not meeting continuing study eligibility|2|||
149094819|NCT00819013|537827553|FG001|Overall Study|Not meeting continuing study eligibility|1|||
149094820|NCT00819013|537827554|FG002|Overall Study|Not meeting continuing study eligibility|2|||
149094821|NCT00819013|537827555|FG003|Overall Study|Not meeting continuing study eligibility|1|||
149094822|NCT00819013|537827552|FG000|Overall Study|Adverse Event|0|||
149094823|NCT00819013|537827553|FG001|Overall Study|Adverse Event|0|||
149094824|NCT00819013|537827554|FG002|Overall Study|Adverse Event|1|||
149094825|NCT00819013|537827555|FG003|Overall Study|Adverse Event|0|||
149094826|NCT00819013|537827552|FG000|Overall Study|Withdrawal by Subject|1|||
149094827|NCT00819013|537827553|FG001|Overall Study|Withdrawal by Subject|0|||
149094828|NCT00819013|537827554|FG002|Overall Study|Withdrawal by Subject|1|||
149094829|NCT00819013|537827555|FG003|Overall Study|Withdrawal by Subject|0|||
149094830|NCT00819013|537827552|FG000|Overall Study|Lost to Follow-up|0|||
149094831|NCT00819013|537827553|FG001|Overall Study|Lost to Follow-up|0|||
149094832|NCT00819013|537827554|FG002|Overall Study|Lost to Follow-up|1|||
149094833|NCT00819013|537827555|FG003|Overall Study|Lost to Follow-up|2|||
149094834|NCT00819013|537827552|FG000|Overall Study|Death|0|||
149094835|NCT00819013|537827553|FG001|Overall Study|Death|0|||
149094836|NCT00819013|537827554|FG002|Overall Study|Death|0|||
149094837|NCT00819013|537827555|FG003|Overall Study|Death|1|||
149094838|NCT00607997|537827556|FG000|Overall Study|Lack of Efficacy|6|||
149094839|NCT00607997|537827557|FG001|Overall Study|Lack of Efficacy|20|||
149094840|NCT00607997|537827558|FG002|Overall Study|Lack of Efficacy|14|||
149094841|NCT00607997|537827559|FG003|Overall Study|Lack of Efficacy|10|||
149094842|NCT00607997|537827556|FG000|Overall Study|Death|8|||
149094843|NCT00607997|537827557|FG001|Overall Study|Death|5|||
149094844|NCT00607997|537827558|FG002|Overall Study|Death|2|||
149094845|NCT00607997|537827559|FG003|Overall Study|Death|5|||
149094846|NCT00607997|537827556|FG000|Overall Study|Adverse Event|3|||
149094847|NCT00607997|537827557|FG001|Overall Study|Adverse Event|1|||
149094848|NCT00607997|537827558|FG002|Overall Study|Adverse Event|2|||
149094849|NCT00607997|537827559|FG003|Overall Study|Adverse Event|0|||
149094850|NCT00607997|537827556|FG000|Overall Study|Physician Decision|4|||
149094851|NCT00607997|537827557|FG001|Overall Study|Physician Decision|1|||
149094852|NCT00607997|537827558|FG002|Overall Study|Physician Decision|0|||
149094853|NCT00607997|537827559|FG003|Overall Study|Physician Decision|0|||
149094854|NCT00607997|537827556|FG000|Overall Study|Relapse, recurrent illness|4|||
149094855|NCT00607997|537827557|FG001|Overall Study|Relapse, recurrent illness|0|||
149094856|NCT00607997|537827558|FG002|Overall Study|Relapse, recurrent illness|2|||
149094857|NCT00607997|537827559|FG003|Overall Study|Relapse, recurrent illness|0|||
149094858|NCT00607997|537827556|FG000|Overall Study|Other without explanation|2|||
149094859|NCT00607997|537827557|FG001|Overall Study|Other without explanation|0|||
149094860|NCT00607997|537827558|FG002|Overall Study|Other without explanation|4|||
149094861|NCT00607997|537827559|FG003|Overall Study|Other without explanation|1|||
149094862|NCT00839332|537827560|FG000|Phase 1|Disease Progression|38|||
149094863|NCT00839332|537827561|FG001|Phase 1|Disease Progression|0|||
149094864|NCT00839332|537827562|FG002|Phase 1|Disease Progression|0|||
149094865|NCT00839332|537827560|FG000|Phase 1|Adverse Event|6|||
149094866|NCT00839332|537827561|FG001|Phase 1|Adverse Event|0|||
149094867|NCT00839332|537827562|FG002|Phase 1|Adverse Event|0|||
149094868|NCT00839332|537827560|FG000|Phase 1|Withdrawal by Subject|4|||
149094869|NCT00839332|537827561|FG001|Phase 1|Withdrawal by Subject|0|||
149094870|NCT00839332|537827562|FG002|Phase 1|Withdrawal by Subject|0|||
149094871|NCT00839332|537827560|FG000|Phase 1|Physician Decision|2|||
149094872|NCT00839332|537827561|FG001|Phase 1|Physician Decision|0|||
149094873|NCT00839332|537827562|FG002|Phase 1|Physician Decision|0|||
149094874|NCT00839332|537827560|FG000|Phase 2|Protocol Violation|0|||
149094875|NCT00839332|537827561|FG001|Phase 2|Protocol Violation|1|||
149094876|NCT00839332|537827562|FG002|Phase 2|Protocol Violation|0|||
149094877|NCT00839332|537827560|FG000|Phase 2|Disease Progression|0|||
149094878|NCT00839332|537827561|FG001|Phase 2|Disease Progression|46|||
149094879|NCT00839332|537827562|FG002|Phase 2|Disease Progression|21|||
149094880|NCT00839332|537827560|FG000|Phase 2|Adverse Event|0|||
149094881|NCT00839332|537827561|FG001|Phase 2|Adverse Event|8|||
149094882|NCT00839332|537827562|FG002|Phase 2|Adverse Event|6|||
149094883|NCT00839332|537827560|FG000|Phase 2|Death|0|||
149094884|NCT00839332|537827561|FG001|Phase 2|Death|4|||
149094885|NCT00839332|537827562|FG002|Phase 2|Death|2|||
149094886|NCT00839332|537827560|FG000|Phase 2|Withdrawal by Subject|0|||
149094887|NCT00839332|537827561|FG001|Phase 2|Withdrawal by Subject|5|||
149094888|NCT00839332|537827562|FG002|Phase 2|Withdrawal by Subject|8|||
149094889|NCT00839332|537827560|FG000|Phase 2|Physician Decision|0|||
149094890|NCT00839332|537827561|FG001|Phase 2|Physician Decision|4|||
149094891|NCT00839332|537827562|FG002|Phase 2|Physician Decision|1|||
149094892|NCT00839332|537827560|FG000|Phase 2|Lost to Follow-up|0|||
149094893|NCT00839332|537827561|FG001|Phase 2|Lost to Follow-up|0|||
149094894|NCT00839332|537827562|FG002|Phase 2|Lost to Follow-up|1|||
149094895|NCT04414397|537827564|FG000|Control Period|Withdrawal by Subject|2|||
149094896|NCT04414397|537827565|FG001|Control Period|Withdrawal by Subject|2|||
149094897|NCT04414397|537827564|FG000|Control Period|Lost to Follow-up|0|||
149094898|NCT04414397|537827565|FG001|Control Period|Lost to Follow-up|4|||
149094899|NCT04414397|537827564|FG000|Control Period|Protocol deviation|0|||
149094900|NCT04414397|537827565|FG001|Control Period|Protocol deviation|1|||
149094901|NCT04414397|537827564|FG000|Post-Control Period|Withdrawal by Subject|3|||
149094902|NCT04414397|537827565|FG001|Post-Control Period|Withdrawal by Subject|6|||
149094903|NCT04414397|537827564|FG000|Post-Control Period|Lost to Follow-up|4|||
149094904|NCT04414397|537827565|FG001|Post-Control Period|Lost to Follow-up|9|||
149094905|NCT04414397|537827564|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
149094906|NCT04414397|537827565|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
149094907|NCT04414397|537827564|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
149094908|NCT04414397|537827565|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
149094909|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
149094910|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
149094911|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
149094912|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Other|1|||
149094913|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Other|0|||
149094914|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Other|0|||
149094915|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Physician Decision|3|||
149094916|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Physician Decision|0|||
149094917|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Physician Decision|0|||
149094918|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
149094919|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
149094920|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
149094921|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
149094922|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
149094923|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
149094924|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Adverse Event|18|||
149094925|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Adverse Event|0|||
149094926|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Adverse Event|0|||
149094927|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
149094928|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
149094929|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
149094930|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
149094931|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
149094932|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
149094933|NCT03030599|537827568|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
149094934|NCT03030599|537827569|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
149094935|NCT03030599|537827570|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
149094936|NCT03030599|537827568|FG000|Stable Dose|Protocol deviation|3|||
149094937|NCT03030599|537827569|FG001|Stable Dose|Protocol deviation|0|||
149094938|NCT03030599|537827570|FG002|Stable Dose|Protocol deviation|0|||
149094939|NCT03030599|537827568|FG000|Stable Dose|Adverse Event|1|||
149094940|NCT03030599|537827569|FG001|Stable Dose|Adverse Event|0|||
149094941|NCT03030599|537827570|FG002|Stable Dose|Adverse Event|0|||
149094942|NCT03030599|537827568|FG000|Stable Dose|Lost to Follow-up|1|||
149094943|NCT03030599|537827569|FG001|Stable Dose|Lost to Follow-up|0|||
149094944|NCT03030599|537827570|FG002|Stable Dose|Lost to Follow-up|0|||
149094945|NCT03030599|537827568|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
149094946|NCT03030599|537827569|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
149094947|NCT03030599|537827570|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
149094948|NCT03030599|537827568|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
149094949|NCT03030599|537827569|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
149094950|NCT03030599|537827570|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
149094951|NCT03030599|537827568|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
149094952|NCT03030599|537827569|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
149094953|NCT03030599|537827570|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
149094954|NCT03030599|537827568|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
149094955|NCT03030599|537827569|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
149094956|NCT03030599|537827570|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
149094957|NCT03030599|537827568|FG000|Open-label Extension|Adverse Event|3|||
149094958|NCT03030599|537827569|FG001|Open-label Extension|Adverse Event|0|||
149094959|NCT03030599|537827570|FG002|Open-label Extension|Adverse Event|0|||
149094960|NCT03030599|537827568|FG000|Open-label Extension|Lost to Follow-up|2|||
149094961|NCT03030599|537827569|FG001|Open-label Extension|Lost to Follow-up|0|||
149094962|NCT03030599|537827570|FG002|Open-label Extension|Lost to Follow-up|0|||
149094963|NCT03030599|537827568|FG000|Open-label Extension|Lack of Efficacy|1|||
149094964|NCT03030599|537827569|FG001|Open-label Extension|Lack of Efficacy|0|||
149094965|NCT03030599|537827570|FG002|Open-label Extension|Lack of Efficacy|0|||
149094966|NCT03030599|537827568|FG000|Open-label Extension|Other Reason|1|||
149094967|NCT03030599|537827569|FG001|Open-label Extension|Other Reason|0|||
149094968|NCT03030599|537827570|FG002|Open-label Extension|Other Reason|0|||
149094969|NCT03640754|537827571|FG000|Overall Study|Withdrawal by Subject|1|||
149094970|NCT03640754|537827572|FG001|Overall Study|Withdrawal by Subject|0|||
149094971|NCT03640754|537827571|FG000|Overall Study|Lost to Follow-up|0|||
149094972|NCT03640754|537827572|FG001|Overall Study|Lost to Follow-up|1|||
149094973|NCT01679613|537827575|FG000|Overall Study|other than stated above|0|||
149094974|NCT01679613|537827576|FG001|Overall Study|other than stated above|1|||
149094975|NCT01679613|537827577|FG002|Overall Study|other than stated above|2|||
149094976|NCT01679613|537827578|FG003|Overall Study|other than stated above|2|||
149094977|NCT01374971|537827579|FG000|Overall Study|Withdrawal by Subject|1|||
149094978|NCT00509925|537827581|FG000|Overall Study|Personal reasons|0|||
149094979|NCT00509925|537827582|FG001|Overall Study|Personal reasons|1|||
149094980|NCT00230971|537827584|FG000|Randomization|No study drug administered|3|||
149094981|NCT00230971|537827585|FG001|Randomization|No study drug administered|3|||
149094982|NCT00230971|537827584|FG000|Baseline Participants|Lost to Follow-up|5|||
149094983|NCT00230971|537827585|FG001|Baseline Participants|Lost to Follow-up|12|||
149094984|NCT00230971|537827584|FG000|Baseline Participants|Death|6|||
149094985|NCT00230971|537827585|FG001|Baseline Participants|Death|5|||
149094986|NCT00230971|537827584|FG000|Baseline Participants|Withdrawal by Subject|7|||
149094987|NCT00230971|537827585|FG001|Baseline Participants|Withdrawal by Subject|1|||
149094988|NCT00230971|537827584|FG000|Baseline Participants|Adverse Event|1|||
149094989|NCT00230971|537827585|FG001|Baseline Participants|Adverse Event|0|||
149094990|NCT00230971|537827584|FG000|Baseline Participants|No bacteria observed|1|||
149094991|NCT00230971|537827585|FG001|Baseline Participants|No bacteria observed|0|||
149094992|NCT00230971|537827584|FG000|Baseline Participants|Failure to return|1|||
149094993|NCT00230971|537827585|FG001|Baseline Participants|Failure to return|1|||
149094994|NCT00230971|537827584|FG000|Baseline Participants|Reintervention|1|||
149094995|NCT00230971|537827585|FG001|Baseline Participants|Reintervention|0|||
149094996|NCT04380688|537827586|FG000|Overall Study|Death|2|||
149094997|NCT04380688|537827587|FG001|Overall Study|Death|2|||
149094998|NCT04380688|537827586|FG000|Overall Study|Lost to Follow-up|2|||
149094999|NCT04380688|537827587|FG001|Overall Study|Lost to Follow-up|4|||
149095000|NCT04380688|537827586|FG000|Overall Study|Withdrawal by Subject|3|||
149095001|NCT04380688|537827587|FG001|Overall Study|Withdrawal by Subject|3|||
149095002|NCT00951171|537827591|FG000|Overall Study|Adverse Event|2|||
149095003|NCT00951171|537827592|FG001|Overall Study|Adverse Event|0|||
149095004|NCT00919061|537827593|FG000|Overall Study|Adverse Event|1|||
149095005|NCT00919061|537827593|FG000|Overall Study|Withdrawal by Subject|1|||
149095006|NCT05294328|537827594|FG000|Overall Study|Adverse Event|1|||
149095007|NCT05294328|537827595|FG001|Overall Study|Adverse Event|0|||
149095008|NCT05294328|537827596|FG002|Overall Study|Adverse Event|0|||
149095009|NCT05294328|537827594|FG000|Overall Study|Physician Decision|1|||
149095010|NCT05294328|537827595|FG001|Overall Study|Physician Decision|1|||
149095011|NCT05294328|537827596|FG002|Overall Study|Physician Decision|0|||
149095012|NCT05294328|537827594|FG000|Overall Study|Withdrawal by Subject|0|||
149095013|NCT05294328|537827595|FG001|Overall Study|Withdrawal by Subject|2|||
149095014|NCT05294328|537827596|FG002|Overall Study|Withdrawal by Subject|1|||
149095015|NCT05294328|537827594|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
149095016|NCT05294328|537827595|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
149095017|NCT05294328|537827596|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
149095018|NCT04267393|537827597|FG000|Randomization|Adverse Event|1|||
149095019|NCT04267393|537827598|FG001|Randomization|Adverse Event|0|||
149095020|NCT04267393|537827599|FG002|Randomization|Adverse Event|0|||
149095021|NCT04267393|537827597|FG000|Randomization|Administrative Reasons by Sponsor|0|||
149095022|NCT04267393|537827598|FG001|Randomization|Administrative Reasons by Sponsor|1|||
149095023|NCT04267393|537827599|FG002|Randomization|Administrative Reasons by Sponsor|0|||
149095024|NCT04267393|537827597|FG000|Treatment Period|Adverse Event|0|||
149095025|NCT04267393|537827598|FG001|Treatment Period|Adverse Event|2|||
149095026|NCT04267393|537827599|FG002|Treatment Period|Adverse Event|3|||
149095027|NCT04267393|537827597|FG000|Treatment Period|Participant Withdrew Consent|0|||
149095028|NCT04267393|537827598|FG001|Treatment Period|Participant Withdrew Consent|0|||
149095029|NCT04267393|537827599|FG002|Treatment Period|Participant Withdrew Consent|1|||
149095030|NCT04267393|537827597|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
149095031|NCT04267393|537827598|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
149095032|NCT04267393|537827599|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
149095033|NCT01904136|537829434|FG000|Overall Study|Physician Decision|0|||
149095034|NCT01904136|537829435|FG001|Overall Study|Physician Decision|0|||
149095035|NCT01904136|537829436|FG002|Overall Study|Physician Decision|0|||
149095036|NCT01904136|537829437|FG003|Overall Study|Physician Decision|0|||
149095037|NCT01904136|537829438|FG004|Overall Study|Physician Decision|0|||
149095038|NCT01904136|537829439|FG005|Overall Study|Physician Decision|1|||
149095039|NCT01904136|537829440|FG006|Overall Study|Physician Decision|0|||
149095040|NCT01904136|537829441|FG007|Overall Study|Physician Decision|0|||
149095041|NCT01904136|537829442|FG008|Overall Study|Physician Decision|0|||
149095042|NCT00460564|537829445|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
149095043|NCT00460564|537829446|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
149095044|NCT00460564|537829447|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149095045|NCT00460564|537829448|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149095046|NCT00460564|537829449|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149095047|NCT00460564|537829450|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149095048|NCT00460564|537829451|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149095049|NCT00460564|537829452|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
149095050|NCT00460564|537829445|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
149095051|NCT00460564|537829446|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095052|NCT00460564|537829447|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095053|NCT00460564|537829448|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095054|NCT00460564|537829449|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095055|NCT00460564|537829450|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095056|NCT00460564|537829451|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095057|NCT00460564|537829452|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
149095058|NCT00460564|537829445|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149095059|NCT00460564|537829446|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149095060|NCT00460564|537829447|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149095061|NCT00460564|537829448|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149095062|NCT00460564|537829449|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
149095063|NCT00460564|537829450|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
149095064|NCT00460564|537829451|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
149095065|NCT00460564|537829452|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
149095066|NCT00460564|537829445|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149095067|NCT00460564|537829446|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149095068|NCT00460564|537829447|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149095069|NCT00460564|537829448|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149095070|NCT00460564|537829449|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
149095071|NCT00460564|537829450|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
149095072|NCT00460564|537829451|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149095073|NCT00460564|537829452|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
149095074|NCT00460564|537829445|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095075|NCT00460564|537829446|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095076|NCT00460564|537829447|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095077|NCT00460564|537829448|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095078|NCT00460564|537829449|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
149095079|NCT00460564|537829450|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095080|NCT00460564|537829451|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095081|NCT00460564|537829452|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
149095082|NCT04238520|537829454|FG000|Overall Study|Withdrawal by Subject|1|||
149095083|NCT04238520|537829455|FG001|Overall Study|Withdrawal by Subject|1|||
149095084|NCT04238520|537829454|FG000|Overall Study|Lost to Follow-up|1|||
149095085|NCT04238520|537829455|FG001|Overall Study|Lost to Follow-up|2|||
149095086|NCT04238520|537829454|FG000|Overall Study|Death|0|||
149095087|NCT04238520|537829455|FG001|Overall Study|Death|2|||
149095088|NCT04238520|537829454|FG000|Overall Study|Unsafe home environment for research staff|0|||
149095089|NCT04238520|537829455|FG001|Overall Study|Unsafe home environment for research staff|1|||
149095090|NCT01004185|537829459|FG000|Overall Study|Adverse Event|1|||
149095091|NCT01004185|537829460|FG001|Overall Study|Adverse Event|1|||
149095092|NCT01004185|537829459|FG000|Overall Study|Lost to Follow-up|0|||
149095093|NCT01004185|537829460|FG001|Overall Study|Lost to Follow-up|1|||
149095094|NCT01004185|537829459|FG000|Overall Study|Lack of Efficacy|2|||
149095095|NCT01004185|537829460|FG001|Overall Study|Lack of Efficacy|1|||
149095096|NCT01004185|537829459|FG000|Overall Study|Sponsor Terminated Study|4|||
149095097|NCT01004185|537829460|FG001|Overall Study|Sponsor Terminated Study|5|||
149095098|NCT01004185|537829459|FG000|Overall Study|Withdrawal by Subject|2|||
149095099|NCT01004185|537829460|FG001|Overall Study|Withdrawal by Subject|1|||
149095100|NCT03214250|537829461|FG000|Overall Study|Death|5|||
149095101|NCT03214250|537829462|FG001|Overall Study|Death|5|||
149095102|NCT03214250|537829463|FG002|Overall Study|Death|7|||
149095103|NCT03214250|537829464|FG003|Overall Study|Death|4|||
149095104|NCT03214250|537829465|FG004|Overall Study|Death|23|||
149095105|NCT03214250|537829466|FG005|Overall Study|Death|23|||
149095106|NCT03214250|537829467|FG006|Overall Study|Death|24|||
149095107|NCT03214250|537829461|FG000|Overall Study|Lost to Follow-up|0|||
149095108|NCT03214250|537829462|FG001|Overall Study|Lost to Follow-up|0|||
149095109|NCT03214250|537829463|FG002|Overall Study|Lost to Follow-up|0|||
149095110|NCT03214250|537829464|FG003|Overall Study|Lost to Follow-up|1|||
149095111|NCT03214250|537829465|FG004|Overall Study|Lost to Follow-up|1|||
149095112|NCT03214250|537829466|FG005|Overall Study|Lost to Follow-up|2|||
149095113|NCT03214250|537829467|FG006|Overall Study|Lost to Follow-up|0|||
149095114|NCT03214250|537829461|FG000|Overall Study|Other|0|||
149095115|NCT03214250|537829462|FG001|Overall Study|Other|0|||
149095116|NCT03214250|537829463|FG002|Overall Study|Other|0|||
149095117|NCT03214250|537829464|FG003|Overall Study|Other|0|||
149095118|NCT03214250|537829465|FG004|Overall Study|Other|1|||
149095119|NCT03214250|537829466|FG005|Overall Study|Other|1|||
149095120|NCT03214250|537829467|FG006|Overall Study|Other|2|||
149095121|NCT03214250|537829461|FG000|Overall Study|Remains on Study|2|||
149095122|NCT03214250|537829462|FG001|Overall Study|Remains on Study|2|||
149095123|NCT03214250|537829463|FG002|Overall Study|Remains on Study|0|||
149095124|NCT03214250|537829464|FG003|Overall Study|Remains on Study|1|||
149095125|NCT03214250|537829465|FG004|Overall Study|Remains on Study|7|||
149095126|NCT03214250|537829466|FG005|Overall Study|Remains on Study|5|||
149095127|NCT03214250|537829467|FG006|Overall Study|Remains on Study|3|||
149095128|NCT03214250|537829461|FG000|Overall Study|Withdrawal by Subject|0|||
149095129|NCT03214250|537829462|FG001|Overall Study|Withdrawal by Subject|0|||
149095130|NCT03214250|537829463|FG002|Overall Study|Withdrawal by Subject|1|||
149095131|NCT03214250|537829464|FG003|Overall Study|Withdrawal by Subject|2|||
149095132|NCT03214250|537829465|FG004|Overall Study|Withdrawal by Subject|5|||
149095133|NCT03214250|537829466|FG005|Overall Study|Withdrawal by Subject|0|||
149095134|NCT03214250|537829467|FG006|Overall Study|Withdrawal by Subject|2|||
149095135|NCT00053352|537829471|FG000|Overall Study|Lost to Follow-up|0|||
149095136|NCT00053352|537829472|FG001|Overall Study|Lost to Follow-up|1|||
149095137|NCT00053352|537829471|FG000|Overall Study|Physician Decision|11|||
149095138|NCT00053352|537829472|FG001|Overall Study|Physician Decision|1|||
149095139|NCT00053352|537829471|FG000|Overall Study|Withdrawal by Subject|1|||
149095140|NCT00053352|537829472|FG001|Overall Study|Withdrawal by Subject|0|||
149095141|NCT00053352|537829471|FG000|Overall Study|Ineligible|8|||
149095142|NCT00053352|537829472|FG001|Overall Study|Ineligible|8|||
149095143|NCT00053352|537829471|FG000|Overall Study|Disease at new site|1|||
149095144|NCT00053352|537829472|FG001|Overall Study|Disease at new site|0|||
149095145|NCT02741713|537829475|FG000|Overall Study|Surgery type changed intra-operatively|2|||
149095146|NCT02741713|537829476|FG001|Overall Study|Surgery type changed intra-operatively|1|||
149095147|NCT01388478|537829477|FG000|Overall Study|Adverse Event|4|||
149095148|NCT01388478|537829477|FG000|Overall Study|Withdrawal by Subject|1|||
149095149|NCT01037413|537829478|FG000|Part A: Skin Testing|Adverse Event|1|||
149095150|NCT01037413|537829479|FG001|Part A: Skin Testing|Adverse Event|0|||
149095151|NCT01037413|537829478|FG000|Part A: Skin Testing|Protocol Violation|1|||
149095152|NCT01037413|537829479|FG001|Part A: Skin Testing|Protocol Violation|0|||
149095153|NCT01037413|537829478|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
149095154|NCT01037413|537829479|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
149095155|NCT01037413|537829478|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
149095156|NCT01037413|537829479|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
149095157|NCT00619983|537829483|FG000|Test Drug Alone|Withdrawal by Subject|1|||
149095158|NCT00619983|537829484|FG001|Test Drug Alone|Withdrawal by Subject|0|||
149095159|NCT00619983|537829485|FG002|Test Drug Alone|Withdrawal by Subject|0|||
149095160|NCT00619983|537829486|FG003|Test Drug Alone|Withdrawal by Subject|1|||
149095161|NCT00619983|537829483|FG000|Test Drug Alone|Failure of daily diary device|1|||
149095162|NCT00619983|537829484|FG001|Test Drug Alone|Failure of daily diary device|1|||
149095163|NCT00619983|537829485|FG002|Test Drug Alone|Failure of daily diary device|2|||
149095164|NCT00619983|537829486|FG003|Test Drug Alone|Failure of daily diary device|2|||
149095165|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
149095166|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
149095167|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
149095168|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
149095169|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
149095170|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
149095171|NCT03201900|537829487|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
149095172|NCT03201900|537829487|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
149095173|NCT03201900|537829487|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
149095174|NCT03201900|537829487|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
149095175|NCT03201900|537829487|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
149095176|NCT03201900|537829487|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
149095177|NCT03201900|537829487|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
149095178|NCT02971228|537829488|FG000|Overall Study|Withdrawal by Subject|1|||
149095179|NCT02971228|537829489|FG001|Overall Study|Withdrawal by Subject|1|||
149095180|NCT02971228|537829490|FG002|Overall Study|Withdrawal by Subject|0|||
149095181|NCT02971228|537829491|FG003|Overall Study|Withdrawal by Subject|0|||
149095182|NCT02971228|537829492|FG004|Overall Study|Withdrawal by Subject|0|||
149095183|NCT02971228|537829488|FG000|Overall Study|Logistical challenges|0|||
149095184|NCT02971228|537829489|FG001|Overall Study|Logistical challenges|1|||
149095185|NCT02971228|537829490|FG002|Overall Study|Logistical challenges|0|||
149095186|NCT02971228|537829491|FG003|Overall Study|Logistical challenges|0|||
149095187|NCT02971228|537829492|FG004|Overall Study|Logistical challenges|0|||
149095188|NCT02560389|537829501|FG000|Overall Study|Lost to Follow-up|1|||
149095189|NCT02560389|537829502|FG001|Overall Study|Lost to Follow-up|2|||
149095190|NCT02560389|537829503|FG002|Overall Study|Lost to Follow-up|2|||
149095191|NCT02560389|537829501|FG000|Overall Study|Tested positive for illicit substance|0|||
149095192|NCT02560389|537829502|FG001|Overall Study|Tested positive for illicit substance|1|||
149095193|NCT02560389|537829503|FG002|Overall Study|Tested positive for illicit substance|0|||
149095194|NCT02716298|537829504|FG000|First Intervention (1 Month)|Lens discomfort|1|||
149095195|NCT02716298|537829505|FG001|First Intervention (1 Month)|Lens discomfort|1|||
149095196|NCT00550446|537829506|FG000|Up To Week 12|Adverse Event|2|||
149095197|NCT00550446|537829507|FG001|Up To Week 12|Adverse Event|2|||
149095198|NCT00550446|537829508|FG002|Up To Week 12|Adverse Event|0|||
149095199|NCT00550446|537829509|FG003|Up To Week 12|Adverse Event|0|||
149095200|NCT00550446|537829510|FG004|Up To Week 12|Adverse Event|2|||
149095201|NCT00550446|537829511|FG005|Up To Week 12|Adverse Event|2|||
149095202|NCT00550446|537829512|FG006|Up To Week 12|Adverse Event|1|||
149095203|NCT00550446|537829513|FG007|Up To Week 12|Adverse Event|0|||
149095204|NCT00550446|537829514|FG008|Up To Week 12|Adverse Event|0|||
149095205|NCT00550446|537829515|FG009|Up To Week 12|Adverse Event|0|||
149095206|NCT00550446|537829516|FG010|Up To Week 12|Adverse Event|0|||
149095207|NCT00550446|537829506|FG000|Up To Week 12|Lack of Efficacy|3|||
149095208|NCT00550446|537829507|FG001|Up To Week 12|Lack of Efficacy|1|||
149095209|NCT00550446|537829508|FG002|Up To Week 12|Lack of Efficacy|0|||
149095210|NCT00550446|537829509|FG003|Up To Week 12|Lack of Efficacy|1|||
149095211|NCT00550446|537829510|FG004|Up To Week 12|Lack of Efficacy|0|||
149095212|NCT00550446|537829511|FG005|Up To Week 12|Lack of Efficacy|3|||
149095213|NCT00550446|537829512|FG006|Up To Week 12|Lack of Efficacy|3|||
149095214|NCT00550446|537829513|FG007|Up To Week 12|Lack of Efficacy|0|||
149095215|NCT00550446|537829514|FG008|Up To Week 12|Lack of Efficacy|0|||
149095216|NCT00550446|537829515|FG009|Up To Week 12|Lack of Efficacy|0|||
149095217|NCT00550446|537829516|FG010|Up To Week 12|Lack of Efficacy|0|||
149095218|NCT00550446|537829506|FG000|Up To Week 12|Lost to Follow-up|0|||
149095219|NCT00550446|537829507|FG001|Up To Week 12|Lost to Follow-up|1|||
149095220|NCT00550446|537829508|FG002|Up To Week 12|Lost to Follow-up|0|||
149095221|NCT00550446|537829509|FG003|Up To Week 12|Lost to Follow-up|0|||
149095222|NCT00550446|537829510|FG004|Up To Week 12|Lost to Follow-up|1|||
149095223|NCT00550446|537829511|FG005|Up To Week 12|Lost to Follow-up|1|||
149095224|NCT00550446|537829512|FG006|Up To Week 12|Lost to Follow-up|2|||
149095225|NCT00550446|537829513|FG007|Up To Week 12|Lost to Follow-up|0|||
149095226|NCT00550446|537829514|FG008|Up To Week 12|Lost to Follow-up|0|||
149095227|NCT00550446|537829515|FG009|Up To Week 12|Lost to Follow-up|0|||
149095228|NCT00550446|537829516|FG010|Up To Week 12|Lost to Follow-up|0|||
149095229|NCT00550446|537829506|FG000|Up To Week 12|Withdrawal by Subject|2|||
149095230|NCT00550446|537829507|FG001|Up To Week 12|Withdrawal by Subject|0|||
149095231|NCT00550446|537829508|FG002|Up To Week 12|Withdrawal by Subject|3|||
149095232|NCT00550446|537829509|FG003|Up To Week 12|Withdrawal by Subject|2|||
149095233|NCT00550446|537829510|FG004|Up To Week 12|Withdrawal by Subject|0|||
149095234|NCT00550446|537829511|FG005|Up To Week 12|Withdrawal by Subject|1|||
149095235|NCT00550446|537829512|FG006|Up To Week 12|Withdrawal by Subject|3|||
149095236|NCT00550446|537829513|FG007|Up To Week 12|Withdrawal by Subject|0|||
149095237|NCT00550446|537829514|FG008|Up To Week 12|Withdrawal by Subject|0|||
149095238|NCT00550446|537829515|FG009|Up To Week 12|Withdrawal by Subject|0|||
149095239|NCT00550446|537829516|FG010|Up To Week 12|Withdrawal by Subject|0|||
149095240|NCT00550446|537829506|FG000|Up To Week 12|Other|3|||
149095241|NCT00550446|537829507|FG001|Up To Week 12|Other|0|||
149095242|NCT00550446|537829508|FG002|Up To Week 12|Other|0|||
149095243|NCT00550446|537829509|FG003|Up To Week 12|Other|0|||
149095244|NCT00550446|537829510|FG004|Up To Week 12|Other|0|||
149095245|NCT00550446|537829511|FG005|Up To Week 12|Other|1|||
149095246|NCT00550446|537829512|FG006|Up To Week 12|Other|4|||
149095247|NCT00550446|537829513|FG007|Up To Week 12|Other|0|||
149095248|NCT00550446|537829514|FG008|Up To Week 12|Other|0|||
149095249|NCT00550446|537829515|FG009|Up To Week 12|Other|0|||
149095250|NCT00550446|537829516|FG010|Up To Week 12|Other|0|||
149095251|NCT00550446|537829506|FG000|Up To Week 12|Randomized not treated|0|||
149095252|NCT00550446|537829507|FG001|Up To Week 12|Randomized not treated|1|||
149095253|NCT00550446|537829508|FG002|Up To Week 12|Randomized not treated|1|||
149095254|NCT00550446|537829509|FG003|Up To Week 12|Randomized not treated|0|||
149095255|NCT00550446|537829510|FG004|Up To Week 12|Randomized not treated|0|||
149095256|NCT00550446|537829511|FG005|Up To Week 12|Randomized not treated|0|||
149095257|NCT00550446|537829512|FG006|Up To Week 12|Randomized not treated|0|||
149095258|NCT00550446|537829513|FG007|Up To Week 12|Randomized not treated|0|||
149095259|NCT00550446|537829514|FG008|Up To Week 12|Randomized not treated|0|||
149095260|NCT00550446|537829515|FG009|Up To Week 12|Randomized not treated|0|||
149095261|NCT00550446|537829516|FG010|Up To Week 12|Randomized not treated|0|||
149095262|NCT00550446|537829506|FG000|Post Week 12|Adverse Event|2|||
149095263|NCT00550446|537829507|FG001|Post Week 12|Adverse Event|1|||
149095264|NCT00550446|537829508|FG002|Post Week 12|Adverse Event|1|||
149095265|NCT00550446|537829509|FG003|Post Week 12|Adverse Event|1|||
149095266|NCT00550446|537829510|FG004|Post Week 12|Adverse Event|1|||
149095267|NCT00550446|537829511|FG005|Post Week 12|Adverse Event|1|||
149095268|NCT00550446|537829512|FG006|Post Week 12|Adverse Event|0|||
149095269|NCT00550446|537829513|FG007|Post Week 12|Adverse Event|0|||
149095270|NCT00550446|537829514|FG008|Post Week 12|Adverse Event|0|||
149095271|NCT00550446|537829515|FG009|Post Week 12|Adverse Event|4|||
149095272|NCT00550446|537829516|FG010|Post Week 12|Adverse Event|0|||
149095273|NCT00550446|537829506|FG000|Post Week 12|Lack of Efficacy|0|||
149095274|NCT00550446|537829507|FG001|Post Week 12|Lack of Efficacy|0|||
149095275|NCT00550446|537829508|FG002|Post Week 12|Lack of Efficacy|1|||
149095276|NCT00550446|537829509|FG003|Post Week 12|Lack of Efficacy|0|||
149095277|NCT00550446|537829510|FG004|Post Week 12|Lack of Efficacy|0|||
149095278|NCT00550446|537829511|FG005|Post Week 12|Lack of Efficacy|0|||
149095279|NCT00550446|537829512|FG006|Post Week 12|Lack of Efficacy|0|||
149095280|NCT00550446|537829513|FG007|Post Week 12|Lack of Efficacy|1|||
149095281|NCT00550446|537829514|FG008|Post Week 12|Lack of Efficacy|1|||
149095282|NCT00550446|537829515|FG009|Post Week 12|Lack of Efficacy|2|||
149095283|NCT00550446|537829516|FG010|Post Week 12|Lack of Efficacy|1|||
149095284|NCT00550446|537829506|FG000|Post Week 12|Lost to Follow-up|0|||
149095285|NCT00550446|537829507|FG001|Post Week 12|Lost to Follow-up|0|||
149095286|NCT00550446|537829508|FG002|Post Week 12|Lost to Follow-up|1|||
149095287|NCT00550446|537829509|FG003|Post Week 12|Lost to Follow-up|1|||
149095288|NCT00550446|537829510|FG004|Post Week 12|Lost to Follow-up|0|||
149095289|NCT00550446|537829511|FG005|Post Week 12|Lost to Follow-up|0|||
149095290|NCT00550446|537829512|FG006|Post Week 12|Lost to Follow-up|1|||
149095291|NCT00550446|537829513|FG007|Post Week 12|Lost to Follow-up|0|||
149095292|NCT00550446|537829514|FG008|Post Week 12|Lost to Follow-up|0|||
149095293|NCT00550446|537829515|FG009|Post Week 12|Lost to Follow-up|0|||
149095294|NCT00550446|537829516|FG010|Post Week 12|Lost to Follow-up|0|||
149095295|NCT00550446|537829506|FG000|Post Week 12|Withdrawal by Subject|0|||
149095296|NCT00550446|537829507|FG001|Post Week 12|Withdrawal by Subject|0|||
149095297|NCT00550446|537829508|FG002|Post Week 12|Withdrawal by Subject|0|||
149095298|NCT00550446|537829509|FG003|Post Week 12|Withdrawal by Subject|0|||
149095299|NCT00550446|537829510|FG004|Post Week 12|Withdrawal by Subject|1|||
149095300|NCT00550446|537829511|FG005|Post Week 12|Withdrawal by Subject|0|||
149095301|NCT00550446|537829512|FG006|Post Week 12|Withdrawal by Subject|0|||
149095302|NCT00550446|537829513|FG007|Post Week 12|Withdrawal by Subject|0|||
149095303|NCT00550446|537829514|FG008|Post Week 12|Withdrawal by Subject|0|||
149095304|NCT00550446|537829515|FG009|Post Week 12|Withdrawal by Subject|0|||
149095305|NCT00550446|537829516|FG010|Post Week 12|Withdrawal by Subject|0|||
149095306|NCT00550446|537829506|FG000|Post Week 12|Other|1|||
149095307|NCT00550446|537829507|FG001|Post Week 12|Other|1|||
149095308|NCT00550446|537829508|FG002|Post Week 12|Other|0|||
149095309|NCT00550446|537829509|FG003|Post Week 12|Other|1|||
149095310|NCT00550446|537829510|FG004|Post Week 12|Other|0|||
149095311|NCT00550446|537829511|FG005|Post Week 12|Other|0|||
149095312|NCT00550446|537829512|FG006|Post Week 12|Other|1|||
149095313|NCT00550446|537829513|FG007|Post Week 12|Other|0|||
149095314|NCT00550446|537829514|FG008|Post Week 12|Other|1|||
149095315|NCT00550446|537829515|FG009|Post Week 12|Other|1|||
149095316|NCT00550446|537829516|FG010|Post Week 12|Other|0|||
149095317|NCT00129649|537829519|FG000|Overall Study|Withdrawal by Subject|76|||
149095318|NCT00129649|537829520|FG001|Overall Study|Withdrawal by Subject|65|||
149095319|NCT02482935|537829521|FG000|Period 1|Withdrawal by Subject|1|||
149095320|NCT02482935|537829522|FG001|Period 1|Withdrawal by Subject|0|||
149095321|NCT01321723|537829523|FG000|Overall Study|Adverse Event|3|||
149095322|NCT01321723|537829524|FG001|Overall Study|Adverse Event|5|||
149095323|NCT01321723|537829525|FG002|Overall Study|Adverse Event|2|||
149095324|NCT01321723|537829523|FG000|Overall Study|Withdrawal by Subject|2|||
149095325|NCT01321723|537829524|FG001|Overall Study|Withdrawal by Subject|0|||
149095326|NCT01321723|537829525|FG002|Overall Study|Withdrawal by Subject|2|||
149095327|NCT04952701|537829526|FG000|Control Lens|Physician Decision|4|||
149095328|NCT04952701|537829526|FG000|Test Lens|Physician Decision|1|||
149095329|NCT04081389|537829528|FG000|Overall Study|Withdrawal by Subject|0|||
149095330|NCT04081389|537829529|FG001|Overall Study|Withdrawal by Subject|0|||
149095331|NCT04081389|537829530|FG002|Overall Study|Withdrawal by Subject|1|||
149095332|NCT04081389|537829531|FG003|Overall Study|Withdrawal by Subject|0|||
149095333|NCT00827775|537829537|FG000|Overall Study|Withdrawal by Subject|0|||
149095334|NCT00827775|537829538|FG001|Overall Study|Withdrawal by Subject|5|||
149095335|NCT01670188|537829542|FG000|Overall Study|Death|0|||
149095336|NCT01670188|537829543|FG001|Overall Study|Death|1|||
149095337|NCT02025985|537829548|FG000|Overall Study|Consent withdrawn|0|||
149095338|NCT02025985|537829549|FG001|Overall Study|Consent withdrawn|0|||
149095339|NCT02025985|537829550|FG002|Overall Study|Consent withdrawn|1|||
149095340|NCT02025985|537829551|FG003|Overall Study|Consent withdrawn|0|||
149095341|NCT02025985|537829552|FG004|Overall Study|Consent withdrawn|0|||
149095342|NCT02025985|537829548|FG000|Overall Study|Termination of study by Sponsor|4|||
149095343|NCT02025985|537829549|FG001|Overall Study|Termination of study by Sponsor|3|||
149095344|NCT02025985|537829550|FG002|Overall Study|Termination of study by Sponsor|1|||
149095345|NCT02025985|537829551|FG003|Overall Study|Termination of study by Sponsor|1|||
149095346|NCT02025985|537829552|FG004|Overall Study|Termination of study by Sponsor|3|||
149095347|NCT02025985|537829548|FG000|Overall Study|Death|21|||
149095348|NCT02025985|537829549|FG001|Overall Study|Death|20|||
149095349|NCT02025985|537829550|FG002|Overall Study|Death|23|||
149095350|NCT02025985|537829551|FG003|Overall Study|Death|20|||
149095351|NCT02025985|537829552|FG004|Overall Study|Death|17|||
149095352|NCT00866918|537829553|FG000|Overall Study|Death|1|||
149095353|NCT00866918|537829554|FG001|Overall Study|Death|5|||
149095354|NCT00866918|537829553|FG000|Overall Study|Lack of Efficacy|1|||
149095355|NCT00866918|537829554|FG001|Overall Study|Lack of Efficacy|1|||
149095356|NCT00866918|537829553|FG000|Overall Study|Physician Decision|10|||
149095357|NCT00866918|537829554|FG001|Overall Study|Physician Decision|2|||
149095358|NCT00866918|537829553|FG000|Overall Study|Ineligible|2|||
149095359|NCT00866918|537829554|FG001|Overall Study|Ineligible|4|||
149095360|NCT00866918|537829553|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
149095361|NCT00866918|537829554|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
149095362|NCT00866918|537829553|FG000|Overall Study|Secondary malignancy|1|||
149095363|NCT00866918|537829554|FG001|Overall Study|Secondary malignancy|0|||
149095364|NCT00527514|537829555|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
149095365|NCT00527514|537829555|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
149095366|NCT00527514|537829555|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
149095367|NCT00527514|537829555|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
149095368|NCT00527514|537829555|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
149095369|NCT00527514|537829555|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
149095370|NCT00527514|537829555|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
149095371|NCT00001941|537829556|FG000|Overall Study|not treated- rapidly progressing disease|0|||
149095372|NCT00001941|537829557|FG001|Overall Study|not treated- rapidly progressing disease|0|||
149095373|NCT00001941|537829558|FG002|Overall Study|not treated- rapidly progressing disease|0|||
149095374|NCT00001941|537829559|FG003|Overall Study|not treated- rapidly progressing disease|0|||
149095375|NCT00001941|537829560|FG004|Overall Study|not treated- rapidly progressing disease|1|||
149095376|NCT00802438|537829561|FG000|Overall Study|Screen Failure|20|||
149095377|NCT00802438|537829561|FG000|Overall Study|Withdrawal by Subject|7|||
149095378|NCT00802438|537829561|FG000|Overall Study|Physician Decision|1|||
149095379|NCT03175198|537829563|FG000|Overall Study|Adverse Event|480|||
149095380|NCT03175198|537829563|FG000|Overall Study|No actual visit|120|||
149095381|NCT03175198|537829563|FG000|Overall Study|Registration rule not followed|4|||
149095382|NCT03175198|537829563|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
149095383|NCT03175198|537829563|FG000|Overall Study|Other personal reason|509|||
149095384|NCT03175198|537829563|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
149095385|NCT03175198|537829563|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
149095386|NCT03175198|537829563|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
149095387|NCT03175198|537829563|FG000|Overall Study|To conduct invasive treatment of operation|53|||
149095388|NCT03175198|537829563|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
149095389|NCT01200485|537829568|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
149095390|NCT01200485|537829569|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
149095391|NCT01200485|537829570|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
149095392|NCT01200485|537829568|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
149095393|NCT01200485|537829569|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
149095394|NCT01200485|537829570|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
149095395|NCT06080438|537829571|FG000|Overall Study|Lost to Follow-up|2|||
149095396|NCT03589300|537829573|FG000|Overall Study|Adverse Event|2|||
149095397|NCT03589300|537829573|FG000|Overall Study|Death|4|||
149095398|NCT03589300|537829573|FG000|Overall Study|Lost to Follow-up|12|||
149095399|NCT03589300|537829573|FG000|Overall Study|Withdrawal by Subject|5|||
149095400|NCT02630706|537829574|FG000|Overall Study|Adverse Event|2|||
149095401|NCT02630706|537829575|FG001|Overall Study|Adverse Event|1|||
149095402|NCT02630706|537829576|FG002|Overall Study|Adverse Event|1|||
149095403|NCT02630706|537829574|FG000|Overall Study|Lost to Follow-up|0|||
149095404|NCT02630706|537829575|FG001|Overall Study|Lost to Follow-up|1|||
149095405|NCT02630706|537829576|FG002|Overall Study|Lost to Follow-up|2|||
149095406|NCT02630706|537829574|FG000|Overall Study|Physician Decision|1|||
149095407|NCT02630706|537829575|FG001|Overall Study|Physician Decision|1|||
149095408|NCT02630706|537829576|FG002|Overall Study|Physician Decision|0|||
149095409|NCT02630706|537829574|FG000|Overall Study|Pregnancy|0|||
149095410|NCT02630706|537829575|FG001|Overall Study|Pregnancy|1|||
149095411|NCT02630706|537829576|FG002|Overall Study|Pregnancy|0|||
149095412|NCT02630706|537829574|FG000|Overall Study|Withdrawal by Subject|4|||
149095413|NCT02630706|537829575|FG001|Overall Study|Withdrawal by Subject|5|||
149095414|NCT02630706|537829576|FG002|Overall Study|Withdrawal by Subject|7|||
149095415|NCT01678898|537829578|FG000|PB-102-F01|Adverse Event|0|||
149095416|NCT01678898|537829579|FG001|PB-102-F01|Adverse Event|1|||
149095417|NCT01678898|537829580|FG002|PB-102-F01|Adverse Event|0|||
149095418|NCT01678898|537829578|FG000|PB-102-F01|Physician Decision|0|||
149095419|NCT01678898|537829579|FG001|PB-102-F01|Physician Decision|1|||
149095420|NCT01678898|537829580|FG002|PB-102-F01|Physician Decision|0|||
149095421|NCT00776984|537829581|FG000|Overall Study|Adverse Event|8|||
149095422|NCT00776984|537829582|FG001|Overall Study|Adverse Event|2|||
149095423|NCT00776984|537829581|FG000|Overall Study|Protocol Violation|4|||
149095424|NCT00776984|537829582|FG001|Overall Study|Protocol Violation|2|||
149095425|NCT00776984|537829581|FG000|Overall Study|Lost to Follow-up|2|||
149095426|NCT00776984|537829582|FG001|Overall Study|Lost to Follow-up|0|||
149095427|NCT00776984|537829581|FG000|Overall Study|Withdrawal by Subject|12|||
149095428|NCT00776984|537829582|FG001|Overall Study|Withdrawal by Subject|7|||
149095429|NCT00776984|537829581|FG000|Overall Study|Lack of Efficacy|0|||
149095430|NCT00776984|537829582|FG001|Overall Study|Lack of Efficacy|1|||
149095431|NCT00776984|537829581|FG000|Overall Study|Other|5|||
149095432|NCT00776984|537829582|FG001|Overall Study|Other|9|||
149095433|NCT01544309|537829585|FG000|Overall Study|Withdrawal by Subject|12|||
149095434|NCT01544309|537829586|FG001|Overall Study|Withdrawal by Subject|7|||
149095435|NCT01544309|537829585|FG000|Overall Study|Protocol Violation|2|||
149095436|NCT01544309|537829586|FG001|Overall Study|Protocol Violation|1|||
149095437|NCT01544309|537829585|FG000|Overall Study|Physician Decision|4|||
149095438|NCT01544309|537829586|FG001|Overall Study|Physician Decision|1|||
149095439|NCT01544309|537829585|FG000|Overall Study|Not performed pre-dose examination|1|||
149095440|NCT01544309|537829586|FG001|Overall Study|Not performed pre-dose examination|2|||
149095441|NCT01544309|537829585|FG000|Overall Study|Administered prohibit prior medication|1|||
149095442|NCT01544309|537829586|FG001|Overall Study|Administered prohibit prior medication|0|||
149095443|NCT02551692|537829589|FG000|Overall Study|Lost to Follow-up|0|||
149095444|NCT02551692|537829590|FG001|Overall Study|Lost to Follow-up|1|||
149095445|NCT02551692|537829591|FG002|Overall Study|Lost to Follow-up|4|||
149095446|NCT02551692|537829589|FG000|Overall Study|Withdrawal by Subject|1|||
149095447|NCT02551692|537829590|FG001|Overall Study|Withdrawal by Subject|0|||
149095448|NCT02551692|537829591|FG002|Overall Study|Withdrawal by Subject|1|||
149095449|NCT01091519|537829592|FG000|Overall Study|Adverse Event|12|||
149095450|NCT01091519|537829593|FG001|Overall Study|Adverse Event|16|||
149095451|NCT01091519|537829592|FG000|Overall Study|Death|1|||
149095452|NCT01091519|537829593|FG001|Overall Study|Death|0|||
149095453|NCT01091519|537829592|FG000|Overall Study|Lack of Efficacy|16|||
149095454|NCT01091519|537829593|FG001|Overall Study|Lack of Efficacy|19|||
149095455|NCT01091519|537829592|FG000|Overall Study|Lost to Follow-up|14|||
149095456|NCT01091519|537829593|FG001|Overall Study|Lost to Follow-up|24|||
149095457|NCT01091519|537829592|FG000|Overall Study|Withdrawal by Subject|2|||
149095458|NCT01091519|537829593|FG001|Overall Study|Withdrawal by Subject|2|||
149095459|NCT01091519|537829592|FG000|Overall Study|Other|6|||
149095460|NCT01091519|537829593|FG001|Overall Study|Other|8|||
149095461|NCT01091519|537829592|FG000|Overall Study|Randomized not treated|4|||
149095462|NCT01091519|537829593|FG001|Overall Study|Randomized not treated|4|||
149095463|NCT01196741|537829596|FG000|Overall Study|Disease progression|34|||
149095464|NCT01196741|537829597|FG001|Overall Study|Disease progression|14|||
149095465|NCT01196741|537829596|FG000|Overall Study|Adverse Event|10|||
149095466|NCT01196741|537829597|FG001|Overall Study|Adverse Event|6|||
149095467|NCT01196741|537829596|FG000|Overall Study|Serious Adverse Event|3|||
149095468|NCT01196741|537829597|FG001|Overall Study|Serious Adverse Event|1|||
149095469|NCT01196741|537829596|FG000|Overall Study|Dose limiting Adverse Event|2|||
149095470|NCT01196741|537829597|FG001|Overall Study|Dose limiting Adverse Event|1|||
149095471|NCT01196741|537829596|FG000|Overall Study|Withdrawal by Subject|3|||
149095472|NCT01196741|537829597|FG001|Overall Study|Withdrawal by Subject|0|||
149095473|NCT01196741|537829596|FG000|Overall Study|Other reason|3|||
149095474|NCT01196741|537829597|FG001|Overall Study|Other reason|3|||
149095475|NCT01196741|537829596|FG000|Overall Study|Other|3|||
149095476|NCT01196741|537829597|FG001|Overall Study|Other|2|||
149095477|NCT01196741|537829596|FG000|Overall Study|Protocol Violation|2|||
149095478|NCT01196741|537829597|FG001|Overall Study|Protocol Violation|1|||
149095479|NCT01227928|537829598|FG000|Overall Study|Lost to Follow-up|4|||
149095480|NCT01227928|537829599|FG001|Overall Study|Lost to Follow-up|2|||
149095481|NCT01227928|537829598|FG000|Overall Study|Withdrawal by Subject|4|||
149095482|NCT01227928|537829599|FG001|Overall Study|Withdrawal by Subject|3|||
149095483|NCT01227928|537829598|FG000|Overall Study|Death|14|||
149095484|NCT01227928|537829599|FG001|Overall Study|Death|12|||
149095485|NCT04582864|537829600|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
149095486|NCT04582864|537829600|FG000|Overall Study|Death|1|||
149095487|NCT01204775|537829603|FG000|Overall Study|Poor/non-compliance|0|||
149095488|NCT01204775|537829604|FG001|Overall Study|Poor/non-compliance|1|||
149095489|NCT01204775|537829603|FG000|Overall Study|Withdrawal by Subject|1|||
149095490|NCT01204775|537829604|FG001|Overall Study|Withdrawal by Subject|0|||
149095491|NCT00276016|537829605|FG000|Intervention 1|Withdrawal by Subject|0|||
149095492|NCT00276016|537829606|FG001|Intervention 1|Withdrawal by Subject|1|||
149095493|NCT00276016|537829607|FG002|Intervention 1|Withdrawal by Subject|0|||
149095494|NCT00276016|537829608|FG003|Intervention 1|Withdrawal by Subject|0|||
149095495|NCT00276016|537829609|FG004|Intervention 1|Withdrawal by Subject|0|||
149095496|NCT00276016|537829610|FG005|Intervention 1|Withdrawal by Subject|0|||
149095497|NCT02056873|537829615|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
149095498|NCT00605566|537831466|FG000|Overall Study|Adverse Event|1|||
149095499|NCT00605566|537831466|FG000|Overall Study|Clinical deterioration|1|||
149095500|NCT00605566|537831466|FG000|Overall Study|Poor compliance in run-in period|1|||
149095501|NCT01932762|537831469|FG000|Overall Study|Withdrawal by Subject|1|||
149095502|NCT01932762|537831470|FG001|Overall Study|Withdrawal by Subject|2|||
149095503|NCT01932762|537831471|FG002|Overall Study|Withdrawal by Subject|0|||
149095504|NCT01932762|537831472|FG003|Overall Study|Withdrawal by Subject|0|||
149095505|NCT01932762|537831469|FG000|Overall Study|Lost to Follow-up|4|||
149095506|NCT01932762|537831470|FG001|Overall Study|Lost to Follow-up|0|||
149095507|NCT01932762|537831471|FG002|Overall Study|Lost to Follow-up|0|||
149095508|NCT01932762|537831472|FG003|Overall Study|Lost to Follow-up|1|||
149095509|NCT01932762|537831469|FG000|Overall Study|Physician Decision|1|||
149095510|NCT01932762|537831470|FG001|Overall Study|Physician Decision|0|||
149095511|NCT01932762|537831471|FG002|Overall Study|Physician Decision|0|||
149095512|NCT01932762|537831472|FG003|Overall Study|Physician Decision|0|||
149095513|NCT03864341|537831473|FG000|Overall Study|Withdrawal by Subject|1|||
149095514|NCT01066936|537831474|FG000|Overall Study|Death|2|||
149095515|NCT01066936|537831474|FG000|Overall Study|Device revised/removed|1|||
149095516|NCT01066936|537831474|FG000|Overall Study|Lost to Follow-up|3|||
149095517|NCT01066936|537831474|FG000|Overall Study|Withdrawal by Subject|4|||
149095518|NCT00695136|537831475|FG000|Overall Study|Withdrawal by Subject|1|||
149095519|NCT00695136|537831475|FG000|Overall Study|unrelated adverse event|1|||
149095520|NCT01726049|537831477|FG000|Overall Study|Death|1|||
149095521|NCT01726049|537831478|FG001|Overall Study|Death|1|||
149095522|NCT01726049|537831477|FG000|Overall Study|Adverse Event|4|||
149095523|NCT01726049|537831478|FG001|Overall Study|Adverse Event|1|||
149095524|NCT01726049|537831477|FG000|Overall Study|refused second HC|0|||
149095525|NCT01726049|537831478|FG001|Overall Study|refused second HC|2|||
149095526|NCT04156399|537831483|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
149095527|NCT04156399|537831483|FG000|Overall Study|study suspension due to COVID pandemic|3|||
149095528|NCT01333111|537831486|FG000|Overall Study|patient undergoing major surgery|0|||
149095529|NCT01333111|537831487|FG001|Overall Study|patient undergoing major surgery|2|||
149095530|NCT01333111|537831488|FG002|Overall Study|patient undergoing major surgery|0|||
149095531|NCT01333111|537831486|FG000|Overall Study|personal reasons|0|||
149095532|NCT01333111|537831487|FG001|Overall Study|personal reasons|0|||
149095533|NCT01333111|537831488|FG002|Overall Study|personal reasons|1|||
149095534|NCT01333111|537831486|FG000|Overall Study|unclassified|1|||
149095535|NCT01333111|537831487|FG001|Overall Study|unclassified|0|||
149095536|NCT01333111|537831488|FG002|Overall Study|unclassified|0|||
149095537|NCT01333111|537831486|FG000|Overall Study|withdrawal criteria|0|||
149095538|NCT01333111|537831487|FG001|Overall Study|withdrawal criteria|1|||
149095539|NCT01333111|537831488|FG002|Overall Study|withdrawal criteria|0|||
149095540|NCT01333111|537831486|FG000|Overall Study|Non-compliance|1|||
149095541|NCT01333111|537831487|FG001|Overall Study|Non-compliance|0|||
149095542|NCT01333111|537831488|FG002|Overall Study|Non-compliance|0|||
149095543|NCT01333111|537831486|FG000|Overall Study|Ineffective therapy|0|||
149095544|NCT01333111|537831487|FG001|Overall Study|Ineffective therapy|0|||
149095545|NCT01333111|537831488|FG002|Overall Study|Ineffective therapy|1|||
149095546|NCT02418845|537831494|FG000|Overall Study|Lost to Follow-up|7|||
149095547|NCT02418845|537831495|FG001|Overall Study|Lost to Follow-up|2|||
149095548|NCT02418845|537831494|FG000|Overall Study|Lack of Efficacy|0|||
149095549|NCT02418845|537831495|FG001|Overall Study|Lack of Efficacy|3|||
149095550|NCT02418845|537831494|FG000|Overall Study|Physician Decision|5|||
149095551|NCT02418845|537831495|FG001|Overall Study|Physician Decision|5|||
149095552|NCT02418845|537831494|FG000|Overall Study|Protocol Violation|1|||
149095553|NCT02418845|537831495|FG001|Overall Study|Protocol Violation|0|||
149095554|NCT02418845|537831494|FG000|Overall Study|Withdrawal by Subject|3|||
149095555|NCT02418845|537831495|FG001|Overall Study|Withdrawal by Subject|2|||
149095556|NCT00487552|537831499|FG000|Overall Study|Unsuccessful magnet placements|3|||
149095557|NCT00487552|537831499|FG000|Overall Study|Death due to progressive malignancy|2|||
149095558|NCT00487552|537831499|FG000|Overall Study|Stent not placed|1|||
149095559|NCT03119688|537831500|FG000|Overall Study|Adverse Event|4|||
149095560|NCT02705625|537831501|FG000|Overall Study|Protocol Violation|1|||
149095561|NCT02705625|537831502|FG001|Overall Study|Protocol Violation|0|||
149095562|NCT02705625|537831503|FG002|Overall Study|Protocol Violation|0|||
149095563|NCT02705625|537831501|FG000|Overall Study|Adverse Event|6|||
149095564|NCT02705625|537831502|FG001|Overall Study|Adverse Event|5|||
149095565|NCT02705625|537831503|FG002|Overall Study|Adverse Event|2|||
149095566|NCT02705625|537831501|FG000|Overall Study|Death|0|||
149095567|NCT02705625|537831502|FG001|Overall Study|Death|0|||
149095568|NCT02705625|537831503|FG002|Overall Study|Death|1|||
149095569|NCT02705625|537831501|FG000|Overall Study|Withdrawal by Subject|1|||
149095570|NCT02705625|537831502|FG001|Overall Study|Withdrawal by Subject|4|||
149095571|NCT02705625|537831503|FG002|Overall Study|Withdrawal by Subject|5|||
149095572|NCT02705625|537831501|FG000|Overall Study|Lost to Follow-up|0|||
149095573|NCT02705625|537831502|FG001|Overall Study|Lost to Follow-up|0|||
149095574|NCT02705625|537831503|FG002|Overall Study|Lost to Follow-up|1|||
149095575|NCT02705625|537831501|FG000|Overall Study|Non-compliance|0|||
149095576|NCT02705625|537831502|FG001|Overall Study|Non-compliance|1|||
149095577|NCT02705625|537831503|FG002|Overall Study|Non-compliance|1|||
149095578|NCT02705625|537831501|FG000|Overall Study|Overdosing|0|||
149095579|NCT02705625|537831502|FG001|Overall Study|Overdosing|0|||
149095580|NCT02705625|537831503|FG002|Overall Study|Overdosing|1|||
149095581|NCT00863798|537831504|FG000|Overall Study|Adverse Event|5|||
149095582|NCT00863798|537831505|FG001|Overall Study|Adverse Event|2|||
149095583|NCT00863798|537831506|FG002|Overall Study|Adverse Event|4|||
149095584|NCT00863798|537831504|FG000|Overall Study|Participant failed to return|2|||
149095585|NCT00863798|537831505|FG001|Overall Study|Participant failed to return|1|||
149095586|NCT00863798|537831506|FG002|Overall Study|Participant failed to return|0|||
149095587|NCT00863798|537831504|FG000|Overall Study|Investigator request|1|||
149095588|NCT00863798|537831505|FG001|Overall Study|Investigator request|2|||
149095589|NCT00863798|537831506|FG002|Overall Study|Investigator request|1|||
149095590|NCT00863798|537831504|FG000|Overall Study|Lack of Efficacy|4|||
149095591|NCT00863798|537831505|FG001|Overall Study|Lack of Efficacy|3|||
149095592|NCT00863798|537831506|FG002|Overall Study|Lack of Efficacy|6|||
149095593|NCT00863798|537831504|FG000|Overall Study|Lost to Follow-up|6|||
149095594|NCT00863798|537831505|FG001|Overall Study|Lost to Follow-up|9|||
149095595|NCT00863798|537831506|FG002|Overall Study|Lost to Follow-up|5|||
149095596|NCT00863798|537831504|FG000|Overall Study|Other|2|||
149095597|NCT00863798|537831505|FG001|Overall Study|Other|3|||
149095598|NCT00863798|537831506|FG002|Overall Study|Other|1|||
149095599|NCT00863798|537831504|FG000|Overall Study|Protocol Violation|0|||
149095600|NCT00863798|537831505|FG001|Overall Study|Protocol Violation|1|||
149095601|NCT00863798|537831506|FG002|Overall Study|Protocol Violation|1|||
149095602|NCT00863798|537831504|FG000|Overall Study|Withdrawal by Subject|8|||
149095603|NCT00863798|537831505|FG001|Overall Study|Withdrawal by Subject|7|||
149095604|NCT00863798|537831506|FG002|Overall Study|Withdrawal by Subject|4|||
149095605|NCT00863798|537831504|FG000|Overall Study|Randomized not treated|4|||
149095606|NCT00863798|537831505|FG001|Overall Study|Randomized not treated|2|||
149095607|NCT00863798|537831506|FG002|Overall Study|Randomized not treated|3|||
149095608|NCT01470599|537831507|FG000|Overall Study|Did not meet entrance criteria|1|||
149095609|NCT01470599|537831508|FG001|Overall Study|Did not meet entrance criteria|0|||
149095610|NCT01470599|537831507|FG000|Overall Study|Lost to Follow-up|2|||
149095611|NCT01470599|537831508|FG001|Overall Study|Lost to Follow-up|1|||
149095612|NCT01470599|537831507|FG000|Overall Study|Withdrawal by Subject|3|||
149095613|NCT01470599|537831508|FG001|Overall Study|Withdrawal by Subject|4|||
149095614|NCT01470599|537831507|FG000|Overall Study|Other|1|||
149095615|NCT01470599|537831508|FG001|Overall Study|Other|0|||
149095616|NCT01470599|537831507|FG000|Overall Study|Protocol Violation|3|||
149095617|NCT01470599|537831508|FG001|Overall Study|Protocol Violation|1|||
149095618|NCT01470599|537831507|FG000|Overall Study|Adverse event related to study drug|2|||
149095619|NCT01470599|537831508|FG001|Overall Study|Adverse event related to study drug|5|||
149095620|NCT01470599|537831507|FG000|Overall Study|Insufficient clinical response|6|||
149095621|NCT01470599|537831508|FG001|Overall Study|Insufficient clinical response|27|||
149095622|NCT01470599|537831507|FG000|Overall Study|Adverse event not related to study drug|1|||
149095623|NCT01470599|537831508|FG001|Overall Study|Adverse event not related to study drug|5|||
149095624|NCT00195442|537831509|FG000|Overall Study|Less than expected therapeutic effect|38|||
149095625|NCT00195442|537831509|FG000|Overall Study|Lost to Follow-up|27|||
149095626|NCT00195442|537831509|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
149095627|NCT00195442|537831509|FG000|Overall Study|Intermittent product shortage|21|||
149095628|NCT00195442|537831509|FG000|Overall Study|Death|7|||
149095629|NCT00195442|537831509|FG000|Overall Study|No reason specified|4|||
149095630|NCT00195442|537831509|FG000|Overall Study|Poor cooperation|2|||
149095631|NCT00195442|537831509|FG000|Overall Study|Other|14|||
149095632|NCT00847132|537831512|FG000|Overall Study|Death|1|||
149095633|NCT00847132|537831513|FG001|Overall Study|Death|1|||
149095634|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
149095635|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
149095636|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
149095637|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
149095638|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
149095639|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
149095640|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
149095641|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
149095642|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
149095643|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
149095644|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
149095645|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
149095646|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
149095647|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
149095648|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
149095649|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
149095650|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
149095651|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
149095652|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
149095653|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
149095654|NCT02637856|537831520|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
149095655|NCT02637856|537831521|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
149095656|NCT02637856|537831520|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
149095657|NCT02637856|537831521|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
149095658|NCT02637856|537831520|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
149095659|NCT02637856|537831521|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
149095660|NCT02509312|537831522|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
149095661|NCT02509312|537831523|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
149095662|NCT02509312|537831522|FG000|Overall Study|Obstetrician refusal|0|||
149095663|NCT02509312|537831523|FG001|Overall Study|Obstetrician refusal|1|||
149095664|NCT02509312|537831522|FG000|Overall Study|Patient elected for TOLAC|1|||
149095665|NCT02509312|537831523|FG001|Overall Study|Patient elected for TOLAC|0|||
149095666|NCT02509312|537831522|FG000|Overall Study|Cesarean deemed stat|1|||
149095667|NCT02509312|537831523|FG001|Overall Study|Cesarean deemed stat|0|||
149095668|NCT02509312|537831522|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
149095669|NCT02509312|537831523|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
149095670|NCT02815735|537831524|FG000|First Intervention (4 Weeks)|Discomfort|1|||
149095671|NCT02815735|537831525|FG001|First Intervention (4 Weeks)|Discomfort|0|||
149095672|NCT02815735|537831524|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
149095673|NCT02815735|537831525|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
149095674|NCT02815735|537831524|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
149095675|NCT02815735|537831525|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
149095676|NCT02815735|537831524|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
149095677|NCT02815735|537831525|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
149095678|NCT00702650|537831526|FG000|Overall Study|Withdrawal by Subject|9|||
149095679|NCT00702650|537831526|FG000|Overall Study|Non-Compliance of Study Drug|3|||
149095680|NCT00702650|537831526|FG000|Overall Study|Lost to Follow-up|2|||
149095681|NCT00702650|537831526|FG000|Overall Study|Non-Compliance with Site Directives|1|||
149095682|NCT00702650|537831526|FG000|Overall Study|Sponsor Request|1|||
149095683|NCT00702650|537831526|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
149095684|NCT00702650|537831526|FG000|Overall Study|Adverse Event|3|||
149095685|NCT00943722|537831528|FG000|Base Study|Adverse Event|0|||
149095686|NCT00943722|537831529|FG001|Base Study|Adverse Event|0|||
149095687|NCT00943722|537831530|FG002|Base Study|Adverse Event|0|||
149095688|NCT00943722|537831531|FG003|Base Study|Adverse Event|1|||
149095689|NCT00943722|537831532|FG004|Base Study|Adverse Event|0|||
149095690|NCT00943722|537831533|FG005|Base Study|Adverse Event|0|||
149095691|NCT00943722|537831534|FG006|Base Study|Adverse Event|0|||
149095692|NCT00943722|537831528|FG000|Base Study|Lost to Follow-up|12|||
149095693|NCT00943722|537831529|FG001|Base Study|Lost to Follow-up|8|||
149095694|NCT00943722|537831530|FG002|Base Study|Lost to Follow-up|10|||
149095695|NCT00943722|537831531|FG003|Base Study|Lost to Follow-up|8|||
149095696|NCT00943722|537831532|FG004|Base Study|Lost to Follow-up|11|||
149095697|NCT00943722|537831533|FG005|Base Study|Lost to Follow-up|0|||
149095698|NCT00943722|537831534|FG006|Base Study|Lost to Follow-up|0|||
149095699|NCT00943722|537831528|FG000|Base Study|Physician Decision|1|||
149095700|NCT00943722|537831529|FG001|Base Study|Physician Decision|0|||
149095701|NCT00943722|537831530|FG002|Base Study|Physician Decision|0|||
149095702|NCT00943722|537831531|FG003|Base Study|Physician Decision|0|||
149095703|NCT00943722|537831532|FG004|Base Study|Physician Decision|1|||
149095704|NCT00943722|537831533|FG005|Base Study|Physician Decision|0|||
149095705|NCT00943722|537831534|FG006|Base Study|Physician Decision|0|||
149095706|NCT00943722|537831528|FG000|Base Study|Pregnancy|0|||
149095707|NCT00943722|537831529|FG001|Base Study|Pregnancy|0|||
149095708|NCT00943722|537831530|FG002|Base Study|Pregnancy|1|||
149095709|NCT00943722|537831531|FG003|Base Study|Pregnancy|0|||
149095710|NCT00943722|537831532|FG004|Base Study|Pregnancy|2|||
149095711|NCT00943722|537831533|FG005|Base Study|Pregnancy|0|||
149095712|NCT00943722|537831534|FG006|Base Study|Pregnancy|0|||
149095713|NCT00943722|537831528|FG000|Base Study|Protocol Violation|0|||
149095714|NCT00943722|537831529|FG001|Base Study|Protocol Violation|1|||
149095715|NCT00943722|537831530|FG002|Base Study|Protocol Violation|0|||
149095716|NCT00943722|537831531|FG003|Base Study|Protocol Violation|0|||
149095717|NCT00943722|537831532|FG004|Base Study|Protocol Violation|2|||
149095718|NCT00943722|537831533|FG005|Base Study|Protocol Violation|0|||
149095719|NCT00943722|537831534|FG006|Base Study|Protocol Violation|0|||
149095720|NCT00943722|537831528|FG000|Base Study|Withdrawal by Subject|12|||
149095721|NCT00943722|537831529|FG001|Base Study|Withdrawal by Subject|13|||
149095722|NCT00943722|537831530|FG002|Base Study|Withdrawal by Subject|2|||
149095723|NCT00943722|537831531|FG003|Base Study|Withdrawal by Subject|13|||
149095724|NCT00943722|537831532|FG004|Base Study|Withdrawal by Subject|8|||
149095725|NCT00943722|537831533|FG005|Base Study|Withdrawal by Subject|0|||
149095726|NCT00943722|537831534|FG006|Base Study|Withdrawal by Subject|0|||
149095727|NCT00943722|537831528|FG000|Base Study|Month 12 visit not completed|0|||
149095728|NCT00943722|537831529|FG001|Base Study|Month 12 visit not completed|0|||
149095729|NCT00943722|537831530|FG002|Base Study|Month 12 visit not completed|0|||
149095730|NCT00943722|537831531|FG003|Base Study|Month 12 visit not completed|0|||
149095731|NCT00943722|537831532|FG004|Base Study|Month 12 visit not completed|2|||
149095732|NCT00943722|537831533|FG005|Base Study|Month 12 visit not completed|0|||
149095733|NCT00943722|537831534|FG006|Base Study|Month 12 visit not completed|0|||
149095734|NCT00943722|537831528|FG000|First Extension Study: EXT 1|Adverse Event|0|||
149095735|NCT00943722|537831529|FG001|First Extension Study: EXT 1|Adverse Event|0|||
149095736|NCT00943722|537831530|FG002|First Extension Study: EXT 1|Adverse Event|0|||
149095737|NCT00943722|537831531|FG003|First Extension Study: EXT 1|Adverse Event|0|||
149095738|NCT00943722|537831532|FG004|First Extension Study: EXT 1|Adverse Event|0|||
149095739|NCT00943722|537831533|FG005|First Extension Study: EXT 1|Adverse Event|1|||
149095740|NCT00943722|537831534|FG006|First Extension Study: EXT 1|Adverse Event|0|||
149095741|NCT00943722|537831528|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
149095742|NCT00943722|537831529|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
149095743|NCT00943722|537831530|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
149095744|NCT00943722|537831531|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
149095745|NCT00943722|537831532|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
149095746|NCT00943722|537831533|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
149095747|NCT00943722|537831534|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
149095748|NCT00943722|537831528|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
149095749|NCT00943722|537831529|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
149095750|NCT00943722|537831530|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
149095751|NCT00943722|537831531|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
149095752|NCT00943722|537831532|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
149095753|NCT00943722|537831533|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
149095754|NCT00943722|537831534|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
149095755|NCT00943722|537831528|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
149095756|NCT00943722|537831529|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
149095757|NCT00943722|537831530|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
149095758|NCT00943722|537831531|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
149095759|NCT00943722|537831532|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
149095760|NCT00943722|537831533|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
149095761|NCT00943722|537831534|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
149095762|NCT00943722|537831528|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
149095763|NCT00943722|537831529|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
149095764|NCT00943722|537831530|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
149095765|NCT00943722|537831531|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
149095766|NCT00943722|537831532|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
149095767|NCT00943722|537831533|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
149095768|NCT00943722|537831534|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
149095769|NCT00943722|537831528|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
149095770|NCT00943722|537831529|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
149095771|NCT00943722|537831530|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
149095772|NCT00943722|537831531|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
149095773|NCT00943722|537831532|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
149095774|NCT00943722|537831533|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
149095775|NCT00943722|537831534|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
149095776|NCT00943722|537831528|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
149095777|NCT00943722|537831529|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
149095778|NCT00943722|537831530|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
149095779|NCT00943722|537831531|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
149095780|NCT00943722|537831532|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
149095781|NCT00943722|537831533|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
149095782|NCT00943722|537831534|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
149095783|NCT00943722|537831528|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
149095784|NCT00943722|537831529|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
149095785|NCT00943722|537831530|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
149095786|NCT00943722|537831531|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
149095787|NCT00943722|537831532|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
149095788|NCT00943722|537831533|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
149095789|NCT00943722|537831534|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
149095790|NCT00943722|537831528|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
149095791|NCT00943722|537831529|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
149095792|NCT00943722|537831530|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
149095793|NCT00943722|537831531|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
149095794|NCT00943722|537831532|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
149095795|NCT00943722|537831533|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
149095796|NCT00943722|537831534|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
149095797|NCT01772823|537831535|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
149095798|NCT01772823|537831536|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
149095799|NCT01772823|537831535|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
149095800|NCT01772823|537831536|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
149095801|NCT01772823|537831535|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
149095802|NCT01772823|537831536|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
149095803|NCT01772823|537831535|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
149095804|NCT01772823|537831536|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
149095805|NCT01772823|537831535|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
149095806|NCT01772823|537831536|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
149095807|NCT01772823|537831535|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
149095808|NCT01772823|537831536|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
149095809|NCT01772823|537831535|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
149095810|NCT01772823|537831536|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
149095811|NCT01772823|537831535|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
149095812|NCT01772823|537831536|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
149095813|NCT01772823|537831535|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
149095814|NCT01772823|537831536|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
149095815|NCT01772823|537831535|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
149095816|NCT01772823|537831536|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
149095817|NCT01772823|537831535|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
149095818|NCT01772823|537831536|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
149095819|NCT01772823|537831535|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
149095820|NCT01772823|537831536|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
149095821|NCT01772823|537831535|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
149095822|NCT01772823|537831536|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
149095823|NCT01772823|537831535|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
149095824|NCT01772823|537831536|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
149095825|NCT01772823|537831535|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
149095826|NCT01772823|537831536|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
149095827|NCT01772823|537831535|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
149095828|NCT01772823|537831536|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
149095829|NCT01036165|537831541|FG000|Overall Study|Adverse Event|6|||
149095830|NCT01036165|537831541|FG000|Overall Study|Lost to Follow-up|2|||
149095831|NCT01036165|537831541|FG000|Overall Study|Withdrawal by Subject|3|||
149095832|NCT01036165|537831541|FG000|Overall Study|Device Related Issues|3|||
149095833|NCT01036165|537831541|FG000|Overall Study|Problems finding proper area to inject|1|||
149095834|NCT02895360|537831544|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
149095835|NCT02895360|537831545|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
149095836|NCT02895360|537831546|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
149095837|NCT02895360|537831547|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
149095838|NCT02895360|537831548|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
149095839|NCT02895360|537831549|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
149095840|NCT02895360|537831544|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
149095841|NCT02895360|537831545|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
149095842|NCT02895360|537831546|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
149095843|NCT02895360|537831547|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
149095844|NCT02895360|537831548|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
149095845|NCT02895360|537831549|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
149095846|NCT02895360|537831544|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
149095847|NCT02895360|537831545|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
149095848|NCT02895360|537831546|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
149095849|NCT02895360|537831547|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
149095850|NCT02895360|537831548|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
149095851|NCT02895360|537831549|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
149095852|NCT02895360|537831544|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
149095853|NCT02895360|537831545|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
149095854|NCT02895360|537831546|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
149095855|NCT02895360|537831547|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
149095856|NCT02895360|537831548|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
149095857|NCT02895360|537831549|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
149095858|NCT02895360|537831544|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
149095859|NCT02895360|537831545|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
149095860|NCT02895360|537831546|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
149095861|NCT02895360|537831547|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
149095862|NCT02895360|537831548|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
149095863|NCT02895360|537831549|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
149095864|NCT02895360|537831544|FG000|Phase 2a|Adverse Event|0|||
149095865|NCT02895360|537831545|FG001|Phase 2a|Adverse Event|0|||
149095866|NCT02895360|537831546|FG002|Phase 2a|Adverse Event|0|||
149095867|NCT02895360|537831547|FG003|Phase 2a|Adverse Event|0|||
149095868|NCT02895360|537831548|FG004|Phase 2a|Adverse Event|0|||
149095869|NCT02895360|537831549|FG005|Phase 2a|Adverse Event|1|||
149095870|NCT02895360|537831544|FG000|Phase 2a|Progressive disease|0|||
149095871|NCT02895360|537831545|FG001|Phase 2a|Progressive disease|0|||
149095872|NCT02895360|537831546|FG002|Phase 2a|Progressive disease|0|||
149095873|NCT02895360|537831547|FG003|Phase 2a|Progressive disease|0|||
149095874|NCT02895360|537831548|FG004|Phase 2a|Progressive disease|11|||
149095875|NCT02895360|537831549|FG005|Phase 2a|Progressive disease|11|||
149095876|NCT00307164|537831550|FG000|Overall Study|Death|1|||
149095877|NCT00307164|537831551|FG001|Overall Study|Death|0|||
149095878|NCT00307164|537831550|FG000|Overall Study|Severe debilitation, unable to continue|1|||
149095879|NCT00307164|537831551|FG001|Overall Study|Severe debilitation, unable to continue|0|||
149095880|NCT00307164|537831550|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
149095881|NCT00307164|537831551|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
149095882|NCT00307164|537831550|FG000|Overall Study|Withdrawal by Subject|1|||
149095883|NCT00307164|537831551|FG001|Overall Study|Withdrawal by Subject|8|||
149095884|NCT00307164|537831550|FG000|Overall Study|Not compliant with requirements|4|||
149095885|NCT00307164|537831551|FG001|Overall Study|Not compliant with requirements|4|||
149095886|NCT00307164|537831550|FG000|Overall Study|Lost to Follow-up|6|||
149095887|NCT00307164|537831551|FG001|Overall Study|Lost to Follow-up|1|||
149095888|NCT01649297|537831553|FG000|Overall Study|Adverse Event|5|||
149095889|NCT01649297|537831554|FG001|Overall Study|Adverse Event|5|||
149095890|NCT01649297|537831555|FG002|Overall Study|Adverse Event|4|||
149095891|NCT01649297|537831556|FG003|Overall Study|Adverse Event|13|||
149095892|NCT01649297|537831557|FG004|Overall Study|Adverse Event|1|||
149095893|NCT01649297|537831553|FG000|Overall Study|Lack of Efficacy|0|||
149095894|NCT01649297|537831554|FG001|Overall Study|Lack of Efficacy|0|||
149095895|NCT01649297|537831555|FG002|Overall Study|Lack of Efficacy|0|||
149095896|NCT01649297|537831556|FG003|Overall Study|Lack of Efficacy|0|||
149095897|NCT01649297|537831557|FG004|Overall Study|Lack of Efficacy|1|||
149095898|NCT01649297|537831553|FG000|Overall Study|Non compliant with Protocol|1|||
149095899|NCT01649297|537831554|FG001|Overall Study|Non compliant with Protocol|0|||
149095900|NCT01649297|537831555|FG002|Overall Study|Non compliant with Protocol|3|||
149095901|NCT01649297|537831556|FG003|Overall Study|Non compliant with Protocol|2|||
149095902|NCT01649297|537831557|FG004|Overall Study|Non compliant with Protocol|1|||
149095903|NCT01649297|537831553|FG000|Overall Study|Lost to Follow-up|1|||
149095904|NCT01649297|537831554|FG001|Overall Study|Lost to Follow-up|1|||
149095905|NCT01649297|537831555|FG002|Overall Study|Lost to Follow-up|4|||
149095906|NCT01649297|537831556|FG003|Overall Study|Lost to Follow-up|3|||
149095907|NCT01649297|537831557|FG004|Overall Study|Lost to Follow-up|0|||
149095908|NCT01649297|537831553|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
149095909|NCT01649297|537831554|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
149095910|NCT01649297|537831555|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
149095911|NCT01649297|537831556|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
149095912|NCT01649297|537831557|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
149095913|NCT01649297|537831553|FG000|Overall Study|For other reason|4|||
149095914|NCT01649297|537831554|FG001|Overall Study|For other reason|1|||
149095915|NCT01649297|537831555|FG002|Overall Study|For other reason|2|||
149095916|NCT01649297|537831556|FG003|Overall Study|For other reason|0|||
149095917|NCT01649297|537831557|FG004|Overall Study|For other reason|0|||
149095918|NCT01685047|537831558|FG000|Overall Study|Withdrawal by Subject|20|||
149095919|NCT01685047|537831558|FG000|Overall Study|Death|26|||
149095920|NCT01685047|537831558|FG000|Overall Study|Lost to Follow-up|8|||
149095921|NCT01685047|537831558|FG000|Overall Study|Physician Decision|25|||
149095922|NCT01685047|537831558|FG000|Overall Study|Adverse Event|5|||
149095923|NCT01685047|537831558|FG000|Overall Study|patient withdrawn by sponsor|1|||
149095924|NCT01732926|537831560|FG000|Overall Study|Study Terminated by Sponsor|168|||
149095925|NCT01732926|537831561|FG001|Overall Study|Study Terminated by Sponsor|80|||
149095926|NCT01732926|537831560|FG000|Overall Study|Withdrawal by Subject|46|||
149095927|NCT01732926|537831561|FG001|Overall Study|Withdrawal by Subject|8|||
149095928|NCT01732926|537831560|FG000|Overall Study|Physician Decision|24|||
149095929|NCT01732926|537831561|FG001|Overall Study|Physician Decision|11|||
149095930|NCT01732926|537831560|FG000|Overall Study|Other Reason|21|||
149095931|NCT01732926|537831561|FG001|Overall Study|Other Reason|4|||
149095932|NCT01732926|537831560|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
149095933|NCT01732926|537831561|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
149095934|NCT01732926|537831560|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
149095935|NCT01732926|537831561|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
149095936|NCT02262364|537831566|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
149095937|NCT01049984|537831567|FG000|Overall Study|Withdrawal by Subject|1|||
149095938|NCT01049984|537831568|FG001|Overall Study|Withdrawal by Subject|5|||
149095939|NCT01049984|537831567|FG000|Overall Study|Protocol Violation|3|||
149095940|NCT01049984|537831568|FG001|Overall Study|Protocol Violation|4|||
149095941|NCT01049984|537831567|FG000|Overall Study|Lost to Follow-up|2|||
149095942|NCT01049984|537831568|FG001|Overall Study|Lost to Follow-up|1|||
149095943|NCT01049984|537831567|FG000|Overall Study|Adverse Event|13|||
149095944|NCT01049984|537831568|FG001|Overall Study|Adverse Event|7|||
149095945|NCT01049984|537831567|FG000|Overall Study|Treatment failure|0|||
149095946|NCT01049984|537831568|FG001|Overall Study|Treatment failure|2|||
149095947|NCT00337285|537831571|FG000|Overall Study|Withdrawal by Subject|42|||
149095948|NCT00337285|537831571|FG000|Overall Study|Lost to Follow-up|41|||
149095949|NCT00337285|537831571|FG000|Overall Study|Adverse Event|28|||
149095950|NCT00337285|537831571|FG000|Overall Study|Protocol Violation|27|||
149095951|NCT00337285|537831571|FG000|Overall Study|Lack of Efficacy|11|||
149095952|NCT00337285|537831571|FG000|Overall Study|Death|1|||
149095953|NCT00337285|537831571|FG000|Overall Study|Physician Decision|1|||
149095954|NCT00337285|537831571|FG000|Overall Study|Lack of protocol compliance|7|||
149095955|NCT01040403|537831573|FG000|Overall Study|Adverse Event|10|||
149095956|NCT01040403|537831573|FG000|Overall Study|Protocol Violation|2|||
149095957|NCT01040403|537831573|FG000|Overall Study|Lost to Follow-up|1|||
149095958|NCT01040403|537831573|FG000|Overall Study|Not treated|1|||
149095959|NCT01040403|537831573|FG000|Overall Study|Other reason not defined above|6|||
149095960|NCT00594178|537831583|FG000|Overall Study|Physician Decision|5|||
149095961|NCT00496626|537831584|FG000|Overall Study|Lost to Follow-up|0|||
149095962|NCT00496626|537831585|FG001|Overall Study|Lost to Follow-up|1|||
149095963|NCT00496626|537831584|FG000|Overall Study|Protocol Violation|1|||
149095964|NCT00496626|537831585|FG001|Overall Study|Protocol Violation|0|||
149095965|NCT00496626|537831584|FG000|Overall Study|Withdrawal by Subject|5|||
149095966|NCT00496626|537831585|FG001|Overall Study|Withdrawal by Subject|4|||
149095967|NCT00496626|537831584|FG000|Overall Study|Relocated|0|||
149095968|NCT00496626|537831585|FG001|Overall Study|Relocated|1|||
149095969|NCT04191148|537831590|FG000|Overall Study|Withdrawal by Subject|1|||
149095970|NCT04191148|537831591|FG001|Overall Study|Withdrawal by Subject|0|||
149095971|NCT04191148|537831590|FG000|Overall Study|Adverse Event|1|||
149095972|NCT04191148|537831591|FG001|Overall Study|Adverse Event|0|||
149095973|NCT01874665|537831592|FG000|Overall Study|Adverse Event|6|||
149095974|NCT01874665|537831593|FG001|Overall Study|Adverse Event|2|||
149095975|NCT01874665|537831592|FG000|Overall Study|Withdrawal by Subject|4|||
149095976|NCT01874665|537831593|FG001|Overall Study|Withdrawal by Subject|1|||
149095977|NCT01874665|537831592|FG000|Overall Study|Physician Decision|3|||
149095978|NCT01874665|537831593|FG001|Overall Study|Physician Decision|0|||
149095979|NCT01874665|537831592|FG000|Overall Study|Clinical Progressive Disease|4|||
149095980|NCT01874665|537831593|FG001|Overall Study|Clinical Progressive Disease|3|||
149095981|NCT01874665|537831592|FG000|Overall Study|Study Terminated by Sponsor|0|||
149095982|NCT01874665|537831593|FG001|Overall Study|Study Terminated by Sponsor|2|||
149095983|NCT01874665|537831592|FG000|Overall Study|Documented Progressive Disease|11|||
149095984|NCT01874665|537831593|FG001|Overall Study|Documented Progressive Disease|7|||
149095985|NCT01874665|537831592|FG000|Overall Study|Other|2|||
149095986|NCT01874665|537831593|FG001|Overall Study|Other|0|||
149095987|NCT02647788|537831594|FG000|Overall Study|Lost to Follow-up|13|||
149095988|NCT02647788|537831595|FG001|Overall Study|Lost to Follow-up|11|||
149095989|NCT02647788|537831594|FG000|Overall Study|Did not want opiate|0|||
149095990|NCT02647788|537831595|FG001|Overall Study|Did not want opiate|1|||
149095991|NCT02647788|537831594|FG000|Overall Study|Withdrawal by Subject|1|||
149095992|NCT02647788|537831595|FG001|Overall Study|Withdrawal by Subject|0|||
149095993|NCT02647788|537831594|FG000|Overall Study|Felt itchy with assigned medication|1|||
149095994|NCT02647788|537831595|FG001|Overall Study|Felt itchy with assigned medication|0|||
149095995|NCT02647788|537831594|FG000|Overall Study|Felt nauseous with assigned medication|1|||
149095996|NCT02647788|537831595|FG001|Overall Study|Felt nauseous with assigned medication|1|||
149095997|NCT03245619|537831596|FG000|Part A (Up to Day 22)|Physician Decision|4|||
149095998|NCT03245619|537831597|FG001|Part A (Up to Day 22)|Physician Decision|6|||
149095999|NCT03245619|537831598|FG002|Part A (Up to Day 22)|Physician Decision|6|||
149096000|NCT03245619|537831599|FG003|Part A (Up to Day 22)|Physician Decision|0|||
149096001|NCT03245619|537831600|FG004|Part A (Up to Day 22)|Physician Decision|0|||
149096002|NCT03245619|537831601|FG005|Part A (Up to Day 22)|Physician Decision|0|||
149096003|NCT03245619|537831602|FG006|Part A (Up to Day 22)|Physician Decision|0|||
149096004|NCT03245619|537831603|FG007|Part A (Up to Day 22)|Physician Decision|0|||
149096005|NCT03245619|537831604|FG008|Part A (Up to Day 22)|Physician Decision|0|||
149096006|NCT03245619|537831605|FG009|Part A (Up to Day 22)|Physician Decision|0|||
149096007|NCT03245619|537831606|FG010|Part A (Up to Day 22)|Physician Decision|0|||
149096008|NCT03245619|537831607|FG011|Part A (Up to Day 22)|Physician Decision|0|||
149096009|NCT03245619|537831608|FG012|Part A (Up to Day 22)|Physician Decision|0|||
149096010|NCT03245619|537831609|FG013|Part A (Up to Day 22)|Physician Decision|0|||
149096011|NCT03245619|537831610|FG014|Part A (Up to Day 22)|Physician Decision|0|||
149096012|NCT03245619|537831611|FG015|Part A (Up to Day 22)|Physician Decision|0|||
149096013|NCT03245619|537831612|FG016|Part A (Up to Day 22)|Physician Decision|0|||
149096014|NCT00776659|537831629|FG000|Overall Study|Lost to Follow-up|15|||
149096015|NCT00776659|537831629|FG000|Overall Study|Withdrawal by Subject|10|||
149096016|NCT00776659|537831629|FG000|Overall Study|Study Terminated by Sponsor|1|||
149096017|NCT01233999|537831632|FG000|Overall Study|Withdrawal by Subject|1|||
149096018|NCT01233999|537831632|FG000|Overall Study|Lost to Follow-up|1|||
149096019|NCT02246218|537831633|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
149096020|NCT02246218|537831634|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
149096021|NCT02246218|537831633|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
149096022|NCT02246218|537831634|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
149096023|NCT02246218|537831633|FG000|Overall Study|Adverse Event|1|||
149096024|NCT02246218|537831634|FG001|Overall Study|Adverse Event|1|||
149096025|NCT02246218|537831633|FG000|Overall Study|Lost to Follow-up|1|||
149096026|NCT02246218|537831634|FG001|Overall Study|Lost to Follow-up|0|||
149096027|NCT02212301|537831635|FG000|Period 1|Lost to Follow-up|0|||
149096028|NCT02212301|537831636|FG001|Period 1|Lost to Follow-up|1|||
149096029|NCT00578318|537831637|FG000|Overall Study|Lost to Follow-up|2|||
149096030|NCT00578318|537831638|FG001|Overall Study|Lost to Follow-up|0|||
149096031|NCT00578318|537831637|FG000|Overall Study|Physician Decision|1|||
149096032|NCT00578318|537831638|FG001|Overall Study|Physician Decision|0|||
149096033|NCT03041701|537831639|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
149096034|NCT03041701|537831640|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
149096035|NCT03041701|537831641|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
149096036|NCT03041701|537831639|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
149096037|NCT03041701|537831640|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
149096038|NCT03041701|537831641|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
149096039|NCT00920699|537831642|FG000|Overall Study|Withdrawal by Subject|2|||
149096040|NCT00920699|537831643|FG001|Overall Study|Withdrawal by Subject|0|||
149096041|NCT00920699|537831644|FG002|Overall Study|Withdrawal by Subject|2|||
149096042|NCT00920699|537831642|FG000|Overall Study|no longer met eligibility|0|||
149096043|NCT00920699|537831643|FG001|Overall Study|no longer met eligibility|1|||
149096044|NCT00920699|537831644|FG002|Overall Study|no longer met eligibility|0|||
149096045|NCT00920699|537831642|FG000|Overall Study|Lost to Follow-up|0|||
149096046|NCT00920699|537831643|FG001|Overall Study|Lost to Follow-up|0|||
149096047|NCT00920699|537831644|FG002|Overall Study|Lost to Follow-up|2|||
149096048|NCT02202109|537833415|FG000|Overall Study|Lost to Follow-up|88|||
149096049|NCT02202109|537833416|FG001|Overall Study|Lost to Follow-up|87|||
149096050|NCT02202109|537833415|FG000|Overall Study|Withdrawal by Subject|2|||
149096051|NCT02202109|537833416|FG001|Overall Study|Withdrawal by Subject|0|||
149096052|NCT00320398|537833428|FG000|Overall Study|Adverse Event|1|||
149096053|NCT00320398|537833429|FG001|Overall Study|Adverse Event|4|||
149096054|NCT00320398|537833428|FG000|Overall Study|Other|1|||
149096055|NCT00320398|537833429|FG001|Overall Study|Other|0|||
149096056|NCT01057251|537833431|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
149096057|NCT01057251|537833432|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
149096058|NCT01057251|537833431|FG000|Overall Study|Adverse Event|4|||
149096059|NCT01057251|537833432|FG001|Overall Study|Adverse Event|2|||
149096060|NCT01057251|537833431|FG000|Overall Study|Lack of Efficacy|2|||
149096061|NCT01057251|537833432|FG001|Overall Study|Lack of Efficacy|11|||
149096062|NCT01057251|537833431|FG000|Overall Study|Protocol Violation|6|||
149096063|NCT01057251|537833432|FG001|Overall Study|Protocol Violation|2|||
149096064|NCT01057251|537833431|FG000|Overall Study|Withdrawal by Subject|4|||
149096065|NCT01057251|537833432|FG001|Overall Study|Withdrawal by Subject|5|||
149096066|NCT01057251|537833431|FG000|Overall Study|Lost to Follow-up|7|||
149096067|NCT01057251|537833432|FG001|Overall Study|Lost to Follow-up|6|||
149096068|NCT01057251|537833431|FG000|Overall Study|Other Reason|1|||
149096069|NCT01057251|537833432|FG001|Overall Study|Other Reason|1|||
149096070|NCT04544865|537833433|FG000|Overall Study|Death|0|||
149096071|NCT04544865|537833434|FG001|Overall Study|Death|2|||
149096072|NCT04544865|537833433|FG000|Overall Study|Lost to Follow-up|11|||
149096073|NCT04544865|537833434|FG001|Overall Study|Lost to Follow-up|7|||
149096074|NCT04544865|537833433|FG000|Overall Study|Withdrawal by Subject|0|||
149096075|NCT04544865|537833434|FG001|Overall Study|Withdrawal by Subject|1|||
149096076|NCT04544865|537833433|FG000|Overall Study|Other|0|||
149096077|NCT04544865|537833434|FG001|Overall Study|Other|1|||
149096078|NCT02973802|537833437|FG000|Overall Study|Lost to Follow-up|1|||
149096079|NCT02973802|537833437|FG000|Overall Study|Withdrawal by Subject|1|||
149096080|NCT01850823|537833439|FG000|Overall Study|Early Visit Window|0|||
149096081|NCT01850823|537833440|FG001|Overall Study|Early Visit Window|1|||
149096082|NCT01850823|537833441|FG002|Overall Study|Early Visit Window|4|||
149096083|NCT01850823|537833439|FG000|Overall Study|Enrolled in Error|0|||
149096084|NCT01850823|537833440|FG001|Overall Study|Enrolled in Error|1|||
149096085|NCT01850823|537833441|FG002|Overall Study|Enrolled in Error|2|||
149096086|NCT01850823|537833439|FG000|Overall Study|Lack of Efficacy|1|||
149096087|NCT01850823|537833440|FG001|Overall Study|Lack of Efficacy|0|||
149096088|NCT01850823|537833441|FG002|Overall Study|Lack of Efficacy|0|||
149096089|NCT01850823|537833439|FG000|Overall Study|Lost to Follow-up|0|||
149096090|NCT01850823|537833440|FG001|Overall Study|Lost to Follow-up|0|||
149096091|NCT01850823|537833441|FG002|Overall Study|Lost to Follow-up|1|||
149096092|NCT01850823|537833439|FG000|Overall Study|Restricted Medication|0|||
149096093|NCT01850823|537833440|FG001|Overall Study|Restricted Medication|0|||
149096094|NCT01850823|537833441|FG002|Overall Study|Restricted Medication|2|||
149096095|NCT01850823|537833439|FG000|Overall Study|Significant worstening of SAR|0|||
149096096|NCT01850823|537833440|FG001|Overall Study|Significant worstening of SAR|1|||
149096097|NCT01850823|537833441|FG002|Overall Study|Significant worstening of SAR|0|||
149096098|NCT01850823|537833439|FG000|Overall Study|Withdrawal by Subject|2|||
149096099|NCT01850823|537833440|FG001|Overall Study|Withdrawal by Subject|0|||
149096100|NCT01850823|537833441|FG002|Overall Study|Withdrawal by Subject|1|||
149096101|NCT01751165|537833442|FG000|Overall Study|Adverse event, serious fatal|1|||
149096102|NCT01751165|537833443|FG001|Overall Study|Adverse event, serious fatal|0|||
149096103|NCT01751165|537833444|FG002|Overall Study|Adverse event, serious fatal|1|||
149096104|NCT01751165|537833442|FG000|Overall Study|Withdrawal by Subject|0|||
149096105|NCT01751165|537833443|FG001|Overall Study|Withdrawal by Subject|0|||
149096106|NCT01751165|537833444|FG002|Overall Study|Withdrawal by Subject|1|||
149096107|NCT01751165|537833442|FG000|Overall Study|Serious adverse event|0|||
149096108|NCT01751165|537833443|FG001|Overall Study|Serious adverse event|2|||
149096109|NCT01751165|537833444|FG002|Overall Study|Serious adverse event|0|||
149096110|NCT01751165|537833442|FG000|Overall Study|Lost to Follow-up|1|||
149096111|NCT01751165|537833443|FG001|Overall Study|Lost to Follow-up|1|||
149096112|NCT01751165|537833444|FG002|Overall Study|Lost to Follow-up|1|||
149096113|NCT00988533|537833445|FG000|Overall Study|Lost to Follow-up|3|||
149096114|NCT00913523|537833449|FG000|Overall Study|Withdrawal by Subject|3|||
149096115|NCT00913523|537833450|FG001|Overall Study|Withdrawal by Subject|2|||
149096116|NCT00913523|537833451|FG002|Overall Study|Withdrawal by Subject|2|||
149096117|NCT00913523|537833449|FG000|Overall Study|Lost to Follow-up|1|||
149096118|NCT00913523|537833450|FG001|Overall Study|Lost to Follow-up|1|||
149096119|NCT00913523|537833451|FG002|Overall Study|Lost to Follow-up|1|||
149096120|NCT00913523|537833449|FG000|Overall Study|Adverse Event|1|||
149096121|NCT00913523|537833450|FG001|Overall Study|Adverse Event|0|||
149096122|NCT00913523|537833451|FG002|Overall Study|Adverse Event|0|||
149096123|NCT00913523|537833449|FG000|Overall Study|Protocol Violation|5|||
149096124|NCT00913523|537833450|FG001|Overall Study|Protocol Violation|8|||
149096125|NCT00913523|537833451|FG002|Overall Study|Protocol Violation|8|||
149096126|NCT00913523|537833449|FG000|Overall Study|Pregnancy|1|||
149096127|NCT00913523|537833450|FG001|Overall Study|Pregnancy|3|||
149096128|NCT00913523|537833451|FG002|Overall Study|Pregnancy|0|||
149096129|NCT00913523|537833449|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
149096130|NCT00913523|537833450|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
149096131|NCT00913523|537833451|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
149096132|NCT01202409|537833452|FG000|Overall Study|Adverse Event|1|||
149096133|NCT01202409|537833452|FG000|Overall Study|Ineligible - KRAS mutants|7|||
149096134|NCT00553605|537833453|FG000|Overall Study|Did not meet entrance criteria|1|||
149096135|NCT00553605|537833454|FG001|Overall Study|Did not meet entrance criteria|3|||
149096136|NCT00553605|537833453|FG000|Overall Study|Did not receive full dose|1|||
149096137|NCT00553605|537833454|FG001|Overall Study|Did not receive full dose|0|||
149096138|NCT00553605|537833453|FG000|Overall Study|Randomized but not treated|2|||
149096139|NCT00553605|537833454|FG001|Overall Study|Randomized but not treated|0|||
149096140|NCT00292981|537833458|FG000|Overall Study|Adverse Event|1|||
149096141|NCT00292981|537833458|FG000|Overall Study|Lost to Follow-up|13|||
149096142|NCT00292981|537833458|FG000|Overall Study|Withdrawal by Subject|22|||
149096143|NCT00292981|537833458|FG000|Overall Study|Other|3|||
149096144|NCT01085812|537833459|FG000|Open-Label Period|Adverse Event|0|||
149096145|NCT01085812|537833460|FG001|Open-Label Period|Adverse Event|80|||
149096146|NCT01085812|537833459|FG000|Open-Label Period|Lack of Efficacy|0|||
149096147|NCT01085812|537833460|FG001|Open-Label Period|Lack of Efficacy|26|||
149096148|NCT01085812|537833459|FG000|Open-Label Period|Protocol Violation|0|||
149096149|NCT01085812|537833460|FG001|Open-Label Period|Protocol Violation|39|||
149096150|NCT01085812|537833459|FG000|Open-Label Period|Withdrawal by Subject|0|||
149096151|NCT01085812|537833460|FG001|Open-Label Period|Withdrawal by Subject|53|||
149096152|NCT01085812|537833459|FG000|Open-Label Period|Lost to Follow-up|0|||
149096153|NCT01085812|537833460|FG001|Open-Label Period|Lost to Follow-up|42|||
149096154|NCT01085812|537833459|FG000|Double-Blind Period|Adverse Event|3|||
149096155|NCT01085812|537833460|FG001|Double-Blind Period|Adverse Event|8|||
149096156|NCT01085812|537833459|FG000|Double-Blind Period|Protocol Violation|2|||
149096157|NCT01085812|537833460|FG001|Double-Blind Period|Protocol Violation|7|||
149096158|NCT01085812|537833459|FG000|Double-Blind Period|Withdrawal by Subject|11|||
149096159|NCT01085812|537833460|FG001|Double-Blind Period|Withdrawal by Subject|24|||
149096160|NCT01085812|537833459|FG000|Double-Blind Period|Lost to Follow-up|5|||
149096161|NCT01085812|537833460|FG001|Double-Blind Period|Lost to Follow-up|17|||
149096162|NCT01085812|537833459|FG000|Double-Blind Period|Other Reasons|0|||
149096163|NCT01085812|537833460|FG001|Double-Blind Period|Other Reasons|2|||
149096164|NCT01085812|537833459|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
149096165|NCT01085812|537833460|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
149096166|NCT01085812|537833459|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
149096167|NCT01085812|537833460|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
149096168|NCT01085812|537833459|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
149096169|NCT01085812|537833460|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
149096170|NCT01085812|537833459|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
149096171|NCT01085812|537833460|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
149096172|NCT01085812|537833459|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
149096173|NCT01085812|537833460|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
149096174|NCT04582669|537833462|FG000|Overall Study|Subject missed appointment(s).|1|||
149096175|NCT04582669|537833463|FG001|Overall Study|Subject missed appointment(s).|0|||
149096176|NCT04582669|537833464|FG002|Overall Study|Subject missed appointment(s).|1|||
149096177|NCT04582669|537833465|FG003|Overall Study|Subject missed appointment(s).|2|||
149096178|NCT04582669|537833462|FG000|Overall Study|Protocol Violation|0|||
149096179|NCT04582669|537833463|FG001|Overall Study|Protocol Violation|1|||
149096180|NCT04582669|537833464|FG002|Overall Study|Protocol Violation|1|||
149096181|NCT04582669|537833465|FG003|Overall Study|Protocol Violation|0|||
149096182|NCT01274559|537833468|FG000|Overall Study|Adverse Event|57|||
149096183|NCT01274559|537833469|FG001|Overall Study|Adverse Event|13|||
149096184|NCT01274559|537833468|FG000|Overall Study|Death|1|||
149096185|NCT01274559|537833469|FG001|Overall Study|Death|1|||
149096186|NCT01274559|537833468|FG000|Overall Study|Lost to Follow-up|3|||
149096187|NCT01274559|537833469|FG001|Overall Study|Lost to Follow-up|3|||
149096188|NCT01274559|537833468|FG000|Overall Study|Non-compliance with Study Drug|2|||
149096189|NCT01274559|537833469|FG001|Overall Study|Non-compliance with Study Drug|4|||
149096190|NCT01274559|537833468|FG000|Overall Study|Physician Decision|2|||
149096191|NCT01274559|537833469|FG001|Overall Study|Physician Decision|1|||
149096192|NCT01274559|537833468|FG000|Overall Study|Protocol Violation|28|||
149096193|NCT01274559|537833469|FG001|Overall Study|Protocol Violation|23|||
149096194|NCT01274559|537833468|FG000|Overall Study|Study Terminated by Sponsor|79|||
149096195|NCT01274559|537833469|FG001|Overall Study|Study Terminated by Sponsor|87|||
149096196|NCT01274559|537833468|FG000|Overall Study|Withdrawal by Subject|25|||
149096197|NCT01274559|537833469|FG001|Overall Study|Withdrawal by Subject|13|||
149096198|NCT03503162|537833477|FG000|Overall Study|did not meet eligibility|1|||
149096199|NCT00025506|537833478|FG000|Overall Study|Ineligible: clerical error|1|||
149096200|NCT00025506|537833478|FG000|Overall Study|Ineligible: wrong cell type|5|||
149096201|NCT00025506|537833478|FG000|Overall Study|Ineligible: inadequate pathology|2|||
149096202|NCT00025506|537833478|FG000|Overall Study|Never Treated|2|||
149096203|NCT02547441|537833479|FG000|Double-Blind Study Period|Adverse Event|4|||
149096204|NCT02547441|537833480|FG001|Double-Blind Study Period|Adverse Event|9|||
149096205|NCT02547441|537833479|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
149096206|NCT02547441|537833480|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
149096207|NCT02547441|537833479|FG000|Double-Blind Study Period|Physician Decision|1|||
149096208|NCT02547441|537833480|FG001|Double-Blind Study Period|Physician Decision|0|||
149096209|NCT02547441|537833479|FG000|Double-Blind Study Period|Protocol Violation|1|||
149096210|NCT02547441|537833480|FG001|Double-Blind Study Period|Protocol Violation|2|||
149096211|NCT02547441|537833479|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
149096212|NCT02547441|537833480|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
149096213|NCT02547441|537833479|FG000|Double-Blind Study Period|Sponsor Decision|1|||
149096214|NCT02547441|537833480|FG001|Double-Blind Study Period|Sponsor Decision|0|||
149096215|NCT02547441|537833479|FG000|Open-Label Study Period|Adverse Event|10|||
149096216|NCT02547441|537833480|FG001|Open-Label Study Period|Adverse Event|11|||
149096217|NCT02547441|537833479|FG000|Open-Label Study Period|Lack of Efficacy|3|||
149096218|NCT02547441|537833480|FG001|Open-Label Study Period|Lack of Efficacy|2|||
149096219|NCT02547441|537833479|FG000|Open-Label Study Period|Lost to Follow-up|7|||
149096220|NCT02547441|537833480|FG001|Open-Label Study Period|Lost to Follow-up|8|||
149096221|NCT02547441|537833479|FG000|Open-Label Study Period|Physician Decision|1|||
149096222|NCT02547441|537833480|FG001|Open-Label Study Period|Physician Decision|0|||
149096223|NCT02547441|537833479|FG000|Open-Label Study Period|Protocol Violation|2|||
149096224|NCT02547441|537833480|FG001|Open-Label Study Period|Protocol Violation|0|||
149096225|NCT02547441|537833479|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
149096226|NCT02547441|537833480|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
149096227|NCT02547441|537833479|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
149096228|NCT02547441|537833480|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
149096229|NCT01322009|537833481|FG000|Overall Study|Death|0|||
149096230|NCT01322009|537833482|FG001|Overall Study|Death|1|||
149096231|NCT01322009|537833481|FG000|Overall Study|Adverse Event|0|||
149096232|NCT01322009|537833482|FG001|Overall Study|Adverse Event|1|||
149096233|NCT01322009|537833481|FG000|Overall Study|ng tube discontinued|0|||
149096234|NCT01322009|537833482|FG001|Overall Study|ng tube discontinued|1|||
149096235|NCT01657877|537833483|FG000|Overall Study|Withdrawal by Subject|4|||
149096236|NCT01657877|537833483|FG000|Overall Study|Protocol Violation|6|||
149096237|NCT01657877|537833483|FG000|Overall Study|Adverse Event|2|||
149096238|NCT01657877|537833483|FG000|Overall Study|Other Reason|2|||
149096239|NCT00905034|537833485|FG000|Overall Study|Withdrawal by Subject|1|||
149096240|NCT00394589|537833486|FG000|Overall Study|Adverse Event|2|||
149096241|NCT00394589|537833487|FG001|Overall Study|Adverse Event|1|||
149096242|NCT00394589|537833488|FG002|Overall Study|Adverse Event|2|||
149096243|NCT00394589|537833486|FG000|Overall Study|Lack of Efficacy|2|||
149096244|NCT00394589|537833487|FG001|Overall Study|Lack of Efficacy|2|||
149096245|NCT00394589|537833488|FG002|Overall Study|Lack of Efficacy|3|||
149096246|NCT00394589|537833486|FG000|Overall Study|Protocol Violation|4|||
149096247|NCT00394589|537833487|FG001|Overall Study|Protocol Violation|0|||
149096248|NCT00394589|537833488|FG002|Overall Study|Protocol Violation|2|||
149096249|NCT03409731|537833490|FG000|Overall Study|Withdrawal by Subject|17|||
149096250|NCT03409731|537833490|FG000|Overall Study|Death|4|||
149096251|NCT01114672|537833491|FG000|Overall Study|Death|0|||
149096252|NCT01114672|537833492|FG001|Overall Study|Death|1|||
149096253|NCT01114672|537833491|FG000|Overall Study|Withdrawal by Subject|2|||
149096254|NCT01114672|537833492|FG001|Overall Study|Withdrawal by Subject|1|||
149096255|NCT01114672|537833491|FG000|Overall Study|Lost to Follow-up|1|||
149096256|NCT01114672|537833492|FG001|Overall Study|Lost to Follow-up|0|||
149096257|NCT01114672|537833491|FG000|Overall Study|transplanted|1|||
149096258|NCT01114672|537833492|FG001|Overall Study|transplanted|0|||
149096259|NCT01710800|537833495|FG000|Overall Study|Withdrawal by Subject|21|||
149096260|NCT01710800|537833495|FG000|Overall Study|Protocol Violation|1|||
149096261|NCT02427958|537833496|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
149096262|NCT02427958|537833496|FG000|Overall Study|Lost to Follow-up|6|||
149096263|NCT02427958|537833496|FG000|Overall Study|Withdrawal by Subject|14|||
149096264|NCT02427958|537833496|FG000|Overall Study|Lack of Efficacy|1|||
149096265|NCT02287883|537833504|FG000|Overall Study|Death|8|||
149096266|NCT02287883|537833505|FG001|Overall Study|Death|7|||
149096267|NCT02287883|537833504|FG000|Overall Study|No longer eligible|222|||
149096268|NCT02287883|537833505|FG001|Overall Study|No longer eligible|182|||
149096269|NCT02287883|537833504|FG000|Overall Study|Non-response to survey|229|||
149096270|NCT02287883|537833505|FG001|Overall Study|Non-response to survey|237|||
149096271|NCT01978236|537833506|FG000|Overall Study|Discontinued due to study close|2|||
149096272|NCT00634920|537833507|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
149096273|NCT00634920|537833508|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
149096274|NCT00634920|537833509|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
149096275|NCT00634920|537833507|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
149096276|NCT00634920|537833508|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
149096277|NCT00634920|537833509|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
149096278|NCT00634920|537833507|FG000|Period 1 - Pre-Randomization|Rejections|0|||
149096279|NCT00634920|537833508|FG001|Period 1 - Pre-Randomization|Rejections|0|||
149096280|NCT00634920|537833509|FG002|Period 1 - Pre-Randomization|Rejections|55|||
149096281|NCT00634920|537833507|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
149096282|NCT00634920|537833508|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
149096283|NCT00634920|537833509|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
149096284|NCT00634920|537833507|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
149096285|NCT00634920|537833508|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
149096286|NCT00634920|537833509|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
149096287|NCT00634920|537833507|FG000|Period 1 - Pre-Randomization|Other issues|0|||
149096288|NCT00634920|537833508|FG001|Period 1 - Pre-Randomization|Other issues|0|||
149096289|NCT00634920|537833509|FG002|Period 1 - Pre-Randomization|Other issues|6|||
149096290|NCT00634920|537833507|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
149096291|NCT00634920|537833508|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
149096292|NCT00634920|537833509|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
149096293|NCT00634920|537833507|FG000|Period 2 - Post-Randomization|Rejection|11|||
149096294|NCT00634920|537833508|FG001|Period 2 - Post-Randomization|Rejection|5|||
149096295|NCT00634920|537833509|FG002|Period 2 - Post-Randomization|Rejection|0|||
149096296|NCT00634920|537833507|FG000|Period 2 - Post-Randomization|Death|2|||
149096297|NCT00634920|537833508|FG001|Period 2 - Post-Randomization|Death|5|||
149096298|NCT00634920|537833509|FG002|Period 2 - Post-Randomization|Death|0|||
149096299|NCT00634920|537833507|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
149096300|NCT00634920|537833508|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
149096301|NCT00634920|537833509|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
149096302|NCT00634920|537833507|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
149096303|NCT00634920|537833508|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
149096304|NCT00634920|537833509|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
149096305|NCT01527500|537833511|FG000|Part A|Administrative|11|||
149096306|NCT01527500|537833512|FG001|Part A|Administrative|7|||
149096307|NCT01527500|537833511|FG000|Part A|Adverse Event|4|||
149096308|NCT01527500|537833512|FG001|Part A|Adverse Event|2|||
149096309|NCT01527500|537833511|FG000|Part A|Death|4|||
149096310|NCT01527500|537833512|FG001|Part A|Death|1|||
149096311|NCT01527500|537833511|FG000|Part A|Lost to Follow-up|0|||
149096312|NCT01527500|537833512|FG001|Part A|Lost to Follow-up|1|||
149096313|NCT01527500|537833511|FG000|Part A|Protocol Deviation|9|||
149096314|NCT01527500|537833512|FG001|Part A|Protocol Deviation|2|||
149096315|NCT01527500|537833511|FG000|Part A|Withdrawal by Subject|2|||
149096316|NCT01527500|537833512|FG001|Part A|Withdrawal by Subject|0|||
149096317|NCT01527500|537833511|FG000|Part B|Adverse Event|1|||
149096318|NCT01527500|537833512|FG001|Part B|Adverse Event|0|||
149096319|NCT00372255|537833513|FG000|Overall Study|Withdrawn for other reasons|2|||
149096320|NCT00372255|537833514|FG001|Overall Study|Withdrawn for other reasons|1|||
149096321|NCT02573883|537833515|FG000|Six Month Follow Up|Lost to Follow-up|1|||
149096322|NCT02573883|537833516|FG001|Six Month Follow Up|Lost to Follow-up|0|||
149096323|NCT02573883|537833517|FG002|Six Month Follow Up|Lost to Follow-up|0|||
149096324|NCT02573883|537833518|FG003|Six Month Follow Up|Lost to Follow-up|0|||
149096325|NCT02573883|537833515|FG000|One Year Follow Up|Lost to Follow-up|2|||
149096326|NCT02573883|537833516|FG001|One Year Follow Up|Lost to Follow-up|1|||
149096327|NCT02573883|537833517|FG002|One Year Follow Up|Lost to Follow-up|0|||
149096328|NCT02573883|537833518|FG003|One Year Follow Up|Lost to Follow-up|0|||
149096329|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
149096330|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
149096331|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
149096332|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
149096333|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
149096334|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
149096335|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
149096336|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
149096337|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
149096338|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
149096339|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
149096340|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
149096341|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
149096342|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
149096343|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
149096344|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
149096345|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
149096346|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
149096347|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
149096348|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
149096349|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
149096350|NCT01125566|537833524|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
149096351|NCT01125566|537833525|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
149096352|NCT01125566|537833526|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
149096353|NCT01125566|537833524|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
149096354|NCT01125566|537833525|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
149096355|NCT01125566|537833526|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
149096356|NCT01125566|537833524|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
149096357|NCT01125566|537833525|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
149096358|NCT01125566|537833526|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
149096359|NCT01125566|537833524|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
149096360|NCT01125566|537833525|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
149096361|NCT01125566|537833526|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
149096362|NCT01125566|537833524|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
149096363|NCT01125566|537833525|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
149096364|NCT01125566|537833526|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
149096365|NCT01560585|537833527|FG000|Overall Study|Physician Decision|3|||
149096366|NCT00519285|537833528|FG000|Overall Study|Adverse Event|127|||
149096367|NCT00519285|537833529|FG001|Overall Study|Adverse Event|266|||
149096368|NCT00519285|537833528|FG000|Overall Study|Disease progression|334|||
149096369|NCT00519285|537833529|FG001|Overall Study|Disease progression|186|||
149096370|NCT00519285|537833528|FG000|Overall Study|Physician Decision|75|||
149096371|NCT00519285|537833529|FG001|Overall Study|Physician Decision|47|||
149096372|NCT00519285|537833528|FG000|Overall Study|Participant's request|53|||
149096373|NCT00519285|537833529|FG001|Overall Study|Participant's request|84|||
149096374|NCT00519285|537833528|FG000|Overall Study|Consent withdrawn|4|||
149096375|NCT00519285|537833529|FG001|Overall Study|Consent withdrawn|5|||
149096376|NCT00519285|537833528|FG000|Overall Study|Poor compliance to protocol|5|||
149096377|NCT00519285|537833529|FG001|Overall Study|Poor compliance to protocol|7|||
149096378|NCT00519285|537833528|FG000|Overall Study|Reason unspecified|5|||
149096379|NCT00519285|537833529|FG001|Overall Study|Reason unspecified|8|||
149096380|NCT00519285|537833528|FG000|Overall Study|Not treated|8|||
149096381|NCT00519285|537833529|FG001|Overall Study|Not treated|7|||
149096382|NCT00519285|537833528|FG000|Overall Study|Treatment ongoing|1|||
149096383|NCT00519285|537833529|FG001|Overall Study|Treatment ongoing|2|||
149096384|NCT02970305|537833530|FG000|Overall Study|Adverse Event|10|||
149096385|NCT02970305|537833531|FG001|Overall Study|Adverse Event|6|||
149096386|NCT02970305|537833530|FG000|Overall Study|Lack of Efficacy|1|||
149096387|NCT02970305|537833531|FG001|Overall Study|Lack of Efficacy|1|||
149096388|NCT02970305|537833530|FG000|Overall Study|Noncompliance with study drug|2|||
149096389|NCT02970305|537833531|FG001|Overall Study|Noncompliance with study drug|4|||
149096390|NCT02970305|537833530|FG000|Overall Study|Protocol Violation|2|||
149096391|NCT02970305|537833531|FG001|Overall Study|Protocol Violation|2|||
149096392|NCT02970305|537833530|FG000|Overall Study|Withdrawal by Subject|12|||
149096393|NCT02970305|537833531|FG001|Overall Study|Withdrawal by Subject|11|||
149096394|NCT02970305|537833530|FG000|Overall Study|Not further specified|1|||
149096395|NCT02970305|537833531|FG001|Overall Study|Not further specified|2|||
149096396|NCT02970305|537833530|FG000|Overall Study|Lost to Follow-up|1|||
149096397|NCT02970305|537833531|FG001|Overall Study|Lost to Follow-up|2|||
149096398|NCT01813305|537833533|FG000|Overall Study|Withdrawal by Subject|12|||
149096399|NCT01813305|537833534|FG001|Overall Study|Withdrawal by Subject|5|||
149096400|NCT01813305|537833533|FG000|Overall Study|Safety Concern|4|||
149096401|NCT01813305|537833534|FG001|Overall Study|Safety Concern|0|||
149096402|NCT01813305|537833533|FG000|Overall Study|Ulcer became worse|4|||
149096403|NCT01813305|537833534|FG001|Overall Study|Ulcer became worse|0|||
149096404|NCT01813305|537833533|FG000|Overall Study|Physician Decision|4|||
149096405|NCT01813305|537833534|FG001|Overall Study|Physician Decision|0|||
149096406|NCT01813305|537833533|FG000|Overall Study|Lost to Follow-up|3|||
149096407|NCT01813305|537833534|FG001|Overall Study|Lost to Follow-up|1|||
149096408|NCT01813305|537833533|FG000|Overall Study|Protocol Violation|1|||
149096409|NCT01813305|537833534|FG001|Overall Study|Protocol Violation|0|||
149096410|NCT01813305|537833533|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
149096411|NCT01813305|537833534|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
149096412|NCT00988117|537833535|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
149096413|NCT00988117|537833535|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
149096414|NCT04088500|537833536|FG000|Overall Study|Reason unknown|1|||
149096415|NCT04088500|537833536|FG000|Overall Study|Participant withdrew consent|1|||
149096416|NCT04088500|537833536|FG000|Overall Study|Disease progression|3|||
149096417|NCT02930837|537833540|FG000|Overall Study|Adverse Event|6|||
149096418|NCT02930837|537833540|FG000|Overall Study|Lost to Follow-up|5|||
149096419|NCT02930837|537833540|FG000|Overall Study|Withdrawal by Subject|1|||
149096420|NCT00006436|537833542|FG000|Overall Study|Refused further treatment|2|||
149096421|NCT00006436|537833542|FG000|Overall Study|Declined to participate (before treatment started)|1|||
149096422|NCT01071317|537833543|FG000|Overall Study|Lost to Follow-up|2|||
149096423|NCT01071317|537833544|FG001|Overall Study|Lost to Follow-up|2|||
149096424|NCT01283971|537833547|FG000|Overall Study|Adverse Event|3|||
149096425|NCT01283971|537833548|FG001|Overall Study|Adverse Event|5|||
149096426|NCT01283971|537833547|FG000|Overall Study|Insufficient therapeutic responses|3|||
149096427|NCT01283971|537833548|FG001|Overall Study|Insufficient therapeutic responses|3|||
149096428|NCT01283971|537833547|FG000|Overall Study|Protocol Violation|5|||
149096429|NCT01283971|537833548|FG001|Overall Study|Protocol Violation|1|||
149096430|NCT01283971|537833547|FG000|Overall Study|Refused treatment|3|||
149096431|NCT01283971|537833548|FG001|Overall Study|Refused treatment|1|||
149096432|NCT01283971|537833547|FG000|Overall Study|Failure to return|0|||
149096433|NCT01283971|537833548|FG001|Overall Study|Failure to return|1|||
149096434|NCT01283971|537833547|FG000|Overall Study|Administrative reasons|1|||
149096435|NCT01283971|537833548|FG001|Overall Study|Administrative reasons|1|||
149096436|NCT02598934|537833557|FG000|Overall Study|Adverse Event|11|||
149096437|NCT02598934|537833558|FG001|Overall Study|Adverse Event|13|||
149096438|NCT02598934|537833557|FG000|Overall Study|Failure to Return|3|||
149096439|NCT02598934|537833558|FG001|Overall Study|Failure to Return|3|||
149096440|NCT02598934|537833557|FG000|Overall Study|Withdrawal by Subject|2|||
149096441|NCT02598934|537833558|FG001|Overall Study|Withdrawal by Subject|3|||
149096442|NCT02598934|537833557|FG000|Overall Study|Administrative|2|||
149096443|NCT02598934|537833558|FG001|Overall Study|Administrative|1|||
149096444|NCT02598934|537833557|FG000|Overall Study|Protocol Violation|1|||
149096445|NCT02598934|537833558|FG001|Overall Study|Protocol Violation|2|||
149096446|NCT02481934|537833560|FG000|Overall Study|Death|2|||
149096447|NCT03749616|537833564|FG000|Overall Study|Lost to Follow-up|4|||
149096448|NCT03749616|537833565|FG001|Overall Study|Lost to Follow-up|7|||
149096449|NCT03749616|537833564|FG000|Overall Study|Screen Failure|1|||
149096450|NCT03749616|537833565|FG001|Overall Study|Screen Failure|1|||
149096451|NCT03749616|537833564|FG000|Overall Study|Withdrawal by Subject|2|||
149096452|NCT03749616|537833565|FG001|Overall Study|Withdrawal by Subject|0|||
149096453|NCT03302559|537833566|FG000|Overall Study|Adverse Event|2|||
149096454|NCT03302559|537833566|FG000|Overall Study|Lost to Follow-up|1|||
149096455|NCT03302559|537833566|FG000|Overall Study|Withdrew Consent|3|||
149096456|NCT00664105|537835292|FG000|Overall Study|Death|3|||
149096457|NCT00664105|537835292|FG000|Overall Study|Withdrawal by Subject|5|||
149096458|NCT00664105|537835292|FG000|Overall Study|Adverse Event|9|||
149096459|NCT00664105|537835292|FG000|Overall Study|Disease progression|7|||
149096460|NCT01468077|537835299|FG000|Overall Study|Adverse Event|2|||
149096461|NCT01468077|537835300|FG001|Overall Study|Adverse Event|2|||
149096462|NCT01468077|537835299|FG000|Overall Study|Lack of Efficacy|1|||
149096463|NCT01468077|537835300|FG001|Overall Study|Lack of Efficacy|1|||
149096464|NCT01468077|537835299|FG000|Overall Study|Physician Decision|1|||
149096465|NCT01468077|537835300|FG001|Overall Study|Physician Decision|0|||
149096466|NCT04843579|537835301|FG000|Overall Study|Adverse Event|1|||
149096467|NCT04843579|537835301|FG000|Overall Study|Disease Progression|1|||
149096468|NCT03024996|537835303|FG000|Overall Study|Death|57|||
149096469|NCT03024996|537835304|FG001|Overall Study|Death|55|||
149096470|NCT03024996|537835303|FG000|Overall Study|Disease relapse|1|||
149096471|NCT03024996|537835304|FG001|Overall Study|Disease relapse|0|||
149096472|NCT03024996|537835303|FG000|Overall Study|Lost to Follow-up|5|||
149096473|NCT03024996|537835304|FG001|Overall Study|Lost to Follow-up|10|||
149096474|NCT03024996|537835303|FG000|Overall Study|Other|3|||
149096475|NCT03024996|537835304|FG001|Overall Study|Other|3|||
149096476|NCT03024996|537835303|FG000|Overall Study|Physician Decision|0|||
149096477|NCT03024996|537835304|FG001|Overall Study|Physician Decision|1|||
149096478|NCT03024996|537835303|FG000|Overall Study|Study terminated by sponsor|303|||
149096479|NCT03024996|537835304|FG001|Overall Study|Study terminated by sponsor|283|||
149096480|NCT03024996|537835303|FG000|Overall Study|Withdrawal by Subject|21|||
149096481|NCT03024996|537835304|FG001|Overall Study|Withdrawal by Subject|36|||
149096482|NCT00478647|537835305|FG000|Overall Study|Adverse Event|1|||
149096483|NCT00478647|537835305|FG000|Overall Study|Withdrawal by Subject|1|||
149096484|NCT00639769|537835307|FG000|Overall Study|Death|2|||
149096485|NCT00639769|537835307|FG000|Overall Study|Adverse Event|7|||
149096486|NCT00639769|537835307|FG000|Overall Study|Lack of Efficacy|1|||
149096487|NCT00639769|537835307|FG000|Overall Study|Disease progression|26|||
149096488|NCT00639769|537835307|FG000|Overall Study|Withdrawal by Subject|4|||
149096489|NCT00784147|537835308|FG000|Overall Study|Lost to Follow-up|2|||
149096490|NCT00784147|537835309|FG001|Overall Study|Lost to Follow-up|4|||
149096491|NCT00784147|537835308|FG000|Overall Study|Withdrawal by Subject|1|||
149096492|NCT00784147|537835309|FG001|Overall Study|Withdrawal by Subject|3|||
149096493|NCT00784147|537835308|FG000|Overall Study|Physician Decision|2|||
149096494|NCT00784147|537835309|FG001|Overall Study|Physician Decision|1|||
149096495|NCT00784147|537835308|FG000|Overall Study|Protocol Violation|1|||
149096496|NCT00784147|537835309|FG001|Overall Study|Protocol Violation|1|||
149096497|NCT00784147|537835308|FG000|Overall Study|Death|2|||
149096498|NCT00784147|537835309|FG001|Overall Study|Death|0|||
149096499|NCT01475461|537835311|FG000|Run-in Period|Not meet eligibility criteria|16|||
149096500|NCT01475461|537835312|FG001|Run-in Period|Not meet eligibility criteria|0|||
149096501|NCT01475461|537835313|FG002|Run-in Period|Not meet eligibility criteria|0|||
149096502|NCT01475461|537835314|FG003|Run-in Period|Not meet eligibility criteria|0|||
149096503|NCT01475461|537835315|FG004|Run-in Period|Not meet eligibility criteria|0|||
149096504|NCT01475461|537835316|FG005|Run-in Period|Not meet eligibility criteria|0|||
149096505|NCT01475461|537835317|FG006|Run-in Period|Not meet eligibility criteria|0|||
149096506|NCT01475461|537835311|FG000|Run-in Period|Lost to Follow-up|7|||
149096507|NCT01475461|537835312|FG001|Run-in Period|Lost to Follow-up|0|||
149096508|NCT01475461|537835313|FG002|Run-in Period|Lost to Follow-up|0|||
149096509|NCT01475461|537835314|FG003|Run-in Period|Lost to Follow-up|0|||
149096510|NCT01475461|537835315|FG004|Run-in Period|Lost to Follow-up|0|||
149096511|NCT01475461|537835316|FG005|Run-in Period|Lost to Follow-up|0|||
149096512|NCT01475461|537835317|FG006|Run-in Period|Lost to Follow-up|0|||
149096513|NCT01475461|537835311|FG000|Run-in Period|Withdrawal by Subject|11|||
149096514|NCT01475461|537835312|FG001|Run-in Period|Withdrawal by Subject|0|||
149096515|NCT01475461|537835313|FG002|Run-in Period|Withdrawal by Subject|0|||
149096516|NCT01475461|537835314|FG003|Run-in Period|Withdrawal by Subject|0|||
149096517|NCT01475461|537835315|FG004|Run-in Period|Withdrawal by Subject|0|||
149096518|NCT01475461|537835316|FG005|Run-in Period|Withdrawal by Subject|0|||
149096519|NCT01475461|537835317|FG006|Run-in Period|Withdrawal by Subject|0|||
149096520|NCT01475461|537835311|FG000|Run-in Period|Other|3|||
149096521|NCT01475461|537835312|FG001|Run-in Period|Other|0|||
149096522|NCT01475461|537835313|FG002|Run-in Period|Other|0|||
149096523|NCT01475461|537835314|FG003|Run-in Period|Other|0|||
149096524|NCT01475461|537835315|FG004|Run-in Period|Other|0|||
149096525|NCT01475461|537835316|FG005|Run-in Period|Other|0|||
149096526|NCT01475461|537835317|FG006|Run-in Period|Other|0|||
149096527|NCT01475461|537835311|FG000|Run-in Period|Protocol Violation|4|||
149096528|NCT01475461|537835312|FG001|Run-in Period|Protocol Violation|0|||
149096529|NCT01475461|537835313|FG002|Run-in Period|Protocol Violation|0|||
149096530|NCT01475461|537835314|FG003|Run-in Period|Protocol Violation|0|||
149096531|NCT01475461|537835315|FG004|Run-in Period|Protocol Violation|0|||
149096532|NCT01475461|537835316|FG005|Run-in Period|Protocol Violation|0|||
149096533|NCT01475461|537835317|FG006|Run-in Period|Protocol Violation|0|||
149096534|NCT01475461|537835311|FG000|Treatment Period|Death|0|||
149096535|NCT01475461|537835312|FG001|Treatment Period|Death|0|||
149096536|NCT01475461|537835313|FG002|Treatment Period|Death|0|||
149096537|NCT01475461|537835314|FG003|Treatment Period|Death|1|||
149096538|NCT01475461|537835315|FG004|Treatment Period|Death|0|||
149096539|NCT01475461|537835316|FG005|Treatment Period|Death|0|||
149096540|NCT01475461|537835317|FG006|Treatment Period|Death|0|||
149096541|NCT01475461|537835311|FG000|Treatment Period|Lost to Follow-up|0|||
149096542|NCT01475461|537835312|FG001|Treatment Period|Lost to Follow-up|3|||
149096543|NCT01475461|537835313|FG002|Treatment Period|Lost to Follow-up|2|||
149096544|NCT01475461|537835314|FG003|Treatment Period|Lost to Follow-up|3|||
149096545|NCT01475461|537835315|FG004|Treatment Period|Lost to Follow-up|1|||
149096546|NCT01475461|537835316|FG005|Treatment Period|Lost to Follow-up|2|||
149096547|NCT01475461|537835317|FG006|Treatment Period|Lost to Follow-up|1|||
149096548|NCT01475461|537835311|FG000|Treatment Period|Withdrawal by Subject|0|||
149096549|NCT01475461|537835312|FG001|Treatment Period|Withdrawal by Subject|2|||
149096550|NCT01475461|537835313|FG002|Treatment Period|Withdrawal by Subject|2|||
149096551|NCT01475461|537835314|FG003|Treatment Period|Withdrawal by Subject|0|||
149096552|NCT01475461|537835315|FG004|Treatment Period|Withdrawal by Subject|2|||
149096553|NCT01475461|537835316|FG005|Treatment Period|Withdrawal by Subject|2|||
149096554|NCT01475461|537835317|FG006|Treatment Period|Withdrawal by Subject|0|||
149096555|NCT01475461|537835311|FG000|Treatment Period|Other|0|||
149096556|NCT01475461|537835312|FG001|Treatment Period|Other|1|||
149096557|NCT01475461|537835313|FG002|Treatment Period|Other|0|||
149096558|NCT01475461|537835314|FG003|Treatment Period|Other|0|||
149096559|NCT01475461|537835315|FG004|Treatment Period|Other|0|||
149096560|NCT01475461|537835316|FG005|Treatment Period|Other|0|||
149096561|NCT01475461|537835317|FG006|Treatment Period|Other|0|||
149096562|NCT01475461|537835311|FG000|Treatment Period|Protocol Violation|0|||
149096563|NCT01475461|537835312|FG001|Treatment Period|Protocol Violation|1|||
149096564|NCT01475461|537835313|FG002|Treatment Period|Protocol Violation|0|||
149096565|NCT01475461|537835314|FG003|Treatment Period|Protocol Violation|0|||
149096566|NCT01475461|537835315|FG004|Treatment Period|Protocol Violation|0|||
149096567|NCT01475461|537835316|FG005|Treatment Period|Protocol Violation|0|||
149096568|NCT01475461|537835317|FG006|Treatment Period|Protocol Violation|1|||
149096569|NCT01475461|537835311|FG000|Treatment Period|Lack of Efficacy|0|||
149096570|NCT01475461|537835312|FG001|Treatment Period|Lack of Efficacy|2|||
149096571|NCT01475461|537835313|FG002|Treatment Period|Lack of Efficacy|0|||
149096572|NCT01475461|537835314|FG003|Treatment Period|Lack of Efficacy|2|||
149096573|NCT01475461|537835315|FG004|Treatment Period|Lack of Efficacy|1|||
149096574|NCT01475461|537835316|FG005|Treatment Period|Lack of Efficacy|1|||
149096575|NCT01475461|537835317|FG006|Treatment Period|Lack of Efficacy|0|||
149096576|NCT01475461|537835311|FG000|Treatment Period|Medication Error|0|||
149096577|NCT01475461|537835312|FG001|Treatment Period|Medication Error|0|||
149096578|NCT01475461|537835313|FG002|Treatment Period|Medication Error|0|||
149096579|NCT01475461|537835314|FG003|Treatment Period|Medication Error|1|||
149096580|NCT01475461|537835315|FG004|Treatment Period|Medication Error|0|||
149096581|NCT01475461|537835316|FG005|Treatment Period|Medication Error|0|||
149096582|NCT01475461|537835317|FG006|Treatment Period|Medication Error|0|||
149096583|NCT01475461|537835311|FG000|Treatment Period|Adverse Event|0|||
149096584|NCT01475461|537835312|FG001|Treatment Period|Adverse Event|0|||
149096585|NCT01475461|537835313|FG002|Treatment Period|Adverse Event|0|||
149096586|NCT01475461|537835314|FG003|Treatment Period|Adverse Event|1|||
149096587|NCT01475461|537835315|FG004|Treatment Period|Adverse Event|0|||
149096588|NCT01475461|537835316|FG005|Treatment Period|Adverse Event|0|||
149096589|NCT01475461|537835317|FG006|Treatment Period|Adverse Event|0|||
149096590|NCT01774019|537835318|FG000|Overall Study|No longer meets protocol criteria|2|||
149096591|NCT01774019|537835319|FG001|Overall Study|No longer meets protocol criteria|0|||
149096592|NCT01774019|537835318|FG000|Overall Study|Withdrawal by Subject|1|||
149096593|NCT01774019|537835319|FG001|Overall Study|Withdrawal by Subject|0|||
149096594|NCT01774019|537835318|FG000|Overall Study|Surgery delayed > 120 days|1|||
149096595|NCT01774019|537835319|FG001|Overall Study|Surgery delayed > 120 days|0|||
149096596|NCT01774019|537835318|FG000|Overall Study|Patient refused surgery|1|||
149096597|NCT01774019|537835319|FG001|Overall Study|Patient refused surgery|1|||
149096598|NCT01774019|537835318|FG000|Overall Study|Unable to implant study device|1|||
149096599|NCT01774019|537835319|FG001|Overall Study|Unable to implant study device|0|||
149096600|NCT01774019|537835318|FG000|Overall Study|Lost to Follow-up|0|||
149096601|NCT01774019|537835319|FG001|Overall Study|Lost to Follow-up|3|||
149096602|NCT01167192|537835322|FG000|Overall Study|Adverse Event|1|||
149096603|NCT01167192|537835322|FG000|Overall Study|Death|1|||
149096604|NCT01167192|537835322|FG000|Overall Study|Withdrawal by Subject|1|||
149096605|NCT01167192|537835322|FG000|Overall Study|Insurance denial|1|||
149096606|NCT01336205|537835323|FG000|Overall Study|Other|22|||
149096607|NCT01336205|537835324|FG001|Overall Study|Other|9|||
149096608|NCT01336205|537835323|FG000|Overall Study|Lost to Follow-up|40|||
149096609|NCT01336205|537835324|FG001|Overall Study|Lost to Follow-up|20|||
149096610|NCT01336205|537835323|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
149096611|NCT01336205|537835324|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
149096612|NCT01336205|537835323|FG000|Overall Study|Lack of Efficacy|4|||
149096613|NCT01336205|537835324|FG001|Overall Study|Lack of Efficacy|0|||
149096614|NCT01336205|537835323|FG000|Overall Study|Severe noncompliance with protocol|9|||
149096615|NCT01336205|537835324|FG001|Overall Study|Severe noncompliance with protocol|2|||
149096616|NCT01336205|537835323|FG000|Overall Study|Adverse Event|56|||
149096617|NCT01336205|537835324|FG001|Overall Study|Adverse Event|6|||
149096618|NCT01336205|537835323|FG000|Overall Study|Death|1|||
149096619|NCT01336205|537835324|FG001|Overall Study|Death|1|||
149096620|NCT01336205|537835323|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
149096621|NCT01336205|537835324|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
149096622|NCT01336205|537835323|FG000|Overall Study|Withdrawal by Subject|72|||
149096623|NCT01336205|537835324|FG001|Overall Study|Withdrawal by Subject|38|||
149096624|NCT01336205|537835323|FG000|Overall Study|Did not receive treatment|4|||
149096625|NCT01336205|537835324|FG001|Overall Study|Did not receive treatment|0|||
149096626|NCT02835092|537835325|FG000|Overall Study|Withdrawal by Subject|3|||
149096627|NCT02835092|537835326|FG001|Overall Study|Withdrawal by Subject|6|||
149096628|NCT02835092|537835327|FG002|Overall Study|Withdrawal by Subject|3|||
149096629|NCT02835092|537835325|FG000|Overall Study|Lost to Follow-up|0|||
149096630|NCT02835092|537835326|FG001|Overall Study|Lost to Follow-up|2|||
149096631|NCT02835092|537835327|FG002|Overall Study|Lost to Follow-up|0|||
149096632|NCT00713206|537835328|FG000|Overall Study|Lost to Follow-up|4|||
149096633|NCT00713206|537835329|FG001|Overall Study|Lost to Follow-up|4|||
149096634|NCT00713206|537835328|FG000|Overall Study|Death|1|||
149096635|NCT00713206|537835329|FG001|Overall Study|Death|0|||
149096636|NCT02561806|537835330|FG000|Induction Period|Adverse Event|0|||
149096637|NCT02561806|537835331|FG001|Induction Period|Adverse Event|2|||
149096638|NCT02561806|537835330|FG000|Induction Period|Lack of Efficacy|1|||
149096639|NCT02561806|537835331|FG001|Induction Period|Lack of Efficacy|0|||
149096640|NCT02561806|537835330|FG000|Induction Period|Withdrawal by Subject|0|||
149096641|NCT02561806|537835331|FG001|Induction Period|Withdrawal by Subject|2|||
149096642|NCT02561806|537835330|FG000|Induction Period|Site staff became unblinded|1|||
149096643|NCT02561806|537835331|FG001|Induction Period|Site staff became unblinded|0|||
149096644|NCT02561806|537835330|FG000|Induction Period|Randomized but not treated|0|||
149096645|NCT02561806|537835331|FG001|Induction Period|Randomized but not treated|1|||
149096646|NCT02561806|537835330|FG000|Maintenance Period|Adverse Event|2|||
149096647|NCT02561806|537835331|FG001|Maintenance Period|Adverse Event|1|||
149096648|NCT02561806|537835330|FG000|Maintenance Period|Lack of Efficacy|3|||
149096649|NCT02561806|537835331|FG001|Maintenance Period|Lack of Efficacy|1|||
149096650|NCT02561806|537835330|FG000|Maintenance Period|Lost to Follow-up|2|||
149096651|NCT02561806|537835331|FG001|Maintenance Period|Lost to Follow-up|2|||
149096652|NCT02561806|537835330|FG000|Maintenance Period|Protocol Violation|1|||
149096653|NCT02561806|537835331|FG001|Maintenance Period|Protocol Violation|0|||
149096654|NCT02561806|537835330|FG000|Maintenance Period|Withdrawal by Subject|5|||
149096655|NCT02561806|537835331|FG001|Maintenance Period|Withdrawal by Subject|3|||
149096656|NCT02561806|537835330|FG000|Maintenance Period|Site staff became unblinded|0|||
149096657|NCT02561806|537835331|FG001|Maintenance Period|Site staff became unblinded|1|||
149096658|NCT02561806|537835330|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
149096659|NCT02561806|537835331|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
149096660|NCT02561806|537835330|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
149096661|NCT02561806|537835331|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
149096662|NCT04545476|537835332|FG000|Overall Study|Lost to Follow-up|1|||
149096663|NCT04545476|537835333|FG001|Overall Study|Lost to Follow-up|1|||
149096664|NCT04545476|537835334|FG002|Overall Study|Lost to Follow-up|0|||
149096665|NCT04545476|537835335|FG003|Overall Study|Lost to Follow-up|0|||
149096666|NCT00545571|537835341|FG000|Overall Study|Administrative Reasons|1|||
149096667|NCT00545571|537835341|FG000|Overall Study|Adverse Event|2|||
149096668|NCT00545571|537835341|FG000|Overall Study|Death|5|||
149096669|NCT00545571|537835341|FG000|Overall Study|Lack of Efficacy|1|||
149096670|NCT00545571|537835341|FG000|Overall Study|Protocol Violation|2|||
149096671|NCT00545571|537835341|FG000|Overall Study|Refused Treatment|1|||
149096672|NCT00545571|537835341|FG000|Overall Study|Screen Failure|16|||
149096673|NCT00545571|537835341|FG000|Overall Study|Transfusion|12|||
149096674|NCT00545571|537835341|FG000|Overall Study|Early Termination of Study|24|||
149096675|NCT00545571|537835341|FG000|Overall Study|Kidney Transplantation|3|||
149096676|NCT01193218|537835343|FG000|0-12 Weeks|Adverse Event|6|||
149096677|NCT01193218|537835344|FG001|0-12 Weeks|Adverse Event|0|||
149096678|NCT01193218|537835345|FG002|0-12 Weeks|Adverse Event|1|||
149096679|NCT01193218|537835346|FG003|0-12 Weeks|Adverse Event|0|||
149096680|NCT01193218|537835347|FG004|0-12 Weeks|Adverse Event|0|||
149096681|NCT01193218|537835348|FG005|0-12 Weeks|Adverse Event|2|||
149096682|NCT01193218|537835349|FG006|0-12 Weeks|Adverse Event|2|||
149096683|NCT01193218|537835350|FG007|0-12 Weeks|Adverse Event|0|||
149096684|NCT01193218|537835343|FG000|0-12 Weeks|Protocol Violation|0|||
149096685|NCT01193218|537835344|FG001|0-12 Weeks|Protocol Violation|0|||
149096686|NCT01193218|537835345|FG002|0-12 Weeks|Protocol Violation|0|||
149096687|NCT01193218|537835346|FG003|0-12 Weeks|Protocol Violation|0|||
149096688|NCT01193218|537835347|FG004|0-12 Weeks|Protocol Violation|1|||
149096689|NCT01193218|537835348|FG005|0-12 Weeks|Protocol Violation|1|||
149096690|NCT01193218|537835349|FG006|0-12 Weeks|Protocol Violation|0|||
149096691|NCT01193218|537835350|FG007|0-12 Weeks|Protocol Violation|0|||
149096692|NCT01193218|537835343|FG000|0-12 Weeks|Withdrawal by Subject|3|||
149096693|NCT01193218|537835344|FG001|0-12 Weeks|Withdrawal by Subject|0|||
149096694|NCT01193218|537835345|FG002|0-12 Weeks|Withdrawal by Subject|2|||
149096695|NCT01193218|537835346|FG003|0-12 Weeks|Withdrawal by Subject|0|||
149096696|NCT01193218|537835347|FG004|0-12 Weeks|Withdrawal by Subject|0|||
149096697|NCT01193218|537835348|FG005|0-12 Weeks|Withdrawal by Subject|0|||
149096698|NCT01193218|537835349|FG006|0-12 Weeks|Withdrawal by Subject|1|||
149096699|NCT01193218|537835350|FG007|0-12 Weeks|Withdrawal by Subject|0|||
149096700|NCT01193218|537835343|FG000|12-52 Weeks|Adverse Event|1|||
149096701|NCT01193218|537835344|FG001|12-52 Weeks|Adverse Event|0|||
149096702|NCT01193218|537835345|FG002|12-52 Weeks|Adverse Event|1|||
149096703|NCT01193218|537835346|FG003|12-52 Weeks|Adverse Event|2|||
149096704|NCT01193218|537835347|FG004|12-52 Weeks|Adverse Event|3|||
149096705|NCT01193218|537835348|FG005|12-52 Weeks|Adverse Event|3|||
149096706|NCT01193218|537835349|FG006|12-52 Weeks|Adverse Event|1|||
149096707|NCT01193218|537835350|FG007|12-52 Weeks|Adverse Event|2|||
149096708|NCT01193218|537835343|FG000|12-52 Weeks|Lack of Efficacy|0|||
149096709|NCT01193218|537835344|FG001|12-52 Weeks|Lack of Efficacy|0|||
149096710|NCT01193218|537835345|FG002|12-52 Weeks|Lack of Efficacy|0|||
149096711|NCT01193218|537835346|FG003|12-52 Weeks|Lack of Efficacy|0|||
149096712|NCT01193218|537835347|FG004|12-52 Weeks|Lack of Efficacy|0|||
149096713|NCT01193218|537835348|FG005|12-52 Weeks|Lack of Efficacy|0|||
149096714|NCT01193218|537835349|FG006|12-52 Weeks|Lack of Efficacy|1|||
149096715|NCT01193218|537835350|FG007|12-52 Weeks|Lack of Efficacy|0|||
149096716|NCT01193218|537835343|FG000|12-52 Weeks|Withdrawal by Subject|3|||
149096717|NCT01193218|537835344|FG001|12-52 Weeks|Withdrawal by Subject|0|||
149096718|NCT01193218|537835345|FG002|12-52 Weeks|Withdrawal by Subject|3|||
149096719|NCT01193218|537835346|FG003|12-52 Weeks|Withdrawal by Subject|0|||
149096720|NCT01193218|537835347|FG004|12-52 Weeks|Withdrawal by Subject|0|||
149096721|NCT01193218|537835348|FG005|12-52 Weeks|Withdrawal by Subject|2|||
149096722|NCT01193218|537835349|FG006|12-52 Weeks|Withdrawal by Subject|1|||
149096723|NCT01193218|537835350|FG007|12-52 Weeks|Withdrawal by Subject|2|||
149096724|NCT01193218|537835343|FG000|12-52 Weeks|Other reason than above|1|||
149096725|NCT01193218|537835344|FG001|12-52 Weeks|Other reason than above|0|||
149096726|NCT01193218|537835345|FG002|12-52 Weeks|Other reason than above|0|||
149096727|NCT01193218|537835346|FG003|12-52 Weeks|Other reason than above|1|||
149096728|NCT01193218|537835347|FG004|12-52 Weeks|Other reason than above|1|||
149096729|NCT01193218|537835348|FG005|12-52 Weeks|Other reason than above|0|||
149096730|NCT01193218|537835349|FG006|12-52 Weeks|Other reason than above|0|||
149096731|NCT01193218|537835350|FG007|12-52 Weeks|Other reason than above|0|||
149096732|NCT00363649|537835351|FG000|Overall Study|Withdrawal by Subject|1|||
149096733|NCT00363649|537835352|FG001|Overall Study|Withdrawal by Subject|1|||
149096734|NCT00363649|537835351|FG000|Overall Study|Adverse Event|6|||
149096735|NCT00363649|537835352|FG001|Overall Study|Adverse Event|0|||
149096736|NCT01013740|537835353|FG000|Overall Study|Lost to Follow-up|3|||
149096737|NCT01013740|537835354|FG001|Overall Study|Lost to Follow-up|5|||
149096738|NCT01013740|537835353|FG000|Overall Study|Physician Decision|2|||
149096739|NCT01013740|537835354|FG001|Overall Study|Physician Decision|0|||
149096740|NCT01013740|537835353|FG000|Overall Study|Withdrawal by Subject|2|||
149096741|NCT01013740|537835354|FG001|Overall Study|Withdrawal by Subject|10|||
149096742|NCT01013740|537835353|FG000|Overall Study|study close / terminated : done in error|2|||
149096743|NCT01013740|537835354|FG001|Overall Study|study close / terminated : done in error|1|||
149096744|NCT01013740|537835353|FG000|Overall Study|Missing|2|||
149096745|NCT01013740|537835354|FG001|Overall Study|Missing|1|||
149096746|NCT01013740|537835353|FG000|Overall Study|Ongoing: Study records not completed|0|||
149096747|NCT01013740|537835354|FG001|Overall Study|Ongoing: Study records not completed|2|||
149096748|NCT03811834|537835357|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
149096749|NCT00576823|537835358|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
149096750|NCT00576823|537835359|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
149096751|NCT00576823|537835360|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
149096752|NCT00576823|537835358|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
149096753|NCT00576823|537835359|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
149096754|NCT00576823|537835360|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
149096755|NCT01242371|537835361|FG000|Overall Study|Withdrawal by Subject|2|||
149096756|NCT01242371|537835362|FG001|Overall Study|Withdrawal by Subject|2|||
149096757|NCT01242371|537835361|FG000|Overall Study|Protocol Violation|0|||
149096758|NCT01242371|537835362|FG001|Overall Study|Protocol Violation|3|||
149096759|NCT00510146|537835363|FG000|Double-Blind Treatment|Adverse Event|30|||
149096760|NCT00510146|537835364|FG001|Double-Blind Treatment|Adverse Event|13|||
149096761|NCT00510146|537835363|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
149096762|NCT00510146|537835364|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
149096763|NCT00510146|537835363|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
149096764|NCT00510146|537835364|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
149096765|NCT00510146|537835363|FG000|Double-Blind Treatment|Physician Decision|6|||
149096766|NCT00510146|537835364|FG001|Double-Blind Treatment|Physician Decision|0|||
149096767|NCT00510146|537835363|FG000|Double-Blind Treatment|Protocol Violation|1|||
149096768|NCT00510146|537835364|FG001|Double-Blind Treatment|Protocol Violation|2|||
149096769|NCT00510146|537835363|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
149096770|NCT00510146|537835364|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
149096771|NCT00510146|537835363|FG000|Double-Blind Treatment|Clinical Relapse|0|||
149096772|NCT00510146|537835364|FG001|Double-Blind Treatment|Clinical Relapse|1|||
149096773|NCT00510146|537835363|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
149096774|NCT00510146|537835364|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
149096775|NCT00510146|537835363|FG000|Open-Label Treatment|Adverse Event|22|||
149096776|NCT00510146|537835364|FG001|Open-Label Treatment|Adverse Event|8|||
149096777|NCT00510146|537835363|FG000|Open-Label Treatment|Death|1|||
149096778|NCT00510146|537835364|FG001|Open-Label Treatment|Death|1|||
149096779|NCT00510146|537835363|FG000|Open-Label Treatment|Lack of Efficacy|4|||
149096780|NCT00510146|537835364|FG001|Open-Label Treatment|Lack of Efficacy|0|||
149096781|NCT00510146|537835363|FG000|Open-Label Treatment|Lost to Follow-up|10|||
149096782|NCT00510146|537835364|FG001|Open-Label Treatment|Lost to Follow-up|1|||
149096783|NCT00510146|537835363|FG000|Open-Label Treatment|Physician Decision|3|||
149096784|NCT00510146|537835364|FG001|Open-Label Treatment|Physician Decision|1|||
149096785|NCT00510146|537835363|FG000|Open-Label Treatment|Protocol Violation|4|||
149096786|NCT00510146|537835364|FG001|Open-Label Treatment|Protocol Violation|2|||
149096787|NCT00510146|537835363|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
149096788|NCT00510146|537835364|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
149096789|NCT00510146|537835363|FG000|Open-Label Treatment|Clinical Relapse|1|||
149096790|NCT00510146|537835364|FG001|Open-Label Treatment|Clinical Relapse|1|||
149096791|NCT00510146|537835363|FG000|Open-Label Treatment|Sponsor Decision|2|||
149096792|NCT00510146|537835364|FG001|Open-Label Treatment|Sponsor Decision|0|||
149096793|NCT03188536|537835367|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
149096794|NCT03188536|537835367|FG000|Overall Study|Not participated/met inclusion criteria|1|||
149096795|NCT01930214|537835368|FG000|Overall Study|Death|4|||
149096796|NCT01930214|537835369|FG001|Overall Study|Death|4|||
149096797|NCT01930214|537835370|FG002|Overall Study|Death|11|||
149096798|NCT01930214|537835368|FG000|Overall Study|Lost to Follow-up|12|||
149096799|NCT01930214|537835369|FG001|Overall Study|Lost to Follow-up|13|||
149096800|NCT01930214|537835370|FG002|Overall Study|Lost to Follow-up|12|||
149096801|NCT01930214|537835368|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
149096802|NCT01930214|537835369|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
149096803|NCT01930214|537835370|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
149096804|NCT01930214|537835368|FG000|Overall Study|Physician Decision|2|||
149096805|NCT01930214|537835369|FG001|Overall Study|Physician Decision|0|||
149096806|NCT01930214|537835370|FG002|Overall Study|Physician Decision|0|||
149096807|NCT00025662|537835371|FG000|Overall Study|Withdrawal by Subject|2|||
149096808|NCT00025662|537835371|FG000|Overall Study|Technical failure of manipulation|1|||
149096809|NCT02132117|537835374|FG000|Overall Study|Adverse Event|6|||
149096810|NCT02132117|537835375|FG001|Overall Study|Adverse Event|1|||
149096811|NCT02132117|537835374|FG000|Overall Study|Lost to Follow-up|2|||
149096812|NCT02132117|537835375|FG001|Overall Study|Lost to Follow-up|2|||
149096813|NCT02132117|537835374|FG000|Overall Study|Personal Reasons|1|||
149096814|NCT02132117|537835375|FG001|Overall Study|Personal Reasons|2|||
149096815|NCT02132117|537835374|FG000|Overall Study|Other Miscellaneous Reasons|2|||
149096816|NCT02132117|537835375|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149096817|NCT04947436|537835376|FG000|Overall Study|Lost to Follow-up|3|||
149096818|NCT04947436|537835377|FG001|Overall Study|Lost to Follow-up|7|||
149096819|NCT04947436|537835378|FG002|Overall Study|Lost to Follow-up|5|||
149096820|NCT04947436|537835376|FG000|Overall Study|Death|1|||
149096821|NCT04947436|537835377|FG001|Overall Study|Death|1|||
149096822|NCT04947436|537835378|FG002|Overall Study|Death|1|||
149096823|NCT02161185|537835382|FG000|Treatment Phase|Administrative/Other|7|||
149096824|NCT02864342|537835383|FG000|Overall Study|Eligibility Criteria Deviation|2|||
149096825|NCT02864342|537835384|FG001|Overall Study|Eligibility Criteria Deviation|3|||
149096826|NCT02864342|537835383|FG000|Overall Study|Withdrawal by Subject|4|||
149096827|NCT02864342|537835384|FG001|Overall Study|Withdrawal by Subject|2|||
149096828|NCT02864342|537835383|FG000|Overall Study|Device Technology Issue|6|||
149096829|NCT02864342|537835384|FG001|Overall Study|Device Technology Issue|7|||
149096830|NCT02864342|537835383|FG000|Overall Study|Death|0|||
149096831|NCT02864342|537835384|FG001|Overall Study|Death|1|||
149096832|NCT02864342|537835383|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
149096833|NCT02864342|537835384|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
149096834|NCT02864342|537835383|FG000|Overall Study|Lost to Follow-up|1|||
149096835|NCT02864342|537835384|FG001|Overall Study|Lost to Follow-up|5|||
149096836|NCT02864342|537835383|FG000|Overall Study|Lost Device|1|||
149096837|NCT02864342|537835384|FG001|Overall Study|Lost Device|0|||
149096838|NCT02864342|537835383|FG000|Overall Study|Adverse Event|1|||
149096839|NCT02864342|537835384|FG001|Overall Study|Adverse Event|0|||
149096840|NCT00582114|537835388|FG000|Overall Study|Death|4|||
149096841|NCT00582114|537835389|FG001|Overall Study|Death|4|||
149096842|NCT00582114|537835388|FG000|Overall Study|Kidney Transplant|3|||
149096843|NCT00582114|537835389|FG001|Overall Study|Kidney Transplant|1|||
149096844|NCT00582114|537835388|FG000|Overall Study|Lost to Follow-up|7|||
149096845|NCT00582114|537835389|FG001|Overall Study|Lost to Follow-up|6|||
149096846|NCT00582114|537835388|FG000|Overall Study|Withdrawal by Subject|8|||
149096847|NCT00582114|537835389|FG001|Overall Study|Withdrawal by Subject|16|||
149096848|NCT00582114|537835388|FG000|Overall Study|Adverse Event|1|||
149096849|NCT00582114|537835389|FG001|Overall Study|Adverse Event|1|||
149096850|NCT00582114|537835388|FG000|Overall Study|Physician Decision|0|||
149096851|NCT00582114|537835389|FG001|Overall Study|Physician Decision|6|||
149096852|NCT00582114|537835388|FG000|Overall Study|Stopped by data safety monitoring board|19|||
149096853|NCT00582114|537835389|FG001|Overall Study|Stopped by data safety monitoring board|20|||
149096854|NCT00118703|537835390|FG000|Overall Study|Protocol Violation|1|||
149096855|NCT00118703|537835391|FG001|Overall Study|Protocol Violation|0|||
149096856|NCT00118703|537835390|FG000|Overall Study|Adverse Event|1|||
149096857|NCT00118703|537835391|FG001|Overall Study|Adverse Event|1|||
149096858|NCT00118703|537835390|FG000|Overall Study|Participant took two different treatment|0|||
149096859|NCT00118703|537835391|FG001|Overall Study|Participant took two different treatment|1|||
149096860|NCT00118703|537835390|FG000|Overall Study|Withdrawal by Subject|2|||
149096861|NCT00118703|537835391|FG001|Overall Study|Withdrawal by Subject|5|||
149096862|NCT00118703|537835390|FG000|Overall Study|Lost to Follow-up|1|||
149096863|NCT00118703|537835391|FG001|Overall Study|Lost to Follow-up|2|||
149096864|NCT00130728|537835396|FG000|Overall Study|Death|258|||
149096865|NCT00130728|537835397|FG001|Overall Study|Death|258|||
149096866|NCT00130728|537835396|FG000|Overall Study|Lost to Follow-up|4|||
149096867|NCT00130728|537835397|FG001|Overall Study|Lost to Follow-up|0|||
149096868|NCT00130728|537835396|FG000|Overall Study|Withdrawal by Subject|0|||
149096869|NCT00130728|537835397|FG001|Overall Study|Withdrawal by Subject|2|||
149096870|NCT01209286|537835399|FG000|Overall Study|Adverse Event|4|||
149096871|NCT01209286|537835400|FG001|Overall Study|Adverse Event|3|||
149096872|NCT01209286|537835401|FG002|Overall Study|Adverse Event|1|||
149096873|NCT01209286|537835399|FG000|Overall Study|Hematological Relapse After Remission|0|||
149096874|NCT01209286|537835400|FG001|Overall Study|Hematological Relapse After Remission|1|||
149096875|NCT01209286|537835401|FG002|Overall Study|Hematological Relapse After Remission|1|||
149096876|NCT01209286|537835399|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
149096877|NCT01209286|537835400|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
149096878|NCT01209286|537835401|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
149096879|NCT01209286|537835399|FG000|Overall Study|Physician Decision|0|||
149096880|NCT01209286|537835400|FG001|Overall Study|Physician Decision|2|||
149096881|NCT01209286|537835401|FG002|Overall Study|Physician Decision|0|||
149096882|NCT01209286|537835399|FG000|Overall Study|Other|0|||
149096883|NCT01209286|537835400|FG001|Overall Study|Other|1|||
149096884|NCT01209286|537835401|FG002|Overall Study|Other|0|||
149096885|NCT01349036|537835402|FG000|Overall Study|Disease progression|13|||
149096886|NCT01349036|537835403|FG001|Overall Study|Disease progression|22|||
149096887|NCT01349036|537835402|FG000|Overall Study|Other|1|||
149096888|NCT01349036|537835403|FG001|Overall Study|Other|0|||
149096889|NCT01349036|537835402|FG000|Overall Study|Withdrawal by Subject|0|||
149096890|NCT01349036|537835403|FG001|Overall Study|Withdrawal by Subject|2|||
149096891|NCT03796208|537835404|FG000|Overall Study|Withdrawal by Subject|3|||
149096892|NCT03796208|537835405|FG001|Overall Study|Withdrawal by Subject|0|||
149096893|NCT03796208|537835404|FG000|Overall Study|Loss of pregnancy|1|||
149096894|NCT03796208|537835405|FG001|Overall Study|Loss of pregnancy|1|||
149096895|NCT03796208|537835404|FG000|Overall Study|Changed prenatal clinics|0|||
149096896|NCT03796208|537835405|FG001|Overall Study|Changed prenatal clinics|5|||
149096897|NCT03796208|537835404|FG000|Overall Study|Lost to Follow-up|20|||
149096898|NCT03796208|537835405|FG001|Overall Study|Lost to Follow-up|16|||
149096899|NCT01020747|537835407|FG000|Overall Study|Withdrawal by Subject|1|||
149096900|NCT03448536|537835409|FG000|Overall Study|Protocol Violation|2|||
149096901|NCT03448536|537835410|FG001|Overall Study|Protocol Violation|0|||
149096902|NCT03448536|537835409|FG000|Overall Study|Pregnancy|1|||
149096903|NCT03448536|537835410|FG001|Overall Study|Pregnancy|0|||
149096904|NCT03448536|537835409|FG000|Overall Study|Withdrawal by Subject|1|||
149096905|NCT03448536|537835410|FG001|Overall Study|Withdrawal by Subject|2|||
149096906|NCT03448536|537835409|FG000|Overall Study|Lost to Follow-up|3|||
149096907|NCT03448536|537835410|FG001|Overall Study|Lost to Follow-up|2|||
149096908|NCT03448536|537835409|FG000|Overall Study|Inadequate pain reporter|1|||
149096909|NCT03448536|537835410|FG001|Overall Study|Inadequate pain reporter|0|||
149096910|NCT03448536|537835409|FG000|Overall Study|Other|3|||
149096911|NCT03448536|537835410|FG001|Overall Study|Other|0|||
149096912|NCT03448536|537835409|FG000|Overall Study|Physician Decision|1|||
149096913|NCT03448536|537835410|FG001|Overall Study|Physician Decision|0|||
149096914|NCT03120949|537835411|FG000|Overall Study|randomized in error|1|||
149096915|NCT03120949|537835412|FG001|Overall Study|randomized in error|0|||
149096916|NCT03120949|537835411|FG000|Overall Study|Death|13|||
149096917|NCT03120949|537835412|FG001|Overall Study|Death|13|||
149096918|NCT03120949|537835411|FG000|Overall Study|Lost to Follow-up|23|||
149096919|NCT03120949|537835412|FG001|Overall Study|Lost to Follow-up|13|||
149096920|NCT03120949|537835411|FG000|Overall Study|Withdrawal by Subject|139|||
149096921|NCT03120949|537835412|FG001|Overall Study|Withdrawal by Subject|124|||
149096922|NCT03120949|537835411|FG000|Overall Study|Covid-19|43|||
149096923|NCT03120949|537835412|FG001|Overall Study|Covid-19|34|||
149096924|NCT03120949|537835411|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
149096925|NCT03120949|537835412|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
149096926|NCT03120949|537835411|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
149096927|NCT03120949|537835412|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
149096928|NCT03120949|537835411|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
149096929|NCT03120949|537835412|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
149096930|NCT03120949|537835411|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
149096931|NCT03120949|537835412|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
149096932|NCT03120949|537835411|FG000|Overall Study|Site was closed|2|||
149096933|NCT03120949|537835412|FG001|Overall Study|Site was closed|3|||
149096934|NCT03120949|537835411|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
149096935|NCT03120949|537835412|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
149096936|NCT03120949|537835411|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
149096937|NCT03120949|537835412|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
149096938|NCT03120949|537835411|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
149096939|NCT03120949|537835412|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
149096940|NCT03120949|537835411|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
149096941|NCT03120949|537835412|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
149096942|NCT03120949|537835411|FG000|Overall Study|Other: Adverse Event|0|||
149096943|NCT03120949|537835412|FG001|Overall Study|Other: Adverse Event|1|||
149096944|NCT03120949|537835411|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
149096945|NCT03120949|537835412|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
149096946|NCT03120949|537835411|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
149096947|NCT03120949|537835412|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
149096948|NCT03120949|537835411|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
149096949|NCT03120949|537835412|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
149096950|NCT03120949|537835411|FG000|Overall Study|Personal Reasons|0|||
149096951|NCT03120949|537835412|FG001|Overall Study|Personal Reasons|1|||
149096952|NCT03120949|537835411|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
149096953|NCT03120949|537835412|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
149096954|NCT03120949|537835411|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
149096955|NCT03120949|537835412|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
149096956|NCT03120949|537835411|FG000|Overall Study|Compliance With Medication|0|||
149096957|NCT03120949|537835412|FG001|Overall Study|Compliance With Medication|1|||
149096958|NCT03120949|537835411|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
149096959|NCT03120949|537835412|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
149096960|NCT03120949|537835411|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
149096961|NCT03120949|537835412|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
149096962|NCT03120949|537835411|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
149096963|NCT03120949|537835412|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
149096964|NCT01705145|537835413|FG000|Part B|Adverse Event|1|||
149096965|NCT00312845|537835414|FG000|Overall Study|Adverse Event|19|||
149096966|NCT00312845|537835415|FG001|Overall Study|Adverse Event|5|||
149096967|NCT00312845|537835414|FG000|Overall Study|Death|2|||
149096968|NCT00312845|537835415|FG001|Overall Study|Death|2|||
149096969|NCT00312845|537835414|FG000|Overall Study|Withdrawal by Subject|14|||
149096970|NCT00312845|537835415|FG001|Overall Study|Withdrawal by Subject|6|||
149096971|NCT00312845|537835414|FG000|Overall Study|Disease Progression|56|||
149096972|NCT00312845|537835415|FG001|Overall Study|Disease Progression|77|||
149096973|NCT00312845|537835414|FG000|Overall Study|Lost to Follow-up|2|||
149096974|NCT00312845|537835415|FG001|Overall Study|Lost to Follow-up|0|||
149096975|NCT00312845|537835414|FG000|Overall Study|Other|6|||
149096976|NCT00312845|537835415|FG001|Overall Study|Other|5|||
149096977|NCT01078584|537835416|FG000|Overall Study|Final Status Unknown|1073|||
149096978|NCT01078584|537835416|FG000|Overall Study|Lost to Follow-up|670|||
149096979|NCT01078584|537835416|FG000|Overall Study|Non-serious Adverse Event|577|||
149096980|NCT01078584|537835416|FG000|Overall Study|Withdrawal of Consent|244|||
149096981|NCT01078584|537835416|FG000|Overall Study|Physician Withdrew from Study|90|||
149096982|NCT01078584|537835416|FG000|Overall Study|Non-compliance|67|||
149096983|NCT01078584|537835416|FG000|Overall Study|Blood Pressure Controlled|49|||
149096984|NCT01078584|537835416|FG000|Overall Study|Physician Switched Medication|26|||
149096985|NCT01078584|537835416|FG000|Overall Study|Physician Discontinued Patient|12|||
149096986|NCT01078584|537835416|FG000|Overall Study|Lack of Efficacy|98|||
149096987|NCT01078584|537835416|FG000|Overall Study|Protocol Violation|75|||
149096988|NCT01078584|537835416|FG000|Overall Study|Serious Adverse Event|27|||
149096989|NCT01078584|537835416|FG000|Overall Study|Multiple Reasons|2|||
149096990|NCT01208870|537835417|FG000|Overall Study|Lost to Follow-up|2|||
149096991|NCT01208870|537835418|FG001|Overall Study|Lost to Follow-up|8|||
149096992|NCT01121185|537835419|FG000|Overall Study|Not infused|0|||
149096993|NCT01121185|537835420|FG001|Overall Study|Not infused|1|||
149096994|NCT01121185|537835419|FG000|Overall Study|Not transplanted|1|||
149096995|NCT01121185|537835420|FG001|Overall Study|Not transplanted|0|||
149096996|NCT00424177|537835421|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
149096997|NCT00424177|537835421|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
149096998|NCT00424177|537835421|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
149096999|NCT00424177|537835421|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
149097000|NCT00424177|537835421|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
149097001|NCT00424177|537835421|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
149097002|NCT00424177|537835421|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
149097003|NCT00424177|537835421|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
149097004|NCT00424177|537835421|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
149097005|NCT00424177|537835421|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
149097006|NCT01393613|537835422|FG000|Overall Study|Adverse Event|11|||
149097007|NCT01393613|537835423|FG001|Overall Study|Adverse Event|11|||
149097008|NCT01393613|537835424|FG002|Overall Study|Adverse Event|13|||
149097009|NCT01393613|537835425|FG003|Overall Study|Adverse Event|22|||
149097010|NCT01393613|537835422|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
149097011|NCT01393613|537835423|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
149097012|NCT01393613|537835424|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
149097013|NCT01393613|537835425|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
149097014|NCT01393613|537835422|FG000|Overall Study|Physician Decision|2|||
149097015|NCT01393613|537835423|FG001|Overall Study|Physician Decision|0|||
149097016|NCT01393613|537835424|FG002|Overall Study|Physician Decision|0|||
149097017|NCT01393613|537835425|FG003|Overall Study|Physician Decision|1|||
149097018|NCT01393613|537835422|FG000|Overall Study|Withdrawal by Subject|15|||
149097019|NCT01393613|537835423|FG001|Overall Study|Withdrawal by Subject|25|||
149097020|NCT01393613|537835424|FG002|Overall Study|Withdrawal by Subject|23|||
149097021|NCT01393613|537835425|FG003|Overall Study|Withdrawal by Subject|21|||
149097022|NCT01393613|537835422|FG000|Overall Study|Protocol Deviation|2|||
149097023|NCT01393613|537835423|FG001|Overall Study|Protocol Deviation|1|||
149097024|NCT01393613|537835424|FG002|Overall Study|Protocol Deviation|0|||
149097025|NCT01393613|537835425|FG003|Overall Study|Protocol Deviation|0|||
149097026|NCT01393613|537835422|FG000|Overall Study|Lack of Efficacy|9|||
149097027|NCT01393613|537835423|FG001|Overall Study|Lack of Efficacy|20|||
149097028|NCT01393613|537835424|FG002|Overall Study|Lack of Efficacy|16|||
149097029|NCT01393613|537835425|FG003|Overall Study|Lack of Efficacy|21|||
149097030|NCT00474383|537835426|FG000|Main Study|Adverse Event|11|||
149097031|NCT00474383|537835427|FG001|Main Study|Adverse Event|0|||
149097032|NCT00474383|537835426|FG000|Main Study|Symptomatic Deterioration|1|||
149097033|NCT00474383|537835427|FG001|Main Study|Symptomatic Deterioration|0|||
149097034|NCT00474383|537835426|FG000|Main Study|Progressive Disease|23|||
149097035|NCT00474383|537835427|FG001|Main Study|Progressive Disease|0|||
149097036|NCT00474383|537835426|FG000|Main Study|Other|1|||
149097037|NCT00474383|537835427|FG001|Main Study|Other|0|||
149097038|NCT00474383|537835426|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
149097039|NCT00474383|537835427|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
149097040|NCT00474383|537835426|FG000|Extension|Progressive Disease|0|||
149097041|NCT00474383|537835427|FG001|Extension|Progressive Disease|5|||
149097042|NCT00316589|537835428|FG000|Overall Study|Withdrawal by Subject|0|||
149097043|NCT00316589|537835429|FG001|Overall Study|Withdrawal by Subject|5|||
149097044|NCT00316589|537835430|FG002|Overall Study|Withdrawal by Subject|0|||
149097045|NCT00316589|537835431|FG003|Overall Study|Withdrawal by Subject|1|||
149097046|NCT00316589|537835428|FG000|Overall Study|Subject unwilling/unable to comply|0|||
149097047|NCT00316589|537835429|FG001|Overall Study|Subject unwilling/unable to comply|6|||
149097048|NCT00316589|537835430|FG002|Overall Study|Subject unwilling/unable to comply|0|||
149097049|NCT00316589|537835431|FG003|Overall Study|Subject unwilling/unable to comply|2|||
149097050|NCT00316589|537835428|FG000|Overall Study|Adverse Event|1|||
149097051|NCT00316589|537835429|FG001|Overall Study|Adverse Event|0|||
149097052|NCT00316589|537835430|FG002|Overall Study|Adverse Event|0|||
149097053|NCT00316589|537835431|FG003|Overall Study|Adverse Event|1|||
149097054|NCT00316589|537835428|FG000|Overall Study|Physician Decision|0|||
149097055|NCT00316589|537835429|FG001|Overall Study|Physician Decision|1|||
149097056|NCT00316589|537835430|FG002|Overall Study|Physician Decision|0|||
149097057|NCT00316589|537835431|FG003|Overall Study|Physician Decision|0|||
149097058|NCT00316589|537835428|FG000|Overall Study|Other reason|0|||
149097059|NCT00316589|537835429|FG001|Overall Study|Other reason|12|||
149097060|NCT00316589|537835430|FG002|Overall Study|Other reason|1|||
149097061|NCT00316589|537835431|FG003|Overall Study|Other reason|1|||
149097062|NCT01502371|537835436|FG000|Overall Study|Withdrawal by Subject|1|||
149097063|NCT01502371|537835437|FG001|Overall Study|Withdrawal by Subject|2|||
149097064|NCT01502371|537835438|FG002|Overall Study|Withdrawal by Subject|1|||
149097065|NCT01502371|537835439|FG003|Overall Study|Withdrawal by Subject|1|||
149097066|NCT01502371|537835440|FG004|Overall Study|Withdrawal by Subject|1|||
149097067|NCT01502371|537835436|FG000|Overall Study|Adverse Event|2|||
149097068|NCT01502371|537835437|FG001|Overall Study|Adverse Event|1|||
149097069|NCT01502371|537835438|FG002|Overall Study|Adverse Event|0|||
149097070|NCT01502371|537835439|FG003|Overall Study|Adverse Event|4|||
149097071|NCT01502371|537835440|FG004|Overall Study|Adverse Event|3|||
149097072|NCT01502371|537835436|FG000|Overall Study|Treatment Failure|22|||
149097073|NCT01502371|537835437|FG001|Overall Study|Treatment Failure|20|||
149097074|NCT01502371|537835438|FG002|Overall Study|Treatment Failure|12|||
149097075|NCT01502371|537835439|FG003|Overall Study|Treatment Failure|19|||
149097076|NCT01502371|537835440|FG004|Overall Study|Treatment Failure|30|||
149097077|NCT01502371|537835436|FG000|Overall Study|Lack of Efficacy|3|||
149097078|NCT01502371|537835437|FG001|Overall Study|Lack of Efficacy|3|||
149097079|NCT01502371|537835438|FG002|Overall Study|Lack of Efficacy|2|||
149097080|NCT01502371|537835439|FG003|Overall Study|Lack of Efficacy|2|||
149097081|NCT01502371|537835440|FG004|Overall Study|Lack of Efficacy|4|||
149097082|NCT01502371|537835436|FG000|Overall Study|Physician Decision|3|||
149097083|NCT01502371|537835437|FG001|Overall Study|Physician Decision|0|||
149097084|NCT01502371|537835438|FG002|Overall Study|Physician Decision|0|||
149097085|NCT01502371|537835439|FG003|Overall Study|Physician Decision|0|||
149097086|NCT01502371|537835440|FG004|Overall Study|Physician Decision|1|||
149097087|NCT01502371|537835436|FG000|Overall Study|Noncompliance with Study Drug|0|||
149097088|NCT01502371|537835437|FG001|Overall Study|Noncompliance with Study Drug|0|||
149097089|NCT01502371|537835438|FG002|Overall Study|Noncompliance with Study Drug|1|||
149097090|NCT01502371|537835439|FG003|Overall Study|Noncompliance with Study Drug|2|||
149097091|NCT01502371|537835440|FG004|Overall Study|Noncompliance with Study Drug|1|||
149097092|NCT01502371|537835436|FG000|Overall Study|Technical Problems|1|||
149097093|NCT01502371|537835437|FG001|Overall Study|Technical Problems|0|||
149097094|NCT01502371|537835438|FG002|Overall Study|Technical Problems|2|||
149097095|NCT01502371|537835439|FG003|Overall Study|Technical Problems|4|||
149097096|NCT01502371|537835440|FG004|Overall Study|Technical Problems|1|||
149097097|NCT01502371|537835436|FG000|Overall Study|Protocol Violation|9|||
149097098|NCT01502371|537835437|FG001|Overall Study|Protocol Violation|5|||
149097099|NCT01502371|537835438|FG002|Overall Study|Protocol Violation|6|||
149097100|NCT01502371|537835439|FG003|Overall Study|Protocol Violation|5|||
149097101|NCT01502371|537835440|FG004|Overall Study|Protocol Violation|10|||
149097102|NCT01502371|537835436|FG000|Overall Study|Excluded Medication|0|||
149097103|NCT01502371|537835437|FG001|Overall Study|Excluded Medication|1|||
149097104|NCT01502371|537835438|FG002|Overall Study|Excluded Medication|1|||
149097105|NCT01502371|537835439|FG003|Overall Study|Excluded Medication|0|||
149097106|NCT01502371|537835440|FG004|Overall Study|Excluded Medication|1|||
149097107|NCT00702520|537835441|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
149097108|NCT00702520|537835442|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
149097109|NCT00702520|537835443|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
149097110|NCT00702520|537835444|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
149097111|NCT00702520|537835441|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
149097112|NCT00702520|537835442|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
149097113|NCT00702520|537835443|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
149097114|NCT00702520|537835444|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
149097115|NCT00702520|537835441|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
149097116|NCT00702520|537835442|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
149097117|NCT00702520|537835443|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
149097118|NCT00702520|537835444|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
149097119|NCT02154347|537835445|FG000|Double-blind Period|Adverse Event|1|||
149097120|NCT02154347|537835446|FG001|Double-blind Period|Adverse Event|2|||
149097121|NCT02154347|537835445|FG000|Double-blind Period|Lack of Efficacy|1|||
149097122|NCT02154347|537835446|FG001|Double-blind Period|Lack of Efficacy|0|||
149097123|NCT02154347|537835445|FG000|Double-blind Period|Physician Decision|0|||
149097124|NCT02154347|537835446|FG001|Double-blind Period|Physician Decision|1|||
149097125|NCT02154347|537835445|FG000|Double-blind Period|Withdrawal by Subject|1|||
149097126|NCT02154347|537835446|FG001|Double-blind Period|Withdrawal by Subject|1|||
149097127|NCT02154347|537835445|FG000|Open-label Period|Adverse Event|3|||
149097128|NCT02154347|537835446|FG001|Open-label Period|Adverse Event|4|||
149097129|NCT02154347|537835445|FG000|Open-label Period|Lack of Efficacy|4|||
149097130|NCT02154347|537835446|FG001|Open-label Period|Lack of Efficacy|19|||
149097131|NCT02154347|537835445|FG000|Open-label Period|Protocol Violation|0|||
149097132|NCT02154347|537835446|FG001|Open-label Period|Protocol Violation|1|||
149097133|NCT02154347|537835445|FG000|Open-label Period|Withdrawal by Subject|0|||
149097134|NCT02154347|537835446|FG001|Open-label Period|Withdrawal by Subject|1|||
149097135|NCT05041439|537835447|FG000|Overall Study|Withdrawal by Subject|1|||
149097136|NCT05041439|537835448|FG001|Overall Study|Withdrawal by Subject|1|||
149097137|NCT05041439|537835447|FG000|Overall Study|Death|1|||
149097138|NCT05041439|537835448|FG001|Overall Study|Death|0|||
149097139|NCT02250183|537835449|FG000|Overall Study|Withdrawal by Subject|2|||
149097140|NCT02250183|537835449|FG000|Overall Study|Adverse Event|5|||
149097141|NCT02250183|537835449|FG000|Overall Study|Lost to Follow-up|1|||
149097142|NCT02210208|537836931|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
149097143|NCT02210208|537836931|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
149097144|NCT02210208|537836931|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
149097145|NCT03834623|537836932|FG000|Overall Study|Progression|0|||
149097146|NCT03834623|537836933|FG001|Overall Study|Progression|1|||
149097147|NCT04333147|537836938|FG000|Overall Study|Adverse Event|43|||
149097148|NCT04333147|537836939|FG001|Overall Study|Adverse Event|40|||
149097149|NCT04333147|537836938|FG000|Overall Study|Lack of Efficacy|49|||
149097150|NCT04333147|537836939|FG001|Overall Study|Lack of Efficacy|48|||
149097151|NCT04333147|537836938|FG000|Overall Study|Lost to Follow-up|19|||
149097152|NCT04333147|537836939|FG001|Overall Study|Lost to Follow-up|16|||
149097153|NCT04333147|537836938|FG000|Overall Study|Physician Decision|17|||
149097154|NCT04333147|537836939|FG001|Overall Study|Physician Decision|20|||
149097155|NCT04333147|537836938|FG000|Overall Study|Withdrawal by Subject|65|||
149097156|NCT04333147|537836939|FG001|Overall Study|Withdrawal by Subject|68|||
149097157|NCT04333147|537836938|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
149097158|NCT04333147|537836939|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
149097159|NCT04333147|537836938|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
149097160|NCT04333147|537836939|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
149097161|NCT04333147|537836938|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
149097162|NCT04333147|537836939|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
149097163|NCT04606199|537836940|FG000|Overall Study|Withdrawal by Subject|2|||
149097164|NCT00477464|537836943|FG000|Overall Study|Lost to Follow-up|1|||
149097165|NCT00477464|537836943|FG000|Overall Study|Death|36|||
149097166|NCT00477464|537836943|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
149097167|NCT03596242|537836944|FG000|Overall Study|Lost to Follow-up|2|||
149097168|NCT03596242|537836945|FG001|Overall Study|Lost to Follow-up|2|||
149097169|NCT03357471|537836949|FG000|Overall Study|Adverse Event|1|||
149097170|NCT03357471|537836950|FG001|Overall Study|Adverse Event|0|||
149097171|NCT03357471|537836949|FG000|Overall Study|Lost to Follow-up|1|||
149097172|NCT03357471|537836950|FG001|Overall Study|Lost to Follow-up|0|||
149097173|NCT00706914|537836951|FG000|Overall Study|Lack of Efficacy|0|||
149097174|NCT00706914|537836952|FG001|Overall Study|Lack of Efficacy|1|||
149097175|NCT00706914|537836953|FG002|Overall Study|Lack of Efficacy|0|||
149097176|NCT00706914|537836951|FG000|Overall Study|Lost to Follow-up|1|||
149097177|NCT00706914|537836952|FG001|Overall Study|Lost to Follow-up|0|||
149097178|NCT00706914|537836953|FG002|Overall Study|Lost to Follow-up|0|||
149097179|NCT00706914|537836951|FG000|Overall Study|Adverse Event|2|||
149097180|NCT00706914|537836952|FG001|Overall Study|Adverse Event|2|||
149097181|NCT00706914|537836953|FG002|Overall Study|Adverse Event|0|||
149097182|NCT00706914|537836951|FG000|Overall Study|Protocol Violation|3|||
149097183|NCT00706914|537836952|FG001|Overall Study|Protocol Violation|1|||
149097184|NCT00706914|537836953|FG002|Overall Study|Protocol Violation|1|||
149097185|NCT03294941|537836954|FG000|Overall Study|Withdrawal by Subject|0|||
149097186|NCT03294941|537836955|FG001|Overall Study|Withdrawal by Subject|2|||
149097187|NCT00916305|537836956|FG000|Overall Study|Lost to Follow-up|21|||
149097188|NCT00916305|537836957|FG001|Overall Study|Lost to Follow-up|27|||
149097189|NCT00916305|537836956|FG000|Overall Study|Withdrawal by Subject|0|||
149097190|NCT00916305|537836957|FG001|Overall Study|Withdrawal by Subject|1|||
149097191|NCT04051242|537836962|FG000|Overall Study|Withdrawal by Subject|1|||
149097192|NCT04051242|537836962|FG000|Overall Study|Physician Decision|1|||
149097193|NCT04035577|537836965|FG000|Overall Study|Lost to Follow-up|1|||
149097194|NCT04035577|537836965|FG000|Overall Study|Withdrawal by Subject|1|||
149097195|NCT00846768|537836966|FG000|Overall Study|Adverse Event|0|||
149097196|NCT00846768|537836967|FG001|Overall Study|Adverse Event|1|||
149097197|NCT00846768|537836968|FG002|Overall Study|Adverse Event|0|||
149097198|NCT00846768|537836969|FG003|Overall Study|Adverse Event|0|||
149097199|NCT04358068|537836970|FG000|Overall Study|Did not initiate study treatment|2|||
149097200|NCT04358068|537836971|FG001|Overall Study|Did not initiate study treatment|2|||
149097201|NCT01841112|537836976|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
149097202|NCT01841112|537836977|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
149097203|NCT01841112|537836978|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
149097204|NCT01841112|537836979|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
149097205|NCT01841112|537836980|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
149097206|NCT03029819|537836983|FG000|Overall Study|Lost to Follow-up|3|||
149097207|NCT03029819|537836984|FG001|Overall Study|Lost to Follow-up|5|||
149097208|NCT03029819|537836983|FG000|Overall Study|Removed due to disruptive behavior|0|||
149097209|NCT03029819|537836984|FG001|Overall Study|Removed due to disruptive behavior|1|||
149097210|NCT01215032|537836987|FG000|Overall Study|Adverse Event|3|||
149097211|NCT01215032|537836987|FG000|Overall Study|Lack of Efficacy|17|||
149097212|NCT02725008|537836988|FG000|Overall Study|Lost to Follow-up|7|||
149097213|NCT02725008|537836989|FG001|Overall Study|Lost to Follow-up|9|||
149097214|NCT02725008|537836988|FG000|Overall Study|Withdrawal by Subject|2|||
149097215|NCT02725008|537836989|FG001|Overall Study|Withdrawal by Subject|2|||
149097216|NCT02725008|537836988|FG000|Overall Study|Admitted to hospital|0|||
149097217|NCT02725008|537836989|FG001|Overall Study|Admitted to hospital|1|||
149097218|NCT02175745|537836996|FG000|Overall Study|Not Eligible|1|||
149097219|NCT00983892|537836997|FG000|Overall Study|Withdrawal by Subject|10|||
149097220|NCT00983892|537836998|FG001|Overall Study|Withdrawal by Subject|12|||
149097221|NCT00808899|537836999|FG000|Overall Study|Death|1|||
149097222|NCT00808899|537836999|FG000|Overall Study|Physician Decision|3|||
149097223|NCT03028012|537837000|FG000|Overall Study|Lost to Follow-up|2|||
149097224|NCT03028012|537837001|FG001|Overall Study|Lost to Follow-up|3|||
149097225|NCT03028012|537837002|FG002|Overall Study|Lost to Follow-up|3|||
149097226|NCT01424189|537837013|FG000|Overall Study|Adverse Event|1|||
149097227|NCT01424189|537837014|FG001|Overall Study|Adverse Event|0|||
149097228|NCT01424189|537837013|FG000|Overall Study|Lost to Follow-up|4|||
149097229|NCT01424189|537837014|FG001|Overall Study|Lost to Follow-up|1|||
149097230|NCT01424189|537837013|FG000|Overall Study|Withdrawal by Subject|4|||
149097231|NCT01424189|537837014|FG001|Overall Study|Withdrawal by Subject|4|||
149097232|NCT01424189|537837013|FG000|Overall Study|Subject moved|1|||
149097233|NCT01424189|537837014|FG001|Overall Study|Subject moved|0|||
149097234|NCT01424189|537837013|FG000|Overall Study|Death|3|||
149097235|NCT01424189|537837014|FG001|Overall Study|Death|1|||
149097236|NCT04688086|537837015|FG000|Overall Study|Lost to Follow-up|164|||
149097237|NCT04688086|537837015|FG000|Overall Study|Imaging error;|64|||
149097238|NCT01203956|537837016|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
149097239|NCT01203956|537837017|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
149097240|NCT01329419|537837020|FG000|Overall Study|Protocol Violation|235|||
149097241|NCT04522778|537837021|FG000|Overall Study|Patient did not want to wear the device|1|||
149097242|NCT04522778|537837022|FG001|Overall Study|Patient did not want to wear the device|0|||
149097243|NCT04522778|537837021|FG000|Overall Study|Lost to Follow-up|0|||
149097244|NCT04522778|537837022|FG001|Overall Study|Lost to Follow-up|1|||
149097245|NCT00069277|537837025|FG000|Overall Study|Adverse Event|3|||
149097246|NCT00069277|537837025|FG000|Overall Study|Withdrawal by Subject|1|||
149097247|NCT00069277|537837025|FG000|Overall Study|Progressive Disease|15|||
149097248|NCT00069277|537837025|FG000|Overall Study|Physician Decision|2|||
149097249|NCT01225159|537837026|FG000|Overall Study|Change operation|1|||
149097250|NCT01225159|537837027|FG001|Overall Study|Change operation|0|||
149097251|NCT02230306|537837028|FG000|Overall Study|Did not receive study treatment|1|||
149097252|NCT03512288|537837034|FG000|Overall Study|Adverse Event|1|||
149097253|NCT03512288|537837035|FG001|Overall Study|Adverse Event|0|||
149097254|NCT03512288|537837034|FG000|Overall Study|Lost to Follow-up|12|||
149097255|NCT03512288|537837035|FG001|Overall Study|Lost to Follow-up|15|||
149097256|NCT03512288|537837034|FG000|Overall Study|Physician Decision|0|||
149097257|NCT03512288|537837035|FG001|Overall Study|Physician Decision|2|||
149097258|NCT03512288|537837034|FG000|Overall Study|Protocol Violation|6|||
149097259|NCT03512288|537837035|FG001|Overall Study|Protocol Violation|4|||
149097260|NCT03512288|537837034|FG000|Overall Study|Medication error without associated adverse event|1|||
149097261|NCT03512288|537837035|FG001|Overall Study|Medication error without associated adverse event|0|||
149097262|NCT03512288|537837034|FG000|Overall Study|No longer met eligibility criteria|5|||
149097263|NCT03512288|537837035|FG001|Overall Study|No longer met eligibility criteria|2|||
149097264|NCT03512288|537837034|FG000|Overall Study|Withdrawal by parent/guardian|14|||
149097265|NCT03512288|537837035|FG001|Overall Study|Withdrawal by parent/guardian|18|||
149097266|NCT03512288|537837034|FG000|Overall Study|Other|1|||
149097267|NCT03512288|537837035|FG001|Overall Study|Other|1|||
149097268|NCT03512288|537837034|FG000|Overall Study|Randomized but not treated|1|||
149097269|NCT03512288|537837035|FG001|Overall Study|Randomized but not treated|1|||
149097270|NCT01077622|537837037|FG000|Overall Study|Physician Decision|2|||
149097271|NCT01077622|537837037|FG000|Overall Study|Withdrawal by Subject|1|||
149097272|NCT01503164|537837046|FG000|Overall Study|Withdrawal by Subject|2|||
149097273|NCT01503164|537837047|FG001|Overall Study|Withdrawal by Subject|1|||
149097274|NCT04088136|537837050|FG000|Overall Study|Withdrawal by Subject|5|||
149097275|NCT04088136|537837051|FG001|Overall Study|Withdrawal by Subject|0|||
149097276|NCT04088136|537837050|FG000|Overall Study|Lack of Efficacy|0|||
149097277|NCT04088136|537837051|FG001|Overall Study|Lack of Efficacy|1|||
149097278|NCT01177228|537837052|FG000|Overall Study|Positive tuberculosis test|0|||
149097279|NCT01177228|537837053|FG001|Overall Study|Positive tuberculosis test|1|||
149097280|NCT01177228|537837054|FG002|Overall Study|Positive tuberculosis test|0|||
149097281|NCT01177228|537837055|FG003|Overall Study|Positive tuberculosis test|0|||
149097282|NCT01177228|537837052|FG000|Overall Study|Worsening disease activity|1|||
149097283|NCT01177228|537837053|FG001|Overall Study|Worsening disease activity|0|||
149097284|NCT01177228|537837054|FG002|Overall Study|Worsening disease activity|0|||
149097285|NCT01177228|537837055|FG003|Overall Study|Worsening disease activity|0|||
149097286|NCT01177228|537837052|FG000|Overall Study|Withdrawal by Subject|0|||
149097287|NCT01177228|537837053|FG001|Overall Study|Withdrawal by Subject|1|||
149097288|NCT01177228|537837054|FG002|Overall Study|Withdrawal by Subject|0|||
149097289|NCT01177228|537837055|FG003|Overall Study|Withdrawal by Subject|0|||
149097290|NCT04159805|537837056|FG000|Overall Study|Withdrawal by Subject|0|||
149097291|NCT04159805|537837057|FG001|Overall Study|Withdrawal by Subject|2|||
149097292|NCT04159805|537837058|FG002|Overall Study|Withdrawal by Subject|2|||
149097293|NCT01482819|537837063|FG000|Overall Study|Lost to Follow-up|2|||
149097294|NCT00562484|537837064|FG000|Overall Study|Adverse Event|6|||
149097295|NCT00562484|537837065|FG001|Overall Study|Adverse Event|1|||
149097296|NCT00562484|537837064|FG000|Overall Study|Protocol Violation|11|||
149097297|NCT00562484|537837065|FG001|Overall Study|Protocol Violation|2|||
149097298|NCT00562484|537837064|FG000|Overall Study|Withdrawal by Subject|12|||
149097299|NCT00562484|537837065|FG001|Overall Study|Withdrawal by Subject|9|||
149097300|NCT00562484|537837064|FG000|Overall Study|Moved away from the study area|20|||
149097301|NCT00562484|537837065|FG001|Overall Study|Moved away from the study area|9|||
149097302|NCT00562484|537837064|FG000|Overall Study|Lost to Follow-up|132|||
149097303|NCT00562484|537837065|FG001|Overall Study|Lost to Follow-up|71|||
149097304|NCT00562484|537837064|FG000|Overall Study|Reason not provided or not specified|25|||
149097305|NCT00562484|537837065|FG001|Overall Study|Reason not provided or not specified|12|||
149097306|NCT03325608|537837068|FG000|Overall Study|Lost to Follow-up|23|||
149097307|NCT03325608|537837069|FG001|Overall Study|Lost to Follow-up|23|||
149097308|NCT03325608|537837070|FG002|Overall Study|Lost to Follow-up|30|||
149097309|NCT03325608|537837071|FG003|Overall Study|Lost to Follow-up|30|||
149097310|NCT03325608|537837068|FG000|Overall Study|Death of Caregiver|0|||
149097311|NCT03325608|537837069|FG001|Overall Study|Death of Caregiver|0|||
149097312|NCT03325608|537837070|FG002|Overall Study|Death of Caregiver|2|||
149097313|NCT03325608|537837071|FG003|Overall Study|Death of Caregiver|2|||
149097314|NCT03325608|537837068|FG000|Overall Study|Death of Care Recipient|34|||
149097315|NCT03325608|537837069|FG001|Overall Study|Death of Care Recipient|34|||
149097316|NCT03325608|537837070|FG002|Overall Study|Death of Care Recipient|28|||
149097317|NCT03325608|537837071|FG003|Overall Study|Death of Care Recipient|28|||
149097318|NCT03325608|537837068|FG000|Overall Study|Withdrawal by Subject|49|||
149097319|NCT03325608|537837069|FG001|Overall Study|Withdrawal by Subject|49|||
149097320|NCT03325608|537837070|FG002|Overall Study|Withdrawal by Subject|35|||
149097321|NCT03325608|537837071|FG003|Overall Study|Withdrawal by Subject|35|||
149097322|NCT03325608|537837068|FG000|Overall Study|Ineligible|7|||
149097323|NCT03325608|537837069|FG001|Overall Study|Ineligible|7|||
149097324|NCT03325608|537837070|FG002|Overall Study|Ineligible|5|||
149097325|NCT03325608|537837071|FG003|Overall Study|Ineligible|5|||
149097326|NCT02188784|537837072|FG000|Overall Study|Death|3|||
149097327|NCT02188784|537837073|FG001|Overall Study|Death|1|||
149097328|NCT02188784|537837072|FG000|Overall Study|Lost to Follow-up|1|||
149097329|NCT02188784|537837073|FG001|Overall Study|Lost to Follow-up|0|||
149097330|NCT02188784|537837072|FG000|Overall Study|Withdrawal by Subject|3|||
149097331|NCT02188784|537837073|FG001|Overall Study|Withdrawal by Subject|9|||
149097332|NCT02188784|537837072|FG000|Overall Study|Physician Decision|2|||
149097333|NCT02188784|537837073|FG001|Overall Study|Physician Decision|3|||
149097334|NCT02473913|537837074|FG000|Overall Study|Lost to Follow-up|3|||
149097335|NCT02473913|537837075|FG001|Overall Study|Lost to Follow-up|3|||
149097336|NCT03282799|537837080|FG000|Overall Study|Pregnancy|1|||
149097337|NCT03282799|537837081|FG001|Overall Study|Pregnancy|0|||
149097338|NCT03282799|537837080|FG000|Overall Study|Physician Decision|1|||
149097339|NCT03282799|537837081|FG001|Overall Study|Physician Decision|0|||
149097340|NCT03614676|537838928|FG000|Overall Study|Delivery before planned visit|2|||
149097341|NCT03614676|537838929|FG001|Overall Study|Delivery before planned visit|0|||
149097342|NCT03614676|537838928|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
149097343|NCT03614676|537838929|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
149097344|NCT03614676|537838928|FG000|Overall Study|Migrated / moved from the study area|30|||
149097345|NCT03614676|537838929|FG001|Overall Study|Migrated / moved from the study area|22|||
149097346|NCT03614676|537838928|FG000|Overall Study|Lost to Follow-up|17|||
149097347|NCT03614676|537838929|FG001|Overall Study|Lost to Follow-up|42|||
149097348|NCT03614676|537838928|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
149097349|NCT03614676|537838929|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
149097350|NCT03614676|537838928|FG000|Overall Study|Other|16|||
149097351|NCT03614676|537838929|FG001|Overall Study|Other|47|||
149097352|NCT03614676|537838928|FG000|Overall Study|Protocol Violation|0|||
149097353|NCT03614676|537838929|FG001|Overall Study|Protocol Violation|2|||
149097354|NCT03614676|537838928|FG000|Overall Study|Neonatal event of interest|0|||
149097355|NCT03614676|537838929|FG001|Overall Study|Neonatal event of interest|6|||
149097356|NCT03614676|537838928|FG000|Overall Study|Death in infant greater than 28 days old|0|||
149097357|NCT03614676|537838929|FG001|Overall Study|Death in infant greater than 28 days old|12|||
149097358|NCT03614676|537838928|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
149097359|NCT03614676|537838929|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
149097360|NCT00497874|537838930|FG000|Overall Study|Withdrawal by Subject|48|||
149097361|NCT00497874|537838931|FG001|Overall Study|Withdrawal by Subject|17|||
149097362|NCT00497874|537838930|FG000|Overall Study|Illness|8|||
149097363|NCT00497874|537838931|FG001|Overall Study|Illness|4|||
149097364|NCT00497874|537838930|FG000|Overall Study|Death|2|||
149097365|NCT00497874|537838931|FG001|Overall Study|Death|4|||
149097366|NCT00497874|537838930|FG000|Overall Study|Unable to contact|52|||
149097367|NCT00497874|537838931|FG001|Overall Study|Unable to contact|67|||
149097368|NCT00497874|537838930|FG000|Overall Study|Unable to schedule|37|||
149097369|NCT00497874|537838931|FG001|Overall Study|Unable to schedule|24|||
149097370|NCT02080403|537838932|FG000|Overall Study|Adverse Event|5|||
149097371|NCT02080403|537838933|FG001|Overall Study|Adverse Event|1|||
149097372|NCT02080403|537838932|FG000|Overall Study|Death|0|||
149097373|NCT02080403|537838933|FG001|Overall Study|Death|2|||
149097374|NCT02080403|537838932|FG000|Overall Study|Lost to Follow-up|2|||
149097375|NCT02080403|537838933|FG001|Overall Study|Lost to Follow-up|0|||
149097376|NCT02080403|537838932|FG000|Overall Study|Pregnancy|0|||
149097377|NCT02080403|537838933|FG001|Overall Study|Pregnancy|1|||
149097378|NCT02080403|537838932|FG000|Overall Study|Protocol Violation|3|||
149097379|NCT02080403|537838933|FG001|Overall Study|Protocol Violation|7|||
149097380|NCT02080403|537838932|FG000|Overall Study|Withdrawal by Subject|5|||
149097381|NCT02080403|537838933|FG001|Overall Study|Withdrawal by Subject|1|||
149097382|NCT01999972|537838934|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
149097383|NCT01999972|537838935|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
149097384|NCT01999972|537838936|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
149097385|NCT01999972|537838937|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
149097386|NCT01999972|537838938|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
149097387|NCT01999972|537838939|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
149097388|NCT01999972|537838934|FG000|Dose Escalation Part|Death|0|||
149097389|NCT01999972|537838935|FG001|Dose Escalation Part|Death|1|||
149097390|NCT01999972|537838936|FG002|Dose Escalation Part|Death|0|||
149097391|NCT01999972|537838937|FG003|Dose Escalation Part|Death|0|||
149097392|NCT01999972|537838938|FG004|Dose Escalation Part|Death|0|||
149097393|NCT01999972|537838939|FG005|Dose Escalation Part|Death|0|||
149097394|NCT01999972|537838934|FG000|Dose Escalation Part|Enrolled but not treated|0|||
149097395|NCT01999972|537838935|FG001|Dose Escalation Part|Enrolled but not treated|0|||
149097396|NCT01999972|537838936|FG002|Dose Escalation Part|Enrolled but not treated|1|||
149097397|NCT01999972|537838937|FG003|Dose Escalation Part|Enrolled but not treated|1|||
149097398|NCT01999972|537838938|FG004|Dose Escalation Part|Enrolled but not treated|0|||
149097399|NCT01999972|537838939|FG005|Dose Escalation Part|Enrolled but not treated|0|||
149097400|NCT01999972|537838934|FG000|Dose Escalation Part|Disease progression|3|||
149097401|NCT01999972|537838935|FG001|Dose Escalation Part|Disease progression|2|||
149097402|NCT01999972|537838936|FG002|Dose Escalation Part|Disease progression|3|||
149097403|NCT01999972|537838937|FG003|Dose Escalation Part|Disease progression|6|||
149097404|NCT01999972|537838938|FG004|Dose Escalation Part|Disease progression|0|||
149097405|NCT01999972|537838939|FG005|Dose Escalation Part|Disease progression|0|||
149097406|NCT01999972|537838934|FG000|Dose Escalation Part|Adverse Event|0|||
149097407|NCT01999972|537838935|FG001|Dose Escalation Part|Adverse Event|0|||
149097408|NCT01999972|537838936|FG002|Dose Escalation Part|Adverse Event|0|||
149097409|NCT01999972|537838937|FG003|Dose Escalation Part|Adverse Event|2|||
149097410|NCT01999972|537838938|FG004|Dose Escalation Part|Adverse Event|0|||
149097411|NCT01999972|537838939|FG005|Dose Escalation Part|Adverse Event|0|||
149097412|NCT01999972|537838934|FG000|Dose Escalation Part|Global deterioration of health status|1|||
149097413|NCT01999972|537838935|FG001|Dose Escalation Part|Global deterioration of health status|0|||
149097414|NCT01999972|537838936|FG002|Dose Escalation Part|Global deterioration of health status|0|||
149097415|NCT01999972|537838937|FG003|Dose Escalation Part|Global deterioration of health status|1|||
149097416|NCT01999972|537838938|FG004|Dose Escalation Part|Global deterioration of health status|0|||
149097417|NCT01999972|537838939|FG005|Dose Escalation Part|Global deterioration of health status|0|||
149097418|NCT01999972|537838934|FG000|Dose Expansion Part|Death|0|||
149097419|NCT01999972|537838935|FG001|Dose Expansion Part|Death|0|||
149097420|NCT01999972|537838936|FG002|Dose Expansion Part|Death|0|||
149097421|NCT01999972|537838937|FG003|Dose Expansion Part|Death|0|||
149097422|NCT01999972|537838938|FG004|Dose Expansion Part|Death|2|||
149097423|NCT01999972|537838939|FG005|Dose Expansion Part|Death|1|||
149097424|NCT01999972|537838934|FG000|Dose Expansion Part|Disease progression|0|||
149097425|NCT01999972|537838935|FG001|Dose Expansion Part|Disease progression|0|||
149097426|NCT01999972|537838936|FG002|Dose Expansion Part|Disease progression|0|||
149097427|NCT01999972|537838937|FG003|Dose Expansion Part|Disease progression|0|||
149097428|NCT01999972|537838938|FG004|Dose Expansion Part|Disease progression|9|||
149097429|NCT01999972|537838939|FG005|Dose Expansion Part|Disease progression|3|||
149097430|NCT01999972|537838934|FG000|Dose Expansion Part|Sponsor decision|0|||
149097431|NCT01999972|537838935|FG001|Dose Expansion Part|Sponsor decision|0|||
149097432|NCT01999972|537838936|FG002|Dose Expansion Part|Sponsor decision|0|||
149097433|NCT01999972|537838937|FG003|Dose Expansion Part|Sponsor decision|0|||
149097434|NCT01999972|537838938|FG004|Dose Expansion Part|Sponsor decision|1|||
149097435|NCT01999972|537838939|FG005|Dose Expansion Part|Sponsor decision|0|||
149097436|NCT01999972|537838934|FG000|Dose Expansion Part|Adverse Event|0|||
149097437|NCT01999972|537838935|FG001|Dose Expansion Part|Adverse Event|0|||
149097438|NCT01999972|537838936|FG002|Dose Expansion Part|Adverse Event|0|||
149097439|NCT01999972|537838937|FG003|Dose Expansion Part|Adverse Event|0|||
149097440|NCT01999972|537838938|FG004|Dose Expansion Part|Adverse Event|4|||
149097441|NCT01999972|537838939|FG005|Dose Expansion Part|Adverse Event|2|||
149097442|NCT01999972|537838934|FG000|Dose Expansion Part|Participant's non-compliance|0|||
149097443|NCT01999972|537838935|FG001|Dose Expansion Part|Participant's non-compliance|0|||
149097444|NCT01999972|537838936|FG002|Dose Expansion Part|Participant's non-compliance|0|||
149097445|NCT01999972|537838937|FG003|Dose Expansion Part|Participant's non-compliance|0|||
149097446|NCT01999972|537838938|FG004|Dose Expansion Part|Participant's non-compliance|0|||
149097447|NCT01999972|537838939|FG005|Dose Expansion Part|Participant's non-compliance|1|||
149097448|NCT01999972|537838934|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
149097449|NCT01999972|537838935|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
149097450|NCT01999972|537838936|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
149097451|NCT01999972|537838937|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
149097452|NCT01999972|537838938|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
149097453|NCT01999972|537838939|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
149097454|NCT01999972|537838934|FG000|Dose Expansion Part|Changed to standard of care|0|||
149097455|NCT01999972|537838935|FG001|Dose Expansion Part|Changed to standard of care|0|||
149097456|NCT01999972|537838936|FG002|Dose Expansion Part|Changed to standard of care|0|||
149097457|NCT01999972|537838937|FG003|Dose Expansion Part|Changed to standard of care|0|||
149097458|NCT01999972|537838938|FG004|Dose Expansion Part|Changed to standard of care|1|||
149097459|NCT01999972|537838939|FG005|Dose Expansion Part|Changed to standard of care|0|||
149097460|NCT01171183|537838940|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
149097461|NCT01171183|537838941|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
149097462|NCT01171183|537838940|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
149097463|NCT01171183|537838941|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
149097464|NCT01171183|537838940|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
149097465|NCT01171183|537838941|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
149097466|NCT01171183|537838940|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
149097467|NCT01171183|537838941|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
149097468|NCT01171183|537838940|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
149097469|NCT01171183|537838941|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
149097470|NCT01171183|537838940|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
149097471|NCT01171183|537838941|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
149097472|NCT01101334|537838942|FG000|Overall Study|Adverse Event|9|||
149097473|NCT01101334|537838943|FG001|Overall Study|Adverse Event|4|||
149097474|NCT01101334|537838942|FG000|Overall Study|Death|7|||
149097475|NCT01101334|537838943|FG001|Overall Study|Death|1|||
149097476|NCT01101334|537838942|FG000|Overall Study|Withdrawal by Subject|4|||
149097477|NCT01101334|537838943|FG001|Overall Study|Withdrawal by Subject|3|||
149097478|NCT01101334|537838942|FG000|Overall Study|Withdrawal by Sponsor|1|||
149097479|NCT01101334|537838943|FG001|Overall Study|Withdrawal by Sponsor|1|||
149097480|NCT01101334|537838942|FG000|Overall Study|Progressive Disease|22|||
149097481|NCT01101334|537838943|FG001|Overall Study|Progressive Disease|35|||
149097482|NCT01101334|537838942|FG000|Overall Study|Other|2|||
149097483|NCT01101334|537838943|FG001|Overall Study|Other|1|||
149097484|NCT02826798|537838950|FG000|Overall Study|Withdrawal by Subject|0|||
149097485|NCT02826798|537838951|FG001|Overall Study|Withdrawal by Subject|1|||
149097486|NCT02826798|537838952|FG002|Overall Study|Withdrawal by Subject|0|||
149097487|NCT02826798|537838953|FG003|Overall Study|Withdrawal by Subject|1|||
149097488|NCT02826798|537838954|FG004|Overall Study|Withdrawal by Subject|0|||
149097489|NCT02806505|537838955|FG000|Overall Study|Adverse event/intercurrent illness|1|||
149097490|NCT02806505|537838956|FG001|Overall Study|Adverse event/intercurrent illness|3|||
149097491|NCT02806505|537838955|FG000|Overall Study|Death|4|||
149097492|NCT02806505|537838956|FG001|Overall Study|Death|0|||
149097493|NCT02806505|537838955|FG000|Overall Study|Did not cooperate/refused treatment|3|||
149097494|NCT02806505|537838956|FG001|Overall Study|Did not cooperate/refused treatment|3|||
149097495|NCT02806505|537838955|FG000|Overall Study|Failure to return|0|||
149097496|NCT02806505|537838956|FG001|Overall Study|Failure to return|1|||
149097497|NCT02806505|537838955|FG000|Overall Study|Insufficient therapeutic response|2|||
149097498|NCT02806505|537838956|FG001|Overall Study|Insufficient therapeutic response|4|||
149097499|NCT03440047|537838958|FG000|Overall Study|Withdrawal by Subject|2|||
149097500|NCT01181609|537838959|FG000|Overall Study|Adverse Event|1|||
149097501|NCT01181609|537838959|FG000|Overall Study|Withdrawal by Subject|1|||
149097502|NCT01181609|537838959|FG000|Overall Study|Lost to Follow-up|1|||
149097503|NCT01181609|537838959|FG000|Overall Study|Death|50|||
149097504|NCT01722045|537838960|FG000|Overall Study|Adverse Event|8|||
149097505|NCT01722045|537838960|FG000|Overall Study|Death|3|||
149097506|NCT01722045|537838960|FG000|Overall Study|Withdrawal by Subject|8|||
149097507|NCT01722045|537838960|FG000|Overall Study|Lost to Follow-up|4|||
149097508|NCT01722045|537838960|FG000|Overall Study|Protocol Deviation|1|||
149097509|NCT01722045|537838960|FG000|Overall Study|Physician Decision|3|||
149097510|NCT01722045|537838960|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
149097511|NCT00612352|537838961|FG000|Overall Study|Adverse Event|1|||
149097512|NCT00612352|537838962|FG001|Overall Study|Adverse Event|0|||
149097513|NCT00612352|537838961|FG000|Overall Study|Withdrawal by Subject|3|||
149097514|NCT00612352|537838962|FG001|Overall Study|Withdrawal by Subject|5|||
149097515|NCT00612352|537838961|FG000|Overall Study|moved out of state|1|||
149097516|NCT00612352|537838962|FG001|Overall Study|moved out of state|0|||
149097517|NCT00612352|537838961|FG000|Overall Study|didn't return calls/show up on test date|4|||
149097518|NCT00612352|537838962|FG001|Overall Study|didn't return calls/show up on test date|1|||
149097519|NCT02161406|537838963|FG000|Overall Study|Death|2|||
149097520|NCT02161406|537838964|FG001|Overall Study|Death|1|||
149097521|NCT02161406|537838963|FG000|Overall Study|Lost to Follow-up|2|||
149097522|NCT02161406|537838964|FG001|Overall Study|Lost to Follow-up|1|||
149097523|NCT02161406|537838963|FG000|Overall Study|Withdrawal by Subject|2|||
149097524|NCT02161406|537838964|FG001|Overall Study|Withdrawal by Subject|4|||
149097525|NCT02161406|537838963|FG000|Overall Study|investigator withdrew subject|3|||
149097526|NCT02161406|537838964|FG001|Overall Study|investigator withdrew subject|1|||
149097527|NCT02161406|537838963|FG000|Overall Study|Lack of Efficacy|1|||
149097528|NCT02161406|537838964|FG001|Overall Study|Lack of Efficacy|1|||
149097529|NCT02161406|537838963|FG000|Overall Study|relocation|0|||
149097530|NCT02161406|537838964|FG001|Overall Study|relocation|1|||
149097531|NCT00263211|537838967|FG000|Overall Study|Death|1|||
149097532|NCT00263211|537838968|FG001|Overall Study|Death|0|||
149097533|NCT00263211|537838967|FG000|Overall Study|Withdrawal by Subject|3|||
149097534|NCT00263211|537838968|FG001|Overall Study|Withdrawal by Subject|0|||
149097535|NCT00263211|537838967|FG000|Overall Study|Protocol Violation|1|||
149097536|NCT00263211|537838968|FG001|Overall Study|Protocol Violation|0|||
149097537|NCT00263211|537838967|FG000|Overall Study|Disease Progression|0|||
149097538|NCT00263211|537838968|FG001|Overall Study|Disease Progression|1|||
149097539|NCT02034162|537838969|FG000|Double-blind|Lost to Follow-up|3|||
149097540|NCT02034162|537838970|FG001|Double-blind|Lost to Follow-up|0|||
149097541|NCT02034162|537838971|FG002|Double-blind|Lost to Follow-up|0|||
149097542|NCT02034162|537838969|FG000|Double-blind|Physician Decision|1|||
149097543|NCT02034162|537838970|FG001|Double-blind|Physician Decision|0|||
149097544|NCT02034162|537838971|FG002|Double-blind|Physician Decision|0|||
149097545|NCT02034162|537838969|FG000|Double-blind|Protocol Violation|0|||
149097546|NCT02034162|537838970|FG001|Double-blind|Protocol Violation|1|||
149097547|NCT02034162|537838971|FG002|Double-blind|Protocol Violation|0|||
149097548|NCT02034162|537838969|FG000|Double-blind|Withdrawal by Subject|5|||
149097549|NCT02034162|537838970|FG001|Double-blind|Withdrawal by Subject|7|||
149097550|NCT02034162|537838971|FG002|Double-blind|Withdrawal by Subject|0|||
149097551|NCT00760513|537838972|FG000|Overall Study|Withdrawal by Subject|5|||
149097552|NCT00760513|537838973|FG001|Overall Study|Withdrawal by Subject|7|||
149097553|NCT01053247|537838979|FG000|Overall Study|Withdrawal by Subject|9|||
149097554|NCT01053247|537838980|FG001|Overall Study|Withdrawal by Subject|4|||
149097555|NCT01053247|537838981|FG002|Overall Study|Withdrawal by Subject|15|||
149097556|NCT01053247|537838979|FG000|Overall Study|Lack of Efficacy|1|||
149097557|NCT01053247|537838980|FG001|Overall Study|Lack of Efficacy|0|||
149097558|NCT01053247|537838981|FG002|Overall Study|Lack of Efficacy|1|||
149097559|NCT01053247|537838979|FG000|Overall Study|Protocol Violation|2|||
149097560|NCT01053247|537838980|FG001|Overall Study|Protocol Violation|1|||
149097561|NCT01053247|537838981|FG002|Overall Study|Protocol Violation|2|||
149097562|NCT01053247|537838979|FG000|Overall Study|Lost to Follow-up|8|||
149097563|NCT01053247|537838980|FG001|Overall Study|Lost to Follow-up|5|||
149097564|NCT01053247|537838981|FG002|Overall Study|Lost to Follow-up|7|||
149097565|NCT01053247|537838979|FG000|Overall Study|Adverse Event|0|||
149097566|NCT01053247|537838980|FG001|Overall Study|Adverse Event|9|||
149097567|NCT01053247|537838981|FG002|Overall Study|Adverse Event|3|||
149097568|NCT00874497|537838988|FG000|Overall Study|Lost to Follow-up|2|||
149097569|NCT00874497|537838989|FG001|Overall Study|Lost to Follow-up|4|||
149097570|NCT00874497|537838988|FG000|Overall Study|Adverse Event|9|||
149097571|NCT00874497|537838989|FG001|Overall Study|Adverse Event|4|||
149097572|NCT00874497|537838988|FG000|Overall Study|Sponsor Discontinued Trial|7|||
149097573|NCT00874497|537838989|FG001|Overall Study|Sponsor Discontinued Trial|3|||
149097574|NCT00874497|537838988|FG000|Overall Study|Met Withdrawal Criteria|4|||
149097575|NCT00874497|537838989|FG001|Overall Study|Met Withdrawal Criteria|2|||
149097576|NCT00874497|537838988|FG000|Overall Study|Physician Decision|1|||
149097577|NCT00874497|537838989|FG001|Overall Study|Physician Decision|1|||
149097578|NCT00874497|537838988|FG000|Overall Study|Withdrawal by Subject|5|||
149097579|NCT00874497|537838989|FG001|Overall Study|Withdrawal by Subject|4|||
149097580|NCT00505414|537838991|FG000|Titration Phase|Adverse Event|0|||
149097581|NCT00505414|537838992|FG001|Titration Phase|Adverse Event|0|||
149097582|NCT00505414|537838993|FG002|Titration Phase|Adverse Event|0|||
149097583|NCT00505414|537838994|FG003|Titration Phase|Adverse Event|8|||
149097584|NCT00505414|537838995|FG004|Titration Phase|Adverse Event|3|||
149097585|NCT00505414|537838991|FG000|Titration Phase|Death|0|||
149097586|NCT00505414|537838992|FG001|Titration Phase|Death|0|||
149097587|NCT00505414|537838993|FG002|Titration Phase|Death|0|||
149097588|NCT00505414|537838994|FG003|Titration Phase|Death|2|||
149097589|NCT00505414|537838995|FG004|Titration Phase|Death|0|||
149097590|NCT00505414|537838991|FG000|Titration Phase|Lack of Efficacy|0|||
149097591|NCT00505414|537838992|FG001|Titration Phase|Lack of Efficacy|0|||
149097592|NCT00505414|537838993|FG002|Titration Phase|Lack of Efficacy|0|||
149097593|NCT00505414|537838994|FG003|Titration Phase|Lack of Efficacy|10|||
149097594|NCT00505414|537838995|FG004|Titration Phase|Lack of Efficacy|1|||
149097595|NCT00505414|537838991|FG000|Titration Phase|Protocol Violation|0|||
149097596|NCT00505414|537838992|FG001|Titration Phase|Protocol Violation|0|||
149097597|NCT00505414|537838993|FG002|Titration Phase|Protocol Violation|0|||
149097598|NCT00505414|537838994|FG003|Titration Phase|Protocol Violation|0|||
149097599|NCT00505414|537838995|FG004|Titration Phase|Protocol Violation|1|||
149097600|NCT00505414|537838991|FG000|Titration Phase|Withdrawal by Subject|0|||
149097601|NCT00505414|537838992|FG001|Titration Phase|Withdrawal by Subject|0|||
149097602|NCT00505414|537838993|FG002|Titration Phase|Withdrawal by Subject|0|||
149097603|NCT00505414|537838994|FG003|Titration Phase|Withdrawal by Subject|3|||
149097604|NCT00505414|537838995|FG004|Titration Phase|Withdrawal by Subject|4|||
149097605|NCT00505414|537838991|FG000|Titration Phase|Underlying disease and therapy required|0|||
149097606|NCT00505414|537838992|FG001|Titration Phase|Underlying disease and therapy required|0|||
149097607|NCT00505414|537838993|FG002|Titration Phase|Underlying disease and therapy required|0|||
149097608|NCT00505414|537838994|FG003|Titration Phase|Underlying disease and therapy required|7|||
149097609|NCT00505414|537838995|FG004|Titration Phase|Underlying disease and therapy required|3|||
149097610|NCT00505414|537838991|FG000|Maintenance Phase|Adverse Event|2|||
149097611|NCT00505414|537838992|FG001|Maintenance Phase|Adverse Event|2|||
149097612|NCT00505414|537838993|FG002|Maintenance Phase|Adverse Event|3|||
149097613|NCT00505414|537838994|FG003|Maintenance Phase|Adverse Event|0|||
149097614|NCT00505414|537838995|FG004|Maintenance Phase|Adverse Event|0|||
149097615|NCT00505414|537838991|FG000|Maintenance Phase|Death|2|||
149097616|NCT00505414|537838992|FG001|Maintenance Phase|Death|0|||
149097617|NCT00505414|537838993|FG002|Maintenance Phase|Death|1|||
149097618|NCT00505414|537838994|FG003|Maintenance Phase|Death|0|||
149097619|NCT00505414|537838995|FG004|Maintenance Phase|Death|0|||
149097620|NCT00505414|537838991|FG000|Maintenance Phase|Lack of Efficacy|2|||
149097621|NCT00505414|537838992|FG001|Maintenance Phase|Lack of Efficacy|1|||
149097622|NCT00505414|537838993|FG002|Maintenance Phase|Lack of Efficacy|1|||
149097623|NCT00505414|537838994|FG003|Maintenance Phase|Lack of Efficacy|0|||
149097624|NCT00505414|537838995|FG004|Maintenance Phase|Lack of Efficacy|0|||
149097625|NCT00505414|537838991|FG000|Maintenance Phase|Withdrawal by Subject|0|||
149097626|NCT00505414|537838992|FG001|Maintenance Phase|Withdrawal by Subject|0|||
149097627|NCT00505414|537838993|FG002|Maintenance Phase|Withdrawal by Subject|1|||
149097628|NCT00505414|537838994|FG003|Maintenance Phase|Withdrawal by Subject|0|||
149097629|NCT00505414|537838995|FG004|Maintenance Phase|Withdrawal by Subject|0|||
149097630|NCT00505414|537838991|FG000|Maintenance Phase|underlying disease and therapy required|0|||
149097631|NCT00505414|537838992|FG001|Maintenance Phase|underlying disease and therapy required|2|||
149097632|NCT00505414|537838993|FG002|Maintenance Phase|underlying disease and therapy required|2|||
149097633|NCT00505414|537838994|FG003|Maintenance Phase|underlying disease and therapy required|0|||
149097634|NCT00505414|537838995|FG004|Maintenance Phase|underlying disease and therapy required|0|||
149097635|NCT00644878|537838996|FG000|Overall Study|Adverse Event|2|||
149097636|NCT00644878|537838996|FG000|Overall Study|Abnormal laboratory value|3|||
149097637|NCT00644878|537838996|FG000|Overall Study|Protocol deviation|2|||
149097638|NCT00644878|537838996|FG000|Overall Study|Treatment duration completed as per protocol|11|||
149097639|NCT04353817|537838997|FG000|Overall Study|Adverse Event|0|||
149097640|NCT04353817|537838998|FG001|Overall Study|Adverse Event|1|||
149097641|NCT00665223|537838999|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
149097642|NCT00665223|537839000|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
149097643|NCT00665223|537839001|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
149097644|NCT00665223|537838999|FG000|Randomized Phase (26 Weeks)|Death|0|||
149097645|NCT00665223|537839000|FG001|Randomized Phase (26 Weeks)|Death|0|||
149097646|NCT00665223|537839001|FG002|Randomized Phase (26 Weeks)|Death|1|||
149097647|NCT00665223|537838999|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
149097648|NCT00665223|537839000|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
149097649|NCT00665223|537839001|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
149097650|NCT00665223|537838999|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
149097651|NCT00665223|537839000|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
149097652|NCT00665223|537839001|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
149097653|NCT00665223|537838999|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
149097654|NCT00665223|537839000|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
149097655|NCT00665223|537839001|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
149097656|NCT00665223|537838999|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
149097657|NCT00665223|537839000|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
149097658|NCT00665223|537839001|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
149097659|NCT00665223|537838999|FG000|Open-Label Period (26 Weeks)|Death|0|||
149097660|NCT00665223|537839000|FG001|Open-Label Period (26 Weeks)|Death|1|||
149097661|NCT00665223|537839001|FG002|Open-Label Period (26 Weeks)|Death|0|||
149097662|NCT00665223|537838999|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
149097663|NCT00665223|537839000|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
149097664|NCT00665223|537839001|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
149097665|NCT00665223|537838999|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
149097666|NCT00665223|537839000|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
149097667|NCT00665223|537839001|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
149097668|NCT00665223|537838999|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
149097669|NCT00665223|537839000|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
149097670|NCT00665223|537839001|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
149097671|NCT00665223|537838999|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
149097672|NCT00665223|537839000|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
149097673|NCT00665223|537839001|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
149097674|NCT00591591|537839002|FG000|Overall Study|Withdrawal by Subject|1|||
149097675|NCT00591591|537839003|FG001|Overall Study|Withdrawal by Subject|37|||
149097676|NCT00591591|537839002|FG000|Overall Study|Lack of Efficacy|10|||
149097677|NCT00591591|537839003|FG001|Overall Study|Lack of Efficacy|2|||
149097678|NCT00002597|537839004|FG000|Overall Study|Protocol Violation|19|||
149097679|NCT00002597|537839005|FG001|Overall Study|Protocol Violation|17|||
149097680|NCT00002597|537839004|FG000|Overall Study|Withdrawal by Subject|7|||
149097681|NCT00002597|537839005|FG001|Overall Study|Withdrawal by Subject|6|||
149097682|NCT00338949|537839006|FG000|Subject Screening|Screen failures|11|||
149097683|NCT00338949|537839007|FG001|Subject Screening|Screen failures|11|||
149097684|NCT00338949|537839006|FG000|Randomization|Withdrawal by Subject|1|||
149097685|NCT00338949|537839007|FG001|Randomization|Withdrawal by Subject|0|||
149097686|NCT00338949|537839006|FG000|Randomization|Adverse Event|0|||
149097687|NCT00338949|537839007|FG001|Randomization|Adverse Event|5|||
149097688|NCT00878553|537839008|FG000|Sleep Study|Withdrawal by Subject|2|||
149097689|NCT00878553|537839009|FG001|Sleep Study|Withdrawal by Subject|0|||
149097690|NCT00878553|537839010|FG002|Sleep Study|Withdrawal by Subject|0|||
149097691|NCT00878553|537839011|FG003|Sleep Study|Withdrawal by Subject|0|||
149097692|NCT00878553|537839012|FG004|Sleep Study|Withdrawal by Subject|0|||
149097693|NCT00878553|537839008|FG000|Sleep Study|Lost to Follow-up|1|||
149097694|NCT00878553|537839009|FG001|Sleep Study|Lost to Follow-up|0|||
149097695|NCT00878553|537839010|FG002|Sleep Study|Lost to Follow-up|0|||
149097696|NCT00878553|537839011|FG003|Sleep Study|Lost to Follow-up|0|||
149097697|NCT00878553|537839012|FG004|Sleep Study|Lost to Follow-up|0|||
149097698|NCT00878553|537839008|FG000|Sleep Study|car accident|1|||
149097699|NCT00878553|537839009|FG001|Sleep Study|car accident|0|||
149097700|NCT00878553|537839010|FG002|Sleep Study|car accident|0|||
149097701|NCT00878553|537839011|FG003|Sleep Study|car accident|0|||
149097702|NCT00878553|537839012|FG004|Sleep Study|car accident|0|||
149097703|NCT00878553|537839008|FG000|Sleep Study|family emergency|1|||
149097704|NCT00878553|537839009|FG001|Sleep Study|family emergency|0|||
149097705|NCT00878553|537839010|FG002|Sleep Study|family emergency|0|||
149097706|NCT00878553|537839011|FG003|Sleep Study|family emergency|0|||
149097707|NCT00878553|537839012|FG004|Sleep Study|family emergency|0|||
149097708|NCT00878553|537839008|FG000|PK Study|Withdrawal by Subject|0|||
149097709|NCT00878553|537839009|FG001|PK Study|Withdrawal by Subject|0|||
149097710|NCT00878553|537839010|FG002|PK Study|Withdrawal by Subject|0|||
149097711|NCT00878553|537839011|FG003|PK Study|Withdrawal by Subject|1|||
149097712|NCT00878553|537839012|FG004|PK Study|Withdrawal by Subject|0|||
149097713|NCT02143063|537839013|FG000|Overall Study|Lost to Follow-up|16|||
149097714|NCT02143063|537839014|FG001|Overall Study|Lost to Follow-up|28|||
149097715|NCT02143063|537839015|FG002|Overall Study|Lost to Follow-up|29|||
149097716|NCT02143063|537839013|FG000|Overall Study|Withdrawal by Subject|0|||
149097717|NCT02143063|537839014|FG001|Overall Study|Withdrawal by Subject|1|||
149097718|NCT02143063|537839015|FG002|Overall Study|Withdrawal by Subject|0|||
149097719|NCT02143063|537839013|FG000|Overall Study|Death|0|||
149097720|NCT02143063|537839014|FG001|Overall Study|Death|1|||
149097721|NCT02143063|537839015|FG002|Overall Study|Death|1|||
149097722|NCT02601209|537839016|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
149097723|NCT02601209|537839017|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
149097724|NCT02601209|537839018|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
149097725|NCT02601209|537839019|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
149097726|NCT02601209|537839020|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
149097727|NCT02601209|537839021|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
149097728|NCT02601209|537839022|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
149097729|NCT02601209|537839023|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
149097730|NCT02601209|537839024|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
149097731|NCT02601209|537839016|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
149097732|NCT02601209|537839017|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
149097733|NCT02601209|537839018|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
149097734|NCT02601209|537839019|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
149097735|NCT02601209|537839020|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
149097736|NCT02601209|537839021|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
149097737|NCT02601209|537839022|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
149097738|NCT02601209|537839023|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
149097739|NCT02601209|537839024|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
149097740|NCT02062645|537839025|FG000|Overall Study|Adverse Event|2|||
149097741|NCT02062645|537839025|FG000|Overall Study|Protocol Violation|8|||
149097742|NCT02062645|537839025|FG000|Overall Study|Lost to Follow-up|5|||
149097743|NCT02261285|537839028|FG000|Overall Study|Disease progression|0|||
149097744|NCT02261285|537839029|FG001|Overall Study|Disease progression|0|||
149097745|NCT02261285|537839030|FG002|Overall Study|Disease progression|1|||
149097746|NCT01891890|537839032|FG000|Overall Study|Lost to Follow-up|0|||
149097747|NCT01891890|537839033|FG001|Overall Study|Lost to Follow-up|0|||
149097748|NCT01891890|537839034|FG002|Overall Study|Lost to Follow-up|1|||
149097749|NCT01891890|537839032|FG000|Overall Study|Study ended before endpoint reached|7|||
149097750|NCT01891890|537839033|FG001|Overall Study|Study ended before endpoint reached|3|||
149097751|NCT01891890|537839034|FG002|Overall Study|Study ended before endpoint reached|6|||
149097752|NCT01161628|537839035|FG000|Overall Study|Death|6|||
149097753|NCT01161628|537839035|FG000|Overall Study|Lack of Efficacy|2|||
149097754|NCT01263925|537839040|FG000|Overall Study|Protocol Violation|1|||
149097755|NCT01263925|537839041|FG001|Overall Study|Protocol Violation|0|||
149097756|NCT01263925|537839040|FG000|Overall Study|Lack of Efficacy|0|||
149097757|NCT01263925|537839041|FG001|Overall Study|Lack of Efficacy|1|||
149097758|NCT01263925|537839040|FG000|Overall Study|Adverse Event|23|||
149097759|NCT01263925|537839041|FG001|Overall Study|Adverse Event|22|||
149097760|NCT01263925|537839040|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
149097761|NCT01263925|537839041|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
149097762|NCT01263925|537839040|FG000|Overall Study|Withdrawal by Subject|6|||
149097763|NCT01263925|537839041|FG001|Overall Study|Withdrawal by Subject|8|||
149097764|NCT01263925|537839040|FG000|Overall Study|Other|4|||
149097765|NCT01263925|537839041|FG001|Overall Study|Other|4|||
149097766|NCT01263925|537839040|FG000|Overall Study|Lost to Follow-up|3|||
149097767|NCT01263925|537839041|FG001|Overall Study|Lost to Follow-up|1|||
149097768|NCT01263925|537839040|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
149097769|NCT01263925|537839041|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
149097770|NCT01263925|537839040|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
149097771|NCT01263925|537839041|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
149097772|NCT01263925|537839040|FG000|Overall Study|AE/ Withdrawal|1|||
149097773|NCT01263925|537839041|FG001|Overall Study|AE/ Withdrawal|4|||
149097774|NCT01263925|537839040|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
149097775|NCT01263925|537839041|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
149097776|NCT01263925|537839040|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
149097777|NCT01263925|537839041|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
149097778|NCT01263925|537839040|FG000|Overall Study|Withdrawal/ Not specified|0|||
149097779|NCT01263925|537839041|FG001|Overall Study|Withdrawal/ Not specified|1|||
149097780|NCT01726517|537839045|FG000|Overall Study|Withdrawal by Subject|0|||
149097781|NCT01726517|537839046|FG001|Overall Study|Withdrawal by Subject|0|||
149097782|NCT01726517|537839047|FG002|Overall Study|Withdrawal by Subject|1|||
149097783|NCT01726517|537839048|FG003|Overall Study|Withdrawal by Subject|0|||
149097784|NCT01726517|537839049|FG004|Overall Study|Withdrawal by Subject|0|||
149097785|NCT00770588|537839050|FG000|Overall Study|Adverse Event|9|||
149097786|NCT00770588|537839051|FG001|Overall Study|Adverse Event|2|||
149097787|NCT00770588|537839050|FG000|Overall Study|Death caused by progression of disease|70|||
149097788|NCT00770588|537839051|FG001|Overall Study|Death caused by progression of disease|91|||
149097789|NCT00770588|537839050|FG000|Overall Study|Lost to Follow-up|1|||
149097790|NCT00770588|537839051|FG001|Overall Study|Lost to Follow-up|1|||
149097791|NCT00770588|537839050|FG000|Overall Study|Withdrawal by Subject|1|||
149097792|NCT00770588|537839051|FG001|Overall Study|Withdrawal by Subject|1|||
149097793|NCT00361842|537839054|FG000|Overall Study|Withdrawal by Subject|2|||
149097794|NCT00361842|537839055|FG001|Overall Study|Withdrawal by Subject|3|||
149097795|NCT00361842|537839054|FG000|Overall Study|Death|2|||
149097796|NCT00361842|537839055|FG001|Overall Study|Death|1|||
149097797|NCT00361842|537839054|FG000|Overall Study|Disease progression|19|||
149097798|NCT00361842|537839055|FG001|Overall Study|Disease progression|20|||
149097799|NCT00361842|537839054|FG000|Overall Study|Adverse Event|2|||
149097800|NCT00361842|537839055|FG001|Overall Study|Adverse Event|3|||
149097801|NCT00361842|537839054|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
149097802|NCT00361842|537839055|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
149097803|NCT00361842|537839054|FG000|Overall Study|Other|1|||
149097804|NCT00361842|537839055|FG001|Overall Study|Other|0|||
149097805|NCT00361842|537839054|FG000|Overall Study|Other|0|||
149097806|NCT00361842|537839055|FG001|Overall Study|Other|2|||
149097807|NCT01220856|537839056|FG000|Overall Study|graft loss|3|||
149097808|NCT01220856|537839057|FG001|Overall Study|graft loss|3|||
149097809|NCT01220856|537839056|FG000|Overall Study|Lost to Follow-up|1|||
149097810|NCT01220856|537839057|FG001|Overall Study|Lost to Follow-up|0|||
149097811|NCT04206384|537839058|FG000|Overall Study|Withdrawal by Subject|8|||
149097812|NCT04206384|537839058|FG000|Overall Study|Adverse Event|2|||
149097813|NCT02212197|537839059|FG000|Overall Study|Need for radiotherapy|1|||
149097814|NCT02212197|537839060|FG001|Overall Study|Need for radiotherapy|0|||
149097815|NCT02212197|537839061|FG002|Overall Study|Need for radiotherapy|0|||
149097816|NCT03015181|537839062|FG000|Overall Study|Enrolled, but product never administered|1|||
149097817|NCT03015181|537839063|FG001|Overall Study|Enrolled, but product never administered|0|||
149097818|NCT03015181|537839064|FG002|Overall Study|Enrolled, but product never administered|0|||
149097819|NCT03015181|537839065|FG003|Overall Study|Enrolled, but product never administered|0|||
149097820|NCT03015181|537839066|FG004|Overall Study|Enrolled, but product never administered|0|||
149097821|NCT03015181|537839067|FG005|Overall Study|Enrolled, but product never administered|0|||
149097822|NCT03015181|537839068|FG006|Overall Study|Enrolled, but product never administered|0|||
149097823|NCT03015181|537839062|FG000|Overall Study|Withdrawal by Subject|0|||
149097824|NCT03015181|537839063|FG001|Overall Study|Withdrawal by Subject|0|||
149097825|NCT03015181|537839064|FG002|Overall Study|Withdrawal by Subject|0|||
149097826|NCT03015181|537839065|FG003|Overall Study|Withdrawal by Subject|0|||
149097827|NCT03015181|537839066|FG004|Overall Study|Withdrawal by Subject|0|||
149097828|NCT03015181|537839067|FG005|Overall Study|Withdrawal by Subject|1|||
149097829|NCT03015181|537839068|FG006|Overall Study|Withdrawal by Subject|0|||
149097830|NCT03015181|537839062|FG000|Overall Study|Physician Decision|0|||
149097831|NCT03015181|537839063|FG001|Overall Study|Physician Decision|0|||
149097832|NCT03015181|537839064|FG002|Overall Study|Physician Decision|0|||
149097833|NCT03015181|537839065|FG003|Overall Study|Physician Decision|0|||
149097834|NCT03015181|537839066|FG004|Overall Study|Physician Decision|0|||
149097835|NCT03015181|537839067|FG005|Overall Study|Physician Decision|0|||
149097836|NCT03015181|537839068|FG006|Overall Study|Physician Decision|1|||
149097837|NCT01260142|537839069|FG000|Treatment Period 1|Study on hold|1|||
149097838|NCT01260142|537839070|FG001|Treatment Period 1|Study on hold|1|||
149097839|NCT01260142|537839071|FG002|Treatment Period 1|Study on hold|0|||
149097840|NCT01260142|537839072|FG003|Treatment Period 1|Study on hold|0|||
149097841|NCT01260142|537839073|FG004|Treatment Period 1|Study on hold|1|||
149097842|NCT01260142|537839074|FG005|Treatment Period 1|Study on hold|2|||
149097843|NCT01260142|537839069|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
149097844|NCT01260142|537839070|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
149097845|NCT01260142|537839071|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
149097846|NCT01260142|537839072|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
149097847|NCT01260142|537839073|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
149097848|NCT01260142|537839074|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
149097849|NCT01260142|537839069|FG000|Treatment Period 1|Withdrawal by Subject|0|||
149097850|NCT01260142|537839070|FG001|Treatment Period 1|Withdrawal by Subject|0|||
149097851|NCT01260142|537839071|FG002|Treatment Period 1|Withdrawal by Subject|0|||
149097852|NCT01260142|537839072|FG003|Treatment Period 1|Withdrawal by Subject|0|||
149097853|NCT01260142|537839073|FG004|Treatment Period 1|Withdrawal by Subject|0|||
149097854|NCT01260142|537839074|FG005|Treatment Period 1|Withdrawal by Subject|1|||
149097855|NCT00496834|537839075|FG000|Overall Study|Withdrawal by Subject|4|||
149097856|NCT00496834|537839076|FG001|Overall Study|Withdrawal by Subject|6|||
149097857|NCT00496834|537839075|FG000|Overall Study|Contraindicated medication administered|0|||
149097858|NCT00496834|537839076|FG001|Overall Study|Contraindicated medication administered|1|||
149097859|NCT00496834|537839075|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
149097860|NCT00496834|537839076|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
149097861|NCT00496834|537839075|FG000|Overall Study|Adverse Event|5|||
149097862|NCT00496834|537839076|FG001|Overall Study|Adverse Event|3|||
149097863|NCT00496834|537839075|FG000|Overall Study|IP administration violation|2|||
149097864|NCT00496834|537839076|FG001|Overall Study|IP administration violation|0|||
149097865|NCT00496834|537839075|FG000|Overall Study|Lost to Follow-up|2|||
149097866|NCT00496834|537839076|FG001|Overall Study|Lost to Follow-up|0|||
149097867|NCT00496834|537839075|FG000|Overall Study|Blood Pressure control failure|2|||
149097868|NCT00496834|537839076|FG001|Overall Study|Blood Pressure control failure|1|||
149097869|NCT00356759|537839077|FG000|Overall Study|Death|5|||
149097870|NCT00356759|537839078|FG001|Overall Study|Death|2|||
149097871|NCT00356759|537839077|FG000|Overall Study|Withdrawal by Subject|2|||
149097872|NCT00356759|537839078|FG001|Overall Study|Withdrawal by Subject|2|||
149097873|NCT00356759|537839077|FG000|Overall Study|Adverse Event|1|||
149097874|NCT00356759|537839078|FG001|Overall Study|Adverse Event|3|||
149097875|NCT00356759|537839077|FG000|Overall Study|Lost to Follow-up|1|||
149097876|NCT00356759|537839078|FG001|Overall Study|Lost to Follow-up|1|||
149097877|NCT00356759|537839077|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
149097878|NCT00356759|537839078|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
149097879|NCT01494298|537839079|FG000|Overall Study|Protocol Violation|2|||
149097880|NCT01494298|537839080|FG001|Overall Study|Protocol Violation|8|||
149097881|NCT03821064|537839081|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
149097882|NCT02998918|537839083|FG000|Overall Study|Withdrawal by Subject|1|||
149097883|NCT02998918|537839084|FG001|Overall Study|Withdrawal by Subject|0|||
149097884|NCT00942188|537839085|FG000|Overall Study|Adverse Event|0|||
149097885|NCT00942188|537839086|FG001|Overall Study|Adverse Event|3|||
149097886|NCT00942188|537839087|FG002|Overall Study|Adverse Event|2|||
149097887|NCT00942188|537839088|FG003|Overall Study|Adverse Event|0|||
149097888|NCT00942188|537839085|FG000|Overall Study|Lack of Efficacy|0|||
149097889|NCT00942188|537839086|FG001|Overall Study|Lack of Efficacy|0|||
149097890|NCT00942188|537839087|FG002|Overall Study|Lack of Efficacy|0|||
149097891|NCT00942188|537839088|FG003|Overall Study|Lack of Efficacy|1|||
149097892|NCT00942188|537839085|FG000|Overall Study|Protocol Violation|1|||
149097893|NCT00942188|537839086|FG001|Overall Study|Protocol Violation|1|||
149097894|NCT00942188|537839087|FG002|Overall Study|Protocol Violation|0|||
149097895|NCT00942188|537839088|FG003|Overall Study|Protocol Violation|0|||
149097896|NCT00942188|537839085|FG000|Overall Study|Lost to Follow-up|2|||
149097897|NCT00942188|537839086|FG001|Overall Study|Lost to Follow-up|1|||
149097898|NCT00942188|537839087|FG002|Overall Study|Lost to Follow-up|2|||
149097899|NCT00942188|537839088|FG003|Overall Study|Lost to Follow-up|0|||
149097900|NCT00942188|537839085|FG000|Overall Study|Withdrawal by Subject|1|||
149097901|NCT00942188|537839086|FG001|Overall Study|Withdrawal by Subject|3|||
149097902|NCT00942188|537839087|FG002|Overall Study|Withdrawal by Subject|4|||
149097903|NCT00942188|537839088|FG003|Overall Study|Withdrawal by Subject|2|||
149097904|NCT00942188|537839085|FG000|Overall Study|Physician Decision|0|||
149097905|NCT00942188|537839086|FG001|Overall Study|Physician Decision|0|||
149097906|NCT00942188|537839087|FG002|Overall Study|Physician Decision|1|||
149097907|NCT00942188|537839088|FG003|Overall Study|Physician Decision|0|||
149097908|NCT00942188|537839085|FG000|Overall Study|Sponsor Decision|0|||
149097909|NCT00942188|537839086|FG001|Overall Study|Sponsor Decision|2|||
149097910|NCT00942188|537839087|FG002|Overall Study|Sponsor Decision|0|||
149097911|NCT00942188|537839088|FG003|Overall Study|Sponsor Decision|1|||
149097912|NCT02979613|537839089|FG000|Double-Blind Phase|Withdrew Consent|2|||
149097913|NCT02979613|537839090|FG001|Double-Blind Phase|Withdrew Consent|4|||
149097914|NCT02979613|537839089|FG000|Double-Blind Phase|Pregnancy|2|||
149097915|NCT02979613|537839090|FG001|Double-Blind Phase|Pregnancy|2|||
149097916|NCT02979613|537839089|FG000|Double-Blind Phase|Adverse Event|2|||
149097917|NCT02979613|537839090|FG001|Double-Blind Phase|Adverse Event|0|||
149097918|NCT02979613|537839089|FG000|Double-Blind Phase|Lost to Follow-up|1|||
149097919|NCT02979613|537839090|FG001|Double-Blind Phase|Lost to Follow-up|1|||
149097920|NCT02979613|537839089|FG000|Double-Blind Phase|Protocol Violation|1|||
149097921|NCT02979613|537839090|FG001|Double-Blind Phase|Protocol Violation|1|||
149097922|NCT02979613|537839089|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
149097923|NCT02979613|537839090|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
149097924|NCT02979613|537839089|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
149097925|NCT02979613|537839090|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
149097926|NCT02979613|537839089|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
149097927|NCT02979613|537839090|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
149097928|NCT02979613|537839089|FG000|Open-Label Extension (OLE) Phase|Death|0|||
149097929|NCT02979613|537839090|FG001|Open-Label Extension (OLE) Phase|Death|1|||
149097930|NCT02979613|537839089|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
149097931|NCT02979613|537839090|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
149097932|NCT04944784|537839095|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
149097933|NCT04944784|537839096|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
149097934|NCT04944784|537839097|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
149097935|NCT04944784|537839098|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
149097936|NCT04944784|537839095|FG000|Double-blind Period|Adverse Event|20|||
149097937|NCT04944784|537839096|FG001|Double-blind Period|Adverse Event|4|||
149097938|NCT04944784|537839097|FG002|Double-blind Period|Adverse Event|0|||
149097939|NCT04944784|537839098|FG003|Double-blind Period|Adverse Event|0|||
149097940|NCT04944784|537839095|FG000|Double-blind Period|Withdrawal by Subject|15|||
149097941|NCT04944784|537839096|FG001|Double-blind Period|Withdrawal by Subject|4|||
149097942|NCT04944784|537839097|FG002|Double-blind Period|Withdrawal by Subject|0|||
149097943|NCT04944784|537839098|FG003|Double-blind Period|Withdrawal by Subject|0|||
149097944|NCT04944784|537839095|FG000|Double-blind Period|Death|7|||
149097945|NCT04944784|537839096|FG001|Double-blind Period|Death|2|||
149097946|NCT04944784|537839097|FG002|Double-blind Period|Death|0|||
149097947|NCT04944784|537839098|FG003|Double-blind Period|Death|0|||
149097948|NCT04944784|537839095|FG000|Double-blind Period|Physician Decision|2|||
149097949|NCT04944784|537839096|FG001|Double-blind Period|Physician Decision|1|||
149097950|NCT04944784|537839097|FG002|Double-blind Period|Physician Decision|0|||
149097951|NCT04944784|537839098|FG003|Double-blind Period|Physician Decision|0|||
149097952|NCT04944784|537839095|FG000|Double-blind Period|Lack of Efficacy|0|||
149097953|NCT04944784|537839096|FG001|Double-blind Period|Lack of Efficacy|1|||
149097954|NCT04944784|537839097|FG002|Double-blind Period|Lack of Efficacy|0|||
149097955|NCT04944784|537839098|FG003|Double-blind Period|Lack of Efficacy|0|||
149097956|NCT04944784|537839095|FG000|Double-blind Period|Sponsor Request|2|||
149097957|NCT04944784|537839096|FG001|Double-blind Period|Sponsor Request|1|||
149097958|NCT04944784|537839097|FG002|Double-blind Period|Sponsor Request|0|||
149097959|NCT04944784|537839098|FG003|Double-blind Period|Sponsor Request|0|||
149097960|NCT04944784|537839095|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
149097961|NCT04944784|537839096|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
149097962|NCT04944784|537839097|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
149097963|NCT04944784|537839098|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
149097964|NCT04944784|537839095|FG000|Double-blind Period|Participant Choice|1|||
149097965|NCT04944784|537839096|FG001|Double-blind Period|Participant Choice|1|||
149097966|NCT04944784|537839097|FG002|Double-blind Period|Participant Choice|0|||
149097967|NCT04944784|537839098|FG003|Double-blind Period|Participant Choice|0|||
149097968|NCT04944784|537839095|FG000|Double-blind Period|Progressive Disease|2|||
149097969|NCT04944784|537839096|FG001|Double-blind Period|Progressive Disease|2|||
149097970|NCT04944784|537839097|FG002|Double-blind Period|Progressive Disease|0|||
149097971|NCT04944784|537839098|FG003|Double-blind Period|Progressive Disease|0|||
149097972|NCT04944784|537839095|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
149097973|NCT04944784|537839096|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
149097974|NCT04944784|537839097|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
149097975|NCT04944784|537839098|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
149097976|NCT04944784|537839095|FG000|Active Drug Period|Adverse Event|0|||
149097977|NCT04944784|537839096|FG001|Active Drug Period|Adverse Event|0|||
149097978|NCT04944784|537839097|FG002|Active Drug Period|Adverse Event|3|||
149097979|NCT04944784|537839098|FG003|Active Drug Period|Adverse Event|6|||
149097980|NCT04944784|537839095|FG000|Active Drug Period|Withdrawal by Subject|0|||
149097981|NCT04944784|537839096|FG001|Active Drug Period|Withdrawal by Subject|0|||
149097982|NCT04944784|537839097|FG002|Active Drug Period|Withdrawal by Subject|4|||
149097983|NCT04944784|537839098|FG003|Active Drug Period|Withdrawal by Subject|7|||
149097984|NCT04944784|537839095|FG000|Active Drug Period|Death|0|||
149097985|NCT04944784|537839096|FG001|Active Drug Period|Death|0|||
149097986|NCT04944784|537839097|FG002|Active Drug Period|Death|3|||
149097987|NCT04944784|537839098|FG003|Active Drug Period|Death|4|||
149097988|NCT04944784|537839095|FG000|Active Drug Period|Lack of Efficacy|0|||
149097989|NCT04944784|537839096|FG001|Active Drug Period|Lack of Efficacy|0|||
149097990|NCT04944784|537839097|FG002|Active Drug Period|Lack of Efficacy|2|||
149097991|NCT04944784|537839098|FG003|Active Drug Period|Lack of Efficacy|2|||
149097992|NCT04944784|537839095|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
149097993|NCT04944784|537839096|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
149097994|NCT04944784|537839097|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
149097995|NCT04944784|537839098|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
149097996|NCT04944784|537839095|FG000|Active Drug Period|Participant Choice|0|||
149097997|NCT04944784|537839096|FG001|Active Drug Period|Participant Choice|0|||
149097998|NCT04944784|537839097|FG002|Active Drug Period|Participant Choice|0|||
149097999|NCT04944784|537839098|FG003|Active Drug Period|Participant Choice|1|||
149098000|NCT04944784|537839095|FG000|Active Drug Period|Progressive Disease|0|||
149098001|NCT04944784|537839096|FG001|Active Drug Period|Progressive Disease|0|||
149098002|NCT04944784|537839097|FG002|Active Drug Period|Progressive Disease|4|||
149098003|NCT04944784|537839098|FG003|Active Drug Period|Progressive Disease|4|||
149098004|NCT04944784|537839095|FG000|Active Drug Period|Lost to Follow-up|0|||
149098005|NCT04944784|537839096|FG001|Active Drug Period|Lost to Follow-up|0|||
149098006|NCT04944784|537839097|FG002|Active Drug Period|Lost to Follow-up|0|||
149098007|NCT04944784|537839098|FG003|Active Drug Period|Lost to Follow-up|1|||
149098008|NCT01568112|537839099|FG000|Overall Study|Randomized But Not Treated|0|||
149098009|NCT01568112|537839100|FG001|Overall Study|Randomized But Not Treated|1|||
149098010|NCT01568112|537839101|FG002|Overall Study|Randomized But Not Treated|0|||
149098011|NCT01568112|537839102|FG003|Overall Study|Randomized But Not Treated|0|||
149098012|NCT01568112|537839099|FG000|Overall Study|Withdrew due to Adverse Event|2|||
149098013|NCT01568112|537839100|FG001|Overall Study|Withdrew due to Adverse Event|4|||
149098014|NCT01568112|537839101|FG002|Overall Study|Withdrew due to Adverse Event|6|||
149098015|NCT01568112|537839102|FG003|Overall Study|Withdrew due to Adverse Event|3|||
149098016|NCT01568112|537839099|FG000|Overall Study|Lost to Follow-up|0|||
149098017|NCT01568112|537839100|FG001|Overall Study|Lost to Follow-up|0|||
149098018|NCT01568112|537839101|FG002|Overall Study|Lost to Follow-up|0|||
149098019|NCT01568112|537839102|FG003|Overall Study|Lost to Follow-up|1|||
149098020|NCT01568112|537839099|FG000|Overall Study|Withdrawal by Subject|2|||
149098021|NCT01568112|537839100|FG001|Overall Study|Withdrawal by Subject|3|||
149098022|NCT01568112|537839101|FG002|Overall Study|Withdrawal by Subject|0|||
149098023|NCT01568112|537839102|FG003|Overall Study|Withdrawal by Subject|7|||
149098024|NCT01568112|537839099|FG000|Overall Study|Withdrawal by Physician|1|||
149098025|NCT01568112|537839100|FG001|Overall Study|Withdrawal by Physician|0|||
149098026|NCT01568112|537839101|FG002|Overall Study|Withdrawal by Physician|1|||
149098027|NCT01568112|537839102|FG003|Overall Study|Withdrawal by Physician|1|||
149098028|NCT02388347|537840659|FG000|Overall Study|Withdrawal by Subject|0|||
149098029|NCT02388347|537840660|FG001|Overall Study|Withdrawal by Subject|0|||
149098030|NCT02388347|537840661|FG002|Overall Study|Withdrawal by Subject|1|||
149098031|NCT02388347|537840662|FG003|Overall Study|Withdrawal by Subject|0|||
149098032|NCT02388347|537840663|FG004|Overall Study|Withdrawal by Subject|0|||
149098033|NCT02820597|537840664|FG000|Overall Study|Lost to Follow-up|12|||
149098034|NCT03458728|537840665|FG000|Overall Study|Adverse Event|1|||
149098035|NCT03458728|537840666|FG001|Overall Study|Adverse Event|0|||
149098036|NCT03458728|537840665|FG000|Overall Study|Physician Decision|1|||
149098037|NCT03458728|537840666|FG001|Overall Study|Physician Decision|0|||
149098038|NCT03458728|537840665|FG000|Overall Study|Progressive disease - clinical assessment|1|||
149098039|NCT03458728|537840666|FG001|Overall Study|Progressive disease - clinical assessment|0|||
149098040|NCT03458728|537840665|FG000|Overall Study|Progressive disease - radiological progression|21|||
149098041|NCT03458728|537840666|FG001|Overall Study|Progressive disease - radiological progression|6|||
149098042|NCT03458728|537840665|FG000|Overall Study|Withdrawal by Subject|0|||
149098043|NCT03458728|537840666|FG001|Overall Study|Withdrawal by Subject|1|||
149098044|NCT00030823|537840669|FG000|Overall Study|Withdrawal by Subject|1|||
149098045|NCT04523207|537840670|FG000|Overall Study|Adverse Event|5|||
149098046|NCT04523207|537840671|FG001|Overall Study|Adverse Event|1|||
149098047|NCT04523207|537840670|FG000|Overall Study|Lost to Follow-up|2|||
149098048|NCT04523207|537840671|FG001|Overall Study|Lost to Follow-up|0|||
149098049|NCT04523207|537840670|FG000|Overall Study|Withdrawal by Subject|2|||
149098050|NCT04523207|537840671|FG001|Overall Study|Withdrawal by Subject|0|||
149098051|NCT04523207|537840670|FG000|Overall Study|Progressive Disease|2|||
149098052|NCT04523207|537840671|FG001|Overall Study|Progressive Disease|1|||
149098053|NCT04523207|537840670|FG000|Overall Study|Other|7|||
149098054|NCT04523207|537840671|FG001|Overall Study|Other|1|||
149098055|NCT03113383|537840672|FG000|Overall Study|Death|4|||
149098056|NCT03113383|537840673|FG001|Overall Study|Death|0|||
149098057|NCT03062449|537840675|FG000|Overall Study|Withdrawal by Subject|7|||
149098058|NCT03062449|537840676|FG001|Overall Study|Withdrawal by Subject|1|||
149098059|NCT04702893|537840678|FG000|Overall Study|Other reasons than listed|11|||
149098060|NCT04702893|537840678|FG000|Overall Study|Withdrawal by Subject|3|||
149098061|NCT04702893|537840678|FG000|Overall Study|Lost to Follow-up|7|||
149098062|NCT04702893|537840678|FG000|Overall Study|Death|10|||
149098063|NCT04702893|537840678|FG000|Overall Study|Not treated|6|||
149098064|NCT00408928|537840679|FG000|Overall Study|Withdrawal by Subject|1|||
149098065|NCT00408928|537840679|FG000|Overall Study|Death|1|||
149098066|NCT00408928|537840679|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
149098067|NCT01114139|537840682|FG000|Overall Study|Adverse Event|3|||
149098068|NCT01114139|537840683|FG001|Overall Study|Adverse Event|2|||
149098069|NCT01114139|537840682|FG000|Overall Study|Lost to Follow-up|15|||
149098070|NCT01114139|537840683|FG001|Overall Study|Lost to Follow-up|3|||
149098071|NCT01114139|537840682|FG000|Overall Study|Withdrawal by Subject|17|||
149098072|NCT01114139|537840683|FG001|Overall Study|Withdrawal by Subject|6|||
149098073|NCT01114139|537840682|FG000|Overall Study|Other-Missed 1 visit|1|||
149098074|NCT01114139|537840683|FG001|Overall Study|Other-Missed 1 visit|0|||
149098075|NCT01114139|537840682|FG000|Overall Study|Other-Protocol Violation|1|||
149098076|NCT01114139|537840683|FG001|Overall Study|Other-Protocol Violation|0|||
149098077|NCT01114139|537840682|FG000|Overall Study|Other-Out of window for study drug dose|1|||
149098078|NCT01114139|537840683|FG001|Overall Study|Other-Out of window for study drug dose|0|||
149098079|NCT01114139|537840682|FG000|Overall Study|Other-Participant falsified records|0|||
149098080|NCT01114139|537840683|FG001|Overall Study|Other-Participant falsified records|1|||
149098081|NCT01114139|537840682|FG000|Overall Study|Other-Participant went on hospice|0|||
149098082|NCT01114139|537840683|FG001|Overall Study|Other-Participant went on hospice|1|||
149098083|NCT01114139|537840682|FG000|Overall Study|Other-Physician changed treatment|1|||
149098084|NCT01114139|537840683|FG001|Overall Study|Other-Physician changed treatment|0|||
149098085|NCT01114139|537840682|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
149098086|NCT01114139|537840683|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
149098087|NCT02536742|537840685|FG000|Overall Study|Did not start protocol therapy|1|||
149098088|NCT02536742|537840685|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
149098089|NCT04629443|537840686|FG000|Overall Study|Adverse Event|2|||
149098090|NCT04629443|537840687|FG001|Overall Study|Adverse Event|1|||
149098091|NCT04629443|537840688|FG002|Overall Study|Adverse Event|2|||
149098092|NCT04629443|537840686|FG000|Overall Study|Progressive Disease|2|||
149098093|NCT04629443|537840687|FG001|Overall Study|Progressive Disease|3|||
149098094|NCT04629443|537840688|FG002|Overall Study|Progressive Disease|3|||
149098095|NCT04629443|537840686|FG000|Overall Study|Physician Decision|1|||
149098096|NCT04629443|537840687|FG001|Overall Study|Physician Decision|3|||
149098097|NCT04629443|537840688|FG002|Overall Study|Physician Decision|0|||
149098098|NCT00858247|537840695|FG000|Baseline Assessment|Withdrawal by Subject|1|||
149098099|NCT00858247|537840696|FG001|Baseline Assessment|Withdrawal by Subject|1|||
149098100|NCT00858247|537840695|FG000|Baseline Assessment|Poor IV access|1|||
149098101|NCT00858247|537840696|FG001|Baseline Assessment|Poor IV access|0|||
149098102|NCT00858247|537840695|FG000|Baseline Assessment|Protocol Violation|0|||
149098103|NCT00858247|537840696|FG001|Baseline Assessment|Protocol Violation|1|||
149098104|NCT00858247|537840695|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
149098105|NCT00858247|537840696|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
149098106|NCT02512861|537840697|FG000|Overall Study|Protocol Violation|3|||
149098107|NCT02512861|537840698|FG001|Overall Study|Protocol Violation|7|||
149098108|NCT02512861|537840697|FG000|Overall Study|Physician Decision|3|||
149098109|NCT02512861|537840698|FG001|Overall Study|Physician Decision|1|||
149098110|NCT02512861|537840697|FG000|Overall Study|Withdrawal by Subject|0|||
149098111|NCT02512861|537840698|FG001|Overall Study|Withdrawal by Subject|1|||
149098112|NCT01172639|537840699|FG000|Overall Study|Death|1|||
149098113|NCT01172639|537840700|FG001|Overall Study|Death|1|||
149098114|NCT01172639|537840701|FG002|Overall Study|Death|0|||
149098115|NCT01172639|537840702|FG003|Overall Study|Death|0|||
149098116|NCT01172639|537840703|FG004|Overall Study|Death|0|||
149098117|NCT01172639|537840699|FG000|Overall Study|Lost to Follow-up|9|||
149098118|NCT01172639|537840700|FG001|Overall Study|Lost to Follow-up|7|||
149098119|NCT01172639|537840701|FG002|Overall Study|Lost to Follow-up|11|||
149098120|NCT01172639|537840702|FG003|Overall Study|Lost to Follow-up|6|||
149098121|NCT01172639|537840703|FG004|Overall Study|Lost to Follow-up|6|||
149098122|NCT01172639|537840699|FG000|Overall Study|Withdrawal by Subject|3|||
149098123|NCT01172639|537840700|FG001|Overall Study|Withdrawal by Subject|3|||
149098124|NCT01172639|537840701|FG002|Overall Study|Withdrawal by Subject|5|||
149098125|NCT01172639|537840702|FG003|Overall Study|Withdrawal by Subject|5|||
149098126|NCT01172639|537840703|FG004|Overall Study|Withdrawal by Subject|0|||
149098127|NCT02447432|537840704|FG000|Epoch 001|Adverse Event|1|||
149098128|NCT02447432|537840705|FG001|Epoch 001|Adverse Event|1|||
149098129|NCT02447432|537840704|FG000|Epoch 001|Withdrawal by Subject|0|||
149098130|NCT02447432|537840705|FG001|Epoch 001|Withdrawal by Subject|4|||
149098131|NCT02447432|537840704|FG000|Epoch 001|Migrated/moved from study area|3|||
149098132|NCT02447432|537840705|FG001|Epoch 001|Migrated/moved from study area|5|||
149098133|NCT02447432|537840704|FG000|Epoch 001|Lost to Follow-up|1|||
149098134|NCT02447432|537840705|FG001|Epoch 001|Lost to Follow-up|3|||
149098135|NCT01585298|537840706|FG000|Overall Study|Study completion was not documented.|1|||
149098136|NCT01585298|537840706|FG000|Overall Study|Protocol deviation|1|||
149098137|NCT01585298|537840706|FG000|Overall Study|Administrative problems|4|||
149098138|NCT01585298|537840706|FG000|Overall Study|Lost to Follow-up|2|||
149098139|NCT01585298|537840706|FG000|Overall Study|Withdrawal by Subject|4|||
149098140|NCT01585298|537840706|FG000|Overall Study|Abnormal test procedure results|1|||
149098141|NCT01585298|537840706|FG000|Overall Study|Adverse Event|24|||
149098142|NCT01426113|537840716|FG000|Overall Study|Study Discontinued|1|||
149098143|NCT01426113|537840717|FG001|Overall Study|Study Discontinued|1|||
149098144|NCT01426113|537840716|FG000|Overall Study|Adverse Event|0|||
149098145|NCT01426113|537840717|FG001|Overall Study|Adverse Event|1|||
149098146|NCT00468130|537840720|FG000|Overall Study|Adverse Event|2|||
149098147|NCT00468130|537840721|FG001|Overall Study|Adverse Event|1|||
149098148|NCT00468130|537840720|FG000|Overall Study|Withdrawal by Subject|0|||
149098149|NCT00468130|537840721|FG001|Overall Study|Withdrawal by Subject|1|||
149098150|NCT02485899|537840722|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
149098151|NCT02485899|537840723|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
149098152|NCT02485899|537840722|FG000|Overall Study|Withdrawal by Subject|1|||
149098153|NCT02485899|537840723|FG001|Overall Study|Withdrawal by Subject|0|||
149098154|NCT02485899|537840722|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
149098155|NCT02485899|537840723|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
149098156|NCT00436956|537840724|FG000|Overall Study|Not evaluable|1|||
149098157|NCT00436956|537840725|FG001|Overall Study|Not evaluable|0|||
149098158|NCT03517111|537840727|FG000|Enrolled|Withdrawal by Subject|0|||
149098159|NCT03517111|537840728|FG001|Enrolled|Withdrawal by Subject|1|||
149098160|NCT03517111|537840729|FG002|Enrolled|Withdrawal by Subject|0|||
149098161|NCT03517111|537840727|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
149098162|NCT03517111|537840728|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
149098163|NCT03517111|537840729|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
149098164|NCT03517111|537840727|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
149098165|NCT03517111|537840728|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
149098166|NCT03517111|537840729|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
149098167|NCT03517111|537840727|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
149098168|NCT03517111|537840728|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
149098169|NCT03517111|537840729|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
149098170|NCT03517111|537840727|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
149098171|NCT03517111|537840728|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
149098172|NCT03517111|537840729|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
149098173|NCT00912223|537840730|FG000|Overall Study|Withdrawal by Subject|1|||
149098174|NCT00912223|537840730|FG000|Overall Study|Not transplanted|1|||
149098175|NCT00912223|537840730|FG000|Overall Study|Transformed disease|1|||
149098176|NCT02719743|537840731|FG000|Overall Study|Consent withdrawal|0|||
149098177|NCT02719743|537840732|FG001|Overall Study|Consent withdrawal|2|||
149098178|NCT02719743|537840733|FG002|Overall Study|Consent withdrawal|0|||
149098179|NCT02719743|537840734|FG003|Overall Study|Consent withdrawal|1|||
149098180|NCT02719743|537840735|FG004|Overall Study|Consent withdrawal|0|||
149098181|NCT02719743|537840731|FG000|Overall Study|Migrated/moved from study area|0|||
149098182|NCT02719743|537840732|FG001|Overall Study|Migrated/moved from study area|0|||
149098183|NCT02719743|537840733|FG002|Overall Study|Migrated/moved from study area|0|||
149098184|NCT02719743|537840734|FG003|Overall Study|Migrated/moved from study area|0|||
149098185|NCT02719743|537840735|FG004|Overall Study|Migrated/moved from study area|2|||
149098186|NCT02719743|537840731|FG000|Overall Study|Lost to Follow-up|1|||
149098187|NCT02719743|537840732|FG001|Overall Study|Lost to Follow-up|1|||
149098188|NCT02719743|537840733|FG002|Overall Study|Lost to Follow-up|0|||
149098189|NCT02719743|537840734|FG003|Overall Study|Lost to Follow-up|0|||
149098190|NCT02719743|537840735|FG004|Overall Study|Lost to Follow-up|0|||
149098191|NCT01438840|537840736|FG000|Core Study|Adverse Event|0|||
149098192|NCT01438840|537840737|FG001|Core Study|Adverse Event|3|||
149098193|NCT01438840|537840738|FG002|Core Study|Adverse Event|0|||
149098194|NCT01438840|537840736|FG000|Core Study|Lack of Efficacy|15|||
149098195|NCT01438840|537840737|FG001|Core Study|Lack of Efficacy|7|||
149098196|NCT01438840|537840738|FG002|Core Study|Lack of Efficacy|0|||
149098197|NCT01438840|537840736|FG000|Core Study|Withdrawal of consent|1|||
149098198|NCT01438840|537840737|FG001|Core Study|Withdrawal of consent|0|||
149098199|NCT01438840|537840738|FG002|Core Study|Withdrawal of consent|0|||
149098200|NCT01438840|537840736|FG000|Extension Phase|Adverse Event|0|||
149098201|NCT01438840|537840737|FG001|Extension Phase|Adverse Event|0|||
149098202|NCT01438840|537840738|FG002|Extension Phase|Adverse Event|3|||
149098203|NCT01438840|537840736|FG000|Extension Phase|Lost to Follow-up|0|||
149098204|NCT01438840|537840737|FG001|Extension Phase|Lost to Follow-up|0|||
149098205|NCT01438840|537840738|FG002|Extension Phase|Lost to Follow-up|1|||
149098206|NCT01438840|537840736|FG000|Extension Phase|Withdrawal by Subject|0|||
149098207|NCT01438840|537840737|FG001|Extension Phase|Withdrawal by Subject|0|||
149098208|NCT01438840|537840738|FG002|Extension Phase|Withdrawal by Subject|3|||
149098209|NCT01438840|537840736|FG000|Extension Phase|Lack of Efficacy|0|||
149098210|NCT01438840|537840737|FG001|Extension Phase|Lack of Efficacy|0|||
149098211|NCT01438840|537840738|FG002|Extension Phase|Lack of Efficacy|2|||
149098212|NCT01438840|537840736|FG000|Extension Phase|Other|0|||
149098213|NCT01438840|537840737|FG001|Extension Phase|Other|0|||
149098214|NCT01438840|537840738|FG002|Extension Phase|Other|1|||
149098215|NCT00461123|537840741|FG000|Overall Study|Adverse Event|1|||
149098216|NCT00461123|537840742|FG001|Overall Study|Adverse Event|0|||
149098217|NCT00461123|537840741|FG000|Overall Study|Lost to Follow-up|1|||
149098218|NCT00461123|537840742|FG001|Overall Study|Lost to Follow-up|1|||
149098219|NCT00461123|537840741|FG000|Overall Study|Protocol Violation|3|||
149098220|NCT00461123|537840742|FG001|Overall Study|Protocol Violation|2|||
149098221|NCT00461123|537840741|FG000|Overall Study|Withdrawal by Subject|1|||
149098222|NCT00461123|537840742|FG001|Overall Study|Withdrawal by Subject|3|||
149098223|NCT02604342|537840743|FG000|Overall Study|Death|32|||
149098224|NCT02604342|537840744|FG001|Overall Study|Death|16|||
149098225|NCT02604342|537840743|FG000|Overall Study|Progression of disease|1|||
149098226|NCT02604342|537840744|FG001|Overall Study|Progression of disease|0|||
149098227|NCT02604342|537840743|FG000|Overall Study|Withdrawal by Subject|5|||
149098228|NCT02604342|537840744|FG001|Overall Study|Withdrawal by Subject|6|||
149098229|NCT02604342|537840743|FG000|Overall Study|Other|1|||
149098230|NCT02604342|537840744|FG001|Overall Study|Other|0|||
149098231|NCT02604342|537840743|FG000|Overall Study|Study Termination by Sponsor|1|||
149098232|NCT02604342|537840744|FG001|Overall Study|Study Termination by Sponsor|0|||
149098233|NCT02604342|537840743|FG000|Overall Study|Lost to Follow-up|1|||
149098234|NCT02604342|537840744|FG001|Overall Study|Lost to Follow-up|1|||
149098235|NCT02604342|537840743|FG000|Overall Study|Physician Decision|2|||
149098236|NCT02604342|537840744|FG001|Overall Study|Physician Decision|0|||
149098237|NCT02024750|537840745|FG000|Overall Study|Withdrawal by Subject|2|||
149098238|NCT02024750|537840746|FG001|Overall Study|Withdrawal by Subject|1|||
149098239|NCT00927901|537840747|FG000|Treatment Period 1|Subject withdrew consent|0|||
149098240|NCT00927901|537840748|FG001|Treatment Period 1|Subject withdrew consent|0|||
149098241|NCT00927901|537840749|FG002|Treatment Period 1|Subject withdrew consent|1|||
149098242|NCT00927901|537840750|FG003|Treatment Period 1|Subject withdrew consent|0|||
149098243|NCT00927901|537840747|FG000|Treatment Period 4|Adverse Event|0|||
149098244|NCT00927901|537840748|FG001|Treatment Period 4|Adverse Event|0|||
149098245|NCT00927901|537840749|FG002|Treatment Period 4|Adverse Event|0|||
149098246|NCT00927901|537840750|FG003|Treatment Period 4|Adverse Event|1|||
149098247|NCT00927901|537840747|FG000|Treatment Period 4|Subject withdrew consent|0|||
149098248|NCT00927901|537840748|FG001|Treatment Period 4|Subject withdrew consent|0|||
149098249|NCT00927901|537840749|FG002|Treatment Period 4|Subject withdrew consent|1|||
149098250|NCT00927901|537840750|FG003|Treatment Period 4|Subject withdrew consent|0|||
149098251|NCT02344173|537840751|FG000|Procedure|Ablation Procedure Not Performed|7|||
149098252|NCT02344173|537840751|FG000|12-month Visit|Death|8|||
149098253|NCT02344173|537840751|FG000|12-month Visit|Withdrawal by Subject|30|||
149098254|NCT02344173|537840751|FG000|12-month Visit|Lost to Follow-up|58|||
149098255|NCT01702519|537840752|FG000|Washout Period|Lost to Follow-up|1|||
149098256|NCT01702519|537840753|FG001|Washout Period|Lost to Follow-up|0|||
149098257|NCT01702519|537840752|FG000|Washout Period|Withdrawal by Subject|0|||
149098258|NCT01702519|537840753|FG001|Washout Period|Withdrawal by Subject|2|||
149098259|NCT03738397|537840754|FG000|Overall Study|Adverse Event|3|||
149098260|NCT03738397|537840755|FG001|Overall Study|Adverse Event|7|||
149098261|NCT03738397|537840754|FG000|Overall Study|Withdrawal by Subject|8|||
149098262|NCT03738397|537840755|FG001|Overall Study|Withdrawal by Subject|11|||
149098263|NCT03738397|537840754|FG000|Overall Study|Lost to Follow-up|7|||
149098264|NCT03738397|537840755|FG001|Overall Study|Lost to Follow-up|5|||
149098265|NCT03738397|537840754|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
149098266|NCT03738397|537840755|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
149098267|NCT03738397|537840754|FG000|Overall Study|Other|4|||
149098268|NCT03738397|537840755|FG001|Overall Study|Other|6|||
149098269|NCT00746356|537840758|FG000|Overall Study|Withdrawal by Subject|2|||
149098270|NCT00746356|537840759|FG001|Overall Study|Withdrawal by Subject|3|||
149098271|NCT00746356|537840758|FG000|Overall Study|Death|7|||
149098272|NCT00746356|537840759|FG001|Overall Study|Death|3|||
149098273|NCT00746356|537840758|FG000|Overall Study|Lost to Follow-up|1|||
149098274|NCT00746356|537840759|FG001|Overall Study|Lost to Follow-up|0|||
149098275|NCT00746356|537840758|FG000|Overall Study|Removal of Device|0|||
149098276|NCT00746356|537840759|FG001|Overall Study|Removal of Device|1|||
149098277|NCT00746356|537840758|FG000|Overall Study|Patient relocated|1|||
149098278|NCT00746356|537840759|FG001|Overall Study|Patient relocated|0|||
149098279|NCT03605368|537840762|FG000|Overall Study|Lost to Follow-up|2|||
149098280|NCT03605368|537840763|FG001|Overall Study|Lost to Follow-up|1|||
149098281|NCT03605368|537840764|FG002|Overall Study|Lost to Follow-up|3|||
149098282|NCT03605368|537840765|FG003|Overall Study|Lost to Follow-up|2|||
149098283|NCT03605368|537840762|FG000|Overall Study|Withdrawal by Subject|0|||
149098284|NCT03605368|537840763|FG001|Overall Study|Withdrawal by Subject|0|||
149098285|NCT03605368|537840764|FG002|Overall Study|Withdrawal by Subject|4|||
149098286|NCT03605368|537840765|FG003|Overall Study|Withdrawal by Subject|3|||
149098287|NCT02881047|537840766|FG000|Overall Study|Adverse Event|1|||
149098288|NCT02881047|537840766|FG000|Overall Study|Withdrawal by Subject|1|||
149098289|NCT02484547|537840767|FG000|Placebo-Controlled Period|Adverse Event|10|||
149098290|NCT02484547|537840768|FG001|Placebo-Controlled Period|Adverse Event|13|||
149098291|NCT02484547|537840769|FG002|Placebo-Controlled Period|Adverse Event|20|||
149098292|NCT02484547|537840770|FG003|Placebo-Controlled Period|Adverse Event|0|||
149098293|NCT02484547|537840771|FG004|Placebo-Controlled Period|Adverse Event|0|||
149098294|NCT02484547|537840772|FG005|Placebo-Controlled Period|Adverse Event|0|||
149098295|NCT02484547|537840773|FG006|Placebo-Controlled Period|Adverse Event|0|||
149098296|NCT02484547|537840767|FG000|Placebo-Controlled Period|Change of Treatment|0|||
149098297|NCT02484547|537840768|FG001|Placebo-Controlled Period|Change of Treatment|0|||
149098298|NCT02484547|537840769|FG002|Placebo-Controlled Period|Change of Treatment|1|||
149098299|NCT02484547|537840770|FG003|Placebo-Controlled Period|Change of Treatment|0|||
149098300|NCT02484547|537840771|FG004|Placebo-Controlled Period|Change of Treatment|0|||
149098301|NCT02484547|537840772|FG005|Placebo-Controlled Period|Change of Treatment|0|||
149098302|NCT02484547|537840773|FG006|Placebo-Controlled Period|Change of Treatment|0|||
149098303|NCT02484547|537840767|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
149098304|NCT02484547|537840768|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
149098305|NCT02484547|537840769|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
149098306|NCT02484547|537840770|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
149098307|NCT02484547|537840771|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
149098308|NCT02484547|537840772|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
149098309|NCT02484547|537840773|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
149098310|NCT02484547|537840767|FG000|Placebo-Controlled Period|Death|5|||
149098311|NCT02484547|537840768|FG001|Placebo-Controlled Period|Death|0|||
149098312|NCT02484547|537840769|FG002|Placebo-Controlled Period|Death|6|||
149098313|NCT02484547|537840770|FG003|Placebo-Controlled Period|Death|0|||
149098314|NCT02484547|537840771|FG004|Placebo-Controlled Period|Death|0|||
149098315|NCT02484547|537840772|FG005|Placebo-Controlled Period|Death|0|||
149098316|NCT02484547|537840773|FG006|Placebo-Controlled Period|Death|0|||
149098317|NCT02484547|537840767|FG000|Placebo-Controlled Period|Disease Progression|2|||
149098318|NCT02484547|537840768|FG001|Placebo-Controlled Period|Disease Progression|0|||
149098319|NCT02484547|537840769|FG002|Placebo-Controlled Period|Disease Progression|1|||
149098320|NCT02484547|537840770|FG003|Placebo-Controlled Period|Disease Progression|0|||
149098321|NCT02484547|537840771|FG004|Placebo-Controlled Period|Disease Progression|0|||
149098322|NCT02484547|537840772|FG005|Placebo-Controlled Period|Disease Progression|0|||
149098323|NCT02484547|537840773|FG006|Placebo-Controlled Period|Disease Progression|0|||
149098324|NCT02484547|537840767|FG000|Placebo-Controlled Period|Investigator Decision|2|||
149098325|NCT02484547|537840768|FG001|Placebo-Controlled Period|Investigator Decision|2|||
149098326|NCT02484547|537840769|FG002|Placebo-Controlled Period|Investigator Decision|5|||
149098327|NCT02484547|537840770|FG003|Placebo-Controlled Period|Investigator Decision|0|||
149098328|NCT02484547|537840771|FG004|Placebo-Controlled Period|Investigator Decision|0|||
149098329|NCT02484547|537840772|FG005|Placebo-Controlled Period|Investigator Decision|0|||
149098330|NCT02484547|537840773|FG006|Placebo-Controlled Period|Investigator Decision|0|||
149098331|NCT02484547|537840767|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
149098332|NCT02484547|537840768|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
149098333|NCT02484547|537840769|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
149098334|NCT02484547|537840770|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
149098335|NCT02484547|537840771|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
149098336|NCT02484547|537840772|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
149098337|NCT02484547|537840773|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
149098338|NCT02484547|537840767|FG000|Placebo-Controlled Period|Relocation|1|||
149098339|NCT02484547|537840768|FG001|Placebo-Controlled Period|Relocation|1|||
149098340|NCT02484547|537840769|FG002|Placebo-Controlled Period|Relocation|1|||
149098341|NCT02484547|537840770|FG003|Placebo-Controlled Period|Relocation|0|||
149098342|NCT02484547|537840771|FG004|Placebo-Controlled Period|Relocation|0|||
149098343|NCT02484547|537840772|FG005|Placebo-Controlled Period|Relocation|0|||
149098344|NCT02484547|537840773|FG006|Placebo-Controlled Period|Relocation|0|||
149098345|NCT02484547|537840767|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
149098346|NCT02484547|537840768|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
149098347|NCT02484547|537840769|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
149098348|NCT02484547|537840770|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
149098349|NCT02484547|537840771|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
149098350|NCT02484547|537840772|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
149098351|NCT02484547|537840773|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
149098352|NCT02484547|537840767|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
149098353|NCT02484547|537840768|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
149098354|NCT02484547|537840769|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
149098355|NCT02484547|537840770|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149098356|NCT02484547|537840771|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149098357|NCT02484547|537840772|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149098358|NCT02484547|537840773|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
149098359|NCT02484547|537840767|FG000|Placebo-Controlled Period|Reason not Specified|216|||
149098360|NCT02484547|537840768|FG001|Placebo-Controlled Period|Reason not Specified|194|||
149098361|NCT02484547|537840769|FG002|Placebo-Controlled Period|Reason not Specified|183|||
149098362|NCT02484547|537840770|FG003|Placebo-Controlled Period|Reason not Specified|0|||
149098363|NCT02484547|537840771|FG004|Placebo-Controlled Period|Reason not Specified|0|||
149098364|NCT02484547|537840772|FG005|Placebo-Controlled Period|Reason not Specified|0|||
149098365|NCT02484547|537840773|FG006|Placebo-Controlled Period|Reason not Specified|0|||
149098366|NCT02484547|537840767|FG000|Long-Term Extension Period|Adverse Event|0|||
149098367|NCT02484547|537840768|FG001|Long-Term Extension Period|Adverse Event|0|||
149098368|NCT02484547|537840769|FG002|Long-Term Extension Period|Adverse Event|0|||
149098369|NCT02484547|537840770|FG003|Long-Term Extension Period|Adverse Event|0|||
149098370|NCT02484547|537840771|FG004|Long-Term Extension Period|Adverse Event|1|||
149098371|NCT02484547|537840772|FG005|Long-Term Extension Period|Adverse Event|3|||
149098372|NCT02484547|537840773|FG006|Long-Term Extension Period|Adverse Event|2|||
149098373|NCT02484547|537840767|FG000|Long-Term Extension Period|Death|0|||
149098374|NCT02484547|537840768|FG001|Long-Term Extension Period|Death|0|||
149098375|NCT02484547|537840769|FG002|Long-Term Extension Period|Death|0|||
149098376|NCT02484547|537840770|FG003|Long-Term Extension Period|Death|0|||
149098377|NCT02484547|537840771|FG004|Long-Term Extension Period|Death|0|||
149098378|NCT02484547|537840772|FG005|Long-Term Extension Period|Death|3|||
149098379|NCT02484547|537840773|FG006|Long-Term Extension Period|Death|0|||
149098380|NCT02484547|537840767|FG000|Long-Term Extension Period|Disease Progression|0|||
149098381|NCT02484547|537840768|FG001|Long-Term Extension Period|Disease Progression|0|||
149098382|NCT02484547|537840769|FG002|Long-Term Extension Period|Disease Progression|0|||
149098383|NCT02484547|537840770|FG003|Long-Term Extension Period|Disease Progression|0|||
149098384|NCT02484547|537840771|FG004|Long-Term Extension Period|Disease Progression|2|||
149098385|NCT02484547|537840772|FG005|Long-Term Extension Period|Disease Progression|4|||
149098386|NCT02484547|537840773|FG006|Long-Term Extension Period|Disease Progression|0|||
149098387|NCT02484547|537840767|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
149098388|NCT02484547|537840768|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
149098389|NCT02484547|537840769|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
149098390|NCT02484547|537840770|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
149098391|NCT02484547|537840771|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
149098392|NCT02484547|537840772|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
149098393|NCT02484547|537840773|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
149098394|NCT02484547|537840767|FG000|Long-Term Extension Period|Loss of Capacity|0|||
149098395|NCT02484547|537840768|FG001|Long-Term Extension Period|Loss of Capacity|0|||
149098396|NCT02484547|537840769|FG002|Long-Term Extension Period|Loss of Capacity|0|||
149098397|NCT02484547|537840770|FG003|Long-Term Extension Period|Loss of Capacity|0|||
149098398|NCT02484547|537840771|FG004|Long-Term Extension Period|Loss of Capacity|1|||
149098399|NCT02484547|537840772|FG005|Long-Term Extension Period|Loss of Capacity|0|||
149098400|NCT02484547|537840773|FG006|Long-Term Extension Period|Loss of Capacity|0|||
149098401|NCT02484547|537840767|FG000|Long-Term Extension Period|Change of Treatment|0|||
149098402|NCT02484547|537840768|FG001|Long-Term Extension Period|Change of Treatment|0|||
149098403|NCT02484547|537840769|FG002|Long-Term Extension Period|Change of Treatment|0|||
149098404|NCT02484547|537840770|FG003|Long-Term Extension Period|Change of Treatment|0|||
149098405|NCT02484547|537840771|FG004|Long-Term Extension Period|Change of Treatment|0|||
149098406|NCT02484547|537840772|FG005|Long-Term Extension Period|Change of Treatment|0|||
149098407|NCT02484547|537840773|FG006|Long-Term Extension Period|Change of Treatment|1|||
149098408|NCT02484547|537840767|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
149098409|NCT02484547|537840768|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
149098410|NCT02484547|537840769|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
149098411|NCT02484547|537840770|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
149098412|NCT02484547|537840771|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
149098413|NCT02484547|537840772|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
149098414|NCT02484547|537840773|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
149098415|NCT02484547|537840767|FG000|Long-Term Extension Period|Investigator Decision|0|||
149098416|NCT02484547|537840768|FG001|Long-Term Extension Period|Investigator Decision|0|||
149098417|NCT02484547|537840769|FG002|Long-Term Extension Period|Investigator Decision|0|||
149098418|NCT02484547|537840770|FG003|Long-Term Extension Period|Investigator Decision|2|||
149098419|NCT02484547|537840771|FG004|Long-Term Extension Period|Investigator Decision|1|||
149098420|NCT02484547|537840772|FG005|Long-Term Extension Period|Investigator Decision|0|||
149098421|NCT02484547|537840773|FG006|Long-Term Extension Period|Investigator Decision|1|||
149098422|NCT02484547|537840767|FG000|Long-Term Extension Period|Relocation|0|||
149098423|NCT02484547|537840768|FG001|Long-Term Extension Period|Relocation|0|||
149098424|NCT02484547|537840769|FG002|Long-Term Extension Period|Relocation|0|||
149098425|NCT02484547|537840770|FG003|Long-Term Extension Period|Relocation|1|||
149098426|NCT02484547|537840771|FG004|Long-Term Extension Period|Relocation|1|||
149098427|NCT02484547|537840772|FG005|Long-Term Extension Period|Relocation|0|||
149098428|NCT02484547|537840773|FG006|Long-Term Extension Period|Relocation|0|||
149098429|NCT02484547|537840767|FG000|Long-Term Extension Period|Study Visit Burden|0|||
149098430|NCT02484547|537840768|FG001|Long-Term Extension Period|Study Visit Burden|0|||
149098431|NCT02484547|537840769|FG002|Long-Term Extension Period|Study Visit Burden|0|||
149098432|NCT02484547|537840770|FG003|Long-Term Extension Period|Study Visit Burden|2|||
149098433|NCT02484547|537840771|FG004|Long-Term Extension Period|Study Visit Burden|0|||
149098434|NCT02484547|537840772|FG005|Long-Term Extension Period|Study Visit Burden|0|||
149098435|NCT02484547|537840773|FG006|Long-Term Extension Period|Study Visit Burden|3|||
149098436|NCT02484547|537840767|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
149098437|NCT02484547|537840768|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
149098438|NCT02484547|537840769|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
149098439|NCT02484547|537840770|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
149098440|NCT02484547|537840771|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
149098441|NCT02484547|537840772|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
149098442|NCT02484547|537840773|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
149098443|NCT02484547|537840767|FG000|Long-Term Extension Period|Reason not Specified|0|||
149098444|NCT02484547|537840768|FG001|Long-Term Extension Period|Reason not Specified|0|||
149098445|NCT02484547|537840769|FG002|Long-Term Extension Period|Reason not Specified|0|||
149098446|NCT02484547|537840770|FG003|Long-Term Extension Period|Reason not Specified|119|||
149098447|NCT02484547|537840771|FG004|Long-Term Extension Period|Reason not Specified|117|||
149098448|NCT02484547|537840772|FG005|Long-Term Extension Period|Reason not Specified|223|||
149098449|NCT02484547|537840773|FG006|Long-Term Extension Period|Reason not Specified|231|||
149098450|NCT03765164|537840774|FG000|Pre-intervention|Withdrawal by Subject|5|||
149098451|NCT03765164|537840775|FG001|Pre-intervention|Withdrawal by Subject|6|||
149098452|NCT01665599|537840776|FG000|Overall Study|Adverse Event|1|||
149098453|NCT01665599|537840776|FG000|Overall Study|Consent Withdrawn|1|||
149098454|NCT01665599|537840776|FG000|Overall Study|Investigator/Sponsor decision|1|||
149098455|NCT01665599|537840776|FG000|Overall Study|Death|1|||
149098456|NCT01665599|537840776|FG000|Overall Study|Lost to Follow-up|2|||
149098457|NCT01665599|537840776|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
149098458|NCT01665599|537840776|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
149098459|NCT04814992|537840786|FG000|Overall Study|Withdrawal by Subject|6|||
149098460|NCT04814992|537840787|FG001|Overall Study|Withdrawal by Subject|3|||
149098461|NCT04814992|537840786|FG000|Overall Study|Lost to Follow-up|1|||
149098462|NCT04814992|537840787|FG001|Overall Study|Lost to Follow-up|4|||
149098463|NCT01831726|537840792|FG000|Overall Study|Adverse Event|16|||
149098464|NCT01831726|537840792|FG000|Overall Study|Death|7|||
149098465|NCT01831726|537840792|FG000|Overall Study|Disease Progression|49|||
149098466|NCT01831726|537840792|FG000|Overall Study|Physician Decision|1|||
149098467|NCT01831726|537840792|FG000|Overall Study|Subject/guardian decision|7|||
149098468|NCT00514813|537840796|FG000|Overall Study|Study terminated|14|||
149098469|NCT00514813|537840797|FG001|Overall Study|Study terminated|74|||
149098470|NCT00514813|537840798|FG002|Overall Study|Study terminated|40|||
149098471|NCT00514813|537840799|FG003|Overall Study|Study terminated|2|||
149098472|NCT00514813|537840796|FG000|Overall Study|Adverse Event|0|||
149098473|NCT00514813|537840797|FG001|Overall Study|Adverse Event|2|||
149098474|NCT00514813|537840798|FG002|Overall Study|Adverse Event|2|||
149098475|NCT00514813|537840799|FG003|Overall Study|Adverse Event|0|||
149098476|NCT00514813|537840796|FG000|Overall Study|Protocol Violation|1|||
149098477|NCT00514813|537840797|FG001|Overall Study|Protocol Violation|0|||
149098478|NCT00514813|537840798|FG002|Overall Study|Protocol Violation|0|||
149098479|NCT00514813|537840799|FG003|Overall Study|Protocol Violation|0|||
149098480|NCT00514813|537840796|FG000|Overall Study|Withdrawal by Subject|0|||
149098481|NCT00514813|537840797|FG001|Overall Study|Withdrawal by Subject|1|||
149098482|NCT00514813|537840798|FG002|Overall Study|Withdrawal by Subject|0|||
149098483|NCT00514813|537840799|FG003|Overall Study|Withdrawal by Subject|0|||
149098484|NCT00514813|537840796|FG000|Overall Study|Lack of Efficacy|0|||
149098485|NCT00514813|537840797|FG001|Overall Study|Lack of Efficacy|1|||
149098486|NCT00514813|537840798|FG002|Overall Study|Lack of Efficacy|0|||
149098487|NCT00514813|537840799|FG003|Overall Study|Lack of Efficacy|0|||
149098488|NCT00514813|537840796|FG000|Overall Study|Kidney transplant|0|||
149098489|NCT00514813|537840797|FG001|Overall Study|Kidney transplant|6|||
149098490|NCT00514813|537840798|FG002|Overall Study|Kidney transplant|2|||
149098491|NCT00514813|537840799|FG003|Overall Study|Kidney transplant|0|||
149098492|NCT00514813|537840796|FG000|Overall Study|Death|0|||
149098493|NCT00514813|537840797|FG001|Overall Study|Death|2|||
149098494|NCT00514813|537840798|FG002|Overall Study|Death|3|||
149098495|NCT00514813|537840799|FG003|Overall Study|Death|2|||
149098496|NCT01075100|537840800|FG000|Overall Study|Adverse Event|15|||
149098497|NCT01075100|537840801|FG001|Overall Study|Adverse Event|18|||
149098498|NCT01075100|537840800|FG000|Overall Study|Patient Request|4|||
149098499|NCT01075100|537840801|FG001|Overall Study|Patient Request|4|||
149098500|NCT01075100|537840800|FG000|Overall Study|Investigator Request|2|||
149098501|NCT01075100|537840801|FG001|Overall Study|Investigator Request|1|||
149098502|NCT01075100|537840800|FG000|Overall Study|Disease Progression|25|||
149098503|NCT01075100|537840801|FG001|Overall Study|Disease Progression|29|||
149098504|NCT01075100|537840800|FG000|Overall Study|Other|3|||
149098505|NCT01075100|537840801|FG001|Overall Study|Other|1|||
149098506|NCT00908349|537842173|FG000|Overall Study|Adverse Event|10|||
149098507|NCT00908349|537842173|FG000|Overall Study|Withdrawal by Subject|9|||
149098508|NCT00908349|537842173|FG000|Overall Study|Physician Decision|5|||
149098509|NCT00908349|537842173|FG000|Overall Study|Lost to Follow-up|5|||
149098510|NCT00908349|537842173|FG000|Overall Study|Various|6|||
149098511|NCT00971997|537842174|FG000|Overall Study|Adverse Event|2|||
149098512|NCT00971997|537842174|FG000|Overall Study|Death|1|||
149098513|NCT00971997|537842174|FG000|Overall Study|Protocol Violation|4|||
149098514|NCT00971997|537842174|FG000|Overall Study|Withdrawal by Subject|5|||
149098515|NCT00971997|537842174|FG000|Overall Study|Physician Decision|7|||
149098516|NCT00761956|537842179|FG000|Overall Study|Lost to Follow-up|6|||
149098517|NCT00761956|537842180|FG001|Overall Study|Lost to Follow-up|11|||
149098518|NCT00761956|537842179|FG000|Overall Study|Withdrawal by Subject|3|||
149098519|NCT00761956|537842180|FG001|Overall Study|Withdrawal by Subject|8|||
149098520|NCT00761956|537842179|FG000|Overall Study|Death|0|||
149098521|NCT00761956|537842180|FG001|Overall Study|Death|1|||
149098522|NCT00761956|537842179|FG000|Overall Study|Adverse Event|26|||
149098523|NCT00761956|537842180|FG001|Overall Study|Adverse Event|34|||
149098524|NCT04398368|537842183|FG000|Overall Study|Withdrawal by Subject|2|||
149098525|NCT02808975|537842184|FG000|Overall Study|Adverse Event|3|||
149098526|NCT02808975|537842185|FG001|Overall Study|Adverse Event|4|||
149098527|NCT02808975|537842184|FG000|Overall Study|Withdrew consent|9|||
149098528|NCT02808975|537842185|FG001|Overall Study|Withdrew consent|8|||
149098529|NCT02808975|537842184|FG000|Overall Study|Lost to Follow-up|4|||
149098530|NCT02808975|537842185|FG001|Overall Study|Lost to Follow-up|6|||
149098531|NCT02808975|537842184|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
149098532|NCT02808975|537842185|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
149098533|NCT02808975|537842184|FG000|Overall Study|Other, not specified|5|||
149098534|NCT02808975|537842185|FG001|Overall Study|Other, not specified|1|||
149098535|NCT03602586|537842186|FG000|Overall Study|Withdrawal by Subject|3|||
149098536|NCT00511836|537842189|FG000|Double-blind Period|Lost to Follow-up|1|||
149098537|NCT00511836|537842190|FG001|Double-blind Period|Lost to Follow-up|0|||
149098538|NCT01755546|537842191|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
149098539|NCT01755546|537842191|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
149098540|NCT01755546|537842191|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
149098541|NCT01755546|537842191|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
149098542|NCT01755546|537842191|FG000|Titration Phase|Adverse Event|11|||
149098543|NCT01755546|537842191|FG000|Titration Phase|Lack of Efficacy|18|||
149098544|NCT01755546|537842191|FG000|Titration Phase|Protocol Violation|9|||
149098545|NCT01755546|537842191|FG000|Titration Phase|Lost to Follow-up|2|||
149098546|NCT01755546|537842191|FG000|Titration Phase|Other and Continuing|22|||
149098547|NCT01755546|537842191|FG000|Titration Phase|Withdrawal by Subject|8|||
149098548|NCT01755546|537842191|FG000|Long Term Treatment|Adverse Event|12|||
149098549|NCT01755546|537842191|FG000|Long Term Treatment|Lack of Efficacy|6|||
149098550|NCT01755546|537842191|FG000|Long Term Treatment|Protocol Violation|10|||
149098551|NCT01755546|537842191|FG000|Long Term Treatment|Withdrawal by Subject|35|||
149098552|NCT01755546|537842191|FG000|Long Term Treatment|Lost to Follow-up|17|||
149098553|NCT01755546|537842191|FG000|Long Term Treatment|other and ongoing|41|||
149098554|NCT00891046|537842192|FG000|Overall Study|Protocol Violation|1|||
149098555|NCT00891046|537842193|FG001|Overall Study|Protocol Violation|1|||
149098556|NCT00891046|537842194|FG002|Overall Study|Protocol Violation|0|||
149098557|NCT00891046|537842195|FG003|Overall Study|Protocol Violation|0|||
149098558|NCT00891046|537842196|FG004|Overall Study|Protocol Violation|1|||
149098559|NCT00891046|537842192|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
149098560|NCT00891046|537842193|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
149098561|NCT00891046|537842194|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
149098562|NCT00891046|537842195|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
149098563|NCT00891046|537842196|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
149098564|NCT00891046|537842192|FG000|Overall Study|Administrative problems|0|||
149098565|NCT00891046|537842193|FG001|Overall Study|Administrative problems|0|||
149098566|NCT00891046|537842194|FG002|Overall Study|Administrative problems|0|||
149098567|NCT00891046|537842195|FG003|Overall Study|Administrative problems|0|||
149098568|NCT00891046|537842196|FG004|Overall Study|Administrative problems|1|||
149098569|NCT00891046|537842192|FG000|Overall Study|Participant no longer required drug|0|||
149098570|NCT00891046|537842193|FG001|Overall Study|Participant no longer required drug|2|||
149098571|NCT00891046|537842194|FG002|Overall Study|Participant no longer required drug|0|||
149098572|NCT00891046|537842195|FG003|Overall Study|Participant no longer required drug|0|||
149098573|NCT00891046|537842196|FG004|Overall Study|Participant no longer required drug|1|||
149098574|NCT00891046|537842192|FG000|Overall Study|Adverse Event|4|||
149098575|NCT00891046|537842193|FG001|Overall Study|Adverse Event|3|||
149098576|NCT00891046|537842194|FG002|Overall Study|Adverse Event|2|||
149098577|NCT00891046|537842195|FG003|Overall Study|Adverse Event|0|||
149098578|NCT00891046|537842196|FG004|Overall Study|Adverse Event|14|||
149098579|NCT00891046|537842192|FG000|Overall Study|Withdrawal by Subject|2|||
149098580|NCT00891046|537842193|FG001|Overall Study|Withdrawal by Subject|1|||
149098581|NCT00891046|537842194|FG002|Overall Study|Withdrawal by Subject|2|||
149098582|NCT00891046|537842195|FG003|Overall Study|Withdrawal by Subject|1|||
149098583|NCT00891046|537842196|FG004|Overall Study|Withdrawal by Subject|1|||
149098584|NCT00891046|537842192|FG000|Overall Study|Lost to Follow-up|0|||
149098585|NCT00891046|537842193|FG001|Overall Study|Lost to Follow-up|0|||
149098586|NCT00891046|537842194|FG002|Overall Study|Lost to Follow-up|0|||
149098587|NCT00891046|537842195|FG003|Overall Study|Lost to Follow-up|0|||
149098588|NCT00891046|537842196|FG004|Overall Study|Lost to Follow-up|1|||
149098589|NCT00362375|537842197|FG000|Overall Study|Lost to Follow-up|40|||
149098590|NCT00362375|537842198|FG001|Overall Study|Lost to Follow-up|35|||
149098591|NCT02106195|537842199|FG000|Overall Study|Adverse Event|2|||
149098592|NCT02106195|537842199|FG000|Overall Study|Protocol Violation|1|||
149098593|NCT04984239|537842200|FG000|Overall Study|Lost to Follow-up|1|||
149098594|NCT01951378|537842203|FG000|Overall Study|Study Terminated-Not completed|23|||
149098595|NCT01951378|537842204|FG001|Overall Study|Study Terminated-Not completed|17|||
149098596|NCT03568812|537842205|FG000|Overall Study|Physician Decision|0|||
149098597|NCT03568812|537842206|FG001|Overall Study|Physician Decision|1|||
149098598|NCT03194867|537842213|FG000|Overall Study|Incorrect completion of end of study form|0|||
149098599|NCT03194867|537842214|FG001|Overall Study|Incorrect completion of end of study form|0|||
149098600|NCT03194867|537842215|FG002|Overall Study|Incorrect completion of end of study form|1|||
149098601|NCT03194867|537842216|FG003|Overall Study|Incorrect completion of end of study form|0|||
149098602|NCT00634842|537842217|FG000|Overall Study|Adverse Event|2|||
149098603|NCT00634842|537842218|FG001|Overall Study|Adverse Event|3|||
149098604|NCT00634842|537842217|FG000|Overall Study|Protocol Violation|8|||
149098605|NCT00634842|537842218|FG001|Overall Study|Protocol Violation|4|||
149098606|NCT00634842|537842217|FG000|Overall Study|Move to another state|1|||
149098607|NCT00634842|537842218|FG001|Overall Study|Move to another state|0|||
149098608|NCT00634842|537842217|FG000|Overall Study|Inclusion criteria were not met|1|||
149098609|NCT00634842|537842218|FG001|Overall Study|Inclusion criteria were not met|0|||
149098610|NCT00634842|537842217|FG000|Overall Study|Lost to Follow-up|1|||
149098611|NCT00634842|537842218|FG001|Overall Study|Lost to Follow-up|2|||
149098612|NCT00634842|537842217|FG000|Overall Study|Physician Decision|1|||
149098613|NCT00634842|537842218|FG001|Overall Study|Physician Decision|0|||
149098614|NCT00634842|537842217|FG000|Overall Study|Withdrawal by Subject|1|||
149098615|NCT00634842|537842218|FG001|Overall Study|Withdrawal by Subject|3|||
149098616|NCT00634842|537842217|FG000|Overall Study|Lack of time and intolerance to drug|0|||
149098617|NCT00634842|537842218|FG001|Overall Study|Lack of time and intolerance to drug|1|||
149098618|NCT00634842|537842217|FG000|Overall Study|Discontinued due to injection|0|||
149098619|NCT00634842|537842218|FG001|Overall Study|Discontinued due to injection|2|||
149098620|NCT00634842|537842217|FG000|Overall Study|No need of study drug to treat diabetes|0|||
149098621|NCT00634842|537842218|FG001|Overall Study|No need of study drug to treat diabetes|1|||
149098622|NCT00634842|537842217|FG000|Overall Study|No wish to keep taking Avandia|0|||
149098623|NCT00634842|537842218|FG001|Overall Study|No wish to keep taking Avandia|1|||
149098624|NCT00634842|537842217|FG000|Overall Study|Subject off study drug for too long|0|||
149098625|NCT00634842|537842218|FG001|Overall Study|Subject off study drug for too long|1|||
149098626|NCT00543062|537842219|FG000|Overall Study|Withdrawal by Subject|1|||
149098627|NCT00543062|537842220|FG001|Overall Study|Withdrawal by Subject|0|||
149098628|NCT00543062|537842221|FG002|Overall Study|Withdrawal by Subject|2|||
149098629|NCT00543062|537842222|FG003|Overall Study|Withdrawal by Subject|0|||
149098630|NCT00543062|537842219|FG000|Overall Study|Adverse Event|0|||
149098631|NCT00543062|537842220|FG001|Overall Study|Adverse Event|1|||
149098632|NCT00543062|537842221|FG002|Overall Study|Adverse Event|1|||
149098633|NCT00543062|537842222|FG003|Overall Study|Adverse Event|1|||
149098634|NCT00543062|537842219|FG000|Overall Study|Protocol Violation|1|||
149098635|NCT00543062|537842220|FG001|Overall Study|Protocol Violation|0|||
149098636|NCT00543062|537842221|FG002|Overall Study|Protocol Violation|0|||
149098637|NCT00543062|537842222|FG003|Overall Study|Protocol Violation|0|||
149098638|NCT00464945|537842223|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
149098639|NCT00464945|537842224|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
149098640|NCT00464945|537842223|FG000|Infant Series|Protocol Violation|1|||
149098641|NCT00464945|537842224|FG001|Infant Series|Protocol Violation|0|||
149098642|NCT00464945|537842223|FG000|Infant Series|Lost to Follow-up|1|||
149098643|NCT00464945|537842224|FG001|Infant Series|Lost to Follow-up|0|||
149098644|NCT00464945|537842223|FG000|After Infant Series|Withdrawal by Subject|0|||
149098645|NCT00464945|537842224|FG001|After Infant Series|Withdrawal by Subject|2|||
149098646|NCT00464945|537842223|FG000|Toddler Dose|Lost to Follow-up|0|||
149098647|NCT00464945|537842224|FG001|Toddler Dose|Lost to Follow-up|1|||
149098648|NCT03927690|537842227|FG000|Overall Study|Withdrawal by Subject|3|||
149098649|NCT03927690|537842228|FG001|Overall Study|Withdrawal by Subject|1|||
149098650|NCT03927690|537842229|FG002|Overall Study|Withdrawal by Subject|1|||
149098651|NCT03927690|537842227|FG000|Overall Study|Adverse Event|1|||
149098652|NCT03927690|537842228|FG001|Overall Study|Adverse Event|0|||
149098653|NCT03927690|537842229|FG002|Overall Study|Adverse Event|0|||
149098654|NCT03927690|537842227|FG000|Overall Study|Death|1|||
149098655|NCT03927690|537842228|FG001|Overall Study|Death|0|||
149098656|NCT03927690|537842229|FG002|Overall Study|Death|0|||
149098657|NCT03927690|537842227|FG000|Overall Study|Lost to Follow-up|2|||
149098658|NCT03927690|537842228|FG001|Overall Study|Lost to Follow-up|2|||
149098659|NCT03927690|537842229|FG002|Overall Study|Lost to Follow-up|1|||
149098660|NCT01844726|537842236|FG000|Overall Study|Withdrawal by Subject|0|||
149098661|NCT01844726|537842237|FG001|Overall Study|Withdrawal by Subject|1|||
149098662|NCT01844726|537842236|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
149098663|NCT01844726|537842237|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
149098664|NCT03898960|537842240|FG000|Overall Study|Death|10|||
149098665|NCT00548847|537842241|FG000|Overall Study|Disease progression|7|||
149098666|NCT03463577|537842242|FG000|Overall Study|Lost to Follow-up|238|||
149098667|NCT03463577|537842243|FG001|Overall Study|Lost to Follow-up|435|||
149098668|NCT03463577|537842244|FG002|Overall Study|Lost to Follow-up|0|||
149098669|NCT03463577|537842245|FG003|Overall Study|Lost to Follow-up|0|||
149098670|NCT03463577|537842246|FG004|Overall Study|Lost to Follow-up|0|||
149098671|NCT03463577|537842247|FG005|Overall Study|Lost to Follow-up|0|||
149098672|NCT03463577|537842242|FG000|Overall Study|With unknown pregnancy outcome|0|||
149098673|NCT03463577|537842243|FG001|Overall Study|With unknown pregnancy outcome|5|||
149098674|NCT03463577|537842244|FG002|Overall Study|With unknown pregnancy outcome|0|||
149098675|NCT03463577|537842245|FG003|Overall Study|With unknown pregnancy outcome|0|||
149098676|NCT03463577|537842246|FG004|Overall Study|With unknown pregnancy outcome|0|||
149098677|NCT03463577|537842247|FG005|Overall Study|With unknown pregnancy outcome|0|||
149098678|NCT03463577|537842242|FG000|Overall Study|Maternal death|2|||
149098679|NCT03463577|537842243|FG001|Overall Study|Maternal death|0|||
149098680|NCT03463577|537842244|FG002|Overall Study|Maternal death|0|||
149098681|NCT03463577|537842245|FG003|Overall Study|Maternal death|0|||
149098682|NCT03463577|537842246|FG004|Overall Study|Maternal death|0|||
149098683|NCT03463577|537842247|FG005|Overall Study|Maternal death|0|||
149098684|NCT03463577|537842242|FG000|Overall Study|Neonatal death|0|||
149098685|NCT03463577|537842243|FG001|Overall Study|Neonatal death|0|||
149098686|NCT03463577|537842244|FG002|Overall Study|Neonatal death|0|||
149098687|NCT03463577|537842245|FG003|Overall Study|Neonatal death|15|||
149098688|NCT03463577|537842246|FG004|Overall Study|Neonatal death|17|||
149098689|NCT03463577|537842247|FG005|Overall Study|Neonatal death|0|||
149098690|NCT00236184|537842248|FG000|Overall Study|Adverse Event|5|||
149098691|NCT00236184|537842249|FG001|Overall Study|Adverse Event|2|||
149098692|NCT00236184|537842248|FG000|Overall Study|Lack of Efficacy|0|||
149098693|NCT00236184|537842249|FG001|Overall Study|Lack of Efficacy|1|||
149098694|NCT00236184|537842248|FG000|Overall Study|Lost to Follow-up|3|||
149098695|NCT00236184|537842249|FG001|Overall Study|Lost to Follow-up|4|||
149098696|NCT00236184|537842248|FG000|Overall Study|Physician Decision|1|||
149098697|NCT00236184|537842249|FG001|Overall Study|Physician Decision|1|||
149098698|NCT00236184|537842248|FG000|Overall Study|Withdrawal by Subject|3|||
149098699|NCT00236184|537842249|FG001|Overall Study|Withdrawal by Subject|0|||
149098700|NCT00236184|537842248|FG000|Overall Study|Protocol Violation|3|||
149098701|NCT00236184|537842249|FG001|Overall Study|Protocol Violation|0|||
149098702|NCT00236184|537842248|FG000|Overall Study|non-compliance with study drug|2|||
149098703|NCT00236184|537842249|FG001|Overall Study|non-compliance with study drug|1|||
149098704|NCT00236184|537842248|FG000|Overall Study|other|1|||
149098705|NCT00236184|537842249|FG001|Overall Study|other|2|||
149098706|NCT01101997|537842250|FG000|Overall Study|Withdrawal by Subject|2|||
149098709|NCT00469456|537842253|FG000|Overall Study|Adverse Event|4|||
149098710|NCT00469456|537842254|FG001|Overall Study|Adverse Event|3|||
149098711|NCT00469456|537842253|FG000|Overall Study|Protocol Violation|1|||
149098712|NCT00469456|537842254|FG001|Overall Study|Protocol Violation|0|||
149098713|NCT00469456|537842253|FG000|Overall Study|Withdrawal by Subject|4|||
149098714|NCT00469456|537842254|FG001|Overall Study|Withdrawal by Subject|1|||
149098715|NCT01588366|537842261|FG000|Overall Study|Adverse Event|0|||
149098716|NCT01588366|537842262|FG001|Overall Study|Adverse Event|1|||
149098717|NCT01588366|537842263|FG002|Overall Study|Adverse Event|0|||
149098718|NCT01588366|537842264|FG003|Overall Study|Adverse Event|1|||
149098719|NCT01588366|537842265|FG004|Overall Study|Adverse Event|0|||
149098720|NCT01588366|537842266|FG005|Overall Study|Adverse Event|2|||
149098721|NCT01772563|537842269|FG000|Cycle 1|Dose limiting toxicity|2|||
149098722|NCT01772563|537842269|FG000|Cycle 1|Progressive disease|2|||
149098723|NCT01772563|537842269|FG000|Cycle 2 and Beyond|Progressive disease|17|||
149098724|NCT01772563|537842269|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
149098725|NCT01772563|537842269|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
149098726|NCT03974100|537842271|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
149098727|NCT03974100|537842272|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
149098728|NCT03974100|537842273|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
149098729|NCT03974100|537842274|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
149098730|NCT03974100|537842275|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
149098731|NCT03974100|537842271|FG000|TP1 - Day 1 to Week 52|Death|1|||
149098732|NCT03974100|537842272|FG001|TP1 - Day 1 to Week 52|Death|0|||
149098733|NCT03974100|537842273|FG002|TP1 - Day 1 to Week 52|Death|0|||
149098734|NCT03974100|537842274|FG003|TP1 - Day 1 to Week 52|Death|0|||
149098735|NCT03974100|537842275|FG004|TP1 - Day 1 to Week 52|Death|0|||
149098736|NCT03974100|537842271|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
149098737|NCT03974100|537842272|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
149098738|NCT03974100|537842273|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
149098739|NCT03974100|537842274|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
149098740|NCT03974100|537842275|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
149098741|NCT03974100|537842271|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
149098742|NCT03974100|537842272|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
149098743|NCT03974100|537842273|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
149098744|NCT03974100|537842274|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
149098745|NCT03974100|537842275|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
149098746|NCT03974100|537842271|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
149098747|NCT03974100|537842272|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
149098748|NCT03974100|537842273|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
149098749|NCT03974100|537842274|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
149098750|NCT03974100|537842275|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
149098751|NCT03974100|537842271|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
149098752|NCT03974100|537842272|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
149098753|NCT03974100|537842273|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
149098754|NCT03974100|537842274|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
149098755|NCT03974100|537842275|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
149098756|NCT03974100|537842271|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
149098757|NCT03974100|537842272|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
149098758|NCT03974100|537842273|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
149098759|NCT03974100|537842274|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
149098760|NCT03974100|537842275|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
149098761|NCT00690378|537842276|FG000|Overall Study|Adverse Event|1|||
149098762|NCT00690378|537842277|FG001|Overall Study|Adverse Event|0|||
149098763|NCT00690378|537842276|FG000|Overall Study|Withdrawal by Subject|2|||
149098764|NCT00690378|537842277|FG001|Overall Study|Withdrawal by Subject|0|||
149098765|NCT00690378|537842276|FG000|Overall Study|Protocol Violation|1|||
149098766|NCT00690378|537842277|FG001|Overall Study|Protocol Violation|0|||
149098767|NCT00690378|537842276|FG000|Overall Study|Lost to Follow-up|2|||
149098768|NCT00690378|537842277|FG001|Overall Study|Lost to Follow-up|3|||
149098769|NCT00690378|537842276|FG000|Overall Study|Did not meet inc/exc criteria|13|||
149098770|NCT00690378|537842277|FG001|Overall Study|Did not meet inc/exc criteria|11|||
149098771|NCT00690378|537842276|FG000|Overall Study|Social problem|1|||
149098772|NCT00690378|537842277|FG001|Overall Study|Social problem|0|||
149098773|NCT00935259|537842278|FG000|Period 1|Administrative (scheduling conflict)|1|||
149098774|NCT00935259|537842279|FG001|Period 1|Administrative (scheduling conflict)|1|||
149098775|NCT03318783|537842280|FG000|Overall Study|Withdrawal by Subject|0|||
149098776|NCT03318783|537842281|FG001|Overall Study|Withdrawal by Subject|1|||
149098777|NCT03318783|537842280|FG000|Overall Study|Death|0|||
149098778|NCT03318783|537842281|FG001|Overall Study|Death|1|||
149098779|NCT00623363|537842284|FG000|Overall Study|Adverse Event|2|||
149098780|NCT00623363|537842285|FG001|Overall Study|Adverse Event|2|||
149098781|NCT01174264|537842289|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
149098782|NCT01174264|537842290|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
149098783|NCT01174264|537842291|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
149098784|NCT01174264|537842289|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
149098785|NCT01174264|537842290|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
149098786|NCT01174264|537842291|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
149098787|NCT01174264|537842289|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
149098788|NCT01174264|537842290|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
149098789|NCT01174264|537842291|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
149098790|NCT01185171|537842293|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
149098791|NCT01185171|537842293|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
149098792|NCT01185171|537842293|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
149098793|NCT01185171|537842293|FG000|Maintenance|Elevated liver transaminases|3|||
149098794|NCT01185171|537842293|FG000|Maintenance|Rush|2|||
149098795|NCT01185171|537842293|FG000|Maintenance|Diarrhea|1|||
149098796|NCT01185171|537842293|FG000|Maintenance|Xerostomia|1|||
149098797|NCT01185171|537842293|FG000|Maintenance|Nausea|1|||
149098798|NCT01185171|537842293|FG000|Maintenance|Comorbid Illness|2|||
149098799|NCT01185171|537842293|FG000|Maintenance|Withdrawal by Subject|1|||
149098800|NCT01185171|537842293|FG000|Maintenance|Disease Recurrence|1|||
149098801|NCT00573651|537842298|FG000|Overall Study|Lost to Follow-up|3|||
149098802|NCT00573651|537842298|FG000|Overall Study|Withdrawal by Subject|1|||
149098803|NCT01837797|537842299|FG000|Period 1|Adverse Event|9|||
149098804|NCT01837797|537842300|FG001|Period 1|Adverse Event|0|||
149098805|NCT01837797|537842301|FG002|Period 1|Adverse Event|0|||
149098806|NCT01837797|537842302|FG003|Period 1|Adverse Event|0|||
149098807|NCT01837797|537842303|FG004|Period 1|Adverse Event|0|||
149098808|NCT01837797|537842299|FG000|Period 1|Withdrawal by Subject|6|||
149098809|NCT01837797|537842300|FG001|Period 1|Withdrawal by Subject|0|||
149098810|NCT01837797|537842301|FG002|Period 1|Withdrawal by Subject|0|||
149098811|NCT01837797|537842302|FG003|Period 1|Withdrawal by Subject|0|||
149098812|NCT01837797|537842303|FG004|Period 1|Withdrawal by Subject|0|||
149098813|NCT01837797|537842299|FG000|Period 1|Administrative reasons|76|||
149098814|NCT01837797|537842300|FG001|Period 1|Administrative reasons|0|||
149098815|NCT01837797|537842301|FG002|Period 1|Administrative reasons|0|||
149098816|NCT01837797|537842302|FG003|Period 1|Administrative reasons|0|||
149098817|NCT01837797|537842303|FG004|Period 1|Administrative reasons|0|||
149098818|NCT01837797|537842299|FG000|Period 1|Withdrawal of consent before treatment|1|||
149098819|NCT01837797|537842300|FG001|Period 1|Withdrawal of consent before treatment|0|||
149098820|NCT01837797|537842301|FG002|Period 1|Withdrawal of consent before treatment|0|||
149098821|NCT01837797|537842302|FG003|Period 1|Withdrawal of consent before treatment|0|||
149098822|NCT01837797|537842303|FG004|Period 1|Withdrawal of consent before treatment|0|||
149098823|NCT01837797|537842299|FG000|Period 1|Other|10|||
149098824|NCT01837797|537842300|FG001|Period 1|Other|0|||
149098825|NCT01837797|537842301|FG002|Period 1|Other|0|||
149098826|NCT01837797|537842302|FG003|Period 1|Other|0|||
149098827|NCT01837797|537842303|FG004|Period 1|Other|0|||
149098828|NCT01837797|537842299|FG000|Period 2|Administrative or other reasons|0|||
149098829|NCT01837797|537842300|FG001|Period 2|Administrative or other reasons|5|||
149098830|NCT01837797|537842301|FG002|Period 2|Administrative or other reasons|2|||
149098831|NCT01837797|537842302|FG003|Period 2|Administrative or other reasons|4|||
149098832|NCT01837797|537842303|FG004|Period 2|Administrative or other reasons|0|||
149098833|NCT01837797|537842299|FG000|Period 2|Adverse Event|0|||
149098834|NCT01837797|537842300|FG001|Period 2|Adverse Event|0|||
149098835|NCT01837797|537842301|FG002|Period 2|Adverse Event|0|||
149098836|NCT01837797|537842302|FG003|Period 2|Adverse Event|1|||
149098837|NCT01837797|537842303|FG004|Period 2|Adverse Event|0|||
149098838|NCT01837797|537842299|FG000|Period 3|Adverse Event|0|||
149098839|NCT01837797|537842300|FG001|Period 3|Adverse Event|0|||
149098840|NCT01837797|537842301|FG002|Period 3|Adverse Event|0|||
149098841|NCT01837797|537842302|FG003|Period 3|Adverse Event|0|||
149098842|NCT01837797|537842303|FG004|Period 3|Adverse Event|1|||
149098843|NCT01837797|537842299|FG000|Period 3|Administrative reasons|0|||
149098844|NCT01837797|537842300|FG001|Period 3|Administrative reasons|0|||
149098845|NCT01837797|537842301|FG002|Period 3|Administrative reasons|0|||
149098846|NCT01837797|537842302|FG003|Period 3|Administrative reasons|0|||
149098847|NCT01837797|537842303|FG004|Period 3|Administrative reasons|20|||
149098848|NCT01837797|537842299|FG000|Period 3|Other|0|||
149098849|NCT01837797|537842300|FG001|Period 3|Other|0|||
149098850|NCT01837797|537842301|FG002|Period 3|Other|0|||
149098851|NCT01837797|537842302|FG003|Period 3|Other|0|||
149098852|NCT01837797|537842303|FG004|Period 3|Other|2|||
149098853|NCT03797989|537842304|FG000|VAC069A|Withdrawal by Subject|0|||
149098854|NCT03797989|537842305|FG001|VAC069A|Withdrawal by Subject|0|||
149098855|NCT03797989|537842306|FG002|VAC069A|Withdrawal by Subject|1|||
149098856|NCT03797989|537842307|FG003|VAC069A|Withdrawal by Subject|0|||
149098857|NCT03797989|537842308|FG004|VAC069A|Withdrawal by Subject|0|||
149098858|NCT03797989|537842309|FG005|VAC069A|Withdrawal by Subject|0|||
149098859|NCT03797989|537842310|FG006|VAC069A|Withdrawal by Subject|0|||
149098860|NCT03797989|537842311|FG007|VAC069A|Withdrawal by Subject|0|||
149098861|NCT03797989|537842312|FG008|VAC069A|Withdrawal by Subject|0|||
149098862|NCT03797989|537842313|FG009|VAC069A|Withdrawal by Subject|0|||
149098863|NCT03797989|537842314|FG010|VAC069A|Withdrawal by Subject|0|||
149098864|NCT03797989|537842315|FG011|VAC069A|Withdrawal by Subject|0|||
149098865|NCT04052997|537842316|FG000|Overall Study|Withdrawal by Subject|17|||
149098866|NCT04052997|537842316|FG000|Overall Study|Physician Decision|50|||
149098867|NCT04052997|537842316|FG000|Overall Study|Death|43|||
149098868|NCT04052997|537842316|FG000|Overall Study|Lost to Follow-up|5|||
149098869|NCT04052997|537842316|FG000|Overall Study|Progression of Disease|1|||
149098870|NCT00143598|537842325|FG000|Overall Study|Lost to Follow-up|23|||
149098871|NCT00143598|537842326|FG001|Overall Study|Lost to Follow-up|21|||
149098872|NCT00143598|537842325|FG000|Overall Study|Withdrawal by Subject|33|||
149098873|NCT00143598|537842326|FG001|Overall Study|Withdrawal by Subject|37|||
149098874|NCT00143598|537842325|FG000|Overall Study|Death|36|||
149098875|NCT00143598|537842326|FG001|Overall Study|Death|36|||
149098876|NCT03900715|537842327|FG000|Overall Study|Protocol Deviation|1|||
149098877|NCT03900715|537842327|FG000|Overall Study|Lack of Efficacy|1|||
149098878|NCT03900715|537842327|FG000|Overall Study|Progressive Disease|6|||
149098879|NCT03900715|537842327|FG000|Overall Study|Adverse Event|2|||
149098880|NCT03900715|537842327|FG000|Overall Study|Other reasons|11|||
149098881|NCT03898700|537844383|FG000|Overall Study|Withdrawal by Subject|2|||
149098882|NCT00701909|537844384|FG000|Overall Study|Withdrawal by Subject|0|||
149098883|NCT00701909|537844385|FG001|Overall Study|Withdrawal by Subject|1|||
149098884|NCT04009629|537844386|FG000|Overall Study|Withdrawal by Subject|2|||
149098885|NCT04009629|537844387|FG001|Overall Study|Withdrawal by Subject|0|||
149098886|NCT01663506|537844389|FG000|Overall Study|Lack of Efficacy|3|||
149098887|NCT01663506|537844389|FG000|Overall Study|Consent Withdrawal by Subject|1|||
149098888|NCT01663506|537844389|FG000|Overall Study|Lost to Follow-up|1|||
149098889|NCT01663506|537844389|FG000|Overall Study|Adverse Event|1|||
149098890|NCT01663506|537844389|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
149098891|NCT02438371|537844390|FG000|Overall Study|Lost to Follow-up|3|||
149098892|NCT02438371|537844391|FG001|Overall Study|Lost to Follow-up|2|||
149098893|NCT02438371|537844390|FG000|Overall Study|Withdrawal by Subject|1|||
149098894|NCT02438371|537844391|FG001|Overall Study|Withdrawal by Subject|1|||
149098895|NCT01161446|537844392|FG000|Overall Study|Lost to Follow-up|18|||
149098896|NCT01161446|537844393|FG001|Overall Study|Lost to Follow-up|14|||
149098897|NCT01161446|537844392|FG000|Overall Study|Withdrawal by Subject|0|||
149098898|NCT01161446|537844393|FG001|Overall Study|Withdrawal by Subject|1|||
149098899|NCT01010204|537844395|FG000|Overall Study|Lost to Follow-up|2|||
149098900|NCT01010204|537844396|FG001|Overall Study|Lost to Follow-up|2|||
149098901|NCT01010204|537844395|FG000|Overall Study|Adverse Event|1|||
149098902|NCT01010204|537844396|FG001|Overall Study|Adverse Event|3|||
149098903|NCT01010204|537844395|FG000|Overall Study|Withdrawal by Subject|2|||
149098904|NCT01010204|537844396|FG001|Overall Study|Withdrawal by Subject|3|||
149098905|NCT01010204|537844395|FG000|Overall Study|psychiatric hospitalization|2|||
149098906|NCT01010204|537844396|FG001|Overall Study|psychiatric hospitalization|1|||
149098907|NCT01513330|537844397|FG000|SenSura Mio First,|Adverse Event|2|||
149098908|NCT01513330|537844398|FG001|SenSura Mio First,|Adverse Event|0|||
149098909|NCT01513330|537844397|FG000|SenSura Mio First,|Lack of Efficacy|0|||
149098910|NCT01513330|537844398|FG001|SenSura Mio First,|Lack of Efficacy|1|||
149098911|NCT01513330|537844397|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
149098912|NCT01513330|537844398|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
149098913|NCT01513330|537844397|FG000|SenSura Mio First,|Other|1|||
149098914|NCT01513330|537844398|FG001|SenSura Mio First,|Other|0|||
149098915|NCT01513330|537844397|FG000|Standard Care First,|Lack of Efficacy|2|||
149098916|NCT01513330|537844398|FG001|Standard Care First,|Lack of Efficacy|2|||
149098917|NCT01513330|537844397|FG000|Standard Care First,|Withdrawal by Subject|1|||
149098918|NCT01513330|537844398|FG001|Standard Care First,|Withdrawal by Subject|2|||
149098919|NCT01513330|537844397|FG000|Standard Care First,|Other|1|||
149098920|NCT01513330|537844398|FG001|Standard Care First,|Other|0|||
149098921|NCT01519778|537844399|FG000|Overall Study|Withdrawal by Subject|3|||
149098922|NCT01519778|537844399|FG000|Overall Study|Lost to Follow-up|10|||
149098923|NCT01519778|537844399|FG000|Overall Study|Physician Decision|1|||
149098924|NCT01547117|537844404|FG000|Overall Study|Physician Decision|0|||
149098925|NCT01547117|537844405|FG001|Overall Study|Physician Decision|1|||
149098926|NCT01547117|537844406|FG002|Overall Study|Physician Decision|1|||
149098927|NCT01547117|537844407|FG003|Overall Study|Physician Decision|3|||
149098928|NCT01547117|537844404|FG000|Overall Study|Withdrawal by Subject|1|||
149098929|NCT01547117|537844405|FG001|Overall Study|Withdrawal by Subject|2|||
149098930|NCT01547117|537844406|FG002|Overall Study|Withdrawal by Subject|1|||
149098931|NCT01547117|537844407|FG003|Overall Study|Withdrawal by Subject|2|||
149098932|NCT03021551|537844411|FG000|Overall Study|Equipment Issues|2|||
149098933|NCT03021551|537844411|FG000|Overall Study|Protocol Violation|1|||
149098934|NCT00412880|537844412|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
149098935|NCT00412880|537844412|FG000|Overall Study|Consent withdrawn|1|||
149098936|NCT00412880|537844412|FG000|Overall Study|Adverse Event|1|||
149098937|NCT00412880|537844412|FG000|Overall Study|Progressive disease|20|||
149098938|NCT03491215|537844413|FG000|Overall Study|Death|6|||
149098939|NCT03491215|537844414|FG001|Overall Study|Death|2|||
149098940|NCT03491215|537844415|FG002|Overall Study|Death|1|||
149098941|NCT03491215|537844416|FG003|Overall Study|Death|0|||
149098942|NCT03491215|537844413|FG000|Overall Study|Physician Decision|1|||
149098943|NCT03491215|537844414|FG001|Overall Study|Physician Decision|0|||
149098944|NCT03491215|537844415|FG002|Overall Study|Physician Decision|0|||
149098945|NCT03491215|537844416|FG003|Overall Study|Physician Decision|0|||
149098946|NCT00551135|537844423|FG000|Overall Study|Adverse Event|1|||
149098947|NCT00551135|537844424|FG001|Overall Study|Adverse Event|0|||
149098948|NCT00551135|537844425|FG002|Overall Study|Adverse Event|1|||
149098949|NCT00551135|537844426|FG003|Overall Study|Adverse Event|1|||
149098950|NCT00551135|537844423|FG000|Overall Study|Lost to Follow-up|0|||
149098951|NCT00551135|537844424|FG001|Overall Study|Lost to Follow-up|0|||
149098952|NCT00551135|537844425|FG002|Overall Study|Lost to Follow-up|0|||
149098953|NCT00551135|537844426|FG003|Overall Study|Lost to Follow-up|1|||
149098954|NCT00551135|537844423|FG000|Overall Study|Other|3|||
149098955|NCT00551135|537844424|FG001|Overall Study|Other|2|||
149098956|NCT00551135|537844425|FG002|Overall Study|Other|1|||
149098957|NCT00551135|537844426|FG003|Overall Study|Other|2|||
149098958|NCT00551135|537844423|FG000|Overall Study|Withdrawal by Subject|1|||
149098959|NCT00551135|537844424|FG001|Overall Study|Withdrawal by Subject|0|||
149098960|NCT00551135|537844425|FG002|Overall Study|Withdrawal by Subject|3|||
149098961|NCT00551135|537844426|FG003|Overall Study|Withdrawal by Subject|1|||
149098962|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
149098963|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
149098964|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
149098965|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
149098966|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
149098967|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
149098968|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
149098969|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
149098970|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
149098971|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
149098972|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
149098973|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
149098974|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
149098975|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
149098976|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
149098977|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
149098978|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
149098979|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
149098980|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
149098981|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
149098982|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
149098983|NCT04599855|537844427|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
149098984|NCT04599855|537844428|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
149098985|NCT04599855|537844429|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
149098986|NCT04599855|537844427|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
149098987|NCT04599855|537844428|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
149098988|NCT04599855|537844429|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
149098989|NCT04599855|537844427|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
149098990|NCT04599855|537844428|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
149098991|NCT04599855|537844429|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
149098992|NCT04599855|537844427|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
149098993|NCT04599855|537844428|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
149098994|NCT04599855|537844429|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
149098995|NCT04599855|537844427|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
149098996|NCT04599855|537844428|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
149098997|NCT04599855|537844429|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
149098998|NCT04599855|537844427|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
149098999|NCT04599855|537844428|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
149099000|NCT04599855|537844429|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
149099001|NCT04599855|537844427|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
149099002|NCT04599855|537844428|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
149099003|NCT04599855|537844429|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
149099004|NCT04799418|537844430|FG000|Overall Study|Death|1|||
149099005|NCT04799418|537844431|FG001|Overall Study|Death|1|||
149099006|NCT04799418|537844430|FG000|Overall Study|Lack of Efficacy|14|||
149099007|NCT04799418|537844431|FG001|Overall Study|Lack of Efficacy|14|||
149099008|NCT04799418|537844430|FG000|Overall Study|Withdrawal by Subject|10|||
149099009|NCT04799418|537844431|FG001|Overall Study|Withdrawal by Subject|7|||
149099010|NCT04799418|537844430|FG000|Overall Study|Adverse Event|3|||
149099011|NCT04799418|537844431|FG001|Overall Study|Adverse Event|2|||
149099012|NCT01379703|537844434|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
149099013|NCT01379703|537844435|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
149099014|NCT01379703|537844436|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
149099015|NCT01379703|537844434|FG000|Study Start Through 9 Months|Adverse Event|0|||
149099016|NCT01379703|537844435|FG001|Study Start Through 9 Months|Adverse Event|14|||
149099017|NCT01379703|537844436|FG002|Study Start Through 9 Months|Adverse Event|10|||
149099018|NCT01379703|537844434|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
149099019|NCT01379703|537844435|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
149099020|NCT01379703|537844436|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
149099021|NCT01379703|537844434|FG000|Study Start Through 9 Months|Treatment Failure|0|||
149099022|NCT01379703|537844435|FG001|Study Start Through 9 Months|Treatment Failure|2|||
149099023|NCT01379703|537844436|FG002|Study Start Through 9 Months|Treatment Failure|2|||
149099024|NCT01379703|537844434|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
149099025|NCT01379703|537844435|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
149099026|NCT01379703|537844436|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
149099027|NCT01379703|537844434|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
149099028|NCT01379703|537844435|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
149099029|NCT01379703|537844436|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
149099030|NCT01379703|537844434|FG000|Study Start Through 9 Months|Medication not available|0|||
149099031|NCT01379703|537844435|FG001|Study Start Through 9 Months|Medication not available|2|||
149099032|NCT01379703|537844436|FG002|Study Start Through 9 Months|Medication not available|1|||
149099033|NCT01379703|537844434|FG000|Study Start Through 9 Months|Poor general condition|0|||
149099034|NCT01379703|537844435|FG001|Study Start Through 9 Months|Poor general condition|1|||
149099035|NCT01379703|537844436|FG002|Study Start Through 9 Months|Poor general condition|0|||
149099036|NCT01379703|537844434|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
149099037|NCT01379703|537844435|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
149099038|NCT01379703|537844436|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
149099039|NCT01379703|537844434|FG000|Study Start Through 9 Months|Reason unknown|2|||
149099040|NCT01379703|537844435|FG001|Study Start Through 9 Months|Reason unknown|31|||
149099041|NCT01379703|537844436|FG002|Study Start Through 9 Months|Reason unknown|24|||
149099042|NCT01379703|537844434|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
149099043|NCT01379703|537844435|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
149099044|NCT01379703|537844436|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
149099045|NCT01379703|537844434|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
149099046|NCT01379703|537844435|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
149099047|NCT01379703|537844436|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
149099048|NCT01379703|537844434|FG000|9 Months Through 18 Months|Adverse Event|0|||
149099049|NCT01379703|537844435|FG001|9 Months Through 18 Months|Adverse Event|6|||
149099050|NCT01379703|537844436|FG002|9 Months Through 18 Months|Adverse Event|0|||
149099051|NCT01379703|537844434|FG000|9 Months Through 18 Months|Treatment failure|0|||
149099052|NCT01379703|537844435|FG001|9 Months Through 18 Months|Treatment failure|5|||
149099053|NCT01379703|537844436|FG002|9 Months Through 18 Months|Treatment failure|0|||
149099054|NCT01379703|537844434|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
149099055|NCT01379703|537844435|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
149099056|NCT01379703|537844436|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
149099057|NCT01379703|537844434|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
149099058|NCT01379703|537844435|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
149099059|NCT01379703|537844436|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
149099060|NCT01379703|537844434|FG000|9 Months Through 18 Months|Fatigue|0|||
149099061|NCT01379703|537844435|FG001|9 Months Through 18 Months|Fatigue|1|||
149099062|NCT01379703|537844436|FG002|9 Months Through 18 Months|Fatigue|0|||
149099063|NCT01379703|537844434|FG000|9 Months Through 18 Months|Reason Unknown|0|||
149099064|NCT01379703|537844435|FG001|9 Months Through 18 Months|Reason Unknown|23|||
149099065|NCT01379703|537844436|FG002|9 Months Through 18 Months|Reason Unknown|0|||
149099066|NCT02669407|537844439|FG000|Overall Study|Physician Decision|3|||
149099067|NCT00704171|537844440|FG000|Overall Study|Withdrawal by Subject|1|||
149099068|NCT00704171|537844441|FG001|Overall Study|Withdrawal by Subject|0|||
149099069|NCT03634839|537844442|FG000|First Intervention (2 Hours)|Adverse Event|0|||
149099070|NCT03634839|537844443|FG001|First Intervention (2 Hours)|Adverse Event|2|||
149099071|NCT00719043|537844451|FG000|Overall Study|Adverse Event|5|||
149099072|NCT00719043|537844452|FG001|Overall Study|Adverse Event|1|||
149099073|NCT00719043|537844453|FG002|Overall Study|Adverse Event|2|||
149099074|NCT00719043|537844454|FG003|Overall Study|Adverse Event|2|||
149099075|NCT00719043|537844455|FG004|Overall Study|Adverse Event|1|||
149099076|NCT00719043|537844456|FG005|Overall Study|Adverse Event|4|||
149099077|NCT00719043|537844457|FG006|Overall Study|Adverse Event|4|||
149099078|NCT00719043|537844451|FG000|Overall Study|Lost to Follow-up|14|||
149099079|NCT00719043|537844452|FG001|Overall Study|Lost to Follow-up|10|||
149099080|NCT00719043|537844453|FG002|Overall Study|Lost to Follow-up|8|||
149099081|NCT00719043|537844454|FG003|Overall Study|Lost to Follow-up|9|||
149099082|NCT00719043|537844455|FG004|Overall Study|Lost to Follow-up|10|||
149099083|NCT00719043|537844456|FG005|Overall Study|Lost to Follow-up|9|||
149099084|NCT00719043|537844457|FG006|Overall Study|Lost to Follow-up|9|||
149099085|NCT00719043|537844451|FG000|Overall Study|Protocol Violation|0|||
149099086|NCT00719043|537844452|FG001|Overall Study|Protocol Violation|0|||
149099087|NCT00719043|537844453|FG002|Overall Study|Protocol Violation|0|||
149099088|NCT00719043|537844454|FG003|Overall Study|Protocol Violation|0|||
149099089|NCT00719043|537844455|FG004|Overall Study|Protocol Violation|0|||
149099090|NCT00719043|537844456|FG005|Overall Study|Protocol Violation|1|||
149099091|NCT00719043|537844457|FG006|Overall Study|Protocol Violation|0|||
149099092|NCT00719043|537844451|FG000|Overall Study|Other|1|||
149099093|NCT00719043|537844452|FG001|Overall Study|Other|0|||
149099094|NCT00719043|537844453|FG002|Overall Study|Other|1|||
149099095|NCT00719043|537844454|FG003|Overall Study|Other|2|||
149099096|NCT00719043|537844455|FG004|Overall Study|Other|0|||
149099097|NCT00719043|537844456|FG005|Overall Study|Other|2|||
149099098|NCT00719043|537844457|FG006|Overall Study|Other|1|||
149099099|NCT00719043|537844451|FG000|Overall Study|Withdrawal by Subject|12|||
149099100|NCT00719043|537844452|FG001|Overall Study|Withdrawal by Subject|14|||
149099101|NCT00719043|537844453|FG002|Overall Study|Withdrawal by Subject|9|||
149099102|NCT00719043|537844454|FG003|Overall Study|Withdrawal by Subject|10|||
149099103|NCT00719043|537844455|FG004|Overall Study|Withdrawal by Subject|16|||
149099104|NCT00719043|537844456|FG005|Overall Study|Withdrawal by Subject|18|||
149099105|NCT00719043|537844457|FG006|Overall Study|Withdrawal by Subject|14|||
149099106|NCT00302159|537844458|FG000|Overall Study|pt declined before treatment started|1|||
149099107|NCT00302159|537844458|FG000|Overall Study|pt started Avastin|1|||
149099108|NCT00813098|537844459|FG000|Overall Study|Adverse Event|2|||
149099109|NCT00813098|537844460|FG001|Overall Study|Adverse Event|4|||
149099110|NCT00813098|537844461|FG002|Overall Study|Adverse Event|1|||
149099111|NCT00813098|537844459|FG000|Overall Study|Withdrawal by Subject|0|||
149099112|NCT00813098|537844460|FG001|Overall Study|Withdrawal by Subject|1|||
149099113|NCT00813098|537844461|FG002|Overall Study|Withdrawal by Subject|0|||
149099114|NCT00813098|537844459|FG000|Overall Study|Inability to complete study procedures|1|||
149099115|NCT00813098|537844460|FG001|Overall Study|Inability to complete study procedures|0|||
149099116|NCT00813098|537844461|FG002|Overall Study|Inability to complete study procedures|0|||
149099117|NCT00813098|537844459|FG000|Overall Study|Lost to Follow-up|0|||
149099118|NCT00813098|537844460|FG001|Overall Study|Lost to Follow-up|1|||
149099119|NCT00813098|537844461|FG002|Overall Study|Lost to Follow-up|0|||
149099120|NCT00813098|537844459|FG000|Overall Study|Protocol Violation|0|||
149099121|NCT00813098|537844460|FG001|Overall Study|Protocol Violation|0|||
149099122|NCT00813098|537844461|FG002|Overall Study|Protocol Violation|1|||
149099123|NCT00813098|537844459|FG000|Overall Study|Principal Investigator decision|0|||
149099124|NCT00813098|537844460|FG001|Overall Study|Principal Investigator decision|1|||
149099125|NCT00813098|537844461|FG002|Overall Study|Principal Investigator decision|0|||
149099126|NCT00813098|537844459|FG000|Overall Study|Withdrew Consent|0|||
149099127|NCT00813098|537844460|FG001|Overall Study|Withdrew Consent|1|||
149099128|NCT00813098|537844461|FG002|Overall Study|Withdrew Consent|0|||
149099129|NCT03470545|537844462|FG000|Overall Study|Death|0|||
149099130|NCT03470545|537844463|FG001|Overall Study|Death|1|||
149099131|NCT03470545|537844462|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
149099132|NCT03470545|537844463|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
149099133|NCT03470545|537844462|FG000|Overall Study|Adverse Event|2|||
149099134|NCT03470545|537844463|FG001|Overall Study|Adverse Event|0|||
149099135|NCT03470545|537844462|FG000|Overall Study|Withdrawal by Subject|1|||
149099136|NCT03470545|537844463|FG001|Overall Study|Withdrawal by Subject|1|||
149099137|NCT03470545|537844462|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
149099138|NCT03470545|537844463|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
149099139|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
149099140|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
149099141|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
149099142|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
149099143|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
149099144|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
149099145|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
149099146|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
149099147|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
149099148|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
149099149|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
149099150|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
149099151|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
149099152|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
149099153|NCT01664923|537844464|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
149099154|NCT01664923|537844465|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
149099155|NCT01664923|537844464|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
149099156|NCT01664923|537844465|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
149099157|NCT01664923|537844464|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
149099158|NCT01664923|537844465|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
149099159|NCT01664923|537844464|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
149099160|NCT01664923|537844465|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
149099161|NCT01664923|537844464|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
149099162|NCT01664923|537844465|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
149099163|NCT01664923|537844464|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
149099164|NCT01664923|537844465|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
149099165|NCT01664923|537844464|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
149099166|NCT01664923|537844465|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
149099167|NCT03672175|537844470|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
149099168|NCT03672175|537844471|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
149099169|NCT03672175|537844472|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
149099170|NCT03672175|537844470|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
149099171|NCT03672175|537844471|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
149099172|NCT03672175|537844472|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
149099173|NCT03672175|537844470|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
149099174|NCT03672175|537844471|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
149099175|NCT03672175|537844472|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
149099176|NCT03672175|537844470|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
149099177|NCT03672175|537844471|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
149099178|NCT03672175|537844472|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
149099179|NCT03672175|537844470|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
149099180|NCT03672175|537844471|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
149099181|NCT03672175|537844472|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
149099182|NCT03672175|537844470|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
149099183|NCT03672175|537844471|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
149099184|NCT03672175|537844472|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
149099185|NCT03672175|537844470|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
149099186|NCT03672175|537844471|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
149099187|NCT03672175|537844472|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
149099188|NCT03672175|537844470|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
149099189|NCT03672175|537844471|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
149099190|NCT03672175|537844472|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
149099191|NCT03672175|537844470|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
149099192|NCT03672175|537844471|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
149099193|NCT03672175|537844472|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
149099194|NCT03672175|537844470|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
149099195|NCT03672175|537844471|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
149099196|NCT03672175|537844472|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
149099197|NCT03672175|537844470|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
149099198|NCT03672175|537844471|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
149099199|NCT03672175|537844472|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
149099200|NCT03672175|537844470|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
149099201|NCT03672175|537844471|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
149099202|NCT03672175|537844472|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
149099203|NCT01086384|537844476|FG000|2-week Run-in Period|Adverse Event|1|||
149099204|NCT01086384|537844477|FG001|2-week Run-in Period|Adverse Event|0|||
149099205|NCT01086384|537844478|FG002|2-week Run-in Period|Adverse Event|0|||
149099206|NCT01086384|537844476|FG000|2-week Run-in Period|Protocol Violation|1|||
149099207|NCT01086384|537844477|FG001|2-week Run-in Period|Protocol Violation|0|||
149099208|NCT01086384|537844478|FG002|2-week Run-in Period|Protocol Violation|0|||
149099209|NCT01086384|537844476|FG000|2-week Run-in Period|Lost to Follow-up|1|||
149099210|NCT01086384|537844477|FG001|2-week Run-in Period|Lost to Follow-up|0|||
149099211|NCT01086384|537844478|FG002|2-week Run-in Period|Lost to Follow-up|0|||
149099212|NCT01086384|537844476|FG000|2-week Run-in Period|Physician Decision|6|||
149099213|NCT01086384|537844477|FG001|2-week Run-in Period|Physician Decision|0|||
149099214|NCT01086384|537844478|FG002|2-week Run-in Period|Physician Decision|0|||
149099215|NCT01086384|537844476|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
149099216|NCT01086384|537844477|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
149099217|NCT01086384|537844478|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
149099218|NCT01086384|537844476|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
149099219|NCT01086384|537844477|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
149099220|NCT01086384|537844478|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
149099221|NCT01086384|537844476|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
149099222|NCT01086384|537844477|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
149099223|NCT01086384|537844478|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
149099224|NCT01086384|537844476|FG000|2-week Run-in Period|Randomized in Error|1|||
149099225|NCT01086384|537844477|FG001|2-week Run-in Period|Randomized in Error|0|||
149099226|NCT01086384|537844478|FG002|2-week Run-in Period|Randomized in Error|0|||
149099227|NCT01086384|537844476|FG000|Treatment Period|Withdrawal by Subject|0|||
149099228|NCT01086384|537844477|FG001|Treatment Period|Withdrawal by Subject|53|||
149099229|NCT01086384|537844478|FG002|Treatment Period|Withdrawal by Subject|55|||
149099230|NCT01086384|537844476|FG000|Treatment Period|Protocol Violation|0|||
149099231|NCT01086384|537844477|FG001|Treatment Period|Protocol Violation|26|||
149099232|NCT01086384|537844478|FG002|Treatment Period|Protocol Violation|17|||
149099233|NCT01086384|537844476|FG000|Treatment Period|Lack of Efficacy|0|||
149099234|NCT01086384|537844477|FG001|Treatment Period|Lack of Efficacy|22|||
149099235|NCT01086384|537844478|FG002|Treatment Period|Lack of Efficacy|13|||
149099236|NCT01086384|537844476|FG000|Treatment Period|Adverse Event|0|||
149099237|NCT01086384|537844477|FG001|Treatment Period|Adverse Event|19|||
149099238|NCT01086384|537844478|FG002|Treatment Period|Adverse Event|15|||
149099239|NCT01086384|537844476|FG000|Treatment Period|Lost to Follow-up|0|||
149099240|NCT01086384|537844477|FG001|Treatment Period|Lost to Follow-up|11|||
149099241|NCT01086384|537844478|FG002|Treatment Period|Lost to Follow-up|9|||
149099242|NCT01086384|537844476|FG000|Treatment Period|Physician Decision|0|||
149099243|NCT01086384|537844477|FG001|Treatment Period|Physician Decision|9|||
149099244|NCT01086384|537844478|FG002|Treatment Period|Physician Decision|6|||
149099245|NCT01086384|537844476|FG000|Treatment Period|Study Closed/Terminated|0|||
149099246|NCT01086384|537844477|FG001|Treatment Period|Study Closed/Terminated|7|||
149099247|NCT01086384|537844478|FG002|Treatment Period|Study Closed/Terminated|8|||
149099248|NCT01086384|537844476|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
149099249|NCT01086384|537844477|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
149099250|NCT01086384|537844478|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
149099251|NCT01086384|537844476|FG000|Treatment Period|Received Treatment in Error|0|||
149099252|NCT01086384|537844477|FG001|Treatment Period|Received Treatment in Error|1|||
149099253|NCT01086384|537844478|FG002|Treatment Period|Received Treatment in Error|0|||
149099254|NCT02586415|537844483|FG000|Overall Study|Death|13|||
149099255|NCT02586415|537844484|FG001|Overall Study|Death|23|||
149099256|NCT02586415|537844483|FG000|Overall Study|Lost to Follow-up|1|||
149099257|NCT02586415|537844484|FG001|Overall Study|Lost to Follow-up|2|||
149099258|NCT00832000|537844485|FG000|Overall Study|Adverse Event|2|||
149099259|NCT00832000|537844486|FG001|Overall Study|Adverse Event|0|||
149099260|NCT00832000|537844485|FG000|Overall Study|Withdrawal by Subject|1|||
149099261|NCT00832000|537844486|FG001|Overall Study|Withdrawal by Subject|0|||
149099262|NCT00832000|537844485|FG000|Overall Study|No calls to IVR in either period|1|||
149099263|NCT00832000|537844486|FG001|Overall Study|No calls to IVR in either period|1|||
149099264|NCT00832000|537844485|FG000|Overall Study|No calls to IVR in period 2|2|||
149099265|NCT00832000|537844486|FG001|Overall Study|No calls to IVR in period 2|0|||
149099266|NCT02725567|537844488|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
149099267|NCT02725567|537844489|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
149099268|NCT02725567|537844488|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
149099269|NCT02725567|537844489|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
149099270|NCT02725567|537844488|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
149099271|NCT02725567|537844489|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
149099272|NCT01898442|537844490|FG000|Overall Study|Hemolysis/technical problems|1|||
149099273|NCT01898442|537844491|FG001|Overall Study|Hemolysis/technical problems|2|||
149099274|NCT01898442|537844492|FG002|Overall Study|Hemolysis/technical problems|2|||
149099275|NCT01898442|537844490|FG000|Overall Study|Patient vomited pills|0|||
149099276|NCT01898442|537844491|FG001|Overall Study|Patient vomited pills|0|||
149099277|NCT01898442|537844492|FG002|Overall Study|Patient vomited pills|1|||
149099278|NCT00255944|537844493|FG000|Overall Study|Lost to Follow-up|797|||
149099279|NCT00255944|537844494|FG001|Overall Study|Lost to Follow-up|834|||
149099280|NCT01129115|537844496|FG000|Overall Study|Adverse Event|1|||
149099281|NCT01129115|537844497|FG001|Overall Study|Adverse Event|2|||
149099282|NCT01129115|537844498|FG002|Overall Study|Adverse Event|3|||
149099283|NCT01129115|537844499|FG003|Overall Study|Adverse Event|3|||
149099284|NCT01129115|537844496|FG000|Overall Study|Withdrawal by Subject|1|||
149099285|NCT01129115|537844497|FG001|Overall Study|Withdrawal by Subject|3|||
149099286|NCT01129115|537844498|FG002|Overall Study|Withdrawal by Subject|1|||
149099287|NCT01129115|537844499|FG003|Overall Study|Withdrawal by Subject|4|||
149099288|NCT01129115|537844496|FG000|Overall Study|Protocol Violation|0|||
149099289|NCT01129115|537844497|FG001|Overall Study|Protocol Violation|2|||
149099290|NCT01129115|537844498|FG002|Overall Study|Protocol Violation|2|||
149099291|NCT01129115|537844499|FG003|Overall Study|Protocol Violation|2|||
149099292|NCT01747837|537844501|FG000|Overall Study|Lost to Follow-up|5|||
149099293|NCT01747837|537844502|FG001|Overall Study|Lost to Follow-up|2|||
149099294|NCT01747837|537844501|FG000|Overall Study|Death|4|||
149099295|NCT01747837|537844502|FG001|Overall Study|Death|4|||
149099296|NCT00817336|537844504|FG000|Overall Study|Withdrawal by Subject|1|||
149099297|NCT00817336|537844505|FG001|Overall Study|Withdrawal by Subject|1|||
149099298|NCT00511797|537844506|FG000|Overall Study|Adverse Event|1|||
149099299|NCT00511797|537844507|FG001|Overall Study|Adverse Event|2|||
149099300|NCT00511797|537844508|FG002|Overall Study|Adverse Event|2|||
149099301|NCT00511797|537844509|FG003|Overall Study|Adverse Event|2|||
149099302|NCT00511797|537844506|FG000|Overall Study|Lost to Follow-up|1|||
149099303|NCT00511797|537844507|FG001|Overall Study|Lost to Follow-up|0|||
149099304|NCT00511797|537844508|FG002|Overall Study|Lost to Follow-up|0|||
149099305|NCT00511797|537844509|FG003|Overall Study|Lost to Follow-up|1|||
149099306|NCT00511797|537844506|FG000|Overall Study|Pregnancy|0|||
149099307|NCT00511797|537844507|FG001|Overall Study|Pregnancy|0|||
149099308|NCT00511797|537844508|FG002|Overall Study|Pregnancy|0|||
149099309|NCT00511797|537844509|FG003|Overall Study|Pregnancy|1|||
149099310|NCT00511797|537844506|FG000|Overall Study|Protocol Violation|0|||
149099311|NCT00511797|537844507|FG001|Overall Study|Protocol Violation|2|||
149099312|NCT00511797|537844508|FG002|Overall Study|Protocol Violation|2|||
149099313|NCT00511797|537844509|FG003|Overall Study|Protocol Violation|3|||
149099314|NCT00511797|537844506|FG000|Overall Study|Withdrawal by Subject|3|||
149099315|NCT00511797|537844507|FG001|Overall Study|Withdrawal by Subject|3|||
149099316|NCT00511797|537844508|FG002|Overall Study|Withdrawal by Subject|4|||
149099317|NCT00511797|537844509|FG003|Overall Study|Withdrawal by Subject|2|||
149099318|NCT00511797|537844506|FG000|Overall Study|Never dispensed|1|||
149099319|NCT00511797|537844507|FG001|Overall Study|Never dispensed|0|||
149099320|NCT00511797|537844508|FG002|Overall Study|Never dispensed|1|||
149099321|NCT00511797|537844509|FG003|Overall Study|Never dispensed|3|||
149099322|NCT00511797|537844506|FG000|Overall Study|Study drug not taken|0|||
149099323|NCT00511797|537844507|FG001|Overall Study|Study drug not taken|1|||
149099324|NCT00511797|537844508|FG002|Overall Study|Study drug not taken|0|||
149099325|NCT00511797|537844509|FG003|Overall Study|Study drug not taken|1|||
149099326|NCT00511797|537844506|FG000|Overall Study|Partially missing diary|0|||
149099327|NCT00511797|537844507|FG001|Overall Study|Partially missing diary|0|||
149099328|NCT00511797|537844508|FG002|Overall Study|Partially missing diary|1|||
149099329|NCT00511797|537844509|FG003|Overall Study|Partially missing diary|0|||
149099330|NCT00511797|537844506|FG000|Overall Study|Other (moving etc)|1|||
149099331|NCT00511797|537844507|FG001|Overall Study|Other (moving etc)|0|||
149099332|NCT00511797|537844508|FG002|Overall Study|Other (moving etc)|1|||
149099333|NCT00511797|537844509|FG003|Overall Study|Other (moving etc)|2|||
149099334|NCT01121913|537844510|FG000|First Intervention Period|Adverse Event|0|||
149099335|NCT01121913|537844511|FG001|First Intervention Period|Adverse Event|0|||
149099336|NCT01121913|537844512|FG002|First Intervention Period|Adverse Event|1|||
149099337|NCT01121913|537844513|FG003|First Intervention Period|Adverse Event|0|||
149099338|NCT01121913|537844510|FG000|First Washout Period|Withdrawal by Subject|1|||
149099339|NCT01121913|537844511|FG001|First Washout Period|Withdrawal by Subject|0|||
149099340|NCT01121913|537844512|FG002|First Washout Period|Withdrawal by Subject|0|||
149099341|NCT01121913|537844513|FG003|First Washout Period|Withdrawal by Subject|0|||
149099342|NCT01121913|537844510|FG000|Second Intervention Period|Adverse Event|0|||
149099343|NCT01121913|537844511|FG001|Second Intervention Period|Adverse Event|0|||
149099344|NCT01121913|537844512|FG002|Second Intervention Period|Adverse Event|1|||
149099345|NCT01121913|537844513|FG003|Second Intervention Period|Adverse Event|0|||
149099346|NCT01121913|537844510|FG000|Second Washout Period|Withdrawal by Subject|0|||
149099347|NCT01121913|537844511|FG001|Second Washout Period|Withdrawal by Subject|0|||
149099348|NCT01121913|537844512|FG002|Second Washout Period|Withdrawal by Subject|1|||
149099349|NCT01121913|537844513|FG003|Second Washout Period|Withdrawal by Subject|0|||
149099350|NCT01121913|537844510|FG000|Third Washout Period|Adverse Event|1|||
149099351|NCT01121913|537844511|FG001|Third Washout Period|Adverse Event|0|||
149099352|NCT01121913|537844512|FG002|Third Washout Period|Adverse Event|0|||
149099353|NCT01121913|537844513|FG003|Third Washout Period|Adverse Event|0|||
149099354|NCT02019641|537844520|FG000|10-Week Follow up|Withdrawal by investigator|2|||
149099355|NCT02019641|537844521|FG001|10-Week Follow up|Withdrawal by investigator|0|||
149099356|NCT02019641|537844522|FG002|10-Week Follow up|Withdrawal by investigator|0|||
149099357|NCT02019641|537844520|FG000|10-Week Follow up|Withdrawal by Subject|1|||
149099358|NCT02019641|537844521|FG001|10-Week Follow up|Withdrawal by Subject|1|||
149099359|NCT02019641|537844522|FG002|10-Week Follow up|Withdrawal by Subject|0|||
149099360|NCT02019641|537844520|FG000|20-Week Follow up|Withdrawal by investigator|0|||
149099361|NCT02019641|537844521|FG001|20-Week Follow up|Withdrawal by investigator|0|||
149099362|NCT02019641|537844522|FG002|20-Week Follow up|Withdrawal by investigator|1|||
149099363|NCT03410108|537844525|FG000|Overall Study|Ongoing|41|||
149099364|NCT03410108|537844525|FG000|Overall Study|Adverse Event|4|||
149099365|NCT03410108|537844525|FG000|Overall Study|Progressive Disease|58|||
149099366|NCT03410108|537844525|FG000|Overall Study|Withdrawal by Subject|1|||
149099367|NCT03856047|537844526|FG000|Overall Study|Withdrawal by Subject|0|||
149099368|NCT03856047|537844527|FG001|Overall Study|Withdrawal by Subject|1|||
149099369|NCT03856047|537844528|FG002|Overall Study|Withdrawal by Subject|1|||
149099370|NCT03856047|537844529|FG003|Overall Study|Withdrawal by Subject|0|||
149099371|NCT03856047|537844530|FG004|Overall Study|Withdrawal by Subject|3|||
149099372|NCT03856047|537844531|FG005|Overall Study|Withdrawal by Subject|0|||
149099373|NCT03856047|537844532|FG006|Overall Study|Withdrawal by Subject|2|||
149099374|NCT03856047|537844526|FG000|Overall Study|Lost to Follow-up|4|||
149099375|NCT03856047|537844527|FG001|Overall Study|Lost to Follow-up|2|||
149099376|NCT03856047|537844528|FG002|Overall Study|Lost to Follow-up|3|||
149099377|NCT03856047|537844529|FG003|Overall Study|Lost to Follow-up|1|||
149099378|NCT03856047|537844530|FG004|Overall Study|Lost to Follow-up|4|||
149099379|NCT03856047|537844531|FG005|Overall Study|Lost to Follow-up|4|||
149099380|NCT03856047|537844532|FG006|Overall Study|Lost to Follow-up|4|||
149099381|NCT00937521|537844534|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
149099382|NCT00937521|537844535|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
149099383|NCT00937521|537844536|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
149099384|NCT00937521|537844537|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
149099385|NCT00937521|537844538|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
149099386|NCT00937521|537844539|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
149099387|NCT00937521|537844540|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
149099388|NCT00937521|537844541|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
149099389|NCT00937521|537844534|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
149099390|NCT00937521|537844535|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
149099391|NCT00937521|537844536|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
149099392|NCT00937521|537844537|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
149099393|NCT00937521|537844538|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
149099394|NCT00937521|537844539|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
149099395|NCT00937521|537844540|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
149099396|NCT00937521|537844541|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
149099397|NCT00937521|537844534|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
149099398|NCT00937521|537844535|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
149099399|NCT00937521|537844536|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
149099400|NCT00937521|537844537|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
149099401|NCT00937521|537844538|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
149099402|NCT00937521|537844539|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
149099403|NCT00937521|537844540|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
149099404|NCT00937521|537844541|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
149099405|NCT00937521|537844534|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
149099406|NCT00937521|537844535|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
149099407|NCT00937521|537844536|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
149099408|NCT00937521|537844537|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
149099409|NCT00937521|537844538|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
149099410|NCT00937521|537844539|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
149099411|NCT00937521|537844540|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
149099412|NCT00937521|537844541|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
149099413|NCT00937521|537844534|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
149099414|NCT00937521|537844535|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
149099415|NCT00937521|537844536|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
149099416|NCT00937521|537844537|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
149099417|NCT00937521|537844538|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
149099418|NCT00937521|537844539|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
149099419|NCT00937521|537844540|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
149099420|NCT00937521|537844541|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
149099421|NCT00937521|537844534|FG000|Booster Phase|Adverse Event|0|||
149099422|NCT00937521|537844535|FG001|Booster Phase|Adverse Event|0|||
149099423|NCT00937521|537844536|FG002|Booster Phase|Adverse Event|0|||
149099424|NCT00937521|537844537|FG003|Booster Phase|Adverse Event|0|||
149099425|NCT00937521|537844538|FG004|Booster Phase|Adverse Event|0|||
149099426|NCT00937521|537844539|FG005|Booster Phase|Adverse Event|0|||
149099427|NCT00937521|537844540|FG006|Booster Phase|Adverse Event|1|||
149099428|NCT00937521|537844541|FG007|Booster Phase|Adverse Event|0|||
149099429|NCT00937521|537844534|FG000|Booster Phase|Withdrawal by Subject|1|||
149099430|NCT00937521|537844535|FG001|Booster Phase|Withdrawal by Subject|0|||
149099431|NCT00937521|537844536|FG002|Booster Phase|Withdrawal by Subject|0|||
149099432|NCT00937521|537844537|FG003|Booster Phase|Withdrawal by Subject|1|||
149099433|NCT00937521|537844538|FG004|Booster Phase|Withdrawal by Subject|0|||
149099434|NCT00937521|537844539|FG005|Booster Phase|Withdrawal by Subject|0|||
149099435|NCT00937521|537844540|FG006|Booster Phase|Withdrawal by Subject|0|||
149099436|NCT00937521|537844541|FG007|Booster Phase|Withdrawal by Subject|2|||
149099437|NCT00937521|537844534|FG000|Booster Phase|Lost to Follow-up|2|||
149099438|NCT00937521|537844535|FG001|Booster Phase|Lost to Follow-up|2|||
149099439|NCT00937521|537844536|FG002|Booster Phase|Lost to Follow-up|4|||
149099440|NCT00937521|537844537|FG003|Booster Phase|Lost to Follow-up|2|||
149099441|NCT00937521|537844538|FG004|Booster Phase|Lost to Follow-up|4|||
149099442|NCT00937521|537844539|FG005|Booster Phase|Lost to Follow-up|4|||
149099443|NCT00937521|537844540|FG006|Booster Phase|Lost to Follow-up|3|||
149099444|NCT00937521|537844541|FG007|Booster Phase|Lost to Follow-up|0|||
149099445|NCT00937521|537844534|FG000|Booster Phase|Administrative Reason|0|||
149099446|NCT00937521|537844535|FG001|Booster Phase|Administrative Reason|0|||
149099447|NCT00937521|537844536|FG002|Booster Phase|Administrative Reason|1|||
149099448|NCT00937521|537844537|FG003|Booster Phase|Administrative Reason|0|||
149099449|NCT00937521|537844538|FG004|Booster Phase|Administrative Reason|1|||
149099450|NCT00937521|537844539|FG005|Booster Phase|Administrative Reason|1|||
149099451|NCT00937521|537844540|FG006|Booster Phase|Administrative Reason|0|||
149099452|NCT00937521|537844541|FG007|Booster Phase|Administrative Reason|0|||
149099453|NCT00937521|537844534|FG000|Booster Phase|Protocol Deviation|0|||
149099454|NCT00937521|537844535|FG001|Booster Phase|Protocol Deviation|0|||
149099455|NCT00937521|537844536|FG002|Booster Phase|Protocol Deviation|0|||
149099456|NCT00937521|537844537|FG003|Booster Phase|Protocol Deviation|0|||
149099457|NCT00937521|537844538|FG004|Booster Phase|Protocol Deviation|0|||
149099458|NCT00937521|537844539|FG005|Booster Phase|Protocol Deviation|0|||
149099459|NCT00937521|537844540|FG006|Booster Phase|Protocol Deviation|1|||
149099460|NCT00937521|537844541|FG007|Booster Phase|Protocol Deviation|0|||
149099461|NCT01721746|537844545|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
149099462|NCT01721746|537844546|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
149099463|NCT01721746|537844545|FG000|Pre-Treatment|Withdrawal by Subject|1|||
149099464|NCT01721746|537844546|FG001|Pre-Treatment|Withdrawal by Subject|16|||
149099465|NCT01721746|537844545|FG000|Pre-Treatment|Poor/Non-compliance|1|||
149099466|NCT01721746|537844546|FG001|Pre-Treatment|Poor/Non-compliance|0|||
149099467|NCT01721746|537844545|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
149099468|NCT01721746|537844546|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
149099469|NCT01721746|537844545|FG000|Treatment|Disease Progression|192|||
149099470|NCT01721746|537844546|FG001|Treatment|Disease Progression|74|||
149099471|NCT01721746|537844545|FG000|Treatment|Study Drug Toxicity|19|||
149099472|NCT01721746|537844546|FG001|Treatment|Study Drug Toxicity|11|||
149099473|NCT01721746|537844545|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
149099474|NCT01721746|537844546|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
149099475|NCT01721746|537844545|FG000|Treatment|Participant request to discontinue Study treatment|26|||
149099476|NCT01721746|537844546|FG001|Treatment|Participant request to discontinue Study treatment|7|||
149099477|NCT01721746|537844545|FG000|Treatment|Participant withdrew consent|4|||
149099478|NCT01721746|537844546|FG001|Treatment|Participant withdrew consent|2|||
149099479|NCT01721746|537844545|FG000|Treatment|Maximum Clinical Benefit|9|||
149099480|NCT01721746|537844546|FG001|Treatment|Maximum Clinical Benefit|3|||
149099481|NCT01721746|537844545|FG000|Treatment|Poor/Non-compliance|2|||
149099482|NCT01721746|537844546|FG001|Treatment|Poor/Non-compliance|0|||
149099483|NCT01721746|537844545|FG000|Treatment|Participant no longer met Study criteria|4|||
149099484|NCT01721746|537844546|FG001|Treatment|Participant no longer met Study criteria|0|||
149099485|NCT01721746|537844545|FG000|Treatment|Other reasons|6|||
149099486|NCT01721746|537844546|FG001|Treatment|Other reasons|2|||
149099487|NCT00239681|537844549|FG000|Overall Study|Adverse Event|100|||
149099488|NCT00239681|537844550|FG001|Overall Study|Adverse Event|99|||
149099489|NCT00239681|537844549|FG000|Overall Study|Withdrawal by Subject|458|||
149099490|NCT00239681|537844550|FG001|Overall Study|Withdrawal by Subject|489|||
149099491|NCT00239681|537844549|FG000|Overall Study|Lost to Follow-up|28|||
149099492|NCT00239681|537844550|FG001|Overall Study|Lost to Follow-up|22|||
149099493|NCT00239681|537844549|FG000|Overall Study|Protocol Violation|4|||
149099494|NCT00239681|537844550|FG001|Overall Study|Protocol Violation|4|||
149099495|NCT00239681|537844549|FG000|Overall Study|Physician Decision|13|||
149099496|NCT00239681|537844550|FG001|Overall Study|Physician Decision|17|||
149099497|NCT00239681|537844549|FG000|Overall Study|No information chacked on CaseReportForm|90|||
149099498|NCT00239681|537844550|FG001|Overall Study|No information chacked on CaseReportForm|84|||
149099499|NCT02447718|537844551|FG000|Overall Study|Lost to Follow-up|8|||
149099500|NCT02447718|537844552|FG001|Overall Study|Lost to Follow-up|0|||
149099501|NCT02447718|537844551|FG000|Overall Study|Withdrawal by Subject|3|||
149099502|NCT02447718|537844552|FG001|Overall Study|Withdrawal by Subject|0|||
149099503|NCT02447718|537844551|FG000|Overall Study|Screen Failure|1|||
149099504|NCT02447718|537844552|FG001|Overall Study|Screen Failure|0|||
149099505|NCT02654132|537844553|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
149099506|NCT02654132|537844554|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
149099507|NCT02654132|537844553|FG000|Treatment Period|Disease progression|43|||
149099508|NCT02654132|537844554|FG001|Treatment Period|Disease progression|38|||
149099509|NCT02654132|537844553|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
149099510|NCT02654132|537844554|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
149099511|NCT02654132|537844553|FG000|Treatment Period|Other reasons|4|||
149099512|NCT02654132|537844554|FG001|Treatment Period|Other reasons|2|||
149099513|NCT02654132|537844553|FG000|Treatment Period|Study drug toxicity|2|||
149099514|NCT02654132|537844554|FG001|Treatment Period|Study drug toxicity|2|||
149099515|NCT02654132|537844553|FG000|Treatment Period|Withdrawal by Subject|2|||
149099516|NCT02654132|537844554|FG001|Treatment Period|Withdrawal by Subject|1|||
149099517|NCT02654132|537844553|FG000|Treatment Period|Maximum Clinical Benefit|0|||
149099518|NCT02654132|537844554|FG001|Treatment Period|Maximum Clinical Benefit|2|||
149099519|NCT02654132|537844553|FG000|Treatment Period|Participant request to discontinue|2|||
149099520|NCT02654132|537844554|FG001|Treatment Period|Participant request to discontinue|0|||
149099521|NCT02654132|537844553|FG000|Treatment Period|Administrative reasons by sponsor|0|||
149099522|NCT02654132|537844554|FG001|Treatment Period|Administrative reasons by sponsor|1|||
149099523|NCT02654132|537844553|FG000|Treatment Period|Death|1|||
149099524|NCT02654132|537844554|FG001|Treatment Period|Death|0|||
149099525|NCT00909532|537844557|FG000|Overall Study|Adverse Event|4|||
149099526|NCT00909532|537844558|FG001|Overall Study|Adverse Event|1|||
149099527|NCT00909532|537844557|FG000|Overall Study|Pregnancy|0|||
149099528|NCT00909532|537844558|FG001|Overall Study|Pregnancy|1|||
149099529|NCT00909532|537844557|FG000|Overall Study|Prohibited Medication|2|||
149099530|NCT00909532|537844558|FG001|Overall Study|Prohibited Medication|1|||
149099531|NCT00909532|537844557|FG000|Overall Study|Withdrawal of Consent|1|||
149099532|NCT00909532|537844558|FG001|Overall Study|Withdrawal of Consent|1|||
149099533|NCT00909532|537844557|FG000|Overall Study|Noncompliance with Study Requirements|0|||
149099534|NCT00909532|537844558|FG001|Overall Study|Noncompliance with Study Requirements|2|||
149099535|NCT00909532|537844557|FG000|Overall Study|Physician Decision|1|||
149099536|NCT00909532|537844558|FG001|Overall Study|Physician Decision|0|||
149099537|NCT00909532|537844557|FG000|Overall Study|Wrong Genotype|1|||
149099538|NCT00909532|537844558|FG001|Overall Study|Wrong Genotype|0|||
149099539|NCT00909532|537844557|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
149099540|NCT00909532|537844558|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
149099541|NCT01209598|537844559|FG000|Overall Study|Withdrawal by Subject|1|||
149099542|NCT01209598|537844560|FG001|Overall Study|Withdrawal by Subject|0|||
149099543|NCT00934700|537844561|FG000|Overall Study|missing scan|5|||
149099544|NCT00934700|537844562|FG001|Overall Study|missing scan|9|||
149099545|NCT00934700|537844561|FG000|Overall Study|Death|8|||
149099546|NCT00934700|537844562|FG001|Overall Study|Death|3|||
149099547|NCT01639742|537846371|FG000|Overall Study|Study Ongoing|17|||
149099548|NCT01639742|537846371|FG000|Overall Study|Lost to Follow-up|1|||
149099549|NCT01266018|537846372|FG000|Overall Study|Physician Decision|1|||
149099550|NCT01266018|537846373|FG001|Overall Study|Physician Decision|0|||
149099551|NCT01266018|537846372|FG000|Overall Study|Progressive disease|0|||
149099552|NCT01266018|537846373|FG001|Overall Study|Progressive disease|1|||
149099553|NCT02370251|537846374|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
149099554|NCT02370251|537846374|FG000|Overall Study|Death|4|||
149099555|NCT04469465|537846375|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
149099556|NCT04469465|537846376|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
149099557|NCT04469465|537846375|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
149099558|NCT04469465|537846376|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
149099559|NCT04469465|537846375|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
149099560|NCT04469465|537846376|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
149099561|NCT04469465|537846375|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
149099562|NCT04469465|537846376|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
149099563|NCT04469465|537846375|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
149099564|NCT04469465|537846376|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
149099565|NCT04469465|537846375|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
149099566|NCT04469465|537846376|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
149099567|NCT04469465|537846375|FG000|Long-Term Extension (LTE)|Death|0|||
149099568|NCT04469465|537846376|FG001|Long-Term Extension (LTE)|Death|1|||
149099569|NCT04469465|537846375|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
149099570|NCT04469465|537846376|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
149099571|NCT04120376|537846377|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
149099572|NCT04120376|537846378|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
149099573|NCT02053610|537846379|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
149099574|NCT02053610|537846380|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
149099575|NCT02053610|537846379|FG000|Overall Study|Withdrew Consent|2|||
149099576|NCT02053610|537846380|FG001|Overall Study|Withdrew Consent|9|||
149099577|NCT02053610|537846379|FG000|Overall Study|Death|5|||
149099578|NCT02053610|537846380|FG001|Overall Study|Death|5|||
149099579|NCT02053610|537846379|FG000|Overall Study|Administrative/Other|1|||
149099580|NCT02053610|537846380|FG001|Overall Study|Administrative/Other|1|||
149099581|NCT02053610|537846379|FG000|Overall Study|Disease Progression|2|||
149099582|NCT02053610|537846380|FG001|Overall Study|Disease Progression|3|||
149099583|NCT02053610|537846379|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
149099584|NCT02053610|537846380|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
149099585|NCT02053610|537846379|FG000|Overall Study|Did not Receive Treatment|4|||
149099586|NCT02053610|537846380|FG001|Overall Study|Did not Receive Treatment|2|||
149099587|NCT02053610|537846379|FG000|Overall Study|Insufficient Therapeutic Response|1|||
149099588|NCT02053610|537846380|FG001|Overall Study|Insufficient Therapeutic Response|1|||
149099589|NCT02053610|537846379|FG000|Overall Study|Violation of Selection Criteria|1|||
149099590|NCT02053610|537846380|FG001|Overall Study|Violation of Selection Criteria|0|||
149099591|NCT02641587|537846381|FG000|Confinement Period|Adverse Event|1|||
149099592|NCT02641587|537846382|FG001|Confinement Period|Adverse Event|0|||
149099593|NCT02641587|537846381|FG000|Confinement Period|Withdrawal by Subject|2|||
149099594|NCT02641587|537846382|FG001|Confinement Period|Withdrawal by Subject|1|||
149099595|NCT02641587|537846381|FG000|Ambulatory Period|Withdrawal by Subject|1|||
149099596|NCT02641587|537846382|FG001|Ambulatory Period|Withdrawal by Subject|0|||
149099597|NCT01150045|537846384|FG000|Overall Study|Protocol Violation|0|||
149099598|NCT01150045|537846385|FG001|Overall Study|Protocol Violation|1|||
149099599|NCT01150045|537846386|FG002|Overall Study|Protocol Violation|0|||
149099600|NCT01150045|537846387|FG003|Overall Study|Protocol Violation|1|||
149099601|NCT00328562|537846391|FG000|Overall Study|Disease progression|1|||
149099602|NCT03305809|537846392|FG000|Overall Study|Adverse Event|2|||
149099603|NCT03305809|537846393|FG001|Overall Study|Adverse Event|2|||
149099604|NCT03305809|537846394|FG002|Overall Study|Adverse Event|6|||
149099605|NCT03305809|537846395|FG003|Overall Study|Adverse Event|6|||
149099606|NCT03305809|537846392|FG000|Overall Study|Death|0|||
149099607|NCT03305809|537846393|FG001|Overall Study|Death|0|||
149099608|NCT03305809|537846394|FG002|Overall Study|Death|1|||
149099609|NCT03305809|537846395|FG003|Overall Study|Death|1|||
149099610|NCT03305809|537846392|FG000|Overall Study|Lost to Follow-up|1|||
149099611|NCT03305809|537846393|FG001|Overall Study|Lost to Follow-up|2|||
149099612|NCT03305809|537846394|FG002|Overall Study|Lost to Follow-up|0|||
149099613|NCT03305809|537846395|FG003|Overall Study|Lost to Follow-up|0|||
149099614|NCT03305809|537846392|FG000|Overall Study|Sponsor Decision|1|||
149099615|NCT03305809|537846393|FG001|Overall Study|Sponsor Decision|0|||
149099616|NCT03305809|537846394|FG002|Overall Study|Sponsor Decision|1|||
149099617|NCT03305809|537846395|FG003|Overall Study|Sponsor Decision|8|||
149099618|NCT03305809|537846392|FG000|Overall Study|Physician Decision|0|||
149099619|NCT03305809|537846393|FG001|Overall Study|Physician Decision|0|||
149099620|NCT03305809|537846394|FG002|Overall Study|Physician Decision|2|||
149099621|NCT03305809|537846395|FG003|Overall Study|Physician Decision|4|||
149099622|NCT03305809|537846392|FG000|Overall Study|Progressive Disease|0|||
149099623|NCT03305809|537846393|FG001|Overall Study|Progressive Disease|0|||
149099624|NCT03305809|537846394|FG002|Overall Study|Progressive Disease|1|||
149099625|NCT03305809|537846395|FG003|Overall Study|Progressive Disease|0|||
149099626|NCT03305809|537846392|FG000|Overall Study|Protocol Violation|1|||
149099627|NCT03305809|537846393|FG001|Overall Study|Protocol Violation|0|||
149099628|NCT03305809|537846394|FG002|Overall Study|Protocol Violation|2|||
149099629|NCT03305809|537846395|FG003|Overall Study|Protocol Violation|3|||
149099630|NCT03305809|537846392|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
149099631|NCT03305809|537846393|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
149099632|NCT03305809|537846394|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
149099633|NCT03305809|537846395|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
149099634|NCT03305809|537846392|FG000|Overall Study|Withdrawal by Subject|2|||
149099635|NCT03305809|537846393|FG001|Overall Study|Withdrawal by Subject|4|||
149099636|NCT03305809|537846394|FG002|Overall Study|Withdrawal by Subject|5|||
149099637|NCT03305809|537846395|FG003|Overall Study|Withdrawal by Subject|2|||
149099638|NCT03305809|537846392|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
149099639|NCT03305809|537846393|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
149099640|NCT03305809|537846394|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
149099641|NCT03305809|537846395|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
149099642|NCT00816556|537846396|FG000|Overall Study|Adverse Event|1|||
149099643|NCT00816556|537846397|FG001|Overall Study|Adverse Event|1|||
149099644|NCT00816556|537846398|FG002|Overall Study|Adverse Event|1|||
149099645|NCT00816556|537846396|FG000|Overall Study|Withdrawal by Subject|1|||
149099646|NCT00816556|537846397|FG001|Overall Study|Withdrawal by Subject|1|||
149099647|NCT00816556|537846398|FG002|Overall Study|Withdrawal by Subject|1|||
149099648|NCT00816556|537846396|FG000|Overall Study|Lost to Follow-up|0|||
149099649|NCT00816556|537846397|FG001|Overall Study|Lost to Follow-up|0|||
149099650|NCT00816556|537846398|FG002|Overall Study|Lost to Follow-up|1|||
149099651|NCT00810342|537846399|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
149099652|NCT00810342|537846400|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
149099653|NCT00810342|537846399|FG000|Month 1 Follow-up|Pregnancy|1|||
149099654|NCT00810342|537846400|FG001|Month 1 Follow-up|Pregnancy|0|||
149099655|NCT00810342|537846399|FG000|6-month Follow-up|Lost to Follow-up|18|||
149099656|NCT00810342|537846400|FG001|6-month Follow-up|Lost to Follow-up|6|||
149099657|NCT00810342|537846399|FG000|6-month Follow-up|Pregnancy|6|||
149099658|NCT00810342|537846400|FG001|6-month Follow-up|Pregnancy|2|||
149099659|NCT00810342|537846399|FG000|12-month Followup|Pregnancy|9|||
149099660|NCT00810342|537846400|FG001|12-month Followup|Pregnancy|10|||
149099661|NCT00810342|537846399|FG000|12-month Followup|Lost to Follow-up|3|||
149099662|NCT00810342|537846400|FG001|12-month Followup|Lost to Follow-up|1|||
149099663|NCT03065933|537846401|FG000|Overall Study|study terminated|5|||
149099664|NCT04504630|537846402|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
149099665|NCT04504630|537846403|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
149099666|NCT04504630|537846402|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
149099667|NCT04504630|537846403|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
149099668|NCT02330562|537846404|FG000|Overall Study|Adverse Event|0|||
149099669|NCT02330562|537846405|FG001|Overall Study|Adverse Event|0|||
149099670|NCT02330562|537846406|FG002|Overall Study|Adverse Event|3|||
149099671|NCT02330562|537846407|FG003|Overall Study|Adverse Event|0|||
149099672|NCT02330562|537846408|FG004|Overall Study|Adverse Event|3|||
149099673|NCT02330562|537846409|FG005|Overall Study|Adverse Event|1|||
149099674|NCT02330562|537846410|FG006|Overall Study|Adverse Event|0|||
149099675|NCT02330562|537846411|FG007|Overall Study|Adverse Event|0|||
149099676|NCT02330562|537846412|FG008|Overall Study|Adverse Event|0|||
149099677|NCT02330562|537846413|FG009|Overall Study|Adverse Event|1|||
149099678|NCT02330562|537846414|FG010|Overall Study|Adverse Event|1|||
149099679|NCT02330562|537846404|FG000|Overall Study|Participant decision|1|||
149099680|NCT02330562|537846405|FG001|Overall Study|Participant decision|0|||
149099681|NCT02330562|537846406|FG002|Overall Study|Participant decision|4|||
149099682|NCT02330562|537846407|FG003|Overall Study|Participant decision|1|||
149099683|NCT02330562|537846408|FG004|Overall Study|Participant decision|5|||
149099684|NCT02330562|537846409|FG005|Overall Study|Participant decision|2|||
149099685|NCT02330562|537846410|FG006|Overall Study|Participant decision|0|||
149099686|NCT02330562|537846411|FG007|Overall Study|Participant decision|0|||
149099687|NCT02330562|537846412|FG008|Overall Study|Participant decision|0|||
149099688|NCT02330562|537846413|FG009|Overall Study|Participant decision|3|||
149099689|NCT02330562|537846414|FG010|Overall Study|Participant decision|0|||
149099690|NCT02330562|537846404|FG000|Overall Study|Disease progression|5|||
149099691|NCT02330562|537846405|FG001|Overall Study|Disease progression|3|||
149099692|NCT02330562|537846406|FG002|Overall Study|Disease progression|20|||
149099693|NCT02330562|537846407|FG003|Overall Study|Disease progression|28|||
149099694|NCT02330562|537846408|FG004|Overall Study|Disease progression|23|||
149099695|NCT02330562|537846409|FG005|Overall Study|Disease progression|7|||
149099696|NCT02330562|537846410|FG006|Overall Study|Disease progression|1|||
149099697|NCT02330562|537846411|FG007|Overall Study|Disease progression|1|||
149099698|NCT02330562|537846412|FG008|Overall Study|Disease progression|1|||
149099699|NCT02330562|537846413|FG009|Overall Study|Disease progression|0|||
149099700|NCT02330562|537846414|FG010|Overall Study|Disease progression|5|||
149099701|NCT02330562|537846404|FG000|Overall Study|Other reasons|0|||
149099702|NCT02330562|537846405|FG001|Overall Study|Other reasons|0|||
149099703|NCT02330562|537846406|FG002|Overall Study|Other reasons|0|||
149099704|NCT02330562|537846407|FG003|Overall Study|Other reasons|1|||
149099705|NCT02330562|537846408|FG004|Overall Study|Other reasons|0|||
149099706|NCT02330562|537846409|FG005|Overall Study|Other reasons|0|||
149099707|NCT02330562|537846410|FG006|Overall Study|Other reasons|0|||
149099708|NCT02330562|537846411|FG007|Overall Study|Other reasons|0|||
149099709|NCT02330562|537846412|FG008|Overall Study|Other reasons|0|||
149099710|NCT02330562|537846413|FG009|Overall Study|Other reasons|0|||
149099711|NCT02330562|537846414|FG010|Overall Study|Other reasons|0|||
149099712|NCT02330562|537846404|FG000|Overall Study|Withdrawal by Subject|0|||
149099713|NCT02330562|537846405|FG001|Overall Study|Withdrawal by Subject|0|||
149099714|NCT02330562|537846406|FG002|Overall Study|Withdrawal by Subject|0|||
149099715|NCT02330562|537846407|FG003|Overall Study|Withdrawal by Subject|0|||
149099716|NCT02330562|537846408|FG004|Overall Study|Withdrawal by Subject|0|||
149099717|NCT02330562|537846409|FG005|Overall Study|Withdrawal by Subject|0|||
149099718|NCT02330562|537846410|FG006|Overall Study|Withdrawal by Subject|0|||
149099719|NCT02330562|537846411|FG007|Overall Study|Withdrawal by Subject|0|||
149099720|NCT02330562|537846412|FG008|Overall Study|Withdrawal by Subject|0|||
149099721|NCT02330562|537846413|FG009|Overall Study|Withdrawal by Subject|1|||
149099722|NCT02330562|537846414|FG010|Overall Study|Withdrawal by Subject|0|||
149099723|NCT01288209|537846415|FG000|Overall Study|Withdrawal by Subject|1|||
149099724|NCT01288209|537846416|FG001|Overall Study|Withdrawal by Subject|3|||
149099725|NCT01288209|537846415|FG000|Overall Study|Other|1|||
149099726|NCT01288209|537846416|FG001|Overall Study|Other|0|||
149099727|NCT01496365|537846417|FG000|Overall Study|Adverse Event|2|||
149099728|NCT01496365|537846418|FG001|Overall Study|Adverse Event|3|||
149099729|NCT01496365|537846419|FG002|Overall Study|Adverse Event|3|||
149099730|NCT01496365|537846420|FG003|Overall Study|Adverse Event|2|||
149099731|NCT01496365|537846421|FG004|Overall Study|Adverse Event|5|||
149099732|NCT01496365|537846422|FG005|Overall Study|Adverse Event|6|||
149099733|NCT01496365|537846423|FG006|Overall Study|Adverse Event|4|||
149099734|NCT01496365|537846417|FG000|Overall Study|Withdrawal by Subject|6|||
149099735|NCT01496365|537846418|FG001|Overall Study|Withdrawal by Subject|6|||
149099736|NCT01496365|537846419|FG002|Overall Study|Withdrawal by Subject|0|||
149099737|NCT01496365|537846420|FG003|Overall Study|Withdrawal by Subject|1|||
149099738|NCT01496365|537846421|FG004|Overall Study|Withdrawal by Subject|3|||
149099739|NCT01496365|537846422|FG005|Overall Study|Withdrawal by Subject|2|||
149099740|NCT01496365|537846423|FG006|Overall Study|Withdrawal by Subject|1|||
149099741|NCT01496365|537846417|FG000|Overall Study|Protocol Violation|2|||
149099742|NCT01496365|537846418|FG001|Overall Study|Protocol Violation|1|||
149099743|NCT01496365|537846419|FG002|Overall Study|Protocol Violation|1|||
149099744|NCT01496365|537846420|FG003|Overall Study|Protocol Violation|0|||
149099745|NCT01496365|537846421|FG004|Overall Study|Protocol Violation|0|||
149099746|NCT01496365|537846422|FG005|Overall Study|Protocol Violation|1|||
149099747|NCT01496365|537846423|FG006|Overall Study|Protocol Violation|0|||
149099748|NCT01496365|537846417|FG000|Overall Study|Lack of Efficacy|1|||
149099749|NCT01496365|537846418|FG001|Overall Study|Lack of Efficacy|0|||
149099750|NCT01496365|537846419|FG002|Overall Study|Lack of Efficacy|0|||
149099751|NCT01496365|537846420|FG003|Overall Study|Lack of Efficacy|0|||
149099752|NCT01496365|537846421|FG004|Overall Study|Lack of Efficacy|0|||
149099753|NCT01496365|537846422|FG005|Overall Study|Lack of Efficacy|1|||
149099754|NCT01496365|537846423|FG006|Overall Study|Lack of Efficacy|0|||
149099755|NCT01496365|537846417|FG000|Overall Study|Lost to Follow-up|0|||
149099756|NCT01496365|537846418|FG001|Overall Study|Lost to Follow-up|1|||
149099757|NCT01496365|537846419|FG002|Overall Study|Lost to Follow-up|0|||
149099758|NCT01496365|537846420|FG003|Overall Study|Lost to Follow-up|0|||
149099759|NCT01496365|537846421|FG004|Overall Study|Lost to Follow-up|2|||
149099760|NCT01496365|537846422|FG005|Overall Study|Lost to Follow-up|0|||
149099761|NCT01496365|537846423|FG006|Overall Study|Lost to Follow-up|0|||
149099762|NCT01496365|537846417|FG000|Overall Study|Other|4|||
149099763|NCT01496365|537846418|FG001|Overall Study|Other|4|||
149099764|NCT01496365|537846419|FG002|Overall Study|Other|2|||
149099765|NCT01496365|537846420|FG003|Overall Study|Other|1|||
149099766|NCT01496365|537846421|FG004|Overall Study|Other|3|||
149099767|NCT01496365|537846422|FG005|Overall Study|Other|0|||
149099768|NCT01496365|537846423|FG006|Overall Study|Other|1|||
149099769|NCT01015677|537846424|FG000|Overall Study|Adverse Event|0|||
149099770|NCT01015677|537846425|FG001|Overall Study|Adverse Event|1|||
149099771|NCT01015677|537846426|FG002|Overall Study|Adverse Event|0|||
149099772|NCT01015677|537846424|FG000|Overall Study|Lack of Efficacy|0|||
149099773|NCT01015677|537846425|FG001|Overall Study|Lack of Efficacy|1|||
149099774|NCT01015677|537846426|FG002|Overall Study|Lack of Efficacy|0|||
149099775|NCT01015677|537846424|FG000|Overall Study|Protocol Violation|0|||
149099776|NCT01015677|537846425|FG001|Overall Study|Protocol Violation|1|||
149099777|NCT01015677|537846426|FG002|Overall Study|Protocol Violation|0|||
149099778|NCT01015677|537846424|FG000|Overall Study|Withdrawal by Subject|1|||
149099779|NCT01015677|537846425|FG001|Overall Study|Withdrawal by Subject|1|||
149099780|NCT01015677|537846426|FG002|Overall Study|Withdrawal by Subject|0|||
149099781|NCT02232399|537846427|FG000|Overall Study|Adverse Event|1|||
149099782|NCT02232399|537846428|FG001|Overall Study|Adverse Event|0|||
149099783|NCT02232399|537846427|FG000|Overall Study|Withdrawal by Subject|0|||
149099784|NCT02232399|537846428|FG001|Overall Study|Withdrawal by Subject|1|||
149099785|NCT01660256|537846429|FG000|Overall Study|Adverse Event|4|||
149099786|NCT01660256|537846430|FG001|Overall Study|Adverse Event|0|||
149099787|NCT01660256|537846431|FG002|Overall Study|Adverse Event|2|||
149099788|NCT01660256|537846429|FG000|Overall Study|Withdrawal by Subject|1|||
149099789|NCT01660256|537846430|FG001|Overall Study|Withdrawal by Subject|0|||
149099790|NCT01660256|537846431|FG002|Overall Study|Withdrawal by Subject|2|||
149099791|NCT02165397|537846435|FG000|Overall Study|Death|7|||
149099792|NCT02165397|537846436|FG001|Overall Study|Death|10|||
149099793|NCT02165397|537846437|FG002|Overall Study|Death|8|||
149099794|NCT02165397|537846435|FG000|Overall Study|Lost to Follow-up|1|||
149099795|NCT02165397|537846436|FG001|Overall Study|Lost to Follow-up|3|||
149099796|NCT02165397|537846437|FG002|Overall Study|Lost to Follow-up|0|||
149099797|NCT02165397|537846435|FG000|Overall Study|Withdrawal by Subject|6|||
149099798|NCT02165397|537846436|FG001|Overall Study|Withdrawal by Subject|6|||
149099799|NCT02165397|537846437|FG002|Overall Study|Withdrawal by Subject|1|||
149099800|NCT02165397|537846435|FG000|Overall Study|Other, Not Specified|0|||
149099801|NCT02165397|537846436|FG001|Overall Study|Other, Not Specified|0|||
149099802|NCT02165397|537846437|FG002|Overall Study|Other, Not Specified|1|||
149099803|NCT03297398|537846438|FG000|Overall Study|Sponsor's decision|6|||
149099804|NCT03297398|537846439|FG001|Overall Study|Sponsor's decision|9|||
149099805|NCT03297398|537846440|FG002|Overall Study|Sponsor's decision|7|||
149099806|NCT03297398|537846438|FG000|Overall Study|Adverse Event|1|||
149099807|NCT03297398|537846439|FG001|Overall Study|Adverse Event|4|||
149099808|NCT03297398|537846440|FG002|Overall Study|Adverse Event|4|||
149099809|NCT03297398|537846438|FG000|Overall Study|Withdrawal by Subject|1|||
149099810|NCT03297398|537846439|FG001|Overall Study|Withdrawal by Subject|2|||
149099811|NCT03297398|537846440|FG002|Overall Study|Withdrawal by Subject|2|||
149099812|NCT03297398|537846438|FG000|Overall Study|Protocol Violation|0|||
149099813|NCT03297398|537846439|FG001|Overall Study|Protocol Violation|2|||
149099814|NCT03297398|537846440|FG002|Overall Study|Protocol Violation|0|||
149099815|NCT03297398|537846438|FG000|Overall Study|Physician Decision|0|||
149099816|NCT03297398|537846439|FG001|Overall Study|Physician Decision|0|||
149099817|NCT03297398|537846440|FG002|Overall Study|Physician Decision|1|||
149099818|NCT03297398|537846438|FG000|Overall Study|Lost to Follow-up|0|||
149099819|NCT03297398|537846439|FG001|Overall Study|Lost to Follow-up|0|||
149099820|NCT03297398|537846440|FG002|Overall Study|Lost to Follow-up|1|||
149099821|NCT03481556|537846443|FG000|Overall Study|Adverse Event|1|||
149099822|NCT03481556|537846444|FG001|Overall Study|Adverse Event|0|||
149099823|NCT03481556|537846445|FG002|Overall Study|Adverse Event|0|||
149099824|NCT03481556|537846446|FG003|Overall Study|Adverse Event|0|||
149099825|NCT03481556|537846443|FG000|Overall Study|Death|4|||
149099826|NCT03481556|537846444|FG001|Overall Study|Death|2|||
149099827|NCT03481556|537846445|FG002|Overall Study|Death|3|||
149099828|NCT03481556|537846446|FG003|Overall Study|Death|16|||
149099829|NCT03481556|537846443|FG000|Overall Study|Study Terminated by Sponsor|10|||
149099830|NCT03481556|537846444|FG001|Overall Study|Study Terminated by Sponsor|5|||
149099831|NCT03481556|537846445|FG002|Overall Study|Study Terminated by Sponsor|2|||
149099832|NCT03481556|537846446|FG003|Overall Study|Study Terminated by Sponsor|9|||
149099833|NCT01316887|537846447|FG000|Overall Study|Adverse Event|13|||
149099834|NCT01316887|537846448|FG001|Overall Study|Adverse Event|21|||
149099835|NCT01316887|537846449|FG002|Overall Study|Adverse Event|17|||
149099836|NCT01316887|537846447|FG000|Overall Study|Lack of Efficacy|9|||
149099837|NCT01316887|537846448|FG001|Overall Study|Lack of Efficacy|3|||
149099838|NCT01316887|537846449|FG002|Overall Study|Lack of Efficacy|1|||
149099839|NCT01316887|537846447|FG000|Overall Study|Protocol Violation|2|||
149099840|NCT01316887|537846448|FG001|Overall Study|Protocol Violation|6|||
149099841|NCT01316887|537846449|FG002|Overall Study|Protocol Violation|6|||
149099842|NCT01316887|537846447|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
149099843|NCT01316887|537846448|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
149099844|NCT01316887|537846449|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
149099845|NCT01316887|537846447|FG000|Overall Study|Study Closed/Terminated|2|||
149099846|NCT01316887|537846448|FG001|Overall Study|Study Closed/Terminated|4|||
149099847|NCT01316887|537846449|FG002|Overall Study|Study Closed/Terminated|3|||
149099848|NCT01316887|537846447|FG000|Overall Study|Lost to Follow-up|1|||
149099849|NCT01316887|537846448|FG001|Overall Study|Lost to Follow-up|7|||
149099850|NCT01316887|537846449|FG002|Overall Study|Lost to Follow-up|5|||
149099851|NCT01316887|537846447|FG000|Overall Study|Withdrawal by Subject|8|||
149099852|NCT01316887|537846448|FG001|Overall Study|Withdrawal by Subject|16|||
149099853|NCT01316887|537846449|FG002|Overall Study|Withdrawal by Subject|15|||
149099854|NCT02172950|537846450|FG000|Overall Study|Physician Decision|3|||
149099855|NCT02172950|537846451|FG001|Overall Study|Physician Decision|3|||
149099856|NCT02172950|537846450|FG000|Overall Study|Lack of Efficacy|1|||
149099857|NCT02172950|537846451|FG001|Overall Study|Lack of Efficacy|0|||
149099858|NCT02172950|537846450|FG000|Overall Study|Adverse Event|4|||
149099859|NCT02172950|537846451|FG001|Overall Study|Adverse Event|1|||
149099860|NCT02172950|537846450|FG000|Overall Study|Withdrawal by Subject|10|||
149099861|NCT02172950|537846451|FG001|Overall Study|Withdrawal by Subject|0|||
149099862|NCT02172950|537846450|FG000|Overall Study|Protocol Violation|1|||
149099863|NCT02172950|537846451|FG001|Overall Study|Protocol Violation|0|||
149099864|NCT02172950|537846450|FG000|Overall Study|Lost to Follow-up|1|||
149099865|NCT02172950|537846451|FG001|Overall Study|Lost to Follow-up|0|||
149099866|NCT02172950|537846450|FG000|Overall Study|Death|1|||
149099867|NCT02172950|537846451|FG001|Overall Study|Death|0|||
149099868|NCT02172950|537846450|FG000|Overall Study|Patient traveling|1|||
149099869|NCT02172950|537846451|FG001|Overall Study|Patient traveling|0|||
149099870|NCT02172950|537846450|FG000|Overall Study|Patient went to other country|1|||
149099871|NCT02172950|537846451|FG001|Overall Study|Patient went to other country|0|||
149099872|NCT02172950|537846450|FG000|Overall Study|Patient relocated overseas|1|||
149099873|NCT02172950|537846451|FG001|Overall Study|Patient relocated overseas|1|||
149099874|NCT02172950|537846450|FG000|Overall Study|Patient moving|1|||
149099875|NCT02172950|537846451|FG001|Overall Study|Patient moving|0|||
149099876|NCT00107978|537846452|FG000|Overall Study|Adverse Event|1|||
149099877|NCT00107978|537846453|FG001|Overall Study|Adverse Event|5|||
149099878|NCT00107978|537846452|FG000|Overall Study|Death|3|||
149099879|NCT00107978|537846453|FG001|Overall Study|Death|3|||
149099880|NCT00107978|537846452|FG000|Overall Study|Lost to Follow-up|20|||
149099881|NCT00107978|537846453|FG001|Overall Study|Lost to Follow-up|28|||
149099882|NCT00107978|537846452|FG000|Overall Study|Withdrawal by Subject|4|||
149099883|NCT00107978|537846453|FG001|Overall Study|Withdrawal by Subject|9|||
149099884|NCT00107978|537846452|FG000|Overall Study|Protocol Violation|0|||
149099885|NCT00107978|537846453|FG001|Overall Study|Protocol Violation|1|||
149099886|NCT00107978|537846452|FG000|Overall Study|Other|5|||
149099887|NCT00107978|537846453|FG001|Overall Study|Other|4|||
149099888|NCT00350298|537846454|FG000|Overall Study|Death|7|||
149099889|NCT00350298|537846455|FG001|Overall Study|Death|8|||
149099890|NCT00350298|537846454|FG000|Overall Study|Lost to Follow-up|1|||
149099891|NCT00350298|537846455|FG001|Overall Study|Lost to Follow-up|2|||
149099892|NCT00350298|537846454|FG000|Overall Study|Withdrawal by Subject|1|||
149099893|NCT00350298|537846455|FG001|Overall Study|Withdrawal by Subject|3|||
149099894|NCT00853229|537846460|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
149099895|NCT00853229|537846461|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
149099896|NCT01777490|537846465|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
149099897|NCT01777490|537846466|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
149099898|NCT01777490|537846467|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
149099899|NCT01777490|537846468|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
149099900|NCT00585975|537846469|FG000|Overall Study|Withdrawal by Subject|3|||
149099901|NCT00585975|537846470|FG001|Overall Study|Withdrawal by Subject|3|||
149099902|NCT00585975|537846469|FG000|Overall Study|Lost to Follow-up|2|||
149099903|NCT00585975|537846470|FG001|Overall Study|Lost to Follow-up|1|||
149099904|NCT00585975|537846469|FG000|Overall Study|Enrollment met/over-enrolled|10|||
149099905|NCT00585975|537846470|FG001|Overall Study|Enrollment met/over-enrolled|9|||
149099906|NCT01006616|537846473|FG000|Period 1 (6 Months)|Adverse Event|10|||
149099907|NCT01006616|537846474|FG001|Period 1 (6 Months)|Adverse Event|31|||
149099908|NCT01006616|537846475|FG002|Period 1 (6 Months)|Adverse Event|37|||
149099909|NCT01006616|537846476|FG003|Period 1 (6 Months)|Adverse Event|9|||
149099910|NCT01006616|537846473|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
149099911|NCT01006616|537846474|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
149099912|NCT01006616|537846475|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
149099913|NCT01006616|537846476|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
149099914|NCT01006616|537846473|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
149099915|NCT01006616|537846474|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
149099916|NCT01006616|537846475|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
149099917|NCT01006616|537846476|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
149099918|NCT01006616|537846473|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
149099919|NCT01006616|537846474|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
149099920|NCT01006616|537846475|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
149099921|NCT01006616|537846476|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
149099922|NCT01006616|537846473|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
149099923|NCT01006616|537846474|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
149099924|NCT01006616|537846475|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
149099925|NCT01006616|537846476|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
149099926|NCT01006616|537846473|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
149099927|NCT01006616|537846474|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
149099928|NCT01006616|537846475|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
149099929|NCT01006616|537846476|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
149099930|NCT01006616|537846473|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
149099931|NCT01006616|537846474|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
149099932|NCT01006616|537846475|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
149099933|NCT01006616|537846476|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
149099934|NCT01006616|537846473|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
149099935|NCT01006616|537846474|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
149099936|NCT01006616|537846475|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
149099937|NCT01006616|537846476|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
149099938|NCT01006616|537846473|FG000|Period 1 (6 Months)|Not Treated|0|||
149099939|NCT01006616|537846474|FG001|Period 1 (6 Months)|Not Treated|0|||
149099940|NCT01006616|537846475|FG002|Period 1 (6 Months)|Not Treated|1|||
149099941|NCT01006616|537846476|FG003|Period 1 (6 Months)|Not Treated|1|||
149099942|NCT01006616|537846473|FG000|Period 2 (18 Months)|Adverse Event|6|||
149099943|NCT01006616|537846474|FG001|Period 2 (18 Months)|Adverse Event|6|||
149099944|NCT01006616|537846475|FG002|Period 2 (18 Months)|Adverse Event|6|||
149099945|NCT01006616|537846476|FG003|Period 2 (18 Months)|Adverse Event|4|||
149099946|NCT01006616|537846473|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
149099947|NCT01006616|537846474|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
149099948|NCT01006616|537846475|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
149099949|NCT01006616|537846476|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
149099950|NCT01006616|537846473|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
149099951|NCT01006616|537846474|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
149099952|NCT01006616|537846475|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
149099953|NCT01006616|537846476|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
149099954|NCT01006616|537846473|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
149099955|NCT01006616|537846474|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
149099956|NCT01006616|537846475|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
149099957|NCT01006616|537846476|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
149099958|NCT01006616|537846473|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
149099959|NCT01006616|537846474|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
149099960|NCT01006616|537846475|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
149099961|NCT01006616|537846476|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
149099962|NCT01006616|537846473|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
149099963|NCT01006616|537846474|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
149099964|NCT01006616|537846475|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
149099965|NCT01006616|537846476|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
149099966|NCT01006616|537846473|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
149099967|NCT01006616|537846474|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
149099968|NCT01006616|537846475|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
149099969|NCT01006616|537846476|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
149099970|NCT01006616|537846473|FG000|Period 2 (18 Months)|Study Terminated|63|||
149099971|NCT01006616|537846474|FG001|Period 2 (18 Months)|Study Terminated|46|||
149099972|NCT01006616|537846475|FG002|Period 2 (18 Months)|Study Terminated|44|||
149099973|NCT01006616|537846476|FG003|Period 2 (18 Months)|Study Terminated|70|||
149099974|NCT02777242|537846483|FG000|Overall Study|Other|2|||
149099975|NCT02777242|537846483|FG000|Overall Study|Lost to Follow-up|1|||
149099976|NCT02777242|537846483|FG000|Overall Study|Multiple|1|||
149099977|NCT02777242|537846483|FG000|Overall Study|Sponsor's request|1|||
149099978|NCT02777242|537846483|FG000|Overall Study|Withdrawal by Subject|1|||
149099979|NCT05178979|537846484|FG000|Overall Study|Death|0|||
149099980|NCT05178979|537846485|FG001|Overall Study|Death|5|||
149099981|NCT05178979|537846486|FG002|Overall Study|Death|0|||
149099982|NCT05178979|537846487|FG003|Overall Study|Death|3|||
149099983|NCT05178979|537846484|FG000|Overall Study|Adverse Event|0|||
149099984|NCT05178979|537846485|FG001|Overall Study|Adverse Event|1|||
149099985|NCT05178979|537846486|FG002|Overall Study|Adverse Event|0|||
149099986|NCT05178979|537846487|FG003|Overall Study|Adverse Event|0|||
149099987|NCT05178979|537846484|FG000|Overall Study|Lost to Follow-up|1|||
149099988|NCT05178979|537846485|FG001|Overall Study|Lost to Follow-up|8|||
149099989|NCT05178979|537846486|FG002|Overall Study|Lost to Follow-up|3|||
149099990|NCT05178979|537846487|FG003|Overall Study|Lost to Follow-up|8|||
149099991|NCT02299427|537846488|FG000|Overall Study|Withdrawal by Subject|1|||
149099992|NCT02299427|537846489|FG001|Overall Study|Withdrawal by Subject|0|||
149099993|NCT02299427|537846488|FG000|Overall Study|Lost to Follow-up|1|||
149099994|NCT02299427|537846489|FG001|Overall Study|Lost to Follow-up|3|||
149099995|NCT02299427|537846488|FG000|Overall Study|not adherent to dog website use|21|||
149099996|NCT02299427|537846489|FG001|Overall Study|not adherent to dog website use|0|||
149099997|NCT03269695|537846490|FG000|Overall Study|Adverse Event|2|||
149099998|NCT03269695|537846491|FG001|Overall Study|Adverse Event|1|||
149099999|NCT03269695|537846490|FG000|Overall Study|Lack of Efficacy|0|||
149100000|NCT03269695|537846491|FG001|Overall Study|Lack of Efficacy|1|||
149100001|NCT03269695|537846490|FG000|Overall Study|Withdrawal by Subject|0|||
149100002|NCT03269695|537846491|FG001|Overall Study|Withdrawal by Subject|1|||
149100003|NCT01313624|537846492|FG000|Double-Blind Phase|Adverse Event|27|||
149100004|NCT01313624|537846493|FG001|Double-Blind Phase|Adverse Event|4|||
149100005|NCT01313624|537846492|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
149100006|NCT01313624|537846493|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
149100007|NCT01313624|537846492|FG000|Double-Blind Phase|Lost to Follow-up|0|||
149100008|NCT01313624|537846493|FG001|Double-Blind Phase|Lost to Follow-up|2|||
149100009|NCT01313624|537846492|FG000|Double-Blind Phase|Physician Decision|1|||
149100010|NCT01313624|537846493|FG001|Double-Blind Phase|Physician Decision|0|||
149100011|NCT01313624|537846492|FG000|Double-Blind Phase|Lack of Efficacy|1|||
149100012|NCT01313624|537846493|FG001|Double-Blind Phase|Lack of Efficacy|0|||
149100013|NCT01313624|537846492|FG000|Open-Label Phase|Adverse Event|1|||
149100014|NCT01313624|537846493|FG001|Open-Label Phase|Adverse Event|10|||
149100015|NCT01313624|537846492|FG000|Open-Label Phase|Withdrawal by Subject|2|||
149100016|NCT01313624|537846493|FG001|Open-Label Phase|Withdrawal by Subject|2|||
149100017|NCT01313624|537846492|FG000|Open-Label Phase|Lost to Follow-up|1|||
149100018|NCT01313624|537846493|FG001|Open-Label Phase|Lost to Follow-up|1|||
149100019|NCT00104637|537846494|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
149100020|NCT00104637|537846495|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
149100021|NCT01017263|537846496|FG000|Overall Study|not eligible|12|||
149100022|NCT01880437|537846499|FG000|Overall Study|Death|12|||
149100023|NCT01880437|537846500|FG001|Overall Study|Death|4|||
149100024|NCT01880437|537846501|FG002|Overall Study|Death|17|||
149100025|NCT01880437|537846499|FG000|Overall Study|Study terminated by Sponsor|3|||
149100026|NCT01880437|537846500|FG001|Overall Study|Study terminated by Sponsor|0|||
149100027|NCT01880437|537846501|FG002|Overall Study|Study terminated by Sponsor|2|||
149100028|NCT03713320|537846502|FG000|Randomized Period|Adverse Event|1|||
149100029|NCT03713320|537846503|FG001|Randomized Period|Adverse Event|5|||
149100030|NCT03713320|537846504|FG002|Randomized Period|Adverse Event|0|||
149100031|NCT03713320|537846502|FG000|Randomized Period|Physician Decision|1|||
149100032|NCT03713320|537846503|FG001|Randomized Period|Physician Decision|1|||
149100033|NCT03713320|537846504|FG002|Randomized Period|Physician Decision|0|||
149100034|NCT03713320|537846502|FG000|Randomized Period|Withdrawal by Subject|4|||
149100035|NCT03713320|537846503|FG001|Randomized Period|Withdrawal by Subject|0|||
149100036|NCT03713320|537846504|FG002|Randomized Period|Withdrawal by Subject|0|||
149100037|NCT03713320|537846502|FG000|Randomized Period|Participant decision|3|||
149100038|NCT03713320|537846503|FG001|Randomized Period|Participant decision|1|||
149100039|NCT03713320|537846504|FG002|Randomized Period|Participant decision|0|||
149100040|NCT03713320|537846502|FG000|Randomized Period|Study terminated by sponsor|6|||
149100041|NCT03713320|537846503|FG001|Randomized Period|Study terminated by sponsor|3|||
149100042|NCT03713320|537846504|FG002|Randomized Period|Study terminated by sponsor|0|||
149100043|NCT03713320|537846502|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
149100044|NCT03713320|537846503|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
149100045|NCT03713320|537846504|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
149100046|NCT03713320|537846502|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
149100047|NCT03713320|537846503|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
149100048|NCT03713320|537846504|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
149100049|NCT00085566|537846505|FG000|Overall Study|Adverse Event|0|||
149100050|NCT00085566|537846506|FG001|Overall Study|Adverse Event|0|||
149100051|NCT00085566|537846507|FG002|Overall Study|Adverse Event|10|||
149100052|NCT00085566|537846505|FG000|Overall Study|Patient Not treated|0|||
149100053|NCT00085566|537846506|FG001|Overall Study|Patient Not treated|0|||
149100054|NCT00085566|537846507|FG002|Overall Study|Patient Not treated|3|||
149100055|NCT00085566|537846505|FG000|Overall Study|Clinical progression|0|||
149100056|NCT00085566|537846506|FG001|Overall Study|Clinical progression|0|||
149100057|NCT00085566|537846507|FG002|Overall Study|Clinical progression|1|||
149100058|NCT00087555|537846509|FG000|Overall Study|Adverse Event|3|||
149100059|NCT00087555|537846510|FG001|Overall Study|Adverse Event|6|||
149100060|NCT00087555|537846511|FG002|Overall Study|Adverse Event|14|||
149100061|NCT00087555|537846509|FG000|Overall Study|Lost to Follow-up|0|||
149100062|NCT00087555|537846510|FG001|Overall Study|Lost to Follow-up|1|||
149100063|NCT00087555|537846511|FG002|Overall Study|Lost to Follow-up|1|||
149100064|NCT00087555|537846509|FG000|Overall Study|Non - Compliance|1|||
149100065|NCT00087555|537846510|FG001|Overall Study|Non - Compliance|0|||
149100066|NCT00087555|537846511|FG002|Overall Study|Non - Compliance|0|||
149100067|NCT00087555|537846509|FG000|Overall Study|Protocol Violation|0|||
149100068|NCT00087555|537846510|FG001|Overall Study|Protocol Violation|0|||
149100069|NCT00087555|537846511|FG002|Overall Study|Protocol Violation|2|||
149100070|NCT00087555|537846509|FG000|Overall Study|Screen Failure|1|||
149100071|NCT00087555|537846510|FG001|Overall Study|Screen Failure|1|||
149100072|NCT00087555|537846511|FG002|Overall Study|Screen Failure|0|||
149100073|NCT00087555|537846509|FG000|Overall Study|Pregnancy|0|||
149100074|NCT00087555|537846510|FG001|Overall Study|Pregnancy|1|||
149100075|NCT00087555|537846511|FG002|Overall Study|Pregnancy|1|||
149100076|NCT00087555|537846509|FG000|Overall Study|Withdrawal by Subject|3|||
149100077|NCT00087555|537846510|FG001|Overall Study|Withdrawal by Subject|2|||
149100078|NCT00087555|537846511|FG002|Overall Study|Withdrawal by Subject|1|||
149100079|NCT00087555|537846509|FG000|Overall Study|Lack of Efficacy|2|||
149100080|NCT00087555|537846510|FG001|Overall Study|Lack of Efficacy|0|||
149100081|NCT00087555|537846511|FG002|Overall Study|Lack of Efficacy|1|||
149100082|NCT00087555|537846509|FG000|Overall Study|Non Compliance|0|||
149100083|NCT00087555|537846510|FG001|Overall Study|Non Compliance|0|||
149100084|NCT00087555|537846511|FG002|Overall Study|Non Compliance|1|||
149100085|NCT00087555|537846509|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
149100086|NCT00087555|537846510|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
149100087|NCT00087555|537846511|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
149100088|NCT00087555|537846509|FG000|Overall Study|Patient wanted to go back on Med|1|||
149100089|NCT00087555|537846510|FG001|Overall Study|Patient wanted to go back on Med|0|||
149100090|NCT00087555|537846511|FG002|Overall Study|Patient wanted to go back on Med|0|||
149100091|NCT05523219|537846512|FG000|Overall Study|Wrong inclusion|1|||
149100092|NCT05523219|537846512|FG000|Overall Study|Lost to Follow-up|7|||
149100093|NCT03772613|537846513|FG000|Overall Study|Lost to Follow-up|0|||
149100094|NCT03772613|537846514|FG001|Overall Study|Lost to Follow-up|1|||
149100095|NCT03772613|537846515|FG002|Overall Study|Lost to Follow-up|1|||
149100096|NCT00661713|537846516|FG000|Overall Study|Death|1|||
149100097|NCT00661713|537846517|FG001|Overall Study|Death|0|||
149100098|NCT00661713|537846518|FG002|Overall Study|Death|0|||
149100099|NCT00661713|537846519|FG003|Overall Study|Death|0|||
149100100|NCT00661713|537846520|FG004|Overall Study|Death|1|||
149100101|NCT00661713|537846521|FG005|Overall Study|Death|0|||
149100102|NCT00661713|537846522|FG006|Overall Study|Death|0|||
149100103|NCT00661713|537846523|FG007|Overall Study|Death|0|||
149100104|NCT00661713|537846516|FG000|Overall Study|Unable to Classify|1|||
149100105|NCT00661713|537846517|FG001|Overall Study|Unable to Classify|0|||
149100106|NCT00661713|537846518|FG002|Overall Study|Unable to Classify|0|||
149100107|NCT00661713|537846519|FG003|Overall Study|Unable to Classify|0|||
149100108|NCT00661713|537846520|FG004|Overall Study|Unable to Classify|0|||
149100109|NCT00661713|537846521|FG005|Overall Study|Unable to Classify|0|||
149100110|NCT00661713|537846522|FG006|Overall Study|Unable to Classify|0|||
149100111|NCT00661713|537846523|FG007|Overall Study|Unable to Classify|0|||
149100112|NCT00661713|537846516|FG000|Overall Study|Protocol Violation|1|||
149100113|NCT00661713|537846517|FG001|Overall Study|Protocol Violation|6|||
149100114|NCT00661713|537846518|FG002|Overall Study|Protocol Violation|3|||
149100115|NCT00661713|537846519|FG003|Overall Study|Protocol Violation|3|||
149100116|NCT00661713|537846520|FG004|Overall Study|Protocol Violation|0|||
149100117|NCT00661713|537846521|FG005|Overall Study|Protocol Violation|2|||
149100118|NCT00661713|537846522|FG006|Overall Study|Protocol Violation|2|||
149100119|NCT00661713|537846523|FG007|Overall Study|Protocol Violation|1|||
149100120|NCT00661713|537846516|FG000|Overall Study|Withdrawal by Subject|11|||
149100121|NCT00661713|537846517|FG001|Overall Study|Withdrawal by Subject|25|||
149100122|NCT00661713|537846518|FG002|Overall Study|Withdrawal by Subject|12|||
149100123|NCT00661713|537846519|FG003|Overall Study|Withdrawal by Subject|21|||
149100124|NCT00661713|537846520|FG004|Overall Study|Withdrawal by Subject|12|||
149100125|NCT00661713|537846521|FG005|Overall Study|Withdrawal by Subject|26|||
149100126|NCT00661713|537846522|FG006|Overall Study|Withdrawal by Subject|45|||
149100127|NCT00661713|537846523|FG007|Overall Study|Withdrawal by Subject|9|||
149100128|NCT00661713|537846516|FG000|Overall Study|Lost to Follow-up|2|||
149100129|NCT00661713|537846517|FG001|Overall Study|Lost to Follow-up|7|||
149100130|NCT00661713|537846518|FG002|Overall Study|Lost to Follow-up|2|||
149100131|NCT00661713|537846519|FG003|Overall Study|Lost to Follow-up|2|||
149100132|NCT00661713|537846520|FG004|Overall Study|Lost to Follow-up|5|||
149100133|NCT00661713|537846521|FG005|Overall Study|Lost to Follow-up|7|||
149100134|NCT00661713|537846522|FG006|Overall Study|Lost to Follow-up|14|||
149100135|NCT00661713|537846523|FG007|Overall Study|Lost to Follow-up|1|||
149100136|NCT00661713|537846516|FG000|Overall Study|Administrative Reason|0|||
149100137|NCT00661713|537846517|FG001|Overall Study|Administrative Reason|1|||
149100138|NCT00661713|537846518|FG002|Overall Study|Administrative Reason|0|||
149100139|NCT00661713|537846519|FG003|Overall Study|Administrative Reason|2|||
149100140|NCT00661713|537846520|FG004|Overall Study|Administrative Reason|2|||
149100141|NCT00661713|537846521|FG005|Overall Study|Administrative Reason|2|||
149100142|NCT00661713|537846522|FG006|Overall Study|Administrative Reason|1|||
149100143|NCT00661713|537846523|FG007|Overall Study|Administrative Reason|0|||
149100144|NCT00661713|537846516|FG000|Overall Study|Adverse Event|0|||
149100145|NCT00661713|537846517|FG001|Overall Study|Adverse Event|0|||
149100146|NCT00661713|537846518|FG002|Overall Study|Adverse Event|0|||
149100147|NCT00661713|537846519|FG003|Overall Study|Adverse Event|0|||
149100148|NCT00661713|537846520|FG004|Overall Study|Adverse Event|0|||
149100149|NCT00661713|537846521|FG005|Overall Study|Adverse Event|0|||
149100150|NCT00661713|537846522|FG006|Overall Study|Adverse Event|1|||
149100151|NCT00661713|537846523|FG007|Overall Study|Adverse Event|0|||
149100152|NCT00661713|537846516|FG000|Overall Study|Inappropriate Enrollment|0|||
149100153|NCT00661713|537846517|FG001|Overall Study|Inappropriate Enrollment|0|||
149100154|NCT00661713|537846518|FG002|Overall Study|Inappropriate Enrollment|0|||
149100155|NCT00661713|537846519|FG003|Overall Study|Inappropriate Enrollment|0|||
149100156|NCT00661713|537846520|FG004|Overall Study|Inappropriate Enrollment|0|||
149100157|NCT00661713|537846521|FG005|Overall Study|Inappropriate Enrollment|0|||
149100158|NCT00661713|537846522|FG006|Overall Study|Inappropriate Enrollment|1|||
149100159|NCT00661713|537846523|FG007|Overall Study|Inappropriate Enrollment|0|||
149100160|NCT04594733|537846525|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
149100161|NCT04594733|537846526|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
149100162|NCT04594733|537846525|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
149100163|NCT04594733|537846526|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
149100164|NCT04594733|537846525|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
149100165|NCT04594733|537846526|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
149100166|NCT00691678|537846533|FG000|Overall Study|Adverse Event|5|||
149100167|NCT00691678|537846533|FG000|Overall Study|life events, pain|11|||
149100168|NCT01251887|537846534|FG000|Overall Study|Scheduling conflict|1|||
149100169|NCT01251887|537846535|FG001|Overall Study|Scheduling conflict|2|||
149100170|NCT01251887|537846536|FG002|Overall Study|Scheduling conflict|2|||
149100171|NCT01251887|537846534|FG000|Overall Study|Physician Decision|0|||
149100172|NCT01251887|537846535|FG001|Overall Study|Physician Decision|1|||
149100173|NCT01251887|537846536|FG002|Overall Study|Physician Decision|0|||
149100174|NCT03049306|537846539|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
149100175|NCT03049306|537846540|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
149100176|NCT03151551|537846541|FG000|Open-Label Treatment Period|Adverse Event|0|||
149100177|NCT03151551|537846542|FG001|Open-Label Treatment Period|Adverse Event|2|||
149100178|NCT03151551|537846541|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
149100179|NCT03151551|537846542|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
149100180|NCT03151551|537846541|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
149100181|NCT03151551|537846542|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
149100182|NCT03151551|537846541|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
149100183|NCT03151551|537846542|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
149100184|NCT03151551|537846541|FG000|Open-Label Treatment Period|Physician Decision|3|||
149100185|NCT03151551|537846542|FG001|Open-Label Treatment Period|Physician Decision|0|||
149100186|NCT03151551|537846541|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
149100187|NCT03151551|537846542|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
149100188|NCT03151551|537846541|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
149100189|NCT03151551|537846542|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
149100190|NCT03151551|537846541|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
149100191|NCT03151551|537846542|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
149100192|NCT03151551|537846541|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
149100193|NCT03151551|537846542|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
149100194|NCT03151551|537846541|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
149100195|NCT03151551|537846542|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
149100196|NCT01190449|537846543|FG000|Overall Study|Ineligible|0|||
149100197|NCT01190449|537846544|FG001|Overall Study|Ineligible|4|||
149100198|NCT04811339|537846545|FG000|Overall Study|lack of transportation not wanting to return|4|||
149100199|NCT04811339|537846546|FG001|Overall Study|lack of transportation not wanting to return|8|||
149100200|NCT04811339|537846547|FG002|Overall Study|lack of transportation not wanting to return|0|||
149100201|NCT04811339|537846545|FG000|Overall Study|Adverse Event|3|||
149100202|NCT04811339|537846546|FG001|Overall Study|Adverse Event|0|||
149100203|NCT04811339|537846547|FG002|Overall Study|Adverse Event|0|||
149100204|NCT04811339|537846545|FG000|Overall Study|Lost to Follow-up|1|||
149100205|NCT04811339|537846546|FG001|Overall Study|Lost to Follow-up|0|||
149100206|NCT04811339|537846547|FG002|Overall Study|Lost to Follow-up|0|||
149100207|NCT04811339|537846545|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
149100208|NCT04811339|537846546|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
149100209|NCT04811339|537846547|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
149100210|NCT04811339|537846545|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
149100211|NCT04811339|537846546|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
149100212|NCT04811339|537846547|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
149100213|NCT04811339|537846545|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
149100214|NCT04811339|537846546|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
149100215|NCT04811339|537846547|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
149100216|NCT04811339|537846545|FG000|Overall Study|Withdrawal by Subject|0|||
149100217|NCT04811339|537846546|FG001|Overall Study|Withdrawal by Subject|3|||
149100218|NCT04811339|537846547|FG002|Overall Study|Withdrawal by Subject|0|||
149100219|NCT04811339|537846545|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
149100220|NCT04811339|537846546|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
149100221|NCT04811339|537846547|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
149100222|NCT04811339|537846545|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
149100223|NCT04811339|537846546|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
149100224|NCT04811339|537846547|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
149100225|NCT05896696|537846550|FG000|Overall Study|Screening Failure|7|||
149100226|NCT05896696|537846550|FG000|Overall Study|Withdrawal by Subject|2|||
149100227|NCT00903760|537848702|FG000|Overall Study|Disease Progression/Death|8|||
149100228|NCT00903760|537848703|FG001|Overall Study|Disease Progression/Death|6|||
149100229|NCT00903760|537848702|FG000|Overall Study|Stem Cell Transplant|8|||
149100230|NCT00903760|537848703|FG001|Overall Study|Stem Cell Transplant|4|||
149100231|NCT00903760|537848702|FG000|Overall Study|Physician Decision|1|||
149100232|NCT00903760|537848703|FG001|Overall Study|Physician Decision|2|||
149100233|NCT00903760|537848702|FG000|Overall Study|Death|0|||
149100234|NCT00903760|537848703|FG001|Overall Study|Death|1|||
149100235|NCT00903760|537848702|FG000|Overall Study|Lost to Follow-up|1|||
149100236|NCT00903760|537848703|FG001|Overall Study|Lost to Follow-up|0|||
149100237|NCT00903760|537848702|FG000|Overall Study|Withdrawal by Subject|1|||
149100238|NCT00903760|537848703|FG001|Overall Study|Withdrawal by Subject|2|||
149100239|NCT00903760|537848702|FG000|Overall Study|Off treatment for long period|0|||
149100240|NCT00903760|537848703|FG001|Overall Study|Off treatment for long period|1|||
149100241|NCT01256671|537848709|FG000|Overall Study|Adverse Event|29|||
149100242|NCT01256671|537848709|FG000|Overall Study|Lost to Follow-up|16|||
149100243|NCT01256671|537848709|FG000|Overall Study|Withdrawal by Subject|31|||
149100244|NCT01256671|537848709|FG000|Overall Study|Physician Decision|3|||
149100245|NCT01256671|537848709|FG000|Overall Study|Lack of Efficacy|4|||
149100246|NCT01256671|537848709|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
149100247|NCT04411186|537848710|FG000|Overall Study|Withdrawn due to protocol violation|0|||
149100248|NCT04411186|537848711|FG001|Overall Study|Withdrawn due to protocol violation|1|||
149100249|NCT01165177|537848712|FG000|Overall Study|Serious Adverse Event|227|||
149100250|NCT01165177|537848713|FG001|Overall Study|Serious Adverse Event|235|||
149100251|NCT01165177|537848712|FG000|Overall Study|Withdrawal by Subject|368|||
149100252|NCT01165177|537848713|FG001|Overall Study|Withdrawal by Subject|354|||
149100253|NCT01165177|537848712|FG000|Overall Study|Protocol Violation|19|||
149100254|NCT01165177|537848713|FG001|Overall Study|Protocol Violation|21|||
149100255|NCT01165177|537848712|FG000|Overall Study|Non-serious adverse event|30|||
149100256|NCT01165177|537848713|FG001|Overall Study|Non-serious adverse event|18|||
149100257|NCT01165177|537848712|FG000|Overall Study|Other unspecified reasons|47|||
149100258|NCT01165177|537848713|FG001|Overall Study|Other unspecified reasons|35|||
149100259|NCT01165177|537848712|FG000|Overall Study|Suspected HZ episode|0|||
149100260|NCT01165177|537848713|FG001|Overall Study|Suspected HZ episode|2|||
149100261|NCT01165177|537848712|FG000|Overall Study|Lost to Follow-up|183|||
149100262|NCT01165177|537848713|FG001|Overall Study|Lost to Follow-up|194|||
149100263|NCT01165177|537848712|FG000|Overall Study|Migrated/ moved from study area|48|||
149100264|NCT01165177|537848713|FG001|Overall Study|Migrated/ moved from study area|43|||
149100265|NCT00781937|537848715|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
149100266|NCT00781937|537848716|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
149100267|NCT00781937|537848715|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
149100268|NCT00781937|537848716|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
149100269|NCT00781937|537848715|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
149100270|NCT00781937|537848716|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
149100271|NCT00781937|537848715|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
149100272|NCT00781937|537848716|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
149100273|NCT00781937|537848715|FG000|Main Trial Period Through Week 56|Unclassified|10|||
149100274|NCT00781937|537848716|FG001|Main Trial Period Through Week 56|Unclassified|15|||
149100275|NCT00781937|537848715|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
149100276|NCT00781937|537848716|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
149100277|NCT00781937|537848715|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
149100278|NCT00781937|537848716|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
149100279|NCT02094898|537848722|FG000|Overall Study|Clinical Worsening|2|||
149100280|NCT02094898|537848722|FG000|Overall Study|Adverse Event|2|||
149100281|NCT02094898|537848722|FG000|Overall Study|Lack of Efficacy|1|||
149100282|NCT03520075|537848723|FG000|Phase 1 (Dose Escalation)|Death|2|||
149100283|NCT03520075|537848724|FG001|Phase 1 (Dose Escalation)|Death|2|||
149100284|NCT03520075|537848725|FG002|Phase 1 (Dose Escalation)|Death|3|||
149100285|NCT03520075|537848726|FG003|Phase 1 (Dose Escalation)|Death|2|||
149100286|NCT03520075|537848727|FG004|Phase 1 (Dose Escalation)|Death|6|||
149100287|NCT03520075|537848728|FG005|Phase 1 (Dose Escalation)|Death|5|||
149100288|NCT03520075|537848729|FG006|Phase 1 (Dose Escalation)|Death|3|||
149100289|NCT03520075|537848730|FG007|Phase 1 (Dose Escalation)|Death|2|||
149100290|NCT03520075|537848731|FG008|Phase 1 (Dose Escalation)|Death|3|||
149100291|NCT03520075|537848732|FG009|Phase 1 (Dose Escalation)|Death|1|||
149100292|NCT03520075|537848733|FG010|Phase 1 (Dose Escalation)|Death|5|||
149100293|NCT03520075|537848734|FG011|Phase 1 (Dose Escalation)|Death|7|||
149100294|NCT03520075|537848735|FG012|Phase 1 (Dose Escalation)|Death|11|||
149100295|NCT03520075|537848736|FG013|Phase 1 (Dose Escalation)|Death|0|||
149100296|NCT03520075|537848737|FG014|Phase 1 (Dose Escalation)|Death|0|||
149100297|NCT03520075|537848738|FG015|Phase 1 (Dose Escalation)|Death|0|||
149100298|NCT03520075|537848739|FG016|Phase 1 (Dose Escalation)|Death|0|||
149100299|NCT03520075|537848740|FG017|Phase 1 (Dose Escalation)|Death|0|||
149100300|NCT03520075|537848741|FG018|Phase 1 (Dose Escalation)|Death|0|||
149100301|NCT03520075|537848723|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
149100302|NCT03520075|537848724|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100303|NCT03520075|537848725|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100304|NCT03520075|537848726|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
149100305|NCT03520075|537848727|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
149100306|NCT03520075|537848728|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
149100307|NCT03520075|537848729|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100308|NCT03520075|537848730|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
149100309|NCT03520075|537848731|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100310|NCT03520075|537848732|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
149100311|NCT03520075|537848733|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100312|NCT03520075|537848734|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100313|NCT03520075|537848735|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
149100314|NCT03520075|537848736|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100315|NCT03520075|537848737|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100316|NCT03520075|537848738|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100317|NCT03520075|537848739|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100318|NCT03520075|537848740|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100319|NCT03520075|537848741|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
149100320|NCT03520075|537848723|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100321|NCT03520075|537848724|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
149100322|NCT03520075|537848725|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100323|NCT03520075|537848726|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
149100324|NCT03520075|537848727|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
149100325|NCT03520075|537848728|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100326|NCT03520075|537848729|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100327|NCT03520075|537848730|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100328|NCT03520075|537848731|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100329|NCT03520075|537848732|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100330|NCT03520075|537848733|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
149100331|NCT03520075|537848734|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100332|NCT03520075|537848735|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
149100333|NCT03520075|537848736|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100334|NCT03520075|537848737|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100335|NCT03520075|537848738|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100336|NCT03520075|537848739|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100337|NCT03520075|537848740|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100338|NCT03520075|537848741|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
149100339|NCT03520075|537848723|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100340|NCT03520075|537848724|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100341|NCT03520075|537848725|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100342|NCT03520075|537848726|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100343|NCT03520075|537848727|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100344|NCT03520075|537848728|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100345|NCT03520075|537848729|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100346|NCT03520075|537848730|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100347|NCT03520075|537848731|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100348|NCT03520075|537848732|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
149100349|NCT03520075|537848733|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100350|NCT03520075|537848734|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100351|NCT03520075|537848735|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
149100352|NCT03520075|537848736|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100353|NCT03520075|537848737|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100354|NCT03520075|537848738|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100355|NCT03520075|537848739|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100356|NCT03520075|537848740|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100357|NCT03520075|537848741|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
149100358|NCT03520075|537848723|FG000|Phase 2 (Dose Expansion)|Death|0|||
149100359|NCT03520075|537848724|FG001|Phase 2 (Dose Expansion)|Death|0|||
149100360|NCT03520075|537848725|FG002|Phase 2 (Dose Expansion)|Death|0|||
149100361|NCT03520075|537848726|FG003|Phase 2 (Dose Expansion)|Death|0|||
149100362|NCT03520075|537848727|FG004|Phase 2 (Dose Expansion)|Death|0|||
149100363|NCT03520075|537848728|FG005|Phase 2 (Dose Expansion)|Death|0|||
149100364|NCT03520075|537848729|FG006|Phase 2 (Dose Expansion)|Death|0|||
149100365|NCT03520075|537848730|FG007|Phase 2 (Dose Expansion)|Death|0|||
149100366|NCT03520075|537848731|FG008|Phase 2 (Dose Expansion)|Death|0|||
149100367|NCT03520075|537848732|FG009|Phase 2 (Dose Expansion)|Death|0|||
149100368|NCT03520075|537848733|FG010|Phase 2 (Dose Expansion)|Death|0|||
149100369|NCT03520075|537848734|FG011|Phase 2 (Dose Expansion)|Death|0|||
149100370|NCT03520075|537848735|FG012|Phase 2 (Dose Expansion)|Death|0|||
149100371|NCT03520075|537848736|FG013|Phase 2 (Dose Expansion)|Death|20|||
149100372|NCT03520075|537848737|FG014|Phase 2 (Dose Expansion)|Death|13|||
149100373|NCT03520075|537848738|FG015|Phase 2 (Dose Expansion)|Death|9|||
149100374|NCT03520075|537848739|FG016|Phase 2 (Dose Expansion)|Death|5|||
149100375|NCT03520075|537848740|FG017|Phase 2 (Dose Expansion)|Death|14|||
149100376|NCT03520075|537848741|FG018|Phase 2 (Dose Expansion)|Death|12|||
149100377|NCT03520075|537848723|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100378|NCT03520075|537848724|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100379|NCT03520075|537848725|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100380|NCT03520075|537848726|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100381|NCT03520075|537848727|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100382|NCT03520075|537848728|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100383|NCT03520075|537848729|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100384|NCT03520075|537848730|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100385|NCT03520075|537848731|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100386|NCT03520075|537848732|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100387|NCT03520075|537848733|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100388|NCT03520075|537848734|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100389|NCT03520075|537848735|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100390|NCT03520075|537848736|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
149100391|NCT03520075|537848737|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
149100392|NCT03520075|537848738|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
149100393|NCT03520075|537848739|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
149100394|NCT03520075|537848740|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
149100395|NCT03520075|537848741|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
149100396|NCT03520075|537848723|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100397|NCT03520075|537848724|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100398|NCT03520075|537848725|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100399|NCT03520075|537848726|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100400|NCT03520075|537848727|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100401|NCT03520075|537848728|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100402|NCT03520075|537848729|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100403|NCT03520075|537848730|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100404|NCT03520075|537848731|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100405|NCT03520075|537848732|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100406|NCT03520075|537848733|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100407|NCT03520075|537848734|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100408|NCT03520075|537848735|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100409|NCT03520075|537848736|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100410|NCT03520075|537848737|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149100411|NCT03520075|537848738|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149100412|NCT03520075|537848739|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100413|NCT03520075|537848740|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
149100414|NCT03520075|537848741|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
149100415|NCT03520075|537848723|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100416|NCT03520075|537848724|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100417|NCT03520075|537848725|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100418|NCT03520075|537848726|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100419|NCT03520075|537848727|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100420|NCT03520075|537848728|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100421|NCT03520075|537848729|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100422|NCT03520075|537848730|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100423|NCT03520075|537848731|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100424|NCT03520075|537848732|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100425|NCT03520075|537848733|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100426|NCT03520075|537848734|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100427|NCT03520075|537848735|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100428|NCT03520075|537848736|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
149100429|NCT03520075|537848737|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100430|NCT03520075|537848738|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100431|NCT03520075|537848739|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
149100432|NCT03520075|537848740|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
149100433|NCT03520075|537848741|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
149100434|NCT04014790|537848744|FG000|Overall Study|Death|4|||
149100435|NCT04014790|537848744|FG000|Overall Study|Adverse Event|1|||
149100436|NCT04014790|537848744|FG000|Overall Study|Withdrawal by Subject|1|||
149100437|NCT03546816|537848745|FG000|Overall Study|Adverse Event|5|||
149100438|NCT03546816|537848746|FG001|Overall Study|Adverse Event|3|||
149100439|NCT03546816|537848745|FG000|Overall Study|Lack of Efficacy|2|||
149100440|NCT03546816|537848746|FG001|Overall Study|Lack of Efficacy|4|||
149100441|NCT03546816|537848745|FG000|Overall Study|Pregnancy|1|||
149100442|NCT03546816|537848746|FG001|Overall Study|Pregnancy|0|||
149100443|NCT03546816|537848745|FG000|Overall Study|Physician Decision|2|||
149100444|NCT03546816|537848746|FG001|Overall Study|Physician Decision|0|||
149100445|NCT03546816|537848745|FG000|Overall Study|Withdrawal by Subject|8|||
149100446|NCT03546816|537848746|FG001|Overall Study|Withdrawal by Subject|10|||
149100447|NCT03546816|537848745|FG000|Overall Study|Lost to Follow-up|3|||
149100448|NCT03546816|537848746|FG001|Overall Study|Lost to Follow-up|2|||
149100449|NCT01657799|537848750|FG000|Overall Study|Adverse Event Related to progression|6|||
149100450|NCT01657799|537848751|FG001|Overall Study|Adverse Event Related to progression|8|||
149100451|NCT01657799|537848752|FG002|Overall Study|Adverse Event Related to progression|12|||
149100452|NCT01657799|537848750|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
149100453|NCT01657799|537848751|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
149100454|NCT01657799|537848752|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
149100455|NCT01657799|537848750|FG000|Overall Study|Withdrawal by Subject|13|||
149100456|NCT01657799|537848751|FG001|Overall Study|Withdrawal by Subject|10|||
149100457|NCT01657799|537848752|FG002|Overall Study|Withdrawal by Subject|10|||
149100458|NCT01657799|537848750|FG000|Overall Study|Lost to Follow-up|1|||
149100459|NCT01657799|537848751|FG001|Overall Study|Lost to Follow-up|0|||
149100460|NCT01657799|537848752|FG002|Overall Study|Lost to Follow-up|1|||
149100461|NCT01657799|537848750|FG000|Overall Study|Disease Progression|2|||
149100462|NCT01657799|537848751|FG001|Overall Study|Disease Progression|4|||
149100463|NCT01657799|537848752|FG002|Overall Study|Disease Progression|4|||
149100464|NCT01657799|537848750|FG000|Overall Study|Progressive Disease Clinical|7|||
149100465|NCT01657799|537848751|FG001|Overall Study|Progressive Disease Clinical|4|||
149100466|NCT01657799|537848752|FG002|Overall Study|Progressive Disease Clinical|7|||
149100467|NCT01657799|537848750|FG000|Overall Study|Radiographic & Clinical Progression|16|||
149100468|NCT01657799|537848751|FG001|Overall Study|Radiographic & Clinical Progression|11|||
149100469|NCT01657799|537848752|FG002|Overall Study|Radiographic & Clinical Progression|15|||
149100470|NCT01657799|537848750|FG000|Overall Study|Other|52|||
149100471|NCT01657799|537848751|FG001|Overall Study|Other|62|||
149100472|NCT01657799|537848752|FG002|Overall Study|Other|49|||
149100473|NCT01646385|537848762|FG000|Overall Study|Death|202|||
149100474|NCT01646385|537848763|FG001|Overall Study|Death|222|||
149100475|NCT01646385|537848762|FG000|Overall Study|Switched to alternate biologic|636|||
149100476|NCT01646385|537848763|FG001|Overall Study|Switched to alternate biologic|649|||
149100477|NCT02706951|537848764|FG000|Period 1|Adverse Event|1|||
149100478|NCT02706951|537848765|FG001|Period 1|Adverse Event|5|||
149100479|NCT02706951|537848766|FG002|Period 1|Adverse Event|3|||
149100480|NCT02706951|537848767|FG003|Period 1|Adverse Event|0|||
149100481|NCT02706951|537848768|FG004|Period 1|Adverse Event|0|||
149100482|NCT02706951|537848764|FG000|Period 1|Withdrawal by Subject|10|||
149100483|NCT02706951|537848765|FG001|Period 1|Withdrawal by Subject|6|||
149100484|NCT02706951|537848766|FG002|Period 1|Withdrawal by Subject|6|||
149100485|NCT02706951|537848767|FG003|Period 1|Withdrawal by Subject|0|||
149100486|NCT02706951|537848768|FG004|Period 1|Withdrawal by Subject|0|||
149100487|NCT02706951|537848764|FG000|Period 1|Lost to Follow-up|0|||
149100488|NCT02706951|537848765|FG001|Period 1|Lost to Follow-up|4|||
149100489|NCT02706951|537848766|FG002|Period 1|Lost to Follow-up|1|||
149100490|NCT02706951|537848767|FG003|Period 1|Lost to Follow-up|0|||
149100491|NCT02706951|537848768|FG004|Period 1|Lost to Follow-up|0|||
149100492|NCT02706951|537848764|FG000|Period 1|Other|2|||
149100493|NCT02706951|537848765|FG001|Period 1|Other|1|||
149100494|NCT02706951|537848766|FG002|Period 1|Other|0|||
149100495|NCT02706951|537848767|FG003|Period 1|Other|0|||
149100496|NCT02706951|537848768|FG004|Period 1|Other|0|||
149100497|NCT02706951|537848764|FG000|Period 2|Adverse Event|0|||
149100498|NCT02706951|537848765|FG001|Period 2|Adverse Event|0|||
149100499|NCT02706951|537848766|FG002|Period 2|Adverse Event|0|||
149100500|NCT02706951|537848767|FG003|Period 2|Adverse Event|25|||
149100501|NCT02706951|537848768|FG004|Period 2|Adverse Event|34|||
149100502|NCT02706951|537848764|FG000|Period 2|Withdrawal by Subject|0|||
149100503|NCT02706951|537848765|FG001|Period 2|Withdrawal by Subject|0|||
149100504|NCT02706951|537848766|FG002|Period 2|Withdrawal by Subject|0|||
149100505|NCT02706951|537848767|FG003|Period 2|Withdrawal by Subject|38|||
149100506|NCT02706951|537848768|FG004|Period 2|Withdrawal by Subject|44|||
149100507|NCT02706951|537848764|FG000|Period 2|Lost to Follow-up|0|||
149100508|NCT02706951|537848765|FG001|Period 2|Lost to Follow-up|0|||
149100509|NCT02706951|537848766|FG002|Period 2|Lost to Follow-up|0|||
149100510|NCT02706951|537848767|FG003|Period 2|Lost to Follow-up|17|||
149100511|NCT02706951|537848768|FG004|Period 2|Lost to Follow-up|9|||
149100512|NCT02706951|537848764|FG000|Period 2|COVID-19 Related|0|||
149100513|NCT02706951|537848765|FG001|Period 2|COVID-19 Related|0|||
149100514|NCT02706951|537848766|FG002|Period 2|COVID-19 Related|0|||
149100515|NCT02706951|537848767|FG003|Period 2|COVID-19 Related|1|||
149100516|NCT02706951|537848768|FG004|Period 2|COVID-19 Related|2|||
149100517|NCT02706951|537848764|FG000|Period 2|Other|0|||
149100518|NCT02706951|537848765|FG001|Period 2|Other|0|||
149100519|NCT02706951|537848766|FG002|Period 2|Other|0|||
149100520|NCT02706951|537848767|FG003|Period 2|Other|37|||
149100521|NCT02706951|537848768|FG004|Period 2|Other|31|||
149100522|NCT04294667|537848771|FG000|Overall Study|Lack of Efficacy|4|||
149100523|NCT04294667|537848772|FG001|Overall Study|Lack of Efficacy|4|||
149100524|NCT04294667|537848771|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
149100525|NCT04294667|537848772|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
149100526|NCT04294667|537848771|FG000|Overall Study|Patient has a Renal Flare|1|||
149100527|NCT04294667|537848772|FG001|Overall Study|Patient has a Renal Flare|0|||
149100528|NCT04294667|537848771|FG000|Overall Study|SLE Worsening|0|||
149100529|NCT04294667|537848772|FG001|Overall Study|SLE Worsening|1|||
149100530|NCT04294667|537848771|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
149100531|NCT04294667|537848772|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
149100532|NCT04294667|537848771|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
149100533|NCT04294667|537848772|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
149100534|NCT04294667|537848771|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
149100535|NCT04294667|537848772|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
149100536|NCT04294667|537848771|FG000|Overall Study|Subject Moved to Another State|0|||
149100537|NCT04294667|537848772|FG001|Overall Study|Subject Moved to Another State|1|||
149100538|NCT04294667|537848771|FG000|Overall Study|Adverse event, serious fatal|0|||
149100539|NCT04294667|537848772|FG001|Overall Study|Adverse event, serious fatal|1|||
149100540|NCT04294667|537848771|FG000|Overall Study|Adverse event, non-fatal|3|||
149100541|NCT04294667|537848772|FG001|Overall Study|Adverse event, non-fatal|4|||
149100542|NCT00611715|537848773|FG000|Overall Study|Disease Progression|24|||
149100543|NCT00611715|537848774|FG001|Overall Study|Disease Progression|4|||
149100544|NCT00611715|537848773|FG000|Overall Study|Withdrawal by Subject|5|||
149100545|NCT00611715|537848774|FG001|Overall Study|Withdrawal by Subject|1|||
149100546|NCT00611715|537848773|FG000|Overall Study|Adverse Event|9|||
149100547|NCT00611715|537848774|FG001|Overall Study|Adverse Event|1|||
149100548|NCT00611715|537848773|FG000|Overall Study|Death|1|||
149100549|NCT00611715|537848774|FG001|Overall Study|Death|0|||
149100550|NCT00611715|537848773|FG000|Overall Study|two patients are still on treatment|2|||
149100551|NCT00611715|537848774|FG001|Overall Study|two patients are still on treatment|0|||
149100552|NCT01841697|537848775|FG000|Overall Study|Death|0|||
149100553|NCT01841697|537848776|FG001|Overall Study|Death|1|||
149100554|NCT01841697|537848775|FG000|Overall Study|Lost to Follow-up|4|||
149100555|NCT01841697|537848776|FG001|Overall Study|Lost to Follow-up|1|||
149100556|NCT01841697|537848775|FG000|Overall Study|Withdrawal by Subject|16|||
149100557|NCT01841697|537848776|FG001|Overall Study|Withdrawal by Subject|16|||
149100558|NCT00233389|537848779|FG000|Overall Study|Adverse Event|5|||
149100559|NCT00233389|537848780|FG001|Overall Study|Adverse Event|5|||
149100560|NCT00233389|537848779|FG000|Overall Study|Lack of Efficacy|11|||
149100561|NCT00233389|537848780|FG001|Overall Study|Lack of Efficacy|8|||
149100562|NCT00233389|537848779|FG000|Overall Study|Lost to Follow-up|1|||
149100563|NCT00233389|537848780|FG001|Overall Study|Lost to Follow-up|1|||
149100564|NCT00233389|537848779|FG000|Overall Study|Physician Decision|1|||
149100565|NCT00233389|537848780|FG001|Overall Study|Physician Decision|0|||
149100566|NCT00233389|537848779|FG000|Overall Study|Protocol Violation|0|||
149100567|NCT00233389|537848780|FG001|Overall Study|Protocol Violation|1|||
149100568|NCT00233389|537848779|FG000|Overall Study|Withdrawal by Subject|0|||
149100569|NCT00233389|537848780|FG001|Overall Study|Withdrawal by Subject|1|||
149100570|NCT04962698|537848781|FG000|Motor Imagery|Technical difficulty|1|||
149100571|NCT04962698|537848782|FG001|Motor Imagery|Technical difficulty|0|||
149100572|NCT04962698|537848781|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
149100573|NCT04962698|537848782|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
149100574|NCT04962698|537848781|FG000|Kinesthetic MI|Technical difficulty|1|||
149100575|NCT04962698|537848782|FG001|Kinesthetic MI|Technical difficulty|0|||
149100576|NCT04962698|537848781|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
149100577|NCT04962698|537848782|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
149100578|NCT04962698|537848781|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
149100579|NCT04962698|537848782|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
149100580|NCT04962698|537848781|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
149100581|NCT04962698|537848782|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
149100582|NCT04962698|537848781|FG000|Virtual-hand Interaction|Technical difficulty|1|||
149100583|NCT04962698|537848782|FG001|Virtual-hand Interaction|Technical difficulty|0|||
149100584|NCT04962698|537848781|FG000|Robotic Action Observation|Technical difficulty|1|||
149100585|NCT04962698|537848782|FG001|Robotic Action Observation|Technical difficulty|0|||
149100586|NCT04962698|537848781|FG000|Rest|Technical difficulty|1|||
149100587|NCT04962698|537848782|FG001|Rest|Technical difficulty|0|||
149100588|NCT04962698|537848781|FG000|Rest|Exclusion criteria met after enrollment|0|||
149100589|NCT04962698|537848782|FG001|Rest|Exclusion criteria met after enrollment|2|||
149100590|NCT02312206|537848786|FG000|Overall Study|Adverse Event|3|||
149100591|NCT02312206|537848787|FG001|Overall Study|Adverse Event|6|||
149100592|NCT02312206|537848786|FG000|Overall Study|Withdrawal by Subject|6|||
149100593|NCT02312206|537848787|FG001|Overall Study|Withdrawal by Subject|6|||
149100594|NCT02312206|537848786|FG000|Overall Study|Physician Decision|7|||
149100595|NCT02312206|537848787|FG001|Overall Study|Physician Decision|6|||
149100596|NCT02312206|537848786|FG000|Overall Study|Death|31|||
149100597|NCT02312206|537848787|FG001|Overall Study|Death|36|||
149100598|NCT02312206|537848786|FG000|Overall Study|Study Terminated by Sponsor|81|||
149100599|NCT02312206|537848787|FG001|Overall Study|Study Terminated by Sponsor|74|||
149100600|NCT02312206|537848786|FG000|Overall Study|Patient transferred to hospice|0|||
149100601|NCT02312206|537848787|FG001|Overall Study|Patient transferred to hospice|1|||
149100602|NCT02312206|537848786|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
149100603|NCT02312206|537848787|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
149100604|NCT02312206|537848786|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
149100605|NCT02312206|537848787|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
149100606|NCT02312206|537848786|FG000|Overall Study|Disease Progression|1|||
149100607|NCT02312206|537848787|FG001|Overall Study|Disease Progression|0|||
149100608|NCT03082612|537848788|FG000|Overall Study|Lost to Follow-up|2|||
149100609|NCT03082612|537848789|FG001|Overall Study|Lost to Follow-up|0|||
149100610|NCT00992992|537848790|FG000|Overall Study|Lost to Follow-up|3|||
149100611|NCT00992992|537848790|FG000|Overall Study|Death|16|||
149100612|NCT00992992|537848790|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
149100613|NCT00992992|537848790|FG000|Overall Study|Sponsor Closed the Study|4|||
149100614|NCT00952848|537848791|FG000|Overall Study|Withdrawal by Subject|4|||
149100615|NCT00217022|537848792|FG000|Overall Study|Withdrawal by Subject|1|||
149100616|NCT00217022|537848793|FG001|Overall Study|Withdrawal by Subject|1|||
149100617|NCT00458393|537848794|FG000|Overall Study|Withdrawal by Subject|67|||
149100618|NCT00458393|537848795|FG001|Overall Study|Withdrawal by Subject|80|||
149100619|NCT00458393|537848794|FG000|Overall Study|Physician Decision|31|||
149100620|NCT00458393|537848795|FG001|Overall Study|Physician Decision|22|||
149100621|NCT00458393|537848794|FG000|Overall Study|Relocated|77|||
149100622|NCT00458393|537848795|FG001|Overall Study|Relocated|81|||
149100623|NCT00458393|537848794|FG000|Overall Study|Lost to Follow-up|115|||
149100624|NCT00458393|537848795|FG001|Overall Study|Lost to Follow-up|92|||
149100625|NCT00458393|537848794|FG000|Overall Study|Sites marked other on the form.|19|||
149100626|NCT00458393|537848795|FG001|Overall Study|Sites marked other on the form.|20|||
149100627|NCT02564718|537848802|FG000|Overall Study|Withdrew from treatment|0|||
149100628|NCT02564718|537848803|FG001|Overall Study|Withdrew from treatment|1|||
149100629|NCT03845075|537848804|FG000|Part 1 - DB|Withdrawal by Subject|1|||
149100630|NCT03845075|537848805|FG001|Part 1 - DB|Withdrawal by Subject|1|||
149100631|NCT03845075|537848806|FG002|Part 1 - DB|Withdrawal by Subject|0|||
149100632|NCT03845075|537848807|FG003|Part 1 - DB|Withdrawal by Subject|0|||
149100633|NCT03845075|537848804|FG000|Part 1 - DB|Adverse Event|0|||
149100634|NCT03845075|537848805|FG001|Part 1 - DB|Adverse Event|1|||
149100635|NCT03845075|537848806|FG002|Part 1 - DB|Adverse Event|0|||
149100636|NCT03845075|537848807|FG003|Part 1 - DB|Adverse Event|0|||
149100637|NCT03845075|537848804|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
149100638|NCT03845075|537848805|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
149100639|NCT03845075|537848806|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
149100640|NCT03845075|537848807|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
149100641|NCT01560871|537848808|FG000|Overall Study|transportation issues|2|||
149100642|NCT01560871|537848809|FG001|Overall Study|transportation issues|1|||
149100643|NCT01560871|537848808|FG000|Overall Study|relocation|1|||
149100644|NCT01560871|537848809|FG001|Overall Study|relocation|0|||
149100645|NCT01560871|537848808|FG000|Overall Study|readmission to a hospital|2|||
149100646|NCT01560871|537848809|FG001|Overall Study|readmission to a hospital|1|||
149100647|NCT01560871|537848808|FG000|Overall Study|Lost to Follow-up|1|||
149100648|NCT01560871|537848809|FG001|Overall Study|Lost to Follow-up|0|||
149100649|NCT00857233|537848810|FG000|Overall Study|Adverse Event|24|||
149100650|NCT00857233|537848810|FG000|Overall Study|Lack of Efficacy|1|||
149100651|NCT00857233|537848810|FG000|Overall Study|Non-compliance|1|||
149100652|NCT00857233|537848810|FG000|Overall Study|Withdrawal of Consent|9|||
149100653|NCT00857233|537848810|FG000|Overall Study|Lost to Follow-up|4|||
149100654|NCT00857233|537848810|FG000|Overall Study|Nursing Home Placement|14|||
149100655|NCT00857233|537848810|FG000|Overall Study|Other Reasons|2|||
149100656|NCT05043883|537848811|FG000|Overall Study|Minimum required measurements could not be taken|4|||
149100657|NCT02980705|537848812|FG000|Overall Study|Adverse Event|0|||
149100658|NCT02980705|537848813|FG001|Overall Study|Adverse Event|1|||
149100659|NCT02980705|537848812|FG000|Overall Study|Withdrawal by Subject|6|||
149100660|NCT02980705|537848813|FG001|Overall Study|Withdrawal by Subject|9|||
149100661|NCT02980705|537848812|FG000|Overall Study|withdrew participation|0|||
149100662|NCT02980705|537848813|FG001|Overall Study|withdrew participation|1|||
149100663|NCT02980705|537848812|FG000|Overall Study|Lost to Follow-up|2|||
149100664|NCT02980705|537848813|FG001|Overall Study|Lost to Follow-up|0|||
149100665|NCT00263575|537848814|FG000|Titration Period|Adverse Event|14|||
149100666|NCT00263575|537848814|FG000|Titration Period|Withdrawal by Subject|10|||
149100667|NCT00263575|537848814|FG000|Titration Period|Protocol Violation|9|||
149100668|NCT00263575|537848814|FG000|Titration Period|Sponsor Decision|2|||
149100669|NCT00263575|537848814|FG000|Titration Period|Other|2|||
149100670|NCT00263575|537848814|FG000|Titration Period|Lack of Efficacy|6|||
149100671|NCT00263575|537848814|FG000|Maintence Period|Adverse Event|23|||
149100672|NCT00263575|537848814|FG000|Maintence Period|Withdrawal by Subject|8|||
149100673|NCT00263575|537848814|FG000|Maintence Period|Protocol Violation|4|||
149100674|NCT00263575|537848814|FG000|Maintence Period|Lack of Efficacy|4|||
149100675|NCT00263575|537848814|FG000|Maintence Period|Physician Decision|6|||
149100676|NCT00263575|537848814|FG000|Maintence Period|Lost to Follow-up|1|||
149100677|NCT00263575|537848814|FG000|Maintence Period|Sponsor Decision|24|||
149100678|NCT00263575|537848814|FG000|Maintence Period|Other|7|||
149100679|NCT01130168|537848820|FG000|Period 1|Withdrawal by Subject|0|||
149100680|NCT01130168|537848821|FG001|Period 1|Withdrawal by Subject|1|||
149100681|NCT01130168|537848822|FG002|Period 1|Withdrawal by Subject|0|||
149100682|NCT01130168|537848823|FG003|Period 1|Withdrawal by Subject|1|||
149100683|NCT01130168|537848824|FG004|Period 1|Withdrawal by Subject|0|||
149100684|NCT01130168|537848825|FG005|Period 1|Withdrawal by Subject|0|||
149100685|NCT01130168|537848820|FG000|Period 1|Discontinued For Other Reason|0|||
149100686|NCT01130168|537848821|FG001|Period 1|Discontinued For Other Reason|0|||
149100687|NCT01130168|537848822|FG002|Period 1|Discontinued For Other Reason|1|||
149100688|NCT01130168|537848823|FG003|Period 1|Discontinued For Other Reason|1|||
149100689|NCT01130168|537848824|FG004|Period 1|Discontinued For Other Reason|0|||
149100690|NCT01130168|537848825|FG005|Period 1|Discontinued For Other Reason|0|||
149100691|NCT01130168|537848820|FG000|Period 1|Adverse Event|0|||
149100692|NCT01130168|537848821|FG001|Period 1|Adverse Event|0|||
149100693|NCT01130168|537848822|FG002|Period 1|Adverse Event|0|||
149100694|NCT01130168|537848823|FG003|Period 1|Adverse Event|1|||
149100695|NCT01130168|537848824|FG004|Period 1|Adverse Event|0|||
149100696|NCT01130168|537848825|FG005|Period 1|Adverse Event|0|||
149100697|NCT04354168|537848828|FG000|Overall Study|Lost to Follow-up|22|||
149100698|NCT01781832|537848829|FG000|Overall Study|Withdrawal by Subject|1|||
149100699|NCT02287233|537848830|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
149100700|NCT02287233|537848831|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
149100701|NCT02287233|537848832|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
149100702|NCT02287233|537848830|FG000|Overall Study|Adverse Event Related to Progression|0|||
149100703|NCT02287233|537848831|FG001|Overall Study|Adverse Event Related to Progression|2|||
149100704|NCT02287233|537848832|FG002|Overall Study|Adverse Event Related to Progression|8|||
149100705|NCT02287233|537848830|FG000|Overall Study|Physician Decision|1|||
149100706|NCT02287233|537848831|FG001|Overall Study|Physician Decision|2|||
149100707|NCT02287233|537848832|FG002|Overall Study|Physician Decision|4|||
149100708|NCT02287233|537848830|FG000|Overall Study|Progressive Disease with Death|0|||
149100709|NCT02287233|537848831|FG001|Overall Study|Progressive Disease with Death|0|||
149100710|NCT02287233|537848832|FG002|Overall Study|Progressive Disease with Death|10|||
149100711|NCT02287233|537848830|FG000|Overall Study|Progressive Disease Without Death|2|||
149100712|NCT02287233|537848831|FG001|Overall Study|Progressive Disease Without Death|3|||
149100713|NCT02287233|537848832|FG002|Overall Study|Progressive Disease Without Death|20|||
149100714|NCT02287233|537848830|FG000|Overall Study|Withdrawal by Subject|1|||
149100715|NCT02287233|537848831|FG001|Overall Study|Withdrawal by Subject|1|||
149100716|NCT02287233|537848832|FG002|Overall Study|Withdrawal by Subject|7|||
149100717|NCT02287233|537848830|FG000|Overall Study|Other|3|||
149100718|NCT02287233|537848831|FG001|Overall Study|Other|0|||
149100719|NCT02287233|537848832|FG002|Overall Study|Other|15|||
149100720|NCT02287233|537848830|FG000|Overall Study|Did Not Receive Treatment|0|||
149100721|NCT02287233|537848831|FG001|Overall Study|Did Not Receive Treatment|0|||
149100722|NCT02287233|537848832|FG002|Overall Study|Did Not Receive Treatment|2|||
149100723|NCT02804399|537848833|FG000|Period 2|Adverse Event|0|||
149100724|NCT02804399|537848834|FG001|Period 2|Adverse Event|1|||
149100725|NCT01774305|537848835|FG000|Overall Study|Physician Decision|1|||
149100726|NCT01774305|537848836|FG001|Overall Study|Physician Decision|0|||
149100727|NCT01157377|537848837|FG000|Overall Study|Lost to Follow-up|0|||
149100728|NCT01157377|537848838|FG001|Overall Study|Lost to Follow-up|0|||
149100729|NCT01157377|537848839|FG002|Overall Study|Lost to Follow-up|1|||
149100730|NCT01157377|537848840|FG003|Overall Study|Lost to Follow-up|0|||
149100731|NCT01157377|537848841|FG004|Overall Study|Lost to Follow-up|1|||
149100732|NCT01157377|537848842|FG005|Overall Study|Lost to Follow-up|1|||
149100733|NCT01157377|537848843|FG006|Overall Study|Lost to Follow-up|0|||
149100734|NCT01157377|537848837|FG000|Overall Study|Personal Reasons|2|||
149100735|NCT01157377|537848838|FG001|Overall Study|Personal Reasons|1|||
149100736|NCT01157377|537848839|FG002|Overall Study|Personal Reasons|0|||
149100737|NCT01157377|537848840|FG003|Overall Study|Personal Reasons|1|||
149100738|NCT01157377|537848841|FG004|Overall Study|Personal Reasons|0|||
149100739|NCT01157377|537848842|FG005|Overall Study|Personal Reasons|0|||
149100740|NCT01157377|537848843|FG006|Overall Study|Personal Reasons|0|||
149100741|NCT01157377|537848837|FG000|Overall Study|Protocol Violation|0|||
149100742|NCT01157377|537848838|FG001|Overall Study|Protocol Violation|0|||
149100743|NCT01157377|537848839|FG002|Overall Study|Protocol Violation|0|||
149100744|NCT01157377|537848840|FG003|Overall Study|Protocol Violation|0|||
149100745|NCT01157377|537848841|FG004|Overall Study|Protocol Violation|0|||
149100746|NCT01157377|537848842|FG005|Overall Study|Protocol Violation|1|||
149100747|NCT01157377|537848843|FG006|Overall Study|Protocol Violation|0|||
149100748|NCT01157377|537848837|FG000|Overall Study|Lack of Efficacy|0|||
149100749|NCT01157377|537848838|FG001|Overall Study|Lack of Efficacy|0|||
149100750|NCT01157377|537848839|FG002|Overall Study|Lack of Efficacy|0|||
149100751|NCT01157377|537848840|FG003|Overall Study|Lack of Efficacy|0|||
149100752|NCT01157377|537848841|FG004|Overall Study|Lack of Efficacy|0|||
149100753|NCT01157377|537848842|FG005|Overall Study|Lack of Efficacy|0|||
149100754|NCT01157377|537848843|FG006|Overall Study|Lack of Efficacy|1|||
149100755|NCT01157377|537848837|FG000|Overall Study|Other Miscellaneous Reasons|0|||
149100756|NCT01157377|537848838|FG001|Overall Study|Other Miscellaneous Reasons|2|||
149100757|NCT01157377|537848839|FG002|Overall Study|Other Miscellaneous Reasons|0|||
149100758|NCT01157377|537848840|FG003|Overall Study|Other Miscellaneous Reasons|0|||
149100759|NCT01157377|537848841|FG004|Overall Study|Other Miscellaneous Reasons|1|||
149100760|NCT01157377|537848842|FG005|Overall Study|Other Miscellaneous Reasons|1|||
149100761|NCT01157377|537848843|FG006|Overall Study|Other Miscellaneous Reasons|1|||
149100762|NCT00904722|537848846|FG000|Overall Study|Physician Decision|1|||
149100763|NCT01801982|537848850|FG000|Overall Study|Lost to Follow-up|1|||
149100764|NCT00727506|537848851|FG000|Overall Study|Adverse Event|0|||
149100765|NCT00727506|537848852|FG001|Overall Study|Adverse Event|0|||
149100766|NCT00727506|537848853|FG002|Overall Study|Adverse Event|4|||
149100767|NCT00727506|537848854|FG003|Overall Study|Adverse Event|4|||
149100768|NCT00727506|537848855|FG004|Overall Study|Adverse Event|1|||
149100769|NCT00727506|537848856|FG005|Overall Study|Adverse Event|8|||
149100770|NCT00727506|537848851|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
149100771|NCT00727506|537848852|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149100772|NCT00727506|537848853|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
149100773|NCT00727506|537848854|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149100774|NCT00727506|537848855|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149100775|NCT00727506|537848856|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
149100776|NCT00727506|537848851|FG000|Overall Study|Progressive disease|4|||
149100777|NCT00727506|537848852|FG001|Overall Study|Progressive disease|7|||
149100778|NCT00727506|537848853|FG002|Overall Study|Progressive disease|9|||
149100779|NCT00727506|537848854|FG003|Overall Study|Progressive disease|28|||
149100780|NCT00727506|537848855|FG004|Overall Study|Progressive disease|38|||
149100781|NCT00727506|537848856|FG005|Overall Study|Progressive disease|28|||
149100782|NCT00727506|537848851|FG000|Overall Study|Refused to continue medication|0|||
149100783|NCT00727506|537848852|FG001|Overall Study|Refused to continue medication|1|||
149100784|NCT00727506|537848853|FG002|Overall Study|Refused to continue medication|2|||
149100785|NCT00727506|537848854|FG003|Overall Study|Refused to continue medication|3|||
149100786|NCT00727506|537848855|FG004|Overall Study|Refused to continue medication|1|||
149100787|NCT00727506|537848856|FG005|Overall Study|Refused to continue medication|2|||
149100788|NCT00727506|537848851|FG000|Overall Study|Other reason not described above|0|||
149100789|NCT00727506|537848852|FG001|Overall Study|Other reason not described above|0|||
149100790|NCT00727506|537848853|FG002|Overall Study|Other reason not described above|1|||
149100791|NCT00727506|537848854|FG003|Overall Study|Other reason not described above|4|||
149100792|NCT00727506|537848855|FG004|Overall Study|Other reason not described above|1|||
149100793|NCT00727506|537848856|FG005|Overall Study|Other reason not described above|1|||
149100794|NCT01482429|537848857|FG000|Care Usual|Protocol Violation|0|||
149100795|NCT01482429|537848858|FG001|Care Usual|Protocol Violation|172|||
149100796|NCT01482429|537848857|FG000|Care Usual|Lost to Follow-up|0|||
149100797|NCT01482429|537848858|FG001|Care Usual|Lost to Follow-up|1|||
149100798|NCT01482429|537848857|FG000|Protocol|Protocol Violation|275|||
149100799|NCT01482429|537848858|FG001|Protocol|Protocol Violation|0|||
149100800|NCT03561597|537848859|FG000|Overall Study|Lost to Follow-up|20|||
149100801|NCT04887506|537848860|FG000|Overall Study|Death|1|||
149100802|NCT04887506|537848861|FG001|Overall Study|Death|1|||
149100803|NCT04887506|537848860|FG000|Overall Study|Withdrawal by Subject|0|||
149100804|NCT04887506|537848861|FG001|Overall Study|Withdrawal by Subject|3|||
149100805|NCT04887506|537848860|FG000|Overall Study|Adverse Event|4|||
149100806|NCT04887506|537848861|FG001|Overall Study|Adverse Event|3|||
149100807|NCT04887506|537848860|FG000|Overall Study|Other - Not Reported|1|||
149100808|NCT04887506|537848861|FG001|Overall Study|Other - Not Reported|1|||
149100809|NCT01024036|537848885|FG000|Blinded Treatment|Adverse Event|1|||
149100810|NCT01024036|537848886|FG001|Blinded Treatment|Adverse Event|1|||
149100811|NCT01024036|537848885|FG000|Blinded Treatment|Lack of Efficacy|16|||
149100812|NCT01024036|537848886|FG001|Blinded Treatment|Lack of Efficacy|14|||
149100813|NCT01024036|537848885|FG000|Blinded Treatment|Physician Decision|1|||
149100814|NCT01024036|537848886|FG001|Blinded Treatment|Physician Decision|0|||
149100815|NCT01024036|537848885|FG000|Blinded Treatment|Death|0|||
149100816|NCT01024036|537848886|FG001|Blinded Treatment|Death|2|||
149100817|NCT01024036|537848885|FG000|Blinded Treatment|Withdrawal by Subject|4|||
149100818|NCT01024036|537848886|FG001|Blinded Treatment|Withdrawal by Subject|3|||
149100819|NCT01024036|537848885|FG000|Unblinded Treatment|Adverse Event|0|||
149100820|NCT01024036|537848886|FG001|Unblinded Treatment|Adverse Event|1|||
149100821|NCT01024036|537848885|FG000|Unblinded Treatment|Lack of Efficacy|0|||
149100822|NCT01024036|537848886|FG001|Unblinded Treatment|Lack of Efficacy|2|||
149100823|NCT01024036|537848885|FG000|Follow-Up Period|Lost to Follow-up|1|||
149100824|NCT01024036|537848886|FG001|Follow-Up Period|Lost to Follow-up|1|||
149100825|NCT01024036|537848885|FG000|Follow-Up Period|Withdrawal by Subject|0|||
149100826|NCT01024036|537848886|FG001|Follow-Up Period|Withdrawal by Subject|1|||
149100827|NCT01024036|537848885|FG000|Follow-Up Period|Adverse Event|4|||
149100828|NCT01024036|537848886|FG001|Follow-Up Period|Adverse Event|1|||
149100829|NCT03167151|537850684|FG000|Overall Study|Withdrawal by Subject|1|||
149100830|NCT03167151|537850685|FG001|Overall Study|Withdrawal by Subject|0|||
149100831|NCT03167151|537850686|FG002|Overall Study|Withdrawal by Subject|0|||
149100832|NCT03167151|537850684|FG000|Overall Study|No evidence of tumour at surgery|0|||
149100833|NCT03167151|537850685|FG001|Overall Study|No evidence of tumour at surgery|1|||
149100834|NCT03167151|537850686|FG002|Overall Study|No evidence of tumour at surgery|1|||
149100835|NCT01458522|537850687|FG000|Overall Study|Withdrawal by Subject|2|||
149100836|NCT01458522|537850688|FG001|Overall Study|Withdrawal by Subject|2|||
149100837|NCT01458522|537850687|FG000|Overall Study|Physician Decision|1|||
149100838|NCT01458522|537850688|FG001|Overall Study|Physician Decision|9|||
149100839|NCT00516139|537850689|FG000|Overall Study|Adverse Event|27|||
149100840|NCT00516139|537850689|FG000|Overall Study|Lost to Follow-up|1|||
149100841|NCT00516139|537850689|FG000|Overall Study|Protocol Violation|1|||
149100842|NCT00516139|537850689|FG000|Overall Study|Withdrawal by Subject|8|||
149100843|NCT00516139|537850689|FG000|Overall Study|Lack of Efficacy|1|||
149100844|NCT00416598|537850690|FG000|Induction & Intensification|Adverse Event|38|||
149100845|NCT00416598|537850690|FG000|Induction & Intensification|Death|32|||
149100846|NCT00416598|537850690|FG000|Induction & Intensification|Withdrawal by Subject|46|||
149100847|NCT00416598|537850690|FG000|Induction & Intensification|Alternative Treatment|135|||
149100848|NCT00416598|537850690|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
149100849|NCT00416598|537850690|FG000|Induction & Intensification|Relapse/progression|29|||
149100850|NCT00416598|537850690|FG000|Induction & Intensification|Failed induction|87|||
149100851|NCT00416598|537850690|FG000|Decitabine Maintenance|Adverse Event|5|||
149100852|NCT00416598|537850690|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
149100853|NCT00416598|537850690|FG000|Decitabine Maintenance|Progression/relapse|38|||
149100854|NCT00416598|537850690|FG000|Decitabine Maintenance|Alternative treatment|2|||
149100855|NCT00416598|537850690|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
149100856|NCT02166476|537850697|FG000|Overall Study|Withdrawal by Subject|5|||
149100857|NCT02166476|537850698|FG001|Overall Study|Withdrawal by Subject|7|||
149100858|NCT02166476|537850697|FG000|Overall Study|Adverse Event|3|||
149100859|NCT02166476|537850698|FG001|Overall Study|Adverse Event|3|||
149100860|NCT02166476|537850697|FG000|Overall Study|Lost to Follow-up|5|||
149100861|NCT02166476|537850698|FG001|Overall Study|Lost to Follow-up|10|||
149100862|NCT02166476|537850697|FG000|Overall Study|Physician Decision|1|||
149100863|NCT02166476|537850698|FG001|Overall Study|Physician Decision|0|||
149100864|NCT02166476|537850697|FG000|Overall Study|Unable to Come for Visit|0|||
149100865|NCT02166476|537850698|FG001|Overall Study|Unable to Come for Visit|3|||
149100866|NCT04367480|537850705|FG000|Overall Study|Adverse Event|1|||
149100867|NCT04367480|537850706|FG001|Overall Study|Adverse Event|1|||
149100868|NCT04367480|537850705|FG000|Overall Study|Death|1|||
149100869|NCT04367480|537850706|FG001|Overall Study|Death|0|||
149100870|NCT04367480|537850705|FG000|Overall Study|Lost to Follow-up|1|||
149100871|NCT04367480|537850706|FG001|Overall Study|Lost to Follow-up|1|||
149100872|NCT04367480|537850705|FG000|Overall Study|Withdrawal by Subject|0|||
149100873|NCT04367480|537850706|FG001|Overall Study|Withdrawal by Subject|3|||
149100874|NCT04367480|537850705|FG000|Overall Study|App glitch during the study|1|||
149100875|NCT04367480|537850706|FG001|Overall Study|App glitch during the study|0|||
149100876|NCT04367480|537850705|FG000|Overall Study|Device Distribution Error|0|||
149100877|NCT04367480|537850706|FG001|Overall Study|Device Distribution Error|2|||
149100878|NCT04367480|537850705|FG000|Overall Study|Ineligible after Randomization|0|||
149100879|NCT04367480|537850706|FG001|Overall Study|Ineligible after Randomization|1|||
149100880|NCT04367480|537850705|FG000|Overall Study|Other Medical Reasons|0|||
149100881|NCT04367480|537850706|FG001|Overall Study|Other Medical Reasons|2|||
149100882|NCT03382561|537850707|FG000|Overall Study|Disease progression|47|||
149100883|NCT03382561|537850708|FG001|Overall Study|Disease progression|6|||
149100884|NCT03382561|537850707|FG000|Overall Study|Adverse Event|10|||
149100885|NCT03382561|537850708|FG001|Overall Study|Adverse Event|2|||
149100886|NCT03382561|537850707|FG000|Overall Study|Death|8|||
149100887|NCT03382561|537850708|FG001|Overall Study|Death|3|||
149100888|NCT03382561|537850707|FG000|Overall Study|Withdrawal by Subject|6|||
149100889|NCT03382561|537850708|FG001|Overall Study|Withdrawal by Subject|5|||
149100890|NCT03382561|537850707|FG000|Overall Study|Alternative therapy|2|||
149100891|NCT03382561|537850708|FG001|Overall Study|Alternative therapy|8|||
149100892|NCT03382561|537850707|FG000|Overall Study|Never started treatment|3|||
149100893|NCT03382561|537850708|FG001|Overall Study|Never started treatment|6|||
149100894|NCT03382561|537850707|FG000|Overall Study|Lack of Efficacy|0|||
149100895|NCT03382561|537850708|FG001|Overall Study|Lack of Efficacy|1|||
149100896|NCT03382561|537850707|FG000|Overall Study|Physician Decision|0|||
149100897|NCT03382561|537850708|FG001|Overall Study|Physician Decision|1|||
149100898|NCT03382561|537850707|FG000|Overall Study|Other complicating disease|0|||
149100899|NCT03382561|537850708|FG001|Overall Study|Other complicating disease|1|||
149100900|NCT01131104|537850709|FG000|Overall Study|Withdrawal by Subject|3|||
149100901|NCT01131104|537850709|FG000|Overall Study|Physician Decision|4|||
149100902|NCT01131104|537850709|FG000|Overall Study|Information Not Available|5|||
149100903|NCT01131104|537850709|FG000|Overall Study|No Information on Index Date of Onset|1|||
149100904|NCT04836559|537850712|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
149100905|NCT04836559|537850713|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
149100906|NCT04836559|537850714|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
149100907|NCT04836559|537850715|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
149100908|NCT04836559|537850716|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
149100909|NCT04836559|537850717|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
149100910|NCT04836559|537850718|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
149100911|NCT04836559|537850719|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
149100912|NCT04836559|537850712|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
149100913|NCT04836559|537850713|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
149100914|NCT04836559|537850714|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
149100915|NCT04836559|537850715|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
149100916|NCT04836559|537850716|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
149100917|NCT04836559|537850717|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
149100918|NCT04836559|537850718|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
149100919|NCT04836559|537850719|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
149100920|NCT04836559|537850712|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
149100921|NCT04836559|537850713|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100922|NCT04836559|537850714|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100923|NCT04836559|537850715|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100924|NCT04836559|537850716|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100925|NCT04836559|537850717|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100926|NCT04836559|537850718|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100927|NCT04836559|537850719|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
149100928|NCT04836559|537850712|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
149100929|NCT04836559|537850713|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100930|NCT04836559|537850714|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100931|NCT04836559|537850715|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100932|NCT04836559|537850716|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100933|NCT04836559|537850717|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100934|NCT04836559|537850718|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100935|NCT04836559|537850719|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
149100936|NCT04836559|537850712|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100937|NCT04836559|537850713|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100938|NCT04836559|537850714|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100939|NCT04836559|537850715|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
149100940|NCT04836559|537850716|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100941|NCT04836559|537850717|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100942|NCT04836559|537850718|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100943|NCT04836559|537850719|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
149100944|NCT04836559|537850712|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
149100945|NCT04836559|537850713|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
149100946|NCT04836559|537850714|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
149100947|NCT04836559|537850715|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
149100948|NCT04836559|537850716|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
149100949|NCT04836559|537850717|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
149100950|NCT04836559|537850718|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
149100951|NCT04836559|537850719|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
149100952|NCT04836559|537850712|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
149100953|NCT04836559|537850713|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
149100954|NCT04836559|537850714|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
149100955|NCT04836559|537850715|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
149100956|NCT04836559|537850716|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
149100957|NCT04836559|537850717|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
149100958|NCT04836559|537850718|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
149100959|NCT04836559|537850719|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
149100960|NCT04836559|537850712|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
149100961|NCT04836559|537850713|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
149100962|NCT04836559|537850714|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
149100963|NCT04836559|537850715|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
149100964|NCT04836559|537850716|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
149100965|NCT04836559|537850717|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
149100966|NCT04836559|537850718|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
149100967|NCT04836559|537850719|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
149100968|NCT04836559|537850712|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100969|NCT04836559|537850713|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100970|NCT04836559|537850714|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100971|NCT04836559|537850715|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100972|NCT04836559|537850716|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100973|NCT04836559|537850717|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100974|NCT04836559|537850718|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
149100975|NCT04836559|537850719|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
149100976|NCT00730015|537850720|FG000|Overall Study|Adverse Event|11|||
149100977|NCT00730015|537850721|FG001|Overall Study|Adverse Event|10|||
149100978|NCT00730015|537850722|FG002|Overall Study|Adverse Event|8|||
149100979|NCT00730015|537850720|FG000|Overall Study|Protocol Violation|2|||
149100980|NCT00730015|537850721|FG001|Overall Study|Protocol Violation|6|||
149100981|NCT00730015|537850722|FG002|Overall Study|Protocol Violation|4|||
149100982|NCT00730015|537850720|FG000|Overall Study|Withdrawal by Subject|12|||
149100983|NCT00730015|537850721|FG001|Overall Study|Withdrawal by Subject|12|||
149100984|NCT00730015|537850722|FG002|Overall Study|Withdrawal by Subject|8|||
149100985|NCT00730015|537850720|FG000|Overall Study|Lost to Follow-up|4|||
149100986|NCT00730015|537850721|FG001|Overall Study|Lost to Follow-up|10|||
149100987|NCT00730015|537850722|FG002|Overall Study|Lost to Follow-up|3|||
149100988|NCT00730015|537850720|FG000|Overall Study|Lack of Efficacy|1|||
149100989|NCT00730015|537850721|FG001|Overall Study|Lack of Efficacy|2|||
149100990|NCT00730015|537850722|FG002|Overall Study|Lack of Efficacy|8|||
149100991|NCT00730015|537850720|FG000|Overall Study|Other Reason|1|||
149100992|NCT00730015|537850721|FG001|Overall Study|Other Reason|0|||
149100993|NCT00730015|537850722|FG002|Overall Study|Other Reason|1|||
149100994|NCT01432626|537850723|FG000|Overall Study|LV function recovered|2|||
149100995|NCT01432626|537850723|FG000|Overall Study|Withdrawal by Subject|2|||
149100996|NCT01432626|537850723|FG000|Overall Study|Only 1 image competed|2|||
149100997|NCT01432626|537850723|FG000|Overall Study|Imaging agent not available|1|||
149100998|NCT05382039|537850724|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
149100999|NCT05382039|537850725|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
149101000|NCT05382039|537850726|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
149101001|NCT05382039|537850724|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
149101002|NCT05382039|537850725|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
149101003|NCT05382039|537850726|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
149101004|NCT05382039|537850724|FG000|Overall Study|waiting for confirmation|0|||
149101005|NCT05382039|537850725|FG001|Overall Study|waiting for confirmation|0|||
149101006|NCT05382039|537850726|FG002|Overall Study|waiting for confirmation|1|||
149101007|NCT03210519|537850729|FG000|Overall Study|Adverse Event|2|||
149101008|NCT03210519|537850730|FG001|Overall Study|Adverse Event|0|||
149101009|NCT02270671|537850731|FG000|Overall Study|Withdrawal by Subject|1|||
149101010|NCT02270671|537850732|FG001|Overall Study|Withdrawal by Subject|1|||
149101011|NCT02270671|537850731|FG000|Overall Study|Protocol Violation|0|||
149101012|NCT02270671|537850732|FG001|Overall Study|Protocol Violation|1|||
149101013|NCT02270671|537850731|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
149101014|NCT02270671|537850732|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
149101015|NCT02270671|537850731|FG000|Overall Study|Lost to Follow-up|2|||
149101016|NCT02270671|537850732|FG001|Overall Study|Lost to Follow-up|1|||
149101017|NCT00174447|537850733|FG000|Overall Study|Adverse Event|19|||
149101018|NCT00174447|537850733|FG000|Overall Study|Withdrawal by Subject|15|||
149101019|NCT00174447|537850733|FG000|Overall Study|Protocol Violation|1|||
149101020|NCT00174447|537850733|FG000|Overall Study|Lack of Efficacy|1|||
149101021|NCT00174447|537850733|FG000|Overall Study|Administrative reason/Other|2|||
149101022|NCT02229578|537850734|FG000|Overall Study|Withdrawal by Subject|1|||
149101023|NCT02229578|537850735|FG001|Overall Study|Withdrawal by Subject|3|||
149101024|NCT02229578|537850734|FG000|Overall Study|Protocol Violation|2|||
149101025|NCT02229578|537850735|FG001|Overall Study|Protocol Violation|0|||
149101026|NCT01777334|537850736|FG000|Overall Study|Adverse Event|18|||
149101027|NCT01777334|537850737|FG001|Overall Study|Adverse Event|14|||
149101028|NCT01777334|537850736|FG000|Overall Study|Lack of Efficacy|15|||
149101029|NCT01777334|537850737|FG001|Overall Study|Lack of Efficacy|29|||
149101030|NCT01777334|537850736|FG000|Overall Study|Protocol Violation|3|||
149101031|NCT01777334|537850737|FG001|Overall Study|Protocol Violation|7|||
149101032|NCT01777334|537850736|FG000|Overall Study|Lost to Follow-up|3|||
149101033|NCT01777334|537850737|FG001|Overall Study|Lost to Follow-up|2|||
149101034|NCT01777334|537850736|FG000|Overall Study|Withdrawal by Subject|14|||
149101035|NCT01777334|537850737|FG001|Overall Study|Withdrawal by Subject|11|||
149101036|NCT03603639|537850738|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
149101037|NCT03603639|537850739|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
149101038|NCT03603639|537850740|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
149101039|NCT03603639|537850741|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
149101040|NCT03603639|537850742|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
149101041|NCT03603639|537850743|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
149101042|NCT03603639|537850738|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
149101043|NCT03603639|537850739|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
149101044|NCT03603639|537850740|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
149101045|NCT03603639|537850741|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
149101046|NCT03603639|537850742|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
149101047|NCT03603639|537850743|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
149101048|NCT00727415|537850747|FG000|Phase I|Dose Limiting Toxicity|2|||
149101049|NCT00756457|537850749|FG000|Overall Study|Lost to Follow-up|1|||
149101050|NCT00756457|537850750|FG001|Overall Study|Lost to Follow-up|2|||
149101051|NCT03414047|537850754|FG000|Overall Study|Adverse Event|0|||
149101052|NCT03414047|537850755|FG001|Overall Study|Adverse Event|0|||
149101053|NCT03414047|537850756|FG002|Overall Study|Adverse Event|1|||
149101054|NCT03414047|537850757|FG003|Overall Study|Adverse Event|1|||
149101055|NCT03414047|537850754|FG000|Overall Study|Physician Decision|1|||
149101056|NCT03414047|537850755|FG001|Overall Study|Physician Decision|0|||
149101057|NCT03414047|537850756|FG002|Overall Study|Physician Decision|0|||
149101058|NCT03414047|537850757|FG003|Overall Study|Physician Decision|1|||
149101059|NCT03414047|537850754|FG000|Overall Study|Withdrawal by Subject|1|||
149101060|NCT03414047|537850755|FG001|Overall Study|Withdrawal by Subject|0|||
149101061|NCT03414047|537850756|FG002|Overall Study|Withdrawal by Subject|2|||
149101062|NCT03414047|537850757|FG003|Overall Study|Withdrawal by Subject|0|||
149101063|NCT04593823|537850758|FG000|Overall Study|Withdrawal by Subject|1|||
149101064|NCT04593823|537850759|FG001|Overall Study|Withdrawal by Subject|1|||
149101065|NCT04593823|537850758|FG000|Overall Study|Lost to Follow-up|0|||
149101066|NCT04593823|537850759|FG001|Overall Study|Lost to Follow-up|1|||
149101067|NCT02250534|537850760|FG000|Overall Study|Lost to Follow-up|18|||
149101068|NCT02250534|537850761|FG001|Overall Study|Lost to Follow-up|28|||
149101069|NCT02250534|537850762|FG002|Overall Study|Lost to Follow-up|33|||
149101070|NCT02250534|537850760|FG000|Overall Study|Personal reasons|7|||
149101071|NCT02250534|537850761|FG001|Overall Study|Personal reasons|8|||
149101072|NCT02250534|537850762|FG002|Overall Study|Personal reasons|14|||
149101073|NCT02250534|537850760|FG000|Overall Study|Adverse Event|6|||
149101074|NCT02250534|537850761|FG001|Overall Study|Adverse Event|3|||
149101075|NCT02250534|537850762|FG002|Overall Study|Adverse Event|8|||
149101076|NCT02250534|537850760|FG000|Overall Study|incarcerated|2|||
149101077|NCT02250534|537850761|FG001|Overall Study|incarcerated|1|||
149101078|NCT02250534|537850762|FG002|Overall Study|incarcerated|2|||
149101079|NCT02250534|537850760|FG000|Overall Study|Withdrawal by Subject|0|||
149101080|NCT02250534|537850761|FG001|Overall Study|Withdrawal by Subject|1|||
149101081|NCT02250534|537850762|FG002|Overall Study|Withdrawal by Subject|2|||
149101082|NCT02250534|537850760|FG000|Overall Study|Death|0|||
149101083|NCT02250534|537850761|FG001|Overall Study|Death|1|||
149101084|NCT02250534|537850762|FG002|Overall Study|Death|1|||
149101085|NCT02250534|537850760|FG000|Overall Study|Physician Decision|1|||
149101086|NCT02250534|537850761|FG001|Overall Study|Physician Decision|3|||
149101087|NCT02250534|537850762|FG002|Overall Study|Physician Decision|1|||
149101088|NCT02250534|537850760|FG000|Overall Study|Protocol Violation|1|||
149101089|NCT02250534|537850761|FG001|Overall Study|Protocol Violation|0|||
149101090|NCT02250534|537850762|FG002|Overall Study|Protocol Violation|1|||
149101091|NCT02250534|537850760|FG000|Overall Study|Reason unknown|1|||
149101092|NCT02250534|537850761|FG001|Overall Study|Reason unknown|0|||
149101093|NCT02250534|537850762|FG002|Overall Study|Reason unknown|0|||
149101094|NCT01253447|537850764|FG000|Overall Study|Adverse Event|2|||
149101095|NCT02108652|537850765|FG000|Overall Study|Death|253|||
149101096|NCT02108652|537850765|FG000|Overall Study|Lost to Follow-up|2|||
149101097|NCT02108652|537850765|FG000|Overall Study|Withdrawal by Subject|16|||
149101098|NCT02108652|537850765|FG000|Overall Study|Study Terminated By Sponsor|31|||
149101099|NCT02108652|537850765|FG000|Overall Study|Non-Compliance|1|||
149101100|NCT02108652|537850765|FG000|Overall Study|Physician Decision|6|||
149101101|NCT02108652|537850765|FG000|Overall Study|Progression Of Disease|1|||
149101102|NCT00537329|537850768|FG000|Overall Study|Death|10|||
149101103|NCT00537329|537850768|FG000|Overall Study|Adverse Event|3|||
149101104|NCT00537329|537850768|FG000|Overall Study|Lack of Efficacy|2|||
149101105|NCT00537329|537850768|FG000|Overall Study|Lost to Follow-up|6|||
149101106|NCT00537329|537850768|FG000|Overall Study|Withdrawal by Subject|4|||
149101107|NCT00537329|537850768|FG000|Overall Study|Other|1|||
149101108|NCT03599622|537850771|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
149101109|NCT03599622|537850772|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
149101110|NCT03599622|537850773|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
149101111|NCT03599622|537850774|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
149101112|NCT03599622|537850771|FG000|Pre-Treatment Period|Other reasons|1|||
149101113|NCT03599622|537850772|FG001|Pre-Treatment Period|Other reasons|1|||
149101114|NCT03599622|537850773|FG002|Pre-Treatment Period|Other reasons|1|||
149101115|NCT03599622|537850774|FG003|Pre-Treatment Period|Other reasons|0|||
149101116|NCT03599622|537850771|FG000|Treatment Period|Adverse Event|11|||
149101117|NCT03599622|537850772|FG001|Treatment Period|Adverse Event|20|||
149101118|NCT03599622|537850773|FG002|Treatment Period|Adverse Event|18|||
149101119|NCT03599622|537850774|FG003|Treatment Period|Adverse Event|2|||
149101120|NCT03599622|537850771|FG000|Treatment Period|Lack of Efficacy|18|||
149101121|NCT03599622|537850772|FG001|Treatment Period|Lack of Efficacy|12|||
149101122|NCT03599622|537850773|FG002|Treatment Period|Lack of Efficacy|13|||
149101123|NCT03599622|537850774|FG003|Treatment Period|Lack of Efficacy|2|||
149101124|NCT03599622|537850771|FG000|Treatment Period|Withdrawal by Subject|5|||
149101125|NCT03599622|537850772|FG001|Treatment Period|Withdrawal by Subject|11|||
149101126|NCT03599622|537850773|FG002|Treatment Period|Withdrawal by Subject|16|||
149101127|NCT03599622|537850774|FG003|Treatment Period|Withdrawal by Subject|1|||
149101128|NCT03599622|537850771|FG000|Treatment Period|Other reasons|4|||
149101129|NCT03599622|537850772|FG001|Treatment Period|Other reasons|6|||
149101130|NCT03599622|537850773|FG002|Treatment Period|Other reasons|7|||
149101131|NCT03599622|537850774|FG003|Treatment Period|Other reasons|0|||
149101132|NCT03599622|537850771|FG000|Treatment Period|Lost to Follow-up|1|||
149101133|NCT03599622|537850772|FG001|Treatment Period|Lost to Follow-up|0|||
149101134|NCT03599622|537850773|FG002|Treatment Period|Lost to Follow-up|0|||
149101135|NCT03599622|537850774|FG003|Treatment Period|Lost to Follow-up|0|||
149101136|NCT03599622|537850771|FG000|Treatment Period|Study terminated by sponsor|7|||
149101137|NCT03599622|537850772|FG001|Treatment Period|Study terminated by sponsor|20|||
149101138|NCT03599622|537850773|FG002|Treatment Period|Study terminated by sponsor|15|||
149101139|NCT03599622|537850774|FG003|Treatment Period|Study terminated by sponsor|0|||
149101140|NCT03599622|537850771|FG000|Treatment Period|Site terminated by sponsor|0|||
149101141|NCT03599622|537850772|FG001|Treatment Period|Site terminated by sponsor|1|||
149101142|NCT03599622|537850773|FG002|Treatment Period|Site terminated by sponsor|0|||
149101143|NCT03599622|537850774|FG003|Treatment Period|Site terminated by sponsor|0|||
149101144|NCT01278615|537850777|FG000|Overall Study|Withdrawal by Subject|2|||
149101145|NCT00905359|537850778|FG000|Overall Study|Lost to Follow-up|17|||
149101146|NCT00905359|537850779|FG001|Overall Study|Lost to Follow-up|10|||
149101147|NCT00905359|537850778|FG000|Overall Study|Death|2|||
149101148|NCT00905359|537850779|FG001|Overall Study|Death|0|||
149101149|NCT00905359|537850778|FG000|Overall Study|Withdrawal consent|5|||
149101150|NCT00905359|537850779|FG001|Overall Study|Withdrawal consent|6|||
149101151|NCT02138253|537850780|FG000|Overall Study|Adverse Event|3|||
149101152|NCT02138253|537850781|FG001|Overall Study|Adverse Event|3|||
149101153|NCT02138253|537850780|FG000|Overall Study|Lost to Follow-up|2|||
149101154|NCT02138253|537850781|FG001|Overall Study|Lost to Follow-up|1|||
149101155|NCT02138253|537850780|FG000|Overall Study|Physician Decision|2|||
149101156|NCT02138253|537850781|FG001|Overall Study|Physician Decision|0|||
149101157|NCT02138253|537850780|FG000|Overall Study|Non compliance|1|||
149101158|NCT02138253|537850781|FG001|Overall Study|Non compliance|0|||
149101159|NCT02138253|537850780|FG000|Overall Study|Withdrawal by Subject|1|||
149101160|NCT02138253|537850781|FG001|Overall Study|Withdrawal by Subject|0|||
149101161|NCT01918371|537850782|FG000|Overall Study|Missing Data|1|||
149101162|NCT01918371|537850783|FG001|Overall Study|Missing Data|1|||
149101163|NCT01006889|537850784|FG000|Overall Study|Withdrawal by Subject|3|||
149101164|NCT00243022|537850785|FG000|Overall Study|Withdrawal by Subject|1|||
149101165|NCT00243022|537850786|FG001|Overall Study|Withdrawal by Subject|0|||
149101166|NCT00243022|537850785|FG000|Overall Study|Death|1|||
149101167|NCT00243022|537850786|FG001|Overall Study|Death|0|||
149101168|NCT00243022|537850785|FG000|Overall Study|Difficult Travel Distance|0|||
149101169|NCT00243022|537850786|FG001|Overall Study|Difficult Travel Distance|1|||
149101170|NCT01390441|537850791|FG000|Treatment Period|Protocol Violation|0|||
149101171|NCT01390441|537850792|FG001|Treatment Period|Protocol Violation|1|||
149101172|NCT01390441|537850793|FG002|Treatment Period|Protocol Violation|0|||
149101173|NCT01390441|537850794|FG003|Treatment Period|Protocol Violation|0|||
149101174|NCT01390441|537850795|FG004|Treatment Period|Protocol Violation|0|||
149101175|NCT01390441|537850791|FG000|Treatment Period|Physician Decision|0|||
149101176|NCT01390441|537850792|FG001|Treatment Period|Physician Decision|0|||
149101177|NCT01390441|537850793|FG002|Treatment Period|Physician Decision|0|||
149101178|NCT01390441|537850794|FG003|Treatment Period|Physician Decision|1|||
149101179|NCT01390441|537850795|FG004|Treatment Period|Physician Decision|0|||
149101180|NCT01390441|537850791|FG000|Treatment Period|Lack of Efficacy|0|||
149101181|NCT01390441|537850792|FG001|Treatment Period|Lack of Efficacy|0|||
149101182|NCT01390441|537850793|FG002|Treatment Period|Lack of Efficacy|0|||
149101183|NCT01390441|537850794|FG003|Treatment Period|Lack of Efficacy|0|||
149101184|NCT01390441|537850795|FG004|Treatment Period|Lack of Efficacy|1|||
149101185|NCT01390441|537850791|FG000|Treatment Period|Unknown due to early stopping of study|0|||
149101186|NCT01390441|537850792|FG001|Treatment Period|Unknown due to early stopping of study|0|||
149101187|NCT01390441|537850793|FG002|Treatment Period|Unknown due to early stopping of study|8|||
149101188|NCT01390441|537850794|FG003|Treatment Period|Unknown due to early stopping of study|11|||
149101189|NCT01390441|537850795|FG004|Treatment Period|Unknown due to early stopping of study|7|||
149101190|NCT01390441|537850791|FG000|Treatment Period|Adverse Event|0|||
149101191|NCT01390441|537850792|FG001|Treatment Period|Adverse Event|0|||
149101192|NCT01390441|537850793|FG002|Treatment Period|Adverse Event|1|||
149101193|NCT01390441|537850794|FG003|Treatment Period|Adverse Event|1|||
149101194|NCT01390441|537850795|FG004|Treatment Period|Adverse Event|2|||
149101195|NCT01390441|537850791|FG000|Treatment Period|Withdrawal by Subject|0|||
149101196|NCT01390441|537850792|FG001|Treatment Period|Withdrawal by Subject|0|||
149101197|NCT01390441|537850793|FG002|Treatment Period|Withdrawal by Subject|1|||
149101198|NCT01390441|537850794|FG003|Treatment Period|Withdrawal by Subject|0|||
149101199|NCT01390441|537850795|FG004|Treatment Period|Withdrawal by Subject|1|||
149101200|NCT01390441|537850791|FG000|Treatment Period|Lost to Follow-up|1|||
149101201|NCT01390441|537850792|FG001|Treatment Period|Lost to Follow-up|0|||
149101202|NCT01390441|537850793|FG002|Treatment Period|Lost to Follow-up|0|||
149101203|NCT01390441|537850794|FG003|Treatment Period|Lost to Follow-up|0|||
149101204|NCT01390441|537850795|FG004|Treatment Period|Lost to Follow-up|0|||
149101205|NCT01390441|537850791|FG000|Extension Period|Protocol Violation|3|||
149101206|NCT01390441|537850792|FG001|Extension Period|Protocol Violation|1|||
149101207|NCT01390441|537850793|FG002|Extension Period|Protocol Violation|0|||
149101208|NCT01390441|537850794|FG003|Extension Period|Protocol Violation|1|||
149101209|NCT01390441|537850795|FG004|Extension Period|Protocol Violation|0|||
149101210|NCT00621192|537850796|FG000|Overall Study|Withdrawal by Subject|0|||
149101211|NCT00621192|537850797|FG001|Overall Study|Withdrawal by Subject|0|||
149101212|NCT00621192|537850798|FG002|Overall Study|Withdrawal by Subject|2|||
149101213|NCT00621192|537850799|FG003|Overall Study|Withdrawal by Subject|0|||
149101214|NCT00621192|537850796|FG000|Overall Study|Physician Decision|1|||
149101215|NCT00621192|537850797|FG001|Overall Study|Physician Decision|3|||
149101216|NCT00621192|537850798|FG002|Overall Study|Physician Decision|0|||
149101217|NCT00621192|537850799|FG003|Overall Study|Physician Decision|0|||
149101218|NCT00621192|537850796|FG000|Overall Study|Protocol Violation|1|||
149101219|NCT00621192|537850797|FG001|Overall Study|Protocol Violation|0|||
149101220|NCT00621192|537850798|FG002|Overall Study|Protocol Violation|0|||
149101221|NCT00621192|537850799|FG003|Overall Study|Protocol Violation|1|||
149101222|NCT00621192|537850796|FG000|Overall Study|Adverse Event|0|||
149101223|NCT00621192|537850797|FG001|Overall Study|Adverse Event|1|||
149101224|NCT00621192|537850798|FG002|Overall Study|Adverse Event|0|||
149101225|NCT00621192|537850799|FG003|Overall Study|Adverse Event|1|||
149101226|NCT00621192|537850796|FG000|Overall Study|Death|2|||
149101227|NCT00621192|537850797|FG001|Overall Study|Death|5|||
149101228|NCT00621192|537850798|FG002|Overall Study|Death|0|||
149101229|NCT00621192|537850799|FG003|Overall Study|Death|0|||
149101230|NCT00621192|537850796|FG000|Overall Study|Final Assessments not Completed|0|||
149101231|NCT00621192|537850797|FG001|Overall Study|Final Assessments not Completed|0|||
149101232|NCT00621192|537850798|FG002|Overall Study|Final Assessments not Completed|3|||
149101233|NCT00621192|537850799|FG003|Overall Study|Final Assessments not Completed|1|||
149101234|NCT04706793|537850800|FG000|Treatment|Disease worsening|10|||
149101235|NCT04706793|537850801|FG001|Treatment|Disease worsening|10|||
149101236|NCT04706793|537850800|FG000|Follow-up|Lack of Efficacy|1|||
149101237|NCT04706793|537850801|FG001|Follow-up|Lack of Efficacy|0|||
149101238|NCT04706793|537850800|FG000|Follow-up|Disease worsening|8|||
149101239|NCT04706793|537850801|FG001|Follow-up|Disease worsening|10|||
149101240|NCT04706793|537850800|FG000|Follow-up|Adverse Event|1|||
149101241|NCT04706793|537850801|FG001|Follow-up|Adverse Event|0|||
149101242|NCT00823836|537850804|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
149101243|NCT00823836|537850805|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
149101244|NCT00823836|537850804|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
149101245|NCT00823836|537850805|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
149101246|NCT00823836|537850804|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
149101247|NCT00823836|537850805|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
149101248|NCT00823836|537850804|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
149101249|NCT00823836|537850805|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
149101250|NCT00823836|537850804|FG000|Long-term Phase|Adverse Event|3|||
149101251|NCT00823836|537850805|FG001|Long-term Phase|Adverse Event|2|||
149101252|NCT00823836|537850804|FG000|Long-term Phase|Physician Decision|1|||
149101253|NCT00823836|537850805|FG001|Long-term Phase|Physician Decision|2|||
149101254|NCT00823836|537850804|FG000|Long-term Phase|Withdrawal by Subject|1|||
149101255|NCT00823836|537850805|FG001|Long-term Phase|Withdrawal by Subject|1|||
149101256|NCT01099579|537850806|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
149101257|NCT01099579|537850807|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
149101258|NCT01099579|537850808|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
149101259|NCT01099579|537850806|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
149101260|NCT01099579|537850807|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
149101261|NCT01099579|537850808|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
149101262|NCT01099579|537850806|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
149101263|NCT01099579|537850807|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
149101264|NCT01099579|537850808|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
149101265|NCT01099579|537850806|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
149101266|NCT01099579|537850807|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
149101267|NCT01099579|537850808|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
149101268|NCT01099579|537850806|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
149101269|NCT01099579|537850807|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
149101270|NCT01099579|537850808|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
149101271|NCT01099579|537850806|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
149101272|NCT01099579|537850807|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
149101273|NCT01099579|537850808|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
149101274|NCT01099579|537850806|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
149101275|NCT01099579|537850807|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
149101276|NCT01099579|537850808|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
149101277|NCT01099579|537850806|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
149101278|NCT01099579|537850807|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
149101279|NCT01099579|537850808|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
149101280|NCT01099579|537850806|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
149101281|NCT01099579|537850807|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
149101282|NCT01099579|537850808|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
149101283|NCT01099579|537850806|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
149101284|NCT01099579|537850807|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
149101285|NCT01099579|537850808|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
149101286|NCT02725528|537850809|FG000|Overall Study|Lost to Follow-up|1|||
149101287|NCT02725528|537850810|FG001|Overall Study|Lost to Follow-up|4|||
149101288|NCT02725528|537850809|FG000|Overall Study|Withdrawal by Subject|0|||
149101289|NCT02725528|537850810|FG001|Overall Study|Withdrawal by Subject|1|||
149101290|NCT02706847|537850813|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
149101291|NCT02706847|537850814|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
149101292|NCT02706847|537850815|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
149101293|NCT02706847|537850816|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
149101294|NCT02706847|537850813|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
149101295|NCT02706847|537850814|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
149101296|NCT02706847|537850815|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
149101297|NCT02706847|537850816|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
149101298|NCT02706847|537850813|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
149101299|NCT02706847|537850814|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
149101300|NCT02706847|537850815|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
149101301|NCT02706847|537850816|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
149101302|NCT02706847|537850813|FG000|Period 1: Day 1 to Week 12|Other|4|||
149101303|NCT02706847|537850814|FG001|Period 1: Day 1 to Week 12|Other|4|||
149101304|NCT02706847|537850815|FG002|Period 1: Day 1 to Week 12|Other|2|||
149101305|NCT02706847|537850816|FG003|Period 1: Day 1 to Week 12|Other|2|||
149101306|NCT02706847|537850813|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
149101307|NCT02706847|537850814|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
149101308|NCT02706847|537850815|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
149101309|NCT02706847|537850816|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
149101310|NCT02706847|537850813|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
149101311|NCT02706847|537850814|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
149101312|NCT02706847|537850815|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
149101313|NCT02706847|537850816|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
149101314|NCT02706847|537850813|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
149101315|NCT02706847|537850814|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
149101316|NCT02706847|537850815|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
149101317|NCT02706847|537850816|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
149101318|NCT02706847|537850813|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
149101319|NCT02706847|537850814|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
149101320|NCT02706847|537850815|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
149101321|NCT02706847|537850816|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
149101322|NCT02706847|537850813|FG000|Period 1: Week 12 to Week 24|Other|1|||
149101323|NCT02706847|537850814|FG001|Period 1: Week 12 to Week 24|Other|0|||
149101324|NCT02706847|537850815|FG002|Period 1: Week 12 to Week 24|Other|1|||
149101325|NCT02706847|537850816|FG003|Period 1: Week 12 to Week 24|Other|4|||
149101326|NCT02706847|537850813|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
149101327|NCT02706847|537850814|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
149101328|NCT02706847|537850815|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
149101329|NCT02706847|537850816|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
149101330|NCT02706847|537850813|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
149101331|NCT02706847|537850814|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
149101332|NCT02706847|537850815|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
149101333|NCT02706847|537850816|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
149101334|NCT02706847|537850813|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
149101335|NCT02706847|537850814|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
149101336|NCT02706847|537850815|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
149101337|NCT02706847|537850816|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
149101338|NCT02706847|537850813|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
149101339|NCT02706847|537850814|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
149101340|NCT02706847|537850815|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
149101341|NCT02706847|537850816|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
149101342|NCT02706847|537850813|FG000|Period 2: Week 24 to Week 260|Other|8|||
149101343|NCT02706847|537850814|FG001|Period 2: Week 24 to Week 260|Other|5|||
149101344|NCT02706847|537850815|FG002|Period 2: Week 24 to Week 260|Other|15|||
149101345|NCT02706847|537850816|FG003|Period 2: Week 24 to Week 260|Other|15|||
149101346|NCT03432390|537850817|FG000|Apnea Period|Protocol Violation|2|||
149101347|NCT03432390|537850818|FG001|Apnea Period|Protocol Violation|2|||
149101348|NCT02058836|537850819|FG000|Overall Study|Withdrawal by Subject|1|||
149101349|NCT02058836|537850820|FG001|Overall Study|Withdrawal by Subject|1|||
149101350|NCT02168478|537850823|FG000|Overall Study|Withdrawal by Subject|1|||
149101351|NCT02168478|537850823|FG000|Overall Study|Did Not Consent to Participation|2|||
149101352|NCT02168478|537850823|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
149101353|NCT05314374|537850832|FG000|Overall Study|Adverse Event|2|||
149101354|NCT05314374|537850833|FG001|Overall Study|Adverse Event|2|||
149101355|NCT02650466|537850834|FG000|Overall Study|Physician Decision|1|||
149101356|NCT02650466|537850834|FG000|Overall Study|Withdrawal by Subject|5|||
149101357|NCT02650466|537850834|FG000|Overall Study|Lost to Follow-up|1|||
149101358|NCT01214421|537850835|FG000|Overall Study|Lost to Follow-up|7|||
149101359|NCT01214421|537850836|FG001|Overall Study|Lost to Follow-up|3|||
149101360|NCT01214421|537850837|FG002|Overall Study|Lost to Follow-up|7|||
149101361|NCT01214421|537850838|FG003|Overall Study|Lost to Follow-up|3|||
149101362|NCT01214421|537850835|FG000|Overall Study|Adverse Event|16|||
149101363|NCT01214421|537850836|FG001|Overall Study|Adverse Event|35|||
149101364|NCT01214421|537850837|FG002|Overall Study|Adverse Event|14|||
149101365|NCT01214421|537850838|FG003|Overall Study|Adverse Event|3|||
149101366|NCT01214421|537850835|FG000|Overall Study|Sponsor Discontinued Site|1|||
149101367|NCT01214421|537850836|FG001|Overall Study|Sponsor Discontinued Site|2|||
149101368|NCT01214421|537850837|FG002|Overall Study|Sponsor Discontinued Site|0|||
149101369|NCT01214421|537850838|FG003|Overall Study|Sponsor Discontinued Site|0|||
149101370|NCT01214421|537850835|FG000|Overall Study|Withdrawal Criteria Met|3|||
149101371|NCT01214421|537850836|FG001|Overall Study|Withdrawal Criteria Met|0|||
149101372|NCT01214421|537850837|FG002|Overall Study|Withdrawal Criteria Met|2|||
149101373|NCT01214421|537850838|FG003|Overall Study|Withdrawal Criteria Met|1|||
149101374|NCT01214421|537850835|FG000|Overall Study|Physician Decision|2|||
149101375|NCT01214421|537850836|FG001|Overall Study|Physician Decision|0|||
149101376|NCT01214421|537850837|FG002|Overall Study|Physician Decision|4|||
149101377|NCT01214421|537850838|FG003|Overall Study|Physician Decision|0|||
149101378|NCT01214421|537850835|FG000|Overall Study|Withdrawal by Subject|21|||
149101379|NCT01214421|537850836|FG001|Overall Study|Withdrawal by Subject|18|||
149101380|NCT01214421|537850837|FG002|Overall Study|Withdrawal by Subject|11|||
149101381|NCT01214421|537850838|FG003|Overall Study|Withdrawal by Subject|2|||
149101382|NCT03783689|537850842|FG000|Overall Study|Adverse Event|2|||
149101383|NCT03783689|537850843|FG001|Overall Study|Adverse Event|0|||
149101384|NCT03783689|537850842|FG000|Overall Study|Lost to Follow-up|2|||
149101385|NCT03783689|537850843|FG001|Overall Study|Lost to Follow-up|1|||
149101386|NCT03783689|537850842|FG000|Overall Study|Physician Decision|2|||
149101387|NCT03783689|537850843|FG001|Overall Study|Physician Decision|1|||
149101388|NCT03783689|537850842|FG000|Overall Study|Withdrawal by Subject|3|||
149101389|NCT03783689|537850843|FG001|Overall Study|Withdrawal by Subject|3|||
149101390|NCT02392104|537850845|FG000|Overall Study|discontinuation of warfarin|3|||
149101391|NCT02392104|537850845|FG000|Overall Study|bleeding event|1|||
149101392|NCT02392104|537850845|FG000|Overall Study|transferred care to another doctor|2|||
149101393|NCT02392104|537850845|FG000|Overall Study|INR goal range changed|1|||
149101394|NCT02392104|537850845|FG000|Overall Study|admitted to skilled nursing facility|3|||
149101395|NCT02392104|537850845|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
149101396|NCT02636608|537850849|FG000|Overall Study|Failure to Return|4|||
149101397|NCT02636608|537850849|FG000|Overall Study|Insufficient Virological Response|1|||
149101398|NCT02636608|537850849|FG000|Overall Study|Death|3|||
149101399|NCT02636608|537850849|FG000|Overall Study|Other|2|||
149101400|NCT02636608|537850849|FG000|Overall Study|Did Not Receive Treatment|1|||
149101401|NCT03912532|537850850|FG000|Overall Study|Adverse Event|3|||
149101402|NCT03912532|537850851|FG001|Overall Study|Adverse Event|3|||
149101403|NCT03912532|537850852|FG002|Overall Study|Adverse Event|2|||
149101404|NCT03912532|537850853|FG003|Overall Study|Adverse Event|2|||
149101405|NCT03912532|537850850|FG000|Overall Study|Lost to Follow-up|3|||
149101406|NCT03912532|537850851|FG001|Overall Study|Lost to Follow-up|2|||
149101407|NCT03912532|537850852|FG002|Overall Study|Lost to Follow-up|1|||
149101408|NCT03912532|537850853|FG003|Overall Study|Lost to Follow-up|2|||
149101409|NCT03912532|537850850|FG000|Overall Study|Withdrawal by Subject|1|||
149101410|NCT03912532|537850851|FG001|Overall Study|Withdrawal by Subject|1|||
149101411|NCT03912532|537850852|FG002|Overall Study|Withdrawal by Subject|2|||
149101412|NCT03912532|537850853|FG003|Overall Study|Withdrawal by Subject|0|||
149101413|NCT03912532|537850850|FG000|Overall Study|Physician Decision|1|||
149101414|NCT03912532|537850851|FG001|Overall Study|Physician Decision|0|||
149101415|NCT03912532|537850852|FG002|Overall Study|Physician Decision|0|||
149101416|NCT03912532|537850853|FG003|Overall Study|Physician Decision|3|||
149101417|NCT03912532|537850850|FG000|Overall Study|Other|0|||
149101418|NCT03912532|537850851|FG001|Overall Study|Other|1|||
149101419|NCT03912532|537850852|FG002|Overall Study|Other|1|||
149101420|NCT03912532|537850853|FG003|Overall Study|Other|0|||
149101421|NCT03522389|537850854|FG000|Overall Study|Lost to Follow-up|1|||
149101422|NCT03522389|537850855|FG001|Overall Study|Lost to Follow-up|1|||
149101423|NCT03522389|537850856|FG002|Overall Study|Lost to Follow-up|2|||
149101424|NCT03522389|537850854|FG000|Overall Study|had herniated nucleus pulposus|0|||
149101425|NCT03522389|537850855|FG001|Overall Study|had herniated nucleus pulposus|1|||
149101426|NCT03522389|537850856|FG002|Overall Study|had herniated nucleus pulposus|0|||
149101427|NCT03522389|537850854|FG000|Overall Study|go to work in other province|1|||
149101428|NCT03522389|537850855|FG001|Overall Study|go to work in other province|0|||
149101429|NCT03522389|537850856|FG002|Overall Study|go to work in other province|0|||
149101430|NCT00966264|537852570|FG000|Overall Study|Lost to Follow-up|4|||
149101431|NCT00966264|537852571|FG001|Overall Study|Lost to Follow-up|3|||
149101432|NCT00487825|537852572|FG000|Overall Study|Adverse Event|2|||
149101433|NCT00487825|537852573|FG001|Overall Study|Adverse Event|2|||
149101434|NCT00487825|537852572|FG000|Overall Study|Lack of Efficacy|1|||
149101435|NCT00487825|537852573|FG001|Overall Study|Lack of Efficacy|1|||
149101436|NCT00487825|537852572|FG000|Overall Study|Other|3|||
149101437|NCT00487825|537852573|FG001|Overall Study|Other|2|||
149101438|NCT01986114|537852576|FG000|Overall Study|Adverse Event|59|||
149101439|NCT01986114|537852576|FG000|Overall Study|Lack of Efficacy|23|||
149101440|NCT01986114|537852576|FG000|Overall Study|Withdrawal by Subject|58|||
149101441|NCT01986114|537852576|FG000|Overall Study|Noncompliance|3|||
149101442|NCT01986114|537852576|FG000|Overall Study|Protocol Violation|1|||
149101443|NCT01986114|537852576|FG000|Overall Study|Lost to Follow-up|5|||
149101444|NCT01986114|537852576|FG000|Overall Study|Other reason|7|||
149101445|NCT01190644|537852577|FG000|Overall Study|Death|2|||
149101446|NCT01190644|537852577|FG000|Overall Study|Disease progression|1|||
149101447|NCT02366143|537852578|FG000|Overall Study|Death|307|||
149101448|NCT02366143|537852579|FG001|Overall Study|Death|278|||
149101449|NCT02366143|537852580|FG002|Overall Study|Death|280|||
149101450|NCT02366143|537852578|FG000|Overall Study|Lost to Follow-up|2|||
149101451|NCT02366143|537852579|FG001|Overall Study|Lost to Follow-up|4|||
149101452|NCT02366143|537852580|FG002|Overall Study|Lost to Follow-up|2|||
149101453|NCT02366143|537852578|FG000|Overall Study|Physician Decision|1|||
149101454|NCT02366143|537852579|FG001|Overall Study|Physician Decision|2|||
149101455|NCT02366143|537852580|FG002|Overall Study|Physician Decision|1|||
149101456|NCT02366143|537852578|FG000|Overall Study|Protocol Violation|0|||
149101457|NCT02366143|537852579|FG001|Overall Study|Protocol Violation|0|||
149101458|NCT02366143|537852580|FG002|Overall Study|Protocol Violation|2|||
149101459|NCT02366143|537852578|FG000|Overall Study|Withdrawal by Subject|16|||
149101460|NCT02366143|537852579|FG001|Overall Study|Withdrawal by Subject|17|||
149101461|NCT02366143|537852580|FG002|Overall Study|Withdrawal by Subject|22|||
149101462|NCT02366143|537852578|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
149101463|NCT02366143|537852579|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
149101464|NCT02366143|537852580|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
149101465|NCT02366143|537852578|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
149101466|NCT02366143|537852579|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
149101467|NCT02366143|537852580|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
149101468|NCT02366143|537852578|FG000|Overall Study|Randomization Error|1|||
149101469|NCT02366143|537852579|FG001|Overall Study|Randomization Error|0|||
149101470|NCT02366143|537852580|FG002|Overall Study|Randomization Error|0|||
149101471|NCT02366143|537852578|FG000|Overall Study|PI Move and Site Closure|1|||
149101472|NCT02366143|537852579|FG001|Overall Study|PI Move and Site Closure|0|||
149101473|NCT02366143|537852580|FG002|Overall Study|PI Move and Site Closure|1|||
149101474|NCT02366143|537852578|FG000|Overall Study|Study Terminated By Sponsor|0|||
149101475|NCT02366143|537852579|FG001|Overall Study|Study Terminated By Sponsor|0|||
149101476|NCT02366143|537852580|FG002|Overall Study|Study Terminated By Sponsor|2|||
149101477|NCT02366143|537852578|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
149101478|NCT02366143|537852579|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
149101479|NCT02366143|537852580|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
149101480|NCT02366143|537852578|FG000|Overall Study|Patient moved to roll-over study|1|||
149101481|NCT02366143|537852579|FG001|Overall Study|Patient moved to roll-over study|19|||
149101482|NCT02366143|537852580|FG002|Overall Study|Patient moved to roll-over study|28|||
149101483|NCT02366143|537852578|FG000|Overall Study|Patient moved to commercial stock|0|||
149101484|NCT02366143|537852579|FG001|Overall Study|Patient moved to commercial stock|0|||
149101485|NCT02366143|537852580|FG002|Overall Study|Patient moved to commercial stock|1|||
149101486|NCT02366143|537852578|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
149101487|NCT02366143|537852579|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
149101488|NCT02366143|537852580|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
149101489|NCT02366143|537852578|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
149101490|NCT02366143|537852579|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
149101491|NCT02366143|537852580|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
149101492|NCT02366143|537852578|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
149101493|NCT02366143|537852579|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
149119470|NCT04988867|537916350|FG000|Overall Study|Study drug noncompliance|1|||
149101494|NCT02366143|537852580|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
149101495|NCT02366143|537852578|FG000|Overall Study|Requester's instructions|1|||
149101496|NCT02366143|537852579|FG001|Overall Study|Requester's instructions|1|||
149101497|NCT02366143|537852580|FG002|Overall Study|Requester's instructions|1|||
149101498|NCT02366143|537852578|FG000|Overall Study|Uneligible|0|||
149101499|NCT02366143|537852579|FG001|Overall Study|Uneligible|1|||
149101500|NCT02366143|537852580|FG002|Overall Study|Uneligible|0|||
149101501|NCT02366143|537852578|FG000|Overall Study|Post Trial Migration|0|||
149101502|NCT02366143|537852579|FG001|Overall Study|Post Trial Migration|1|||
149101503|NCT02366143|537852580|FG002|Overall Study|Post Trial Migration|0|||
149101504|NCT02366143|537852578|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
149101505|NCT02366143|537852579|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
149101506|NCT02366143|537852580|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
149101507|NCT02366143|537852578|FG000|Overall Study|Patient switched to PTAP|0|||
149101508|NCT02366143|537852579|FG001|Overall Study|Patient switched to PTAP|1|||
149101509|NCT02366143|537852580|FG002|Overall Study|Patient switched to PTAP|0|||
149101510|NCT02366143|537852578|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
149101511|NCT02366143|537852579|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
149101512|NCT02366143|537852580|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
149101513|NCT02172911|537852581|FG000|Overall Study|Serious Adverse Event|0|||
149101514|NCT02172911|537852582|FG001|Overall Study|Serious Adverse Event|1|||
149101515|NCT02172911|537852581|FG000|Overall Study|Progression of Disease|0|||
149101516|NCT02172911|537852582|FG001|Overall Study|Progression of Disease|1|||
149101517|NCT02172911|537852581|FG000|Overall Study|Loss of insurance coverage|1|||
149101518|NCT02172911|537852582|FG001|Overall Study|Loss of insurance coverage|0|||
149101519|NCT00575042|537852585|FG000|Overall Study|Adverse Event|2|||
149101520|NCT00575042|537852585|FG000|Overall Study|Lost to Follow-up|1|||
149101521|NCT04795336|537852588|FG000|Overall Study|Withdrawal by Subject|3|||
149101522|NCT04795336|537852589|FG001|Overall Study|Withdrawal by Subject|4|||
149101523|NCT04795336|537852590|FG002|Overall Study|Withdrawal by Subject|3|||
149101524|NCT04795336|537852591|FG003|Overall Study|Withdrawal by Subject|12|||
149101525|NCT04795336|537852588|FG000|Overall Study|Lost study logs|0|||
149101526|NCT04795336|537852589|FG001|Overall Study|Lost study logs|1|||
149101527|NCT04795336|537852590|FG002|Overall Study|Lost study logs|0|||
149101528|NCT04795336|537852591|FG003|Overall Study|Lost study logs|2|||
149101529|NCT04795336|537852588|FG000|Overall Study|Did not take study medication|2|||
149101530|NCT04795336|537852589|FG001|Overall Study|Did not take study medication|0|||
149101531|NCT04795336|537852590|FG002|Overall Study|Did not take study medication|0|||
149101532|NCT04795336|537852591|FG003|Overall Study|Did not take study medication|0|||
149101533|NCT01638390|537852592|FG000|Overall Study|screening failures|21|||
149101534|NCT01536587|537852599|FG000|Overall Study|Adverse Event|2|||
149101535|NCT02666664|537852600|FG000|Overall Study|Physician Decision|0|||
149101536|NCT02666664|537852601|FG001|Overall Study|Physician Decision|1|||
149101537|NCT02666664|537852600|FG000|Overall Study|Protocol Violation|0|||
149101538|NCT02666664|537852601|FG001|Overall Study|Protocol Violation|2|||
149101539|NCT02666664|537852600|FG000|Overall Study|Other|0|||
149101540|NCT02666664|537852601|FG001|Overall Study|Other|1|||
149101541|NCT02666664|537852600|FG000|Overall Study|Adverse Event|12|||
149101542|NCT02666664|537852601|FG001|Overall Study|Adverse Event|37|||
149101543|NCT02666664|537852600|FG000|Overall Study|Withdrawal by participant|23|||
149101544|NCT02666664|537852601|FG001|Overall Study|Withdrawal by participant|40|||
149101545|NCT02666664|537852600|FG000|Overall Study|Sponsor decision|0|||
149101546|NCT02666664|537852601|FG001|Overall Study|Sponsor decision|1|||
149101547|NCT02666664|537852600|FG000|Overall Study|Lost to Follow-up|1|||
149101548|NCT02666664|537852601|FG001|Overall Study|Lost to Follow-up|2|||
149101549|NCT04596995|537852602|FG000|Overall Study|Lack of Efficacy|8|||
149101550|NCT04596995|537852602|FG000|Overall Study|Lost to Follow-up|3|||
149101551|NCT04596995|537852602|FG000|Overall Study|Withdrawal by Subject|12|||
149101552|NCT04596995|537852602|FG000|Overall Study|Sponsor decision|3|||
149101553|NCT04596995|537852602|FG000|Overall Study|Enrolled in managed access program|3|||
149101554|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
149101555|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
149101556|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
149101557|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Death|4|||
149101558|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Death|2|||
149101559|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Death|3|||
149101560|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
149101561|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
149101562|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
149101563|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
149101564|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
149101565|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
149101566|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
149101567|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
149101568|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
149101569|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
149101570|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
149101571|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
149101572|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
149101573|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
149101574|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
149101575|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
149101576|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
149101577|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
149101578|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
149101579|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
149101580|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
149101581|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
149101582|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
149101583|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
149101584|NCT02783573|537852603|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
149101585|NCT02783573|537852604|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
149101586|NCT02783573|537852605|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
149101587|NCT02783573|537852603|FG000|Delayed-Start Period|Sponsor Decision|0|||
149101588|NCT02783573|537852604|FG001|Delayed-Start Period|Sponsor Decision|17|||
149101589|NCT02783573|537852605|FG002|Delayed-Start Period|Sponsor Decision|12|||
149101590|NCT00589303|537852606|FG000|Overall Study|Withdrawal by Subject|2|||
149101591|NCT00589303|537852607|FG001|Overall Study|Withdrawal by Subject|1|||
149101592|NCT04978350|537852608|FG000|Overall Study|Lost to Follow-up|6|||
149101593|NCT00013611|537852609|FG000|Overall Study|Lost to Follow-up|91|||
149101594|NCT00013611|537852610|FG001|Overall Study|Lost to Follow-up|100|||
149101595|NCT02577003|537852611|FG000|Overall Study|Adverse Event|2|||
149101596|NCT02577003|537852612|FG001|Overall Study|Adverse Event|4|||
149101597|NCT02577003|537852611|FG000|Overall Study|Withdrawal by Subject|0|||
149101598|NCT02577003|537852612|FG001|Overall Study|Withdrawal by Subject|1|||
149101599|NCT02786004|537852613|FG000|Overall Study|Withdrawal by Subject|0|||
149101600|NCT02786004|537852614|FG001|Overall Study|Withdrawal by Subject|1|||
149101601|NCT04351269|537852615|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
149101602|NCT04351269|537852616|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
149101603|NCT04351269|537852617|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
149101604|NCT04351269|537852615|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
149101605|NCT04351269|537852616|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
149101606|NCT04351269|537852617|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
149101607|NCT04351269|537852615|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
149101608|NCT04351269|537852616|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
149101609|NCT04351269|537852617|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
149101610|NCT04351269|537852615|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
149101611|NCT04351269|537852616|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
149101612|NCT04351269|537852617|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
149101613|NCT04351269|537852615|FG000|Overall Study|Lost to Follow-up|1|||
149101614|NCT04351269|537852616|FG001|Overall Study|Lost to Follow-up|3|||
149101615|NCT04351269|537852617|FG002|Overall Study|Lost to Follow-up|0|||
149101616|NCT04486313|537852620|FG000|Overall Study|Lost to Follow-up|7|||
149101617|NCT04486313|537852621|FG001|Overall Study|Lost to Follow-up|9|||
149101618|NCT04486313|537852620|FG000|Overall Study|Withdrawal by Subject|8|||
149101619|NCT04486313|537852621|FG001|Overall Study|Withdrawal by Subject|6|||
149101620|NCT04486313|537852620|FG000|Overall Study|Physician Decision|1|||
149101621|NCT04486313|537852621|FG001|Overall Study|Physician Decision|1|||
149101622|NCT04486313|537852620|FG000|Overall Study|Death|2|||
149101623|NCT04486313|537852621|FG001|Overall Study|Death|0|||
149101624|NCT04486313|537852620|FG000|Overall Study|Protocol Violation|1|||
149101625|NCT04486313|537852621|FG001|Overall Study|Protocol Violation|1|||
149101626|NCT00126659|537852622|FG000|Overall Study|Adverse Event|0|||
149101627|NCT00126659|537852623|FG001|Overall Study|Adverse Event|0|||
149101628|NCT00126659|537852624|FG002|Overall Study|Adverse Event|2|||
149101629|NCT01013961|537852627|FG000|Overall Study|Adverse Event|2|||
149101630|NCT01013961|537852628|FG001|Overall Study|Adverse Event|2|||
149101631|NCT01013961|537852627|FG000|Overall Study|Withdrawal by Subject|1|||
149101632|NCT01013961|537852628|FG001|Overall Study|Withdrawal by Subject|0|||
149101633|NCT01013961|537852627|FG000|Overall Study|Physician Decision|0|||
149101634|NCT01013961|537852628|FG001|Overall Study|Physician Decision|1|||
149101635|NCT03865953|537852639|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
149101636|NCT03865953|537852640|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
149101637|NCT03865953|537852639|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
149101638|NCT03865953|537852640|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
149101639|NCT03865953|537852639|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
149101640|NCT03865953|537852640|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
149101641|NCT00943787|537852641|FG000|Overall Study|Physician Decision|4|||
149101642|NCT00943787|537852641|FG000|Overall Study|Withdrawal by Subject|3|||
149101643|NCT01162135|537852644|FG000|Overall Study|Withdrawal by Subject|1|||
149101644|NCT01162135|537852644|FG000|Overall Study|Severe back pain|1|||
149101645|NCT01162135|537852644|FG000|Overall Study|Ineligible|1|||
149101646|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
149101647|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
149101648|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
149101649|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
149101650|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
149101651|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
149101652|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
149101653|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
149101654|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
149101655|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
149101656|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
149101657|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
149101658|NCT01216072|537852650|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
149101659|NCT01216072|537852651|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
149101660|NCT01216072|537852650|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
149101661|NCT01216072|537852651|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
149101662|NCT01216072|537852650|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
149101663|NCT01216072|537852651|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
149101664|NCT01216072|537852650|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
149101665|NCT01216072|537852651|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
149101666|NCT02402322|537852654|FG000|Pretreatment|Withdrawal by Subject|3|||
149101667|NCT02402322|537852655|FG001|Pretreatment|Withdrawal by Subject|1|||
149101668|NCT02402322|537852656|FG002|Pretreatment|Withdrawal by Subject|1|||
149101669|NCT02402322|537852654|FG000|Follow-up|Withdrawal by Subject|6|||
149101670|NCT02402322|537852655|FG001|Follow-up|Withdrawal by Subject|3|||
149101671|NCT02402322|537852656|FG002|Follow-up|Withdrawal by Subject|24|||
149101672|NCT02818998|537852657|FG000|Overall Study|Adverse Event|3|||
149101673|NCT02818998|537852658|FG001|Overall Study|Adverse Event|2|||
149101674|NCT02818998|537852659|FG002|Overall Study|Adverse Event|1|||
149101675|NCT02818998|537852657|FG000|Overall Study|Lost to Follow-up|4|||
149101676|NCT02818998|537852658|FG001|Overall Study|Lost to Follow-up|1|||
149101677|NCT02818998|537852659|FG002|Overall Study|Lost to Follow-up|2|||
149101678|NCT02818998|537852657|FG000|Overall Study|Withdrawal by sponsor|0|||
149101679|NCT02818998|537852658|FG001|Overall Study|Withdrawal by sponsor|1|||
149101680|NCT02818998|537852659|FG002|Overall Study|Withdrawal by sponsor|1|||
149101681|NCT02818998|537852657|FG000|Overall Study|Death|3|||
149101682|NCT02818998|537852658|FG001|Overall Study|Death|6|||
149101683|NCT02818998|537852659|FG002|Overall Study|Death|8|||
149101684|NCT02818998|537852657|FG000|Overall Study|Withdrawal by Subject|7|||
149101685|NCT02818998|537852658|FG001|Overall Study|Withdrawal by Subject|6|||
149101686|NCT02818998|537852659|FG002|Overall Study|Withdrawal by Subject|6|||
149101687|NCT02818998|537852657|FG000|Overall Study|Physician Decision|1|||
149101688|NCT02818998|537852658|FG001|Overall Study|Physician Decision|0|||
149101689|NCT02818998|537852659|FG002|Overall Study|Physician Decision|0|||
149101690|NCT01296555|537852661|FG000|Overall Study|Adverse Event|0|||
149101691|NCT01296555|537852662|FG001|Overall Study|Adverse Event|0|||
149101692|NCT01296555|537852663|FG002|Overall Study|Adverse Event|1|||
149101693|NCT01296555|537852664|FG003|Overall Study|Adverse Event|1|||
149101694|NCT01296555|537852665|FG004|Overall Study|Adverse Event|2|||
149101695|NCT01296555|537852666|FG005|Overall Study|Adverse Event|4|||
149101696|NCT01296555|537852667|FG006|Overall Study|Adverse Event|1|||
149101697|NCT01296555|537852668|FG007|Overall Study|Adverse Event|4|||
149101698|NCT01296555|537852669|FG008|Overall Study|Adverse Event|3|||
149101699|NCT01296555|537852670|FG009|Overall Study|Adverse Event|1|||
149101700|NCT01296555|537852671|FG010|Overall Study|Adverse Event|0|||
149101701|NCT01296555|537852672|FG011|Overall Study|Adverse Event|4|||
149101702|NCT01296555|537852673|FG012|Overall Study|Adverse Event|1|||
149101703|NCT01296555|537852674|FG013|Overall Study|Adverse Event|4|||
149101704|NCT01296555|537852675|FG014|Overall Study|Adverse Event|0|||
149101705|NCT01296555|537852676|FG015|Overall Study|Adverse Event|0|||
149101706|NCT01296555|537852677|FG016|Overall Study|Adverse Event|0|||
149101707|NCT01296555|537852678|FG017|Overall Study|Adverse Event|0|||
149101708|NCT01296555|537852679|FG018|Overall Study|Adverse Event|0|||
149101709|NCT01296555|537852680|FG019|Overall Study|Adverse Event|1|||
149101710|NCT01296555|537852681|FG020|Overall Study|Adverse Event|0|||
149101711|NCT01296555|537852682|FG021|Overall Study|Adverse Event|0|||
149101712|NCT01296555|537852683|FG022|Overall Study|Adverse Event|0|||
149101713|NCT01296555|537852684|FG023|Overall Study|Adverse Event|0|||
149101714|NCT01296555|537852685|FG024|Overall Study|Adverse Event|0|||
149101715|NCT01296555|537852686|FG025|Overall Study|Adverse Event|0|||
149101716|NCT01296555|537852687|FG026|Overall Study|Adverse Event|0|||
149101717|NCT01296555|537852688|FG027|Overall Study|Adverse Event|0|||
149101718|NCT01296555|537852689|FG028|Overall Study|Adverse Event|0|||
149101719|NCT01296555|537852661|FG000|Overall Study|Reason Not Specified|0|||
149101720|NCT01296555|537852662|FG001|Overall Study|Reason Not Specified|0|||
149101721|NCT01296555|537852663|FG002|Overall Study|Reason Not Specified|0|||
149101722|NCT01296555|537852664|FG003|Overall Study|Reason Not Specified|0|||
149101723|NCT01296555|537852665|FG004|Overall Study|Reason Not Specified|0|||
149101724|NCT01296555|537852666|FG005|Overall Study|Reason Not Specified|0|||
149101725|NCT01296555|537852667|FG006|Overall Study|Reason Not Specified|0|||
149101726|NCT01296555|537852668|FG007|Overall Study|Reason Not Specified|0|||
149101727|NCT01296555|537852669|FG008|Overall Study|Reason Not Specified|0|||
149101728|NCT01296555|537852670|FG009|Overall Study|Reason Not Specified|0|||
149101729|NCT01296555|537852671|FG010|Overall Study|Reason Not Specified|0|||
149101730|NCT01296555|537852672|FG011|Overall Study|Reason Not Specified|0|||
149101731|NCT01296555|537852673|FG012|Overall Study|Reason Not Specified|0|||
149101732|NCT01296555|537852674|FG013|Overall Study|Reason Not Specified|1|||
149101733|NCT01296555|537852675|FG014|Overall Study|Reason Not Specified|2|||
149101734|NCT01296555|537852676|FG015|Overall Study|Reason Not Specified|3|||
149101735|NCT01296555|537852677|FG016|Overall Study|Reason Not Specified|7|||
149101736|NCT01296555|537852678|FG017|Overall Study|Reason Not Specified|4|||
149101737|NCT01296555|537852679|FG018|Overall Study|Reason Not Specified|3|||
149101738|NCT01296555|537852680|FG019|Overall Study|Reason Not Specified|7|||
149101739|NCT01296555|537852681|FG020|Overall Study|Reason Not Specified|11|||
149101740|NCT01296555|537852682|FG021|Overall Study|Reason Not Specified|5|||
149101741|NCT01296555|537852683|FG022|Overall Study|Reason Not Specified|5|||
149101742|NCT01296555|537852684|FG023|Overall Study|Reason Not Specified|7|||
149101743|NCT01296555|537852685|FG024|Overall Study|Reason Not Specified|2|||
149101744|NCT01296555|537852686|FG025|Overall Study|Reason Not Specified|2|||
149101745|NCT01296555|537852687|FG026|Overall Study|Reason Not Specified|19|||
149101746|NCT01296555|537852688|FG027|Overall Study|Reason Not Specified|11|||
149101747|NCT01296555|537852689|FG028|Overall Study|Reason Not Specified|9|||
149101748|NCT01296555|537852661|FG000|Overall Study|Physician Decision|0|||
149101749|NCT01296555|537852662|FG001|Overall Study|Physician Decision|0|||
149101750|NCT01296555|537852663|FG002|Overall Study|Physician Decision|0|||
149101751|NCT01296555|537852664|FG003|Overall Study|Physician Decision|0|||
149101752|NCT01296555|537852665|FG004|Overall Study|Physician Decision|1|||
149101753|NCT01296555|537852666|FG005|Overall Study|Physician Decision|0|||
149101754|NCT01296555|537852667|FG006|Overall Study|Physician Decision|0|||
149101755|NCT01296555|537852668|FG007|Overall Study|Physician Decision|0|||
149101756|NCT01296555|537852669|FG008|Overall Study|Physician Decision|0|||
149101757|NCT01296555|537852670|FG009|Overall Study|Physician Decision|0|||
149101758|NCT01296555|537852671|FG010|Overall Study|Physician Decision|0|||
149101759|NCT01296555|537852672|FG011|Overall Study|Physician Decision|0|||
149101760|NCT01296555|537852673|FG012|Overall Study|Physician Decision|0|||
149101761|NCT01296555|537852674|FG013|Overall Study|Physician Decision|1|||
149101762|NCT01296555|537852675|FG014|Overall Study|Physician Decision|0|||
149101763|NCT01296555|537852676|FG015|Overall Study|Physician Decision|0|||
149101764|NCT01296555|537852677|FG016|Overall Study|Physician Decision|0|||
149101765|NCT01296555|537852678|FG017|Overall Study|Physician Decision|0|||
149101766|NCT01296555|537852679|FG018|Overall Study|Physician Decision|0|||
149101767|NCT01296555|537852680|FG019|Overall Study|Physician Decision|1|||
149101768|NCT01296555|537852681|FG020|Overall Study|Physician Decision|0|||
149101769|NCT01296555|537852682|FG021|Overall Study|Physician Decision|0|||
149101770|NCT01296555|537852683|FG022|Overall Study|Physician Decision|0|||
149101771|NCT01296555|537852684|FG023|Overall Study|Physician Decision|0|||
149101772|NCT01296555|537852685|FG024|Overall Study|Physician Decision|0|||
149101773|NCT01296555|537852686|FG025|Overall Study|Physician Decision|0|||
149101774|NCT01296555|537852687|FG026|Overall Study|Physician Decision|0|||
149101775|NCT01296555|537852688|FG027|Overall Study|Physician Decision|0|||
149101776|NCT01296555|537852689|FG028|Overall Study|Physician Decision|0|||
149101777|NCT01296555|537852661|FG000|Overall Study|Progressive Disease|6|||
149101778|NCT01296555|537852662|FG001|Overall Study|Progressive Disease|3|||
149101779|NCT01296555|537852663|FG002|Overall Study|Progressive Disease|3|||
149101780|NCT01296555|537852664|FG003|Overall Study|Progressive Disease|7|||
149101781|NCT01296555|537852665|FG004|Overall Study|Progressive Disease|6|||
149101782|NCT01296555|537852666|FG005|Overall Study|Progressive Disease|16|||
149101783|NCT01296555|537852667|FG006|Overall Study|Progressive Disease|16|||
149101784|NCT01296555|537852668|FG007|Overall Study|Progressive Disease|8|||
149101785|NCT01296555|537852669|FG008|Overall Study|Progressive Disease|7|||
149101786|NCT01296555|537852670|FG009|Overall Study|Progressive Disease|18|||
149101787|NCT01296555|537852671|FG010|Overall Study|Progressive Disease|7|||
149101788|NCT01296555|537852672|FG011|Overall Study|Progressive Disease|14|||
149101789|NCT01296555|537852673|FG012|Overall Study|Progressive Disease|5|||
149101790|NCT01296555|537852674|FG013|Overall Study|Progressive Disease|12|||
149101791|NCT01296555|537852675|FG014|Overall Study|Progressive Disease|1|||
149101792|NCT01296555|537852676|FG015|Overall Study|Progressive Disease|1|||
149101793|NCT01296555|537852677|FG016|Overall Study|Progressive Disease|0|||
149101794|NCT01296555|537852678|FG017|Overall Study|Progressive Disease|0|||
149101795|NCT01296555|537852679|FG018|Overall Study|Progressive Disease|0|||
149101796|NCT01296555|537852680|FG019|Overall Study|Progressive Disease|1|||
149101797|NCT01296555|537852681|FG020|Overall Study|Progressive Disease|0|||
149101798|NCT01296555|537852682|FG021|Overall Study|Progressive Disease|0|||
149101799|NCT01296555|537852683|FG022|Overall Study|Progressive Disease|0|||
149101800|NCT01296555|537852684|FG023|Overall Study|Progressive Disease|0|||
149101801|NCT01296555|537852685|FG024|Overall Study|Progressive Disease|1|||
149101802|NCT01296555|537852686|FG025|Overall Study|Progressive Disease|0|||
149101803|NCT01296555|537852687|FG026|Overall Study|Progressive Disease|5|||
149101804|NCT01296555|537852688|FG027|Overall Study|Progressive Disease|1|||
149101805|NCT01296555|537852689|FG028|Overall Study|Progressive Disease|0|||
149101806|NCT01296555|537852661|FG000|Overall Study|Protocol Violation|0|||
149101807|NCT01296555|537852662|FG001|Overall Study|Protocol Violation|0|||
149101808|NCT01296555|537852663|FG002|Overall Study|Protocol Violation|0|||
149101809|NCT01296555|537852664|FG003|Overall Study|Protocol Violation|0|||
149101810|NCT01296555|537852665|FG004|Overall Study|Protocol Violation|0|||
149101811|NCT01296555|537852666|FG005|Overall Study|Protocol Violation|0|||
149101812|NCT01296555|537852667|FG006|Overall Study|Protocol Violation|0|||
149101813|NCT01296555|537852668|FG007|Overall Study|Protocol Violation|0|||
149101814|NCT01296555|537852669|FG008|Overall Study|Protocol Violation|0|||
149101815|NCT01296555|537852670|FG009|Overall Study|Protocol Violation|0|||
149101816|NCT01296555|537852671|FG010|Overall Study|Protocol Violation|0|||
149101817|NCT01296555|537852672|FG011|Overall Study|Protocol Violation|0|||
149101818|NCT01296555|537852673|FG012|Overall Study|Protocol Violation|0|||
149101819|NCT01296555|537852674|FG013|Overall Study|Protocol Violation|1|||
149101820|NCT01296555|537852675|FG014|Overall Study|Protocol Violation|0|||
149101821|NCT01296555|537852676|FG015|Overall Study|Protocol Violation|0|||
149101822|NCT01296555|537852677|FG016|Overall Study|Protocol Violation|0|||
149101823|NCT01296555|537852678|FG017|Overall Study|Protocol Violation|0|||
149101824|NCT01296555|537852679|FG018|Overall Study|Protocol Violation|0|||
149101825|NCT01296555|537852680|FG019|Overall Study|Protocol Violation|0|||
149101826|NCT01296555|537852681|FG020|Overall Study|Protocol Violation|0|||
149101827|NCT01296555|537852682|FG021|Overall Study|Protocol Violation|0|||
149101828|NCT01296555|537852683|FG022|Overall Study|Protocol Violation|0|||
149101829|NCT01296555|537852684|FG023|Overall Study|Protocol Violation|0|||
149101830|NCT01296555|537852685|FG024|Overall Study|Protocol Violation|0|||
149101831|NCT01296555|537852686|FG025|Overall Study|Protocol Violation|0|||
149101832|NCT01296555|537852687|FG026|Overall Study|Protocol Violation|0|||
149101833|NCT01296555|537852688|FG027|Overall Study|Protocol Violation|0|||
149101834|NCT01296555|537852689|FG028|Overall Study|Protocol Violation|0|||
149101835|NCT01296555|537852661|FG000|Overall Study|Study Terminated By Sponsor|0|||
149101836|NCT01296555|537852662|FG001|Overall Study|Study Terminated By Sponsor|0|||
149101837|NCT01296555|537852663|FG002|Overall Study|Study Terminated By Sponsor|0|||
149101838|NCT01296555|537852664|FG003|Overall Study|Study Terminated By Sponsor|0|||
149101839|NCT01296555|537852665|FG004|Overall Study|Study Terminated By Sponsor|0|||
149101840|NCT01296555|537852666|FG005|Overall Study|Study Terminated By Sponsor|0|||
149101841|NCT01296555|537852667|FG006|Overall Study|Study Terminated By Sponsor|0|||
149101842|NCT01296555|537852668|FG007|Overall Study|Study Terminated By Sponsor|0|||
149101843|NCT01296555|537852669|FG008|Overall Study|Study Terminated By Sponsor|0|||
149101844|NCT01296555|537852670|FG009|Overall Study|Study Terminated By Sponsor|0|||
149101845|NCT01296555|537852671|FG010|Overall Study|Study Terminated By Sponsor|0|||
149101846|NCT01296555|537852672|FG011|Overall Study|Study Terminated By Sponsor|0|||
149101847|NCT01296555|537852673|FG012|Overall Study|Study Terminated By Sponsor|0|||
149101848|NCT01296555|537852674|FG013|Overall Study|Study Terminated By Sponsor|0|||
149101849|NCT01296555|537852675|FG014|Overall Study|Study Terminated By Sponsor|0|||
149101850|NCT01296555|537852676|FG015|Overall Study|Study Terminated By Sponsor|0|||
149101851|NCT01296555|537852677|FG016|Overall Study|Study Terminated By Sponsor|0|||
149101852|NCT01296555|537852678|FG017|Overall Study|Study Terminated By Sponsor|0|||
149101853|NCT01296555|537852679|FG018|Overall Study|Study Terminated By Sponsor|0|||
149101854|NCT01296555|537852680|FG019|Overall Study|Study Terminated By Sponsor|0|||
149101855|NCT01296555|537852681|FG020|Overall Study|Study Terminated By Sponsor|0|||
149101856|NCT01296555|537852682|FG021|Overall Study|Study Terminated By Sponsor|0|||
149101857|NCT01296555|537852683|FG022|Overall Study|Study Terminated By Sponsor|0|||
149101858|NCT01296555|537852684|FG023|Overall Study|Study Terminated By Sponsor|0|||
149101859|NCT01296555|537852685|FG024|Overall Study|Study Terminated By Sponsor|0|||
149101860|NCT01296555|537852686|FG025|Overall Study|Study Terminated By Sponsor|1|||
149101861|NCT01296555|537852687|FG026|Overall Study|Study Terminated By Sponsor|0|||
149101862|NCT01296555|537852688|FG027|Overall Study|Study Terminated By Sponsor|0|||
149101863|NCT01296555|537852689|FG028|Overall Study|Study Terminated By Sponsor|0|||
149101864|NCT01296555|537852661|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101865|NCT01296555|537852662|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101866|NCT01296555|537852663|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101867|NCT01296555|537852664|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101868|NCT01296555|537852665|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101869|NCT01296555|537852666|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101870|NCT01296555|537852667|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101871|NCT01296555|537852668|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101872|NCT01296555|537852669|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101873|NCT01296555|537852670|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101874|NCT01296555|537852671|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101875|NCT01296555|537852672|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101876|NCT01296555|537852673|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101877|NCT01296555|537852674|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101878|NCT01296555|537852675|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101879|NCT01296555|537852676|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101880|NCT01296555|537852677|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101881|NCT01296555|537852678|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101882|NCT01296555|537852679|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101883|NCT01296555|537852680|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
149101884|NCT01296555|537852681|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101885|NCT01296555|537852682|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101886|NCT01296555|537852683|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101887|NCT01296555|537852684|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101888|NCT01296555|537852685|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101889|NCT01296555|537852686|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101890|NCT01296555|537852687|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101891|NCT01296555|537852688|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101892|NCT01296555|537852689|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
149101893|NCT01296555|537852661|FG000|Overall Study|Death|0|||
149101894|NCT01296555|537852662|FG001|Overall Study|Death|0|||
149101895|NCT01296555|537852663|FG002|Overall Study|Death|0|||
149101896|NCT01296555|537852664|FG003|Overall Study|Death|2|||
149101897|NCT01296555|537852665|FG004|Overall Study|Death|1|||
149101898|NCT01296555|537852666|FG005|Overall Study|Death|0|||
149101899|NCT01296555|537852667|FG006|Overall Study|Death|2|||
149101900|NCT01296555|537852668|FG007|Overall Study|Death|0|||
149101901|NCT01296555|537852669|FG008|Overall Study|Death|0|||
149101902|NCT01296555|537852670|FG009|Overall Study|Death|1|||
149101903|NCT01296555|537852671|FG010|Overall Study|Death|0|||
149101904|NCT01296555|537852672|FG011|Overall Study|Death|1|||
149101905|NCT01296555|537852673|FG012|Overall Study|Death|0|||
149101906|NCT01296555|537852674|FG013|Overall Study|Death|2|||
149101907|NCT01296555|537852675|FG014|Overall Study|Death|27|||
149101908|NCT01296555|537852676|FG015|Overall Study|Death|15|||
149101909|NCT01296555|537852677|FG016|Overall Study|Death|11|||
149101910|NCT01296555|537852678|FG017|Overall Study|Death|11|||
149101911|NCT01296555|537852679|FG018|Overall Study|Death|17|||
149101912|NCT01296555|537852680|FG019|Overall Study|Death|12|||
149101913|NCT01296555|537852681|FG020|Overall Study|Death|13|||
149101914|NCT01296555|537852682|FG021|Overall Study|Death|12|||
149101915|NCT01296555|537852683|FG022|Overall Study|Death|12|||
149101916|NCT01296555|537852684|FG023|Overall Study|Death|13|||
149101917|NCT01296555|537852685|FG024|Overall Study|Death|7|||
149101918|NCT01296555|537852686|FG025|Overall Study|Death|7|||
149101919|NCT01296555|537852687|FG026|Overall Study|Death|35|||
149101920|NCT01296555|537852688|FG027|Overall Study|Death|92|||
149101921|NCT01296555|537852689|FG028|Overall Study|Death|44|||
149101922|NCT01296555|537852661|FG000|Overall Study|Lost to Follow-up|0|||
149101923|NCT01296555|537852662|FG001|Overall Study|Lost to Follow-up|0|||
149101924|NCT01296555|537852663|FG002|Overall Study|Lost to Follow-up|0|||
149101925|NCT01296555|537852664|FG003|Overall Study|Lost to Follow-up|0|||
149101926|NCT01296555|537852665|FG004|Overall Study|Lost to Follow-up|0|||
149101927|NCT01296555|537852666|FG005|Overall Study|Lost to Follow-up|0|||
149101928|NCT01296555|537852667|FG006|Overall Study|Lost to Follow-up|0|||
149101929|NCT01296555|537852668|FG007|Overall Study|Lost to Follow-up|0|||
149101930|NCT01296555|537852669|FG008|Overall Study|Lost to Follow-up|0|||
149101931|NCT01296555|537852670|FG009|Overall Study|Lost to Follow-up|0|||
149101932|NCT01296555|537852671|FG010|Overall Study|Lost to Follow-up|0|||
149101933|NCT01296555|537852672|FG011|Overall Study|Lost to Follow-up|0|||
149101934|NCT01296555|537852673|FG012|Overall Study|Lost to Follow-up|0|||
149101935|NCT01296555|537852674|FG013|Overall Study|Lost to Follow-up|0|||
149101936|NCT01296555|537852675|FG014|Overall Study|Lost to Follow-up|2|||
149101937|NCT01296555|537852676|FG015|Overall Study|Lost to Follow-up|1|||
149101938|NCT01296555|537852677|FG016|Overall Study|Lost to Follow-up|0|||
149101939|NCT01296555|537852678|FG017|Overall Study|Lost to Follow-up|2|||
149101940|NCT01296555|537852679|FG018|Overall Study|Lost to Follow-up|0|||
149101941|NCT01296555|537852680|FG019|Overall Study|Lost to Follow-up|2|||
149101942|NCT01296555|537852681|FG020|Overall Study|Lost to Follow-up|3|||
149101943|NCT01296555|537852682|FG021|Overall Study|Lost to Follow-up|2|||
149101944|NCT01296555|537852683|FG022|Overall Study|Lost to Follow-up|0|||
149101945|NCT01296555|537852684|FG023|Overall Study|Lost to Follow-up|0|||
149101946|NCT01296555|537852685|FG024|Overall Study|Lost to Follow-up|0|||
149101947|NCT01296555|537852686|FG025|Overall Study|Lost to Follow-up|0|||
149101948|NCT01296555|537852687|FG026|Overall Study|Lost to Follow-up|3|||
149101949|NCT01296555|537852688|FG027|Overall Study|Lost to Follow-up|13|||
149101950|NCT01296555|537852689|FG028|Overall Study|Lost to Follow-up|5|||
149101951|NCT01296555|537852661|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149101952|NCT01296555|537852662|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149101953|NCT01296555|537852663|FG002|Overall Study|Non-Compliance With Study Drug|0|||
149101954|NCT01296555|537852664|FG003|Overall Study|Non-Compliance With Study Drug|0|||
149101955|NCT01296555|537852665|FG004|Overall Study|Non-Compliance With Study Drug|0|||
149101956|NCT01296555|537852666|FG005|Overall Study|Non-Compliance With Study Drug|0|||
149101957|NCT01296555|537852667|FG006|Overall Study|Non-Compliance With Study Drug|0|||
149101958|NCT01296555|537852668|FG007|Overall Study|Non-Compliance With Study Drug|1|||
149101959|NCT01296555|537852669|FG008|Overall Study|Non-Compliance With Study Drug|0|||
149101960|NCT01296555|537852670|FG009|Overall Study|Non-Compliance With Study Drug|0|||
149101961|NCT01296555|537852671|FG010|Overall Study|Non-Compliance With Study Drug|0|||
149101962|NCT01296555|537852672|FG011|Overall Study|Non-Compliance With Study Drug|0|||
149101963|NCT01296555|537852673|FG012|Overall Study|Non-Compliance With Study Drug|0|||
149101964|NCT01296555|537852674|FG013|Overall Study|Non-Compliance With Study Drug|0|||
149101965|NCT01296555|537852675|FG014|Overall Study|Non-Compliance With Study Drug|0|||
149101966|NCT01296555|537852676|FG015|Overall Study|Non-Compliance With Study Drug|0|||
149101967|NCT01296555|537852677|FG016|Overall Study|Non-Compliance With Study Drug|0|||
149101968|NCT01296555|537852678|FG017|Overall Study|Non-Compliance With Study Drug|0|||
149101969|NCT01296555|537852679|FG018|Overall Study|Non-Compliance With Study Drug|0|||
149101970|NCT01296555|537852680|FG019|Overall Study|Non-Compliance With Study Drug|0|||
149101971|NCT01296555|537852681|FG020|Overall Study|Non-Compliance With Study Drug|0|||
149101972|NCT01296555|537852682|FG021|Overall Study|Non-Compliance With Study Drug|0|||
149101973|NCT01296555|537852683|FG022|Overall Study|Non-Compliance With Study Drug|0|||
149101974|NCT01296555|537852684|FG023|Overall Study|Non-Compliance With Study Drug|0|||
149101975|NCT01296555|537852685|FG024|Overall Study|Non-Compliance With Study Drug|0|||
149101976|NCT01296555|537852686|FG025|Overall Study|Non-Compliance With Study Drug|0|||
149101977|NCT01296555|537852687|FG026|Overall Study|Non-Compliance With Study Drug|0|||
149101978|NCT01296555|537852688|FG027|Overall Study|Non-Compliance With Study Drug|0|||
149101979|NCT01296555|537852689|FG028|Overall Study|Non-Compliance With Study Drug|0|||
149101980|NCT01296555|537852661|FG000|Overall Study|Withdrawal by Subject|0|||
149101981|NCT01296555|537852662|FG001|Overall Study|Withdrawal by Subject|0|||
149101982|NCT01296555|537852663|FG002|Overall Study|Withdrawal by Subject|0|||
149101983|NCT01296555|537852664|FG003|Overall Study|Withdrawal by Subject|0|||
149101984|NCT01296555|537852665|FG004|Overall Study|Withdrawal by Subject|1|||
149101985|NCT01296555|537852666|FG005|Overall Study|Withdrawal by Subject|0|||
149101986|NCT01296555|537852667|FG006|Overall Study|Withdrawal by Subject|1|||
149101987|NCT01296555|537852668|FG007|Overall Study|Withdrawal by Subject|0|||
149101988|NCT01296555|537852669|FG008|Overall Study|Withdrawal by Subject|0|||
149101989|NCT01296555|537852670|FG009|Overall Study|Withdrawal by Subject|0|||
149101990|NCT01296555|537852671|FG010|Overall Study|Withdrawal by Subject|1|||
149101991|NCT01296555|537852672|FG011|Overall Study|Withdrawal by Subject|1|||
149101992|NCT01296555|537852673|FG012|Overall Study|Withdrawal by Subject|0|||
149101993|NCT01296555|537852674|FG013|Overall Study|Withdrawal by Subject|0|||
149101994|NCT01296555|537852675|FG014|Overall Study|Withdrawal by Subject|3|||
149101995|NCT01296555|537852676|FG015|Overall Study|Withdrawal by Subject|0|||
149101996|NCT01296555|537852677|FG016|Overall Study|Withdrawal by Subject|2|||
149101997|NCT01296555|537852678|FG017|Overall Study|Withdrawal by Subject|1|||
149101998|NCT01296555|537852679|FG018|Overall Study|Withdrawal by Subject|0|||
149101999|NCT01296555|537852680|FG019|Overall Study|Withdrawal by Subject|1|||
149102000|NCT01296555|537852681|FG020|Overall Study|Withdrawal by Subject|1|||
149102001|NCT01296555|537852682|FG021|Overall Study|Withdrawal by Subject|1|||
149102002|NCT01296555|537852683|FG022|Overall Study|Withdrawal by Subject|3|||
149102003|NCT01296555|537852684|FG023|Overall Study|Withdrawal by Subject|0|||
149102004|NCT01296555|537852685|FG024|Overall Study|Withdrawal by Subject|0|||
149102005|NCT01296555|537852686|FG025|Overall Study|Withdrawal by Subject|0|||
149102006|NCT01296555|537852687|FG026|Overall Study|Withdrawal by Subject|8|||
149102007|NCT01296555|537852688|FG027|Overall Study|Withdrawal by Subject|4|||
149102008|NCT01296555|537852689|FG028|Overall Study|Withdrawal by Subject|2|||
149102009|NCT01704547|537852692|FG000|Overall Study|Physician Decision|4|||
149102010|NCT01704547|537852692|FG000|Overall Study|Withdrawal by Subject|1|||
149102011|NCT02413593|537852693|FG000|Overall Study|Lost to Follow-up|3|||
149102012|NCT02413593|537852693|FG000|Overall Study|Adverse Event|1|||
149102013|NCT01101061|537852694|FG000|Overall Study|Adverse Event|0|||
149102014|NCT01101061|537852695|FG001|Overall Study|Adverse Event|0|||
149102015|NCT01101061|537852696|FG002|Overall Study|Adverse Event|1|||
149102016|NCT01101061|537852697|FG003|Overall Study|Adverse Event|0|||
149102017|NCT01101061|537852698|FG004|Overall Study|Adverse Event|0|||
149102018|NCT01101061|537852699|FG005|Overall Study|Adverse Event|0|||
149102019|NCT00409409|537852700|FG000|Overall Study|Adverse Event|7|||
149102020|NCT00409409|537852701|FG001|Overall Study|Adverse Event|2|||
149102021|NCT00409409|537852700|FG000|Overall Study|Withdrawal by Subject|1|||
149102022|NCT00409409|537852701|FG001|Overall Study|Withdrawal by Subject|1|||
149102023|NCT00409409|537852700|FG000|Overall Study|Any other reason not above-mentioned|0|||
149102024|NCT00409409|537852701|FG001|Overall Study|Any other reason not above-mentioned|1|||
149102025|NCT02569957|537852702|FG000|Overall Study|Withdrawal by Subject|0|||
149102026|NCT02569957|537852703|FG001|Overall Study|Withdrawal by Subject|1|||
149102027|NCT02635386|537852704|FG000|Overall Study|Pregnancy|2|||
149102028|NCT02635386|537852705|FG001|Overall Study|Pregnancy|0|||
149102029|NCT02635386|537852706|FG002|Overall Study|Pregnancy|0|||
149102030|NCT02635386|537852707|FG003|Overall Study|Pregnancy|0|||
149102031|NCT02635386|537852708|FG004|Overall Study|Pregnancy|2|||
149102032|NCT02635386|537852704|FG000|Overall Study|Withdrawal by Subject|1|||
149102033|NCT02635386|537852705|FG001|Overall Study|Withdrawal by Subject|1|||
149102034|NCT02635386|537852706|FG002|Overall Study|Withdrawal by Subject|0|||
149102035|NCT02635386|537852707|FG003|Overall Study|Withdrawal by Subject|1|||
149102036|NCT02635386|537852708|FG004|Overall Study|Withdrawal by Subject|0|||
149102037|NCT02635386|537852704|FG000|Overall Study|Physician Decision|0|||
149102038|NCT02635386|537852705|FG001|Overall Study|Physician Decision|1|||
149102039|NCT02635386|537852706|FG002|Overall Study|Physician Decision|0|||
149102040|NCT02635386|537852707|FG003|Overall Study|Physician Decision|0|||
149102041|NCT02635386|537852708|FG004|Overall Study|Physician Decision|0|||
149102042|NCT02635386|537852704|FG000|Overall Study|Moved Out of State|0|||
149102043|NCT02635386|537852705|FG001|Overall Study|Moved Out of State|1|||
149102044|NCT02635386|537852706|FG002|Overall Study|Moved Out of State|0|||
149102045|NCT02635386|537852707|FG003|Overall Study|Moved Out of State|0|||
149102046|NCT02635386|537852708|FG004|Overall Study|Moved Out of State|0|||
149102047|NCT02635386|537852704|FG000|Overall Study|Noncompliant|0|||
149102048|NCT02635386|537852705|FG001|Overall Study|Noncompliant|2|||
149102049|NCT02635386|537852706|FG002|Overall Study|Noncompliant|1|||
149102050|NCT02635386|537852707|FG003|Overall Study|Noncompliant|1|||
149102051|NCT02635386|537852708|FG004|Overall Study|Noncompliant|1|||
149102052|NCT02635386|537852704|FG000|Overall Study|side effects|0|||
149102053|NCT02635386|537852705|FG001|Overall Study|side effects|0|||
149102054|NCT02635386|537852706|FG002|Overall Study|side effects|1|||
149102055|NCT02635386|537852707|FG003|Overall Study|side effects|4|||
149102056|NCT02635386|537852708|FG004|Overall Study|side effects|6|||
149102057|NCT02635386|537852704|FG000|Overall Study|needed other major surgery|0|||
149102058|NCT02635386|537852705|FG001|Overall Study|needed other major surgery|1|||
149102059|NCT02635386|537852706|FG002|Overall Study|needed other major surgery|0|||
149102060|NCT02635386|537852707|FG003|Overall Study|needed other major surgery|0|||
149102061|NCT02635386|537852708|FG004|Overall Study|needed other major surgery|0|||
149102062|NCT02635386|537852704|FG000|Overall Study|Other medical problems not drug related|0|||
149102063|NCT02635386|537852705|FG001|Overall Study|Other medical problems not drug related|0|||
149102064|NCT02635386|537852706|FG002|Overall Study|Other medical problems not drug related|0|||
149102065|NCT02635386|537852707|FG003|Overall Study|Other medical problems not drug related|1|||
149102066|NCT02635386|537852708|FG004|Overall Study|Other medical problems not drug related|0|||
149102067|NCT01087814|537852710|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
149102068|NCT01087814|537852711|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
149102069|NCT01087814|537852710|FG000|Second Intervention (5 Days)|Physician Decision|1|||
149102070|NCT01087814|537852711|FG001|Second Intervention (5 Days)|Physician Decision|0|||
149102071|NCT01427738|537852712|FG000|Overall Study|Death|12|||
149102072|NCT01427738|537852713|FG001|Overall Study|Death|9|||
149102073|NCT01427738|537852712|FG000|Overall Study|Severe debilitation, unable to continue|0|||
149102074|NCT01427738|537852713|FG001|Overall Study|Severe debilitation, unable to continue|1|||
149102075|NCT01427738|537852712|FG000|Overall Study|Subject unable to get to clinic|5|||
149102076|NCT01427738|537852713|FG001|Overall Study|Subject unable to get to clinic|2|||
149102077|NCT01427738|537852712|FG000|Overall Study|Withdrawal by Subject|0|||
149102078|NCT01427738|537852713|FG001|Overall Study|Withdrawal by Subject|2|||
149102079|NCT01427738|537852712|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
149102080|NCT01427738|537852713|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
149102081|NCT01427738|537852712|FG000|Overall Study|Lost to Follow-up|1|||
149102082|NCT01427738|537852713|FG001|Overall Study|Lost to Follow-up|5|||
149102083|NCT02658175|537852714|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
149102084|NCT02658175|537852715|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
149102085|NCT02658175|537852716|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
149102086|NCT02658175|537852714|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
149102087|NCT02658175|537852715|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
149102088|NCT02658175|537852716|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
149102089|NCT02658175|537852714|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
149102090|NCT02658175|537852715|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
149102091|NCT02658175|537852716|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
149102092|NCT02658175|537852714|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
149102093|NCT02658175|537852715|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
149102094|NCT02658175|537852716|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
149102095|NCT02658175|537852714|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
149102096|NCT02658175|537852715|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
149102097|NCT02658175|537852716|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
149102098|NCT02658175|537852714|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
149102099|NCT02658175|537852715|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
149102100|NCT02658175|537852716|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
149102101|NCT02658175|537852714|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
149102102|NCT02658175|537852715|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
149102103|NCT02658175|537852716|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
149102104|NCT02658175|537852714|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
149102105|NCT02658175|537852715|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
149102106|NCT02658175|537852716|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
149102107|NCT02658175|537852714|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
149102108|NCT02658175|537852715|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
149102109|NCT02658175|537852716|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
149102110|NCT02658175|537852714|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
149102111|NCT02658175|537852715|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
149102112|NCT02658175|537852716|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
149102113|NCT02918292|537852721|FG000|Study Enrollment Prior to Transplant|Death|1|||
149102114|NCT02918292|537852721|FG000|Study Follow up After Transplant|Death|6|||
149102115|NCT04913948|537852722|FG000|Overall Study|Withdrawal by Subject|2|||
149102116|NCT04913948|537852722|FG000|Overall Study|Sample processing issues|1|||
149102117|NCT04913948|537852722|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
149102118|NCT03783871|537852725|FG000|Overall Study|Withdrawal by Subject|15|||
149102119|NCT03783871|537852725|FG000|Overall Study|Death|13|||
149102120|NCT03783871|537852725|FG000|Overall Study|Lost to Follow-up|2|||
149102121|NCT05990387|537852726|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
149102122|NCT05990387|537852727|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
149102123|NCT00815919|537852728|FG000|Overall Study|Unrelated Fungal Infection|1|||
149102124|NCT00815919|537852728|FG000|Overall Study|AML Relapse|1|||
149102125|NCT00815919|537852728|FG000|Overall Study|Lack of Efficacy|2|||
149102126|NCT00604188|537852729|FG000|Overall Study|Adverse Event|1|||
149102127|NCT00604188|537852730|FG001|Overall Study|Adverse Event|4|||
149102128|NCT00604188|537852729|FG000|Overall Study|Lost to Follow-up|17|||
149102129|NCT00604188|537852730|FG001|Overall Study|Lost to Follow-up|15|||
149102130|NCT00604188|537852729|FG000|Overall Study|Withdrawal by Subject|5|||
149102131|NCT00604188|537852730|FG001|Overall Study|Withdrawal by Subject|1|||
149102132|NCT00604188|537852729|FG000|Overall Study|Non-compliance with protocol|4|||
149102133|NCT00604188|537852730|FG001|Overall Study|Non-compliance with protocol|4|||
149102134|NCT00604188|537852729|FG000|Overall Study|Did not receive study drug|0|||
149102135|NCT00604188|537852730|FG001|Overall Study|Did not receive study drug|1|||
149102136|NCT04680637|537852731|FG000|Overall Study|Lost to Follow-up|0|||
149102137|NCT04680637|537852732|FG001|Overall Study|Lost to Follow-up|1|||
149102138|NCT04680637|537852733|FG002|Overall Study|Lost to Follow-up|0|||
149102139|NCT04680637|537852734|FG003|Overall Study|Lost to Follow-up|1|||
149102140|NCT04680637|537852731|FG000|Overall Study|Death|1|||
149102141|NCT04680637|537852732|FG001|Overall Study|Death|0|||
149102142|NCT04680637|537852733|FG002|Overall Study|Death|0|||
149102143|NCT04680637|537852734|FG003|Overall Study|Death|0|||
149102144|NCT04680637|537852731|FG000|Overall Study|Withdrawal by Subject|7|||
149102145|NCT04680637|537852732|FG001|Overall Study|Withdrawal by Subject|10|||
149102146|NCT04680637|537852733|FG002|Overall Study|Withdrawal by Subject|17|||
149102147|NCT04680637|537852734|FG003|Overall Study|Withdrawal by Subject|15|||
149102148|NCT04680637|537852731|FG000|Overall Study|Decision by Sponsor|21|||
149102149|NCT04680637|537852732|FG001|Overall Study|Decision by Sponsor|15|||
149102150|NCT04680637|537852733|FG002|Overall Study|Decision by Sponsor|7|||
149102151|NCT04680637|537852734|FG003|Overall Study|Decision by Sponsor|32|||
149102152|NCT04599907|537852736|FG000|Overall Study|Withdrawal by Subject|1|||
149102153|NCT04599907|537852737|FG001|Overall Study|Withdrawal by Subject|7|||
149102154|NCT04599907|537852738|FG002|Overall Study|Withdrawal by Subject|6|||
149102155|NCT04599907|537852736|FG000|Overall Study|Lost to Follow-up|0|||
149102156|NCT04599907|537852737|FG001|Overall Study|Lost to Follow-up|1|||
149102157|NCT04599907|537852738|FG002|Overall Study|Lost to Follow-up|0|||
149102158|NCT00443599|537852744|FG000|Overall Study|Physician Decision|2|||
149102159|NCT00443599|537852745|FG001|Overall Study|Physician Decision|1|||
149102160|NCT00443599|537852744|FG000|Overall Study|Death|1|||
149102161|NCT00443599|537852745|FG001|Overall Study|Death|1|||
149102162|NCT00443599|537852744|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
149102163|NCT00443599|537852745|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
149102164|NCT04464421|537854432|FG000|Overall Study|Lost to Follow-up|2|||
149102165|NCT04464421|537854433|FG001|Overall Study|Lost to Follow-up|2|||
149102166|NCT01234883|537854434|FG000|Overall Study|Early treatment release|8|||
149102167|NCT01234883|537854435|FG001|Overall Study|Early treatment release|10|||
149102168|NCT01234883|537854434|FG000|Overall Study|Parent/guardian withdrew consent|1|||
149102169|NCT01234883|537854435|FG001|Overall Study|Parent/guardian withdrew consent|2|||
149102170|NCT01234883|537854434|FG000|Overall Study|Technical difficulties with IV infusion|0|||
149102171|NCT01234883|537854435|FG001|Overall Study|Technical difficulties with IV infusion|1|||
149102172|NCT01234883|537854434|FG000|Overall Study|Inclusion/exclusion failure|1|||
149102173|NCT01234883|537854435|FG001|Overall Study|Inclusion/exclusion failure|0|||
149102174|NCT01271504|537854436|FG000|Overall Study|Death|7|||
149102175|NCT01271504|537854437|FG001|Overall Study|Death|6|||
149102176|NCT01271504|537854438|FG002|Overall Study|Death|32|||
149102177|NCT01271504|537854439|FG003|Overall Study|Death|32|||
149102178|NCT01271504|537854436|FG000|Overall Study|Lost to Follow-up|0|||
149102179|NCT01271504|537854437|FG001|Overall Study|Lost to Follow-up|1|||
149102180|NCT01271504|537854438|FG002|Overall Study|Lost to Follow-up|3|||
149102181|NCT01271504|537854439|FG003|Overall Study|Lost to Follow-up|1|||
149102182|NCT01271504|537854436|FG000|Overall Study|Protocol Violation|0|||
149102183|NCT01271504|537854437|FG001|Overall Study|Protocol Violation|0|||
149102184|NCT01271504|537854438|FG002|Overall Study|Protocol Violation|0|||
149102185|NCT01271504|537854439|FG003|Overall Study|Protocol Violation|2|||
149102186|NCT01271504|537854436|FG000|Overall Study|Administrative Reasons|0|||
149102187|NCT01271504|537854437|FG001|Overall Study|Administrative Reasons|0|||
149102188|NCT01271504|537854438|FG002|Overall Study|Administrative Reasons|6|||
149102189|NCT01271504|537854439|FG003|Overall Study|Administrative Reasons|5|||
149102190|NCT01271504|537854436|FG000|Overall Study|Withdrawal by Subject|0|||
149102191|NCT01271504|537854437|FG001|Overall Study|Withdrawal by Subject|0|||
149102192|NCT01271504|537854438|FG002|Overall Study|Withdrawal by Subject|1|||
149102193|NCT01271504|537854439|FG003|Overall Study|Withdrawal by Subject|3|||
149102194|NCT01271504|537854436|FG000|Overall Study|Other|0|||
149102195|NCT01271504|537854437|FG001|Overall Study|Other|1|||
149102196|NCT01271504|537854438|FG002|Overall Study|Other|2|||
149102197|NCT01271504|537854439|FG003|Overall Study|Other|0|||
149102198|NCT00940875|537854446|FG000|Treatment Phase|Adverse Event|9|||
149102199|NCT00940875|537854447|FG001|Treatment Phase|Adverse Event|3|||
149102200|NCT00940875|537854446|FG000|Treatment Phase|Death|3|||
149102201|NCT00940875|537854447|FG001|Treatment Phase|Death|5|||
149102202|NCT00940875|537854446|FG000|Treatment Phase|Lack of Efficacy|1|||
149102203|NCT00940875|537854447|FG001|Treatment Phase|Lack of Efficacy|0|||
149102204|NCT00940875|537854446|FG000|Treatment Phase|Withdrawal by Subject|3|||
149102205|NCT00940875|537854447|FG001|Treatment Phase|Withdrawal by Subject|0|||
149102206|NCT00940875|537854446|FG000|Treatment Phase|Disease progression|9|||
149102207|NCT00940875|537854447|FG001|Treatment Phase|Disease progression|11|||
149102208|NCT00940875|537854446|FG000|Treatment Phase|Physician Decision|1|||
149102209|NCT00940875|537854447|FG001|Treatment Phase|Physician Decision|0|||
149102210|NCT00940875|537854446|FG000|Post-Study Treatment|Death|0|||
149102211|NCT00940875|537854447|FG001|Post-Study Treatment|Death|1|||
149102212|NCT00940875|537854446|FG000|Post-Study Treatment|Disease Progression|0|||
149102213|NCT00940875|537854447|FG001|Post-Study Treatment|Disease Progression|2|||
149102214|NCT00490945|537854448|FG000|Overall Study|Adverse Event|0|||
149102215|NCT00490945|537854449|FG001|Overall Study|Adverse Event|1|||
149102216|NCT00490945|537854450|FG002|Overall Study|Adverse Event|0|||
149102217|NCT00490945|537854451|FG003|Overall Study|Adverse Event|0|||
149102218|NCT00490945|537854452|FG004|Overall Study|Adverse Event|0|||
149102219|NCT03721705|537854462|FG000|Overall Study|Adverse Event|2|||
149102220|NCT03721705|537854463|FG001|Overall Study|Adverse Event|0|||
149102221|NCT03721705|537854462|FG000|Overall Study|Withdrawal by Subject|4|||
149102222|NCT03721705|537854463|FG001|Overall Study|Withdrawal by Subject|10|||
149102223|NCT03721705|537854462|FG000|Overall Study|No Suitable Study Partner|1|||
149102224|NCT03721705|537854463|FG001|Overall Study|No Suitable Study Partner|0|||
149102225|NCT03721705|537854462|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
149102226|NCT03721705|537854463|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
149102227|NCT03721705|537854462|FG000|Overall Study|Death|0|||
149102228|NCT03721705|537854463|FG001|Overall Study|Death|1|||
149102229|NCT02947100|537854469|FG000|Overall Study|study terminated early|3|||
149102230|NCT02947100|537854469|FG000|Overall Study|did not meet inclusion criteria|1|||
149102231|NCT00822770|537854470|FG000|Overall Study|Not treated|1|||
149102232|NCT00822770|537854471|FG001|Overall Study|Not treated|0|||
149102233|NCT00822770|537854470|FG000|Overall Study|Complication/Incomplete treatment|1|||
149102234|NCT00822770|537854471|FG001|Overall Study|Complication/Incomplete treatment|0|||
149102235|NCT00822770|537854470|FG000|Overall Study|Death|1|||
149102236|NCT00822770|537854471|FG001|Overall Study|Death|1|||
149102237|NCT02472145|537854475|FG000|Overall Study|Death|10|||
149102238|NCT02472145|537854476|FG001|Overall Study|Death|101|||
149102239|NCT02472145|537854477|FG002|Overall Study|Death|99|||
149102240|NCT02472145|537854475|FG000|Overall Study|Lost to Follow-up|0|||
149102241|NCT02472145|537854476|FG001|Overall Study|Lost to Follow-up|1|||
149102242|NCT02472145|537854477|FG002|Overall Study|Lost to Follow-up|0|||
149102243|NCT02472145|537854475|FG000|Overall Study|Withdrawal by Subject|0|||
149102244|NCT02472145|537854476|FG001|Overall Study|Withdrawal by Subject|9|||
149102245|NCT02472145|537854477|FG002|Overall Study|Withdrawal by Subject|13|||
149102246|NCT02472145|537854475|FG000|Overall Study|Sponsor decision|0|||
149102247|NCT02472145|537854476|FG001|Overall Study|Sponsor decision|3|||
149102248|NCT02472145|537854477|FG002|Overall Study|Sponsor decision|2|||
149102249|NCT02472145|537854475|FG000|Overall Study|Other|0|||
149102250|NCT02472145|537854476|FG001|Overall Study|Other|45|||
149102251|NCT02472145|537854477|FG002|Overall Study|Other|43|||
149102252|NCT01080326|537854478|FG000|Overall Study|Patient deterioration prior to procedure|3|||
149102253|NCT01080326|537854478|FG000|Overall Study|Surgeon decision|1|||
149102254|NCT00632021|537854479|FG000|Overall Study|Withdrawal/death|4|||
149102255|NCT00632021|537854480|FG001|Overall Study|Withdrawal/death|7|||
149102256|NCT01628692|537854481|FG000|Overall Study|Lack of Efficacy|4|||
149102257|NCT01628692|537854482|FG001|Overall Study|Lack of Efficacy|4|||
149102258|NCT01628692|537854483|FG002|Overall Study|Lack of Efficacy|5|||
149102259|NCT01628692|537854484|FG003|Overall Study|Lack of Efficacy|1|||
149102260|NCT01628692|537854485|FG004|Overall Study|Lack of Efficacy|4|||
149102261|NCT01628692|537854486|FG005|Overall Study|Lack of Efficacy|7|||
149102262|NCT01628692|537854481|FG000|Overall Study|Adverse Event|2|||
149102263|NCT01628692|537854482|FG001|Overall Study|Adverse Event|0|||
149102264|NCT01628692|537854483|FG002|Overall Study|Adverse Event|2|||
149102265|NCT01628692|537854484|FG003|Overall Study|Adverse Event|0|||
149102266|NCT01628692|537854485|FG004|Overall Study|Adverse Event|0|||
149102267|NCT01628692|537854486|FG005|Overall Study|Adverse Event|0|||
149102268|NCT01628692|537854481|FG000|Overall Study|Withdrawal by Subject|0|||
149102269|NCT01628692|537854482|FG001|Overall Study|Withdrawal by Subject|1|||
149102270|NCT01628692|537854483|FG002|Overall Study|Withdrawal by Subject|1|||
149102271|NCT01628692|537854484|FG003|Overall Study|Withdrawal by Subject|0|||
149102272|NCT01628692|537854485|FG004|Overall Study|Withdrawal by Subject|0|||
149102273|NCT01628692|537854486|FG005|Overall Study|Withdrawal by Subject|0|||
149102274|NCT01628692|537854481|FG000|Overall Study|Death|0|||
149102275|NCT01628692|537854482|FG001|Overall Study|Death|1|||
149102276|NCT01628692|537854483|FG002|Overall Study|Death|0|||
149102277|NCT01628692|537854484|FG003|Overall Study|Death|0|||
149102278|NCT01628692|537854485|FG004|Overall Study|Death|0|||
149102279|NCT01628692|537854486|FG005|Overall Study|Death|0|||
149102280|NCT01628692|537854481|FG000|Overall Study|Poor compliance/noncompliance|1|||
149102281|NCT01628692|537854482|FG001|Overall Study|Poor compliance/noncompliance|0|||
149102282|NCT01628692|537854483|FG002|Overall Study|Poor compliance/noncompliance|0|||
149102283|NCT01628692|537854484|FG003|Overall Study|Poor compliance/noncompliance|0|||
149102284|NCT01628692|537854485|FG004|Overall Study|Poor compliance/noncompliance|0|||
149102285|NCT01628692|537854486|FG005|Overall Study|Poor compliance/noncompliance|0|||
149102286|NCT01628692|537854481|FG000|Overall Study|Administrative reason by sponsor|0|||
149102287|NCT01628692|537854482|FG001|Overall Study|Administrative reason by sponsor|0|||
149102288|NCT01628692|537854483|FG002|Overall Study|Administrative reason by sponsor|0|||
149102289|NCT01628692|537854484|FG003|Overall Study|Administrative reason by sponsor|0|||
149102290|NCT01628692|537854485|FG004|Overall Study|Administrative reason by sponsor|0|||
149102291|NCT01628692|537854486|FG005|Overall Study|Administrative reason by sponsor|1|||
149102292|NCT01628692|537854481|FG000|Overall Study|Completed 12 Week only|0|||
149102293|NCT01628692|537854482|FG001|Overall Study|Completed 12 Week only|0|||
149102294|NCT01628692|537854483|FG002|Overall Study|Completed 12 Week only|0|||
149102295|NCT01628692|537854484|FG003|Overall Study|Completed 12 Week only|0|||
149102296|NCT01628692|537854485|FG004|Overall Study|Completed 12 Week only|0|||
149102297|NCT01628692|537854486|FG005|Overall Study|Completed 12 Week only|1|||
149102298|NCT01182181|537854487|FG000|First Intervention|Adverse Event|1|||
149102299|NCT01182181|537854488|FG001|First Intervention|Adverse Event|0|||
149102300|NCT01182181|537854487|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
149102301|NCT01182181|537854488|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
149102302|NCT01587118|537854491|FG000|Overall Study|Adverse Event|3|||
149102303|NCT01587118|537854491|FG000|Overall Study|Lost to Follow-up|2|||
149102304|NCT01587118|537854491|FG000|Overall Study|Relocation|1|||
149102305|NCT01587118|537854491|FG000|Overall Study|nonresponse|1|||
149102306|NCT00745498|537854500|FG000|Overall Study|Lost to Follow-up|1|||
149102307|NCT00745498|537854501|FG001|Overall Study|Lost to Follow-up|1|||
149102308|NCT00745498|537854502|FG002|Overall Study|Lost to Follow-up|3|||
149102309|NCT00745498|537854500|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
149102310|NCT00745498|537854501|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
149102311|NCT00745498|537854502|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
149102312|NCT00745498|537854500|FG000|Overall Study|Non-PDR related VH|0|||
149102313|NCT00745498|537854501|FG001|Overall Study|Non-PDR related VH|1|||
149102314|NCT00745498|537854502|FG002|Overall Study|Non-PDR related VH|1|||
149102315|NCT00745498|537854500|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
149102316|NCT00745498|537854501|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
149102317|NCT00745498|537854502|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
149102318|NCT03174782|537854503|FG000|Overall Study|Protocol Violation|1|||
149102319|NCT03174782|537854504|FG001|Overall Study|Protocol Violation|0|||
149102320|NCT03174782|537854503|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
149102321|NCT03174782|537854504|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
149102322|NCT00778921|537854505|FG000|Overall Study|Adverse Event|9|||
149102323|NCT00778921|537854506|FG001|Overall Study|Adverse Event|10|||
149102324|NCT00778921|537854507|FG002|Overall Study|Adverse Event|14|||
149102325|NCT00778921|537854505|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
149102326|NCT00778921|537854506|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
149102327|NCT00778921|537854507|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
149102328|NCT00778921|537854505|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
149102329|NCT00778921|537854506|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
149102330|NCT00778921|537854507|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
149102331|NCT00778921|537854505|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
149102332|NCT00778921|537854506|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
149102333|NCT00778921|537854507|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
149102334|NCT00778921|537854505|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
149102335|NCT00778921|537854506|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
149102336|NCT00778921|537854507|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
149102337|NCT00778921|537854505|FG000|Overall Study|Patient withdrew request|3|||
149102338|NCT00778921|537854506|FG001|Overall Study|Patient withdrew request|1|||
149102339|NCT00778921|537854507|FG002|Overall Study|Patient withdrew request|6|||
149102340|NCT00778921|537854505|FG000|Overall Study|Lost to Follow-up|0|||
149102341|NCT00778921|537854506|FG001|Overall Study|Lost to Follow-up|2|||
149102342|NCT00778921|537854507|FG002|Overall Study|Lost to Follow-up|1|||
149102343|NCT00778921|537854505|FG000|Overall Study|Administrative Problems|1|||
149102344|NCT00778921|537854506|FG001|Overall Study|Administrative Problems|2|||
149102345|NCT00778921|537854507|FG002|Overall Study|Administrative Problems|0|||
149102346|NCT00778921|537854505|FG000|Overall Study|Protocol Violation|3|||
149102347|NCT00778921|537854506|FG001|Overall Study|Protocol Violation|0|||
149102348|NCT00778921|537854507|FG002|Overall Study|Protocol Violation|2|||
149102349|NCT00778921|537854505|FG000|Overall Study|Not treated|0|||
149102350|NCT00778921|537854506|FG001|Overall Study|Not treated|2|||
149102351|NCT00778921|537854507|FG002|Overall Study|Not treated|2|||
149102352|NCT03178045|537854508|FG000|Overall Study|Withdrawal by Subject|5|||
149102353|NCT03178045|537854509|FG001|Overall Study|Withdrawal by Subject|7|||
149102354|NCT03178045|537854508|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
149102355|NCT03178045|537854509|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
149102356|NCT03178045|537854508|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
149102357|NCT03178045|537854509|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
149102358|NCT03636373|537854510|FG000|Overall Study|Study closure due to Covid-19|1|||
149102359|NCT03636373|537854511|FG001|Overall Study|Study closure due to Covid-19|0|||
149102360|NCT00572533|537854512|FG000|Overall Study|Death|4|||
149102361|NCT00572533|537854513|FG001|Overall Study|Death|1|||
149102362|NCT00572533|537854512|FG000|Overall Study|Received Kidney Transplant|2|||
149102363|NCT00572533|537854513|FG001|Overall Study|Received Kidney Transplant|1|||
149102364|NCT00572533|537854512|FG000|Overall Study|Social Issues|1|||
149102365|NCT00572533|537854513|FG001|Overall Study|Social Issues|0|||
149102366|NCT00572533|537854512|FG000|Overall Study|Transfer out of Facility|0|||
149102367|NCT00572533|537854513|FG001|Overall Study|Transfer out of Facility|1|||
149102368|NCT01078922|537854514|FG000|Overall Study|Adverse Event|1|||
149102369|NCT02353468|537854515|FG000|Overall Study|Study terminated|3|||
149102370|NCT00003477|537854516|FG000|Overall Study|Not evalauable|4|||
149102371|NCT00267098|537854517|FG000|Overall Study|Death|0|||
149102372|NCT00267098|537854518|FG001|Overall Study|Death|0|||
149102373|NCT00267098|537854519|FG002|Overall Study|Death|57|||
149102374|NCT00267098|537854520|FG003|Overall Study|Death|66|||
149102375|NCT00267098|537854521|FG004|Overall Study|Death|14|||
149102376|NCT00267098|537854522|FG005|Overall Study|Death|23|||
149102377|NCT00267098|537854523|FG006|Overall Study|Death|28|||
149102378|NCT00267098|537854524|FG007|Overall Study|Death|9|||
149102379|NCT00267098|537854517|FG000|Overall Study|Lost to Follow-up|0|||
149102380|NCT00267098|537854518|FG001|Overall Study|Lost to Follow-up|0|||
149102381|NCT00267098|537854519|FG002|Overall Study|Lost to Follow-up|6|||
149102382|NCT00267098|537854520|FG003|Overall Study|Lost to Follow-up|5|||
149102383|NCT00267098|537854521|FG004|Overall Study|Lost to Follow-up|2|||
149102384|NCT00267098|537854522|FG005|Overall Study|Lost to Follow-up|3|||
149102385|NCT00267098|537854523|FG006|Overall Study|Lost to Follow-up|1|||
149102386|NCT00267098|537854524|FG007|Overall Study|Lost to Follow-up|1|||
149102387|NCT00267098|537854517|FG000|Overall Study|Withdrawal by Subject|8|||
149102388|NCT00267098|537854518|FG001|Overall Study|Withdrawal by Subject|0|||
149102389|NCT00267098|537854519|FG002|Overall Study|Withdrawal by Subject|24|||
149102390|NCT00267098|537854520|FG003|Overall Study|Withdrawal by Subject|21|||
149102391|NCT00267098|537854521|FG004|Overall Study|Withdrawal by Subject|12|||
149102392|NCT00267098|537854522|FG005|Overall Study|Withdrawal by Subject|9|||
149102393|NCT00267098|537854523|FG006|Overall Study|Withdrawal by Subject|12|||
149102394|NCT00267098|537854524|FG007|Overall Study|Withdrawal by Subject|5|||
149102395|NCT00267098|537854517|FG000|Overall Study|Physician Decision|5|||
149102396|NCT00267098|537854518|FG001|Overall Study|Physician Decision|0|||
149102397|NCT00267098|537854519|FG002|Overall Study|Physician Decision|7|||
149102398|NCT00267098|537854520|FG003|Overall Study|Physician Decision|11|||
149102399|NCT00267098|537854521|FG004|Overall Study|Physician Decision|5|||
149102400|NCT00267098|537854522|FG005|Overall Study|Physician Decision|4|||
149102401|NCT00267098|537854523|FG006|Overall Study|Physician Decision|3|||
149102402|NCT00267098|537854524|FG007|Overall Study|Physician Decision|0|||
149102403|NCT00267098|537854517|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
149102404|NCT00267098|537854518|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149102405|NCT00267098|537854519|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149102406|NCT00267098|537854520|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149102407|NCT00267098|537854521|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
149102408|NCT00267098|537854522|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149102409|NCT00267098|537854523|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149102410|NCT00267098|537854524|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
149102411|NCT00267098|537854517|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102412|NCT00267098|537854518|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
149102413|NCT00267098|537854519|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102414|NCT00267098|537854520|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102415|NCT00267098|537854521|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102416|NCT00267098|537854522|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102417|NCT00267098|537854523|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102418|NCT00267098|537854524|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
149102419|NCT00267098|537854517|FG000|Overall Study|Site closure|0|||
149102420|NCT00267098|537854518|FG001|Overall Study|Site closure|0|||
149102421|NCT00267098|537854519|FG002|Overall Study|Site closure|0|||
149102422|NCT00267098|537854520|FG003|Overall Study|Site closure|1|||
149102423|NCT00267098|537854521|FG004|Overall Study|Site closure|0|||
149102424|NCT00267098|537854522|FG005|Overall Study|Site closure|1|||
149102425|NCT00267098|537854523|FG006|Overall Study|Site closure|1|||
149102426|NCT00267098|537854524|FG007|Overall Study|Site closure|0|||
149102427|NCT00267098|537854517|FG000|Overall Study|Explanted Medtronic device|0|||
149102428|NCT00267098|537854518|FG001|Overall Study|Explanted Medtronic device|0|||
149102429|NCT00267098|537854519|FG002|Overall Study|Explanted Medtronic device|0|||
149102430|NCT00267098|537854520|FG003|Overall Study|Explanted Medtronic device|1|||
149102431|NCT00267098|537854521|FG004|Overall Study|Explanted Medtronic device|0|||
149102432|NCT00267098|537854522|FG005|Overall Study|Explanted Medtronic device|0|||
149102433|NCT00267098|537854523|FG006|Overall Study|Explanted Medtronic device|0|||
149102434|NCT00267098|537854524|FG007|Overall Study|Explanted Medtronic device|0|||
149102435|NCT00267098|537854517|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102436|NCT00267098|537854518|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102437|NCT00267098|537854519|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102438|NCT00267098|537854520|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102439|NCT00267098|537854521|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
149102440|NCT00267098|537854522|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102441|NCT00267098|537854523|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102442|NCT00267098|537854524|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
149102443|NCT00267098|537854517|FG000|Overall Study|Subject listed for heart transplant|0|||
149102444|NCT00267098|537854518|FG001|Overall Study|Subject listed for heart transplant|0|||
149102445|NCT00267098|537854519|FG002|Overall Study|Subject listed for heart transplant|0|||
149102446|NCT00267098|537854520|FG003|Overall Study|Subject listed for heart transplant|0|||
149102447|NCT00267098|537854521|FG004|Overall Study|Subject listed for heart transplant|0|||
149102448|NCT00267098|537854522|FG005|Overall Study|Subject listed for heart transplant|0|||
149102449|NCT00267098|537854523|FG006|Overall Study|Subject listed for heart transplant|1|||
149102450|NCT00267098|537854524|FG007|Overall Study|Subject listed for heart transplant|0|||
149102451|NCT00267098|537854517|FG000|Overall Study|Sponsor withdrew subject|0|||
149102452|NCT00267098|537854518|FG001|Overall Study|Sponsor withdrew subject|0|||
149102453|NCT00267098|537854519|FG002|Overall Study|Sponsor withdrew subject|0|||
149102454|NCT00267098|537854520|FG003|Overall Study|Sponsor withdrew subject|1|||
149102455|NCT00267098|537854521|FG004|Overall Study|Sponsor withdrew subject|0|||
149102456|NCT00267098|537854522|FG005|Overall Study|Sponsor withdrew subject|0|||
149102457|NCT00267098|537854523|FG006|Overall Study|Sponsor withdrew subject|0|||
149102458|NCT00267098|537854524|FG007|Overall Study|Sponsor withdrew subject|0|||
149102459|NCT01575873|537854525|FG000|Overall Study|Withdrawal by Subject|15|||
149102460|NCT01575873|537854526|FG001|Overall Study|Withdrawal by Subject|20|||
149102461|NCT01575873|537854527|FG002|Overall Study|Withdrawal by Subject|34|||
149102462|NCT01575873|537854528|FG003|Overall Study|Withdrawal by Subject|34|||
149102463|NCT01575873|537854525|FG000|Overall Study|Adverse Event|7|||
149102464|NCT01575873|537854526|FG001|Overall Study|Adverse Event|7|||
149102465|NCT01575873|537854527|FG002|Overall Study|Adverse Event|9|||
149102466|NCT01575873|537854528|FG003|Overall Study|Adverse Event|12|||
149102467|NCT01575873|537854525|FG000|Overall Study|Lost to Follow-up|1|||
149102468|NCT01575873|537854526|FG001|Overall Study|Lost to Follow-up|3|||
149102469|NCT01575873|537854527|FG002|Overall Study|Lost to Follow-up|13|||
149102470|NCT01575873|537854528|FG003|Overall Study|Lost to Follow-up|5|||
149102471|NCT01575873|537854525|FG000|Overall Study|Death|3|||
149102472|NCT01575873|537854526|FG001|Overall Study|Death|2|||
149102473|NCT01575873|537854527|FG002|Overall Study|Death|8|||
149102474|NCT01575873|537854528|FG003|Overall Study|Death|9|||
149102475|NCT01575873|537854525|FG000|Overall Study|Noncompliance|1|||
149102476|NCT01575873|537854526|FG001|Overall Study|Noncompliance|2|||
149102477|NCT01575873|537854527|FG002|Overall Study|Noncompliance|4|||
149102478|NCT01575873|537854528|FG003|Overall Study|Noncompliance|3|||
149102479|NCT01575873|537854525|FG000|Overall Study|Administrative decision|1|||
149102480|NCT01575873|537854526|FG001|Overall Study|Administrative decision|1|||
149102481|NCT01575873|537854527|FG002|Overall Study|Administrative decision|1|||
149102482|NCT01575873|537854528|FG003|Overall Study|Administrative decision|0|||
149102483|NCT01575873|537854525|FG000|Overall Study|Protocol deviation|0|||
149102484|NCT01575873|537854526|FG001|Overall Study|Protocol deviation|1|||
149102485|NCT01575873|537854527|FG002|Overall Study|Protocol deviation|0|||
149102486|NCT01575873|537854528|FG003|Overall Study|Protocol deviation|1|||
149102487|NCT01575873|537854525|FG000|Overall Study|Requirement for Alternative Therapy|0|||
149102488|NCT01575873|537854526|FG001|Overall Study|Requirement for Alternative Therapy|0|||
149102489|NCT01575873|537854527|FG002|Overall Study|Requirement for Alternative Therapy|1|||
149102490|NCT01575873|537854528|FG003|Overall Study|Requirement for Alternative Therapy|1|||
149102491|NCT01575873|537854525|FG000|Overall Study|Other|0|||
149102492|NCT01575873|537854526|FG001|Overall Study|Other|0|||
149102493|NCT01575873|537854527|FG002|Overall Study|Other|4|||
149102494|NCT01575873|537854528|FG003|Overall Study|Other|2|||
149102495|NCT00798304|537854529|FG000|Overall Study|Adverse Event|0|||
149102496|NCT00798304|537854530|FG001|Overall Study|Adverse Event|1|||
149102497|NCT00798304|537854531|FG002|Overall Study|Adverse Event|1|||
149102498|NCT00798304|537854529|FG000|Overall Study|Discontinuation by Sponsor|14|||
149102499|NCT00798304|537854530|FG001|Overall Study|Discontinuation by Sponsor|21|||
149102500|NCT00798304|537854531|FG002|Overall Study|Discontinuation by Sponsor|9|||
149102501|NCT02031536|537854532|FG000|Overall Study|ineligible|1|||
149102502|NCT02031536|537854533|FG001|Overall Study|ineligible|0|||
149102503|NCT04211389|537854534|FG000|Overall Study|Adverse Event|1|||
149102504|NCT04211389|537854535|FG001|Overall Study|Adverse Event|2|||
149102505|NCT04211389|537854534|FG000|Overall Study|Lost to Follow-up|15|||
149102506|NCT04211389|537854535|FG001|Overall Study|Lost to Follow-up|7|||
149102507|NCT04211389|537854534|FG000|Overall Study|Protocol Violation|0|||
149102508|NCT04211389|537854535|FG001|Overall Study|Protocol Violation|1|||
149102509|NCT04211389|537854534|FG000|Overall Study|Withdrawal by Subject|10|||
149102510|NCT04211389|537854535|FG001|Overall Study|Withdrawal by Subject|11|||
149102511|NCT00547534|537854539|FG000|Overall Study|Adverse Event|7|||
149102512|NCT00547534|537854539|FG000|Overall Study|Disease Progression|4|||
149102513|NCT02688530|537854551|FG000|Overall Study|Withdrawal by Subject|0|||
149102514|NCT02688530|537854552|FG001|Overall Study|Withdrawal by Subject|1|||
149102515|NCT02688530|537854553|FG002|Overall Study|Withdrawal by Subject|0|||
149102516|NCT02688530|537854554|FG003|Overall Study|Withdrawal by Subject|0|||
149102517|NCT02688530|537854551|FG000|Overall Study|Lost to Follow-up|0|||
149102518|NCT02688530|537854552|FG001|Overall Study|Lost to Follow-up|0|||
149102519|NCT02688530|537854553|FG002|Overall Study|Lost to Follow-up|2|||
149102520|NCT02688530|537854554|FG003|Overall Study|Lost to Follow-up|0|||
149102521|NCT01658020|537854555|FG000|Overall Study|Adverse Event|3|||
149102522|NCT01658020|537854556|FG001|Overall Study|Adverse Event|3|||
149102523|NCT01658020|537854555|FG000|Overall Study|Lost to Follow-up|1|||
149102524|NCT01658020|537854556|FG001|Overall Study|Lost to Follow-up|0|||
149102525|NCT01658020|537854555|FG000|Overall Study|Withdrawal by Subject|4|||
149102526|NCT01658020|537854556|FG001|Overall Study|Withdrawal by Subject|5|||
149102527|NCT01658020|537854555|FG000|Overall Study|Protocol Violation|0|||
149102528|NCT01658020|537854556|FG001|Overall Study|Protocol Violation|1|||
149102529|NCT04206085|537854557|FG000|Overall Study|Lost to Follow-up|0|||
149102530|NCT04206085|537854558|FG001|Overall Study|Lost to Follow-up|1|||
149102531|NCT04206085|537854559|FG002|Overall Study|Lost to Follow-up|0|||
149102532|NCT04206085|537854557|FG000|Overall Study|Lost to Follow-up|0|||
149102533|NCT04206085|537854558|FG001|Overall Study|Lost to Follow-up|0|||
149102534|NCT04206085|537854559|FG002|Overall Study|Lost to Follow-up|1|||
149102535|NCT00725543|537854560|FG000|Overall Study|Adverse Event|10|||
149102536|NCT00725543|537854560|FG000|Overall Study|Lack of Efficacy|3|||
149102537|NCT00725543|537854560|FG000|Overall Study|Withdrawal by Subject|10|||
149102538|NCT00725543|537854560|FG000|Overall Study|Physician Decision|5|||
149102539|NCT00725543|537854560|FG000|Overall Study|Lost to Follow-up|4|||
149102540|NCT00725543|537854560|FG000|Overall Study|Non-compliance|2|||
149102541|NCT00725543|537854560|FG000|Overall Study|Other|119|||
149102542|NCT01062971|537854567|FG000|Overall Study|Protocol Violation|1|||
149102543|NCT01062971|537854568|FG001|Overall Study|Protocol Violation|3|||
149102544|NCT01062971|537854567|FG000|Overall Study|Lost to Follow-up|3|||
149102545|NCT01062971|537854568|FG001|Overall Study|Lost to Follow-up|4|||
149102546|NCT01530087|537854569|FG000|Overall Study|Physician Decision|2|||
149102547|NCT02760485|537854570|FG000|Phase 1|Death|3|||
149102548|NCT02760485|537854571|FG001|Phase 1|Death|6|||
149102549|NCT02760485|537854572|FG002|Phase 1|Death|0|||
149102550|NCT02760485|537854570|FG000|Phase 1|Withdrawal by Subject|2|||
149102551|NCT02760485|537854571|FG001|Phase 1|Withdrawal by Subject|0|||
149102552|NCT02760485|537854572|FG002|Phase 1|Withdrawal by Subject|0|||
149102553|NCT02760485|537854570|FG000|Phase 1|Progressive Disease|1|||
149102554|NCT02760485|537854571|FG001|Phase 1|Progressive Disease|0|||
149102555|NCT02760485|537854572|FG002|Phase 1|Progressive Disease|0|||
149102556|NCT02760485|537854570|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
149102557|NCT02760485|537854571|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
149102558|NCT02760485|537854572|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
149102559|NCT02760485|537854570|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
149102560|NCT02760485|537854571|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
149102561|NCT02760485|537854572|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
149102562|NCT02760485|537854570|FG000|Phase 2|Death|0|||
149102563|NCT02760485|537854571|FG001|Phase 2|Death|0|||
149102564|NCT02760485|537854572|FG002|Phase 2|Death|12|||
149102565|NCT02760485|537854570|FG000|Phase 2|Withdrawal by Subject|0|||
149102566|NCT02760485|537854571|FG001|Phase 2|Withdrawal by Subject|0|||
149102567|NCT02760485|537854572|FG002|Phase 2|Withdrawal by Subject|3|||
149102568|NCT02760485|537854570|FG000|Phase 2|Progressive Disease|0|||
149102569|NCT02760485|537854571|FG001|Phase 2|Progressive Disease|0|||
149102570|NCT02760485|537854572|FG002|Phase 2|Progressive Disease|1|||
149102571|NCT02760485|537854570|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
149102572|NCT02760485|537854571|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
149102573|NCT02760485|537854572|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
149102574|NCT03845023|537854573|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
149102575|NCT03845023|537854574|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
149102576|NCT03845023|537854575|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
149102577|NCT03845023|537854576|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
149102578|NCT03845023|537854573|FG000|Follow-Up (14 Days)|Adverse Event|0|||
149102579|NCT03845023|537854574|FG001|Follow-Up (14 Days)|Adverse Event|0|||
149102580|NCT03845023|537854575|FG002|Follow-Up (14 Days)|Adverse Event|1|||
149102581|NCT03845023|537854576|FG003|Follow-Up (14 Days)|Adverse Event|1|||
149102582|NCT01182207|537854577|FG000|First Intervention|Positive Hepatitis Results|0|||
149102583|NCT01182207|537854578|FG001|First Intervention|Positive Hepatitis Results|1|||
149102584|NCT01182207|537854577|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
149102585|NCT01182207|537854578|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
149102586|NCT02353871|537854579|FG000|Overall Study|Protocol deviation|0|||
149102587|NCT02353871|537854580|FG001|Overall Study|Protocol deviation|1|||
149102588|NCT02353871|537854579|FG000|Overall Study|Consent withdrawn|1|||
149102589|NCT02353871|537854580|FG001|Overall Study|Consent withdrawn|8|||
149102590|NCT02353871|537854579|FG000|Overall Study|Lost to Follow-up|2|||
149102591|NCT02353871|537854580|FG001|Overall Study|Lost to Follow-up|0|||
149102592|NCT04750577|537854586|FG000|Overall Study|Adverse Event|2|||
149102593|NCT04750577|537854587|FG001|Overall Study|Adverse Event|10|||
149102594|NCT04750577|537854588|FG002|Overall Study|Adverse Event|8|||
149102595|NCT04750577|537854589|FG003|Overall Study|Adverse Event|1|||
149102596|NCT04750577|537854586|FG000|Overall Study|Change of residence|0|||
149102597|NCT04750577|537854587|FG001|Overall Study|Change of residence|0|||
149102598|NCT04750577|537854588|FG002|Overall Study|Change of residence|1|||
149102599|NCT04750577|537854589|FG003|Overall Study|Change of residence|0|||
149102600|NCT04750577|537854586|FG000|Overall Study|Burden of study procedures|0|||
149102601|NCT04750577|537854587|FG001|Overall Study|Burden of study procedures|2|||
149102602|NCT04750577|537854588|FG002|Overall Study|Burden of study procedures|2|||
149102603|NCT04750577|537854589|FG003|Overall Study|Burden of study procedures|0|||
149102604|NCT04750577|537854586|FG000|Overall Study|Prematurely discontinued|0|||
149102605|NCT04750577|537854587|FG001|Overall Study|Prematurely discontinued|0|||
149102606|NCT04750577|537854588|FG002|Overall Study|Prematurely discontinued|0|||
149102607|NCT04750577|537854589|FG003|Overall Study|Prematurely discontinued|2|||
149102608|NCT04750577|537854586|FG000|Overall Study|Protocol deviation|1|||
149102609|NCT04750577|537854587|FG001|Overall Study|Protocol deviation|1|||
149102610|NCT04750577|537854588|FG002|Overall Study|Protocol deviation|1|||
149102611|NCT04750577|537854589|FG003|Overall Study|Protocol deviation|1|||
149102612|NCT04750577|537854586|FG000|Overall Study|Other than listed|3|||
149102613|NCT04750577|537854587|FG001|Overall Study|Other than listed|2|||
149102614|NCT04750577|537854588|FG002|Overall Study|Other than listed|2|||
149102615|NCT04750577|537854589|FG003|Overall Study|Other than listed|1|||
149102616|NCT04750577|537854586|FG000|Overall Study|Not treated|0|||
149102617|NCT04750577|537854587|FG001|Overall Study|Not treated|0|||
149102618|NCT04750577|537854588|FG002|Overall Study|Not treated|0|||
149102619|NCT04750577|537854589|FG003|Overall Study|Not treated|2|||
149102620|NCT02647645|537854592|FG000|Overall Study|Lost to Follow-up|2|||
149102621|NCT02647645|537854593|FG001|Overall Study|Lost to Follow-up|1|||
149102622|NCT03371823|537854596|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
149102623|NCT03371823|537854597|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
149102624|NCT01466790|537854598|FG000|Overall Study|Adverse Event|1|||
149102625|NCT01466790|537854599|FG001|Overall Study|Adverse Event|0|||
149102626|NCT01466790|537854600|FG002|Overall Study|Adverse Event|0|||
149102627|NCT01466790|537854601|FG003|Overall Study|Adverse Event|0|||
149102628|NCT01466790|537854602|FG004|Overall Study|Adverse Event|2|||
149102629|NCT01466790|537854603|FG005|Overall Study|Adverse Event|0|||
149102630|NCT01466790|537854604|FG006|Overall Study|Adverse Event|0|||
149102631|NCT01466790|537854605|FG007|Overall Study|Adverse Event|0|||
149102632|NCT01466790|537854598|FG000|Overall Study|Lost to Follow-up|2|||
149102633|NCT01466790|537854599|FG001|Overall Study|Lost to Follow-up|0|||
149102634|NCT01466790|537854600|FG002|Overall Study|Lost to Follow-up|0|||
149102635|NCT01466790|537854601|FG003|Overall Study|Lost to Follow-up|0|||
149102636|NCT01466790|537854602|FG004|Overall Study|Lost to Follow-up|0|||
149102637|NCT01466790|537854603|FG005|Overall Study|Lost to Follow-up|0|||
149102638|NCT01466790|537854604|FG006|Overall Study|Lost to Follow-up|0|||
149102639|NCT01466790|537854605|FG007|Overall Study|Lost to Follow-up|0|||
149102640|NCT01466790|537854598|FG000|Overall Study|Withdrawal by Subject|1|||
149102641|NCT01466790|537854599|FG001|Overall Study|Withdrawal by Subject|1|||
149102642|NCT01466790|537854600|FG002|Overall Study|Withdrawal by Subject|0|||
149102643|NCT01466790|537854601|FG003|Overall Study|Withdrawal by Subject|0|||
149102644|NCT01466790|537854602|FG004|Overall Study|Withdrawal by Subject|1|||
149102645|NCT01466790|537854603|FG005|Overall Study|Withdrawal by Subject|0|||
149102646|NCT01466790|537854604|FG006|Overall Study|Withdrawal by Subject|1|||
149102647|NCT01466790|537854605|FG007|Overall Study|Withdrawal by Subject|1|||
149102648|NCT00356811|537854607|FG000|Overall Study|Death|35|||
149102649|NCT00356811|537854607|FG000|Overall Study|Lost to Follow-up|2|||
149102650|NCT00356811|537854607|FG000|Overall Study|Withdrawal by Subject|6|||
149102651|NCT00356811|537854607|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
149102652|NCT00356811|537854607|FG000|Overall Study|Study Is Terminating|3|||
149102653|NCT00356811|537854607|FG000|Overall Study|Site Closed during Follow-up|2|||
149102654|NCT02386839|537854608|FG000|Overall Study|Death|1|||
149102655|NCT02386839|537854609|FG001|Overall Study|Death|0|||
149102656|NCT02386839|537854608|FG000|Overall Study|Withdrawal by Subject|9|||
149102657|NCT02386839|537854609|FG001|Overall Study|Withdrawal by Subject|10|||
149102658|NCT02386839|537854608|FG000|Overall Study|Lost to Follow-up|4|||
149102659|NCT02386839|537854609|FG001|Overall Study|Lost to Follow-up|4|||
149102660|NCT02386839|537854608|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
149102661|NCT02386839|537854609|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
149102662|NCT02386839|537854608|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
149102663|NCT02386839|537854609|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
149102664|NCT02386839|537854608|FG000|Overall Study|Other (unspecified)|1|||
149102665|NCT02386839|537854609|FG001|Overall Study|Other (unspecified)|0|||
149102666|NCT02242643|537854612|FG000|Overall Study|Protocol Violation|1|||
149102667|NCT02242643|537854613|FG001|Overall Study|Protocol Violation|2|||
149102668|NCT02242643|537854612|FG000|Overall Study|Withdrawal by Subject|15|||
149102669|NCT02242643|537854613|FG001|Overall Study|Withdrawal by Subject|10|||
149102670|NCT02242643|537854612|FG000|Overall Study|Migrated/moved from study area|1|||
149102671|NCT02242643|537854613|FG001|Overall Study|Migrated/moved from study area|3|||
149102672|NCT02242643|537854612|FG000|Overall Study|Lost to Follow-up|54|||
149102673|NCT02242643|537854613|FG001|Overall Study|Lost to Follow-up|61|||
149102674|NCT02242643|537854612|FG000|Overall Study|Child placed in foster care by family|0|||
149102675|NCT02242643|537854613|FG001|Overall Study|Child placed in foster care by family|1|||
149102676|NCT02242643|537854612|FG000|Overall Study|Non-compliance|1|||
149102677|NCT02242643|537854613|FG001|Overall Study|Non-compliance|0|||
149102678|NCT02242643|537854612|FG000|Overall Study|Consent withdrawal by parent|1|||
149102679|NCT02242643|537854613|FG001|Overall Study|Consent withdrawal by parent|0|||
149102680|NCT02242643|537854612|FG000|Overall Study|Protocol requirements not followed|1|||
149102681|NCT02242643|537854613|FG001|Overall Study|Protocol requirements not followed|0|||
149102682|NCT02242643|537854612|FG000|Overall Study|Language barrier|1|||
149102683|NCT02242643|537854613|FG001|Overall Study|Language barrier|0|||
149102684|NCT02242643|537854612|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
149102685|NCT02242643|537854613|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
149102686|NCT01103232|537854615|FG000|Overall Study|Withdrawal by Subject|1|||
149102687|NCT01103232|537854616|FG001|Overall Study|Withdrawal by Subject|1|||
149102688|NCT01103232|537854615|FG000|Overall Study|Protocol Violation|0|||
149102689|NCT01103232|537854616|FG001|Overall Study|Protocol Violation|1|||
149102690|NCT05093504|537854617|FG000|Overall Study|Death|0|||
149102691|NCT05093504|537854618|FG001|Overall Study|Death|1|||
149102692|NCT05347485|537854623|FG000|Overall Study|Death|14|||
149102693|NCT05347485|537854623|FG000|Overall Study|Lost to Follow-up|2|||
149102694|NCT05347485|537854623|FG000|Overall Study|Withdrawal by Subject|13|||
149102695|NCT05347485|537854623|FG000|Overall Study|Progressive Disease|1|||
149102696|NCT05347485|537854623|FG000|Overall Study|Study Terminated by Sponsor|49|||
149102697|NCT05347485|537854623|FG000|Overall Study|Other|1|||
149102698|NCT05347485|537854623|FG000|Overall Study|Enrolled (consented) but not treated|4|||
149102699|NCT05347485|537854623|FG000|Overall Study|Disease Relapse|2|||
149102700|NCT03733899|537854624|FG000|Period 1|Protocol Violation|0|||
149102701|NCT03733899|537854625|FG001|Period 1|Protocol Violation|0|||
149102702|NCT03733899|537854626|FG002|Period 1|Protocol Violation|0|||
149102703|NCT03733899|537854627|FG003|Period 1|Protocol Violation|0|||
149102704|NCT03733899|537854628|FG004|Period 1|Protocol Violation|0|||
149102705|NCT03733899|537854629|FG005|Period 1|Protocol Violation|1|||
149102706|NCT03733899|537854624|FG000|Period 2|Unscuccessful Treatment|0|||
149102707|NCT03733899|537854625|FG001|Period 2|Unscuccessful Treatment|1|||
149102708|NCT03733899|537854626|FG002|Period 2|Unscuccessful Treatment|0|||
149102709|NCT03733899|537854627|FG003|Period 2|Unscuccessful Treatment|0|||
149102710|NCT03733899|537854628|FG004|Period 2|Unscuccessful Treatment|0|||
149102711|NCT03733899|537854629|FG005|Period 2|Unscuccessful Treatment|0|||
149102712|NCT03733899|537854624|FG000|Period 3|Withdrawal by Subject|1|||
149102713|NCT03733899|537854625|FG001|Period 3|Withdrawal by Subject|0|||
149102714|NCT03733899|537854626|FG002|Period 3|Withdrawal by Subject|0|||
149102715|NCT03733899|537854627|FG003|Period 3|Withdrawal by Subject|0|||
149102716|NCT03733899|537854628|FG004|Period 3|Withdrawal by Subject|0|||
149102717|NCT03733899|537854629|FG005|Period 3|Withdrawal by Subject|0|||
149102718|NCT03526679|537855555|FG000|Overall Study|still under treatment|2|||
149102719|NCT04369053|537855556|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
149102720|NCT04369053|537855556|FG000|Overall Study|Withdrawal by Subject|773|||
149102721|NCT04369053|537855556|FG000|Overall Study|Lost to Follow-up|182|||
149102722|NCT04369053|537855556|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
149102723|NCT05064488|537855557|FG000|Overall Study|Withdrawal by Subject|2|||
149102724|NCT05064488|537855558|FG001|Overall Study|Withdrawal by Subject|0|||
149102725|NCT04090528|537855561|FG000|Overall Study|participants still on study|9|||
149102726|NCT04090528|537855562|FG001|Overall Study|participants still on study|13|||
149102727|NCT04916002|537855563|FG000|Overall Study|Adverse Event|0|||
149102728|NCT04916002|537855564|FG001|Overall Study|Adverse Event|1|||
149102729|NCT04916002|537855565|FG002|Overall Study|Adverse Event|0|||
149102730|NCT04916002|537855566|FG003|Overall Study|Adverse Event|1|||
149102731|NCT04916002|537855567|FG004|Overall Study|Adverse Event|0|||
149102732|NCT04916002|537855563|FG000|Overall Study|Withdrawal by Subject|3|||
149102733|NCT04916002|537855564|FG001|Overall Study|Withdrawal by Subject|1|||
149102734|NCT04916002|537855565|FG002|Overall Study|Withdrawal by Subject|0|||
149102735|NCT04916002|537855566|FG003|Overall Study|Withdrawal by Subject|1|||
149102736|NCT04916002|537855567|FG004|Overall Study|Withdrawal by Subject|0|||
149102737|NCT04916002|537855563|FG000|Overall Study|Death|8|||
149102738|NCT04916002|537855564|FG001|Overall Study|Death|7|||
149102739|NCT04916002|537855565|FG002|Overall Study|Death|4|||
149102740|NCT04916002|537855566|FG003|Overall Study|Death|9|||
149102741|NCT04916002|537855567|FG004|Overall Study|Death|0|||
149102742|NCT04916002|537855563|FG000|Overall Study|Study Terminated by Sponsor|11|||
149102743|NCT04916002|537855564|FG001|Overall Study|Study Terminated by Sponsor|10|||
149102744|NCT04916002|537855565|FG002|Overall Study|Study Terminated by Sponsor|8|||
149119471|NCT01327495|537916351|FG000|Overall Study|Adverse Event|2|||
149119472|NCT01327495|537916352|FG001|Overall Study|Adverse Event|1|||
149102745|NCT04916002|537855566|FG003|Overall Study|Study Terminated by Sponsor|5|||
149102746|NCT04916002|537855567|FG004|Overall Study|Study Terminated by Sponsor|4|||
149102747|NCT04916002|537855563|FG000|Overall Study|End of trial|1|||
149102748|NCT04916002|537855564|FG001|Overall Study|End of trial|0|||
149102749|NCT04916002|537855565|FG002|Overall Study|End of trial|0|||
149102750|NCT04916002|537855566|FG003|Overall Study|End of trial|0|||
149102751|NCT04916002|537855567|FG004|Overall Study|End of trial|0|||
149102752|NCT04916002|537855563|FG000|Overall Study|Progressive disease|0|||
149102753|NCT04916002|537855564|FG001|Overall Study|Progressive disease|0|||
149102754|NCT04916002|537855565|FG002|Overall Study|Progressive disease|1|||
149102755|NCT04916002|537855566|FG003|Overall Study|Progressive disease|0|||
149102756|NCT04916002|537855567|FG004|Overall Study|Progressive disease|0|||
149102757|NCT04916002|537855563|FG000|Overall Study|Participant non-compliance|2|||
149102758|NCT04916002|537855564|FG001|Overall Study|Participant non-compliance|0|||
149102759|NCT04916002|537855565|FG002|Overall Study|Participant non-compliance|0|||
149102760|NCT04916002|537855566|FG003|Overall Study|Participant non-compliance|0|||
149102761|NCT04916002|537855567|FG004|Overall Study|Participant non-compliance|0|||
149102762|NCT04082429|537855568|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
149102763|NCT04082429|537855569|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
149102764|NCT04082429|537855570|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
149102765|NCT04082429|537855571|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
149102766|NCT04082429|537855572|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
149102767|NCT04082429|537855573|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
149102768|NCT04082429|537855574|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
149102769|NCT04082429|537855575|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
149102770|NCT04082429|537855576|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
149102771|NCT04082429|537855568|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102772|NCT04082429|537855569|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102773|NCT04082429|537855570|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102774|NCT04082429|537855571|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102775|NCT04082429|537855572|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
149102776|NCT04082429|537855573|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102777|NCT04082429|537855574|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102778|NCT04082429|537855575|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102779|NCT04082429|537855576|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
149102780|NCT04082429|537855568|FG000|Main Part (After the Treatment Pause)|Death|0|||
149102781|NCT04082429|537855569|FG001|Main Part (After the Treatment Pause)|Death|0|||
149102782|NCT04082429|537855570|FG002|Main Part (After the Treatment Pause)|Death|0|||
149102783|NCT04082429|537855571|FG003|Main Part (After the Treatment Pause)|Death|0|||
149102784|NCT04082429|537855572|FG004|Main Part (After the Treatment Pause)|Death|1|||
149102785|NCT04082429|537855573|FG005|Main Part (After the Treatment Pause)|Death|0|||
149102786|NCT04082429|537855574|FG006|Main Part (After the Treatment Pause)|Death|0|||
149102787|NCT04082429|537855575|FG007|Main Part (After the Treatment Pause)|Death|0|||
149102788|NCT04082429|537855576|FG008|Main Part (After the Treatment Pause)|Death|0|||
149102789|NCT04082429|537855568|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102790|NCT04082429|537855569|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102791|NCT04082429|537855570|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102792|NCT04082429|537855571|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
149102793|NCT04082429|537855572|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102794|NCT04082429|537855573|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
149119473|NCT01327495|537916353|FG002|Overall Study|Adverse Event|1|||
148891782|NCT02123134|537082340|FG000|Overall Study|Withdrawal of consent|3|||
148891783|NCT02123134|537082341|FG001|Overall Study|Withdrawal of consent|2|||
148891784|NCT02123134|537082340|FG000|Overall Study|Administrative decision|0|||
148891785|NCT02123134|537082341|FG001|Overall Study|Administrative decision|1|||
148891786|NCT01731912|537082347|FG000|Overall Study|noncompliance|2|||
148891787|NCT02043938|537082348|FG000|Overall Study|Withdrawal by Subject|7|||
148891788|NCT02043938|537082348|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
148891789|NCT02043938|537082348|FG000|Overall Study|No show by subject|1|||
148891790|NCT02043938|537082348|FG000|Overall Study|Investigator decision|1|||
148891791|NCT03010527|537082349|FG000|Overall Study|Death|0|||
148891792|NCT03010527|537082350|FG001|Overall Study|Death|0|||
148891793|NCT03010527|537082351|FG002|Overall Study|Death|1|||
148891794|NCT03010527|537082349|FG000|Overall Study|Adverse Event|0|||
148891795|NCT03010527|537082350|FG001|Overall Study|Adverse Event|4|||
148891796|NCT03010527|537082351|FG002|Overall Study|Adverse Event|2|||
148891797|NCT03010527|537082349|FG000|Overall Study|Protocol Violation|0|||
148891798|NCT03010527|537082350|FG001|Overall Study|Protocol Violation|1|||
148891799|NCT03010527|537082351|FG002|Overall Study|Protocol Violation|0|||
148891800|NCT03010527|537082349|FG000|Overall Study|Lost to Follow-up|0|||
148891801|NCT03010527|537082350|FG001|Overall Study|Lost to Follow-up|2|||
148891802|NCT03010527|537082351|FG002|Overall Study|Lost to Follow-up|1|||
148891803|NCT03010527|537082349|FG000|Overall Study|Withdrawal by Subject|0|||
148891804|NCT03010527|537082350|FG001|Overall Study|Withdrawal by Subject|3|||
148891805|NCT03010527|537082351|FG002|Overall Study|Withdrawal by Subject|4|||
148891806|NCT03010527|537082349|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
148891807|NCT03010527|537082350|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
148891808|NCT03010527|537082351|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
148891809|NCT03010527|537082349|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
148891810|NCT03010527|537082350|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
148891811|NCT03010527|537082351|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
148891812|NCT03010527|537082349|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
148891813|NCT03010527|537082350|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
148891814|NCT03010527|537082351|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
148891815|NCT01458639|537082352|FG000|Overall Study|Physician Decision|4|||
148891816|NCT01458639|537082352|FG000|Overall Study|Equipment issue|1|||
148891817|NCT01458639|537082352|FG000|Overall Study|Inability to obtain subject blood sample|1|||
148891818|NCT02656017|537082353|FG000|Overall Study|Study burden|3|||
148891819|NCT02656017|537082354|FG001|Overall Study|Study burden|3|||
148891820|NCT02656017|537082353|FG000|Overall Study|Adverse Event|2|||
148891821|NCT02656017|537082354|FG001|Overall Study|Adverse Event|1|||
148891822|NCT02656017|537082353|FG000|Overall Study|Unable/unwilling to take study medication|2|||
148891823|NCT02656017|537082354|FG001|Overall Study|Unable/unwilling to take study medication|1|||
148891824|NCT02656017|537082353|FG000|Overall Study|Began Tolvaptan|1|||
148891825|NCT02656017|537082354|FG001|Overall Study|Began Tolvaptan|1|||
148891826|NCT02656017|537082353|FG000|Overall Study|Withdrawal by Subject|1|||
148891827|NCT02656017|537082354|FG001|Overall Study|Withdrawal by Subject|0|||
148891828|NCT01755234|537082355|FG000|Overall Study|Lost to Follow-up|11|||
148891829|NCT01755234|537082356|FG001|Overall Study|Lost to Follow-up|6|||
148891830|NCT01755234|537082355|FG000|Overall Study|Change in surgical case|2|||
148891831|NCT01755234|537082356|FG001|Overall Study|Change in surgical case|1|||
148891832|NCT01755234|537082355|FG000|Overall Study|case cancelled|1|||
148891833|NCT01755234|537082356|FG001|Overall Study|case cancelled|0|||
148891834|NCT01755234|537082355|FG000|Overall Study|Withdrawal by Subject|0|||
148891835|NCT01755234|537082356|FG001|Overall Study|Withdrawal by Subject|1|||
148891836|NCT01755234|537082355|FG000|Overall Study|unblinded|1|||
148891837|NCT01755234|537082356|FG001|Overall Study|unblinded|0|||
148891838|NCT00622505|537082357|FG000|Overall Study|Adverse Event|9|||
148891839|NCT00622505|537082358|FG001|Overall Study|Adverse Event|7|||
148891840|NCT00622505|537082357|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
148891841|NCT00622505|537082358|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
148891842|NCT00622505|537082357|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
148891843|NCT00622505|537082358|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
148891844|NCT00622505|537082357|FG000|Overall Study|Withdrawal by Subject|12|||
148891845|NCT00622505|537082358|FG001|Overall Study|Withdrawal by Subject|5|||
148891846|NCT00622505|537082357|FG000|Overall Study|Administrative Problems|2|||
148891847|NCT00622505|537082358|FG001|Overall Study|Administrative Problems|4|||
148891848|NCT00622505|537082357|FG000|Overall Study|Death|2|||
148891849|NCT00622505|537082358|FG001|Overall Study|Death|2|||
148891850|NCT04701333|537082376|FG000|Overall Study|Lost to Follow-up|3|||
148891851|NCT04701333|537082377|FG001|Overall Study|Lost to Follow-up|7|||
148891852|NCT04701333|537082376|FG000|Overall Study|Withdrawal by Subject|0|||
148891853|NCT04701333|537082377|FG001|Overall Study|Withdrawal by Subject|1|||
148891854|NCT01292187|537082378|FG000|Overall Study|Adverse Event|10|||
148891855|NCT01292187|537082379|FG001|Overall Study|Adverse Event|5|||
148891856|NCT01292187|537082378|FG000|Overall Study|Withdrawal by Subject|6|||
148891857|NCT01292187|537082379|FG001|Overall Study|Withdrawal by Subject|5|||
148891858|NCT01292187|537082378|FG000|Overall Study|All other reasons|1|||
148891859|NCT01292187|537082379|FG001|Overall Study|All other reasons|3|||
148891860|NCT02920892|537082380|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
148891861|NCT02920892|537082381|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
148891862|NCT02920892|537082382|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
148891863|NCT02920892|537082380|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
148891864|NCT02920892|537082381|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
148891865|NCT02920892|537082382|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
148891866|NCT02920892|537082380|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
148891867|NCT02920892|537082381|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
148891868|NCT02920892|537082382|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
148891869|NCT02920892|537082380|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
148891870|NCT02920892|537082381|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
148891871|NCT02920892|537082382|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
148891872|NCT02920892|537082380|FG000|Placebo-Controlled Period|Physician Decision|0|||
148891873|NCT02920892|537082381|FG001|Placebo-Controlled Period|Physician Decision|0|||
148891874|NCT02920892|537082382|FG002|Placebo-Controlled Period|Physician Decision|1|||
148891875|NCT02920892|537082380|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
148891876|NCT02920892|537082381|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
148891877|NCT02920892|537082382|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
148891878|NCT02920892|537082380|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
148891879|NCT02920892|537082381|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
148891880|NCT02920892|537082382|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
148891881|NCT02920892|537082380|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
148891882|NCT02920892|537082381|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
148891883|NCT02920892|537082382|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
148891884|NCT02520726|537082383|FG000|Overall Study|Lost to Follow-up|3|||
148891885|NCT02520726|537082384|FG001|Overall Study|Lost to Follow-up|2|||
148891886|NCT01216202|537082385|FG000|Overall Study|Withdrawal by Subject|8|||
148891887|NCT01216202|537082386|FG001|Overall Study|Withdrawal by Subject|0|||
148891888|NCT01216202|537082385|FG000|Overall Study|Death|0|||
148891889|NCT01216202|537082386|FG001|Overall Study|Death|2|||
148891890|NCT01216202|537082385|FG000|Overall Study|Lost to Follow-up|14|||
148891891|NCT01216202|537082386|FG001|Overall Study|Lost to Follow-up|0|||
148891892|NCT00614380|537082392|FG000|Overall Study|Adverse Event|14|||
148891893|NCT00614380|537082393|FG001|Overall Study|Adverse Event|4|||
148891894|NCT00614380|537082394|FG002|Overall Study|Adverse Event|0|||
148891895|NCT00614380|537082395|FG003|Overall Study|Adverse Event|0|||
148891896|NCT00614380|537082392|FG000|Overall Study|Lost to Follow-up|6|||
148891897|NCT00614380|537082393|FG001|Overall Study|Lost to Follow-up|1|||
148891898|NCT00614380|537082394|FG002|Overall Study|Lost to Follow-up|0|||
148891899|NCT00614380|537082395|FG003|Overall Study|Lost to Follow-up|0|||
148891900|NCT00614380|537082392|FG000|Overall Study|Non compliant with the protocol|12|||
148891901|NCT00614380|537082393|FG001|Overall Study|Non compliant with the protocol|2|||
148891902|NCT00614380|537082394|FG002|Overall Study|Non compliant with the protocol|1|||
148891903|NCT00614380|537082395|FG003|Overall Study|Non compliant with the protocol|2|||
148891904|NCT00614380|537082392|FG000|Overall Study|Consent withdrawn|3|||
148891905|NCT00614380|537082393|FG001|Overall Study|Consent withdrawn|1|||
148891906|NCT00614380|537082394|FG002|Overall Study|Consent withdrawn|0|||
148891907|NCT00614380|537082395|FG003|Overall Study|Consent withdrawn|0|||
148891908|NCT01506271|537082396|FG000|Overall Study|Progressive disease|0|||
148891909|NCT01506271|537082397|FG001|Overall Study|Progressive disease|1|||
148891910|NCT01506271|537082398|FG002|Overall Study|Progressive disease|0|||
148891911|NCT01506271|537082396|FG000|Overall Study|Protocol Violation|3|||
148891912|NCT01506271|537082397|FG001|Overall Study|Protocol Violation|1|||
148891913|NCT01506271|537082398|FG002|Overall Study|Protocol Violation|0|||
148891914|NCT01506271|537082396|FG000|Overall Study|Death|0|||
148891915|NCT01506271|537082397|FG001|Overall Study|Death|1|||
148891916|NCT01506271|537082398|FG002|Overall Study|Death|0|||
148891917|NCT01506271|537082396|FG000|Overall Study|Adverse Event|0|||
148891918|NCT01506271|537082397|FG001|Overall Study|Adverse Event|2|||
148891919|NCT01506271|537082398|FG002|Overall Study|Adverse Event|0|||
148891920|NCT01506271|537082396|FG000|Overall Study|Insufficient supply of study drug|1|||
148891921|NCT01506271|537082397|FG001|Overall Study|Insufficient supply of study drug|0|||
148891922|NCT01506271|537082398|FG002|Overall Study|Insufficient supply of study drug|0|||
148891923|NCT01506271|537082396|FG000|Overall Study|Withdrawal by Subject|0|||
148891924|NCT01506271|537082397|FG001|Overall Study|Withdrawal by Subject|1|||
148891925|NCT01506271|537082398|FG002|Overall Study|Withdrawal by Subject|1|||
148891926|NCT01506271|537082396|FG000|Overall Study|Lost to Follow-up|0|||
148891927|NCT01506271|537082397|FG001|Overall Study|Lost to Follow-up|1|||
148891928|NCT01506271|537082398|FG002|Overall Study|Lost to Follow-up|2|||
148891929|NCT01391663|537082399|FG000|Overall Study|Withdrawal by Subject|0|||
148891930|NCT01391663|537082400|FG001|Overall Study|Withdrawal by Subject|0|||
148891931|NCT01391663|537082401|FG002|Overall Study|Withdrawal by Subject|1|||
148891932|NCT01391663|537082402|FG003|Overall Study|Withdrawal by Subject|0|||
148891933|NCT03515824|537082403|FG000|Overall Study|Death|3|||
148891934|NCT03515824|537082404|FG001|Overall Study|Death|2|||
148891935|NCT03515824|537082405|FG002|Overall Study|Death|6|||
148891936|NCT03515824|537082406|FG003|Overall Study|Death|0|||
148891937|NCT03515824|537082403|FG000|Overall Study|Lost to Follow-up|0|||
148891938|NCT03515824|537082404|FG001|Overall Study|Lost to Follow-up|1|||
148891939|NCT03515824|537082405|FG002|Overall Study|Lost to Follow-up|1|||
148891940|NCT03515824|537082406|FG003|Overall Study|Lost to Follow-up|0|||
148891941|NCT03515824|537082403|FG000|Overall Study|Study terminated by sponsor|0|||
148891942|NCT03515824|537082404|FG001|Overall Study|Study terminated by sponsor|1|||
148891943|NCT03515824|537082405|FG002|Overall Study|Study terminated by sponsor|6|||
148891944|NCT03515824|537082406|FG003|Overall Study|Study terminated by sponsor|0|||
148891945|NCT03515824|537082403|FG000|Overall Study|Status not recorded|0|||
148891946|NCT03515824|537082404|FG001|Overall Study|Status not recorded|0|||
148891947|NCT03515824|537082405|FG002|Overall Study|Status not recorded|2|||
148891948|NCT03515824|537082406|FG003|Overall Study|Status not recorded|0|||
148891949|NCT01787461|537082408|FG000|Overall Study|Adverse Event|4|||
148891950|NCT01787461|537082409|FG001|Overall Study|Adverse Event|3|||
148891951|NCT01787461|537082408|FG000|Overall Study|Lost to Follow-up|3|||
148891952|NCT01787461|537082409|FG001|Overall Study|Lost to Follow-up|2|||
148891953|NCT01787461|537082408|FG000|Overall Study|No longer met eligibility criteria|1|||
148891954|NCT01787461|537082409|FG001|Overall Study|No longer met eligibility criteria|0|||
148891955|NCT01787461|537082408|FG000|Overall Study|Withdrawal by Subject|3|||
148891956|NCT01787461|537082409|FG001|Overall Study|Withdrawal by Subject|4|||
148891957|NCT01787461|537082408|FG000|Overall Study|Protocol Violation|3|||
148891958|NCT01787461|537082409|FG001|Overall Study|Protocol Violation|0|||
148891959|NCT00152503|537082410|FG000|Overall Study|Adverse Event|4|||
148891960|NCT04816214|537082412|FG000|Overall Study|Progressive Disease|4|||
148891961|NCT04816214|537082413|FG001|Overall Study|Progressive Disease|0|||
148891962|NCT04816214|537082414|FG002|Overall Study|Progressive Disease|0|||
148891963|NCT04816214|537082412|FG000|Overall Study|Death|1|||
148891964|NCT04816214|537082413|FG001|Overall Study|Death|0|||
148891965|NCT04816214|537082414|FG002|Overall Study|Death|0|||
148891966|NCT04816214|537082412|FG000|Overall Study|Study Terminated by Sponsor|1|||
148891967|NCT04816214|537082413|FG001|Overall Study|Study Terminated by Sponsor|0|||
148891968|NCT04816214|537082414|FG002|Overall Study|Study Terminated by Sponsor|0|||
148891969|NCT01774799|537082415|FG000|Overall Study|Lost to Follow-up|1|||
148891970|NCT01774799|537082416|FG001|Overall Study|Lost to Follow-up|1|||
148891971|NCT01774799|537082417|FG002|Overall Study|Lost to Follow-up|0|||
148891972|NCT01774799|537082418|FG003|Overall Study|Lost to Follow-up|0|||
148891973|NCT02910466|537082419|FG000|Overall Study|Adverse Event|1|||
148891974|NCT02910466|537082419|FG000|Overall Study|Withdrawal by Subject|3|||
148891975|NCT02910466|537082419|FG000|Overall Study|Lost to Follow-up|5|||
148891976|NCT02910466|537082419|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
148891977|NCT02910466|537082419|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
148891978|NCT05051579|537082423|FG000|Overall Study|Withdrawal by Subject|3|||
148891979|NCT05051579|537082424|FG001|Overall Study|Withdrawal by Subject|5|||
148891980|NCT05051579|537082425|FG002|Overall Study|Withdrawal by Subject|2|||
148891981|NCT05051579|537082426|FG003|Overall Study|Withdrawal by Subject|1|||
148891982|NCT05051579|537082427|FG004|Overall Study|Withdrawal by Subject|4|||
148891983|NCT05051579|537082428|FG005|Overall Study|Withdrawal by Subject|0|||
148891984|NCT05051579|537082429|FG006|Overall Study|Withdrawal by Subject|4|||
148891985|NCT05051579|537082423|FG000|Overall Study|Lost to Follow-up|1|||
148891986|NCT05051579|537082424|FG001|Overall Study|Lost to Follow-up|0|||
148891987|NCT05051579|537082425|FG002|Overall Study|Lost to Follow-up|0|||
148891988|NCT05051579|537082426|FG003|Overall Study|Lost to Follow-up|0|||
148891989|NCT05051579|537082427|FG004|Overall Study|Lost to Follow-up|1|||
148891990|NCT05051579|537082428|FG005|Overall Study|Lost to Follow-up|0|||
148891991|NCT05051579|537082429|FG006|Overall Study|Lost to Follow-up|1|||
148891992|NCT05051579|537082423|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
148891993|NCT05051579|537082424|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
148891994|NCT05051579|537082425|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
148891995|NCT05051579|537082426|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
148891996|NCT05051579|537082427|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
148891997|NCT05051579|537082428|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
148891998|NCT05051579|537082429|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
148891999|NCT05051579|537082423|FG000|Overall Study|Adverse Event|2|||
148892000|NCT05051579|537082424|FG001|Overall Study|Adverse Event|1|||
148892001|NCT05051579|537082425|FG002|Overall Study|Adverse Event|0|||
148892002|NCT05051579|537082426|FG003|Overall Study|Adverse Event|4|||
148892003|NCT05051579|537082427|FG004|Overall Study|Adverse Event|1|||
148892004|NCT05051579|537082428|FG005|Overall Study|Adverse Event|2|||
148892005|NCT05051579|537082429|FG006|Overall Study|Adverse Event|0|||
148892006|NCT05051579|537082423|FG000|Overall Study|Inadvertent Enrollment|0|||
148892007|NCT05051579|537082424|FG001|Overall Study|Inadvertent Enrollment|0|||
148892008|NCT05051579|537082425|FG002|Overall Study|Inadvertent Enrollment|0|||
148892009|NCT05051579|537082426|FG003|Overall Study|Inadvertent Enrollment|0|||
148892010|NCT05051579|537082427|FG004|Overall Study|Inadvertent Enrollment|0|||
148892011|NCT05051579|537082428|FG005|Overall Study|Inadvertent Enrollment|0|||
148892012|NCT05051579|537082429|FG006|Overall Study|Inadvertent Enrollment|1|||
148892013|NCT05051579|537082423|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
148892014|NCT05051579|537082424|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
148892015|NCT05051579|537082425|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
148892016|NCT05051579|537082426|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
148892017|NCT05051579|537082427|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
148892018|NCT05051579|537082428|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
148892019|NCT05051579|537082429|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
148892020|NCT05051579|537082423|FG000|Overall Study|Sponsor Decision|0|||
148892021|NCT05051579|537082424|FG001|Overall Study|Sponsor Decision|0|||
148892022|NCT05051579|537082425|FG002|Overall Study|Sponsor Decision|0|||
148892023|NCT05051579|537082426|FG003|Overall Study|Sponsor Decision|0|||
148892024|NCT05051579|537082427|FG004|Overall Study|Sponsor Decision|1|||
148892025|NCT05051579|537082428|FG005|Overall Study|Sponsor Decision|0|||
148892026|NCT05051579|537082429|FG006|Overall Study|Sponsor Decision|0|||
148892027|NCT05051579|537082423|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
148892028|NCT05051579|537082424|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
148892029|NCT05051579|537082425|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
148892030|NCT05051579|537082426|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
148892031|NCT05051579|537082427|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
148892032|NCT05051579|537082428|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
148892033|NCT05051579|537082429|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
148892034|NCT04332107|537082436|FG000|Day 3|Lost to Follow-up|23|||
148892035|NCT04332107|537082437|FG001|Day 3|Lost to Follow-up|14|||
148892036|NCT04332107|537082436|FG000|Day 3|Missing outcome data|3|||
148892037|NCT04332107|537082437|FG001|Day 3|Missing outcome data|6|||
148892038|NCT04332107|537082436|FG000|Day 14|Lost to Follow-up|13|||
148892039|NCT04332107|537082437|FG001|Day 14|Lost to Follow-up|4|||
148892040|NCT04332107|537082436|FG000|Day 14|Missing outcome data|4|||
148892041|NCT04332107|537082437|FG001|Day 14|Missing outcome data|4|||
148892042|NCT04332107|537082436|FG000|Day 21|Lost to Follow-up|10|||
148892043|NCT04332107|537082437|FG001|Day 21|Lost to Follow-up|2|||
148892044|NCT00717249|537082438|FG000|Overall Study|Lens Discomfort|4|||
148892045|NCT00717249|537082439|FG001|Overall Study|Lens Discomfort|1|||
148892046|NCT00717249|537082438|FG000|Overall Study|Unsatisfactory visual Response|0|||
148892047|NCT00717249|537082439|FG001|Overall Study|Unsatisfactory visual Response|2|||
148892048|NCT00717249|537082438|FG000|Overall Study|Adverse Event|4|||
148892049|NCT00717249|537082439|FG001|Overall Study|Adverse Event|2|||
148892050|NCT00717249|537082438|FG000|Overall Study|Lost to Follow-up|2|||
148892051|NCT00717249|537082439|FG001|Overall Study|Lost to Follow-up|0|||
148892052|NCT00717249|537082438|FG000|Overall Study|Withdrawal by Subject|1|||
148892053|NCT00717249|537082439|FG001|Overall Study|Withdrawal by Subject|2|||
148892054|NCT00717249|537082438|FG000|Overall Study|Pregnancy|6|||
148892055|NCT00717249|537082439|FG001|Overall Study|Pregnancy|3|||
148892056|NCT00717249|537082438|FG000|Overall Study|Protocol Violation|0|||
148892057|NCT00717249|537082439|FG001|Overall Study|Protocol Violation|2|||
148892058|NCT00717249|537082438|FG000|Overall Study|Subject became Ineligible|1|||
148892059|NCT00717249|537082439|FG001|Overall Study|Subject became Ineligible|1|||
148892060|NCT00717249|537082438|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
148892061|NCT00717249|537082439|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
148892062|NCT00717249|537082438|FG000|Overall Study|Gastric Surgery|0|||
148892063|NCT00717249|537082439|FG001|Overall Study|Gastric Surgery|1|||
148892064|NCT00717249|537082438|FG000|Overall Study|Diagnosed with Diabetes|1|||
148892065|NCT00717249|537082439|FG001|Overall Study|Diagnosed with Diabetes|0|||
148892066|NCT00717249|537082438|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
148892067|NCT00717249|537082439|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
148892068|NCT00717249|537082438|FG000|Overall Study|Subject relocated|1|||
148892069|NCT00717249|537082439|FG001|Overall Study|Subject relocated|0|||
148892070|NCT00717249|537082438|FG000|Overall Study|Headaches|1|||
148892071|NCT00717249|537082439|FG001|Overall Study|Headaches|0|||
148892072|NCT01670721|537082440|FG000|Overall Study|Participant's decision|15|||
148892073|NCT01670721|537082440|FG000|Overall Study|Other than specified above|38|||
148892074|NCT03799341|537082441|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
148892075|NCT03799341|537082442|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
148892076|NCT03799341|537082443|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
148892077|NCT03799341|537082441|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
148892078|NCT03799341|537082442|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
148892079|NCT03799341|537082443|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
148892080|NCT03799341|537082441|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
148892081|NCT03799341|537082442|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
148892082|NCT03799341|537082443|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
148892083|NCT03799341|537082441|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
148892084|NCT03799341|537082442|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
148892085|NCT03799341|537082443|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
148892086|NCT03799341|537082441|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
148892087|NCT03799341|537082442|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
148892088|NCT03799341|537082443|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
148892089|NCT03799341|537082441|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
148892090|NCT03799341|537082442|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
148892091|NCT03799341|537082443|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
148892092|NCT03100149|537082444|FG000|Overall Study|Adverse Event|0|||
148892093|NCT03100149|537082445|FG001|Overall Study|Adverse Event|1|||
148892094|NCT03100149|537082446|FG002|Overall Study|Adverse Event|0|||
148892095|NCT03100149|537082444|FG000|Overall Study|Participant Moved out of Country|0|||
148892096|NCT03100149|537082445|FG001|Overall Study|Participant Moved out of Country|0|||
148892097|NCT03100149|537082446|FG002|Overall Study|Participant Moved out of Country|1|||
148892098|NCT03100149|537082444|FG000|Overall Study|Withdrawal by Subject|0|||
148892099|NCT03100149|537082445|FG001|Overall Study|Withdrawal by Subject|3|||
148892100|NCT03100149|537082446|FG002|Overall Study|Withdrawal by Subject|1|||
148892101|NCT01871519|537082452|FG000|Overall Study|Death|26|||
148892102|NCT01871519|537082452|FG000|Overall Study|Lost to Follow-up|15|||
148892103|NCT01871519|537082452|FG000|Overall Study|Withdrawal by Subject|49|||
148892104|NCT00320515|537082453|FG000|Overall Study|Death|33|||
148892105|NCT00320515|537082453|FG000|Overall Study|Lost to Follow-up|6|||
148892106|NCT00320515|537082453|FG000|Overall Study|Physician Decision|2|||
148892107|NCT00320515|537082453|FG000|Overall Study|Withdrawal by Subject|8|||
148892108|NCT01063153|537082454|FG000|Overall Study|Found Ineligible During Screening|2|||
148892109|NCT01063153|537082455|FG001|Overall Study|Found Ineligible During Screening|0|||
148892110|NCT01063153|537082454|FG000|Overall Study|Lost to Follow-up|0|||
148892111|NCT01063153|537082455|FG001|Overall Study|Lost to Follow-up|7|||
148892112|NCT01063153|537082454|FG000|Overall Study|Withdrawal by Subject|0|||
148892113|NCT01063153|537082455|FG001|Overall Study|Withdrawal by Subject|1|||
148892114|NCT01063153|537082454|FG000|Overall Study|Physician Decision|0|||
148892115|NCT01063153|537082455|FG001|Overall Study|Physician Decision|4|||
148892116|NCT00350844|537082456|FG000|Overall Study|Lost to Follow-up|1|||
148892117|NCT01420926|537082457|FG000|Overall Study|Adverse Event|6|||
148892118|NCT01420926|537082458|FG001|Overall Study|Adverse Event|4|||
148892119|NCT01420926|537082457|FG000|Overall Study|Death|18|||
148892120|NCT01420926|537082458|FG001|Overall Study|Death|17|||
148892121|NCT01420926|537082457|FG000|Overall Study|Withdrawal by Subject|11|||
148892122|NCT01420926|537082458|FG001|Overall Study|Withdrawal by Subject|17|||
148892123|NCT01420926|537082457|FG000|Overall Study|Non-protocol treatment|17|||
148892124|NCT01420926|537082458|FG001|Overall Study|Non-protocol treatment|20|||
148892125|NCT01420926|537082457|FG000|Overall Study|Physician Decision|8|||
148892126|NCT01420926|537082458|FG001|Overall Study|Physician Decision|5|||
148892127|NCT01232868|537083561|FG000|Overall Study|Lost to Follow-up|2|||
148892128|NCT01232868|537083562|FG001|Overall Study|Lost to Follow-up|4|||
148892129|NCT03737123|537083563|FG000|Study Treatment|Adverse Event|2|||
148892130|NCT03737123|537083564|FG001|Study Treatment|Adverse Event|0|||
148892131|NCT03737123|537083563|FG000|Study Treatment|Disease Progression|2|||
148892132|NCT03737123|537083564|FG001|Study Treatment|Disease Progression|0|||
148892133|NCT03737123|537083563|FG000|Study Treatment|Withdrawal by Subject|2|||
148892134|NCT03737123|537083564|FG001|Study Treatment|Withdrawal by Subject|0|||
148892135|NCT03737123|537083563|FG000|Follow up|Death|1|||
148892136|NCT03737123|537083564|FG001|Follow up|Death|0|||
148892137|NCT03737123|537083563|FG000|Follow up|Withdrawal by Subject|1|||
148892138|NCT03737123|537083564|FG001|Follow up|Withdrawal by Subject|0|||
148892139|NCT03737123|537083563|FG000|Follow up|Termination of study|4|||
148892140|NCT03737123|537083564|FG001|Follow up|Termination of study|0|||
148892141|NCT01342913|537083579|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
148892142|NCT01342913|537083580|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148892143|NCT01342913|537083581|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
148892144|NCT01342913|537083579|FG000|2-week Run-in Period|Physician Decision|6|||
148892145|NCT01342913|537083580|FG001|2-week Run-in Period|Physician Decision|0|||
148892146|NCT01342913|537083581|FG002|2-week Run-in Period|Physician Decision|0|||
148892147|NCT01342913|537083579|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
148892148|NCT01342913|537083580|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
148892149|NCT01342913|537083581|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
148892150|NCT01342913|537083579|FG000|2-week Run-in Period|Adverse Event|2|||
148892151|NCT01342913|537083580|FG001|2-week Run-in Period|Adverse Event|0|||
148892152|NCT01342913|537083581|FG002|2-week Run-in Period|Adverse Event|0|||
148892153|NCT01342913|537083579|FG000|2-week Run-in Period|Protocol Violation|5|||
148892154|NCT01342913|537083580|FG001|2-week Run-in Period|Protocol Violation|0|||
148892155|NCT01342913|537083581|FG002|2-week Run-in Period|Protocol Violation|0|||
148892156|NCT01342913|537083579|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
148892157|NCT01342913|537083580|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
148892158|NCT01342913|537083581|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
148892159|NCT01342913|537083579|FG000|Double-Blind Treatment Period|Adverse Event|0|||
148892160|NCT01342913|537083580|FG001|Double-Blind Treatment Period|Adverse Event|3|||
148892161|NCT01342913|537083581|FG002|Double-Blind Treatment Period|Adverse Event|6|||
148892162|NCT01342913|537083579|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
148892163|NCT01342913|537083580|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
148892164|NCT01342913|537083581|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
148892165|NCT01342913|537083579|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
148892166|NCT01342913|537083580|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
148892167|NCT01342913|537083581|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
148892168|NCT01342913|537083579|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
148892169|NCT01342913|537083580|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
148892170|NCT01342913|537083581|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
148892171|NCT01342913|537083579|FG000|Double-Blind Treatment Period|Physician Decision|0|||
148892172|NCT01342913|537083580|FG001|Double-Blind Treatment Period|Physician Decision|2|||
148892173|NCT01342913|537083581|FG002|Double-Blind Treatment Period|Physician Decision|0|||
148892174|NCT01342913|537083579|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
148892175|NCT01342913|537083580|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
148892176|NCT01342913|537083581|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
148892177|NCT03291067|537083584|FG000|Overall Study|Adverse Event|0|||
148892178|NCT03291067|537083585|FG001|Overall Study|Adverse Event|2|||
148892179|NCT03291067|537083586|FG002|Overall Study|Adverse Event|17|||
148892180|NCT03291067|537083587|FG003|Overall Study|Adverse Event|3|||
148892181|NCT03291067|537083584|FG000|Overall Study|Lost to Follow-up|2|||
148892182|NCT03291067|537083585|FG001|Overall Study|Lost to Follow-up|1|||
148892183|NCT03291067|537083586|FG002|Overall Study|Lost to Follow-up|0|||
148892184|NCT03291067|537083587|FG003|Overall Study|Lost to Follow-up|1|||
148892185|NCT03291067|537083584|FG000|Overall Study|Physician Decision|0|||
148892186|NCT03291067|537083585|FG001|Overall Study|Physician Decision|0|||
148892187|NCT03291067|537083586|FG002|Overall Study|Physician Decision|1|||
148892188|NCT03291067|537083587|FG003|Overall Study|Physician Decision|0|||
148892189|NCT03291067|537083584|FG000|Overall Study|Protocol Violation|5|||
148892190|NCT03291067|537083585|FG001|Overall Study|Protocol Violation|3|||
148892191|NCT03291067|537083586|FG002|Overall Study|Protocol Violation|4|||
148892192|NCT03291067|537083587|FG003|Overall Study|Protocol Violation|2|||
148892193|NCT03291067|537083584|FG000|Overall Study|Withdrawal by Subject|3|||
148892194|NCT03291067|537083585|FG001|Overall Study|Withdrawal by Subject|4|||
148892195|NCT03291067|537083586|FG002|Overall Study|Withdrawal by Subject|7|||
148892196|NCT03291067|537083587|FG003|Overall Study|Withdrawal by Subject|5|||
148892197|NCT03291067|537083584|FG000|Overall Study|Other|0|||
148892198|NCT03291067|537083585|FG001|Overall Study|Other|4|||
148892199|NCT03291067|537083586|FG002|Overall Study|Other|4|||
148892200|NCT03291067|537083587|FG003|Overall Study|Other|6|||
148892201|NCT03683173|537083588|FG000|Completed Follow-up|Unavailable|235|||
148892202|NCT03683173|537083589|FG001|Completed Follow-up|Unavailable|217|||
148892203|NCT03683173|537083588|FG000|Completed Follow-up|Refused|69|||
148892204|NCT03683173|537083589|FG001|Completed Follow-up|Refused|59|||
148892205|NCT03683173|537083588|FG000|Completed Follow-up|Disconnected phone|65|||
148892206|NCT03683173|537083589|FG001|Completed Follow-up|Disconnected phone|95|||
148892207|NCT03683173|537083588|FG000|Completed Follow-up|Health issue/deceased|10|||
148892208|NCT03683173|537083589|FG001|Completed Follow-up|Health issue/deceased|4|||
148892209|NCT03683173|537083588|FG000|Completed Follow-up|Moved away|8|||
148892210|NCT03683173|537083589|FG001|Completed Follow-up|Moved away|1|||
148892211|NCT03016312|537083590|FG000|Overall Study|discontinued before the treatment started|0|||
148892212|NCT03016312|537083591|FG001|Overall Study|discontinued before the treatment started|1|||
148892213|NCT03016312|537083590|FG000|Overall Study|Withdrawal by Subject|37|||
148892214|NCT03016312|537083591|FG001|Overall Study|Withdrawal by Subject|44|||
148892215|NCT03016312|537083590|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
148892216|NCT03016312|537083591|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
148892217|NCT03016312|537083590|FG000|Overall Study|Physician Decision|1|||
148892218|NCT03016312|537083591|FG001|Overall Study|Physician Decision|3|||
148892219|NCT03016312|537083590|FG000|Overall Study|Lost to Follow-up|12|||
148892220|NCT03016312|537083591|FG001|Overall Study|Lost to Follow-up|12|||
148892221|NCT03016312|537083590|FG000|Overall Study|Death|210|||
148892222|NCT03016312|537083591|FG001|Overall Study|Death|184|||
148892223|NCT03016312|537083590|FG000|Overall Study|loss to contact|1|||
148892224|NCT03016312|537083591|FG001|Overall Study|loss to contact|0|||
148892225|NCT03016312|537083590|FG000|Overall Study|started a new cancer therapy|1|||
148892226|NCT03016312|537083591|FG001|Overall Study|started a new cancer therapy|0|||
148892227|NCT02995980|537083592|FG000|Overall Study|Lost to Follow-up|14|||
148892228|NCT01169103|537083594|FG000|Overall Study|Lost to Follow-up|3|||
148892229|NCT01169103|537083595|FG001|Overall Study|Lost to Follow-up|3|||
148892230|NCT01169103|537083594|FG000|Overall Study|Withdrawal by Subject|3|||
148892231|NCT01169103|537083595|FG001|Overall Study|Withdrawal by Subject|1|||
148892232|NCT02634333|537083596|FG000|Overall Study|Completed out of Window|3|||
148892233|NCT02634333|537083597|FG001|Overall Study|Completed out of Window|2|||
148892234|NCT02634333|537083596|FG000|Overall Study|Missed Visit|5|||
148892235|NCT02634333|537083597|FG001|Overall Study|Missed Visit|2|||
148892236|NCT02634333|537083596|FG000|Overall Study|Lost to Follow-up|12|||
148892237|NCT02634333|537083597|FG001|Overall Study|Lost to Follow-up|7|||
148892238|NCT02634333|537083596|FG000|Overall Study|Withdrawal by Subject|9|||
148892239|NCT02634333|537083597|FG001|Overall Study|Withdrawal by Subject|13|||
148892240|NCT02634333|537083596|FG000|Overall Study|Death|11|||
148892241|NCT02634333|537083597|FG001|Overall Study|Death|8|||
148892242|NCT02611479|537083598|FG000|Baseline Enrollment|Exited study|13|||
148892243|NCT02611479|537083598|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
148892244|NCT02611479|537083598|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
148892245|NCT02611479|537083598|FG000|Data Cleaning|No baseline function or pain metrics|2|||
148892246|NCT03275740|537083601|FG000|Overall Study|Adverse Event|0|||
148892247|NCT03275740|537083602|FG001|Overall Study|Adverse Event|0|||
148892248|NCT03275740|537083603|FG002|Overall Study|Adverse Event|0|||
148892249|NCT03275740|537083604|FG003|Overall Study|Adverse Event|0|||
148892250|NCT03275740|537083605|FG004|Overall Study|Adverse Event|1|||
148892251|NCT03275740|537083606|FG005|Overall Study|Adverse Event|0|||
148892252|NCT03275740|537083607|FG006|Overall Study|Adverse Event|0|||
148892253|NCT03275740|537083608|FG007|Overall Study|Adverse Event|0|||
148892254|NCT03275740|537083609|FG008|Overall Study|Adverse Event|0|||
148892255|NCT03275740|537083610|FG009|Overall Study|Adverse Event|0|||
148892256|NCT03275740|537083611|FG010|Overall Study|Adverse Event|0|||
148892257|NCT03275740|537083612|FG011|Overall Study|Adverse Event|0|||
148892258|NCT03275740|537083601|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892259|NCT03275740|537083602|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892260|NCT03275740|537083603|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892261|NCT03275740|537083604|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892262|NCT03275740|537083605|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892263|NCT03275740|537083606|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
148892264|NCT03275740|537083607|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892265|NCT03275740|537083608|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892266|NCT03275740|537083609|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892267|NCT03275740|537083610|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892268|NCT03275740|537083611|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892269|NCT03275740|537083612|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
148892270|NCT03275740|537083601|FG000|Overall Study|Withdrawal by Subject|0|||
148892271|NCT03275740|537083602|FG001|Overall Study|Withdrawal by Subject|0|||
148892272|NCT03275740|537083603|FG002|Overall Study|Withdrawal by Subject|0|||
148892273|NCT03275740|537083604|FG003|Overall Study|Withdrawal by Subject|0|||
148892274|NCT03275740|537083605|FG004|Overall Study|Withdrawal by Subject|0|||
148892275|NCT03275740|537083606|FG005|Overall Study|Withdrawal by Subject|0|||
148892276|NCT03275740|537083607|FG006|Overall Study|Withdrawal by Subject|0|||
148892277|NCT03275740|537083608|FG007|Overall Study|Withdrawal by Subject|0|||
148892278|NCT03275740|537083609|FG008|Overall Study|Withdrawal by Subject|1|||
148892279|NCT03275740|537083610|FG009|Overall Study|Withdrawal by Subject|1|||
148892280|NCT03275740|537083611|FG010|Overall Study|Withdrawal by Subject|0|||
148892281|NCT03275740|537083612|FG011|Overall Study|Withdrawal by Subject|0|||
148892282|NCT00890825|537083613|FG000|Overall Study|Withdrawal by Subject|1|||
148892283|NCT00890825|537083614|FG001|Overall Study|Withdrawal by Subject|0|||
148892284|NCT00890825|537083613|FG000|Overall Study|Alive at data cut off (DCO)|13|||
148892285|NCT00890825|537083614|FG001|Overall Study|Alive at data cut off (DCO)|14|||
148892286|NCT03546621|537083617|FG000|Overall Study|Withdrawal by Subject|0|||
148892287|NCT03546621|537083618|FG001|Overall Study|Withdrawal by Subject|1|||
148892288|NCT03546621|537083619|FG002|Overall Study|Withdrawal by Subject|2|||
149102795|NCT04082429|537855574|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102796|NCT04082429|537855575|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102797|NCT04082429|537855576|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
149102798|NCT04082429|537855568|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
149102799|NCT04082429|537855569|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
148892289|NCT03546621|537083620|FG003|Overall Study|Withdrawal by Subject|1|||
148892290|NCT03546621|537083617|FG000|Overall Study|Lost to Follow-up|0|||
148892291|NCT03546621|537083618|FG001|Overall Study|Lost to Follow-up|1|||
148892292|NCT03546621|537083619|FG002|Overall Study|Lost to Follow-up|0|||
148892293|NCT03546621|537083620|FG003|Overall Study|Lost to Follow-up|0|||
148892294|NCT03546621|537083617|FG000|Overall Study|Adverse Event|0|||
148892295|NCT03546621|537083618|FG001|Overall Study|Adverse Event|1|||
148892296|NCT03546621|537083619|FG002|Overall Study|Adverse Event|0|||
148892297|NCT03546621|537083620|FG003|Overall Study|Adverse Event|1|||
148892298|NCT03546621|537083617|FG000|Overall Study|Progressive disease|0|||
148892299|NCT03546621|537083618|FG001|Overall Study|Progressive disease|0|||
148892300|NCT03546621|537083619|FG002|Overall Study|Progressive disease|0|||
148892301|NCT03546621|537083620|FG003|Overall Study|Progressive disease|1|||
148892302|NCT00660192|537083625|FG000|Overall Study|Lost to Follow-up|2|||
148892303|NCT00660192|537083626|FG001|Overall Study|Lost to Follow-up|3|||
148892304|NCT00377520|537083627|FG000|Overall Study|Ineligible (Prior radiation)|1|||
148892305|NCT04908397|537083629|FG000|Overall Study|Withdrawal by Subject|2|||
148892306|NCT00462306|537083630|FG000|Overall Study|insufficient data|0|||
148892307|NCT00462306|537083631|FG001|Overall Study|insufficient data|13|||
148892308|NCT00920855|537083632|FG000|Overall Study|Adverse Event|1|||
148892309|NCT00920855|537083633|FG001|Overall Study|Adverse Event|1|||
148892310|NCT00920855|537083634|FG002|Overall Study|Adverse Event|4|||
148892311|NCT00920855|537083632|FG000|Overall Study|Withdrawal by Subject|2|||
148892312|NCT00920855|537083633|FG001|Overall Study|Withdrawal by Subject|1|||
148892313|NCT00920855|537083634|FG002|Overall Study|Withdrawal by Subject|6|||
148892314|NCT00920855|537083632|FG000|Overall Study|Disease progression|2|||
148892315|NCT00920855|537083633|FG001|Overall Study|Disease progression|1|||
148892316|NCT00920855|537083634|FG002|Overall Study|Disease progression|10|||
148892317|NCT00920855|537083632|FG000|Overall Study|Noncompliance to study medication|0|||
148892318|NCT00920855|537083633|FG001|Overall Study|Noncompliance to study medication|0|||
148892319|NCT00920855|537083634|FG002|Overall Study|Noncompliance to study medication|1|||
148892320|NCT00920855|537083632|FG000|Overall Study|Response plateau; started maintenance|0|||
148892321|NCT00920855|537083633|FG001|Overall Study|Response plateau; started maintenance|0|||
148892322|NCT00920855|537083634|FG002|Overall Study|Response plateau; started maintenance|1|||
148892323|NCT00539994|537083635|FG000|Overall Study|Lost to Follow-up|2|||
148892324|NCT00539994|537083636|FG001|Overall Study|Lost to Follow-up|1|||
148892325|NCT00539994|537083637|FG002|Overall Study|Lost to Follow-up|0|||
148892326|NCT00539994|537083635|FG000|Overall Study|Withdrawal by Subject|1|||
148892327|NCT00539994|537083636|FG001|Overall Study|Withdrawal by Subject|0|||
148892328|NCT00539994|537083637|FG002|Overall Study|Withdrawal by Subject|1|||
148892329|NCT00539994|537083635|FG000|Overall Study|Physician Decision|0|||
148892330|NCT00539994|537083636|FG001|Overall Study|Physician Decision|0|||
148892331|NCT00539994|537083637|FG002|Overall Study|Physician Decision|1|||
148892332|NCT00510835|537083641|FG000|Overall Study|Withdrawal by Subject|6|||
148892333|NCT00510835|537083642|FG001|Overall Study|Withdrawal by Subject|2|||
148892334|NCT00510835|537083643|FG002|Overall Study|Withdrawal by Subject|2|||
148892335|NCT05470985|537083644|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
148892336|NCT05470985|537083645|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
148892337|NCT05470985|537083644|FG000|Double Blind Treatment Period|Physician Decision|0|||
148892338|NCT05470985|537083645|FG001|Double Blind Treatment Period|Physician Decision|1|||
148892339|NCT05470985|537083644|FG000|Long Term Extension|Adverse Event|0|||
148892340|NCT05470985|537083645|FG001|Long Term Extension|Adverse Event|1|||
148892341|NCT05470985|537083644|FG000|Long Term Extension|Study terminated by sponsor|2|||
148892342|NCT05470985|537083645|FG001|Long Term Extension|Study terminated by sponsor|0|||
148892343|NCT01917747|537083646|FG000|Overall Study|Withdrawal by Subject|1|||
148892344|NCT01917747|537083647|FG001|Overall Study|Withdrawal by Subject|2|||
148892345|NCT01917747|537083646|FG000|Overall Study|Lost to Follow-up|18|||
148892346|NCT01917747|537083647|FG001|Overall Study|Lost to Follow-up|9|||
148892347|NCT03649074|537083648|FG000|Overall Study|Lost to Follow-up|2|||
148892348|NCT03649074|537083649|FG001|Overall Study|Lost to Follow-up|1|||
148892349|NCT03649074|537083648|FG000|Overall Study|Adverse Event|1|||
148892350|NCT03649074|537083649|FG001|Overall Study|Adverse Event|0|||
148892351|NCT03649074|537083648|FG000|Overall Study|Physician Decision|1|||
148892352|NCT03649074|537083649|FG001|Overall Study|Physician Decision|0|||
148892353|NCT03649074|537083648|FG000|Overall Study|Withdrawal by Subject|0|||
148892354|NCT03649074|537083649|FG001|Overall Study|Withdrawal by Subject|2|||
148892355|NCT03649074|537083648|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
148892356|NCT03649074|537083649|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
148892357|NCT03649074|537083648|FG000|Overall Study|Other|1|||
148892358|NCT03649074|537083649|FG001|Overall Study|Other|0|||
148892359|NCT04393493|537083652|FG000|First 4 Days of Intervention|Early improvement|5|||
148892360|NCT04393493|537083653|FG001|First 4 Days of Intervention|Early improvement|7|||
148892361|NCT00990106|537083657|FG000|Overall Study|"too busy to continue"|1|||
148892362|NCT00990106|537083658|FG001|Overall Study|"too busy to continue"|2|||
148892363|NCT00990106|537083657|FG000|Overall Study|Lost to Follow-up|1|||
148892364|NCT00990106|537083658|FG001|Overall Study|Lost to Follow-up|3|||
148892365|NCT00990106|537083657|FG000|Overall Study|Withdrawal by Subject|2|||
148892366|NCT00990106|537083658|FG001|Overall Study|Withdrawal by Subject|1|||
148892367|NCT00990106|537083657|FG000|Overall Study|opted for open label prazosin|1|||
148892368|NCT00990106|537083658|FG001|Overall Study|opted for open label prazosin|1|||
148892369|NCT00990106|537083657|FG000|Overall Study|relocation/deployment|4|||
148892370|NCT00990106|537083658|FG001|Overall Study|relocation/deployment|1|||
148892371|NCT00990106|537083657|FG000|Overall Study|started exclusionary medication|0|||
148892372|NCT00990106|537083658|FG001|Overall Study|started exclusionary medication|1|||
148892373|NCT00990106|537083657|FG000|Overall Study|planned major surgery|0|||
148892374|NCT00990106|537083658|FG001|Overall Study|planned major surgery|1|||
148892375|NCT00990106|537083657|FG000|Overall Study|scheduling conflicts|0|||
148892376|NCT00990106|537083658|FG001|Overall Study|scheduling conflicts|2|||
148892377|NCT02926638|537083671|FG000|Overall Study|Progression|2|||
148892378|NCT02926638|537083672|FG001|Overall Study|Progression|5|||
148892379|NCT02926638|537083671|FG000|Overall Study|Ineligible|1|||
148892380|NCT02926638|537083672|FG001|Overall Study|Ineligible|0|||
148892381|NCT02926638|537083671|FG000|Overall Study|Not protocol specified|1|||
148892382|NCT02926638|537083672|FG001|Overall Study|Not protocol specified|0|||
148892383|NCT04481243|537085596|FG000|Overall Study|Withdrawal by Subject|4|||
148892384|NCT04564846|537085597|FG000|Overall Study|Withdrawal by Subject|2|||
148892385|NCT04564846|537085598|FG001|Overall Study|Withdrawal by Subject|1|||
148892386|NCT04564846|537085597|FG000|Overall Study|Physician Decision|0|||
148892387|NCT04564846|537085598|FG001|Overall Study|Physician Decision|1|||
148892388|NCT04564846|537085597|FG000|Overall Study|Lost to Follow-up|0|||
148892389|NCT04564846|537085598|FG001|Overall Study|Lost to Follow-up|1|||
148892390|NCT04564846|537085597|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
148892391|NCT04564846|537085598|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
148892392|NCT04564846|537085597|FG000|Overall Study|Subject non-compliance|1|||
148892393|NCT04564846|537085598|FG001|Overall Study|Subject non-compliance|0|||
148892394|NCT00445549|537085599|FG000|Overall Study|progressive disease|12|||
148892395|NCT05482308|537085606|FG000|Overall Study|Withdrawal by Subject|1|||
148892396|NCT05482308|537085607|FG001|Overall Study|Withdrawal by Subject|0|||
148892397|NCT05482308|537085606|FG000|Overall Study|No longer meets eligibility criteria|0|||
148892398|NCT05482308|537085607|FG001|Overall Study|No longer meets eligibility criteria|1|||
148892399|NCT04319198|537085608|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
148892400|NCT04319198|537085609|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
148892401|NCT04319198|537085610|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
148892402|NCT04319198|537085608|FG000|Overall Study|Death|0|||
148892403|NCT04319198|537085609|FG001|Overall Study|Death|3|||
148892404|NCT04319198|537085610|FG002|Overall Study|Death|3|||
148892405|NCT04319198|537085608|FG000|Overall Study|Reason Not Specified|0|||
148892406|NCT04319198|537085609|FG001|Overall Study|Reason Not Specified|2|||
148892407|NCT04319198|537085610|FG002|Overall Study|Reason Not Specified|4|||
148892408|NCT04319198|537085608|FG000|Overall Study|Withdrawal of Consent|0|||
148892409|NCT04319198|537085609|FG001|Overall Study|Withdrawal of Consent|0|||
148892410|NCT04319198|537085610|FG002|Overall Study|Withdrawal of Consent|5|||
148892411|NCT04319198|537085608|FG000|Overall Study|Site Terminated by Sponsor|0|||
148892412|NCT04319198|537085609|FG001|Overall Study|Site Terminated by Sponsor|1|||
148892413|NCT04319198|537085610|FG002|Overall Study|Site Terminated by Sponsor|0|||
148892414|NCT05801991|537085611|FG000|Overall Study|Lost to Follow-up|1|||
148892415|NCT05801991|537085612|FG001|Overall Study|Lost to Follow-up|0|||
148892416|NCT03489863|537085616|FG000|Overall Study|Withdrawal by Subject|0|||
148892417|NCT03489863|537085617|FG001|Overall Study|Withdrawal by Subject|1|||
148892418|NCT00141453|537085618|FG000|Overall Study|Protocol Violation|6|||
148892419|NCT00141453|537085619|FG001|Overall Study|Protocol Violation|5|||
148892420|NCT06039579|537085622|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892421|NCT06039579|537085623|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892422|NCT06039579|537085624|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892423|NCT06039579|537085625|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892424|NCT06039579|537085626|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892425|NCT06039579|537085627|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892426|NCT06039579|537085628|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
148892427|NCT06039579|537085629|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
148892428|NCT02792231|537085634|FG000|Overall Study|Patient/guardian decision|32|||
148892429|NCT02792231|537085635|FG001|Overall Study|Patient/guardian decision|42|||
148892430|NCT02792231|537085634|FG000|Overall Study|Adverse Event|15|||
148892431|NCT02792231|537085635|FG001|Overall Study|Adverse Event|11|||
148892432|NCT02792231|537085634|FG000|Overall Study|Physician Decision|14|||
148892433|NCT02792231|537085635|FG001|Overall Study|Physician Decision|12|||
148892434|NCT02792231|537085634|FG000|Overall Study|Lack of Efficacy|7|||
148892435|NCT02792231|537085635|FG001|Overall Study|Lack of Efficacy|9|||
148892436|NCT02792231|537085634|FG000|Overall Study|Lost to Follow-up|9|||
148892437|NCT02792231|537085635|FG001|Overall Study|Lost to Follow-up|5|||
148892438|NCT02792231|537085634|FG000|Overall Study|Pregnancy|1|||
148892439|NCT02792231|537085635|FG001|Overall Study|Pregnancy|3|||
148892440|NCT02792231|537085634|FG000|Overall Study|Non-compliance with study treatment|2|||
148892441|NCT02792231|537085635|FG001|Overall Study|Non-compliance with study treatment|1|||
148892442|NCT02792231|537085634|FG000|Overall Study|Protocol deviation|2|||
148892443|NCT02792231|537085635|FG001|Overall Study|Protocol deviation|0|||
148892444|NCT02792231|537085634|FG000|Overall Study|Technical problems|0|||
148892445|NCT02792231|537085635|FG001|Overall Study|Technical problems|1|||
148892446|NCT04073186|537085636|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
148892447|NCT04073186|537085636|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
148892448|NCT04073186|537085636|FG000|First Wearing Cycle|Protocol Violation|1|||
148892449|NCT04073186|537085636|FG000|First Wearing Cycle|Lens Discomfort|2|||
148892450|NCT04073186|537085636|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
148892451|NCT04073186|537085636|FG000|Second Wearing Cycle|Adverse Event|1|||
148892452|NCT00473434|537085637|FG000|Overall Study|Physician Decision|3|||
148892453|NCT00473434|537085637|FG000|Overall Study|Withdrawal by Subject|9|||
148892454|NCT00473434|537085637|FG000|Overall Study|Compliance|3|||
148892455|NCT00473434|537085637|FG000|Overall Study|Lack of Efficacy|3|||
148892456|NCT00473434|537085637|FG000|Overall Study|Adverse Event|3|||
148892457|NCT00473434|537085637|FG000|Overall Study|Patient was selling medication to others|1|||
148892458|NCT00473434|537085637|FG000|Overall Study|Safety evaluation|1|||
148892459|NCT00473434|537085637|FG000|Overall Study|Reason not specified|6|||
148892460|NCT00473434|537085637|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
148892461|NCT00473434|537085637|FG000|Overall Study|Switching to trial medication|1|||
148892462|NCT00473434|537085637|FG000|Overall Study|No longer required|1|||
148892463|NCT02349633|537085638|FG000|Overall Study|Death|0|||
148892464|NCT02349633|537085639|FG001|Overall Study|Death|1|||
148892465|NCT02349633|537085640|FG002|Overall Study|Death|0|||
148892466|NCT02349633|537085641|FG003|Overall Study|Death|0|||
148892467|NCT02349633|537085642|FG004|Overall Study|Death|0|||
148892468|NCT02349633|537085643|FG005|Overall Study|Death|1|||
148892469|NCT02349633|537085644|FG006|Overall Study|Death|1|||
148892470|NCT02349633|537085645|FG007|Overall Study|Death|1|||
148892471|NCT02349633|537085646|FG008|Overall Study|Death|0|||
148892472|NCT02349633|537085647|FG009|Overall Study|Death|1|||
148892473|NCT02349633|537085648|FG010|Overall Study|Death|0|||
148892474|NCT02349633|537085649|FG011|Overall Study|Death|0|||
148892475|NCT02349633|537085650|FG012|Overall Study|Death|0|||
148892476|NCT02349633|537085651|FG013|Overall Study|Death|0|||
148892477|NCT02349633|537085638|FG000|Overall Study|Withdrawal by Subject|0|||
148892478|NCT02349633|537085639|FG001|Overall Study|Withdrawal by Subject|0|||
148892479|NCT02349633|537085640|FG002|Overall Study|Withdrawal by Subject|0|||
148892480|NCT02349633|537085641|FG003|Overall Study|Withdrawal by Subject|1|||
148892481|NCT02349633|537085642|FG004|Overall Study|Withdrawal by Subject|0|||
148892482|NCT02349633|537085643|FG005|Overall Study|Withdrawal by Subject|0|||
148892483|NCT02349633|537085644|FG006|Overall Study|Withdrawal by Subject|0|||
148892484|NCT02349633|537085645|FG007|Overall Study|Withdrawal by Subject|2|||
148892485|NCT02349633|537085646|FG008|Overall Study|Withdrawal by Subject|2|||
148892486|NCT02349633|537085647|FG009|Overall Study|Withdrawal by Subject|1|||
148892487|NCT02349633|537085648|FG010|Overall Study|Withdrawal by Subject|0|||
148892488|NCT02349633|537085649|FG011|Overall Study|Withdrawal by Subject|0|||
148892489|NCT02349633|537085650|FG012|Overall Study|Withdrawal by Subject|0|||
148892490|NCT02349633|537085651|FG013|Overall Study|Withdrawal by Subject|0|||
148892491|NCT02349633|537085638|FG000|Overall Study|Withdrawal of informed consent|0|||
148892492|NCT02349633|537085639|FG001|Overall Study|Withdrawal of informed consent|0|||
148892493|NCT02349633|537085640|FG002|Overall Study|Withdrawal of informed consent|0|||
148892494|NCT02349633|537085641|FG003|Overall Study|Withdrawal of informed consent|1|||
148892495|NCT02349633|537085642|FG004|Overall Study|Withdrawal of informed consent|1|||
148892496|NCT02349633|537085643|FG005|Overall Study|Withdrawal of informed consent|0|||
148892497|NCT02349633|537085644|FG006|Overall Study|Withdrawal of informed consent|0|||
148892498|NCT02349633|537085645|FG007|Overall Study|Withdrawal of informed consent|3|||
148892499|NCT02349633|537085646|FG008|Overall Study|Withdrawal of informed consent|0|||
148892500|NCT02349633|537085647|FG009|Overall Study|Withdrawal of informed consent|0|||
148892501|NCT02349633|537085648|FG010|Overall Study|Withdrawal of informed consent|0|||
148892502|NCT02349633|537085649|FG011|Overall Study|Withdrawal of informed consent|0|||
148892503|NCT02349633|537085650|FG012|Overall Study|Withdrawal of informed consent|0|||
148892504|NCT02349633|537085651|FG013|Overall Study|Withdrawal of informed consent|0|||
148892505|NCT02349633|537085638|FG000|Overall Study|Transition to compassionate use|0|||
148892506|NCT02349633|537085639|FG001|Overall Study|Transition to compassionate use|0|||
148892507|NCT02349633|537085640|FG002|Overall Study|Transition to compassionate use|0|||
148892508|NCT02349633|537085641|FG003|Overall Study|Transition to compassionate use|0|||
148892509|NCT02349633|537085642|FG004|Overall Study|Transition to compassionate use|1|||
148892510|NCT02349633|537085643|FG005|Overall Study|Transition to compassionate use|0|||
148892511|NCT02349633|537085644|FG006|Overall Study|Transition to compassionate use|0|||
148892512|NCT02349633|537085645|FG007|Overall Study|Transition to compassionate use|3|||
148892513|NCT02349633|537085646|FG008|Overall Study|Transition to compassionate use|0|||
148892514|NCT02349633|537085647|FG009|Overall Study|Transition to compassionate use|1|||
148892515|NCT02349633|537085648|FG010|Overall Study|Transition to compassionate use|0|||
148892516|NCT02349633|537085649|FG011|Overall Study|Transition to compassionate use|0|||
148892517|NCT02349633|537085650|FG012|Overall Study|Transition to compassionate use|0|||
148892518|NCT02349633|537085651|FG013|Overall Study|Transition to compassionate use|0|||
148892519|NCT02349633|537085638|FG000|Overall Study|Early termination of survival follow-up|0|||
148892520|NCT02349633|537085639|FG001|Overall Study|Early termination of survival follow-up|0|||
148892521|NCT02349633|537085640|FG002|Overall Study|Early termination of survival follow-up|0|||
148892522|NCT02349633|537085641|FG003|Overall Study|Early termination of survival follow-up|0|||
148892523|NCT02349633|537085642|FG004|Overall Study|Early termination of survival follow-up|0|||
148892524|NCT02349633|537085643|FG005|Overall Study|Early termination of survival follow-up|0|||
148892525|NCT02349633|537085644|FG006|Overall Study|Early termination of survival follow-up|0|||
148892526|NCT02349633|537085645|FG007|Overall Study|Early termination of survival follow-up|4|||
148892527|NCT02349633|537085646|FG008|Overall Study|Early termination of survival follow-up|0|||
148892528|NCT02349633|537085647|FG009|Overall Study|Early termination of survival follow-up|0|||
148892529|NCT02349633|537085648|FG010|Overall Study|Early termination of survival follow-up|0|||
148892530|NCT02349633|537085649|FG011|Overall Study|Early termination of survival follow-up|0|||
148892531|NCT02349633|537085650|FG012|Overall Study|Early termination of survival follow-up|0|||
148892532|NCT02349633|537085651|FG013|Overall Study|Early termination of survival follow-up|0|||
148892533|NCT02349633|537085638|FG000|Overall Study|Termination by sponsor|0|||
148892534|NCT02349633|537085639|FG001|Overall Study|Termination by sponsor|0|||
148892535|NCT02349633|537085640|FG002|Overall Study|Termination by sponsor|0|||
148892536|NCT02349633|537085641|FG003|Overall Study|Termination by sponsor|0|||
148892537|NCT02349633|537085642|FG004|Overall Study|Termination by sponsor|0|||
148892538|NCT02349633|537085643|FG005|Overall Study|Termination by sponsor|0|||
148892539|NCT02349633|537085644|FG006|Overall Study|Termination by sponsor|0|||
148892540|NCT02349633|537085645|FG007|Overall Study|Termination by sponsor|1|||
148892541|NCT02349633|537085646|FG008|Overall Study|Termination by sponsor|0|||
148892542|NCT02349633|537085647|FG009|Overall Study|Termination by sponsor|2|||
148892543|NCT02349633|537085648|FG010|Overall Study|Termination by sponsor|0|||
148892544|NCT02349633|537085649|FG011|Overall Study|Termination by sponsor|0|||
148892545|NCT02349633|537085650|FG012|Overall Study|Termination by sponsor|0|||
148892546|NCT02349633|537085651|FG013|Overall Study|Termination by sponsor|0|||
148892547|NCT02349633|537085638|FG000|Overall Study|Other|0|||
148892548|NCT02349633|537085639|FG001|Overall Study|Other|0|||
148892549|NCT02349633|537085640|FG002|Overall Study|Other|0|||
148892550|NCT02349633|537085641|FG003|Overall Study|Other|0|||
148892551|NCT02349633|537085642|FG004|Overall Study|Other|0|||
148892552|NCT02349633|537085643|FG005|Overall Study|Other|0|||
148892553|NCT02349633|537085644|FG006|Overall Study|Other|0|||
148892554|NCT02349633|537085645|FG007|Overall Study|Other|2|||
148892555|NCT02349633|537085646|FG008|Overall Study|Other|0|||
148892556|NCT02349633|537085647|FG009|Overall Study|Other|0|||
148892557|NCT02349633|537085648|FG010|Overall Study|Other|0|||
148892558|NCT02349633|537085649|FG011|Overall Study|Other|0|||
148892559|NCT02349633|537085650|FG012|Overall Study|Other|0|||
148892560|NCT02349633|537085651|FG013|Overall Study|Other|0|||
148892561|NCT01220167|537085655|FG000|Period 3|Urine positive for substance abuse|0|||
148892562|NCT01220167|537085656|FG001|Period 3|Urine positive for substance abuse|1|||
148892563|NCT01220167|537085657|FG002|Period 3|Urine positive for substance abuse|0|||
148892564|NCT00667628|537085660|FG000|Overall Study|Lost to Follow-up|1|||
148892565|NCT00667628|537085661|FG001|Overall Study|Lost to Follow-up|0|||
148892566|NCT00667628|537085660|FG000|Overall Study|Death|6|||
148892567|NCT00667628|537085661|FG001|Overall Study|Death|6|||
148892568|NCT00667628|537085660|FG000|Overall Study|Investigator Considers in Best Interest|1|||
148892569|NCT00667628|537085661|FG001|Overall Study|Investigator Considers in Best Interest|0|||
148892570|NCT00667628|537085660|FG000|Overall Study|Sponsor Terminated Study|17|||
148892571|NCT00667628|537085661|FG001|Overall Study|Sponsor Terminated Study|21|||
148892572|NCT04663321|537085662|FG000|Overall Study|Study terminated by Sponsor|2|||
148892573|NCT04663321|537085663|FG001|Overall Study|Study terminated by Sponsor|1|||
148892574|NCT04663321|537085664|FG002|Overall Study|Study terminated by Sponsor|2|||
148892575|NCT04663321|537085662|FG000|Overall Study|Withdrawal by Subject|10|||
148892576|NCT04663321|537085663|FG001|Overall Study|Withdrawal by Subject|3|||
148892577|NCT04663321|537085664|FG002|Overall Study|Withdrawal by Subject|2|||
148892578|NCT04663321|537085662|FG000|Overall Study|Not provided|0|||
148892579|NCT04663321|537085663|FG001|Overall Study|Not provided|0|||
148892580|NCT04663321|537085664|FG002|Overall Study|Not provided|1|||
148892581|NCT03360682|537085665|FG000|Overall Study|Adverse Event|3|||
148892582|NCT01962441|537085668|FG000|Randomized Period|Randomized but Never Treated|4|||
148892583|NCT01962441|537085669|FG001|Randomized Period|Randomized but Never Treated|2|||
148892584|NCT01962441|537085670|FG002|Randomized Period|Randomized but Never Treated|3|||
148892585|NCT01962441|537085668|FG000|Randomized Period|Lost to Follow-up|2|||
148892586|NCT01962441|537085669|FG001|Randomized Period|Lost to Follow-up|4|||
148892587|NCT01962441|537085670|FG002|Randomized Period|Lost to Follow-up|4|||
148892588|NCT01962441|537085668|FG000|Randomized Period|Withdrew Consent|3|||
148892589|NCT01962441|537085669|FG001|Randomized Period|Withdrew Consent|3|||
148892590|NCT01962441|537085670|FG002|Randomized Period|Withdrew Consent|2|||
148892591|NCT01962441|537085668|FG000|Randomized Period|Adverse Event|1|||
148892592|NCT01962441|537085669|FG001|Randomized Period|Adverse Event|1|||
148892593|NCT01962441|537085670|FG002|Randomized Period|Adverse Event|0|||
148892594|NCT01962441|537085668|FG000|Randomized Period|Death|0|||
148892595|NCT01962441|537085669|FG001|Randomized Period|Death|0|||
148892596|NCT01962441|537085670|FG002|Randomized Period|Death|2|||
148892597|NCT01962441|537085668|FG000|Randomized Period|Protocol Violation|0|||
148892598|NCT01962441|537085669|FG001|Randomized Period|Protocol Violation|1|||
148892599|NCT01962441|537085670|FG002|Randomized Period|Protocol Violation|0|||
148892600|NCT01962441|537085668|FG000|Retreatment Substudy|Lack of Efficacy|1|||
148892601|NCT01962441|537085669|FG001|Retreatment Substudy|Lack of Efficacy|0|||
148892602|NCT01962441|537085670|FG002|Retreatment Substudy|Lack of Efficacy|0|||
148892603|NCT01962441|537085668|FG000|Retreatment Substudy|Lost to Follow-up|1|||
148892604|NCT01962441|537085669|FG001|Retreatment Substudy|Lost to Follow-up|0|||
148892605|NCT01962441|537085670|FG002|Retreatment Substudy|Lost to Follow-up|0|||
148892606|NCT04862065|537085671|FG000|Screening|Protocol Violation|54|||
148892607|NCT04862065|537085672|FG001|Screening|Protocol Violation|0|||
148892608|NCT04862065|537085673|FG002|Screening|Protocol Violation|0|||
148892609|NCT04862065|537085671|FG000|Screening|Insufficient Sample|1|||
148892610|NCT04862065|537085672|FG001|Screening|Insufficient Sample|0|||
148892611|NCT04862065|537085673|FG002|Screening|Insufficient Sample|0|||
148892612|NCT04862065|537085671|FG000|Follow-Up|Lost to Follow-up|3|||
148892613|NCT04862065|537085672|FG001|Follow-Up|Lost to Follow-up|0|||
148892614|NCT04862065|537085673|FG002|Follow-Up|Lost to Follow-up|0|||
148892615|NCT01453140|537085674|FG000|Overall Study|Adverse Event|3|||
148892616|NCT00743249|537085675|FG000|Overall Study|Adverse Event|0|||
148892617|NCT00743249|537085676|FG001|Overall Study|Adverse Event|4|||
148892618|NCT00743249|537085675|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
148892619|NCT00743249|537085676|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
148892620|NCT00743249|537085675|FG000|Overall Study|Unsuccessful insertion of stent|2|||
148892621|NCT00743249|537085676|FG001|Overall Study|Unsuccessful insertion of stent|1|||
148892622|NCT00423657|537085677|FG000|Overall Study|Withdrew consent|10|||
148892623|NCT00423657|537085678|FG001|Overall Study|Withdrew consent|8|||
148892624|NCT00423657|537085677|FG000|Overall Study|Non-compliance|0|||
148892625|NCT00423657|537085678|FG001|Overall Study|Non-compliance|1|||
148892626|NCT00423657|537085677|FG000|Overall Study|Other|15|||
148892627|NCT00423657|537085678|FG001|Overall Study|Other|16|||
148892628|NCT00423657|537085677|FG000|Overall Study|Request of sponsor/investigator|1|||
148892629|NCT00423657|537085678|FG001|Overall Study|Request of sponsor/investigator|0|||
148892630|NCT02748863|537085679|FG000|Treatment Period 1|Adverse Event|0|||
148892631|NCT02748863|537085680|FG001|Treatment Period 1|Adverse Event|1|||
148892632|NCT02748863|537085681|FG002|Treatment Period 1|Adverse Event|0|||
148892633|NCT02748863|537085682|FG003|Treatment Period 1|Adverse Event|0|||
148892634|NCT02748863|537085683|FG004|Treatment Period 1|Adverse Event|0|||
148892635|NCT02748863|537085679|FG000|Treatment Period 1|Lack of Efficacy|0|||
148892636|NCT02748863|537085680|FG001|Treatment Period 1|Lack of Efficacy|0|||
148892637|NCT02748863|537085681|FG002|Treatment Period 1|Lack of Efficacy|1|||
148892638|NCT02748863|537085682|FG003|Treatment Period 1|Lack of Efficacy|0|||
148892639|NCT02748863|537085683|FG004|Treatment Period 1|Lack of Efficacy|0|||
148892640|NCT02748863|537085679|FG000|Treatment Period 1|Withdrawal by Subject|0|||
148892641|NCT02748863|537085680|FG001|Treatment Period 1|Withdrawal by Subject|1|||
148892642|NCT02748863|537085681|FG002|Treatment Period 1|Withdrawal by Subject|1|||
148892643|NCT02748863|537085682|FG003|Treatment Period 1|Withdrawal by Subject|0|||
148892644|NCT02748863|537085683|FG004|Treatment Period 1|Withdrawal by Subject|0|||
148892645|NCT02748863|537085679|FG000|Treatment Period 2|Lost to Follow-up|2|||
148892646|NCT02748863|537085680|FG001|Treatment Period 2|Lost to Follow-up|0|||
148892647|NCT02748863|537085681|FG002|Treatment Period 2|Lost to Follow-up|0|||
148892648|NCT02748863|537085682|FG003|Treatment Period 2|Lost to Follow-up|0|||
148892649|NCT02748863|537085683|FG004|Treatment Period 2|Lost to Follow-up|0|||
148892650|NCT02748863|537085679|FG000|Treatment Period 2|Adverse Event|3|||
148892651|NCT02748863|537085680|FG001|Treatment Period 2|Adverse Event|2|||
148892652|NCT02748863|537085681|FG002|Treatment Period 2|Adverse Event|0|||
148892653|NCT02748863|537085682|FG003|Treatment Period 2|Adverse Event|2|||
148892654|NCT02748863|537085683|FG004|Treatment Period 2|Adverse Event|0|||
148892655|NCT02748863|537085679|FG000|Treatment Period 2|Lack of Efficacy|0|||
148892656|NCT02748863|537085680|FG001|Treatment Period 2|Lack of Efficacy|1|||
148892657|NCT02748863|537085681|FG002|Treatment Period 2|Lack of Efficacy|0|||
148892658|NCT02748863|537085682|FG003|Treatment Period 2|Lack of Efficacy|0|||
148892659|NCT02748863|537085683|FG004|Treatment Period 2|Lack of Efficacy|0|||
148892660|NCT02748863|537085679|FG000|Treatment Period 2|Pregnancy|0|||
149102800|NCT04082429|537855570|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
148892661|NCT02748863|537085680|FG001|Treatment Period 2|Pregnancy|0|||
148892662|NCT02748863|537085681|FG002|Treatment Period 2|Pregnancy|0|||
148892663|NCT02748863|537085682|FG003|Treatment Period 2|Pregnancy|0|||
148892664|NCT02748863|537085683|FG004|Treatment Period 2|Pregnancy|1|||
148892665|NCT02422498|537085684|FG000|Overall Study|Inevaluable|4|||
148892666|NCT02653326|537085685|FG000|Overall Study|Lost to Follow-up|10|||
148892667|NCT02653326|537085686|FG001|Overall Study|Lost to Follow-up|7|||
148892668|NCT03206216|537085690|FG000|Overall Study|Withdrawal by Subject|0|||
148892669|NCT03206216|537085691|FG001|Overall Study|Withdrawal by Subject|1|||
148892670|NCT00231777|537085692|FG000|Overall Study|Lost to Follow-up|3|||
148892671|NCT00231777|537085693|FG001|Overall Study|Lost to Follow-up|0|||
148892672|NCT00231777|537085692|FG000|Overall Study|Other|3|||
148892673|NCT00231777|537085693|FG001|Overall Study|Other|2|||
148892674|NCT00657046|537085694|FG000|Overall Study|Adverse Event|1|||
148892675|NCT00657046|537085695|FG001|Overall Study|Adverse Event|1|||
148892676|NCT00657046|537085696|FG002|Overall Study|Adverse Event|0|||
148892677|NCT00657046|537085694|FG000|Overall Study|Protocol Violation|2|||
148892678|NCT00657046|537085695|FG001|Overall Study|Protocol Violation|2|||
148892679|NCT00657046|537085696|FG002|Overall Study|Protocol Violation|0|||
148892680|NCT00657046|537085694|FG000|Overall Study|Withdrawal by Subject|1|||
148892681|NCT00657046|537085695|FG001|Overall Study|Withdrawal by Subject|0|||
148892682|NCT00657046|537085696|FG002|Overall Study|Withdrawal by Subject|0|||
148892683|NCT00657046|537085694|FG000|Overall Study|Death|0|||
148892684|NCT00657046|537085695|FG001|Overall Study|Death|0|||
148892685|NCT00657046|537085696|FG002|Overall Study|Death|1|||
148892686|NCT00657046|537085694|FG000|Overall Study|Surgery|0|||
148892687|NCT00657046|537085695|FG001|Overall Study|Surgery|0|||
148892688|NCT00657046|537085696|FG002|Overall Study|Surgery|1|||
148892689|NCT01239381|537085699|FG000|Overall Study|Protocol Violation|1|||
148892690|NCT01239381|537085699|FG000|Overall Study|Withdrawal by Subject|1|||
148892691|NCT06237049|537085700|FG000|Overall Study|Death|0|||
148892692|NCT06237049|537085701|FG001|Overall Study|Death|0|||
148892693|NCT06237049|537085702|FG002|Overall Study|Death|0|||
148892694|NCT06237049|537085703|FG003|Overall Study|Death|1|||
148892695|NCT06237049|537085700|FG000|Overall Study|Lost to Follow-up|11|||
148892696|NCT06237049|537085701|FG001|Overall Study|Lost to Follow-up|5|||
148892697|NCT06237049|537085702|FG002|Overall Study|Lost to Follow-up|8|||
148892698|NCT06237049|537085703|FG003|Overall Study|Lost to Follow-up|8|||
148892699|NCT06237049|537085700|FG000|Overall Study|Protocol Violation|0|||
148892700|NCT06237049|537085701|FG001|Overall Study|Protocol Violation|1|||
148892701|NCT06237049|537085702|FG002|Overall Study|Protocol Violation|0|||
148892702|NCT06237049|537085703|FG003|Overall Study|Protocol Violation|1|||
148892703|NCT06237049|537085700|FG000|Overall Study|Withdrawal by Subject|4|||
148892704|NCT06237049|537085701|FG001|Overall Study|Withdrawal by Subject|2|||
148892705|NCT06237049|537085702|FG002|Overall Study|Withdrawal by Subject|1|||
148892706|NCT06237049|537085703|FG003|Overall Study|Withdrawal by Subject|0|||
148892707|NCT02525471|537085704|FG000|Overall Study|Screen Failure|6|||
148892708|NCT02525471|537085704|FG000|Overall Study|Withdrawal by Subject|4|||
148892709|NCT02525471|537085704|FG000|Overall Study|Death|1|||
148892710|NCT04678115|537085705|FG000|Overall Study|Lost to Follow-up|1|||
148892711|NCT04678115|537085706|FG001|Overall Study|Lost to Follow-up|0|||
148892712|NCT00844376|537085707|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
148892713|NCT00844376|537085708|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
148892714|NCT00988884|537085709|FG000|Overall Study|Adverse Event|0|||
148892715|NCT00988884|537085710|FG001|Overall Study|Adverse Event|1|||
148892716|NCT00988884|537085709|FG000|Overall Study|Lost to Follow-up|20|||
148892717|NCT00988884|537085710|FG001|Overall Study|Lost to Follow-up|16|||
148892718|NCT00988884|537085709|FG000|Overall Study|Protocol Violation|0|||
148892719|NCT00988884|537085710|FG001|Overall Study|Protocol Violation|1|||
148892720|NCT00988884|537085709|FG000|Overall Study|Withdrawal by Subject|15|||
148892721|NCT00988884|537085710|FG001|Overall Study|Withdrawal by Subject|18|||
148892722|NCT04621448|537085711|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
148892723|NCT04621448|537085712|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
148892724|NCT04621448|537085713|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
148892725|NCT04621448|537085714|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
148892726|NCT04621448|537085711|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
148892727|NCT04621448|537085712|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
148892728|NCT04621448|537085713|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
148892729|NCT04621448|537085714|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
148892730|NCT04621448|537085711|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
148892731|NCT04621448|537085712|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
148892732|NCT04621448|537085713|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
148892733|NCT04621448|537085714|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
148892734|NCT04621448|537085711|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
148892735|NCT04621448|537085712|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
148892736|NCT04621448|537085713|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
148892737|NCT04621448|537085714|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
148892738|NCT00468299|537085723|FG000|Overall Study|Withdrawal by Subject|0|||
148892739|NCT00468299|537085724|FG001|Overall Study|Withdrawal by Subject|1|||
148892740|NCT03318549|537085730|FG000|Overall Study|Withdrawal by Subject|5|||
148892741|NCT03318549|537085731|FG001|Overall Study|Withdrawal by Subject|19|||
148892742|NCT03318549|537085732|FG002|Overall Study|Withdrawal by Subject|2|||
148892743|NCT03318549|537085733|FG003|Overall Study|Withdrawal by Subject|0|||
148892744|NCT03318549|537085734|FG004|Overall Study|Withdrawal by Subject|0|||
148892745|NCT03318549|537085735|FG005|Overall Study|Withdrawal by Subject|0|||
148892746|NCT03318549|537085736|FG006|Overall Study|Withdrawal by Subject|0|||
148892747|NCT03318549|537085730|FG000|Overall Study|Physician Decision|0|||
148892748|NCT03318549|537085731|FG001|Overall Study|Physician Decision|4|||
148892749|NCT03318549|537085732|FG002|Overall Study|Physician Decision|1|||
148892750|NCT03318549|537085733|FG003|Overall Study|Physician Decision|0|||
148892751|NCT03318549|537085734|FG004|Overall Study|Physician Decision|0|||
148892752|NCT03318549|537085735|FG005|Overall Study|Physician Decision|0|||
148892753|NCT03318549|537085736|FG006|Overall Study|Physician Decision|0|||
148892754|NCT03318549|537085730|FG000|Overall Study|Lost to Follow-up|0|||
148892755|NCT03318549|537085731|FG001|Overall Study|Lost to Follow-up|3|||
148892756|NCT03318549|537085732|FG002|Overall Study|Lost to Follow-up|3|||
148892757|NCT03318549|537085733|FG003|Overall Study|Lost to Follow-up|0|||
148892758|NCT03318549|537085734|FG004|Overall Study|Lost to Follow-up|0|||
148892759|NCT03318549|537085735|FG005|Overall Study|Lost to Follow-up|0|||
148892760|NCT03318549|537085736|FG006|Overall Study|Lost to Follow-up|0|||
148892761|NCT02741245|537085741|FG000|Overall Study|Adverse Event|0|||
148892762|NCT02741245|537085742|FG001|Overall Study|Adverse Event|0|||
148892763|NCT02741245|537085743|FG002|Overall Study|Adverse Event|0|||
148892764|NCT02741245|537085744|FG003|Overall Study|Adverse Event|2|||
148892765|NCT02741245|537085745|FG004|Overall Study|Adverse Event|2|||
148892766|NCT02741245|537085741|FG000|Overall Study|Protocol Violation|0|||
148892767|NCT02741245|537085742|FG001|Overall Study|Protocol Violation|1|||
148892768|NCT02741245|537085743|FG002|Overall Study|Protocol Violation|0|||
148892769|NCT02741245|537085744|FG003|Overall Study|Protocol Violation|1|||
148892770|NCT02741245|537085745|FG004|Overall Study|Protocol Violation|0|||
148892771|NCT02741245|537085741|FG000|Overall Study|Withdrawal by Subject|0|||
148892772|NCT02741245|537085742|FG001|Overall Study|Withdrawal by Subject|0|||
148892773|NCT02741245|537085743|FG002|Overall Study|Withdrawal by Subject|0|||
148892774|NCT02741245|537085744|FG003|Overall Study|Withdrawal by Subject|1|||
148892775|NCT02741245|537085745|FG004|Overall Study|Withdrawal by Subject|0|||
148892776|NCT03253679|537085747|FG000|Overall Study|Screen Failure|1|||
148892777|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
148892778|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
148892779|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
148892780|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
148892781|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
148892782|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
148892783|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
148892784|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
148892785|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
148892786|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
148892787|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
148892788|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
148892789|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
148892790|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
148892791|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
148892792|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
148892793|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
148892794|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
148892795|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
148892796|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
148892797|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
148892798|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
148892799|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
148892800|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
148892801|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
148892802|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
148892803|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
148892804|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
148892805|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
148892806|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
148892807|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
148892808|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
148892809|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
148892810|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
148892811|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
148892812|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
148892813|NCT02586623|537085748|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
148892814|NCT02586623|537085749|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
148892815|NCT02586623|537085750|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
148892816|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
148892817|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
148892818|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
148892819|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
148892820|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
148892821|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
148892822|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
148892823|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
148892824|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
148892825|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
148892826|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
148892827|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
148892828|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
148892829|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
148892830|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
148892831|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
148892832|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
148892833|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
148892834|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
148892835|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
148892836|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
148892837|NCT02586623|537085748|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
148892838|NCT02586623|537085749|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
148892839|NCT02586623|537085750|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
148892840|NCT00871871|537085756|FG000|Part I|Adverse Event|0|||
148892841|NCT00871871|537085757|FG001|Part I|Adverse Event|2|||
148892842|NCT00871871|537085758|FG002|Part I|Adverse Event|0|||
148892843|NCT00871871|537085759|FG003|Part I|Adverse Event|0|||
148892844|NCT00871871|537085756|FG000|Part I|Withdrawal by Subject|3|||
148892845|NCT00871871|537085757|FG001|Part I|Withdrawal by Subject|0|||
148892846|NCT00871871|537085758|FG002|Part I|Withdrawal by Subject|0|||
148892847|NCT00871871|537085759|FG003|Part I|Withdrawal by Subject|0|||
148892848|NCT00871871|537085756|FG000|Part I|Laboratory abnormality|0|||
148892849|NCT00871871|537085757|FG001|Part I|Laboratory abnormality|1|||
148892850|NCT00871871|537085758|FG002|Part I|Laboratory abnormality|0|||
148892851|NCT00871871|537085759|FG003|Part I|Laboratory abnormality|0|||
148892852|NCT00871871|537085756|FG000|Part II|Lack of Efficacy|0|||
148892853|NCT00871871|537085757|FG001|Part II|Lack of Efficacy|0|||
148892854|NCT00871871|537085758|FG002|Part II|Lack of Efficacy|1|||
148892855|NCT00871871|537085759|FG003|Part II|Lack of Efficacy|0|||
148892856|NCT00871871|537085756|FG000|Part II|Withdrawal by Subject|0|||
148892857|NCT00871871|537085757|FG001|Part II|Withdrawal by Subject|0|||
148892858|NCT00871871|537085758|FG002|Part II|Withdrawal by Subject|2|||
148892859|NCT00871871|537085759|FG003|Part II|Withdrawal by Subject|1|||
148892860|NCT00871871|537085756|FG000|Part II|Adverse Event|0|||
148892861|NCT00871871|537085757|FG001|Part II|Adverse Event|0|||
148892862|NCT00871871|537085758|FG002|Part II|Adverse Event|1|||
148892863|NCT00871871|537085759|FG003|Part II|Adverse Event|2|||
148892864|NCT00871871|537085756|FG000|Part II|Protocol Violation|0|||
148892865|NCT00871871|537085757|FG001|Part II|Protocol Violation|0|||
148892866|NCT00871871|537085758|FG002|Part II|Protocol Violation|0|||
148892867|NCT00871871|537085759|FG003|Part II|Protocol Violation|1|||
148892868|NCT03863509|537085760|FG000|Overall Study|COVID-19 shutdown period|0|||
148892869|NCT03863509|537085761|FG001|Overall Study|COVID-19 shutdown period|4|||
148892870|NCT03863509|537085762|FG002|Overall Study|COVID-19 shutdown period|0|||
148892871|NCT03863509|537085760|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
148892872|NCT03863509|537085761|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
148892873|NCT03863509|537085762|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
148892874|NCT03863509|537085760|FG000|Overall Study|Lost to Follow-up|8|||
148892875|NCT03863509|537085761|FG001|Overall Study|Lost to Follow-up|0|||
148892876|NCT03863509|537085762|FG002|Overall Study|Lost to Follow-up|2|||
148892877|NCT03863509|537085760|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
148892878|NCT03863509|537085761|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
148892879|NCT03863509|537085762|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
148892880|NCT03863509|537085760|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
148892881|NCT03863509|537085761|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
148892882|NCT03863509|537085762|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
148892883|NCT03861273|537085763|FG000|Screening Phase (3 Weeks)|Other|1|||
148892884|NCT03861273|537085763|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
148892885|NCT03861273|537085763|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
148892886|NCT03861273|537085763|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
148892887|NCT03861273|537085763|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
148892888|NCT00191334|537085766|FG000|Overall Study|Adverse Event|4|||
148892889|NCT00191334|537085766|FG000|Overall Study|Disease Progression or Relapse|8|||
148892890|NCT00191334|537085766|FG000|Overall Study|Physician Decision|1|||
148892891|NCT00191334|537085766|FG000|Overall Study|Withdrawal by Subject|4|||
148892892|NCT01116648|537085767|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
148892893|NCT01116648|537085768|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
148892894|NCT01116648|537085769|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
148892895|NCT01116648|537085770|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
148892896|NCT01116648|537085771|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
148892897|NCT01116648|537085772|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
148892898|NCT01116648|537085773|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
148892899|NCT01116648|537085774|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
148892900|NCT01116648|537085775|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
148892901|NCT01116648|537085776|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
148892902|NCT01116648|537085777|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
148892903|NCT01116648|537085778|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
148892904|NCT01116648|537085779|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
148892905|NCT01116648|537085780|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
148892906|NCT01116648|537085781|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
148892907|NCT04539938|537085782|FG000|Overall Study|Death|30|||
148892908|NCT04539938|537085782|FG000|Overall Study|Withdrawal by Subject|4|||
148892909|NCT01405768|537086795|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
148892910|NCT01405768|537086796|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
148892911|NCT00882440|537086799|FG000|Overall Study|Adverse Event|2|||
148892912|NCT00882440|537086800|FG001|Overall Study|Adverse Event|2|||
148892913|NCT00882440|537086801|FG002|Overall Study|Adverse Event|2|||
148892914|NCT00882440|537086802|FG003|Overall Study|Adverse Event|1|||
148892915|NCT00882440|537086803|FG004|Overall Study|Adverse Event|1|||
148892916|NCT00882440|537086804|FG005|Overall Study|Adverse Event|4|||
148892917|NCT00882440|537086805|FG006|Overall Study|Adverse Event|2|||
148892918|NCT00882440|537086799|FG000|Overall Study|Lack of Efficacy|3|||
148892919|NCT00882440|537086800|FG001|Overall Study|Lack of Efficacy|5|||
148892920|NCT00882440|537086801|FG002|Overall Study|Lack of Efficacy|2|||
148892921|NCT00882440|537086802|FG003|Overall Study|Lack of Efficacy|0|||
148892922|NCT00882440|537086803|FG004|Overall Study|Lack of Efficacy|0|||
148892923|NCT00882440|537086804|FG005|Overall Study|Lack of Efficacy|3|||
148892924|NCT00882440|537086805|FG006|Overall Study|Lack of Efficacy|0|||
148892925|NCT00882440|537086799|FG000|Overall Study|Lost to Follow-up|2|||
148892926|NCT00882440|537086800|FG001|Overall Study|Lost to Follow-up|0|||
148892927|NCT00882440|537086801|FG002|Overall Study|Lost to Follow-up|1|||
148892928|NCT00882440|537086802|FG003|Overall Study|Lost to Follow-up|1|||
148892929|NCT00882440|537086803|FG004|Overall Study|Lost to Follow-up|1|||
148892930|NCT00882440|537086804|FG005|Overall Study|Lost to Follow-up|0|||
148892931|NCT00882440|537086805|FG006|Overall Study|Lost to Follow-up|1|||
148892932|NCT00882440|537086799|FG000|Overall Study|Protocol Violation|0|||
148892933|NCT00882440|537086800|FG001|Overall Study|Protocol Violation|0|||
148892934|NCT00882440|537086801|FG002|Overall Study|Protocol Violation|1|||
148892935|NCT00882440|537086802|FG003|Overall Study|Protocol Violation|1|||
148892936|NCT00882440|537086803|FG004|Overall Study|Protocol Violation|1|||
148892937|NCT00882440|537086804|FG005|Overall Study|Protocol Violation|0|||
148892938|NCT00882440|537086805|FG006|Overall Study|Protocol Violation|0|||
148892939|NCT00882440|537086799|FG000|Overall Study|Withdrawal by Subject|2|||
148892940|NCT00882440|537086800|FG001|Overall Study|Withdrawal by Subject|1|||
148892941|NCT00882440|537086801|FG002|Overall Study|Withdrawal by Subject|1|||
148892942|NCT00882440|537086802|FG003|Overall Study|Withdrawal by Subject|0|||
148892943|NCT00882440|537086803|FG004|Overall Study|Withdrawal by Subject|6|||
148892944|NCT00882440|537086804|FG005|Overall Study|Withdrawal by Subject|0|||
148892945|NCT00882440|537086805|FG006|Overall Study|Withdrawal by Subject|1|||
148892946|NCT00882440|537086799|FG000|Overall Study|Patient Uncooperative|2|||
148892947|NCT00882440|537086800|FG001|Overall Study|Patient Uncooperative|0|||
148892948|NCT00882440|537086801|FG002|Overall Study|Patient Uncooperative|0|||
148892949|NCT00882440|537086802|FG003|Overall Study|Patient Uncooperative|0|||
148892950|NCT00882440|537086803|FG004|Overall Study|Patient Uncooperative|1|||
148892951|NCT00882440|537086804|FG005|Overall Study|Patient Uncooperative|0|||
148892952|NCT00882440|537086805|FG006|Overall Study|Patient Uncooperative|0|||
148892953|NCT01381016|537086807|FG000|Overall Study|Lost to Follow-up|1|||
148892954|NCT01381016|537086808|FG001|Overall Study|Lost to Follow-up|1|||
148892955|NCT01381016|537086807|FG000|Overall Study|Screen Failure|2|||
148892956|NCT01381016|537086808|FG001|Overall Study|Screen Failure|2|||
148892957|NCT01381016|537086807|FG000|Overall Study|Withdrawal by Subject|0|||
148892958|NCT01381016|537086808|FG001|Overall Study|Withdrawal by Subject|1|||
148892959|NCT01381016|537086807|FG000|Overall Study|Physician Decision|0|||
148892960|NCT01381016|537086808|FG001|Overall Study|Physician Decision|2|||
148892961|NCT01451723|537086818|FG000|Overall Study|study halted|6|||
148892962|NCT01451723|537086819|FG001|Overall Study|study halted|5|||
148892963|NCT01631435|537086820|FG000|Overall Study|Adverse Event|2|||
148892964|NCT01631435|537086820|FG000|Overall Study|Withdrawal by Subject|2|||
148892965|NCT01631435|537086820|FG000|Overall Study|incomplete study procedure|5|||
148892966|NCT01421017|537086821|FG000|Overall Study|Withdrawal by Subject|2|||
148892967|NCT01421017|537086822|FG001|Overall Study|Withdrawal by Subject|0|||
148892968|NCT01421017|537086823|FG002|Overall Study|Withdrawal by Subject|0|||
148892969|NCT01421017|537086821|FG000|Overall Study|POD|0|||
148892970|NCT01421017|537086822|FG001|Overall Study|POD|6|||
148892971|NCT01421017|537086823|FG002|Overall Study|POD|3|||
148892972|NCT00308139|537086824|FG000|Overall Study|Adverse Event|20|||
148892973|NCT00308139|537086825|FG001|Overall Study|Adverse Event|14|||
148892974|NCT00308139|537086824|FG000|Overall Study|Lost to Follow-up|13|||
148892975|NCT00308139|537086825|FG001|Overall Study|Lost to Follow-up|8|||
148892976|NCT00308139|537086824|FG000|Overall Study|Protocol Violation|3|||
148892977|NCT00308139|537086825|FG001|Overall Study|Protocol Violation|2|||
148892978|NCT00308139|537086824|FG000|Overall Study|Withdrawal of Consent|40|||
148892979|NCT00308139|537086825|FG001|Overall Study|Withdrawal of Consent|42|||
148892980|NCT00308139|537086824|FG000|Overall Study|Investigator Decision|11|||
148892981|NCT00308139|537086825|FG001|Overall Study|Investigator Decision|10|||
148892982|NCT00308139|537086824|FG000|Overall Study|Loss of Glucose Control|5|||
148892983|NCT00308139|537086825|FG001|Overall Study|Loss of Glucose Control|7|||
148892984|NCT00308139|537086824|FG000|Overall Study|Administrative|1|||
148892985|NCT00308139|537086825|FG001|Overall Study|Administrative|4|||
148892986|NCT00308139|537086824|FG000|Overall Study|Other|1|||
148892987|NCT00308139|537086825|FG001|Overall Study|Other|0|||
148892988|NCT00833040|537086826|FG000|Overall Study|Adverse Event|0|||
148892989|NCT00833040|537086827|FG001|Overall Study|Adverse Event|0|||
148892990|NCT00833040|537086828|FG002|Overall Study|Adverse Event|0|||
148892991|NCT00833040|537086829|FG003|Overall Study|Adverse Event|0|||
148892992|NCT00833040|537086830|FG004|Overall Study|Adverse Event|0|||
148892993|NCT00833040|537086831|FG005|Overall Study|Adverse Event|1|||
148892994|NCT02313766|537086832|FG000|Overall Study|surgery cancelled|1|||
148892995|NCT02313766|537086833|FG001|Overall Study|surgery cancelled|0|||
148892996|NCT02313766|537086834|FG002|Overall Study|surgery cancelled|0|||
148892997|NCT02313766|537086832|FG000|Overall Study|Lost to Follow-up|0|||
148892998|NCT02313766|537086833|FG001|Overall Study|Lost to Follow-up|2|||
148892999|NCT02313766|537086834|FG002|Overall Study|Lost to Follow-up|0|||
148893000|NCT02313766|537086832|FG000|Overall Study|Adverse Event|0|||
148893001|NCT02313766|537086833|FG001|Overall Study|Adverse Event|1|||
148893002|NCT02313766|537086834|FG002|Overall Study|Adverse Event|0|||
148893003|NCT00416624|537086840|FG000|Overall Study|Withdrawal by Subject|1|||
148893004|NCT00416624|537086841|FG001|Overall Study|Withdrawal by Subject|6|||
148893005|NCT00416624|537086842|FG002|Overall Study|Withdrawal by Subject|4|||
148893006|NCT00416624|537086843|FG003|Overall Study|Withdrawal by Subject|9|||
148893007|NCT00416624|537086840|FG000|Overall Study|Death|4|||
148893008|NCT00416624|537086841|FG001|Overall Study|Death|7|||
148893009|NCT00416624|537086842|FG002|Overall Study|Death|7|||
148893010|NCT00416624|537086843|FG003|Overall Study|Death|1|||
148893011|NCT00416624|537086840|FG000|Overall Study|Adverse Event|8|||
148893012|NCT00416624|537086841|FG001|Overall Study|Adverse Event|3|||
148893013|NCT00416624|537086842|FG002|Overall Study|Adverse Event|2|||
148893014|NCT00416624|537086843|FG003|Overall Study|Adverse Event|2|||
148893015|NCT00416624|537086840|FG000|Overall Study|Other|8|||
148893016|NCT00416624|537086841|FG001|Overall Study|Other|11|||
148893017|NCT00416624|537086842|FG002|Overall Study|Other|5|||
148893018|NCT00416624|537086843|FG003|Overall Study|Other|5|||
148893019|NCT00416624|537086840|FG000|Overall Study|Cancel|1|||
148893020|NCT00416624|537086841|FG001|Overall Study|Cancel|0|||
148893021|NCT00416624|537086842|FG002|Overall Study|Cancel|0|||
148893022|NCT00416624|537086843|FG003|Overall Study|Cancel|0|||
148893023|NCT01005251|537086844|FG000|Overall Study|Withdrawal by Subject|2|||
148893024|NCT01005251|537086845|FG001|Overall Study|Withdrawal by Subject|5|||
148893025|NCT01005251|537086846|FG002|Overall Study|Withdrawal by Subject|3|||
148893026|NCT01005251|537086847|FG003|Overall Study|Withdrawal by Subject|4|||
148893027|NCT01005251|537086848|FG004|Overall Study|Withdrawal by Subject|9|||
148893028|NCT01005251|537086844|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
148893029|NCT01005251|537086845|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
148893030|NCT01005251|537086846|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
148893031|NCT01005251|537086847|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
148893032|NCT01005251|537086848|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
148893033|NCT01005251|537086844|FG000|Overall Study|Adverse Event|2|||
148893034|NCT01005251|537086845|FG001|Overall Study|Adverse Event|6|||
148893035|NCT01005251|537086846|FG002|Overall Study|Adverse Event|8|||
148893036|NCT01005251|537086847|FG003|Overall Study|Adverse Event|5|||
148893037|NCT01005251|537086848|FG004|Overall Study|Adverse Event|4|||
148893038|NCT01005251|537086844|FG000|Overall Study|Protocol Violation|1|||
148893039|NCT01005251|537086845|FG001|Overall Study|Protocol Violation|0|||
148893040|NCT01005251|537086846|FG002|Overall Study|Protocol Violation|0|||
148893041|NCT01005251|537086847|FG003|Overall Study|Protocol Violation|0|||
148893042|NCT01005251|537086848|FG004|Overall Study|Protocol Violation|2|||
148893043|NCT01005251|537086844|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
148893044|NCT01005251|537086845|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
148893045|NCT01005251|537086846|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
148893046|NCT01005251|537086847|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
148893047|NCT01005251|537086848|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
148893048|NCT01005251|537086844|FG000|Overall Study|Lost to Follow-up|1|||
148893049|NCT01005251|537086845|FG001|Overall Study|Lost to Follow-up|4|||
148893050|NCT01005251|537086846|FG002|Overall Study|Lost to Follow-up|2|||
148893051|NCT01005251|537086847|FG003|Overall Study|Lost to Follow-up|0|||
148893052|NCT01005251|537086848|FG004|Overall Study|Lost to Follow-up|0|||
148893053|NCT01005251|537086844|FG000|Overall Study|Physician Decision|0|||
148893054|NCT01005251|537086845|FG001|Overall Study|Physician Decision|0|||
148893055|NCT01005251|537086846|FG002|Overall Study|Physician Decision|0|||
148893056|NCT01005251|537086847|FG003|Overall Study|Physician Decision|0|||
148893057|NCT01005251|537086848|FG004|Overall Study|Physician Decision|2|||
148893058|NCT01005251|537086844|FG000|Overall Study|Patient moved|1|||
148893059|NCT01005251|537086845|FG001|Overall Study|Patient moved|0|||
148893060|NCT01005251|537086846|FG002|Overall Study|Patient moved|0|||
148893061|NCT01005251|537086847|FG003|Overall Study|Patient moved|0|||
148893062|NCT01005251|537086848|FG004|Overall Study|Patient moved|0|||
148893063|NCT01005251|537086844|FG000|Overall Study|Wrong drug dispensed|0|||
148893064|NCT01005251|537086845|FG001|Overall Study|Wrong drug dispensed|1|||
148893065|NCT01005251|537086846|FG002|Overall Study|Wrong drug dispensed|0|||
148893066|NCT01005251|537086847|FG003|Overall Study|Wrong drug dispensed|0|||
148893067|NCT01005251|537086848|FG004|Overall Study|Wrong drug dispensed|0|||
148893068|NCT01005251|537086844|FG000|Overall Study|Randomized in error|0|||
148893069|NCT01005251|537086845|FG001|Overall Study|Randomized in error|0|||
148893070|NCT01005251|537086846|FG002|Overall Study|Randomized in error|1|||
148893071|NCT01005251|537086847|FG003|Overall Study|Randomized in error|1|||
148893072|NCT01005251|537086848|FG004|Overall Study|Randomized in error|0|||
148893073|NCT01005251|537086844|FG000|Overall Study|Lack of Efficacy|0|||
148893074|NCT01005251|537086845|FG001|Overall Study|Lack of Efficacy|0|||
148893075|NCT01005251|537086846|FG002|Overall Study|Lack of Efficacy|1|||
148893076|NCT01005251|537086847|FG003|Overall Study|Lack of Efficacy|1|||
148893077|NCT01005251|537086848|FG004|Overall Study|Lack of Efficacy|0|||
148893078|NCT00962208|537086850|FG000|Overall Study|Could not achieve good vision|9|||
148893079|NCT00962208|537086851|FG001|Overall Study|Could not achieve good vision|0|||
148893080|NCT00962208|537086850|FG000|Overall Study|Contraindicated to continue study|5|||
148893081|NCT00962208|537086851|FG001|Overall Study|Contraindicated to continue study|1|||
148893082|NCT00962208|537086850|FG000|Overall Study|Lost to Follow-up|0|||
148893083|NCT00962208|537086851|FG001|Overall Study|Lost to Follow-up|9|||
148893084|NCT00657540|537086852|FG000|Overall Study|Lost to Follow-up|1|||
148893085|NCT00657540|537086853|FG001|Overall Study|Lost to Follow-up|4|||
148893086|NCT04245111|537086856|FG000|Overall Study|Lost to Follow-up|5|||
148893087|NCT04245111|537086857|FG001|Overall Study|Lost to Follow-up|1|||
148893088|NCT04245111|537086858|FG002|Overall Study|Lost to Follow-up|1|||
148893089|NCT05196828|537086861|FG000|Overall Study|Withdrawal by Subject|2|||
148893090|NCT05196828|537086862|FG001|Overall Study|Withdrawal by Subject|0|||
148893091|NCT05196828|537086861|FG000|Overall Study|Lost to Follow-up|0|||
148893092|NCT05196828|537086862|FG001|Overall Study|Lost to Follow-up|4|||
148893093|NCT05196828|537086861|FG000|Overall Study|Adverse Event|1|||
148893094|NCT05196828|537086862|FG001|Overall Study|Adverse Event|0|||
148893095|NCT00499681|537086866|FG000|Overall Study|toxicity|0|||
148893096|NCT00499681|537086867|FG001|Overall Study|toxicity|1|||
148893097|NCT00499681|537086866|FG000|Overall Study|disease progression|0|||
148893098|NCT00499681|537086867|FG001|Overall Study|disease progression|1|||
148893099|NCT00739401|537086868|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
148893100|NCT00739401|537086868|FG000|Overall Study|Death|3|||
148893101|NCT00739401|537086868|FG000|Overall Study|Withdrawal by Subject|4|||
148893102|NCT04575155|537086869|FG000|2 Month|Withdrawal by Subject|1|||
148893103|NCT04575155|537086870|FG001|2 Month|Withdrawal by Subject|1|||
148893104|NCT04575155|537086869|FG000|2 Month|Lost to Follow-up|5|||
148893105|NCT04575155|537086870|FG001|2 Month|Lost to Follow-up|3|||
148893106|NCT04575155|537086869|FG000|2 Month|Ineligible|1|||
148893107|NCT04575155|537086870|FG001|2 Month|Ineligible|0|||
148893108|NCT03915717|537086873|FG000|Overall Study|EchoMark Not Implanted|6|||
148893109|NCT03748823|537086875|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
148893110|NCT03748823|537086876|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
148893111|NCT03748823|537086875|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
148893112|NCT03748823|537086876|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
148893113|NCT03748823|537086875|FG000|Extension Period|Withdrawal by Subject|9|||
148893114|NCT03748823|537086876|FG001|Extension Period|Withdrawal by Subject|12|||
148893115|NCT03748823|537086875|FG000|Extension Period|Death|2|||
148893116|NCT03748823|537086876|FG001|Extension Period|Death|2|||
148893117|NCT03748823|537086875|FG000|Extension Period|Other than Specified|0|||
148893118|NCT03748823|537086876|FG001|Extension Period|Other than Specified|1|||
148893119|NCT03748823|537086875|FG000|Extension Period|Protocol Violation|1|||
148893120|NCT03748823|537086876|FG001|Extension Period|Protocol Violation|0|||
148893121|NCT03748823|537086875|FG000|Extension Period|Lost to Follow-up|0|||
148893122|NCT03748823|537086876|FG001|Extension Period|Lost to Follow-up|1|||
148893123|NCT03748823|537086875|FG000|Extension Period|Lack of Efficacy|0|||
148893124|NCT03748823|537086876|FG001|Extension Period|Lack of Efficacy|1|||
148893125|NCT03748823|537086875|FG000|Extension Period|Physician Decision|1|||
148893126|NCT03748823|537086876|FG001|Extension Period|Physician Decision|2|||
148893127|NCT02738008|537086877|FG000|Overall Study|Study Terminated by Sponsor|1|||
149102801|NCT04082429|537855571|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
148893128|NCT02738008|537086878|FG001|Overall Study|Study Terminated by Sponsor|5|||
148893129|NCT02738008|537086879|FG002|Overall Study|Study Terminated by Sponsor|3|||
148893130|NCT02738008|537086877|FG000|Overall Study|Adverse Event|0|||
148893131|NCT02738008|537086878|FG001|Overall Study|Adverse Event|1|||
148893132|NCT02738008|537086879|FG002|Overall Study|Adverse Event|2|||
148893133|NCT03550378|537086880|FG000|Overall Study|Death|0|||
148893134|NCT03550378|537086881|FG001|Overall Study|Death|1|||
148893135|NCT04486235|537086882|FG000|Overall Study|Pregnancy|1|||
148893136|NCT04486235|537086883|FG001|Overall Study|Pregnancy|0|||
148893137|NCT04486235|537086882|FG000|Overall Study|Lost to Follow-up|1|||
148893138|NCT04486235|537086883|FG001|Overall Study|Lost to Follow-up|0|||
148893139|NCT04590014|537086884|FG000|Overall Study|Withdrawal by Subject|1|||
148893140|NCT04590014|537086885|FG001|Overall Study|Withdrawal by Subject|0|||
148893141|NCT03935126|537086886|FG000|Overall Study|Study termination by sponsor|3|||
148893142|NCT00399516|537086887|FG000|Overall Study|Lost to Follow-up|2|||
148893143|NCT00982735|537086888|FG000|Overall Study|Lost to Follow-up|6|||
148893144|NCT00982735|537086888|FG000|Overall Study|Patient ineligible for trial|224|||
148893145|NCT01091675|537086889|FG000|Overall Study|Adverse Event|7|||
148893146|NCT01091675|537086889|FG000|Overall Study|Lack of Efficacy|27|||
148893147|NCT03040141|537086893|FG000|Overall Study|Death|1|||
148893148|NCT03040141|537086894|FG001|Overall Study|Death|2|||
148893149|NCT03040141|537086895|FG002|Overall Study|Death|3|||
148893150|NCT03040141|537086893|FG000|Overall Study|Withdrawal by Subject|3|||
148893151|NCT03040141|537086894|FG001|Overall Study|Withdrawal by Subject|1|||
148893152|NCT03040141|537086895|FG002|Overall Study|Withdrawal by Subject|1|||
148893153|NCT03040141|537086893|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
148893154|NCT03040141|537086894|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
148893155|NCT03040141|537086895|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
148893156|NCT03040141|537086893|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
148893157|NCT03040141|537086894|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
148893158|NCT03040141|537086895|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
148893159|NCT04879628|537086896|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
148893160|NCT04879628|537086897|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
148893161|NCT04879628|537086898|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
148893162|NCT04879628|537086899|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
148893163|NCT04879628|537086896|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
148893164|NCT04879628|537086897|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
148893165|NCT04879628|537086898|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
148893166|NCT04879628|537086899|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
148893167|NCT04879628|537086896|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
148893168|NCT04879628|537086897|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
148893169|NCT04879628|537086898|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
148893170|NCT04879628|537086899|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
148893171|NCT04879628|537086896|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
148893172|NCT04879628|537086897|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
148893173|NCT04879628|537086898|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
148893174|NCT04879628|537086899|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
148893175|NCT03064490|537086900|FG000|Overall Study|Physician Decision|5|||
148893176|NCT02775916|537086905|FG000|Overall Study|Adverse Event|1|||
148893177|NCT02775916|537086906|FG001|Overall Study|Adverse Event|0|||
148893178|NCT02775916|537086905|FG000|Overall Study|Subject/Guardian Decision|2|||
148893179|NCT02775916|537086906|FG001|Overall Study|Subject/Guardian Decision|0|||
149102802|NCT04082429|537855572|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
149102803|NCT04082429|537855573|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
149102804|NCT04082429|537855574|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
149102805|NCT04082429|537855575|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
149102806|NCT04082429|537855576|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
149102807|NCT04082429|537855568|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
149102808|NCT04082429|537855569|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102809|NCT04082429|537855570|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102810|NCT04082429|537855571|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102811|NCT04082429|537855572|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102812|NCT04082429|537855573|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
149102813|NCT04082429|537855574|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102814|NCT04082429|537855575|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102815|NCT04082429|537855576|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
149102816|NCT04082429|537855568|FG000|Extension Part|Ongoing|0|||
149102817|NCT04082429|537855569|FG001|Extension Part|Ongoing|7|||
149102818|NCT04082429|537855570|FG002|Extension Part|Ongoing|17|||
149102819|NCT04082429|537855571|FG003|Extension Part|Ongoing|6|||
149102820|NCT04082429|537855572|FG004|Extension Part|Ongoing|45|||
149102821|NCT04082429|537855573|FG005|Extension Part|Ongoing|0|||
149102822|NCT04082429|537855574|FG006|Extension Part|Ongoing|10|||
149102823|NCT04082429|537855575|FG007|Extension Part|Ongoing|23|||
149102824|NCT04082429|537855576|FG008|Extension Part|Ongoing|25|||
149102825|NCT05923112|537855577|FG000|Overall Study|Protocol Violation|4|||
149119474|NCT01327495|537916354|FG003|Overall Study|Adverse Event|0|||
149102826|NCT05923112|537855577|FG000|Overall Study|No informed consent on publication of study results|243|||
149102827|NCT03118050|537855578|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
149102828|NCT03118050|537855579|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
149102829|NCT03118050|537855580|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
149102830|NCT03118050|537855581|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
149102831|NCT03118050|537855582|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
149102832|NCT03118050|537855583|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
149102833|NCT03118050|537855584|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
149102834|NCT04991766|537855585|FG000|Overall Study|Withdrawal by Subject|2|||
149102835|NCT04991766|537855586|FG001|Overall Study|Withdrawal by Subject|0|||
149102836|NCT05499130|537855594|FG000|Overall Study|Adverse Event|2|||
149102837|NCT05499130|537855595|FG001|Overall Study|Adverse Event|0|||
149102838|NCT05499130|537855596|FG002|Overall Study|Adverse Event|1|||
149102839|NCT05499130|537855597|FG003|Overall Study|Adverse Event|0|||
149102840|NCT05499130|537855598|FG004|Overall Study|Adverse Event|1|||
149102841|NCT05499130|537855599|FG005|Overall Study|Adverse Event|4|||
149102842|NCT05499130|537855600|FG006|Overall Study|Adverse Event|1|||
149102843|NCT05499130|537855601|FG007|Overall Study|Adverse Event|0|||
149102844|NCT05499130|537855594|FG000|Overall Study|Lack of Efficacy|1|||
149102845|NCT05499130|537855595|FG001|Overall Study|Lack of Efficacy|0|||
149102846|NCT05499130|537855596|FG002|Overall Study|Lack of Efficacy|0|||
149102847|NCT05499130|537855597|FG003|Overall Study|Lack of Efficacy|0|||
149102848|NCT05499130|537855598|FG004|Overall Study|Lack of Efficacy|5|||
149102849|NCT05499130|537855599|FG005|Overall Study|Lack of Efficacy|0|||
149102850|NCT05499130|537855600|FG006|Overall Study|Lack of Efficacy|1|||
149102851|NCT05499130|537855601|FG007|Overall Study|Lack of Efficacy|0|||
149102852|NCT05499130|537855594|FG000|Overall Study|Withdrawal by Subject|2|||
149102853|NCT05499130|537855595|FG001|Overall Study|Withdrawal by Subject|0|||
149102854|NCT05499130|537855596|FG002|Overall Study|Withdrawal by Subject|0|||
149102855|NCT05499130|537855597|FG003|Overall Study|Withdrawal by Subject|0|||
149102856|NCT05499130|537855598|FG004|Overall Study|Withdrawal by Subject|1|||
149102857|NCT05499130|537855599|FG005|Overall Study|Withdrawal by Subject|2|||
149102858|NCT05499130|537855600|FG006|Overall Study|Withdrawal by Subject|0|||
149102859|NCT05499130|537855601|FG007|Overall Study|Withdrawal by Subject|0|||
149102860|NCT05499130|537855594|FG000|Overall Study|Lost to Follow-up|0|||
149102861|NCT05499130|537855595|FG001|Overall Study|Lost to Follow-up|0|||
149102862|NCT05499130|537855596|FG002|Overall Study|Lost to Follow-up|0|||
149102863|NCT05499130|537855597|FG003|Overall Study|Lost to Follow-up|0|||
149102864|NCT05499130|537855598|FG004|Overall Study|Lost to Follow-up|0|||
149102865|NCT05499130|537855599|FG005|Overall Study|Lost to Follow-up|2|||
149102866|NCT05499130|537855600|FG006|Overall Study|Lost to Follow-up|0|||
149102867|NCT05499130|537855601|FG007|Overall Study|Lost to Follow-up|0|||
149102868|NCT05499130|537855594|FG000|Overall Study|Other Than Specified|0|||
149102869|NCT05499130|537855595|FG001|Overall Study|Other Than Specified|0|||
149102870|NCT05499130|537855596|FG002|Overall Study|Other Than Specified|0|||
149102871|NCT05499130|537855597|FG003|Overall Study|Other Than Specified|0|||
149102872|NCT05499130|537855598|FG004|Overall Study|Other Than Specified|1|||
149102873|NCT05499130|537855599|FG005|Overall Study|Other Than Specified|1|||
149102874|NCT05499130|537855600|FG006|Overall Study|Other Than Specified|2|||
149102875|NCT05499130|537855601|FG007|Overall Study|Other Than Specified|0|||
149102876|NCT05499130|537855594|FG000|Overall Study|Protocol Violation|0|||
149102877|NCT05499130|537855595|FG001|Overall Study|Protocol Violation|0|||
149102878|NCT05499130|537855596|FG002|Overall Study|Protocol Violation|0|||
149102879|NCT05499130|537855597|FG003|Overall Study|Protocol Violation|0|||
149102880|NCT05499130|537855598|FG004|Overall Study|Protocol Violation|1|||
149102881|NCT05499130|537855599|FG005|Overall Study|Protocol Violation|0|||
149102882|NCT05499130|537855600|FG006|Overall Study|Protocol Violation|0|||
149102883|NCT05499130|537855601|FG007|Overall Study|Protocol Violation|0|||
149102884|NCT04889118|537855605|FG000|Overall Study|Death|49|||
149102885|NCT04889118|537855606|FG001|Overall Study|Death|47|||
149102886|NCT04889118|537855605|FG000|Overall Study|Sponsor Decision|15|||
149102887|NCT04889118|537855606|FG001|Overall Study|Sponsor Decision|20|||
149102888|NCT05147350|537855607|FG000|Overall Study|Death|2|||
149102889|NCT05147350|537855608|FG001|Overall Study|Death|3|||
149102890|NCT05147350|537855609|FG002|Overall Study|Death|3|||
149102891|NCT05147350|537855610|FG003|Overall Study|Death|2|||
149102892|NCT05147350|537855611|FG004|Overall Study|Death|2|||
149102893|NCT05147350|537855612|FG005|Overall Study|Death|1|||
149102894|NCT05147350|537855613|FG006|Overall Study|Death|1|||
149102895|NCT05147350|537855614|FG007|Overall Study|Death|3|||
149102896|NCT05147350|537855607|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
149102897|NCT05147350|537855608|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
149102898|NCT05147350|537855609|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
149102899|NCT05147350|537855610|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
149102900|NCT05147350|537855611|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
149102901|NCT05147350|537855612|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
149102902|NCT05147350|537855613|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
149102903|NCT05147350|537855614|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
149102904|NCT05147350|537855607|FG000|Overall Study|Withdrawal by Subject|0|||
149102905|NCT05147350|537855608|FG001|Overall Study|Withdrawal by Subject|0|||
149102906|NCT05147350|537855609|FG002|Overall Study|Withdrawal by Subject|3|||
149102907|NCT05147350|537855610|FG003|Overall Study|Withdrawal by Subject|1|||
149102908|NCT05147350|537855611|FG004|Overall Study|Withdrawal by Subject|1|||
149102909|NCT05147350|537855612|FG005|Overall Study|Withdrawal by Subject|0|||
149102910|NCT05147350|537855613|FG006|Overall Study|Withdrawal by Subject|1|||
149102911|NCT05147350|537855614|FG007|Overall Study|Withdrawal by Subject|0|||
149102912|NCT05147350|537855607|FG000|Overall Study|Other Reasons|0|||
149102913|NCT05147350|537855608|FG001|Overall Study|Other Reasons|0|||
149102914|NCT05147350|537855609|FG002|Overall Study|Other Reasons|2|||
149102915|NCT05147350|537855610|FG003|Overall Study|Other Reasons|0|||
149102916|NCT05147350|537855611|FG004|Overall Study|Other Reasons|0|||
149102917|NCT05147350|537855612|FG005|Overall Study|Other Reasons|2|||
149102918|NCT05147350|537855613|FG006|Overall Study|Other Reasons|1|||
149102919|NCT05147350|537855614|FG007|Overall Study|Other Reasons|1|||
149102920|NCT06136897|537855617|FG000|Overall Study|Ineligible|3|||
149102921|NCT06136897|537855617|FG000|Overall Study|Mutation status not confirmed|7|||
149102922|NCT06136897|537855617|FG000|Overall Study|Adverse Event|2|||
149102923|NCT06136897|537855617|FG000|Overall Study|Death|1|||
149102924|NCT06136897|537855617|FG000|Overall Study|Disease progression|18|||
149102925|NCT06136897|537855617|FG000|Overall Study|Other complicating disease|1|||
149102926|NCT06136897|537855617|FG000|Overall Study|Withdrawal by Subject|1|||
149102927|NCT06136897|537855617|FG000|Overall Study|Still on treatment|1|||
149102928|NCT06136897|537855617|FG000|Overall Study|Lost to Follow-up|1|||
149102929|NCT02437071|537855620|FG000|Overall Study|Withdrawal by Subject|1|||
149102930|NCT02437071|537855621|FG001|Overall Study|Withdrawal by Subject|0|||
149102931|NCT03802617|537855622|FG000|Overall Study|Adverse Event|0|||
149102932|NCT03802617|537855623|FG001|Overall Study|Adverse Event|4|||
149102933|NCT03802617|537855624|FG002|Overall Study|Adverse Event|5|||
149102934|NCT03802617|537855625|FG003|Overall Study|Adverse Event|1|||
149102935|NCT03802617|537855622|FG000|Overall Study|Lack of Efficacy|0|||
149102936|NCT03802617|537855623|FG001|Overall Study|Lack of Efficacy|1|||
149102937|NCT03802617|537855624|FG002|Overall Study|Lack of Efficacy|0|||
149102938|NCT03802617|537855625|FG003|Overall Study|Lack of Efficacy|2|||
149102939|NCT03802617|537855622|FG000|Overall Study|Protocol Violation|1|||
149102940|NCT03802617|537855623|FG001|Overall Study|Protocol Violation|1|||
149102941|NCT03802617|537855624|FG002|Overall Study|Protocol Violation|1|||
149102942|NCT03802617|537855625|FG003|Overall Study|Protocol Violation|0|||
149102943|NCT03802617|537855622|FG000|Overall Study|Withdrawal by Subject|1|||
149102944|NCT03802617|537855623|FG001|Overall Study|Withdrawal by Subject|1|||
149102945|NCT03802617|537855624|FG002|Overall Study|Withdrawal by Subject|1|||
149102946|NCT03802617|537855625|FG003|Overall Study|Withdrawal by Subject|0|||
149102947|NCT03802617|537855622|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
149102948|NCT03802617|537855623|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
149102949|NCT03802617|537855624|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
149102950|NCT03802617|537855625|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
149102951|NCT04788511|537855626|FG000|Overall Study|Withdrawal by Subject|2|||
149102952|NCT04788511|537855627|FG001|Overall Study|Withdrawal by Subject|1|||
149102953|NCT04788511|537855626|FG000|Overall Study|Lost to Follow-up|2|||
149102954|NCT04788511|537855627|FG001|Overall Study|Lost to Follow-up|7|||
149102955|NCT04788511|537855626|FG000|Overall Study|Death|3|||
149102956|NCT04788511|537855627|FG001|Overall Study|Death|4|||
149102957|NCT05903183|537855628|FG000|Main Trial Part (365 Days)|Death|1|||
149102958|NCT05903183|537855629|FG001|Main Trial Part (365 Days)|Death|0|||
149102959|NCT05903183|537855630|FG002|Main Trial Part (365 Days)|Death|0|||
149102960|NCT05903183|537855631|FG003|Main Trial Part (365 Days)|Death|0|||
149102961|NCT05903183|537855632|FG004|Main Trial Part (365 Days)|Death|0|||
149102962|NCT05903183|537855628|FG000|Main Trial Part (365 Days)|Other|1|||
149102963|NCT05903183|537855629|FG001|Main Trial Part (365 Days)|Other|2|||
149102964|NCT05903183|537855630|FG002|Main Trial Part (365 Days)|Other|1|||
149102965|NCT05903183|537855631|FG003|Main Trial Part (365 Days)|Other|0|||
149102966|NCT05903183|537855632|FG004|Main Trial Part (365 Days)|Other|0|||
149102967|NCT05903183|537855628|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
149102968|NCT05903183|537855629|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
149102969|NCT05903183|537855630|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
149102970|NCT05903183|537855631|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
149102971|NCT05903183|537855632|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
149102972|NCT05903183|537855628|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
149102973|NCT05903183|537855629|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
149102974|NCT05903183|537855630|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
149102975|NCT05903183|537855631|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
149102976|NCT05903183|537855632|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
149102977|NCT05903183|537855628|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
149102978|NCT05903183|537855629|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
149102979|NCT05903183|537855630|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
149102980|NCT05903183|537855631|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
149102981|NCT05903183|537855632|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
149102982|NCT03698019|537855633|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
149102983|NCT03698019|537855634|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
149102984|NCT03698019|537855633|FG000|Step 1: Registration|Withdrawal by Subject|7|||
149102985|NCT03698019|537855634|FG001|Step 1: Registration|Withdrawal by Subject|2|||
149102986|NCT03698019|537855633|FG000|Step 1: Registration|Toxicity|0|||
149102987|NCT03698019|537855634|FG001|Step 1: Registration|Toxicity|1|||
149102988|NCT03698019|537855633|FG000|Step 1: Registration|Disease Progression|0|||
149102989|NCT03698019|537855634|FG001|Step 1: Registration|Disease Progression|12|||
149102990|NCT03698019|537855633|FG000|Step 1: Registration|Co-morbidities|0|||
149102991|NCT03698019|537855634|FG001|Step 1: Registration|Co-morbidities|1|||
149102992|NCT03698019|537855633|FG000|Step 1: Registration|Scheduling Issues|1|||
149102993|NCT03698019|537855634|FG001|Step 1: Registration|Scheduling Issues|0|||
149102994|NCT03698019|537855633|FG000|Step 1: Registration|Participant Refusal|0|||
149102995|NCT03698019|537855634|FG001|Step 1: Registration|Participant Refusal|1|||
149102996|NCT03698019|537855633|FG000|Step 2: Surgery|Participant Refusal|2|||
149102997|NCT03698019|537855634|FG001|Step 2: Surgery|Participant Refusal|1|||
149102998|NCT03698019|537855633|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
149102999|NCT03698019|537855634|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
149103000|NCT03698019|537855633|FG000|Step 2: Surgery|Metastatic Disease|16|||
149103001|NCT03698019|537855634|FG001|Step 2: Surgery|Metastatic Disease|9|||
149103002|NCT03698019|537855633|FG000|Step 2: Surgery|Residual Disease|2|||
149103003|NCT03698019|537855634|FG001|Step 2: Surgery|Residual Disease|1|||
149103004|NCT03698019|537855633|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
149103005|NCT03698019|537855634|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
149103006|NCT03698019|537855633|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
149103007|NCT03698019|537855634|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
149103008|NCT03698019|537855633|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
149103009|NCT03698019|537855634|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
149103010|NCT03698019|537855633|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
149103011|NCT03698019|537855634|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
149103012|NCT03698019|537855633|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
149103013|NCT03698019|537855634|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
149103014|NCT03698019|537855633|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
149103015|NCT03698019|537855634|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
149103016|NCT03698019|537855633|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
149103017|NCT03698019|537855634|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
149103018|NCT03698019|537855633|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
149103019|NCT03698019|537855634|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
149103020|NCT00569127|537855635|FG000|Overall Study|Adverse Event|57|||
149103021|NCT00569127|537855636|FG001|Overall Study|Adverse Event|47|||
149103022|NCT00569127|537855635|FG000|Overall Study|Withdrawal by Subject|13|||
149103023|NCT00569127|537855636|FG001|Overall Study|Withdrawal by Subject|27|||
149103024|NCT00569127|537855635|FG000|Overall Study|Progression|99|||
149103025|NCT00569127|537855636|FG001|Overall Study|Progression|100|||
149103026|NCT00569127|537855635|FG000|Overall Study|Death|4|||
149103027|NCT00569127|537855636|FG001|Overall Study|Death|3|||
149103028|NCT00569127|537855635|FG000|Overall Study|Other|20|||
149103029|NCT00569127|537855636|FG001|Overall Study|Other|19|||
149103030|NCT00569127|537855635|FG000|Overall Study|Lost to Follow-up|0|||
149103031|NCT00569127|537855636|FG001|Overall Study|Lost to Follow-up|3|||
149103032|NCT00569127|537855635|FG000|Overall Study|Not Eligible|14|||
149103033|NCT00569127|537855636|FG001|Overall Study|Not Eligible|11|||
149103034|NCT00569127|537855635|FG000|Overall Study|Still on Treatment|7|||
149103035|NCT00569127|537855636|FG001|Overall Study|Still on Treatment|3|||
149103036|NCT03725605|537855637|FG000|Overall Study|Unsuccessful TIL expansion|2|||
149103037|NCT02282917|537856254|FG000|Overall Study|Withdrawal by Subject|1|||
149103038|NCT02282917|537856254|FG000|Overall Study|Screen Failure/Not Eligible|1|||
149103039|NCT04590404|537856255|FG000|Overall Study|Death|16|||
149103040|NCT04590404|537856256|FG001|Overall Study|Death|17|||
149103041|NCT04590404|537856255|FG000|Overall Study|Withdrawal by Subject|7|||
149103042|NCT04590404|537856256|FG001|Overall Study|Withdrawal by Subject|2|||
149103043|NCT03149029|537856271|FG000|Overall Study|Adverse Event|2|||
149103044|NCT03149029|537856272|FG001|Overall Study|Adverse Event|0|||
149103045|NCT05739994|537856279|FG000|Overall Study|Withdrawal by Subject|2|||
149103046|NCT05739994|537856280|FG001|Overall Study|Withdrawal by Subject|2|||
149103047|NCT05739994|537856281|FG002|Overall Study|Withdrawal by Subject|4|||
149103048|NCT03299959|537856282|FG000|Overall Study|Lost to Follow-up|7|||
149103049|NCT03299959|537856283|FG001|Overall Study|Lost to Follow-up|9|||
149103050|NCT03299959|537856282|FG000|Overall Study|Death|1|||
149103051|NCT03299959|537856283|FG001|Overall Study|Death|0|||
149103052|NCT03299959|537856282|FG000|Overall Study|Withdrawal by Subject|13|||
149103053|NCT03299959|537856283|FG001|Overall Study|Withdrawal by Subject|9|||
149103054|NCT03299959|537856282|FG000|Overall Study|Changes in study team and government regulations|1|||
149103055|NCT03299959|537856283|FG001|Overall Study|Changes in study team and government regulations|1|||
149103056|NCT03299959|537856282|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
149103057|NCT03299959|537856283|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
149103058|NCT03735121|537856284|FG000|Overall Study|Death|3|||
149103059|NCT03735121|537856285|FG001|Overall Study|Death|6|||
149103060|NCT03735121|537856286|FG002|Overall Study|Death|19|||
149103061|NCT03735121|537856287|FG003|Overall Study|Death|97|||
149103062|NCT03735121|537856288|FG004|Overall Study|Death|205|||
149103063|NCT03735121|537856284|FG000|Overall Study|Lost to Follow-up|0|||
149103064|NCT03735121|537856285|FG001|Overall Study|Lost to Follow-up|0|||
149103065|NCT03735121|537856286|FG002|Overall Study|Lost to Follow-up|0|||
149103066|NCT03735121|537856287|FG003|Overall Study|Lost to Follow-up|2|||
149103067|NCT03735121|537856288|FG004|Overall Study|Lost to Follow-up|3|||
149103068|NCT03735121|537856284|FG000|Overall Study|New Therapy|0|||
149103069|NCT03735121|537856285|FG001|Overall Study|New Therapy|1|||
149103070|NCT03735121|537856286|FG002|Overall Study|New Therapy|0|||
149103071|NCT03735121|537856287|FG003|Overall Study|New Therapy|0|||
149103072|NCT03735121|537856288|FG004|Overall Study|New Therapy|0|||
149103073|NCT03735121|537856284|FG000|Overall Study|Study Ended by Sponsor|1|||
149103074|NCT03735121|537856285|FG001|Overall Study|Study Ended by Sponsor|0|||
149103075|NCT03735121|537856286|FG002|Overall Study|Study Ended by Sponsor|1|||
149103076|NCT03735121|537856287|FG003|Overall Study|Study Ended by Sponsor|17|||
149103077|NCT03735121|537856288|FG004|Overall Study|Study Ended by Sponsor|28|||
149103078|NCT03735121|537856284|FG000|Overall Study|Withdrawal by Subject|1|||
149103079|NCT03735121|537856285|FG001|Overall Study|Withdrawal by Subject|1|||
149103080|NCT03735121|537856286|FG002|Overall Study|Withdrawal by Subject|6|||
149103081|NCT03735121|537856287|FG003|Overall Study|Withdrawal by Subject|8|||
149103082|NCT03735121|537856288|FG004|Overall Study|Withdrawal by Subject|11|||
149103083|NCT02176863|537856289|FG000|Overall Study|Physician Decision|1|||
149103084|NCT02176863|537856290|FG001|Overall Study|Physician Decision|0|||
149103085|NCT02176863|537856291|FG002|Overall Study|Physician Decision|0|||
149103086|NCT02176863|537856292|FG003|Overall Study|Physician Decision|0|||
149103087|NCT02176863|537856293|FG004|Overall Study|Physician Decision|0|||
149103088|NCT02176863|537856289|FG000|Overall Study|Adverse Event|10|||
149103089|NCT02176863|537856290|FG001|Overall Study|Adverse Event|4|||
149103090|NCT02176863|537856291|FG002|Overall Study|Adverse Event|4|||
149103091|NCT02176863|537856292|FG003|Overall Study|Adverse Event|1|||
149103092|NCT02176863|537856293|FG004|Overall Study|Adverse Event|1|||
149103093|NCT02176863|537856289|FG000|Overall Study|Protocol Violation|2|||
149103094|NCT02176863|537856290|FG001|Overall Study|Protocol Violation|0|||
149103095|NCT02176863|537856291|FG002|Overall Study|Protocol Violation|1|||
149103096|NCT02176863|537856292|FG003|Overall Study|Protocol Violation|1|||
149103097|NCT02176863|537856293|FG004|Overall Study|Protocol Violation|0|||
149103098|NCT02176863|537856289|FG000|Overall Study|Withdrawal by Subject|4|||
149103099|NCT02176863|537856290|FG001|Overall Study|Withdrawal by Subject|2|||
149103100|NCT02176863|537856291|FG002|Overall Study|Withdrawal by Subject|2|||
149103101|NCT02176863|537856292|FG003|Overall Study|Withdrawal by Subject|3|||
149103102|NCT02176863|537856293|FG004|Overall Study|Withdrawal by Subject|4|||
149103103|NCT02176863|537856289|FG000|Overall Study|Reason not specified|0|||
149103104|NCT02176863|537856290|FG001|Overall Study|Reason not specified|1|||
149103105|NCT02176863|537856291|FG002|Overall Study|Reason not specified|1|||
149103106|NCT02176863|537856292|FG003|Overall Study|Reason not specified|2|||
149103107|NCT02176863|537856293|FG004|Overall Study|Reason not specified|1|||
149103108|NCT02176863|537856289|FG000|Overall Study|Lost to Follow-up|0|||
149103109|NCT02176863|537856290|FG001|Overall Study|Lost to Follow-up|1|||
149103110|NCT02176863|537856291|FG002|Overall Study|Lost to Follow-up|1|||
149103111|NCT02176863|537856292|FG003|Overall Study|Lost to Follow-up|0|||
149103112|NCT02176863|537856293|FG004|Overall Study|Lost to Follow-up|0|||
149103113|NCT06077773|537856294|FG000|Overall Study|Withdrawal by Subject|1|||
149103114|NCT06077773|537856295|FG001|Overall Study|Withdrawal by Subject|0|||
149103115|NCT06077773|537856296|FG002|Overall Study|Withdrawal by Subject|1|||
149103116|NCT06077773|537856294|FG000|Overall Study|Lost to Follow-up|0|||
149103117|NCT06077773|537856295|FG001|Overall Study|Lost to Follow-up|1|||
149103118|NCT06077773|537856296|FG002|Overall Study|Lost to Follow-up|0|||
149103119|NCT06077773|537856294|FG000|Overall Study|Adverse Event|0|||
149103120|NCT06077773|537856295|FG001|Overall Study|Adverse Event|0|||
149103121|NCT06077773|537856296|FG002|Overall Study|Adverse Event|2|||
149103122|NCT02473042|537856297|FG000|Overall Study|Withdrawal by Subject|1|||
149103123|NCT02473042|537856298|FG001|Overall Study|Withdrawal by Subject|0|||
149103124|NCT02473042|537856297|FG000|Overall Study|Patient became ineligible after enrollment|2|||
149103125|NCT02473042|537856298|FG001|Overall Study|Patient became ineligible after enrollment|5|||
149103126|NCT02473042|537856297|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
149103127|NCT02473042|537856298|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
149103128|NCT02473042|537856297|FG000|Overall Study|PACU data unable to be collected|3|||
149103129|NCT02473042|537856298|FG001|Overall Study|PACU data unable to be collected|0|||
149103130|NCT03007732|537856299|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
149103131|NCT03007732|537856300|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
149103132|NCT03007732|537856301|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
149103133|NCT03007732|537856302|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
149103134|NCT03668223|537856303|FG000|Overall Study|Death|10|||
149103135|NCT03668223|537856304|FG001|Overall Study|Death|5|||
149103136|NCT03668223|537856303|FG000|Overall Study|Lost to Follow-up|12|||
149103137|NCT03668223|537856304|FG001|Overall Study|Lost to Follow-up|12|||
149103138|NCT03668223|537856303|FG000|Overall Study|Withdrawal by Subject|8|||
149103139|NCT03668223|537856304|FG001|Overall Study|Withdrawal by Subject|3|||
149103140|NCT01503086|537856305|FG000|Overall Study|Lost to Follow-up|0|||
149103141|NCT01503086|537856306|FG001|Overall Study|Lost to Follow-up|1|||
149103142|NCT01503086|537856307|FG002|Overall Study|Lost to Follow-up|0|||
149103143|NCT01503086|537856305|FG000|Overall Study|Did Not Start Treatment|4|||
149103144|NCT01503086|537856306|FG001|Overall Study|Did Not Start Treatment|3|||
149103145|NCT01503086|537856307|FG002|Overall Study|Did Not Start Treatment|3|||
149103146|NCT01503086|537856305|FG000|Overall Study|Progressive disease|3|||
149103147|NCT01503086|537856306|FG001|Overall Study|Progressive disease|1|||
149103148|NCT01503086|537856307|FG002|Overall Study|Progressive disease|0|||
149103149|NCT01503086|537856305|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
149103150|NCT01503086|537856306|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
149103151|NCT01503086|537856307|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
149103152|NCT01503086|537856305|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
149103153|NCT01503086|537856306|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
149103154|NCT01503086|537856307|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
149103155|NCT05502783|537856308|FG000|Overall Study|Lack of Efficacy|1|||
149103156|NCT04870957|537856309|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
149103157|NCT04870957|537856310|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
149103158|NCT04870957|537856311|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
149103159|NCT04870957|537856312|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
149103160|NCT04870957|537856313|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
149103161|NCT04870957|537856314|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
149103162|NCT04870957|537856309|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
149103163|NCT04870957|537856310|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
149103164|NCT04870957|537856311|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
149103165|NCT04870957|537856312|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
149103166|NCT04870957|537856313|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
149103167|NCT04870957|537856314|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
149103168|NCT04870957|537856309|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
149103169|NCT04870957|537856310|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
149103170|NCT04870957|537856311|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
149103171|NCT04870957|537856312|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
149103172|NCT04870957|537856313|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
149103173|NCT04870957|537856314|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
149103174|NCT04870957|537856309|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
149103175|NCT04870957|537856310|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
149103176|NCT04870957|537856311|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
149103177|NCT04870957|537856312|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
149103178|NCT04870957|537856313|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
149103179|NCT04870957|537856314|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
149103180|NCT04870957|537856309|FG000|T2 (Randomization) - T3|Adverse Event|1|||
149103181|NCT04870957|537856310|FG001|T2 (Randomization) - T3|Adverse Event|1|||
149103182|NCT04870957|537856311|FG002|T2 (Randomization) - T3|Adverse Event|0|||
149103183|NCT04870957|537856312|FG003|T2 (Randomization) - T3|Adverse Event|0|||
149103184|NCT04870957|537856313|FG004|T2 (Randomization) - T3|Adverse Event|0|||
149103185|NCT04870957|537856314|FG005|T2 (Randomization) - T3|Adverse Event|0|||
149103186|NCT04870957|537856309|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
149103187|NCT04870957|537856310|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
149103188|NCT04870957|537856311|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
149103189|NCT04870957|537856312|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
149103190|NCT04870957|537856313|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
149103191|NCT04870957|537856314|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
149103192|NCT04870957|537856309|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
149103193|NCT04870957|537856310|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
149103194|NCT04870957|537856311|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
149103195|NCT04870957|537856312|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
149103196|NCT04870957|537856313|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
149103197|NCT04870957|537856314|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
149103198|NCT04870957|537856309|FG000|T2 (Randomization) - T3|Physician Decision|0|||
149103199|NCT04870957|537856310|FG001|T2 (Randomization) - T3|Physician Decision|0|||
149103200|NCT04870957|537856311|FG002|T2 (Randomization) - T3|Physician Decision|2|||
149103201|NCT04870957|537856312|FG003|T2 (Randomization) - T3|Physician Decision|1|||
149103202|NCT04870957|537856313|FG004|T2 (Randomization) - T3|Physician Decision|0|||
149103203|NCT04870957|537856314|FG005|T2 (Randomization) - T3|Physician Decision|0|||
149103204|NCT04870957|537856309|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
149103205|NCT04870957|537856310|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
149103206|NCT04870957|537856311|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
149103207|NCT04870957|537856312|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
149103208|NCT04870957|537856313|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
149103209|NCT04870957|537856314|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
149103210|NCT04870957|537856309|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
149103211|NCT04870957|537856310|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
149103212|NCT04870957|537856311|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
149103213|NCT04870957|537856312|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
149103214|NCT04870957|537856313|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
149103215|NCT04870957|537856314|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
149103216|NCT04870957|537856309|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
149103217|NCT04870957|537856310|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
149103218|NCT04870957|537856311|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
149103219|NCT04870957|537856312|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
149103220|NCT04870957|537856313|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
149103221|NCT04870957|537856314|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
149103222|NCT04870957|537856309|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
149103223|NCT04870957|537856310|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
149103224|NCT04870957|537856311|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
149103225|NCT04870957|537856312|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
149103226|NCT04870957|537856313|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
149103227|NCT04870957|537856314|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
149103228|NCT04870957|537856309|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
149103229|NCT04870957|537856310|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
149103230|NCT04870957|537856311|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
149103231|NCT04870957|537856312|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
149103232|NCT04870957|537856313|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
149103233|NCT04870957|537856314|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
149103234|NCT04870957|537856309|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
149103235|NCT04870957|537856310|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
149103236|NCT04870957|537856311|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
149103237|NCT04870957|537856312|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
149103238|NCT04870957|537856313|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
149103239|NCT04870957|537856314|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
149103240|NCT04870957|537856309|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
149103241|NCT04870957|537856310|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
149103242|NCT04870957|537856311|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
149103243|NCT04870957|537856312|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
149103244|NCT04870957|537856313|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
149103245|NCT04870957|537856314|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
149103246|NCT04870957|537856309|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
149103247|NCT04870957|537856310|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
149103248|NCT04870957|537856311|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
149103249|NCT04870957|537856312|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
149103250|NCT04870957|537856313|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
149103251|NCT04870957|537856314|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
149103252|NCT04870957|537856309|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
149103253|NCT04870957|537856310|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
149103254|NCT04870957|537856311|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
149103255|NCT04870957|537856312|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
149103256|NCT04870957|537856313|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
149103257|NCT04870957|537856314|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
149103258|NCT05970640|537856315|FG000|Overall Study|Adverse Event|1|||
149103259|NCT05970640|537856316|FG001|Overall Study|Adverse Event|3|||
149103260|NCT05970640|537856317|FG002|Overall Study|Adverse Event|1|||
149103261|NCT05970640|537856318|FG003|Overall Study|Adverse Event|0|||
149103262|NCT05970640|537856315|FG000|Overall Study|Withdrawal by Subject|0|||
149103263|NCT05970640|537856316|FG001|Overall Study|Withdrawal by Subject|0|||
149103264|NCT05970640|537856317|FG002|Overall Study|Withdrawal by Subject|1|||
149103265|NCT05970640|537856318|FG003|Overall Study|Withdrawal by Subject|1|||
149103266|NCT05970640|537856315|FG000|Overall Study|Sponsor decision|0|||
149103267|NCT05970640|537856316|FG001|Overall Study|Sponsor decision|0|||
149103268|NCT05970640|537856317|FG002|Overall Study|Sponsor decision|1|||
149103269|NCT05970640|537856318|FG003|Overall Study|Sponsor decision|1|||
149103270|NCT04340843|537856319|FG000|Overall Study|Adverse Event|0|||
149103271|NCT04340843|537856320|FG001|Overall Study|Adverse Event|2|||
149103272|NCT04340843|537856319|FG000|Overall Study|Withdrawal by Subject|0|||
149103273|NCT04340843|537856320|FG001|Overall Study|Withdrawal by Subject|2|||
149103274|NCT03459846|537856323|FG000|Overall Study|Death|52|||
149103275|NCT03459846|537856324|FG001|Overall Study|Death|46|||
149103276|NCT03459846|537856323|FG000|Overall Study|Study terminated by sponsor|24|||
149103277|NCT03459846|537856324|FG001|Overall Study|Study terminated by sponsor|28|||
149103278|NCT03459846|537856323|FG000|Overall Study|Withdrawal by Subject|2|||
149103279|NCT03459846|537856324|FG001|Overall Study|Withdrawal by Subject|2|||
149103280|NCT01090011|537857354|FG000|Overall Study|Progressive disease|128|||
149103281|NCT01090011|537857354|FG000|Overall Study|Adverse Event|32|||
149103282|NCT01090011|537857354|FG000|Overall Study|Protocol Violation|1|||
149103283|NCT01090011|537857354|FG000|Overall Study|Refusal to start/continue medication|5|||
149103284|NCT01090011|537857354|FG000|Overall Study|Other reason not defined above|5|||
149103285|NCT00321685|537857361|FG000|Overall Study|Adverse Event|18|||
149103286|NCT00321685|537857361|FG000|Overall Study|Death|2|||
149103287|NCT00321685|537857361|FG000|Overall Study|Withdrawal by Subject|8|||
149103288|NCT00321685|537857361|FG000|Overall Study|Alternative therapy|1|||
149103289|NCT00321685|537857361|FG000|Overall Study|Complicating disese|1|||
149103290|NCT00321685|537857361|FG000|Overall Study|Other|5|||
149103291|NCT00321685|537857361|FG000|Overall Study|Not start protocol therapy|2|||
149103292|NCT00321685|537857361|FG000|Overall Study|Ineligible|2|||
149103293|NCT01730950|537857365|FG000|Overall Study|Protocol Violation|6|||
149103294|NCT01730950|537857366|FG001|Overall Study|Protocol Violation|6|||
149103295|NCT03023722|537857367|FG000|Overall Study|No follow-up assessment|4|||
149103296|NCT03616964|537857368|FG000|Overall Study|Adverse Event|15|||
149103297|NCT03616964|537857369|FG001|Overall Study|Adverse Event|10|||
149103298|NCT03616964|537857370|FG002|Overall Study|Adverse Event|16|||
149103299|NCT03616964|537857368|FG000|Overall Study|Death|3|||
149103300|NCT03616964|537857369|FG001|Overall Study|Death|0|||
149103301|NCT03616964|537857370|FG002|Overall Study|Death|4|||
149103302|NCT03616964|537857368|FG000|Overall Study|Lack of Efficacy|4|||
149103303|NCT03616964|537857369|FG001|Overall Study|Lack of Efficacy|8|||
149103304|NCT03616964|537857370|FG002|Overall Study|Lack of Efficacy|8|||
149103305|NCT03616964|537857368|FG000|Overall Study|Lost to Follow-up|2|||
149103306|NCT03616964|537857369|FG001|Overall Study|Lost to Follow-up|1|||
149103307|NCT03616964|537857370|FG002|Overall Study|Lost to Follow-up|3|||
149103308|NCT03616964|537857368|FG000|Overall Study|Withdrawal by Subject|18|||
149103309|NCT03616964|537857369|FG001|Overall Study|Withdrawal by Subject|14|||
149103310|NCT03616964|537857370|FG002|Overall Study|Withdrawal by Subject|21|||
149103311|NCT03616964|537857368|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
149103312|NCT03616964|537857369|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
149103313|NCT03616964|537857370|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
149103314|NCT03616964|537857368|FG000|Overall Study|Sponsor's Decision|1|||
149103315|NCT03616964|537857369|FG001|Overall Study|Sponsor's Decision|0|||
149103316|NCT03616964|537857370|FG002|Overall Study|Sponsor's Decision|0|||
149103317|NCT03616964|537857368|FG000|Overall Study|Physician Decision|0|||
149103318|NCT03616964|537857369|FG001|Overall Study|Physician Decision|2|||
149103319|NCT03616964|537857370|FG002|Overall Study|Physician Decision|0|||
149103320|NCT03616964|537857368|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
149103321|NCT03616964|537857369|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
149103322|NCT03616964|537857370|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
149103323|NCT03616964|537857368|FG000|Overall Study|Protocol Violation|0|||
149103324|NCT03616964|537857369|FG001|Overall Study|Protocol Violation|1|||
149103325|NCT03616964|537857370|FG002|Overall Study|Protocol Violation|0|||
149103326|NCT03616964|537857368|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
149103327|NCT03616964|537857369|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
149103328|NCT03616964|537857370|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
149103329|NCT03616964|537857368|FG000|Overall Study|Randomized but Never Treated|1|||
149103330|NCT03616964|537857369|FG001|Overall Study|Randomized but Never Treated|1|||
149103331|NCT03616964|537857370|FG002|Overall Study|Randomized but Never Treated|1|||
149103332|NCT00129935|537857371|FG000|Overall Study|Adverse Event|18|||
149103333|NCT00129935|537857372|FG001|Overall Study|Adverse Event|56|||
149103334|NCT00129935|537857371|FG000|Overall Study|Death|1|||
149103335|NCT00129935|537857372|FG001|Overall Study|Death|1|||
149103336|NCT00129935|537857371|FG000|Overall Study|Withdrawal by Subject|7|||
149103337|NCT00129935|537857372|FG001|Overall Study|Withdrawal by Subject|20|||
149103338|NCT00129935|537857371|FG000|Overall Study|Protocol Violation|0|||
149103339|NCT00129935|537857372|FG001|Overall Study|Protocol Violation|4|||
149103340|NCT00129935|537857371|FG000|Overall Study|Physician Decision|3|||
149103341|NCT00129935|537857372|FG001|Overall Study|Physician Decision|4|||
149103342|NCT00129935|537857371|FG000|Overall Study|Recurrence|1|||
149103343|NCT00129935|537857372|FG001|Overall Study|Recurrence|3|||
149103344|NCT00129935|537857371|FG000|Overall Study|Second primary|0|||
149103345|NCT00129935|537857372|FG001|Overall Study|Second primary|1|||
149103346|NCT00129935|537857371|FG000|Overall Study|Other|3|||
149103347|NCT00129935|537857372|FG001|Overall Study|Other|2|||
149103348|NCT00129935|537857371|FG000|Overall Study|Crossed to the other arm|2|||
149103349|NCT00129935|537857372|FG001|Overall Study|Crossed to the other arm|1|||
149103350|NCT00129935|537857371|FG000|Overall Study|Incorrect study treatment|1|||
149103351|NCT00129935|537857372|FG001|Overall Study|Incorrect study treatment|0|||
149103352|NCT03020069|537857374|FG000|Overall Study|Lost to Follow-up|0|||
149103353|NCT03020069|537857375|FG001|Overall Study|Lost to Follow-up|1|||
149103354|NCT02056626|537857376|FG000|Overall Study|patient did not follow directions|3|||
149103355|NCT02056626|537857377|FG001|Overall Study|patient did not follow directions|1|||
149103356|NCT02056626|537857378|FG002|Overall Study|patient did not follow directions|0|||
149103357|NCT02056626|537857379|FG003|Overall Study|patient did not follow directions|0|||
149103358|NCT05765435|537857380|FG000|Overall Study|Lost to Follow-up|0|||
149103359|NCT05765435|537857381|FG001|Overall Study|Lost to Follow-up|1|||
149103360|NCT05765435|537857382|FG002|Overall Study|Lost to Follow-up|0|||
149103361|NCT05765435|537857380|FG000|Overall Study|Withdrawal by Subject|0|||
149103362|NCT05765435|537857381|FG001|Overall Study|Withdrawal by Subject|0|||
149103363|NCT05765435|537857382|FG002|Overall Study|Withdrawal by Subject|1|||
149103364|NCT01952847|537857383|FG000|Overall Study|Ineligible|1|||
149103365|NCT01952847|537857384|FG001|Overall Study|Ineligible|0|||
149103366|NCT01952847|537857385|FG002|Overall Study|Ineligible|0|||
149103367|NCT01952847|537857386|FG003|Overall Study|Ineligible|0|||
149103368|NCT01952847|537857383|FG000|Overall Study|Lack of Insurance Coverage|0|||
149103369|NCT01952847|537857384|FG001|Overall Study|Lack of Insurance Coverage|1|||
149103370|NCT01952847|537857385|FG002|Overall Study|Lack of Insurance Coverage|0|||
149103371|NCT01952847|537857386|FG003|Overall Study|Lack of Insurance Coverage|0|||
149103372|NCT01952847|537857383|FG000|Overall Study|Withdrawal by Subject|1|||
149103373|NCT01952847|537857384|FG001|Overall Study|Withdrawal by Subject|1|||
149103374|NCT01952847|537857385|FG002|Overall Study|Withdrawal by Subject|0|||
149103375|NCT01952847|537857386|FG003|Overall Study|Withdrawal by Subject|1|||
149103376|NCT00882115|537857389|FG000|Overall Study|Withdrawal by Subject|3|||
149103377|NCT00882115|537857389|FG000|Overall Study|did not respond to DEP challe|6|||
149103378|NCT01850589|537857390|FG000|Overall Study|Withdrawal by Subject|8|||
149103379|NCT01850589|537857391|FG001|Overall Study|Withdrawal by Subject|0|||
149103380|NCT01843777|537857392|FG000|Overall Study|Withdrawal by Subject|1|||
149103381|NCT01843777|537857393|FG001|Overall Study|Withdrawal by Subject|0|||
149103382|NCT03721172|537857394|FG000|Placebo-controlled Phase|Adverse Event|7|||
149103383|NCT03721172|537857395|FG001|Placebo-controlled Phase|Adverse Event|7|||
149103384|NCT03721172|537857396|FG002|Placebo-controlled Phase|Adverse Event|0|||
149103385|NCT03721172|537857394|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
149103386|NCT03721172|537857395|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
149103387|NCT03721172|537857396|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
149103388|NCT03721172|537857394|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
149103389|NCT03721172|537857395|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
149103390|NCT03721172|537857396|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
149103391|NCT03721172|537857394|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
149103392|NCT03721172|537857395|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
149103393|NCT03721172|537857396|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
149103394|NCT03721172|537857394|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
149103395|NCT03721172|537857395|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
149103396|NCT03721172|537857396|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
149103397|NCT03721172|537857394|FG000|Placebo-controlled Phase|Other|3|||
149103398|NCT03721172|537857395|FG001|Placebo-controlled Phase|Other|0|||
149103399|NCT03721172|537857396|FG002|Placebo-controlled Phase|Other|0|||
149103400|NCT03721172|537857394|FG000|Apremilast Extension Phase|Adverse Event|0|||
149103401|NCT03721172|537857395|FG001|Apremilast Extension Phase|Adverse Event|0|||
149103402|NCT03721172|537857396|FG002|Apremilast Extension Phase|Adverse Event|10|||
149103403|NCT03721172|537857394|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
149103404|NCT03721172|537857395|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
149103405|NCT03721172|537857396|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
149103406|NCT03721172|537857394|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
149103407|NCT03721172|537857395|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
149103408|NCT03721172|537857396|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
149103409|NCT03721172|537857394|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
149103410|NCT03721172|537857395|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
149103411|NCT03721172|537857396|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
149103412|NCT03721172|537857394|FG000|Apremilast Extension Phase|Protocol Violation|0|||
149103413|NCT03721172|537857395|FG001|Apremilast Extension Phase|Protocol Violation|0|||
149103414|NCT03721172|537857396|FG002|Apremilast Extension Phase|Protocol Violation|1|||
149103415|NCT03721172|537857394|FG000|Apremilast Extension Phase|Physician Decision|0|||
149103416|NCT03721172|537857395|FG001|Apremilast Extension Phase|Physician Decision|0|||
149103417|NCT03721172|537857396|FG002|Apremilast Extension Phase|Physician Decision|1|||
149103418|NCT03721172|537857394|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
149103419|NCT03721172|537857395|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
149103420|NCT03721172|537857396|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
149103421|NCT03721172|537857394|FG000|Apremilast Extension Phase|Other|0|||
149103422|NCT03721172|537857395|FG001|Apremilast Extension Phase|Other|0|||
149103423|NCT03721172|537857396|FG002|Apremilast Extension Phase|Other|3|||
149103424|NCT03721172|537857394|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
149103425|NCT03721172|537857395|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
149103426|NCT03721172|537857396|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
149103427|NCT01318876|537857398|FG000|Day 8 Survey|email address invalid|96|||
149103428|NCT01318876|537857398|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
149103429|NCT01318876|537857398|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
149103430|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
149103431|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
149103432|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
149103433|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
149103434|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
149103435|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
149103436|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
149103437|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
149103438|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
149103439|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
149103440|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
149103441|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
149103442|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
149103443|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
149103444|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
149103445|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
149103446|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
149103447|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
149103448|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Missing|2|||
149103449|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Missing|1|||
149103450|NCT00443209|537857399|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
149103451|NCT00443209|537857400|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
149103452|NCT00443209|537857399|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
149103453|NCT00443209|537857400|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
149103454|NCT00443209|537857399|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
149103455|NCT00443209|537857400|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
149103456|NCT00443209|537857399|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
149103457|NCT00443209|537857400|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
149103458|NCT00443209|537857399|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
149103459|NCT00443209|537857400|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
149103460|NCT00443209|537857399|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
149103461|NCT00443209|537857400|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
149103462|NCT00443209|537857399|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
149103463|NCT00443209|537857400|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
149103464|NCT00224029|537857402|FG000|Overall Study|Lost to Follow-up|1|||
149103465|NCT00224029|537857402|FG000|Overall Study|Withdrawal by Subject|4|||
149103466|NCT00224029|537857402|FG000|Overall Study|Other|1|||
149103467|NCT01728623|537857403|FG000|Overall Study|Disease progression|26|||
149103468|NCT01728623|537857403|FG000|Overall Study|Adverse Event|1|||
149103469|NCT01728623|537857403|FG000|Overall Study|Withdrawal by Subject|1|||
149103470|NCT03513068|537857404|FG000|Overall Study|Death|1|||
149103471|NCT03513068|537857405|FG001|Overall Study|Death|0|||
149103472|NCT03513068|537857404|FG000|Overall Study|Withdrawal by Subject|4|||
149103473|NCT03513068|537857405|FG001|Overall Study|Withdrawal by Subject|6|||
149103474|NCT01236352|537857412|FG000|Overall Study|Death|0|||
149103475|NCT01236352|537857413|FG001|Overall Study|Death|0|||
149103476|NCT01236352|537857414|FG002|Overall Study|Death|0|||
149103477|NCT01236352|537857415|FG003|Overall Study|Death|0|||
149103478|NCT01236352|537857416|FG004|Overall Study|Death|0|||
149103479|NCT01236352|537857417|FG005|Overall Study|Death|0|||
149103480|NCT01236352|537857418|FG006|Overall Study|Death|0|||
149103481|NCT01236352|537857419|FG007|Overall Study|Death|1|||
149103482|NCT01236352|537857420|FG008|Overall Study|Death|0|||
149103483|NCT01236352|537857421|FG009|Overall Study|Death|0|||
149103484|NCT01236352|537857422|FG010|Overall Study|Death|0|||
149103485|NCT01236352|537857412|FG000|Overall Study|Withdrawal by Subject|0|||
149103486|NCT01236352|537857413|FG001|Overall Study|Withdrawal by Subject|0|||
149103487|NCT01236352|537857414|FG002|Overall Study|Withdrawal by Subject|0|||
149103488|NCT01236352|537857415|FG003|Overall Study|Withdrawal by Subject|0|||
149103489|NCT01236352|537857416|FG004|Overall Study|Withdrawal by Subject|0|||
149103490|NCT01236352|537857417|FG005|Overall Study|Withdrawal by Subject|0|||
149103491|NCT01236352|537857418|FG006|Overall Study|Withdrawal by Subject|0|||
149103492|NCT01236352|537857419|FG007|Overall Study|Withdrawal by Subject|0|||
149103493|NCT01236352|537857420|FG008|Overall Study|Withdrawal by Subject|0|||
149103494|NCT01236352|537857421|FG009|Overall Study|Withdrawal by Subject|2|||
149103495|NCT01236352|537857422|FG010|Overall Study|Withdrawal by Subject|1|||
149103496|NCT01236352|537857412|FG000|Overall Study|Adverse Event|0|||
149103497|NCT01236352|537857413|FG001|Overall Study|Adverse Event|0|||
149103498|NCT01236352|537857414|FG002|Overall Study|Adverse Event|0|||
149103499|NCT01236352|537857415|FG003|Overall Study|Adverse Event|0|||
149103500|NCT01236352|537857416|FG004|Overall Study|Adverse Event|0|||
149103501|NCT01236352|537857417|FG005|Overall Study|Adverse Event|0|||
149103502|NCT01236352|537857418|FG006|Overall Study|Adverse Event|2|||
149103503|NCT01236352|537857419|FG007|Overall Study|Adverse Event|0|||
149103504|NCT01236352|537857420|FG008|Overall Study|Adverse Event|0|||
149103505|NCT01236352|537857421|FG009|Overall Study|Adverse Event|4|||
149103506|NCT01236352|537857422|FG010|Overall Study|Adverse Event|1|||
149103507|NCT01236352|537857412|FG000|Overall Study|Study drug toxicity|0|||
149103508|NCT01236352|537857413|FG001|Overall Study|Study drug toxicity|0|||
149103509|NCT01236352|537857414|FG002|Overall Study|Study drug toxicity|0|||
149103510|NCT01236352|537857415|FG003|Overall Study|Study drug toxicity|0|||
149103511|NCT01236352|537857416|FG004|Overall Study|Study drug toxicity|0|||
149103512|NCT01236352|537857417|FG005|Overall Study|Study drug toxicity|1|||
149103513|NCT01236352|537857418|FG006|Overall Study|Study drug toxicity|1|||
149103514|NCT01236352|537857419|FG007|Overall Study|Study drug toxicity|0|||
149103515|NCT01236352|537857420|FG008|Overall Study|Study drug toxicity|0|||
149103516|NCT01236352|537857421|FG009|Overall Study|Study drug toxicity|2|||
149103517|NCT01236352|537857422|FG010|Overall Study|Study drug toxicity|2|||
149103518|NCT01236352|537857412|FG000|Overall Study|Disease progression|1|||
149103519|NCT01236352|537857413|FG001|Overall Study|Disease progression|2|||
149103520|NCT01236352|537857414|FG002|Overall Study|Disease progression|1|||
149103521|NCT01236352|537857415|FG003|Overall Study|Disease progression|2|||
149103522|NCT01236352|537857416|FG004|Overall Study|Disease progression|2|||
149103523|NCT01236352|537857417|FG005|Overall Study|Disease progression|2|||
149103524|NCT01236352|537857418|FG006|Overall Study|Disease progression|1|||
149103525|NCT01236352|537857419|FG007|Overall Study|Disease progression|3|||
149103526|NCT01236352|537857420|FG008|Overall Study|Disease progression|2|||
149103527|NCT01236352|537857421|FG009|Overall Study|Disease progression|2|||
149103528|NCT01236352|537857422|FG010|Overall Study|Disease progression|2|||
149103529|NCT01236352|537857412|FG000|Overall Study|Poor/Non-compliance|1|||
149103530|NCT01236352|537857413|FG001|Overall Study|Poor/Non-compliance|0|||
149103531|NCT01236352|537857414|FG002|Overall Study|Poor/Non-compliance|0|||
149103532|NCT01236352|537857415|FG003|Overall Study|Poor/Non-compliance|0|||
149103533|NCT01236352|537857416|FG004|Overall Study|Poor/Non-compliance|0|||
149103534|NCT01236352|537857417|FG005|Overall Study|Poor/Non-compliance|0|||
149103535|NCT01236352|537857418|FG006|Overall Study|Poor/Non-compliance|0|||
149103536|NCT01236352|537857419|FG007|Overall Study|Poor/Non-compliance|0|||
149103537|NCT01236352|537857420|FG008|Overall Study|Poor/Non-compliance|0|||
149103538|NCT01236352|537857421|FG009|Overall Study|Poor/Non-compliance|0|||
149103539|NCT01236352|537857422|FG010|Overall Study|Poor/Non-compliance|0|||
149103540|NCT01236352|537857412|FG000|Overall Study|Maximum clinical benefit|1|||
149103541|NCT01236352|537857413|FG001|Overall Study|Maximum clinical benefit|1|||
149103542|NCT01236352|537857414|FG002|Overall Study|Maximum clinical benefit|1|||
149103543|NCT01236352|537857415|FG003|Overall Study|Maximum clinical benefit|0|||
149103544|NCT01236352|537857416|FG004|Overall Study|Maximum clinical benefit|2|||
149103545|NCT01236352|537857417|FG005|Overall Study|Maximum clinical benefit|0|||
149103546|NCT01236352|537857418|FG006|Overall Study|Maximum clinical benefit|3|||
149103547|NCT01236352|537857419|FG007|Overall Study|Maximum clinical benefit|1|||
149103548|NCT01236352|537857420|FG008|Overall Study|Maximum clinical benefit|1|||
149103549|NCT01236352|537857421|FG009|Overall Study|Maximum clinical benefit|4|||
149103550|NCT01236352|537857422|FG010|Overall Study|Maximum clinical benefit|2|||
149103551|NCT01236352|537857412|FG000|Overall Study|Subject request to discontinue treatment|0|||
149103552|NCT01236352|537857413|FG001|Overall Study|Subject request to discontinue treatment|0|||
149103553|NCT01236352|537857414|FG002|Overall Study|Subject request to discontinue treatment|1|||
149103554|NCT01236352|537857415|FG003|Overall Study|Subject request to discontinue treatment|1|||
149103555|NCT01236352|537857416|FG004|Overall Study|Subject request to discontinue treatment|0|||
149103556|NCT01236352|537857417|FG005|Overall Study|Subject request to discontinue treatment|1|||
149103557|NCT01236352|537857418|FG006|Overall Study|Subject request to discontinue treatment|0|||
149103558|NCT01236352|537857419|FG007|Overall Study|Subject request to discontinue treatment|0|||
149103559|NCT01236352|537857420|FG008|Overall Study|Subject request to discontinue treatment|0|||
149103560|NCT01236352|537857421|FG009|Overall Study|Subject request to discontinue treatment|1|||
149103561|NCT01236352|537857422|FG010|Overall Study|Subject request to discontinue treatment|4|||
149103562|NCT01236352|537857412|FG000|Overall Study|Subject to receive drug via EAP|1|||
149103563|NCT01236352|537857413|FG001|Overall Study|Subject to receive drug via EAP|1|||
149103564|NCT01236352|537857414|FG002|Overall Study|Subject to receive drug via EAP|1|||
149103565|NCT01236352|537857415|FG003|Overall Study|Subject to receive drug via EAP|0|||
149103566|NCT01236352|537857416|FG004|Overall Study|Subject to receive drug via EAP|0|||
149103567|NCT01236352|537857417|FG005|Overall Study|Subject to receive drug via EAP|0|||
149103568|NCT01236352|537857418|FG006|Overall Study|Subject to receive drug via EAP|0|||
149103569|NCT01236352|537857419|FG007|Overall Study|Subject to receive drug via EAP|2|||
149103570|NCT01236352|537857420|FG008|Overall Study|Subject to receive drug via EAP|0|||
149103571|NCT01236352|537857421|FG009|Overall Study|Subject to receive drug via EAP|4|||
149103572|NCT01236352|537857422|FG010|Overall Study|Subject to receive drug via EAP|0|||
149103573|NCT01236352|537857412|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
149103574|NCT01236352|537857413|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
149103575|NCT01236352|537857414|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
149103576|NCT01236352|537857415|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
149103577|NCT01236352|537857416|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
149103578|NCT01236352|537857417|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
149103579|NCT01236352|537857418|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
149103580|NCT01236352|537857419|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
149103581|NCT01236352|537857420|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
149103582|NCT01236352|537857421|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
149103583|NCT01236352|537857422|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
149103584|NCT01236352|537857412|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103585|NCT01236352|537857413|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103586|NCT01236352|537857414|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103587|NCT01236352|537857415|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103588|NCT01236352|537857416|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103589|NCT01236352|537857417|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103590|NCT01236352|537857418|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103591|NCT01236352|537857419|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103592|NCT01236352|537857420|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103593|NCT01236352|537857421|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
149103594|NCT01236352|537857422|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
149103595|NCT01236352|537857412|FG000|Overall Study|Lack of response to drug|0|||
149103596|NCT01236352|537857413|FG001|Overall Study|Lack of response to drug|0|||
149103597|NCT01236352|537857414|FG002|Overall Study|Lack of response to drug|0|||
149103598|NCT01236352|537857415|FG003|Overall Study|Lack of response to drug|0|||
149103599|NCT01236352|537857416|FG004|Overall Study|Lack of response to drug|0|||
149103600|NCT01236352|537857417|FG005|Overall Study|Lack of response to drug|0|||
149103601|NCT01236352|537857418|FG006|Overall Study|Lack of response to drug|0|||
149103602|NCT01236352|537857419|FG007|Overall Study|Lack of response to drug|0|||
149103603|NCT01236352|537857420|FG008|Overall Study|Lack of response to drug|0|||
149103604|NCT01236352|537857421|FG009|Overall Study|Lack of response to drug|1|||
149103605|NCT01236352|537857422|FG010|Overall Study|Lack of response to drug|1|||
149103606|NCT01236352|537857412|FG000|Overall Study|Patient transferred to IST|0|||
149103607|NCT01236352|537857413|FG001|Overall Study|Patient transferred to IST|0|||
149103608|NCT01236352|537857414|FG002|Overall Study|Patient transferred to IST|0|||
149103609|NCT01236352|537857415|FG003|Overall Study|Patient transferred to IST|0|||
149103610|NCT01236352|537857416|FG004|Overall Study|Patient transferred to IST|0|||
149103611|NCT01236352|537857417|FG005|Overall Study|Patient transferred to IST|0|||
149103612|NCT01236352|537857418|FG006|Overall Study|Patient transferred to IST|0|||
149103613|NCT01236352|537857419|FG007|Overall Study|Patient transferred to IST|0|||
149103614|NCT01236352|537857420|FG008|Overall Study|Patient transferred to IST|0|||
149103615|NCT01236352|537857421|FG009|Overall Study|Patient transferred to IST|2|||
149103616|NCT01236352|537857422|FG010|Overall Study|Patient transferred to IST|6|||
149103617|NCT01850030|537857425|FG000|Overall Study|Adverse Event|64|||
149103618|NCT01850030|537857426|FG001|Overall Study|Adverse Event|82|||
149103619|NCT01850030|537857425|FG000|Overall Study|Lack of Efficacy|3|||
149103620|NCT01850030|537857426|FG001|Overall Study|Lack of Efficacy|1|||
149103621|NCT01850030|537857425|FG000|Overall Study|Lost to Follow-up|5|||
149103622|NCT01850030|537857426|FG001|Overall Study|Lost to Follow-up|5|||
149103623|NCT01850030|537857425|FG000|Overall Study|Withdrawal by Subject|3|||
149103624|NCT01850030|537857426|FG001|Overall Study|Withdrawal by Subject|4|||
149103625|NCT01850030|537857425|FG000|Overall Study|Protocol Violation|24|||
149103626|NCT01850030|537857426|FG001|Overall Study|Protocol Violation|28|||
149103627|NCT01850030|537857425|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
149103628|NCT01850030|537857426|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
149103629|NCT00246090|537857427|FG000|Overall Study|Adverse Event|25|||
149103630|NCT00246090|537857427|FG000|Overall Study|Withdrawal by Subject|7|||
149103631|NCT00246090|537857427|FG000|Overall Study|Progressive Disease|212|||
149103632|NCT00246090|537857427|FG000|Overall Study|Clinical Progression|30|||
149103633|NCT00246090|537857427|FG000|Overall Study|Physician Decision|11|||
149103634|NCT00246090|537857427|FG000|Overall Study|Not Otherwise Specified|10|||
149103635|NCT00763451|537857430|FG000|Overall Study|Adverse Event|4|||
149103636|NCT00763451|537857431|FG001|Overall Study|Adverse Event|6|||
149103637|NCT00763451|537857432|FG002|Overall Study|Adverse Event|19|||
149103638|NCT00763451|537857433|FG003|Overall Study|Adverse Event|14|||
149103639|NCT00763451|537857430|FG000|Overall Study|Lack of Efficacy|1|||
149103640|NCT00763451|537857431|FG001|Overall Study|Lack of Efficacy|4|||
149103641|NCT00763451|537857432|FG002|Overall Study|Lack of Efficacy|3|||
149103642|NCT00763451|537857433|FG003|Overall Study|Lack of Efficacy|2|||
149103643|NCT00763451|537857430|FG000|Overall Study|Withdrawal by Subject|1|||
149103644|NCT00763451|537857431|FG001|Overall Study|Withdrawal by Subject|6|||
149103645|NCT00763451|537857432|FG002|Overall Study|Withdrawal by Subject|9|||
149103646|NCT00763451|537857433|FG003|Overall Study|Withdrawal by Subject|7|||
149103647|NCT00763451|537857430|FG000|Overall Study|Protocol Violation|0|||
149103648|NCT00763451|537857431|FG001|Overall Study|Protocol Violation|0|||
149103649|NCT00763451|537857432|FG002|Overall Study|Protocol Violation|1|||
149103650|NCT00763451|537857433|FG003|Overall Study|Protocol Violation|0|||
149103651|NCT00763451|537857430|FG000|Overall Study|Poor Compliance to Protocol|1|||
149103652|NCT00763451|537857431|FG001|Overall Study|Poor Compliance to Protocol|1|||
149103653|NCT00763451|537857432|FG002|Overall Study|Poor Compliance to Protocol|2|||
149103654|NCT00763451|537857433|FG003|Overall Study|Poor Compliance to Protocol|2|||
149103655|NCT00763451|537857430|FG000|Overall Study|Familial and Personal Reasons|5|||
149103656|NCT00763451|537857431|FG001|Overall Study|Familial and Personal Reasons|3|||
149103657|NCT00763451|537857432|FG002|Overall Study|Familial and Personal Reasons|5|||
149103658|NCT00763451|537857433|FG003|Overall Study|Familial and Personal Reasons|4|||
149103659|NCT00763451|537857430|FG000|Overall Study|Randomized but not Treated|1|||
149103660|NCT00763451|537857431|FG001|Overall Study|Randomized but not Treated|1|||
149103661|NCT00763451|537857432|FG002|Overall Study|Randomized but not Treated|0|||
149103662|NCT00763451|537857433|FG003|Overall Study|Randomized but not Treated|0|||
149103663|NCT00763451|537857430|FG000|Overall Study|Study Site Reason|0|||
149103664|NCT00763451|537857431|FG001|Overall Study|Study Site Reason|1|||
149103665|NCT00763451|537857432|FG002|Overall Study|Study Site Reason|1|||
149103666|NCT00763451|537857433|FG003|Overall Study|Study Site Reason|1|||
149103667|NCT01827046|537857434|FG000|Overall Study|Lost to Follow-up|1|||
149103668|NCT01827046|537857435|FG001|Overall Study|Lost to Follow-up|5|||
149103669|NCT01827046|537857434|FG000|Overall Study|Withdrawal by Subject|0|||
149103670|NCT01827046|537857435|FG001|Overall Study|Withdrawal by Subject|4|||
149103671|NCT05594589|537857442|FG000|Overall Study|Other|0|||
149103672|NCT05594589|537857443|FG001|Overall Study|Other|1|||
149103673|NCT05594589|537857444|FG002|Overall Study|Other|0|||
149103674|NCT02554383|537857446|FG000|Overall Study|Ineligible|3|||
149103675|NCT02554383|537857447|FG001|Overall Study|Ineligible|2|||
149103676|NCT02554383|537857446|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
149103677|NCT02554383|537857447|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
149103678|NCT02554383|537857446|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
149103679|NCT02554383|537857447|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
149103680|NCT02554383|537857446|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
149103681|NCT02554383|537857447|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
149103682|NCT02581059|537857448|FG000|Study Treatment|Disease Progression|1|||
149103683|NCT02581059|537857449|FG001|Study Treatment|Disease Progression|1|||
149103684|NCT02581059|537857448|FG000|Study Treatment|Adverse Event|2|||
149103685|NCT02581059|537857449|FG001|Study Treatment|Adverse Event|1|||
149103686|NCT02581059|537857448|FG000|Study Treatment|Death|1|||
149103687|NCT02581059|537857449|FG001|Study Treatment|Death|1|||
149103688|NCT02581059|537857448|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
149103689|NCT02581059|537857449|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
149103690|NCT02581059|537857448|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
149103691|NCT02581059|537857449|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
149103692|NCT02581059|537857448|FG000|Follow up|Death|1|||
149103693|NCT02581059|537857449|FG001|Follow up|Death|3|||
149103694|NCT02581059|537857448|FG000|Follow up|study terminated|1|||
149103695|NCT02581059|537857449|FG001|Follow up|study terminated|1|||
149103696|NCT02581059|537857448|FG000|Follow up|screen failure|0|||
149103697|NCT02581059|537857449|FG001|Follow up|screen failure|1|||
149103698|NCT02581059|537857448|FG000|Follow up|Patient started new clinical trial|1|||
149103699|NCT02581059|537857449|FG001|Follow up|Patient started new clinical trial|0|||
149103700|NCT03569891|537857450|FG000|Lead-in|Ineligible during lead-in|8|||
149103701|NCT03569891|537857450|FG000|Lead-in|Withdrawal by Subject|3|||
149103702|NCT03569891|537857450|FG000|Lead-in|Risks related to COVID-19|2|||
149103703|NCT03569891|537857450|FG000|AMT-061|Adverse Event|1|||
149103704|NCT02037256|537857451|FG000|Overall Study|Protocol Violation|0|||
149103705|NCT02037256|537857452|FG001|Overall Study|Protocol Violation|1|||
149103706|NCT02037256|537857451|FG000|Overall Study|Withdrawn prior to Velcade|0|||
149103707|NCT02037256|537857452|FG001|Overall Study|Withdrawn prior to Velcade|2|||
149103708|NCT01310699|537857455|FG000|Overall Study|Patients did not complete tandem.|4|||
149103709|NCT01310699|537857456|FG001|Overall Study|Patients did not complete tandem.|6|||
149103710|NCT00926575|537857457|FG000|Overall Study|Adverse Event|1|||
149103711|NCT00926575|537857458|FG001|Overall Study|Adverse Event|1|||
149103712|NCT00926575|537857457|FG000|Overall Study|Death|4|||
149103713|NCT00926575|537857458|FG001|Overall Study|Death|4|||
149103714|NCT00926575|537857457|FG000|Overall Study|Lost to Follow-up|1|||
149103715|NCT00926575|537857458|FG001|Overall Study|Lost to Follow-up|1|||
149103716|NCT00926575|537857457|FG000|Overall Study|Physician Decision|1|||
149103717|NCT00926575|537857458|FG001|Overall Study|Physician Decision|2|||
149103718|NCT00926575|537857457|FG000|Overall Study|Protocol Violation|1|||
149103719|NCT00926575|537857458|FG001|Overall Study|Protocol Violation|0|||
149103720|NCT00926575|537857457|FG000|Overall Study|Withdrawal by Subject|8|||
149103721|NCT00926575|537857458|FG001|Overall Study|Withdrawal by Subject|9|||
149103722|NCT02101983|537857459|FG000|Overall Study|Physician Decision|1|||
149103723|NCT02101983|537857460|FG001|Overall Study|Physician Decision|0|||
149103724|NCT00826228|537859643|FG000|Overall Study|Withdrawal by Subject|1|||
149103725|NCT01246999|537859644|FG000|Overall Study|Lost to Follow-up|0|||
149103726|NCT01246999|537859645|FG001|Overall Study|Lost to Follow-up|1|||
149103727|NCT01246999|537859646|FG002|Overall Study|Lost to Follow-up|0|||
149103728|NCT01246999|537859647|FG003|Overall Study|Lost to Follow-up|0|||
149103729|NCT01246999|537859644|FG000|Overall Study|Withdrawal by Subject|0|||
149103730|NCT01246999|537859645|FG001|Overall Study|Withdrawal by Subject|0|||
149103731|NCT01246999|537859646|FG002|Overall Study|Withdrawal by Subject|0|||
149103732|NCT01246999|537859647|FG003|Overall Study|Withdrawal by Subject|2|||
149103733|NCT04650698|537859648|FG000|Overall Study|Protocol Violation|2|||
149103734|NCT04650698|537859649|FG001|Overall Study|Protocol Violation|1|||
149103735|NCT04650698|537859648|FG000|Overall Study|Withdrawal by Subject|0|||
149103736|NCT04650698|537859649|FG001|Overall Study|Withdrawal by Subject|1|||
149103737|NCT00307047|537859650|FG000|Overall Study|Lost to Follow-up|35|||
149103738|NCT00307047|537859651|FG001|Overall Study|Lost to Follow-up|24|||
149103739|NCT00307047|537859650|FG000|Overall Study|Withdrawal by Subject|6|||
149103740|NCT00307047|537859651|FG001|Overall Study|Withdrawal by Subject|6|||
149103741|NCT00307047|537859650|FG000|Overall Study|Physician Decision|1|||
149103742|NCT00307047|537859651|FG001|Overall Study|Physician Decision|2|||
149103743|NCT00307047|537859650|FG000|Overall Study|Lost to follow-up for other reasons|0|||
149103744|NCT00307047|537859651|FG001|Overall Study|Lost to follow-up for other reasons|1|||
149103745|NCT00307047|537859650|FG000|Overall Study|All death, all MI, all Revascularization|27|||
149103746|NCT00307047|537859651|FG001|Overall Study|All death, all MI, all Revascularization|16|||
149103747|NCT00379769|537859652|FG000|Main Study|Death|57|||
149103748|NCT00379769|537859653|FG001|Main Study|Death|67|||
149103749|NCT00379769|537859654|FG002|Main Study|Death|54|||
149103750|NCT00379769|537859655|FG003|Main Study|Death|72|||
149103751|NCT00379769|537859656|FG004|Main Study|Death|0|||
149103752|NCT00379769|537859657|FG005|Main Study|Death|0|||
149103753|NCT00379769|537859652|FG000|Main Study|Adverse Event|5|||
149103754|NCT00379769|537859653|FG001|Main Study|Adverse Event|8|||
149103755|NCT00379769|537859654|FG002|Main Study|Adverse Event|10|||
149103756|NCT00379769|537859655|FG003|Main Study|Adverse Event|11|||
149103757|NCT00379769|537859656|FG004|Main Study|Adverse Event|0|||
149103758|NCT00379769|537859657|FG005|Main Study|Adverse Event|0|||
149103759|NCT00379769|537859652|FG000|Main Study|Lost to Follow-up|29|||
149103760|NCT00379769|537859653|FG001|Main Study|Lost to Follow-up|29|||
149103761|NCT00379769|537859654|FG002|Main Study|Lost to Follow-up|25|||
149103762|NCT00379769|537859655|FG003|Main Study|Lost to Follow-up|26|||
149103763|NCT00379769|537859656|FG004|Main Study|Lost to Follow-up|0|||
149103764|NCT00379769|537859657|FG005|Main Study|Lost to Follow-up|0|||
149103765|NCT00379769|537859652|FG000|Main Study|Withdrawal by Subject|46|||
149103766|NCT00379769|537859653|FG001|Main Study|Withdrawal by Subject|56|||
149103767|NCT00379769|537859654|FG002|Main Study|Withdrawal by Subject|72|||
149103768|NCT00379769|537859655|FG003|Main Study|Withdrawal by Subject|70|||
149103769|NCT00379769|537859656|FG004|Main Study|Withdrawal by Subject|0|||
149103770|NCT00379769|537859657|FG005|Main Study|Withdrawal by Subject|0|||
149103771|NCT00379769|537859652|FG000|Main Study|Moved to survival status follow-up only|27|||
149103772|NCT00379769|537859653|FG001|Main Study|Moved to survival status follow-up only|25|||
149103773|NCT00379769|537859654|FG002|Main Study|Moved to survival status follow-up only|32|||
149103774|NCT00379769|537859655|FG003|Main Study|Moved to survival status follow-up only|36|||
149103775|NCT00379769|537859656|FG004|Main Study|Moved to survival status follow-up only|0|||
149103776|NCT00379769|537859657|FG005|Main Study|Moved to survival status follow-up only|0|||
149103777|NCT00379769|537859652|FG000|Main Study|Participant moved|3|||
149103778|NCT00379769|537859653|FG001|Main Study|Participant moved|2|||
149103779|NCT00379769|537859654|FG002|Main Study|Participant moved|3|||
149103780|NCT00379769|537859655|FG003|Main Study|Participant moved|3|||
149103781|NCT00379769|537859656|FG004|Main Study|Participant moved|0|||
149103782|NCT00379769|537859657|FG005|Main Study|Participant moved|0|||
149103783|NCT00379769|537859652|FG000|Main Study|Poor compliance|3|||
149103784|NCT00379769|537859653|FG001|Main Study|Poor compliance|2|||
149103785|NCT00379769|537859654|FG002|Main Study|Poor compliance|2|||
149103786|NCT00379769|537859655|FG003|Main Study|Poor compliance|1|||
149103787|NCT00379769|537859656|FG004|Main Study|Poor compliance|0|||
149103788|NCT00379769|537859657|FG005|Main Study|Poor compliance|0|||
149103789|NCT00379769|537859652|FG000|Main Study|Prohibited glucose lowering medication|0|||
149103790|NCT00379769|537859653|FG001|Main Study|Prohibited glucose lowering medication|3|||
149103791|NCT00379769|537859654|FG002|Main Study|Prohibited glucose lowering medication|0|||
149103792|NCT00379769|537859655|FG003|Main Study|Prohibited glucose lowering medication|1|||
149103793|NCT00379769|537859656|FG004|Main Study|Prohibited glucose lowering medication|0|||
149103794|NCT00379769|537859657|FG005|Main Study|Prohibited glucose lowering medication|0|||
149103795|NCT00379769|537859652|FG000|Main Study|Site closed|4|||
149103796|NCT00379769|537859653|FG001|Main Study|Site closed|4|||
149103797|NCT00379769|537859654|FG002|Main Study|Site closed|4|||
149103798|NCT00379769|537859655|FG003|Main Study|Site closed|8|||
149103799|NCT00379769|537859656|FG004|Main Study|Site closed|0|||
149103800|NCT00379769|537859657|FG005|Main Study|Site closed|0|||
149103801|NCT00379769|537859652|FG000|Main Study|Entry criteria violation|0|||
149103802|NCT00379769|537859653|FG001|Main Study|Entry criteria violation|0|||
149103803|NCT00379769|537859654|FG002|Main Study|Entry criteria violation|1|||
149103804|NCT00379769|537859655|FG003|Main Study|Entry criteria violation|1|||
149103805|NCT00379769|537859656|FG004|Main Study|Entry criteria violation|0|||
149103806|NCT00379769|537859657|FG005|Main Study|Entry criteria violation|0|||
149103807|NCT00379769|537859652|FG000|Main Study|Participant did not take study drug|0|||
149103808|NCT00379769|537859653|FG001|Main Study|Participant did not take study drug|0|||
149103809|NCT00379769|537859654|FG002|Main Study|Participant did not take study drug|1|||
149103810|NCT00379769|537859655|FG003|Main Study|Participant did not take study drug|0|||
149103811|NCT00379769|537859656|FG004|Main Study|Participant did not take study drug|0|||
149103812|NCT00379769|537859657|FG005|Main Study|Participant did not take study drug|0|||
149103813|NCT00379769|537859652|FG000|Main Study|Physician Decision|2|||
149103814|NCT00379769|537859653|FG001|Main Study|Physician Decision|2|||
149103815|NCT00379769|537859654|FG002|Main Study|Physician Decision|1|||
149103816|NCT00379769|537859655|FG003|Main Study|Physician Decision|1|||
149103817|NCT00379769|537859656|FG004|Main Study|Physician Decision|0|||
149103818|NCT00379769|537859657|FG005|Main Study|Physician Decision|0|||
149103819|NCT00379769|537859652|FG000|Main Study|Participant completed study at visit 27|1|||
149103820|NCT00379769|537859653|FG001|Main Study|Participant completed study at visit 27|0|||
149103821|NCT00379769|537859654|FG002|Main Study|Participant completed study at visit 27|0|||
149103822|NCT00379769|537859655|FG003|Main Study|Participant completed study at visit 27|0|||
149103823|NCT00379769|537859656|FG004|Main Study|Participant completed study at visit 27|0|||
149103824|NCT00379769|537859657|FG005|Main Study|Participant completed study at visit 27|0|||
149103825|NCT00379769|537859652|FG000|Main Study|Personal reasons|1|||
149103826|NCT00379769|537859653|FG001|Main Study|Personal reasons|0|||
149103827|NCT00379769|537859654|FG002|Main Study|Personal reasons|0|||
149103828|NCT00379769|537859655|FG003|Main Study|Personal reasons|0|||
149103829|NCT00379769|537859656|FG004|Main Study|Personal reasons|0|||
149103830|NCT00379769|537859657|FG005|Main Study|Personal reasons|0|||
149103831|NCT00379769|537859652|FG000|Main Study|Risk of heart failure|0|||
149103832|NCT00379769|537859653|FG001|Main Study|Risk of heart failure|1|||
149103833|NCT00379769|537859654|FG002|Main Study|Risk of heart failure|0|||
149103834|NCT00379769|537859655|FG003|Main Study|Risk of heart failure|0|||
149103835|NCT00379769|537859656|FG004|Main Study|Risk of heart failure|0|||
149103836|NCT00379769|537859657|FG005|Main Study|Risk of heart failure|0|||
149103837|NCT00379769|537859652|FG000|Main Study|Investigator refused to log temperature|0|||
149103838|NCT00379769|537859653|FG001|Main Study|Investigator refused to log temperature|0|||
149103839|NCT00379769|537859654|FG002|Main Study|Investigator refused to log temperature|1|||
149103840|NCT00379769|537859655|FG003|Main Study|Investigator refused to log temperature|0|||
149103841|NCT00379769|537859656|FG004|Main Study|Investigator refused to log temperature|0|||
149103842|NCT00379769|537859657|FG005|Main Study|Investigator refused to log temperature|0|||
149103843|NCT00379769|537859652|FG000|Main Study|Reason unspecified|0|||
149103844|NCT00379769|537859653|FG001|Main Study|Reason unspecified|0|||
149103845|NCT00379769|537859654|FG002|Main Study|Reason unspecified|1|||
149103846|NCT00379769|537859655|FG003|Main Study|Reason unspecified|0|||
149103847|NCT00379769|537859656|FG004|Main Study|Reason unspecified|0|||
149103848|NCT00379769|537859657|FG005|Main Study|Reason unspecified|0|||
149103849|NCT00379769|537859652|FG000|Observational Follow-up|Death|0|||
149103850|NCT00379769|537859653|FG001|Observational Follow-up|Death|0|||
149103851|NCT00379769|537859654|FG002|Observational Follow-up|Death|0|||
149103852|NCT00379769|537859655|FG003|Observational Follow-up|Death|0|||
149103853|NCT00379769|537859656|FG004|Observational Follow-up|Death|78|||
149103854|NCT00379769|537859657|FG005|Observational Follow-up|Death|70|||
149103855|NCT00379769|537859652|FG000|Observational Follow-up|Adverse Event|0|||
149103856|NCT00379769|537859653|FG001|Observational Follow-up|Adverse Event|0|||
149103857|NCT00379769|537859654|FG002|Observational Follow-up|Adverse Event|0|||
149103858|NCT00379769|537859655|FG003|Observational Follow-up|Adverse Event|0|||
149103859|NCT00379769|537859656|FG004|Observational Follow-up|Adverse Event|1|||
149103860|NCT00379769|537859657|FG005|Observational Follow-up|Adverse Event|0|||
149103861|NCT00379769|537859652|FG000|Observational Follow-up|Lost to Follow-up|0|||
149103862|NCT00379769|537859653|FG001|Observational Follow-up|Lost to Follow-up|0|||
149103863|NCT00379769|537859654|FG002|Observational Follow-up|Lost to Follow-up|0|||
149103864|NCT00379769|537859655|FG003|Observational Follow-up|Lost to Follow-up|0|||
149103865|NCT00379769|537859656|FG004|Observational Follow-up|Lost to Follow-up|25|||
149103866|NCT00379769|537859657|FG005|Observational Follow-up|Lost to Follow-up|27|||
149103867|NCT00379769|537859652|FG000|Observational Follow-up|Withdrawal by Subject|0|||
149103868|NCT00379769|537859653|FG001|Observational Follow-up|Withdrawal by Subject|0|||
149103869|NCT00379769|537859654|FG002|Observational Follow-up|Withdrawal by Subject|0|||
149103870|NCT00379769|537859655|FG003|Observational Follow-up|Withdrawal by Subject|0|||
149103871|NCT00379769|537859656|FG004|Observational Follow-up|Withdrawal by Subject|12|||
149103872|NCT00379769|537859657|FG005|Observational Follow-up|Withdrawal by Subject|12|||
149103873|NCT00379769|537859652|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
149103874|NCT00379769|537859653|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
149103875|NCT00379769|537859654|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
149103876|NCT00379769|537859655|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
149103877|NCT00379769|537859656|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
149103878|NCT00379769|537859657|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
149103879|NCT00379769|537859652|FG000|Observational Follow-up|Physician Decision|0|||
149103880|NCT00379769|537859653|FG001|Observational Follow-up|Physician Decision|0|||
149103881|NCT00379769|537859654|FG002|Observational Follow-up|Physician Decision|0|||
149103882|NCT00379769|537859655|FG003|Observational Follow-up|Physician Decision|0|||
149103883|NCT00379769|537859656|FG004|Observational Follow-up|Physician Decision|8|||
149103884|NCT00379769|537859657|FG005|Observational Follow-up|Physician Decision|8|||
149103885|NCT00379769|537859652|FG000|Observational Follow-up|Site Closed Early|0|||
149103886|NCT00379769|537859653|FG001|Observational Follow-up|Site Closed Early|0|||
149103887|NCT00379769|537859654|FG002|Observational Follow-up|Site Closed Early|0|||
149103888|NCT00379769|537859655|FG003|Observational Follow-up|Site Closed Early|0|||
149103889|NCT00379769|537859656|FG004|Observational Follow-up|Site Closed Early|6|||
149103890|NCT00379769|537859657|FG005|Observational Follow-up|Site Closed Early|7|||
149103891|NCT00379769|537859652|FG000|Observational Follow-up|Participant Moved|0|||
149103892|NCT00379769|537859653|FG001|Observational Follow-up|Participant Moved|0|||
149103893|NCT00379769|537859654|FG002|Observational Follow-up|Participant Moved|0|||
149103894|NCT00379769|537859655|FG003|Observational Follow-up|Participant Moved|0|||
149103895|NCT00379769|537859656|FG004|Observational Follow-up|Participant Moved|0|||
149103896|NCT00379769|537859657|FG005|Observational Follow-up|Participant Moved|1|||
149103897|NCT00379769|537859652|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
149103898|NCT00379769|537859653|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
149103899|NCT00379769|537859654|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
149103900|NCT00379769|537859655|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
149103901|NCT00379769|537859656|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
149103902|NCT00379769|537859657|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
149103903|NCT03778294|537859658|FG000|Overall Study|Death|1|||
149103904|NCT03778294|537859658|FG000|Overall Study|Issues with insurance|1|||
149103905|NCT03778294|537859658|FG000|Overall Study|disease progression before treatment|2|||
149103906|NCT02825251|537859659|FG000|Overall Study|Adverse Event|0|||
149103907|NCT02825251|537859660|FG001|Overall Study|Adverse Event|1|||
149103908|NCT02825251|537859659|FG000|Overall Study|Lost to Follow-up|0|||
149103909|NCT02825251|537859660|FG001|Overall Study|Lost to Follow-up|1|||
149103910|NCT02825251|537859659|FG000|Overall Study|Withdrawal by Subject|1|||
149103911|NCT02825251|537859660|FG001|Overall Study|Withdrawal by Subject|4|||
149103912|NCT02825251|537859659|FG000|Overall Study|Unclassified|2|||
149103913|NCT02825251|537859660|FG001|Overall Study|Unclassified|0|||
149103914|NCT01689363|537859664|FG000|Overall Study|Protocol Violation|0|||
149103915|NCT01689363|537859665|FG001|Overall Study|Protocol Violation|1|||
149103916|NCT01689363|537859666|FG002|Overall Study|Protocol Violation|0|||
149103917|NCT01689363|537859667|FG003|Overall Study|Protocol Violation|0|||
149103918|NCT01689363|537859668|FG004|Overall Study|Protocol Violation|0|||
149103919|NCT01689363|537859669|FG005|Overall Study|Protocol Violation|0|||
149103920|NCT01689363|537859670|FG006|Overall Study|Protocol Violation|0|||
149103921|NCT01689363|537859671|FG007|Overall Study|Protocol Violation|0|||
149103922|NCT02104505|537859672|FG000|First Intervention (14 Days)|Adverse Event|2|||
149103923|NCT02104505|537859673|FG001|First Intervention (14 Days)|Adverse Event|0|||
149103924|NCT02104505|537859672|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
149103925|NCT02104505|537859673|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
149103926|NCT02104505|537859672|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
149103927|NCT02104505|537859673|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
149103928|NCT02104505|537859672|FG000|First Intervention (14 Days)|exclusionary condition|0|||
149103929|NCT02104505|537859673|FG001|First Intervention (14 Days)|exclusionary condition|1|||
149103930|NCT02104505|537859672|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
149103931|NCT02104505|537859673|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
149103932|NCT02104505|537859672|FG000|Second Intervention (14 Days)|Adverse Event|2|||
149103933|NCT02104505|537859673|FG001|Second Intervention (14 Days)|Adverse Event|0|||
149103934|NCT01845805|537859674|FG000|Overall Study|Withdrawal by Subject|1|||
149103935|NCT01845805|537859675|FG001|Overall Study|Withdrawal by Subject|2|||
149103936|NCT01845805|537859674|FG000|Overall Study|Disease Progression|13|||
149103937|NCT01845805|537859675|FG001|Overall Study|Disease Progression|14|||
149103938|NCT01845805|537859674|FG000|Overall Study|Drug-related Toxicity|4|||
149103939|NCT01845805|537859675|FG001|Overall Study|Drug-related Toxicity|0|||
149103940|NCT02859064|537859676|FG000|Overall Study|Progressive Disease|3|||
149103941|NCT02859064|537859676|FG000|Overall Study|Physician Decision|1|||
149103942|NCT02859064|537859676|FG000|Overall Study|Withdrawal by Subject|1|||
149103943|NCT02859064|537859676|FG000|Overall Study|Death|1|||
149103944|NCT00127842|537859677|FG000|Overall Study|Adverse Event|15|||
149103945|NCT00127842|537859677|FG000|Overall Study|Withdrawal by Subject|3|||
149103946|NCT00127842|537859677|FG000|Overall Study|Lost to Follow-up|1|||
149103947|NCT00127842|537859677|FG000|Overall Study|Lack of Efficacy|12|||
149103948|NCT00127842|537859677|FG000|Overall Study|Noncompliance|2|||
149103949|NCT00127842|537859677|FG000|Overall Study|Protocol Violation|1|||
149103950|NCT00127842|537859677|FG000|Overall Study|Other|5|||
149103951|NCT00667459|537859678|FG000|Overall Study|Death|0|||
149103952|NCT00667459|537859679|FG001|Overall Study|Death|2|||
149103953|NCT00667459|537859678|FG000|Overall Study|Lost to Follow-up|8|||
149103954|NCT00667459|537859679|FG001|Overall Study|Lost to Follow-up|43|||
149103955|NCT02568397|537859680|FG000|Period 2|Withdrawal by Subject|0|||
149103956|NCT02568397|537859681|FG001|Period 2|Withdrawal by Subject|1|||
149103957|NCT02568397|537859680|FG000|Period 2|Physician Decision|0|||
149103958|NCT02568397|537859681|FG001|Period 2|Physician Decision|1|||
149103959|NCT02354651|537859682|FG000|Overall Study|Withdrawal by Subject|2|||
149103960|NCT02354651|537859682|FG000|Overall Study|Physician Decision|1|||
149103961|NCT00581893|537859683|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
149103962|NCT00581893|537859684|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
149103963|NCT00590564|537859685|FG000|Overall Study|Withdrawal by Subject|4|||
149103964|NCT00590564|537859685|FG000|Overall Study|Lost to Follow-up|6|||
149103965|NCT00590564|537859685|FG000|Overall Study|Protocol Violation|1|||
149103966|NCT00590564|537859685|FG000|Overall Study|Patient Found to be Ineligible|1|||
149103967|NCT00590564|537859685|FG000|Overall Study|Patient Non-compliance|6|||
149103968|NCT01377389|537859688|FG000|Overall Study|Withdrawal by Subject|1|||
149103969|NCT01377389|537859688|FG000|Overall Study|Screen failure|2|||
149103970|NCT01434680|537859689|FG000|Overall Study|Withdrawal by Subject|1|||
149103971|NCT01434680|537859690|FG001|Overall Study|Withdrawal by Subject|0|||
149103972|NCT01434680|537859691|FG002|Overall Study|Withdrawal by Subject|2|||
149103973|NCT01434680|537859692|FG003|Overall Study|Withdrawal by Subject|0|||
149103974|NCT01434680|537859689|FG000|Overall Study|Lost to Follow-up|1|||
149103975|NCT01434680|537859690|FG001|Overall Study|Lost to Follow-up|1|||
149103976|NCT01434680|537859691|FG002|Overall Study|Lost to Follow-up|0|||
149103977|NCT01434680|537859692|FG003|Overall Study|Lost to Follow-up|0|||
149103978|NCT01434680|537859689|FG000|Overall Study|Protocol Violation|1|||
149103979|NCT01434680|537859690|FG001|Overall Study|Protocol Violation|1|||
149103980|NCT01434680|537859691|FG002|Overall Study|Protocol Violation|0|||
149103981|NCT01434680|537859692|FG003|Overall Study|Protocol Violation|0|||
149103982|NCT00725712|537859694|FG000|Overall Study|Withdrawal by Subject|2|||
149103983|NCT00725712|537859695|FG001|Overall Study|Withdrawal by Subject|1|||
149103984|NCT00725712|537859694|FG000|Overall Study|Protocol Violation|1|||
149103985|NCT00725712|537859695|FG001|Overall Study|Protocol Violation|0|||
149103986|NCT00725712|537859694|FG000|Overall Study|Progressive disease|37|||
149103987|NCT00725712|537859695|FG001|Overall Study|Progressive disease|16|||
149103988|NCT00725712|537859694|FG000|Overall Study|Clinical progression not based on RECIST|0|||
149103989|NCT00725712|537859695|FG001|Overall Study|Clinical progression not based on RECIST|3|||
149103990|NCT00725712|537859694|FG000|Overall Study|Adverse Event|5|||
149103991|NCT00725712|537859695|FG001|Overall Study|Adverse Event|5|||
149103992|NCT00725712|537859694|FG000|Overall Study|Death|2|||
149103993|NCT00725712|537859695|FG001|Overall Study|Death|0|||
149103994|NCT00725712|537859694|FG000|Overall Study|Other: Death|1|||
149103995|NCT00725712|537859695|FG001|Overall Study|Other: Death|0|||
149103996|NCT00725712|537859694|FG000|Overall Study|Hospitalized, unable to continue|0|||
149103997|NCT00725712|537859695|FG001|Overall Study|Hospitalized, unable to continue|1|||
149103998|NCT02684123|537859699|FG000|Phase 1|Lack of Efficacy|5|||
149103999|NCT02684123|537859700|FG001|Phase 1|Lack of Efficacy|0|||
149104000|NCT02684123|537859699|FG000|Phase 1|Adverse Event|3|||
149104001|NCT02684123|537859700|FG001|Phase 1|Adverse Event|0|||
149104002|NCT02684123|537859699|FG000|Phase 1|Lost to Follow-up|0|||
149104003|NCT02684123|537859700|FG001|Phase 1|Lost to Follow-up|1|||
149104004|NCT02684123|537859699|FG000|Phase 2|Lack of Efficacy|1|||
149104005|NCT02684123|537859700|FG001|Phase 2|Lack of Efficacy|8|||
149104006|NCT02037477|537859704|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
149104007|NCT02037477|537859705|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
149104008|NCT02037477|537859706|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
149104009|NCT02037477|537859707|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
149104010|NCT01245140|537859708|FG000|Overall Study|Adverse Event|1|||
149104011|NCT01245140|537859709|FG001|Overall Study|Adverse Event|3|||
149104012|NCT01245140|537859708|FG000|Overall Study|Lack of Efficacy|2|||
149104013|NCT01245140|537859709|FG001|Overall Study|Lack of Efficacy|4|||
149104014|NCT01245140|537859708|FG000|Overall Study|Protocol Violation|0|||
149104015|NCT01245140|537859709|FG001|Overall Study|Protocol Violation|1|||
149104016|NCT01245140|537859708|FG000|Overall Study|Withdrawal by Subject|0|||
149104017|NCT01245140|537859709|FG001|Overall Study|Withdrawal by Subject|1|||
149104018|NCT01245140|537859708|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
149104019|NCT01245140|537859709|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
149104020|NCT02635360|537859710|FG000|Overall Study|Adverse Event|0|||
149104021|NCT02635360|537859711|FG001|Overall Study|Adverse Event|3|||
149104022|NCT02635360|537859710|FG000|Overall Study|Withdrawal by Subject|2|||
149104023|NCT02635360|537859711|FG001|Overall Study|Withdrawal by Subject|0|||
149104024|NCT02635360|537859710|FG000|Overall Study|Non-Compliance|3|||
149104025|NCT02635360|537859711|FG001|Overall Study|Non-Compliance|1|||
149104026|NCT02635360|537859710|FG000|Overall Study|Disease Progression|0|||
149104027|NCT02635360|537859711|FG001|Overall Study|Disease Progression|2|||
149104028|NCT02635360|537859710|FG000|Overall Study|Lost to Follow-up|1|||
149104029|NCT02635360|537859711|FG001|Overall Study|Lost to Follow-up|1|||
149104030|NCT00334542|537859712|FG000|Overall Study|Adverse Event|3|||
149104031|NCT00334542|537859712|FG000|Overall Study|Withdrawal by Subject|1|||
149104032|NCT00334542|537859712|FG000|Overall Study|New cancer diagnosis|1|||
149104033|NCT02367352|537859721|FG000|Overall Study|Progressive disease|7|||
149104034|NCT02367352|537859722|FG001|Overall Study|Progressive disease|0|||
149104035|NCT02367352|537859723|FG002|Overall Study|Progressive disease|0|||
149104036|NCT02367352|537859721|FG000|Overall Study|Participant Received Alternative Therapy|1|||
149104037|NCT02367352|537859722|FG001|Overall Study|Participant Received Alternative Therapy|0|||
149104038|NCT02367352|537859723|FG002|Overall Study|Participant Received Alternative Therapy|0|||
149104039|NCT02367352|537859721|FG000|Overall Study|Adverse Event|1|||
149104040|NCT02367352|537859722|FG001|Overall Study|Adverse Event|0|||
149104041|NCT02367352|537859723|FG002|Overall Study|Adverse Event|0|||
149104042|NCT01437423|537859728|FG000|Overall Study|Lost to Follow-up|12|||
149104043|NCT01437423|537859728|FG000|Overall Study|Off label usage|3|||
149104044|NCT01375751|537859729|FG000|Overall Study|Other|0|||
149104045|NCT01375751|537859730|FG001|Overall Study|Other|1|||
149104046|NCT01375751|537859731|FG002|Overall Study|Other|0|||
149104047|NCT02980523|537859732|FG000|Overall Study|Lost to Follow-up|1|||
149104048|NCT02980523|537859733|FG001|Overall Study|Lost to Follow-up|4|||
149104049|NCT02980523|537859734|FG002|Overall Study|Lost to Follow-up|1|||
149104050|NCT02980523|537859735|FG003|Overall Study|Lost to Follow-up|2|||
149104051|NCT02980523|537859736|FG004|Overall Study|Lost to Follow-up|1|||
149104052|NCT02980523|537859732|FG000|Overall Study|Excluded from analysis|1|||
149104053|NCT02980523|537859733|FG001|Overall Study|Excluded from analysis|3|||
149104054|NCT02980523|537859734|FG002|Overall Study|Excluded from analysis|1|||
149104055|NCT02980523|537859735|FG003|Overall Study|Excluded from analysis|1|||
149104056|NCT02980523|537859736|FG004|Overall Study|Excluded from analysis|1|||
149104057|NCT02980523|537859732|FG000|Overall Study|Lack of Efficacy|1|||
149104058|NCT02980523|537859733|FG001|Overall Study|Lack of Efficacy|4|||
149104059|NCT02980523|537859734|FG002|Overall Study|Lack of Efficacy|4|||
149104060|NCT02980523|537859735|FG003|Overall Study|Lack of Efficacy|5|||
149104061|NCT02980523|537859736|FG004|Overall Study|Lack of Efficacy|8|||
149104062|NCT02980523|537859732|FG000|Overall Study|Did not receive intervention|0|||
149104063|NCT02980523|537859733|FG001|Overall Study|Did not receive intervention|0|||
149104064|NCT02980523|537859734|FG002|Overall Study|Did not receive intervention|0|||
149104065|NCT02980523|537859735|FG003|Overall Study|Did not receive intervention|1|||
149104066|NCT02980523|537859736|FG004|Overall Study|Did not receive intervention|0|||
149104067|NCT02552147|537859737|FG000|First Intervention (7 Days)|Protocol Violation|1|||
149104068|NCT02552147|537859738|FG001|First Intervention (7 Days)|Protocol Violation|0|||
149104069|NCT02552147|537859737|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
149104070|NCT02552147|537859738|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
149104071|NCT00872001|537859744|FG000|Overall Study|Adverse Event|34|||
149104072|NCT00872001|537859745|FG001|Overall Study|Adverse Event|23|||
149104073|NCT00872001|537859744|FG000|Overall Study|Protocol Defined Clinical Event|5|||
149104074|NCT00872001|537859745|FG001|Overall Study|Protocol Defined Clinical Event|7|||
149104075|NCT00872001|537859744|FG000|Overall Study|Lost to Follow-up|13|||
149104076|NCT00872001|537859745|FG001|Overall Study|Lost to Follow-up|12|||
149104077|NCT00872001|537859744|FG000|Overall Study|Withdrawal by Subject|18|||
149104078|NCT00872001|537859745|FG001|Overall Study|Withdrawal by Subject|30|||
149104079|NCT00872001|537859744|FG000|Overall Study|Protocol Violation|5|||
149104080|NCT00872001|537859745|FG001|Overall Study|Protocol Violation|8|||
149104081|NCT00872001|537859744|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
149104082|NCT00872001|537859745|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
149104083|NCT00872001|537859744|FG000|Overall Study|Administrative|23|||
149104084|NCT00872001|537859745|FG001|Overall Study|Administrative|15|||
149104085|NCT02599688|537859753|FG000|Overall Study|Lack of Efficacy|1|||
149104086|NCT02599688|537859753|FG000|Overall Study|Withdrawal by Subject|1|||
149104087|NCT02599688|537859753|FG000|Overall Study|Termination by Sponsor|2|||
149104088|NCT03016598|537859754|FG000|Overall Study|Lost to Follow-up|0|||
149104089|NCT03016598|537859755|FG001|Overall Study|Lost to Follow-up|2|||
149104090|NCT02049515|537859759|FG000|Overall Study|Adverse Event|46|||
149104091|NCT02049515|537859760|FG001|Overall Study|Adverse Event|2|||
149104092|NCT02049515|537859759|FG000|Overall Study|Protocol-specified Disease Progression|23|||
149104093|NCT02049515|537859760|FG001|Overall Study|Protocol-specified Disease Progression|2|||
149104094|NCT02049515|537859759|FG000|Overall Study|Death|6|||
149104095|NCT02049515|537859760|FG001|Overall Study|Death|0|||
149104096|NCT02049515|537859759|FG000|Overall Study|Physician Decision|5|||
149104097|NCT02049515|537859760|FG001|Overall Study|Physician Decision|1|||
149104098|NCT02049515|537859759|FG000|Overall Study|Withdrawal by Subject|3|||
149104099|NCT02049515|537859760|FG001|Overall Study|Withdrawal by Subject|0|||
149104100|NCT02049515|537859759|FG000|Overall Study|Termination of the Study by Sponsor|2|||
149104101|NCT02049515|537859760|FG001|Overall Study|Termination of the Study by Sponsor|0|||
149104102|NCT02049515|537859759|FG000|Overall Study|Protocol Violation|1|||
149104103|NCT02049515|537859760|FG001|Overall Study|Protocol Violation|1|||
149104104|NCT02049515|537859759|FG000|Overall Study|Clinical Deterioration|1|||
149104105|NCT02049515|537859760|FG001|Overall Study|Clinical Deterioration|0|||
149104106|NCT02049515|537859759|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
149104107|NCT02049515|537859760|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
149104108|NCT02049515|537859759|FG000|Overall Study|Treatment Interruption >42 Days|1|||
149104109|NCT02049515|537859760|FG001|Overall Study|Treatment Interruption >42 Days|0|||
149104110|NCT02049515|537859759|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
149104111|NCT02049515|537859760|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
149104112|NCT02872012|537859764|FG000|Overall Study|Withdrawal by Subject|1|||
149104113|NCT02872012|537859765|FG001|Overall Study|Withdrawal by Subject|0|||
149104114|NCT02872012|537859766|FG002|Overall Study|Withdrawal by Subject|0|||
149104115|NCT02872012|537859767|FG003|Overall Study|Withdrawal by Subject|0|||
149104116|NCT02872012|537859768|FG004|Overall Study|Withdrawal by Subject|0|||
149104117|NCT03000348|537859769|FG000|Overall Study|Adverse Event|1|||
149104118|NCT03000348|537859770|FG001|Overall Study|Adverse Event|1|||
149104119|NCT03000348|537859771|FG002|Overall Study|Adverse Event|1|||
149104120|NCT03000348|537859772|FG003|Overall Study|Adverse Event|1|||
149104121|NCT03000348|537859773|FG004|Overall Study|Adverse Event|1|||
149104122|NCT03000348|537859774|FG005|Overall Study|Adverse Event|1|||
149104123|NCT03000348|537859769|FG000|Overall Study|Lost to Follow-up|0|||
149104124|NCT03000348|537859770|FG001|Overall Study|Lost to Follow-up|0|||
149104125|NCT03000348|537859771|FG002|Overall Study|Lost to Follow-up|1|||
149104126|NCT03000348|537859772|FG003|Overall Study|Lost to Follow-up|0|||
149104127|NCT03000348|537859773|FG004|Overall Study|Lost to Follow-up|0|||
149104128|NCT03000348|537859774|FG005|Overall Study|Lost to Follow-up|0|||
149104129|NCT03000348|537859769|FG000|Overall Study|Withdrawal by Subject|0|||
149104130|NCT03000348|537859770|FG001|Overall Study|Withdrawal by Subject|1|||
149104131|NCT03000348|537859771|FG002|Overall Study|Withdrawal by Subject|0|||
149104132|NCT03000348|537859772|FG003|Overall Study|Withdrawal by Subject|0|||
149104133|NCT03000348|537859773|FG004|Overall Study|Withdrawal by Subject|0|||
149104134|NCT03000348|537859774|FG005|Overall Study|Withdrawal by Subject|0|||
149104135|NCT03000348|537859769|FG000|Overall Study|Consent|0|||
149104136|NCT03000348|537859770|FG001|Overall Study|Consent|0|||
149104137|NCT03000348|537859771|FG002|Overall Study|Consent|0|||
149104138|NCT03000348|537859772|FG003|Overall Study|Consent|0|||
149104139|NCT03000348|537859773|FG004|Overall Study|Consent|1|||
149104140|NCT03000348|537859774|FG005|Overall Study|Consent|0|||
149104141|NCT03000348|537859769|FG000|Overall Study|Failure to expectorate sputum|1|||
149104142|NCT03000348|537859770|FG001|Overall Study|Failure to expectorate sputum|0|||
149104143|NCT03000348|537859771|FG002|Overall Study|Failure to expectorate sputum|1|||
149104144|NCT03000348|537859772|FG003|Overall Study|Failure to expectorate sputum|0|||
149104145|NCT03000348|537859773|FG004|Overall Study|Failure to expectorate sputum|1|||
149104146|NCT03000348|537859774|FG005|Overall Study|Failure to expectorate sputum|0|||
149104147|NCT03000348|537859769|FG000|Overall Study|No gram negative|1|||
149104148|NCT03000348|537859770|FG001|Overall Study|No gram negative|2|||
149104149|NCT03000348|537859771|FG002|Overall Study|No gram negative|1|||
149104150|NCT03000348|537859772|FG003|Overall Study|No gram negative|1|||
149104151|NCT03000348|537859773|FG004|Overall Study|No gram negative|1|||
149104152|NCT03000348|537859774|FG005|Overall Study|No gram negative|1|||
149104153|NCT03000348|537859769|FG000|Overall Study|Patient had no transport|0|||
149104154|NCT03000348|537859770|FG001|Overall Study|Patient had no transport|0|||
149104155|NCT03000348|537859771|FG002|Overall Study|Patient had no transport|0|||
149104156|NCT03000348|537859772|FG003|Overall Study|Patient had no transport|1|||
149104157|NCT03000348|537859773|FG004|Overall Study|Patient had no transport|0|||
149104158|NCT03000348|537859774|FG005|Overall Study|Patient had no transport|0|||
149104159|NCT03000348|537859769|FG000|Overall Study|Dosing|0|||
149104160|NCT03000348|537859770|FG001|Overall Study|Dosing|0|||
149104161|NCT03000348|537859771|FG002|Overall Study|Dosing|0|||
149104162|NCT03000348|537859772|FG003|Overall Study|Dosing|0|||
149104163|NCT03000348|537859773|FG004|Overall Study|Dosing|1|||
149104164|NCT03000348|537859774|FG005|Overall Study|Dosing|0|||
149104165|NCT01667549|537859775|FG000|Overall Study|Withdrawal by Subject|3|||
149104166|NCT01667549|537859776|FG001|Overall Study|Withdrawal by Subject|5|||
149104167|NCT01667549|537859777|FG002|Overall Study|Withdrawal by Subject|7|||
149104168|NCT01667549|537859778|FG003|Overall Study|Withdrawal by Subject|6|||
149104169|NCT01667549|537859779|FG004|Overall Study|Withdrawal by Subject|1|||
149104170|NCT01407276|537859780|FG000|Overall Study|Withdrawal by Subject|0|||
149104171|NCT01407276|537859781|FG001|Overall Study|Withdrawal by Subject|0|||
149104172|NCT01407276|537859782|FG002|Overall Study|Withdrawal by Subject|0|||
149104173|NCT01407276|537859783|FG003|Overall Study|Withdrawal by Subject|0|||
149104174|NCT01407276|537859784|FG004|Overall Study|Withdrawal by Subject|0|||
149104175|NCT01407276|537859785|FG005|Overall Study|Withdrawal by Subject|0|||
149104176|NCT01407276|537859786|FG006|Overall Study|Withdrawal by Subject|0|||
149104177|NCT01407276|537859787|FG007|Overall Study|Withdrawal by Subject|1|||
149104178|NCT01807182|537859788|FG000|Overall Study|Death|1|||
149104179|NCT01807182|537859788|FG000|Overall Study|New therapy|1|||
149104180|NCT01807182|537859788|FG000|Overall Study|Moved to hospice care|1|||
149104181|NCT00478205|537859790|FG000|Overall Study|Adverse Event|182|||
149104182|NCT00478205|537859791|FG001|Overall Study|Adverse Event|39|||
149104183|NCT00478205|537859790|FG000|Overall Study|Medication Non-compliance|9|||
149104184|NCT00478205|537859791|FG001|Overall Study|Medication Non-compliance|4|||
149104185|NCT00478205|537859790|FG000|Overall Study|Protocol Violation|15|||
149104186|NCT00478205|537859791|FG001|Overall Study|Protocol Violation|5|||
149104187|NCT00478205|537859790|FG000|Overall Study|Request of Investigator or Sponsor|4|||
149104188|NCT00478205|537859791|FG001|Overall Study|Request of Investigator or Sponsor|5|||
149104189|NCT00478205|537859790|FG000|Overall Study|Withdrawal by Subject|61|||
149104190|NCT00478205|537859791|FG001|Overall Study|Withdrawal by Subject|22|||
149104191|NCT00478205|537859790|FG000|Overall Study|Lack of Efficacy|1|||
149104192|NCT00478205|537859791|FG001|Overall Study|Lack of Efficacy|0|||
149104193|NCT00478205|537859790|FG000|Overall Study|Other|24|||
149104194|NCT00478205|537859791|FG001|Overall Study|Other|12|||
149104195|NCT04092452|537859793|FG000|Overall Study|Adverse Event|1|||
149104196|NCT04092452|537859794|FG001|Overall Study|Adverse Event|3|||
149104197|NCT04092452|537859795|FG002|Overall Study|Adverse Event|3|||
149104198|NCT04092452|537859796|FG003|Overall Study|Adverse Event|7|||
149104199|NCT04092452|537859793|FG000|Overall Study|Lack of Efficacy|1|||
149104200|NCT04092452|537859794|FG001|Overall Study|Lack of Efficacy|1|||
149104201|NCT04092452|537859795|FG002|Overall Study|Lack of Efficacy|1|||
149104202|NCT04092452|537859796|FG003|Overall Study|Lack of Efficacy|0|||
149104203|NCT04092452|537859793|FG000|Overall Study|Lost to Follow-up|4|||
149104204|NCT04092452|537859794|FG001|Overall Study|Lost to Follow-up|3|||
149104205|NCT04092452|537859795|FG002|Overall Study|Lost to Follow-up|5|||
149104206|NCT04092452|537859796|FG003|Overall Study|Lost to Follow-up|1|||
149104207|NCT04092452|537859793|FG000|Overall Study|Non-Compliance With Study Drug|0|||
149104208|NCT04092452|537859794|FG001|Overall Study|Non-Compliance With Study Drug|0|||
149104209|NCT04092452|537859795|FG002|Overall Study|Non-Compliance With Study Drug|1|||
149104210|NCT04092452|537859796|FG003|Overall Study|Non-Compliance With Study Drug|1|||
149104211|NCT04092452|537859793|FG000|Overall Study|Physician Decision|1|||
149104212|NCT04092452|537859794|FG001|Overall Study|Physician Decision|0|||
149104213|NCT04092452|537859795|FG002|Overall Study|Physician Decision|1|||
149104214|NCT04092452|537859796|FG003|Overall Study|Physician Decision|0|||
149104215|NCT04092452|537859793|FG000|Overall Study|Pregnancy|2|||
149104216|NCT04092452|537859794|FG001|Overall Study|Pregnancy|0|||
149104217|NCT04092452|537859795|FG002|Overall Study|Pregnancy|0|||
149104218|NCT04092452|537859796|FG003|Overall Study|Pregnancy|0|||
149104219|NCT04092452|537859793|FG000|Overall Study|Protocol Deviation|1|||
149104220|NCT04092452|537859794|FG001|Overall Study|Protocol Deviation|0|||
149104221|NCT04092452|537859795|FG002|Overall Study|Protocol Deviation|0|||
149104222|NCT04092452|537859796|FG003|Overall Study|Protocol Deviation|0|||
149104223|NCT04092452|537859793|FG000|Overall Study|Withdrawal by Subject|3|||
149104224|NCT04092452|537859794|FG001|Overall Study|Withdrawal by Subject|10|||
149104225|NCT04092452|537859795|FG002|Overall Study|Withdrawal by Subject|3|||
149104226|NCT04092452|537859796|FG003|Overall Study|Withdrawal by Subject|5|||
149104227|NCT04092452|537859793|FG000|Overall Study|Other|0|||
149104228|NCT04092452|537859794|FG001|Overall Study|Other|0|||
149104229|NCT04092452|537859795|FG002|Overall Study|Other|1|||
149104230|NCT04092452|537859796|FG003|Overall Study|Other|2|||
149104231|NCT01791413|537859797|FG000|Overall Study|Lost to Follow-up|5|||
149104232|NCT01791413|537859798|FG001|Overall Study|Lost to Follow-up|1|||
149104233|NCT00825305|537859808|FG000|Overall Study|Adverse Event|1|||
149104234|NCT00825305|537859809|FG001|Overall Study|Adverse Event|1|||
149104235|NCT00825305|537859808|FG000|Overall Study|Withdrawal by Subject|6|||
149104236|NCT00825305|537859809|FG001|Overall Study|Withdrawal by Subject|12|||
149104237|NCT00825305|537859808|FG000|Overall Study|Inappropriate inclusion|1|||
149104238|NCT00825305|537859809|FG001|Overall Study|Inappropriate inclusion|0|||
149104239|NCT00825305|537859808|FG000|Overall Study|Protocol Violation|9|||
149104240|NCT00825305|537859809|FG001|Overall Study|Protocol Violation|9|||
149104241|NCT00825305|537859808|FG000|Overall Study|Can not be classified|0|||
149104242|NCT00825305|537859809|FG001|Overall Study|Can not be classified|1|||
149104243|NCT04016272|537859810|FG000|Overall Study|Withdrawal by Subject|1|||
149104244|NCT04016272|537859811|FG001|Overall Study|Withdrawal by Subject|2|||
149104245|NCT00115336|537859814|FG000|Overall Study|Hospital discharge before study drug|0|||
149104246|NCT00115336|537859815|FG001|Overall Study|Hospital discharge before study drug|1|||
149104247|NCT00715117|537859826|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
149104248|NCT00715117|537859827|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
149104249|NCT01191008|537859831|FG000|Overall Study|Protocol Violation|7|||
149104250|NCT01191008|537859831|FG000|Overall Study|Lost to Follow-up|8|||
149104251|NCT00978562|537859832|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
149104252|NCT04886518|537859835|FG000|Overall Study|Noncompliance with study drug|1|||
149104253|NCT04886518|537859836|FG001|Overall Study|Noncompliance with study drug|0|||
149104254|NCT04886518|537859837|FG002|Overall Study|Noncompliance with study drug|0|||
149104255|NCT04886518|537859835|FG000|Overall Study|Adverse Event|0|||
149104256|NCT04886518|537859836|FG001|Overall Study|Adverse Event|1|||
149104257|NCT04886518|537859837|FG002|Overall Study|Adverse Event|0|||
149104258|NCT04886518|537859835|FG000|Overall Study|Withdrawal by Subject|1|||
149104259|NCT04886518|537859836|FG001|Overall Study|Withdrawal by Subject|0|||
149104260|NCT04886518|537859837|FG002|Overall Study|Withdrawal by Subject|0|||
149104261|NCT02035696|537862172|FG000|Overall Study|Lost to Follow-up|0|||
149104262|NCT02035696|537862173|FG001|Overall Study|Lost to Follow-up|3|||
149104263|NCT02035696|537862174|FG002|Overall Study|Lost to Follow-up|1|||
149104264|NCT02035696|537862175|FG003|Overall Study|Lost to Follow-up|2|||
149104265|NCT02035696|537862172|FG000|Overall Study|Withdrawal by Subject|3|||
149104266|NCT02035696|537862173|FG001|Overall Study|Withdrawal by Subject|0|||
149104267|NCT02035696|537862174|FG002|Overall Study|Withdrawal by Subject|2|||
149104268|NCT02035696|537862175|FG003|Overall Study|Withdrawal by Subject|1|||
149104269|NCT01867047|537862177|FG000|Overall Study|Lost to Follow-up|3|||
149104270|NCT01867047|537862178|FG001|Overall Study|Lost to Follow-up|3|||
149104271|NCT01867047|537862177|FG000|Overall Study|Withdrawal by Subject|2|||
149104272|NCT01867047|537862178|FG001|Overall Study|Withdrawal by Subject|0|||
149104273|NCT01867047|537862177|FG000|Overall Study|Physician Decision|2|||
149104274|NCT01867047|537862178|FG001|Overall Study|Physician Decision|0|||
149104275|NCT01867047|537862177|FG000|Overall Study|surgery not indicated in protocol|1|||
149104276|NCT01867047|537862178|FG001|Overall Study|surgery not indicated in protocol|2|||
149104277|NCT01385748|537862179|FG000|Overall Study|Withdrawal by Subject|7|||
149104278|NCT01385748|537862180|FG001|Overall Study|Withdrawal by Subject|4|||
149104279|NCT01385748|537862181|FG002|Overall Study|Withdrawal by Subject|5|||
149104280|NCT01385748|537862179|FG000|Overall Study|Noncompliance|3|||
149104281|NCT01385748|537862180|FG001|Overall Study|Noncompliance|1|||
149104282|NCT01385748|537862181|FG002|Overall Study|Noncompliance|6|||
149104283|NCT01385748|537862179|FG000|Overall Study|Other|1|||
149104284|NCT01385748|537862180|FG001|Overall Study|Other|7|||
149104285|NCT01385748|537862181|FG002|Overall Study|Other|1|||
149104286|NCT01385748|537862179|FG000|Overall Study|Adverse Event|4|||
149104287|NCT01385748|537862180|FG001|Overall Study|Adverse Event|2|||
149104288|NCT01385748|537862181|FG002|Overall Study|Adverse Event|1|||
149104289|NCT04292470|537862183|FG000|Overall Study|Withdrawal by Subject|0|||
149104290|NCT04292470|537862184|FG001|Overall Study|Withdrawal by Subject|1|||
149104291|NCT01454739|537862185|FG000|Overall Study|Protocol Violation|2|||
149104292|NCT01454739|537862186|FG001|Overall Study|Protocol Violation|3|||
149104293|NCT01454739|537862185|FG000|Overall Study|Withdrawal by Subject|2|||
149104294|NCT01454739|537862186|FG001|Overall Study|Withdrawal by Subject|6|||
149104295|NCT01454739|537862185|FG000|Overall Study|Other|3|||
149104296|NCT01454739|537862186|FG001|Overall Study|Other|5|||
149104297|NCT01454739|537862185|FG000|Overall Study|Physician Decision|0|||
149104298|NCT01454739|537862186|FG001|Overall Study|Physician Decision|5|||
149104299|NCT01454739|537862185|FG000|Overall Study|Lost to Follow-up|0|||
149104300|NCT01454739|537862186|FG001|Overall Study|Lost to Follow-up|1|||
149104301|NCT01454739|537862185|FG000|Overall Study|Adverse Event|0|||
149104302|NCT01454739|537862186|FG001|Overall Study|Adverse Event|1|||
149104303|NCT02906020|537862187|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
149104304|NCT02906020|537862188|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
149104305|NCT02906020|537862189|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
149104306|NCT02906020|537862190|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
149104307|NCT02906020|537862191|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
149104308|NCT02906020|537862192|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
149104309|NCT02906020|537862193|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
149104310|NCT02906020|537862194|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
149104311|NCT02906020|537862195|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
149104312|NCT02906020|537862196|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
149104313|NCT02906020|537862197|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
149104314|NCT02906020|537862198|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
149104315|NCT02906020|537862199|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
149104316|NCT02906020|537862200|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
149104317|NCT02906020|537862201|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
149104318|NCT02906020|537862202|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
149104319|NCT02906020|537862187|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104320|NCT02906020|537862188|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104321|NCT02906020|537862189|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104322|NCT02906020|537862190|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104323|NCT02906020|537862191|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104324|NCT02906020|537862192|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104325|NCT02906020|537862193|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104326|NCT02906020|537862194|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104327|NCT02906020|537862195|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
149104328|NCT02906020|537862196|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
149104329|NCT02906020|537862197|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104330|NCT02906020|537862198|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104331|NCT02906020|537862199|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104332|NCT02906020|537862200|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104333|NCT02906020|537862201|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104334|NCT02906020|537862202|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
149104335|NCT02906020|537862187|FG000|Part 2: Double-blind Treatment Period|Other|0|||
149104336|NCT02906020|537862188|FG001|Part 2: Double-blind Treatment Period|Other|0|||
149104337|NCT02906020|537862189|FG002|Part 2: Double-blind Treatment Period|Other|0|||
149104338|NCT02906020|537862190|FG003|Part 2: Double-blind Treatment Period|Other|0|||
149104339|NCT02906020|537862191|FG004|Part 2: Double-blind Treatment Period|Other|0|||
149104340|NCT02906020|537862192|FG005|Part 2: Double-blind Treatment Period|Other|0|||
149104341|NCT02906020|537862193|FG006|Part 2: Double-blind Treatment Period|Other|0|||
149104342|NCT02906020|537862194|FG007|Part 2: Double-blind Treatment Period|Other|0|||
149104343|NCT02906020|537862195|FG008|Part 2: Double-blind Treatment Period|Other|6|||
149104344|NCT02906020|537862196|FG009|Part 2: Double-blind Treatment Period|Other|10|||
149104345|NCT02906020|537862197|FG010|Part 2: Double-blind Treatment Period|Other|0|||
149104346|NCT02906020|537862198|FG011|Part 2: Double-blind Treatment Period|Other|0|||
149104347|NCT02906020|537862199|FG012|Part 2: Double-blind Treatment Period|Other|0|||
149104348|NCT02906020|537862200|FG013|Part 2: Double-blind Treatment Period|Other|0|||
149104349|NCT02906020|537862201|FG014|Part 2: Double-blind Treatment Period|Other|0|||
149104350|NCT02906020|537862202|FG015|Part 2: Double-blind Treatment Period|Other|0|||
149104351|NCT02906020|537862187|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104352|NCT02906020|537862188|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104353|NCT02906020|537862189|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104354|NCT02906020|537862190|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104355|NCT02906020|537862191|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104356|NCT02906020|537862192|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104357|NCT02906020|537862193|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104358|NCT02906020|537862194|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104359|NCT02906020|537862195|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104360|NCT02906020|537862196|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104361|NCT02906020|537862197|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104362|NCT02906020|537862198|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104363|NCT02906020|537862199|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
149104364|NCT02906020|537862200|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
149104365|NCT02906020|537862201|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104366|NCT02906020|537862202|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
149104367|NCT02906020|537862187|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104368|NCT02906020|537862188|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104369|NCT02906020|537862189|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104370|NCT02906020|537862190|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104371|NCT02906020|537862191|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104372|NCT02906020|537862192|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104373|NCT02906020|537862193|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104374|NCT02906020|537862194|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104375|NCT02906020|537862195|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104376|NCT02906020|537862196|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104377|NCT02906020|537862197|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104378|NCT02906020|537862198|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104379|NCT02906020|537862199|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
149104380|NCT02906020|537862200|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
149104381|NCT02906020|537862201|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
149104382|NCT02906020|537862202|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
149104383|NCT02906020|537862187|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104384|NCT02906020|537862188|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104385|NCT02906020|537862189|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104386|NCT02906020|537862190|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104387|NCT02906020|537862191|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104388|NCT02906020|537862192|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104389|NCT02906020|537862193|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104390|NCT02906020|537862194|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104391|NCT02906020|537862195|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104392|NCT02906020|537862196|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104393|NCT02906020|537862197|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104394|NCT02906020|537862198|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104395|NCT02906020|537862199|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
149104396|NCT02906020|537862200|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
149104397|NCT02906020|537862201|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104398|NCT02906020|537862202|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
149104399|NCT02906020|537862187|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149119475|NCT01327495|537916355|FG004|Overall Study|Adverse Event|0|||
149104400|NCT02906020|537862188|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104401|NCT02906020|537862189|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104402|NCT02906020|537862190|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104403|NCT02906020|537862191|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104404|NCT02906020|537862192|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104405|NCT02906020|537862193|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104406|NCT02906020|537862194|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104407|NCT02906020|537862195|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104408|NCT02906020|537862196|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104409|NCT02906020|537862197|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104410|NCT02906020|537862198|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104411|NCT02906020|537862199|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
149104412|NCT02906020|537862200|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
149104413|NCT02906020|537862201|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104414|NCT02906020|537862202|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
149104415|NCT02906020|537862187|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104416|NCT02906020|537862188|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104417|NCT02906020|537862189|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104418|NCT02906020|537862190|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104419|NCT02906020|537862191|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104420|NCT02906020|537862192|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104421|NCT02906020|537862193|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104422|NCT02906020|537862194|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104423|NCT02906020|537862195|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104424|NCT02906020|537862196|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104425|NCT02906020|537862197|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104426|NCT02906020|537862198|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
149104427|NCT02906020|537862199|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
149104428|NCT02906020|537862200|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
149104429|NCT02906020|537862201|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
149104430|NCT02906020|537862202|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
149104431|NCT02906020|537862187|FG000|Part 2: Long-term Follow-up Period|Other|0|||
149104432|NCT02906020|537862188|FG001|Part 2: Long-term Follow-up Period|Other|0|||
149104433|NCT02906020|537862189|FG002|Part 2: Long-term Follow-up Period|Other|0|||
149104434|NCT02906020|537862190|FG003|Part 2: Long-term Follow-up Period|Other|0|||
149104435|NCT02906020|537862191|FG004|Part 2: Long-term Follow-up Period|Other|0|||
149104436|NCT02906020|537862192|FG005|Part 2: Long-term Follow-up Period|Other|0|||
149104437|NCT02906020|537862193|FG006|Part 2: Long-term Follow-up Period|Other|0|||
149104438|NCT02906020|537862194|FG007|Part 2: Long-term Follow-up Period|Other|0|||
149104439|NCT02906020|537862195|FG008|Part 2: Long-term Follow-up Period|Other|0|||
149104440|NCT02906020|537862196|FG009|Part 2: Long-term Follow-up Period|Other|0|||
149104441|NCT02906020|537862197|FG010|Part 2: Long-term Follow-up Period|Other|0|||
149104442|NCT02906020|537862198|FG011|Part 2: Long-term Follow-up Period|Other|0|||
149104443|NCT02906020|537862199|FG012|Part 2: Long-term Follow-up Period|Other|13|||
149104444|NCT02906020|537862200|FG013|Part 2: Long-term Follow-up Period|Other|8|||
149104445|NCT02906020|537862201|FG014|Part 2: Long-term Follow-up Period|Other|3|||
149104446|NCT02906020|537862202|FG015|Part 2: Long-term Follow-up Period|Other|2|||
149104447|NCT04698915|537862203|FG000|Overall Study|Adverse Event|2|||
149104448|NCT04698915|537862204|FG001|Overall Study|Adverse Event|0|||
149104449|NCT04698915|537862203|FG000|Overall Study|Death|23|||
149104450|NCT04698915|537862204|FG001|Overall Study|Death|20|||
149104451|NCT04698915|537862203|FG000|Overall Study|Physician Decision|1|||
149104452|NCT04698915|537862204|FG001|Overall Study|Physician Decision|1|||
149104453|NCT04698915|537862203|FG000|Overall Study|Lost to Follow-up|1|||
149104454|NCT04698915|537862204|FG001|Overall Study|Lost to Follow-up|0|||
149104455|NCT04698915|537862203|FG000|Overall Study|Study Terminated by Sponsor|55|||
149104456|NCT04698915|537862204|FG001|Overall Study|Study Terminated by Sponsor|60|||
149104457|NCT04698915|537862203|FG000|Overall Study|Withdrawal by Subject|2|||
149104458|NCT04698915|537862204|FG001|Overall Study|Withdrawal by Subject|3|||
149104459|NCT05878873|537862207|FG000|Overall Study|Lost to Follow-up|2|||
149104460|NCT05878873|537862208|FG001|Overall Study|Lost to Follow-up|0|||
149104461|NCT00633945|537862210|FG000|Overall Study|Physician Decision|2|||
149104462|NCT02375347|537862211|FG000|Overall Study|Protocol Violation|1|||
149104463|NCT00193479|537862212|FG000|Induction Chemotherapy|Adverse Event|2|||
149104464|NCT00193479|537862212|FG000|Induction Chemotherapy|Disease Progression|1|||
149104465|NCT00193479|537862212|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
149104466|NCT00193479|537862212|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
149104467|NCT00559377|537862213|FG000|Overall Study|Withdrawal by Subject|9|||
149104468|NCT01547598|537862215|FG000|Overall Study|Withdrew consent|1|||
149104469|NCT01547598|537862216|FG001|Overall Study|Withdrew consent|1|||
149104470|NCT01547598|537862215|FG000|Overall Study|Lost to Follow-up|1|||
149104471|NCT01547598|537862216|FG001|Overall Study|Lost to Follow-up|1|||
149104472|NCT01547598|537862215|FG000|Overall Study|Adverse Event|1|||
149104473|NCT01547598|537862216|FG001|Overall Study|Adverse Event|1|||
149104474|NCT01547598|537862215|FG000|Overall Study|Protocol Violation|1|||
149104475|NCT01547598|537862216|FG001|Overall Study|Protocol Violation|1|||
149104476|NCT01547598|537862215|FG000|Overall Study|Other Miscellaneous Reasons|2|||
149104477|NCT01547598|537862216|FG001|Overall Study|Other Miscellaneous Reasons|1|||
149104478|NCT02229227|537862223|FG000|Overall Study|Adverse Event|14|||
149104479|NCT02229227|537862224|FG001|Overall Study|Adverse Event|9|||
149104480|NCT02229227|537862223|FG000|Overall Study|Lack of Efficacy|3|||
149104481|NCT02229227|537862224|FG001|Overall Study|Lack of Efficacy|3|||
149104482|NCT02229227|537862223|FG000|Overall Study|Protocol Violation|6|||
149104483|NCT02229227|537862224|FG001|Overall Study|Protocol Violation|8|||
149104484|NCT02229227|537862223|FG000|Overall Study|Protocol defined stopping criteria|1|||
149104485|NCT02229227|537862224|FG001|Overall Study|Protocol defined stopping criteria|3|||
149104486|NCT02229227|537862223|FG000|Overall Study|Lost to Follow-up|3|||
149104487|NCT02229227|537862224|FG001|Overall Study|Lost to Follow-up|3|||
149104488|NCT02229227|537862223|FG000|Overall Study|Study terminated by sponsor|11|||
149104489|NCT02229227|537862224|FG001|Overall Study|Study terminated by sponsor|11|||
149104490|NCT02229227|537862223|FG000|Overall Study|Withdrawal by Subject|8|||
149104491|NCT02229227|537862224|FG001|Overall Study|Withdrawal by Subject|12|||
149104492|NCT02229227|537862223|FG000|Overall Study|Other|0|||
149104493|NCT02229227|537862224|FG001|Overall Study|Other|1|||
149104494|NCT02229227|537862223|FG000|Overall Study|Physician Decision|5|||
149104495|NCT02229227|537862224|FG001|Overall Study|Physician Decision|12|||
149104496|NCT00340704|537862225|FG000|PK Study|Adverse Event|0|||
149104497|NCT00340704|537862226|FG001|PK Study|Adverse Event|1|||
149104498|NCT00340704|537862227|FG002|PK Study|Adverse Event|0|||
149104499|NCT00340704|537862228|FG003|PK Study|Adverse Event|0|||
149104500|NCT00340704|537862229|FG004|PK Study|Adverse Event|0|||
149104501|NCT00340704|537862230|FG005|PK Study|Adverse Event|0|||
149104502|NCT00340704|537862231|FG006|PK Study|Adverse Event|0|||
149104503|NCT00340704|537862232|FG007|PK Study|Adverse Event|0|||
149104504|NCT00340704|537862233|FG008|PK Study|Adverse Event|0|||
149104505|NCT00340704|537862225|FG000|PK Study|Not treated|0|||
149104506|NCT00340704|537862226|FG001|PK Study|Not treated|0|||
149104507|NCT00340704|537862227|FG002|PK Study|Not treated|1|||
149104508|NCT00340704|537862228|FG003|PK Study|Not treated|0|||
149104509|NCT00340704|537862229|FG004|PK Study|Not treated|0|||
149104510|NCT00340704|537862230|FG005|PK Study|Not treated|0|||
149104511|NCT00340704|537862231|FG006|PK Study|Not treated|0|||
149104512|NCT00340704|537862232|FG007|PK Study|Not treated|0|||
149104513|NCT00340704|537862233|FG008|PK Study|Not treated|0|||
149104514|NCT00340704|537862225|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
149104515|NCT00340704|537862226|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
149104516|NCT00340704|537862227|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
149104517|NCT00340704|537862228|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
149104518|NCT00340704|537862229|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
149104519|NCT00340704|537862230|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
149104520|NCT00340704|537862231|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
149104521|NCT00340704|537862232|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
149104522|NCT00340704|537862233|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
149104523|NCT00340704|537862225|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104524|NCT00340704|537862226|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104525|NCT00340704|537862227|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104526|NCT00340704|537862228|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104527|NCT00340704|537862229|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104528|NCT00340704|537862230|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
149104529|NCT00340704|537862231|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104530|NCT00340704|537862232|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104531|NCT00340704|537862233|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
149104532|NCT00340704|537862225|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104533|NCT00340704|537862226|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104534|NCT00340704|537862227|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104535|NCT00340704|537862228|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104536|NCT00340704|537862229|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
149104537|NCT00340704|537862230|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
149104538|NCT00340704|537862231|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104539|NCT00340704|537862232|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104540|NCT00340704|537862233|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
149104541|NCT00340704|537862225|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
149119476|NCT01327495|537916356|FG005|Overall Study|Adverse Event|2|||
149104542|NCT00340704|537862226|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
149104543|NCT00340704|537862227|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
149104544|NCT00340704|537862228|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
149104545|NCT00340704|537862229|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
149104546|NCT00340704|537862230|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
149104547|NCT00340704|537862231|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
149104548|NCT00340704|537862232|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
149104549|NCT00340704|537862233|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
149104550|NCT04071301|537862234|FG000|Overall Study|Withdrawal by Subject|6|||
149104551|NCT04071301|537862234|FG000|Overall Study|Death|1|||
149104552|NCT01453023|537862235|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
149104553|NCT01453023|537862236|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
149104554|NCT01453023|537862235|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
149104555|NCT01453023|537862236|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
149104556|NCT01453023|537862235|FG000|Treatment Period 2|Protocol Violation|0|||
149104557|NCT01453023|537862236|FG001|Treatment Period 2|Protocol Violation|1|||
149104558|NCT02879383|537862237|FG000|First 24 Weeks|Physician Decision|0|||
149104559|NCT02879383|537862238|FG001|First 24 Weeks|Physician Decision|1|||
149104560|NCT02879383|537862239|FG002|First 24 Weeks|Physician Decision|0|||
149104561|NCT02879383|537862240|FG003|First 24 Weeks|Physician Decision|0|||
149104562|NCT02125279|537862241|FG000|Overall Study|Lack of Efficacy|2|||
149104563|NCT02125279|537862241|FG000|Overall Study|Withdrawal by Subject|6|||
149104564|NCT02125279|537862241|FG000|Overall Study|Protocol Violation|1|||
149104565|NCT02125279|537862241|FG000|Overall Study|Lost to Follow-up|4|||
149104566|NCT01607879|537862246|FG000|Overall Study|Death|1|||
149104567|NCT01607879|537862247|FG001|Overall Study|Death|0|||
149104568|NCT04468230|537862249|FG000|Overall Study|Adverse Event|2|||
149104569|NCT03845140|537862250|FG000|Overall Study|Participant travelled outside study area|0|||
149104570|NCT03845140|537862251|FG001|Overall Study|Participant travelled outside study area|1|||
149104571|NCT03845140|537862252|FG002|Overall Study|Participant travelled outside study area|0|||
149104572|NCT03845140|537862253|FG003|Overall Study|Participant travelled outside study area|0|||
149104573|NCT03845140|537862254|FG004|Overall Study|Participant travelled outside study area|0|||
149104574|NCT03845140|537862255|FG005|Overall Study|Participant travelled outside study area|0|||
149104575|NCT01592045|537862263|FG000|Overall Study|Disease Progression|1|||
149104576|NCT01592045|537862264|FG001|Overall Study|Disease Progression|1|||
149104577|NCT01592045|537862263|FG000|Overall Study|Adverse Event|1|||
149104578|NCT01592045|537862264|FG001|Overall Study|Adverse Event|1|||
149104579|NCT01592045|537862263|FG000|Overall Study|Withdrawal by Subject|1|||
149104580|NCT01592045|537862264|FG001|Overall Study|Withdrawal by Subject|0|||
149104581|NCT01592045|537862263|FG000|Overall Study|Moved out of country|2|||
149104582|NCT01592045|537862264|FG001|Overall Study|Moved out of country|0|||
149104583|NCT01790295|537862269|FG000|Overall Study|Adverse Event|1|||
149104584|NCT01790295|537862269|FG000|Overall Study|Death|4|||
149104585|NCT01790295|537862269|FG000|Overall Study|Lack of Efficacy|2|||
149104586|NCT01790295|537862269|FG000|Overall Study|Study closure|4|||
149104587|NCT00420784|537862273|FG000|Overall Study|Adverse Event|11|||
149104588|NCT00420784|537862274|FG001|Overall Study|Adverse Event|29|||
149104589|NCT00420784|537862275|FG002|Overall Study|Adverse Event|10|||
149104590|NCT00420784|537862276|FG003|Overall Study|Adverse Event|5|||
149104591|NCT00420784|537862273|FG000|Overall Study|Withdrawal by Subject|0|||
149104592|NCT00420784|537862274|FG001|Overall Study|Withdrawal by Subject|1|||
149104593|NCT00420784|537862275|FG002|Overall Study|Withdrawal by Subject|0|||
149104594|NCT00420784|537862276|FG003|Overall Study|Withdrawal by Subject|0|||
149104595|NCT00420784|537862273|FG000|Overall Study|Lost to Follow-up|0|||
149104596|NCT00420784|537862274|FG001|Overall Study|Lost to Follow-up|0|||
149104597|NCT00420784|537862275|FG002|Overall Study|Lost to Follow-up|2|||
149104598|NCT00420784|537862276|FG003|Overall Study|Lost to Follow-up|1|||
149104599|NCT00420784|537862273|FG000|Overall Study|Virologic Stopping Rule|17|||
149104600|NCT00420784|537862274|FG001|Overall Study|Virologic Stopping Rule|26|||
149104601|NCT00420784|537862275|FG002|Overall Study|Virologic Stopping Rule|41|||
149104602|NCT00420784|537862276|FG003|Overall Study|Virologic Stopping Rule|67|||
149104603|NCT00420784|537862273|FG000|Overall Study|Other|1|||
149104604|NCT00420784|537862274|FG001|Overall Study|Other|2|||
149104605|NCT00420784|537862275|FG002|Overall Study|Other|0|||
149104606|NCT00420784|537862276|FG003|Overall Study|Other|5|||
149104607|NCT02417441|537862279|FG000|Overall Study|Inconclusive due to missing data|52|||
149104608|NCT02417441|537862280|FG001|Overall Study|Inconclusive due to missing data|19|||
149104609|NCT00983853|537862283|FG000|Overall Study|Lost to Follow-up|1|||
149104610|NCT00983853|537862284|FG001|Overall Study|Lost to Follow-up|1|||
149104611|NCT00983853|537862285|FG002|Overall Study|Lost to Follow-up|2|||
149104612|NCT00983853|537862286|FG003|Overall Study|Lost to Follow-up|2|||
149104613|NCT00983853|537862287|FG004|Overall Study|Lost to Follow-up|2|||
149104614|NCT00983853|537862288|FG005|Overall Study|Lost to Follow-up|1|||
149104615|NCT00983853|537862283|FG000|Overall Study|Withdrawal by Subject|0|||
149104616|NCT00983853|537862284|FG001|Overall Study|Withdrawal by Subject|0|||
149104617|NCT00983853|537862285|FG002|Overall Study|Withdrawal by Subject|1|||
149104618|NCT00983853|537862286|FG003|Overall Study|Withdrawal by Subject|0|||
149104619|NCT00983853|537862287|FG004|Overall Study|Withdrawal by Subject|1|||
149104620|NCT00983853|537862288|FG005|Overall Study|Withdrawal by Subject|0|||
149104621|NCT00983853|537862283|FG000|Overall Study|Unable to come to study follow-up visits|0|||
149104622|NCT00983853|537862284|FG001|Overall Study|Unable to come to study follow-up visits|1|||
149104623|NCT00983853|537862285|FG002|Overall Study|Unable to come to study follow-up visits|0|||
149104624|NCT00983853|537862286|FG003|Overall Study|Unable to come to study follow-up visits|0|||
149104625|NCT00983853|537862287|FG004|Overall Study|Unable to come to study follow-up visits|0|||
149104626|NCT00983853|537862288|FG005|Overall Study|Unable to come to study follow-up visits|0|||
149104627|NCT01012947|537862302|FG000|Overall Study|Lost to Follow-up|131|||
149104628|NCT01012947|537862303|FG001|Overall Study|Lost to Follow-up|135|||
149104629|NCT01012947|537862304|FG002|Overall Study|Lost to Follow-up|130|||
149104630|NCT01012947|537862305|FG003|Overall Study|Lost to Follow-up|118|||
149104631|NCT01012947|537862306|FG004|Overall Study|Lost to Follow-up|142|||
149104632|NCT02127125|537862307|FG000|Overall Study|Lost to Follow-up|0|||
149104633|NCT02127125|537862308|FG001|Overall Study|Lost to Follow-up|0|||
149104634|NCT02127125|537862309|FG002|Overall Study|Lost to Follow-up|0|||
149104635|NCT02127125|537862310|FG003|Overall Study|Lost to Follow-up|0|||
149104636|NCT02127125|537862311|FG004|Overall Study|Lost to Follow-up|2|||
149104637|NCT02127125|537862312|FG005|Overall Study|Lost to Follow-up|1|||
149104638|NCT02127125|537862313|FG006|Overall Study|Lost to Follow-up|0|||
149104639|NCT02127125|537862314|FG007|Overall Study|Lost to Follow-up|0|||
149104640|NCT02127125|537862315|FG008|Overall Study|Lost to Follow-up|0|||
149104641|NCT02127125|537862307|FG000|Overall Study|Withdrawal by Subject|0|||
149104642|NCT02127125|537862308|FG001|Overall Study|Withdrawal by Subject|0|||
149104643|NCT02127125|537862309|FG002|Overall Study|Withdrawal by Subject|0|||
149104644|NCT02127125|537862310|FG003|Overall Study|Withdrawal by Subject|1|||
149104645|NCT02127125|537862311|FG004|Overall Study|Withdrawal by Subject|0|||
149104646|NCT02127125|537862312|FG005|Overall Study|Withdrawal by Subject|0|||
149104647|NCT02127125|537862313|FG006|Overall Study|Withdrawal by Subject|0|||
149104648|NCT02127125|537862314|FG007|Overall Study|Withdrawal by Subject|0|||
149104649|NCT02127125|537862315|FG008|Overall Study|Withdrawal by Subject|0|||
149104650|NCT02127125|537862307|FG000|Overall Study|Physician Decision|0|||
149104651|NCT02127125|537862308|FG001|Overall Study|Physician Decision|0|||
149104652|NCT02127125|537862309|FG002|Overall Study|Physician Decision|1|||
149104653|NCT02127125|537862310|FG003|Overall Study|Physician Decision|0|||
149104654|NCT02127125|537862311|FG004|Overall Study|Physician Decision|1|||
149104655|NCT02127125|537862312|FG005|Overall Study|Physician Decision|2|||
149104656|NCT02127125|537862313|FG006|Overall Study|Physician Decision|0|||
149104657|NCT02127125|537862314|FG007|Overall Study|Physician Decision|0|||
149104658|NCT02127125|537862315|FG008|Overall Study|Physician Decision|0|||
149104659|NCT02493946|537862319|FG000|DB Period|Withdrawal by Subject|8|||
149104660|NCT02493946|537862320|FG001|DB Period|Withdrawal by Subject|5|||
149104661|NCT02493946|537862321|FG002|DB Period|Withdrawal by Subject|0|||
149104662|NCT02493946|537862319|FG000|Open Label Period|Withdrawal by Subject|0|||
149104663|NCT02493946|537862320|FG001|Open Label Period|Withdrawal by Subject|0|||
149104664|NCT02493946|537862321|FG002|Open Label Period|Withdrawal by Subject|74|||
149104665|NCT02493946|537862319|FG000|Open Label Period|Adverse Event|0|||
149104666|NCT02493946|537862320|FG001|Open Label Period|Adverse Event|0|||
149104667|NCT02493946|537862321|FG002|Open Label Period|Adverse Event|4|||
149104668|NCT02493946|537862319|FG000|Open Label Period|Lost to Follow-up|0|||
149104669|NCT02493946|537862320|FG001|Open Label Period|Lost to Follow-up|0|||
149104670|NCT02493946|537862321|FG002|Open Label Period|Lost to Follow-up|1|||
149104671|NCT02493946|537862319|FG000|Open Label Period|Investigator decision, non-compliance|0|||
149104672|NCT02493946|537862320|FG001|Open Label Period|Investigator decision, non-compliance|0|||
149104673|NCT02493946|537862321|FG002|Open Label Period|Investigator decision, non-compliance|2|||
149104674|NCT02493946|537862319|FG000|Open Label Period|Investigator decision, non-availability|0|||
149104675|NCT02493946|537862320|FG001|Open Label Period|Investigator decision, non-availability|0|||
149104676|NCT02493946|537862321|FG002|Open Label Period|Investigator decision, non-availability|1|||
149104677|NCT02493946|537862319|FG000|Open Label Period|Pregnancy|0|||
149104678|NCT02493946|537862320|FG001|Open Label Period|Pregnancy|0|||
149104679|NCT02493946|537862321|FG002|Open Label Period|Pregnancy|3|||
149104680|NCT02493946|537862319|FG000|Open Label Period|Site error|0|||
149104681|NCT02493946|537862320|FG001|Open Label Period|Site error|0|||
149104682|NCT02493946|537862321|FG002|Open Label Period|Site error|1|||
149104683|NCT03332784|537862324|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104684|NCT03332784|537862325|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
149104685|NCT03332784|537862326|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104686|NCT03332784|537862327|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104687|NCT03332784|537862328|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104688|NCT03332784|537862329|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104689|NCT03332784|537862330|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104690|NCT03332784|537862331|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104691|NCT03332784|537862332|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104692|NCT03332784|537862333|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104693|NCT03332784|537862334|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104694|NCT03332784|537862335|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104695|NCT03332784|537862336|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104696|NCT03332784|537862337|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104697|NCT03332784|537862338|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
149104698|NCT03332784|537862339|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104699|NCT03332784|537862340|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104700|NCT03332784|537862341|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104701|NCT03332784|537862342|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104702|NCT03332784|537862343|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
149104703|NCT01018732|537862349|FG000|Overall Study|Lost to Follow-up|0|||
149104704|NCT01018732|537862350|FG001|Overall Study|Lost to Follow-up|0|||
149104705|NCT01018732|537862351|FG002|Overall Study|Lost to Follow-up|3|||
149104706|NCT01018732|537862349|FG000|Overall Study|Protocol Violation|1|||
149104707|NCT01018732|537862350|FG001|Overall Study|Protocol Violation|1|||
149104708|NCT01018732|537862351|FG002|Overall Study|Protocol Violation|0|||
149104709|NCT01018732|537862349|FG000|Overall Study|Inappropriate Enrollment|0|||
149104710|NCT01018732|537862350|FG001|Overall Study|Inappropriate Enrollment|1|||
149104711|NCT01018732|537862351|FG002|Overall Study|Inappropriate Enrollment|0|||
149104712|NCT01018732|537862349|FG000|Overall Study|Unable to Classify|0|||
149104713|NCT01018732|537862350|FG001|Overall Study|Unable to Classify|0|||
149104714|NCT01018732|537862351|FG002|Overall Study|Unable to Classify|1|||
149104715|NCT01536171|537862352|FG000|Overall Study|Withdrawal by Subject|1|||
149104716|NCT02165826|537862353|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
149104717|NCT02165826|537862354|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
149104718|NCT02165826|537862355|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
149104719|NCT02165826|537862353|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
149104720|NCT02165826|537862354|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
149104721|NCT02165826|537862355|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
149104722|NCT02165826|537862353|FG000|Main Treatment Period|Lost to Follow-up|4|||
149104723|NCT02165826|537862354|FG001|Main Treatment Period|Lost to Follow-up|2|||
149104724|NCT02165826|537862355|FG002|Main Treatment Period|Lost to Follow-up|1|||
149104725|NCT02165826|537862353|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
149104726|NCT02165826|537862354|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
149104727|NCT02165826|537862355|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
149104728|NCT02165826|537862353|FG000|Main Treatment Period|Lack of Efficacy|2|||
149104729|NCT02165826|537862354|FG001|Main Treatment Period|Lack of Efficacy|0|||
149104730|NCT02165826|537862355|FG002|Main Treatment Period|Lack of Efficacy|0|||
149104731|NCT02165826|537862353|FG000|Main Treatment Period|Reason Not Specified|8|||
149104732|NCT02165826|537862354|FG001|Main Treatment Period|Reason Not Specified|5|||
149104733|NCT02165826|537862355|FG002|Main Treatment Period|Reason Not Specified|16|||
149104734|NCT02165826|537862353|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
149104735|NCT02165826|537862354|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
149104736|NCT02165826|537862355|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
149104737|NCT02165826|537862353|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
149104738|NCT02165826|537862354|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
149104739|NCT02165826|537862355|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
149104740|NCT02165826|537862353|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
149104741|NCT02165826|537862354|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
149104742|NCT02165826|537862355|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
149104743|NCT02165826|537862353|FG000|Down-Titration Period|Reason Not Specified|1|||
149104744|NCT02165826|537862354|FG001|Down-Titration Period|Reason Not Specified|0|||
149104745|NCT02165826|537862355|FG002|Down-Titration Period|Reason Not Specified|2|||
149104746|NCT02394665|537862359|FG000|Overall Study|Physician Decision|1|||
149104747|NCT02394665|537862360|FG001|Overall Study|Physician Decision|0|||
149104748|NCT02394665|537862361|FG002|Overall Study|Physician Decision|0|||
149104749|NCT02201901|537862365|FG000|Overall Study|Randomized but never treated|0|||
149104750|NCT02201901|537862366|FG001|Overall Study|Randomized but never treated|1|||
149104751|NCT02201901|537862367|FG002|Overall Study|Randomized but never treated|0|||
149104752|NCT02201901|537862365|FG000|Overall Study|Lack of Efficacy|7|||
149104753|NCT02201901|537862366|FG001|Overall Study|Lack of Efficacy|1|||
149104754|NCT02201901|537862367|FG002|Overall Study|Lack of Efficacy|6|||
149104755|NCT02201901|537862365|FG000|Overall Study|Death|3|||
149104756|NCT02201901|537862366|FG001|Overall Study|Death|3|||
149104757|NCT02201901|537862367|FG002|Overall Study|Death|3|||
149104758|NCT02201901|537862365|FG000|Overall Study|Lost to Follow-up|2|||
149104759|NCT02201901|537862366|FG001|Overall Study|Lost to Follow-up|3|||
149104760|NCT02201901|537862367|FG002|Overall Study|Lost to Follow-up|2|||
149104761|NCT02201901|537862365|FG000|Overall Study|Withdrew Consent|2|||
149104762|NCT02201901|537862366|FG001|Overall Study|Withdrew Consent|0|||
149104763|NCT02201901|537862367|FG002|Overall Study|Withdrew Consent|2|||
149104764|NCT02201901|537862365|FG000|Overall Study|Adverse Event|1|||
149104765|NCT02201901|537862366|FG001|Overall Study|Adverse Event|1|||
149104766|NCT02201901|537862367|FG002|Overall Study|Adverse Event|0|||
149104767|NCT00490698|537862370|FG000|Overall Study|Withdrawal by Subject|1|||
149104768|NCT00490698|537862370|FG000|Overall Study|Disease Progression|7|||
149104769|NCT00490698|537862370|FG000|Overall Study|Physician Decision|2|||
149104770|NCT00738283|537862374|FG000|Overall Study|Death|1|||
149104771|NCT00738283|537862374|FG000|Overall Study|Transfer to another facility|2|||
149104772|NCT00738283|537862374|FG000|Overall Study|Discharge home prior to end of study|1|||
149104773|NCT02559310|537862377|FG000|Overall Study|Death|4|||
149104774|NCT02559310|537862378|FG001|Overall Study|Death|3|||
149104775|NCT02559310|537862377|FG000|Overall Study|Lost to Follow-up|5|||
149104776|NCT02559310|537862378|FG001|Overall Study|Lost to Follow-up|3|||
149104777|NCT02559310|537862377|FG000|Overall Study|Physician Decision|2|||
149104778|NCT02559310|537862378|FG001|Overall Study|Physician Decision|1|||
149104779|NCT02559310|537862377|FG000|Overall Study|Withdrawal by Subject|13|||
149104780|NCT02559310|537862378|FG001|Overall Study|Withdrawal by Subject|9|||
149104781|NCT02559310|537862377|FG000|Overall Study|Sponsor Decision|0|||
149104782|NCT02559310|537862378|FG001|Overall Study|Sponsor Decision|1|||
149104783|NCT02559310|537862377|FG000|Overall Study|Randomized but not treated|3|||
149104784|NCT02559310|537862378|FG001|Overall Study|Randomized but not treated|2|||
149104785|NCT02633397|537862379|FG000|Overall Study|Adverse Event|8|||
149104786|NCT02633397|537862380|FG001|Overall Study|Adverse Event|8|||
149104787|NCT02633397|537862379|FG000|Overall Study|Study Burden|4|||
149104788|NCT02633397|537862380|FG001|Overall Study|Study Burden|1|||
149104789|NCT02633397|537862379|FG000|Overall Study|Treatment interruption|2|||
149104790|NCT02633397|537862380|FG001|Overall Study|Treatment interruption|5|||
149104791|NCT02633397|537862379|FG000|Overall Study|Death|2|||
149104792|NCT02633397|537862380|FG001|Overall Study|Death|2|||
149104793|NCT02633397|537862379|FG000|Overall Study|Physician Decision|0|||
149104794|NCT02633397|537862380|FG001|Overall Study|Physician Decision|1|||
149104795|NCT03595878|537862381|FG000|Overall Study|Death|2|||
149104796|NCT03595878|537862382|FG001|Overall Study|Death|1|||
149104797|NCT03595878|537862383|FG002|Overall Study|Death|0|||
149104798|NCT03595878|537862381|FG000|Overall Study|Disease progression|2|||
149104799|NCT03595878|537862382|FG001|Overall Study|Disease progression|1|||
149104800|NCT03595878|537862383|FG002|Overall Study|Disease progression|2|||
149104801|NCT00469859|537862384|FG000|Overall Study|Inevaluable|0|||
149104802|NCT00469859|537862385|FG001|Overall Study|Inevaluable|2|||
149104803|NCT03494985|537862386|FG000|Overall Study|Adverse Event|3|||
149104804|NCT03494985|537862387|FG001|Overall Study|Adverse Event|2|||
149104805|NCT03494985|537862388|FG002|Overall Study|Adverse Event|3|||
149104806|NCT03494985|537862389|FG003|Overall Study|Adverse Event|0|||
149104807|NCT03494985|537862386|FG000|Overall Study|Other (Withdrawal of consent)|2|||
149104808|NCT03494985|537862387|FG001|Overall Study|Other (Withdrawal of consent)|3|||
149104809|NCT03494985|537862388|FG002|Overall Study|Other (Withdrawal of consent)|2|||
149104810|NCT03494985|537862389|FG003|Overall Study|Other (Withdrawal of consent)|5|||
149104811|NCT03494985|537862386|FG000|Overall Study|Other (Not specified)|0|||
149104812|NCT03494985|537862387|FG001|Overall Study|Other (Not specified)|1|||
149104813|NCT03494985|537862388|FG002|Overall Study|Other (Not specified)|1|||
149104814|NCT03494985|537862389|FG003|Overall Study|Other (Not specified)|0|||
149104815|NCT04124471|537862390|FG000|Overall Study|screen failure|1|||
149104816|NCT03036124|537862391|FG000|Overall Study|Lost to Follow-up|0|||
149104817|NCT03036124|537862392|FG001|Overall Study|Lost to Follow-up|2|||
149104818|NCT03036124|537862391|FG000|Overall Study|Withdrawal by Subject|5|||
149104819|NCT03036124|537862392|FG001|Overall Study|Withdrawal by Subject|4|||
149104820|NCT02282059|537862393|FG000|Overall Study|Other|15|||
149104821|NCT02282059|537862394|FG001|Overall Study|Other|3|||
149104822|NCT02282059|537862393|FG000|Overall Study|Participant refused further follow-up|8|||
149104823|NCT02282059|537862394|FG001|Overall Study|Participant refused further follow-up|4|||
149104824|NCT02282059|537862393|FG000|Overall Study|Lost to Follow-up|19|||
149104825|NCT02282059|537862394|FG001|Overall Study|Lost to Follow-up|3|||
149104826|NCT02282059|537862393|FG000|Overall Study|Death|40|||
149104827|NCT02282059|537862394|FG001|Overall Study|Death|8|||
149104828|NCT02394925|537862395|FG000|Overall Study|Adverse Event|1|||
149104829|NCT02394925|537862395|FG000|Overall Study|Lens Discomfort|3|||
149104830|NCT02394925|537862395|FG000|Overall Study|Lens handling difficulities|5|||
149104831|NCT02394925|537862395|FG000|Overall Study|Lost to Follow-up|9|||
149104832|NCT02394925|537862395|FG000|Overall Study|Protocol Violation|5|||
149104833|NCT02394925|537862395|FG000|Overall Study|No longer meet eligibility criteria|1|||
149104834|NCT02394925|537862395|FG000|Overall Study|Unsatisfactory Visual Response|5|||
149104835|NCT02358668|537864581|FG000|Overall Study|Adverse Event|2|||
149104836|NCT02358668|537864582|FG001|Overall Study|Adverse Event|0|||
149104837|NCT02358668|537864583|FG002|Overall Study|Adverse Event|0|||
149104838|NCT02358668|537864581|FG000|Overall Study|Withdrawal by Subject|0|||
149104839|NCT02358668|537864582|FG001|Overall Study|Withdrawal by Subject|1|||
149104840|NCT02358668|537864583|FG002|Overall Study|Withdrawal by Subject|0|||
149104841|NCT02419417|537864584|FG000|Overall Study|Disease progression|5|||
149104842|NCT02419417|537864585|FG001|Overall Study|Disease progression|4|||
149104843|NCT02419417|537864586|FG002|Overall Study|Disease progression|13|||
149104844|NCT02419417|537864587|FG003|Overall Study|Disease progression|10|||
149104845|NCT02419417|537864588|FG004|Overall Study|Disease progression|10|||
149104846|NCT02419417|537864589|FG005|Overall Study|Disease progression|3|||
149104847|NCT02419417|537864590|FG006|Overall Study|Disease progression|4|||
149104848|NCT02419417|537864591|FG007|Overall Study|Disease progression|5|||
149104849|NCT02419417|537864592|FG008|Overall Study|Disease progression|13|||
149104850|NCT02419417|537864593|FG009|Overall Study|Disease progression|9|||
149104851|NCT02419417|537864594|FG010|Overall Study|Disease progression|0|||
149104852|NCT02419417|537864584|FG000|Overall Study|Study drug toxicity|0|||
149104853|NCT02419417|537864585|FG001|Overall Study|Study drug toxicity|0|||
149104854|NCT02419417|537864586|FG002|Overall Study|Study drug toxicity|0|||
149104855|NCT02419417|537864587|FG003|Overall Study|Study drug toxicity|0|||
149104856|NCT02419417|537864588|FG004|Overall Study|Study drug toxicity|1|||
149104857|NCT02419417|537864589|FG005|Overall Study|Study drug toxicity|0|||
149104858|NCT02419417|537864590|FG006|Overall Study|Study drug toxicity|0|||
149104859|NCT02419417|537864591|FG007|Overall Study|Study drug toxicity|0|||
149104860|NCT02419417|537864592|FG008|Overall Study|Study drug toxicity|0|||
149104861|NCT02419417|537864593|FG009|Overall Study|Study drug toxicity|0|||
149104862|NCT02419417|537864594|FG010|Overall Study|Study drug toxicity|0|||
149104863|NCT02419417|537864584|FG000|Overall Study|Adverse event unrelated to study drug|0|||
149104864|NCT02419417|537864585|FG001|Overall Study|Adverse event unrelated to study drug|0|||
149104865|NCT02419417|537864586|FG002|Overall Study|Adverse event unrelated to study drug|0|||
149104866|NCT02419417|537864587|FG003|Overall Study|Adverse event unrelated to study drug|0|||
149104867|NCT02419417|537864588|FG004|Overall Study|Adverse event unrelated to study drug|2|||
149104868|NCT02419417|537864589|FG005|Overall Study|Adverse event unrelated to study drug|1|||
149104869|NCT02419417|537864590|FG006|Overall Study|Adverse event unrelated to study drug|0|||
149104870|NCT02419417|537864591|FG007|Overall Study|Adverse event unrelated to study drug|1|||
149104871|NCT02419417|537864592|FG008|Overall Study|Adverse event unrelated to study drug|0|||
149104872|NCT02419417|537864593|FG009|Overall Study|Adverse event unrelated to study drug|0|||
149104873|NCT02419417|537864594|FG010|Overall Study|Adverse event unrelated to study drug|0|||
149104874|NCT02419417|537864584|FG000|Overall Study|Participant request to discontinue|0|||
149104875|NCT02419417|537864585|FG001|Overall Study|Participant request to discontinue|0|||
149104876|NCT02419417|537864586|FG002|Overall Study|Participant request to discontinue|0|||
149104877|NCT02419417|537864587|FG003|Overall Study|Participant request to discontinue|0|||
149104878|NCT02419417|537864588|FG004|Overall Study|Participant request to discontinue|0|||
149104879|NCT02419417|537864589|FG005|Overall Study|Participant request to discontinue|0|||
149104880|NCT02419417|537864590|FG006|Overall Study|Participant request to discontinue|0|||
149104881|NCT02419417|537864591|FG007|Overall Study|Participant request to discontinue|0|||
149104882|NCT02419417|537864592|FG008|Overall Study|Participant request to discontinue|0|||
149104883|NCT02419417|537864593|FG009|Overall Study|Participant request to discontinue|1|||
149104884|NCT02419417|537864594|FG010|Overall Study|Participant request to discontinue|0|||
149104885|NCT02419417|537864584|FG000|Overall Study|Withdrawal by Subject|0|||
149104886|NCT02419417|537864585|FG001|Overall Study|Withdrawal by Subject|0|||
149104887|NCT02419417|537864586|FG002|Overall Study|Withdrawal by Subject|0|||
149104888|NCT02419417|537864587|FG003|Overall Study|Withdrawal by Subject|0|||
149104889|NCT02419417|537864588|FG004|Overall Study|Withdrawal by Subject|0|||
149104890|NCT02419417|537864589|FG005|Overall Study|Withdrawal by Subject|0|||
149104891|NCT02419417|537864590|FG006|Overall Study|Withdrawal by Subject|0|||
149104892|NCT02419417|537864591|FG007|Overall Study|Withdrawal by Subject|0|||
149104893|NCT02419417|537864592|FG008|Overall Study|Withdrawal by Subject|0|||
149104894|NCT02419417|537864593|FG009|Overall Study|Withdrawal by Subject|0|||
149104895|NCT02419417|537864594|FG010|Overall Study|Withdrawal by Subject|1|||
149104896|NCT01240551|537864595|FG000|Overall Study|Refused further treatment|3|||
149104897|NCT01240551|537864596|FG001|Overall Study|Refused further treatment|2|||
149104898|NCT01240551|537864595|FG000|Overall Study|Lost to Follow-up|1|||
149104899|NCT01240551|537864596|FG001|Overall Study|Lost to Follow-up|1|||
149104900|NCT02737826|537864602|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
149104901|NCT02737826|537864603|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
149104902|NCT02737826|537864604|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
149104903|NCT00078377|537864605|FG000|Overall Study|Adverse Event|2|||
149104904|NCT00078377|537864606|FG001|Overall Study|Adverse Event|5|||
149104905|NCT00078377|537864607|FG002|Overall Study|Adverse Event|1|||
149104906|NCT00078377|537864605|FG000|Overall Study|Lack of Efficacy|2|||
149104907|NCT00078377|537864606|FG001|Overall Study|Lack of Efficacy|0|||
149104908|NCT00078377|537864607|FG002|Overall Study|Lack of Efficacy|2|||
149104909|NCT00078377|537864605|FG000|Overall Study|Lost to Follow-up|0|||
149104910|NCT00078377|537864606|FG001|Overall Study|Lost to Follow-up|1|||
149104911|NCT00078377|537864607|FG002|Overall Study|Lost to Follow-up|1|||
149104912|NCT00078377|537864605|FG000|Overall Study|Physician Decision|2|||
149104913|NCT00078377|537864606|FG001|Overall Study|Physician Decision|0|||
149104914|NCT00078377|537864607|FG002|Overall Study|Physician Decision|0|||
149104915|NCT00078377|537864605|FG000|Overall Study|Withdrawal by Subject|3|||
149104916|NCT00078377|537864606|FG001|Overall Study|Withdrawal by Subject|4|||
149104917|NCT00078377|537864607|FG002|Overall Study|Withdrawal by Subject|4|||
149104918|NCT00078377|537864605|FG000|Overall Study|Miscellaneous|2|||
149104919|NCT00078377|537864606|FG001|Overall Study|Miscellaneous|6|||
149104920|NCT00078377|537864607|FG002|Overall Study|Miscellaneous|1|||
149104921|NCT01317875|537864608|FG000|Overall Study|Other|0|||
149104922|NCT01317875|537864609|FG001|Overall Study|Other|0|||
149104923|NCT01317875|537864610|FG002|Overall Study|Other|1|||
149104924|NCT01317875|537864611|FG003|Overall Study|Other|0|||
149104925|NCT01317875|537864612|FG004|Overall Study|Other|0|||
149104926|NCT01317875|537864613|FG005|Overall Study|Other|0|||
149104927|NCT01317875|537864614|FG006|Overall Study|Other|0|||
149104928|NCT01317875|537864615|FG007|Overall Study|Other|0|||
149104929|NCT01317875|537864616|FG008|Overall Study|Other|0|||
149104930|NCT01317875|537864617|FG009|Overall Study|Other|0|||
149104931|NCT01317875|537864608|FG000|Overall Study|Noncompliance with study drug|0|||
149104932|NCT01317875|537864609|FG001|Overall Study|Noncompliance with study drug|0|||
149104933|NCT01317875|537864610|FG002|Overall Study|Noncompliance with study drug|1|||
149104934|NCT01317875|537864611|FG003|Overall Study|Noncompliance with study drug|0|||
149104935|NCT01317875|537864612|FG004|Overall Study|Noncompliance with study drug|0|||
149104936|NCT01317875|537864613|FG005|Overall Study|Noncompliance with study drug|0|||
149104937|NCT01317875|537864614|FG006|Overall Study|Noncompliance with study drug|0|||
149104938|NCT01317875|537864615|FG007|Overall Study|Noncompliance with study drug|0|||
149104939|NCT01317875|537864616|FG008|Overall Study|Noncompliance with study drug|0|||
149104940|NCT01317875|537864617|FG009|Overall Study|Noncompliance with study drug|0|||
149104941|NCT01317875|537864608|FG000|Overall Study|Progressive Disease|1|||
149104942|NCT01317875|537864609|FG001|Overall Study|Progressive Disease|0|||
149104943|NCT01317875|537864610|FG002|Overall Study|Progressive Disease|2|||
149104944|NCT01317875|537864611|FG003|Overall Study|Progressive Disease|0|||
149104945|NCT01317875|537864612|FG004|Overall Study|Progressive Disease|1|||
149104946|NCT01317875|537864613|FG005|Overall Study|Progressive Disease|0|||
149104947|NCT01317875|537864614|FG006|Overall Study|Progressive Disease|0|||
149104948|NCT01317875|537864615|FG007|Overall Study|Progressive Disease|1|||
149104949|NCT01317875|537864616|FG008|Overall Study|Progressive Disease|0|||
149104950|NCT01317875|537864617|FG009|Overall Study|Progressive Disease|0|||
149104951|NCT01317875|537864608|FG000|Overall Study|Withdrawal by Subject|0|||
149104952|NCT01317875|537864609|FG001|Overall Study|Withdrawal by Subject|0|||
149104953|NCT01317875|537864610|FG002|Overall Study|Withdrawal by Subject|0|||
149104954|NCT01317875|537864611|FG003|Overall Study|Withdrawal by Subject|0|||
149104955|NCT01317875|537864612|FG004|Overall Study|Withdrawal by Subject|1|||
149104956|NCT01317875|537864613|FG005|Overall Study|Withdrawal by Subject|0|||
149104957|NCT01317875|537864614|FG006|Overall Study|Withdrawal by Subject|0|||
149104958|NCT01317875|537864615|FG007|Overall Study|Withdrawal by Subject|3|||
149104959|NCT01317875|537864616|FG008|Overall Study|Withdrawal by Subject|0|||
149104960|NCT01317875|537864617|FG009|Overall Study|Withdrawal by Subject|0|||
149104961|NCT01317875|537864608|FG000|Overall Study|Physician Decision|0|||
149104962|NCT01317875|537864609|FG001|Overall Study|Physician Decision|1|||
149104963|NCT01317875|537864610|FG002|Overall Study|Physician Decision|1|||
149104964|NCT01317875|537864611|FG003|Overall Study|Physician Decision|0|||
149104965|NCT01317875|537864612|FG004|Overall Study|Physician Decision|2|||
149104966|NCT01317875|537864613|FG005|Overall Study|Physician Decision|0|||
149104967|NCT01317875|537864614|FG006|Overall Study|Physician Decision|0|||
149104968|NCT01317875|537864615|FG007|Overall Study|Physician Decision|2|||
149104969|NCT01317875|537864616|FG008|Overall Study|Physician Decision|0|||
149104970|NCT01317875|537864617|FG009|Overall Study|Physician Decision|0|||
149104971|NCT01317875|537864608|FG000|Overall Study|Death|0|||
149104972|NCT01317875|537864609|FG001|Overall Study|Death|0|||
149104973|NCT01317875|537864610|FG002|Overall Study|Death|2|||
149104974|NCT01317875|537864611|FG003|Overall Study|Death|1|||
149104975|NCT01317875|537864612|FG004|Overall Study|Death|0|||
149104976|NCT01317875|537864613|FG005|Overall Study|Death|1|||
149104977|NCT01317875|537864614|FG006|Overall Study|Death|0|||
149104978|NCT01317875|537864615|FG007|Overall Study|Death|4|||
149104979|NCT01317875|537864616|FG008|Overall Study|Death|0|||
149104980|NCT01317875|537864617|FG009|Overall Study|Death|0|||
149104981|NCT01317875|537864608|FG000|Overall Study|Adverse Event|2|||
149104982|NCT01317875|537864609|FG001|Overall Study|Adverse Event|1|||
149104983|NCT01317875|537864610|FG002|Overall Study|Adverse Event|2|||
149104984|NCT01317875|537864611|FG003|Overall Study|Adverse Event|1|||
149104985|NCT01317875|537864612|FG004|Overall Study|Adverse Event|5|||
149104986|NCT01317875|537864613|FG005|Overall Study|Adverse Event|1|||
149104987|NCT01317875|537864614|FG006|Overall Study|Adverse Event|2|||
149104988|NCT01317875|537864615|FG007|Overall Study|Adverse Event|5|||
149104989|NCT01317875|537864616|FG008|Overall Study|Adverse Event|0|||
149104990|NCT01317875|537864617|FG009|Overall Study|Adverse Event|0|||
149104991|NCT01381575|537864618|FG000|Overall Study|Serious Adverse Event|1|||
149104992|NCT01381575|537864619|FG001|Overall Study|Serious Adverse Event|0|||
149104993|NCT01381575|537864620|FG002|Overall Study|Serious Adverse Event|0|||
149104994|NCT01381575|537864618|FG000|Overall Study|Non-Serious Adverse Event|0|||
149104995|NCT01381575|537864619|FG001|Overall Study|Non-Serious Adverse Event|0|||
149104996|NCT01381575|537864620|FG002|Overall Study|Non-Serious Adverse Event|1|||
149104997|NCT01381575|537864618|FG000|Overall Study|Protocol Violation|0|||
149104998|NCT01381575|537864619|FG001|Overall Study|Protocol Violation|1|||
149104999|NCT01381575|537864620|FG002|Overall Study|Protocol Violation|1|||
149105000|NCT01381575|537864618|FG000|Overall Study|Withdrawal by Subject|15|||
149105001|NCT01381575|537864619|FG001|Overall Study|Withdrawal by Subject|9|||
149105002|NCT01381575|537864620|FG002|Overall Study|Withdrawal by Subject|7|||
149105003|NCT01381575|537864618|FG000|Overall Study|Migrated/moved from study area|2|||
149105004|NCT01381575|537864619|FG001|Overall Study|Migrated/moved from study area|12|||
149105005|NCT01381575|537864620|FG002|Overall Study|Migrated/moved from study area|2|||
149105006|NCT01381575|537864618|FG000|Overall Study|Lost to Follow-up|8|||
149105007|NCT01381575|537864619|FG001|Overall Study|Lost to Follow-up|17|||
149105008|NCT01381575|537864620|FG002|Overall Study|Lost to Follow-up|9|||
149105009|NCT01200342|537864627|FG000|Overall Study|Disease Progression|1|||
149105010|NCT04546217|537864630|FG000|Overall Study|Withdrawal by Subject|2|||
149105011|NCT04546217|537864631|FG001|Overall Study|Withdrawal by Subject|0|||
149105012|NCT04546217|537864630|FG000|Overall Study|Uncontrolled hypertension|1|||
149105013|NCT04546217|537864631|FG001|Overall Study|Uncontrolled hypertension|0|||
149105014|NCT02550938|537864632|FG000|Overall Study|Lost to Follow-up|8|||
149105015|NCT02550938|537864633|FG001|Overall Study|Lost to Follow-up|7|||
149105016|NCT02550938|537864634|FG002|Overall Study|Lost to Follow-up|12|||
149105017|NCT02550938|537864635|FG003|Overall Study|Lost to Follow-up|11|||
149105018|NCT01367847|537864636|FG000|Overall Study|Withdrawal by Subject|2|||
149105019|NCT01367847|537864637|FG001|Overall Study|Withdrawal by Subject|2|||
149105020|NCT01439867|537864640|FG000|Overall Study|Non-compliance|0|||
149105021|NCT01439867|537864641|FG001|Overall Study|Non-compliance|1|||
149105022|NCT01439867|537864640|FG000|Overall Study|Withdrawal by Subject|1|||
149105023|NCT01439867|537864641|FG001|Overall Study|Withdrawal by Subject|2|||
149105024|NCT01439867|537864640|FG000|Overall Study|Administrative Decision|4|||
149105025|NCT01439867|537864641|FG001|Overall Study|Administrative Decision|5|||
149105026|NCT01439867|537864640|FG000|Overall Study|Protocol-specified Criteria|1|||
149105027|NCT01439867|537864641|FG001|Overall Study|Protocol-specified Criteria|0|||
149105028|NCT00863512|537864642|FG000|Overall Study|Adverse Event|2|||
149105029|NCT00863512|537864643|FG001|Overall Study|Adverse Event|0|||
149105030|NCT00863512|537864642|FG000|Overall Study|Withdrawal by Subject|11|||
149105031|NCT00863512|537864643|FG001|Overall Study|Withdrawal by Subject|0|||
149105032|NCT00863512|537864642|FG000|Overall Study|Physician Decision|1|||
149105033|NCT00863512|537864643|FG001|Overall Study|Physician Decision|0|||
149105034|NCT00983749|537864650|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
149105035|NCT00983749|537864651|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
149105036|NCT01375673|537864674|FG000|Overall Study|Withdrawal by Subject|0|||
149105037|NCT01375673|537864675|FG001|Overall Study|Withdrawal by Subject|1|||
149105038|NCT00979953|537864676|FG000|Overall Study|Adverse Event|5|||
149105039|NCT00979953|537864677|FG001|Overall Study|Adverse Event|2|||
149105040|NCT00979953|537864678|FG002|Overall Study|Adverse Event|17|||
149105041|NCT00979953|537864679|FG003|Overall Study|Adverse Event|4|||
149105042|NCT00979953|537864676|FG000|Overall Study|Lack of Efficacy|1|||
149105043|NCT00979953|537864677|FG001|Overall Study|Lack of Efficacy|2|||
149105044|NCT00979953|537864678|FG002|Overall Study|Lack of Efficacy|0|||
149105045|NCT00979953|537864679|FG003|Overall Study|Lack of Efficacy|0|||
149105046|NCT00979953|537864676|FG000|Overall Study|Lost to Follow-up|1|||
149105047|NCT00979953|537864677|FG001|Overall Study|Lost to Follow-up|1|||
149105048|NCT00979953|537864678|FG002|Overall Study|Lost to Follow-up|1|||
149105049|NCT00979953|537864679|FG003|Overall Study|Lost to Follow-up|0|||
149105050|NCT00979953|537864676|FG000|Overall Study|Withdrawal by Subject|0|||
149105051|NCT00979953|537864677|FG001|Overall Study|Withdrawal by Subject|0|||
149105052|NCT00979953|537864678|FG002|Overall Study|Withdrawal by Subject|2|||
149105053|NCT00979953|537864679|FG003|Overall Study|Withdrawal by Subject|1|||
149105054|NCT00979953|537864676|FG000|Overall Study|Protocol Violation|1|||
149105055|NCT00979953|537864677|FG001|Overall Study|Protocol Violation|0|||
149105056|NCT00979953|537864678|FG002|Overall Study|Protocol Violation|2|||
149105057|NCT00979953|537864679|FG003|Overall Study|Protocol Violation|2|||
149105058|NCT01124097|537864680|FG000|Overall Study|Withdrawal by Subject|4|||
149105059|NCT01124097|537864681|FG001|Overall Study|Withdrawal by Subject|3|||
149105060|NCT01124097|537864682|FG002|Overall Study|Withdrawal by Subject|2|||
149105061|NCT01124097|537864683|FG003|Overall Study|Withdrawal by Subject|3|||
149105062|NCT01124097|537864680|FG000|Overall Study|Lack of Efficacy|2|||
149105063|NCT01124097|537864681|FG001|Overall Study|Lack of Efficacy|3|||
149105064|NCT01124097|537864682|FG002|Overall Study|Lack of Efficacy|1|||
149105065|NCT01124097|537864683|FG003|Overall Study|Lack of Efficacy|3|||
149105066|NCT01124097|537864680|FG000|Overall Study|Adverse Event|24|||
149105067|NCT01124097|537864681|FG001|Overall Study|Adverse Event|15|||
149105068|NCT01124097|537864682|FG002|Overall Study|Adverse Event|15|||
149105069|NCT01124097|537864683|FG003|Overall Study|Adverse Event|7|||
149105070|NCT01124097|537864680|FG000|Overall Study|Protocol Violation|2|||
149105071|NCT01124097|537864681|FG001|Overall Study|Protocol Violation|0|||
149105072|NCT01124097|537864682|FG002|Overall Study|Protocol Violation|2|||
149105073|NCT01124097|537864683|FG003|Overall Study|Protocol Violation|1|||
149105074|NCT01124097|537864680|FG000|Overall Study|Physician Decision|2|||
149105075|NCT01124097|537864681|FG001|Overall Study|Physician Decision|1|||
149105076|NCT01124097|537864682|FG002|Overall Study|Physician Decision|0|||
149105077|NCT01124097|537864683|FG003|Overall Study|Physician Decision|0|||
149105078|NCT04829747|537864689|FG000|Overall Study|Protocol Violation|1|||
149105079|NCT00425607|537864697|FG000|Overall Study|Death|1|||
149105080|NCT00425607|537864697|FG000|Overall Study|Withdrawal by Subject|1|||
149105081|NCT00079339|537864698|FG000|Overall Study|Adverse Event|1|||
149105082|NCT00079339|537864699|FG001|Overall Study|Adverse Event|7|||
149105083|NCT00079339|537864700|FG002|Overall Study|Adverse Event|2|||
149105084|NCT00079339|537864698|FG000|Overall Study|Death|1|||
149105085|NCT00079339|537864699|FG001|Overall Study|Death|0|||
149105086|NCT00079339|537864700|FG002|Overall Study|Death|0|||
149105087|NCT00079339|537864698|FG000|Overall Study|Non-compliance|0|||
149105088|NCT00079339|537864699|FG001|Overall Study|Non-compliance|0|||
149105089|NCT00079339|537864700|FG002|Overall Study|Non-compliance|1|||
149105090|NCT00079339|537864698|FG000|Overall Study|Withdrawal by Subject|0|||
149105091|NCT00079339|537864699|FG001|Overall Study|Withdrawal by Subject|4|||
149105092|NCT00079339|537864700|FG002|Overall Study|Withdrawal by Subject|1|||
149105093|NCT00079339|537864698|FG000|Overall Study|Disease progression|3|||
149105094|NCT00079339|537864699|FG001|Overall Study|Disease progression|28|||
149105095|NCT00079339|537864700|FG002|Overall Study|Disease progression|2|||
149105096|NCT02563548|537864701|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
149105097|NCT02563548|537864702|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
149105098|NCT02563548|537864703|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
149105099|NCT02563548|537864704|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
149105100|NCT02563548|537864705|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
149105101|NCT02563548|537864706|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
149105102|NCT02563548|537864701|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
149105103|NCT02563548|537864702|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
149105104|NCT02563548|537864703|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
149105105|NCT02563548|537864704|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
149105106|NCT02563548|537864705|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
149105107|NCT02563548|537864706|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
149105108|NCT02563548|537864701|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
149105109|NCT02563548|537864702|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
149105110|NCT02563548|537864703|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
149105111|NCT02563548|537864704|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
149105112|NCT02563548|537864705|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
149105113|NCT02563548|537864706|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
149105114|NCT02563548|537864701|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
149105115|NCT02563548|537864702|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
149105116|NCT02563548|537864703|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
149105117|NCT02563548|537864704|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
149105118|NCT02563548|537864705|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
149105119|NCT02563548|537864706|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
149105120|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
149105121|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
149105122|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
149105123|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
149105124|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
149105125|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
149105126|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
149105127|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
149105128|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
149105129|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
149105130|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
149105131|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
149105132|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
149105133|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
149105134|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
149105135|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
149105136|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
149105137|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
149105138|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
149105139|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
149105140|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
149105141|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
149105142|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
149105143|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
149105144|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
149105145|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
149105146|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
149105147|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
149105148|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
149105149|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
149105150|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
149105151|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
149105152|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
149105153|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
149105154|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
149105155|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
149105156|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
149105157|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
149105158|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
149105159|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
149105160|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
149105161|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
149105162|NCT02563548|537864701|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
149105163|NCT02563548|537864702|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
149105164|NCT02563548|537864703|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
149105165|NCT02563548|537864704|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
149105166|NCT02563548|537864705|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
149105167|NCT02563548|537864706|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
149105168|NCT00203047|537864707|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
149105169|NCT00203047|537864708|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
149105170|NCT00203047|537864707|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
149105171|NCT00203047|537864708|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
149105172|NCT00203047|537864707|FG000|Overall Study|Withdrawal by Subject|13|||
149105173|NCT00203047|537864708|FG001|Overall Study|Withdrawal by Subject|47|||
149105174|NCT00203047|537864707|FG000|Overall Study|Teva requested participant withdrawal|1|||
149105175|NCT00203047|537864708|FG001|Overall Study|Teva requested participant withdrawal|1|||
149105176|NCT00203047|537864707|FG000|Overall Study|Physician Decision|8|||
149105177|NCT00203047|537864708|FG001|Overall Study|Physician Decision|7|||
149105178|NCT00203047|537864707|FG000|Overall Study|Non-compliance|4|||
149105179|NCT00203047|537864708|FG001|Overall Study|Non-compliance|8|||
149105180|NCT00203047|537864707|FG000|Overall Study|Protocol Violation|1|||
149105181|NCT00203047|537864708|FG001|Overall Study|Protocol Violation|0|||
149105182|NCT00203047|537864707|FG000|Overall Study|Lost to Follow-up|11|||
149105183|NCT00203047|537864708|FG001|Overall Study|Lost to Follow-up|5|||
149105184|NCT00203047|537864707|FG000|Overall Study|Adverse Event|8|||
149105185|NCT00203047|537864708|FG001|Overall Study|Adverse Event|18|||
149105186|NCT00203047|537864707|FG000|Overall Study|Death|1|||
149105187|NCT00203047|537864708|FG001|Overall Study|Death|2|||
149105188|NCT00203047|537864707|FG000|Overall Study|Pregnancy|3|||
149105189|NCT00203047|537864708|FG001|Overall Study|Pregnancy|0|||
149105190|NCT00203047|537864707|FG000|Overall Study|Other|5|||
149105191|NCT00203047|537864708|FG001|Overall Study|Other|5|||
149105192|NCT00121667|537864709|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
149105193|NCT00121667|537864710|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
149105194|NCT00121667|537864711|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
149105195|NCT00121667|537864712|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
149105196|NCT00121667|537864709|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
149105197|NCT00121667|537864710|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
149105198|NCT00121667|537864711|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
149105199|NCT00121667|537864712|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
149105200|NCT00121667|537864709|FG000|Short Term (ST) Period|Adverse Event|5|||
149105201|NCT00121667|537864710|FG001|Short Term (ST) Period|Adverse Event|6|||
149105202|NCT00121667|537864711|FG002|Short Term (ST) Period|Adverse Event|5|||
149105203|NCT00121667|537864712|FG003|Short Term (ST) Period|Adverse Event|3|||
149105204|NCT00121667|537864709|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
149105205|NCT00121667|537864710|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
149105206|NCT00121667|537864711|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
149105207|NCT00121667|537864712|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
149105208|NCT00121667|537864709|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
149105209|NCT00121667|537864710|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
149105210|NCT00121667|537864711|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
149105211|NCT00121667|537864712|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
149105212|NCT00121667|537864709|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
149105213|NCT00121667|537864710|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
149105214|NCT00121667|537864711|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
149105215|NCT00121667|537864712|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
149105216|NCT00121667|537864709|FG000|Short Term (ST) Period|Other Reason|3|||
149105217|NCT00121667|537864710|FG001|Short Term (ST) Period|Other Reason|0|||
149105218|NCT00121667|537864711|FG002|Short Term (ST) Period|Other Reason|0|||
149105219|NCT00121667|537864712|FG003|Short Term (ST) Period|Other Reason|0|||
149105220|NCT00121667|537864709|FG000|Short Term (ST) Period|Death|0|||
149105221|NCT00121667|537864710|FG001|Short Term (ST) Period|Death|0|||
149105222|NCT00121667|537864711|FG002|Short Term (ST) Period|Death|0|||
149105223|NCT00121667|537864712|FG003|Short Term (ST) Period|Death|1|||
149105224|NCT00121667|537864709|FG000|Short Term (ST) Period|Pregnancy|0|||
149105225|NCT00121667|537864710|FG001|Short Term (ST) Period|Pregnancy|0|||
149105226|NCT00121667|537864711|FG002|Short Term (ST) Period|Pregnancy|0|||
149105227|NCT00121667|537864712|FG003|Short Term (ST) Period|Pregnancy|1|||
149105228|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
149105229|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
149105230|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
149105231|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
149105232|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
149105233|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
149105234|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
149105235|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
149105236|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
149105237|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
149105238|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
149105239|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
149105240|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
149105241|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
149105242|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
149105243|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
149105244|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
149105245|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
149105246|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
149105247|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
149105248|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
149105249|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
149105250|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
149105251|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
149105252|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
149105253|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
149105254|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
149105255|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
149105256|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
149105257|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
149105258|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
149105259|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
149105260|NCT00121667|537864709|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
149105261|NCT00121667|537864710|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
149105262|NCT00121667|537864711|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
149105263|NCT00121667|537864712|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
149105264|NCT05186311|537864713|FG000|Part A: Serum|Withdrawal by Subject|1|||
149105265|NCT00723125|537864731|FG000|Overall Study|Met Dx|1|||
149105266|NCT00723125|537864732|FG001|Overall Study|Met Dx|0|||
149105267|NCT00723125|537864731|FG000|Overall Study|Withdrawal by Subject|15|||
149105268|NCT00723125|537864732|FG001|Overall Study|Withdrawal by Subject|6|||
149105269|NCT00723125|537864731|FG000|Overall Study|Adverse Event|2|||
149105270|NCT00723125|537864732|FG001|Overall Study|Adverse Event|0|||
149105271|NCT02781311|537864741|FG000|Overall Study|Adverse Event|2|||
149105272|NCT02781311|537864742|FG001|Overall Study|Adverse Event|6|||
149105273|NCT02781311|537864743|FG002|Overall Study|Adverse Event|1|||
149105274|NCT02781311|537864741|FG000|Overall Study|Withdrawal of Consent|11|||
149105275|NCT02781311|537864742|FG001|Overall Study|Withdrawal of Consent|12|||
149105276|NCT02781311|537864743|FG002|Overall Study|Withdrawal of Consent|2|||
149105277|NCT02781311|537864741|FG000|Overall Study|Lost to Follow-up|11|||
149105278|NCT02781311|537864742|FG001|Overall Study|Lost to Follow-up|8|||
149105279|NCT02781311|537864743|FG002|Overall Study|Lost to Follow-up|1|||
149105280|NCT02781311|537864741|FG000|Overall Study|Non-Compliance with Study Drug|2|||
149105281|NCT02781311|537864742|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149105282|NCT02781311|537864743|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149105283|NCT04547023|537864752|FG000|Overall Study|Did Not Receive Intervention|3|||
149105284|NCT04547023|537864753|FG001|Overall Study|Did Not Receive Intervention|2|||
149105285|NCT04547023|537864752|FG000|Overall Study|Lost to Follow-up|1|||
149105286|NCT04547023|537864753|FG001|Overall Study|Lost to Follow-up|1|||
149105287|NCT00250432|537864754|FG000|Overall Study|Adverse Event|25|||
149105288|NCT00250432|537864755|FG001|Overall Study|Adverse Event|29|||
149105289|NCT00250432|537864754|FG000|Overall Study|Lack of Efficacy|2|||
149105290|NCT00250432|537864755|FG001|Overall Study|Lack of Efficacy|1|||
149105291|NCT00250432|537864754|FG000|Overall Study|Lost to Follow-up|6|||
149105292|NCT00250432|537864755|FG001|Overall Study|Lost to Follow-up|5|||
149105293|NCT00250432|537864754|FG000|Overall Study|Patient Moved|0|||
149105294|NCT00250432|537864755|FG001|Overall Study|Patient Moved|1|||
149105295|NCT00250432|537864754|FG000|Overall Study|Protocol Violation|0|||
149105296|NCT00250432|537864755|FG001|Overall Study|Protocol Violation|3|||
149105297|NCT00250432|537864754|FG000|Overall Study|Withdrawal by Subject|6|||
149105298|NCT00250432|537864755|FG001|Overall Study|Withdrawal by Subject|2|||
149105299|NCT00250432|537864754|FG000|Overall Study|Pt died out of posttherapy report period|6|||
149105300|NCT00250432|537864755|FG001|Overall Study|Pt died out of posttherapy report period|5|||
149105301|NCT00250432|537864754|FG000|Overall Study|Pt was considered untreatable|0|||
149105302|NCT00250432|537864755|FG001|Overall Study|Pt was considered untreatable|1|||
149105303|NCT01011868|537864756|FG000|After Week 18 Follow-up|Adverse Event|8|||
149105304|NCT01011868|537864757|FG001|After Week 18 Follow-up|Adverse Event|6|||
149105305|NCT01011868|537864758|FG002|After Week 18 Follow-up|Adverse Event|13|||
149105306|NCT01011868|537864756|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
149105307|NCT01011868|537864757|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
149105308|NCT01011868|537864758|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
149105309|NCT01011868|537864756|FG000|After Week 18 Follow-up|Protocol Violation|1|||
149105310|NCT01011868|537864757|FG001|After Week 18 Follow-up|Protocol Violation|1|||
149105311|NCT01011868|537864758|FG002|After Week 18 Follow-up|Protocol Violation|1|||
149105312|NCT01011868|537864756|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
149105313|NCT01011868|537864757|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
149105314|NCT01011868|537864758|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
149105315|NCT01011868|537864756|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
149105316|NCT01011868|537864757|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
149105317|NCT01011868|537864758|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
149105318|NCT01011868|537864756|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
149105319|NCT01011868|537864757|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
149105320|NCT01011868|537864758|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
149105321|NCT01011868|537864756|FG000|After Week 78 Follow-up|Adverse Event|14|||
149105322|NCT01011868|537864757|FG001|After Week 78 Follow-up|Adverse Event|18|||
149105323|NCT01011868|537864758|FG002|After Week 78 Follow-up|Adverse Event|21|||
149105324|NCT01011868|537864756|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
149105325|NCT01011868|537864757|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
149105326|NCT01011868|537864758|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
149105327|NCT01011868|537864756|FG000|After Week 78 Follow-up|Protocol Violation|9|||
149105328|NCT01011868|537864757|FG001|After Week 78 Follow-up|Protocol Violation|1|||
149105329|NCT01011868|537864758|FG002|After Week 78 Follow-up|Protocol Violation|2|||
149105330|NCT01011868|537864756|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
149105331|NCT01011868|537864757|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
149105332|NCT01011868|537864758|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
149105333|NCT01011868|537864756|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
149105334|NCT01011868|537864757|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
149105335|NCT01011868|537864758|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
149105336|NCT01011868|537864756|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
149105337|NCT01011868|537864757|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
149105338|NCT01011868|537864758|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
149105339|NCT01262092|537864759|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
149105340|NCT01262092|537864760|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
149105341|NCT01262092|537864759|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
149105342|NCT01262092|537864760|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
149105343|NCT01262092|537864759|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
149105344|NCT01262092|537864760|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
149105345|NCT01262092|537864759|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
149105346|NCT01262092|537864760|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
149105347|NCT03784820|537864761|FG000|Overall Study|Lost to Follow-up|5|||
149105348|NCT03784820|537864762|FG001|Overall Study|Lost to Follow-up|5|||
149105349|NCT03784820|537864763|FG002|Overall Study|Lost to Follow-up|3|||
149105350|NCT03784820|537864764|FG003|Overall Study|Lost to Follow-up|3|||
149105351|NCT01255761|537864765|FG000|Overall Study|Adverse Event|29|||
149105352|NCT01255761|537864766|FG001|Overall Study|Adverse Event|43|||
149105353|NCT01255761|537864765|FG000|Overall Study|Lack of Efficacy|86|||
149105354|NCT01255761|537864766|FG001|Overall Study|Lack of Efficacy|74|||
149105355|NCT01255761|537864765|FG000|Overall Study|Protocol Violation|9|||
149105356|NCT01255761|537864766|FG001|Overall Study|Protocol Violation|5|||
149105357|NCT01255761|537864765|FG000|Overall Study|Lost to Follow-up|10|||
149105358|NCT01255761|537864766|FG001|Overall Study|Lost to Follow-up|8|||
149105359|NCT01255761|537864765|FG000|Overall Study|Withdrawal by Subject|11|||
149105360|NCT01255761|537864766|FG001|Overall Study|Withdrawal by Subject|27|||
149105361|NCT01255761|537864765|FG000|Overall Study|Other Reasons|37|||
149105362|NCT01255761|537864766|FG001|Overall Study|Other Reasons|18|||
149105363|NCT04147858|537864767|FG000|Overall Study|Adverse Event|6|||
149105364|NCT04147858|537864768|FG001|Overall Study|Adverse Event|6|||
149105365|NCT04147858|537864769|FG002|Overall Study|Adverse Event|6|||
149105366|NCT04147858|537864767|FG000|Overall Study|Lack of Efficacy|3|||
149105367|NCT04147858|537864768|FG001|Overall Study|Lack of Efficacy|3|||
149105368|NCT04147858|537864769|FG002|Overall Study|Lack of Efficacy|1|||
149105369|NCT04147858|537864767|FG000|Overall Study|Lost to Follow-up|1|||
149105370|NCT04147858|537864768|FG001|Overall Study|Lost to Follow-up|6|||
149105371|NCT04147858|537864769|FG002|Overall Study|Lost to Follow-up|2|||
149105372|NCT04147858|537864767|FG000|Overall Study|Withdrawal by Subject|3|||
149105373|NCT04147858|537864768|FG001|Overall Study|Withdrawal by Subject|4|||
149105374|NCT04147858|537864769|FG002|Overall Study|Withdrawal by Subject|10|||
149105375|NCT04147858|537864767|FG000|Overall Study|Subject Noncompliance, Other|4|||
149105376|NCT04147858|537864768|FG001|Overall Study|Subject Noncompliance, Other|3|||
149105377|NCT04147858|537864769|FG002|Overall Study|Subject Noncompliance, Other|1|||
149105378|NCT02336425|537864770|FG000|Overall Study|Study terminated.|2|||
149105379|NCT02336425|537864771|FG001|Overall Study|Study terminated.|2|||
149105380|NCT02336425|537864772|FG002|Overall Study|Study terminated.|3|||
149105381|NCT02336425|537864773|FG003|Overall Study|Study terminated.|3|||
149105382|NCT00658606|537864776|FG000|Overall Study|Adverse Event|2|||
149105383|NCT00658606|537864777|FG001|Overall Study|Adverse Event|1|||
149105384|NCT00658606|537864776|FG000|Overall Study|Lack of Efficacy|6|||
149105385|NCT00658606|537864777|FG001|Overall Study|Lack of Efficacy|3|||
149105386|NCT00658606|537864776|FG000|Overall Study|Lost to Follow-up|1|||
149105387|NCT00658606|537864777|FG001|Overall Study|Lost to Follow-up|0|||
149105388|NCT00658606|537864776|FG000|Overall Study|Withdrawal by Subject|7|||
149105389|NCT00658606|537864777|FG001|Overall Study|Withdrawal by Subject|16|||
149105390|NCT00658606|537864776|FG000|Overall Study|Lack of Compliance|0|||
149105391|NCT00658606|537864777|FG001|Overall Study|Lack of Compliance|3|||
149105392|NCT04905849|537864778|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
149105393|NCT04905849|537864779|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
149105394|NCT01056263|537864786|FG000|Overall Study|Adverse Event|12|||
149105395|NCT01056263|537864786|FG000|Overall Study|Death|1|||
149105396|NCT01056263|537864786|FG000|Overall Study|Withdrawal by Subject|1|||
149105397|NCT01056263|537864786|FG000|Overall Study|Lack of Efficacy|29|||
149105398|NCT01056263|537864786|FG000|Overall Study|Progressive disease|2|||
149105399|NCT01056263|537864786|FG000|Overall Study|Neoplasm progression|1|||
149105400|NCT01056263|537864786|FG000|Overall Study|Objective progression or relapse|1|||
149105401|NCT01056263|537864786|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
149105402|NCT00838929|537864790|FG000|Overall Study|Protocol Violation|0|||
149105403|NCT00838929|537864791|FG001|Overall Study|Protocol Violation|1|||
149105404|NCT00838929|537864792|FG002|Overall Study|Protocol Violation|0|||
149105405|NCT00838929|537864790|FG000|Overall Study|Disease progression|0|||
149105406|NCT00838929|537864791|FG001|Overall Study|Disease progression|2|||
149105407|NCT00838929|537864792|FG002|Overall Study|Disease progression|1|||
149105408|NCT01068210|537864797|FG000|Overall Study|Lost to Follow-up|1|||
149105409|NCT01068210|537864798|FG001|Overall Study|Lost to Follow-up|2|||
149105410|NCT01068210|537864799|FG002|Overall Study|Lost to Follow-up|2|||
149105411|NCT01068210|537864800|FG003|Overall Study|Lost to Follow-up|1|||
149105412|NCT01068210|537864797|FG000|Overall Study|Second cancer|0|||
149105413|NCT01068210|537864798|FG001|Overall Study|Second cancer|1|||
149105414|NCT01068210|537864799|FG002|Overall Study|Second cancer|0|||
149105415|NCT01068210|537864800|FG003|Overall Study|Second cancer|0|||
149105416|NCT01068210|537864797|FG000|Overall Study|Disease progression|0|||
149105417|NCT01068210|537864798|FG001|Overall Study|Disease progression|0|||
149105418|NCT01068210|537864799|FG002|Overall Study|Disease progression|0|||
149105419|NCT01068210|537864800|FG003|Overall Study|Disease progression|2|||
149105420|NCT00699842|537864801|FG000|Overall Study|Death|0|||
149105421|NCT00699842|537864802|FG001|Overall Study|Death|1|||
149105422|NCT00699842|537864803|FG002|Overall Study|Death|0|||
149105423|NCT01806389|537864806|FG000|Overall Study|Withdrawal by Subject|4|||
149105424|NCT04021043|537866434|FG000|Overall Study|Adverse Event|3|||
149105425|NCT04021043|537866435|FG001|Overall Study|Adverse Event|1|||
149105426|NCT04021043|537866436|FG002|Overall Study|Adverse Event|1|||
149105427|NCT04021043|537866437|FG003|Overall Study|Adverse Event|0|||
149105428|NCT04021043|537866434|FG000|Overall Study|Death|2|||
149105429|NCT04021043|537866435|FG001|Overall Study|Death|3|||
149105430|NCT04021043|537866436|FG002|Overall Study|Death|1|||
149105431|NCT04021043|537866437|FG003|Overall Study|Death|3|||
149105432|NCT04021043|537866434|FG000|Overall Study|Withdrawal by Subject|1|||
149105433|NCT04021043|537866435|FG001|Overall Study|Withdrawal by Subject|1|||
149105434|NCT04021043|537866436|FG002|Overall Study|Withdrawal by Subject|1|||
149105435|NCT04021043|537866437|FG003|Overall Study|Withdrawal by Subject|6|||
149105436|NCT04021043|537866434|FG000|Overall Study|Discontinued due to disease progression|4|||
149105437|NCT04021043|537866435|FG001|Overall Study|Discontinued due to disease progression|5|||
149105438|NCT04021043|537866436|FG002|Overall Study|Discontinued due to disease progression|7|||
149105439|NCT04021043|537866437|FG003|Overall Study|Discontinued due to disease progression|10|||
149105440|NCT04441905|537866438|FG000|Overall Study|Lost to Follow-up|1|||
149105441|NCT04441905|537866439|FG001|Overall Study|Lost to Follow-up|0|||
149105442|NCT04441905|537866440|FG002|Overall Study|Lost to Follow-up|0|||
149105443|NCT04441905|537866441|FG003|Overall Study|Lost to Follow-up|0|||
149105444|NCT04441905|537866442|FG004|Overall Study|Lost to Follow-up|0|||
149105445|NCT04441905|537866443|FG005|Overall Study|Lost to Follow-up|0|||
149105446|NCT04441905|537866438|FG000|Overall Study|Enrolled but treatment not administered|0|||
149105447|NCT04441905|537866439|FG001|Overall Study|Enrolled but treatment not administered|1|||
149105448|NCT04441905|537866440|FG002|Overall Study|Enrolled but treatment not administered|0|||
149105449|NCT04441905|537866441|FG003|Overall Study|Enrolled but treatment not administered|0|||
149105450|NCT04441905|537866442|FG004|Overall Study|Enrolled but treatment not administered|0|||
149105451|NCT04441905|537866443|FG005|Overall Study|Enrolled but treatment not administered|0|||
149105452|NCT04441905|537866438|FG000|Overall Study|Became ineligible after enrollment|0|||
149105453|NCT04441905|537866439|FG001|Overall Study|Became ineligible after enrollment|0|||
149105454|NCT04441905|537866440|FG002|Overall Study|Became ineligible after enrollment|0|||
149105455|NCT04441905|537866441|FG003|Overall Study|Became ineligible after enrollment|0|||
149105456|NCT04441905|537866442|FG004|Overall Study|Became ineligible after enrollment|1|||
149105457|NCT04441905|537866443|FG005|Overall Study|Became ineligible after enrollment|0|||
149105458|NCT02562235|537866444|FG000|Overall Study|Adverse Event|3|||
149105459|NCT03945773|537866445|FG000|Overall Study|Consent Withdrawn|1|||
149105460|NCT03945773|537866446|FG001|Overall Study|Consent Withdrawn|1|||
149105461|NCT03945773|537866445|FG000|Overall Study|Lost to Follow-up|1|||
149105462|NCT03945773|537866446|FG001|Overall Study|Lost to Follow-up|0|||
149105463|NCT03945773|537866445|FG000|Overall Study|Death|46|||
149105464|NCT03945773|537866446|FG001|Overall Study|Death|22|||
149105465|NCT03945773|537866445|FG000|Overall Study|Physician Decision|1|||
149105466|NCT03945773|537866446|FG001|Overall Study|Physician Decision|0|||
149105467|NCT03945773|537866445|FG000|Overall Study|Other|1|||
149105468|NCT03945773|537866446|FG001|Overall Study|Other|0|||
149105469|NCT03945773|537866445|FG000|Overall Study|Ongoing at the time of DCO|4|||
149105470|NCT03945773|537866446|FG001|Overall Study|Ongoing at the time of DCO|3|||
149105471|NCT01920932|537866447|FG000|Overall Study|Death|1|||
149105472|NCT01920932|537866447|FG000|Overall Study|Withdrawal of consent|1|||
149105473|NCT04024462|537866448|FG000|Overall Study|Withdrawal by Subject|6|||
149105474|NCT04024462|537866449|FG001|Overall Study|Withdrawal by Subject|7|||
149105475|NCT04024462|537866448|FG000|Overall Study|Progressive Disease|0|||
149105476|NCT04024462|537866449|FG001|Overall Study|Progressive Disease|1|||
149105477|NCT04024462|537866448|FG000|Overall Study|Adverse Event|0|||
149105478|NCT04024462|537866449|FG001|Overall Study|Adverse Event|1|||
149105479|NCT04024462|537866448|FG000|Overall Study|Death|0|||
149105480|NCT04024462|537866449|FG001|Overall Study|Death|1|||
149105481|NCT04024462|537866448|FG000|Overall Study|Lost to Follow-up|1|||
149105482|NCT04024462|537866449|FG001|Overall Study|Lost to Follow-up|0|||
149105483|NCT04024462|537866448|FG000|Overall Study|Ongoing in the Study|94|||
149105484|NCT04024462|537866449|FG001|Overall Study|Ongoing in the Study|89|||
149105485|NCT05274750|537866450|FG000|Overall Study|Adverse Event|0|||
149105486|NCT05274750|537866451|FG001|Overall Study|Adverse Event|1|||
149105487|NCT05274750|537866450|FG000|Overall Study|Lost to Follow-up|2|||
149105488|NCT05274750|537866451|FG001|Overall Study|Lost to Follow-up|3|||
149105489|NCT05274750|537866450|FG000|Overall Study|Physician Decision|3|||
149105490|NCT05274750|537866451|FG001|Overall Study|Physician Decision|0|||
149105491|NCT05274750|537866450|FG000|Overall Study|Withdrawal by Subject|10|||
149105492|NCT05274750|537866451|FG001|Overall Study|Withdrawal by Subject|9|||
149105493|NCT05274750|537866450|FG000|Overall Study|GCP Violation|0|||
149105494|NCT05274750|537866451|FG001|Overall Study|GCP Violation|4|||
149105495|NCT05274750|537866450|FG000|Overall Study|Randomized, not treated|0|||
149105496|NCT05274750|537866451|FG001|Overall Study|Randomized, not treated|1|||
149105497|NCT04328623|537866456|FG000|Overall Study|Protocol Violation|0|||
149105498|NCT04328623|537866457|FG001|Overall Study|Protocol Violation|1|||
149105499|NCT05687032|537866458|FG000|Treatment Phase|Adverse Event|13|||
149105500|NCT05687032|537866458|FG000|Treatment Phase|Death|1|||
149105501|NCT05687032|537866458|FG000|Treatment Phase|Physician Decision|3|||
149105502|NCT05687032|537866458|FG000|Treatment Phase|Progressive disease|9|||
149105503|NCT05687032|537866458|FG000|Treatment Phase|Withdrawal by Subject|5|||
149105504|NCT05687032|537866458|FG000|Follow-Up Phase|Death|16|||
149105505|NCT05687032|537866458|FG000|Follow-Up Phase|Ongoing|26|||
149105506|NCT03912662|537866461|FG000|Overall Study|Adverse Event|3|||
149105507|NCT03912662|537866461|FG000|Overall Study|Adverse Event and Death|1|||
149105508|NCT03912662|537866461|FG000|Overall Study|Death|1|||
149105509|NCT03912662|537866461|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
149105510|NCT03912662|537866461|FG000|Overall Study|Mesh Removal|1|||
149105511|NCT03912662|537866461|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
149105512|NCT03912662|537866461|FG000|Overall Study|Early study termination|20|||
149105513|NCT03880019|537866463|FG000|Overall Study|Competing disease|1|||
149105514|NCT03934099|537866464|FG000|Overall Study|Adverse Event|0|||
149105515|NCT03934099|537866465|FG001|Overall Study|Adverse Event|3|||
149105516|NCT03934099|537866466|FG002|Overall Study|Adverse Event|1|||
149105517|NCT03934099|537866467|FG003|Overall Study|Adverse Event|0|||
149105518|NCT03934099|537866464|FG000|Overall Study|Lost to Follow-up|1|||
149105519|NCT03934099|537866465|FG001|Overall Study|Lost to Follow-up|2|||
149105520|NCT03934099|537866466|FG002|Overall Study|Lost to Follow-up|1|||
149105521|NCT03934099|537866467|FG003|Overall Study|Lost to Follow-up|1|||
149105522|NCT03934099|537866464|FG000|Overall Study|Protocol Violation|1|||
149105523|NCT03934099|537866465|FG001|Overall Study|Protocol Violation|0|||
149105524|NCT03934099|537866466|FG002|Overall Study|Protocol Violation|0|||
149105525|NCT03934099|537866467|FG003|Overall Study|Protocol Violation|0|||
149105526|NCT03934099|537866464|FG000|Overall Study|Withdrawal by Subject|2|||
149105527|NCT03934099|537866465|FG001|Overall Study|Withdrawal by Subject|0|||
149105528|NCT03934099|537866466|FG002|Overall Study|Withdrawal by Subject|1|||
149105529|NCT03934099|537866467|FG003|Overall Study|Withdrawal by Subject|1|||
149105530|NCT03934099|537866464|FG000|Overall Study|Other reasons|0|||
149105531|NCT03934099|537866465|FG001|Overall Study|Other reasons|1|||
149105532|NCT03934099|537866466|FG002|Overall Study|Other reasons|0|||
149105533|NCT03934099|537866467|FG003|Overall Study|Other reasons|0|||
149105534|NCT05628285|537866468|FG000|Overall Study|Lost to Follow-up|1|||
149105535|NCT02339506|537866469|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
149105536|NCT02339506|537866470|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
149105537|NCT02339506|537866469|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
149105538|NCT02339506|537866470|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
149105539|NCT02869867|537866471|FG000|Overall Study|Protocol Violation|1|||
149105540|NCT02869867|537866472|FG001|Overall Study|Protocol Violation|0|||
149105541|NCT02869867|537866471|FG000|Overall Study|Lost to Follow-up|5|||
149105542|NCT02869867|537866472|FG001|Overall Study|Lost to Follow-up|5|||
149105543|NCT05218499|537866473|FG000|Overall Study|Not treated|1|||
149105544|NCT05218499|537866474|FG001|Overall Study|Not treated|1|||
149105545|NCT05218499|537866475|FG002|Overall Study|Not treated|8|||
149105546|NCT05218499|537866473|FG000|Overall Study|Death|2|||
149105547|NCT05218499|537866474|FG001|Overall Study|Death|0|||
149105548|NCT05218499|537866475|FG002|Overall Study|Death|0|||
149105549|NCT05218499|537866473|FG000|Overall Study|Other than listed|3|||
149105550|NCT05218499|537866474|FG001|Overall Study|Other than listed|7|||
149105551|NCT05218499|537866475|FG002|Overall Study|Other than listed|10|||
149105552|NCT05218499|537866473|FG000|Overall Study|Protocol deviation|5|||
149105553|NCT05218499|537866474|FG001|Overall Study|Protocol deviation|6|||
149105554|NCT05218499|537866475|FG002|Overall Study|Protocol deviation|4|||
149105555|NCT05218499|537866473|FG000|Overall Study|Technical problems|0|||
149105556|NCT05218499|537866474|FG001|Overall Study|Technical problems|1|||
149105557|NCT05218499|537866475|FG002|Overall Study|Technical problems|0|||
149105558|NCT05218499|537866473|FG000|Overall Study|Burden of trial procedures|0|||
149105559|NCT05218499|537866474|FG001|Overall Study|Burden of trial procedures|1|||
149105560|NCT05218499|537866475|FG002|Overall Study|Burden of trial procedures|2|||
149105561|NCT05218499|537866473|FG000|Overall Study|Clinical disease progression|6|||
149105562|NCT05218499|537866474|FG001|Overall Study|Clinical disease progression|6|||
149105563|NCT05218499|537866475|FG002|Overall Study|Clinical disease progression|11|||
149105564|NCT05218499|537866473|FG000|Overall Study|Objective disease progression|44|||
149105565|NCT05218499|537866474|FG001|Overall Study|Objective disease progression|61|||
149105566|NCT05218499|537866475|FG002|Overall Study|Objective disease progression|42|||
149105567|NCT05218499|537866473|FG000|Overall Study|Adverse Event|11|||
149105568|NCT05218499|537866474|FG001|Overall Study|Adverse Event|36|||
149105569|NCT05218499|537866475|FG002|Overall Study|Adverse Event|9|||
149105570|NCT05218499|537866473|FG000|Overall Study|On treatment at time of snapshot|18|||
149105571|NCT05218499|537866474|FG001|Overall Study|On treatment at time of snapshot|29|||
149105572|NCT05218499|537866475|FG002|Overall Study|On treatment at time of snapshot|0|||
149105573|NCT05555615|537866477|FG000|Overall Study|Adverse Event|7|||
149105574|NCT05555615|537866477|FG000|Overall Study|Lack of Efficacy|12|||
149105575|NCT05555615|537866477|FG000|Overall Study|Lost to Follow-up|10|||
149105576|NCT05555615|537866477|FG000|Overall Study|Noncompliance with study drug|5|||
149105577|NCT05555615|537866477|FG000|Overall Study|Physician Decision|2|||
149105578|NCT05555615|537866477|FG000|Overall Study|Study terminated by sponsor|80|||
149105579|NCT05555615|537866477|FG000|Overall Study|Prohibited medication use|2|||
149105580|NCT05555615|537866477|FG000|Overall Study|Withdrawal by Subject|20|||
149105581|NCT05555615|537866477|FG000|Overall Study|Not further specified|4|||
149105582|NCT03635086|537866478|FG000|Overall Study|Withdrawal of consent|0|||
149105583|NCT03635086|537866479|FG001|Overall Study|Withdrawal of consent|0|||
149105584|NCT03635086|537866480|FG002|Overall Study|Withdrawal of consent|1|||
149105585|NCT03635086|537866481|FG003|Overall Study|Withdrawal of consent|0|||
149105586|NCT03635086|537866482|FG004|Overall Study|Withdrawal of consent|0|||
149105587|NCT03635086|537866478|FG000|Overall Study|Adverse Event|0|||
149105588|NCT03635086|537866479|FG001|Overall Study|Adverse Event|1|||
149105589|NCT03635086|537866480|FG002|Overall Study|Adverse Event|0|||
149105590|NCT03635086|537866481|FG003|Overall Study|Adverse Event|0|||
149105591|NCT03635086|537866482|FG004|Overall Study|Adverse Event|0|||
149105592|NCT03635086|537866478|FG000|Overall Study|Lost to Follow-up|1|||
149105593|NCT03635086|537866479|FG001|Overall Study|Lost to Follow-up|0|||
149105594|NCT03635086|537866480|FG002|Overall Study|Lost to Follow-up|0|||
149105595|NCT03635086|537866481|FG003|Overall Study|Lost to Follow-up|0|||
149105596|NCT03635086|537866482|FG004|Overall Study|Lost to Follow-up|0|||
149105597|NCT02196077|537866483|FG000|Overall Study|Adverse Event|4|||
149105598|NCT02196077|537866483|FG000|Overall Study|Lack of Efficacy|1|||
149105599|NCT02196077|537866483|FG000|Overall Study|Withdrawal by Subject|14|||
149105600|NCT02196077|537866483|FG000|Overall Study|Physician Decision|1|||
149105601|NCT02196077|537866483|FG000|Overall Study|Lost to Follow-up|3|||
149105602|NCT02196077|537866483|FG000|Overall Study|Protocol Violation|24|||
149105603|NCT03482752|537866486|FG000|Overall Study|Withdrawal by Subject|2|||
149105604|NCT03482752|537866486|FG000|Overall Study|Lost to Follow-up|1|||
149105605|NCT03482752|537866486|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
149105606|NCT02844777|537866487|FG000|Overall Study|Withdrawal by Subject|2|||
149105607|NCT02844777|537866488|FG001|Overall Study|Withdrawal by Subject|0|||
149105608|NCT02844777|537866489|FG002|Overall Study|Withdrawal by Subject|0|||
149105609|NCT01776008|537866490|FG000|Overall Study|ineligible|2|||
149105610|NCT00150618|537866491|FG000|Overall Study|Adverse Event|2|||
149105611|NCT00150618|537866492|FG001|Overall Study|Adverse Event|2|||
149105612|NCT00150618|537866493|FG002|Overall Study|Adverse Event|6|||
149105613|NCT00150618|537866494|FG003|Overall Study|Adverse Event|9|||
149105614|NCT00150618|537866495|FG004|Overall Study|Adverse Event|5|||
149105615|NCT00150618|537866491|FG000|Overall Study|Withdrawal by Subject|6|||
149105616|NCT00150618|537866492|FG001|Overall Study|Withdrawal by Subject|8|||
149105617|NCT00150618|537866493|FG002|Overall Study|Withdrawal by Subject|8|||
149105618|NCT00150618|537866494|FG003|Overall Study|Withdrawal by Subject|4|||
149105619|NCT00150618|537866495|FG004|Overall Study|Withdrawal by Subject|5|||
149105620|NCT00150618|537866491|FG000|Overall Study|Lost to Follow-up|4|||
149105621|NCT00150618|537866492|FG001|Overall Study|Lost to Follow-up|1|||
149105622|NCT00150618|537866493|FG002|Overall Study|Lost to Follow-up|5|||
149105623|NCT00150618|537866494|FG003|Overall Study|Lost to Follow-up|8|||
149105624|NCT00150618|537866495|FG004|Overall Study|Lost to Follow-up|4|||
149105625|NCT00150618|537866491|FG000|Overall Study|Protocol Violation|1|||
149105626|NCT00150618|537866492|FG001|Overall Study|Protocol Violation|0|||
149105627|NCT00150618|537866493|FG002|Overall Study|Protocol Violation|0|||
149105628|NCT00150618|537866494|FG003|Overall Study|Protocol Violation|0|||
149105629|NCT00150618|537866495|FG004|Overall Study|Protocol Violation|1|||
149105630|NCT00150618|537866491|FG000|Overall Study|Lack of Efficacy|1|||
149105631|NCT00150618|537866492|FG001|Overall Study|Lack of Efficacy|4|||
149105632|NCT00150618|537866493|FG002|Overall Study|Lack of Efficacy|7|||
149105633|NCT00150618|537866494|FG003|Overall Study|Lack of Efficacy|4|||
149105634|NCT00150618|537866495|FG004|Overall Study|Lack of Efficacy|6|||
149105635|NCT00150618|537866491|FG000|Overall Study|No study meds|0|||
149105636|NCT00150618|537866492|FG001|Overall Study|No study meds|0|||
149105637|NCT00150618|537866493|FG002|Overall Study|No study meds|0|||
149105638|NCT00150618|537866494|FG003|Overall Study|No study meds|0|||
149105639|NCT00150618|537866495|FG004|Overall Study|No study meds|2|||
149105640|NCT00150618|537866491|FG000|Overall Study|Physician Decision|0|||
149105641|NCT00150618|537866492|FG001|Overall Study|Physician Decision|2|||
149105642|NCT00150618|537866493|FG002|Overall Study|Physician Decision|0|||
149105643|NCT00150618|537866494|FG003|Overall Study|Physician Decision|0|||
149105644|NCT00150618|537866495|FG004|Overall Study|Physician Decision|1|||
149105645|NCT00150618|537866491|FG000|Overall Study|Lack of compliance|2|||
149105646|NCT00150618|537866492|FG001|Overall Study|Lack of compliance|1|||
149105647|NCT00150618|537866493|FG002|Overall Study|Lack of compliance|1|||
149105648|NCT00150618|537866494|FG003|Overall Study|Lack of compliance|0|||
149105649|NCT00150618|537866495|FG004|Overall Study|Lack of compliance|1|||
149105650|NCT00150618|537866491|FG000|Overall Study|Abnormal ECG|1|||
149105651|NCT00150618|537866492|FG001|Overall Study|Abnormal ECG|0|||
149105652|NCT00150618|537866493|FG002|Overall Study|Abnormal ECG|0|||
149105653|NCT00150618|537866494|FG003|Overall Study|Abnormal ECG|0|||
149105654|NCT00150618|537866495|FG004|Overall Study|Abnormal ECG|0|||
149105655|NCT00150618|537866491|FG000|Overall Study|Sponsor's decision|0|||
149105656|NCT00150618|537866492|FG001|Overall Study|Sponsor's decision|0|||
149105657|NCT00150618|537866493|FG002|Overall Study|Sponsor's decision|0|||
149105658|NCT00150618|537866494|FG003|Overall Study|Sponsor's decision|1|||
149105659|NCT00150618|537866495|FG004|Overall Study|Sponsor's decision|0|||
149105660|NCT01163474|537866497|FG000|Overall Study|Withdrawal by Subject|1|||
149105661|NCT01163474|537866497|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
149105662|NCT01163474|537866497|FG000|Overall Study|Lost to Follow-up|3|||
149105663|NCT00762476|537866498|FG000|Overall Study|Adverse Event|7|||
149105664|NCT00762476|537866499|FG001|Overall Study|Adverse Event|1|||
149105665|NCT00762476|537866498|FG000|Overall Study|Lost to Follow-up|2|||
149105666|NCT00762476|537866499|FG001|Overall Study|Lost to Follow-up|0|||
149105667|NCT00762476|537866498|FG000|Overall Study|Protocol Violation|5|||
149105668|NCT00762476|537866499|FG001|Overall Study|Protocol Violation|6|||
149105669|NCT00762476|537866498|FG000|Overall Study|Physician Decision|2|||
149105670|NCT00762476|537866499|FG001|Overall Study|Physician Decision|14|||
149105671|NCT00762476|537866498|FG000|Overall Study|Withdrawal by Subject|6|||
149105672|NCT00762476|537866499|FG001|Overall Study|Withdrawal by Subject|12|||
149105673|NCT00762476|537866498|FG000|Overall Study|antibiotic use|0|||
149105674|NCT00762476|537866499|FG001|Overall Study|antibiotic use|1|||
149105675|NCT00762476|537866498|FG000|Overall Study|non-compliance with study visits|0|||
149105676|NCT00762476|537866499|FG001|Overall Study|non-compliance with study visits|2|||
149105677|NCT00762476|537866498|FG000|Overall Study|Seasonal allergies|1|||
149105678|NCT00762476|537866499|FG001|Overall Study|Seasonal allergies|0|||
149105679|NCT00965497|537866500|FG000|Overall Study|Physician Decision|1|||
149105680|NCT02878603|537866501|FG000|Overall Study|Lost to Follow-up|4|||
149105681|NCT02878603|537866502|FG001|Overall Study|Lost to Follow-up|1|||
149105682|NCT02878603|537866501|FG000|Overall Study|Withdrawal by Subject|1|||
149105683|NCT02878603|537866502|FG001|Overall Study|Withdrawal by Subject|1|||
149105684|NCT02878603|537866501|FG000|Overall Study|Death|1|||
149105685|NCT02878603|537866502|FG001|Overall Study|Death|0|||
149105686|NCT02878603|537866501|FG000|Overall Study|Physician Decision|0|||
149105687|NCT02878603|537866502|FG001|Overall Study|Physician Decision|3|||
149105688|NCT02689453|537866503|FG000|Overall Study|Progressive disease|0|||
149105689|NCT02689453|537866504|FG001|Overall Study|Progressive disease|1|||
149105690|NCT02689453|537866505|FG002|Overall Study|Progressive disease|1|||
149105691|NCT01162486|537866506|FG000|Overall Study|low ANC|1|||
149105692|NCT01162486|537866507|FG001|Overall Study|low ANC|0|||
149105693|NCT01162486|537866508|FG002|Overall Study|low ANC|0|||
149105694|NCT01162486|537866509|FG003|Overall Study|low ANC|0|||
149105695|NCT01162486|537866510|FG004|Overall Study|low ANC|0|||
149105696|NCT01162486|537866506|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
149105697|NCT01162486|537866507|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
149105698|NCT01162486|537866508|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
149105699|NCT01162486|537866509|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
149105700|NCT01162486|537866510|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
149105701|NCT01162486|537866506|FG000|Overall Study|elevated LFTs|0|||
149105702|NCT01162486|537866507|FG001|Overall Study|elevated LFTs|0|||
149105703|NCT01162486|537866508|FG002|Overall Study|elevated LFTs|1|||
149105704|NCT01162486|537866509|FG003|Overall Study|elevated LFTs|0|||
149105705|NCT01162486|537866510|FG004|Overall Study|elevated LFTs|0|||
149105706|NCT01162486|537866506|FG000|Overall Study|Pregnancy|0|||
149105707|NCT01162486|537866507|FG001|Overall Study|Pregnancy|0|||
149105708|NCT01162486|537866508|FG002|Overall Study|Pregnancy|0|||
149105709|NCT01162486|537866509|FG003|Overall Study|Pregnancy|1|||
149105710|NCT01162486|537866510|FG004|Overall Study|Pregnancy|0|||
149105711|NCT00953615|537866511|FG000|Overall Study|Adverse Event|1|||
149105712|NCT02498236|537866514|FG000|Overall Study|Did not show for testing|1|||
149105713|NCT02498236|537866515|FG001|Overall Study|Did not show for testing|0|||
149105714|NCT02498236|537866516|FG002|Overall Study|Did not show for testing|0|||
149105715|NCT02498236|537866517|FG003|Overall Study|Did not show for testing|0|||
149105716|NCT02498236|537866518|FG004|Overall Study|Did not show for testing|0|||
149105717|NCT02498236|537866519|FG005|Overall Study|Did not show for testing|0|||
149105718|NCT02498236|537866520|FG006|Overall Study|Did not show for testing|0|||
149105719|NCT02498236|537866521|FG007|Overall Study|Did not show for testing|1|||
149105720|NCT02498236|537866514|FG000|Overall Study|Equipment failure|0|||
149105721|NCT02498236|537866515|FG001|Overall Study|Equipment failure|0|||
149105722|NCT02498236|537866516|FG002|Overall Study|Equipment failure|0|||
149105723|NCT02498236|537866517|FG003|Overall Study|Equipment failure|0|||
149105724|NCT02498236|537866518|FG004|Overall Study|Equipment failure|0|||
149105725|NCT02498236|537866519|FG005|Overall Study|Equipment failure|0|||
149105726|NCT02498236|537866520|FG006|Overall Study|Equipment failure|1|||
149105727|NCT02498236|537866521|FG007|Overall Study|Equipment failure|0|||
149105728|NCT02498236|537866514|FG000|Overall Study|Withdrawal by Subject|0|||
149105729|NCT02498236|537866515|FG001|Overall Study|Withdrawal by Subject|0|||
149105730|NCT02498236|537866516|FG002|Overall Study|Withdrawal by Subject|0|||
149105731|NCT02498236|537866517|FG003|Overall Study|Withdrawal by Subject|0|||
149105732|NCT02498236|537866518|FG004|Overall Study|Withdrawal by Subject|1|||
149105733|NCT02498236|537866519|FG005|Overall Study|Withdrawal by Subject|0|||
149105734|NCT02498236|537866520|FG006|Overall Study|Withdrawal by Subject|0|||
149105735|NCT02498236|537866521|FG007|Overall Study|Withdrawal by Subject|0|||
149105736|NCT02296892|537866522|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
149105737|NCT02296892|537866523|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
149105738|NCT02296892|537866524|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
149105739|NCT02296892|537866522|FG000|Overall Study|Lost to Follow-up|5|||
149105740|NCT02296892|537866523|FG001|Overall Study|Lost to Follow-up|0|||
149105741|NCT02296892|537866524|FG002|Overall Study|Lost to Follow-up|1|||
149105742|NCT00585078|537866525|FG000|Overall Study|Withdrawal by Subject|4|||
149105743|NCT00585078|537866525|FG000|Overall Study|Poor performance status|1|||
149105744|NCT00585078|537866525|FG000|Overall Study|Disease Progression|24|||
149105745|NCT00585078|537866525|FG000|Overall Study|Adverse Event|10|||
149105746|NCT00585078|537866525|FG000|Overall Study|Death|1|||
149105747|NCT00383123|537866528|FG000|Overall Study|Adverse Event|1|||
149105748|NCT00383123|537866529|FG001|Overall Study|Adverse Event|0|||
149105749|NCT00383123|537866528|FG000|Overall Study|Lost to Follow-up|68|||
149105750|NCT00383123|537866529|FG001|Overall Study|Lost to Follow-up|61|||
149105751|NCT00383123|537866528|FG000|Overall Study|Protocol Violation|5|||
149105752|NCT00383123|537866529|FG001|Overall Study|Protocol Violation|1|||
149105753|NCT00383123|537866528|FG000|Overall Study|Withdrawal by Subject|27|||
149105754|NCT00383123|537866529|FG001|Overall Study|Withdrawal by Subject|18|||
149105755|NCT00383123|537866528|FG000|Overall Study|Other reason|10|||
149105756|NCT00383123|537866529|FG001|Overall Study|Other reason|6|||
149105757|NCT01814072|537866530|FG000|Overall Study|Lost to Follow-up|2|||
149105758|NCT01814072|537866531|FG001|Overall Study|Lost to Follow-up|2|||
149105759|NCT01814072|537866532|FG002|Overall Study|Lost to Follow-up|2|||
149105760|NCT01814072|537866533|FG003|Overall Study|Lost to Follow-up|0|||
149105761|NCT01814072|537866534|FG004|Overall Study|Lost to Follow-up|2|||
149105762|NCT01814072|537866535|FG005|Overall Study|Lost to Follow-up|3|||
149105763|NCT01814072|537866536|FG006|Overall Study|Lost to Follow-up|3|||
149105764|NCT01814072|537866537|FG007|Overall Study|Lost to Follow-up|1|||
149105765|NCT01814072|537866538|FG008|Overall Study|Lost to Follow-up|2|||
149105766|NCT01814072|537866539|FG009|Overall Study|Lost to Follow-up|3|||
149105767|NCT01814072|537866540|FG010|Overall Study|Lost to Follow-up|1|||
149105768|NCT01814072|537866541|FG011|Overall Study|Lost to Follow-up|2|||
149105769|NCT01814072|537866542|FG012|Overall Study|Lost to Follow-up|2|||
149105770|NCT01814072|537866543|FG013|Overall Study|Lost to Follow-up|1|||
149105771|NCT01814072|537866544|FG014|Overall Study|Lost to Follow-up|2|||
149105772|NCT01814072|537866545|FG015|Overall Study|Lost to Follow-up|1|||
149105773|NCT01814072|537866546|FG016|Overall Study|Lost to Follow-up|3|||
149105774|NCT01814072|537866547|FG017|Overall Study|Lost to Follow-up|1|||
149105775|NCT01814072|537866548|FG018|Overall Study|Lost to Follow-up|3|||
149105776|NCT01814072|537866549|FG019|Overall Study|Lost to Follow-up|3|||
149105777|NCT01814072|537866550|FG020|Overall Study|Lost to Follow-up|2|||
149105778|NCT01814072|537866551|FG021|Overall Study|Lost to Follow-up|1|||
149105779|NCT01814072|537866552|FG022|Overall Study|Lost to Follow-up|3|||
149105780|NCT01814072|537866553|FG023|Overall Study|Lost to Follow-up|1|||
149105781|NCT01814072|537866554|FG024|Overall Study|Lost to Follow-up|4|||
149105782|NCT01814072|537866555|FG025|Overall Study|Lost to Follow-up|1|||
149105783|NCT01814072|537866556|FG026|Overall Study|Lost to Follow-up|1|||
149105784|NCT01814072|537866557|FG027|Overall Study|Lost to Follow-up|2|||
149105785|NCT01814072|537866558|FG028|Overall Study|Lost to Follow-up|3|||
149105786|NCT01814072|537866559|FG029|Overall Study|Lost to Follow-up|3|||
149105787|NCT01814072|537866560|FG030|Overall Study|Lost to Follow-up|2|||
149105788|NCT01814072|537866561|FG031|Overall Study|Lost to Follow-up|0|||
149105789|NCT01814072|537866530|FG000|Overall Study|Withdrawal by Subject|2|||
149105790|NCT01814072|537866531|FG001|Overall Study|Withdrawal by Subject|0|||
149105791|NCT01814072|537866532|FG002|Overall Study|Withdrawal by Subject|1|||
149105792|NCT01814072|537866533|FG003|Overall Study|Withdrawal by Subject|0|||
149105793|NCT01814072|537866534|FG004|Overall Study|Withdrawal by Subject|2|||
149105794|NCT01814072|537866535|FG005|Overall Study|Withdrawal by Subject|3|||
149105795|NCT01814072|537866536|FG006|Overall Study|Withdrawal by Subject|1|||
149105796|NCT01814072|537866537|FG007|Overall Study|Withdrawal by Subject|0|||
149105797|NCT01814072|537866538|FG008|Overall Study|Withdrawal by Subject|1|||
149105798|NCT01814072|537866539|FG009|Overall Study|Withdrawal by Subject|2|||
149105799|NCT01814072|537866540|FG010|Overall Study|Withdrawal by Subject|0|||
149105800|NCT01814072|537866541|FG011|Overall Study|Withdrawal by Subject|0|||
149105801|NCT01814072|537866542|FG012|Overall Study|Withdrawal by Subject|1|||
149105802|NCT01814072|537866543|FG013|Overall Study|Withdrawal by Subject|1|||
149105803|NCT01814072|537866544|FG014|Overall Study|Withdrawal by Subject|1|||
149105804|NCT01814072|537866545|FG015|Overall Study|Withdrawal by Subject|1|||
149105805|NCT01814072|537866546|FG016|Overall Study|Withdrawal by Subject|0|||
149105806|NCT01814072|537866547|FG017|Overall Study|Withdrawal by Subject|0|||
149105807|NCT01814072|537866548|FG018|Overall Study|Withdrawal by Subject|0|||
149105808|NCT01814072|537866549|FG019|Overall Study|Withdrawal by Subject|2|||
149105809|NCT01814072|537866550|FG020|Overall Study|Withdrawal by Subject|0|||
149105810|NCT01814072|537866551|FG021|Overall Study|Withdrawal by Subject|0|||
149105811|NCT01814072|537866552|FG022|Overall Study|Withdrawal by Subject|1|||
149105812|NCT01814072|537866553|FG023|Overall Study|Withdrawal by Subject|0|||
149105813|NCT01814072|537866554|FG024|Overall Study|Withdrawal by Subject|2|||
149105814|NCT01814072|537866555|FG025|Overall Study|Withdrawal by Subject|1|||
149105815|NCT01814072|537866556|FG026|Overall Study|Withdrawal by Subject|1|||
149105816|NCT01814072|537866557|FG027|Overall Study|Withdrawal by Subject|2|||
149105817|NCT01814072|537866558|FG028|Overall Study|Withdrawal by Subject|1|||
149105818|NCT01814072|537866559|FG029|Overall Study|Withdrawal by Subject|0|||
149105819|NCT01814072|537866560|FG030|Overall Study|Withdrawal by Subject|0|||
149105820|NCT01814072|537866561|FG031|Overall Study|Withdrawal by Subject|0|||
149105821|NCT03566979|537866563|FG000|Overall Study|Withdrawal by Subject|2|||
149105822|NCT03566979|537866564|FG001|Overall Study|Withdrawal by Subject|0|||
149105823|NCT03566979|537866565|FG002|Overall Study|Withdrawal by Subject|1|||
149105824|NCT03566979|537866566|FG003|Overall Study|Withdrawal by Subject|1|||
149105825|NCT03566979|537866563|FG000|Overall Study|Lost to Follow-up|2|||
149105826|NCT03566979|537866564|FG001|Overall Study|Lost to Follow-up|7|||
149105827|NCT03566979|537866565|FG002|Overall Study|Lost to Follow-up|9|||
149105828|NCT03566979|537866566|FG003|Overall Study|Lost to Follow-up|5|||
149105829|NCT03566979|537866563|FG000|Overall Study|Adverse Event|1|||
149105830|NCT03566979|537866564|FG001|Overall Study|Adverse Event|0|||
149105831|NCT03566979|537866565|FG002|Overall Study|Adverse Event|0|||
149105832|NCT03566979|537866566|FG003|Overall Study|Adverse Event|0|||
149105833|NCT03375320|537866572|FG000|Overall Study|Adverse Event|34|||
149105834|NCT03375320|537866573|FG001|Overall Study|Adverse Event|9|||
149105835|NCT03375320|537866574|FG002|Overall Study|Adverse Event|10|||
149105836|NCT03375320|537866575|FG003|Overall Study|Adverse Event|0|||
149105837|NCT03375320|537866572|FG000|Overall Study|Death|6|||
149105838|NCT03375320|537866573|FG001|Overall Study|Death|3|||
149105839|NCT03375320|537866574|FG002|Overall Study|Death|0|||
149105840|NCT03375320|537866575|FG003|Overall Study|Death|0|||
149105841|NCT03375320|537866572|FG000|Overall Study|Withdrawal by Subject|7|||
149105842|NCT03375320|537866573|FG001|Overall Study|Withdrawal by Subject|4|||
149105843|NCT03375320|537866574|FG002|Overall Study|Withdrawal by Subject|5|||
149105844|NCT03375320|537866575|FG003|Overall Study|Withdrawal by Subject|4|||
149105845|NCT03375320|537866572|FG000|Overall Study|Progressive disease|55|||
149105846|NCT03375320|537866573|FG001|Overall Study|Progressive disease|41|||
149105847|NCT03375320|537866574|FG002|Overall Study|Progressive disease|29|||
149105848|NCT03375320|537866575|FG003|Overall Study|Progressive disease|24|||
149105849|NCT03375320|537866572|FG000|Overall Study|Alternative treatment|6|||
149105850|NCT03375320|537866573|FG001|Overall Study|Alternative treatment|1|||
149105851|NCT03375320|537866574|FG002|Overall Study|Alternative treatment|1|||
149105852|NCT03375320|537866575|FG003|Overall Study|Alternative treatment|0|||
149105853|NCT03375320|537866572|FG000|Overall Study|Other disease|1|||
149105854|NCT03375320|537866573|FG001|Overall Study|Other disease|1|||
149105855|NCT03375320|537866574|FG002|Overall Study|Other disease|3|||
149105856|NCT03375320|537866575|FG003|Overall Study|Other disease|0|||
149105857|NCT03375320|537866572|FG000|Overall Study|Withdrawal prior to initiation|2|||
149105858|NCT03375320|537866573|FG001|Overall Study|Withdrawal prior to initiation|2|||
149105859|NCT03375320|537866574|FG002|Overall Study|Withdrawal prior to initiation|1|||
149105860|NCT03375320|537866575|FG003|Overall Study|Withdrawal prior to initiation|0|||
149105861|NCT03375320|537866572|FG000|Overall Study|Physician Decision|1|||
149105862|NCT03375320|537866573|FG001|Overall Study|Physician Decision|1|||
149105863|NCT03375320|537866574|FG002|Overall Study|Physician Decision|1|||
149105864|NCT03375320|537866575|FG003|Overall Study|Physician Decision|1|||
149105865|NCT03375320|537866572|FG000|Overall Study|Non-compliance|1|||
149105866|NCT03375320|537866573|FG001|Overall Study|Non-compliance|0|||
149105867|NCT03375320|537866574|FG002|Overall Study|Non-compliance|0|||
149105868|NCT03375320|537866575|FG003|Overall Study|Non-compliance|0|||
149105869|NCT03348631|537866576|FG000|Overall Study|Not Eligible, No treatment|0|||
149105870|NCT03348631|537866577|FG001|Overall Study|Not Eligible, No treatment|1|||
149105871|NCT03348631|537866576|FG000|Overall Study|Not Eligible, Treated|2|||
149105872|NCT03348631|537866577|FG001|Overall Study|Not Eligible, Treated|0|||
149105873|NCT03348631|537866576|FG000|Overall Study|Eligible, No Treatment|1|||
149105874|NCT03348631|537866577|FG001|Overall Study|Eligible, No Treatment|0|||
149105875|NCT03388632|537866578|FG000|Triplet C|Clinical progression|0|||
149105876|NCT03388632|537866579|FG001|Triplet C|Clinical progression|0|||
149105877|NCT03388632|537866580|FG002|Triplet C|Clinical progression|0|||
149105878|NCT03388632|537866581|FG003|Triplet C|Clinical progression|0|||
149105879|NCT03388632|537866582|FG004|Triplet C|Clinical progression|1|||
149105880|NCT03388632|537866583|FG005|Triplet C|Clinical progression|0|||
149105881|NCT03388632|537866584|FG006|Triplet C|Clinical progression|0|||
149105882|NCT03388632|537866585|FG007|Triplet C|Clinical progression|0|||
149105883|NCT03388632|537866586|FG008|Triplet C|Clinical progression|0|||
149105884|NCT03388632|537866578|FG000|Triplet C|42-day lapse in tx|0|||
149105885|NCT03388632|537866579|FG001|Triplet C|42-day lapse in tx|0|||
149105886|NCT03388632|537866580|FG002|Triplet C|42-day lapse in tx|0|||
149105887|NCT03388632|537866581|FG003|Triplet C|42-day lapse in tx|0|||
149105888|NCT03388632|537866582|FG004|Triplet C|42-day lapse in tx|1|||
149105889|NCT03388632|537866583|FG005|Triplet C|42-day lapse in tx|0|||
149105890|NCT03388632|537866584|FG006|Triplet C|42-day lapse in tx|0|||
149105891|NCT03388632|537866585|FG007|Triplet C|42-day lapse in tx|0|||
149105892|NCT03388632|537866586|FG008|Triplet C|42-day lapse in tx|0|||
149105893|NCT03388632|537866578|FG000|Triplet C|Adverse Event|0|||
149105894|NCT03388632|537866579|FG001|Triplet C|Adverse Event|0|||
149105895|NCT03388632|537866580|FG002|Triplet C|Adverse Event|0|||
149105896|NCT03388632|537866581|FG003|Triplet C|Adverse Event|0|||
149105897|NCT03388632|537866582|FG004|Triplet C|Adverse Event|0|||
149105898|NCT03388632|537866583|FG005|Triplet C|Adverse Event|0|||
149105899|NCT03388632|537866584|FG006|Triplet C|Adverse Event|0|||
149105900|NCT03388632|537866585|FG007|Triplet C|Adverse Event|0|||
149105901|NCT03388632|537866586|FG008|Triplet C|Adverse Event|1|||
149105902|NCT03388632|537866578|FG000|Triplet C|Switched to alternative treatment|0|||
149105903|NCT03388632|537866579|FG001|Triplet C|Switched to alternative treatment|0|||
149105904|NCT03388632|537866580|FG002|Triplet C|Switched to alternative treatment|0|||
149105905|NCT03388632|537866581|FG003|Triplet C|Switched to alternative treatment|0|||
149105906|NCT03388632|537866582|FG004|Triplet C|Switched to alternative treatment|0|||
149105907|NCT03388632|537866583|FG005|Triplet C|Switched to alternative treatment|0|||
149105908|NCT03388632|537866584|FG006|Triplet C|Switched to alternative treatment|0|||
149105909|NCT03388632|537866585|FG007|Triplet C|Switched to alternative treatment|1|||
149105910|NCT03388632|537866586|FG008|Triplet C|Switched to alternative treatment|0|||
149105911|NCT03388632|537866578|FG000|Triplet C|Participant choice|0|||
149105912|NCT03388632|537866579|FG001|Triplet C|Participant choice|0|||
149105913|NCT03388632|537866580|FG002|Triplet C|Participant choice|0|||
149105914|NCT03388632|537866581|FG003|Triplet C|Participant choice|0|||
149105915|NCT03388632|537866582|FG004|Triplet C|Participant choice|0|||
149105916|NCT03388632|537866583|FG005|Triplet C|Participant choice|1|||
149105917|NCT03388632|537866584|FG006|Triplet C|Participant choice|0|||
149105918|NCT03388632|537866585|FG007|Triplet C|Participant choice|0|||
149105919|NCT03388632|537866586|FG008|Triplet C|Participant choice|0|||
149105920|NCT03595124|537867590|FG000|Overall Study|Physician Decision|1|||
149105921|NCT03595124|537867591|FG001|Overall Study|Physician Decision|1|||
149105922|NCT03595124|537867592|FG002|Overall Study|Physician Decision|1|||
149105923|NCT03595124|537867590|FG000|Overall Study|Ineligible|1|||
149105924|NCT03595124|537867591|FG001|Overall Study|Ineligible|1|||
149105925|NCT03595124|537867592|FG002|Overall Study|Ineligible|0|||
149105926|NCT03595124|537867590|FG000|Overall Study|Disease Progression|4|||
149105927|NCT03595124|537867591|FG001|Overall Study|Disease Progression|1|||
149105928|NCT03595124|537867592|FG002|Overall Study|Disease Progression|4|||
149105929|NCT03607422|537867595|FG000|Overall Study|Adverse Event|7|||
149105930|NCT03607422|537867596|FG001|Overall Study|Adverse Event|3|||
149105931|NCT03607422|537867597|FG002|Overall Study|Adverse Event|2|||
149105932|NCT03607422|537867598|FG003|Overall Study|Adverse Event|0|||
149105933|NCT03607422|537867599|FG004|Overall Study|Adverse Event|2|||
149105934|NCT03607422|537867600|FG005|Overall Study|Adverse Event|0|||
149105935|NCT03607422|537867595|FG000|Overall Study|Withdrawal by Subject|11|||
149105936|NCT03607422|537867596|FG001|Overall Study|Withdrawal by Subject|3|||
149105937|NCT03607422|537867597|FG002|Overall Study|Withdrawal by Subject|6|||
149105938|NCT03607422|537867598|FG003|Overall Study|Withdrawal by Subject|2|||
149105939|NCT03607422|537867599|FG004|Overall Study|Withdrawal by Subject|0|||
149105940|NCT03607422|537867600|FG005|Overall Study|Withdrawal by Subject|0|||
149105941|NCT03607422|537867595|FG000|Overall Study|Lost to Follow-up|0|||
149105942|NCT03607422|537867596|FG001|Overall Study|Lost to Follow-up|0|||
149105943|NCT03607422|537867597|FG002|Overall Study|Lost to Follow-up|1|||
149105944|NCT03607422|537867598|FG003|Overall Study|Lost to Follow-up|0|||
149105945|NCT03607422|537867599|FG004|Overall Study|Lost to Follow-up|0|||
149105946|NCT03607422|537867600|FG005|Overall Study|Lost to Follow-up|0|||
149105947|NCT03607422|537867595|FG000|Overall Study|Other|12|||
149105948|NCT03607422|537867596|FG001|Overall Study|Other|4|||
149105949|NCT03607422|537867597|FG002|Overall Study|Other|1|||
149105950|NCT03607422|537867598|FG003|Overall Study|Other|2|||
149105951|NCT03607422|537867599|FG004|Overall Study|Other|0|||
149105952|NCT03607422|537867600|FG005|Overall Study|Other|2|||
149105953|NCT03607422|537867595|FG000|Overall Study|Ongoing at Time of Analysis|8|||
149105954|NCT03607422|537867596|FG001|Overall Study|Ongoing at Time of Analysis|0|||
149105955|NCT03607422|537867597|FG002|Overall Study|Ongoing at Time of Analysis|2|||
149105956|NCT03607422|537867598|FG003|Overall Study|Ongoing at Time of Analysis|1|||
149105957|NCT03607422|537867599|FG004|Overall Study|Ongoing at Time of Analysis|1|||
149105958|NCT03607422|537867600|FG005|Overall Study|Ongoing at Time of Analysis|1|||
149105959|NCT04832971|537867601|FG000|Double-Blind (DB) Treatment Period|Death|1|||
149105960|NCT04832971|537867602|FG001|Double-Blind (DB) Treatment Period|Death|0|||
149105961|NCT04832971|537867603|FG002|Double-Blind (DB) Treatment Period|Death|0|||
149105962|NCT04832971|537867604|FG003|Double-Blind (DB) Treatment Period|Death|0|||
149105963|NCT04832971|537867605|FG004|Double-Blind (DB) Treatment Period|Death|0|||
149105964|NCT04832971|537867606|FG005|Double-Blind (DB) Treatment Period|Death|0|||
149105965|NCT04832971|537867607|FG006|Double-Blind (DB) Treatment Period|Death|0|||
149105966|NCT04832971|537867608|FG007|Double-Blind (DB) Treatment Period|Death|0|||
149105967|NCT04832971|537867609|FG008|Double-Blind (DB) Treatment Period|Death|0|||
149105968|NCT04832971|537867610|FG009|Double-Blind (DB) Treatment Period|Death|0|||
149105969|NCT04832971|537867601|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149105970|NCT04832971|537867602|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149105971|NCT04832971|537867603|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
149105972|NCT04832971|537867604|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105973|NCT04832971|537867605|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105974|NCT04832971|537867606|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105975|NCT04832971|537867607|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105976|NCT04832971|537867608|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105977|NCT04832971|537867609|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105978|NCT04832971|537867610|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
149105979|NCT04832971|537867601|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
149105980|NCT04832971|537867602|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
149105981|NCT04832971|537867603|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
149105982|NCT04832971|537867604|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
149105983|NCT04832971|537867605|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149105984|NCT04832971|537867606|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149105985|NCT04832971|537867607|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149105986|NCT04832971|537867608|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149105987|NCT04832971|537867609|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149105988|NCT04832971|537867610|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
149105989|NCT04832971|537867601|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105990|NCT04832971|537867602|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
149105991|NCT04832971|537867603|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105992|NCT04832971|537867604|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105993|NCT04832971|537867605|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105994|NCT04832971|537867606|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105995|NCT04832971|537867607|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105996|NCT04832971|537867608|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105997|NCT04832971|537867609|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105998|NCT04832971|537867610|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
149105999|NCT04832971|537867601|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
149106000|NCT04832971|537867602|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
149106001|NCT04832971|537867603|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
149106002|NCT04832971|537867604|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
149106003|NCT04832971|537867605|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
149106004|NCT04832971|537867606|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
149106005|NCT04832971|537867607|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
149106006|NCT04832971|537867608|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
149106007|NCT04832971|537867609|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
149106008|NCT04832971|537867610|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
149106009|NCT04832971|537867601|FG000|Open-Label Extension (OLE) Period|Death|0|||
149106010|NCT04832971|537867602|FG001|Open-Label Extension (OLE) Period|Death|0|||
149106011|NCT04832971|537867603|FG002|Open-Label Extension (OLE) Period|Death|0|||
149106012|NCT04832971|537867604|FG003|Open-Label Extension (OLE) Period|Death|0|||
149106013|NCT04832971|537867605|FG004|Open-Label Extension (OLE) Period|Death|0|||
149106014|NCT04832971|537867606|FG005|Open-Label Extension (OLE) Period|Death|0|||
149106015|NCT04832971|537867607|FG006|Open-Label Extension (OLE) Period|Death|0|||
149106016|NCT04832971|537867608|FG007|Open-Label Extension (OLE) Period|Death|1|||
149106017|NCT04832971|537867609|FG008|Open-Label Extension (OLE) Period|Death|0|||
149106018|NCT04832971|537867610|FG009|Open-Label Extension (OLE) Period|Death|0|||
149106019|NCT04832971|537867601|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106020|NCT04832971|537867602|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106021|NCT04832971|537867603|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106022|NCT04832971|537867604|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106023|NCT04832971|537867605|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106024|NCT04832971|537867606|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106025|NCT04832971|537867607|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
149106026|NCT04832971|537867608|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
149106027|NCT04832971|537867609|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106028|NCT04832971|537867610|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
149106029|NCT04832971|537867601|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
149106030|NCT04832971|537867602|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
149106031|NCT04832971|537867603|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
149106032|NCT04832971|537867604|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
149106033|NCT04832971|537867605|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
149106034|NCT04832971|537867606|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
149106035|NCT04832971|537867607|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
149106036|NCT04832971|537867608|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
149106037|NCT04832971|537867609|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
149106038|NCT04832971|537867610|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
149106039|NCT04832971|537867601|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149106040|NCT04832971|537867602|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149106041|NCT04832971|537867603|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149106042|NCT04832971|537867604|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149106043|NCT04832971|537867605|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
149106044|NCT04832971|537867606|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
149106045|NCT04832971|537867607|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149106046|NCT04832971|537867608|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
149106047|NCT04832971|537867609|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
149106048|NCT04832971|537867610|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
149106049|NCT04832971|537867601|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106050|NCT04832971|537867602|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106051|NCT04832971|537867603|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106052|NCT04832971|537867604|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106053|NCT04832971|537867605|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106054|NCT04832971|537867606|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106055|NCT04832971|537867607|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
149106056|NCT04832971|537867608|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
149106057|NCT04832971|537867609|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
149106058|NCT04832971|537867610|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
149106059|NCT03584152|537867611|FG000|Overall Study|Discontinued intervention|7|||
149106060|NCT03584152|537867612|FG001|Overall Study|Discontinued intervention|4|||
149106061|NCT00433511|537867617|FG000|Step 1|Adverse Event|50|||
149106062|NCT00433511|537867618|FG001|Step 1|Adverse Event|157|||
149106063|NCT00433511|537867619|FG002|Step 1|Adverse Event|153|||
149106064|NCT00433511|537867617|FG000|Step 1|Withdrawal by Subject|45|||
149106065|NCT00433511|537867618|FG001|Step 1|Withdrawal by Subject|143|||
149106066|NCT00433511|537867619|FG002|Step 1|Withdrawal by Subject|154|||
149106067|NCT00433511|537867617|FG000|Step 1|Death|3|||
149106068|NCT00433511|537867618|FG001|Step 1|Death|1|||
149106069|NCT00433511|537867619|FG002|Step 1|Death|1|||
149106070|NCT00433511|537867617|FG000|Step 1|Physician Decision|1|||
149106071|NCT00433511|537867618|FG001|Step 1|Physician Decision|4|||
149106072|NCT00433511|537867619|FG002|Step 1|Physician Decision|3|||
149106073|NCT00433511|537867617|FG000|Step 1|Never started protocol therapy|28|||
149106074|NCT00433511|537867618|FG001|Step 1|Never started protocol therapy|64|||
149106075|NCT00433511|537867619|FG002|Step 1|Never started protocol therapy|66|||
149106076|NCT00433511|537867617|FG000|Step 1|Alternative therapy|2|||
149106077|NCT00433511|537867618|FG001|Step 1|Alternative therapy|1|||
149106078|NCT00433511|537867619|FG002|Step 1|Alternative therapy|3|||
149106079|NCT00433511|537867617|FG000|Step 1|Disease progression, relapse|5|||
149106080|NCT00433511|537867618|FG001|Step 1|Disease progression, relapse|3|||
149106081|NCT00433511|537867619|FG002|Step 1|Disease progression, relapse|3|||
149106082|NCT00433511|537867617|FG000|Step 1|Other complicating disease|2|||
149106083|NCT00433511|537867618|FG001|Step 1|Other complicating disease|6|||
149106084|NCT00433511|537867619|FG002|Step 1|Other complicating disease|3|||
149106085|NCT00433511|537867617|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
149106086|NCT00433511|537867618|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
149106087|NCT00433511|537867619|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
149106088|NCT00433511|537867617|FG000|Step 1|Suspected recurrence|0|||
149106089|NCT00433511|537867618|FG001|Step 1|Suspected recurrence|1|||
149106090|NCT00433511|537867619|FG002|Step 1|Suspected recurrence|0|||
149106091|NCT00433511|537867617|FG000|Step 1|Insurance/drug distribution issues|0|||
149106092|NCT00433511|537867618|FG001|Step 1|Insurance/drug distribution issues|1|||
149106093|NCT00433511|537867619|FG002|Step 1|Insurance/drug distribution issues|2|||
149106094|NCT00433511|537867617|FG000|Step 1|Patient moved|0|||
149106095|NCT00433511|537867618|FG001|Step 1|Patient moved|0|||
149106096|NCT00433511|537867619|FG002|Step 1|Patient moved|1|||
149106097|NCT00433511|537867617|FG000|Step 2 (Arm D)|Adverse Event|0|||
149106098|NCT00433511|537867618|FG001|Step 2 (Arm D)|Adverse Event|0|||
149106099|NCT00433511|537867619|FG002|Step 2 (Arm D)|Adverse Event|135|||
149106100|NCT00433511|537867617|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
149106101|NCT00433511|537867618|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
149106102|NCT00433511|537867619|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
149106103|NCT00433511|537867617|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
149106104|NCT00433511|537867618|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
149106105|NCT00433511|537867619|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
149106106|NCT00433511|537867617|FG000|Step 2 (Arm D)|Physician Decision|0|||
149106107|NCT00433511|537867618|FG001|Step 2 (Arm D)|Physician Decision|0|||
149106108|NCT00433511|537867619|FG002|Step 2 (Arm D)|Physician Decision|9|||
149106109|NCT00433511|537867617|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
149106110|NCT00433511|537867618|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
149106111|NCT00433511|537867619|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
149106112|NCT00433511|537867617|FG000|Step 2 (Arm D)|Other complicating disease|0|||
149106113|NCT00433511|537867618|FG001|Step 2 (Arm D)|Other complicating disease|0|||
149106114|NCT00433511|537867619|FG002|Step 2 (Arm D)|Other complicating disease|3|||
149106115|NCT00433511|537867617|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
149106116|NCT00433511|537867618|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
149106117|NCT00433511|537867619|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
149106118|NCT00433511|537867617|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
149106119|NCT00433511|537867618|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
149106120|NCT00433511|537867619|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
149106121|NCT00433511|537867617|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
149106122|NCT00433511|537867618|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
149106123|NCT00433511|537867619|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
149106124|NCT00433511|537867617|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
149106125|NCT00433511|537867618|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
149106126|NCT00433511|537867619|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
149106127|NCT02312557|537867620|FG000|Overall Study|Survival follow-up|4|||
149106128|NCT00742326|537867621|FG000|Overall Study|Physician Decision|0|||
149106129|NCT00742326|537867622|FG001|Overall Study|Physician Decision|1|||
149106130|NCT03698994|537867626|FG000|Overall Study|Adverse Event|2|||
149106131|NCT03698994|537867626|FG000|Overall Study|Death|1|||
149106132|NCT03698994|537867626|FG000|Overall Study|Physician Decision|1|||
149106133|NCT03698994|537867626|FG000|Overall Study|Withdrawal by Subject|3|||
149106134|NCT03698994|537867626|FG000|Overall Study|Progressive Disease|12|||
149106135|NCT04042077|537867631|FG000|Overall Study|Adverse Event|0|||
149106136|NCT04042077|537867632|FG001|Overall Study|Adverse Event|1|||
149106137|NCT04042077|537867631|FG000|Overall Study|Death|2|||
149106138|NCT04042077|537867632|FG001|Overall Study|Death|1|||
149106139|NCT04042077|537867631|FG000|Overall Study|Physician Decision|2|||
149106140|NCT04042077|537867632|FG001|Overall Study|Physician Decision|0|||
149106141|NCT04042077|537867631|FG000|Overall Study|Withdrawal by Subject|3|||
149106142|NCT04042077|537867632|FG001|Overall Study|Withdrawal by Subject|2|||
149106143|NCT04042077|537867631|FG000|Overall Study|Lack of Efficacy|0|||
149106144|NCT04042077|537867632|FG001|Overall Study|Lack of Efficacy|1|||
149106145|NCT01080300|537867633|FG000|Overall Study|Adverse Event|49|||
149106146|NCT01080300|537867634|FG001|Overall Study|Adverse Event|35|||
149106147|NCT01080300|537867633|FG000|Overall Study|Lack of Efficacy|12|||
149106148|NCT01080300|537867634|FG001|Overall Study|Lack of Efficacy|15|||
149106149|NCT01080300|537867633|FG000|Overall Study|Protocol Violation|7|||
149106150|NCT01080300|537867634|FG001|Overall Study|Protocol Violation|13|||
149106151|NCT01080300|537867633|FG000|Overall Study|Lost to Follow-up|10|||
149106152|NCT01080300|537867634|FG001|Overall Study|Lost to Follow-up|6|||
149106153|NCT01080300|537867633|FG000|Overall Study|Death|0|||
149106154|NCT01080300|537867634|FG001|Overall Study|Death|1|||
149106155|NCT01080300|537867633|FG000|Overall Study|Withdrawal by Subject|12|||
149106156|NCT01080300|537867634|FG001|Overall Study|Withdrawal by Subject|28|||
149106157|NCT01080300|537867633|FG000|Overall Study|Reasons not specified|4|||
149106158|NCT01080300|537867634|FG001|Overall Study|Reasons not specified|6|||
149106159|NCT02615938|537867636|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
149106160|NCT02615938|537867637|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
149106161|NCT02615938|537867638|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
149106162|NCT02615938|537867639|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
149106163|NCT02615938|537867636|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
149106164|NCT02615938|537867637|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
149106165|NCT02615938|537867638|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
149106166|NCT02615938|537867639|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
149106167|NCT02615938|537867636|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
149106168|NCT02615938|537867637|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
149106169|NCT02615938|537867638|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
149106170|NCT02615938|537867639|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
149106171|NCT03692052|537867643|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
149106172|NCT03692052|537867643|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
149106173|NCT03692052|537867643|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
149106174|NCT03692052|537867643|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
149106175|NCT04596540|537867644|FG000|Overall Study|Withdrawal by Subject|9|||
149106176|NCT04596540|537867645|FG001|Overall Study|Withdrawal by Subject|8|||
149106177|NCT04596540|537867646|FG002|Overall Study|Withdrawal by Subject|5|||
149106178|NCT04596540|537867644|FG000|Overall Study|Lost to Follow-up|1|||
149106179|NCT04596540|537867645|FG001|Overall Study|Lost to Follow-up|2|||
149106180|NCT04596540|537867646|FG002|Overall Study|Lost to Follow-up|1|||
149106181|NCT04596540|537867644|FG000|Overall Study|Sponsor Decision|2|||
149106182|NCT04596540|537867645|FG001|Overall Study|Sponsor Decision|0|||
149106183|NCT04596540|537867646|FG002|Overall Study|Sponsor Decision|0|||
149106184|NCT04596540|537867644|FG000|Overall Study|Physician Decision|0|||
149106185|NCT04596540|537867645|FG001|Overall Study|Physician Decision|1|||
149106186|NCT04596540|537867646|FG002|Overall Study|Physician Decision|1|||
149106187|NCT04596540|537867644|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
149106188|NCT04596540|537867645|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
149106189|NCT04596540|537867646|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
149106190|NCT04596540|537867644|FG000|Overall Study|Other Than Specified|5|||
149106191|NCT04596540|537867645|FG001|Overall Study|Other Than Specified|5|||
149106192|NCT04596540|537867646|FG002|Overall Study|Other Than Specified|2|||
149106193|NCT04526665|537867649|FG000|Overall Study|Withdrawal by Subject|6|||
149106194|NCT04526665|537867650|FG001|Overall Study|Withdrawal by Subject|3|||
149106195|NCT04526665|537867649|FG000|Overall Study|Adverse Event|4|||
149106196|NCT04526665|537867650|FG001|Overall Study|Adverse Event|1|||
149106197|NCT04526665|537867649|FG000|Overall Study|Physician Decision|2|||
149106198|NCT04526665|537867650|FG001|Overall Study|Physician Decision|2|||
149106199|NCT04526665|537867649|FG000|Overall Study|Death|2|||
149106200|NCT04526665|537867650|FG001|Overall Study|Death|0|||
149106201|NCT04526665|537867649|FG000|Overall Study|Other|0|||
149106202|NCT04526665|537867650|FG001|Overall Study|Other|1|||
149106203|NCT04704219|537867652|FG000|Overall Study|Screen Failure|1|||
149106204|NCT04704219|537867652|FG000|Overall Study|Withdrawal by Subject|1|||
149106205|NCT04704219|537867652|FG000|Overall Study|Death|78|||
149106206|NCT04704219|537867652|FG000|Overall Study|Participants Ongoing|80|||
149106207|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
149106208|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
149106209|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
149106210|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
149106211|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
149106212|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
149106213|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
149106214|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
149106215|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
149106216|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
149106217|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
149106218|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
149106219|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
149106220|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
149106221|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
149106222|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
149106223|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
149106224|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
149106225|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
149106226|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
149106227|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
149106228|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
149106229|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
149106230|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
149106231|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
149106232|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
149106233|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
149106234|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
149106235|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
149106236|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
149106237|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
149106238|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
149106239|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
149106240|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
149106241|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
149106242|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
149106243|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
149106244|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
149106245|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
149106246|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
149106247|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
149106248|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
149106249|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
149106250|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
149106251|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
149106252|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
149106253|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
149106254|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
149106255|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
149106256|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
149106257|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
149106258|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
149106259|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
149106260|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
149106261|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
149106262|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
149106263|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
149106264|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
149106265|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
149106266|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
149106267|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
149106268|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
149106269|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
149106270|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
149106271|NCT00217737|537867653|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
149106272|NCT00217737|537867654|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
149106273|NCT00217737|537867655|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
149106274|NCT00217737|537867656|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
149106275|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
149106276|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
149106277|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
149106278|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
149106279|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
149106280|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
149106281|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
149106282|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
149106283|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Study suspension|0|||
149106284|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Study suspension|45|||
149106285|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Study suspension|0|||
149106286|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Study suspension|0|||
149106287|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
149106288|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
149106289|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
149106290|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
149106291|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Death|2|||
149106292|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Death|3|||
149106293|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Death|0|||
149106294|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Death|0|||
149106295|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
149106296|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
149106297|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
149106298|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
149106299|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
149106300|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
149106301|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
149106302|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
149106303|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
149106304|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
149106305|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
149106306|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
149106307|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
149106308|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
149106309|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
149106310|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
149106311|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
149106312|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
149106313|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
149106314|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
149106315|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
149106316|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
149106317|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
149106318|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
149106319|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
149106320|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
149106321|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
149106322|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
149106323|NCT00217737|537867653|FG000|Step 2 Randomization/Registration|Other|1|||
149106324|NCT00217737|537867654|FG001|Step 2 Randomization/Registration|Other|2|||
149106325|NCT00217737|537867655|FG002|Step 2 Randomization/Registration|Other|0|||
149106326|NCT00217737|537867656|FG003|Step 2 Randomization/Registration|Other|0|||
149106327|NCT03213704|537867657|FG000|Overall Study|Physician Decision|3|||
149106328|NCT03213704|537867657|FG000|Overall Study|Protocol Violation|1|||
149106329|NCT03213704|537867657|FG000|Overall Study|Progressive disease|4|||
149106330|NCT04949802|537869082|FG000|Overall Study|Lost to Follow-up|3|||
149106331|NCT00233480|537869085|FG000|Overall Study|Underwent status II heart transplant|0|||
149106332|NCT00233480|537869086|FG001|Overall Study|Underwent status II heart transplant|1|||
149106333|NCT01443403|537869087|FG000|Overall Study|Adverse Event|1|||
149106334|NCT01443403|537869088|FG001|Overall Study|Adverse Event|1|||
149106335|NCT01443403|537869089|FG002|Overall Study|Adverse Event|4|||
149106336|NCT01443403|537869090|FG003|Overall Study|Adverse Event|5|||
149106337|NCT01443403|537869087|FG000|Overall Study|Withdrawal by Subject|0|||
149106338|NCT01443403|537869088|FG001|Overall Study|Withdrawal by Subject|1|||
149106339|NCT01443403|537869089|FG002|Overall Study|Withdrawal by Subject|2|||
149106340|NCT01443403|537869090|FG003|Overall Study|Withdrawal by Subject|1|||
149106341|NCT01443403|537869087|FG000|Overall Study|Lost to Follow-up|0|||
149106342|NCT01443403|537869088|FG001|Overall Study|Lost to Follow-up|0|||
149106343|NCT01443403|537869089|FG002|Overall Study|Lost to Follow-up|0|||
149106344|NCT01443403|537869090|FG003|Overall Study|Lost to Follow-up|1|||
149106345|NCT01443403|537869087|FG000|Overall Study|Protocol Violation|2|||
149106346|NCT01443403|537869088|FG001|Overall Study|Protocol Violation|1|||
149106347|NCT01443403|537869089|FG002|Overall Study|Protocol Violation|1|||
149106348|NCT01443403|537869090|FG003|Overall Study|Protocol Violation|1|||
149106349|NCT01443403|537869087|FG000|Overall Study|Use of Prohibited Treatment|2|||
149106350|NCT01443403|537869088|FG001|Overall Study|Use of Prohibited Treatment|3|||
149106351|NCT01443403|537869089|FG002|Overall Study|Use of Prohibited Treatment|0|||
149106352|NCT01443403|537869090|FG003|Overall Study|Use of Prohibited Treatment|0|||
149106353|NCT01443403|537869087|FG000|Overall Study|Other - Miscellaneous|1|||
149106354|NCT01443403|537869088|FG001|Overall Study|Other - Miscellaneous|0|||
149106355|NCT01443403|537869089|FG002|Overall Study|Other - Miscellaneous|0|||
149106356|NCT01443403|537869090|FG003|Overall Study|Other - Miscellaneous|1|||
149106357|NCT03258723|537869091|FG000|Overall Study|COVID Interruption of study|54|||
149106358|NCT03258723|537869091|FG000|Overall Study|Lost to Follow-up|8|||
149106359|NCT01107899|537869092|FG000|Overall Study|Physician Decision|5|||
149106360|NCT01107899|537869093|FG001|Overall Study|Physician Decision|0|||
149106361|NCT01107899|537869094|FG002|Overall Study|Physician Decision|3|||
149106362|NCT01107899|537869092|FG000|Overall Study|Withdrawal by Subject|0|||
149106363|NCT01107899|537869093|FG001|Overall Study|Withdrawal by Subject|0|||
149106364|NCT01107899|537869094|FG002|Overall Study|Withdrawal by Subject|1|||
149106365|NCT00953771|537869095|FG000|Overall Study|Death|1|||
149106366|NCT00953771|537869096|FG001|Overall Study|Death|0|||
149106367|NCT00974259|537869097|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
149106368|NCT00974259|537869098|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
149106369|NCT00592293|537869100|FG000|Overall Study|Withdrawal by Subject|1|||
149106370|NCT01606319|537869101|FG000|Overall Study|Lost to Follow-up|17|||
149106371|NCT01606319|537869102|FG001|Overall Study|Lost to Follow-up|14|||
149106372|NCT01606319|537869101|FG000|Overall Study|Withdrawal by Subject|9|||
149106373|NCT01606319|537869102|FG001|Overall Study|Withdrawal by Subject|12|||
149106374|NCT01606319|537869101|FG000|Overall Study|Physician Decision|1|||
149106375|NCT01606319|537869102|FG001|Overall Study|Physician Decision|2|||
149106376|NCT01606319|537869101|FG000|Overall Study|Lack of Efficacy|6|||
149106377|NCT01606319|537869102|FG001|Overall Study|Lack of Efficacy|8|||
149106378|NCT01606319|537869101|FG000|Overall Study|Adverse Event|1|||
149106379|NCT01606319|537869102|FG001|Overall Study|Adverse Event|4|||
149106380|NCT01784523|537869105|FG000|Overall Study|Study closed early|7|||
149106381|NCT01784523|537869106|FG001|Overall Study|Study closed early|4|||
149106382|NCT00022659|537869109|FG000|Overall Study|Ineligible: wrong primary|1|||
149106383|NCT00022659|537869109|FG000|Overall Study|Never treated|1|||
149106384|NCT03377361|537869110|FG000|Pre-Treatment|Subject withdrew consent|0|||
149106385|NCT03377361|537869111|FG001|Pre-Treatment|Subject withdrew consent|0|||
149106386|NCT03377361|537869112|FG002|Pre-Treatment|Subject withdrew consent|0|||
149106387|NCT03377361|537869113|FG003|Pre-Treatment|Subject withdrew consent|0|||
149106388|NCT03377361|537869114|FG004|Pre-Treatment|Subject withdrew consent|0|||
149106389|NCT03377361|537869115|FG005|Pre-Treatment|Subject withdrew consent|0|||
149106390|NCT03377361|537869116|FG006|Pre-Treatment|Subject withdrew consent|0|||
149106391|NCT03377361|537869117|FG007|Pre-Treatment|Subject withdrew consent|3|||
149106392|NCT03377361|537869118|FG008|Pre-Treatment|Subject withdrew consent|1|||
149106393|NCT03377361|537869119|FG009|Pre-Treatment|Subject withdrew consent|0|||
149106394|NCT03377361|537869110|FG000|Pre-Treatment|Not Reported|0|||
149106395|NCT03377361|537869111|FG001|Pre-Treatment|Not Reported|0|||
149106396|NCT03377361|537869112|FG002|Pre-Treatment|Not Reported|0|||
149106397|NCT03377361|537869113|FG003|Pre-Treatment|Not Reported|0|||
149106398|NCT03377361|537869114|FG004|Pre-Treatment|Not Reported|0|||
149106399|NCT03377361|537869115|FG005|Pre-Treatment|Not Reported|0|||
149106400|NCT03377361|537869116|FG006|Pre-Treatment|Not Reported|0|||
149106401|NCT03377361|537869117|FG007|Pre-Treatment|Not Reported|0|||
149106402|NCT03377361|537869118|FG008|Pre-Treatment|Not Reported|3|||
149106403|NCT03377361|537869119|FG009|Pre-Treatment|Not Reported|0|||
149106404|NCT03377361|537869110|FG000|Treatment Period|Disease Progression|3|||
149106405|NCT03377361|537869111|FG001|Treatment Period|Disease Progression|2|||
149106406|NCT03377361|537869112|FG002|Treatment Period|Disease Progression|5|||
149106407|NCT03377361|537869113|FG003|Treatment Period|Disease Progression|3|||
149106408|NCT03377361|537869114|FG004|Treatment Period|Disease Progression|3|||
149106409|NCT03377361|537869115|FG005|Treatment Period|Disease Progression|3|||
149106410|NCT03377361|537869116|FG006|Treatment Period|Disease Progression|6|||
149106411|NCT03377361|537869117|FG007|Treatment Period|Disease Progression|106|||
149106412|NCT03377361|537869118|FG008|Treatment Period|Disease Progression|48|||
149106413|NCT03377361|537869119|FG009|Treatment Period|Disease Progression|59|||
149106414|NCT03377361|537869110|FG000|Treatment Period|Study Drug Toxicity|0|||
149106415|NCT03377361|537869111|FG001|Treatment Period|Study Drug Toxicity|0|||
149106416|NCT03377361|537869112|FG002|Treatment Period|Study Drug Toxicity|0|||
149106417|NCT03377361|537869113|FG003|Treatment Period|Study Drug Toxicity|1|||
149106418|NCT03377361|537869114|FG004|Treatment Period|Study Drug Toxicity|0|||
149106419|NCT03377361|537869115|FG005|Treatment Period|Study Drug Toxicity|0|||
149106420|NCT03377361|537869116|FG006|Treatment Period|Study Drug Toxicity|0|||
149106421|NCT03377361|537869117|FG007|Treatment Period|Study Drug Toxicity|7|||
149106422|NCT03377361|537869118|FG008|Treatment Period|Study Drug Toxicity|2|||
149106423|NCT03377361|537869119|FG009|Treatment Period|Study Drug Toxicity|16|||
149106424|NCT03377361|537869110|FG000|Treatment Period|Death|0|||
149106425|NCT03377361|537869111|FG001|Treatment Period|Death|0|||
149106426|NCT03377361|537869112|FG002|Treatment Period|Death|1|||
149106427|NCT03377361|537869113|FG003|Treatment Period|Death|0|||
149106428|NCT03377361|537869114|FG004|Treatment Period|Death|0|||
149106429|NCT03377361|537869115|FG005|Treatment Period|Death|0|||
149106430|NCT03377361|537869116|FG006|Treatment Period|Death|0|||
149106431|NCT03377361|537869117|FG007|Treatment Period|Death|2|||
149106432|NCT03377361|537869118|FG008|Treatment Period|Death|1|||
149106433|NCT03377361|537869119|FG009|Treatment Period|Death|3|||
149106434|NCT03377361|537869110|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106435|NCT03377361|537869111|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106436|NCT03377361|537869112|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106437|NCT03377361|537869113|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106438|NCT03377361|537869114|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106439|NCT03377361|537869115|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106440|NCT03377361|537869116|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
149106441|NCT03377361|537869117|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
149106442|NCT03377361|537869118|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
149106443|NCT03377361|537869119|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
149106444|NCT03377361|537869110|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
149106445|NCT03377361|537869111|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
149106446|NCT03377361|537869112|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
149106447|NCT03377361|537869113|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
149106448|NCT03377361|537869114|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
149106449|NCT03377361|537869115|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
149106450|NCT03377361|537869116|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
149106451|NCT03377361|537869117|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
149106452|NCT03377361|537869118|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
149106453|NCT03377361|537869119|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
149106454|NCT03377361|537869110|FG000|Treatment Period|Subject Withdrew Consent|0|||
149106455|NCT03377361|537869111|FG001|Treatment Period|Subject Withdrew Consent|0|||
149106456|NCT03377361|537869112|FG002|Treatment Period|Subject Withdrew Consent|0|||
149106457|NCT03377361|537869113|FG003|Treatment Period|Subject Withdrew Consent|0|||
149106458|NCT03377361|537869114|FG004|Treatment Period|Subject Withdrew Consent|0|||
149106459|NCT03377361|537869115|FG005|Treatment Period|Subject Withdrew Consent|0|||
149106460|NCT03377361|537869116|FG006|Treatment Period|Subject Withdrew Consent|0|||
149106461|NCT03377361|537869117|FG007|Treatment Period|Subject Withdrew Consent|0|||
149106462|NCT03377361|537869118|FG008|Treatment Period|Subject Withdrew Consent|2|||
149106463|NCT03377361|537869119|FG009|Treatment Period|Subject Withdrew Consent|1|||
149106464|NCT03377361|537869110|FG000|Treatment Period|No longer meets study criteria|0|||
149106465|NCT03377361|537869111|FG001|Treatment Period|No longer meets study criteria|1|||
149106466|NCT03377361|537869112|FG002|Treatment Period|No longer meets study criteria|0|||
149106467|NCT03377361|537869113|FG003|Treatment Period|No longer meets study criteria|0|||
149106468|NCT03377361|537869114|FG004|Treatment Period|No longer meets study criteria|0|||
149106469|NCT03377361|537869115|FG005|Treatment Period|No longer meets study criteria|0|||
149106470|NCT03377361|537869116|FG006|Treatment Period|No longer meets study criteria|0|||
149106471|NCT03377361|537869117|FG007|Treatment Period|No longer meets study criteria|1|||
149106472|NCT03377361|537869118|FG008|Treatment Period|No longer meets study criteria|0|||
149106473|NCT03377361|537869119|FG009|Treatment Period|No longer meets study criteria|0|||
149106474|NCT03377361|537869110|FG000|Treatment Period|Other Reasons|0|||
149106475|NCT03377361|537869111|FG001|Treatment Period|Other Reasons|0|||
149106476|NCT03377361|537869112|FG002|Treatment Period|Other Reasons|0|||
149106477|NCT03377361|537869113|FG003|Treatment Period|Other Reasons|3|||
149106478|NCT03377361|537869114|FG004|Treatment Period|Other Reasons|0|||
149106479|NCT03377361|537869115|FG005|Treatment Period|Other Reasons|0|||
149106480|NCT03377361|537869116|FG006|Treatment Period|Other Reasons|0|||
149106481|NCT03377361|537869117|FG007|Treatment Period|Other Reasons|2|||
149106482|NCT03377361|537869118|FG008|Treatment Period|Other Reasons|0|||
149106483|NCT03377361|537869119|FG009|Treatment Period|Other Reasons|1|||
149106484|NCT02838134|537869120|FG000|Overall Study|Lost to Follow-up|1|||
149106485|NCT02838134|537869121|FG001|Overall Study|Lost to Follow-up|2|||
149106486|NCT02838134|537869120|FG000|Overall Study|logistic problems|1|||
149106487|NCT02838134|537869121|FG001|Overall Study|logistic problems|1|||
149106488|NCT00794924|537869122|FG000|Overall Study|Lost to Follow-up|6|||
149106489|NCT00794924|537869123|FG001|Overall Study|Lost to Follow-up|8|||
149106490|NCT00794924|537869122|FG000|Overall Study|Withdrawal by Subject|48|||
149106491|NCT00794924|537869123|FG001|Overall Study|Withdrawal by Subject|60|||
149106492|NCT00794924|537869122|FG000|Overall Study|Adverse Event|6|||
149106493|NCT00794924|537869123|FG001|Overall Study|Adverse Event|2|||
149106494|NCT03274895|537869124|FG000|Overall Study|Lack of Efficacy|1|||
149106495|NCT03274895|537869125|FG001|Overall Study|Lack of Efficacy|0|||
149106496|NCT03274895|537869124|FG000|Overall Study|Adverse Event|8|||
149106497|NCT03274895|537869125|FG001|Overall Study|Adverse Event|7|||
149106498|NCT03274895|537869124|FG000|Overall Study|Lost to Follow-up|1|||
149106499|NCT03274895|537869125|FG001|Overall Study|Lost to Follow-up|0|||
149106500|NCT03274895|537869124|FG000|Overall Study|Diagnosis not confirmed|3|||
149106501|NCT03274895|537869125|FG001|Overall Study|Diagnosis not confirmed|4|||
149106502|NCT01294436|537869126|FG000|Overall Study|Adverse Event|10|||
149106503|NCT01294436|537869127|FG001|Overall Study|Adverse Event|17|||
149106504|NCT01294436|537869126|FG000|Overall Study|Withdrawal by Subject|11|||
149106505|NCT01294436|537869127|FG001|Overall Study|Withdrawal by Subject|28|||
149106506|NCT01294436|537869126|FG000|Overall Study|subject no longer meets study criteria|5|||
149106507|NCT01294436|537869127|FG001|Overall Study|subject no longer meets study criteria|20|||
149106508|NCT01294436|537869126|FG000|Overall Study|poor/non-compliance|2|||
149106509|NCT01294436|537869127|FG001|Overall Study|poor/non-compliance|5|||
149106510|NCT02389764|537869128|FG000|Overall Study|Lack of Efficacy|9|||
149106511|NCT04674189|537869132|FG000|Overall Study|Adverse Event|0|||
149106512|NCT04674189|537869133|FG001|Overall Study|Adverse Event|0|||
149106513|NCT04674189|537869134|FG002|Overall Study|Adverse Event|1|||
149106514|NCT04674189|537869132|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
149106515|NCT04674189|537869133|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
149106516|NCT04674189|537869134|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
149106517|NCT04674189|537869132|FG000|Overall Study|Physician Decision|1|||
149106518|NCT04674189|537869133|FG001|Overall Study|Physician Decision|0|||
149106519|NCT04674189|537869134|FG002|Overall Study|Physician Decision|0|||
149106520|NCT04674189|537869132|FG000|Overall Study|Withdrawal by Participant|83|||
149106521|NCT04674189|537869133|FG001|Overall Study|Withdrawal by Participant|71|||
149106522|NCT04674189|537869134|FG002|Overall Study|Withdrawal by Participant|142|||
149106523|NCT04674189|537869132|FG000|Overall Study|Lost to Follow-up|55|||
149106524|NCT04674189|537869133|FG001|Overall Study|Lost to Follow-up|53|||
149106525|NCT04674189|537869134|FG002|Overall Study|Lost to Follow-up|44|||
149106526|NCT04674189|537869132|FG000|Overall Study|Miscellaneous|27|||
149106527|NCT04674189|537869133|FG001|Overall Study|Miscellaneous|23|||
149106528|NCT04674189|537869134|FG002|Overall Study|Miscellaneous|207|||
149106529|NCT04674189|537869132|FG000|Overall Study|Did Not Receive Treatment|3|||
149106530|NCT04674189|537869133|FG001|Overall Study|Did Not Receive Treatment|1|||
149106531|NCT04674189|537869134|FG002|Overall Study|Did Not Receive Treatment|2|||
149106532|NCT01637077|537869135|FG000|Overall Study|Cancel|1|||
149106533|NCT01637077|537869136|FG001|Overall Study|Cancel|1|||
149106534|NCT01637077|537869135|FG000|Overall Study|Withdrawal by Subject|1|||
149106535|NCT01637077|537869136|FG001|Overall Study|Withdrawal by Subject|0|||
149106536|NCT01637077|537869135|FG000|Overall Study|No cycle 1 questionnaire data|2|||
149106537|NCT01637077|537869136|FG001|Overall Study|No cycle 1 questionnaire data|0|||
149106538|NCT02638103|537869139|FG000|Overall Study|Adverse Event|13|||
149106539|NCT02638103|537869140|FG001|Overall Study|Adverse Event|12|||
149106540|NCT02638103|537869141|FG002|Overall Study|Adverse Event|19|||
149106541|NCT02638103|537869142|FG003|Overall Study|Adverse Event|12|||
149106542|NCT02638103|537869139|FG000|Overall Study|Withdrawal by Subject|43|||
149106543|NCT02638103|537869140|FG001|Overall Study|Withdrawal by Subject|53|||
149106544|NCT02638103|537869141|FG002|Overall Study|Withdrawal by Subject|30|||
149106545|NCT02638103|537869142|FG003|Overall Study|Withdrawal by Subject|61|||
149106546|NCT02638103|537869139|FG000|Overall Study|Protocol Violation|1|||
149106547|NCT02638103|537869140|FG001|Overall Study|Protocol Violation|2|||
149106548|NCT02638103|537869141|FG002|Overall Study|Protocol Violation|1|||
149106549|NCT02638103|537869142|FG003|Overall Study|Protocol Violation|4|||
149106550|NCT02638103|537869139|FG000|Overall Study|Pregnancy|2|||
149106551|NCT02638103|537869140|FG001|Overall Study|Pregnancy|3|||
149106552|NCT02638103|537869141|FG002|Overall Study|Pregnancy|0|||
149106553|NCT02638103|537869142|FG003|Overall Study|Pregnancy|1|||
149106554|NCT02638103|537869139|FG000|Overall Study|Non-compliance to Study Procedures|2|||
149106555|NCT02638103|537869140|FG001|Overall Study|Non-compliance to Study Procedures|1|||
149106556|NCT02638103|537869141|FG002|Overall Study|Non-compliance to Study Procedures|1|||
149106557|NCT02638103|537869142|FG003|Overall Study|Non-compliance to Study Procedures|1|||
149106558|NCT02638103|537869139|FG000|Overall Study|Lost to Follow-up|26|||
149106559|NCT02638103|537869140|FG001|Overall Study|Lost to Follow-up|33|||
149106560|NCT02638103|537869141|FG002|Overall Study|Lost to Follow-up|20|||
149106561|NCT02638103|537869142|FG003|Overall Study|Lost to Follow-up|37|||
149106562|NCT02638103|537869139|FG000|Overall Study|Lack of Efficacy|14|||
149106563|NCT02638103|537869140|FG001|Overall Study|Lack of Efficacy|10|||
149106564|NCT02638103|537869141|FG002|Overall Study|Lack of Efficacy|12|||
149106565|NCT02638103|537869142|FG003|Overall Study|Lack of Efficacy|22|||
149106566|NCT02638103|537869139|FG000|Overall Study|Other than specified|5|||
149106567|NCT02638103|537869140|FG001|Overall Study|Other than specified|4|||
149106568|NCT02638103|537869141|FG002|Overall Study|Other than specified|2|||
149106569|NCT02638103|537869142|FG003|Overall Study|Other than specified|4|||
149106570|NCT01358331|537869143|FG000|Overall Study|Lost to Follow-up|0|||
149106571|NCT01358331|537869144|FG001|Overall Study|Lost to Follow-up|0|||
149106572|NCT01358331|537869145|FG002|Overall Study|Lost to Follow-up|0|||
149106573|NCT01358331|537869146|FG003|Overall Study|Lost to Follow-up|1|||
149106574|NCT01358331|537869147|FG004|Overall Study|Lost to Follow-up|0|||
149106575|NCT01358331|537869148|FG005|Overall Study|Lost to Follow-up|0|||
149106576|NCT01358331|537869143|FG000|Overall Study|Withdrawal by Subject|0|||
149106577|NCT01358331|537869144|FG001|Overall Study|Withdrawal by Subject|0|||
149106578|NCT01358331|537869145|FG002|Overall Study|Withdrawal by Subject|0|||
149106579|NCT01358331|537869146|FG003|Overall Study|Withdrawal by Subject|1|||
149106580|NCT01358331|537869147|FG004|Overall Study|Withdrawal by Subject|1|||
149106581|NCT01358331|537869148|FG005|Overall Study|Withdrawal by Subject|1|||
149106582|NCT01358331|537869143|FG000|Overall Study|Adverse Events|1|||
149106583|NCT01358331|537869144|FG001|Overall Study|Adverse Events|1|||
149106584|NCT01358331|537869145|FG002|Overall Study|Adverse Events|1|||
149106585|NCT01358331|537869146|FG003|Overall Study|Adverse Events|0|||
149106586|NCT01358331|537869147|FG004|Overall Study|Adverse Events|1|||
149106587|NCT01358331|537869148|FG005|Overall Study|Adverse Events|5|||
149106588|NCT01358331|537869143|FG000|Overall Study|Symptomatic Deterioration|0|||
149106589|NCT01358331|537869144|FG001|Overall Study|Symptomatic Deterioration|0|||
149106590|NCT01358331|537869145|FG002|Overall Study|Symptomatic Deterioration|0|||
149106591|NCT01358331|537869146|FG003|Overall Study|Symptomatic Deterioration|0|||
149106592|NCT01358331|537869147|FG004|Overall Study|Symptomatic Deterioration|1|||
149106593|NCT01358331|537869148|FG005|Overall Study|Symptomatic Deterioration|0|||
149106594|NCT01358331|537869143|FG000|Overall Study|Participants did not wish to continue|0|||
149106595|NCT01358331|537869144|FG001|Overall Study|Participants did not wish to continue|0|||
149106596|NCT01358331|537869145|FG002|Overall Study|Participants did not wish to continue|0|||
149106597|NCT01358331|537869146|FG003|Overall Study|Participants did not wish to continue|0|||
149106598|NCT01358331|537869147|FG004|Overall Study|Participants did not wish to continue|1|||
149106599|NCT01358331|537869148|FG005|Overall Study|Participants did not wish to continue|0|||
149106600|NCT01358331|537869143|FG000|Overall Study|Progress of disease under investigation|1|||
149106601|NCT01358331|537869144|FG001|Overall Study|Progress of disease under investigation|2|||
149106602|NCT01358331|537869145|FG002|Overall Study|Progress of disease under investigation|3|||
149106603|NCT01358331|537869146|FG003|Overall Study|Progress of disease under investigation|1|||
149106604|NCT01358331|537869147|FG004|Overall Study|Progress of disease under investigation|3|||
149106605|NCT01358331|537869148|FG005|Overall Study|Progress of disease under investigation|0|||
149106606|NCT04907357|537869149|FG000|Overall Study|Death|0|||
149106607|NCT04907357|537869150|FG001|Overall Study|Death|1|||
149106608|NCT04907357|537869149|FG000|Overall Study|Lost to Follow-up|9|||
149106609|NCT04907357|537869150|FG001|Overall Study|Lost to Follow-up|18|||
149106610|NCT04907357|537869149|FG000|Overall Study|Physician Decision|1|||
149106611|NCT04907357|537869150|FG001|Overall Study|Physician Decision|0|||
149106612|NCT04907357|537869149|FG000|Overall Study|Withdrawal by Subject|0|||
149106613|NCT04907357|537869150|FG001|Overall Study|Withdrawal by Subject|1|||
149106614|NCT04907357|537869149|FG000|Overall Study|Unable to attend visits|1|||
149106615|NCT04907357|537869150|FG001|Overall Study|Unable to attend visits|0|||
149106616|NCT04907357|537869149|FG000|Overall Study|Incarcerated|1|||
149106617|NCT04907357|537869150|FG001|Overall Study|Incarcerated|1|||
149106618|NCT03342196|537869151|FG000|Overall Study|Physician Decision|1|||
149106619|NCT00546078|537869152|FG000|Overall Study|Lost to Follow-up|1|||
149106620|NCT00546078|537869153|FG001|Overall Study|Lost to Follow-up|3|||
149106621|NCT00546078|537869152|FG000|Overall Study|Withdrawal by Subject|2|||
149106622|NCT00546078|537869153|FG001|Overall Study|Withdrawal by Subject|3|||
149106623|NCT00546078|537869152|FG000|Overall Study|Other reason|1|||
149106624|NCT00546078|537869153|FG001|Overall Study|Other reason|1|||
149106625|NCT03358238|537869158|FG000|Overall Study|Withdrawal by Subject|0|||
149106626|NCT03358238|537869159|FG001|Overall Study|Withdrawal by Subject|1|||
149106627|NCT01431950|537869160|FG000|Overall Study|Study Site Closed/Terminated|7|||
149106628|NCT01431950|537869161|FG001|Overall Study|Study Site Closed/Terminated|3|||
149106629|NCT01431950|537869160|FG000|Overall Study|Withdrawal by Subject|4|||
149106630|NCT01431950|537869161|FG001|Overall Study|Withdrawal by Subject|3|||
149106631|NCT01431950|537869160|FG000|Overall Study|Protocol Violation|2|||
149106632|NCT01431950|537869161|FG001|Overall Study|Protocol Violation|3|||
149106633|NCT01431950|537869160|FG000|Overall Study|Adverse Event|2|||
149106634|NCT01431950|537869161|FG001|Overall Study|Adverse Event|2|||
149106635|NCT01431950|537869160|FG000|Overall Study|Physician Decision|2|||
149106636|NCT01431950|537869161|FG001|Overall Study|Physician Decision|1|||
149106637|NCT01431950|537869160|FG000|Overall Study|Lack of Efficacy|2|||
149106638|NCT01431950|537869161|FG001|Overall Study|Lack of Efficacy|1|||
149106639|NCT01431950|537869160|FG000|Overall Study|Lost to Follow-up|0|||
149106640|NCT01431950|537869161|FG001|Overall Study|Lost to Follow-up|1|||
149106641|NCT01431950|537869160|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
149106642|NCT01431950|537869161|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
149106643|NCT01261247|537869162|FG000|Overall Study|Ineligible|2|||
149106644|NCT01210651|537869163|FG000|Overall Study|Lost to Follow-up|1|||
149106645|NCT01210651|537869164|FG001|Overall Study|Lost to Follow-up|1|||
149106646|NCT01210651|537869163|FG000|Overall Study|schedule conflicts|1|||
149106647|NCT01210651|537869164|FG001|Overall Study|schedule conflicts|5|||
149106648|NCT01210651|537869163|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
149106649|NCT01210651|537869164|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
149106650|NCT01210651|537869163|FG000|Overall Study|Withdrawal by Subject|1|||
149106651|NCT01210651|537869164|FG001|Overall Study|Withdrawal by Subject|1|||
149106652|NCT01210651|537869163|FG000|Overall Study|Injury outside study|2|||
149106653|NCT01210651|537869164|FG001|Overall Study|Injury outside study|0|||
149106654|NCT01740154|537869165|FG000|Overall Study|Adverse Event|1|||
149106655|NCT05226130|537869169|FG000|Overall Study|Lost to Follow-up|0|||
149106656|NCT05226130|537869170|FG001|Overall Study|Lost to Follow-up|1|||
149106657|NCT05226130|537869169|FG000|Overall Study|Not treatment adherent|0|||
149106658|NCT05226130|537869170|FG001|Overall Study|Not treatment adherent|2|||
149106659|NCT03358472|537869171|FG000|Overall Study|Death|6|||
149106660|NCT03358472|537869172|FG001|Overall Study|Death|3|||
149106661|NCT03358472|537869173|FG002|Overall Study|Death|10|||
149106662|NCT03358472|537869171|FG000|Overall Study|Physician Decision|0|||
149106663|NCT03358472|537869172|FG001|Overall Study|Physician Decision|1|||
149106664|NCT03358472|537869173|FG002|Overall Study|Physician Decision|0|||
149106665|NCT03358472|537869171|FG000|Overall Study|Withdrawal by Subject|0|||
149106666|NCT03358472|537869172|FG001|Overall Study|Withdrawal by Subject|0|||
149106667|NCT03358472|537869173|FG002|Overall Study|Withdrawal by Subject|1|||
149106668|NCT03358472|537869171|FG000|Overall Study|On-going at clinical cut off date|9|||
149106669|NCT03358472|537869172|FG001|Overall Study|On-going at clinical cut off date|6|||
149106670|NCT03358472|537869173|FG002|Overall Study|On-going at clinical cut off date|5|||
149106671|NCT03974022|537869174|FG000|Overall Study|Death|0|||
149106672|NCT03974022|537869175|FG001|Overall Study|Death|1|||
149106673|NCT03974022|537869176|FG002|Overall Study|Death|0|||
149106674|NCT03974022|537869177|FG003|Overall Study|Death|2|||
149106675|NCT03974022|537869178|FG004|Overall Study|Death|0|||
149106676|NCT03974022|537869179|FG005|Overall Study|Death|1|||
149106677|NCT03974022|537869180|FG006|Overall Study|Death|0|||
149106678|NCT03974022|537869181|FG007|Overall Study|Death|2|||
149106679|NCT03974022|537869182|FG008|Overall Study|Death|1|||
149106680|NCT03974022|537869183|FG009|Overall Study|Death|4|||
149106681|NCT03974022|537869184|FG010|Overall Study|Death|0|||
149106682|NCT03974022|537869185|FG011|Overall Study|Death|0|||
149106683|NCT03974022|537869186|FG012|Overall Study|Death|0|||
149106684|NCT03974022|537869187|FG013|Overall Study|Death|33|||
149106685|NCT03974022|537869188|FG014|Overall Study|Death|40|||
149106686|NCT03974022|537869174|FG000|Overall Study|Withdrawal by Subject|0|||
149106687|NCT03974022|537869175|FG001|Overall Study|Withdrawal by Subject|0|||
149106688|NCT03974022|537869176|FG002|Overall Study|Withdrawal by Subject|0|||
149106689|NCT03974022|537869177|FG003|Overall Study|Withdrawal by Subject|0|||
149106690|NCT03974022|537869178|FG004|Overall Study|Withdrawal by Subject|0|||
149106691|NCT03974022|537869179|FG005|Overall Study|Withdrawal by Subject|4|||
149106692|NCT03974022|537869180|FG006|Overall Study|Withdrawal by Subject|4|||
149106693|NCT03974022|537869181|FG007|Overall Study|Withdrawal by Subject|2|||
149106694|NCT03974022|537869182|FG008|Overall Study|Withdrawal by Subject|2|||
149106695|NCT03974022|537869183|FG009|Overall Study|Withdrawal by Subject|3|||
149106696|NCT03974022|537869184|FG010|Overall Study|Withdrawal by Subject|0|||
149106697|NCT03974022|537869185|FG011|Overall Study|Withdrawal by Subject|1|||
149106698|NCT03974022|537869186|FG012|Overall Study|Withdrawal by Subject|0|||
149106699|NCT03974022|537869187|FG013|Overall Study|Withdrawal by Subject|3|||
149106700|NCT03974022|537869188|FG014|Overall Study|Withdrawal by Subject|9|||
149106701|NCT03974022|537869174|FG000|Overall Study|Lost to Follow-up|0|||
149106702|NCT03974022|537869175|FG001|Overall Study|Lost to Follow-up|0|||
149106703|NCT03974022|537869176|FG002|Overall Study|Lost to Follow-up|0|||
149106704|NCT03974022|537869177|FG003|Overall Study|Lost to Follow-up|0|||
149106705|NCT03974022|537869178|FG004|Overall Study|Lost to Follow-up|0|||
149106706|NCT03974022|537869179|FG005|Overall Study|Lost to Follow-up|0|||
149106707|NCT03974022|537869180|FG006|Overall Study|Lost to Follow-up|1|||
149106708|NCT03974022|537869181|FG007|Overall Study|Lost to Follow-up|0|||
149106709|NCT03974022|537869182|FG008|Overall Study|Lost to Follow-up|0|||
149106710|NCT03974022|537869183|FG009|Overall Study|Lost to Follow-up|0|||
149106711|NCT03974022|537869184|FG010|Overall Study|Lost to Follow-up|0|||
149106712|NCT03974022|537869185|FG011|Overall Study|Lost to Follow-up|0|||
149106713|NCT03974022|537869186|FG012|Overall Study|Lost to Follow-up|0|||
149106714|NCT03974022|537869187|FG013|Overall Study|Lost to Follow-up|1|||
149106715|NCT03974022|537869188|FG014|Overall Study|Lost to Follow-up|1|||
149106716|NCT03974022|537869174|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
149106717|NCT03974022|537869175|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
149106718|NCT03974022|537869176|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
149106719|NCT03974022|537869177|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
149106720|NCT03974022|537869178|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
149106721|NCT03974022|537869179|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
149106722|NCT03974022|537869180|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
149106723|NCT03974022|537869181|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
149106724|NCT03974022|537869182|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
149106725|NCT03974022|537869183|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
149106726|NCT03974022|537869184|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
149106727|NCT03974022|537869185|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
149106728|NCT03974022|537869186|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
149106729|NCT03974022|537869187|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
149106730|NCT03974022|537869188|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
149106731|NCT04013971|537869191|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
149106732|NCT04013971|537869192|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
149106733|NCT04013971|537869191|FG000|Overall Study|Missing biomechanical data|0|||
149106734|NCT04013971|537869192|FG001|Overall Study|Missing biomechanical data|1|||
149106735|NCT01340014|537869195|FG000|Period 1, First 7 Days|Adverse Event|1|||
149106736|NCT01340014|537869196|FG001|Period 1, First 7 Days|Adverse Event|0|||
149106737|NCT01340014|537869195|FG000|Period 1, First 7 Days|Personal Reasons|1|||
149106738|NCT01340014|537869196|FG001|Period 1, First 7 Days|Personal Reasons|0|||
149106739|NCT01340014|537869195|FG000|Period 2, Second 7 Days|Adverse Event|0|||
149106740|NCT01340014|537869196|FG001|Period 2, Second 7 Days|Adverse Event|1|||
149106741|NCT02520310|537869197|FG000|At 6 Months Clinical Follow-up|Death|1|||
149106742|NCT02520310|537869197|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
149106743|NCT02520310|537869197|FG000|AT 3 Year Clinical Follow-up|Death|2|||
149106744|NCT02520310|537869197|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
149106745|NCT02520310|537869197|FG000|AT 4 Year Clinical Follow-up|Death|1|||
149106746|NCT02520310|537869197|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
149106747|NCT05032066|537869198|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
149106748|NCT05032066|537869199|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
149106749|NCT05032066|537869200|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
149106750|NCT05032066|537869198|FG000|Part 1: Core Phase|Physician Decision|0|||
149106751|NCT05032066|537869199|FG001|Part 1: Core Phase|Physician Decision|1|||
149106752|NCT05032066|537869200|FG002|Part 1: Core Phase|Physician Decision|1|||
149106753|NCT05032066|537869198|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
149106754|NCT05032066|537869199|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
149106755|NCT05032066|537869200|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
149106756|NCT05032066|537869198|FG000|Part 1: Core Phase|Death|3|||
149106757|NCT05032066|537869199|FG001|Part 1: Core Phase|Death|4|||
149106758|NCT05032066|537869200|FG002|Part 1: Core Phase|Death|2|||
149106759|NCT05032066|537869198|FG000|Part 1: Core Phase|Adverse Event|2|||
149106760|NCT05032066|537869199|FG001|Part 1: Core Phase|Adverse Event|3|||
149106761|NCT05032066|537869200|FG002|Part 1: Core Phase|Adverse Event|0|||
149106762|NCT05032066|537869198|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
149106763|NCT05032066|537869199|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
149106764|NCT05032066|537869200|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
149106765|NCT05032066|537869198|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
149106766|NCT05032066|537869199|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
149106767|NCT05032066|537869200|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
149106768|NCT05032066|537869198|FG000|Part 2: Extension Phase|Physician Decision|1|||
149106769|NCT05032066|537869199|FG001|Part 2: Extension Phase|Physician Decision|2|||
149106770|NCT05032066|537869200|FG002|Part 2: Extension Phase|Physician Decision|0|||
149106771|NCT05032066|537869198|FG000|Part 2: Extension Phase|Death|2|||
149106772|NCT05032066|537869199|FG001|Part 2: Extension Phase|Death|4|||
149106773|NCT05032066|537869200|FG002|Part 2: Extension Phase|Death|5|||
149106774|NCT04577573|537869203|FG000|Overall Study|Technical - invalid protocol|0|||
149106775|NCT04577573|537869204|FG001|Overall Study|Technical - invalid protocol|2|||
149106776|NCT04577573|537869205|FG002|Overall Study|Technical - invalid protocol|0|||
149106777|NCT04297618|537869206|FG000|Overall Study|Adverse Event|1|||
149106778|NCT04297618|537869206|FG000|Overall Study|Withdrawal by Subject|1|||
149106779|NCT04680533|537869214|FG000|Overall Study|Screen failure|1|||
149106780|NCT01183390|537870775|FG000|First Intervention|Adverse Event|0|||
149106781|NCT01183390|537870776|FG001|First Intervention|Adverse Event|1|||
149106782|NCT00474526|537870777|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
149106783|NCT00474526|537870778|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
149106784|NCT00474526|537870779|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
149106785|NCT00474526|537870780|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
149106786|NCT00474526|537870781|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
149106787|NCT00474526|537870782|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
149106788|NCT00474526|537870783|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
149106789|NCT00474526|537870784|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
149106790|NCT00474526|537870785|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
149106791|NCT00474526|537870786|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
149106792|NCT00474526|537870787|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
149106793|NCT00474526|537870788|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
149106794|NCT00474526|537870789|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
149106795|NCT00474526|537870790|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
149106796|NCT00474526|537870791|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
149106797|NCT00474526|537870792|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
149106798|NCT00474526|537870793|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
149106799|NCT00474526|537870777|FG000|Overall Study|Adverse Event|2|||
149106800|NCT00474526|537870778|FG001|Overall Study|Adverse Event|0|||
149106801|NCT00474526|537870779|FG002|Overall Study|Adverse Event|2|||
149106802|NCT00474526|537870780|FG003|Overall Study|Adverse Event|4|||
149106803|NCT00474526|537870781|FG004|Overall Study|Adverse Event|2|||
149106804|NCT00474526|537870782|FG005|Overall Study|Adverse Event|1|||
149106805|NCT00474526|537870783|FG006|Overall Study|Adverse Event|1|||
149106806|NCT00474526|537870784|FG007|Overall Study|Adverse Event|0|||
149106807|NCT00474526|537870785|FG008|Overall Study|Adverse Event|0|||
149106808|NCT00474526|537870786|FG009|Overall Study|Adverse Event|0|||
149106809|NCT00474526|537870787|FG010|Overall Study|Adverse Event|0|||
149106810|NCT00474526|537870788|FG011|Overall Study|Adverse Event|0|||
149106811|NCT00474526|537870789|FG012|Overall Study|Adverse Event|0|||
149106812|NCT00474526|537870790|FG013|Overall Study|Adverse Event|0|||
149106813|NCT00474526|537870791|FG014|Overall Study|Adverse Event|1|||
149106814|NCT00474526|537870792|FG015|Overall Study|Adverse Event|1|||
149106815|NCT00474526|537870793|FG016|Overall Study|Adverse Event|0|||
149106816|NCT00474526|537870777|FG000|Overall Study|Death|0|||
149106817|NCT00474526|537870778|FG001|Overall Study|Death|0|||
149106818|NCT00474526|537870779|FG002|Overall Study|Death|0|||
149106819|NCT00474526|537870780|FG003|Overall Study|Death|0|||
149106820|NCT00474526|537870781|FG004|Overall Study|Death|0|||
149106821|NCT00474526|537870782|FG005|Overall Study|Death|0|||
149106822|NCT00474526|537870783|FG006|Overall Study|Death|0|||
149106823|NCT00474526|537870784|FG007|Overall Study|Death|0|||
149106824|NCT00474526|537870785|FG008|Overall Study|Death|0|||
149106825|NCT00474526|537870786|FG009|Overall Study|Death|0|||
149106826|NCT00474526|537870787|FG010|Overall Study|Death|0|||
149106827|NCT00474526|537870788|FG011|Overall Study|Death|0|||
149106828|NCT00474526|537870789|FG012|Overall Study|Death|0|||
149106829|NCT00474526|537870790|FG013|Overall Study|Death|3|||
149106830|NCT00474526|537870791|FG014|Overall Study|Death|0|||
149106831|NCT00474526|537870792|FG015|Overall Study|Death|0|||
149106832|NCT00474526|537870793|FG016|Overall Study|Death|0|||
149106833|NCT00474526|537870777|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106834|NCT00474526|537870778|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
149106835|NCT00474526|537870779|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106836|NCT00474526|537870780|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
149106837|NCT00474526|537870781|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
149106838|NCT00474526|537870782|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106839|NCT00474526|537870783|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106840|NCT00474526|537870784|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106841|NCT00474526|537870785|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106842|NCT00474526|537870786|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106843|NCT00474526|537870787|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106844|NCT00474526|537870788|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106845|NCT00474526|537870789|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106846|NCT00474526|537870790|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
149106847|NCT00474526|537870791|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
149106848|NCT00474526|537870792|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106849|NCT00474526|537870793|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
149106850|NCT00474526|537870777|FG000|Overall Study|Lost to Follow-up|8|||
149106851|NCT00474526|537870778|FG001|Overall Study|Lost to Follow-up|6|||
149106852|NCT00474526|537870779|FG002|Overall Study|Lost to Follow-up|13|||
149106853|NCT00474526|537870780|FG003|Overall Study|Lost to Follow-up|29|||
149106854|NCT00474526|537870781|FG004|Overall Study|Lost to Follow-up|11|||
149106855|NCT00474526|537870782|FG005|Overall Study|Lost to Follow-up|5|||
149106856|NCT00474526|537870783|FG006|Overall Study|Lost to Follow-up|8|||
149106857|NCT00474526|537870784|FG007|Overall Study|Lost to Follow-up|1|||
149106858|NCT00474526|537870785|FG008|Overall Study|Lost to Follow-up|0|||
149106859|NCT00474526|537870786|FG009|Overall Study|Lost to Follow-up|6|||
149106860|NCT00474526|537870787|FG010|Overall Study|Lost to Follow-up|2|||
149106861|NCT00474526|537870788|FG011|Overall Study|Lost to Follow-up|4|||
149106862|NCT00474526|537870789|FG012|Overall Study|Lost to Follow-up|6|||
149106863|NCT00474526|537870790|FG013|Overall Study|Lost to Follow-up|74|||
149106864|NCT00474526|537870791|FG014|Overall Study|Lost to Follow-up|29|||
149106865|NCT00474526|537870792|FG015|Overall Study|Lost to Follow-up|4|||
149106866|NCT00474526|537870793|FG016|Overall Study|Lost to Follow-up|5|||
149106867|NCT00474526|537870777|FG000|Overall Study|Protocol Violation|2|||
149106868|NCT00474526|537870778|FG001|Overall Study|Protocol Violation|6|||
149106869|NCT00474526|537870779|FG002|Overall Study|Protocol Violation|4|||
149106870|NCT00474526|537870780|FG003|Overall Study|Protocol Violation|12|||
149106871|NCT00474526|537870781|FG004|Overall Study|Protocol Violation|3|||
149106872|NCT00474526|537870782|FG005|Overall Study|Protocol Violation|1|||
149106873|NCT00474526|537870783|FG006|Overall Study|Protocol Violation|3|||
149106874|NCT00474526|537870784|FG007|Overall Study|Protocol Violation|0|||
149106875|NCT00474526|537870785|FG008|Overall Study|Protocol Violation|0|||
149106876|NCT00474526|537870786|FG009|Overall Study|Protocol Violation|4|||
149106877|NCT00474526|537870787|FG010|Overall Study|Protocol Violation|2|||
149106878|NCT00474526|537870788|FG011|Overall Study|Protocol Violation|2|||
149106879|NCT00474526|537870789|FG012|Overall Study|Protocol Violation|4|||
149106880|NCT00474526|537870790|FG013|Overall Study|Protocol Violation|19|||
149106881|NCT00474526|537870791|FG014|Overall Study|Protocol Violation|9|||
149106882|NCT00474526|537870792|FG015|Overall Study|Protocol Violation|6|||
149106883|NCT00474526|537870793|FG016|Overall Study|Protocol Violation|2|||
149106884|NCT00474526|537870777|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
149106885|NCT00474526|537870778|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
149106886|NCT00474526|537870779|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
149106887|NCT00474526|537870780|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
149106888|NCT00474526|537870781|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
149106889|NCT00474526|537870782|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
149106890|NCT00474526|537870783|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
149106891|NCT00474526|537870784|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
149106892|NCT00474526|537870785|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
149106893|NCT00474526|537870786|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
149106894|NCT00474526|537870787|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
149106895|NCT00474526|537870788|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
149106896|NCT00474526|537870789|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
149106897|NCT00474526|537870790|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
149106898|NCT00474526|537870791|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
149106899|NCT00474526|537870792|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
149106900|NCT00474526|537870793|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
149106901|NCT00474526|537870777|FG000|Overall Study|Withdrawal by Subject|9|||
149106902|NCT00474526|537870778|FG001|Overall Study|Withdrawal by Subject|24|||
149106903|NCT00474526|537870779|FG002|Overall Study|Withdrawal by Subject|21|||
149106904|NCT00474526|537870780|FG003|Overall Study|Withdrawal by Subject|52|||
149106905|NCT00474526|537870781|FG004|Overall Study|Withdrawal by Subject|38|||
149106906|NCT00474526|537870782|FG005|Overall Study|Withdrawal by Subject|6|||
149106907|NCT00474526|537870783|FG006|Overall Study|Withdrawal by Subject|12|||
149106908|NCT00474526|537870784|FG007|Overall Study|Withdrawal by Subject|4|||
149106909|NCT00474526|537870785|FG008|Overall Study|Withdrawal by Subject|4|||
149106910|NCT00474526|537870786|FG009|Overall Study|Withdrawal by Subject|13|||
149106911|NCT00474526|537870787|FG010|Overall Study|Withdrawal by Subject|5|||
149106912|NCT00474526|537870788|FG011|Overall Study|Withdrawal by Subject|4|||
149106913|NCT00474526|537870789|FG012|Overall Study|Withdrawal by Subject|4|||
149106914|NCT00474526|537870790|FG013|Overall Study|Withdrawal by Subject|37|||
149106915|NCT00474526|537870791|FG014|Overall Study|Withdrawal by Subject|22|||
149106916|NCT00474526|537870792|FG015|Overall Study|Withdrawal by Subject|1|||
149106917|NCT00474526|537870793|FG016|Overall Study|Withdrawal by Subject|1|||
149106918|NCT02763215|537870794|FG000|Overall Study|Participants withdrew from study|3|||
149106919|NCT02763215|537870794|FG000|Overall Study|Missed visit|1|||
149106920|NCT02763215|537870794|FG000|Overall Study|Visit outside visit-window|1|||
149106921|NCT02763215|537870794|FG000|Overall Study|Death|1|||
149106922|NCT02763215|537870794|FG000|Overall Study|Lost to Follow-up|1|||
149106923|NCT02179177|537870796|FG000|Overall Study|Lost to Follow-up|1|||
149106924|NCT02179177|537870797|FG001|Overall Study|Lost to Follow-up|1|||
149106925|NCT02179177|537870796|FG000|Overall Study|Withdrawal by Subject|1|||
149106926|NCT02179177|537870797|FG001|Overall Study|Withdrawal by Subject|1|||
149106927|NCT04340947|537870798|FG000|7-day Washout Period|Lost to Follow-up|5|||
149106928|NCT04340947|537870799|FG001|7-day Washout Period|Lost to Follow-up|4|||
149106929|NCT01907906|537870802|FG000|Overall Study|Withdrawal by Subject|1|||
149106930|NCT01907906|537870803|FG001|Overall Study|Withdrawal by Subject|0|||
149106931|NCT01907906|537870802|FG000|Overall Study|Physician Decision|3|||
149106932|NCT01907906|537870803|FG001|Overall Study|Physician Decision|1|||
149106933|NCT00884650|537870804|FG000|Overall Study|Did not return complete pain diaries|7|||
149106934|NCT00884650|537870805|FG001|Overall Study|Did not return complete pain diaries|7|||
149106935|NCT00884650|537870804|FG000|Overall Study|Admitted Post-Op|1|||
149106936|NCT00884650|537870805|FG001|Overall Study|Admitted Post-Op|0|||
149106937|NCT00884650|537870804|FG000|Overall Study|Femoral Stress Fracture|1|||
149106938|NCT00884650|537870805|FG001|Overall Study|Femoral Stress Fracture|0|||
149106939|NCT00884650|537870804|FG000|Overall Study|Pain Pump Complication|0|||
149106940|NCT00884650|537870805|FG001|Overall Study|Pain Pump Complication|1|||
149106941|NCT04052425|537870814|FG000|24-Week Double-blind Period|Adverse Event|0|||
149106942|NCT04052425|537870815|FG001|24-Week Double-blind Period|Adverse Event|1|||
149106943|NCT04052425|537870816|FG002|24-Week Double-blind Period|Adverse Event|0|||
149106944|NCT04052425|537870817|FG003|24-Week Double-blind Period|Adverse Event|0|||
149106945|NCT04052425|537870814|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
149106946|NCT04052425|537870815|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
149106947|NCT04052425|537870816|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
149106948|NCT04052425|537870817|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
149106949|NCT04052425|537870814|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
149106950|NCT04052425|537870815|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
149106951|NCT04052425|537870816|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
149106952|NCT04052425|537870817|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
149106953|NCT04052425|537870814|FG000|24-Week Double-blind Period|Physician Decision|1|||
149106954|NCT04052425|537870815|FG001|24-Week Double-blind Period|Physician Decision|0|||
149106955|NCT04052425|537870816|FG002|24-Week Double-blind Period|Physician Decision|0|||
149106956|NCT04052425|537870817|FG003|24-Week Double-blind Period|Physician Decision|0|||
149106957|NCT04052425|537870814|FG000|24-Week Double-blind Period|Protocol Violation|1|||
149106958|NCT04052425|537870815|FG001|24-Week Double-blind Period|Protocol Violation|0|||
149106959|NCT04052425|537870816|FG002|24-Week Double-blind Period|Protocol Violation|0|||
149106960|NCT04052425|537870817|FG003|24-Week Double-blind Period|Protocol Violation|0|||
149106961|NCT04052425|537870814|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
149106962|NCT04052425|537870815|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
149106963|NCT04052425|537870816|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
149106964|NCT04052425|537870817|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
149106965|NCT04052425|537870814|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
149106966|NCT04052425|537870815|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
149106967|NCT04052425|537870816|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
149106968|NCT04052425|537870817|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
149106969|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
149106970|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
149106971|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
149106972|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
149106973|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
149106974|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
149106975|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
149106976|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
149106977|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
149106978|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
149106979|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
149106980|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
149106981|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
149106982|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
149106983|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
149106984|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
149106985|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
149106986|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
149106987|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
149106988|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
149106989|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
149106990|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
149106991|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
149106992|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
149106993|NCT04052425|537870814|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
149106994|NCT04052425|537870815|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
149106995|NCT04052425|537870816|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
149106996|NCT04052425|537870817|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
149106997|NCT04334278|537870818|FG000|Overall Study|Lost to Follow-up|0|||
149106998|NCT04334278|537870819|FG001|Overall Study|Lost to Follow-up|3|||
149106999|NCT04334278|537870818|FG000|Overall Study|Withdrawal by Subject|4|||
149107000|NCT04334278|537870819|FG001|Overall Study|Withdrawal by Subject|2|||
149107001|NCT01821937|537870820|FG000|Overall Study|Adverse Event|0|||
149107002|NCT01821937|537870821|FG001|Overall Study|Adverse Event|3|||
149107003|NCT01677299|537870822|FG000|Overall Study|Adverse Event|0|||
149107004|NCT01677299|537870823|FG001|Overall Study|Adverse Event|2|||
149107005|NCT01677299|537870824|FG002|Overall Study|Adverse Event|1|||
149107006|NCT01677299|537870825|FG003|Overall Study|Adverse Event|0|||
149107007|NCT01677299|537870822|FG000|Overall Study|Withdrawal by Subject|0|||
149107008|NCT01677299|537870823|FG001|Overall Study|Withdrawal by Subject|1|||
149107009|NCT01677299|537870824|FG002|Overall Study|Withdrawal by Subject|0|||
149107010|NCT01677299|537870825|FG003|Overall Study|Withdrawal by Subject|1|||
149107011|NCT00732992|537870826|FG000|Overall Study|Adverse Event|1|||
149107012|NCT00732992|537870827|FG001|Overall Study|Adverse Event|1|||
149107013|NCT00732992|537870826|FG000|Overall Study|Objective Progression or Relapse|3|||
149107014|NCT00732992|537870827|FG001|Overall Study|Objective Progression or Relapse|5|||
149107015|NCT00732992|537870826|FG000|Overall Study|Global Deterioration of Health Status|1|||
149107016|NCT00732992|537870827|FG001|Overall Study|Global Deterioration of Health Status|0|||
149107017|NCT00732992|537870826|FG000|Overall Study|Withdrawal by Subject|1|||
149107018|NCT00732992|537870827|FG001|Overall Study|Withdrawal by Subject|0|||
149107019|NCT01969851|537870828|FG000|Overall Study|Adverse Event|0|||
149107020|NCT01969851|537870829|FG001|Overall Study|Adverse Event|0|||
149107021|NCT01969851|537870830|FG002|Overall Study|Adverse Event|3|||
149107022|NCT01969851|537870828|FG000|Overall Study|Lack of Efficacy|0|||
149107023|NCT01969851|537870829|FG001|Overall Study|Lack of Efficacy|3|||
149107024|NCT01969851|537870830|FG002|Overall Study|Lack of Efficacy|1|||
149107025|NCT01969851|537870828|FG000|Overall Study|Withdrawal by Subject|1|||
149107026|NCT01969851|537870829|FG001|Overall Study|Withdrawal by Subject|0|||
149107027|NCT01969851|537870830|FG002|Overall Study|Withdrawal by Subject|1|||
149107028|NCT01969851|537870828|FG000|Overall Study|No effective dose in Titration period|0|||
149107029|NCT01969851|537870829|FG001|Overall Study|No effective dose in Titration period|0|||
149107030|NCT01969851|537870830|FG002|Overall Study|No effective dose in Titration period|1|||
149107031|NCT01969851|537870828|FG000|Overall Study|Sponsor decision|0|||
149107032|NCT01969851|537870829|FG001|Overall Study|Sponsor decision|0|||
149107033|NCT01969851|537870830|FG002|Overall Study|Sponsor decision|1|||
149107034|NCT01245374|537870832|FG000|Overall Study|Protocol Violation|1|||
149107035|NCT01245374|537870832|FG000|Overall Study|Withdrawal by Subject|3|||
149107036|NCT01782690|537870834|FG000|Overall Study|Not reported|7|||
149107037|NCT01782690|537870834|FG000|Overall Study|Toxicity of gemcitabine|1|||
149107038|NCT01782690|537870834|FG000|Overall Study|Toxicity of erlotinib|1|||
149107039|NCT01782690|537870834|FG000|Overall Study|Lost to Follow-up|31|||
149107040|NCT01782690|537870834|FG000|Overall Study|Withdrawal of informed consent|2|||
149107041|NCT01782690|537870834|FG000|Overall Study|Absent rash|9|||
149107042|NCT01782690|537870834|FG000|Overall Study|Physician Decision|13|||
149107043|NCT01782690|537870834|FG000|Overall Study|Patient's wish|21|||
149107044|NCT01782690|537870834|FG000|Overall Study|Tumor progression|74|||
149107045|NCT01782690|537870834|FG000|Overall Study|Death|133|||
149107046|NCT01782690|537870834|FG000|Overall Study|Study completion unknown|7|||
149107047|NCT04199052|537870837|FG000|Overall Study|Lost to Follow-up|11|||
149107048|NCT04199052|537870838|FG001|Overall Study|Lost to Follow-up|18|||
149107049|NCT04946942|537870839|FG000|Overall Study|Lost to Follow-up|6|||
149107050|NCT04946942|537870840|FG001|Overall Study|Lost to Follow-up|2|||
149107051|NCT04946942|537870841|FG002|Overall Study|Lost to Follow-up|0|||
149107052|NCT00365547|537870842|FG000|Overall Study|Insurance did not cover Avastin|1|||
149107053|NCT00365547|537870842|FG000|Overall Study|Screen failure|1|||
149107054|NCT00365547|537870842|FG000|Overall Study|Withdrawal by Subject|1|||
149107055|NCT03170518|537870843|FG000|Overall Study|Lost to Follow-up|4|||
149107056|NCT03170518|537870844|FG001|Overall Study|Lost to Follow-up|1|||
149107057|NCT03170518|537870845|FG002|Overall Study|Lost to Follow-up|0|||
149107058|NCT03170518|537870843|FG000|Overall Study|Physician Decision|1|||
149107059|NCT03170518|537870844|FG001|Overall Study|Physician Decision|0|||
149107060|NCT03170518|537870845|FG002|Overall Study|Physician Decision|0|||
149107061|NCT03170518|537870843|FG000|Overall Study|Withdrawal by Subject|4|||
149107062|NCT03170518|537870844|FG001|Overall Study|Withdrawal by Subject|5|||
149107063|NCT03170518|537870845|FG002|Overall Study|Withdrawal by Subject|2|||
149107064|NCT03170518|537870843|FG000|Overall Study|Site terminated by sponsor|0|||
149107065|NCT03170518|537870844|FG001|Overall Study|Site terminated by sponsor|1|||
149107066|NCT03170518|537870845|FG002|Overall Study|Site terminated by sponsor|0|||
149107067|NCT03170518|537870843|FG000|Overall Study|Non-compliance with study drug|1|||
149107068|NCT03170518|537870844|FG001|Overall Study|Non-compliance with study drug|0|||
149107069|NCT03170518|537870845|FG002|Overall Study|Non-compliance with study drug|1|||
149107070|NCT03170518|537870843|FG000|Overall Study|Withdrawal by parent/guardian|2|||
149107071|NCT03170518|537870844|FG001|Overall Study|Withdrawal by parent/guardian|0|||
149107072|NCT03170518|537870845|FG002|Overall Study|Withdrawal by parent/guardian|0|||
149107073|NCT02257918|537870846|FG000|Overall Study|Lost to Follow-up|4|||
149107074|NCT02257918|537870847|FG001|Overall Study|Lost to Follow-up|1|||
149107075|NCT02257918|537870848|FG002|Overall Study|Lost to Follow-up|0|||
149107076|NCT02257918|537870846|FG000|Overall Study|Withdrawal by Subject|0|||
149107077|NCT02257918|537870847|FG001|Overall Study|Withdrawal by Subject|0|||
149107078|NCT02257918|537870848|FG002|Overall Study|Withdrawal by Subject|1|||
149107079|NCT02257918|537870846|FG000|Overall Study|Pregnancy|0|||
149107080|NCT02257918|537870847|FG001|Overall Study|Pregnancy|0|||
149107081|NCT02257918|537870848|FG002|Overall Study|Pregnancy|1|||
149107082|NCT03023423|537870849|FG000|Overall Study|Death|5|||
149107083|NCT03023423|537870850|FG001|Overall Study|Death|12|||
149107084|NCT03023423|537870851|FG002|Overall Study|Death|20|||
149107085|NCT03023423|537870849|FG000|Overall Study|Other|0|||
149107086|NCT03023423|537870850|FG001|Overall Study|Other|2|||
149107087|NCT03023423|537870851|FG002|Overall Study|Other|2|||
149107088|NCT03023423|537870849|FG000|Overall Study|Ongoing|2|||
149107089|NCT03023423|537870850|FG001|Overall Study|Ongoing|32|||
149107090|NCT03023423|537870851|FG002|Overall Study|Ongoing|24|||
149107091|NCT03512197|537870852|FG000|Overall Study|Guardian decision|1|||
149107092|NCT03512197|537870853|FG001|Overall Study|Guardian decision|1|||
149107093|NCT03512197|537870852|FG000|Overall Study|Lack of Efficacy|19|||
149107094|NCT03512197|537870853|FG001|Overall Study|Lack of Efficacy|11|||
149107095|NCT03512197|537870852|FG000|Overall Study|New Therapy for Study Indication|16|||
149107096|NCT03512197|537870853|FG001|Overall Study|New Therapy for Study Indication|16|||
149107097|NCT03512197|537870852|FG000|Overall Study|Physician Decision|60|||
149107098|NCT03512197|537870853|FG001|Overall Study|Physician Decision|60|||
149107099|NCT03512197|537870852|FG000|Overall Study|Protocol Violation|0|||
149107100|NCT03512197|537870853|FG001|Overall Study|Protocol Violation|2|||
149107101|NCT03512197|537870852|FG000|Overall Study|Terminated by Sponsored|46|||
149107102|NCT03512197|537870853|FG001|Overall Study|Terminated by Sponsored|50|||
149107103|NCT03512197|537870852|FG000|Overall Study|Subject Decision|15|||
149107104|NCT03512197|537870853|FG001|Overall Study|Subject Decision|12|||
149107105|NCT03512197|537870852|FG000|Overall Study|Withdrawal of informed consent|20|||
149107106|NCT03512197|537870853|FG001|Overall Study|Withdrawal of informed consent|14|||
149107107|NCT03512197|537870852|FG000|Overall Study|Adverse Event|30|||
149107108|NCT03512197|537870853|FG001|Overall Study|Adverse Event|34|||
149107109|NCT03512197|537870852|FG000|Overall Study|Death|14|||
149107110|NCT03512197|537870853|FG001|Overall Study|Death|9|||
149107111|NCT03512197|537870852|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
149107112|NCT03512197|537870853|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
149107113|NCT03512197|537870852|FG000|Overall Study|Missing|3|||
149107114|NCT03512197|537870853|FG001|Overall Study|Missing|13|||
149107115|NCT03842436|537870854|FG000|Overall Study|Lost to Follow-up|1|||
149107116|NCT01948076|537870855|FG000|Overall Study|Withdrawal by Subject|0|||
149107117|NCT01948076|537870856|FG001|Overall Study|Withdrawal by Subject|1|||
149107118|NCT01151423|537870857|FG000|Overall Study|Study terminated by Sponsor|9|||
149107119|NCT01151423|537870858|FG001|Overall Study|Study terminated by Sponsor|10|||
149107120|NCT01151423|537870857|FG000|Overall Study|Protocol Violation|0|||
149107121|NCT01151423|537870858|FG001|Overall Study|Protocol Violation|1|||
149107122|NCT01151423|537870857|FG000|Overall Study|Physician Decision|1|||
149107123|NCT01151423|537870858|FG001|Overall Study|Physician Decision|1|||
149107124|NCT01151423|537870857|FG000|Overall Study|Pregnancy|0|||
149107125|NCT01151423|537870858|FG001|Overall Study|Pregnancy|1|||
149107126|NCT01151423|537870857|FG000|Overall Study|Death|0|||
149107127|NCT01151423|537870858|FG001|Overall Study|Death|1|||
149107128|NCT01151423|537870857|FG000|Overall Study|Adverse Event|3|||
149107129|NCT01151423|537870858|FG001|Overall Study|Adverse Event|0|||
149107130|NCT01151423|537870857|FG000|Overall Study|Withdrawal by Subject|1|||
149107131|NCT01151423|537870858|FG001|Overall Study|Withdrawal by Subject|3|||
149107132|NCT01151423|537870857|FG000|Overall Study|Lost to Follow-up|1|||
149107133|NCT01151423|537870858|FG001|Overall Study|Lost to Follow-up|0|||
149107134|NCT01151423|537870857|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
149107135|NCT01151423|537870858|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
149107136|NCT01151423|537870857|FG000|Overall Study|Participated in other clinical trial|1|||
149107137|NCT01151423|537870858|FG001|Overall Study|Participated in other clinical trial|0|||
149107138|NCT01263054|537870859|FG000|Overall Study|Death|1|||
149107139|NCT01263054|537870860|FG001|Overall Study|Death|0|||
149107140|NCT01263054|537870859|FG000|Overall Study|Lost to Follow-up|2|||
149107141|NCT01263054|537870860|FG001|Overall Study|Lost to Follow-up|2|||
149107142|NCT01263054|537870859|FG000|Overall Study|Withdrawal by Subject|1|||
149107143|NCT01263054|537870860|FG001|Overall Study|Withdrawal by Subject|3|||
149107144|NCT01263054|537870859|FG000|Overall Study|Qualification Violation|1|||
149107145|NCT01263054|537870860|FG001|Overall Study|Qualification Violation|0|||
149107146|NCT01263054|537870859|FG000|Overall Study|Other|0|||
149107147|NCT01263054|537870860|FG001|Overall Study|Other|1|||
149107148|NCT00936598|537870861|FG000|Overall Study|Withdrawal by Subject|1|||
149107149|NCT00936598|537870862|FG001|Overall Study|Withdrawal by Subject|0|||
149107150|NCT00936598|537870861|FG000|Overall Study|Ineligible after consent|1|||
149107151|NCT00936598|537870862|FG001|Overall Study|Ineligible after consent|0|||
149107152|NCT00681668|537870863|FG000|Overall Study|Protocol Violation|1|||
149107153|NCT00681668|537870863|FG000|Overall Study|Withdrawal by Subject|1|||
149107154|NCT04277507|537870866|FG000|Overall Study|Lost to Follow-up|17|||
149107155|NCT04277507|537870866|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
149107156|NCT04277507|537870866|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
149107157|NCT04277507|537870866|FG000|Overall Study|Withdrawal by Subject|3|||
149107158|NCT04277507|537870866|FG000|Overall Study|Death due to COVID-19|1|||
149107159|NCT04277507|537870866|FG000|Overall Study|Data missing for full evaluation|5|||
149107160|NCT00583947|537870876|FG000|Cross-over Period|Adverse Event|2|||
149107161|NCT00583947|537870877|FG001|Cross-over Period|Adverse Event|0|||
149107162|NCT00583947|537870876|FG000|Cross-over Period|Withdrawal by Subject|2|||
149107163|NCT00583947|537870877|FG001|Cross-over Period|Withdrawal by Subject|0|||
149107164|NCT00583947|537870876|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
149107165|NCT00583947|537870877|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
149107166|NCT00583947|537870876|FG000|Cross-over Period|Other|1|||
149107167|NCT00583947|537870877|FG001|Cross-over Period|Other|1|||
149107168|NCT00486252|537870878|FG000|Overall Study|Adverse Event|7|||
149107169|NCT00486252|537870878|FG000|Overall Study|Lack of Efficacy|9|||
149107170|NCT00486252|537870878|FG000|Overall Study|Lost to Follow-up|24|||
149107171|NCT00486252|537870878|FG000|Overall Study|Other|18|||
149107172|NCT05101993|537870884|FG000|Overall Study|Withdrawal by Subject|1|||
149107173|NCT01124838|537870885|FG000|Overall Study|Miscellaneous|4|||
149107174|NCT01124838|537870886|FG001|Overall Study|Miscellaneous|2|||
149107175|NCT01124838|537870885|FG000|Overall Study|Adverse Event|7|||
149107176|NCT01124838|537870886|FG001|Overall Study|Adverse Event|11|||
149107177|NCT01124838|537870885|FG000|Overall Study|Lack of Efficacy|2|||
149107178|NCT01124838|537870886|FG001|Overall Study|Lack of Efficacy|0|||
149107179|NCT01124838|537870885|FG000|Overall Study|Withdrawal by Subject|3|||
149107180|NCT01124838|537870886|FG001|Overall Study|Withdrawal by Subject|2|||
149107181|NCT01124838|537870885|FG000|Overall Study|Lost to Follow-up|2|||
149107182|NCT01124838|537870886|FG001|Overall Study|Lost to Follow-up|0|||
149107183|NCT02065882|537870887|FG000|Part I: PK/PD|Screening failure|5|||
149107184|NCT02065882|537870887|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
149107185|NCT02065882|537870887|FG000|Part I: PK/PD|Adverse Event|1|||
149107186|NCT02065882|537870887|FG000|Part II: Clinical Efficacy|Screening failure|7|||
149107187|NCT02065882|537870887|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
149107188|NCT02065882|537870887|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
149107189|NCT02065882|537870887|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
149107190|NCT02065882|537870887|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
149107191|NCT02065882|537870887|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
149107192|NCT06719986|537870888|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
149107193|NCT06719986|537870889|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
149107194|NCT06719986|537870890|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
149107195|NCT06719986|537870888|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
149107196|NCT06719986|537870889|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
149107197|NCT06719986|537870890|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
149107198|NCT02600897|537870891|FG000|Overall Study|Death|1|||
149107199|NCT02600897|537870892|FG001|Overall Study|Death|2|||
149107200|NCT02600897|537870893|FG002|Overall Study|Death|1|||
149107201|NCT02600897|537870894|FG003|Overall Study|Death|2|||
149107202|NCT02600897|537870895|FG004|Overall Study|Death|3|||
149107203|NCT02600897|537870896|FG005|Overall Study|Death|2|||
149107204|NCT02600897|537870897|FG006|Overall Study|Death|10|||
149107205|NCT02600897|537870898|FG007|Overall Study|Death|7|||
149107206|NCT02600897|537870899|FG008|Overall Study|Death|20|||
149107207|NCT02600897|537870891|FG000|Overall Study|Lost to Follow-up|1|||
149107208|NCT02600897|537870892|FG001|Overall Study|Lost to Follow-up|0|||
149107209|NCT02600897|537870893|FG002|Overall Study|Lost to Follow-up|0|||
149107210|NCT02600897|537870894|FG003|Overall Study|Lost to Follow-up|0|||
149107211|NCT02600897|537870895|FG004|Overall Study|Lost to Follow-up|0|||
149107212|NCT02600897|537870896|FG005|Overall Study|Lost to Follow-up|0|||
149107213|NCT02600897|537870897|FG006|Overall Study|Lost to Follow-up|0|||
149107214|NCT02600897|537870898|FG007|Overall Study|Lost to Follow-up|1|||
149107215|NCT02600897|537870899|FG008|Overall Study|Lost to Follow-up|0|||
149107216|NCT02600897|537870891|FG000|Overall Study|Withdrawal by Subject|0|||
149107217|NCT02600897|537870892|FG001|Overall Study|Withdrawal by Subject|0|||
149107218|NCT02600897|537870893|FG002|Overall Study|Withdrawal by Subject|0|||
149107219|NCT02600897|537870894|FG003|Overall Study|Withdrawal by Subject|0|||
149107220|NCT02600897|537870895|FG004|Overall Study|Withdrawal by Subject|0|||
149107221|NCT02600897|537870896|FG005|Overall Study|Withdrawal by Subject|0|||
149107222|NCT02600897|537870897|FG006|Overall Study|Withdrawal by Subject|0|||
149107223|NCT02600897|537870898|FG007|Overall Study|Withdrawal by Subject|4|||
149107224|NCT02600897|537870899|FG008|Overall Study|Withdrawal by Subject|2|||
149107225|NCT02600897|537870891|FG000|Overall Study|Reason Not Specified|0|||
149107226|NCT02600897|537870892|FG001|Overall Study|Reason Not Specified|0|||
149107227|NCT02600897|537870893|FG002|Overall Study|Reason Not Specified|0|||
149107228|NCT02600897|537870894|FG003|Overall Study|Reason Not Specified|0|||
149107229|NCT02600897|537870895|FG004|Overall Study|Reason Not Specified|0|||
149107230|NCT02600897|537870896|FG005|Overall Study|Reason Not Specified|0|||
149107231|NCT02600897|537870897|FG006|Overall Study|Reason Not Specified|0|||
149107232|NCT02600897|537870898|FG007|Overall Study|Reason Not Specified|0|||
149107233|NCT02600897|537870899|FG008|Overall Study|Reason Not Specified|1|||
149107234|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Adverse Event|10|||
149107235|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Adverse Event|9|||
149107236|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Adverse Event|7|||
149107237|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
149107238|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
149107239|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
149107240|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
149107241|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
149107242|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
149107243|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Physician Decision|7|||
149107244|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Physician Decision|3|||
149107245|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Physician Decision|2|||
149107246|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Pregnancy|2|||
149107247|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Pregnancy|1|||
149107248|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Pregnancy|3|||
149107249|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
149107250|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
149107251|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
149107252|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
149107253|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
149107254|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
149107255|NCT02614183|537870902|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
149107256|NCT02614183|537870903|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
149107257|NCT02614183|537870904|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
149107258|NCT02614183|537870902|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
149107259|NCT02614183|537870903|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
149107260|NCT02614183|537870904|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
149107261|NCT02614183|537870902|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
149107262|NCT02614183|537870903|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
149107263|NCT02614183|537870904|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
149107264|NCT02614183|537870902|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
149107265|NCT02614183|537870903|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
149107266|NCT02614183|537870904|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
149107267|NCT02614183|537870902|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
149107268|NCT02614183|537870903|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
149107269|NCT02614183|537870904|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
149107270|NCT05992922|537870905|FG000|Overall Study|Adverse Event|6|||
149107271|NCT05992922|537870906|FG001|Overall Study|Adverse Event|0|||
149107272|NCT05992922|537870905|FG000|Overall Study|Sponsor Termination of Study|14|||
149107273|NCT05992922|537870906|FG001|Overall Study|Sponsor Termination of Study|20|||
149107274|NCT02473965|537872552|FG000|Overall Study|Adverse Event|6|||
149107275|NCT02473965|537872553|FG001|Overall Study|Adverse Event|4|||
149107276|NCT02473965|537872552|FG000|Overall Study|MG worsening|4|||
149107277|NCT02473965|537872553|FG001|Overall Study|MG worsening|1|||
149107278|NCT02473965|537872552|FG000|Overall Study|Withdrawal by Subject|2|||
149107279|NCT02473965|537872553|FG001|Overall Study|Withdrawal by Subject|3|||
149107280|NCT02473965|537872552|FG000|Overall Study|Physician Decision|0|||
149107281|NCT02473965|537872553|FG001|Overall Study|Physician Decision|2|||
149107282|NCT03816761|537872554|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
149107283|NCT03816761|537872555|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
149107284|NCT03816761|537872556|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
149107285|NCT03816761|537872557|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
149107286|NCT03816761|537872558|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
149107287|NCT03816761|537872559|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
149107288|NCT03816761|537872554|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
149107289|NCT03816761|537872555|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
149107290|NCT03816761|537872556|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
149107291|NCT03816761|537872557|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
149107292|NCT03816761|537872558|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
149107293|NCT03816761|537872559|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
149107294|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Adverse Event|2|||
149107295|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Adverse Event|0|||
149107296|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Adverse Event|0|||
149107297|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Adverse Event|0|||
149107298|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
149107299|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
149107300|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
149107301|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
149107302|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
149107303|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
149107304|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
149107305|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
149107306|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Physician Decision|1|||
149107307|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Physician Decision|0|||
149107308|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Physician Decision|0|||
149107309|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Physician Decision|0|||
149107310|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Pregnancy|1|||
149107311|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Pregnancy|0|||
149107312|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Pregnancy|0|||
149107313|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Pregnancy|0|||
149107314|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
149107315|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
149107316|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
149107317|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
149107318|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
149107319|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
149107320|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
149107321|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
149107322|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
149107323|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
149107324|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
149107325|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
149107326|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
149107327|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
149107328|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
149107329|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
149107330|NCT04057573|537872564|FG000|24-Week Double-Blind Period|Not Treated|1|||
149107331|NCT04057573|537872565|FG001|24-Week Double-Blind Period|Not Treated|0|||
149107332|NCT04057573|537872566|FG002|24-Week Double-Blind Period|Not Treated|0|||
149107333|NCT04057573|537872567|FG003|24-Week Double-Blind Period|Not Treated|0|||
149107334|NCT04057573|537872564|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
149107335|NCT04057573|537872565|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
149107336|NCT04057573|537872566|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
149107337|NCT04057573|537872567|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
149107338|NCT04057573|537872564|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
149107339|NCT04057573|537872565|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
149107340|NCT04057573|537872566|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
149107341|NCT04057573|537872567|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
149107342|NCT04057573|537872564|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
149107343|NCT04057573|537872565|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
149107344|NCT04057573|537872566|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
149107345|NCT04057573|537872567|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
149107346|NCT04057573|537872564|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
149107347|NCT04057573|537872565|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
149107348|NCT04057573|537872566|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
149107349|NCT04057573|537872567|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
149107350|NCT04057573|537872564|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
149107351|NCT04057573|537872565|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
149107352|NCT04057573|537872566|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
149107353|NCT04057573|537872567|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
149107354|NCT04991753|537872568|FG000|Overall Study|Withdrawal by Subject|0|||
149107355|NCT04991753|537872569|FG001|Overall Study|Withdrawal by Subject|1|||
149107356|NCT02797522|537872572|FG000|Overall Study|Study Terminated by Sponsor|0|||
149107357|NCT02797522|537872573|FG001|Overall Study|Study Terminated by Sponsor|0|||
149107358|NCT02797522|537872574|FG002|Overall Study|Study Terminated by Sponsor|0|||
149107359|NCT02797522|537872575|FG003|Overall Study|Study Terminated by Sponsor|0|||
149107360|NCT02797522|537872576|FG004|Overall Study|Study Terminated by Sponsor|0|||
149107361|NCT02797522|537872577|FG005|Overall Study|Study Terminated by Sponsor|0|||
149107362|NCT02797522|537872578|FG006|Overall Study|Study Terminated by Sponsor|0|||
149107363|NCT02797522|537872579|FG007|Overall Study|Study Terminated by Sponsor|4|||
149107364|NCT02797522|537872580|FG008|Overall Study|Study Terminated by Sponsor|2|||
149107365|NCT02797522|537872581|FG009|Overall Study|Study Terminated by Sponsor|4|||
149107366|NCT02797522|537872582|FG010|Overall Study|Study Terminated by Sponsor|1|||
149107367|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
149107368|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
149107369|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
149107370|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
149107371|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
149107372|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
149107373|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
149107374|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
149107375|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
149107376|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
149107377|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
149107378|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
149107379|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
149107380|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
149107381|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
149107382|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
149107383|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
149107384|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
149107385|NCT00132678|537872585|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
149107386|NCT00132678|537872586|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
149107387|NCT00132678|537872587|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
149107388|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Death|2|||
149107389|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Death|0|||
149107390|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Death|0|||
149107391|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
149107392|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
149107393|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
149107394|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
149107395|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
149107396|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
149107397|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
149107398|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
149107399|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
149107400|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
149107401|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
149107402|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
149107403|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
149107404|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
149107405|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
149107406|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
149107407|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
149107408|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
149107409|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
149107410|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
149107411|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
149107412|NCT00132678|537872585|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
149107413|NCT00132678|537872586|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
149107414|NCT00132678|537872587|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
149107415|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
149107416|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
149107417|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
149107418|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
149107419|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
149107420|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
149107421|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
149107422|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
149107423|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
149107424|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
149107425|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
149107426|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
149107427|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
149107428|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
149107429|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
149107430|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
149107431|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
149107432|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
149107433|NCT00132678|537872585|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
149107434|NCT00132678|537872586|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
149107435|NCT00132678|537872587|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
149107436|NCT03299049|537872588|FG000|Overall Study|On-going|486|||
149107437|NCT03299049|537872589|FG001|Overall Study|On-going|481|||
149107438|NCT03299049|537872588|FG000|Overall Study|Withdrawal by Subject|6|||
149107439|NCT03299049|537872589|FG001|Overall Study|Withdrawal by Subject|21|||
149107440|NCT03299049|537872588|FG000|Overall Study|Physician Decision|5|||
149107441|NCT03299049|537872589|FG001|Overall Study|Physician Decision|1|||
149107442|NCT03299049|537872588|FG000|Overall Study|Lost to Follow-up|2|||
149107443|NCT03299049|537872589|FG001|Overall Study|Lost to Follow-up|0|||
149107444|NCT03299049|537872588|FG000|Overall Study|Pregnancy|1|||
149107445|NCT03299049|537872589|FG001|Overall Study|Pregnancy|3|||
149107446|NCT03299049|537872588|FG000|Overall Study|Protocol Violation|1|||
149107447|NCT03299049|537872589|FG001|Overall Study|Protocol Violation|1|||
149107448|NCT03299049|537872588|FG000|Overall Study|Lack of Efficacy|9|||
149107449|NCT03299049|537872589|FG001|Overall Study|Lack of Efficacy|3|||
149107450|NCT03299049|537872588|FG000|Overall Study|Adverse Event|12|||
149107451|NCT03299049|537872589|FG001|Overall Study|Adverse Event|13|||
149107452|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
149107453|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
149107454|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
149107455|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
149107456|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
149107457|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
149107458|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
149107459|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
149107460|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
149107461|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
149107462|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
149107463|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
149107464|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
149107465|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
149107466|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
149107467|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
149107468|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
149107469|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
149107470|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
149107471|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
149107472|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
149107473|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
149107474|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
149107475|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
149107476|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
149107477|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
149107478|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
149107479|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
149107480|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149107481|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149107482|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149107483|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149107484|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
149107485|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149107486|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
149107487|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
149107488|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
149107489|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
149107490|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
149107491|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
149107492|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
149107493|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
149107494|NCT01888874|537872590|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
149107495|NCT01888874|537872591|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
149107496|NCT01888874|537872592|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
149107497|NCT01888874|537872593|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
149107498|NCT01888874|537872594|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
149107499|NCT01888874|537872595|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
149107500|NCT01888874|537872596|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
149107501|NCT01888874|537872590|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
149107502|NCT01888874|537872591|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
149107503|NCT01888874|537872592|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
149107504|NCT01888874|537872593|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149107505|NCT01888874|537872594|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
149107506|NCT01888874|537872595|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149107507|NCT01888874|537872596|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
149107508|NCT01888874|537872590|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
149107509|NCT01888874|537872591|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
149107510|NCT01888874|537872592|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
149107511|NCT01888874|537872593|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
149107512|NCT01888874|537872594|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
149107513|NCT01888874|537872595|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
149107514|NCT01888874|537872596|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
149107515|NCT01888874|537872590|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
149107516|NCT01888874|537872591|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
149107517|NCT01888874|537872592|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
149107518|NCT01888874|537872593|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
149107519|NCT01888874|537872594|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
149107520|NCT01888874|537872595|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
149107521|NCT01888874|537872596|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
149107522|NCT01888874|537872590|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
149107523|NCT01888874|537872591|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
149107524|NCT01888874|537872592|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
149107525|NCT01888874|537872593|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
149107526|NCT01888874|537872594|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
149107527|NCT01888874|537872595|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
149107528|NCT01888874|537872596|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
149107529|NCT01888874|537872590|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
149107530|NCT01888874|537872591|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
149107531|NCT01888874|537872592|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
149107532|NCT01888874|537872593|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
149107533|NCT01888874|537872594|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
149107534|NCT01888874|537872595|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
149107535|NCT01888874|537872596|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
149107536|NCT01888874|537872590|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
149107537|NCT01888874|537872591|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
149107538|NCT01888874|537872592|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
149107539|NCT01888874|537872593|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
149107540|NCT01888874|537872594|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
149107541|NCT01888874|537872595|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
149107542|NCT01888874|537872596|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
149107543|NCT00475644|537872598|FG000|Overall Study|Protocol Violation|13|||
149107544|NCT01411241|537872601|FG000|Overall Study|Protocol Violation|0|||
149107545|NCT01411241|537872602|FG001|Overall Study|Protocol Violation|5|||
149107546|NCT01411241|537872601|FG000|Overall Study|Withdrawal by Subject|9|||
149107547|NCT01411241|537872602|FG001|Overall Study|Withdrawal by Subject|10|||
149107548|NCT01411241|537872601|FG000|Overall Study|Serious Adverse Event|0|||
149107549|NCT01411241|537872602|FG001|Overall Study|Serious Adverse Event|3|||
149107550|NCT01411241|537872601|FG000|Overall Study|Lost to Follow-up|2|||
149107551|NCT01411241|537872602|FG001|Overall Study|Lost to Follow-up|4|||
149107552|NCT02980042|537872605|FG000|Overall Study|Lost to Follow-up|5|||
149107553|NCT02980042|537872606|FG001|Overall Study|Lost to Follow-up|0|||
149107554|NCT02980042|537872605|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
149107555|NCT02980042|537872606|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
149107556|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
149107557|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
149107558|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
149107559|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
149107560|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
149107561|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
149107562|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
149107563|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
149107564|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
149107565|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
149107566|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
149107567|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
149107568|NCT00790400|537872613|FG000|Double-blind Period (Core Phase)|Death|1|||
149107569|NCT00790400|537872614|FG001|Double-blind Period (Core Phase)|Death|0|||
149107570|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
149107571|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
149107572|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
149107573|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
149107574|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
149107575|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
149107576|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
149107577|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
149107578|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
149107579|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
149107580|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Death|1|||
149107581|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Death|0|||
149107582|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
149107583|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
149107584|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
149107585|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
149107586|NCT00790400|537872613|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
149107587|NCT00790400|537872614|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
149107588|NCT01483144|537872615|FG000|Overall Study|Adverse Event|9|||
149107589|NCT01483144|537872616|FG001|Overall Study|Adverse Event|4|||
149107590|NCT01483144|537872617|FG002|Overall Study|Adverse Event|6|||
149107591|NCT01483144|537872615|FG000|Overall Study|Withdrawal by Subject|0|||
149107592|NCT01483144|537872616|FG001|Overall Study|Withdrawal by Subject|2|||
149107593|NCT01483144|537872617|FG002|Overall Study|Withdrawal by Subject|5|||
149107594|NCT01483144|537872615|FG000|Overall Study|Physician Decision|1|||
149107595|NCT01483144|537872616|FG001|Overall Study|Physician Decision|0|||
149107596|NCT01483144|537872617|FG002|Overall Study|Physician Decision|0|||
149107597|NCT01483144|537872615|FG000|Overall Study|Lost to Follow-up|2|||
149107598|NCT01483144|537872616|FG001|Overall Study|Lost to Follow-up|4|||
149107599|NCT01483144|537872617|FG002|Overall Study|Lost to Follow-up|1|||
149107600|NCT01483144|537872615|FG000|Overall Study|Protocol Violation|3|||
149107601|NCT01483144|537872616|FG001|Overall Study|Protocol Violation|3|||
149107602|NCT01483144|537872617|FG002|Overall Study|Protocol Violation|3|||
149107603|NCT02460575|537872618|FG000|Overall Study|Lost to Follow-up|1|||
149107604|NCT02460575|537872619|FG001|Overall Study|Lost to Follow-up|0|||
149107605|NCT04307940|537872620|FG000|Overall Study|Adverse Event|1|||
149107606|NCT04307940|537872621|FG001|Overall Study|Adverse Event|0|||
149107607|NCT04307940|537872622|FG002|Overall Study|Adverse Event|0|||
149107608|NCT04307940|537872620|FG000|Overall Study|Withdrawal by Subject|2|||
149107609|NCT04307940|537872621|FG001|Overall Study|Withdrawal by Subject|3|||
149107610|NCT04307940|537872622|FG002|Overall Study|Withdrawal by Subject|1|||
149107611|NCT04307940|537872620|FG000|Overall Study|Lost to Follow-up|2|||
149107612|NCT04307940|537872621|FG001|Overall Study|Lost to Follow-up|0|||
149107613|NCT04307940|537872622|FG002|Overall Study|Lost to Follow-up|1|||
149107614|NCT02521363|537872623|FG000|Overall Study|Withdrawal by Subject|1|||
149107615|NCT02521363|537872624|FG001|Overall Study|Withdrawal by Subject|2|||
149107616|NCT05543174|537872625|FG000|Overall Study|Ongoing|7|||
149107617|NCT03104075|537872631|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
149107618|NCT03104075|537872632|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
149107619|NCT04896008|537872633|FG000|Overall Study|Ongoing|70|||
149107620|NCT04896008|537872634|FG001|Overall Study|Ongoing|38|||
149107621|NCT04896008|537872633|FG000|Overall Study|Adverse Event|0|||
149107622|NCT04896008|537872634|FG001|Overall Study|Adverse Event|2|||
149107623|NCT04896008|537872633|FG000|Overall Study|Death|5|||
149107624|NCT04896008|537872634|FG001|Overall Study|Death|10|||
149107625|NCT04896008|537872633|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
149107626|NCT04896008|537872634|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
149107627|NCT04896008|537872633|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
149107628|NCT04896008|537872634|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
149107629|NCT04896008|537872633|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
149107630|NCT04896008|537872634|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
149107631|NCT04896008|537872633|FG000|Overall Study|Withdrawal by Subject|1|||
149107632|NCT04896008|537872634|FG001|Overall Study|Withdrawal by Subject|4|||
149107633|NCT04896008|537872633|FG000|Overall Study|Investigator Decision|2|||
149107634|NCT04896008|537872634|FG001|Overall Study|Investigator Decision|0|||
149107635|NCT04896008|537872633|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
149107636|NCT04896008|537872634|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
149107637|NCT04201288|537872637|FG000|Overall Study|Death|1|||
149107638|NCT04201288|537872638|FG001|Overall Study|Death|1|||
149107639|NCT04201288|537872637|FG000|Overall Study|Lost to Follow-up|5|||
149107640|NCT04201288|537872638|FG001|Overall Study|Lost to Follow-up|3|||
149107641|NCT04201288|537872637|FG000|Overall Study|Withdrawal by Subject|1|||
149107642|NCT04201288|537872638|FG001|Overall Study|Withdrawal by Subject|0|||
149107643|NCT00944229|537872641|FG000|Overall Study|Withdrawal by Subject|11|||
149107644|NCT00944229|537872641|FG000|Overall Study|Physician Decision|14|||
149107645|NCT01270828|537872642|FG000|Pregabalin CR SB|Reason Unspecified|0|||
149107646|NCT01270828|537872643|FG001|Pregabalin CR SB|Reason Unspecified|0|||
149107647|NCT01270828|537872644|FG002|Pregabalin CR SB|Reason Unspecified|8|||
149107648|NCT01270828|537872642|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
149107649|NCT01270828|537872643|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
149107650|NCT01270828|537872644|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
149107651|NCT01270828|537872642|FG000|Pregabalin CR SB|Related adverse event|0|||
149107652|NCT01270828|537872643|FG001|Pregabalin CR SB|Related adverse event|0|||
149107653|NCT01270828|537872644|FG002|Pregabalin CR SB|Related adverse event|46|||
149107654|NCT01270828|537872642|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
149107655|NCT01270828|537872643|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
149107656|NCT01270828|537872644|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
149107657|NCT01270828|537872642|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
149107658|NCT01270828|537872643|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
149107659|NCT01270828|537872644|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
149107660|NCT01270828|537872642|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
149107661|NCT01270828|537872643|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
149107662|NCT01270828|537872644|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
149107663|NCT01270828|537872642|FG000|Pregabalin CR SB|Unrelated AE|0|||
149107664|NCT01270828|537872643|FG001|Pregabalin CR SB|Unrelated AE|0|||
149107665|NCT01270828|537872644|FG002|Pregabalin CR SB|Unrelated AE|8|||
149107666|NCT01270828|537872642|FG000|Pregabalin CR SB|Protocol Violation|0|||
149107667|NCT01270828|537872643|FG001|Pregabalin CR SB|Protocol Violation|0|||
149107668|NCT01270828|537872644|FG002|Pregabalin CR SB|Protocol Violation|8|||
149107669|NCT01270828|537872642|FG000|Double Blind Phase|Death|0|||
149107670|NCT01270828|537872643|FG001|Double Blind Phase|Death|1|||
149107671|NCT01270828|537872644|FG002|Double Blind Phase|Death|0|||
149107672|NCT01270828|537872642|FG000|Double Blind Phase|Protocol Violation|0|||
149107673|NCT01270828|537872643|FG001|Double Blind Phase|Protocol Violation|1|||
149107674|NCT01270828|537872644|FG002|Double Blind Phase|Protocol Violation|0|||
149107675|NCT01270828|537872642|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
149107676|NCT01270828|537872643|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
149107677|NCT01270828|537872644|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
149107678|NCT01270828|537872642|FG000|Double Blind Phase|Reason Unspecified|7|||
149107679|NCT01270828|537872643|FG001|Double Blind Phase|Reason Unspecified|4|||
149107680|NCT01270828|537872644|FG002|Double Blind Phase|Reason Unspecified|0|||
149107681|NCT01270828|537872642|FG000|Double Blind Phase|Withdrawal by Subject|6|||
149107682|NCT01270828|537872643|FG001|Double Blind Phase|Withdrawal by Subject|15|||
149107683|NCT01270828|537872644|FG002|Double Blind Phase|Withdrawal by Subject|0|||
149107684|NCT01270828|537872642|FG000|Double Blind Phase|Lost to Follow-up|1|||
149107685|NCT01270828|537872643|FG001|Double Blind Phase|Lost to Follow-up|2|||
149107686|NCT01270828|537872644|FG002|Double Blind Phase|Lost to Follow-up|0|||
149107687|NCT01270828|537872642|FG000|Double Blind Phase|Lack of Efficacy|2|||
149107688|NCT01270828|537872643|FG001|Double Blind Phase|Lack of Efficacy|11|||
149107689|NCT01270828|537872644|FG002|Double Blind Phase|Lack of Efficacy|0|||
149107690|NCT01270828|537872642|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
149107691|NCT01270828|537872643|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
149107692|NCT01270828|537872644|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
149107693|NCT01270828|537872642|FG000|Double Blind Phase|Adverse event related to study drug|5|||
149107694|NCT01270828|537872643|FG001|Double Blind Phase|Adverse event related to study drug|7|||
149107695|NCT01270828|537872644|FG002|Double Blind Phase|Adverse event related to study drug|0|||
149107696|NCT01810939|537872647|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
149107697|NCT01810939|537872648|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
149107698|NCT01810939|537872649|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
149107699|NCT01810939|537872647|FG000|Part A Treatment Period|Protocol Violation|2|||
149107700|NCT01810939|537872648|FG001|Part A Treatment Period|Protocol Violation|0|||
149107701|NCT01810939|537872649|FG002|Part A Treatment Period|Protocol Violation|0|||
149107702|NCT01810939|537872647|FG000|Part A Treatment Period|Adverse Event|10|||
149107703|NCT01810939|537872648|FG001|Part A Treatment Period|Adverse Event|0|||
149107704|NCT01810939|537872649|FG002|Part A Treatment Period|Adverse Event|0|||
149107705|NCT01810939|537872647|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
149107706|NCT01810939|537872648|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
149107707|NCT01810939|537872649|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
149107708|NCT01810939|537872647|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
149107709|NCT01810939|537872648|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
149107710|NCT01810939|537872649|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
149107711|NCT01810939|537872647|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
149107712|NCT01810939|537872648|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
149107713|NCT01810939|537872649|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
149107714|NCT01810939|537872647|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
149107715|NCT01810939|537872648|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
149107716|NCT01810939|537872649|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
149107717|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
149107718|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
149107719|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
149107720|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
149107721|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
149107722|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
149107723|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
149107724|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
149107725|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
149107726|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
149107727|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
149107728|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
149107729|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
149107730|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
149107731|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
149107732|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
149107733|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
149107734|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
149107735|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
149107736|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
149107737|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
149107738|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
149107739|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
149107740|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
149107741|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
149107742|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
149107743|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
149107744|NCT01810939|537872647|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
149107745|NCT01810939|537872648|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
149107746|NCT01810939|537872649|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
149107747|NCT02963090|537872650|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
149107748|NCT02963090|537872651|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
149107749|NCT04400487|537872652|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
149107750|NCT04400487|537872652|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
149107751|NCT04400487|537872652|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
149107752|NCT02153905|537872653|FG000|Overall Study|Death|1|||
149107753|NCT02153905|537872654|FG001|Overall Study|Death|0|||
149107754|NCT00520845|537872655|FG000|Overall Study|Death|3|||
149107755|NCT00520845|537872655|FG000|Overall Study|Adverse Event|4|||
149107756|NCT00520845|537872655|FG000|Overall Study|Disease Progression, relapse|13|||
149107757|NCT00520845|537872655|FG000|Overall Study|Withdrawal by Subject|1|||
149107758|NCT00520845|537872655|FG000|Overall Study|Alternative Therapy|1|||
149107759|NCT01516749|537872658|FG000|Active Therapy|Lost to Follow-up|1|||
149107760|NCT01516749|537872658|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
149107761|NCT00351377|537872659|FG000|Overall Study|Adverse Event|5|||
149107762|NCT00351377|537872659|FG000|Overall Study|Death|1|||
149107763|NCT00351377|537872659|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
149107764|NCT01732549|537872660|FG000|Overall Study|Adverse Event|13|||
149107765|NCT01732549|537872661|FG001|Overall Study|Adverse Event|3|||
149107766|NCT01732549|537872660|FG000|Overall Study|Consent withdrawn|13|||
149107767|NCT01732549|537872661|FG001|Overall Study|Consent withdrawn|6|||
149107768|NCT01732549|537872660|FG000|Overall Study|Disease progression|37|||
149107769|NCT01732549|537872661|FG001|Overall Study|Disease progression|50|||
149107770|NCT01732549|537872660|FG000|Overall Study|Other|8|||
149107771|NCT01732549|537872661|FG001|Overall Study|Other|14|||
149107772|NCT02030002|537872662|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
149107773|NCT02030002|537872662|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
149107774|NCT02030002|537872662|FG000|Follow-up|Lost to Follow-up|2|||
149107775|NCT03994731|537872664|FG000|Pegloticase + IMM Period|Death|2|||
149107776|NCT03994731|537872665|FG001|Pegloticase + IMM Period|Death|0|||
149107777|NCT03994731|537872664|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
149107778|NCT03994731|537872665|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
149107779|NCT03994731|537872664|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
149107780|NCT03994731|537872665|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
149107781|NCT01681992|537872668|FG000|Overall Study|Adverse Event|3|||
149107782|NCT01681992|537872669|FG001|Overall Study|Adverse Event|2|||
149107783|NCT01681992|537872670|FG002|Overall Study|Adverse Event|3|||
149107784|NCT01681992|537872668|FG000|Overall Study|Lost to Follow-up|36|||
149107785|NCT01681992|537872669|FG001|Overall Study|Lost to Follow-up|38|||
149107786|NCT01681992|537872670|FG002|Overall Study|Lost to Follow-up|53|||
149107787|NCT01681992|537872668|FG000|Overall Study|As Per Sponsor Decision|0|||
149107788|NCT01681992|537872669|FG001|Overall Study|As Per Sponsor Decision|0|||
149107789|NCT01681992|537872670|FG002|Overall Study|As Per Sponsor Decision|1|||
149107790|NCT01681992|537872668|FG000|Overall Study|Protocol Violation|0|||
149107791|NCT01681992|537872669|FG001|Overall Study|Protocol Violation|0|||
149107792|NCT01681992|537872670|FG002|Overall Study|Protocol Violation|1|||
149107793|NCT01681992|537872668|FG000|Overall Study|Withdrawal by Subject|27|||
149107794|NCT01681992|537872669|FG001|Overall Study|Withdrawal by Subject|30|||
149107795|NCT01681992|537872670|FG002|Overall Study|Withdrawal by Subject|25|||
149107796|NCT02406248|537872675|FG000|Overall Study|Death|7|||
149107797|NCT02406248|537872675|FG000|Overall Study|Withdrawal by Subject|2|||
149107798|NCT04805073|537872684|FG000|Overall Study|study personnel not available|2|||
149107799|NCT04805073|537872685|FG001|Overall Study|study personnel not available|0|||
149107800|NCT04805073|537872684|FG000|Overall Study|spinal anesthesia failure|0|||
149107801|NCT04805073|537872685|FG001|Overall Study|spinal anesthesia failure|1|||
149107802|NCT04805073|537872684|FG000|Overall Study|Lost to Follow-up|0|||
149107803|NCT04805073|537872685|FG001|Overall Study|Lost to Follow-up|2|||
149107804|NCT03017742|537872690|FG000|Overall Study|Protocol Violation|36|||
149107805|NCT03017742|537872690|FG000|Overall Study|Withdrawal by Subject|37|||
149107806|NCT00953147|537874705|FG000|Overall Study|Adverse Event|8|||
149107807|NCT00953147|537874706|FG001|Overall Study|Adverse Event|16|||
149107808|NCT00953147|537874707|FG002|Overall Study|Adverse Event|6|||
149107809|NCT00953147|537874705|FG000|Overall Study|Protocol Violation|2|||
149107810|NCT00953147|537874706|FG001|Overall Study|Protocol Violation|8|||
149107811|NCT00953147|537874707|FG002|Overall Study|Protocol Violation|4|||
149107812|NCT00953147|537874705|FG000|Overall Study|Withdrawal by Subject|13|||
149107813|NCT00953147|537874706|FG001|Overall Study|Withdrawal by Subject|15|||
149107814|NCT00953147|537874707|FG002|Overall Study|Withdrawal by Subject|12|||
149107815|NCT00953147|537874705|FG000|Overall Study|Lost to Follow-up|8|||
149107816|NCT00953147|537874706|FG001|Overall Study|Lost to Follow-up|9|||
149107817|NCT00953147|537874707|FG002|Overall Study|Lost to Follow-up|4|||
149107818|NCT00953147|537874705|FG000|Overall Study|Physician Decision|2|||
149107819|NCT00953147|537874706|FG001|Overall Study|Physician Decision|7|||
149107820|NCT00953147|537874707|FG002|Overall Study|Physician Decision|3|||
149107821|NCT00953147|537874705|FG000|Overall Study|Other|4|||
149107822|NCT00953147|537874706|FG001|Overall Study|Other|11|||
149107823|NCT00953147|537874707|FG002|Overall Study|Other|13|||
149107824|NCT01484431|537874709|FG000|Period 1: High Dose|Physician Decision|0|||
149107825|NCT01484431|537874710|FG001|Period 1: High Dose|Physician Decision|1|||
149107826|NCT01484431|537874711|FG002|Period 1: High Dose|Physician Decision|0|||
149107827|NCT01484431|537874709|FG000|Period 2|Death|0|||
149107828|NCT01484431|537874710|FG001|Period 2|Death|1|||
149107829|NCT01484431|537874711|FG002|Period 2|Death|1|||
149107830|NCT01484431|537874709|FG000|Period 2|Physician Decision|0|||
149107831|NCT01484431|537874710|FG001|Period 2|Physician Decision|0|||
149107832|NCT01484431|537874711|FG002|Period 2|Physician Decision|1|||
149107833|NCT01484431|537874709|FG000|Period 2|Non-Compliance with Study Drug|1|||
149107834|NCT01484431|537874710|FG001|Period 2|Non-Compliance with Study Drug|0|||
149107835|NCT01484431|537874711|FG002|Period 2|Non-Compliance with Study Drug|0|||
149107836|NCT01251770|537874712|FG000|Overall Study|Protocol Violation|13|||
149107837|NCT01251770|537874713|FG001|Overall Study|Protocol Violation|7|||
149107838|NCT02113124|537874714|FG000|Overall Study|Unable to retrieve blood sample|1|||
149107839|NCT02113124|537874715|FG001|Overall Study|Unable to retrieve blood sample|1|||
149107840|NCT02514239|537874716|FG000|Overall Study|Refused to continue trial medication|0|||
149107841|NCT02514239|537874717|FG001|Overall Study|Refused to continue trial medication|0|||
149107842|NCT02514239|537874718|FG002|Overall Study|Refused to continue trial medication|0|||
149107843|NCT02514239|537874719|FG003|Overall Study|Refused to continue trial medication|0|||
149107844|NCT02514239|537874720|FG004|Overall Study|Refused to continue trial medication|0|||
149107845|NCT02514239|537874721|FG005|Overall Study|Refused to continue trial medication|0|||
149107846|NCT02514239|537874722|FG006|Overall Study|Refused to continue trial medication|0|||
149107847|NCT02514239|537874723|FG007|Overall Study|Refused to continue trial medication|0|||
149107848|NCT02514239|537874724|FG008|Overall Study|Refused to continue trial medication|0|||
149107849|NCT02514239|537874725|FG009|Overall Study|Refused to continue trial medication|1|||
149107850|NCT02514239|537874716|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107851|NCT02514239|537874717|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107852|NCT02514239|537874718|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107853|NCT02514239|537874719|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107854|NCT02514239|537874720|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107855|NCT02514239|537874721|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107856|NCT02514239|537874722|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107857|NCT02514239|537874723|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
149107858|NCT02514239|537874724|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
149107859|NCT02514239|537874725|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
149107860|NCT02514239|537874716|FG000|Overall Study|Not treated|0|||
149107861|NCT02514239|537874717|FG001|Overall Study|Not treated|1|||
149107862|NCT02514239|537874718|FG002|Overall Study|Not treated|0|||
149107863|NCT02514239|537874719|FG003|Overall Study|Not treated|0|||
149107864|NCT02514239|537874720|FG004|Overall Study|Not treated|0|||
149107865|NCT02514239|537874721|FG005|Overall Study|Not treated|0|||
149107866|NCT02514239|537874722|FG006|Overall Study|Not treated|0|||
149107867|NCT02514239|537874723|FG007|Overall Study|Not treated|0|||
149107868|NCT02514239|537874724|FG008|Overall Study|Not treated|0|||
149107869|NCT02514239|537874725|FG009|Overall Study|Not treated|0|||
149107870|NCT02514239|537874716|FG000|Overall Study|Other Adverse Events|2|||
149107871|NCT02514239|537874717|FG001|Overall Study|Other Adverse Events|0|||
149107872|NCT02514239|537874718|FG002|Overall Study|Other Adverse Events|0|||
149107873|NCT02514239|537874719|FG003|Overall Study|Other Adverse Events|1|||
149107874|NCT02514239|537874720|FG004|Overall Study|Other Adverse Events|0|||
149107875|NCT02514239|537874721|FG005|Overall Study|Other Adverse Events|1|||
149107876|NCT02514239|537874722|FG006|Overall Study|Other Adverse Events|0|||
149107877|NCT02514239|537874723|FG007|Overall Study|Other Adverse Events|1|||
149107878|NCT02514239|537874724|FG008|Overall Study|Other Adverse Events|2|||
149107879|NCT02514239|537874725|FG009|Overall Study|Other Adverse Events|0|||
149107880|NCT02514239|537874716|FG000|Overall Study|Progressive disease|3|||
149107881|NCT02514239|537874717|FG001|Overall Study|Progressive disease|3|||
149107882|NCT02514239|537874718|FG002|Overall Study|Progressive disease|2|||
149107883|NCT02514239|537874719|FG003|Overall Study|Progressive disease|2|||
149107884|NCT02514239|537874720|FG004|Overall Study|Progressive disease|3|||
149107885|NCT02514239|537874721|FG005|Overall Study|Progressive disease|3|||
149107886|NCT02514239|537874722|FG006|Overall Study|Progressive disease|4|||
149107887|NCT02514239|537874723|FG007|Overall Study|Progressive disease|2|||
149107888|NCT02514239|537874724|FG008|Overall Study|Progressive disease|5|||
149107889|NCT02514239|537874725|FG009|Overall Study|Progressive disease|0|||
149107890|NCT01901419|537874726|FG000|Overall Study|Protocol Violation|2|||
149107891|NCT01901419|537874727|FG001|Overall Study|Protocol Violation|6|||
149107892|NCT01901419|537874726|FG000|Overall Study|unavailable researchers|6|||
149107893|NCT01901419|537874727|FG001|Overall Study|unavailable researchers|3|||
149107894|NCT01020877|537874732|FG000|Second Intervention|Withdrawal by Subject|1|||
149107895|NCT01020877|537874733|FG001|Second Intervention|Withdrawal by Subject|0|||
149107896|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
149107897|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
149107898|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
149107899|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
149107900|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Death|13|||
149107901|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Death|12|||
149107902|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Progression|257|||
149107903|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Progression|218|||
149107904|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
149107905|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
149107906|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
149107907|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
149107908|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
149107909|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
149107910|NCT01006980|537874735|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
149107911|NCT01006980|537874736|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
149107912|NCT01006980|537874735|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
149107913|NCT01006980|537874736|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
149107914|NCT01006980|537874735|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
149107915|NCT01006980|537874736|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
149107916|NCT01006980|537874735|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
149107917|NCT01006980|537874736|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
149107918|NCT01006980|537874735|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
149107919|NCT01006980|537874736|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
149107920|NCT01006980|537874735|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
149107921|NCT01006980|537874736|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
149107922|NCT00078338|537874737|FG000|Overall Study|Adverse Event|31|||
149107923|NCT00078338|537874738|FG001|Overall Study|Adverse Event|24|||
149107924|NCT00078338|537874737|FG000|Overall Study|Lost to Follow-up|17|||
149107925|NCT00078338|537874738|FG001|Overall Study|Lost to Follow-up|2|||
149107926|NCT00078338|537874737|FG000|Overall Study|Protocol Violation|2|||
149107927|NCT00078338|537874738|FG001|Overall Study|Protocol Violation|2|||
149107928|NCT00078338|537874737|FG000|Overall Study|Disease Progression|4|||
149107929|NCT00078338|537874738|FG001|Overall Study|Disease Progression|7|||
149107930|NCT00078338|537874737|FG000|Overall Study|Other|28|||
149107931|NCT00078338|537874738|FG001|Overall Study|Other|16|||
149107932|NCT00078338|537874737|FG000|Overall Study|Subjects randomized, but not treated|3|||
149107933|NCT00078338|537874738|FG001|Overall Study|Subjects randomized, but not treated|3|||
149107934|NCT00709228|537874747|FG000|Overall Study|Not treated|14|||
149107935|NCT00709228|537874747|FG000|Overall Study|Eligibility criteria not met|281|||
149107936|NCT00709228|537874747|FG000|Overall Study|Adverse events|2|||
149107937|NCT00709228|537874747|FG000|Overall Study|Discontinued treatment|14|||
149107938|NCT00709228|537874747|FG000|Overall Study|Did not enter follow-up|4|||
149107939|NCT00709228|537874747|FG000|Overall Study|Discontinued follow-up|5|||
149107940|NCT00709228|537874747|FG000|Overall Study|Disease progression|1|||
149107941|NCT00709228|537874747|FG000|Overall Study|Lost to Follow-up|6|||
149107942|NCT00709228|537874747|FG000|Overall Study|Non-compliance|5|||
149107943|NCT02870972|537874748|FG000|Overall Study|Adverse Event|1|||
149107944|NCT02870972|537874749|FG001|Overall Study|Adverse Event|0|||
149107945|NCT02870972|537874750|FG002|Overall Study|Adverse Event|0|||
149107946|NCT02870972|537874751|FG003|Overall Study|Adverse Event|0|||
149107947|NCT02870972|537874752|FG004|Overall Study|Adverse Event|0|||
149107948|NCT04497389|537874753|FG000|Overall Study|Withdrawal by Subject|1|||
149107949|NCT04497389|537874754|FG001|Overall Study|Withdrawal by Subject|0|||
149107950|NCT00789360|537874755|FG000|Overall Study|Protocol Violation|3|||
149107951|NCT00789360|537874756|FG001|Overall Study|Protocol Violation|1|||
149107952|NCT03559062|537874757|FG000|Overall Study|Other|0|||
149107953|NCT03559062|537874758|FG001|Overall Study|Other|1|||
149107954|NCT03559062|537874759|FG002|Overall Study|Other|0|||
149107955|NCT01594827|537874765|FG000|Overall Study|Adverse Event|1|||
149107956|NCT01594827|537874766|FG001|Overall Study|Adverse Event|0|||
149107957|NCT01594827|537874765|FG000|Overall Study|Physician Decision|3|||
149107958|NCT01594827|537874766|FG001|Overall Study|Physician Decision|0|||
149107959|NCT03445533|537874768|FG000|Overall Study|Progressive Disease|48|||
149107960|NCT03445533|537874769|FG001|Overall Study|Progressive Disease|81|||
149107961|NCT03445533|537874768|FG000|Overall Study|Adverse Event|60|||
149107962|NCT03445533|537874769|FG001|Overall Study|Adverse Event|64|||
149107963|NCT03445533|537874768|FG000|Overall Study|Death|9|||
149107964|NCT03445533|537874769|FG001|Overall Study|Death|19|||
149107965|NCT03445533|537874768|FG000|Overall Study|Miscellaneous|0|||
149107966|NCT03445533|537874769|FG001|Overall Study|Miscellaneous|16|||
149107967|NCT03445533|537874768|FG000|Overall Study|Withdrawal by Subject|3|||
149107968|NCT03445533|537874769|FG001|Overall Study|Withdrawal by Subject|4|||
149107969|NCT03445533|537874768|FG000|Overall Study|Physician Decision|1|||
149107970|NCT03445533|537874769|FG001|Overall Study|Physician Decision|3|||
149107971|NCT03445533|537874768|FG000|Overall Study|Sponsor Decision|0|||
149107972|NCT03445533|537874769|FG001|Overall Study|Sponsor Decision|1|||
149107973|NCT03445533|537874768|FG000|Overall Study|Lost to Follow-up|0|||
149107974|NCT03445533|537874769|FG001|Overall Study|Lost to Follow-up|1|||
149107975|NCT03445533|537874768|FG000|Overall Study|Never Received any Study Treatment|7|||
149107976|NCT03445533|537874769|FG001|Overall Study|Never Received any Study Treatment|4|||
149107977|NCT02615509|537874770|FG000|Overall Study|Lost to Follow-up|134|||
149107978|NCT02615509|537874770|FG000|Overall Study|Death|4|||
149107979|NCT02615509|537874770|FG000|Overall Study|Withdrawal by Subject|8|||
149107980|NCT03334253|537874771|FG000|Overall Study|Withdrawal by Subject|1|||
149107981|NCT03334253|537874772|FG001|Overall Study|Withdrawal by Subject|0|||
149107982|NCT03334253|537874771|FG000|Overall Study|Lost to Follow-up|4|||
149107983|NCT03334253|537874772|FG001|Overall Study|Lost to Follow-up|3|||
149107984|NCT03334253|537874771|FG000|Overall Study|Moved residence|2|||
149107985|NCT03334253|537874772|FG001|Overall Study|Moved residence|2|||
149107986|NCT03274453|537874773|FG000|Overall Study|Lost to Follow-up|2|||
149107987|NCT03274453|537874774|FG001|Overall Study|Lost to Follow-up|5|||
149107988|NCT03274453|537874775|FG002|Overall Study|Lost to Follow-up|4|||
149107989|NCT03274453|537874776|FG003|Overall Study|Lost to Follow-up|1|||
149107990|NCT03274453|537874773|FG000|Overall Study|Physician Decision|2|||
149107991|NCT03274453|537874774|FG001|Overall Study|Physician Decision|0|||
149107992|NCT03274453|537874775|FG002|Overall Study|Physician Decision|0|||
149107993|NCT03274453|537874776|FG003|Overall Study|Physician Decision|3|||
149107994|NCT03274453|537874773|FG000|Overall Study|Surgery Cancelled|0|||
149107995|NCT03274453|537874774|FG001|Overall Study|Surgery Cancelled|1|||
149107996|NCT03274453|537874775|FG002|Overall Study|Surgery Cancelled|0|||
149107997|NCT03274453|537874776|FG003|Overall Study|Surgery Cancelled|0|||
149107998|NCT00968526|537874778|FG000|Overall Study|Adverse Event|2|||
149107999|NCT00968526|537874779|FG001|Overall Study|Adverse Event|0|||
149108000|NCT00968526|537874778|FG000|Overall Study|Migrated/moved from study area|1|||
149108001|NCT00968526|537874779|FG001|Overall Study|Migrated/moved from study area|0|||
149108002|NCT00945672|537874780|FG000|Overall Study|Withdrawal by Subject|0|||
149108003|NCT00945672|537874781|FG001|Overall Study|Withdrawal by Subject|0|||
149108004|NCT00945672|537874782|FG002|Overall Study|Withdrawal by Subject|0|||
149108005|NCT00945672|537874783|FG003|Overall Study|Withdrawal by Subject|1|||
149108006|NCT03926195|537874787|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
149108007|NCT03926195|537874788|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
149108008|NCT03926195|537874787|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
149108009|NCT03926195|537874788|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
149108010|NCT03926195|537874787|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
149108011|NCT03926195|537874788|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
149108012|NCT03926195|537874787|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
149108013|NCT03926195|537874788|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
149108014|NCT03926195|537874787|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
149108015|NCT03926195|537874788|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
149108016|NCT03926195|537874787|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
149108017|NCT03926195|537874788|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
149108018|NCT00447590|537874789|FG000|Overall Study|Withdrawal by Subject|26|||
149108019|NCT00447590|537874789|FG000|Overall Study|Lost to Follow-up|24|||
149108020|NCT00447590|537874789|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
149108021|NCT01967069|537874790|FG000|Overall Study|Adverse Event|2|||
149108022|NCT01967069|537874791|FG001|Overall Study|Adverse Event|2|||
149108023|NCT01967069|537874790|FG000|Overall Study|Lost to Follow-up|5|||
149108024|NCT01967069|537874791|FG001|Overall Study|Lost to Follow-up|2|||
149108025|NCT01967069|537874790|FG000|Overall Study|Withdrawal by Subject|1|||
149108026|NCT01967069|537874791|FG001|Overall Study|Withdrawal by Subject|3|||
149108027|NCT01967069|537874790|FG000|Overall Study|Lack of Efficacy|0|||
149108028|NCT01967069|537874791|FG001|Overall Study|Lack of Efficacy|1|||
149108029|NCT05569421|537874792|FG000|Overall Study|Withdrawal by Subject|1|||
149108030|NCT05569421|537874793|FG001|Overall Study|Withdrawal by Subject|0|||
149108031|NCT05569421|537874794|FG002|Overall Study|Withdrawal by Subject|0|||
149108032|NCT00504075|537874795|FG000|Overall Study|Adverse Event|1|||
149108033|NCT00504075|537874795|FG000|Overall Study|Lost to Follow-up|5|||
149108034|NCT00504075|537874795|FG000|Overall Study|Withdrawal by Subject|1|||
149108035|NCT00504075|537874795|FG000|Overall Study|Required other therapeutic intervention|1|||
149108036|NCT01689857|537874797|FG000|Overall Study|Lost to Follow-up|5|||
149108037|NCT01689857|537874798|FG001|Overall Study|Lost to Follow-up|2|||
149108038|NCT00874731|537874799|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
149108039|NCT00874731|537874800|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
149108040|NCT00874731|537874801|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
149108041|NCT00874731|537874799|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
149108042|NCT00874731|537874800|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
149108043|NCT00874731|537874801|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
149108044|NCT00874731|537874799|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
149108045|NCT00874731|537874800|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
149108046|NCT00874731|537874801|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
149108047|NCT01736540|537874805|FG000|Overall Study|Did not complete scan within 45 days|2|||
149108048|NCT01736540|537874805|FG000|Overall Study|Death|1|||
149108049|NCT01736540|537874805|FG000|Overall Study|Abnormal test procedure|1|||
149108050|NCT01736540|537874805|FG000|Overall Study|Withdrawal by Subject|5|||
149108051|NCT01736540|537874805|FG000|Overall Study|Protocol Violation|1|||
149108052|NCT01736540|537874805|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
149108053|NCT01736540|537874805|FG000|Overall Study|No show for MRI appointment|1|||
149108054|NCT01736540|537874805|FG000|Overall Study|Unable to make MRI appointment|3|||
149108055|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
149108056|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
149108057|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
149108058|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
149108059|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
149108060|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
149108061|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
149108062|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
149108063|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
149108064|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
149108065|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
149108066|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
149108067|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
149108068|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
149108069|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
149108070|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
149108071|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
149108072|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
149108073|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
149108074|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
149108075|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
149108076|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
149108077|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
149108078|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
149108079|NCT00479882|537874808|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
149108080|NCT00479882|537874809|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
149108081|NCT00479882|537874810|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
149108082|NCT00479882|537874811|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
149108083|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
149108084|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
149108085|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
149108086|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
149108087|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
149108088|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
149108089|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
149108090|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
149108091|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
149108092|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
149108093|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
149108094|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
149108095|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
149108096|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
149108097|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
149108098|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
149108099|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
149108100|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
149108101|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
149108102|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
149108103|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
149108104|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
149108105|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
149108106|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
149108107|NCT00479882|537874808|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
149108108|NCT00479882|537874809|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
149108109|NCT00479882|537874810|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
149108110|NCT00479882|537874811|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
149108111|NCT03812029|537874812|FG000|Overall Study|Protocol Violation|1|||
149108112|NCT03812029|537874813|FG001|Overall Study|Protocol Violation|0|||
149108113|NCT03812029|537874814|FG002|Overall Study|Protocol Violation|0|||
149108114|NCT03812029|537874815|FG003|Overall Study|Protocol Violation|1|||
149108115|NCT03812029|537874816|FG004|Overall Study|Protocol Violation|0|||
149108116|NCT03812029|537874812|FG000|Overall Study|Withdrawal by Subject|1|||
149108117|NCT03812029|537874813|FG001|Overall Study|Withdrawal by Subject|0|||
149108118|NCT03812029|537874814|FG002|Overall Study|Withdrawal by Subject|0|||
149108119|NCT03812029|537874815|FG003|Overall Study|Withdrawal by Subject|2|||
149108120|NCT03812029|537874816|FG004|Overall Study|Withdrawal by Subject|2|||
149108121|NCT03812029|537874812|FG000|Overall Study|Stopping rules|0|||
149108122|NCT03812029|537874813|FG001|Overall Study|Stopping rules|1|||
149108123|NCT03812029|537874814|FG002|Overall Study|Stopping rules|0|||
149108124|NCT03812029|537874815|FG003|Overall Study|Stopping rules|0|||
149108125|NCT03812029|537874816|FG004|Overall Study|Stopping rules|0|||
149108126|NCT03812029|537874812|FG000|Overall Study|Adverse Event|0|||
149108127|NCT03812029|537874813|FG001|Overall Study|Adverse Event|9|||
149108128|NCT03812029|537874814|FG002|Overall Study|Adverse Event|0|||
149108129|NCT03812029|537874815|FG003|Overall Study|Adverse Event|3|||
149108130|NCT03812029|537874816|FG004|Overall Study|Adverse Event|5|||
149108131|NCT03812029|537874812|FG000|Overall Study|Lost to Follow-up|0|||
149108132|NCT03812029|537874813|FG001|Overall Study|Lost to Follow-up|0|||
149108133|NCT03812029|537874814|FG002|Overall Study|Lost to Follow-up|0|||
149108134|NCT03812029|537874815|FG003|Overall Study|Lost to Follow-up|0|||
149108135|NCT03812029|537874816|FG004|Overall Study|Lost to Follow-up|3|||
149108136|NCT00581477|537874817|FG000|Overall Study|Physician Decision|2|||
149108137|NCT03106753|537874818|FG000|Overall Study|Withdrawal by Subject|0|||
149108138|NCT03106753|537874819|FG001|Overall Study|Withdrawal by Subject|1|||
149108139|NCT03149042|537874820|FG000|Overall Study|Invasive FFR not performed|21|||
149108140|NCT03149042|537874820|FG000|Overall Study|Poor CT Image Quality|1|||
149108141|NCT03149042|537874820|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
149108142|NCT01643044|537874821|FG000|Overall Study|Lost to Follow-up|1|||
149108143|NCT01643044|537874822|FG001|Overall Study|Lost to Follow-up|1|||
149108144|NCT01643044|537874821|FG000|Overall Study|Miscarried baby|2|||
149108145|NCT01643044|537874822|FG001|Overall Study|Miscarried baby|2|||
149108146|NCT01643044|537874821|FG000|Overall Study|Delivered outside of hospital|1|||
149108147|NCT01643044|537874822|FG001|Overall Study|Delivered outside of hospital|2|||
149108148|NCT00790205|537874823|FG000|Overall Study|Lost to Follow-up|61|||
149108149|NCT00790205|537874824|FG001|Overall Study|Lost to Follow-up|71|||
149108150|NCT00790205|537874823|FG000|Overall Study|Withdrawal by Subject|299|||
149108151|NCT00790205|537874824|FG001|Overall Study|Withdrawal by Subject|363|||
149108152|NCT02643628|537874825|FG000|Overall Study|Lost to Follow-up|1|||
149108153|NCT02643628|537874826|FG001|Overall Study|Lost to Follow-up|4|||
149108154|NCT02643628|537874825|FG000|Overall Study|Withdrawal by Subject|0|||
149108155|NCT02643628|537874826|FG001|Overall Study|Withdrawal by Subject|1|||
149108156|NCT02643628|537874825|FG000|Overall Study|Relocated out of state|0|||
149108157|NCT02643628|537874826|FG001|Overall Study|Relocated out of state|1|||
149108158|NCT03933462|537874829|FG000|Overall Study|Adverse Event|2|||
149108159|NCT03933462|537874830|FG001|Overall Study|Adverse Event|0|||
149108160|NCT02975102|537874832|FG000|Overall Study|Adverse Event|2|||
149108161|NCT02975102|537874833|FG001|Overall Study|Adverse Event|1|||
149108162|NCT04148651|537874834|FG000|Overall Study|Lost to Follow-up|2|||
149108163|NCT03519204|537874837|FG000|Overall Study|Lost to Follow-up|3|||
149108164|NCT03519204|537874838|FG001|Overall Study|Lost to Follow-up|8|||
149108165|NCT03519204|537874837|FG000|Overall Study|Withdrawal by Subject|9|||
149108166|NCT03519204|537874838|FG001|Overall Study|Withdrawal by Subject|7|||
149108167|NCT03519204|537874837|FG000|Overall Study|Other Miscellaneous Reasons|1|||
149108168|NCT03519204|537874838|FG001|Overall Study|Other Miscellaneous Reasons|0|||
149108169|NCT03392168|537874839|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
149108170|NCT03392168|537874840|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
149108171|NCT03392168|537874841|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
149108172|NCT03392168|537874842|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
149108173|NCT03392168|537874839|FG000|Period 2: Cohort 2|Other|0|||
149108174|NCT03392168|537874840|FG001|Period 2: Cohort 2|Other|1|||
149108175|NCT03392168|537874841|FG002|Period 2: Cohort 2|Other|0|||
149108176|NCT03392168|537874842|FG003|Period 2: Cohort 2|Other|0|||
149108177|NCT02609672|537874843|FG000|Overall Study|Lost to Follow-up|3|||
149108178|NCT02609672|537874844|FG001|Overall Study|Lost to Follow-up|1|||
149108179|NCT02597712|537874846|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
149108180|NCT02597712|537874847|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
149108181|NCT02597712|537874846|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
149108182|NCT02597712|537874847|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
149108183|NCT02597712|537874846|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
149108184|NCT02597712|537874847|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
149108185|NCT01441635|537874851|FG000|Overall Study|Adverse Event|4|||
149108186|NCT01441635|537874852|FG001|Overall Study|Adverse Event|3|||
149108187|NCT01441635|537874853|FG002|Overall Study|Adverse Event|1|||
149108188|NCT01441635|537874854|FG003|Overall Study|Adverse Event|5|||
149108189|NCT01441635|537874855|FG004|Overall Study|Adverse Event|1|||
149108190|NCT01441635|537874856|FG005|Overall Study|Adverse Event|2|||
149108191|NCT01441635|537874857|FG006|Overall Study|Adverse Event|2|||
149108192|NCT01441635|537874858|FG007|Overall Study|Adverse Event|2|||
149108193|NCT01441635|537874859|FG008|Overall Study|Adverse Event|1|||
149108194|NCT01441635|537874860|FG009|Overall Study|Adverse Event|0|||
149108195|NCT01441635|537874851|FG000|Overall Study|Withdrawal by Subject|1|||
149108196|NCT01441635|537874852|FG001|Overall Study|Withdrawal by Subject|1|||
149108197|NCT01441635|537874853|FG002|Overall Study|Withdrawal by Subject|0|||
149108198|NCT01441635|537874854|FG003|Overall Study|Withdrawal by Subject|1|||
149108199|NCT01441635|537874855|FG004|Overall Study|Withdrawal by Subject|0|||
149108200|NCT01441635|537874856|FG005|Overall Study|Withdrawal by Subject|0|||
149108201|NCT01441635|537874857|FG006|Overall Study|Withdrawal by Subject|2|||
149108202|NCT01441635|537874858|FG007|Overall Study|Withdrawal by Subject|0|||
149108203|NCT01441635|537874859|FG008|Overall Study|Withdrawal by Subject|1|||
149108204|NCT01441635|537874860|FG009|Overall Study|Withdrawal by Subject|1|||
149108205|NCT01441635|537874851|FG000|Overall Study|Lost to Follow-up|0|||
149108206|NCT01441635|537874852|FG001|Overall Study|Lost to Follow-up|1|||
149108207|NCT01441635|537874853|FG002|Overall Study|Lost to Follow-up|1|||
149108208|NCT01441635|537874854|FG003|Overall Study|Lost to Follow-up|1|||
149108209|NCT01441635|537874855|FG004|Overall Study|Lost to Follow-up|1|||
149108210|NCT01441635|537874856|FG005|Overall Study|Lost to Follow-up|3|||
149108211|NCT01441635|537874857|FG006|Overall Study|Lost to Follow-up|1|||
149108212|NCT01441635|537874858|FG007|Overall Study|Lost to Follow-up|1|||
149108213|NCT01441635|537874859|FG008|Overall Study|Lost to Follow-up|0|||
149108214|NCT01441635|537874860|FG009|Overall Study|Lost to Follow-up|1|||
149108215|NCT01441635|537874851|FG000|Overall Study|Noncompliance|0|||
149108216|NCT01441635|537874852|FG001|Overall Study|Noncompliance|1|||
149108217|NCT01441635|537874853|FG002|Overall Study|Noncompliance|0|||
149108218|NCT01441635|537874854|FG003|Overall Study|Noncompliance|0|||
149108219|NCT01441635|537874855|FG004|Overall Study|Noncompliance|0|||
149108220|NCT01441635|537874856|FG005|Overall Study|Noncompliance|0|||
149108221|NCT01441635|537874857|FG006|Overall Study|Noncompliance|1|||
149108222|NCT01441635|537874858|FG007|Overall Study|Noncompliance|0|||
149108223|NCT01441635|537874859|FG008|Overall Study|Noncompliance|0|||
149108224|NCT01441635|537874860|FG009|Overall Study|Noncompliance|0|||
149108225|NCT01441635|537874851|FG000|Overall Study|Surgery or Invasive Intervention|0|||
149108226|NCT01441635|537874852|FG001|Overall Study|Surgery or Invasive Intervention|0|||
149108227|NCT01441635|537874853|FG002|Overall Study|Surgery or Invasive Intervention|1|||
149108228|NCT01441635|537874854|FG003|Overall Study|Surgery or Invasive Intervention|0|||
149108229|NCT01441635|537874855|FG004|Overall Study|Surgery or Invasive Intervention|0|||
149108230|NCT01441635|537874856|FG005|Overall Study|Surgery or Invasive Intervention|0|||
149108231|NCT01441635|537874857|FG006|Overall Study|Surgery or Invasive Intervention|0|||
149108232|NCT01441635|537874858|FG007|Overall Study|Surgery or Invasive Intervention|0|||
149108233|NCT01441635|537874859|FG008|Overall Study|Surgery or Invasive Intervention|0|||
149108234|NCT01441635|537874860|FG009|Overall Study|Surgery or Invasive Intervention|0|||
149108235|NCT01441635|537874851|FG000|Overall Study|Received Exclusionary Medication|1|||
149108236|NCT01441635|537874852|FG001|Overall Study|Received Exclusionary Medication|0|||
149108237|NCT01441635|537874853|FG002|Overall Study|Received Exclusionary Medication|0|||
149108238|NCT01441635|537874854|FG003|Overall Study|Received Exclusionary Medication|0|||
149108239|NCT01441635|537874855|FG004|Overall Study|Received Exclusionary Medication|0|||
149108240|NCT01441635|537874856|FG005|Overall Study|Received Exclusionary Medication|0|||
149108241|NCT01441635|537874857|FG006|Overall Study|Received Exclusionary Medication|0|||
149108242|NCT01441635|537874858|FG007|Overall Study|Received Exclusionary Medication|0|||
149108243|NCT01441635|537874859|FG008|Overall Study|Received Exclusionary Medication|0|||
149108244|NCT01441635|537874860|FG009|Overall Study|Received Exclusionary Medication|0|||
149108245|NCT01441635|537874851|FG000|Overall Study|Other|0|||
149108246|NCT01441635|537874852|FG001|Overall Study|Other|0|||
149108247|NCT01441635|537874853|FG002|Overall Study|Other|0|||
149108248|NCT01441635|537874854|FG003|Overall Study|Other|0|||
149108249|NCT01441635|537874855|FG004|Overall Study|Other|0|||
149108250|NCT01441635|537874856|FG005|Overall Study|Other|0|||
149108251|NCT01441635|537874857|FG006|Overall Study|Other|0|||
149108252|NCT01441635|537874858|FG007|Overall Study|Other|1|||
149108253|NCT01441635|537874859|FG008|Overall Study|Other|0|||
149108254|NCT01441635|537874860|FG009|Overall Study|Other|0|||
149108255|NCT02637323|537874861|FG000|Overall Study|Lost to Follow-up|2|||
149108256|NCT02637323|537874862|FG001|Overall Study|Lost to Follow-up|0|||
149108257|NCT02637323|537874861|FG000|Overall Study|Protocol Violation|0|||
149108258|NCT02637323|537874862|FG001|Overall Study|Protocol Violation|1|||
149108259|NCT01825577|537874863|FG000|Overall Study|Physician Decision|2|||
149108260|NCT01825577|537874863|FG000|Overall Study|Withdrawal by Subject|1|||
149108261|NCT01825577|537874863|FG000|Overall Study|Withdrawn by family members|2|||
149108262|NCT01825577|537874863|FG000|Overall Study|Lack of Efficacy|3|||
149108263|NCT00358644|537874864|FG000|Overall Study|Progressive Disease|21|||
149108264|NCT00358644|537874864|FG000|Overall Study|Adverse Event|7|||
149108265|NCT00358644|537874864|FG000|Overall Study|Death|11|||
149108266|NCT00358644|537874864|FG000|Overall Study|Withdrawal by Subject|4|||
149108267|NCT00358644|537874864|FG000|Overall Study|Physician Decision|6|||
149108268|NCT00358644|537874864|FG000|Overall Study|Patient not eligible for study|1|||
149108269|NCT00513708|537874865|FG000|Overall Study|Lost to Follow-up|4|||
149108270|NCT00513708|537874866|FG001|Overall Study|Lost to Follow-up|4|||
149108271|NCT00513708|537874867|FG002|Overall Study|Lost to Follow-up|4|||
149108272|NCT00368875|537874868|FG000|Overall Study|Adverse Event|0|||
149108273|NCT00368875|537874869|FG001|Overall Study|Adverse Event|12|||
149108274|NCT00368875|537874868|FG000|Overall Study|Progressive disease|3|||
149108275|NCT00368875|537874869|FG001|Overall Study|Progressive disease|27|||
149108276|NCT00368875|537874868|FG000|Overall Study|Withdrawal by Subject|2|||
149108277|NCT00368875|537874869|FG001|Overall Study|Withdrawal by Subject|6|||
149108278|NCT00368875|537874868|FG000|Overall Study|Other Reason|0|||
149108279|NCT00368875|537874869|FG001|Overall Study|Other Reason|2|||
149108280|NCT00368875|537874868|FG000|Overall Study|Alternative Therapy|1|||
149108281|NCT00368875|537874869|FG001|Overall Study|Alternative Therapy|1|||
149108282|NCT03327831|537874870|FG000|Overall Study|Lost to Follow-up|2|||
149108283|NCT01564277|537874871|FG000|Overall Study|Protocol Violation|0|||
149108284|NCT01564277|537874872|FG001|Overall Study|Protocol Violation|1|||
149108285|NCT01564277|537874871|FG000|Overall Study|Physician Decision|1|||
149108286|NCT01564277|537874872|FG001|Overall Study|Physician Decision|0|||
149108287|NCT02595372|537874873|FG000|Overall Study|Adverse Event|6|||
149108288|NCT02595372|537874873|FG000|Overall Study|Physician Decision|2|||
149108289|NCT02595372|537874873|FG000|Overall Study|Disease Progression|1|||
149108290|NCT00401258|537874876|FG000|Overall Study|Adverse Event|7|||
149108291|NCT00699153|537877326|FG000|Overall Study|Lost to Follow-up|1|||
149108292|NCT00699153|537877327|FG001|Overall Study|Lost to Follow-up|0|||
149108293|NCT00699153|537877326|FG000|Overall Study|Adverse Event|0|||
149108294|NCT00699153|537877327|FG001|Overall Study|Adverse Event|2|||
149108295|NCT00699153|537877326|FG000|Overall Study|Protocol Violation|1|||
149108296|NCT00699153|537877327|FG001|Overall Study|Protocol Violation|0|||
149108297|NCT00699153|537877326|FG000|Overall Study|Travel Problem|1|||
149108298|NCT00699153|537877327|FG001|Overall Study|Travel Problem|0|||
149108299|NCT04996004|537877330|FG000|Phase I|Death|1|||
149108300|NCT04996004|537877331|FG001|Phase I|Death|2|||
149108301|NCT04996004|537877332|FG002|Phase I|Death|1|||
149108302|NCT04996004|537877333|FG003|Phase I|Death|0|||
149108303|NCT04996004|537877334|FG004|Phase I|Death|0|||
149108304|NCT04996004|537877335|FG005|Phase I|Death|0|||
149108305|NCT04996004|537877330|FG000|Phase I|Study terminated by sponsor|2|||
149108306|NCT04996004|537877331|FG001|Phase I|Study terminated by sponsor|1|||
149108307|NCT04996004|537877332|FG002|Phase I|Study terminated by sponsor|2|||
149108308|NCT04996004|537877333|FG003|Phase I|Study terminated by sponsor|0|||
149108309|NCT04996004|537877334|FG004|Phase I|Study terminated by sponsor|0|||
149108310|NCT04996004|537877335|FG005|Phase I|Study terminated by sponsor|0|||
149108311|NCT04996004|537877330|FG000|Phase II|Study terminated by sponsor|0|||
149108312|NCT04996004|537877331|FG001|Phase II|Study terminated by sponsor|0|||
149108313|NCT04996004|537877332|FG002|Phase II|Study terminated by sponsor|0|||
149108314|NCT04996004|537877333|FG003|Phase II|Study terminated by sponsor|20|||
149108315|NCT04996004|537877334|FG004|Phase II|Study terminated by sponsor|10|||
149108316|NCT04996004|537877335|FG005|Phase II|Study terminated by sponsor|10|||
149108317|NCT04996004|537877330|FG000|Phase II|Withdrawal by Subject|0|||
149108318|NCT04996004|537877331|FG001|Phase II|Withdrawal by Subject|0|||
149108319|NCT04996004|537877332|FG002|Phase II|Withdrawal by Subject|0|||
149108320|NCT04996004|537877333|FG003|Phase II|Withdrawal by Subject|0|||
149108321|NCT04996004|537877334|FG004|Phase II|Withdrawal by Subject|1|||
149108322|NCT04996004|537877335|FG005|Phase II|Withdrawal by Subject|2|||
149108323|NCT04996004|537877330|FG000|Phase II|Death|0|||
149108324|NCT04996004|537877331|FG001|Phase II|Death|0|||
149108325|NCT04996004|537877332|FG002|Phase II|Death|0|||
149108326|NCT04996004|537877333|FG003|Phase II|Death|12|||
149108327|NCT04996004|537877334|FG004|Phase II|Death|2|||
149108328|NCT04996004|537877335|FG005|Phase II|Death|9|||
149108329|NCT04996004|537877330|FG000|Phase II|Other|0|||
149108330|NCT04996004|537877331|FG001|Phase II|Other|0|||
149108331|NCT04996004|537877332|FG002|Phase II|Other|0|||
149108332|NCT04996004|537877333|FG003|Phase II|Other|0|||
149108333|NCT04996004|537877334|FG004|Phase II|Other|0|||
149108334|NCT04996004|537877335|FG005|Phase II|Other|1|||
149108335|NCT03374488|537877336|FG000|Overall Study|Death|13|||
149108336|NCT03374488|537877337|FG001|Overall Study|Death|13|||
149108337|NCT03374488|537877336|FG000|Overall Study|Withdrawal by Subject|3|||
149108338|NCT03374488|537877337|FG001|Overall Study|Withdrawal by Subject|1|||
149108339|NCT03374488|537877336|FG000|Overall Study|Physician Decision|3|||
149108340|NCT03374488|537877337|FG001|Overall Study|Physician Decision|0|||
149108341|NCT03054337|537877340|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
149108342|NCT03054337|537877341|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
149108343|NCT03054337|537877342|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
149108344|NCT03054337|537877343|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
149108345|NCT03054337|537877344|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
149108346|NCT03054337|537877345|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
149108347|NCT00609947|537877352|FG000|Overall Study|Death|1|||
149108348|NCT05105087|537877353|FG000|Overall Study|Withdrawal by Subject|2|||
149108349|NCT05105087|537877353|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
149108350|NCT03199469|537877359|FG000|Overall Study|Randomized, not treated|0|||
149108351|NCT03199469|537877360|FG001|Overall Study|Randomized, not treated|3|||
149108352|NCT03199469|537877359|FG000|Overall Study|Withdrawal by Subject|1|||
149108353|NCT03199469|537877360|FG001|Overall Study|Withdrawal by Subject|0|||
149108354|NCT03199469|537877359|FG000|Overall Study|Death|1|||
149108355|NCT03199469|537877360|FG001|Overall Study|Death|3|||
149108356|NCT03199469|537877359|FG000|Overall Study|Ongoing|5|||
149108357|NCT03199469|537877360|FG001|Overall Study|Ongoing|14|||
149108358|NCT01023958|537877367|FG000|Overall Study|Progressive disease|48|||
149108359|NCT01023958|537877367|FG000|Overall Study|Other adverse event|1|||
149108360|NCT01023958|537877367|FG000|Overall Study|Refused to continue medication|1|||
149108361|NCT02362503|537877371|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
149108362|NCT02362503|537877372|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
149108363|NCT02362503|537877373|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
149108364|NCT02362503|537877371|FG000|Double-blind Period-Up to 8 Days|Death|1|||
149108365|NCT02362503|537877372|FG001|Double-blind Period-Up to 8 Days|Death|0|||
149108366|NCT02362503|537877373|FG002|Double-blind Period-Up to 8 Days|Death|0|||
149108367|NCT02362503|537877371|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
149108368|NCT02362503|537877372|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
149108369|NCT02362503|537877373|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
149108370|NCT02362503|537877371|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
149108371|NCT02362503|537877372|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
149108372|NCT02362503|537877373|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
149108373|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
149108374|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
149108375|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
149108376|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
149108377|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
149108378|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
149108379|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
149108380|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
149108381|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
149108382|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
149108383|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
149108384|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
149108385|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
149108386|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
149108387|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
149108388|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
149108389|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
149108390|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
149108391|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
149108392|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
149108393|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
149108394|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
149108395|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
149108396|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
149108397|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
149108398|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
149108399|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
149108400|NCT02362503|537877371|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
149108401|NCT02362503|537877372|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
149108402|NCT02362503|537877373|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
149108403|NCT05143138|537877374|FG000|Overall Study|Death|5|||
149108404|NCT05143138|537877375|FG001|Overall Study|Death|35|||
149108405|NCT05143138|537877376|FG002|Overall Study|Death|1|||
149108406|NCT05143138|537877374|FG000|Overall Study|Lost to Follow-up|2|||
149108407|NCT05143138|537877375|FG001|Overall Study|Lost to Follow-up|4|||
149108408|NCT05143138|537877376|FG002|Overall Study|Lost to Follow-up|0|||
149108409|NCT05143138|537877374|FG000|Overall Study|withdrawal|1|||
149108410|NCT05143138|537877375|FG001|Overall Study|withdrawal|1|||
149108411|NCT05143138|537877376|FG002|Overall Study|withdrawal|0|||
149108412|NCT04245345|537877385|FG000|Overall Study|Death|1|||
149108413|NCT04245345|537877385|FG000|Overall Study|Exited prior to implant|5|||
149108414|NCT04245345|537877385|FG000|Overall Study|Exited prior to 1-month|9|||
149108415|NCT04245345|537877385|FG000|Overall Study|Missed 1-month visit|3|||
149108416|NCT04245345|537877385|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
149108417|NCT04245345|537877385|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
149108418|NCT01834586|537877386|FG000|Overall Study|Adverse Event|1|||
149108419|NCT03443414|537877387|FG000|Overall Study|Adverse Event|6|||
149108420|NCT03443414|537877388|FG001|Overall Study|Adverse Event|0|||
149108421|NCT03443414|537877389|FG002|Overall Study|Adverse Event|4|||
149108422|NCT03443414|537877390|FG003|Overall Study|Adverse Event|2|||
149108423|NCT03443414|537877391|FG004|Overall Study|Adverse Event|3|||
149108424|NCT03443414|537877387|FG000|Overall Study|Withdrawal by Subject|3|||
149108425|NCT03443414|537877388|FG001|Overall Study|Withdrawal by Subject|2|||
149108426|NCT03443414|537877389|FG002|Overall Study|Withdrawal by Subject|2|||
149108427|NCT03443414|537877390|FG003|Overall Study|Withdrawal by Subject|2|||
149108428|NCT03443414|537877391|FG004|Overall Study|Withdrawal by Subject|1|||
149108429|NCT03443414|537877387|FG000|Overall Study|Death|0|||
149108430|NCT03443414|537877388|FG001|Overall Study|Death|1|||
149108431|NCT03443414|537877389|FG002|Overall Study|Death|0|||
149108432|NCT03443414|537877390|FG003|Overall Study|Death|1|||
149108433|NCT03443414|537877391|FG004|Overall Study|Death|0|||
149108434|NCT03443414|537877387|FG000|Overall Study|Reason not specified|2|||
149108435|NCT03443414|537877388|FG001|Overall Study|Reason not specified|0|||
149108436|NCT03443414|537877389|FG002|Overall Study|Reason not specified|0|||
149108437|NCT03443414|537877390|FG003|Overall Study|Reason not specified|0|||
149108438|NCT03443414|537877391|FG004|Overall Study|Reason not specified|1|||
149108439|NCT03325777|537877394|FG000|Overall Study|Lost to Follow-up|9|||
149108440|NCT03325777|537877395|FG001|Overall Study|Lost to Follow-up|12|||
149108441|NCT01436305|537877405|FG000|Overall Study|Death|1|||
149108442|NCT01436305|537877406|FG001|Overall Study|Death|0|||
149108443|NCT01436305|537877407|FG002|Overall Study|Death|0|||
149108444|NCT01436305|537877405|FG000|Overall Study|Lost to Follow-up|0|||
149108445|NCT01436305|537877406|FG001|Overall Study|Lost to Follow-up|1|||
149108446|NCT01436305|537877407|FG002|Overall Study|Lost to Follow-up|0|||
149108447|NCT01436305|537877405|FG000|Overall Study|Withdrawal by Subject|1|||
149108448|NCT01436305|537877406|FG001|Overall Study|Withdrawal by Subject|3|||
149108449|NCT01436305|537877407|FG002|Overall Study|Withdrawal by Subject|0|||
149108450|NCT03355209|537877413|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
149108451|NCT03355209|537877414|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
149108452|NCT03355209|537877415|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
149108453|NCT03355209|537877416|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
149108454|NCT03355209|537877417|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
149108455|NCT03355209|537877418|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
149108456|NCT03355209|537877413|FG000|Part 1: Double-Blind Period|Death|0|||
149108457|NCT03355209|537877414|FG001|Part 1: Double-Blind Period|Death|0|||
149108458|NCT03355209|537877415|FG002|Part 1: Double-Blind Period|Death|1|||
149108459|NCT03355209|537877416|FG003|Part 1: Double-Blind Period|Death|0|||
149108460|NCT03355209|537877417|FG004|Part 1: Double-Blind Period|Death|0|||
149108461|NCT03355209|537877418|FG005|Part 1: Double-Blind Period|Death|0|||
149108462|NCT03355209|537877413|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
149108463|NCT03355209|537877414|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
149108464|NCT03355209|537877415|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
149108465|NCT03355209|537877416|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
149108466|NCT03355209|537877417|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
149108467|NCT03355209|537877418|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
149108468|NCT03355209|537877413|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
149108469|NCT03355209|537877414|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
149108470|NCT03355209|537877415|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
149108471|NCT03355209|537877416|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
149108472|NCT03355209|537877417|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
149108473|NCT03355209|537877418|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
149108474|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
149108475|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
149108476|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
149108477|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
149108478|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
149108479|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
149108480|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
149108481|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
149108482|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
149108483|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
149108484|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
149108485|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
149108486|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
149108487|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
149108488|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
149108489|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
149108490|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
149108491|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
149108492|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
149108493|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
149108494|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
149108495|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
149108496|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
149108497|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
149108498|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
149108499|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
149108500|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
149108501|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149108502|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
149108503|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
149108504|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
149108505|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
149108506|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
149108507|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
149108508|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
149108509|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
149108510|NCT03355209|537877413|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
149108511|NCT03355209|537877414|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
149108512|NCT03355209|537877415|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
149108513|NCT03355209|537877416|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
149108514|NCT03355209|537877417|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
149108515|NCT03355209|537877418|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
149108516|NCT05262751|537877422|FG000|Washout Period 2|Adverse Event|1|||
149108517|NCT05262751|537877423|FG001|Washout Period 2|Adverse Event|0|||
149108518|NCT05262751|537877424|FG002|Washout Period 2|Adverse Event|0|||
149108519|NCT05262751|537877425|FG003|Washout Period 2|Adverse Event|0|||
149108520|NCT05262751|537877426|FG004|Washout Period 2|Adverse Event|0|||
149108521|NCT05262751|537877427|FG005|Washout Period 2|Adverse Event|0|||
149108522|NCT05262751|537877422|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
149108523|NCT05262751|537877423|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
149108524|NCT05262751|537877424|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
149108525|NCT05262751|537877425|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
149108526|NCT05262751|537877426|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
149108527|NCT05262751|537877427|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
149108528|NCT03690427|537877428|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
149108529|NCT03690427|537877429|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
149108530|NCT01721954|537877430|FG000|Overall Study|Death|58|||
149108531|NCT01721954|537877431|FG001|Overall Study|Death|64|||
149108532|NCT01721954|537877430|FG000|Overall Study|Withdrawal by Subject|8|||
149108533|NCT01721954|537877431|FG001|Overall Study|Withdrawal by Subject|4|||
149108534|NCT01721954|537877430|FG000|Overall Study|Adverse Event|2|||
149108535|NCT01721954|537877431|FG001|Overall Study|Adverse Event|0|||
149108536|NCT01721954|537877430|FG000|Overall Study|Lost to Follow-up|2|||
149108537|NCT01721954|537877431|FG001|Overall Study|Lost to Follow-up|1|||
149108538|NCT02956837|537877434|FG000|Overall Study|Serious Adverse Events|0|||
149108539|NCT02956837|537877435|FG001|Overall Study|Serious Adverse Events|1|||
149108540|NCT02956837|537877436|FG002|Overall Study|Serious Adverse Events|0|||
149108541|NCT02956837|537877437|FG003|Overall Study|Serious Adverse Events|0|||
149108542|NCT02956837|537877434|FG000|Overall Study|Withdrawal by Subject|0|||
149108543|NCT02956837|537877435|FG001|Overall Study|Withdrawal by Subject|1|||
149108544|NCT02956837|537877436|FG002|Overall Study|Withdrawal by Subject|0|||
149108545|NCT02956837|537877437|FG003|Overall Study|Withdrawal by Subject|3|||
149108546|NCT02956837|537877434|FG000|Overall Study|Lost to Follow-up|0|||
149108547|NCT02956837|537877435|FG001|Overall Study|Lost to Follow-up|1|||
149108548|NCT02956837|537877436|FG002|Overall Study|Lost to Follow-up|2|||
149108549|NCT02956837|537877437|FG003|Overall Study|Lost to Follow-up|0|||
149108550|NCT01727505|537877442|FG000|First 24 Hours|Adverse Event|0|||
149108551|NCT01727505|537877443|FG001|First 24 Hours|Adverse Event|1|||
149108552|NCT01727505|537877442|FG000|Second 24 Hours|Missing data|0|||
149108553|NCT01727505|537877443|FG001|Second 24 Hours|Missing data|1|||
149108554|NCT01594970|537877445|FG000|Overall Study|Non-Adverse Event Related|4|||
149108555|NCT01594970|537877446|FG001|Overall Study|Non-Adverse Event Related|5|||
149108556|NCT01594970|537877447|FG002|Overall Study|Non-Adverse Event Related|6|||
149108557|NCT01594970|537877445|FG000|Overall Study|Adverse Event|17|||
149108558|NCT01594970|537877446|FG001|Overall Study|Adverse Event|23|||
149108559|NCT01594970|537877447|FG002|Overall Study|Adverse Event|23|||
149108560|NCT01594970|537877445|FG000|Overall Study|Lost to Follow-up|54|||
149108561|NCT01594970|537877446|FG001|Overall Study|Lost to Follow-up|54|||
149108562|NCT01594970|537877447|FG002|Overall Study|Lost to Follow-up|37|||
149108563|NCT01427725|537877448|FG000|Overall Study|Lost to Follow-up|17|||
149108564|NCT01427725|537877448|FG000|Overall Study|Protocol Violation|1|||
149108565|NCT01427725|537877448|FG000|Overall Study|Drug not administered|1|||
149108566|NCT01427725|537877448|FG000|Overall Study|Failure to visit|7|||
149108567|NCT01427725|537877448|FG000|Overall Study|Adverse Event|46|||
149108568|NCT01427725|537877448|FG000|Overall Study|Failure to visit after administration|40|||
149108569|NCT01427725|537877448|FG000|Overall Study|Patient's rejection|27|||
149108570|NCT01427725|537877448|FG000|Overall Study|Transfer to a different hospital|17|||
149108571|NCT01427725|537877448|FG000|Overall Study|Lack of Efficacy|8|||
149108572|NCT01427725|537877448|FG000|Overall Study|Death|7|||
149108573|NCT01427725|537877448|FG000|Overall Study|Symptom improvement|6|||
149108574|NCT01427725|537877448|FG000|Overall Study|AE and Patient's rejection|5|||
149108575|NCT01427725|537877448|FG000|Overall Study|Physician Decision|5|||
149108576|NCT01427725|537877448|FG000|Overall Study|Exacerbation of underlying disease|5|||
149108577|NCT01427725|537877448|FG000|Overall Study|Oral feeding difficulty|5|||
149108578|NCT01427725|537877448|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
149108579|NCT01427725|537877448|FG000|Overall Study|Forgetting prescription|1|||
149108580|NCT01427725|537877448|FG000|Overall Study|Other|2|||
149108581|NCT01299480|537877449|FG000|Overall Study|No longer willing to participate|19|||
149108582|NCT01299480|537877450|FG001|Overall Study|No longer willing to participate|17|||
149108583|NCT01299480|537877451|FG002|Overall Study|No longer willing to participate|14|||
149108584|NCT01299480|537877452|FG003|Overall Study|No longer willing to participate|13|||
149108585|NCT01299480|537877453|FG004|Overall Study|No longer willing to participate|10|||
149108586|NCT01299480|537877449|FG000|Overall Study|Protocol Violation|7|||
149108587|NCT01299480|537877450|FG001|Overall Study|Protocol Violation|5|||
149108588|NCT01299480|537877451|FG002|Overall Study|Protocol Violation|8|||
149108589|NCT01299480|537877452|FG003|Overall Study|Protocol Violation|1|||
149108590|NCT01299480|537877453|FG004|Overall Study|Protocol Violation|1|||
149108591|NCT01299480|537877449|FG000|Overall Study|Withdrawal by Subject|3|||
149108592|NCT01299480|537877450|FG001|Overall Study|Withdrawal by Subject|4|||
149108593|NCT01299480|537877451|FG002|Overall Study|Withdrawal by Subject|7|||
149108594|NCT01299480|537877452|FG003|Overall Study|Withdrawal by Subject|3|||
149108595|NCT01299480|537877453|FG004|Overall Study|Withdrawal by Subject|4|||
149108596|NCT01299480|537877449|FG000|Overall Study|Adverse Event|6|||
149108597|NCT01299480|537877450|FG001|Overall Study|Adverse Event|4|||
149108598|NCT01299480|537877451|FG002|Overall Study|Adverse Event|5|||
149108599|NCT01299480|537877452|FG003|Overall Study|Adverse Event|4|||
149108600|NCT01299480|537877453|FG004|Overall Study|Adverse Event|0|||
149108601|NCT01299480|537877449|FG000|Overall Study|Withdrawal due to pregnancy|0|||
149108602|NCT01299480|537877450|FG001|Overall Study|Withdrawal due to pregnancy|1|||
149108603|NCT01299480|537877451|FG002|Overall Study|Withdrawal due to pregnancy|1|||
149108604|NCT01299480|537877452|FG003|Overall Study|Withdrawal due to pregnancy|0|||
149108605|NCT01299480|537877453|FG004|Overall Study|Withdrawal due to pregnancy|0|||
149108606|NCT01299480|537877449|FG000|Overall Study|Physician Decision|1|||
149108607|NCT01299480|537877450|FG001|Overall Study|Physician Decision|1|||
149108608|NCT01299480|537877451|FG002|Overall Study|Physician Decision|0|||
149108609|NCT01299480|537877452|FG003|Overall Study|Physician Decision|2|||
149108610|NCT01299480|537877453|FG004|Overall Study|Physician Decision|0|||
149108611|NCT01299480|537877449|FG000|Overall Study|Lost to Follow-up|3|||
149108612|NCT01299480|537877450|FG001|Overall Study|Lost to Follow-up|1|||
149108613|NCT01299480|537877451|FG002|Overall Study|Lost to Follow-up|2|||
149108614|NCT01299480|537877452|FG003|Overall Study|Lost to Follow-up|1|||
149108615|NCT01299480|537877453|FG004|Overall Study|Lost to Follow-up|2|||
149108616|NCT01299480|537877449|FG000|Overall Study|Other|3|||
149108617|NCT01299480|537877450|FG001|Overall Study|Other|2|||
149108618|NCT01299480|537877451|FG002|Overall Study|Other|3|||
149108619|NCT01299480|537877452|FG003|Overall Study|Other|0|||
149108620|NCT01299480|537877453|FG004|Overall Study|Other|3|||
149108621|NCT01299480|537877449|FG000|Overall Study|Started, but not vaccinated|0|||
149108622|NCT01299480|537877450|FG001|Overall Study|Started, but not vaccinated|0|||
149108623|NCT01299480|537877451|FG002|Overall Study|Started, but not vaccinated|1|||
149108624|NCT01299480|537877452|FG003|Overall Study|Started, but not vaccinated|1|||
149108625|NCT01299480|537877453|FG004|Overall Study|Started, but not vaccinated|0|||
149108626|NCT01430468|537877460|FG000|Overall Study|Physician Decision|2|||
149108627|NCT01430468|537877461|FG001|Overall Study|Physician Decision|1|||
149108628|NCT01430468|537877460|FG000|Overall Study|Withdrawal by Subject|5|||
149108629|NCT01430468|537877461|FG001|Overall Study|Withdrawal by Subject|5|||
149108630|NCT01281839|537877462|FG000|Overall Study|Lost to Follow-up|6|||
149108631|NCT01281839|537877463|FG001|Overall Study|Lost to Follow-up|3|||
149108632|NCT01281839|537877462|FG000|Overall Study|Withdrawal by Subject|4|||
149108633|NCT01281839|537877463|FG001|Overall Study|Withdrawal by Subject|10|||
149108634|NCT01281839|537877462|FG000|Overall Study|Reason not specified|0|||
149108635|NCT01281839|537877463|FG001|Overall Study|Reason not specified|1|||
149108636|NCT01305239|537877464|FG000|Overall Study|Adverse Event|22|||
149108637|NCT01305239|537877464|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
149108638|NCT01754753|537877467|FG000|Overall Study|Study close|43|||
149108639|NCT01754753|537877468|FG001|Overall Study|Study close|44|||
149108640|NCT01754753|537877467|FG000|Overall Study|Lost to Follow-up|9|||
149108641|NCT01754753|537877468|FG001|Overall Study|Lost to Follow-up|5|||
149108642|NCT00344032|537877469|FG000|Overall Study|Adverse Event|0|||
149108643|NCT00344032|537877470|FG001|Overall Study|Adverse Event|1|||
149108644|NCT00344032|537877469|FG000|Overall Study|Withdrawal by Subject|6|||
149108645|NCT00344032|537877470|FG001|Overall Study|Withdrawal by Subject|2|||
149108646|NCT00344032|537877469|FG000|Overall Study|Lost to Follow-up|4|||
149108647|NCT00344032|537877470|FG001|Overall Study|Lost to Follow-up|6|||
149108648|NCT00344032|537877469|FG000|Overall Study|Physician Decision|4|||
149108649|NCT00344032|537877470|FG001|Overall Study|Physician Decision|1|||
149108650|NCT05131477|537877477|FG000|PART 1|Withdrawal by Subject|2|||
149108651|NCT05131477|537877478|FG001|PART 1|Withdrawal by Subject|9|||
149108652|NCT05131477|537877479|FG002|PART 1|Withdrawal by Subject|6|||
149108653|NCT05131477|537877480|FG003|PART 1|Withdrawal by Subject|2|||
149108654|NCT05131477|537877481|FG004|PART 1|Withdrawal by Subject|8|||
149108655|NCT05131477|537877482|FG005|PART 1|Withdrawal by Subject|0|||
149108656|NCT05131477|537877483|FG006|PART 1|Withdrawal by Subject|0|||
149108657|NCT05131477|537877484|FG007|PART 1|Withdrawal by Subject|0|||
149108658|NCT05131477|537877485|FG008|PART 1|Withdrawal by Subject|0|||
149108659|NCT05131477|537877486|FG009|PART 1|Withdrawal by Subject|0|||
149108660|NCT05131477|537877487|FG010|PART 1|Withdrawal by Subject|0|||
149108661|NCT05131477|537877488|FG011|PART 1|Withdrawal by Subject|0|||
149108662|NCT05131477|537877489|FG012|PART 1|Withdrawal by Subject|0|||
149108663|NCT05131477|537877490|FG013|PART 1|Withdrawal by Subject|0|||
149108664|NCT05131477|537877477|FG000|PART 1|Physician Decision|1|||
149108665|NCT05131477|537877478|FG001|PART 1|Physician Decision|0|||
149108666|NCT05131477|537877479|FG002|PART 1|Physician Decision|0|||
149108667|NCT05131477|537877480|FG003|PART 1|Physician Decision|0|||
149108668|NCT05131477|537877481|FG004|PART 1|Physician Decision|0|||
149108669|NCT05131477|537877482|FG005|PART 1|Physician Decision|0|||
149108670|NCT05131477|537877483|FG006|PART 1|Physician Decision|0|||
149108671|NCT05131477|537877484|FG007|PART 1|Physician Decision|0|||
149108672|NCT05131477|537877485|FG008|PART 1|Physician Decision|0|||
149108673|NCT05131477|537877486|FG009|PART 1|Physician Decision|0|||
149108674|NCT05131477|537877487|FG010|PART 1|Physician Decision|0|||
149108675|NCT05131477|537877488|FG011|PART 1|Physician Decision|0|||
149108676|NCT05131477|537877489|FG012|PART 1|Physician Decision|0|||
149108677|NCT05131477|537877490|FG013|PART 1|Physician Decision|0|||
149108678|NCT05131477|537877477|FG000|PART 1|Adverse Event|3|||
149108679|NCT05131477|537877478|FG001|PART 1|Adverse Event|5|||
149108680|NCT05131477|537877479|FG002|PART 1|Adverse Event|1|||
149108681|NCT05131477|537877480|FG003|PART 1|Adverse Event|6|||
149108682|NCT05131477|537877481|FG004|PART 1|Adverse Event|4|||
149108683|NCT05131477|537877482|FG005|PART 1|Adverse Event|0|||
149108684|NCT05131477|537877483|FG006|PART 1|Adverse Event|0|||
149108685|NCT05131477|537877484|FG007|PART 1|Adverse Event|0|||
149108686|NCT05131477|537877485|FG008|PART 1|Adverse Event|0|||
149108687|NCT05131477|537877486|FG009|PART 1|Adverse Event|0|||
149108688|NCT05131477|537877487|FG010|PART 1|Adverse Event|0|||
149108689|NCT05131477|537877488|FG011|PART 1|Adverse Event|0|||
149108690|NCT05131477|537877489|FG012|PART 1|Adverse Event|0|||
149108691|NCT05131477|537877490|FG013|PART 1|Adverse Event|0|||
149108692|NCT05131477|537877477|FG000|PART 1|unclassified|1|||
149108693|NCT05131477|537877478|FG001|PART 1|unclassified|1|||
149108694|NCT05131477|537877479|FG002|PART 1|unclassified|0|||
149108695|NCT05131477|537877480|FG003|PART 1|unclassified|0|||
149108696|NCT05131477|537877481|FG004|PART 1|unclassified|4|||
149108697|NCT05131477|537877482|FG005|PART 1|unclassified|0|||
149108698|NCT05131477|537877483|FG006|PART 1|unclassified|0|||
149108699|NCT05131477|537877484|FG007|PART 1|unclassified|0|||
149108700|NCT05131477|537877485|FG008|PART 1|unclassified|0|||
149108701|NCT05131477|537877486|FG009|PART 1|unclassified|0|||
149108702|NCT05131477|537877487|FG010|PART 1|unclassified|0|||
149108703|NCT05131477|537877488|FG011|PART 1|unclassified|0|||
149108704|NCT05131477|537877489|FG012|PART 1|unclassified|0|||
149108705|NCT05131477|537877490|FG013|PART 1|unclassified|0|||
149108706|NCT05131477|537877477|FG000|PART 1|Randomized and not treated|0|||
149108707|NCT05131477|537877478|FG001|PART 1|Randomized and not treated|0|||
149108708|NCT05131477|537877479|FG002|PART 1|Randomized and not treated|0|||
149108709|NCT05131477|537877480|FG003|PART 1|Randomized and not treated|1|||
149108710|NCT05131477|537877481|FG004|PART 1|Randomized and not treated|1|||
149108711|NCT05131477|537877482|FG005|PART 1|Randomized and not treated|0|||
149108712|NCT05131477|537877483|FG006|PART 1|Randomized and not treated|0|||
149108713|NCT05131477|537877484|FG007|PART 1|Randomized and not treated|0|||
149108714|NCT05131477|537877485|FG008|PART 1|Randomized and not treated|0|||
149108715|NCT05131477|537877486|FG009|PART 1|Randomized and not treated|0|||
149108716|NCT05131477|537877487|FG010|PART 1|Randomized and not treated|0|||
149108717|NCT05131477|537877488|FG011|PART 1|Randomized and not treated|0|||
149108718|NCT05131477|537877489|FG012|PART 1|Randomized and not treated|0|||
149108719|NCT05131477|537877490|FG013|PART 1|Randomized and not treated|0|||
149108720|NCT05131477|537877477|FG000|PART 1|Protocol Violation|2|||
149108721|NCT05131477|537877478|FG001|PART 1|Protocol Violation|0|||
149108722|NCT05131477|537877479|FG002|PART 1|Protocol Violation|0|||
149108723|NCT05131477|537877480|FG003|PART 1|Protocol Violation|1|||
149108724|NCT05131477|537877481|FG004|PART 1|Protocol Violation|0|||
149108725|NCT05131477|537877482|FG005|PART 1|Protocol Violation|0|||
149108726|NCT05131477|537877483|FG006|PART 1|Protocol Violation|0|||
149108727|NCT05131477|537877484|FG007|PART 1|Protocol Violation|0|||
149108728|NCT05131477|537877485|FG008|PART 1|Protocol Violation|0|||
149108729|NCT05131477|537877486|FG009|PART 1|Protocol Violation|0|||
149108730|NCT05131477|537877487|FG010|PART 1|Protocol Violation|0|||
149108731|NCT05131477|537877488|FG011|PART 1|Protocol Violation|0|||
149108732|NCT05131477|537877489|FG012|PART 1|Protocol Violation|0|||
149108733|NCT05131477|537877490|FG013|PART 1|Protocol Violation|0|||
149108734|NCT05131477|537877477|FG000|PART 1|Lack of Efficacy|0|||
149108735|NCT05131477|537877478|FG001|PART 1|Lack of Efficacy|1|||
149108736|NCT05131477|537877479|FG002|PART 1|Lack of Efficacy|1|||
149108737|NCT05131477|537877480|FG003|PART 1|Lack of Efficacy|2|||
149108738|NCT05131477|537877481|FG004|PART 1|Lack of Efficacy|5|||
149108739|NCT05131477|537877482|FG005|PART 1|Lack of Efficacy|0|||
149108740|NCT05131477|537877483|FG006|PART 1|Lack of Efficacy|0|||
149108741|NCT05131477|537877484|FG007|PART 1|Lack of Efficacy|0|||
149108742|NCT05131477|537877485|FG008|PART 1|Lack of Efficacy|0|||
149108743|NCT05131477|537877486|FG009|PART 1|Lack of Efficacy|0|||
149108744|NCT05131477|537877487|FG010|PART 1|Lack of Efficacy|0|||
149108745|NCT05131477|537877488|FG011|PART 1|Lack of Efficacy|0|||
149108746|NCT05131477|537877489|FG012|PART 1|Lack of Efficacy|0|||
149108747|NCT05131477|537877490|FG013|PART 1|Lack of Efficacy|0|||
149108748|NCT05131477|537877477|FG000|PART 2|Withdrawal by Subject|0|||
149108749|NCT05131477|537877478|FG001|PART 2|Withdrawal by Subject|0|||
149108750|NCT05131477|537877479|FG002|PART 2|Withdrawal by Subject|0|||
149108751|NCT05131477|537877480|FG003|PART 2|Withdrawal by Subject|0|||
149108752|NCT05131477|537877481|FG004|PART 2|Withdrawal by Subject|0|||
149108753|NCT05131477|537877482|FG005|PART 2|Withdrawal by Subject|0|||
149108754|NCT05131477|537877483|FG006|PART 2|Withdrawal by Subject|2|||
149108755|NCT05131477|537877484|FG007|PART 2|Withdrawal by Subject|0|||
149108756|NCT05131477|537877485|FG008|PART 2|Withdrawal by Subject|0|||
149108757|NCT05131477|537877486|FG009|PART 2|Withdrawal by Subject|0|||
149108758|NCT05131477|537877487|FG010|PART 2|Withdrawal by Subject|2|||
149108759|NCT05131477|537877488|FG011|PART 2|Withdrawal by Subject|0|||
149108760|NCT05131477|537877489|FG012|PART 2|Withdrawal by Subject|2|||
149108761|NCT05131477|537877490|FG013|PART 2|Withdrawal by Subject|2|||
149108762|NCT05131477|537877477|FG000|PART 2|Other|0|||
149108763|NCT05131477|537877478|FG001|PART 2|Other|0|||
149108764|NCT05131477|537877479|FG002|PART 2|Other|0|||
149108765|NCT05131477|537877480|FG003|PART 2|Other|0|||
149108766|NCT05131477|537877481|FG004|PART 2|Other|0|||
149108767|NCT05131477|537877482|FG005|PART 2|Other|0|||
149108768|NCT05131477|537877483|FG006|PART 2|Other|0|||
149108769|NCT05131477|537877484|FG007|PART 2|Other|0|||
149108770|NCT05131477|537877485|FG008|PART 2|Other|1|||
149108771|NCT05131477|537877486|FG009|PART 2|Other|1|||
149108772|NCT05131477|537877487|FG010|PART 2|Other|0|||
149108773|NCT05131477|537877488|FG011|PART 2|Other|0|||
149108774|NCT05131477|537877489|FG012|PART 2|Other|1|||
149108775|NCT05131477|537877490|FG013|PART 2|Other|0|||
149108776|NCT05131477|537877477|FG000|PART 2|Lack of Efficacy|0|||
149108777|NCT05131477|537877478|FG001|PART 2|Lack of Efficacy|0|||
149108778|NCT05131477|537877479|FG002|PART 2|Lack of Efficacy|0|||
149108779|NCT05131477|537877480|FG003|PART 2|Lack of Efficacy|0|||
149108780|NCT05131477|537877481|FG004|PART 2|Lack of Efficacy|0|||
149108781|NCT05131477|537877482|FG005|PART 2|Lack of Efficacy|1|||
149108782|NCT05131477|537877483|FG006|PART 2|Lack of Efficacy|1|||
149108783|NCT05131477|537877484|FG007|PART 2|Lack of Efficacy|0|||
149108784|NCT05131477|537877485|FG008|PART 2|Lack of Efficacy|3|||
149108785|NCT05131477|537877486|FG009|PART 2|Lack of Efficacy|0|||
149108786|NCT05131477|537877487|FG010|PART 2|Lack of Efficacy|1|||
149108787|NCT05131477|537877488|FG011|PART 2|Lack of Efficacy|0|||
149108788|NCT05131477|537877489|FG012|PART 2|Lack of Efficacy|2|||
149108789|NCT05131477|537877490|FG013|PART 2|Lack of Efficacy|0|||
149108790|NCT05131477|537877477|FG000|PART 2|Unclassified|0|||
149108791|NCT05131477|537877478|FG001|PART 2|Unclassified|0|||
149108792|NCT05131477|537877479|FG002|PART 2|Unclassified|0|||
149108793|NCT05131477|537877480|FG003|PART 2|Unclassified|0|||
149108794|NCT05131477|537877481|FG004|PART 2|Unclassified|0|||
149108795|NCT05131477|537877482|FG005|PART 2|Unclassified|0|||
149108796|NCT05131477|537877483|FG006|PART 2|Unclassified|0|||
149108797|NCT05131477|537877484|FG007|PART 2|Unclassified|0|||
149108798|NCT05131477|537877485|FG008|PART 2|Unclassified|0|||
149108799|NCT05131477|537877486|FG009|PART 2|Unclassified|0|||
149108800|NCT05131477|537877487|FG010|PART 2|Unclassified|1|||
149108801|NCT05131477|537877488|FG011|PART 2|Unclassified|0|||
149108802|NCT05131477|537877489|FG012|PART 2|Unclassified|0|||
149108803|NCT05131477|537877490|FG013|PART 2|Unclassified|0|||
149108804|NCT05131477|537877477|FG000|PART 2|Re-randomized and not treated|0|||
149108805|NCT05131477|537877478|FG001|PART 2|Re-randomized and not treated|0|||
149108806|NCT05131477|537877479|FG002|PART 2|Re-randomized and not treated|0|||
149108807|NCT05131477|537877480|FG003|PART 2|Re-randomized and not treated|0|||
149108808|NCT05131477|537877481|FG004|PART 2|Re-randomized and not treated|0|||
149108809|NCT05131477|537877482|FG005|PART 2|Re-randomized and not treated|0|||
149108810|NCT05131477|537877483|FG006|PART 2|Re-randomized and not treated|0|||
149108811|NCT05131477|537877484|FG007|PART 2|Re-randomized and not treated|1|||
149108812|NCT05131477|537877485|FG008|PART 2|Re-randomized and not treated|0|||
149108813|NCT05131477|537877486|FG009|PART 2|Re-randomized and not treated|0|||
149108814|NCT05131477|537877487|FG010|PART 2|Re-randomized and not treated|1|||
149108815|NCT05131477|537877488|FG011|PART 2|Re-randomized and not treated|0|||
149108816|NCT05131477|537877489|FG012|PART 2|Re-randomized and not treated|1|||
149108817|NCT05131477|537877490|FG013|PART 2|Re-randomized and not treated|1|||
149108818|NCT02194829|537877491|FG000|Overall Study|Adverse Event|2|||
149108819|NCT02194829|537877492|FG001|Overall Study|Adverse Event|2|||
149108820|NCT02194829|537877491|FG000|Overall Study|Death|0|||
149108821|NCT02194829|537877492|FG001|Overall Study|Death|1|||
149108822|NCT02194829|537877491|FG000|Overall Study|Disease progression|0|||
149108823|NCT02194829|537877492|FG001|Overall Study|Disease progression|1|||
149108824|NCT02194829|537877491|FG000|Overall Study|Withdrawal by Subject|0|||
149108825|NCT02194829|537877492|FG001|Overall Study|Withdrawal by Subject|1|||
149108826|NCT02194829|537877491|FG000|Overall Study|Never started protocol therapy|0|||
149108827|NCT02194829|537877492|FG001|Overall Study|Never started protocol therapy|1|||
149108828|NCT06840769|537877496|FG000|Overall Study|Withdrawal by Subject|1|||
149108829|NCT06840769|537877497|FG001|Overall Study|Withdrawal by Subject|0|||
149108830|NCT06840769|537877498|FG002|Overall Study|Withdrawal by Subject|0|||
149108831|NCT06840769|537877499|FG003|Overall Study|Withdrawal by Subject|0|||
149108832|NCT06840769|537877500|FG004|Overall Study|Withdrawal by Subject|0|||
149108833|NCT02726945|537877501|FG000|Overall Study|Withdrawal by Subject|0|||
149108834|NCT02726945|537877502|FG001|Overall Study|Withdrawal by Subject|0|||
149108835|NCT02726945|537877503|FG002|Overall Study|Withdrawal by Subject|1|||
149108836|NCT02726945|537877501|FG000|Overall Study|Elected to have total knee replacement|0|||
149108837|NCT02726945|537877502|FG001|Overall Study|Elected to have total knee replacement|1|||
149108838|NCT02726945|537877503|FG002|Overall Study|Elected to have total knee replacement|0|||
149108839|NCT04624243|537879140|FG000|Overall Study|Death|0|||
149108840|NCT04624243|537879141|FG001|Overall Study|Death|1|||
149108841|NCT04624243|537879142|FG002|Overall Study|Death|0|||
149108842|NCT04624243|537879143|FG003|Overall Study|Death|0|||
149108843|NCT04624243|537879144|FG004|Overall Study|Death|0|||
149108844|NCT04624243|537879140|FG000|Overall Study|Lost to Follow-up|2|||
149108845|NCT04624243|537879141|FG001|Overall Study|Lost to Follow-up|3|||
149108846|NCT04624243|537879142|FG002|Overall Study|Lost to Follow-up|7|||
149108847|NCT04624243|537879143|FG003|Overall Study|Lost to Follow-up|1|||
149108848|NCT04624243|537879144|FG004|Overall Study|Lost to Follow-up|3|||
149108849|NCT04624243|537879140|FG000|Overall Study|Physician Decision|3|||
149108850|NCT04624243|537879141|FG001|Overall Study|Physician Decision|8|||
149108851|NCT04624243|537879142|FG002|Overall Study|Physician Decision|15|||
149108852|NCT04624243|537879143|FG003|Overall Study|Physician Decision|2|||
149108853|NCT04624243|537879144|FG004|Overall Study|Physician Decision|11|||
149108854|NCT04624243|537879140|FG000|Overall Study|Withdrawal by Subject|19|||
149108855|NCT04624243|537879141|FG001|Overall Study|Withdrawal by Subject|44|||
149108856|NCT04624243|537879142|FG002|Overall Study|Withdrawal by Subject|40|||
149108857|NCT04624243|537879143|FG003|Overall Study|Withdrawal by Subject|21|||
149108858|NCT04624243|537879144|FG004|Overall Study|Withdrawal by Subject|39|||
149108859|NCT04624243|537879140|FG000|Overall Study|Miscellaneous|3|||
149108860|NCT04624243|537879141|FG001|Overall Study|Miscellaneous|12|||
149108861|NCT04624243|537879142|FG002|Overall Study|Miscellaneous|9|||
149108862|NCT04624243|537879143|FG003|Overall Study|Miscellaneous|4|||
149108863|NCT04624243|537879144|FG004|Overall Study|Miscellaneous|6|||
149108864|NCT03322540|537879147|FG000|Overall Study|Death|21|||
149108865|NCT03322540|537879148|FG001|Overall Study|Death|28|||
149108866|NCT03322540|537879147|FG000|Overall Study|Lost to Follow-up|0|||
149108867|NCT03322540|537879148|FG001|Overall Study|Lost to Follow-up|1|||
149108868|NCT03322540|537879147|FG000|Overall Study|Physician Decision|7|||
149108869|NCT03322540|537879148|FG001|Overall Study|Physician Decision|6|||
149108870|NCT03322540|537879147|FG000|Overall Study|Withdrawal by Subject|3|||
149108871|NCT03322540|537879148|FG001|Overall Study|Withdrawal by Subject|1|||
149108872|NCT03322540|537879147|FG000|Overall Study|Study terminated by sponsor|0|||
149108873|NCT03322540|537879148|FG001|Overall Study|Study terminated by sponsor|1|||
149108874|NCT02493062|537879153|FG000|Overall Study|Physician Decision|12|||
149108875|NCT01327612|537879154|FG000|Overall Study|Withdrawal by Subject|0|||
149108876|NCT01327612|537879155|FG001|Overall Study|Withdrawal by Subject|0|||
149108877|NCT01327612|537879156|FG002|Overall Study|Withdrawal by Subject|0|||
149108878|NCT01327612|537879157|FG003|Overall Study|Withdrawal by Subject|0|||
149108879|NCT01327612|537879158|FG004|Overall Study|Withdrawal by Subject|0|||
149108880|NCT01327612|537879159|FG005|Overall Study|Withdrawal by Subject|1|||
149108881|NCT01327612|537879160|FG006|Overall Study|Withdrawal by Subject|0|||
149108882|NCT01327612|537879154|FG000|Overall Study|Disease Progression|1|||
149108883|NCT01327612|537879155|FG001|Overall Study|Disease Progression|1|||
149108884|NCT01327612|537879156|FG002|Overall Study|Disease Progression|1|||
149108885|NCT01327612|537879157|FG003|Overall Study|Disease Progression|0|||
149108886|NCT01327612|537879158|FG004|Overall Study|Disease Progression|1|||
149108887|NCT01327612|537879159|FG005|Overall Study|Disease Progression|2|||
149108888|NCT01327612|537879160|FG006|Overall Study|Disease Progression|2|||
149108889|NCT01327612|537879154|FG000|Overall Study|Administrative Decision|0|||
149108890|NCT01327612|537879155|FG001|Overall Study|Administrative Decision|0|||
149108891|NCT01327612|537879156|FG002|Overall Study|Administrative Decision|0|||
149108892|NCT01327612|537879157|FG003|Overall Study|Administrative Decision|1|||
149108893|NCT01327612|537879158|FG004|Overall Study|Administrative Decision|0|||
149108894|NCT01327612|537879159|FG005|Overall Study|Administrative Decision|0|||
149108895|NCT01327612|537879160|FG006|Overall Study|Administrative Decision|0|||
149108896|NCT01327612|537879154|FG000|Overall Study|Death|0|||
149108897|NCT01327612|537879155|FG001|Overall Study|Death|0|||
149108898|NCT01327612|537879156|FG002|Overall Study|Death|0|||
149108899|NCT01327612|537879157|FG003|Overall Study|Death|0|||
149108900|NCT01327612|537879158|FG004|Overall Study|Death|1|||
149108901|NCT01327612|537879159|FG005|Overall Study|Death|0|||
149108902|NCT01327612|537879160|FG006|Overall Study|Death|0|||
149108903|NCT01016262|537879162|FG000|Double-blind Phase|Adverse Event|0|||
149108904|NCT01016262|537879163|FG001|Double-blind Phase|Adverse Event|0|||
149108905|NCT01016262|537879164|FG002|Double-blind Phase|Adverse Event|1|||
149108906|NCT01016262|537879165|FG003|Double-blind Phase|Adverse Event|0|||
149108907|NCT01016262|537879166|FG004|Double-blind Phase|Adverse Event|0|||
149108908|NCT01016262|537879167|FG005|Double-blind Phase|Adverse Event|0|||
149108909|NCT01016262|537879162|FG000|Double-blind Phase|Lack of Efficacy|1|||
149108910|NCT01016262|537879163|FG001|Double-blind Phase|Lack of Efficacy|0|||
149108911|NCT01016262|537879164|FG002|Double-blind Phase|Lack of Efficacy|5|||
149108912|NCT01016262|537879165|FG003|Double-blind Phase|Lack of Efficacy|0|||
149108913|NCT01016262|537879166|FG004|Double-blind Phase|Lack of Efficacy|0|||
149108914|NCT01016262|537879167|FG005|Double-blind Phase|Lack of Efficacy|0|||
149108915|NCT01016262|537879162|FG000|Double-blind Phase|Disease Progression|0|||
149108916|NCT01016262|537879163|FG001|Double-blind Phase|Disease Progression|1|||
149108917|NCT01016262|537879164|FG002|Double-blind Phase|Disease Progression|2|||
149108918|NCT01016262|537879165|FG003|Double-blind Phase|Disease Progression|0|||
149108919|NCT01016262|537879166|FG004|Double-blind Phase|Disease Progression|0|||
149108920|NCT01016262|537879167|FG005|Double-blind Phase|Disease Progression|0|||
149108921|NCT01016262|537879162|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
149108922|NCT01016262|537879163|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
149108923|NCT01016262|537879164|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
149108924|NCT01016262|537879165|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
149108925|NCT01016262|537879166|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
149108926|NCT01016262|537879167|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
149108927|NCT01016262|537879162|FG000|Open-Label Phase|Adverse Event|0|||
149108928|NCT01016262|537879163|FG001|Open-Label Phase|Adverse Event|0|||
149108929|NCT01016262|537879164|FG002|Open-Label Phase|Adverse Event|0|||
149108930|NCT01016262|537879165|FG003|Open-Label Phase|Adverse Event|1|||
149108931|NCT01016262|537879166|FG004|Open-Label Phase|Adverse Event|0|||
149108932|NCT01016262|537879167|FG005|Open-Label Phase|Adverse Event|0|||
149108933|NCT01016262|537879162|FG000|Open-Label Phase|Lost to Follow-up|0|||
149108934|NCT01016262|537879163|FG001|Open-Label Phase|Lost to Follow-up|0|||
149108935|NCT01016262|537879164|FG002|Open-Label Phase|Lost to Follow-up|0|||
149108936|NCT01016262|537879165|FG003|Open-Label Phase|Lost to Follow-up|0|||
149108937|NCT01016262|537879166|FG004|Open-Label Phase|Lost to Follow-up|1|||
149108938|NCT01016262|537879167|FG005|Open-Label Phase|Lost to Follow-up|0|||
149108939|NCT01016262|537879162|FG000|Open-Label Phase|Lack of Efficacy|0|||
149108940|NCT01016262|537879163|FG001|Open-Label Phase|Lack of Efficacy|0|||
149108941|NCT01016262|537879164|FG002|Open-Label Phase|Lack of Efficacy|0|||
149108942|NCT01016262|537879165|FG003|Open-Label Phase|Lack of Efficacy|1|||
149108943|NCT01016262|537879166|FG004|Open-Label Phase|Lack of Efficacy|0|||
149108944|NCT01016262|537879167|FG005|Open-Label Phase|Lack of Efficacy|0|||
149108945|NCT01016262|537879162|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
149108946|NCT01016262|537879163|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
149108947|NCT01016262|537879164|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
149108948|NCT01016262|537879165|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
149108949|NCT01016262|537879166|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
149108950|NCT01016262|537879167|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
149108951|NCT01730378|537879170|FG000|Overall Study|Lost to Follow-up|1|||
149108952|NCT01730378|537879171|FG001|Overall Study|Lost to Follow-up|0|||
149108953|NCT01853475|537879172|FG000|Overall Study|Withdrawal by Subject|0|||
149108954|NCT01853475|537879173|FG001|Overall Study|Withdrawal by Subject|1|||
149108955|NCT01853475|537879174|FG002|Overall Study|Withdrawal by Subject|0|||
149108956|NCT00659880|537879175|FG000|Overall Study|Lost to Follow-up|5|||
149108957|NCT02159040|537879176|FG000|Overall Study|Death|1|||
149108958|NCT01031628|537879177|FG000|Overall Study|Study terminated early|0|||
149108959|NCT01031628|537879178|FG001|Overall Study|Study terminated early|1|||
149108960|NCT01031628|537879179|FG002|Overall Study|Study terminated early|3|||
149108961|NCT01031628|537879180|FG003|Overall Study|Study terminated early|0|||
149108962|NCT03080493|537879181|FG000|Overall Study|Did not provide NRS pain results|1|||
149108963|NCT03080493|537879182|FG001|Overall Study|Did not provide NRS pain results|0|||
149108964|NCT03080493|537879181|FG000|Overall Study|Adverse Event|0|||
149108965|NCT03080493|537879182|FG001|Overall Study|Adverse Event|1|||
149108966|NCT03080493|537879181|FG000|Overall Study|Randomization error (parity group)|0|||
149108967|NCT03080493|537879182|FG001|Overall Study|Randomization error (parity group)|1|||
149108968|NCT01304498|537879183|FG000|Overall Study|Adverse Event|1|||
149108969|NCT01304498|537879184|FG001|Overall Study|Adverse Event|1|||
149108970|NCT01304498|537879183|FG000|Overall Study|Withdrawal by Subject|2|||
149108971|NCT01304498|537879184|FG001|Overall Study|Withdrawal by Subject|3|||
149108972|NCT01304498|537879183|FG000|Overall Study|Protocol Violation|1|||
149108973|NCT01304498|537879184|FG001|Overall Study|Protocol Violation|0|||
149108974|NCT01304498|537879183|FG000|Overall Study|Lost to Follow-up|2|||
149108975|NCT01304498|537879184|FG001|Overall Study|Lost to Follow-up|1|||
149108976|NCT00755417|537879185|FG000|Overall Study|Adverse Event|28|||
149108977|NCT00755417|537879186|FG001|Overall Study|Adverse Event|20|||
149108978|NCT00755417|537879187|FG002|Overall Study|Adverse Event|7|||
149108979|NCT00755417|537879185|FG000|Overall Study|Lack of Efficacy|8|||
149108980|NCT00755417|537879186|FG001|Overall Study|Lack of Efficacy|4|||
149108981|NCT00755417|537879187|FG002|Overall Study|Lack of Efficacy|9|||
149108982|NCT00755417|537879185|FG000|Overall Study|Protocol Violation|2|||
149108983|NCT00755417|537879186|FG001|Overall Study|Protocol Violation|1|||
149108984|NCT00755417|537879187|FG002|Overall Study|Protocol Violation|1|||
149108985|NCT00755417|537879185|FG000|Overall Study|Lost to Follow-up|3|||
149108986|NCT00755417|537879186|FG001|Overall Study|Lost to Follow-up|0|||
149108987|NCT00755417|537879187|FG002|Overall Study|Lost to Follow-up|1|||
149108988|NCT00755417|537879185|FG000|Overall Study|Withdrawal by Subject|12|||
149108989|NCT00755417|537879186|FG001|Overall Study|Withdrawal by Subject|12|||
149108990|NCT00755417|537879187|FG002|Overall Study|Withdrawal by Subject|12|||
149108991|NCT00755417|537879185|FG000|Overall Study|Not specified or missing data|9|||
149108992|NCT00755417|537879186|FG001|Overall Study|Not specified or missing data|18|||
149108993|NCT00755417|537879187|FG002|Overall Study|Not specified or missing data|12|||
149108994|NCT02803593|537879190|FG000|Overall Study|Lost to Follow-up|17|||
149108995|NCT02803593|537879191|FG001|Overall Study|Lost to Follow-up|35|||
149108996|NCT03004404|537879195|FG000|Period 2|Adverse Event|0|||
149108997|NCT03004404|537879196|FG001|Period 2|Adverse Event|0|||
149108998|NCT03004404|537879197|FG002|Period 2|Adverse Event|0|||
149108999|NCT03004404|537879198|FG003|Period 2|Adverse Event|0|||
149109000|NCT03004404|537879199|FG004|Period 2|Adverse Event|0|||
149109001|NCT03004404|537879200|FG005|Period 2|Adverse Event|0|||
149109002|NCT03004404|537879201|FG006|Period 2|Adverse Event|0|||
149109003|NCT03004404|537879202|FG007|Period 2|Adverse Event|0|||
149109004|NCT03004404|537879203|FG008|Period 2|Adverse Event|1|||
149109005|NCT03004404|537879204|FG009|Period 2|Adverse Event|0|||
149109006|NCT03004404|537879205|FG010|Period 2|Adverse Event|0|||
149109007|NCT03004404|537879206|FG011|Period 2|Adverse Event|0|||
149109008|NCT03004404|537879207|FG012|Period 2|Adverse Event|0|||
149109009|NCT03004404|537879208|FG013|Period 2|Adverse Event|0|||
149109010|NCT03004404|537879209|FG014|Period 2|Adverse Event|0|||
149109011|NCT03004404|537879210|FG015|Period 2|Adverse Event|1|||
149109012|NCT02522728|537879215|FG000|Overall Study|Withdrawal by Subject|6|||
149109013|NCT02522728|537879216|FG001|Overall Study|Withdrawal by Subject|6|||
149109014|NCT02522728|537879215|FG000|Overall Study|Death|4|||
149109015|NCT02522728|537879216|FG001|Overall Study|Death|3|||
149109016|NCT02522728|537879215|FG000|Overall Study|Adverse Event|2|||
149109017|NCT02522728|537879216|FG001|Overall Study|Adverse Event|1|||
149109018|NCT02522728|537879215|FG000|Overall Study|Did not receive randomized study device|0|||
149109019|NCT02522728|537879216|FG001|Overall Study|Did not receive randomized study device|1|||
149109020|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
149109021|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
149109022|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
149109023|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
149109024|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
149109025|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
149109026|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
149109027|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
149109028|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
149109029|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
149109030|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
149109031|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
149109032|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
149109033|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
149109034|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
149109035|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
149109036|NCT04210843|537879217|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
149109037|NCT04210843|537879218|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
149109038|NCT04210843|537879217|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
149109039|NCT04210843|537879218|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
149109040|NCT04210843|537879217|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
149109041|NCT04210843|537879218|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
149109042|NCT04210843|537879217|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
149109043|NCT04210843|537879218|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
149109044|NCT04210843|537879217|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
149109045|NCT04210843|537879218|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
149109046|NCT04210843|537879217|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
149109047|NCT04210843|537879218|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
149109048|NCT04210843|537879217|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
149109049|NCT04210843|537879218|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
149109050|NCT04210843|537879217|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
149109051|NCT04210843|537879218|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
149109052|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
149109053|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
149109054|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
149109055|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
149109056|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
149109057|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
149109058|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
149109059|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
149109060|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
149109061|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
149109062|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
149109063|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
149109064|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
149109065|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
149109066|NCT04210843|537879217|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
149109067|NCT04210843|537879218|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
149109068|NCT01099917|537879219|FG000|Overall Study|Adverse Event|3|||
149109069|NCT01099917|537879219|FG000|Overall Study|Not Treated|24|||
149109070|NCT01266161|537879220|FG000|Overall Study|Ineligible|1|||
149109071|NCT01266161|537879221|FG001|Overall Study|Ineligible|0|||
149109072|NCT01266161|537879220|FG000|Overall Study|Lack of Efficacy|0|||
149109073|NCT01266161|537879221|FG001|Overall Study|Lack of Efficacy|1|||
149109074|NCT01266161|537879220|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
149109075|NCT01266161|537879221|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
149109076|NCT02990468|537879222|FG000|Phase 2: MTD|Change in treatment|0|||
149109077|NCT02990468|537879223|FG001|Phase 2: MTD|Change in treatment|0|||
149109078|NCT02990468|537879224|FG002|Phase 2: MTD|Change in treatment|1|||
149109079|NCT01081886|537879225|FG000|Overall Study|Study termination|11|||
149109080|NCT01081886|537879226|FG001|Overall Study|Study termination|13|||
149109081|NCT02567708|537879227|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
149109082|NCT02567708|537879228|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
149109083|NCT02567708|537879227|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
149109084|NCT02567708|537879228|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
149109085|NCT02567708|537879227|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
149109086|NCT02567708|537879228|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
149109087|NCT02567708|537879227|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
149109088|NCT02567708|537879228|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
149109089|NCT00706654|537879229|FG000|Conversion Phase|Lost to Follow-up|4|||
149109090|NCT00706654|537879230|FG001|Conversion Phase|Lost to Follow-up|0|||
149109091|NCT00706654|537879231|FG002|Conversion Phase|Lost to Follow-up|0|||
149109092|NCT00706654|537879232|FG003|Conversion Phase|Lost to Follow-up|0|||
149109093|NCT00706654|537879229|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
149109094|NCT00706654|537879230|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
149109095|NCT00706654|537879231|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
149109096|NCT00706654|537879232|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
149109097|NCT00706654|537879229|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
149109098|NCT00706654|537879230|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
149109099|NCT00706654|537879231|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
149109100|NCT00706654|537879232|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
149109101|NCT00706654|537879229|FG000|Conversion Phase|Withdrawn by Investigator|14|||
149109102|NCT00706654|537879230|FG001|Conversion Phase|Withdrawn by Investigator|0|||
149109103|NCT00706654|537879231|FG002|Conversion Phase|Withdrawn by Investigator|0|||
149109104|NCT00706654|537879232|FG003|Conversion Phase|Withdrawn by Investigator|0|||
149109105|NCT00706654|537879229|FG000|Conversion Phase|Withdrew Consent|38|||
149109106|NCT00706654|537879230|FG001|Conversion Phase|Withdrew Consent|0|||
149109107|NCT00706654|537879231|FG002|Conversion Phase|Withdrew Consent|0|||
149109108|NCT00706654|537879232|FG003|Conversion Phase|Withdrew Consent|0|||
149109109|NCT00706654|537879229|FG000|Conversion Phase|Adverse Event|18|||
149109110|NCT00706654|537879230|FG001|Conversion Phase|Adverse Event|0|||
149109111|NCT00706654|537879231|FG002|Conversion Phase|Adverse Event|0|||
149109112|NCT00706654|537879232|FG003|Conversion Phase|Adverse Event|0|||
149109113|NCT00706654|537879229|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
149109114|NCT00706654|537879230|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
149109115|NCT00706654|537879231|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
149109116|NCT00706654|537879232|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
149109117|NCT00706654|537879229|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
149109118|NCT00706654|537879230|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
149109119|NCT00706654|537879231|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
149109120|NCT00706654|537879232|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
149109121|NCT00706654|537879229|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
149109122|NCT00706654|537879230|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
149109123|NCT00706654|537879231|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
149109124|NCT00706654|537879232|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
149109125|NCT00706654|537879229|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
149109126|NCT00706654|537879230|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
149109127|NCT00706654|537879231|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
149109128|NCT00706654|537879232|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
149109129|NCT00706654|537879229|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
149109130|NCT00706654|537879230|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
149109131|NCT00706654|537879231|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
149109132|NCT00706654|537879232|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
149109133|NCT00706654|537879229|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
149109134|NCT00706654|537879230|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
149109135|NCT00706654|537879231|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
149109136|NCT00706654|537879232|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
149109137|NCT00706654|537879229|FG000|Oral Stabilization Phase|Withdrew consent|55|||
149109138|NCT00706654|537879230|FG001|Oral Stabilization Phase|Withdrew consent|0|||
149109139|NCT00706654|537879231|FG002|Oral Stabilization Phase|Withdrew consent|0|||
149109140|NCT00706654|537879232|FG003|Oral Stabilization Phase|Withdrew consent|0|||
149109141|NCT00706654|537879229|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
149109142|NCT00706654|537879230|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
149109143|NCT00706654|537879231|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
149109144|NCT00706654|537879232|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
149109145|NCT00706654|537879229|FG000|Oral Stabilization Phase|Adverse Event|21|||
149109146|NCT00706654|537879230|FG001|Oral Stabilization Phase|Adverse Event|0|||
149109147|NCT00706654|537879231|FG002|Oral Stabilization Phase|Adverse Event|0|||
149109148|NCT00706654|537879232|FG003|Oral Stabilization Phase|Adverse Event|0|||
149109149|NCT00706654|537879229|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
149109150|NCT00706654|537879230|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149109151|NCT00706654|537879231|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149109152|NCT00706654|537879232|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
149109153|NCT00706654|537879229|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
149109154|NCT00706654|537879230|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149109155|NCT00706654|537879231|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149109156|NCT00706654|537879232|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
149109157|NCT00706654|537879229|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
149109158|NCT00706654|537879230|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
149109159|NCT00706654|537879231|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
149109160|NCT00706654|537879232|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
149109161|NCT00706654|537879229|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
149109162|NCT00706654|537879230|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
149109163|NCT00706654|537879231|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
149109164|NCT00706654|537879232|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
149109165|NCT00706654|537879229|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
149109166|NCT00706654|537879230|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
149109167|NCT00706654|537879231|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
149109168|NCT00706654|537879232|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
149109169|NCT00706654|537879229|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
149109170|NCT00706654|537879230|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
149109171|NCT00706654|537879231|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
149109172|NCT00706654|537879232|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
149109173|NCT00706654|537879229|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
149109174|NCT00706654|537879230|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
149109175|NCT00706654|537879231|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
149109176|NCT00706654|537879232|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
149109177|NCT00706654|537879229|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
149109178|NCT00706654|537879230|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
149109179|NCT00706654|537879231|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
149109180|NCT00706654|537879232|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
149109181|NCT00706654|537879229|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
149109182|NCT00706654|537879230|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
149109183|NCT00706654|537879231|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
149109184|NCT00706654|537879232|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
149109185|NCT00706654|537879229|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
149109186|NCT00706654|537879230|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
149109187|NCT00706654|537879231|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
149109188|NCT00706654|537879232|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
149109189|NCT01151215|537879236|FG000|Overall Study|Worsening of condition under study|1|||
149109190|NCT01151215|537879237|FG001|Overall Study|Worsening of condition under study|1|||
149109191|NCT01151215|537879238|FG002|Overall Study|Worsening of condition under study|1|||
149109192|NCT01151215|537879236|FG000|Overall Study|Death|16|||
149109193|NCT01151215|537879237|FG001|Overall Study|Death|20|||
149109194|NCT01151215|537879238|FG002|Overall Study|Death|11|||
149109195|NCT01151215|537879236|FG000|Overall Study|Lost to Follow-up|0|||
149109196|NCT01151215|537879237|FG001|Overall Study|Lost to Follow-up|0|||
149109197|NCT01151215|537879238|FG002|Overall Study|Lost to Follow-up|3|||
149109198|NCT01151215|537879236|FG000|Overall Study|Withdrawal by Subject|3|||
149109199|NCT01151215|537879237|FG001|Overall Study|Withdrawal by Subject|1|||
149109200|NCT01151215|537879238|FG002|Overall Study|Withdrawal by Subject|2|||
149109201|NCT01151215|537879236|FG000|Overall Study|Disease progression|0|||
149109202|NCT01151215|537879237|FG001|Overall Study|Disease progression|1|||
149109203|NCT01151215|537879238|FG002|Overall Study|Disease progression|1|||
149109204|NCT01151215|537879236|FG000|Overall Study|Safety as judged by the investigator|0|||
149109205|NCT01151215|537879237|FG001|Overall Study|Safety as judged by the investigator|0|||
149109206|NCT01151215|537879238|FG002|Overall Study|Safety as judged by the investigator|1|||
149109207|NCT01154140|537879239|FG000|Overall Study|Death|71|||
149109208|NCT01154140|537879240|FG001|Overall Study|Death|81|||
149109209|NCT01154140|537879239|FG000|Overall Study|Lost to Follow-up|4|||
149109210|NCT01154140|537879240|FG001|Overall Study|Lost to Follow-up|5|||
149109211|NCT01154140|537879239|FG000|Overall Study|Withdrawal by Subject|12|||
149109212|NCT01154140|537879240|FG001|Overall Study|Withdrawal by Subject|13|||
149109213|NCT01154140|537879239|FG000|Overall Study|Other|3|||
149109214|NCT01154140|537879240|FG001|Overall Study|Other|1|||
149109215|NCT01154140|537879239|FG000|Overall Study|Randomized but not treated|1|||
149109216|NCT01154140|537879240|FG001|Overall Study|Randomized but not treated|2|||
149109217|NCT01374568|537879245|FG000|Overall Study|Lab unable to analyze BTM|0|||
149109218|NCT01374568|537879246|FG001|Overall Study|Lab unable to analyze BTM|2|||
149109219|NCT04276051|537879247|FG000|Overall Study|Lost to Follow-up|0|||
149109220|NCT04276051|537879248|FG001|Overall Study|Lost to Follow-up|1|||
149109221|NCT04276051|537879247|FG000|Overall Study|Physician Decision|0|||
149109222|NCT04276051|537879248|FG001|Overall Study|Physician Decision|1|||
149109223|NCT04276051|537879247|FG000|Overall Study|Withdrawal by Subject|1|||
149109224|NCT04276051|537879248|FG001|Overall Study|Withdrawal by Subject|1|||
149109225|NCT01912404|537879249|FG000|Overall Study|Due to personal reasons|1|||
149109226|NCT01912404|537879250|FG001|Overall Study|Due to personal reasons|0|||
149109227|NCT02269423|537879251|FG000|Overall Study|Discontinued due to change in residence|0|||
149109228|NCT02269423|537879252|FG001|Overall Study|Discontinued due to change in residence|1|||
149109229|NCT02269423|537879253|FG002|Overall Study|Discontinued due to change in residence|0|||
149109230|NCT02269423|537879254|FG003|Overall Study|Discontinued due to change in residence|1|||
149109231|NCT00617929|537879257|FG000|Overall Study|Physician Decision|1|||
149109232|NCT03229486|537879258|FG000|Overall Study|Protocol Violation|0|||
149109233|NCT03229486|537879259|FG001|Overall Study|Protocol Violation|1|||
149109234|NCT00856245|537879263|FG000|Overall Study|Was not transplanted|5|||
149109235|NCT00760747|537879270|FG000|Study Period II|Adverse Event|3|||
149109236|NCT00760747|537879271|FG001|Study Period II|Adverse Event|4|||
149109237|NCT00760747|537879270|FG000|Study Period II|Lack of Efficacy|0|||
149109238|NCT00760747|537879271|FG001|Study Period II|Lack of Efficacy|6|||
149109239|NCT00760747|537879270|FG000|Study Period II|Parent/Caregiver Decision|3|||
149109240|NCT00760747|537879271|FG001|Study Period II|Parent/Caregiver Decision|0|||
149109241|NCT00760747|537879270|FG000|Study Period II|Protocol Violation|6|||
149109242|NCT00760747|537879271|FG001|Study Period II|Protocol Violation|3|||
149109243|NCT00760747|537879270|FG000|Study Period II|Withdrawal by Subject|1|||
149109244|NCT00760747|537879271|FG001|Study Period II|Withdrawal by Subject|0|||
149109245|NCT00760747|537879270|FG000|Study Period II|No drug administered|0|||
149109246|NCT00760747|537879271|FG001|Study Period II|No drug administered|1|||
149109247|NCT00760747|537879270|FG000|Study Period III|Adverse Event|1|||
149109248|NCT00760747|537879271|FG001|Study Period III|Adverse Event|0|||
149109249|NCT00760747|537879270|FG000|Study Period III|Lack of Efficacy|1|||
149109250|NCT00760747|537879271|FG001|Study Period III|Lack of Efficacy|0|||
149109251|NCT00760747|537879270|FG000|Study Period III|Parent/Caregiver Decision|0|||
149109252|NCT00760747|537879271|FG001|Study Period III|Parent/Caregiver Decision|1|||
149109253|NCT00760747|537879270|FG000|Study Period III|Protocol Violation|1|||
149109254|NCT00760747|537879271|FG001|Study Period III|Protocol Violation|1|||
149109255|NCT00760747|537879270|FG000|Study Period III|Physician Decision|0|||
149109256|NCT00760747|537879271|FG001|Study Period III|Physician Decision|1|||
149109257|NCT01443923|537879272|FG000|Overall Study|Adverse Event|1|||
149109258|NCT01443923|537879273|FG001|Overall Study|Adverse Event|0|||
149109259|NCT04160988|537879276|FG000|Overall Study|poor image quality|28|||
149109260|NCT00844597|537879277|FG000|Overall Study|Adverse Event|0|||
149109261|NCT00844597|537879278|FG001|Overall Study|Adverse Event|0|||
149109262|NCT00844597|537879279|FG002|Overall Study|Adverse Event|0|||
149109263|NCT00844597|537879280|FG003|Overall Study|Adverse Event|1|||
149109264|NCT00844597|537879281|FG004|Overall Study|Adverse Event|0|||
149109265|NCT00844597|537879282|FG005|Overall Study|Adverse Event|0|||
149109266|NCT01250509|537879283|FG000|Overall Study|Lost to Follow-up|5|||
149109267|NCT01250509|537879284|FG001|Overall Study|Lost to Follow-up|2|||
149109268|NCT02670122|537879285|FG000|Overall Study|Lost to Follow-up|4|||
149109269|NCT02762903|537879291|FG000|Overall Study|Lost to Follow-up|0|||
149109270|NCT02762903|537879292|FG001|Overall Study|Lost to Follow-up|1|||
149109271|NCT01228175|537879293|FG000|Overall Study|Lost to Follow-up|64|||
149109272|NCT01228175|537879294|FG001|Overall Study|Lost to Follow-up|50|||
149109273|NCT01228175|537879293|FG000|Overall Study|Withdrawal by Subject|1|||
149109274|NCT01228175|537879294|FG001|Overall Study|Withdrawal by Subject|2|||
149109275|NCT01228175|537879293|FG000|Overall Study|Physician Decision|1|||
149109276|NCT01228175|537879294|FG001|Overall Study|Physician Decision|1|||
149109277|NCT00108745|537879295|FG000|Overall Study|Withdrawal by Subject|19|||
149109278|NCT00108745|537879296|FG001|Overall Study|Withdrawal by Subject|12|||
149109279|NCT00108745|537879297|FG002|Overall Study|Withdrawal by Subject|12|||
149109280|NCT00108745|537879295|FG000|Overall Study|Never Treated|8|||
149109281|NCT00108745|537879296|FG001|Overall Study|Never Treated|10|||
149109282|NCT00108745|537879297|FG002|Overall Study|Never Treated|12|||
149109283|NCT00108745|537879295|FG000|Overall Study|Ineligible|7|||
149109284|NCT00108745|537879296|FG001|Overall Study|Ineligible|13|||
149109285|NCT00108745|537879297|FG002|Overall Study|Ineligible|13|||
149109286|NCT00243074|537879299|FG000|Overall Study|Ineligible|6|||
149109287|NCT00243074|537879299|FG000|Overall Study|Adverse Event|6|||
149109288|NCT00243074|537879299|FG000|Overall Study|Withdrawal by Subject|2|||
149109289|NCT00243074|537879299|FG000|Overall Study|Lack of Efficacy|36|||
149109290|NCT00243074|537879299|FG000|Overall Study|Death|2|||
149109291|NCT00243074|537879299|FG000|Overall Study|not protocol specified|1|||
149109292|NCT00243074|537879299|FG000|Overall Study|Did not receive any treatment|1|||
149109293|NCT03041792|537879300|FG000|Overall Study|Adverse Event|4|||
149109294|NCT03041792|537879301|FG001|Overall Study|Adverse Event|0|||
149109295|NCT03041792|537879300|FG000|Overall Study|Death in the family|0|||
149109296|NCT03041792|537879301|FG001|Overall Study|Death in the family|2|||
149109297|NCT03041792|537879300|FG000|Overall Study|Randomized but not treated|0|||
149109298|NCT03041792|537879301|FG001|Overall Study|Randomized but not treated|1|||
149109299|NCT00475228|537879306|FG000|Overall Study|Lost to Follow-up|17|||
149109300|NCT00475228|537879307|FG001|Overall Study|Lost to Follow-up|17|||
149109301|NCT02209181|537879308|FG000|Overall Study|Adverse Event|1|||
149109302|NCT02209181|537879309|FG001|Overall Study|Adverse Event|0|||
149109303|NCT02209181|537879310|FG002|Overall Study|Adverse Event|1|||
149109304|NCT02209181|537879311|FG003|Overall Study|Adverse Event|0|||
149109305|NCT02209181|537879308|FG000|Overall Study|Withdrawal by Subject|0|||
149109306|NCT02209181|537879309|FG001|Overall Study|Withdrawal by Subject|1|||
149109307|NCT02209181|537879310|FG002|Overall Study|Withdrawal by Subject|0|||
149109308|NCT02209181|537879311|FG003|Overall Study|Withdrawal by Subject|0|||
149109309|NCT02579772|537879312|FG000|Overall Study|Withdrawal by Subject|0|||
149109310|NCT02579772|537879313|FG001|Overall Study|Withdrawal by Subject|1|||
149109311|NCT02579772|537879312|FG000|Overall Study|Usage of additional antioxidants|1|||
149109312|NCT02579772|537879313|FG001|Overall Study|Usage of additional antioxidants|0|||
149109313|NCT02579772|537879312|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
149109314|NCT02579772|537879313|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
149109315|NCT00862836|537879315|FG000|Overall Study|Withdrawal by Subject|1|||
149109316|NCT04463680|537879321|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
149109317|NCT04463680|537879321|FG000|Overall Study|Not eligible due to implant duration of use|1|||
149109318|NCT04463680|537879321|FG000|Overall Study|Withdrawal by Subject|3|||
149109319|NCT04855734|537879322|FG000|Overall Study|Lost to Follow-up|2|||
149109320|NCT04855734|537879323|FG001|Overall Study|Lost to Follow-up|2|||
149109321|NCT04535544|537879326|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
149109322|NCT04535544|537879327|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
149109323|NCT04535544|537879328|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
149109324|NCT04535544|537879329|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
149109325|NCT04535544|537879326|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
149109326|NCT04535544|537879327|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
149109327|NCT04535544|537879328|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
149109328|NCT04535544|537879329|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
149109329|NCT04535544|537879326|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
149109330|NCT04535544|537879327|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
149109331|NCT04535544|537879328|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
149109332|NCT04535544|537879329|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
149109333|NCT04535544|537879326|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
149109334|NCT04535544|537879327|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
149109335|NCT04535544|537879328|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
149109336|NCT04535544|537879329|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
149109337|NCT04535544|537879326|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
149109338|NCT04535544|537879327|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
149109339|NCT04535544|537879328|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
149109340|NCT04535544|537879329|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
149109341|NCT04535544|537879326|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
149109342|NCT04535544|537879327|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
149109343|NCT04535544|537879328|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
149109344|NCT04535544|537879329|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
149109345|NCT04535544|537879326|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
149109346|NCT04535544|537879327|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
149109347|NCT04535544|537879328|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
149109348|NCT04535544|537879329|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
149109349|NCT04535544|537879326|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
149109350|NCT04535544|537879327|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
149109351|NCT04535544|537879328|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
149109352|NCT04535544|537879329|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
149109353|NCT03939689|537881043|FG000|Overall Study|Radiographic progression|14|||
149109354|NCT03939689|537881044|FG001|Overall Study|Radiographic progression|17|||
149109355|NCT03939689|537881043|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
149109356|NCT03939689|537881044|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
149109357|NCT03939689|537881043|FG000|Overall Study|Adverse Event|1|||
149109358|NCT03939689|537881044|FG001|Overall Study|Adverse Event|8|||
149109359|NCT03939689|537881043|FG000|Overall Study|Unequivocal clinical progression|2|||
149109360|NCT03939689|537881044|FG001|Overall Study|Unequivocal clinical progression|5|||
149109361|NCT03939689|537881043|FG000|Overall Study|Other|1|||
149109362|NCT03939689|537881044|FG001|Overall Study|Other|4|||
149109363|NCT03939689|537881043|FG000|Overall Study|Death|0|||
149109364|NCT03939689|537881044|FG001|Overall Study|Death|3|||
149109365|NCT03939689|537881043|FG000|Overall Study|Participant decision|0|||
149109366|NCT03939689|537881044|FG001|Overall Study|Participant decision|3|||
149109367|NCT03939689|537881043|FG000|Overall Study|Withdrawal of consent|2|||
149109368|NCT03939689|537881044|FG001|Overall Study|Withdrawal of consent|1|||
149109369|NCT03939689|537881043|FG000|Overall Study|Investigator decision|1|||
149109370|NCT03939689|537881044|FG001|Overall Study|Investigator decision|0|||
149109371|NCT04427280|537881045|FG000|Overall Study|Withdrawal by Subject|0|||
149109372|NCT04427280|537881046|FG001|Overall Study|Withdrawal by Subject|2|||
149109373|NCT02412735|537881057|FG000|Overall Study|Adverse Event|0|||
149109374|NCT02412735|537881058|FG001|Overall Study|Adverse Event|1|||
149109375|NCT02412735|537881059|FG002|Overall Study|Adverse Event|2|||
149109376|NCT02412735|537881057|FG000|Overall Study|Withdrawal by Subject|23|||
149109377|NCT02412735|537881058|FG001|Overall Study|Withdrawal by Subject|27|||
149109378|NCT02412735|537881059|FG002|Overall Study|Withdrawal by Subject|22|||
149109379|NCT02412735|537881057|FG000|Overall Study|Investigator Decision|3|||
149109380|NCT02412735|537881058|FG001|Overall Study|Investigator Decision|3|||
149109381|NCT02412735|537881059|FG002|Overall Study|Investigator Decision|2|||
149109382|NCT02412735|537881057|FG000|Overall Study|Lost to Follow-up|17|||
149109383|NCT02412735|537881058|FG001|Overall Study|Lost to Follow-up|11|||
149109384|NCT02412735|537881059|FG002|Overall Study|Lost to Follow-up|18|||
149109385|NCT02412735|537881057|FG000|Overall Study|Reason not Specified|3|||
149109386|NCT02412735|537881058|FG001|Overall Study|Reason not Specified|2|||
149109387|NCT02412735|537881059|FG002|Overall Study|Reason not Specified|2|||
149109388|NCT01228318|537881060|FG000|Overall Study|Clinic no show to receive intervention|1|||
149109389|NCT01228318|537881061|FG001|Overall Study|Clinic no show to receive intervention|0|||
149109390|NCT01228318|537881060|FG000|Overall Study|Unable to contact|2|||
149109391|NCT01228318|537881061|FG001|Overall Study|Unable to contact|5|||
149109392|NCT01228318|537881060|FG000|Overall Study|Moved|0|||
149109393|NCT01228318|537881061|FG001|Overall Study|Moved|2|||
149109394|NCT01228318|537881060|FG000|Overall Study|Incarcerated|1|||
149109395|NCT01228318|537881061|FG001|Overall Study|Incarcerated|0|||
149109396|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
149109397|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
149109398|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
149109399|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
149109400|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149109401|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
149109402|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
149109403|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
149109404|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
149109405|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
149109406|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
149109407|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
149109408|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
149109409|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
149109410|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
149109411|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
149109412|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
149109413|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
149109414|NCT00603525|537881066|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
149109415|NCT00603525|537881067|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
149109416|NCT00603525|537881068|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
149109417|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
149109418|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
149109419|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
149109420|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
149109421|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
149109422|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
149109423|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
149109424|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
149109425|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
149109426|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
149109427|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
149109428|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
149109429|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
149109430|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
149109431|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
149109432|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
149109433|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
149109434|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
149109435|NCT00603525|537881066|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
149109436|NCT00603525|537881067|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
149109437|NCT00603525|537881068|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
149109438|NCT00603525|537881066|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
149109439|NCT00603525|537881067|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
149109440|NCT00603525|537881068|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
149109441|NCT00770029|537881069|FG000|Overall Study|Lost to Follow-up|2|||
149109442|NCT00770029|537881070|FG001|Overall Study|Lost to Follow-up|0|||
149109443|NCT00770029|537881069|FG000|Overall Study|Withdrawal by Subject|3|||
149109444|NCT00770029|537881070|FG001|Overall Study|Withdrawal by Subject|3|||
149109445|NCT00770029|537881069|FG000|Overall Study|Adverse Event|1|||
149109446|NCT00770029|537881070|FG001|Overall Study|Adverse Event|0|||
149109447|NCT02124811|537881071|FG000|Overall Study|Early termination|2|||
149109448|NCT02124811|537881072|FG001|Overall Study|Early termination|2|||
149109449|NCT02124811|537881071|FG000|Overall Study|Withdrawal by Subject|1|||
149109450|NCT02124811|537881072|FG001|Overall Study|Withdrawal by Subject|0|||
149109451|NCT04043143|537881073|FG000|Overall Study|Lost to Follow-up|5|||
149109452|NCT04043143|537881074|FG001|Overall Study|Lost to Follow-up|5|||
149109453|NCT04043143|537881073|FG000|Overall Study|screen failure|1|||
149109454|NCT04043143|537881074|FG001|Overall Study|screen failure|0|||
149109455|NCT03480932|537881075|FG000|Overall Study|Death|1|||
149109456|NCT03480932|537881076|FG001|Overall Study|Death|1|||
149109457|NCT03480932|537881077|FG002|Overall Study|Death|0|||
149109458|NCT03480932|537881075|FG000|Overall Study|Lost to Follow-up|0|||
149109459|NCT03480932|537881076|FG001|Overall Study|Lost to Follow-up|2|||
149109460|NCT03480932|537881077|FG002|Overall Study|Lost to Follow-up|3|||
149109461|NCT03480932|537881075|FG000|Overall Study|Incarcerated|2|||
149109462|NCT03480932|537881076|FG001|Overall Study|Incarcerated|2|||
149109463|NCT03480932|537881077|FG002|Overall Study|Incarcerated|2|||
149109464|NCT01294397|537881081|FG000|Overall Study|Withdrawal by Subject|1|||
149109465|NCT01294397|537881081|FG000|Overall Study|Administrative Decision|1|||
149109466|NCT01661205|537881082|FG000|Overall Study|Physician Decision|2|||
149109467|NCT00426127|537881083|FG000|Overall Study|Adverse Event|1|||
149109468|NCT00426127|537881083|FG000|Overall Study|Removed due to disease progression|1|||
149109469|NCT03111095|537881087|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
149109470|NCT03111095|537881088|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
149109471|NCT03111095|537881087|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
149109472|NCT03111095|537881088|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
149109473|NCT00955708|537881094|FG000|Overall Study|Death|269|||
149109474|NCT00955708|537881094|FG000|Overall Study|Lost to Follow-up|72|||
149109475|NCT00955708|537881094|FG000|Overall Study|Physician Decision|36|||
149109476|NCT00955708|537881094|FG000|Overall Study|Protocol Violation|134|||
149109477|NCT00955708|537881094|FG000|Overall Study|Registry Conclusion|186|||
149109478|NCT00955708|537881094|FG000|Overall Study|Product removed from service|94|||
149109479|NCT00955708|537881094|FG000|Overall Study|Patient Refused to participate further|116|||
149109480|NCT00955708|537881094|FG000|Overall Study|Closure of study location|60|||
149109481|NCT00955708|537881094|FG000|Overall Study|Patient changed care provider/moved|91|||
149109482|NCT03738475|537881095|FG000|Overall Study|Participant Non-Compliance|1|||
149109483|NCT03738475|537881096|FG001|Overall Study|Participant Non-Compliance|0|||
149109484|NCT00737477|537881097|FG000|Overall Study|Adverse Event|9|||
149109485|NCT00737477|537881097|FG000|Overall Study|Death|9|||
149109486|NCT00737477|537881097|FG000|Overall Study|Treatment Refusal|1|||
149109487|NCT00737477|537881097|FG000|Overall Study|Withdrawal by Subject|1|||
149109488|NCT00737477|537881097|FG000|Overall Study|Renal Transplantation|10|||
149109489|NCT00737477|537881097|FG000|Overall Study|Other|4|||
149109490|NCT01132820|537881098|FG000|Overall Study|Ineligible: wrong cell type|1|||
149109491|NCT01132820|537881098|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
149109492|NCT01132820|537881098|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
149109493|NCT01132820|537881098|FG000|Overall Study|Never treated|1|||
149109494|NCT01132820|537881098|FG000|Overall Study|Inadequate data|1|||
149109495|NCT01370655|537881099|FG000|Period 1|Adverse Event|2|||
149109496|NCT01370655|537881100|FG001|Period 1|Adverse Event|0|||
149109497|NCT01370655|537881101|FG002|Period 1|Adverse Event|0|||
149109498|NCT01370655|537881102|FG003|Period 1|Adverse Event|0|||
149109499|NCT01370655|537881103|FG004|Period 1|Adverse Event|0|||
149109500|NCT01370655|537881104|FG005|Period 1|Adverse Event|0|||
149109501|NCT01370655|537881105|FG006|Period 1|Adverse Event|1|||
149109502|NCT01370655|537881106|FG007|Period 1|Adverse Event|0|||
149109503|NCT01370655|537881107|FG008|Period 1|Adverse Event|0|||
149109504|NCT01370655|537881108|FG009|Period 1|Adverse Event|0|||
149109505|NCT01370655|537881109|FG010|Period 1|Adverse Event|0|||
149109506|NCT01370655|537881110|FG011|Period 1|Adverse Event|0|||
149109507|NCT01370655|537881099|FG000|Period 2|Adverse Event|0|||
149109508|NCT01370655|537881100|FG001|Period 2|Adverse Event|0|||
149109509|NCT01370655|537881101|FG002|Period 2|Adverse Event|1|||
149109510|NCT01370655|537881102|FG003|Period 2|Adverse Event|0|||
149109511|NCT01370655|537881103|FG004|Period 2|Adverse Event|1|||
149109512|NCT01370655|537881104|FG005|Period 2|Adverse Event|0|||
149109513|NCT01370655|537881105|FG006|Period 2|Adverse Event|0|||
149109514|NCT01370655|537881106|FG007|Period 2|Adverse Event|1|||
149109515|NCT01370655|537881107|FG008|Period 2|Adverse Event|0|||
149109516|NCT01370655|537881108|FG009|Period 2|Adverse Event|0|||
149109517|NCT01370655|537881109|FG010|Period 2|Adverse Event|0|||
149109518|NCT01370655|537881110|FG011|Period 2|Adverse Event|0|||
149109519|NCT01370655|537881099|FG000|Period 2|met protocol specified stopping criteria|0|||
149109520|NCT01370655|537881100|FG001|Period 2|met protocol specified stopping criteria|0|||
149109521|NCT01370655|537881101|FG002|Period 2|met protocol specified stopping criteria|1|||
149109522|NCT01370655|537881102|FG003|Period 2|met protocol specified stopping criteria|0|||
149109523|NCT01370655|537881103|FG004|Period 2|met protocol specified stopping criteria|0|||
149109524|NCT01370655|537881104|FG005|Period 2|met protocol specified stopping criteria|0|||
149109525|NCT01370655|537881105|FG006|Period 2|met protocol specified stopping criteria|1|||
149109526|NCT01370655|537881106|FG007|Period 2|met protocol specified stopping criteria|0|||
149109527|NCT01370655|537881107|FG008|Period 2|met protocol specified stopping criteria|1|||
149109528|NCT01370655|537881108|FG009|Period 2|met protocol specified stopping criteria|0|||
149109529|NCT01370655|537881109|FG010|Period 2|met protocol specified stopping criteria|1|||
149109530|NCT01370655|537881110|FG011|Period 2|met protocol specified stopping criteria|0|||
149109531|NCT01370655|537881099|FG000|Period 2|Withdrawal by Subject|0|||
149109532|NCT01370655|537881100|FG001|Period 2|Withdrawal by Subject|0|||
149109533|NCT01370655|537881101|FG002|Period 2|Withdrawal by Subject|0|||
149109534|NCT01370655|537881102|FG003|Period 2|Withdrawal by Subject|0|||
149109535|NCT01370655|537881103|FG004|Period 2|Withdrawal by Subject|0|||
149109536|NCT01370655|537881104|FG005|Period 2|Withdrawal by Subject|0|||
149109537|NCT01370655|537881105|FG006|Period 2|Withdrawal by Subject|0|||
149109538|NCT01370655|537881106|FG007|Period 2|Withdrawal by Subject|0|||
149109539|NCT01370655|537881107|FG008|Period 2|Withdrawal by Subject|1|||
149109540|NCT01370655|537881108|FG009|Period 2|Withdrawal by Subject|0|||
149109541|NCT01370655|537881109|FG010|Period 2|Withdrawal by Subject|0|||
149109542|NCT01370655|537881110|FG011|Period 2|Withdrawal by Subject|0|||
149109543|NCT02057575|537881112|FG000|Overall Study|Adverse Event|0|||
149109544|NCT02057575|537881113|FG001|Overall Study|Adverse Event|2|||
149109545|NCT02057575|537881114|FG002|Overall Study|Adverse Event|0|||
149109546|NCT02057575|537881115|FG003|Overall Study|Adverse Event|1|||
149109547|NCT02057575|537881112|FG000|Overall Study|Withdrawal by Subject|1|||
149109548|NCT02057575|537881113|FG001|Overall Study|Withdrawal by Subject|0|||
149109549|NCT02057575|537881114|FG002|Overall Study|Withdrawal by Subject|0|||
149109550|NCT02057575|537881115|FG003|Overall Study|Withdrawal by Subject|0|||
149109551|NCT02057575|537881112|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
149109552|NCT02057575|537881113|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
149109553|NCT02057575|537881114|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
149109554|NCT02057575|537881115|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
149109555|NCT02057575|537881112|FG000|Overall Study|Protocol Violation|0|||
149109556|NCT02057575|537881113|FG001|Overall Study|Protocol Violation|1|||
149109557|NCT02057575|537881114|FG002|Overall Study|Protocol Violation|0|||
149109558|NCT02057575|537881115|FG003|Overall Study|Protocol Violation|0|||
149109559|NCT01735175|537881117|FG000|Overall Study|Withdrawal by Subject|9|||
149109560|NCT01735175|537881118|FG001|Overall Study|Withdrawal by Subject|2|||
149109561|NCT01735175|537881117|FG000|Overall Study|Lost to Follow-up|4|||
149109562|NCT01735175|537881118|FG001|Overall Study|Lost to Follow-up|2|||
149109563|NCT01735175|537881117|FG000|Overall Study|Death|3|||
149109564|NCT01735175|537881118|FG001|Overall Study|Death|2|||
149109565|NCT01735175|537881117|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
149109566|NCT01735175|537881118|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
149109567|NCT01485120|537881121|FG000|Overall Study|Withdrawal by Subject|2|||
149109568|NCT00422734|537881122|FG000|Overall Study|Physician Decision|1|||
149109569|NCT00422734|537881123|FG001|Overall Study|Physician Decision|1|||
149109570|NCT00422734|537881122|FG000|Overall Study|Protocol Violation|1|||
149109571|NCT00422734|537881123|FG001|Overall Study|Protocol Violation|6|||
149109572|NCT00422734|537881122|FG000|Overall Study|Withdrawal by Subject|12|||
149109573|NCT00422734|537881123|FG001|Overall Study|Withdrawal by Subject|8|||
149109574|NCT00422734|537881122|FG000|Overall Study|Adverse Event|0|||
149109575|NCT00422734|537881123|FG001|Overall Study|Adverse Event|3|||
149109576|NCT00422734|537881122|FG000|Overall Study|Partner Decision|0|||
149109577|NCT00422734|537881123|FG001|Overall Study|Partner Decision|3|||
149109578|NCT02344342|537881124|FG000|Overall Study|Industry partner dropped out|11|||
149109579|NCT02344342|537881125|FG001|Overall Study|Industry partner dropped out|9|||
149109580|NCT02344342|537881126|FG002|Overall Study|Industry partner dropped out|14|||
149109581|NCT02344342|537881127|FG003|Overall Study|Industry partner dropped out|10|||
149109582|NCT00848484|537881128|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
149109583|NCT00848484|537881129|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
149109584|NCT00848484|537881128|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
149109585|NCT00848484|537881129|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
149109586|NCT00848484|537881128|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
149109587|NCT00848484|537881129|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
149109588|NCT00848484|537881128|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
149109589|NCT00848484|537881129|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
149109590|NCT00848484|537881128|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
149109591|NCT00848484|537881129|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
149109592|NCT01889069|537881133|FG000|Overall Study|Death|18|||
149109593|NCT01889069|537881133|FG000|Overall Study|Progression of Disease|14|||
149109594|NCT01889069|537881133|FG000|Overall Study|Lost to Follow-up|6|||
149109595|NCT01889069|537881133|FG000|Overall Study|Other|4|||
149109596|NCT01889069|537881133|FG000|Overall Study|Consent Withdrawal|3|||
149109597|NCT01426347|537881138|FG000|Overall Study|Lost to Follow-up|0|||
149109598|NCT01426347|537881139|FG001|Overall Study|Lost to Follow-up|3|||
149109599|NCT01426347|537881138|FG000|Overall Study|Protocol Violation|2|||
149109600|NCT01426347|537881139|FG001|Overall Study|Protocol Violation|0|||
149109601|NCT01426347|537881138|FG000|Overall Study|Withdrawal by Subject|5|||
149109602|NCT01426347|537881139|FG001|Overall Study|Withdrawal by Subject|0|||
149109603|NCT00455741|537881140|FG000|Overall Study|Physician Decision|0|||
149109604|NCT00455741|537881141|FG001|Overall Study|Physician Decision|1|||
149109605|NCT00664534|537881142|FG000|Overall Study|Adverse Event|2|||
149109606|NCT00664534|537881143|FG001|Overall Study|Adverse Event|3|||
149109607|NCT00664534|537881142|FG000|Overall Study|Lost to Follow-up|6|||
149109608|NCT00664534|537881143|FG001|Overall Study|Lost to Follow-up|10|||
149109609|NCT00664534|537881142|FG000|Overall Study|Protocol Violation|10|||
149109610|NCT00664534|537881143|FG001|Overall Study|Protocol Violation|8|||
149109611|NCT00664534|537881142|FG000|Overall Study|Withdrawal by Subject|7|||
149109612|NCT00664534|537881143|FG001|Overall Study|Withdrawal by Subject|6|||
149109613|NCT00664534|537881142|FG000|Overall Study|Physician Decision|8|||
149109614|NCT00664534|537881143|FG001|Overall Study|Physician Decision|0|||
149109615|NCT00664534|537881142|FG000|Overall Study|Sponsor decision|8|||
149109616|NCT00664534|537881143|FG001|Overall Study|Sponsor decision|6|||
149109617|NCT00935532|537881146|FG000|Overall Study|Adverse Event|11|||
149109618|NCT00935532|537881147|FG001|Overall Study|Adverse Event|6|||
149109619|NCT00935532|537881146|FG000|Overall Study|Death|1|||
149109620|NCT00935532|537881147|FG001|Overall Study|Death|0|||
149109621|NCT00935532|537881146|FG000|Overall Study|Lost to Follow-up|1|||
149109622|NCT00935532|537881147|FG001|Overall Study|Lost to Follow-up|0|||
149109623|NCT00935532|537881146|FG000|Overall Study|Physician Decision|1|||
149109624|NCT00935532|537881147|FG001|Overall Study|Physician Decision|2|||
149109625|NCT00935532|537881146|FG000|Overall Study|Protocol Violation|2|||
149109626|NCT00935532|537881147|FG001|Overall Study|Protocol Violation|1|||
149109627|NCT00935532|537881146|FG000|Overall Study|Subject Decision|2|||
149109628|NCT00935532|537881147|FG001|Overall Study|Subject Decision|1|||
149109629|NCT00935532|537881146|FG000|Overall Study|Sponsor Decision|0|||
149109630|NCT00935532|537881147|FG001|Overall Study|Sponsor Decision|1|||
149109631|NCT00935532|537881146|FG000|Overall Study|Loss Glucose Control|4|||
149109632|NCT00935532|537881147|FG001|Overall Study|Loss Glucose Control|0|||
149109633|NCT00402051|537881150|FG000|Overall Study|Progressive Disease|13|||
149109634|NCT00402051|537881151|FG001|Overall Study|Progressive Disease|20|||
149109635|NCT00402051|537881150|FG000|Overall Study|Adverse Event|11|||
149109636|NCT00402051|537881151|FG001|Overall Study|Adverse Event|4|||
149109637|NCT00402051|537881150|FG000|Overall Study|Physician Decision|7|||
149109638|NCT00402051|537881151|FG001|Overall Study|Physician Decision|3|||
149109639|NCT00402051|537881150|FG000|Overall Study|Withdrawal by Subject|3|||
149109640|NCT00402051|537881151|FG001|Overall Study|Withdrawal by Subject|3|||
149109641|NCT00402051|537881150|FG000|Overall Study|Death - Related to Study Drug|1|||
149109642|NCT00402051|537881151|FG001|Overall Study|Death - Related to Study Drug|2|||
149109643|NCT00402051|537881150|FG000|Overall Study|Death Due to Study Disease|2|||
149109644|NCT00402051|537881151|FG001|Overall Study|Death Due to Study Disease|1|||
149109645|NCT00402051|537881150|FG000|Overall Study|Death Due to Adverse Event|0|||
149109646|NCT00402051|537881151|FG001|Overall Study|Death Due to Adverse Event|2|||
149109647|NCT00402051|537881150|FG000|Overall Study|Lost to Follow-up|1|||
149109648|NCT00402051|537881151|FG001|Overall Study|Lost to Follow-up|0|||
149109649|NCT00996606|537881162|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
149109650|NCT00996606|537881162|FG000|Overall Study|Insufficient Therapeutic Response|2|||
149109651|NCT00996606|537881162|FG000|Overall Study|Protocol Violation|1|||
149109652|NCT00996606|537881162|FG000|Overall Study|Withdrawal by Subject|3|||
149109653|NCT00277095|537881164|FG000|Overall Study|Death|2|||
149109654|NCT00277095|537881164|FG000|Overall Study|Explanted|7|||
149109655|NCT00277095|537881164|FG000|Overall Study|Lost to Follow-up|2|||
149109656|NCT00277095|537881164|FG000|Overall Study|Missed Follow-up|9|||
149109657|NCT00277095|537881164|FG000|Overall Study|Physician Decision|1|||
149109658|NCT05415748|537881168|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
149109659|NCT05415748|537881169|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
149109660|NCT05415748|537881170|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
149109661|NCT05415748|537881171|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
149109662|NCT05415748|537881168|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
149109663|NCT05415748|537881169|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
149109664|NCT05415748|537881170|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
149109665|NCT05415748|537881171|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
149109666|NCT03075527|537881172|FG000|Overall Study|Death|1|||
149109667|NCT03075527|537881172|FG000|Overall Study|Withdrawal by Subject|1|||
149109668|NCT03075527|537881172|FG000|Overall Study|Physician Decision|3|||
149109669|NCT03075527|537881172|FG000|Overall Study|Progression/Relapse|14|||
149109670|NCT00281320|537881180|FG000|Overall Study|Adverse Event|12|||
149109671|NCT00281320|537881181|FG001|Overall Study|Adverse Event|9|||
149109672|NCT00281320|537881180|FG000|Overall Study|Lack of Efficacy|4|||
149109673|NCT00281320|537881181|FG001|Overall Study|Lack of Efficacy|3|||
149109674|NCT00281320|537881180|FG000|Overall Study|Withdrawal by Subject|5|||
149109675|NCT00281320|537881181|FG001|Overall Study|Withdrawal by Subject|6|||
149109676|NCT00281320|537881180|FG000|Overall Study|Lost to Follow-up|1|||
149109677|NCT00281320|537881181|FG001|Overall Study|Lost to Follow-up|2|||
149109678|NCT00281320|537881180|FG000|Overall Study|Other|3|||
149109679|NCT00281320|537881181|FG001|Overall Study|Other|1|||
149109680|NCT01447576|537881182|FG000|Overall Study|Lost to Follow-up|52|||
149109681|NCT01447576|537881182|FG000|Overall Study|Adverse Event|127|||
149109682|NCT01447576|537881182|FG000|Overall Study|Participant met withdrawal criteria|40|||
149109683|NCT01447576|537881182|FG000|Overall Study|Withdrawal by Subject|100|||
149109684|NCT01447576|537881182|FG000|Overall Study|Protocol deviation|83|||
149109685|NCT01447576|537881182|FG000|Overall Study|Lack of Efficacy|68|||
149109686|NCT01447576|537881182|FG000|Overall Study|Physician Decision|6|||
149109687|NCT00975676|537881184|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
149109688|NCT00975676|537881185|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
149109689|NCT02548078|537881186|FG000|Overall Study|Serious adverse event/Adverse event|1|||
149109690|NCT02548078|537881187|FG001|Overall Study|Serious adverse event/Adverse event|0|||
149109691|NCT02548078|537881186|FG000|Overall Study|Moved from study area|3|||
149109692|NCT02548078|537881187|FG001|Overall Study|Moved from study area|3|||
149109693|NCT02548078|537881186|FG000|Overall Study|Lost to Follow-up|1|||
149109694|NCT02548078|537881187|FG001|Overall Study|Lost to Follow-up|3|||
149109695|NCT03128671|537881188|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
149109696|NCT03128671|537881189|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
149109697|NCT03128671|537881188|FG000|Allocation|Death|1|||
149109698|NCT03128671|537881189|FG001|Allocation|Death|0|||
149109699|NCT03128671|537881188|FG000|Allocation|Withdrawal by Subject|4|||
149109700|NCT03128671|537881189|FG001|Allocation|Withdrawal by Subject|0|||
149109701|NCT03128671|537881188|FG000|Intervention|Withdrawal by Subject|11|||
149109702|NCT03128671|537881189|FG001|Intervention|Withdrawal by Subject|10|||
149109703|NCT03128671|537881188|FG000|Intervention|Palliative/hospice care initiated|9|||
149109704|NCT03128671|537881189|FG001|Intervention|Palliative/hospice care initiated|10|||
149109705|NCT03128671|537881188|FG000|Intervention|Death|13|||
149109706|NCT03128671|537881189|FG001|Intervention|Death|11|||
149109707|NCT03128671|537881188|FG000|Intervention|Interrupted by hurricane|1|||
149109708|NCT03128671|537881189|FG001|Intervention|Interrupted by hurricane|0|||
149109709|NCT03128671|537881188|FG000|Intervention|Physician Decision|2|||
149109710|NCT03128671|537881189|FG001|Intervention|Physician Decision|3|||
149109711|NCT04641962|537881191|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
149109712|NCT04641962|537881192|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
149109713|NCT04641962|537881193|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
149109714|NCT04641962|537881194|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
149109715|NCT04641962|537881195|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
149109716|NCT04641962|537881191|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
149109717|NCT04641962|537881192|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
149109718|NCT04641962|537881193|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
149109719|NCT04641962|537881194|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
149109720|NCT04641962|537881195|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
149109721|NCT04641962|537881191|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
149109722|NCT04641962|537881192|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
149109723|NCT04641962|537881193|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
149109724|NCT04641962|537881194|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
149109725|NCT04641962|537881195|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
149109726|NCT04641962|537881191|FG000|DBT Period: Up to 52 Weeks|Death|1|||
149109727|NCT04641962|537881192|FG001|DBT Period: Up to 52 Weeks|Death|0|||
149109728|NCT04641962|537881193|FG002|DBT Period: Up to 52 Weeks|Death|0|||
149109729|NCT04641962|537881194|FG003|DBT Period: Up to 52 Weeks|Death|0|||
149109730|NCT04641962|537881195|FG004|DBT Period: Up to 52 Weeks|Death|0|||
149109731|NCT04641962|537881191|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
149109732|NCT04641962|537881192|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
149109733|NCT04641962|537881193|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
149109734|NCT04641962|537881194|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
149109735|NCT04641962|537881195|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
149109736|NCT04641962|537881191|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
149109737|NCT04641962|537881192|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
149109738|NCT04641962|537881193|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
149109739|NCT04641962|537881194|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
149109740|NCT04641962|537881195|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
149109741|NCT04641962|537881191|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
149109742|NCT04641962|537881192|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
149109743|NCT04641962|537881193|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
149109744|NCT04641962|537881194|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
149109745|NCT04641962|537881195|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
149109746|NCT02592707|537881198|FG000|Overall Study|Consent Withdrawn|0|||
149109747|NCT02592707|537881199|FG001|Overall Study|Consent Withdrawn|1|||
149109748|NCT02592707|537881200|FG002|Overall Study|Consent Withdrawn|2|||
149109749|NCT02592707|537881201|FG003|Overall Study|Consent Withdrawn|0|||
149109750|NCT02592707|537881198|FG000|Overall Study|Death|1|||
149109751|NCT02592707|537881199|FG001|Overall Study|Death|0|||
149109752|NCT02592707|537881200|FG002|Overall Study|Death|0|||
149109753|NCT02592707|537881201|FG003|Overall Study|Death|0|||
149109754|NCT02592707|537881198|FG000|Overall Study|Progressive Disease|4|||
149109755|NCT02592707|537881199|FG001|Overall Study|Progressive Disease|4|||
149109756|NCT02592707|537881200|FG002|Overall Study|Progressive Disease|3|||
149109757|NCT02592707|537881201|FG003|Overall Study|Progressive Disease|3|||
149109758|NCT02592707|537881198|FG000|Overall Study|Other|0|||
149109759|NCT02592707|537881199|FG001|Overall Study|Other|0|||
149109760|NCT02592707|537881200|FG002|Overall Study|Other|1|||
149109761|NCT02592707|537881201|FG003|Overall Study|Other|2|||
149109762|NCT02592707|537881198|FG000|Overall Study|Never entered LTFU period|1|||
149109763|NCT02592707|537881199|FG001|Overall Study|Never entered LTFU period|0|||
149109764|NCT02592707|537881200|FG002|Overall Study|Never entered LTFU period|0|||
149109765|NCT02592707|537881201|FG003|Overall Study|Never entered LTFU period|2|||
149109766|NCT02998476|537881206|FG000|Overall Study|Lost to Follow-up|1|||
149109767|NCT02998476|537881207|FG001|Overall Study|Lost to Follow-up|0|||
149109768|NCT02998476|537881206|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
149109769|NCT02998476|537881207|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
149109770|NCT02998476|537881206|FG000|Overall Study|Withdrawal by Subject|1|||
149109771|NCT02998476|537881207|FG001|Overall Study|Withdrawal by Subject|2|||
149109772|NCT02998476|537881206|FG000|Overall Study|Death|45|||
149109773|NCT02998476|537881207|FG001|Overall Study|Death|2|||
149109774|NCT02998476|537881206|FG000|Overall Study|Other|6|||
149109775|NCT02998476|537881207|FG001|Overall Study|Other|1|||
149109776|NCT03832595|537881208|FG000|Overall Study|Death|142|||
149109777|NCT03832595|537881209|FG001|Overall Study|Death|130|||
149109778|NCT03832595|537881208|FG000|Overall Study|Medical management without dialysis|37|||
149109779|NCT03832595|537881209|FG001|Overall Study|Medical management without dialysis|1|||
149109780|NCT03277352|537881210|FG000|Overall Study|Study Terminated By Sponsor|2|||
149109781|NCT03277352|537881210|FG000|Overall Study|Withdrawal by Subject|4|||
149109782|NCT03277352|537881210|FG000|Overall Study|Death|4|||
149109783|NCT01920477|537883973|FG000|Overall Study|Adverse Event|0|||
149109784|NCT01920477|537883974|FG001|Overall Study|Adverse Event|1|||
149109785|NCT01920477|537883973|FG000|Overall Study|Lack of Efficacy|1|||
149109786|NCT01920477|537883974|FG001|Overall Study|Lack of Efficacy|0|||
149109787|NCT01920477|537883973|FG000|Overall Study|Study closed/terminated|14|||
149109788|NCT01920477|537883974|FG001|Overall Study|Study closed/terminated|15|||
149109789|NCT01920477|537883973|FG000|Overall Study|Withdrawal by Subject|0|||
149109790|NCT01920477|537883974|FG001|Overall Study|Withdrawal by Subject|1|||
149109791|NCT01681277|537883975|FG000|Overall Study|Adverse Event|1|||
149109792|NCT01681277|537883976|FG001|Overall Study|Adverse Event|0|||
149109793|NCT01681277|537883977|FG002|Overall Study|Adverse Event|0|||
149109794|NCT01681277|537883978|FG003|Overall Study|Adverse Event|0|||
149109795|NCT01681277|537883979|FG004|Overall Study|Adverse Event|0|||
149109796|NCT01667926|537883980|FG000|Overall Study|Withdrawal by Subject|1|||
149109797|NCT01667926|537883981|FG001|Overall Study|Withdrawal by Subject|2|||
149109798|NCT01667926|537883982|FG002|Overall Study|Withdrawal by Subject|2|||
149109799|NCT01667926|537883980|FG000|Overall Study|Physician Decision|0|||
149109800|NCT01667926|537883981|FG001|Overall Study|Physician Decision|0|||
149109801|NCT01667926|537883982|FG002|Overall Study|Physician Decision|1|||
149109802|NCT01667926|537883980|FG000|Overall Study|Time committment|0|||
149109803|NCT01667926|537883981|FG001|Overall Study|Time committment|0|||
149109804|NCT01667926|537883982|FG002|Overall Study|Time committment|2|||
149109805|NCT01667926|537883980|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
149109806|NCT01667926|537883981|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
149109807|NCT01667926|537883982|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
149109808|NCT01667926|537883980|FG000|Overall Study|Lost to Follow-up|1|||
149109809|NCT01667926|537883981|FG001|Overall Study|Lost to Follow-up|2|||
149109810|NCT01667926|537883982|FG002|Overall Study|Lost to Follow-up|1|||
149109811|NCT01667926|537883980|FG000|Overall Study|Side effects|3|||
149109812|NCT01667926|537883981|FG001|Overall Study|Side effects|0|||
149109813|NCT01667926|537883982|FG002|Overall Study|Side effects|0|||
149109814|NCT03838731|537883983|FG000|Overall Study|Pregnancy|0|||
149109815|NCT03838731|537883984|FG001|Overall Study|Pregnancy|1|||
149109816|NCT03838731|537883983|FG000|Overall Study|Withdrawal of consent|1|||
149109817|NCT03838731|537883984|FG001|Overall Study|Withdrawal of consent|0|||
149109818|NCT02271984|537883987|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109819|NCT02271984|537883988|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109820|NCT02271984|537883989|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109821|NCT02271984|537883990|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109822|NCT02271984|537883991|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109823|NCT02271984|537883992|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
149109824|NCT02271984|537883993|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109825|NCT02271984|537883994|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
149109826|NCT02271984|537883995|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109827|NCT02271984|537883996|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109828|NCT02271984|537883997|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109829|NCT02271984|537883998|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
149109830|NCT01088984|537883999|FG000|Phase 1|Death|2|||
149109831|NCT01088984|537884000|FG001|Phase 1|Death|1|||
149109832|NCT01088984|537883999|FG000|Phase 1|Disease Progression|2|||
149109833|NCT01088984|537884000|FG001|Phase 1|Disease Progression|4|||
149109834|NCT01088984|537883999|FG000|Phase 1|Other|1|||
149109835|NCT01088984|537884000|FG001|Phase 1|Other|1|||
149109836|NCT01088984|537883999|FG000|Phase 2|Death|0|||
149109837|NCT01088984|537884000|FG001|Phase 2|Death|5|||
149109838|NCT01088984|537883999|FG000|Phase 2|Withdrawal by Subject|0|||
149109839|NCT01088984|537884000|FG001|Phase 2|Withdrawal by Subject|1|||
149109840|NCT01088984|537883999|FG000|Phase 2|DIsease Progression|0|||
149109841|NCT01088984|537884000|FG001|Phase 2|DIsease Progression|25|||
149109842|NCT01088984|537883999|FG000|Phase 2|Other|0|||
149109843|NCT01088984|537884000|FG001|Phase 2|Other|1|||
149109844|NCT01182441|537884005|FG000|Overall Study|Patient Still in Follow-up|152|||
149109845|NCT01182441|537884006|FG001|Overall Study|Patient Still in Follow-up|72|||
149109846|NCT01182441|537884005|FG000|Overall Study|Death|37|||
149109847|NCT01182441|537884006|FG001|Overall Study|Death|25|||
149109848|NCT01182441|537884005|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
149109849|NCT01182441|537884006|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
149109850|NCT01182441|537884005|FG000|Overall Study|Lost to Follow-up|5|||
149109851|NCT01182441|537884006|FG001|Overall Study|Lost to Follow-up|8|||
149109852|NCT01182441|537884005|FG000|Overall Study|Withdrawal by Subject|6|||
149109853|NCT01182441|537884006|FG001|Overall Study|Withdrawal by Subject|13|||
149109854|NCT01182441|537884005|FG000|Overall Study|Implant Not Attempted|4|||
149109855|NCT01182441|537884006|FG001|Overall Study|Implant Not Attempted|0|||
149109856|NCT01182441|537884005|FG000|Overall Study|Adverse Event|2|||
149109857|NCT01182441|537884006|FG001|Overall Study|Adverse Event|0|||
149109858|NCT01182441|537884005|FG000|Overall Study|Physician Decision|1|||
149109859|NCT01182441|537884006|FG001|Overall Study|Physician Decision|1|||
149109860|NCT04079868|537884007|FG000|Overall Study|Lost to Follow-up|100|||
149109861|NCT04079868|537884008|FG001|Overall Study|Lost to Follow-up|200|||
149109862|NCT04079868|537884007|FG000|Overall Study|Physician Decision|100|||
149109863|NCT04079868|537884008|FG001|Overall Study|Physician Decision|0|||
149109864|NCT05620108|537884009|FG000|Overall Study|Physician Decision|1|||
149109865|NCT05620108|537884010|FG001|Overall Study|Physician Decision|2|||
149109866|NCT02038842|537884011|FG000|Overall Study|Withdrawal by Subject|2|||
149109867|NCT02038842|537884012|FG001|Overall Study|Withdrawal by Subject|2|||
149109868|NCT02038842|537884013|FG002|Overall Study|Withdrawal by Subject|0|||
149109869|NCT02038842|537884014|FG003|Overall Study|Withdrawal by Subject|0|||
149109870|NCT02038842|537884011|FG000|Overall Study|Participant decision|0|||
149109871|NCT02038842|537884012|FG001|Overall Study|Participant decision|0|||
149109872|NCT02038842|537884013|FG002|Overall Study|Participant decision|2|||
149109873|NCT02038842|537884014|FG003|Overall Study|Participant decision|1|||
149109874|NCT02038842|537884011|FG000|Overall Study|Adverse Event|0|||
149109875|NCT02038842|537884012|FG001|Overall Study|Adverse Event|0|||
149109876|NCT02038842|537884013|FG002|Overall Study|Adverse Event|3|||
149109877|NCT02038842|537884014|FG003|Overall Study|Adverse Event|1|||
149109878|NCT02038842|537884011|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
149109879|NCT02038842|537884012|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
149109880|NCT02038842|537884013|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
149109881|NCT02038842|537884014|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
149109882|NCT01757197|537884017|FG000|Overall Study|Death|2|||
149109883|NCT05332912|537884018|FG000|Overall Study|Withdrawal by Subject|0|||
149109884|NCT05332912|537884019|FG001|Overall Study|Withdrawal by Subject|1|||
149109885|NCT05332912|537884020|FG002|Overall Study|Withdrawal by Subject|2|||
149109886|NCT05332912|537884021|FG003|Overall Study|Withdrawal by Subject|0|||
149109887|NCT05332912|537884018|FG000|Overall Study|Lost to Follow-up|0|||
149109888|NCT05332912|537884019|FG001|Overall Study|Lost to Follow-up|0|||
149109889|NCT05332912|537884020|FG002|Overall Study|Lost to Follow-up|1|||
149109890|NCT05332912|537884021|FG003|Overall Study|Lost to Follow-up|0|||
149109891|NCT01174446|537884022|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
149109892|NCT01174446|537884023|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
149109893|NCT01174446|537884024|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
149109894|NCT01174446|537884025|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
149109895|NCT01174446|537884022|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
149109896|NCT01174446|537884023|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
149109897|NCT01174446|537884024|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
149109898|NCT01174446|537884025|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
149109899|NCT01174446|537884022|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
149109900|NCT01174446|537884023|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
149109901|NCT01174446|537884024|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
149109902|NCT01174446|537884025|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
149109903|NCT01174446|537884022|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
149109904|NCT01174446|537884023|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
149109905|NCT01174446|537884024|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
149109906|NCT01174446|537884025|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
149109907|NCT05000216|537884027|FG000|Stage 1|Lost to Follow-up|0|||
149109908|NCT05000216|537884028|FG001|Stage 1|Lost to Follow-up|0|||
149109909|NCT05000216|537884029|FG002|Stage 1|Lost to Follow-up|0|||
149109910|NCT05000216|537884030|FG003|Stage 1|Lost to Follow-up|0|||
149109911|NCT05000216|537884031|FG004|Stage 1|Lost to Follow-up|0|||
149109912|NCT05000216|537884032|FG005|Stage 1|Lost to Follow-up|0|||
149109913|NCT05000216|537884033|FG006|Stage 1|Lost to Follow-up|1|||
149109914|NCT05000216|537884034|FG007|Stage 1|Lost to Follow-up|1|||
149109915|NCT05000216|537884035|FG008|Stage 1|Lost to Follow-up|0|||
149109916|NCT05000216|537884036|FG009|Stage 1|Lost to Follow-up|2|||
149109917|NCT05000216|537884037|FG010|Stage 1|Lost to Follow-up|3|||
149109918|NCT05000216|537884038|FG011|Stage 1|Lost to Follow-up|0|||
149109919|NCT05000216|537884039|FG012|Stage 1|Lost to Follow-up|0|||
149109920|NCT05000216|537884040|FG013|Stage 1|Lost to Follow-up|0|||
149109921|NCT05000216|537884041|FG014|Stage 1|Lost to Follow-up|0|||
149109922|NCT05000216|537884042|FG015|Stage 1|Lost to Follow-up|0|||
149109923|NCT05000216|537884043|FG016|Stage 1|Lost to Follow-up|0|||
149109924|NCT05000216|537884044|FG017|Stage 1|Lost to Follow-up|0|||
149109925|NCT05000216|537884045|FG018|Stage 1|Lost to Follow-up|0|||
149109926|NCT05000216|537884046|FG019|Stage 1|Lost to Follow-up|0|||
149109927|NCT05000216|537884047|FG020|Stage 1|Lost to Follow-up|0|||
149109928|NCT05000216|537884048|FG021|Stage 1|Lost to Follow-up|0|||
149109929|NCT05000216|537884027|FG000|Stage 1|Physician Decision|0|||
149109930|NCT05000216|537884028|FG001|Stage 1|Physician Decision|0|||
149109931|NCT05000216|537884029|FG002|Stage 1|Physician Decision|0|||
149109932|NCT05000216|537884030|FG003|Stage 1|Physician Decision|0|||
149109933|NCT05000216|537884031|FG004|Stage 1|Physician Decision|0|||
149109934|NCT05000216|537884032|FG005|Stage 1|Physician Decision|0|||
149109935|NCT05000216|537884033|FG006|Stage 1|Physician Decision|0|||
149109936|NCT05000216|537884034|FG007|Stage 1|Physician Decision|1|||
149109937|NCT05000216|537884035|FG008|Stage 1|Physician Decision|1|||
149109938|NCT05000216|537884036|FG009|Stage 1|Physician Decision|0|||
149109939|NCT05000216|537884037|FG010|Stage 1|Physician Decision|0|||
149109940|NCT05000216|537884038|FG011|Stage 1|Physician Decision|0|||
149109941|NCT05000216|537884039|FG012|Stage 1|Physician Decision|0|||
149109942|NCT05000216|537884040|FG013|Stage 1|Physician Decision|0|||
149109943|NCT05000216|537884041|FG014|Stage 1|Physician Decision|0|||
149109944|NCT05000216|537884042|FG015|Stage 1|Physician Decision|0|||
149109945|NCT05000216|537884043|FG016|Stage 1|Physician Decision|0|||
149109946|NCT05000216|537884044|FG017|Stage 1|Physician Decision|0|||
149109947|NCT05000216|537884045|FG018|Stage 1|Physician Decision|0|||
149109948|NCT05000216|537884046|FG019|Stage 1|Physician Decision|0|||
149109949|NCT05000216|537884047|FG020|Stage 1|Physician Decision|0|||
149109950|NCT05000216|537884048|FG021|Stage 1|Physician Decision|0|||
149109951|NCT05000216|537884027|FG000|Stage 1|Withdrawal by Subject|0|||
149109952|NCT05000216|537884028|FG001|Stage 1|Withdrawal by Subject|1|||
149109953|NCT05000216|537884029|FG002|Stage 1|Withdrawal by Subject|0|||
149109954|NCT05000216|537884030|FG003|Stage 1|Withdrawal by Subject|0|||
149109955|NCT05000216|537884031|FG004|Stage 1|Withdrawal by Subject|0|||
149109956|NCT05000216|537884032|FG005|Stage 1|Withdrawal by Subject|0|||
149109957|NCT05000216|537884033|FG006|Stage 1|Withdrawal by Subject|0|||
149109958|NCT05000216|537884034|FG007|Stage 1|Withdrawal by Subject|0|||
149109959|NCT05000216|537884035|FG008|Stage 1|Withdrawal by Subject|0|||
149109960|NCT05000216|537884036|FG009|Stage 1|Withdrawal by Subject|3|||
149109961|NCT05000216|537884037|FG010|Stage 1|Withdrawal by Subject|10|||
149109962|NCT05000216|537884038|FG011|Stage 1|Withdrawal by Subject|0|||
149109963|NCT05000216|537884039|FG012|Stage 1|Withdrawal by Subject|0|||
149109964|NCT05000216|537884040|FG013|Stage 1|Withdrawal by Subject|0|||
149109965|NCT05000216|537884041|FG014|Stage 1|Withdrawal by Subject|0|||
149109966|NCT05000216|537884042|FG015|Stage 1|Withdrawal by Subject|0|||
149109967|NCT05000216|537884043|FG016|Stage 1|Withdrawal by Subject|0|||
149109968|NCT05000216|537884044|FG017|Stage 1|Withdrawal by Subject|0|||
149109969|NCT05000216|537884045|FG018|Stage 1|Withdrawal by Subject|0|||
149109970|NCT05000216|537884046|FG019|Stage 1|Withdrawal by Subject|0|||
149109971|NCT05000216|537884047|FG020|Stage 1|Withdrawal by Subject|0|||
149109972|NCT05000216|537884048|FG021|Stage 1|Withdrawal by Subject|0|||
149109973|NCT05000216|537884027|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
149109974|NCT05000216|537884028|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
149109975|NCT05000216|537884029|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
149109976|NCT05000216|537884030|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
149109977|NCT05000216|537884031|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
149109978|NCT05000216|537884032|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
149109979|NCT05000216|537884033|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
149109980|NCT05000216|537884034|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
149109981|NCT05000216|537884035|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
149109982|NCT05000216|537884036|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
149109983|NCT05000216|537884037|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
149109984|NCT05000216|537884038|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
149109985|NCT05000216|537884039|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
149109986|NCT05000216|537884040|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
149109987|NCT05000216|537884041|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
149109988|NCT05000216|537884042|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
149109989|NCT05000216|537884043|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
149109990|NCT05000216|537884044|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
149109991|NCT05000216|537884045|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
149109992|NCT05000216|537884046|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
149109993|NCT05000216|537884047|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
149109994|NCT05000216|537884048|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
149109995|NCT05000216|537884027|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149109996|NCT05000216|537884028|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149109997|NCT05000216|537884029|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149109998|NCT05000216|537884030|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149109999|NCT05000216|537884031|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110000|NCT05000216|537884032|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110001|NCT05000216|537884033|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110002|NCT05000216|537884034|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110003|NCT05000216|537884035|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
149110004|NCT05000216|537884036|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110005|NCT05000216|537884037|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110006|NCT05000216|537884038|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110007|NCT05000216|537884039|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110008|NCT05000216|537884040|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110009|NCT05000216|537884041|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110010|NCT05000216|537884042|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110011|NCT05000216|537884043|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110012|NCT05000216|537884044|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110013|NCT05000216|537884045|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110014|NCT05000216|537884046|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110015|NCT05000216|537884047|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110016|NCT05000216|537884048|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
149110017|NCT05000216|537884027|FG000|Stage 1|Other|0|||
149110018|NCT05000216|537884028|FG001|Stage 1|Other|0|||
149110019|NCT05000216|537884029|FG002|Stage 1|Other|0|||
149110020|NCT05000216|537884030|FG003|Stage 1|Other|0|||
149110021|NCT05000216|537884031|FG004|Stage 1|Other|1|||
149110022|NCT05000216|537884032|FG005|Stage 1|Other|0|||
149110023|NCT05000216|537884033|FG006|Stage 1|Other|0|||
149110024|NCT05000216|537884034|FG007|Stage 1|Other|2|||
149110025|NCT05000216|537884035|FG008|Stage 1|Other|0|||
149110026|NCT05000216|537884036|FG009|Stage 1|Other|0|||
149110027|NCT05000216|537884037|FG010|Stage 1|Other|1|||
149110028|NCT05000216|537884038|FG011|Stage 1|Other|1|||
149110029|NCT05000216|537884039|FG012|Stage 1|Other|0|||
149110030|NCT05000216|537884040|FG013|Stage 1|Other|0|||
149110031|NCT05000216|537884041|FG014|Stage 1|Other|0|||
149110032|NCT05000216|537884042|FG015|Stage 1|Other|0|||
149110033|NCT05000216|537884043|FG016|Stage 1|Other|0|||
149110034|NCT05000216|537884044|FG017|Stage 1|Other|0|||
149110035|NCT05000216|537884045|FG018|Stage 1|Other|0|||
149110036|NCT05000216|537884046|FG019|Stage 1|Other|0|||
149110037|NCT05000216|537884047|FG020|Stage 1|Other|0|||
149110038|NCT05000216|537884048|FG021|Stage 1|Other|0|||
149110039|NCT05000216|537884027|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
149110040|NCT05000216|537884028|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
149110041|NCT05000216|537884029|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
149110042|NCT05000216|537884030|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
149110043|NCT05000216|537884031|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
149110044|NCT05000216|537884032|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
149110045|NCT05000216|537884033|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
149110046|NCT05000216|537884034|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
149110047|NCT05000216|537884035|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
149110048|NCT05000216|537884036|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
149110049|NCT05000216|537884037|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
149110050|NCT05000216|537884038|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
149110051|NCT05000216|537884039|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
149110052|NCT05000216|537884040|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
149110053|NCT05000216|537884041|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
149110054|NCT05000216|537884042|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
149110055|NCT05000216|537884043|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
149110056|NCT05000216|537884044|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
149110057|NCT05000216|537884045|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
149110058|NCT05000216|537884046|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
149110059|NCT05000216|537884047|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
149110060|NCT05000216|537884048|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
149110061|NCT05000216|537884027|FG000|Stage 2|Lost to Follow-up|0|||
149110062|NCT05000216|537884028|FG001|Stage 2|Lost to Follow-up|0|||
149110063|NCT05000216|537884029|FG002|Stage 2|Lost to Follow-up|0|||
149110064|NCT05000216|537884030|FG003|Stage 2|Lost to Follow-up|0|||
149110065|NCT05000216|537884031|FG004|Stage 2|Lost to Follow-up|0|||
149110066|NCT05000216|537884032|FG005|Stage 2|Lost to Follow-up|0|||
149110067|NCT05000216|537884033|FG006|Stage 2|Lost to Follow-up|0|||
149110068|NCT05000216|537884034|FG007|Stage 2|Lost to Follow-up|0|||
149110069|NCT05000216|537884035|FG008|Stage 2|Lost to Follow-up|0|||
149110070|NCT05000216|537884036|FG009|Stage 2|Lost to Follow-up|0|||
149110071|NCT05000216|537884037|FG010|Stage 2|Lost to Follow-up|0|||
149110072|NCT05000216|537884038|FG011|Stage 2|Lost to Follow-up|0|||
149110073|NCT05000216|537884039|FG012|Stage 2|Lost to Follow-up|0|||
149110074|NCT05000216|537884040|FG013|Stage 2|Lost to Follow-up|0|||
149110075|NCT05000216|537884041|FG014|Stage 2|Lost to Follow-up|0|||
149110076|NCT05000216|537884042|FG015|Stage 2|Lost to Follow-up|0|||
149110077|NCT05000216|537884043|FG016|Stage 2|Lost to Follow-up|4|||
149110078|NCT05000216|537884044|FG017|Stage 2|Lost to Follow-up|0|||
149110079|NCT05000216|537884045|FG018|Stage 2|Lost to Follow-up|0|||
149110080|NCT05000216|537884046|FG019|Stage 2|Lost to Follow-up|0|||
149110081|NCT05000216|537884047|FG020|Stage 2|Lost to Follow-up|0|||
149110082|NCT05000216|537884048|FG021|Stage 2|Lost to Follow-up|0|||
149110083|NCT05000216|537884027|FG000|Stage 2|Physician Decision|0|||
149110084|NCT05000216|537884028|FG001|Stage 2|Physician Decision|0|||
149110085|NCT05000216|537884029|FG002|Stage 2|Physician Decision|0|||
149110086|NCT05000216|537884030|FG003|Stage 2|Physician Decision|0|||
149110087|NCT05000216|537884031|FG004|Stage 2|Physician Decision|0|||
149110088|NCT05000216|537884032|FG005|Stage 2|Physician Decision|0|||
149110089|NCT05000216|537884033|FG006|Stage 2|Physician Decision|0|||
149110090|NCT05000216|537884034|FG007|Stage 2|Physician Decision|0|||
149110091|NCT05000216|537884035|FG008|Stage 2|Physician Decision|0|||
149110092|NCT05000216|537884036|FG009|Stage 2|Physician Decision|0|||
149110093|NCT05000216|537884037|FG010|Stage 2|Physician Decision|0|||
149110094|NCT05000216|537884038|FG011|Stage 2|Physician Decision|0|||
149110095|NCT05000216|537884039|FG012|Stage 2|Physician Decision|1|||
149110096|NCT05000216|537884040|FG013|Stage 2|Physician Decision|0|||
149110097|NCT05000216|537884041|FG014|Stage 2|Physician Decision|0|||
149110098|NCT05000216|537884042|FG015|Stage 2|Physician Decision|0|||
149110099|NCT05000216|537884043|FG016|Stage 2|Physician Decision|0|||
149110100|NCT05000216|537884044|FG017|Stage 2|Physician Decision|0|||
149110101|NCT05000216|537884045|FG018|Stage 2|Physician Decision|0|||
149110102|NCT05000216|537884046|FG019|Stage 2|Physician Decision|0|||
149110103|NCT05000216|537884047|FG020|Stage 2|Physician Decision|0|||
149110104|NCT05000216|537884048|FG021|Stage 2|Physician Decision|0|||
149110105|NCT05000216|537884027|FG000|Stage 2|Withdrawal by Subject|0|||
149110106|NCT05000216|537884028|FG001|Stage 2|Withdrawal by Subject|0|||
149110107|NCT05000216|537884029|FG002|Stage 2|Withdrawal by Subject|0|||
149110108|NCT05000216|537884030|FG003|Stage 2|Withdrawal by Subject|0|||
149110109|NCT05000216|537884031|FG004|Stage 2|Withdrawal by Subject|0|||
149110110|NCT05000216|537884032|FG005|Stage 2|Withdrawal by Subject|0|||
149110111|NCT05000216|537884033|FG006|Stage 2|Withdrawal by Subject|0|||
149110112|NCT05000216|537884034|FG007|Stage 2|Withdrawal by Subject|0|||
149110113|NCT05000216|537884035|FG008|Stage 2|Withdrawal by Subject|0|||
149110114|NCT05000216|537884036|FG009|Stage 2|Withdrawal by Subject|0|||
149110115|NCT05000216|537884037|FG010|Stage 2|Withdrawal by Subject|0|||
149110116|NCT05000216|537884038|FG011|Stage 2|Withdrawal by Subject|0|||
149110117|NCT05000216|537884039|FG012|Stage 2|Withdrawal by Subject|0|||
149110118|NCT05000216|537884040|FG013|Stage 2|Withdrawal by Subject|0|||
149110119|NCT05000216|537884041|FG014|Stage 2|Withdrawal by Subject|2|||
149110120|NCT05000216|537884042|FG015|Stage 2|Withdrawal by Subject|0|||
149110121|NCT05000216|537884043|FG016|Stage 2|Withdrawal by Subject|9|||
149110122|NCT05000216|537884044|FG017|Stage 2|Withdrawal by Subject|0|||
149110123|NCT05000216|537884045|FG018|Stage 2|Withdrawal by Subject|0|||
149110124|NCT05000216|537884046|FG019|Stage 2|Withdrawal by Subject|0|||
149110125|NCT05000216|537884047|FG020|Stage 2|Withdrawal by Subject|0|||
149110126|NCT05000216|537884048|FG021|Stage 2|Withdrawal by Subject|0|||
149110127|NCT05000216|537884027|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
149110128|NCT05000216|537884028|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
149110129|NCT05000216|537884029|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
149110130|NCT05000216|537884030|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
149110131|NCT05000216|537884031|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
149110132|NCT05000216|537884032|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
149110133|NCT05000216|537884033|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
149110134|NCT05000216|537884034|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
149110135|NCT05000216|537884035|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
149110136|NCT05000216|537884036|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
149110137|NCT05000216|537884037|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
149110138|NCT05000216|537884038|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
149110139|NCT05000216|537884039|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
149110140|NCT05000216|537884040|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
149110141|NCT05000216|537884041|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
149110142|NCT05000216|537884042|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
149110143|NCT05000216|537884043|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
149110144|NCT05000216|537884044|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
149110145|NCT05000216|537884045|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
149110146|NCT05000216|537884046|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
149110147|NCT05000216|537884047|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
149110148|NCT05000216|537884048|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
149110149|NCT05000216|537884027|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110150|NCT05000216|537884028|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110151|NCT05000216|537884029|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110152|NCT05000216|537884030|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110153|NCT05000216|537884031|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110154|NCT05000216|537884032|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110155|NCT05000216|537884033|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110156|NCT05000216|537884034|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110157|NCT05000216|537884035|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110158|NCT05000216|537884036|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110159|NCT05000216|537884037|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110160|NCT05000216|537884038|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110161|NCT05000216|537884039|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110162|NCT05000216|537884040|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110163|NCT05000216|537884041|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
149110164|NCT05000216|537884042|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110165|NCT05000216|537884043|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
149110166|NCT05000216|537884044|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110167|NCT05000216|537884045|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110168|NCT05000216|537884046|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110169|NCT05000216|537884047|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110170|NCT05000216|537884048|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
149110171|NCT05000216|537884027|FG000|Stage 2|Other reason|0|||
149110172|NCT05000216|537884028|FG001|Stage 2|Other reason|0|||
149110173|NCT05000216|537884029|FG002|Stage 2|Other reason|0|||
149110174|NCT05000216|537884030|FG003|Stage 2|Other reason|0|||
149110175|NCT05000216|537884031|FG004|Stage 2|Other reason|0|||
149110176|NCT05000216|537884032|FG005|Stage 2|Other reason|0|||
149110177|NCT05000216|537884033|FG006|Stage 2|Other reason|0|||
149110178|NCT05000216|537884034|FG007|Stage 2|Other reason|0|||
149110179|NCT05000216|537884035|FG008|Stage 2|Other reason|0|||
149110180|NCT05000216|537884036|FG009|Stage 2|Other reason|0|||
149110181|NCT05000216|537884037|FG010|Stage 2|Other reason|0|||
149110182|NCT05000216|537884038|FG011|Stage 2|Other reason|0|||
149110183|NCT05000216|537884039|FG012|Stage 2|Other reason|0|||
149110184|NCT05000216|537884040|FG013|Stage 2|Other reason|0|||
149110185|NCT05000216|537884041|FG014|Stage 2|Other reason|0|||
149110186|NCT05000216|537884042|FG015|Stage 2|Other reason|0|||
149110187|NCT05000216|537884043|FG016|Stage 2|Other reason|1|||
149110188|NCT05000216|537884044|FG017|Stage 2|Other reason|0|||
149110189|NCT05000216|537884045|FG018|Stage 2|Other reason|0|||
149110190|NCT05000216|537884046|FG019|Stage 2|Other reason|0|||
149110191|NCT05000216|537884047|FG020|Stage 2|Other reason|0|||
149110192|NCT05000216|537884048|FG021|Stage 2|Other reason|0|||
149110193|NCT05000216|537884027|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
149110194|NCT05000216|537884028|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
149110195|NCT05000216|537884029|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
149110196|NCT05000216|537884030|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
149110197|NCT05000216|537884031|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
149110198|NCT05000216|537884032|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
149110199|NCT05000216|537884033|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
149110200|NCT05000216|537884034|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
149110201|NCT05000216|537884035|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
149110202|NCT05000216|537884036|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
149110203|NCT05000216|537884037|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
149110204|NCT05000216|537884038|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
149110205|NCT05000216|537884039|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
149110206|NCT05000216|537884040|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
149110207|NCT05000216|537884041|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
149110208|NCT05000216|537884042|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
149110209|NCT05000216|537884043|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
149110210|NCT05000216|537884044|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
149110211|NCT05000216|537884045|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
149110212|NCT05000216|537884046|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
149110213|NCT05000216|537884047|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
149110214|NCT05000216|537884048|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
149110215|NCT05000216|537884027|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110216|NCT05000216|537884028|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110217|NCT05000216|537884029|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110218|NCT05000216|537884030|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110219|NCT05000216|537884031|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110220|NCT05000216|537884032|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110221|NCT05000216|537884033|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110222|NCT05000216|537884034|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110223|NCT05000216|537884035|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110224|NCT05000216|537884036|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110225|NCT05000216|537884037|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110226|NCT05000216|537884038|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110227|NCT05000216|537884039|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110228|NCT05000216|537884040|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110229|NCT05000216|537884041|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110230|NCT05000216|537884042|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
149110231|NCT05000216|537884043|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110232|NCT05000216|537884044|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110233|NCT05000216|537884045|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110234|NCT05000216|537884046|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110235|NCT05000216|537884047|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110236|NCT05000216|537884048|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
149110237|NCT05000216|537884027|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110238|NCT05000216|537884028|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110239|NCT05000216|537884029|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110240|NCT05000216|537884030|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110241|NCT05000216|537884031|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110242|NCT05000216|537884032|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110243|NCT05000216|537884033|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110244|NCT05000216|537884034|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110245|NCT05000216|537884035|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110246|NCT05000216|537884036|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110247|NCT05000216|537884037|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110248|NCT05000216|537884038|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110249|NCT05000216|537884039|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110250|NCT05000216|537884040|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
149110251|NCT05000216|537884041|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110252|NCT05000216|537884042|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
149110253|NCT05000216|537884043|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110254|NCT05000216|537884044|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110255|NCT05000216|537884045|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
149110256|NCT05000216|537884046|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110257|NCT05000216|537884047|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110258|NCT05000216|537884048|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
149110259|NCT04076943|537884049|FG000|Overall Study|Withdrawal by Subject|12|||
149110260|NCT04076943|537884049|FG000|Overall Study|Adverse Event|1|||
149110261|NCT04076943|537884049|FG000|Overall Study|Progressive Disease|2|||
149110262|NCT04076943|537884049|FG000|Overall Study|Death|13|||
149110263|NCT04076943|537884049|FG000|Overall Study|Other than specified|6|||
149110264|NCT02224703|537884052|FG000|Overall Study|Adverse Event|0|||
149110265|NCT02224703|537884053|FG001|Overall Study|Adverse Event|5|||
149110266|NCT02224703|537884054|FG002|Overall Study|Adverse Event|0|||
149110267|NCT02224703|537884052|FG000|Overall Study|Withdrawn by investigator|1|||
149110268|NCT02224703|537884053|FG001|Overall Study|Withdrawn by investigator|0|||
149110269|NCT02224703|537884054|FG002|Overall Study|Withdrawn by investigator|0|||
149110270|NCT02224703|537884052|FG000|Overall Study|Advised by medical monitor|1|||
149110271|NCT02224703|537884053|FG001|Overall Study|Advised by medical monitor|0|||
149110272|NCT02224703|537884054|FG002|Overall Study|Advised by medical monitor|0|||
149110273|NCT02224703|537884052|FG000|Overall Study|Withdrawn by parent/guardian|0|||
149110274|NCT02224703|537884053|FG001|Overall Study|Withdrawn by parent/guardian|1|||
149110275|NCT02224703|537884054|FG002|Overall Study|Withdrawn by parent/guardian|0|||
149110276|NCT02224703|537884052|FG000|Overall Study|Lack of Efficacy|1|||
149110277|NCT02224703|537884053|FG001|Overall Study|Lack of Efficacy|0|||
149110278|NCT02224703|537884054|FG002|Overall Study|Lack of Efficacy|0|||
149110279|NCT00863681|537884055|FG000|Overall Study|Other|2|||
149110280|NCT00863681|537884056|FG001|Overall Study|Other|0|||
149110281|NCT00863681|537884057|FG002|Overall Study|Other|0|||
149110282|NCT00863681|537884055|FG000|Overall Study|Missing|1|||
149110283|NCT00863681|537884056|FG001|Overall Study|Missing|0|||
149110284|NCT00863681|537884057|FG002|Overall Study|Missing|0|||
149110285|NCT00863681|537884055|FG000|Overall Study|Death|40|||
149110286|NCT00863681|537884056|FG001|Overall Study|Death|23|||
149110287|NCT00863681|537884057|FG002|Overall Study|Death|6|||
149110288|NCT00863681|537884055|FG000|Overall Study|Withdrawal by Subject|12|||
149110289|NCT00863681|537884056|FG001|Overall Study|Withdrawal by Subject|5|||
149110290|NCT00863681|537884057|FG002|Overall Study|Withdrawal by Subject|2|||
149110291|NCT00863681|537884055|FG000|Overall Study|Protocol Violation|2|||
149110292|NCT00863681|537884056|FG001|Overall Study|Protocol Violation|0|||
149110293|NCT00863681|537884057|FG002|Overall Study|Protocol Violation|0|||
149110294|NCT00863681|537884055|FG000|Overall Study|Lost to Follow-up|3|||
149110295|NCT00863681|537884056|FG001|Overall Study|Lost to Follow-up|0|||
149110296|NCT00863681|537884057|FG002|Overall Study|Lost to Follow-up|3|||
149110297|NCT00863681|537884055|FG000|Overall Study|Adverse Event|28|||
149110298|NCT00863681|537884056|FG001|Overall Study|Adverse Event|10|||
149110299|NCT00863681|537884057|FG002|Overall Study|Adverse Event|6|||
149110300|NCT00863681|537884055|FG000|Overall Study|Lack of Efficacy|2|||
149110301|NCT00863681|537884056|FG001|Overall Study|Lack of Efficacy|2|||
149110302|NCT00863681|537884057|FG002|Overall Study|Lack of Efficacy|1|||
149110303|NCT00863681|537884055|FG000|Overall Study|Non-compliance with study drug|1|||
149110304|NCT00863681|537884056|FG001|Overall Study|Non-compliance with study drug|3|||
149110305|NCT00863681|537884057|FG002|Overall Study|Non-compliance with study drug|0|||
149110306|NCT03596762|537884058|FG000|Overall Study|Protocol Violation|0|||
149110307|NCT03596762|537884059|FG001|Overall Study|Protocol Violation|0|||
149110308|NCT03596762|537884060|FG002|Overall Study|Protocol Violation|0|||
149110309|NCT03596762|537884061|FG003|Overall Study|Protocol Violation|0|||
149110310|NCT03596762|537884062|FG004|Overall Study|Protocol Violation|1|||
149110311|NCT03596762|537884058|FG000|Overall Study|Adverse Event|2|||
149110312|NCT03596762|537884059|FG001|Overall Study|Adverse Event|0|||
149110313|NCT03596762|537884060|FG002|Overall Study|Adverse Event|1|||
149110314|NCT03596762|537884061|FG003|Overall Study|Adverse Event|0|||
149110315|NCT03596762|537884062|FG004|Overall Study|Adverse Event|5|||
149110316|NCT03596762|537884058|FG000|Overall Study|Withdrawal by Subject|2|||
149110317|NCT03596762|537884059|FG001|Overall Study|Withdrawal by Subject|1|||
149110318|NCT03596762|537884060|FG002|Overall Study|Withdrawal by Subject|0|||
149110319|NCT03596762|537884061|FG003|Overall Study|Withdrawal by Subject|1|||
149110320|NCT03596762|537884062|FG004|Overall Study|Withdrawal by Subject|1|||
149110321|NCT03842228|537884063|FG000|Overall Study|Adverse Event|1|||
149110322|NCT03842228|537884064|FG001|Overall Study|Adverse Event|1|||
149110323|NCT03842228|537884065|FG002|Overall Study|Adverse Event|1|||
149110324|NCT03842228|537884066|FG003|Overall Study|Adverse Event|0|||
149110325|NCT03842228|537884067|FG004|Overall Study|Adverse Event|0|||
149110326|NCT03842228|537884068|FG005|Overall Study|Adverse Event|0|||
149110327|NCT03842228|537884069|FG006|Overall Study|Adverse Event|0|||
149110328|NCT03842228|537884063|FG000|Overall Study|Death|0|||
149110329|NCT03842228|537884064|FG001|Overall Study|Death|1|||
149110330|NCT03842228|537884065|FG002|Overall Study|Death|0|||
149110331|NCT03842228|537884066|FG003|Overall Study|Death|0|||
149110332|NCT03842228|537884067|FG004|Overall Study|Death|0|||
149110333|NCT03842228|537884068|FG005|Overall Study|Death|0|||
149110334|NCT03842228|537884069|FG006|Overall Study|Death|0|||
149110335|NCT03842228|537884063|FG000|Overall Study|Withdrawal by Subject|0|||
149110336|NCT03842228|537884064|FG001|Overall Study|Withdrawal by Subject|0|||
149110337|NCT03842228|537884065|FG002|Overall Study|Withdrawal by Subject|2|||
149110338|NCT03842228|537884066|FG003|Overall Study|Withdrawal by Subject|1|||
149110339|NCT03842228|537884067|FG004|Overall Study|Withdrawal by Subject|0|||
149110340|NCT03842228|537884068|FG005|Overall Study|Withdrawal by Subject|0|||
149110341|NCT03842228|537884069|FG006|Overall Study|Withdrawal by Subject|2|||
149110342|NCT03842228|537884063|FG000|Overall Study|Progression|8|||
149110343|NCT03842228|537884064|FG001|Overall Study|Progression|1|||
149110344|NCT03842228|537884065|FG002|Overall Study|Progression|7|||
149110345|NCT03842228|537884066|FG003|Overall Study|Progression|5|||
149110346|NCT03842228|537884067|FG004|Overall Study|Progression|4|||
149110347|NCT03842228|537884068|FG005|Overall Study|Progression|2|||
149110348|NCT03842228|537884069|FG006|Overall Study|Progression|3|||
149110349|NCT02195479|537884070|FG000|Overall Study|Lost to Follow-up|18|||
149110350|NCT02195479|537884071|FG001|Overall Study|Lost to Follow-up|15|||
149110351|NCT02195479|537884070|FG000|Overall Study|Death|217|||
149110352|NCT02195479|537884071|FG001|Overall Study|Death|171|||
149110353|NCT02195479|537884070|FG000|Overall Study|Physician Decision|1|||
149110354|NCT02195479|537884071|FG001|Overall Study|Physician Decision|0|||
149110355|NCT02195479|537884070|FG000|Overall Study|Withdrawal by Subject|30|||
149110356|NCT02195479|537884071|FG001|Overall Study|Withdrawal by Subject|30|||
149110357|NCT02195479|537884070|FG000|Overall Study|Other|3|||
149110358|NCT02195479|537884071|FG001|Overall Study|Other|4|||
149110359|NCT02195479|537884070|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
149110360|NCT02195479|537884071|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
149110361|NCT01263509|537884072|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
149110362|NCT01263509|537884073|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
149110363|NCT01263509|537884074|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
149110364|NCT01263509|537884075|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
149110365|NCT01263509|537884072|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
149110366|NCT01263509|537884073|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
149110367|NCT01263509|537884074|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
149110368|NCT01263509|537884075|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
149110369|NCT01263509|537884072|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
149110370|NCT01263509|537884073|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
149110371|NCT01263509|537884074|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149110372|NCT01263509|537884075|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
149110373|NCT01263509|537884072|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
149110374|NCT01263509|537884073|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
149110375|NCT01263509|537884074|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149110376|NCT01263509|537884075|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
149110377|NCT01263509|537884072|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
149110378|NCT01263509|537884073|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
149110379|NCT01263509|537884074|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
149110380|NCT01263509|537884075|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
149110381|NCT05071053|537884076|FG000|Overall Study|Progressive disease|30|||
149110382|NCT05071053|537884076|FG000|Overall Study|Adverse Event|5|||
149110383|NCT01602510|537884084|FG000|Open Label Phase|Adverse Event|46|||
149110384|NCT01602510|537884085|FG001|Open Label Phase|Adverse Event|0|||
149110385|NCT01602510|537884086|FG002|Open Label Phase|Adverse Event|0|||
149110386|NCT01602510|537884084|FG000|Open Label Phase|Lack of Efficacy|22|||
149110387|NCT01602510|537884085|FG001|Open Label Phase|Lack of Efficacy|0|||
149110388|NCT01602510|537884086|FG002|Open Label Phase|Lack of Efficacy|0|||
149110389|NCT01602510|537884084|FG000|Open Label Phase|Protocol Violation|15|||
149110390|NCT01602510|537884085|FG001|Open Label Phase|Protocol Violation|0|||
149110391|NCT01602510|537884086|FG002|Open Label Phase|Protocol Violation|0|||
149110392|NCT01602510|537884084|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
149110393|NCT01602510|537884085|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
149110394|NCT01602510|537884086|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
149110395|NCT01602510|537884084|FG000|Open Label Phase|Lost to Follow-up|22|||
149110396|NCT01602510|537884085|FG001|Open Label Phase|Lost to Follow-up|0|||
149110397|NCT01602510|537884086|FG002|Open Label Phase|Lost to Follow-up|0|||
149110398|NCT01602510|537884084|FG000|Open Label Phase|Physician Decision|19|||
149110399|NCT01602510|537884085|FG001|Open Label Phase|Physician Decision|0|||
149110400|NCT01602510|537884086|FG002|Open Label Phase|Physician Decision|0|||
149110401|NCT01602510|537884084|FG000|Open Label Phase|Withdrawal by Subject|57|||
149110402|NCT01602510|537884085|FG001|Open Label Phase|Withdrawal by Subject|0|||
149110403|NCT01602510|537884086|FG002|Open Label Phase|Withdrawal by Subject|0|||
149110404|NCT01602510|537884084|FG000|Randomized Phase|Adverse Event|0|||
149110405|NCT01602510|537884085|FG001|Randomized Phase|Adverse Event|2|||
149110406|NCT01602510|537884086|FG002|Randomized Phase|Adverse Event|6|||
149110407|NCT01602510|537884084|FG000|Randomized Phase|Lack of Efficacy|0|||
149110408|NCT01602510|537884085|FG001|Randomized Phase|Lack of Efficacy|4|||
149110409|NCT01602510|537884086|FG002|Randomized Phase|Lack of Efficacy|4|||
149110410|NCT01602510|537884084|FG000|Randomized Phase|Protocol Violation|0|||
149110411|NCT01602510|537884085|FG001|Randomized Phase|Protocol Violation|3|||
149110412|NCT01602510|537884086|FG002|Randomized Phase|Protocol Violation|3|||
149110413|NCT01602510|537884084|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
149110414|NCT01602510|537884085|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
149110415|NCT01602510|537884086|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
149110416|NCT01602510|537884084|FG000|Randomized Phase|Lost to Follow-up|0|||
149110417|NCT01602510|537884085|FG001|Randomized Phase|Lost to Follow-up|1|||
149110418|NCT01602510|537884086|FG002|Randomized Phase|Lost to Follow-up|3|||
149110419|NCT01602510|537884084|FG000|Randomized Phase|Physician Decision|0|||
149110420|NCT01602510|537884085|FG001|Randomized Phase|Physician Decision|0|||
149110421|NCT01602510|537884086|FG002|Randomized Phase|Physician Decision|2|||
149110422|NCT01602510|537884084|FG000|Randomized Phase|Withdrawal by Subject|0|||
149110423|NCT01602510|537884085|FG001|Randomized Phase|Withdrawal by Subject|6|||
149110424|NCT01602510|537884086|FG002|Randomized Phase|Withdrawal by Subject|7|||
149110425|NCT01001390|537884087|FG000|Overall Study|Failure to wear AFO device|2|||
149110426|NCT01001390|537884088|FG001|Overall Study|Failure to wear AFO device|0|||
149110427|NCT00895895|537884089|FG000|Period 1|Adverse Event|7|||
149110428|NCT00895895|537884090|FG001|Period 1|Adverse Event|6|||
149110429|NCT00895895|537884091|FG002|Period 1|Adverse Event|4|||
149110430|NCT00895895|537884092|FG003|Period 1|Adverse Event|6|||
149110431|NCT00895895|537884093|FG004|Period 1|Adverse Event|7|||
149110432|NCT00895895|537884089|FG000|Period 1|Death|0|||
149110433|NCT00895895|537884090|FG001|Period 1|Death|0|||
149110434|NCT00895895|537884091|FG002|Period 1|Death|0|||
149110435|NCT00895895|537884092|FG003|Period 1|Death|0|||
149110436|NCT00895895|537884093|FG004|Period 1|Death|1|||
149110437|NCT00895895|537884089|FG000|Period 1|discontinued by sponsor|2|||
149110438|NCT00895895|537884090|FG001|Period 1|discontinued by sponsor|1|||
149110439|NCT00895895|537884091|FG002|Period 1|discontinued by sponsor|2|||
149110440|NCT00895895|537884092|FG003|Period 1|discontinued by sponsor|1|||
149110441|NCT00895895|537884093|FG004|Period 1|discontinued by sponsor|1|||
149110442|NCT00895895|537884089|FG000|Period 1|failed to return|0|||
149110443|NCT00895895|537884090|FG001|Period 1|failed to return|0|||
149110444|NCT00895895|537884091|FG002|Period 1|failed to return|1|||
149110445|NCT00895895|537884092|FG003|Period 1|failed to return|0|||
149110446|NCT00895895|537884093|FG004|Period 1|failed to return|1|||
149110447|NCT00895895|537884089|FG000|Period 1|investigator request|0|||
149110448|NCT00895895|537884090|FG001|Period 1|investigator request|1|||
149110449|NCT00895895|537884091|FG002|Period 1|investigator request|0|||
149110450|NCT00895895|537884092|FG003|Period 1|investigator request|0|||
149110451|NCT00895895|537884093|FG004|Period 1|investigator request|0|||
149110452|NCT00895895|537884089|FG000|Period 1|Lost to Follow-up|2|||
149110453|NCT00895895|537884090|FG001|Period 1|Lost to Follow-up|1|||
149110454|NCT00895895|537884091|FG002|Period 1|Lost to Follow-up|3|||
149110455|NCT00895895|537884092|FG003|Period 1|Lost to Follow-up|2|||
149110456|NCT00895895|537884093|FG004|Period 1|Lost to Follow-up|3|||
149110457|NCT00895895|537884089|FG000|Period 1|Other|1|||
149110458|NCT00895895|537884090|FG001|Period 1|Other|2|||
149110459|NCT00895895|537884091|FG002|Period 1|Other|1|||
149110460|NCT00895895|537884092|FG003|Period 1|Other|1|||
149110461|NCT00895895|537884093|FG004|Period 1|Other|1|||
149110462|NCT00895895|537884089|FG000|Period 1|Protocol Violation|0|||
149110463|NCT00895895|537884090|FG001|Period 1|Protocol Violation|1|||
149110464|NCT00895895|537884091|FG002|Period 1|Protocol Violation|0|||
149110465|NCT00895895|537884092|FG003|Period 1|Protocol Violation|0|||
149110466|NCT00895895|537884093|FG004|Period 1|Protocol Violation|0|||
149110467|NCT00895895|537884089|FG000|Period 1|Withdrawal by Subject|6|||
149110468|NCT00895895|537884090|FG001|Period 1|Withdrawal by Subject|6|||
149110469|NCT00895895|537884091|FG002|Period 1|Withdrawal by Subject|8|||
149110470|NCT00895895|537884092|FG003|Period 1|Withdrawal by Subject|2|||
149110471|NCT00895895|537884093|FG004|Period 1|Withdrawal by Subject|4|||
149110472|NCT00895895|537884089|FG000|Period 1|unsatisfactory response-efficacy|2|||
149110473|NCT00895895|537884090|FG001|Period 1|unsatisfactory response-efficacy|0|||
149110474|NCT00895895|537884091|FG002|Period 1|unsatisfactory response-efficacy|0|||
149110475|NCT00895895|537884092|FG003|Period 1|unsatisfactory response-efficacy|0|||
149110476|NCT00895895|537884093|FG004|Period 1|unsatisfactory response-efficacy|0|||
149110477|NCT00895895|537884089|FG000|Period 1|randomized and not treated|1|||
149110478|NCT00895895|537884090|FG001|Period 1|randomized and not treated|3|||
149110479|NCT00895895|537884091|FG002|Period 1|randomized and not treated|1|||
149110480|NCT00895895|537884092|FG003|Period 1|randomized and not treated|1|||
149110481|NCT00895895|537884093|FG004|Period 1|randomized and not treated|2|||
149110482|NCT00895895|537884089|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
149110483|NCT00895895|537884090|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
149110484|NCT00895895|537884091|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
149110485|NCT00895895|537884092|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
149110486|NCT00895895|537884093|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
149110487|NCT00895895|537884089|FG000|After Period 1, Prior to Period 2|Other|0|||
149110488|NCT00895895|537884090|FG001|After Period 1, Prior to Period 2|Other|0|||
149110489|NCT00895895|537884091|FG002|After Period 1, Prior to Period 2|Other|1|||
149110490|NCT00895895|537884092|FG003|After Period 1, Prior to Period 2|Other|0|||
149110491|NCT00895895|537884093|FG004|After Period 1, Prior to Period 2|Other|0|||
149110492|NCT00895895|537884089|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
149110493|NCT00895895|537884090|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
149110494|NCT00895895|537884091|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
149110495|NCT00895895|537884092|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
149110496|NCT00895895|537884093|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
149110497|NCT00895895|537884089|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
149110498|NCT00895895|537884090|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
149110499|NCT00895895|537884091|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
149110500|NCT00895895|537884092|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
149110501|NCT00895895|537884093|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
149110502|NCT00895895|537884089|FG000|Period 2|Adverse Event|3|||
149110503|NCT00895895|537884090|FG001|Period 2|Adverse Event|3|||
149110504|NCT00895895|537884091|FG002|Period 2|Adverse Event|5|||
149110505|NCT00895895|537884092|FG003|Period 2|Adverse Event|2|||
149110506|NCT00895895|537884093|FG004|Period 2|Adverse Event|5|||
149110507|NCT00895895|537884089|FG000|Period 2|Death|0|||
149110508|NCT00895895|537884090|FG001|Period 2|Death|0|||
149110509|NCT00895895|537884091|FG002|Period 2|Death|1|||
149110510|NCT00895895|537884092|FG003|Period 2|Death|0|||
149110511|NCT00895895|537884093|FG004|Period 2|Death|0|||
149110512|NCT00895895|537884089|FG000|Period 2|discontinued by sponsor|44|||
149110513|NCT00895895|537884090|FG001|Period 2|discontinued by sponsor|44|||
149110514|NCT00895895|537884091|FG002|Period 2|discontinued by sponsor|38|||
149110515|NCT00895895|537884092|FG003|Period 2|discontinued by sponsor|46|||
149110516|NCT00895895|537884093|FG004|Period 2|discontinued by sponsor|37|||
149110517|NCT00895895|537884089|FG000|Period 2|failed to return|2|||
149110518|NCT00895895|537884090|FG001|Period 2|failed to return|0|||
149110519|NCT00895895|537884091|FG002|Period 2|failed to return|0|||
149110520|NCT00895895|537884092|FG003|Period 2|failed to return|0|||
149110521|NCT00895895|537884093|FG004|Period 2|failed to return|0|||
149110522|NCT00895895|537884089|FG000|Period 2|investigator request|2|||
149110523|NCT00895895|537884090|FG001|Period 2|investigator request|0|||
149110524|NCT00895895|537884091|FG002|Period 2|investigator request|0|||
149110525|NCT00895895|537884092|FG003|Period 2|investigator request|0|||
149110526|NCT00895895|537884093|FG004|Period 2|investigator request|0|||
149110527|NCT00895895|537884089|FG000|Period 2|Lost to Follow-up|1|||
149110528|NCT00895895|537884090|FG001|Period 2|Lost to Follow-up|2|||
149110529|NCT00895895|537884091|FG002|Period 2|Lost to Follow-up|1|||
149110530|NCT00895895|537884092|FG003|Period 2|Lost to Follow-up|1|||
149110531|NCT00895895|537884093|FG004|Period 2|Lost to Follow-up|0|||
149110532|NCT00895895|537884089|FG000|Period 2|Other|1|||
149110533|NCT00895895|537884090|FG001|Period 2|Other|1|||
149110534|NCT00895895|537884091|FG002|Period 2|Other|3|||
149110535|NCT00895895|537884092|FG003|Period 2|Other|1|||
149110536|NCT00895895|537884093|FG004|Period 2|Other|1|||
149110537|NCT00895895|537884089|FG000|Period 2|Protocol Violation|1|||
149110538|NCT00895895|537884090|FG001|Period 2|Protocol Violation|0|||
149110539|NCT00895895|537884091|FG002|Period 2|Protocol Violation|1|||
149110540|NCT00895895|537884092|FG003|Period 2|Protocol Violation|1|||
149110541|NCT00895895|537884093|FG004|Period 2|Protocol Violation|1|||
149110542|NCT00895895|537884089|FG000|Period 2|Withdrawal by Subject|0|||
149110543|NCT00895895|537884090|FG001|Period 2|Withdrawal by Subject|2|||
149110544|NCT00895895|537884091|FG002|Period 2|Withdrawal by Subject|0|||
149110545|NCT00895895|537884092|FG003|Period 2|Withdrawal by Subject|3|||
149110546|NCT00895895|537884093|FG004|Period 2|Withdrawal by Subject|5|||
149110547|NCT00895895|537884089|FG000|Period 2|unsatisfactory response-efficacy|2|||
149110548|NCT00895895|537884090|FG001|Period 2|unsatisfactory response-efficacy|1|||
149110549|NCT00895895|537884091|FG002|Period 2|unsatisfactory response-efficacy|0|||
149110550|NCT00895895|537884092|FG003|Period 2|unsatisfactory response-efficacy|0|||
149110551|NCT00895895|537884093|FG004|Period 2|unsatisfactory response-efficacy|0|||
149110552|NCT01261000|537884094|FG000|Overall Study|Screen failure|1|||
149110553|NCT03019640|537884095|FG000|Overall Study|Screen Failures|4|||
149110554|NCT03019640|537884095|FG000|Overall Study|Adverse Event|3|||
149110555|NCT03019640|537884095|FG000|Overall Study|Participant Relapsed|1|||
149110556|NCT04916730|537884103|FG000|Overall Study|Withdrawal by Subject|4|||
149110557|NCT04916730|537884104|FG001|Overall Study|Withdrawal by Subject|2|||
149110558|NCT04916730|537884103|FG000|Overall Study|Lost to Follow-up|0|||
149110559|NCT04916730|537884104|FG001|Overall Study|Lost to Follow-up|2|||
149110560|NCT04916730|537884103|FG000|Overall Study|Physician Decision|1|||
149110561|NCT04916730|537884104|FG001|Overall Study|Physician Decision|0|||
149110562|NCT04978090|537884107|FG000|Overall Study|unable to adequately fit device|2|||
149110563|NCT02227992|537884110|FG000|Overall Study|Lost to Follow-up|1|||
149110564|NCT02227992|537884111|FG001|Overall Study|Lost to Follow-up|1|||
149110565|NCT01371708|537884112|FG000|Overall Study|Insufficient clinical response|3|||
149110566|NCT01371708|537884113|FG001|Overall Study|Insufficient clinical response|2|||
149110567|NCT01371708|537884114|FG002|Overall Study|Insufficient clinical response|0|||
149110568|NCT01371708|537884112|FG000|Overall Study|Lost to Follow-up|5|||
149110569|NCT01371708|537884113|FG001|Overall Study|Lost to Follow-up|9|||
149110570|NCT01371708|537884114|FG002|Overall Study|Lost to Follow-up|7|||
149110571|NCT01371708|537884112|FG000|Overall Study|Protocol Violation|2|||
149110572|NCT01371708|537884113|FG001|Overall Study|Protocol Violation|1|||
149110573|NCT01371708|537884114|FG002|Overall Study|Protocol Violation|2|||
149110574|NCT01371708|537884112|FG000|Overall Study|No longer willing to participate|7|||
149110575|NCT01371708|537884113|FG001|Overall Study|No longer willing to participate|7|||
149110576|NCT01371708|537884114|FG002|Overall Study|No longer willing to participate|13|||
149110577|NCT01371708|537884112|FG000|Overall Study|Medication error/not related to AE|0|||
149110578|NCT01371708|537884113|FG001|Overall Study|Medication error/not related to AE|1|||
149110579|NCT01371708|537884114|FG002|Overall Study|Medication error/not related to AE|0|||
149110580|NCT01371708|537884112|FG000|Overall Study|Other|3|||
149110581|NCT01371708|537884113|FG001|Overall Study|Other|2|||
149110582|NCT01371708|537884114|FG002|Overall Study|Other|4|||
149110583|NCT01371708|537884112|FG000|Overall Study|Adverse Event|5|||
149110584|NCT01371708|537884113|FG001|Overall Study|Adverse Event|8|||
149110585|NCT01371708|537884114|FG002|Overall Study|Adverse Event|12|||
149110586|NCT01371708|537884112|FG000|Overall Study|Started but did not receive treatment|1|||
149110587|NCT01371708|537884113|FG001|Overall Study|Started but did not receive treatment|0|||
149110588|NCT01371708|537884114|FG002|Overall Study|Started but did not receive treatment|1|||
149110589|NCT02514551|537884115|FG000|Overall Study|Lost to Follow-up|0|||
149110590|NCT02514551|537884116|FG001|Overall Study|Lost to Follow-up|1|||
149110591|NCT02514551|537884115|FG000|Overall Study|Participant Never Treated|0|||
149110592|NCT02514551|537884116|FG001|Overall Study|Participant Never Treated|2|||
149110593|NCT00632502|537884120|FG000|Overall Study|Adverse Event|0|||
149110594|NCT00632502|537884121|FG001|Overall Study|Adverse Event|1|||
149110595|NCT00632502|537884120|FG000|Overall Study|Randomized not treated|3|||
149110596|NCT00632502|537884121|FG001|Overall Study|Randomized not treated|0|||
149110597|NCT04954326|537884122|FG000|Overall Study|Protocol Violation|0|||
149110598|NCT04954326|537884123|FG001|Overall Study|Protocol Violation|1|||
149110599|NCT04954326|537884122|FG000|Overall Study|Death|0|||
149110600|NCT04954326|537884123|FG001|Overall Study|Death|2|||
149110601|NCT04954326|537884122|FG000|Overall Study|Physician Decision|0|||
149110602|NCT04954326|537884123|FG001|Overall Study|Physician Decision|1|||
149110603|NCT01213524|537884124|FG000|Baseline|Withdrawal by Subject|5|||
149110604|NCT01213524|537884124|FG000|Baseline|high breath alcohol levels|1|||
149110605|NCT01213524|537884124|FG000|Baseline|Physician Decision|1|||
149110606|NCT01213524|537884124|FG000|Session 2|Withdrawal by Subject|5|||
149110607|NCT01213524|537884124|FG000|Session 3|Withdrawal by Subject|4|||
149110608|NCT01213524|537884124|FG000|Session 4|Physician Decision|1|||
149110609|NCT01213524|537884124|FG000|Session 4|Withdrawal by Subject|2|||
149110610|NCT02519348|537884130|FG000|Overall Study|Death|31|||
149110611|NCT02519348|537884131|FG001|Overall Study|Death|74|||
149110612|NCT02519348|537884132|FG002|Overall Study|Death|47|||
149110613|NCT02519348|537884133|FG003|Overall Study|Death|54|||
149110614|NCT02519348|537884134|FG004|Overall Study|Death|63|||
149110615|NCT02519348|537884135|FG005|Overall Study|Death|18|||
149110616|NCT02519348|537884136|FG006|Overall Study|Death|2|||
149110617|NCT02519348|537884137|FG007|Overall Study|Death|5|||
149110618|NCT02519348|537884138|FG008|Overall Study|Death|5|||
149110619|NCT02519348|537884130|FG000|Overall Study|Withdrawal by Subject|4|||
149110620|NCT02519348|537884131|FG001|Overall Study|Withdrawal by Subject|7|||
149110621|NCT02519348|537884132|FG002|Overall Study|Withdrawal by Subject|4|||
149110622|NCT02519348|537884133|FG003|Overall Study|Withdrawal by Subject|3|||
149110623|NCT02519348|537884134|FG004|Overall Study|Withdrawal by Subject|3|||
149110624|NCT02519348|537884135|FG005|Overall Study|Withdrawal by Subject|2|||
149110625|NCT02519348|537884136|FG006|Overall Study|Withdrawal by Subject|0|||
149110626|NCT02519348|537884137|FG007|Overall Study|Withdrawal by Subject|0|||
149110627|NCT02519348|537884138|FG008|Overall Study|Withdrawal by Subject|1|||
149110628|NCT02519348|537884130|FG000|Overall Study|Lost to Follow-up|0|||
149110629|NCT02519348|537884131|FG001|Overall Study|Lost to Follow-up|0|||
149110630|NCT02519348|537884132|FG002|Overall Study|Lost to Follow-up|1|||
149110631|NCT02519348|537884133|FG003|Overall Study|Lost to Follow-up|0|||
149110632|NCT02519348|537884134|FG004|Overall Study|Lost to Follow-up|2|||
149110633|NCT02519348|537884135|FG005|Overall Study|Lost to Follow-up|1|||
149110634|NCT02519348|537884136|FG006|Overall Study|Lost to Follow-up|1|||
149110635|NCT02519348|537884137|FG007|Overall Study|Lost to Follow-up|0|||
149110636|NCT02519348|537884138|FG008|Overall Study|Lost to Follow-up|0|||
149110637|NCT02519348|537884130|FG000|Overall Study|Other|0|||
149110638|NCT02519348|537884131|FG001|Overall Study|Other|3|||
149110639|NCT02519348|537884132|FG002|Overall Study|Other|0|||
149110640|NCT02519348|537884133|FG003|Overall Study|Other|0|||
149110641|NCT02519348|537884134|FG004|Overall Study|Other|1|||
149110642|NCT02519348|537884135|FG005|Overall Study|Other|0|||
149110643|NCT02519348|537884136|FG006|Overall Study|Other|0|||
149110644|NCT02519348|537884137|FG007|Overall Study|Other|0|||
149110645|NCT02519348|537884138|FG008|Overall Study|Other|0|||
149110646|NCT02519348|537884130|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
149110647|NCT02519348|537884131|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
149110648|NCT02519348|537884132|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
149110649|NCT02519348|537884133|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
149110650|NCT02519348|537884134|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
149110651|NCT02519348|537884135|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
149110652|NCT02519348|537884136|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
149110653|NCT02519348|537884137|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
149110654|NCT02519348|537884138|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
149110655|NCT05239598|537884139|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
149110656|NCT05239598|537884140|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
149110657|NCT05239598|537884139|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
149110658|NCT05239598|537884140|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
149110659|NCT05855967|537884141|FG000|Overall Study|Withdrawal by Subject|7|||
149110660|NCT05855967|537884142|FG001|Overall Study|Withdrawal by Subject|5|||
149110661|NCT05855967|537884141|FG000|Overall Study|Lost to Follow-up|2|||
149110662|NCT05855967|537884142|FG001|Overall Study|Lost to Follow-up|1|||
149110663|NCT04147195|537884143|FG000|Overall Study|Adverse Event|0|||
149110664|NCT04147195|537884144|FG001|Overall Study|Adverse Event|3|||
149110665|NCT04147195|537884143|FG000|Overall Study|Study Terminated by Sponsor|4|||
149110666|NCT04147195|537884144|FG001|Overall Study|Study Terminated by Sponsor|2|||
149110667|NCT04147195|537884143|FG000|Overall Study|Withdrawal by Subject|0|||
149110668|NCT04147195|537884144|FG001|Overall Study|Withdrawal by Subject|1|||
149110669|NCT06926673|537884145|FG000|Overall Study|Lost to Follow-up|0|||
149110670|NCT06926673|537884146|FG001|Overall Study|Lost to Follow-up|0|||
149110671|NCT06926673|537884147|FG002|Overall Study|Lost to Follow-up|0|||
149110672|NCT06926673|537884148|FG003|Overall Study|Lost to Follow-up|1|||
149110673|NCT06926673|537884149|FG004|Overall Study|Lost to Follow-up|0|||
149110674|NCT06926673|537884150|FG005|Overall Study|Lost to Follow-up|0|||
149110675|NCT06926673|537884151|FG006|Overall Study|Lost to Follow-up|0|||
149110676|NCT06926673|537884145|FG000|Overall Study|Physician Decision|0|||
149110677|NCT06926673|537884146|FG001|Overall Study|Physician Decision|0|||
149110678|NCT06926673|537884147|FG002|Overall Study|Physician Decision|0|||
149110679|NCT06926673|537884148|FG003|Overall Study|Physician Decision|0|||
149110680|NCT06926673|537884149|FG004|Overall Study|Physician Decision|0|||
149110681|NCT06926673|537884150|FG005|Overall Study|Physician Decision|0|||
149110682|NCT06926673|537884151|FG006|Overall Study|Physician Decision|1|||
149110683|NCT06926673|537884145|FG000|Overall Study|Withdrawal by Subject|0|||
149110684|NCT06926673|537884146|FG001|Overall Study|Withdrawal by Subject|3|||
149110685|NCT06926673|537884147|FG002|Overall Study|Withdrawal by Subject|2|||
149110686|NCT06926673|537884148|FG003|Overall Study|Withdrawal by Subject|1|||
149110687|NCT06926673|537884149|FG004|Overall Study|Withdrawal by Subject|0|||
149110688|NCT06926673|537884150|FG005|Overall Study|Withdrawal by Subject|2|||
149110689|NCT06926673|537884151|FG006|Overall Study|Withdrawal by Subject|0|||
149110690|NCT01424813|537884152|FG000|Overall Study|Withdrawal by Subject|3|||
149110691|NCT01424813|537884153|FG001|Overall Study|Withdrawal by Subject|0|||
149110692|NCT01424813|537884152|FG000|Overall Study|Protocol Violation|1|||
149110693|NCT01424813|537884153|FG001|Overall Study|Protocol Violation|0|||
149110694|NCT01424813|537884152|FG000|Overall Study|Other|1|||
149110695|NCT01424813|537884153|FG001|Overall Study|Other|2|||
149110696|NCT02942004|537885904|FG000|Overall Study|Withdrawal by Subject|0|||
149110697|NCT02942004|537885905|FG001|Overall Study|Withdrawal by Subject|2|||
149110698|NCT02942004|537885906|FG002|Overall Study|Withdrawal by Subject|3|||
149110699|NCT02942004|537885904|FG000|Overall Study|Lost to Follow-up|1|||
149110700|NCT02942004|537885905|FG001|Overall Study|Lost to Follow-up|1|||
149110701|NCT02942004|537885906|FG002|Overall Study|Lost to Follow-up|2|||
149110702|NCT02942004|537885904|FG000|Overall Study|Randomized but not dosed|3|||
149110703|NCT02942004|537885905|FG001|Overall Study|Randomized but not dosed|9|||
149110704|NCT02942004|537885906|FG002|Overall Study|Randomized but not dosed|4|||
149110705|NCT05627258|537885907|FG000|Overall Study|Lost to Follow-up|1|||
149110706|NCT05627258|537885908|FG001|Overall Study|Lost to Follow-up|0|||
149110707|NCT05627258|537885909|FG002|Overall Study|Lost to Follow-up|0|||
149110708|NCT05627258|537885910|FG003|Overall Study|Lost to Follow-up|0|||
149110709|NCT05627258|537885911|FG004|Overall Study|Lost to Follow-up|0|||
149110710|NCT05627258|537885912|FG005|Overall Study|Lost to Follow-up|0|||
149110711|NCT05627258|537885907|FG000|Overall Study|Withdrawal by Subject|0|||
149110712|NCT05627258|537885908|FG001|Overall Study|Withdrawal by Subject|0|||
149110713|NCT05627258|537885909|FG002|Overall Study|Withdrawal by Subject|0|||
149110714|NCT05627258|537885910|FG003|Overall Study|Withdrawal by Subject|0|||
149110715|NCT05627258|537885911|FG004|Overall Study|Withdrawal by Subject|2|||
149110716|NCT05627258|537885912|FG005|Overall Study|Withdrawal by Subject|0|||
149110717|NCT05627258|537885907|FG000|Overall Study|Enrolled, but product not administered|1|||
149110718|NCT05627258|537885908|FG001|Overall Study|Enrolled, but product not administered|0|||
149110719|NCT05627258|537885909|FG002|Overall Study|Enrolled, but product not administered|0|||
149110720|NCT05627258|537885910|FG003|Overall Study|Enrolled, but product not administered|0|||
149110721|NCT05627258|537885911|FG004|Overall Study|Enrolled, but product not administered|0|||
149110722|NCT05627258|537885912|FG005|Overall Study|Enrolled, but product not administered|0|||
149110723|NCT05627258|537885907|FG000|Overall Study|Other subject illness/injury|1|||
149110724|NCT05627258|537885908|FG001|Overall Study|Other subject illness/injury|0|||
149110725|NCT05627258|537885909|FG002|Overall Study|Other subject illness/injury|0|||
149110726|NCT05627258|537885910|FG003|Overall Study|Other subject illness/injury|0|||
149110727|NCT05627258|537885911|FG004|Overall Study|Other subject illness/injury|0|||
149110728|NCT05627258|537885912|FG005|Overall Study|Other subject illness/injury|0|||
149110729|NCT05627258|537885907|FG000|Overall Study|Subject moved from area|0|||
149110730|NCT05627258|537885908|FG001|Overall Study|Subject moved from area|0|||
149110731|NCT05627258|537885909|FG002|Overall Study|Subject moved from area|1|||
149110732|NCT05627258|537885910|FG003|Overall Study|Subject moved from area|0|||
149110733|NCT05627258|537885911|FG004|Overall Study|Subject moved from area|0|||
149110734|NCT05627258|537885912|FG005|Overall Study|Subject moved from area|0|||
149110735|NCT04517669|537885913|FG000|Overall Study|Lost to Follow-up|2|||
149110736|NCT04517669|537885913|FG000|Overall Study|Withdrawal by Subject|3|||
149110737|NCT04517669|537885913|FG000|Overall Study|Drug withdrawn|44|||
149110738|NCT04517669|537885913|FG000|Overall Study|Other|1|||
149110739|NCT04517669|537885913|FG000|Overall Study|Eligibility criteria not met|4|||
149110740|NCT04517669|537885913|FG000|Overall Study|Did not receive treatment|3|||
149110741|NCT02138786|537885914|FG000|Overall Study|Adverse Event|0|||
149110742|NCT02138786|537885915|FG001|Overall Study|Adverse Event|2|||
149110743|NCT02138786|537885916|FG002|Overall Study|Adverse Event|1|||
149110744|NCT02138786|537885914|FG000|Overall Study|Death|1|||
149110745|NCT02138786|537885915|FG001|Overall Study|Death|7|||
149110746|NCT02138786|537885916|FG002|Overall Study|Death|2|||
149110747|NCT02138786|537885914|FG000|Overall Study|Disease Progression|1|||
149110748|NCT02138786|537885915|FG001|Overall Study|Disease Progression|1|||
149110749|NCT02138786|537885916|FG002|Overall Study|Disease Progression|3|||
149110750|NCT02138786|537885914|FG000|Overall Study|Withdrawal by Subject|1|||
149110751|NCT02138786|537885915|FG001|Overall Study|Withdrawal by Subject|2|||
149110752|NCT02138786|537885916|FG002|Overall Study|Withdrawal by Subject|0|||
149110753|NCT02138786|537885914|FG000|Overall Study|Patient's Wish|0|||
149110754|NCT02138786|537885915|FG001|Overall Study|Patient's Wish|2|||
149110755|NCT02138786|537885916|FG002|Overall Study|Patient's Wish|0|||
149110756|NCT02138786|537885914|FG000|Overall Study|Sponsor Terminated Study|0|||
149110757|NCT02138786|537885915|FG001|Overall Study|Sponsor Terminated Study|1|||
149110758|NCT02138786|537885916|FG002|Overall Study|Sponsor Terminated Study|1|||
149110759|NCT02138786|537885914|FG000|Overall Study|Non-Compliance|0|||
149110760|NCT02138786|537885915|FG001|Overall Study|Non-Compliance|0|||
149110761|NCT02138786|537885916|FG002|Overall Study|Non-Compliance|1|||
149110762|NCT02088957|537885917|FG000|Overall Study|Lack of Efficacy|1|||
149110763|NCT02088957|537885918|FG001|Overall Study|Lack of Efficacy|0|||
149110764|NCT01923662|537885922|FG000|Overall Study|Withdrawal by Subject|1|||
149110765|NCT00677534|537885926|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
149110766|NCT00677534|537885926|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
149110767|NCT00677534|537885926|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
149110768|NCT02687035|537885927|FG000|Overall Study|Withdrawal by Subject|1|||
149110769|NCT02687035|537885927|FG000|Overall Study|Death|87|||
149110770|NCT02687035|537885927|FG000|Overall Study|Lost to Follow-up|1|||
149110771|NCT02687035|537885927|FG000|Overall Study|Missed Visit|87|||
149110772|NCT02687035|537885927|FG000|Overall Study|Did not receive Study Device|8|||
149110773|NCT00667394|537885930|FG000|Overall Study|Adverse Event|3|||
149110774|NCT00667394|537885931|FG001|Overall Study|Adverse Event|0|||
149110775|NCT00667394|537885930|FG000|Overall Study|Progressive disease|1|||
149110776|NCT00667394|537885931|FG001|Overall Study|Progressive disease|0|||
149110777|NCT04638660|537885936|FG000|Overall Study|Withdrawal by Subject|2|||
149110778|NCT04638660|537885937|FG001|Overall Study|Withdrawal by Subject|0|||
149110779|NCT04638660|537885936|FG000|Overall Study|Lost to Follow-up|1|||
149110780|NCT04638660|537885937|FG001|Overall Study|Lost to Follow-up|0|||
149110781|NCT04481373|537885942|FG000|Overall Study|Protocol Violation|1|||
149110782|NCT04481373|537885943|FG001|Overall Study|Protocol Violation|0|||
149110783|NCT04481373|537885942|FG000|Overall Study|Viral load in hospital not over 1000|2|||
149110784|NCT04481373|537885943|FG001|Overall Study|Viral load in hospital not over 1000|1|||
149110785|NCT04481373|537885942|FG000|Overall Study|Death before hospital discharge|1|||
149110786|NCT04481373|537885943|FG001|Overall Study|Death before hospital discharge|0|||
149110787|NCT00332462|537885944|FG000|Overall Study|Adverse Event|5|||
149110788|NCT00332462|537885944|FG000|Overall Study|Abnormal Lab Value|1|||
149110789|NCT00332462|537885944|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
149110790|NCT00332462|537885944|FG000|Overall Study|no longer requires study drug|1|||
149110791|NCT00332462|537885944|FG000|Overall Study|Death|3|||
149110792|NCT00332462|537885944|FG000|Overall Study|Graft Loss|2|||
149110793|NCT02922023|537885947|FG000|Overall Study|Lost to Follow-up|2|||
149110794|NCT02922023|537885948|FG001|Overall Study|Lost to Follow-up|0|||
149110795|NCT02766777|537885961|FG000|Overall Study|Adverse Event|12|||
149110796|NCT02766777|537885961|FG000|Overall Study|Lost to Follow-up|16|||
149110797|NCT02766777|537885961|FG000|Overall Study|Non-Compliance With Study Drug|1|||
149110798|NCT02766777|537885961|FG000|Overall Study|Protocol Violation|1|||
149110799|NCT02766777|537885961|FG000|Overall Study|Withdrawal by Subject|4|||
149110800|NCT01886287|537885962|FG000|Overall Study|Radiographic disease progression|1|||
149110801|NCT01886287|537885962|FG000|Overall Study|Clinical progression due to disease|1|||
149110802|NCT02593123|537885963|FG000|Overall Study|Physician Decision|2|||
149110803|NCT02593123|537885964|FG001|Overall Study|Physician Decision|1|||
149110804|NCT02593123|537885963|FG000|Overall Study|Relapse|1|||
149110805|NCT02593123|537885964|FG001|Overall Study|Relapse|1|||
149110806|NCT00504777|537885965|FG000|Overall Study|Adverse Event|1|||
149110807|NCT01195623|537885969|FG000|Overall Study|Lost to Follow-up|35|||
149110808|NCT01195623|537885970|FG001|Overall Study|Lost to Follow-up|37|||
149110809|NCT00534495|537885972|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
149110810|NCT00534495|537885973|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
149110811|NCT00534495|537885974|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
149110812|NCT00534495|537885972|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
149110813|NCT00534495|537885973|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
149110814|NCT00534495|537885974|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
149110815|NCT00534495|537885972|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
149110816|NCT00534495|537885973|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
149110817|NCT00534495|537885974|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
149110818|NCT00534495|537885972|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
149110819|NCT00534495|537885973|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
149110820|NCT00534495|537885974|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
149110821|NCT00534495|537885972|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
149110822|NCT00534495|537885973|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
149110823|NCT00534495|537885974|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
149110824|NCT00534495|537885972|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
149110825|NCT00534495|537885973|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
149110826|NCT00534495|537885974|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
149110827|NCT00534495|537885972|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
149110828|NCT00534495|537885973|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
149110829|NCT00534495|537885974|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
149110830|NCT00534495|537885972|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
149110831|NCT00534495|537885973|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
149110832|NCT00534495|537885974|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
149110833|NCT00534495|537885972|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
149110834|NCT00534495|537885973|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
149110835|NCT00534495|537885974|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
149110836|NCT01572740|537885975|FG000|Overall Study|Adverse Event|1|||
149110837|NCT01572740|537885976|FG001|Overall Study|Adverse Event|1|||
149110838|NCT01572740|537885975|FG000|Overall Study|Withdrawal by Subject|1|||
149110839|NCT01572740|537885976|FG001|Overall Study|Withdrawal by Subject|1|||
149110840|NCT01572740|537885975|FG000|Overall Study|unclassified|4|||
149110841|NCT01572740|537885976|FG001|Overall Study|unclassified|3|||
149110842|NCT00214019|537885980|FG000|Overall Study|Lost to Follow-up|11|||
149110843|NCT00214019|537885980|FG000|Overall Study|Withdrawal by Subject|2|||
149110844|NCT00214019|537885980|FG000|Overall Study|Screen Failed prior to randomization|17|||
149110845|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
149110846|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
149110847|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
149110848|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
149110849|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
149110850|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
149110851|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
149110852|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
149110853|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
149110854|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
149110855|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
149110856|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
149110857|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
149110858|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
149110859|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
149110860|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
149110861|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
149110862|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
149110863|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
149110864|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110865|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110866|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110867|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
149110868|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110869|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110870|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110871|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
149110872|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
149110873|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
149110874|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
149110875|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
149110876|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
149110877|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
149110878|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
149110879|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
149110880|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
149110881|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
149110882|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
149110883|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
149110884|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
149110885|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
149110886|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
149110887|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
149110888|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
149110889|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
149110890|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
149110891|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
149110892|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
149110893|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
149110894|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
149110895|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
149110896|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
149110897|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
149110898|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
149110899|NCT00477490|537885983|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
149110900|NCT00477490|537885984|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
149110901|NCT00477490|537885985|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
149110902|NCT00477490|537885986|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
149110903|NCT00477490|537885987|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
149110904|NCT00477490|537885988|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
149110905|NCT00477490|537885989|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
149110906|NCT00477490|537885990|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
149110907|NCT00477490|537885991|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
149110908|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
149110909|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
149110910|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
149110911|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
149110912|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
149110913|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
149110914|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
149110915|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
149110916|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
149110917|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
149110918|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
149110919|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
149110920|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
149110921|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
149110922|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
149110923|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
149110924|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
149110925|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
149110926|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
149110927|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
149110928|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
149110929|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
149110930|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
149110931|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
149110932|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
149110933|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
149110934|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
149110935|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
149110936|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
149110937|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
149110938|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
149110939|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
149110940|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
149110941|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
149110942|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
149110943|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
149110944|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110945|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
149110946|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110947|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110948|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110949|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110950|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110951|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110952|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
149110953|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
149110954|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
149110955|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
149110956|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
149110957|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
149110958|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
149110959|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
149110960|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
149110961|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
149110962|NCT00477490|537885983|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
149110963|NCT00477490|537885984|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
149110964|NCT00477490|537885985|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
149110965|NCT00477490|537885986|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
149110966|NCT00477490|537885987|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
149110967|NCT00477490|537885988|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
149110968|NCT00477490|537885989|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
149110969|NCT00477490|537885990|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
149110970|NCT00477490|537885991|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
149110971|NCT01465763|537885994|FG000|Overall Study|Withdrawal by Subject|4|||
149110972|NCT01465763|537885995|FG001|Overall Study|Withdrawal by Subject|0|||
149110973|NCT01465763|537885996|FG002|Overall Study|Withdrawal by Subject|1|||
149110974|NCT01465763|537885994|FG000|Overall Study|Insufficient Clinical Response|11|||
149110975|NCT01465763|537885995|FG001|Overall Study|Insufficient Clinical Response|0|||
149110976|NCT01465763|537885996|FG002|Overall Study|Insufficient Clinical Response|1|||
149110977|NCT01465763|537885994|FG000|Overall Study|Adverse Event|9|||
149110978|NCT01465763|537885995|FG001|Overall Study|Adverse Event|0|||
149110979|NCT01465763|537885996|FG002|Overall Study|Adverse Event|1|||
149110980|NCT01465763|537885994|FG000|Overall Study|Other|2|||
149110981|NCT01465763|537885995|FG001|Overall Study|Other|0|||
149110982|NCT01465763|537885996|FG002|Overall Study|Other|0|||
149110983|NCT01465763|537885994|FG000|Overall Study|Protocol Violation|4|||
149110984|NCT01465763|537885995|FG001|Overall Study|Protocol Violation|1|||
149110985|NCT01465763|537885996|FG002|Overall Study|Protocol Violation|1|||
149110986|NCT01465763|537885994|FG000|Overall Study|Death|1|||
149110987|NCT01465763|537885995|FG001|Overall Study|Death|0|||
149110988|NCT01465763|537885996|FG002|Overall Study|Death|0|||
149110989|NCT01646177|537885997|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
149110990|NCT01646177|537885998|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
149110991|NCT01646177|537885999|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
149110992|NCT01646177|537886000|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
149110993|NCT01646177|537886001|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149110994|NCT01646177|537886002|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149110995|NCT01646177|537886003|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149110996|NCT01646177|537886004|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149110997|NCT01646177|537886005|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149110998|NCT01646177|537886006|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149110999|NCT01646177|537886007|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149111000|NCT01646177|537886008|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
149111001|NCT01646177|537885997|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
149111002|NCT01646177|537885998|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
149111003|NCT01646177|537885999|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
149111004|NCT01646177|537886000|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
149111005|NCT01646177|537886001|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111006|NCT01646177|537886002|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111007|NCT01646177|537886003|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111008|NCT01646177|537886004|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111009|NCT01646177|537886005|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111010|NCT01646177|537886006|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111011|NCT01646177|537886007|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111012|NCT01646177|537886008|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
149111013|NCT01646177|537885997|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
149111014|NCT01646177|537885998|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
149111015|NCT01646177|537885999|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
149111016|NCT01646177|537886000|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
149111017|NCT01646177|537886001|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111018|NCT01646177|537886002|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111019|NCT01646177|537886003|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111020|NCT01646177|537886004|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111021|NCT01646177|537886005|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111022|NCT01646177|537886006|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111023|NCT01646177|537886007|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111024|NCT01646177|537886008|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
149111025|NCT01646177|537885997|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
149111026|NCT01646177|537885998|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
149111027|NCT01646177|537885999|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
149111028|NCT01646177|537886000|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
149111029|NCT01646177|537886001|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111030|NCT01646177|537886002|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111031|NCT01646177|537886003|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111032|NCT01646177|537886004|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111033|NCT01646177|537886005|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111034|NCT01646177|537886006|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111035|NCT01646177|537886007|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111036|NCT01646177|537886008|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
149111037|NCT01646177|537885997|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111038|NCT01646177|537885998|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111039|NCT01646177|537885999|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
149111040|NCT01646177|537886000|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
149111041|NCT01646177|537886001|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111042|NCT01646177|537886002|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111043|NCT01646177|537886003|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111044|NCT01646177|537886004|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111045|NCT01646177|537886005|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111046|NCT01646177|537886006|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111047|NCT01646177|537886007|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111048|NCT01646177|537886008|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
149111049|NCT01646177|537885997|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
149111050|NCT01646177|537885998|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
149111051|NCT01646177|537885999|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
149111052|NCT01646177|537886000|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111053|NCT01646177|537886001|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111054|NCT01646177|537886002|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111055|NCT01646177|537886003|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111056|NCT01646177|537886004|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111057|NCT01646177|537886005|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111058|NCT01646177|537886006|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111059|NCT01646177|537886007|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111060|NCT01646177|537886008|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
149111061|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111062|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111063|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111064|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111065|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
149111066|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
149111067|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
149111068|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
149111069|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111070|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111071|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111072|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
149111073|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111074|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111075|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111076|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111077|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
149111078|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
149111079|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
149111080|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
149111081|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111082|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111083|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111084|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
149111085|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111086|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111087|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111088|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111089|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
149111090|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
149111091|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
149111092|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
149111093|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111094|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111095|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111096|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
149111097|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111098|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111099|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111100|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111101|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
149111102|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
149111103|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
149111104|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
149111105|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111106|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111107|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111108|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
149111109|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111110|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111111|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111112|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111113|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
149111114|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
149111115|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
149111116|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
149111117|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111118|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111119|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111120|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
149111121|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111122|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111123|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111124|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111125|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
149111126|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
149111127|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111128|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
149111129|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111130|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111131|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111132|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
149111133|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111134|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111135|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111136|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111137|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
149111138|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
149111139|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
149111140|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
149111141|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111142|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111143|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111144|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
149111145|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
149111146|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
149111147|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
149111148|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
149111149|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
149111150|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
149111151|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
149111152|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
149111153|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
149111154|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
149111155|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
149111156|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
149111157|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111158|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111159|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111160|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111161|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
149111162|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
149111163|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
149111164|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
149111165|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111166|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111167|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111168|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
149111169|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111170|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111171|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111172|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111173|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111174|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111175|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111176|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
149111177|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111178|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111179|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111180|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
149111181|NCT01646177|537885997|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111182|NCT01646177|537885998|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111183|NCT01646177|537885999|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111184|NCT01646177|537886000|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111185|NCT01646177|537886001|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111186|NCT01646177|537886002|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
149111187|NCT01646177|537886003|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
149111188|NCT01646177|537886004|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
149111189|NCT01646177|537886005|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111190|NCT01646177|537886006|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111191|NCT01646177|537886007|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111192|NCT01646177|537886008|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
149111193|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111194|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111195|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111196|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111197|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111198|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111199|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111200|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
149111201|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
149111202|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
149111203|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
149111204|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
149111205|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111206|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111207|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111208|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111209|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111210|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111211|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111212|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
149111213|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
149111214|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
149111215|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
149111216|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
149111217|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111218|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111219|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111220|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111221|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111222|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111223|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111224|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
149111225|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
149111226|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
149111227|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
149111228|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
149111229|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111230|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111231|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111232|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111233|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111234|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111235|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111236|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
149111237|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
149111238|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
149111239|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
149111240|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
149111241|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111242|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111243|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111244|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111245|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111246|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111247|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111248|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
149111249|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
149111250|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
149111251|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
149111252|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
149111253|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111254|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111255|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111256|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111257|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111258|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111259|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111260|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
149111261|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
149111262|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
149111263|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
149111264|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
149111265|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111266|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111267|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111268|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111269|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111270|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111271|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111272|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111273|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
149111274|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
149111275|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
149111276|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
149111277|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111278|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111279|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111280|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111281|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111282|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111283|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111284|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111285|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
149111286|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
149111287|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
149111288|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
149111289|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111290|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111291|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111292|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111293|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111294|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111295|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111296|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111297|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
149111298|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
149111299|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
149111300|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
149111301|NCT01646177|537885997|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111302|NCT01646177|537885998|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111303|NCT01646177|537885999|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111304|NCT01646177|537886000|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111305|NCT01646177|537886001|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111306|NCT01646177|537886002|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111307|NCT01646177|537886003|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111308|NCT01646177|537886004|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111309|NCT01646177|537886005|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111310|NCT01646177|537886006|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
149111311|NCT01646177|537886007|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
149111312|NCT01646177|537886008|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
149111313|NCT02920970|537886011|FG000|First Intervention|Protocol Violation|0|||
149111314|NCT02920970|537886012|FG001|First Intervention|Protocol Violation|1|||
149111315|NCT02920970|537886011|FG000|First Intervention|Adverse Event|0|||
149111316|NCT02920970|537886012|FG001|First Intervention|Adverse Event|1|||
149111317|NCT02920970|537886011|FG000|Second Intervention|Poor Lens Fit|1|||
149111318|NCT02920970|537886012|FG001|Second Intervention|Poor Lens Fit|0|||
149111319|NCT01711853|537886013|FG000|Overall Study|Not treated|3|||
149111320|NCT04191616|537886014|FG000|Pre-assignment Period|Did not receive study treatment|2|||
149111321|NCT04191616|537886014|FG000|Treatment Period|Death|37|||
149111322|NCT04191616|537886014|FG000|Treatment Period|Sponsor decision|11|||
149111323|NCT04191616|537886014|FG000|Treatment Period|Withdrawal by Subject|4|||
149111324|NCT04230122|537886015|FG000|Overall Study|Lost to Follow-up|1|||
149111325|NCT04230122|537886016|FG001|Overall Study|Lost to Follow-up|0|||
149111326|NCT00604708|537886018|FG000|Overall Study|Withdrawal by Subject|9|||
149111327|NCT00604708|537886019|FG001|Overall Study|Withdrawal by Subject|10|||
149111328|NCT00604708|537886018|FG000|Overall Study|Protocol Violation|2|||
149111329|NCT00604708|537886019|FG001|Overall Study|Protocol Violation|8|||
149111330|NCT00604708|537886018|FG000|Overall Study|Lost to Follow-up|5|||
149111331|NCT00604708|537886019|FG001|Overall Study|Lost to Follow-up|5|||
149111332|NCT00604708|537886018|FG000|Overall Study|administrative reasons|9|||
149111333|NCT00604708|537886019|FG001|Overall Study|administrative reasons|11|||
149111334|NCT00604708|537886018|FG000|Overall Study|Adverse Event|6|||
149111335|NCT00604708|537886019|FG001|Overall Study|Adverse Event|6|||
149111336|NCT01277887|537886021|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
149111337|NCT01277887|537886022|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
149111338|NCT01277887|537886021|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
149111339|NCT01277887|537886022|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
149111340|NCT01277887|537886021|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
149111341|NCT01277887|537886022|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
149111342|NCT03651700|537886023|FG000|Overall Study|Withdrawal by Subject|1|||
149111343|NCT03651700|537886024|FG001|Overall Study|Withdrawal by Subject|0|||
149111344|NCT05479734|537886027|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
149111345|NCT05479734|537886028|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
149111346|NCT05479734|537886027|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
149111347|NCT05479734|537886028|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
149111348|NCT05479734|537886027|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
149111349|NCT05479734|537886028|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
149111350|NCT05479734|537886027|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
149111351|NCT05479734|537886028|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
149111352|NCT03945825|537886029|FG000|Overall Study|Enrolled but treatment not administered|0|||
149111353|NCT03945825|537886030|FG001|Overall Study|Enrolled but treatment not administered|0|||
149111354|NCT03945825|537886031|FG002|Overall Study|Enrolled but treatment not administered|0|||
149111355|NCT03945825|537886032|FG003|Overall Study|Enrolled but treatment not administered|0|||
149111356|NCT03945825|537886033|FG004|Overall Study|Enrolled but treatment not administered|1|||
149111357|NCT03945825|537886034|FG005|Overall Study|Enrolled but treatment not administered|0|||
149111358|NCT03945825|537886029|FG000|Overall Study|Lost to Follow-up|1|||
149111359|NCT03945825|537886030|FG001|Overall Study|Lost to Follow-up|5|||
149111360|NCT03945825|537886031|FG002|Overall Study|Lost to Follow-up|0|||
149111361|NCT03945825|537886032|FG003|Overall Study|Lost to Follow-up|1|||
149111362|NCT03945825|537886033|FG004|Overall Study|Lost to Follow-up|2|||
149111363|NCT03945825|537886034|FG005|Overall Study|Lost to Follow-up|2|||
149111364|NCT03945825|537886029|FG000|Overall Study|Withdrawal by Subject|1|||
149111365|NCT03945825|537886030|FG001|Overall Study|Withdrawal by Subject|0|||
149111366|NCT03945825|537886031|FG002|Overall Study|Withdrawal by Subject|1|||
149111367|NCT03945825|537886032|FG003|Overall Study|Withdrawal by Subject|1|||
149111368|NCT03945825|537886033|FG004|Overall Study|Withdrawal by Subject|0|||
149111369|NCT03945825|537886034|FG005|Overall Study|Withdrawal by Subject|1|||
149111370|NCT00600613|537886035|FG000|Overall Study|Protocol Deviation|1|||
149111371|NCT01509547|537886038|FG000|Overall Study|Lost to Follow-up|24|||
149111372|NCT01509547|537886039|FG001|Overall Study|Lost to Follow-up|14|||
149111373|NCT01509547|537886038|FG000|Overall Study|Withdrawal by Subject|11|||
149111374|NCT01509547|537886039|FG001|Overall Study|Withdrawal by Subject|24|||
149111375|NCT01509547|537886038|FG000|Overall Study|Physician Decision|0|||
149111376|NCT01509547|537886039|FG001|Overall Study|Physician Decision|1|||
149111377|NCT01399918|537886040|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
149111378|NCT03197766|537886041|FG000|Overall Study|Withdrawal by Subject|2|||
149111379|NCT03197766|537886042|FG001|Overall Study|Withdrawal by Subject|0|||
149111380|NCT00570908|537886043|FG000|Overall Study|Adverse Event|5|||
149111381|NCT00570908|537886043|FG000|Overall Study|Withdrawal by Subject|2|||
149111382|NCT01110408|537886044|FG000|Overall Study|Protocol Violation|1|||
149111383|NCT01110408|537886045|FG001|Overall Study|Protocol Violation|0|||
149111384|NCT00669877|537886046|FG000|Overall Study|Disease Progression/Death|4|||
149111385|NCT03635099|537886047|FG000|Period 1|Adverse Event|1|||
149111386|NCT03635099|537886048|FG001|Period 1|Adverse Event|0|||
149111387|NCT03635099|537886049|FG002|Period 1|Adverse Event|0|||
149111388|NCT03635099|537886050|FG003|Period 1|Adverse Event|1|||
149111389|NCT03635099|537886051|FG004|Period 1|Adverse Event|0|||
149111390|NCT03635099|537886052|FG005|Period 1|Adverse Event|0|||
149111391|NCT03635099|537886053|FG006|Period 1|Adverse Event|0|||
149111392|NCT03635099|537886054|FG007|Period 1|Adverse Event|0|||
149111393|NCT03635099|537886047|FG000|Period 1|Protocol Violation|0|||
149111394|NCT03635099|537886048|FG001|Period 1|Protocol Violation|0|||
149111395|NCT03635099|537886049|FG002|Period 1|Protocol Violation|1|||
149111396|NCT03635099|537886050|FG003|Period 1|Protocol Violation|0|||
149111397|NCT03635099|537886051|FG004|Period 1|Protocol Violation|0|||
149111398|NCT03635099|537886052|FG005|Period 1|Protocol Violation|0|||
149111399|NCT03635099|537886053|FG006|Period 1|Protocol Violation|0|||
149111400|NCT03635099|537886054|FG007|Period 1|Protocol Violation|0|||
149111401|NCT03635099|537886047|FG000|Period 1|Lost to Follow-up|0|||
149111402|NCT03635099|537886048|FG001|Period 1|Lost to Follow-up|0|||
149111403|NCT03635099|537886049|FG002|Period 1|Lost to Follow-up|1|||
149111404|NCT03635099|537886050|FG003|Period 1|Lost to Follow-up|2|||
149111405|NCT03635099|537886051|FG004|Period 1|Lost to Follow-up|1|||
149111406|NCT03635099|537886052|FG005|Period 1|Lost to Follow-up|0|||
149111407|NCT03635099|537886053|FG006|Period 1|Lost to Follow-up|1|||
149111408|NCT03635099|537886054|FG007|Period 1|Lost to Follow-up|2|||
149111409|NCT03635099|537886047|FG000|Period 1|Withdrawal by Subject|3|||
149111410|NCT03635099|537886048|FG001|Period 1|Withdrawal by Subject|3|||
149111411|NCT03635099|537886049|FG002|Period 1|Withdrawal by Subject|5|||
149111412|NCT03635099|537886050|FG003|Period 1|Withdrawal by Subject|2|||
149111413|NCT03635099|537886051|FG004|Period 1|Withdrawal by Subject|2|||
149111414|NCT03635099|537886052|FG005|Period 1|Withdrawal by Subject|0|||
149111415|NCT03635099|537886053|FG006|Period 1|Withdrawal by Subject|3|||
149111416|NCT03635099|537886054|FG007|Period 1|Withdrawal by Subject|0|||
149111417|NCT03635099|537886047|FG000|Period 1|History of suicidal ideation|0|||
149111418|NCT03635099|537886048|FG001|Period 1|History of suicidal ideation|0|||
149111419|NCT03635099|537886049|FG002|Period 1|History of suicidal ideation|1|||
149111420|NCT03635099|537886050|FG003|Period 1|History of suicidal ideation|0|||
149111421|NCT03635099|537886051|FG004|Period 1|History of suicidal ideation|0|||
149111422|NCT03635099|537886052|FG005|Period 1|History of suicidal ideation|0|||
149111423|NCT03635099|537886053|FG006|Period 1|History of suicidal ideation|0|||
149111424|NCT03635099|537886054|FG007|Period 1|History of suicidal ideation|0|||
149111425|NCT03635099|537886047|FG000|Period 1|pursue other treatment options|0|||
149111426|NCT03635099|537886048|FG001|Period 1|pursue other treatment options|0|||
149111427|NCT03635099|537886049|FG002|Period 1|pursue other treatment options|0|||
149111428|NCT03635099|537886050|FG003|Period 1|pursue other treatment options|0|||
149111429|NCT03635099|537886051|FG004|Period 1|pursue other treatment options|0|||
149111430|NCT03635099|537886052|FG005|Period 1|pursue other treatment options|1|||
149111431|NCT03635099|537886053|FG006|Period 1|pursue other treatment options|0|||
149111432|NCT03635099|537886054|FG007|Period 1|pursue other treatment options|0|||
149111433|NCT03635099|537886047|FG000|Not Eligible for Period 2|Pregnancy|0|||
149111434|NCT03635099|537886048|FG001|Not Eligible for Period 2|Pregnancy|0|||
149111435|NCT03635099|537886049|FG002|Not Eligible for Period 2|Pregnancy|0|||
149111436|NCT03635099|537886050|FG003|Not Eligible for Period 2|Pregnancy|1|||
149111437|NCT03635099|537886051|FG004|Not Eligible for Period 2|Pregnancy|0|||
149111438|NCT03635099|537886052|FG005|Not Eligible for Period 2|Pregnancy|0|||
149111439|NCT03635099|537886053|FG006|Not Eligible for Period 2|Pregnancy|0|||
149111440|NCT03635099|537886054|FG007|Not Eligible for Period 2|Pregnancy|0|||
149111441|NCT03635099|537886047|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
149111442|NCT03635099|537886048|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111443|NCT03635099|537886049|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111444|NCT03635099|537886050|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111445|NCT03635099|537886051|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111446|NCT03635099|537886052|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111447|NCT03635099|537886053|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111448|NCT03635099|537886054|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
149111449|NCT03635099|537886047|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
149111450|NCT03635099|537886048|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
149111451|NCT03635099|537886049|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
149111452|NCT03635099|537886050|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
149111453|NCT03635099|537886051|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
149111454|NCT03635099|537886052|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
149111455|NCT03635099|537886053|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
149111456|NCT03635099|537886054|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
149111457|NCT03635099|537886047|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
149111458|NCT03635099|537886048|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
149111459|NCT03635099|537886049|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
149111460|NCT03635099|537886050|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
149111461|NCT03635099|537886051|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
149111462|NCT03635099|537886052|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
149111463|NCT03635099|537886053|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
149111464|NCT03635099|537886054|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
149111465|NCT03635099|537886047|FG000|Period 2|Adverse Event|0|||
149111466|NCT03635099|537886048|FG001|Period 2|Adverse Event|0|||
149111467|NCT03635099|537886049|FG002|Period 2|Adverse Event|1|||
149111468|NCT03635099|537886050|FG003|Period 2|Adverse Event|0|||
149111469|NCT03635099|537886051|FG004|Period 2|Adverse Event|1|||
149111470|NCT03635099|537886052|FG005|Period 2|Adverse Event|0|||
149111471|NCT03635099|537886053|FG006|Period 2|Adverse Event|0|||
149111472|NCT03635099|537886054|FG007|Period 2|Adverse Event|0|||
149111473|NCT03635099|537886047|FG000|Period 2|Lost to Follow-up|0|||
149111474|NCT03635099|537886048|FG001|Period 2|Lost to Follow-up|0|||
149111475|NCT03635099|537886049|FG002|Period 2|Lost to Follow-up|1|||
149111476|NCT03635099|537886050|FG003|Period 2|Lost to Follow-up|0|||
149111477|NCT03635099|537886051|FG004|Period 2|Lost to Follow-up|4|||
149111478|NCT03635099|537886052|FG005|Period 2|Lost to Follow-up|0|||
149111479|NCT03635099|537886053|FG006|Period 2|Lost to Follow-up|0|||
149111480|NCT03635099|537886054|FG007|Period 2|Lost to Follow-up|0|||
149111481|NCT03635099|537886047|FG000|Period 2|Withdrawal by Subject|0|||
149111482|NCT03635099|537886048|FG001|Period 2|Withdrawal by Subject|0|||
149111483|NCT03635099|537886049|FG002|Period 2|Withdrawal by Subject|7|||
149111484|NCT03635099|537886050|FG003|Period 2|Withdrawal by Subject|4|||
149111485|NCT03635099|537886051|FG004|Period 2|Withdrawal by Subject|7|||
149111486|NCT03635099|537886052|FG005|Period 2|Withdrawal by Subject|0|||
149111487|NCT03635099|537886053|FG006|Period 2|Withdrawal by Subject|0|||
149111488|NCT03635099|537886054|FG007|Period 2|Withdrawal by Subject|0|||
149111489|NCT04103892|537886055|FG000|Overall Study|Adverse Event|0|||
149111490|NCT04103892|537886056|FG001|Overall Study|Adverse Event|0|||
149111491|NCT04103892|537886057|FG002|Overall Study|Adverse Event|0|||
149111492|NCT04103892|537886058|FG003|Overall Study|Adverse Event|3|||
149111493|NCT04103892|537886055|FG000|Overall Study|Lost to Follow-up|0|||
149111494|NCT04103892|537886056|FG001|Overall Study|Lost to Follow-up|0|||
149111495|NCT04103892|537886057|FG002|Overall Study|Lost to Follow-up|2|||
149111496|NCT04103892|537886058|FG003|Overall Study|Lost to Follow-up|0|||
149111497|NCT04103892|537886055|FG000|Overall Study|Protocol Violation|0|||
149111498|NCT04103892|537886056|FG001|Overall Study|Protocol Violation|0|||
149111499|NCT04103892|537886057|FG002|Overall Study|Protocol Violation|1|||
149111500|NCT04103892|537886058|FG003|Overall Study|Protocol Violation|1|||
149111501|NCT04103892|537886055|FG000|Overall Study|Withdrawal by Subject|1|||
149111502|NCT04103892|537886056|FG001|Overall Study|Withdrawal by Subject|0|||
149111503|NCT04103892|537886057|FG002|Overall Study|Withdrawal by Subject|2|||
149111504|NCT04103892|537886058|FG003|Overall Study|Withdrawal by Subject|5|||
149111505|NCT04103892|537886055|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
149111506|NCT04103892|537886056|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
149111507|NCT04103892|537886057|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
149111508|NCT04103892|537886058|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
149111509|NCT03008005|537886059|FG000|Overall Study|Physician Decision|1|||
149111510|NCT03008005|537886060|FG001|Overall Study|Physician Decision|0|||
149111511|NCT03008005|537886061|FG002|Overall Study|Physician Decision|0|||
149111512|NCT03008005|537886059|FG000|Overall Study|Withdrawal by Subject|1|||
149111513|NCT03008005|537886060|FG001|Overall Study|Withdrawal by Subject|0|||
149111514|NCT03008005|537886061|FG002|Overall Study|Withdrawal by Subject|0|||
149111515|NCT03008005|537886059|FG000|Overall Study|Ineligible|0|||
149111516|NCT03008005|537886060|FG001|Overall Study|Ineligible|1|||
149111517|NCT03008005|537886061|FG002|Overall Study|Ineligible|0|||
149111518|NCT01435772|537886063|FG000|Overall Study|Adverse Event|1|||
149111519|NCT01435772|537886064|FG001|Overall Study|Adverse Event|0|||
149111520|NCT01435772|537886065|FG002|Overall Study|Adverse Event|2|||
149111521|NCT01435772|537886063|FG000|Overall Study|Withdrawal by Subject|0|||
149111522|NCT01435772|537886064|FG001|Overall Study|Withdrawal by Subject|1|||
149111523|NCT01435772|537886065|FG002|Overall Study|Withdrawal by Subject|3|||
149111524|NCT01435772|537886063|FG000|Overall Study|Other - study termination|2|||
149111525|NCT01435772|537886064|FG001|Overall Study|Other - study termination|2|||
149111526|NCT01435772|537886065|FG002|Overall Study|Other - study termination|10|||
149111527|NCT03238963|537886066|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
149111528|NCT03238963|537886067|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
149111529|NCT03238963|537886066|FG000|Overall Study|Withdrawal by Subject|1|||
149111530|NCT03238963|537886067|FG001|Overall Study|Withdrawal by Subject|1|||
149111531|NCT03238963|537886066|FG000|Overall Study|Lost to Follow-up|1|||
149111532|NCT03238963|537886067|FG001|Overall Study|Lost to Follow-up|0|||
149111533|NCT03238963|537886066|FG000|Overall Study|Protocol Violation|1|||
149111534|NCT03238963|537886067|FG001|Overall Study|Protocol Violation|1|||
149111535|NCT03238963|537886066|FG000|Overall Study|Adverse Event|1|||
149111536|NCT03238963|537886067|FG001|Overall Study|Adverse Event|0|||
149111537|NCT05823012|537886068|FG000|Titration Period|Adverse Event|1|||
149111538|NCT05823012|537886068|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
149111539|NCT05823012|537886068|FG000|Maintenance Period|Adverse Event|1|||
149111540|NCT05823012|537886068|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
149111541|NCT05823012|537886068|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
149111542|NCT07149155|537886072|FG000|Overall Study|Lost to Follow-up|10|||
149111543|NCT03345576|537886073|FG000|Overall Study|Withdrawal by Subject|2|||
149111544|NCT03345576|537886074|FG001|Overall Study|Withdrawal by Subject|2|||
149111545|NCT03345576|537886073|FG000|Overall Study|Adverse Event|1|||
149111546|NCT03345576|537886074|FG001|Overall Study|Adverse Event|0|||
149111547|NCT04707664|537887778|FG000|Overall Study|Adverse Event|2|||
149111548|NCT04707664|537887779|FG001|Overall Study|Adverse Event|0|||
149111549|NCT04707664|537887778|FG000|Overall Study|Death|1|||
149111550|NCT04707664|537887779|FG001|Overall Study|Death|2|||
149111551|NCT04707664|537887778|FG000|Overall Study|Withdrawal by Subject|13|||
149111552|NCT04707664|537887779|FG001|Overall Study|Withdrawal by Subject|21|||
149111553|NCT04707664|537887778|FG000|Overall Study|Lost to Follow-up|11|||
149111554|NCT04707664|537887779|FG001|Overall Study|Lost to Follow-up|13|||
149111555|NCT04707664|537887778|FG000|Overall Study|Not treated|2|||
149111556|NCT04707664|537887779|FG001|Overall Study|Not treated|0|||
149111557|NCT02706405|537887784|FG000|Overall Study|Death|3|||
149111558|NCT02706405|537887785|FG001|Overall Study|Death|2|||
149111559|NCT02706405|537887786|FG002|Overall Study|Death|0|||
149111560|NCT02706405|537887787|FG003|Overall Study|Death|1|||
149111561|NCT02706405|537887788|FG004|Overall Study|Death|0|||
149111562|NCT02706405|537887789|FG005|Overall Study|Death|0|||
149111563|NCT02706405|537887790|FG006|Overall Study|Death|3|||
149111564|NCT02706405|537887791|FG007|Overall Study|Death|4|||
149111565|NCT02706405|537887784|FG000|Overall Study|Disease progression|0|||
149111566|NCT02706405|537887785|FG001|Overall Study|Disease progression|0|||
149111567|NCT02706405|537887786|FG002|Overall Study|Disease progression|0|||
149111568|NCT02706405|537887787|FG003|Overall Study|Disease progression|0|||
149111569|NCT02706405|537887788|FG004|Overall Study|Disease progression|0|||
149111570|NCT02706405|537887789|FG005|Overall Study|Disease progression|0|||
149111571|NCT02706405|537887790|FG006|Overall Study|Disease progression|0|||
149111572|NCT02706405|537887791|FG007|Overall Study|Disease progression|1|||
149111573|NCT02706405|537887784|FG000|Overall Study|Pt moved to new therapy|0|||
149111574|NCT02706405|537887785|FG001|Overall Study|Pt moved to new therapy|0|||
149111575|NCT02706405|537887786|FG002|Overall Study|Pt moved to new therapy|0|||
149111576|NCT02706405|537887787|FG003|Overall Study|Pt moved to new therapy|0|||
149111577|NCT02706405|537887788|FG004|Overall Study|Pt moved to new therapy|0|||
149111578|NCT02706405|537887789|FG005|Overall Study|Pt moved to new therapy|1|||
149111579|NCT02706405|537887790|FG006|Overall Study|Pt moved to new therapy|0|||
149111580|NCT02706405|537887791|FG007|Overall Study|Pt moved to new therapy|1|||
149111581|NCT02706405|537887784|FG000|Overall Study|Physician Decision|1|||
149111582|NCT02706405|537887785|FG001|Overall Study|Physician Decision|0|||
149111583|NCT02706405|537887786|FG002|Overall Study|Physician Decision|0|||
149111584|NCT02706405|537887787|FG003|Overall Study|Physician Decision|0|||
149111585|NCT02706405|537887788|FG004|Overall Study|Physician Decision|0|||
149111586|NCT02706405|537887789|FG005|Overall Study|Physician Decision|0|||
149111587|NCT02706405|537887790|FG006|Overall Study|Physician Decision|0|||
149111588|NCT02706405|537887791|FG007|Overall Study|Physician Decision|0|||
149111589|NCT02304705|537887792|FG000|Overall Study|Withdrawal by Subject|2|||
149111590|NCT02304705|537887793|FG001|Overall Study|Withdrawal by Subject|0|||
149111591|NCT02304705|537887792|FG000|Overall Study|Physician Decision|2|||
149111592|NCT02304705|537887793|FG001|Overall Study|Physician Decision|4|||
149111593|NCT02304705|537887792|FG000|Overall Study|Death|0|||
149111594|NCT02304705|537887793|FG001|Overall Study|Death|1|||
149111595|NCT02304705|537887792|FG000|Overall Study|Lost to Follow-up|0|||
149111596|NCT02304705|537887793|FG001|Overall Study|Lost to Follow-up|2|||
149111597|NCT01195948|537887794|FG000|Overall Study|Lost to Follow-up|0|||
149111598|NCT01195948|537887795|FG001|Overall Study|Lost to Follow-up|1|||
149111599|NCT01195948|537887796|FG002|Overall Study|Lost to Follow-up|2|||
149111600|NCT03140280|537887797|FG000|Overall Study|Physician Decision|5|||
149111601|NCT05577715|537887808|FG000|Overall Study|Withdrawal by Subject|1|||
149111602|NCT05577715|537887808|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
149111603|NCT05577715|537887808|FG000|Overall Study|Lost to Follow-up|1|||
149111604|NCT05577715|537887808|FG000|Overall Study|Death|6|||
149111605|NCT03412773|537887809|FG000|Overall Study|Lost to Follow-up|0|||
149111606|NCT03412773|537887810|FG001|Overall Study|Lost to Follow-up|7|||
149111607|NCT03412773|537887811|FG002|Overall Study|Lost to Follow-up|6|||
149111608|NCT03412773|537887809|FG000|Overall Study|Withdrawal by Subject|0|||
149111609|NCT03412773|537887810|FG001|Overall Study|Withdrawal by Subject|15|||
149111610|NCT03412773|537887811|FG002|Overall Study|Withdrawal by Subject|19|||
149111611|NCT03412773|537887809|FG000|Overall Study|Study Closed By Sponsor|3|||
149111612|NCT03412773|537887810|FG001|Overall Study|Study Closed By Sponsor|46|||
149111613|NCT03412773|537887811|FG002|Overall Study|Study Closed By Sponsor|33|||
149111614|NCT03412773|537887809|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
149111615|NCT03412773|537887810|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
149111616|NCT03412773|537887811|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
149111617|NCT03412773|537887809|FG000|Overall Study|Death|7|||
149111618|NCT03412773|537887810|FG001|Overall Study|Death|259|||
149111619|NCT03412773|537887811|FG002|Overall Study|Death|273|||
149111620|NCT03412773|537887809|FG000|Overall Study|Physician Decision|0|||
149111621|NCT03412773|537887810|FG001|Overall Study|Physician Decision|0|||
149111622|NCT03412773|537887811|FG002|Overall Study|Physician Decision|1|||
149111623|NCT02643303|537887815|FG000|Overall Study|Progressive Disease|4|||
149111624|NCT02643303|537887816|FG001|Overall Study|Progressive Disease|4|||
149111625|NCT02643303|537887817|FG002|Overall Study|Progressive Disease|1|||
149111626|NCT02643303|537887818|FG003|Overall Study|Progressive Disease|12|||
149111627|NCT02643303|537887819|FG004|Overall Study|Progressive Disease|6|||
149111628|NCT02643303|537887820|FG005|Overall Study|Progressive Disease|4|||
149111629|NCT02643303|537887821|FG006|Overall Study|Progressive Disease|8|||
149111630|NCT02643303|537887822|FG007|Overall Study|Progressive Disease|2|||
149111631|NCT02643303|537887823|FG008|Overall Study|Progressive Disease|6|||
149111632|NCT02643303|537887815|FG000|Overall Study|Adverse Event|0|||
149111633|NCT02643303|537887816|FG001|Overall Study|Adverse Event|1|||
149111634|NCT02643303|537887817|FG002|Overall Study|Adverse Event|0|||
149111635|NCT02643303|537887818|FG003|Overall Study|Adverse Event|0|||
149111636|NCT02643303|537887819|FG004|Overall Study|Adverse Event|1|||
149111637|NCT02643303|537887820|FG005|Overall Study|Adverse Event|0|||
149111638|NCT02643303|537887821|FG006|Overall Study|Adverse Event|0|||
149111639|NCT02643303|537887822|FG007|Overall Study|Adverse Event|0|||
149111640|NCT02643303|537887823|FG008|Overall Study|Adverse Event|0|||
149111641|NCT02643303|537887815|FG000|Overall Study|Withdrawal by Subject|0|||
149111642|NCT02643303|537887816|FG001|Overall Study|Withdrawal by Subject|0|||
149111643|NCT02643303|537887817|FG002|Overall Study|Withdrawal by Subject|0|||
149111644|NCT02643303|537887818|FG003|Overall Study|Withdrawal by Subject|1|||
149111645|NCT02643303|537887819|FG004|Overall Study|Withdrawal by Subject|0|||
149111646|NCT02643303|537887820|FG005|Overall Study|Withdrawal by Subject|0|||
149111647|NCT02643303|537887821|FG006|Overall Study|Withdrawal by Subject|1|||
149111648|NCT02643303|537887822|FG007|Overall Study|Withdrawal by Subject|1|||
149111649|NCT02643303|537887823|FG008|Overall Study|Withdrawal by Subject|1|||
149111650|NCT03057847|537887830|FG000|Overall Study|Lost to Follow-up|16|||
149111651|NCT03301155|537887832|FG000|Overall Study|Сompliance with exclusion criteria|8|||
149111652|NCT03301155|537887833|FG001|Overall Study|Сompliance with exclusion criteria|7|||
149111653|NCT01706705|537887836|FG000|Overall Study|Death|1|||
149111654|NCT01706705|537887836|FG000|Overall Study|Lack of Efficacy|13|||
149111655|NCT01706705|537887836|FG000|Overall Study|Non-clinical|6|||
149111656|NCT03510455|537887837|FG000|Overall Study|Physician Decision|1|||
149111657|NCT00384189|537887838|FG000|Overall Study|Reason Not Specified|50|||
149111658|NCT00384189|537887839|FG001|Overall Study|Reason Not Specified|57|||
149111659|NCT00384189|537887840|FG002|Overall Study|Reason Not Specified|58|||
149111660|NCT00384189|537887841|FG003|Overall Study|Reason Not Specified|40|||
149111661|NCT04958642|537887842|FG000|Overall Study|Transferred to OLEX program|3|||
149111662|NCT04958642|537887843|FG001|Overall Study|Transferred to OLEX program|0|||
149111663|NCT04958642|537887844|FG002|Overall Study|Transferred to OLEX program|5|||
149111664|NCT04958642|537887842|FG000|Overall Study|Death|0|||
149111665|NCT04958642|537887843|FG001|Overall Study|Death|0|||
149111666|NCT04958642|537887844|FG002|Overall Study|Death|1|||
149111667|NCT04958642|537887842|FG000|Overall Study|Withdrawal by Subject|4|||
149111668|NCT04958642|537887843|FG001|Overall Study|Withdrawal by Subject|9|||
149111669|NCT04958642|537887844|FG002|Overall Study|Withdrawal by Subject|13|||
149111670|NCT04958642|537887842|FG000|Overall Study|Investigator's Decision|0|||
149111671|NCT04958642|537887843|FG001|Overall Study|Investigator's Decision|0|||
149111672|NCT04958642|537887844|FG002|Overall Study|Investigator's Decision|1|||
149111673|NCT04958642|537887842|FG000|Overall Study|Adverse Event|1|||
149111674|NCT04958642|537887843|FG001|Overall Study|Adverse Event|0|||
149111675|NCT04958642|537887844|FG002|Overall Study|Adverse Event|1|||
149111676|NCT04958642|537887842|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
149111677|NCT04958642|537887843|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
149111678|NCT04958642|537887844|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
149111679|NCT04958642|537887842|FG000|Overall Study|Lost to Follow-up|1|||
149111680|NCT04958642|537887843|FG001|Overall Study|Lost to Follow-up|0|||
149111681|NCT04958642|537887844|FG002|Overall Study|Lost to Follow-up|0|||
149111682|NCT04958642|537887842|FG000|Overall Study|Transferred to EAP following study termination|0|||
149111683|NCT04958642|537887843|FG001|Overall Study|Transferred to EAP following study termination|0|||
149111684|NCT04958642|537887844|FG002|Overall Study|Transferred to EAP following study termination|1|||
149111685|NCT04958642|537887842|FG000|Overall Study|Transferred to Expanded Access Program|1|||
149111686|NCT04958642|537887843|FG001|Overall Study|Transferred to Expanded Access Program|0|||
149111687|NCT04958642|537887844|FG002|Overall Study|Transferred to Expanded Access Program|0|||
149111688|NCT01199068|537887845|FG000|Overall Study|Unacceptable toxicity|0|||
149111689|NCT01199068|537887846|FG001|Overall Study|Unacceptable toxicity|0|||
149111690|NCT01199068|537887847|FG002|Overall Study|Unacceptable toxicity|2|||
149111691|NCT01199068|537887845|FG000|Overall Study|Progressive disease|3|||
149111692|NCT01199068|537887846|FG001|Overall Study|Progressive disease|3|||
149111693|NCT01199068|537887847|FG002|Overall Study|Progressive disease|6|||
149111694|NCT01199068|537887845|FG000|Overall Study|Withdrawal by Subject|0|||
149111695|NCT01199068|537887846|FG001|Overall Study|Withdrawal by Subject|0|||
149111696|NCT01199068|537887847|FG002|Overall Study|Withdrawal by Subject|1|||
149111697|NCT01250925|537887848|FG000|Overall Study|Lost to Follow-up|1|||
149111698|NCT01250925|537887849|FG001|Overall Study|Lost to Follow-up|1|||
149111699|NCT01250925|537887850|FG002|Overall Study|Lost to Follow-up|0|||
149111700|NCT01250925|537887848|FG000|Overall Study|Withdrawal by Subject|2|||
149111701|NCT01250925|537887849|FG001|Overall Study|Withdrawal by Subject|0|||
149111702|NCT01250925|537887850|FG002|Overall Study|Withdrawal by Subject|0|||
149111703|NCT01250925|537887848|FG000|Overall Study|Protocol Violation|2|||
149111704|NCT01250925|537887849|FG001|Overall Study|Protocol Violation|0|||
149111705|NCT01250925|537887850|FG002|Overall Study|Protocol Violation|0|||
149111706|NCT01250925|537887848|FG000|Overall Study|Physician Decision|0|||
149111707|NCT01250925|537887849|FG001|Overall Study|Physician Decision|2|||
149111708|NCT01250925|537887850|FG002|Overall Study|Physician Decision|1|||
149111709|NCT01250925|537887848|FG000|Overall Study|Adverse Event|0|||
149111710|NCT01250925|537887849|FG001|Overall Study|Adverse Event|0|||
149111711|NCT01250925|537887850|FG002|Overall Study|Adverse Event|1|||
149111712|NCT00678301|537887851|FG000|Overall Study|Non-compliance with study procedures|0|||
149111713|NCT00678301|537887852|FG001|Overall Study|Non-compliance with study procedures|1|||
149111714|NCT00678301|537887851|FG000|Overall Study|Adverse Event|1|||
149111715|NCT00678301|537887852|FG001|Overall Study|Adverse Event|0|||
149111716|NCT00678301|537887851|FG000|Overall Study|Withdrawal by Subject|4|||
149111717|NCT00678301|537887852|FG001|Overall Study|Withdrawal by Subject|0|||
149111718|NCT00678301|537887851|FG000|Overall Study|Lost to Follow-up|3|||
149111719|NCT00678301|537887852|FG001|Overall Study|Lost to Follow-up|1|||
149111720|NCT03338296|537887853|FG000|Overall Study|Adverse Event|0|||
149111721|NCT03338296|537887854|FG001|Overall Study|Adverse Event|1|||
149111722|NCT03338296|537887853|FG000|Overall Study|Withdrawal by Subject|14|||
149111723|NCT03338296|537887854|FG001|Overall Study|Withdrawal by Subject|13|||
149111724|NCT03338296|537887853|FG000|Overall Study|Lost to Follow-up|10|||
149111725|NCT03338296|537887854|FG001|Overall Study|Lost to Follow-up|10|||
149111726|NCT03338296|537887853|FG000|Overall Study|Study Terminated by Sponsor|77|||
149111727|NCT03338296|537887854|FG001|Overall Study|Study Terminated by Sponsor|76|||
149111728|NCT03338296|537887853|FG000|Overall Study|Other|2|||
149111729|NCT03338296|537887854|FG001|Overall Study|Other|7|||
149111730|NCT03338296|537887853|FG000|Overall Study|Missing|0|||
149111731|NCT03338296|537887854|FG001|Overall Study|Missing|1|||
149111732|NCT01939353|537887855|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
149111733|NCT01939353|537887855|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
149111734|NCT01939353|537887855|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
149111735|NCT01939353|537887855|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
149111736|NCT01939353|537887855|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
149111737|NCT04421950|537887861|FG000|Overall Study|Dropped or lost to follow up|4|||
149111738|NCT04421950|537887862|FG001|Overall Study|Dropped or lost to follow up|2|||
149111739|NCT05048238|537887863|FG000|Overall Study|Withdrawal by Subject|1|||
149111740|NCT00335140|537887868|FG000|Overall Study|Ineligible|1|||
149111741|NCT01371825|537887873|FG000|Overall Study|Death|4|||
149111742|NCT02807272|537887874|FG000|Overall Study|Death|9|||
149111743|NCT02807272|537887875|FG001|Overall Study|Death|5|||
149111744|NCT02807272|537887876|FG002|Overall Study|Death|2|||
149111745|NCT02807272|537887877|FG003|Overall Study|Death|0|||
149111746|NCT02807272|537887878|FG004|Overall Study|Death|1|||
149111747|NCT02807272|537887874|FG000|Overall Study|Lost to Follow-up|1|||
149111748|NCT02807272|537887875|FG001|Overall Study|Lost to Follow-up|0|||
149111749|NCT02807272|537887876|FG002|Overall Study|Lost to Follow-up|0|||
149111750|NCT02807272|537887877|FG003|Overall Study|Lost to Follow-up|0|||
149111751|NCT02807272|537887878|FG004|Overall Study|Lost to Follow-up|0|||
149111752|NCT02807272|537887874|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
149111753|NCT02807272|537887875|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
149111754|NCT02807272|537887876|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
149111755|NCT02807272|537887877|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
149111756|NCT02807272|537887878|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
149111757|NCT02807272|537887874|FG000|Overall Study|Protocol-defined Disease Progression|0|||
149111758|NCT02807272|537887875|FG001|Overall Study|Protocol-defined Disease Progression|1|||
149111759|NCT02807272|537887876|FG002|Overall Study|Protocol-defined Disease Progression|0|||
149111760|NCT02807272|537887877|FG003|Overall Study|Protocol-defined Disease Progression|0|||
149111761|NCT02807272|537887878|FG004|Overall Study|Protocol-defined Disease Progression|1|||
149111762|NCT02807272|537887874|FG000|Overall Study|Study Terminated by Sponsor|1|||
149111763|NCT02807272|537887875|FG001|Overall Study|Study Terminated by Sponsor|0|||
149111764|NCT02807272|537887876|FG002|Overall Study|Study Terminated by Sponsor|0|||
149111765|NCT02807272|537887877|FG003|Overall Study|Study Terminated by Sponsor|1|||
149111766|NCT02807272|537887878|FG004|Overall Study|Study Terminated by Sponsor|0|||
149111767|NCT02807272|537887874|FG000|Overall Study|Other|1|||
149111768|NCT02807272|537887875|FG001|Overall Study|Other|0|||
149111769|NCT02807272|537887876|FG002|Overall Study|Other|0|||
149111770|NCT02807272|537887877|FG003|Overall Study|Other|0|||
149111771|NCT02807272|537887878|FG004|Overall Study|Other|1|||
149111772|NCT01038427|537887881|FG000|Overall Study|Lost to follow up|1|||
149111773|NCT01038427|537887882|FG001|Overall Study|Lost to follow up|1|||
149111774|NCT01038427|537887883|FG002|Overall Study|Lost to follow up|0|||
149111775|NCT01038427|537887881|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
149111776|NCT01038427|537887882|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
149111777|NCT01038427|537887883|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
149111778|NCT01038427|537887881|FG000|Overall Study|Withdrew consent|0|||
149111779|NCT01038427|537887882|FG001|Overall Study|Withdrew consent|0|||
149111780|NCT01038427|537887883|FG002|Overall Study|Withdrew consent|1|||
149111781|NCT01038427|537887881|FG000|Overall Study|Adverse Event|2|||
149111782|NCT01038427|537887882|FG001|Overall Study|Adverse Event|2|||
149111783|NCT01038427|537887883|FG002|Overall Study|Adverse Event|1|||
149111784|NCT01038427|537887881|FG000|Overall Study|Enrolled in error|0|||
149111785|NCT01038427|537887882|FG001|Overall Study|Enrolled in error|1|||
149111786|NCT01038427|537887883|FG002|Overall Study|Enrolled in error|1|||
149111787|NCT01038427|537887881|FG000|Overall Study|Other|0|||
149111788|NCT01038427|537887882|FG001|Overall Study|Other|2|||
149111789|NCT01038427|537887883|FG002|Overall Study|Other|0|||
149111790|NCT00588692|537887884|FG000|Overall Study|Withdrawal by Subject|4|||
149111791|NCT00588692|537887885|FG001|Overall Study|Withdrawal by Subject|2|||
149111792|NCT00588692|537887884|FG000|Overall Study|Hip Surgery|0|||
149111793|NCT00588692|537887885|FG001|Overall Study|Hip Surgery|1|||
149111794|NCT00588692|537887884|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
149111795|NCT00588692|537887885|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
149111796|NCT00588692|537887884|FG000|Overall Study|Cancer|1|||
149111797|NCT00588692|537887885|FG001|Overall Study|Cancer|0|||
149111798|NCT00588692|537887884|FG000|Overall Study|Death|1|||
149111799|NCT00588692|537887885|FG001|Overall Study|Death|0|||
149111800|NCT01137578|537887889|FG000|Overall Study|Participant requested to Discontinue|3|||
149111801|NCT01137578|537887890|FG001|Overall Study|Participant requested to Discontinue|0|||
149111802|NCT01137578|537887891|FG002|Overall Study|Participant requested to Discontinue|0|||
149111803|NCT01137578|537887889|FG000|Overall Study|Withdrawal by Subject|1|||
149111804|NCT01137578|537887890|FG001|Overall Study|Withdrawal by Subject|0|||
149111805|NCT01137578|537887891|FG002|Overall Study|Withdrawal by Subject|0|||
149111806|NCT01137578|537887889|FG000|Overall Study|Other|12|||
149111807|NCT01137578|537887890|FG001|Overall Study|Other|2|||
149111808|NCT01137578|537887891|FG002|Overall Study|Other|6|||
149111809|NCT01361594|537887892|FG000|Overall Study|Withdrawal by Subject|1|||
149111810|NCT01361594|537887893|FG001|Overall Study|Withdrawal by Subject|2|||
149111811|NCT00415051|537887894|FG000|Overall Study|Protocol Violation|1|||
149111812|NCT01461005|537887895|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
149111813|NCT01436253|537887896|FG000|Overall Study|Lost to Follow-up|182|||
149111814|NCT01436253|537887896|FG000|Overall Study|Not meeting all eligibility criteria|117|||
149111815|NCT04844879|537887899|FG000|Overall Study|Death|1|||
149111816|NCT04844879|537887899|FG000|Overall Study|Withdrawal by Subject|1|||
149111817|NCT04844879|537887899|FG000|Overall Study|Adverse Event|1|||
149111818|NCT04520659|537887900|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
149111819|NCT04520659|537887901|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
149111820|NCT04520659|537887902|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
149111821|NCT04520659|537887903|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
149111822|NCT04485611|537887908|FG000|Prehabilitation|Physician Decision|1|||
149111823|NCT04879849|537887909|FG000|Overall Study|Lost to Follow-up|0|||
149111824|NCT04879849|537887910|FG001|Overall Study|Lost to Follow-up|0|||
149111825|NCT04879849|537887911|FG002|Overall Study|Lost to Follow-up|0|||
149111826|NCT04879849|537887912|FG003|Overall Study|Lost to Follow-up|1|||
149111827|NCT04879849|537887913|FG004|Overall Study|Lost to Follow-up|0|||
149111828|NCT04879849|537887914|FG005|Overall Study|Lost to Follow-up|0|||
149111829|NCT04879849|537887915|FG006|Overall Study|Lost to Follow-up|0|||
149111830|NCT04879849|537887916|FG007|Overall Study|Lost to Follow-up|0|||
149111831|NCT04879849|537887909|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
149111832|NCT04879849|537887910|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
149111833|NCT04879849|537887911|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
149111834|NCT04879849|537887912|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
149111835|NCT04879849|537887913|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
149111836|NCT04879849|537887914|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
149111837|NCT04879849|537887915|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
149111838|NCT04879849|537887916|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
149111839|NCT04879849|537887909|FG000|Overall Study|Withdrawal by Subject|0|||
149111840|NCT04879849|537887910|FG001|Overall Study|Withdrawal by Subject|0|||
149111841|NCT04879849|537887911|FG002|Overall Study|Withdrawal by Subject|0|||
149111842|NCT04879849|537887912|FG003|Overall Study|Withdrawal by Subject|0|||
149111843|NCT04879849|537887913|FG004|Overall Study|Withdrawal by Subject|2|||
149111844|NCT04879849|537887914|FG005|Overall Study|Withdrawal by Subject|0|||
149111845|NCT04879849|537887915|FG006|Overall Study|Withdrawal by Subject|1|||
149111846|NCT04879849|537887916|FG007|Overall Study|Withdrawal by Subject|0|||
149111847|NCT04879849|537887909|FG000|Overall Study|Progressive Disease|0|||
149111848|NCT04879849|537887910|FG001|Overall Study|Progressive Disease|0|||
149111849|NCT04879849|537887911|FG002|Overall Study|Progressive Disease|1|||
149111850|NCT04879849|537887912|FG003|Overall Study|Progressive Disease|0|||
149111851|NCT04879849|537887913|FG004|Overall Study|Progressive Disease|0|||
149111852|NCT04879849|537887914|FG005|Overall Study|Progressive Disease|0|||
149111853|NCT04879849|537887915|FG006|Overall Study|Progressive Disease|0|||
149111854|NCT04879849|537887916|FG007|Overall Study|Progressive Disease|0|||
149111855|NCT04879849|537887909|FG000|Overall Study|Death|0|||
149111856|NCT04879849|537887910|FG001|Overall Study|Death|0|||
149111857|NCT04879849|537887911|FG002|Overall Study|Death|1|||
149111858|NCT04879849|537887912|FG003|Overall Study|Death|1|||
149111859|NCT04879849|537887913|FG004|Overall Study|Death|1|||
149111860|NCT04879849|537887914|FG005|Overall Study|Death|2|||
149111861|NCT04879849|537887915|FG006|Overall Study|Death|1|||
149111862|NCT04879849|537887916|FG007|Overall Study|Death|2|||
149111863|NCT04879849|537887909|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
149111864|NCT04879849|537887910|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
149111865|NCT04879849|537887911|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
149111866|NCT04879849|537887912|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
149111867|NCT04879849|537887913|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
149111868|NCT04879849|537887914|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
149111869|NCT04879849|537887915|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
149111870|NCT04879849|537887916|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
149111871|NCT04879849|537887909|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111872|NCT04879849|537887910|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111873|NCT04879849|537887911|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111874|NCT04879849|537887912|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111875|NCT04879849|537887913|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111876|NCT04879849|537887914|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111877|NCT04879849|537887915|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
149111878|NCT04879849|537887916|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
149111879|NCT04879849|537887909|FG000|Overall Study|Reason Not Specified|1|||
149111880|NCT04879849|537887910|FG001|Overall Study|Reason Not Specified|0|||
149111881|NCT04879849|537887911|FG002|Overall Study|Reason Not Specified|0|||
149111882|NCT04879849|537887912|FG003|Overall Study|Reason Not Specified|0|||
149111883|NCT04879849|537887913|FG004|Overall Study|Reason Not Specified|0|||
149111884|NCT04879849|537887914|FG005|Overall Study|Reason Not Specified|0|||
149111885|NCT04879849|537887915|FG006|Overall Study|Reason Not Specified|0|||
149111886|NCT04879849|537887916|FG007|Overall Study|Reason Not Specified|0|||
149111887|NCT04201262|537887918|FG000|Primary Treatment Period|Adverse Event|1|||
149111888|NCT04201262|537887919|FG001|Primary Treatment Period|Adverse Event|2|||
149111889|NCT04201262|537887918|FG000|Primary Treatment Period|Physician Decision|1|||
149111890|NCT04201262|537887919|FG001|Primary Treatment Period|Physician Decision|1|||
149111891|NCT04201262|537887918|FG000|Long-term Extension Period|Death|1|||
149111892|NCT04201262|537887919|FG001|Long-term Extension Period|Death|0|||
149111893|NCT05217641|537887923|FG000|Overall Study|Lost to Follow-up|1|||
149111894|NCT05217641|537887924|FG001|Overall Study|Lost to Follow-up|1|||
149111895|NCT05217641|537887925|FG002|Overall Study|Lost to Follow-up|0|||
149111896|NCT05217641|537887926|FG003|Overall Study|Lost to Follow-up|1|||
149111897|NCT05217641|537887927|FG004|Overall Study|Lost to Follow-up|1|||
149111898|NCT05217641|537887928|FG005|Overall Study|Lost to Follow-up|0|||
149111899|NCT05217641|537887923|FG000|Overall Study|Withdrawal by Subject|0|||
149111900|NCT05217641|537887924|FG001|Overall Study|Withdrawal by Subject|0|||
149111901|NCT05217641|537887925|FG002|Overall Study|Withdrawal by Subject|0|||
149111902|NCT05217641|537887926|FG003|Overall Study|Withdrawal by Subject|3|||
149111903|NCT05217641|537887927|FG004|Overall Study|Withdrawal by Subject|1|||
149111904|NCT05217641|537887928|FG005|Overall Study|Withdrawal by Subject|0|||
149111905|NCT05217641|537887923|FG000|Overall Study|Other: participant did not specify reason|0|||
149111906|NCT05217641|537887924|FG001|Overall Study|Other: participant did not specify reason|0|||
149111907|NCT05217641|537887925|FG002|Overall Study|Other: participant did not specify reason|0|||
149111908|NCT05217641|537887926|FG003|Overall Study|Other: participant did not specify reason|0|||
149111909|NCT05217641|537887927|FG004|Overall Study|Other: participant did not specify reason|1|||
149111910|NCT05217641|537887928|FG005|Overall Study|Other: participant did not specify reason|0|||
149111911|NCT05217641|537887923|FG000|Overall Study|Extended Follow up|1|||
149111912|NCT05217641|537887924|FG001|Overall Study|Extended Follow up|1|||
149111913|NCT05217641|537887925|FG002|Overall Study|Extended Follow up|0|||
149111914|NCT05217641|537887926|FG003|Overall Study|Extended Follow up|0|||
149111915|NCT05217641|537887927|FG004|Overall Study|Extended Follow up|1|||
149111916|NCT05217641|537887928|FG005|Overall Study|Extended Follow up|0|||
149111917|NCT05292586|537887929|FG000|Overall Study|Withdrawal by Subject|3|||
149111918|NCT05292586|537887930|FG001|Overall Study|Withdrawal by Subject|10|||
149111919|NCT05292586|537887929|FG000|Overall Study|Randomization error|3|||
149111920|NCT05292586|537887930|FG001|Overall Study|Randomization error|7|||
149111921|NCT05292586|537887929|FG000|Overall Study|Adverse Event|3|||
149111922|NCT05292586|537887930|FG001|Overall Study|Adverse Event|0|||
149111923|NCT05292586|537887929|FG000|Overall Study|Lost to Follow-up|0|||
149111924|NCT05292586|537887930|FG001|Overall Study|Lost to Follow-up|1|||
149111925|NCT05292586|537887929|FG000|Overall Study|Patient refused treatment|1|||
149111926|NCT05292586|537887930|FG001|Overall Study|Patient refused treatment|0|||
149111927|NCT05292586|537887929|FG000|Overall Study|Patient could not travel to the study site|1|||
149111928|NCT05292586|537887930|FG001|Overall Study|Patient could not travel to the study site|0|||
149111929|NCT05292586|537887929|FG000|Overall Study|Technical issues with the masterscope|0|||
149111930|NCT05292586|537887930|FG001|Overall Study|Technical issues with the masterscope|3|||
149111931|NCT05292586|537887929|FG000|Overall Study|Patient moved to a different state|0|||
149111932|NCT05292586|537887930|FG001|Overall Study|Patient moved to a different state|1|||
149111933|NCT02397447|537887931|FG000|Overall Study|Lost to Follow-up|2|||
149111934|NCT02397447|537887932|FG001|Overall Study|Lost to Follow-up|2|||
149111935|NCT02994069|537887933|FG000|Overall Study|Death|7|||
149111936|NCT02994069|537887934|FG001|Overall Study|Death|13|||
149111937|NCT02994069|537887933|FG000|Overall Study|Adverse Event|1|||
149111938|NCT02994069|537887934|FG001|Overall Study|Adverse Event|0|||
149111939|NCT02994069|537887933|FG000|Overall Study|Other|2|||
149111940|NCT02994069|537887934|FG001|Overall Study|Other|0|||
149111941|NCT02994069|537887933|FG000|Overall Study|still on follow up/treatment|5|||
149111942|NCT02994069|537887934|FG001|Overall Study|still on follow up/treatment|6|||
149111943|NCT03829501|537889957|FG000|Overall Study|Withdrawal of Consent|2|||
149111944|NCT03829501|537889958|FG001|Overall Study|Withdrawal of Consent|0|||
149111945|NCT03829501|537889959|FG002|Overall Study|Withdrawal of Consent|3|||
149111946|NCT03829501|537889960|FG003|Overall Study|Withdrawal of Consent|0|||
149111947|NCT03829501|537889961|FG004|Overall Study|Withdrawal of Consent|1|||
149111948|NCT03829501|537889962|FG005|Overall Study|Withdrawal of Consent|1|||
149111949|NCT03829501|537889963|FG006|Overall Study|Withdrawal of Consent|0|||
149111950|NCT03829501|537889964|FG007|Overall Study|Withdrawal of Consent|10|||
149111951|NCT03829501|537889965|FG008|Overall Study|Withdrawal of Consent|10|||
149111952|NCT03829501|537889966|FG009|Overall Study|Withdrawal of Consent|3|||
149111953|NCT03829501|537889967|FG010|Overall Study|Withdrawal of Consent|4|||
149111954|NCT03829501|537889968|FG011|Overall Study|Withdrawal of Consent|4|||
149111955|NCT03829501|537889969|FG012|Overall Study|Withdrawal of Consent|4|||
149111956|NCT03829501|537889970|FG013|Overall Study|Withdrawal of Consent|0|||
149111957|NCT03829501|537889971|FG014|Overall Study|Withdrawal of Consent|3|||
149111958|NCT03829501|537889972|FG015|Overall Study|Withdrawal of Consent|0|||
149111959|NCT03829501|537889973|FG016|Overall Study|Withdrawal of Consent|1|||
149111960|NCT03829501|537889974|FG017|Overall Study|Withdrawal of Consent|1|||
149111961|NCT03829501|537889975|FG018|Overall Study|Withdrawal of Consent|0|||
149111962|NCT03829501|537889976|FG019|Overall Study|Withdrawal of Consent|0|||
149111963|NCT03829501|537889977|FG020|Overall Study|Withdrawal of Consent|3|||
149111964|NCT03829501|537889978|FG021|Overall Study|Withdrawal of Consent|0|||
149111965|NCT03829501|537889979|FG022|Overall Study|Withdrawal of Consent|1|||
149111966|NCT03829501|537889957|FG000|Overall Study|PD|0|||
149111967|NCT03829501|537889958|FG001|Overall Study|PD|0|||
149111968|NCT03829501|537889959|FG002|Overall Study|PD|0|||
149111969|NCT03829501|537889960|FG003|Overall Study|PD|2|||
149111970|NCT03829501|537889961|FG004|Overall Study|PD|0|||
149111971|NCT03829501|537889962|FG005|Overall Study|PD|0|||
149111972|NCT03829501|537889963|FG006|Overall Study|PD|0|||
149111973|NCT03829501|537889964|FG007|Overall Study|PD|0|||
149111974|NCT03829501|537889965|FG008|Overall Study|PD|0|||
149111975|NCT03829501|537889966|FG009|Overall Study|PD|0|||
149111976|NCT03829501|537889967|FG010|Overall Study|PD|0|||
149111977|NCT03829501|537889968|FG011|Overall Study|PD|0|||
149111978|NCT03829501|537889969|FG012|Overall Study|PD|0|||
149111979|NCT03829501|537889970|FG013|Overall Study|PD|0|||
149111980|NCT03829501|537889971|FG014|Overall Study|PD|0|||
149111981|NCT03829501|537889972|FG015|Overall Study|PD|1|||
149111982|NCT03829501|537889973|FG016|Overall Study|PD|0|||
149111983|NCT03829501|537889974|FG017|Overall Study|PD|0|||
149111984|NCT03829501|537889975|FG018|Overall Study|PD|0|||
149111985|NCT03829501|537889976|FG019|Overall Study|PD|0|||
149111986|NCT03829501|537889977|FG020|Overall Study|PD|1|||
149111987|NCT03829501|537889978|FG021|Overall Study|PD|0|||
149111988|NCT03829501|537889979|FG022|Overall Study|PD|0|||
149111989|NCT03829501|537889957|FG000|Overall Study|Study Terminated by Sponsor|0|||
149111990|NCT03829501|537889958|FG001|Overall Study|Study Terminated by Sponsor|0|||
149111991|NCT03829501|537889959|FG002|Overall Study|Study Terminated by Sponsor|0|||
149111992|NCT03829501|537889960|FG003|Overall Study|Study Terminated by Sponsor|0|||
149111993|NCT03829501|537889961|FG004|Overall Study|Study Terminated by Sponsor|0|||
149111994|NCT03829501|537889962|FG005|Overall Study|Study Terminated by Sponsor|0|||
149111995|NCT03829501|537889963|FG006|Overall Study|Study Terminated by Sponsor|0|||
149111996|NCT03829501|537889964|FG007|Overall Study|Study Terminated by Sponsor|3|||
149111997|NCT03829501|537889965|FG008|Overall Study|Study Terminated by Sponsor|1|||
149111998|NCT03829501|537889966|FG009|Overall Study|Study Terminated by Sponsor|0|||
149111999|NCT03829501|537889967|FG010|Overall Study|Study Terminated by Sponsor|0|||
149112000|NCT03829501|537889968|FG011|Overall Study|Study Terminated by Sponsor|0|||
149112001|NCT03829501|537889969|FG012|Overall Study|Study Terminated by Sponsor|0|||
149112002|NCT03829501|537889970|FG013|Overall Study|Study Terminated by Sponsor|0|||
149112003|NCT03829501|537889971|FG014|Overall Study|Study Terminated by Sponsor|3|||
149112004|NCT03829501|537889972|FG015|Overall Study|Study Terminated by Sponsor|2|||
149112005|NCT03829501|537889973|FG016|Overall Study|Study Terminated by Sponsor|2|||
149112006|NCT03829501|537889974|FG017|Overall Study|Study Terminated by Sponsor|0|||
149112007|NCT03829501|537889975|FG018|Overall Study|Study Terminated by Sponsor|0|||
149112008|NCT03829501|537889976|FG019|Overall Study|Study Terminated by Sponsor|0|||
149112009|NCT03829501|537889977|FG020|Overall Study|Study Terminated by Sponsor|1|||
149112010|NCT03829501|537889978|FG021|Overall Study|Study Terminated by Sponsor|0|||
149112011|NCT03829501|537889979|FG022|Overall Study|Study Terminated by Sponsor|3|||
149112012|NCT03829501|537889957|FG000|Overall Study|Lost to Follow Up|0|||
149112013|NCT03829501|537889958|FG001|Overall Study|Lost to Follow Up|0|||
149112014|NCT03829501|537889959|FG002|Overall Study|Lost to Follow Up|0|||
149112015|NCT03829501|537889960|FG003|Overall Study|Lost to Follow Up|0|||
149112016|NCT03829501|537889961|FG004|Overall Study|Lost to Follow Up|1|||
149112017|NCT03829501|537889962|FG005|Overall Study|Lost to Follow Up|0|||
149112018|NCT03829501|537889963|FG006|Overall Study|Lost to Follow Up|0|||
149112019|NCT03829501|537889964|FG007|Overall Study|Lost to Follow Up|2|||
149112020|NCT03829501|537889965|FG008|Overall Study|Lost to Follow Up|2|||
149112021|NCT03829501|537889966|FG009|Overall Study|Lost to Follow Up|0|||
149112022|NCT03829501|537889967|FG010|Overall Study|Lost to Follow Up|2|||
149112023|NCT03829501|537889968|FG011|Overall Study|Lost to Follow Up|1|||
149112024|NCT03829501|537889969|FG012|Overall Study|Lost to Follow Up|0|||
149112025|NCT03829501|537889970|FG013|Overall Study|Lost to Follow Up|1|||
149112026|NCT03829501|537889971|FG014|Overall Study|Lost to Follow Up|1|||
149112027|NCT03829501|537889972|FG015|Overall Study|Lost to Follow Up|0|||
149112028|NCT03829501|537889973|FG016|Overall Study|Lost to Follow Up|0|||
149112029|NCT03829501|537889974|FG017|Overall Study|Lost to Follow Up|0|||
149112030|NCT03829501|537889975|FG018|Overall Study|Lost to Follow Up|0|||
149112031|NCT03829501|537889976|FG019|Overall Study|Lost to Follow Up|0|||
149112032|NCT03829501|537889977|FG020|Overall Study|Lost to Follow Up|0|||
149112033|NCT03829501|537889978|FG021|Overall Study|Lost to Follow Up|0|||
149112034|NCT03829501|537889979|FG022|Overall Study|Lost to Follow Up|1|||
149112035|NCT03829501|537889957|FG000|Overall Study|Death|2|||
149112036|NCT03829501|537889958|FG001|Overall Study|Death|4|||
149112037|NCT03829501|537889959|FG002|Overall Study|Death|5|||
149112038|NCT03829501|537889960|FG003|Overall Study|Death|6|||
149112039|NCT03829501|537889961|FG004|Overall Study|Death|5|||
149112040|NCT03829501|537889962|FG005|Overall Study|Death|4|||
149112041|NCT03829501|537889963|FG006|Overall Study|Death|5|||
149112042|NCT03829501|537889964|FG007|Overall Study|Death|24|||
149112043|NCT03829501|537889965|FG008|Overall Study|Death|22|||
149112044|NCT03829501|537889966|FG009|Overall Study|Death|6|||
149112045|NCT03829501|537889967|FG010|Overall Study|Death|3|||
149112046|NCT03829501|537889968|FG011|Overall Study|Death|10|||
149112047|NCT03829501|537889969|FG012|Overall Study|Death|10|||
149112048|NCT03829501|537889970|FG013|Overall Study|Death|5|||
149112049|NCT03829501|537889971|FG014|Overall Study|Death|7|||
149112050|NCT03829501|537889972|FG015|Overall Study|Death|2|||
149112051|NCT03829501|537889973|FG016|Overall Study|Death|2|||
149112052|NCT03829501|537889974|FG017|Overall Study|Death|1|||
149112053|NCT03829501|537889975|FG018|Overall Study|Death|1|||
149112054|NCT03829501|537889976|FG019|Overall Study|Death|1|||
149112055|NCT03829501|537889977|FG020|Overall Study|Death|1|||
149112056|NCT03829501|537889978|FG021|Overall Study|Death|2|||
149112057|NCT03829501|537889979|FG022|Overall Study|Death|3|||
149112058|NCT03829501|537889957|FG000|Overall Study|Miscellaneous|0|||
149112059|NCT03829501|537889958|FG001|Overall Study|Miscellaneous|0|||
149112060|NCT03829501|537889959|FG002|Overall Study|Miscellaneous|1|||
149112061|NCT03829501|537889960|FG003|Overall Study|Miscellaneous|0|||
149112062|NCT03829501|537889961|FG004|Overall Study|Miscellaneous|0|||
149112063|NCT03829501|537889962|FG005|Overall Study|Miscellaneous|0|||
149112064|NCT03829501|537889963|FG006|Overall Study|Miscellaneous|0|||
149112065|NCT03829501|537889964|FG007|Overall Study|Miscellaneous|1|||
149112066|NCT03829501|537889965|FG008|Overall Study|Miscellaneous|0|||
149112067|NCT03829501|537889966|FG009|Overall Study|Miscellaneous|0|||
149112068|NCT03829501|537889967|FG010|Overall Study|Miscellaneous|0|||
149112069|NCT03829501|537889968|FG011|Overall Study|Miscellaneous|0|||
149112070|NCT03829501|537889969|FG012|Overall Study|Miscellaneous|0|||
149112071|NCT03829501|537889970|FG013|Overall Study|Miscellaneous|0|||
149112072|NCT03829501|537889971|FG014|Overall Study|Miscellaneous|0|||
149112073|NCT03829501|537889972|FG015|Overall Study|Miscellaneous|0|||
149112074|NCT03829501|537889973|FG016|Overall Study|Miscellaneous|0|||
149112075|NCT03829501|537889974|FG017|Overall Study|Miscellaneous|0|||
149112076|NCT03829501|537889975|FG018|Overall Study|Miscellaneous|0|||
149112077|NCT03829501|537889976|FG019|Overall Study|Miscellaneous|0|||
149112078|NCT03829501|537889977|FG020|Overall Study|Miscellaneous|0|||
149112079|NCT03829501|537889978|FG021|Overall Study|Miscellaneous|0|||
149112080|NCT03829501|537889979|FG022|Overall Study|Miscellaneous|1|||
149112081|NCT04942366|537889980|FG000|Overall Study|Withdrawal by Subject|5|||
149112082|NCT04942366|537889981|FG001|Overall Study|Withdrawal by Subject|5|||
149112083|NCT04020185|537889991|FG000|Overall Study|Death|0|||
149112084|NCT04020185|537889992|FG001|Overall Study|Death|0|||
149112085|NCT04020185|537889993|FG002|Overall Study|Death|1|||
149112086|NCT04020185|537889994|FG003|Overall Study|Death|2|||
149112087|NCT04020185|537889995|FG004|Overall Study|Death|1|||
149112088|NCT04020185|537889996|FG005|Overall Study|Death|0|||
149112089|NCT04020185|537889997|FG006|Overall Study|Death|1|||
149112090|NCT04020185|537889998|FG007|Overall Study|Death|0|||
149112091|NCT04020185|537889991|FG000|Overall Study|Consent withdrawn|1|||
149112092|NCT04020185|537889992|FG001|Overall Study|Consent withdrawn|0|||
149112093|NCT04020185|537889993|FG002|Overall Study|Consent withdrawn|0|||
149112094|NCT04020185|537889994|FG003|Overall Study|Consent withdrawn|0|||
149112095|NCT04020185|537889995|FG004|Overall Study|Consent withdrawn|2|||
149112096|NCT04020185|537889996|FG005|Overall Study|Consent withdrawn|0|||
149112097|NCT04020185|537889997|FG006|Overall Study|Consent withdrawn|1|||
149112098|NCT04020185|537889998|FG007|Overall Study|Consent withdrawn|1|||
149112099|NCT04020185|537889991|FG000|Overall Study|Patient in hospice|0|||
149112100|NCT04020185|537889992|FG001|Overall Study|Patient in hospice|1|||
149112101|NCT04020185|537889993|FG002|Overall Study|Patient in hospice|0|||
149112102|NCT04020185|537889994|FG003|Overall Study|Patient in hospice|0|||
149112103|NCT04020185|537889995|FG004|Overall Study|Patient in hospice|0|||
149112104|NCT04020185|537889996|FG005|Overall Study|Patient in hospice|0|||
149112105|NCT04020185|537889997|FG006|Overall Study|Patient in hospice|0|||
149112106|NCT04020185|537889998|FG007|Overall Study|Patient in hospice|0|||
149112107|NCT04020185|537889991|FG000|Overall Study|Continuing on expanded access|0|||
149112108|NCT04020185|537889992|FG001|Overall Study|Continuing on expanded access|0|||
149112109|NCT04020185|537889993|FG002|Overall Study|Continuing on expanded access|0|||
149112110|NCT04020185|537889994|FG003|Overall Study|Continuing on expanded access|0|||
149112111|NCT04020185|537889995|FG004|Overall Study|Continuing on expanded access|0|||
149112112|NCT04020185|537889996|FG005|Overall Study|Continuing on expanded access|0|||
149112113|NCT04020185|537889997|FG006|Overall Study|Continuing on expanded access|1|||
149112114|NCT04020185|537889998|FG007|Overall Study|Continuing on expanded access|1|||
149112115|NCT00626197|537889999|FG000|Overall Study|Did not cooperate|2|||
149112116|NCT00626197|537890000|FG001|Overall Study|Did not cooperate|6|||
149112117|NCT00626197|537890001|FG002|Overall Study|Did not cooperate|1|||
149112118|NCT00626197|537889999|FG000|Overall Study|Failure to return|6|||
149112119|NCT00626197|537890000|FG001|Overall Study|Failure to return|5|||
149112120|NCT00626197|537890001|FG002|Overall Study|Failure to return|6|||
149112121|NCT00626197|537889999|FG000|Overall Study|Adverse event, serious fatal|3|||
149112122|NCT00626197|537890000|FG001|Overall Study|Adverse event, serious fatal|6|||
149112123|NCT00626197|537890001|FG002|Overall Study|Adverse event, serious fatal|6|||
149112124|NCT00626197|537889999|FG000|Overall Study|Adverse Event|1|||
149112125|NCT00626197|537890000|FG001|Overall Study|Adverse Event|1|||
149112126|NCT00626197|537890001|FG002|Overall Study|Adverse Event|2|||
149112127|NCT00626197|537889999|FG000|Overall Study|Withdrawal by Subject|17|||
149112128|NCT00626197|537890000|FG001|Overall Study|Withdrawal by Subject|17|||
149112129|NCT00626197|537890001|FG002|Overall Study|Withdrawal by Subject|7|||
149112130|NCT00626197|537889999|FG000|Overall Study|Administrative reasons|15|||
149112131|NCT00626197|537890000|FG001|Overall Study|Administrative reasons|19|||
149112132|NCT00626197|537890001|FG002|Overall Study|Administrative reasons|55|||
149112133|NCT04833127|537890002|FG000|Overall Study|Lost to Follow-up|1|||
149112134|NCT04833127|537890003|FG001|Overall Study|Lost to Follow-up|1|||
149112135|NCT04335591|537890008|FG000|Overall Study|Adverse Event|5|||
149112136|NCT04335591|537890009|FG001|Overall Study|Adverse Event|2|||
149112137|NCT04335591|537890010|FG002|Overall Study|Adverse Event|3|||
149112138|NCT04335591|537890011|FG003|Overall Study|Adverse Event|2|||
149112139|NCT04335591|537890008|FG000|Overall Study|Protocol Violation|1|||
149112140|NCT04335591|537890009|FG001|Overall Study|Protocol Violation|0|||
149112141|NCT04335591|537890010|FG002|Overall Study|Protocol Violation|0|||
149112142|NCT04335591|537890011|FG003|Overall Study|Protocol Violation|0|||
149112143|NCT04335591|537890008|FG000|Overall Study|Withdrawal by Subject|8|||
149112144|NCT04335591|537890009|FG001|Overall Study|Withdrawal by Subject|4|||
149112145|NCT04335591|537890010|FG002|Overall Study|Withdrawal by Subject|4|||
149112146|NCT04335591|537890011|FG003|Overall Study|Withdrawal by Subject|5|||
149112147|NCT04335591|537890008|FG000|Overall Study|Subject planning pregnancy|0|||
149112148|NCT04335591|537890009|FG001|Overall Study|Subject planning pregnancy|1|||
149112149|NCT04335591|537890010|FG002|Overall Study|Subject planning pregnancy|0|||
149112150|NCT04335591|537890011|FG003|Overall Study|Subject planning pregnancy|0|||
149112151|NCT04335591|537890008|FG000|Overall Study|Ukrainian Russian war conflict|4|||
149112152|NCT04335591|537890009|FG001|Overall Study|Ukrainian Russian war conflict|5|||
149112153|NCT04335591|537890010|FG002|Overall Study|Ukrainian Russian war conflict|2|||
149112154|NCT04335591|537890011|FG003|Overall Study|Ukrainian Russian war conflict|0|||
149112155|NCT05282121|537890012|FG000|Overall Study|Adverse Event|1|||
149112156|NCT05282121|537890013|FG001|Overall Study|Adverse Event|1|||
149112157|NCT05282121|537890014|FG002|Overall Study|Adverse Event|4|||
149112158|NCT05282121|537890015|FG003|Overall Study|Adverse Event|1|||
149112159|NCT05282121|537890012|FG000|Overall Study|Study Terminated by Sponsor|1|||
149112160|NCT05282121|537890013|FG001|Overall Study|Study Terminated by Sponsor|2|||
149112161|NCT05282121|537890014|FG002|Overall Study|Study Terminated by Sponsor|2|||
149112162|NCT05282121|537890015|FG003|Overall Study|Study Terminated by Sponsor|2|||
149112163|NCT05282121|537890012|FG000|Overall Study|Other than listed|0|||
149112164|NCT05282121|537890013|FG001|Overall Study|Other than listed|0|||
149112165|NCT05282121|537890014|FG002|Overall Study|Other than listed|1|||
149112166|NCT05282121|537890015|FG003|Overall Study|Other than listed|0|||
149112167|NCT05282121|537890012|FG000|Overall Study|No reason available|0|||
149112168|NCT05282121|537890013|FG001|Overall Study|No reason available|0|||
149112169|NCT05282121|537890014|FG002|Overall Study|No reason available|1|||
149112170|NCT05282121|537890015|FG003|Overall Study|No reason available|0|||
149112171|NCT01077128|537890025|FG000|Overall Study|Adverse Event|8|||
149112172|NCT01077128|537890025|FG000|Overall Study|Lack of Efficacy|1|||
149112173|NCT01077128|537890025|FG000|Overall Study|Disease exacerbation|1|||
149112174|NCT01077128|537890025|FG000|Overall Study|Adverse event and consent withdrawal|1|||
149112175|NCT01077128|537890025|FG000|Overall Study|Adverse event and disease exacerbation|1|||
149112176|NCT01077128|537890025|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
149112177|NCT01077128|537890025|FG000|Overall Study|Other|54|||
149112178|NCT00847626|537890026|FG000|Overall Study|Adverse Event|10|||
149112179|NCT00847626|537890027|FG001|Overall Study|Adverse Event|10|||
149112180|NCT00847626|537890028|FG002|Overall Study|Adverse Event|6|||
149112181|NCT00847626|537890029|FG003|Overall Study|Adverse Event|19|||
149112182|NCT00847626|537890030|FG004|Overall Study|Adverse Event|11|||
149112183|NCT00847626|537890031|FG005|Overall Study|Adverse Event|22|||
149112184|NCT00847626|537890032|FG006|Overall Study|Adverse Event|4|||
149112185|NCT00847626|537890033|FG007|Overall Study|Adverse Event|6|||
149112186|NCT00847626|537890034|FG008|Overall Study|Adverse Event|3|||
149112187|NCT00847626|537890035|FG009|Overall Study|Adverse Event|6|||
149112188|NCT00847626|537890036|FG010|Overall Study|Adverse Event|6|||
149112189|NCT00847626|537890026|FG000|Overall Study|Protocol Violation|2|||
149112190|NCT00847626|537890027|FG001|Overall Study|Protocol Violation|1|||
149112191|NCT00847626|537890028|FG002|Overall Study|Protocol Violation|2|||
149112192|NCT00847626|537890029|FG003|Overall Study|Protocol Violation|1|||
149112193|NCT00847626|537890030|FG004|Overall Study|Protocol Violation|1|||
149112194|NCT00847626|537890031|FG005|Overall Study|Protocol Violation|1|||
149112195|NCT00847626|537890032|FG006|Overall Study|Protocol Violation|1|||
149112196|NCT00847626|537890033|FG007|Overall Study|Protocol Violation|1|||
149112197|NCT00847626|537890034|FG008|Overall Study|Protocol Violation|0|||
149112198|NCT00847626|537890035|FG009|Overall Study|Protocol Violation|1|||
149112199|NCT00847626|537890036|FG010|Overall Study|Protocol Violation|1|||
149112200|NCT00847626|537890026|FG000|Overall Study|Lost to Follow-up|0|||
149112201|NCT00847626|537890027|FG001|Overall Study|Lost to Follow-up|1|||
149112202|NCT00847626|537890028|FG002|Overall Study|Lost to Follow-up|1|||
149112203|NCT00847626|537890029|FG003|Overall Study|Lost to Follow-up|1|||
149112204|NCT00847626|537890030|FG004|Overall Study|Lost to Follow-up|0|||
149112205|NCT00847626|537890031|FG005|Overall Study|Lost to Follow-up|3|||
149112206|NCT00847626|537890032|FG006|Overall Study|Lost to Follow-up|1|||
149112207|NCT00847626|537890033|FG007|Overall Study|Lost to Follow-up|3|||
149112208|NCT00847626|537890034|FG008|Overall Study|Lost to Follow-up|1|||
149112209|NCT00847626|537890035|FG009|Overall Study|Lost to Follow-up|0|||
149112210|NCT00847626|537890036|FG010|Overall Study|Lost to Follow-up|1|||
149112211|NCT00847626|537890026|FG000|Overall Study|Withdrawal by Subject|5|||
149112212|NCT00847626|537890027|FG001|Overall Study|Withdrawal by Subject|5|||
149112213|NCT00847626|537890028|FG002|Overall Study|Withdrawal by Subject|3|||
149112214|NCT00847626|537890029|FG003|Overall Study|Withdrawal by Subject|8|||
149112215|NCT00847626|537890030|FG004|Overall Study|Withdrawal by Subject|12|||
149112216|NCT00847626|537890031|FG005|Overall Study|Withdrawal by Subject|9|||
149112217|NCT00847626|537890032|FG006|Overall Study|Withdrawal by Subject|8|||
149112218|NCT00847626|537890033|FG007|Overall Study|Withdrawal by Subject|4|||
149112219|NCT00847626|537890034|FG008|Overall Study|Withdrawal by Subject|4|||
149112220|NCT00847626|537890035|FG009|Overall Study|Withdrawal by Subject|5|||
149112221|NCT00847626|537890036|FG010|Overall Study|Withdrawal by Subject|2|||
149112222|NCT00847626|537890026|FG000|Overall Study|Lack of Efficacy|3|||
149112223|NCT00847626|537890027|FG001|Overall Study|Lack of Efficacy|1|||
149112224|NCT00847626|537890028|FG002|Overall Study|Lack of Efficacy|0|||
149112225|NCT00847626|537890029|FG003|Overall Study|Lack of Efficacy|1|||
149112226|NCT00847626|537890030|FG004|Overall Study|Lack of Efficacy|2|||
149112227|NCT00847626|537890031|FG005|Overall Study|Lack of Efficacy|0|||
149112228|NCT00847626|537890032|FG006|Overall Study|Lack of Efficacy|6|||
149112229|NCT00847626|537890033|FG007|Overall Study|Lack of Efficacy|2|||
149112230|NCT00847626|537890034|FG008|Overall Study|Lack of Efficacy|5|||
149112231|NCT00847626|537890035|FG009|Overall Study|Lack of Efficacy|1|||
149112232|NCT00847626|537890036|FG010|Overall Study|Lack of Efficacy|7|||
149112233|NCT00847626|537890026|FG000|Overall Study|Other|1|||
149112234|NCT00847626|537890027|FG001|Overall Study|Other|5|||
149112235|NCT00847626|537890028|FG002|Overall Study|Other|4|||
149112236|NCT00847626|537890029|FG003|Overall Study|Other|1|||
149112237|NCT00847626|537890030|FG004|Overall Study|Other|2|||
149112238|NCT00847626|537890031|FG005|Overall Study|Other|2|||
149112239|NCT00847626|537890032|FG006|Overall Study|Other|2|||
149112240|NCT00847626|537890033|FG007|Overall Study|Other|3|||
149112241|NCT00847626|537890034|FG008|Overall Study|Other|1|||
149112242|NCT00847626|537890035|FG009|Overall Study|Other|1|||
149112243|NCT00847626|537890036|FG010|Overall Study|Other|3|||
149112244|NCT04546425|537890039|FG000|Overall Study|Protocol Violation|1|||
149112245|NCT04546425|537890040|FG001|Overall Study|Protocol Violation|1|||
149112246|NCT04546425|537890041|FG002|Overall Study|Protocol Violation|0|||
149112247|NCT04546425|537890042|FG003|Overall Study|Protocol Violation|0|||
149112248|NCT04546425|537890039|FG000|Overall Study|Adverse Event|3|||
149112249|NCT04546425|537890040|FG001|Overall Study|Adverse Event|0|||
149112250|NCT04546425|537890041|FG002|Overall Study|Adverse Event|0|||
149112251|NCT04546425|537890042|FG003|Overall Study|Adverse Event|0|||
149112252|NCT04546425|537890039|FG000|Overall Study|Lost to Follow-up|5|||
149112253|NCT04546425|537890040|FG001|Overall Study|Lost to Follow-up|4|||
149112254|NCT04546425|537890041|FG002|Overall Study|Lost to Follow-up|0|||
149112255|NCT04546425|537890042|FG003|Overall Study|Lost to Follow-up|0|||
149112256|NCT04546425|537890039|FG000|Overall Study|No Longer met eligibility criteria|3|||
149112257|NCT04546425|537890040|FG001|Overall Study|No Longer met eligibility criteria|3|||
149112258|NCT04546425|537890041|FG002|Overall Study|No Longer met eligibility criteria|1|||
149112259|NCT04546425|537890042|FG003|Overall Study|No Longer met eligibility criteria|1|||
149112260|NCT04546425|537890039|FG000|Overall Study|Withdrawal by parent/guardian|6|||
149112261|NCT04546425|537890040|FG001|Overall Study|Withdrawal by parent/guardian|5|||
149112262|NCT04546425|537890041|FG002|Overall Study|Withdrawal by parent/guardian|1|||
149112263|NCT04546425|537890042|FG003|Overall Study|Withdrawal by parent/guardian|1|||
149112264|NCT02979249|537890048|FG000|Overall Study|Lost to Follow-up|2|||
149112265|NCT02979249|537890048|FG000|Overall Study|Withdrawal by Subject|4|||
149112266|NCT01125046|537890049|FG000|First 6 Months of Treatment|Death|1|||
149112267|NCT01125046|537890049|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
149112268|NCT01125046|537890049|FG000|First 6 Months of Treatment|Non-compliance|1|||
149112269|NCT01125046|537890049|FG000|First 6 Months of Treatment|Surgery|1|||
149112270|NCT01125046|537890049|FG000|First 6 Months of Treatment|Progressive Disease|7|||
149112271|NCT01125046|537890049|FG000|First 6 Months of Treatment|Adverse Event|2|||
149112272|NCT01125046|537890049|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
149112273|NCT01125046|537890049|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
149112274|NCT01125046|537890049|FG000|Follow-up/Data Cut Off Point|Death|29|||
149112275|NCT01125046|537890049|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
149112276|NCT01685229|537890050|FG000|Overall Study|Subjects missing Study Exit form|3|||
149112277|NCT01685229|537890051|FG001|Overall Study|Subjects missing Study Exit form|1|||
149112278|NCT01685229|537890050|FG000|Overall Study|Lost to Follow-up|16|||
149112279|NCT01685229|537890051|FG001|Overall Study|Lost to Follow-up|10|||
149112280|NCT01685229|537890050|FG000|Overall Study|Withdrawal by Subject|6|||
149112281|NCT01685229|537890051|FG001|Overall Study|Withdrawal by Subject|5|||
149112282|NCT01685229|537890050|FG000|Overall Study|Death|1|||
149112283|NCT01685229|537890051|FG001|Overall Study|Death|0|||
149112284|NCT01399697|537890057|FG000|Overall Study|Adverse Event|13|||
149112285|NCT01399697|537890058|FG001|Overall Study|Adverse Event|3|||
149112286|NCT01399697|537890059|FG002|Overall Study|Adverse Event|1|||
149112287|NCT01399697|537890057|FG000|Overall Study|Lost to Follow-up|2|||
149112288|NCT01399697|537890058|FG001|Overall Study|Lost to Follow-up|0|||
149112289|NCT01399697|537890059|FG002|Overall Study|Lost to Follow-up|0|||
149112290|NCT01399697|537890057|FG000|Overall Study|Withdrawal by Subject|8|||
149112291|NCT01399697|537890058|FG001|Overall Study|Withdrawal by Subject|0|||
149112292|NCT01399697|537890059|FG002|Overall Study|Withdrawal by Subject|0|||
149112293|NCT01399697|537890057|FG000|Overall Study|Investigator Decisión|1|||
149112294|NCT01399697|537890058|FG001|Overall Study|Investigator Decisión|0|||
149112295|NCT01399697|537890059|FG002|Overall Study|Investigator Decisión|2|||
149112296|NCT01399697|537890057|FG000|Overall Study|Lack of Efficacy|9|||
149112297|NCT01399697|537890058|FG001|Overall Study|Lack of Efficacy|0|||
149112298|NCT01399697|537890059|FG002|Overall Study|Lack of Efficacy|1|||
149112299|NCT01399697|537890057|FG000|Overall Study|Protocol Violation|2|||
149112300|NCT01399697|537890058|FG001|Overall Study|Protocol Violation|0|||
149112301|NCT01399697|537890059|FG002|Overall Study|Protocol Violation|0|||
149112302|NCT01399697|537890057|FG000|Overall Study|Non-Compliant|1|||
149112303|NCT01399697|537890058|FG001|Overall Study|Non-Compliant|0|||
149112304|NCT01399697|537890059|FG002|Overall Study|Non-Compliant|0|||
149112305|NCT01399697|537890057|FG000|Overall Study|Inclusion Error|2|||
149112306|NCT01399697|537890058|FG001|Overall Study|Inclusion Error|0|||
149112307|NCT01399697|537890059|FG002|Overall Study|Inclusion Error|0|||
149112308|NCT01399697|537890057|FG000|Overall Study|Positive result for hepatitis B|1|||
149112309|NCT01399697|537890058|FG001|Overall Study|Positive result for hepatitis B|0|||
149112310|NCT01399697|537890059|FG002|Overall Study|Positive result for hepatitis B|0|||
149112311|NCT01399697|537890057|FG000|Overall Study|Clinical RA remission|1|||
149112312|NCT01399697|537890058|FG001|Overall Study|Clinical RA remission|0|||
149112313|NCT01399697|537890059|FG002|Overall Study|Clinical RA remission|0|||
149112314|NCT01399697|537890057|FG000|Overall Study|Sponsor Decision|1|||
149112315|NCT01399697|537890058|FG001|Overall Study|Sponsor Decision|0|||
149112316|NCT01399697|537890059|FG002|Overall Study|Sponsor Decision|0|||
149112317|NCT02964325|537890060|FG000|Overall Study|Lost to Follow-up|3|||
149112318|NCT02964325|537890061|FG001|Overall Study|Lost to Follow-up|3|||
149112319|NCT02964325|537890060|FG000|Overall Study|Physician Decision|5|||
149112320|NCT02964325|537890061|FG001|Overall Study|Physician Decision|4|||
149112321|NCT02964325|537890060|FG000|Overall Study|Death|1|||
149112322|NCT02964325|537890061|FG001|Overall Study|Death|3|||
149112323|NCT02964325|537890060|FG000|Overall Study|Withdrawal by Subject|2|||
149112324|NCT02964325|537890061|FG001|Overall Study|Withdrawal by Subject|1|||
149112325|NCT02964325|537890060|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
149112326|NCT02964325|537890061|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
149112327|NCT00967005|537890063|FG000|Overall Study|Lost to Follow-up|7|||
149112328|NCT00967005|537890064|FG001|Overall Study|Lost to Follow-up|10|||
149112329|NCT04868539|537890067|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
149112330|NCT04868539|537890068|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
149112331|NCT01401153|537890071|FG000|First Test Day|Learning disabilities; illness|1|||
149112332|NCT01401153|537890072|FG001|First Test Day|Learning disabilities; illness|10|||
149112333|NCT01401153|537890071|FG000|Second Test Day|illness|0|||
149112334|NCT01401153|537890072|FG001|Second Test Day|illness|5|||
149112335|NCT01818531|537890075|FG000|Overall Study|Withdrawn for case delay after block|1|||
149112336|NCT01818531|537890076|FG001|Overall Study|Withdrawn for case delay after block|0|||
149112337|NCT01818531|537890075|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
149112338|NCT01818531|537890076|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
149112339|NCT01818531|537890075|FG000|Overall Study|Withdrawn for failure to place block|0|||
149112340|NCT01818531|537890076|FG001|Overall Study|Withdrawn for failure to place block|1|||
149112341|NCT01677767|537890077|FG000|Overall Study|Adverse Event|1|||
149112342|NCT01677767|537890077|FG000|Overall Study|Death|4|||
149112343|NCT01677767|537890077|FG000|Overall Study|Protocol Violation|4|||
149112344|NCT01677767|537890077|FG000|Overall Study|Withdrawal by Subject|10|||
149112345|NCT01677767|537890077|FG000|Overall Study|Non-compliance by the participants|3|||
149112346|NCT01162863|537890078|FG000|Overall Study|Lack of Efficacy|1|||
149112347|NCT01162863|537890079|FG001|Overall Study|Lack of Efficacy|0|||
149112348|NCT01162863|537890080|FG002|Overall Study|Lack of Efficacy|0|||
149112349|NCT01162863|537890078|FG000|Overall Study|Adverse Event|0|||
149112350|NCT01162863|537890079|FG001|Overall Study|Adverse Event|1|||
149112351|NCT01162863|537890080|FG002|Overall Study|Adverse Event|0|||
149112352|NCT00820170|537890081|FG000|Overall Study|Adverse Event|0|||
149112353|NCT00820170|537890082|FG001|Overall Study|Adverse Event|0|||
149112354|NCT00820170|537890083|FG002|Overall Study|Adverse Event|0|||
149112355|NCT00820170|537890084|FG003|Overall Study|Adverse Event|0|||
149112356|NCT00820170|537890085|FG004|Overall Study|Adverse Event|2|||
149112357|NCT00820170|537890081|FG000|Overall Study|Progressive Disease|0|||
149112358|NCT00820170|537890082|FG001|Overall Study|Progressive Disease|0|||
149112359|NCT00820170|537890083|FG002|Overall Study|Progressive Disease|0|||
149112360|NCT00820170|537890084|FG003|Overall Study|Progressive Disease|0|||
149112361|NCT00820170|537890085|FG004|Overall Study|Progressive Disease|2|||
149112362|NCT03995316|537890086|FG000|Overall Study|Lost to Follow-up|10|||
149112363|NCT03995316|537890087|FG001|Overall Study|Lost to Follow-up|3|||
149112364|NCT02202785|537890088|FG000|Overall Study|Study Terminated by Sponsor|1|||
149112365|NCT02202785|537890089|FG001|Overall Study|Study Terminated by Sponsor|6|||
149112366|NCT02202785|537890090|FG002|Overall Study|Study Terminated by Sponsor|4|||
149112367|NCT02202785|537890088|FG000|Overall Study|Withdrawal by Subject|0|||
149112368|NCT02202785|537890089|FG001|Overall Study|Withdrawal by Subject|1|||
149112369|NCT02202785|537890090|FG002|Overall Study|Withdrawal by Subject|0|||
149112370|NCT02202785|537890088|FG000|Overall Study|Lost to Follow-up|0|||
149112371|NCT02202785|537890089|FG001|Overall Study|Lost to Follow-up|1|||
149112372|NCT02202785|537890090|FG002|Overall Study|Lost to Follow-up|0|||
149112373|NCT02202785|537890088|FG000|Overall Study|Reason not Specified|10|||
149112374|NCT02202785|537890089|FG001|Overall Study|Reason not Specified|7|||
149112375|NCT02202785|537890090|FG002|Overall Study|Reason not Specified|13|||
149112376|NCT02180243|537890091|FG000|Overall Study|Withdrawal by Subject|12|||
149112377|NCT02180243|537890092|FG001|Overall Study|Withdrawal by Subject|12|||
149112378|NCT02180243|537890091|FG000|Overall Study|Lost to Follow-up|12|||
149112379|NCT02180243|537890092|FG001|Overall Study|Lost to Follow-up|2|||
149112380|NCT06285240|537890093|FG000|Overall Study|Withdrawal by Subject|2|||
149112381|NCT06285240|537890094|FG001|Overall Study|Withdrawal by Subject|0|||
149112382|NCT06285240|537890095|FG002|Overall Study|Withdrawal by Subject|0|||
149112383|NCT06285240|537890096|FG003|Overall Study|Withdrawal by Subject|0|||
149112384|NCT06285240|537890093|FG000|Overall Study|Serious Adverse Event|0|||
149112385|NCT06285240|537890094|FG001|Overall Study|Serious Adverse Event|0|||
149112386|NCT06285240|537890095|FG002|Overall Study|Serious Adverse Event|1|||
149112387|NCT06285240|537890096|FG003|Overall Study|Serious Adverse Event|0|||
149112388|NCT05140915|537890097|FG000|Overall Study|Lost to Follow-up|2|||
149112389|NCT05140915|537890098|FG001|Overall Study|Lost to Follow-up|1|||
149112390|NCT03361865|537890099|FG000|Overall Study|Death|17|||
149112391|NCT03361865|537890100|FG001|Overall Study|Death|18|||
149112392|NCT03361865|537890099|FG000|Overall Study|Physician Decision|1|||
149112393|NCT03361865|537890100|FG001|Overall Study|Physician Decision|9|||
149112394|NCT03361865|537890099|FG000|Overall Study|Withdrawal by Subject|1|||
149112395|NCT03361865|537890100|FG001|Overall Study|Withdrawal by Subject|0|||
149112396|NCT03852719|537890101|FG000|Overall Study|Withdrawal of consent|8|||
149112397|NCT03852719|537890102|FG001|Overall Study|Withdrawal of consent|8|||
149112398|NCT03852719|537890103|FG002|Overall Study|Withdrawal of consent|9|||
149112399|NCT03852719|537890101|FG000|Overall Study|Physician Decision|5|||
149112400|NCT03852719|537890102|FG001|Overall Study|Physician Decision|4|||
149112401|NCT03852719|537890103|FG002|Overall Study|Physician Decision|1|||
149112402|NCT03852719|537890101|FG000|Overall Study|Pregnancy|2|||
149112403|NCT03852719|537890102|FG001|Overall Study|Pregnancy|1|||
149112404|NCT03852719|537890103|FG002|Overall Study|Pregnancy|0|||
149112405|NCT03852719|537890101|FG000|Overall Study|Death|1|||
149112406|NCT03852719|537890102|FG001|Overall Study|Death|0|||
149112407|NCT03852719|537890103|FG002|Overall Study|Death|0|||
149112408|NCT03852719|537890101|FG000|Overall Study|Reason not Specified|3|||
149112409|NCT03852719|537890102|FG001|Overall Study|Reason not Specified|3|||
149112410|NCT03852719|537890103|FG002|Overall Study|Reason not Specified|5|||
149112411|NCT03852719|537890101|FG000|Overall Study|Adverse Event|2|||
149112412|NCT03852719|537890102|FG001|Overall Study|Adverse Event|1|||
149112413|NCT03852719|537890103|FG002|Overall Study|Adverse Event|4|||
149112414|NCT03852719|537890101|FG000|Overall Study|Progressive disease|1|||
149112415|NCT03852719|537890102|FG001|Overall Study|Progressive disease|4|||
149112416|NCT03852719|537890103|FG002|Overall Study|Progressive disease|1|||
149112417|NCT03852719|537890101|FG000|Overall Study|Lost to Follow-up|1|||
149112418|NCT03852719|537890102|FG001|Overall Study|Lost to Follow-up|0|||
149112419|NCT03852719|537890103|FG002|Overall Study|Lost to Follow-up|0|||
149112420|NCT01647542|537890105|FG000|Overall Study|Major Protocol Deviation|1|||
149112421|NCT01647542|537890106|FG001|Overall Study|Major Protocol Deviation|0|||
149112422|NCT01647542|537890107|FG002|Overall Study|Major Protocol Deviation|0|||
149112423|NCT01647542|537890105|FG000|Overall Study|Adverse Event|4|||
149112424|NCT01647542|537890106|FG001|Overall Study|Adverse Event|5|||
149112425|NCT01647542|537890107|FG002|Overall Study|Adverse Event|4|||
149112426|NCT01647542|537890105|FG000|Overall Study|Lost to Follow-up|0|||
149112427|NCT01647542|537890106|FG001|Overall Study|Lost to Follow-up|2|||
149112428|NCT01647542|537890107|FG002|Overall Study|Lost to Follow-up|2|||
149112429|NCT01647542|537890105|FG000|Overall Study|Withdrawal by Subject|6|||
149112430|NCT01647542|537890106|FG001|Overall Study|Withdrawal by Subject|4|||
149112431|NCT01647542|537890107|FG002|Overall Study|Withdrawal by Subject|0|||
149112432|NCT01647542|537890105|FG000|Overall Study|Study Termination|64|||
149112433|NCT01647542|537890106|FG001|Overall Study|Study Termination|61|||
149112434|NCT01647542|537890107|FG002|Overall Study|Study Termination|65|||
149112435|NCT01647542|537890105|FG000|Overall Study|Lack of Efficacy|1|||
149112436|NCT01647542|537890106|FG001|Overall Study|Lack of Efficacy|1|||
149112437|NCT01647542|537890107|FG002|Overall Study|Lack of Efficacy|0|||
149112438|NCT01647542|537890105|FG000|Overall Study|Death|0|||
149112439|NCT01647542|537890106|FG001|Overall Study|Death|0|||
149112440|NCT01647542|537890107|FG002|Overall Study|Death|1|||
149112441|NCT02819024|537890108|FG000|Overall Study|Withdrawal by Subject|1|||
149112442|NCT05576662|537890109|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
149112443|NCT05576662|537890110|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
149112444|NCT05576662|537890109|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
149112445|NCT05576662|537890110|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
149112446|NCT05576662|537890109|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
149112447|NCT05576662|537890110|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
149112448|NCT05576662|537890109|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
149112449|NCT05576662|537890110|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
149112450|NCT03633799|537890115|FG000|Overall Study|Adverse Event|349|||
149112451|NCT03633799|537890115|FG000|Overall Study|Withdrawal by Subject|288|||
149112452|NCT03633799|537890115|FG000|Overall Study|Lost to Follow-up|97|||
149112453|NCT03633799|537890115|FG000|Overall Study|Physician Decision|9|||
149112454|NCT03633799|537890115|FG000|Overall Study|Protocol Violation|4|||
149112455|NCT03633799|537890115|FG000|Overall Study|Pregnancy|20|||
149112456|NCT03633799|537890115|FG000|Overall Study|other|39|||
149112457|NCT03633799|537890115|FG000|Overall Study|ongoing within third year of study|106|||
149112458|NCT03633799|537890115|FG000|Overall Study|unsuccessful study drug placement|19|||
149112459|NCT02367040|537890118|FG000|Overall Study|Lost to Follow-up|1|||
149112460|NCT02367040|537890119|FG001|Overall Study|Lost to Follow-up|1|||
149112461|NCT02367040|537890118|FG000|Overall Study|Lack of Efficacy|1|||
149112462|NCT02367040|537890119|FG001|Overall Study|Lack of Efficacy|0|||
149112463|NCT02367040|537890118|FG000|Overall Study|Additional primary malignancy|1|||
149112464|NCT02367040|537890119|FG001|Overall Study|Additional primary malignancy|1|||
149112465|NCT02367040|537890118|FG000|Overall Study|AE not associated with clinical disease progression|117|||
149112466|NCT02367040|537890119|FG001|Overall Study|AE not associated with clinical disease progression|12|||
149112467|NCT02367040|537890118|FG000|Overall Study|AE associated with clinical disease progression|1|||
149112468|NCT02367040|537890119|FG001|Overall Study|AE associated with clinical disease progression|4|||
149112469|NCT02367040|537890118|FG000|Overall Study|Physician Decision|2|||
149112470|NCT02367040|537890119|FG001|Overall Study|Physician Decision|8|||
149112471|NCT02367040|537890118|FG000|Overall Study|Non-compliance to study drug|1|||
149112472|NCT02367040|537890119|FG001|Overall Study|Non-compliance to study drug|0|||
149112473|NCT02367040|537890118|FG000|Overall Study|Failure to meet continuation criteria|1|||
149112474|NCT02367040|537890119|FG001|Overall Study|Failure to meet continuation criteria|0|||
149112475|NCT02367040|537890118|FG000|Overall Study|Switching to other therapy|2|||
149112476|NCT02367040|537890119|FG001|Overall Study|Switching to other therapy|0|||
149112477|NCT02367040|537890118|FG000|Overall Study|Withdrawal by Subject|51|||
149112478|NCT02367040|537890119|FG001|Overall Study|Withdrawal by Subject|16|||
149112479|NCT02367040|537890118|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
149112480|NCT02367040|537890119|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149112481|NCT02367040|537890118|FG000|Overall Study|Patient decision|40|||
149112482|NCT02367040|537890119|FG001|Overall Study|Patient decision|14|||
149112483|NCT02367040|537890118|FG000|Overall Study|Required procedure failed|1|||
149112484|NCT02367040|537890119|FG001|Overall Study|Required procedure failed|0|||
149112485|NCT02367040|537890118|FG000|Overall Study|Randomized by mistake with study treatment|1|||
149112486|NCT02367040|537890119|FG001|Overall Study|Randomized by mistake with study treatment|0|||
149112487|NCT02367040|537890118|FG000|Overall Study|Protocol Violation|1|||
149112488|NCT02367040|537890119|FG001|Overall Study|Protocol Violation|0|||
149112489|NCT02367040|537890118|FG000|Overall Study|Progressive disease - radiological progression|54|||
149112490|NCT02367040|537890119|FG001|Overall Study|Progressive disease - radiological progression|80|||
149112491|NCT02367040|537890118|FG000|Overall Study|Progressive disease - clinical progression|6|||
149112492|NCT02367040|537890119|FG001|Overall Study|Progressive disease - clinical progression|6|||
149112493|NCT02367040|537890118|FG000|Overall Study|Drug not administered|3|||
149112494|NCT02367040|537890119|FG001|Overall Study|Drug not administered|2|||
149112495|NCT02367040|537890118|FG000|Overall Study|Progressive disease|0|||
149112496|NCT02367040|537890119|FG001|Overall Study|Progressive disease|1|||
149112497|NCT02367040|537890118|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
149112498|NCT02367040|537890119|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
149112499|NCT02367040|537890118|FG000|Overall Study|Death|2|||
149112500|NCT02367040|537890119|FG001|Overall Study|Death|0|||
149112501|NCT02367040|537890118|FG000|Overall Study|Study terminated by sponsor|19|||
149112502|NCT02367040|537890119|FG001|Overall Study|Study terminated by sponsor|2|||
149112503|NCT02477618|537890120|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
149112504|NCT02477618|537890121|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
149112505|NCT02477618|537890120|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
149112506|NCT02477618|537890121|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
149112507|NCT02477618|537890120|FG000|Overall Study|Adverse Event|1|||
149112508|NCT02477618|537890121|FG001|Overall Study|Adverse Event|1|||
149112509|NCT02477618|537890120|FG000|Overall Study|Transferred Away from Study Site|1|||
149112510|NCT02477618|537890121|FG001|Overall Study|Transferred Away from Study Site|0|||
149112511|NCT02477618|537890120|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
149112512|NCT02477618|537890121|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
149112513|NCT02446821|537890122|FG000|Overall Study|Adverse Event|28|||
149112514|NCT02446821|537890122|FG000|Overall Study|Withdrawal by Subject|6|||
149112515|NCT02446821|537890122|FG000|Overall Study|Lost to Follow-up|22|||
149112516|NCT02446821|537890122|FG000|Overall Study|other|9|||
149112517|NCT02446821|537890122|FG000|Overall Study|insertion failure|3|||
149112518|NCT03007420|537890123|FG000|Overall Study|Withdrawal by Subject|0|||
149112519|NCT03007420|537890124|FG001|Overall Study|Withdrawal by Subject|2|||
149112520|NCT03007420|537890123|FG000|Overall Study|Physician Decision|0|||
149112521|NCT03007420|537890124|FG001|Overall Study|Physician Decision|1|||
149112522|NCT02284009|537890128|FG000|Overall Study|Adverse Event|3|||
149112523|NCT02284009|537890129|FG001|Overall Study|Adverse Event|0|||
149112524|NCT02284009|537890128|FG000|Overall Study|Lost to Follow-up|1|||
149112525|NCT02284009|537890129|FG001|Overall Study|Lost to Follow-up|3|||
149112526|NCT02284009|537890128|FG000|Overall Study|Physician Decision|0|||
149112527|NCT02284009|537890129|FG001|Overall Study|Physician Decision|2|||
149112528|NCT02284009|537890128|FG000|Overall Study|Withdrawal by Subject|2|||
149112529|NCT02284009|537890129|FG001|Overall Study|Withdrawal by Subject|5|||
149112530|NCT01876082|537891760|FG000|Overall Study|Withdrawal by Subject|0|||
149112531|NCT01876082|537891761|FG001|Overall Study|Withdrawal by Subject|2|||
149112532|NCT01876082|537891760|FG000|Overall Study|Protocol Violation|1|||
149112533|NCT01876082|537891761|FG001|Overall Study|Protocol Violation|0|||
149112534|NCT01876082|537891760|FG000|Overall Study|Adverse Event|1|||
149112535|NCT01876082|537891761|FG001|Overall Study|Adverse Event|1|||
149112536|NCT01876082|537891760|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
149112537|NCT01876082|537891761|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
149112538|NCT02964013|537891762|FG000|Overall Study|Death|58|||
149112539|NCT02964013|537891763|FG001|Overall Study|Death|239|||
149112540|NCT02964013|537891764|FG002|Overall Study|Death|38|||
149112541|NCT02964013|537891765|FG003|Overall Study|Death|10|||
149112542|NCT02964013|537891766|FG004|Overall Study|Death|33|||
149112543|NCT02964013|537891762|FG000|Overall Study|Lost to Follow-up|1|||
149112544|NCT02964013|537891763|FG001|Overall Study|Lost to Follow-up|4|||
149112545|NCT02964013|537891764|FG002|Overall Study|Lost to Follow-up|2|||
149112546|NCT02964013|537891765|FG003|Overall Study|Lost to Follow-up|0|||
149112547|NCT02964013|537891766|FG004|Overall Study|Lost to Follow-up|0|||
149112548|NCT02964013|537891762|FG000|Overall Study|Physician Decision|0|||
149112549|NCT02964013|537891763|FG001|Overall Study|Physician Decision|1|||
149112550|NCT02964013|537891764|FG002|Overall Study|Physician Decision|0|||
149112551|NCT02964013|537891765|FG003|Overall Study|Physician Decision|0|||
149112552|NCT02964013|537891766|FG004|Overall Study|Physician Decision|0|||
149112553|NCT02964013|537891762|FG000|Overall Study|Sponsor Decision|3|||
149112554|NCT02964013|537891763|FG001|Overall Study|Sponsor Decision|22|||
149112555|NCT02964013|537891764|FG002|Overall Study|Sponsor Decision|11|||
149112556|NCT02964013|537891765|FG003|Overall Study|Sponsor Decision|0|||
149112557|NCT02964013|537891766|FG004|Overall Study|Sponsor Decision|7|||
149112558|NCT02964013|537891762|FG000|Overall Study|Withdrawal by Subject|6|||
149112559|NCT02964013|537891763|FG001|Overall Study|Withdrawal by Subject|27|||
149112560|NCT02964013|537891764|FG002|Overall Study|Withdrawal by Subject|9|||
149112561|NCT02964013|537891765|FG003|Overall Study|Withdrawal by Subject|0|||
149112562|NCT02964013|537891766|FG004|Overall Study|Withdrawal by Subject|0|||
149112563|NCT02964013|537891762|FG000|Overall Study|Not Treated|0|||
149112564|NCT02964013|537891763|FG001|Overall Study|Not Treated|2|||
149112565|NCT02964013|537891764|FG002|Overall Study|Not Treated|0|||
149112566|NCT02964013|537891765|FG003|Overall Study|Not Treated|1|||
149112567|NCT02964013|537891766|FG004|Overall Study|Not Treated|0|||
149112568|NCT01123070|537891767|FG000|Part B Double Blind Period|Protocol Violation|0|||
149112569|NCT01123070|537891768|FG001|Part B Double Blind Period|Protocol Violation|0|||
149112570|NCT01123070|537891769|FG002|Part B Double Blind Period|Protocol Violation|0|||
149112571|NCT01123070|537891770|FG003|Part B Double Blind Period|Protocol Violation|1|||
149112572|NCT01123070|537891767|FG000|Part B Double Blind Period|Adverse Event|0|||
149112573|NCT01123070|537891768|FG001|Part B Double Blind Period|Adverse Event|0|||
149112574|NCT01123070|537891769|FG002|Part B Double Blind Period|Adverse Event|2|||
149112575|NCT01123070|537891770|FG003|Part B Double Blind Period|Adverse Event|0|||
149112576|NCT01123070|537891767|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
149112577|NCT01123070|537891768|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
149112578|NCT01123070|537891769|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
149112579|NCT01123070|537891770|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
149112580|NCT00747227|537891771|FG000|Overall Study|Death|3|||
149112581|NCT00747227|537891772|FG001|Overall Study|Death|1|||
149112582|NCT00747227|537891771|FG000|Overall Study|Withdrawal by Subject|1|||
149112583|NCT00747227|537891772|FG001|Overall Study|Withdrawal by Subject|0|||
149112584|NCT00747227|537891771|FG000|Overall Study|Lost to Follow-up|1|||
149112585|NCT00747227|537891772|FG001|Overall Study|Lost to Follow-up|2|||
149112586|NCT00747227|537891771|FG000|Overall Study|Illness|1|||
149112587|NCT00747227|537891772|FG001|Overall Study|Illness|1|||
149112588|NCT03284229|537891773|FG000|Overall Study|Lost to Follow-up|3|||
149112589|NCT03554629|537891774|FG000|Overall Study|Inadequate data|6|||
149112590|NCT00663702|537891776|FG000|Overall Study|Adverse Event|8|||
149112591|NCT00663702|537891777|FG001|Overall Study|Adverse Event|4|||
149112592|NCT00663702|537891776|FG000|Overall Study|Withdrawal by Subject|3|||
149112593|NCT00663702|537891777|FG001|Overall Study|Withdrawal by Subject|1|||
149112594|NCT00663702|537891776|FG000|Overall Study|Pregnancy|0|||
149112595|NCT00663702|537891777|FG001|Overall Study|Pregnancy|1|||
149112596|NCT00663702|537891776|FG000|Overall Study|Lost to Follow-up|3|||
149112597|NCT00663702|537891777|FG001|Overall Study|Lost to Follow-up|0|||
149112598|NCT00663702|537891776|FG000|Overall Study|Death|1|||
149112599|NCT00663702|537891777|FG001|Overall Study|Death|1|||
149112600|NCT00663702|537891776|FG000|Overall Study|Lack of Efficacy|3|||
149112601|NCT00663702|537891777|FG001|Overall Study|Lack of Efficacy|3|||
149112602|NCT01977677|537891778|FG000|Overall Study|Unrelated Adverse Event|0|||
149112603|NCT01977677|537891779|FG001|Overall Study|Unrelated Adverse Event|0|||
149112604|NCT01977677|537891780|FG002|Overall Study|Unrelated Adverse Event|1|||
149112605|NCT01498887|537891781|FG000|Overall Study|Administrative problems|1|||
149112606|NCT01498887|537891782|FG001|Overall Study|Administrative problems|0|||
149112607|NCT01498887|537891781|FG000|Overall Study|Lost to Follow-up|1|||
149112608|NCT01498887|537891782|FG001|Overall Study|Lost to Follow-up|1|||
149112609|NCT01498887|537891781|FG000|Overall Study|Withdrawal by Subject|1|||
149112610|NCT01498887|537891782|FG001|Overall Study|Withdrawal by Subject|0|||
149112611|NCT01498887|537891781|FG000|Overall Study|Protocol Violation|1|||
149112612|NCT01498887|537891782|FG001|Overall Study|Protocol Violation|3|||
149112613|NCT01498887|537891781|FG000|Overall Study|Lack of Efficacy|5|||
149112614|NCT01498887|537891782|FG001|Overall Study|Lack of Efficacy|3|||
149112615|NCT01498887|537891781|FG000|Overall Study|Abnormal result from test procedure|1|||
149112616|NCT01498887|537891782|FG001|Overall Study|Abnormal result from test procedure|1|||
149112617|NCT01498887|537891781|FG000|Overall Study|Abnormal laboratory value|2|||
149112618|NCT01498887|537891782|FG001|Overall Study|Abnormal laboratory value|2|||
149112619|NCT01498887|537891781|FG000|Overall Study|Adverse Event|4|||
149112620|NCT01498887|537891782|FG001|Overall Study|Adverse Event|1|||
149112621|NCT00667225|537891787|FG000|Overall Study|Subject had no more lesions to treat.|1|||
149112622|NCT00667225|537891788|FG001|Overall Study|Subject had no more lesions to treat.|0|||
149112623|NCT00667225|537891787|FG000|Overall Study|Lost to Follow-up|0|||
149112624|NCT00667225|537891788|FG001|Overall Study|Lost to Follow-up|1|||
149112625|NCT03056300|537891789|FG000|Overall Study|Surgical reason per study protocol|3|||
149112626|NCT02993406|537891796|FG000|Overall Study|Withdrawal by Subject|170|||
149112627|NCT02993406|537891797|FG001|Overall Study|Withdrawal by Subject|196|||
149112628|NCT02993406|537891796|FG000|Overall Study|Physician Decision|3|||
149112629|NCT02993406|537891797|FG001|Overall Study|Physician Decision|5|||
149112630|NCT02993406|537891796|FG000|Overall Study|Lost to Follow-up|12|||
149112631|NCT02993406|537891797|FG001|Overall Study|Lost to Follow-up|13|||
149112632|NCT02993406|537891796|FG000|Overall Study|Unclassifiable Response|105|||
149112633|NCT02993406|537891797|FG001|Overall Study|Unclassifiable Response|139|||
149112634|NCT02993406|537891796|FG000|Overall Study|Administrative decision|1|||
149112635|NCT02993406|537891797|FG001|Overall Study|Administrative decision|0|||
149112636|NCT02993406|537891796|FG000|Overall Study|Sponsor decision|4|||
149112637|NCT02993406|537891797|FG001|Overall Study|Sponsor decision|5|||
149112638|NCT03563157|537891798|FG000|Overall Study|Progressive Disease|2|||
149112639|NCT02248818|537891799|FG000|Screening|Protocol Violation|0|||
149112640|NCT02248818|537891800|FG001|Screening|Protocol Violation|0|||
149112641|NCT02248818|537891801|FG002|Screening|Protocol Violation|0|||
149112642|NCT02248818|537891802|FG003|Screening|Protocol Violation|0|||
149112643|NCT02248818|537891803|FG004|Screening|Protocol Violation|0|||
149112644|NCT02248818|537891804|FG005|Screening|Protocol Violation|0|||
149112645|NCT02248818|537891805|FG006|Screening|Protocol Violation|0|||
149112646|NCT02248818|537891806|FG007|Screening|Protocol Violation|0|||
149112647|NCT02248818|537891807|FG008|Screening|Protocol Violation|7|||
149112648|NCT02248818|537891799|FG000|Screening|Study fully enrolled|0|||
149112649|NCT02248818|537891800|FG001|Screening|Study fully enrolled|0|||
149112650|NCT02248818|537891801|FG002|Screening|Study fully enrolled|0|||
149112651|NCT02248818|537891802|FG003|Screening|Study fully enrolled|0|||
149112652|NCT02248818|537891803|FG004|Screening|Study fully enrolled|0|||
149112653|NCT02248818|537891804|FG005|Screening|Study fully enrolled|0|||
149112654|NCT02248818|537891805|FG006|Screening|Study fully enrolled|0|||
149112655|NCT02248818|537891806|FG007|Screening|Study fully enrolled|0|||
149112656|NCT02248818|537891807|FG008|Screening|Study fully enrolled|14|||
149112657|NCT02248818|537891799|FG000|Screening|Physician Decision|0|||
149112658|NCT02248818|537891800|FG001|Screening|Physician Decision|0|||
149112659|NCT02248818|537891801|FG002|Screening|Physician Decision|0|||
149112660|NCT02248818|537891802|FG003|Screening|Physician Decision|0|||
149112661|NCT02248818|537891803|FG004|Screening|Physician Decision|0|||
149112662|NCT02248818|537891804|FG005|Screening|Physician Decision|0|||
149112663|NCT02248818|537891805|FG006|Screening|Physician Decision|0|||
149112664|NCT02248818|537891806|FG007|Screening|Physician Decision|0|||
149112665|NCT02248818|537891807|FG008|Screening|Physician Decision|73|||
149112666|NCT02248818|537891799|FG000|Screening|Withdrawal by Subject|0|||
149112667|NCT02248818|537891800|FG001|Screening|Withdrawal by Subject|0|||
149112668|NCT02248818|537891801|FG002|Screening|Withdrawal by Subject|0|||
149112669|NCT02248818|537891802|FG003|Screening|Withdrawal by Subject|0|||
149112670|NCT02248818|537891803|FG004|Screening|Withdrawal by Subject|0|||
149112671|NCT02248818|537891804|FG005|Screening|Withdrawal by Subject|0|||
149112672|NCT02248818|537891805|FG006|Screening|Withdrawal by Subject|0|||
149112673|NCT02248818|537891806|FG007|Screening|Withdrawal by Subject|0|||
149112674|NCT02248818|537891807|FG008|Screening|Withdrawal by Subject|6|||
149112675|NCT02248818|537891799|FG000|Screening|Lost to Follow-up|0|||
149112676|NCT02248818|537891800|FG001|Screening|Lost to Follow-up|0|||
149112677|NCT02248818|537891801|FG002|Screening|Lost to Follow-up|0|||
149112678|NCT02248818|537891802|FG003|Screening|Lost to Follow-up|0|||
149112679|NCT02248818|537891803|FG004|Screening|Lost to Follow-up|0|||
149112680|NCT02248818|537891804|FG005|Screening|Lost to Follow-up|0|||
149112681|NCT02248818|537891805|FG006|Screening|Lost to Follow-up|0|||
149112682|NCT02248818|537891806|FG007|Screening|Lost to Follow-up|0|||
149112683|NCT02248818|537891807|FG008|Screening|Lost to Follow-up|7|||
149112684|NCT02248818|537891799|FG000|Randomised Study|Administrative - randomization error|0|||
149112685|NCT02248818|537891800|FG001|Randomised Study|Administrative - randomization error|0|||
149112686|NCT02248818|537891801|FG002|Randomised Study|Administrative - randomization error|0|||
149112687|NCT02248818|537891802|FG003|Randomised Study|Administrative - randomization error|0|||
149112688|NCT02248818|537891803|FG004|Randomised Study|Administrative - randomization error|0|||
149112689|NCT02248818|537891804|FG005|Randomised Study|Administrative - randomization error|8|||
149112690|NCT02248818|537891805|FG006|Randomised Study|Administrative - randomization error|0|||
149112691|NCT02248818|537891806|FG007|Randomised Study|Administrative - randomization error|0|||
149112692|NCT02248818|537891807|FG008|Randomised Study|Administrative - randomization error|0|||
149112693|NCT05262517|537891808|FG000|Overall Study|Randomized but not treated|5|||
149112694|NCT05262517|537891809|FG001|Overall Study|Randomized but not treated|11|||
149112695|NCT02942277|537891810|FG000|Year 1|Withdrawal by Subject|0|||
149112696|NCT02942277|537891811|FG001|Year 1|Withdrawal by Subject|0|||
149112697|NCT02942277|537891812|FG002|Year 1|Withdrawal by Subject|0|||
149112698|NCT02942277|537891813|FG003|Year 1|Withdrawal by Subject|0|||
149112699|NCT02942277|537891814|FG004|Year 1|Withdrawal by Subject|1|||
149112700|NCT02942277|537891815|FG005|Year 1|Withdrawal by Subject|3|||
149112701|NCT02942277|537891816|FG006|Year 1|Withdrawal by Subject|0|||
149112702|NCT02942277|537891817|FG007|Year 1|Withdrawal by Subject|1|||
149112703|NCT02942277|537891818|FG008|Year 1|Withdrawal by Subject|0|||
149112704|NCT02942277|537891819|FG009|Year 1|Withdrawal by Subject|0|||
149112705|NCT02942277|537891820|FG010|Year 1|Withdrawal by Subject|3|||
149112706|NCT02942277|537891810|FG000|Year 1|Travel|0|||
149112707|NCT02942277|537891811|FG001|Year 1|Travel|1|||
149112708|NCT02942277|537891812|FG002|Year 1|Travel|0|||
149112709|NCT02942277|537891813|FG003|Year 1|Travel|0|||
149112710|NCT02942277|537891814|FG004|Year 1|Travel|4|||
149112711|NCT02942277|537891815|FG005|Year 1|Travel|5|||
149112712|NCT02942277|537891816|FG006|Year 1|Travel|0|||
149112713|NCT02942277|537891817|FG007|Year 1|Travel|0|||
149112714|NCT02942277|537891818|FG008|Year 1|Travel|0|||
149112715|NCT02942277|537891819|FG009|Year 1|Travel|0|||
149112716|NCT02942277|537891820|FG010|Year 1|Travel|8|||
149112717|NCT02942277|537891810|FG000|Year 1|Joined Army|0|||
149112718|NCT02942277|537891811|FG001|Year 1|Joined Army|1|||
149112719|NCT02942277|537891812|FG002|Year 1|Joined Army|0|||
149112720|NCT02942277|537891813|FG003|Year 1|Joined Army|0|||
149112721|NCT02942277|537891814|FG004|Year 1|Joined Army|0|||
149112722|NCT02942277|537891815|FG005|Year 1|Joined Army|0|||
149112723|NCT02942277|537891816|FG006|Year 1|Joined Army|0|||
149112724|NCT02942277|537891817|FG007|Year 1|Joined Army|0|||
149112725|NCT02942277|537891818|FG008|Year 1|Joined Army|0|||
149112726|NCT02942277|537891819|FG009|Year 1|Joined Army|0|||
149112727|NCT02942277|537891820|FG010|Year 1|Joined Army|0|||
149112728|NCT02942277|537891810|FG000|Year 1|Subject met withdrawal criteria|0|||
149112729|NCT02942277|537891811|FG001|Year 1|Subject met withdrawal criteria|0|||
149112730|NCT02942277|537891812|FG002|Year 1|Subject met withdrawal criteria|0|||
149112731|NCT02942277|537891813|FG003|Year 1|Subject met withdrawal criteria|1|||
149112732|NCT02942277|537891814|FG004|Year 1|Subject met withdrawal criteria|0|||
149112733|NCT02942277|537891815|FG005|Year 1|Subject met withdrawal criteria|0|||
149112734|NCT02942277|537891816|FG006|Year 1|Subject met withdrawal criteria|0|||
149112735|NCT02942277|537891817|FG007|Year 1|Subject met withdrawal criteria|0|||
149112736|NCT02942277|537891818|FG008|Year 1|Subject met withdrawal criteria|0|||
149112737|NCT02942277|537891819|FG009|Year 1|Subject met withdrawal criteria|0|||
149112738|NCT02942277|537891820|FG010|Year 1|Subject met withdrawal criteria|0|||
149112739|NCT02942277|537891810|FG000|Year 1|Lost to Follow-up|0|||
149112740|NCT02942277|537891811|FG001|Year 1|Lost to Follow-up|0|||
149112741|NCT02942277|537891812|FG002|Year 1|Lost to Follow-up|0|||
149112742|NCT02942277|537891813|FG003|Year 1|Lost to Follow-up|0|||
149112743|NCT02942277|537891814|FG004|Year 1|Lost to Follow-up|1|||
149112744|NCT02942277|537891815|FG005|Year 1|Lost to Follow-up|0|||
149112745|NCT02942277|537891816|FG006|Year 1|Lost to Follow-up|0|||
149112746|NCT02942277|537891817|FG007|Year 1|Lost to Follow-up|0|||
149112747|NCT02942277|537891818|FG008|Year 1|Lost to Follow-up|0|||
149112748|NCT02942277|537891819|FG009|Year 1|Lost to Follow-up|0|||
149112749|NCT02942277|537891820|FG010|Year 1|Lost to Follow-up|2|||
149112750|NCT02942277|537891810|FG000|Year 1|Protocol Violation|0|||
149112751|NCT02942277|537891811|FG001|Year 1|Protocol Violation|0|||
149112752|NCT02942277|537891812|FG002|Year 1|Protocol Violation|0|||
149112753|NCT02942277|537891813|FG003|Year 1|Protocol Violation|0|||
149112754|NCT02942277|537891814|FG004|Year 1|Protocol Violation|1|||
149112755|NCT02942277|537891815|FG005|Year 1|Protocol Violation|1|||
149112756|NCT02942277|537891816|FG006|Year 1|Protocol Violation|0|||
149112757|NCT02942277|537891817|FG007|Year 1|Protocol Violation|0|||
149112758|NCT02942277|537891818|FG008|Year 1|Protocol Violation|0|||
149112759|NCT02942277|537891819|FG009|Year 1|Protocol Violation|0|||
149112760|NCT02942277|537891820|FG010|Year 1|Protocol Violation|2|||
149112761|NCT02942277|537891810|FG000|Year 1|Pregnancy|0|||
149112762|NCT02942277|537891811|FG001|Year 1|Pregnancy|0|||
149112763|NCT02942277|537891812|FG002|Year 1|Pregnancy|0|||
149112764|NCT02942277|537891813|FG003|Year 1|Pregnancy|0|||
149112765|NCT02942277|537891814|FG004|Year 1|Pregnancy|0|||
149112766|NCT02942277|537891815|FG005|Year 1|Pregnancy|1|||
149112767|NCT02942277|537891816|FG006|Year 1|Pregnancy|0|||
149112768|NCT02942277|537891817|FG007|Year 1|Pregnancy|0|||
149112769|NCT02942277|537891818|FG008|Year 1|Pregnancy|0|||
149112770|NCT02942277|537891819|FG009|Year 1|Pregnancy|0|||
149112771|NCT02942277|537891820|FG010|Year 1|Pregnancy|0|||
149112772|NCT02942277|537891810|FG000|Year 2|Lost to Follow-up|0|||
149112773|NCT02942277|537891811|FG001|Year 2|Lost to Follow-up|0|||
149112774|NCT02942277|537891812|FG002|Year 2|Lost to Follow-up|0|||
149112775|NCT02942277|537891813|FG003|Year 2|Lost to Follow-up|0|||
149112776|NCT02942277|537891814|FG004|Year 2|Lost to Follow-up|2|||
149112777|NCT02942277|537891815|FG005|Year 2|Lost to Follow-up|1|||
149112778|NCT02942277|537891816|FG006|Year 2|Lost to Follow-up|0|||
149112779|NCT02942277|537891817|FG007|Year 2|Lost to Follow-up|0|||
149112780|NCT02942277|537891818|FG008|Year 2|Lost to Follow-up|0|||
149112781|NCT02942277|537891819|FG009|Year 2|Lost to Follow-up|0|||
149112782|NCT02942277|537891820|FG010|Year 2|Lost to Follow-up|0|||
149112783|NCT02942277|537891810|FG000|Year 2|Did not rescreen|0|||
149112784|NCT02942277|537891811|FG001|Year 2|Did not rescreen|0|||
149112785|NCT02942277|537891812|FG002|Year 2|Did not rescreen|1|||
149112786|NCT02942277|537891813|FG003|Year 2|Did not rescreen|1|||
149112787|NCT02942277|537891814|FG004|Year 2|Did not rescreen|9|||
149112788|NCT02942277|537891815|FG005|Year 2|Did not rescreen|6|||
149112789|NCT02942277|537891816|FG006|Year 2|Did not rescreen|0|||
149112790|NCT02942277|537891817|FG007|Year 2|Did not rescreen|1|||
149112791|NCT02942277|537891818|FG008|Year 2|Did not rescreen|0|||
149112792|NCT02942277|537891819|FG009|Year 2|Did not rescreen|0|||
149112793|NCT02942277|537891820|FG010|Year 2|Did not rescreen|21|||
149112794|NCT02942277|537891810|FG000|Year 2|Met withdrawal criteria|0|||
149112795|NCT02942277|537891811|FG001|Year 2|Met withdrawal criteria|0|||
149112796|NCT02942277|537891812|FG002|Year 2|Met withdrawal criteria|0|||
149112797|NCT02942277|537891813|FG003|Year 2|Met withdrawal criteria|0|||
149112798|NCT02942277|537891814|FG004|Year 2|Met withdrawal criteria|1|||
149112799|NCT02942277|537891815|FG005|Year 2|Met withdrawal criteria|2|||
149112800|NCT02942277|537891816|FG006|Year 2|Met withdrawal criteria|0|||
149112801|NCT02942277|537891817|FG007|Year 2|Met withdrawal criteria|0|||
149112802|NCT02942277|537891818|FG008|Year 2|Met withdrawal criteria|0|||
149112803|NCT02942277|537891819|FG009|Year 2|Met withdrawal criteria|0|||
149112804|NCT02942277|537891820|FG010|Year 2|Met withdrawal criteria|1|||
149112805|NCT02942277|537891810|FG000|Year 2|Travel|0|||
149112806|NCT02942277|537891811|FG001|Year 2|Travel|1|||
149112807|NCT02942277|537891812|FG002|Year 2|Travel|0|||
149112808|NCT02942277|537891813|FG003|Year 2|Travel|0|||
149112809|NCT02942277|537891814|FG004|Year 2|Travel|0|||
149112810|NCT02942277|537891815|FG005|Year 2|Travel|1|||
149112811|NCT02942277|537891816|FG006|Year 2|Travel|0|||
149112812|NCT02942277|537891817|FG007|Year 2|Travel|0|||
149112813|NCT02942277|537891818|FG008|Year 2|Travel|0|||
149112814|NCT02942277|537891819|FG009|Year 2|Travel|1|||
149112815|NCT02942277|537891820|FG010|Year 2|Travel|3|||
149112816|NCT02942277|537891810|FG000|Year 2|Non-compliant|0|||
149112817|NCT02942277|537891811|FG001|Year 2|Non-compliant|0|||
149112818|NCT02942277|537891812|FG002|Year 2|Non-compliant|0|||
149112819|NCT02942277|537891813|FG003|Year 2|Non-compliant|0|||
149112820|NCT02942277|537891814|FG004|Year 2|Non-compliant|1|||
149112821|NCT02942277|537891815|FG005|Year 2|Non-compliant|1|||
149112822|NCT02942277|537891816|FG006|Year 2|Non-compliant|0|||
149112823|NCT02942277|537891817|FG007|Year 2|Non-compliant|0|||
149112824|NCT02942277|537891818|FG008|Year 2|Non-compliant|0|||
149112825|NCT02942277|537891819|FG009|Year 2|Non-compliant|0|||
149112826|NCT02942277|537891820|FG010|Year 2|Non-compliant|0|||
149112827|NCT02942277|537891810|FG000|Year 2|Withdrawal by Subject|0|||
149112828|NCT02942277|537891811|FG001|Year 2|Withdrawal by Subject|0|||
149112829|NCT02942277|537891812|FG002|Year 2|Withdrawal by Subject|0|||
149112830|NCT02942277|537891813|FG003|Year 2|Withdrawal by Subject|0|||
149112831|NCT02942277|537891814|FG004|Year 2|Withdrawal by Subject|0|||
149112832|NCT02942277|537891815|FG005|Year 2|Withdrawal by Subject|0|||
149112833|NCT02942277|537891816|FG006|Year 2|Withdrawal by Subject|1|||
149112834|NCT02942277|537891817|FG007|Year 2|Withdrawal by Subject|0|||
149112835|NCT02942277|537891818|FG008|Year 2|Withdrawal by Subject|0|||
149112836|NCT02942277|537891819|FG009|Year 2|Withdrawal by Subject|0|||
149112837|NCT02942277|537891820|FG010|Year 2|Withdrawal by Subject|0|||
149112838|NCT05602727|537891821|FG000|Overall Study|Physician Decision|0|||
149112839|NCT05602727|537891822|FG001|Overall Study|Physician Decision|1|||
149112840|NCT05602727|537891823|FG002|Overall Study|Physician Decision|0|||
149112841|NCT05602727|537891821|FG000|Overall Study|Randomized by mistake without study medication|1|||
149112842|NCT05602727|537891822|FG001|Overall Study|Randomized by mistake without study medication|0|||
149112843|NCT05602727|537891823|FG002|Overall Study|Randomized by mistake without study medication|0|||
149112844|NCT05602727|537891821|FG000|Overall Study|Study termination by Sponsor|18|||
149112845|NCT05602727|537891822|FG001|Overall Study|Study termination by Sponsor|15|||
149112846|NCT05602727|537891823|FG002|Overall Study|Study termination by Sponsor|19|||
149112847|NCT05602727|537891821|FG000|Overall Study|Withdrawal by Subject|2|||
149112848|NCT05602727|537891822|FG001|Overall Study|Withdrawal by Subject|1|||
149112849|NCT05602727|537891823|FG002|Overall Study|Withdrawal by Subject|1|||
149112850|NCT05602727|537891821|FG000|Overall Study|Various reasons|1|||
149112851|NCT05602727|537891822|FG001|Overall Study|Various reasons|6|||
149112852|NCT05602727|537891823|FG002|Overall Study|Various reasons|1|||
149112853|NCT02187159|537891824|FG000|Overall Study|Protocol Violation|4|||
149112854|NCT02187159|537891825|FG001|Overall Study|Protocol Violation|6|||
149112855|NCT02187159|537891826|FG002|Overall Study|Protocol Violation|3|||
149112856|NCT02187159|537891827|FG003|Overall Study|Protocol Violation|4|||
149112857|NCT02187159|537891824|FG000|Overall Study|Lack of Efficacy|10|||
149112858|NCT02187159|537891825|FG001|Overall Study|Lack of Efficacy|5|||
149112859|NCT02187159|537891826|FG002|Overall Study|Lack of Efficacy|4|||
149112860|NCT02187159|537891827|FG003|Overall Study|Lack of Efficacy|7|||
149112861|NCT02187159|537891824|FG000|Overall Study|Adverse Event|28|||
149112862|NCT02187159|537891825|FG001|Overall Study|Adverse Event|33|||
149112863|NCT02187159|537891826|FG002|Overall Study|Adverse Event|42|||
149112864|NCT02187159|537891827|FG003|Overall Study|Adverse Event|50|||
149112865|NCT02187159|537891824|FG000|Overall Study|Withdrawal by Subject|24|||
149112866|NCT02187159|537891825|FG001|Overall Study|Withdrawal by Subject|28|||
149112867|NCT02187159|537891826|FG002|Overall Study|Withdrawal by Subject|25|||
149112868|NCT02187159|537891827|FG003|Overall Study|Withdrawal by Subject|26|||
149112869|NCT02187159|537891824|FG000|Overall Study|Other|3|||
149112870|NCT02187159|537891825|FG001|Overall Study|Other|7|||
149112871|NCT02187159|537891826|FG002|Overall Study|Other|3|||
149112872|NCT02187159|537891827|FG003|Overall Study|Other|9|||
149112873|NCT04325282|537891828|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
149112874|NCT04325282|537891829|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
149112875|NCT04325282|537891828|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
149112876|NCT04325282|537891829|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
149112877|NCT00527787|537891837|FG000|Overall Study|Adverse Event|14|||
149112878|NCT00527787|537891838|FG001|Overall Study|Adverse Event|24|||
149112879|NCT00527787|537891837|FG000|Overall Study|Withdrawal by Subject|13|||
149112880|NCT00527787|537891838|FG001|Overall Study|Withdrawal by Subject|25|||
149112881|NCT00527787|537891837|FG000|Overall Study|Lost to Follow-up|5|||
149112882|NCT00527787|537891838|FG001|Overall Study|Lost to Follow-up|2|||
149112883|NCT00527787|537891837|FG000|Overall Study|Duodenal Ulcer|1|||
149112884|NCT00527787|537891838|FG001|Overall Study|Duodenal Ulcer|10|||
149112885|NCT00527787|537891837|FG000|Overall Study|misc|5|||
149112886|NCT00527787|537891838|FG001|Overall Study|misc|2|||
149112887|NCT00461981|537891839|FG000|Overall Study|Lost to Follow-up|9|||
149112888|NCT00461981|537891840|FG001|Overall Study|Lost to Follow-up|6|||
149112889|NCT00461981|537891839|FG000|Overall Study|Withdrawal by Subject|2|||
149112890|NCT00461981|537891840|FG001|Overall Study|Withdrawal by Subject|3|||
149112891|NCT03031496|537891841|FG000|Period 1|Adverse Event|2|||
149112892|NCT03031496|537891842|FG001|Period 1|Adverse Event|0|||
149112893|NCT03031496|537891841|FG000|Period 1|Withdrawal by Subject|0|||
149112894|NCT03031496|537891842|FG001|Period 1|Withdrawal by Subject|2|||
149112895|NCT03868787|537891843|FG000|Overall Study|Withdrawal by Subject|2|||
149112896|NCT03868787|537891844|FG001|Overall Study|Withdrawal by Subject|1|||
149112897|NCT02510040|537891845|FG000|Overall Study|Deemed no longer eligible|18|||
149112898|NCT02510040|537891846|FG001|Overall Study|Deemed no longer eligible|3|||
149112899|NCT02510040|537891847|FG002|Overall Study|Deemed no longer eligible|1|||
149112900|NCT01518153|537891850|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
149112901|NCT01518153|537891851|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
149112902|NCT01518153|537891852|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
149112903|NCT01518153|537891850|FG000|Stem Cell Transplant|Death|2|||
149112904|NCT01518153|537891851|FG001|Stem Cell Transplant|Death|0|||
149112905|NCT01518153|537891852|FG002|Stem Cell Transplant|Death|0|||
149112906|NCT01518153|537891850|FG000|Stem Cell Transplant|Secondary graft failure|1|||
149112907|NCT01518153|537891851|FG001|Stem Cell Transplant|Secondary graft failure|0|||
149112908|NCT01518153|537891852|FG002|Stem Cell Transplant|Secondary graft failure|0|||
149112909|NCT01518153|537891850|FG000|Stem Cell Transplant|Adverse Event|1|||
149112910|NCT01518153|537891851|FG001|Stem Cell Transplant|Adverse Event|0|||
149112911|NCT01518153|537891852|FG002|Stem Cell Transplant|Adverse Event|0|||
149112912|NCT01518153|537891850|FG000|Donor Lymphocyte Infusion|Death|0|||
149112913|NCT01518153|537891851|FG001|Donor Lymphocyte Infusion|Death|2|||
149112914|NCT01518153|537891852|FG002|Donor Lymphocyte Infusion|Death|1|||
149112915|NCT01327846|537891855|FG000|Core Phase|Subject decision (vital status: missing)|1|||
149112916|NCT01327846|537891856|FG001|Core Phase|Subject decision (vital status: missing)|2|||
149112917|NCT01327846|537891857|FG002|Core Phase|Subject decision (vital status: missing)|2|||
149112918|NCT01327846|537891858|FG003|Core Phase|Subject decision (vital status: missing)|1|||
149112919|NCT01327846|537891855|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
149112920|NCT01327846|537891856|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
149112921|NCT01327846|537891857|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
149112922|NCT01327846|537891858|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
149112923|NCT01327846|537891855|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
149112924|NCT01327846|537891856|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
149112925|NCT01327846|537891857|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
149112926|NCT01327846|537891858|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
149112927|NCT01327846|537891855|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
149112928|NCT01327846|537891856|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
149112929|NCT01327846|537891857|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
149112930|NCT01327846|537891858|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
149112931|NCT01327846|537891855|FG000|Core Phase|Lost to Follow-up|3|||
149112932|NCT01327846|537891856|FG001|Core Phase|Lost to Follow-up|3|||
149112933|NCT01327846|537891857|FG002|Core Phase|Lost to Follow-up|4|||
149112934|NCT01327846|537891858|FG003|Core Phase|Lost to Follow-up|5|||
149112935|NCT01327846|537891855|FG000|Extension Phase|Study terminated by sponsor|1073|||
149112936|NCT01327846|537891856|FG001|Extension Phase|Study terminated by sponsor|1124|||
149112937|NCT01327846|537891857|FG002|Extension Phase|Study terminated by sponsor|1067|||
149112938|NCT01327846|537891858|FG003|Extension Phase|Study terminated by sponsor|1660|||
149112939|NCT01327846|537891855|FG000|Extension Phase|Withdrawal by Subject|20|||
149112940|NCT01327846|537891856|FG001|Extension Phase|Withdrawal by Subject|13|||
149112941|NCT01327846|537891857|FG002|Extension Phase|Withdrawal by Subject|19|||
149112942|NCT01327846|537891858|FG003|Extension Phase|Withdrawal by Subject|37|||
149112943|NCT01327846|537891855|FG000|Extension Phase|Lost to Follow-up|4|||
149112944|NCT01327846|537891856|FG001|Extension Phase|Lost to Follow-up|3|||
149112945|NCT01327846|537891857|FG002|Extension Phase|Lost to Follow-up|4|||
149112946|NCT01327846|537891858|FG003|Extension Phase|Lost to Follow-up|7|||
149112947|NCT01327846|537891855|FG000|Extension Phase|Technical Problems|2|||
149112948|NCT01327846|537891856|FG001|Extension Phase|Technical Problems|4|||
149112949|NCT01327846|537891857|FG002|Extension Phase|Technical Problems|2|||
149112950|NCT01327846|537891858|FG003|Extension Phase|Technical Problems|2|||
149112951|NCT01840410|537891860|FG000|Overall Study|Physician Decision|1|||
149112952|NCT01840410|537891861|FG001|Overall Study|Physician Decision|2|||
149112953|NCT01840410|537891860|FG000|Overall Study|Pregnancy|1|||
149112954|NCT01840410|537891861|FG001|Overall Study|Pregnancy|0|||
149112955|NCT01840410|537891860|FG000|Overall Study|Protocol deviation|1|||
149112956|NCT01840410|537891861|FG001|Overall Study|Protocol deviation|0|||
149112957|NCT01840410|537891860|FG000|Overall Study|Lost to Follow-up|1|||
149112958|NCT01840410|537891861|FG001|Overall Study|Lost to Follow-up|0|||
149112959|NCT01840410|537891860|FG000|Overall Study|Withdrawal by Subject|2|||
149112960|NCT01840410|537891861|FG001|Overall Study|Withdrawal by Subject|1|||
149112961|NCT01840410|537891860|FG000|Overall Study|Adverse Event|1|||
149112962|NCT01840410|537891861|FG001|Overall Study|Adverse Event|1|||
149112963|NCT00839956|537891862|FG000|Overall Study|Adverse Event|2|||
149112964|NCT00839956|537891862|FG000|Overall Study|Lack of Efficacy|6|||
149112965|NCT00839956|537891862|FG000|Overall Study|Physician Decision|1|||
149112966|NCT00839956|537891862|FG000|Overall Study|Withdrawal by Subject|3|||
149112967|NCT01495598|537891865|FG000|Overall Study|Death during follow up period|2|||
149112968|NCT01495598|537891865|FG000|Overall Study|Death on study|1|||
149112969|NCT01495598|537891865|FG000|Overall Study|Lost to Follow-up|3|||
149112970|NCT01495598|537891865|FG000|Overall Study|Physician Decision|8|||
149112971|NCT03083665|537891866|FG000|Double-Blind Period|Adverse Event|5|||
149112972|NCT03083665|537891867|FG001|Double-Blind Period|Adverse Event|4|||
149112973|NCT03083665|537891868|FG002|Double-Blind Period|Adverse Event|5|||
149112974|NCT03083665|537891869|FG003|Double-Blind Period|Adverse Event|0|||
149112975|NCT03083665|537891870|FG004|Double-Blind Period|Adverse Event|0|||
149112976|NCT03083665|537891871|FG005|Double-Blind Period|Adverse Event|0|||
149112977|NCT03083665|537891866|FG000|Double-Blind Period|Lack of Efficacy|0|||
149112978|NCT03083665|537891867|FG001|Double-Blind Period|Lack of Efficacy|0|||
149112979|NCT03083665|537891868|FG002|Double-Blind Period|Lack of Efficacy|1|||
149112980|NCT03083665|537891869|FG003|Double-Blind Period|Lack of Efficacy|0|||
149112981|NCT03083665|537891870|FG004|Double-Blind Period|Lack of Efficacy|0|||
149112982|NCT03083665|537891871|FG005|Double-Blind Period|Lack of Efficacy|0|||
149112983|NCT03083665|537891866|FG000|Double-Blind Period|Protocol Violation|1|||
149112984|NCT03083665|537891867|FG001|Double-Blind Period|Protocol Violation|0|||
149112985|NCT03083665|537891868|FG002|Double-Blind Period|Protocol Violation|1|||
149112986|NCT03083665|537891869|FG003|Double-Blind Period|Protocol Violation|0|||
149112987|NCT03083665|537891870|FG004|Double-Blind Period|Protocol Violation|0|||
149112988|NCT03083665|537891871|FG005|Double-Blind Period|Protocol Violation|0|||
149112989|NCT03083665|537891866|FG000|Double-Blind Period|Lost to Follow-up|1|||
149112990|NCT03083665|537891867|FG001|Double-Blind Period|Lost to Follow-up|0|||
149112991|NCT03083665|537891868|FG002|Double-Blind Period|Lost to Follow-up|1|||
149112992|NCT03083665|537891869|FG003|Double-Blind Period|Lost to Follow-up|0|||
149112993|NCT03083665|537891870|FG004|Double-Blind Period|Lost to Follow-up|0|||
149112994|NCT03083665|537891871|FG005|Double-Blind Period|Lost to Follow-up|0|||
149112995|NCT03083665|537891866|FG000|Double-Blind Period|Withdrawal by Subject|3|||
149112996|NCT03083665|537891867|FG001|Double-Blind Period|Withdrawal by Subject|0|||
149112997|NCT03083665|537891868|FG002|Double-Blind Period|Withdrawal by Subject|0|||
149112998|NCT03083665|537891869|FG003|Double-Blind Period|Withdrawal by Subject|0|||
149112999|NCT03083665|537891870|FG004|Double-Blind Period|Withdrawal by Subject|0|||
149113000|NCT03083665|537891871|FG005|Double-Blind Period|Withdrawal by Subject|0|||
149113001|NCT03083665|537891866|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
149113002|NCT03083665|537891867|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
149113003|NCT03083665|537891868|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
149113004|NCT03083665|537891869|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
149113005|NCT03083665|537891870|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
149113006|NCT03083665|537891871|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
149113007|NCT03083665|537891866|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
149113008|NCT03083665|537891867|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
149113009|NCT03083665|537891868|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
149113010|NCT03083665|537891869|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
149113011|NCT03083665|537891870|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
149113012|NCT03083665|537891871|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
149113013|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
149113014|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
149113015|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
149113016|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
149113017|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
149113018|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
149113019|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
149113020|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
149113021|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
149113022|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
149113023|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
149113024|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
149113025|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
149113026|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
149113027|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
149113028|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
149113029|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
149113030|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
149113031|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
149113032|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
149113033|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
149113034|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
149113035|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
149113036|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
149113037|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
149113038|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
149113039|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
149113040|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
149113041|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
149113042|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
149113043|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
149113044|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
149113045|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
149113046|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
149113047|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
149113048|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
149113049|NCT03083665|537891866|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
149113050|NCT03083665|537891867|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
149113051|NCT03083665|537891868|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
149113052|NCT03083665|537891869|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
149113053|NCT03083665|537891870|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
149113054|NCT03083665|537891871|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
149113055|NCT01289210|537891872|FG000|Overall Study|Adverse Event|1|||
149113056|NCT01040169|537891889|FG000|Overall Study|Lost to Follow-up|3|||
149113057|NCT01040169|537891890|FG001|Overall Study|Lost to Follow-up|8|||
149113058|NCT00350727|537891891|FG000|Phase I: Dose Escalation|Adverse Event|4|||
149113059|NCT00350727|537891892|FG001|Phase I: Dose Escalation|Adverse Event|0|||
149113060|NCT00350727|537891893|FG002|Phase I: Dose Escalation|Adverse Event|0|||
149113061|NCT00350727|537891891|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
149113062|NCT00350727|537891892|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
149113063|NCT00350727|537891893|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
149113064|NCT00350727|537891891|FG000|Phase I: Dose Escalation|Death|1|||
149113065|NCT00350727|537891892|FG001|Phase I: Dose Escalation|Death|0|||
149113066|NCT00350727|537891893|FG002|Phase I: Dose Escalation|Death|0|||
149113067|NCT00350727|537891891|FG000|Phase I: Dose Escalation|Physician Decision|1|||
149113068|NCT00350727|537891892|FG001|Phase I: Dose Escalation|Physician Decision|0|||
149113069|NCT00350727|537891893|FG002|Phase I: Dose Escalation|Physician Decision|0|||
149113070|NCT00350727|537891891|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
149113071|NCT00350727|537891892|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
149113072|NCT00350727|537891893|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
149113073|NCT00350727|537891891|FG000|Phase II|Disease Progression|0|||
149113074|NCT00350727|537891892|FG001|Phase II|Disease Progression|15|||
149113075|NCT00350727|537891893|FG002|Phase II|Disease Progression|16|||
149113076|NCT00350727|537891891|FG000|Phase II|Clinical Deterioration|0|||
149113077|NCT00350727|537891892|FG001|Phase II|Clinical Deterioration|1|||
149113078|NCT00350727|537891893|FG002|Phase II|Clinical Deterioration|0|||
149113079|NCT00350727|537891891|FG000|Phase II|Withdrawal by Subject|0|||
149113080|NCT00350727|537891892|FG001|Phase II|Withdrawal by Subject|2|||
149113081|NCT00350727|537891893|FG002|Phase II|Withdrawal by Subject|1|||
149113082|NCT00350727|537891891|FG000|Phase II|Adverse Event|0|||
149113083|NCT00350727|537891892|FG001|Phase II|Adverse Event|1|||
149113084|NCT00350727|537891893|FG002|Phase II|Adverse Event|1|||
149113085|NCT00350727|537891891|FG000|Phase II|Death|0|||
149113086|NCT00350727|537891892|FG001|Phase II|Death|0|||
149113087|NCT00350727|537891893|FG002|Phase II|Death|2|||
149113088|NCT00350727|537891891|FG000|Phase II|Sponsor Terminated Study|0|||
149113089|NCT00350727|537891892|FG001|Phase II|Sponsor Terminated Study|0|||
149113090|NCT00350727|537891893|FG002|Phase II|Sponsor Terminated Study|1|||
149113091|NCT00350727|537891891|FG000|Phase II|Enrolled in Rollover Study|0|||
149113092|NCT00350727|537891892|FG001|Phase II|Enrolled in Rollover Study|0|||
149113093|NCT00350727|537891893|FG002|Phase II|Enrolled in Rollover Study|1|||
149113094|NCT03551691|537891899|FG000|Overall Study|Withdrawal by Subject|3|||
149113095|NCT03551691|537891900|FG001|Overall Study|Withdrawal by Subject|3|||
149113096|NCT00288639|537892866|FG000|Overall Study|Adverse Event|5|||
149113097|NCT00288639|537892866|FG000|Overall Study|Lack of Efficacy|4|||
149113098|NCT00288639|537892866|FG000|Overall Study|Withdrawal by Subject|2|||
149113099|NCT00288639|537892866|FG000|Overall Study|Other|1|||
149113100|NCT01876901|537892877|FG000|Overall Study|Protocol Violation|10|||
149113101|NCT01876901|537892878|FG001|Overall Study|Protocol Violation|2|||
149113102|NCT01876901|537892877|FG000|Overall Study|No or other surgical intervention|7|||
149113103|NCT01876901|537892878|FG001|Overall Study|No or other surgical intervention|5|||
149113104|NCT04313608|537892881|FG000|Overall Study|Death|12|||
149113105|NCT04313608|537892882|FG001|Overall Study|Death|3|||
149113106|NCT01712061|537892883|FG000|Overall Study|Adverse Event|4|||
149113107|NCT01712061|537892884|FG001|Overall Study|Adverse Event|9|||
149113108|NCT01712061|537892885|FG002|Overall Study|Adverse Event|5|||
149113109|NCT01712061|537892883|FG000|Overall Study|Death|0|||
149113110|NCT01712061|537892884|FG001|Overall Study|Death|0|||
149113111|NCT01712061|537892885|FG002|Overall Study|Death|1|||
149113112|NCT01712061|537892883|FG000|Overall Study|Lost to Follow-up|1|||
149113113|NCT01712061|537892884|FG001|Overall Study|Lost to Follow-up|0|||
149113114|NCT01712061|537892885|FG002|Overall Study|Lost to Follow-up|1|||
149113115|NCT01712061|537892883|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
149113116|NCT01712061|537892884|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
149113117|NCT01712061|537892885|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
149113118|NCT01712061|537892883|FG000|Overall Study|Medication Error Without Associated AE|0|||
149113119|NCT01712061|537892884|FG001|Overall Study|Medication Error Without Associated AE|1|||
149113120|NCT01712061|537892885|FG002|Overall Study|Medication Error Without Associated AE|0|||
149113121|NCT01712061|537892883|FG000|Overall Study|Withdrawal by Subject|1|||
149113122|NCT01712061|537892884|FG001|Overall Study|Withdrawal by Subject|7|||
149113123|NCT01712061|537892885|FG002|Overall Study|Withdrawal by Subject|1|||
149113124|NCT01712061|537892883|FG000|Overall Study|Other|0|||
149113125|NCT01712061|537892884|FG001|Overall Study|Other|3|||
149113126|NCT01712061|537892885|FG002|Overall Study|Other|0|||
149113127|NCT00879775|537892888|FG000|Overall Study|Lost to Follow-up|2|||
149113128|NCT00879775|537892889|FG001|Overall Study|Lost to Follow-up|1|||
149113129|NCT00842244|537892890|FG000|Overall Study|Death|3|||
149113130|NCT00842244|537892890|FG000|Overall Study|Withdrawal by Subject|1|||
149113131|NCT00842244|537892890|FG000|Overall Study|Other|17|||
149113132|NCT01068665|537892891|FG000|Overall Study|Adverse Event|5|||
149113133|NCT01068665|537892892|FG001|Overall Study|Adverse Event|4|||
149113134|NCT01068665|537892891|FG000|Overall Study|Lack of Efficacy|0|||
149113135|NCT01068665|537892892|FG001|Overall Study|Lack of Efficacy|2|||
149113136|NCT01068665|537892891|FG000|Overall Study|Protocol Violation|5|||
149113137|NCT01068665|537892892|FG001|Overall Study|Protocol Violation|2|||
149113138|NCT01068665|537892891|FG000|Overall Study|Withdrawal Criteria|3|||
149113139|NCT01068665|537892892|FG001|Overall Study|Withdrawal Criteria|9|||
149113140|NCT01068665|537892891|FG000|Overall Study|Other|17|||
149113141|NCT01068665|537892892|FG001|Overall Study|Other|12|||
149113142|NCT02992691|537892895|FG000|Overall Study|Adverse Event|2|||
149113143|NCT02992691|537892895|FG000|Overall Study|Withdrawal by Subject|1|||
149113144|NCT00392925|537892897|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
149113145|NCT00392925|537892898|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
149113146|NCT00392925|537892899|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
149113147|NCT00392925|537892900|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
149113148|NCT00392925|537892897|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
149113149|NCT00392925|537892898|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
149113150|NCT00392925|537892899|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
149113151|NCT00392925|537892900|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
149113152|NCT00392925|537892897|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
149113153|NCT00392925|537892898|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
149113154|NCT00392925|537892899|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
149113155|NCT00392925|537892900|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
149113156|NCT00392925|537892897|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
149113157|NCT00392925|537892898|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
149113158|NCT00392925|537892899|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
149113159|NCT00392925|537892900|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
149113160|NCT00392925|537892897|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
149113161|NCT00392925|537892898|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
149113162|NCT00392925|537892899|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
149113163|NCT00392925|537892900|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
149113164|NCT00392925|537892897|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
149113165|NCT00392925|537892898|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
149113166|NCT00392925|537892899|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
149113167|NCT00392925|537892900|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
149113168|NCT00392925|537892897|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
149113169|NCT00392925|537892898|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
149113170|NCT00392925|537892899|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
149113171|NCT00392925|537892900|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
149113172|NCT00392925|537892897|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
149113173|NCT00392925|537892898|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
149113174|NCT00392925|537892899|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
149113175|NCT00392925|537892900|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
149113176|NCT00392925|537892897|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
149113177|NCT00392925|537892898|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
149113178|NCT00392925|537892899|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
149113179|NCT00392925|537892900|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
149113180|NCT03552523|537892901|FG000|Overall Study|Withdrawal by Subject|1|||
149113181|NCT03552523|537892902|FG001|Overall Study|Withdrawal by Subject|1|||
149113182|NCT03538938|537892903|FG000|Overall Study|Death|0|||
149113183|NCT03538938|537892904|FG001|Overall Study|Death|0|||
149113184|NCT03538938|537892905|FG002|Overall Study|Death|2|||
149113185|NCT03538938|537892906|FG003|Overall Study|Death|0|||
149113186|NCT03538938|537892907|FG004|Overall Study|Death|0|||
149113187|NCT03538938|537892908|FG005|Overall Study|Death|1|||
149113188|NCT03538938|537892909|FG006|Overall Study|Death|0|||
149113189|NCT03538938|537892910|FG007|Overall Study|Death|1|||
149113190|NCT03538938|537892911|FG008|Overall Study|Death|1|||
149113191|NCT03538938|537892912|FG009|Overall Study|Death|1|||
149113192|NCT03538938|537892913|FG010|Overall Study|Death|0|||
149113193|NCT03538938|537892914|FG011|Overall Study|Death|0|||
149113194|NCT03538938|537892915|FG012|Overall Study|Death|1|||
149113195|NCT03538938|537892916|FG013|Overall Study|Death|1|||
149113196|NCT03538938|537892917|FG014|Overall Study|Death|0|||
149113197|NCT03538938|537892918|FG015|Overall Study|Death|1|||
149113198|NCT03538938|537892903|FG000|Overall Study|Withdrawal by Subject|4|||
149113199|NCT03538938|537892904|FG001|Overall Study|Withdrawal by Subject|6|||
149113200|NCT03538938|537892905|FG002|Overall Study|Withdrawal by Subject|5|||
149113201|NCT03538938|537892906|FG003|Overall Study|Withdrawal by Subject|3|||
149113202|NCT03538938|537892907|FG004|Overall Study|Withdrawal by Subject|0|||
149113203|NCT03538938|537892908|FG005|Overall Study|Withdrawal by Subject|0|||
149113204|NCT03538938|537892909|FG006|Overall Study|Withdrawal by Subject|3|||
149113205|NCT03538938|537892910|FG007|Overall Study|Withdrawal by Subject|1|||
149113206|NCT03538938|537892911|FG008|Overall Study|Withdrawal by Subject|5|||
149113207|NCT03538938|537892912|FG009|Overall Study|Withdrawal by Subject|1|||
149113208|NCT03538938|537892913|FG010|Overall Study|Withdrawal by Subject|2|||
149113209|NCT03538938|537892914|FG011|Overall Study|Withdrawal by Subject|1|||
149113210|NCT03538938|537892915|FG012|Overall Study|Withdrawal by Subject|3|||
149113211|NCT03538938|537892916|FG013|Overall Study|Withdrawal by Subject|0|||
149113212|NCT03538938|537892917|FG014|Overall Study|Withdrawal by Subject|2|||
149113213|NCT03538938|537892918|FG015|Overall Study|Withdrawal by Subject|4|||
149113214|NCT03538938|537892903|FG000|Overall Study|Incarcerated|0|||
149113215|NCT03538938|537892904|FG001|Overall Study|Incarcerated|0|||
149113216|NCT03538938|537892905|FG002|Overall Study|Incarcerated|0|||
149113217|NCT03538938|537892906|FG003|Overall Study|Incarcerated|0|||
149113218|NCT03538938|537892907|FG004|Overall Study|Incarcerated|0|||
149113219|NCT03538938|537892908|FG005|Overall Study|Incarcerated|0|||
149113220|NCT03538938|537892909|FG006|Overall Study|Incarcerated|0|||
149113221|NCT03538938|537892910|FG007|Overall Study|Incarcerated|0|||
149113222|NCT03538938|537892911|FG008|Overall Study|Incarcerated|0|||
149113223|NCT03538938|537892912|FG009|Overall Study|Incarcerated|0|||
149113224|NCT03538938|537892913|FG010|Overall Study|Incarcerated|0|||
149113225|NCT03538938|537892914|FG011|Overall Study|Incarcerated|1|||
149113226|NCT03538938|537892915|FG012|Overall Study|Incarcerated|0|||
149113227|NCT03538938|537892916|FG013|Overall Study|Incarcerated|0|||
149113228|NCT03538938|537892917|FG014|Overall Study|Incarcerated|0|||
149113229|NCT03538938|537892918|FG015|Overall Study|Incarcerated|0|||
149113230|NCT00755105|537892919|FG000|Overall Study|Withdrawal by Subject|9|||
149113231|NCT00755105|537892920|FG001|Overall Study|Withdrawal by Subject|11|||
149113232|NCT00755105|537892921|FG002|Overall Study|Withdrawal by Subject|4|||
149113233|NCT04145700|537892924|FG000|Overall Study|Withdrawal by Subject|8|||
149113234|NCT04145700|537892925|FG001|Overall Study|Withdrawal by Subject|3|||
149113235|NCT00203268|537892929|FG000|Early Treatment|only treated one headache|2|||
149113236|NCT00203268|537892929|FG000|Early Treatment|Lost to Follow-up|1|||
149113237|NCT00203268|537892929|FG000|Early Treatment|Withdrawal by Subject|1|||
149113238|NCT00594880|537892930|FG000|Overall Study|Withdrawal by Subject|1|||
149113239|NCT00594880|537892931|FG001|Overall Study|Withdrawal by Subject|1|||
149113240|NCT00594880|537892930|FG000|Overall Study|Lost to Follow-up|1|||
149113241|NCT00594880|537892931|FG001|Overall Study|Lost to Follow-up|0|||
149113242|NCT01254747|537892934|FG000|Overall Study|Unacceptable subjective vision|0|||
149113243|NCT01254747|537892935|FG001|Overall Study|Unacceptable subjective vision|0|||
149113244|NCT01254747|537892936|FG002|Overall Study|Unacceptable subjective vision|0|||
149113245|NCT01254747|537892937|FG003|Overall Study|Unacceptable subjective vision|2|||
149113246|NCT01254747|537892934|FG000|Overall Study|Difficult removal handling|0|||
149113247|NCT01254747|537892935|FG001|Overall Study|Difficult removal handling|0|||
149113248|NCT01254747|537892936|FG002|Overall Study|Difficult removal handling|1|||
149113249|NCT01254747|537892937|FG003|Overall Study|Difficult removal handling|0|||
149113250|NCT01254747|537892934|FG000|Overall Study|Symptoms and problems|0|||
149113251|NCT01254747|537892935|FG001|Overall Study|Symptoms and problems|2|||
149113252|NCT01254747|537892936|FG002|Overall Study|Symptoms and problems|1|||
149113253|NCT01254747|537892937|FG003|Overall Study|Symptoms and problems|0|||
149113254|NCT01254747|537892934|FG000|Overall Study|Lost to Follow-up|0|||
149113255|NCT01254747|537892935|FG001|Overall Study|Lost to Follow-up|0|||
149113256|NCT01254747|537892936|FG002|Overall Study|Lost to Follow-up|1|||
149113257|NCT01254747|537892937|FG003|Overall Study|Lost to Follow-up|0|||
149113258|NCT01254747|537892934|FG000|Overall Study|Biomicroscopy|0|||
149113259|NCT01254747|537892935|FG001|Overall Study|Biomicroscopy|0|||
149113260|NCT01254747|537892936|FG002|Overall Study|Biomicroscopy|1|||
149113261|NCT01254747|537892937|FG003|Overall Study|Biomicroscopy|0|||
149113262|NCT01254747|537892934|FG000|Overall Study|Discomfort|0|||
149113263|NCT01254747|537892935|FG001|Overall Study|Discomfort|4|||
149113264|NCT01254747|537892936|FG002|Overall Study|Discomfort|0|||
149113265|NCT01254747|537892937|FG003|Overall Study|Discomfort|0|||
149113266|NCT00245960|537892938|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
149113267|NCT00245960|537892939|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
149113268|NCT00245960|537892938|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
149113269|NCT00245960|537892939|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
149113270|NCT00245960|537892938|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
149113271|NCT00245960|537892939|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
149113272|NCT00245960|537892938|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
149113273|NCT00245960|537892939|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
149113274|NCT00245960|537892938|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
149113275|NCT00245960|537892939|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
149113276|NCT00245960|537892938|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
149113277|NCT00245960|537892939|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
149113278|NCT00245960|537892938|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
149113279|NCT00245960|537892939|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
149113280|NCT00245960|537892938|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
149113281|NCT00245960|537892939|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
149113282|NCT00245960|537892938|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
149113283|NCT00245960|537892939|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
149113284|NCT00245960|537892938|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
149113285|NCT00245960|537892939|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
149113286|NCT00245960|537892938|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
149113287|NCT00245960|537892939|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
149113288|NCT00245960|537892938|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
149113289|NCT00245960|537892939|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
149113290|NCT00737698|537892940|FG000|Overall Study|Withdrawal by Subject|6|||
149113291|NCT00737698|537892941|FG001|Overall Study|Withdrawal by Subject|5|||
149113292|NCT00737698|537892942|FG002|Overall Study|Withdrawal by Subject|3|||
149113293|NCT00737698|537892940|FG000|Overall Study|Death|0|||
149113294|NCT00737698|537892941|FG001|Overall Study|Death|0|||
149113295|NCT00737698|537892942|FG002|Overall Study|Death|1|||
149113296|NCT01067846|537892943|FG000|Overall Study|Lost to Follow-up|17|||
149113297|NCT01067846|537892944|FG001|Overall Study|Lost to Follow-up|19|||
149113298|NCT01067846|537892943|FG000|Overall Study|Withdrawal by Subject|1|||
149113299|NCT01067846|537892944|FG001|Overall Study|Withdrawal by Subject|0|||
149113300|NCT01067846|537892943|FG000|Overall Study|participation in other tx study|1|||
149113301|NCT01067846|537892944|FG001|Overall Study|participation in other tx study|0|||
149113302|NCT02817906|537892945|FG000|Overall Study|Adverse Event|3|||
149113303|NCT02817906|537892946|FG001|Overall Study|Adverse Event|0|||
149113304|NCT02817906|537892945|FG000|Overall Study|Lack of Efficacy|1|||
149113305|NCT02817906|537892946|FG001|Overall Study|Lack of Efficacy|0|||
149113306|NCT02817906|537892945|FG000|Overall Study|Protocol Violation|1|||
149113307|NCT02817906|537892946|FG001|Overall Study|Protocol Violation|1|||
149113308|NCT02817906|537892945|FG000|Overall Study|Study Terminated by Sponsor|2|||
149113309|NCT02817906|537892946|FG001|Overall Study|Study Terminated by Sponsor|2|||
149113310|NCT02817906|537892945|FG000|Overall Study|Withdrawal by Subject|7|||
149113311|NCT02817906|537892946|FG001|Overall Study|Withdrawal by Subject|0|||
149113312|NCT02817906|537892945|FG000|Overall Study|Other|2|||
149113313|NCT02817906|537892946|FG001|Overall Study|Other|2|||
149113314|NCT00972322|537892952|FG000|Overall Study|Adverse Event|2|||
149113315|NCT00972322|537892953|FG001|Overall Study|Adverse Event|1|||
149113316|NCT00972322|537892952|FG000|Overall Study|Positive drug screen|0|||
149113317|NCT00972322|537892953|FG001|Overall Study|Positive drug screen|1|||
149113318|NCT00972322|537892952|FG000|Overall Study|Lost to Follow-up|0|||
149113319|NCT00972322|537892953|FG001|Overall Study|Lost to Follow-up|1|||
149113320|NCT00972322|537892952|FG000|Overall Study|Consistently high glucose values|1|||
149113321|NCT00972322|537892953|FG001|Overall Study|Consistently high glucose values|0|||
149113322|NCT04958200|537892954|FG000|Overall Study|Withdrawal by Subject|0|||
149113323|NCT04958200|537892955|FG001|Overall Study|Withdrawal by Subject|2|||
149113324|NCT04958200|537892954|FG000|Overall Study|Lost to Follow-up|3|||
149113325|NCT04958200|537892955|FG001|Overall Study|Lost to Follow-up|2|||
149113326|NCT02387970|537892956|FG000|Overall Study|Did not complete 1-year follow up|1|||
149113327|NCT02387970|537892957|FG001|Overall Study|Did not complete 1-year follow up|2|||
149113328|NCT03086655|537892964|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
149113329|NCT03086655|537892965|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
149113330|NCT03086655|537892964|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
149113331|NCT03086655|537892965|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
149113332|NCT03086655|537892964|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
149113333|NCT03086655|537892965|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
149113334|NCT03086655|537892964|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
149113335|NCT03086655|537892965|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
149113336|NCT03086655|537892964|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
149113337|NCT03086655|537892965|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
149113338|NCT03086655|537892964|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
149113339|NCT03086655|537892965|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
149113340|NCT03086655|537892964|FG000|12 Month Follow-up = Final Assessment|Death|0|||
149113341|NCT03086655|537892965|FG001|12 Month Follow-up = Final Assessment|Death|1|||
149113342|NCT03841526|537892966|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
149113343|NCT03841526|537892967|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
149113344|NCT03841526|537892968|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
149113345|NCT03841526|537892969|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
149113346|NCT03841526|537892970|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
149113347|NCT03841526|537892971|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
149113348|NCT03841526|537892966|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
149113349|NCT03841526|537892967|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
149113350|NCT03841526|537892968|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
149113351|NCT03841526|537892969|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
149113352|NCT03841526|537892970|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
149113353|NCT03841526|537892971|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
149113354|NCT03841526|537892966|FG000|Outpatient Phase Treatment|Physician Decision|0|||
149113355|NCT03841526|537892967|FG001|Outpatient Phase Treatment|Physician Decision|1|||
149113356|NCT03841526|537892968|FG002|Outpatient Phase Treatment|Physician Decision|0|||
149113357|NCT03841526|537892969|FG003|Outpatient Phase Treatment|Physician Decision|0|||
149113358|NCT03841526|537892970|FG004|Outpatient Phase Treatment|Physician Decision|0|||
149113359|NCT03841526|537892971|FG005|Outpatient Phase Treatment|Physician Decision|0|||
149113360|NCT03841526|537892966|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
149113361|NCT03841526|537892967|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
149113362|NCT03841526|537892968|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
149113363|NCT03841526|537892969|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
149113364|NCT03841526|537892970|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
149113365|NCT03841526|537892971|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
149113366|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
149113367|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
149113368|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
149113369|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
149113370|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
149113371|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
149113372|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
149113373|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
149113374|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
149113375|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
149113376|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
149113377|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
149113378|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
149113379|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
149113380|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
149113381|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
149113382|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
149113383|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
149113384|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
149113385|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
149113386|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
149113387|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
149113388|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
149113389|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
149113390|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
149113391|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
149113392|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
149113393|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
149113394|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
149113395|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
149113396|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
149113397|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
149113398|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
149113399|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
149113400|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
149113401|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
149113402|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
149113403|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
149113404|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
149113405|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
149113406|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
149113407|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
149113408|NCT03524092|537892976|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
149113409|NCT03524092|537892977|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
149113410|NCT03524092|537892978|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
149113411|NCT03524092|537892979|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
149113412|NCT03524092|537892980|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
149113413|NCT03524092|537892981|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
149113414|NCT03524092|537892976|FG000|Loss of Response Rescue Period|Adverse Event|0|||
149113415|NCT03524092|537892977|FG001|Loss of Response Rescue Period|Adverse Event|0|||
149113416|NCT03524092|537892978|FG002|Loss of Response Rescue Period|Adverse Event|0|||
149113417|NCT03524092|537892979|FG003|Loss of Response Rescue Period|Adverse Event|2|||
149113418|NCT03524092|537892980|FG004|Loss of Response Rescue Period|Adverse Event|0|||
149113419|NCT03524092|537892981|FG005|Loss of Response Rescue Period|Adverse Event|0|||
149113420|NCT03524092|537892976|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
149113421|NCT03524092|537892977|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
149113422|NCT03524092|537892978|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
149113423|NCT03524092|537892979|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
149113424|NCT03524092|537892980|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
149113425|NCT03524092|537892981|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
149113426|NCT03524092|537892976|FG000|Loss of Response Rescue Period|Pregnancy|0|||
149113427|NCT03524092|537892977|FG001|Loss of Response Rescue Period|Pregnancy|0|||
149113428|NCT03524092|537892978|FG002|Loss of Response Rescue Period|Pregnancy|0|||
149113429|NCT03524092|537892979|FG003|Loss of Response Rescue Period|Pregnancy|1|||
149113430|NCT03524092|537892980|FG004|Loss of Response Rescue Period|Pregnancy|0|||
149113431|NCT03524092|537892981|FG005|Loss of Response Rescue Period|Pregnancy|0|||
149113432|NCT03524092|537892976|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
149113433|NCT03524092|537892977|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
149113434|NCT03524092|537892978|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
149113435|NCT03524092|537892979|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
149113436|NCT03524092|537892980|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
149113437|NCT03524092|537892981|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
149113438|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
149113439|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
149113440|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
149113441|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
149113442|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
149113443|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
149113444|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
149113445|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
149113446|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
149113447|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
149113448|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
149113449|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
149113450|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
149113451|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
149113452|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
149113453|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
149113454|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
149113455|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
149113456|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
149113457|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
149113458|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
149113459|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
149113460|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
149113461|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
149113462|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
149113463|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
149113464|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
149113465|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
149113466|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
149113467|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
149113468|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
149113469|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
149113470|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
149113471|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
149113472|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
149113473|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
149113474|NCT03524092|537892976|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
149113475|NCT03524092|537892977|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
149113476|NCT03524092|537892978|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
149113477|NCT03524092|537892979|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
149113478|NCT03524092|537892980|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
149113479|NCT03524092|537892981|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
149113480|NCT03524092|537892976|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
149113481|NCT03524092|537892977|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
149113482|NCT03524092|537892978|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
149113483|NCT03524092|537892979|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
149113484|NCT03524092|537892980|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
149113485|NCT03524092|537892981|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
149113486|NCT03524092|537892976|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
149113487|NCT03524092|537892977|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
149113488|NCT03524092|537892978|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
149113489|NCT03524092|537892979|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
149113490|NCT03524092|537892980|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
149113491|NCT03524092|537892981|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
149113492|NCT03524092|537892976|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
149113493|NCT03524092|537892977|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
149113494|NCT03524092|537892978|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
149113495|NCT03524092|537892979|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
149113496|NCT03524092|537892980|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
149113497|NCT03524092|537892981|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
149113498|NCT03524092|537892976|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
149113499|NCT03524092|537892977|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
149113500|NCT03524092|537892978|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
149113501|NCT03524092|537892979|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
149113502|NCT03524092|537892980|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
149113503|NCT03524092|537892981|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
149113504|NCT04303780|537892982|FG000|Overall Study|Death|104|||
149113505|NCT04303780|537892983|FG001|Overall Study|Death|85|||
149113506|NCT04303780|537892982|FG000|Overall Study|Lost to Follow-up|5|||
149113507|NCT04303780|537892983|FG001|Overall Study|Lost to Follow-up|2|||
149113508|NCT04303780|537892982|FG000|Overall Study|Withdrawal by Subject|12|||
149113509|NCT04303780|537892983|FG001|Overall Study|Withdrawal by Subject|39|||
149113510|NCT04303780|537892982|FG000|Overall Study|Ongoing in study|50|||
149113511|NCT04303780|537892983|FG001|Overall Study|Ongoing in study|45|||
149113512|NCT00918879|537894219|FG000|Overall Study|Withdrawal by Subject|4|||
149113513|NCT00918879|537894220|FG001|Overall Study|Withdrawal by Subject|4|||
149113514|NCT00918879|537894219|FG000|Overall Study|Lost to Follow-up|1|||
149113515|NCT00918879|537894220|FG001|Overall Study|Lost to Follow-up|1|||
149113516|NCT00918879|537894219|FG000|Overall Study|Severe non-compliance to protocol|1|||
149113517|NCT00918879|537894220|FG001|Overall Study|Severe non-compliance to protocol|1|||
149113518|NCT00357110|537894221|FG000|Overall Study|Early study termination|5|||
149113519|NCT00357110|537894222|FG001|Overall Study|Early study termination|5|||
149113520|NCT03339245|537894225|FG000|Overall Study|Adverse Event|1|||
149113521|NCT03339245|537894226|FG001|Overall Study|Adverse Event|1|||
149113522|NCT03339245|537894225|FG000|Overall Study|Withdrawal by Subject|1|||
149113523|NCT03339245|537894226|FG001|Overall Study|Withdrawal by Subject|0|||
149113524|NCT00515671|537894227|FG000|Overall Study|Lost to Follow-up|13|||
149113525|NCT00515671|537894228|FG001|Overall Study|Lost to Follow-up|10|||
149113526|NCT00515671|537894227|FG000|Overall Study|Withdrawal by Subject|3|||
149113527|NCT00515671|537894228|FG001|Overall Study|Withdrawal by Subject|5|||
149113528|NCT00515671|537894227|FG000|Overall Study|incarcerated|1|||
149113529|NCT00515671|537894228|FG001|Overall Study|incarcerated|2|||
149113530|NCT01283152|537894229|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
149113531|NCT01283152|537894230|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
149113532|NCT01283152|537894229|FG000|Overall Study|Refused HESA|1|||
149113533|NCT01283152|537894230|FG001|Overall Study|Refused HESA|0|||
149113534|NCT00567567|537894231|FG000|Overall Study|Adverse Event|0|||
149113535|NCT00567567|537894232|FG001|Overall Study|Adverse Event|2|||
149113536|NCT00567567|537894233|FG002|Overall Study|Adverse Event|5|||
149113537|NCT00567567|537894231|FG000|Overall Study|Death|8|||
149113538|NCT00567567|537894232|FG001|Overall Study|Death|1|||
149113539|NCT00567567|537894233|FG002|Overall Study|Death|5|||
149113540|NCT00567567|537894231|FG000|Overall Study|Lack of Efficacy|16|||
149113541|NCT00567567|537894232|FG001|Overall Study|Lack of Efficacy|17|||
149113542|NCT00567567|537894233|FG002|Overall Study|Lack of Efficacy|48|||
149113543|NCT00567567|537894231|FG000|Overall Study|Lost to Follow-up|0|||
149113544|NCT00567567|537894232|FG001|Overall Study|Lost to Follow-up|0|||
149113545|NCT00567567|537894233|FG002|Overall Study|Lost to Follow-up|1|||
149113546|NCT00567567|537894231|FG000|Overall Study|Physician Decision|16|||
149113547|NCT00567567|537894232|FG001|Overall Study|Physician Decision|18|||
149113548|NCT00567567|537894233|FG002|Overall Study|Physician Decision|84|||
149113549|NCT00567567|537894231|FG000|Overall Study|Withdrawal by Subject|0|||
149113550|NCT00567567|537894232|FG001|Overall Study|Withdrawal by Subject|0|||
149113551|NCT00567567|537894233|FG002|Overall Study|Withdrawal by Subject|2|||
149113552|NCT00567567|537894231|FG000|Overall Study|Ineligible|4|||
149113553|NCT00567567|537894232|FG001|Overall Study|Ineligible|0|||
149113554|NCT00567567|537894233|FG002|Overall Study|Ineligible|9|||
149113555|NCT00567567|537894231|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
149113556|NCT00567567|537894232|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
149113557|NCT00567567|537894233|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
149113558|NCT00567567|537894231|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
149113559|NCT00567567|537894232|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
149113560|NCT00567567|537894233|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
149113561|NCT00567567|537894231|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
149113562|NCT00567567|537894232|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
149113563|NCT00567567|537894233|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
149113564|NCT03433677|537894234|FG000|Period 1|Protocol Violation|1|||
149113565|NCT03433677|537894235|FG001|Period 1|Protocol Violation|0|||
149113566|NCT03433677|537894234|FG000|Period 2|Withdrawal by Subject|1|||
149113567|NCT03433677|537894235|FG001|Period 2|Withdrawal by Subject|1|||
149113568|NCT03330405|537894236|FG000|Overall Study|Other|1|||
149113569|NCT03330405|537894237|FG001|Overall Study|Other|3|||
149113570|NCT03330405|537894238|FG002|Overall Study|Other|1|||
149113571|NCT03330405|537894239|FG003|Overall Study|Other|0|||
149113572|NCT03330405|537894240|FG004|Overall Study|Other|2|||
149113573|NCT03330405|537894241|FG005|Overall Study|Other|0|||
149113574|NCT03330405|537894242|FG006|Overall Study|Other|1|||
149113575|NCT03330405|537894243|FG007|Overall Study|Other|0|||
149113576|NCT03330405|537894244|FG008|Overall Study|Other|0|||
149113577|NCT03330405|537894245|FG009|Overall Study|Other|0|||
149113578|NCT03330405|537894246|FG010|Overall Study|Other|0|||
149113579|NCT03330405|537894236|FG000|Overall Study|Progressive disease|8|||
149113580|NCT03330405|537894237|FG001|Overall Study|Progressive disease|27|||
149113581|NCT03330405|537894238|FG002|Overall Study|Progressive disease|4|||
149113582|NCT03330405|537894239|FG003|Overall Study|Progressive disease|18|||
149113583|NCT03330405|537894240|FG004|Overall Study|Progressive disease|16|||
149113584|NCT03330405|537894241|FG005|Overall Study|Progressive disease|14|||
149113585|NCT03330405|537894242|FG006|Overall Study|Progressive disease|7|||
149113586|NCT03330405|537894243|FG007|Overall Study|Progressive disease|29|||
149113587|NCT03330405|537894244|FG008|Overall Study|Progressive disease|9|||
149113588|NCT03330405|537894245|FG009|Overall Study|Progressive disease|11|||
149113589|NCT03330405|537894246|FG010|Overall Study|Progressive disease|5|||
149113590|NCT03330405|537894236|FG000|Overall Study|Withdrawal by Subject|1|||
149113591|NCT03330405|537894237|FG001|Overall Study|Withdrawal by Subject|4|||
149113592|NCT03330405|537894238|FG002|Overall Study|Withdrawal by Subject|0|||
149113593|NCT03330405|537894239|FG003|Overall Study|Withdrawal by Subject|1|||
149113594|NCT03330405|537894240|FG004|Overall Study|Withdrawal by Subject|1|||
149113595|NCT03330405|537894241|FG005|Overall Study|Withdrawal by Subject|1|||
149113596|NCT03330405|537894242|FG006|Overall Study|Withdrawal by Subject|0|||
149113597|NCT03330405|537894243|FG007|Overall Study|Withdrawal by Subject|2|||
149113598|NCT03330405|537894244|FG008|Overall Study|Withdrawal by Subject|2|||
149113599|NCT03330405|537894245|FG009|Overall Study|Withdrawal by Subject|1|||
149113600|NCT03330405|537894246|FG010|Overall Study|Withdrawal by Subject|1|||
149113601|NCT03330405|537894236|FG000|Overall Study|Global deterioration of health status|2|||
149113602|NCT03330405|537894237|FG001|Overall Study|Global deterioration of health status|3|||
149113603|NCT03330405|537894238|FG002|Overall Study|Global deterioration of health status|0|||
149113604|NCT03330405|537894239|FG003|Overall Study|Global deterioration of health status|2|||
149113605|NCT03330405|537894240|FG004|Overall Study|Global deterioration of health status|3|||
149113606|NCT03330405|537894241|FG005|Overall Study|Global deterioration of health status|3|||
149113607|NCT03330405|537894242|FG006|Overall Study|Global deterioration of health status|0|||
149113608|NCT03330405|537894243|FG007|Overall Study|Global deterioration of health status|2|||
149113609|NCT03330405|537894244|FG008|Overall Study|Global deterioration of health status|8|||
149113610|NCT03330405|537894245|FG009|Overall Study|Global deterioration of health status|4|||
149113611|NCT03330405|537894246|FG010|Overall Study|Global deterioration of health status|1|||
149113612|NCT03330405|537894236|FG000|Overall Study|Adverse Event|0|||
149113613|NCT03330405|537894237|FG001|Overall Study|Adverse Event|1|||
149113614|NCT03330405|537894238|FG002|Overall Study|Adverse Event|0|||
149113615|NCT03330405|537894239|FG003|Overall Study|Adverse Event|1|||
149113616|NCT03330405|537894240|FG004|Overall Study|Adverse Event|1|||
149113617|NCT03330405|537894241|FG005|Overall Study|Adverse Event|1|||
149113618|NCT03330405|537894242|FG006|Overall Study|Adverse Event|3|||
149113619|NCT03330405|537894243|FG007|Overall Study|Adverse Event|4|||
149113620|NCT03330405|537894244|FG008|Overall Study|Adverse Event|2|||
149113621|NCT03330405|537894245|FG009|Overall Study|Adverse Event|2|||
149113622|NCT03330405|537894246|FG010|Overall Study|Adverse Event|2|||
149113623|NCT03330405|537894236|FG000|Overall Study|Death|0|||
149113624|NCT03330405|537894237|FG001|Overall Study|Death|4|||
149113625|NCT03330405|537894238|FG002|Overall Study|Death|0|||
149113626|NCT03330405|537894239|FG003|Overall Study|Death|0|||
149113627|NCT03330405|537894240|FG004|Overall Study|Death|0|||
149113628|NCT03330405|537894241|FG005|Overall Study|Death|1|||
149113629|NCT03330405|537894242|FG006|Overall Study|Death|0|||
149113630|NCT03330405|537894243|FG007|Overall Study|Death|2|||
149113631|NCT03330405|537894244|FG008|Overall Study|Death|0|||
149113632|NCT03330405|537894245|FG009|Overall Study|Death|0|||
149113633|NCT03330405|537894246|FG010|Overall Study|Death|0|||
149113634|NCT03330405|537894236|FG000|Overall Study|Physician Decision|0|||
149113635|NCT03330405|537894237|FG001|Overall Study|Physician Decision|0|||
149113636|NCT03330405|537894238|FG002|Overall Study|Physician Decision|0|||
149113637|NCT03330405|537894239|FG003|Overall Study|Physician Decision|0|||
149113638|NCT03330405|537894240|FG004|Overall Study|Physician Decision|0|||
149113639|NCT03330405|537894241|FG005|Overall Study|Physician Decision|0|||
149113640|NCT03330405|537894242|FG006|Overall Study|Physician Decision|0|||
149113641|NCT03330405|537894243|FG007|Overall Study|Physician Decision|1|||
149113642|NCT03330405|537894244|FG008|Overall Study|Physician Decision|0|||
149113643|NCT03330405|537894245|FG009|Overall Study|Physician Decision|0|||
149113644|NCT03330405|537894246|FG010|Overall Study|Physician Decision|0|||
149113645|NCT01736189|537894247|FG000|Overall Study|Violation of registration criteria|41|||
149113646|NCT01736189|537894247|FG000|Overall Study|Protocol Violation|4|||
149113647|NCT01736189|537894247|FG000|Overall Study|Criteria and protocol violations|1|||
149113648|NCT01499303|537894250|FG000|Overall Study|Ongoing|2|||
149113649|NCT01499303|537894251|FG001|Overall Study|Ongoing|1|||
149113650|NCT01499303|537894250|FG000|Overall Study|Withdrawal by Subject|0|||
149113651|NCT01499303|537894251|FG001|Overall Study|Withdrawal by Subject|1|||
149113652|NCT01499303|537894250|FG000|Overall Study|Adverse Event|1|||
149113653|NCT01499303|537894251|FG001|Overall Study|Adverse Event|4|||
149113654|NCT01499303|537894250|FG000|Overall Study|Other|0|||
149113655|NCT01499303|537894251|FG001|Overall Study|Other|1|||
149113656|NCT03809039|537894252|FG000|Part 1|Withdrawal by Subject|1|||
149113657|NCT03809039|537894253|FG001|Part 1|Withdrawal by Subject|0|||
149113658|NCT03809039|537894254|FG002|Part 1|Withdrawal by Subject|0|||
149113659|NCT03809039|537894255|FG003|Part 1|Withdrawal by Subject|1|||
149113660|NCT03809039|537894256|FG004|Part 1|Withdrawal by Subject|0|||
149113661|NCT03809039|537894257|FG005|Part 1|Withdrawal by Subject|0|||
149113662|NCT03809039|537894258|FG006|Part 1|Withdrawal by Subject|0|||
149113663|NCT03809039|537894259|FG007|Part 1|Withdrawal by Subject|0|||
149113664|NCT03809039|537894260|FG008|Part 1|Withdrawal by Subject|0|||
149113665|NCT03809039|537894252|FG000|Part 3|Withdrawn by study termination|0|||
149113666|NCT03809039|537894253|FG001|Part 3|Withdrawn by study termination|0|||
149113667|NCT03809039|537894254|FG002|Part 3|Withdrawn by study termination|0|||
149113668|NCT03809039|537894255|FG003|Part 3|Withdrawn by study termination|0|||
149113669|NCT03809039|537894256|FG004|Part 3|Withdrawn by study termination|0|||
149113670|NCT03809039|537894257|FG005|Part 3|Withdrawn by study termination|0|||
149113671|NCT03809039|537894258|FG006|Part 3|Withdrawn by study termination|0|||
149113672|NCT03809039|537894259|FG007|Part 3|Withdrawn by study termination|2|||
149113673|NCT03809039|537894260|FG008|Part 3|Withdrawn by study termination|6|||
149113674|NCT00608868|537894263|FG000|Overall Study|Withdrawal by Subject|7|||
149113675|NCT00608868|537894263|FG000|Overall Study|Protocol Violation|3|||
149113676|NCT00608868|537894263|FG000|Overall Study|Lost to Follow-up|2|||
149113677|NCT00608868|537894263|FG000|Overall Study|Adverse Event|1|||
149113678|NCT00608868|537894263|FG000|Overall Study|Physician Decision|2|||
149113679|NCT03853551|537894266|FG000|Overall Study|Death|2|||
149113680|NCT03853551|537894266|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
149113681|NCT00702962|537894267|FG000|Overall Study|Progressive disease|0|||
149113682|NCT00702962|537894268|FG001|Overall Study|Progressive disease|1|||
149113683|NCT00702962|537894267|FG000|Overall Study|Hospitalized for other health disorder|1|||
149113684|NCT00702962|537894268|FG001|Overall Study|Hospitalized for other health disorder|0|||
149113685|NCT02476175|537894269|FG000|Overall Study|Adverse Event|2|||
149113686|NCT01252355|537894270|FG000|Overall Study|Adverse Event|9|||
149113687|NCT01252355|537894271|FG001|Overall Study|Adverse Event|17|||
149113688|NCT01252355|537894272|FG002|Overall Study|Adverse Event|22|||
149113689|NCT01252355|537894270|FG000|Overall Study|Lack of Efficacy|6|||
149113690|NCT01252355|537894271|FG001|Overall Study|Lack of Efficacy|4|||
149113691|NCT01252355|537894272|FG002|Overall Study|Lack of Efficacy|2|||
149113692|NCT01252355|537894270|FG000|Overall Study|Lost to Follow-up|0|||
149113693|NCT01252355|537894271|FG001|Overall Study|Lost to Follow-up|0|||
149113694|NCT01252355|537894272|FG002|Overall Study|Lost to Follow-up|1|||
149113695|NCT01252355|537894270|FG000|Overall Study|Poor Compliance to Protocol|1|||
149113696|NCT01252355|537894271|FG001|Overall Study|Poor Compliance to Protocol|1|||
149113697|NCT01252355|537894272|FG002|Overall Study|Poor Compliance to Protocol|1|||
149113698|NCT01252355|537894270|FG000|Overall Study|Progressive Disease|2|||
149113699|NCT01252355|537894271|FG001|Overall Study|Progressive Disease|0|||
149113700|NCT01252355|537894272|FG002|Overall Study|Progressive Disease|0|||
149113701|NCT01252355|537894270|FG000|Overall Study|Sponsor Early Termination of Study|149|||
149113702|NCT01252355|537894271|FG001|Overall Study|Sponsor Early Termination of Study|149|||
149113703|NCT01252355|537894272|FG002|Overall Study|Sponsor Early Termination of Study|146|||
149113704|NCT01252355|537894270|FG000|Overall Study|Randomized but not Treated|2|||
149113705|NCT01252355|537894271|FG001|Overall Study|Randomized but not Treated|0|||
149113706|NCT01252355|537894272|FG002|Overall Study|Randomized but not Treated|0|||
149113707|NCT01252355|537894270|FG000|Overall Study|Other Than Above|8|||
149113708|NCT01252355|537894271|FG001|Overall Study|Other Than Above|7|||
149113709|NCT01252355|537894272|FG002|Overall Study|Other Than Above|7|||
149113710|NCT02175641|537894274|FG000|Overall Study|Death|3|||
149113711|NCT02175641|537894275|FG001|Overall Study|Death|4|||
149113712|NCT02175641|537894274|FG000|Overall Study|Lost to Follow-up|4|||
149113713|NCT02175641|537894275|FG001|Overall Study|Lost to Follow-up|4|||
149113714|NCT02175641|537894274|FG000|Overall Study|Withdrawal by Subject|7|||
149113715|NCT02175641|537894275|FG001|Overall Study|Withdrawal by Subject|4|||
149113716|NCT02175641|537894274|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
149113717|NCT02175641|537894275|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
149113718|NCT02175641|537894274|FG000|Overall Study|Developed Contraindicated Condition|8|||
149113719|NCT02175641|537894275|FG001|Overall Study|Developed Contraindicated Condition|0|||
149113720|NCT01923467|537894280|FG000|Overall Study|Lost to Follow-up|62|||
149113721|NCT01923467|537894280|FG000|Overall Study|Subject non-interest|479|||
149113722|NCT02242097|537894281|FG000|Ibrutinib Treatment|Adverse Event|16|||
149113723|NCT02242097|537894281|FG000|Ibrutinib Treatment|Physician Decision|1|||
149113724|NCT02242097|537894281|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
149113725|NCT02242097|537894281|FG000|Ibrutinib Treatment|Death|1|||
149113726|NCT02242097|537894281|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
149113727|NCT02242097|537894281|FG000|Post Therapy Follow Up|Death|3|||
149113728|NCT02242097|537894281|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
149113729|NCT03435692|537894282|FG000|Overall Study|Lack of Efficacy|2|||
149113730|NCT03435692|537894283|FG001|Overall Study|Lack of Efficacy|2|||
149113731|NCT03435692|537894284|FG002|Overall Study|Lack of Efficacy|0|||
149113732|NCT01145898|537894285|FG000|3-year Treatment|medication change by treating physician|3|||
149113733|NCT01145898|537894286|FG001|3-year Treatment|medication change by treating physician|16|||
149113734|NCT02440425|537894287|FG000|Overall Study|Death likely due to disease progression|1|||
149113735|NCT02440425|537894287|FG000|Overall Study|Withdrawal by Subject|2|||
149113736|NCT02440425|537894287|FG000|Overall Study|Adverse Event|1|||
149113737|NCT02440425|537894287|FG000|Overall Study|Adverse Event/Ineligible|1|||
149113738|NCT00780559|537894294|FG000|Overall Study|Lost to Follow-up|2|||
149113739|NCT00780559|537894295|FG001|Overall Study|Lost to Follow-up|7|||
149113740|NCT00780559|537894294|FG000|Overall Study|Death|1|||
149113741|NCT00780559|537894295|FG001|Overall Study|Death|0|||
149113742|NCT04462289|537894296|FG000|Overall Study|Lost to Follow-up|4|||
149113743|NCT04462289|537894297|FG001|Overall Study|Lost to Follow-up|5|||
149113744|NCT04462289|537894296|FG000|Overall Study|Death|0|||
149113745|NCT04462289|537894297|FG001|Overall Study|Death|3|||
149113746|NCT04462289|537894296|FG000|Overall Study|Withdrawal by Subject|1|||
149113747|NCT04462289|537894297|FG001|Overall Study|Withdrawal by Subject|3|||
149113748|NCT00818779|537894298|FG000|Overall Study|Protocol Violation|1|||
149113749|NCT00818779|537894299|FG001|Overall Study|Protocol Violation|0|||
149113750|NCT00818779|537894298|FG000|Overall Study|Lost to Follow-up|1|||
149113751|NCT00818779|537894299|FG001|Overall Study|Lost to Follow-up|0|||
149113752|NCT00818779|537894298|FG000|Overall Study|Adverse Event|4|||
149113753|NCT00818779|537894299|FG001|Overall Study|Adverse Event|1|||
149113754|NCT04343976|537894305|FG000|Overall Study|Withdrawal by Subject|0|||
149113755|NCT04343976|537894306|FG001|Overall Study|Withdrawal by Subject|1|||
149113756|NCT02807883|537894307|FG000|Overall Study|Withdrawal by Subject|2|||
149113757|NCT00694109|537894308|FG000|Overall Study|Physician Decision|3|||
149113758|NCT00694109|537894308|FG000|Overall Study|Adverse Event|74|||
149113759|NCT00694109|537894308|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
149113760|NCT00694109|537894308|FG000|Overall Study|Lack of Efficacy|2|||
149113761|NCT00694109|537894308|FG000|Overall Study|Withdrawal by Subject|13|||
149113762|NCT00694109|537894308|FG000|Overall Study|Pregnancy|1|||
149113763|NCT00694109|537894308|FG000|Overall Study|Enrolled but not treated|1|||
149113764|NCT00694109|537894308|FG000|Overall Study|Other|2|||
149113765|NCT00694109|537894308|FG000|Overall Study|Consented but no additional treatment|3|||
149113766|NCT00846807|537894309|FG000|Overall Study|Adverse Event|270|||
149113767|NCT00846807|537894309|FG000|Overall Study|Lost to Follow-up|94|||
149113768|NCT00846807|537894309|FG000|Overall Study|Withdrawal by Subject|56|||
149113769|NCT00846807|537894309|FG000|Overall Study|Non compliant with European label|7|||
149113770|NCT00846807|537894309|FG000|Overall Study|Switch to other anticoagulants|89|||
149113771|NCT00846807|537894309|FG000|Overall Study|No prescription after hospital discharge|56|||
149113772|NCT00846807|537894309|FG000|Overall Study|Other|60|||
149113773|NCT03686423|537894315|FG000|Overall Study|Withdrawal by Subject|9|||
149113774|NCT03686423|537894315|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
149113775|NCT02833077|537894316|FG000|Overall Study|Adverse Event|1|||
149113776|NCT02833077|537894317|FG001|Overall Study|Adverse Event|2|||
149113777|NCT02833077|537894316|FG000|Overall Study|Lost to Follow-up|10|||
149113778|NCT02833077|537894317|FG001|Overall Study|Lost to Follow-up|1|||
149113779|NCT02833077|537894316|FG000|Overall Study|Personal Reasons|6|||
149113780|NCT02833077|537894317|FG001|Overall Study|Personal Reasons|4|||
149113781|NCT02833077|537894316|FG000|Overall Study|Protocol Deviation|0|||
149113782|NCT02833077|537894317|FG001|Overall Study|Protocol Deviation|1|||
149113783|NCT04608773|537894318|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
149113784|NCT04608773|537894319|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
149113785|NCT04608773|537894318|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
149113786|NCT04608773|537894319|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
149113787|NCT04608773|537894318|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
149113788|NCT04608773|537894319|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
149113789|NCT04608773|537894318|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
149113790|NCT04608773|537894319|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
149113791|NCT04608773|537894318|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
149113792|NCT04608773|537894319|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
149113793|NCT01077518|537894320|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
149113794|NCT01077518|537894321|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
149113795|NCT01077518|537894322|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
149113796|NCT01077518|537894320|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
149113797|NCT01077518|537894321|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
149113798|NCT01077518|537894322|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
149113799|NCT01077518|537894320|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
149113800|NCT01077518|537894321|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
149113801|NCT01077518|537894322|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
149113802|NCT01077518|537894320|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
149113803|NCT01077518|537894321|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
149113804|NCT01077518|537894322|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
149113805|NCT01077518|537894320|FG000|Optional Ofa Phase|Physician Decision|0|||
149113806|NCT01077518|537894321|FG001|Optional Ofa Phase|Physician Decision|0|||
149113807|NCT01077518|537894322|FG002|Optional Ofa Phase|Physician Decision|1|||
149113808|NCT01077518|537894320|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
149113809|NCT01077518|537894321|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
149113810|NCT01077518|537894322|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
149113811|NCT01077518|537894320|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
149113812|NCT01077518|537894321|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
149113813|NCT01077518|537894322|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
149113814|NCT00316017|537894323|FG000|Overall Study|Protocol Violation|11|||
149113815|NCT00316017|537894324|FG001|Overall Study|Protocol Violation|13|||
149113816|NCT00316017|537894325|FG002|Overall Study|Protocol Violation|19|||
149113817|NCT05511038|537894337|FG000|Overall|Withdrawal by Subject|5|||
149113818|NCT05511038|537894338|FG001|Overall|Withdrawal by Subject|3|||
149113819|NCT05511038|537894337|FG000|Overall|Screen Failure|20|||
149113820|NCT05511038|537894338|FG001|Overall|Screen Failure|1|||
149113821|NCT05511038|537894337|FG000|Overall|Physician Decision|3|||
149113822|NCT05511038|537894338|FG001|Overall|Physician Decision|0|||
149113823|NCT05511038|537894337|FG000|Overall|Lost to Follow-up|3|||
149113824|NCT05511038|537894338|FG001|Overall|Lost to Follow-up|0|||
149113825|NCT05511038|537894337|FG000|Overall|Death|1|||
149113826|NCT05511038|537894338|FG001|Overall|Death|0|||
149113827|NCT05511038|537894337|FG000|Screening|Withdrawal by Subject|1|||
149113828|NCT05511038|537894338|FG001|Screening|Withdrawal by Subject|0|||
149113829|NCT05511038|537894337|FG000|Screening|Lost to Follow Up (1 participant)|1|||
149113830|NCT05511038|537894338|FG001|Screening|Lost to Follow Up (1 participant)|0|||
149113831|NCT05511038|537894337|FG000|Screening|Screen Failure|3|||
149113832|NCT05511038|537894338|FG001|Screening|Screen Failure|0|||
149113833|NCT05511038|537894337|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
149113834|NCT05511038|537894338|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
149113835|NCT05511038|537894337|FG000|Treatment|Withdrawal by Subject|5|||
149113836|NCT05511038|537894338|FG001|Treatment|Withdrawal by Subject|3|||
149113837|NCT05511038|537894337|FG000|Treatment|Physician Decision|4|||
149113838|NCT05511038|537894338|FG001|Treatment|Physician Decision|0|||
149113839|NCT05511038|537894337|FG000|Treatment|Lost to Follow-up|2|||
149113840|NCT05511038|537894338|FG001|Treatment|Lost to Follow-up|0|||
149113841|NCT05511038|537894337|FG000|Treatment|Death|1|||
149113842|NCT05511038|537894338|FG001|Treatment|Death|0|||
149113843|NCT05511038|537894337|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
149113844|NCT05511038|537894338|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
149113845|NCT05511038|537894337|FG000|Treatment|Refuse by subject|1|||
149113846|NCT05511038|537894338|FG001|Treatment|Refuse by subject|0|||
149113847|NCT05511038|537894337|FG000|Treatment|Subject did not go to the site for visit|1|||
149113848|NCT05511038|537894338|FG001|Treatment|Subject did not go to the site for visit|0|||
149113849|NCT05543187|537894341|FG000|Overall Study|Ongoing|3|||
149113850|NCT05543187|537894342|FG001|Overall Study|Ongoing|2|||
149113851|NCT04777864|537894343|FG000|Overall Study|Lost to Follow-up|8|||
149113852|NCT04777864|537894344|FG001|Overall Study|Lost to Follow-up|19|||
149113853|NCT04893460|537894350|FG000|Overall Study|Lost to Follow-up|18|||
149113854|NCT05718466|537895784|FG000|Overall Study|Withdrawal by Subject|1|||
149113855|NCT05718466|537895785|FG001|Overall Study|Withdrawal by Subject|2|||
149113856|NCT05718466|537895784|FG000|Overall Study|Death|0|||
149113857|NCT05718466|537895785|FG001|Overall Study|Death|1|||
149113858|NCT00387426|537895786|FG000|Overall Study|Lack of Response|7|||
149113859|NCT00387426|537895786|FG000|Overall Study|Toxicities|4|||
149113860|NCT00387426|537895786|FG000|Overall Study|Disease Progression|3|||
149113861|NCT01253135|537895787|FG000|Original Protocol|Protocol Amendment|15|||
149113862|NCT01253135|537895787|FG000|Amended Protocol|Non-compliance|1|||
149113863|NCT01901432|537895788|FG000|Overall Study|Adverse Event|0|||
149113864|NCT01901432|537895789|FG001|Overall Study|Adverse Event|1|||
149113865|NCT01901432|537895790|FG002|Overall Study|Adverse Event|1|||
149113866|NCT01901432|537895791|FG003|Overall Study|Adverse Event|0|||
149113867|NCT01901432|537895792|FG004|Overall Study|Adverse Event|1|||
149113868|NCT01901432|537895788|FG000|Overall Study|Withdrawal by Subject|0|||
149113869|NCT01901432|537895789|FG001|Overall Study|Withdrawal by Subject|0|||
149113870|NCT01901432|537895790|FG002|Overall Study|Withdrawal by Subject|1|||
149113871|NCT01901432|537895791|FG003|Overall Study|Withdrawal by Subject|0|||
149113872|NCT01901432|537895792|FG004|Overall Study|Withdrawal by Subject|5|||
149113873|NCT01901432|537895788|FG000|Overall Study|Physician Decision|0|||
149113874|NCT01901432|537895789|FG001|Overall Study|Physician Decision|0|||
149113875|NCT01901432|537895790|FG002|Overall Study|Physician Decision|0|||
149113876|NCT01901432|537895791|FG003|Overall Study|Physician Decision|0|||
149113877|NCT01901432|537895792|FG004|Overall Study|Physician Decision|2|||
149113878|NCT01901432|537895788|FG000|Overall Study|Patient decision to stop study drug|0|||
149113879|NCT01901432|537895789|FG001|Overall Study|Patient decision to stop study drug|0|||
149113880|NCT01901432|537895790|FG002|Overall Study|Patient decision to stop study drug|0|||
149113881|NCT01901432|537895791|FG003|Overall Study|Patient decision to stop study drug|0|||
149113882|NCT01901432|537895792|FG004|Overall Study|Patient decision to stop study drug|1|||
149113883|NCT00379288|537895793|FG000|Overall Study|Adverse Event|5|||
149113884|NCT00379288|537895794|FG001|Overall Study|Adverse Event|6|||
149113885|NCT00379288|537895795|FG002|Overall Study|Adverse Event|2|||
149113886|NCT00379288|537895796|FG003|Overall Study|Adverse Event|0|||
149113887|NCT00379288|537895793|FG000|Overall Study|Treatment Failure|0|||
149113888|NCT00379288|537895794|FG001|Overall Study|Treatment Failure|1|||
149113889|NCT00379288|537895795|FG002|Overall Study|Treatment Failure|0|||
149113890|NCT00379288|537895796|FG003|Overall Study|Treatment Failure|1|||
149113891|NCT00379288|537895793|FG000|Overall Study|Lost to Follow-up|3|||
149113892|NCT00379288|537895794|FG001|Overall Study|Lost to Follow-up|3|||
149113893|NCT00379288|537895795|FG002|Overall Study|Lost to Follow-up|2|||
149113894|NCT00379288|537895796|FG003|Overall Study|Lost to Follow-up|0|||
149113895|NCT00379288|537895793|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
149113896|NCT00379288|537895794|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
149113897|NCT00379288|537895795|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
149113898|NCT00379288|537895796|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
149113899|NCT00379288|537895793|FG000|Overall Study|Subject withdrew-related to study drug|1|||
149113900|NCT00379288|537895794|FG001|Overall Study|Subject withdrew-related to study drug|0|||
149113901|NCT00379288|537895795|FG002|Overall Study|Subject withdrew-related to study drug|0|||
149113902|NCT00379288|537895796|FG003|Overall Study|Subject withdrew-related to study drug|1|||
149113903|NCT00379288|537895793|FG000|Overall Study|Noncompliance with protocol|8|||
149113904|NCT00379288|537895794|FG001|Overall Study|Noncompliance with protocol|6|||
149113905|NCT00379288|537895795|FG002|Overall Study|Noncompliance with protocol|2|||
149113906|NCT00379288|537895796|FG003|Overall Study|Noncompliance with protocol|1|||
149113907|NCT00379288|537895793|FG000|Overall Study|Did not meet protocol eligibility|0|||
149113908|NCT00379288|537895794|FG001|Overall Study|Did not meet protocol eligibility|1|||
149113909|NCT00379288|537895795|FG002|Overall Study|Did not meet protocol eligibility|0|||
149113910|NCT00379288|537895796|FG003|Overall Study|Did not meet protocol eligibility|2|||
149113911|NCT00379288|537895793|FG000|Overall Study|Administrative|2|||
149113912|NCT00379288|537895794|FG001|Overall Study|Administrative|2|||
149113913|NCT00379288|537895795|FG002|Overall Study|Administrative|0|||
149113914|NCT00379288|537895796|FG003|Overall Study|Administrative|1|||
149113915|NCT01015560|537895797|FG000|Overall Study|Adverse Event|1|||
149113916|NCT01015560|537895797|FG000|Overall Study|Not protocol specified|1|||
149113917|NCT01015560|537895797|FG000|Overall Study|Withdrawal by Subject|1|||
149113918|NCT01255631|537895805|FG000|Overall Study|poor enrollment, no data analyzed|9|||
149113919|NCT01255631|537895806|FG001|Overall Study|poor enrollment, no data analyzed|6|||
149113920|NCT02815579|537895814|FG000|Overall Study|Non-payment of loan down-payment|16|||
149113921|NCT02815579|537895815|FG001|Overall Study|Non-payment of loan down-payment|0|||
149113922|NCT02815579|537895814|FG000|Overall Study|Withdrawal by Subject|7|||
149113923|NCT02815579|537895815|FG001|Overall Study|Withdrawal by Subject|1|||
149113924|NCT02815579|537895814|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
149113925|NCT02815579|537895815|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
149113926|NCT02815579|537895814|FG000|Overall Study|Lost to Follow-up|7|||
149113927|NCT02815579|537895815|FG001|Overall Study|Lost to Follow-up|4|||
149113928|NCT02815579|537895814|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
149113929|NCT02815579|537895815|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
149113930|NCT02815579|537895814|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
149113931|NCT02815579|537895815|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
149113932|NCT02815579|537895814|FG000|Overall Study|Death|5|||
149113933|NCT02815579|537895815|FG001|Overall Study|Death|4|||
149113934|NCT02815579|537895814|FG000|Overall Study|Imprisoned|0|||
149113935|NCT02815579|537895815|FG001|Overall Study|Imprisoned|2|||
149113936|NCT02815579|537895814|FG000|Overall Study|Did not meet enrollment criteria|0|||
149113937|NCT02815579|537895815|FG001|Overall Study|Did not meet enrollment criteria|1|||
149113938|NCT00264303|537895816|FG000|Overall Study|Adverse Event|4|||
149113939|NCT00264303|537895817|FG001|Overall Study|Adverse Event|3|||
149113940|NCT00264303|537895816|FG000|Overall Study|Lack of Efficacy|10|||
149113941|NCT00264303|537895817|FG001|Overall Study|Lack of Efficacy|13|||
149113942|NCT00264303|537895816|FG000|Overall Study|Lost to Follow-up|3|||
149113943|NCT00264303|537895817|FG001|Overall Study|Lost to Follow-up|3|||
149113944|NCT00264303|537895816|FG000|Overall Study|Withdrawal by Subject|2|||
149113945|NCT00264303|537895817|FG001|Overall Study|Withdrawal by Subject|3|||
149113946|NCT00264303|537895816|FG000|Overall Study|Various reasons listed in study report|6|||
149113947|NCT00264303|537895817|FG001|Overall Study|Various reasons listed in study report|7|||
149113948|NCT02389452|537895818|FG000|Overall Study|Lost to Follow-up|13|||
149113949|NCT02389452|537895818|FG000|Overall Study|Adverse Event|1|||
149113950|NCT02389452|537895818|FG000|Overall Study|Withdrawal by Subject|5|||
149113951|NCT02389452|537895818|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
149113952|NCT02311673|537895822|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
149113953|NCT02311673|537895823|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
149113954|NCT02311673|537895824|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
149113955|NCT02311673|537895825|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
149113956|NCT01014208|537895828|FG000|Overall Study|Lost to Follow-up|2|||
149113957|NCT01014208|537895829|FG001|Overall Study|Lost to Follow-up|5|||
149113958|NCT01014208|537895828|FG000|Overall Study|Participant Withdrew Consent|12|||
149113959|NCT01014208|537895829|FG001|Overall Study|Participant Withdrew Consent|12|||
149113960|NCT01014208|537895828|FG000|Overall Study|Did Not Receive Study Drug|2|||
149113961|NCT01014208|537895829|FG001|Overall Study|Did Not Receive Study Drug|0|||
149113962|NCT01014208|537895828|FG000|Overall Study|Study Closed/terminated|78|||
149113963|NCT01014208|537895829|FG001|Overall Study|Study Closed/terminated|83|||
149113964|NCT00414908|537895837|FG000|Overall Study|Protocol Violation|1|||
149113965|NCT00414908|537895838|FG001|Overall Study|Protocol Violation|1|||
149113966|NCT01076153|537895839|FG000|Overall Study|Symptoms improved/resolved|10|||
149113967|NCT01076153|537895839|FG000|Overall Study|Adverse Event|1|||
149113968|NCT04165031|537895840|FG000|Overall Study|Adverse Event|1|||
149113969|NCT04165031|537895841|FG001|Overall Study|Adverse Event|1|||
149113970|NCT04165031|537895842|FG002|Overall Study|Adverse Event|0|||
149113971|NCT04165031|537895843|FG003|Overall Study|Adverse Event|0|||
149113972|NCT04165031|537895844|FG004|Overall Study|Adverse Event|0|||
149113973|NCT04165031|537895845|FG005|Overall Study|Adverse Event|0|||
149113974|NCT04165031|537895840|FG000|Overall Study|Withdrawal by Subject|0|||
149113975|NCT04165031|537895841|FG001|Overall Study|Withdrawal by Subject|0|||
149113976|NCT04165031|537895842|FG002|Overall Study|Withdrawal by Subject|1|||
149113977|NCT04165031|537895843|FG003|Overall Study|Withdrawal by Subject|0|||
149113978|NCT04165031|537895844|FG004|Overall Study|Withdrawal by Subject|0|||
149113979|NCT04165031|537895845|FG005|Overall Study|Withdrawal by Subject|0|||
149113980|NCT00818168|537895846|FG000|Overall Study|Lack of Efficacy|18|||
149113981|NCT00818168|537895846|FG000|Overall Study|Pregnancy|2|||
149113982|NCT00818168|537895846|FG000|Overall Study|Withdrawal by Subject|16|||
149113983|NCT00818168|537895846|FG000|Overall Study|Lost to Follow-up|7|||
149113984|NCT00818168|537895846|FG000|Overall Study|Adverse Event|19|||
149113985|NCT00818168|537895846|FG000|Overall Study|Reason for Non-completion Not reported|6|||
149113986|NCT00818168|537895846|FG000|Overall Study|Participant Moved|2|||
149113987|NCT00743431|537895849|FG000|Overall Study|Toxicity|6|||
149113988|NCT00743431|537895849|FG000|Overall Study|Tumor progression|56|||
149113989|NCT00743431|537895849|FG000|Overall Study|Withdrawal by Subject|13|||
149113990|NCT00743431|537895849|FG000|Overall Study|Death|9|||
149113991|NCT00743431|537895849|FG000|Overall Study|Reason for discontinuation not specified|29|||
149113992|NCT00743431|537895849|FG000|Overall Study|No documentation available|13|||
149113993|NCT03309813|537895850|FG000|Main Randomized Study|Withdrawal by Subject|1|||
149113994|NCT03309813|537895851|FG001|Main Randomized Study|Withdrawal by Subject|0|||
149113995|NCT04978493|537895852|FG000|Overall Study|No reason available|0|||
149113996|NCT04978493|537895853|FG001|Overall Study|No reason available|1|||
149113997|NCT04978493|537895852|FG000|Overall Study|Adverse Event|1|||
149113998|NCT04978493|537895853|FG001|Overall Study|Adverse Event|0|||
149113999|NCT01128114|537895854|FG000|Overall Study|Treatment Withdrawn|6|||
149114000|NCT01128114|537895854|FG000|Overall Study|Screening Failed|2|||
149114001|NCT02206061|537895855|FG000|Overall Study|Withdrawal by Subject|4|||
149114002|NCT02206061|537895856|FG001|Overall Study|Withdrawal by Subject|7|||
149114003|NCT02206061|537895857|FG002|Overall Study|Withdrawal by Subject|1|||
149114004|NCT02206061|537895855|FG000|Overall Study|Lost to Follow-up|14|||
149114005|NCT02206061|537895856|FG001|Overall Study|Lost to Follow-up|7|||
149114006|NCT02206061|537895857|FG002|Overall Study|Lost to Follow-up|20|||
149114007|NCT04187326|537895858|FG000|Overall Study|Lost to Follow-up|2|||
149114008|NCT04187326|537895859|FG001|Overall Study|Lost to Follow-up|1|||
149114009|NCT04187326|537895858|FG000|Overall Study|Computer error- task was only partially completed.|0|||
149114010|NCT04187326|537895859|FG001|Overall Study|Computer error- task was only partially completed.|1|||
149114011|NCT02738853|537895862|FG000|Enrollment|Inclusion/Exclusion not met|21|||
149114012|NCT02738853|537895862|FG000|Enrollment|Withdrawal by Subject|3|||
149114013|NCT02738853|537895862|FG000|Enrollment|Subject treated with commercially available device|6|||
149114014|NCT02738853|537895862|FG000|Enrollment|Study Enrollment Closed|3|||
149114015|NCT02738853|537895862|FG000|Procedure|Death|1|||
149114016|NCT02738853|537895862|FG000|1 Month|Death|2|||
149114017|NCT02738853|537895862|FG000|6 Month|Death|4|||
149114018|NCT02738853|537895862|FG000|6 Month|Withdrawal by Subject|2|||
149114019|NCT02738853|537895862|FG000|1 Year|Death|6|||
149114020|NCT02738853|537895862|FG000|1 Year|Withdrawal by Subject|1|||
149114021|NCT02738853|537895862|FG000|2 Year|Death|2|||
149114022|NCT02738853|537895862|FG000|2 Year|Lost to Follow-up|1|||
149114023|NCT02738853|537895862|FG000|3 Year|Death|2|||
149114024|NCT02738853|537895862|FG000|3 Year|Withdrawal by Subject|1|||
149114025|NCT02738853|537895862|FG000|4 Year|Death|9|||
149114026|NCT02738853|537895862|FG000|5 Year|Lost to Follow-up|4|||
149114027|NCT04157400|537895864|FG000|Overall Study|Withdrawal by Subject|1|||
149114028|NCT04157400|537895864|FG000|Overall Study|Lost to Follow-up|3|||
149114029|NCT01803282|537895866|FG000|Overall Study|Progressive Disease|4|||
149114030|NCT01803282|537895867|FG001|Overall Study|Progressive Disease|3|||
149114031|NCT01803282|537895868|FG002|Overall Study|Progressive Disease|6|||
149114032|NCT01803282|537895869|FG003|Overall Study|Progressive Disease|22|||
149114033|NCT01803282|537895870|FG004|Overall Study|Progressive Disease|5|||
149114034|NCT01803282|537895871|FG005|Overall Study|Progressive Disease|8|||
149114035|NCT01803282|537895872|FG006|Overall Study|Progressive Disease|23|||
149114036|NCT01803282|537895873|FG007|Overall Study|Progressive Disease|24|||
149114037|NCT01803282|537895874|FG008|Overall Study|Progressive Disease|3|||
149114038|NCT01803282|537895875|FG009|Overall Study|Progressive Disease|29|||
149114039|NCT01803282|537895876|FG010|Overall Study|Progressive Disease|6|||
149114040|NCT01803282|537895877|FG011|Overall Study|Progressive Disease|11|||
149114041|NCT01803282|537895866|FG000|Overall Study|Death|0|||
149114042|NCT01803282|537895867|FG001|Overall Study|Death|0|||
149114043|NCT01803282|537895868|FG002|Overall Study|Death|0|||
149114044|NCT01803282|537895869|FG003|Overall Study|Death|0|||
149114045|NCT01803282|537895870|FG004|Overall Study|Death|2|||
149114046|NCT01803282|537895871|FG005|Overall Study|Death|1|||
149114047|NCT01803282|537895872|FG006|Overall Study|Death|1|||
149114048|NCT01803282|537895873|FG007|Overall Study|Death|5|||
149114049|NCT01803282|537895874|FG008|Overall Study|Death|1|||
149114050|NCT01803282|537895875|FG009|Overall Study|Death|1|||
149114051|NCT01803282|537895876|FG010|Overall Study|Death|0|||
149114052|NCT01803282|537895877|FG011|Overall Study|Death|0|||
149114053|NCT01803282|537895866|FG000|Overall Study|Withdrew Consent|0|||
149114054|NCT01803282|537895867|FG001|Overall Study|Withdrew Consent|0|||
149114055|NCT01803282|537895868|FG002|Overall Study|Withdrew Consent|0|||
149114056|NCT01803282|537895869|FG003|Overall Study|Withdrew Consent|6|||
149114057|NCT01803282|537895870|FG004|Overall Study|Withdrew Consent|1|||
149114058|NCT01803282|537895871|FG005|Overall Study|Withdrew Consent|0|||
149114059|NCT01803282|537895872|FG006|Overall Study|Withdrew Consent|8|||
149114060|NCT01803282|537895873|FG007|Overall Study|Withdrew Consent|3|||
149114061|NCT01803282|537895874|FG008|Overall Study|Withdrew Consent|1|||
149114062|NCT01803282|537895875|FG009|Overall Study|Withdrew Consent|5|||
149114063|NCT01803282|537895876|FG010|Overall Study|Withdrew Consent|0|||
149114064|NCT01803282|537895877|FG011|Overall Study|Withdrew Consent|1|||
149114065|NCT01803282|537895866|FG000|Overall Study|Investigator's Discretion|0|||
149114066|NCT01803282|537895867|FG001|Overall Study|Investigator's Discretion|0|||
149114067|NCT01803282|537895868|FG002|Overall Study|Investigator's Discretion|0|||
149114068|NCT01803282|537895869|FG003|Overall Study|Investigator's Discretion|7|||
149114069|NCT01803282|537895870|FG004|Overall Study|Investigator's Discretion|2|||
149114070|NCT01803282|537895871|FG005|Overall Study|Investigator's Discretion|1|||
149114071|NCT01803282|537895872|FG006|Overall Study|Investigator's Discretion|7|||
149114072|NCT01803282|537895873|FG007|Overall Study|Investigator's Discretion|10|||
149114073|NCT01803282|537895874|FG008|Overall Study|Investigator's Discretion|6|||
149114074|NCT01803282|537895875|FG009|Overall Study|Investigator's Discretion|7|||
149114075|NCT01803282|537895876|FG010|Overall Study|Investigator's Discretion|1|||
149114076|NCT01803282|537895877|FG011|Overall Study|Investigator's Discretion|0|||
149114077|NCT01803282|537895866|FG000|Overall Study|Adverse Event|0|||
149114078|NCT01803282|537895867|FG001|Overall Study|Adverse Event|0|||
149114079|NCT01803282|537895868|FG002|Overall Study|Adverse Event|0|||
149114080|NCT01803282|537895869|FG003|Overall Study|Adverse Event|0|||
149114081|NCT01803282|537895870|FG004|Overall Study|Adverse Event|0|||
149114082|NCT01803282|537895871|FG005|Overall Study|Adverse Event|0|||
149114083|NCT01803282|537895872|FG006|Overall Study|Adverse Event|1|||
149114084|NCT01803282|537895873|FG007|Overall Study|Adverse Event|2|||
149114085|NCT01803282|537895874|FG008|Overall Study|Adverse Event|0|||
149114086|NCT01803282|537895875|FG009|Overall Study|Adverse Event|1|||
149114087|NCT01803282|537895876|FG010|Overall Study|Adverse Event|0|||
149114088|NCT01803282|537895877|FG011|Overall Study|Adverse Event|3|||
149114089|NCT01803282|537895866|FG000|Overall Study|Non-Compliance with Study Drug|0|||
149114090|NCT01803282|537895867|FG001|Overall Study|Non-Compliance with Study Drug|0|||
149114091|NCT01803282|537895868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
149114092|NCT01803282|537895869|FG003|Overall Study|Non-Compliance with Study Drug|1|||
149114093|NCT01803282|537895870|FG004|Overall Study|Non-Compliance with Study Drug|0|||
149114094|NCT01803282|537895871|FG005|Overall Study|Non-Compliance with Study Drug|0|||
149114095|NCT01803282|537895872|FG006|Overall Study|Non-Compliance with Study Drug|0|||
149114096|NCT01803282|537895873|FG007|Overall Study|Non-Compliance with Study Drug|0|||
149114097|NCT01803282|537895874|FG008|Overall Study|Non-Compliance with Study Drug|0|||
149114098|NCT01803282|537895875|FG009|Overall Study|Non-Compliance with Study Drug|0|||
149114099|NCT01803282|537895876|FG010|Overall Study|Non-Compliance with Study Drug|0|||
149114100|NCT01803282|537895877|FG011|Overall Study|Non-Compliance with Study Drug|0|||
149114101|NCT01803282|537895866|FG000|Overall Study|Unknown Reason|0|||
149114102|NCT01803282|537895867|FG001|Overall Study|Unknown Reason|0|||
149114103|NCT01803282|537895868|FG002|Overall Study|Unknown Reason|0|||
149114104|NCT01803282|537895869|FG003|Overall Study|Unknown Reason|0|||
149114105|NCT01803282|537895870|FG004|Overall Study|Unknown Reason|0|||
149114106|NCT01803282|537895871|FG005|Overall Study|Unknown Reason|0|||
149114107|NCT01803282|537895872|FG006|Overall Study|Unknown Reason|0|||
149114108|NCT01803282|537895873|FG007|Overall Study|Unknown Reason|1|||
149114109|NCT01803282|537895874|FG008|Overall Study|Unknown Reason|0|||
149114110|NCT01803282|537895875|FG009|Overall Study|Unknown Reason|0|||
149114111|NCT01803282|537895876|FG010|Overall Study|Unknown Reason|0|||
149114112|NCT01803282|537895877|FG011|Overall Study|Unknown Reason|0|||
149114113|NCT01803282|537895866|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
149114114|NCT01803282|537895867|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
149114115|NCT01803282|537895868|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
149114116|NCT01803282|537895869|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
149114117|NCT01803282|537895870|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
149114118|NCT01803282|537895871|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
149114119|NCT01803282|537895872|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
149114120|NCT01803282|537895873|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
149114121|NCT01803282|537895874|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
149114122|NCT01803282|537895875|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
149114123|NCT01803282|537895876|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
149114124|NCT01803282|537895877|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
149114125|NCT01803282|537895866|FG000|Overall Study|Enrolled but Never Treated|0|||
149114126|NCT01803282|537895867|FG001|Overall Study|Enrolled but Never Treated|0|||
149114127|NCT01803282|537895868|FG002|Overall Study|Enrolled but Never Treated|0|||
149114128|NCT01803282|537895869|FG003|Overall Study|Enrolled but Never Treated|0|||
149114129|NCT01803282|537895870|FG004|Overall Study|Enrolled but Never Treated|1|||
149114130|NCT01803282|537895871|FG005|Overall Study|Enrolled but Never Treated|0|||
149114131|NCT01803282|537895872|FG006|Overall Study|Enrolled but Never Treated|1|||
149114132|NCT01803282|537895873|FG007|Overall Study|Enrolled but Never Treated|1|||
149114133|NCT01803282|537895874|FG008|Overall Study|Enrolled but Never Treated|0|||
149114134|NCT01803282|537895875|FG009|Overall Study|Enrolled but Never Treated|1|||
149114135|NCT01803282|537895876|FG010|Overall Study|Enrolled but Never Treated|0|||
149114136|NCT01803282|537895877|FG011|Overall Study|Enrolled but Never Treated|0|||
149114137|NCT02671500|537895879|FG000|Overall Study|Lack of Efficacy|12|||
149114138|NCT02671500|537895879|FG000|Overall Study|Lost to Follow-up|2|||
149114139|NCT05235269|537895887|FG000|Overall Study|Adverse Event|1|||
149114140|NCT05235269|537895887|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
149114141|NCT05235269|537895887|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
149114142|NCT03810235|537895888|FG000|Overall Study|Withdrawal by Subject|2|||
149114143|NCT03810235|537895889|FG001|Overall Study|Withdrawal by Subject|0|||
149114144|NCT00798434|537895890|FG000|Double-Blind|Adverse Event|22|||
149114145|NCT00798434|537895891|FG001|Double-Blind|Adverse Event|46|||
149114146|NCT00798434|537895890|FG000|Double-Blind|Death|0|||
149114147|NCT00798434|537895891|FG001|Double-Blind|Death|1|||
149114148|NCT00798434|537895890|FG000|Double-Blind|Lost to Follow-up|1|||
149114149|NCT00798434|537895891|FG001|Double-Blind|Lost to Follow-up|0|||
149114150|NCT00798434|537895890|FG000|Double-Blind|Lack of Efficacy|8|||
149114151|NCT00798434|537895891|FG001|Double-Blind|Lack of Efficacy|12|||
149114152|NCT00798434|537895890|FG000|Double-Blind|Withdrawal by Subject|17|||
149114153|NCT00798434|537895891|FG001|Double-Blind|Withdrawal by Subject|14|||
149114154|NCT00798434|537895890|FG000|Double-Blind|Protocol Violation|1|||
149114155|NCT00798434|537895891|FG001|Double-Blind|Protocol Violation|4|||
149114156|NCT00798434|537895890|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
149114157|NCT00798434|537895891|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
149114158|NCT00798434|537895890|FG000|Double-Blind|Other|1|||
149114159|NCT00798434|537895891|FG001|Double-Blind|Other|0|||
149114160|NCT00798434|537895890|FG000|Double-Blind|Not Treated|3|||
149114161|NCT00798434|537895891|FG001|Double-Blind|Not Treated|6|||
149114162|NCT00798434|537895890|FG000|Open-Label|Adverse Event|33|||
149114163|NCT00798434|537895891|FG001|Open-Label|Adverse Event|11|||
149114164|NCT00798434|537895890|FG000|Open-Label|Lack of Efficacy|5|||
149114165|NCT00798434|537895891|FG001|Open-Label|Lack of Efficacy|11|||
149114166|NCT00798434|537895890|FG000|Open-Label|Withdrawal by Subject|2|||
149114167|NCT00798434|537895891|FG001|Open-Label|Withdrawal by Subject|7|||
149114168|NCT00798434|537895890|FG000|Open-Label|Protocol Violation|1|||
149114169|NCT00798434|537895891|FG001|Open-Label|Protocol Violation|0|||
149114170|NCT00798434|537895890|FG000|Open-Label|Other|1|||
149114171|NCT00798434|537895891|FG001|Open-Label|Other|2|||
149114172|NCT00798434|537895890|FG000|Open-Label|Not Treated|0|||
149114173|NCT00798434|537895891|FG001|Open-Label|Not Treated|1|||
149114174|NCT01217437|537895895|FG000|Overall Study|Adverse Event|0|||
149114175|NCT01217437|537895896|FG001|Overall Study|Adverse Event|8|||
149114176|NCT01217437|537895895|FG000|Overall Study|Death|5|||
149114177|NCT01217437|537895896|FG001|Overall Study|Death|0|||
149114178|NCT01217437|537895895|FG000|Overall Study|Lack of Efficacy|29|||
149114179|NCT01217437|537895896|FG001|Overall Study|Lack of Efficacy|25|||
149114180|NCT01217437|537895895|FG000|Overall Study|Physician Decision|8|||
149114181|NCT01217437|537895896|FG001|Overall Study|Physician Decision|5|||
149114182|NCT01217437|537895895|FG000|Overall Study|Withdrawal by Subject|0|||
149114183|NCT01217437|537895896|FG001|Overall Study|Withdrawal by Subject|2|||
149114184|NCT01217437|537895895|FG000|Overall Study|Ineligible|1|||
149114185|NCT01217437|537895896|FG001|Overall Study|Ineligible|1|||
149114186|NCT03682185|537895899|FG000|Overall Study|Lost to Follow-up|4|||
149114187|NCT03682185|537895900|FG001|Overall Study|Lost to Follow-up|7|||
149114188|NCT03682185|537895901|FG002|Overall Study|Lost to Follow-up|4|||
149114189|NCT03682185|537895902|FG003|Overall Study|Lost to Follow-up|7|||
149114190|NCT03682185|537895903|FG004|Overall Study|Lost to Follow-up|1|||
149114191|NCT03682185|537895899|FG000|Overall Study|Withdrawal by Subject|7|||
149114192|NCT03682185|537895900|FG001|Overall Study|Withdrawal by Subject|3|||
149114193|NCT03682185|537895901|FG002|Overall Study|Withdrawal by Subject|7|||
149114194|NCT03682185|537895902|FG003|Overall Study|Withdrawal by Subject|3|||
149114195|NCT03682185|537895903|FG004|Overall Study|Withdrawal by Subject|0|||
149114196|NCT04908631|537895904|FG000|Overall Study|Lost to Follow-up|1|||
149114197|NCT04908631|537895904|FG000|Overall Study|Physician Decision|1|||
149114198|NCT04908631|537895904|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
149114199|NCT02336451|537895908|FG000|Overall Study|Adverse Event|1|||
149114200|NCT02336451|537895909|FG001|Overall Study|Adverse Event|2|||
149114201|NCT02336451|537895910|FG002|Overall Study|Adverse Event|0|||
149114202|NCT02336451|537895911|FG003|Overall Study|Adverse Event|6|||
149114203|NCT02336451|537895912|FG004|Overall Study|Adverse Event|4|||
149114204|NCT02336451|537895908|FG000|Overall Study|Death|6|||
149114205|NCT02336451|537895909|FG001|Overall Study|Death|2|||
149114206|NCT02336451|537895910|FG002|Overall Study|Death|3|||
149114207|NCT02336451|537895911|FG003|Overall Study|Death|6|||
149114208|NCT02336451|537895912|FG004|Overall Study|Death|6|||
149114209|NCT02336451|537895908|FG000|Overall Study|Physician Decision|9|||
149114210|NCT02336451|537895909|FG001|Overall Study|Physician Decision|6|||
149114211|NCT02336451|537895910|FG002|Overall Study|Physician Decision|7|||
149114212|NCT02336451|537895911|FG003|Overall Study|Physician Decision|16|||
149114213|NCT02336451|537895912|FG004|Overall Study|Physician Decision|3|||
149114214|NCT02336451|537895908|FG000|Overall Study|Progressive disease|23|||
149114215|NCT02336451|537895909|FG001|Overall Study|Progressive disease|26|||
149114216|NCT02336451|537895910|FG002|Overall Study|Progressive disease|2|||
149114217|NCT02336451|537895911|FG003|Overall Study|Progressive disease|14|||
149114218|NCT02336451|537895912|FG004|Overall Study|Progressive disease|4|||
149114219|NCT02336451|537895908|FG000|Overall Study|Protocol Violation|1|||
149114220|NCT02336451|537895909|FG001|Overall Study|Protocol Violation|0|||
149114221|NCT02336451|537895910|FG002|Overall Study|Protocol Violation|0|||
149114222|NCT02336451|537895911|FG003|Overall Study|Protocol Violation|0|||
149114223|NCT02336451|537895912|FG004|Overall Study|Protocol Violation|0|||
149114224|NCT02336451|537895908|FG000|Overall Study|Patient/guardian decision|2|||
149114225|NCT02336451|537895909|FG001|Overall Study|Patient/guardian decision|4|||
149114226|NCT02336451|537895910|FG002|Overall Study|Patient/guardian decision|0|||
149114227|NCT02336451|537895911|FG003|Overall Study|Patient/guardian decision|2|||
149114228|NCT02336451|537895912|FG004|Overall Study|Patient/guardian decision|1|||
149114229|NCT03548220|537895914|FG000|Overall Study|Lost to Follow-up|1|||
149114230|NCT03548220|537895915|FG001|Overall Study|Lost to Follow-up|0|||
149114231|NCT03548220|537895916|FG002|Overall Study|Lost to Follow-up|0|||
149114232|NCT03548220|537895917|FG003|Overall Study|Lost to Follow-up|0|||
149114233|NCT03520712|537895918|FG000|Overall Study|Early termination of the study by Sponsor|2|||
149114234|NCT04531982|537895921|FG000|Overall Study|Withdrawal by Subject|10|||
149114235|NCT04531982|537895922|FG001|Overall Study|Withdrawal by Subject|11|||
149114236|NCT04531982|537895921|FG000|Overall Study|Adverse Event|6|||
149114237|NCT04531982|537895922|FG001|Overall Study|Adverse Event|14|||
149114238|NCT04531982|537895921|FG000|Overall Study|Protocol Violation|6|||
149114239|NCT04531982|537895922|FG001|Overall Study|Protocol Violation|9|||
149114240|NCT04531982|537895921|FG000|Overall Study|Non-compliance with study drug|3|||
149114241|NCT04531982|537895922|FG001|Overall Study|Non-compliance with study drug|2|||
149114242|NCT04531982|537895921|FG000|Overall Study|Use of prohibited medication|2|||
149114243|NCT04531982|537895922|FG001|Overall Study|Use of prohibited medication|0|||
149114244|NCT04531982|537895921|FG000|Overall Study|Lost to Follow-up|0|||
149114245|NCT04531982|537895922|FG001|Overall Study|Lost to Follow-up|1|||
149114246|NCT04531982|537895921|FG000|Overall Study|Geopolitical conflict|2|||
149114247|NCT04531982|537895922|FG001|Overall Study|Geopolitical conflict|0|||
149114248|NCT04531982|537895921|FG000|Overall Study|Lack of Efficacy|3|||
149114249|NCT04531982|537895922|FG001|Overall Study|Lack of Efficacy|1|||
149114250|NCT03578887|537895923|FG000|Overall Study|Withdrawal by Subject|7|||
149114251|NCT03578887|537895924|FG001|Overall Study|Withdrawal by Subject|2|||
149114252|NCT03578887|537895925|FG002|Overall Study|Withdrawal by Subject|1|||
149114253|NCT03578887|537895923|FG000|Overall Study|Lost to Follow-up|13|||
149114254|NCT03578887|537895924|FG001|Overall Study|Lost to Follow-up|1|||
149114255|NCT03578887|537895925|FG002|Overall Study|Lost to Follow-up|4|||
149114256|NCT03578887|537895923|FG000|Overall Study|Physician Decision|0|||
149114257|NCT03578887|537895924|FG001|Overall Study|Physician Decision|1|||
149114258|NCT03578887|537895925|FG002|Overall Study|Physician Decision|1|||
149114259|NCT00890695|537898005|FG000|Overall Study|Protocol Violation|1|||
149114260|NCT00890695|537898006|FG001|Overall Study|Protocol Violation|0|||
149114261|NCT00833261|537898015|FG000|Overall Study|Withdrawal by Subject|4|||
149114262|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
149114263|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
149114264|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
149114265|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
149114266|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
149114267|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
149114268|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
149114269|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
149114270|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
149114271|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
149114272|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
149114273|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
149114274|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Death|1|||
149114275|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Death|2|||
149114276|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Death|2|||
149114277|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Death|0|||
149114278|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Death|0|||
149114279|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Death|0|||
149114280|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
149114281|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
149114282|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
149114283|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
149114284|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
149114285|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
149114286|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
149114287|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
149114288|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
149114289|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
149114290|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
149114291|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
149114292|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
149114293|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
149114294|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
149114295|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
149114296|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
149114297|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
149114298|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
149114299|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
149114300|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
149114301|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
149114302|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
149114303|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
149114304|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
149114305|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
149114306|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
149114307|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
149114308|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
149114309|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
149114310|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
149114311|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
149114312|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
149114313|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
149114314|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
149114315|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
149114316|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
149114317|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
149114318|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
149114319|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
149114320|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
149114321|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
149114322|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Site closure|0|||
149114323|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Site closure|0|||
149114324|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Site closure|1|||
149114325|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Site closure|0|||
149114326|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Site closure|0|||
149114327|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Site closure|0|||
149114328|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
149114329|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
149114330|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
149114331|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
149114332|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
149114333|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
149114334|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
149114335|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
149114336|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
149114337|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
149114338|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
149114339|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
149114340|NCT03439254|537898016|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
149114341|NCT03439254|537898017|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
149114342|NCT03439254|537898018|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
149114343|NCT03439254|537898019|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
149114344|NCT03439254|537898020|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
149114345|NCT03439254|537898021|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
149114346|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
149114347|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
149114348|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
149114349|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
149114350|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
149114351|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
149114352|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
149114353|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
149114354|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
149114355|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
149114356|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
149114357|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
149114358|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
149114359|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
149114360|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
149114361|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
149114362|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
149114363|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
149114364|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
149114365|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
149114366|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
149114367|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
149114368|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
149114369|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
149114370|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
149114371|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
149114372|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
149114373|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
149114374|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
149114375|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
149114376|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
149114377|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
149114378|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
149114379|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
149114380|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
149114381|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
149114382|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
149114383|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
149114384|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
149114385|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
149114386|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
149114387|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
149114388|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
149114389|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
149114390|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
149114391|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
149114392|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
149114393|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
149114394|NCT03439254|537898016|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
149114395|NCT03439254|537898017|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
149114396|NCT03439254|537898018|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
149114397|NCT03439254|537898019|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
149114398|NCT03439254|537898020|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
149114399|NCT03439254|537898021|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
149114400|NCT00837694|537898022|FG000|Overall Study|Lost to Follow-up|2|||
149114401|NCT00837694|537898023|FG001|Overall Study|Lost to Follow-up|0|||
149114402|NCT00837694|537898024|FG002|Overall Study|Lost to Follow-up|2|||
149114403|NCT00837694|537898025|FG003|Overall Study|Lost to Follow-up|1|||
149114404|NCT00837694|537898026|FG004|Overall Study|Lost to Follow-up|1|||
149114405|NCT00837694|537898027|FG005|Overall Study|Lost to Follow-up|1|||
149114406|NCT01008553|537898028|FG000|Period 1 (Titration Period)|Physician Decision|2|||
149114407|NCT01008553|537898029|FG001|Period 1 (Titration Period)|Physician Decision|0|||
149114408|NCT01008553|537898030|FG002|Period 1 (Titration Period)|Physician Decision|0|||
149114409|NCT01008553|537898028|FG000|Period 1 (Titration Period)|Adverse Event|33|||
149114410|NCT01008553|537898029|FG001|Period 1 (Titration Period)|Adverse Event|0|||
149114411|NCT01008553|537898030|FG002|Period 1 (Titration Period)|Adverse Event|0|||
149114412|NCT01008553|537898028|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
149114413|NCT01008553|537898029|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
149114414|NCT01008553|537898030|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
149114415|NCT01008553|537898028|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
149114416|NCT01008553|537898029|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
149114417|NCT01008553|537898030|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
149114418|NCT01008553|537898028|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
149114419|NCT01008553|537898029|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
149114420|NCT01008553|537898030|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
149114421|NCT01008553|537898028|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
149114422|NCT01008553|537898029|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
149114423|NCT01008553|537898030|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
149114424|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
149114425|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
149114426|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
149114427|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
149114428|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
149114429|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
149114430|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
149114431|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
149114432|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
149114433|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
149114434|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
149114435|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
149114436|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
149114437|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
149114438|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
149114439|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
149114440|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
149114441|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
149114442|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
149114443|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
149114444|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
149114445|NCT01008553|537898028|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
149114446|NCT01008553|537898029|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
149114447|NCT01008553|537898030|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
149114448|NCT03482466|537898034|FG000|Overall Study|Protocol Violation|2|||
149114449|NCT04552899|537898035|FG000|Overall Study|Adverse Event|4|||
149114450|NCT04552899|537898036|FG001|Overall Study|Adverse Event|3|||
149114451|NCT04552899|537898035|FG000|Overall Study|Death|4|||
149114452|NCT04552899|537898036|FG001|Overall Study|Death|4|||
149114453|NCT04552899|537898035|FG000|Overall Study|Lost to Follow-up|8|||
149114454|NCT04552899|537898036|FG001|Overall Study|Lost to Follow-up|13|||
149114455|NCT04552899|537898035|FG000|Overall Study|Lung Transplant|4|||
149114456|NCT04552899|537898036|FG001|Overall Study|Lung Transplant|3|||
149114457|NCT04552899|537898035|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
149114458|NCT04552899|537898036|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
149114459|NCT04552899|537898035|FG000|Overall Study|Physician Decision|3|||
149114460|NCT04552899|537898036|FG001|Overall Study|Physician Decision|4|||
149114461|NCT04552899|537898035|FG000|Overall Study|Study Terminated By Sponsor|237|||
149114462|NCT04552899|537898036|FG001|Overall Study|Study Terminated By Sponsor|239|||
149114463|NCT04552899|537898035|FG000|Overall Study|Withdrawal by Subject|15|||
149114464|NCT04552899|537898036|FG001|Overall Study|Withdrawal by Subject|17|||
149114465|NCT00731133|537898039|FG000|Overall Study|Withdrawal by Subject|10|||
149114466|NCT02383940|537898040|FG000|Overall Study|Adverse Event|1|||
149114467|NCT02383940|537898041|FG001|Overall Study|Adverse Event|0|||
149114468|NCT02383940|537898040|FG000|Overall Study|Lost to Follow-up|2|||
149114469|NCT02383940|537898041|FG001|Overall Study|Lost to Follow-up|2|||
149114470|NCT02383940|537898040|FG000|Overall Study|Physician Decision|2|||
149114471|NCT02383940|537898041|FG001|Overall Study|Physician Decision|0|||
149114472|NCT02383940|537898040|FG000|Overall Study|Withdrawal by Subject|1|||
149114473|NCT02383940|537898041|FG001|Overall Study|Withdrawal by Subject|1|||
149114474|NCT02383940|537898040|FG000|Overall Study|Randomized but not treated|2|||
149114475|NCT02383940|537898041|FG001|Overall Study|Randomized but not treated|0|||
149114476|NCT02383940|537898040|FG000|Overall Study|Other than specified above|1|||
149114477|NCT02383940|537898041|FG001|Overall Study|Other than specified above|0|||
149114478|NCT02672852|537898043|FG000|Part A1|Disease Worsening|1|||
149114479|NCT02672852|537898044|FG001|Part A1|Disease Worsening|0|||
149114480|NCT02672852|537898045|FG002|Part A1|Disease Worsening|0|||
149114481|NCT02672852|537898046|FG003|Part A1|Disease Worsening|0|||
149114482|NCT02672852|537898047|FG004|Part A1|Disease Worsening|0|||
149114483|NCT02672852|537898048|FG005|Part A1|Disease Worsening|0|||
149114484|NCT02672852|537898049|FG006|Part A1|Disease Worsening|0|||
149114485|NCT02672852|537898043|FG000|Part A1|Adverse Event|0|||
149114486|NCT02672852|537898044|FG001|Part A1|Adverse Event|1|||
149114487|NCT02672852|537898045|FG002|Part A1|Adverse Event|0|||
149114488|NCT02672852|537898046|FG003|Part A1|Adverse Event|0|||
149114489|NCT02672852|537898047|FG004|Part A1|Adverse Event|0|||
149114490|NCT02672852|537898048|FG005|Part A1|Adverse Event|0|||
149114491|NCT02672852|537898049|FG006|Part A1|Adverse Event|0|||
149114492|NCT02672852|537898043|FG000|Part A1|Lost to Follow-up|1|||
149114493|NCT02672852|537898044|FG001|Part A1|Lost to Follow-up|2|||
149114494|NCT02672852|537898045|FG002|Part A1|Lost to Follow-up|0|||
149114495|NCT02672852|537898046|FG003|Part A1|Lost to Follow-up|0|||
149114496|NCT02672852|537898047|FG004|Part A1|Lost to Follow-up|0|||
149114497|NCT02672852|537898048|FG005|Part A1|Lost to Follow-up|0|||
149114498|NCT02672852|537898049|FG006|Part A1|Lost to Follow-up|0|||
149114499|NCT02672852|537898043|FG000|Part A1|Withdrawal by Subject|1|||
149114500|NCT02672852|537898044|FG001|Part A1|Withdrawal by Subject|1|||
149114501|NCT02672852|537898045|FG002|Part A1|Withdrawal by Subject|0|||
149114502|NCT02672852|537898046|FG003|Part A1|Withdrawal by Subject|0|||
149114503|NCT02672852|537898047|FG004|Part A1|Withdrawal by Subject|0|||
149114504|NCT02672852|537898048|FG005|Part A1|Withdrawal by Subject|0|||
149114505|NCT02672852|537898049|FG006|Part A1|Withdrawal by Subject|0|||
149114506|NCT02672852|537898043|FG000|Part A2|Disease worsening|0|||
149114507|NCT02672852|537898044|FG001|Part A2|Disease worsening|0|||
149114508|NCT02672852|537898045|FG002|Part A2|Disease worsening|1|||
149114509|NCT02672852|537898046|FG003|Part A2|Disease worsening|0|||
149114510|NCT02672852|537898047|FG004|Part A2|Disease worsening|0|||
149114511|NCT02672852|537898048|FG005|Part A2|Disease worsening|0|||
149114512|NCT02672852|537898049|FG006|Part A2|Disease worsening|0|||
149114513|NCT02672852|537898043|FG000|Part A2|Adverse Event|0|||
149114514|NCT02672852|537898044|FG001|Part A2|Adverse Event|0|||
149114515|NCT02672852|537898045|FG002|Part A2|Adverse Event|3|||
149114516|NCT02672852|537898046|FG003|Part A2|Adverse Event|0|||
149114517|NCT02672852|537898047|FG004|Part A2|Adverse Event|0|||
149114518|NCT02672852|537898048|FG005|Part A2|Adverse Event|0|||
149114519|NCT02672852|537898049|FG006|Part A2|Adverse Event|0|||
149114520|NCT02672852|537898043|FG000|Part A2|Lost to Follow-up|0|||
149114521|NCT02672852|537898044|FG001|Part A2|Lost to Follow-up|0|||
149114522|NCT02672852|537898045|FG002|Part A2|Lost to Follow-up|2|||
149114523|NCT02672852|537898046|FG003|Part A2|Lost to Follow-up|0|||
149114524|NCT02672852|537898047|FG004|Part A2|Lost to Follow-up|0|||
149114525|NCT02672852|537898048|FG005|Part A2|Lost to Follow-up|0|||
149114526|NCT02672852|537898049|FG006|Part A2|Lost to Follow-up|0|||
149114527|NCT02672852|537898043|FG000|Part A2|Withdrawal by Subject|0|||
149114528|NCT02672852|537898044|FG001|Part A2|Withdrawal by Subject|0|||
149114529|NCT02672852|537898045|FG002|Part A2|Withdrawal by Subject|1|||
149114530|NCT02672852|537898046|FG003|Part A2|Withdrawal by Subject|0|||
149114531|NCT02672852|537898047|FG004|Part A2|Withdrawal by Subject|0|||
149114532|NCT02672852|537898048|FG005|Part A2|Withdrawal by Subject|0|||
149114533|NCT02672852|537898049|FG006|Part A2|Withdrawal by Subject|0|||
149114534|NCT02672852|537898043|FG000|Part A2|Other|0|||
149114535|NCT02672852|537898044|FG001|Part A2|Other|0|||
149114536|NCT02672852|537898045|FG002|Part A2|Other|3|||
149114537|NCT02672852|537898046|FG003|Part A2|Other|0|||
149114538|NCT02672852|537898047|FG004|Part A2|Other|0|||
149114539|NCT02672852|537898048|FG005|Part A2|Other|0|||
149114540|NCT02672852|537898049|FG006|Part A2|Other|0|||
149114541|NCT02672852|537898043|FG000|Part A2|Not entered in Part B|0|||
149114542|NCT02672852|537898044|FG001|Part A2|Not entered in Part B|0|||
149114543|NCT02672852|537898045|FG002|Part A2|Not entered in Part B|0|||
149114544|NCT02672852|537898046|FG003|Part A2|Not entered in Part B|4|||
149114545|NCT02672852|537898047|FG004|Part A2|Not entered in Part B|0|||
149114546|NCT02672852|537898048|FG005|Part A2|Not entered in Part B|0|||
149114547|NCT02672852|537898049|FG006|Part A2|Not entered in Part B|0|||
149114548|NCT02672852|537898043|FG000|Part B|Disease worsening|0|||
149114549|NCT02672852|537898044|FG001|Part B|Disease worsening|0|||
149114550|NCT02672852|537898045|FG002|Part B|Disease worsening|0|||
149114551|NCT02672852|537898046|FG003|Part B|Disease worsening|0|||
149114552|NCT02672852|537898047|FG004|Part B|Disease worsening|1|||
149114553|NCT02672852|537898048|FG005|Part B|Disease worsening|0|||
149114554|NCT02672852|537898049|FG006|Part B|Disease worsening|1|||
149114555|NCT02672852|537898043|FG000|Part B|Worsening pre-existing condition|0|||
149114556|NCT02672852|537898044|FG001|Part B|Worsening pre-existing condition|0|||
149114557|NCT02672852|537898045|FG002|Part B|Worsening pre-existing condition|0|||
149114558|NCT02672852|537898046|FG003|Part B|Worsening pre-existing condition|0|||
149114559|NCT02672852|537898047|FG004|Part B|Worsening pre-existing condition|0|||
149114560|NCT02672852|537898048|FG005|Part B|Worsening pre-existing condition|1|||
149114561|NCT02672852|537898049|FG006|Part B|Worsening pre-existing condition|0|||
149114562|NCT02672852|537898043|FG000|Part B|Other adverse event|0|||
149114563|NCT02672852|537898044|FG001|Part B|Other adverse event|0|||
149114564|NCT02672852|537898045|FG002|Part B|Other adverse event|0|||
149114565|NCT02672852|537898046|FG003|Part B|Other adverse event|0|||
149114566|NCT02672852|537898047|FG004|Part B|Other adverse event|3|||
149114567|NCT02672852|537898048|FG005|Part B|Other adverse event|5|||
149114568|NCT02672852|537898049|FG006|Part B|Other adverse event|1|||
149114569|NCT02672852|537898043|FG000|Part B|Lost to Follow-up|0|||
149114570|NCT02672852|537898044|FG001|Part B|Lost to Follow-up|0|||
149114571|NCT02672852|537898045|FG002|Part B|Lost to Follow-up|0|||
149114572|NCT02672852|537898046|FG003|Part B|Lost to Follow-up|0|||
149114573|NCT02672852|537898047|FG004|Part B|Lost to Follow-up|3|||
149114574|NCT02672852|537898048|FG005|Part B|Lost to Follow-up|4|||
149114575|NCT02672852|537898049|FG006|Part B|Lost to Follow-up|1|||
149114576|NCT02672852|537898043|FG000|Part B|Withdrawal by Subject|0|||
149114577|NCT02672852|537898044|FG001|Part B|Withdrawal by Subject|0|||
149114578|NCT02672852|537898045|FG002|Part B|Withdrawal by Subject|0|||
149114579|NCT02672852|537898046|FG003|Part B|Withdrawal by Subject|0|||
149114580|NCT02672852|537898047|FG004|Part B|Withdrawal by Subject|5|||
149114581|NCT02672852|537898048|FG005|Part B|Withdrawal by Subject|0|||
149114582|NCT02672852|537898049|FG006|Part B|Withdrawal by Subject|7|||
149114583|NCT02672852|537898043|FG000|Part B|Other|0|||
149114584|NCT02672852|537898044|FG001|Part B|Other|0|||
149114585|NCT02672852|537898045|FG002|Part B|Other|0|||
149114586|NCT02672852|537898046|FG003|Part B|Other|0|||
149114587|NCT02672852|537898047|FG004|Part B|Other|4|||
149114588|NCT02672852|537898048|FG005|Part B|Other|1|||
149114589|NCT02672852|537898049|FG006|Part B|Other|2|||
149114590|NCT01725126|537898050|FG000|Overall Study|Protocol Violation|0|||
149114591|NCT01725126|537898051|FG001|Overall Study|Protocol Violation|1|||
149114592|NCT01725126|537898052|FG002|Overall Study|Protocol Violation|0|||
149114593|NCT01725126|537898053|FG003|Overall Study|Protocol Violation|0|||
149114594|NCT01725126|537898054|FG004|Overall Study|Protocol Violation|0|||
149114595|NCT01725126|537898055|FG005|Overall Study|Protocol Violation|0|||
149114596|NCT01725126|537898050|FG000|Overall Study|Withdrawal by Subject|0|||
149114597|NCT01725126|537898051|FG001|Overall Study|Withdrawal by Subject|0|||
149114598|NCT01725126|537898052|FG002|Overall Study|Withdrawal by Subject|0|||
149114599|NCT01725126|537898053|FG003|Overall Study|Withdrawal by Subject|1|||
149114600|NCT01725126|537898054|FG004|Overall Study|Withdrawal by Subject|0|||
149114601|NCT01725126|537898055|FG005|Overall Study|Withdrawal by Subject|0|||
149114602|NCT01240915|537898058|FG000|Overall Study|Adverse Event|0|||
149114603|NCT01240915|537898059|FG001|Overall Study|Adverse Event|0|||
149114604|NCT01240915|537898060|FG002|Overall Study|Adverse Event|0|||
149114605|NCT01240915|537898061|FG003|Overall Study|Adverse Event|1|||
149114606|NCT01240915|537898062|FG004|Overall Study|Adverse Event|0|||
149114607|NCT01240915|537898063|FG005|Overall Study|Adverse Event|2|||
149114608|NCT01240915|537898064|FG006|Overall Study|Adverse Event|0|||
149114609|NCT01240915|537898065|FG007|Overall Study|Adverse Event|0|||
149114610|NCT01240915|537898066|FG008|Overall Study|Adverse Event|1|||
149114611|NCT01240915|537898058|FG000|Overall Study|Lost to Follow-up|0|||
149114612|NCT01240915|537898059|FG001|Overall Study|Lost to Follow-up|0|||
149114613|NCT01240915|537898060|FG002|Overall Study|Lost to Follow-up|0|||
149114614|NCT01240915|537898061|FG003|Overall Study|Lost to Follow-up|0|||
149114615|NCT01240915|537898062|FG004|Overall Study|Lost to Follow-up|1|||
149114616|NCT01240915|537898063|FG005|Overall Study|Lost to Follow-up|1|||
149114617|NCT01240915|537898064|FG006|Overall Study|Lost to Follow-up|0|||
149114618|NCT01240915|537898065|FG007|Overall Study|Lost to Follow-up|1|||
149114619|NCT01240915|537898066|FG008|Overall Study|Lost to Follow-up|1|||
149114620|NCT01240915|537898058|FG000|Overall Study|Withdrawal by Subject|2|||
149114621|NCT01240915|537898059|FG001|Overall Study|Withdrawal by Subject|1|||
149114622|NCT01240915|537898060|FG002|Overall Study|Withdrawal by Subject|0|||
149114623|NCT01240915|537898061|FG003|Overall Study|Withdrawal by Subject|2|||
149114624|NCT01240915|537898062|FG004|Overall Study|Withdrawal by Subject|0|||
149114625|NCT01240915|537898063|FG005|Overall Study|Withdrawal by Subject|4|||
149114626|NCT01240915|537898064|FG006|Overall Study|Withdrawal by Subject|2|||
149114627|NCT01240915|537898065|FG007|Overall Study|Withdrawal by Subject|3|||
149114628|NCT01240915|537898066|FG008|Overall Study|Withdrawal by Subject|3|||
149114629|NCT01240915|537898058|FG000|Overall Study|Other|0|||
149114630|NCT01240915|537898059|FG001|Overall Study|Other|0|||
149114631|NCT01240915|537898060|FG002|Overall Study|Other|0|||
149114632|NCT01240915|537898061|FG003|Overall Study|Other|0|||
149114633|NCT01240915|537898062|FG004|Overall Study|Other|2|||
149114634|NCT01240915|537898063|FG005|Overall Study|Other|0|||
149114635|NCT01240915|537898064|FG006|Overall Study|Other|0|||
149114636|NCT01240915|537898065|FG007|Overall Study|Other|0|||
149114637|NCT01240915|537898066|FG008|Overall Study|Other|0|||
149114638|NCT01240915|537898058|FG000|Overall Study|Insufficient Clinical Response|0|||
149114639|NCT01240915|537898059|FG001|Overall Study|Insufficient Clinical Response|0|||
149114640|NCT01240915|537898060|FG002|Overall Study|Insufficient Clinical Response|0|||
149114641|NCT01240915|537898061|FG003|Overall Study|Insufficient Clinical Response|0|||
149114642|NCT01240915|537898062|FG004|Overall Study|Insufficient Clinical Response|1|||
149114643|NCT01240915|537898063|FG005|Overall Study|Insufficient Clinical Response|3|||
149114644|NCT01240915|537898064|FG006|Overall Study|Insufficient Clinical Response|6|||
149114645|NCT01240915|537898065|FG007|Overall Study|Insufficient Clinical Response|0|||
149114646|NCT01240915|537898066|FG008|Overall Study|Insufficient Clinical Response|3|||
149114647|NCT01598662|537898068|FG000|Overall Study|Lost to Follow-up|10|||
149114648|NCT01598662|537898069|FG001|Overall Study|Lost to Follow-up|17|||
149114649|NCT01598662|537898068|FG000|Overall Study|Physician Decision|1|||
149114650|NCT01598662|537898069|FG001|Overall Study|Physician Decision|2|||
149114651|NCT01598662|537898068|FG000|Overall Study|IUD expelled before month 6|0|||
149114652|NCT01598662|537898069|FG001|Overall Study|IUD expelled before month 6|2|||
149114653|NCT02574845|537898072|FG000|Overall Study|Consent withdrawn further participation|0|||
149114654|NCT02574845|537898073|FG001|Overall Study|Consent withdrawn further participation|0|||
149114655|NCT02574845|537898074|FG002|Overall Study|Consent withdrawn further participation|0|||
149114656|NCT02574845|537898075|FG003|Overall Study|Consent withdrawn further participation|0|||
149114657|NCT02574845|537898076|FG004|Overall Study|Consent withdrawn further participation|1|||
149114658|NCT02574845|537898077|FG005|Overall Study|Consent withdrawn further participation|0|||
149114659|NCT02574845|537898072|FG000|Overall Study|Adverse Event|0|||
149114660|NCT02574845|537898073|FG001|Overall Study|Adverse Event|1|||
149114661|NCT02574845|537898074|FG002|Overall Study|Adverse Event|0|||
149114662|NCT02574845|537898075|FG003|Overall Study|Adverse Event|0|||
149114663|NCT02574845|537898076|FG004|Overall Study|Adverse Event|0|||
149114664|NCT02574845|537898077|FG005|Overall Study|Adverse Event|1|||
149114665|NCT01867333|537898078|FG000|Overall Study|Withdrawal by Subject|1|||
149114666|NCT01867333|537898079|FG001|Overall Study|Withdrawal by Subject|0|||
149114667|NCT01867333|537898078|FG000|Overall Study|Adverse Event|1|||
149114668|NCT01867333|537898079|FG001|Overall Study|Adverse Event|0|||
149114669|NCT01867333|537898078|FG000|Overall Study|Participant choice|1|||
149114670|NCT01867333|537898079|FG001|Overall Study|Participant choice|2|||
149114671|NCT01867333|537898078|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
149114672|NCT01867333|537898079|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
149114673|NCT01867333|537898078|FG000|Overall Study|Death|0|||
149114674|NCT01867333|537898079|FG001|Overall Study|Death|1|||
149114675|NCT01867333|537898078|FG000|Overall Study|Physician Decision|3|||
149114676|NCT01867333|537898079|FG001|Overall Study|Physician Decision|2|||
149114677|NCT01867333|537898078|FG000|Overall Study|Switched to alternative treatment|1|||
149114678|NCT01867333|537898079|FG001|Overall Study|Switched to alternative treatment|0|||
149114679|NCT01696045|537898083|FG000|Overall Study|Study drug toxicity|1|||
149114680|NCT01696045|537898084|FG001|Overall Study|Study drug toxicity|5|||
149114681|NCT01696045|537898083|FG000|Overall Study|Disease progression|2|||
149114682|NCT01696045|537898084|FG001|Overall Study|Disease progression|2|||
149114683|NCT01559129|537898085|FG000|Treatment Phase|Adverse Event|0|||
149114684|NCT01559129|537898086|FG001|Treatment Phase|Adverse Event|2|||
149114685|NCT01559129|537898085|FG000|Treatment Phase|Progressive Disease|1|||
149114686|NCT01559129|537898086|FG001|Treatment Phase|Progressive Disease|1|||
149114687|NCT01559129|537898085|FG000|Treatment Phase|Lack of Efficacy|0|||
149114688|NCT01559129|537898086|FG001|Treatment Phase|Lack of Efficacy|1|||
149114689|NCT01559129|537898085|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
149114690|NCT01559129|537898086|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
149114691|NCT01559129|537898085|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
149114692|NCT01559129|537898086|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
149114693|NCT01559129|537898085|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
149114694|NCT01559129|537898086|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
149114695|NCT01559129|537898085|FG000|Open-label Extension Period|Adverse Event|1|||
149114696|NCT01559129|537898086|FG001|Open-label Extension Period|Adverse Event|0|||
149114697|NCT01559129|537898085|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
149114698|NCT01559129|537898086|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
149114699|NCT03525392|537898087|FG000|Overall Study|Adverse Event|1|||
149114700|NCT03525392|537898088|FG001|Overall Study|Adverse Event|0|||
149114701|NCT03525392|537898089|FG002|Overall Study|Adverse Event|2|||
149114702|NCT03525392|537898090|FG003|Overall Study|Adverse Event|0|||
149114703|NCT03525392|537898091|FG004|Overall Study|Adverse Event|0|||
149114704|NCT03525392|537898087|FG000|Overall Study|Progressive disease|0|||
149114705|NCT03525392|537898088|FG001|Overall Study|Progressive disease|1|||
149114706|NCT03525392|537898089|FG002|Overall Study|Progressive disease|1|||
149114707|NCT03525392|537898090|FG003|Overall Study|Progressive disease|3|||
149114708|NCT03525392|537898091|FG004|Overall Study|Progressive disease|1|||
149114709|NCT00831129|537898094|FG000|Overall Study|Adverse Event|0|||
149114710|NCT00831129|537898095|FG001|Overall Study|Adverse Event|1|||
149114711|NCT00831129|537898094|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
149114712|NCT00831129|537898095|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
149114713|NCT03291288|537898099|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
149114714|NCT03291288|537898100|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
149114715|NCT03291288|537898099|FG000|Drug-drug Interaction Phase|Disease progression|1|||
149114716|NCT03291288|537898100|FG001|Drug-drug Interaction Phase|Disease progression|0|||
149114717|NCT03291288|537898099|FG000|Drug-drug Interaction Phase|Other|3|||
149114718|NCT03291288|537898100|FG001|Drug-drug Interaction Phase|Other|0|||
149114719|NCT03291288|537898099|FG000|Pexidartinib Only|Ongoing|0|||
149114720|NCT03291288|537898100|FG001|Pexidartinib Only|Ongoing|2|||
149114721|NCT04276415|537898101|FG000|Overall Study|Adverse Event|0|||
149114722|NCT04276415|537898102|FG001|Overall Study|Adverse Event|0|||
149114723|NCT04276415|537898103|FG002|Overall Study|Adverse Event|0|||
149114724|NCT04276415|537898104|FG003|Overall Study|Adverse Event|3|||
149114725|NCT04276415|537898105|FG004|Overall Study|Adverse Event|0|||
149114726|NCT04276415|537898106|FG005|Overall Study|Adverse Event|0|||
149114727|NCT04276415|537898101|FG000|Overall Study|Clinical progression|1|||
149114728|NCT04276415|537898102|FG001|Overall Study|Clinical progression|1|||
149114729|NCT04276415|537898103|FG002|Overall Study|Clinical progression|0|||
149114730|NCT04276415|537898104|FG003|Overall Study|Clinical progression|0|||
149114731|NCT04276415|537898105|FG004|Overall Study|Clinical progression|1|||
149114732|NCT04276415|537898106|FG005|Overall Study|Clinical progression|0|||
149114733|NCT04276415|537898101|FG000|Overall Study|Other|0|||
149114734|NCT04276415|537898102|FG001|Overall Study|Other|0|||
149114735|NCT04276415|537898103|FG002|Overall Study|Other|0|||
149114736|NCT04276415|537898104|FG003|Overall Study|Other|1|||
149114737|NCT04276415|537898105|FG004|Overall Study|Other|0|||
149114738|NCT04276415|537898106|FG005|Overall Study|Other|0|||
149114739|NCT04276415|537898101|FG000|Overall Study|Physician Decision|0|||
149114740|NCT04276415|537898102|FG001|Overall Study|Physician Decision|0|||
149114741|NCT04276415|537898103|FG002|Overall Study|Physician Decision|1|||
149114742|NCT04276415|537898104|FG003|Overall Study|Physician Decision|3|||
149114743|NCT04276415|537898105|FG004|Overall Study|Physician Decision|2|||
149114744|NCT04276415|537898106|FG005|Overall Study|Physician Decision|0|||
149114745|NCT04276415|537898101|FG000|Overall Study|Progressive disease|3|||
149114746|NCT04276415|537898102|FG001|Overall Study|Progressive disease|3|||
149114747|NCT04276415|537898103|FG002|Overall Study|Progressive disease|4|||
149114748|NCT04276415|537898104|FG003|Overall Study|Progressive disease|5|||
149114749|NCT04276415|537898105|FG004|Overall Study|Progressive disease|1|||
149114750|NCT04276415|537898106|FG005|Overall Study|Progressive disease|2|||
149114751|NCT04276415|537898101|FG000|Overall Study|Withdrawal by patient|0|||
149114752|NCT04276415|537898102|FG001|Overall Study|Withdrawal by patient|0|||
149114753|NCT04276415|537898103|FG002|Overall Study|Withdrawal by patient|0|||
149114754|NCT04276415|537898104|FG003|Overall Study|Withdrawal by patient|1|||
149114755|NCT04276415|537898105|FG004|Overall Study|Withdrawal by patient|2|||
149114756|NCT04276415|537898106|FG005|Overall Study|Withdrawal by patient|0|||
149114757|NCT00208325|537898107|FG000|Overall Study|Death|18|||
149114758|NCT00208325|537898108|FG001|Overall Study|Death|19|||
149114759|NCT00208325|537898109|FG002|Overall Study|Death|7|||
149114760|NCT00208325|537898110|FG003|Overall Study|Death|5|||
149114761|NCT00208325|537898107|FG000|Overall Study|Withdrawal by Subject|0|||
149114762|NCT00208325|537898108|FG001|Overall Study|Withdrawal by Subject|1|||
149114763|NCT00208325|537898109|FG002|Overall Study|Withdrawal by Subject|0|||
149114764|NCT00208325|537898110|FG003|Overall Study|Withdrawal by Subject|0|||
149114765|NCT00208325|537898107|FG000|Overall Study|Revision|4|||
149114766|NCT00208325|537898108|FG001|Overall Study|Revision|1|||
149114767|NCT00208325|537898109|FG002|Overall Study|Revision|0|||
149114768|NCT00208325|537898110|FG003|Overall Study|Revision|4|||
149114769|NCT00208325|537898107|FG000|Overall Study|Lost to Follow-up|1|||
149114770|NCT00208325|537898108|FG001|Overall Study|Lost to Follow-up|0|||
149114771|NCT00208325|537898109|FG002|Overall Study|Lost to Follow-up|2|||
149114772|NCT00208325|537898110|FG003|Overall Study|Lost to Follow-up|0|||
149114773|NCT00208325|537898107|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
149114774|NCT00208325|537898108|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
149114775|NCT00208325|537898109|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
149114776|NCT00208325|537898110|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
149114777|NCT00208325|537898107|FG000|Overall Study|Does not wish to Continue in Study|5|||
149114778|NCT00208325|537898108|FG001|Overall Study|Does not wish to Continue in Study|8|||
149114779|NCT00208325|537898109|FG002|Overall Study|Does not wish to Continue in Study|3|||
149114780|NCT00208325|537898110|FG003|Overall Study|Does not wish to Continue in Study|2|||
149114781|NCT00208325|537898107|FG000|Overall Study|Other|2|||
149114782|NCT00208325|537898108|FG001|Overall Study|Other|1|||
149114783|NCT00208325|537898109|FG002|Overall Study|Other|1|||
149114784|NCT00208325|537898110|FG003|Overall Study|Other|0|||
149114785|NCT00208325|537898107|FG000|Overall Study|Mis-Randomized|17|||
149114786|NCT00208325|537898108|FG001|Overall Study|Mis-Randomized|20|||
149114787|NCT00208325|537898109|FG002|Overall Study|Mis-Randomized|0|||
149114788|NCT00208325|537898110|FG003|Overall Study|Mis-Randomized|0|||
149114789|NCT02145468|537898111|FG000|Overall Study|Withdrawal by Subject|5|||
149114790|NCT02145468|537898112|FG001|Overall Study|Withdrawal by Subject|8|||
149114791|NCT00586612|537898113|FG000|Primary Phase|Protocol Violation|1|||
149114792|NCT00586612|537898114|FG001|Primary Phase|Protocol Violation|0|||
149114793|NCT00586612|537898113|FG000|Primary Phase|Lost to Follow-up|0|||
149114794|NCT00586612|537898114|FG001|Primary Phase|Lost to Follow-up|1|||
149114795|NCT00586612|537898113|FG000|Primary Phase|Withdrawal by Subject|0|||
149114796|NCT00586612|537898114|FG001|Primary Phase|Withdrawal by Subject|2|||
149114797|NCT00586612|537898113|FG000|Booster Phase|Lost to Follow-up|3|||
149114798|NCT00586612|537898114|FG001|Booster Phase|Lost to Follow-up|1|||
149114799|NCT00623805|537898115|FG000|Overall Study|Adverse Event|9|||
149114800|NCT00623805|537898116|FG001|Overall Study|Adverse Event|6|||
149114801|NCT00623805|537898115|FG000|Overall Study|Death|2|||
149114802|NCT00623805|537898116|FG001|Overall Study|Death|0|||
149114803|NCT00623805|537898115|FG000|Overall Study|Lack of Efficacy|3|||
149114804|NCT00623805|537898116|FG001|Overall Study|Lack of Efficacy|7|||
149114805|NCT00623805|537898115|FG000|Overall Study|Lost to Follow-up|2|||
149114806|NCT00623805|537898116|FG001|Overall Study|Lost to Follow-up|2|||
149114807|NCT00623805|537898115|FG000|Overall Study|Protocol Violation|1|||
149114808|NCT00623805|537898116|FG001|Overall Study|Protocol Violation|1|||
149114809|NCT00623805|537898115|FG000|Overall Study|Reason not Specified|3|||
149114810|NCT00623805|537898116|FG001|Overall Study|Reason not Specified|6|||
149114811|NCT02906007|537898123|FG000|Overall Study|Physician Decision|0|||
149114812|NCT02906007|537898124|FG001|Overall Study|Physician Decision|0|||
149114813|NCT02906007|537898125|FG002|Overall Study|Physician Decision|1|||
149114814|NCT02906007|537898123|FG000|Overall Study|Died|1|||
149114815|NCT02906007|537898124|FG001|Overall Study|Died|0|||
149114816|NCT02906007|537898125|FG002|Overall Study|Died|0|||
149114817|NCT06655558|537898126|FG000|Overall Study|Protocol Violation|1|||
149114818|NCT02344290|537898134|FG000|Overall Study|Withdrawal by Subject|315|||
149114819|NCT02344290|537898135|FG001|Overall Study|Withdrawal by Subject|324|||
149114820|NCT02344290|537898134|FG000|Overall Study|Lost to Follow-up|258|||
149114821|NCT02344290|537898135|FG001|Overall Study|Lost to Follow-up|249|||
149114822|NCT02344290|537898134|FG000|Overall Study|Unable to get to clinic|69|||
149114823|NCT02344290|537898135|FG001|Overall Study|Unable to get to clinic|60|||
149114824|NCT02344290|537898134|FG000|Overall Study|Physician Decision|25|||
149114825|NCT02344290|537898135|FG001|Overall Study|Physician Decision|25|||
149114826|NCT02344290|537898134|FG000|Overall Study|Site Closure|15|||
149114827|NCT02344290|537898135|FG001|Overall Study|Site Closure|19|||
149114828|NCT02344290|537898134|FG000|Overall Study|Other|5|||
149114829|NCT02344290|537898135|FG001|Overall Study|Other|3|||
149114830|NCT04998812|537898136|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
149114831|NCT04998812|537898137|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
149114832|NCT04998812|537898136|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
149114833|NCT04998812|537898137|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
149114834|NCT04998812|537898136|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
149114835|NCT04998812|537898137|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
149114836|NCT04998812|537898136|FG000|Vaccination Period|Ongoing in study|23|||
149114837|NCT04998812|537898137|FG001|Vaccination Period|Ongoing in study|23|||
149114838|NCT04047862|537898141|FG000|Overall Study|Death|0|||
149114839|NCT04047862|537898142|FG001|Overall Study|Death|0|||
149114840|NCT04047862|537898143|FG002|Overall Study|Death|4|||
149114841|NCT04047862|537898144|FG003|Overall Study|Death|7|||
149114842|NCT04047862|537898145|FG004|Overall Study|Death|2|||
149114843|NCT04047862|537898146|FG005|Overall Study|Death|4|||
149114844|NCT04047862|537898147|FG006|Overall Study|Death|3|||
149114845|NCT04047862|537898148|FG007|Overall Study|Death|24|||
149114846|NCT04047862|537898149|FG008|Overall Study|Death|24|||
149114847|NCT04047862|537898150|FG009|Overall Study|Death|22|||
149114848|NCT04047862|537898151|FG010|Overall Study|Death|35|||
149114849|NCT04047862|537898152|FG011|Overall Study|Death|18|||
149114850|NCT04047862|537898153|FG012|Overall Study|Death|14|||
149114851|NCT04047862|537898154|FG013|Overall Study|Death|6|||
149114852|NCT04047862|537898155|FG014|Overall Study|Death|19|||
149114853|NCT04047862|537898156|FG015|Overall Study|Death|42|||
149114854|NCT04047862|537898157|FG016|Overall Study|Death|9|||
149114855|NCT04047862|537898158|FG017|Overall Study|Death|8|||
149114856|NCT04047862|537898159|FG018|Overall Study|Death|10|||
149114857|NCT04047862|537898141|FG000|Overall Study|Withdrawal by Subject|0|||
149114858|NCT04047862|537898142|FG001|Overall Study|Withdrawal by Subject|0|||
149114859|NCT04047862|537898143|FG002|Overall Study|Withdrawal by Subject|0|||
149114860|NCT04047862|537898144|FG003|Overall Study|Withdrawal by Subject|5|||
149114861|NCT04047862|537898145|FG004|Overall Study|Withdrawal by Subject|2|||
149114862|NCT04047862|537898146|FG005|Overall Study|Withdrawal by Subject|0|||
149114863|NCT04047862|537898147|FG006|Overall Study|Withdrawal by Subject|1|||
149114864|NCT04047862|537898148|FG007|Overall Study|Withdrawal by Subject|0|||
149114865|NCT04047862|537898149|FG008|Overall Study|Withdrawal by Subject|4|||
149114866|NCT04047862|537898150|FG009|Overall Study|Withdrawal by Subject|4|||
149114867|NCT04047862|537898151|FG010|Overall Study|Withdrawal by Subject|4|||
149114868|NCT04047862|537898152|FG011|Overall Study|Withdrawal by Subject|2|||
149114869|NCT04047862|537898153|FG012|Overall Study|Withdrawal by Subject|3|||
149114870|NCT04047862|537898154|FG013|Overall Study|Withdrawal by Subject|0|||
149114871|NCT04047862|537898155|FG014|Overall Study|Withdrawal by Subject|9|||
149114872|NCT04047862|537898156|FG015|Overall Study|Withdrawal by Subject|5|||
149114873|NCT04047862|537898157|FG016|Overall Study|Withdrawal by Subject|1|||
149114874|NCT04047862|537898158|FG017|Overall Study|Withdrawal by Subject|3|||
149114875|NCT04047862|537898159|FG018|Overall Study|Withdrawal by Subject|1|||
149114876|NCT04047862|537898141|FG000|Overall Study|Lost to Follow-up|0|||
149114877|NCT04047862|537898142|FG001|Overall Study|Lost to Follow-up|0|||
149114878|NCT04047862|537898143|FG002|Overall Study|Lost to Follow-up|1|||
149114879|NCT04047862|537898144|FG003|Overall Study|Lost to Follow-up|0|||
149114880|NCT04047862|537898145|FG004|Overall Study|Lost to Follow-up|0|||
149114881|NCT04047862|537898146|FG005|Overall Study|Lost to Follow-up|0|||
149114882|NCT04047862|537898147|FG006|Overall Study|Lost to Follow-up|0|||
149114883|NCT04047862|537898148|FG007|Overall Study|Lost to Follow-up|1|||
149114884|NCT04047862|537898149|FG008|Overall Study|Lost to Follow-up|0|||
149114885|NCT04047862|537898150|FG009|Overall Study|Lost to Follow-up|1|||
149114886|NCT04047862|537898151|FG010|Overall Study|Lost to Follow-up|0|||
149114887|NCT04047862|537898152|FG011|Overall Study|Lost to Follow-up|3|||
149114888|NCT04047862|537898153|FG012|Overall Study|Lost to Follow-up|0|||
149114889|NCT04047862|537898154|FG013|Overall Study|Lost to Follow-up|0|||
149114890|NCT04047862|537898155|FG014|Overall Study|Lost to Follow-up|2|||
149114891|NCT04047862|537898156|FG015|Overall Study|Lost to Follow-up|2|||
149114892|NCT04047862|537898157|FG016|Overall Study|Lost to Follow-up|1|||
149114893|NCT04047862|537898158|FG017|Overall Study|Lost to Follow-up|0|||
149114894|NCT04047862|537898159|FG018|Overall Study|Lost to Follow-up|0|||
149114895|NCT04047862|537898141|FG000|Overall Study|Physician Decision|0|||
149114896|NCT04047862|537898142|FG001|Overall Study|Physician Decision|0|||
149114897|NCT04047862|537898143|FG002|Overall Study|Physician Decision|0|||
149114898|NCT04047862|537898144|FG003|Overall Study|Physician Decision|1|||
149114899|NCT04047862|537898145|FG004|Overall Study|Physician Decision|0|||
149114900|NCT04047862|537898146|FG005|Overall Study|Physician Decision|0|||
149114901|NCT04047862|537898147|FG006|Overall Study|Physician Decision|0|||
149114902|NCT04047862|537898148|FG007|Overall Study|Physician Decision|0|||
149114903|NCT04047862|537898149|FG008|Overall Study|Physician Decision|0|||
149114904|NCT04047862|537898150|FG009|Overall Study|Physician Decision|0|||
149114905|NCT04047862|537898151|FG010|Overall Study|Physician Decision|0|||
149114906|NCT04047862|537898152|FG011|Overall Study|Physician Decision|0|||
149114907|NCT04047862|537898153|FG012|Overall Study|Physician Decision|0|||
149114908|NCT04047862|537898154|FG013|Overall Study|Physician Decision|0|||
149114909|NCT04047862|537898155|FG014|Overall Study|Physician Decision|1|||
149114910|NCT04047862|537898156|FG015|Overall Study|Physician Decision|0|||
149114911|NCT04047862|537898157|FG016|Overall Study|Physician Decision|1|||
149114912|NCT04047862|537898158|FG017|Overall Study|Physician Decision|0|||
149114913|NCT04047862|537898159|FG018|Overall Study|Physician Decision|0|||
149114914|NCT04047862|537898141|FG000|Overall Study|Completed all Assessments|1|||
149114915|NCT04047862|537898142|FG001|Overall Study|Completed all Assessments|3|||
149114916|NCT04047862|537898143|FG002|Overall Study|Completed all Assessments|1|||
149114917|NCT04047862|537898144|FG003|Overall Study|Completed all Assessments|3|||
149114918|NCT04047862|537898145|FG004|Overall Study|Completed all Assessments|2|||
149114919|NCT04047862|537898146|FG005|Overall Study|Completed all Assessments|5|||
149114920|NCT04047862|537898147|FG006|Overall Study|Completed all Assessments|7|||
149114921|NCT04047862|537898148|FG007|Overall Study|Completed all Assessments|0|||
149114922|NCT04047862|537898149|FG008|Overall Study|Completed all Assessments|0|||
149114923|NCT04047862|537898150|FG009|Overall Study|Completed all Assessments|0|||
149114924|NCT04047862|537898151|FG010|Overall Study|Completed all Assessments|0|||
149114925|NCT04047862|537898152|FG011|Overall Study|Completed all Assessments|0|||
149114926|NCT04047862|537898153|FG012|Overall Study|Completed all Assessments|0|||
149114927|NCT04047862|537898154|FG013|Overall Study|Completed all Assessments|0|||
149114928|NCT04047862|537898155|FG014|Overall Study|Completed all Assessments|0|||
149114929|NCT04047862|537898156|FG015|Overall Study|Completed all Assessments|0|||
149114930|NCT04047862|537898157|FG016|Overall Study|Completed all Assessments|0|||
149114931|NCT04047862|537898158|FG017|Overall Study|Completed all Assessments|0|||
149114932|NCT04047862|537898159|FG018|Overall Study|Completed all Assessments|0|||
149114933|NCT04047862|537898141|FG000|Overall Study|Sponsor Decision|0|||
149114934|NCT04047862|537898142|FG001|Overall Study|Sponsor Decision|0|||
149114935|NCT04047862|537898143|FG002|Overall Study|Sponsor Decision|0|||
149114936|NCT04047862|537898144|FG003|Overall Study|Sponsor Decision|0|||
149114937|NCT04047862|537898145|FG004|Overall Study|Sponsor Decision|0|||
149114938|NCT04047862|537898146|FG005|Overall Study|Sponsor Decision|0|||
149114939|NCT04047862|537898147|FG006|Overall Study|Sponsor Decision|0|||
149114940|NCT04047862|537898148|FG007|Overall Study|Sponsor Decision|13|||
149114941|NCT04047862|537898149|FG008|Overall Study|Sponsor Decision|10|||
149114942|NCT04047862|537898150|FG009|Overall Study|Sponsor Decision|18|||
149114943|NCT04047862|537898151|FG010|Overall Study|Sponsor Decision|3|||
149114944|NCT04047862|537898152|FG011|Overall Study|Sponsor Decision|3|||
149114945|NCT04047862|537898153|FG012|Overall Study|Sponsor Decision|4|||
149114946|NCT04047862|537898154|FG013|Overall Study|Sponsor Decision|0|||
149114947|NCT04047862|537898155|FG014|Overall Study|Sponsor Decision|7|||
149114948|NCT04047862|537898156|FG015|Overall Study|Sponsor Decision|8|||
149114949|NCT04047862|537898157|FG016|Overall Study|Sponsor Decision|9|||
149114950|NCT04047862|537898158|FG017|Overall Study|Sponsor Decision|7|||
149114951|NCT04047862|537898159|FG018|Overall Study|Sponsor Decision|8|||
149114952|NCT04047862|537898141|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114953|NCT04047862|537898142|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114954|NCT04047862|537898143|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114955|NCT04047862|537898144|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114956|NCT04047862|537898145|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114957|NCT04047862|537898146|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114958|NCT04047862|537898147|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114959|NCT04047862|537898148|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
149114960|NCT04047862|537898149|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
149114961|NCT04047862|537898150|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114962|NCT04047862|537898151|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
149114963|NCT04047862|537898152|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114964|NCT04047862|537898153|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114965|NCT04047862|537898154|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
149114966|NCT04047862|537898155|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
149114967|NCT04047862|537898156|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
149114968|NCT04047862|537898157|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
149114969|NCT04047862|537898158|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
149114970|NCT04047862|537898159|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
149114971|NCT04047862|537898141|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114972|NCT04047862|537898142|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114973|NCT04047862|537898143|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114974|NCT04047862|537898144|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114975|NCT04047862|537898145|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114976|NCT04047862|537898146|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114977|NCT04047862|537898147|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114978|NCT04047862|537898148|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114979|NCT04047862|537898149|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114980|NCT04047862|537898150|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114981|NCT04047862|537898151|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114982|NCT04047862|537898152|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114983|NCT04047862|537898153|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114984|NCT04047862|537898154|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114985|NCT04047862|537898155|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114986|NCT04047862|537898156|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
149114987|NCT04047862|537898157|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114988|NCT04047862|537898158|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
149114989|NCT04047862|537898159|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
149114990|NCT04047862|537898141|FG000|Overall Study|Other|0|||
149114991|NCT04047862|537898142|FG001|Overall Study|Other|0|||
149114992|NCT04047862|537898143|FG002|Overall Study|Other|0|||
149114993|NCT04047862|537898144|FG003|Overall Study|Other|0|||
149114994|NCT04047862|537898145|FG004|Overall Study|Other|0|||
149114995|NCT04047862|537898146|FG005|Overall Study|Other|0|||
149114996|NCT04047862|537898147|FG006|Overall Study|Other|0|||
149114997|NCT04047862|537898148|FG007|Overall Study|Other|0|||
149114998|NCT04047862|537898149|FG008|Overall Study|Other|0|||
149114999|NCT04047862|537898150|FG009|Overall Study|Other|0|||
149115000|NCT04047862|537898151|FG010|Overall Study|Other|0|||
149115001|NCT04047862|537898152|FG011|Overall Study|Other|0|||
149115002|NCT04047862|537898153|FG012|Overall Study|Other|0|||
149115003|NCT04047862|537898154|FG013|Overall Study|Other|0|||
149115004|NCT04047862|537898155|FG014|Overall Study|Other|2|||
149115005|NCT04047862|537898156|FG015|Overall Study|Other|1|||
149115006|NCT04047862|537898157|FG016|Overall Study|Other|1|||
149115007|NCT04047862|537898158|FG017|Overall Study|Other|1|||
149115008|NCT04047862|537898159|FG018|Overall Study|Other|0|||
149115009|NCT06748729|537898164|FG000|Overall Study|Withdrawal by Subject|1|||
149115010|NCT04500769|537899883|FG000|Overall Study|Withdrawal by Subject|5|||
149115011|NCT00568178|537899884|FG000|Double Blind Base Study|Adverse Event|0|||
149115012|NCT00568178|537899885|FG001|Double Blind Base Study|Adverse Event|2|||
149115013|NCT00568178|537899886|FG002|Double Blind Base Study|Adverse Event|1|||
149115014|NCT00568178|537899887|FG003|Double Blind Base Study|Adverse Event|2|||
149115015|NCT00568178|537899888|FG004|Double Blind Base Study|Adverse Event|0|||
149115016|NCT00568178|537899889|FG005|Double Blind Base Study|Adverse Event|0|||
149115017|NCT00568178|537899884|FG000|Double Blind Base Study|Lost to Follow-up|1|||
149115018|NCT00568178|537899885|FG001|Double Blind Base Study|Lost to Follow-up|0|||
149115019|NCT00568178|537899886|FG002|Double Blind Base Study|Lost to Follow-up|0|||
149115020|NCT00568178|537899887|FG003|Double Blind Base Study|Lost to Follow-up|1|||
149115021|NCT00568178|537899888|FG004|Double Blind Base Study|Lost to Follow-up|0|||
149115022|NCT00568178|537899889|FG005|Double Blind Base Study|Lost to Follow-up|0|||
149115023|NCT00568178|537899884|FG000|Double Blind Base Study|Physician Decision|1|||
149115024|NCT00568178|537899885|FG001|Double Blind Base Study|Physician Decision|1|||
149115025|NCT00568178|537899886|FG002|Double Blind Base Study|Physician Decision|0|||
149115026|NCT00568178|537899887|FG003|Double Blind Base Study|Physician Decision|1|||
149115027|NCT00568178|537899888|FG004|Double Blind Base Study|Physician Decision|0|||
149115028|NCT00568178|537899889|FG005|Double Blind Base Study|Physician Decision|0|||
149115029|NCT00568178|537899884|FG000|Double Blind Base Study|Protocol Violation|3|||
149115030|NCT00568178|537899885|FG001|Double Blind Base Study|Protocol Violation|2|||
149115031|NCT00568178|537899886|FG002|Double Blind Base Study|Protocol Violation|0|||
149115032|NCT00568178|537899887|FG003|Double Blind Base Study|Protocol Violation|0|||
149115033|NCT00568178|537899888|FG004|Double Blind Base Study|Protocol Violation|0|||
149115034|NCT00568178|537899889|FG005|Double Blind Base Study|Protocol Violation|0|||
149115035|NCT00568178|537899884|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
149115036|NCT00568178|537899885|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
149115037|NCT00568178|537899886|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
149115038|NCT00568178|537899887|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
149115039|NCT00568178|537899888|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
149115040|NCT00568178|537899889|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
149115041|NCT00568178|537899884|FG000|Double Blind Base Study|Progressive Disease|0|||
149115042|NCT00568178|537899885|FG001|Double Blind Base Study|Progressive Disease|0|||
149115043|NCT00568178|537899886|FG002|Double Blind Base Study|Progressive Disease|0|||
149115044|NCT00568178|537899887|FG003|Double Blind Base Study|Progressive Disease|1|||
149115045|NCT00568178|537899888|FG004|Double Blind Base Study|Progressive Disease|0|||
149115046|NCT00568178|537899889|FG005|Double Blind Base Study|Progressive Disease|0|||
149115047|NCT00568178|537899884|FG000|Open Label Extension|Adverse Event|0|||
149115048|NCT00568178|537899885|FG001|Open Label Extension|Adverse Event|0|||
149115049|NCT00568178|537899886|FG002|Open Label Extension|Adverse Event|0|||
149115050|NCT00568178|537899887|FG003|Open Label Extension|Adverse Event|0|||
149115051|NCT00568178|537899888|FG004|Open Label Extension|Adverse Event|11|||
149115052|NCT00568178|537899889|FG005|Open Label Extension|Adverse Event|8|||
149115053|NCT00568178|537899884|FG000|Open Label Extension|Protocol Violation|0|||
149115054|NCT00568178|537899885|FG001|Open Label Extension|Protocol Violation|0|||
149115055|NCT00568178|537899886|FG002|Open Label Extension|Protocol Violation|0|||
149115056|NCT00568178|537899887|FG003|Open Label Extension|Protocol Violation|0|||
149115057|NCT00568178|537899888|FG004|Open Label Extension|Protocol Violation|1|||
149115058|NCT00568178|537899889|FG005|Open Label Extension|Protocol Violation|0|||
149115059|NCT00568178|537899884|FG000|Open Label Extension|Lost to Follow-up|0|||
149115060|NCT00568178|537899885|FG001|Open Label Extension|Lost to Follow-up|0|||
149115061|NCT00568178|537899886|FG002|Open Label Extension|Lost to Follow-up|0|||
149115062|NCT00568178|537899887|FG003|Open Label Extension|Lost to Follow-up|0|||
149115063|NCT00568178|537899888|FG004|Open Label Extension|Lost to Follow-up|6|||
149115064|NCT00568178|537899889|FG005|Open Label Extension|Lost to Follow-up|11|||
149115065|NCT00568178|537899884|FG000|Open Label Extension|Physician Decision|0|||
149115066|NCT00568178|537899885|FG001|Open Label Extension|Physician Decision|0|||
149115067|NCT00568178|537899886|FG002|Open Label Extension|Physician Decision|0|||
149115068|NCT00568178|537899887|FG003|Open Label Extension|Physician Decision|0|||
149115069|NCT00568178|537899888|FG004|Open Label Extension|Physician Decision|9|||
149115070|NCT00568178|537899889|FG005|Open Label Extension|Physician Decision|8|||
149115071|NCT00568178|537899884|FG000|Open Label Extension|Pregnancy|0|||
149115072|NCT00568178|537899885|FG001|Open Label Extension|Pregnancy|0|||
149115073|NCT00568178|537899886|FG002|Open Label Extension|Pregnancy|0|||
149115074|NCT00568178|537899887|FG003|Open Label Extension|Pregnancy|0|||
149115075|NCT00568178|537899888|FG004|Open Label Extension|Pregnancy|0|||
149115076|NCT00568178|537899889|FG005|Open Label Extension|Pregnancy|1|||
149115077|NCT00568178|537899884|FG000|Open Label Extension|Progressive Disease|0|||
149115078|NCT00568178|537899885|FG001|Open Label Extension|Progressive Disease|0|||
149115079|NCT00568178|537899886|FG002|Open Label Extension|Progressive Disease|0|||
149115080|NCT00568178|537899887|FG003|Open Label Extension|Progressive Disease|0|||
149115081|NCT00568178|537899888|FG004|Open Label Extension|Progressive Disease|3|||
149115082|NCT00568178|537899889|FG005|Open Label Extension|Progressive Disease|1|||
149115083|NCT00568178|537899884|FG000|Open Label Extension|Termination of Trial|0|||
149115084|NCT00568178|537899885|FG001|Open Label Extension|Termination of Trial|0|||
149115085|NCT00568178|537899886|FG002|Open Label Extension|Termination of Trial|0|||
149115086|NCT00568178|537899887|FG003|Open Label Extension|Termination of Trial|0|||
149115087|NCT00568178|537899888|FG004|Open Label Extension|Termination of Trial|45|||
149115088|NCT00568178|537899889|FG005|Open Label Extension|Termination of Trial|47|||
149115089|NCT00568178|537899884|FG000|Open Label Extension|Withdrawal by Subject|0|||
149115090|NCT00568178|537899885|FG001|Open Label Extension|Withdrawal by Subject|0|||
149115091|NCT00568178|537899886|FG002|Open Label Extension|Withdrawal by Subject|0|||
149115092|NCT00568178|537899887|FG003|Open Label Extension|Withdrawal by Subject|0|||
149115093|NCT00568178|537899888|FG004|Open Label Extension|Withdrawal by Subject|4|||
149115094|NCT00568178|537899889|FG005|Open Label Extension|Withdrawal by Subject|4|||
149115095|NCT01332630|537899890|FG000|Overall Study|Withdrawal by Subject|3|||
149115096|NCT01008410|537899892|FG000|Overall Study|Adverse Event|13|||
149115097|NCT01008410|537899893|FG001|Overall Study|Adverse Event|7|||
149115098|NCT01008410|537899892|FG000|Overall Study|Withdrawal by Subject|6|||
149115099|NCT01008410|537899893|FG001|Overall Study|Withdrawal by Subject|2|||
149115100|NCT01008410|537899892|FG000|Overall Study|Lost to Follow-up|1|||
149115101|NCT01008410|537899893|FG001|Overall Study|Lost to Follow-up|0|||
149115102|NCT01008410|537899892|FG000|Overall Study|Noncompliance|1|||
149115103|NCT01008410|537899893|FG001|Overall Study|Noncompliance|0|||
149115104|NCT01008410|537899892|FG000|Overall Study|Low Cortisol|2|||
149115105|NCT01008410|537899893|FG001|Overall Study|Low Cortisol|0|||
149115106|NCT01008410|537899892|FG000|Overall Study|Lack of Efficacy|2|||
149115107|NCT01008410|537899893|FG001|Overall Study|Lack of Efficacy|6|||
149115108|NCT01008410|537899892|FG000|Overall Study|Met Exclusion Criterion|0|||
149115109|NCT01008410|537899893|FG001|Overall Study|Met Exclusion Criterion|1|||
149115110|NCT02787044|537899900|FG000|Overall Study|Lost to Follow-up|15|||
149115111|NCT02787044|537899901|FG001|Overall Study|Lost to Follow-up|19|||
149115112|NCT03889704|537899902|FG000|Overall Study|Study terminated due to pandemic|1|||
149115113|NCT02591953|537899903|FG000|Overall Study|Lost to Follow-up|6|||
149115114|NCT02591953|537899904|FG001|Overall Study|Lost to Follow-up|6|||
149115115|NCT01517295|537899905|FG000|Overall Study|Physician Decision|1|||
149115116|NCT01517295|537899906|FG001|Overall Study|Physician Decision|0|||
149115117|NCT03248882|537899907|FG000|Overall Study|Adverse Event|3|||
149115118|NCT03248882|537899908|FG001|Overall Study|Adverse Event|3|||
149115119|NCT03248882|537899909|FG002|Overall Study|Adverse Event|2|||
149115120|NCT03248882|537899910|FG003|Overall Study|Adverse Event|6|||
149115121|NCT03248882|537899911|FG004|Overall Study|Adverse Event|9|||
149115122|NCT03248882|537899907|FG000|Overall Study|Lost to Follow-up|0|||
149115123|NCT03248882|537899908|FG001|Overall Study|Lost to Follow-up|0|||
149115124|NCT03248882|537899909|FG002|Overall Study|Lost to Follow-up|0|||
149115125|NCT03248882|537899910|FG003|Overall Study|Lost to Follow-up|0|||
149115126|NCT03248882|537899911|FG004|Overall Study|Lost to Follow-up|1|||
149115127|NCT03248882|537899907|FG000|Overall Study|Protocol Violation|2|||
149115128|NCT03248882|537899908|FG001|Overall Study|Protocol Violation|0|||
149115129|NCT03248882|537899909|FG002|Overall Study|Protocol Violation|2|||
149115130|NCT03248882|537899910|FG003|Overall Study|Protocol Violation|0|||
149115131|NCT03248882|537899911|FG004|Overall Study|Protocol Violation|1|||
149115132|NCT03248882|537899907|FG000|Overall Study|Withdrawal by Subject|2|||
149115133|NCT03248882|537899908|FG001|Overall Study|Withdrawal by Subject|2|||
149115134|NCT03248882|537899909|FG002|Overall Study|Withdrawal by Subject|3|||
149115135|NCT03248882|537899910|FG003|Overall Study|Withdrawal by Subject|4|||
149115136|NCT03248882|537899911|FG004|Overall Study|Withdrawal by Subject|2|||
149115137|NCT04308590|537899912|FG000|Overall Study|Adverse Event|12|||
149115138|NCT04308590|537899913|FG001|Overall Study|Adverse Event|2|||
149115139|NCT04308590|537899912|FG000|Overall Study|Withdrawal by Subject|10|||
149115140|NCT04308590|537899913|FG001|Overall Study|Withdrawal by Subject|4|||
149115141|NCT04308590|537899912|FG000|Overall Study|Death|1|||
149115142|NCT04308590|537899913|FG001|Overall Study|Death|0|||
149115143|NCT04308590|537899912|FG000|Overall Study|Lost to Follow-up|1|||
149115144|NCT04308590|537899913|FG001|Overall Study|Lost to Follow-up|1|||
149115145|NCT04308590|537899912|FG000|Overall Study|Physician Decision|1|||
149115146|NCT04308590|537899913|FG001|Overall Study|Physician Decision|0|||
149115147|NCT04308590|537899912|FG000|Overall Study|Subject does not want to continue with Pi|0|||
149115148|NCT04308590|537899913|FG001|Overall Study|Subject does not want to continue with Pi|1|||
149115149|NCT01156376|537899915|FG000|Overall Study|Adverse Event|1|||
149115150|NCT01156376|537899916|FG001|Overall Study|Adverse Event|0|||
149115151|NCT01156376|537899917|FG002|Overall Study|Adverse Event|1|||
149115152|NCT01156376|537899915|FG000|Overall Study|Withdrawal by Subject|0|||
149115153|NCT01156376|537899916|FG001|Overall Study|Withdrawal by Subject|0|||
149115154|NCT01156376|537899917|FG002|Overall Study|Withdrawal by Subject|3|||
149115155|NCT05487586|537899918|FG000|Overall Study|Death|22|||
149115156|NCT05487586|537899918|FG000|Overall Study|Physician Decision|1|||
149115157|NCT05487586|537899918|FG000|Overall Study|Transfer to another hospital|4|||
149115158|NCT05487586|537899918|FG000|Overall Study|Other|1|||
149115159|NCT01493427|537899919|FG000|Overall Study|Adverse Event|10|||
149115160|NCT01493427|537899919|FG000|Overall Study|Personal Reasons|4|||
149115161|NCT01493427|537899919|FG000|Overall Study|Lost to Follow-up|2|||
149115162|NCT01493427|537899919|FG000|Overall Study|Inability to Follow Instructions|2|||
149115163|NCT01493427|537899919|FG000|Overall Study|Other|2|||
149115164|NCT00565773|537899920|FG000|Overall Study|Withdrawal by Subject|1|||
149115165|NCT00565773|537899920|FG000|Overall Study|Physician Decision|1|||
149115166|NCT05775991|537899921|FG000|Overall Study|Withdrawal by Subject|0|||
149115167|NCT05775991|537899922|FG001|Overall Study|Withdrawal by Subject|0|||
149115168|NCT05775991|537899923|FG002|Overall Study|Withdrawal by Subject|2|||
149115169|NCT01075958|537899924|FG000|Overall Study|Blood sample could not be obtained|44|||
149115170|NCT01072630|537899931|FG000|Overall Study|Adverse Event|11|||
149115171|NCT01072630|537899932|FG001|Overall Study|Adverse Event|19|||
149115172|NCT01072630|537899933|FG002|Overall Study|Adverse Event|2|||
149115173|NCT01072630|537899931|FG000|Overall Study|Lack of Efficacy|10|||
149115174|NCT01072630|537899932|FG001|Overall Study|Lack of Efficacy|10|||
149115175|NCT01072630|537899933|FG002|Overall Study|Lack of Efficacy|1|||
149115176|NCT01072630|537899931|FG000|Overall Study|Withdrawal by Subject|8|||
149115177|NCT01072630|537899932|FG001|Overall Study|Withdrawal by Subject|7|||
149115178|NCT01072630|537899933|FG002|Overall Study|Withdrawal by Subject|2|||
149115179|NCT01072630|537899931|FG000|Overall Study|Protocol Violation|10|||
149115180|NCT01072630|537899932|FG001|Overall Study|Protocol Violation|8|||
149115181|NCT01072630|537899933|FG002|Overall Study|Protocol Violation|4|||
149115182|NCT01072630|537899931|FG000|Overall Study|Lost to Follow-up|11|||
149115183|NCT01072630|537899932|FG001|Overall Study|Lost to Follow-up|11|||
149115184|NCT01072630|537899933|FG002|Overall Study|Lost to Follow-up|1|||
149115185|NCT01072630|537899931|FG000|Overall Study|Noncompliance with study medication|1|||
149115186|NCT01072630|537899932|FG001|Overall Study|Noncompliance with study medication|1|||
149115187|NCT01072630|537899933|FG002|Overall Study|Noncompliance with study medication|1|||
149115188|NCT01072630|537899931|FG000|Overall Study|Noncompliance with study procedures|1|||
149115189|NCT01072630|537899932|FG001|Overall Study|Noncompliance with study procedures|2|||
149115190|NCT01072630|537899933|FG002|Overall Study|Noncompliance with study procedures|1|||
149115191|NCT01072630|537899931|FG000|Overall Study|Other|3|||
149115192|NCT01072630|537899932|FG001|Overall Study|Other|2|||
149115193|NCT01072630|537899933|FG002|Overall Study|Other|1|||
149115194|NCT02781090|537899937|FG000|3-Month Follow-Up|Missed Visit|20|||
149115195|NCT02781090|537899938|FG001|3-Month Follow-Up|Missed Visit|20|||
149115196|NCT02781090|537899937|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
149115197|NCT02781090|537899938|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
149115198|NCT02781090|537899937|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
149115199|NCT02781090|537899938|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
149115200|NCT02781090|537899937|FG000|3-Month Follow-Up|Death|1|||
149115201|NCT02781090|537899938|FG001|3-Month Follow-Up|Death|0|||
149115202|NCT02781090|537899937|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
149115203|NCT02781090|537899938|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
149115204|NCT02781090|537899937|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
149115205|NCT02781090|537899938|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
149115206|NCT02781090|537899937|FG000|6-Month Follow-Up|Death|0|||
149115207|NCT02781090|537899938|FG001|6-Month Follow-Up|Death|1|||
149115208|NCT00643617|537899939|FG000|Overall Study|Death|6|||
149115209|NCT00643617|537899940|FG001|Overall Study|Death|9|||
149115210|NCT00643617|537899939|FG000|Overall Study|Lost to Follow-up|42|||
149115211|NCT00643617|537899940|FG001|Overall Study|Lost to Follow-up|51|||
149115212|NCT02075073|537899941|FG000|Overall Study|Withdrawal by Subject|0|||
149115213|NCT02075073|537899942|FG001|Overall Study|Withdrawal by Subject|1|||
149115214|NCT02075073|537899943|FG002|Overall Study|Withdrawal by Subject|0|||
149115215|NCT02683785|537899963|FG000|Overall Study|Withdrawal by Subject|1|||
149115216|NCT02683785|537899964|FG001|Overall Study|Withdrawal by Subject|1|||
149115217|NCT02683785|537899963|FG000|Overall Study|Lost to Follow-up|0|||
149115218|NCT02683785|537899964|FG001|Overall Study|Lost to Follow-up|1|||
149115219|NCT02683785|537899963|FG000|Overall Study|Adverse Event|0|||
149115220|NCT02683785|537899964|FG001|Overall Study|Adverse Event|2|||
149115221|NCT00416195|537899965|FG000|Overall Study|Adverse Event|1|||
149115222|NCT00416195|537899966|FG001|Overall Study|Adverse Event|2|||
149115223|NCT00416195|537899965|FG000|Overall Study|Protocol Violation|1|||
149115224|NCT00416195|537899966|FG001|Overall Study|Protocol Violation|1|||
149115225|NCT00416195|537899965|FG000|Overall Study|Other|0|||
149115226|NCT00416195|537899966|FG001|Overall Study|Other|1|||
149115227|NCT01305408|537899971|FG000|Overall Study|Adverse Event|10|||
149115228|NCT01305408|537899972|FG001|Overall Study|Adverse Event|7|||
149115229|NCT01305408|537899971|FG000|Overall Study|Lack of Efficacy|3|||
149115230|NCT01305408|537899972|FG001|Overall Study|Lack of Efficacy|4|||
149115231|NCT01305408|537899971|FG000|Overall Study|Withdrawal by Subject|9|||
149115232|NCT01305408|537899972|FG001|Overall Study|Withdrawal by Subject|9|||
149115233|NCT01305408|537899971|FG000|Overall Study|Protocol Violation|4|||
149115234|NCT01305408|537899972|FG001|Overall Study|Protocol Violation|6|||
149115235|NCT01305408|537899971|FG000|Overall Study|Lost to Follow-up|5|||
149115236|NCT01305408|537899972|FG001|Overall Study|Lost to Follow-up|3|||
149115237|NCT01305408|537899971|FG000|Overall Study|Noncompliance with study medication|0|||
149115238|NCT01305408|537899972|FG001|Overall Study|Noncompliance with study medication|1|||
149115239|NCT01305408|537899971|FG000|Overall Study|Noncompliance with study procedures|0|||
149115240|NCT01305408|537899972|FG001|Overall Study|Noncompliance with study procedures|1|||
149115241|NCT01305408|537899971|FG000|Overall Study|Other|1|||
149115242|NCT01305408|537899972|FG001|Overall Study|Other|0|||
149115243|NCT03101462|537899973|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
149115244|NCT03101462|537899974|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
149115245|NCT02530970|537899976|FG000|Overall Study|Adverse Event|8|||
149115246|NCT02530970|537899976|FG000|Overall Study|Lost to Follow-up|88|||
149115247|NCT02530970|537899976|FG000|Overall Study|Physician Decision|5|||
149115248|NCT02530970|537899976|FG000|Overall Study|Withdrawal by Subject|14|||
149115249|NCT02530970|537899976|FG000|Overall Study|Death|6|||
149115250|NCT02530970|537899976|FG000|Overall Study|Hospitalization|1|||
149115251|NCT02530970|537899976|FG000|Overall Study|Insurance|2|||
149115252|NCT02530970|537899976|FG000|Overall Study|Explant|2|||
149115253|NCT02530970|537899976|FG000|Overall Study|Change in Provider|5|||
149115254|NCT02530970|537899976|FG000|Overall Study|Relocation|3|||
149115255|NCT02770612|537899980|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
149115256|NCT03846453|537899981|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
149115257|NCT03846453|537899982|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
149115258|NCT03846453|537899983|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
149115259|NCT03846453|537899981|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
149115260|NCT03846453|537899982|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
149115261|NCT03846453|537899983|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
149115262|NCT03846453|537899981|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
149115263|NCT03846453|537899982|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
149115264|NCT03846453|537899983|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
149115265|NCT03846453|537899981|FG000|Placebo Run-in (14 Days)|Other|2|||
149115266|NCT03846453|537899982|FG001|Placebo Run-in (14 Days)|Other|0|||
149115267|NCT03846453|537899983|FG002|Placebo Run-in (14 Days)|Other|0|||
149115268|NCT03846453|537899981|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
149115269|NCT03846453|537899982|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
149115270|NCT03846453|537899983|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
149115271|NCT03846453|537899981|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
149115272|NCT03846453|537899982|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
149115273|NCT03846453|537899983|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
149115274|NCT03846453|537899981|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
149115275|NCT03846453|537899982|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
149115276|NCT03846453|537899983|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
149115277|NCT03846453|537899981|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
149115278|NCT03846453|537899982|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
149115279|NCT03846453|537899983|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
149115280|NCT03846453|537899981|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
149115281|NCT03846453|537899982|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
149115282|NCT03846453|537899983|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
149115283|NCT00468143|537899984|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
149115284|NCT00468143|537899985|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
149115285|NCT00468143|537899984|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
149115286|NCT00468143|537899985|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
149115287|NCT01606670|537899986|FG000|Overall Study|Adverse Event|6|||
149115288|NCT01606670|537899986|FG000|Overall Study|Lack of Efficacy|2|||
149115289|NCT01606670|537899986|FG000|Overall Study|Lost to Follow-up|3|||
149115290|NCT01606670|537899986|FG000|Overall Study|Withdrawal by Subject|3|||
149115291|NCT01606670|537899986|FG000|Overall Study|Other Reason|2|||
149115292|NCT02636725|537899987|FG000|Overall Study|Adverse Event|1|||
149115293|NCT00368927|537899991|FG000|Overall Study|Lost to Follow-up|2|||
149115294|NCT00368927|537899992|FG001|Overall Study|Lost to Follow-up|0|||
149115295|NCT00368927|537899991|FG000|Overall Study|Adverse Event|1|||
149115296|NCT00368927|537899992|FG001|Overall Study|Adverse Event|1|||
149115297|NCT00368927|537899991|FG000|Overall Study|Withdrawal by Subject|1|||
149115298|NCT00368927|537899992|FG001|Overall Study|Withdrawal by Subject|2|||
149115299|NCT00368927|537899991|FG000|Overall Study|Physician Decision|1|||
149115300|NCT00368927|537899992|FG001|Overall Study|Physician Decision|0|||
149115301|NCT01152814|537899993|FG000|Overall Study|Lost to Follow-up|2|||
149115302|NCT00886795|537899994|FG000|Overall Study|Lack of Efficacy|1|||
149115303|NCT03284203|537899995|FG000|Overall Study|Lost to Follow-up|3|||
149115304|NCT01877239|537899998|FG000|Overall Study|Adverse Event|4|||
149115305|NCT01877239|537899998|FG000|Overall Study|Disease Remission|1|||
149115306|NCT01877239|537899998|FG000|Overall Study|Withdrawal by Subject|4|||
149115307|NCT01877239|537899998|FG000|Overall Study|Other|2|||
149115308|NCT01877239|537899998|FG000|Overall Study|Lack of Efficacy|4|||
149115309|NCT01877239|537899998|FG000|Overall Study|Data not available|35|||
149115310|NCT01669577|537900002|FG000|Overall Study|Death|22|||
149115311|NCT01669577|537900002|FG000|Overall Study|Lost to Follow-up|78|||
149115312|NCT01669577|537900002|FG000|Overall Study|Physician Decision|34|||
149115313|NCT01283516|537900003|FG000|Overall Study|Adverse Event|0|||
149115314|NCT01283516|537900004|FG001|Overall Study|Adverse Event|0|||
149115315|NCT01283516|537900005|FG002|Overall Study|Adverse Event|0|||
149115316|NCT01283516|537900006|FG003|Overall Study|Adverse Event|0|||
149115317|NCT01283516|537900007|FG004|Overall Study|Adverse Event|0|||
149115318|NCT01283516|537900008|FG005|Overall Study|Adverse Event|0|||
149115319|NCT01283516|537900009|FG006|Overall Study|Adverse Event|2|||
149115320|NCT01283516|537900010|FG007|Overall Study|Adverse Event|0|||
149115321|NCT01283516|537900011|FG008|Overall Study|Adverse Event|28|||
149115322|NCT01283516|537900003|FG000|Overall Study|Death|0|||
149115323|NCT01283516|537900004|FG001|Overall Study|Death|0|||
149115324|NCT01283516|537900005|FG002|Overall Study|Death|0|||
149115325|NCT01283516|537900006|FG003|Overall Study|Death|0|||
149115326|NCT01283516|537900007|FG004|Overall Study|Death|0|||
149115327|NCT01283516|537900008|FG005|Overall Study|Death|1|||
149115328|NCT01283516|537900009|FG006|Overall Study|Death|0|||
149115329|NCT01283516|537900010|FG007|Overall Study|Death|1|||
149115330|NCT01283516|537900011|FG008|Overall Study|Death|12|||
149115331|NCT01283516|537900003|FG000|Overall Study|Disease Progression|2|||
149115332|NCT01283516|537900004|FG001|Overall Study|Disease Progression|2|||
149115333|NCT01283516|537900005|FG002|Overall Study|Disease Progression|3|||
149115334|NCT01283516|537900006|FG003|Overall Study|Disease Progression|3|||
149115335|NCT01283516|537900007|FG004|Overall Study|Disease Progression|13|||
149115336|NCT01283516|537900008|FG005|Overall Study|Disease Progression|8|||
149115337|NCT01283516|537900009|FG006|Overall Study|Disease Progression|6|||
149115338|NCT01283516|537900010|FG007|Overall Study|Disease Progression|3|||
149115339|NCT01283516|537900011|FG008|Overall Study|Disease Progression|139|||
149115340|NCT01283516|537900003|FG000|Overall Study|Withdrawal by Subject|0|||
149115341|NCT01283516|537900004|FG001|Overall Study|Withdrawal by Subject|0|||
149115342|NCT01283516|537900005|FG002|Overall Study|Withdrawal by Subject|0|||
149115343|NCT01283516|537900006|FG003|Overall Study|Withdrawal by Subject|0|||
149115344|NCT01283516|537900007|FG004|Overall Study|Withdrawal by Subject|1|||
149115345|NCT01283516|537900008|FG005|Overall Study|Withdrawal by Subject|0|||
149115346|NCT01283516|537900009|FG006|Overall Study|Withdrawal by Subject|1|||
149115347|NCT01283516|537900010|FG007|Overall Study|Withdrawal by Subject|0|||
149115348|NCT01283516|537900011|FG008|Overall Study|Withdrawal by Subject|36|||
149115349|NCT01283516|537900003|FG000|Overall Study|Administrative problems|0|||
149115350|NCT01283516|537900004|FG001|Overall Study|Administrative problems|0|||
149115351|NCT01283516|537900005|FG002|Overall Study|Administrative problems|0|||
149115352|NCT01283516|537900006|FG003|Overall Study|Administrative problems|0|||
149115353|NCT01283516|537900007|FG004|Overall Study|Administrative problems|0|||
149115354|NCT01283516|537900008|FG005|Overall Study|Administrative problems|1|||
149115355|NCT01283516|537900009|FG006|Overall Study|Administrative problems|1|||
149115356|NCT01283516|537900010|FG007|Overall Study|Administrative problems|1|||
149115357|NCT01283516|537900011|FG008|Overall Study|Administrative problems|39|||
149115358|NCT01283516|537900003|FG000|Overall Study|Lost to Follow-up|0|||
149115359|NCT01283516|537900004|FG001|Overall Study|Lost to Follow-up|0|||
149115360|NCT01283516|537900005|FG002|Overall Study|Lost to Follow-up|0|||
149115361|NCT01283516|537900006|FG003|Overall Study|Lost to Follow-up|0|||
149115362|NCT01283516|537900007|FG004|Overall Study|Lost to Follow-up|0|||
149115363|NCT01283516|537900008|FG005|Overall Study|Lost to Follow-up|0|||
149115364|NCT01283516|537900009|FG006|Overall Study|Lost to Follow-up|0|||
149115365|NCT01283516|537900010|FG007|Overall Study|Lost to Follow-up|0|||
149115366|NCT01283516|537900011|FG008|Overall Study|Lost to Follow-up|1|||
149115367|NCT00132873|537900017|FG000|Overall Study|Adverse Event|3|||
149115368|NCT00132873|537900017|FG000|Overall Study|Lost to Follow-up|1|||
149115369|NCT00132873|537900017|FG000|Overall Study|Lack of Efficacy|1|||
149115370|NCT00132873|537900017|FG000|Overall Study|Withdrawal by Subject|3|||
149115371|NCT00132873|537900017|FG000|Overall Study|Planned Pregnancy|1|||
149115372|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
149115373|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
149115374|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
149115375|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
149115376|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
149115377|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
149115378|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
149115379|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
149115380|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
149115381|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
149115382|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Adverse Event|0|||
149115383|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Adverse Event|0|||
149115384|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Adverse Event|3|||
149115385|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Adverse Event|2|||
149115386|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Adverse Event|13|||
149115387|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
149115388|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
149115389|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
149115390|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
149115391|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
149115392|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Patient's wish|0|||
149115393|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Patient's wish|0|||
149115394|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Patient's wish|19|||
149115395|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Patient's wish|9|||
149115396|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Patient's wish|20|||
149115397|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
149115398|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
149115399|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
149115400|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
149115401|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
149115402|NCT00444275|537900018|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
149115403|NCT00444275|537900019|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
149115404|NCT00444275|537900020|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
149115405|NCT00444275|537900021|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
149115406|NCT00444275|537900022|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
149115407|NCT01204710|537900026|FG000|Randomization Treatment|Lost to Follow-up|1|||
149115408|NCT01204710|537900027|FG001|Randomization Treatment|Lost to Follow-up|0|||
149115409|NCT01204710|537900026|FG000|Randomization Treatment|Withdrawal by Subject|6|||
149115410|NCT01204710|537900027|FG001|Randomization Treatment|Withdrawal by Subject|5|||
149115411|NCT01204710|537900026|FG000|Randomization Treatment|Physician Decision|3|||
149115412|NCT01204710|537900027|FG001|Randomization Treatment|Physician Decision|2|||
149115413|NCT01204710|537900026|FG000|Randomization Treatment|Entry criteria not met|0|||
149115414|NCT01204710|537900027|FG001|Randomization Treatment|Entry criteria not met|1|||
149115415|NCT01204710|537900026|FG000|Randomization Treatment|Adverse Event|4|||
149115416|NCT01204710|537900027|FG001|Randomization Treatment|Adverse Event|2|||
149115417|NCT01204710|537900026|FG000|Randomization Treatment|Sponsor Decision|0|||
149115418|NCT01204710|537900027|FG001|Randomization Treatment|Sponsor Decision|1|||
149115419|NCT01204710|537900026|FG000|Randomization Treatment|Worsening of General condition|0|||
149115420|NCT01204710|537900027|FG001|Randomization Treatment|Worsening of General condition|1|||
149115421|NCT01204710|537900026|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
149115422|NCT01204710|537900027|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
149115423|NCT01204710|537900026|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
149115424|NCT01204710|537900027|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
149115425|NCT01204710|537900026|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
149115426|NCT01204710|537900027|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
149115427|NCT01204710|537900026|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
149115428|NCT01204710|537900027|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
149115429|NCT01896726|537900028|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
149115430|NCT01896726|537900028|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
149115431|NCT05543707|537900032|FG000|Overall Study|Study drug non-compliance/|5|||
149115432|NCT05543707|537900033|FG001|Overall Study|Study drug non-compliance/|0|||
149115433|NCT05543707|537900032|FG000|Overall Study|Withdrawal by Subject|1|||
149115434|NCT05543707|537900033|FG001|Overall Study|Withdrawal by Subject|1|||
149115435|NCT05543707|537900032|FG000|Overall Study|Adverse Event|1|||
149115436|NCT05543707|537900033|FG001|Overall Study|Adverse Event|0|||
149115437|NCT05543707|537900032|FG000|Overall Study|concurrent illness|0|||
149115438|NCT05543707|537900033|FG001|Overall Study|concurrent illness|1|||
149115439|NCT05543707|537900032|FG000|Overall Study|Pregnancy|1|||
149115440|NCT05543707|537900033|FG001|Overall Study|Pregnancy|1|||
149115441|NCT03826030|537900036|FG000|Overall Study|Withdrawal by Subject|2|||
149115442|NCT03826030|537900037|FG001|Overall Study|Withdrawal by Subject|0|||
149115443|NCT03826030|537900038|FG002|Overall Study|Withdrawal by Subject|1|||
149115444|NCT03826030|537900036|FG000|Overall Study|Lost to Follow-up|1|||
149115445|NCT03826030|537900037|FG001|Overall Study|Lost to Follow-up|1|||
149115446|NCT03826030|537900038|FG002|Overall Study|Lost to Follow-up|1|||
149115447|NCT03826030|537900036|FG000|Overall Study|Too busy to return for visits|1|||
149115448|NCT03826030|537900037|FG001|Overall Study|Too busy to return for visits|0|||
149115449|NCT03826030|537900038|FG002|Overall Study|Too busy to return for visits|0|||
149115450|NCT01967147|537902099|FG000|Overall Study|Adverse Event|5|||
149115451|NCT01967147|537902100|FG001|Overall Study|Adverse Event|2|||
149115452|NCT01967147|537902099|FG000|Overall Study|Lack of Efficacy|1|||
149115453|NCT01967147|537902100|FG001|Overall Study|Lack of Efficacy|4|||
149115454|NCT01967147|537902099|FG000|Overall Study|Lost to Follow-up|1|||
149115455|NCT01967147|537902100|FG001|Overall Study|Lost to Follow-up|2|||
149115456|NCT01967147|537902099|FG000|Overall Study|Withdrawal by Subject|2|||
149115457|NCT01967147|537902100|FG001|Overall Study|Withdrawal by Subject|4|||
149115458|NCT01967147|537902099|FG000|Overall Study|Non-compliance with Study Drug|0|||
149115459|NCT01967147|537902100|FG001|Overall Study|Non-compliance with Study Drug|3|||
149115460|NCT01967147|537902099|FG000|Overall Study|Other|4|||
149115461|NCT01967147|537902100|FG001|Overall Study|Other|5|||
149115462|NCT03843554|537902101|FG000|Overall Study|Physician Decision|0|||
149115463|NCT03843554|537902102|FG001|Overall Study|Physician Decision|2|||
149115464|NCT01099215|537902103|FG000|Overall Study|Withdrawal by Subject|1|||
149115465|NCT01099215|537902104|FG001|Overall Study|Withdrawal by Subject|0|||
149115466|NCT01099215|537902103|FG000|Overall Study|Adverse Event|0|||
149115467|NCT01099215|537902104|FG001|Overall Study|Adverse Event|1|||
149115468|NCT04396366|537902110|FG000|Overall Study|Adverse Event|1|||
149115469|NCT04396366|537902111|FG001|Overall Study|Adverse Event|0|||
149115470|NCT00166712|537902112|FG000|Overall Study|Death|0|||
149115471|NCT00166712|537902113|FG001|Overall Study|Death|1|||
149115472|NCT00166712|537902112|FG000|Overall Study|Adverse Event|1|||
149115473|NCT00166712|537902113|FG001|Overall Study|Adverse Event|0|||
149115474|NCT00166712|537902112|FG000|Overall Study|Withdrawal by Subject|1|||
149115475|NCT00166712|537902113|FG001|Overall Study|Withdrawal by Subject|2|||
149115476|NCT00166712|537902112|FG000|Overall Study|Physician Decision|0|||
149115477|NCT00166712|537902113|FG001|Overall Study|Physician Decision|2|||
149115478|NCT04684394|537902114|FG000|Overall Study|Death|1|||
149115479|NCT04684394|537902115|FG001|Overall Study|Death|2|||
149115480|NCT04684394|537902114|FG000|Overall Study|Lost to Follow-up|1|||
149115481|NCT04684394|537902115|FG001|Overall Study|Lost to Follow-up|0|||
149115482|NCT04684394|537902114|FG000|Overall Study|Withdrawal by Subject|2|||
149115483|NCT04684394|537902115|FG001|Overall Study|Withdrawal by Subject|0|||
149115484|NCT04684394|537902114|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
149115485|NCT04684394|537902115|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
149115486|NCT03986944|537902116|FG000|Overall Study|Adverse Event|1|||
149115487|NCT03986944|537902117|FG001|Overall Study|Adverse Event|2|||
149115488|NCT03986944|537902118|FG002|Overall Study|Adverse Event|3|||
149115489|NCT03986944|537902116|FG000|Overall Study|Protocol Violation|0|||
149115490|NCT03986944|537902117|FG001|Overall Study|Protocol Violation|1|||
149115491|NCT03986944|537902118|FG002|Overall Study|Protocol Violation|1|||
149115492|NCT03986944|537902116|FG000|Overall Study|Withdrawal by Subject|3|||
149115493|NCT03986944|537902117|FG001|Overall Study|Withdrawal by Subject|5|||
149115494|NCT03986944|537902118|FG002|Overall Study|Withdrawal by Subject|5|||
149115495|NCT03986944|537902116|FG000|Overall Study|Study termination|10|||
149115496|NCT03986944|537902117|FG001|Overall Study|Study termination|10|||
149115497|NCT03986944|537902118|FG002|Overall Study|Study termination|10|||
149115498|NCT03986944|537902116|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
149115499|NCT03986944|537902117|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
149115500|NCT03986944|537902118|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
149115501|NCT03986944|537902116|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
149115502|NCT03986944|537902117|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
149115503|NCT03986944|537902118|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
149115504|NCT03002220|537902120|FG000|Overall Study|Lack of Efficacy|2|||
149115505|NCT03002220|537902120|FG000|Overall Study|Withdrawal by Subject|3|||
149115506|NCT03002220|537902120|FG000|Overall Study|Adverse Event|2|||
149115507|NCT03002220|537902120|FG000|Overall Study|Disease progression|13|||
149115508|NCT03002220|537902120|FG000|Overall Study|Physician Decision|1|||
149115509|NCT01183260|537902122|FG000|Overall Study|Intraop screen failure|2|||
149115510|NCT01183260|537902123|FG001|Overall Study|Intraop screen failure|0|||
149115511|NCT01183260|537902122|FG000|Overall Study|Withdrawal by Subject|1|||
149115512|NCT01183260|537902123|FG001|Overall Study|Withdrawal by Subject|1|||
149115513|NCT01183260|537902122|FG000|Overall Study|Revised within 30 days|0|||
149115514|NCT01183260|537902123|FG001|Overall Study|Revised within 30 days|1|||
149115515|NCT01183260|537902122|FG000|Overall Study|Death|1|||
149115516|NCT01183260|537902123|FG001|Overall Study|Death|0|||
149115517|NCT01202903|537902127|FG000|Overall Study|Administrative Probelms|1|||
149115518|NCT01202903|537902128|FG001|Overall Study|Administrative Probelms|4|||
149115519|NCT01202903|537902127|FG000|Overall Study|Protocol Violation|0|||
149115520|NCT01202903|537902128|FG001|Overall Study|Protocol Violation|1|||
149115521|NCT01202903|537902127|FG000|Overall Study|Death|1|||
149115522|NCT01202903|537902128|FG001|Overall Study|Death|0|||
149115523|NCT01202903|537902127|FG000|Overall Study|Lost to Follow-up|1|||
149115524|NCT01202903|537902128|FG001|Overall Study|Lost to Follow-up|1|||
149115525|NCT01202903|537902127|FG000|Overall Study|Lack of Efficacy|1|||
149115526|NCT01202903|537902128|FG001|Overall Study|Lack of Efficacy|3|||
149115527|NCT01202903|537902127|FG000|Overall Study|Adverse Event|3|||
149115528|NCT01202903|537902128|FG001|Overall Study|Adverse Event|3|||
149115529|NCT01202903|537902127|FG000|Overall Study|Withdrawal by Subject|4|||
149115530|NCT01202903|537902128|FG001|Overall Study|Withdrawal by Subject|4|||
149115531|NCT01302080|537902129|FG000|Overall Study|Withdrew Consent|92|||
149115532|NCT01302080|537902130|FG001|Overall Study|Withdrew Consent|39|||
149115533|NCT01302080|537902129|FG000|Overall Study|Patient/Family Moved|28|||
149115534|NCT01302080|537902130|FG001|Overall Study|Patient/Family Moved|3|||
149115535|NCT01302080|537902129|FG000|Overall Study|Lost to Follow-up|192|||
149115536|NCT01302080|537902130|FG001|Overall Study|Lost to Follow-up|93|||
149115537|NCT01302080|537902129|FG000|Overall Study|Death|1|||
149115538|NCT01302080|537902130|FG001|Overall Study|Death|0|||
149115539|NCT01302080|537902129|FG000|Overall Study|Other|52|||
149115540|NCT01302080|537902130|FG001|Overall Study|Other|8|||
149115541|NCT01302080|537902129|FG000|Overall Study|Reason Missing For Discontinuation|1|||
149115542|NCT01302080|537902130|FG001|Overall Study|Reason Missing For Discontinuation|0|||
149115543|NCT01531673|537902131|FG000|Overall Study|Non-Compliance|0|||
149115544|NCT01531673|537902132|FG001|Overall Study|Non-Compliance|0|||
149115545|NCT01531673|537902133|FG002|Overall Study|Non-Compliance|0|||
149115546|NCT01531673|537902134|FG003|Overall Study|Non-Compliance|0|||
149115547|NCT01531673|537902135|FG004|Overall Study|Non-Compliance|0|||
149115548|NCT01531673|537902136|FG005|Overall Study|Non-Compliance|1|||
149115549|NCT01531673|537902137|FG006|Overall Study|Non-Compliance|0|||
149115550|NCT01531673|537902138|FG007|Overall Study|Non-Compliance|0|||
149115551|NCT01531673|537902139|FG008|Overall Study|Non-Compliance|0|||
149115552|NCT01531673|537902140|FG009|Overall Study|Non-Compliance|0|||
149115553|NCT01531673|537902141|FG010|Overall Study|Non-Compliance|0|||
149115554|NCT01531673|537902142|FG011|Overall Study|Non-Compliance|0|||
149115555|NCT01531673|537902143|FG012|Overall Study|Non-Compliance|0|||
149115556|NCT01531673|537902131|FG000|Overall Study|Adverse Event|0|||
149115557|NCT01531673|537902132|FG001|Overall Study|Adverse Event|1|||
149115558|NCT01531673|537902133|FG002|Overall Study|Adverse Event|0|||
149115559|NCT01531673|537902134|FG003|Overall Study|Adverse Event|0|||
149115560|NCT01531673|537902135|FG004|Overall Study|Adverse Event|0|||
149115561|NCT01531673|537902136|FG005|Overall Study|Adverse Event|0|||
149115562|NCT01531673|537902137|FG006|Overall Study|Adverse Event|0|||
149115563|NCT01531673|537902138|FG007|Overall Study|Adverse Event|0|||
149115564|NCT01531673|537902139|FG008|Overall Study|Adverse Event|0|||
149115565|NCT01531673|537902140|FG009|Overall Study|Adverse Event|0|||
149115566|NCT01531673|537902141|FG010|Overall Study|Adverse Event|0|||
149115567|NCT01531673|537902142|FG011|Overall Study|Adverse Event|0|||
149115568|NCT01531673|537902143|FG012|Overall Study|Adverse Event|0|||
149115569|NCT01531673|537902131|FG000|Overall Study|Lost to Follow-up|0|||
149115570|NCT01531673|537902132|FG001|Overall Study|Lost to Follow-up|0|||
149115571|NCT01531673|537902133|FG002|Overall Study|Lost to Follow-up|0|||
149115572|NCT01531673|537902134|FG003|Overall Study|Lost to Follow-up|0|||
149115573|NCT01531673|537902135|FG004|Overall Study|Lost to Follow-up|1|||
149115574|NCT01531673|537902136|FG005|Overall Study|Lost to Follow-up|0|||
149115575|NCT01531673|537902137|FG006|Overall Study|Lost to Follow-up|0|||
149115576|NCT01531673|537902138|FG007|Overall Study|Lost to Follow-up|0|||
149115577|NCT01531673|537902139|FG008|Overall Study|Lost to Follow-up|0|||
149115578|NCT01531673|537902140|FG009|Overall Study|Lost to Follow-up|0|||
149115579|NCT01531673|537902141|FG010|Overall Study|Lost to Follow-up|0|||
149115580|NCT01531673|537902142|FG011|Overall Study|Lost to Follow-up|0|||
149115581|NCT01531673|537902143|FG012|Overall Study|Lost to Follow-up|0|||
149115582|NCT01531673|537902131|FG000|Overall Study|Other|0|||
149115583|NCT01531673|537902132|FG001|Overall Study|Other|0|||
149115584|NCT01531673|537902133|FG002|Overall Study|Other|0|||
149115585|NCT01531673|537902134|FG003|Overall Study|Other|1|||
149115586|NCT01531673|537902135|FG004|Overall Study|Other|0|||
149115587|NCT01531673|537902136|FG005|Overall Study|Other|0|||
149115588|NCT01531673|537902137|FG006|Overall Study|Other|0|||
149115589|NCT01531673|537902138|FG007|Overall Study|Other|0|||
149115590|NCT01531673|537902139|FG008|Overall Study|Other|0|||
149115591|NCT01531673|537902140|FG009|Overall Study|Other|1|||
149115592|NCT01531673|537902141|FG010|Overall Study|Other|0|||
149115593|NCT01531673|537902142|FG011|Overall Study|Other|0|||
149115594|NCT01531673|537902143|FG012|Overall Study|Other|0|||
149115595|NCT00297427|537902160|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
149115596|NCT00297427|537902161|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
149115597|NCT00297427|537902160|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
149115598|NCT00297427|537902161|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
149115599|NCT00297427|537902160|FG000|Phase 1: Initial Intervention|Death|0|||
149115600|NCT00297427|537902161|FG001|Phase 1: Initial Intervention|Death|1|||
149115601|NCT00297427|537902160|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
149115602|NCT00297427|537902161|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
149115603|NCT00297427|537902160|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
149115604|NCT00297427|537902161|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
149115605|NCT00297427|537902160|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
149115606|NCT00297427|537902161|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
149115607|NCT00297427|537902160|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
149115608|NCT00297427|537902161|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
149115609|NCT00297427|537902160|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
149115610|NCT00297427|537902161|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
149115611|NCT01127893|537902162|FG000|Overall Study|Study Termination by the Sponsor|1|||
149115612|NCT01262677|537902163|FG000|Overall Study|Does not meet entrance criteria|0|||
149115613|NCT01262677|537902164|FG001|Overall Study|Does not meet entrance criteria|2|||
149115614|NCT01262677|537902165|FG002|Overall Study|Does not meet entrance criteria|0|||
149115615|NCT01262677|537902163|FG000|Overall Study|Insufficient clinical response|0|||
149115616|NCT01262677|537902164|FG001|Overall Study|Insufficient clinical response|0|||
149115617|NCT01262677|537902165|FG002|Overall Study|Insufficient clinical response|1|||
149115618|NCT01262677|537902163|FG000|Overall Study|Lost to Follow-up|1|||
149115619|NCT01262677|537902164|FG001|Overall Study|Lost to Follow-up|0|||
149115620|NCT01262677|537902165|FG002|Overall Study|Lost to Follow-up|2|||
149115621|NCT01262677|537902163|FG000|Overall Study|No longer willing to participate|3|||
149115622|NCT01262677|537902164|FG001|Overall Study|No longer willing to participate|3|||
149115623|NCT01262677|537902165|FG002|Overall Study|No longer willing to participate|2|||
149115624|NCT01262677|537902163|FG000|Overall Study|Reason not provided|2|||
149115625|NCT01262677|537902164|FG001|Overall Study|Reason not provided|1|||
149115626|NCT01262677|537902165|FG002|Overall Study|Reason not provided|3|||
149115627|NCT01262677|537902163|FG000|Overall Study|Protocol Violation|0|||
149115628|NCT01262677|537902164|FG001|Overall Study|Protocol Violation|1|||
149115629|NCT01262677|537902165|FG002|Overall Study|Protocol Violation|1|||
149115630|NCT01262677|537902163|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
149115631|NCT01262677|537902164|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
149115632|NCT01262677|537902165|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
149115633|NCT01638429|537902178|FG000|Overall Study|Withdrawal by Subject|1|||
149115634|NCT01470001|537902179|FG000|Overall Study|Lost to Follow-up|1|||
149115635|NCT01470001|537902180|FG001|Overall Study|Lost to Follow-up|1|||
149115636|NCT01470001|537902179|FG000|Overall Study|Physician Decision|2|||
149115637|NCT01470001|537902180|FG001|Overall Study|Physician Decision|0|||
149115638|NCT01470001|537902179|FG000|Overall Study|Withdrawal by Subject|2|||
149115639|NCT01470001|537902180|FG001|Overall Study|Withdrawal by Subject|1|||
149115640|NCT03268603|537902181|FG000|Overall Study|Withdrawal by Subject|6|||
149115641|NCT03268603|537902181|FG000|Overall Study|Physician Decision|1|||
149115642|NCT03268603|537902181|FG000|Overall Study|Withdrawn due to disease progression|2|||
149115643|NCT02060370|537902187|FG000|Overall Study|Physician Decision|1|||
149115644|NCT01896557|537902188|FG000|Clopidogrel Alone|Adverse Event|1|||
149115645|NCT01896557|537902189|FG001|Clopidogrel Alone|Adverse Event|0|||
149115646|NCT01896557|537902188|FG000|Clopidogrel + GI Protector|low adherence|1|||
149115647|NCT01896557|537902189|FG001|Clopidogrel + GI Protector|low adherence|1|||
149115648|NCT01896557|537902188|FG000|Clopidogrel + GI Protector|Reading error|1|||
149115649|NCT01896557|537902189|FG001|Clopidogrel + GI Protector|Reading error|3|||
149115650|NCT04939701|537902190|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
149115651|NCT04939701|537902191|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
149115652|NCT04939701|537902192|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
149115653|NCT04939701|537902190|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
149115654|NCT04939701|537902191|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
149115655|NCT04939701|537902192|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
149115656|NCT04939701|537902190|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
149115657|NCT04939701|537902191|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
149115658|NCT04939701|537902192|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
149115659|NCT04939701|537902190|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
149115660|NCT04939701|537902191|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
149115661|NCT04939701|537902192|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
149115662|NCT04939701|537902190|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
149115663|NCT04939701|537902191|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
149115664|NCT04939701|537902192|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
149115665|NCT04939701|537902190|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
149115666|NCT04939701|537902191|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
149115667|NCT04939701|537902192|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
149115668|NCT04939701|537902190|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
149115669|NCT04939701|537902191|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
149115670|NCT04939701|537902192|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
149115671|NCT02182947|537902197|FG000|Overall Study|Withdrawal by Subject|7|||
149115672|NCT02182947|537902197|FG000|Overall Study|Lost to Follow-up|3|||
149115673|NCT02182947|537902197|FG000|Overall Study|Failed screening activities|8|||
149115674|NCT00356408|537902198|FG000|Overall Study|Adverse Event|9|||
149115675|NCT00356408|537902198|FG000|Overall Study|Lack of Efficacy|36|||
149115676|NCT00356408|537902198|FG000|Overall Study|Lost to Follow-up|2|||
149115677|NCT00356408|537902198|FG000|Overall Study|Withdrawal by Subject|6|||
149115678|NCT00356408|537902198|FG000|Overall Study|Other: Principal investigator discretion|3|||
149115679|NCT00356408|537902198|FG000|Overall Study|Other: Sponsor request|1|||
149115680|NCT00356408|537902198|FG000|Overall Study|Other: Azathioprine stopped|1|||
149115681|NCT00356408|537902198|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
149115682|NCT00356408|537902198|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
149115683|NCT02233803|537902200|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
149115684|NCT02233803|537902201|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
149115685|NCT02233803|537902200|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
149115686|NCT02233803|537902201|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
149115687|NCT02233803|537902200|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
149115688|NCT02233803|537902201|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
149115689|NCT02233803|537902200|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
149115690|NCT02233803|537902201|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
149115691|NCT02233803|537902200|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
149115692|NCT02233803|537902201|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
149115693|NCT02233803|537902200|FG000|Washout Period (4-Wks)|Physician Decision|1|||
149115694|NCT02233803|537902201|FG001|Washout Period (4-Wks)|Physician Decision|0|||
149115695|NCT02233803|537902200|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
149115696|NCT02233803|537902201|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
149115697|NCT02233803|537902200|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
149115698|NCT02233803|537902201|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
149115699|NCT02233803|537902200|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
149115700|NCT02233803|537902201|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
149115701|NCT03653208|537902204|FG000|Overall Study|Withdrawal by Subject|0|||
149115702|NCT03653208|537902205|FG001|Overall Study|Withdrawal by Subject|0|||
149115703|NCT03653208|537902206|FG002|Overall Study|Withdrawal by Subject|0|||
149115704|NCT03653208|537902207|FG003|Overall Study|Withdrawal by Subject|0|||
149115705|NCT03653208|537902208|FG004|Overall Study|Withdrawal by Subject|1|||
149115706|NCT03653208|537902209|FG005|Overall Study|Withdrawal by Subject|0|||
149115707|NCT03653208|537902210|FG006|Overall Study|Withdrawal by Subject|0|||
149115708|NCT03653208|537902211|FG007|Overall Study|Withdrawal by Subject|1|||
149115709|NCT03653208|537902212|FG008|Overall Study|Withdrawal by Subject|1|||
149115710|NCT04662931|537902215|FG000|Overall Study|Withdrawal by Subject|17|||
149115711|NCT04662931|537902215|FG000|Overall Study|Death|3|||
149115712|NCT04662931|537902215|FG000|Overall Study|Lost to Follow-up|3|||
149115713|NCT04662931|537902215|FG000|Overall Study|Guardian Decision|1|||
149115714|NCT02406677|537902216|FG000|Overall Study|Death|16|||
149115715|NCT02406677|537902217|FG001|Overall Study|Death|8|||
149115716|NCT02406677|537902216|FG000|Overall Study|Discharged without P2Y12|1|||
149115717|NCT02406677|537902217|FG001|Overall Study|Discharged without P2Y12|3|||
149115718|NCT02406677|537902216|FG000|Overall Study|Discharged on prasugrel|283|||
149115719|NCT02406677|537902217|FG001|Overall Study|Discharged on prasugrel|587|||
149115720|NCT02406677|537902216|FG000|Overall Study|Withdrawal by Subject|1|||
149115721|NCT02406677|537902217|FG001|Overall Study|Withdrawal by Subject|0|||
149115722|NCT01114880|537902218|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
149115723|NCT01114880|537902219|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
149115724|NCT01114880|537902218|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
149115725|NCT01114880|537902219|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
149115726|NCT01114880|537902218|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
149115727|NCT01114880|537902219|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
149115728|NCT01114880|537902218|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
149115729|NCT01114880|537902219|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
149115730|NCT01114880|537902218|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
149115731|NCT01114880|537902219|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
149115732|NCT01114880|537902218|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
149115733|NCT01114880|537902219|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
149115734|NCT04531904|537902222|FG000|Overall Study|Lost to Follow-up|1|||
149115735|NCT04531904|537902222|FG000|Overall Study|Death|14|||
149115736|NCT04531098|537902223|FG000|Stage I|Adverse Event|0|||
149115737|NCT04531098|537902224|FG001|Stage I|Adverse Event|0|||
149115738|NCT04531098|537902225|FG002|Stage I|Adverse Event|3|||
149115739|NCT04531098|537902223|FG000|Stage I|Protocol Violation|0|||
149115740|NCT04531098|537902224|FG001|Stage I|Protocol Violation|0|||
149115741|NCT04531098|537902225|FG002|Stage I|Protocol Violation|5|||
149115742|NCT04531098|537902223|FG000|Stage I|Withdrawal by Subject|0|||
149115743|NCT04531098|537902224|FG001|Stage I|Withdrawal by Subject|5|||
149115744|NCT04531098|537902225|FG002|Stage I|Withdrawal by Subject|10|||
149115745|NCT04531098|537902223|FG000|Stage II|Adverse Event|1|||
149115746|NCT04531098|537902224|FG001|Stage II|Adverse Event|2|||
149115747|NCT04531098|537902225|FG002|Stage II|Adverse Event|0|||
149115748|NCT04531098|537902223|FG000|Stage II|Protocol Violation|1|||
149115749|NCT04531098|537902224|FG001|Stage II|Protocol Violation|2|||
149115750|NCT04531098|537902225|FG002|Stage II|Protocol Violation|0|||
149115751|NCT04531098|537902223|FG000|Stage II|Withdrawal by Subject|3|||
149115752|NCT04531098|537902224|FG001|Stage II|Withdrawal by Subject|1|||
149115753|NCT04531098|537902225|FG002|Stage II|Withdrawal by Subject|0|||
149115754|NCT04531098|537902223|FG000|Stage II|Moved from study area|8|||
149115755|NCT04531098|537902224|FG001|Stage II|Moved from study area|5|||
149115756|NCT04531098|537902225|FG002|Stage II|Moved from study area|0|||
149115757|NCT00283244|537902226|FG000|Overall Study|Adverse Event|0|||
149115758|NCT00283244|537902227|FG001|Overall Study|Adverse Event|8|||
149115759|NCT00283244|537902228|FG002|Overall Study|Adverse Event|11|||
149115760|NCT00283244|537902226|FG000|Overall Study|Death|4|||
149115761|NCT00283244|537902227|FG001|Overall Study|Death|3|||
149115762|NCT00283244|537902228|FG002|Overall Study|Death|2|||
149115763|NCT00283244|537902226|FG000|Overall Study|Lack of Efficacy|8|||
149115764|NCT00283244|537902227|FG001|Overall Study|Lack of Efficacy|32|||
149115765|NCT00283244|537902228|FG002|Overall Study|Lack of Efficacy|26|||
149115766|NCT00283244|537902226|FG000|Overall Study|Withdrawal by Subject|1|||
149115767|NCT00283244|537902227|FG001|Overall Study|Withdrawal by Subject|2|||
149115768|NCT00283244|537902228|FG002|Overall Study|Withdrawal by Subject|2|||
149115769|NCT00283244|537902226|FG000|Overall Study|Physician Decision|0|||
149115770|NCT00283244|537902227|FG001|Overall Study|Physician Decision|0|||
149115771|NCT00283244|537902228|FG002|Overall Study|Physician Decision|1|||
149115772|NCT00283244|537902226|FG000|Overall Study|Medical illness (other complicating dz)|4|||
149115773|NCT00283244|537902227|FG001|Overall Study|Medical illness (other complicating dz)|3|||
149115774|NCT00283244|537902228|FG002|Overall Study|Medical illness (other complicating dz)|6|||
149115775|NCT00283244|537902226|FG000|Overall Study|Clinical deterioration|1|||
149115776|NCT00283244|537902227|FG001|Overall Study|Clinical deterioration|3|||
149115777|NCT00283244|537902228|FG002|Overall Study|Clinical deterioration|3|||
149115778|NCT02628028|537902229|FG000|Dosing Period|Withdrawal by Subject|0|||
149115779|NCT02628028|537902230|FG001|Dosing Period|Withdrawal by Subject|0|||
149115780|NCT02628028|537902231|FG002|Dosing Period|Withdrawal by Subject|1|||
149115781|NCT02628028|537902232|FG003|Dosing Period|Withdrawal by Subject|0|||
149115782|NCT02628028|537902233|FG004|Dosing Period|Withdrawal by Subject|2|||
149115783|NCT02628028|537902234|FG005|Dosing Period|Withdrawal by Subject|4|||
149115784|NCT02628028|537902235|FG006|Dosing Period|Withdrawal by Subject|1|||
149115785|NCT02628028|537902236|FG007|Dosing Period|Withdrawal by Subject|1|||
149115786|NCT02628028|537902229|FG000|Dosing Period|Adverse Event|0|||
149115787|NCT02628028|537902230|FG001|Dosing Period|Adverse Event|0|||
149115788|NCT02628028|537902231|FG002|Dosing Period|Adverse Event|0|||
149115789|NCT02628028|537902232|FG003|Dosing Period|Adverse Event|0|||
149115790|NCT02628028|537902233|FG004|Dosing Period|Adverse Event|2|||
149115791|NCT02628028|537902234|FG005|Dosing Period|Adverse Event|1|||
149115792|NCT02628028|537902235|FG006|Dosing Period|Adverse Event|3|||
149115793|NCT02628028|537902236|FG007|Dosing Period|Adverse Event|2|||
149115794|NCT02628028|537902229|FG000|Dosing Period|Death|0|||
149115795|NCT02628028|537902230|FG001|Dosing Period|Death|0|||
149115796|NCT02628028|537902231|FG002|Dosing Period|Death|0|||
149115797|NCT02628028|537902232|FG003|Dosing Period|Death|0|||
149115798|NCT02628028|537902233|FG004|Dosing Period|Death|0|||
149115799|NCT02628028|537902234|FG005|Dosing Period|Death|0|||
149115800|NCT02628028|537902235|FG006|Dosing Period|Death|0|||
149115801|NCT02628028|537902236|FG007|Dosing Period|Death|1|||
149115802|NCT02628028|537902229|FG000|Dosing Period|Lack of Efficacy|0|||
149115803|NCT02628028|537902230|FG001|Dosing Period|Lack of Efficacy|0|||
149115804|NCT02628028|537902231|FG002|Dosing Period|Lack of Efficacy|0|||
149115805|NCT02628028|537902232|FG003|Dosing Period|Lack of Efficacy|0|||
149115806|NCT02628028|537902233|FG004|Dosing Period|Lack of Efficacy|3|||
149115807|NCT02628028|537902234|FG005|Dosing Period|Lack of Efficacy|0|||
149115808|NCT02628028|537902235|FG006|Dosing Period|Lack of Efficacy|1|||
149115809|NCT02628028|537902236|FG007|Dosing Period|Lack of Efficacy|0|||
149115810|NCT02628028|537902229|FG000|Dosing Period|Study Terminated by Sponsor|0|||
149115811|NCT02628028|537902230|FG001|Dosing Period|Study Terminated by Sponsor|0|||
149115812|NCT02628028|537902231|FG002|Dosing Period|Study Terminated by Sponsor|0|||
149115813|NCT02628028|537902232|FG003|Dosing Period|Study Terminated by Sponsor|0|||
149115814|NCT02628028|537902233|FG004|Dosing Period|Study Terminated by Sponsor|7|||
149115815|NCT02628028|537902234|FG005|Dosing Period|Study Terminated by Sponsor|6|||
149115816|NCT02628028|537902235|FG006|Dosing Period|Study Terminated by Sponsor|7|||
149115817|NCT02628028|537902236|FG007|Dosing Period|Study Terminated by Sponsor|7|||
149115818|NCT02628028|537902229|FG000|Dosing Period|Physician Decision|0|||
149115819|NCT02628028|537902230|FG001|Dosing Period|Physician Decision|0|||
149115820|NCT02628028|537902231|FG002|Dosing Period|Physician Decision|0|||
149115821|NCT02628028|537902232|FG003|Dosing Period|Physician Decision|0|||
149115822|NCT02628028|537902233|FG004|Dosing Period|Physician Decision|0|||
149115823|NCT02628028|537902234|FG005|Dosing Period|Physician Decision|1|||
149115824|NCT02628028|537902235|FG006|Dosing Period|Physician Decision|0|||
149115825|NCT02628028|537902236|FG007|Dosing Period|Physician Decision|0|||
149115826|NCT02628028|537902229|FG000|Dosing Period|Site Terminated by Sponsor|0|||
149115827|NCT02628028|537902230|FG001|Dosing Period|Site Terminated by Sponsor|0|||
149115828|NCT02628028|537902231|FG002|Dosing Period|Site Terminated by Sponsor|0|||
149115829|NCT02628028|537902232|FG003|Dosing Period|Site Terminated by Sponsor|0|||
149115830|NCT02628028|537902233|FG004|Dosing Period|Site Terminated by Sponsor|0|||
149115831|NCT02628028|537902234|FG005|Dosing Period|Site Terminated by Sponsor|1|||
149115832|NCT02628028|537902235|FG006|Dosing Period|Site Terminated by Sponsor|1|||
149115833|NCT02628028|537902236|FG007|Dosing Period|Site Terminated by Sponsor|0|||
149115834|NCT02628028|537902229|FG000|Dosing Period|Lost to Follow-up|0|||
149115835|NCT02628028|537902230|FG001|Dosing Period|Lost to Follow-up|0|||
149115836|NCT02628028|537902231|FG002|Dosing Period|Lost to Follow-up|0|||
149115837|NCT02628028|537902232|FG003|Dosing Period|Lost to Follow-up|0|||
149115838|NCT02628028|537902233|FG004|Dosing Period|Lost to Follow-up|0|||
149115839|NCT02628028|537902234|FG005|Dosing Period|Lost to Follow-up|0|||
149115840|NCT02628028|537902235|FG006|Dosing Period|Lost to Follow-up|1|||
149115841|NCT02628028|537902236|FG007|Dosing Period|Lost to Follow-up|0|||
149115842|NCT02628028|537902229|FG000|Dosing Period|Other|0|||
149115843|NCT02628028|537902230|FG001|Dosing Period|Other|0|||
149115844|NCT02628028|537902231|FG002|Dosing Period|Other|0|||
149115845|NCT02628028|537902232|FG003|Dosing Period|Other|0|||
149115846|NCT02628028|537902233|FG004|Dosing Period|Other|2|||
149115847|NCT02628028|537902234|FG005|Dosing Period|Other|1|||
149115848|NCT02628028|537902235|FG006|Dosing Period|Other|2|||
149115849|NCT02628028|537902236|FG007|Dosing Period|Other|4|||
149115850|NCT02628028|537902229|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
149115851|NCT02628028|537902230|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
149115852|NCT02628028|537902231|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
149115853|NCT02628028|537902232|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
149115854|NCT02628028|537902233|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
149115855|NCT02628028|537902234|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
149115856|NCT02628028|537902235|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
149115857|NCT02628028|537902236|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
149115858|NCT02628028|537902229|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
149115859|NCT02628028|537902230|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
149115860|NCT02628028|537902231|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
149115861|NCT02628028|537902232|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
149115862|NCT02628028|537902233|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
149115863|NCT02628028|537902234|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
149115864|NCT02628028|537902235|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
149115865|NCT02628028|537902236|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
149115866|NCT02628028|537902229|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
149115867|NCT02628028|537902230|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
149115868|NCT02628028|537902231|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
149115869|NCT02628028|537902232|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
149115870|NCT02628028|537902233|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
149115871|NCT02628028|537902234|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
149115872|NCT02628028|537902235|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
149115873|NCT02628028|537902236|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
149115874|NCT02628028|537902229|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
149115875|NCT02628028|537902230|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
149115876|NCT02628028|537902231|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
149115877|NCT02628028|537902232|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
149115878|NCT02628028|537902233|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
149115879|NCT02628028|537902234|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
149115880|NCT02628028|537902235|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
149115881|NCT02628028|537902236|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
149115882|NCT02628028|537902229|FG000|Long-term Extension (LTE) Period|Other|0|||
149115883|NCT02628028|537902230|FG001|Long-term Extension (LTE) Period|Other|0|||
149115884|NCT02628028|537902231|FG002|Long-term Extension (LTE) Period|Other|0|||
149115885|NCT02628028|537902232|FG003|Long-term Extension (LTE) Period|Other|0|||
149115886|NCT02628028|537902233|FG004|Long-term Extension (LTE) Period|Other|0|||
149115887|NCT02628028|537902234|FG005|Long-term Extension (LTE) Period|Other|3|||
149115888|NCT02628028|537902235|FG006|Long-term Extension (LTE) Period|Other|4|||
149115889|NCT02628028|537902236|FG007|Long-term Extension (LTE) Period|Other|3|||
149115890|NCT03519997|537902239|FG000|Overall Study|Adverse Event|4|||
149115891|NCT03519997|537902239|FG000|Overall Study|Withdrawal by Subject|2|||
149115892|NCT03519997|537902239|FG000|Overall Study|Protocol Violation|1|||
149115893|NCT03361605|537902240|FG000|Overall Study|Analyzable data not available|3|||
149115894|NCT00186888|537902241|FG000|Overall Study|Toxicity|0|||
149115895|NCT00186888|537902242|FG001|Overall Study|Toxicity|1|||
149115896|NCT00186888|537902243|FG002|Overall Study|Toxicity|0|||
149115897|NCT00186888|537902241|FG000|Overall Study|Relapse or progression of disease|4|||
149115898|NCT00186888|537902242|FG001|Overall Study|Relapse or progression of disease|2|||
149115899|NCT00186888|537902243|FG002|Overall Study|Relapse or progression of disease|0|||
149115900|NCT02108964|537902244|FG000|Overall Study|Progressive disease|15|||
149115901|NCT02108964|537902245|FG001|Overall Study|Progressive disease|31|||
149115902|NCT02108964|537902246|FG002|Overall Study|Progressive disease|54|||
149115903|NCT02108964|537902247|FG003|Overall Study|Progressive disease|7|||
149115904|NCT02108964|537902248|FG004|Overall Study|Progressive disease|20|||
149115905|NCT02108964|537902249|FG005|Overall Study|Progressive disease|4|||
149115906|NCT02108964|537902250|FG006|Overall Study|Progressive disease|6|||
149115907|NCT02108964|537902251|FG007|Overall Study|Progressive disease|33|||
149115908|NCT02108964|537902244|FG000|Overall Study|Physician Decision|1|||
149115909|NCT02108964|537902245|FG001|Overall Study|Physician Decision|5|||
149115910|NCT02108964|537902246|FG002|Overall Study|Physician Decision|7|||
149115911|NCT02108964|537902247|FG003|Overall Study|Physician Decision|1|||
149115912|NCT02108964|537902248|FG004|Overall Study|Physician Decision|2|||
149115913|NCT02108964|537902249|FG005|Overall Study|Physician Decision|1|||
149115914|NCT02108964|537902250|FG006|Overall Study|Physician Decision|1|||
149115915|NCT02108964|537902251|FG007|Overall Study|Physician Decision|3|||
149115916|NCT02108964|537902244|FG000|Overall Study|Adverse Event|0|||
149115917|NCT02108964|537902245|FG001|Overall Study|Adverse Event|0|||
149115918|NCT02108964|537902246|FG002|Overall Study|Adverse Event|4|||
149115919|NCT02108964|537902247|FG003|Overall Study|Adverse Event|0|||
149115920|NCT02108964|537902248|FG004|Overall Study|Adverse Event|1|||
149115921|NCT02108964|537902249|FG005|Overall Study|Adverse Event|0|||
149115922|NCT02108964|537902250|FG006|Overall Study|Adverse Event|3|||
149115923|NCT02108964|537902251|FG007|Overall Study|Adverse Event|2|||
149115924|NCT02108964|537902244|FG000|Overall Study|Death|1|||
149115925|NCT02108964|537902245|FG001|Overall Study|Death|1|||
149115926|NCT02108964|537902246|FG002|Overall Study|Death|4|||
149115927|NCT02108964|537902247|FG003|Overall Study|Death|0|||
149115928|NCT02108964|537902248|FG004|Overall Study|Death|3|||
149115929|NCT02108964|537902249|FG005|Overall Study|Death|0|||
149115930|NCT02108964|537902250|FG006|Overall Study|Death|0|||
149115931|NCT02108964|537902251|FG007|Overall Study|Death|2|||
149115932|NCT02108964|537902244|FG000|Overall Study|Subject/Guardian decision|0|||
149115933|NCT02108964|537902245|FG001|Overall Study|Subject/Guardian decision|1|||
149115934|NCT02108964|537902246|FG002|Overall Study|Subject/Guardian decision|4|||
149115935|NCT02108964|537902247|FG003|Overall Study|Subject/Guardian decision|0|||
149115936|NCT02108964|537902248|FG004|Overall Study|Subject/Guardian decision|2|||
149115937|NCT02108964|537902249|FG005|Overall Study|Subject/Guardian decision|0|||
149115938|NCT02108964|537902250|FG006|Overall Study|Subject/Guardian decision|1|||
149115939|NCT02108964|537902251|FG007|Overall Study|Subject/Guardian decision|2|||
149115940|NCT02108964|537902244|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115941|NCT02108964|537902245|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115942|NCT02108964|537902246|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115943|NCT02108964|537902247|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115944|NCT02108964|537902248|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115945|NCT02108964|537902249|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115946|NCT02108964|537902250|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
149115947|NCT02108964|537902251|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
149115948|NCT03006848|537902252|FG000|Overall Study|Adverse Event|1|||
149115949|NCT03006848|537902252|FG000|Overall Study|Physician Decision|1|||
149115950|NCT03006848|537902252|FG000|Overall Study|Lack of Efficacy|16|||
149115951|NCT04372121|537902253|FG000|Overall Study|Lost to Follow-up|0|||
149115952|NCT04372121|537902254|FG001|Overall Study|Lost to Follow-up|0|||
149115953|NCT04372121|537902255|FG002|Overall Study|Lost to Follow-up|0|||
149115954|NCT04372121|537902256|FG003|Overall Study|Lost to Follow-up|1|||
149115955|NCT04372121|537902253|FG000|Overall Study|Protocol Violation|0|||
149115956|NCT04372121|537902254|FG001|Overall Study|Protocol Violation|0|||
149115957|NCT04372121|537902255|FG002|Overall Study|Protocol Violation|1|||
149115958|NCT04372121|537902256|FG003|Overall Study|Protocol Violation|0|||
149115959|NCT04372121|537902253|FG000|Overall Study|Withdrawal by Subject|3|||
149115960|NCT04372121|537902254|FG001|Overall Study|Withdrawal by Subject|1|||
149115961|NCT04372121|537902255|FG002|Overall Study|Withdrawal by Subject|0|||
149115962|NCT04372121|537902256|FG003|Overall Study|Withdrawal by Subject|0|||
149115963|NCT04372121|537902253|FG000|Overall Study|Study termination|6|||
149115964|NCT04372121|537902254|FG001|Overall Study|Study termination|5|||
149115965|NCT04372121|537902255|FG002|Overall Study|Study termination|1|||
149115966|NCT04372121|537902256|FG003|Overall Study|Study termination|1|||
149115967|NCT04372121|537902253|FG000|Overall Study|Hysterectomy planned|1|||
149115968|NCT04372121|537902254|FG001|Overall Study|Hysterectomy planned|0|||
149115969|NCT04372121|537902255|FG002|Overall Study|Hysterectomy planned|0|||
149115970|NCT04372121|537902256|FG003|Overall Study|Hysterectomy planned|0|||
149115971|NCT03820947|537902259|FG000|Overall Study|Physician Decision|0|||
149115972|NCT03820947|537902260|FG001|Overall Study|Physician Decision|1|||
149115973|NCT03820947|537902261|FG002|Overall Study|Physician Decision|1|||
149115974|NCT03820947|537902262|FG003|Overall Study|Physician Decision|0|||
149115975|NCT03820947|537902263|FG004|Overall Study|Physician Decision|3|||
149115976|NCT03820947|537902259|FG000|Overall Study|Withdrawal by Subject|6|||
149115977|NCT03820947|537902260|FG001|Overall Study|Withdrawal by Subject|10|||
149115978|NCT03820947|537902261|FG002|Overall Study|Withdrawal by Subject|3|||
149115979|NCT03820947|537902262|FG003|Overall Study|Withdrawal by Subject|8|||
149115980|NCT03820947|537902263|FG004|Overall Study|Withdrawal by Subject|5|||
149115981|NCT03820947|537902259|FG000|Overall Study|Procedure Not Attempted|0|||
149115982|NCT03820947|537902260|FG001|Overall Study|Procedure Not Attempted|2|||
149115983|NCT03820947|537902261|FG002|Overall Study|Procedure Not Attempted|1|||
149115984|NCT03820947|537902262|FG003|Overall Study|Procedure Not Attempted|0|||
149115985|NCT03820947|537902263|FG004|Overall Study|Procedure Not Attempted|0|||
149115986|NCT03820947|537902259|FG000|Overall Study|Other Exit|1|||
149115987|NCT03820947|537902260|FG001|Overall Study|Other Exit|3|||
149115988|NCT03820947|537902261|FG002|Overall Study|Other Exit|3|||
149115989|NCT03820947|537902262|FG003|Overall Study|Other Exit|3|||
149115990|NCT03820947|537902263|FG004|Overall Study|Other Exit|0|||
149115991|NCT03820947|537902259|FG000|Overall Study|Follow-up Not Done|10|||
149115992|NCT03820947|537902260|FG001|Overall Study|Follow-up Not Done|13|||
149115993|NCT03820947|537902261|FG002|Overall Study|Follow-up Not Done|2|||
149115994|NCT03820947|537902262|FG003|Overall Study|Follow-up Not Done|3|||
149115995|NCT03820947|537902263|FG004|Overall Study|Follow-up Not Done|12|||
149115996|NCT03820947|537902259|FG000|Overall Study|Death|0|||
149115997|NCT03820947|537902260|FG001|Overall Study|Death|0|||
149115998|NCT03820947|537902261|FG002|Overall Study|Death|0|||
149115999|NCT03820947|537902262|FG003|Overall Study|Death|0|||
149116000|NCT03820947|537902263|FG004|Overall Study|Death|9|||
149116001|NCT03820947|537902259|FG000|Overall Study|Lost to Follow-up|4|||
149116002|NCT03820947|537902260|FG001|Overall Study|Lost to Follow-up|6|||
149116003|NCT03820947|537902261|FG002|Overall Study|Lost to Follow-up|0|||
149116004|NCT03820947|537902262|FG003|Overall Study|Lost to Follow-up|0|||
149116005|NCT03820947|537902263|FG004|Overall Study|Lost to Follow-up|9|||
149116006|NCT02218606|537904073|FG000|Overall Study|Adverse Event|1|||
149116007|NCT02218606|537904074|FG001|Overall Study|Adverse Event|1|||
149116008|NCT02218606|537904073|FG000|Overall Study|Death|15|||
149116009|NCT02218606|537904074|FG001|Overall Study|Death|28|||
149116010|NCT02218606|537904073|FG000|Overall Study|Physician Decision|0|||
149116011|NCT02218606|537904074|FG001|Overall Study|Physician Decision|1|||
149116012|NCT02218606|537904073|FG000|Overall Study|Withdrawal by Subject|4|||
149116013|NCT02218606|537904074|FG001|Overall Study|Withdrawal by Subject|0|||
149116014|NCT02218606|537904073|FG000|Overall Study|Noncompliance|1|||
149116015|NCT02218606|537904074|FG001|Overall Study|Noncompliance|0|||
149116016|NCT02218606|537904073|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
149116017|NCT02218606|537904074|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
149116018|NCT02218606|537904073|FG000|Overall Study|Other|2|||
149116019|NCT02218606|537904074|FG001|Overall Study|Other|1|||
149116020|NCT02218606|537904073|FG000|Overall Study|Never started treatment|0|||
149116021|NCT02218606|537904074|FG001|Overall Study|Never started treatment|1|||
149116022|NCT03203473|537904075|FG000|Induction Phase|Never started primary treatment|2|||
149116023|NCT03203473|537904076|FG001|Induction Phase|Never started primary treatment|0|||
149116024|NCT03203473|537904077|FG002|Induction Phase|Never started primary treatment|0|||
149116025|NCT03203473|537904075|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
149116026|NCT03203473|537904076|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
149116027|NCT03203473|537904077|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
149116028|NCT03203473|537904075|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
149116029|NCT03203473|537904076|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
149116030|NCT03203473|537904077|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
149116031|NCT03203473|537904075|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
149116032|NCT03203473|537904076|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
149116033|NCT03203473|537904077|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
149116034|NCT03203473|537904075|FG000|Arm Allocation Phase|started salvage therapy|0|||
149116035|NCT03203473|537904076|FG001|Arm Allocation Phase|started salvage therapy|5|||
149116036|NCT03203473|537904077|FG002|Arm Allocation Phase|started salvage therapy|0|||
149116037|NCT03203473|537904075|FG000|Arm Allocation Phase|Disease progression|0|||
149116038|NCT03203473|537904076|FG001|Arm Allocation Phase|Disease progression|0|||
149116039|NCT03203473|537904077|FG002|Arm Allocation Phase|Disease progression|37|||
149116040|NCT03203473|537904075|FG000|Arm Allocation Phase|Adverse Event|0|||
149116041|NCT03203473|537904076|FG001|Arm Allocation Phase|Adverse Event|0|||
149116042|NCT03203473|537904077|FG002|Arm Allocation Phase|Adverse Event|11|||
149116043|NCT03203473|537904075|FG000|Arm Allocation Phase|Physician Decision|0|||
149116044|NCT03203473|537904076|FG001|Arm Allocation Phase|Physician Decision|0|||
149116045|NCT03203473|537904077|FG002|Arm Allocation Phase|Physician Decision|3|||
149116046|NCT03203473|537904075|FG000|Arm Allocation Phase|Death|0|||
149116047|NCT03203473|537904076|FG001|Arm Allocation Phase|Death|0|||
149116048|NCT03203473|537904077|FG002|Arm Allocation Phase|Death|1|||
149116049|NCT03203473|537904075|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
149116050|NCT03203473|537904076|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
149116051|NCT03203473|537904077|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
149116052|NCT03203473|537904075|FG000|Arm Allocation Phase|Intercurrent illness|0|||
149116053|NCT03203473|537904076|FG001|Arm Allocation Phase|Intercurrent illness|0|||
149116054|NCT03203473|537904077|FG002|Arm Allocation Phase|Intercurrent illness|1|||
149116055|NCT03203473|537904075|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
149116056|NCT03203473|537904076|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
149116057|NCT03203473|537904077|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
149116058|NCT02314780|537904082|FG000|Overall Study|organizational reasons|0|||
149116059|NCT02314780|537904083|FG001|Overall Study|organizational reasons|2|||
149116060|NCT02314780|537904084|FG002|Overall Study|organizational reasons|0|||
149116061|NCT02314780|537904082|FG000|Overall Study|Adverse Event|0|||
149116062|NCT02314780|537904083|FG001|Overall Study|Adverse Event|1|||
149116063|NCT02314780|537904084|FG002|Overall Study|Adverse Event|0|||
149116064|NCT01077271|537904088|FG000|Overall Study|Parental desire|8|||
149116065|NCT01077271|537904088|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
149116066|NCT01077271|537904088|FG000|Overall Study|Noncompliance|2|||
149116067|NCT01077271|537904088|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
149116068|NCT01077271|537904088|FG000|Overall Study|Changed doctors|2|||
149116069|NCT01077271|537904088|FG000|Overall Study|Parents thought too many injections|2|||
149116070|NCT01077271|537904088|FG000|Overall Study|End of RSV season nearly reached|1|||
149116071|NCT01077271|537904088|FG000|Overall Study|Mother unconvinced of the necessity|1|||
149116072|NCT00215137|537904089|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
149116073|NCT00215137|537904090|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
149116074|NCT00215137|537904091|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
149116075|NCT00215137|537904089|FG000|Randomization Period|Lost to Follow-up|0|||
149116076|NCT00215137|537904090|FG001|Randomization Period|Lost to Follow-up|1|||
149116077|NCT00215137|537904091|FG002|Randomization Period|Lost to Follow-up|0|||
149116078|NCT00215137|537904089|FG000|Randomization Period|Withdrawal by Subject|0|||
149116079|NCT00215137|537904090|FG001|Randomization Period|Withdrawal by Subject|1|||
149116080|NCT00215137|537904091|FG002|Randomization Period|Withdrawal by Subject|0|||
149116081|NCT03333876|537904092|FG000|Screening Period|Screen Failure|4|||
149116082|NCT03333876|537904092|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
149116083|NCT03333876|537904092|FG000|Mandibular Advancement|Adverse Event|2|||
149116084|NCT03333876|537904092|FG000|Mandibular Advancement|Product Damage|2|||
149116085|NCT00095498|537904094|FG000|Overall Study|Physician Decision|9|||
149116086|NCT00095498|537904095|FG001|Overall Study|Physician Decision|10|||
149116087|NCT00095498|537904096|FG002|Overall Study|Physician Decision|8|||
149116088|NCT00095498|537904094|FG000|Overall Study|Adverse Event|1|||
149116089|NCT00095498|537904095|FG001|Overall Study|Adverse Event|0|||
149116090|NCT00095498|537904096|FG002|Overall Study|Adverse Event|1|||
149116091|NCT00095498|537904094|FG000|Overall Study|Withdrawal by Subject|15|||
149116092|NCT00095498|537904095|FG001|Overall Study|Withdrawal by Subject|16|||
149116093|NCT00095498|537904096|FG002|Overall Study|Withdrawal by Subject|15|||
149116094|NCT00095498|537904094|FG000|Overall Study|Disease progression|0|||
149116095|NCT00095498|537904095|FG001|Overall Study|Disease progression|1|||
149116096|NCT00095498|537904096|FG002|Overall Study|Disease progression|1|||
149116097|NCT00095498|537904094|FG000|Overall Study|Ineligibility determined|3|||
149116098|NCT00095498|537904095|FG001|Overall Study|Ineligibility determined|0|||
149116099|NCT00095498|537904096|FG002|Overall Study|Ineligibility determined|2|||
149116100|NCT00095498|537904094|FG000|Overall Study|Lost to Follow-up|1|||
149116101|NCT00095498|537904095|FG001|Overall Study|Lost to Follow-up|1|||
149116102|NCT00095498|537904096|FG002|Overall Study|Lost to Follow-up|2|||
149116103|NCT00095498|537904094|FG000|Overall Study|Noncompliance|1|||
149116104|NCT00095498|537904095|FG001|Overall Study|Noncompliance|0|||
149116105|NCT00095498|537904096|FG002|Overall Study|Noncompliance|1|||
149116106|NCT00095498|537904094|FG000|Overall Study|Other|6|||
149116107|NCT00095498|537904095|FG001|Overall Study|Other|7|||
149116108|NCT00095498|537904096|FG002|Overall Study|Other|6|||
149116109|NCT00095498|537904094|FG000|Overall Study|Protocol Violation|0|||
149116110|NCT00095498|537904095|FG001|Overall Study|Protocol Violation|0|||
149116111|NCT00095498|537904096|FG002|Overall Study|Protocol Violation|1|||
149116112|NCT00095498|537904094|FG000|Overall Study|Requirement for alternative therapy|1|||
149116113|NCT00095498|537904095|FG001|Overall Study|Requirement for alternative therapy|0|||
149116114|NCT00095498|537904096|FG002|Overall Study|Requirement for alternative therapy|2|||
149116115|NCT00640133|537904098|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
149116116|NCT00640133|537904099|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
149116117|NCT00640133|537904098|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
149116118|NCT00640133|537904099|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
149116119|NCT00640133|537904098|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
149116120|NCT00640133|537904099|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
149116121|NCT00128102|537904100|FG000|Overall Study|Site Discontinued|3|||
149116122|NCT00128102|537904101|FG001|Overall Study|Site Discontinued|6|||
149116123|NCT00128102|537904100|FG000|Overall Study|Other|0|||
149116124|NCT00128102|537904101|FG001|Overall Study|Other|1|||
149116125|NCT00128102|537904100|FG000|Overall Study|Progressive Disease|255|||
149116126|NCT00128102|537904101|FG001|Overall Study|Progressive Disease|285|||
149116127|NCT00128102|537904100|FG000|Overall Study|Adverse Event|34|||
149116128|NCT00128102|537904101|FG001|Overall Study|Adverse Event|11|||
149116129|NCT00128102|537904100|FG000|Overall Study|Death|12|||
149116130|NCT00128102|537904101|FG001|Overall Study|Death|13|||
149116131|NCT00128102|537904100|FG000|Overall Study|Physician Decision|3|||
149116132|NCT00128102|537904101|FG001|Overall Study|Physician Decision|3|||
149116133|NCT00128102|537904100|FG000|Overall Study|Withdrawal by Subject|19|||
149116134|NCT00128102|537904101|FG001|Overall Study|Withdrawal by Subject|11|||
149116135|NCT00128102|537904100|FG000|Overall Study|Protocol Violation|2|||
149116136|NCT00128102|537904101|FG001|Overall Study|Protocol Violation|2|||
149116137|NCT04476251|537904104|FG000|Overall Study|Not treated|1|||
149116138|NCT03446781|537904105|FG000|Overall Study|Lost to Follow-up|11|||
149116139|NCT03446781|537904106|FG001|Overall Study|Lost to Follow-up|5|||
149116140|NCT03446781|537904105|FG000|Overall Study|Withdrawal by Subject|9|||
149116141|NCT03446781|537904106|FG001|Overall Study|Withdrawal by Subject|7|||
149116142|NCT03446781|537904105|FG000|Overall Study|Adverse Event|8|||
149116143|NCT03446781|537904106|FG001|Overall Study|Adverse Event|2|||
149116144|NCT03446781|537904105|FG000|Overall Study|Protocol Violation|0|||
149116145|NCT03446781|537904106|FG001|Overall Study|Protocol Violation|3|||
149116146|NCT03896152|537904109|FG000|Overall Study|Patient/guardian decision|1|||
149116147|NCT03896152|537904110|FG001|Overall Study|Patient/guardian decision|1|||
149116148|NCT03896152|537904109|FG000|Overall Study|Adverse Event|0|||
149116149|NCT03896152|537904110|FG001|Overall Study|Adverse Event|1|||
149116150|NCT03896152|537904109|FG000|Overall Study|Physician Decision|1|||
149116151|NCT03896152|537904110|FG001|Overall Study|Physician Decision|0|||
149116152|NCT03896152|537904109|FG000|Overall Study|Technical problems|1|||
149116153|NCT03896152|537904110|FG001|Overall Study|Technical problems|0|||
149116154|NCT02236988|537904111|FG000|Overall Study|Lost to Follow-up|0|||
149116155|NCT02236988|537904112|FG001|Overall Study|Lost to Follow-up|0|||
149116156|NCT02236988|537904113|FG002|Overall Study|Lost to Follow-up|0|||
149116157|NCT02236988|537904114|FG003|Overall Study|Lost to Follow-up|1|||
149116158|NCT02236988|537904111|FG000|Overall Study|Unable to Comply with Study Visits|0|||
149116159|NCT02236988|537904112|FG001|Overall Study|Unable to Comply with Study Visits|0|||
149116160|NCT02236988|537904113|FG002|Overall Study|Unable to Comply with Study Visits|0|||
149116161|NCT02236988|537904114|FG003|Overall Study|Unable to Comply with Study Visits|2|||
149116162|NCT01461811|537904115|FG000|Overall Study|Adverse Event|2|||
149116163|NCT01461811|537904116|FG001|Overall Study|Adverse Event|1|||
149116164|NCT01461811|537904115|FG000|Overall Study|Subject decision unrelated to an AE|1|||
149116165|NCT01461811|537904116|FG001|Overall Study|Subject decision unrelated to an AE|1|||
149116166|NCT01461811|537904115|FG000|Overall Study|Noncompliance|1|||
149116167|NCT01461811|537904116|FG001|Overall Study|Noncompliance|1|||
149116168|NCT03733314|537904117|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
149116169|NCT03733314|537904118|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
149116170|NCT03733314|537904117|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
149116171|NCT03733314|537904118|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
149116172|NCT03733314|537904117|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
149116173|NCT03733314|537904118|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
149116174|NCT03733314|537904117|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
149116175|NCT03733314|537904118|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
149116176|NCT03733314|537904117|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
149116177|NCT03733314|537904118|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
149116178|NCT03733314|537904117|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
149116179|NCT03733314|537904118|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
149116180|NCT04514510|537904119|FG000|Overall Study|Lost to Follow-up|0|||
149116181|NCT04514510|537904120|FG001|Overall Study|Lost to Follow-up|1|||
149116182|NCT04514510|537904119|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
149116183|NCT04514510|537904120|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
149116184|NCT00821587|537904125|FG000|Overall Study|Physician Decision|0|||
149116185|NCT00821587|537904126|FG001|Overall Study|Physician Decision|1|||
149116186|NCT01208103|537904129|FG000|Overall Study|Adverse Event|1|||
149116187|NCT01208103|537904129|FG000|Overall Study|Withdrawal by Subject|1|||
149116188|NCT00864253|537904132|FG000|Overall Study|Adverse Event|56|||
149116189|NCT00864253|537904133|FG001|Overall Study|Adverse Event|11|||
149116190|NCT00864253|537904132|FG000|Overall Study|Unrelated Adverse Event|3|||
149116191|NCT00864253|537904133|FG001|Overall Study|Unrelated Adverse Event|1|||
149116192|NCT00864253|537904132|FG000|Overall Study|Physician Decision|11|||
149116193|NCT00864253|537904133|FG001|Overall Study|Physician Decision|15|||
149116194|NCT00864253|537904132|FG000|Overall Study|Protocol Violation|0|||
149116195|NCT00864253|537904133|FG001|Overall Study|Protocol Violation|2|||
149116196|NCT00864253|537904132|FG000|Overall Study|Lost to Follow-up|1|||
149116197|NCT00864253|537904133|FG001|Overall Study|Lost to Follow-up|1|||
149116198|NCT00864253|537904132|FG000|Overall Study|Withdrawal by Subject|18|||
149116199|NCT00864253|537904133|FG001|Overall Study|Withdrawal by Subject|18|||
149116200|NCT00864253|537904132|FG000|Overall Study|Death|1|||
149116201|NCT00864253|537904133|FG001|Overall Study|Death|0|||
149116202|NCT00864253|537904132|FG000|Overall Study|Ongoing|2|||
149116203|NCT00864253|537904133|FG001|Overall Study|Ongoing|3|||
149116204|NCT00864253|537904132|FG000|Overall Study|Untreated|7|||
149116205|NCT00864253|537904133|FG001|Overall Study|Untreated|7|||
149116206|NCT01111240|537904134|FG000|Overall Study|Adverse Event|190|||
149116207|NCT01111240|537904134|FG000|Overall Study|Lack of Efficacy|545|||
149116208|NCT01111240|537904134|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
149116209|NCT01111240|537904134|FG000|Overall Study|Other|312|||
149116210|NCT01989169|537904135|FG000|Period 2|Adverse Event|0|||
149116211|NCT01989169|537904136|FG001|Period 2|Adverse Event|1|||
149116212|NCT01585155|537904137|FG000|Overall Study|Adverse Event|1|||
149116213|NCT01585155|537904137|FG000|Overall Study|Lack of Efficacy|2|||
149116214|NCT01585155|537904137|FG000|Overall Study|Worsening ulcerative colitis|2|||
149116215|NCT02235311|537904142|FG000|Overall Study|Lost to Follow-up|0|||
149116216|NCT02235311|537904143|FG001|Overall Study|Lost to Follow-up|1|||
149116217|NCT02235311|537904142|FG000|Overall Study|Protocol Violation|0|||
149116218|NCT02235311|537904143|FG001|Overall Study|Protocol Violation|1|||
149116219|NCT04655027|537904144|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
149116220|NCT04655027|537904145|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
149116221|NCT00658788|537904146|FG000|Overall Study|Adverse Event|11|||
149116222|NCT00658788|537904146|FG000|Overall Study|Withdrawal by Subject|13|||
149116223|NCT00658788|537904146|FG000|Overall Study|Lost to Follow-up|18|||
149116224|NCT00658788|537904146|FG000|Overall Study|Treatment Discontinuation|32|||
149116225|NCT00653523|537904147|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
149116226|NCT00653523|537904147|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
149116227|NCT00653523|537904147|FG000|Overall Study|Adverse Event|7|||
149116228|NCT00653523|537904147|FG000|Overall Study|Withdrawal by Subject|6|||
149116229|NCT00653523|537904147|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
149116230|NCT00653523|537904147|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
149116231|NCT05384938|537904150|FG000|Overall Study|Withdrawal by Subject|8|||
149116232|NCT05384938|537904150|FG000|Overall Study|Lost to Follow-up|6|||
149116233|NCT05384938|537904150|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
149116234|NCT03898167|537904151|FG000|Overall Study|Terminated phone call early|7|||
149116235|NCT03898167|537904152|FG001|Overall Study|Terminated phone call early|0|||
149116236|NCT03898167|537904153|FG002|Overall Study|Terminated phone call early|0|||
149116237|NCT03898167|537904151|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
149116238|NCT03898167|537904152|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
149116239|NCT03898167|537904153|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
149116240|NCT00384397|537904156|FG000|Overall Study|Adverse Event|0|||
149116241|NCT00384397|537904157|FG001|Overall Study|Adverse Event|1|||
149116242|NCT00384397|537904158|FG002|Overall Study|Adverse Event|2|||
149116243|NCT00384397|537904156|FG000|Overall Study|Protocol Violation|7|||
149116244|NCT00384397|537904157|FG001|Overall Study|Protocol Violation|15|||
149116245|NCT00384397|537904158|FG002|Overall Study|Protocol Violation|13|||
149116246|NCT00384397|537904156|FG000|Overall Study|Lost to Follow-up|11|||
149116247|NCT00384397|537904157|FG001|Overall Study|Lost to Follow-up|13|||
149116248|NCT00384397|537904158|FG002|Overall Study|Lost to Follow-up|3|||
149116249|NCT00384397|537904156|FG000|Overall Study|Withdrawal by Subject|14|||
149116250|NCT00384397|537904157|FG001|Overall Study|Withdrawal by Subject|17|||
149116251|NCT00384397|537904158|FG002|Overall Study|Withdrawal by Subject|15|||
149116252|NCT01525238|537904159|FG000|Overall Study|Withdrawal by Subject|1|||
149116253|NCT01525238|537904160|FG001|Overall Study|Withdrawal by Subject|0|||
149116254|NCT01525238|537904161|FG002|Overall Study|Withdrawal by Subject|0|||
149116255|NCT01214642|537904162|FG000|Overall Study|Progressive Disease|3|||
149116256|NCT01214642|537904163|FG001|Overall Study|Progressive Disease|2|||
149116257|NCT01214642|537904164|FG002|Overall Study|Progressive Disease|3|||
149116258|NCT01214642|537904165|FG003|Overall Study|Progressive Disease|5|||
149116259|NCT01214642|537904166|FG004|Overall Study|Progressive Disease|5|||
149116260|NCT01214642|537904167|FG005|Overall Study|Progressive Disease|3|||
149116261|NCT01214642|537904168|FG006|Overall Study|Progressive Disease|5|||
149116262|NCT01214642|537904169|FG007|Overall Study|Progressive Disease|3|||
149116263|NCT01214642|537904170|FG008|Overall Study|Progressive Disease|10|||
149116264|NCT01214642|537904171|FG009|Overall Study|Progressive Disease|2|||
149116265|NCT01214642|537904172|FG010|Overall Study|Progressive Disease|1|||
149116266|NCT01214642|537904173|FG011|Overall Study|Progressive Disease|4|||
149116267|NCT01214642|537904162|FG000|Overall Study|Adverse Event|0|||
149116268|NCT01214642|537904163|FG001|Overall Study|Adverse Event|1|||
149116269|NCT01214642|537904164|FG002|Overall Study|Adverse Event|0|||
149116270|NCT01214642|537904165|FG003|Overall Study|Adverse Event|0|||
149116271|NCT01214642|537904166|FG004|Overall Study|Adverse Event|0|||
149116272|NCT01214642|537904167|FG005|Overall Study|Adverse Event|0|||
149116273|NCT01214642|537904168|FG006|Overall Study|Adverse Event|1|||
149116274|NCT01214642|537904169|FG007|Overall Study|Adverse Event|0|||
149116275|NCT01214642|537904170|FG008|Overall Study|Adverse Event|0|||
149116276|NCT01214642|537904171|FG009|Overall Study|Adverse Event|1|||
149116277|NCT01214642|537904172|FG010|Overall Study|Adverse Event|1|||
149116278|NCT01214642|537904173|FG011|Overall Study|Adverse Event|0|||
149116279|NCT01214642|537904162|FG000|Overall Study|Death|0|||
149116280|NCT01214642|537904163|FG001|Overall Study|Death|0|||
149116281|NCT01214642|537904164|FG002|Overall Study|Death|1|||
149116282|NCT01214642|537904165|FG003|Overall Study|Death|0|||
149116283|NCT01214642|537904166|FG004|Overall Study|Death|0|||
149116284|NCT01214642|537904167|FG005|Overall Study|Death|0|||
149116285|NCT01214642|537904168|FG006|Overall Study|Death|0|||
149116286|NCT01214642|537904169|FG007|Overall Study|Death|0|||
149116287|NCT01214642|537904170|FG008|Overall Study|Death|0|||
149116288|NCT01214642|537904171|FG009|Overall Study|Death|0|||
149116289|NCT01214642|537904172|FG010|Overall Study|Death|1|||
149116290|NCT01214642|537904173|FG011|Overall Study|Death|0|||
149116291|NCT01214642|537904162|FG000|Overall Study|Withdrawal by Subject|0|||
149116292|NCT01214642|537904163|FG001|Overall Study|Withdrawal by Subject|0|||
149116293|NCT01214642|537904164|FG002|Overall Study|Withdrawal by Subject|1|||
149116294|NCT01214642|537904165|FG003|Overall Study|Withdrawal by Subject|0|||
149116295|NCT01214642|537904166|FG004|Overall Study|Withdrawal by Subject|0|||
149116296|NCT01214642|537904167|FG005|Overall Study|Withdrawal by Subject|0|||
149116297|NCT01214642|537904168|FG006|Overall Study|Withdrawal by Subject|0|||
149116298|NCT01214642|537904169|FG007|Overall Study|Withdrawal by Subject|0|||
149116299|NCT01214642|537904170|FG008|Overall Study|Withdrawal by Subject|3|||
149116300|NCT01214642|537904171|FG009|Overall Study|Withdrawal by Subject|1|||
149116301|NCT01214642|537904172|FG010|Overall Study|Withdrawal by Subject|1|||
149116302|NCT01214642|537904173|FG011|Overall Study|Withdrawal by Subject|0|||
149116303|NCT01214642|537904162|FG000|Overall Study|Physician Decision|0|||
149116304|NCT01214642|537904163|FG001|Overall Study|Physician Decision|0|||
149116305|NCT01214642|537904164|FG002|Overall Study|Physician Decision|1|||
149116306|NCT01214642|537904165|FG003|Overall Study|Physician Decision|1|||
149116307|NCT01214642|537904166|FG004|Overall Study|Physician Decision|1|||
149116308|NCT01214642|537904167|FG005|Overall Study|Physician Decision|0|||
149116309|NCT01214642|537904168|FG006|Overall Study|Physician Decision|0|||
149116310|NCT01214642|537904169|FG007|Overall Study|Physician Decision|0|||
149116311|NCT01214642|537904170|FG008|Overall Study|Physician Decision|0|||
149116312|NCT01214642|537904171|FG009|Overall Study|Physician Decision|0|||
149116313|NCT01214642|537904172|FG010|Overall Study|Physician Decision|0|||
149116314|NCT01214642|537904173|FG011|Overall Study|Physician Decision|2|||
149116315|NCT04696653|537904176|FG000|Overall Study|left organization|18|||
149116316|NCT04696653|537904176|FG000|Overall Study|Lost to Follow-up|3|||
149116317|NCT01946529|537904177|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
149116318|NCT01946529|537904178|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
149116319|NCT01946529|537904179|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
149116320|NCT01946529|537904177|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
149116321|NCT01946529|537904178|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
149116322|NCT01946529|537904179|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
149116323|NCT01732822|537905889|FG000|Overall Study|Withdrawal by Subject|123|||
149116324|NCT01732822|537905890|FG001|Overall Study|Withdrawal by Subject|113|||
149116325|NCT05020327|537905891|FG000|Overall Study|Physician Decision|3|||
149116326|NCT05020327|537905892|FG001|Overall Study|Physician Decision|0|||
149116327|NCT05020327|537905893|FG002|Overall Study|Physician Decision|0|||
149116328|NCT05020327|537905891|FG000|Overall Study|Withdrawal by Subject|1|||
149116329|NCT05020327|537905892|FG001|Overall Study|Withdrawal by Subject|1|||
149116330|NCT05020327|537905893|FG002|Overall Study|Withdrawal by Subject|0|||
149116331|NCT05020327|537905891|FG000|Overall Study|personal/cultural, ineligible|12|||
149116332|NCT05020327|537905892|FG001|Overall Study|personal/cultural, ineligible|0|||
149116333|NCT05020327|537905893|FG002|Overall Study|personal/cultural, ineligible|0|||
149116334|NCT00591370|537905894|FG000|Overall Study|Not Treated|2|||
149116335|NCT00095056|537905896|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
149116336|NCT00095056|537905897|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
149116337|NCT00095056|537905896|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
149116338|NCT00095056|537905897|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
149116339|NCT00095056|537905896|FG000|Phase A (Weeks 0-12)|Death|1|||
149116340|NCT00095056|537905897|FG001|Phase A (Weeks 0-12)|Death|0|||
149116341|NCT00095056|537905896|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
149116342|NCT00095056|537905897|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
149116343|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
149116344|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
149116345|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
149116346|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
149116347|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
149116348|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
149116349|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
149116350|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
149116351|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Death|3|||
149116352|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Death|1|||
149116353|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
149116354|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
149116355|NCT00095056|537905896|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
149116356|NCT00095056|537905897|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
149116357|NCT00306670|537905898|FG000|Overall Study|patients recruited; Genentech, the st|0|||
149116358|NCT00306670|537905899|FG001|Overall Study|patients recruited; Genentech, the st|2|||
149116359|NCT00503139|537905903|FG000|Overall Study|Case Report Forms were not collected|4|||
149116360|NCT00503139|537905903|FG000|Overall Study|Protocol Violation|4|||
149116361|NCT02735577|537905907|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
149116362|NCT02735577|537905907|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
149116363|NCT00833833|537905908|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
149116364|NCT00833833|537905909|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
149116365|NCT00833833|537905910|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
149116366|NCT00833833|537905911|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
149116367|NCT00833833|537905912|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
149116368|NCT00833833|537905913|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
149116369|NCT00833833|537905908|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
149116370|NCT00833833|537905909|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
149116371|NCT00833833|537905910|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
149116372|NCT00833833|537905911|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
149116373|NCT00833833|537905912|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
149116374|NCT00833833|537905913|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
149116375|NCT00833833|537905908|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
149116376|NCT00833833|537905909|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
149116377|NCT00833833|537905910|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
149116378|NCT00833833|537905911|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
149116379|NCT00833833|537905912|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
149116380|NCT00833833|537905913|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
149116381|NCT00833833|537905908|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
149116382|NCT00833833|537905909|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
149116383|NCT00833833|537905910|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
149116384|NCT00833833|537905911|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
149116385|NCT00833833|537905912|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
149116386|NCT00833833|537905913|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
149116387|NCT00833833|537905908|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
149116388|NCT00833833|537905909|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116389|NCT00833833|537905910|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
149116390|NCT00833833|537905911|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116391|NCT00833833|537905912|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116392|NCT00833833|537905913|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116393|NCT00833833|537905908|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
149116394|NCT00833833|537905909|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
149116395|NCT00833833|537905910|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
149116396|NCT00833833|537905911|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
149116397|NCT00833833|537905912|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
149116398|NCT00833833|537905913|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
149116399|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
149116400|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
149116401|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
149116402|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
149116403|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
149116404|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
149116405|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
149116406|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
149116407|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
149116408|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
149116409|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
149116410|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
149116411|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
149116412|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
149116413|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
149116414|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
149116415|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
149116416|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
149116417|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116418|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116419|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116420|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
149116421|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
149116422|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
149116423|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
149116424|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
149116425|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
149116426|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
149116427|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
149116428|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
149116429|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
149116430|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
149116431|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
149116432|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
149116433|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
149116434|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
149116435|NCT00833833|537905908|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149116436|NCT00833833|537905909|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149116437|NCT00833833|537905910|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149116438|NCT00833833|537905911|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149116439|NCT00833833|537905912|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
149116440|NCT00833833|537905913|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
149116441|NCT02040259|537905914|FG000|Overall Study|Death|280|||
149116442|NCT02040259|537905914|FG000|Overall Study|Lost to Follow-up|76|||
149116443|NCT02040259|537905914|FG000|Overall Study|Assessment not completed|3|||
149116444|NCT02040259|537905914|FG000|Overall Study|Withdrawal by Subject|4|||
149116445|NCT00316602|537905915|FG000|Overall Study|Withdrawal by Subject|3|||
149116446|NCT00316602|537905916|FG001|Overall Study|Withdrawal by Subject|2|||
149116447|NCT00316602|537905915|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
149116448|NCT00316602|537905916|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
149116449|NCT00316602|537905915|FG000|Overall Study|Adverse Event|1|||
149116450|NCT00316602|537905916|FG001|Overall Study|Adverse Event|0|||
149116451|NCT00316602|537905915|FG000|Overall Study|Other|3|||
149116452|NCT00316602|537905916|FG001|Overall Study|Other|6|||
149116453|NCT01142232|537905917|FG000|Overall Study|Adverse Event|1|||
149116454|NCT01142232|537905918|FG001|Overall Study|Adverse Event|2|||
149116455|NCT01142232|537905919|FG002|Overall Study|Adverse Event|1|||
149116456|NCT01142232|537905920|FG003|Overall Study|Adverse Event|0|||
149116457|NCT01142232|537905921|FG004|Overall Study|Adverse Event|4|||
149116458|NCT01142232|537905917|FG000|Overall Study|Death|0|||
149116459|NCT01142232|537905918|FG001|Overall Study|Death|0|||
149116460|NCT01142232|537905919|FG002|Overall Study|Death|0|||
149116461|NCT01142232|537905920|FG003|Overall Study|Death|0|||
149116462|NCT01142232|537905921|FG004|Overall Study|Death|1|||
149116463|NCT01142232|537905917|FG000|Overall Study|Disease Progression|2|||
149116464|NCT01142232|537905918|FG001|Overall Study|Disease Progression|0|||
149116465|NCT01142232|537905919|FG002|Overall Study|Disease Progression|1|||
149116466|NCT01142232|537905920|FG003|Overall Study|Disease Progression|2|||
149116467|NCT01142232|537905921|FG004|Overall Study|Disease Progression|12|||
149116468|NCT01142232|537905917|FG000|Overall Study|Withdrawal by Subject|0|||
149116469|NCT01142232|537905918|FG001|Overall Study|Withdrawal by Subject|0|||
149116470|NCT01142232|537905919|FG002|Overall Study|Withdrawal by Subject|0|||
149116471|NCT01142232|537905920|FG003|Overall Study|Withdrawal by Subject|1|||
149116472|NCT01142232|537905921|FG004|Overall Study|Withdrawal by Subject|3|||
149116473|NCT01142232|537905917|FG000|Overall Study|Physician Decision|0|||
149116474|NCT01142232|537905918|FG001|Overall Study|Physician Decision|1|||
149116475|NCT01142232|537905919|FG002|Overall Study|Physician Decision|0|||
149116476|NCT01142232|537905920|FG003|Overall Study|Physician Decision|2|||
149116477|NCT01142232|537905921|FG004|Overall Study|Physician Decision|10|||
149116478|NCT01142232|537905917|FG000|Overall Study|Alternative Therapy|0|||
149116479|NCT01142232|537905918|FG001|Overall Study|Alternative Therapy|1|||
149116480|NCT01142232|537905919|FG002|Overall Study|Alternative Therapy|1|||
149116481|NCT01142232|537905920|FG003|Overall Study|Alternative Therapy|0|||
149116482|NCT01142232|537905921|FG004|Overall Study|Alternative Therapy|1|||
149116483|NCT01142232|537905917|FG000|Overall Study|Off Trt for other complicating disease|0|||
149116484|NCT01142232|537905918|FG001|Overall Study|Off Trt for other complicating disease|0|||
149116485|NCT01142232|537905919|FG002|Overall Study|Off Trt for other complicating disease|0|||
149116486|NCT01142232|537905920|FG003|Overall Study|Off Trt for other complicating disease|0|||
149116487|NCT01142232|537905921|FG004|Overall Study|Off Trt for other complicating disease|1|||
149116488|NCT01142232|537905917|FG000|Overall Study|Noncompliance|0|||
149116489|NCT01142232|537905918|FG001|Overall Study|Noncompliance|0|||
149116490|NCT01142232|537905919|FG002|Overall Study|Noncompliance|0|||
149116491|NCT01142232|537905920|FG003|Overall Study|Noncompliance|0|||
149116492|NCT01142232|537905921|FG004|Overall Study|Noncompliance|2|||
149116493|NCT00626990|537905922|FG000|Overall Study|Lack of Efficacy|6|||
149116494|NCT00626990|537905923|FG001|Overall Study|Lack of Efficacy|7|||
149116495|NCT00626990|537905924|FG002|Overall Study|Lack of Efficacy|49|||
149116496|NCT00626990|537905925|FG003|Overall Study|Lack of Efficacy|40|||
149116497|NCT00626990|537905922|FG000|Overall Study|Adverse Event|1|||
149116498|NCT00626990|537905923|FG001|Overall Study|Adverse Event|7|||
149116499|NCT00626990|537905924|FG002|Overall Study|Adverse Event|14|||
149116500|NCT00626990|537905925|FG003|Overall Study|Adverse Event|28|||
149116501|NCT00626990|537905922|FG000|Overall Study|Death|0|||
149116502|NCT00626990|537905923|FG001|Overall Study|Death|1|||
149116503|NCT00626990|537905924|FG002|Overall Study|Death|0|||
149116504|NCT00626990|537905925|FG003|Overall Study|Death|0|||
149116505|NCT00626990|537905922|FG000|Overall Study|Withdrawal by Subject|3|||
149116506|NCT00626990|537905923|FG001|Overall Study|Withdrawal by Subject|1|||
149116507|NCT00626990|537905924|FG002|Overall Study|Withdrawal by Subject|5|||
149116508|NCT00626990|537905925|FG003|Overall Study|Withdrawal by Subject|11|||
149116509|NCT00626990|537905922|FG000|Overall Study|Protocol Violation|0|||
149116510|NCT00626990|537905923|FG001|Overall Study|Protocol Violation|1|||
149116511|NCT00626990|537905924|FG002|Overall Study|Protocol Violation|1|||
149116512|NCT00626990|537905925|FG003|Overall Study|Protocol Violation|0|||
149116513|NCT00626990|537905922|FG000|Overall Study|Various different reasons/missing|4|||
149116514|NCT00626990|537905923|FG001|Overall Study|Various different reasons/missing|8|||
149116515|NCT00626990|537905924|FG002|Overall Study|Various different reasons/missing|8|||
149116516|NCT00626990|537905925|FG003|Overall Study|Various different reasons/missing|16|||
149116517|NCT04138576|537905926|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
149116518|NCT01994837|537905927|FG000|Overall Study|Progressive disease per protocol|23|||
149116519|NCT01994837|537905927|FG000|Overall Study|Adv event related to progressive disease|3|||
149116520|NCT01994837|537905927|FG000|Overall Study|Fatal progressive disease|2|||
149116521|NCT01994837|537905927|FG000|Overall Study|Adverse event not related to progression|1|||
149116522|NCT01994837|537905927|FG000|Overall Study|Chose palliative care|1|||
149116523|NCT01994837|537905927|FG000|Overall Study|Proceeded to transplant|1|||
149116524|NCT01994837|537905927|FG000|Overall Study|Removed from study due to no response|1|||
149116525|NCT00574873|537905929|FG000|Overall Study|Withdrawal by Subject|18|||
149116526|NCT00574873|537905930|FG001|Overall Study|Withdrawal by Subject|19|||
149116527|NCT00574873|537905929|FG000|Overall Study|Investigator request|18|||
149116528|NCT00574873|537905930|FG001|Overall Study|Investigator request|8|||
149116529|NCT00574873|537905929|FG000|Overall Study|Death|15|||
149116530|NCT00574873|537905930|FG001|Overall Study|Death|14|||
149116531|NCT00574873|537905929|FG000|Overall Study|Lost to Follow-up|14|||
149116532|NCT00574873|537905930|FG001|Overall Study|Lost to Follow-up|5|||
149116533|NCT00574873|537905929|FG000|Overall Study|Other|40|||
149116534|NCT00574873|537905930|FG001|Overall Study|Other|4|||
149116535|NCT00574873|537905929|FG000|Overall Study|Discontinuation of study by sponsor|5|||
149116536|NCT00574873|537905930|FG001|Overall Study|Discontinuation of study by sponsor|199|||
149116537|NCT00574873|537905929|FG000|Overall Study|Blank, site closed per local regulations|2|||
149116538|NCT00574873|537905930|FG001|Overall Study|Blank, site closed per local regulations|2|||
149116539|NCT00574873|537905929|FG000|Overall Study|Extension Study|126|||
149116540|NCT00574873|537905930|FG001|Overall Study|Extension Study|0|||
149116541|NCT00581555|537905931|FG000|Overall Study|Adverse Event|4|||
149116542|NCT00581555|537905932|FG001|Overall Study|Adverse Event|3|||
149116543|NCT00581555|537905931|FG000|Overall Study|Physician Decision|3|||
149116544|NCT00581555|537905932|FG001|Overall Study|Physician Decision|2|||
149116545|NCT00581555|537905931|FG000|Overall Study|Withdrawal by Subject|18|||
149116546|NCT00581555|537905932|FG001|Overall Study|Withdrawal by Subject|9|||
149116547|NCT00581555|537905931|FG000|Overall Study|Lost to Follow-up|2|||
149116548|NCT00581555|537905932|FG001|Overall Study|Lost to Follow-up|2|||
149116549|NCT00581555|537905931|FG000|Overall Study|Other reasons|16|||
149116550|NCT00581555|537905932|FG001|Overall Study|Other reasons|4|||
149116551|NCT05816330|537905933|FG000|Overall Study|Withdrawal by Subject|4|||
149116552|NCT05816330|537905934|FG001|Overall Study|Withdrawal by Subject|1|||
149116553|NCT00201643|537905935|FG000|Overall Study|Withdrawal by Subject|5|||
149116554|NCT00201643|537905936|FG001|Overall Study|Withdrawal by Subject|4|||
149116555|NCT03568318|537905937|FG000|Overall Study|Adverse Event|3|||
149116556|NCT03568318|537905938|FG001|Overall Study|Adverse Event|1|||
149116557|NCT03568318|537905939|FG002|Overall Study|Adverse Event|1|||
149116558|NCT03568318|537905940|FG003|Overall Study|Adverse Event|0|||
149116559|NCT03568318|537905941|FG004|Overall Study|Adverse Event|1|||
149116560|NCT03568318|537905942|FG005|Overall Study|Adverse Event|0|||
149116561|NCT03568318|537905937|FG000|Overall Study|Withdrawal by Subject|6|||
149116562|NCT03568318|537905938|FG001|Overall Study|Withdrawal by Subject|5|||
149116563|NCT03568318|537905939|FG002|Overall Study|Withdrawal by Subject|2|||
149116564|NCT03568318|537905940|FG003|Overall Study|Withdrawal by Subject|1|||
149116565|NCT03568318|537905941|FG004|Overall Study|Withdrawal by Subject|0|||
149116566|NCT03568318|537905942|FG005|Overall Study|Withdrawal by Subject|0|||
149116567|NCT03568318|537905937|FG000|Overall Study|Lost to Follow-up|3|||
149116568|NCT03568318|537905938|FG001|Overall Study|Lost to Follow-up|2|||
149116569|NCT03568318|537905939|FG002|Overall Study|Lost to Follow-up|2|||
149116570|NCT03568318|537905940|FG003|Overall Study|Lost to Follow-up|2|||
149116571|NCT03568318|537905941|FG004|Overall Study|Lost to Follow-up|1|||
149116572|NCT03568318|537905942|FG005|Overall Study|Lost to Follow-up|0|||
149116573|NCT03568318|537905937|FG000|Overall Study|Other|3|||
149116574|NCT03568318|537905938|FG001|Overall Study|Other|1|||
149116575|NCT03568318|537905939|FG002|Overall Study|Other|3|||
149116576|NCT03568318|537905940|FG003|Overall Study|Other|0|||
149116577|NCT03568318|537905941|FG004|Overall Study|Other|0|||
149116578|NCT03568318|537905942|FG005|Overall Study|Other|0|||
149116579|NCT03568318|537905937|FG000|Overall Study|Ongoing at Time of Analysis|5|||
149116580|NCT03568318|537905938|FG001|Overall Study|Ongoing at Time of Analysis|3|||
149116581|NCT03568318|537905939|FG002|Overall Study|Ongoing at Time of Analysis|2|||
149116582|NCT03568318|537905940|FG003|Overall Study|Ongoing at Time of Analysis|1|||
149116583|NCT03568318|537905941|FG004|Overall Study|Ongoing at Time of Analysis|0|||
149116584|NCT03568318|537905942|FG005|Overall Study|Ongoing at Time of Analysis|0|||
149116585|NCT04410523|537905943|FG000|Overall Study|Study terminated by sponsor|1|||
149116586|NCT04410523|537905944|FG001|Overall Study|Study terminated by sponsor|3|||
149116587|NCT04410523|537905945|FG002|Overall Study|Study terminated by sponsor|2|||
149116588|NCT04410523|537905946|FG003|Overall Study|Study terminated by sponsor|6|||
149116589|NCT04410523|537905947|FG004|Overall Study|Study terminated by sponsor|3|||
149116590|NCT04410523|537905948|FG005|Overall Study|Study terminated by sponsor|4|||
149116591|NCT04410523|537905943|FG000|Overall Study|Adverse Event|1|||
149116592|NCT04410523|537905944|FG001|Overall Study|Adverse Event|0|||
149116593|NCT04410523|537905945|FG002|Overall Study|Adverse Event|0|||
149116594|NCT04410523|537905946|FG003|Overall Study|Adverse Event|0|||
149116595|NCT04410523|537905947|FG004|Overall Study|Adverse Event|0|||
149116596|NCT04410523|537905948|FG005|Overall Study|Adverse Event|2|||
149116597|NCT04410523|537905943|FG000|Overall Study|Lost to Follow-up|0|||
149116598|NCT04410523|537905944|FG001|Overall Study|Lost to Follow-up|1|||
149116599|NCT04410523|537905945|FG002|Overall Study|Lost to Follow-up|0|||
149116600|NCT04410523|537905946|FG003|Overall Study|Lost to Follow-up|0|||
149116601|NCT04410523|537905947|FG004|Overall Study|Lost to Follow-up|0|||
149116602|NCT04410523|537905948|FG005|Overall Study|Lost to Follow-up|0|||
149116603|NCT04410523|537905943|FG000|Overall Study|Physician Decision|0|||
149116604|NCT04410523|537905944|FG001|Overall Study|Physician Decision|1|||
149116605|NCT04410523|537905945|FG002|Overall Study|Physician Decision|0|||
149116606|NCT04410523|537905946|FG003|Overall Study|Physician Decision|0|||
149116607|NCT04410523|537905947|FG004|Overall Study|Physician Decision|0|||
149116608|NCT04410523|537905948|FG005|Overall Study|Physician Decision|0|||
149116609|NCT04410523|537905943|FG000|Overall Study|Pregnancy|0|||
149116610|NCT04410523|537905944|FG001|Overall Study|Pregnancy|0|||
149116611|NCT04410523|537905945|FG002|Overall Study|Pregnancy|0|||
149116612|NCT04410523|537905946|FG003|Overall Study|Pregnancy|0|||
149116613|NCT04410523|537905947|FG004|Overall Study|Pregnancy|0|||
149116614|NCT04410523|537905948|FG005|Overall Study|Pregnancy|1|||
149116615|NCT04410523|537905943|FG000|Overall Study|Protocol deviation|0|||
149116616|NCT04410523|537905944|FG001|Overall Study|Protocol deviation|0|||
149116617|NCT04410523|537905945|FG002|Overall Study|Protocol deviation|0|||
149116618|NCT04410523|537905946|FG003|Overall Study|Protocol deviation|0|||
149116619|NCT04410523|537905947|FG004|Overall Study|Protocol deviation|0|||
149116620|NCT04410523|537905948|FG005|Overall Study|Protocol deviation|2|||
149116621|NCT04410523|537905943|FG000|Overall Study|Subject decision|2|||
149116622|NCT04410523|537905944|FG001|Overall Study|Subject decision|0|||
149116623|NCT04410523|537905945|FG002|Overall Study|Subject decision|0|||
149116624|NCT04410523|537905946|FG003|Overall Study|Subject decision|1|||
149116625|NCT04410523|537905947|FG004|Overall Study|Subject decision|0|||
149116626|NCT04410523|537905948|FG005|Overall Study|Subject decision|1|||
149116627|NCT02040584|537905952|FG000|Overall Study|Adverse Event|13|||
149116628|NCT02040584|537905953|FG001|Overall Study|Adverse Event|6|||
149116629|NCT02040584|537905952|FG000|Overall Study|Protocol Violation|9|||
149116630|NCT02040584|537905953|FG001|Overall Study|Protocol Violation|11|||
149116631|NCT02040584|537905952|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149116632|NCT02040584|537905953|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
149116633|NCT02040584|537905952|FG000|Overall Study|Death|6|||
149116634|NCT02040584|537905953|FG001|Overall Study|Death|3|||
149116635|NCT02040584|537905952|FG000|Overall Study|Transplant rejection/retransplant|0|||
149116636|NCT02040584|537905953|FG001|Overall Study|Transplant rejection/retransplant|1|||
149116637|NCT02040584|537905952|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
149116638|NCT02040584|537905953|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
149116639|NCT00996476|537905954|FG000|Overall Study|Withdrawal by Subject|1|||
149116640|NCT00996476|537905955|FG001|Overall Study|Withdrawal by Subject|2|||
149116641|NCT00996476|537905956|FG002|Overall Study|Withdrawal by Subject|1|||
149116642|NCT00996476|537905957|FG003|Overall Study|Withdrawal by Subject|0|||
149116643|NCT00996476|537905958|FG004|Overall Study|Withdrawal by Subject|1|||
149116644|NCT00996476|537905954|FG000|Overall Study|Adverse Event|0|||
149116645|NCT00996476|537905955|FG001|Overall Study|Adverse Event|1|||
149116646|NCT00996476|537905956|FG002|Overall Study|Adverse Event|0|||
149116647|NCT00996476|537905957|FG003|Overall Study|Adverse Event|0|||
149116648|NCT00996476|537905958|FG004|Overall Study|Adverse Event|1|||
149116649|NCT01802567|537905959|FG000|Overall Study|Withdrawal by Subject|2|||
149116650|NCT01802567|537905959|FG000|Overall Study|Physician Decision|1|||
149116651|NCT01802567|537905959|FG000|Overall Study|Lack of Efficacy|7|||
149116652|NCT01802567|537905959|FG000|Overall Study|Consented but did not start therapy|7|||
149116653|NCT01802567|537905959|FG000|Overall Study|Protocol Violation|1|||
149116654|NCT01940939|537905960|FG000|Overall Study|Withdrawal by Subject|2|||
149116655|NCT01940939|537905961|FG001|Overall Study|Withdrawal by Subject|8|||
149116656|NCT01895101|537905962|FG000|Overall Study|OPCAB procedure|1|||
149116657|NCT01895101|537905963|FG001|Overall Study|OPCAB procedure|1|||
149116658|NCT01895101|537905964|FG002|Overall Study|OPCAB procedure|3|||
149116659|NCT01895101|537905962|FG000|Overall Study|Withdrawal by Subject|0|||
149116660|NCT01895101|537905963|FG001|Overall Study|Withdrawal by Subject|1|||
149116661|NCT01895101|537905964|FG002|Overall Study|Withdrawal by Subject|2|||
149116662|NCT01895101|537905962|FG000|Overall Study|another study, enrolled in other study|0|||
149116663|NCT01895101|537905963|FG001|Overall Study|another study, enrolled in other study|1|||
149116664|NCT01895101|537905964|FG002|Overall Study|another study, enrolled in other study|0|||
149116665|NCT01895101|537905962|FG000|Overall Study|Death|0|||
149116666|NCT01895101|537905963|FG001|Overall Study|Death|1|||
149116667|NCT01895101|537905964|FG002|Overall Study|Death|0|||
149116668|NCT01895101|537905962|FG000|Overall Study|coagulation disorder|0|||
149116669|NCT01895101|537905963|FG001|Overall Study|coagulation disorder|1|||
149116670|NCT01895101|537905964|FG002|Overall Study|coagulation disorder|0|||
149116671|NCT00436852|537905965|FG000|Overall Study|Death|23|||
149116672|NCT00436852|537905966|FG001|Overall Study|Death|34|||
149116673|NCT00436852|537905965|FG000|Overall Study|Lack of Efficacy|9|||
149116674|NCT00436852|537905966|FG001|Overall Study|Lack of Efficacy|7|||
149116675|NCT00436852|537905965|FG000|Overall Study|Withdrawal by Subject|2|||
149116676|NCT00436852|537905966|FG001|Overall Study|Withdrawal by Subject|4|||
149116677|NCT00436852|537905965|FG000|Overall Study|Ineligible|1|||
149116678|NCT00436852|537905966|FG001|Overall Study|Ineligible|0|||
149116679|NCT00370682|537905967|FG000|Overall Study|Moved from area|0|||
149116680|NCT00370682|537905968|FG001|Overall Study|Moved from area|2|||
149116681|NCT00370682|537905969|FG002|Overall Study|Moved from area|0|||
149116682|NCT00370682|537905967|FG000|Overall Study|Lost to Follow-up|0|||
149116683|NCT00370682|537905968|FG001|Overall Study|Lost to Follow-up|1|||
149116684|NCT00370682|537905969|FG002|Overall Study|Lost to Follow-up|1|||
149116685|NCT03167359|537905970|FG000|Overall Study|Physician Decision|1|||
149116686|NCT03167359|537905970|FG000|Overall Study|Lost to Follow-up|1|||
149116687|NCT03339583|537905971|FG000|First Intervention (14 Days)|Adverse Event|1|||
149116688|NCT03339583|537905972|FG001|First Intervention (14 Days)|Adverse Event|0|||
149116689|NCT03339583|537905971|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
149116690|NCT03339583|537905972|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
149116691|NCT03339583|537905971|FG000|Second Intervention (14 Days)|Adverse Event|0|||
149116692|NCT03339583|537905972|FG001|Second Intervention (14 Days)|Adverse Event|1|||
149116693|NCT03339583|537905971|FG000|Follow-up (14 Days)|Physician Decision|6|||
149116694|NCT03339583|537905972|FG001|Follow-up (14 Days)|Physician Decision|3|||
149116695|NCT00943852|537905973|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116696|NCT00943852|537905974|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116697|NCT00943852|537905975|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116698|NCT00943852|537905976|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
149116699|NCT00943852|537905977|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116700|NCT00943852|537905978|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116701|NCT00943852|537905979|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116702|NCT00943852|537905980|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116703|NCT00943852|537905981|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116704|NCT00943852|537905982|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
149116705|NCT00943852|537905973|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116706|NCT00943852|537905974|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116707|NCT00943852|537905975|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116708|NCT00943852|537905976|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116709|NCT00943852|537905977|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116710|NCT00943852|537905978|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
149116711|NCT00943852|537905979|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116712|NCT00943852|537905980|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116713|NCT00943852|537905981|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116714|NCT00943852|537905982|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
149116715|NCT00943852|537905973|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116716|NCT00943852|537905974|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116717|NCT00943852|537905975|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116718|NCT00943852|537905976|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116719|NCT00943852|537905977|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116720|NCT00943852|537905978|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116721|NCT00943852|537905979|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
149116722|NCT00943852|537905980|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116723|NCT00943852|537905981|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116724|NCT00943852|537905982|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
149116725|NCT00943852|537905973|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116726|NCT00943852|537905974|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116727|NCT00943852|537905975|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116728|NCT00943852|537905976|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116729|NCT00943852|537905977|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116730|NCT00943852|537905978|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116731|NCT00943852|537905979|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116732|NCT00943852|537905980|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
149116733|NCT00943852|537905981|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116734|NCT00943852|537905982|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
149116735|NCT00943852|537905973|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
149116736|NCT00943852|537905974|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149116737|NCT00943852|537905975|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
149116738|NCT00943852|537905976|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
149116739|NCT00943852|537905977|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149116740|NCT00943852|537905978|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149116741|NCT00943852|537905979|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
149116742|NCT00943852|537905980|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149116743|NCT00943852|537905981|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149116744|NCT00943852|537905982|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
149116745|NCT00734591|537905983|FG000|Screening for Prospective Period|Site did not participate|1604|||
149116746|NCT00734591|537905984|FG001|Screening for Prospective Period|Site did not participate|1488|||
149116747|NCT00734591|537905983|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
149116748|NCT00734591|537905984|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
149116749|NCT00734591|537905983|FG000|Prospective Period|Withdrawal by Subject|11|||
149116750|NCT00734591|537905984|FG001|Prospective Period|Withdrawal by Subject|9|||
149116751|NCT00734591|537905983|FG000|Prospective Period|Lost to Follow-up|37|||
149116752|NCT00734591|537905984|FG001|Prospective Period|Lost to Follow-up|33|||
149116753|NCT00734591|537905983|FG000|Prospective Period|Study Terminated|1|||
149116754|NCT00734591|537905984|FG001|Prospective Period|Study Terminated|0|||
149116755|NCT00734591|537905983|FG000|Prospective Period|Other|2|||
149116756|NCT00734591|537905984|FG001|Prospective Period|Other|2|||
149116757|NCT01656200|537905985|FG000|Overall Study|Withdrawal by Subject|1|||
149116758|NCT00730275|537905986|FG000|Overall Study|Withdrawal by Subject|0|||
149116759|NCT00730275|537905987|FG001|Overall Study|Withdrawal by Subject|0|||
149116760|NCT00730275|537905988|FG002|Overall Study|Withdrawal by Subject|0|||
149116761|NCT00730275|537905989|FG003|Overall Study|Withdrawal by Subject|1|||
149116762|NCT03921723|537905995|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
149116763|NCT03921723|537905995|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
149116764|NCT03015129|537905996|FG000|Overall Study|Death|2|||
149116765|NCT03015129|537905997|FG001|Overall Study|Death|2|||
149116766|NCT03015129|537905996|FG000|Overall Study|Lost to Follow-up|0|||
149116767|NCT03015129|537905997|FG001|Overall Study|Lost to Follow-up|1|||
149116768|NCT03015129|537905996|FG000|Overall Study|Progression of disease|38|||
149116769|NCT03015129|537905997|FG001|Overall Study|Progression of disease|33|||
149116770|NCT03015129|537905996|FG000|Overall Study|Adverse Event|0|||
149116771|NCT03015129|537905997|FG001|Overall Study|Adverse Event|4|||
149116772|NCT00338962|537905999|FG000|Overall Study|Lost to Follow-up|3|||
149116773|NCT00338962|537906000|FG001|Overall Study|Lost to Follow-up|3|||
149116774|NCT00338962|537906001|FG002|Overall Study|Lost to Follow-up|2|||
149116775|NCT00338962|537906002|FG003|Overall Study|Lost to Follow-up|3|||
149116776|NCT00338962|537905999|FG000|Overall Study|Withdrawal by Subject|1|||
149116777|NCT00338962|537906000|FG001|Overall Study|Withdrawal by Subject|0|||
149116778|NCT00338962|537906001|FG002|Overall Study|Withdrawal by Subject|0|||
149116779|NCT00338962|537906002|FG003|Overall Study|Withdrawal by Subject|0|||
149116780|NCT00338962|537905999|FG000|Overall Study|No Transportation|2|||
149116781|NCT00338962|537906000|FG001|Overall Study|No Transportation|0|||
149116782|NCT00338962|537906001|FG002|Overall Study|No Transportation|0|||
149116783|NCT00338962|537906002|FG003|Overall Study|No Transportation|0|||
149116784|NCT00338962|537905999|FG000|Overall Study|Time Constraint|2|||
149116785|NCT00338962|537906000|FG001|Overall Study|Time Constraint|0|||
149116786|NCT00338962|537906001|FG002|Overall Study|Time Constraint|0|||
149116787|NCT00338962|537906002|FG003|Overall Study|Time Constraint|0|||
149116788|NCT00338962|537905999|FG000|Overall Study|Moved|0|||
149116789|NCT00338962|537906000|FG001|Overall Study|Moved|1|||
149116790|NCT00338962|537906001|FG002|Overall Study|Moved|0|||
149116791|NCT00338962|537906002|FG003|Overall Study|Moved|0|||
149116792|NCT00338962|537905999|FG000|Overall Study|Adverse Event|0|||
149116793|NCT00338962|537906000|FG001|Overall Study|Adverse Event|0|||
149116794|NCT00338962|537906001|FG002|Overall Study|Adverse Event|2|||
149116795|NCT00338962|537906002|FG003|Overall Study|Adverse Event|0|||
149116796|NCT00338962|537905999|FG000|Overall Study|Poor Compliance|0|||
149116797|NCT00338962|537906000|FG001|Overall Study|Poor Compliance|0|||
149116798|NCT00338962|537906001|FG002|Overall Study|Poor Compliance|2|||
149116799|NCT00338962|537906002|FG003|Overall Study|Poor Compliance|0|||
149116800|NCT03046121|537906003|FG000|Overall Study|Death|32|||
149116801|NCT03046121|537906004|FG001|Overall Study|Death|60|||
149116802|NCT03046121|537906003|FG000|Overall Study|Withdrawal by Subject|14|||
149116803|NCT03046121|537906004|FG001|Overall Study|Withdrawal by Subject|12|||
149116804|NCT03214640|537906005|FG000|Overall Study|Protocol Violation|1|||
149116805|NCT03214640|537906006|FG001|Overall Study|Protocol Violation|2|||
149116806|NCT03214640|537906007|FG002|Overall Study|Protocol Violation|1|||
149116807|NCT03214640|537906008|FG003|Overall Study|Protocol Violation|4|||
149116808|NCT04155047|537906009|FG000|Overall Study|Adverse Event|1|||
149116809|NCT04155047|537906010|FG001|Overall Study|Adverse Event|0|||
149119477|NCT01327495|537916351|FG000|Overall Study|Withdrawal by Subject|0|||
149116810|NCT04155047|537906009|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
149116811|NCT04155047|537906010|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
149116812|NCT04488770|537906011|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116813|NCT04488770|537906012|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116814|NCT04488770|537906013|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116815|NCT04488770|537906014|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
149116816|NCT04488770|537906015|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116817|NCT04488770|537906016|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116818|NCT04488770|537906017|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116819|NCT04488770|537906018|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116820|NCT04488770|537906019|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116821|NCT04488770|537906020|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116822|NCT04488770|537906021|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116823|NCT04488770|537906022|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116824|NCT04488770|537906023|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
149116825|NCT04488770|537906011|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
149116826|NCT04488770|537906012|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116827|NCT04488770|537906013|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116828|NCT04488770|537906014|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116829|NCT04488770|537906015|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116830|NCT04488770|537906016|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116831|NCT04488770|537906017|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116832|NCT04488770|537906018|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116833|NCT04488770|537906019|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116834|NCT04488770|537906020|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116835|NCT04488770|537906021|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116836|NCT04488770|537906022|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116837|NCT04488770|537906023|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
149116838|NCT04488770|537906011|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116839|NCT04488770|537906012|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116840|NCT04488770|537906013|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116841|NCT04488770|537906014|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116842|NCT04488770|537906015|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116843|NCT04488770|537906016|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
149116844|NCT04488770|537906017|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
149116845|NCT04488770|537906018|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116846|NCT04488770|537906019|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116847|NCT04488770|537906020|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116848|NCT04488770|537906021|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116849|NCT04488770|537906022|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116850|NCT04488770|537906023|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
149116851|NCT04488770|537906011|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116852|NCT04488770|537906012|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116853|NCT04488770|537906013|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116854|NCT04488770|537906014|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116855|NCT04488770|537906015|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
149116856|NCT04488770|537906016|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116857|NCT04488770|537906017|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116858|NCT04488770|537906018|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116859|NCT04488770|537906019|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116860|NCT04488770|537906020|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116861|NCT04488770|537906021|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116862|NCT04488770|537906022|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116863|NCT04488770|537906023|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
149116864|NCT03547739|537906024|FG000|Overall Study|Death|0|||
149116865|NCT03547739|537906025|FG001|Overall Study|Death|1|||
149116866|NCT03547739|537906026|FG002|Overall Study|Death|5|||
149116867|NCT03547739|537906024|FG000|Overall Study|Adverse Event|24|||
149116868|NCT03547739|537906025|FG001|Overall Study|Adverse Event|11|||
149116869|NCT03547739|537906026|FG002|Overall Study|Adverse Event|13|||
149116870|NCT03547739|537906024|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
149116871|NCT03547739|537906025|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
149116872|NCT03547739|537906026|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
149116873|NCT03547739|537906024|FG000|Overall Study|Lost to Follow-up|80|||
149116874|NCT03547739|537906025|FG001|Overall Study|Lost to Follow-up|84|||
149116875|NCT03547739|537906026|FG002|Overall Study|Lost to Follow-up|116|||
149116876|NCT00635661|537906032|FG000|Overall Study|Withdrawal by Subject|4|||
149116877|NCT00403767|537906033|FG000|Overall Study|Adverse Event|993|||
149116878|NCT00403767|537906034|FG001|Overall Study|Adverse Event|919|||
149116879|NCT00403767|537906033|FG000|Overall Study|Non-compliant with study medication|134|||
149116880|NCT00403767|537906034|FG001|Overall Study|Non-compliant with study medication|164|||
149116881|NCT00403767|537906033|FG000|Overall Study|Consent withdrawn|671|||
149116882|NCT00403767|537906034|FG001|Overall Study|Consent withdrawn|673|||
149116883|NCT00403767|537906033|FG000|Overall Study|Investigator dec./not protocol-related|191|||
149116884|NCT00403767|537906034|FG001|Overall Study|Investigator dec./not protocol-related|178|||
149116885|NCT00403767|537906033|FG000|Overall Study|Lost to Follow-up|6|||
149116886|NCT00403767|537906034|FG001|Overall Study|Lost to Follow-up|8|||
149116887|NCT00403767|537906033|FG000|Overall Study|Protocol Violation|142|||
149116888|NCT00403767|537906034|FG001|Overall Study|Protocol Violation|124|||
149116889|NCT00403767|537906033|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
149116890|NCT00403767|537906034|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
149116891|NCT00403767|537906033|FG000|Overall Study|Study terminated by sponsor|82|||
149116892|NCT00403767|537906034|FG001|Overall Study|Study terminated by sponsor|69|||
149116893|NCT00403767|537906033|FG000|Overall Study|Missing/incomplete data|1|||
149116894|NCT00403767|537906034|FG001|Overall Study|Missing/incomplete data|1|||
149116895|NCT03192475|537906041|FG000|Overall Study|Death|0|||
149116896|NCT03192475|537906042|FG001|Overall Study|Death|1|||
149116897|NCT03192475|537906041|FG000|Overall Study|Lost to Follow-up|13|||
149116898|NCT03192475|537906042|FG001|Overall Study|Lost to Follow-up|8|||
149116899|NCT01641159|537906043|FG000|Overall Study|Lost to Follow-up|2|||
149116900|NCT01641159|537906044|FG001|Overall Study|Lost to Follow-up|1|||
149116901|NCT01641159|537906043|FG000|Overall Study|Withdrawal by Subject|0|||
149116902|NCT01641159|537906044|FG001|Overall Study|Withdrawal by Subject|1|||
149116903|NCT00798590|537906045|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
149116904|NCT00798590|537906046|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
149116905|NCT05330676|537906049|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
149116906|NCT05330676|537906050|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
149116907|NCT02045875|537906053|FG000|Overall Study|Lost to Follow-up|3|||
149116908|NCT02045875|537906054|FG001|Overall Study|Lost to Follow-up|0|||
149116909|NCT02045875|537906053|FG000|Overall Study|Withdrawal by Subject|4|||
149116910|NCT02045875|537906054|FG001|Overall Study|Withdrawal by Subject|3|||
149116911|NCT01276379|537906055|FG000|Overall Study|Screening failure|40|||
149116912|NCT01743989|537906056|FG000|Treatment Phase|Unstable MR4.0|0|||
149116913|NCT01743989|537906057|FG001|Treatment Phase|Unstable MR4.0|6|||
149116914|NCT01743989|537906058|FG002|Treatment Phase|Unstable MR4.0|263|||
149116915|NCT01743989|537906056|FG000|Treatment Phase|Adverse Event|0|||
149116916|NCT01743989|537906057|FG001|Treatment Phase|Adverse Event|4|||
149116917|NCT01743989|537906058|FG002|Treatment Phase|Adverse Event|67|||
149116918|NCT01743989|537906056|FG000|Treatment Phase|Withdrawal by Subject|1|||
149116919|NCT01743989|537906057|FG001|Treatment Phase|Withdrawal by Subject|3|||
149116920|NCT01743989|537906058|FG002|Treatment Phase|Withdrawal by Subject|28|||
149116921|NCT01743989|537906056|FG000|Treatment Phase|Death|0|||
149116922|NCT01743989|537906057|FG001|Treatment Phase|Death|1|||
149116923|NCT01743989|537906058|FG002|Treatment Phase|Death|3|||
149116924|NCT01743989|537906056|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
149116925|NCT01743989|537906057|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
149116926|NCT01743989|537906058|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
149116927|NCT01743989|537906056|FG000|Treatment Phase|Protocol deviation|0|||
149116928|NCT01743989|537906057|FG001|Treatment Phase|Protocol deviation|0|||
149116929|NCT01743989|537906058|FG002|Treatment Phase|Protocol deviation|3|||
149116930|NCT01743989|537906056|FG000|Treatment Phase|Pregnancy|0|||
149116931|NCT01743989|537906057|FG001|Treatment Phase|Pregnancy|0|||
149116932|NCT01743989|537906058|FG002|Treatment Phase|Pregnancy|2|||
149116933|NCT01743989|537906056|FG000|Treatment Phase|Lost to Follow-up|0|||
149116934|NCT01743989|537906057|FG001|Treatment Phase|Lost to Follow-up|0|||
149116935|NCT01743989|537906058|FG002|Treatment Phase|Lost to Follow-up|2|||
149116936|NCT01743989|537906056|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
149116937|NCT01743989|537906057|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
149116938|NCT01743989|537906058|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
149116939|NCT01743989|537906056|FG000|Treatment Phase|Administrative problems|0|||
149116940|NCT01743989|537906057|FG001|Treatment Phase|Administrative problems|0|||
149116941|NCT01743989|537906058|FG002|Treatment Phase|Administrative problems|1|||
149116942|NCT01743989|537906056|FG000|Treatment Phase|New cancer (CML) therapy|0|||
149116943|NCT01743989|537906057|FG001|Treatment Phase|New cancer (CML) therapy|1|||
149116944|NCT01743989|537906058|FG002|Treatment Phase|New cancer (CML) therapy|0|||
149116945|NCT01743989|537906056|FG000|Treatment Phase|Physician Decision|0|||
149116946|NCT01743989|537906057|FG001|Treatment Phase|Physician Decision|0|||
149116947|NCT01743989|537906058|FG002|Treatment Phase|Physician Decision|3|||
149116948|NCT01743989|537906056|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
149116949|NCT01743989|537906057|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
149116950|NCT01743989|537906058|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
149116951|NCT01743989|537906056|FG000|Treatment Phase|Not randomized by mistake|0|||
149116952|NCT01743989|537906057|FG001|Treatment Phase|Not randomized by mistake|0|||
149116953|NCT01743989|537906058|FG002|Treatment Phase|Not randomized by mistake|1|||
149116954|NCT01743989|537906056|FG000|Treatment Phase|Included by mistake|0|||
149116955|NCT01743989|537906057|FG001|Treatment Phase|Included by mistake|0|||
149116956|NCT01743989|537906058|FG002|Treatment Phase|Included by mistake|1|||
149116957|NCT01743989|537906056|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
149116958|NCT01743989|537906057|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
149116959|NCT01743989|537906058|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
149116960|NCT01743989|537906056|FG000|TFR Phase|Adverse Event|0|||
149116961|NCT01743989|537906057|FG001|TFR Phase|Adverse Event|1|||
149116962|NCT01743989|537906058|FG002|TFR Phase|Adverse Event|0|||
149116963|NCT01743989|537906056|FG000|TFR Phase|Lost to Follow-up|0|||
149116964|NCT01743989|537906057|FG001|TFR Phase|Lost to Follow-up|2|||
149116965|NCT01743989|537906058|FG002|TFR Phase|Lost to Follow-up|0|||
149116966|NCT01743989|537906056|FG000|TFR Phase|Physician Decision|0|||
149116967|NCT01743989|537906057|FG001|TFR Phase|Physician Decision|1|||
149116968|NCT01743989|537906058|FG002|TFR Phase|Physician Decision|0|||
149116969|NCT01743989|537906056|FG000|TFR Phase|Logistical problems|0|||
149116970|NCT01743989|537906057|FG001|TFR Phase|Logistical problems|2|||
149116971|NCT01743989|537906058|FG002|TFR Phase|Logistical problems|0|||
149116972|NCT01743989|537906056|FG000|TFR Phase|Protocol deviation|0|||
149116973|NCT01743989|537906057|FG001|TFR Phase|Protocol deviation|1|||
149116974|NCT01743989|537906058|FG002|TFR Phase|Protocol deviation|0|||
149116975|NCT01743989|537906056|FG000|TFR Phase|Withdrawal by Subject|0|||
149116976|NCT01743989|537906057|FG001|TFR Phase|Withdrawal by Subject|2|||
149116977|NCT01743989|537906058|FG002|TFR Phase|Withdrawal by Subject|0|||
149116978|NCT01743989|537906056|FG000|Re-treatment Phase|Adverse Event|8|||
149116979|NCT01743989|537906057|FG001|Re-treatment Phase|Adverse Event|4|||
149116980|NCT01743989|537906058|FG002|Re-treatment Phase|Adverse Event|0|||
149116981|NCT01743989|537906056|FG000|Re-treatment Phase|Death|1|||
149116982|NCT01743989|537906057|FG001|Re-treatment Phase|Death|1|||
149116983|NCT01743989|537906058|FG002|Re-treatment Phase|Death|0|||
149116984|NCT01743989|537906056|FG000|Re-treatment Phase|Administrative problems|1|||
149116985|NCT01743989|537906057|FG001|Re-treatment Phase|Administrative problems|1|||
149116986|NCT01743989|537906058|FG002|Re-treatment Phase|Administrative problems|0|||
149116987|NCT01743989|537906056|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
149116988|NCT01743989|537906057|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
149116989|NCT01743989|537906058|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
149116990|NCT01743989|537906056|FG000|Re-treatment Phase|Unstable MR|1|||
149116991|NCT01743989|537906057|FG001|Re-treatment Phase|Unstable MR|0|||
149116992|NCT01743989|537906058|FG002|Re-treatment Phase|Unstable MR|0|||
149116993|NCT01743989|537906056|FG000|Re-treatment Phase|Physician Decision|0|||
149116994|NCT01743989|537906057|FG001|Re-treatment Phase|Physician Decision|1|||
149116995|NCT01743989|537906058|FG002|Re-treatment Phase|Physician Decision|0|||
149116996|NCT01743989|537906056|FG000|Re-treatment Phase|Lost to Follow-up|0|||
149116997|NCT01743989|537906057|FG001|Re-treatment Phase|Lost to Follow-up|1|||
149116998|NCT01743989|537906058|FG002|Re-treatment Phase|Lost to Follow-up|0|||
149116999|NCT02731690|537908136|FG000|Overall Study|Adverse Event|1|||
149117000|NCT02731690|537908136|FG000|Overall Study|Withdrawal by Subject|3|||
149117001|NCT02731690|537908136|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
149117002|NCT03828747|537908137|FG000|Double-Blind Treatment Period|Adverse Event|6|||
149117003|NCT03828747|537908138|FG001|Double-Blind Treatment Period|Adverse Event|6|||
149117004|NCT03828747|537908137|FG000|Double-Blind Treatment Period|Death|1|||
149117005|NCT03828747|537908138|FG001|Double-Blind Treatment Period|Death|1|||
149117006|NCT03828747|537908137|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
149117007|NCT03828747|537908138|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
149117008|NCT03828747|537908137|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
149117009|NCT03828747|537908138|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
149117010|NCT03828747|537908137|FG000|Double-Blind Treatment Period|Physician Decision|1|||
149117011|NCT03828747|537908138|FG001|Double-Blind Treatment Period|Physician Decision|4|||
149117012|NCT03828747|537908137|FG000|Double-Blind Treatment Period|Various reasons|5|||
149117013|NCT03828747|537908138|FG001|Double-Blind Treatment Period|Various reasons|3|||
149117014|NCT03828747|537908137|FG000|Open-Label Extension|Adverse Event|9|||
149117015|NCT03828747|537908138|FG001|Open-Label Extension|Adverse Event|7|||
149117016|NCT03828747|537908137|FG000|Open-Label Extension|Death|0|||
149117017|NCT03828747|537908138|FG001|Open-Label Extension|Death|2|||
149117018|NCT03828747|537908137|FG000|Open-Label Extension|Lost to Follow-up|4|||
149117019|NCT03828747|537908138|FG001|Open-Label Extension|Lost to Follow-up|0|||
149117020|NCT03828747|537908137|FG000|Open-Label Extension|Withdrawal by Subject|31|||
149117021|NCT03828747|537908138|FG001|Open-Label Extension|Withdrawal by Subject|30|||
149117022|NCT03828747|537908137|FG000|Open-Label Extension|Various reasons|4|||
149117023|NCT03828747|537908138|FG001|Open-Label Extension|Various reasons|4|||
149117024|NCT03828747|537908137|FG000|Open-Label Extension|Physician Decision|6|||
149117025|NCT03828747|537908138|FG001|Open-Label Extension|Physician Decision|2|||
149117026|NCT02898077|537908142|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
149117027|NCT02898077|537908143|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
149117028|NCT02898077|537908142|FG000|Overall Study|Lost to Follow-up|4|||
149117029|NCT02898077|537908143|FG001|Overall Study|Lost to Follow-up|3|||
149117030|NCT02898077|537908142|FG000|Overall Study|Physician Decision|0|||
149117031|NCT02898077|537908143|FG001|Overall Study|Physician Decision|2|||
149117032|NCT02898077|537908142|FG000|Overall Study|Sponsor Decision|32|||
149117033|NCT02898077|537908143|FG001|Overall Study|Sponsor Decision|13|||
149117034|NCT02898077|537908142|FG000|Overall Study|Withdrawal by Subject|6|||
149117035|NCT02898077|537908143|FG001|Overall Study|Withdrawal by Subject|3|||
149117036|NCT02898077|537908142|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
149117037|NCT02898077|537908143|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
149117038|NCT02898077|537908142|FG000|Overall Study|Ended extension period|3|||
149117039|NCT02898077|537908143|FG001|Overall Study|Ended extension period|0|||
149117040|NCT00490490|537908144|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
149117041|NCT00490490|537908144|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
149117042|NCT03207451|537908145|FG000|Overall Study|scheduling conflict|1|||
149117043|NCT03207451|537908146|FG001|Overall Study|scheduling conflict|0|||
149117044|NCT03207451|537908147|FG002|Overall Study|scheduling conflict|2|||
149117045|NCT03207451|537908148|FG003|Overall Study|scheduling conflict|2|||
149117046|NCT03207451|537908145|FG000|Overall Study|Adverse Event|0|||
149117047|NCT03207451|537908146|FG001|Overall Study|Adverse Event|0|||
149117048|NCT03207451|537908147|FG002|Overall Study|Adverse Event|0|||
149117049|NCT03207451|537908148|FG003|Overall Study|Adverse Event|1|||
149117050|NCT02141620|537908149|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
149117051|NCT02141620|537908150|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
149117052|NCT00772330|537908151|FG000|Overall Study|Lost to Follow-up|3|||
149117053|NCT01519089|537908152|FG000|Overall Study|Adverse Event|4|||
149117054|NCT01519089|537908153|FG001|Overall Study|Adverse Event|4|||
149117055|NCT01519089|537908152|FG000|Overall Study|Lack of Efficacy|0|||
149117056|NCT01519089|537908153|FG001|Overall Study|Lack of Efficacy|2|||
149117057|NCT01519089|537908152|FG000|Overall Study|Lost to Follow-up|1|||
149117058|NCT01519089|537908153|FG001|Overall Study|Lost to Follow-up|0|||
149117059|NCT01519089|537908152|FG000|Overall Study|Withdrawal by Subject|0|||
149117060|NCT01519089|537908153|FG001|Overall Study|Withdrawal by Subject|2|||
149117061|NCT01519089|537908152|FG000|Overall Study|Other|2|||
149117062|NCT01519089|537908153|FG001|Overall Study|Other|6|||
149117063|NCT01519089|537908152|FG000|Overall Study|Not received study drug|0|||
149117064|NCT01519089|537908153|FG001|Overall Study|Not received study drug|1|||
149117065|NCT00127205|537908154|FG000|Overall Study|Adverse Event|228|||
149117066|NCT00127205|537908155|FG001|Overall Study|Adverse Event|387|||
149117067|NCT00127205|537908156|FG002|Overall Study|Adverse Event|273|||
149117068|NCT00127205|537908154|FG000|Overall Study|Death|8|||
149117069|NCT00127205|537908155|FG001|Overall Study|Death|6|||
149117070|NCT00127205|537908156|FG002|Overall Study|Death|5|||
149117071|NCT00127205|537908154|FG000|Overall Study|Withdrawal by Subject|318|||
149117072|NCT00127205|537908155|FG001|Overall Study|Withdrawal by Subject|310|||
149117073|NCT00127205|537908156|FG002|Overall Study|Withdrawal by Subject|172|||
149117074|NCT00127205|537908154|FG000|Overall Study|Other-non protocol specified|142|||
149117075|NCT00127205|537908155|FG001|Overall Study|Other-non protocol specified|129|||
149117076|NCT00127205|537908156|FG002|Overall Study|Other-non protocol specified|77|||
149117077|NCT00127205|537908154|FG000|Overall Study|Data not reported|6|||
149117078|NCT00127205|537908155|FG001|Overall Study|Data not reported|10|||
149117079|NCT00127205|537908156|FG002|Overall Study|Data not reported|1|||
149117080|NCT00127205|537908154|FG000|Overall Study|Progression|127|||
149117081|NCT00127205|537908155|FG001|Overall Study|Progression|131|||
149117082|NCT00127205|537908156|FG002|Overall Study|Progression|84|||
149117083|NCT01353859|537908157|FG000|Overall Study|Adverse Event|3|||
149117084|NCT01353859|537908157|FG000|Overall Study|Lack of Efficacy|1|||
149117085|NCT01659853|537908162|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
149117086|NCT01659853|537908163|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
149117087|NCT01659853|537908162|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
149117088|NCT01659853|537908163|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
149117089|NCT05032872|537908164|FG000|Overall Study|Adverse Event|1|||
149117090|NCT05032872|537908165|FG001|Overall Study|Adverse Event|0|||
149117091|NCT05032872|537908164|FG000|Overall Study|Lost to Follow-up|2|||
149117092|NCT05032872|537908165|FG001|Overall Study|Lost to Follow-up|4|||
149117093|NCT05032872|537908164|FG000|Overall Study|Withdrawal by Subject|4|||
149117094|NCT05032872|537908165|FG001|Overall Study|Withdrawal by Subject|3|||
149117095|NCT00910039|537908166|FG000|Overall Study|Physician Decision|1|||
149117096|NCT00406692|537908171|FG000|Overall Study|Withdrawal by Subject|4|||
149117097|NCT00406692|537908171|FG000|Overall Study|Physician Decision|1|||
149117098|NCT00406692|537908171|FG000|Overall Study|Adverse Event|1|||
149117099|NCT00406692|537908171|FG000|Overall Study|Lack of Efficacy|1|||
149117100|NCT00400725|537908172|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
149117101|NCT00400725|537908173|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
149117102|NCT00400725|537908174|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
149119797|NCT00006011|537917970|FG001|Overall Study|Death|1|||
149117103|NCT00400725|537908172|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
149117104|NCT00400725|537908173|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
149117105|NCT00400725|537908174|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
149117106|NCT00400725|537908172|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
149117107|NCT00400725|537908173|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
149117108|NCT00400725|537908174|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
149117109|NCT00400725|537908172|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
149117110|NCT00400725|537908173|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
149117111|NCT00400725|537908174|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
149117112|NCT00400725|537908172|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
149117113|NCT00400725|537908173|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
149117114|NCT00400725|537908174|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
149117115|NCT00400725|537908172|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
149117116|NCT00400725|537908173|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
149117117|NCT00400725|537908174|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
149117118|NCT00400725|537908172|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
149117119|NCT00400725|537908173|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
149117120|NCT00400725|537908174|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
149117121|NCT00400725|537908172|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
149117122|NCT00400725|537908173|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
149117123|NCT00400725|537908174|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
149117124|NCT00400725|537908172|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
149117125|NCT00400725|537908173|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
149117126|NCT00400725|537908174|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
149117127|NCT01744392|537908177|FG000|Overall Study|Physician Decision|1|||
149117128|NCT01696955|537908185|FG000|Main Study|Protocol Violation|1|||
149117129|NCT01696955|537908186|FG001|Main Study|Protocol Violation|0|||
149117130|NCT01696955|537908185|FG000|Main Study|Withdrawal by Subject|1|||
149117131|NCT01696955|537908186|FG001|Main Study|Withdrawal by Subject|1|||
149117132|NCT00573859|537908189|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
149117133|NCT00573859|537908189|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
149117134|NCT01280357|537908194|FG000|Overall Study|Excluded no internal monitoring|14|||
149117135|NCT01280357|537908194|FG000|Overall Study|IInsufficient data/No data supplied|12|||
149117136|NCT02229851|537908195|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
149117137|NCT02229851|537908196|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
149117138|NCT02229851|537908197|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
149117139|NCT02229851|537908198|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
149117140|NCT02229851|537908199|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
149117141|NCT02229851|537908200|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
149117142|NCT02229851|537908201|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
149117143|NCT02229851|537908195|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
149117144|NCT02229851|537908196|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
149117145|NCT02229851|537908197|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
149117146|NCT02229851|537908198|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
149117147|NCT02229851|537908199|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
149117148|NCT02229851|537908200|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
149117149|NCT02229851|537908201|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
149117150|NCT02229851|537908195|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
149117151|NCT02229851|537908196|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
149117152|NCT02229851|537908197|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
149117153|NCT02229851|537908198|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
149117154|NCT02229851|537908199|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
149117155|NCT02229851|537908200|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
149117156|NCT02229851|537908201|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
149117157|NCT02229851|537908195|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149117158|NCT02229851|537908196|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149117159|NCT02229851|537908197|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
149117160|NCT02229851|537908198|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149117161|NCT02229851|537908199|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149117162|NCT02229851|537908200|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149117163|NCT02229851|537908201|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
149117164|NCT02229851|537908195|FG000|Main Phase (Double-blind Phase)|Death|1|||
149117165|NCT02229851|537908196|FG001|Main Phase (Double-blind Phase)|Death|1|||
149117166|NCT02229851|537908197|FG002|Main Phase (Double-blind Phase)|Death|0|||
149117167|NCT02229851|537908198|FG003|Main Phase (Double-blind Phase)|Death|0|||
149117168|NCT02229851|537908199|FG004|Main Phase (Double-blind Phase)|Death|0|||
149117169|NCT02229851|537908200|FG005|Main Phase (Double-blind Phase)|Death|0|||
149117170|NCT02229851|537908201|FG006|Main Phase (Double-blind Phase)|Death|0|||
149117171|NCT02229851|537908195|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
149117172|NCT02229851|537908196|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
149117173|NCT02229851|537908197|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
149117174|NCT02229851|537908198|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
149117175|NCT02229851|537908199|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
149117176|NCT02229851|537908200|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
149117177|NCT02229851|537908201|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
149117178|NCT02229851|537908195|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
149117179|NCT02229851|537908196|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
149117180|NCT02229851|537908197|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
149117181|NCT02229851|537908198|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
149117182|NCT02229851|537908199|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
149117183|NCT02229851|537908200|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
149117184|NCT02229851|537908201|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
149117185|NCT02229851|537908195|FG000|Extension Phase (Open-label Phase)|Death|0|||
149117186|NCT02229851|537908196|FG001|Extension Phase (Open-label Phase)|Death|0|||
149117187|NCT02229851|537908197|FG002|Extension Phase (Open-label Phase)|Death|0|||
149117188|NCT02229851|537908198|FG003|Extension Phase (Open-label Phase)|Death|1|||
149117189|NCT02229851|537908199|FG004|Extension Phase (Open-label Phase)|Death|0|||
149117190|NCT02229851|537908200|FG005|Extension Phase (Open-label Phase)|Death|1|||
149117191|NCT02229851|537908201|FG006|Extension Phase (Open-label Phase)|Death|1|||
149117192|NCT03541200|537908202|FG000|Overall Study|Adverse Event|19|||
149117193|NCT03541200|537908202|FG000|Overall Study|Death|1|||
149117194|NCT03541200|537908202|FG000|Overall Study|Lost to Follow-up|10|||
149117195|NCT03541200|537908202|FG000|Overall Study|Physician Decision|1|||
149117196|NCT03541200|537908202|FG000|Overall Study|Protocol Violation|51|||
149117197|NCT03541200|537908202|FG000|Overall Study|Withdrawal by Subject|23|||
149117198|NCT03541200|537908202|FG000|Overall Study|other|8|||
149117199|NCT00688870|537908203|FG000|Infant Series|Parent or legal guardian request|4|||
149117200|NCT00688870|537908204|FG001|Infant Series|Parent or legal guardian request|0|||
149117201|NCT00992225|537908205|FG000|Overall Study|Entry Criteria Not Met|8|||
149117202|NCT00992225|537908205|FG000|Overall Study|Adverse Event|2|||
149117217|NCT03466073|537908208|FG000|Overall Study|Death|1|||
149117218|NCT03466073|537908209|FG001|Overall Study|Death|0|||
149117219|NCT03466073|537908210|FG002|Overall Study|Death|0|||
149117220|NCT03466073|537908211|FG003|Overall Study|Death|0|||
149117221|NCT03466073|537908212|FG004|Overall Study|Death|0|||
149117222|NCT03466073|537908213|FG005|Overall Study|Death|1|||
149117223|NCT00744757|537908214|FG000|Overall Study|Objective disease progression|7|||
149117224|NCT00744757|537908214|FG000|Overall Study|Physician Decision|5|||
149117225|NCT00744757|537908214|FG000|Overall Study|Withdrawal by Subject|1|||
149117226|NCT00744757|537908214|FG000|Overall Study|Death|6|||
149117227|NCT00744757|537908214|FG000|Overall Study|Adverse Event|2|||
149117228|NCT03682302|537908215|FG000|Overall Study|Lost to Follow-up|1|||
149117229|NCT03682302|537908216|FG001|Overall Study|Lost to Follow-up|2|||
149117230|NCT03682302|537908217|FG002|Overall Study|Lost to Follow-up|0|||
149117231|NCT03682302|537908218|FG003|Overall Study|Lost to Follow-up|1|||
149117232|NCT03682302|537908215|FG000|Overall Study|Study drug was not administered|0|||
149117233|NCT03682302|537908216|FG001|Overall Study|Study drug was not administered|0|||
149117234|NCT03682302|537908217|FG002|Overall Study|Study drug was not administered|1|||
149117235|NCT03682302|537908218|FG003|Overall Study|Study drug was not administered|1|||
149117236|NCT00532493|537908219|FG000|Overall Study|Death|1|||
149117237|NCT00532493|537908220|FG001|Overall Study|Death|1|||
149117238|NCT00532493|537908219|FG000|Overall Study|Lost to Follow-up|10|||
149117239|NCT00532493|537908220|FG001|Overall Study|Lost to Follow-up|7|||
149117240|NCT00532493|537908219|FG000|Overall Study|Withdrawal by Subject|7|||
149117241|NCT00532493|537908220|FG001|Overall Study|Withdrawal by Subject|9|||
149117242|NCT00532493|537908219|FG000|Overall Study|Physician Decision|1|||
149117243|NCT00532493|537908220|FG001|Overall Study|Physician Decision|6|||
149117244|NCT00532493|537908219|FG000|Overall Study|Adverse Event|6|||
149117245|NCT00532493|537908220|FG001|Overall Study|Adverse Event|5|||
149117246|NCT00532493|537908219|FG000|Overall Study|Protocol Deviation|1|||
149117247|NCT00532493|537908220|FG001|Overall Study|Protocol Deviation|0|||
149117248|NCT00532493|537908219|FG000|Overall Study|Subject Moved Away|3|||
149117249|NCT00532493|537908220|FG001|Overall Study|Subject Moved Away|1|||
149117250|NCT00532493|537908219|FG000|Overall Study|Contraindicative Medication|1|||
149117251|NCT00532493|537908220|FG001|Overall Study|Contraindicative Medication|0|||
149117252|NCT00888927|537908229|FG000|Overall Study|Adverse Event|0|||
149117253|NCT00888927|537908230|FG001|Overall Study|Adverse Event|0|||
149117254|NCT00888927|537908231|FG002|Overall Study|Adverse Event|0|||
149117255|NCT00888927|537908232|FG003|Overall Study|Adverse Event|1|||
149117256|NCT00888927|537908229|FG000|Overall Study|Withdrawal of consent|0|||
149117257|NCT00888927|537908230|FG001|Overall Study|Withdrawal of consent|0|||
149117258|NCT00888927|537908231|FG002|Overall Study|Withdrawal of consent|0|||
149117259|NCT00888927|537908232|FG003|Overall Study|Withdrawal of consent|1|||
149117260|NCT03459443|537908233|FG000|Overall Study|Lack of Efficacy|3|||
149117261|NCT03459443|537908233|FG000|Overall Study|Adverse Event|1|||
149117262|NCT03459443|537908233|FG000|Overall Study|Sponsor's decision to close the study|18|||
149117263|NCT02153073|537908234|FG000|Overall Study|Case Report Forms Uncollected|230|||
149117264|NCT02153073|537908234|FG000|Overall Study|Protocol Deviation|68|||
149117265|NCT03702231|537908235|FG000|Overall Study|Withdrawal by Subject|1|||
149117266|NCT03702231|537908236|FG001|Overall Study|Withdrawal by Subject|0|||
149117267|NCT03702231|537908237|FG002|Overall Study|Withdrawal by Subject|0|||
149117268|NCT03702231|537908235|FG000|Overall Study|Protocol Violation|0|||
149117269|NCT03702231|537908236|FG001|Overall Study|Protocol Violation|0|||
149117270|NCT03702231|537908237|FG002|Overall Study|Protocol Violation|1|||
149117271|NCT03702231|537908235|FG000|Overall Study|Change in CLL Treatment|0|||
149117272|NCT03702231|537908236|FG001|Overall Study|Change in CLL Treatment|0|||
149117273|NCT03702231|537908237|FG002|Overall Study|Change in CLL Treatment|1|||
149117274|NCT03702231|537908235|FG000|Overall Study|COVID Pandemic|1|||
149117275|NCT03702231|537908236|FG001|Overall Study|COVID Pandemic|4|||
149117276|NCT03702231|537908237|FG002|Overall Study|COVID Pandemic|1|||
149117277|NCT03702231|537908235|FG000|Overall Study|Non-compliance|0|||
149117278|NCT03702231|537908236|FG001|Overall Study|Non-compliance|0|||
149117279|NCT03702231|537908237|FG002|Overall Study|Non-compliance|1|||
149117280|NCT01607476|537908239|FG000|Overall Study|Withdrawal by Subject|1|||
149117281|NCT01607476|537908240|FG001|Overall Study|Withdrawal by Subject|0|||
149117282|NCT01607476|537908241|FG002|Overall Study|Withdrawal by Subject|1|||
149117283|NCT01607476|537908239|FG000|Overall Study|Lost to Follow-up|0|||
149117284|NCT01607476|537908240|FG001|Overall Study|Lost to Follow-up|0|||
149117285|NCT01607476|537908241|FG002|Overall Study|Lost to Follow-up|2|||
149117286|NCT04445987|537908242|FG000|Overall Study|Adverse Event|0|||
149117287|NCT04445987|537908243|FG001|Overall Study|Adverse Event|0|||
149117288|NCT04445987|537908244|FG002|Overall Study|Adverse Event|1|||
149117289|NCT04445987|537908245|FG003|Overall Study|Adverse Event|0|||
149117290|NCT04445987|537908246|FG004|Overall Study|Adverse Event|4|||
149117291|NCT04445987|537908247|FG005|Overall Study|Adverse Event|0|||
149117292|NCT04445987|537908242|FG000|Overall Study|Lost to Follow-up|4|||
149117293|NCT04445987|537908243|FG001|Overall Study|Lost to Follow-up|3|||
149117294|NCT04445987|537908244|FG002|Overall Study|Lost to Follow-up|1|||
149117295|NCT04445987|537908245|FG003|Overall Study|Lost to Follow-up|1|||
149117296|NCT04445987|537908246|FG004|Overall Study|Lost to Follow-up|29|||
149117297|NCT04445987|537908247|FG005|Overall Study|Lost to Follow-up|0|||
149117298|NCT04445987|537908242|FG000|Overall Study|Physician Decision|0|||
149117299|NCT04445987|537908243|FG001|Overall Study|Physician Decision|0|||
149117300|NCT04445987|537908244|FG002|Overall Study|Physician Decision|0|||
149117301|NCT04445987|537908245|FG003|Overall Study|Physician Decision|0|||
149117302|NCT04445987|537908246|FG004|Overall Study|Physician Decision|1|||
149117303|NCT04445987|537908247|FG005|Overall Study|Physician Decision|0|||
149117304|NCT04445987|537908242|FG000|Overall Study|Protocol Violation|1|||
149117305|NCT04445987|537908243|FG001|Overall Study|Protocol Violation|0|||
149117306|NCT04445987|537908244|FG002|Overall Study|Protocol Violation|0|||
149117307|NCT04445987|537908245|FG003|Overall Study|Protocol Violation|0|||
149117308|NCT04445987|537908246|FG004|Overall Study|Protocol Violation|2|||
149117309|NCT04445987|537908247|FG005|Overall Study|Protocol Violation|0|||
149117310|NCT04445987|537908242|FG000|Overall Study|Withdrawal by Subject|4|||
149117311|NCT04445987|537908243|FG001|Overall Study|Withdrawal by Subject|0|||
149117312|NCT04445987|537908244|FG002|Overall Study|Withdrawal by Subject|1|||
149117313|NCT04445987|537908245|FG003|Overall Study|Withdrawal by Subject|0|||
149117314|NCT04445987|537908246|FG004|Overall Study|Withdrawal by Subject|18|||
149117315|NCT04445987|537908247|FG005|Overall Study|Withdrawal by Subject|1|||
149117316|NCT04445987|537908242|FG000|Overall Study|Other reason|0|||
149117317|NCT04445987|537908243|FG001|Overall Study|Other reason|0|||
149117318|NCT04445987|537908244|FG002|Overall Study|Other reason|1|||
149117319|NCT04445987|537908245|FG003|Overall Study|Other reason|0|||
149117320|NCT04445987|537908246|FG004|Overall Study|Other reason|2|||
149117321|NCT04445987|537908247|FG005|Overall Study|Other reason|0|||
149117322|NCT00293059|537908250|FG000|Overall Study|Adverse Event|12|||
149117323|NCT00293059|537908251|FG001|Overall Study|Adverse Event|4|||
149117324|NCT00293059|537908250|FG000|Overall Study|Lack of Efficacy|2|||
149117325|NCT00293059|537908251|FG001|Overall Study|Lack of Efficacy|0|||
149117326|NCT00293059|537908250|FG000|Overall Study|Lost to Follow-up|2|||
149117327|NCT00293059|537908251|FG001|Overall Study|Lost to Follow-up|3|||
149117328|NCT00293059|537908250|FG000|Overall Study|Pregnancy|1|||
149117329|NCT00293059|537908251|FG001|Overall Study|Pregnancy|1|||
149117330|NCT00293059|537908250|FG000|Overall Study|Protocol Violation|2|||
149117331|NCT00293059|537908251|FG001|Overall Study|Protocol Violation|0|||
149117332|NCT00293059|537908250|FG000|Overall Study|Withdrawal by Subject|11|||
149117333|NCT00293059|537908251|FG001|Overall Study|Withdrawal by Subject|5|||
149117334|NCT00293059|537908250|FG000|Overall Study|Participant moved out of state|1|||
149117335|NCT00293059|537908251|FG001|Overall Study|Participant moved out of state|0|||
149117336|NCT00293059|537908250|FG000|Overall Study|Participant stopped study drug|1|||
149117337|NCT00293059|537908251|FG001|Overall Study|Participant stopped study drug|0|||
149117338|NCT00293059|537908250|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
149117339|NCT00293059|537908251|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
149117340|NCT00293059|537908250|FG000|Overall Study|missing|3|||
149117341|NCT00293059|537908251|FG001|Overall Study|missing|5|||
149117342|NCT02001064|537908255|FG000|Overall Study|Withdrawal by Subject|2|||
149117343|NCT02001064|537908256|FG001|Overall Study|Withdrawal by Subject|1|||
149117344|NCT01609062|537908257|FG000|Extension Phase|Terminated by Sponsor|14|||
149117345|NCT01609062|537908258|FG001|Extension Phase|Terminated by Sponsor|9|||
149117346|NCT01609062|537908257|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
149117347|NCT01609062|537908258|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
149117348|NCT01609062|537908257|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
149117349|NCT01609062|537908258|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
149117350|NCT00680992|537908259|FG000|Overall Study|Complete Resection (as per protocol)|25|||
149117351|NCT00680992|537908260|FG001|Overall Study|Complete Resection (as per protocol)|121|||
149117352|NCT00680992|537908261|FG002|Overall Study|Complete Resection (as per protocol)|0|||
149117353|NCT00680992|537908259|FG000|Overall Study|Administrative Decision|83|||
149117354|NCT00680992|537908260|FG001|Overall Study|Administrative Decision|42|||
149117355|NCT00680992|537908261|FG002|Overall Study|Administrative Decision|5|||
149117356|NCT00680992|537908259|FG000|Overall Study|End of Trial|32|||
149117357|NCT00680992|537908260|FG001|Overall Study|End of Trial|12|||
149117358|NCT00680992|537908261|FG002|Overall Study|End of Trial|3|||
149117359|NCT00680992|537908259|FG000|Overall Study|Withdrawal by Subject|33|||
149117360|NCT00680992|537908260|FG001|Overall Study|Withdrawal by Subject|11|||
149117361|NCT00680992|537908261|FG002|Overall Study|Withdrawal by Subject|1|||
149117362|NCT00680992|537908259|FG000|Overall Study|Adverse Event|21|||
149117363|NCT00680992|537908260|FG001|Overall Study|Adverse Event|19|||
149117364|NCT00680992|537908261|FG002|Overall Study|Adverse Event|1|||
149117365|NCT00680992|537908259|FG000|Overall Study|Other|19|||
149117366|NCT00680992|537908260|FG001|Overall Study|Other|14|||
149117367|NCT00680992|537908261|FG002|Overall Study|Other|1|||
149117368|NCT00680992|537908259|FG000|Overall Study|Disease Progression|21|||
149117369|NCT00680992|537908260|FG001|Overall Study|Disease Progression|9|||
149117370|NCT00680992|537908261|FG002|Overall Study|Disease Progression|0|||
149117371|NCT00680992|537908259|FG000|Overall Study|Lost to Follow-up|12|||
149117372|NCT00680992|537908260|FG001|Overall Study|Lost to Follow-up|14|||
149117373|NCT00680992|537908261|FG002|Overall Study|Lost to Follow-up|0|||
149117374|NCT00680992|537908259|FG000|Overall Study|Noncompliance|4|||
149117375|NCT00680992|537908260|FG001|Overall Study|Noncompliance|6|||
149117376|NCT00680992|537908261|FG002|Overall Study|Noncompliance|0|||
149117377|NCT00680992|537908259|FG000|Overall Study|Requirement for Alternative Therapy|8|||
149117378|NCT00680992|537908260|FG001|Overall Study|Requirement for Alternative Therapy|2|||
149117379|NCT00680992|537908261|FG002|Overall Study|Requirement for Alternative Therapy|0|||
149117380|NCT00680992|537908259|FG000|Overall Study|Pregnancy|5|||
149117381|NCT00680992|537908260|FG001|Overall Study|Pregnancy|0|||
149117382|NCT00680992|537908261|FG002|Overall Study|Pregnancy|1|||
149117383|NCT00680992|537908259|FG000|Overall Study|Death|5|||
149117384|NCT00680992|537908260|FG001|Overall Study|Death|1|||
149117385|NCT00680992|537908261|FG002|Overall Study|Death|0|||
149117386|NCT00680992|537908259|FG000|Overall Study|Ineligibility Determined|0|||
149117387|NCT00680992|537908260|FG001|Overall Study|Ineligibility Determined|1|||
149117388|NCT00680992|537908261|FG002|Overall Study|Ineligibility Determined|0|||
149117389|NCT02425904|537908264|FG000|Overall Study|Lost to Follow-up|1|||
149117390|NCT02425904|537908265|FG001|Overall Study|Lost to Follow-up|0|||
149117391|NCT02425904|537908264|FG000|Overall Study|Withdrawal by Subject|2|||
149117392|NCT02425904|537908265|FG001|Overall Study|Withdrawal by Subject|0|||
149117393|NCT02425904|537908264|FG000|Overall Study|Death|0|||
149117394|NCT02425904|537908265|FG001|Overall Study|Death|3|||
149117395|NCT03842358|537908266|FG000|Overall Study|Poor DOT probe contact with breast|2|||
149117396|NCT03842358|537908266|FG000|Overall Study|DOT system problem|1|||
149117397|NCT03842358|537908266|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
149117398|NCT03842358|537908266|FG000|Overall Study|No biopsy after physician review|4|||
149117399|NCT03842358|537908266|FG000|Overall Study|Patient withdrew|2|||
149117400|NCT02626455|537908267|FG000|Overall Study|Other|1|||
149117401|NCT02626455|537908268|FG001|Overall Study|Other|1|||
149117402|NCT02626455|537908269|FG002|Overall Study|Other|0|||
149117403|NCT02626455|537908270|FG003|Overall Study|Other|0|||
149117404|NCT02626455|537908271|FG004|Overall Study|Other|0|||
149117405|NCT02626455|537908272|FG005|Overall Study|Other|17|||
149117406|NCT02626455|537908273|FG006|Overall Study|Other|23|||
149117407|NCT02626455|537908267|FG000|Overall Study|Withdrawal by Subject|1|||
149117408|NCT02626455|537908268|FG001|Overall Study|Withdrawal by Subject|0|||
149117409|NCT02626455|537908269|FG002|Overall Study|Withdrawal by Subject|0|||
149117410|NCT02626455|537908270|FG003|Overall Study|Withdrawal by Subject|0|||
149117411|NCT02626455|537908271|FG004|Overall Study|Withdrawal by Subject|0|||
149117412|NCT02626455|537908272|FG005|Overall Study|Withdrawal by Subject|10|||
149117413|NCT02626455|537908273|FG006|Overall Study|Withdrawal by Subject|6|||
149117414|NCT02626455|537908267|FG000|Overall Study|Physician Decision|0|||
149117415|NCT02626455|537908268|FG001|Overall Study|Physician Decision|2|||
149117416|NCT02626455|537908269|FG002|Overall Study|Physician Decision|2|||
149117417|NCT02626455|537908270|FG003|Overall Study|Physician Decision|2|||
149117418|NCT02626455|537908271|FG004|Overall Study|Physician Decision|1|||
149117419|NCT02626455|537908272|FG005|Overall Study|Physician Decision|10|||
149117420|NCT02626455|537908273|FG006|Overall Study|Physician Decision|3|||
149117421|NCT02626455|537908267|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149117422|NCT02626455|537908268|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149117423|NCT02626455|537908269|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149117424|NCT02626455|537908270|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149117425|NCT02626455|537908271|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149117426|NCT02626455|537908272|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
149117427|NCT02626455|537908273|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
149117428|NCT02626455|537908267|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149117429|NCT02626455|537908268|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149117430|NCT02626455|537908269|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149117431|NCT02626455|537908270|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149117432|NCT02626455|537908271|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149117433|NCT02626455|537908272|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
149117434|NCT02626455|537908273|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
149117435|NCT02626455|537908267|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
149117436|NCT02626455|537908268|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
149117437|NCT02626455|537908269|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
149117438|NCT02626455|537908270|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
149117439|NCT02626455|537908271|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
149117440|NCT02626455|537908272|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
149117441|NCT02626455|537908273|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
149117442|NCT02626455|537908267|FG000|Overall Study|Patient decision|0|||
149117443|NCT02626455|537908268|FG001|Overall Study|Patient decision|1|||
149117444|NCT02626455|537908269|FG002|Overall Study|Patient decision|0|||
149117445|NCT02626455|537908270|FG003|Overall Study|Patient decision|0|||
149117446|NCT02626455|537908271|FG004|Overall Study|Patient decision|1|||
149117447|NCT02626455|537908272|FG005|Overall Study|Patient decision|36|||
149117448|NCT02626455|537908273|FG006|Overall Study|Patient decision|22|||
149117449|NCT02626455|537908267|FG000|Overall Study|Protocol Violation|0|||
149117450|NCT02626455|537908268|FG001|Overall Study|Protocol Violation|0|||
149117451|NCT02626455|537908269|FG002|Overall Study|Protocol Violation|0|||
149117452|NCT02626455|537908270|FG003|Overall Study|Protocol Violation|0|||
149117453|NCT02626455|537908271|FG004|Overall Study|Protocol Violation|0|||
149117454|NCT02626455|537908272|FG005|Overall Study|Protocol Violation|0|||
149117455|NCT02626455|537908273|FG006|Overall Study|Protocol Violation|1|||
149117456|NCT02626455|537908267|FG000|Overall Study|Progressive disease - radiological progression|0|||
149117457|NCT02626455|537908268|FG001|Overall Study|Progressive disease - radiological progression|0|||
149117458|NCT02626455|537908269|FG002|Overall Study|Progressive disease - radiological progression|0|||
149117459|NCT02626455|537908270|FG003|Overall Study|Progressive disease - radiological progression|0|||
149117460|NCT02626455|537908271|FG004|Overall Study|Progressive disease - radiological progression|0|||
149117461|NCT02626455|537908272|FG005|Overall Study|Progressive disease - radiological progression|11|||
149117462|NCT02626455|537908273|FG006|Overall Study|Progressive disease - radiological progression|22|||
149117463|NCT02626455|537908267|FG000|Overall Study|Progressive disease - clinical progression|0|||
149117464|NCT02626455|537908268|FG001|Overall Study|Progressive disease - clinical progression|0|||
149117465|NCT02626455|537908269|FG002|Overall Study|Progressive disease - clinical progression|0|||
149117466|NCT02626455|537908270|FG003|Overall Study|Progressive disease - clinical progression|0|||
149117467|NCT02626455|537908271|FG004|Overall Study|Progressive disease - clinical progression|0|||
149117468|NCT02626455|537908272|FG005|Overall Study|Progressive disease - clinical progression|1|||
149117469|NCT02626455|537908273|FG006|Overall Study|Progressive disease - clinical progression|2|||
149117470|NCT02626455|537908267|FG000|Overall Study|Lost to Follow-up|0|||
149117471|NCT02626455|537908268|FG001|Overall Study|Lost to Follow-up|0|||
149117472|NCT02626455|537908269|FG002|Overall Study|Lost to Follow-up|0|||
149117473|NCT02626455|537908270|FG003|Overall Study|Lost to Follow-up|0|||
149117474|NCT02626455|537908271|FG004|Overall Study|Lost to Follow-up|0|||
149117475|NCT02626455|537908272|FG005|Overall Study|Lost to Follow-up|1|||
149117476|NCT02626455|537908273|FG006|Overall Study|Lost to Follow-up|0|||
149117477|NCT02626455|537908267|FG000|Overall Study|AE not associated with clinical disease progression|1|||
149117478|NCT02626455|537908268|FG001|Overall Study|AE not associated with clinical disease progression|1|||
149117479|NCT02626455|537908269|FG002|Overall Study|AE not associated with clinical disease progression|0|||
149117480|NCT02626455|537908270|FG003|Overall Study|AE not associated with clinical disease progression|2|||
149117481|NCT02626455|537908271|FG004|Overall Study|AE not associated with clinical disease progression|1|||
149117482|NCT02626455|537908272|FG005|Overall Study|AE not associated with clinical disease progression|65|||
149117483|NCT02626455|537908273|FG006|Overall Study|AE not associated with clinical disease progression|21|||
149117484|NCT02626455|537908267|FG000|Overall Study|AE associated with clinical disease progression|0|||
149117485|NCT02626455|537908268|FG001|Overall Study|AE associated with clinical disease progression|0|||
149117486|NCT02626455|537908269|FG002|Overall Study|AE associated with clinical disease progression|0|||
149117487|NCT02626455|537908270|FG003|Overall Study|AE associated with clinical disease progression|0|||
149117488|NCT02626455|537908271|FG004|Overall Study|AE associated with clinical disease progression|0|||
149117489|NCT02626455|537908272|FG005|Overall Study|AE associated with clinical disease progression|1|||
149117490|NCT02626455|537908273|FG006|Overall Study|AE associated with clinical disease progression|2|||
149117491|NCT02626455|537908267|FG000|Overall Study|Study intervention never administered|0|||
149117492|NCT02626455|537908268|FG001|Overall Study|Study intervention never administered|0|||
149117493|NCT02626455|537908269|FG002|Overall Study|Study intervention never administered|0|||
149117494|NCT02626455|537908270|FG003|Overall Study|Study intervention never administered|0|||
149117495|NCT02626455|537908271|FG004|Overall Study|Study intervention never administered|0|||
149117496|NCT02626455|537908272|FG005|Overall Study|Study intervention never administered|1|||
149117497|NCT02626455|537908273|FG006|Overall Study|Study intervention never administered|3|||
149117498|NCT06665919|537908274|FG000|Overall Study|Withdrawal by Subject|4|||
149117499|NCT06665919|537908275|FG001|Overall Study|Withdrawal by Subject|4|||
149117500|NCT06665919|537908276|FG002|Overall Study|Withdrawal by Subject|4|||
149117501|NCT06665919|537908274|FG000|Overall Study|Non-compliance to Treatment|4|||
149117502|NCT06665919|537908275|FG001|Overall Study|Non-compliance to Treatment|1|||
149117503|NCT06665919|537908276|FG002|Overall Study|Non-compliance to Treatment|6|||
149117504|NCT06665919|537908274|FG000|Overall Study|Lost to Follow-up|3|||
149117505|NCT06665919|537908275|FG001|Overall Study|Lost to Follow-up|0|||
149117506|NCT06665919|537908276|FG002|Overall Study|Lost to Follow-up|2|||
149117507|NCT06665919|537908274|FG000|Overall Study|Physician Decision|4|||
149117508|NCT06665919|537908275|FG001|Overall Study|Physician Decision|0|||
149117509|NCT06665919|537908276|FG002|Overall Study|Physician Decision|1|||
149117510|NCT05148962|537908277|FG000|Overall Study|Withdrawal by Subject|1|||
149117511|NCT05148962|537908278|FG001|Overall Study|Withdrawal by Subject|1|||
149117512|NCT05148962|537908279|FG002|Overall Study|Withdrawal by Subject|0|||
149117513|NCT05148962|537908280|FG003|Overall Study|Withdrawal by Subject|1|||
149117514|NCT05148962|537908281|FG004|Overall Study|Withdrawal by Subject|0|||
149117515|NCT05148962|537908277|FG000|Overall Study|Participant was early terminated per protocol|0|||
149117516|NCT05148962|537908278|FG001|Overall Study|Participant was early terminated per protocol|0|||
149117517|NCT05148962|537908279|FG002|Overall Study|Participant was early terminated per protocol|3|||
149117518|NCT05148962|537908280|FG003|Overall Study|Participant was early terminated per protocol|5|||
149117519|NCT05148962|537908281|FG004|Overall Study|Participant was early terminated per protocol|2|||
149117520|NCT05148962|537908277|FG000|Overall Study|Miscellaneous|0|||
149117521|NCT05148962|537908278|FG001|Overall Study|Miscellaneous|0|||
149117522|NCT05148962|537908279|FG002|Overall Study|Miscellaneous|0|||
149117523|NCT05148962|537908280|FG003|Overall Study|Miscellaneous|1|||
149117524|NCT05148962|537908281|FG004|Overall Study|Miscellaneous|0|||
149117525|NCT01200290|537908282|FG000|Treatment Period|Adverse Event|1|||
149117526|NCT01200290|537908282|FG000|Post-Treatment Follow-Up Period|Death|2|||
149117527|NCT01144377|537908283|FG000|52 Week Treatment Period|Adverse Event|0|||
149117528|NCT01144377|537908284|FG001|52 Week Treatment Period|Adverse Event|0|||
149117529|NCT01144377|537908285|FG002|52 Week Treatment Period|Adverse Event|3|||
149117530|NCT01144377|537908286|FG003|52 Week Treatment Period|Adverse Event|2|||
149117531|NCT01144377|537908287|FG004|52 Week Treatment Period|Adverse Event|1|||
149117532|NCT01144377|537908283|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
149117533|NCT01144377|537908284|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
149117534|NCT01144377|537908285|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
149117535|NCT01144377|537908286|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
149117536|NCT01144377|537908287|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
149117537|NCT01144377|537908283|FG000|52 Week Treatment Period|Protocol Violation|0|||
149117538|NCT01144377|537908284|FG001|52 Week Treatment Period|Protocol Violation|0|||
149117539|NCT01144377|537908285|FG002|52 Week Treatment Period|Protocol Violation|0|||
149117540|NCT01144377|537908286|FG003|52 Week Treatment Period|Protocol Violation|0|||
149117541|NCT01144377|537908287|FG004|52 Week Treatment Period|Protocol Violation|1|||
149117542|NCT01144377|537908283|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
149117543|NCT01144377|537908284|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
149117544|NCT01144377|537908285|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
149117545|NCT01144377|537908286|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
149117546|NCT01144377|537908287|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
149117547|NCT01144377|537908283|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
149117548|NCT01144377|537908284|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
149117549|NCT01144377|537908285|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
149117550|NCT01144377|537908286|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
149117551|NCT01144377|537908287|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
149117552|NCT01144377|537908283|FG000|52 Week Treatment Period|Sponsor Decision|0|||
149117553|NCT01144377|537908284|FG001|52 Week Treatment Period|Sponsor Decision|0|||
149117554|NCT01144377|537908285|FG002|52 Week Treatment Period|Sponsor Decision|0|||
149117555|NCT01144377|537908286|FG003|52 Week Treatment Period|Sponsor Decision|0|||
149117556|NCT01144377|537908287|FG004|52 Week Treatment Period|Sponsor Decision|1|||
149117557|NCT01144377|537908283|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
149117558|NCT01144377|537908284|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
149117559|NCT01144377|537908285|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
149117560|NCT01144377|537908286|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
149117561|NCT01144377|537908287|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
149117562|NCT01144377|537908283|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
149117563|NCT01144377|537908284|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
149117564|NCT01144377|537908285|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
149117565|NCT01144377|537908286|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
149117566|NCT01144377|537908287|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
149117567|NCT01144377|537908283|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
149117568|NCT01144377|537908284|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
149117569|NCT01144377|537908285|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
149117570|NCT01144377|537908286|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
149117571|NCT01144377|537908287|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
149117572|NCT02980731|537909667|FG000|Overall Study|Death|63|||
149117573|NCT02980731|537909667|FG000|Overall Study|Withdrawal by Subject|6|||
149117574|NCT02980731|537909667|FG000|Overall Study|Lost to Follow-up|5|||
149117575|NCT02980731|537909667|FG000|Overall Study|Study terminated by Sponsor|4|||
149117576|NCT02980731|537909667|FG000|Overall Study|Completed survival follow-up period|65|||
149117577|NCT02980731|537909667|FG000|Overall Study|COVID-19 infection|1|||
149117578|NCT02980731|537909667|FG000|Overall Study|Other, not specified|66|||
149117579|NCT00091169|537909668|FG000|Overall Study|Disease progression|3|||
149117580|NCT00091169|537909669|FG001|Overall Study|Disease progression|1|||
149117581|NCT00091169|537909668|FG000|Overall Study|Adverse Event|11|||
149117582|NCT00091169|537909669|FG001|Overall Study|Adverse Event|17|||
149117583|NCT00091169|537909668|FG000|Overall Study|Death|4|||
149117584|NCT00091169|537909669|FG001|Overall Study|Death|1|||
149117585|NCT00091169|537909668|FG000|Overall Study|Withdrawal by Subject|10|||
149117586|NCT00091169|537909669|FG001|Overall Study|Withdrawal by Subject|13|||
149117587|NCT00091169|537909668|FG000|Overall Study|Other|3|||
149117588|NCT00091169|537909669|FG001|Overall Study|Other|4|||
149117589|NCT00091169|537909668|FG000|Overall Study|Not start protocol therapy|26|||
149117590|NCT00091169|537909669|FG001|Overall Study|Not start protocol therapy|17|||
149117591|NCT00307684|537909670|FG000|Open Label Phase|Lack of Efficacy|0|||
149117592|NCT00307684|537909671|FG001|Open Label Phase|Lack of Efficacy|0|||
149117593|NCT00307684|537909672|FG002|Open Label Phase|Lack of Efficacy|3|||
149117594|NCT00307684|537909670|FG000|Open Label Phase|Adverse Event|0|||
149117595|NCT00307684|537909671|FG001|Open Label Phase|Adverse Event|0|||
149117596|NCT00307684|537909672|FG002|Open Label Phase|Adverse Event|16|||
149117597|NCT00307684|537909670|FG000|Open Label Phase|Withdrawal by Subject|0|||
149117598|NCT00307684|537909671|FG001|Open Label Phase|Withdrawal by Subject|0|||
149117599|NCT00307684|537909672|FG002|Open Label Phase|Withdrawal by Subject|15|||
149117600|NCT00307684|537909670|FG000|Open Label Phase|Lost to Follow-up|0|||
149117601|NCT00307684|537909671|FG001|Open Label Phase|Lost to Follow-up|0|||
149117602|NCT00307684|537909672|FG002|Open Label Phase|Lost to Follow-up|11|||
149117603|NCT00307684|537909670|FG000|Open Label Phase|non compliance|0|||
149117604|NCT00307684|537909671|FG001|Open Label Phase|non compliance|0|||
149117605|NCT00307684|537909672|FG002|Open Label Phase|non compliance|5|||
149117606|NCT00307684|537909670|FG000|Open Label Phase|other|0|||
149117607|NCT00307684|537909671|FG001|Open Label Phase|other|0|||
149117608|NCT00307684|537909672|FG002|Open Label Phase|other|6|||
149117609|NCT00307684|537909670|FG000|Double Blind Phase|Lack of Efficacy|2|||
149117610|NCT00307684|537909671|FG001|Double Blind Phase|Lack of Efficacy|5|||
149117611|NCT00307684|537909672|FG002|Double Blind Phase|Lack of Efficacy|0|||
149117612|NCT02580305|537909673|FG000|Overall Study|Adverse Event|15|||
149117613|NCT02580305|537909674|FG001|Overall Study|Adverse Event|19|||
149117614|NCT02580305|537909675|FG002|Overall Study|Adverse Event|10|||
149117615|NCT02580305|537909673|FG000|Overall Study|Lack of Efficacy|5|||
149117616|NCT02580305|537909674|FG001|Overall Study|Lack of Efficacy|0|||
149117617|NCT02580305|537909675|FG002|Overall Study|Lack of Efficacy|2|||
149117618|NCT02580305|537909673|FG000|Overall Study|Protocol Violation|4|||
149117619|NCT02580305|537909674|FG001|Overall Study|Protocol Violation|9|||
149117620|NCT02580305|537909675|FG002|Overall Study|Protocol Violation|6|||
149117621|NCT02580305|537909673|FG000|Overall Study|Lost to Follow-up|4|||
149117622|NCT02580305|537909674|FG001|Overall Study|Lost to Follow-up|4|||
149117623|NCT02580305|537909675|FG002|Overall Study|Lost to Follow-up|2|||
149117624|NCT02580305|537909673|FG000|Overall Study|Withdrawal by Subject|11|||
149117625|NCT02580305|537909674|FG001|Overall Study|Withdrawal by Subject|9|||
149117626|NCT02580305|537909675|FG002|Overall Study|Withdrawal by Subject|7|||
149117627|NCT02580305|537909673|FG000|Overall Study|Randomized in error and never treated|4|||
149117628|NCT02580305|537909674|FG001|Overall Study|Randomized in error and never treated|8|||
149117629|NCT02580305|537909675|FG002|Overall Study|Randomized in error and never treated|5|||
149117630|NCT00224887|537909676|FG000|Overall Study|Pregnancy|6|||
149117631|NCT00224887|537909677|FG001|Overall Study|Pregnancy|6|||
149117632|NCT03582943|537909678|FG000|Allocated to Groups|Withdrawal by Subject|1|||
149117633|NCT03582943|537909679|FG001|Allocated to Groups|Withdrawal by Subject|1|||
149117634|NCT03582943|537909678|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
149117635|NCT03582943|537909679|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
149117636|NCT03582943|537909678|FG000|Analyzed|Protocol Violation|4|||
149117637|NCT03582943|537909679|FG001|Analyzed|Protocol Violation|1|||
149117638|NCT03527550|537909680|FG000|Overall Study|Lost to Follow-up|4|||
149117639|NCT03527550|537909681|FG001|Overall Study|Lost to Follow-up|2|||
149117640|NCT03527550|537909680|FG000|Overall Study|Withdrawal by Subject|4|||
149117641|NCT03527550|537909681|FG001|Overall Study|Withdrawal by Subject|1|||
149117642|NCT03527550|537909680|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
149117643|NCT03527550|537909681|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
149117644|NCT03053518|537909684|FG000|Overall Study|Withdrawal by Subject|3|||
149117645|NCT03053518|537909684|FG000|Overall Study|Lost to Follow-up|2|||
149117646|NCT03053518|537909684|FG000|Overall Study|Ineligible|5|||
149117647|NCT02683876|537909685|FG000|Overall Study|samples damaged during shipping|2|||
149117648|NCT02683876|537909686|FG001|Overall Study|samples damaged during shipping|0|||
149117649|NCT02071290|537909687|FG000|Overall Study|Death|1|||
149117650|NCT02071290|537909688|FG001|Overall Study|Death|0|||
149117651|NCT02071290|537909687|FG000|Overall Study|Withdrawal by Subject|0|||
149117652|NCT02071290|537909688|FG001|Overall Study|Withdrawal by Subject|1|||
149117653|NCT02071290|537909687|FG000|Overall Study|Protocol Violation|3|||
149117654|NCT02071290|537909688|FG001|Overall Study|Protocol Violation|5|||
149117655|NCT02071290|537909687|FG000|Overall Study|Physician Decision|0|||
149117656|NCT02071290|537909688|FG001|Overall Study|Physician Decision|1|||
149117657|NCT00939822|537909689|FG000|Overall Study|Lost to Follow-up|1|||
149117658|NCT00939822|537909690|FG001|Overall Study|Lost to Follow-up|0|||
149117659|NCT00939822|537909689|FG000|Overall Study|withdrew from study due to busy schedule|1|||
149117660|NCT00939822|537909690|FG001|Overall Study|withdrew from study due to busy schedule|1|||
149117661|NCT00939822|537909689|FG000|Overall Study|Mental health issues|0|||
149117662|NCT00939822|537909690|FG001|Overall Study|Mental health issues|2|||
149117663|NCT01232738|537909691|FG000|Overall Study|Death|3|||
149117664|NCT01232738|537909691|FG000|Overall Study|Physician Decision|2|||
149117665|NCT01232738|537909691|FG000|Overall Study|Lost to Follow-up|1|||
149117666|NCT01232738|537909691|FG000|Overall Study|Withdrawal by Subject|2|||
149117667|NCT01232738|537909691|FG000|Overall Study|Adverse Event|5|||
149117668|NCT02797080|537909705|FG000|Overall Study|Lost to Follow-up|1|||
149117669|NCT02797080|537909705|FG000|Overall Study|Withdrawal by Subject|1|||
149117670|NCT00951015|537909708|FG000|Randomization Phase 96 Week|Adverse Event|1|||
149117671|NCT00951015|537909709|FG001|Randomization Phase 96 Week|Adverse Event|1|||
149117672|NCT00951015|537909710|FG002|Randomization Phase 96 Week|Adverse Event|2|||
149117673|NCT00951015|537909711|FG003|Randomization Phase 96 Week|Adverse Event|5|||
149117674|NCT00951015|537909712|FG004|Randomization Phase 96 Week|Adverse Event|0|||
149117675|NCT00951015|537909708|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
149117676|NCT00951015|537909709|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
149117677|NCT00951015|537909710|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
149117678|NCT00951015|537909711|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
149117679|NCT00951015|537909712|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
149117680|NCT00951015|537909708|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
149117681|NCT00951015|537909709|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
149117682|NCT00951015|537909710|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
149117683|NCT00951015|537909711|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
149117684|NCT00951015|537909712|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
149117685|NCT00951015|537909708|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
149117686|NCT00951015|537909709|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
149117687|NCT00951015|537909710|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
149117688|NCT00951015|537909711|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
149117689|NCT00951015|537909712|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
149117690|NCT00951015|537909708|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
149117691|NCT00951015|537909709|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
149117692|NCT00951015|537909710|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
149117693|NCT00951015|537909711|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
149117694|NCT00951015|537909712|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
149117695|NCT00951015|537909708|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
149117696|NCT00951015|537909709|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
149117697|NCT00951015|537909710|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
149117698|NCT00951015|537909711|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
149117699|NCT00951015|537909712|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
149117700|NCT00951015|537909708|FG000|Open-label Phase|Adverse Event|0|||
149117701|NCT00951015|537909709|FG001|Open-label Phase|Adverse Event|0|||
149117702|NCT00951015|537909710|FG002|Open-label Phase|Adverse Event|0|||
149117703|NCT00951015|537909711|FG003|Open-label Phase|Adverse Event|0|||
149117704|NCT00951015|537909712|FG004|Open-label Phase|Adverse Event|3|||
149117705|NCT00951015|537909708|FG000|Open-label Phase|Lack of Efficacy|0|||
149117706|NCT00951015|537909709|FG001|Open-label Phase|Lack of Efficacy|0|||
149117707|NCT00951015|537909710|FG002|Open-label Phase|Lack of Efficacy|0|||
149117708|NCT00951015|537909711|FG003|Open-label Phase|Lack of Efficacy|0|||
149117709|NCT00951015|537909712|FG004|Open-label Phase|Lack of Efficacy|1|||
149117710|NCT00951015|537909708|FG000|Open-label Phase|Protocol Violation|0|||
149117711|NCT00951015|537909709|FG001|Open-label Phase|Protocol Violation|0|||
149117712|NCT00951015|537909710|FG002|Open-label Phase|Protocol Violation|0|||
149117713|NCT00951015|537909711|FG003|Open-label Phase|Protocol Violation|0|||
149117714|NCT00951015|537909712|FG004|Open-label Phase|Protocol Violation|12|||
149117715|NCT00951015|537909708|FG000|Open-label Phase|Lost to Follow-up|0|||
149117716|NCT00951015|537909709|FG001|Open-label Phase|Lost to Follow-up|0|||
149117717|NCT00951015|537909710|FG002|Open-label Phase|Lost to Follow-up|0|||
149117718|NCT00951015|537909711|FG003|Open-label Phase|Lost to Follow-up|0|||
149117719|NCT00951015|537909712|FG004|Open-label Phase|Lost to Follow-up|12|||
149117720|NCT00951015|537909708|FG000|Open-label Phase|Withdrawal by Subject|0|||
149117721|NCT00951015|537909709|FG001|Open-label Phase|Withdrawal by Subject|0|||
149117722|NCT00951015|537909710|FG002|Open-label Phase|Withdrawal by Subject|0|||
149117723|NCT00951015|537909711|FG003|Open-label Phase|Withdrawal by Subject|0|||
149117724|NCT00951015|537909712|FG004|Open-label Phase|Withdrawal by Subject|14|||
149117725|NCT00951015|537909708|FG000|Open-label Phase|Physician Decision|0|||
149117726|NCT00951015|537909709|FG001|Open-label Phase|Physician Decision|0|||
149117727|NCT00951015|537909710|FG002|Open-label Phase|Physician Decision|0|||
149117728|NCT00951015|537909711|FG003|Open-label Phase|Physician Decision|0|||
149117729|NCT00951015|537909712|FG004|Open-label Phase|Physician Decision|8|||
149117730|NCT03819634|537909714|FG000|Overall Study|Physician Decision|2|||
149117731|NCT01416389|537909715|FG000|Overall Study|Lost to Follow-up|1|||
149117732|NCT01416389|537909716|FG001|Overall Study|Lost to Follow-up|0|||
149117733|NCT01416389|537909715|FG000|Overall Study|Started New Therapy|2|||
149117734|NCT01416389|537909716|FG001|Overall Study|Started New Therapy|0|||
149117735|NCT00757627|537909717|FG000|Overall Study|Adverse Event|15|||
149117736|NCT00757627|537909717|FG000|Overall Study|Lack of Efficacy|10|||
149117737|NCT00757627|537909717|FG000|Overall Study|Lost to Follow-up|28|||
149117738|NCT00757627|537909717|FG000|Overall Study|Withdrawal by Subject|27|||
149117739|NCT00757627|537909717|FG000|Overall Study|Other|1|||
149117740|NCT01259089|537909718|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
149117741|NCT01259089|537909719|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
149117742|NCT01259089|537909720|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
149117743|NCT01259089|537909721|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
149117744|NCT01259089|537909722|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
149117745|NCT01259089|537909723|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
149117746|NCT01259089|537909718|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
149117747|NCT01259089|537909719|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
149117748|NCT01259089|537909720|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
149117749|NCT01259089|537909721|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
149117750|NCT01259089|537909722|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
149117751|NCT01259089|537909723|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
149117752|NCT01259089|537909718|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
149117753|NCT01259089|537909719|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
149117754|NCT01259089|537909720|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
149117755|NCT01259089|537909721|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
149117756|NCT01259089|537909722|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
149117757|NCT01259089|537909723|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
149117758|NCT01259089|537909718|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
149117759|NCT01259089|537909719|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
149117760|NCT01259089|537909720|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
149117761|NCT01259089|537909721|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
149117762|NCT01259089|537909722|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
149117763|NCT01259089|537909723|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
149117764|NCT01259089|537909718|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
149117765|NCT01259089|537909719|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
149117766|NCT01259089|537909720|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
149117767|NCT01259089|537909721|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
149117768|NCT01259089|537909722|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
149117769|NCT01259089|537909723|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
149117770|NCT01259089|537909718|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
149117771|NCT01259089|537909719|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
149117772|NCT01259089|537909720|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
149117773|NCT01259089|537909721|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
149117774|NCT01259089|537909722|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
149117775|NCT01259089|537909723|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
149117776|NCT01259089|537909718|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
149117777|NCT01259089|537909719|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
149117778|NCT01259089|537909720|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
149117779|NCT01259089|537909721|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
149117780|NCT01259089|537909722|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
149117781|NCT01259089|537909723|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
149117782|NCT01259089|537909718|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
149117783|NCT01259089|537909719|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
149117784|NCT01259089|537909720|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
149117785|NCT01259089|537909721|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
149117786|NCT01259089|537909722|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
149117787|NCT01259089|537909723|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
149117788|NCT01259089|537909718|FG000|Survival Follow up for Two Years|Death|3|||
149117789|NCT01259089|537909719|FG001|Survival Follow up for Two Years|Death|2|||
149117790|NCT01259089|537909720|FG002|Survival Follow up for Two Years|Death|2|||
149117791|NCT01259089|537909721|FG003|Survival Follow up for Two Years|Death|3|||
149117792|NCT01259089|537909722|FG004|Survival Follow up for Two Years|Death|6|||
149117793|NCT01259089|537909723|FG005|Survival Follow up for Two Years|Death|13|||
149117794|NCT01259089|537909718|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
149117795|NCT01259089|537909719|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
149117796|NCT01259089|537909720|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
149117797|NCT01259089|537909721|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
149117798|NCT01259089|537909722|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
149117799|NCT01259089|537909723|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
149117800|NCT01259089|537909718|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
149117801|NCT01259089|537909719|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
149117802|NCT01259089|537909720|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
149117803|NCT01259089|537909721|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
149117804|NCT01259089|537909722|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
149117805|NCT01259089|537909723|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
149117806|NCT01769326|537909726|FG000|Overall Study|Lost to Follow-up|1|||
149117807|NCT01769326|537909727|FG001|Overall Study|Lost to Follow-up|2|||
149117808|NCT01769326|537909728|FG002|Overall Study|Lost to Follow-up|0|||
149117809|NCT01769326|537909729|FG003|Overall Study|Lost to Follow-up|0|||
149117810|NCT01769326|537909726|FG000|Overall Study|unrelated injry|1|||
149117811|NCT01769326|537909727|FG001|Overall Study|unrelated injry|1|||
149117812|NCT01769326|537909728|FG002|Overall Study|unrelated injry|0|||
149117813|NCT01769326|537909729|FG003|Overall Study|unrelated injry|0|||
149117814|NCT01769326|537909726|FG000|Overall Study|got a job|0|||
149117815|NCT01769326|537909727|FG001|Overall Study|got a job|1|||
149117816|NCT01769326|537909728|FG002|Overall Study|got a job|0|||
149117817|NCT01769326|537909729|FG003|Overall Study|got a job|0|||
149117818|NCT01769326|537909726|FG000|Overall Study|Got sick and could not complete study|0|||
149117819|NCT01769326|537909727|FG001|Overall Study|Got sick and could not complete study|0|||
149117820|NCT01769326|537909728|FG002|Overall Study|Got sick and could not complete study|1|||
149117821|NCT01769326|537909729|FG003|Overall Study|Got sick and could not complete study|0|||
149117822|NCT01413503|537909730|FG000|Overall Study|Lost to Follow-up|1|||
149117823|NCT03772587|537909731|FG000|Overall Study|COVID-19|0|||
149117824|NCT03772587|537909732|FG001|Overall Study|COVID-19|0|||
149117825|NCT03772587|537909733|FG002|Overall Study|COVID-19|1|||
149117826|NCT03772587|537909734|FG003|Overall Study|COVID-19|1|||
149117827|NCT03772587|537909735|FG004|Overall Study|COVID-19|0|||
149117828|NCT03772587|537909731|FG000|Overall Study|Withdrawal by Subject|1|||
149117829|NCT03772587|537909732|FG001|Overall Study|Withdrawal by Subject|0|||
149117830|NCT03772587|537909733|FG002|Overall Study|Withdrawal by Subject|0|||
149117831|NCT03772587|537909734|FG003|Overall Study|Withdrawal by Subject|0|||
149117832|NCT03772587|537909735|FG004|Overall Study|Withdrawal by Subject|0|||
149117833|NCT05260021|537909738|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
149117834|NCT05260021|537909739|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
149117835|NCT05260021|537909740|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
149117836|NCT05260021|537909738|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
149117837|NCT05260021|537909739|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
149117838|NCT05260021|537909740|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
149117839|NCT05260021|537909738|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
149117840|NCT05260021|537909739|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
149117841|NCT05260021|537909740|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
149117842|NCT05260021|537909738|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
149117843|NCT05260021|537909739|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
149117844|NCT05260021|537909740|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
149117845|NCT05260021|537909738|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
149117846|NCT05260021|537909739|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
149117847|NCT05260021|537909740|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
149117848|NCT00607724|537909741|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
149117849|NCT00607724|537909742|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
149117850|NCT00607724|537909743|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
149117851|NCT00607724|537909744|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
149117852|NCT00607724|537909745|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
149117853|NCT00607724|537909746|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
149117854|NCT00607724|537909747|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
149117855|NCT00607724|537909741|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
149117856|NCT00607724|537909742|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
149117857|NCT00607724|537909743|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
149117858|NCT00607724|537909744|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
149117859|NCT00607724|537909745|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
149117860|NCT00607724|537909746|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
149117861|NCT00607724|537909747|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
149117862|NCT00607724|537909741|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
149117863|NCT00607724|537909742|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
149117864|NCT00607724|537909743|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
149117865|NCT00607724|537909744|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
149117866|NCT00607724|537909745|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
149117867|NCT00607724|537909746|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
149117868|NCT00607724|537909747|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
149117869|NCT00607724|537909741|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
149117870|NCT00607724|537909742|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
149117871|NCT00607724|537909743|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
149117872|NCT00607724|537909744|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
149117873|NCT00607724|537909745|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
149117874|NCT00607724|537909746|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
149117875|NCT00607724|537909747|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
149117876|NCT00607724|537909741|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
149117877|NCT00607724|537909742|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
149117878|NCT00607724|537909743|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
149117879|NCT00607724|537909744|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
149117880|NCT00607724|537909745|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
149117881|NCT00607724|537909746|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
149117882|NCT00607724|537909747|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
149117883|NCT00151281|537909748|FG000|Overall Study|Not evaluable|3|||
149117884|NCT01133418|537909751|FG000|Overall Study|Lost to Follow-up|5|||
149117885|NCT01133418|537909752|FG001|Overall Study|Lost to Follow-up|6|||
149117886|NCT04150068|537909753|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
149117887|NCT04150068|537909754|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
149117888|NCT04150068|537909755|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
149117889|NCT04150068|537909753|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
149117890|NCT04150068|537909754|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
149117891|NCT04150068|537909755|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
149117892|NCT05316701|537909756|FG000|Overall Study|Adverse Event|0|||
149117893|NCT05316701|537909757|FG001|Overall Study|Adverse Event|1|||
149117894|NCT05316701|537909756|FG000|Overall Study|Death|3|||
149117895|NCT05316701|537909757|FG001|Overall Study|Death|9|||
149117896|NCT05316701|537909756|FG000|Overall Study|Lost to Follow-up|1|||
149117897|NCT05316701|537909757|FG001|Overall Study|Lost to Follow-up|0|||
149117898|NCT05316701|537909756|FG000|Overall Study|Physician Decision|1|||
149117899|NCT05316701|537909757|FG001|Overall Study|Physician Decision|4|||
149117900|NCT05316701|537909756|FG000|Overall Study|Withdrawal by Subject|3|||
149117901|NCT05316701|537909757|FG001|Overall Study|Withdrawal by Subject|5|||
149117902|NCT05316701|537909756|FG000|Overall Study|Progression/Relapse|14|||
149117903|NCT05316701|537909757|FG001|Overall Study|Progression/Relapse|9|||
149117904|NCT05316701|537909756|FG000|Overall Study|Received Standard of Care|1|||
149117905|NCT05316701|537909757|FG001|Overall Study|Received Standard of Care|0|||
149117906|NCT05316701|537909756|FG000|Overall Study|Ongoing|70|||
149117907|NCT05316701|537909757|FG001|Overall Study|Ongoing|64|||
149117908|NCT04679935|537909758|FG000|Overall Study|Death|0|||
149117909|NCT04679935|537909759|FG001|Overall Study|Death|1|||
149117910|NCT04362189|537909764|FG000|Overall Study|Lost to Follow-up|0|||
149117911|NCT04362189|537909765|FG001|Overall Study|Lost to Follow-up|1|||
149117912|NCT04362189|537909764|FG000|Overall Study|Withdrawal by Subject|1|||
149117913|NCT04362189|537909765|FG001|Overall Study|Withdrawal by Subject|0|||
149117914|NCT04362189|537909764|FG000|Overall Study|FDA Clinical Hold|7|||
149117915|NCT04362189|537909765|FG001|Overall Study|FDA Clinical Hold|2|||
149117916|NCT04362189|537909764|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
149117917|NCT04362189|537909765|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
149117918|NCT04362189|537909764|FG000|Overall Study|Adverse Event|0|||
149117919|NCT04362189|537909765|FG001|Overall Study|Adverse Event|2|||
149117920|NCT04362189|537909764|FG000|Overall Study|Death|4|||
149117921|NCT04362189|537909765|FG001|Overall Study|Death|1|||
149117922|NCT02111681|537909766|FG000|Overall Study|Death|5|||
149117923|NCT02111681|537909766|FG000|Overall Study|Lack of Efficacy|2|||
149117924|NCT02111681|537909766|FG000|Overall Study|Progression of disease|4|||
149117925|NCT04349631|537909769|FG000|Overall Study|Lost to Follow-up|3|||
149117926|NCT04349631|537909769|FG000|Overall Study|Withdrawal by Subject|7|||
149117927|NCT01022112|537909770|FG000|Overall Study|Adverse Event|1|||
149117928|NCT01022112|537909771|FG001|Overall Study|Adverse Event|2|||
149117929|NCT01022112|537909772|FG002|Overall Study|Adverse Event|0|||
149117930|NCT01022112|537909773|FG003|Overall Study|Adverse Event|1|||
149117931|NCT01022112|537909774|FG004|Overall Study|Adverse Event|0|||
149117932|NCT01022112|537909770|FG000|Overall Study|Lack of Efficacy|1|||
149117933|NCT01022112|537909771|FG001|Overall Study|Lack of Efficacy|0|||
149117934|NCT01022112|537909772|FG002|Overall Study|Lack of Efficacy|0|||
149117935|NCT01022112|537909773|FG003|Overall Study|Lack of Efficacy|0|||
149117936|NCT01022112|537909774|FG004|Overall Study|Lack of Efficacy|1|||
149117937|NCT01022112|537909770|FG000|Overall Study|Physician Decision|0|||
149117938|NCT01022112|537909771|FG001|Overall Study|Physician Decision|0|||
149117939|NCT01022112|537909772|FG002|Overall Study|Physician Decision|1|||
149117940|NCT01022112|537909773|FG003|Overall Study|Physician Decision|0|||
149117941|NCT01022112|537909774|FG004|Overall Study|Physician Decision|1|||
149117942|NCT01022112|537909770|FG000|Overall Study|Withdrawal by Subject|0|||
149117943|NCT01022112|537909771|FG001|Overall Study|Withdrawal by Subject|1|||
149117944|NCT01022112|537909772|FG002|Overall Study|Withdrawal by Subject|2|||
149117945|NCT01022112|537909773|FG003|Overall Study|Withdrawal by Subject|2|||
149117946|NCT01022112|537909774|FG004|Overall Study|Withdrawal by Subject|1|||
149117947|NCT01022112|537909770|FG000|Overall Study|Fasting plasma glucose level increased|1|||
149117948|NCT01022112|537909771|FG001|Overall Study|Fasting plasma glucose level increased|0|||
149117949|NCT01022112|537909772|FG002|Overall Study|Fasting plasma glucose level increased|0|||
149117950|NCT01022112|537909773|FG003|Overall Study|Fasting plasma glucose level increased|0|||
149117951|NCT01022112|537909774|FG004|Overall Study|Fasting plasma glucose level increased|7|||
149117952|NCT00775463|537911291|FG000|Overall Study|Withdrawal by Subject|0|||
149117953|NCT00775463|537911292|FG001|Overall Study|Withdrawal by Subject|1|||
149117954|NCT00775463|537911291|FG000|Overall Study|Adverse Event|7|||
149117955|NCT00775463|537911292|FG001|Overall Study|Adverse Event|9|||
149117956|NCT00775463|537911291|FG000|Overall Study|Protocol Violation|2|||
149117957|NCT00775463|537911292|FG001|Overall Study|Protocol Violation|2|||
149117958|NCT00775463|537911291|FG000|Overall Study|Lost to Follow-up|1|||
149117959|NCT00775463|537911292|FG001|Overall Study|Lost to Follow-up|0|||
149117960|NCT00775463|537911291|FG000|Overall Study|Lack of Efficacy|1|||
149117961|NCT00775463|537911292|FG001|Overall Study|Lack of Efficacy|1|||
149117962|NCT02366468|537911302|FG000|Overall Study|Adverse Event|2|||
149117963|NCT02366468|537911303|FG001|Overall Study|Adverse Event|0|||
149117964|NCT02366468|537911302|FG000|Overall Study|Withdrawal by Subject|1|||
149117965|NCT02366468|537911303|FG001|Overall Study|Withdrawal by Subject|5|||
149117966|NCT02366468|537911302|FG000|Overall Study|Lost to Follow-up|2|||
149117967|NCT02366468|537911303|FG001|Overall Study|Lost to Follow-up|0|||
149117968|NCT02366468|537911302|FG000|Overall Study|Death|1|||
149117969|NCT02366468|537911303|FG001|Overall Study|Death|2|||
149117970|NCT02366468|537911302|FG000|Overall Study|Other|0|||
149117971|NCT02366468|537911303|FG001|Overall Study|Other|2|||
149117972|NCT03651622|537911304|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
149117973|NCT03651622|537911305|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
149117974|NCT03651622|537911306|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
149117975|NCT03651622|537911304|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
149117976|NCT03651622|537911305|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
149117977|NCT03651622|537911306|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
149117978|NCT03651622|537911304|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
149117979|NCT03651622|537911305|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
149117980|NCT03651622|537911306|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
149117981|NCT03651622|537911304|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
149117982|NCT03651622|537911305|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
149117983|NCT03651622|537911306|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
149117984|NCT03651622|537911304|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
149117985|NCT03651622|537911305|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
149117986|NCT03651622|537911306|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
149117987|NCT01153321|537911307|FG000|Overall Study|Development of study withdrawal criteria|0|||
149117988|NCT01153321|537911308|FG001|Overall Study|Development of study withdrawal criteria|1|||
149117989|NCT01153321|537911307|FG000|Overall Study|Withdrawal by Subject|0|||
149117990|NCT01153321|537911308|FG001|Overall Study|Withdrawal by Subject|1|||
149117991|NCT01153321|537911307|FG000|Overall Study|Adverse Event|1|||
149117992|NCT01153321|537911308|FG001|Overall Study|Adverse Event|1|||
149117993|NCT00488475|537911309|FG000|Overall Study|Other|1754|||
149117994|NCT00299494|537911324|FG000|Overall Study|Withdrawal by Subject|0|||
149117995|NCT00299494|537911325|FG001|Overall Study|Withdrawal by Subject|0|||
149117996|NCT00299494|537911326|FG002|Overall Study|Withdrawal by Subject|0|||
149117997|NCT00299494|537911327|FG003|Overall Study|Withdrawal by Subject|3|||
149117998|NCT00299494|537911328|FG004|Overall Study|Withdrawal by Subject|1|||
149117999|NCT00299494|537911329|FG005|Overall Study|Withdrawal by Subject|4|||
149118000|NCT00299494|537911324|FG000|Overall Study|Physician Decision|0|||
149118001|NCT00299494|537911325|FG001|Overall Study|Physician Decision|0|||
149118002|NCT00299494|537911326|FG002|Overall Study|Physician Decision|0|||
149118003|NCT00299494|537911327|FG003|Overall Study|Physician Decision|0|||
149118004|NCT00299494|537911328|FG004|Overall Study|Physician Decision|1|||
149118005|NCT00299494|537911329|FG005|Overall Study|Physician Decision|0|||
149118006|NCT00299494|537911324|FG000|Overall Study|Death|3|||
149118007|NCT00299494|537911325|FG001|Overall Study|Death|1|||
149118008|NCT00299494|537911326|FG002|Overall Study|Death|4|||
149118009|NCT00299494|537911327|FG003|Overall Study|Death|6|||
149118010|NCT00299494|537911328|FG004|Overall Study|Death|18|||
149118011|NCT00299494|537911329|FG005|Overall Study|Death|19|||
149118012|NCT00299494|537911324|FG000|Overall Study|Lost to Follow-up|0|||
149118013|NCT00299494|537911325|FG001|Overall Study|Lost to Follow-up|0|||
149118014|NCT00299494|537911326|FG002|Overall Study|Lost to Follow-up|0|||
149118015|NCT00299494|537911327|FG003|Overall Study|Lost to Follow-up|0|||
149118016|NCT00299494|537911328|FG004|Overall Study|Lost to Follow-up|3|||
149118017|NCT00299494|537911329|FG005|Overall Study|Lost to Follow-up|1|||
149118018|NCT00299494|537911324|FG000|Overall Study|Other - Unspecified|0|||
149118019|NCT00299494|537911325|FG001|Overall Study|Other - Unspecified|0|||
149118020|NCT00299494|537911326|FG002|Overall Study|Other - Unspecified|0|||
149118021|NCT00299494|537911327|FG003|Overall Study|Other - Unspecified|0|||
149118022|NCT00299494|537911328|FG004|Overall Study|Other - Unspecified|3|||
149118023|NCT00299494|537911329|FG005|Overall Study|Other - Unspecified|1|||
149118024|NCT00299494|537911324|FG000|Overall Study|Other - site closure|0|||
149118025|NCT00299494|537911325|FG001|Overall Study|Other - site closure|0|||
149118026|NCT00299494|537911326|FG002|Overall Study|Other - site closure|0|||
149118027|NCT00299494|537911327|FG003|Overall Study|Other - site closure|1|||
149118028|NCT00299494|537911328|FG004|Overall Study|Other - site closure|1|||
149118029|NCT00299494|537911329|FG005|Overall Study|Other - site closure|1|||
149118030|NCT01417104|537911333|FG000|Overall Study|Withdrawal by Subject|5|||
149118031|NCT01417104|537911334|FG001|Overall Study|Withdrawal by Subject|1|||
149118032|NCT01417104|537911333|FG000|Overall Study|Failure to make contact|0|||
149118033|NCT01417104|537911334|FG001|Overall Study|Failure to make contact|1|||
149118034|NCT01417104|537911333|FG000|Overall Study|Adverse Event|1|||
149118035|NCT01417104|537911334|FG001|Overall Study|Adverse Event|0|||
149118036|NCT01365481|537911335|FG000|Overall Study|Adverse Event|6|||
149118037|NCT01365481|537911336|FG001|Overall Study|Adverse Event|9|||
149118038|NCT01365481|537911337|FG002|Overall Study|Adverse Event|0|||
149118039|NCT01365481|537911338|FG003|Overall Study|Adverse Event|2|||
149118040|NCT01365481|537911335|FG000|Overall Study|Withdrawal by Subject|0|||
149118041|NCT01365481|537911336|FG001|Overall Study|Withdrawal by Subject|2|||
149118042|NCT01365481|537911337|FG002|Overall Study|Withdrawal by Subject|1|||
149118043|NCT01365481|537911338|FG003|Overall Study|Withdrawal by Subject|1|||
149118044|NCT01365481|537911335|FG000|Overall Study|Lost to Follow-up|1|||
149118045|NCT01365481|537911336|FG001|Overall Study|Lost to Follow-up|1|||
149118046|NCT01365481|537911337|FG002|Overall Study|Lost to Follow-up|2|||
149118047|NCT01365481|537911338|FG003|Overall Study|Lost to Follow-up|3|||
149118048|NCT01365481|537911335|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149118049|NCT01365481|537911336|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149118050|NCT01365481|537911337|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149118051|NCT01365481|537911338|FG003|Overall Study|Abnormal laboratory value(s)|0|||
149118052|NCT01365481|537911335|FG000|Overall Study|Administrative problems|0|||
149118053|NCT01365481|537911336|FG001|Overall Study|Administrative problems|1|||
149118054|NCT01365481|537911337|FG002|Overall Study|Administrative problems|0|||
149118055|NCT01365481|537911338|FG003|Overall Study|Administrative problems|0|||
149118056|NCT01365481|537911335|FG000|Overall Study|Protocol deviation|0|||
149118057|NCT01365481|537911336|FG001|Overall Study|Protocol deviation|1|||
149118058|NCT01365481|537911337|FG002|Overall Study|Protocol deviation|0|||
149118059|NCT01365481|537911338|FG003|Overall Study|Protocol deviation|1|||
149118060|NCT01365481|537911335|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
149118061|NCT01365481|537911336|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
149118062|NCT01365481|537911337|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
149118063|NCT01365481|537911338|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
149118064|NCT00958841|537911343|FG000|Overall Study|Abnormal laboratory value(s)|1|||
149118065|NCT00958841|537911343|FG000|Overall Study|Abnormal test procedure result(s)|3|||
149118066|NCT00958841|537911343|FG000|Overall Study|Administrative problems|1|||
149118067|NCT00958841|537911343|FG000|Overall Study|Adverse Event|8|||
149118068|NCT00958841|537911343|FG000|Overall Study|New cancer therapy|5|||
149118069|NCT00958841|537911343|FG000|Overall Study|Withdrawal by Subject|1|||
149118070|NCT00958841|537911343|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
149118071|NCT00958841|537911343|FG000|Overall Study|Completed M6/did not enter extension|27|||
149118072|NCT00958841|537911343|FG000|Overall Study|Discontinued prior to M*|28|||
149118073|NCT01125514|537911345|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
149118074|NCT01125514|537911345|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
149118075|NCT01125514|537911345|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
149118076|NCT01125514|537911345|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
149118077|NCT01125514|537911345|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
149118078|NCT01125514|537911345|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
149118079|NCT00858364|537911346|FG000|Overall Study|Administrative Decision|3|||
149118080|NCT00858364|537911347|FG001|Overall Study|Administrative Decision|2|||
149118081|NCT00858364|537911346|FG000|Overall Study|Adverse Event|5|||
149118082|NCT00858364|537911347|FG001|Overall Study|Adverse Event|2|||
149118083|NCT00858364|537911346|FG000|Overall Study|Withdrawal by Subject|44|||
149118084|NCT00858364|537911347|FG001|Overall Study|Withdrawal by Subject|118|||
149118085|NCT00858364|537911346|FG000|Overall Study|Ineligibility Determined|1|||
149118086|NCT00858364|537911347|FG001|Overall Study|Ineligibility Determined|10|||
149118087|NCT00858364|537911346|FG000|Overall Study|Lost to Follow-up|24|||
149118088|NCT00858364|537911347|FG001|Overall Study|Lost to Follow-up|54|||
149118089|NCT00858364|537911346|FG000|Overall Study|Noncompliance|3|||
149118090|NCT00858364|537911347|FG001|Overall Study|Noncompliance|4|||
149118091|NCT00858364|537911346|FG000|Overall Study|Protocol Deviation|0|||
149118092|NCT00858364|537911347|FG001|Overall Study|Protocol Deviation|2|||
149118093|NCT00858364|537911346|FG000|Overall Study|Other|9|||
149118094|NCT00858364|537911347|FG001|Overall Study|Other|17|||
149118095|NCT00858364|537911346|FG000|Overall Study|Missing|1|||
149118096|NCT00858364|537911347|FG001|Overall Study|Missing|1|||
149118097|NCT00858364|537911346|FG000|Overall Study|Still on-study|114|||
149118098|NCT00858364|537911347|FG001|Overall Study|Still on-study|247|||
149118099|NCT03980808|537911348|FG000|Overall Study|Lost to Follow-up|2|||
149118100|NCT03980808|537911349|FG001|Overall Study|Lost to Follow-up|2|||
149118101|NCT00436605|537911353|FG000|Overall Study|Protocol Violation|3|||
149118102|NCT02755818|537911354|FG000|Overall Study|Withdrawal by Subject|0|||
149118103|NCT02755818|537911355|FG001|Overall Study|Withdrawal by Subject|0|||
149118104|NCT02755818|537911356|FG002|Overall Study|Withdrawal by Subject|0|||
149118105|NCT02755818|537911357|FG003|Overall Study|Withdrawal by Subject|2|||
149118106|NCT02755818|537911354|FG000|Overall Study|withdrawal by PI|0|||
149118107|NCT02755818|537911355|FG001|Overall Study|withdrawal by PI|0|||
149118108|NCT02755818|537911356|FG002|Overall Study|withdrawal by PI|1|||
149118109|NCT02755818|537911357|FG003|Overall Study|withdrawal by PI|1|||
149118110|NCT03014011|537911358|FG000|First Intervention|Withdrawal by Subject|1|||
149118111|NCT03014011|537911359|FG001|First Intervention|Withdrawal by Subject|0|||
149118112|NCT03014011|537911358|FG000|Washout|Withdrawal by Subject|1|||
149118113|NCT03014011|537911359|FG001|Washout|Withdrawal by Subject|0|||
149118114|NCT00929110|537911360|FG000|Overall Study|Adverse Event|40|||
149118115|NCT00929110|537911361|FG001|Overall Study|Adverse Event|29|||
149118116|NCT00929110|537911362|FG002|Overall Study|Adverse Event|18|||
149118117|NCT00929110|537911360|FG000|Overall Study|Subject withdrew consent|40|||
149118118|NCT00929110|537911361|FG001|Overall Study|Subject withdrew consent|23|||
149118119|NCT00929110|537911362|FG002|Overall Study|Subject withdrew consent|26|||
149118120|NCT00929110|537911360|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
149118121|NCT00929110|537911361|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
149118122|NCT00929110|537911362|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
149118123|NCT00929110|537911360|FG000|Overall Study|Lost to Follow-up|7|||
149118124|NCT00929110|537911361|FG001|Overall Study|Lost to Follow-up|7|||
149118125|NCT00929110|537911362|FG002|Overall Study|Lost to Follow-up|3|||
149118126|NCT00929110|537911360|FG000|Overall Study|Protocol deviation|5|||
149118127|NCT00929110|537911361|FG001|Overall Study|Protocol deviation|2|||
149118128|NCT00929110|537911362|FG002|Overall Study|Protocol deviation|4|||
149118129|NCT00929110|537911360|FG000|Overall Study|Administrative problems|4|||
149118130|NCT00929110|537911361|FG001|Overall Study|Administrative problems|1|||
149118131|NCT00929110|537911362|FG002|Overall Study|Administrative problems|2|||
149118132|NCT00929110|537911360|FG000|Overall Study|Death|2|||
149118133|NCT00929110|537911361|FG001|Overall Study|Death|2|||
149118134|NCT00929110|537911362|FG002|Overall Study|Death|2|||
149118135|NCT00929110|537911360|FG000|Overall Study|Abnormal laboratory value(s)|0|||
149118136|NCT00929110|537911361|FG001|Overall Study|Abnormal laboratory value(s)|1|||
149118137|NCT00929110|537911362|FG002|Overall Study|Abnormal laboratory value(s)|0|||
149118138|NCT00929110|537911360|FG000|Overall Study|Abnormal test procedure result(s)|0|||
149119798|NCT00006011|537917971|FG002|Overall Study|Death|2|||
149118139|NCT00929110|537911361|FG001|Overall Study|Abnormal test procedure result(s)|1|||
149118140|NCT00929110|537911362|FG002|Overall Study|Abnormal test procedure result(s)|1|||
149118141|NCT00929110|537911360|FG000|Overall Study|Patient inability to use the device|0|||
149118142|NCT00929110|537911361|FG001|Overall Study|Patient inability to use the device|1|||
149118143|NCT00929110|537911362|FG002|Overall Study|Patient inability to use the device|0|||
149118144|NCT02416453|537911365|FG000|Overall Study|Adverse Event|0|||
149118145|NCT02416453|537911366|FG001|Overall Study|Adverse Event|0|||
149118146|NCT02416453|537911367|FG002|Overall Study|Adverse Event|0|||
149118147|NCT02416453|537911368|FG003|Overall Study|Adverse Event|2|||
149118148|NCT02416453|537911369|FG004|Overall Study|Adverse Event|0|||
149118149|NCT02416453|537911370|FG005|Overall Study|Adverse Event|1|||
149118150|NCT02416453|537911371|FG006|Overall Study|Adverse Event|0|||
149118151|NCT02416453|537911372|FG007|Overall Study|Adverse Event|0|||
149118152|NCT02416453|537911373|FG008|Overall Study|Adverse Event|0|||
149118153|NCT02416453|537911374|FG009|Overall Study|Adverse Event|0|||
149118154|NCT02416453|537911375|FG010|Overall Study|Adverse Event|0|||
149118155|NCT02416453|537911365|FG000|Overall Study|Lost to Follow-up|1|||
149118156|NCT02416453|537911366|FG001|Overall Study|Lost to Follow-up|3|||
149118157|NCT02416453|537911367|FG002|Overall Study|Lost to Follow-up|0|||
149118158|NCT02416453|537911368|FG003|Overall Study|Lost to Follow-up|8|||
149118159|NCT02416453|537911369|FG004|Overall Study|Lost to Follow-up|0|||
149118160|NCT02416453|537911370|FG005|Overall Study|Lost to Follow-up|5|||
149118161|NCT02416453|537911371|FG006|Overall Study|Lost to Follow-up|1|||
149118162|NCT02416453|537911372|FG007|Overall Study|Lost to Follow-up|3|||
149118163|NCT02416453|537911373|FG008|Overall Study|Lost to Follow-up|1|||
149118164|NCT02416453|537911374|FG009|Overall Study|Lost to Follow-up|0|||
149118165|NCT02416453|537911375|FG010|Overall Study|Lost to Follow-up|0|||
149118166|NCT02416453|537911365|FG000|Overall Study|Physician Decision|0|||
149118167|NCT02416453|537911366|FG001|Overall Study|Physician Decision|0|||
149118168|NCT02416453|537911367|FG002|Overall Study|Physician Decision|0|||
149118169|NCT02416453|537911368|FG003|Overall Study|Physician Decision|0|||
149118170|NCT02416453|537911369|FG004|Overall Study|Physician Decision|0|||
149118171|NCT02416453|537911370|FG005|Overall Study|Physician Decision|1|||
149118172|NCT02416453|537911371|FG006|Overall Study|Physician Decision|1|||
149118173|NCT02416453|537911372|FG007|Overall Study|Physician Decision|1|||
149118174|NCT02416453|537911373|FG008|Overall Study|Physician Decision|0|||
149118175|NCT02416453|537911374|FG009|Overall Study|Physician Decision|0|||
149118176|NCT02416453|537911375|FG010|Overall Study|Physician Decision|0|||
149118177|NCT02416453|537911365|FG000|Overall Study|Withdrawal by Subject|2|||
149118178|NCT02416453|537911366|FG001|Overall Study|Withdrawal by Subject|0|||
149118179|NCT02416453|537911367|FG002|Overall Study|Withdrawal by Subject|0|||
149118180|NCT02416453|537911368|FG003|Overall Study|Withdrawal by Subject|5|||
149118181|NCT02416453|537911369|FG004|Overall Study|Withdrawal by Subject|1|||
149118182|NCT02416453|537911370|FG005|Overall Study|Withdrawal by Subject|8|||
149118183|NCT02416453|537911371|FG006|Overall Study|Withdrawal by Subject|0|||
149118184|NCT02416453|537911372|FG007|Overall Study|Withdrawal by Subject|8|||
149118185|NCT02416453|537911373|FG008|Overall Study|Withdrawal by Subject|4|||
149118186|NCT02416453|537911374|FG009|Overall Study|Withdrawal by Subject|0|||
149118187|NCT02416453|537911375|FG010|Overall Study|Withdrawal by Subject|0|||
149118188|NCT02416453|537911365|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118189|NCT02416453|537911366|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118190|NCT02416453|537911367|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
149118191|NCT02416453|537911368|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118192|NCT02416453|537911369|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118193|NCT02416453|537911370|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118194|NCT02416453|537911371|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118195|NCT02416453|537911372|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118196|NCT02416453|537911373|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118197|NCT02416453|537911374|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118198|NCT02416453|537911375|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
149118199|NCT02416453|537911365|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118200|NCT02416453|537911366|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118201|NCT02416453|537911367|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118202|NCT02416453|537911368|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118203|NCT02416453|537911369|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118204|NCT02416453|537911370|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
149118205|NCT02416453|537911371|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118206|NCT02416453|537911372|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118207|NCT02416453|537911373|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118208|NCT02416453|537911374|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118209|NCT02416453|537911375|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
149118210|NCT01163292|537911377|FG000|Overall Study|Lack of Efficacy|9|||
149118211|NCT01163292|537911378|FG001|Overall Study|Lack of Efficacy|0|||
149118212|NCT01163292|537911377|FG000|Overall Study|Adverse Event|6|||
149118213|NCT01163292|537911378|FG001|Overall Study|Adverse Event|0|||
149118214|NCT01163292|537911377|FG000|Overall Study|Initiation of biological therapy|0|||
149118215|NCT01163292|537911378|FG001|Overall Study|Initiation of biological therapy|15|||
149118216|NCT01163292|537911377|FG000|Overall Study|Sufficient response to adalimumab|8|||
149118217|NCT01163292|537911378|FG001|Overall Study|Sufficient response to adalimumab|0|||
149118218|NCT01163292|537911377|FG000|Overall Study|Refusal to receive adalimumab|7|||
149118219|NCT01163292|537911378|FG001|Overall Study|Refusal to receive adalimumab|0|||
149118220|NCT01163292|537911377|FG000|Overall Study|Economic reasons|6|||
149118221|NCT01163292|537911378|FG001|Overall Study|Economic reasons|0|||
149118222|NCT01163292|537911377|FG000|Overall Study|No further visits|5|||
149118223|NCT01163292|537911378|FG001|Overall Study|No further visits|7|||
149118224|NCT02535091|537911379|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
149118225|NCT02535091|537911380|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
149118226|NCT02535091|537911381|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
149118227|NCT02535091|537911379|FG000|Overall Study|Withdrawal by Subject|14|||
149118228|NCT02535091|537911380|FG001|Overall Study|Withdrawal by Subject|5|||
149118229|NCT02535091|537911381|FG002|Overall Study|Withdrawal by Subject|121|||
149118230|NCT02535091|537911379|FG000|Overall Study|Adverse Event|9|||
149118231|NCT02535091|537911380|FG001|Overall Study|Adverse Event|4|||
149118232|NCT02535091|537911381|FG002|Overall Study|Adverse Event|170|||
149118233|NCT02535091|537911379|FG000|Overall Study|Other|4|||
149118234|NCT02535091|537911380|FG001|Overall Study|Other|3|||
149118235|NCT02535091|537911381|FG002|Overall Study|Other|81|||
149118236|NCT02535091|537911379|FG000|Overall Study|Lost to Follow-up|0|||
149118237|NCT02535091|537911380|FG001|Overall Study|Lost to Follow-up|1|||
149118238|NCT02535091|537911381|FG002|Overall Study|Lost to Follow-up|19|||
149118239|NCT02535091|537911379|FG000|Overall Study|Protocol Violation|0|||
149118240|NCT02535091|537911380|FG001|Overall Study|Protocol Violation|1|||
149118241|NCT02535091|537911381|FG002|Overall Study|Protocol Violation|11|||
149118242|NCT02535091|537911379|FG000|Overall Study|Pregnancy|0|||
149118243|NCT02535091|537911380|FG001|Overall Study|Pregnancy|0|||
149118244|NCT02535091|537911381|FG002|Overall Study|Pregnancy|7|||
149118245|NCT03223662|537911388|FG000|Overall Study|Physician Decision|1|||
149118246|NCT03223662|537911388|FG000|Overall Study|Study closure|1|||
149118247|NCT02643472|537911396|FG000|Overall Study|Death|2|||
149118248|NCT02643472|537911397|FG001|Overall Study|Death|5|||
149118249|NCT02643472|537911396|FG000|Overall Study|Withdrawal by Subject|3|||
149118250|NCT02643472|537911397|FG001|Overall Study|Withdrawal by Subject|2|||
149118251|NCT02643472|537911396|FG000|Overall Study|Protocol Violation|0|||
149118252|NCT02643472|537911397|FG001|Overall Study|Protocol Violation|1|||
149118253|NCT02643472|537911396|FG000|Overall Study|Lost to Follow-up|22|||
149118254|NCT02643472|537911397|FG001|Overall Study|Lost to Follow-up|26|||
149118255|NCT01258595|537911398|FG000|Overall Study|Lost to Follow-up|1|||
149118256|NCT01258595|537911399|FG001|Overall Study|Lost to Follow-up|0|||
149118257|NCT01258595|537911398|FG000|Overall Study|Withdrawal by Subject|0|||
149118258|NCT01258595|537911399|FG001|Overall Study|Withdrawal by Subject|1|||
149118259|NCT01215188|537911400|FG000|Overall Study|Lost to Follow-up|22|||
149118260|NCT01215188|537911401|FG001|Overall Study|Lost to Follow-up|22|||
149118261|NCT01215188|537911402|FG002|Overall Study|Lost to Follow-up|16|||
149118262|NCT01215188|537911400|FG000|Overall Study|Adverse Event|1|||
149118263|NCT01215188|537911401|FG001|Overall Study|Adverse Event|1|||
149118264|NCT01215188|537911402|FG002|Overall Study|Adverse Event|3|||
149118265|NCT01215188|537911400|FG000|Overall Study|Physician Decision|2|||
149118266|NCT01215188|537911401|FG001|Overall Study|Physician Decision|1|||
149118267|NCT01215188|537911402|FG002|Overall Study|Physician Decision|0|||
149118268|NCT01215188|537911400|FG000|Overall Study|Lack of Efficacy|0|||
149118269|NCT01215188|537911401|FG001|Overall Study|Lack of Efficacy|0|||
149118270|NCT01215188|537911402|FG002|Overall Study|Lack of Efficacy|1|||
149118271|NCT01215188|537911400|FG000|Overall Study|Protocol Violation|1|||
149118272|NCT01215188|537911401|FG001|Overall Study|Protocol Violation|1|||
149118273|NCT01215188|537911402|FG002|Overall Study|Protocol Violation|1|||
149118274|NCT01215188|537911400|FG000|Overall Study|Withdrawal by Subject|32|||
149118275|NCT01215188|537911401|FG001|Overall Study|Withdrawal by Subject|34|||
149118276|NCT01215188|537911402|FG002|Overall Study|Withdrawal by Subject|31|||
149118277|NCT01012414|537911403|FG000|Overall Study|Withdrawal by Subject|2|||
149118278|NCT01012414|537911403|FG000|Overall Study|Lost to Follow-up|1|||
149118279|NCT01012414|537911403|FG000|Overall Study|Trial was stopped before completed|7|||
149118280|NCT02601300|537911404|FG000|Induction Phase|Lack of Efficacy|2|||
149118281|NCT02601300|537911404|FG000|Induction Phase|Protocol Violation|1|||
149118282|NCT02601300|537911404|FG000|Extension Phase|Withdrawal by Subject|3|||
149118283|NCT02601300|537911404|FG000|Extension Phase|Adverse Event|4|||
149118284|NCT02601300|537911404|FG000|Extension Phase|Lack of Efficacy|10|||
149118285|NCT02310100|537911405|FG000|Overall Study|Physician Decision|3|||
149118286|NCT02310100|537911405|FG000|Overall Study|Withdrawal by Subject|10|||
149118287|NCT02310100|537911405|FG000|Overall Study|Enrollment closure|1|||
149118288|NCT02310100|537911405|FG000|Overall Study|Unapproved ablation operator|1|||
149118289|NCT02310100|537911405|FG000|Overall Study|Visit compliance|1|||
149118290|NCT02310100|537911405|FG000|Overall Study|Lost to Follow-up|2|||
149118291|NCT01127763|537911406|FG000|Overall Study|Adverse Event|2|||
149118292|NCT01127763|537911406|FG000|Overall Study|Withdrawal by Subject|1|||
149118293|NCT01127763|537911406|FG000|Overall Study|Physician Decision|2|||
149118294|NCT00528931|537911407|FG000|Overall Study|Lost to Follow-up|1|||
149118295|NCT01253018|537911409|FG000|Overall Study|Lost to Follow-up|1|||
149118296|NCT01253018|537911410|FG001|Overall Study|Lost to Follow-up|1|||
149118297|NCT01253018|537911409|FG000|Overall Study|Robot Repair Issues|2|||
149118298|NCT01253018|537911410|FG001|Overall Study|Robot Repair Issues|0|||
149118299|NCT01253018|537911409|FG000|Overall Study|Withdrawal by Subject|1|||
149118300|NCT01253018|537911410|FG001|Overall Study|Withdrawal by Subject|1|||
149118301|NCT01489891|537911411|FG000|Overall Study|Endoscopy failure|1|||
149118302|NCT01489891|537911412|FG001|Overall Study|Endoscopy failure|0|||
149118303|NCT00948766|537911413|FG000|Core Study|Adverse Event|73|||
149118304|NCT00948766|537911414|FG001|Core Study|Adverse Event|51|||
149118305|NCT00948766|537911413|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
149118306|NCT00948766|537911414|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
149118307|NCT00948766|537911413|FG000|Core Study|Patient Withdrew Consent|27|||
149118308|NCT00948766|537911414|FG001|Core Study|Patient Withdrew Consent|46|||
149118309|NCT00948766|537911413|FG000|Core Study|Lost to Follow-up|3|||
149118310|NCT00948766|537911414|FG001|Core Study|Lost to Follow-up|2|||
149118311|NCT00948766|537911413|FG000|Core Study|Administrative Problems|2|||
149118312|NCT00948766|537911414|FG001|Core Study|Administrative Problems|2|||
149118313|NCT00948766|537911413|FG000|Core Study|Death|1|||
149118314|NCT00948766|537911414|FG001|Core Study|Death|1|||
149118315|NCT00948766|537911413|FG000|Core Study|Protocol Deviation|8|||
149118316|NCT00948766|537911414|FG001|Core Study|Protocol Deviation|10|||
149118317|NCT00948766|537911413|FG000|Extension Study|Adverse Event|43|||
149118318|NCT00948766|537911414|FG001|Extension Study|Adverse Event|0|||
149118319|NCT00948766|537911413|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
149118320|NCT00948766|537911414|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
149118321|NCT00948766|537911413|FG000|Extension Study|Study Drug No Longer Required|1|||
149118322|NCT00948766|537911414|FG001|Extension Study|Study Drug No Longer Required|0|||
149118323|NCT00948766|537911413|FG000|Extension Study|Patient Withdrew Consent|32|||
149118324|NCT00948766|537911414|FG001|Extension Study|Patient Withdrew Consent|0|||
149118325|NCT00948766|537911413|FG000|Extension Study|Lost to Follow-up|8|||
149118326|NCT00948766|537911414|FG001|Extension Study|Lost to Follow-up|0|||
149118327|NCT00948766|537911413|FG000|Extension Study|Administrative Problems|1|||
149118328|NCT00948766|537911414|FG001|Extension Study|Administrative Problems|0|||
149118329|NCT00948766|537911413|FG000|Extension Study|Death|4|||
149118330|NCT00948766|537911414|FG001|Extension Study|Death|0|||
149118331|NCT01036438|537911415|FG000|Overall Study|Adverse Event|7|||
149118332|NCT01036438|537911416|FG001|Overall Study|Adverse Event|8|||
149118333|NCT01036438|537911415|FG000|Overall Study|Death|0|||
149118334|NCT01036438|537911416|FG001|Overall Study|Death|1|||
149118335|NCT01036438|537911415|FG000|Overall Study|No effect of study treatment|3|||
149118336|NCT01036438|537911416|FG001|Overall Study|No effect of study treatment|1|||
149118337|NCT00777088|537911417|FG000|Overall Study|PED Treatment not attempted|1|||
149118338|NCT01278173|537911418|FG000|Overall Study|Lack of Efficacy|13|||
149118339|NCT01278173|537911418|FG000|Overall Study|Adverse Event|8|||
149118340|NCT01278173|537911418|FG000|Overall Study|Administrative or other reason|4|||
149118341|NCT01278173|537911418|FG000|Overall Study|Protocol Violation|1|||
149118342|NCT01278173|537911418|FG000|Overall Study|Withdrawal by Subject|1|||
149118343|NCT03592745|537911419|FG000|Overall Study|Adverse Event|0|||
149118344|NCT03592745|537911420|FG001|Overall Study|Adverse Event|2|||
149118345|NCT03592745|537911419|FG000|Overall Study|Lost to Follow-up|2|||
149118346|NCT03592745|537911420|FG001|Overall Study|Lost to Follow-up|0|||
149118347|NCT03592745|537911419|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
149118348|NCT03592745|537911420|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
149118349|NCT02729831|537911422|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
149118350|NCT02729831|537911423|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
149118351|NCT02729831|537911424|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
149118352|NCT02729831|537911425|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
149118353|NCT02729831|537911422|FG000|1 Week Post-visit|Lost to Follow-up|43|||
149118354|NCT02729831|537911423|FG001|1 Week Post-visit|Lost to Follow-up|40|||
149118355|NCT02729831|537911424|FG002|1 Week Post-visit|Lost to Follow-up|38|||
149118356|NCT02729831|537911425|FG003|1 Week Post-visit|Lost to Follow-up|36|||
149118357|NCT02729831|537911422|FG000|6 Month Follow-up|Lost to Follow-up|54|||
149118358|NCT02729831|537911423|FG001|6 Month Follow-up|Lost to Follow-up|51|||
149118359|NCT02729831|537911424|FG002|6 Month Follow-up|Lost to Follow-up|48|||
149118360|NCT02729831|537911425|FG003|6 Month Follow-up|Lost to Follow-up|42|||
149118361|NCT02729831|537911422|FG000|6 Month Follow-up|Death|1|||
149118362|NCT02729831|537911423|FG001|6 Month Follow-up|Death|3|||
149118363|NCT02729831|537911424|FG002|6 Month Follow-up|Death|0|||
149118364|NCT02729831|537911425|FG003|6 Month Follow-up|Death|1|||
149118365|NCT02091206|537911426|FG000|Treatment Period|Adverse Event|0|||
149118366|NCT02091206|537911427|FG001|Treatment Period|Adverse Event|1|||
149118367|NCT02091206|537911428|FG002|Treatment Period|Adverse Event|0|||
149118368|NCT02091206|537911429|FG003|Treatment Period|Adverse Event|0|||
149118369|NCT02091206|537911426|FG000|Treatment Period|Met withdrawal criteria|0|||
149118370|NCT02091206|537911427|FG001|Treatment Period|Met withdrawal criteria|0|||
149118371|NCT02091206|537911428|FG002|Treatment Period|Met withdrawal criteria|1|||
149118372|NCT02091206|537911429|FG003|Treatment Period|Met withdrawal criteria|0|||
149118373|NCT02091206|537911426|FG000|Taper Period|Participant refused study drug|1|||
149118374|NCT02091206|537911427|FG001|Taper Period|Participant refused study drug|0|||
149118375|NCT02091206|537911428|FG002|Taper Period|Participant refused study drug|0|||
149118376|NCT02091206|537911429|FG003|Taper Period|Participant refused study drug|1|||
149118377|NCT02091206|537911426|FG000|Taper Period|Lost to Follow-up|0|||
149118378|NCT02091206|537911427|FG001|Taper Period|Lost to Follow-up|0|||
149118379|NCT02091206|537911428|FG002|Taper Period|Lost to Follow-up|0|||
149118380|NCT02091206|537911429|FG003|Taper Period|Lost to Follow-up|1|||
149118381|NCT05051462|537911436|FG000|Overall Study|Lost to Follow-up|1|||
149118382|NCT05051462|537911437|FG001|Overall Study|Lost to Follow-up|8|||
149118383|NCT05051462|537911436|FG000|Overall Study|Withdrawal by Subject|1|||
149118384|NCT05051462|537911437|FG001|Overall Study|Withdrawal by Subject|0|||
149118385|NCT05051462|537911436|FG000|Overall Study|Protocol Violation|0|||
149118386|NCT05051462|537911437|FG001|Overall Study|Protocol Violation|2|||
149118387|NCT05597787|537911443|FG000|Overall Study|Withdrawal by Subject|0|||
149118388|NCT05597787|537911444|FG001|Overall Study|Withdrawal by Subject|0|||
149118389|NCT05597787|537911445|FG002|Overall Study|Withdrawal by Subject|1|||
149118390|NCT01241604|537911446|FG000|Screening Period|Screen Failure|3|||
149118391|NCT01241604|537911447|FG001|Screening Period|Screen Failure|0|||
149118392|NCT01241604|537911448|FG002|Screening Period|Screen Failure|0|||
149118393|NCT01593787|537911449|FG000|Overall Study|Adverse Event|1|||
149118394|NCT01593787|537911450|FG001|Overall Study|Adverse Event|0|||
149118395|NCT01593787|537911451|FG002|Overall Study|Adverse Event|0|||
149118396|NCT00969709|537913025|FG000|Overall Study|Adverse Event|3|||
149118397|NCT00969709|537913026|FG001|Overall Study|Adverse Event|13|||
149118398|NCT00969709|537913027|FG002|Overall Study|Adverse Event|26|||
149118399|NCT00969709|537913028|FG003|Overall Study|Adverse Event|12|||
149118400|NCT00969709|537913025|FG000|Overall Study|Lack of Efficacy|7|||
149118401|NCT00969709|537913026|FG001|Overall Study|Lack of Efficacy|4|||
149118402|NCT00969709|537913027|FG002|Overall Study|Lack of Efficacy|1|||
149118403|NCT00969709|537913028|FG003|Overall Study|Lack of Efficacy|3|||
149118404|NCT00969709|537913025|FG000|Overall Study|Protocol Violation|9|||
149118405|NCT00969709|537913026|FG001|Overall Study|Protocol Violation|5|||
149118406|NCT00969709|537913027|FG002|Overall Study|Protocol Violation|9|||
149118407|NCT00969709|537913028|FG003|Overall Study|Protocol Violation|10|||
149118408|NCT00969709|537913025|FG000|Overall Study|Withdrawal by Subject|9|||
149118409|NCT00969709|537913026|FG001|Overall Study|Withdrawal by Subject|12|||
149118410|NCT00969709|537913027|FG002|Overall Study|Withdrawal by Subject|11|||
149118411|NCT00969709|537913028|FG003|Overall Study|Withdrawal by Subject|23|||
149118412|NCT00969709|537913025|FG000|Overall Study|Lost to Follow-up|10|||
149118413|NCT00969709|537913026|FG001|Overall Study|Lost to Follow-up|14|||
149118414|NCT00969709|537913027|FG002|Overall Study|Lost to Follow-up|8|||
149118415|NCT00969709|537913028|FG003|Overall Study|Lost to Follow-up|15|||
149118416|NCT00969709|537913025|FG000|Overall Study|Other reasons|0|||
149118417|NCT00969709|537913026|FG001|Overall Study|Other reasons|0|||
149118418|NCT00969709|537913027|FG002|Overall Study|Other reasons|3|||
149118419|NCT00969709|537913028|FG003|Overall Study|Other reasons|0|||
149118420|NCT03037931|537913029|FG000|Overall Study|Death|354|||
149118421|NCT03037931|537913030|FG001|Overall Study|Death|367|||
149118422|NCT03037931|537913029|FG000|Overall Study|Lost to Follow-up|7|||
149118423|NCT03037931|537913030|FG001|Overall Study|Lost to Follow-up|4|||
149118424|NCT03037931|537913029|FG000|Overall Study|Withdrawal by Subject|48|||
149118425|NCT03037931|537913030|FG001|Overall Study|Withdrawal by Subject|41|||
149118426|NCT02075476|537913031|FG000|Overall Study|Death|2|||
149118427|NCT02075476|537913032|FG001|Overall Study|Death|2|||
149118428|NCT02075476|537913031|FG000|Overall Study|Lost to Follow-up|1|||
149118429|NCT02075476|537913032|FG001|Overall Study|Lost to Follow-up|3|||
149118430|NCT01789567|537913035|FG000|Overall Study|Death|6|||
149118431|NCT02914275|537913036|FG000|Overall Study|Lost to Follow-up|84|||
149118432|NCT02914275|537913037|FG001|Overall Study|Lost to Follow-up|29|||
149118433|NCT02914275|537913036|FG000|Overall Study|Withdrawal by Subject|26|||
149118434|NCT02914275|537913037|FG001|Overall Study|Withdrawal by Subject|10|||
149118435|NCT02914275|537913036|FG000|Overall Study|Protocol Violation|1|||
149118436|NCT02914275|537913037|FG001|Overall Study|Protocol Violation|1|||
149118437|NCT02914275|537913036|FG000|Overall Study|Physician Decision|3|||
149118438|NCT02914275|537913037|FG001|Overall Study|Physician Decision|1|||
149118439|NCT02914275|537913036|FG000|Overall Study|Other|4|||
149118440|NCT02914275|537913037|FG001|Overall Study|Other|1|||
149118441|NCT02914275|537913036|FG000|Overall Study|Excluded due to invalid informed consent|3|||
149118442|NCT02914275|537913037|FG001|Overall Study|Excluded due to invalid informed consent|0|||
149118443|NCT00872989|537913038|FG000|Overall Study|Adverse Event|7|||
149118444|NCT00872989|537913039|FG001|Overall Study|Adverse Event|15|||
149118445|NCT00872989|537913038|FG000|Overall Study|Withdrawal by Subject|8|||
149118446|NCT00872989|537913039|FG001|Overall Study|Withdrawal by Subject|5|||
149118447|NCT00872989|537913038|FG000|Overall Study|Progression/relapse|47|||
149118448|NCT00872989|537913039|FG001|Overall Study|Progression/relapse|35|||
149118449|NCT00872989|537913038|FG000|Overall Study|Not protocol specified|3|||
149118450|NCT00872989|537913039|FG001|Overall Study|Not protocol specified|8|||
149118451|NCT02407990|537913040|FG000|Overall Study|Death|2|||
149118452|NCT02407990|537913041|FG001|Overall Study|Death|22|||
149118453|NCT02407990|537913042|FG002|Overall Study|Death|23|||
149118454|NCT02407990|537913043|FG003|Overall Study|Death|7|||
149118455|NCT02407990|537913044|FG004|Overall Study|Death|17|||
149118456|NCT02407990|537913045|FG005|Overall Study|Death|16|||
149118457|NCT02407990|537913046|FG006|Overall Study|Death|10|||
149118458|NCT02407990|537913047|FG007|Overall Study|Death|248|||
149118459|NCT02407990|537913040|FG000|Overall Study|Lost to Follow-up|0|||
149118460|NCT02407990|537913041|FG001|Overall Study|Lost to Follow-up|1|||
149118461|NCT02407990|537913042|FG002|Overall Study|Lost to Follow-up|0|||
149118462|NCT02407990|537913043|FG003|Overall Study|Lost to Follow-up|0|||
149118463|NCT02407990|537913044|FG004|Overall Study|Lost to Follow-up|0|||
149118464|NCT02407990|537913045|FG005|Overall Study|Lost to Follow-up|0|||
149118465|NCT02407990|537913046|FG006|Overall Study|Lost to Follow-up|0|||
149118466|NCT02407990|537913047|FG007|Overall Study|Lost to Follow-up|17|||
149118467|NCT02407990|537913040|FG000|Overall Study|Progressive Disease|0|||
149118468|NCT02407990|537913041|FG001|Overall Study|Progressive Disease|0|||
149118469|NCT02407990|537913042|FG002|Overall Study|Progressive Disease|0|||
149118470|NCT02407990|537913043|FG003|Overall Study|Progressive Disease|0|||
149118471|NCT02407990|537913044|FG004|Overall Study|Progressive Disease|0|||
149118472|NCT02407990|537913045|FG005|Overall Study|Progressive Disease|0|||
149118473|NCT02407990|537913046|FG006|Overall Study|Progressive Disease|0|||
149118474|NCT02407990|537913047|FG007|Overall Study|Progressive Disease|1|||
149118475|NCT02407990|537913040|FG000|Overall Study|Withdrawal by Subject|0|||
149118476|NCT02407990|537913041|FG001|Overall Study|Withdrawal by Subject|0|||
149118477|NCT02407990|537913042|FG002|Overall Study|Withdrawal by Subject|0|||
149118478|NCT02407990|537913043|FG003|Overall Study|Withdrawal by Subject|0|||
149118479|NCT02407990|537913044|FG004|Overall Study|Withdrawal by Subject|1|||
149118480|NCT02407990|537913045|FG005|Overall Study|Withdrawal by Subject|0|||
149118481|NCT02407990|537913046|FG006|Overall Study|Withdrawal by Subject|0|||
149118482|NCT02407990|537913047|FG007|Overall Study|Withdrawal by Subject|30|||
149118483|NCT02407990|537913040|FG000|Overall Study|Study Terminated by Sponsor|1|||
149118484|NCT02407990|537913041|FG001|Overall Study|Study Terminated by Sponsor|3|||
149118485|NCT02407990|537913042|FG002|Overall Study|Study Terminated by Sponsor|3|||
149118486|NCT02407990|537913043|FG003|Overall Study|Study Terminated by Sponsor|0|||
149118487|NCT02407990|537913044|FG004|Overall Study|Study Terminated by Sponsor|3|||
149118488|NCT02407990|537913045|FG005|Overall Study|Study Terminated by Sponsor|4|||
149118489|NCT02407990|537913046|FG006|Overall Study|Study Terminated by Sponsor|3|||
149118490|NCT02407990|537913047|FG007|Overall Study|Study Terminated by Sponsor|37|||
149118491|NCT02407990|537913040|FG000|Overall Study|Logistics|0|||
149118492|NCT02407990|537913041|FG001|Overall Study|Logistics|0|||
149118493|NCT02407990|537913042|FG002|Overall Study|Logistics|0|||
149118494|NCT02407990|537913043|FG003|Overall Study|Logistics|0|||
149118495|NCT02407990|537913044|FG004|Overall Study|Logistics|0|||
149118496|NCT02407990|537913045|FG005|Overall Study|Logistics|0|||
149118497|NCT02407990|537913046|FG006|Overall Study|Logistics|0|||
149118498|NCT02407990|537913047|FG007|Overall Study|Logistics|1|||
149118499|NCT02407990|537913040|FG000|Overall Study|Rolled into long-term extension study|0|||
149118500|NCT02407990|537913041|FG001|Overall Study|Rolled into long-term extension study|0|||
149118501|NCT02407990|537913042|FG002|Overall Study|Rolled into long-term extension study|0|||
149118502|NCT02407990|537913043|FG003|Overall Study|Rolled into long-term extension study|0|||
149118503|NCT02407990|537913044|FG004|Overall Study|Rolled into long-term extension study|0|||
149118504|NCT02407990|537913045|FG005|Overall Study|Rolled into long-term extension study|0|||
149118505|NCT02407990|537913046|FG006|Overall Study|Rolled into long-term extension study|0|||
149118506|NCT02407990|537913047|FG007|Overall Study|Rolled into long-term extension study|1|||
149118507|NCT00923260|537913048|FG000|Overall Study|Lost to Follow-up|1|||
149118508|NCT00923260|537913049|FG001|Overall Study|Lost to Follow-up|1|||
149118509|NCT03900416|537913052|FG000|Six Week Follow-up|Lost to Follow-up|1|||
149118510|NCT03900416|537913053|FG001|Six Week Follow-up|Lost to Follow-up|0|||
149118511|NCT03900416|537913052|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
149118512|NCT03900416|537913053|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
149118513|NCT03900416|537913052|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
149118514|NCT03900416|537913053|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
149118515|NCT03900416|537913052|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
149118516|NCT03900416|537913053|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
149118517|NCT03900416|537913052|FG000|Twelve Week Follow-up|Adverse Event|1|||
149118518|NCT03900416|537913053|FG001|Twelve Week Follow-up|Adverse Event|1|||
149118519|NCT03900416|537913052|FG000|Six Month Follow-up|Lost to Follow-up|4|||
149118520|NCT03900416|537913053|FG001|Six Month Follow-up|Lost to Follow-up|3|||
149118521|NCT03900416|537913052|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
149118522|NCT03900416|537913053|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
149118523|NCT00836745|537913054|FG000|Overall Study|Death|2|||
149118524|NCT00836745|537913054|FG000|Overall Study|Lost to Follow-up|10|||
149118525|NCT00836745|537913054|FG000|Overall Study|Adverse Event|3|||
149118526|NCT00836745|537913054|FG000|Overall Study|Objective progression or relapse|4|||
149118527|NCT00836745|537913054|FG000|Overall Study|Other|2|||
149118528|NCT05540717|537913055|FG000|Overall Study|Lost to Follow-up|2|||
149118529|NCT05540717|537913056|FG001|Overall Study|Lost to Follow-up|5|||
149118530|NCT05540717|537913055|FG000|Overall Study|Withdrawal by Subject|6|||
149118531|NCT05540717|537913056|FG001|Overall Study|Withdrawal by Subject|6|||
149118532|NCT05540717|537913055|FG000|Overall Study|Sponsor request|1|||
149118533|NCT05540717|537913056|FG001|Overall Study|Sponsor request|0|||
149118534|NCT05540717|537913055|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
149118535|NCT05540717|537913056|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
149118536|NCT05540717|537913055|FG000|Overall Study|Other|0|||
149118537|NCT05540717|537913056|FG001|Overall Study|Other|1|||
149118538|NCT03377699|537913060|FG000|Overall Study|Withdrawal by Subject|2|||
149118539|NCT03377699|537913061|FG001|Overall Study|Withdrawal by Subject|9|||
149118540|NCT03377699|537913060|FG000|Overall Study|Lost to Follow-up|1|||
149118541|NCT03377699|537913061|FG001|Overall Study|Lost to Follow-up|1|||
149118542|NCT03377699|537913060|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
149118543|NCT03377699|537913061|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
149118544|NCT03377699|537913060|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
149118545|NCT03377699|537913061|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
149118546|NCT03377699|537913060|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
149118547|NCT03377699|537913061|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
149118548|NCT03377699|537913060|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
149118549|NCT03377699|537913061|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
149118550|NCT00774930|537913064|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
149118551|NCT00774930|537913065|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
149118552|NCT00774930|537913064|FG000|DB Phase|Adverse Event|1|||
149118553|NCT00774930|537913065|FG001|DB Phase|Adverse Event|2|||
149118554|NCT00774930|537913064|FG000|DB Phase|Subject Decision|1|||
149118555|NCT00774930|537913065|FG001|DB Phase|Subject Decision|5|||
149118556|NCT00774930|537913064|FG000|DB Phase|Sponsor Decision|0|||
149118557|NCT00774930|537913065|FG001|DB Phase|Sponsor Decision|1|||
149118558|NCT00774930|537913064|FG000|DB Phase|Disease Progression|1|||
149118559|NCT00774930|537913065|FG001|DB Phase|Disease Progression|1|||
149118560|NCT00774930|537913064|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
149118561|NCT00774930|537913065|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
149118562|NCT00774930|537913064|FG000|IOL Phase|Adverse Event|1|||
149118563|NCT00774930|537913065|FG001|IOL Phase|Adverse Event|1|||
149118564|NCT00774930|537913064|FG000|IOL Phase|Subject Decision|4|||
149118565|NCT00774930|537913065|FG001|IOL Phase|Subject Decision|3|||
149118566|NCT00774930|537913064|FG000|IOL Phase|Physician Decision|3|||
149118567|NCT00774930|537913065|FG001|IOL Phase|Physician Decision|2|||
149118568|NCT00774930|537913064|FG000|IOL Phase|Sponsor Decision|1|||
149118569|NCT00774930|537913065|FG001|IOL Phase|Sponsor Decision|0|||
149118570|NCT00774930|537913064|FG000|IOL Phase|Disease Progression|2|||
149118571|NCT00774930|537913065|FG001|IOL Phase|Disease Progression|1|||
149118572|NCT00774930|537913064|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
149118573|NCT00774930|537913065|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
149118574|NCT00774930|537913064|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
149118575|NCT00774930|537913065|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
149118576|NCT00774930|537913064|FG000|IOL Phase|Other|1|||
149118577|NCT00774930|537913065|FG001|IOL Phase|Other|0|||
149118578|NCT00774930|537913064|FG000|IOL Phase|Brain radiation|0|||
149118579|NCT00774930|537913065|FG001|IOL Phase|Brain radiation|1|||
149118580|NCT00774930|537913064|FG000|LTOLE Phase|Adverse Event|7|||
149118581|NCT00774930|537913065|FG001|LTOLE Phase|Adverse Event|3|||
149118582|NCT00774930|537913064|FG000|LTOLE Phase|Subject decision|0|||
149118583|NCT00774930|537913065|FG001|LTOLE Phase|Subject decision|5|||
149118584|NCT00774930|537913064|FG000|LTOLE Phase|Physician Decision|4|||
149118585|NCT00774930|537913065|FG001|LTOLE Phase|Physician Decision|1|||
149118586|NCT00774930|537913064|FG000|LTOLE Phase|Sponsor decision|2|||
149118587|NCT00774930|537913065|FG001|LTOLE Phase|Sponsor decision|1|||
149118588|NCT00774930|537913064|FG000|LTOLE Phase|Disease Progression|2|||
149118589|NCT00774930|537913065|FG001|LTOLE Phase|Disease Progression|5|||
149118590|NCT00774930|537913064|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
149118591|NCT00774930|537913065|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
149118592|NCT00774930|537913064|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
149118593|NCT00774930|537913065|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
149118594|NCT01177800|537913070|FG000|Overall Study|Adverse Event|9|||
149118595|NCT01177800|537913071|FG001|Overall Study|Adverse Event|3|||
149118596|NCT01177800|537913070|FG000|Overall Study|Protocol Violation|0|||
149118597|NCT01177800|537913071|FG001|Overall Study|Protocol Violation|1|||
149118598|NCT01177800|537913070|FG000|Overall Study|Physician Decision|1|||
149118599|NCT01177800|537913071|FG001|Overall Study|Physician Decision|0|||
149118600|NCT01177800|537913070|FG000|Overall Study|Withdrawal of informed consent|0|||
149118601|NCT01177800|537913071|FG001|Overall Study|Withdrawal of informed consent|1|||
149118602|NCT04032613|537913072|FG000|Overall Study|Did not complete post-program assessment|5|||
149118603|NCT04032613|537913073|FG001|Overall Study|Did not complete post-program assessment|2|||
149118604|NCT00424385|537913074|FG000|Cohort 0|Withdrawal by Subject|5|||
149118605|NCT00424385|537913074|FG000|Cohort 0|Physician Decision|1|||
149118606|NCT00424385|537913074|FG000|Cohort 1|Withdrawal by Subject|1|||
149118607|NCT05560243|537913079|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
149118608|NCT05870228|537913080|FG000|Overall Study|Lost to Follow-up|2|||
149118609|NCT05870228|537913081|FG001|Overall Study|Lost to Follow-up|0|||
149118610|NCT05870228|537913080|FG000|Overall Study|Withdrawal by Subject|1|||
149118611|NCT05870228|537913081|FG001|Overall Study|Withdrawal by Subject|0|||
149118612|NCT03231800|537913086|FG000|Overall Study|Lost to Follow-up|0|||
149118613|NCT03231800|537913087|FG001|Overall Study|Lost to Follow-up|2|||
149118614|NCT03231800|537913086|FG000|Overall Study|Protocol Violation|1|||
149118615|NCT03231800|537913087|FG001|Overall Study|Protocol Violation|1|||
149118616|NCT03231800|537913086|FG000|Overall Study|reason not provided|2|||
149118617|NCT03231800|537913087|FG001|Overall Study|reason not provided|0|||
149118618|NCT00859222|537913089|FG000|Overall Study|Adverse Event|2|||
149118619|NCT00859222|537913090|FG001|Overall Study|Adverse Event|3|||
149118620|NCT00859222|537913091|FG002|Overall Study|Adverse Event|6|||
149118621|NCT00859222|537913092|FG003|Overall Study|Adverse Event|24|||
149118622|NCT00859222|537913093|FG004|Overall Study|Adverse Event|15|||
149118623|NCT00859222|537913089|FG000|Overall Study|DLT|1|||
149118624|NCT00859222|537913090|FG001|Overall Study|DLT|0|||
149118625|NCT00859222|537913091|FG002|Overall Study|DLT|0|||
149118626|NCT00859222|537913092|FG003|Overall Study|DLT|0|||
149118627|NCT00859222|537913093|FG004|Overall Study|DLT|0|||
149118628|NCT00941070|537913094|FG000|Overall Study|Patient non-compliant|1|||
149118629|NCT03174431|537913095|FG000|Overall Study|Withdrawal by Subject|14|||
149118630|NCT03174431|537913096|FG001|Overall Study|Withdrawal by Subject|11|||
149118631|NCT03174431|537913095|FG000|Overall Study|alternative treatment|2|||
149118632|NCT03174431|537913096|FG001|Overall Study|alternative treatment|0|||
149118633|NCT03174431|537913095|FG000|Overall Study|Lost to Follow-up|1|||
149118634|NCT03174431|537913096|FG001|Overall Study|Lost to Follow-up|5|||
149118635|NCT04075994|537913099|FG000|Overall Study|Withdrawal by Subject|8|||
149118636|NCT04075994|537913100|FG001|Overall Study|Withdrawal by Subject|9|||
149118637|NCT04075994|537913099|FG000|Overall Study|Adverse Event|2|||
149118638|NCT04075994|537913100|FG001|Overall Study|Adverse Event|2|||
149118639|NCT04075994|537913099|FG000|Overall Study|Investigator withdrew|3|||
149118640|NCT04075994|537913100|FG001|Overall Study|Investigator withdrew|1|||
149118641|NCT01941719|537913104|FG000|Overall Study|Lost to Follow-up|20|||
149118642|NCT01941719|537913105|FG001|Overall Study|Lost to Follow-up|19|||
149118643|NCT00252577|537913106|FG000|Overall Study|Lost to Follow-up|20|||
149118644|NCT04035499|537913107|FG000|Overall Study|Death|2|||
149118645|NCT04035499|537913107|FG000|Overall Study|Withdrawal by Subject|1|||
149118646|NCT01655693|537913108|FG000|Overall Study|Progression of Disease|92|||
149118647|NCT01655693|537913109|FG001|Overall Study|Progression of Disease|76|||
149118648|NCT01655693|537913110|FG002|Overall Study|Progression of Disease|58|||
149118649|NCT01655693|537913108|FG000|Overall Study|Death|8|||
149118650|NCT01655693|537913109|FG001|Overall Study|Death|9|||
149118651|NCT01655693|537913110|FG002|Overall Study|Death|12|||
149118652|NCT01655693|537913108|FG000|Overall Study|Serious Adverse Event|3|||
149118653|NCT01655693|537913109|FG001|Overall Study|Serious Adverse Event|15|||
149118654|NCT01655693|537913110|FG002|Overall Study|Serious Adverse Event|11|||
149118655|NCT01655693|537913108|FG000|Overall Study|Withdrawal by Subject|3|||
149118656|NCT01655693|537913109|FG001|Overall Study|Withdrawal by Subject|2|||
149118657|NCT01655693|537913110|FG002|Overall Study|Withdrawal by Subject|20|||
149118658|NCT01655693|537913108|FG000|Overall Study|Adverse Event|3|||
149118659|NCT01655693|537913109|FG001|Overall Study|Adverse Event|11|||
149118660|NCT01655693|537913110|FG002|Overall Study|Adverse Event|3|||
149118661|NCT01655693|537913108|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
149118662|NCT01655693|537913109|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
149118663|NCT01655693|537913110|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
149118664|NCT01655693|537913108|FG000|Overall Study|Non-Compliance|0|||
149118665|NCT01655693|537913109|FG001|Overall Study|Non-Compliance|0|||
149118666|NCT01655693|537913110|FG002|Overall Study|Non-Compliance|7|||
149118667|NCT01655693|537913108|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
149118668|NCT01655693|537913109|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
149118669|NCT01655693|537913110|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
149118670|NCT01655693|537913108|FG000|Overall Study|Protocol Violation|1|||
149118671|NCT01655693|537913109|FG001|Overall Study|Protocol Violation|0|||
149118672|NCT01655693|537913110|FG002|Overall Study|Protocol Violation|3|||
149118673|NCT01655693|537913108|FG000|Overall Study|Lost to Follow-up|1|||
149118674|NCT01655693|537913109|FG001|Overall Study|Lost to Follow-up|0|||
149118675|NCT01655693|537913110|FG002|Overall Study|Lost to Follow-up|1|||
149118676|NCT01655693|537913108|FG000|Overall Study|Screening Failure|1|||
149118677|NCT01655693|537913109|FG001|Overall Study|Screening Failure|0|||
149118678|NCT01655693|537913110|FG002|Overall Study|Screening Failure|0|||
149118679|NCT01655693|537913108|FG000|Overall Study|Other|8|||
149118680|NCT01655693|537913109|FG001|Overall Study|Other|6|||
149118681|NCT01655693|537913110|FG002|Overall Study|Other|15|||
149118682|NCT00291642|537913119|FG000|Overall Study|Adverse Event|1|||
149118683|NCT00291642|537913120|FG001|Overall Study|Adverse Event|0|||
149118684|NCT00291642|537913121|FG002|Overall Study|Adverse Event|1|||
149118685|NCT00291642|537913122|FG003|Overall Study|Adverse Event|0|||
149118686|NCT00291642|537913123|FG004|Overall Study|Adverse Event|1|||
149118687|NCT00291642|537913119|FG000|Overall Study|Patient missed visit|0|||
149118688|NCT00291642|537913120|FG001|Overall Study|Patient missed visit|0|||
149118689|NCT00291642|537913121|FG002|Overall Study|Patient missed visit|1|||
149118690|NCT00291642|537913122|FG003|Overall Study|Patient missed visit|0|||
149118691|NCT00291642|537913123|FG004|Overall Study|Patient missed visit|0|||
149118692|NCT00291642|537913119|FG000|Overall Study|Intake of prohibited medication|1|||
149118693|NCT00291642|537913120|FG001|Overall Study|Intake of prohibited medication|0|||
149118694|NCT00291642|537913121|FG002|Overall Study|Intake of prohibited medication|0|||
149118695|NCT00291642|537913122|FG003|Overall Study|Intake of prohibited medication|0|||
149118696|NCT00291642|537913123|FG004|Overall Study|Intake of prohibited medication|0|||
149118697|NCT00735475|537913124|FG000|Overall Study|Adverse Event|0|||
149118698|NCT00735475|537913125|FG001|Overall Study|Adverse Event|1|||
149118699|NCT00735475|537913124|FG000|Overall Study|Death|1|||
149118700|NCT00735475|537913125|FG001|Overall Study|Death|1|||
149118701|NCT00735475|537913124|FG000|Overall Study|Lost to Follow-up|3|||
149118702|NCT00735475|537913125|FG001|Overall Study|Lost to Follow-up|3|||
149118703|NCT00735475|537913124|FG000|Overall Study|Physician Decision|0|||
149118704|NCT00735475|537913125|FG001|Overall Study|Physician Decision|1|||
149118705|NCT00735475|537913124|FG000|Overall Study|Withdrawal by Subject|4|||
149118706|NCT00735475|537913125|FG001|Overall Study|Withdrawal by Subject|5|||
149118707|NCT03189745|537913133|FG000|Overall Study|Conflict in work schedule of participant|1|||
149118708|NCT03189745|537913134|FG001|Overall Study|Conflict in work schedule of participant|1|||
149118709|NCT05086276|537913135|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
149118710|NCT05086276|537913136|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
149118711|NCT05017103|537913137|FG000|Overall Study|Death|2|||
149118712|NCT01238900|537914772|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
149118713|NCT01238900|537914772|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
149118714|NCT03241927|537914773|FG000|Overall Study|study terminated|1|||
149118715|NCT03241927|537914774|FG001|Overall Study|study terminated|0|||
149118716|NCT01198756|537914775|FG000|Overall Study|Adverse Event|0|||
149118717|NCT01198756|537914776|FG001|Overall Study|Adverse Event|0|||
149118718|NCT01198756|537914777|FG002|Overall Study|Adverse Event|0|||
149118719|NCT01198756|537914778|FG003|Overall Study|Adverse Event|1|||
149118720|NCT01198756|537914775|FG000|Overall Study|Protocol Violation|0|||
149118721|NCT01198756|537914776|FG001|Overall Study|Protocol Violation|0|||
149118722|NCT01198756|537914777|FG002|Overall Study|Protocol Violation|0|||
149118723|NCT01198756|537914778|FG003|Overall Study|Protocol Violation|2|||
149118724|NCT01198756|537914775|FG000|Overall Study|Withdrawal by Subject|9|||
149118725|NCT01198756|537914776|FG001|Overall Study|Withdrawal by Subject|4|||
149118726|NCT01198756|537914777|FG002|Overall Study|Withdrawal by Subject|7|||
149118727|NCT01198756|537914778|FG003|Overall Study|Withdrawal by Subject|5|||
149118728|NCT01198756|537914775|FG000|Overall Study|Lost to Follow-up|29|||
149118729|NCT01198756|537914776|FG001|Overall Study|Lost to Follow-up|36|||
149118730|NCT01198756|537914777|FG002|Overall Study|Lost to Follow-up|23|||
149118731|NCT01198756|537914778|FG003|Overall Study|Lost to Follow-up|18|||
149118732|NCT02915302|537914781|FG000|Overall Study|Adverse Event|3|||
149118733|NCT02915302|537914782|FG001|Overall Study|Adverse Event|0|||
149118734|NCT02915302|537914781|FG000|Overall Study|Protocol Violation|20|||
149118735|NCT02915302|537914782|FG001|Overall Study|Protocol Violation|27|||
149118736|NCT02915302|537914781|FG000|Overall Study|Lost to Follow-up|19|||
149118737|NCT02915302|537914782|FG001|Overall Study|Lost to Follow-up|22|||
149118738|NCT02915302|537914781|FG000|Overall Study|Withdrawal by Subject|22|||
149118739|NCT02915302|537914782|FG001|Overall Study|Withdrawal by Subject|29|||
149118740|NCT02915302|537914781|FG000|Overall Study|Other|1|||
149118741|NCT02915302|537914782|FG001|Overall Study|Other|0|||
149118742|NCT00591721|537914785|FG000|Overall Study|Withdrawal by Subject|10|||
149118743|NCT00591721|537914786|FG001|Overall Study|Withdrawal by Subject|10|||
149118744|NCT00591721|537914785|FG000|Overall Study|Lost to Follow-up|1|||
149118745|NCT00591721|537914786|FG001|Overall Study|Lost to Follow-up|4|||
149118746|NCT00591721|537914785|FG000|Overall Study|Intervention not received|10|||
149118747|NCT00591721|537914786|FG001|Overall Study|Intervention not received|8|||
149118748|NCT03809429|537914787|FG000|Overall Study|Withdrawal by Subject|7|||
149118749|NCT03809429|537914788|FG001|Overall Study|Withdrawal by Subject|3|||
149118750|NCT03809429|537914787|FG000|Overall Study|Adverse Event|6|||
149118751|NCT03809429|537914788|FG001|Overall Study|Adverse Event|9|||
149118752|NCT03809429|537914787|FG000|Overall Study|COVID-19|3|||
149118753|NCT03809429|537914788|FG001|Overall Study|COVID-19|1|||
149118754|NCT03809429|537914787|FG000|Overall Study|Participant was discontinued by investigator|12|||
149118755|NCT03809429|537914788|FG001|Overall Study|Participant was discontinued by investigator|7|||
149118756|NCT02383056|537914791|FG000|Overall Study|Adverse Event|1|||
149118757|NCT02383056|537914792|FG001|Overall Study|Adverse Event|0|||
149118758|NCT02383056|537914791|FG000|Overall Study|Lost to Follow-up|0|||
149118759|NCT02383056|537914792|FG001|Overall Study|Lost to Follow-up|2|||
149118760|NCT03507777|537914793|FG000|Overall Study|Lost to Follow-up|5|||
149118761|NCT03507777|537914794|FG001|Overall Study|Lost to Follow-up|7|||
149118762|NCT03507777|537914793|FG000|Overall Study|Withdrawal by Subject|6|||
149118763|NCT03507777|537914794|FG001|Overall Study|Withdrawal by Subject|11|||
149118764|NCT03507777|537914793|FG000|Overall Study|Death|30|||
149118765|NCT03507777|537914794|FG001|Overall Study|Death|44|||
149118766|NCT03507777|537914793|FG000|Overall Study|Other Reasons|3|||
149118767|NCT03507777|537914794|FG001|Overall Study|Other Reasons|8|||
149118768|NCT02245737|537914795|FG000|Overall Study|Adverse Event|23|||
149118769|NCT02245737|537914796|FG001|Overall Study|Adverse Event|26|||
149118770|NCT02245737|537914797|FG002|Overall Study|Adverse Event|33|||
149118771|NCT02245737|537914795|FG000|Overall Study|Condition Worsened|9|||
149118772|NCT02245737|537914796|FG001|Overall Study|Condition Worsened|10|||
149118773|NCT02245737|537914797|FG002|Overall Study|Condition Worsened|9|||
149118774|NCT02245737|537914795|FG000|Overall Study|Death|2|||
149118775|NCT02245737|537914796|FG001|Overall Study|Death|4|||
149118776|NCT02245737|537914797|FG002|Overall Study|Death|4|||
149118777|NCT02245737|537914795|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
149118778|NCT02245737|537914796|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
149118779|NCT02245737|537914797|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
149118780|NCT02245737|537914795|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
149118781|NCT02245737|537914796|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
149118782|NCT02245737|537914797|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
149118783|NCT02245737|537914795|FG000|Overall Study|Lost to Follow-up|2|||
149118784|NCT02245737|537914796|FG001|Overall Study|Lost to Follow-up|5|||
149118785|NCT02245737|537914797|FG002|Overall Study|Lost to Follow-up|4|||
149118786|NCT02245737|537914795|FG000|Overall Study|Other-determined by Investigator|9|||
149118787|NCT02245737|537914796|FG001|Overall Study|Other-determined by Investigator|10|||
149118788|NCT02245737|537914797|FG002|Overall Study|Other-determined by Investigator|10|||
149118789|NCT02245737|537914795|FG000|Overall Study|Physician Decision|6|||
149118790|NCT02245737|537914796|FG001|Overall Study|Physician Decision|3|||
149118791|NCT02245737|537914797|FG002|Overall Study|Physician Decision|6|||
149118792|NCT02245737|537914795|FG000|Overall Study|Protocol Violation|3|||
149118793|NCT02245737|537914796|FG001|Overall Study|Protocol Violation|2|||
149118794|NCT02245737|537914797|FG002|Overall Study|Protocol Violation|3|||
149118795|NCT02245737|537914795|FG000|Overall Study|Withdrawal by Subject|40|||
149118796|NCT02245737|537914796|FG001|Overall Study|Withdrawal by Subject|41|||
149118797|NCT02245737|537914797|FG002|Overall Study|Withdrawal by Subject|44|||
149118798|NCT02245737|537914795|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
149118799|NCT02245737|537914796|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
149118800|NCT02245737|537914797|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
149118801|NCT02245737|537914795|FG000|Overall Study|Sponsor Decision|445|||
149118802|NCT02245737|537914796|FG001|Overall Study|Sponsor Decision|430|||
149118803|NCT02245737|537914797|FG002|Overall Study|Sponsor Decision|432|||
149118804|NCT01144052|537914803|FG000|Overall Study|Withdrawal by Subject|1|||
149118805|NCT01144052|537914804|FG001|Overall Study|Withdrawal by Subject|1|||
149118806|NCT03836716|537914805|FG000|Overall Study|Adverse Event|3|||
149118807|NCT03836716|537914805|FG000|Overall Study|Death|22|||
149118808|NCT03836716|537914805|FG000|Overall Study|Withdrawal by Subject|8|||
149118809|NCT03836716|537914805|FG000|Overall Study|Study terminated by sponsor|87|||
149118810|NCT03122223|537914808|FG000|Overall Study|Withdrawal by Subject|2|||
149118811|NCT03122223|537914809|FG001|Overall Study|Withdrawal by Subject|2|||
149118812|NCT03122223|537914810|FG002|Overall Study|Withdrawal by Subject|1|||
149118813|NCT03122223|537914811|FG003|Overall Study|Withdrawal by Subject|0|||
149118814|NCT03122223|537914808|FG000|Overall Study|Lost to Follow-up|0|||
149118815|NCT03122223|537914809|FG001|Overall Study|Lost to Follow-up|2|||
149118816|NCT03122223|537914810|FG002|Overall Study|Lost to Follow-up|2|||
149118817|NCT03122223|537914811|FG003|Overall Study|Lost to Follow-up|0|||
149118818|NCT03122223|537914808|FG000|Overall Study|Participant unable to adhere|1|||
149118819|NCT03122223|537914809|FG001|Overall Study|Participant unable to adhere|1|||
149118820|NCT03122223|537914810|FG002|Overall Study|Participant unable to adhere|1|||
149118821|NCT03122223|537914811|FG003|Overall Study|Participant unable to adhere|0|||
149118822|NCT01820585|537914812|FG000|Overall Study|Adverse Event|9|||
149118823|NCT01820585|537914813|FG001|Overall Study|Adverse Event|13|||
149118824|NCT01820585|537914814|FG002|Overall Study|Adverse Event|23|||
149118825|NCT01820585|537914815|FG003|Overall Study|Adverse Event|34|||
149118826|NCT01820585|537914812|FG000|Overall Study|Lack of Efficacy|9|||
149118827|NCT01820585|537914813|FG001|Overall Study|Lack of Efficacy|7|||
149118828|NCT01820585|537914814|FG002|Overall Study|Lack of Efficacy|5|||
149118829|NCT01820585|537914815|FG003|Overall Study|Lack of Efficacy|1|||
149118830|NCT01820585|537914812|FG000|Overall Study|Withdrawal by Subject|3|||
149118831|NCT01820585|537914813|FG001|Overall Study|Withdrawal by Subject|7|||
149118832|NCT01820585|537914814|FG002|Overall Study|Withdrawal by Subject|3|||
149118833|NCT01820585|537914815|FG003|Overall Study|Withdrawal by Subject|8|||
149118834|NCT01820585|537914812|FG000|Overall Study|Lost to Follow-up|3|||
149118835|NCT01820585|537914813|FG001|Overall Study|Lost to Follow-up|3|||
149118836|NCT01820585|537914814|FG002|Overall Study|Lost to Follow-up|0|||
149118837|NCT01820585|537914815|FG003|Overall Study|Lost to Follow-up|3|||
149118838|NCT01820585|537914812|FG000|Overall Study|Protocol Violation|3|||
149118839|NCT01820585|537914813|FG001|Overall Study|Protocol Violation|1|||
149118840|NCT01820585|537914814|FG002|Overall Study|Protocol Violation|1|||
149118841|NCT01820585|537914815|FG003|Overall Study|Protocol Violation|1|||
149118842|NCT01820585|537914812|FG000|Overall Study|Subject non-compliance|0|||
149118843|NCT01820585|537914813|FG001|Overall Study|Subject non-compliance|0|||
149118844|NCT01820585|537914814|FG002|Overall Study|Subject non-compliance|1|||
149118845|NCT01820585|537914815|FG003|Overall Study|Subject non-compliance|2|||
149118846|NCT01820585|537914812|FG000|Overall Study|at sponsor request|0|||
149118847|NCT01820585|537914813|FG001|Overall Study|at sponsor request|0|||
149118848|NCT01820585|537914814|FG002|Overall Study|at sponsor request|1|||
149118849|NCT01820585|537914815|FG003|Overall Study|at sponsor request|0|||
149118850|NCT01820585|537914812|FG000|Overall Study|Pregnancy|0|||
149118851|NCT01820585|537914813|FG001|Overall Study|Pregnancy|1|||
149118852|NCT01820585|537914814|FG002|Overall Study|Pregnancy|0|||
149118853|NCT01820585|537914815|FG003|Overall Study|Pregnancy|0|||
149118854|NCT01712659|537914818|FG000|Dose Escalation|Physician Decision|0|||
149118855|NCT01712659|537914819|FG001|Dose Escalation|Physician Decision|1|||
149118856|NCT01712659|537914820|FG002|Dose Escalation|Physician Decision|0|||
149118857|NCT01712659|537914821|FG003|Dose Escalation|Physician Decision|0|||
149118858|NCT01712659|537914822|FG004|Dose Escalation|Physician Decision|0|||
149118859|NCT01712659|537914818|FG000|Dose Escalation|Unable to take study drug|0|||
149118860|NCT01712659|537914819|FG001|Dose Escalation|Unable to take study drug|1|||
149118861|NCT01712659|537914820|FG002|Dose Escalation|Unable to take study drug|0|||
149118862|NCT01712659|537914821|FG003|Dose Escalation|Unable to take study drug|0|||
149118863|NCT01712659|537914822|FG004|Dose Escalation|Unable to take study drug|0|||
149118864|NCT01712659|537914818|FG000|Dose Expansion|Early disease progression|1|||
149118865|NCT01712659|537914819|FG001|Dose Expansion|Early disease progression|0|||
149118866|NCT01712659|537914820|FG002|Dose Expansion|Early disease progression|0|||
149118867|NCT01712659|537914821|FG003|Dose Expansion|Early disease progression|0|||
149118868|NCT01712659|537914822|FG004|Dose Expansion|Early disease progression|0|||
149118869|NCT01712659|537914818|FG000|Dose Expansion|Physician Decision|1|||
149118870|NCT01712659|537914819|FG001|Dose Expansion|Physician Decision|0|||
149118871|NCT01712659|537914820|FG002|Dose Expansion|Physician Decision|0|||
149118872|NCT01712659|537914821|FG003|Dose Expansion|Physician Decision|0|||
149118873|NCT01712659|537914822|FG004|Dose Expansion|Physician Decision|0|||
149118874|NCT02285153|537914823|FG000|Overall Study|Adverse Event|1|||
149118875|NCT02285153|537914824|FG001|Overall Study|Adverse Event|0|||
149118876|NCT00548262|537914825|FG000|Overall Study|Death|21|||
149118877|NCT00548262|537914825|FG000|Overall Study|Adverse Event|2|||
149118878|NCT00548262|537914825|FG000|Overall Study|Lack of Efficacy|4|||
149118879|NCT00548262|537914825|FG000|Overall Study|Lost to Follow-up|1|||
149118880|NCT00548262|537914825|FG000|Overall Study|Other|3|||
149118881|NCT00548262|537914825|FG000|Overall Study|Withdrawal by Subject|1|||
149118882|NCT02544451|537914826|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
149118883|NCT02544451|537914827|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
149118884|NCT02544451|537914828|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
149118885|NCT02544451|537914829|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
149118886|NCT02544451|537914826|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
149118887|NCT02544451|537914827|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
149118888|NCT02544451|537914828|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
149118889|NCT02544451|537914829|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
149118890|NCT02544451|537914826|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
149118891|NCT02544451|537914827|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
149118892|NCT02544451|537914828|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
149118893|NCT02544451|537914829|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
149118894|NCT02544451|537914826|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
149118895|NCT02544451|537914827|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
149118896|NCT02544451|537914828|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
149118897|NCT02544451|537914829|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
149118898|NCT02544451|537914826|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
149118899|NCT02544451|537914827|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
149118900|NCT02544451|537914828|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
149118901|NCT02544451|537914829|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
149118902|NCT02544451|537914826|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
149118903|NCT02544451|537914827|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
149118904|NCT02544451|537914828|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
149118905|NCT02544451|537914829|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
149118906|NCT00844532|537914832|FG000|Overall Study|Death|16|||
149118907|NCT00844532|537914832|FG000|Overall Study|Withdrawal by Subject|16|||
149118908|NCT00844532|537914832|FG000|Overall Study|Lost to Follow-up|7|||
149118909|NCT02576587|537914833|FG000|Baseline|Equipment failure|0|||
149118910|NCT02576587|537914834|FG001|Baseline|Equipment failure|1|||
149118911|NCT02576587|537914833|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
149118912|NCT02576587|537914834|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
149118913|NCT02576587|537914833|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
149118914|NCT02576587|537914834|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
149118915|NCT02576587|537914833|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
149118916|NCT02576587|537914834|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
149118917|NCT03590366|537914835|FG000|Overall Study|Adverse Event|0|||
149118918|NCT03590366|537914836|FG001|Overall Study|Adverse Event|3|||
149118919|NCT03590366|537914835|FG000|Overall Study|Lost to Follow-up|3|||
149118920|NCT03590366|537914836|FG001|Overall Study|Lost to Follow-up|3|||
149118921|NCT03590366|537914835|FG000|Overall Study|Withdrawal by Subject|0|||
149118922|NCT03590366|537914836|FG001|Overall Study|Withdrawal by Subject|2|||
149118923|NCT00738894|537914838|FG000|Overall Study|Lost to Follow-up|23|||
149118924|NCT00738894|537914839|FG001|Overall Study|Lost to Follow-up|13|||
149118925|NCT00738894|537914838|FG000|Overall Study|Withdrawal by Subject|10|||
149118926|NCT00738894|537914839|FG001|Overall Study|Withdrawal by Subject|15|||
149118927|NCT00738894|537914838|FG000|Overall Study|Physician Decision|4|||
149118928|NCT00738894|537914839|FG001|Overall Study|Physician Decision|5|||
149118929|NCT00738894|537914838|FG000|Overall Study|Death|2|||
149118930|NCT00738894|537914839|FG001|Overall Study|Death|0|||
149118931|NCT02656329|537914840|FG000|Overall Study|Lost to Follow-up|2|||
149118932|NCT02656329|537914841|FG001|Overall Study|Lost to Follow-up|3|||
149118933|NCT02656329|537914840|FG000|Overall Study|Withdrawal by Subject|7|||
149118934|NCT02656329|537914841|FG001|Overall Study|Withdrawal by Subject|6|||
149118935|NCT02656329|537914840|FG000|Overall Study|Study termination by Sponsor|150|||
149118936|NCT02656329|537914841|FG001|Overall Study|Study termination by Sponsor|142|||
149118937|NCT02656329|537914840|FG000|Overall Study|Other than specified above|5|||
149118938|NCT02656329|537914841|FG001|Overall Study|Other than specified above|6|||
149118939|NCT01081665|537914842|FG000|Overall Study|Death|41|||
149118940|NCT01081665|537914842|FG000|Overall Study|Lost to Follow-up|18|||
149118941|NCT01081665|537914842|FG000|Overall Study|Withdrawal by Subject|17|||
149118942|NCT01081665|537914842|FG000|Overall Study|Change of dialysis unit|10|||
149118943|NCT01081665|537914842|FG000|Overall Study|Regulation of iPTH|5|||
149118944|NCT01081665|537914842|FG000|Overall Study|Change in renal replacement therapy|2|||
149118945|NCT01081665|537914842|FG000|Overall Study|Adverse Event|1|||
149118946|NCT01081665|537914842|FG000|Overall Study|Lack of Efficacy|1|||
149118947|NCT01747551|537914853|FG000|Overall Study|Progressive Disease|24|||
149118948|NCT01747551|537914854|FG001|Overall Study|Progressive Disease|17|||
149118949|NCT01747551|537914853|FG000|Overall Study|Death|3|||
149118950|NCT01747551|537914854|FG001|Overall Study|Death|1|||
149118951|NCT01747551|537914853|FG000|Overall Study|Adverse Event|7|||
149118952|NCT01747551|537914854|FG001|Overall Study|Adverse Event|1|||
149118953|NCT01747551|537914853|FG000|Overall Study|Prolonged Treatment Delay|2|||
149118954|NCT01747551|537914854|FG001|Overall Study|Prolonged Treatment Delay|0|||
149118955|NCT01747551|537914853|FG000|Overall Study|Withdrawal by Subject|3|||
149118956|NCT01747551|537914854|FG001|Overall Study|Withdrawal by Subject|1|||
149118957|NCT01747551|537914853|FG000|Overall Study|Physician Decision|2|||
149118958|NCT01747551|537914854|FG001|Overall Study|Physician Decision|1|||
149118959|NCT01747551|537914853|FG000|Overall Study|Other|2|||
149118960|NCT01747551|537914854|FG001|Overall Study|Other|0|||
149118961|NCT02546921|537914856|FG000|Overall Study|Adverse Event|0|||
149118962|NCT02546921|537914857|FG001|Overall Study|Adverse Event|5|||
149118963|NCT02546921|537914858|FG002|Overall Study|Adverse Event|2|||
149118964|NCT02546921|537914859|FG003|Overall Study|Adverse Event|0|||
149118965|NCT02546921|537914860|FG004|Overall Study|Adverse Event|0|||
149118966|NCT02546921|537914861|FG005|Overall Study|Adverse Event|0|||
149118967|NCT02546921|537914862|FG006|Overall Study|Adverse Event|0|||
149118968|NCT02546921|537914856|FG000|Overall Study|Evidence of Disease Progression|1|||
149118969|NCT02546921|537914857|FG001|Overall Study|Evidence of Disease Progression|0|||
149118970|NCT02546921|537914858|FG002|Overall Study|Evidence of Disease Progression|0|||
149118971|NCT02546921|537914859|FG003|Overall Study|Evidence of Disease Progression|0|||
149118972|NCT02546921|537914860|FG004|Overall Study|Evidence of Disease Progression|1|||
149118973|NCT02546921|537914861|FG005|Overall Study|Evidence of Disease Progression|0|||
149118974|NCT02546921|537914862|FG006|Overall Study|Evidence of Disease Progression|0|||
149118975|NCT02546921|537914856|FG000|Overall Study|Patient Choice|0|||
149118976|NCT02546921|537914857|FG001|Overall Study|Patient Choice|1|||
149118977|NCT02546921|537914858|FG002|Overall Study|Patient Choice|0|||
149118978|NCT02546921|537914859|FG003|Overall Study|Patient Choice|0|||
149118979|NCT02546921|537914860|FG004|Overall Study|Patient Choice|0|||
149118980|NCT02546921|537914861|FG005|Overall Study|Patient Choice|1|||
149118981|NCT02546921|537914862|FG006|Overall Study|Patient Choice|0|||
149118982|NCT01373151|537914863|FG000|Period 1|Lack of Efficacy|3|||
149118983|NCT01373151|537914864|FG001|Period 1|Lack of Efficacy|0|||
149118984|NCT01373151|537914865|FG002|Period 1|Lack of Efficacy|0|||
149118985|NCT01373151|537914866|FG003|Period 1|Lack of Efficacy|0|||
149118986|NCT01373151|537914867|FG004|Period 1|Lack of Efficacy|1|||
149118987|NCT01373151|537914868|FG005|Period 1|Lack of Efficacy|0|||
149118988|NCT01373151|537914869|FG006|Period 1|Lack of Efficacy|0|||
149118989|NCT01373151|537914863|FG000|Period 1|Adverse Event|0|||
149118990|NCT01373151|537914864|FG001|Period 1|Adverse Event|0|||
149118991|NCT01373151|537914865|FG002|Period 1|Adverse Event|1|||
149118992|NCT01373151|537914866|FG003|Period 1|Adverse Event|0|||
149118993|NCT01373151|537914867|FG004|Period 1|Adverse Event|4|||
149118994|NCT01373151|537914868|FG005|Period 1|Adverse Event|3|||
149118995|NCT01373151|537914869|FG006|Period 1|Adverse Event|0|||
149118996|NCT01373151|537914863|FG000|Period 1|Withdrawal by Subject|2|||
149118997|NCT01373151|537914864|FG001|Period 1|Withdrawal by Subject|0|||
149118998|NCT01373151|537914865|FG002|Period 1|Withdrawal by Subject|3|||
149118999|NCT01373151|537914866|FG003|Period 1|Withdrawal by Subject|1|||
149119000|NCT01373151|537914867|FG004|Period 1|Withdrawal by Subject|0|||
149119001|NCT01373151|537914868|FG005|Period 1|Withdrawal by Subject|1|||
149119002|NCT01373151|537914869|FG006|Period 1|Withdrawal by Subject|0|||
149119003|NCT01373151|537914863|FG000|Period 2|Lack of Efficacy|9|||
149119004|NCT01373151|537914864|FG001|Period 2|Lack of Efficacy|0|||
149119005|NCT01373151|537914865|FG002|Period 2|Lack of Efficacy|0|||
149119006|NCT01373151|537914866|FG003|Period 2|Lack of Efficacy|1|||
149119007|NCT01373151|537914867|FG004|Period 2|Lack of Efficacy|2|||
149119008|NCT01373151|537914868|FG005|Period 2|Lack of Efficacy|0|||
149119009|NCT01373151|537914869|FG006|Period 2|Lack of Efficacy|3|||
149119010|NCT01373151|537914863|FG000|Period 2|Adverse Event|0|||
149119011|NCT01373151|537914864|FG001|Period 2|Adverse Event|0|||
149119012|NCT01373151|537914865|FG002|Period 2|Adverse Event|3|||
149119013|NCT01373151|537914866|FG003|Period 2|Adverse Event|3|||
149119014|NCT01373151|537914867|FG004|Period 2|Adverse Event|0|||
149119015|NCT01373151|537914868|FG005|Period 2|Adverse Event|0|||
149119016|NCT01373151|537914869|FG006|Period 2|Adverse Event|1|||
149119017|NCT01373151|537914863|FG000|Period 2|subject request to discontinue|0|||
149119018|NCT01373151|537914864|FG001|Period 2|subject request to discontinue|1|||
149119019|NCT01373151|537914865|FG002|Period 2|subject request to discontinue|0|||
149119020|NCT01373151|537914866|FG003|Period 2|subject request to discontinue|0|||
149119021|NCT01373151|537914867|FG004|Period 2|subject request to discontinue|0|||
149119022|NCT01373151|537914868|FG005|Period 2|subject request to discontinue|0|||
149119023|NCT01373151|537914869|FG006|Period 2|subject request to discontinue|0|||
149119024|NCT01373151|537914863|FG000|Period 2|Withdrawal by Subject|0|||
149119025|NCT01373151|537914864|FG001|Period 2|Withdrawal by Subject|0|||
149119026|NCT01373151|537914865|FG002|Period 2|Withdrawal by Subject|0|||
149119027|NCT01373151|537914866|FG003|Period 2|Withdrawal by Subject|1|||
149119028|NCT01373151|537914867|FG004|Period 2|Withdrawal by Subject|0|||
149119029|NCT01373151|537914868|FG005|Period 2|Withdrawal by Subject|0|||
149119030|NCT01373151|537914869|FG006|Period 2|Withdrawal by Subject|0|||
149119031|NCT01373151|537914863|FG000|Period 2|Other|0|||
149119032|NCT01373151|537914864|FG001|Period 2|Other|0|||
149119033|NCT01373151|537914865|FG002|Period 2|Other|1|||
149119034|NCT01373151|537914866|FG003|Period 2|Other|0|||
149119035|NCT01373151|537914867|FG004|Period 2|Other|0|||
149119036|NCT01373151|537914868|FG005|Period 2|Other|0|||
149119037|NCT01373151|537914869|FG006|Period 2|Other|1|||
149119038|NCT03026075|537914873|FG000|Overall Study|Physician Decision|1|||
149119039|NCT03381339|537914876|FG000|Overall Study|Protocol Violation|4|||
149119040|NCT03381339|537914877|FG001|Overall Study|Protocol Violation|3|||
149119041|NCT03381339|537914876|FG000|Overall Study|Lost to Follow-up|0|||
149119042|NCT03381339|537914877|FG001|Overall Study|Lost to Follow-up|1|||
149119043|NCT03117998|537914881|FG000|Overall Study|Adverse Event|1|||
149119044|NCT03117998|537914882|FG001|Overall Study|Adverse Event|0|||
149119045|NCT03117998|537914883|FG002|Overall Study|Adverse Event|0|||
149119046|NCT03117998|537914884|FG003|Overall Study|Adverse Event|0|||
149119047|NCT03117998|537914885|FG004|Overall Study|Adverse Event|0|||
149119048|NCT03117998|537914886|FG005|Overall Study|Adverse Event|0|||
149119049|NCT03117998|537914881|FG000|Overall Study|Withdrawal by Subject|0|||
149119050|NCT03117998|537914882|FG001|Overall Study|Withdrawal by Subject|0|||
149119051|NCT03117998|537914883|FG002|Overall Study|Withdrawal by Subject|2|||
149119052|NCT03117998|537914884|FG003|Overall Study|Withdrawal by Subject|3|||
149119053|NCT03117998|537914885|FG004|Overall Study|Withdrawal by Subject|3|||
149119054|NCT03117998|537914886|FG005|Overall Study|Withdrawal by Subject|0|||
149119055|NCT03117998|537914881|FG000|Overall Study|Physician Decision|0|||
149119056|NCT03117998|537914882|FG001|Overall Study|Physician Decision|1|||
149119057|NCT03117998|537914883|FG002|Overall Study|Physician Decision|1|||
149119058|NCT03117998|537914884|FG003|Overall Study|Physician Decision|0|||
149119059|NCT03117998|537914885|FG004|Overall Study|Physician Decision|0|||
149119060|NCT03117998|537914886|FG005|Overall Study|Physician Decision|0|||
149119061|NCT03117998|537914881|FG000|Overall Study|Lost to Follow-up|0|||
149119062|NCT03117998|537914882|FG001|Overall Study|Lost to Follow-up|0|||
149119063|NCT03117998|537914883|FG002|Overall Study|Lost to Follow-up|0|||
149119064|NCT03117998|537914884|FG003|Overall Study|Lost to Follow-up|1|||
149119065|NCT03117998|537914885|FG004|Overall Study|Lost to Follow-up|4|||
149119066|NCT03117998|537914886|FG005|Overall Study|Lost to Follow-up|0|||
149119067|NCT03117998|537914881|FG000|Overall Study|Subject noncompliance|0|||
149119068|NCT03117998|537914882|FG001|Overall Study|Subject noncompliance|0|||
149119069|NCT03117998|537914883|FG002|Overall Study|Subject noncompliance|1|||
149119070|NCT03117998|537914884|FG003|Overall Study|Subject noncompliance|0|||
149119071|NCT03117998|537914885|FG004|Overall Study|Subject noncompliance|0|||
149119072|NCT03117998|537914886|FG005|Overall Study|Subject noncompliance|2|||
149119073|NCT03117998|537914881|FG000|Overall Study|Protocol Violation|0|||
149119074|NCT03117998|537914882|FG001|Overall Study|Protocol Violation|0|||
149119075|NCT03117998|537914883|FG002|Overall Study|Protocol Violation|0|||
149119076|NCT03117998|537914884|FG003|Overall Study|Protocol Violation|0|||
149119077|NCT03117998|537914885|FG004|Overall Study|Protocol Violation|0|||
149119078|NCT03117998|537914886|FG005|Overall Study|Protocol Violation|1|||
149119079|NCT04927247|537914887|FG000|Overall Study|Other|2|||
149119080|NCT04927247|537914888|FG001|Overall Study|Other|1|||
149119081|NCT04927247|537914887|FG000|Overall Study|Physician Decision|0|||
149119082|NCT04927247|537914888|FG001|Overall Study|Physician Decision|1|||
149119083|NCT04927247|537914887|FG000|Overall Study|Adverse Event|1|||
149119084|NCT04927247|537914888|FG001|Overall Study|Adverse Event|0|||
149119085|NCT01468181|537914890|FG000|Overall Study|Adverse Event|8|||
149119086|NCT01468181|537914891|FG001|Overall Study|Adverse Event|1|||
149119087|NCT01468181|537914892|FG002|Overall Study|Adverse Event|6|||
149119088|NCT01468181|537914893|FG003|Overall Study|Adverse Event|2|||
149119089|NCT01468181|537914894|FG004|Overall Study|Adverse Event|2|||
149119090|NCT01468181|537914890|FG000|Overall Study|Protocol Violation|2|||
149119091|NCT01468181|537914891|FG001|Overall Study|Protocol Violation|0|||
149119092|NCT01468181|537914892|FG002|Overall Study|Protocol Violation|1|||
149119093|NCT01468181|537914893|FG003|Overall Study|Protocol Violation|0|||
149119094|NCT01468181|537914894|FG004|Overall Study|Protocol Violation|1|||
149119095|NCT01468181|537914890|FG000|Overall Study|Physician Decision|0|||
149119096|NCT01468181|537914891|FG001|Overall Study|Physician Decision|0|||
149119097|NCT01468181|537914892|FG002|Overall Study|Physician Decision|0|||
149119098|NCT01468181|537914893|FG003|Overall Study|Physician Decision|1|||
149119099|NCT01468181|537914894|FG004|Overall Study|Physician Decision|1|||
149119100|NCT01468181|537914890|FG000|Overall Study|Lost to Follow-up|0|||
149119101|NCT01468181|537914891|FG001|Overall Study|Lost to Follow-up|0|||
149119102|NCT01468181|537914892|FG002|Overall Study|Lost to Follow-up|1|||
149119103|NCT01468181|537914893|FG003|Overall Study|Lost to Follow-up|0|||
149119104|NCT01468181|537914894|FG004|Overall Study|Lost to Follow-up|1|||
149119105|NCT01468181|537914890|FG000|Overall Study|Withdrawal by Subject|0|||
149119106|NCT01468181|537914891|FG001|Overall Study|Withdrawal by Subject|1|||
149119107|NCT01468181|537914892|FG002|Overall Study|Withdrawal by Subject|0|||
149119108|NCT01468181|537914893|FG003|Overall Study|Withdrawal by Subject|0|||
149119109|NCT01468181|537914894|FG004|Overall Study|Withdrawal by Subject|0|||
149119110|NCT04828837|537914895|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
149119111|NCT04828837|537914896|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
149119112|NCT04828837|537914895|FG000|Overall Study|Lost to Follow-up|2|||
149119113|NCT04828837|537914896|FG001|Overall Study|Lost to Follow-up|6|||
149119114|NCT04828837|537914895|FG000|Overall Study|Lack of Efficacy|1|||
149119115|NCT04828837|537914896|FG001|Overall Study|Lack of Efficacy|0|||
149119116|NCT04828837|537914895|FG000|Overall Study|Admitted due to pneumothorax.|1|||
149119117|NCT04828837|537914896|FG001|Overall Study|Admitted due to pneumothorax.|0|||
149119118|NCT04828837|537914895|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
149119119|NCT04828837|537914896|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
149119120|NCT01397422|537914897|FG000|Overall Study|Adverse Event|0|||
149119121|NCT01397422|537914898|FG001|Overall Study|Adverse Event|3|||
149119122|NCT01397422|537914899|FG002|Overall Study|Adverse Event|3|||
149119123|NCT01397422|537914900|FG003|Overall Study|Adverse Event|8|||
149119124|NCT01397422|537914897|FG000|Overall Study|Withdrawal by Subject|1|||
149119125|NCT01397422|537914898|FG001|Overall Study|Withdrawal by Subject|0|||
149119126|NCT01397422|537914899|FG002|Overall Study|Withdrawal by Subject|0|||
149119127|NCT01397422|537914900|FG003|Overall Study|Withdrawal by Subject|0|||
149119128|NCT01397422|537914897|FG000|Overall Study|Increased bradykinesia related to PD|1|||
149119129|NCT01397422|537914898|FG001|Overall Study|Increased bradykinesia related to PD|0|||
149119130|NCT01397422|537914899|FG002|Overall Study|Increased bradykinesia related to PD|0|||
149119131|NCT01397422|537914900|FG003|Overall Study|Increased bradykinesia related to PD|0|||
149119132|NCT00545753|537914901|FG000|Overall Study|Withdrawal by Subject|0|||
149119133|NCT00545753|537914902|FG001|Overall Study|Withdrawal by Subject|1|||
149119134|NCT00545753|537914903|FG002|Overall Study|Withdrawal by Subject|10|||
149119135|NCT00545753|537914901|FG000|Overall Study|Lost to Follow-up|13|||
149119136|NCT00545753|537914902|FG001|Overall Study|Lost to Follow-up|3|||
149119137|NCT00545753|537914903|FG002|Overall Study|Lost to Follow-up|12|||
149119138|NCT00545753|537914901|FG000|Overall Study|Protocol Violation|3|||
149119139|NCT00545753|537914902|FG001|Overall Study|Protocol Violation|1|||
149119140|NCT00545753|537914903|FG002|Overall Study|Protocol Violation|4|||
149119141|NCT04664400|537914904|FG000|Overall Study|Withdrawal by Subject|2|||
149119142|NCT01011153|537914909|FG000|Overall Study|Less than 78 cases completed|8|||
149119143|NCT01011153|537914910|FG001|Overall Study|Less than 78 cases completed|11|||
149119144|NCT01011153|537914911|FG002|Overall Study|Less than 78 cases completed|9|||
149119145|NCT01081132|537914916|FG000|Overall Study|Lack of Efficacy|25|||
149119146|NCT01081132|537914917|FG001|Overall Study|Lack of Efficacy|9|||
149119147|NCT01081132|537914916|FG000|Overall Study|Withdrawal by Subject|13|||
149119148|NCT01081132|537914917|FG001|Overall Study|Withdrawal by Subject|16|||
149119149|NCT01081132|537914916|FG000|Overall Study|Lost to Follow-up|4|||
149119150|NCT01081132|537914917|FG001|Overall Study|Lost to Follow-up|11|||
149119151|NCT01081132|537914916|FG000|Overall Study|Adverse Event|3|||
149119152|NCT01081132|537914917|FG001|Overall Study|Adverse Event|9|||
149119153|NCT01081132|537914916|FG000|Overall Study|Non Compliance|4|||
149119154|NCT01081132|537914917|FG001|Overall Study|Non Compliance|2|||
149119155|NCT01081132|537914916|FG000|Overall Study|Lack Of Compliance|0|||
149119156|NCT01081132|537914917|FG001|Overall Study|Lack Of Compliance|1|||
149119157|NCT01081132|537914916|FG000|Overall Study|Missed Visits|1|||
149119158|NCT01081132|537914917|FG001|Overall Study|Missed Visits|1|||
149119159|NCT01081132|537914916|FG000|Overall Study|Stopped Taking Meds|2|||
149119160|NCT01081132|537914917|FG001|Overall Study|Stopped Taking Meds|0|||
149119161|NCT01081132|537914916|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
149119162|NCT01081132|537914917|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
149119163|NCT01081132|537914916|FG000|Overall Study|Declined Taper Phase|0|||
149119164|NCT01081132|537914917|FG001|Overall Study|Declined Taper Phase|1|||
149119165|NCT01081132|537914916|FG000|Overall Study|Protocol Violation|3|||
149119166|NCT01081132|537914917|FG001|Overall Study|Protocol Violation|1|||
149119167|NCT02297139|537914918|FG000|Overall Study|Disease progression|0|||
149119168|NCT02297139|537914919|FG001|Overall Study|Disease progression|1|||
149119169|NCT02297139|537914918|FG000|Overall Study|Study drug toxicity|0|||
149119170|NCT02297139|537914919|FG001|Overall Study|Study drug toxicity|4|||
149119171|NCT02297139|537914918|FG000|Overall Study|Participant request to discontinue study treatment|0|||
149119172|NCT02297139|537914919|FG001|Overall Study|Participant request to discontinue study treatment|1|||
149119173|NCT02297139|537914918|FG000|Overall Study|Maximum clinical benefit|1|||
149119174|NCT02297139|537914919|FG001|Overall Study|Maximum clinical benefit|0|||
149119175|NCT02297139|537914918|FG000|Overall Study|Administrative reason by sponsor|0|||
149119176|NCT02297139|537914919|FG001|Overall Study|Administrative reason by sponsor|2|||
149119177|NCT02297139|537914918|FG000|Overall Study|Other reasons|0|||
149119178|NCT02297139|537914919|FG001|Overall Study|Other reasons|8|||
149119179|NCT02101385|537914922|FG000|Study Treatment|Disease Progression|9|||
149119180|NCT02101385|537914923|FG001|Study Treatment|Disease Progression|3|||
149119181|NCT02101385|537914922|FG000|Study Treatment|Alternative therapy|0|||
149119182|NCT02101385|537914923|FG001|Study Treatment|Alternative therapy|1|||
149119183|NCT02101385|537914922|FG000|Study Treatment|No treatment, per protocol criteria|0|||
149119184|NCT02101385|537914923|FG001|Study Treatment|No treatment, per protocol criteria|4|||
149119185|NCT02101385|537914922|FG000|Study Treatment|Patient Non compliance|0|||
149119186|NCT02101385|537914923|FG001|Study Treatment|Patient Non compliance|2|||
149119187|NCT02101385|537914922|FG000|Study Treatment|Withdrawal by Subject|5|||
149119188|NCT02101385|537914923|FG001|Study Treatment|Withdrawal by Subject|2|||
149119189|NCT02101385|537914922|FG000|Study Treatment|screen failure|1|||
149119190|NCT02101385|537914923|FG001|Study Treatment|screen failure|0|||
149119191|NCT02101385|537914922|FG000|Study Treatment|AE/Side Effects/Complications|8|||
149119192|NCT02101385|537914923|FG001|Study Treatment|AE/Side Effects/Complications|0|||
149119193|NCT02101385|537914922|FG000|Study Treatment|Lost to Follow-up|1|||
149119194|NCT02101385|537914923|FG001|Study Treatment|Lost to Follow-up|0|||
149119195|NCT02101385|537914922|FG000|Study Treatment|Disease Progression before treatment|1|||
149119196|NCT02101385|537914923|FG001|Study Treatment|Disease Progression before treatment|0|||
149119197|NCT02101385|537914922|FG000|Study Treatment|Death|1|||
149119198|NCT02101385|537914923|FG001|Study Treatment|Death|0|||
149119199|NCT02101385|537914922|FG000|Follow up|Lost to Follow-up|4|||
149119200|NCT02101385|537914923|FG001|Follow up|Lost to Follow-up|9|||
149119201|NCT02101385|537914922|FG000|Follow up|Refused to follow up|5|||
149119202|NCT02101385|537914923|FG001|Follow up|Refused to follow up|4|||
149119203|NCT02101385|537914922|FG000|Follow up|Death|21|||
149119204|NCT02101385|537914923|FG001|Follow up|Death|39|||
149119205|NCT02101385|537914922|FG000|Follow up|study completed|33|||
149119206|NCT02101385|537914923|FG001|Follow up|study completed|52|||
149119207|NCT02101385|537914922|FG000|Follow up|screen failure|2|||
149119208|NCT02101385|537914923|FG001|Follow up|screen failure|0|||
149119209|NCT02101385|537914922|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
149119210|NCT02101385|537914923|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
149119211|NCT02101385|537914922|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
149119212|NCT02101385|537914923|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
149119213|NCT02101385|537914922|FG000|Follow up|Withdrawal by Subject|2|||
149119214|NCT02101385|537914923|FG001|Follow up|Withdrawal by Subject|2|||
149119215|NCT02101385|537914922|FG000|Follow up|PI requested closure of site|0|||
149119216|NCT02101385|537914923|FG001|Follow up|PI requested closure of site|5|||
149119217|NCT04577001|537914927|FG000|Overall Study|Subject became ineligible|0|||
149119218|NCT04577001|537914928|FG001|Overall Study|Subject became ineligible|1|||
149119219|NCT05618912|537914929|FG000|Overall Study|Lost to Follow-up|14|||
149119220|NCT05618912|537914930|FG001|Overall Study|Lost to Follow-up|19|||
149119221|NCT03973931|537914931|FG000|Overall Study|Lost to Follow-up|47|||
149119222|NCT03973931|537914932|FG001|Overall Study|Lost to Follow-up|63|||
149119223|NCT03973931|537914933|FG002|Overall Study|Lost to Follow-up|51|||
149119224|NCT03973931|537914934|FG003|Overall Study|Lost to Follow-up|54|||
149119225|NCT03973931|537914931|FG000|Overall Study|opted out|6|||
149119226|NCT03973931|537914932|FG001|Overall Study|opted out|5|||
149119227|NCT03973931|537914933|FG002|Overall Study|opted out|5|||
149119228|NCT03973931|537914934|FG003|Overall Study|opted out|1|||
149119229|NCT01982448|537914935|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
149119230|NCT01982448|537914936|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
149119231|NCT01982448|537914935|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
149119232|NCT01982448|537914936|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
149119233|NCT01982448|537914935|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
149119234|NCT01982448|537914936|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
149119235|NCT01982448|537914935|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
149119236|NCT01982448|537914936|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
149119237|NCT02516332|537916268|FG000|Overall Study|Withdrawal by Subject|2|||
149119238|NCT02516332|537916269|FG001|Overall Study|Withdrawal by Subject|1|||
149119239|NCT02516332|537916270|FG002|Overall Study|Withdrawal by Subject|2|||
149119240|NCT03695237|537916271|FG000|Overall Study|Withdrawal by Subject|1|||
149119241|NCT03695237|537916272|FG001|Overall Study|Withdrawal by Subject|3|||
149119242|NCT03695237|537916271|FG000|Overall Study|Lost to Follow-up|1|||
149119243|NCT03695237|537916272|FG001|Overall Study|Lost to Follow-up|2|||
149119244|NCT03695237|537916271|FG000|Overall Study|Other, Not Specified|8|||
149119245|NCT03695237|537916272|FG001|Overall Study|Other, Not Specified|2|||
149119246|NCT00055601|537916273|FG000|Overall Study|Protocol Violation|1|||
149119247|NCT00055601|537916274|FG001|Overall Study|Protocol Violation|1|||
149119248|NCT00055601|537916273|FG000|Overall Study|No protocol treatment received|1|||
149119249|NCT00055601|537916274|FG001|Overall Study|No protocol treatment received|1|||
149119250|NCT03541174|537916277|FG000|Part 1 Double-Blind|Adverse Event|6|||
149119251|NCT03541174|537916278|FG001|Part 1 Double-Blind|Adverse Event|5|||
149119252|NCT03541174|537916279|FG002|Part 1 Double-Blind|Adverse Event|2|||
149119253|NCT03541174|537916280|FG003|Part 1 Double-Blind|Adverse Event|0|||
149119254|NCT03541174|537916281|FG004|Part 1 Double-Blind|Adverse Event|0|||
149119255|NCT03541174|537916282|FG005|Part 1 Double-Blind|Adverse Event|0|||
149119256|NCT03541174|537916277|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
149119257|NCT03541174|537916278|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
149119258|NCT03541174|537916279|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
149119259|NCT03541174|537916280|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
149119260|NCT03541174|537916281|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
149119261|NCT03541174|537916282|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
149119262|NCT03541174|537916277|FG000|Part 1 Double-Blind|Other reasons|3|||
149119263|NCT03541174|537916278|FG001|Part 1 Double-Blind|Other reasons|2|||
149119264|NCT03541174|537916279|FG002|Part 1 Double-Blind|Other reasons|3|||
149119265|NCT03541174|537916280|FG003|Part 1 Double-Blind|Other reasons|0|||
149119266|NCT03541174|537916281|FG004|Part 1 Double-Blind|Other reasons|0|||
149119267|NCT03541174|537916282|FG005|Part 1 Double-Blind|Other reasons|0|||
149119268|NCT03541174|537916277|FG000|Part 2 Single-Blind|Adverse Event|0|||
149119269|NCT03541174|537916278|FG001|Part 2 Single-Blind|Adverse Event|0|||
149119270|NCT03541174|537916279|FG002|Part 2 Single-Blind|Adverse Event|0|||
149119271|NCT03541174|537916280|FG003|Part 2 Single-Blind|Adverse Event|25|||
149119272|NCT03541174|537916281|FG004|Part 2 Single-Blind|Adverse Event|0|||
149119273|NCT03541174|537916282|FG005|Part 2 Single-Blind|Adverse Event|0|||
149119274|NCT03541174|537916277|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
149119275|NCT03541174|537916278|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
149119276|NCT03541174|537916279|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
149119277|NCT03541174|537916280|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
149119278|NCT03541174|537916281|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
149119279|NCT03541174|537916282|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
149119280|NCT03541174|537916277|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
149119281|NCT03541174|537916278|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
149119282|NCT03541174|537916279|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
149119283|NCT03541174|537916280|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
149119284|NCT03541174|537916281|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
149119285|NCT03541174|537916282|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
149119286|NCT03541174|537916277|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
149119287|NCT03541174|537916278|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
149119288|NCT03541174|537916279|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
149119289|NCT03541174|537916280|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
149119290|NCT03541174|537916281|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
149119291|NCT03541174|537916282|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
149119292|NCT03541174|537916277|FG000|Part 2 Single-Blind|Death|0|||
149119293|NCT03541174|537916278|FG001|Part 2 Single-Blind|Death|0|||
149119294|NCT03541174|537916279|FG002|Part 2 Single-Blind|Death|0|||
149119295|NCT03541174|537916280|FG003|Part 2 Single-Blind|Death|5|||
149119296|NCT03541174|537916281|FG004|Part 2 Single-Blind|Death|0|||
149119297|NCT03541174|537916282|FG005|Part 2 Single-Blind|Death|0|||
149119298|NCT03541174|537916277|FG000|Part 2 Single-Blind|Pregnancy|0|||
149119299|NCT03541174|537916278|FG001|Part 2 Single-Blind|Pregnancy|0|||
149119300|NCT03541174|537916279|FG002|Part 2 Single-Blind|Pregnancy|0|||
149119301|NCT03541174|537916280|FG003|Part 2 Single-Blind|Pregnancy|1|||
149119302|NCT03541174|537916281|FG004|Part 2 Single-Blind|Pregnancy|0|||
149119303|NCT03541174|537916282|FG005|Part 2 Single-Blind|Pregnancy|0|||
149119304|NCT03541174|537916277|FG000|Part 2 Single-Blind|Other reasons|0|||
149119305|NCT03541174|537916278|FG001|Part 2 Single-Blind|Other reasons|0|||
149119306|NCT03541174|537916279|FG002|Part 2 Single-Blind|Other reasons|0|||
149119307|NCT03541174|537916280|FG003|Part 2 Single-Blind|Other reasons|32|||
149119308|NCT03541174|537916281|FG004|Part 2 Single-Blind|Other reasons|0|||
149119309|NCT03541174|537916282|FG005|Part 2 Single-Blind|Other reasons|0|||
149119310|NCT03541174|537916277|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149119311|NCT03541174|537916278|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149119312|NCT03541174|537916279|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149119313|NCT03541174|537916280|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
149119314|NCT03541174|537916281|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
149119315|NCT03541174|537916282|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
149119316|NCT03541174|537916277|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
149119317|NCT03541174|537916278|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
149119318|NCT03541174|537916279|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
149119319|NCT03541174|537916280|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
149119320|NCT03541174|537916281|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
149119321|NCT03541174|537916282|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
149119322|NCT03541174|537916277|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
149119323|NCT03541174|537916278|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
149119324|NCT03541174|537916279|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
149119325|NCT03541174|537916280|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
149119326|NCT03541174|537916281|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
149119327|NCT03541174|537916282|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
149119328|NCT03541174|537916277|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
149119329|NCT03541174|537916278|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
149119330|NCT03541174|537916279|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
149119331|NCT03541174|537916280|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
149119332|NCT03541174|537916281|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
149119333|NCT03541174|537916282|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
149119334|NCT03541174|537916277|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
149119335|NCT03541174|537916278|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
149119336|NCT03541174|537916279|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
149119337|NCT03541174|537916280|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
149119338|NCT03541174|537916281|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
149119339|NCT03541174|537916282|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
149119340|NCT00605215|537916283|FG000|Overall Study|Death|0|||
149119341|NCT00605215|537916284|FG001|Overall Study|Death|0|||
149119342|NCT00605215|537916285|FG002|Overall Study|Death|1|||
149119343|NCT00605215|537916283|FG000|Overall Study|Adverse Event|19|||
149119344|NCT00605215|537916284|FG001|Overall Study|Adverse Event|21|||
149119345|NCT00605215|537916285|FG002|Overall Study|Adverse Event|26|||
149119346|NCT00605215|537916283|FG000|Overall Study|Refusal to sign the re-consent form|8|||
149119347|NCT00605215|537916284|FG001|Overall Study|Refusal to sign the re-consent form|3|||
149119348|NCT00605215|537916285|FG002|Overall Study|Refusal to sign the re-consent form|3|||
149119349|NCT00605215|537916283|FG000|Overall Study|Withdrawal by Subject|39|||
149119350|NCT00605215|537916284|FG001|Overall Study|Withdrawal by Subject|37|||
149119351|NCT00605215|537916285|FG002|Overall Study|Withdrawal by Subject|27|||
149119352|NCT00605215|537916283|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
149119353|NCT00605215|537916284|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
149119354|NCT00605215|537916285|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
149119355|NCT00605215|537916283|FG000|Overall Study|Protocol Violation|3|||
149119356|NCT00605215|537916284|FG001|Overall Study|Protocol Violation|4|||
149119357|NCT00605215|537916285|FG002|Overall Study|Protocol Violation|1|||
149119358|NCT00605215|537916283|FG000|Overall Study|Pregnancy|8|||
149119359|NCT00605215|537916284|FG001|Overall Study|Pregnancy|5|||
149119360|NCT00605215|537916285|FG002|Overall Study|Pregnancy|4|||
149119361|NCT00605215|537916283|FG000|Overall Study|Lost to Follow-up|8|||
149119362|NCT00605215|537916284|FG001|Overall Study|Lost to Follow-up|5|||
149119363|NCT00605215|537916285|FG002|Overall Study|Lost to Follow-up|2|||
149119364|NCT00605215|537916283|FG000|Overall Study|Other than specified|0|||
149119365|NCT00605215|537916284|FG001|Overall Study|Other than specified|2|||
149119366|NCT00605215|537916285|FG002|Overall Study|Other than specified|1|||
149119367|NCT00275262|537916292|FG000|Overall Study|Adverse Event|2|||
149119368|NCT00275262|537916293|FG001|Overall Study|Adverse Event|0|||
149119369|NCT00275262|537916292|FG000|Overall Study|Disease progression|2|||
149119370|NCT00275262|537916293|FG001|Overall Study|Disease progression|5|||
149119574|NCT02489968|537916383|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
149119575|NCT02489968|537916384|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
149119576|NCT02489968|537916385|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
149119577|NCT02489968|537916386|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
149119578|NCT02489968|537916381|FG000|Open-label Treatment Period|Other than specified above|204|||
149119579|NCT02489968|537916382|FG001|Open-label Treatment Period|Other than specified above|189|||
149119580|NCT02489968|537916383|FG002|Open-label Treatment Period|Other than specified above|0|||
149119581|NCT02489968|537916384|FG003|Open-label Treatment Period|Other than specified above|0|||
149119582|NCT02489968|537916385|FG004|Open-label Treatment Period|Other than specified above|0|||
149119583|NCT02489968|537916386|FG005|Open-label Treatment Period|Other than specified above|0|||
149119584|NCT02489968|537916381|FG000|Double-blind Treatment Period|Adverse Event|0|||
149119585|NCT02489968|537916382|FG001|Double-blind Treatment Period|Adverse Event|0|||
149119586|NCT02489968|537916383|FG002|Double-blind Treatment Period|Adverse Event|2|||
149119587|NCT02489968|537916384|FG003|Double-blind Treatment Period|Adverse Event|6|||
149119588|NCT02489968|537916385|FG004|Double-blind Treatment Period|Adverse Event|4|||
149119589|NCT02489968|537916386|FG005|Double-blind Treatment Period|Adverse Event|5|||
149119590|NCT02489968|537916381|FG000|Double-blind Treatment Period|Protocol Violation|0|||
149119591|NCT02489968|537916382|FG001|Double-blind Treatment Period|Protocol Violation|0|||
149119592|NCT02489968|537916383|FG002|Double-blind Treatment Period|Protocol Violation|0|||
149119593|NCT02489968|537916384|FG003|Double-blind Treatment Period|Protocol Violation|0|||
149119594|NCT02489968|537916385|FG004|Double-blind Treatment Period|Protocol Violation|1|||
149119595|NCT02489968|537916386|FG005|Double-blind Treatment Period|Protocol Violation|1|||
149119596|NCT02489968|537916381|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
149119597|NCT02489968|537916382|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
149119598|NCT02489968|537916383|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
149119599|NCT02489968|537916384|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
149119600|NCT02489968|537916385|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
149119601|NCT02489968|537916386|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
149119602|NCT02489968|537916381|FG000|Double-blind Treatment Period|Other than specified above|0|||
149119603|NCT02489968|537916382|FG001|Double-blind Treatment Period|Other than specified above|0|||
149119604|NCT02489968|537916383|FG002|Double-blind Treatment Period|Other than specified above|0|||
149119605|NCT02489968|537916384|FG003|Double-blind Treatment Period|Other than specified above|0|||
149119606|NCT02489968|537916385|FG004|Double-blind Treatment Period|Other than specified above|1|||
149119607|NCT02489968|537916386|FG005|Double-blind Treatment Period|Other than specified above|0|||
149119608|NCT03738423|537916388|FG000|Overall Study|Withdrawal by Subject|9|||
149119609|NCT03738423|537916389|FG001|Overall Study|Withdrawal by Subject|12|||
149119610|NCT03738423|537916390|FG002|Overall Study|Withdrawal by Subject|9|||
149119611|NCT03738423|537916391|FG003|Overall Study|Withdrawal by Subject|12|||
149119612|NCT03738423|537916392|FG004|Overall Study|Withdrawal by Subject|10|||
149119613|NCT03738423|537916388|FG000|Overall Study|Lack of Efficacy|3|||
149119614|NCT03738423|537916389|FG001|Overall Study|Lack of Efficacy|1|||
149119615|NCT03738423|537916390|FG002|Overall Study|Lack of Efficacy|1|||
149119616|NCT03738423|537916391|FG003|Overall Study|Lack of Efficacy|1|||
149119617|NCT03738423|537916392|FG004|Overall Study|Lack of Efficacy|2|||
149119618|NCT03738423|537916388|FG000|Overall Study|Lost to Follow-up|1|||
149119619|NCT03738423|537916389|FG001|Overall Study|Lost to Follow-up|0|||
149119620|NCT03738423|537916390|FG002|Overall Study|Lost to Follow-up|1|||
149119621|NCT03738423|537916391|FG003|Overall Study|Lost to Follow-up|1|||
149119622|NCT03738423|537916392|FG004|Overall Study|Lost to Follow-up|0|||
149119623|NCT03738423|537916388|FG000|Overall Study|Protocol Violation|1|||
149119624|NCT03738423|537916389|FG001|Overall Study|Protocol Violation|0|||
149119625|NCT03738423|537916390|FG002|Overall Study|Protocol Violation|0|||
149119626|NCT03738423|537916391|FG003|Overall Study|Protocol Violation|0|||
149119627|NCT03738423|537916392|FG004|Overall Study|Protocol Violation|1|||
149119628|NCT03738423|537916388|FG000|Overall Study|Physician Decision|0|||
149119629|NCT03738423|537916389|FG001|Overall Study|Physician Decision|0|||
149119630|NCT03738423|537916390|FG002|Overall Study|Physician Decision|1|||
149119631|NCT03738423|537916391|FG003|Overall Study|Physician Decision|0|||
149119632|NCT03738423|537916392|FG004|Overall Study|Physician Decision|1|||
149119633|NCT03738423|537916388|FG000|Overall Study|Death|0|||
149119634|NCT03738423|537916389|FG001|Overall Study|Death|0|||
149119635|NCT03738423|537916390|FG002|Overall Study|Death|0|||
149119636|NCT03738423|537916391|FG003|Overall Study|Death|0|||
149119637|NCT03738423|537916392|FG004|Overall Study|Death|1|||
149119638|NCT03738423|537916388|FG000|Overall Study|Randomized but never treated|0|||
149119639|NCT03738423|537916389|FG001|Overall Study|Randomized but never treated|0|||
149119640|NCT03738423|537916390|FG002|Overall Study|Randomized but never treated|1|||
149119641|NCT03738423|537916391|FG003|Overall Study|Randomized but never treated|1|||
149119642|NCT03738423|537916392|FG004|Overall Study|Randomized but never treated|0|||
149119643|NCT01865747|537916399|FG000|Overall Study (ITT)|Adverse Event|32|||
149119644|NCT01865747|537916400|FG001|Overall Study (ITT)|Adverse Event|31|||
149119645|NCT01865747|537916399|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
149119646|NCT01865747|537916400|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
149119647|NCT01865747|537916399|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
149119648|NCT01865747|537916400|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
149119649|NCT01865747|537916399|FG000|Overall Study (ITT)|Protocol Violation|1|||
149119650|NCT01865747|537916400|FG001|Overall Study (ITT)|Protocol Violation|1|||
149119651|NCT01865747|537916399|FG000|Overall Study (ITT)|Physician Decision|5|||
149119652|NCT01865747|537916400|FG001|Overall Study (ITT)|Physician Decision|2|||
149119653|NCT01865747|537916399|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
149119654|NCT01865747|537916400|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
149119655|NCT01865747|537916399|FG000|Overall Study (ITT)|Sponsor Decision|0|||
149119656|NCT01865747|537916400|FG001|Overall Study (ITT)|Sponsor Decision|1|||
149119657|NCT01865747|537916399|FG000|Overall Study (ITT)|Progressive Disease|122|||
149119658|NCT01865747|537916400|FG001|Overall Study (ITT)|Progressive Disease|158|||
149119659|NCT01865747|537916399|FG000|Overall Study (ITT)|Reason Not Provided|0|||
149119660|NCT01865747|537916400|FG001|Overall Study (ITT)|Reason Not Provided|1|||
149119661|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
149119662|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
149119663|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
149119664|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
149119665|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
149119666|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
149119667|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
149119668|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
149119669|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
149119670|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
149119671|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
149119672|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
149119673|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
149119674|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
149119675|NCT01865747|537916399|FG000|Primary Intent to Treat (PITT)|Other|0|||
149119676|NCT01865747|537916400|FG001|Primary Intent to Treat (PITT)|Other|1|||
149119677|NCT04625413|537916401|FG000|Overall Study|Hospice|2|||
149119678|NCT04625413|537916401|FG000|Overall Study|Distress|1|||
149119679|NCT04625413|537916401|FG000|Overall Study|Not feeling well|1|||
149119680|NCT03981861|537916402|FG000|Overall Study|Withdrawal by Subject|3|||
149119681|NCT00925353|537916403|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
149119682|NCT01342341|537917937|FG000|Overall Study|Lost to Follow-up|4|||
149119683|NCT01342341|537917938|FG001|Overall Study|Lost to Follow-up|4|||
149119684|NCT01302067|537917943|FG000|Overall Study|Death|0|||
149119685|NCT01302067|537917944|FG001|Overall Study|Death|0|||
149119686|NCT01302067|537917945|FG002|Overall Study|Death|1|||
149119687|NCT01302067|537917943|FG000|Overall Study|Physician Decision|9|||
149119688|NCT01302067|537917944|FG001|Overall Study|Physician Decision|5|||
149119689|NCT01302067|537917945|FG002|Overall Study|Physician Decision|14|||
149119690|NCT01302067|537917943|FG000|Overall Study|Lack of Efficacy|8|||
149119691|NCT01302067|537917944|FG001|Overall Study|Lack of Efficacy|4|||
149119692|NCT01302067|537917945|FG002|Overall Study|Lack of Efficacy|2|||
149119693|NCT01302067|537917943|FG000|Overall Study|Lost to Follow-up|9|||
149119694|NCT01302067|537917944|FG001|Overall Study|Lost to Follow-up|4|||
149119695|NCT01302067|537917945|FG002|Overall Study|Lost to Follow-up|15|||
149119696|NCT01302067|537917943|FG000|Overall Study|Withdrawal by Subject|13|||
149119697|NCT01302067|537917944|FG001|Overall Study|Withdrawal by Subject|6|||
149119698|NCT01302067|537917945|FG002|Overall Study|Withdrawal by Subject|10|||
149119699|NCT01302067|537917943|FG000|Overall Study|Other|1|||
149119700|NCT01302067|537917944|FG001|Overall Study|Other|1|||
149119701|NCT01302067|537917945|FG002|Overall Study|Other|3|||
149119702|NCT01302067|537917943|FG000|Overall Study|Protocol Violation|11|||
149119703|NCT01302067|537917944|FG001|Overall Study|Protocol Violation|0|||
149119704|NCT01302067|537917945|FG002|Overall Study|Protocol Violation|8|||
149119705|NCT01302067|537917943|FG000|Overall Study|Adverse Event|27|||
149119706|NCT01302067|537917944|FG001|Overall Study|Adverse Event|14|||
149119707|NCT01302067|537917945|FG002|Overall Study|Adverse Event|45|||
149119708|NCT02738203|537917947|FG000|Overall Study|Failed IUD Insertion|2|||
149119709|NCT02738203|537917948|FG001|Overall Study|Failed IUD Insertion|2|||
149119710|NCT02738203|537917947|FG000|Overall Study|Protocol Violation|0|||
149119711|NCT02738203|537917948|FG001|Overall Study|Protocol Violation|1|||
149119712|NCT00266227|537917949|FG000|Initial Treatment|Adverse Event|0|||
149119713|NCT00266227|537917950|FG001|Initial Treatment|Adverse Event|0|||
149119714|NCT00266227|537917951|FG002|Initial Treatment|Adverse Event|13|||
149119715|NCT00266227|537917949|FG000|Initial Treatment|Lost to Follow-up|0|||
149119716|NCT00266227|537917950|FG001|Initial Treatment|Lost to Follow-up|0|||
149119717|NCT00266227|537917951|FG002|Initial Treatment|Lost to Follow-up|6|||
149119718|NCT00266227|537917949|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
149119719|NCT00266227|537917950|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
149119720|NCT00266227|537917951|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
149119721|NCT00266227|537917949|FG000|Initial Treatment|Physician decision to withdraw|0|||
149119722|NCT00266227|537917950|FG001|Initial Treatment|Physician decision to withdraw|0|||
149119723|NCT00266227|537917951|FG002|Initial Treatment|Physician decision to withdraw|12|||
149119724|NCT00266227|537917949|FG000|Initial Treatment|Pregnancy|0|||
149119725|NCT00266227|537917950|FG001|Initial Treatment|Pregnancy|0|||
149119726|NCT00266227|537917951|FG002|Initial Treatment|Pregnancy|1|||
149119727|NCT00266227|537917949|FG000|Retreatment: Up to Week 48|Death|1|||
149119728|NCT00266227|537917950|FG001|Retreatment: Up to Week 48|Death|0|||
149119729|NCT00266227|537917951|FG002|Retreatment: Up to Week 48|Death|0|||
149119730|NCT00266227|537917949|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
149119731|NCT00266227|537917950|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
149119732|NCT00266227|537917951|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
149119733|NCT00266227|537917949|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
149119734|NCT00266227|537917950|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
149119735|NCT00266227|537917951|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
149119736|NCT00266227|537917949|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
149119737|NCT00266227|537917950|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
149119738|NCT00266227|537917951|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
149119739|NCT00266227|537917949|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
149119740|NCT00266227|537917950|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
149119741|NCT00266227|537917951|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
149119742|NCT00266227|537917949|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
149119743|NCT00266227|537917950|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
149119744|NCT00266227|537917951|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
149119745|NCT00266227|537917949|FG000|Retreatment: Week 48 to Week 72|Death|1|||
149119746|NCT00266227|537917950|FG001|Retreatment: Week 48 to Week 72|Death|1|||
149119747|NCT00266227|537917951|FG002|Retreatment: Week 48 to Week 72|Death|0|||
149119748|NCT00266227|537917949|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
149119749|NCT00266227|537917950|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
149119750|NCT00266227|537917951|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
149119751|NCT00266227|537917949|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
149119752|NCT00266227|537917950|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
149119753|NCT00266227|537917951|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
149119754|NCT00266227|537917949|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
149119755|NCT00266227|537917950|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
149119756|NCT00266227|537917951|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
149119757|NCT00266227|537917949|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
149119758|NCT00266227|537917950|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
149119759|NCT00266227|537917951|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
149119760|NCT03573583|537917952|FG000|Overall Study|Lost to Follow-up|1|||
149119761|NCT03573583|537917953|FG001|Overall Study|Lost to Follow-up|0|||
149119762|NCT03573583|537917952|FG000|Overall Study|Withdrawal by Subject|1|||
149119763|NCT03573583|537917953|FG001|Overall Study|Withdrawal by Subject|1|||
149119764|NCT01239043|537917955|FG000|Overall Study|Protocol Violation|2|||
149119765|NCT01239043|537917956|FG001|Overall Study|Protocol Violation|1|||
149119766|NCT02929329|537917959|FG000|Overall Study|Withdrawal by Subject|24|||
149119767|NCT02929329|537917960|FG001|Overall Study|Withdrawal by Subject|21|||
149119768|NCT02929329|537917959|FG000|Overall Study|Lost to Follow-up|26|||
149119769|NCT02929329|537917960|FG001|Overall Study|Lost to Follow-up|20|||
149119770|NCT02929329|537917959|FG000|Overall Study|Death|1054|||
149119771|NCT02929329|537917960|FG001|Overall Study|Death|1051|||
149119772|NCT02121301|537917961|FG000|Overall Study|Protocol Violation|1|||
149119773|NCT02121301|537917962|FG001|Overall Study|Protocol Violation|4|||
149119774|NCT02121301|537917963|FG002|Overall Study|Protocol Violation|1|||
149119775|NCT00037830|537917966|FG000|Overall Study|Adverse Event|2|||
149119776|NCT00037830|537917967|FG001|Overall Study|Adverse Event|0|||
149119777|NCT00037830|537917968|FG002|Overall Study|Adverse Event|0|||
149119778|NCT00037830|537917966|FG000|Overall Study|Withdrawal by Subject|4|||
149119779|NCT00037830|537917967|FG001|Overall Study|Withdrawal by Subject|5|||
149119780|NCT00037830|537917968|FG002|Overall Study|Withdrawal by Subject|1|||
149119781|NCT00037830|537917966|FG000|Overall Study|Protocol Violation|2|||
149119782|NCT00037830|537917967|FG001|Overall Study|Protocol Violation|2|||
149119783|NCT00037830|537917968|FG002|Overall Study|Protocol Violation|0|||
149119784|NCT00037830|537917966|FG000|Overall Study|Unrelated Medical Problem|2|||
149119785|NCT00037830|537917967|FG001|Overall Study|Unrelated Medical Problem|0|||
149119786|NCT00037830|537917968|FG002|Overall Study|Unrelated Medical Problem|0|||
149119787|NCT00006011|537917969|FG000|Overall Study|Disease progression|13|||
149119788|NCT00006011|537917970|FG001|Overall Study|Disease progression|6|||
149119789|NCT00006011|537917971|FG002|Overall Study|Disease progression|26|||
149119790|NCT00006011|537917969|FG000|Overall Study|Refused further treatment|15|||
149119791|NCT00006011|537917970|FG001|Overall Study|Refused further treatment|13|||
149119792|NCT00006011|537917971|FG002|Overall Study|Refused further treatment|26|||
149119793|NCT00006011|537917969|FG000|Overall Study|Adverse Event|15|||
149119794|NCT00006011|537917970|FG001|Overall Study|Adverse Event|39|||
149119795|NCT00006011|537917971|FG002|Overall Study|Adverse Event|5|||
149119796|NCT00006011|537917969|FG000|Overall Study|Death|0|||
149119805|NCT01639560|537917974|FG000|Overall Study|Withdrawal by Subject|9|||
149119806|NCT01639560|537917975|FG001|Overall Study|Withdrawal by Subject|14|||
149119807|NCT01639560|537917974|FG000|Overall Study|Lack of Efficacy|1|||
149119808|NCT01639560|537917975|FG001|Overall Study|Lack of Efficacy|2|||
149119809|NCT01639560|537917974|FG000|Overall Study|Lost to Follow-up|9|||
149119810|NCT01639560|537917975|FG001|Overall Study|Lost to Follow-up|11|||
149119811|NCT01639560|537917974|FG000|Overall Study|Adverse Event|0|||
149119812|NCT01639560|537917975|FG001|Overall Study|Adverse Event|2|||
149119813|NCT00766363|537917984|FG000|Overall Study|Withdrawal by Subject|1|||
149119814|NCT00766363|537917985|FG001|Overall Study|Withdrawal by Subject|0|||
149119815|NCT00766363|537917986|FG002|Overall Study|Withdrawal by Subject|0|||
149119816|NCT00766363|537917987|FG003|Overall Study|Withdrawal by Subject|0|||
149119817|NCT00766363|537917984|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
149119818|NCT00766363|537917985|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
149119819|NCT00766363|537917986|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
149119820|NCT00766363|537917987|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
149119821|NCT01631227|537917988|FG000|Overall Study|withdrawn consent|27|||
149119822|NCT01631227|537917989|FG001|Overall Study|withdrawn consent|21|||
149119823|NCT01631227|537917988|FG000|Overall Study|Adverse Event|1|||
149119824|NCT01631227|537917989|FG001|Overall Study|Adverse Event|0|||
149119825|NCT01631227|537917988|FG000|Overall Study|administrative|2|||
149119826|NCT01631227|537917989|FG001|Overall Study|administrative|1|||
149119827|NCT03020576|537917992|FG000|Overall Study|Withdrawal by Subject|1|||
149119828|NCT03020576|537917993|FG001|Overall Study|Withdrawal by Subject|2|||
149119829|NCT03292432|537917994|FG000|Overall Study|Lost to Follow-up|11|||
149119830|NCT03292432|537917995|FG001|Overall Study|Lost to Follow-up|8|||
149119831|NCT03292432|537917994|FG000|Overall Study|Death|2|||
149119832|NCT03292432|537917995|FG001|Overall Study|Death|1|||
149119833|NCT03292432|537917994|FG000|Overall Study|Withdrawal by Subject|1|||
149119834|NCT03292432|537917995|FG001|Overall Study|Withdrawal by Subject|2|||
149119835|NCT03292432|537917994|FG000|Overall Study|Site closed before any data collected|1|||
149119836|NCT03292432|537917995|FG001|Overall Study|Site closed before any data collected|0|||
149119837|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
149119838|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
149119839|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
149119840|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
149119841|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
149119842|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
149119843|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
149119844|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
149119845|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
149119846|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
149119847|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
149119848|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
149119849|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
149119850|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
149119851|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
149119852|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
149119853|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
149119854|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
149119855|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
149119856|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
149119857|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
149119858|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
149119859|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
149119860|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
149119861|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
149119862|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
149119863|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
149119864|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
149119865|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
149119866|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
149119867|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
149119868|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
149119869|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
149119870|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
149119871|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
149119872|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
149119873|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
149119874|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
149119875|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
149119876|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
149119877|NCT00700427|537918000|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
149119878|NCT00700427|537918001|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
149119879|NCT00700427|537918002|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
149119880|NCT00700427|537918003|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
149119881|NCT00700427|537918004|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
149119882|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
149119883|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
149119884|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
149119885|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
149119886|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
149119887|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
149119888|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
149119889|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
149119890|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
149119891|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
149119892|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
149119893|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
149119894|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
149119895|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
149119896|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
149119897|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
149119898|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
149119899|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
149119900|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
149119901|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
149119902|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
149119903|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
149119904|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
149119905|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
149119906|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
149119907|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
149119908|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
149119909|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
149119910|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
149119911|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
149119912|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
149119913|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
149119914|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
149119915|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
149119916|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
149119917|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
149119918|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
149119919|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
149119920|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
149119921|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
149119922|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
149119923|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
149119924|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
149119925|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
149119926|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
149119927|NCT00700427|537918000|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
149119928|NCT00700427|537918001|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
149119929|NCT00700427|537918002|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
149119930|NCT00700427|537918003|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
149119931|NCT00700427|537918004|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
149119932|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
149119933|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
149119934|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
149119935|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
149119936|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
149119937|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
149119938|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
149119939|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
149119940|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
149119941|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
149119942|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
149119943|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
149119944|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
149119945|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
149119946|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
149119947|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
149119948|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
149119949|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
149119950|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
149119951|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
149119952|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
149119953|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
149119954|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
149119955|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
149119956|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
149119957|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
149119958|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
149119959|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
149119960|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
149119961|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
149119962|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
149119963|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
149119964|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
149119965|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
149119966|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
149119967|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
149119968|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
149119969|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
149119970|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
149119971|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
149119972|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
149119973|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
149119974|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
149119975|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
149119976|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
149119977|NCT00700427|537918000|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
149119978|NCT00700427|537918001|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
149119979|NCT00700427|537918002|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
149119980|NCT00700427|537918003|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
149119981|NCT00700427|537918004|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
149119982|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
149119983|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
149119984|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
149119985|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
149119986|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
149119987|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
149119988|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
149119989|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
149119990|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
149119991|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
149119992|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
149119993|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
149119994|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
149119995|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
149119996|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
149119997|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
149119998|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
149119999|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
149120000|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
149120001|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
149120002|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
149120003|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
149120004|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
149120005|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
149120006|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
149120007|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
149120008|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
149120009|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
149120010|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
149120011|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
149120012|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
149120013|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
149120014|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
149120015|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
149120016|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
149120017|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
149120018|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
149120019|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
149120020|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
149120021|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
149120022|NCT00700427|537918000|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
149120023|NCT00700427|537918001|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
149120024|NCT00700427|537918002|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
149120025|NCT00700427|537918003|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
149120026|NCT00700427|537918004|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
149120027|NCT02057523|537918009|FG000|Overall Study|Withdrawal by Subject|1|||
149120028|NCT02057523|537918009|FG000|Overall Study|Lack of Efficacy|1|||
149120029|NCT00964886|537918012|FG000|Overall Study|Lost to Follow-up|2|||
149120030|NCT00964886|537918013|FG001|Overall Study|Lost to Follow-up|2|||
149120031|NCT00964886|537918014|FG002|Overall Study|Lost to Follow-up|6|||
149120032|NCT00964886|537918015|FG003|Overall Study|Lost to Follow-up|4|||
149120033|NCT00964886|537918012|FG000|Overall Study|Withdrawal by Subject|6|||
149120034|NCT00964886|537918013|FG001|Overall Study|Withdrawal by Subject|2|||
149120035|NCT00964886|537918014|FG002|Overall Study|Withdrawal by Subject|5|||
149120036|NCT00964886|537918015|FG003|Overall Study|Withdrawal by Subject|3|||
149120037|NCT00964886|537918012|FG000|Overall Study|Adverse Event|3|||
149120038|NCT00964886|537918013|FG001|Overall Study|Adverse Event|1|||
149120039|NCT00964886|537918014|FG002|Overall Study|Adverse Event|5|||
149120040|NCT00964886|537918015|FG003|Overall Study|Adverse Event|2|||
149120041|NCT00964886|537918012|FG000|Overall Study|Protocol Violation|0|||
149120042|NCT00964886|537918013|FG001|Overall Study|Protocol Violation|2|||
149120043|NCT00964886|537918014|FG002|Overall Study|Protocol Violation|0|||
149120044|NCT00964886|537918015|FG003|Overall Study|Protocol Violation|0|||
149120045|NCT03500159|537918020|FG000|Overall Study|Study Terminated|2|||
149120046|NCT03500159|537918021|FG001|Overall Study|Study Terminated|1|||
149120047|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
149120048|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
149120049|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
149120050|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
149120051|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
149120052|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
149120053|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
149120054|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
149120055|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
149120056|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
149120057|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
149120058|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
149120059|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
149120060|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
149120061|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
149120062|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
149120063|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
149120064|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
149120065|NCT03412747|537918026|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
149120066|NCT03412747|537918027|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
149120067|NCT03412747|537918028|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
149120068|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
149120069|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
149120070|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
149120071|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
149120072|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
149120073|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
149120074|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
149120075|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
149120076|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
149120077|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
149120078|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
149120079|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
149120080|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
149120081|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
149120082|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
149120083|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
149120084|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
149120085|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
149120086|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
149120087|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
149120088|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
149120089|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
149120090|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
149120091|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
149120092|NCT03412747|537918026|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
149120093|NCT03412747|537918027|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
149120094|NCT03412747|537918028|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
149120095|NCT03484273|537918029|FG000|Overall Study|Equipment Malfunction|1|||
149120096|NCT03484273|537918029|FG000|Overall Study|Data excluded from analysis|1|||
149120097|NCT00468104|537918033|FG000|First Intervention|Protocol Violation|2|||
149120098|NCT00468104|537918034|FG001|First Intervention|Protocol Violation|1|||
149120099|NCT00468104|537918033|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
149120100|NCT00468104|537918034|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
149120101|NCT00468104|537918033|FG000|First Intervention|died within 3 weeks|1|||
149120102|NCT00468104|537918034|FG001|First Intervention|died within 3 weeks|0|||
149120103|NCT00468104|537918033|FG000|First Intervention|malposition/blocked chest tube tube|2|||
149120104|NCT00468104|537918034|FG001|First Intervention|malposition/blocked chest tube tube|0|||
149120105|NCT00468104|537918033|FG000|First Intervention|large lung mass with minimal effusion|1|||
149120106|NCT00468104|537918034|FG001|First Intervention|large lung mass with minimal effusion|0|||
149120107|NCT00468104|537918033|FG000|First Intervention|associated prolonged pneumothorax|1|||
149120108|NCT00468104|537918034|FG001|First Intervention|associated prolonged pneumothorax|0|||
149120109|NCT00468104|537918033|FG000|First Intervention|trapped lung|1|||
149120110|NCT00468104|537918034|FG001|First Intervention|trapped lung|0|||
149120111|NCT00468104|537918033|FG000|Second Intervention|Withdrawal by Subject|5|||
149120112|NCT00468104|537918034|FG001|Second Intervention|Withdrawal by Subject|2|||
149120113|NCT00468104|537918033|FG000|Second Intervention|discarded for malposition of chest tube|0|||
149120114|NCT00468104|537918034|FG001|Second Intervention|discarded for malposition of chest tube|2|||
149120115|NCT01263665|537918035|FG000|Overall Study|Withdrew Consent|1|||
149120116|NCT01263665|537918035|FG000|Overall Study|Lost to Follow-up|3|||
149120117|NCT01263665|537918035|FG000|Overall Study|Death|2|||
149120118|NCT01263665|537918035|FG000|Overall Study|Amputation above the ankle|1|||
149120119|NCT01263665|537918035|FG000|Overall Study|Surgical Bypass|2|||
149120120|NCT02706899|537918038|FG000|Overall Study|Withdrawal by Subject|1|||
149120121|NCT02706899|537918039|FG001|Overall Study|Withdrawal by Subject|0|||
149120122|NCT02706899|537918038|FG000|Overall Study|Death|8|||
149120123|NCT02706899|537918039|FG001|Overall Study|Death|0|||
149120124|NCT02706899|537918038|FG000|Overall Study|Study Termination by Sponsor|4|||
149120125|NCT02706899|537918039|FG001|Overall Study|Study Termination by Sponsor|6|||
149120126|NCT00324675|537918040|FG000|Overall Study|Adverse Event|1|||
149120127|NCT00324675|537918041|FG001|Overall Study|Adverse Event|0|||
149120128|NCT00381615|537918042|FG000|Overall Study|Withdrawal by Subject|1|||
149120129|NCT00381615|537918043|FG001|Overall Study|Withdrawal by Subject|3|||
149120130|NCT00381615|537918044|FG002|Overall Study|Withdrawal by Subject|0|||
149120131|NCT00381615|537918045|FG003|Overall Study|Withdrawal by Subject|1|||
149120132|NCT00381615|537918042|FG000|Overall Study|Lost to Follow-up|3|||
149120133|NCT00381615|537918043|FG001|Overall Study|Lost to Follow-up|2|||
149120134|NCT00381615|537918044|FG002|Overall Study|Lost to Follow-up|0|||
149120135|NCT00381615|537918045|FG003|Overall Study|Lost to Follow-up|1|||
149120136|NCT00381615|537918042|FG000|Overall Study|Protocol Violation|0|||
149120137|NCT00381615|537918043|FG001|Overall Study|Protocol Violation|0|||
149120138|NCT00381615|537918044|FG002|Overall Study|Protocol Violation|1|||
149120139|NCT00381615|537918045|FG003|Overall Study|Protocol Violation|0|||
149120140|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|Death|1|||
149120141|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|Death|1|||
149120142|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
149120143|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
149120144|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
149120145|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
149120146|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
149120147|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
149120148|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
149120149|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
149120150|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
149120151|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
149120152|NCT00371683|537918046|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
149120153|NCT00371683|537918047|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
149120154|NCT00371683|537918046|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
149120155|NCT00371683|537918047|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
149120156|NCT00371683|537918046|FG000|Follow-Up Period - Randomized Patients|Death|0|||
149120157|NCT00371683|537918047|FG001|Follow-Up Period - Randomized Patients|Death|2|||
149120158|NCT00371683|537918046|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
149120159|NCT00371683|537918047|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
149120160|NCT00371683|537918046|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
149120161|NCT00371683|537918047|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
149120162|NCT03181789|537918049|FG000|Overall Study|Withdrawal by Subject|0|||
149120163|NCT03181789|537918050|FG001|Overall Study|Withdrawal by Subject|1|||
149120164|NCT03181789|537918051|FG002|Overall Study|Withdrawal by Subject|1|||
149120165|NCT03181789|537918052|FG003|Overall Study|Withdrawal by Subject|0|||
149120166|NCT03181789|537918049|FG000|Overall Study|Lost to Follow-up|7|||
149120167|NCT03181789|537918050|FG001|Overall Study|Lost to Follow-up|1|||
149120168|NCT03181789|537918051|FG002|Overall Study|Lost to Follow-up|0|||
149120169|NCT03181789|537918052|FG003|Overall Study|Lost to Follow-up|0|||
149120170|NCT03181789|537918049|FG000|Overall Study|Participant unable to adhere to visit|0|||
149120171|NCT03181789|537918050|FG001|Overall Study|Participant unable to adhere to visit|1|||
149120172|NCT03181789|537918051|FG002|Overall Study|Participant unable to adhere to visit|0|||
149120173|NCT03181789|537918052|FG003|Overall Study|Participant unable to adhere to visit|0|||
149120174|NCT01131182|537918053|FG000|Overall Study|Withdrawal by Subject|1|||
149120175|NCT01131182|537918054|FG001|Overall Study|Withdrawal by Subject|1|||
149120176|NCT01131182|537918053|FG000|Overall Study|Lost to Follow-up|14|||
149120177|NCT01131182|537918054|FG001|Overall Study|Lost to Follow-up|15|||
149120178|NCT01131182|537918053|FG000|Overall Study|Other Reason|1|||
149120179|NCT01131182|537918054|FG001|Overall Study|Other Reason|0|||
149120180|NCT03001076|537918055|FG000|Overall Study|Withdrawal by patient|2|||
149120181|NCT03001076|537918056|FG001|Overall Study|Withdrawal by patient|0|||
149120182|NCT03001076|537918055|FG000|Overall Study|Other|1|||
149120183|NCT03001076|537918056|FG001|Overall Study|Other|0|||
149120184|NCT03001076|537918055|FG000|Overall Study|Adverse Event|3|||
149120185|NCT03001076|537918056|FG001|Overall Study|Adverse Event|3|||
149120186|NCT03001076|537918055|FG000|Overall Study|Sponsor decision|1|||
149120187|NCT03001076|537918056|FG001|Overall Study|Sponsor decision|0|||
149120188|NCT03001076|537918055|FG000|Overall Study|Lost to Follow-up|0|||
149120189|NCT03001076|537918056|FG001|Overall Study|Lost to Follow-up|2|||
149120190|NCT04602221|537918057|FG000|Overall Study|Discontinuation of trial treatment|0|||
149120191|NCT04602221|537918058|FG001|Overall Study|Discontinuation of trial treatment|0|||
149120192|NCT04602221|537918059|FG002|Overall Study|Discontinuation of trial treatment|1|||
149120193|NCT04602221|537918060|FG003|Overall Study|Discontinuation of trial treatment|0|||
149120194|NCT04602221|537918061|FG004|Overall Study|Discontinuation of trial treatment|0|||
149120195|NCT04602221|537918062|FG005|Overall Study|Discontinuation of trial treatment|0|||
149120196|NCT04602221|537918063|FG006|Overall Study|Discontinuation of trial treatment|0|||
149120197|NCT04602221|537918064|FG007|Overall Study|Discontinuation of trial treatment|0|||
149120198|NCT04602221|537918065|FG008|Overall Study|Discontinuation of trial treatment|0|||
149120199|NCT04602221|537918066|FG009|Overall Study|Discontinuation of trial treatment|0|||
149120200|NCT04602221|537918067|FG010|Overall Study|Discontinuation of trial treatment|0|||
149120201|NCT04602221|537918068|FG011|Overall Study|Discontinuation of trial treatment|0|||
149120202|NCT04602221|537918069|FG012|Overall Study|Discontinuation of trial treatment|0|||
149120203|NCT04602221|537918070|FG013|Overall Study|Discontinuation of trial treatment|0|||
149120204|NCT04602221|537918071|FG014|Overall Study|Discontinuation of trial treatment|0|||
149120205|NCT04602221|537918072|FG015|Overall Study|Discontinuation of trial treatment|0|||
149120206|NCT04602221|537918073|FG016|Overall Study|Discontinuation of trial treatment|0|||
149120207|NCT04602221|537918074|FG017|Overall Study|Discontinuation of trial treatment|0|||
149120208|NCT04602221|537918057|FG000|Overall Study|Other than listed|0|||
149120209|NCT04602221|537918058|FG001|Overall Study|Other than listed|0|||
149120210|NCT04602221|537918059|FG002|Overall Study|Other than listed|0|||
149120226|NCT04602221|537918057|FG000|Overall Study|Withdrawal by Subject|0|||
149120227|NCT04602221|537918058|FG001|Overall Study|Withdrawal by Subject|0|||
149120228|NCT04602221|537918059|FG002|Overall Study|Withdrawal by Subject|0|||
149120229|NCT04602221|537918060|FG003|Overall Study|Withdrawal by Subject|0|||
149120230|NCT04602221|537918061|FG004|Overall Study|Withdrawal by Subject|0|||
149120231|NCT04602221|537918062|FG005|Overall Study|Withdrawal by Subject|0|||
149120232|NCT04602221|537918063|FG006|Overall Study|Withdrawal by Subject|0|||
149120233|NCT04602221|537918064|FG007|Overall Study|Withdrawal by Subject|0|||
149120234|NCT04602221|537918065|FG008|Overall Study|Withdrawal by Subject|0|||
149120235|NCT04602221|537918066|FG009|Overall Study|Withdrawal by Subject|0|||
149120236|NCT04602221|537918067|FG010|Overall Study|Withdrawal by Subject|0|||
149120237|NCT04602221|537918068|FG011|Overall Study|Withdrawal by Subject|0|||
149120238|NCT04602221|537918069|FG012|Overall Study|Withdrawal by Subject|1|||
149120239|NCT04602221|537918070|FG013|Overall Study|Withdrawal by Subject|0|||
149120240|NCT04602221|537918071|FG014|Overall Study|Withdrawal by Subject|0|||
149120241|NCT04602221|537918072|FG015|Overall Study|Withdrawal by Subject|0|||
149120242|NCT04602221|537918073|FG016|Overall Study|Withdrawal by Subject|0|||
149120243|NCT04602221|537918074|FG017|Overall Study|Withdrawal by Subject|0|||
149120244|NCT04602221|537918057|FG000|Overall Study|Lost to Follow-up|0|||
149120245|NCT04602221|537918058|FG001|Overall Study|Lost to Follow-up|0|||
149120246|NCT04602221|537918059|FG002|Overall Study|Lost to Follow-up|0|||
149120247|NCT04602221|537918060|FG003|Overall Study|Lost to Follow-up|0|||
149120248|NCT04602221|537918061|FG004|Overall Study|Lost to Follow-up|0|||
149120249|NCT04602221|537918062|FG005|Overall Study|Lost to Follow-up|1|||
149120250|NCT04602221|537918063|FG006|Overall Study|Lost to Follow-up|0|||
149120251|NCT04602221|537918064|FG007|Overall Study|Lost to Follow-up|0|||
149120252|NCT04602221|537918065|FG008|Overall Study|Lost to Follow-up|0|||
149120253|NCT04602221|537918066|FG009|Overall Study|Lost to Follow-up|0|||
149120254|NCT04602221|537918067|FG010|Overall Study|Lost to Follow-up|0|||
149120255|NCT04602221|537918068|FG011|Overall Study|Lost to Follow-up|0|||
149120256|NCT04602221|537918069|FG012|Overall Study|Lost to Follow-up|0|||
149120257|NCT04602221|537918070|FG013|Overall Study|Lost to Follow-up|0|||
149120258|NCT04602221|537918071|FG014|Overall Study|Lost to Follow-up|0|||
149120259|NCT04602221|537918072|FG015|Overall Study|Lost to Follow-up|0|||
149120260|NCT04602221|537918073|FG016|Overall Study|Lost to Follow-up|0|||
149120261|NCT04602221|537918074|FG017|Overall Study|Lost to Follow-up|0|||
149120262|NCT01080716|537918075|FG000|Part 1|Physician Decision|1|||
149120263|NCT01080716|537918076|FG001|Part 1|Physician Decision|0|||
149120264|NCT01080716|537918077|FG002|Part 1|Physician Decision|0|||
149120265|NCT01080716|537918078|FG003|Part 1|Physician Decision|0|||
149120266|NCT01056718|537918079|FG000|Overall Study|Withdrawal by Subject|2|||
149120267|NCT01056718|537918079|FG000|Overall Study|Ischemia on baseline stress test|1|||
149120268|NCT01139580|537918080|FG000|Overall Study|Adverse Event|5|||
149120269|NCT01139580|537918081|FG001|Overall Study|Adverse Event|4|||
149120270|NCT01139580|537918080|FG000|Overall Study|Lost to Follow-up|9|||
149120271|NCT01139580|537918081|FG001|Overall Study|Lost to Follow-up|1|||
149120272|NCT01139580|537918080|FG000|Overall Study|Lack of Efficacy|0|||
149120273|NCT01139580|537918081|FG001|Overall Study|Lack of Efficacy|2|||
149120274|NCT01139580|537918080|FG000|Overall Study|Withdrawal by Subject|6|||
149120275|NCT01139580|537918081|FG001|Overall Study|Withdrawal by Subject|9|||
149120276|NCT01139580|537918080|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
149120277|NCT01139580|537918081|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
149120278|NCT01139580|537918080|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
149120279|NCT01139580|537918081|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
149120280|NCT01139580|537918080|FG000|Overall Study|Misrandomized|1|||
149120281|NCT01139580|537918081|FG001|Overall Study|Misrandomized|0|||
149120282|NCT01139580|537918080|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
149120283|NCT01139580|537918081|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
149120284|NCT01139580|537918080|FG000|Overall Study|Participant Randomization in Error|0|||
149120285|NCT01139580|537918081|FG001|Overall Study|Participant Randomization in Error|1|||
149120286|NCT00633880|537918082|FG000|Open Label Titration|Lack of Efficacy|1|||
149120287|NCT00633880|537918083|FG001|Open Label Titration|Lack of Efficacy|0|||
149120288|NCT00633880|537918084|FG002|Open Label Titration|Lack of Efficacy|0|||
149120289|NCT00633880|537918082|FG000|Open Label Titration|Adverse Event|13|||
149120290|NCT00633880|537918083|FG001|Open Label Titration|Adverse Event|0|||
149120291|NCT00633880|537918084|FG002|Open Label Titration|Adverse Event|0|||
149120292|NCT00633880|537918082|FG000|Open Label Titration|Treatment Failure|55|||
149120293|NCT00633880|537918083|FG001|Open Label Titration|Treatment Failure|0|||
149120294|NCT00633880|537918084|FG002|Open Label Titration|Treatment Failure|0|||
149120295|NCT00633880|537918082|FG000|Open Label Titration|Protocol Violation|6|||
149120296|NCT00633880|537918083|FG001|Open Label Titration|Protocol Violation|0|||
149120297|NCT00633880|537918084|FG002|Open Label Titration|Protocol Violation|0|||
149120298|NCT00633880|537918082|FG000|Open Label Titration|Physician Decision|1|||
149120299|NCT00633880|537918083|FG001|Open Label Titration|Physician Decision|0|||
149120300|NCT00633880|537918084|FG002|Open Label Titration|Physician Decision|0|||
149120301|NCT00633880|537918082|FG000|Open Label Titration|Withdrawal by Subject|4|||
149120302|NCT00633880|537918083|FG001|Open Label Titration|Withdrawal by Subject|0|||
149120303|NCT00633880|537918084|FG002|Open Label Titration|Withdrawal by Subject|0|||
149120304|NCT00700778|537918085|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
149120305|NCT00350103|537918086|FG000|Overall Study|Adverse Event|12|||
149120306|NCT00350103|537918087|FG001|Overall Study|Adverse Event|29|||
149120307|NCT00350103|537918088|FG002|Overall Study|Adverse Event|17|||
149120308|NCT00350103|537918086|FG000|Overall Study|Lack of Efficacy|5|||
149120309|NCT00350103|537918087|FG001|Overall Study|Lack of Efficacy|1|||
149120310|NCT00350103|537918088|FG002|Overall Study|Lack of Efficacy|3|||
149120311|NCT00350103|537918086|FG000|Overall Study|Withdrawal by Subject|6|||
149120312|NCT00350103|537918087|FG001|Overall Study|Withdrawal by Subject|6|||
149120313|NCT00350103|537918088|FG002|Overall Study|Withdrawal by Subject|8|||
149120314|NCT00350103|537918086|FG000|Overall Study|Protocol Violation|0|||
149120315|NCT00350103|537918087|FG001|Overall Study|Protocol Violation|0|||
149120316|NCT00350103|537918088|FG002|Overall Study|Protocol Violation|1|||
149120317|NCT00350103|537918086|FG000|Overall Study|Unsatisfactory Compliance|2|||
149120318|NCT00350103|537918087|FG001|Overall Study|Unsatisfactory Compliance|2|||
149120319|NCT00350103|537918088|FG002|Overall Study|Unsatisfactory Compliance|1|||
149120320|NCT00350103|537918086|FG000|Overall Study|Investigator´s decision|1|||
149120321|NCT00350103|537918087|FG001|Overall Study|Investigator´s decision|1|||
149120322|NCT00350103|537918088|FG002|Overall Study|Investigator´s decision|0|||
149120323|NCT00350103|537918086|FG000|Overall Study|Exclusion criteria met|0|||
149120324|NCT00350103|537918087|FG001|Overall Study|Exclusion criteria met|0|||
149120325|NCT00350103|537918088|FG002|Overall Study|Exclusion criteria met|1|||
149120326|NCT00350103|537918086|FG000|Overall Study|Patient relocated|0|||
149120327|NCT00350103|537918087|FG001|Overall Study|Patient relocated|0|||
149120328|NCT00350103|537918088|FG002|Overall Study|Patient relocated|1|||
149120329|NCT00350103|537918086|FG000|Overall Study|Need for prohibited medication|1|||
149120330|NCT00350103|537918087|FG001|Overall Study|Need for prohibited medication|0|||
149120331|NCT00350103|537918088|FG002|Overall Study|Need for prohibited medication|0|||
149120332|NCT00350103|537918086|FG000|Overall Study|Personal reasons|0|||
149120333|NCT00350103|537918087|FG001|Overall Study|Personal reasons|0|||
149120334|NCT00350103|537918088|FG002|Overall Study|Personal reasons|1|||
149120335|NCT00350103|537918086|FG000|Overall Study|Patient stopped feeling pain|1|||
149120336|NCT00350103|537918087|FG001|Overall Study|Patient stopped feeling pain|0|||
149120337|NCT00350103|537918088|FG002|Overall Study|Patient stopped feeling pain|0|||
149120338|NCT00350103|537918086|FG000|Overall Study|PR greater than 250ms|0|||
149120339|NCT00350103|537918087|FG001|Overall Study|PR greater than 250ms|0|||
149120340|NCT00350103|537918088|FG002|Overall Study|PR greater than 250ms|1|||
149120341|NCT00350103|537918086|FG000|Overall Study|Wrong calculation of QT interval|0|||
149120342|NCT00350103|537918087|FG001|Overall Study|Wrong calculation of QT interval|0|||
149120343|NCT00350103|537918088|FG002|Overall Study|Wrong calculation of QT interval|1|||
149120344|NCT00350103|537918086|FG000|Overall Study|Sponsor mistake|1|||
149120345|NCT00350103|537918087|FG001|Overall Study|Sponsor mistake|0|||
149120346|NCT00350103|537918088|FG002|Overall Study|Sponsor mistake|0|||
149120347|NCT00350103|537918086|FG000|Overall Study|Randomization mistake|0|||
149120348|NCT00350103|537918087|FG001|Overall Study|Randomization mistake|1|||
149120349|NCT00350103|537918088|FG002|Overall Study|Randomization mistake|1|||
149120350|NCT00350103|537918086|FG000|Overall Study|Sponsor´s decision|0|||
149120351|NCT00350103|537918087|FG001|Overall Study|Sponsor´s decision|1|||
149120352|NCT00350103|537918088|FG002|Overall Study|Sponsor´s decision|0|||
149120353|NCT00350103|537918086|FG000|Overall Study|Lost, Reason unknown|1|||
149120354|NCT00350103|537918087|FG001|Overall Study|Lost, Reason unknown|1|||
149120355|NCT00350103|537918088|FG002|Overall Study|Lost, Reason unknown|0|||
149120356|NCT02842151|537918089|FG000|Overall Study|Adverse Event|1|||
149120357|NCT02842151|537918089|FG000|Overall Study|Subject moved too far away|1|||
149120358|NCT02559895|537918090|FG000|Overall Study|Adverse Event|3|||
149120359|NCT02559895|537918091|FG001|Overall Study|Adverse Event|3|||
149120360|NCT02559895|537918092|FG002|Overall Study|Adverse Event|2|||
149120361|NCT02559895|537918093|FG003|Overall Study|Adverse Event|1|||
149120362|NCT02559895|537918090|FG000|Overall Study|Lack of Efficacy|2|||
149120363|NCT02559895|537918091|FG001|Overall Study|Lack of Efficacy|3|||
149120364|NCT02559895|537918092|FG002|Overall Study|Lack of Efficacy|2|||
149120365|NCT02559895|537918093|FG003|Overall Study|Lack of Efficacy|8|||
149120366|NCT02559895|537918090|FG000|Overall Study|Lost to Follow-up|22|||
149120367|NCT02559895|537918091|FG001|Overall Study|Lost to Follow-up|16|||
149120368|NCT02559895|537918092|FG002|Overall Study|Lost to Follow-up|12|||
149120369|NCT02559895|537918093|FG003|Overall Study|Lost to Follow-up|17|||
149120370|NCT02559895|537918090|FG000|Overall Study|Physician Decision|1|||
149120371|NCT02559895|537918091|FG001|Overall Study|Physician Decision|1|||
149120372|NCT02559895|537918092|FG002|Overall Study|Physician Decision|3|||
149120373|NCT02559895|537918093|FG003|Overall Study|Physician Decision|0|||
149120374|NCT02559895|537918090|FG000|Overall Study|Withdrawal by Subject|16|||
149120375|NCT02559895|537918091|FG001|Overall Study|Withdrawal by Subject|9|||
149120376|NCT02559895|537918092|FG002|Overall Study|Withdrawal by Subject|20|||
149120377|NCT02559895|537918093|FG003|Overall Study|Withdrawal by Subject|9|||
149120378|NCT02559895|537918090|FG000|Overall Study|Study Burden|10|||
149120379|NCT02559895|537918091|FG001|Overall Study|Study Burden|16|||
149120386|NCT00760474|537918094|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
149120387|NCT00760474|537918095|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
149120388|NCT00760474|537918094|FG000|Placebo Washout Period|Other|0|||
149120389|NCT00760474|537918095|FG001|Placebo Washout Period|Other|1|||
149120390|NCT00760474|537918094|FG000|Period 2 (P2)|Lost to Follow-up|1|||
149120391|NCT00760474|537918095|FG001|Period 2 (P2)|Lost to Follow-up|0|||
149120392|NCT00760474|537918094|FG000|Period 2 (P2)|Adverse Event|0|||
149120393|NCT00760474|537918095|FG001|Period 2 (P2)|Adverse Event|1|||
149120394|NCT02432196|537918096|FG000|Overall Study|Exit - did not receive study device|1|||
149120395|NCT02432196|537918096|FG000|Overall Study|Death|2|||
149120396|NCT02432196|537918096|FG000|Overall Study|Reoperation|3|||
149120397|NCT01905150|537918097|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
149120398|NCT01905150|537918098|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
149120399|NCT00611975|537918101|FG000|Overall Study|Withdrawal by Subject|3|||
149120400|NCT00611975|537918102|FG001|Overall Study|Withdrawal by Subject|7|||
149120401|NCT00611975|537918101|FG000|Overall Study|Pregnancy|2|||
149120402|NCT00611975|537918102|FG001|Overall Study|Pregnancy|1|||
149120403|NCT03465904|537918103|FG000|Overall Study|Withdrawal by Subject|9|||
149120404|NCT03465904|537918104|FG001|Overall Study|Withdrawal by Subject|5|||
149120405|NCT03465904|537918103|FG000|Overall Study|Lost to Follow-up|11|||
149120406|NCT03465904|537918104|FG001|Overall Study|Lost to Follow-up|9|||
149120407|NCT03465904|537918103|FG000|Overall Study|Protocol Violation|20|||
149120408|NCT03465904|537918104|FG001|Overall Study|Protocol Violation|15|||
149120409|NCT01305200|537918105|FG000|Overall Study|Physician Decision|4|||
149120410|NCT01305200|537918106|FG001|Overall Study|Physician Decision|6|||
149120411|NCT01305200|537918107|FG002|Overall Study|Physician Decision|1|||
149120412|NCT01305200|537918105|FG000|Overall Study|Withdrawal by Subject|24|||
149120413|NCT01305200|537918106|FG001|Overall Study|Withdrawal by Subject|21|||
149120414|NCT01305200|537918107|FG002|Overall Study|Withdrawal by Subject|1|||
149120415|NCT01305200|537918105|FG000|Overall Study|Ineligible|1|||
149120416|NCT01305200|537918106|FG001|Overall Study|Ineligible|2|||
149120417|NCT01305200|537918107|FG002|Overall Study|Ineligible|1|||
149120418|NCT01305200|537918105|FG000|Overall Study|Death|0|||
149120419|NCT01305200|537918106|FG001|Overall Study|Death|2|||
149120420|NCT01305200|537918107|FG002|Overall Study|Death|0|||
